id|nct_id|result_group_id|ctgov_group_code|period|reason|count
2432232|NCT04336475|8327401|P2|Overall Study|Lost to Follow-up|2
2432233|NCT04336475|8327402|P1|Overall Study|Lost to Follow-up|0
2432234|NCT04336475|8327401|P2|Overall Study|upper respiratory infection|0
2432235|NCT04336475|8327402|P1|Overall Study|upper respiratory infection|1
2432236|NCT04336475|8327401|P2|Overall Study|pain|0
2432237|NCT04336475|8327402|P1|Overall Study|pain|1
2432238|NCT04322526|8327410|P2|Washout (1 Week)|Lost to Follow-up|2
2432239|NCT04322526|8327411|P1|Washout (1 Week)|Lost to Follow-up|1
2432240|NCT04322526|8327410|P2|First Intervention (1 Day)|Withdrawal by Subject|1
2432241|NCT04322526|8327411|P1|First Intervention (1 Day)|Withdrawal by Subject|1
2432242|NCT04287517|8327430|P2|Overall Study|Withdrawal by Subject|1
2432243|NCT04287517|8327431|P1|Overall Study|Withdrawal by Subject|1
2432244|NCT04272775|8327447|P2|Overall Study|Progressive Disease|1
2432245|NCT04272775|8327448|P1|Overall Study|Progressive Disease|3
2432246|NCT04272775|8327447|P2|Overall Study|Adverse Event|2
2432247|NCT04272775|8327448|P1|Overall Study|Adverse Event|1
2432248|NCT04272775|8327447|P2|Overall Study|Withdrawal by Subject|2
2432249|NCT04272775|8327448|P1|Overall Study|Withdrawal by Subject|1
2432250|NCT04272775|8327447|P2|Overall Study|Symptomatic Deterioration|1
2432251|NCT04272775|8327448|P1|Overall Study|Symptomatic Deterioration|1
2432252|NCT04272775|8327447|P2|Overall Study|Protocol Violation|1
2432253|NCT04272775|8327448|P1|Overall Study|Protocol Violation|0
2432254|NCT04272775|8327447|P2|Overall Study|Study Terminated by Sponsor|0
2432255|NCT04272775|8327448|P1|Overall Study|Study Terminated by Sponsor|1
2432256|NCT04222699|8327488|P1|Overall Study|Lost to Follow-up|2
2432257|NCT04179838|8327544|P2|Second Intervention (1 Day)|Protocol Violation|1
2432258|NCT04179838|8327545|P1|Second Intervention (1 Day)|Protocol Violation|0
2432259|NCT04179838|8327544|P2|First Intervention (1 Day)|Withdrawal by Subject|3
2432260|NCT04179838|8327545|P1|First Intervention (1 Day)|Withdrawal by Subject|0
2432261|NCT04149353|8327692|P1|Overall Study|Study terminated|1
2432262|NCT04123665|8327729|P2|Overall Study|Lost to Follow-up|0
2432263|NCT04123665|8327730|P1|Overall Study|Lost to Follow-up|1
2432264|NCT04123665|8327729|P2|Overall Study|Withdrawal by Subject|0
2432265|NCT04123665|8327730|P1|Overall Study|Withdrawal by Subject|7
2432266|NCT04106817|8327794|P3|Overall Study|Lost to Follow-up|0
2432267|NCT04106817|8327795|P2|Overall Study|Lost to Follow-up|0
2432268|NCT04106817|8327796|P1|Overall Study|Lost to Follow-up|1
2432269|NCT04098809|8327812|P2|Overall Study|Physician Decision|1
2432270|NCT04098809|8327813|P1|Overall Study|Physician Decision|2
2432271|NCT04098809|8327812|P2|Overall Study|Withdrawal by Subject|3
2432272|NCT04098809|8327813|P1|Overall Study|Withdrawal by Subject|1
2432273|NCT04091659|8327841|P2|Overall Study|Lost to Follow-up|1
2432274|NCT04091659|8327842|P1|Overall Study|Lost to Follow-up|0
2432275|NCT04091659|8327841|P2|Overall Study|Protocol Violation|0
2432276|NCT04091659|8327842|P1|Overall Study|Protocol Violation|3
2432277|NCT04080297|8327892|P2|Overall Study|concurrent illness|0
2432278|NCT04080297|8327893|P1|Overall Study|concurrent illness|1
2432279|NCT04080297|8327892|P2|Overall Study|Adverse Event|3
2432280|NCT04080297|8327893|P1|Overall Study|Adverse Event|1
2432281|NCT04053465|8328013|P2|Overall Study|Withdrawal by Subject|4
2432282|NCT04053465|8328014|P1|Overall Study|Withdrawal by Subject|4
2432283|NCT04048681|8328056|P5|Overall Study|family emergency|0
2432284|NCT04048681|8328057|P4|Overall Study|family emergency|1
2432285|NCT04048681|8328058|P3|Overall Study|family emergency|0
2432286|NCT04048681|8328059|P2|Overall Study|family emergency|0
2432287|NCT04048681|8328060|P1|Overall Study|family emergency|0
2432288|NCT04035564|8328134|P2|Overall Study|Guardian declined consent|2
2432289|NCT04035564|8328135|P1|Overall Study|Guardian declined consent|1
2432290|NCT04035564|8328134|P2|Overall Study|No laboratory available|2
2432291|NCT04035564|8328135|P1|Overall Study|No laboratory available|2
2432292|NCT04035564|8328134|P2|Overall Study|Protocol Violation|2
2432293|NCT04035564|8328135|P1|Overall Study|Protocol Violation|1
2432294|NCT04032652|8328166|P2|Overall Study|The study was terminated and the PI has|1
2432295|NCT04032652|8328167|P1|Overall Study|The study was terminated and the PI has|1
2432296|NCT04015232|8328275|P2|Overall Study|Medical Grounds|3
2432297|NCT04015232|8328276|P1|Overall Study|Medical Grounds|3
2432298|NCT04015232|8328275|P2|Overall Study|Protocol Violation|0
2432299|NCT04015232|8328276|P1|Overall Study|Protocol Violation|1
2432300|NCT04015232|8328275|P2|Overall Study|Withdrawal by Subject|4
2432301|NCT04015232|8328276|P1|Overall Study|Withdrawal by Subject|7
2432302|NCT04014062|8328348|P2|Period I: Dosing|Withdrawal by Subject|1
2432303|NCT04014062|8328349|P1|Period I: Dosing|Withdrawal by Subject|3
2432304|NCT04014062|8328348|P2|Period I: Dosing|Medical Grounds|5
2432305|NCT04014062|8328349|P1|Period I: Dosing|Medical Grounds|4
2432306|NCT04002648|8328404|P2|Overall Study|Lost to Follow-up|0
2432307|NCT04002648|8328405|P1|Overall Study|Lost to Follow-up|2
2432308|NCT04000815|8328416|P3|Overall Study|Hypertension occured on follow up|2
2432309|NCT04000815|8328417|P2|Overall Study|Hypertension occured on follow up|0
2432310|NCT04000815|8328418|P1|Overall Study|Hypertension occured on follow up|0
2432311|NCT04000815|8328416|P3|Overall Study|Right ovarian cyst occured|0
2432312|NCT04000815|8328417|P2|Overall Study|Right ovarian cyst occured|0
2432313|NCT04000815|8328418|P1|Overall Study|Right ovarian cyst occured|1
2432314|NCT04000815|8328416|P3|Overall Study|Withdrawal by Subject|2
2432315|NCT04000815|8328417|P2|Overall Study|Withdrawal by Subject|3
2432316|NCT04000815|8328418|P1|Overall Study|Withdrawal by Subject|4
2432317|NCT04000815|8328416|P3|Overall Study|Lost to Follow-up|3
2432318|NCT04000815|8328417|P2|Overall Study|Lost to Follow-up|2
2432319|NCT04000815|8328418|P1|Overall Study|Lost to Follow-up|9
2432320|NCT03982433|8328501|P1|Overall Study|Lost to Follow-up|1
2432321|NCT03966365|8328805|P2|Overall Study|Protocol Violation|0
2432322|NCT03966365|8328806|P1|Overall Study|Protocol Violation|1
2432323|NCT03965403|8328824|P1|Overall Study|Subject not meeting eligibility criteria|1
2432324|NCT03965052|8328837|P2|Overall Study|Protocol Violation|0
2432325|NCT03965052|8328838|P1|Overall Study|Protocol Violation|1
2432326|NCT03961308|8328858|P2|Overall Study|Adverse Event|1
2432327|NCT03961308|8328859|P1|Overall Study|Adverse Event|0
2432328|NCT03961308|8328858|P2|Overall Study|Lost to Follow-up|1
2432329|NCT03961308|8328859|P1|Overall Study|Lost to Follow-up|0
2432330|NCT03961308|8328858|P2|Overall Study|Other|0
2432331|NCT03961308|8328859|P1|Overall Study|Other|1
2432332|NCT03961308|8328858|P2|Overall Study|Withdrawal by Subject|0
2432333|NCT03961308|8328859|P1|Overall Study|Withdrawal by Subject|1
2432334|NCT03948581|8328897|P2|Overall Study|Lost to Follow-up|1
2432335|NCT03948581|8328898|P1|Overall Study|Lost to Follow-up|0
2432336|NCT03946124|8328908|P1|Overall Study|Withdrawal by Subject|19
2432337|NCT03933449|8329173|P2|Overall Study|Ongoing in Study|6
2432338|NCT03933449|8329174|P1|Overall Study|Ongoing in Study|20
2432339|NCT03933449|8329173|P2|Overall Study|Death|51
2432340|NCT03933449|8329174|P1|Overall Study|Death|36
2432341|NCT03933449|8329173|P2|Overall Study|Adverse Event|4
2432342|NCT03933449|8329174|P1|Overall Study|Adverse Event|6
2432343|NCT03927950|8329196|P1|Overall Study|Adverse Event|9
2432344|NCT03923933|8329203|P2|Overall Study|Withdrawal by Subject|1
2432345|NCT03923933|8329204|P1|Overall Study|Withdrawal by Subject|0
2432346|NCT03923933|8329203|P2|Overall Study|Lost to Follow-up|0
2432347|NCT03923933|8329204|P1|Overall Study|Lost to Follow-up|1
2432348|NCT03905642|8329244|P1|Overall Study|Completed study but not 24 of 28 days|2
2432349|NCT03905642|8329244|P1|Overall Study|Lack of Efficacy|1
2432350|NCT03905642|8329244|P1|Overall Study|Adverse Event|1
2432351|NCT03905642|8329244|P1|Overall Study|Pregnancy|1
2432352|NCT03905642|8329244|P1|Overall Study|Withdrawal by Subject|3
2432353|NCT03902392|8329255|P2|Overall Study|Lost to Follow-up|7
2432354|NCT03902392|8329256|P1|Overall Study|Lost to Follow-up|7
2432355|NCT03899064|8329296|P1|Overall Study|Other|2
2432356|NCT03899064|8329296|P1|Overall Study|Withdrawal by Subject|2
2432357|NCT03899064|8329296|P1|Overall Study|Protocol Violation|2
2432358|NCT03899064|8329296|P1|Overall Study|Lost to Follow-up|1
2432359|NCT03897179|8329311|P1|Overall Study|Withdrawal by Subject|1
2432360|NCT03892564|8329436|P1|Overall Study|Withdrawal by Subject|2
2432361|NCT03888391|8329463|P1|Overall Study|Lost to Follow-up|15
2432362|NCT03882047|8329494|P3|Overall Study|Did Not Meet Eligibility|1
2432363|NCT03882047|8329495|P2|Overall Study|Did Not Meet Eligibility|0
2432364|NCT03882047|8329496|P1|Overall Study|Did Not Meet Eligibility|0
2432365|NCT03882047|8329494|P3|Overall Study|Noncompliance With Protocol|0
2432366|NCT03882047|8329495|P2|Overall Study|Noncompliance With Protocol|0
2432367|NCT03882047|8329496|P1|Overall Study|Noncompliance With Protocol|2
2432368|NCT03882047|8329494|P3|Overall Study|Did Not Wish to Continue|1
2432369|NCT03882047|8329495|P2|Overall Study|Did Not Wish to Continue|4
2432370|NCT03882047|8329496|P1|Overall Study|Did Not Wish to Continue|1
2432371|NCT03882047|8329494|P3|Overall Study|Lost to Follow-up|0
2432372|NCT03882047|8329495|P2|Overall Study|Lost to Follow-up|1
2432373|NCT03882047|8329496|P1|Overall Study|Lost to Follow-up|0
2432374|NCT03882047|8329494|P3|Overall Study|Treatment Failure|12
2432375|NCT03882047|8329495|P2|Overall Study|Treatment Failure|3
2432376|NCT03882047|8329496|P1|Overall Study|Treatment Failure|3
2432377|NCT03882047|8329494|P3|Overall Study|Adverse Event|2
2432378|NCT03882047|8329495|P2|Overall Study|Adverse Event|2
2432379|NCT03882047|8329496|P1|Overall Study|Adverse Event|0
2432380|NCT03879772|8329552|P5|Overall Study|Did Not Meet Entry Requirements|0
2432381|NCT03879772|8329553|P4|Overall Study|Did Not Meet Entry Requirements|0
2432382|NCT03879772|8329554|P3|Overall Study|Did Not Meet Entry Requirements|1
2432383|NCT03879772|8329555|P2|Overall Study|Did Not Meet Entry Requirements|0
2432384|NCT03879772|8329556|P1|Overall Study|Did Not Meet Entry Requirements|1
2432385|NCT03879772|8329552|P5|Overall Study|Protocol Violation|2
2432386|NCT03879772|8329553|P4|Overall Study|Protocol Violation|1
2432387|NCT03879772|8329554|P3|Overall Study|Protocol Violation|3
2432388|NCT03879772|8329555|P2|Overall Study|Protocol Violation|0
2432389|NCT03879772|8329556|P1|Overall Study|Protocol Violation|0
2432390|NCT03879772|8329552|P5|Overall Study|Withdrawal by Subject|1
2432391|NCT03879772|8329553|P4|Overall Study|Withdrawal by Subject|1
2432392|NCT03879772|8329554|P3|Overall Study|Withdrawal by Subject|3
2432393|NCT03879772|8329555|P2|Overall Study|Withdrawal by Subject|1
2432394|NCT03879772|8329556|P1|Overall Study|Withdrawal by Subject|0
2432395|NCT03879772|8329552|P5|Overall Study|Lost to Follow-up|1
2432396|NCT03879772|8329553|P4|Overall Study|Lost to Follow-up|0
2432397|NCT03879772|8329554|P3|Overall Study|Lost to Follow-up|0
2432398|NCT03879772|8329555|P2|Overall Study|Lost to Follow-up|0
2432399|NCT03879772|8329556|P1|Overall Study|Lost to Follow-up|0
2432400|NCT03879772|8329552|P5|Overall Study|Treatment Failure|1
2432401|NCT03879772|8329553|P4|Overall Study|Treatment Failure|2
2432402|NCT03879772|8329554|P3|Overall Study|Treatment Failure|0
2432403|NCT03879772|8329555|P2|Overall Study|Treatment Failure|0
2432404|NCT03879772|8329556|P1|Overall Study|Treatment Failure|1
2432405|NCT03879772|8329552|P5|Overall Study|Adverse Event|3
2432406|NCT03879772|8329553|P4|Overall Study|Adverse Event|4
2432407|NCT03879772|8329554|P3|Overall Study|Adverse Event|3
2432408|NCT03879772|8329555|P2|Overall Study|Adverse Event|2
2432409|NCT03879772|8329556|P1|Overall Study|Adverse Event|2
2432410|NCT03878758|8329593|P1|Overall Study|Improper consent documentation|1
2432411|NCT03878758|8329593|P1|Overall Study|Protocol defined|2
2432412|NCT03878758|8329593|P1|Overall Study|Withdrawal by Subject|1
2432413|NCT03868631|8329647|P2|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1
2432414|NCT03868631|8329648|P1|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1
2432415|NCT03868631|8329647|P2|Week 6 to Week 12 (Study Completion)|Protocol Violation|0
2432416|NCT03868631|8329648|P1|Week 6 to Week 12 (Study Completion)|Protocol Violation|1
2432417|NCT03868631|8329647|P2|Week 6 to Week 12 (Study Completion)|Adverse Event|0
2432418|NCT03868631|8329648|P1|Week 6 to Week 12 (Study Completion)|Adverse Event|2
2432419|NCT03868631|8329647|P2|Baseline to Week 6|Withdrawal by Subject|0
2432420|NCT03868631|8329648|P1|Baseline to Week 6|Withdrawal by Subject|3
2432421|NCT03868631|8329647|P2|Baseline to Week 6|Protocol Violation|1
2432422|NCT03868631|8329648|P1|Baseline to Week 6|Protocol Violation|1
2432423|NCT03868631|8329647|P2|Baseline to Week 6|Adverse Event|3
2432424|NCT03868631|8329648|P1|Baseline to Week 6|Adverse Event|0
2432425|NCT03861559|8329678|P2|Overall Study|Did not meet eligibility requirements|0
2432426|NCT03861559|8329679|P1|Overall Study|Did not meet eligibility requirements|1
2432427|NCT03861559|8329678|P2|Overall Study|Noncompliance|1
2432428|NCT03861559|8329679|P1|Overall Study|Noncompliance|1
2432429|NCT03861559|8329678|P2|Overall Study|Treatment failure|2
2432430|NCT03861559|8329679|P1|Overall Study|Treatment failure|0
2432431|NCT03861559|8329678|P2|Overall Study|Adverse Event|2
2432432|NCT03861559|8329679|P1|Overall Study|Adverse Event|0
2432433|NCT03855228|8329767|P4|Overall Study|Did Not Meet Entry Requirements|1
2432434|NCT03855228|8329768|P3|Overall Study|Did Not Meet Entry Requirements|1
2432435|NCT03855228|8329769|P2|Overall Study|Did Not Meet Entry Requirements|2
2432436|NCT03855228|8329770|P1|Overall Study|Did Not Meet Entry Requirements|0
2432437|NCT03855228|8329767|P4|Overall Study|Protocol Violation|1
2432438|NCT03855228|8329768|P3|Overall Study|Protocol Violation|2
2432439|NCT03855228|8329769|P2|Overall Study|Protocol Violation|1
2432440|NCT03855228|8329770|P1|Overall Study|Protocol Violation|0
2432441|NCT03855228|8329767|P4|Overall Study|Lost to Follow-up|1
2432442|NCT03855228|8329768|P3|Overall Study|Lost to Follow-up|0
2432443|NCT03855228|8329769|P2|Overall Study|Lost to Follow-up|0
2432444|NCT03855228|8329770|P1|Overall Study|Lost to Follow-up|0
2432445|NCT03855228|8329767|P4|Overall Study|Treatment Failure|8
2432446|NCT03855228|8329768|P3|Overall Study|Treatment Failure|1
2432447|NCT03855228|8329769|P2|Overall Study|Treatment Failure|2
2432448|NCT03855228|8329770|P1|Overall Study|Treatment Failure|1
2432449|NCT03855228|8329767|P4|Overall Study|Adverse Event|8
2432450|NCT03855228|8329768|P3|Overall Study|Adverse Event|4
2432451|NCT03855228|8329769|P2|Overall Study|Adverse Event|4
2432452|NCT03855228|8329770|P1|Overall Study|Adverse Event|2
2432453|NCT03855189|8329819|P3|Overall Study|Did Not Return|0
2432454|NCT03855189|8329820|P2|Overall Study|Did Not Return|3
2432455|NCT03855189|8329821|P1|Overall Study|Did Not Return|4
2432456|NCT03855189|8329819|P3|Overall Study|Noncompliance with Protocol|0
2432457|NCT03855189|8329820|P2|Overall Study|Noncompliance with Protocol|1
2432458|NCT03855189|8329821|P1|Overall Study|Noncompliance with Protocol|0
2432459|NCT03855189|8329819|P3|Overall Study|Treatment Failure|2
2432460|NCT03855189|8329820|P2|Overall Study|Treatment Failure|1
2432461|NCT03855189|8329821|P1|Overall Study|Treatment Failure|1
2432462|NCT03855189|8329819|P3|Overall Study|Adverse Event|4
2432463|NCT03855189|8329820|P2|Overall Study|Adverse Event|2
2432464|NCT03855189|8329821|P1|Overall Study|Adverse Event|5
2432465|NCT03850496|8329940|P3|Overall Study|Lost to Follow-up|4
2432466|NCT03850496|8329941|P2|Overall Study|Lost to Follow-up|1
2432467|NCT03850496|8329942|P1|Overall Study|Lost to Follow-up|0
2432468|NCT03850496|8329940|P3|Overall Study|Withdrawal by Subject|0
2432469|NCT03850496|8329941|P2|Overall Study|Withdrawal by Subject|0
2432470|NCT03850496|8329942|P1|Overall Study|Withdrawal by Subject|1
2432471|NCT03850444|8329952|P2|Overall Study|Ongoing in Study|59
2432472|NCT03850444|8329953|P1|Overall Study|Ongoing in Study|78
2432473|NCT03850444|8329952|P2|Overall Study|Withdrawal by Subject|1
2432474|NCT03850444|8329953|P1|Overall Study|Withdrawal by Subject|0
2432475|NCT03850444|8329952|P2|Overall Study|Lost to Follow-up|1
2432476|NCT03850444|8329953|P1|Overall Study|Lost to Follow-up|0
2432477|NCT03850444|8329952|P2|Overall Study|Death|64
2432478|NCT03850444|8329953|P1|Overall Study|Death|38
2432479|NCT03850444|8329952|P2|Overall Study|Adverse Event|9
2432480|NCT03850444|8329953|P1|Overall Study|Adverse Event|12
2432481|NCT03850093|8329982|P3|Overall Study|Withdrawal by Subject|2
2432482|NCT03850093|8329983|P2|Overall Study|Withdrawal by Subject|0
2432483|NCT03850093|8329984|P1|Overall Study|Withdrawal by Subject|1
2432484|NCT03849300|8330023|P4|Overall Study|scheduling/transportation conflict|2
2432485|NCT03849300|8330024|P3|Overall Study|scheduling/transportation conflict|3
2432486|NCT03849300|8330025|P2|Overall Study|scheduling/transportation conflict|4
2432487|NCT03849300|8330026|P1|Overall Study|scheduling/transportation conflict|4
2432488|NCT03849300|8330023|P4|Overall Study|move out to different area|4
2432489|NCT03849300|8330024|P3|Overall Study|move out to different area|1
2432490|NCT03849300|8330025|P2|Overall Study|move out to different area|3
2432491|NCT03849300|8330026|P1|Overall Study|move out to different area|1
2432492|NCT03836729|8330165|P1|Treatment Period 2 (Up to Day 7)|Adverse Event|1
2432493|NCT03836664|8330279|P2|Overall Study|Didn't complete forms and lost drug|3
2432494|NCT03836664|8330280|P1|Overall Study|Didn't complete forms and lost drug|3
2432495|NCT03832387|8330292|P2|Overall Study|EXCLUSION CRITERIA|1
2432496|NCT03832387|8330293|P1|Overall Study|EXCLUSION CRITERIA|3
2432497|NCT03832387|8330292|P2|Overall Study|Protocol Violation|6
2432498|NCT03832387|8330293|P1|Overall Study|Protocol Violation|2
2432499|NCT03832322|8330323|P2|Overall Study|Failed cecal intubation in 2nd exam|1
2432500|NCT03832322|8330324|P1|Overall Study|Failed cecal intubation in 2nd exam|3
2432501|NCT03831282|8330341|P1|Overall Study|Could not place sensor|1
2432502|NCT03824912|8330391|P3|Overall Study|Participation in another study|0
2432503|NCT03824912|8330392|P2|Overall Study|Participation in another study|1
2432504|NCT03824912|8330393|P1|Overall Study|Participation in another study|0
2432505|NCT03824912|8330391|P3|Overall Study|Withdrawal by Subject|1
2432506|NCT03824912|8330392|P2|Overall Study|Withdrawal by Subject|2
2432507|NCT03824912|8330393|P1|Overall Study|Withdrawal by Subject|3
2432508|NCT03824912|8330391|P3|Overall Study|Protocol Violation|1
2432509|NCT03824912|8330392|P2|Overall Study|Protocol Violation|4
2432510|NCT03824912|8330393|P1|Overall Study|Protocol Violation|1
2432511|NCT03824912|8330391|P3|Overall Study|Non-Compliance with Study Drug|1
2432512|NCT03824912|8330392|P2|Overall Study|Non-Compliance with Study Drug|0
2432513|NCT03824912|8330393|P1|Overall Study|Non-Compliance with Study Drug|0
2432514|NCT03824912|8330391|P3|Overall Study|Negative Baseline Culture Result|57
2432515|NCT03824912|8330392|P2|Overall Study|Negative Baseline Culture Result|112
2432516|NCT03824912|8330393|P1|Overall Study|Negative Baseline Culture Result|118
2432517|NCT03824912|8330391|P3|Overall Study|Lost to Follow-up|8
2432518|NCT03824912|8330392|P2|Overall Study|Lost to Follow-up|15
2432519|NCT03824912|8330393|P1|Overall Study|Lost to Follow-up|18
2432520|NCT03822884|8330419|P6|Overall Study|Withdrawal by Subject|0
2432521|NCT03822884|8330420|P5|Overall Study|Withdrawal by Subject|1
2432522|NCT03822884|8330421|P4|Overall Study|Withdrawal by Subject|0
2432523|NCT03822884|8330422|P3|Overall Study|Withdrawal by Subject|0
2432524|NCT03822884|8330423|P2|Overall Study|Withdrawal by Subject|0
2432525|NCT03822884|8330424|P1|Overall Study|Withdrawal by Subject|0
2432526|NCT03817879|8330549|P2|Overall Study|Withdrawal by Subject|1
2432527|NCT03817879|8330550|P1|Overall Study|Withdrawal by Subject|0
2432528|NCT03817879|8330549|P2|Overall Study|Drop out|12
2432529|NCT03817879|8330550|P1|Overall Study|Drop out|5
2432530|NCT03811093|8330730|P2|Overall Study|Unable to measure body fat percentage|0
2432531|NCT03811093|8330731|P1|Overall Study|Unable to measure body fat percentage|2
2432532|NCT03811093|8330730|P2|Overall Study|Lack of Efficacy, Withdrawal by Subject|4
2432533|NCT03811093|8330731|P1|Overall Study|Lack of Efficacy, Withdrawal by Subject|0
2432534|NCT03809104|8330741|P1|Overall Study|Withdrawal by Subject|3
2432535|NCT03805971|8330840|P1|Overall Study|Protocol Violation|2
2432536|NCT03805971|8330840|P1|Overall Study|Withdrawal by Subject|1
2432537|NCT03801148|8330866|P4|Follow-Up (12 Days)|Lost to Follow-up|0
2432538|NCT03801148|8330867|P3|Follow-Up (12 Days)|Lost to Follow-up|1
2432539|NCT03801148|8330868|P2|Follow-Up (12 Days)|Lost to Follow-up|1
2432540|NCT03801148|8330869|P1|Follow-Up (12 Days)|Lost to Follow-up|0
2432541|NCT03801148|8330866|P4|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2432542|NCT03801148|8330867|P3|Washout Period (at Least 5 Days)|Withdrawal by Subject|1
2432543|NCT03801148|8330868|P2|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2432544|NCT03801148|8330869|P1|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2432545|NCT03801148|8330866|P4|Washout Period (at Least 5 Days)|Lost to Follow-up|1
2432546|NCT03801148|8330867|P3|Washout Period (at Least 5 Days)|Lost to Follow-up|0
2432547|NCT03801148|8330868|P2|Washout Period (at Least 5 Days)|Lost to Follow-up|0
2432548|NCT03801148|8330869|P1|Washout Period (at Least 5 Days)|Lost to Follow-up|0
2432549|NCT03801148|8330866|P4|Period 1 (2 Days)|Adverse Event|0
2432550|NCT03801148|8330867|P3|Period 1 (2 Days)|Adverse Event|0
2432551|NCT03801148|8330868|P2|Period 1 (2 Days)|Adverse Event|1
2432552|NCT03801148|8330869|P1|Period 1 (2 Days)|Adverse Event|1
2432553|NCT03793556|8330990|P2|Overall Study|Lost to Follow-up|1
2432554|NCT03793556|8330991|P1|Overall Study|Lost to Follow-up|1
2432555|NCT03793556|8330990|P2|Overall Study|Withdrawal by Subject|1
2432556|NCT03793556|8330991|P1|Overall Study|Withdrawal by Subject|12
2432557|NCT03787212|8331046|P2|Period 1|Study Termination|2
2432558|NCT03787212|8331047|P1|Period 1|Study Termination|2
2432559|NCT03783780|8331053|P1|Overall Study|Withdrawn prior to completion|1
2432560|NCT03781375|8331087|P2|Open-label Phase|Other|2
2432561|NCT03781375|8331088|P1|Open-label Phase|Other|2
2432562|NCT03781375|8331087|P2|Open-label Phase|Suboptimal Clinical Response|0
2432563|NCT03781375|8331088|P1|Open-label Phase|Suboptimal Clinical Response|1
2432564|NCT03781375|8331087|P2|Open-label Phase|Protocol Issues|1
2432565|NCT03781375|8331088|P1|Open-label Phase|Protocol Issues|0
2432566|NCT03781375|8331087|P2|Double-blind Phase|Other|3
2432567|NCT03781375|8331088|P1|Double-blind Phase|Other|1
2432568|NCT03781375|8331087|P2|Double-blind Phase|Lack of Response|2
2432569|NCT03781375|8331088|P1|Double-blind Phase|Lack of Response|6
2432570|NCT03781375|8331087|P2|Double-blind Phase|Adverse Event|1
2432571|NCT03781375|8331088|P1|Double-blind Phase|Adverse Event|0
2432572|NCT03780959|8331102|P3|Part 2|Response Status|6
2432573|NCT03780959|8331103|P2|Part 2|Response Status|18
2432574|NCT03780959|8331104|P1|Part 2|Response Status|0
2432575|NCT03780959|8331102|P3|Part 2|Withdrawal by Parent/Guardian|0
2432576|NCT03780959|8331103|P2|Part 2|Withdrawal by Parent/Guardian|1
2432577|NCT03780959|8331104|P1|Part 2|Withdrawal by Parent/Guardian|0
2432578|NCT03780959|8331102|P3|Part 1|Response Status|0
2432579|NCT03780959|8331103|P2|Part 1|Response Status|0
2432580|NCT03780959|8331104|P1|Part 1|Response Status|2
2432581|NCT03780959|8331102|P3|Part 1|Withdrawal by Parent/Guardian|0
2432582|NCT03780959|8331103|P2|Part 1|Withdrawal by Parent/Guardian|0
2432583|NCT03780959|8331104|P1|Part 1|Withdrawal by Parent/Guardian|1
2432584|NCT03780959|8331102|P3|Part 1|Withdrawal by Subject|0
2432585|NCT03780959|8331103|P2|Part 1|Withdrawal by Subject|0
2432586|NCT03780959|8331104|P1|Part 1|Withdrawal by Subject|1
2432587|NCT03780959|8331102|P3|Part 1|Adverse Event|0
2432588|NCT03780959|8331103|P2|Part 1|Adverse Event|0
2432589|NCT03780959|8331104|P1|Part 1|Adverse Event|1
2432590|NCT03772327|8331196|P2|Overall Study|Withdrawal by Subject|3
2432591|NCT03772327|8331197|P1|Overall Study|Withdrawal by Subject|2
2432592|NCT03772327|8331196|P2|Overall Study|Lost to Follow-up|4
2432593|NCT03772327|8331197|P1|Overall Study|Lost to Follow-up|3
2432594|NCT03765138|8331277|P1|Overall Study|Lost to Follow-up|1
2432595|NCT03764813|8331287|P4|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0
2432596|NCT03764813|8331288|P3|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1
2432597|NCT03764813|8331289|P2|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1
2432598|NCT03764813|8331290|P1|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0
2432599|NCT03762668|8331411|P2|Period 1, First Week of Wear|Withdrawal by Subject|1
2432600|NCT03762668|8331412|P1|Period 1, First Week of Wear|Withdrawal by Subject|0
2432601|NCT03760510|8331420|P2|Overall Study|Not ventilated for 24 hours|97
2432602|NCT03760510|8331421|P1|Overall Study|Not ventilated for 24 hours|105
2432603|NCT03759587|8331433|P1|Overall Study|Ongoing|19
2432604|NCT03755882|8331481|P2|Period 1|Unsatisfactory Lens Fitting Test Article|0
2432605|NCT03755882|8331482|P1|Period 1|Unsatisfactory Lens Fitting Test Article|3
2432606|NCT03755882|8331481|P2|Period 1|Protocol Violation|0
2432607|NCT03755882|8331482|P1|Period 1|Protocol Violation|1
2432608|NCT03742271|8331604|P1|Overall Study|Protocol Violation|1
2432609|NCT03742271|8331604|P1|Overall Study|Failed Insertion & removal|3
2432610|NCT03742271|8331604|P1|Overall Study|Lost to Follow-up|4
2432611|NCT03742271|8331604|P1|Overall Study|Withdrawal by Subject|3
2432612|NCT03742271|8331604|P1|Overall Study|Unsatisfactory Visual Response|1
2432613|NCT03739242|8331623|P2|Overall Study|Protocol Violation|1
2432614|NCT03739242|8331624|P1|Overall Study|Protocol Violation|0
2432615|NCT03739242|8331623|P2|Overall Study|Withdrawal by Subject|1
2432616|NCT03739242|8331624|P1|Overall Study|Withdrawal by Subject|1
2432617|NCT03733899|8331679|P6|Period 3|Withdrawal by Subject|0
2432618|NCT03733899|8331680|P5|Period 3|Withdrawal by Subject|0
2432619|NCT03733899|8331681|P4|Period 3|Withdrawal by Subject|0
2432620|NCT03733899|8331682|P3|Period 3|Withdrawal by Subject|0
2432621|NCT03733899|8331683|P2|Period 3|Withdrawal by Subject|0
2432622|NCT03733899|8331684|P1|Period 3|Withdrawal by Subject|1
2432623|NCT03733899|8331679|P6|Period 2|Unscuccessful Treatment|0
2432624|NCT03733899|8331680|P5|Period 2|Unscuccessful Treatment|0
2432625|NCT03733899|8331681|P4|Period 2|Unscuccessful Treatment|0
2432626|NCT03733899|8331682|P3|Period 2|Unscuccessful Treatment|0
2432627|NCT03733899|8331683|P2|Period 2|Unscuccessful Treatment|1
2432628|NCT03733899|8331684|P1|Period 2|Unscuccessful Treatment|0
2432629|NCT03733899|8331679|P6|Period 1|Protocol Violation|1
2432630|NCT03733899|8331680|P5|Period 1|Protocol Violation|0
2432631|NCT03733899|8331681|P4|Period 1|Protocol Violation|0
2432632|NCT03733899|8331682|P3|Period 1|Protocol Violation|0
2432633|NCT03733899|8331683|P2|Period 1|Protocol Violation|0
2432634|NCT03733899|8331684|P1|Period 1|Protocol Violation|0
2432635|NCT03733470|8331712|P2|Overall Study|PI Decision|1
2432636|NCT03733470|8331713|P1|Overall Study|PI Decision|1
2432637|NCT03728140|8331721|P2|Overall Study|Abnormal embryo transfer operation|7
2432638|NCT03728140|8331722|P1|Overall Study|Abnormal embryo transfer operation|10
2432639|NCT03725982|8331768|P2|First Intervention|Physician Decision|1
2432640|NCT03725982|8331769|P1|First Intervention|Physician Decision|1
2432641|NCT03725982|8331768|P2|First Intervention|Withdrawal by Subject|1
2432642|NCT03725982|8331769|P1|First Intervention|Withdrawal by Subject|0
2432643|NCT03725085|8331786|P1|Overall Study|Lost to Follow-up|2
2432644|NCT03724981|8331794|P2|First Device|Protocol Violation|1
2432645|NCT03724981|8331795|P1|First Device|Protocol Violation|1
2432646|NCT03722264|8331843|P1|Overall Study|Physician Decision|3
2432647|NCT03720847|8331911|P2|Washout|Physician Decision|2
2432648|NCT03720847|8331912|P1|Washout|Physician Decision|1
2432649|NCT03718000|8331938|P2|Overall Study|Pregnancy|1
2432650|NCT03718000|8331939|P1|Overall Study|Pregnancy|0
2432651|NCT03718000|8331938|P2|Overall Study|Relocation|4
2432652|NCT03718000|8331939|P1|Overall Study|Relocation|2
2432653|NCT03717064|8331961|P1|Period 2|Adverse Event|1
2432654|NCT03716050|8331993|P8|Overall Study|Protocol Violation|2
2432655|NCT03716050|8331994|P7|Overall Study|Protocol Violation|0
2432656|NCT03716050|8331995|P6|Overall Study|Protocol Violation|0
2432657|NCT03716050|8331996|P5|Overall Study|Protocol Violation|0
2432658|NCT03716050|8331997|P4|Overall Study|Protocol Violation|1
2432659|NCT03716050|8331998|P3|Overall Study|Protocol Violation|0
2432660|NCT03716050|8331999|P2|Overall Study|Protocol Violation|0
2432661|NCT03716050|8332000|P1|Overall Study|Protocol Violation|0
2432662|NCT03716050|8331993|P8|Overall Study|Physician Decision|0
2432663|NCT03716050|8331994|P7|Overall Study|Physician Decision|0
2432664|NCT03716050|8331995|P6|Overall Study|Physician Decision|0
2432665|NCT03716050|8331996|P5|Overall Study|Physician Decision|0
2432666|NCT03716050|8331997|P4|Overall Study|Physician Decision|1
2432667|NCT03716050|8331998|P3|Overall Study|Physician Decision|0
2432668|NCT03716050|8331999|P2|Overall Study|Physician Decision|0
2432669|NCT03716050|8332000|P1|Overall Study|Physician Decision|0
2432670|NCT03716050|8331993|P8|Overall Study|Lost to Follow-up|0
2432671|NCT03716050|8331994|P7|Overall Study|Lost to Follow-up|0
2432672|NCT03716050|8331995|P6|Overall Study|Lost to Follow-up|0
2432673|NCT03716050|8331996|P5|Overall Study|Lost to Follow-up|0
2432674|NCT03716050|8331997|P4|Overall Study|Lost to Follow-up|0
2432675|NCT03716050|8331998|P3|Overall Study|Lost to Follow-up|1
2432676|NCT03716050|8331999|P2|Overall Study|Lost to Follow-up|0
2432677|NCT03716050|8332000|P1|Overall Study|Lost to Follow-up|0
2432678|NCT03715530|8332074|P3|Overall Study|Lost to Follow-up|2
2432679|NCT03715530|8332075|P2|Overall Study|Lost to Follow-up|1
2432680|NCT03715530|8332076|P1|Overall Study|Lost to Follow-up|3
2432681|NCT03714672|8332131|P4|Overall Study|Lost to Follow-up|0
2432682|NCT03714672|8332132|P3|Overall Study|Lost to Follow-up|0
2432683|NCT03714672|8332133|P2|Overall Study|Lost to Follow-up|1
2432684|NCT03714672|8332134|P1|Overall Study|Lost to Follow-up|1
2432685|NCT03714672|8332131|P4|Overall Study|Other Reason|1
2432686|NCT03714672|8332132|P3|Overall Study|Other Reason|1
2432687|NCT03714672|8332133|P2|Overall Study|Other Reason|2
2432688|NCT03714672|8332134|P1|Overall Study|Other Reason|1
2432689|NCT03714672|8332131|P4|Overall Study|Physician Decision|0
2432690|NCT03714672|8332132|P3|Overall Study|Physician Decision|0
2432691|NCT03714672|8332133|P2|Overall Study|Physician Decision|1
2432692|NCT03714672|8332134|P1|Overall Study|Physician Decision|0
2432693|NCT03714672|8332131|P4|Overall Study|Adverse Event|0
2432694|NCT03714672|8332132|P3|Overall Study|Adverse Event|3
2432695|NCT03714672|8332133|P2|Overall Study|Adverse Event|0
2432696|NCT03714672|8332134|P1|Overall Study|Adverse Event|0
2432697|NCT03712917|8332188|P3|Overall Study|Lost to Follow-up|5
2432698|NCT03712917|8332189|P2|Overall Study|Lost to Follow-up|4
2432699|NCT03712917|8332190|P1|Overall Study|Lost to Follow-up|9
2432700|NCT03712917|8332188|P3|Overall Study|Adverse Event|3
2432701|NCT03712917|8332189|P2|Overall Study|Adverse Event|4
2432702|NCT03712917|8332190|P1|Overall Study|Adverse Event|0
2432703|NCT03712917|8332188|P3|Overall Study|Pregnancy|1
2432704|NCT03712917|8332189|P2|Overall Study|Pregnancy|0
2432705|NCT03712917|8332190|P1|Overall Study|Pregnancy|0
2432706|NCT03708744|8332227|P4|Overall Study|Withdrawal by Subject|0
2432707|NCT03708744|8332228|P3|Overall Study|Withdrawal by Subject|1
2432708|NCT03708744|8332229|P2|Overall Study|Withdrawal by Subject|0
2432709|NCT03708744|8332230|P1|Overall Study|Withdrawal by Subject|0
2432710|NCT03707821|8332264|P2|Overall Study|Unsatisfactory Lens Fitting|0
2432711|NCT03707821|8332265|P1|Overall Study|Unsatisfactory Lens Fitting|1
2432712|NCT03707821|8332264|P2|Overall Study|Unsatisfactory Visual Response|0
2432713|NCT03707821|8332265|P1|Overall Study|Unsatisfactory Visual Response|1
2432714|NCT03707821|8332264|P2|Overall Study|Protocol Violation|1
2432715|NCT03707821|8332265|P1|Overall Study|Protocol Violation|0
2432716|NCT03707522|8332287|P4|Overall Study|Lost to Follow-up|36
2432717|NCT03707522|8332288|P3|Overall Study|Lost to Follow-up|41
2432718|NCT03707522|8332289|P2|Overall Study|Lost to Follow-up|27
2432719|NCT03707522|8332290|P1|Overall Study|Lost to Follow-up|24
2432720|NCT03700671|8332419|P2|Overall Study|Lack of Efficacy|2
2432721|NCT03700671|8332420|P1|Overall Study|Lack of Efficacy|1
2432722|NCT03698591|8332434|P2|Overall Study|Could not establish TMS dosage|1
2432723|NCT03698591|8332435|P1|Overall Study|Could not establish TMS dosage|0
2432724|NCT03698591|8332434|P2|Overall Study|Equipment Error|0
2432725|NCT03698591|8332435|P1|Overall Study|Equipment Error|1
2432726|NCT03698591|8332434|P2|Overall Study|Ineligible for financial compensation|0
2432727|NCT03698591|8332435|P1|Overall Study|Ineligible for financial compensation|1
2432728|NCT03698591|8332434|P2|Overall Study|Failed health screen|1
2432729|NCT03698591|8332435|P1|Overall Study|Failed health screen|0
2432730|NCT03698591|8332434|P2|Overall Study|Failed drug screen|1
2432731|NCT03698591|8332435|P1|Overall Study|Failed drug screen|1
2432732|NCT03698591|8332434|P2|Overall Study|Withdrawal by Subject|2
2432733|NCT03698591|8332435|P1|Overall Study|Withdrawal by Subject|2
2432734|NCT03694821|8332478|P3|Overall Study|Study terminated|4
2432735|NCT03694821|8332479|P2|Overall Study|Study terminated|8
2432736|NCT03694821|8332480|P1|Overall Study|Study terminated|4
2432737|NCT03693989|8332511|P2|Overall Study|Protocol Violation|4
2432738|NCT03693989|8332512|P1|Overall Study|Protocol Violation|3
2432739|NCT03693950|8332536|P2|Overall Study|Withdrawal by Subject|0
2432740|NCT03693950|8332537|P1|Overall Study|Withdrawal by Subject|1
2432741|NCT03688620|8332562|P3|Overall Study|Withdrawal by Subject|6
2432742|NCT03688620|8332563|P2|Overall Study|Withdrawal by Subject|0
2432743|NCT03688620|8332564|P1|Overall Study|Withdrawal by Subject|0
2432744|NCT03688620|8332562|P3|Overall Study|Lost to Follow-up|1
2432745|NCT03688620|8332563|P2|Overall Study|Lost to Follow-up|0
2432746|NCT03688620|8332564|P1|Overall Study|Lost to Follow-up|16
2432747|NCT03688620|8332562|P3|Overall Study|Unwilling to attend the scheduled visit|0
2432748|NCT03688620|8332563|P2|Overall Study|Unwilling to attend the scheduled visit|1
2432749|NCT03688620|8332564|P1|Overall Study|Unwilling to attend the scheduled visit|0
2432750|NCT03688620|8332562|P3|Overall Study|Other|1
2432751|NCT03688620|8332563|P2|Overall Study|Other|0
2432752|NCT03688620|8332564|P1|Overall Study|Other|0
2432753|NCT03687736|8333045|P1|Overall Study|Withdrawal by Subject|3
2432754|NCT03687736|8333045|P1|Overall Study|Lost to Follow-up|7
2432755|NCT03685643|8333076|P2|Overall Study|Lost to Follow-up|22
2432756|NCT03685643|8333077|P1|Overall Study|Lost to Follow-up|14
2432757|NCT03683758|8333126|P2|Overall Study|Adverse Event|0
2432758|NCT03683758|8333127|P1|Overall Study|Adverse Event|1
2432759|NCT03683758|8333126|P2|Overall Study|Illness preventing participation|0
2432760|NCT03683758|8333127|P1|Overall Study|Illness preventing participation|1
2432761|NCT03683758|8333126|P2|Overall Study|Non-study commitment conflict|3
2432762|NCT03683758|8333127|P1|Overall Study|Non-study commitment conflict|1
2432763|NCT03679741|8333219|P2|Period 2|Withdrawal by Subject|1
2432764|NCT03679741|8333220|P1|Period 2|Withdrawal by Subject|1
2432765|NCT03679741|8333219|P2|Period 2|Adverse Event|1
2432766|NCT03679741|8333220|P1|Period 2|Adverse Event|2
2432767|NCT03679741|8333219|P2|Period 1|Withdrawal by Subject|1
2432768|NCT03679741|8333220|P1|Period 1|Withdrawal by Subject|0
2432769|NCT03679741|8333219|P2|Period 1|Adverse Event|1
2432770|NCT03679741|8333220|P1|Period 1|Adverse Event|1
2432771|NCT03679741|8333219|P2|Period 1|Lost to Follow-up|1
2432772|NCT03679741|8333220|P1|Period 1|Lost to Follow-up|0
2432773|NCT03679741|8333219|P2|Period 1|No longer meet eligibility criteria|0
2432774|NCT03679741|8333220|P1|Period 1|No longer meet eligibility criteria|1
2432775|NCT03678870|8333263|P2|Overall Study|Lost to Follow-up|2
2432776|NCT03678870|8333264|P1|Overall Study|Lost to Follow-up|3
2432777|NCT03678870|8333263|P2|Overall Study|prescribed non- protocol medications|6
2432778|NCT03678870|8333264|P1|Overall Study|prescribed non- protocol medications|10
2432779|NCT03677375|8333276|P1|Overall Study|Physician Decision|1
2432780|NCT03677375|8333276|P1|Overall Study|Adverse Event|3
2432781|NCT03677375|8333276|P1|Overall Study|Incomplete procedure|8
2432782|NCT03674177|8333331|P4|Overall Study|Lost to Follow-up|2
2432783|NCT03674177|8333332|P3|Overall Study|Lost to Follow-up|0
2432784|NCT03674177|8333333|P2|Overall Study|Lost to Follow-up|1
2432785|NCT03674177|8333334|P1|Overall Study|Lost to Follow-up|2
2432786|NCT03673670|8333398|P6|Treatment Period 3 (3 Days)|Adverse Event|0
2432787|NCT03673670|8333399|P5|Treatment Period 3 (3 Days)|Adverse Event|1
2432788|NCT03673670|8333400|P4|Treatment Period 3 (3 Days)|Adverse Event|0
2432789|NCT03673670|8333401|P3|Treatment Period 3 (3 Days)|Adverse Event|0
2432790|NCT03673670|8333402|P2|Treatment Period 3 (3 Days)|Adverse Event|0
2432791|NCT03673670|8333403|P1|Treatment Period 3 (3 Days)|Adverse Event|0
2432792|NCT03673670|8333398|P6|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
2432793|NCT03673670|8333399|P5|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1
2432794|NCT03673670|8333400|P4|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
2432795|NCT03673670|8333401|P3|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
2432796|NCT03673670|8333402|P2|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
2432797|NCT03673670|8333403|P1|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
2432798|NCT03673670|8333398|P6|Treatment Period 2 (3 Days)|Adverse Event|0
2432799|NCT03673670|8333399|P5|Treatment Period 2 (3 Days)|Adverse Event|1
2432800|NCT03673670|8333400|P4|Treatment Period 2 (3 Days)|Adverse Event|0
2432801|NCT03673670|8333401|P3|Treatment Period 2 (3 Days)|Adverse Event|1
2432802|NCT03673670|8333402|P2|Treatment Period 2 (3 Days)|Adverse Event|0
2432803|NCT03673670|8333403|P1|Treatment Period 2 (3 Days)|Adverse Event|0
2432804|NCT03673670|8333398|P6|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1
2432805|NCT03673670|8333399|P5|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
2432806|NCT03673670|8333400|P4|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
2432807|NCT03673670|8333401|P3|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
2432808|NCT03673670|8333402|P2|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
2432809|NCT03673670|8333403|P1|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
2432810|NCT03673670|8333398|P6|Treatment Period 1 (3 Days)|Adverse Event|1
2432811|NCT03673670|8333399|P5|Treatment Period 1 (3 Days)|Adverse Event|0
2432812|NCT03673670|8333400|P4|Treatment Period 1 (3 Days)|Adverse Event|0
2432813|NCT03673670|8333401|P3|Treatment Period 1 (3 Days)|Adverse Event|0
2432814|NCT03673670|8333402|P2|Treatment Period 1 (3 Days)|Adverse Event|0
2432815|NCT03673670|8333403|P1|Treatment Period 1 (3 Days)|Adverse Event|0
2432816|NCT03673670|8333398|P6|Treatment Period 1 (3 Days)|Physician Decision|0
2432817|NCT03673670|8333399|P5|Treatment Period 1 (3 Days)|Physician Decision|0
2432818|NCT03673670|8333400|P4|Treatment Period 1 (3 Days)|Physician Decision|0
2432819|NCT03673670|8333401|P3|Treatment Period 1 (3 Days)|Physician Decision|1
2432820|NCT03673670|8333402|P2|Treatment Period 1 (3 Days)|Physician Decision|0
2432821|NCT03673670|8333403|P1|Treatment Period 1 (3 Days)|Physician Decision|0
2432822|NCT03673670|8333398|P6|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
2432823|NCT03673670|8333399|P5|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
2432824|NCT03673670|8333400|P4|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
2432825|NCT03673670|8333401|P3|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
2432826|NCT03673670|8333402|P2|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
2432827|NCT03673670|8333403|P1|Treatment Period 1 (3 Days)|Withdrawal by Subject|1
2432828|NCT03670537|8333450|P1|Overall Study|Protocol Violation|1
2432829|NCT03669081|8333456|P2|Overall Study|Data could not be validated|1
2432830|NCT03669081|8333457|P1|Overall Study|Data could not be validated|1
2432831|NCT03663179|8333522|P2|Overall Study|Revealed exclusionary condition|0
2432832|NCT03663179|8333523|P1|Overall Study|Revealed exclusionary condition|1
2432833|NCT03663179|8333522|P2|Overall Study|Lost to Follow-up|1
2432834|NCT03663179|8333523|P1|Overall Study|Lost to Follow-up|1
2432835|NCT03663179|8333522|P2|Overall Study|Withdrawal by Subject|0
2432836|NCT03663179|8333523|P1|Overall Study|Withdrawal by Subject|2
2432837|NCT03662334|8333533|P2|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0
2432838|NCT03662334|8333534|P1|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1
2432839|NCT03658876|8333639|P2|Overall Study|Transplantation/other operation|5
2432840|NCT03658876|8333640|P1|Overall Study|Transplantation/other operation|1
2432841|NCT03658876|8333639|P2|Overall Study|Intercurrent illness|4
2432842|NCT03658876|8333640|P1|Overall Study|Intercurrent illness|6
2432843|NCT03658876|8333639|P2|Overall Study|Death|1
2432844|NCT03658876|8333640|P1|Overall Study|Death|0
2432845|NCT03658876|8333639|P2|Overall Study|Withdrawal by Subject|0
2432846|NCT03658876|8333640|P1|Overall Study|Withdrawal by Subject|2
2432847|NCT03658876|8333639|P2|Overall Study|Protocol Violation|2
2432848|NCT03658876|8333640|P1|Overall Study|Protocol Violation|3
2432849|NCT03658811|8333646|P1|Overall Study|Lost to Follow-up|3
2432850|NCT03655106|8333700|P2|Overall Study|Protocol Violation|0
2432851|NCT03655106|8333701|P1|Overall Study|Protocol Violation|3
2432852|NCT03655106|8333700|P2|Overall Study|Duplicate Enrollment|1
2432853|NCT03655106|8333701|P1|Overall Study|Duplicate Enrollment|1
2432854|NCT03655106|8333700|P2|Overall Study|Lost to Follow-up|1
2432855|NCT03655106|8333701|P1|Overall Study|Lost to Follow-up|2
2432856|NCT03655106|8333700|P2|Overall Study|Withdrawal by Subject|2
2432857|NCT03655106|8333701|P1|Overall Study|Withdrawal by Subject|3
2432858|NCT03653429|8333738|P2|Overall Study|Physician Decision|10
2432859|NCT03653429|8333739|P1|Overall Study|Physician Decision|4
2432860|NCT03648983|8333805|P1|Overall Study|Study was terminated due to PI departure|95
2432861|NCT03646656|8333832|P2|Overall Study|Withdrawal by Subject|0
2432862|NCT03646656|8333833|P1|Overall Study|Withdrawal by Subject|2
2432863|NCT03646656|8333832|P2|Overall Study|Lost to Follow-up|0
2432864|NCT03646656|8333833|P1|Overall Study|Lost to Follow-up|1
2432865|NCT03645421|8333867|P4|Overall Study|Study specific withdrawal criteria|0
2432866|NCT03645421|8333868|P3|Overall Study|Study specific withdrawal criteria|1
2432867|NCT03645421|8333869|P2|Overall Study|Study specific withdrawal criteria|0
2432868|NCT03645421|8333870|P1|Overall Study|Study specific withdrawal criteria|0
2432869|NCT03645421|8333867|P4|Overall Study|Withdrawal by patient|3
2432870|NCT03645421|8333868|P3|Overall Study|Withdrawal by patient|0
2432871|NCT03645421|8333869|P2|Overall Study|Withdrawal by patient|0
2432872|NCT03645421|8333870|P1|Overall Study|Withdrawal by patient|0
2432873|NCT03645421|8333867|P4|Overall Study|Adverse Event|1
2432874|NCT03645421|8333868|P3|Overall Study|Adverse Event|4
2432875|NCT03645421|8333869|P2|Overall Study|Adverse Event|0
2432876|NCT03645421|8333870|P1|Overall Study|Adverse Event|0
2432877|NCT03643575|8333975|P6|Washout: 7 Days|Non compliance check in|0
2432878|NCT03643575|8333976|P5|Washout: 7 Days|Non compliance check in|0
2432879|NCT03643575|8333977|P4|Washout: 7 Days|Non compliance check in|0
2432880|NCT03643575|8333978|P3|Washout: 7 Days|Non compliance check in|0
2432881|NCT03643575|8333979|P2|Washout: 7 Days|Non compliance check in|1
2432882|NCT03643575|8333980|P1|Washout: 7 Days|Non compliance check in|0
2432883|NCT03643575|8333975|P6|Washout: 7 Days|Adverse Event|0
2432884|NCT03643575|8333976|P5|Washout: 7 Days|Adverse Event|0
2432885|NCT03643575|8333977|P4|Washout: 7 Days|Adverse Event|0
2432886|NCT03643575|8333978|P3|Washout: 7 Days|Adverse Event|0
2432887|NCT03643575|8333979|P2|Washout: 7 Days|Adverse Event|0
2432888|NCT03643575|8333980|P1|Washout: 7 Days|Adverse Event|1
2432889|NCT03643575|8333975|P6|Washout: 7 Days|Withdrew consent due to illness|0
2432890|NCT03643575|8333976|P5|Washout: 7 Days|Withdrew consent due to illness|0
2432891|NCT03643575|8333977|P4|Washout: 7 Days|Withdrew consent due to illness|1
2432892|NCT03643575|8333978|P3|Washout: 7 Days|Withdrew consent due to illness|0
2432893|NCT03643575|8333979|P2|Washout: 7 Days|Withdrew consent due to illness|0
2432894|NCT03643575|8333980|P1|Washout: 7 Days|Withdrew consent due to illness|0
2432895|NCT03643159|8334038|P1|Overall Study|Withdrawal by Subject|1
2432896|NCT03643159|8334038|P1|Overall Study|Adverse Event|1
2432897|NCT03642873|8334045|P6|Third Intervention (1 Day)|Screen failure|0
2432898|NCT03642873|8334046|P5|Third Intervention (1 Day)|Screen failure|1
2432899|NCT03642873|8334047|P4|Third Intervention (1 Day)|Screen failure|0
2432900|NCT03642873|8334048|P3|Third Intervention (1 Day)|Screen failure|0
2432901|NCT03642873|8334049|P2|Third Intervention (1 Day)|Screen failure|0
2432902|NCT03642873|8334050|P1|Third Intervention (1 Day)|Screen failure|0
2432903|NCT03642262|8334082|P2|Period 1|Adverse Event|1
2432904|NCT03642262|8334083|P1|Period 1|Adverse Event|0
2432905|NCT03642262|8334082|P2|Period 1|Withdrawal by Subject|1
2432906|NCT03642262|8334083|P1|Period 1|Withdrawal by Subject|1
2432907|NCT03641508|8334104|P2|First Injection|Lost to Follow-up|0
2432908|NCT03641508|8334105|P1|First Injection|Lost to Follow-up|2
2432909|NCT03640559|8334132|P2|Overall Study|Withdrawal by Subject|0
2432910|NCT03640559|8334133|P1|Overall Study|Withdrawal by Subject|1
2432911|NCT03640559|8334132|P2|Overall Study|Physician Decision|1
2432912|NCT03640559|8334133|P1|Overall Study|Physician Decision|1
2432913|NCT03640052|8334139|P5|Overall Study|Lost to Follow-up|0
2432914|NCT03640052|8334140|P4|Overall Study|Lost to Follow-up|0
2432915|NCT03640052|8334141|P3|Overall Study|Lost to Follow-up|0
2432916|NCT03640052|8334142|P2|Overall Study|Lost to Follow-up|1
2432917|NCT03640052|8334143|P1|Overall Study|Lost to Follow-up|0
2432918|NCT03639675|8334160|P1|Overall Study|Withdrawal by Subject|1
2432919|NCT03638635|8334182|P2|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22
2432920|NCT03638635|8334183|P1|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39
2432921|NCT03638635|8334182|P2|Initial Hospitalization|Withdrawal by study personnel|1
2432922|NCT03638635|8334183|P1|Initial Hospitalization|Withdrawal by study personnel|0
2432923|NCT03638635|8334182|P2|Initial Hospitalization|Study terminated prematurely|1
2432924|NCT03638635|8334183|P1|Initial Hospitalization|Study terminated prematurely|0
2432925|NCT03634579|8334276|P1|Overall Study|study termination|9
2432926|NCT03633825|8334374|P2|Follow up|Lost to Follow-up|450
2432927|NCT03633825|8334375|P1|Follow up|Lost to Follow-up|478
2432928|NCT03633825|8334374|P2|Enrollment|Post not classified as crisis|13757
2432929|NCT03633825|8334375|P1|Enrollment|Post not classified as crisis|13967
2432930|NCT03633825|8334374|P2|Enrollment|Did not post on network|5080
2432931|NCT03633825|8334375|P1|Enrollment|Did not post on network|5066
2432932|NCT03630016|8334508|P1|Overall Study|Poor Sensor Placement|1
2432933|NCT03629184|8334514|P2|Overall Study|Physician Decision|0
2432934|NCT03629184|8334515|P1|Overall Study|Physician Decision|1
2432935|NCT03629184|8334514|P2|Overall Study|Withdrawal by Subject|1
2432936|NCT03629184|8334515|P1|Overall Study|Withdrawal by Subject|2
2432937|NCT03629054|8334565|P2|Period 2 (4 Days)|Not treated|1
2432938|NCT03629054|8334566|P1|Period 2 (4 Days)|Not treated|0
2432939|NCT03629041|8334590|P4|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
2432940|NCT03629041|8334591|P3|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
2432941|NCT03629041|8334592|P2|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1
2432942|NCT03629041|8334593|P1|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
2432943|NCT03628599|8334634|P2|Overall Study|Adverse Event|1
2432944|NCT03628599|8334635|P1|Overall Study|Adverse Event|0
2432945|NCT03628417|8334665|P2|Overall Study|Death|1
2432946|NCT03628417|8334666|P1|Overall Study|Death|1
2432947|NCT03620708|8334719|P3|Overall Study|Withdrawal by Subject|1
2432948|NCT03620708|8334720|P2|Overall Study|Withdrawal by Subject|0
2432949|NCT03620708|8334721|P1|Overall Study|Withdrawal by Subject|0
2432950|NCT03620708|8334719|P3|Overall Study|Lost to Follow-up|2
2432951|NCT03620708|8334720|P2|Overall Study|Lost to Follow-up|1
2432952|NCT03620708|8334721|P1|Overall Study|Lost to Follow-up|1
2432953|NCT03618628|8334802|P1|Overall Study|Lost to Follow-up|1
2432954|NCT03618628|8334802|P1|Overall Study|Death|1
2432955|NCT03616977|8334860|P2|Period 3|Adverse Event|1
2432956|NCT03616977|8334861|P1|Period 3|Adverse Event|1
2432957|NCT03616977|8334860|P2|Period 1|Physician Decision|1
2432958|NCT03616977|8334861|P1|Period 1|Physician Decision|0
2432959|NCT03616600|8334871|P2|Overall Study|Withdrawal by Subject|0
2432960|NCT03616600|8334872|P1|Overall Study|Withdrawal by Subject|1
2432961|NCT03614975|8334955|P2|Overall Study|Specimens not in lab batch shipment|1
2432962|NCT03614975|8334956|P1|Overall Study|Specimens not in lab batch shipment|1
2432963|NCT03614975|8334955|P2|Overall Study|Withdrawal by Subject|2
2432964|NCT03614975|8334956|P1|Overall Study|Withdrawal by Subject|2
2432965|NCT03614975|8334955|P2|Overall Study|Physician Decision|5
2432966|NCT03614975|8334956|P1|Overall Study|Physician Decision|7
2432967|NCT03614078|8334969|P3|Overall Study|Dizziness and Rash|0
2432968|NCT03614078|8334970|P2|Overall Study|Dizziness and Rash|1
2432969|NCT03614078|8334971|P1|Overall Study|Dizziness and Rash|0
2432970|NCT03614078|8334969|P3|Overall Study|Adverse Event|0
2432971|NCT03614078|8334970|P2|Overall Study|Adverse Event|2
2432972|NCT03614078|8334971|P1|Overall Study|Adverse Event|0
2432973|NCT03614078|8334969|P3|Overall Study|Exacerbation of Psoriasis|0
2432974|NCT03614078|8334970|P2|Overall Study|Exacerbation of Psoriasis|1
2432975|NCT03614078|8334971|P1|Overall Study|Exacerbation of Psoriasis|0
2432976|NCT03614078|8334969|P3|Overall Study|Patient Did Not Meet Eligibility|0
2432977|NCT03614078|8334970|P2|Overall Study|Patient Did Not Meet Eligibility|0
2432978|NCT03614078|8334971|P1|Overall Study|Patient Did Not Meet Eligibility|1
2432979|NCT03614078|8334969|P3|Overall Study|High Neutrophils|2
2432980|NCT03614078|8334970|P2|Overall Study|High Neutrophils|0
2432981|NCT03614078|8334971|P1|Overall Study|High Neutrophils|0
2432982|NCT03614078|8334969|P3|Overall Study|Participant Did Not Return for Visit|0
2432983|NCT03614078|8334970|P2|Overall Study|Participant Did Not Return for Visit|1
2432984|NCT03614078|8334971|P1|Overall Study|Participant Did Not Return for Visit|0
2432985|NCT03614078|8334969|P3|Overall Study|Withdrawal by Subject|3
2432986|NCT03614078|8334970|P2|Overall Study|Withdrawal by Subject|2
2432987|NCT03614078|8334971|P1|Overall Study|Withdrawal by Subject|2
2432988|NCT03613649|8335000|P12|Fourth Treatment|Physician Decision|0
2432989|NCT03613649|8335001|P11|Fourth Treatment|Physician Decision|0
2432990|NCT03613649|8335002|P10|Fourth Treatment|Physician Decision|0
2432991|NCT03613649|8335003|P9|Fourth Treatment|Physician Decision|0
2432992|NCT03613649|8335004|P8|Fourth Treatment|Physician Decision|0
2432993|NCT03613649|8335005|P7|Fourth Treatment|Physician Decision|1
2432994|NCT03613649|8335006|P6|Fourth Treatment|Physician Decision|0
2432995|NCT03613649|8335007|P5|Fourth Treatment|Physician Decision|0
2432996|NCT03613649|8335008|P4|Fourth Treatment|Physician Decision|0
2432997|NCT03613649|8335009|P3|Fourth Treatment|Physician Decision|0
2432998|NCT03613649|8335010|P2|Fourth Treatment|Physician Decision|0
2432999|NCT03613649|8335011|P1|Fourth Treatment|Physician Decision|0
2433000|NCT03613649|8335000|P12|Fourth Treatment|Protocol Violation|0
2433001|NCT03613649|8335001|P11|Fourth Treatment|Protocol Violation|0
2433002|NCT03613649|8335002|P10|Fourth Treatment|Protocol Violation|0
2433003|NCT03613649|8335003|P9|Fourth Treatment|Protocol Violation|0
2433004|NCT03613649|8335004|P8|Fourth Treatment|Protocol Violation|0
2433005|NCT03613649|8335005|P7|Fourth Treatment|Protocol Violation|0
2433006|NCT03613649|8335006|P6|Fourth Treatment|Protocol Violation|0
2433007|NCT03613649|8335007|P5|Fourth Treatment|Protocol Violation|1
2433008|NCT03613649|8335008|P4|Fourth Treatment|Protocol Violation|0
2433009|NCT03613649|8335009|P3|Fourth Treatment|Protocol Violation|0
2433010|NCT03613649|8335010|P2|Fourth Treatment|Protocol Violation|0
2433011|NCT03613649|8335011|P1|Fourth Treatment|Protocol Violation|1
2433012|NCT03613649|8335000|P12|Third Treatment|Protocol Violation|1
2433013|NCT03613649|8335001|P11|Third Treatment|Protocol Violation|0
2433014|NCT03613649|8335002|P10|Third Treatment|Protocol Violation|0
2433015|NCT03613649|8335003|P9|Third Treatment|Protocol Violation|0
2433016|NCT03613649|8335004|P8|Third Treatment|Protocol Violation|0
2433017|NCT03613649|8335005|P7|Third Treatment|Protocol Violation|1
2433018|NCT03613649|8335006|P6|Third Treatment|Protocol Violation|0
2433019|NCT03613649|8335007|P5|Third Treatment|Protocol Violation|0
2433020|NCT03613649|8335008|P4|Third Treatment|Protocol Violation|0
2433021|NCT03613649|8335009|P3|Third Treatment|Protocol Violation|0
2433022|NCT03613649|8335010|P2|Third Treatment|Protocol Violation|0
2433023|NCT03613649|8335011|P1|Third Treatment|Protocol Violation|0
2433024|NCT03613649|8335000|P12|Third Treatment|Lost to Follow-up|1
2433025|NCT03613649|8335001|P11|Third Treatment|Lost to Follow-up|0
2433026|NCT03613649|8335002|P10|Third Treatment|Lost to Follow-up|0
2433027|NCT03613649|8335003|P9|Third Treatment|Lost to Follow-up|0
2433028|NCT03613649|8335004|P8|Third Treatment|Lost to Follow-up|0
2433029|NCT03613649|8335005|P7|Third Treatment|Lost to Follow-up|0
2433030|NCT03613649|8335006|P6|Third Treatment|Lost to Follow-up|0
2433031|NCT03613649|8335007|P5|Third Treatment|Lost to Follow-up|1
2433032|NCT03613649|8335008|P4|Third Treatment|Lost to Follow-up|0
2433033|NCT03613649|8335009|P3|Third Treatment|Lost to Follow-up|0
2433034|NCT03613649|8335010|P2|Third Treatment|Lost to Follow-up|0
2433035|NCT03613649|8335011|P1|Third Treatment|Lost to Follow-up|0
2433036|NCT03613649|8335000|P12|Second Treatment|Withdrawal by Subject|0
2433037|NCT03613649|8335001|P11|Second Treatment|Withdrawal by Subject|0
2433038|NCT03613649|8335002|P10|Second Treatment|Withdrawal by Subject|0
2433039|NCT03613649|8335003|P9|Second Treatment|Withdrawal by Subject|0
2433040|NCT03613649|8335004|P8|Second Treatment|Withdrawal by Subject|0
2433041|NCT03613649|8335005|P7|Second Treatment|Withdrawal by Subject|0
2433042|NCT03613649|8335006|P6|Second Treatment|Withdrawal by Subject|0
2433043|NCT03613649|8335007|P5|Second Treatment|Withdrawal by Subject|1
2433044|NCT03613649|8335008|P4|Second Treatment|Withdrawal by Subject|0
2433045|NCT03613649|8335009|P3|Second Treatment|Withdrawal by Subject|0
2433046|NCT03613649|8335010|P2|Second Treatment|Withdrawal by Subject|0
2433047|NCT03613649|8335011|P1|Second Treatment|Withdrawal by Subject|0
2433048|NCT03613649|8335000|P12|Second Treatment|Lost to Follow-up|0
2433049|NCT03613649|8335001|P11|Second Treatment|Lost to Follow-up|0
2433050|NCT03613649|8335002|P10|Second Treatment|Lost to Follow-up|0
2433051|NCT03613649|8335003|P9|Second Treatment|Lost to Follow-up|0
2433052|NCT03613649|8335004|P8|Second Treatment|Lost to Follow-up|0
2433053|NCT03613649|8335005|P7|Second Treatment|Lost to Follow-up|0
2433054|NCT03613649|8335006|P6|Second Treatment|Lost to Follow-up|0
2433055|NCT03613649|8335007|P5|Second Treatment|Lost to Follow-up|0
2433056|NCT03613649|8335008|P4|Second Treatment|Lost to Follow-up|0
2433057|NCT03613649|8335009|P3|Second Treatment|Lost to Follow-up|1
2433058|NCT03613649|8335010|P2|Second Treatment|Lost to Follow-up|0
2433059|NCT03613649|8335011|P1|Second Treatment|Lost to Follow-up|0
2433060|NCT03613129|8335156|P5|Pre-treatment Assessment|Withdrawal by Subject|0
2433061|NCT03613129|8335157|P4|Pre-treatment Assessment|Withdrawal by Subject|0
2433062|NCT03613129|8335158|P3|Pre-treatment Assessment|Withdrawal by Subject|0
2433063|NCT03613129|8335159|P2|Pre-treatment Assessment|Withdrawal by Subject|0
2433064|NCT03613129|8335160|P1|Pre-treatment Assessment|Withdrawal by Subject|1
2433065|NCT03613129|8335156|P5|Pre-treatment Assessment|Protocol Violation|0
2433066|NCT03613129|8335157|P4|Pre-treatment Assessment|Protocol Violation|0
2433067|NCT03613129|8335158|P3|Pre-treatment Assessment|Protocol Violation|0
2433068|NCT03613129|8335159|P2|Pre-treatment Assessment|Protocol Violation|0
2433069|NCT03613129|8335160|P1|Pre-treatment Assessment|Protocol Violation|2
2433070|NCT03610269|8335230|P1|Overall Study|Screen fail|4
2433071|NCT03610269|8335230|P1|Overall Study|Unable to draw blood|1
2433072|NCT03610269|8335230|P1|Overall Study|Protocol Violation|1
2433073|NCT03610269|8335230|P1|Overall Study|Physician Decision|10
2433074|NCT03609619|8335236|P2|Overall Study|Lost to Follow-up|1
2433075|NCT03609619|8335237|P1|Overall Study|Lost to Follow-up|1
2433076|NCT03609619|8335236|P2|Overall Study|Withdrawal by Subject|3
2433077|NCT03609619|8335237|P1|Overall Study|Withdrawal by Subject|2
2433078|NCT03609619|8335236|P2|Overall Study|Protocol Violation|0
2433079|NCT03609619|8335237|P1|Overall Study|Protocol Violation|5
2433080|NCT03609619|8335236|P2|Overall Study|Lack of Efficacy|2
2433081|NCT03609619|8335237|P1|Overall Study|Lack of Efficacy|1
2433082|NCT03609619|8335236|P2|Overall Study|Adverse Event|0
2433083|NCT03609619|8335237|P1|Overall Study|Adverse Event|1
2433084|NCT03605303|8335318|P2|Period 1|Study Terminated|1
2433085|NCT03605303|8335319|P1|Period 1|Study Terminated|2
2433086|NCT03604341|8335329|P2|Overall Study|Protocol Violation|1
2433087|NCT03604341|8335330|P1|Overall Study|Protocol Violation|0
2433088|NCT03604341|8335329|P2|Overall Study|Adverse Event|0
2433089|NCT03604341|8335330|P1|Overall Study|Adverse Event|1
2433090|NCT03604341|8335329|P2|Overall Study|Withdrawal by Subject|1
2433091|NCT03604341|8335330|P1|Overall Study|Withdrawal by Subject|1
2433092|NCT03603028|8335410|P1|Overall Study|Withdrawal by Subject|1
2433093|NCT03601715|8335418|P3|Second Intervention|Lost to Follow-up|0
2433094|NCT03601715|8335419|P2|Second Intervention|Lost to Follow-up|1
2433095|NCT03601715|8335420|P1|Second Intervention|Lost to Follow-up|1
2433096|NCT03599349|8335434|P1|Overall Study|Lost to Follow-up|1
2433097|NCT03590743|8335507|P2|Overall Study|Withdrawal by Subject|1
2433098|NCT03590743|8335508|P1|Overall Study|Withdrawal by Subject|0
2433099|NCT03590613|8335520|P4|Period 2, 4 Days|Physician Decision|1
2433100|NCT03590613|8335521|P3|Period 2, 4 Days|Physician Decision|0
2433101|NCT03590613|8335522|P2|Period 2, 4 Days|Physician Decision|0
2433102|NCT03590613|8335523|P1|Period 2, 4 Days|Physician Decision|0
2433103|NCT03588572|8335643|P2|Visitation 3|Withdrawal by Subject|0
2433104|NCT03588572|8335644|P1|Visitation 3|Withdrawal by Subject|1
2433105|NCT03588572|8335643|P2|Visitation 3|Physician Decision|1
2433106|NCT03588572|8335644|P1|Visitation 3|Physician Decision|1
2433107|NCT03588572|8335643|P2|Visitation 3|Lost to Follow-up|1
2433108|NCT03588572|8335644|P1|Visitation 3|Lost to Follow-up|1
2433109|NCT03588572|8335643|P2|Visitation 2|Withdrawal by Subject|0
2433110|NCT03588572|8335644|P1|Visitation 2|Withdrawal by Subject|1
2433111|NCT03588572|8335643|P2|Visitation 2|Lack of Efficacy|1
2433112|NCT03588572|8335644|P1|Visitation 2|Lack of Efficacy|0
2433113|NCT03588572|8335643|P2|Visitation 2|Lost to Follow-up|1
2433114|NCT03588572|8335644|P1|Visitation 2|Lost to Follow-up|1
2433115|NCT03588572|8335643|P2|Visitation 1|Lack of Efficacy|1
2433116|NCT03588572|8335644|P1|Visitation 1|Lack of Efficacy|1
2433117|NCT03586830|8335766|P4|Overall Study|Withdrawal by Subject|1
2433118|NCT03586830|8335767|P3|Overall Study|Withdrawal by Subject|3
2433119|NCT03586830|8335768|P2|Overall Study|Withdrawal by Subject|0
2433120|NCT03586830|8335769|P1|Overall Study|Withdrawal by Subject|1
2433121|NCT03586830|8335766|P4|Overall Study|Lost to Follow-up|1
2433122|NCT03586830|8335767|P3|Overall Study|Lost to Follow-up|2
2433123|NCT03586830|8335768|P2|Overall Study|Lost to Follow-up|2
2433124|NCT03586830|8335769|P1|Overall Study|Lost to Follow-up|0
2433125|NCT03586830|8335766|P4|Overall Study|Site terminated by Sponsor|3
2433126|NCT03586830|8335767|P3|Overall Study|Site terminated by Sponsor|3
2433127|NCT03586830|8335768|P2|Overall Study|Site terminated by Sponsor|4
2433128|NCT03586830|8335769|P1|Overall Study|Site terminated by Sponsor|1
2433129|NCT03586726|8335791|P1|Overall Study|Withdrawal by Subject|1
2433130|NCT03585959|8335808|P1|Overall Study|Unsuccessful Procedure|2
2433131|NCT03585959|8335808|P1|Overall Study|Physician Decision|1
2433132|NCT03585504|8335849|P2|Overall Study|Lost to Follow-up|29
2433133|NCT03585504|8335850|P1|Overall Study|Lost to Follow-up|26
2433134|NCT03585296|8335860|P1|Overall Study|Withdrawal by Subject|2
2433135|NCT03585296|8335860|P1|Overall Study|Lost to Follow-up|2
2433136|NCT03585296|8335860|P1|Overall Study|Adverse Event|1
2433137|NCT03583385|8335864|P2|Treatment Period 2|Adverse Event|0
2433138|NCT03583385|8335865|P1|Treatment Period 2|Adverse Event|1
2433139|NCT03583385|8335864|P2|Treatment Period 1|Withdrawal by Subject|1
2433140|NCT03583385|8335865|P1|Treatment Period 1|Withdrawal by Subject|1
2433141|NCT03582943|8335883|P2|Analyzed|Protocol Violation|1
2433142|NCT03582943|8335884|P1|Analyzed|Protocol Violation|4
2433143|NCT03582943|8335883|P2|Intervention and Follow up|Withdrawal by Subject|2
2433144|NCT03582943|8335884|P1|Intervention and Follow up|Withdrawal by Subject|4
2433145|NCT03582943|8335883|P2|Allocated to Groups|Withdrawal by Subject|1
2433146|NCT03582943|8335884|P1|Allocated to Groups|Withdrawal by Subject|1
2433147|NCT03582813|8335892|P2|Overall Study|Withdrawal by Subject|0
2433148|NCT03582813|8335893|P1|Overall Study|Withdrawal by Subject|1
2433149|NCT03582813|8335892|P2|Overall Study|Lost to Follow-up|21
2433150|NCT03582813|8335893|P1|Overall Study|Lost to Follow-up|18
2433151|NCT03582215|8335960|P8|Overall Study|Adverse Event|2
2433152|NCT03582215|8335961|P7|Overall Study|Adverse Event|2
2433153|NCT03582215|8335962|P6|Overall Study|Adverse Event|0
2433154|NCT03582215|8335963|P5|Overall Study|Adverse Event|0
2433155|NCT03582215|8335964|P4|Overall Study|Adverse Event|0
2433156|NCT03582215|8335965|P3|Overall Study|Adverse Event|0
2433157|NCT03582215|8335966|P2|Overall Study|Adverse Event|0
2433158|NCT03582215|8335967|P1|Overall Study|Adverse Event|1
2433159|NCT03581825|8336008|P2|Period 2|Unsatisfactory Vision to Test|1
2433160|NCT03581825|8336009|P1|Period 2|Unsatisfactory Vision to Test|0
2433161|NCT03581825|8336008|P2|Period 1|Lens Discomfort|0
2433162|NCT03581825|8336009|P1|Period 1|Lens Discomfort|1
2433163|NCT03579940|8336054|P11|Period 2|Withdrawal by Subject|0
2433164|NCT03579940|8336055|P10|Period 2|Withdrawal by Subject|0
2433165|NCT03579940|8336056|P9|Period 2|Withdrawal by Subject|0
2433166|NCT03579940|8336057|P8|Period 2|Withdrawal by Subject|0
2433167|NCT03579940|8336058|P7|Period 2|Withdrawal by Subject|0
2433168|NCT03579940|8336059|P6|Period 2|Withdrawal by Subject|0
2433169|NCT03579940|8336060|P5|Period 2|Withdrawal by Subject|0
2433170|NCT03579940|8336061|P4|Period 2|Withdrawal by Subject|0
2433171|NCT03579940|8336062|P3|Period 2|Withdrawal by Subject|1
2433172|NCT03579940|8336063|P2|Period 2|Withdrawal by Subject|0
2433173|NCT03579940|8336064|P1|Period 2|Withdrawal by Subject|0
2433174|NCT03579719|8336104|P1|Overall Study|Protocol deviation, pre-existent disease|1
2433175|NCT03578146|8336156|P6|Overall Study|Lost to Follow-up|1
2433176|NCT03578146|8336157|P5|Overall Study|Lost to Follow-up|0
2433177|NCT03578146|8336158|P4|Overall Study|Lost to Follow-up|0
2433178|NCT03578146|8336159|P3|Overall Study|Lost to Follow-up|1
2433179|NCT03578146|8336160|P2|Overall Study|Lost to Follow-up|1
2433180|NCT03578146|8336161|P1|Overall Study|Lost to Follow-up|0
2433181|NCT03578146|8336156|P6|Overall Study|Did Not Receive Treatment|2
2433182|NCT03578146|8336157|P5|Overall Study|Did Not Receive Treatment|0
2433183|NCT03578146|8336158|P4|Overall Study|Did Not Receive Treatment|0
2433184|NCT03578146|8336159|P3|Overall Study|Did Not Receive Treatment|0
2433185|NCT03578146|8336160|P2|Overall Study|Did Not Receive Treatment|0
2433186|NCT03578146|8336161|P1|Overall Study|Did Not Receive Treatment|1
2433187|NCT03575871|8336293|P3|Overall Study|Other than specified|0
2433188|NCT03575871|8336294|P2|Overall Study|Other than specified|2
2433189|NCT03575871|8336295|P1|Overall Study|Other than specified|2
2433190|NCT03575871|8336293|P3|Overall Study|Withdrawal by Subject|9
2433191|NCT03575871|8336294|P2|Overall Study|Withdrawal by Subject|1
2433192|NCT03575871|8336295|P1|Overall Study|Withdrawal by Subject|6
2433193|NCT03575871|8336293|P3|Overall Study|Protocol Deviation|1
2433194|NCT03575871|8336294|P2|Overall Study|Protocol Deviation|1
2433195|NCT03575871|8336295|P1|Overall Study|Protocol Deviation|1
2433196|NCT03575871|8336293|P3|Overall Study|Lost to Follow-up|1
2433197|NCT03575871|8336294|P2|Overall Study|Lost to Follow-up|1
2433198|NCT03575871|8336295|P1|Overall Study|Lost to Follow-up|1
2433199|NCT03575871|8336293|P3|Overall Study|Lack of Efficacy|7
2433200|NCT03575871|8336294|P2|Overall Study|Lack of Efficacy|4
2433201|NCT03575871|8336295|P1|Overall Study|Lack of Efficacy|5
2433202|NCT03575871|8336293|P3|Overall Study|Death|0
2433203|NCT03575871|8336294|P2|Overall Study|Death|0
2433204|NCT03575871|8336295|P1|Overall Study|Death|1
2433205|NCT03575871|8336293|P3|Overall Study|Adverse Event|8
2433206|NCT03575871|8336294|P2|Overall Study|Adverse Event|5
2433207|NCT03575871|8336295|P1|Overall Study|Adverse Event|5
2433208|NCT03575702|8336359|P2|Overall Study|Patient non compliance|0
2433209|NCT03575702|8336360|P1|Overall Study|Patient non compliance|4
2433210|NCT03575702|8336359|P2|Overall Study|Protocol Violation|1
2433211|NCT03575702|8336360|P1|Overall Study|Protocol Violation|0
2433212|NCT03575702|8336359|P2|Overall Study|Lost to Follow-up|2
2433213|NCT03575702|8336360|P1|Overall Study|Lost to Follow-up|1
2433214|NCT03575702|8336359|P2|Overall Study|Withdrawal by Subject|1
2433215|NCT03575702|8336360|P1|Overall Study|Withdrawal by Subject|1
2433216|NCT03573817|8336416|P2|Overall Study|Withdrawal by Subject|1
2433217|NCT03573817|8336417|P1|Overall Study|Withdrawal by Subject|1
2433218|NCT03573817|8336416|P2|Overall Study|Protocol Violation|1
2433219|NCT03573817|8336417|P1|Overall Study|Protocol Violation|0
2433220|NCT03573817|8336416|P2|Overall Study|Adverse Event|2
2433221|NCT03573817|8336417|P1|Overall Study|Adverse Event|0
2433222|NCT03569202|8336711|P2|Part 3|Other|1
2433223|NCT03569202|8336712|P1|Part 3|Other|1
2433224|NCT03569202|8336711|P2|Part 3|Physician Decision|0
2433225|NCT03569202|8336712|P1|Part 3|Physician Decision|1
2433226|NCT03568942|8336761|P1|Overall Study|Lost to Follow-up|1
2433227|NCT03568942|8336761|P1|Overall Study|Family emergency|1
2433228|NCT03566979|8336809|P4|Overall Study|Adverse Event|0
2433229|NCT03566979|8336810|P3|Overall Study|Adverse Event|0
2433230|NCT03566979|8336811|P2|Overall Study|Adverse Event|0
2433231|NCT03566979|8336812|P1|Overall Study|Adverse Event|1
2433232|NCT03566979|8336809|P4|Overall Study|Lost to Follow-up|5
2433233|NCT03566979|8336810|P3|Overall Study|Lost to Follow-up|9
2433234|NCT03566979|8336811|P2|Overall Study|Lost to Follow-up|7
2433235|NCT03566979|8336812|P1|Overall Study|Lost to Follow-up|2
2433236|NCT03566979|8336809|P4|Overall Study|Withdrawal by Subject|1
2433237|NCT03566979|8336810|P3|Overall Study|Withdrawal by Subject|1
2433238|NCT03566979|8336811|P2|Overall Study|Withdrawal by Subject|0
2433239|NCT03566979|8336812|P1|Overall Study|Withdrawal by Subject|2
2433240|NCT03566810|8336828|P4|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
2433241|NCT03566810|8336829|P3|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
2433242|NCT03566810|8336830|P2|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1
2433243|NCT03566810|8336831|P1|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
2433244|NCT03562117|8337196|P3|Part 1, Up to 3 Days|Adverse Event|0
2433245|NCT03562117|8337197|P2|Part 1, Up to 3 Days|Adverse Event|0
2433246|NCT03562117|8337198|P1|Part 1, Up to 3 Days|Adverse Event|1
2433247|NCT03559062|8337346|P3|Overall Study|Other|0
2433248|NCT03559062|8337347|P2|Overall Study|Other|1
2433249|NCT03559062|8337348|P1|Overall Study|Other|0
2433250|NCT03558555|8337361|P2|Overall Study|Lost to Follow-up|1
2433251|NCT03558555|8337362|P1|Overall Study|Lost to Follow-up|2
2433252|NCT03557801|8337390|P3|Overall Study|Lost to Follow-up|0
2433253|NCT03557801|8337391|P2|Overall Study|Lost to Follow-up|1
2433254|NCT03557801|8337392|P1|Overall Study|Lost to Follow-up|0
2433255|NCT03557801|8337390|P3|Overall Study|Withdrawal by Subject|3
2433256|NCT03557801|8337391|P2|Overall Study|Withdrawal by Subject|0
2433257|NCT03557801|8337392|P1|Overall Study|Withdrawal by Subject|1
2433258|NCT03557801|8337390|P3|Overall Study|Protocol Violation|0
2433259|NCT03557801|8337391|P2|Overall Study|Protocol Violation|0
2433260|NCT03557801|8337392|P1|Overall Study|Protocol Violation|1
2433261|NCT03555890|8337458|P4|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1
2433262|NCT03555890|8337459|P3|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2433263|NCT03555890|8337460|P2|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2433264|NCT03555890|8337461|P1|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2433265|NCT03554005|8337620|P6|Overall Study|Other|1
2433266|NCT03554005|8337621|P5|Overall Study|Other|0
2433267|NCT03554005|8337622|P4|Overall Study|Other|0
2433268|NCT03554005|8337623|P3|Overall Study|Other|0
2433269|NCT03554005|8337624|P2|Overall Study|Other|0
2433270|NCT03554005|8337625|P1|Overall Study|Other|0
2433271|NCT03554005|8337620|P6|Overall Study|Physician Decision|0
2433272|NCT03554005|8337621|P5|Overall Study|Physician Decision|1
2433273|NCT03554005|8337622|P4|Overall Study|Physician Decision|0
2433274|NCT03554005|8337623|P3|Overall Study|Physician Decision|0
2433275|NCT03554005|8337624|P2|Overall Study|Physician Decision|0
2433276|NCT03554005|8337625|P1|Overall Study|Physician Decision|0
2433277|NCT03554005|8337620|P6|Overall Study|Adverse Event|3
2433278|NCT03554005|8337621|P5|Overall Study|Adverse Event|0
2433279|NCT03554005|8337622|P4|Overall Study|Adverse Event|0
2433280|NCT03554005|8337623|P3|Overall Study|Adverse Event|0
2433281|NCT03554005|8337624|P2|Overall Study|Adverse Event|0
2433282|NCT03554005|8337625|P1|Overall Study|Adverse Event|0
2433283|NCT03554005|8337620|P6|Overall Study|Disease Progression|6
2433284|NCT03554005|8337621|P5|Overall Study|Disease Progression|5
2433285|NCT03554005|8337622|P4|Overall Study|Disease Progression|1
2433286|NCT03554005|8337623|P3|Overall Study|Disease Progression|1
2433287|NCT03554005|8337624|P2|Overall Study|Disease Progression|1
2433288|NCT03554005|8337625|P1|Overall Study|Disease Progression|1
2433289|NCT03554005|8337620|P6|Overall Study|Not in participant's best interest|1
2433290|NCT03554005|8337621|P5|Overall Study|Not in participant's best interest|0
2433291|NCT03554005|8337622|P4|Overall Study|Not in participant's best interest|0
2433292|NCT03554005|8337623|P3|Overall Study|Not in participant's best interest|0
2433293|NCT03554005|8337624|P2|Overall Study|Not in participant's best interest|0
2433294|NCT03554005|8337625|P1|Overall Study|Not in participant's best interest|0
2433295|NCT03552549|8337653|P2|Overall Study|Administrative|14
2433296|NCT03552549|8337654|P1|Overall Study|Administrative|0
2433297|NCT03552549|8337653|P2|Overall Study|Did not meet eligibility criteria|0
2433298|NCT03552549|8337654|P1|Overall Study|Did not meet eligibility criteria|1
2433299|NCT03552549|8337653|P2|Overall Study|Did not complete study treatment|3
2433300|NCT03552549|8337654|P1|Overall Study|Did not complete study treatment|2
2433301|NCT03552549|8337653|P2|Overall Study|Not in participant's best interest|1
2433302|NCT03552549|8337654|P1|Overall Study|Not in participant's best interest|2
2433303|NCT03552549|8337653|P2|Overall Study|Unknown (no reason provided)|2
2433304|NCT03552549|8337654|P1|Overall Study|Unknown (no reason provided)|4
2433305|NCT03552549|8337653|P2|Overall Study|Withdrawal by Subject|7
2433306|NCT03552549|8337654|P1|Overall Study|Withdrawal by Subject|7
2433307|NCT03552549|8337653|P2|Overall Study|Adverse event in first 12 months|8
2433308|NCT03552549|8337654|P1|Overall Study|Adverse event in first 12 months|12
2433309|NCT03552549|8337653|P2|Overall Study|Disease progression|17
2433310|NCT03552549|8337654|P1|Overall Study|Disease progression|25
2433311|NCT03552523|8337692|P2|Overall Study|Withdrawal by Subject|1
2433312|NCT03552523|8337693|P1|Overall Study|Withdrawal by Subject|1
2433313|NCT03551743|8337710|P4|Overall Study|Withdrawal by Subject|0
2433314|NCT03551743|8337711|P3|Overall Study|Withdrawal by Subject|0
2433315|NCT03551743|8337712|P2|Overall Study|Withdrawal by Subject|0
2433316|NCT03551743|8337713|P1|Overall Study|Withdrawal by Subject|1
2433317|NCT03551743|8337710|P4|Overall Study|Adverse Event|0
2433318|NCT03551743|8337711|P3|Overall Study|Adverse Event|0
2433319|NCT03551743|8337712|P2|Overall Study|Adverse Event|0
2433320|NCT03551743|8337713|P1|Overall Study|Adverse Event|1
2433321|NCT03551730|8337759|P4|Overall Study|Adverse Event|0
2433322|NCT03551730|8337760|P3|Overall Study|Adverse Event|0
2433323|NCT03551730|8337761|P2|Overall Study|Adverse Event|0
2433324|NCT03551730|8337762|P1|Overall Study|Adverse Event|1
2433325|NCT03550378|8337884|P2|Overall Study|Death|1
2433326|NCT03550378|8337885|P1|Overall Study|Death|0
2433327|NCT03549429|8337938|P2|Overall Study|Protocol Violation|3
2433328|NCT03549429|8337939|P1|Overall Study|Protocol Violation|5
2433329|NCT03549338|8337952|P3|Overall Study|Clinical Progression|0
2433330|NCT03549338|8337953|P2|Overall Study|Clinical Progression|1
2433331|NCT03549338|8337954|P1|Overall Study|Clinical Progression|0
2433332|NCT03549338|8337952|P3|Overall Study|Progressive Disease|0
2433333|NCT03549338|8337953|P2|Overall Study|Progressive Disease|0
2433334|NCT03549338|8337954|P1|Overall Study|Progressive Disease|1
2433335|NCT03549130|8337962|P2|Overall Study|Lost to Follow-up|1
2433336|NCT03549130|8337963|P1|Overall Study|Lost to Follow-up|0
2433337|NCT03549130|8337962|P2|Overall Study|Adverse Event|1
2433338|NCT03549130|8337963|P1|Overall Study|Adverse Event|0
2433339|NCT03549117|8337981|P2|Overall Study|Withdrawal by Subject|0
2433340|NCT03549117|8337982|P1|Overall Study|Withdrawal by Subject|1
2433341|NCT03547531|8338010|P2|Overall Study|having family occasion|2
2433342|NCT03547531|8338011|P1|Overall Study|having family occasion|0
2433343|NCT03547531|8338010|P2|Overall Study|not coming in data collection : sick|2
2433344|NCT03547531|8338011|P1|Overall Study|not coming in data collection : sick|2
2433345|NCT03547154|8338025|P2|Overall Study|Continued treatment beyond 12 mo.|50
2433346|NCT03547154|8338026|P1|Overall Study|Continued treatment beyond 12 mo.|58
2433347|NCT03547154|8338025|P2|Overall Study|Not Selected|1
2433348|NCT03547154|8338026|P1|Overall Study|Not Selected|0
2433349|NCT03547154|8338025|P2|Overall Study|Withdrawal by Subject|6
2433350|NCT03547154|8338026|P1|Overall Study|Withdrawal by Subject|10
2433351|NCT03547154|8338025|P2|Overall Study|Insufficient Therapeutic Response|10
2433352|NCT03547154|8338026|P1|Overall Study|Insufficient Therapeutic Response|13
2433353|NCT03547154|8338025|P2|Overall Study|Physician Decision|3
2433354|NCT03547154|8338026|P1|Overall Study|Physician Decision|4
2433355|NCT03547154|8338025|P2|Overall Study|Protocol Violation|1
2433356|NCT03547154|8338026|P1|Overall Study|Protocol Violation|6
2433357|NCT03547154|8338025|P2|Overall Study|Adverse Event|31
2433358|NCT03547154|8338026|P1|Overall Study|Adverse Event|26
2433359|NCT03547154|8338025|P2|Overall Study|Disease Progression/Recurrence|14
2433360|NCT03547154|8338026|P1|Overall Study|Disease Progression/Recurrence|6
2433361|NCT03546842|8338038|P1|Overall Study|Withdrawal by Subject|2
2433362|NCT03546842|8338038|P1|Overall Study|Protocol Violation|1
2433363|NCT03546621|8338051|P4|Overall Study|Progressive disease|1
2433364|NCT03546621|8338052|P3|Overall Study|Progressive disease|0
2433365|NCT03546621|8338053|P2|Overall Study|Progressive disease|0
2433366|NCT03546621|8338054|P1|Overall Study|Progressive disease|0
2433367|NCT03546621|8338051|P4|Overall Study|Adverse Event|1
2433368|NCT03546621|8338052|P3|Overall Study|Adverse Event|0
2433369|NCT03546621|8338053|P2|Overall Study|Adverse Event|1
2433370|NCT03546621|8338054|P1|Overall Study|Adverse Event|0
2433371|NCT03546621|8338051|P4|Overall Study|Lost to Follow-up|0
2433372|NCT03546621|8338052|P3|Overall Study|Lost to Follow-up|0
2433373|NCT03546621|8338053|P2|Overall Study|Lost to Follow-up|1
2433374|NCT03546621|8338054|P1|Overall Study|Lost to Follow-up|0
2433375|NCT03546621|8338051|P4|Overall Study|Withdrawal by Subject|1
2433376|NCT03546621|8338052|P3|Overall Study|Withdrawal by Subject|2
2433377|NCT03546621|8338053|P2|Overall Study|Withdrawal by Subject|1
2433378|NCT03546621|8338054|P1|Overall Study|Withdrawal by Subject|0
2433379|NCT03545984|8338144|P2|Overall Study|CSF cases not present during rotation|9
2433380|NCT03545984|8338145|P1|Overall Study|CSF cases not present during rotation|11
2433381|NCT03543137|8338230|P2|Study Period 2: Up to Day 8|Adverse Event|1
2433382|NCT03543137|8338231|P1|Study Period 2: Up to Day 8|Adverse Event|0
2433383|NCT03543137|8338230|P2|Study Period 2: Up to Day 8|Protocol Violation|0
2433384|NCT03543137|8338231|P1|Study Period 2: Up to Day 8|Protocol Violation|1
2433385|NCT03543137|8338230|P2|Study Period 2: Up to Day 8|Withdrawal by Subject|0
2433386|NCT03543137|8338231|P1|Study Period 2: Up to Day 8|Withdrawal by Subject|1
2433387|NCT03541044|8338251|P2|Study Period 2: Up to Day 8|Withdrawal by Subject|0
2433388|NCT03541044|8338252|P1|Study Period 2: Up to Day 8|Withdrawal by Subject|1
2433389|NCT03541044|8338251|P2|Study Period 2: Up to Day 8|Protocol Violation|0
2433390|NCT03541044|8338252|P1|Study Period 2: Up to Day 8|Protocol Violation|1
2433391|NCT03535844|8338413|P2|Overall Study|Withdrawal by Subject|1
2433392|NCT03535844|8338414|P1|Overall Study|Withdrawal by Subject|0
2433393|NCT03531905|8338671|P3|Overall Study|Could not speak with the participant|0
2433394|NCT03531905|8338672|P2|Overall Study|Could not speak with the participant|0
2433395|NCT03531905|8338673|P1|Overall Study|Could not speak with the participant|1
2433396|NCT03531905|8338671|P3|Overall Study|Participant was out of town|0
2433397|NCT03531905|8338672|P2|Overall Study|Participant was out of town|0
2433398|NCT03531905|8338673|P1|Overall Study|Participant was out of town|1
2433399|NCT03531905|8338671|P3|Overall Study|Lost to Follow-up|1
2433400|NCT03531905|8338672|P2|Overall Study|Lost to Follow-up|2
2433401|NCT03531905|8338673|P1|Overall Study|Lost to Follow-up|2
2433402|NCT03531905|8338671|P3|Overall Study|Withdrawal by Subject|2
2433403|NCT03531905|8338672|P2|Overall Study|Withdrawal by Subject|3
2433404|NCT03531905|8338673|P1|Overall Study|Withdrawal by Subject|3
2433405|NCT03528369|8338750|P3|Overall Study|Adverse Event|0
2433406|NCT03528369|8338751|P2|Overall Study|Adverse Event|1
2433407|NCT03528369|8338752|P1|Overall Study|Adverse Event|0
2433408|NCT03528369|8338750|P3|Overall Study|Lost to Follow-up|0
2433409|NCT03528369|8338751|P2|Overall Study|Lost to Follow-up|0
2433410|NCT03528369|8338752|P1|Overall Study|Lost to Follow-up|1
2433411|NCT03528369|8338750|P3|Overall Study|Withdrawal by Subject|0
2433412|NCT03528369|8338751|P2|Overall Study|Withdrawal by Subject|0
2433413|NCT03528369|8338752|P1|Overall Study|Withdrawal by Subject|2
2433414|NCT03528174|8338781|P1|Overall Study|sensors dislodged|1
2433415|NCT03528174|8338781|P1|Overall Study|Adverse Event|1
2433416|NCT03527966|8338801|P2|Overall Study|Lost to Follow-up|0
2433417|NCT03527966|8338802|P1|Overall Study|Lost to Follow-up|3
2433418|NCT03525678|8338832|P3|Overall Study|Death|4
2433419|NCT03525678|8338833|P2|Overall Study|Death|31
2433420|NCT03525678|8338834|P1|Overall Study|Death|32
2433421|NCT03525678|8338832|P3|Overall Study|Lost to Follow-up|0
2433422|NCT03525678|8338833|P2|Overall Study|Lost to Follow-up|0
2433423|NCT03525678|8338834|P1|Overall Study|Lost to Follow-up|1
2433424|NCT03525678|8338832|P3|Overall Study|Physician Decision|0
2433425|NCT03525678|8338833|P2|Overall Study|Physician Decision|2
2433426|NCT03525678|8338834|P1|Overall Study|Physician Decision|1
2433427|NCT03525678|8338832|P3|Overall Study|Withdrawal by Subject|0
2433428|NCT03525678|8338833|P2|Overall Study|Withdrawal by Subject|1
2433429|NCT03525678|8338834|P1|Overall Study|Withdrawal by Subject|3
2433430|NCT03525678|8338832|P3|Overall Study|Ongoing at the time of interim analysis|21
2433431|NCT03525678|8338833|P2|Overall Study|Ongoing at the time of interim analysis|65
2433432|NCT03525678|8338834|P1|Overall Study|Ongoing at the time of interim analysis|60
2433433|NCT03524157|8339037|P3|Overall Study|cytology not readable|1
2433434|NCT03524157|8339038|P2|Overall Study|cytology not readable|0
2433435|NCT03524157|8339039|P1|Overall Study|cytology not readable|0
2433436|NCT03522675|8339093|P1|Overall Study|Non-reactive to histamine|1
2433437|NCT03522675|8339093|P1|Overall Study|Screen fail|1
2433438|NCT03522506|8339111|P4|Washout Period 2 (7 Days)|Withdrawal by Subject|1
2433439|NCT03522506|8339112|P3|Washout Period 2 (7 Days)|Withdrawal by Subject|0
2433440|NCT03522506|8339113|P2|Washout Period 2 (7 Days)|Withdrawal by Subject|0
2433441|NCT03522506|8339114|P1|Washout Period 2 (7 Days)|Withdrawal by Subject|0
2433442|NCT03522506|8339111|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|1
2433443|NCT03522506|8339112|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2433444|NCT03522506|8339113|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2433445|NCT03522506|8339114|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2433446|NCT03521791|8339176|P2|Overall Study|Protocol Violation|17
2433447|NCT03521791|8339177|P1|Overall Study|Protocol Violation|7
2433448|NCT03520959|8339224|P2|Overall Study|Study terminated by Sponsor|1
2433449|NCT03520959|8339225|P1|Overall Study|Study terminated by Sponsor|0
2433450|NCT03519932|8339272|P2|First Intervention|Adverse Event|3
2433451|NCT03519932|8339273|P1|First Intervention|Adverse Event|1
2433452|NCT03519919|8339299|P1|Overall Study|Screen Failure|1
2433453|NCT03519919|8339299|P1|Overall Study|Lack of Efficacy|1
2433454|NCT03519919|8339299|P1|Overall Study|Withdrawal by Subject|1
2433455|NCT03519867|8339351|P10|Overall Study|Reason not provided|0
2433456|NCT03519867|8339352|P9|Overall Study|Reason not provided|1
2433457|NCT03519867|8339353|P8|Overall Study|Reason not provided|1
2433458|NCT03519867|8339354|P7|Overall Study|Reason not provided|0
2433459|NCT03519867|8339355|P6|Overall Study|Reason not provided|1
2433460|NCT03519867|8339356|P5|Overall Study|Reason not provided|0
2433461|NCT03519867|8339357|P4|Overall Study|Reason not provided|1
2433462|NCT03519867|8339358|P3|Overall Study|Reason not provided|1
2433463|NCT03519867|8339359|P2|Overall Study|Reason not provided|1
2433464|NCT03519867|8339360|P1|Overall Study|Reason not provided|1
2433465|NCT03519867|8339351|P10|Overall Study|Admin. of other reversal agent|0
2433466|NCT03519867|8339352|P9|Overall Study|Admin. of other reversal agent|0
2433467|NCT03519867|8339353|P8|Overall Study|Admin. of other reversal agent|0
2433468|NCT03519867|8339354|P7|Overall Study|Admin. of other reversal agent|0
2433469|NCT03519867|8339355|P6|Overall Study|Admin. of other reversal agent|1
2433470|NCT03519867|8339356|P5|Overall Study|Admin. of other reversal agent|0
2433471|NCT03519867|8339357|P4|Overall Study|Admin. of other reversal agent|0
2433472|NCT03519867|8339358|P3|Overall Study|Admin. of other reversal agent|0
2433473|NCT03519867|8339359|P2|Overall Study|Admin. of other reversal agent|1
2433474|NCT03519867|8339360|P1|Overall Study|Admin. of other reversal agent|1
2433475|NCT03519867|8339351|P10|Overall Study|Admin. of relaxant other than Zemuron®|0
2433476|NCT03519867|8339352|P9|Overall Study|Admin. of relaxant other than Zemuron®|0
2433477|NCT03519867|8339353|P8|Overall Study|Admin. of relaxant other than Zemuron®|0
2433478|NCT03519867|8339354|P7|Overall Study|Admin. of relaxant other than Zemuron®|1
2433479|NCT03519867|8339355|P6|Overall Study|Admin. of relaxant other than Zemuron®|0
2433480|NCT03519867|8339356|P5|Overall Study|Admin. of relaxant other than Zemuron®|0
2433481|NCT03519867|8339357|P4|Overall Study|Admin. of relaxant other than Zemuron®|0
2433482|NCT03519867|8339358|P3|Overall Study|Admin. of relaxant other than Zemuron®|0
2433483|NCT03519867|8339359|P2|Overall Study|Admin. of relaxant other than Zemuron®|0
2433484|NCT03519867|8339360|P1|Overall Study|Admin. of relaxant other than Zemuron®|0
2433485|NCT03519867|8339351|P10|Overall Study|Protocol Violation|0
2433486|NCT03519867|8339352|P9|Overall Study|Protocol Violation|0
2433487|NCT03519867|8339353|P8|Overall Study|Protocol Violation|0
2433488|NCT03519867|8339354|P7|Overall Study|Protocol Violation|0
2433489|NCT03519867|8339355|P6|Overall Study|Protocol Violation|1
2433490|NCT03519867|8339356|P5|Overall Study|Protocol Violation|0
2433491|NCT03519867|8339357|P4|Overall Study|Protocol Violation|0
2433492|NCT03519867|8339358|P3|Overall Study|Protocol Violation|0
2433493|NCT03519867|8339359|P2|Overall Study|Protocol Violation|0
2433494|NCT03519867|8339360|P1|Overall Study|Protocol Violation|0
2433495|NCT03519867|8339351|P10|Overall Study|Adverse Event|0
2433496|NCT03519867|8339352|P9|Overall Study|Adverse Event|0
2433497|NCT03519867|8339353|P8|Overall Study|Adverse Event|0
2433498|NCT03519867|8339354|P7|Overall Study|Adverse Event|0
2433499|NCT03519867|8339355|P6|Overall Study|Adverse Event|0
2433500|NCT03519867|8339356|P5|Overall Study|Adverse Event|0
2433501|NCT03519867|8339357|P4|Overall Study|Adverse Event|0
2433502|NCT03519867|8339358|P3|Overall Study|Adverse Event|0
2433503|NCT03519867|8339359|P2|Overall Study|Adverse Event|1
2433504|NCT03519867|8339360|P1|Overall Study|Adverse Event|1
2433505|NCT03519854|8339410|P18|Overall Study|Technical Error|0
2433506|NCT03519854|8339411|P17|Overall Study|Technical Error|0
2433507|NCT03519854|8339412|P16|Overall Study|Technical Error|0
2433508|NCT03519854|8339413|P15|Overall Study|Technical Error|0
2433509|NCT03519854|8339414|P14|Overall Study|Technical Error|0
2433510|NCT03519854|8339415|P13|Overall Study|Technical Error|0
2433511|NCT03519854|8339416|P12|Overall Study|Technical Error|0
2433512|NCT03519854|8339417|P11|Overall Study|Technical Error|0
2433513|NCT03519854|8339418|P10|Overall Study|Technical Error|0
2433514|NCT03519854|8339419|P9|Overall Study|Technical Error|0
2433515|NCT03519854|8339420|P8|Overall Study|Technical Error|0
2433516|NCT03519854|8339421|P7|Overall Study|Technical Error|0
2433517|NCT03519854|8339422|P6|Overall Study|Technical Error|0
2433518|NCT03519854|8339423|P5|Overall Study|Technical Error|0
2433519|NCT03519854|8339424|P4|Overall Study|Technical Error|0
2433520|NCT03519854|8339425|P3|Overall Study|Technical Error|1
2433521|NCT03519854|8339426|P2|Overall Study|Technical Error|0
2433522|NCT03519854|8339427|P1|Overall Study|Technical Error|0
2433523|NCT03519516|8339593|P2|Overall Study|Adverse Event|1
2433524|NCT03519516|8339594|P1|Overall Study|Adverse Event|0
2433525|NCT03519204|8339655|P2|Overall Study|Other Miscellaneous Reasons|0
2433526|NCT03519204|8339656|P1|Overall Study|Other Miscellaneous Reasons|1
2433527|NCT03519204|8339655|P2|Overall Study|Withdrawal by Subject|7
2433528|NCT03519204|8339656|P1|Overall Study|Withdrawal by Subject|9
2433529|NCT03519204|8339655|P2|Overall Study|Lost to Follow-up|8
2433530|NCT03519204|8339656|P1|Overall Study|Lost to Follow-up|3
2433531|NCT03518008|8339673|P2|Period 2, Second Week of Wear|Family emergency|1
2433532|NCT03518008|8339674|P1|Period 2, Second Week of Wear|Family emergency|0
2433533|NCT03513588|8339757|P3|Overall Study|Death|1
2433534|NCT03513588|8339758|P2|Overall Study|Death|0
2433535|NCT03513588|8339759|P1|Overall Study|Death|0
2433536|NCT03513588|8339757|P3|Overall Study|Study dosing paused by sponsor|0
2433537|NCT03513588|8339758|P2|Overall Study|Study dosing paused by sponsor|1
2433538|NCT03513588|8339759|P1|Overall Study|Study dosing paused by sponsor|1
2433539|NCT03513588|8339757|P3|Overall Study|Lost to Follow-up|1
2433540|NCT03513588|8339758|P2|Overall Study|Lost to Follow-up|1
2433541|NCT03513588|8339759|P1|Overall Study|Lost to Follow-up|0
2433542|NCT03512028|8339834|P2|Overall Study|Protocol Violation|0
2433543|NCT03512028|8339835|P1|Overall Study|Protocol Violation|2
2433544|NCT03512028|8339834|P2|Overall Study|Withdrawal by Subject|0
2433545|NCT03512028|8339835|P1|Overall Study|Withdrawal by Subject|2
2433546|NCT03511105|8339843|P2|Overall Study|Withdrew consent|0
2433547|NCT03511105|8339844|P1|Overall Study|Withdrew consent|1
2433548|NCT03511105|8339843|P2|Overall Study|Adverse Event|0
2433549|NCT03511105|8339844|P1|Overall Study|Adverse Event|1
2433550|NCT03510273|8339898|P1|Overall Study|Moved away from study area|4
2433551|NCT03510273|8339898|P1|Overall Study|Care outside study, ineligible to cont.|3
2433552|NCT03510273|8339898|P1|Overall Study|Withdrawal by Subject|2
2433553|NCT03509948|8339903|P2|Overall Study|Protocol Violation|1
2433554|NCT03509948|8339904|P1|Overall Study|Protocol Violation|0
2433555|NCT03508843|8339970|P1|Overall Study|technical difficulties|2
2433556|NCT03508843|8339970|P1|Overall Study|Withdrawal by Subject|1
2433557|NCT03508050|8339992|P2|Overall Study|Sustained desaturation|1
2433558|NCT03508050|8339993|P1|Overall Study|Sustained desaturation|0
2433559|NCT03508050|8339992|P2|Overall Study|Negative biopsy, surgery cancelled|1
2433560|NCT03508050|8339993|P1|Overall Study|Negative biopsy, surgery cancelled|3
2433561|NCT03508050|8339992|P2|Overall Study|Mucus plug|0
2433562|NCT03508050|8339993|P1|Overall Study|Mucus plug|1
2433563|NCT03508050|8339992|P2|Overall Study|Pleural adhesions|0
2433564|NCT03508050|8339993|P1|Overall Study|Pleural adhesions|1
2433565|NCT03506425|8340051|P3|Overall Study|Withdrawal by Subject|1
2433566|NCT03506425|8340052|P2|Overall Study|Withdrawal by Subject|0
2433567|NCT03506425|8340053|P1|Overall Study|Withdrawal by Subject|0
2433568|NCT03506425|8340051|P3|Overall Study|Death|0
2433569|NCT03506425|8340052|P2|Overall Study|Death|0
2433570|NCT03506425|8340053|P1|Overall Study|Death|1
2433571|NCT03506425|8340051|P3|Overall Study|Adverse Event|0
2433572|NCT03506425|8340052|P2|Overall Study|Adverse Event|3
2433573|NCT03506425|8340053|P1|Overall Study|Adverse Event|1
2433574|NCT03504189|8340093|P1|Overall Study|Device Failure|2
2433575|NCT03504189|8340093|P1|Overall Study|Screening Failure|1
2433576|NCT03504189|8340093|P1|Overall Study|Withdrawal by Subject|1
2433577|NCT03503188|8340108|P2|Overall Study|Non eligible in the sub study|1
2433578|NCT03503188|8340109|P1|Overall Study|Non eligible in the sub study|0
2433579|NCT03501277|8340146|P4|Intervention Period 3 (4 Days)|Adverse Event|1
2433580|NCT03501277|8340147|P3|Intervention Period 3 (4 Days)|Adverse Event|0
2433581|NCT03501277|8340148|P2|Intervention Period 3 (4 Days)|Adverse Event|0
2433582|NCT03501277|8340149|P1|Intervention Period 3 (4 Days)|Adverse Event|0
2433583|NCT03501277|8340146|P4|Intervention Period 2 (4 Days)|Adverse Event|1
2433584|NCT03501277|8340147|P3|Intervention Period 2 (4 Days)|Adverse Event|0
2433585|NCT03501277|8340148|P2|Intervention Period 2 (4 Days)|Adverse Event|0
2433586|NCT03501277|8340149|P1|Intervention Period 2 (4 Days)|Adverse Event|0
2433587|NCT03501277|8340146|P4|Intervention Period 1 (4 Days)|Adverse Event|1
2433588|NCT03501277|8340147|P3|Intervention Period 1 (4 Days)|Adverse Event|0
2433589|NCT03501277|8340148|P2|Intervention Period 1 (4 Days)|Adverse Event|0
2433590|NCT03501277|8340149|P1|Intervention Period 1 (4 Days)|Adverse Event|0
2433591|NCT03501277|8340146|P4|Intervention Period 1 (4 Days)|Other|0
2433592|NCT03501277|8340147|P3|Intervention Period 1 (4 Days)|Other|1
2433593|NCT03501277|8340148|P2|Intervention Period 1 (4 Days)|Other|0
2433594|NCT03501277|8340149|P1|Intervention Period 1 (4 Days)|Other|0
2433595|NCT03500679|8340189|P2|Overall Study|Withdrawal by Subject|0
2433596|NCT03500679|8340190|P1|Overall Study|Withdrawal by Subject|3
2433597|NCT03500679|8340189|P2|Overall Study|Lost to Follow-up|3
2433598|NCT03500679|8340190|P1|Overall Study|Lost to Follow-up|6
2433599|NCT03500224|8340257|P1|Overall Study|Withdrawal by Subject|2
2433600|NCT03500211|8340296|P2|Overall Study|Withdrawal by Subject|1
2433601|NCT03500211|8340297|P1|Overall Study|Withdrawal by Subject|1
2433602|NCT03500159|8340313|P2|Overall Study|Study Terminated|1
2433603|NCT03500159|8340314|P1|Overall Study|Study Terminated|2
2433604|NCT03497039|8340332|P2|Overall Study|Protocol Violation|1
2433605|NCT03497039|8340333|P1|Overall Study|Protocol Violation|0
2433606|NCT03497039|8340332|P2|Overall Study|Withdrawal by Subject|0
2433607|NCT03497039|8340333|P1|Overall Study|Withdrawal by Subject|1
2433608|NCT03494985|8340471|P4|Overall Study|Other (Not specified)|0
2433609|NCT03494985|8340472|P3|Overall Study|Other (Not specified)|1
2433610|NCT03494985|8340473|P2|Overall Study|Other (Not specified)|1
2433611|NCT03494985|8340474|P1|Overall Study|Other (Not specified)|0
2433612|NCT03494985|8340471|P4|Overall Study|Other (Withdrawal of consent)|5
2433613|NCT03494985|8340472|P3|Overall Study|Other (Withdrawal of consent)|2
2433614|NCT03494985|8340473|P2|Overall Study|Other (Withdrawal of consent)|3
2433615|NCT03494985|8340474|P1|Overall Study|Other (Withdrawal of consent)|2
2433616|NCT03494985|8340471|P4|Overall Study|Adverse Event|0
2433617|NCT03494985|8340472|P3|Overall Study|Adverse Event|3
2433618|NCT03494985|8340473|P2|Overall Study|Adverse Event|2
2433619|NCT03494985|8340474|P1|Overall Study|Adverse Event|3
2433620|NCT03493386|8340523|P4|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2433621|NCT03493386|8340524|P3|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2433622|NCT03493386|8340525|P2|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1
2433623|NCT03493386|8340526|P1|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2433624|NCT03492554|8340646|P2|Overall Study|Protocol Violation|14
2433625|NCT03492554|8340647|P1|Overall Study|Protocol Violation|0
2433626|NCT03491553|8340674|P6|Overall Study|Withdrew Consent|0
2433627|NCT03491553|8340675|P5|Overall Study|Withdrew Consent|0
2433628|NCT03491553|8340676|P4|Overall Study|Withdrew Consent|0
2433629|NCT03491553|8340677|P3|Overall Study|Withdrew Consent|0
2433630|NCT03491553|8340678|P2|Overall Study|Withdrew Consent|1
2433631|NCT03491553|8340679|P1|Overall Study|Withdrew Consent|1
2433632|NCT03491553|8340674|P6|Overall Study|Adverse Event|0
2433633|NCT03491553|8340675|P5|Overall Study|Adverse Event|0
2433634|NCT03491553|8340676|P4|Overall Study|Adverse Event|1
2433635|NCT03491553|8340677|P3|Overall Study|Adverse Event|0
2433636|NCT03491553|8340678|P2|Overall Study|Adverse Event|0
2433637|NCT03491553|8340679|P1|Overall Study|Adverse Event|0
2433638|NCT03489720|8340822|P2|Overall Study|Withdrawal by Subject|0
2433639|NCT03489720|8340823|P1|Overall Study|Withdrawal by Subject|2
2433640|NCT03489551|8340848|P1|Overall Study|Withdrawal by Subject|2
2433641|NCT03489304|8340852|P1|Overall Study|Lost to Follow-up|4
2433642|NCT03488108|8340860|P2|Second Intervention (12 Weeks)|Withdrawal by Subject|0
2433643|NCT03488108|8340861|P1|Second Intervention (12 Weeks)|Withdrawal by Subject|1
2433644|NCT03488108|8340860|P2|First Intervention (12 Weeks)|Withdrawal by Subject|1
2433645|NCT03488108|8340861|P1|First Intervention (12 Weeks)|Withdrawal by Subject|0
2433646|NCT03486392|8340888|P5|Overall Study|Death|1
2433647|NCT03486392|8340889|P4|Overall Study|Death|0
2433648|NCT03486392|8340890|P3|Overall Study|Death|0
2433649|NCT03486392|8340891|P2|Overall Study|Death|0
2433650|NCT03486392|8340892|P1|Overall Study|Death|0
2433651|NCT03486392|8340888|P5|Overall Study|Withdrawal by Subject|1
2433652|NCT03486392|8340889|P4|Overall Study|Withdrawal by Subject|4
2433653|NCT03486392|8340890|P3|Overall Study|Withdrawal by Subject|6
2433654|NCT03486392|8340891|P2|Overall Study|Withdrawal by Subject|0
2433655|NCT03486392|8340892|P1|Overall Study|Withdrawal by Subject|3
2433656|NCT03486392|8340888|P5|Overall Study|Lost to Follow-up|2
2433657|NCT03486392|8340889|P4|Overall Study|Lost to Follow-up|5
2433658|NCT03486392|8340890|P3|Overall Study|Lost to Follow-up|8
2433659|NCT03486392|8340891|P2|Overall Study|Lost to Follow-up|0
2433660|NCT03486392|8340892|P1|Overall Study|Lost to Follow-up|0
2433661|NCT03483623|8340935|P1|Overall Study|43 complete sets achieved|1
2433662|NCT03482453|8340982|P12|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2433663|NCT03482453|8340983|P11|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1
2433664|NCT03482453|8340984|P10|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2433665|NCT03482453|8340985|P9|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2433666|NCT03482453|8340986|P8|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2433667|NCT03482453|8340987|P7|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2433668|NCT03482453|8340988|P6|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2433669|NCT03482453|8340989|P5|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2433670|NCT03482453|8340990|P4|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2433671|NCT03482453|8340991|P3|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2433672|NCT03482453|8340992|P2|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2433673|NCT03482453|8340993|P1|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
2433674|NCT03481309|8341116|P6|Washout (at Least 3 Days)|Withdrawal by Subject|0
2433675|NCT03481309|8341117|P5|Washout (at Least 3 Days)|Withdrawal by Subject|0
2433676|NCT03481309|8341118|P4|Washout (at Least 3 Days)|Withdrawal by Subject|0
2433677|NCT03481309|8341119|P3|Washout (at Least 3 Days)|Withdrawal by Subject|0
2433678|NCT03481309|8341120|P2|Washout (at Least 3 Days)|Withdrawal by Subject|0
2433679|NCT03481309|8341121|P1|Washout (at Least 3 Days)|Withdrawal by Subject|1
2433680|NCT03480841|8341163|P1|Overall Study|Lost to Follow-up|2
2433681|NCT03480152|8341174|P3|Phase I|Signed consent. Died before treatment.|0
2433682|NCT03480152|8341175|P2|Phase I|Signed consent. Died before treatment.|0
2433683|NCT03480152|8341176|P1|Phase I|Signed consent. Died before treatment.|1
2433684|NCT03479216|8341215|P2|Overall Study|Physician Decision|3
2433685|NCT03479216|8341216|P1|Overall Study|Physician Decision|2
2433686|NCT03479216|8341215|P2|Overall Study|Withdrawal by Subject|2
2433687|NCT03479216|8341216|P1|Overall Study|Withdrawal by Subject|3
2433688|NCT03478891|8341237|P3|Overall Study|Lost to Follow-up|1
2433689|NCT03478891|8341238|P2|Overall Study|Lost to Follow-up|0
2433690|NCT03478891|8341239|P1|Overall Study|Lost to Follow-up|1
2433691|NCT03478891|8341237|P3|Overall Study|Moved from area|1
2433692|NCT03478891|8341238|P2|Overall Study|Moved from area|0
2433693|NCT03478891|8341239|P1|Overall Study|Moved from area|0
2433694|NCT03478891|8341237|P3|Overall Study|Enrolled, but product never administered|1
2433695|NCT03478891|8341238|P2|Overall Study|Enrolled, but product never administered|0
2433696|NCT03478891|8341239|P1|Overall Study|Enrolled, but product never administered|0
2433697|NCT03478696|8341290|P2|Overall Study|Withdrawal by Subject|4
2433698|NCT03478696|8341291|P1|Overall Study|Withdrawal by Subject|9
2433699|NCT03478696|8341290|P2|Overall Study|Physician Decision|3
2433700|NCT03478696|8341291|P1|Overall Study|Physician Decision|6
2433701|NCT03478696|8341290|P2|Overall Study|Lost to Follow-up|0
2433702|NCT03478696|8341291|P1|Overall Study|Lost to Follow-up|1
2433703|NCT03478696|8341290|P2|Overall Study|Adverse Event|5
2433704|NCT03478696|8341291|P1|Overall Study|Adverse Event|1
2433705|NCT03478683|8341305|P2|Overall Study|Withdrawal by Subject|7
2433706|NCT03478683|8341306|P1|Overall Study|Withdrawal by Subject|7
2433707|NCT03478683|8341305|P2|Overall Study|Physician Decision|3
2433708|NCT03478683|8341306|P1|Overall Study|Physician Decision|1
2433709|NCT03478683|8341305|P2|Overall Study|Lost to Follow-up|5
2433710|NCT03478683|8341306|P1|Overall Study|Lost to Follow-up|0
2433711|NCT03478683|8341305|P2|Overall Study|Adverse Event|3
2433712|NCT03478683|8341306|P1|Overall Study|Adverse Event|5
2433713|NCT03478657|8341320|P2|Overall Study|Withdrawal by Subject|1
2433714|NCT03478657|8341321|P1|Overall Study|Withdrawal by Subject|0
2433715|NCT03478644|8341336|P2|Phase 2|Lost to Follow-up|0
2433716|NCT03478644|8341337|P1|Phase 2|Lost to Follow-up|1
2433717|NCT03478644|8341336|P2|Phase 2|Withdrawal by Subject|1
2433718|NCT03478644|8341337|P1|Phase 2|Withdrawal by Subject|2
2433719|NCT03478371|8341349|P1|Overall Study|Lost to Follow-up|4
2433720|NCT03478371|8341349|P1|Overall Study|non-compliance|1
2433721|NCT03477903|8341371|P1|Overall Study|Study Terminated by Sponsor|1
2433722|NCT03475875|8341428|P2|Period 2|Protocol Violation|1
2433723|NCT03475875|8341429|P1|Period 2|Protocol Violation|0
2433724|NCT03475875|8341428|P2|Period 2|Adverse Event|0
2433725|NCT03475875|8341429|P1|Period 2|Adverse Event|3
2433726|NCT03475875|8341428|P2|Period 1|Adverse Event|1
2433727|NCT03475875|8341429|P1|Period 1|Adverse Event|2
2433728|NCT03475875|8341428|P2|Period 1|Lost to Follow-up|0
2433729|NCT03475875|8341429|P1|Period 1|Lost to Follow-up|1
2433730|NCT03474081|8341467|P2|Overall Study|Investigator site closed|0
2433731|NCT03474081|8341468|P1|Overall Study|Investigator site closed|1
2433732|NCT03474081|8341467|P2|Overall Study|Withdrawal by Subject|7
2433733|NCT03474081|8341468|P1|Overall Study|Withdrawal by Subject|5
2433734|NCT03474081|8341467|P2|Overall Study|Physician Decision|2
2433735|NCT03474081|8341468|P1|Overall Study|Physician Decision|3
2433736|NCT03474081|8341467|P2|Overall Study|Lost to Follow-up|1
2433737|NCT03474081|8341468|P1|Overall Study|Lost to Follow-up|2
2433738|NCT03474081|8341467|P2|Overall Study|Adverse Event|3
2433739|NCT03474081|8341468|P1|Overall Study|Adverse Event|6
2433740|NCT03473808|8341484|P1|Overall Study|Withdrawal by Subject|1
2433741|NCT03473236|8341501|P10|Overall Study|Withdrawal by Subject|0
2433742|NCT03473236|8341502|P9|Overall Study|Withdrawal by Subject|1
2433743|NCT03473236|8341503|P8|Overall Study|Withdrawal by Subject|0
2433744|NCT03473236|8341504|P7|Overall Study|Withdrawal by Subject|0
2433745|NCT03473236|8341505|P6|Overall Study|Withdrawal by Subject|1
2433746|NCT03473236|8341506|P5|Overall Study|Withdrawal by Subject|0
2433747|NCT03473236|8341507|P4|Overall Study|Withdrawal by Subject|0
2433748|NCT03473236|8341508|P3|Overall Study|Withdrawal by Subject|0
2433749|NCT03473236|8341509|P2|Overall Study|Withdrawal by Subject|0
2433750|NCT03473236|8341510|P1|Overall Study|Withdrawal by Subject|0
2433751|NCT03473197|8341630|P1|Overall Study|Withdrawal by Subject|5
2433752|NCT03473197|8341630|P1|Overall Study|Lost to Follow-up|1
2433753|NCT03473197|8341630|P1|Overall Study|Adverse Event|4
2433754|NCT03472547|8341642|P1|Overall Study|Withdrawal by Subject|30
2433755|NCT03472534|8341646|P1|Overall Study|Adverse Event|2
2433756|NCT03472534|8341646|P1|Overall Study|Withdrawal by Subject|9
2433757|NCT03471871|8341672|P5|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
2433758|NCT03471871|8341673|P4|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1
2433759|NCT03471871|8341674|P3|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
2433760|NCT03471871|8341675|P2|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
2433761|NCT03471871|8341676|P1|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
2433762|NCT03471871|8341672|P5|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1
2433763|NCT03471871|8341673|P4|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
2433764|NCT03471871|8341674|P3|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
2433765|NCT03471871|8341675|P2|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
2433766|NCT03471871|8341676|P1|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
2433767|NCT03471871|8341672|P5|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1
2433768|NCT03471871|8341673|P4|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
2433769|NCT03471871|8341674|P3|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
2433770|NCT03471871|8341675|P2|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
2433771|NCT03471871|8341676|P1|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
2433772|NCT03471871|8341672|P5|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1
2433773|NCT03471871|8341673|P4|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1
2433774|NCT03471871|8341674|P3|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
2433775|NCT03471871|8341675|P2|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
2433776|NCT03471871|8341676|P1|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
2433777|NCT03471871|8341672|P5|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
2433778|NCT03471871|8341673|P4|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
2433779|NCT03471871|8341674|P3|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1
2433780|NCT03471871|8341675|P2|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
2433781|NCT03471871|8341676|P1|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
2433782|NCT03468543|8341804|P1|Overall Study|Protocol stopping rules met|3
2433783|NCT03467971|8341816|P2|Treatment Period 2|Withdrawal by Subject|1
2433784|NCT03467971|8341817|P1|Treatment Period 2|Withdrawal by Subject|0
2433785|NCT03467945|8341841|P4|Treatment Period 3|Withdrawal by Subject|1
2433786|NCT03467945|8341842|P3|Treatment Period 3|Withdrawal by Subject|2
2433787|NCT03467945|8341843|P2|Treatment Period 3|Withdrawal by Subject|0
2433788|NCT03467945|8341844|P1|Treatment Period 3|Withdrawal by Subject|1
2433789|NCT03467945|8341841|P4|Treatment Period 2|Withdrawal by Subject|0
2433790|NCT03467945|8341842|P3|Treatment Period 2|Withdrawal by Subject|0
2433791|NCT03467945|8341843|P2|Treatment Period 2|Withdrawal by Subject|1
2433792|NCT03467945|8341844|P1|Treatment Period 2|Withdrawal by Subject|0
2433793|NCT03466658|8341896|P1|Overall Study|Withdrawal by Subject|3
2433794|NCT03466086|8341902|P2|Period 1|Withdrawal by Subject|0
2433795|NCT03466086|8341903|P1|Period 1|Withdrawal by Subject|1
2433796|NCT03466086|8341902|P2|Period 1|Sponsor decision due to study timeline|0
2433797|NCT03466086|8341903|P1|Period 1|Sponsor decision due to study timeline|1
2433798|NCT03466073|8341917|P6|Overall Study|Death|1
2433799|NCT03466073|8341918|P5|Overall Study|Death|0
2433800|NCT03466073|8341919|P4|Overall Study|Death|0
2433801|NCT03466073|8341920|P3|Overall Study|Death|0
2433802|NCT03466073|8341921|P2|Overall Study|Death|0
2433803|NCT03466073|8341922|P1|Overall Study|Death|1
2433804|NCT03466060|8341955|P6|Period 2|Lens Handling Difficulties|0
2433805|NCT03466060|8341956|P5|Period 2|Lens Handling Difficulties|0
2433806|NCT03466060|8341957|P4|Period 2|Lens Handling Difficulties|0
2433807|NCT03466060|8341958|P3|Period 2|Lens Handling Difficulties|1
2433808|NCT03466060|8341959|P2|Period 2|Lens Handling Difficulties|0
2433809|NCT03466060|8341960|P1|Period 2|Lens Handling Difficulties|0
2433810|NCT03466060|8341955|P6|Period 1|Grade 2 Conjunctivitis|0
2433811|NCT03466060|8341956|P5|Period 1|Grade 2 Conjunctivitis|0
2433812|NCT03466060|8341957|P4|Period 1|Grade 2 Conjunctivitis|0
2433813|NCT03466060|8341958|P3|Period 1|Grade 2 Conjunctivitis|1
2433814|NCT03466060|8341959|P2|Period 1|Grade 2 Conjunctivitis|0
2433815|NCT03466060|8341960|P1|Period 1|Grade 2 Conjunctivitis|0
2433816|NCT03466060|8341955|P6|Period 1|Lost to Follow-up|0
2433817|NCT03466060|8341956|P5|Period 1|Lost to Follow-up|0
2433818|NCT03466060|8341957|P4|Period 1|Lost to Follow-up|1
2433819|NCT03466060|8341958|P3|Period 1|Lost to Follow-up|0
2433820|NCT03466060|8341959|P2|Period 1|Lost to Follow-up|0
2433821|NCT03466060|8341960|P1|Period 1|Lost to Follow-up|0
2433822|NCT03466060|8341955|P6|Period 1|Withdrawal by Subject|0
2433823|NCT03466060|8341956|P5|Period 1|Withdrawal by Subject|0
2433824|NCT03466060|8341957|P4|Period 1|Withdrawal by Subject|0
2433825|NCT03466060|8341958|P3|Period 1|Withdrawal by Subject|2
2433826|NCT03466060|8341959|P2|Period 1|Withdrawal by Subject|0
2433827|NCT03466060|8341960|P1|Period 1|Withdrawal by Subject|0
2433828|NCT03466060|8341955|P6|Period 1|Test Lens Damage|0
2433829|NCT03466060|8341956|P5|Period 1|Test Lens Damage|0
2433830|NCT03466060|8341957|P4|Period 1|Test Lens Damage|0
2433831|NCT03466060|8341958|P3|Period 1|Test Lens Damage|0
2433832|NCT03466060|8341959|P2|Period 1|Test Lens Damage|2
2433833|NCT03466060|8341960|P1|Period 1|Test Lens Damage|0
2433834|NCT03465904|8341976|P2|Overall Study|Ineligible for mITT analysis|47
2433835|NCT03465904|8341977|P1|Overall Study|Ineligible for mITT analysis|62
2433836|NCT03465904|8341976|P2|Overall Study|Protocol Violation|5
2433837|NCT03465904|8341977|P1|Overall Study|Protocol Violation|8
2433838|NCT03465904|8341976|P2|Overall Study|Lost to Follow-up|9
2433839|NCT03465904|8341977|P1|Overall Study|Lost to Follow-up|10
2433840|NCT03465904|8341976|P2|Overall Study|Withdrawal by Subject|5
2433841|NCT03465904|8341977|P1|Overall Study|Withdrawal by Subject|9
2433842|NCT03465436|8341999|P4|Period 4|Protocol Violation|0
2433843|NCT03465436|8342000|P3|Period 4|Protocol Violation|1
2433844|NCT03465436|8342001|P2|Period 4|Protocol Violation|0
2433845|NCT03465436|8342002|P1|Period 4|Protocol Violation|0
2433846|NCT03465436|8341999|P4|Period 3|Protocol Violation|0
2433847|NCT03465436|8342000|P3|Period 3|Protocol Violation|0
2433848|NCT03465436|8342001|P2|Period 3|Protocol Violation|1
2433849|NCT03465436|8342002|P1|Period 3|Protocol Violation|1
2433850|NCT03465436|8341999|P4|Period 2|Protocol Violation|0
2433851|NCT03465436|8342000|P3|Period 2|Protocol Violation|0
2433852|NCT03465436|8342001|P2|Period 2|Protocol Violation|1
2433853|NCT03465436|8342002|P1|Period 2|Protocol Violation|0
2433854|NCT03465436|8341999|P4|Period 1|Protocol Violation|0
2433855|NCT03465436|8342000|P3|Period 1|Protocol Violation|1
2433856|NCT03465436|8342001|P2|Period 1|Protocol Violation|0
2433857|NCT03465436|8342002|P1|Period 1|Protocol Violation|0
2433858|NCT03463031|8342058|P2|Overall Study|Use of prohibited medication by subject|0
2433859|NCT03463031|8342059|P1|Overall Study|Use of prohibited medication by subject|1
2433860|NCT03463031|8342058|P2|Overall Study|Adverse Event|1
2433861|NCT03463031|8342059|P1|Overall Study|Adverse Event|4
2433862|NCT03463031|8342058|P2|Overall Study|Lost to Follow-up|1
2433863|NCT03463031|8342059|P1|Overall Study|Lost to Follow-up|1
2433864|NCT03463031|8342058|P2|Overall Study|Investigator/Sponsor Decision|1
2433865|NCT03463031|8342059|P1|Overall Study|Investigator/Sponsor Decision|0
2433866|NCT03463031|8342058|P2|Overall Study|Withdrawal by Subject|2
2433867|NCT03463031|8342059|P1|Overall Study|Withdrawal by Subject|4
2433868|NCT03461757|8342109|P2|Overall Study|Other Reasons|4
2433869|NCT03461757|8342110|P1|Overall Study|Other Reasons|1
2433870|NCT03461757|8342109|P2|Overall Study|Withdrawal by Subject|7
2433871|NCT03461757|8342110|P1|Overall Study|Withdrawal by Subject|7
2433872|NCT03461757|8342109|P2|Overall Study|Protocol Violation|1
2433873|NCT03461757|8342110|P1|Overall Study|Protocol Violation|1
2433874|NCT03461757|8342109|P2|Overall Study|Pregnancy|0
2433875|NCT03461757|8342110|P1|Overall Study|Pregnancy|2
2433876|NCT03461757|8342109|P2|Overall Study|Non-compliance with study treatment|1
2433877|NCT03461757|8342110|P1|Overall Study|Non-compliance with study treatment|0
2433878|NCT03461757|8342109|P2|Overall Study|Not Experienced Moderate/Severe Migraine|25
2433879|NCT03461757|8342110|P1|Overall Study|Not Experienced Moderate/Severe Migraine|28
2433880|NCT03461757|8342109|P2|Overall Study|Lost to Follow-up|7
2433881|NCT03461757|8342110|P1|Overall Study|Lost to Follow-up|13
2433882|NCT03461757|8342109|P2|Overall Study|Adverse Event|0
2433883|NCT03461757|8342110|P1|Overall Study|Adverse Event|1
2433884|NCT03459196|8342279|P1|Overall Study|Subject didn't receive study catheter|2
2433885|NCT03458702|8342323|P2|Study Condition B (Yoga or Rest)|Lost to Follow-up|2
2433886|NCT03458702|8342324|P1|Study Condition B (Yoga or Rest)|Lost to Follow-up|4
2433887|NCT03458702|8342323|P2|Study Condition A (Yoga or Rest)|Lost to Follow-up|6
2433888|NCT03458702|8342324|P1|Study Condition A (Yoga or Rest)|Lost to Follow-up|4
2433889|NCT03457727|8342353|P4|Part 2, Washout Period 1 (5 Days)|Adverse Event|1
2433890|NCT03457727|8342354|P3|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
2433891|NCT03457727|8342355|P2|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
2433892|NCT03457727|8342356|P1|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
2433893|NCT03457636|8342553|P1|Overall Study|Lost to Follow-up|2
2433894|NCT03456960|8342566|P6|Period 2 (1 Day)|Adverse Event|0
2433895|NCT03456960|8342567|P5|Period 2 (1 Day)|Adverse Event|0
2433896|NCT03456960|8342568|P4|Period 2 (1 Day)|Adverse Event|1
2433897|NCT03456960|8342569|P3|Period 2 (1 Day)|Adverse Event|0
2433898|NCT03456960|8342570|P2|Period 2 (1 Day)|Adverse Event|0
2433899|NCT03456960|8342571|P1|Period 2 (1 Day)|Adverse Event|1
2433900|NCT03456960|8342566|P6|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
2433901|NCT03456960|8342567|P5|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
2433902|NCT03456960|8342568|P4|Washout Period (at Least 14 Days)|Withdrawal by Subject|2
2433903|NCT03456960|8342569|P3|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
2433904|NCT03456960|8342570|P2|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
2433905|NCT03456960|8342571|P1|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
2433906|NCT03456856|8342663|P1|Overall Study|Withdrawal by Subject|1
2433907|NCT03456856|8342663|P1|Overall Study|Lost to Follow-up|2
2433908|NCT03455543|8342682|P2|Overall Study|Physician Decision|0
2433909|NCT03455543|8342683|P1|Overall Study|Physician Decision|2
2433910|NCT03455543|8342682|P2|Overall Study|Withdrawal by Subject|2
2433911|NCT03455543|8342683|P1|Overall Study|Withdrawal by Subject|7
2433912|NCT03455543|8342682|P2|Overall Study|Adverse Event|5
2433913|NCT03455543|8342683|P1|Overall Study|Adverse Event|2
2433914|NCT03451721|8343050|P1|Overall Study|Death|1
2433915|NCT03450070|8343059|P1|Overall Study|Withdrawal by Subject|8
2433916|NCT03448536|8343104|P2|Overall Study|Physician Decision|0
2433917|NCT03448536|8343105|P1|Overall Study|Physician Decision|1
2433918|NCT03448536|8343104|P2|Overall Study|Other|0
2433919|NCT03448536|8343105|P1|Overall Study|Other|3
2433920|NCT03448536|8343104|P2|Overall Study|Inadequate pain reporter|0
2433921|NCT03448536|8343105|P1|Overall Study|Inadequate pain reporter|1
2433922|NCT03448536|8343104|P2|Overall Study|Lost to Follow-up|2
2433923|NCT03448536|8343105|P1|Overall Study|Lost to Follow-up|3
2433924|NCT03448536|8343104|P2|Overall Study|Withdrawal by Subject|2
2433925|NCT03448536|8343105|P1|Overall Study|Withdrawal by Subject|1
2433926|NCT03448536|8343104|P2|Overall Study|Pregnancy|0
2433927|NCT03448536|8343105|P1|Overall Study|Pregnancy|1
2433928|NCT03448536|8343104|P2|Overall Study|Protocol Violation|0
2433929|NCT03448536|8343105|P1|Overall Study|Protocol Violation|2
2433930|NCT03447821|8343132|P3|Overall Study|Lost to Follow-up|1
2433931|NCT03447821|8343133|P2|Overall Study|Lost to Follow-up|0
2433932|NCT03447821|8343134|P1|Overall Study|Lost to Follow-up|0
2433933|NCT03447821|8343132|P3|Overall Study|Withdrawal by Subject|0
2433934|NCT03447821|8343133|P2|Overall Study|Withdrawal by Subject|1
2433935|NCT03447821|8343134|P1|Overall Study|Withdrawal by Subject|1
2433936|NCT03447353|8343170|P1|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1
2433937|NCT03447353|8343170|P1|Overall Study|Scheduling Conflicts|3
2433938|NCT03447353|8343170|P1|Overall Study|Lost to Follow-up|4
2433939|NCT03447353|8343170|P1|Overall Study|Failure at Screening Visit|2
2433940|NCT03447249|8343186|P2|Overall Study|Other|0
2433941|NCT03447249|8343187|P1|Overall Study|Other|3
2433942|NCT03447249|8343186|P2|Overall Study|Withdrawal of consent (not due to AE)|0
2433943|NCT03447249|8343187|P1|Overall Study|Withdrawal of consent (not due to AE)|1
2433944|NCT03447249|8343186|P2|Overall Study|Adverse Event|0
2433945|NCT03447249|8343187|P1|Overall Study|Adverse Event|1
2433946|NCT03444584|8343294|P2|Overall Study|Other|1
2433947|NCT03444584|8343295|P1|Overall Study|Other|0
2433948|NCT03444584|8343294|P2|Overall Study|Withdrawal by Subject|1
2433949|NCT03444584|8343295|P1|Overall Study|Withdrawal by Subject|0
2434033|NCT03434119|8344536|P1|Overall Study|Withdrawal by Subject|7
2433950|NCT03443713|8343365|P3|First at Home Period (9-14 Days)|Withdrawal by Subject|1
2433951|NCT03443713|8343366|P2|First at Home Period (9-14 Days)|Withdrawal by Subject|0
2433952|NCT03443713|8343367|P1|First at Home Period (9-14 Days)|Withdrawal by Subject|0
2433953|NCT03443414|8343401|P5|Overall Study|Reason not specified|1
2433954|NCT03443414|8343402|P4|Overall Study|Reason not specified|0
2433955|NCT03443414|8343403|P3|Overall Study|Reason not specified|0
2433956|NCT03443414|8343404|P2|Overall Study|Reason not specified|0
2433957|NCT03443414|8343405|P1|Overall Study|Reason not specified|2
2433958|NCT03443414|8343401|P5|Overall Study|Death|0
2433959|NCT03443414|8343402|P4|Overall Study|Death|1
2433960|NCT03443414|8343403|P3|Overall Study|Death|0
2433961|NCT03443414|8343404|P2|Overall Study|Death|1
2433962|NCT03443414|8343405|P1|Overall Study|Death|0
2433963|NCT03443414|8343401|P5|Overall Study|Withdrawal by Subject|1
2433964|NCT03443414|8343402|P4|Overall Study|Withdrawal by Subject|2
2433965|NCT03443414|8343403|P3|Overall Study|Withdrawal by Subject|2
2433966|NCT03443414|8343404|P2|Overall Study|Withdrawal by Subject|2
2433967|NCT03443414|8343405|P1|Overall Study|Withdrawal by Subject|3
2433968|NCT03443414|8343401|P5|Overall Study|Adverse Event|3
2433969|NCT03443414|8343402|P4|Overall Study|Adverse Event|2
2433970|NCT03443414|8343403|P3|Overall Study|Adverse Event|4
2433971|NCT03443414|8343404|P2|Overall Study|Adverse Event|0
2433972|NCT03443414|8343405|P1|Overall Study|Adverse Event|6
2433973|NCT03441984|8343565|P12|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2433974|NCT03441984|8343566|P11|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2433975|NCT03441984|8343567|P10|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2433976|NCT03441984|8343568|P9|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2433977|NCT03441984|8343569|P8|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2433978|NCT03441984|8343570|P7|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2433979|NCT03441984|8343571|P6|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2433980|NCT03441984|8343572|P5|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2433981|NCT03441984|8343573|P4|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2433982|NCT03441984|8343574|P3|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1
2433983|NCT03441984|8343575|P2|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2433984|NCT03441984|8343576|P1|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
2433985|NCT03441789|8343937|P2|Overall Study|Lost to Follow-up|1
2433986|NCT03441789|8343938|P1|Overall Study|Lost to Follow-up|0
2433987|NCT03441789|8343937|P2|Overall Study|Protocol Violation|1
2433988|NCT03441789|8343938|P1|Overall Study|Protocol Violation|0
2433989|NCT03441789|8343937|P2|Overall Study|Adverse Event|1
2433990|NCT03441789|8343938|P1|Overall Study|Adverse Event|0
2433991|NCT03441789|8343937|P2|Overall Study|Withdrawal by Subject|1
2433992|NCT03441789|8343938|P1|Overall Study|Withdrawal by Subject|1
2433993|NCT03440918|8344120|P2|Overall Study|Protocol Violation|16
2433994|NCT03440918|8344121|P1|Overall Study|Protocol Violation|0
2433995|NCT03439072|8344217|P2|Overall Study|Physician Decision|1
2433996|NCT03439072|8344218|P1|Overall Study|Physician Decision|0
2433997|NCT03439072|8344217|P2|Overall Study|Withdrawal by Subject|3
2433998|NCT03439072|8344218|P1|Overall Study|Withdrawal by Subject|2
2433999|NCT03438539|8344256|P6|Overall Study|Lost to Follow-up|8
2434000|NCT03438539|8344257|P5|Overall Study|Lost to Follow-up|3
2434001|NCT03438539|8344258|P4|Overall Study|Lost to Follow-up|9
2434002|NCT03438539|8344259|P3|Overall Study|Lost to Follow-up|10
2434003|NCT03438539|8344260|P2|Overall Study|Lost to Follow-up|4
2434004|NCT03438539|8344261|P1|Overall Study|Lost to Follow-up|8
2434005|NCT03438383|8344289|P2|Overall Study|Protocol Violation|3
2434006|NCT03438383|8344290|P1|Overall Study|Protocol Violation|9
2434007|NCT03437733|8344321|P2|Overall Study|Eligibility criteria not met|3
2434008|NCT03437733|8344322|P1|Overall Study|Eligibility criteria not met|0
2434009|NCT03437447|8344362|P3|Treatment Period 1|Withdrawal by Subject|1
2434010|NCT03437447|8344363|P2|Treatment Period 1|Withdrawal by Subject|0
2434011|NCT03437447|8344364|P1|Treatment Period 1|Withdrawal by Subject|0
2434012|NCT03436732|8344419|P2|Overall Study|Death|1
2434013|NCT03436732|8344420|P1|Overall Study|Death|0
2434014|NCT03436732|8344419|P2|Overall Study|Adverse Event|0
2434015|NCT03436732|8344420|P1|Overall Study|Adverse Event|2
2434016|NCT03436732|8344419|P2|Overall Study|Off study after cycle 1|0
2434017|NCT03436732|8344420|P1|Overall Study|Off study after cycle 1|1
2434018|NCT03436732|8344419|P2|Overall Study|Not treated-enrolled in different study|0
2434019|NCT03436732|8344420|P1|Overall Study|Not treated-enrolled in different study|1
2434020|NCT03434977|8344463|P2|Washout Period (at Least 6 Days)|Adverse Event|1
2434021|NCT03434977|8344464|P1|Washout Period (at Least 6 Days)|Adverse Event|0
2434022|NCT03434249|8344500|P2|Overall Study|Difficulties in completing daily diary|1
2434023|NCT03434249|8344501|P1|Overall Study|Difficulties in completing daily diary|2
2434024|NCT03434249|8344500|P2|Overall Study|Non-compliance of family|1
2434025|NCT03434249|8344501|P1|Overall Study|Non-compliance of family|2
2434026|NCT03434249|8344500|P2|Overall Study|Lost to Follow-up|1
2434027|NCT03434249|8344501|P1|Overall Study|Lost to Follow-up|0
2434028|NCT03434249|8344500|P2|Overall Study|Adverse Event|0
2434029|NCT03434249|8344501|P1|Overall Study|Adverse Event|1
2434030|NCT03434119|8344535|P2|Overall Study|Other than specified|5
2434031|NCT03434119|8344536|P1|Overall Study|Other than specified|7
2434032|NCT03434119|8344535|P2|Overall Study|Withdrawal by Subject|5
2434034|NCT03434119|8344535|P2|Overall Study|Study Terminated by Sponsor|102
2434035|NCT03434119|8344536|P1|Overall Study|Study Terminated by Sponsor|91
2434036|NCT03434119|8344535|P2|Overall Study|Poor Compliance to Protocol|1
2434037|NCT03434119|8344536|P1|Overall Study|Poor Compliance to Protocol|0
2434038|NCT03434119|8344535|P2|Overall Study|Adverse Event|0
2434039|NCT03434119|8344536|P1|Overall Study|Adverse Event|1
2434040|NCT03434119|8344535|P2|Overall Study|Randomized but not treated|0
2434041|NCT03434119|8344536|P1|Overall Study|Randomized but not treated|1
2434042|NCT03433703|8344554|P1|Overall Study|Study terminated by Sponsor|2
2434043|NCT03433677|8344563|P2|Period 2|Withdrawal by Subject|1
2434044|NCT03433677|8344564|P1|Period 2|Withdrawal by Subject|1
2434045|NCT03433677|8344563|P2|Period 1|Protocol Violation|0
2434046|NCT03433677|8344564|P1|Period 1|Protocol Violation|1
2434047|NCT03432533|8344584|P2|Overall Study|Withdrawal by Subject|9
2434048|NCT03432533|8344585|P1|Overall Study|Withdrawal by Subject|14
2434049|NCT03432533|8344584|P2|Overall Study|Lost to Follow-up|2
2434050|NCT03432533|8344585|P1|Overall Study|Lost to Follow-up|1
2434051|NCT03432390|8344601|P2|Apnea Period|Protocol Violation|2
2434052|NCT03432390|8344602|P1|Apnea Period|Protocol Violation|2
2434053|NCT03431441|8344612|P1|Overall Study|Dispensed Incorrect Replacement Lens|1
2434054|NCT03431441|8344612|P1|Overall Study|Adverse Event|2
2434055|NCT03431441|8344612|P1|Overall Study|Withdrawal by Subject|2
2434056|NCT03430245|8344645|P1|Overall Study|Lost to Follow-up|1
2434057|NCT03430245|8344645|P1|Overall Study|Withdrawal by Subject|6
2434058|NCT03429556|8344671|P4|Overall Study|Lost to Follow-up|0
2434059|NCT03429556|8344672|P3|Overall Study|Lost to Follow-up|0
2434060|NCT03429556|8344673|P2|Overall Study|Lost to Follow-up|1
2434061|NCT03429556|8344674|P1|Overall Study|Lost to Follow-up|0
2434062|NCT03428997|8344720|P1|Overall Study|Lost to Follow-up|4
2434063|NCT03428997|8344720|P1|Overall Study|Withdrawal by Subject|3
2434064|NCT03428997|8344720|P1|Overall Study|Sponsor decision.|1
2434065|NCT03428152|8344728|P2|Overall Study|Lack of Efficacy|4
2434066|NCT03428152|8344729|P1|Overall Study|Lack of Efficacy|0
2434067|NCT03428152|8344728|P2|Overall Study|Protocol Violation|5
2434068|NCT03428152|8344729|P1|Overall Study|Protocol Violation|3
2434069|NCT03428152|8344728|P2|Overall Study|Physician Decision|2
2434070|NCT03428152|8344729|P1|Overall Study|Physician Decision|4
2434071|NCT03427892|8344745|P1|Overall Study|Lost to Follow-up|2
2434072|NCT03427073|8344769|P8|Overall Study|Physician Decision|1
2434073|NCT03427073|8344770|P7|Overall Study|Physician Decision|1
2434074|NCT03427073|8344771|P6|Overall Study|Physician Decision|0
2434075|NCT03427073|8344772|P5|Overall Study|Physician Decision|0
2434076|NCT03427073|8344773|P4|Overall Study|Physician Decision|0
2434077|NCT03427073|8344774|P3|Overall Study|Physician Decision|0
2434078|NCT03427073|8344775|P2|Overall Study|Physician Decision|0
2434079|NCT03427073|8344776|P1|Overall Study|Physician Decision|0
2434080|NCT03427073|8344769|P8|Overall Study|Disease Progression|3
2434081|NCT03427073|8344770|P7|Overall Study|Disease Progression|2
2434082|NCT03427073|8344771|P6|Overall Study|Disease Progression|4
2434083|NCT03427073|8344772|P5|Overall Study|Disease Progression|3
2434084|NCT03427073|8344773|P4|Overall Study|Disease Progression|3
2434085|NCT03427073|8344774|P3|Overall Study|Disease Progression|1
2434086|NCT03427073|8344775|P2|Overall Study|Disease Progression|1
2434087|NCT03427073|8344776|P1|Overall Study|Disease Progression|1
2434088|NCT03426787|8344826|P1|Overall Study|Unrelated to intervention death|1
2434089|NCT03426787|8344826|P1|Overall Study|Lost to Follow-up|7
2434090|NCT03426787|8344826|P1|Overall Study|Withdrawal by Subject|6
2434091|NCT03426631|8344836|P2|Overall Study|Lost to Follow-up|1
2434092|NCT03426631|8344837|P1|Overall Study|Lost to Follow-up|0
2434093|NCT03426436|8344849|P1|Overall Study|ECGs not saved|4
2434094|NCT03426436|8344849|P1|Overall Study|Consent issue|1
2434095|NCT03426436|8344849|P1|Overall Study|Withdrawal by Subject|2
2434096|NCT03426436|8344849|P1|Overall Study|Incorrect lead placement|12
2434097|NCT03426137|8344857|P3|Overall Study|Withdrawal by Subject|0
2434098|NCT03426137|8344858|P2|Overall Study|Withdrawal by Subject|0
2434099|NCT03426137|8344859|P1|Overall Study|Withdrawal by Subject|3
2434100|NCT03421730|8344901|P12|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2434101|NCT03421730|8344902|P11|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2434102|NCT03421730|8344903|P10|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2434103|NCT03421730|8344904|P9|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2434104|NCT03421730|8344905|P8|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2434105|NCT03421730|8344906|P7|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2434106|NCT03421730|8344907|P6|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2434107|NCT03421730|8344908|P5|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2
2434108|NCT03421730|8344909|P4|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2434109|NCT03421730|8344910|P3|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2434110|NCT03421730|8344911|P2|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2434111|NCT03421730|8344912|P1|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
2434112|NCT03421730|8344901|P12|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2434113|NCT03421730|8344902|P11|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2434114|NCT03421730|8344903|P10|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2434115|NCT03421730|8344904|P9|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2434116|NCT03421730|8344905|P8|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2434117|NCT03421730|8344906|P7|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2434118|NCT03421730|8344907|P6|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2434119|NCT03421730|8344908|P5|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2434120|NCT03421730|8344909|P4|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2434121|NCT03421730|8344910|P3|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2434122|NCT03421730|8344911|P2|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2
2434123|NCT03421730|8344912|P1|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
2434124|NCT03421379|8344985|P2|Period 1|Did not receive treatment|2
2434125|NCT03421379|8344986|P1|Period 1|Did not receive treatment|1
2434126|NCT03421379|8344985|P2|Period 1|Physician Decision|1
2434127|NCT03421379|8344986|P1|Period 1|Physician Decision|1
2434128|NCT03421379|8344985|P2|Period 1|Withdrawal by Subject|1
2434129|NCT03421379|8344986|P1|Period 1|Withdrawal by Subject|0
2434130|NCT03420300|8345032|P1|Overall Study|Death|2
2434131|NCT03419962|8345041|P1|Overall Study|Missing completion data|31
2434132|NCT03419962|8345041|P1|Overall Study|Difficulty in inhaling the doses|1
2434133|NCT03419962|8345041|P1|Overall Study|Lost to Follow-up|3
2434134|NCT03419962|8345041|P1|Overall Study|Refusal of continuing with trial drug|1
2434135|NCT03419962|8345041|P1|Overall Study|Change to other medication|1
2434136|NCT03418571|8345100|P2|Overall Study|Consent withdrawn by legal guardian|0
2434137|NCT03418571|8345101|P1|Overall Study|Consent withdrawn by legal guardian|1
2434138|NCT03418376|8345113|P4|Overall Study|Exacerbation|0
2434139|NCT03418376|8345114|P3|Overall Study|Exacerbation|0
2434140|NCT03418376|8345115|P2|Overall Study|Exacerbation|1
2434141|NCT03418376|8345116|P1|Overall Study|Exacerbation|0
2434142|NCT03418376|8345113|P4|Overall Study|Personal reasons|1
2434143|NCT03418376|8345114|P3|Overall Study|Personal reasons|2
2434144|NCT03418376|8345115|P2|Overall Study|Personal reasons|2
2434145|NCT03418376|8345116|P1|Overall Study|Personal reasons|0
2434146|NCT03418376|8345113|P4|Overall Study|Musculoskeletal injury|0
2434147|NCT03418376|8345114|P3|Overall Study|Musculoskeletal injury|1
2434148|NCT03418376|8345115|P2|Overall Study|Musculoskeletal injury|2
2434149|NCT03418376|8345116|P1|Overall Study|Musculoskeletal injury|1
2434150|NCT03417830|8345174|P2|Part A (up to 26 Days)|Study Closed/Terminated|0
2434151|NCT03417830|8345175|P1|Part A (up to 26 Days)|Study Closed/Terminated|1
2434152|NCT03417505|8345274|P2|First Lens Type (30 Days)|Lost to Follow-up|1
2434153|NCT03417505|8345275|P1|First Lens Type (30 Days)|Lost to Follow-up|1
2434154|NCT03417219|8345306|P2|Overall Study|Lost to Follow-up|3
2434155|NCT03417219|8345307|P1|Overall Study|Lost to Follow-up|0
2434156|NCT03417024|8345317|P1|Overall Study|Physician Decision|2
2434157|NCT03417024|8345317|P1|Overall Study|Study Termination prior to follow-up|11
2434158|NCT03415178|8345406|P2|Single Arm Period (up to Week 16)|Adverse Event|1
2434159|NCT03415178|8345407|P1|Single Arm Period (up to Week 16)|Adverse Event|0
2434160|NCT03415178|8345406|P2|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2
2434161|NCT03415178|8345407|P1|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0
2434162|NCT03414359|8345444|P2|Overall Study|Protocol Violation|1
2434163|NCT03414359|8345445|P1|Overall Study|Protocol Violation|0
2434164|NCT03414359|8345444|P2|Overall Study|Lack of Efficacy|1
2434165|NCT03414359|8345445|P1|Overall Study|Lack of Efficacy|1
2434166|NCT03412929|8345482|P1|Overall Study|Protocol Violation|3
2434167|NCT03412019|8345493|P2|Overall Study|Withdrawal by Subject|1
2434168|NCT03412019|8345494|P1|Overall Study|Withdrawal by Subject|1
2434169|NCT03408639|8345543|P2|Overall Study|Physician Decision|6
2434170|NCT03408639|8345544|P1|Overall Study|Physician Decision|3
2434171|NCT03408639|8345543|P2|Overall Study|Withdrawal by Subject|7
2434172|NCT03408639|8345544|P1|Overall Study|Withdrawal by Subject|2
2434173|NCT03408639|8345543|P2|Overall Study|Lost to Follow-up|4
2434174|NCT03408639|8345544|P1|Overall Study|Lost to Follow-up|1
2434175|NCT03408639|8345543|P2|Overall Study|Death|5
2434176|NCT03408639|8345544|P1|Overall Study|Death|5
2434177|NCT03407430|8345669|P2|Washout|Protocol Violation|0
2434178|NCT03407430|8345670|P1|Washout|Protocol Violation|1
2434179|NCT03406260|8345771|P6|Period 1|Adverse Event|0
2434180|NCT03406260|8345772|P5|Period 1|Adverse Event|1
2434181|NCT03406260|8345773|P4|Period 1|Adverse Event|0
2434182|NCT03406260|8345774|P3|Period 1|Adverse Event|0
2434183|NCT03406260|8345775|P2|Period 1|Adverse Event|0
2434184|NCT03406260|8345776|P1|Period 1|Adverse Event|0
2434185|NCT03405935|8345788|P1|Overall Study|Still on Study|83
2434186|NCT03405935|8345788|P1|Overall Study|Adverse Event|3
2434187|NCT03405818|8345799|P1|Overall Study|Lost to Follow-up|4
2434188|NCT03405818|8345799|P1|Overall Study|Withdrawal by Subject|4
2434189|NCT03404843|8345853|P2|Overall Study|Study difficulties unrelated to Tx|1
2434190|NCT03404843|8345854|P1|Overall Study|Study difficulties unrelated to Tx|4
2434191|NCT03404206|8345883|P3|Overall Study|Lost to Follow-up|0
2434192|NCT03404206|8345884|P2|Overall Study|Lost to Follow-up|1
2434193|NCT03404206|8345885|P1|Overall Study|Lost to Follow-up|3
2434194|NCT03404206|8345883|P3|Overall Study|Withdrawal by Subject|0
2434195|NCT03404206|8345884|P2|Overall Study|Withdrawal by Subject|1
2434196|NCT03404206|8345885|P1|Overall Study|Withdrawal by Subject|1
2434197|NCT03403036|8345980|P1|Overall Study|Lack of Efficacy|5
2434198|NCT03402893|8346007|P1|Overall Study|Withdrawal by Subject|1
2434199|NCT03402750|8346018|P2|Overall Study|Lost to Follow-up|1
2434200|NCT03402750|8346019|P1|Overall Study|Lost to Follow-up|2
2434201|NCT03400787|8346078|P2|Overall Study|Unblinded before 3-month follow-upa-|6
2434202|NCT03400787|8346079|P1|Overall Study|Unblinded before 3-month follow-upa-|0
2434203|NCT03400787|8346078|P2|Overall Study|Protocol Violation|2
2434204|NCT03400787|8346079|P1|Overall Study|Protocol Violation|0
2434205|NCT03400787|8346078|P2|Overall Study|Death|0
2434206|NCT03400787|8346079|P1|Overall Study|Death|1
2434207|NCT03400787|8346078|P2|Overall Study|Lost to Follow-up|0
2434208|NCT03400787|8346079|P1|Overall Study|Lost to Follow-up|1
2434209|NCT03396835|8346284|P1|Overall Study|Did not meet criteria for data analysis|1
2434210|NCT03396835|8346284|P1|Overall Study|Withdrawn prior to completion|1
2434211|NCT03394391|8346301|P2|Overall Study|Lost to Follow-up|2
2434212|NCT03394391|8346302|P1|Overall Study|Lost to Follow-up|1
2434213|NCT03392194|8346388|P2|Overall Study|Conflicts with personal schedule|0
2434214|NCT03392194|8346389|P1|Overall Study|Conflicts with personal schedule|1
2434215|NCT03392194|8346388|P2|Overall Study|Withdrawal by Subject|2
2434216|NCT03392194|8346389|P1|Overall Study|Withdrawal by Subject|1
2434217|NCT03390426|8346424|P2|Overall Study|Protocol Violation|1
2434218|NCT03390426|8346425|P1|Overall Study|Protocol Violation|0
2434219|NCT03390166|8346439|P2|Overall Study|Move to work oversea|1
2434220|NCT03390166|8346440|P1|Overall Study|Move to work oversea|0
2434221|NCT03390166|8346439|P2|Overall Study|To drug therapy course|1
2434222|NCT03390166|8346440|P1|Overall Study|To drug therapy course|0
2434223|NCT03390166|8346439|P2|Overall Study|To militarycamp for conscript|0
2434224|NCT03390166|8346440|P1|Overall Study|To militarycamp for conscript|1
2434225|NCT03390166|8346439|P2|Overall Study|Move from study area|2
2434226|NCT03390166|8346440|P1|Overall Study|Move from study area|3
2434227|NCT03390166|8346439|P2|Overall Study|Physician Decision|1
2434228|NCT03390166|8346440|P1|Overall Study|Physician Decision|2
2434229|NCT03390166|8346439|P2|Overall Study|Lost to Follow-up|4
2434230|NCT03390166|8346440|P1|Overall Study|Lost to Follow-up|6
2434231|NCT03390166|8346439|P2|Overall Study|Death|1
2434232|NCT03390166|8346440|P1|Overall Study|Death|0
2434233|NCT03387683|8346454|P2|Overall Study|Did not receive treatment|0
2434234|NCT03387683|8346455|P1|Overall Study|Did not receive treatment|1
2434235|NCT03387683|8346454|P2|Overall Study|In receipt of disallowed medication|0
2434236|NCT03387683|8346455|P1|Overall Study|In receipt of disallowed medication|1
2434237|NCT03387462|8346463|P1|Overall Study|Lost to Follow-up|1
2434238|NCT03387059|8346472|P2|Overall Study|Study termination|4
2434239|NCT03387059|8346473|P1|Overall Study|Study termination|5
2434240|NCT03387046|8346487|P2|Overall Study|Adverse Event|1
2434241|NCT03387046|8346488|P1|Overall Study|Adverse Event|1
2434242|NCT03386474|8346514|P2|Overall Study|Adverse Event|1
2434243|NCT03386474|8346515|P1|Overall Study|Adverse Event|0
2434244|NCT03386474|8346514|P2|Overall Study|Death|0
2434245|NCT03386474|8346515|P1|Overall Study|Death|1
2434246|NCT03386448|8346537|P2|Overall Study|Adverse Event|2
2434247|NCT03386448|8346538|P1|Overall Study|Adverse Event|0
2434248|NCT03386435|8346546|P2|Overall Study|Protocol Violation|7
2434249|NCT03386435|8346547|P1|Overall Study|Protocol Violation|5
2434250|NCT03384316|8346570|P2|Overall Study|Screen failure|1
2434251|NCT03384316|8346571|P1|Overall Study|Screen failure|0
2434252|NCT03383887|8346594|P2|Overall Study|Lost to Follow-up|1
2434253|NCT03383887|8346595|P1|Overall Study|Lost to Follow-up|0
2434254|NCT03383783|8346603|P1|Overall Study|Withdrawal by Subject|2
2434255|NCT03383614|8346681|P4|Overall Study|Withdrawal by Subject|0
2434256|NCT03383614|8346682|P3|Overall Study|Withdrawal by Subject|0
2434257|NCT03383614|8346683|P2|Overall Study|Withdrawal by Subject|1
2434258|NCT03383614|8346684|P1|Overall Study|Withdrawal by Subject|0
2434259|NCT03382834|8346941|P2|Overall Study|Withdrawal by Subject|1
2434260|NCT03382834|8346942|P1|Overall Study|Withdrawal by Subject|0
2434261|NCT03382834|8346941|P2|Overall Study|Lost to Follow-up|0
2434262|NCT03382834|8346942|P1|Overall Study|Lost to Follow-up|1
2434263|NCT03382262|8346958|P4|Overall Study|Withdrawal by Subject|1
2434264|NCT03382262|8346959|P3|Overall Study|Withdrawal by Subject|0
2434265|NCT03382262|8346960|P2|Overall Study|Withdrawal by Subject|0
2434266|NCT03382262|8346961|P1|Overall Study|Withdrawal by Subject|0
2434267|NCT03382262|8346958|P4|Overall Study|Physician Decision|0
2434268|NCT03382262|8346959|P3|Overall Study|Physician Decision|1
2434269|NCT03382262|8346960|P2|Overall Study|Physician Decision|0
2434270|NCT03382262|8346961|P1|Overall Study|Physician Decision|0
2434271|NCT03380429|8347110|P5|Overall Study|Adverse Event|0
2434272|NCT03380429|8347111|P4|Overall Study|Adverse Event|2
2434273|NCT03380429|8347112|P3|Overall Study|Adverse Event|1
2434274|NCT03380429|8347113|P2|Overall Study|Adverse Event|1
2434275|NCT03380429|8347114|P1|Overall Study|Adverse Event|1
2434276|NCT03380429|8347110|P5|Overall Study|Lack of Efficacy|1
2434277|NCT03380429|8347111|P4|Overall Study|Lack of Efficacy|2
2434278|NCT03380429|8347112|P3|Overall Study|Lack of Efficacy|0
2434279|NCT03380429|8347113|P2|Overall Study|Lack of Efficacy|0
2434280|NCT03380429|8347114|P1|Overall Study|Lack of Efficacy|0
2434281|NCT03380429|8347110|P5|Overall Study|Protocol Violation|1
2434282|NCT03380429|8347111|P4|Overall Study|Protocol Violation|0
2434283|NCT03380429|8347112|P3|Overall Study|Protocol Violation|1
2434284|NCT03380429|8347113|P2|Overall Study|Protocol Violation|0
2434285|NCT03380429|8347114|P1|Overall Study|Protocol Violation|1
2434286|NCT03380429|8347110|P5|Overall Study|Lost to Follow-up|1
2434287|NCT03380429|8347111|P4|Overall Study|Lost to Follow-up|3
2434288|NCT03380429|8347112|P3|Overall Study|Lost to Follow-up|4
2434289|NCT03380429|8347113|P2|Overall Study|Lost to Follow-up|2
2434290|NCT03380429|8347114|P1|Overall Study|Lost to Follow-up|0
2434291|NCT03380429|8347110|P5|Overall Study|Withdrawal by Subject|1
2434292|NCT03380429|8347111|P4|Overall Study|Withdrawal by Subject|2
2434293|NCT03380429|8347112|P3|Overall Study|Withdrawal by Subject|5
2434294|NCT03380429|8347113|P2|Overall Study|Withdrawal by Subject|3
2434295|NCT03380429|8347114|P1|Overall Study|Withdrawal by Subject|3
2434296|NCT03380429|8347110|P5|Overall Study|Physician Decision|1
2434297|NCT03380429|8347111|P4|Overall Study|Physician Decision|1
2434298|NCT03380429|8347112|P3|Overall Study|Physician Decision|0
2434299|NCT03380429|8347113|P2|Overall Study|Physician Decision|1
2434300|NCT03380429|8347114|P1|Overall Study|Physician Decision|0
2434301|NCT03380390|8347167|P1|Overall Study|Adverse Event|3
2434302|NCT03379376|8347259|P1|Overall Study|Death|1
2434303|NCT03379376|8347259|P1|Overall Study|Overwhelmed, didn't want to continue|1
2434304|NCT03379376|8347259|P1|Overall Study|Did not wish to complete follow up|1
2434305|NCT03379376|8347259|P1|Overall Study|Lost to Follow-up|2
2434306|NCT03379233|8347269|P2|Overall Study|Technical issues with Concept 2 inhalers|6
2434307|NCT03379233|8347270|P1|Overall Study|Technical issues with Concept 2 inhalers|1
2434308|NCT03376516|8347302|P1|Overall Study|Consent withdrawn|1
2434309|NCT03376516|8347302|P1|Overall Study|Not treated|1
2434310|NCT03374995|8347368|P2|Overall Study|Withdrawal by Subject|1
2434311|NCT03374995|8347369|P1|Overall Study|Withdrawal by Subject|0
2434312|NCT03374488|8347383|P2|Overall Study|On-going at clinical cut off date|28
2434313|NCT03374488|8347384|P1|Overall Study|On-going at clinical cut off date|30
2434314|NCT03374488|8347383|P2|Overall Study|Withdrawal by Subject|1
2434315|NCT03374488|8347384|P1|Overall Study|Withdrawal by Subject|1
2434316|NCT03374488|8347383|P2|Overall Study|Death|8
2434317|NCT03374488|8347384|P1|Overall Study|Death|10
2434318|NCT03374189|8347396|P2|Overall Study|Lost to Follow-up|0
2434319|NCT03374189|8347397|P1|Overall Study|Lost to Follow-up|1
2434320|NCT03372603|8347478|P2|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0
2434321|NCT03372603|8347479|P1|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1
2434322|NCT03372603|8347478|P2|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0
2434323|NCT03372603|8347479|P1|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1
2434324|NCT03372551|8347521|P2|First Intervention (1 Week)|Withdrawal by Subject|0
2434325|NCT03372551|8347522|P1|First Intervention (1 Week)|Withdrawal by Subject|1
2434326|NCT03372369|8347552|P2|Intervention and Follow-Up Period|Withdrawal by Subject|3
2434327|NCT03372369|8347553|P1|Intervention and Follow-Up Period|Withdrawal by Subject|3
2434328|NCT03372369|8347552|P2|Qualification Period|Inconsistent Eligibility Results|9
2434329|NCT03372369|8347553|P1|Qualification Period|Inconsistent Eligibility Results|10
2434330|NCT03372369|8347552|P2|Qualification Period|Withdrawal by Subject|13
2434331|NCT03372369|8347553|P1|Qualification Period|Withdrawal by Subject|16
2434332|NCT03371459|8347565|P2|Washout|Lost to Follow-up|1
2434333|NCT03371459|8347566|P1|Washout|Lost to Follow-up|0
2434334|NCT03371381|8347574|P1|Overall Study|Other|4
2434335|NCT03371381|8347574|P1|Overall Study|Study terminated by sponsor|3
2434336|NCT03371381|8347574|P1|Overall Study|Death|5
2434337|NCT03370419|8347595|P1|Overall Study|Lost to Follow-up|16
2434338|NCT03370289|8347599|P1|Overall Study|Sample Size Sufficient|4
2434339|NCT03370289|8347599|P1|Overall Study|Screen Failure|1
2434340|NCT03369704|8347635|P2|Follow-up Epoch|Lost to Follow-up|0
2434341|NCT03369704|8347636|P1|Follow-up Epoch|Lost to Follow-up|1
2434342|NCT03369704|8347635|P2|Treatment Epoch|Adverse Event|0
2434343|NCT03369704|8347636|P1|Treatment Epoch|Adverse Event|2
2434344|NCT03369704|8347635|P2|Treatment Epoch|Lack of Efficacy|2
2434345|NCT03369704|8347636|P1|Treatment Epoch|Lack of Efficacy|0
2434346|NCT03369704|8347635|P2|Treatment Epoch|Lost to Follow-up|1
2434347|NCT03369704|8347636|P1|Treatment Epoch|Lost to Follow-up|0
2434348|NCT03369704|8347635|P2|Treatment Epoch|Protocol Violation|0
2434349|NCT03369704|8347636|P1|Treatment Epoch|Protocol Violation|1
2434350|NCT03369704|8347635|P2|Treatment Epoch|technical problems|0
2434351|NCT03369704|8347636|P1|Treatment Epoch|technical problems|1
2434352|NCT03368807|8347756|P1|Period 1 (Blinded CGM)|Lost to Follow-up|1
2434353|NCT03368807|8347756|P1|Period 1 (Blinded CGM)|Sponsor Decision|1
2434354|NCT03368807|8347756|P1|Period 1 (Blinded CGM)|Protocol Violation|1
2434355|NCT03368807|8347756|P1|Period 1 (Blinded CGM)|Withdrawal by Subject|3
2434356|NCT03368170|8347772|P2|Overall Study|Adverse Event|1
2434357|NCT03368170|8347773|P1|Overall Study|Adverse Event|2
2434358|NCT03365934|8347805|P1|Overall Study|Withdrawal by Subject|1
2434359|NCT03365934|8347805|P1|Overall Study|Adverse Event|1
2434360|NCT03365011|8348095|P2|Overall Study|Withdrawal by Subject|2
2434361|NCT03365011|8348096|P1|Overall Study|Withdrawal by Subject|1
2434362|NCT03364608|8348106|P1|Overall Study|Lost to Follow-up|2
2434363|NCT03364608|8348106|P1|Overall Study|Protocol Violation|2
2434364|NCT03364608|8348106|P1|Overall Study|Withdrawal by Subject|4
2434365|NCT03364335|8348133|P5|Overall Study|Lost to Follow-up|11
2434366|NCT03364335|8348134|P4|Overall Study|Lost to Follow-up|11
2434367|NCT03364335|8348135|P3|Overall Study|Lost to Follow-up|10
2434368|NCT03364335|8348136|P2|Overall Study|Lost to Follow-up|7
2434369|NCT03364335|8348137|P1|Overall Study|Lost to Follow-up|7
2434370|NCT03364335|8348133|P5|Overall Study|Adverse Event|0
2434371|NCT03364335|8348134|P4|Overall Study|Adverse Event|2
2434372|NCT03364335|8348135|P3|Overall Study|Adverse Event|1
2434373|NCT03364335|8348136|P2|Overall Study|Adverse Event|4
2434374|NCT03364335|8348137|P1|Overall Study|Adverse Event|3
2434375|NCT03363906|8348209|P2|Period 2 (Test or Reference)|Lost to Follow-up|0
2434376|NCT03363906|8348210|P1|Period 2 (Test or Reference)|Lost to Follow-up|1
2434377|NCT03363906|8348209|P2|Period 2 (Test or Reference)|Withdrawal by Subject|1
2434378|NCT03363906|8348210|P1|Period 2 (Test or Reference)|Withdrawal by Subject|1
2434379|NCT03363906|8348209|P2|Period 2 (Test or Reference)|Adverse Event|0
2434380|NCT03363906|8348210|P1|Period 2 (Test or Reference)|Adverse Event|2
2434381|NCT03363906|8348209|P2|Period 1 (Reference or Test)|Adverse Event|2
2434382|NCT03363906|8348210|P1|Period 1 (Reference or Test)|Adverse Event|1
2434383|NCT03361865|8348280|P2|Overall Study|On-going at clinical cut off date|39
2434384|NCT03361865|8348281|P1|Overall Study|On-going at clinical cut off date|29
2434385|NCT03361865|8348280|P2|Overall Study|Physician Decision|0
2434386|NCT03361865|8348281|P1|Overall Study|Physician Decision|1
2434387|NCT03361865|8348280|P2|Overall Study|Death|10
2434388|NCT03361865|8348281|P1|Overall Study|Death|13
2434389|NCT03361176|8348293|P2|Overall Study|Withdrawal by Subject|1
2434390|NCT03361176|8348294|P1|Overall Study|Withdrawal by Subject|0
2434391|NCT03361176|8348293|P2|Overall Study|Adverse Event|2
2434392|NCT03361176|8348294|P1|Overall Study|Adverse Event|0
2434393|NCT03361176|8348293|P2|Overall Study|Lost to Follow-up|2
2434394|NCT03361176|8348294|P1|Overall Study|Lost to Follow-up|1
2434395|NCT03360071|8348327|P2|Overall Study|Lost to Follow-up|0
2434396|NCT03360071|8348328|P1|Overall Study|Lost to Follow-up|1
2434397|NCT03358472|8348352|P3|Overall Study|On-going at clinical cut off date|5
2434398|NCT03358472|8348353|P2|Overall Study|On-going at clinical cut off date|6
2434399|NCT03358472|8348354|P1|Overall Study|On-going at clinical cut off date|9
2434400|NCT03358472|8348352|P3|Overall Study|Withdrawal by Subject|1
2434401|NCT03358472|8348353|P2|Overall Study|Withdrawal by Subject|0
2434402|NCT03358472|8348354|P1|Overall Study|Withdrawal by Subject|0
2434403|NCT03358472|8348352|P3|Overall Study|Physician Decision|0
2434404|NCT03358472|8348353|P2|Overall Study|Physician Decision|1
2434405|NCT03358472|8348354|P1|Overall Study|Physician Decision|0
2434406|NCT03358472|8348352|P3|Overall Study|Death|10
2434407|NCT03358472|8348353|P2|Overall Study|Death|3
2434408|NCT03358472|8348354|P1|Overall Study|Death|6
2434409|NCT03358329|8348383|P1|Overall Study|Withdrawal by Subject|2
2434410|NCT03358329|8348383|P1|Overall Study|Lost to Follow-up|2
2434411|NCT03357952|8348391|P2|Overall Study|Sponsor Decision|0
2434412|NCT03357952|8348392|P1|Overall Study|Sponsor Decision|9
2434413|NCT03357952|8348391|P2|Overall Study|Withdrawal by Subject|1
2434414|NCT03357952|8348392|P1|Overall Study|Withdrawal by Subject|0
2434415|NCT03357471|8348401|P2|Overall Study|Lost to Follow-up|0
2434416|NCT03357471|8348402|P1|Overall Study|Lost to Follow-up|1
2434417|NCT03357471|8348401|P2|Overall Study|Adverse Event|0
2434418|NCT03357471|8348402|P1|Overall Study|Adverse Event|1
2434419|NCT03356977|8348426|P1|Overall Study|Withdrawal by parent/guardian|2
2434420|NCT03356977|8348426|P1|Overall Study|Lost to Follow-up|3
2434421|NCT03354663|8348474|P1|Completed 30-day Visit|Missed Visit|1
2434422|NCT03354663|8348474|P1|Completed 30-day Visit|Withdrawal by Subject|1
2434423|NCT03354663|8348474|P1|Enrollment to Catheter Insertion|Adverse Event|1
2434424|NCT03354663|8348474|P1|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4
2434425|NCT03352713|8348515|P1|Overall Study|Device incompatible/stolen|5
2434426|NCT03352713|8348515|P1|Overall Study|Completed 0 EMAs|8
2434427|NCT03352713|8348515|P1|Overall Study|Withdrawn by investigator|5
2434428|NCT03352713|8348515|P1|Overall Study|Lost to Follow-up|8
2434429|NCT03351738|8348544|P6|Overall Study|Withdrawal by Subject|0
2434430|NCT03351738|8348545|P5|Overall Study|Withdrawal by Subject|0
2434431|NCT03351738|8348546|P4|Overall Study|Withdrawal by Subject|1
2434432|NCT03351738|8348547|P3|Overall Study|Withdrawal by Subject|0
2434433|NCT03351738|8348548|P2|Overall Study|Withdrawal by Subject|1
2434434|NCT03351738|8348549|P1|Overall Study|Withdrawal by Subject|0
2434435|NCT03351335|8348701|P3|Overall Study|Failure to maintain inclusion/exclusion|4
2434436|NCT03351335|8348702|P2|Overall Study|Failure to maintain inclusion/exclusion|0
2434437|NCT03351335|8348703|P1|Overall Study|Failure to maintain inclusion/exclusion|0
2434438|NCT03351231|8348723|P1|Safety Follow-Up Period|Other reason|2
2434439|NCT03351231|8348723|P1|Safety Follow-Up Period|Participant withdrew consent|1
2434440|NCT03351231|8348723|P1|Combination Therapy Period|Adverse Event unrelated to study drug|1
2434441|NCT03351231|8348723|P1|Combination Therapy Period|Study drug toxicity|1
2434442|NCT03351231|8348723|P1|Combination Therapy Period|Disease progression|2
2434443|NCT03351231|8348723|P1|Combination Therapy Period|Administrative reason by the Sponsor|1
2434444|NCT03350984|8348747|P2|Overall Study|Physician Decision|0
2434445|NCT03350984|8348748|P1|Overall Study|Physician Decision|1
2434446|NCT03350984|8348747|P2|Overall Study|Protocol Violation|2
2434447|NCT03350984|8348748|P1|Overall Study|Protocol Violation|1
2434448|NCT03350984|8348747|P2|Overall Study|Lost to Follow-up|6
2434449|NCT03350984|8348748|P1|Overall Study|Lost to Follow-up|5
2434450|NCT03350984|8348747|P2|Overall Study|Death|0
2434451|NCT03350984|8348748|P1|Overall Study|Death|1
2434452|NCT03350256|8348815|P1|Overall Study|Lack of Efficacy|2
2434453|NCT03350256|8348815|P1|Overall Study|Lost to Follow-up|1
2434454|NCT03350256|8348815|P1|Overall Study|Subject moving out of state|1
2434455|NCT03350256|8348815|P1|Overall Study|Withdrawal by Subject|3
2434456|NCT03350256|8348815|P1|Overall Study|Did not proceed to permanent implant|3
2434457|NCT03350256|8348815|P1|Overall Study|Trial failure|12
2434458|NCT03350256|8348815|P1|Overall Study|Adverse Event|2
2434459|NCT03350256|8348815|P1|Overall Study|Denial by insurance|1
2434460|NCT03350256|8348815|P1|Overall Study|Non compliance|2
2434461|NCT03350256|8348815|P1|Overall Study|Protocol Violation|3
2434462|NCT03350256|8348815|P1|Overall Study|Recommended for other therapies|2
2434463|NCT03350256|8348815|P1|Overall Study|Inclusion/exclusion violation|4
2434464|NCT03349515|8348889|P2|Overall Study|Physician Decision|1
2434465|NCT03349515|8348890|P1|Overall Study|Physician Decision|3
2434466|NCT03349515|8348889|P2|Overall Study|Lack of Efficacy|0
2434467|NCT03349515|8348890|P1|Overall Study|Lack of Efficacy|2
2434468|NCT03349437|8348896|P3|Screening|Withdrawn|0
2434469|NCT03349437|8348897|P2|Screening|Withdrawn|0
2434470|NCT03349437|8348898|P1|Screening|Withdrawn|1
2434471|NCT03349437|8348896|P3|Screening|Screen Fail|0
2434472|NCT03349437|8348897|P2|Screening|Screen Fail|0
2434473|NCT03349437|8348898|P1|Screening|Screen Fail|4
2434474|NCT03349333|8348905|P1|Overall Study|Patients in treatment less than 24 month|8
2434475|NCT03349333|8348905|P1|Overall Study|3-week lapse between pralatrexate doses|1
2434476|NCT03349333|8348905|P1|Overall Study|Physician Decision|2
2434477|NCT03349333|8348905|P1|Overall Study|Conditions interfere with participation|2
2434478|NCT03349333|8348905|P1|Overall Study|Withdrawal by Subject|5
2434479|NCT03349333|8348905|P1|Overall Study|Other|6
2434480|NCT03349333|8348905|P1|Overall Study|Adverse Event|11
2434481|NCT03349333|8348905|P1|Overall Study|Progression of Disease|36
2434482|NCT03349099|8348928|P2|Overall Study|Stone migrated from the kidney|0
2434483|NCT03349099|8348929|P1|Overall Study|Stone migrated from the kidney|1
2434484|NCT03349099|8348928|P2|Overall Study|Physician Decision|4
2434485|NCT03349099|8348929|P1|Overall Study|Physician Decision|3
2434486|NCT03349060|8348942|P3|Overall Study|Other|0
2434487|NCT03349060|8348943|P2|Overall Study|Other|1
2434488|NCT03349060|8348944|P1|Overall Study|Other|2
2434489|NCT03349060|8348942|P3|Overall Study|Withdrawal By Parent/Guardian|0
2434490|NCT03349060|8348943|P2|Overall Study|Withdrawal By Parent/Guardian|1
2434491|NCT03349060|8348944|P1|Overall Study|Withdrawal By Parent/Guardian|0
2434492|NCT03349060|8348942|P3|Overall Study|Medication error,no linked adverse event|1
2434493|NCT03349060|8348943|P2|Overall Study|Medication error,no linked adverse event|0
2434494|NCT03349060|8348944|P1|Overall Study|Medication error,no linked adverse event|0
2434495|NCT03349060|8348942|P3|Overall Study|Withdrawal by Subject|4
2434496|NCT03349060|8348943|P2|Overall Study|Withdrawal by Subject|3
2434497|NCT03349060|8348944|P1|Overall Study|Withdrawal by Subject|5
2434498|NCT03349060|8348942|P3|Overall Study|Protocol Violation|1
2434499|NCT03349060|8348943|P2|Overall Study|Protocol Violation|2
2434500|NCT03349060|8348944|P1|Overall Study|Protocol Violation|2
2434501|NCT03349060|8348942|P3|Overall Study|Lost to Follow-up|1
2434502|NCT03349060|8348943|P2|Overall Study|Lost to Follow-up|1
2434503|NCT03349060|8348944|P1|Overall Study|Lost to Follow-up|2
2434504|NCT03349060|8348942|P3|Overall Study|Lack of Efficacy|2
2434505|NCT03349060|8348943|P2|Overall Study|Lack of Efficacy|0
2434506|NCT03349060|8348944|P1|Overall Study|Lack of Efficacy|1
2434507|NCT03349060|8348942|P3|Overall Study|Adverse Event|7
2434508|NCT03349060|8348943|P2|Overall Study|Adverse Event|9
2434509|NCT03349060|8348944|P1|Overall Study|Adverse Event|9
2434510|NCT03348904|8349086|P3|Overall Study|Administrative reason by the sponsor|0
2434511|NCT03348904|8349087|P2|Overall Study|Administrative reason by the sponsor|1
2434512|NCT03348904|8349088|P1|Overall Study|Administrative reason by the sponsor|0
2434513|NCT03346759|8349164|P2|Second Menstrual Cycle|Lost to Follow-up|0
2434514|NCT03346759|8349165|P1|Second Menstrual Cycle|Lost to Follow-up|1
2434515|NCT03346759|8349164|P2|First Menstrual Cycle|Withdrawal by Subject|0
2434516|NCT03346759|8349165|P1|First Menstrual Cycle|Withdrawal by Subject|1
2434517|NCT03346759|8349164|P2|Enrollment to Baseline Data Collected|Lost to Follow-up|3
2434518|NCT03346759|8349165|P1|Enrollment to Baseline Data Collected|Lost to Follow-up|2
2434519|NCT03346070|8349210|P5|Overall Study|Screen Failure|1
2434520|NCT03346070|8349211|P4|Overall Study|Screen Failure|1
2434521|NCT03346070|8349212|P3|Overall Study|Screen Failure|0
2434522|NCT03346070|8349213|P2|Overall Study|Screen Failure|0
2434523|NCT03346070|8349214|P1|Overall Study|Screen Failure|0
2434524|NCT03346070|8349210|P5|Overall Study|Study medication not received as planned|2
2434525|NCT03346070|8349211|P4|Overall Study|Study medication not received as planned|3
2434526|NCT03346070|8349212|P3|Overall Study|Study medication not received as planned|2
2434527|NCT03346070|8349213|P2|Overall Study|Study medication not received as planned|3
2434528|NCT03346070|8349214|P1|Overall Study|Study medication not received as planned|2
2434529|NCT03346070|8349210|P5|Overall Study|Withdrawal by Subject|0
2434530|NCT03346070|8349211|P4|Overall Study|Withdrawal by Subject|1
2434531|NCT03346070|8349212|P3|Overall Study|Withdrawal by Subject|0
2434532|NCT03346070|8349213|P2|Overall Study|Withdrawal by Subject|0
2434533|NCT03346070|8349214|P1|Overall Study|Withdrawal by Subject|1
2434534|NCT03346070|8349210|P5|Overall Study|Physician Decision|1
2434535|NCT03346070|8349211|P4|Overall Study|Physician Decision|1
2434536|NCT03346070|8349212|P3|Overall Study|Physician Decision|0
2434537|NCT03346070|8349213|P2|Overall Study|Physician Decision|0
2434538|NCT03346070|8349214|P1|Overall Study|Physician Decision|0
2434539|NCT03346070|8349210|P5|Overall Study|Lost to Follow-up|0
2434540|NCT03346070|8349211|P4|Overall Study|Lost to Follow-up|0
2434541|NCT03346070|8349212|P3|Overall Study|Lost to Follow-up|2
2434542|NCT03346070|8349213|P2|Overall Study|Lost to Follow-up|1
2434543|NCT03346070|8349214|P1|Overall Study|Lost to Follow-up|0
2434544|NCT03346070|8349210|P5|Overall Study|Death|1
2434545|NCT03346070|8349211|P4|Overall Study|Death|0
2434546|NCT03346070|8349212|P3|Overall Study|Death|0
2434547|NCT03346070|8349213|P2|Overall Study|Death|0
2434548|NCT03346070|8349214|P1|Overall Study|Death|0
2434549|NCT03345472|8349298|P1|3 Months to 12 Months|Death|1
2434550|NCT03345472|8349298|P1|3 Months to 12 Months|Adverse Event|1
2434551|NCT03345472|8349298|P1|3 Months to 12 Months|Withdrawal by Subject|1
2434552|NCT03345472|8349298|P1|3 Months to 12 Months|Lost to Follow-up|2
2434553|NCT03345472|8349298|P1|3 Months to 12 Months|Physician Decision|3
2434554|NCT03345472|8349298|P1|Implant to 3 Months|Adverse Event|1
2434555|NCT03345472|8349298|P1|Implant to 3 Months|Physician Decision|1
2434556|NCT03345472|8349298|P1|Implant to 3 Months|Withdrawal by Subject|2
2434557|NCT03345407|8349312|P7|Overall Study|Adverse Event|16
2434558|NCT03345407|8349313|P6|Overall Study|Adverse Event|5
2434559|NCT03345407|8349314|P5|Overall Study|Adverse Event|6
2434560|NCT03345407|8349315|P4|Overall Study|Adverse Event|4
2434561|NCT03345407|8349316|P3|Overall Study|Adverse Event|5
2434562|NCT03345407|8349317|P2|Overall Study|Adverse Event|0
2434563|NCT03345407|8349318|P1|Overall Study|Adverse Event|4
2434564|NCT03345407|8349312|P7|Overall Study|Lack of Efficacy|3
2434565|NCT03345407|8349313|P6|Overall Study|Lack of Efficacy|0
2434566|NCT03345407|8349314|P5|Overall Study|Lack of Efficacy|1
2434567|NCT03345407|8349315|P4|Overall Study|Lack of Efficacy|1
2434568|NCT03345407|8349316|P3|Overall Study|Lack of Efficacy|1
2434569|NCT03345407|8349317|P2|Overall Study|Lack of Efficacy|1
2434570|NCT03345407|8349318|P1|Overall Study|Lack of Efficacy|1
2434571|NCT03345407|8349312|P7|Overall Study|Protocol Violation|3
2434572|NCT03345407|8349313|P6|Overall Study|Protocol Violation|0
2434573|NCT03345407|8349314|P5|Overall Study|Protocol Violation|1
2434574|NCT03345407|8349315|P4|Overall Study|Protocol Violation|0
2434575|NCT03345407|8349316|P3|Overall Study|Protocol Violation|0
2434576|NCT03345407|8349317|P2|Overall Study|Protocol Violation|0
2434577|NCT03345407|8349318|P1|Overall Study|Protocol Violation|2
2434578|NCT03345407|8349312|P7|Overall Study|Protocol-defined stopping criteria|1
2434579|NCT03345407|8349313|P6|Overall Study|Protocol-defined stopping criteria|1
2434580|NCT03345407|8349314|P5|Overall Study|Protocol-defined stopping criteria|2
2434581|NCT03345407|8349315|P4|Overall Study|Protocol-defined stopping criteria|0
2434582|NCT03345407|8349316|P3|Overall Study|Protocol-defined stopping criteria|0
2434583|NCT03345407|8349317|P2|Overall Study|Protocol-defined stopping criteria|0
2434584|NCT03345407|8349318|P1|Overall Study|Protocol-defined stopping criteria|9
2434585|NCT03345407|8349312|P7|Overall Study|Lost to Follow-up|3
2434586|NCT03345407|8349313|P6|Overall Study|Lost to Follow-up|2
2434587|NCT03345407|8349314|P5|Overall Study|Lost to Follow-up|1
2434588|NCT03345407|8349315|P4|Overall Study|Lost to Follow-up|0
2434589|NCT03345407|8349316|P3|Overall Study|Lost to Follow-up|1
2434590|NCT03345407|8349317|P2|Overall Study|Lost to Follow-up|0
2434591|NCT03345407|8349318|P1|Overall Study|Lost to Follow-up|2
2434592|NCT03345407|8349312|P7|Overall Study|Physician Decision|3
2434593|NCT03345407|8349313|P6|Overall Study|Physician Decision|2
2434594|NCT03345407|8349314|P5|Overall Study|Physician Decision|1
2434595|NCT03345407|8349315|P4|Overall Study|Physician Decision|0
2434596|NCT03345407|8349316|P3|Overall Study|Physician Decision|0
2434597|NCT03345407|8349317|P2|Overall Study|Physician Decision|1
2434598|NCT03345407|8349318|P1|Overall Study|Physician Decision|3
2434599|NCT03345407|8349312|P7|Overall Study|Withdrawal by Subject|16
2434600|NCT03345407|8349313|P6|Overall Study|Withdrawal by Subject|6
2434601|NCT03345407|8349314|P5|Overall Study|Withdrawal by Subject|3
2434602|NCT03345407|8349315|P4|Overall Study|Withdrawal by Subject|6
2434603|NCT03345407|8349316|P3|Overall Study|Withdrawal by Subject|5
2434604|NCT03345407|8349317|P2|Overall Study|Withdrawal by Subject|1
2434605|NCT03345407|8349318|P1|Overall Study|Withdrawal by Subject|11
2434606|NCT03343639|8349555|P2|Overall Study|Protocol Violation|1
2434607|NCT03343639|8349556|P1|Overall Study|Protocol Violation|0
2434608|NCT03343639|8349555|P2|Overall Study|Lost to Follow-up|5
2434609|NCT03343639|8349556|P1|Overall Study|Lost to Follow-up|4
2434610|NCT03343639|8349555|P2|Overall Study|Withdrawal by Subject|6
2434611|NCT03343639|8349556|P1|Overall Study|Withdrawal by Subject|10
2434612|NCT03343067|8349584|P3|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1
2434613|NCT03343067|8349585|P2|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3
2434614|NCT03343067|8349586|P1|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0
2434615|NCT03342560|8349711|P1|Overall Study|Lost to Follow-up|2
2434616|NCT03341923|8349719|P2|Period 2, Second 14 Days of Wear|Adverse Event|1
2434617|NCT03341923|8349720|P1|Period 2, Second 14 Days of Wear|Adverse Event|0
2434618|NCT03341637|8349747|P2|Overall Study|Reason not Specified|1
2434619|NCT03341637|8349748|P1|Overall Study|Reason not Specified|1
2434620|NCT03341637|8349747|P2|Overall Study|Withdrawal by Subject|3
2434621|NCT03341637|8349748|P1|Overall Study|Withdrawal by Subject|3
2434622|NCT03341637|8349747|P2|Overall Study|Lost to Follow-up|0
2434623|NCT03341637|8349748|P1|Overall Study|Lost to Follow-up|1
2434624|NCT03340961|8349778|P4|Overall Study|Other|3
2434625|NCT03340961|8349779|P3|Overall Study|Other|1
2434626|NCT03340961|8349780|P2|Overall Study|Other|2
2434627|NCT03340961|8349781|P1|Overall Study|Other|0
2434628|NCT03340961|8349778|P4|Overall Study|Adverse Event|0
2434629|NCT03340961|8349779|P3|Overall Study|Adverse Event|0
2434630|NCT03340961|8349780|P2|Overall Study|Adverse Event|1
2434631|NCT03340961|8349781|P1|Overall Study|Adverse Event|1
2434632|NCT03340961|8349778|P4|Overall Study|Protocol Violation|0
2434633|NCT03340961|8349779|P3|Overall Study|Protocol Violation|1
2434634|NCT03340961|8349780|P2|Overall Study|Protocol Violation|0
2434635|NCT03340961|8349781|P1|Overall Study|Protocol Violation|1
2434636|NCT03340961|8349778|P4|Overall Study|Subject developed an exclusion criterion|0
2434637|NCT03340961|8349779|P3|Overall Study|Subject developed an exclusion criterion|0
2434638|NCT03340961|8349780|P2|Overall Study|Subject developed an exclusion criterion|1
2434639|NCT03340961|8349781|P1|Overall Study|Subject developed an exclusion criterion|0
2434640|NCT03340961|8349778|P4|Overall Study|rongful enrollment (I/E criteria not me|1
2434641|NCT03340961|8349779|P3|Overall Study|rongful enrollment (I/E criteria not me|0
2434642|NCT03340961|8349780|P2|Overall Study|rongful enrollment (I/E criteria not me|0
2434643|NCT03340961|8349781|P1|Overall Study|rongful enrollment (I/E criteria not me|0
2434644|NCT03340961|8349778|P4|Overall Study|Use of prohibited treatment|3
2434645|NCT03340961|8349779|P3|Overall Study|Use of prohibited treatment|2
2434646|NCT03340961|8349780|P2|Overall Study|Use of prohibited treatment|3
2434647|NCT03340961|8349781|P1|Overall Study|Use of prohibited treatment|0
2434648|NCT03340961|8349778|P4|Overall Study|Withdrawal by Subject|6
2434649|NCT03340961|8349779|P3|Overall Study|Withdrawal by Subject|3
2434650|NCT03340961|8349780|P2|Overall Study|Withdrawal by Subject|1
2434651|NCT03340961|8349781|P1|Overall Study|Withdrawal by Subject|3
2434652|NCT03340961|8349778|P4|Overall Study|Lost to Follow-up|1
2434653|NCT03340961|8349779|P3|Overall Study|Lost to Follow-up|0
2434654|NCT03340961|8349780|P2|Overall Study|Lost to Follow-up|1
2434655|NCT03340961|8349781|P1|Overall Study|Lost to Follow-up|0
2434656|NCT03340961|8349778|P4|Overall Study|Adverse Event|4
2434657|NCT03340961|8349779|P3|Overall Study|Adverse Event|2
2434658|NCT03340961|8349780|P2|Overall Study|Adverse Event|3
2434659|NCT03340961|8349781|P1|Overall Study|Adverse Event|1
2434660|NCT03339726|8349829|P3|Overall Study|Lost to Follow-up|0
2434661|NCT03339726|8349830|P2|Overall Study|Lost to Follow-up|1
2434662|NCT03339726|8349831|P1|Overall Study|Lost to Follow-up|0
2434663|NCT03339726|8349829|P3|Overall Study|Withdrawal by Subject|0
2434664|NCT03339726|8349830|P2|Overall Study|Withdrawal by Subject|0
2434665|NCT03339726|8349831|P1|Overall Study|Withdrawal by Subject|1
2434666|NCT03339583|8349889|P2|Follow-up (14 Days)|Physician Decision|3
2434667|NCT03339583|8349890|P1|Follow-up (14 Days)|Physician Decision|6
2434668|NCT03339583|8349889|P2|Second Intervention (14 Days)|Adverse Event|1
2434669|NCT03339583|8349890|P1|Second Intervention (14 Days)|Adverse Event|0
2434670|NCT03339583|8349889|P2|Second Intervention (14 Days)|unrelated acute exacerbation|1
2434671|NCT03339583|8349890|P1|Second Intervention (14 Days)|unrelated acute exacerbation|0
2434672|NCT03339583|8349889|P2|First Intervention (14 Days)|Adverse Event|0
2434673|NCT03339583|8349890|P1|First Intervention (14 Days)|Adverse Event|1
2434674|NCT03339453|8349928|P2|First Visit of Glucagon Treatment|Adverse Event|1
2434675|NCT03339453|8349929|P1|First Visit of Glucagon Treatment|Adverse Event|0
2434676|NCT03338816|8349947|P2|Open-Label Extension Period|Ongoing in Study|47
2434677|NCT03338816|8349948|P1|Open-Label Extension Period|Ongoing in Study|46
2434678|NCT03338816|8349947|P2|6-Month Double-blind Period|Adverse Event|1
2434679|NCT03338816|8349948|P1|6-Month Double-blind Period|Adverse Event|0
2434680|NCT03338400|8350010|P2|Overall Study|Lost to Follow-up|2
2434681|NCT03338400|8350011|P1|Overall Study|Lost to Follow-up|1
2434682|NCT03337477|8350019|P2|Overall Study|Lost to Follow-up|2
2434683|NCT03337477|8350020|P1|Overall Study|Lost to Follow-up|0
2434684|NCT03337477|8350019|P2|Overall Study|Death|1
2434685|NCT03337477|8350020|P1|Overall Study|Death|0
2434686|NCT03337477|8350019|P2|Overall Study|Withdrawal by Subject|1
2434687|NCT03337477|8350020|P1|Overall Study|Withdrawal by Subject|0
2434688|NCT03337477|8350019|P2|Overall Study|not categorized into the listed ones|9
2434689|NCT03337477|8350020|P1|Overall Study|not categorized into the listed ones|11
2434690|NCT03337308|8350044|P4|Overall Study|Protocol Violation|0
2434691|NCT03337308|8350045|P3|Overall Study|Protocol Violation|0
2434692|NCT03337308|8350046|P2|Overall Study|Protocol Violation|1
2434693|NCT03337308|8350047|P1|Overall Study|Protocol Violation|0
2434694|NCT03337308|8350044|P4|Overall Study|Withdrawal by Subject|1
2434695|NCT03337308|8350045|P3|Overall Study|Withdrawal by Subject|2
2434696|NCT03337308|8350046|P2|Overall Study|Withdrawal by Subject|1
2434697|NCT03337308|8350047|P1|Overall Study|Withdrawal by Subject|2
2434698|NCT03337308|8350044|P4|Overall Study|Lost to Follow-up|0
2434699|NCT03337308|8350045|P3|Overall Study|Lost to Follow-up|0
2434700|NCT03337308|8350046|P2|Overall Study|Lost to Follow-up|2
2434701|NCT03337308|8350047|P1|Overall Study|Lost to Follow-up|1
2434702|NCT03337308|8350044|P4|Overall Study|Adverse Event|1
2434703|NCT03337308|8350045|P3|Overall Study|Adverse Event|3
2434704|NCT03337308|8350046|P2|Overall Study|Adverse Event|3
2434705|NCT03337308|8350047|P1|Overall Study|Adverse Event|2
2434706|NCT03336502|8350092|P2|Overall Study|Adverse Event|5
2434707|NCT03336502|8350093|P1|Overall Study|Adverse Event|2
2434708|NCT03336502|8350092|P2|Overall Study|Death|2
2434709|NCT03336502|8350093|P1|Overall Study|Death|1
2434710|NCT03336502|8350092|P2|Overall Study|Prohibited Drugs|1
2434711|NCT03336502|8350093|P1|Overall Study|Prohibited Drugs|1
2434712|NCT03336502|8350092|P2|Overall Study|Physician Decision|1
2434713|NCT03336502|8350093|P1|Overall Study|Physician Decision|0
2434714|NCT03335566|8350129|P2|Overall Study|Other than specified above|2
2434715|NCT03335566|8350130|P1|Overall Study|Other than specified above|1
2434716|NCT03335566|8350129|P2|Overall Study|Protocol Violation|0
2434717|NCT03335566|8350130|P1|Overall Study|Protocol Violation|1
2434718|NCT03335566|8350129|P2|Overall Study|Technical Problems|0
2434719|NCT03335566|8350130|P1|Overall Study|Technical Problems|1
2434720|NCT03335566|8350129|P2|Overall Study|Lost to Follow-up|0
2434721|NCT03335566|8350130|P1|Overall Study|Lost to Follow-up|1
2434722|NCT03335566|8350129|P2|Overall Study|Adverse Event|1
2434723|NCT03335566|8350130|P1|Overall Study|Adverse Event|0
2434724|NCT03334422|8350354|P4|Overall Study|Pregnancy|0
2434725|NCT03334422|8350355|P3|Overall Study|Pregnancy|0
2434726|NCT03334422|8350356|P2|Overall Study|Pregnancy|1
2434727|NCT03334422|8350357|P1|Overall Study|Pregnancy|0
2434728|NCT03334422|8350354|P4|Overall Study|Inability to obtain laboratory samples|0
2434729|NCT03334422|8350355|P3|Overall Study|Inability to obtain laboratory samples|0
2434730|NCT03334422|8350356|P2|Overall Study|Inability to obtain laboratory samples|1
2434731|NCT03334422|8350357|P1|Overall Study|Inability to obtain laboratory samples|0
2434732|NCT03334422|8350354|P4|Overall Study|Lost to Follow-up|1
2434733|NCT03334422|8350355|P3|Overall Study|Lost to Follow-up|0
2434734|NCT03334422|8350356|P2|Overall Study|Lost to Follow-up|0
2434735|NCT03334422|8350357|P1|Overall Study|Lost to Follow-up|0
2434736|NCT03334422|8350354|P4|Overall Study|Withdrawal by Subject|0
2434737|NCT03334422|8350355|P3|Overall Study|Withdrawal by Subject|1
2434738|NCT03334422|8350356|P2|Overall Study|Withdrawal by Subject|3
2434739|NCT03334422|8350357|P1|Overall Study|Withdrawal by Subject|8
2434740|NCT03334422|8350354|P4|Overall Study|Lack of Efficacy|3
2434741|NCT03334422|8350355|P3|Overall Study|Lack of Efficacy|7
2434742|NCT03334422|8350356|P2|Overall Study|Lack of Efficacy|2
2434743|NCT03334422|8350357|P1|Overall Study|Lack of Efficacy|10
2434744|NCT03334422|8350354|P4|Overall Study|Adverse Event|2
2434745|NCT03334422|8350355|P3|Overall Study|Adverse Event|2
2434746|NCT03334422|8350356|P2|Overall Study|Adverse Event|3
2434747|NCT03334422|8350357|P1|Overall Study|Adverse Event|1
2434748|NCT03334396|8350460|P4|Overall Study|Started New Job|0
2434749|NCT03334396|8350461|P3|Overall Study|Started New Job|0
2434750|NCT03334396|8350462|P2|Overall Study|Started New Job|0
2434751|NCT03334396|8350463|P1|Overall Study|Started New Job|1
2434752|NCT03334396|8350460|P4|Overall Study|Ineligible|0
2434753|NCT03334396|8350461|P3|Overall Study|Ineligible|0
2434754|NCT03334396|8350462|P2|Overall Study|Ineligible|1
2434755|NCT03334396|8350463|P1|Overall Study|Ineligible|0
2434756|NCT03334396|8350460|P4|Overall Study|Pregnancy|0
2434757|NCT03334396|8350461|P3|Overall Study|Pregnancy|0
2434758|NCT03334396|8350462|P2|Overall Study|Pregnancy|1
2434759|NCT03334396|8350463|P1|Overall Study|Pregnancy|0
2434760|NCT03334396|8350460|P4|Overall Study|Withdrawal by Subject|2
2434761|NCT03334396|8350461|P3|Overall Study|Withdrawal by Subject|7
2434762|NCT03334396|8350462|P2|Overall Study|Withdrawal by Subject|5
2434763|NCT03334396|8350463|P1|Overall Study|Withdrawal by Subject|10
2434764|NCT03334396|8350460|P4|Overall Study|Physician Decision|0
2434765|NCT03334396|8350461|P3|Overall Study|Physician Decision|0
2434766|NCT03334396|8350462|P2|Overall Study|Physician Decision|0
2434767|NCT03334396|8350463|P1|Overall Study|Physician Decision|1
2434768|NCT03334396|8350460|P4|Overall Study|Lost to Follow-up|0
2434769|NCT03334396|8350461|P3|Overall Study|Lost to Follow-up|1
2434770|NCT03334396|8350462|P2|Overall Study|Lost to Follow-up|0
2434771|NCT03334396|8350463|P1|Overall Study|Lost to Follow-up|0
2434772|NCT03334396|8350460|P4|Overall Study|Lack of Efficacy|3
2434773|NCT03334396|8350461|P3|Overall Study|Lack of Efficacy|1
2434774|NCT03334396|8350462|P2|Overall Study|Lack of Efficacy|4
2434775|NCT03334396|8350463|P1|Overall Study|Lack of Efficacy|10
2434776|NCT03334396|8350460|P4|Overall Study|Adverse Event|0
2434777|NCT03334396|8350461|P3|Overall Study|Adverse Event|1
2434778|NCT03334396|8350462|P2|Overall Study|Adverse Event|0
2434779|NCT03334396|8350463|P1|Overall Study|Adverse Event|1
2434780|NCT03334214|8350564|P2|Overall Study|Other|0
2434781|NCT03334214|8350565|P1|Overall Study|Other|1
2434782|NCT03334214|8350564|P2|Overall Study|Withdrawal by Subject|1
2434783|NCT03334214|8350565|P1|Overall Study|Withdrawal by Subject|0
2434784|NCT03334214|8350564|P2|Overall Study|Adverse Event or Serious Adverse Event|1
2434785|NCT03334214|8350565|P1|Overall Study|Adverse Event or Serious Adverse Event|0
2434786|NCT03333876|8350591|P1|Mandibular Advancement|Product Damage|2
2434787|NCT03333876|8350591|P1|Mandibular Advancement|Adverse Event|2
2434788|NCT03333876|8350591|P1|Nasal Dilator|Bed Partner Lost to follow up|6
2434789|NCT03333876|8350591|P1|Screening Period|Screen Failure|4
2434790|NCT03331315|8350788|P2|Overall Study|Physician Decision|14
2434791|NCT03331315|8350789|P1|Overall Study|Physician Decision|18
2434792|NCT03331042|8350826|P4|Overall Study|Lost to Follow-up|1
2434793|NCT03331042|8350827|P3|Overall Study|Lost to Follow-up|0
2434794|NCT03331042|8350828|P2|Overall Study|Lost to Follow-up|0
2434795|NCT03331042|8350829|P1|Overall Study|Lost to Follow-up|0
2434796|NCT03331042|8350826|P4|Overall Study|Physician Decision|0
2434797|NCT03331042|8350827|P3|Overall Study|Physician Decision|1
2434798|NCT03331042|8350828|P2|Overall Study|Physician Decision|0
2434799|NCT03331042|8350829|P1|Overall Study|Physician Decision|0
2434800|NCT03331042|8350826|P4|Overall Study|Protocol Violation|0
2434801|NCT03331042|8350827|P3|Overall Study|Protocol Violation|0
2434802|NCT03331042|8350828|P2|Overall Study|Protocol Violation|0
2434803|NCT03331042|8350829|P1|Overall Study|Protocol Violation|1
2434804|NCT03329885|8350926|P9|Overall Study|Sponsor discontinued the study early|0
2434805|NCT03329885|8350927|P8|Overall Study|Sponsor discontinued the study early|1
2434806|NCT03329885|8350928|P7|Overall Study|Sponsor discontinued the study early|1
2434807|NCT03329885|8350929|P6|Overall Study|Sponsor discontinued the study early|0
2434808|NCT03329885|8350930|P5|Overall Study|Sponsor discontinued the study early|0
2434809|NCT03329885|8350931|P4|Overall Study|Sponsor discontinued the study early|0
2434810|NCT03329885|8350932|P3|Overall Study|Sponsor discontinued the study early|0
2434811|NCT03329885|8350933|P2|Overall Study|Sponsor discontinued the study early|0
2434812|NCT03329885|8350934|P1|Overall Study|Sponsor discontinued the study early|0
2434813|NCT03329573|8351102|P4|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
2434814|NCT03329573|8351103|P3|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
2434815|NCT03329573|8351104|P2|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1
2434816|NCT03329573|8351105|P1|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
2434817|NCT03329573|8351102|P4|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
2434818|NCT03329573|8351103|P3|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
2434819|NCT03329573|8351104|P2|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
2434820|NCT03329573|8351105|P1|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1
2434821|NCT03329573|8351102|P4|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0
2434822|NCT03329573|8351103|P3|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0
2434823|NCT03329573|8351104|P2|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2
2434824|NCT03329573|8351105|P1|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1
2434825|NCT03329573|8351102|P4|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
2434826|NCT03329573|8351103|P3|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
2434827|NCT03329573|8351104|P2|Treatment Period 1 (Up to 5 Days)|Adverse Event|1
2434828|NCT03329573|8351105|P1|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
2434829|NCT03328182|8351219|P1|Overall Study|No Product Evaluated|1
2434830|NCT03328182|8351219|P1|Overall Study|Protocol Violation|2
2434831|NCT03328182|8351219|P1|Overall Study|Withdrawal by Subject|1
2434832|NCT03327402|8351224|P1|Overall Study|Other (Visit Out-Of-Window)|1
2434833|NCT03327402|8351224|P1|Overall Study|Withdrawal by Subject|1
2434834|NCT03326323|8351522|P1|Overall Study|Unable to receive ANH protocol|3
2434835|NCT03325894|8351529|P2|Overall Study|Other (Not received Treatment)|0
2434836|NCT03325894|8351530|P1|Overall Study|Other (Not received Treatment)|1
2434837|NCT03325894|8351529|P2|Overall Study|Study Terminated by Sponsor|43
2434838|NCT03325894|8351530|P1|Overall Study|Study Terminated by Sponsor|38
2434839|NCT03325894|8351529|P2|Overall Study|Lack of Efficacy|14
2434840|NCT03325894|8351530|P1|Overall Study|Lack of Efficacy|8
2434841|NCT03325894|8351529|P2|Overall Study|Lost to Follow-up|9
2434842|NCT03325894|8351530|P1|Overall Study|Lost to Follow-up|4
2434843|NCT03325894|8351529|P2|Overall Study|Withdrawal by Subject|6
2434844|NCT03325894|8351530|P1|Overall Study|Withdrawal by Subject|10
2434845|NCT03325894|8351529|P2|Overall Study|Protocol Violation|2
2434846|NCT03325894|8351530|P1|Overall Study|Protocol Violation|1
2434847|NCT03325894|8351529|P2|Overall Study|Adverse Event|3
2434848|NCT03325894|8351530|P1|Overall Study|Adverse Event|2
2434849|NCT03325881|8351598|P2|Overall Study|Not treated|0
2434850|NCT03325881|8351599|P1|Overall Study|Not treated|1
2434851|NCT03325881|8351598|P2|Overall Study|Lack of Efficacy|0
2434852|NCT03325881|8351599|P1|Overall Study|Lack of Efficacy|2
2434853|NCT03325881|8351598|P2|Overall Study|Withdrawal by Subject|2
2434854|NCT03325881|8351599|P1|Overall Study|Withdrawal by Subject|0
2434855|NCT03325881|8351598|P2|Overall Study|Protocol Violation|1
2434856|NCT03325881|8351599|P1|Overall Study|Protocol Violation|0
2434857|NCT03325673|8351627|P2|Overall Study|Adverse Event|0
2434858|NCT03325673|8351628|P1|Overall Study|Adverse Event|4
2434859|NCT03323736|8351643|P3|Overall Study|Iontophoresis fill/no iontophoresis|0
2434860|NCT03323736|8351644|P2|Overall Study|Iontophoresis fill/no iontophoresis|2
2434861|NCT03323736|8351645|P1|Overall Study|Iontophoresis fill/no iontophoresis|2
2434862|NCT03323736|8351643|P3|Overall Study|Withdrawal Before Treatment|1
2434863|NCT03323736|8351644|P2|Overall Study|Withdrawal Before Treatment|1
2434864|NCT03323736|8351645|P1|Overall Study|Withdrawal Before Treatment|3
2434865|NCT03323736|8351643|P3|Overall Study|Screen Failure|1
2434866|NCT03323736|8351644|P2|Overall Study|Screen Failure|9
2434867|NCT03323736|8351645|P1|Overall Study|Screen Failure|14
2434868|NCT03323086|8351672|P2|Overall Study|Lost to Follow-up|2
2434869|NCT03323086|8351673|P1|Overall Study|Lost to Follow-up|3
2434870|NCT03322566|8351701|P3|Overall Study|On-going at clinical cut off date|36
2434871|NCT03322566|8351702|P2|Overall Study|On-going at clinical cut off date|74
2434872|NCT03322566|8351703|P1|Overall Study|On-going at clinical cut off date|68
2434873|NCT03322566|8351701|P3|Overall Study|Withdrawal by Subject|5
2434874|NCT03322566|8351702|P2|Overall Study|Withdrawal by Subject|1
2434875|NCT03322566|8351703|P1|Overall Study|Withdrawal by Subject|3
2434876|NCT03322566|8351701|P3|Overall Study|Physician Decision|1
2434877|NCT03322566|8351702|P2|Overall Study|Physician Decision|0
2434878|NCT03322566|8351703|P1|Overall Study|Physician Decision|0
2434879|NCT03322566|8351701|P3|Overall Study|Death|13
2434880|NCT03322566|8351702|P2|Overall Study|Death|12
2434881|NCT03322566|8351703|P1|Overall Study|Death|20
2434882|NCT03322540|8351722|P2|Overall Study|Participants Ongoing|59
2434883|NCT03322540|8351723|P1|Overall Study|Participants Ongoing|63
2434884|NCT03322540|8351722|P2|Overall Study|Withdrawal by Subject|1
2434885|NCT03322540|8351723|P1|Overall Study|Withdrawal by Subject|2
2434886|NCT03322540|8351722|P2|Overall Study|Physician Decision|1
2434887|NCT03322540|8351723|P1|Overall Study|Physician Decision|0
2434888|NCT03322540|8351722|P2|Overall Study|Lost to Follow-up|1
2434889|NCT03322540|8351723|P1|Overall Study|Lost to Follow-up|0
2434890|NCT03322540|8351722|P2|Overall Study|Death|15
2434891|NCT03322540|8351723|P1|Overall Study|Death|12
2434892|NCT03322514|8351731|P2|Overall Study|Withdrawal by Subject|1
2434893|NCT03322514|8351732|P1|Overall Study|Withdrawal by Subject|1
2434894|NCT03322423|8351742|P2|Period 2|Subject not eligible for Pytergiumectomy|1
2434895|NCT03322423|8351743|P1|Period 2|Subject not eligible for Pytergiumectomy|0
2434896|NCT03322423|8351742|P2|Period 2|Protocol Violation|0
2434897|NCT03322423|8351743|P1|Period 2|Protocol Violation|1
2434898|NCT03322423|8351742|P2|Period 2|Dispensed incorrect lens in left eye|1
2434899|NCT03322423|8351743|P1|Period 2|Dispensed incorrect lens in left eye|0
2434900|NCT03322423|8351742|P2|Period 1|Unsatisfactory Lens Fitting|0
2434901|NCT03322423|8351743|P1|Period 1|Unsatisfactory Lens Fitting|1
2434902|NCT03322423|8351742|P2|Period 1|Incorrect Lens Dispensed|0
2434903|NCT03322423|8351743|P1|Period 1|Incorrect Lens Dispensed|1
2434904|NCT03322423|8351742|P2|Period 1|Withdrawal by Subject|1
2434905|NCT03322423|8351743|P1|Period 1|Withdrawal by Subject|0
2434906|NCT03322423|8351742|P2|Period 1|Subject no longer eligible|1
2434907|NCT03322423|8351743|P1|Period 1|Subject no longer eligible|0
2434908|NCT03322293|8351756|P3|Overall Study|Lost to Follow-up|1
2434909|NCT03322293|8351757|P2|Overall Study|Lost to Follow-up|0
2434910|NCT03322293|8351758|P1|Overall Study|Lost to Follow-up|0
2434911|NCT03321396|8351778|P1|Overall Study|Physician Decision|1
2434912|NCT03320941|8351797|P5|Overall Study|subject/guardian decision|0
2434913|NCT03320941|8351798|P4|Overall Study|subject/guardian decision|1
2434914|NCT03320941|8351799|P3|Overall Study|subject/guardian decision|0
2434915|NCT03320941|8351800|P2|Overall Study|subject/guardian decision|0
2434916|NCT03320941|8351801|P1|Overall Study|subject/guardian decision|0
2434917|NCT03320564|8351902|P1|Overall Study|Protocol Violation|1
2434918|NCT03319719|8351918|P1|Overall Study|Lost to Follow-up|1
2434919|NCT03319212|8351951|P2|Overall Study|Physician Decision|0
2434920|NCT03319212|8351952|P1|Overall Study|Physician Decision|1
2434921|NCT03319212|8351951|P2|Overall Study|Lost to Follow-up|1
2434922|NCT03319212|8351952|P1|Overall Study|Lost to Follow-up|0
2434923|NCT03319212|8351951|P2|Overall Study|Withdrawal by Subject|1
2434924|NCT03319212|8351952|P1|Overall Study|Withdrawal by Subject|0
2434925|NCT03319212|8351951|P2|Overall Study|Adverse Event|2
2434926|NCT03319212|8351952|P1|Overall Study|Adverse Event|2
2434927|NCT03319212|8351951|P2|Overall Study|Discontinued as moving out of local area|1
2434928|NCT03319212|8351952|P1|Overall Study|Discontinued as moving out of local area|0
2434929|NCT03316911|8352052|P2|Overall Study|Lost to Follow-up|29
2434930|NCT03316911|8352053|P1|Overall Study|Lost to Follow-up|33
2434931|NCT03316131|8352098|P2|Treatment Period 2|Protocol deviation|0
2434932|NCT03316131|8352099|P1|Treatment Period 2|Protocol deviation|1
2434933|NCT03315286|8352220|P2|Overall Study|Protocol Violation|1
2434934|NCT03315286|8352221|P1|Overall Study|Protocol Violation|0
2434935|NCT03315286|8352220|P2|Overall Study|Withdrawal by Subject|0
2434936|NCT03315286|8352221|P1|Overall Study|Withdrawal by Subject|1
2434937|NCT03315286|8352220|P2|Overall Study|Lost to Follow-up|3
2434938|NCT03315286|8352221|P1|Overall Study|Lost to Follow-up|0
2434939|NCT03314519|8352264|P2|Overall Study|Protocol Violation|2
2434940|NCT03314519|8352265|P1|Overall Study|Protocol Violation|3
2434941|NCT03314233|8352275|P1|Overall Study|No longer eligible at time of delivery|1
2434942|NCT03313037|8352288|P2|Overall Study|Randomized but not treated|0
2434943|NCT03313037|8352289|P1|Overall Study|Randomized but not treated|1
2434944|NCT03313037|8352288|P2|Overall Study|Lost to Follow-up|8
2434945|NCT03313037|8352289|P1|Overall Study|Lost to Follow-up|9
2434946|NCT03313037|8352288|P2|Overall Study|No longer meets eligibility criteria|7
2434947|NCT03313037|8352289|P1|Overall Study|No longer meets eligibility criteria|1
2434948|NCT03313037|8352288|P2|Overall Study|Withdrawal by Subject|3
2434949|NCT03313037|8352289|P1|Overall Study|Withdrawal by Subject|4
2434950|NCT03313037|8352288|P2|Overall Study|Other|1
2434951|NCT03313037|8352289|P1|Overall Study|Other|1
2434952|NCT03313037|8352288|P2|Overall Study|Protocol Violation|1
2434953|NCT03313037|8352289|P1|Overall Study|Protocol Violation|4
2434954|NCT03312933|8352311|P1|Overall Study|Withdrawal by Subject|3
2434955|NCT03312933|8352311|P1|Overall Study|Lost to Follow-up|36
2434956|NCT03312933|8352311|P1|Overall Study|Protocol Violation|15
2434957|NCT03312543|8352317|P2|Regression (Week 12 to Week 24)|Death|1
2434958|NCT03312543|8352318|P1|Regression (Week 12 to Week 24)|Death|0
2434959|NCT03312543|8352317|P2|Regression (Week 12 to Week 24)|Protocol Violation|1
2434960|NCT03312543|8352318|P1|Regression (Week 12 to Week 24)|Protocol Violation|1
2434961|NCT03312543|8352317|P2|Treatment (Baseline to Week 12)|Protocol Violation|1
2434962|NCT03312543|8352318|P1|Treatment (Baseline to Week 12)|Protocol Violation|1
2434963|NCT03312543|8352317|P2|Treatment (Baseline to Week 12)|Withdrawal by Subject|4
2434964|NCT03312543|8352318|P1|Treatment (Baseline to Week 12)|Withdrawal by Subject|3
2434965|NCT03312543|8352317|P2|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2
2434966|NCT03312543|8352318|P1|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1
2434967|NCT03312543|8352317|P2|Before Treatment (Screening to Baseline)|Lost to Follow-up|2
2434968|NCT03312543|8352318|P1|Before Treatment (Screening to Baseline)|Lost to Follow-up|0
2434969|NCT03311841|8352414|P5|14-day Wash-out|Non-Compliance With Study Drug|0
2434970|NCT03311841|8352415|P4|14-day Wash-out|Non-Compliance With Study Drug|1
2434971|NCT03311841|8352416|P3|14-day Wash-out|Non-Compliance With Study Drug|0
2434972|NCT03311841|8352417|P2|14-day Wash-out|Non-Compliance With Study Drug|0
2434973|NCT03311841|8352418|P1|14-day Wash-out|Non-Compliance With Study Drug|0
2434974|NCT03311841|8352414|P5|14-day Wash-out|Adverse Event|0
2434975|NCT03311841|8352415|P4|14-day Wash-out|Adverse Event|0
2434976|NCT03311841|8352416|P3|14-day Wash-out|Adverse Event|0
2434977|NCT03311841|8352417|P2|14-day Wash-out|Adverse Event|1
2434978|NCT03311841|8352418|P1|14-day Wash-out|Adverse Event|0
2434979|NCT03311659|8352519|P1|Overall Study|Protocol Violation|1
2434980|NCT03311646|8352534|P1|Overall Study|PI Withdrawal for Positive Drug Screen|4
2434981|NCT03311646|8352534|P1|Overall Study|Lost to Follow-up|5
2434982|NCT03311646|8352534|P1|Overall Study|Withdrawal by Subject|5
2434983|NCT03311646|8352534|P1|Overall Study|Physician Decision|1
2434984|NCT03311230|8352545|P4|Overall Study|Unrelated injury|0
2434985|NCT03311230|8352546|P3|Overall Study|Unrelated injury|0
2434986|NCT03311230|8352547|P2|Overall Study|Unrelated injury|1
2434987|NCT03311230|8352548|P1|Overall Study|Unrelated injury|0
2434988|NCT03311230|8352545|P4|Overall Study|Withdrawal by Subject|7
2434989|NCT03311230|8352546|P3|Overall Study|Withdrawal by Subject|2
2434990|NCT03311230|8352547|P2|Overall Study|Withdrawal by Subject|4
2434991|NCT03311230|8352548|P1|Overall Study|Withdrawal by Subject|1
2434992|NCT03310580|8352573|P3|Overall Study|Adverse Event|0
2434993|NCT03310580|8352574|P2|Overall Study|Adverse Event|1
2434994|NCT03310580|8352575|P1|Overall Study|Adverse Event|0
2434995|NCT03310411|8352608|P4|Period 1|Adverse Event|1
2434996|NCT03310411|8352609|P3|Period 1|Adverse Event|0
2434997|NCT03310411|8352610|P2|Period 1|Adverse Event|0
2434998|NCT03310411|8352611|P1|Period 1|Adverse Event|0
2434999|NCT03310268|8352632|P3|Overall Study|(Not specified)|0
2435000|NCT03310268|8352633|P2|Overall Study|(Not specified)|5
2435001|NCT03310268|8352634|P1|Overall Study|(Not specified)|1
2435002|NCT03309202|8352649|P4|Overall Study|Lost to Follow-up|0
2435003|NCT03309202|8352650|P3|Overall Study|Lost to Follow-up|0
2435004|NCT03309202|8352651|P2|Overall Study|Lost to Follow-up|0
2435005|NCT03309202|8352652|P1|Overall Study|Lost to Follow-up|1
2435006|NCT03308968|8352737|P3|Open-Label Period (12 Weeks)|Lack of Efficacy|0
2435007|NCT03308968|8352738|P2|Open-Label Period (12 Weeks)|Lack of Efficacy|2
2435008|NCT03308968|8352739|P1|Open-Label Period (12 Weeks)|Lack of Efficacy|1
2435009|NCT03308968|8352737|P3|Open-Label Period (12 Weeks)|Lost to Follow-up|1
2435010|NCT03308968|8352738|P2|Open-Label Period (12 Weeks)|Lost to Follow-up|1
2435011|NCT03308968|8352739|P1|Open-Label Period (12 Weeks)|Lost to Follow-up|0
2435012|NCT03308968|8352737|P3|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1
2435013|NCT03308968|8352738|P2|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0
2435014|NCT03308968|8352739|P1|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0
2435015|NCT03308968|8352737|P3|Open-Label Period (12 Weeks)|Protocol Violation|1
2435016|NCT03308968|8352738|P2|Open-Label Period (12 Weeks)|Protocol Violation|1
2435017|NCT03308968|8352739|P1|Open-Label Period (12 Weeks)|Protocol Violation|0
2435018|NCT03308968|8352737|P3|Open-Label Period (12 Weeks)|Withdrawal by Subject|7
2435019|NCT03308968|8352738|P2|Open-Label Period (12 Weeks)|Withdrawal by Subject|5
2435020|NCT03308968|8352739|P1|Open-Label Period (12 Weeks)|Withdrawal by Subject|5
2435021|NCT03308968|8352737|P3|Open-Label Period (12 Weeks)|Adverse Event|1
2435022|NCT03308968|8352738|P2|Open-Label Period (12 Weeks)|Adverse Event|1
2435023|NCT03308968|8352739|P1|Open-Label Period (12 Weeks)|Adverse Event|4
2435024|NCT03308968|8352737|P3|Open-Label Period (12 Weeks)|Other than specified|1
2435025|NCT03308968|8352738|P2|Open-Label Period (12 Weeks)|Other than specified|2
2435026|NCT03308968|8352739|P1|Open-Label Period (12 Weeks)|Other than specified|1
2435027|NCT03308968|8352737|P3|Double-Blind Period (12 Weeks)|Other than specified|2
2435028|NCT03308968|8352738|P2|Double-Blind Period (12 Weeks)|Other than specified|0
2435029|NCT03308968|8352739|P1|Double-Blind Period (12 Weeks)|Other than specified|1
2435030|NCT03308968|8352737|P3|Double-Blind Period (12 Weeks)|Lack of Efficacy|0
2435031|NCT03308968|8352738|P2|Double-Blind Period (12 Weeks)|Lack of Efficacy|1
2435032|NCT03308968|8352739|P1|Double-Blind Period (12 Weeks)|Lack of Efficacy|1
2435033|NCT03308968|8352737|P3|Double-Blind Period (12 Weeks)|Lost to Follow-up|0
2435034|NCT03308968|8352738|P2|Double-Blind Period (12 Weeks)|Lost to Follow-up|0
2435035|NCT03308968|8352739|P1|Double-Blind Period (12 Weeks)|Lost to Follow-up|1
2435036|NCT03308968|8352737|P3|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0
2435037|NCT03308968|8352738|P2|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1
2435038|NCT03308968|8352739|P1|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1
2435039|NCT03308968|8352737|P3|Double-Blind Period (12 Weeks)|Protocol Violation|2
2435040|NCT03308968|8352738|P2|Double-Blind Period (12 Weeks)|Protocol Violation|0
2435041|NCT03308968|8352739|P1|Double-Blind Period (12 Weeks)|Protocol Violation|6
2435042|NCT03308968|8352737|P3|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3
2435043|NCT03308968|8352738|P2|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2
2435044|NCT03308968|8352739|P1|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2
2435045|NCT03308968|8352737|P3|Double-Blind Period (12 Weeks)|Adverse Event|4
2435046|NCT03308968|8352738|P2|Double-Blind Period (12 Weeks)|Adverse Event|1
2435047|NCT03308968|8352739|P1|Double-Blind Period (12 Weeks)|Adverse Event|3
2435048|NCT03308825|8352817|P4|Overall Study|Protocol Violation|0
2435049|NCT03308825|8352818|P3|Overall Study|Protocol Violation|0
2435050|NCT03308825|8352819|P2|Overall Study|Protocol Violation|2
2435051|NCT03308825|8352820|P1|Overall Study|Protocol Violation|0
2435052|NCT03308825|8352817|P4|Overall Study|Lost to Follow-up|0
2435053|NCT03308825|8352818|P3|Overall Study|Lost to Follow-up|1
2435054|NCT03308825|8352819|P2|Overall Study|Lost to Follow-up|2
2435055|NCT03308825|8352820|P1|Overall Study|Lost to Follow-up|2
2435056|NCT03307252|8352908|P11|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1
2435057|NCT03307252|8352909|P10|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
2435058|NCT03307252|8352910|P9|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
2435059|NCT03307252|8352911|P8|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
2435060|NCT03307252|8352912|P7|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
2435061|NCT03307252|8352913|P6|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
2435062|NCT03307252|8352914|P5|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
2435063|NCT03307252|8352915|P4|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
2435064|NCT03307252|8352916|P3|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
2435065|NCT03307252|8352917|P2|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
2435066|NCT03307252|8352918|P1|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
2435067|NCT03307252|8352908|P11|Part 2, Period 4|Other than listed|0
2435068|NCT03307252|8352909|P10|Part 2, Period 4|Other than listed|0
2435069|NCT03307252|8352910|P9|Part 2, Period 4|Other than listed|0
2435070|NCT03307252|8352911|P8|Part 2, Period 4|Other than listed|0
2435071|NCT03307252|8352912|P7|Part 2, Period 4|Other than listed|1
2435072|NCT03307252|8352913|P6|Part 2, Period 4|Other than listed|0
2435073|NCT03307252|8352914|P5|Part 2, Period 4|Other than listed|0
2435074|NCT03307252|8352915|P4|Part 2, Period 4|Other than listed|0
2435075|NCT03307252|8352916|P3|Part 2, Period 4|Other than listed|0
2435076|NCT03307252|8352917|P2|Part 2, Period 4|Other than listed|0
2435077|NCT03307252|8352918|P1|Part 2, Period 4|Other than listed|0
2435078|NCT03307252|8352908|P11|Part 2, Period 3|Other than listed|0
2435079|NCT03307252|8352909|P10|Part 2, Period 3|Other than listed|0
2435080|NCT03307252|8352910|P9|Part 2, Period 3|Other than listed|0
2435081|NCT03307252|8352911|P8|Part 2, Period 3|Other than listed|0
2435082|NCT03307252|8352912|P7|Part 2, Period 3|Other than listed|0
2435083|NCT03307252|8352913|P6|Part 2, Period 3|Other than listed|0
2435084|NCT03307252|8352914|P5|Part 2, Period 3|Other than listed|1
2435085|NCT03307252|8352915|P4|Part 2, Period 3|Other than listed|0
2435086|NCT03307252|8352916|P3|Part 2, Period 3|Other than listed|0
2435087|NCT03307252|8352917|P2|Part 2, Period 3|Other than listed|0
2435088|NCT03307252|8352918|P1|Part 2, Period 3|Other than listed|0
2435089|NCT03307252|8352908|P11|Part 2, Period 1|Treatment not received|0
2435090|NCT03307252|8352909|P10|Part 2, Period 1|Treatment not received|0
2435091|NCT03307252|8352910|P9|Part 2, Period 1|Treatment not received|0
2435092|NCT03307252|8352911|P8|Part 2, Period 1|Treatment not received|0
2435093|NCT03307252|8352912|P7|Part 2, Period 1|Treatment not received|0
2435094|NCT03307252|8352913|P6|Part 2, Period 1|Treatment not received|1
2435095|NCT03307252|8352914|P5|Part 2, Period 1|Treatment not received|0
2435096|NCT03307252|8352915|P4|Part 2, Period 1|Treatment not received|0
2435097|NCT03307252|8352916|P3|Part 2, Period 1|Treatment not received|0
2435098|NCT03307252|8352917|P2|Part 2, Period 1|Treatment not received|0
2435099|NCT03307252|8352918|P1|Part 2, Period 1|Treatment not received|0
2435100|NCT03305770|8353222|P2|Overall Study|Subject moved|0
2435101|NCT03305770|8353223|P1|Overall Study|Subject moved|1
2435102|NCT03305770|8353222|P2|Overall Study|Physician Decision - prior to dispense|1
2435103|NCT03305770|8353223|P1|Overall Study|Physician Decision - prior to dispense|0
2435104|NCT03305731|8353231|P1|Overall Study|Protocol Violation|1
2435105|NCT03305419|8353248|P8|Part B (14 Days)|Physician Decision|0
2435106|NCT03305419|8353249|P7|Part B (14 Days)|Physician Decision|1
2435107|NCT03305419|8353250|P6|Part B (14 Days)|Physician Decision|8
2435108|NCT03305419|8353251|P5|Part B (14 Days)|Physician Decision|2
2435109|NCT03305419|8353252|P4|Part B (14 Days)|Physician Decision|0
2435110|NCT03305419|8353253|P3|Part B (14 Days)|Physician Decision|0
2435111|NCT03305419|8353254|P2|Part B (14 Days)|Physician Decision|0
2435112|NCT03305419|8353255|P1|Part B (14 Days)|Physician Decision|0
2435113|NCT03305419|8353248|P8|Part B (14 Days)|Adverse Event|0
2435114|NCT03305419|8353249|P7|Part B (14 Days)|Adverse Event|4
2435115|NCT03305419|8353250|P6|Part B (14 Days)|Adverse Event|2
2435116|NCT03305419|8353251|P5|Part B (14 Days)|Adverse Event|1
2435117|NCT03305419|8353252|P4|Part B (14 Days)|Adverse Event|0
2435118|NCT03305419|8353253|P3|Part B (14 Days)|Adverse Event|0
2435119|NCT03305419|8353254|P2|Part B (14 Days)|Adverse Event|0
2435120|NCT03305419|8353255|P1|Part B (14 Days)|Adverse Event|0
2435121|NCT03305419|8353248|P8|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
2435122|NCT03305419|8353249|P7|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
2435123|NCT03305419|8353250|P6|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
2435124|NCT03305419|8353251|P5|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
2435125|NCT03305419|8353252|P4|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
2435126|NCT03305419|8353253|P3|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
2435127|NCT03305419|8353254|P2|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
2435128|NCT03305419|8353255|P1|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1
2435129|NCT03305419|8353248|P8|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
2435130|NCT03305419|8353249|P7|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
2435131|NCT03305419|8353250|P6|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
2435132|NCT03305419|8353251|P5|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
2435133|NCT03305419|8353252|P4|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
2435134|NCT03305419|8353253|P3|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
2435219|NCT03293485|8354103|P1|Overall Study|Withdrawal by Subject|2
2435135|NCT03305419|8353254|P2|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
2435136|NCT03305419|8353255|P1|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1
2435137|NCT03305419|8353248|P8|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
2435138|NCT03305419|8353249|P7|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
2435139|NCT03305419|8353250|P6|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
2435140|NCT03305419|8353251|P5|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
2435141|NCT03305419|8353252|P4|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
2435142|NCT03305419|8353253|P3|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
2435143|NCT03305419|8353254|P2|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1
2435144|NCT03305419|8353255|P1|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
2435145|NCT03305055|8353396|P2|Overall Study|Adverse Event|1
2435146|NCT03305055|8353397|P1|Overall Study|Adverse Event|1
2435147|NCT03305055|8353396|P2|Overall Study|Withdrawal by Subject|1
2435148|NCT03305055|8353397|P1|Overall Study|Withdrawal by Subject|0
2435149|NCT03304873|8353415|P2|Overall Study|Lost to Follow-up|8
2435150|NCT03304873|8353416|P1|Overall Study|Lost to Follow-up|1
2435151|NCT03303521|8353509|P2|Overall Study|Adverse Event|0
2435152|NCT03303521|8353510|P1|Overall Study|Adverse Event|1
2435153|NCT03303521|8353509|P2|Overall Study|Non-comliance to study protocol|1
2435154|NCT03303521|8353510|P1|Overall Study|Non-comliance to study protocol|0
2435155|NCT03303521|8353509|P2|Overall Study|Transferred to non-study dialysis center|0
2435156|NCT03303521|8353510|P1|Overall Study|Transferred to non-study dialysis center|1
2435157|NCT03303521|8353509|P2|Overall Study|Investigational product discontinuation|1
2435158|NCT03303521|8353510|P1|Overall Study|Investigational product discontinuation|0
2435159|NCT03303521|8353509|P2|Overall Study|Kidney transplantation|1
2435160|NCT03303521|8353510|P1|Overall Study|Kidney transplantation|0
2435161|NCT03303521|8353509|P2|Overall Study|Death|0
2435162|NCT03303521|8353510|P1|Overall Study|Death|1
2435163|NCT03303521|8353509|P2|Overall Study|Withdrawal by Subject|0
2435164|NCT03303521|8353510|P1|Overall Study|Withdrawal by Subject|2
2435165|NCT03303417|8353520|P2|Overall Study|Withdrawal by Subject|1
2435166|NCT03303417|8353521|P1|Overall Study|Withdrawal by Subject|1
2435167|NCT03302975|8353535|P1|Overall Study|Lost to Follow-up|4
2435168|NCT03302936|8353543|P2|Overall Study|Protocol Violation|4
2435169|NCT03302936|8353544|P1|Overall Study|Protocol Violation|3
2435170|NCT03302559|8353565|P1|Overall Study|Withdrew Consent|3
2435171|NCT03302559|8353565|P1|Overall Study|Lost to Follow-up|1
2435172|NCT03302559|8353565|P1|Overall Study|Adverse Event|2
2435173|NCT03301844|8353581|P2|Overall Study|suspected colon cancer|1
2435174|NCT03301844|8353582|P1|Overall Study|suspected colon cancer|1
2435175|NCT03301649|8353610|P3|Overall Study|Other than specified|0
2435176|NCT03301649|8353611|P2|Overall Study|Other than specified|3
2435177|NCT03301649|8353612|P1|Overall Study|Other than specified|5
2435178|NCT03301649|8353610|P3|Overall Study|Withdrawal by Subject|0
2435179|NCT03301649|8353611|P2|Overall Study|Withdrawal by Subject|4
2435180|NCT03301649|8353612|P1|Overall Study|Withdrawal by Subject|10
2435181|NCT03301649|8353610|P3|Overall Study|Protocol Violation|1
2435182|NCT03301649|8353611|P2|Overall Study|Protocol Violation|1
2435183|NCT03301649|8353612|P1|Overall Study|Protocol Violation|0
2435184|NCT03301649|8353610|P3|Overall Study|Lost to Follow-up|3
2435185|NCT03301649|8353611|P2|Overall Study|Lost to Follow-up|11
2435186|NCT03301649|8353612|P1|Overall Study|Lost to Follow-up|11
2435187|NCT03301649|8353610|P3|Overall Study|Need alternate therapy due to live lice|81
2435188|NCT03301649|8353611|P2|Overall Study|Need alternate therapy due to live lice|25
2435189|NCT03301649|8353612|P1|Overall Study|Need alternate therapy due to live lice|17
2435190|NCT03300570|8353697|P2|Overall Study|Inadequate bowel prep|0
2435191|NCT03300570|8353698|P1|Overall Study|Inadequate bowel prep|1
2435192|NCT03300570|8353697|P2|Overall Study|Withdrawal by Subject|0
2435193|NCT03300570|8353698|P1|Overall Study|Withdrawal by Subject|1
2435194|NCT03300570|8353697|P2|Overall Study|Adverse Event|1
2435195|NCT03300570|8353698|P1|Overall Study|Adverse Event|0
2435196|NCT03300024|8353721|P2|Overall Study|Physician Decision|6
2435197|NCT03300024|8353722|P1|Overall Study|Physician Decision|4
2435198|NCT03298867|8353776|P2|Overall Study|Continued in the Follow-Up Period|1
2435199|NCT03298867|8353777|P1|Overall Study|Continued in the Follow-Up Period|0
2435200|NCT03298867|8353776|P2|Overall Study|Did not Continue in the Follow-Up Period|1
2435201|NCT03298867|8353777|P1|Overall Study|Did not Continue in the Follow-Up Period|2
2435202|NCT03296566|8353901|P2|Overall Study|Withdrawal by Subject|3
2435203|NCT03296566|8353902|P1|Overall Study|Withdrawal by Subject|0
2435204|NCT03296566|8353901|P2|Overall Study|Lost to Follow-up|46
2435205|NCT03296566|8353902|P1|Overall Study|Lost to Follow-up|19
2435206|NCT03295201|8353999|P2|Overall Study|Hospital admission|1
2435207|NCT03295201|8354000|P1|Overall Study|Hospital admission|0
2435208|NCT03295201|8353999|P2|Overall Study|Lost to Follow-up|1
2435209|NCT03295201|8354000|P1|Overall Study|Lost to Follow-up|1
2435210|NCT03294538|8354086|P3|Overall Study|Outside of Visit Window|1
2435211|NCT03294538|8354087|P2|Overall Study|Outside of Visit Window|4
2435212|NCT03294538|8354088|P1|Overall Study|Outside of Visit Window|4
2435213|NCT03294538|8354086|P3|Overall Study|Lost to Follow-up|0
2435214|NCT03294538|8354087|P2|Overall Study|Lost to Follow-up|0
2435215|NCT03294538|8354088|P1|Overall Study|Lost to Follow-up|1
2435216|NCT03294538|8354086|P3|Overall Study|Adverse Event|1
2435217|NCT03294538|8354087|P2|Overall Study|Adverse Event|1
2435218|NCT03294538|8354088|P1|Overall Study|Adverse Event|0
2435220|NCT03293485|8354103|P1|Overall Study|Screen Failure|2
2435221|NCT03293485|8354103|P1|Overall Study|Death|1
2435222|NCT03293394|8354114|P2|Follow-up (6 Months)|Adverse Event|2
2435223|NCT03293394|8354115|P1|Follow-up (6 Months)|Adverse Event|4
2435224|NCT03291288|8354206|P2|Pexidartinib Only|Ongoing|13
2435225|NCT03291288|8354207|P1|Pexidartinib Only|Ongoing|0
2435226|NCT03291288|8354206|P2|Pexidartinib Only|Other|2
2435227|NCT03291288|8354207|P1|Pexidartinib Only|Other|0
2435228|NCT03291288|8354206|P2|Pexidartinib Only|Patient request|1
2435229|NCT03291288|8354207|P1|Pexidartinib Only|Patient request|0
2435230|NCT03291288|8354206|P2|Pexidartinib Only|Disease progression|8
2435231|NCT03291288|8354207|P1|Pexidartinib Only|Disease progression|0
2435232|NCT03291288|8354206|P2|Pexidartinib Only|Adverse Event|1
2435233|NCT03291288|8354207|P1|Pexidartinib Only|Adverse Event|0
2435234|NCT03291288|8354206|P2|Drug-drug Interaction Phase|Did not receive treatment|0
2435235|NCT03291288|8354207|P1|Drug-drug Interaction Phase|Did not receive treatment|2
2435236|NCT03291288|8354206|P2|Drug-drug Interaction Phase|Disease progression|0
2435237|NCT03291288|8354207|P1|Drug-drug Interaction Phase|Disease progression|2
2435238|NCT03291288|8354206|P2|Drug-drug Interaction Phase|Adverse Event|0
2435239|NCT03291288|8354207|P1|Drug-drug Interaction Phase|Adverse Event|3
2435240|NCT03290300|8354281|P1|Overall Study|Lost to Follow-up|3
2435241|NCT03289676|8354301|P2|Overall Study|Lost to Follow-up|1
2435242|NCT03289676|8354302|P1|Overall Study|Lost to Follow-up|0
2435243|NCT03289676|8354301|P2|Overall Study|Protocol Violation|0
2435244|NCT03289676|8354302|P1|Overall Study|Protocol Violation|2
2435245|NCT03289676|8354301|P2|Overall Study|Withdrawal by Subject|0
2435246|NCT03289676|8354302|P1|Overall Study|Withdrawal by Subject|2
2435247|NCT03289208|8354352|P3|Overall Study|Adverse Event|0
2435248|NCT03289208|8354353|P2|Overall Study|Adverse Event|0
2435249|NCT03289208|8354354|P1|Overall Study|Adverse Event|1
2435250|NCT03288779|8354371|P1|Overall Study|Withdrawal by Subject|3
2435251|NCT03287791|8354394|P3|Overall Study|Did not meet inclusion criteria|0
2435252|NCT03287791|8354395|P2|Overall Study|Did not meet inclusion criteria|0
2435253|NCT03287791|8354396|P1|Overall Study|Did not meet inclusion criteria|1
2435254|NCT03287791|8354394|P3|Overall Study|Non-compliance|0
2435255|NCT03287791|8354395|P2|Overall Study|Non-compliance|1
2435256|NCT03287791|8354396|P1|Overall Study|Non-compliance|0
2435257|NCT03287791|8354394|P3|Overall Study|Too much time between 2 visits|0
2435258|NCT03287791|8354395|P2|Overall Study|Too much time between 2 visits|1
2435259|NCT03287791|8354396|P1|Overall Study|Too much time between 2 visits|0
2435260|NCT03287791|8354394|P3|Overall Study|Participant was enrolled at 2 sites|1
2435261|NCT03287791|8354395|P2|Overall Study|Participant was enrolled at 2 sites|0
2435262|NCT03287791|8354396|P1|Overall Study|Participant was enrolled at 2 sites|1
2435263|NCT03287791|8354394|P3|Overall Study|Protocol Violation|1
2435264|NCT03287791|8354395|P2|Overall Study|Protocol Violation|2
2435265|NCT03287791|8354396|P1|Overall Study|Protocol Violation|7
2435266|NCT03287791|8354394|P3|Overall Study|Lost to Follow-up|11
2435267|NCT03287791|8354395|P2|Overall Study|Lost to Follow-up|14
2435268|NCT03287791|8354396|P1|Overall Study|Lost to Follow-up|8
2435269|NCT03287791|8354394|P3|Overall Study|Missed more than 6 consecutive doses|2
2435270|NCT03287791|8354395|P2|Overall Study|Missed more than 6 consecutive doses|2
2435271|NCT03287791|8354396|P1|Overall Study|Missed more than 6 consecutive doses|3
2435272|NCT03287791|8354394|P3|Overall Study|Withdrawal by Subject|17
2435273|NCT03287791|8354395|P2|Overall Study|Withdrawal by Subject|12
2435274|NCT03287791|8354396|P1|Overall Study|Withdrawal by Subject|12
2435275|NCT03287791|8354394|P3|Overall Study|Adverse Event|3
2435276|NCT03287791|8354395|P2|Overall Study|Adverse Event|4
2435277|NCT03287791|8354396|P1|Overall Study|Adverse Event|0
2435278|NCT03287791|8354394|P3|Overall Study|Insufficient Therapeutic Response|1
2435279|NCT03287791|8354395|P2|Overall Study|Insufficient Therapeutic Response|0
2435280|NCT03287791|8354396|P1|Overall Study|Insufficient Therapeutic Response|0
2435281|NCT03286218|8354423|P12|Treatment Phase Period 4|Withdrawal by Subject|1
2435282|NCT03286218|8354424|P11|Treatment Phase Period 4|Withdrawal by Subject|0
2435283|NCT03286218|8354425|P10|Treatment Phase Period 4|Withdrawal by Subject|0
2435284|NCT03286218|8354426|P9|Treatment Phase Period 4|Withdrawal by Subject|0
2435285|NCT03286218|8354427|P8|Treatment Phase Period 4|Withdrawal by Subject|0
2435286|NCT03286218|8354428|P7|Treatment Phase Period 4|Withdrawal by Subject|0
2435287|NCT03286218|8354429|P6|Treatment Phase Period 4|Withdrawal by Subject|0
2435288|NCT03286218|8354430|P5|Treatment Phase Period 4|Withdrawal by Subject|0
2435289|NCT03286218|8354431|P4|Treatment Phase Period 4|Withdrawal by Subject|0
2435290|NCT03286218|8354432|P3|Treatment Phase Period 4|Withdrawal by Subject|0
2435291|NCT03286218|8354433|P2|Treatment Phase Period 4|Withdrawal by Subject|0
2435292|NCT03286218|8354434|P1|Treatment Phase Period 4|Withdrawal by Subject|0
2435293|NCT03286218|8354423|P12|Treatment Phase Period 1|Withdrawal by Subject|1
2435294|NCT03286218|8354424|P11|Treatment Phase Period 1|Withdrawal by Subject|0
2435295|NCT03286218|8354425|P10|Treatment Phase Period 1|Withdrawal by Subject|0
2435296|NCT03286218|8354426|P9|Treatment Phase Period 1|Withdrawal by Subject|0
2435297|NCT03286218|8354427|P8|Treatment Phase Period 1|Withdrawal by Subject|0
2435298|NCT03286218|8354428|P7|Treatment Phase Period 1|Withdrawal by Subject|0
2435299|NCT03286218|8354429|P6|Treatment Phase Period 1|Withdrawal by Subject|1
2435300|NCT03286218|8354430|P5|Treatment Phase Period 1|Withdrawal by Subject|0
2435301|NCT03286218|8354431|P4|Treatment Phase Period 1|Withdrawal by Subject|1
2435302|NCT03286218|8354432|P3|Treatment Phase Period 1|Withdrawal by Subject|1
2435303|NCT03286218|8354433|P2|Treatment Phase Period 1|Withdrawal by Subject|0
2435304|NCT03286218|8354434|P1|Treatment Phase Period 1|Withdrawal by Subject|0
2435305|NCT03286218|8354423|P12|Qualification Phase Period 2|Withdrawal by Subject|0
2435306|NCT03286218|8354424|P11|Qualification Phase Period 2|Withdrawal by Subject|0
2435307|NCT03286218|8354425|P10|Qualification Phase Period 2|Withdrawal by Subject|0
2435308|NCT03286218|8354426|P9|Qualification Phase Period 2|Withdrawal by Subject|0
2435309|NCT03286218|8354427|P8|Qualification Phase Period 2|Withdrawal by Subject|0
2435310|NCT03286218|8354428|P7|Qualification Phase Period 2|Withdrawal by Subject|0
2435311|NCT03286218|8354429|P6|Qualification Phase Period 2|Withdrawal by Subject|0
2435312|NCT03286218|8354430|P5|Qualification Phase Period 2|Withdrawal by Subject|0
2435313|NCT03286218|8354431|P4|Qualification Phase Period 2|Withdrawal by Subject|0
2435314|NCT03286218|8354432|P3|Qualification Phase Period 2|Withdrawal by Subject|0
2435315|NCT03286218|8354433|P2|Qualification Phase Period 2|Withdrawal by Subject|2
2435316|NCT03286218|8354434|P1|Qualification Phase Period 2|Withdrawal by Subject|1
2435317|NCT03286218|8354423|P12|Qualification Phase Period 2|Protocol Violation|0
2435318|NCT03286218|8354424|P11|Qualification Phase Period 2|Protocol Violation|0
2435319|NCT03286218|8354425|P10|Qualification Phase Period 2|Protocol Violation|0
2435320|NCT03286218|8354426|P9|Qualification Phase Period 2|Protocol Violation|0
2435321|NCT03286218|8354427|P8|Qualification Phase Period 2|Protocol Violation|0
2435322|NCT03286218|8354428|P7|Qualification Phase Period 2|Protocol Violation|0
2435323|NCT03286218|8354429|P6|Qualification Phase Period 2|Protocol Violation|0
2435324|NCT03286218|8354430|P5|Qualification Phase Period 2|Protocol Violation|0
2435325|NCT03286218|8354431|P4|Qualification Phase Period 2|Protocol Violation|0
2435326|NCT03286218|8354432|P3|Qualification Phase Period 2|Protocol Violation|0
2435327|NCT03286218|8354433|P2|Qualification Phase Period 2|Protocol Violation|0
2435328|NCT03286218|8354434|P1|Qualification Phase Period 2|Protocol Violation|2
2435329|NCT03286218|8354423|P12|Qualification Phase Period 2|Lost to Follow-up|0
2435330|NCT03286218|8354424|P11|Qualification Phase Period 2|Lost to Follow-up|0
2435331|NCT03286218|8354425|P10|Qualification Phase Period 2|Lost to Follow-up|0
2435332|NCT03286218|8354426|P9|Qualification Phase Period 2|Lost to Follow-up|0
2435333|NCT03286218|8354427|P8|Qualification Phase Period 2|Lost to Follow-up|0
2435334|NCT03286218|8354428|P7|Qualification Phase Period 2|Lost to Follow-up|0
2435335|NCT03286218|8354429|P6|Qualification Phase Period 2|Lost to Follow-up|0
2435336|NCT03286218|8354430|P5|Qualification Phase Period 2|Lost to Follow-up|0
2435337|NCT03286218|8354431|P4|Qualification Phase Period 2|Lost to Follow-up|0
2435338|NCT03286218|8354432|P3|Qualification Phase Period 2|Lost to Follow-up|0
2435339|NCT03286218|8354433|P2|Qualification Phase Period 2|Lost to Follow-up|1
2435340|NCT03286218|8354434|P1|Qualification Phase Period 2|Lost to Follow-up|0
2435341|NCT03286218|8354423|P12|Qualification Phase Period 2|Failure to meet randomization criteria|0
2435342|NCT03286218|8354424|P11|Qualification Phase Period 2|Failure to meet randomization criteria|0
2435343|NCT03286218|8354425|P10|Qualification Phase Period 2|Failure to meet randomization criteria|0
2435344|NCT03286218|8354426|P9|Qualification Phase Period 2|Failure to meet randomization criteria|0
2435345|NCT03286218|8354427|P8|Qualification Phase Period 2|Failure to meet randomization criteria|0
2435346|NCT03286218|8354428|P7|Qualification Phase Period 2|Failure to meet randomization criteria|0
2435347|NCT03286218|8354429|P6|Qualification Phase Period 2|Failure to meet randomization criteria|0
2435348|NCT03286218|8354430|P5|Qualification Phase Period 2|Failure to meet randomization criteria|0
2435349|NCT03286218|8354431|P4|Qualification Phase Period 2|Failure to meet randomization criteria|0
2435350|NCT03286218|8354432|P3|Qualification Phase Period 2|Failure to meet randomization criteria|0
2435351|NCT03286218|8354433|P2|Qualification Phase Period 2|Failure to meet randomization criteria|15
2435352|NCT03286218|8354434|P1|Qualification Phase Period 2|Failure to meet randomization criteria|14
2435353|NCT03286218|8354423|P12|Qualification Phase Period 2|Adverse Event|0
2435354|NCT03286218|8354424|P11|Qualification Phase Period 2|Adverse Event|0
2435355|NCT03286218|8354425|P10|Qualification Phase Period 2|Adverse Event|0
2435356|NCT03286218|8354426|P9|Qualification Phase Period 2|Adverse Event|0
2435357|NCT03286218|8354427|P8|Qualification Phase Period 2|Adverse Event|0
2435358|NCT03286218|8354428|P7|Qualification Phase Period 2|Adverse Event|0
2435359|NCT03286218|8354429|P6|Qualification Phase Period 2|Adverse Event|0
2435360|NCT03286218|8354430|P5|Qualification Phase Period 2|Adverse Event|0
2435361|NCT03286218|8354431|P4|Qualification Phase Period 2|Adverse Event|0
2435362|NCT03286218|8354432|P3|Qualification Phase Period 2|Adverse Event|0
2435363|NCT03286218|8354433|P2|Qualification Phase Period 2|Adverse Event|1
2435364|NCT03286218|8354434|P1|Qualification Phase Period 2|Adverse Event|0
2435365|NCT03286218|8354423|P12|Qualification Phase Period 1|Withdrawal by Subject|0
2435366|NCT03286218|8354424|P11|Qualification Phase Period 1|Withdrawal by Subject|0
2435367|NCT03286218|8354425|P10|Qualification Phase Period 1|Withdrawal by Subject|0
2435368|NCT03286218|8354426|P9|Qualification Phase Period 1|Withdrawal by Subject|0
2435369|NCT03286218|8354427|P8|Qualification Phase Period 1|Withdrawal by Subject|0
2435370|NCT03286218|8354428|P7|Qualification Phase Period 1|Withdrawal by Subject|0
2435371|NCT03286218|8354429|P6|Qualification Phase Period 1|Withdrawal by Subject|0
2435372|NCT03286218|8354430|P5|Qualification Phase Period 1|Withdrawal by Subject|0
2435373|NCT03286218|8354431|P4|Qualification Phase Period 1|Withdrawal by Subject|0
2435374|NCT03286218|8354432|P3|Qualification Phase Period 1|Withdrawal by Subject|0
2435375|NCT03286218|8354433|P2|Qualification Phase Period 1|Withdrawal by Subject|1
2435376|NCT03286218|8354434|P1|Qualification Phase Period 1|Withdrawal by Subject|0
2435377|NCT03286218|8354423|P12|Qualification Phase Period 1|Adverse Event|0
2435378|NCT03286218|8354424|P11|Qualification Phase Period 1|Adverse Event|0
2435379|NCT03286218|8354425|P10|Qualification Phase Period 1|Adverse Event|0
2435380|NCT03286218|8354426|P9|Qualification Phase Period 1|Adverse Event|0
2435381|NCT03286218|8354427|P8|Qualification Phase Period 1|Adverse Event|0
2435382|NCT03286218|8354428|P7|Qualification Phase Period 1|Adverse Event|0
2435383|NCT03286218|8354429|P6|Qualification Phase Period 1|Adverse Event|0
2435384|NCT03286218|8354430|P5|Qualification Phase Period 1|Adverse Event|0
2435385|NCT03286218|8354431|P4|Qualification Phase Period 1|Adverse Event|0
2435386|NCT03286218|8354432|P3|Qualification Phase Period 1|Adverse Event|0
2435387|NCT03286218|8354433|P2|Qualification Phase Period 1|Adverse Event|0
2435388|NCT03286218|8354434|P1|Qualification Phase Period 1|Adverse Event|1
2435389|NCT03285295|8354548|P5|Alinity s Chagas Follow-Up|Lost to Follow-up|0
2435390|NCT03285295|8354549|P4|Alinity s Chagas Follow-Up|Lost to Follow-up|0
2435391|NCT03285295|8354550|P3|Alinity s Chagas Follow-Up|Lost to Follow-up|0
2435392|NCT03285295|8354551|P2|Alinity s Chagas Follow-Up|Lost to Follow-up|0
2435393|NCT03285295|8354552|P1|Alinity s Chagas Follow-Up|Lost to Follow-up|13
2435394|NCT03285295|8354548|P5|Alinity s Chagas|No Results Generated|0
2435395|NCT03285295|8354549|P4|Alinity s Chagas|No Results Generated|0
2435396|NCT03285295|8354550|P3|Alinity s Chagas|No Results Generated|0
2435397|NCT03285295|8354551|P2|Alinity s Chagas|No Results Generated|0
2435398|NCT03285295|8354552|P1|Alinity s Chagas|No Results Generated|105
2435399|NCT03285295|8354548|P5|Alinity s Chagas|No Results on Comparator Assay|0
2435400|NCT03285295|8354549|P4|Alinity s Chagas|No Results on Comparator Assay|0
2435401|NCT03285295|8354550|P3|Alinity s Chagas|No Results on Comparator Assay|0
2435402|NCT03285295|8354551|P2|Alinity s Chagas|No Results on Comparator Assay|0
2435403|NCT03285295|8354552|P1|Alinity s Chagas|No Results on Comparator Assay|38
2435404|NCT03285295|8354548|P5|Alinity s Chagas|Protocol Violation|0
2435405|NCT03285295|8354549|P4|Alinity s Chagas|Protocol Violation|0
2435406|NCT03285295|8354550|P3|Alinity s Chagas|Protocol Violation|0
2435407|NCT03285295|8354551|P2|Alinity s Chagas|Protocol Violation|0
2435408|NCT03285295|8354552|P1|Alinity s Chagas|Protocol Violation|76
2435409|NCT03285295|8354548|P5|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
2435410|NCT03285295|8354549|P4|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
2435411|NCT03285295|8354550|P3|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
2435412|NCT03285295|8354551|P2|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
2435413|NCT03285295|8354552|P1|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14
2435414|NCT03285295|8354548|P5|Alinity s Anti-HBc|No Results Generated|0
2435415|NCT03285295|8354549|P4|Alinity s Anti-HBc|No Results Generated|0
2435416|NCT03285295|8354550|P3|Alinity s Anti-HBc|No Results Generated|0
2435417|NCT03285295|8354551|P2|Alinity s Anti-HBc|No Results Generated|0
2435418|NCT03285295|8354552|P1|Alinity s Anti-HBc|No Results Generated|70
2435419|NCT03285295|8354548|P5|Alinity s Anti-HBc|No Results on Comparator Assay|0
2435420|NCT03285295|8354549|P4|Alinity s Anti-HBc|No Results on Comparator Assay|0
2435421|NCT03285295|8354550|P3|Alinity s Anti-HBc|No Results on Comparator Assay|0
2435422|NCT03285295|8354551|P2|Alinity s Anti-HBc|No Results on Comparator Assay|1
2435423|NCT03285295|8354552|P1|Alinity s Anti-HBc|No Results on Comparator Assay|13
2435424|NCT03285295|8354548|P5|Alinity s Anti-HBc|Protocol Violation|0
2435425|NCT03285295|8354549|P4|Alinity s Anti-HBc|Protocol Violation|0
2435426|NCT03285295|8354550|P3|Alinity s Anti-HBc|Protocol Violation|0
2435427|NCT03285295|8354551|P2|Alinity s Anti-HBc|Protocol Violation|0
2435428|NCT03285295|8354552|P1|Alinity s Anti-HBc|Protocol Violation|8
2435429|NCT03285295|8354548|P5|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
2435430|NCT03285295|8354549|P4|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
2435431|NCT03285295|8354550|P3|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
2435432|NCT03285295|8354551|P2|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
2435433|NCT03285295|8354552|P1|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11
2435434|NCT03285295|8354548|P5|Alinity s HIV Ag/Ab Combo|No Results Generated|0
2435435|NCT03285295|8354549|P4|Alinity s HIV Ag/Ab Combo|No Results Generated|0
2435436|NCT03285295|8354550|P3|Alinity s HIV Ag/Ab Combo|No Results Generated|0
2435437|NCT03285295|8354551|P2|Alinity s HIV Ag/Ab Combo|No Results Generated|0
2435438|NCT03285295|8354552|P1|Alinity s HIV Ag/Ab Combo|No Results Generated|72
2435439|NCT03285295|8354548|P5|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
2435440|NCT03285295|8354549|P4|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
2435441|NCT03285295|8354550|P3|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
2435442|NCT03285295|8354551|P2|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
2435443|NCT03285295|8354552|P1|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16
2435444|NCT03285295|8354548|P5|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
2435445|NCT03285295|8354549|P4|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
2435446|NCT03285295|8354550|P3|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
2435447|NCT03285295|8354551|P2|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
2435448|NCT03285295|8354552|P1|Alinity s HIV Ag/Ab Combo|Protocol Violation|11
2435449|NCT03285295|8354548|P5|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
2435450|NCT03285295|8354549|P4|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
2435451|NCT03285295|8354550|P3|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
2435452|NCT03285295|8354551|P2|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
2435453|NCT03285295|8354552|P1|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18
2435454|NCT03285295|8354548|P5|Alinity s Anti-HCV|No Results Generated|0
2435455|NCT03285295|8354549|P4|Alinity s Anti-HCV|No Results Generated|0
2435456|NCT03285295|8354550|P3|Alinity s Anti-HCV|No Results Generated|0
2435457|NCT03285295|8354551|P2|Alinity s Anti-HCV|No Results Generated|0
2435458|NCT03285295|8354552|P1|Alinity s Anti-HCV|No Results Generated|71
2435459|NCT03285295|8354548|P5|Alinity s Anti-HCV|No Results on Comparator Assay|0
2435460|NCT03285295|8354549|P4|Alinity s Anti-HCV|No Results on Comparator Assay|0
2435461|NCT03285295|8354550|P3|Alinity s Anti-HCV|No Results on Comparator Assay|0
2435462|NCT03285295|8354551|P2|Alinity s Anti-HCV|No Results on Comparator Assay|0
2435463|NCT03285295|8354552|P1|Alinity s Anti-HCV|No Results on Comparator Assay|13
2435464|NCT03285295|8354548|P5|Alinity s Anti-HCV|Protocol Violation|0
2435465|NCT03285295|8354549|P4|Alinity s Anti-HCV|Protocol Violation|0
2435466|NCT03285295|8354550|P3|Alinity s Anti-HCV|Protocol Violation|0
2435467|NCT03285295|8354551|P2|Alinity s Anti-HCV|Protocol Violation|0
2435468|NCT03285295|8354552|P1|Alinity s Anti-HCV|Protocol Violation|12
2435469|NCT03285295|8354548|P5|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
2435470|NCT03285295|8354549|P4|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
2435471|NCT03285295|8354550|P3|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
2435472|NCT03285295|8354551|P2|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
2435473|NCT03285295|8354552|P1|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4
2435474|NCT03285295|8354548|P5|Alinity s HTLV I/II|No Results Generated|0
2435475|NCT03285295|8354549|P4|Alinity s HTLV I/II|No Results Generated|0
2435476|NCT03285295|8354550|P3|Alinity s HTLV I/II|No Results Generated|0
2435477|NCT03285295|8354551|P2|Alinity s HTLV I/II|No Results Generated|0
2435478|NCT03285295|8354552|P1|Alinity s HTLV I/II|No Results Generated|70
2435479|NCT03285295|8354548|P5|Alinity s HTLV I/II|No Result on Comparator Assay|0
2435480|NCT03285295|8354549|P4|Alinity s HTLV I/II|No Result on Comparator Assay|0
2435481|NCT03285295|8354550|P3|Alinity s HTLV I/II|No Result on Comparator Assay|0
2435482|NCT03285295|8354551|P2|Alinity s HTLV I/II|No Result on Comparator Assay|0
2435483|NCT03285295|8354552|P1|Alinity s HTLV I/II|No Result on Comparator Assay|15
2435484|NCT03285295|8354548|P5|Alinity s HTLV I/II|Protocol Violation|0
2435485|NCT03285295|8354549|P4|Alinity s HTLV I/II|Protocol Violation|0
2435486|NCT03285295|8354550|P3|Alinity s HTLV I/II|Protocol Violation|0
2435487|NCT03285295|8354551|P2|Alinity s HTLV I/II|Protocol Violation|0
2435488|NCT03285295|8354552|P1|Alinity s HTLV I/II|Protocol Violation|6
2435489|NCT03285295|8354548|P5|Alinity s HBsAg|No Results Generated|0
2435490|NCT03285295|8354549|P4|Alinity s HBsAg|No Results Generated|0
2435491|NCT03285295|8354550|P3|Alinity s HBsAg|No Results Generated|0
2435492|NCT03285295|8354551|P2|Alinity s HBsAg|No Results Generated|6
2435493|NCT03285295|8354552|P1|Alinity s HBsAg|No Results Generated|74
2435494|NCT03285295|8354548|P5|Alinity s HBsAg|No Result on Comparator Assay|0
2435495|NCT03285295|8354549|P4|Alinity s HBsAg|No Result on Comparator Assay|0
2435496|NCT03285295|8354550|P3|Alinity s HBsAg|No Result on Comparator Assay|0
2435497|NCT03285295|8354551|P2|Alinity s HBsAg|No Result on Comparator Assay|0
2435498|NCT03285295|8354552|P1|Alinity s HBsAg|No Result on Comparator Assay|17
2435499|NCT03285295|8354548|P5|Alinity s HBsAg|Protocol Violation|0
2435500|NCT03285295|8354549|P4|Alinity s HBsAg|Protocol Violation|0
2435501|NCT03285295|8354550|P3|Alinity s HBsAg|Protocol Violation|0
2435502|NCT03285295|8354551|P2|Alinity s HBsAg|Protocol Violation|0
2435503|NCT03285295|8354552|P1|Alinity s HBsAg|Protocol Violation|11
2435504|NCT03283709|8354588|P2|Overall Study|trial terminated|1
2435505|NCT03283709|8354589|P1|Overall Study|trial terminated|0
2435506|NCT03283319|8354625|P6|Overall Study|BARDA regulatory agency or IRB decision|0
2435507|NCT03283319|8354626|P5|Overall Study|BARDA regulatory agency or IRB decision|0
2435508|NCT03283319|8354627|P4|Overall Study|BARDA regulatory agency or IRB decision|1
2435509|NCT03283319|8354628|P3|Overall Study|BARDA regulatory agency or IRB decision|0
2435510|NCT03283319|8354629|P2|Overall Study|BARDA regulatory agency or IRB decision|0
2435511|NCT03283319|8354630|P1|Overall Study|BARDA regulatory agency or IRB decision|0
2435512|NCT03283319|8354625|P6|Overall Study|Withdrawal by Subject|1
2435513|NCT03283319|8354626|P5|Overall Study|Withdrawal by Subject|0
2435514|NCT03283319|8354627|P4|Overall Study|Withdrawal by Subject|1
2435515|NCT03283319|8354628|P3|Overall Study|Withdrawal by Subject|2
2435516|NCT03283319|8354629|P2|Overall Study|Withdrawal by Subject|2
2435517|NCT03283319|8354630|P1|Overall Study|Withdrawal by Subject|2
2435518|NCT03283319|8354625|P6|Overall Study|Lost to Follow-up|3
2435519|NCT03283319|8354626|P5|Overall Study|Lost to Follow-up|4
2435520|NCT03283319|8354627|P4|Overall Study|Lost to Follow-up|5
2435521|NCT03283319|8354628|P3|Overall Study|Lost to Follow-up|5
2435522|NCT03283319|8354629|P2|Overall Study|Lost to Follow-up|4
2435523|NCT03283319|8354630|P1|Overall Study|Lost to Follow-up|5
2435524|NCT03283098|8354772|P2|Overall Study|Withdrawal by Subject|1
2435525|NCT03283098|8354773|P1|Overall Study|Withdrawal by Subject|0
2435526|NCT03282240|8354829|P3|Overall Study|Withdrawal by Subject|1
2435527|NCT03282240|8354830|P2|Overall Study|Withdrawal by Subject|0
2435528|NCT03282240|8354831|P1|Overall Study|Withdrawal by Subject|1
2435529|NCT03282240|8354829|P3|Overall Study|Protocol Deviation|2
2435530|NCT03282240|8354830|P2|Overall Study|Protocol Deviation|1
2435531|NCT03282240|8354831|P1|Overall Study|Protocol Deviation|4
2435532|NCT03282240|8354829|P3|Overall Study|Lost to Follow-up|0
2435533|NCT03282240|8354830|P2|Overall Study|Lost to Follow-up|0
2435534|NCT03282240|8354831|P1|Overall Study|Lost to Follow-up|3
2435535|NCT03282240|8354829|P3|Overall Study|Adverse Event|0
2435536|NCT03282240|8354830|P2|Overall Study|Adverse Event|2
2435537|NCT03282240|8354831|P1|Overall Study|Adverse Event|2
2435538|NCT03281668|8354883|P1|Overall Study|Lost to Follow-up|1
2435539|NCT03281668|8354883|P1|Overall Study|Withdrawal by Subject|4
2435540|NCT03281668|8354883|P1|Overall Study|scheduling conflict, family circumstance|2
2435541|NCT03281668|8354883|P1|Overall Study|Physician Decision|1
2435542|NCT03280615|8354931|P2|Overall Study|Withdrawal by Subject|2
2435543|NCT03280615|8354932|P1|Overall Study|Withdrawal by Subject|2
2435544|NCT03280615|8354931|P2|Overall Study|Adverse Event|1
2435545|NCT03280615|8354932|P1|Overall Study|Adverse Event|1
2435546|NCT03280615|8354931|P2|Overall Study|Lost to Follow-up|2
2435547|NCT03280615|8354932|P1|Overall Study|Lost to Follow-up|1
2435548|NCT03280550|8354944|P2|Overall Study|Physician Decision|1
2435549|NCT03280550|8354945|P1|Overall Study|Physician Decision|0
2435550|NCT03280550|8354944|P2|Overall Study|Withdrawal by Subject|2
2435551|NCT03280550|8354945|P1|Overall Study|Withdrawal by Subject|2
2435552|NCT03280537|8354997|P2|Overall Study|Withdrawal by Subject|4
2435553|NCT03280537|8354998|P1|Overall Study|Withdrawal by Subject|2
2435554|NCT03280381|8355050|P2|Overall Study|Physician Decision|2
2435555|NCT03280381|8355051|P1|Overall Study|Physician Decision|0
2435556|NCT03280108|8355061|P2|Overall Study|Lost to Follow-up|0
2435557|NCT03280108|8355062|P1|Overall Study|Lost to Follow-up|2
2435558|NCT03278106|8355099|P1|Overall Study|No protocol treatment|1
2435559|NCT03278028|8355515|P2|Overall Study|Pregnancy|1
2435560|NCT03278028|8355516|P1|Overall Study|Pregnancy|0
2435561|NCT03278028|8355515|P2|Overall Study|Withdrawal by Subject|1
2435562|NCT03278028|8355516|P1|Overall Study|Withdrawal by Subject|3
2435563|NCT03278028|8355515|P2|Overall Study|Lost to Follow-up|0
2435564|NCT03278028|8355516|P1|Overall Study|Lost to Follow-up|1
2435565|NCT03277846|8355524|P2|Overall Study|Inpatient stay too brief|11
2435566|NCT03277846|8355525|P1|Overall Study|Inpatient stay too brief|12
2435567|NCT03276078|8355570|P1|Overall Study|Adverse Event|1
2435568|NCT03276026|8355599|P2|Overall Study|Protocol Violation|0
2435569|NCT03276026|8355600|P1|Overall Study|Protocol Violation|1
2435570|NCT03274986|8355628|P2|Overall Study|Lost to Follow-up|1
2435571|NCT03274986|8355629|P1|Overall Study|Lost to Follow-up|0
2435572|NCT03274986|8355628|P2|Overall Study|Withdrawal by Subject|1
2435573|NCT03274986|8355629|P1|Overall Study|Withdrawal by Subject|0
2435574|NCT03274453|8355696|P4|Overall Study|Surgery Cancelled|0
2435575|NCT03274453|8355697|P3|Overall Study|Surgery Cancelled|0
2435576|NCT03274453|8355698|P2|Overall Study|Surgery Cancelled|1
2435577|NCT03274453|8355699|P1|Overall Study|Surgery Cancelled|0
2435578|NCT03274453|8355696|P4|Overall Study|Physician Decision|3
2435579|NCT03274453|8355697|P3|Overall Study|Physician Decision|0
2435580|NCT03274453|8355698|P2|Overall Study|Physician Decision|0
2435581|NCT03274453|8355699|P1|Overall Study|Physician Decision|2
2435582|NCT03274453|8355696|P4|Overall Study|Lost to Follow-up|1
2435583|NCT03274453|8355697|P3|Overall Study|Lost to Follow-up|4
2435584|NCT03274453|8355698|P2|Overall Study|Lost to Follow-up|5
2435585|NCT03274453|8355699|P1|Overall Study|Lost to Follow-up|2
2435586|NCT03273946|8355709|P1|Overall Study|Participant relative refused to use drug|1
2435587|NCT03273946|8355709|P1|Overall Study|Participant refused to use the drug|2
2435588|NCT03273946|8355709|P1|Overall Study|Unwillingness of the guardian|1
2435589|NCT03273946|8355709|P1|Overall Study|Withdrawal by Subject|5
2435590|NCT03273387|8355729|P2|Overall Study|Withdrawal by Subject|1
2435591|NCT03273387|8355730|P1|Overall Study|Withdrawal by Subject|1
2435592|NCT03273387|8355729|P2|Overall Study|Death|2
2435593|NCT03273387|8355730|P1|Overall Study|Death|2
2435594|NCT03271021|8355783|P2|Overall Study|Miscellaneous|8
2435595|NCT03271021|8355784|P1|Overall Study|Miscellaneous|9
2435596|NCT03271021|8355783|P2|Overall Study|Abnormal Lab Results|0
2435597|NCT03271021|8355784|P1|Overall Study|Abnormal Lab Results|1
2435598|NCT03271021|8355783|P2|Overall Study|Protocol Violation|4
2435599|NCT03271021|8355784|P1|Overall Study|Protocol Violation|6
2435600|NCT03271021|8355783|P2|Overall Study|Lost to Follow-up|39
2435601|NCT03271021|8355784|P1|Overall Study|Lost to Follow-up|34
2435602|NCT03271021|8355783|P2|Overall Study|Withdrawal by Subject|53
2435603|NCT03271021|8355784|P1|Overall Study|Withdrawal by Subject|36
2435604|NCT03271021|8355783|P2|Overall Study|Adverse Event|2
2435605|NCT03271021|8355784|P1|Overall Study|Adverse Event|3
2435606|NCT03270657|8355802|P1|Overall Study|Withdrawal by Subject|1
2435607|NCT03270644|8355808|P1|Day 4 - 10 Propranolol Reference|Adverse Event|1
2435608|NCT03270644|8355808|P1|Day 1 Lasmiditan Reference|Physician Decision|1
2435609|NCT03270085|8355831|P2|Overall Study|Withdrawal by Subject|0
2435610|NCT03270085|8355832|P1|Overall Study|Withdrawal by Subject|1
2435611|NCT03269552|8355842|P1|Overall Study|Adverse Event|2
2435612|NCT03268941|8355853|P7|Part 2: Days 17 to 25|Withdrawal by Subject|1
2435613|NCT03268941|8355854|P6|Part 2: Days 17 to 25|Withdrawal by Subject|0
2435614|NCT03268941|8355855|P5|Part 2: Days 17 to 25|Withdrawal by Subject|0
2435615|NCT03268941|8355856|P4|Part 2: Days 17 to 25|Withdrawal by Subject|0
2435616|NCT03268941|8355857|P3|Part 2: Days 17 to 25|Withdrawal by Subject|0
2435617|NCT03268941|8355858|P2|Part 2: Days 17 to 25|Withdrawal by Subject|0
2435618|NCT03268941|8355859|P1|Part 2: Days 17 to 25|Withdrawal by Subject|0
2435619|NCT03268941|8355853|P7|Part 2: Days 17 to 25|Reason not specified|1
2435620|NCT03268941|8355854|P6|Part 2: Days 17 to 25|Reason not specified|0
2435621|NCT03268941|8355855|P5|Part 2: Days 17 to 25|Reason not specified|0
2435622|NCT03268941|8355856|P4|Part 2: Days 17 to 25|Reason not specified|0
2435623|NCT03268941|8355857|P3|Part 2: Days 17 to 25|Reason not specified|0
2435624|NCT03268941|8355858|P2|Part 2: Days 17 to 25|Reason not specified|0
2435625|NCT03268941|8355859|P1|Part 2: Days 17 to 25|Reason not specified|0
2435626|NCT03268941|8355853|P7|Part 1 (Days 1 to 9)|Protocol Deviation|0
2435627|NCT03268941|8355854|P6|Part 1 (Days 1 to 9)|Protocol Deviation|0
2435628|NCT03268941|8355855|P5|Part 1 (Days 1 to 9)|Protocol Deviation|0
2435629|NCT03268941|8355856|P4|Part 1 (Days 1 to 9)|Protocol Deviation|0
2435630|NCT03268941|8355857|P3|Part 1 (Days 1 to 9)|Protocol Deviation|0
2435631|NCT03268941|8355858|P2|Part 1 (Days 1 to 9)|Protocol Deviation|0
2435632|NCT03268941|8355859|P1|Part 1 (Days 1 to 9)|Protocol Deviation|1
2435633|NCT03268941|8355853|P7|Part 1 (Days 1 to 9)|Adverse Event|0
2435634|NCT03268941|8355854|P6|Part 1 (Days 1 to 9)|Adverse Event|0
2435635|NCT03268941|8355855|P5|Part 1 (Days 1 to 9)|Adverse Event|0
2435636|NCT03268941|8355856|P4|Part 1 (Days 1 to 9)|Adverse Event|1
2435637|NCT03268941|8355857|P3|Part 1 (Days 1 to 9)|Adverse Event|0
2435638|NCT03268941|8355858|P2|Part 1 (Days 1 to 9)|Adverse Event|0
2435639|NCT03268941|8355859|P1|Part 1 (Days 1 to 9)|Adverse Event|0
2435640|NCT03268941|8355853|P7|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
2435641|NCT03268941|8355854|P6|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
2435642|NCT03268941|8355855|P5|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
2435643|NCT03268941|8355856|P4|Part 1 (Days 1 to 9)|Withdrawal by Subject|1
2435644|NCT03268941|8355857|P3|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
2435645|NCT03268941|8355858|P2|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
2435646|NCT03268941|8355859|P1|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
2435647|NCT03268746|8355921|P1|Overall Study|Withdrawal by Subject|1
2435648|NCT03268590|8355943|P1|Overall Study|Previously unknown exclusion criteria|1
2435649|NCT03268005|8355978|P2|Overall Study|Withdrawal by Subject|11
2435650|NCT03268005|8355979|P1|Overall Study|Withdrawal by Subject|11
2435651|NCT03268005|8355978|P2|Overall Study|Lost to Follow-up|2
2435652|NCT03268005|8355979|P1|Overall Study|Lost to Follow-up|2
2435653|NCT03268005|8355978|P2|Overall Study|Death|1
2435654|NCT03268005|8355979|P1|Overall Study|Death|2
2435655|NCT03267940|8356093|P6|Expansion (Maximum Exposure: 421 Days)|Death|6
2435656|NCT03267940|8356094|P5|Expansion (Maximum Exposure: 421 Days)|Death|0
2435657|NCT03267940|8356095|P4|Expansion (Maximum Exposure: 421 Days)|Death|13
2435658|NCT03267940|8356096|P3|Expansion (Maximum Exposure: 421 Days)|Death|10
2435659|NCT03267940|8356097|P2|Expansion (Maximum Exposure: 421 Days)|Death|0
2435660|NCT03267940|8356098|P1|Expansion (Maximum Exposure: 421 Days)|Death|0
2435661|NCT03267940|8356093|P6|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3
2435662|NCT03267940|8356094|P5|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5
2435663|NCT03267940|8356095|P4|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4
2435664|NCT03267940|8356096|P3|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7
2435665|NCT03267940|8356097|P2|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0
2435666|NCT03267940|8356098|P1|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0
2435667|NCT03267940|8356093|P6|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
2435668|NCT03267940|8356094|P5|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
2435669|NCT03267940|8356095|P4|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
2435670|NCT03267940|8356096|P3|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2
2435671|NCT03267940|8356097|P2|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0
2435672|NCT03267940|8356098|P1|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0
2435673|NCT03267940|8356093|P6|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
2435674|NCT03267940|8356094|P5|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2
2435675|NCT03267940|8356095|P4|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1
2435676|NCT03267940|8356096|P3|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2
2435677|NCT03267940|8356097|P2|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
2435678|NCT03267940|8356098|P1|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
2435679|NCT03267940|8356093|P6|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
2435680|NCT03267940|8356094|P5|Expansion (Maximum Exposure: 421 Days)|Other than specified|2
2435681|NCT03267940|8356095|P4|Expansion (Maximum Exposure: 421 Days)|Other than specified|3
2435682|NCT03267940|8356096|P3|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
2435683|NCT03267940|8356097|P2|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
2435684|NCT03267940|8356098|P1|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
2435685|NCT03267940|8356093|P6|Run-in Portion (Max. Exposure: 508 Days)|Death|0
2435686|NCT03267940|8356094|P5|Run-in Portion (Max. Exposure: 508 Days)|Death|0
2435687|NCT03267940|8356095|P4|Run-in Portion (Max. Exposure: 508 Days)|Death|0
2435688|NCT03267940|8356096|P3|Run-in Portion (Max. Exposure: 508 Days)|Death|0
2435689|NCT03267940|8356097|P2|Run-in Portion (Max. Exposure: 508 Days)|Death|3
2435690|NCT03267940|8356098|P1|Run-in Portion (Max. Exposure: 508 Days)|Death|7
2435691|NCT03267940|8356093|P6|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
2435692|NCT03267940|8356094|P5|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
2435693|NCT03267940|8356095|P4|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
2435694|NCT03267940|8356096|P3|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
2435695|NCT03267940|8356097|P2|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1
2435696|NCT03267940|8356098|P1|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
2435697|NCT03267940|8356093|P6|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
2435698|NCT03267940|8356094|P5|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
2435699|NCT03267940|8356095|P4|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
2435700|NCT03267940|8356096|P3|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
2435701|NCT03267940|8356097|P2|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1
2435702|NCT03267940|8356098|P1|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
2435703|NCT03267940|8356093|P6|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
2435704|NCT03267940|8356094|P5|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
2435705|NCT03267940|8356095|P4|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
2435706|NCT03267940|8356096|P3|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
2435707|NCT03267940|8356097|P2|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2
2435708|NCT03267940|8356098|P1|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1
2435709|NCT03267576|8356200|P2|Period 2: Day 44 to 71|Withdrawal by Subject|1
2435710|NCT03267576|8356201|P1|Period 2: Day 44 to 71|Withdrawal by Subject|1
2435711|NCT03267576|8356200|P2|Period 2: Day 44 to 71|Lost to Follow-up|1
2435712|NCT03267576|8356201|P1|Period 2: Day 44 to 71|Lost to Follow-up|0
2435713|NCT03267511|8356239|P4|Overall Study|Lost to Follow-up|1
2435714|NCT03267511|8356240|P3|Overall Study|Lost to Follow-up|0
2435715|NCT03267511|8356241|P2|Overall Study|Lost to Follow-up|0
2435716|NCT03267511|8356242|P1|Overall Study|Lost to Follow-up|0
2435717|NCT03267264|8356258|P4|Overall Study|Withdrawal by Subject|4
2435718|NCT03267264|8356259|P3|Overall Study|Withdrawal by Subject|2
2435719|NCT03267264|8356260|P2|Overall Study|Withdrawal by Subject|0
2435720|NCT03267264|8356261|P1|Overall Study|Withdrawal by Subject|1
2435721|NCT03267212|8356278|P2|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0
2435722|NCT03267212|8356279|P1|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1
2435723|NCT03267212|8356278|P2|First Intervention|Withdrawal by Subject|1
2435724|NCT03267212|8356279|P1|First Intervention|Withdrawal by Subject|1
2435725|NCT03267212|8356278|P2|First Intervention|Lost to Follow-up|2
2435726|NCT03267212|8356279|P1|First Intervention|Lost to Follow-up|0
2435727|NCT03266172|8356305|P3|Part C Washout Period (7 Days)|Withdrawal by Subject|1
2435728|NCT03266172|8356306|P2|Part C Washout Period (7 Days)|Withdrawal by Subject|0
2435729|NCT03266172|8356307|P1|Part C Washout Period (7 Days)|Withdrawal by Subject|0
2435730|NCT03266172|8356305|P3|Part C Washout Period (7 Days)|Withdrawal by Subject|1
2435731|NCT03266172|8356306|P2|Part C Washout Period (7 Days)|Withdrawal by Subject|0
2435732|NCT03266172|8356307|P1|Part C Washout Period (7 Days)|Withdrawal by Subject|0
2435733|NCT03266172|8356305|P3|Part B: Washout (7 Days)|Withdrawal by Subject|0
2435734|NCT03266172|8356306|P2|Part B: Washout (7 Days)|Withdrawal by Subject|2
2435735|NCT03266172|8356307|P1|Part B: Washout (7 Days)|Withdrawal by Subject|0
2435736|NCT03266172|8356305|P3|Part A: Washout Period (7 Days)|Withdrawal by Subject|0
2435737|NCT03266172|8356306|P2|Part A: Washout Period (7 Days)|Withdrawal by Subject|0
2435738|NCT03266172|8356307|P1|Part A: Washout Period (7 Days)|Withdrawal by Subject|1
2435739|NCT03266172|8356305|P3|Part A: Washout Period (7 Days)|Adverse Event|0
2435740|NCT03266172|8356306|P2|Part A: Washout Period (7 Days)|Adverse Event|0
2435741|NCT03266172|8356307|P1|Part A: Washout Period (7 Days)|Adverse Event|1
2435742|NCT03266172|8356305|P3|Part A: Period 1(2 Days)|Withdrawal by Subject|0
2435743|NCT03266172|8356306|P2|Part A: Period 1(2 Days)|Withdrawal by Subject|0
2435744|NCT03266172|8356307|P1|Part A: Period 1(2 Days)|Withdrawal by Subject|1
2435745|NCT03265600|8356554|P2|Overall Study|Partially completed 8 wk or 24 wk survey|5
2435746|NCT03265600|8356555|P1|Overall Study|Partially completed 8 wk or 24 wk survey|3
2435747|NCT03265600|8356554|P2|Overall Study|Withdrawal by Subject|2
2435748|NCT03265600|8356555|P1|Overall Study|Withdrawal by Subject|4
2435749|NCT03265600|8356554|P2|Overall Study|Lost to Follow-up|5
2435750|NCT03265600|8356555|P1|Overall Study|Lost to Follow-up|17
2435751|NCT03265132|8356581|P2|Overall Study|Withdrawal by Subject|1
2435752|NCT03265132|8356582|P1|Overall Study|Withdrawal by Subject|0
2435753|NCT03265132|8356581|P2|Overall Study|Progressive disease|2
2435754|NCT03265132|8356582|P1|Overall Study|Progressive disease|0
2435755|NCT03265132|8356581|P2|Overall Study|Lack of Efficacy|2
2435756|NCT03265132|8356582|P1|Overall Study|Lack of Efficacy|0
2435757|NCT03265132|8356581|P2|Overall Study|Adverse Event|1
2435758|NCT03265132|8356582|P1|Overall Study|Adverse Event|0
2435759|NCT03265119|8356680|P2|Overall Study|Lack of Compliance|0
2435760|NCT03265119|8356681|P1|Overall Study|Lack of Compliance|1
2435761|NCT03265119|8356680|P2|Overall Study|Lost to Follow-up|0
2435762|NCT03265119|8356681|P1|Overall Study|Lost to Follow-up|1
2435763|NCT03265119|8356680|P2|Overall Study|Withdrawal by Subject|4
2435764|NCT03265119|8356681|P1|Overall Study|Withdrawal by Subject|2
2435765|NCT03265119|8356680|P2|Overall Study|Protocol Violation|2
2435766|NCT03265119|8356681|P1|Overall Study|Protocol Violation|1
2435767|NCT03265119|8356680|P2|Overall Study|Lack of Efficacy|0
2435768|NCT03265119|8356681|P1|Overall Study|Lack of Efficacy|3
2435769|NCT03265119|8356680|P2|Overall Study|Adverse Event|1
2435770|NCT03265119|8356681|P1|Overall Study|Adverse Event|2
2435771|NCT03264456|8356689|P1|Overall Study|Lost to Follow-up|1
2435772|NCT03264456|8356689|P1|Overall Study|Withdrawal by Subject|3
2435773|NCT03263806|8356724|P2|Overall Study|Study Termination|6
2435774|NCT03263806|8356725|P1|Overall Study|Study Termination|5
2435775|NCT03263806|8356724|P2|Overall Study|Withdrawal by Subject|1
2435776|NCT03263806|8356725|P1|Overall Study|Withdrawal by Subject|0
2435777|NCT03263806|8356724|P2|Overall Study|Elevated Troponin (failed screen)|0
2435778|NCT03263806|8356725|P1|Overall Study|Elevated Troponin (failed screen)|1
2435779|NCT03263702|8356739|P2|Overall Study|Withdrawal by Subject|2
2435780|NCT03263702|8356740|P1|Overall Study|Withdrawal by Subject|1
2435781|NCT03263702|8356739|P2|Overall Study|Lost to Follow-up|2
2435782|NCT03263702|8356740|P1|Overall Study|Lost to Follow-up|2
2435783|NCT03262233|8356770|P4|Overall Study|data collection artifact|0
2435784|NCT03262233|8356771|P3|Overall Study|data collection artifact|0
2435785|NCT03262233|8356772|P2|Overall Study|data collection artifact|1
2435786|NCT03262233|8356773|P1|Overall Study|data collection artifact|0
2435787|NCT03262233|8356770|P4|Overall Study|Protocol Violation|13
2435788|NCT03262233|8356771|P3|Overall Study|Protocol Violation|2
2435789|NCT03262233|8356772|P2|Overall Study|Protocol Violation|10
2435790|NCT03262233|8356773|P1|Overall Study|Protocol Violation|5
2435791|NCT03262233|8356770|P4|Overall Study|Declined due to shock|3
2435792|NCT03262233|8356771|P3|Overall Study|Declined due to shock|2
2435793|NCT03262233|8356772|P2|Overall Study|Declined due to shock|2
2435794|NCT03262233|8356773|P1|Overall Study|Declined due to shock|1
2435795|NCT03262233|8356770|P4|Overall Study|Withdrawal by Subject|13
2435796|NCT03262233|8356771|P3|Overall Study|Withdrawal by Subject|21
2435797|NCT03262233|8356772|P2|Overall Study|Withdrawal by Subject|8
2435798|NCT03262233|8356773|P1|Overall Study|Withdrawal by Subject|12
2435799|NCT03261531|8356795|P1|Overall Study|Withdrawal by Subject|4
2435800|NCT03261167|8356813|P2|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1
2435801|NCT03261167|8356814|P1|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1
2435802|NCT03261167|8356813|P2|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0
2435803|NCT03261167|8356814|P1|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1
2435804|NCT03261167|8356813|P2|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0
2435805|NCT03261167|8356814|P1|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1
2435806|NCT03261167|8356813|P2|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1
2435807|NCT03261167|8356814|P1|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3
2435808|NCT03261167|8356813|P2|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3
2435809|NCT03261167|8356814|P1|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0
2435810|NCT03260894|8356852|P2|Overall Study|On-going at clinical cut off date|31
2435811|NCT03260894|8356853|P1|Overall Study|On-going at clinical cut off date|36
2435812|NCT03260894|8356852|P2|Overall Study|Withdrawal by Subject|11
2435813|NCT03260894|8356853|P1|Overall Study|Withdrawal by Subject|4
2435814|NCT03260894|8356852|P2|Overall Study|Death|8
2435815|NCT03260894|8356853|P1|Overall Study|Death|6
2435816|NCT03260868|8356865|P2|Overall Study|Other than specified above|0
2435817|NCT03260868|8356866|P1|Overall Study|Other than specified above|1
2435818|NCT03260868|8356865|P2|Overall Study|Study Terminated By Sponsor|1
2435819|NCT03260868|8356866|P1|Overall Study|Study Terminated By Sponsor|2
2435820|NCT03260868|8356865|P2|Overall Study|Poor Compliance to Protocol|2
2435821|NCT03260868|8356866|P1|Overall Study|Poor Compliance to Protocol|0
2435822|NCT03260205|8356988|P5|Overall Study|Participant Who Did Not Received AnyDose|1
2435823|NCT03260205|8356989|P4|Overall Study|Participant Who Did Not Received AnyDose|3
2435824|NCT03260205|8356990|P3|Overall Study|Participant Who Did Not Received AnyDose|2
2435825|NCT03260205|8356991|P2|Overall Study|Participant Who Did Not Received AnyDose|1
2435826|NCT03260205|8356992|P1|Overall Study|Participant Who Did Not Received AnyDose|1
2435827|NCT03260205|8356988|P5|Overall Study|Other: Unspecified|1
2435828|NCT03260205|8356989|P4|Overall Study|Other: Unspecified|1
2435829|NCT03260205|8356990|P3|Overall Study|Other: Unspecified|3
2435830|NCT03260205|8356991|P2|Overall Study|Other: Unspecified|0
2435831|NCT03260205|8356992|P1|Overall Study|Other: Unspecified|0
2435832|NCT03260205|8356988|P5|Overall Study|Withdrawal by Participant or Parent/LAR|2
2435833|NCT03260205|8356989|P4|Overall Study|Withdrawal by Participant or Parent/LAR|0
2435834|NCT03260205|8356990|P3|Overall Study|Withdrawal by Participant or Parent/LAR|1
2435835|NCT03260205|8356991|P2|Overall Study|Withdrawal by Participant or Parent/LAR|5
2435836|NCT03260205|8356992|P1|Overall Study|Withdrawal by Participant or Parent/LAR|4
2435837|NCT03260205|8356988|P5|Overall Study|Protocol Violation|1
2435838|NCT03260205|8356989|P4|Overall Study|Protocol Violation|0
2435839|NCT03260205|8356990|P3|Overall Study|Protocol Violation|2
2435840|NCT03260205|8356991|P2|Overall Study|Protocol Violation|0
2435841|NCT03260205|8356992|P1|Overall Study|Protocol Violation|0
2435842|NCT03260205|8356988|P5|Overall Study|Lost to Follow-up|5
2435843|NCT03260205|8356989|P4|Overall Study|Lost to Follow-up|1
2435844|NCT03260205|8356990|P3|Overall Study|Lost to Follow-up|1
2435845|NCT03260205|8356991|P2|Overall Study|Lost to Follow-up|2
2435846|NCT03260205|8356992|P1|Overall Study|Lost to Follow-up|2
2435847|NCT03260205|8356988|P5|Overall Study|Adverse Event|4
2435848|NCT03260205|8356989|P4|Overall Study|Adverse Event|2
2435849|NCT03260205|8356990|P3|Overall Study|Adverse Event|2
2435850|NCT03260205|8356991|P2|Overall Study|Adverse Event|0
2435851|NCT03260205|8356992|P1|Overall Study|Adverse Event|2
2435852|NCT03259555|8357055|P2|Overall Study|Other|0
2435853|NCT03259555|8357056|P1|Overall Study|Other|1
2435854|NCT03259555|8357055|P2|Overall Study|Physician Decision|2
2435855|NCT03259555|8357056|P1|Overall Study|Physician Decision|1
2435856|NCT03259555|8357055|P2|Overall Study|Withdrawal by Subject|16
2435857|NCT03259555|8357056|P1|Overall Study|Withdrawal by Subject|19
2435858|NCT03259555|8357055|P2|Overall Study|Progressive Disease|2
2435859|NCT03259555|8357056|P1|Overall Study|Progressive Disease|0
2435860|NCT03259555|8357055|P2|Overall Study|Non-Compliance With Study Drug|0
2435861|NCT03259555|8357056|P1|Overall Study|Non-Compliance With Study Drug|1
2435862|NCT03259555|8357055|P2|Overall Study|Lost to Follow-up|2
2435863|NCT03259555|8357056|P1|Overall Study|Lost to Follow-up|0
2435864|NCT03259555|8357055|P2|Overall Study|Lack of Efficacy|4
2435865|NCT03259555|8357056|P1|Overall Study|Lack of Efficacy|6
2435866|NCT03259555|8357055|P2|Overall Study|Adverse Event|4
2435867|NCT03259555|8357056|P1|Overall Study|Adverse Event|6
2435868|NCT03259490|8357066|P2|Period 2|Protocol Violation|0
2435869|NCT03259490|8357067|P1|Period 2|Protocol Violation|1
2435870|NCT03259490|8357066|P2|Period 1|Withdrawal by Subject|1
2435871|NCT03259490|8357067|P1|Period 1|Withdrawal by Subject|0
2435872|NCT03259087|8357098|P5|Period 2 of Part 2|Adverse Event|1
2435873|NCT03259087|8357099|P4|Period 2 of Part 2|Adverse Event|0
2435874|NCT03259087|8357100|P3|Period 2 of Part 2|Adverse Event|0
2435875|NCT03259087|8357101|P2|Period 2 of Part 2|Adverse Event|0
2435876|NCT03259087|8357102|P1|Period 2 of Part 2|Adverse Event|0
2435877|NCT03259087|8357098|P5|Part 1 and Period 1 of Part 2|Adverse Event|1
2435878|NCT03259087|8357099|P4|Part 1 and Period 1 of Part 2|Adverse Event|0
2435879|NCT03259087|8357100|P3|Part 1 and Period 1 of Part 2|Adverse Event|0
2435880|NCT03259087|8357101|P2|Part 1 and Period 1 of Part 2|Adverse Event|0
2435881|NCT03259087|8357102|P1|Part 1 and Period 1 of Part 2|Adverse Event|0
2435882|NCT03258814|8357230|P3|Overall Study|Early Termination|10
2435883|NCT03258814|8357231|P2|Overall Study|Early Termination|3
2435884|NCT03258814|8357232|P1|Overall Study|Early Termination|4
2435885|NCT03258762|8357287|P2|Overall Study|Lost to Follow-up|1
2435886|NCT03258762|8357288|P1|Overall Study|Lost to Follow-up|0
2435887|NCT03258710|8357348|P1|Overall Study|Protocol-defined stopping criteria|1
2435888|NCT03258710|8357348|P1|Overall Study|Adverse Event|1
2435889|NCT03257995|8357386|P6|Overall Study|Protocol deviation|2
2435890|NCT03257995|8357387|P5|Overall Study|Protocol deviation|0
2435891|NCT03257995|8357388|P4|Overall Study|Protocol deviation|0
2435892|NCT03257995|8357389|P3|Overall Study|Protocol deviation|0
2435893|NCT03257995|8357390|P2|Overall Study|Protocol deviation|0
2435894|NCT03257995|8357391|P1|Overall Study|Protocol deviation|0
2435895|NCT03257995|8357386|P6|Overall Study|Adverse Event|0
2435896|NCT03257995|8357387|P5|Overall Study|Adverse Event|0
2435897|NCT03257995|8357388|P4|Overall Study|Adverse Event|0
2435898|NCT03257995|8357389|P3|Overall Study|Adverse Event|0
2435899|NCT03257995|8357390|P2|Overall Study|Adverse Event|1
2435900|NCT03257995|8357391|P1|Overall Study|Adverse Event|0
2435901|NCT03257865|8357441|P2|Overall Study|Lost to Follow-up|4
2435902|NCT03257865|8357442|P1|Overall Study|Lost to Follow-up|4
2435903|NCT03257865|8357441|P2|Overall Study|Other|1
2435904|NCT03257865|8357442|P1|Overall Study|Other|0
2435905|NCT03257865|8357441|P2|Overall Study|Physician Decision|1
2435906|NCT03257865|8357442|P1|Overall Study|Physician Decision|3
2435907|NCT03257865|8357441|P2|Overall Study|Withdrawal by Subject|17
2435908|NCT03257865|8357442|P1|Overall Study|Withdrawal by Subject|23
2435909|NCT03257865|8357441|P2|Overall Study|Non-compliance with Study Drug|2
2435910|NCT03257865|8357442|P1|Overall Study|Non-compliance with Study Drug|0
2435911|NCT03257865|8357441|P2|Overall Study|Lack of Efficacy|2
2435912|NCT03257865|8357442|P1|Overall Study|Lack of Efficacy|1
2435913|NCT03257865|8357441|P2|Overall Study|Adverse Event|8
2435914|NCT03257865|8357442|P1|Overall Study|Adverse Event|4
2435915|NCT03257813|8357452|P2|Overall Study|Protocol Violation|3
2435916|NCT03257813|8357453|P1|Overall Study|Protocol Violation|6
2435917|NCT03257657|8357475|P2|Overall Study|Noted not eligible right after enrolled|1
2435918|NCT03257657|8357476|P1|Overall Study|Noted not eligible right after enrolled|0
2435919|NCT03257657|8357475|P2|Overall Study|Withdrawn|1
2435920|NCT03257657|8357476|P1|Overall Study|Withdrawn|0
2435921|NCT03257657|8357475|P2|Overall Study|Lost to Follow-up|3
2435922|NCT03257657|8357476|P1|Overall Study|Lost to Follow-up|0
2435923|NCT03257631|8357507|P4|Overall Study|Still on Study|4
2435924|NCT03257631|8357508|P3|Overall Study|Still on Study|4
2435925|NCT03257631|8357509|P2|Overall Study|Still on Study|2
2435926|NCT03257631|8357510|P1|Overall Study|Still on Study|3
2435927|NCT03257631|8357507|P4|Overall Study|Lost to Follow-up|0
2435928|NCT03257631|8357508|P3|Overall Study|Lost to Follow-up|1
2435929|NCT03257631|8357509|P2|Overall Study|Lost to Follow-up|0
2435930|NCT03257631|8357510|P1|Overall Study|Lost to Follow-up|0
2435931|NCT03257631|8357507|P4|Overall Study|Withdrawal by Parent/Guardian|1
2435932|NCT03257631|8357508|P3|Overall Study|Withdrawal by Parent/Guardian|4
2435933|NCT03257631|8357509|P2|Overall Study|Withdrawal by Parent/Guardian|2
2435934|NCT03257631|8357510|P1|Overall Study|Withdrawal by Parent/Guardian|0
2435935|NCT03257631|8357507|P4|Overall Study|Progressive Disease|0
2435936|NCT03257631|8357508|P3|Overall Study|Progressive Disease|1
2435937|NCT03257631|8357509|P2|Overall Study|Progressive Disease|0
2435938|NCT03257631|8357510|P1|Overall Study|Progressive Disease|0
2435939|NCT03257631|8357507|P4|Overall Study|Death|5
2435940|NCT03257631|8357508|P3|Overall Study|Death|13
2435941|NCT03257631|8357509|P2|Overall Study|Death|5
2435942|NCT03257631|8357510|P1|Overall Study|Death|8
2435943|NCT03256851|8357572|P2|Overall Study|Withdrawal by Subject|0
2435944|NCT03256851|8357573|P1|Overall Study|Withdrawal by Subject|1
2435945|NCT03256695|8357585|P1|Overall Study|Other than specified|3
2435946|NCT03256695|8357585|P1|Overall Study|Protocol Violation|5
2435947|NCT03256695|8357585|P1|Overall Study|Lack of Efficacy|3
2435948|NCT03256695|8357585|P1|Overall Study|Lost to Follow-up|3
2435949|NCT03256695|8357585|P1|Overall Study|Non-compliance with study drug|1
2435950|NCT03256695|8357585|P1|Overall Study|Withdrawal by Subject|14
2435951|NCT03256695|8357585|P1|Overall Study|Death|2
2435952|NCT03256695|8357585|P1|Overall Study|Adverse Event|8
2435953|NCT03256552|8357593|P1|Overall Study|Withdrawal by Subject|2
2435954|NCT03256552|8357593|P1|Overall Study|Adverse Event|1
2435955|NCT03256552|8357593|P1|Overall Study|Physician Decision|1
2435956|NCT03256552|8357593|P1|Overall Study|Protocol Violation|1
2435957|NCT03256526|8357618|P3|Overall Study|Lost to Follow-up|2
2435958|NCT03256526|8357619|P2|Overall Study|Lost to Follow-up|0
2435959|NCT03256526|8357620|P1|Overall Study|Lost to Follow-up|1
2435960|NCT03256526|8357618|P3|Overall Study|Adverse Event|1
2435961|NCT03256526|8357619|P2|Overall Study|Adverse Event|0
2435962|NCT03256526|8357620|P1|Overall Study|Adverse Event|1
2435963|NCT03255824|8357668|P2|Overall Study|Under-sedation|1
2435964|NCT03255824|8357669|P1|Overall Study|Under-sedation|2
2435965|NCT03255733|8357697|P1|Overall Study|Lost to Follow-up|4
2435966|NCT03255655|8357704|P2|Overall Study|Lost to Follow-up|4
2435967|NCT03255655|8357705|P1|Overall Study|Lost to Follow-up|7
2435968|NCT03255382|8357715|P2|Overall Study|Other|0
2435969|NCT03255382|8357716|P1|Overall Study|Other|6
2435970|NCT03255382|8357715|P2|Overall Study|Withdrawal by Subject|0
2435971|NCT03255382|8357716|P1|Overall Study|Withdrawal by Subject|2
2435972|NCT03255382|8357715|P2|Overall Study|Lost to Follow-up|0
2435973|NCT03255382|8357716|P1|Overall Study|Lost to Follow-up|2
2435974|NCT03255382|8357715|P2|Overall Study|Adverse Event|0
2435975|NCT03255382|8357716|P1|Overall Study|Adverse Event|3
2435976|NCT03255291|8357890|P6|Overall Study|Baseline data collection issues|0
2435977|NCT03255291|8357891|P5|Overall Study|Baseline data collection issues|2
2435978|NCT03255291|8357892|P4|Overall Study|Baseline data collection issues|0
2435979|NCT03255291|8357893|P3|Overall Study|Baseline data collection issues|0
2435980|NCT03255291|8357894|P2|Overall Study|Baseline data collection issues|0
2435981|NCT03255291|8357895|P1|Overall Study|Baseline data collection issues|3
2435982|NCT03255291|8357890|P6|Overall Study|Determined to be ineligible|10
2435983|NCT03255291|8357891|P5|Overall Study|Determined to be ineligible|5
2435984|NCT03255291|8357892|P4|Overall Study|Determined to be ineligible|6
2435985|NCT03255291|8357893|P3|Overall Study|Determined to be ineligible|6
2435986|NCT03255291|8357894|P2|Overall Study|Determined to be ineligible|12
2435987|NCT03255291|8357895|P1|Overall Study|Determined to be ineligible|10
2435988|NCT03255187|8357928|P2|Period From First to Second Follow-up|Withdrawal by Subject|1
2435989|NCT03255187|8357929|P1|Period From First to Second Follow-up|Withdrawal by Subject|0
2435990|NCT03255187|8357928|P2|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3
2435991|NCT03255187|8357929|P1|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1
2435992|NCT03254602|8357969|P1|Overall Study|Lost to Follow-up|4
2435993|NCT03254459|8357977|P2|Overall Study|Miscellaneous|1
2435994|NCT03254459|8357978|P1|Overall Study|Miscellaneous|0
2435995|NCT03254459|8357977|P2|Overall Study|Lost to Follow-up|1
2435996|NCT03254459|8357978|P1|Overall Study|Lost to Follow-up|0
2435997|NCT03254459|8357977|P2|Overall Study|Withdrawal by Subject Consent|1
2435998|NCT03254459|8357978|P1|Overall Study|Withdrawal by Subject Consent|3
2435999|NCT03254459|8357977|P2|Overall Study|Adverse Event|20
2436000|NCT03254459|8357978|P1|Overall Study|Adverse Event|7
2436001|NCT03254134|8358003|P2|Overall Study|Not eligible patients|3630
2436002|NCT03254134|8358004|P1|Overall Study|Not eligible patients|599
2436003|NCT03252015|8358030|P4|Overall Study|Adverse Event|1
2436004|NCT03252015|8358031|P3|Overall Study|Adverse Event|0
2436005|NCT03252015|8358032|P2|Overall Study|Adverse Event|0
2436006|NCT03252015|8358033|P1|Overall Study|Adverse Event|1
2436007|NCT03252015|8358030|P4|Overall Study|Withdrawal by Subject|0
2436008|NCT03252015|8358031|P3|Overall Study|Withdrawal by Subject|1
2436009|NCT03252015|8358032|P2|Overall Study|Withdrawal by Subject|1
2436010|NCT03252015|8358033|P1|Overall Study|Withdrawal by Subject|0
2436011|NCT03251482|8358078|P5|Overall Study|Withdrawal by Subject|0
2436012|NCT03251482|8358079|P4|Overall Study|Withdrawal by Subject|0
2436013|NCT03251482|8358080|P3|Overall Study|Withdrawal by Subject|0
2436014|NCT03251482|8358081|P2|Overall Study|Withdrawal by Subject|1
2436015|NCT03251482|8358082|P1|Overall Study|Withdrawal by Subject|0
2436016|NCT03249935|8358226|P1|Overall Study|Protocol Violation|5
2436017|NCT03249935|8358226|P1|Overall Study|Negative for chlamydia at enrollment|4
2436018|NCT03249935|8358226|P1|Overall Study|Discharged from facility early|36
2436019|NCT03249454|8358237|P11|Overall Study|Withdrawal by Subject|1
2436020|NCT03249454|8358238|P10|Overall Study|Withdrawal by Subject|1
2436021|NCT03249454|8358239|P9|Overall Study|Withdrawal by Subject|0
2436022|NCT03249454|8358240|P8|Overall Study|Withdrawal by Subject|0
2436023|NCT03249454|8358241|P7|Overall Study|Withdrawal by Subject|0
2436024|NCT03249454|8358242|P6|Overall Study|Withdrawal by Subject|0
2436025|NCT03249454|8358243|P5|Overall Study|Withdrawal by Subject|0
2436026|NCT03249454|8358244|P4|Overall Study|Withdrawal by Subject|0
2436027|NCT03249454|8358245|P3|Overall Study|Withdrawal by Subject|0
2436028|NCT03249454|8358246|P2|Overall Study|Withdrawal by Subject|0
2436029|NCT03249454|8358247|P1|Overall Study|Withdrawal by Subject|0
2436030|NCT03248882|8358272|P5|Overall Study|Withdrawal by Subject|2
2436031|NCT03248882|8358273|P4|Overall Study|Withdrawal by Subject|4
2436032|NCT03248882|8358274|P3|Overall Study|Withdrawal by Subject|3
2436033|NCT03248882|8358275|P2|Overall Study|Withdrawal by Subject|2
2436034|NCT03248882|8358276|P1|Overall Study|Withdrawal by Subject|2
2436035|NCT03248882|8358272|P5|Overall Study|Protocol Violation|1
2436036|NCT03248882|8358273|P4|Overall Study|Protocol Violation|0
2436037|NCT03248882|8358274|P3|Overall Study|Protocol Violation|2
2436038|NCT03248882|8358275|P2|Overall Study|Protocol Violation|0
2436039|NCT03248882|8358276|P1|Overall Study|Protocol Violation|2
2436040|NCT03248882|8358272|P5|Overall Study|Lost to Follow-up|1
2436041|NCT03248882|8358273|P4|Overall Study|Lost to Follow-up|0
2436042|NCT03248882|8358274|P3|Overall Study|Lost to Follow-up|0
2436043|NCT03248882|8358275|P2|Overall Study|Lost to Follow-up|0
2436044|NCT03248882|8358276|P1|Overall Study|Lost to Follow-up|0
2436045|NCT03248882|8358272|P5|Overall Study|Adverse Event|9
2436046|NCT03248882|8358273|P4|Overall Study|Adverse Event|6
2436047|NCT03248882|8358274|P3|Overall Study|Adverse Event|2
2436048|NCT03248882|8358275|P2|Overall Study|Adverse Event|3
2436049|NCT03248882|8358276|P1|Overall Study|Adverse Event|3
2436050|NCT03248492|8358318|P5|Overall Study|Other|0
2436051|NCT03248492|8358319|P4|Overall Study|Other|4
2436052|NCT03248492|8358320|P3|Overall Study|Other|0
2436053|NCT03248492|8358321|P2|Overall Study|Other|1
2436054|NCT03248492|8358322|P1|Overall Study|Other|0
2436055|NCT03248492|8358318|P5|Overall Study|Death|0
2436056|NCT03248492|8358319|P4|Overall Study|Death|6
2436057|NCT03248492|8358320|P3|Overall Study|Death|0
2436058|NCT03248492|8358321|P2|Overall Study|Death|0
2436059|NCT03248492|8358322|P1|Overall Study|Death|1
2436060|NCT03248492|8358318|P5|Overall Study|Physician Decision|0
2436061|NCT03248492|8358319|P4|Overall Study|Physician Decision|2
2436062|NCT03248492|8358320|P3|Overall Study|Physician Decision|1
2436063|NCT03248492|8358321|P2|Overall Study|Physician Decision|0
2436064|NCT03248492|8358322|P1|Overall Study|Physician Decision|1
2436065|NCT03248492|8358318|P5|Overall Study|Withdrawal by Subject|1
2436066|NCT03248492|8358319|P4|Overall Study|Withdrawal by Subject|3
2436067|NCT03248492|8358320|P3|Overall Study|Withdrawal by Subject|0
2436068|NCT03248492|8358321|P2|Overall Study|Withdrawal by Subject|3
2436069|NCT03248492|8358322|P1|Overall Study|Withdrawal by Subject|3
2436070|NCT03248492|8358318|P5|Overall Study|Adverse Event|1
2436071|NCT03248492|8358319|P4|Overall Study|Adverse Event|8
2436072|NCT03248492|8358320|P3|Overall Study|Adverse Event|8
2436073|NCT03248492|8358321|P2|Overall Study|Adverse Event|6
2436074|NCT03248492|8358322|P1|Overall Study|Adverse Event|6
2436075|NCT03248492|8358318|P5|Overall Study|Progressive disease per RECIST v1.1|0
2436076|NCT03248492|8358319|P4|Overall Study|Progressive disease per RECIST v1.1|22
2436077|NCT03248492|8358320|P3|Overall Study|Progressive disease per RECIST v1.1|9
2436078|NCT03248492|8358321|P2|Overall Study|Progressive disease per RECIST v1.1|12
2436079|NCT03248492|8358322|P1|Overall Study|Progressive disease per RECIST v1.1|16
2436080|NCT03248492|8358318|P5|Overall Study|Ongoing|2
2436081|NCT03248492|8358319|P4|Overall Study|Ongoing|85
2436082|NCT03248492|8358320|P3|Overall Study|Ongoing|3
2436083|NCT03248492|8358321|P2|Overall Study|Ongoing|26
2436084|NCT03248492|8358322|P1|Overall Study|Ongoing|23
2436085|NCT03247673|8358414|P3|Overall Study|Lost to Follow-up|1
2436086|NCT03247673|8358415|P2|Overall Study|Lost to Follow-up|0
2436087|NCT03247673|8358416|P1|Overall Study|Lost to Follow-up|0
2436088|NCT03247673|8358414|P3|Overall Study|Withdrawal by Subject|3
2436089|NCT03247673|8358415|P2|Overall Study|Withdrawal by Subject|0
2436090|NCT03247673|8358416|P1|Overall Study|Withdrawal by Subject|1
2436091|NCT03246672|8358436|P1|Overall Study|Lost to Follow-up|2
2436092|NCT03246152|8358442|P1|Overall Study|Protocol Violation|1
2436093|NCT03246152|8358442|P1|Overall Study|Lost to Follow-up|2
2436094|NCT03245619|8358474|P17|Part A (Up to Day 22)|Physician Decision|0
2436095|NCT03245619|8358475|P16|Part A (Up to Day 22)|Physician Decision|0
2436096|NCT03245619|8358476|P15|Part A (Up to Day 22)|Physician Decision|0
2436097|NCT03245619|8358477|P14|Part A (Up to Day 22)|Physician Decision|0
2436098|NCT03245619|8358478|P13|Part A (Up to Day 22)|Physician Decision|0
2436099|NCT03245619|8358479|P12|Part A (Up to Day 22)|Physician Decision|0
2436100|NCT03245619|8358480|P11|Part A (Up to Day 22)|Physician Decision|0
2436101|NCT03245619|8358481|P10|Part A (Up to Day 22)|Physician Decision|0
2436102|NCT03245619|8358482|P9|Part A (Up to Day 22)|Physician Decision|0
2436103|NCT03245619|8358483|P8|Part A (Up to Day 22)|Physician Decision|0
2436104|NCT03245619|8358484|P7|Part A (Up to Day 22)|Physician Decision|0
2436105|NCT03245619|8358485|P6|Part A (Up to Day 22)|Physician Decision|0
2436106|NCT03245619|8358486|P5|Part A (Up to Day 22)|Physician Decision|0
2436107|NCT03245619|8358487|P4|Part A (Up to Day 22)|Physician Decision|0
2436108|NCT03245619|8358488|P3|Part A (Up to Day 22)|Physician Decision|6
2436109|NCT03245619|8358489|P2|Part A (Up to Day 22)|Physician Decision|6
2436110|NCT03245619|8358490|P1|Part A (Up to Day 22)|Physician Decision|4
2436111|NCT03245398|8358764|P2|Overall Study|Travelled to another island|0
2436112|NCT03245398|8358765|P1|Overall Study|Travelled to another island|1
2436113|NCT03244800|8358795|P4|Overall Study|Withdrew treatment|1
2436114|NCT03244800|8358796|P3|Overall Study|Withdrew treatment|0
2436115|NCT03244800|8358797|P2|Overall Study|Withdrew treatment|0
2436116|NCT03244800|8358798|P1|Overall Study|Withdrew treatment|0
2436117|NCT03244800|8358795|P4|Overall Study|Adverse Event|1
2436118|NCT03244800|8358796|P3|Overall Study|Adverse Event|0
2436119|NCT03244800|8358797|P2|Overall Study|Adverse Event|1
2436120|NCT03244800|8358798|P1|Overall Study|Adverse Event|0
2436121|NCT03243084|8358877|P2|Washout (1-3 Weeks)|Lost to Follow-up|0
2436122|NCT03243084|8358878|P1|Washout (1-3 Weeks)|Lost to Follow-up|1
2436123|NCT03242434|8358900|P2|Overall Study|Death|2
2436124|NCT03242434|8358901|P1|Overall Study|Death|0
2436125|NCT03240575|8358917|P4|Overall Study|Other|0
2436126|NCT03240575|8358918|P3|Overall Study|Other|0
2436127|NCT03240575|8358919|P2|Overall Study|Other|1
2436128|NCT03240575|8358920|P1|Overall Study|Other|0
2436129|NCT03240575|8358917|P4|Overall Study|Withdrawal by Subject|1
2436130|NCT03240575|8358918|P3|Overall Study|Withdrawal by Subject|0
2436131|NCT03240575|8358919|P2|Overall Study|Withdrawal by Subject|11
2436132|NCT03240575|8358920|P1|Overall Study|Withdrawal by Subject|2
2436133|NCT03240575|8358917|P4|Overall Study|Adverse Event|1
2436134|NCT03240575|8358918|P3|Overall Study|Adverse Event|0
2436135|NCT03240575|8358919|P2|Overall Study|Adverse Event|2
2436136|NCT03240575|8358920|P1|Overall Study|Adverse Event|0
2436137|NCT03239873|8358942|P2|Overall Study|Protocol Violation|0
2436138|NCT03239873|8358943|P1|Overall Study|Protocol Violation|1
2436139|NCT03239873|8358942|P2|Overall Study|Contraindication to study medication|0
2436140|NCT03239873|8358943|P1|Overall Study|Contraindication to study medication|1
2436141|NCT03239873|8358942|P2|Overall Study|Withdrawal by Subject|0
2436142|NCT03239873|8358943|P1|Overall Study|Withdrawal by Subject|2
2436143|NCT03239873|8358942|P2|Overall Study|Withdrawal by Parent/Guardian|11
2436144|NCT03239873|8358943|P1|Overall Study|Withdrawal by Parent/Guardian|12
2436145|NCT03239873|8358942|P2|Overall Study|Physician Decision|0
2436146|NCT03239873|8358943|P1|Overall Study|Physician Decision|1
2436147|NCT03239873|8358942|P2|Overall Study|Lost to Follow-up|16
2436148|NCT03239873|8358943|P1|Overall Study|Lost to Follow-up|15
2436149|NCT03239483|8359079|P2|Overall Study|Withdrawal by Subject|0
2436150|NCT03239483|8359080|P1|Overall Study|Withdrawal by Subject|1
2436151|NCT03239483|8359079|P2|Overall Study|Lost to Follow-up|0
2436152|NCT03239483|8359080|P1|Overall Study|Lost to Follow-up|1
2436153|NCT03238924|8359101|P2|Overall Study|Withdrawal by Subject|2
2436154|NCT03238924|8359102|P1|Overall Study|Withdrawal by Subject|2
2436155|NCT03238911|8359114|P2|Overall Study|Lost to Follow-up|1
2436156|NCT03238911|8359115|P1|Overall Study|Lost to Follow-up|2
2436157|NCT03238911|8359114|P2|Overall Study|Withdrawal by Subject|2
2436158|NCT03238911|8359115|P1|Overall Study|Withdrawal by Subject|1
2436159|NCT03238781|8359158|P3|Overall Study|Decision by sponsor|0
2436160|NCT03238781|8359159|P2|Overall Study|Decision by sponsor|1
2436161|NCT03238781|8359160|P1|Overall Study|Decision by sponsor|0
2436162|NCT03238781|8359158|P3|Overall Study|Withdrawal by Subject|16
2436163|NCT03238781|8359159|P2|Overall Study|Withdrawal by Subject|14
2436164|NCT03238781|8359160|P1|Overall Study|Withdrawal by Subject|23
2436165|NCT03238781|8359158|P3|Overall Study|Lost to Follow-up|2
2436166|NCT03238781|8359159|P2|Overall Study|Lost to Follow-up|1
2436167|NCT03238781|8359160|P1|Overall Study|Lost to Follow-up|2
2436168|NCT03238781|8359158|P3|Overall Study|Adverse Event|2
2436169|NCT03238781|8359159|P2|Overall Study|Adverse Event|1
2436170|NCT03238781|8359160|P1|Overall Study|Adverse Event|1
2436171|NCT03238352|8359210|P3|Overall Study|Withdrawal by Subject|0
2436172|NCT03238352|8359211|P2|Overall Study|Withdrawal by Subject|1
2436173|NCT03238352|8359212|P1|Overall Study|Withdrawal by Subject|0
2436174|NCT03238352|8359210|P3|Overall Study|Lost to Follow-up|1
2436175|NCT03238352|8359211|P2|Overall Study|Lost to Follow-up|2
2436176|NCT03238352|8359212|P1|Overall Study|Lost to Follow-up|0
2436177|NCT03238001|8359223|P1|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4
2436178|NCT03238001|8359223|P1|Visit 2 (Secondary Endpoint Cohort)|Study completion|1
2436179|NCT03238001|8359223|P1|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3
2436180|NCT03238001|8359223|P1|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3
2436181|NCT03238001|8359223|P1|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2
2436182|NCT03238001|8359223|P1|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16
2436183|NCT03238001|8359223|P1|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2
2436184|NCT03238001|8359223|P1|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2
2436185|NCT03237065|8359352|P2|Overall Study|Unable to obtain venous access|1
2436186|NCT03237065|8359353|P1|Overall Study|Unable to obtain venous access|0
2436187|NCT03237065|8359352|P2|Overall Study|Lost to Follow-up|0
2436188|NCT03237065|8359353|P1|Overall Study|Lost to Follow-up|1
2436189|NCT03237065|8359352|P2|Overall Study|Withdrawal by Subject|0
2436190|NCT03237065|8359353|P1|Overall Study|Withdrawal by Subject|3
2436191|NCT03237065|8359352|P2|Overall Study|Protocol Violation|1
2436192|NCT03237065|8359353|P1|Overall Study|Protocol Violation|0
2436193|NCT03237065|8359352|P2|Overall Study|Adverse Event|2
2436194|NCT03237065|8359353|P1|Overall Study|Adverse Event|0
2436195|NCT03237013|8359396|P3|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37
2436196|NCT03237013|8359397|P2|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30
2436197|NCT03237013|8359398|P1|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43
2436198|NCT03236311|8359447|P2|Overall Study|Adverse Event|1
2436199|NCT03236311|8359448|P1|Overall Study|Adverse Event|0
2436200|NCT03236311|8359447|P2|Overall Study|Study terminated by sponsor|2
2436201|NCT03236311|8359448|P1|Overall Study|Study terminated by sponsor|0
2436202|NCT03235726|8359492|P10|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
2436203|NCT03235726|8359493|P9|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
2436204|NCT03235726|8359494|P8|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
2436205|NCT03235726|8359495|P7|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
2436206|NCT03235726|8359496|P6|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
2436207|NCT03235726|8359497|P5|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1
2436208|NCT03235726|8359498|P4|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
2436209|NCT03235726|8359499|P3|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
2436210|NCT03235726|8359500|P2|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
2436211|NCT03235726|8359501|P1|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
2436212|NCT03235726|8359492|P10|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
2436213|NCT03235726|8359493|P9|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
2436214|NCT03235726|8359494|P8|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
2436215|NCT03235726|8359495|P7|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
2436216|NCT03235726|8359496|P6|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
2436217|NCT03235726|8359497|P5|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1
2436218|NCT03235726|8359498|P4|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
2436219|NCT03235726|8359499|P3|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
2436220|NCT03235726|8359500|P2|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
2436221|NCT03235726|8359501|P1|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
2436222|NCT03235349|8359653|P1|Overall Study|Other|1
2436223|NCT03235349|8359653|P1|Overall Study|Adverse Event|1
2436224|NCT03235284|8359663|P3|Overall Study|Adverse Event|1
2436225|NCT03235284|8359664|P2|Overall Study|Adverse Event|2
2436226|NCT03235284|8359665|P1|Overall Study|Adverse Event|1
2436227|NCT03235115|8359682|P6|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1
2436228|NCT03235115|8359683|P5|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
2436229|NCT03235115|8359684|P4|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
2436230|NCT03235115|8359685|P3|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
2436231|NCT03235115|8359686|P2|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
2436232|NCT03235115|8359687|P1|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
2436233|NCT03234036|8359710|P4|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0
2436234|NCT03234036|8359711|P3|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0
2436235|NCT03234036|8359712|P2|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1
2436236|NCT03234036|8359713|P1|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1
2436237|NCT03233529|8359884|P1|Open-Label Period (Day 15 to Day 71)|Adverse Event|1
2436238|NCT03233529|8359884|P1|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1
2436239|NCT03233438|8359928|P2|Overall Study|No recording of dalbavancin|1
2436240|NCT03233438|8359929|P1|Overall Study|No recording of dalbavancin|0
2436241|NCT03233438|8359928|P2|Overall Study|Withdrawal by Subject|1
2436242|NCT03233438|8359929|P1|Overall Study|Withdrawal by Subject|2
2436243|NCT03233438|8359928|P2|Overall Study|Lost to Follow-up|9
2436244|NCT03233438|8359929|P1|Overall Study|Lost to Follow-up|4
2436245|NCT03233308|8359995|P1|Overall Study|Protocol Violation|1
2436246|NCT03233308|8359995|P1|Overall Study|Adverse Event|1
2436247|NCT03233009|8360045|P1|Overall Study|Lost to Follow-up|1
2436248|NCT03232983|8360088|P4|Period 4|Withdrawal by Subject|0
2436249|NCT03232983|8360089|P3|Period 4|Withdrawal by Subject|0
2436250|NCT03232983|8360090|P2|Period 4|Withdrawal by Subject|0
2436251|NCT03232983|8360091|P1|Period 4|Withdrawal by Subject|1
2436252|NCT03232983|8360088|P4|Washout Period 2|Withdrawal by Subject|1
2436253|NCT03232983|8360089|P3|Washout Period 2|Withdrawal by Subject|0
2436254|NCT03232983|8360090|P2|Washout Period 2|Withdrawal by Subject|0
2436255|NCT03232983|8360091|P1|Washout Period 2|Withdrawal by Subject|0
2436256|NCT03232983|8360088|P4|Washout Period 2|Physician Decision|0
2436257|NCT03232983|8360089|P3|Washout Period 2|Physician Decision|1
2436258|NCT03232983|8360090|P2|Washout Period 2|Physician Decision|0
2436259|NCT03232983|8360091|P1|Washout Period 2|Physician Decision|0
2436260|NCT03232983|8360088|P4|Period 1|Physician Decision|0
2436261|NCT03232983|8360089|P3|Period 1|Physician Decision|1
2436262|NCT03232983|8360090|P2|Period 1|Physician Decision|0
2436263|NCT03232983|8360091|P1|Period 1|Physician Decision|0
2436264|NCT03232567|8360135|P4|Overall Study|Withdrawal by Subject|0
2436265|NCT03232567|8360136|P3|Overall Study|Withdrawal by Subject|0
2436266|NCT03232567|8360137|P2|Overall Study|Withdrawal by Subject|1
2436267|NCT03232567|8360138|P1|Overall Study|Withdrawal by Subject|0
2436268|NCT03232333|8360160|P1|Overall Study|Withdrawal by Subject|2
2436269|NCT03232333|8360160|P1|Overall Study|Lost to Follow-up|4
2436270|NCT03232333|8360160|P1|Overall Study|Infection or Osteomyelitis|9
2436271|NCT03231943|8360177|P13|Part 2|Withdrawal by Subject|0
2436272|NCT03231943|8360178|P12|Part 2|Withdrawal by Subject|1
2436273|NCT03231943|8360179|P11|Part 2|Withdrawal by Subject|0
2436274|NCT03231943|8360180|P10|Part 2|Withdrawal by Subject|0
2436275|NCT03231943|8360181|P9|Part 2|Withdrawal by Subject|0
2436276|NCT03231943|8360182|P8|Part 2|Withdrawal by Subject|0
2436277|NCT03231943|8360183|P7|Part 2|Withdrawal by Subject|0
2436278|NCT03231943|8360184|P6|Part 2|Withdrawal by Subject|0
2436279|NCT03231943|8360185|P5|Part 2|Withdrawal by Subject|0
2436280|NCT03231943|8360186|P4|Part 2|Withdrawal by Subject|0
2436281|NCT03231943|8360187|P3|Part 2|Withdrawal by Subject|0
2436282|NCT03231943|8360188|P2|Part 2|Withdrawal by Subject|0
2436283|NCT03231943|8360189|P1|Part 2|Withdrawal by Subject|0
2436284|NCT03231943|8360177|P13|Part 2|Adverse Event|0
2436285|NCT03231943|8360178|P12|Part 2|Adverse Event|0
2436286|NCT03231943|8360179|P11|Part 2|Adverse Event|1
2436287|NCT03231943|8360180|P10|Part 2|Adverse Event|0
2436288|NCT03231943|8360181|P9|Part 2|Adverse Event|0
2436289|NCT03231943|8360182|P8|Part 2|Adverse Event|0
2436290|NCT03231943|8360183|P7|Part 2|Adverse Event|0
2436291|NCT03231943|8360184|P6|Part 2|Adverse Event|0
2436292|NCT03231943|8360185|P5|Part 2|Adverse Event|0
2436293|NCT03231943|8360186|P4|Part 2|Adverse Event|0
2436294|NCT03231943|8360187|P3|Part 2|Adverse Event|0
2436295|NCT03231943|8360188|P2|Part 2|Adverse Event|0
2436296|NCT03231943|8360189|P1|Part 2|Adverse Event|0
2436297|NCT03231943|8360177|P13|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2436298|NCT03231943|8360178|P12|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2436299|NCT03231943|8360179|P11|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2436300|NCT03231943|8360180|P10|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2436301|NCT03231943|8360181|P9|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2436302|NCT03231943|8360182|P8|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2436303|NCT03231943|8360183|P7|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2436304|NCT03231943|8360184|P6|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2436305|NCT03231943|8360185|P5|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2436306|NCT03231943|8360186|P4|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2436307|NCT03231943|8360187|P3|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2436308|NCT03231943|8360188|P2|Part 1, Period 3 (up to Day 45)|Adverse Event|0
2436309|NCT03231943|8360189|P1|Part 1, Period 3 (up to Day 45)|Adverse Event|1
2436310|NCT03231943|8360177|P13|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2436311|NCT03231943|8360178|P12|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2436312|NCT03231943|8360179|P11|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2436313|NCT03231943|8360180|P10|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2436314|NCT03231943|8360181|P9|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2436315|NCT03231943|8360182|P8|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2436316|NCT03231943|8360183|P7|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2436317|NCT03231943|8360184|P6|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2436318|NCT03231943|8360185|P5|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2436319|NCT03231943|8360186|P4|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2436320|NCT03231943|8360187|P3|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2436321|NCT03231943|8360188|P2|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1
2436322|NCT03231943|8360189|P1|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
2436323|NCT03231943|8360177|P13|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2436324|NCT03231943|8360178|P12|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2436325|NCT03231943|8360179|P11|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2436326|NCT03231943|8360180|P10|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2436327|NCT03231943|8360181|P9|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2436328|NCT03231943|8360182|P8|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2436329|NCT03231943|8360183|P7|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2436330|NCT03231943|8360184|P6|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2436331|NCT03231943|8360185|P5|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2436332|NCT03231943|8360186|P4|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2436333|NCT03231943|8360187|P3|Part 1, Period 2 (up to Day 30)|Adverse Event|1
2436334|NCT03231943|8360188|P2|Part 1, Period 2 (up to Day 30)|Adverse Event|1
2436335|NCT03231943|8360189|P1|Part 1, Period 2 (up to Day 30)|Adverse Event|0
2436336|NCT03231709|8360652|P2|Treatment Period 2|Pretreatment Event/Adverse Event|1
2436337|NCT03231709|8360653|P1|Treatment Period 2|Pretreatment Event/Adverse Event|0
2436338|NCT03231709|8360652|P2|Treatment Period 1|Reason not Specified|1
2436339|NCT03231709|8360653|P1|Treatment Period 1|Reason not Specified|0
2436340|NCT03231371|8360671|P1|Overall Study|chose or were ineligible to have MRI|12
2436341|NCT03231371|8360671|P1|Overall Study|Withdrawal by Subject|1
2436342|NCT03231228|8360684|P2|Overall Study|Physician Decision|0
2436343|NCT03231228|8360685|P1|Overall Study|Physician Decision|1
2436344|NCT03231228|8360684|P2|Overall Study|Lost to Follow-up|0
2436345|NCT03231228|8360685|P1|Overall Study|Lost to Follow-up|2
2436346|NCT03230864|8360696|P4|Double Blind Treatment (DBT) Period|Sponsor Decision|0
2436347|NCT03230864|8360697|P3|Double Blind Treatment (DBT) Period|Sponsor Decision|2
2436348|NCT03230864|8360698|P2|Double Blind Treatment (DBT) Period|Sponsor Decision|0
2436349|NCT03230864|8360699|P1|Double Blind Treatment (DBT) Period|Sponsor Decision|0
2436350|NCT03230864|8360696|P4|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1
2436351|NCT03230864|8360697|P3|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1
2436352|NCT03230864|8360698|P2|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0
2436353|NCT03230864|8360699|P1|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0
2436354|NCT03230864|8360696|P4|Double Blind Treatment (DBT) Period|Adverse Event|1
2436355|NCT03230864|8360697|P3|Double Blind Treatment (DBT) Period|Adverse Event|5
2436356|NCT03230864|8360698|P2|Double Blind Treatment (DBT) Period|Adverse Event|0
2436357|NCT03230864|8360699|P1|Double Blind Treatment (DBT) Period|Adverse Event|0
2436358|NCT03230864|8360696|P4|Prospective Confirmation (PC) Period|Study Personnel Decision|0
2436359|NCT03230864|8360697|P3|Prospective Confirmation (PC) Period|Study Personnel Decision|0
2436360|NCT03230864|8360698|P2|Prospective Confirmation (PC) Period|Study Personnel Decision|0
2436361|NCT03230864|8360699|P1|Prospective Confirmation (PC) Period|Study Personnel Decision|1
2436362|NCT03230864|8360696|P4|Prospective Confirmation (PC) Period|Sponsor Decision|0
2436363|NCT03230864|8360697|P3|Prospective Confirmation (PC) Period|Sponsor Decision|0
2436364|NCT03230864|8360698|P2|Prospective Confirmation (PC) Period|Sponsor Decision|9
2436365|NCT03230864|8360699|P1|Prospective Confirmation (PC) Period|Sponsor Decision|9
2436448|NCT03226392|8360965|P1|Overall Study|Technical Problems|0
2436366|NCT03230864|8360696|P4|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0
2436367|NCT03230864|8360697|P3|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0
2436368|NCT03230864|8360698|P2|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5
2436369|NCT03230864|8360699|P1|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14
2436370|NCT03230864|8360696|P4|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
2436371|NCT03230864|8360697|P3|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
2436372|NCT03230864|8360698|P2|Prospective Confirmation (PC) Period|Withdrawal by Subject|1
2436373|NCT03230864|8360699|P1|Prospective Confirmation (PC) Period|Withdrawal by Subject|4
2436374|NCT03230864|8360696|P4|Prospective Confirmation (PC) Period|Protocol Violation|0
2436375|NCT03230864|8360697|P3|Prospective Confirmation (PC) Period|Protocol Violation|0
2436376|NCT03230864|8360698|P2|Prospective Confirmation (PC) Period|Protocol Violation|2
2436377|NCT03230864|8360699|P1|Prospective Confirmation (PC) Period|Protocol Violation|1
2436378|NCT03230864|8360696|P4|Prospective Confirmation (PC) Period|Lack of Efficacy|0
2436379|NCT03230864|8360697|P3|Prospective Confirmation (PC) Period|Lack of Efficacy|0
2436380|NCT03230864|8360698|P2|Prospective Confirmation (PC) Period|Lack of Efficacy|2
2436381|NCT03230864|8360699|P1|Prospective Confirmation (PC) Period|Lack of Efficacy|0
2436382|NCT03230864|8360696|P4|Prospective Confirmation (PC) Period|Adverse Event|0
2436383|NCT03230864|8360697|P3|Prospective Confirmation (PC) Period|Adverse Event|0
2436384|NCT03230864|8360698|P2|Prospective Confirmation (PC) Period|Adverse Event|0
2436385|NCT03230864|8360699|P1|Prospective Confirmation (PC) Period|Adverse Event|3
2436386|NCT03229486|8360717|P2|Overall Study|Protocol Violation|1
2436387|NCT03229486|8360718|P1|Overall Study|Protocol Violation|0
2436388|NCT03229109|8360759|P4|Overall Study|Withdrawal by Subject|1
2436389|NCT03229109|8360760|P3|Overall Study|Withdrawal by Subject|0
2436390|NCT03229109|8360761|P2|Overall Study|Withdrawal by Subject|0
2436391|NCT03229109|8360762|P1|Overall Study|Withdrawal by Subject|0
2436392|NCT03228433|8360778|P6|Overall Study|Positive alcohol test|0
2436393|NCT03228433|8360779|P5|Overall Study|Positive alcohol test|0
2436394|NCT03228433|8360780|P4|Overall Study|Positive alcohol test|1
2436395|NCT03228433|8360781|P3|Overall Study|Positive alcohol test|0
2436396|NCT03228433|8360782|P2|Overall Study|Positive alcohol test|0
2436397|NCT03228433|8360783|P1|Overall Study|Positive alcohol test|0
2436398|NCT03228433|8360778|P6|Overall Study|Lost to Follow-up|0
2436399|NCT03228433|8360779|P5|Overall Study|Lost to Follow-up|0
2436400|NCT03228433|8360780|P4|Overall Study|Lost to Follow-up|0
2436401|NCT03228433|8360781|P3|Overall Study|Lost to Follow-up|0
2436402|NCT03228433|8360782|P2|Overall Study|Lost to Follow-up|0
2436403|NCT03228433|8360783|P1|Overall Study|Lost to Follow-up|1
2436404|NCT03228212|8360858|P2|Period 2|Lost to Follow-up|0
2436405|NCT03228212|8360859|P1|Period 2|Lost to Follow-up|1
2436406|NCT03228212|8360858|P2|Period 1|no longer meets eligibility criteria|1
2436407|NCT03228212|8360859|P1|Period 1|no longer meets eligibility criteria|0
2436408|NCT03228212|8360858|P2|Period 1|Adverse Event|0
2436409|NCT03228212|8360859|P1|Period 1|Adverse Event|1
2436410|NCT03227861|8360875|P1|Overall Study|Other|5
2436411|NCT03227861|8360875|P1|Overall Study|Protocol Violation|1
2436412|NCT03227861|8360875|P1|Overall Study|Adverse Event|1
2436413|NCT03227861|8360875|P1|Overall Study|Withdrawal by Subject|1
2436414|NCT03227861|8360875|P1|Overall Study|Lost to Follow-up|4
2436415|NCT03227692|8360902|P2|Overall Study|Adverse Event|2
2436416|NCT03227692|8360903|P1|Overall Study|Adverse Event|0
2436417|NCT03227692|8360902|P2|Overall Study|Lost to Follow-up|2
2436418|NCT03227692|8360903|P1|Overall Study|Lost to Follow-up|4
2436419|NCT03227692|8360902|P2|Overall Study|Protocol Violation|1
2436420|NCT03227692|8360903|P1|Overall Study|Protocol Violation|1
2436421|NCT03227445|8360931|P4|Period 2 (28 Days)|Withdrawal by Subject|1
2436422|NCT03227445|8360932|P3|Period 2 (28 Days)|Withdrawal by Subject|0
2436423|NCT03227445|8360933|P2|Period 2 (28 Days)|Withdrawal by Subject|1
2436424|NCT03227445|8360934|P1|Period 2 (28 Days)|Withdrawal by Subject|0
2436425|NCT03227445|8360931|P4|Period 2 (28 Days)|Protocol Violation|1
2436426|NCT03227445|8360932|P3|Period 2 (28 Days)|Protocol Violation|0
2436427|NCT03227445|8360933|P2|Period 2 (28 Days)|Protocol Violation|0
2436428|NCT03227445|8360934|P1|Period 2 (28 Days)|Protocol Violation|0
2436429|NCT03227445|8360931|P4|Period 2 (28 Days)|Adverse Event|1
2436430|NCT03227445|8360932|P3|Period 2 (28 Days)|Adverse Event|2
2436431|NCT03227445|8360933|P2|Period 2 (28 Days)|Adverse Event|0
2436432|NCT03227445|8360934|P1|Period 2 (28 Days)|Adverse Event|1
2436433|NCT03227445|8360931|P4|Period 1 (28 Days)|Withdrawal by Subject|1
2436434|NCT03227445|8360932|P3|Period 1 (28 Days)|Withdrawal by Subject|1
2436435|NCT03227445|8360933|P2|Period 1 (28 Days)|Withdrawal by Subject|0
2436436|NCT03227445|8360934|P1|Period 1 (28 Days)|Withdrawal by Subject|0
2436437|NCT03227445|8360931|P4|Period 1 (28 Days)|Protocol Violation|0
2436438|NCT03227445|8360932|P3|Period 1 (28 Days)|Protocol Violation|0
2436439|NCT03227445|8360933|P2|Period 1 (28 Days)|Protocol Violation|0
2436440|NCT03227445|8360934|P1|Period 1 (28 Days)|Protocol Violation|1
2436441|NCT03227445|8360931|P4|Period 1 (28 Days)|Adverse Event|1
2436442|NCT03227445|8360932|P3|Period 1 (28 Days)|Adverse Event|0
2436443|NCT03227445|8360933|P2|Period 1 (28 Days)|Adverse Event|2
2436444|NCT03227445|8360934|P1|Period 1 (28 Days)|Adverse Event|1
2436445|NCT03226392|8360964|P2|Overall Study|Subject/Guardian Decision|6
2436446|NCT03226392|8360965|P1|Overall Study|Subject/Guardian Decision|7
2436447|NCT03226392|8360964|P2|Overall Study|Technical Problems|2
2436449|NCT03226392|8360964|P2|Overall Study|Adverse Event|0
2436450|NCT03226392|8360965|P1|Overall Study|Adverse Event|1
2436451|NCT03226392|8360964|P2|Overall Study|Lost to Follow-up|0
2436452|NCT03226392|8360965|P1|Overall Study|Lost to Follow-up|1
2436453|NCT03226392|8360964|P2|Overall Study|Physician Decision|0
2436454|NCT03226392|8360965|P1|Overall Study|Physician Decision|1
2436455|NCT03226392|8360964|P2|Overall Study|Protocol Deviation|0
2436456|NCT03226392|8360965|P1|Overall Study|Protocol Deviation|1
2436457|NCT03226353|8360977|P1|Overall Study|Screen Failure|5
2436458|NCT03226353|8360977|P1|Overall Study|Withdrawal by Subject|1
2436459|NCT03226275|8361001|P4|Treatment Period 1 (8 Days)|Protocol non-compliance|1
2436460|NCT03226275|8361002|P3|Treatment Period 1 (8 Days)|Protocol non-compliance|0
2436461|NCT03226275|8361003|P2|Treatment Period 1 (8 Days)|Protocol non-compliance|0
2436462|NCT03226275|8361004|P1|Treatment Period 1 (8 Days)|Protocol non-compliance|0
2436463|NCT03226275|8361001|P4|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
2436464|NCT03226275|8361002|P3|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1
2436465|NCT03226275|8361003|P2|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
2436466|NCT03226275|8361004|P1|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
2436467|NCT03224598|8361103|P3|Overall Study|Other|0
2436468|NCT03224598|8361104|P2|Overall Study|Other|1
2436469|NCT03224598|8361105|P1|Overall Study|Other|0
2436470|NCT03224598|8361103|P3|Overall Study|Lost to Follow-up|0
2436471|NCT03224598|8361104|P2|Overall Study|Lost to Follow-up|2
2436472|NCT03224598|8361105|P1|Overall Study|Lost to Follow-up|0
2436473|NCT03224325|8361131|P7|Overall Study|Withdrawal by Subject|0
2436474|NCT03224325|8361132|P6|Overall Study|Withdrawal by Subject|0
2436475|NCT03224325|8361133|P5|Overall Study|Withdrawal by Subject|0
2436476|NCT03224325|8361134|P4|Overall Study|Withdrawal by Subject|1
2436477|NCT03224325|8361135|P3|Overall Study|Withdrawal by Subject|0
2436478|NCT03224325|8361136|P2|Overall Study|Withdrawal by Subject|0
2436479|NCT03224325|8361137|P1|Overall Study|Withdrawal by Subject|0
2436480|NCT03224325|8361131|P7|Overall Study|Adverse Event|1
2436481|NCT03224325|8361132|P6|Overall Study|Adverse Event|0
2436482|NCT03224325|8361133|P5|Overall Study|Adverse Event|0
2436483|NCT03224325|8361134|P4|Overall Study|Adverse Event|0
2436484|NCT03224325|8361135|P3|Overall Study|Adverse Event|0
2436485|NCT03224325|8361136|P2|Overall Study|Adverse Event|0
2436486|NCT03224325|8361137|P1|Overall Study|Adverse Event|1
2436487|NCT03224130|8361200|P2|Overall Study|consent issue|1
2436488|NCT03224130|8361201|P1|Overall Study|consent issue|0
2436489|NCT03223909|8361222|P3|Overall Study|Protocol Violation|16
2436490|NCT03223909|8361223|P2|Overall Study|Protocol Violation|45
2436491|NCT03223909|8361224|P1|Overall Study|Protocol Violation|48
2436492|NCT03223662|8361253|P1|Overall Study|Study closure|1
2436493|NCT03223662|8361253|P1|Overall Study|Physician Decision|1
2436494|NCT03222583|8361338|P2|Overall Study|Other|3
2436495|NCT03222583|8361339|P1|Overall Study|Other|1
2436496|NCT03222583|8361338|P2|Overall Study|Lost to Follow-up|0
2436497|NCT03222583|8361339|P1|Overall Study|Lost to Follow-up|1
2436498|NCT03222583|8361338|P2|Overall Study|Withdrawal by Subject|3
2436499|NCT03222583|8361339|P1|Overall Study|Withdrawal by Subject|3
2436500|NCT03222141|8361389|P1|Overall Study|Lost to Follow-up|3
2436501|NCT03222141|8361389|P1|Overall Study|Death|15
2436502|NCT03219723|8361555|P1|Overall Study|Protocol Deviation|4
2436503|NCT03219723|8361555|P1|Overall Study|Case Report Forms Uncollected|6
2436504|NCT03219216|8361573|P2|Overall Study|Lost to Follow-up|1
2436505|NCT03219216|8361574|P1|Overall Study|Lost to Follow-up|0
2436506|NCT03218397|8361607|P2|Overall Study|Randomized during laboratory off hours|1
2436507|NCT03218397|8361608|P1|Overall Study|Randomized during laboratory off hours|2
2436508|NCT03218397|8361607|P2|Overall Study|No gram-negative bacilli (GNB)|2
2436509|NCT03218397|8361608|P1|Overall Study|No gram-negative bacilli (GNB)|0
2436510|NCT03218397|8361607|P2|Overall Study|Inaccessible hospital records|5
2436511|NCT03218397|8361608|P1|Overall Study|Inaccessible hospital records|2
2436512|NCT03218397|8361607|P2|Overall Study|Mixed culture|2
2436513|NCT03218397|8361608|P1|Overall Study|Mixed culture|2
2436514|NCT03218397|8361607|P2|Overall Study|Comfort care and mixed culture|1
2436515|NCT03218397|8361608|P1|Overall Study|Comfort care and mixed culture|0
2436516|NCT03218397|8361607|P2|Overall Study|Comfort care and positive blood culture|0
2436517|NCT03218397|8361608|P1|Overall Study|Comfort care and positive blood culture|1
2436518|NCT03218397|8361607|P2|Overall Study|Comfort care|5
2436519|NCT03218397|8361608|P1|Overall Study|Comfort care|8
2436520|NCT03218397|8361607|P2|Overall Study|Prior positive blood culture|13
2436521|NCT03218397|8361608|P1|Overall Study|Prior positive blood culture|8
2436522|NCT03217968|8361640|P1|Overall Study|Protocol Violation|6
2436523|NCT03217968|8361640|P1|Overall Study|Lost to Follow-up|1
2436524|NCT03217968|8361640|P1|Overall Study|Withdrawal by Subject|4
2436525|NCT03217175|8361649|P2|Overall Study|Physician Decision|1
2436526|NCT03217175|8361650|P1|Overall Study|Physician Decision|4
2436527|NCT03216850|8361664|P1|Overall Study|Pre-analytical error|6
2436528|NCT03216746|8361672|P4|Overall Study|Lost to Follow-up|6
2436529|NCT03216746|8361673|P3|Overall Study|Lost to Follow-up|5
2436530|NCT03216746|8361674|P2|Overall Study|Lost to Follow-up|8
2436531|NCT03216746|8361675|P1|Overall Study|Lost to Follow-up|6
2436532|NCT03216265|8361709|P3|Overall Study|Withdrawal by Subject|1
2436533|NCT03216265|8361710|P2|Overall Study|Withdrawal by Subject|0
2436534|NCT03216265|8361711|P1|Overall Study|Withdrawal by Subject|0
2436535|NCT03216265|8361709|P3|Overall Study|Lost to Follow-up|0
2436536|NCT03216265|8361710|P2|Overall Study|Lost to Follow-up|1
2436537|NCT03216265|8361711|P1|Overall Study|Lost to Follow-up|0
2436538|NCT03216265|8361709|P3|Overall Study|Adverse Event|2
2436539|NCT03216265|8361710|P2|Overall Study|Adverse Event|0
2436540|NCT03216265|8361711|P1|Overall Study|Adverse Event|2
2436541|NCT03215758|8361768|P2|Overall Study|Subject/Guardian Decision|3
2436542|NCT03215758|8361769|P1|Overall Study|Subject/Guardian Decision|3
2436543|NCT03215758|8361768|P2|Overall Study|Adverse Event|2
2436544|NCT03215758|8361769|P1|Overall Study|Adverse Event|1
2436545|NCT03215758|8361768|P2|Overall Study|Death|1
2436546|NCT03215758|8361769|P1|Overall Study|Death|0
2436547|NCT03215758|8361768|P2|Overall Study|Physician Decision|1
2436548|NCT03215758|8361769|P1|Overall Study|Physician Decision|0
2436549|NCT03215758|8361768|P2|Overall Study|Protocol deviation|1
2436550|NCT03215758|8361769|P1|Overall Study|Protocol deviation|0
2436551|NCT03215758|8361768|P2|Overall Study|Technical Problems|0
2436552|NCT03215758|8361769|P1|Overall Study|Technical Problems|1
2436553|NCT03214952|8361781|P1|Overall Study|Case Report Forms Uncollected|13
2436554|NCT03214952|8361781|P1|Overall Study|Protocol Deviation|45
2436555|NCT03214588|8361796|P3|Overall Study|Reason Not Specified|0
2436556|NCT03214588|8361797|P2|Overall Study|Reason Not Specified|1
2436557|NCT03214588|8361798|P1|Overall Study|Reason Not Specified|0
2436558|NCT03214588|8361796|P3|Overall Study|Adverse Event|2
2436559|NCT03214588|8361797|P2|Overall Study|Adverse Event|0
2436560|NCT03214588|8361798|P1|Overall Study|Adverse Event|1
2436561|NCT03214406|8361865|P2|Overall Study|Lost to Follow-up|2
2436562|NCT03214406|8361866|P1|Overall Study|Lost to Follow-up|0
2436563|NCT03214406|8361865|P2|Overall Study|Withdrawal by Subject|0
2436564|NCT03214406|8361866|P1|Overall Study|Withdrawal by Subject|1
2436565|NCT03214406|8361865|P2|Overall Study|did not meet enrollment criteria|13
2436566|NCT03214406|8361866|P1|Overall Study|did not meet enrollment criteria|9
2436567|NCT03214380|8361880|P6|Treatment Period|Treatment Interruption|0
2436568|NCT03214380|8361881|P5|Treatment Period|Treatment Interruption|0
2436569|NCT03214380|8361882|P4|Treatment Period|Treatment Interruption|0
2436570|NCT03214380|8361883|P3|Treatment Period|Treatment Interruption|1
2436571|NCT03214380|8361884|P2|Treatment Period|Treatment Interruption|0
2436572|NCT03214380|8361885|P1|Treatment Period|Treatment Interruption|0
2436573|NCT03214380|8361880|P6|Treatment Period|Participant schedule|0
2436574|NCT03214380|8361881|P5|Treatment Period|Participant schedule|0
2436575|NCT03214380|8361882|P4|Treatment Period|Participant schedule|0
2436576|NCT03214380|8361883|P3|Treatment Period|Participant schedule|1
2436577|NCT03214380|8361884|P2|Treatment Period|Participant schedule|0
2436578|NCT03214380|8361885|P1|Treatment Period|Participant schedule|0
2436579|NCT03214380|8361880|P6|Treatment Period|Lost to Follow-up|0
2436580|NCT03214380|8361881|P5|Treatment Period|Lost to Follow-up|0
2436581|NCT03214380|8361882|P4|Treatment Period|Lost to Follow-up|0
2436582|NCT03214380|8361883|P3|Treatment Period|Lost to Follow-up|3
2436583|NCT03214380|8361884|P2|Treatment Period|Lost to Follow-up|6
2436584|NCT03214380|8361885|P1|Treatment Period|Lost to Follow-up|0
2436585|NCT03214380|8361880|P6|Treatment Period|Death|0
2436586|NCT03214380|8361881|P5|Treatment Period|Death|0
2436587|NCT03214380|8361882|P4|Treatment Period|Death|0
2436588|NCT03214380|8361883|P3|Treatment Period|Death|2
2436589|NCT03214380|8361884|P2|Treatment Period|Death|1
2436590|NCT03214380|8361885|P1|Treatment Period|Death|0
2436591|NCT03214380|8361880|P6|Treatment Period|Withdrawal by Subject|11
2436592|NCT03214380|8361881|P5|Treatment Period|Withdrawal by Subject|7
2436593|NCT03214380|8361882|P4|Treatment Period|Withdrawal by Subject|0
2436594|NCT03214380|8361883|P3|Treatment Period|Withdrawal by Subject|8
2436595|NCT03214380|8361884|P2|Treatment Period|Withdrawal by Subject|10
2436596|NCT03214380|8361885|P1|Treatment Period|Withdrawal by Subject|0
2436597|NCT03214380|8361880|P6|Treatment Period|Non-Compliance with Study Drug|0
2436598|NCT03214380|8361881|P5|Treatment Period|Non-Compliance with Study Drug|1
2436599|NCT03214380|8361882|P4|Treatment Period|Non-Compliance with Study Drug|0
2436600|NCT03214380|8361883|P3|Treatment Period|Non-Compliance with Study Drug|0
2436601|NCT03214380|8361884|P2|Treatment Period|Non-Compliance with Study Drug|0
2436602|NCT03214380|8361885|P1|Treatment Period|Non-Compliance with Study Drug|0
2436603|NCT03214380|8361880|P6|Treatment Period|Adverse Event|0
2436604|NCT03214380|8361881|P5|Treatment Period|Adverse Event|1
2436605|NCT03214380|8361882|P4|Treatment Period|Adverse Event|0
2436606|NCT03214380|8361883|P3|Treatment Period|Adverse Event|1
2436607|NCT03214380|8361884|P2|Treatment Period|Adverse Event|1
2436608|NCT03214380|8361885|P1|Treatment Period|Adverse Event|0
2436609|NCT03214380|8361880|P6|Lead-in|Participant Schedule|0
2436610|NCT03214380|8361881|P5|Lead-in|Participant Schedule|0
2436611|NCT03214380|8361882|P4|Lead-in|Participant Schedule|0
2436612|NCT03214380|8361883|P3|Lead-in|Participant Schedule|0
2436613|NCT03214380|8361884|P2|Lead-in|Participant Schedule|0
2436614|NCT03214380|8361885|P1|Lead-in|Participant Schedule|2
2436615|NCT03214380|8361880|P6|Lead-in|Non Compliance|0
2436616|NCT03214380|8361881|P5|Lead-in|Non Compliance|0
2436617|NCT03214380|8361882|P4|Lead-in|Non Compliance|0
2436618|NCT03214380|8361883|P3|Lead-in|Non Compliance|0
2436619|NCT03214380|8361884|P2|Lead-in|Non Compliance|0
2436620|NCT03214380|8361885|P1|Lead-in|Non Compliance|1
2436621|NCT03214380|8361880|P6|Lead-in|Natural Disaster|0
2436622|NCT03214380|8361881|P5|Lead-in|Natural Disaster|0
2436623|NCT03214380|8361882|P4|Lead-in|Natural Disaster|0
2436624|NCT03214380|8361883|P3|Lead-in|Natural Disaster|0
2436625|NCT03214380|8361884|P2|Lead-in|Natural Disaster|0
2436626|NCT03214380|8361885|P1|Lead-in|Natural Disaster|9
2436627|NCT03214380|8361880|P6|Lead-in|Family Emergency|0
2436628|NCT03214380|8361881|P5|Lead-in|Family Emergency|0
2436629|NCT03214380|8361882|P4|Lead-in|Family Emergency|0
2436630|NCT03214380|8361883|P3|Lead-in|Family Emergency|0
2436631|NCT03214380|8361884|P2|Lead-in|Family Emergency|0
2436632|NCT03214380|8361885|P1|Lead-in|Family Emergency|1
2436633|NCT03214380|8361880|P6|Lead-in|Withdrawal by Subject|0
2436634|NCT03214380|8361881|P5|Lead-in|Withdrawal by Subject|0
2436635|NCT03214380|8361882|P4|Lead-in|Withdrawal by Subject|14
2436636|NCT03214380|8361883|P3|Lead-in|Withdrawal by Subject|0
2436637|NCT03214380|8361884|P2|Lead-in|Withdrawal by Subject|0
2436638|NCT03214380|8361885|P1|Lead-in|Withdrawal by Subject|41
2436639|NCT03214380|8361880|P6|Lead-in|Protocol Deviation|0
2436640|NCT03214380|8361881|P5|Lead-in|Protocol Deviation|0
2436641|NCT03214380|8361882|P4|Lead-in|Protocol Deviation|3
2436642|NCT03214380|8361883|P3|Lead-in|Protocol Deviation|0
2436643|NCT03214380|8361884|P2|Lead-in|Protocol Deviation|0
2436644|NCT03214380|8361885|P1|Lead-in|Protocol Deviation|7
2436645|NCT03214380|8361880|P6|Lead-in|Physician Decision|0
2436646|NCT03214380|8361881|P5|Lead-in|Physician Decision|0
2436647|NCT03214380|8361882|P4|Lead-in|Physician Decision|0
2436648|NCT03214380|8361883|P3|Lead-in|Physician Decision|0
2436649|NCT03214380|8361884|P2|Lead-in|Physician Decision|0
2436650|NCT03214380|8361885|P1|Lead-in|Physician Decision|6
2436651|NCT03214380|8361880|P6|Lead-in|Eligibility Criteria|0
2436652|NCT03214380|8361881|P5|Lead-in|Eligibility Criteria|0
2436653|NCT03214380|8361882|P4|Lead-in|Eligibility Criteria|0
2436654|NCT03214380|8361883|P3|Lead-in|Eligibility Criteria|0
2436655|NCT03214380|8361884|P2|Lead-in|Eligibility Criteria|0
2436656|NCT03214380|8361885|P1|Lead-in|Eligibility Criteria|3
2436657|NCT03214380|8361880|P6|Lead-in|Lost to Follow-up|0
2436658|NCT03214380|8361881|P5|Lead-in|Lost to Follow-up|0
2436659|NCT03214380|8361882|P4|Lead-in|Lost to Follow-up|1
2436660|NCT03214380|8361883|P3|Lead-in|Lost to Follow-up|0
2436661|NCT03214380|8361884|P2|Lead-in|Lost to Follow-up|0
2436662|NCT03214380|8361885|P1|Lead-in|Lost to Follow-up|4
2436663|NCT03214380|8361880|P6|Lead-in|Adverse Event|0
2436664|NCT03214380|8361881|P5|Lead-in|Adverse Event|0
2436665|NCT03214380|8361882|P4|Lead-in|Adverse Event|1
2436666|NCT03214380|8361883|P3|Lead-in|Adverse Event|0
2436667|NCT03214380|8361884|P2|Lead-in|Adverse Event|0
2436668|NCT03214380|8361885|P1|Lead-in|Adverse Event|3
2436669|NCT03214224|8361918|P3|Validation Study|Practice controls or therapists|6
2436670|NCT03214224|8361919|P2|Validation Study|Practice controls or therapists|0
2436671|NCT03214224|8361920|P1|Validation Study|Practice controls or therapists|0
2436672|NCT03214224|8361918|P3|Validation Study|Withdrawal by Subject|2
2436673|NCT03214224|8361919|P2|Validation Study|Withdrawal by Subject|0
2436674|NCT03214224|8361920|P1|Validation Study|Withdrawal by Subject|0
2436675|NCT03214224|8361918|P3|Validation Study|Protocol Violation|1
2436676|NCT03214224|8361919|P2|Validation Study|Protocol Violation|0
2436677|NCT03214224|8361920|P1|Validation Study|Protocol Violation|0
2436678|NCT03214094|8361929|P1|Overall Study|Protocol Deviation|46
2436679|NCT03214094|8361929|P1|Overall Study|Case Report Forms Uncollected|14
2436680|NCT03214081|8361937|P1|Overall Study|Protocol Deviation|54
2436681|NCT03214081|8361937|P1|Overall Study|Case Report Forms Uncollected|9
2436682|NCT03213509|8361954|P2|Overall Study|Did not consent for verbal autopsy|5
2436683|NCT03213509|8361955|P1|Overall Study|Did not consent for verbal autopsy|4
2436684|NCT03213366|8361968|P2|Overall Study|Lost to Follow-up|4
2436685|NCT03213366|8361969|P1|Overall Study|Lost to Follow-up|9
2436686|NCT03212690|8361995|P1|Overall Study|Protocol Violation|1
2436687|NCT03212521|8362043|P1|Overall Study|Other|1
2436688|NCT03212521|8362043|P1|Overall Study|Withdrawal by Subject|1
2436689|NCT03212521|8362043|P1|Overall Study|Lost to Follow-up|4
2436690|NCT03212521|8362043|P1|Overall Study|Adverse Event|1
2436691|NCT03212326|8362050|P1|Overall Study|Physician Decision|4
2436692|NCT03212261|8362055|P1|Overall Study|Too busy/ No time|5
2436693|NCT03212261|8362055|P1|Overall Study|Family Emergency|1
2436694|NCT03212261|8362055|P1|Overall Study|Lost to Follow-up|7
2436695|NCT03212261|8362055|P1|Overall Study|Tech Trouble- No first study visit|1
2436696|NCT03212261|8362055|P1|Overall Study|Became ineligible d/t tech|2
2436697|NCT03212144|8362063|P2|Second Sequence (4 Weeks)|Lost to Follow-up|1
2436698|NCT03212144|8362064|P1|Second Sequence (4 Weeks)|Lost to Follow-up|1
2436699|NCT03212144|8362063|P2|First Sequence (4 Weeks)|Lost to Follow-up|0
2436700|NCT03212144|8362064|P1|First Sequence (4 Weeks)|Lost to Follow-up|1
2436701|NCT03211858|8362072|P2|Overall Study|Other than specified above|21
2436702|NCT03211858|8362073|P1|Overall Study|Other than specified above|22
2436703|NCT03211858|8362072|P2|Overall Study|Non-serious Hypoglycemia|0
2436704|NCT03211858|8362073|P1|Overall Study|Non-serious Hypoglycemia|1
2436705|NCT03211858|8362072|P2|Overall Study|Poor compliance to protocol|2
2436706|NCT03211858|8362073|P1|Overall Study|Poor compliance to protocol|6
2436707|NCT03211858|8362072|P2|Overall Study|Lack of Efficacy|4
2436708|NCT03211858|8362073|P1|Overall Study|Lack of Efficacy|0
2436709|NCT03211858|8362072|P2|Overall Study|Adverse Event|6
2436710|NCT03211858|8362073|P1|Overall Study|Adverse Event|8
2436711|NCT03210961|8362124|P15|Overall Study|Other|0
2436712|NCT03210961|8362125|P14|Overall Study|Other|2
2436713|NCT03210961|8362126|P13|Overall Study|Other|2
2436714|NCT03210961|8362127|P12|Overall Study|Other|0
2436715|NCT03210961|8362128|P11|Overall Study|Other|1
2436716|NCT03210961|8362129|P10|Overall Study|Other|0
2436717|NCT03210961|8362130|P9|Overall Study|Other|0
2436718|NCT03210961|8362131|P8|Overall Study|Other|0
2436719|NCT03210961|8362132|P7|Overall Study|Other|1
2436720|NCT03210961|8362133|P6|Overall Study|Other|0
2436721|NCT03210961|8362134|P5|Overall Study|Other|0
2436722|NCT03210961|8362135|P4|Overall Study|Other|1
2436723|NCT03210961|8362136|P3|Overall Study|Other|0
2436724|NCT03210961|8362137|P2|Overall Study|Other|0
2436725|NCT03210961|8362138|P1|Overall Study|Other|0
2436726|NCT03210961|8362124|P15|Overall Study|No Longer Meets Eligibility Criteria|0
2436727|NCT03210961|8362125|P14|Overall Study|No Longer Meets Eligibility Criteria|1
2436728|NCT03210961|8362126|P13|Overall Study|No Longer Meets Eligibility Criteria|0
2436729|NCT03210961|8362127|P12|Overall Study|No Longer Meets Eligibility Criteria|0
2436730|NCT03210961|8362128|P11|Overall Study|No Longer Meets Eligibility Criteria|0
2436731|NCT03210961|8362129|P10|Overall Study|No Longer Meets Eligibility Criteria|0
2436732|NCT03210961|8362130|P9|Overall Study|No Longer Meets Eligibility Criteria|0
2436733|NCT03210961|8362131|P8|Overall Study|No Longer Meets Eligibility Criteria|0
2436734|NCT03210961|8362132|P7|Overall Study|No Longer Meets Eligibility Criteria|0
2436735|NCT03210961|8362133|P6|Overall Study|No Longer Meets Eligibility Criteria|0
2436736|NCT03210961|8362134|P5|Overall Study|No Longer Meets Eligibility Criteria|0
2436737|NCT03210961|8362135|P4|Overall Study|No Longer Meets Eligibility Criteria|0
2436738|NCT03210961|8362136|P3|Overall Study|No Longer Meets Eligibility Criteria|0
2436739|NCT03210961|8362137|P2|Overall Study|No Longer Meets Eligibility Criteria|0
2436740|NCT03210961|8362138|P1|Overall Study|No Longer Meets Eligibility Criteria|0
2436741|NCT03210961|8362124|P15|Overall Study|Withdrawal by Subject|1
2436742|NCT03210961|8362125|P14|Overall Study|Withdrawal by Subject|0
2436743|NCT03210961|8362126|P13|Overall Study|Withdrawal by Subject|0
2436744|NCT03210961|8362127|P12|Overall Study|Withdrawal by Subject|0
2436745|NCT03210961|8362128|P11|Overall Study|Withdrawal by Subject|0
2436746|NCT03210961|8362129|P10|Overall Study|Withdrawal by Subject|0
2436747|NCT03210961|8362130|P9|Overall Study|Withdrawal by Subject|0
2436748|NCT03210961|8362131|P8|Overall Study|Withdrawal by Subject|0
2436749|NCT03210961|8362132|P7|Overall Study|Withdrawal by Subject|0
2436750|NCT03210961|8362133|P6|Overall Study|Withdrawal by Subject|0
2436751|NCT03210961|8362134|P5|Overall Study|Withdrawal by Subject|0
2436752|NCT03210961|8362135|P4|Overall Study|Withdrawal by Subject|0
2436753|NCT03210961|8362136|P3|Overall Study|Withdrawal by Subject|0
2436754|NCT03210961|8362137|P2|Overall Study|Withdrawal by Subject|0
2436755|NCT03210961|8362138|P1|Overall Study|Withdrawal by Subject|0
2436756|NCT03210961|8362124|P15|Overall Study|Lost to Follow-up|1
2436757|NCT03210961|8362125|P14|Overall Study|Lost to Follow-up|0
2436758|NCT03210961|8362126|P13|Overall Study|Lost to Follow-up|0
2436759|NCT03210961|8362127|P12|Overall Study|Lost to Follow-up|0
2436760|NCT03210961|8362128|P11|Overall Study|Lost to Follow-up|0
2436761|NCT03210961|8362129|P10|Overall Study|Lost to Follow-up|0
2436762|NCT03210961|8362130|P9|Overall Study|Lost to Follow-up|0
2436763|NCT03210961|8362131|P8|Overall Study|Lost to Follow-up|0
2436764|NCT03210961|8362132|P7|Overall Study|Lost to Follow-up|0
2436765|NCT03210961|8362133|P6|Overall Study|Lost to Follow-up|0
2436766|NCT03210961|8362134|P5|Overall Study|Lost to Follow-up|0
2436767|NCT03210961|8362135|P4|Overall Study|Lost to Follow-up|0
2436768|NCT03210961|8362136|P3|Overall Study|Lost to Follow-up|0
2436769|NCT03210961|8362137|P2|Overall Study|Lost to Follow-up|0
2436770|NCT03210961|8362138|P1|Overall Study|Lost to Follow-up|0
2436771|NCT03210961|8362124|P15|Overall Study|Adverse Event|0
2436772|NCT03210961|8362125|P14|Overall Study|Adverse Event|1
2436773|NCT03210961|8362126|P13|Overall Study|Adverse Event|0
2436774|NCT03210961|8362127|P12|Overall Study|Adverse Event|0
2436775|NCT03210961|8362128|P11|Overall Study|Adverse Event|0
2436776|NCT03210961|8362129|P10|Overall Study|Adverse Event|0
2436777|NCT03210961|8362130|P9|Overall Study|Adverse Event|0
2436778|NCT03210961|8362131|P8|Overall Study|Adverse Event|0
2436779|NCT03210961|8362132|P7|Overall Study|Adverse Event|0
2436780|NCT03210961|8362133|P6|Overall Study|Adverse Event|0
2436781|NCT03210961|8362134|P5|Overall Study|Adverse Event|0
2436782|NCT03210961|8362135|P4|Overall Study|Adverse Event|0
2436783|NCT03210961|8362136|P3|Overall Study|Adverse Event|0
2436784|NCT03210961|8362137|P2|Overall Study|Adverse Event|0
2436785|NCT03210961|8362138|P1|Overall Study|Adverse Event|0
2436786|NCT03210220|8362519|P2|Overall Study|Physician Decision|0
2436787|NCT03210220|8362520|P1|Overall Study|Physician Decision|1
2436788|NCT03209570|8362528|P2|Overall Study|Withdrawal by Subject|3
2436789|NCT03209570|8362529|P1|Overall Study|Withdrawal by Subject|0
2436790|NCT03209570|8362528|P2|Overall Study|Protocol Violation|0
2436791|NCT03209570|8362529|P1|Overall Study|Protocol Violation|1
2436792|NCT03209570|8362528|P2|Overall Study|Incomplete Data|10
2436793|NCT03209570|8362529|P1|Overall Study|Incomplete Data|8
2436794|NCT03209570|8362528|P2|Overall Study|Death|0
2436795|NCT03209570|8362529|P1|Overall Study|Death|1
2436796|NCT03209518|8362539|P1|Overall Study|Protocol Deviation|1
2436797|NCT03209518|8362539|P1|Overall Study|Case Report Forms Uncollected|1
2436798|NCT03209492|8362544|P1|Overall Study|Case Report Forms Uncollected|5
2436799|NCT03207750|8362583|P2|Overall Study|OTHER, NOT SPECIFIED|4
2436800|NCT03207750|8362584|P1|Overall Study|OTHER, NOT SPECIFIED|5
2436801|NCT03207750|8362583|P2|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2
2436802|NCT03207750|8362584|P1|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1
2436803|NCT03207750|8362583|P2|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5
2436804|NCT03207750|8362584|P1|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10
2436805|NCT03207750|8362583|P2|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10
2436806|NCT03207750|8362584|P1|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7
2436807|NCT03207750|8362583|P2|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13
2436808|NCT03207750|8362584|P1|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11
2436809|NCT03207750|8362583|P2|Overall Study|Protocol Violation|1
2436810|NCT03207750|8362584|P1|Overall Study|Protocol Violation|0
2436811|NCT03207750|8362583|P2|Overall Study|Lost to Follow-up|29
2436812|NCT03207750|8362584|P1|Overall Study|Lost to Follow-up|21
2436813|NCT03207750|8362583|P2|Overall Study|Adverse Event|2
2436814|NCT03207750|8362584|P1|Overall Study|Adverse Event|3
2436815|NCT03207243|8362664|P2|Overall Study|Protocol Violation|3
2436816|NCT03207243|8362665|P1|Overall Study|Protocol Violation|0
2436817|NCT03207243|8362664|P2|Overall Study|Protocol Specified Withdrawal Criteria|2
2436818|NCT03207243|8362665|P1|Overall Study|Protocol Specified Withdrawal Criteria|7
2436819|NCT03207243|8362664|P2|Overall Study|Lost to Follow-up|1
2436820|NCT03207243|8362665|P1|Overall Study|Lost to Follow-up|0
2436821|NCT03207243|8362664|P2|Overall Study|Physician Decision|1
2436822|NCT03207243|8362665|P1|Overall Study|Physician Decision|1
2436823|NCT03207243|8362664|P2|Overall Study|Withdrawal by Subject|4
2436824|NCT03207243|8362665|P1|Overall Study|Withdrawal by Subject|2
2436825|NCT03207243|8362664|P2|Overall Study|Loss of Asthma Control|31
2436826|NCT03207243|8362665|P1|Overall Study|Loss of Asthma Control|47
2436827|NCT03207243|8362664|P2|Overall Study|Adverse Event|2
2436828|NCT03207243|8362665|P1|Overall Study|Adverse Event|2
2436829|NCT03206216|8362774|P2|Overall Study|Withdrawal by Subject|1
2436830|NCT03206216|8362775|P1|Overall Study|Withdrawal by Subject|0
2436831|NCT03205163|8362785|P2|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0
2436832|NCT03205163|8362786|P1|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1
2436833|NCT03203291|8362965|P1|Overall Study|Withdrawal by Subject|1
2436834|NCT03201900|8363000|P1|Extension Phase (Up to 124 Weeks)|Ongoing|41
2436835|NCT03201900|8363000|P1|Extension Phase (Up to 124 Weeks)|Withdrawal of consent|1
2436836|NCT03201900|8363000|P1|Extension Phase (Up to 124 Weeks)|Lost to Follow-up|1
2436837|NCT03201900|8363000|P1|Extension Phase (Up to 124 Weeks)|Inadequate therapeutic effect|1
2436838|NCT03201900|8363000|P1|Extension Phase (Up to 124 Weeks)|Pregnancy|1
2436839|NCT03201900|8363000|P1|Extension Phase (Up to 124 Weeks)|Subject choice|1
2436840|NCT03201900|8363000|P1|Treatment Phase (Up to 62 Weeks)|Not treated|2
2436841|NCT03201900|8363000|P1|Treatment Phase (Up to 62 Weeks)|Other than specified|11
2436842|NCT03201900|8363000|P1|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6
2436843|NCT03201900|8363000|P1|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2
2436844|NCT03201900|8363000|P1|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6
2436845|NCT03201900|8363000|P1|Treatment Phase (Up to 62 Weeks)|Subject Choice|1
2436846|NCT03201900|8363000|P1|Treatment Phase (Up to 62 Weeks)|Adverse Event|9
2436847|NCT03200912|8363022|P3|Overall Study|Non-compliance with study drug|0
2436848|NCT03200912|8363023|P2|Overall Study|Non-compliance with study drug|1
2436849|NCT03200912|8363024|P1|Overall Study|Non-compliance with study drug|0
2436850|NCT03200912|8363022|P3|Overall Study|Withdrawal by Subject|4
2436851|NCT03200912|8363023|P2|Overall Study|Withdrawal by Subject|2
2436852|NCT03200912|8363024|P1|Overall Study|Withdrawal by Subject|1
2436853|NCT03200912|8363022|P3|Overall Study|Adverse Event|0
2436854|NCT03200912|8363023|P2|Overall Study|Adverse Event|0
2436855|NCT03200912|8363024|P1|Overall Study|Adverse Event|3
2436856|NCT03200860|8363034|P2|Overall Study|Withdrawal by Subject|0
2436857|NCT03200860|8363035|P1|Overall Study|Withdrawal by Subject|1
2436858|NCT03198767|8363094|P7|Overall Study|Protocol Violation|0
2436859|NCT03198767|8363095|P6|Overall Study|Protocol Violation|0
2436860|NCT03198767|8363096|P5|Overall Study|Protocol Violation|0
2436861|NCT03198767|8363097|P4|Overall Study|Protocol Violation|6
2436862|NCT03198767|8363098|P3|Overall Study|Protocol Violation|0
2436863|NCT03198767|8363099|P2|Overall Study|Protocol Violation|0
2436864|NCT03198767|8363100|P1|Overall Study|Protocol Violation|0
2436865|NCT03198507|8363141|P2|Overall Study|Withdrawal by Subject|0
2436866|NCT03198507|8363142|P1|Overall Study|Withdrawal by Subject|1
2436867|NCT03197883|8363268|P2|Overall Study|Other (Not Specified)|5
2436868|NCT03197883|8363269|P1|Overall Study|Other (Not Specified)|0
2436869|NCT03197883|8363268|P2|Overall Study|Protocol Violation|0
2436870|NCT03197883|8363269|P1|Overall Study|Protocol Violation|1
2436871|NCT03197883|8363268|P2|Overall Study|Lost to Follow-up|0
2436872|NCT03197883|8363269|P1|Overall Study|Lost to Follow-up|1
2436873|NCT03197883|8363268|P2|Overall Study|Adverse Event|1
2436874|NCT03197883|8363269|P1|Overall Study|Adverse Event|1
2436875|NCT03197558|8363299|P1|Overall Study|Tubes not placed|1
2436876|NCT03197376|8363307|P4|Overall Study|Not vaccine related|6
2436877|NCT03197376|8363308|P3|Overall Study|Not vaccine related|0
2436878|NCT03197376|8363309|P2|Overall Study|Not vaccine related|2
2436879|NCT03197376|8363310|P1|Overall Study|Not vaccine related|1
2436880|NCT03197376|8363307|P4|Overall Study|Ineligibility criteria|2
2436881|NCT03197376|8363308|P3|Overall Study|Ineligibility criteria|4
2436882|NCT03197376|8363309|P2|Overall Study|Ineligibility criteria|1
2436883|NCT03197376|8363310|P1|Overall Study|Ineligibility criteria|1
2436884|NCT03197376|8363307|P4|Overall Study|Withdrawal by subject's parents|11
2436885|NCT03197376|8363308|P3|Overall Study|Withdrawal by subject's parents|14
2436886|NCT03197376|8363309|P2|Overall Study|Withdrawal by subject's parents|10
2436887|NCT03197376|8363310|P1|Overall Study|Withdrawal by subject's parents|11
2436888|NCT03197376|8363307|P4|Overall Study|Physician Decision|3
2436889|NCT03197376|8363308|P3|Overall Study|Physician Decision|1
2436890|NCT03197376|8363309|P2|Overall Study|Physician Decision|0
2436891|NCT03197376|8363310|P1|Overall Study|Physician Decision|1
2436892|NCT03197376|8363307|P4|Overall Study|Lost to Follow-up|0
2436893|NCT03197376|8363308|P3|Overall Study|Lost to Follow-up|1
2436894|NCT03197376|8363309|P2|Overall Study|Lost to Follow-up|0
2436895|NCT03197376|8363310|P1|Overall Study|Lost to Follow-up|0
2436896|NCT03197376|8363307|P4|Overall Study|Death|2
2436897|NCT03197376|8363308|P3|Overall Study|Death|0
2436898|NCT03197376|8363309|P2|Overall Study|Death|0
2436899|NCT03197376|8363310|P1|Overall Study|Death|1
2436900|NCT03197376|8363307|P4|Overall Study|Adverse Event|1
2436901|NCT03197376|8363308|P3|Overall Study|Adverse Event|0
2436902|NCT03197376|8363309|P2|Overall Study|Adverse Event|0
2436903|NCT03197376|8363310|P1|Overall Study|Adverse Event|0
2436904|NCT03196635|8363368|P1|Overall Study|Withdrawal by Subject|1
2436905|NCT03196349|8363389|P3|Overall Study|Study Terminated early|11
2436906|NCT03196349|8363390|P2|Overall Study|Study Terminated early|9
2436907|NCT03196349|8363391|P1|Overall Study|Study Terminated early|15
2436908|NCT03196349|8363389|P3|Overall Study|No data entered|0
2436909|NCT03196349|8363390|P2|Overall Study|No data entered|4
2436910|NCT03196349|8363391|P1|Overall Study|No data entered|2
2436911|NCT03196349|8363389|P3|Overall Study|Did not receive study drug|2
2436912|NCT03196349|8363390|P2|Overall Study|Did not receive study drug|1
2436913|NCT03196349|8363391|P1|Overall Study|Did not receive study drug|0
2436914|NCT03194490|8363492|P2|Overall Study|participant developed specific neck pain|0
2436915|NCT03194490|8363493|P1|Overall Study|participant developed specific neck pain|1
2436916|NCT03194490|8363492|P2|Overall Study|Lost to Follow-up|3
2436917|NCT03194490|8363493|P1|Overall Study|Lost to Follow-up|1
2436918|NCT03193047|8363646|P2|Overall Study|Participant Left State|0
2436919|NCT03193047|8363647|P1|Overall Study|Participant Left State|1
2436920|NCT03193047|8363646|P2|Overall Study|Physician Decision|0
2436921|NCT03193047|8363647|P1|Overall Study|Physician Decision|1
2436922|NCT03193021|8363667|P2|Overall Study|Lost to Follow-up|1
2436923|NCT03193021|8363668|P1|Overall Study|Lost to Follow-up|1
2436924|NCT03192475|8363715|P2|Overall Study|Lost to Follow-up|8
2436925|NCT03192475|8363716|P1|Overall Study|Lost to Follow-up|13
2436926|NCT03192475|8363715|P2|Overall Study|Death|1
2436927|NCT03192475|8363716|P1|Overall Study|Death|0
2436928|NCT03192306|8363752|P2|Overall Study|Protocol Violation|1
2436929|NCT03192306|8363753|P1|Overall Study|Protocol Violation|1
2436930|NCT03192306|8363752|P2|Overall Study|Lost to Follow-up|0
2436931|NCT03192306|8363753|P1|Overall Study|Lost to Follow-up|1
2436932|NCT03192306|8363752|P2|Overall Study|Withdrawal by Subject|1
2436933|NCT03192306|8363753|P1|Overall Study|Withdrawal by Subject|1
2436934|NCT03192306|8363752|P2|Overall Study|Did not treat cold sore during study|143
2436935|NCT03192306|8363753|P1|Overall Study|Did not treat cold sore during study|149
2436936|NCT03191552|8363774|P3|Overall Study|Undergone surgery (Progressive hip dyspl|0
2436937|NCT03191552|8363775|P2|Overall Study|Undergone surgery (Progressive hip dyspl|1
2436938|NCT03191552|8363776|P1|Overall Study|Undergone surgery (Progressive hip dyspl|0
2436939|NCT03191552|8363774|P3|Overall Study|Lost to Follow-up|0
2436940|NCT03191552|8363775|P2|Overall Study|Lost to Follow-up|0
2436941|NCT03191552|8363776|P1|Overall Study|Lost to Follow-up|1
2436942|NCT03191396|8363829|P2|Overall Study|Withdrawal by Subject|2
2436943|NCT03191396|8363830|P1|Overall Study|Withdrawal by Subject|3
2436944|NCT03191396|8363829|P2|Overall Study|Lost to Follow-up|3
2436945|NCT03191396|8363830|P1|Overall Study|Lost to Follow-up|0
2436946|NCT03190369|8363918|P2|Overall Study|Randomized but not treated|2
2436947|NCT03190369|8363919|P1|Overall Study|Randomized but not treated|0
2436948|NCT03190369|8363918|P2|Overall Study|Withdraw before treatment|5
2436949|NCT03190369|8363919|P1|Overall Study|Withdraw before treatment|1
2436950|NCT03190369|8363918|P2|Overall Study|Poor compliance to protocol|1
2436951|NCT03190369|8363919|P1|Overall Study|Poor compliance to protocol|0
2436952|NCT03188120|8364060|P1|Overall Study|No visit after the first visit|13
2436953|NCT03188120|8364060|P1|Overall Study|Other than specified|3
2436954|NCT03188120|8364060|P1|Overall Study|Lost to Follow-up|7
2436955|NCT03188120|8364060|P1|Overall Study|Improved|12
2436956|NCT03188120|8364060|P1|Overall Study|Insufficient Effectiveness|8
2436957|NCT03188120|8364060|P1|Overall Study|Adverse Event|4
2436958|NCT03187756|8364065|P1|Overall Study|Termination of study|4
2436959|NCT03187197|8364086|P3|Overall Study|NA in incl/excl criteria, not analyzed.|1
2436960|NCT03187197|8364087|P2|Overall Study|NA in incl/excl criteria, not analyzed.|45
2436961|NCT03187197|8364088|P1|Overall Study|NA in incl/excl criteria, not analyzed.|14
2436962|NCT03187197|8364086|P3|Overall Study|Status missing|3
2436963|NCT03187197|8364087|P2|Overall Study|Status missing|33
2436964|NCT03187197|8364088|P1|Overall Study|Status missing|2
2436965|NCT03187197|8364086|P3|Overall Study|Missing|3
2436966|NCT03187197|8364087|P2|Overall Study|Missing|32
2436967|NCT03187197|8364088|P1|Overall Study|Missing|1
2436968|NCT03187197|8364086|P3|Overall Study|Reason not listed|1
2436969|NCT03187197|8364087|P2|Overall Study|Reason not listed|54
2436970|NCT03187197|8364088|P1|Overall Study|Reason not listed|2
2436971|NCT03187197|8364086|P3|Overall Study|Administrative problem|0
2436972|NCT03187197|8364087|P2|Overall Study|Administrative problem|1
2436973|NCT03187197|8364088|P1|Overall Study|Administrative problem|1
2436974|NCT03187197|8364086|P3|Overall Study|Death|0
2436975|NCT03187197|8364087|P2|Overall Study|Death|11
2436976|NCT03187197|8364088|P1|Overall Study|Death|0
2436977|NCT03187197|8364086|P3|Overall Study|Adverse Event|0
2436978|NCT03187197|8364087|P2|Overall Study|Adverse Event|29
2436979|NCT03187197|8364088|P1|Overall Study|Adverse Event|6
2436980|NCT03187197|8364086|P3|Overall Study|Lost to Follow-up|7
2436981|NCT03187197|8364087|P2|Overall Study|Lost to Follow-up|60
2436982|NCT03187197|8364088|P1|Overall Study|Lost to Follow-up|1
2436983|NCT03187197|8364086|P3|Overall Study|Withdrawal by Subject|4
2436984|NCT03187197|8364087|P2|Overall Study|Withdrawal by Subject|63
2436985|NCT03187197|8364088|P1|Overall Study|Withdrawal by Subject|8
2436986|NCT03187197|8364086|P3|Overall Study|Stopped Pradaxa®/VKA|4
2436987|NCT03187197|8364087|P2|Overall Study|Stopped Pradaxa®/VKA|65
2436988|NCT03187197|8364088|P1|Overall Study|Stopped Pradaxa®/VKA|11
2436989|NCT03185481|8364099|P1|Overall Study|Study Terminated by Sponsor|4
2436990|NCT03185481|8364099|P1|Overall Study|Adverse Event|1
2436991|NCT03184701|8364138|P1|Overall Study|Lost to Follow-up|5
2436992|NCT03184701|8364138|P1|Overall Study|Withdrawal by Subject|6
2436993|NCT03184701|8364138|P1|Overall Study|Physician Decision|3
2436994|NCT03184701|8364138|P1|Overall Study|Death|3
2436995|NCT03184519|8364142|P1|Overall Study|Physician Decision|21
2436996|NCT03184519|8364142|P1|Overall Study|Lost to Follow-up|6
2436997|NCT03184441|8364146|P1|Overall Study|Withdrawal by Subject|1
2436998|NCT03184077|8364172|P2|Overall Study|Lost to Follow-up|21
2436999|NCT03184077|8364173|P1|Overall Study|Lost to Follow-up|21
2437000|NCT03183518|8364192|P1|Overall Study|Other (Withdrawal of consent)|1
2437001|NCT03183518|8364192|P1|Overall Study|Other (Not specified)|2
2437002|NCT03182738|8364255|P2|Overall Study|Withdrawal by Subject|1
2437003|NCT03182738|8364256|P1|Overall Study|Withdrawal by Subject|0
2437004|NCT03182738|8364255|P2|Overall Study|Pregnancy|1
2437005|NCT03182738|8364256|P1|Overall Study|Pregnancy|0
2437006|NCT03182738|8364255|P2|Overall Study|Lost to Follow-up|3
2437007|NCT03182738|8364256|P1|Overall Study|Lost to Follow-up|9
2437008|NCT03181594|8364305|P1|Overall Study|Physician Decision|1
2437009|NCT03181594|8364305|P1|Overall Study|Lost to Follow-up|1
2437010|NCT03181503|8364313|P2|Overall Study|Lost to Follow-up|1
2437011|NCT03181503|8364314|P1|Overall Study|Lost to Follow-up|1
2437012|NCT03181503|8364313|P2|Overall Study|Withdrawal by Subject|0
2437013|NCT03181503|8364314|P1|Overall Study|Withdrawal by Subject|3
2437014|NCT03181503|8364313|P2|Overall Study|Protocol Violation|0
2437015|NCT03181503|8364314|P1|Overall Study|Protocol Violation|1
2437016|NCT03181503|8364313|P2|Overall Study|Adverse Event|2
2437017|NCT03181503|8364314|P1|Overall Study|Adverse Event|2
2437018|NCT03180801|8364362|P3|Overall Study|Lost to Follow-up|3
2437019|NCT03180801|8364363|P2|Overall Study|Lost to Follow-up|2
2437020|NCT03180801|8364364|P1|Overall Study|Lost to Follow-up|0
2437021|NCT03180801|8364362|P3|Overall Study|Withdrawal by Subject|1
2437022|NCT03180801|8364363|P2|Overall Study|Withdrawal by Subject|2
2437023|NCT03180801|8364364|P1|Overall Study|Withdrawal by Subject|2
2437024|NCT03180801|8364362|P3|Overall Study|Adverse Event|2
2437025|NCT03180801|8364363|P2|Overall Study|Adverse Event|0
2437026|NCT03180801|8364364|P1|Overall Study|Adverse Event|1
2437027|NCT03180801|8364362|P3|Overall Study|Inoculation Target Reached|3
2437028|NCT03180801|8364363|P2|Overall Study|Inoculation Target Reached|1
2437029|NCT03180801|8364364|P1|Overall Study|Inoculation Target Reached|1
2437030|NCT03180801|8364362|P3|Overall Study|Non-compliance|0
2437031|NCT03180801|8364363|P2|Overall Study|Non-compliance|4
2437032|NCT03180801|8364364|P1|Overall Study|Non-compliance|1
2437033|NCT03180801|8364362|P3|Overall Study|Physician Decision|1
2437034|NCT03180801|8364363|P2|Overall Study|Physician Decision|3
2437035|NCT03180801|8364364|P1|Overall Study|Physician Decision|3
2437036|NCT03180645|8364405|P3|Overall Study|Adverse Event|2
2437037|NCT03180645|8364406|P2|Overall Study|Adverse Event|1
2437038|NCT03180645|8364407|P1|Overall Study|Adverse Event|0
2437039|NCT03180619|8364449|P3|Overall Study|Still on Study|30
2437040|NCT03180619|8364450|P2|Overall Study|Still on Study|15
2437041|NCT03180619|8364451|P1|Overall Study|Still on Study|75
2437042|NCT03180619|8364449|P3|Overall Study|Death|0
2437043|NCT03180619|8364450|P2|Overall Study|Death|0
2437044|NCT03180619|8364451|P1|Overall Study|Death|1
2437045|NCT03180619|8364449|P3|Overall Study|Withdrew Consent|1
2437046|NCT03180619|8364450|P2|Overall Study|Withdrew Consent|0
2437047|NCT03180619|8364451|P1|Overall Study|Withdrew Consent|2
2437048|NCT03180138|8364608|P3|Overall Study|Found to be >24 mon after randomization|3
2437049|NCT03180138|8364609|P2|Overall Study|Found to be >24 mon after randomization|0
2437050|NCT03180138|8364610|P1|Overall Study|Found to be >24 mon after randomization|3
2437051|NCT03180138|8364608|P3|Overall Study|No prior immunization records|6
2437052|NCT03180138|8364609|P2|Overall Study|No prior immunization records|0
2437053|NCT03180138|8364610|P1|Overall Study|No prior immunization records|17
2437054|NCT03180138|8364608|P3|Overall Study|Mobile-phone could not be verified|15
2437055|NCT03180138|8364609|P2|Overall Study|Mobile-phone could not be verified|13
2437056|NCT03180138|8364610|P1|Overall Study|Mobile-phone could not be verified|2
2437057|NCT03178942|8364623|P2|Overall Study|Lost to Follow-up|2
2437058|NCT03178942|8364624|P1|Overall Study|Lost to Follow-up|1
2437059|NCT03178942|8364623|P2|Overall Study|Withdrawal by Subject|0
2437060|NCT03178942|8364624|P1|Overall Study|Withdrawal by Subject|2
2437061|NCT03178266|8364653|P2|Overall Study|Withdrawal by Subject|2
2437062|NCT03178266|8364654|P1|Overall Study|Withdrawal by Subject|0
2437063|NCT03178266|8364653|P2|Overall Study|Disont. Early|1
2437064|NCT03178266|8364654|P1|Overall Study|Disont. Early|0
2437065|NCT03178266|8364653|P2|Overall Study|Death|1
2437066|NCT03178266|8364654|P1|Overall Study|Death|0
2437067|NCT03176407|8364978|P1|Overall Study|EGD showed esophageal varices=excl. crit|1
2437068|NCT03176407|8364978|P1|Overall Study|human failure|1
2437069|NCT03176407|8364978|P1|Overall Study|Protocol Violation|1
2437070|NCT03176238|8364988|P2|Overall Study|Everolimus dose interrupt > 4 wks|0
2437071|NCT03176238|8364989|P1|Overall Study|Everolimus dose interrupt > 4 wks|9
2437072|NCT03176238|8364988|P2|Overall Study|Changes in the patient's condition|1
2437073|NCT03176238|8364989|P1|Overall Study|Changes in the patient's condition|2
2437074|NCT03176238|8364988|P2|Overall Study|Protocol Violation|0
2437075|NCT03176238|8364989|P1|Overall Study|Protocol Violation|1
2437076|NCT03176238|8364988|P2|Overall Study|Patient is switched to commercial drug|1
2437077|NCT03176238|8364989|P1|Overall Study|Patient is switched to commercial drug|16
2437078|NCT03176238|8364988|P2|Overall Study|Tx duration completed per EAP|1
2437079|NCT03176238|8364989|P1|Overall Study|Tx duration completed per EAP|0
2437080|NCT03176238|8364988|P2|Overall Study|Disease Progression|22
2437081|NCT03176238|8364989|P1|Overall Study|Disease Progression|133
2437082|NCT03176238|8364988|P2|Overall Study|Death|0
2437083|NCT03176238|8364989|P1|Overall Study|Death|3
2437084|NCT03176238|8364988|P2|Overall Study|Administrative problems|0
2437085|NCT03176238|8364989|P1|Overall Study|Administrative problems|1
2437086|NCT03176238|8364988|P2|Overall Study|Lost to Follow-up|0
2437087|NCT03176238|8364989|P1|Overall Study|Lost to Follow-up|3
2437088|NCT03176238|8364988|P2|Overall Study|Consent withdrawal|2
2437089|NCT03176238|8364989|P1|Overall Study|Consent withdrawal|14
2437090|NCT03176238|8364988|P2|Overall Study|Inter-current illness|1
2437091|NCT03176238|8364989|P1|Overall Study|Inter-current illness|0
2437092|NCT03176238|8364988|P2|Overall Study|Abnormal lab value(s)|0
2437093|NCT03176238|8364989|P1|Overall Study|Abnormal lab value(s)|2
2437094|NCT03176238|8364988|P2|Overall Study|Unacceptable AEs|8
2437095|NCT03176238|8364989|P1|Overall Study|Unacceptable AEs|15
2437096|NCT03175562|8365008|P1|Overall Study|Other (Not Specified)|5
2437097|NCT03175562|8365008|P1|Overall Study|Withdrawal by Subject|7
2437098|NCT03175562|8365008|P1|Overall Study|Lost to Follow-up|3
2437099|NCT03175562|8365008|P1|Overall Study|Adverse Event|1
2437100|NCT03175172|8365033|P1|Overall Study|Study Terminated by Sponsor|3
2437101|NCT03175172|8365033|P1|Overall Study|Lost to Follow-up|1
2437102|NCT03175172|8365033|P1|Overall Study|Withdrawal by Subject|3
2437103|NCT03175172|8365033|P1|Overall Study|Death|3
2437104|NCT03175120|8365043|P2|Overall Study|Other|3
2437105|NCT03175120|8365044|P1|Overall Study|Other|2
2437106|NCT03175120|8365043|P2|Overall Study|Withdrawal by Subject|5
2437107|NCT03175120|8365044|P1|Overall Study|Withdrawal by Subject|2
2437108|NCT03175120|8365043|P2|Overall Study|Lost to Follow-up|0
2437109|NCT03175120|8365044|P1|Overall Study|Lost to Follow-up|1
2437110|NCT03175120|8365043|P2|Overall Study|Protocol Violation|2
2437111|NCT03175120|8365044|P1|Overall Study|Protocol Violation|5
2437112|NCT03175120|8365043|P2|Overall Study|Adverse Event|2
2437113|NCT03175120|8365044|P1|Overall Study|Adverse Event|2
2437114|NCT03172481|8365234|P2|Double-blind|Withdrawal by Subject|0
2437115|NCT03172481|8365235|P1|Double-blind|Withdrawal by Subject|1
2437116|NCT03172364|8365243|P2|Overall Study|Protocol Violation|0
2437117|NCT03172364|8365244|P1|Overall Study|Protocol Violation|1
2437118|NCT03172364|8365243|P2|Overall Study|Adverse Event|1
2437119|NCT03172364|8365244|P1|Overall Study|Adverse Event|1
2437120|NCT03171415|8365265|P5|Overall Study|Lost to Follow-up|2
2437121|NCT03171415|8365266|P4|Overall Study|Lost to Follow-up|0
2437122|NCT03171415|8365267|P3|Overall Study|Lost to Follow-up|0
2437123|NCT03171415|8365268|P2|Overall Study|Lost to Follow-up|0
2437124|NCT03171415|8365269|P1|Overall Study|Lost to Follow-up|0
2437125|NCT03170609|8365337|P7|Overall Study|Other|0
2437126|NCT03170609|8365338|P6|Overall Study|Other|1
2437127|NCT03170609|8365339|P5|Overall Study|Other|0
2437128|NCT03170609|8365340|P4|Overall Study|Other|0
2437129|NCT03170609|8365341|P3|Overall Study|Other|0
2437130|NCT03170609|8365342|P2|Overall Study|Other|0
2437131|NCT03170609|8365343|P1|Overall Study|Other|1
2437132|NCT03170609|8365337|P7|Overall Study|Lost to Follow-up|0
2437133|NCT03170609|8365338|P6|Overall Study|Lost to Follow-up|1
2437134|NCT03170609|8365339|P5|Overall Study|Lost to Follow-up|1
2437135|NCT03170609|8365340|P4|Overall Study|Lost to Follow-up|2
2437136|NCT03170609|8365341|P3|Overall Study|Lost to Follow-up|5
2437137|NCT03170609|8365342|P2|Overall Study|Lost to Follow-up|0
2437138|NCT03170609|8365343|P1|Overall Study|Lost to Follow-up|1
2437139|NCT03170609|8365337|P7|Overall Study|Withdrawal by Subject|1
2437140|NCT03170609|8365338|P6|Overall Study|Withdrawal by Subject|0
2437141|NCT03170609|8365339|P5|Overall Study|Withdrawal by Subject|0
2437142|NCT03170609|8365340|P4|Overall Study|Withdrawal by Subject|0
2437143|NCT03170609|8365341|P3|Overall Study|Withdrawal by Subject|0
2437144|NCT03170609|8365342|P2|Overall Study|Withdrawal by Subject|2
2437145|NCT03170609|8365343|P1|Overall Study|Withdrawal by Subject|1
2437146|NCT03170609|8365337|P7|Overall Study|Death|0
2437147|NCT03170609|8365338|P6|Overall Study|Death|0
2437148|NCT03170609|8365339|P5|Overall Study|Death|0
2437149|NCT03170609|8365340|P4|Overall Study|Death|0
2437150|NCT03170609|8365341|P3|Overall Study|Death|1
2437151|NCT03170609|8365342|P2|Overall Study|Death|0
2437152|NCT03170609|8365343|P1|Overall Study|Death|0
2437153|NCT03170544|8365413|P12|Part 1|Not treated|0
2437154|NCT03170544|8365414|P11|Part 1|Not treated|0
2437155|NCT03170544|8365415|P10|Part 1|Not treated|0
2437156|NCT03170544|8365416|P9|Part 1|Not treated|0
2437157|NCT03170544|8365417|P8|Part 1|Not treated|0
2437158|NCT03170544|8365418|P7|Part 1|Not treated|0
2437159|NCT03170544|8365419|P6|Part 1|Not treated|0
2437160|NCT03170544|8365420|P5|Part 1|Not treated|0
2437161|NCT03170544|8365421|P4|Part 1|Not treated|1
2437162|NCT03170544|8365422|P3|Part 1|Not treated|0
2437163|NCT03170544|8365423|P2|Part 1|Not treated|0
2437164|NCT03170544|8365424|P1|Part 1|Not treated|0
2437165|NCT03170544|8365413|P12|Part 1|Lost to Follow-up|0
2437166|NCT03170544|8365414|P11|Part 1|Lost to Follow-up|0
2437167|NCT03170544|8365415|P10|Part 1|Lost to Follow-up|0
2437168|NCT03170544|8365416|P9|Part 1|Lost to Follow-up|0
2437169|NCT03170544|8365417|P8|Part 1|Lost to Follow-up|0
2437170|NCT03170544|8365418|P7|Part 1|Lost to Follow-up|0
2437171|NCT03170544|8365419|P6|Part 1|Lost to Follow-up|0
2437172|NCT03170544|8365420|P5|Part 1|Lost to Follow-up|0
2437173|NCT03170544|8365421|P4|Part 1|Lost to Follow-up|0
2437174|NCT03170544|8365422|P3|Part 1|Lost to Follow-up|0
2437175|NCT03170544|8365423|P2|Part 1|Lost to Follow-up|0
2437176|NCT03170544|8365424|P1|Part 1|Lost to Follow-up|1
2437177|NCT03170232|8365588|P2|Overall Study|Withdrawal by Subject|1
2437178|NCT03170232|8365589|P1|Overall Study|Withdrawal by Subject|0
2437179|NCT03170232|8365588|P2|Overall Study|Lost to Follow-up|0
2437180|NCT03170232|8365589|P1|Overall Study|Lost to Follow-up|1
2437181|NCT03170232|8365588|P2|Overall Study|Study closed/terminated|23
2437182|NCT03170232|8365589|P1|Overall Study|Study closed/terminated|26
2437183|NCT03170232|8365588|P2|Overall Study|Lack of Efficacy|1
2437184|NCT03170232|8365589|P1|Overall Study|Lack of Efficacy|0
2437185|NCT03170232|8365588|P2|Overall Study|Protocol Violation|1
2437186|NCT03170232|8365589|P1|Overall Study|Protocol Violation|0
2437187|NCT03170232|8365588|P2|Overall Study|Adverse Event|1
2437188|NCT03170232|8365589|P1|Overall Study|Adverse Event|0
2437189|NCT03170193|8365667|P7|Overall Study|Lost to Follow-up|0
2437190|NCT03170193|8365668|P6|Overall Study|Lost to Follow-up|0
2437191|NCT03170193|8365669|P5|Overall Study|Lost to Follow-up|0
2437192|NCT03170193|8365670|P4|Overall Study|Lost to Follow-up|0
2437193|NCT03170193|8365671|P3|Overall Study|Lost to Follow-up|0
2437194|NCT03170193|8365672|P2|Overall Study|Lost to Follow-up|1
2437195|NCT03170193|8365673|P1|Overall Study|Lost to Follow-up|1
2437196|NCT03170193|8365667|P7|Overall Study|Withdrawal by Subject|0
2437197|NCT03170193|8365668|P6|Overall Study|Withdrawal by Subject|0
2437198|NCT03170193|8365669|P5|Overall Study|Withdrawal by Subject|0
2437199|NCT03170193|8365670|P4|Overall Study|Withdrawal by Subject|1
2437200|NCT03170193|8365671|P3|Overall Study|Withdrawal by Subject|0
2437201|NCT03170193|8365672|P2|Overall Study|Withdrawal by Subject|0
2437202|NCT03170193|8365673|P1|Overall Study|Withdrawal by Subject|0
2437203|NCT03170154|8365742|P1|Overall Study|Withdrawal by Subject|2
2437204|NCT03170154|8365742|P1|Overall Study|Death|2
2437205|NCT03170154|8365742|P1|Overall Study|Lost to Follow-up|4
2437206|NCT03169530|8365757|P2|Overall Study|Study ended by NIH|17
2437207|NCT03169530|8365758|P1|Overall Study|Study ended by NIH|15
2437208|NCT03169153|8365776|P2|Period 2, Second 30 Days of Wear|Could not attend visit|0
2437209|NCT03169153|8365777|P1|Period 2, Second 30 Days of Wear|Could not attend visit|1
2437210|NCT03169153|8365776|P2|Period 2, Second 30 Days of Wear|Adverse Event|2
2437211|NCT03169153|8365777|P1|Period 2, Second 30 Days of Wear|Adverse Event|1
2437212|NCT03169153|8365776|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|3
2437213|NCT03169153|8365777|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|2
2437214|NCT03169153|8365776|P2|Period 1, First 30 Days of Wear|Lost to Follow-up|1
2437215|NCT03169153|8365777|P1|Period 1, First 30 Days of Wear|Lost to Follow-up|1
2437216|NCT03168919|8365788|P1|Overall Study|Withdrawal by Subject|2
2437217|NCT03168906|8365798|P2|Overall Study|Lack of Efficacy|6
2437218|NCT03168906|8365799|P1|Overall Study|Lack of Efficacy|6
2437219|NCT03168425|8365831|P2|Overall Study|unable to confirm post op opioids|3
2437220|NCT03168425|8365832|P1|Overall Study|unable to confirm post op opioids|2
2437221|NCT03168425|8365831|P2|Overall Study|Lost to Follow-up|8
2437222|NCT03168425|8365832|P1|Overall Study|Lost to Follow-up|5
2437223|NCT03166618|8365908|P2|Overall Study|Study was Terminated|1
2437224|NCT03166618|8365909|P1|Overall Study|Study was Terminated|0
2437225|NCT03166215|8365921|P3|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2
2437226|NCT03166215|8365922|P2|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0
2437227|NCT03166215|8365923|P1|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0
2437228|NCT03166215|8365921|P3|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0
2437229|NCT03166215|8365922|P2|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2
2437230|NCT03166215|8365923|P1|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0
2437231|NCT03166124|8365963|P4|Wash-out Period|Adverse Event|0
2437232|NCT03166124|8365964|P3|Wash-out Period|Adverse Event|1
2437233|NCT03166124|8365965|P2|Wash-out Period|Adverse Event|1
2437234|NCT03166124|8365966|P1|Wash-out Period|Adverse Event|0
2437235|NCT03166124|8365963|P4|Wash-out Period|Withdrawal by Subject|1
2437236|NCT03166124|8365964|P3|Wash-out Period|Withdrawal by Subject|0
2437237|NCT03166124|8365965|P2|Wash-out Period|Withdrawal by Subject|1
2437238|NCT03166124|8365966|P1|Wash-out Period|Withdrawal by Subject|0
2437239|NCT03166124|8365963|P4|Treatment Period 1|Adverse Event|0
2437240|NCT03166124|8365964|P3|Treatment Period 1|Adverse Event|1
2437241|NCT03166124|8365965|P2|Treatment Period 1|Adverse Event|0
2437242|NCT03166124|8365966|P1|Treatment Period 1|Adverse Event|0
2437243|NCT03165110|8366057|P1|Overall Study|Anroid phone software incompatibility|1
2437244|NCT03165045|8366069|P1|Visit 2|Available total CCQ score at vist 2 only|44
2437245|NCT03165045|8366069|P1|Visit 2|No available total CCQ score at all|29
2437246|NCT03165045|8366069|P1|Visit 2|Available CCQ score at visit 1 only|109
2437247|NCT03165045|8366069|P1|Visit 1|No visit 1|10
2437248|NCT03165045|8366069|P1|Visit 1|No treatment documented|10
2437249|NCT03165045|8366069|P1|Visit 1|No registration after visit 1|9
2437250|NCT03162614|8366127|P6|Overall Study|Missed vaccination, exclusion criteria|0
2437251|NCT03162614|8366128|P5|Overall Study|Missed vaccination, exclusion criteria|3
2437252|NCT03162614|8366129|P4|Overall Study|Missed vaccination, exclusion criteria|4
2437253|NCT03162614|8366130|P3|Overall Study|Missed vaccination, exclusion criteria|2
2437254|NCT03162614|8366131|P2|Overall Study|Missed vaccination, exclusion criteria|2
2437255|NCT03162614|8366132|P1|Overall Study|Missed vaccination, exclusion criteria|2
2437256|NCT03162614|8366127|P6|Overall Study|Withdrawal by Subject|0
2437257|NCT03162614|8366128|P5|Overall Study|Withdrawal by Subject|0
2437258|NCT03162614|8366129|P4|Overall Study|Withdrawal by Subject|1
2437259|NCT03162614|8366130|P3|Overall Study|Withdrawal by Subject|1
2437260|NCT03162614|8366131|P2|Overall Study|Withdrawal by Subject|1
2437261|NCT03162614|8366132|P1|Overall Study|Withdrawal by Subject|2
2437262|NCT03162614|8366127|P6|Overall Study|Protocol Violation|0
2437263|NCT03162614|8366128|P5|Overall Study|Protocol Violation|0
2437264|NCT03162614|8366129|P4|Overall Study|Protocol Violation|1
2437265|NCT03162614|8366130|P3|Overall Study|Protocol Violation|0
2437266|NCT03162614|8366131|P2|Overall Study|Protocol Violation|1
2437267|NCT03162614|8366132|P1|Overall Study|Protocol Violation|0
2437268|NCT03162614|8366127|P6|Overall Study|Lost to Follow-up|0
2437269|NCT03162614|8366128|P5|Overall Study|Lost to Follow-up|2
2437270|NCT03162614|8366129|P4|Overall Study|Lost to Follow-up|1
2437271|NCT03162614|8366130|P3|Overall Study|Lost to Follow-up|1
2437272|NCT03162614|8366131|P2|Overall Study|Lost to Follow-up|1
2437273|NCT03162614|8366132|P1|Overall Study|Lost to Follow-up|2
2437274|NCT03162328|8366251|P3|Study Period|Withdrawal by Subject|1
2437275|NCT03162328|8366252|P2|Study Period|Withdrawal by Subject|0
2437276|NCT03162328|8366253|P1|Study Period|Withdrawal by Subject|0
2437277|NCT03162328|8366251|P3|Screening Period|Withdrawal by Subject|0
2437278|NCT03162328|8366252|P2|Screening Period|Withdrawal by Subject|0
2437279|NCT03162328|8366253|P1|Screening Period|Withdrawal by Subject|1
2437280|NCT03162328|8366251|P3|Screening Period|Did not meet inclusion/exclusion|0
2437281|NCT03162328|8366252|P2|Screening Period|Did not meet inclusion/exclusion|0
2437282|NCT03162328|8366253|P1|Screening Period|Did not meet inclusion/exclusion|21
2437283|NCT03162055|8366282|P2|Overall Study|Other|15
2437284|NCT03162055|8366283|P1|Overall Study|Other|8
2437285|NCT03162055|8366282|P2|Overall Study|Incorrect randomization|3
2437286|NCT03162055|8366283|P1|Overall Study|Incorrect randomization|4
2437287|NCT03162055|8366282|P2|Overall Study|Did not receive treatment|0
2437288|NCT03162055|8366283|P1|Overall Study|Did not receive treatment|2
2437289|NCT03162055|8366282|P2|Overall Study|Withdrawal by Subject|2
2437290|NCT03162055|8366283|P1|Overall Study|Withdrawal by Subject|17
2437291|NCT03162055|8366282|P2|Overall Study|Study-specific withdrawal criteria|14
2437292|NCT03162055|8366283|P1|Overall Study|Study-specific withdrawal criteria|22
2437293|NCT03162055|8366282|P2|Overall Study|Lost to Follow-up|1
2437294|NCT03162055|8366283|P1|Overall Study|Lost to Follow-up|0
2437295|NCT03162055|8366282|P2|Overall Study|Death|3
2437296|NCT03162055|8366283|P1|Overall Study|Death|3
2437297|NCT03162055|8366282|P2|Overall Study|Adverse Event|5
2437298|NCT03162055|8366283|P1|Overall Study|Adverse Event|6
2437299|NCT03161405|8366336|P1|Second Intervention Period (6 Days)|Positive urine drug screen|1
2437300|NCT03160716|8366352|P1|Overall Study|Lost to Follow-up|1
2437301|NCT03160703|8366363|P4|Overall Study|Withdrawal by Subject|1
2437302|NCT03160703|8366364|P3|Overall Study|Withdrawal by Subject|0
2437303|NCT03160703|8366365|P2|Overall Study|Withdrawal by Subject|0
2437304|NCT03160703|8366366|P1|Overall Study|Withdrawal by Subject|0
2437305|NCT03159611|8366444|P2|Overall Study|Inability to perform procedures|0
2437306|NCT03159611|8366445|P1|Overall Study|Inability to perform procedures|1
2437307|NCT03159611|8366444|P2|Overall Study|Non-compliance with protocol requirement|2
2437308|NCT03159611|8366445|P1|Overall Study|Non-compliance with protocol requirement|3
2437309|NCT03159611|8366444|P2|Overall Study|Withdrawal by Subject|1
2437310|NCT03159611|8366445|P1|Overall Study|Withdrawal by Subject|1
2437311|NCT03159611|8366444|P2|Overall Study|Adverse Event|0
2437312|NCT03159611|8366445|P1|Overall Study|Adverse Event|1
2437313|NCT03159611|8366444|P2|Overall Study|Protocol Violation|4
2437314|NCT03159611|8366445|P1|Overall Study|Protocol Violation|7
2437315|NCT03159611|8366444|P2|Overall Study|Did Not Meet Exclusion Criteria|3
2437316|NCT03159611|8366445|P1|Overall Study|Did Not Meet Exclusion Criteria|1
2437317|NCT03159611|8366444|P2|Overall Study|Did Not Meet Inclusion Criteria|5
2437318|NCT03159611|8366445|P1|Overall Study|Did Not Meet Inclusion Criteria|9
2437319|NCT03159468|8366465|P6|Overall Study|Withdrawal by Subject|0
2437320|NCT03159468|8366466|P5|Overall Study|Withdrawal by Subject|0
2437321|NCT03159468|8366467|P4|Overall Study|Withdrawal by Subject|0
2437322|NCT03159468|8366468|P3|Overall Study|Withdrawal by Subject|3
2437323|NCT03159468|8366469|P2|Overall Study|Withdrawal by Subject|0
2437324|NCT03159468|8366470|P1|Overall Study|Withdrawal by Subject|0
2437325|NCT03158220|8366519|P2|Overall Study|Physician Decision|0
2437326|NCT03158220|8366520|P1|Overall Study|Physician Decision|1
2437327|NCT03158220|8366519|P2|Overall Study|Lost to Follow-up|5
2437328|NCT03158220|8366520|P1|Overall Study|Lost to Follow-up|8
2437329|NCT03158220|8366519|P2|Overall Study|Status unknown|1
2437330|NCT03158220|8366520|P1|Overall Study|Status unknown|0
2437331|NCT03158220|8366519|P2|Overall Study|Withdrawal by Subject|9
2437332|NCT03158220|8366520|P1|Overall Study|Withdrawal by Subject|8
2437333|NCT03158220|8366519|P2|Overall Study|Screen Failure|1
2437334|NCT03158220|8366520|P1|Overall Study|Screen Failure|0
2437335|NCT03158012|8366557|P2|Overall Study|Withdrawal by Subject|1
2437336|NCT03158012|8366558|P1|Overall Study|Withdrawal by Subject|0
2437337|NCT03157583|8366564|P1|Overall Study|Other (did not meet study criteria)|1
2437338|NCT03157531|8366582|P1|Overall Study|Lost to Follow-up|4
2437339|NCT03157531|8366582|P1|Overall Study|Death|2
2437340|NCT03155269|8366603|P2|Overall Study|Lost to Follow-up|2
2437341|NCT03155269|8366604|P1|Overall Study|Lost to Follow-up|1
2437342|NCT03155269|8366603|P2|Overall Study|Withdrawal by Subject|5
2437343|NCT03155269|8366604|P1|Overall Study|Withdrawal by Subject|4
2437344|NCT03155178|8366650|P4|Overall Study|Did not meet treatment day baseline|7
2437345|NCT03155178|8366651|P3|Overall Study|Did not meet treatment day baseline|7
2437346|NCT03155178|8366652|P2|Overall Study|Did not meet treatment day baseline|7
2437347|NCT03155178|8366653|P1|Overall Study|Did not meet treatment day baseline|7
2437348|NCT03154086|8366697|P15|Part B (Up to 25 Days)|Adverse Event|0
2437349|NCT03154086|8366698|P14|Part B (Up to 25 Days)|Adverse Event|0
2437350|NCT03154086|8366699|P13|Part B (Up to 25 Days)|Adverse Event|0
2437351|NCT03154086|8366700|P12|Part B (Up to 25 Days)|Adverse Event|0
2437352|NCT03154086|8366701|P11|Part B (Up to 25 Days)|Adverse Event|1
2437353|NCT03154086|8366702|P10|Part B (Up to 25 Days)|Adverse Event|0
2437354|NCT03154086|8366703|P9|Part B (Up to 25 Days)|Adverse Event|0
2437355|NCT03154086|8366704|P8|Part B (Up to 25 Days)|Adverse Event|0
2437356|NCT03154086|8366705|P7|Part B (Up to 25 Days)|Adverse Event|0
2437357|NCT03154086|8366706|P6|Part B (Up to 25 Days)|Adverse Event|0
2437358|NCT03154086|8366707|P5|Part B (Up to 25 Days)|Adverse Event|0
2437359|NCT03154086|8366708|P4|Part B (Up to 25 Days)|Adverse Event|0
2437360|NCT03154086|8366709|P3|Part B (Up to 25 Days)|Adverse Event|0
2437361|NCT03154086|8366710|P2|Part B (Up to 25 Days)|Adverse Event|0
2437362|NCT03154086|8366711|P1|Part B (Up to 25 Days)|Adverse Event|0
2437363|NCT03154086|8366697|P15|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2437364|NCT03154086|8366698|P14|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2437365|NCT03154086|8366699|P13|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2437366|NCT03154086|8366700|P12|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2437367|NCT03154086|8366701|P11|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2437368|NCT03154086|8366702|P10|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2437369|NCT03154086|8366703|P9|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2437370|NCT03154086|8366704|P8|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1
2437371|NCT03154086|8366705|P7|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2437372|NCT03154086|8366706|P6|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2437373|NCT03154086|8366707|P5|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2437374|NCT03154086|8366708|P4|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2437375|NCT03154086|8366709|P3|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2437376|NCT03154086|8366710|P2|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2437377|NCT03154086|8366711|P1|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
2437378|NCT03154086|8366697|P15|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2437379|NCT03154086|8366698|P14|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2437380|NCT03154086|8366699|P13|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2437381|NCT03154086|8366700|P12|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2437382|NCT03154086|8366701|P11|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2437383|NCT03154086|8366702|P10|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2437384|NCT03154086|8366703|P9|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1
2437385|NCT03154086|8366704|P8|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2437386|NCT03154086|8366705|P7|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2437387|NCT03154086|8366706|P6|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2437388|NCT03154086|8366707|P5|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2437389|NCT03154086|8366708|P4|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2437390|NCT03154086|8366709|P3|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2437391|NCT03154086|8366710|P2|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2437392|NCT03154086|8366711|P1|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
2437393|NCT03154086|8366697|P15|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2437394|NCT03154086|8366698|P14|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2437395|NCT03154086|8366699|P13|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2437396|NCT03154086|8366700|P12|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2437397|NCT03154086|8366701|P11|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2437398|NCT03154086|8366702|P10|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2437399|NCT03154086|8366703|P9|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2437400|NCT03154086|8366704|P8|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2437401|NCT03154086|8366705|P7|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2437560|NCT03147248|8367793|P3|Overall Study|Pregnancy|0
2437402|NCT03154086|8366706|P6|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2437403|NCT03154086|8366707|P5|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2437404|NCT03154086|8366708|P4|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2437405|NCT03154086|8366709|P3|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2437406|NCT03154086|8366710|P2|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
2437407|NCT03154086|8366711|P1|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1
2437408|NCT03154086|8366697|P15|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2437409|NCT03154086|8366698|P14|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2437410|NCT03154086|8366699|P13|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2437411|NCT03154086|8366700|P12|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2437412|NCT03154086|8366701|P11|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2437413|NCT03154086|8366702|P10|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2437414|NCT03154086|8366703|P9|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2437415|NCT03154086|8366704|P8|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2437416|NCT03154086|8366705|P7|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2437417|NCT03154086|8366706|P6|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2437418|NCT03154086|8366707|P5|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2437419|NCT03154086|8366708|P4|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2437420|NCT03154086|8366709|P3|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1
2437421|NCT03154086|8366710|P2|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2437422|NCT03154086|8366711|P1|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
2437423|NCT03154086|8366697|P15|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2437424|NCT03154086|8366698|P14|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2437425|NCT03154086|8366699|P13|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2437426|NCT03154086|8366700|P12|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2437427|NCT03154086|8366701|P11|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2437428|NCT03154086|8366702|P10|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2437429|NCT03154086|8366703|P9|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2437430|NCT03154086|8366704|P8|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2437431|NCT03154086|8366705|P7|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2437432|NCT03154086|8366706|P6|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2437433|NCT03154086|8366707|P5|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2437434|NCT03154086|8366708|P4|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2437435|NCT03154086|8366709|P3|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2437436|NCT03154086|8366710|P2|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1
2437437|NCT03154086|8366711|P1|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
2437438|NCT03154086|8366697|P15|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2437439|NCT03154086|8366698|P14|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2437440|NCT03154086|8366699|P13|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2437441|NCT03154086|8366700|P12|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2437442|NCT03154086|8366701|P11|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2437443|NCT03154086|8366702|P10|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2437444|NCT03154086|8366703|P9|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2437445|NCT03154086|8366704|P8|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2437446|NCT03154086|8366705|P7|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2437447|NCT03154086|8366706|P6|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2437448|NCT03154086|8366707|P5|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2437449|NCT03154086|8366708|P4|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1
2437450|NCT03154086|8366709|P3|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2437451|NCT03154086|8366710|P2|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2437452|NCT03154086|8366711|P1|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
2437453|NCT03154047|8367111|P1|Overall Study|Withdrawal by Subject|3
2437454|NCT03154047|8367111|P1|Overall Study|Study terminated by sponsor|76
2437455|NCT03154047|8367111|P1|Overall Study|Death|1
2437456|NCT03152552|8367158|P5|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11
2437457|NCT03152552|8367159|P4|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9
2437458|NCT03152552|8367160|P3|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9
2437459|NCT03152552|8367161|P2|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5
2437460|NCT03152552|8367162|P1|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6
2437461|NCT03152552|8367158|P5|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
2437462|NCT03152552|8367159|P4|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1
2437463|NCT03152552|8367160|P3|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
2437464|NCT03152552|8367161|P2|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
2437465|NCT03152552|8367162|P1|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
2437466|NCT03152552|8367158|P5|Treatment Period 1 (12 Weeks)|Technical problems|0
2437467|NCT03152552|8367159|P4|Treatment Period 1 (12 Weeks)|Technical problems|0
2437468|NCT03152552|8367160|P3|Treatment Period 1 (12 Weeks)|Technical problems|1
2437469|NCT03152552|8367161|P2|Treatment Period 1 (12 Weeks)|Technical problems|0
2437470|NCT03152552|8367162|P1|Treatment Period 1 (12 Weeks)|Technical problems|0
2437471|NCT03152552|8367158|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2437472|NCT03152552|8367159|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2437473|NCT03152552|8367160|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
2437474|NCT03152552|8367161|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2437475|NCT03152552|8367162|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2437476|NCT03152552|8367158|P5|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20
2437477|NCT03152552|8367159|P4|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19
2437478|NCT03152552|8367160|P3|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19
2437479|NCT03152552|8367161|P2|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9
2437480|NCT03152552|8367162|P1|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8
2437481|NCT03152552|8367158|P5|Treatment Period 1 (12 Weeks)|Protocol deviation|0
2437482|NCT03152552|8367159|P4|Treatment Period 1 (12 Weeks)|Protocol deviation|0
2437483|NCT03152552|8367160|P3|Treatment Period 1 (12 Weeks)|Protocol deviation|0
2437484|NCT03152552|8367161|P2|Treatment Period 1 (12 Weeks)|Protocol deviation|1
2437485|NCT03152552|8367162|P1|Treatment Period 1 (12 Weeks)|Protocol deviation|0
2437486|NCT03152552|8367158|P5|Treatment Period 1 (12 Weeks)|Death|1
2437487|NCT03152552|8367159|P4|Treatment Period 1 (12 Weeks)|Death|0
2437488|NCT03152552|8367160|P3|Treatment Period 1 (12 Weeks)|Death|0
2437489|NCT03152552|8367161|P2|Treatment Period 1 (12 Weeks)|Death|1
2437490|NCT03152552|8367162|P1|Treatment Period 1 (12 Weeks)|Death|0
2437491|NCT03152526|8367295|P2|Overall Study|Withdrawal by Subject|1
2437492|NCT03152526|8367296|P1|Overall Study|Withdrawal by Subject|0
2437493|NCT03151551|8367318|P2|Overall Study|Ongoing|266
2437494|NCT03151551|8367319|P1|Overall Study|Ongoing|262
2437495|NCT03151551|8367318|P2|Overall Study|Physician Decision|0
2437496|NCT03151551|8367319|P1|Overall Study|Physician Decision|2
2437497|NCT03151551|8367318|P2|Overall Study|Lack of Efficacy|1
2437498|NCT03151551|8367319|P1|Overall Study|Lack of Efficacy|2
2437499|NCT03151551|8367318|P2|Overall Study|Protocol Violation|2
2437500|NCT03151551|8367319|P1|Overall Study|Protocol Violation|1
2437501|NCT03151551|8367318|P2|Overall Study|Withdrawal by Subject|6
2437502|NCT03151551|8367319|P1|Overall Study|Withdrawal by Subject|7
2437503|NCT03151551|8367318|P2|Overall Study|Adverse Event|1
2437504|NCT03151551|8367319|P1|Overall Study|Adverse Event|1
2437505|NCT03151226|8367354|P1|Overall Study|not wear device correctly|1
2437506|NCT03151226|8367354|P1|Overall Study|Withdrawal by Subject|2
2437507|NCT03150719|8367364|P2|Overall Study|Other|0
2437508|NCT03150719|8367365|P1|Overall Study|Other|1
2437509|NCT03150719|8367364|P2|Overall Study|Death|1
2437510|NCT03150719|8367365|P1|Overall Study|Death|0
2437511|NCT03150719|8367364|P2|Overall Study|Adverse Event|1
2437512|NCT03150719|8367365|P1|Overall Study|Adverse Event|0
2437513|NCT03150485|8367381|P6|Overall Study|Unsatisfactory Lens Fitting|0
2437514|NCT03150485|8367382|P5|Overall Study|Unsatisfactory Lens Fitting|0
2437515|NCT03150485|8367383|P4|Overall Study|Unsatisfactory Lens Fitting|0
2437516|NCT03150485|8367384|P3|Overall Study|Unsatisfactory Lens Fitting|0
2437517|NCT03150485|8367385|P2|Overall Study|Unsatisfactory Lens Fitting|1
2437518|NCT03150485|8367386|P1|Overall Study|Unsatisfactory Lens Fitting|0
2437519|NCT03150082|8367563|P2|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
2437520|NCT03150082|8367564|P1|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1
2437521|NCT03149848|8367641|P1|Period 2 (Day 15 to Day 28)|Adverse Event|2
2437522|NCT03149848|8367641|P1|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1
2437523|NCT03148756|8367680|P2|Overall Study|Study Terminated|1
2437524|NCT03148756|8367681|P1|Overall Study|Study Terminated|0
2437525|NCT03148691|8367714|P3|Overall Study|Withdrawal by Subject|0
2437526|NCT03148691|8367715|P2|Overall Study|Withdrawal by Subject|0
2437527|NCT03148691|8367716|P1|Overall Study|Withdrawal by Subject|1
2437528|NCT03148691|8367714|P3|Overall Study|Other|0
2437529|NCT03148691|8367715|P2|Overall Study|Other|0
2437530|NCT03148691|8367716|P1|Overall Study|Other|1
2437531|NCT03148691|8367714|P3|Overall Study|Lost to Follow-up|1
2437532|NCT03148691|8367715|P2|Overall Study|Lost to Follow-up|0
2437533|NCT03148691|8367716|P1|Overall Study|Lost to Follow-up|0
2437534|NCT03148691|8367714|P3|Overall Study|Protocol Violation|7
2437535|NCT03148691|8367715|P2|Overall Study|Protocol Violation|2
2437536|NCT03148691|8367716|P1|Overall Study|Protocol Violation|1
2437537|NCT03148067|8367779|P1|Overall Study|Death|1
2437538|NCT03148067|8367779|P1|Overall Study|Lost to Follow-up|3
2437539|NCT03147248|8367790|P6|Overall Study|Prolonged Dosing Interval|1
2437540|NCT03147248|8367791|P5|Overall Study|Prolonged Dosing Interval|1
2437541|NCT03147248|8367792|P4|Overall Study|Prolonged Dosing Interval|0
2437542|NCT03147248|8367793|P3|Overall Study|Prolonged Dosing Interval|0
2437543|NCT03147248|8367794|P2|Overall Study|Prolonged Dosing Interval|0
2437544|NCT03147248|8367795|P1|Overall Study|Prolonged Dosing Interval|0
2437545|NCT03147248|8367790|P6|Overall Study|Physician Decision|4
2437546|NCT03147248|8367791|P5|Overall Study|Physician Decision|2
2437547|NCT03147248|8367792|P4|Overall Study|Physician Decision|0
2437548|NCT03147248|8367793|P3|Overall Study|Physician Decision|0
2437549|NCT03147248|8367794|P2|Overall Study|Physician Decision|0
2437550|NCT03147248|8367795|P1|Overall Study|Physician Decision|0
2437551|NCT03147248|8367790|P6|Overall Study|Death|4
2437552|NCT03147248|8367791|P5|Overall Study|Death|0
2437553|NCT03147248|8367792|P4|Overall Study|Death|0
2437554|NCT03147248|8367793|P3|Overall Study|Death|0
2437555|NCT03147248|8367794|P2|Overall Study|Death|0
2437556|NCT03147248|8367795|P1|Overall Study|Death|0
2437557|NCT03147248|8367790|P6|Overall Study|Pregnancy|0
2437558|NCT03147248|8367791|P5|Overall Study|Pregnancy|1
2437559|NCT03147248|8367792|P4|Overall Study|Pregnancy|0
2437561|NCT03147248|8367794|P2|Overall Study|Pregnancy|0
2437562|NCT03147248|8367795|P1|Overall Study|Pregnancy|0
2437563|NCT03147248|8367790|P6|Overall Study|Lost to Follow-up|0
2437564|NCT03147248|8367791|P5|Overall Study|Lost to Follow-up|2
2437565|NCT03147248|8367792|P4|Overall Study|Lost to Follow-up|0
2437566|NCT03147248|8367793|P3|Overall Study|Lost to Follow-up|0
2437567|NCT03147248|8367794|P2|Overall Study|Lost to Follow-up|0
2437568|NCT03147248|8367795|P1|Overall Study|Lost to Follow-up|0
2437569|NCT03147248|8367790|P6|Overall Study|Protocol Violation|0
2437570|NCT03147248|8367791|P5|Overall Study|Protocol Violation|2
2437571|NCT03147248|8367792|P4|Overall Study|Protocol Violation|0
2437572|NCT03147248|8367793|P3|Overall Study|Protocol Violation|0
2437573|NCT03147248|8367794|P2|Overall Study|Protocol Violation|0
2437574|NCT03147248|8367795|P1|Overall Study|Protocol Violation|0
2437575|NCT03147248|8367790|P6|Overall Study|Withdrawal by Subject|9
2437576|NCT03147248|8367791|P5|Overall Study|Withdrawal by Subject|12
2437577|NCT03147248|8367792|P4|Overall Study|Withdrawal by Subject|0
2437578|NCT03147248|8367793|P3|Overall Study|Withdrawal by Subject|0
2437579|NCT03147248|8367794|P2|Overall Study|Withdrawal by Subject|0
2437580|NCT03147248|8367795|P1|Overall Study|Withdrawal by Subject|0
2437581|NCT03147248|8367790|P6|Overall Study|Disease progression|2
2437582|NCT03147248|8367791|P5|Overall Study|Disease progression|0
2437583|NCT03147248|8367792|P4|Overall Study|Disease progression|0
2437584|NCT03147248|8367793|P3|Overall Study|Disease progression|0
2437585|NCT03147248|8367794|P2|Overall Study|Disease progression|0
2437586|NCT03147248|8367795|P1|Overall Study|Disease progression|1
2437587|NCT03147248|8367790|P6|Overall Study|Adverse Event|11
2437588|NCT03147248|8367791|P5|Overall Study|Adverse Event|6
2437589|NCT03147248|8367792|P4|Overall Study|Adverse Event|2
2437590|NCT03147248|8367793|P3|Overall Study|Adverse Event|2
2437591|NCT03147248|8367794|P2|Overall Study|Adverse Event|2
2437592|NCT03147248|8367795|P1|Overall Study|Adverse Event|0
2437593|NCT03146741|8367817|P1|Overall Study|Awaiting txp|2
2437594|NCT03146741|8367817|P1|Overall Study|Physician Decision|2
2437595|NCT03146741|8367817|P1|Overall Study|Listeted for MOT|2
2437596|NCT03146741|8367817|P1|Overall Study|Txp with non-HCV+ heart|4
2437597|NCT03146403|8367837|P2|Overall Study|Lost to Follow-up|0
2437598|NCT03146403|8367838|P1|Overall Study|Lost to Follow-up|2
2437599|NCT03146403|8367837|P2|Overall Study|Withdrawal by Subject|3
2437600|NCT03146403|8367838|P1|Overall Study|Withdrawal by Subject|0
2437601|NCT03144180|8367882|P2|Overall Study|Scrub tech removed tube cap|1
2437602|NCT03144180|8367883|P1|Overall Study|Scrub tech removed tube cap|0
2437603|NCT03144180|8367882|P2|Overall Study|Provider forgot to use the Q-cup|1
2437604|NCT03144180|8367883|P1|Overall Study|Provider forgot to use the Q-cup|0
2437605|NCT03144180|8367882|P2|Overall Study|Provider forgot to fill out forms|3
2437606|NCT03144180|8367883|P1|Overall Study|Provider forgot to fill out forms|1
2437607|NCT03144180|8367882|P2|Overall Study|STAT Delivery|1
2437608|NCT03144180|8367883|P1|Overall Study|STAT Delivery|1
2437609|NCT03143166|8367918|P1|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1
2437610|NCT03143101|8367937|P3|Overall Study|Lost to Follow-up|0
2437611|NCT03143101|8367938|P2|Overall Study|Lost to Follow-up|2
2437612|NCT03143101|8367939|P1|Overall Study|Lost to Follow-up|2
2437613|NCT03143101|8367937|P3|Overall Study|Withdrawal by Subject|0
2437614|NCT03143101|8367938|P2|Overall Study|Withdrawal by Subject|1
2437615|NCT03143101|8367939|P1|Overall Study|Withdrawal by Subject|0
2437616|NCT03142932|8367994|P2|Overall Study|Lost to Follow-up|11
2437617|NCT03142932|8367995|P1|Overall Study|Lost to Follow-up|2
2437618|NCT03142750|8368011|P2|Overall Study|Lost to Follow-up|1
2437619|NCT03142750|8368012|P1|Overall Study|Lost to Follow-up|4
2437620|NCT03141307|8368089|P2|Follow-Up|Lost to Follow-up|54
2437621|NCT03141307|8368090|P1|Follow-Up|Lost to Follow-up|97
2437622|NCT03141307|8368089|P2|In-Hospital|Protocol Violation|0
2437623|NCT03141307|8368090|P1|In-Hospital|Protocol Violation|4
2437624|NCT03141307|8368089|P2|In-Hospital|Withdrawal by Subject|2
2437625|NCT03141307|8368090|P1|In-Hospital|Withdrawal by Subject|0
2437626|NCT03141151|8368108|P2|Overall Study|Withdrawal by Subject|2
2437627|NCT03141151|8368109|P1|Overall Study|Withdrawal by Subject|3
2437628|NCT03141151|8368108|P2|Overall Study|Lost to Follow-up|2
2437629|NCT03141151|8368109|P1|Overall Study|Lost to Follow-up|3
2437630|NCT03141086|8368127|P2|Overall Study|Adverse Event|2
2437631|NCT03141086|8368128|P1|Overall Study|Adverse Event|0
2437632|NCT03141086|8368127|P2|Overall Study|Protocol Violation|1
2437633|NCT03141086|8368128|P1|Overall Study|Protocol Violation|0
2437634|NCT03141086|8368127|P2|Overall Study|Withdrawal by Subject|1
2437635|NCT03141086|8368128|P1|Overall Study|Withdrawal by Subject|0
2437636|NCT03141086|8368127|P2|Overall Study|Study Terminated By Sponsor|1
2437637|NCT03141086|8368128|P1|Overall Study|Study Terminated By Sponsor|1
2437638|NCT03139552|8368203|P1|Overall Study|unable to attend tasting due to schedule|3
2437639|NCT03139448|8368246|P2|Overall Study|Physician Decision|2
2437640|NCT03139448|8368247|P1|Overall Study|Physician Decision|0
2437641|NCT03139448|8368246|P2|Overall Study|Screen fail|3
2437642|NCT03139448|8368247|P1|Overall Study|Screen fail|1
2437643|NCT03139448|8368246|P2|Overall Study|Withdrawal by Subject|6
2437644|NCT03139448|8368247|P1|Overall Study|Withdrawal by Subject|3
2437645|NCT03139448|8368246|P2|Overall Study|Location of procedure changed|8
2437646|NCT03139448|8368247|P1|Overall Study|Location of procedure changed|2
2437647|NCT03139448|8368246|P2|Overall Study|Lack of Efficacy|7
2437648|NCT03139448|8368247|P1|Overall Study|Lack of Efficacy|6
2437649|NCT03139279|8368271|P2|Overall Study|Withdrawal by Subject|2
2437650|NCT03139279|8368272|P1|Overall Study|Withdrawal by Subject|0
2437651|NCT03139279|8368271|P2|Overall Study|Protocol Violation|4
2437652|NCT03139279|8368272|P1|Overall Study|Protocol Violation|5
2437653|NCT03139279|8368271|P2|Overall Study|Physician Decision|0
2437654|NCT03139279|8368272|P1|Overall Study|Physician Decision|2
2437655|NCT03139240|8368290|P4|Overall Study|Lost to Follow-up|0
2437656|NCT03139240|8368291|P3|Overall Study|Lost to Follow-up|1
2437657|NCT03139240|8368292|P2|Overall Study|Lost to Follow-up|1
2437658|NCT03139240|8368293|P1|Overall Study|Lost to Follow-up|0
2437659|NCT03138967|8368305|P2|Overall Study|Physician Decision|3
2437660|NCT03138967|8368306|P1|Overall Study|Physician Decision|1
2437661|NCT03138967|8368305|P2|Overall Study|Death|1
2437662|NCT03138967|8368306|P1|Overall Study|Death|0
2437663|NCT03137784|8368365|P6|Overall Study|Non-compliance with study treatment|0
2437664|NCT03137784|8368366|P5|Overall Study|Non-compliance with study treatment|1
2437665|NCT03137784|8368367|P4|Overall Study|Non-compliance with study treatment|0
2437666|NCT03137784|8368368|P3|Overall Study|Non-compliance with study treatment|0
2437667|NCT03137784|8368369|P2|Overall Study|Non-compliance with study treatment|0
2437668|NCT03137784|8368370|P1|Overall Study|Non-compliance with study treatment|0
2437669|NCT03137784|8368365|P6|Overall Study|Subject/guardian decision|0
2437670|NCT03137784|8368366|P5|Overall Study|Subject/guardian decision|0
2437671|NCT03137784|8368367|P4|Overall Study|Subject/guardian decision|0
2437672|NCT03137784|8368368|P3|Overall Study|Subject/guardian decision|0
2437673|NCT03137784|8368369|P2|Overall Study|Subject/guardian decision|0
2437674|NCT03137784|8368370|P1|Overall Study|Subject/guardian decision|1
2437675|NCT03137784|8368365|P6|Overall Study|Adverse Event|0
2437676|NCT03137784|8368366|P5|Overall Study|Adverse Event|0
2437677|NCT03137784|8368367|P4|Overall Study|Adverse Event|0
2437678|NCT03137784|8368368|P3|Overall Study|Adverse Event|0
2437679|NCT03137784|8368369|P2|Overall Study|Adverse Event|1
2437680|NCT03137784|8368370|P1|Overall Study|Adverse Event|1
2437681|NCT03136861|8368427|P7|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
2437682|NCT03136861|8368428|P6|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
2437683|NCT03136861|8368429|P5|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
2437684|NCT03136861|8368430|P4|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
2437685|NCT03136861|8368431|P3|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1
2437686|NCT03136861|8368432|P2|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
2437687|NCT03136861|8368433|P1|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
2437688|NCT03136861|8368427|P7|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
2437689|NCT03136861|8368428|P6|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
2437690|NCT03136861|8368429|P5|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
2437691|NCT03136861|8368430|P4|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
2437692|NCT03136861|8368431|P3|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1
2437693|NCT03136861|8368432|P2|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
2437694|NCT03136861|8368433|P1|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
2437695|NCT03136861|8368427|P7|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1
2437696|NCT03136861|8368428|P6|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
2437697|NCT03136861|8368429|P5|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2
2437698|NCT03136861|8368430|P4|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1
2437699|NCT03136861|8368431|P3|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
2437700|NCT03136861|8368432|P2|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
2437701|NCT03136861|8368433|P1|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
2437702|NCT03136861|8368427|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
2437703|NCT03136861|8368428|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
2437704|NCT03136861|8368429|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
2437705|NCT03136861|8368430|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
2437706|NCT03136861|8368431|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
2437707|NCT03136861|8368432|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1
2437708|NCT03136861|8368433|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1
2437709|NCT03136861|8368427|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
2437710|NCT03136861|8368428|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
2437711|NCT03136861|8368429|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
2437712|NCT03136861|8368430|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
2437713|NCT03136861|8368431|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
2437714|NCT03136861|8368432|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1
2437715|NCT03136861|8368433|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
2437716|NCT03136861|8368427|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
2437717|NCT03136861|8368428|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
2437718|NCT03136861|8368429|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
2437719|NCT03136861|8368430|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
2437720|NCT03136861|8368431|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
2437721|NCT03136861|8368432|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1
2437722|NCT03136861|8368433|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2
2437723|NCT03136861|8368427|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
2437724|NCT03136861|8368428|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
2437725|NCT03136861|8368429|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
2437726|NCT03136861|8368430|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
2437727|NCT03136861|8368431|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
2437728|NCT03136861|8368432|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1
2437729|NCT03136861|8368433|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1
2437730|NCT03136861|8368427|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
2437731|NCT03136861|8368428|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
2437732|NCT03136861|8368429|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
2437733|NCT03136861|8368430|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
2437734|NCT03136861|8368431|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
2437735|NCT03136861|8368432|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2
2437736|NCT03136861|8368433|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3
2437737|NCT03136484|8368448|P2|Overall Study|Death|0
2437738|NCT03136484|8368449|P1|Overall Study|Death|1
2437739|NCT03136484|8368448|P2|Overall Study|Lost to Follow-up|8
2437740|NCT03136484|8368449|P1|Overall Study|Lost to Follow-up|7
2437741|NCT03136484|8368448|P2|Overall Study|Withdrawal by Subject|14
2437742|NCT03136484|8368449|P1|Overall Study|Withdrawal by Subject|19
2437743|NCT03136380|8368577|P5|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
2437744|NCT03136380|8368578|P4|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
2437745|NCT03136380|8368579|P3|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
2437746|NCT03136380|8368580|P2|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1
2437747|NCT03136380|8368581|P1|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
2437748|NCT03136107|8368760|P1|Overall Study|Other (Not specified)|1
2437749|NCT03136068|8368770|P2|Overall Study|Protocol Violation|0
2437750|NCT03136068|8368771|P1|Overall Study|Protocol Violation|1
2437751|NCT03136068|8368770|P2|Overall Study|Lost to Follow-up|1
2437752|NCT03136068|8368771|P1|Overall Study|Lost to Follow-up|1
2437753|NCT03135899|8368793|P8|Overall Study|Withdrawal by Subject|0
2437754|NCT03135899|8368794|P7|Overall Study|Withdrawal by Subject|0
2437755|NCT03135899|8368795|P6|Overall Study|Withdrawal by Subject|2
2437756|NCT03135899|8368796|P5|Overall Study|Withdrawal by Subject|0
2437757|NCT03135899|8368797|P4|Overall Study|Withdrawal by Subject|0
2437758|NCT03135899|8368798|P3|Overall Study|Withdrawal by Subject|0
2437759|NCT03135899|8368799|P2|Overall Study|Withdrawal by Subject|0
2437760|NCT03135899|8368800|P1|Overall Study|Withdrawal by Subject|0
2437761|NCT03135899|8368793|P8|Overall Study|Failed spirometry,unable to repeat visit|0
2437762|NCT03135899|8368794|P7|Overall Study|Failed spirometry,unable to repeat visit|1
2437763|NCT03135899|8368795|P6|Overall Study|Failed spirometry,unable to repeat visit|0
2437764|NCT03135899|8368796|P5|Overall Study|Failed spirometry,unable to repeat visit|0
2437765|NCT03135899|8368797|P4|Overall Study|Failed spirometry,unable to repeat visit|0
2437766|NCT03135899|8368798|P3|Overall Study|Failed spirometry,unable to repeat visit|0
2437767|NCT03135899|8368799|P2|Overall Study|Failed spirometry,unable to repeat visit|0
2437768|NCT03135899|8368800|P1|Overall Study|Failed spirometry,unable to repeat visit|0
2437769|NCT03135548|8368833|P3|Overall Study|Other than listed|2
2437770|NCT03135548|8368834|P2|Overall Study|Other than listed|2
2437771|NCT03135548|8368835|P1|Overall Study|Other than listed|0
2437772|NCT03135548|8368833|P3|Overall Study|Withdrawal by Subject|1
2437773|NCT03135548|8368834|P2|Overall Study|Withdrawal by Subject|2
2437774|NCT03135548|8368835|P1|Overall Study|Withdrawal by Subject|2
2437775|NCT03135548|8368833|P3|Overall Study|Lost to Follow-up|0
2437776|NCT03135548|8368834|P2|Overall Study|Lost to Follow-up|0
2437777|NCT03135548|8368835|P1|Overall Study|Lost to Follow-up|3
2437778|NCT03135431|8368865|P2|Overall Study|Study Surgeon not available|0
2437779|NCT03135431|8368866|P1|Overall Study|Study Surgeon not available|2
2437780|NCT03135028|8368887|P1|Overall Study|Withdrew Consent|1
2437781|NCT03135028|8368887|P1|Overall Study|Study Terminated by Sponsor|2
2437782|NCT03135028|8368887|P1|Overall Study|Death|6
2437783|NCT03134911|8369004|P1|Overall Study|Not meeting inclusion/exclusion criteria|3
2437784|NCT03134911|8369004|P1|Overall Study|Screen failure|31
2437785|NCT03134599|8369037|P6|Week 3|Lost to Follow-up|1
2437786|NCT03134599|8369038|P5|Week 3|Lost to Follow-up|0
2437787|NCT03134599|8369039|P4|Week 3|Lost to Follow-up|1
2437788|NCT03134599|8369040|P3|Week 3|Lost to Follow-up|0
2437789|NCT03134599|8369041|P2|Week 3|Lost to Follow-up|0
2437790|NCT03134599|8369042|P1|Week 3|Lost to Follow-up|0
2437791|NCT03134599|8369037|P6|Week 2|Lost to Follow-up|0
2437792|NCT03134599|8369038|P5|Week 2|Lost to Follow-up|1
2437793|NCT03134599|8369039|P4|Week 2|Lost to Follow-up|1
2437794|NCT03134599|8369040|P3|Week 2|Lost to Follow-up|0
2437795|NCT03134599|8369041|P2|Week 2|Lost to Follow-up|0
2437796|NCT03134599|8369042|P1|Week 2|Lost to Follow-up|1
2437797|NCT03134599|8369037|P6|Week 1|Lost to Follow-up|0
2437798|NCT03134599|8369038|P5|Week 1|Lost to Follow-up|1
2437799|NCT03134599|8369039|P4|Week 1|Lost to Follow-up|0
2437800|NCT03134599|8369040|P3|Week 1|Lost to Follow-up|0
2437801|NCT03134599|8369041|P2|Week 1|Lost to Follow-up|0
2437802|NCT03134599|8369042|P1|Week 1|Lost to Follow-up|0
2437803|NCT03134222|8369082|P3|Overall Study|Randomized but not treated|1
2437804|NCT03134222|8369083|P2|Overall Study|Randomized but not treated|1
2437805|NCT03134222|8369084|P1|Overall Study|Randomized but not treated|0
2437806|NCT03134222|8369082|P3|Overall Study|Still on the study|3
2437807|NCT03134222|8369083|P2|Overall Study|Still on the study|4
2437808|NCT03134222|8369084|P1|Overall Study|Still on the study|3
2437809|NCT03134222|8369082|P3|Overall Study|Lack of Efficacy|0
2437810|NCT03134222|8369083|P2|Overall Study|Lack of Efficacy|0
2437811|NCT03134222|8369084|P1|Overall Study|Lack of Efficacy|1
2437812|NCT03134222|8369082|P3|Overall Study|Investigator's Discretion|1
2437813|NCT03134222|8369083|P2|Overall Study|Investigator's Discretion|0
2437814|NCT03134222|8369084|P1|Overall Study|Investigator's Discretion|0
2437815|NCT03134222|8369082|P3|Overall Study|Withdrew Consent|1
2437816|NCT03134222|8369083|P2|Overall Study|Withdrew Consent|3
2437817|NCT03134222|8369084|P1|Overall Study|Withdrew Consent|0
2437818|NCT03134222|8369082|P3|Overall Study|Lost to Follow-up|1
2437819|NCT03134222|8369083|P2|Overall Study|Lost to Follow-up|2
2437820|NCT03134222|8369084|P1|Overall Study|Lost to Follow-up|1
2437821|NCT03134222|8369082|P3|Overall Study|Adverse Event|0
2437822|NCT03134222|8369083|P2|Overall Study|Adverse Event|1
2437823|NCT03134222|8369084|P1|Overall Study|Adverse Event|4
2437824|NCT03134183|8369100|P2|Overall Study|Withdrawal by Subject|1
2437825|NCT03134183|8369101|P1|Overall Study|Withdrawal by Subject|1
2437826|NCT03133767|8369111|P2|Overall Study|Protocol Violation|1
2437827|NCT03133767|8369112|P1|Overall Study|Protocol Violation|0
2437828|NCT03133767|8369111|P2|Overall Study|Lost to Follow-up|24
2437829|NCT03133767|8369112|P1|Overall Study|Lost to Follow-up|38
2437830|NCT03133481|8369128|P2|Overall Study|FC Catheter fell out post operative day1|4
2437831|NCT03133481|8369129|P1|Overall Study|FC Catheter fell out post operative day1|0
2437832|NCT03132220|8369205|P2|Overall Study|Withdrawal by Subject|4
2437833|NCT03132220|8369206|P1|Overall Study|Withdrawal by Subject|1
2437834|NCT03132220|8369205|P2|Overall Study|Lost to Follow-up|8
2437835|NCT03132220|8369206|P1|Overall Study|Lost to Follow-up|17
2437836|NCT03131999|8369234|P2|Overall Study|Withdrawal by Subject|1
2437837|NCT03131999|8369235|P1|Overall Study|Withdrawal by Subject|0
2437838|NCT03131895|8369245|P4|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
2437839|NCT03131895|8369246|P3|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
2437840|NCT03131895|8369247|P2|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
2437841|NCT03131895|8369248|P1|Intervention Period 2 (2 Days)|Withdrawal by Subject|1
2437842|NCT03131895|8369245|P4|Intervention Period 2 (2 Days)|Lost to Follow-up|0
2437843|NCT03131895|8369246|P3|Intervention Period 2 (2 Days)|Lost to Follow-up|0
2437844|NCT03131895|8369247|P2|Intervention Period 2 (2 Days)|Lost to Follow-up|1
2437845|NCT03131895|8369248|P1|Intervention Period 2 (2 Days)|Lost to Follow-up|0
2437846|NCT03131895|8369245|P4|Washout Period (at Least 5 Days)|Other|0
2437847|NCT03131895|8369246|P3|Washout Period (at Least 5 Days)|Other|2
2437848|NCT03131895|8369247|P2|Washout Period (at Least 5 Days)|Other|0
2437849|NCT03131895|8369248|P1|Washout Period (at Least 5 Days)|Other|0
2437850|NCT03131895|8369245|P4|Washout Period (at Least 5 Days)|Withdrawal by Subject|1
2437851|NCT03131895|8369246|P3|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2437852|NCT03131895|8369247|P2|Washout Period (at Least 5 Days)|Withdrawal by Subject|2
2437853|NCT03131895|8369248|P1|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
2437854|NCT03131895|8369245|P4|Washout Period (at Least 5 Days)|Lost to Follow-up|3
2437855|NCT03131895|8369246|P3|Washout Period (at Least 5 Days)|Lost to Follow-up|2
2437856|NCT03131895|8369247|P2|Washout Period (at Least 5 Days)|Lost to Follow-up|3
2437857|NCT03131895|8369248|P1|Washout Period (at Least 5 Days)|Lost to Follow-up|0
2437858|NCT03131895|8369245|P4|Washout Period (at Least 5 Days)|Adverse Event|1
2437859|NCT03131895|8369246|P3|Washout Period (at Least 5 Days)|Adverse Event|0
2437860|NCT03131895|8369247|P2|Washout Period (at Least 5 Days)|Adverse Event|0
2437861|NCT03131895|8369248|P1|Washout Period (at Least 5 Days)|Adverse Event|1
2437862|NCT03131713|8369268|P2|Overall Study|Lost to Follow-up|0
2437863|NCT03131713|8369269|P1|Overall Study|Lost to Follow-up|5
2437864|NCT03131687|8369293|P6|Overall Study|Inadvertent Enrollment|0
2437865|NCT03131687|8369294|P5|Overall Study|Inadvertent Enrollment|0
2437866|NCT03131687|8369295|P4|Overall Study|Inadvertent Enrollment|1
2437867|NCT03131687|8369296|P3|Overall Study|Inadvertent Enrollment|0
2437868|NCT03131687|8369297|P2|Overall Study|Inadvertent Enrollment|0
2437869|NCT03131687|8369298|P1|Overall Study|Inadvertent Enrollment|0
2437870|NCT03131687|8369293|P6|Overall Study|Principle Investigator Decision|0
2437871|NCT03131687|8369294|P5|Overall Study|Principle Investigator Decision|0
2437872|NCT03131687|8369295|P4|Overall Study|Principle Investigator Decision|0
2437873|NCT03131687|8369296|P3|Overall Study|Principle Investigator Decision|0
2437874|NCT03131687|8369297|P2|Overall Study|Principle Investigator Decision|1
2437875|NCT03131687|8369298|P1|Overall Study|Principle Investigator Decision|0
2437876|NCT03131687|8369293|P6|Overall Study|Participant Started New Diabetic Drug|0
2437877|NCT03131687|8369294|P5|Overall Study|Participant Started New Diabetic Drug|0
2437878|NCT03131687|8369295|P4|Overall Study|Participant Started New Diabetic Drug|0
2437879|NCT03131687|8369296|P3|Overall Study|Participant Started New Diabetic Drug|0
2437880|NCT03131687|8369297|P2|Overall Study|Participant Started New Diabetic Drug|0
2437881|NCT03131687|8369298|P1|Overall Study|Participant Started New Diabetic Drug|1
2437882|NCT03131687|8369293|P6|Overall Study|Lost to Follow-up|2
2437883|NCT03131687|8369294|P5|Overall Study|Lost to Follow-up|4
2437884|NCT03131687|8369295|P4|Overall Study|Lost to Follow-up|1
2437885|NCT03131687|8369296|P3|Overall Study|Lost to Follow-up|0
2437886|NCT03131687|8369297|P2|Overall Study|Lost to Follow-up|4
2437887|NCT03131687|8369298|P1|Overall Study|Lost to Follow-up|1
2437888|NCT03131687|8369293|P6|Overall Study|Withdrawal by Subject|1
2437889|NCT03131687|8369294|P5|Overall Study|Withdrawal by Subject|2
2437890|NCT03131687|8369295|P4|Overall Study|Withdrawal by Subject|1
2437891|NCT03131687|8369296|P3|Overall Study|Withdrawal by Subject|3
2437892|NCT03131687|8369297|P2|Overall Study|Withdrawal by Subject|3
2437893|NCT03131687|8369298|P1|Overall Study|Withdrawal by Subject|3
2437894|NCT03131687|8369293|P6|Overall Study|Death|0
2437895|NCT03131687|8369294|P5|Overall Study|Death|0
2437896|NCT03131687|8369295|P4|Overall Study|Death|0
2437897|NCT03131687|8369296|P3|Overall Study|Death|0
2437898|NCT03131687|8369297|P2|Overall Study|Death|0
2437899|NCT03131687|8369298|P1|Overall Study|Death|1
2437900|NCT03131687|8369293|P6|Overall Study|Adverse Event|2
2437901|NCT03131687|8369294|P5|Overall Study|Adverse Event|2
2437902|NCT03131687|8369295|P4|Overall Study|Adverse Event|1
2437903|NCT03131687|8369296|P3|Overall Study|Adverse Event|0
2437904|NCT03131687|8369297|P2|Overall Study|Adverse Event|1
2437905|NCT03131687|8369298|P1|Overall Study|Adverse Event|0
2437906|NCT03131596|8369408|P2|Overall Study|Lost to Follow-up|0
2437907|NCT03131596|8369409|P1|Overall Study|Lost to Follow-up|3
2437908|NCT03131596|8369408|P2|Overall Study|Protocol Violation|3
2437909|NCT03131596|8369409|P1|Overall Study|Protocol Violation|3
2437910|NCT03131479|8369426|P5|Overall Study|Subject/Guardian Decision|0
2437911|NCT03131479|8369427|P4|Overall Study|Subject/Guardian Decision|1
2437912|NCT03131479|8369428|P3|Overall Study|Subject/Guardian Decision|0
2437913|NCT03131479|8369429|P2|Overall Study|Subject/Guardian Decision|0
2437914|NCT03131479|8369430|P1|Overall Study|Subject/Guardian Decision|0
2437915|NCT03131479|8369426|P5|Overall Study|Adverse Event|0
2437916|NCT03131479|8369427|P4|Overall Study|Adverse Event|1
2437917|NCT03131479|8369428|P3|Overall Study|Adverse Event|1
2437918|NCT03131479|8369429|P2|Overall Study|Adverse Event|0
2437919|NCT03131479|8369430|P1|Overall Study|Adverse Event|0
2437920|NCT03131167|8369525|P13|Overall Study|Other (Unspecified)|0
2437921|NCT03131167|8369526|P12|Overall Study|Other (Unspecified)|0
2437922|NCT03131167|8369527|P11|Overall Study|Other (Unspecified)|0
2437923|NCT03131167|8369528|P10|Overall Study|Other (Unspecified)|0
2437924|NCT03131167|8369529|P9|Overall Study|Other (Unspecified)|0
2437925|NCT03131167|8369530|P8|Overall Study|Other (Unspecified)|0
2437926|NCT03131167|8369531|P7|Overall Study|Other (Unspecified)|0
2437927|NCT03131167|8369532|P6|Overall Study|Other (Unspecified)|1
2437928|NCT03131167|8369533|P5|Overall Study|Other (Unspecified)|0
2437929|NCT03131167|8369534|P4|Overall Study|Other (Unspecified)|0
2437930|NCT03131167|8369535|P3|Overall Study|Other (Unspecified)|0
2437931|NCT03131167|8369536|P2|Overall Study|Other (Unspecified)|0
2437932|NCT03131167|8369537|P1|Overall Study|Other (Unspecified)|0
2437933|NCT03128723|8369624|P1|Overall Study|Withdrawal by Subject|2
2437934|NCT03128307|8369643|P1|Overall Study|Withdrawal by Subject|5
2437935|NCT03128307|8369643|P1|Overall Study|Lost to Follow-up|29
2437936|NCT03128099|8369651|P3|Overall Study|Did not complete all the assessments|1
2437937|NCT03128099|8369652|P2|Overall Study|Did not complete all the assessments|0
2437938|NCT03128099|8369653|P1|Overall Study|Did not complete all the assessments|0
2437939|NCT03128099|8369651|P3|Overall Study|Became homeless and lost contact|0
2437940|NCT03128099|8369652|P2|Overall Study|Became homeless and lost contact|0
2437941|NCT03128099|8369653|P1|Overall Study|Became homeless and lost contact|1
2437942|NCT03128099|8369651|P3|Overall Study|Participant got a full time job.|0
2437943|NCT03128099|8369652|P2|Overall Study|Participant got a full time job.|0
2437944|NCT03128099|8369653|P1|Overall Study|Participant got a full time job.|1
2437945|NCT03128099|8369651|P3|Overall Study|High dose task was too long|0
2437946|NCT03128099|8369652|P2|Overall Study|High dose task was too long|4
2437947|NCT03128099|8369653|P1|Overall Study|High dose task was too long|0
2437948|NCT03127644|8369680|P3|Overall Study|Study-specific withdrawal criteria|2
2437949|NCT03127644|8369681|P2|Overall Study|Study-specific withdrawal criteria|0
2437950|NCT03127644|8369682|P1|Overall Study|Study-specific withdrawal criteria|0
2437951|NCT03127384|8369714|P1|Overall Study|Subject request|2
2437952|NCT03127384|8369714|P1|Overall Study|Lost to Follow-up|4
2437953|NCT03126539|8369750|P5|Overall Study|Lost to Follow-up|0
2437954|NCT03126539|8369751|P4|Overall Study|Lost to Follow-up|0
2437955|NCT03126539|8369752|P3|Overall Study|Lost to Follow-up|1
2437956|NCT03126539|8369753|P2|Overall Study|Lost to Follow-up|1
2437957|NCT03126539|8369754|P1|Overall Study|Lost to Follow-up|1
2437958|NCT03125941|8369782|P2|Overall Study|did not receive intervention|2
2437959|NCT03125941|8369783|P1|Overall Study|did not receive intervention|1
2437960|NCT03125915|8369819|P4|6 Month Follow-up|Lost to Follow-up|3
2437961|NCT03125915|8369820|P3|6 Month Follow-up|Lost to Follow-up|6
2437962|NCT03125915|8369821|P2|6 Month Follow-up|Lost to Follow-up|3
2437963|NCT03125915|8369822|P1|6 Month Follow-up|Lost to Follow-up|7
2437964|NCT03125915|8369819|P4|3 Month Follow-up|Lost to Follow-up|2
2437965|NCT03125915|8369820|P3|3 Month Follow-up|Lost to Follow-up|4
2437966|NCT03125915|8369821|P2|3 Month Follow-up|Lost to Follow-up|4
2437967|NCT03125915|8369822|P1|3 Month Follow-up|Lost to Follow-up|6
2437968|NCT03125915|8369819|P4|1 Month Follow up|Lost to Follow-up|3
2437969|NCT03125915|8369820|P3|1 Month Follow up|Lost to Follow-up|2
2437970|NCT03125915|8369821|P2|1 Month Follow up|Lost to Follow-up|3
2437971|NCT03125915|8369822|P1|1 Month Follow up|Lost to Follow-up|3
2437972|NCT03125200|8369847|P7|Overall Study|Consent Withdrawn by Subject|1
2437973|NCT03125200|8369848|P6|Overall Study|Consent Withdrawn by Subject|0
2437974|NCT03125200|8369849|P5|Overall Study|Consent Withdrawn by Subject|1
2437975|NCT03125200|8369850|P4|Overall Study|Consent Withdrawn by Subject|0
2437976|NCT03125200|8369851|P3|Overall Study|Consent Withdrawn by Subject|0
2437977|NCT03125200|8369852|P2|Overall Study|Consent Withdrawn by Subject|1
2437978|NCT03125200|8369853|P1|Overall Study|Consent Withdrawn by Subject|0
2437979|NCT03125200|8369847|P7|Overall Study|Toxicity|0
2437980|NCT03125200|8369848|P6|Overall Study|Toxicity|0
2437981|NCT03125200|8369849|P5|Overall Study|Toxicity|0
2437982|NCT03125200|8369850|P4|Overall Study|Toxicity|1
2437983|NCT03125200|8369851|P3|Overall Study|Toxicity|0
2437984|NCT03125200|8369852|P2|Overall Study|Toxicity|0
2437985|NCT03125200|8369853|P1|Overall Study|Toxicity|0
2437986|NCT03125200|8369847|P7|Overall Study|Lack of Efficacy|0
2437987|NCT03125200|8369848|P6|Overall Study|Lack of Efficacy|0
2437988|NCT03125200|8369849|P5|Overall Study|Lack of Efficacy|0
2437989|NCT03125200|8369850|P4|Overall Study|Lack of Efficacy|1
2437990|NCT03125200|8369851|P3|Overall Study|Lack of Efficacy|0
2437991|NCT03125200|8369852|P2|Overall Study|Lack of Efficacy|0
2437992|NCT03125200|8369853|P1|Overall Study|Lack of Efficacy|0
2437993|NCT03125200|8369847|P7|Overall Study|Progressive Disease|1
2437994|NCT03125200|8369848|P6|Overall Study|Progressive Disease|0
2437995|NCT03125200|8369849|P5|Overall Study|Progressive Disease|2
2437996|NCT03125200|8369850|P4|Overall Study|Progressive Disease|1
2437997|NCT03125200|8369851|P3|Overall Study|Progressive Disease|2
2437998|NCT03125200|8369852|P2|Overall Study|Progressive Disease|1
2437999|NCT03125200|8369853|P1|Overall Study|Progressive Disease|2
2438000|NCT03125200|8369847|P7|Overall Study|Clinical Progression|0
2438001|NCT03125200|8369848|P6|Overall Study|Clinical Progression|1
2438002|NCT03125200|8369849|P5|Overall Study|Clinical Progression|0
2438003|NCT03125200|8369850|P4|Overall Study|Clinical Progression|1
2438004|NCT03125200|8369851|P3|Overall Study|Clinical Progression|0
2438005|NCT03125200|8369852|P2|Overall Study|Clinical Progression|0
2438006|NCT03125200|8369853|P1|Overall Study|Clinical Progression|0
2438007|NCT03125200|8369847|P7|Overall Study|Study Termination|1
2438008|NCT03125200|8369848|P6|Overall Study|Study Termination|2
2438009|NCT03125200|8369849|P5|Overall Study|Study Termination|1
2438010|NCT03125200|8369850|P4|Overall Study|Study Termination|1
2438011|NCT03125200|8369851|P3|Overall Study|Study Termination|0
2438012|NCT03125200|8369852|P2|Overall Study|Study Termination|0
2438013|NCT03125200|8369853|P1|Overall Study|Study Termination|0
2438014|NCT03124784|8370093|P1|Overall Study|Computer/Equip Malfunction|1
2438015|NCT03124784|8370093|P1|Overall Study|Adverse Event|1
2438016|NCT03124563|8370115|P2|Overall Study|Withdrawal by Subject|1
2438017|NCT03124563|8370116|P1|Overall Study|Withdrawal by Subject|1
2438018|NCT03124563|8370115|P2|Overall Study|Lost to Follow-up|1
2438019|NCT03124563|8370116|P1|Overall Study|Lost to Follow-up|1
2438020|NCT03124407|8370136|P4|Overall Study|Adverse Event|0
2438021|NCT03124407|8370137|P3|Overall Study|Adverse Event|1
2438022|NCT03124407|8370138|P2|Overall Study|Adverse Event|0
2438023|NCT03124407|8370139|P1|Overall Study|Adverse Event|0
2438024|NCT03124407|8370136|P4|Overall Study|Lost to Follow-up|0
2438025|NCT03124407|8370137|P3|Overall Study|Lost to Follow-up|0
2438026|NCT03124407|8370138|P2|Overall Study|Lost to Follow-up|0
2438027|NCT03124407|8370139|P1|Overall Study|Lost to Follow-up|1
2438028|NCT03124381|8370159|P2|Overall Study|Non-Compliance with Study Treatment|0
2438029|NCT03124381|8370160|P1|Overall Study|Non-Compliance with Study Treatment|1
2438030|NCT03124381|8370159|P2|Overall Study|Adverse Event|1
2438031|NCT03124381|8370160|P1|Overall Study|Adverse Event|1
2438032|NCT03124381|8370159|P2|Overall Study|Protocol Violation|1
2438033|NCT03124381|8370160|P1|Overall Study|Protocol Violation|0
2438034|NCT03124381|8370159|P2|Overall Study|Withdrawal by Subject|3
2438035|NCT03124381|8370160|P1|Overall Study|Withdrawal by Subject|6
2438036|NCT03124381|8370159|P2|Overall Study|Lost to Follow-up|1
2438037|NCT03124381|8370160|P1|Overall Study|Lost to Follow-up|1
2438038|NCT03124199|8370267|P1|Overall Study|Lost to Follow-up|4
2438039|NCT03124108|8370276|P3|Overall Study|Adverse Event|0
2438040|NCT03124108|8370277|P2|Overall Study|Adverse Event|1
2438041|NCT03124108|8370278|P1|Overall Study|Adverse Event|0
2438042|NCT03123471|8370446|P2|Apremilast Extension Phase|Withdrawal by Subject|7
2438043|NCT03123471|8370447|P1|Apremilast Extension Phase|Withdrawal by Subject|3
2438044|NCT03123471|8370446|P2|Apremilast Extension Phase|Lack of Efficacy|8
2438045|NCT03123471|8370447|P1|Apremilast Extension Phase|Lack of Efficacy|2
2438046|NCT03123471|8370446|P2|Apremilast Extension Phase|Adverse Event|5
2438047|NCT03123471|8370447|P1|Apremilast Extension Phase|Adverse Event|1
2438048|NCT03123471|8370446|P2|Apremilast Extension Phase|Lost to Follow-up|5
2438049|NCT03123471|8370447|P1|Apremilast Extension Phase|Lost to Follow-up|2
2438050|NCT03123471|8370446|P2|Placebo-controlled Phase|Miscellaneous|1
2438051|NCT03123471|8370447|P1|Placebo-controlled Phase|Miscellaneous|0
2438052|NCT03123471|8370446|P2|Placebo-controlled Phase|Protocol Deviation|1
2438053|NCT03123471|8370447|P1|Placebo-controlled Phase|Protocol Deviation|2
2438054|NCT03123471|8370446|P2|Placebo-controlled Phase|Lost to Follow-up|3
2438055|NCT03123471|8370447|P1|Placebo-controlled Phase|Lost to Follow-up|1
2438056|NCT03123471|8370446|P2|Placebo-controlled Phase|Non-compliance with Study Drug|0
2438057|NCT03123471|8370447|P1|Placebo-controlled Phase|Non-compliance with Study Drug|3
2438058|NCT03123471|8370446|P2|Placebo-controlled Phase|Withdrawal by Subject|16
2438059|NCT03123471|8370447|P1|Placebo-controlled Phase|Withdrawal by Subject|6
2438060|NCT03123471|8370446|P2|Placebo-controlled Phase|Lack of Efficacy|4
2438061|NCT03123471|8370447|P1|Placebo-controlled Phase|Lack of Efficacy|3
2438062|NCT03123471|8370446|P2|Placebo-controlled Phase|Adverse Event|8
2438063|NCT03123471|8370447|P1|Placebo-controlled Phase|Adverse Event|3
2438064|NCT03123354|8370472|P1|Overall Study|Physician Decision|6
2438065|NCT03122548|8370511|P1|Overall Study|Study Terminated by Sponsor|2
2438066|NCT03122548|8370511|P1|Overall Study|Progression - subject went into hospice|1
2438067|NCT03122548|8370511|P1|Overall Study|Death|2
2438068|NCT03122184|8370521|P2|Overall Study|Terminated due to cognitive problem|0
2438069|NCT03122184|8370522|P1|Overall Study|Terminated due to cognitive problem|1
2438070|NCT03122184|8370521|P2|Overall Study|Withdrawal by Subject|0
2438071|NCT03122184|8370522|P1|Overall Study|Withdrawal by Subject|3
2438072|NCT03122184|8370521|P2|Overall Study|Lost to Follow-up|6
2438073|NCT03122184|8370522|P1|Overall Study|Lost to Follow-up|4
2438074|NCT03122145|8370561|P2|Overall Study|Concurrent respiratory disease|0
2438075|NCT03122145|8370562|P1|Overall Study|Concurrent respiratory disease|3
2438076|NCT03121950|8370572|P2|Overall Study|Withdrawal by Subject|2
2438077|NCT03121950|8370573|P1|Overall Study|Withdrawal by Subject|10
2438078|NCT03120676|8370650|P1|Overall Study|Not treated|1
2438079|NCT03120520|8370658|P4|Overall Study|Other|0
2438080|NCT03120520|8370659|P3|Overall Study|Other|0
2438081|NCT03120520|8370660|P2|Overall Study|Other|1
2438082|NCT03120520|8370661|P1|Overall Study|Other|0
2438083|NCT03120520|8370658|P4|Overall Study|Withdrawal by Subject|2
2438084|NCT03120520|8370659|P3|Overall Study|Withdrawal by Subject|3
2438085|NCT03120520|8370660|P2|Overall Study|Withdrawal by Subject|2
2438086|NCT03120520|8370661|P1|Overall Study|Withdrawal by Subject|3
2438087|NCT03120520|8370658|P4|Overall Study|Lost to Follow-up|1
2438088|NCT03120520|8370659|P3|Overall Study|Lost to Follow-up|1
2438089|NCT03120520|8370660|P2|Overall Study|Lost to Follow-up|1
2438090|NCT03120520|8370661|P1|Overall Study|Lost to Follow-up|1
2438091|NCT03120351|8370685|P2|Overall Study|Physician Decision|1
2438092|NCT03120351|8370686|P1|Overall Study|Physician Decision|1
2438093|NCT03120013|8370692|P2|First Intervention (2 Weeks)|Withdrawal by Subject|1
2438094|NCT03120013|8370693|P1|First Intervention (2 Weeks)|Withdrawal by Subject|0
2438095|NCT03119688|8370735|P1|Overall Study|Adverse Event|4
2438096|NCT03119662|8370768|P2|Overall Study|Withdrawal by Subject|1
2438097|NCT03119662|8370769|P1|Overall Study|Withdrawal by Subject|0
2438098|NCT03118947|8370868|P1|Overall Study|Lost to Follow-up|2
2438099|NCT03118947|8370868|P1|Overall Study|Change in patient's living situation|4
2438100|NCT03118947|8370868|P1|Overall Study|Withdrawal by caregiver|3
2438101|NCT03118947|8370868|P1|Overall Study|Withdrawal by Subject|3
2438102|NCT03118947|8370868|P1|Overall Study|Protocol Violation|2
2438103|NCT03118947|8370868|P1|Overall Study|Non-compliance with study drug|1
2438104|NCT03118947|8370868|P1|Overall Study|Lack of Efficacy|4
2438105|NCT03118947|8370868|P1|Overall Study|Death|3
2438106|NCT03118947|8370868|P1|Overall Study|Adverse Event|7
2438107|NCT03118934|8370875|P6|Overall Study|Discontinued prior to exposure|0
2438108|NCT03118934|8370876|P5|Overall Study|Discontinued prior to exposure|2
2438109|NCT03118934|8370877|P4|Overall Study|Discontinued prior to exposure|1
2438110|NCT03118934|8370878|P3|Overall Study|Discontinued prior to exposure|1
2438111|NCT03118934|8370879|P2|Overall Study|Discontinued prior to exposure|1
2438112|NCT03118934|8370880|P1|Overall Study|Discontinued prior to exposure|0
2438113|NCT03118934|8370875|P6|Overall Study|Physician Decision|1
2438114|NCT03118934|8370876|P5|Overall Study|Physician Decision|0
2438115|NCT03118934|8370877|P4|Overall Study|Physician Decision|0
2438116|NCT03118934|8370878|P3|Overall Study|Physician Decision|0
2438117|NCT03118934|8370879|P2|Overall Study|Physician Decision|0
2438118|NCT03118934|8370880|P1|Overall Study|Physician Decision|0
2438119|NCT03118934|8370875|P6|Overall Study|Adverse Event|1
2438120|NCT03118934|8370876|P5|Overall Study|Adverse Event|0
2438121|NCT03118934|8370877|P4|Overall Study|Adverse Event|0
2438122|NCT03118934|8370878|P3|Overall Study|Adverse Event|0
2438123|NCT03118934|8370879|P2|Overall Study|Adverse Event|0
2438124|NCT03118934|8370880|P1|Overall Study|Adverse Event|0
2438125|NCT03118765|8370904|P5|Overall Study|Sponsor Decision|1
2438126|NCT03118765|8370905|P4|Overall Study|Sponsor Decision|0
2438127|NCT03118765|8370906|P3|Overall Study|Sponsor Decision|1
2438128|NCT03118765|8370907|P2|Overall Study|Sponsor Decision|0
2438129|NCT03118765|8370908|P1|Overall Study|Sponsor Decision|1
2438130|NCT03118765|8370904|P5|Overall Study|Lost to Follow-up|0
2438131|NCT03118765|8370905|P4|Overall Study|Lost to Follow-up|0
2438132|NCT03118765|8370906|P3|Overall Study|Lost to Follow-up|1
2438133|NCT03118765|8370907|P2|Overall Study|Lost to Follow-up|0
2438134|NCT03118765|8370908|P1|Overall Study|Lost to Follow-up|1
2438135|NCT03118765|8370904|P5|Overall Study|COPD Exacerbation|0
2438136|NCT03118765|8370905|P4|Overall Study|COPD Exacerbation|1
2438137|NCT03118765|8370906|P3|Overall Study|COPD Exacerbation|0
2438138|NCT03118765|8370907|P2|Overall Study|COPD Exacerbation|0
2438139|NCT03118765|8370908|P1|Overall Study|COPD Exacerbation|1
2438140|NCT03118765|8370904|P5|Overall Study|Violation of Inclusion/ExclusionCriteria|0
2438141|NCT03118765|8370905|P4|Overall Study|Violation of Inclusion/ExclusionCriteria|0
2438142|NCT03118765|8370906|P3|Overall Study|Violation of Inclusion/ExclusionCriteria|1
2438143|NCT03118765|8370907|P2|Overall Study|Violation of Inclusion/ExclusionCriteria|1
2438144|NCT03118765|8370908|P1|Overall Study|Violation of Inclusion/ExclusionCriteria|0
2438145|NCT03118765|8370904|P5|Overall Study|Non compliance with Study Procedures|0
2438146|NCT03118765|8370905|P4|Overall Study|Non compliance with Study Procedures|1
2438147|NCT03118765|8370906|P3|Overall Study|Non compliance with Study Procedures|0
2438148|NCT03118765|8370907|P2|Overall Study|Non compliance with Study Procedures|0
2438149|NCT03118765|8370908|P1|Overall Study|Non compliance with Study Procedures|0
2438150|NCT03118765|8370904|P5|Overall Study|Adverse Event|1
2438151|NCT03118765|8370905|P4|Overall Study|Adverse Event|1
2438152|NCT03118765|8370906|P3|Overall Study|Adverse Event|1
2438153|NCT03118765|8370907|P2|Overall Study|Adverse Event|1
2438154|NCT03118765|8370908|P1|Overall Study|Adverse Event|1
2438155|NCT03118765|8370904|P5|Overall Study|Withdrawal by Subject|0
2438156|NCT03118765|8370905|P4|Overall Study|Withdrawal by Subject|0
2438157|NCT03118765|8370906|P3|Overall Study|Withdrawal by Subject|1
2438158|NCT03118765|8370907|P2|Overall Study|Withdrawal by Subject|0
2438159|NCT03118765|8370908|P1|Overall Study|Withdrawal by Subject|0
2438160|NCT03118739|8371004|P2|Overall Study|Lost to Follow-up|0
2438161|NCT03118739|8371005|P1|Overall Study|Lost to Follow-up|2
2438162|NCT03118739|8371004|P2|Overall Study|Withdrawal by Subject|3
2438163|NCT03118739|8371005|P1|Overall Study|Withdrawal by Subject|5
2438164|NCT03118739|8371004|P2|Overall Study|Physician Decision|1
2438165|NCT03118739|8371005|P1|Overall Study|Physician Decision|0
2438166|NCT03118297|8371118|P2|Overall Study|Lost to Follow-up|2
2438167|NCT03118297|8371119|P1|Overall Study|Lost to Follow-up|0
2438168|NCT03116698|8371265|P4|Overall Study|Death|0
2438169|NCT03116698|8371266|P3|Overall Study|Death|2
2438170|NCT03116698|8371267|P2|Overall Study|Death|0
2438171|NCT03116698|8371268|P1|Overall Study|Death|0
2438172|NCT03116698|8371265|P4|Overall Study|Protocol Violation|0
2438173|NCT03116698|8371266|P3|Overall Study|Protocol Violation|0
2438174|NCT03116698|8371267|P2|Overall Study|Protocol Violation|0
2438175|NCT03116698|8371268|P1|Overall Study|Protocol Violation|1
2438176|NCT03116698|8371265|P4|Overall Study|Physician Decision|0
2438177|NCT03116698|8371266|P3|Overall Study|Physician Decision|0
2438178|NCT03116698|8371267|P2|Overall Study|Physician Decision|1
2438179|NCT03116698|8371268|P1|Overall Study|Physician Decision|1
2438180|NCT03116698|8371265|P4|Overall Study|Lost to Follow-up|0
2438181|NCT03116698|8371266|P3|Overall Study|Lost to Follow-up|0
2438182|NCT03116698|8371267|P2|Overall Study|Lost to Follow-up|0
2438183|NCT03116698|8371268|P1|Overall Study|Lost to Follow-up|2
2438184|NCT03116698|8371265|P4|Overall Study|Withdrawal by Subject|2
2438185|NCT03116698|8371266|P3|Overall Study|Withdrawal by Subject|5
2438186|NCT03116698|8371267|P2|Overall Study|Withdrawal by Subject|4
2438187|NCT03116698|8371268|P1|Overall Study|Withdrawal by Subject|1
2438188|NCT03116698|8371265|P4|Overall Study|Adverse Event|0
2438189|NCT03116698|8371266|P3|Overall Study|Adverse Event|1
2438190|NCT03116698|8371267|P2|Overall Study|Adverse Event|1
2438191|NCT03116698|8371268|P1|Overall Study|Adverse Event|1
2438192|NCT03115476|8371311|P3|LP0084-1369|Trial terminated by Sponsor|160
2438193|NCT03115476|8371312|P2|LP0084-1369|Trial terminated by Sponsor|210
2438194|NCT03115476|8371313|P1|LP0084-1369|Trial terminated by Sponsor|190
2438195|NCT03115476|8371311|P3|LP0084-1369|Death|2
2438196|NCT03115476|8371312|P2|LP0084-1369|Death|0
2438197|NCT03115476|8371313|P1|LP0084-1369|Death|1
2438198|NCT03114969|8371362|P9|Overall Study|Adverse Event|2
2438199|NCT03114969|8371363|P8|Overall Study|Adverse Event|0
2438200|NCT03114969|8371364|P7|Overall Study|Adverse Event|1
2438201|NCT03114969|8371365|P6|Overall Study|Adverse Event|1
2438202|NCT03114969|8371366|P5|Overall Study|Adverse Event|0
2438203|NCT03114969|8371367|P4|Overall Study|Adverse Event|0
2438204|NCT03114969|8371368|P3|Overall Study|Adverse Event|1
2438205|NCT03114969|8371369|P2|Overall Study|Adverse Event|0
2438206|NCT03114969|8371370|P1|Overall Study|Adverse Event|0
2438207|NCT03114969|8371362|P9|Overall Study|Lost to Follow-up|0
2438208|NCT03114969|8371363|P8|Overall Study|Lost to Follow-up|0
2438209|NCT03114969|8371364|P7|Overall Study|Lost to Follow-up|0
2438210|NCT03114969|8371365|P6|Overall Study|Lost to Follow-up|0
2438211|NCT03114969|8371366|P5|Overall Study|Lost to Follow-up|0
2438212|NCT03114969|8371367|P4|Overall Study|Lost to Follow-up|2
2438213|NCT03114969|8371368|P3|Overall Study|Lost to Follow-up|3
2438214|NCT03114969|8371369|P2|Overall Study|Lost to Follow-up|0
2438215|NCT03114969|8371370|P1|Overall Study|Lost to Follow-up|0
2438216|NCT03114488|8371465|P2|Time Period 2|Withdrawal by Subject|3
2438217|NCT03114488|8371466|P1|Time Period 2|Withdrawal by Subject|1
2438218|NCT03111108|8371525|P2|Overall Study|Withdrawal by Subject|0
2438219|NCT03111108|8371526|P1|Overall Study|Withdrawal by Subject|1
2438220|NCT03111108|8371525|P2|Overall Study|Death|1
2438221|NCT03111108|8371526|P1|Overall Study|Death|0
2438222|NCT03110900|8371544|P2|Overall Study|Sponsor withdrew|1
2438223|NCT03110900|8371545|P1|Overall Study|Sponsor withdrew|1
2438224|NCT03110380|8371569|P2|Overall Study|Lost to Follow-up|1
2438225|NCT03110380|8371570|P1|Overall Study|Lost to Follow-up|4
2438226|NCT03110380|8371569|P2|Overall Study|Withdrew Consent|16
2438227|NCT03110380|8371570|P1|Overall Study|Withdrew Consent|9
2438228|NCT03110380|8371569|P2|Overall Study|Protocol Violation|1
2438229|NCT03110380|8371570|P1|Overall Study|Protocol Violation|0
2438230|NCT03110380|8371569|P2|Overall Study|Non-Compliance with Study Drug|1
2438231|NCT03110380|8371570|P1|Overall Study|Non-Compliance with Study Drug|1
2438232|NCT03110380|8371569|P2|Overall Study|Investigator's Discretion|2
2438233|NCT03110380|8371570|P1|Overall Study|Investigator's Discretion|1
2438234|NCT03110380|8371569|P2|Overall Study|Death|1
2438235|NCT03110380|8371570|P1|Overall Study|Death|2
2438236|NCT03110380|8371569|P2|Overall Study|Adverse Event|3
2438237|NCT03110380|8371570|P1|Overall Study|Adverse Event|3
2438238|NCT03110380|8371569|P2|Overall Study|Still in Study|256
2438239|NCT03110380|8371570|P1|Overall Study|Still in Study|264
2438240|NCT03110380|8371569|P2|Overall Study|Randomized and Never Treated|2
2438241|NCT03110380|8371570|P1|Overall Study|Randomized and Never Treated|0
2438242|NCT03110159|8371580|P1|Overall Study|Study termination|1
2438243|NCT03110029|8371591|P2|Overall Study|Withdrawal by Subject|1
2438244|NCT03110029|8371592|P1|Overall Study|Withdrawal by Subject|1
2438245|NCT03109184|8371666|P2|Overall Study|Withdrawal by Subject|1
2438246|NCT03109184|8371667|P1|Overall Study|Withdrawal by Subject|1
2438247|NCT03109184|8371666|P2|Overall Study|Lost to Follow-up|6
2438248|NCT03109184|8371667|P1|Overall Study|Lost to Follow-up|6
2438249|NCT03108157|8371828|P2|Overall Study|Protocol Violation|4
2438250|NCT03108157|8371829|P1|Overall Study|Protocol Violation|15
2438251|NCT03108027|8371835|P6|Period 3|Adverse Event|0
2438252|NCT03108027|8371836|P5|Period 3|Adverse Event|0
2438253|NCT03108027|8371837|P4|Period 3|Adverse Event|0
2438254|NCT03108027|8371838|P3|Period 3|Adverse Event|0
2438255|NCT03108027|8371839|P2|Period 3|Adverse Event|1
2438256|NCT03108027|8371840|P1|Period 3|Adverse Event|0
2438257|NCT03108027|8371835|P6|Period 1|Subject/Guardian Decision|0
2438258|NCT03108027|8371836|P5|Period 1|Subject/Guardian Decision|0
2438259|NCT03108027|8371837|P4|Period 1|Subject/Guardian Decision|2
2438260|NCT03108027|8371838|P3|Period 1|Subject/Guardian Decision|0
2438261|NCT03108027|8371839|P2|Period 1|Subject/Guardian Decision|0
2438262|NCT03108027|8371840|P1|Period 1|Subject/Guardian Decision|0
2438263|NCT03107611|8371857|P3|Overall Study|Worsening signs/symptoms|2
2438264|NCT03107611|8371858|P2|Overall Study|Worsening signs/symptoms|1
2438265|NCT03107611|8371859|P1|Overall Study|Worsening signs/symptoms|2
2438266|NCT03107611|8371857|P3|Overall Study|Withdrawal by Subject|1
2438267|NCT03107611|8371858|P2|Overall Study|Withdrawal by Subject|0
2438268|NCT03107611|8371859|P1|Overall Study|Withdrawal by Subject|1
2438269|NCT03107611|8371857|P3|Overall Study|Protocol Violation|1
2438270|NCT03107611|8371858|P2|Overall Study|Protocol Violation|0
2438271|NCT03107611|8371859|P1|Overall Study|Protocol Violation|0
2438272|NCT03107611|8371857|P3|Overall Study|Lost to Follow-up|3
2438273|NCT03107611|8371858|P2|Overall Study|Lost to Follow-up|3
2438274|NCT03107611|8371859|P1|Overall Study|Lost to Follow-up|3
2438275|NCT03107611|8371857|P3|Overall Study|Adverse Event|2
2438276|NCT03107611|8371858|P2|Overall Study|Adverse Event|0
2438277|NCT03107611|8371859|P1|Overall Study|Adverse Event|1
2438278|NCT03105362|8371928|P1|Overall Study|Lost to Follow-up|1
2438279|NCT03105362|8371928|P1|Overall Study|Withdrawal by Subject|1
2438280|NCT03105297|8371935|P1|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7
2438281|NCT03105297|8371935|P1|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1
2438282|NCT03105297|8371935|P1|Baseline Phase (Day 1)|Other|21
2438283|NCT03104816|8371979|P3|Overall Study|Protocol Violation|2
2438284|NCT03104816|8371980|P2|Overall Study|Protocol Violation|0
2438285|NCT03104816|8371981|P1|Overall Study|Protocol Violation|2
2438286|NCT03104816|8371979|P3|Overall Study|Lack of Efficacy|0
2438287|NCT03104816|8371980|P2|Overall Study|Lack of Efficacy|2
2438288|NCT03104816|8371981|P1|Overall Study|Lack of Efficacy|0
2438289|NCT03103919|8372033|P2|Overall Study|Adverse Event|2
2438290|NCT03103919|8372034|P1|Overall Study|Adverse Event|2
2438291|NCT03103906|8372070|P2|Overall Study|Other|0
2438292|NCT03103906|8372071|P1|Overall Study|Other|2
2438293|NCT03103906|8372070|P2|Overall Study|Adverse Event|3
2438294|NCT03103906|8372071|P1|Overall Study|Adverse Event|2
2438295|NCT03102918|8372098|P2|Overall Study|Protocol Violation|0
2438296|NCT03102918|8372099|P1|Overall Study|Protocol Violation|1
2438297|NCT03102762|8372125|P2|Overall Study|Lost to Follow-up|0
2438298|NCT03102762|8372126|P1|Overall Study|Lost to Follow-up|1
2438299|NCT03102034|8372163|P2|Overall Study|Withdrawal by Subject|0
2438300|NCT03102034|8372164|P1|Overall Study|Withdrawal by Subject|1
2438301|NCT03101462|8372192|P2|Overall Study|Missed Visit 02 and/or Visit 03|1
2438302|NCT03101462|8372193|P1|Overall Study|Missed Visit 02 and/or Visit 03|1
2438303|NCT03101371|8372209|P2|Overall Study|Did not meet eligibility criteria|1
2438304|NCT03101371|8372210|P1|Overall Study|Did not meet eligibility criteria|2
2438305|NCT03101371|8372209|P2|Overall Study|Lost to Follow-up|4
2438306|NCT03101371|8372210|P1|Overall Study|Lost to Follow-up|1
2438307|NCT03101371|8372209|P2|Overall Study|Physician Decision|1
2438308|NCT03101371|8372210|P1|Overall Study|Physician Decision|0
2438309|NCT03101293|8372230|P2|Washout Period (at Least 7 Days)|Positive drug urine screen|0
2438310|NCT03101293|8372231|P1|Washout Period (at Least 7 Days)|Positive drug urine screen|1
2438311|NCT03101150|8372245|P2|Overall Study|Miscarriage|6
2438312|NCT03101150|8372246|P1|Overall Study|Miscarriage|3
2438313|NCT03101150|8372245|P2|Overall Study|Lost to Follow-up|4
2438314|NCT03101150|8372246|P1|Overall Study|Lost to Follow-up|2
2438315|NCT03101020|8372281|P2|Overall Study|Withdrawal by Subject|2
2438316|NCT03101020|8372282|P1|Overall Study|Withdrawal by Subject|0
2438317|NCT03101020|8372281|P2|Overall Study|Ran over by a car|1
2438318|NCT03101020|8372282|P1|Overall Study|Ran over by a car|0
2438319|NCT03101020|8372281|P2|Overall Study|Lack of time to participate|0
2438320|NCT03101020|8372282|P1|Overall Study|Lack of time to participate|1
2438321|NCT03100942|8372317|P4|Overall Study|Randomized but didn't receive study drug|1
2438322|NCT03100942|8372318|P3|Overall Study|Randomized but didn't receive study drug|0
2438323|NCT03100942|8372319|P2|Overall Study|Randomized but didn't receive study drug|1
2438324|NCT03100942|8372320|P1|Overall Study|Randomized but didn't receive study drug|0
2438325|NCT03100942|8372317|P4|Overall Study|Still on the Study|17
2438326|NCT03100942|8372318|P3|Overall Study|Still on the Study|23
2438327|NCT03100942|8372319|P2|Overall Study|Still on the Study|15
2438328|NCT03100942|8372320|P1|Overall Study|Still on the Study|22
2438329|NCT03100942|8372317|P4|Overall Study|Protocol Violation|1
2438330|NCT03100942|8372318|P3|Overall Study|Protocol Violation|0
2438331|NCT03100942|8372319|P2|Overall Study|Protocol Violation|0
2438332|NCT03100942|8372320|P1|Overall Study|Protocol Violation|1
2438333|NCT03100942|8372317|P4|Overall Study|Investigator's Discretion|0
2438334|NCT03100942|8372318|P3|Overall Study|Investigator's Discretion|0
2438335|NCT03100942|8372319|P2|Overall Study|Investigator's Discretion|1
2438336|NCT03100942|8372320|P1|Overall Study|Investigator's Discretion|1
2438337|NCT03100942|8372317|P4|Overall Study|Adverse Event|0
2438338|NCT03100942|8372318|P3|Overall Study|Adverse Event|1
2438339|NCT03100942|8372319|P2|Overall Study|Adverse Event|6
2438340|NCT03100942|8372320|P1|Overall Study|Adverse Event|1
2438341|NCT03100942|8372317|P4|Overall Study|Withdrew Consent|4
2438342|NCT03100942|8372318|P3|Overall Study|Withdrew Consent|2
2438343|NCT03100942|8372319|P2|Overall Study|Withdrew Consent|4
2438344|NCT03100942|8372320|P1|Overall Study|Withdrew Consent|4
2438345|NCT03100838|8372346|P4|Overall Study|Lost to Follow-up|0
2438346|NCT03100838|8372347|P3|Overall Study|Lost to Follow-up|1
2438347|NCT03100838|8372348|P2|Overall Study|Lost to Follow-up|0
2438348|NCT03100838|8372349|P1|Overall Study|Lost to Follow-up|0
2438349|NCT03100838|8372346|P4|Overall Study|Pregnancy|0
2438350|NCT03100838|8372347|P3|Overall Study|Pregnancy|0
2438351|NCT03100838|8372348|P2|Overall Study|Pregnancy|1
2438352|NCT03100838|8372349|P1|Overall Study|Pregnancy|0
2438353|NCT03100838|8372346|P4|Overall Study|Physician Decision|1
2438354|NCT03100838|8372347|P3|Overall Study|Physician Decision|1
2438355|NCT03100838|8372348|P2|Overall Study|Physician Decision|1
2438356|NCT03100838|8372349|P1|Overall Study|Physician Decision|1
2438357|NCT03100838|8372346|P4|Overall Study|Adverse Event|0
2438358|NCT03100838|8372347|P3|Overall Study|Adverse Event|0
2438359|NCT03100838|8372348|P2|Overall Study|Adverse Event|0
2438360|NCT03100838|8372349|P1|Overall Study|Adverse Event|1
2438361|NCT03100825|8372375|P1|Overall Study|Physician Decision|1
2438362|NCT03100825|8372375|P1|Overall Study|Participant/Guardian Decision|7
2438363|NCT03100344|8372402|P4|Overall Study|Lost to Follow-up|1
2438364|NCT03100344|8372403|P3|Overall Study|Lost to Follow-up|1
2438365|NCT03100344|8372404|P2|Overall Study|Lost to Follow-up|1
2438366|NCT03100344|8372405|P1|Overall Study|Lost to Follow-up|1
2438367|NCT03100344|8372402|P4|Overall Study|Withdrawal by Subject|8
2438368|NCT03100344|8372403|P3|Overall Study|Withdrawal by Subject|4
2438369|NCT03100344|8372404|P2|Overall Study|Withdrawal by Subject|7
2438370|NCT03100344|8372405|P1|Overall Study|Withdrawal by Subject|10
2438371|NCT03100344|8372402|P4|Overall Study|Protocol Violation|0
2438372|NCT03100344|8372403|P3|Overall Study|Protocol Violation|0
2438373|NCT03100344|8372404|P2|Overall Study|Protocol Violation|0
2438374|NCT03100344|8372405|P1|Overall Study|Protocol Violation|1
2438375|NCT03100344|8372402|P4|Overall Study|Lack of Efficacy|0
2438376|NCT03100344|8372403|P3|Overall Study|Lack of Efficacy|0
2438377|NCT03100344|8372404|P2|Overall Study|Lack of Efficacy|0
2438378|NCT03100344|8372405|P1|Overall Study|Lack of Efficacy|2
2438379|NCT03100344|8372402|P4|Overall Study|Adverse Event|3
2438380|NCT03100344|8372403|P3|Overall Study|Adverse Event|2
2438381|NCT03100344|8372404|P2|Overall Study|Adverse Event|3
2438382|NCT03100344|8372405|P1|Overall Study|Adverse Event|0
2438383|NCT03100058|8372508|P13|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2438384|NCT03100058|8372509|P12|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2438385|NCT03100058|8372510|P11|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2438386|NCT03100058|8372511|P10|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1
2438387|NCT03100058|8372512|P9|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2438388|NCT03100058|8372513|P8|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2438389|NCT03100058|8372514|P7|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2438390|NCT03100058|8372515|P6|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2438391|NCT03100058|8372516|P5|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2438392|NCT03100058|8372517|P4|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2438393|NCT03100058|8372518|P3|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2438394|NCT03100058|8372519|P2|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2438395|NCT03100058|8372520|P1|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
2438396|NCT03100058|8372508|P13|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1
2438397|NCT03100058|8372509|P12|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2438398|NCT03100058|8372510|P11|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2438399|NCT03100058|8372511|P10|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2438400|NCT03100058|8372512|P9|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2438401|NCT03100058|8372513|P8|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2438402|NCT03100058|8372514|P7|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2438403|NCT03100058|8372515|P6|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2438404|NCT03100058|8372516|P5|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2438405|NCT03100058|8372517|P4|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2438406|NCT03100058|8372518|P3|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2438407|NCT03100058|8372519|P2|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2438408|NCT03100058|8372520|P1|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
2438409|NCT03100058|8372508|P13|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2438410|NCT03100058|8372509|P12|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2438411|NCT03100058|8372510|P11|Epoch 4 (Last 24 Weeks of the Study)|Death|1
2438412|NCT03100058|8372511|P10|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2438413|NCT03100058|8372512|P9|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2438414|NCT03100058|8372513|P8|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2438415|NCT03100058|8372514|P7|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2438416|NCT03100058|8372515|P6|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2438417|NCT03100058|8372516|P5|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2438418|NCT03100058|8372517|P4|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2438419|NCT03100058|8372518|P3|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2438420|NCT03100058|8372519|P2|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2438421|NCT03100058|8372520|P1|Epoch 4 (Last 24 Weeks of the Study)|Death|0
2438422|NCT03100058|8372508|P13|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2
2438423|NCT03100058|8372509|P12|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
2438424|NCT03100058|8372510|P11|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7
2438425|NCT03100058|8372511|P10|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4
2438426|NCT03100058|8372512|P9|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
2438427|NCT03100058|8372513|P8|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
2438428|NCT03100058|8372514|P7|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
2438429|NCT03100058|8372515|P6|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
2438430|NCT03100058|8372516|P5|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
2438431|NCT03100058|8372517|P4|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
2438432|NCT03100058|8372518|P3|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
2438433|NCT03100058|8372519|P2|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
2438434|NCT03100058|8372520|P1|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
2438435|NCT03100058|8372508|P13|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2438436|NCT03100058|8372509|P12|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1
2438437|NCT03100058|8372510|P11|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3
2438438|NCT03100058|8372511|P10|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2438439|NCT03100058|8372512|P9|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2438440|NCT03100058|8372513|P8|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2438441|NCT03100058|8372514|P7|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2438442|NCT03100058|8372515|P6|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2438443|NCT03100058|8372516|P5|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2438444|NCT03100058|8372517|P4|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2438445|NCT03100058|8372518|P3|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2438446|NCT03100058|8372519|P2|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2438447|NCT03100058|8372520|P1|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
2438448|NCT03100058|8372508|P13|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1
2438449|NCT03100058|8372509|P12|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2
2438450|NCT03100058|8372510|P11|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4
2438451|NCT03100058|8372511|P10|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
2438452|NCT03100058|8372512|P9|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
2438453|NCT03100058|8372513|P8|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
2438454|NCT03100058|8372514|P7|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
2438455|NCT03100058|8372515|P6|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
2438456|NCT03100058|8372516|P5|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
2438457|NCT03100058|8372517|P4|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
2438458|NCT03100058|8372518|P3|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
2438459|NCT03100058|8372519|P2|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
2438460|NCT03100058|8372520|P1|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
2438461|NCT03100058|8372508|P13|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2438462|NCT03100058|8372509|P12|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2438463|NCT03100058|8372510|P11|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2438464|NCT03100058|8372511|P10|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2438465|NCT03100058|8372512|P9|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2438466|NCT03100058|8372513|P8|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2438467|NCT03100058|8372514|P7|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1
2438468|NCT03100058|8372515|P6|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2438469|NCT03100058|8372516|P5|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2438470|NCT03100058|8372517|P4|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2438471|NCT03100058|8372518|P3|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2438472|NCT03100058|8372519|P2|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2438473|NCT03100058|8372520|P1|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
2438474|NCT03100058|8372508|P13|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2438475|NCT03100058|8372509|P12|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2438476|NCT03100058|8372510|P11|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2438477|NCT03100058|8372511|P10|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2438478|NCT03100058|8372512|P9|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2438479|NCT03100058|8372513|P8|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2438480|NCT03100058|8372514|P7|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2438481|NCT03100058|8372515|P6|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2438482|NCT03100058|8372516|P5|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2438483|NCT03100058|8372517|P4|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2438484|NCT03100058|8372518|P3|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2438485|NCT03100058|8372519|P2|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
2438486|NCT03100058|8372520|P1|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1
2438487|NCT03100058|8372508|P13|Epoch 3 (24 Weeks of Treatment)|Death|0
2438488|NCT03100058|8372509|P12|Epoch 3 (24 Weeks of Treatment)|Death|0
2438489|NCT03100058|8372510|P11|Epoch 3 (24 Weeks of Treatment)|Death|0
2438490|NCT03100058|8372511|P10|Epoch 3 (24 Weeks of Treatment)|Death|0
2438491|NCT03100058|8372512|P9|Epoch 3 (24 Weeks of Treatment)|Death|0
2438492|NCT03100058|8372513|P8|Epoch 3 (24 Weeks of Treatment)|Death|0
2438493|NCT03100058|8372514|P7|Epoch 3 (24 Weeks of Treatment)|Death|0
2438494|NCT03100058|8372515|P6|Epoch 3 (24 Weeks of Treatment)|Death|0
2438495|NCT03100058|8372516|P5|Epoch 3 (24 Weeks of Treatment)|Death|0
2438496|NCT03100058|8372517|P4|Epoch 3 (24 Weeks of Treatment)|Death|0
2438497|NCT03100058|8372518|P3|Epoch 3 (24 Weeks of Treatment)|Death|0
2438498|NCT03100058|8372519|P2|Epoch 3 (24 Weeks of Treatment)|Death|1
2438499|NCT03100058|8372520|P1|Epoch 3 (24 Weeks of Treatment)|Death|0
2438500|NCT03100058|8372508|P13|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2438501|NCT03100058|8372509|P12|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2438502|NCT03100058|8372510|P11|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2438503|NCT03100058|8372511|P10|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2438504|NCT03100058|8372512|P9|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2438505|NCT03100058|8372513|P8|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2438506|NCT03100058|8372514|P7|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1
2438507|NCT03100058|8372515|P6|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2438508|NCT03100058|8372516|P5|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2438509|NCT03100058|8372517|P4|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1
2438510|NCT03100058|8372518|P3|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2438511|NCT03100058|8372519|P2|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2438512|NCT03100058|8372520|P1|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
2438513|NCT03100058|8372508|P13|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2438514|NCT03100058|8372509|P12|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2438515|NCT03100058|8372510|P11|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2438516|NCT03100058|8372511|P10|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2438517|NCT03100058|8372512|P9|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2438518|NCT03100058|8372513|P8|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1
2438519|NCT03100058|8372514|P7|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2438520|NCT03100058|8372515|P6|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2438521|NCT03100058|8372516|P5|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2438522|NCT03100058|8372517|P4|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1
2438523|NCT03100058|8372518|P3|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2438524|NCT03100058|8372519|P2|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2438525|NCT03100058|8372520|P1|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
2438526|NCT03100058|8372508|P13|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
2438527|NCT03100058|8372509|P12|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
2438528|NCT03100058|8372510|P11|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
2438529|NCT03100058|8372511|P10|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
2438530|NCT03100058|8372512|P9|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
2438531|NCT03100058|8372513|P8|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
2438532|NCT03100058|8372514|P7|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
2438533|NCT03100058|8372515|P6|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
2438534|NCT03100058|8372516|P5|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
2438535|NCT03100058|8372517|P4|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
2438536|NCT03100058|8372518|P3|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
2438537|NCT03100058|8372519|P2|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
2438538|NCT03100058|8372520|P1|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
2438539|NCT03100058|8372508|P13|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
2438540|NCT03100058|8372509|P12|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
2438541|NCT03100058|8372510|P11|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
2438542|NCT03100058|8372511|P10|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
2438543|NCT03100058|8372512|P9|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
2438544|NCT03100058|8372513|P8|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
2438545|NCT03100058|8372514|P7|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
2438546|NCT03100058|8372515|P6|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
2438547|NCT03100058|8372516|P5|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
2438548|NCT03100058|8372517|P4|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
2438549|NCT03100058|8372518|P3|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
2438550|NCT03100058|8372519|P2|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
2438551|NCT03100058|8372520|P1|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
2438552|NCT03100058|8372508|P13|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
2438553|NCT03100058|8372509|P12|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
2438554|NCT03100058|8372510|P11|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
2438555|NCT03100058|8372511|P10|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
2438556|NCT03100058|8372512|P9|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2
2438557|NCT03100058|8372513|P8|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
2438558|NCT03100058|8372514|P7|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
2438559|NCT03100058|8372515|P6|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
2438560|NCT03100058|8372516|P5|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
2438561|NCT03100058|8372517|P4|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
2438562|NCT03100058|8372518|P3|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3
2438563|NCT03100058|8372519|P2|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
2438564|NCT03100058|8372520|P1|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2
2438565|NCT03100058|8372508|P13|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
2438566|NCT03100058|8372509|P12|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
2438567|NCT03100058|8372510|P11|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
2438568|NCT03100058|8372511|P10|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
2438569|NCT03100058|8372512|P9|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2
2438570|NCT03100058|8372513|P8|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11
2438571|NCT03100058|8372514|P7|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3
2438572|NCT03100058|8372515|P6|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
2438573|NCT03100058|8372516|P5|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1
2438574|NCT03100058|8372517|P4|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8
2438575|NCT03100058|8372518|P3|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4
2438576|NCT03100058|8372519|P2|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
2438577|NCT03100058|8372520|P1|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
2438578|NCT03099694|8372727|P2|Overall Study|Lost to Follow-up|5
2438579|NCT03099694|8372728|P1|Overall Study|Lost to Follow-up|9
2438580|NCT03099694|8372727|P2|Overall Study|Withdrawal by Subject|13
2438581|NCT03099694|8372728|P1|Overall Study|Withdrawal by Subject|11
2438582|NCT03099187|8372782|P2|Overall Study|Non-compliance with Protocol procedure|2
2438583|NCT03099187|8372783|P1|Overall Study|Non-compliance with Protocol procedure|1
2438584|NCT03099187|8372782|P2|Overall Study|Randomization error|2
2438585|NCT03099187|8372783|P1|Overall Study|Randomization error|0
2438586|NCT03099187|8372782|P2|Overall Study|Symptomatic deterioration|1
2438587|NCT03099187|8372783|P1|Overall Study|Symptomatic deterioration|0
2438588|NCT03099187|8372782|P2|Overall Study|Disease progression|1
2438589|NCT03099187|8372783|P1|Overall Study|Disease progression|0
2438590|NCT03099187|8372782|P2|Overall Study|Non-compliance with study drug|1
2438591|NCT03099187|8372783|P1|Overall Study|Non-compliance with study drug|0
2438592|NCT03099187|8372782|P2|Overall Study|Lung transplantation|3
2438593|NCT03099187|8372783|P1|Overall Study|Lung transplantation|1
2438594|NCT03099187|8372782|P2|Overall Study|Withdrawal by Subject|6
2438595|NCT03099187|8372783|P1|Overall Study|Withdrawal by Subject|11
2438596|NCT03099187|8372782|P2|Overall Study|Physician Decision|2
2438597|NCT03099187|8372783|P1|Overall Study|Physician Decision|2
2438598|NCT03099187|8372782|P2|Overall Study|Lack of Efficacy|0
2438599|NCT03099187|8372783|P1|Overall Study|Lack of Efficacy|1
2438600|NCT03099187|8372782|P2|Overall Study|Death|7
2438601|NCT03099187|8372783|P1|Overall Study|Death|4
2438602|NCT03099187|8372782|P2|Overall Study|Adverse Event|9
2438603|NCT03099187|8372783|P1|Overall Study|Adverse Event|23
2438604|NCT03099161|8372832|P3|Overall Study|Progressive Disease|1
2438605|NCT03099161|8372833|P2|Overall Study|Progressive Disease|4
2438606|NCT03099161|8372834|P1|Overall Study|Progressive Disease|1
2438607|NCT03099161|8372832|P3|Overall Study|Physician Decision|0
2438608|NCT03099161|8372833|P2|Overall Study|Physician Decision|0
2438609|NCT03099161|8372834|P1|Overall Study|Physician Decision|2
2438610|NCT03099161|8372832|P3|Overall Study|Adverse Event|2
2438611|NCT03099161|8372833|P2|Overall Study|Adverse Event|0
2438612|NCT03099161|8372834|P1|Overall Study|Adverse Event|0
2438613|NCT03099096|8372851|P1|Overall Study|Physician Decision|1
2438614|NCT03099096|8372851|P1|Overall Study|Adverse Event|1
2438615|NCT03098979|8372864|P6|Overall Study|Protocol Violation|1
2438616|NCT03098979|8372865|P5|Overall Study|Protocol Violation|0
2438617|NCT03098979|8372866|P4|Overall Study|Protocol Violation|0
2438618|NCT03098979|8372867|P3|Overall Study|Protocol Violation|0
2438619|NCT03098979|8372868|P2|Overall Study|Protocol Violation|0
2438620|NCT03098979|8372869|P1|Overall Study|Protocol Violation|0
2438621|NCT03098979|8372864|P6|Overall Study|Non-compliance|1
2438622|NCT03098979|8372865|P5|Overall Study|Non-compliance|0
2438623|NCT03098979|8372866|P4|Overall Study|Non-compliance|0
2438624|NCT03098979|8372867|P3|Overall Study|Non-compliance|0
2438625|NCT03098979|8372868|P2|Overall Study|Non-compliance|0
2438626|NCT03098979|8372869|P1|Overall Study|Non-compliance|0
2438627|NCT03098979|8372864|P6|Overall Study|Physician Decision|0
2438628|NCT03098979|8372865|P5|Overall Study|Physician Decision|0
2438629|NCT03098979|8372866|P4|Overall Study|Physician Decision|0
2438630|NCT03098979|8372867|P3|Overall Study|Physician Decision|0
2438631|NCT03098979|8372868|P2|Overall Study|Physician Decision|1
2438632|NCT03098979|8372869|P1|Overall Study|Physician Decision|2
2438633|NCT03098979|8372864|P6|Overall Study|Death|0
2438634|NCT03098979|8372865|P5|Overall Study|Death|1
2438635|NCT03098979|8372866|P4|Overall Study|Death|0
2438636|NCT03098979|8372867|P3|Overall Study|Death|2
2438637|NCT03098979|8372868|P2|Overall Study|Death|0
2438638|NCT03098979|8372869|P1|Overall Study|Death|1
2438639|NCT03098979|8372864|P6|Overall Study|Withdrawal by Subject|1
2438640|NCT03098979|8372865|P5|Overall Study|Withdrawal by Subject|2
2438641|NCT03098979|8372866|P4|Overall Study|Withdrawal by Subject|1
2438642|NCT03098979|8372867|P3|Overall Study|Withdrawal by Subject|1
2438643|NCT03098979|8372868|P2|Overall Study|Withdrawal by Subject|1
2438644|NCT03098979|8372869|P1|Overall Study|Withdrawal by Subject|2
2438645|NCT03098979|8372864|P6|Overall Study|Adverse Event|1
2438646|NCT03098979|8372865|P5|Overall Study|Adverse Event|6
2438647|NCT03098979|8372866|P4|Overall Study|Adverse Event|4
2438648|NCT03098979|8372867|P3|Overall Study|Adverse Event|1
2438649|NCT03098979|8372868|P2|Overall Study|Adverse Event|0
2438650|NCT03098979|8372869|P1|Overall Study|Adverse Event|1
2438651|NCT03097861|8373011|P3|Overall Study|Reason not provided|1
2438652|NCT03097861|8373012|P2|Overall Study|Reason not provided|1
2438653|NCT03097861|8373013|P1|Overall Study|Reason not provided|3
2438654|NCT03097861|8373011|P3|Overall Study|Withdrawal by Subject|3
2438655|NCT03097861|8373012|P2|Overall Study|Withdrawal by Subject|5
2438656|NCT03097861|8373013|P1|Overall Study|Withdrawal by Subject|1
2438657|NCT03097861|8373011|P3|Overall Study|Lost to Follow-up|1
2438658|NCT03097861|8373012|P2|Overall Study|Lost to Follow-up|7
2438659|NCT03097861|8373013|P1|Overall Study|Lost to Follow-up|0
2438660|NCT03097861|8373011|P3|Overall Study|Investigator Decision|0
2438661|NCT03097861|8373012|P2|Overall Study|Investigator Decision|1
2438662|NCT03097861|8373013|P1|Overall Study|Investigator Decision|0
2438663|NCT03097861|8373011|P3|Overall Study|Adverse Event|4
2438664|NCT03097861|8373012|P2|Overall Study|Adverse Event|8
2438665|NCT03097861|8373013|P1|Overall Study|Adverse Event|3
2438666|NCT03097614|8373030|P1|Overall Study|Adverse Event|3
2438667|NCT03097289|8373132|P1|Overall Study|Collected platelet product unusable|3
2438668|NCT03097289|8373132|P1|Overall Study|Equipment failure|2
2438669|NCT03097289|8373132|P1|Overall Study|Adverse Event|1
2438670|NCT03097029|8373139|P1|Overall Study|Withdrawal by Subject|1
2438671|NCT03096483|8373183|P1|Overall Study|Withdrawal by site|1
2438672|NCT03096314|8373212|P2|Screened Vitamin D Deficient|Lost to Follow-up|12
2438673|NCT03096314|8373213|P1|Screened Vitamin D Deficient|Lost to Follow-up|9
2438674|NCT03095651|8373275|P8|Overall Study|Withdrawal by Subject|0
2438675|NCT03095651|8373276|P7|Overall Study|Withdrawal by Subject|0
2438676|NCT03095651|8373277|P6|Overall Study|Withdrawal by Subject|1
2438677|NCT03095651|8373278|P5|Overall Study|Withdrawal by Subject|0
2438678|NCT03095651|8373279|P4|Overall Study|Withdrawal by Subject|0
2438679|NCT03095651|8373280|P3|Overall Study|Withdrawal by Subject|0
2438680|NCT03095651|8373281|P2|Overall Study|Withdrawal by Subject|0
2438681|NCT03095651|8373282|P1|Overall Study|Withdrawal by Subject|0
2438682|NCT03095651|8373275|P8|Overall Study|Lost to Follow-up|0
2438683|NCT03095651|8373276|P7|Overall Study|Lost to Follow-up|0
2438684|NCT03095651|8373277|P6|Overall Study|Lost to Follow-up|0
2438685|NCT03095651|8373278|P5|Overall Study|Lost to Follow-up|0
2438686|NCT03095651|8373279|P4|Overall Study|Lost to Follow-up|1
2438687|NCT03095651|8373280|P3|Overall Study|Lost to Follow-up|0
2438688|NCT03095651|8373281|P2|Overall Study|Lost to Follow-up|1
2438689|NCT03095651|8373282|P1|Overall Study|Lost to Follow-up|1
2438690|NCT03095599|8373561|P2|Overall Study|Withdrawal prior to vaccination|0
2438691|NCT03095599|8373562|P1|Overall Study|Withdrawal prior to vaccination|1
2438692|NCT03095599|8373561|P2|Overall Study|Lost to Follow-up|0
2438693|NCT03095599|8373562|P1|Overall Study|Lost to Follow-up|1
2438694|NCT03095599|8373561|P2|Overall Study|Withdrawal by Subject|0
2438695|NCT03095599|8373562|P1|Overall Study|Withdrawal by Subject|1
2438696|NCT03095521|8373598|P2|Overall Study|Lost to Follow-up|1
2438697|NCT03095521|8373599|P1|Overall Study|Lost to Follow-up|0
2438698|NCT03095521|8373598|P2|Overall Study|Withdrawal by Subject|1
2438699|NCT03095521|8373599|P1|Overall Study|Withdrawal by Subject|0
2438700|NCT03095508|8373617|P2|Overall Study|Adverse Event|1
2438701|NCT03095508|8373618|P1|Overall Study|Adverse Event|0
2438702|NCT03095027|8373666|P2|Period 2, Second Week of Wear|Adverse Event|0
2438703|NCT03095027|8373667|P1|Period 2, Second Week of Wear|Adverse Event|1
2438704|NCT03093350|8373700|P1|Overall Study|Signed consent, never began treartment|1
2438705|NCT03093350|8373700|P1|Overall Study|Death|1
2438706|NCT03093181|8373718|P3|Overall Study|Other (Protocol violation)|1
2438707|NCT03093181|8373719|P2|Overall Study|Other (Protocol violation)|0
2438708|NCT03093181|8373720|P1|Overall Study|Other (Protocol violation)|0
2438709|NCT03093181|8373718|P3|Overall Study|Adverse Event|0
2438710|NCT03093181|8373719|P2|Overall Study|Adverse Event|1
2438711|NCT03093181|8373720|P1|Overall Study|Adverse Event|0
2438712|NCT03093181|8373718|P3|Overall Study|Other (Not specified)|0
2438713|NCT03093181|8373719|P2|Overall Study|Other (Not specified)|0
2438714|NCT03093181|8373720|P1|Overall Study|Other (Not specified)|1
2438715|NCT03093181|8373718|P3|Overall Study|Withdrawal by Subject|2
2438716|NCT03093181|8373719|P2|Overall Study|Withdrawal by Subject|1
2438717|NCT03093181|8373720|P1|Overall Study|Withdrawal by Subject|2
2438718|NCT03092791|8373782|P8|Overall Study|Reason Not Specified|0
2438719|NCT03092791|8373783|P7|Overall Study|Reason Not Specified|0
2438720|NCT03092791|8373784|P6|Overall Study|Reason Not Specified|1
2438721|NCT03092791|8373785|P5|Overall Study|Reason Not Specified|1
2438722|NCT03092791|8373786|P4|Overall Study|Reason Not Specified|0
2438723|NCT03092791|8373787|P3|Overall Study|Reason Not Specified|0
2438724|NCT03092791|8373788|P2|Overall Study|Reason Not Specified|0
2438725|NCT03092791|8373789|P1|Overall Study|Reason Not Specified|0
2438726|NCT03092791|8373782|P8|Overall Study|Death|1
2438727|NCT03092791|8373783|P7|Overall Study|Death|0
2438728|NCT03092791|8373784|P6|Overall Study|Death|1
2438729|NCT03092791|8373785|P5|Overall Study|Death|0
2438730|NCT03092791|8373786|P4|Overall Study|Death|0
2438731|NCT03092791|8373787|P3|Overall Study|Death|0
2438732|NCT03092791|8373788|P2|Overall Study|Death|0
2438733|NCT03092791|8373789|P1|Overall Study|Death|0
2438734|NCT03092791|8373782|P8|Overall Study|Study Termination|55
2438735|NCT03092791|8373783|P7|Overall Study|Study Termination|53
2438736|NCT03092791|8373784|P6|Overall Study|Study Termination|46
2438737|NCT03092791|8373785|P5|Overall Study|Study Termination|55
2438738|NCT03092791|8373786|P4|Overall Study|Study Termination|0
2438739|NCT03092791|8373787|P3|Overall Study|Study Termination|0
2438740|NCT03092791|8373788|P2|Overall Study|Study Termination|0
2438741|NCT03092791|8373789|P1|Overall Study|Study Termination|0
2438742|NCT03092791|8373782|P8|Overall Study|Withdrawal of Consent|4
2438743|NCT03092791|8373783|P7|Overall Study|Withdrawal of Consent|6
2438744|NCT03092791|8373784|P6|Overall Study|Withdrawal of Consent|12
2438745|NCT03092791|8373785|P5|Overall Study|Withdrawal of Consent|4
2438746|NCT03092791|8373786|P4|Overall Study|Withdrawal of Consent|0
2438747|NCT03092791|8373787|P3|Overall Study|Withdrawal of Consent|0
2438748|NCT03092791|8373788|P2|Overall Study|Withdrawal of Consent|0
2438749|NCT03092791|8373789|P1|Overall Study|Withdrawal of Consent|0
2438750|NCT03092791|8373782|P8|Overall Study|Lost to Follow-up|0
2438751|NCT03092791|8373783|P7|Overall Study|Lost to Follow-up|1
2438752|NCT03092791|8373784|P6|Overall Study|Lost to Follow-up|0
2438753|NCT03092791|8373785|P5|Overall Study|Lost to Follow-up|0
2438754|NCT03092791|8373786|P4|Overall Study|Lost to Follow-up|0
2438755|NCT03092791|8373787|P3|Overall Study|Lost to Follow-up|0
2438756|NCT03092791|8373788|P2|Overall Study|Lost to Follow-up|0
2438757|NCT03092791|8373789|P1|Overall Study|Lost to Follow-up|0
2438758|NCT03092752|8373904|P1|Overall Study|<6 month history|245900
2438759|NCT03092752|8373904|P1|Overall Study|Average hospital visit interval >92 days|10779
2438760|NCT03092752|8373904|P1|Overall Study|Having no claim of study drugs|29282
2438761|NCT03092752|8373904|P1|Overall Study|At least one claim with T2DM|61299
2438762|NCT03092752|8373904|P1|Overall Study|Aged <40 years|14209
2438763|NCT03092726|8373969|P2|Overall Study|Withdrawal by Subject|3
2438764|NCT03092726|8373970|P1|Overall Study|Withdrawal by Subject|5
2438765|NCT03092726|8373969|P2|Overall Study|Lost to Follow-up|0
2438766|NCT03092726|8373970|P1|Overall Study|Lost to Follow-up|1
2438767|NCT03092726|8373969|P2|Overall Study|Lack of Efficacy|1
2438768|NCT03092726|8373970|P1|Overall Study|Lack of Efficacy|0
2438769|NCT03092726|8373969|P2|Overall Study|Adverse Event|10
2438770|NCT03092726|8373970|P1|Overall Study|Adverse Event|3
2438771|NCT03092479|8373996|P2|Overall Study|Withdrawal by Subject|0
2438772|NCT03092479|8373997|P1|Overall Study|Withdrawal by Subject|4
2438773|NCT03092479|8373996|P2|Overall Study|Lost to Follow-up|2
2438774|NCT03092479|8373997|P1|Overall Study|Lost to Follow-up|3
2438775|NCT03092375|8374019|P4|Overall Study|Lack of Efficacy|0
2438776|NCT03092375|8374020|P3|Overall Study|Lack of Efficacy|1
2438777|NCT03092375|8374021|P2|Overall Study|Lack of Efficacy|1
2438778|NCT03092375|8374022|P1|Overall Study|Lack of Efficacy|0
2438779|NCT03091777|8374051|P3|Overall Study|Abnormal Laboratory Value|12
2438780|NCT03091777|8374052|P2|Overall Study|Abnormal Laboratory Value|11
2438781|NCT03091777|8374053|P1|Overall Study|Abnormal Laboratory Value|7
2438782|NCT03091777|8374051|P3|Overall Study|Physician Decision|1
2438783|NCT03091777|8374052|P2|Overall Study|Physician Decision|0
2438784|NCT03091777|8374053|P1|Overall Study|Physician Decision|1
2438785|NCT03091777|8374051|P3|Overall Study|Noncompliance with study drug|1
2438786|NCT03091777|8374052|P2|Overall Study|Noncompliance with study drug|3
2438787|NCT03091777|8374053|P1|Overall Study|Noncompliance with study drug|2
2438788|NCT03091777|8374051|P3|Overall Study|Lack of Efficacy|5
2438789|NCT03091777|8374052|P2|Overall Study|Lack of Efficacy|0
2438790|NCT03091777|8374053|P1|Overall Study|Lack of Efficacy|0
2438791|NCT03091777|8374051|P3|Overall Study|Lost to Follow-up|7
2438792|NCT03091777|8374052|P2|Overall Study|Lost to Follow-up|14
2438793|NCT03091777|8374053|P1|Overall Study|Lost to Follow-up|12
2438794|NCT03091777|8374051|P3|Overall Study|Protocol Violation|1
2438795|NCT03091777|8374052|P2|Overall Study|Protocol Violation|1
2438796|NCT03091777|8374053|P1|Overall Study|Protocol Violation|2
2438797|NCT03091777|8374051|P3|Overall Study|Withdrawal by Subject|6
2438798|NCT03091777|8374052|P2|Overall Study|Withdrawal by Subject|2
2438799|NCT03091777|8374053|P1|Overall Study|Withdrawal by Subject|4
2438800|NCT03091777|8374051|P3|Overall Study|Adverse Event|4
2438801|NCT03091777|8374052|P2|Overall Study|Adverse Event|1
2438802|NCT03091777|8374053|P1|Overall Study|Adverse Event|2
2438803|NCT03091777|8374051|P3|Overall Study|Pregnancy|0
2438804|NCT03091777|8374052|P2|Overall Study|Pregnancy|1
2438805|NCT03091777|8374053|P1|Overall Study|Pregnancy|2
2438806|NCT03091439|8374095|P2|Overall Study|Study Terminated by the Sponsor|0
2438807|NCT03091439|8374096|P1|Overall Study|Study Terminated by the Sponsor|1
2438808|NCT03091400|8374120|P2|Washout - 2 Weeks|Withdrawal by Subject|0
2438809|NCT03091400|8374121|P1|Washout - 2 Weeks|Withdrawal by Subject|1
2438810|NCT03091348|8374143|P2|Overall Study|Lost to Follow-up|1
2438811|NCT03091348|8374144|P1|Overall Study|Lost to Follow-up|2
2438812|NCT03090100|8374220|P2|Overall Study|Other|2
2438813|NCT03090100|8374221|P1|Overall Study|Other|2
2438814|NCT03090100|8374220|P2|Overall Study|Non-compliance|0
2438815|NCT03090100|8374221|P1|Overall Study|Non-compliance|2
2438816|NCT03090100|8374220|P2|Overall Study|Protocol Violation|6
2438817|NCT03090100|8374221|P1|Overall Study|Protocol Violation|2
2438818|NCT03090100|8374220|P2|Overall Study|Withdrawal by Subject|19
2438819|NCT03090100|8374221|P1|Overall Study|Withdrawal by Subject|7
2438820|NCT03090100|8374220|P2|Overall Study|Lost to Follow-up|2
2438821|NCT03090100|8374221|P1|Overall Study|Lost to Follow-up|2
2438822|NCT03090100|8374220|P2|Overall Study|Lack of Efficacy|7
2438823|NCT03090100|8374221|P1|Overall Study|Lack of Efficacy|2
2438824|NCT03090100|8374220|P2|Overall Study|Pregnancy|1
2438825|NCT03090100|8374221|P1|Overall Study|Pregnancy|1
2438826|NCT03090100|8374220|P2|Overall Study|Adverse Event|11
2438827|NCT03090100|8374221|P1|Overall Study|Adverse Event|9
2438828|NCT03089580|8374295|P1|Overall Study|Lost to Follow-up|2
2438829|NCT03089216|8374306|P4|Overall Study|Adverse Event|1
2438830|NCT03089216|8374307|P3|Overall Study|Adverse Event|0
2438831|NCT03089216|8374308|P2|Overall Study|Adverse Event|0
2438832|NCT03089216|8374309|P1|Overall Study|Adverse Event|0
2438833|NCT03088917|8374323|P1|Overall Study|Moved outside study region|50
2438834|NCT03088917|8374323|P1|Overall Study|Severe comorbidity/short life expectancy|5
2438835|NCT03088917|8374323|P1|Overall Study|Contact not established|13
2438836|NCT03088917|8374323|P1|Overall Study|Refuse re-evaluation|13
2438837|NCT03088917|8374323|P1|Overall Study|In care/cured elsewhere|15
2438838|NCT03087643|8374374|P2|Overall Study|Death|2
2438839|NCT03087643|8374375|P1|Overall Study|Death|2
2438840|NCT03087643|8374374|P2|Overall Study|Withdrawal by Subject|4
2438841|NCT03087643|8374375|P1|Overall Study|Withdrawal by Subject|2
2438842|NCT03086551|8374404|P2|Washout|Withdrawal by Subject|1
2438843|NCT03086551|8374405|P1|Washout|Withdrawal by Subject|2
2438844|NCT03086551|8374404|P2|Washout|Lost to Follow-up|2
2438845|NCT03086551|8374405|P1|Washout|Lost to Follow-up|1
2438846|NCT03086551|8374404|P2|First Intervention|Lost to Follow-up|1
2438847|NCT03086551|8374405|P1|First Intervention|Lost to Follow-up|0
2438848|NCT03086551|8374404|P2|First Intervention|Failure to meet inclusion criterion|0
2438849|NCT03086551|8374405|P1|First Intervention|Failure to meet inclusion criterion|1
2438850|NCT03086447|8374421|P2|Overall Study|Lens Discomfort|1
2438851|NCT03086447|8374422|P1|Overall Study|Lens Discomfort|2
2438852|NCT03086447|8374421|P2|Overall Study|Adverse Event|0
2438853|NCT03086447|8374422|P1|Overall Study|Adverse Event|3
2438854|NCT03086447|8374421|P2|Overall Study|Lost to Follow-up|1
2438855|NCT03086447|8374422|P1|Overall Study|Lost to Follow-up|0
2438856|NCT03086447|8374421|P2|Overall Study|Protocol Violation|4
2438857|NCT03086447|8374422|P1|Overall Study|Protocol Violation|2
2438858|NCT03086447|8374421|P2|Overall Study|Test Article No Longer Available|0
2438859|NCT03086447|8374422|P1|Overall Study|Test Article No Longer Available|1
2438860|NCT03086447|8374421|P2|Overall Study|Unsatisfactory Lens Fitting|1
2438861|NCT03086447|8374422|P1|Overall Study|Unsatisfactory Lens Fitting|0
2438862|NCT03086447|8374421|P2|Overall Study|Lens Damage|6
2438863|NCT03086447|8374422|P1|Overall Study|Lens Damage|1
2438864|NCT03086447|8374421|P2|Overall Study|Product quality complaint|1
2438865|NCT03086447|8374422|P1|Overall Study|Product quality complaint|0
2438866|NCT03086447|8374421|P2|Overall Study|Lost Lens|5
2438867|NCT03086447|8374422|P1|Overall Study|Lost Lens|2
2438868|NCT03086447|8374421|P2|Overall Study|No Longer Meets Eligibility Criteria|1
2438869|NCT03086447|8374422|P1|Overall Study|No Longer Meets Eligibility Criteria|0
2438870|NCT03086330|8374453|P2|Overall Study|Lost to Follow-up|2
2438871|NCT03086330|8374454|P1|Overall Study|Lost to Follow-up|1
2438872|NCT03086330|8374453|P2|Overall Study|Withdrawal by Subject|2
2438873|NCT03086330|8374454|P1|Overall Study|Withdrawal by Subject|3
2438874|NCT03086135|8374634|P1|Overall Study|Lost to Follow-up|2
2438875|NCT03086135|8374634|P1|Overall Study|Adverse Event|1
2438876|NCT03086018|8374661|P1|Final Testing for End of Trial|Withdrawal by Subject|1
2438877|NCT03086018|8374661|P1|Final Testing for End of Trial|Adverse Event|1
2438878|NCT03085238|8374721|P1|Overall Study|Death|2
2438879|NCT03085238|8374721|P1|Overall Study|Adverse Event|2
2438880|NCT03084315|8374748|P2|Overall Study|Withdrawal by Subject|2
2438881|NCT03084315|8374749|P1|Overall Study|Withdrawal by Subject|2
2438882|NCT03084315|8374748|P2|Overall Study|Lost to Follow-up|7
2438883|NCT03084315|8374749|P1|Overall Study|Lost to Follow-up|8
2438884|NCT03083639|8374772|P2|Washout Period (at Least 6 Days)|Lost to Follow-up|0
2438885|NCT03083639|8374773|P1|Washout Period (at Least 6 Days)|Lost to Follow-up|1
2438886|NCT03083639|8374772|P2|Washout Period (at Least 6 Days)|Pregnancy|1
2438887|NCT03083639|8374773|P1|Washout Period (at Least 6 Days)|Pregnancy|0
2438888|NCT03083483|8374786|P3|Overall Study|technological issues|1
2438889|NCT03083483|8374787|P2|Overall Study|technological issues|0
2438890|NCT03083483|8374788|P1|Overall Study|technological issues|1
2438891|NCT03083483|8374786|P3|Overall Study|Lost to Follow-up|1
2438892|NCT03083483|8374787|P2|Overall Study|Lost to Follow-up|1
2438893|NCT03083483|8374788|P1|Overall Study|Lost to Follow-up|2
2438894|NCT03083483|8374786|P3|Overall Study|Adverse Event|1
2438895|NCT03083483|8374787|P2|Overall Study|Adverse Event|1
2438896|NCT03083483|8374788|P1|Overall Study|Adverse Event|1
2438897|NCT03083470|8374807|P5|Overall Study|Withdrawal by Subject|1
2438898|NCT03083470|8374808|P4|Overall Study|Withdrawal by Subject|0
2438899|NCT03083470|8374809|P3|Overall Study|Withdrawal by Subject|0
2438900|NCT03083470|8374810|P2|Overall Study|Withdrawal by Subject|0
2438901|NCT03083470|8374811|P1|Overall Study|Withdrawal by Subject|0
2438902|NCT03083470|8374807|P5|Overall Study|Lost to Follow-up|1
2438903|NCT03083470|8374808|P4|Overall Study|Lost to Follow-up|0
2438904|NCT03083470|8374809|P3|Overall Study|Lost to Follow-up|0
2438905|NCT03083470|8374810|P2|Overall Study|Lost to Follow-up|0
2438906|NCT03083470|8374811|P1|Overall Study|Lost to Follow-up|0
2438907|NCT03082599|8374859|P2|Overall Study|Lost to Follow-up|0
2438908|NCT03082599|8374860|P1|Overall Study|Lost to Follow-up|1
2438909|NCT03080961|8374886|P1|Overall Study|Withdrawal by Subject|3
2438910|NCT03080493|8374897|P2|Overall Study|Randomization error (parity group)|1
2438911|NCT03080493|8374898|P1|Overall Study|Randomization error (parity group)|0
2438912|NCT03080493|8374897|P2|Overall Study|Adverse Event|1
2438913|NCT03080493|8374898|P1|Overall Study|Adverse Event|0
2438914|NCT03080493|8374897|P2|Overall Study|Did not provide NRS pain results|0
2438915|NCT03080493|8374898|P1|Overall Study|Did not provide NRS pain results|1
2438916|NCT03080454|8374914|P1|Anodal FU (7 Days)|Lost to Follow-up|4
2438917|NCT03080454|8374914|P1|Anodal Doublestim (5 Days)|Adverse Event|1
2438918|NCT03080454|8374914|P1|Baseline|Adverse Event|2
2438919|NCT03078582|8375005|P2|Overall Study|Adverse Event|8
2438920|NCT03078582|8375006|P1|Overall Study|Adverse Event|0
2438921|NCT03078556|8375026|P4|Washout Period 1 (7 Days)|Physician Decision|0
2438922|NCT03078556|8375027|P3|Washout Period 1 (7 Days)|Physician Decision|0
2438923|NCT03078556|8375028|P2|Washout Period 1 (7 Days)|Physician Decision|1
2438924|NCT03078556|8375029|P1|Washout Period 1 (7 Days)|Physician Decision|0
2438925|NCT03078556|8375026|P4|Washout Period 1 (7 Days)|Adverse Event|1
2438926|NCT03078556|8375027|P3|Washout Period 1 (7 Days)|Adverse Event|0
2438927|NCT03078556|8375028|P2|Washout Period 1 (7 Days)|Adverse Event|1
2438928|NCT03078556|8375029|P1|Washout Period 1 (7 Days)|Adverse Event|0
2438929|NCT03078556|8375026|P4|Washout Period 1 (7 Days)|Lost to Follow-up|0
2438930|NCT03078556|8375027|P3|Washout Period 1 (7 Days)|Lost to Follow-up|1
2438931|NCT03078556|8375028|P2|Washout Period 1 (7 Days)|Lost to Follow-up|0
2438932|NCT03078556|8375029|P1|Washout Period 1 (7 Days)|Lost to Follow-up|2
2438933|NCT03078556|8375026|P4|Treatment Period 1 (4 Days)|Adverse Event|0
2438934|NCT03078556|8375027|P3|Treatment Period 1 (4 Days)|Adverse Event|0
2438935|NCT03078556|8375028|P2|Treatment Period 1 (4 Days)|Adverse Event|1
2438936|NCT03078556|8375029|P1|Treatment Period 1 (4 Days)|Adverse Event|0
2438937|NCT03078478|8375173|P2|Maintencance Period 2 (36 Weeks)|Not reconsenting|2
2438938|NCT03078478|8375174|P1|Maintencance Period 2 (36 Weeks)|Not reconsenting|0
2438939|NCT03078478|8375173|P2|Maintencance Period 2 (36 Weeks)|Death|6
2438940|NCT03078478|8375174|P1|Maintencance Period 2 (36 Weeks)|Death|4
2438941|NCT03078478|8375173|P2|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6
2438942|NCT03078478|8375174|P1|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3
2438943|NCT03078478|8375173|P2|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13
2438944|NCT03078478|8375174|P1|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18
2438945|NCT03078478|8375173|P2|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0
2438946|NCT03078478|8375174|P1|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1
2438947|NCT03078478|8375173|P2|Maintenance Period 1 (36 Weeks)|Death|3
2438948|NCT03078478|8375174|P1|Maintenance Period 1 (36 Weeks)|Death|3
2438949|NCT03078478|8375173|P2|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4
2438950|NCT03078478|8375174|P1|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7
2438951|NCT03078478|8375173|P2|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36
2438952|NCT03078478|8375174|P1|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36
2438953|NCT03077724|8375290|P2|Overall Study|Withdrawal by Subject|1
2438954|NCT03077724|8375291|P1|Overall Study|Withdrawal by Subject|3
2438955|NCT03077724|8375290|P2|Overall Study|Lost to Follow-up|1
2438956|NCT03077724|8375291|P1|Overall Study|Lost to Follow-up|5
2438957|NCT03077711|8375303|P2|Overall Study|noncompliant taking medication|0
2438958|NCT03077711|8375304|P1|Overall Study|noncompliant taking medication|2
2438959|NCT03077711|8375303|P2|Overall Study|Lost to Follow-up|2
2438960|NCT03077711|8375304|P1|Overall Study|Lost to Follow-up|2
2438961|NCT03077659|8375323|P3|Overall Study|Withdrawal by Subject|1
2438962|NCT03077659|8375324|P2|Overall Study|Withdrawal by Subject|0
2438963|NCT03077659|8375325|P1|Overall Study|Withdrawal by Subject|0
2438964|NCT03077607|8375356|P2|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2
2438965|NCT03077607|8375357|P1|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2
2438966|NCT03077607|8375356|P2|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0
2438967|NCT03077607|8375357|P1|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1
2438968|NCT03077607|8375356|P2|Period 1 (15 Days)|Death|0
2438969|NCT03077607|8375357|P1|Period 1 (15 Days)|Death|1
2438970|NCT03077607|8375356|P2|Period 1 (15 Days)|Adverse Event|0
2438971|NCT03077607|8375357|P1|Period 1 (15 Days)|Adverse Event|1
2438972|NCT03076996|8375423|P1|Overall Study|Literacy precluded participation|1
2438973|NCT03076996|8375423|P1|Overall Study|Lost to Follow-up|3
2438974|NCT03076996|8375423|P1|Overall Study|Withdrawal by Subject|2
2438975|NCT03076970|8375449|P6|Period 3|Failure to meet I/E criteria|0
2438976|NCT03076970|8375450|P5|Period 3|Failure to meet I/E criteria|1
2438977|NCT03076970|8375451|P4|Period 3|Failure to meet I/E criteria|0
2438978|NCT03076970|8375452|P3|Period 3|Failure to meet I/E criteria|0
2438979|NCT03076970|8375453|P2|Period 3|Failure to meet I/E criteria|0
2438980|NCT03076970|8375454|P1|Period 3|Failure to meet I/E criteria|0
2438981|NCT03076970|8375449|P6|Period 3|Withdrawal by Subject|1
2438982|NCT03076970|8375450|P5|Period 3|Withdrawal by Subject|0
2438983|NCT03076970|8375451|P4|Period 3|Withdrawal by Subject|0
2438984|NCT03076970|8375452|P3|Period 3|Withdrawal by Subject|0
2438985|NCT03076970|8375453|P2|Period 3|Withdrawal by Subject|0
2438986|NCT03076970|8375454|P1|Period 3|Withdrawal by Subject|0
2438987|NCT03076970|8375449|P6|Washout Period 2|Adverse Event|0
2438988|NCT03076970|8375450|P5|Washout Period 2|Adverse Event|1
2438989|NCT03076970|8375451|P4|Washout Period 2|Adverse Event|0
2438990|NCT03076970|8375452|P3|Washout Period 2|Adverse Event|0
2438991|NCT03076970|8375453|P2|Washout Period 2|Adverse Event|0
2438992|NCT03076970|8375454|P1|Washout Period 2|Adverse Event|0
2438993|NCT03076190|8375506|P2|Overall Study|Excluded from Analysis (zero duration ev|7
2438994|NCT03076190|8375507|P1|Overall Study|Excluded from Analysis (zero duration ev|9
2438995|NCT03076190|8375506|P2|Overall Study|Lost to Follow-up|34
2438996|NCT03076190|8375507|P1|Overall Study|Lost to Follow-up|9
2438997|NCT03075904|8375520|P1|Overall Study|Need for Medication not Permitted|1
2438998|NCT03075904|8375520|P1|Overall Study|Physician Decision|3
2438999|NCT03075891|8375530|P2|Overall Study|Drug abuse relapse issue|1
2439000|NCT03075891|8375531|P1|Overall Study|Drug abuse relapse issue|0
2439001|NCT03075891|8375530|P2|Overall Study|Patient requiring study withdrawal|1
2439002|NCT03075891|8375531|P1|Overall Study|Patient requiring study withdrawal|0
2439003|NCT03075891|8375530|P2|Overall Study|Other visits not performed (no time)|0
2439004|NCT03075891|8375531|P1|Overall Study|Other visits not performed (no time)|1
2439005|NCT03075891|8375530|P2|Overall Study|Pregnancy|1
2439006|NCT03075891|8375531|P1|Overall Study|Pregnancy|3
2439007|NCT03075891|8375530|P2|Overall Study|Lost to Follow-up|0
2439008|NCT03075891|8375531|P1|Overall Study|Lost to Follow-up|1
2439009|NCT03075891|8375530|P2|Overall Study|Withdrawal by Subject|6
2439010|NCT03075891|8375531|P1|Overall Study|Withdrawal by Subject|3
2439011|NCT03075891|8375530|P2|Overall Study|Adverse Event|4
2439012|NCT03075891|8375531|P1|Overall Study|Adverse Event|1
2439013|NCT03075839|8375537|P1|Overall Study|Lost to Follow-up|4
2439014|NCT03075527|8375552|P1|Overall Study|Ongoing treatment|2
2439015|NCT03075410|8375576|P9|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
2439016|NCT03075410|8375577|P8|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
2439017|NCT03075410|8375578|P7|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
2439018|NCT03075410|8375579|P6|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
2439019|NCT03075410|8375580|P5|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
2439020|NCT03075410|8375581|P4|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
2439021|NCT03075410|8375582|P3|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
2439022|NCT03075410|8375583|P2|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
2439023|NCT03075410|8375584|P1|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1
2439024|NCT03075410|8375576|P9|Part A-Period 2 (14 Days)|Personal reasons|0
2439025|NCT03075410|8375577|P8|Part A-Period 2 (14 Days)|Personal reasons|0
2439026|NCT03075410|8375578|P7|Part A-Period 2 (14 Days)|Personal reasons|0
2439027|NCT03075410|8375579|P6|Part A-Period 2 (14 Days)|Personal reasons|0
2439028|NCT03075410|8375580|P5|Part A-Period 2 (14 Days)|Personal reasons|0
2439029|NCT03075410|8375581|P4|Part A-Period 2 (14 Days)|Personal reasons|0
2439030|NCT03075410|8375582|P3|Part A-Period 2 (14 Days)|Personal reasons|1
2439031|NCT03075410|8375583|P2|Part A-Period 2 (14 Days)|Personal reasons|0
2439032|NCT03075410|8375584|P1|Part A-Period 2 (14 Days)|Personal reasons|1
2439033|NCT03075163|8375750|P2|Overall Study|not eligible for treatment limb|138
2439034|NCT03075163|8375751|P1|Overall Study|not eligible for treatment limb|138
2439035|NCT03074500|8375782|P3|Overall Study|Adverse Event|1
2439036|NCT03074500|8375783|P2|Overall Study|Adverse Event|0
2439037|NCT03074500|8375784|P1|Overall Study|Adverse Event|0
2439038|NCT03074500|8375782|P3|Overall Study|Lack of Efficacy|0
2439039|NCT03074500|8375783|P2|Overall Study|Lack of Efficacy|1
2439040|NCT03074500|8375784|P1|Overall Study|Lack of Efficacy|0
2439041|NCT03074500|8375782|P3|Overall Study|Lost to Follow-up|0
2439042|NCT03074500|8375783|P2|Overall Study|Lost to Follow-up|0
2439043|NCT03074500|8375784|P1|Overall Study|Lost to Follow-up|1
2439044|NCT03074331|8375821|P1|Overall Study|Withdrew Consent|1
2439045|NCT03074331|8375821|P1|Overall Study|Lost to Follow-up|5
2439046|NCT03074331|8375821|P1|Overall Study|Enrolled but Not Treated|1
2439047|NCT03074162|8375833|P6|Period 3|Withdrawal by Subject|0
2439048|NCT03074162|8375834|P5|Period 3|Withdrawal by Subject|1
2439049|NCT03074162|8375835|P4|Period 3|Withdrawal by Subject|0
2439050|NCT03074162|8375836|P3|Period 3|Withdrawal by Subject|0
2439051|NCT03074162|8375837|P2|Period 3|Withdrawal by Subject|0
2439052|NCT03074162|8375838|P1|Period 3|Withdrawal by Subject|1
2439053|NCT03074162|8375833|P6|Period 2 Including Washout 2|Withdrawal by Subject|1
2439054|NCT03074162|8375834|P5|Period 2 Including Washout 2|Withdrawal by Subject|0
2439055|NCT03074162|8375835|P4|Period 2 Including Washout 2|Withdrawal by Subject|0
2439056|NCT03074162|8375836|P3|Period 2 Including Washout 2|Withdrawal by Subject|1
2439057|NCT03074162|8375837|P2|Period 2 Including Washout 2|Withdrawal by Subject|0
2439058|NCT03074162|8375838|P1|Period 2 Including Washout 2|Withdrawal by Subject|0
2439059|NCT03074162|8375833|P6|Period 1 Including Washout 1|Withdrawal by Subject|0
2439060|NCT03074162|8375834|P5|Period 1 Including Washout 1|Withdrawal by Subject|0
2439061|NCT03074162|8375835|P4|Period 1 Including Washout 1|Withdrawal by Subject|0
2439062|NCT03074162|8375836|P3|Period 1 Including Washout 1|Withdrawal by Subject|1
2439063|NCT03074162|8375837|P2|Period 1 Including Washout 1|Withdrawal by Subject|0
2439064|NCT03074162|8375838|P1|Period 1 Including Washout 1|Withdrawal by Subject|0
2439065|NCT03073798|8375900|P1|Overall Study|Withdrawal by Subject|1
2439066|NCT03073798|8375900|P1|Overall Study|Adverse Event|1
2439067|NCT03073200|8375927|P3|Overall Study|Lack of Efficacy|0
2439068|NCT03073200|8375928|P2|Overall Study|Lack of Efficacy|0
2439069|NCT03073200|8375929|P1|Overall Study|Lack of Efficacy|1
2439070|NCT03073200|8375927|P3|Overall Study|Protocol Violation|0
2439071|NCT03073200|8375928|P2|Overall Study|Protocol Violation|0
2439072|NCT03073200|8375929|P1|Overall Study|Protocol Violation|2
2439073|NCT03073200|8375927|P3|Overall Study|Site closed by sponsor|1
2439074|NCT03073200|8375928|P2|Overall Study|Site closed by sponsor|0
2439075|NCT03073200|8375929|P1|Overall Study|Site closed by sponsor|0
2439076|NCT03073200|8375927|P3|Overall Study|Withdrawal by parent/guardian|1
2439077|NCT03073200|8375928|P2|Overall Study|Withdrawal by parent/guardian|1
2439078|NCT03073200|8375929|P1|Overall Study|Withdrawal by parent/guardian|0
2439079|NCT03073200|8375927|P3|Overall Study|Continuing treatment (Ongoing)|28
2439080|NCT03073200|8375928|P2|Overall Study|Continuing treatment (Ongoing)|106
2439081|NCT03073200|8375929|P1|Overall Study|Continuing treatment (Ongoing)|48
2439082|NCT03073200|8375927|P3|Overall Study|Withdrawal by Subject|0
2439083|NCT03073200|8375928|P2|Overall Study|Withdrawal by Subject|3
2439084|NCT03073200|8375929|P1|Overall Study|Withdrawal by Subject|3
2439085|NCT03073200|8375927|P3|Overall Study|Participant had Crohns disease|0
2439086|NCT03073200|8375928|P2|Overall Study|Participant had Crohns disease|1
2439087|NCT03073200|8375929|P1|Overall Study|Participant had Crohns disease|0
2439088|NCT03073200|8375927|P3|Overall Study|Lost to Follow-up|0
2439089|NCT03073200|8375928|P2|Overall Study|Lost to Follow-up|2
2439090|NCT03073200|8375929|P1|Overall Study|Lost to Follow-up|1
2439091|NCT03073200|8375927|P3|Overall Study|Adverse Event|0
2439092|NCT03073200|8375928|P2|Overall Study|Adverse Event|2
2439093|NCT03073200|8375929|P1|Overall Study|Adverse Event|0
2439094|NCT03072875|8375965|P1|Overall Study|Lost to Follow-up|1
2439095|NCT03072719|8375972|P2|Overall Study|Adverse Event|1
2439096|NCT03072719|8375973|P1|Overall Study|Adverse Event|1
2439097|NCT03071276|8375998|P1|Overall Study|Lack of Efficacy|14
2439098|NCT03071276|8375998|P1|Overall Study|Adverse Event|1
2439099|NCT03071263|8376006|P2|Overall Study|Participant moved to another city|1
2439100|NCT03071263|8376007|P1|Overall Study|Participant moved to another city|0
2439101|NCT03071263|8376006|P2|Overall Study|Physician Decision|0
2439102|NCT03071263|8376007|P1|Overall Study|Physician Decision|1
2439103|NCT03071263|8376006|P2|Overall Study|Withdrawal by Subject|3
2439104|NCT03071263|8376007|P1|Overall Study|Withdrawal by Subject|1
2439105|NCT03071263|8376006|P2|Overall Study|Adverse Event|3
2439106|NCT03071263|8376007|P1|Overall Study|Adverse Event|1
2439107|NCT03070431|8376241|P1|Overall Study|Lost to Follow-up|2
2439108|NCT03070431|8376241|P1|Overall Study|Withdrawal by Subject|2
2439109|NCT03070171|8376263|P2|Treatment Period 4 + Washout|Withdrawal by Subject|1
2439110|NCT03070171|8376264|P1|Treatment Period 4 + Washout|Withdrawal by Subject|0
2439111|NCT03070171|8376263|P2|Treatment Period 2 + Washout|Other Adverse Event|1
2439112|NCT03070171|8376264|P1|Treatment Period 2 + Washout|Other Adverse Event|0
2439113|NCT03070002|8376280|P1|Follow up for 2 Years|Death|1
2439114|NCT03069989|8376288|P2|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0
2439115|NCT03069989|8376289|P1|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1
2439116|NCT03069482|8376396|P2|Overall Study|Physician Decision|0
2439117|NCT03069482|8376397|P1|Overall Study|Physician Decision|1
2439118|NCT03069482|8376396|P2|Overall Study|Lost to Follow-up|1
2439119|NCT03069482|8376397|P1|Overall Study|Lost to Follow-up|0
2439120|NCT03069365|8376507|P1|Overall Study|Adverse Event|1
2439121|NCT03069352|8376515|P2|Overall Study|Ongoing|40
2439122|NCT03069352|8376516|P1|Overall Study|Ongoing|12
2439123|NCT03069313|8376558|P1|Overall Study|Adverse Event|5
2439124|NCT03068767|8376567|P2|Overall Study|Protocol Violation|0
2439125|NCT03068767|8376568|P1|Overall Study|Protocol Violation|3
2439126|NCT03068767|8376567|P2|Overall Study|Lost to Follow-up|3
2439127|NCT03068767|8376568|P1|Overall Study|Lost to Follow-up|7
2439128|NCT03066999|8376614|P2|Overall Study|abnormal urethraBladder neck contracture|2
2439129|NCT03066999|8376615|P1|Overall Study|abnormal urethraBladder neck contracture|0
2439130|NCT03066622|8376635|P2|Overall Study|Withdrawal by Subject|1
2439131|NCT03066622|8376636|P1|Overall Study|Withdrawal by Subject|2
2439132|NCT03066622|8376635|P2|Overall Study|Lost to Follow-up|25
2439133|NCT03066622|8376636|P1|Overall Study|Lost to Follow-up|24
2439134|NCT03066609|8376649|P4|OVERALL STUDY|discontinued follow up|0
2439135|NCT03066609|8376650|P3|OVERALL STUDY|discontinued follow up|0
2439136|NCT03066609|8376651|P2|OVERALL STUDY|discontinued follow up|2
2439137|NCT03066609|8376652|P1|OVERALL STUDY|discontinued follow up|0
2439138|NCT03066609|8376649|P4|OVERALL STUDY|Lack of Efficacy|1
2439139|NCT03066609|8376650|P3|OVERALL STUDY|Lack of Efficacy|1
2439140|NCT03066609|8376651|P2|OVERALL STUDY|Lack of Efficacy|1
2439141|NCT03066609|8376652|P1|OVERALL STUDY|Lack of Efficacy|2
2439142|NCT03066609|8376649|P4|OVERALL STUDY|Pregnancy|0
2439143|NCT03066609|8376650|P3|OVERALL STUDY|Pregnancy|1
2439144|NCT03066609|8376651|P2|OVERALL STUDY|Pregnancy|0
2439145|NCT03066609|8376652|P1|OVERALL STUDY|Pregnancy|1
2439146|NCT03066609|8376649|P4|OVERALL STUDY|Lost to Follow-up|1
2439147|NCT03066609|8376650|P3|OVERALL STUDY|Lost to Follow-up|1
2439148|NCT03066609|8376651|P2|OVERALL STUDY|Lost to Follow-up|1
2439149|NCT03066609|8376652|P1|OVERALL STUDY|Lost to Follow-up|1
2439150|NCT03066609|8376649|P4|OVERALL STUDY|Withdrawal by Subject|2
2439151|NCT03066609|8376650|P3|OVERALL STUDY|Withdrawal by Subject|1
2439152|NCT03066609|8376651|P2|OVERALL STUDY|Withdrawal by Subject|2
2439153|NCT03066609|8376652|P1|OVERALL STUDY|Withdrawal by Subject|4
2439154|NCT03066609|8376649|P4|OVERALL STUDY|Adverse Event|1
2439155|NCT03066609|8376650|P3|OVERALL STUDY|Adverse Event|0
2439156|NCT03066609|8376651|P2|OVERALL STUDY|Adverse Event|2
2439157|NCT03066609|8376652|P1|OVERALL STUDY|Adverse Event|2
2439158|NCT03066609|8376649|P4|MAINTENANCE|Lack of Efficacy|1
2439159|NCT03066609|8376650|P3|MAINTENANCE|Lack of Efficacy|0
2439160|NCT03066609|8376651|P2|MAINTENANCE|Lack of Efficacy|1
2439161|NCT03066609|8376652|P1|MAINTENANCE|Lack of Efficacy|2
2439162|NCT03066609|8376649|P4|MAINTENANCE|Pregnancy|0
2439163|NCT03066609|8376650|P3|MAINTENANCE|Pregnancy|0
2439164|NCT03066609|8376651|P2|MAINTENANCE|Pregnancy|0
2439165|NCT03066609|8376652|P1|MAINTENANCE|Pregnancy|1
2439166|NCT03066609|8376649|P4|MAINTENANCE|Lost to Follow-up|0
2439167|NCT03066609|8376650|P3|MAINTENANCE|Lost to Follow-up|1
2439168|NCT03066609|8376651|P2|MAINTENANCE|Lost to Follow-up|1
2439169|NCT03066609|8376652|P1|MAINTENANCE|Lost to Follow-up|0
2439170|NCT03066609|8376649|P4|MAINTENANCE|Withdrawal by Subject|1
2439171|NCT03066609|8376650|P3|MAINTENANCE|Withdrawal by Subject|1
2439172|NCT03066609|8376651|P2|MAINTENANCE|Withdrawal by Subject|2
2439173|NCT03066609|8376652|P1|MAINTENANCE|Withdrawal by Subject|4
2439174|NCT03066609|8376649|P4|MAINTENANCE|Adverse Event|1
2439175|NCT03066609|8376650|P3|MAINTENANCE|Adverse Event|0
2439176|NCT03066609|8376651|P2|MAINTENANCE|Adverse Event|0
2439177|NCT03066609|8376652|P1|MAINTENANCE|Adverse Event|0
2439178|NCT03066609|8376649|P4|INDUCTION|Adverse Event|0
2439179|NCT03066609|8376650|P3|INDUCTION|Adverse Event|0
2439180|NCT03066609|8376651|P2|INDUCTION|Adverse Event|2
2439181|NCT03066609|8376652|P1|INDUCTION|Adverse Event|2
2439182|NCT03066609|8376649|P4|INDUCTION|Lack of Efficacy|0
2439183|NCT03066609|8376650|P3|INDUCTION|Lack of Efficacy|1
2439184|NCT03066609|8376651|P2|INDUCTION|Lack of Efficacy|0
2439185|NCT03066609|8376652|P1|INDUCTION|Lack of Efficacy|0
2439186|NCT03066609|8376649|P4|INDUCTION|Pregnancy|0
2439187|NCT03066609|8376650|P3|INDUCTION|Pregnancy|1
2439188|NCT03066609|8376651|P2|INDUCTION|Pregnancy|0
2439189|NCT03066609|8376652|P1|INDUCTION|Pregnancy|0
2439190|NCT03066193|8376682|P1|Overall Study|Withdrawal by Subject|1
2439191|NCT03065933|8376695|P1|Overall Study|study terminated|5
2439192|NCT03065530|8376703|P4|Overall Study|Protocol Violation|1
2439193|NCT03065530|8376704|P3|Overall Study|Protocol Violation|1
2439194|NCT03065530|8376705|P2|Overall Study|Protocol Violation|0
2439195|NCT03065530|8376706|P1|Overall Study|Protocol Violation|1
2439196|NCT03065530|8376703|P4|Overall Study|Lack of Efficacy|1
2439197|NCT03065530|8376704|P3|Overall Study|Lack of Efficacy|0
2439198|NCT03065530|8376705|P2|Overall Study|Lack of Efficacy|1
2439199|NCT03065530|8376706|P1|Overall Study|Lack of Efficacy|1
2439200|NCT03065023|8376814|P5|Overall Study|Withdrawal by Subject|0
2439201|NCT03065023|8376815|P4|Overall Study|Withdrawal by Subject|1
2439202|NCT03065023|8376816|P3|Overall Study|Withdrawal by Subject|0
2439203|NCT03065023|8376817|P2|Overall Study|Withdrawal by Subject|0
2439204|NCT03065023|8376818|P1|Overall Study|Withdrawal by Subject|0
2439205|NCT03065023|8376814|P5|Overall Study|Participant Decision|0
2439206|NCT03065023|8376815|P4|Overall Study|Participant Decision|1
2439207|NCT03065023|8376816|P3|Overall Study|Participant Decision|0
2439208|NCT03065023|8376817|P2|Overall Study|Participant Decision|0
2439209|NCT03065023|8376818|P1|Overall Study|Participant Decision|0
2439210|NCT03065023|8376814|P5|Overall Study|Lost to Follow-up|0
2439211|NCT03065023|8376815|P4|Overall Study|Lost to Follow-up|0
2439212|NCT03065023|8376816|P3|Overall Study|Lost to Follow-up|0
2439213|NCT03065023|8376817|P2|Overall Study|Lost to Follow-up|1
2439214|NCT03065023|8376818|P1|Overall Study|Lost to Follow-up|0
2439215|NCT03065023|8376814|P5|Overall Study|Death|0
2439216|NCT03065023|8376815|P4|Overall Study|Death|1
2439217|NCT03065023|8376816|P3|Overall Study|Death|1
2439218|NCT03065023|8376817|P2|Overall Study|Death|0
2439219|NCT03065023|8376818|P1|Overall Study|Death|2
2439220|NCT03065023|8376814|P5|Overall Study|Progressive Disease|0
2439221|NCT03065023|8376815|P4|Overall Study|Progressive Disease|0
2439222|NCT03065023|8376816|P3|Overall Study|Progressive Disease|0
2439223|NCT03065023|8376817|P2|Overall Study|Progressive Disease|1
2439224|NCT03065023|8376818|P1|Overall Study|Progressive Disease|0
2439225|NCT03064841|8376884|P1|Overall Study|Screen failure|2
2439226|NCT03064841|8376884|P1|Overall Study|No glycated haemoglobinA1c measurement|11
2439227|NCT03064841|8376884|P1|Overall Study|Inclusion/exclusion criteria violation|4
2439228|NCT03064451|8376899|P1|Overall Study|Withdrew consent: 3-month FU visit|1
2439229|NCT03064451|8376899|P1|Overall Study|Exited prior to procedure|8
2439230|NCT03064451|8376899|P1|Overall Study|Mapping Failure|4
2439231|NCT03064451|8376899|P1|Overall Study|Lost to Follow-up|1
2439232|NCT03063086|8377001|P6|Overall Study|Physician Decision|0
2439233|NCT03063086|8377002|P5|Overall Study|Physician Decision|0
2439234|NCT03063086|8377003|P4|Overall Study|Physician Decision|1
2439235|NCT03063086|8377004|P3|Overall Study|Physician Decision|0
2439236|NCT03063086|8377005|P2|Overall Study|Physician Decision|0
2439237|NCT03063086|8377006|P1|Overall Study|Physician Decision|0
2439238|NCT03063086|8377001|P6|Overall Study|Non-compliance with study treatment|1
2439239|NCT03063086|8377002|P5|Overall Study|Non-compliance with study treatment|0
2439240|NCT03063086|8377003|P4|Overall Study|Non-compliance with study treatment|1
2439241|NCT03063086|8377004|P3|Overall Study|Non-compliance with study treatment|0
2439242|NCT03063086|8377005|P2|Overall Study|Non-compliance with study treatment|0
2439243|NCT03063086|8377006|P1|Overall Study|Non-compliance with study treatment|0
2439244|NCT03063086|8377001|P6|Overall Study|subject/guardian decision|0
2439245|NCT03063086|8377002|P5|Overall Study|subject/guardian decision|0
2439246|NCT03063086|8377003|P4|Overall Study|subject/guardian decision|0
2439247|NCT03063086|8377004|P3|Overall Study|subject/guardian decision|0
2439248|NCT03063086|8377005|P2|Overall Study|subject/guardian decision|0
2439249|NCT03063086|8377006|P1|Overall Study|subject/guardian decision|1
2439250|NCT03063086|8377001|P6|Overall Study|Adverse Event|0
2439251|NCT03063086|8377002|P5|Overall Study|Adverse Event|0
2439252|NCT03063086|8377003|P4|Overall Study|Adverse Event|1
2439253|NCT03063086|8377004|P3|Overall Study|Adverse Event|1
2439254|NCT03063086|8377005|P2|Overall Study|Adverse Event|1
2439255|NCT03063086|8377006|P1|Overall Study|Adverse Event|1
2439256|NCT03063086|8377001|P6|Overall Study|technical problems|0
2439257|NCT03063086|8377002|P5|Overall Study|technical problems|0
2439258|NCT03063086|8377003|P4|Overall Study|technical problems|0
2439259|NCT03063086|8377004|P3|Overall Study|technical problems|0
2439260|NCT03063086|8377005|P2|Overall Study|technical problems|0
2439261|NCT03063086|8377006|P1|Overall Study|technical problems|1
2439262|NCT03061331|8377102|P2|Washout Period (8 Weeks)|Adverse Event|1
2439263|NCT03061331|8377103|P1|Washout Period (8 Weeks)|Adverse Event|2
2439264|NCT03061214|8377133|P3|Overall Study|Death|0
2439265|NCT03061214|8377134|P2|Overall Study|Death|1
2439266|NCT03061214|8377135|P1|Overall Study|Death|1
2439267|NCT03061214|8377133|P3|Overall Study|Lost to Follow-up|1
2439268|NCT03061214|8377134|P2|Overall Study|Lost to Follow-up|1
2439269|NCT03061214|8377135|P1|Overall Study|Lost to Follow-up|3
2439270|NCT03061214|8377133|P3|Overall Study|Withdrawal by Subject|9
2439271|NCT03061214|8377134|P2|Overall Study|Withdrawal by Subject|26
2439272|NCT03061214|8377135|P1|Overall Study|Withdrawal by Subject|21
2439273|NCT03060512|8377359|P2|Overall Study|Non-compliance with study medication|2
2439274|NCT03060512|8377360|P1|Overall Study|Non-compliance with study medication|1
2439275|NCT03060512|8377359|P2|Overall Study|Withdrawal by Subject|0
2439276|NCT03060512|8377360|P1|Overall Study|Withdrawal by Subject|1
2439277|NCT03060512|8377359|P2|Overall Study|Lost to Follow-up|1
2439278|NCT03060512|8377360|P1|Overall Study|Lost to Follow-up|1
2439279|NCT03060512|8377359|P2|Overall Study|Adverse Event|6
2439280|NCT03060512|8377360|P1|Overall Study|Adverse Event|4
2439281|NCT03058991|8377397|P3|Overall Study|Withdrawal by Subject|0
2439282|NCT03058991|8377398|P2|Overall Study|Withdrawal by Subject|0
2439283|NCT03058991|8377399|P1|Overall Study|Withdrawal by Subject|1
2439284|NCT03058991|8377397|P3|Overall Study|Lost to Follow-up|12
2439285|NCT03058991|8377398|P2|Overall Study|Lost to Follow-up|12
2439286|NCT03058991|8377399|P1|Overall Study|Lost to Follow-up|17
2439287|NCT03058705|8377425|P1|Overall Study|Physician Decision|2
2439288|NCT03058705|8377425|P1|Overall Study|Withdrawal by Subject|2
2439289|NCT03058692|8377431|P2|Overall Study|Withdrawal by Subject|1
2439290|NCT03058692|8377432|P1|Overall Study|Withdrawal by Subject|1
2439291|NCT03058692|8377431|P2|Overall Study|Lost to Follow-up|1
2439292|NCT03058692|8377432|P1|Overall Study|Lost to Follow-up|2
2439293|NCT03056573|8377593|P2|Overall Study|Lost to Follow-up|1
2439294|NCT03056573|8377594|P1|Overall Study|Lost to Follow-up|1
2439295|NCT03056573|8377593|P2|Overall Study|Withdrawal by Subject|0
2439296|NCT03056573|8377594|P1|Overall Study|Withdrawal by Subject|2
2439297|NCT03056573|8377593|P2|Overall Study|Death|4
2439298|NCT03056573|8377594|P1|Overall Study|Death|2
2439299|NCT03056352|8377638|P1|Overall Study|Lost to Follow-up|1
2439300|NCT03056300|8377644|P1|Overall Study|Surgical reason per study protocol|3
2439301|NCT03056040|8377661|P2|Primary Evaluation Period|Pregnancy|1
2439302|NCT03056040|8377662|P1|Primary Evaluation Period|Pregnancy|0
2439303|NCT03056040|8377661|P2|Primary Evaluation Period|Lack of Efficacy|1
2439304|NCT03056040|8377662|P1|Primary Evaluation Period|Lack of Efficacy|0
2439305|NCT03056040|8377661|P2|Primary Evaluation Period|Withdrawal by Subject|1
2439306|NCT03056040|8377662|P1|Primary Evaluation Period|Withdrawal by Subject|1
2439307|NCT03055988|8377676|P2|Period 2|Other than listed|1
2439308|NCT03055988|8377677|P1|Period 2|Other than listed|1
2439309|NCT03055988|8377676|P2|Period 2|Adverse Event|1
2439310|NCT03055988|8377677|P1|Period 2|Adverse Event|0
2439311|NCT03055988|8377676|P2|Period 1|Withdrawal by Subject|4
2439312|NCT03055988|8377677|P1|Period 1|Withdrawal by Subject|0
2439313|NCT03055988|8377676|P2|Period 1|Lost to Follow-up|0
2439314|NCT03055988|8377677|P1|Period 1|Lost to Follow-up|1
2439315|NCT03055988|8377676|P2|Period 1|Adverse Event|1
2439316|NCT03055988|8377677|P1|Period 1|Adverse Event|0
2439317|NCT03055832|8377701|P2|Week 2|Withdrawal by Subject|0
2439318|NCT03055832|8377702|P1|Week 2|Withdrawal by Subject|1
2439319|NCT03055806|8377762|P4|Overall Study|Partner not willing to try intercourse|0
2439320|NCT03055806|8377763|P3|Overall Study|Partner not willing to try intercourse|0
2439321|NCT03055806|8377764|P2|Overall Study|Partner not willing to try intercourse|0
2439322|NCT03055806|8377765|P1|Overall Study|Partner not willing to try intercourse|1
2439323|NCT03055806|8377762|P4|Overall Study|Withdrawal of consent to continue study|6
2439324|NCT03055806|8377763|P3|Overall Study|Withdrawal of consent to continue study|4
2439325|NCT03055806|8377764|P2|Overall Study|Withdrawal of consent to continue study|3
2439326|NCT03055806|8377765|P1|Overall Study|Withdrawal of consent to continue study|2
2439327|NCT03055806|8377762|P4|Overall Study|Withdrawal of consent to continue drug|0
2439328|NCT03055806|8377763|P3|Overall Study|Withdrawal of consent to continue drug|2
2439329|NCT03055806|8377764|P2|Overall Study|Withdrawal of consent to continue drug|1
2439330|NCT03055806|8377765|P1|Overall Study|Withdrawal of consent to continue drug|1
2439331|NCT03055806|8377762|P4|Overall Study|Protocol Violation|0
2439332|NCT03055806|8377763|P3|Overall Study|Protocol Violation|0
2439333|NCT03055806|8377764|P2|Overall Study|Protocol Violation|0
2439334|NCT03055806|8377765|P1|Overall Study|Protocol Violation|1
2439335|NCT03055806|8377762|P4|Overall Study|Physician Decision|1
2439336|NCT03055806|8377763|P3|Overall Study|Physician Decision|0
2439337|NCT03055806|8377764|P2|Overall Study|Physician Decision|0
2439338|NCT03055806|8377765|P1|Overall Study|Physician Decision|1
2439339|NCT03055806|8377762|P4|Overall Study|Lost to Follow-up|7
2439340|NCT03055806|8377763|P3|Overall Study|Lost to Follow-up|6
2439341|NCT03055806|8377764|P2|Overall Study|Lost to Follow-up|3
2439342|NCT03055806|8377765|P1|Overall Study|Lost to Follow-up|0
2439343|NCT03055806|8377762|P4|Overall Study|Adverse Event|1
2439344|NCT03055806|8377763|P3|Overall Study|Adverse Event|1
2439345|NCT03055806|8377764|P2|Overall Study|Adverse Event|0
2439346|NCT03055806|8377765|P1|Overall Study|Adverse Event|0
2439347|NCT03055624|8377807|P1|Overall Study|Study closed|9
2439348|NCT03055494|8377818|P2|Overall Study|Non-compliance with study treatment|0
2439349|NCT03055494|8377819|P1|Overall Study|Non-compliance with study treatment|1
2439350|NCT03055494|8377818|P2|Overall Study|Adverse Event|1
2439351|NCT03055494|8377819|P1|Overall Study|Adverse Event|0
2439352|NCT03055494|8377818|P2|Overall Study|Withdrawal by Subject|0
2439353|NCT03055494|8377819|P1|Overall Study|Withdrawal by Subject|1
2439354|NCT03055494|8377818|P2|Overall Study|Physician Decision|0
2439355|NCT03055494|8377819|P1|Overall Study|Physician Decision|2
2439356|NCT03055494|8377818|P2|Overall Study|Lost to Follow-up|0
2439357|NCT03055494|8377819|P1|Overall Study|Lost to Follow-up|6
2439358|NCT03055338|8377850|P3|Overall Study|Withdrawal by Subject|7
2439359|NCT03055338|8377851|P2|Overall Study|Withdrawal by Subject|8
2439360|NCT03055338|8377852|P1|Overall Study|Withdrawal by Subject|9
2439361|NCT03055338|8377850|P3|Overall Study|Physician Decision|2
2439362|NCT03055338|8377851|P2|Overall Study|Physician Decision|0
2439363|NCT03055338|8377852|P1|Overall Study|Physician Decision|0
2439364|NCT03055338|8377850|P3|Overall Study|No Post-treatment Protocol Contact|0
2439365|NCT03055338|8377851|P2|Overall Study|No Post-treatment Protocol Contact|1
2439366|NCT03055338|8377852|P1|Overall Study|No Post-treatment Protocol Contact|0
2439367|NCT03055338|8377850|P3|Overall Study|Lost to Follow-up|3
2439368|NCT03055338|8377851|P2|Overall Study|Lost to Follow-up|2
2439369|NCT03055338|8377852|P1|Overall Study|Lost to Follow-up|9
2439370|NCT03055260|8377871|P2|Overall Study|Withdrawal by Subject|0
2439371|NCT03055260|8377872|P1|Overall Study|Withdrawal by Subject|1
2439372|NCT03055221|8377880|P1|Overall Study|Study terminated by Sponsor|3
2439373|NCT03055221|8377880|P1|Overall Study|Physician Decision|1
2439374|NCT03055221|8377880|P1|Overall Study|Death|6
2439375|NCT03055221|8377880|P1|Overall Study|Withdrawal by Subject|4
2439376|NCT03055221|8377880|P1|Overall Study|Adverse Event|2
2439377|NCT03055195|8377887|P2|Overall Study|Physician Decision|0
2439378|NCT03055195|8377888|P1|Overall Study|Physician Decision|1
2439379|NCT03055195|8377887|P2|Overall Study|Protocol Violation|1
2439380|NCT03055195|8377888|P1|Overall Study|Protocol Violation|2
2439381|NCT03055195|8377887|P2|Overall Study|Study Terminated by Sponsor|6
2439382|NCT03055195|8377888|P1|Overall Study|Study Terminated by Sponsor|2
2439383|NCT03055195|8377887|P2|Overall Study|Withdrawal by Subject|7
2439384|NCT03055195|8377888|P1|Overall Study|Withdrawal by Subject|6
2439385|NCT03055195|8377887|P2|Overall Study|Lack of Efficacy|0
2439386|NCT03055195|8377888|P1|Overall Study|Lack of Efficacy|1
2439387|NCT03054428|8378080|P3|Overall Study|Lost to Follow-up|1
2439388|NCT03054428|8378081|P2|Overall Study|Lost to Follow-up|0
2439389|NCT03054428|8378082|P1|Overall Study|Lost to Follow-up|0
2439390|NCT03054428|8378080|P3|Overall Study|Withdrawal by Subject|3
2439391|NCT03054428|8378081|P2|Overall Study|Withdrawal by Subject|2
2439392|NCT03054428|8378082|P1|Overall Study|Withdrawal by Subject|3
2439393|NCT03054428|8378080|P3|Overall Study|Transitioned to OLE study|73
2439394|NCT03054428|8378081|P2|Overall Study|Transitioned to OLE study|76
2439395|NCT03054428|8378082|P1|Overall Study|Transitioned to OLE study|76
2439396|NCT03054428|8378080|P3|Overall Study|Discont'd to enroll in OLE: not enrolled|0
2439397|NCT03054428|8378081|P2|Overall Study|Discont'd to enroll in OLE: not enrolled|0
2439398|NCT03054428|8378082|P1|Overall Study|Discont'd to enroll in OLE: not enrolled|1
2439399|NCT03054428|8378080|P3|Overall Study|Discontinued to enroll in OLE: enrolled|1
2439400|NCT03054428|8378081|P2|Overall Study|Discontinued to enroll in OLE: enrolled|0
2439401|NCT03054428|8378082|P1|Overall Study|Discontinued to enroll in OLE: enrolled|0
2439402|NCT03054428|8378080|P3|Overall Study|Lack of Efficacy|0
2439403|NCT03054428|8378081|P2|Overall Study|Lack of Efficacy|1
2439404|NCT03054428|8378082|P1|Overall Study|Lack of Efficacy|3
2439405|NCT03054428|8378080|P3|Overall Study|Physician Decision|1
2439406|NCT03054428|8378081|P2|Overall Study|Physician Decision|1
2439407|NCT03054428|8378082|P1|Overall Study|Physician Decision|0
2439408|NCT03054064|8378178|P1|Overall Study|Change in Status|1
2439409|NCT03054064|8378178|P1|Overall Study|High Blood Pressure|1
2439410|NCT03054064|8378178|P1|Overall Study|Bladder Issue|1
2439411|NCT03054064|8378178|P1|Overall Study|Investigator Decision|2
2439412|NCT03054064|8378178|P1|Overall Study|Lower Extremity Deep Vein Thrombosis|1
2439413|NCT03053427|8378225|P2|Overall Study|Miscellaneous|1
2439414|NCT03053427|8378226|P1|Overall Study|Miscellaneous|0
2439415|NCT03053427|8378225|P2|Overall Study|Withdrawal by Subject|2
2439416|NCT03053427|8378226|P1|Overall Study|Withdrawal by Subject|3
2439417|NCT03053427|8378225|P2|Overall Study|Protocol Deviation|3
2439418|NCT03053427|8378226|P1|Overall Study|Protocol Deviation|3
2439419|NCT03053427|8378225|P2|Overall Study|Worsening of the target disease|1
2439420|NCT03053427|8378226|P1|Overall Study|Worsening of the target disease|0
2439421|NCT03053427|8378225|P2|Overall Study|Lost to Follow-up|2
2439422|NCT03053427|8378226|P1|Overall Study|Lost to Follow-up|2
2439423|NCT03053427|8378225|P2|Overall Study|Lack of Efficacy|3
2439424|NCT03053427|8378226|P1|Overall Study|Lack of Efficacy|1
2439425|NCT03053427|8378225|P2|Overall Study|Adverse Event|4
2439426|NCT03053427|8378226|P1|Overall Study|Adverse Event|4
2439427|NCT03053180|8378248|P1|Overall Study|Failure to Return|1
2439428|NCT03052764|8378259|P2|Double-Blind Treatment Period|Reason not Specified|1
2439429|NCT03052764|8378260|P1|Double-Blind Treatment Period|Reason not Specified|2
2439430|NCT03052764|8378259|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
2439431|NCT03052764|8378260|P1|Double-Blind Treatment Period|Withdrawal by Subject|3
2439432|NCT03052764|8378259|P2|Double-Blind Treatment Period|Protocol Violation|1
2439433|NCT03052764|8378260|P1|Double-Blind Treatment Period|Protocol Violation|2
2439434|NCT03052764|8378259|P2|Double-Blind Treatment Period|Lack of Efficacy|0
2439435|NCT03052764|8378260|P1|Double-Blind Treatment Period|Lack of Efficacy|1
2439436|NCT03052764|8378259|P2|Double-Blind Treatment Period|Adverse Event|0
2439437|NCT03052764|8378260|P1|Double-Blind Treatment Period|Adverse Event|2
2439438|NCT03052725|8378280|P2|Overall Study|Study terminated by sponsor|144
2439439|NCT03052725|8378281|P1|Overall Study|Study terminated by sponsor|143
2439440|NCT03052725|8378280|P2|Overall Study|Site closure|1
2439441|NCT03052725|8378281|P1|Overall Study|Site closure|0
2439442|NCT03052725|8378280|P2|Overall Study|Pregnancy|1
2439443|NCT03052725|8378281|P1|Overall Study|Pregnancy|0
2439444|NCT03052725|8378280|P2|Overall Study|Withdrawal by Subject|4
2439445|NCT03052725|8378281|P1|Overall Study|Withdrawal by Subject|3
2439446|NCT03052725|8378280|P2|Overall Study|Adverse Event|0
2439447|NCT03052725|8378281|P1|Overall Study|Adverse Event|2
2439448|NCT03052426|8378328|P3|Overall Study|Lost to Follow-up|1
2439449|NCT03052426|8378329|P2|Overall Study|Lost to Follow-up|0
2439450|NCT03052426|8378330|P1|Overall Study|Lost to Follow-up|2
2439451|NCT03052426|8378328|P3|Overall Study|Withdrawal by Subject|0
2439452|NCT03052426|8378329|P2|Overall Study|Withdrawal by Subject|1
2439453|NCT03052426|8378330|P1|Overall Study|Withdrawal by Subject|0
2439454|NCT03052322|8378345|P2|Overall Study|Adverse Event|13
2439455|NCT03052322|8378346|P1|Overall Study|Adverse Event|6
2439456|NCT03052322|8378345|P2|Overall Study|Lost to Follow-up|4
2439457|NCT03052322|8378346|P1|Overall Study|Lost to Follow-up|2
2439458|NCT03052322|8378345|P2|Overall Study|Protocol Violation|0
2439459|NCT03052322|8378346|P1|Overall Study|Protocol Violation|1
2439460|NCT03052322|8378345|P2|Overall Study|Lack of Efficacy|2
2439461|NCT03052322|8378346|P1|Overall Study|Lack of Efficacy|1
2439462|NCT03052322|8378345|P2|Overall Study|Death|2
2439463|NCT03052322|8378346|P1|Overall Study|Death|0
2439464|NCT03052322|8378345|P2|Overall Study|Withdrawal by Subject|9
2439465|NCT03052322|8378346|P1|Overall Study|Withdrawal by Subject|10
2439466|NCT03052322|8378345|P2|Overall Study|Other un-specified|2
2439467|NCT03052322|8378346|P1|Overall Study|Other un-specified|1
2439468|NCT03051607|8378407|P1|Overall Study|Adverse Event|66
2439469|NCT03051217|8378417|P7|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
2439470|NCT03051217|8378418|P6|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1
2439471|NCT03051217|8378419|P5|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
2439472|NCT03051217|8378420|P4|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
2439473|NCT03051217|8378421|P3|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
2439474|NCT03051217|8378422|P2|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
2439475|NCT03051217|8378423|P1|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
2439476|NCT03051217|8378417|P7|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
2439477|NCT03051217|8378418|P6|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
2439478|NCT03051217|8378419|P5|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1
2439479|NCT03051217|8378420|P4|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
2439480|NCT03051217|8378421|P3|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
2439481|NCT03051217|8378422|P2|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
2439482|NCT03051217|8378423|P1|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
2439483|NCT03051217|8378417|P7|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
2439484|NCT03051217|8378418|P6|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
2439485|NCT03051217|8378419|P5|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
2439486|NCT03051217|8378420|P4|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1
2439487|NCT03051217|8378421|P3|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
2439488|NCT03051217|8378422|P2|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
2439489|NCT03051217|8378423|P1|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
2439490|NCT03051217|8378417|P7|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
2439491|NCT03051217|8378418|P6|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
2439492|NCT03051217|8378419|P5|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
2439493|NCT03051217|8378420|P4|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1
2439494|NCT03051217|8378421|P3|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
2439495|NCT03051217|8378422|P2|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
2439496|NCT03051217|8378423|P1|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
2439497|NCT03051217|8378417|P7|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
2439498|NCT03051217|8378418|P6|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
2439499|NCT03051217|8378419|P5|Maintenance Period (Week 16 to Week 52)|Adverse Event|2
2439500|NCT03051217|8378420|P4|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
2439501|NCT03051217|8378421|P3|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
2439502|NCT03051217|8378422|P2|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
2439503|NCT03051217|8378423|P1|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
2439504|NCT03051217|8378417|P7|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2439505|NCT03051217|8378418|P6|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2439506|NCT03051217|8378419|P5|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2439507|NCT03051217|8378420|P4|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2439508|NCT03051217|8378421|P3|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
2439509|NCT03051217|8378422|P2|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
2439510|NCT03051217|8378423|P1|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
2439511|NCT03051217|8378417|P7|Initial Period (Week 0 to Week 16)|Protocol Violation|0
2439512|NCT03051217|8378418|P6|Initial Period (Week 0 to Week 16)|Protocol Violation|0
2439513|NCT03051217|8378419|P5|Initial Period (Week 0 to Week 16)|Protocol Violation|0
2439514|NCT03051217|8378420|P4|Initial Period (Week 0 to Week 16)|Protocol Violation|0
2439515|NCT03051217|8378421|P3|Initial Period (Week 0 to Week 16)|Protocol Violation|0
2439516|NCT03051217|8378422|P2|Initial Period (Week 0 to Week 16)|Protocol Violation|1
2439517|NCT03051217|8378423|P1|Initial Period (Week 0 to Week 16)|Protocol Violation|0
2439518|NCT03051217|8378417|P7|Initial Period (Week 0 to Week 16)|Adverse Event|0
2439519|NCT03051217|8378418|P6|Initial Period (Week 0 to Week 16)|Adverse Event|0
2439520|NCT03051217|8378419|P5|Initial Period (Week 0 to Week 16)|Adverse Event|0
2439521|NCT03051217|8378420|P4|Initial Period (Week 0 to Week 16)|Adverse Event|0
2439522|NCT03051217|8378421|P3|Initial Period (Week 0 to Week 16)|Adverse Event|1
2439523|NCT03051217|8378422|P2|Initial Period (Week 0 to Week 16)|Adverse Event|0
2439524|NCT03051217|8378423|P1|Initial Period (Week 0 to Week 16)|Adverse Event|2
2439525|NCT03051165|8378452|P1|Overall Study|Early termination of study|12
2439526|NCT03051165|8378452|P1|Overall Study|Withdrawal by Subject|1
2439527|NCT03051100|8378466|P2|Overall Study|Withdrawal by Subject|0
2439528|NCT03051100|8378467|P1|Overall Study|Withdrawal by Subject|1
2439529|NCT03050372|8378686|P2|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1
2439530|NCT03050372|8378687|P1|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0
2439531|NCT03050372|8378686|P2|Adaptation Night (Night #1 PSG)|Adverse Event|0
2439532|NCT03050372|8378687|P1|Adaptation Night (Night #1 PSG)|Adverse Event|1
2439533|NCT03049852|8378782|P3|Overall Study|Lost to Follow-up|0
2439534|NCT03049852|8378783|P2|Overall Study|Lost to Follow-up|1
2439535|NCT03049852|8378784|P1|Overall Study|Lost to Follow-up|0
2439536|NCT03048058|8378831|P2|Overall Study|Withdrawal by Subject|4
2439537|NCT03048058|8378832|P1|Overall Study|Withdrawal by Subject|0
2439538|NCT03048058|8378831|P2|Overall Study|Lost to Follow-up|0
2439539|NCT03048058|8378832|P1|Overall Study|Lost to Follow-up|4
2439540|NCT03047551|8378858|P2|Overall Study|Ineligible|1
2439541|NCT03047551|8378859|P1|Overall Study|Ineligible|0
2439542|NCT03047551|8378858|P2|Overall Study|Probe malfunction|1
2439543|NCT03047551|8378859|P1|Overall Study|Probe malfunction|0
2439544|NCT03047551|8378858|P2|Overall Study|Withdrawal by Subject|1
2439545|NCT03047551|8378859|P1|Overall Study|Withdrawal by Subject|0
2439546|NCT03047551|8378858|P2|Overall Study|Physician Decision|0
2439547|NCT03047551|8378859|P1|Overall Study|Physician Decision|1
2439548|NCT03047551|8378858|P2|Overall Study|Did not receive TAS|0
2439549|NCT03047551|8378859|P1|Overall Study|Did not receive TAS|1
2439550|NCT03046446|8378936|P1|Overall Study|Non OA related knee surgery|1
2439551|NCT03046446|8378936|P1|Overall Study|Disease Progression (see caveats)|25
2439552|NCT03046446|8378936|P1|Overall Study|Withdrawn by Investigator/Sponsor|3
2439553|NCT03046446|8378936|P1|Overall Study|Withdrawal by Subject|14
2439554|NCT03046446|8378936|P1|Overall Study|Lost to Follow-up|3
2439555|NCT03046446|8378936|P1|Overall Study|Adverse Event|6
2439556|NCT03046446|8378936|P1|Overall Study|Lack of Efficacy|7
2439557|NCT03045887|8378999|P10|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
2439558|NCT03045887|8379000|P9|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
2439559|NCT03045887|8379001|P8|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
2439560|NCT03045887|8379002|P7|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
2439561|NCT03045887|8379003|P6|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
2439562|NCT03045887|8379004|P5|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
2439563|NCT03045887|8379005|P4|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1
2439564|NCT03045887|8379006|P3|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
2439565|NCT03045887|8379007|P2|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
2439566|NCT03045887|8379008|P1|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
2439567|NCT03045887|8378999|P10|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
2439568|NCT03045887|8379000|P9|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
2439569|NCT03045887|8379001|P8|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
2439570|NCT03045887|8379002|P7|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
2439571|NCT03045887|8379003|P6|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
2439572|NCT03045887|8379004|P5|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
2439573|NCT03045887|8379005|P4|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1
2439574|NCT03045887|8379006|P3|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1
2439575|NCT03045887|8379007|P2|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
2439576|NCT03045887|8379008|P1|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
2439577|NCT03045887|8378999|P10|Part A, Period 2 (1 Day)|Adverse Event|0
2439578|NCT03045887|8379000|P9|Part A, Period 2 (1 Day)|Adverse Event|0
2439579|NCT03045887|8379001|P8|Part A, Period 2 (1 Day)|Adverse Event|0
2439580|NCT03045887|8379002|P7|Part A, Period 2 (1 Day)|Adverse Event|0
2439581|NCT03045887|8379003|P6|Part A, Period 2 (1 Day)|Adverse Event|0
2439582|NCT03045887|8379004|P5|Part A, Period 2 (1 Day)|Adverse Event|0
2439583|NCT03045887|8379005|P4|Part A, Period 2 (1 Day)|Adverse Event|0
2439584|NCT03045887|8379006|P3|Part A, Period 2 (1 Day)|Adverse Event|0
2439585|NCT03045887|8379007|P2|Part A, Period 2 (1 Day)|Adverse Event|0
2439586|NCT03045887|8379008|P1|Part A, Period 2 (1 Day)|Adverse Event|1
2439587|NCT03045887|8378999|P10|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
2439588|NCT03045887|8379000|P9|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
2439589|NCT03045887|8379001|P8|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
2439590|NCT03045887|8379002|P7|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
2439591|NCT03045887|8379003|P6|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
2439592|NCT03045887|8379004|P5|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
2439593|NCT03045887|8379005|P4|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1
2439594|NCT03045887|8379006|P3|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
2439595|NCT03045887|8379007|P2|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
2439596|NCT03045887|8379008|P1|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
2439597|NCT03045887|8378999|P10|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
2439598|NCT03045887|8379000|P9|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
2439599|NCT03045887|8379001|P8|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
2439600|NCT03045887|8379002|P7|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
2439601|NCT03045887|8379003|P6|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
2439602|NCT03045887|8379004|P5|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
2439603|NCT03045887|8379005|P4|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
2439604|NCT03045887|8379006|P3|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
2439605|NCT03045887|8379007|P2|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
2439606|NCT03045887|8379008|P1|Part A,Washout Period 1(4 Weeks)|Physician Decision|3
2439607|NCT03045302|8379290|P1|Overall Study|Pre-treatment adverse event|1
2439608|NCT03045081|8379296|P2|Overall Study|Withdrawal by Subject|11
2439609|NCT03045081|8379297|P1|Overall Study|Withdrawal by Subject|6
2439610|NCT03044886|8379316|P3|Overall Study|Lost to Follow-up|12
2439611|NCT03044886|8379317|P2|Overall Study|Lost to Follow-up|10
2439612|NCT03044886|8379318|P1|Overall Study|Lost to Follow-up|15
2439613|NCT03044574|8379370|P2|Overall Study|Lost to Follow-up|45
2439614|NCT03044574|8379371|P1|Overall Study|Lost to Follow-up|37
2439615|NCT03044431|8379397|P1|Overall Study|Lost to Follow-up|59
2439616|NCT03044353|8379410|P3|Overall Study|Adverse Event|0
2439617|NCT03044353|8379411|P2|Overall Study|Adverse Event|1
2439618|NCT03044353|8379412|P1|Overall Study|Adverse Event|0
2439619|NCT03044197|8379495|P2|Overall Study|Withdrawal by Subject|1
2439620|NCT03044197|8379496|P1|Overall Study|Withdrawal by Subject|3
2439621|NCT03044106|8379506|P2|Washout (1 Week)|Withdrawal by Subject|2
2439622|NCT03044106|8379507|P1|Washout (1 Week)|Withdrawal by Subject|0
2439623|NCT03042910|8379626|P1|Overall Study|Enrolled but not treated|1
2439624|NCT03042910|8379626|P1|Overall Study|Withdrawal by Subject|3
2439625|NCT03042910|8379626|P1|Overall Study|Disease Progression|2
2439626|NCT03042910|8379626|P1|Overall Study|Adverse Event|1
2439627|NCT03042559|8379670|P2|Overall Study|drop out|1
2439628|NCT03042559|8379671|P1|Overall Study|drop out|1
2439629|NCT03041792|8379784|P2|Overall Study|Randomized but not treated|1
2439630|NCT03041792|8379785|P1|Overall Study|Randomized but not treated|0
2439631|NCT03041792|8379784|P2|Overall Study|Death in the family|2
2439632|NCT03041792|8379785|P1|Overall Study|Death in the family|0
2439633|NCT03041792|8379784|P2|Overall Study|Adverse Event|0
2439634|NCT03041792|8379785|P1|Overall Study|Adverse Event|4
2439635|NCT03041181|8379850|P2|Overall Study|Disease Progression|2
2439636|NCT03041181|8379851|P1|Overall Study|Disease Progression|1
2439637|NCT03041090|8379867|P2|Overall Study|technical error|3
2439638|NCT03041090|8379868|P1|Overall Study|technical error|0
2439639|NCT03040687|8379881|P3|Overall Study|Withdrawal by Subject|0
2439640|NCT03040687|8379882|P2|Overall Study|Withdrawal by Subject|0
2439641|NCT03040687|8379883|P1|Overall Study|Withdrawal by Subject|1
2439642|NCT03040336|8379939|P2|Overall Study|Withdrawal by Subject|3
2439643|NCT03040336|8379940|P1|Overall Study|Withdrawal by Subject|2
2439644|NCT03040336|8379939|P2|Overall Study|Death|0
2439645|NCT03040336|8379940|P1|Overall Study|Death|1
2439646|NCT03039738|8380053|P2|Overall Study|Incomplete data sets|0
2439647|NCT03039738|8380054|P1|Overall Study|Incomplete data sets|54
2439648|NCT03039621|8380076|P2|Overall Study|Violation of non-inclusion criteria|2
2439649|NCT03039621|8380077|P1|Overall Study|Violation of non-inclusion criteria|1
2439650|NCT03039621|8380076|P2|Overall Study|Necessity to use drugs forbidden by pro|7
2439651|NCT03039621|8380077|P1|Overall Study|Necessity to use drugs forbidden by pro|4
2439652|NCT03039621|8380076|P2|Overall Study|Non-compliance with protocol requirement|5
2439653|NCT03039621|8380077|P1|Overall Study|Non-compliance with protocol requirement|4
2439654|NCT03039621|8380076|P2|Overall Study|Violation of inclusion criteria|2
2439655|NCT03039621|8380077|P1|Overall Study|Violation of inclusion criteria|3
2439656|NCT03039569|8380101|P2|Overall Study|Lost to Follow-up|4
2439657|NCT03039569|8380102|P1|Overall Study|Lost to Follow-up|5
2439658|NCT03039283|8380147|P1|Overall Study|Protocol Violation|2
2439659|NCT03038126|8380308|P2|Overall Study|Too Ill to Participate|2
2439660|NCT03038126|8380309|P1|Overall Study|Too Ill to Participate|1
2439661|NCT03038126|8380308|P2|Overall Study|Long Term Hospitalization|0
2439662|NCT03038126|8380309|P1|Overall Study|Long Term Hospitalization|2
2439663|NCT03038126|8380308|P2|Overall Study|Lost to Follow-up|1
2439664|NCT03038126|8380309|P1|Overall Study|Lost to Follow-up|0
2439665|NCT03038126|8380308|P2|Overall Study|Withdrawal by Subject|0
2439666|NCT03038126|8380309|P1|Overall Study|Withdrawal by Subject|5
2439667|NCT03038126|8380308|P2|Overall Study|Death|1
2439668|NCT03038126|8380309|P1|Overall Study|Death|1
2439669|NCT03037619|8380336|P2|Overall Study|Lost to Follow-up|1
2439670|NCT03037619|8380337|P1|Overall Study|Lost to Follow-up|0
2439671|NCT03037489|8380362|P2|Overall Study|Withdrawal by Subject|0
2439672|NCT03037489|8380363|P1|Overall Study|Withdrawal by Subject|3
2439673|NCT03037489|8380362|P2|Overall Study|Adverse Event|0
2439674|NCT03037489|8380363|P1|Overall Study|Adverse Event|4
2439675|NCT03037307|8380369|P6|Period 1|Did Not Meet Study Criteria|0
2439676|NCT03037307|8380370|P5|Period 1|Did Not Meet Study Criteria|0
2439677|NCT03037307|8380371|P4|Period 1|Did Not Meet Study Criteria|1
2439678|NCT03037307|8380372|P3|Period 1|Did Not Meet Study Criteria|0
2439679|NCT03037307|8380373|P2|Period 1|Did Not Meet Study Criteria|0
2439680|NCT03037307|8380374|P1|Period 1|Did Not Meet Study Criteria|0
2439681|NCT03036852|8380413|P1|Overall Study|Lost to Follow-up|1
2439682|NCT03036852|8380413|P1|Overall Study|Adverse Event|1
2439683|NCT03036852|8380413|P1|Overall Study|Lack of Efficacy|2
2439684|NCT03036852|8380413|P1|Overall Study|Death|2
2439685|NCT03036839|8380470|P3|Overall Study|Withdrew Consent|1
2439686|NCT03036839|8380471|P2|Overall Study|Withdrew Consent|0
2439687|NCT03036839|8380472|P1|Overall Study|Withdrew Consent|0
2439688|NCT03036839|8380470|P3|Overall Study|Death|3
2439689|NCT03036839|8380471|P2|Overall Study|Death|0
2439690|NCT03036839|8380472|P1|Overall Study|Death|3
2439691|NCT03036839|8380470|P3|Overall Study|Adverse Event|1
2439692|NCT03036839|8380471|P2|Overall Study|Adverse Event|0
2439693|NCT03036839|8380472|P1|Overall Study|Adverse Event|0
2439694|NCT03036072|8380698|P2|Overall Study|Physician Decision|1
2439695|NCT03036072|8380699|P1|Overall Study|Physician Decision|0
2439696|NCT03036072|8380698|P2|Overall Study|Withdrawal by Subject|1
2439697|NCT03036072|8380699|P1|Overall Study|Withdrawal by Subject|0
2439698|NCT03036072|8380698|P2|Overall Study|Death|1
2439699|NCT03036072|8380699|P1|Overall Study|Death|0
2439700|NCT03035942|8380719|P3|Overall Study|Adverse Event|5
2439701|NCT03035942|8380720|P2|Overall Study|Adverse Event|4
2439702|NCT03035942|8380721|P1|Overall Study|Adverse Event|8
2439703|NCT03035916|8380750|P3|Overall Study|Puncture failed|0
2439704|NCT03035916|8380751|P2|Overall Study|Puncture failed|2
2439705|NCT03035916|8380752|P1|Overall Study|Puncture failed|0
2439706|NCT03035864|8380801|P2|Follow-up Period|Other|2
2439707|NCT03035864|8380802|P1|Follow-up Period|Other|3
2439708|NCT03035864|8380801|P2|Follow-up Period|Physician Decision|0
2439709|NCT03035864|8380802|P1|Follow-up Period|Physician Decision|1
2439710|NCT03035864|8380801|P2|Follow-up Period|Lost to Follow-up|2
2439711|NCT03035864|8380802|P1|Follow-up Period|Lost to Follow-up|6
2439712|NCT03035864|8380801|P2|Follow-up Period|Adverse Event|0
2439713|NCT03035864|8380802|P1|Follow-up Period|Adverse Event|1
2439714|NCT03035864|8380801|P2|Treatment Period|Other|1
2439715|NCT03035864|8380802|P1|Treatment Period|Other|3
2439716|NCT03035864|8380801|P2|Treatment Period|Adverse Event|0
2439717|NCT03035864|8380802|P1|Treatment Period|Adverse Event|1
2439718|NCT03034967|8380882|P6|Overall Study|Adverse Event, Serious Fatal|1
2439719|NCT03034967|8380883|P5|Overall Study|Adverse Event, Serious Fatal|1
2439720|NCT03034967|8380884|P4|Overall Study|Adverse Event, Serious Fatal|2
2439721|NCT03034967|8380885|P3|Overall Study|Adverse Event, Serious Fatal|1
2439722|NCT03034967|8380886|P2|Overall Study|Adverse Event, Serious Fatal|1
2439723|NCT03034967|8380887|P1|Overall Study|Adverse Event, Serious Fatal|0
2439724|NCT03034967|8380882|P6|Overall Study|Adverse Event, non-fatal|8
2439725|NCT03034967|8380883|P5|Overall Study|Adverse Event, non-fatal|2
2439726|NCT03034967|8380884|P4|Overall Study|Adverse Event, non-fatal|0
2439727|NCT03034967|8380885|P3|Overall Study|Adverse Event, non-fatal|2
2439728|NCT03034967|8380886|P2|Overall Study|Adverse Event, non-fatal|1
2439729|NCT03034967|8380887|P1|Overall Study|Adverse Event, non-fatal|3
2439730|NCT03034967|8380882|P6|Overall Study|Lack of Efficacy|0
2439731|NCT03034967|8380883|P5|Overall Study|Lack of Efficacy|1
2439732|NCT03034967|8380884|P4|Overall Study|Lack of Efficacy|1
2439733|NCT03034967|8380885|P3|Overall Study|Lack of Efficacy|2
2439734|NCT03034967|8380886|P2|Overall Study|Lack of Efficacy|1
2439735|NCT03034967|8380887|P1|Overall Study|Lack of Efficacy|0
2439736|NCT03034967|8380882|P6|Overall Study|Protocol Violation|2
2439737|NCT03034967|8380883|P5|Overall Study|Protocol Violation|0
2439738|NCT03034967|8380884|P4|Overall Study|Protocol Violation|0
2439739|NCT03034967|8380885|P3|Overall Study|Protocol Violation|0
2439740|NCT03034967|8380886|P2|Overall Study|Protocol Violation|0
2439741|NCT03034967|8380887|P1|Overall Study|Protocol Violation|1
2439742|NCT03034967|8380882|P6|Overall Study|Liver function test abnormality|0
2439743|NCT03034967|8380883|P5|Overall Study|Liver function test abnormality|0
2439744|NCT03034967|8380884|P4|Overall Study|Liver function test abnormality|0
2439745|NCT03034967|8380885|P3|Overall Study|Liver function test abnormality|1
2439746|NCT03034967|8380886|P2|Overall Study|Liver function test abnormality|0
2439747|NCT03034967|8380887|P1|Overall Study|Liver function test abnormality|0
2439748|NCT03034967|8380882|P6|Overall Study|Lost to Follow-up|2
2439749|NCT03034967|8380883|P5|Overall Study|Lost to Follow-up|0
2439750|NCT03034967|8380884|P4|Overall Study|Lost to Follow-up|1
2439751|NCT03034967|8380885|P3|Overall Study|Lost to Follow-up|0
2439752|NCT03034967|8380886|P2|Overall Study|Lost to Follow-up|0
2439753|NCT03034967|8380887|P1|Overall Study|Lost to Follow-up|0
2439754|NCT03034967|8380882|P6|Overall Study|Physician Decision|0
2439755|NCT03034967|8380883|P5|Overall Study|Physician Decision|1
2439756|NCT03034967|8380884|P4|Overall Study|Physician Decision|1
2439757|NCT03034967|8380885|P3|Overall Study|Physician Decision|1
2439758|NCT03034967|8380886|P2|Overall Study|Physician Decision|0
2439759|NCT03034967|8380887|P1|Overall Study|Physician Decision|1
2439760|NCT03034967|8380882|P6|Overall Study|Withdrawal by Subject|2
2439761|NCT03034967|8380883|P5|Overall Study|Withdrawal by Subject|9
2439762|NCT03034967|8380884|P4|Overall Study|Withdrawal by Subject|6
2439763|NCT03034967|8380885|P3|Overall Study|Withdrawal by Subject|6
2439764|NCT03034967|8380886|P2|Overall Study|Withdrawal by Subject|2
2439765|NCT03034967|8380887|P1|Overall Study|Withdrawal by Subject|9
2439766|NCT03034954|8381085|P2|Overall Study|Machine malfunction; did not reach 3 mA|0
2439767|NCT03034954|8381086|P1|Overall Study|Machine malfunction; did not reach 3 mA|1
2439768|NCT03034915|8381153|P3|Overall Study|Physician Decision|2
2439769|NCT03034915|8381154|P2|Overall Study|Physician Decision|5
2439770|NCT03034915|8381155|P1|Overall Study|Physician Decision|1
2439771|NCT03034915|8381153|P3|Overall Study|Protocol-defined withdrawal criteria met|29
2439772|NCT03034915|8381154|P2|Overall Study|Protocol-defined withdrawal criteria met|26
2439773|NCT03034915|8381155|P1|Overall Study|Protocol-defined withdrawal criteria met|19
2439774|NCT03034915|8381153|P3|Overall Study|Site closed|4
2439775|NCT03034915|8381154|P2|Overall Study|Site closed|2
2439776|NCT03034915|8381155|P1|Overall Study|Site closed|2
2439777|NCT03034915|8381153|P3|Overall Study|Lack of Efficacy|18
2439778|NCT03034915|8381154|P2|Overall Study|Lack of Efficacy|16
2439779|NCT03034915|8381155|P1|Overall Study|Lack of Efficacy|8
2439780|NCT03034915|8381153|P3|Overall Study|Protocol Deviation|7
2439781|NCT03034915|8381154|P2|Overall Study|Protocol Deviation|14
2439782|NCT03034915|8381155|P1|Overall Study|Protocol Deviation|2
2439783|NCT03034915|8381153|P3|Overall Study|Withdrawal by Subject|41
2439784|NCT03034915|8381154|P2|Overall Study|Withdrawal by Subject|46
2439785|NCT03034915|8381155|P1|Overall Study|Withdrawal by Subject|29
2439786|NCT03034915|8381153|P3|Overall Study|Lost to Follow-up|3
2439787|NCT03034915|8381154|P2|Overall Study|Lost to Follow-up|13
2439788|NCT03034915|8381155|P1|Overall Study|Lost to Follow-up|5
2439789|NCT03034915|8381153|P3|Overall Study|Adverse Event|22
2439790|NCT03034915|8381154|P2|Overall Study|Adverse Event|32
2439791|NCT03034915|8381155|P1|Overall Study|Adverse Event|29
2439792|NCT03034577|8381195|P2|Overall Study|Lost to Follow-up|26
2439793|NCT03034577|8381196|P1|Overall Study|Lost to Follow-up|25
2439794|NCT03034577|8381195|P2|Overall Study|Withdrawal by Subject|9
2439795|NCT03034577|8381196|P1|Overall Study|Withdrawal by Subject|6
2439796|NCT03034057|8381212|P1|Overall Study|Medication error without associated AE|1
2439797|NCT03034057|8381212|P1|Overall Study|Adverse Event|22
2439798|NCT03034057|8381212|P1|Overall Study|Lost to Follow-up|19
2439799|NCT03034057|8381212|P1|Overall Study|Not defined|2
2439800|NCT03034057|8381212|P1|Overall Study|Protocol Violation|1
2439801|NCT03034057|8381212|P1|Overall Study|Withdrawal by Subject|10
2439802|NCT03034044|8381218|P1|Overall Study|Enrolled, but not received Xyntha|1
2439803|NCT03033745|8381241|P3|Overall Study|Withdrawal by Subject|0
2439804|NCT03033745|8381242|P2|Overall Study|Withdrawal by Subject|1
2439805|NCT03033745|8381243|P1|Overall Study|Withdrawal by Subject|0
2439806|NCT03033745|8381241|P3|Overall Study|Adverse Event|1
2439807|NCT03033745|8381242|P2|Overall Study|Adverse Event|0
2439808|NCT03033745|8381243|P1|Overall Study|Adverse Event|1
2439809|NCT03033745|8381241|P3|Overall Study|Protocol Violation|1
2439810|NCT03033745|8381242|P2|Overall Study|Protocol Violation|0
2439811|NCT03033745|8381243|P1|Overall Study|Protocol Violation|0
2439812|NCT03032523|8381326|P2|Overall Study|Physician Decision|0
2439813|NCT03032523|8381327|P1|Overall Study|Physician Decision|1
2439814|NCT03032523|8381326|P2|Overall Study|Withdrawal by Subject|2
2439815|NCT03032523|8381327|P1|Overall Study|Withdrawal by Subject|2
2439816|NCT03032510|8381339|P2|Overall Study|Physician Decision|0
2439817|NCT03032510|8381340|P1|Overall Study|Physician Decision|2
2439818|NCT03032510|8381339|P2|Overall Study|Subject noncompliance|2
2439819|NCT03032510|8381340|P1|Overall Study|Subject noncompliance|4
2439820|NCT03032510|8381339|P2|Overall Study|Withdrawal by Subject|7
2439821|NCT03032510|8381340|P1|Overall Study|Withdrawal by Subject|8
2439822|NCT03032510|8381339|P2|Overall Study|Lost to Follow-up|7
2439823|NCT03032510|8381340|P1|Overall Study|Lost to Follow-up|8
2439824|NCT03032510|8381339|P2|Overall Study|Adverse Event|2
2439825|NCT03032510|8381340|P1|Overall Study|Adverse Event|5
2439826|NCT03031899|8381367|P1|Overall Study|lesion disappeared after stopping habit|1
2439827|NCT03031899|8381367|P1|Overall Study|Protocol Violation|1
2439828|NCT03031496|8381384|P2|Period 1|Withdrawal by Subject|2
2439829|NCT03031496|8381385|P1|Period 1|Withdrawal by Subject|0
2439830|NCT03031496|8381384|P2|Period 1|Adverse Event|0
2439831|NCT03031496|8381385|P1|Period 1|Adverse Event|2
2439832|NCT03031431|8381421|P1|Overall Study|Infant removed by maternal request|1
2439833|NCT03029832|8381509|P2|Overall Study|Study Terminated By Sponsor|1
2439834|NCT03029832|8381510|P1|Overall Study|Study Terminated By Sponsor|1
2439835|NCT03029832|8381509|P2|Overall Study|Death due to Disease Progression|0
2439836|NCT03029832|8381510|P1|Overall Study|Death due to Disease Progression|1
2439837|NCT03029832|8381509|P2|Overall Study|Safety Follow-Up Completed|0
2439838|NCT03029832|8381510|P1|Overall Study|Safety Follow-Up Completed|2
2439839|NCT03029819|8381540|P2|Overall Study|Removed due to disruptive behavior|1
2439840|NCT03029819|8381541|P1|Overall Study|Removed due to disruptive behavior|0
2439841|NCT03029819|8381540|P2|Overall Study|Lost to Follow-up|5
2439842|NCT03029819|8381541|P1|Overall Study|Lost to Follow-up|3
2439843|NCT03029780|8381555|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
2439844|NCT03029780|8381556|P1|Overall Study|Adverse Event Unrelated to Study Drug|0
2439845|NCT03029780|8381555|P2|Overall Study|Study Drug Toxicity|5
2439846|NCT03029780|8381556|P1|Overall Study|Study Drug Toxicity|5
2439847|NCT03029780|8381555|P2|Overall Study|Disease Progression|3
2439848|NCT03029780|8381556|P1|Overall Study|Disease Progression|1
2439849|NCT03029650|8381568|P2|Washout (1 Week)|Physician Decision|1
2439850|NCT03029650|8381569|P1|Washout (1 Week)|Physician Decision|0
2439851|NCT03029650|8381568|P2|Washout (1 Week)|Withdrawal by Subject|1
2439852|NCT03029650|8381569|P1|Washout (1 Week)|Withdrawal by Subject|1
2439853|NCT03029234|8381584|P1|Overall Study|Death|61
2439854|NCT03029234|8381584|P1|Overall Study|Withdrawal by Subject|5
2439855|NCT03029234|8381584|P1|Overall Study|Sponsor Decision|1
2439856|NCT03028870|8381678|P4|Overall Study|Administrative|4
2439857|NCT03028870|8381679|P3|Overall Study|Administrative|12
2439858|NCT03028870|8381680|P2|Overall Study|Administrative|5
2439859|NCT03028870|8381681|P1|Overall Study|Administrative|5
2439860|NCT03028870|8381678|P4|Overall Study|Lack of Efficacy|0
2439861|NCT03028870|8381679|P3|Overall Study|Lack of Efficacy|0
2439862|NCT03028870|8381680|P2|Overall Study|Lack of Efficacy|0
2439863|NCT03028870|8381681|P1|Overall Study|Lack of Efficacy|3
2439864|NCT03028870|8381678|P4|Overall Study|Lost to Follow-up|0
2439865|NCT03028870|8381679|P3|Overall Study|Lost to Follow-up|0
2439866|NCT03028870|8381680|P2|Overall Study|Lost to Follow-up|0
2439867|NCT03028870|8381681|P1|Overall Study|Lost to Follow-up|1
2439868|NCT03028870|8381678|P4|Overall Study|Withdrawal by Subject|2
2439869|NCT03028870|8381679|P3|Overall Study|Withdrawal by Subject|1
2439870|NCT03028870|8381680|P2|Overall Study|Withdrawal by Subject|1
2439871|NCT03028870|8381681|P1|Overall Study|Withdrawal by Subject|1
2439872|NCT03028870|8381678|P4|Overall Study|Adverse Event|3
2439873|NCT03028870|8381679|P3|Overall Study|Adverse Event|3
2439874|NCT03028870|8381680|P2|Overall Study|Adverse Event|4
2439875|NCT03028870|8381681|P1|Overall Study|Adverse Event|7
2439876|NCT03028142|8381881|P6|Overall Study|Withdrawal by Subject|0
2439877|NCT03028142|8381882|P5|Overall Study|Withdrawal by Subject|1
2439878|NCT03028142|8381883|P4|Overall Study|Withdrawal by Subject|0
2439879|NCT03028142|8381884|P3|Overall Study|Withdrawal by Subject|0
2439880|NCT03028142|8381885|P2|Overall Study|Withdrawal by Subject|0
2439881|NCT03028142|8381886|P1|Overall Study|Withdrawal by Subject|0
2439882|NCT03028142|8381881|P6|Overall Study|Adverse Event|1
2439883|NCT03028142|8381882|P5|Overall Study|Adverse Event|0
2439884|NCT03028142|8381883|P4|Overall Study|Adverse Event|0
2439885|NCT03028142|8381884|P3|Overall Study|Adverse Event|0
2439886|NCT03028142|8381885|P2|Overall Study|Adverse Event|1
2439887|NCT03028142|8381886|P1|Overall Study|Adverse Event|1
2439888|NCT03028129|8381905|P2|Overall Study|Withdrawal by Subject|45
2439889|NCT03028129|8381906|P1|Overall Study|Withdrawal by Subject|62
2439890|NCT03028129|8381905|P2|Overall Study|Protocol Violation|1
2439891|NCT03028129|8381906|P1|Overall Study|Protocol Violation|1
2439892|NCT03028129|8381905|P2|Overall Study|Physician Decision|1
2439893|NCT03028129|8381906|P1|Overall Study|Physician Decision|0
2439894|NCT03028129|8381905|P2|Overall Study|Lost to Follow-up|38
2439895|NCT03028129|8381906|P1|Overall Study|Lost to Follow-up|50
2439896|NCT03028129|8381905|P2|Overall Study|Adverse Event|2
2439897|NCT03028129|8381906|P1|Overall Study|Adverse Event|13
2439898|NCT03026530|8382002|P2|Overall Study|Protocol Violation|5
2439899|NCT03026530|8382003|P1|Overall Study|Protocol Violation|2
2439900|NCT03026530|8382002|P2|Overall Study|Lost to Follow-up|24
2439901|NCT03026530|8382003|P1|Overall Study|Lost to Follow-up|19
2439902|NCT03026257|8382017|P6|Overall Study|Withdrawal by Subject|0
2439903|NCT03026257|8382018|P5|Overall Study|Withdrawal by Subject|0
2439904|NCT03026257|8382019|P4|Overall Study|Withdrawal by Subject|0
2439905|NCT03026257|8382020|P3|Overall Study|Withdrawal by Subject|0
2439906|NCT03026257|8382021|P2|Overall Study|Withdrawal by Subject|1
2439907|NCT03026257|8382022|P1|Overall Study|Withdrawal by Subject|1
2439908|NCT03026257|8382017|P6|Overall Study|Protocol Violation|0
2439909|NCT03026257|8382018|P5|Overall Study|Protocol Violation|1
2439910|NCT03026257|8382019|P4|Overall Study|Protocol Violation|1
2439911|NCT03026257|8382020|P3|Overall Study|Protocol Violation|0
2439912|NCT03026257|8382021|P2|Overall Study|Protocol Violation|0
2439913|NCT03026257|8382022|P1|Overall Study|Protocol Violation|1
2439914|NCT03026257|8382017|P6|Overall Study|Lost to Follow-up|0
2439915|NCT03026257|8382018|P5|Overall Study|Lost to Follow-up|0
2439916|NCT03026257|8382019|P4|Overall Study|Lost to Follow-up|0
2439917|NCT03026257|8382020|P3|Overall Study|Lost to Follow-up|0
2439918|NCT03026257|8382021|P2|Overall Study|Lost to Follow-up|0
2439919|NCT03026257|8382022|P1|Overall Study|Lost to Follow-up|1
2439920|NCT03026257|8382017|P6|Overall Study|Adverse Event|0
2439921|NCT03026257|8382018|P5|Overall Study|Adverse Event|0
2439922|NCT03026257|8382019|P4|Overall Study|Adverse Event|0
2439923|NCT03026257|8382020|P3|Overall Study|Adverse Event|0
2439924|NCT03026257|8382021|P2|Overall Study|Adverse Event|0
2439925|NCT03026257|8382022|P1|Overall Study|Adverse Event|3
2439926|NCT03026088|8382036|P1|Overall Study|Study termination|20
2439927|NCT03026075|8382060|P1|Overall Study|Physician Decision|1
2439928|NCT03025217|8382073|P1|Overall Study|Not eligible, poor English|2
2439929|NCT03025217|8382073|P1|Overall Study|Lost to Follow-up|1
2439930|NCT03025217|8382073|P1|Overall Study|Pregnancy|1
2439931|NCT03024606|8382080|P2|Overall Study|Withdrawal by Subject|10
2439932|NCT03024606|8382081|P1|Overall Study|Withdrawal by Subject|9
2439933|NCT03023878|8382109|P1|Long Term Follow-Up (as of 22-10-2019)|Death|2
2439934|NCT03023878|8382109|P1|Long Term Follow-Up (as of 22-10-2019)|Continuing in study|20
2439935|NCT03023878|8382109|P1|Treatment Period|Adverse Event|1
2439936|NCT03023878|8382109|P1|Treatment Period|Withdrawal by Subject|1
2439937|NCT03023878|8382109|P1|Treatment Period|Disease Progression|1
2439938|NCT03023878|8382109|P1|Between Run-In and Treatment Periods|Protocol-specified criteria|2
2439939|NCT03023878|8382109|P1|Pre-Study Run-In Period|Withdrawal by Subject|5
2439940|NCT03023878|8382109|P1|Pre-Study Run-In Period|Death|1
2439941|NCT03023878|8382109|P1|Pre-Study Run-In Period|Protocol-specified criteria|11
2439942|NCT03023423|8382171|P3|Overall Study|Ongoing|24
2439943|NCT03023423|8382172|P2|Overall Study|Ongoing|32
2439944|NCT03023423|8382173|P1|Overall Study|Ongoing|2
2439945|NCT03023423|8382171|P3|Overall Study|Other|2
2439946|NCT03023423|8382172|P2|Overall Study|Other|2
2439947|NCT03023423|8382173|P1|Overall Study|Other|0
2439948|NCT03023423|8382171|P3|Overall Study|Death|20
2439949|NCT03023423|8382172|P2|Overall Study|Death|12
2439950|NCT03023423|8382173|P1|Overall Study|Death|5
2439951|NCT03023137|8382210|P2|Overall Study|Lost the baby in a car accident|0
2439952|NCT03023137|8382211|P1|Overall Study|Lost the baby in a car accident|1
2439953|NCT03023137|8382210|P2|Overall Study|Protocol Violation|4
2439954|NCT03023137|8382211|P1|Overall Study|Protocol Violation|0
2439955|NCT03023137|8382210|P2|Overall Study|Lost to Follow-up|1
2439956|NCT03023137|8382211|P1|Overall Study|Lost to Follow-up|1
2439957|NCT03023137|8382210|P2|Overall Study|Multiple pregnancy|4
2439958|NCT03023137|8382211|P1|Overall Study|Multiple pregnancy|2
2439959|NCT03022799|8382260|P13|Overall Study|Adverse Event|0
2439960|NCT03022799|8382261|P12|Overall Study|Adverse Event|0
2439961|NCT03022799|8382262|P11|Overall Study|Adverse Event|1
2439962|NCT03022799|8382263|P10|Overall Study|Adverse Event|1
2439963|NCT03022799|8382264|P9|Overall Study|Adverse Event|0
2439964|NCT03022799|8382265|P8|Overall Study|Adverse Event|0
2439965|NCT03022799|8382266|P7|Overall Study|Adverse Event|0
2439966|NCT03022799|8382267|P6|Overall Study|Adverse Event|0
2439967|NCT03022799|8382268|P5|Overall Study|Adverse Event|0
2439968|NCT03022799|8382269|P4|Overall Study|Adverse Event|0
2439969|NCT03022799|8382270|P3|Overall Study|Adverse Event|0
2439970|NCT03022799|8382271|P2|Overall Study|Adverse Event|0
2439971|NCT03022799|8382272|P1|Overall Study|Adverse Event|0
2439972|NCT03022630|8382469|P2|Overall Study|Withdrawal by Subject|5
2439973|NCT03022630|8382470|P1|Overall Study|Withdrawal by Subject|0
2439974|NCT03022630|8382469|P2|Overall Study|Death|7
2439975|NCT03022630|8382470|P1|Overall Study|Death|9
2439976|NCT03022422|8382550|P6|Overall Study|3 subjects consented but not vaccinated|0
2439977|NCT03022422|8382551|P5|Overall Study|3 subjects consented but not vaccinated|0
2439978|NCT03022422|8382552|P4|Overall Study|3 subjects consented but not vaccinated|0
2439979|NCT03022422|8382553|P3|Overall Study|3 subjects consented but not vaccinated|3
2439980|NCT03022422|8382554|P2|Overall Study|3 subjects consented but not vaccinated|0
2439981|NCT03022422|8382555|P1|Overall Study|3 subjects consented but not vaccinated|0
2439982|NCT03022045|8382608|P2|Overall Study|Withdrawal by Subject|1
2439983|NCT03022045|8382609|P1|Overall Study|Withdrawal by Subject|1
2439984|NCT03022045|8382608|P2|Overall Study|Adverse Event|1
2439985|NCT03022045|8382609|P1|Overall Study|Adverse Event|0
2439986|NCT03021668|8382638|P2|Overall Study|Physician Decision|1
2439987|NCT03021668|8382639|P1|Overall Study|Physician Decision|0
2439988|NCT03021642|8382651|P2|Washout Period (21 Days)|Adverse Event|1
2439989|NCT03021642|8382652|P1|Washout Period (21 Days)|Adverse Event|1
2439990|NCT03021304|8382710|P1|Overall Study|Lack of Efficacy|1
2439991|NCT03021187|8382719|P4|Overall Study|Lost to Follow-up|4
2439992|NCT03021187|8382720|P3|Overall Study|Lost to Follow-up|1
2439993|NCT03021187|8382721|P2|Overall Study|Lost to Follow-up|3
2439994|NCT03021187|8382722|P1|Overall Study|Lost to Follow-up|10
2439995|NCT03021187|8382719|P4|Overall Study|Withdrawal by Subject|5
2439996|NCT03021187|8382720|P3|Overall Study|Withdrawal by Subject|2
2439997|NCT03021187|8382721|P2|Overall Study|Withdrawal by Subject|6
2439998|NCT03021187|8382722|P1|Overall Study|Withdrawal by Subject|0
2439999|NCT03021187|8382719|P4|Overall Study|Death|0
2440000|NCT03021187|8382720|P3|Overall Study|Death|3
2440001|NCT03021187|8382721|P2|Overall Study|Death|0
2440002|NCT03021187|8382722|P1|Overall Study|Death|0
2440003|NCT03021018|8382878|P3|Overall Study|Fall with subsequent nasal fracture|0
2440004|NCT03021018|8382879|P2|Overall Study|Fall with subsequent nasal fracture|0
2440005|NCT03021018|8382880|P1|Overall Study|Fall with subsequent nasal fracture|1
2440006|NCT03021018|8382878|P3|Overall Study|Adverse Event|0
2440007|NCT03021018|8382879|P2|Overall Study|Adverse Event|0
2440008|NCT03021018|8382880|P1|Overall Study|Adverse Event|1
2440009|NCT03021005|8382911|P2|Overall Study|Lost to Follow-up|26
2440010|NCT03021005|8382912|P1|Overall Study|Lost to Follow-up|39
2440011|NCT03020745|8382926|P10|Part 2 (Up to 169 Days)|Ongoing in study|0
2440012|NCT03020745|8382927|P9|Part 2 (Up to 169 Days)|Ongoing in study|0
2440013|NCT03020745|8382928|P8|Part 2 (Up to 169 Days)|Ongoing in study|1
2440014|NCT03020745|8382929|P7|Part 2 (Up to 169 Days)|Ongoing in study|0
2440015|NCT03020745|8382930|P6|Part 2 (Up to 169 Days)|Ongoing in study|0
2440016|NCT03020745|8382931|P5|Part 2 (Up to 169 Days)|Ongoing in study|0
2440017|NCT03020745|8382932|P4|Part 2 (Up to 169 Days)|Ongoing in study|0
2440018|NCT03020745|8382933|P3|Part 2 (Up to 169 Days)|Ongoing in study|0
2440019|NCT03020745|8382934|P2|Part 2 (Up to 169 Days)|Ongoing in study|0
2440020|NCT03020745|8382935|P1|Part 2 (Up to 169 Days)|Ongoing in study|0
2440021|NCT03020745|8382926|P10|Part 2 (Up to 169 Days)|Adverse Event|0
2440022|NCT03020745|8382927|P9|Part 2 (Up to 169 Days)|Adverse Event|1
2440023|NCT03020745|8382928|P8|Part 2 (Up to 169 Days)|Adverse Event|0
2440024|NCT03020745|8382929|P7|Part 2 (Up to 169 Days)|Adverse Event|0
2440025|NCT03020745|8382930|P6|Part 2 (Up to 169 Days)|Adverse Event|0
2440026|NCT03020745|8382931|P5|Part 2 (Up to 169 Days)|Adverse Event|0
2440027|NCT03020745|8382932|P4|Part 2 (Up to 169 Days)|Adverse Event|0
2440028|NCT03020745|8382933|P3|Part 2 (Up to 169 Days)|Adverse Event|0
2440029|NCT03020745|8382934|P2|Part 2 (Up to 169 Days)|Adverse Event|0
2440030|NCT03020745|8382935|P1|Part 2 (Up to 169 Days)|Adverse Event|0
2440031|NCT03020576|8383196|P2|Overall Study|Withdrawal by Subject|2
2440032|NCT03020576|8383197|P1|Overall Study|Withdrawal by Subject|1
2440033|NCT03020160|8383252|P2|Overall Study|Continuing to receive emicizumab|41
2440034|NCT03020160|8383253|P1|Overall Study|Continuing to receive emicizumab|7
2440035|NCT03020069|8383308|P2|Overall Study|Lost to Follow-up|1
2440036|NCT03020069|8383309|P1|Overall Study|Lost to Follow-up|0
2440037|NCT03019627|8383355|P2|Overall Study|Other|2
2440038|NCT03019627|8383356|P1|Overall Study|Other|2
2440039|NCT03019627|8383355|P2|Overall Study|not compliance|2
2440040|NCT03019627|8383356|P1|Overall Study|not compliance|2
2440041|NCT03019627|8383355|P2|Overall Study|Lost to Follow-up|1
2440042|NCT03019627|8383356|P1|Overall Study|Lost to Follow-up|2
2440043|NCT03019627|8383355|P2|Overall Study|Unrelated to adverse event|3
2440044|NCT03019627|8383356|P1|Overall Study|Unrelated to adverse event|1
2440045|NCT03019627|8383355|P2|Overall Study|Adverse Event|0
2440046|NCT03019627|8383356|P1|Overall Study|Adverse Event|8
2440047|NCT03019549|8383372|P1|Period 2|Withdrawal by Subject|1
2440048|NCT03019549|8383372|P1|Period 2|Physician Decision|2
2440049|NCT03019549|8383372|P1|Period 2|Adverse Event|2
2440050|NCT03019549|8383372|P1|Washout|DId not meet genotype criteria|11
2440051|NCT03019458|8383385|P2|Overall Study|Death|1
2440052|NCT03019458|8383386|P1|Overall Study|Death|0
2440053|NCT03018938|8383400|P2|Overall Study|Not recorded|2
2440054|NCT03018938|8383401|P1|Overall Study|Not recorded|0
2440055|NCT03018938|8383400|P2|Overall Study|Screen failure-After randomization|2
2440056|NCT03018938|8383401|P1|Overall Study|Screen failure-After randomization|4
2440057|NCT03018938|8383400|P2|Overall Study|Sponsor Decision|1
2440058|NCT03018938|8383401|P1|Overall Study|Sponsor Decision|0
2440059|NCT03018938|8383400|P2|Overall Study|Physician Decision|2
2440060|NCT03018938|8383401|P1|Overall Study|Physician Decision|3
2440061|NCT03018938|8383400|P2|Overall Study|Withdrawal by Subject|45
2440062|NCT03018938|8383401|P1|Overall Study|Withdrawal by Subject|38
2440063|NCT03018938|8383400|P2|Overall Study|Lost to Follow-up|32
2440064|NCT03018938|8383401|P1|Overall Study|Lost to Follow-up|21
2440065|NCT03018938|8383400|P2|Overall Study|Death|1
2440066|NCT03018938|8383401|P1|Overall Study|Death|0
2440067|NCT03018340|8383439|P2|Overall Study|Not further specified|1
2440068|NCT03018340|8383440|P1|Overall Study|Not further specified|0
2440069|NCT03018340|8383439|P2|Overall Study|Protocol Violation|7
2440070|NCT03018340|8383440|P1|Overall Study|Protocol Violation|3
2440071|NCT03018340|8383439|P2|Overall Study|Lost to Follow-up|7
2440072|NCT03018340|8383440|P1|Overall Study|Lost to Follow-up|1
2440073|NCT03018340|8383439|P2|Overall Study|Non-compliance with study drug/procedure|4
2440074|NCT03018340|8383440|P1|Overall Study|Non-compliance with study drug/procedure|3
2440075|NCT03018340|8383439|P2|Overall Study|Lack of Efficacy|1
2440076|NCT03018340|8383440|P1|Overall Study|Lack of Efficacy|0
2440077|NCT03018340|8383439|P2|Overall Study|Withdrawal by Subject|8
2440078|NCT03018340|8383440|P1|Overall Study|Withdrawal by Subject|0
2440079|NCT03018340|8383439|P2|Overall Study|Adverse Event|2
2440080|NCT03018340|8383440|P1|Overall Study|Adverse Event|1
2440081|NCT03018106|8383499|P2|Overall Study|Lost to Follow-up|1
2440082|NCT03018106|8383500|P1|Overall Study|Lost to Follow-up|0
2440083|NCT03018028|8383513|P5|Overall Study|Withdrawal by Subject|0
2440084|NCT03018028|8383514|P4|Overall Study|Withdrawal by Subject|2
2440085|NCT03018028|8383515|P3|Overall Study|Withdrawal by Subject|1
2440086|NCT03018028|8383516|P2|Overall Study|Withdrawal by Subject|0
2440087|NCT03018028|8383517|P1|Overall Study|Withdrawal by Subject|3
2440088|NCT03017846|8383762|P1|Overall Study|Adverse Event|2
2440089|NCT03017846|8383762|P1|Overall Study|Lost to Follow-up|3
2440090|NCT03017612|8383770|P1|Overall Study|Adverse Event|2
2440091|NCT03017235|8383780|P2|Overall Study|Cancer, emergency, allergy, active UTI|2
2440092|NCT03017235|8383781|P1|Overall Study|Cancer, emergency, allergy, active UTI|4
2440093|NCT03017235|8383780|P2|Overall Study|Protocol Violation|1
2440094|NCT03017235|8383781|P1|Overall Study|Protocol Violation|2
2440095|NCT03017235|8383780|P2|Overall Study|Adverse Event|1
2440096|NCT03017235|8383781|P1|Overall Study|Adverse Event|0
2440097|NCT03017235|8383780|P2|Overall Study|Lost to Follow-up|7
2440098|NCT03017235|8383781|P1|Overall Study|Lost to Follow-up|2
2440099|NCT03017235|8383780|P2|Overall Study|Withdrawal by Subject|3
2440100|NCT03017235|8383781|P1|Overall Study|Withdrawal by Subject|4
2440101|NCT03016078|8383842|P1|Overall Study|Protocol Violation|1
2440102|NCT03016078|8383842|P1|Overall Study|Protocol Violation|1
2440103|NCT03015220|8383857|P4|Overall Study|Lost to Follow-up|0
2440104|NCT03015220|8383858|P3|Overall Study|Lost to Follow-up|1
2440105|NCT03015220|8383859|P2|Overall Study|Lost to Follow-up|0
2440106|NCT03015220|8383860|P1|Overall Study|Lost to Follow-up|0
2440107|NCT03015220|8383857|P4|Overall Study|Withdrawal by Subject|2
2440108|NCT03015220|8383858|P3|Overall Study|Withdrawal by Subject|2
2440109|NCT03015220|8383859|P2|Overall Study|Withdrawal by Subject|2
2440110|NCT03015220|8383860|P1|Overall Study|Withdrawal by Subject|3
2440111|NCT03015181|8384005|P7|Overall Study|Physician Decision|1
2440112|NCT03015181|8384006|P6|Overall Study|Physician Decision|0
2440113|NCT03015181|8384007|P5|Overall Study|Physician Decision|0
2440114|NCT03015181|8384008|P4|Overall Study|Physician Decision|0
2440115|NCT03015181|8384009|P3|Overall Study|Physician Decision|0
2440116|NCT03015181|8384010|P2|Overall Study|Physician Decision|0
2440117|NCT03015181|8384011|P1|Overall Study|Physician Decision|0
2440118|NCT03015181|8384005|P7|Overall Study|Withdrawal by Subject|0
2440119|NCT03015181|8384006|P6|Overall Study|Withdrawal by Subject|1
2440120|NCT03015181|8384007|P5|Overall Study|Withdrawal by Subject|0
2440121|NCT03015181|8384008|P4|Overall Study|Withdrawal by Subject|0
2440122|NCT03015181|8384009|P3|Overall Study|Withdrawal by Subject|0
2440123|NCT03015181|8384010|P2|Overall Study|Withdrawal by Subject|0
2440124|NCT03015181|8384011|P1|Overall Study|Withdrawal by Subject|0
2440125|NCT03015181|8384005|P7|Overall Study|Enrolled, but product never administered|0
2440126|NCT03015181|8384006|P6|Overall Study|Enrolled, but product never administered|0
2440127|NCT03015181|8384007|P5|Overall Study|Enrolled, but product never administered|0
2440128|NCT03015181|8384008|P4|Overall Study|Enrolled, but product never administered|0
2440129|NCT03015181|8384009|P3|Overall Study|Enrolled, but product never administered|0
2440130|NCT03015181|8384010|P2|Overall Study|Enrolled, but product never administered|0
2440131|NCT03015181|8384011|P1|Overall Study|Enrolled, but product never administered|1
2440132|NCT03014674|8384157|P3|Overall Study|Withdrawal by Subject|0
2440133|NCT03014674|8384158|P2|Overall Study|Withdrawal by Subject|0
2440134|NCT03014674|8384159|P1|Overall Study|Withdrawal by Subject|1
2440135|NCT03014479|8384223|P2|Overall Study|Unacceptable Inability of Site Visit|1
2440136|NCT03014479|8384224|P1|Overall Study|Unacceptable Inability of Site Visit|0
2440137|NCT03014479|8384223|P2|Overall Study|Voluntary Withdrawal|2
2440138|NCT03014479|8384224|P1|Overall Study|Voluntary Withdrawal|0
2440139|NCT03014479|8384223|P2|Overall Study|Adverse Event|1
2440140|NCT03014479|8384224|P1|Overall Study|Adverse Event|0
2440141|NCT03014453|8384270|P1|Overall Study|Refused to take part in|37
2440142|NCT03014453|8384270|P1|Overall Study|Excluded|19
2440143|NCT03014453|8384270|P1|Overall Study|Discontinued GER|3
2440144|NCT03014453|8384270|P1|Overall Study|Lost to Follow-up|12
2440145|NCT03014206|8384274|P1|Overall Study|Registration Violation|12
2440146|NCT03014180|8384278|P1|Overall Study|Protocol Violation|2
2440147|NCT03014011|8384287|P2|Washout|Withdrawal by Subject|0
2440148|NCT03014011|8384288|P1|Washout|Withdrawal by Subject|1
2440149|NCT03014011|8384287|P2|First Intervention|Withdrawal by Subject|0
2440150|NCT03014011|8384288|P1|First Intervention|Withdrawal by Subject|1
2440151|NCT03012828|8384300|P6|Overall Study|Delay to last visit would delay DBL|1
2440152|NCT03012828|8384301|P5|Overall Study|Delay to last visit would delay DBL|0
2440153|NCT03012828|8384302|P4|Overall Study|Delay to last visit would delay DBL|0
2440154|NCT03012828|8384303|P3|Overall Study|Delay to last visit would delay DBL|0
2440155|NCT03012828|8384304|P2|Overall Study|Delay to last visit would delay DBL|0
2440156|NCT03012828|8384305|P1|Overall Study|Delay to last visit would delay DBL|0
2440157|NCT03012828|8384300|P6|Overall Study|Non-compliance with protocol|0
2440158|NCT03012828|8384301|P5|Overall Study|Non-compliance with protocol|1
2440159|NCT03012828|8384302|P4|Overall Study|Non-compliance with protocol|0
2440160|NCT03012828|8384303|P3|Overall Study|Non-compliance with protocol|0
2440161|NCT03012828|8384304|P2|Overall Study|Non-compliance with protocol|0
2440162|NCT03012828|8384305|P1|Overall Study|Non-compliance with protocol|0
2440163|NCT03012828|8384300|P6|Overall Study|Withdrawal by Subject|1
2440164|NCT03012828|8384301|P5|Overall Study|Withdrawal by Subject|0
2440165|NCT03012828|8384302|P4|Overall Study|Withdrawal by Subject|0
2440166|NCT03012828|8384303|P3|Overall Study|Withdrawal by Subject|1
2440167|NCT03012828|8384304|P2|Overall Study|Withdrawal by Subject|0
2440168|NCT03012828|8384305|P1|Overall Study|Withdrawal by Subject|0
2440169|NCT03012828|8384300|P6|Overall Study|Lost to Follow-up|0
2440170|NCT03012828|8384301|P5|Overall Study|Lost to Follow-up|1
2440171|NCT03012828|8384302|P4|Overall Study|Lost to Follow-up|0
2440172|NCT03012828|8384303|P3|Overall Study|Lost to Follow-up|1
2440173|NCT03012828|8384304|P2|Overall Study|Lost to Follow-up|0
2440174|NCT03012828|8384305|P1|Overall Study|Lost to Follow-up|1
2440175|NCT03012334|8384348|P10|Period 4|Adverse Event|0
2440176|NCT03012334|8384349|P9|Period 4|Adverse Event|1
2440177|NCT03012334|8384350|P8|Period 4|Adverse Event|0
2440178|NCT03012334|8384351|P7|Period 4|Adverse Event|0
2440179|NCT03012334|8384352|P6|Period 4|Adverse Event|0
2440180|NCT03012334|8384353|P5|Period 4|Adverse Event|0
2440181|NCT03012334|8384354|P4|Period 4|Adverse Event|0
2440182|NCT03012334|8384355|P3|Period 4|Adverse Event|0
2440183|NCT03012334|8384356|P2|Period 4|Adverse Event|0
2440184|NCT03012334|8384357|P1|Period 4|Adverse Event|0
2440185|NCT03012334|8384348|P10|Period 4|Non-Compliance|0
2440186|NCT03012334|8384349|P9|Period 4|Non-Compliance|0
2440187|NCT03012334|8384350|P8|Period 4|Non-Compliance|0
2440188|NCT03012334|8384351|P7|Period 4|Non-Compliance|1
2440189|NCT03012334|8384352|P6|Period 4|Non-Compliance|0
2440190|NCT03012334|8384353|P5|Period 4|Non-Compliance|0
2440191|NCT03012334|8384354|P4|Period 4|Non-Compliance|0
2440192|NCT03012334|8384355|P3|Period 4|Non-Compliance|0
2440193|NCT03012334|8384356|P2|Period 4|Non-Compliance|0
2440194|NCT03012334|8384357|P1|Period 4|Non-Compliance|0
2440195|NCT03012334|8384348|P10|Period 2|Protocol Violation|0
2440196|NCT03012334|8384349|P9|Period 2|Protocol Violation|0
2440197|NCT03012334|8384350|P8|Period 2|Protocol Violation|1
2440198|NCT03012334|8384351|P7|Period 2|Protocol Violation|0
2440199|NCT03012334|8384352|P6|Period 2|Protocol Violation|0
2440200|NCT03012334|8384353|P5|Period 2|Protocol Violation|0
2440201|NCT03012334|8384354|P4|Period 2|Protocol Violation|0
2440202|NCT03012334|8384355|P3|Period 2|Protocol Violation|1
2440203|NCT03012334|8384356|P2|Period 2|Protocol Violation|0
2440204|NCT03012334|8384357|P1|Period 2|Protocol Violation|0
2440205|NCT03012334|8384348|P10|Period 2|Withdrawal by Subject|0
2440206|NCT03012334|8384349|P9|Period 2|Withdrawal by Subject|0
2440207|NCT03012334|8384350|P8|Period 2|Withdrawal by Subject|0
2440208|NCT03012334|8384351|P7|Period 2|Withdrawal by Subject|0
2440209|NCT03012334|8384352|P6|Period 2|Withdrawal by Subject|0
2440210|NCT03012334|8384353|P5|Period 2|Withdrawal by Subject|0
2440211|NCT03012334|8384354|P4|Period 2|Withdrawal by Subject|0
2440212|NCT03012334|8384355|P3|Period 2|Withdrawal by Subject|0
2440213|NCT03012334|8384356|P2|Period 2|Withdrawal by Subject|1
2440214|NCT03012334|8384357|P1|Period 2|Withdrawal by Subject|0
2440215|NCT03012334|8384348|P10|Period 1|Withdrawal by Subject|1
2440216|NCT03012334|8384349|P9|Period 1|Withdrawal by Subject|0
2440217|NCT03012334|8384350|P8|Period 1|Withdrawal by Subject|0
2440218|NCT03012334|8384351|P7|Period 1|Withdrawal by Subject|0
2440219|NCT03012334|8384352|P6|Period 1|Withdrawal by Subject|0
2440220|NCT03012334|8384353|P5|Period 1|Withdrawal by Subject|0
2440221|NCT03012334|8384354|P4|Period 1|Withdrawal by Subject|0
2440222|NCT03012334|8384355|P3|Period 1|Withdrawal by Subject|0
2440223|NCT03012334|8384356|P2|Period 1|Withdrawal by Subject|0
2440224|NCT03012334|8384357|P1|Period 1|Withdrawal by Subject|0
2440225|NCT03012061|8384427|P3|Overall Study|Adverse Event|0
2440226|NCT03012061|8384428|P2|Overall Study|Adverse Event|0
2440227|NCT03012061|8384429|P1|Overall Study|Adverse Event|2
2440228|NCT03012061|8384427|P3|Overall Study|Lack of Efficacy|0
2440229|NCT03012061|8384428|P2|Overall Study|Lack of Efficacy|1
2440230|NCT03012061|8384429|P1|Overall Study|Lack of Efficacy|0
2440231|NCT03012061|8384427|P3|Overall Study|Protocol Violation|2
2440232|NCT03012061|8384428|P2|Overall Study|Protocol Violation|0
2440233|NCT03012061|8384429|P1|Overall Study|Protocol Violation|0
2440234|NCT03012061|8384427|P3|Overall Study|Met Protocol Withdrawal Criterion|1
2440235|NCT03012061|8384428|P2|Overall Study|Met Protocol Withdrawal Criterion|0
2440236|NCT03012061|8384429|P1|Overall Study|Met Protocol Withdrawal Criterion|0
2440237|NCT03012061|8384427|P3|Overall Study|Study closed/ Terminated|1
2440238|NCT03012061|8384428|P2|Overall Study|Study closed/ Terminated|0
2440239|NCT03012061|8384429|P1|Overall Study|Study closed/ Terminated|0
2440240|NCT03012061|8384427|P3|Overall Study|Lost to Follow-up|0
2440241|NCT03012061|8384428|P2|Overall Study|Lost to Follow-up|1
2440242|NCT03012061|8384429|P1|Overall Study|Lost to Follow-up|2
2440243|NCT03012061|8384427|P3|Overall Study|Investigator Site Closed|0
2440244|NCT03012061|8384428|P2|Overall Study|Investigator Site Closed|2
2440245|NCT03012061|8384429|P1|Overall Study|Investigator Site Closed|1
2440246|NCT03012061|8384427|P3|Overall Study|Withdrawal by Subject|4
2440247|NCT03012061|8384428|P2|Overall Study|Withdrawal by Subject|5
2440248|NCT03012061|8384429|P1|Overall Study|Withdrawal by Subject|1
2440249|NCT03011840|8384454|P2|Overall Study|Not received PIL in post PIL phase|21
2440250|NCT03011840|8384455|P1|Overall Study|Not received PIL in post PIL phase|0
2440251|NCT03011099|8384465|P2|Overall Study|Withdrawal by Subject|2
2440252|NCT03011099|8384466|P1|Overall Study|Withdrawal by Subject|0
2440253|NCT03011034|8384492|P2|Overall Study|Adverse Event|0
2440254|NCT03011034|8384493|P1|Overall Study|Adverse Event|1
2440255|NCT03010501|8384555|P6|Study Week 3|Withdrawal by Subject|0
2440256|NCT03010501|8384556|P5|Study Week 3|Withdrawal by Subject|0
2440257|NCT03010501|8384557|P4|Study Week 3|Withdrawal by Subject|1
2440258|NCT03010501|8384558|P3|Study Week 3|Withdrawal by Subject|0
2440259|NCT03010501|8384559|P2|Study Week 3|Withdrawal by Subject|0
2440260|NCT03010501|8384560|P1|Study Week 3|Withdrawal by Subject|0
2440261|NCT03010501|8384555|P6|Study Week 1|Withdrawal by Subject|0
2440262|NCT03010501|8384556|P5|Study Week 1|Withdrawal by Subject|0
2440263|NCT03010501|8384557|P4|Study Week 1|Withdrawal by Subject|2
2440264|NCT03010501|8384558|P3|Study Week 1|Withdrawal by Subject|0
2440265|NCT03010501|8384559|P2|Study Week 1|Withdrawal by Subject|1
2440266|NCT03010501|8384560|P1|Study Week 1|Withdrawal by Subject|2
2440267|NCT03010254|8384576|P2|Overall Study|Other|3
2440268|NCT03010254|8384577|P1|Overall Study|Other|2
2440269|NCT03010254|8384576|P2|Overall Study|Withdrawal by Subject|1
2440270|NCT03010254|8384577|P1|Overall Study|Withdrawal by Subject|1
2440271|NCT03010254|8384576|P2|Overall Study|Lost to Follow-up|0
2440272|NCT03010254|8384577|P1|Overall Study|Lost to Follow-up|4
2440273|NCT03010254|8384576|P2|Overall Study|Adverse Event|1
2440274|NCT03010254|8384577|P1|Overall Study|Adverse Event|0
2440275|NCT03007966|8384683|P2|Overall Study|Did not meeting inclusion/exclusion|0
2440276|NCT03007966|8384684|P1|Overall Study|Did not meeting inclusion/exclusion|1
2440277|NCT03006562|8384727|P2|Overall Study|Lost to Follow-up|1
2440278|NCT03006562|8384728|P1|Overall Study|Lost to Follow-up|0
2440279|NCT03006341|8384750|P4|Overall Study|Not linked in the EMR|10685
2440280|NCT03006341|8384751|P3|Overall Study|Not linked in the EMR|30993
2440281|NCT03006341|8384752|P2|Overall Study|Not linked in the EMR|67505
2440282|NCT03006341|8384753|P1|Overall Study|Not linked in the EMR|25069
2440283|NCT03005067|8384797|P2|Overall Study|Protocol Violation|1
2440284|NCT03005067|8384798|P1|Overall Study|Protocol Violation|0
2440285|NCT03005067|8384797|P2|Overall Study|Other (reason not specified)|1
2440286|NCT03005067|8384798|P1|Overall Study|Other (reason not specified)|3
2440287|NCT03005067|8384797|P2|Overall Study|Adverse Event|3
2440288|NCT03005067|8384798|P1|Overall Study|Adverse Event|4
2440289|NCT03005067|8384797|P2|Overall Study|Withdrawal by Subject|2
2440290|NCT03005067|8384798|P1|Overall Study|Withdrawal by Subject|3
2440291|NCT03004924|8384826|P3|Overall Study|HSV1 Positive|0
2440292|NCT03004924|8384827|P2|Overall Study|HSV1 Positive|0
2440293|NCT03004924|8384828|P1|Overall Study|HSV1 Positive|1
2440294|NCT03004924|8384826|P3|Overall Study|Missed Study Visit|2
2440295|NCT03004924|8384827|P2|Overall Study|Missed Study Visit|0
2440296|NCT03004924|8384828|P1|Overall Study|Missed Study Visit|0
2440297|NCT03004924|8384826|P3|Overall Study|Terminated by Sponsor|1
2440298|NCT03004924|8384827|P2|Overall Study|Terminated by Sponsor|0
2440299|NCT03004924|8384828|P1|Overall Study|Terminated by Sponsor|0
2440300|NCT03004924|8384826|P3|Overall Study|Pregnancy|0
2440301|NCT03004924|8384827|P2|Overall Study|Pregnancy|1
2440302|NCT03004924|8384828|P1|Overall Study|Pregnancy|0
2440303|NCT03004924|8384826|P3|Overall Study|Screen Failure|0
2440304|NCT03004924|8384827|P2|Overall Study|Screen Failure|0
2440305|NCT03004924|8384828|P1|Overall Study|Screen Failure|1
2440306|NCT03004924|8384826|P3|Overall Study|Withdrawal by parent/guardian|2
2440307|NCT03004924|8384827|P2|Overall Study|Withdrawal by parent/guardian|0
2440308|NCT03004924|8384828|P1|Overall Study|Withdrawal by parent/guardian|1
2440309|NCT03004924|8384826|P3|Overall Study|Physician Decision|1
2440310|NCT03004924|8384827|P2|Overall Study|Physician Decision|0
2440311|NCT03004924|8384828|P1|Overall Study|Physician Decision|1
2440312|NCT03004924|8384826|P3|Overall Study|Lack of Efficacy|2
2440313|NCT03004924|8384827|P2|Overall Study|Lack of Efficacy|4
2440314|NCT03004924|8384828|P1|Overall Study|Lack of Efficacy|2
2440315|NCT03004924|8384826|P3|Overall Study|Lost to Follow-up|4
2440316|NCT03004924|8384827|P2|Overall Study|Lost to Follow-up|1
2440317|NCT03004924|8384828|P1|Overall Study|Lost to Follow-up|6
2440318|NCT03004924|8384826|P3|Overall Study|Withdrawal by Subject|5
2440319|NCT03004924|8384827|P2|Overall Study|Withdrawal by Subject|3
2440320|NCT03004924|8384828|P1|Overall Study|Withdrawal by Subject|5
2440321|NCT03004924|8384826|P3|Overall Study|Protocol Violation|1
2440322|NCT03004924|8384827|P2|Overall Study|Protocol Violation|0
2440323|NCT03004924|8384828|P1|Overall Study|Protocol Violation|4
2440324|NCT03004924|8384826|P3|Overall Study|Adverse Event|10
2440325|NCT03004924|8384827|P2|Overall Study|Adverse Event|5
2440326|NCT03004924|8384828|P1|Overall Study|Adverse Event|6
2440327|NCT03004469|8385072|P3|Overall Study|Other unspecified reason|1
2440328|NCT03004469|8385073|P2|Overall Study|Other unspecified reason|4
2440329|NCT03004469|8385074|P1|Overall Study|Other unspecified reason|0
2440330|NCT03004469|8385072|P3|Overall Study|Withdrawal by Subject|10
2440331|NCT03004469|8385073|P2|Overall Study|Withdrawal by Subject|27
2440332|NCT03004469|8385074|P1|Overall Study|Withdrawal by Subject|29
2440333|NCT03004469|8385072|P3|Overall Study|Protocol Violation|1
2440334|NCT03004469|8385073|P2|Overall Study|Protocol Violation|0
2440335|NCT03004469|8385074|P1|Overall Study|Protocol Violation|0
2440336|NCT03004469|8385072|P3|Overall Study|Non-Compliance with Study Drug|0
2440337|NCT03004469|8385073|P2|Overall Study|Non-Compliance with Study Drug|0
2440338|NCT03004469|8385074|P1|Overall Study|Non-Compliance with Study Drug|2
2440339|NCT03004469|8385072|P3|Overall Study|Lost to Follow-up|6
2440340|NCT03004469|8385073|P2|Overall Study|Lost to Follow-up|14
2440341|NCT03004469|8385074|P1|Overall Study|Lost to Follow-up|23
2440342|NCT03004469|8385072|P3|Overall Study|Lack of Efficacy|1
2440343|NCT03004469|8385073|P2|Overall Study|Lack of Efficacy|0
2440344|NCT03004469|8385074|P1|Overall Study|Lack of Efficacy|1
2440345|NCT03004469|8385072|P3|Overall Study|Adverse Event|6
2440346|NCT03004469|8385073|P2|Overall Study|Adverse Event|4
2440347|NCT03004469|8385074|P1|Overall Study|Adverse Event|6
2440348|NCT03003520|8385117|P2|Follow-up|Withdrawal by Subject|0
2440349|NCT03003520|8385118|P1|Follow-up|Withdrawal by Subject|1
2440350|NCT03003520|8385117|P2|Follow-up|Ongoing|2
2440351|NCT03003520|8385118|P1|Follow-up|Ongoing|12
2440352|NCT03003520|8385117|P2|Follow-up|Death|1
2440353|NCT03003520|8385118|P1|Follow-up|Death|1
2440354|NCT03003520|8385117|P2|Consolidation|Withdrawal by Subject|0
2440355|NCT03003520|8385118|P1|Consolidation|Withdrawal by Subject|1
2440356|NCT03003520|8385117|P2|Consolidation|Progressive disease|1
2440357|NCT03003520|8385118|P1|Consolidation|Progressive disease|3
2440358|NCT03003520|8385117|P2|Consolidation|Adverse Event|0
2440359|NCT03003520|8385118|P1|Consolidation|Adverse Event|2
2440360|NCT03003520|8385117|P2|Consolidation|Ongoing|0
2440361|NCT03003520|8385118|P1|Consolidation|Ongoing|18
2440362|NCT03003520|8385117|P2|Induction|Progressive disease|0
2440363|NCT03003520|8385118|P1|Induction|Progressive disease|1
2440364|NCT03003520|8385117|P2|Induction|Withdrawal by Subject|0
2440365|NCT03003520|8385118|P1|Induction|Withdrawal by Subject|3
2440366|NCT03003520|8385117|P2|Induction|Physician Decision|0
2440367|NCT03003520|8385118|P1|Induction|Physician Decision|2
2440368|NCT03003520|8385117|P2|Induction|Palliative care|0
2440369|NCT03003520|8385118|P1|Induction|Palliative care|1
2440370|NCT03003520|8385117|P2|Induction|Death|0
2440371|NCT03003520|8385118|P1|Induction|Death|1
2440372|NCT03003520|8385117|P2|Induction|Adverse Event|0
2440373|NCT03003520|8385118|P1|Induction|Adverse Event|4
2440374|NCT03003520|8385117|P2|Induction|Ongoing|0
2440375|NCT03003520|8385118|P1|Induction|Ongoing|1
2440376|NCT03003494|8385136|P1|Overall Study|Evaluable PF10 questionnaire at visit1|28
2440377|NCT03003000|8385148|P3|Overall Study|Other than listed|1
2440378|NCT03003000|8385149|P2|Overall Study|Other than listed|1
2440379|NCT03003000|8385150|P1|Overall Study|Other than listed|1
2440380|NCT03003000|8385148|P3|Overall Study|Refused to continue medication|0
2440381|NCT03003000|8385149|P2|Overall Study|Refused to continue medication|0
2440382|NCT03003000|8385150|P1|Overall Study|Refused to continue medication|2
2440383|NCT03003000|8385148|P3|Overall Study|Non-compliant with protocol|1
2440384|NCT03003000|8385149|P2|Overall Study|Non-compliant with protocol|1
2440385|NCT03003000|8385150|P1|Overall Study|Non-compliant with protocol|0
2440386|NCT03003000|8385148|P3|Overall Study|Lack of Efficacy|0
2440387|NCT03003000|8385149|P2|Overall Study|Lack of Efficacy|0
2440388|NCT03003000|8385150|P1|Overall Study|Lack of Efficacy|1
2440389|NCT03003000|8385148|P3|Overall Study|Adverse Event|3
2440390|NCT03003000|8385149|P2|Overall Study|Adverse Event|2
2440391|NCT03003000|8385150|P1|Overall Study|Adverse Event|1
2440392|NCT03002818|8385176|P1|Overall Study|Decision of the investigator|1
2440393|NCT03002623|8385202|P2|Overall Study|Physician Decision|1
2440394|NCT03002623|8385203|P1|Overall Study|Physician Decision|1
2440395|NCT03002623|8385202|P2|Overall Study|Lost to Follow-up|0
2440396|NCT03002623|8385203|P1|Overall Study|Lost to Follow-up|1
2440397|NCT03002610|8385220|P3|Overall Study|Withdrawal by Subject|13
2440398|NCT03002610|8385221|P2|Overall Study|Withdrawal by Subject|25
2440399|NCT03002610|8385222|P1|Overall Study|Withdrawal by Subject|6
2440400|NCT03002194|8385244|P1|Overall Study|Withdrawal by Subject|2
2440401|NCT03002194|8385244|P1|Overall Study|Lack of Efficacy|1
2440402|NCT03002194|8385244|P1|Overall Study|Adverse Event|1
2440403|NCT03002194|8385244|P1|Overall Study|Lost to Follow-up|6
2440404|NCT03001557|8385296|P5|Overall Study|Randomized but not treated|0
2440405|NCT03001557|8385297|P4|Overall Study|Randomized but not treated|0
2440406|NCT03001557|8385298|P3|Overall Study|Randomized but not treated|1
2440407|NCT03001557|8385299|P2|Overall Study|Randomized but not treated|0
2440408|NCT03001557|8385300|P1|Overall Study|Randomized but not treated|0
2440409|NCT03001219|8385599|P2|Extension Period Analysis|Withdrawal by Subject|5
2440410|NCT03001219|8385600|P1|Extension Period Analysis|Withdrawal by Subject|4
2440411|NCT03001219|8385599|P2|Extension Period Analysis|Protocol Deviation|1
2440412|NCT03001219|8385600|P1|Extension Period Analysis|Protocol Deviation|0
2440413|NCT03001219|8385599|P2|Extension Period Analysis|Adverse Event|1
2440414|NCT03001219|8385600|P1|Extension Period Analysis|Adverse Event|1
2440415|NCT03001219|8385599|P2|Extension Period Analysis|Physician Decision|1
2440416|NCT03001219|8385600|P1|Extension Period Analysis|Physician Decision|0
2440417|NCT03001219|8385599|P2|Extension Period Analysis|Participant Non-Compliance|1
2440418|NCT03001219|8385600|P1|Extension Period Analysis|Participant Non-Compliance|0
2440419|NCT03001219|8385599|P2|Extension Period Analysis|Study Termination by Sponsor|36
2440420|NCT03001219|8385600|P1|Extension Period Analysis|Study Termination by Sponsor|0
2440421|NCT03001219|8385599|P2|Proof of Concept|Physician Decision|0
2440422|NCT03001219|8385600|P1|Proof of Concept|Physician Decision|1
2440423|NCT03001219|8385599|P2|Proof of Concept|Adverse Event|1
2440424|NCT03001219|8385600|P1|Proof of Concept|Adverse Event|1
2440425|NCT03001219|8385599|P2|Proof of Concept|Protocol Deviation|1
2440426|NCT03001219|8385600|P1|Proof of Concept|Protocol Deviation|0
2440427|NCT03001219|8385599|P2|Proof of Concept|Withdrawal by Subject|4
2440428|NCT03001219|8385600|P1|Proof of Concept|Withdrawal by Subject|0
2440429|NCT03001219|8385599|P2|Proof of Concept|Study Termination by Sponsor|1
2440430|NCT03001219|8385600|P1|Proof of Concept|Study Termination by Sponsor|0
2440431|NCT03001076|8385661|P2|Overall Study|Lost to Follow-up|2
2440432|NCT03001076|8385662|P1|Overall Study|Lost to Follow-up|0
2440433|NCT03001076|8385661|P2|Overall Study|Sponsor decision|0
2440434|NCT03001076|8385662|P1|Overall Study|Sponsor decision|1
2440435|NCT03001076|8385661|P2|Overall Study|Adverse Event|3
2440436|NCT03001076|8385662|P1|Overall Study|Adverse Event|3
2440437|NCT03001076|8385661|P2|Overall Study|Other|0
2440438|NCT03001076|8385662|P1|Overall Study|Other|1
2440439|NCT03001076|8385661|P2|Overall Study|Withdrawal by patient|0
2440440|NCT03001076|8385662|P1|Overall Study|Withdrawal by patient|2
2440441|NCT03000686|8385696|P4|Part 1, Period 1 (1 Day)|Adverse Event|0
2440442|NCT03000686|8385697|P3|Part 1, Period 1 (1 Day)|Adverse Event|0
2440443|NCT03000686|8385698|P2|Part 1, Period 1 (1 Day)|Adverse Event|1
2440444|NCT03000686|8385699|P1|Part 1, Period 1 (1 Day)|Adverse Event|0
2440445|NCT03000452|8385776|P1|Follow-Up Period|Withdrawal by Subject|3
2440446|NCT03000452|8385776|P1|Follow-Up Period|Death|3
2440447|NCT03000452|8385776|P1|Follow-Up Period|Study Terminated by Sponsor|1
2440448|NCT03000452|8385776|P1|Treatment Period|Miscellaneous|2
2440449|NCT03000452|8385776|P1|Treatment Period|Physician Decision|1
2440450|NCT03000452|8385776|P1|Treatment Period|Progressive Disease (PD)|14
2440451|NCT03000452|8385776|P1|Treatment Period|Death|1
2440452|NCT03000075|8385833|P7|Part B|Adverse Event|0
2440453|NCT03000075|8385834|P6|Part B|Adverse Event|0
2440454|NCT03000075|8385835|P5|Part B|Adverse Event|1
2440455|NCT03000075|8385836|P4|Part B|Adverse Event|0
2440456|NCT03000075|8385837|P3|Part B|Adverse Event|0
2440457|NCT03000075|8385838|P2|Part B|Adverse Event|0
2440458|NCT03000075|8385839|P1|Part B|Adverse Event|0
2440459|NCT03000075|8385833|P7|Part B|Not dosed due to AE|1
2440460|NCT03000075|8385834|P6|Part B|Not dosed due to AE|2
2440461|NCT03000075|8385835|P5|Part B|Not dosed due to AE|0
2440462|NCT03000075|8385836|P4|Part B|Not dosed due to AE|0
2440463|NCT03000075|8385837|P3|Part B|Not dosed due to AE|0
2440464|NCT03000075|8385838|P2|Part B|Not dosed due to AE|0
2440465|NCT03000075|8385839|P1|Part B|Not dosed due to AE|0
2440466|NCT03000075|8385833|P7|Part A|Adverse Event|0
2440467|NCT03000075|8385834|P6|Part A|Adverse Event|0
2440468|NCT03000075|8385835|P5|Part A|Adverse Event|0
2440469|NCT03000075|8385836|P4|Part A|Adverse Event|0
2440470|NCT03000075|8385837|P3|Part A|Adverse Event|0
2440471|NCT03000075|8385838|P2|Part A|Adverse Event|0
2440472|NCT03000075|8385839|P1|Part A|Adverse Event|4
2440473|NCT02999672|8385892|P2|Overall Study|Adverse Event|0
2440474|NCT02999672|8385893|P1|Overall Study|Adverse Event|4
2440475|NCT02999672|8385892|P2|Overall Study|Progressive Disease|5
2440476|NCT02999672|8385893|P1|Overall Study|Progressive Disease|9
2440477|NCT02999672|8385892|P2|Overall Study|Study Terminated by Sponsor|1
2440478|NCT02999672|8385893|P1|Overall Study|Study Terminated by Sponsor|0
2440479|NCT02999672|8385892|P2|Overall Study|Death|1
2440480|NCT02999672|8385893|P1|Overall Study|Death|0
2440481|NCT02999633|8385909|P1|Overall Study|Progressive disease|12
2440482|NCT02999633|8385909|P1|Overall Study|Adverse Event|2
2440483|NCT02999100|8385923|P6|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
2440484|NCT02999100|8385924|P5|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
2440485|NCT02999100|8385925|P4|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
2440486|NCT02999100|8385926|P3|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1
2440487|NCT02999100|8385927|P2|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
2440488|NCT02999100|8385928|P1|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
2440489|NCT02999100|8385923|P6|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1
2440490|NCT02999100|8385924|P5|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
2440491|NCT02999100|8385925|P4|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
2440492|NCT02999100|8385926|P3|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
2440493|NCT02999100|8385927|P2|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
2440494|NCT02999100|8385928|P1|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
2440495|NCT02999100|8385923|P6|Part 1 (up to 15 Days)|Adverse Event|0
2440496|NCT02999100|8385924|P5|Part 1 (up to 15 Days)|Adverse Event|0
2440497|NCT02999100|8385925|P4|Part 1 (up to 15 Days)|Adverse Event|0
2440498|NCT02999100|8385926|P3|Part 1 (up to 15 Days)|Adverse Event|0
2440499|NCT02999100|8385927|P2|Part 1 (up to 15 Days)|Adverse Event|1
2440500|NCT02999100|8385928|P1|Part 1 (up to 15 Days)|Adverse Event|0
2440501|NCT02998996|8386096|P6|Overall Study|Family reasons|0
2440502|NCT02998996|8386097|P5|Overall Study|Family reasons|1
2440503|NCT02998996|8386098|P4|Overall Study|Family reasons|0
2440504|NCT02998996|8386099|P3|Overall Study|Family reasons|0
2440505|NCT02998996|8386100|P2|Overall Study|Family reasons|0
2440506|NCT02998996|8386101|P1|Overall Study|Family reasons|0
2440507|NCT02998996|8386096|P6|Overall Study|Pregnancy|0
2440508|NCT02998996|8386097|P5|Overall Study|Pregnancy|0
2440509|NCT02998996|8386098|P4|Overall Study|Pregnancy|0
2440510|NCT02998996|8386099|P3|Overall Study|Pregnancy|0
2440511|NCT02998996|8386100|P2|Overall Study|Pregnancy|1
2440512|NCT02998996|8386101|P1|Overall Study|Pregnancy|0
2440513|NCT02998996|8386096|P6|Overall Study|Lost to Follow-up|0
2440514|NCT02998996|8386097|P5|Overall Study|Lost to Follow-up|0
2440515|NCT02998996|8386098|P4|Overall Study|Lost to Follow-up|0
2440516|NCT02998996|8386099|P3|Overall Study|Lost to Follow-up|1
2440517|NCT02998996|8386100|P2|Overall Study|Lost to Follow-up|0
2440518|NCT02998996|8386101|P1|Overall Study|Lost to Follow-up|0
2440519|NCT02998671|8386135|P5|Period 2|Lost to Follow-up|0
2440520|NCT02998671|8386136|P4|Period 2|Lost to Follow-up|1
2440521|NCT02998671|8386137|P3|Period 2|Lost to Follow-up|0
2440522|NCT02998671|8386138|P2|Period 2|Lost to Follow-up|0
2440523|NCT02998671|8386139|P1|Period 2|Lost to Follow-up|0
2440524|NCT02998671|8386135|P5|Period 2|Withdrawal by Subject|0
2440525|NCT02998671|8386136|P4|Period 2|Withdrawal by Subject|0
2440526|NCT02998671|8386137|P3|Period 2|Withdrawal by Subject|0
2440527|NCT02998671|8386138|P2|Period 2|Withdrawal by Subject|1
2440528|NCT02998671|8386139|P1|Period 2|Withdrawal by Subject|0
2440529|NCT02998671|8386135|P5|Period 2|Study Terminated By Sponsor|0
2440530|NCT02998671|8386136|P4|Period 2|Study Terminated By Sponsor|3
2440531|NCT02998671|8386137|P3|Period 2|Study Terminated By Sponsor|1
2440532|NCT02998671|8386138|P2|Period 2|Study Terminated By Sponsor|5
2440533|NCT02998671|8386139|P1|Period 2|Study Terminated By Sponsor|3
2440534|NCT02998671|8386135|P5|Period 2|Adverse Event|0
2440535|NCT02998671|8386136|P4|Period 2|Adverse Event|0
2440536|NCT02998671|8386137|P3|Period 2|Adverse Event|0
2440537|NCT02998671|8386138|P2|Period 2|Adverse Event|1
2440538|NCT02998671|8386139|P1|Period 2|Adverse Event|0
2440539|NCT02998671|8386135|P5|Period 1|Adverse Event|1
2440540|NCT02998671|8386136|P4|Period 1|Adverse Event|0
2440541|NCT02998671|8386137|P3|Period 1|Adverse Event|0
2440542|NCT02998671|8386138|P2|Period 1|Adverse Event|0
2440543|NCT02998671|8386139|P1|Period 1|Adverse Event|0
2440544|NCT02998671|8386135|P5|Period 1|Pregnancy|0
2440545|NCT02998671|8386136|P4|Period 1|Pregnancy|0
2440546|NCT02998671|8386137|P3|Period 1|Pregnancy|0
2440547|NCT02998671|8386138|P2|Period 1|Pregnancy|0
2440548|NCT02998671|8386139|P1|Period 1|Pregnancy|1
2440549|NCT02998671|8386135|P5|Period 1|Withdrawal by Subject|2
2440550|NCT02998671|8386136|P4|Period 1|Withdrawal by Subject|0
2440551|NCT02998671|8386137|P3|Period 1|Withdrawal by Subject|0
2440552|NCT02998671|8386138|P2|Period 1|Withdrawal by Subject|2
2440553|NCT02998671|8386139|P1|Period 1|Withdrawal by Subject|1
2440554|NCT02998671|8386135|P5|Period 1|Study Terminated By Sponsor|1
2440555|NCT02998671|8386136|P4|Period 1|Study Terminated By Sponsor|0
2440556|NCT02998671|8386137|P3|Period 1|Study Terminated By Sponsor|0
2440557|NCT02998671|8386138|P2|Period 1|Study Terminated By Sponsor|1
2440558|NCT02998671|8386139|P1|Period 1|Study Terminated By Sponsor|2
2440559|NCT02998476|8386184|P2|Overall Study|Death|2
2440560|NCT02998476|8386185|P1|Overall Study|Death|32
2440561|NCT02998476|8386184|P2|Overall Study|Withdrawal by Subject|2
2440562|NCT02998476|8386185|P1|Overall Study|Withdrawal by Subject|1
2440563|NCT02998476|8386184|P2|Overall Study|Disease Progression|0
2440564|NCT02998476|8386185|P1|Overall Study|Disease Progression|1
2440565|NCT02998476|8386184|P2|Overall Study|Ongoing in study|1
2440566|NCT02998476|8386185|P1|Overall Study|Ongoing in study|21
2440567|NCT02998021|8386195|P2|Overall Study|unsafe home|1
2440568|NCT02998021|8386196|P1|Overall Study|unsafe home|0
2440569|NCT02998021|8386195|P2|Overall Study|Withdrawal by Subject|1
2440570|NCT02998021|8386196|P1|Overall Study|Withdrawal by Subject|3
2440571|NCT02997163|8386271|P4|Overall Study|Adverse Event|1
2440572|NCT02997163|8386272|P3|Overall Study|Adverse Event|0
2440573|NCT02997163|8386273|P2|Overall Study|Adverse Event|0
2440574|NCT02997163|8386274|P1|Overall Study|Adverse Event|1
2440575|NCT02996968|8386406|P2|Overall Study|Withdrawal by Subject|0
2440576|NCT02996968|8386407|P1|Overall Study|Withdrawal by Subject|1
2440577|NCT02996682|8386415|P2|Overall Study|Death|3
2440578|NCT02996682|8386416|P1|Overall Study|Death|0
2440579|NCT02996500|8386495|P6|Overall Study|Withdrawal by Subject|0
2440580|NCT02996500|8386496|P5|Overall Study|Withdrawal by Subject|2
2440581|NCT02996500|8386497|P4|Overall Study|Withdrawal by Subject|0
2440582|NCT02996500|8386498|P3|Overall Study|Withdrawal by Subject|3
2440583|NCT02996500|8386499|P2|Overall Study|Withdrawal by Subject|0
2440584|NCT02996500|8386500|P1|Overall Study|Withdrawal by Subject|3
2440585|NCT02996500|8386495|P6|Overall Study|Protocol Violation|0
2440586|NCT02996500|8386496|P5|Overall Study|Protocol Violation|0
2440587|NCT02996500|8386497|P4|Overall Study|Protocol Violation|1
2440588|NCT02996500|8386498|P3|Overall Study|Protocol Violation|0
2440589|NCT02996500|8386499|P2|Overall Study|Protocol Violation|0
2440590|NCT02996500|8386500|P1|Overall Study|Protocol Violation|0
2440591|NCT02996500|8386495|P6|Overall Study|Other|0
2440592|NCT02996500|8386496|P5|Overall Study|Other|0
2440593|NCT02996500|8386497|P4|Overall Study|Other|0
2440594|NCT02996500|8386498|P3|Overall Study|Other|2
2440595|NCT02996500|8386499|P2|Overall Study|Other|0
2440596|NCT02996500|8386500|P1|Overall Study|Other|2
2440597|NCT02996500|8386495|P6|Overall Study|Progressive Disease|0
2440598|NCT02996500|8386496|P5|Overall Study|Progressive Disease|0
2440599|NCT02996500|8386497|P4|Overall Study|Progressive Disease|0
2440600|NCT02996500|8386498|P3|Overall Study|Progressive Disease|0
2440601|NCT02996500|8386499|P2|Overall Study|Progressive Disease|0
2440602|NCT02996500|8386500|P1|Overall Study|Progressive Disease|1
2440603|NCT02996500|8386495|P6|Overall Study|Non-Compliance With Study Drug|1
2440604|NCT02996500|8386496|P5|Overall Study|Non-Compliance With Study Drug|0
2440605|NCT02996500|8386497|P4|Overall Study|Non-Compliance With Study Drug|0
2440606|NCT02996500|8386498|P3|Overall Study|Non-Compliance With Study Drug|0
2440607|NCT02996500|8386499|P2|Overall Study|Non-Compliance With Study Drug|0
2440608|NCT02996500|8386500|P1|Overall Study|Non-Compliance With Study Drug|0
2440609|NCT02996500|8386495|P6|Overall Study|No Longer Meets Eligibility Criteria|0
2440610|NCT02996500|8386496|P5|Overall Study|No Longer Meets Eligibility Criteria|0
2440611|NCT02996500|8386497|P4|Overall Study|No Longer Meets Eligibility Criteria|0
2440612|NCT02996500|8386498|P3|Overall Study|No Longer Meets Eligibility Criteria|1
2440613|NCT02996500|8386499|P2|Overall Study|No Longer Meets Eligibility Criteria|0
2440614|NCT02996500|8386500|P1|Overall Study|No Longer Meets Eligibility Criteria|0
2440615|NCT02996500|8386495|P6|Overall Study|Lost to Follow-up|1
2440616|NCT02996500|8386496|P5|Overall Study|Lost to Follow-up|0
2440617|NCT02996500|8386497|P4|Overall Study|Lost to Follow-up|0
2440618|NCT02996500|8386498|P3|Overall Study|Lost to Follow-up|0
2440619|NCT02996500|8386499|P2|Overall Study|Lost to Follow-up|0
2440620|NCT02996500|8386500|P1|Overall Study|Lost to Follow-up|1
2440621|NCT02996500|8386495|P6|Overall Study|Lack of Efficacy|0
2440622|NCT02996500|8386496|P5|Overall Study|Lack of Efficacy|2
2440623|NCT02996500|8386497|P4|Overall Study|Lack of Efficacy|0
2440624|NCT02996500|8386498|P3|Overall Study|Lack of Efficacy|0
2440625|NCT02996500|8386499|P2|Overall Study|Lack of Efficacy|0
2440626|NCT02996500|8386500|P1|Overall Study|Lack of Efficacy|0
2440627|NCT02996500|8386495|P6|Overall Study|Adverse Event|2
2440628|NCT02996500|8386496|P5|Overall Study|Adverse Event|1
2440629|NCT02996500|8386497|P4|Overall Study|Adverse Event|3
2440630|NCT02996500|8386498|P3|Overall Study|Adverse Event|4
2440631|NCT02996500|8386499|P2|Overall Study|Adverse Event|1
2440632|NCT02996500|8386500|P1|Overall Study|Adverse Event|1
2440633|NCT02996097|8386683|P2|Overall Study|Lost to Follow-up|11
2440634|NCT02996097|8386684|P1|Overall Study|Lost to Follow-up|11
2440635|NCT02995980|8386691|P1|Overall Study|Lost to Follow-up|14
2440636|NCT02994056|8386766|P1|Overall Study|Withdrew Consent|1
2440637|NCT02994056|8386766|P1|Overall Study|Death|8
2440638|NCT02993926|8386800|P3|Enantone Treatment Phase|Reason Not Specified|0
2440639|NCT02993926|8386801|P2|Enantone Treatment Phase|Reason Not Specified|0
2440640|NCT02993926|8386802|P1|Enantone Treatment Phase|Reason Not Specified|4
2440641|NCT02993926|8386800|P3|Enantone Treatment Phase|Investigator Judgment|0
2440642|NCT02993926|8386801|P2|Enantone Treatment Phase|Investigator Judgment|0
2440643|NCT02993926|8386802|P1|Enantone Treatment Phase|Investigator Judgment|1
2440644|NCT02993926|8386800|P3|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0
2440645|NCT02993926|8386801|P2|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0
2440646|NCT02993926|8386802|P1|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26
2440647|NCT02993926|8386800|P3|Enantone Treatment Phase|Adverse Event|0
2440648|NCT02993926|8386801|P2|Enantone Treatment Phase|Adverse Event|0
2440649|NCT02993926|8386802|P1|Enantone Treatment Phase|Adverse Event|1
2440650|NCT02993783|8386834|P2|Overall Study|Reason not Specified|9
2440651|NCT02993783|8386835|P1|Overall Study|Reason not Specified|6
2440652|NCT02993471|8386865|P1|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1
2440653|NCT02993471|8386865|P1|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1
2440654|NCT02993250|8386916|P2|Overall Study|Lost to Follow-up|1
2440655|NCT02993250|8386917|P1|Overall Study|Lost to Follow-up|0
2440656|NCT02992691|8386937|P1|Overall Study|Withdrawal by Subject|1
2440657|NCT02992691|8386937|P1|Overall Study|Adverse Event|2
2440658|NCT02992288|8386960|P6|Overall Study|Withdrawal by Subject|4
2440659|NCT02992288|8386961|P5|Overall Study|Withdrawal by Subject|3
2440660|NCT02992288|8386962|P4|Overall Study|Withdrawal by Subject|5
2440661|NCT02992288|8386963|P3|Overall Study|Withdrawal by Subject|1
2440662|NCT02992288|8386964|P2|Overall Study|Withdrawal by Subject|2
2440663|NCT02992288|8386965|P1|Overall Study|Withdrawal by Subject|4
2440664|NCT02992288|8386960|P6|Overall Study|Protocol Violation|1
2440665|NCT02992288|8386961|P5|Overall Study|Protocol Violation|0
2440666|NCT02992288|8386962|P4|Overall Study|Protocol Violation|0
2440667|NCT02992288|8386963|P3|Overall Study|Protocol Violation|0
2440668|NCT02992288|8386964|P2|Overall Study|Protocol Violation|0
2440669|NCT02992288|8386965|P1|Overall Study|Protocol Violation|0
2440670|NCT02992288|8386960|P6|Overall Study|Lost to Follow-up|0
2440671|NCT02992288|8386961|P5|Overall Study|Lost to Follow-up|0
2440672|NCT02992288|8386962|P4|Overall Study|Lost to Follow-up|1
2440673|NCT02992288|8386963|P3|Overall Study|Lost to Follow-up|0
2440674|NCT02992288|8386964|P2|Overall Study|Lost to Follow-up|0
2440675|NCT02992288|8386965|P1|Overall Study|Lost to Follow-up|0
2440676|NCT02992288|8386960|P6|Overall Study|Death|0
2440677|NCT02992288|8386961|P5|Overall Study|Death|2
2440678|NCT02992288|8386962|P4|Overall Study|Death|1
2440679|NCT02992288|8386963|P3|Overall Study|Death|2
2440680|NCT02992288|8386964|P2|Overall Study|Death|0
2440681|NCT02992288|8386965|P1|Overall Study|Death|2
2440682|NCT02992288|8386960|P6|Overall Study|Physician Decision|1
2440683|NCT02992288|8386961|P5|Overall Study|Physician Decision|0
2440684|NCT02992288|8386962|P4|Overall Study|Physician Decision|0
2440685|NCT02992288|8386963|P3|Overall Study|Physician Decision|1
2440686|NCT02992288|8386964|P2|Overall Study|Physician Decision|0
2440687|NCT02992288|8386965|P1|Overall Study|Physician Decision|3
2440688|NCT02992288|8386960|P6|Overall Study|Non-compliance with study drug|0
2440689|NCT02992288|8386961|P5|Overall Study|Non-compliance with study drug|1
2440690|NCT02992288|8386962|P4|Overall Study|Non-compliance with study drug|0
2440691|NCT02992288|8386963|P3|Overall Study|Non-compliance with study drug|1
2440692|NCT02992288|8386964|P2|Overall Study|Non-compliance with study drug|1
2440693|NCT02992288|8386965|P1|Overall Study|Non-compliance with study drug|0
2440694|NCT02992288|8386960|P6|Overall Study|Adverse Event|7
2440695|NCT02992288|8386961|P5|Overall Study|Adverse Event|2
2440696|NCT02992288|8386962|P4|Overall Study|Adverse Event|2
2440697|NCT02992288|8386963|P3|Overall Study|Adverse Event|2
2440698|NCT02992288|8386964|P2|Overall Study|Adverse Event|2
2440699|NCT02992288|8386965|P1|Overall Study|Adverse Event|8
2440700|NCT02992132|8387037|P3|Overall Study|Physician Decision|1
2440701|NCT02992132|8387038|P2|Overall Study|Physician Decision|0
2440702|NCT02992132|8387039|P1|Overall Study|Physician Decision|0
2440703|NCT02992132|8387037|P3|Overall Study|Withdrawal by Subject|1
2440704|NCT02992132|8387038|P2|Overall Study|Withdrawal by Subject|2
2440705|NCT02992132|8387039|P1|Overall Study|Withdrawal by Subject|0
2440706|NCT02992132|8387037|P3|Overall Study|Caregiver withdrew consent|2
2440707|NCT02992132|8387038|P2|Overall Study|Caregiver withdrew consent|3
2440708|NCT02992132|8387039|P1|Overall Study|Caregiver withdrew consent|2
2440709|NCT02992132|8387037|P3|Overall Study|Protocol Violation|0
2440710|NCT02992132|8387038|P2|Overall Study|Protocol Violation|2
2440711|NCT02992132|8387039|P1|Overall Study|Protocol Violation|2
2440712|NCT02992132|8387037|P3|Overall Study|Progressive disease|0
2440713|NCT02992132|8387038|P2|Overall Study|Progressive disease|0
2440714|NCT02992132|8387039|P1|Overall Study|Progressive disease|1
2440715|NCT02992132|8387037|P3|Overall Study|Non-compliance with study drug|0
2440716|NCT02992132|8387038|P2|Overall Study|Non-compliance with study drug|0
2440717|NCT02992132|8387039|P1|Overall Study|Non-compliance with study drug|2
2440718|NCT02992132|8387037|P3|Overall Study|Lack of Efficacy|0
2440719|NCT02992132|8387038|P2|Overall Study|Lack of Efficacy|0
2440720|NCT02992132|8387039|P1|Overall Study|Lack of Efficacy|2
2440721|NCT02992132|8387037|P3|Overall Study|Adverse Event|3
2440722|NCT02992132|8387038|P2|Overall Study|Adverse Event|1
2440723|NCT02992132|8387039|P1|Overall Study|Adverse Event|4
2440724|NCT02991859|8387135|P17|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2440725|NCT02991859|8387136|P16|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2440726|NCT02991859|8387137|P15|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2440727|NCT02991859|8387138|P14|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2440728|NCT02991859|8387139|P13|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2440729|NCT02991859|8387140|P12|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2440730|NCT02991859|8387141|P11|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2440731|NCT02991859|8387142|P10|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2440732|NCT02991859|8387143|P9|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1
2440733|NCT02991859|8387144|P8|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2440734|NCT02991859|8387145|P7|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2440735|NCT02991859|8387146|P6|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2440736|NCT02991859|8387147|P5|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2440737|NCT02991859|8387148|P4|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2440738|NCT02991859|8387149|P3|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2440739|NCT02991859|8387150|P2|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2440740|NCT02991859|8387151|P1|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
2440741|NCT02991859|8387135|P17|Wash Out, Up to Day 77|Lost to Follow-up|0
2440742|NCT02991859|8387136|P16|Wash Out, Up to Day 77|Lost to Follow-up|0
2440743|NCT02991859|8387137|P15|Wash Out, Up to Day 77|Lost to Follow-up|0
2440744|NCT02991859|8387138|P14|Wash Out, Up to Day 77|Lost to Follow-up|0
2440745|NCT02991859|8387139|P13|Wash Out, Up to Day 77|Lost to Follow-up|0
2440746|NCT02991859|8387140|P12|Wash Out, Up to Day 77|Lost to Follow-up|0
2440747|NCT02991859|8387141|P11|Wash Out, Up to Day 77|Lost to Follow-up|0
2440748|NCT02991859|8387142|P10|Wash Out, Up to Day 77|Lost to Follow-up|1
2440749|NCT02991859|8387143|P9|Wash Out, Up to Day 77|Lost to Follow-up|0
2440750|NCT02991859|8387144|P8|Wash Out, Up to Day 77|Lost to Follow-up|0
2440751|NCT02991859|8387145|P7|Wash Out, Up to Day 77|Lost to Follow-up|0
2440752|NCT02991859|8387146|P6|Wash Out, Up to Day 77|Lost to Follow-up|0
2440753|NCT02991859|8387147|P5|Wash Out, Up to Day 77|Lost to Follow-up|0
2440754|NCT02991859|8387148|P4|Wash Out, Up to Day 77|Lost to Follow-up|0
2440755|NCT02991859|8387149|P3|Wash Out, Up to Day 77|Lost to Follow-up|0
2440756|NCT02991859|8387150|P2|Wash Out, Up to Day 77|Lost to Follow-up|0
2440757|NCT02991859|8387151|P1|Wash Out, Up to Day 77|Lost to Follow-up|0
2440758|NCT02991859|8387135|P17|Wash Out, Up to Day 77|Withdrawal by Subject|0
2440759|NCT02991859|8387136|P16|Wash Out, Up to Day 77|Withdrawal by Subject|0
2440760|NCT02991859|8387137|P15|Wash Out, Up to Day 77|Withdrawal by Subject|0
2440761|NCT02991859|8387138|P14|Wash Out, Up to Day 77|Withdrawal by Subject|0
2440762|NCT02991859|8387139|P13|Wash Out, Up to Day 77|Withdrawal by Subject|0
2440763|NCT02991859|8387140|P12|Wash Out, Up to Day 77|Withdrawal by Subject|0
2440764|NCT02991859|8387141|P11|Wash Out, Up to Day 77|Withdrawal by Subject|0
2440765|NCT02991859|8387142|P10|Wash Out, Up to Day 77|Withdrawal by Subject|0
2440766|NCT02991859|8387143|P9|Wash Out, Up to Day 77|Withdrawal by Subject|0
2440767|NCT02991859|8387144|P8|Wash Out, Up to Day 77|Withdrawal by Subject|0
2440768|NCT02991859|8387145|P7|Wash Out, Up to Day 77|Withdrawal by Subject|0
2440769|NCT02991859|8387146|P6|Wash Out, Up to Day 77|Withdrawal by Subject|1
2440770|NCT02991859|8387147|P5|Wash Out, Up to Day 77|Withdrawal by Subject|0
2440771|NCT02991859|8387148|P4|Wash Out, Up to Day 77|Withdrawal by Subject|0
2440772|NCT02991859|8387149|P3|Wash Out, Up to Day 77|Withdrawal by Subject|0
2440773|NCT02991859|8387150|P2|Wash Out, Up to Day 77|Withdrawal by Subject|0
2440774|NCT02991859|8387151|P1|Wash Out, Up to Day 77|Withdrawal by Subject|0
2440775|NCT02991859|8387135|P17|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2440776|NCT02991859|8387136|P16|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2440777|NCT02991859|8387137|P15|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2440778|NCT02991859|8387138|P14|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1
2440779|NCT02991859|8387139|P13|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1
2440780|NCT02991859|8387140|P12|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2440781|NCT02991859|8387141|P11|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2440782|NCT02991859|8387142|P10|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2440783|NCT02991859|8387143|P9|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2440784|NCT02991859|8387144|P8|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2440785|NCT02991859|8387145|P7|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2440786|NCT02991859|8387146|P6|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2440787|NCT02991859|8387147|P5|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2440788|NCT02991859|8387148|P4|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2440789|NCT02991859|8387149|P3|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2440790|NCT02991859|8387150|P2|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2440791|NCT02991859|8387151|P1|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
2440792|NCT02991859|8387135|P17|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2440793|NCT02991859|8387136|P16|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2440794|NCT02991859|8387137|P15|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2440795|NCT02991859|8387138|P14|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2440796|NCT02991859|8387139|P13|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2440797|NCT02991859|8387140|P12|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2440798|NCT02991859|8387141|P11|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2440799|NCT02991859|8387142|P10|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2440800|NCT02991859|8387143|P9|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2440801|NCT02991859|8387144|P8|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2440802|NCT02991859|8387145|P7|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2440803|NCT02991859|8387146|P6|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2440804|NCT02991859|8387147|P5|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1
2440805|NCT02991859|8387148|P4|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2440806|NCT02991859|8387149|P3|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2440807|NCT02991859|8387150|P2|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1
2440808|NCT02991859|8387151|P1|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
2440809|NCT02991430|8387446|P3|Post-treatment Observation Period|Study Termination|5
2440810|NCT02991430|8387447|P2|Post-treatment Observation Period|Study Termination|6
2440811|NCT02991430|8387448|P1|Post-treatment Observation Period|Study Termination|3
2440812|NCT02991430|8387446|P3|Treatment Period 2|Lost to Follow-up|1
2440813|NCT02991430|8387447|P2|Treatment Period 2|Lost to Follow-up|0
2440814|NCT02991430|8387448|P1|Treatment Period 2|Lost to Follow-up|0
2440815|NCT02991430|8387446|P3|Treatment Period 2|Study Termination|3
2440816|NCT02991430|8387447|P2|Treatment Period 2|Study Termination|3
2440817|NCT02991430|8387448|P1|Treatment Period 2|Study Termination|6
2440818|NCT02991430|8387446|P3|Treatment Period 1|Withdrawal by Subject|0
2440819|NCT02991430|8387447|P2|Treatment Period 1|Withdrawal by Subject|4
2440820|NCT02991430|8387448|P1|Treatment Period 1|Withdrawal by Subject|0
2440821|NCT02991430|8387446|P3|Treatment Period 1|Adverse Event|2
2440822|NCT02991430|8387447|P2|Treatment Period 1|Adverse Event|0
2440823|NCT02991430|8387448|P1|Treatment Period 1|Adverse Event|1
2440824|NCT02991118|8387485|P2|Overall Study|Lost to Follow-up|9
2440825|NCT02991118|8387486|P1|Overall Study|Lost to Follow-up|1
2440826|NCT02991118|8387485|P2|Overall Study|Could not attend study visits|1
2440827|NCT02991118|8387486|P1|Overall Study|Could not attend study visits|0
2440828|NCT02991118|8387485|P2|Overall Study|Withdrawal by Subject|7
2440829|NCT02991118|8387486|P1|Overall Study|Withdrawal by Subject|1
2440830|NCT02991118|8387485|P2|Overall Study|Adverse Event|2
2440831|NCT02991118|8387486|P1|Overall Study|Adverse Event|2
2440832|NCT02991118|8387485|P2|Overall Study|Moved out of the country|1
2440833|NCT02991118|8387486|P1|Overall Study|Moved out of the country|0
2440834|NCT02991118|8387485|P2|Overall Study|Physician Decision|1
2440835|NCT02991118|8387486|P1|Overall Study|Physician Decision|0
2440836|NCT02991118|8387485|P2|Overall Study|Protocol Violation|3
2440837|NCT02991118|8387486|P1|Overall Study|Protocol Violation|0
2440838|NCT02991118|8387485|P2|Overall Study|Death|8
2440839|NCT02991118|8387486|P1|Overall Study|Death|3
2440840|NCT02991040|8387530|P1|Overall Study|Lost to Follow-up|2
2440841|NCT02991040|8387530|P1|Overall Study|Withdrawal by Subject|2
2440842|NCT02990910|8387545|P2|Overall Study|Lack of Efficacy|10
2440843|NCT02990910|8387546|P1|Overall Study|Lack of Efficacy|6
2440844|NCT02990338|8387556|P2|Overall Study|Randomized but not treated|2
2440845|NCT02990338|8387557|P1|Overall Study|Randomized but not treated|4
2440846|NCT02990338|8387556|P2|Overall Study|Other|4
2440847|NCT02990338|8387557|P1|Overall Study|Other|1
2440848|NCT02990338|8387556|P2|Overall Study|Withdrawal by Subject|5
2440849|NCT02990338|8387557|P1|Overall Study|Withdrawal by Subject|6
2440850|NCT02990338|8387556|P2|Overall Study|Poor compliance to protocol|1
2440851|NCT02990338|8387557|P1|Overall Study|Poor compliance to protocol|0
2440852|NCT02990338|8387556|P2|Overall Study|Progressive disease|66
2440853|NCT02990338|8387557|P1|Overall Study|Progressive disease|88
2440854|NCT02990338|8387556|P2|Overall Study|Adverse Event|11
2440855|NCT02990338|8387557|P1|Overall Study|Adverse Event|19
2440856|NCT02989805|8387605|P2|Overall Study|invalid consent|4
2440857|NCT02989805|8387606|P1|Overall Study|invalid consent|6
2440858|NCT02989649|8387706|P1|Overall Study|Reason Not Specified|13
2440859|NCT02989649|8387706|P1|Overall Study|Lost For Observation During Study|3
2440860|NCT02989649|8387706|P1|Overall Study|Adverse Event/Adverse Drug Reaction|1
2440861|NCT02989649|8387706|P1|Overall Study|Patient/Investigator’s Decision to Stop|403
2440862|NCT02989389|8387742|P10|Period 1|Physician Decision|0
2440863|NCT02989389|8387743|P9|Period 1|Physician Decision|1
2440864|NCT02989389|8387744|P8|Period 1|Physician Decision|0
2440865|NCT02989389|8387745|P7|Period 1|Physician Decision|0
2440866|NCT02989389|8387746|P6|Period 1|Physician Decision|0
2440867|NCT02989389|8387747|P5|Period 1|Physician Decision|0
2440868|NCT02989389|8387748|P4|Period 1|Physician Decision|0
2440869|NCT02989389|8387749|P3|Period 1|Physician Decision|0
2440870|NCT02989389|8387750|P2|Period 1|Physician Decision|0
2440871|NCT02989389|8387751|P1|Period 1|Physician Decision|0
2440872|NCT02989389|8387742|P10|Period 1|Lost to Follow-up|0
2440873|NCT02989389|8387743|P9|Period 1|Lost to Follow-up|0
2440874|NCT02989389|8387744|P8|Period 1|Lost to Follow-up|0
2440875|NCT02989389|8387745|P7|Period 1|Lost to Follow-up|0
2440876|NCT02989389|8387746|P6|Period 1|Lost to Follow-up|0
2440877|NCT02989389|8387747|P5|Period 1|Lost to Follow-up|0
2440878|NCT02989389|8387748|P4|Period 1|Lost to Follow-up|0
2440879|NCT02989389|8387749|P3|Period 1|Lost to Follow-up|0
2440880|NCT02989389|8387750|P2|Period 1|Lost to Follow-up|1
2440881|NCT02989389|8387751|P1|Period 1|Lost to Follow-up|0
2440882|NCT02988622|8387828|P1|Overall Study|Lost to Follow-up|17
2440883|NCT02988219|8387863|P2|Overall Study|Withdrawal by Subject|2
2440884|NCT02988219|8387864|P1|Overall Study|Withdrawal by Subject|0
2440885|NCT02988219|8387863|P2|Overall Study|Lack of Efficacy|1
2440886|NCT02988219|8387864|P1|Overall Study|Lack of Efficacy|1
2440887|NCT02988115|8387883|P2|Overall Study|Lost to Follow-up|0
2440888|NCT02988115|8387884|P1|Overall Study|Lost to Follow-up|1
2440889|NCT02988115|8387883|P2|Overall Study|Withdrawn by Mistake|0
2440890|NCT02988115|8387884|P1|Overall Study|Withdrawn by Mistake|1
2440891|NCT02988115|8387883|P2|Overall Study|Withdrawal by Subject|1
2440892|NCT02988115|8387884|P1|Overall Study|Withdrawal by Subject|1
2440893|NCT02988115|8387883|P2|Overall Study|Sponsor Decision|2
2440894|NCT02988115|8387884|P1|Overall Study|Sponsor Decision|5
2440895|NCT02988115|8387883|P2|Overall Study|Adverse Event|1
2440896|NCT02988115|8387884|P1|Overall Study|Adverse Event|6
2440897|NCT02987972|8387901|P3|Overall Study|Withdrawal by Subject|21
2440898|NCT02987972|8387902|P2|Overall Study|Withdrawal by Subject|17
2440899|NCT02987972|8387903|P1|Overall Study|Withdrawal by Subject|22
2440900|NCT02987972|8387901|P3|Overall Study|Protocol Violation|5
2440901|NCT02987972|8387902|P2|Overall Study|Protocol Violation|1
2440902|NCT02987972|8387903|P1|Overall Study|Protocol Violation|2
2440903|NCT02987972|8387901|P3|Overall Study|Physician Decision|0
2440904|NCT02987972|8387902|P2|Overall Study|Physician Decision|6
2440905|NCT02987972|8387903|P1|Overall Study|Physician Decision|1
2440906|NCT02987972|8387901|P3|Overall Study|Lost to Follow-up|4
2440907|NCT02987972|8387902|P2|Overall Study|Lost to Follow-up|8
2440908|NCT02987972|8387903|P1|Overall Study|Lost to Follow-up|7
2440909|NCT02987972|8387901|P3|Overall Study|Lack of Efficacy|12
2440910|NCT02987972|8387902|P2|Overall Study|Lack of Efficacy|12
2440911|NCT02987972|8387903|P1|Overall Study|Lack of Efficacy|9
2440912|NCT02987972|8387901|P3|Overall Study|Death|0
2440913|NCT02987972|8387902|P2|Overall Study|Death|0
2440914|NCT02987972|8387903|P1|Overall Study|Death|1
2440915|NCT02987972|8387901|P3|Overall Study|Adverse Event|0
2440916|NCT02987972|8387902|P2|Overall Study|Adverse Event|1
2440917|NCT02987972|8387903|P1|Overall Study|Adverse Event|1
2440918|NCT02987660|8387941|P2|Overall Study|Study terminated by sponsor|10
2440919|NCT02987660|8387942|P1|Overall Study|Study terminated by sponsor|10
2440920|NCT02987205|8387976|P1|Overall Study|Withdrawal by Subject|3
2440921|NCT02987205|8387976|P1|Overall Study|Adverse Event|1
2440922|NCT02986854|8388010|P3|Overall Study|Lost to Follow-up|2
2440923|NCT02986854|8388011|P2|Overall Study|Lost to Follow-up|11
2440924|NCT02986854|8388012|P1|Overall Study|Lost to Follow-up|3
2440925|NCT02986854|8388010|P3|Overall Study|Withdrawal by Subject|1
2440926|NCT02986854|8388011|P2|Overall Study|Withdrawal by Subject|1
2440927|NCT02986854|8388012|P1|Overall Study|Withdrawal by Subject|0
2440928|NCT02986373|8388096|P1|Overall Study|Other|24
2440929|NCT02986373|8388096|P1|Overall Study|Withdrawal by Subject|10
2440930|NCT02986373|8388096|P1|Overall Study|Lost to Follow-up|1
2440931|NCT02986373|8388096|P1|Overall Study|Adverse Event|4
2440932|NCT02986139|8388138|P2|Overall Study|Lost to Follow-up|1
2440933|NCT02986139|8388139|P1|Overall Study|Lost to Follow-up|0
2440934|NCT02986139|8388138|P2|Overall Study|Withdrawal by Subject|1
2440935|NCT02986139|8388139|P1|Overall Study|Withdrawal by Subject|0
2440936|NCT02986139|8388138|P2|Overall Study|Sponsor Decision|2
2440937|NCT02986139|8388139|P1|Overall Study|Sponsor Decision|1
2440938|NCT02985996|8388156|P5|Overall Study|Protocol Violation|0
2440939|NCT02985996|8388157|P4|Overall Study|Protocol Violation|0
2440940|NCT02985996|8388158|P3|Overall Study|Protocol Violation|0
2440941|NCT02985996|8388159|P2|Overall Study|Protocol Violation|1
2440942|NCT02985996|8388160|P1|Overall Study|Protocol Violation|0
2440943|NCT02985996|8388156|P5|Overall Study|Withdrawal by Subject|0
2440944|NCT02985996|8388157|P4|Overall Study|Withdrawal by Subject|0
2440945|NCT02985996|8388158|P3|Overall Study|Withdrawal by Subject|1
2440946|NCT02985996|8388159|P2|Overall Study|Withdrawal by Subject|0
2440947|NCT02985996|8388160|P1|Overall Study|Withdrawal by Subject|0
2440948|NCT02985684|8388294|P1|6-Month Closure Success Evaluation|Device Removal|3
2440949|NCT02985684|8388294|P1|6-Month Closure Success Evaluation|Technical Failure (No Device)|5
2440950|NCT02985684|8388294|P1|6-Month Clinical Success Evaluation|Missed Echocardiograph|5
2440951|NCT02985398|8388305|P1|Overall Study|Study Burden|9
2440952|NCT02985398|8388305|P1|Overall Study|Withdrawal by Subject|8
2440953|NCT02985398|8388305|P1|Overall Study|Lost to Follow-up|4
2440954|NCT02985398|8388305|P1|Overall Study|Adverse Event|1
2440955|NCT02984995|8388323|P2|Overall Study|Adverse Event|0
2440956|NCT02984995|8388324|P1|Overall Study|Adverse Event|1
2440957|NCT02984995|8388323|P2|Overall Study|Progressive disease|1
2440958|NCT02984995|8388324|P1|Overall Study|Progressive disease|11
2440959|NCT02984995|8388323|P2|Overall Study|Required stem cell transplant|2
2440960|NCT02984995|8388324|P1|Overall Study|Required stem cell transplant|13
2440961|NCT02984982|8388371|P2|Overall Study|Randomized but not treated|1
2440962|NCT02984982|8388372|P1|Overall Study|Randomized but not treated|0
2440963|NCT02984982|8388371|P2|Overall Study|Withdrawal by Subject|0
2440964|NCT02984982|8388372|P1|Overall Study|Withdrawal by Subject|2
2440965|NCT02984982|8388371|P2|Overall Study|Poor Compliance to Protocol|4
2440966|NCT02984982|8388372|P1|Overall Study|Poor Compliance to Protocol|4
2440967|NCT02984982|8388371|P2|Overall Study|Adverse Event|5
2440968|NCT02984982|8388372|P1|Overall Study|Adverse Event|2
2440969|NCT02984943|8388424|P1|Overall Study|Physician Decision|1
2440970|NCT02984943|8388424|P1|Overall Study|Withdrawal by Subject|3
2440971|NCT02984267|8388538|P2|Overall Study|Withdrawal by Subject|1
2440972|NCT02984267|8388539|P1|Overall Study|Withdrawal by Subject|0
2440973|NCT02984267|8388538|P2|Overall Study|Protocol Violation|0
2440974|NCT02984267|8388539|P1|Overall Study|Protocol Violation|1
2440975|NCT02983617|8388579|P2|Overall Study|Still on Study|28
2440976|NCT02983617|8388580|P1|Overall Study|Still on Study|6
2440977|NCT02983617|8388579|P2|Overall Study|Death|1
2440978|NCT02983617|8388580|P1|Overall Study|Death|0
2440979|NCT02983617|8388579|P2|Overall Study|Adverse Event|1
2440980|NCT02983617|8388580|P1|Overall Study|Adverse Event|0
2440981|NCT02983604|8388598|P4|Overall Study|Enrolled but not Treated|0
2440982|NCT02983604|8388599|P3|Overall Study|Enrolled but not Treated|1
2440983|NCT02983604|8388600|P2|Overall Study|Enrolled but not Treated|0
2440984|NCT02983604|8388601|P1|Overall Study|Enrolled but not Treated|0
2440985|NCT02983305|8388650|P2|Overall Study|incomplete data|0
2440986|NCT02983305|8388651|P1|Overall Study|incomplete data|2
2440987|NCT02982863|8388668|P5|Overall Study|Not eligible patients|492
2440988|NCT02982863|8388669|P4|Overall Study|Not eligible patients|1400
2440989|NCT02982863|8388670|P3|Overall Study|Not eligible patients|1852
2440990|NCT02982863|8388671|P2|Overall Study|Not eligible patients|4261
2440991|NCT02982863|8388672|P1|Overall Study|Not eligible patients|809
2440992|NCT02982720|8388729|P1|Overall Study|Death|1
2440993|NCT02982720|8388729|P1|Overall Study|Adverse Event|3
2440994|NCT02982239|8388739|P2|Overall Study|Lost to Follow-up|2
2440995|NCT02982239|8388740|P1|Overall Study|Lost to Follow-up|3
2440996|NCT02982187|8388756|P8|Overall Study|Withdrawal by Subject|0
2440997|NCT02982187|8388757|P7|Overall Study|Withdrawal by Subject|1
2440998|NCT02982187|8388758|P6|Overall Study|Withdrawal by Subject|0
2440999|NCT02982187|8388759|P5|Overall Study|Withdrawal by Subject|0
2441000|NCT02982187|8388760|P4|Overall Study|Withdrawal by Subject|0
2441001|NCT02982187|8388761|P3|Overall Study|Withdrawal by Subject|0
2441002|NCT02982187|8388762|P2|Overall Study|Withdrawal by Subject|0
2441003|NCT02982187|8388763|P1|Overall Study|Withdrawal by Subject|0
2441004|NCT02982018|8388813|P2|Overall Study|Withdrawal by Subject|1
2441005|NCT02982018|8388814|P1|Overall Study|Withdrawal by Subject|0
2441006|NCT02982018|8388813|P2|Overall Study|Lens Discomfort|0
2441007|NCT02982018|8388814|P1|Overall Study|Lens Discomfort|2
2441008|NCT02982018|8388813|P2|Overall Study|Adverse Event|1
2441009|NCT02982018|8388814|P1|Overall Study|Adverse Event|1
2441010|NCT02982018|8388813|P2|Overall Study|Protocol Violation|1
2441011|NCT02982018|8388814|P1|Overall Study|Protocol Violation|1
2441012|NCT02982018|8388813|P2|Overall Study|Incorrect Lens Dispensed|0
2441013|NCT02982018|8388814|P1|Overall Study|Incorrect Lens Dispensed|1
2441014|NCT02981524|8388828|P1|Overall Study|Withdrawal by Subject|1
2441015|NCT02981524|8388828|P1|Overall Study|Treatment Related Toxicity|1
2441016|NCT02981524|8388828|P1|Overall Study|Death (unrelated)|1
2441017|NCT02981524|8388828|P1|Overall Study|Progressive Disease|14
2441018|NCT02981342|8388840|P4|Overall Study|Lost to Follow-up|0
2441019|NCT02981342|8388841|P3|Overall Study|Lost to Follow-up|0
2441020|NCT02981342|8388842|P2|Overall Study|Lost to Follow-up|1
2441021|NCT02981342|8388843|P1|Overall Study|Lost to Follow-up|0
2441022|NCT02981342|8388840|P4|Overall Study|Randomized, Never Treated|7
2441023|NCT02981342|8388841|P3|Overall Study|Randomized, Never Treated|0
2441024|NCT02981342|8388842|P2|Overall Study|Randomized, Never Treated|1
2441025|NCT02981342|8388843|P1|Overall Study|Randomized, Never Treated|0
2441026|NCT02981342|8388840|P4|Overall Study|Study closed by sponsor|1
2441027|NCT02981342|8388841|P3|Overall Study|Study closed by sponsor|1
2441028|NCT02981342|8388842|P2|Overall Study|Study closed by sponsor|0
2441029|NCT02981342|8388843|P1|Overall Study|Study closed by sponsor|0
2441030|NCT02981342|8388840|P4|Overall Study|Withdrawal by Subject|1
2441031|NCT02981342|8388841|P3|Overall Study|Withdrawal by Subject|3
2441032|NCT02981342|8388842|P2|Overall Study|Withdrawal by Subject|0
2441033|NCT02981342|8388843|P1|Overall Study|Withdrawal by Subject|0
2441034|NCT02981342|8388840|P4|Overall Study|Death|4
2441035|NCT02981342|8388841|P3|Overall Study|Death|9
2441036|NCT02981342|8388842|P2|Overall Study|Death|9
2441037|NCT02981342|8388843|P1|Overall Study|Death|0
2441038|NCT02981342|8388840|P4|Overall Study|Adverse Event|1
2441039|NCT02981342|8388841|P3|Overall Study|Adverse Event|0
2441040|NCT02981342|8388842|P2|Overall Study|Adverse Event|0
2441041|NCT02981342|8388843|P1|Overall Study|Adverse Event|0
2441042|NCT02980783|8388901|P1|Overall Study|Lost to Follow-up|1
2441043|NCT02980601|8388914|P2|Overall Study|Failed to sign consent|0
2441044|NCT02980601|8388915|P1|Overall Study|Failed to sign consent|2
2441045|NCT02980601|8388914|P2|Overall Study|Graft loss|0
2441046|NCT02980601|8388915|P1|Overall Study|Graft loss|1
2441047|NCT02980601|8388914|P2|Overall Study|Death|1
2441048|NCT02980601|8388915|P1|Overall Study|Death|0
2441049|NCT02980601|8388914|P2|Overall Study|Lost to Follow-up|2
2441050|NCT02980601|8388915|P1|Overall Study|Lost to Follow-up|2
2441051|NCT02980523|8389008|P5|Overall Study|Did not receive intervention|0
2441052|NCT02980523|8389009|P4|Overall Study|Did not receive intervention|1
2441053|NCT02980523|8389010|P3|Overall Study|Did not receive intervention|0
2441054|NCT02980523|8389011|P2|Overall Study|Did not receive intervention|0
2441055|NCT02980523|8389012|P1|Overall Study|Did not receive intervention|0
2441056|NCT02980523|8389008|P5|Overall Study|Lack of Efficacy|8
2441057|NCT02980523|8389009|P4|Overall Study|Lack of Efficacy|5
2441058|NCT02980523|8389010|P3|Overall Study|Lack of Efficacy|4
2441059|NCT02980523|8389011|P2|Overall Study|Lack of Efficacy|4
2441060|NCT02980523|8389012|P1|Overall Study|Lack of Efficacy|1
2441061|NCT02980523|8389008|P5|Overall Study|Excluded from analysis|1
2441062|NCT02980523|8389009|P4|Overall Study|Excluded from analysis|1
2441063|NCT02980523|8389010|P3|Overall Study|Excluded from analysis|1
2441064|NCT02980523|8389011|P2|Overall Study|Excluded from analysis|3
2441065|NCT02980523|8389012|P1|Overall Study|Excluded from analysis|1
2441066|NCT02980523|8389008|P5|Overall Study|Lost to Follow-up|1
2441067|NCT02980523|8389009|P4|Overall Study|Lost to Follow-up|2
2441068|NCT02980523|8389010|P3|Overall Study|Lost to Follow-up|1
2441069|NCT02980523|8389011|P2|Overall Study|Lost to Follow-up|4
2441070|NCT02980523|8389012|P1|Overall Study|Lost to Follow-up|1
2441071|NCT02980224|8389056|P2|Overall Study|Withdrawal by Subject|2
2441072|NCT02980224|8389057|P1|Overall Study|Withdrawal by Subject|0
2441073|NCT02980224|8389056|P2|Overall Study|Adverse Event|1
2441074|NCT02980224|8389057|P1|Overall Study|Adverse Event|4
2441075|NCT02980133|8389075|P4|Overall Study|Withdrawal by Subject|0
2441076|NCT02980133|8389076|P3|Overall Study|Withdrawal by Subject|1
2441077|NCT02980133|8389077|P2|Overall Study|Withdrawal by Subject|0
2441078|NCT02980133|8389078|P1|Overall Study|Withdrawal by Subject|0
2441079|NCT02980133|8389075|P4|Overall Study|Withdrawal by parent/guardian|1
2441080|NCT02980133|8389076|P3|Overall Study|Withdrawal by parent/guardian|3
2441081|NCT02980133|8389077|P2|Overall Study|Withdrawal by parent/guardian|3
2441082|NCT02980133|8389078|P1|Overall Study|Withdrawal by parent/guardian|6
2441083|NCT02980133|8389075|P4|Overall Study|Protocol Violation|0
2441084|NCT02980133|8389076|P3|Overall Study|Protocol Violation|0
2441085|NCT02980133|8389077|P2|Overall Study|Protocol Violation|1
2441086|NCT02980133|8389078|P1|Overall Study|Protocol Violation|0
2441087|NCT02980133|8389075|P4|Overall Study|Lost to Follow-up|3
2441088|NCT02980133|8389076|P3|Overall Study|Lost to Follow-up|1
2441089|NCT02980133|8389077|P2|Overall Study|Lost to Follow-up|0
2441090|NCT02980133|8389078|P1|Overall Study|Lost to Follow-up|0
2441091|NCT02980133|8389075|P4|Overall Study|Other than specified|2
2441092|NCT02980133|8389076|P3|Overall Study|Other than specified|2
2441093|NCT02980133|8389077|P2|Overall Study|Other than specified|1
2441094|NCT02980133|8389078|P1|Overall Study|Other than specified|1
2441095|NCT02980107|8389116|P2|Overall Study|Withdrawal by Subject|62
2441096|NCT02980107|8389117|P1|Overall Study|Withdrawal by Subject|51
2441097|NCT02980042|8389131|P2|Overall Study|Insurance issues/treatment plan changes|0
2441098|NCT02980042|8389132|P1|Overall Study|Insurance issues/treatment plan changes|2
2441099|NCT02980042|8389131|P2|Overall Study|Lost to Follow-up|0
2441100|NCT02980042|8389132|P1|Overall Study|Lost to Follow-up|5
2441101|NCT02979639|8389149|P1|Overall Study|Adverse Event|2
2441102|NCT02979639|8389149|P1|Overall Study|Withdrawal by Subject|3
2441103|NCT02979639|8389149|P1|Overall Study|Lost to Follow-up|8
2441104|NCT02979639|8389149|P1|Overall Study|Withdrawal based on medical judgement|1
2441105|NCT02979613|8389181|P2|Open-Label Extension (OLE) Phase|Death|1
2441106|NCT02979613|8389182|P1|Open-Label Extension (OLE) Phase|Death|0
2441107|NCT02979613|8389181|P2|Open-Label Extension (OLE) Phase|Still in the OLE Phase|226
2441108|NCT02979613|8389182|P1|Open-Label Extension (OLE) Phase|Still in the OLE Phase|223
2441109|NCT02979613|8389181|P2|Double-Blind Phase|Randomized but Never Treated|0
2441110|NCT02979613|8389182|P1|Double-Blind Phase|Randomized but Never Treated|2
2441111|NCT02979613|8389181|P2|Double-Blind Phase|Protocol Violation|1
2441112|NCT02979613|8389182|P1|Double-Blind Phase|Protocol Violation|1
2441113|NCT02979613|8389181|P2|Double-Blind Phase|Lost to Follow-up|1
2441114|NCT02979613|8389182|P1|Double-Blind Phase|Lost to Follow-up|1
2441115|NCT02979613|8389181|P2|Double-Blind Phase|Adverse Event|0
2441116|NCT02979613|8389182|P1|Double-Blind Phase|Adverse Event|2
2441117|NCT02979613|8389181|P2|Double-Blind Phase|Pregnancy|2
2441118|NCT02979613|8389182|P1|Double-Blind Phase|Pregnancy|2
2441119|NCT02979613|8389181|P2|Double-Blind Phase|Withdrew Consent|4
2441120|NCT02979613|8389182|P1|Double-Blind Phase|Withdrew Consent|2
2441121|NCT02979535|8389216|P2|Overall Study|Lost to Follow-up|1
2441122|NCT02979535|8389217|P1|Overall Study|Lost to Follow-up|6
2441123|NCT02979535|8389216|P2|Overall Study|Consent withdrawn by participant|18
2441124|NCT02979535|8389217|P1|Overall Study|Consent withdrawn by participant|11
2441125|NCT02979535|8389216|P2|Overall Study|Non compliance with the protocol|82
2441126|NCT02979535|8389217|P1|Overall Study|Non compliance with the protocol|78
2441127|NCT02979431|8389280|P4|Overall Study|Subject left country after Day14|0
2441128|NCT02979431|8389281|P3|Overall Study|Subject left country after Day14|0
2441129|NCT02979431|8389282|P2|Overall Study|Subject left country after Day14|0
2441130|NCT02979431|8389283|P1|Overall Study|Subject left country after Day14|1
2441131|NCT02979431|8389280|P4|Overall Study|Adverse Event|0
2441132|NCT02979431|8389281|P3|Overall Study|Adverse Event|1
2441133|NCT02979431|8389282|P2|Overall Study|Adverse Event|0
2441134|NCT02979431|8389283|P1|Overall Study|Adverse Event|0
2441135|NCT02979431|8389280|P4|Overall Study|Randomized but received no study drug|0
2441136|NCT02979431|8389281|P3|Overall Study|Randomized but received no study drug|0
2441137|NCT02979431|8389282|P2|Overall Study|Randomized but received no study drug|1
2441138|NCT02979431|8389283|P1|Overall Study|Randomized but received no study drug|1
2441139|NCT02979431|8389280|P4|Overall Study|Parent/guardian withdrew consent|1
2441140|NCT02979431|8389281|P3|Overall Study|Parent/guardian withdrew consent|1
2441141|NCT02979431|8389282|P2|Overall Study|Parent/guardian withdrew consent|1
2441142|NCT02979431|8389283|P1|Overall Study|Parent/guardian withdrew consent|2
2441143|NCT02979197|8389364|P3|Overall Study|Subject unable to commit to study dates|0
2441144|NCT02979197|8389365|P2|Overall Study|Subject unable to commit to study dates|1
2441145|NCT02979197|8389366|P1|Overall Study|Subject unable to commit to study dates|0
2441146|NCT02979197|8389364|P3|Overall Study|Protocol Violation|0
2441147|NCT02979197|8389365|P2|Overall Study|Protocol Violation|1
2441148|NCT02979197|8389366|P1|Overall Study|Protocol Violation|0
2441149|NCT02979197|8389364|P3|Overall Study|Adverse Event|0
2441150|NCT02979197|8389365|P2|Overall Study|Adverse Event|2
2441151|NCT02979197|8389366|P1|Overall Study|Adverse Event|4
2441152|NCT02978833|8389409|P2|Overall Study|Study terminated|1
2441153|NCT02978833|8389410|P1|Overall Study|Study terminated|1
2441154|NCT02977572|8389447|P2|Overall Study|Exclusion criterion|2
2441155|NCT02977572|8389448|P1|Overall Study|Exclusion criterion|2
2441156|NCT02977507|8389470|P2|Overall Study|Lost to Follow-up|0
2441157|NCT02977507|8389471|P1|Overall Study|Lost to Follow-up|1
2441158|NCT02977507|8389470|P2|Overall Study|Protocol Deviation|0
2441159|NCT02977507|8389471|P1|Overall Study|Protocol Deviation|1
2441160|NCT02976519|8389501|P7|Treatment Period 2 (Part 2 Only)|Adverse Event|1
2441161|NCT02976519|8389502|P6|Treatment Period 2 (Part 2 Only)|Adverse Event|0
2441162|NCT02976519|8389503|P5|Treatment Period 2 (Part 2 Only)|Adverse Event|0
2441163|NCT02976519|8389504|P4|Treatment Period 2 (Part 2 Only)|Adverse Event|0
2441164|NCT02976519|8389505|P3|Treatment Period 2 (Part 2 Only)|Adverse Event|0
2441165|NCT02976519|8389506|P2|Treatment Period 2 (Part 2 Only)|Adverse Event|0
2441166|NCT02976519|8389507|P1|Treatment Period 2 (Part 2 Only)|Adverse Event|0
2441167|NCT02976519|8389501|P7|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1
2441168|NCT02976519|8389502|P6|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
2441169|NCT02976519|8389503|P5|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
2441170|NCT02976519|8389504|P4|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
2441171|NCT02976519|8389505|P3|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
2441172|NCT02976519|8389506|P2|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
2441173|NCT02976519|8389507|P1|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
2441174|NCT02976519|8389501|P7|Wash-out Period (Part 2 Only)|Reason not listed|1
2441175|NCT02976519|8389502|P6|Wash-out Period (Part 2 Only)|Reason not listed|0
2441176|NCT02976519|8389503|P5|Wash-out Period (Part 2 Only)|Reason not listed|0
2441177|NCT02976519|8389504|P4|Wash-out Period (Part 2 Only)|Reason not listed|0
2441178|NCT02976519|8389505|P3|Wash-out Period (Part 2 Only)|Reason not listed|0
2441179|NCT02976519|8389506|P2|Wash-out Period (Part 2 Only)|Reason not listed|0
2441180|NCT02976519|8389507|P1|Wash-out Period (Part 2 Only)|Reason not listed|0
2441181|NCT02976519|8389501|P7|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
2441182|NCT02976519|8389502|P6|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
2441183|NCT02976519|8389503|P5|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
2441184|NCT02976519|8389504|P4|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1
2441185|NCT02976519|8389505|P3|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
2441186|NCT02976519|8389506|P2|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
2441187|NCT02976519|8389507|P1|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
2441188|NCT02976519|8389501|P7|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
2441189|NCT02976519|8389502|P6|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
2441190|NCT02976519|8389503|P5|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
2441191|NCT02976519|8389504|P4|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
2441192|NCT02976519|8389505|P3|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
2441193|NCT02976519|8389506|P2|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1
2441194|NCT02976519|8389507|P1|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
2441195|NCT02976103|8389538|P2|Overall Study|Lost to Follow-up|8
2441196|NCT02976103|8389539|P1|Overall Study|Lost to Follow-up|12
2441197|NCT02976103|8389538|P2|Overall Study|Withdrawal by Subject|0
2441198|NCT02976103|8389539|P1|Overall Study|Withdrawal by Subject|1
2441199|NCT02975700|8389631|P1|Overall Study|Failed screening criteria|2
2441200|NCT02975700|8389631|P1|Overall Study|Progressive disease|3
2441201|NCT02975700|8389631|P1|Overall Study|Adverse Event|1
2441202|NCT02975206|8389665|P3|Overall Study|Other (e.g., lost to follow up)|6
2441203|NCT02975206|8389666|P2|Overall Study|Other (e.g., lost to follow up)|6
2441204|NCT02975206|8389667|P1|Overall Study|Other (e.g., lost to follow up)|13
2441205|NCT02975206|8389665|P3|Overall Study|Withdrawal by Subject|11
2441206|NCT02975206|8389666|P2|Overall Study|Withdrawal by Subject|11
2441207|NCT02975206|8389667|P1|Overall Study|Withdrawal by Subject|14
2441208|NCT02974855|8389685|P4|Overall Study|Adverse Event|1
2441209|NCT02974855|8389686|P3|Overall Study|Adverse Event|0
2441210|NCT02974855|8389687|P2|Overall Study|Adverse Event|1
2441211|NCT02974855|8389688|P1|Overall Study|Adverse Event|0
2441212|NCT02974842|8389874|P1|Overall Study|Screen failures|4
2441213|NCT02974842|8389874|P1|Overall Study|Withdrawal by Subject|4
2441214|NCT02974543|8389880|P2|Overall Study|Withdrawal by Subject|0
2441215|NCT02974543|8389881|P1|Overall Study|Withdrawal by Subject|1
2441216|NCT02974140|8389901|P1|Overall Study|Study Terminated by Sponsor|36
2441217|NCT02974140|8389901|P1|Overall Study|Lost to Follow-up|1
2441218|NCT02974140|8389901|P1|Overall Study|Adverse Event|2
2441219|NCT02974114|8389917|P3|Overall Study|Other (Not specified)|2
2441220|NCT02974114|8389918|P2|Overall Study|Other (Not specified)|1
2441221|NCT02974114|8389919|P1|Overall Study|Other (Not specified)|0
2441222|NCT02974088|8389962|P2|Overall Study|Adverse Event|1
2441223|NCT02974088|8389963|P1|Overall Study|Adverse Event|0
2441224|NCT02974088|8389962|P2|Overall Study|Lost to Follow-up|2
2441225|NCT02974088|8389963|P1|Overall Study|Lost to Follow-up|0
2441226|NCT02973802|8389969|P1|Overall Study|Withdrawal by Subject|1
2441227|NCT02973802|8389969|P1|Overall Study|Lost to Follow-up|1
2441228|NCT02973100|8389987|P4|Overall Study|Failed to attend Safety followup period|0
2441229|NCT02973100|8389988|P3|Overall Study|Failed to attend Safety followup period|1
2441230|NCT02973100|8389989|P2|Overall Study|Failed to attend Safety followup period|0
2441231|NCT02973100|8389990|P1|Overall Study|Failed to attend Safety followup period|0
2441232|NCT02973100|8389987|P4|Overall Study|Notification of change in address|1
2441233|NCT02973100|8389988|P3|Overall Study|Notification of change in address|0
2441234|NCT02973100|8389989|P2|Overall Study|Notification of change in address|0
2441235|NCT02973100|8389990|P1|Overall Study|Notification of change in address|0
2441236|NCT02973100|8389987|P4|Overall Study|Withdrawal by Subject|4
2441237|NCT02973100|8389988|P3|Overall Study|Withdrawal by Subject|1
2441238|NCT02973100|8389989|P2|Overall Study|Withdrawal by Subject|5
2441239|NCT02973100|8389990|P1|Overall Study|Withdrawal by Subject|3
2441240|NCT02973100|8389987|P4|Overall Study|Lost to Follow-up|0
2441241|NCT02973100|8389988|P3|Overall Study|Lost to Follow-up|1
2441242|NCT02973100|8389989|P2|Overall Study|Lost to Follow-up|1
2441243|NCT02973100|8389990|P1|Overall Study|Lost to Follow-up|3
2441244|NCT02973100|8389987|P4|Overall Study|Adverse Event|2
2441245|NCT02973100|8389988|P3|Overall Study|Adverse Event|1
2441246|NCT02973100|8389989|P2|Overall Study|Adverse Event|2
2441247|NCT02973100|8389990|P1|Overall Study|Adverse Event|1
2441248|NCT02972658|8390030|P4|Overall Study|Sponsor Decision|119
2441249|NCT02972658|8390031|P3|Overall Study|Sponsor Decision|72
2441250|NCT02972658|8390032|P2|Overall Study|Sponsor Decision|127
2441251|NCT02972658|8390033|P1|Overall Study|Sponsor Decision|70
2441252|NCT02972658|8390030|P4|Overall Study|Withdrawal due to Caregiver Circumstance|0
2441253|NCT02972658|8390031|P3|Overall Study|Withdrawal due to Caregiver Circumstance|1
2441254|NCT02972658|8390032|P2|Overall Study|Withdrawal due to Caregiver Circumstance|1
2441255|NCT02972658|8390033|P1|Overall Study|Withdrawal due to Caregiver Circumstance|1
2441256|NCT02972658|8390030|P4|Overall Study|Withdrawal by Subject|6
2441257|NCT02972658|8390031|P3|Overall Study|Withdrawal by Subject|1
2441258|NCT02972658|8390032|P2|Overall Study|Withdrawal by Subject|4
2441259|NCT02972658|8390033|P1|Overall Study|Withdrawal by Subject|4
2441260|NCT02972658|8390030|P4|Overall Study|Progressive Disease|1
2441261|NCT02972658|8390031|P3|Overall Study|Progressive Disease|0
2441262|NCT02972658|8390032|P2|Overall Study|Progressive Disease|1
2441263|NCT02972658|8390033|P1|Overall Study|Progressive Disease|0
2441264|NCT02972658|8390030|P4|Overall Study|Lost to Follow-up|2
2441265|NCT02972658|8390031|P3|Overall Study|Lost to Follow-up|1
2441266|NCT02972658|8390032|P2|Overall Study|Lost to Follow-up|1
2441267|NCT02972658|8390033|P1|Overall Study|Lost to Follow-up|0
2441268|NCT02972658|8390030|P4|Overall Study|Death|1
2441269|NCT02972658|8390031|P3|Overall Study|Death|0
2441270|NCT02972658|8390032|P2|Overall Study|Death|0
2441271|NCT02972658|8390033|P1|Overall Study|Death|0
2441272|NCT02972658|8390030|P4|Overall Study|Other-determined by Investigator|0
2441273|NCT02972658|8390031|P3|Overall Study|Other-determined by Investigator|0
2441274|NCT02972658|8390032|P2|Overall Study|Other-determined by Investigator|1
2441275|NCT02972658|8390033|P1|Overall Study|Other-determined by Investigator|1
2441276|NCT02972658|8390030|P4|Overall Study|Adverse Event|2
2441277|NCT02972658|8390031|P3|Overall Study|Adverse Event|0
2441278|NCT02972658|8390032|P2|Overall Study|Adverse Event|3
2441279|NCT02972658|8390033|P1|Overall Study|Adverse Event|0
2441280|NCT02972632|8390063|P1|Overall Study|Voluntary Withdrawal|10
2441281|NCT02972632|8390063|P1|Overall Study|Lost to Follow-up|4
2441282|NCT02972632|8390063|P1|Overall Study|Pretreatment Event/Adverse Event|3
2441283|NCT02972515|8390093|P1|Overall Study|Lost to Follow-up|78
2441284|NCT02972502|8390102|P2|Overall Study|Withdrawal by Subject|1
2441285|NCT02972502|8390103|P1|Overall Study|Withdrawal by Subject|1
2441286|NCT02972502|8390102|P2|Overall Study|Lost to Follow-up|1
2441287|NCT02972502|8390103|P1|Overall Study|Lost to Follow-up|3
2441288|NCT02972359|8390113|P1|Overall Study|Missing|1
2441289|NCT02972359|8390113|P1|Overall Study|Other reasons|5
2441290|NCT02972359|8390113|P1|Overall Study|Lost to Follow-up|26
2441291|NCT02972359|8390113|P1|Overall Study|Protocol Violation|1
2441292|NCT02972359|8390113|P1|Overall Study|Withdrawal by Subject|30
2441293|NCT02972359|8390113|P1|Overall Study|Death|1
2441294|NCT02972359|8390113|P1|Overall Study|Adverse Event|4
2441295|NCT02972359|8390113|P1|Overall Study|Lack of Efficacy|1
2441296|NCT02972359|8390113|P1|Overall Study|Incl. criteria not met/Exclusion met|2
2441297|NCT02971670|8390128|P4|Overall Study|Withdrawal by Subject|2
2441298|NCT02971670|8390129|P3|Overall Study|Withdrawal by Subject|1
2441299|NCT02971670|8390130|P2|Overall Study|Withdrawal by Subject|1
2441300|NCT02971670|8390131|P1|Overall Study|Withdrawal by Subject|4
2441301|NCT02971605|8390170|P1|Overall Study|Withdrawal by Subject|1
2441302|NCT02971202|8390284|P3|Overall Study|screen fail after consent|1
2441303|NCT02971202|8390285|P2|Overall Study|screen fail after consent|0
2441304|NCT02971202|8390286|P1|Overall Study|screen fail after consent|1
2441305|NCT02971202|8390284|P3|Overall Study|Pregnancy|0
2441306|NCT02971202|8390285|P2|Overall Study|Pregnancy|0
2441307|NCT02971202|8390286|P1|Overall Study|Pregnancy|1
2441308|NCT02971007|8390303|P3|Overall Study|Patient discontinued study drug|0
2441309|NCT02971007|8390304|P2|Overall Study|Patient discontinued study drug|1
2441310|NCT02971007|8390305|P1|Overall Study|Patient discontinued study drug|0
2441311|NCT02971007|8390303|P3|Overall Study|Patient had yeast at Day 5 visit|0
2441312|NCT02971007|8390304|P2|Overall Study|Patient had yeast at Day 5 visit|0
2441313|NCT02971007|8390305|P1|Overall Study|Patient had yeast at Day 5 visit|1
2441314|NCT02971007|8390303|P3|Overall Study|Withdrawal by Subject|0
2441315|NCT02971007|8390304|P2|Overall Study|Withdrawal by Subject|1
2441316|NCT02971007|8390305|P1|Overall Study|Withdrawal by Subject|0
2441317|NCT02971007|8390303|P3|Overall Study|Lost to Follow-up|1
2441318|NCT02971007|8390304|P2|Overall Study|Lost to Follow-up|1
2441319|NCT02971007|8390305|P1|Overall Study|Lost to Follow-up|0
2441320|NCT02971007|8390303|P3|Overall Study|Adverse Event|0
2441321|NCT02971007|8390304|P2|Overall Study|Adverse Event|0
2441322|NCT02971007|8390305|P1|Overall Study|Adverse Event|1
2441323|NCT02970669|8390337|P2|Open-label Period|Physician Decision|0
2441324|NCT02970669|8390338|P1|Open-label Period|Physician Decision|1
2441325|NCT02970669|8390337|P2|Open-label Period|Adverse Event|0
2441326|NCT02970669|8390338|P1|Open-label Period|Adverse Event|1
2441327|NCT02970669|8390337|P2|Open-label Period|Withdrawal by Subject|2
2441328|NCT02970669|8390338|P1|Open-label Period|Withdrawal by Subject|2
2441329|NCT02970669|8390337|P2|Double-blind Period|Withdrawal by Subject|2
2441330|NCT02970669|8390338|P1|Double-blind Period|Withdrawal by Subject|2
2441331|NCT02970669|8390337|P2|Double-blind Period|Physician Decision|2
2441332|NCT02970669|8390338|P1|Double-blind Period|Physician Decision|0
2441333|NCT02970669|8390337|P2|Double-blind Period|Study terminated by sponsor|2
2441334|NCT02970669|8390338|P1|Double-blind Period|Study terminated by sponsor|1
2441335|NCT02970669|8390337|P2|Double-blind Period|Death|0
2441336|NCT02970669|8390338|P1|Double-blind Period|Death|1
2441337|NCT02970669|8390337|P2|Double-blind Period|Adverse Event|0
2441338|NCT02970669|8390338|P1|Double-blind Period|Adverse Event|4
2441339|NCT02969863|8390414|P6|Overall Study|Physician Decision|0
2441340|NCT02969863|8390415|P5|Overall Study|Physician Decision|0
2441341|NCT02969863|8390416|P4|Overall Study|Physician Decision|0
2441342|NCT02969863|8390417|P3|Overall Study|Physician Decision|0
2441343|NCT02969863|8390418|P2|Overall Study|Physician Decision|0
2441344|NCT02969863|8390419|P1|Overall Study|Physician Decision|1
2441345|NCT02969655|8390435|P2|Overall Study|Adverse Event|8
2441346|NCT02969655|8390436|P1|Overall Study|Adverse Event|10
2441347|NCT02969655|8390435|P2|Overall Study|Protocol-specified withdrawal criteria|2
2441348|NCT02969655|8390436|P1|Overall Study|Protocol-specified withdrawal criteria|4
2441349|NCT02969655|8390435|P2|Overall Study|Physician Decision|3
2441350|NCT02969655|8390436|P1|Overall Study|Physician Decision|4
2441351|NCT02969655|8390435|P2|Overall Study|Withdrawal by Subject|2
2441352|NCT02969655|8390436|P1|Overall Study|Withdrawal by Subject|3
2441353|NCT02969590|8390471|P3|Screening Period|Hormones not suppressed post Lupron|0
2441354|NCT02969590|8390472|P2|Screening Period|Hormones not suppressed post Lupron|0
2441355|NCT02969590|8390473|P1|Screening Period|Hormones not suppressed post Lupron|1
2441356|NCT02969408|8390504|P1|Overall Study|Other than specified|1
2441357|NCT02969408|8390504|P1|Overall Study|Protocol Violation|1
2441358|NCT02969408|8390504|P1|Overall Study|Lost to Follow-up|4
2441359|NCT02969408|8390504|P1|Overall Study|Withdrawal by Subject|8
2441360|NCT02969408|8390504|P1|Overall Study|Adverse Event|2
2441361|NCT02969356|8390512|P1|Overall Study|Personal reasons|5
2441362|NCT02969356|8390512|P1|Overall Study|Did not need to be reinjected|6
2441363|NCT02969356|8390512|P1|Overall Study|Lost to Follow-up|3
2441364|NCT02969356|8390512|P1|Overall Study|Consent withdrawn|2
2441365|NCT02969356|8390512|P1|Overall Study|Adverse Event|7
2441366|NCT02969187|8390555|P2|Overall Study|Physician Decision|13
2441367|NCT02969187|8390556|P1|Overall Study|Physician Decision|12
2441368|NCT02969044|8390568|P2|Overall Study|Adverse Event|0
2441369|NCT02969044|8390569|P1|Overall Study|Adverse Event|3
2441370|NCT02969044|8390568|P2|Overall Study|Withdrawal by Subject|6
2441371|NCT02969044|8390569|P1|Overall Study|Withdrawal by Subject|2
2441372|NCT02969018|8390628|P8|Overall Study|Withdrawal by Subject|3
2441373|NCT02969018|8390629|P7|Overall Study|Withdrawal by Subject|4
2441374|NCT02969018|8390630|P6|Overall Study|Withdrawal by Subject|4
2441375|NCT02969018|8390631|P5|Overall Study|Withdrawal by Subject|0
2441376|NCT02969018|8390632|P4|Overall Study|Withdrawal by Subject|1
2441377|NCT02969018|8390633|P3|Overall Study|Withdrawal by Subject|2
2441378|NCT02969018|8390634|P2|Overall Study|Withdrawal by Subject|1
2441379|NCT02969018|8390635|P1|Overall Study|Withdrawal by Subject|0
2441380|NCT02969018|8390628|P8|Overall Study|Protocol Violation|0
2441381|NCT02969018|8390629|P7|Overall Study|Protocol Violation|0
2441382|NCT02969018|8390630|P6|Overall Study|Protocol Violation|0
2441383|NCT02969018|8390631|P5|Overall Study|Protocol Violation|0
2441384|NCT02969018|8390632|P4|Overall Study|Protocol Violation|1
2441385|NCT02969018|8390633|P3|Overall Study|Protocol Violation|1
2441386|NCT02969018|8390634|P2|Overall Study|Protocol Violation|0
2441387|NCT02969018|8390635|P1|Overall Study|Protocol Violation|0
2441388|NCT02969018|8390628|P8|Overall Study|Pregnancy|0
2441389|NCT02969018|8390629|P7|Overall Study|Pregnancy|0
2441390|NCT02969018|8390630|P6|Overall Study|Pregnancy|1
2441391|NCT02969018|8390631|P5|Overall Study|Pregnancy|0
2441392|NCT02969018|8390632|P4|Overall Study|Pregnancy|0
2441393|NCT02969018|8390633|P3|Overall Study|Pregnancy|0
2441394|NCT02969018|8390634|P2|Overall Study|Pregnancy|0
2441395|NCT02969018|8390635|P1|Overall Study|Pregnancy|0
2441396|NCT02969018|8390628|P8|Overall Study|Other|2
2441397|NCT02969018|8390629|P7|Overall Study|Other|0
2441398|NCT02969018|8390630|P6|Overall Study|Other|0
2441399|NCT02969018|8390631|P5|Overall Study|Other|0
2441400|NCT02969018|8390632|P4|Overall Study|Other|1
2441401|NCT02969018|8390633|P3|Overall Study|Other|0
2441402|NCT02969018|8390634|P2|Overall Study|Other|0
2441403|NCT02969018|8390635|P1|Overall Study|Other|0
2441404|NCT02969018|8390628|P8|Overall Study|Non-Compliance With Study Drug|0
2441405|NCT02969018|8390629|P7|Overall Study|Non-Compliance With Study Drug|0
2441406|NCT02969018|8390630|P6|Overall Study|Non-Compliance With Study Drug|0
2441407|NCT02969018|8390631|P5|Overall Study|Non-Compliance With Study Drug|0
2441408|NCT02969018|8390632|P4|Overall Study|Non-Compliance With Study Drug|0
2441409|NCT02969018|8390633|P3|Overall Study|Non-Compliance With Study Drug|0
2441410|NCT02969018|8390634|P2|Overall Study|Non-Compliance With Study Drug|0
2441411|NCT02969018|8390635|P1|Overall Study|Non-Compliance With Study Drug|1
2441412|NCT02969018|8390628|P8|Overall Study|No Longer Meets Eligibility Criteria|0
2441413|NCT02969018|8390629|P7|Overall Study|No Longer Meets Eligibility Criteria|1
2441414|NCT02969018|8390630|P6|Overall Study|No Longer Meets Eligibility Criteria|0
2441415|NCT02969018|8390631|P5|Overall Study|No Longer Meets Eligibility Criteria|0
2441416|NCT02969018|8390632|P4|Overall Study|No Longer Meets Eligibility Criteria|0
2441417|NCT02969018|8390633|P3|Overall Study|No Longer Meets Eligibility Criteria|0
2441418|NCT02969018|8390634|P2|Overall Study|No Longer Meets Eligibility Criteria|0
2441419|NCT02969018|8390635|P1|Overall Study|No Longer Meets Eligibility Criteria|0
2441420|NCT02969018|8390628|P8|Overall Study|Lost to Follow-up|1
2441421|NCT02969018|8390629|P7|Overall Study|Lost to Follow-up|0
2441422|NCT02969018|8390630|P6|Overall Study|Lost to Follow-up|1
2441423|NCT02969018|8390631|P5|Overall Study|Lost to Follow-up|1
2441424|NCT02969018|8390632|P4|Overall Study|Lost to Follow-up|0
2441425|NCT02969018|8390633|P3|Overall Study|Lost to Follow-up|2
2441426|NCT02969018|8390634|P2|Overall Study|Lost to Follow-up|2
2441427|NCT02969018|8390635|P1|Overall Study|Lost to Follow-up|1
2441428|NCT02969018|8390628|P8|Overall Study|Lack of Efficacy|1
2441429|NCT02969018|8390629|P7|Overall Study|Lack of Efficacy|1
2441430|NCT02969018|8390630|P6|Overall Study|Lack of Efficacy|1
2441431|NCT02969018|8390631|P5|Overall Study|Lack of Efficacy|1
2441432|NCT02969018|8390632|P4|Overall Study|Lack of Efficacy|0
2441433|NCT02969018|8390633|P3|Overall Study|Lack of Efficacy|0
2441434|NCT02969018|8390634|P2|Overall Study|Lack of Efficacy|1
2441435|NCT02969018|8390635|P1|Overall Study|Lack of Efficacy|0
2441436|NCT02969018|8390628|P8|Overall Study|Adverse Event|0
2441437|NCT02969018|8390629|P7|Overall Study|Adverse Event|2
2441438|NCT02969018|8390630|P6|Overall Study|Adverse Event|1
2441439|NCT02969018|8390631|P5|Overall Study|Adverse Event|0
2441440|NCT02969018|8390632|P4|Overall Study|Adverse Event|2
2441441|NCT02969018|8390633|P3|Overall Study|Adverse Event|1
2441442|NCT02969018|8390634|P2|Overall Study|Adverse Event|4
2441443|NCT02969018|8390635|P1|Overall Study|Adverse Event|2
2441444|NCT02968979|8390775|P1|Overall Study|Withdrawal by Subject|1
2441445|NCT02968979|8390775|P1|Overall Study|Protocol Violation|7
2441446|NCT02968576|8390900|P2|Overall Study|Pregnancy|1
2441447|NCT02968576|8390901|P1|Overall Study|Pregnancy|0
2441448|NCT02968173|8390937|P1|Overall Study|Withdrawal by Subject|1
2441449|NCT02966795|8391192|P2|Overall Study|Patient Left the Country|1
2441450|NCT02966795|8391193|P1|Overall Study|Patient Left the Country|0
2441451|NCT02966509|8391204|P2|End of Life Utilization and Cost 15month|Patient Still Alive|48
2441452|NCT02966509|8391205|P1|End of Life Utilization and Cost 15month|Patient Still Alive|45
2441453|NCT02966509|8391204|P2|End of Life Utilization and Cost 6 Month|Patient Still Alive|75
2441454|NCT02966509|8391205|P1|End of Life Utilization and Cost 6 Month|Patient Still Alive|69
2441455|NCT02966509|8391204|P2|6 Month Satisfaction Survey|Refused to Answer|11
2441456|NCT02966509|8391205|P1|6 Month Satisfaction Survey|Refused to Answer|8
2441457|NCT02966509|8391204|P2|6 Month Satisfaction Survey|Lost to Follow-up|1
2441458|NCT02966509|8391205|P1|6 Month Satisfaction Survey|Lost to Follow-up|1
2441459|NCT02966509|8391204|P2|6 Month Satisfaction Survey|Withdrawal by Subject|3
2441460|NCT02966509|8391205|P1|6 Month Satisfaction Survey|Withdrawal by Subject|2
2441461|NCT02966509|8391204|P2|6 Month Satisfaction Survey|Death|33
2441462|NCT02966509|8391205|P1|6 Month Satisfaction Survey|Death|36
2441463|NCT02966509|8391204|P2|6 Month Satisfaction Decision Survey|Refused to Answer|2
2441464|NCT02966509|8391205|P1|6 Month Satisfaction Decision Survey|Refused to Answer|0
2441465|NCT02966509|8391204|P2|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
2441466|NCT02966509|8391205|P1|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
2441467|NCT02966509|8391204|P2|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3
2441468|NCT02966509|8391205|P1|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2
2441469|NCT02966509|8391204|P2|6 Month Satisfaction Decision Survey|Death|25
2441470|NCT02966509|8391205|P1|6 Month Satisfaction Decision Survey|Death|22
2441471|NCT02966509|8391204|P2|Baseline Satisfaction Survey|Refused to Answer|2
2441472|NCT02966509|8391205|P1|Baseline Satisfaction Survey|Refused to Answer|1
2441473|NCT02966509|8391204|P2|Baseline Satisfaction Survey|Lost to Follow-up|1
2441474|NCT02966509|8391205|P1|Baseline Satisfaction Survey|Lost to Follow-up|1
2441475|NCT02966509|8391204|P2|Baseline Satisfaction Survey|Death|1
2441476|NCT02966509|8391205|P1|Baseline Satisfaction Survey|Death|0
2441477|NCT02966509|8391204|P2|Baseline Satisfaction Survey|Withdrawal by Subject|3
2441478|NCT02966509|8391205|P1|Baseline Satisfaction Survey|Withdrawal by Subject|2
2441479|NCT02966353|8391229|P1|Overall Study|Protocol deviation|2
2441480|NCT02966353|8391229|P1|Overall Study|Progressive disease|2
2441481|NCT02966353|8391229|P1|Overall Study|Physician Decision|3
2441482|NCT02966353|8391229|P1|Overall Study|Death|4
2441483|NCT02966353|8391229|P1|Overall Study|Adverse Event|4
2441484|NCT02966353|8391229|P1|Overall Study|Withdrawal by Subject|7
2441485|NCT02966340|8391238|P2|Overall Study|startle non-responder|1
2441486|NCT02966340|8391239|P1|Overall Study|startle non-responder|1
2441487|NCT02966340|8391238|P2|Overall Study|data acquisition error|0
2441488|NCT02966340|8391239|P1|Overall Study|data acquisition error|1
2441489|NCT02966340|8391238|P2|Overall Study|Withdrawal by Subject|0
2441490|NCT02966340|8391239|P1|Overall Study|Withdrawal by Subject|1
2441491|NCT02966340|8391238|P2|Overall Study|Lost to Follow-up|1
2441492|NCT02966340|8391239|P1|Overall Study|Lost to Follow-up|0
2441493|NCT02966340|8391238|P2|Overall Study|Adverse Event|1
2441494|NCT02966340|8391239|P1|Overall Study|Adverse Event|0
2441495|NCT02966015|8391284|P2|Inclusion Visit|did not answer questionnaire|3
2441496|NCT02966015|8391285|P1|Inclusion Visit|did not answer questionnaire|8
2441497|NCT02966002|8391291|P1|Overall Study|Lost to Follow-up|1
2441498|NCT02966002|8391291|P1|Overall Study|Adverse Event|1
2441499|NCT02966002|8391291|P1|Overall Study|Withdrawal by Subject|2
2441500|NCT02965846|8391306|P3|Overall Study|Participants not randomized|33
2441501|NCT02965846|8391307|P2|Overall Study|Participants not randomized|0
2441502|NCT02965846|8391308|P1|Overall Study|Participants not randomized|0
2441503|NCT02965846|8391306|P3|Overall Study|Study Terminated By Sponsor|0
2441504|NCT02965846|8391307|P2|Overall Study|Study Terminated By Sponsor|4
2441505|NCT02965846|8391308|P1|Overall Study|Study Terminated By Sponsor|4
2441506|NCT02965846|8391306|P3|Overall Study|Withdrawal by Subject|0
2441507|NCT02965846|8391307|P2|Overall Study|Withdrawal by Subject|1
2441508|NCT02965846|8391308|P1|Overall Study|Withdrawal by Subject|0
2441509|NCT02965846|8391306|P3|Overall Study|Lost to Follow-up|0
2441510|NCT02965846|8391307|P2|Overall Study|Lost to Follow-up|0
2441511|NCT02965846|8391308|P1|Overall Study|Lost to Follow-up|1
2441512|NCT02965833|8391316|P2|Period 2, Second 30 Days of Wear|Protocol Violation|0
2441513|NCT02965833|8391317|P1|Period 2, Second 30 Days of Wear|Protocol Violation|2
2441514|NCT02965833|8391316|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
2441515|NCT02965833|8391317|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
2441516|NCT02965833|8391316|P2|Period 1, First 30 Days of Wear|Protocol Violation|0
2441517|NCT02965833|8391317|P1|Period 1, First 30 Days of Wear|Protocol Violation|1
2441518|NCT02965833|8391316|P2|Period 1, First 30 Days of Wear|Lost to Follow-up|1
2441519|NCT02965833|8391317|P1|Period 1, First 30 Days of Wear|Lost to Follow-up|1
2441520|NCT02965833|8391316|P2|Period 1, First 30 Days of Wear|Adverse Event|1
2441521|NCT02965833|8391317|P1|Period 1, First 30 Days of Wear|Adverse Event|0
2441522|NCT02965820|8391323|P2|Period 2, Second 30 Days|Adverse Event|1
2441523|NCT02965820|8391324|P1|Period 2, Second 30 Days|Adverse Event|1
2441524|NCT02965599|8391363|P2|Overall Study|Protocol-defined stop criteria reached|0
2441525|NCT02965599|8391364|P1|Overall Study|Protocol-defined stop criteria reached|1
2441526|NCT02965456|8391443|P2|Overall Study|Participant ran out of study drug|1
2441527|NCT02965456|8391444|P1|Overall Study|Participant ran out of study drug|0
2441528|NCT02965456|8391443|P2|Overall Study|Protocol Violation|1
2441529|NCT02965456|8391444|P1|Overall Study|Protocol Violation|0
2441530|NCT02965456|8391443|P2|Overall Study|Pregnancy|0
2441531|NCT02965456|8391444|P1|Overall Study|Pregnancy|1
2441532|NCT02965456|8391443|P2|Overall Study|Physician Decision|1
2441533|NCT02965456|8391444|P1|Overall Study|Physician Decision|0
2441534|NCT02965456|8391443|P2|Overall Study|Lack of Efficacy|0
2441535|NCT02965456|8391444|P1|Overall Study|Lack of Efficacy|1
2441536|NCT02965456|8391443|P2|Overall Study|Worsening Condition|2
2441537|NCT02965456|8391444|P1|Overall Study|Worsening Condition|0
2441538|NCT02965456|8391443|P2|Overall Study|Noncompliance with Study Drug|1
2441539|NCT02965456|8391444|P1|Overall Study|Noncompliance with Study Drug|1
2441540|NCT02965456|8391443|P2|Overall Study|Adverse Event|0
2441541|NCT02965456|8391444|P1|Overall Study|Adverse Event|3
2441542|NCT02965456|8391443|P2|Overall Study|Withdrawal by Parent or Guardian|6
2441543|NCT02965456|8391444|P1|Overall Study|Withdrawal by Parent or Guardian|3
2441544|NCT02965456|8391443|P2|Overall Study|Subject Request|13
2441545|NCT02965456|8391444|P1|Overall Study|Subject Request|22
2441546|NCT02965456|8391443|P2|Overall Study|Lost to Follow-up|18
2441547|NCT02965456|8391444|P1|Overall Study|Lost to Follow-up|40
2441548|NCT02964338|8391498|P3|Overall Study|Did not meet criteria|0
2441549|NCT02964338|8391499|P2|Overall Study|Did not meet criteria|0
2441550|NCT02964338|8391500|P1|Overall Study|Did not meet criteria|1
2441551|NCT02964338|8391498|P3|Overall Study|Non-compliant with e-diary|0
2441552|NCT02964338|8391499|P2|Overall Study|Non-compliant with e-diary|1
2441553|NCT02964338|8391500|P1|Overall Study|Non-compliant with e-diary|0
2441554|NCT02964338|8391498|P3|Overall Study|Adverse Event|1
2441555|NCT02964338|8391499|P2|Overall Study|Adverse Event|1
2441556|NCT02964338|8391500|P1|Overall Study|Adverse Event|2
2441557|NCT02964338|8391498|P3|Overall Study|Withdrawal by Subject|1
2441558|NCT02964338|8391499|P2|Overall Study|Withdrawal by Subject|3
2441559|NCT02964338|8391500|P1|Overall Study|Withdrawal by Subject|1
2441560|NCT02964338|8391498|P3|Overall Study|Protocol Violation|0
2441561|NCT02964338|8391499|P2|Overall Study|Protocol Violation|1
2441562|NCT02964338|8391500|P1|Overall Study|Protocol Violation|0
2441563|NCT02964338|8391498|P3|Overall Study|Lost to Follow-up|3
2441564|NCT02964338|8391499|P2|Overall Study|Lost to Follow-up|0
2441565|NCT02964338|8391500|P1|Overall Study|Lost to Follow-up|1
2441566|NCT02964338|8391498|P3|Overall Study|Lack of Efficacy|0
2441567|NCT02964338|8391499|P2|Overall Study|Lack of Efficacy|3
2441568|NCT02964338|8391500|P1|Overall Study|Lack of Efficacy|0
2441569|NCT02964338|8391498|P3|Overall Study|Sponsor terminated study for futility|14
2441570|NCT02964338|8391499|P2|Overall Study|Sponsor terminated study for futility|15
2441571|NCT02964338|8391500|P1|Overall Study|Sponsor terminated study for futility|12
2441572|NCT02964312|8391544|P1|Overall Study|Lack of Efficacy|7
2441573|NCT02964312|8391544|P1|Overall Study|Withdrawal by Subject|8
2441574|NCT02964312|8391544|P1|Overall Study|Lost to Follow-up|12
2441575|NCT02964247|8391552|P2|Overall Study|Withdrawal by Subject|2
2441576|NCT02964247|8391553|P1|Overall Study|Withdrawal by Subject|1
2441577|NCT02964247|8391552|P2|Overall Study|Lost to Follow-up|0
2441578|NCT02964247|8391553|P1|Overall Study|Lost to Follow-up|2
2441579|NCT02963935|8391628|P2|Overall Study|Unclassified|22
2441580|NCT02963935|8391629|P1|Overall Study|Unclassified|13
2441581|NCT02963935|8391628|P2|Overall Study|Lost to Follow-up|6
2441582|NCT02963935|8391629|P1|Overall Study|Lost to Follow-up|1
2441583|NCT02963935|8391628|P2|Overall Study|Lack of Efficacy|2
2441584|NCT02963935|8391629|P1|Overall Study|Lack of Efficacy|0
2441585|NCT02963935|8391628|P2|Overall Study|Protocol Violation|1
2441586|NCT02963935|8391629|P1|Overall Study|Protocol Violation|2
2441587|NCT02963935|8391628|P2|Overall Study|Adverse Event|6
2441588|NCT02963935|8391629|P1|Overall Study|Adverse Event|12
2441589|NCT02963922|8391737|P2|Overall Study|Other|14
2441590|NCT02963922|8391738|P1|Overall Study|Other|8
2441591|NCT02963922|8391737|P2|Overall Study|Lost to Follow-up|3
2441592|NCT02963922|8391738|P1|Overall Study|Lost to Follow-up|2
2441593|NCT02963922|8391737|P2|Overall Study|Lack of Efficacy|1
2441594|NCT02963922|8391738|P1|Overall Study|Lack of Efficacy|1
2441595|NCT02963922|8391737|P2|Overall Study|Protocol deviation|6
2441596|NCT02963922|8391738|P1|Overall Study|Protocol deviation|6
2441597|NCT02963922|8391737|P2|Overall Study|Adverse Event|6
2441598|NCT02963922|8391738|P1|Overall Study|Adverse Event|15
2441599|NCT02963701|8391836|P2|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0
2441600|NCT02963701|8391837|P1|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1
2441601|NCT02962960|8391895|P3|Overall Study|Protocol Violation|0
2441602|NCT02962960|8391896|P2|Overall Study|Protocol Violation|0
2441603|NCT02962960|8391897|P1|Overall Study|Protocol Violation|1
2441604|NCT02962960|8391895|P3|Overall Study|Adverse Event|0
2441605|NCT02962960|8391896|P2|Overall Study|Adverse Event|1
2441606|NCT02962960|8391897|P1|Overall Study|Adverse Event|1
2441607|NCT02962960|8391895|P3|Overall Study|Withdrawal by Subject|0
2441608|NCT02962960|8391896|P2|Overall Study|Withdrawal by Subject|1
2441609|NCT02962960|8391897|P1|Overall Study|Withdrawal by Subject|1
2441610|NCT02962908|8391981|P4|Overall Study|Physician Decision|0
2441611|NCT02962908|8391982|P3|Overall Study|Physician Decision|0
2441612|NCT02962908|8391983|P2|Overall Study|Physician Decision|1
2441613|NCT02962908|8391984|P1|Overall Study|Physician Decision|0
2441614|NCT02962908|8391981|P4|Overall Study|Protocol Violation|0
2441615|NCT02962908|8391982|P3|Overall Study|Protocol Violation|0
2441616|NCT02962908|8391983|P2|Overall Study|Protocol Violation|1
2441617|NCT02962908|8391984|P1|Overall Study|Protocol Violation|0
2441618|NCT02962908|8391981|P4|Overall Study|Withdrawal by Subject|2
2441619|NCT02962908|8391982|P3|Overall Study|Withdrawal by Subject|0
2441620|NCT02962908|8391983|P2|Overall Study|Withdrawal by Subject|3
2441621|NCT02962908|8391984|P1|Overall Study|Withdrawal by Subject|0
2441622|NCT02962908|8391981|P4|Overall Study|Lost to Follow-up|1
2441623|NCT02962908|8391982|P3|Overall Study|Lost to Follow-up|0
2441624|NCT02962908|8391983|P2|Overall Study|Lost to Follow-up|3
2441625|NCT02962908|8391984|P1|Overall Study|Lost to Follow-up|0
2441626|NCT02962882|8392026|P1|Overall Study|Transfer from ICU|32
2441627|NCT02962882|8392026|P1|Overall Study|Withdrawal by Subject|2
2441628|NCT02962882|8392026|P1|Overall Study|Adverse Event|2
2441629|NCT02962648|8392062|P1|Overall Study|Subject had problems with transportation|2
2441630|NCT02962648|8392062|P1|Overall Study|Physician Decision|1
2441631|NCT02962648|8392062|P1|Overall Study|Lost to Follow-up|3
2441632|NCT02962648|8392062|P1|Overall Study|Withdrawal by Subject|3
2441633|NCT02962284|8392100|P2|Overall Study|Withdrawal by Subject|0
2441634|NCT02962284|8392101|P1|Overall Study|Withdrawal by Subject|1
2441635|NCT02962284|8392100|P2|Overall Study|Progressive disease|3
2441636|NCT02962284|8392101|P1|Overall Study|Progressive disease|2
2441637|NCT02962284|8392100|P2|Overall Study|Death|0
2441638|NCT02962284|8392101|P1|Overall Study|Death|2
2441639|NCT02961920|8392132|P2|Overall Study|did not achive stydy protocol schedule|1
2441640|NCT02961920|8392133|P1|Overall Study|did not achive stydy protocol schedule|1
2441641|NCT02961790|8392143|P4|Overall Study|without post baseline data|1
2441642|NCT02961790|8392144|P3|Overall Study|without post baseline data|4
2441643|NCT02961790|8392145|P2|Overall Study|without post baseline data|6
2441644|NCT02961790|8392146|P1|Overall Study|without post baseline data|7
2441645|NCT02961790|8392143|P4|Overall Study|without baseline data|0
2441646|NCT02961790|8392144|P3|Overall Study|without baseline data|1
2441647|NCT02961790|8392145|P2|Overall Study|without baseline data|0
2441648|NCT02961790|8392146|P1|Overall Study|without baseline data|4
2441649|NCT02961790|8392143|P4|Overall Study|Canceled|4
2441650|NCT02961790|8392144|P3|Overall Study|Canceled|1
2441651|NCT02961790|8392145|P2|Overall Study|Canceled|5
2441652|NCT02961790|8392146|P1|Overall Study|Canceled|4
2441653|NCT02961764|8392169|P2|Overall Study|Withdrawal by Subject|0
2441654|NCT02961764|8392170|P1|Overall Study|Withdrawal by Subject|2
2441655|NCT02961764|8392169|P2|Overall Study|Lost to Follow-up|24
2441656|NCT02961764|8392170|P1|Overall Study|Lost to Follow-up|35
2441657|NCT02961764|8392169|P2|Overall Study|Death|0
2441658|NCT02961764|8392170|P1|Overall Study|Death|2
2441659|NCT02961764|8392169|P2|Overall Study|Protocol Violation|1
2441660|NCT02961764|8392170|P1|Overall Study|Protocol Violation|0
2441661|NCT02961751|8392244|P1|Overall Study|Protocol Violation|1
2441662|NCT02961751|8392244|P1|Overall Study|Not Eligible at Enrollment|1
2441663|NCT02961751|8392244|P1|Overall Study|Physician Decision|2
2441664|NCT02961751|8392244|P1|Overall Study|Lost to Follow-up|11
2441665|NCT02961244|8392257|P2|Overall Study|İnadequate data|2
2441666|NCT02961244|8392258|P1|Overall Study|İnadequate data|0
2441667|NCT02961244|8392257|P2|Overall Study|Lost to Follow-up|2
2441668|NCT02961244|8392258|P1|Overall Study|Lost to Follow-up|0
2441669|NCT02961244|8392257|P2|Overall Study|Surgery plan change after study approval|2
2441670|NCT02961244|8392258|P1|Overall Study|Surgery plan change after study approval|0
2441671|NCT02961244|8392257|P2|Overall Study|Withdrawal by Subject|2
2441672|NCT02961244|8392258|P1|Overall Study|Withdrawal by Subject|1
2441673|NCT02961244|8392257|P2|Overall Study|Protocol Violation|1
2441674|NCT02961244|8392258|P1|Overall Study|Protocol Violation|0
2441675|NCT02960854|8392311|P2|Overall Study|Death|6
2441676|NCT02960854|8392312|P1|Overall Study|Death|4
2441677|NCT02960854|8392311|P2|Overall Study|Subject Withdrew Consent|1
2441678|NCT02960854|8392312|P1|Overall Study|Subject Withdrew Consent|0
2441679|NCT02960854|8392311|P2|Overall Study|Subject No Longer Meets Study Criteria|0
2441680|NCT02960854|8392312|P1|Overall Study|Subject No Longer Meets Study Criteria|1
2441681|NCT02960854|8392311|P2|Overall Study|Not Disclosed|2
2441682|NCT02960854|8392312|P1|Overall Study|Not Disclosed|2
2441683|NCT02960217|8392351|P2|Open-Label Extension Phase|Other, Not Specified|1
2441684|NCT02960217|8392352|P1|Open-Label Extension Phase|Other, Not Specified|0
2441685|NCT02960217|8392351|P2|Open-Label Extension Phase|Lack of Efficacy|1
2441686|NCT02960217|8392352|P1|Open-Label Extension Phase|Lack of Efficacy|1
2441687|NCT02960217|8392351|P2|Open-Label Extension Phase|Sponsor Decision|11
2441688|NCT02960217|8392352|P1|Open-Label Extension Phase|Sponsor Decision|18
2441689|NCT02960217|8392351|P2|Open-Label Extension Phase|Adverse Event|0
2441690|NCT02960217|8392352|P1|Open-Label Extension Phase|Adverse Event|1
2441691|NCT02960217|8392351|P2|Maintenance Phase: Treatment Period 2|Other, Not Specified|1
2441692|NCT02960217|8392352|P1|Maintenance Phase: Treatment Period 2|Other, Not Specified|0
2441693|NCT02960217|8392351|P2|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0
2441694|NCT02960217|8392352|P1|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1
2441695|NCT02960217|8392351|P2|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1
2441696|NCT02960217|8392352|P1|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0
2441697|NCT02960217|8392351|P2|Maintenance Phase: Treatment Period 2|Adverse Event|1
2441698|NCT02960217|8392352|P1|Maintenance Phase: Treatment Period 2|Adverse Event|0
2441699|NCT02960217|8392351|P2|Maintenance Phase: Treatment Period 1|Adverse Event|0
2441700|NCT02960217|8392352|P1|Maintenance Phase: Treatment Period 1|Adverse Event|1
2441701|NCT02959983|8392431|P2|Overall Study|Withdrawal by Subject|12
2441702|NCT02959983|8392432|P1|Overall Study|Withdrawal by Subject|7
2441703|NCT02959983|8392431|P2|Overall Study|Adverse Event|1
2441704|NCT02959983|8392432|P1|Overall Study|Adverse Event|5
2441705|NCT02959983|8392431|P2|Overall Study|Physician Decision|0
2441706|NCT02959983|8392432|P1|Overall Study|Physician Decision|1
2441707|NCT02959983|8392431|P2|Overall Study|Other|1
2441708|NCT02959983|8392432|P1|Overall Study|Other|1
2441709|NCT02959983|8392431|P2|Overall Study|Lost to Follow-up|9
2441710|NCT02959983|8392432|P1|Overall Study|Lost to Follow-up|12
2441711|NCT02959983|8392431|P2|Overall Study|Lack of Efficacy|1
2441712|NCT02959983|8392432|P1|Overall Study|Lack of Efficacy|0
2441713|NCT02959983|8392431|P2|Overall Study|Protocol Violation|1
2441714|NCT02959983|8392432|P1|Overall Study|Protocol Violation|0
2441715|NCT02959970|8392446|P2|Overall Study|Lost to Follow-up|5
2441716|NCT02959970|8392447|P1|Overall Study|Lost to Follow-up|1
2441717|NCT02959970|8392446|P2|Overall Study|Withdrawal by Subject|2
2441718|NCT02959970|8392447|P1|Overall Study|Withdrawal by Subject|0
2441719|NCT02959970|8392446|P2|Overall Study|Adverse Event|0
2441720|NCT02959970|8392447|P1|Overall Study|Adverse Event|1
2441721|NCT02959892|8392481|P2|Overall Study|Study termination|1
2441722|NCT02959892|8392482|P1|Overall Study|Study termination|0
2441723|NCT02959892|8392481|P2|Overall Study|PET tracer synthesis failure|0
2441724|NCT02959892|8392482|P1|Overall Study|PET tracer synthesis failure|1
2441725|NCT02959866|8392490|P1|Overall Study|Withdrawal by Subject|1
2441726|NCT02959814|8392579|P1|Overall Study|Excluded by FFR core-lab|24
2441727|NCT02959814|8392579|P1|Overall Study|In-procedure QFR not computed|6
2441728|NCT02959814|8392579|P1|Overall Study|FFR not measured|2
2441729|NCT02959814|8392579|P1|Overall Study|Protocol Violation|7
2441730|NCT02959814|8392579|P1|Overall Study|Excluded based on anatomical criteria|2
2441731|NCT02959814|8392579|P1|Overall Study|Excluded based on diagnostic angiography|16
2441732|NCT02959437|8392602|P4|Overall Study|Participants Ongoing in Study|0
2441733|NCT02959437|8392603|P3|Overall Study|Participants Ongoing in Study|0
2441734|NCT02959437|8392604|P2|Overall Study|Participants Ongoing in Study|0
2441735|NCT02959437|8392605|P1|Overall Study|Participants Ongoing in Study|7
2441736|NCT02959437|8392602|P4|Overall Study|Other Unspecified|0
2441737|NCT02959437|8392603|P3|Overall Study|Other Unspecified|0
2441738|NCT02959437|8392604|P2|Overall Study|Other Unspecified|0
2441739|NCT02959437|8392605|P1|Overall Study|Other Unspecified|2
2441740|NCT02959437|8392602|P4|Overall Study|Study Terminated by Sponsor|0
2441741|NCT02959437|8392603|P3|Overall Study|Study Terminated by Sponsor|0
2441742|NCT02959437|8392604|P2|Overall Study|Study Terminated by Sponsor|0
2441743|NCT02959437|8392605|P1|Overall Study|Study Terminated by Sponsor|2
2441744|NCT02959437|8392602|P4|Overall Study|Progressive Disease|0
2441745|NCT02959437|8392603|P3|Overall Study|Progressive Disease|0
2441746|NCT02959437|8392604|P2|Overall Study|Progressive Disease|1
2441747|NCT02959437|8392605|P1|Overall Study|Progressive Disease|8
2441748|NCT02959437|8392602|P4|Overall Study|Withdrawal by Subject|0
2441749|NCT02959437|8392603|P3|Overall Study|Withdrawal by Subject|0
2441750|NCT02959437|8392604|P2|Overall Study|Withdrawal by Subject|3
2441751|NCT02959437|8392605|P1|Overall Study|Withdrawal by Subject|10
2441752|NCT02959437|8392602|P4|Overall Study|Lost to Follow-up|0
2441753|NCT02959437|8392603|P3|Overall Study|Lost to Follow-up|0
2441754|NCT02959437|8392604|P2|Overall Study|Lost to Follow-up|1
2441755|NCT02959437|8392605|P1|Overall Study|Lost to Follow-up|2
2441756|NCT02959437|8392602|P4|Overall Study|Death|0
2441757|NCT02959437|8392603|P3|Overall Study|Death|0
2441758|NCT02959437|8392604|P2|Overall Study|Death|3
2441759|NCT02959437|8392605|P1|Overall Study|Death|31
2441760|NCT02959177|8392620|P3|Follow-up Post Treatment Phase|Withdrawal by Subject|2
2441761|NCT02959177|8392621|P2|Follow-up Post Treatment Phase|Withdrawal by Subject|0
2441762|NCT02959177|8392622|P1|Follow-up Post Treatment Phase|Withdrawal by Subject|0
2441763|NCT02959177|8392620|P3|Follow-up Post Treatment Phase|Adverse Event|0
2441764|NCT02959177|8392621|P2|Follow-up Post Treatment Phase|Adverse Event|1
2441765|NCT02959177|8392622|P1|Follow-up Post Treatment Phase|Adverse Event|0
2441766|NCT02959177|8392620|P3|Follow-up Post Treatment Phase|Lost to Follow-up|0
2441767|NCT02959177|8392621|P2|Follow-up Post Treatment Phase|Lost to Follow-up|0
2441768|NCT02959177|8392622|P1|Follow-up Post Treatment Phase|Lost to Follow-up|1
2441769|NCT02959177|8392620|P3|Double-Blind Treatment Phase|Withdrawal by Subject|5
2441770|NCT02959177|8392621|P2|Double-Blind Treatment Phase|Withdrawal by Subject|0
2441771|NCT02959177|8392622|P1|Double-Blind Treatment Phase|Withdrawal by Subject|5
2441772|NCT02959177|8392620|P3|Double-Blind Treatment Phase|Protocol Violation|0
2441773|NCT02959177|8392621|P2|Double-Blind Treatment Phase|Protocol Violation|1
2441774|NCT02959177|8392622|P1|Double-Blind Treatment Phase|Protocol Violation|0
2441775|NCT02959177|8392620|P3|Double-Blind Treatment Phase|Physician Decision|0
2441776|NCT02959177|8392621|P2|Double-Blind Treatment Phase|Physician Decision|0
2441777|NCT02959177|8392622|P1|Double-Blind Treatment Phase|Physician Decision|1
2441778|NCT02959177|8392620|P3|Double-Blind Treatment Phase|Adverse Event|0
2441779|NCT02959177|8392621|P2|Double-Blind Treatment Phase|Adverse Event|2
2441780|NCT02959177|8392622|P1|Double-Blind Treatment Phase|Adverse Event|5
2441781|NCT02959138|8392677|P3|Overall Study|Enrolled but Never Treated|0
2441782|NCT02959138|8392678|P2|Overall Study|Enrolled but Never Treated|1
2441783|NCT02959138|8392679|P1|Overall Study|Enrolled but Never Treated|0
2441784|NCT02958553|8392820|P1|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2
2441785|NCT02958553|8392820|P1|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1
2441786|NCT02958267|8392854|P2|Follow-up Visits|Additional treatment pursued|1
2441787|NCT02958267|8392855|P1|Follow-up Visits|Additional treatment pursued|2
2441788|NCT02958267|8392854|P2|Enrollment to Actual Treatment Complete|Physician Decision|0
2441789|NCT02958267|8392855|P1|Enrollment to Actual Treatment Complete|Physician Decision|1
2441790|NCT02958267|8392854|P2|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0
2441791|NCT02958267|8392855|P1|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1
2441792|NCT02957747|8392867|P2|Overall Study|Lost to Follow-up|5
2441793|NCT02957747|8392868|P1|Overall Study|Lost to Follow-up|10
2441794|NCT02957747|8392867|P2|Overall Study|Withdrawal by Subject|3
2441795|NCT02957747|8392868|P1|Overall Study|Withdrawal by Subject|0
2441796|NCT02956967|8392894|P1|Overall Study|Termination of Nivestim administration|29
2441797|NCT02956967|8392894|P1|Overall Study|Missing|1
2441798|NCT02956967|8392894|P1|Overall Study|Lost to Follow-up|5
2441799|NCT02956967|8392894|P1|Overall Study|Reason non-related to neutropenia|10
2441800|NCT02956967|8392894|P1|Overall Study|Adverse Event|3
2441801|NCT02956837|8392921|P4|Overall Study|Lost to Follow-up|0
2441802|NCT02956837|8392922|P3|Overall Study|Lost to Follow-up|2
2441803|NCT02956837|8392923|P2|Overall Study|Lost to Follow-up|1
2441804|NCT02956837|8392924|P1|Overall Study|Lost to Follow-up|0
2441805|NCT02956837|8392921|P4|Overall Study|Withdrawal by Subject|3
2441806|NCT02956837|8392922|P3|Overall Study|Withdrawal by Subject|0
2441807|NCT02956837|8392923|P2|Overall Study|Withdrawal by Subject|1
2441808|NCT02956837|8392924|P1|Overall Study|Withdrawal by Subject|0
2441809|NCT02956837|8392921|P4|Overall Study|Serious Adverse Events|0
2441810|NCT02956837|8392922|P3|Overall Study|Serious Adverse Events|0
2441811|NCT02956837|8392923|P2|Overall Study|Serious Adverse Events|1
2441812|NCT02956837|8392924|P1|Overall Study|Serious Adverse Events|0
2441813|NCT02956629|8393059|P6|Overall Study|Withdrawal by Subject|0
2441814|NCT02956629|8393060|P5|Overall Study|Withdrawal by Subject|0
2441815|NCT02956629|8393061|P4|Overall Study|Withdrawal by Subject|0
2441816|NCT02956629|8393062|P3|Overall Study|Withdrawal by Subject|0
2441817|NCT02956629|8393063|P2|Overall Study|Withdrawal by Subject|1
2441818|NCT02956629|8393064|P1|Overall Study|Withdrawal by Subject|3
2441819|NCT02956629|8393059|P6|Overall Study|Lost to Follow-up|1
2441820|NCT02956629|8393060|P5|Overall Study|Lost to Follow-up|0
2441821|NCT02956629|8393061|P4|Overall Study|Lost to Follow-up|1
2441822|NCT02956629|8393062|P3|Overall Study|Lost to Follow-up|3
2441823|NCT02956629|8393063|P2|Overall Study|Lost to Follow-up|5
2441824|NCT02956629|8393064|P1|Overall Study|Lost to Follow-up|2
2441825|NCT02956629|8393059|P6|Overall Study|Adverse Event|0
2441826|NCT02956629|8393060|P5|Overall Study|Adverse Event|0
2441827|NCT02956629|8393061|P4|Overall Study|Adverse Event|0
2441828|NCT02956629|8393062|P3|Overall Study|Adverse Event|1
2441829|NCT02956629|8393063|P2|Overall Study|Adverse Event|0
2441830|NCT02956629|8393064|P1|Overall Study|Adverse Event|0
2441831|NCT02956460|8393143|P2|Lens 1|Lost to Follow-up|0
2441832|NCT02956460|8393144|P1|Lens 1|Lost to Follow-up|1
2441833|NCT02956005|8393221|P1|Overall Study|Physician Decision|12
2441834|NCT02956005|8393221|P1|Overall Study|Withdrawal by Subject|3
2441835|NCT02956005|8393221|P1|Overall Study|Not eligible|1
2441836|NCT02954952|8393229|P3|Overall Study|No data collected|0
2441837|NCT02954952|8393230|P2|Overall Study|No data collected|1
2441838|NCT02954952|8393231|P1|Overall Study|No data collected|0
2441839|NCT02954952|8393229|P3|Overall Study|Withdrawal by Subject|0
2441840|NCT02954952|8393230|P2|Overall Study|Withdrawal by Subject|0
2441841|NCT02954952|8393231|P1|Overall Study|Withdrawal by Subject|1
2441842|NCT02954848|8393241|P2|Overall Study|Withdrawal by Participant|1
2441843|NCT02954848|8393242|P1|Overall Study|Withdrawal by Participant|0
2441844|NCT02954848|8393241|P2|Overall Study|Adverse Event|3
2441845|NCT02954848|8393242|P1|Overall Study|Adverse Event|2
2441846|NCT02954848|8393241|P2|Overall Study|Randomized but Not Treated|1
2441847|NCT02954848|8393242|P1|Overall Study|Randomized but Not Treated|0
2441848|NCT02954653|8393302|P9|Overall Study|Treatment failure and consent withdrawal|0
2441849|NCT02954653|8393303|P8|Overall Study|Treatment failure and consent withdrawal|0
2441850|NCT02954653|8393304|P7|Overall Study|Treatment failure and consent withdrawal|0
2441851|NCT02954653|8393305|P6|Overall Study|Treatment failure and consent withdrawal|0
2441852|NCT02954653|8393306|P5|Overall Study|Treatment failure and consent withdrawal|0
2441853|NCT02954653|8393307|P4|Overall Study|Treatment failure and consent withdrawal|0
2441854|NCT02954653|8393308|P3|Overall Study|Treatment failure and consent withdrawal|0
2441855|NCT02954653|8393309|P2|Overall Study|Treatment failure and consent withdrawal|1
2441856|NCT02954653|8393310|P1|Overall Study|Treatment failure and consent withdrawal|0
2441857|NCT02954653|8393302|P9|Overall Study|Started another anti-cancer therapy|0
2441858|NCT02954653|8393303|P8|Overall Study|Started another anti-cancer therapy|0
2441859|NCT02954653|8393304|P7|Overall Study|Started another anti-cancer therapy|0
2441860|NCT02954653|8393305|P6|Overall Study|Started another anti-cancer therapy|0
2441861|NCT02954653|8393306|P5|Overall Study|Started another anti-cancer therapy|0
2441862|NCT02954653|8393307|P4|Overall Study|Started another anti-cancer therapy|0
2441863|NCT02954653|8393308|P3|Overall Study|Started another anti-cancer therapy|0
2441864|NCT02954653|8393309|P2|Overall Study|Started another anti-cancer therapy|1
2441865|NCT02954653|8393310|P1|Overall Study|Started another anti-cancer therapy|0
2441866|NCT02954653|8393302|P9|Overall Study|Randomized but did not receive treatment|0
2441867|NCT02954653|8393303|P8|Overall Study|Randomized but did not receive treatment|0
2441868|NCT02954653|8393304|P7|Overall Study|Randomized but did not receive treatment|0
2441869|NCT02954653|8393305|P6|Overall Study|Randomized but did not receive treatment|0
2441870|NCT02954653|8393306|P5|Overall Study|Randomized but did not receive treatment|0
2441871|NCT02954653|8393307|P4|Overall Study|Randomized but did not receive treatment|0
2441872|NCT02954653|8393308|P3|Overall Study|Randomized but did not receive treatment|0
2441873|NCT02954653|8393309|P2|Overall Study|Randomized but did not receive treatment|0
2441874|NCT02954653|8393310|P1|Overall Study|Randomized but did not receive treatment|1
2441875|NCT02954653|8393302|P9|Overall Study|Death|0
2441876|NCT02954653|8393303|P8|Overall Study|Death|0
2441877|NCT02954653|8393304|P7|Overall Study|Death|0
2441878|NCT02954653|8393305|P6|Overall Study|Death|0
2441879|NCT02954653|8393306|P5|Overall Study|Death|0
2441880|NCT02954653|8393307|P4|Overall Study|Death|0
2441881|NCT02954653|8393308|P3|Overall Study|Death|0
2441882|NCT02954653|8393309|P2|Overall Study|Death|1
2441883|NCT02954653|8393310|P1|Overall Study|Death|3
2441884|NCT02954601|8393429|P4|First Intervention (Five Days)|Withdrawal by Subject|0
2441885|NCT02954601|8393430|P3|First Intervention (Five Days)|Withdrawal by Subject|1
2441886|NCT02954601|8393431|P2|First Intervention (Five Days)|Withdrawal by Subject|0
2441887|NCT02954601|8393432|P1|First Intervention (Five Days)|Withdrawal by Subject|0
2441888|NCT02954575|8393454|P1|Overall Study|Adverse Event|1
2441889|NCT02954575|8393454|P1|Overall Study|Withdrawal by Subject|2
2441890|NCT02954354|8393474|P3|Overall Study|Miscellaneous|1
2441891|NCT02954354|8393475|P2|Overall Study|Miscellaneous|2
2441892|NCT02954354|8393476|P1|Overall Study|Miscellaneous|2
2441893|NCT02954354|8393474|P3|Overall Study|Lost to Follow-up|0
2441894|NCT02954354|8393475|P2|Overall Study|Lost to Follow-up|5
2441895|NCT02954354|8393476|P1|Overall Study|Lost to Follow-up|12
2441896|NCT02954354|8393474|P3|Overall Study|Withdrawal by Subject|11
2441897|NCT02954354|8393475|P2|Overall Study|Withdrawal by Subject|9
2441898|NCT02954354|8393476|P1|Overall Study|Withdrawal by Subject|17
2441899|NCT02954354|8393474|P3|Overall Study|Lack of Efficacy|0
2441900|NCT02954354|8393475|P2|Overall Study|Lack of Efficacy|2
2441901|NCT02954354|8393476|P1|Overall Study|Lack of Efficacy|0
2441902|NCT02954354|8393474|P3|Overall Study|Failure to Meet Eligibility Criteria|0
2441903|NCT02954354|8393475|P2|Overall Study|Failure to Meet Eligibility Criteria|0
2441904|NCT02954354|8393476|P1|Overall Study|Failure to Meet Eligibility Criteria|1
2441905|NCT02954354|8393474|P3|Overall Study|Adverse Event|4
2441906|NCT02954354|8393475|P2|Overall Study|Adverse Event|2
2441907|NCT02954354|8393476|P1|Overall Study|Adverse Event|2
2441908|NCT02953938|8393577|P2|Overall Study|Withdrawal by Subject|1
2441909|NCT02953938|8393578|P1|Overall Study|Withdrawal by Subject|1
2441910|NCT02953938|8393577|P2|Overall Study|Adverse Event|1
2441911|NCT02953938|8393578|P1|Overall Study|Adverse Event|0
2441912|NCT02953678|8393607|P1|Overall Study|Reason unspecified|2
2441913|NCT02953678|8393607|P1|Overall Study|Withdrawal by Subject|3
2441914|NCT02953678|8393607|P1|Overall Study|Relapse of Underlying Malignancy|2
2441915|NCT02953678|8393607|P1|Overall Study|Progressive Disease of GVHD|6
2441916|NCT02953678|8393607|P1|Overall Study|Physician Decision|20
2441917|NCT02953678|8393607|P1|Overall Study|Death|7
2441918|NCT02953678|8393607|P1|Overall Study|Adverse Event|20
2441919|NCT02953314|8393618|P2|Overall Study|Withdrawal of consent (not due to AE)|2
2441920|NCT02953314|8393619|P1|Overall Study|Withdrawal of consent (not due to AE)|0
2441921|NCT02953314|8393618|P2|Overall Study|Adverse Event|1
2441922|NCT02953314|8393619|P1|Overall Study|Adverse Event|0
2441923|NCT02952898|8393645|P3|Overall Study|Non-compliance with study drug|2
2441924|NCT02952898|8393646|P2|Overall Study|Non-compliance with study drug|1
2441925|NCT02952898|8393647|P1|Overall Study|Non-compliance with study drug|1
2441926|NCT02952898|8393645|P3|Overall Study|Lost to Follow-up|2
2441927|NCT02952898|8393646|P2|Overall Study|Lost to Follow-up|2
2441928|NCT02952898|8393647|P1|Overall Study|Lost to Follow-up|3
2441929|NCT02952898|8393645|P3|Overall Study|Adverse Event|3
2441930|NCT02952898|8393646|P2|Overall Study|Adverse Event|8
2441931|NCT02952898|8393647|P1|Overall Study|Adverse Event|8
2441932|NCT02952898|8393645|P3|Overall Study|Withdrawal by Subject|8
2441933|NCT02952898|8393646|P2|Overall Study|Withdrawal by Subject|8
2441934|NCT02952898|8393647|P1|Overall Study|Withdrawal by Subject|10
2441935|NCT02952820|8393771|P3|Active Treatment Period (6 Months)|Not treated|1
2441936|NCT02952820|8393772|P2|Active Treatment Period (6 Months)|Not treated|0
2441937|NCT02952820|8393773|P1|Active Treatment Period (6 Months)|Not treated|0
2441938|NCT02952820|8393771|P3|Active Treatment Period (6 Months)|Other than specified|2
2441939|NCT02952820|8393772|P2|Active Treatment Period (6 Months)|Other than specified|6
2441940|NCT02952820|8393773|P1|Active Treatment Period (6 Months)|Other than specified|0
2441941|NCT02952820|8393771|P3|Active Treatment Period (6 Months)|Withdrawal of consent|8
2441942|NCT02952820|8393772|P2|Active Treatment Period (6 Months)|Withdrawal of consent|6
2441943|NCT02952820|8393773|P1|Active Treatment Period (6 Months)|Withdrawal of consent|0
2441944|NCT02952820|8393771|P3|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2
2441945|NCT02952820|8393772|P2|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6
2441946|NCT02952820|8393773|P1|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0
2441947|NCT02952820|8393771|P3|Active Treatment Period (6 Months)|Subject choice|7
2441948|NCT02952820|8393772|P2|Active Treatment Period (6 Months)|Subject choice|10
2441949|NCT02952820|8393773|P1|Active Treatment Period (6 Months)|Subject choice|0
2441950|NCT02952820|8393771|P3|Active Treatment Period (6 Months)|Lost to Follow-up|6
2441951|NCT02952820|8393772|P2|Active Treatment Period (6 Months)|Lost to Follow-up|4
2441952|NCT02952820|8393773|P1|Active Treatment Period (6 Months)|Lost to Follow-up|0
2441953|NCT02952820|8393771|P3|Active Treatment Period (6 Months)|Adverse Event|5
2441954|NCT02952820|8393772|P2|Active Treatment Period (6 Months)|Adverse Event|6
2441955|NCT02952820|8393773|P1|Active Treatment Period (6 Months)|Adverse Event|0
2441956|NCT02952820|8393771|P3|Placebo-Controlled Treatment (6 Months)|Not treated|4
2441957|NCT02952820|8393772|P2|Placebo-Controlled Treatment (6 Months)|Not treated|4
2441958|NCT02952820|8393773|P1|Placebo-Controlled Treatment (6 Months)|Not treated|4
2441959|NCT02952820|8393771|P3|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21
2441960|NCT02952820|8393772|P2|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11
2441961|NCT02952820|8393773|P1|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13
2441962|NCT02952820|8393771|P3|Placebo-Controlled Treatment (6 Months)|Other than specified|13
2441963|NCT02952820|8393772|P2|Placebo-Controlled Treatment (6 Months)|Other than specified|14
2441964|NCT02952820|8393773|P1|Placebo-Controlled Treatment (6 Months)|Other than specified|0
2441965|NCT02952820|8393771|P3|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11
2441966|NCT02952820|8393772|P2|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12
2441967|NCT02952820|8393773|P1|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17
2441968|NCT02952820|8393771|P3|Placebo-Controlled Treatment (6 Months)|Subject choice|17
2441969|NCT02952820|8393772|P2|Placebo-Controlled Treatment (6 Months)|Subject choice|12
2441970|NCT02952820|8393773|P1|Placebo-Controlled Treatment (6 Months)|Subject choice|15
2441971|NCT02952820|8393771|P3|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6
2441972|NCT02952820|8393772|P2|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7
2441973|NCT02952820|8393773|P1|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7
2441974|NCT02952820|8393771|P3|Placebo-Controlled Treatment (6 Months)|Adverse Event|16
2441975|NCT02952820|8393772|P2|Placebo-Controlled Treatment (6 Months)|Adverse Event|9
2441976|NCT02952820|8393773|P1|Placebo-Controlled Treatment (6 Months)|Adverse Event|8
2441977|NCT02952313|8393833|P1|Overall Study|Missed visit|1
2441978|NCT02952313|8393833|P1|Overall Study|Lack of Efficacy|1
2441979|NCT02952313|8393833|P1|Overall Study|Withdrawal by Subject|1
2441980|NCT02952313|8393833|P1|Overall Study|Lost to Follow-up|4
2441981|NCT02952261|8393841|P2|Overall Study|Protocol Violation|0
2441982|NCT02952261|8393842|P1|Overall Study|Protocol Violation|1
2441983|NCT02952261|8393841|P2|Overall Study|Withdrawal by Subject|5
2441984|NCT02952261|8393842|P1|Overall Study|Withdrawal by Subject|4
2441985|NCT02951988|8393857|P4|Double-Blind Treatment Period|Miscellaneous Reasons|0
2441986|NCT02951988|8393858|P3|Double-Blind Treatment Period|Miscellaneous Reasons|1
2441987|NCT02951988|8393859|P2|Double-Blind Treatment Period|Miscellaneous Reasons|2
2441988|NCT02951988|8393860|P1|Double-Blind Treatment Period|Miscellaneous Reasons|0
2441989|NCT02951988|8393857|P4|Double-Blind Treatment Period|Adverse Event|6
2441990|NCT02951988|8393858|P3|Double-Blind Treatment Period|Adverse Event|3
2441991|NCT02951988|8393859|P2|Double-Blind Treatment Period|Adverse Event|8
2441992|NCT02951988|8393860|P1|Double-Blind Treatment Period|Adverse Event|0
2441993|NCT02951988|8393857|P4|Double-Blind Treatment Period|Withdrawal by Subject|28
2441994|NCT02951988|8393858|P3|Double-Blind Treatment Period|Withdrawal by Subject|22
2441995|NCT02951988|8393859|P2|Double-Blind Treatment Period|Withdrawal by Subject|23
2441996|NCT02951988|8393860|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
2441997|NCT02951988|8393857|P4|Double-Blind Treatment Period|Lost to Follow-up|3
2441998|NCT02951988|8393858|P3|Double-Blind Treatment Period|Lost to Follow-up|12
2441999|NCT02951988|8393859|P2|Double-Blind Treatment Period|Lost to Follow-up|4
2442000|NCT02951988|8393860|P1|Double-Blind Treatment Period|Lost to Follow-up|0
2442001|NCT02951988|8393857|P4|Double-Blind Treatment Period|Pregnancy|0
2442002|NCT02951988|8393858|P3|Double-Blind Treatment Period|Pregnancy|1
2442003|NCT02951988|8393859|P2|Double-Blind Treatment Period|Pregnancy|1
2442004|NCT02951988|8393860|P1|Double-Blind Treatment Period|Pregnancy|0
2442005|NCT02951988|8393857|P4|Double-Blind Treatment Period|Protocol Violation|8
2442006|NCT02951988|8393858|P3|Double-Blind Treatment Period|Protocol Violation|4
2442007|NCT02951988|8393859|P2|Double-Blind Treatment Period|Protocol Violation|4
2442008|NCT02951988|8393860|P1|Double-Blind Treatment Period|Protocol Violation|0
2442009|NCT02951988|8393857|P4|Double-Blind Treatment Period|Non-compliance with study drug|0
2442010|NCT02951988|8393858|P3|Double-Blind Treatment Period|Non-compliance with study drug|3
2442011|NCT02951988|8393859|P2|Double-Blind Treatment Period|Non-compliance with study drug|1
2442012|NCT02951988|8393860|P1|Double-Blind Treatment Period|Non-compliance with study drug|0
2442013|NCT02951988|8393857|P4|Double-Blind Treatment Period|Study terminated by sponsor|69
2442014|NCT02951988|8393858|P3|Double-Blind Treatment Period|Study terminated by sponsor|54
2442015|NCT02951988|8393859|P2|Double-Blind Treatment Period|Study terminated by sponsor|58
2442016|NCT02951988|8393860|P1|Double-Blind Treatment Period|Study terminated by sponsor|0
2442017|NCT02951988|8393857|P4|Double-Blind Treatment Period|Site terminated by sponsor|1
2442018|NCT02951988|8393858|P3|Double-Blind Treatment Period|Site terminated by sponsor|1
2442019|NCT02951988|8393859|P2|Double-Blind Treatment Period|Site terminated by sponsor|0
2442020|NCT02951988|8393860|P1|Double-Blind Treatment Period|Site terminated by sponsor|0
2442021|NCT02951988|8393857|P4|Open-Label Treatment Period|Adverse Event|0
2442022|NCT02951988|8393858|P3|Open-Label Treatment Period|Adverse Event|0
2442023|NCT02951988|8393859|P2|Open-Label Treatment Period|Adverse Event|0
2442024|NCT02951988|8393860|P1|Open-Label Treatment Period|Adverse Event|45
2442025|NCT02951988|8393857|P4|Open-Label Treatment Period|Lack of Efficacy|0
2442026|NCT02951988|8393858|P3|Open-Label Treatment Period|Lack of Efficacy|0
2442027|NCT02951988|8393859|P2|Open-Label Treatment Period|Lack of Efficacy|0
2442028|NCT02951988|8393860|P1|Open-Label Treatment Period|Lack of Efficacy|49
2442029|NCT02951988|8393857|P4|Open-Label Treatment Period|Withdrawal by Subject|0
2442030|NCT02951988|8393858|P3|Open-Label Treatment Period|Withdrawal by Subject|0
2442031|NCT02951988|8393859|P2|Open-Label Treatment Period|Withdrawal by Subject|0
2442032|NCT02951988|8393860|P1|Open-Label Treatment Period|Withdrawal by Subject|78
2442033|NCT02951988|8393857|P4|Open-Label Treatment Period|Lost to Follow-up|0
2442034|NCT02951988|8393858|P3|Open-Label Treatment Period|Lost to Follow-up|0
2442035|NCT02951988|8393859|P2|Open-Label Treatment Period|Lost to Follow-up|0
2442036|NCT02951988|8393860|P1|Open-Label Treatment Period|Lost to Follow-up|28
2442037|NCT02951988|8393857|P4|Open-Label Treatment Period|Pregnancy|0
2442038|NCT02951988|8393858|P3|Open-Label Treatment Period|Pregnancy|0
2442039|NCT02951988|8393859|P2|Open-Label Treatment Period|Pregnancy|0
2442040|NCT02951988|8393860|P1|Open-Label Treatment Period|Pregnancy|2
2442041|NCT02951988|8393857|P4|Open-Label Treatment Period|Protocol Violation|0
2442042|NCT02951988|8393858|P3|Open-Label Treatment Period|Protocol Violation|0
2442043|NCT02951988|8393859|P2|Open-Label Treatment Period|Protocol Violation|0
2442044|NCT02951988|8393860|P1|Open-Label Treatment Period|Protocol Violation|22
2442045|NCT02951988|8393857|P4|Open-Label Treatment Period|Non-compliance with study drug|0
2442046|NCT02951988|8393858|P3|Open-Label Treatment Period|Non-compliance with study drug|0
2442047|NCT02951988|8393859|P2|Open-Label Treatment Period|Non-compliance with study drug|0
2442048|NCT02951988|8393860|P1|Open-Label Treatment Period|Non-compliance with study drug|5
2442049|NCT02951988|8393857|P4|Open-Label Treatment Period|Non-compliance with background ADT|0
2442050|NCT02951988|8393858|P3|Open-Label Treatment Period|Non-compliance with background ADT|0
2442051|NCT02951988|8393859|P2|Open-Label Treatment Period|Non-compliance with background ADT|0
2442052|NCT02951988|8393860|P1|Open-Label Treatment Period|Non-compliance with background ADT|2
2442053|NCT02951988|8393857|P4|Open-Label Treatment Period|Study terminated by sponsor|0
2442054|NCT02951988|8393858|P3|Open-Label Treatment Period|Study terminated by sponsor|0
2442055|NCT02951988|8393859|P2|Open-Label Treatment Period|Study terminated by sponsor|0
2442056|NCT02951988|8393860|P1|Open-Label Treatment Period|Study terminated by sponsor|9
2442057|NCT02951988|8393857|P4|Open-Label Treatment Period|Miscellaneous Reasons|0
2442058|NCT02951988|8393858|P3|Open-Label Treatment Period|Miscellaneous Reasons|0
2442059|NCT02951988|8393859|P2|Open-Label Treatment Period|Miscellaneous Reasons|0
2442060|NCT02951988|8393860|P1|Open-Label Treatment Period|Miscellaneous Reasons|8
2442061|NCT02951819|8393893|P2|Overall Study|Ongoing|11
2442062|NCT02951819|8393894|P1|Overall Study|Ongoing|83
2442063|NCT02951819|8393893|P2|Overall Study|Other|0
2442064|NCT02951819|8393894|P1|Overall Study|Other|1
2442065|NCT02951819|8393893|P2|Overall Study|Progressive Disease|0
2442066|NCT02951819|8393894|P1|Overall Study|Progressive Disease|1
2442067|NCT02951819|8393893|P2|Overall Study|Withdrawal by Subject|0
2442068|NCT02951819|8393894|P1|Overall Study|Withdrawal by Subject|1
2442069|NCT02951819|8393893|P2|Overall Study|Death|3
2442070|NCT02951819|8393894|P1|Overall Study|Death|1
2442071|NCT02951780|8393925|P9|Period 2|Scheduling Conflicts|0
2442072|NCT02951780|8393926|P8|Period 2|Scheduling Conflicts|1
2442073|NCT02951780|8393927|P7|Period 2|Scheduling Conflicts|0
2442074|NCT02951780|8393928|P6|Period 2|Scheduling Conflicts|0
2442075|NCT02951780|8393929|P5|Period 2|Scheduling Conflicts|0
2442076|NCT02951780|8393930|P4|Period 2|Scheduling Conflicts|0
2442077|NCT02951780|8393931|P3|Period 2|Scheduling Conflicts|0
2442078|NCT02951780|8393932|P2|Period 2|Scheduling Conflicts|0
2442079|NCT02951780|8393933|P1|Period 2|Scheduling Conflicts|0
2442080|NCT02951780|8393925|P9|Period 1|Scheduling Conflicts|0
2442081|NCT02951780|8393926|P8|Period 1|Scheduling Conflicts|1
2442082|NCT02951780|8393927|P7|Period 1|Scheduling Conflicts|0
2442083|NCT02951780|8393928|P6|Period 1|Scheduling Conflicts|0
2442084|NCT02951780|8393929|P5|Period 1|Scheduling Conflicts|0
2442085|NCT02951780|8393930|P4|Period 1|Scheduling Conflicts|0
2442086|NCT02951780|8393931|P3|Period 1|Scheduling Conflicts|0
2442087|NCT02951780|8393932|P2|Period 1|Scheduling Conflicts|0
2442088|NCT02951780|8393933|P1|Period 1|Scheduling Conflicts|0
2442089|NCT02951780|8393925|P9|Period 1|Adverse Event|0
2442090|NCT02951780|8393926|P8|Period 1|Adverse Event|0
2442091|NCT02951780|8393927|P7|Period 1|Adverse Event|0
2442092|NCT02951780|8393928|P6|Period 1|Adverse Event|0
2442093|NCT02951780|8393929|P5|Period 1|Adverse Event|0
2442094|NCT02951780|8393930|P4|Period 1|Adverse Event|1
2442095|NCT02951780|8393931|P3|Period 1|Adverse Event|0
2442096|NCT02951780|8393932|P2|Period 1|Adverse Event|0
2442097|NCT02951780|8393933|P1|Period 1|Adverse Event|0
2442098|NCT02951767|8393998|P1|Overall Study|Lost to Follow-up|1
2442099|NCT02951767|8393998|P1|Overall Study|Death|59
2442100|NCT02951767|8393998|P1|Overall Study|Withdrawal by Subject|5
2442101|NCT02951767|8393998|P1|Overall Study|Ongoing at data cutoff 04 July 2016|54
2442102|NCT02951533|8394030|P3|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2
2442103|NCT02951533|8394031|P2|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0
2442104|NCT02951533|8394032|P1|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2
2442105|NCT02951533|8394030|P3|Part III (Week 64 Through Week 100)|Lost to Follow-up|0
2442106|NCT02951533|8394031|P2|Part III (Week 64 Through Week 100)|Lost to Follow-up|0
2442107|NCT02951533|8394032|P1|Part III (Week 64 Through Week 100)|Lost to Follow-up|1
2442108|NCT02951533|8394030|P3|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0
2442109|NCT02951533|8394031|P2|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0
2442110|NCT02951533|8394032|P1|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1
2442111|NCT02951533|8394030|P3|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0
2442112|NCT02951533|8394031|P2|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2
2442113|NCT02951533|8394032|P1|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1
2442114|NCT02951533|8394030|P3|Part IIb (Week 32 Through Week 56)|Adverse Event|0
2442115|NCT02951533|8394031|P2|Part IIb (Week 32 Through Week 56)|Adverse Event|2
2442116|NCT02951533|8394032|P1|Part IIb (Week 32 Through Week 56)|Adverse Event|0
2442117|NCT02951533|8394030|P3|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0
2442118|NCT02951533|8394031|P2|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0
2442119|NCT02951533|8394032|P1|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1
2442120|NCT02951533|8394030|P3|Part IIa (Week 24 Through Week 32)|Adverse Event|0
2442121|NCT02951533|8394031|P2|Part IIa (Week 24 Through Week 32)|Adverse Event|1
2442122|NCT02951533|8394032|P1|Part IIa (Week 24 Through Week 32)|Adverse Event|0
2442123|NCT02951533|8394030|P3|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0
2442124|NCT02951533|8394031|P2|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1
2442125|NCT02951533|8394032|P1|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0
2442126|NCT02951533|8394030|P3|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0
2442127|NCT02951533|8394031|P2|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4
2442128|NCT02951533|8394032|P1|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2
2442129|NCT02951533|8394030|P3|Part I (Week 0 Through Week 24)|Lost to Follow-up|0
2442130|NCT02951533|8394031|P2|Part I (Week 0 Through Week 24)|Lost to Follow-up|2
2442131|NCT02951533|8394032|P1|Part I (Week 0 Through Week 24)|Lost to Follow-up|2
2442132|NCT02951533|8394030|P3|Part I (Week 0 Through Week 24)|Adverse Event|0
2442133|NCT02951533|8394031|P2|Part I (Week 0 Through Week 24)|Adverse Event|16
2442134|NCT02951533|8394032|P1|Part I (Week 0 Through Week 24)|Adverse Event|0
2442135|NCT02951052|8394296|P2|Overall Study|Ongoing|0
2442136|NCT02951052|8394297|P1|Overall Study|Ongoing|1
2442137|NCT02951052|8394296|P2|Overall Study|Lack of Efficacy|4
2442138|NCT02951052|8394297|P1|Overall Study|Lack of Efficacy|3
2442139|NCT02951052|8394296|P2|Overall Study|Protocol Violation|3
2442140|NCT02951052|8394297|P1|Overall Study|Protocol Violation|5
2442141|NCT02951052|8394296|P2|Overall Study|Protocol-specified withdrawal criterion|0
2442142|NCT02951052|8394297|P1|Overall Study|Protocol-specified withdrawal criterion|1
2442143|NCT02951052|8394296|P2|Overall Study|Lost to Follow-up|1
2442144|NCT02951052|8394297|P1|Overall Study|Lost to Follow-up|1
2442145|NCT02951052|8394296|P2|Overall Study|Physician Decision|0
2442146|NCT02951052|8394297|P1|Overall Study|Physician Decision|2
2442147|NCT02951052|8394296|P2|Overall Study|Withdrawal by Subject|5
2442148|NCT02951052|8394297|P1|Overall Study|Withdrawal by Subject|1
2442149|NCT02951052|8394296|P2|Overall Study|Adverse Event|5
2442150|NCT02951052|8394297|P1|Overall Study|Adverse Event|13
2442151|NCT02950831|8394465|P1|Overall Study|stimulation trail failure|5
2442152|NCT02950831|8394465|P1|Overall Study|Withdrawal by Subject|3
2442153|NCT02950831|8394465|P1|Overall Study|Lost to Follow-up|1
2442154|NCT02950545|8394507|P6|Session 3 (70 Minutes)|Withdrawal by Subject|1
2442155|NCT02950545|8394508|P5|Session 3 (70 Minutes)|Withdrawal by Subject|0
2442156|NCT02950545|8394509|P4|Session 3 (70 Minutes)|Withdrawal by Subject|0
2442157|NCT02950545|8394510|P3|Session 3 (70 Minutes)|Withdrawal by Subject|0
2442158|NCT02950545|8394511|P2|Session 3 (70 Minutes)|Withdrawal by Subject|0
2442159|NCT02950545|8394512|P1|Session 3 (70 Minutes)|Withdrawal by Subject|0
2442160|NCT02950545|8394507|P6|Washout 2 (5 Minutes)|Withdrawal by Subject|0
2442161|NCT02950545|8394508|P5|Washout 2 (5 Minutes)|Withdrawal by Subject|0
2442162|NCT02950545|8394509|P4|Washout 2 (5 Minutes)|Withdrawal by Subject|0
2442163|NCT02950545|8394510|P3|Washout 2 (5 Minutes)|Withdrawal by Subject|0
2442164|NCT02950545|8394511|P2|Washout 2 (5 Minutes)|Withdrawal by Subject|0
2442165|NCT02950545|8394512|P1|Washout 2 (5 Minutes)|Withdrawal by Subject|1
2442166|NCT02950545|8394507|P6|Session 2 (70 Minutes)|Withdrawal by Subject|0
2442167|NCT02950545|8394508|P5|Session 2 (70 Minutes)|Withdrawal by Subject|1
2442168|NCT02950545|8394509|P4|Session 2 (70 Minutes)|Withdrawal by Subject|0
2442169|NCT02950545|8394510|P3|Session 2 (70 Minutes)|Withdrawal by Subject|0
2442170|NCT02950545|8394511|P2|Session 2 (70 Minutes)|Withdrawal by Subject|0
2442171|NCT02950545|8394512|P1|Session 2 (70 Minutes)|Withdrawal by Subject|0
2442172|NCT02950545|8394507|P6|Washout 1 (5 Minutes)|Withdrawal by Subject|1
2442173|NCT02950545|8394508|P5|Washout 1 (5 Minutes)|Withdrawal by Subject|0
2442174|NCT02950545|8394509|P4|Washout 1 (5 Minutes)|Withdrawal by Subject|1
2442175|NCT02950545|8394510|P3|Washout 1 (5 Minutes)|Withdrawal by Subject|0
2442176|NCT02950545|8394511|P2|Washout 1 (5 Minutes)|Withdrawal by Subject|0
2442177|NCT02950545|8394512|P1|Washout 1 (5 Minutes)|Withdrawal by Subject|1
2442178|NCT02950545|8394507|P6|Session 1 (70 Minutes)|Withdrawal by Subject|1
2442179|NCT02950545|8394508|P5|Session 1 (70 Minutes)|Withdrawal by Subject|0
2442180|NCT02950545|8394509|P4|Session 1 (70 Minutes)|Withdrawal by Subject|0
2442181|NCT02950545|8394510|P3|Session 1 (70 Minutes)|Withdrawal by Subject|0
2442182|NCT02950545|8394511|P2|Session 1 (70 Minutes)|Withdrawal by Subject|0
2442183|NCT02950545|8394512|P1|Session 1 (70 Minutes)|Withdrawal by Subject|0
2442184|NCT02950480|8394521|P2|Overall Study|Withdrawal by Subject|0
2442185|NCT02950480|8394522|P1|Overall Study|Withdrawal by Subject|1
2442186|NCT02949947|8394555|P2|Overall Study|Insurance change|0
2442187|NCT02949947|8394556|P1|Overall Study|Insurance change|1
2442188|NCT02949947|8394555|P2|Overall Study|Non Compliance|1
2442189|NCT02949947|8394556|P1|Overall Study|Non Compliance|0
2442190|NCT02949908|8394589|P1|Overall Study|Study termination|2
2442191|NCT02949271|8394624|P2|Overall Study|Outside the window for cervical dilation|3
2442192|NCT02949271|8394625|P1|Overall Study|Outside the window for cervical dilation|2
2442193|NCT02949271|8394624|P2|Overall Study|Delivered prior to intervention|9
2442194|NCT02949271|8394625|P1|Overall Study|Delivered prior to intervention|7
2442195|NCT02949271|8394624|P2|Overall Study|Withdrawal by Subject|0
2442196|NCT02949271|8394625|P1|Overall Study|Withdrawal by Subject|1
2442197|NCT02949271|8394624|P2|Overall Study|Protocol Violation|3
2442198|NCT02949271|8394625|P1|Overall Study|Protocol Violation|6
2442199|NCT02949271|8394624|P2|Overall Study|Physician Decision|5
2442200|NCT02949271|8394625|P1|Overall Study|Physician Decision|5
2442201|NCT02949271|8394624|P2|Overall Study|Lost to Follow-up|6
2442202|NCT02949271|8394625|P1|Overall Study|Lost to Follow-up|3
2442203|NCT02949271|8394624|P2|Overall Study|Lack of Efficacy|4
2442204|NCT02949271|8394625|P1|Overall Study|Lack of Efficacy|5
2442205|NCT02949219|8394651|P1|Overall Study|Withdrawal by Subject|1
2442206|NCT02949128|8394665|P1|Extension Period|Withdrawal by Subject|1
2442207|NCT02949128|8394665|P1|Extension Period|Physician Decision|1
2442208|NCT02949128|8394665|P1|Initial Evaluation Period|Protocol Violation|1
2442209|NCT02949128|8394665|P1|Initial Evaluation Period|Physician Decision|1
2442210|NCT02949128|8394665|P1|Initial Evaluation Period|Death|2
2442211|NCT02949128|8394665|P1|Initial Evaluation Period|Adverse Event|3
2442212|NCT02949128|8394665|P1|Initial Evaluation Period|Failed to Meet Eligibility Criteria|2
2442213|NCT02949011|8394682|P3|Overall Study|Miscellaneous|6
2442214|NCT02949011|8394683|P2|Overall Study|Miscellaneous|4
2442215|NCT02949011|8394684|P1|Overall Study|Miscellaneous|2
2442216|NCT02949011|8394682|P3|Overall Study|Death|1
2442217|NCT02949011|8394683|P2|Overall Study|Death|0
2442218|NCT02949011|8394684|P1|Overall Study|Death|0
2442219|NCT02949011|8394682|P3|Overall Study|Lost to Follow-up|5
2442220|NCT02949011|8394683|P2|Overall Study|Lost to Follow-up|5
2442221|NCT02949011|8394684|P1|Overall Study|Lost to Follow-up|7
2442222|NCT02949011|8394682|P3|Overall Study|Withdrawal by Subject|21
2442223|NCT02949011|8394683|P2|Overall Study|Withdrawal by Subject|13
2442224|NCT02949011|8394684|P1|Overall Study|Withdrawal by Subject|13
2442225|NCT02949011|8394682|P3|Overall Study|Lack of Efficacy|0
2442226|NCT02949011|8394683|P2|Overall Study|Lack of Efficacy|2
2442227|NCT02949011|8394684|P1|Overall Study|Lack of Efficacy|0
2442228|NCT02949011|8394682|P3|Overall Study|Protocol Deviation|3
2442229|NCT02949011|8394683|P2|Overall Study|Protocol Deviation|3
2442230|NCT02949011|8394684|P1|Overall Study|Protocol Deviation|5
2442231|NCT02949011|8394682|P3|Overall Study|Failed Inclusion/Exclusion Criteria|3
2442232|NCT02949011|8394683|P2|Overall Study|Failed Inclusion/Exclusion Criteria|0
2442233|NCT02949011|8394684|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
2442234|NCT02949011|8394682|P3|Overall Study|Adverse Event|3
2442235|NCT02949011|8394683|P2|Overall Study|Adverse Event|7
2442236|NCT02949011|8394684|P1|Overall Study|Adverse Event|6
2442237|NCT02948634|8394754|P2|Overall Study|Lack of efficacy and study suspended|2
2442238|NCT02948634|8394755|P1|Overall Study|Lack of efficacy and study suspended|10
2442239|NCT02948582|8394765|P6|Washout Period 4|Adverse Event|0
2442240|NCT02948582|8394766|P5|Washout Period 4|Adverse Event|0
2442241|NCT02948582|8394767|P4|Washout Period 4|Adverse Event|0
2442242|NCT02948582|8394768|P3|Washout Period 4|Adverse Event|1
2442243|NCT02948582|8394769|P2|Washout Period 4|Adverse Event|0
2442244|NCT02948582|8394770|P1|Washout Period 4|Adverse Event|1
2442245|NCT02948582|8394765|P6|Washout Period 2|personal reasons|0
2442246|NCT02948582|8394766|P5|Washout Period 2|personal reasons|0
2442247|NCT02948582|8394767|P4|Washout Period 2|personal reasons|1
2442248|NCT02948582|8394768|P3|Washout Period 2|personal reasons|0
2442249|NCT02948582|8394769|P2|Washout Period 2|personal reasons|0
2442250|NCT02948582|8394770|P1|Washout Period 2|personal reasons|0
2442251|NCT02948582|8394765|P6|Washout Period 2|Adverse Event|0
2442252|NCT02948582|8394766|P5|Washout Period 2|Adverse Event|0
2442253|NCT02948582|8394767|P4|Washout Period 2|Adverse Event|0
2442254|NCT02948582|8394768|P3|Washout Period 2|Adverse Event|0
2442255|NCT02948582|8394769|P2|Washout Period 2|Adverse Event|1
2442256|NCT02948582|8394770|P1|Washout Period 2|Adverse Event|0
2442257|NCT02948582|8394765|P6|Washout Period 1|Protocol Violation|1
2442258|NCT02948582|8394766|P5|Washout Period 1|Protocol Violation|0
2442259|NCT02948582|8394767|P4|Washout Period 1|Protocol Violation|0
2442260|NCT02948582|8394768|P3|Washout Period 1|Protocol Violation|0
2442261|NCT02948582|8394769|P2|Washout Period 1|Protocol Violation|0
2442262|NCT02948582|8394770|P1|Washout Period 1|Protocol Violation|0
2442263|NCT02948582|8394765|P6|Washout Period 1|Adverse Event|0
2442264|NCT02948582|8394766|P5|Washout Period 1|Adverse Event|0
2442265|NCT02948582|8394767|P4|Washout Period 1|Adverse Event|0
2442266|NCT02948582|8394768|P3|Washout Period 1|Adverse Event|0
2442267|NCT02948582|8394769|P2|Washout Period 1|Adverse Event|2
2442268|NCT02948582|8394770|P1|Washout Period 1|Adverse Event|0
2442269|NCT02947022|8394892|P1|Overall Study|Study Stopped|1
2442270|NCT02946580|8394913|P2|Overall Study|Did not undergo posterior spinal fusion|1
2442271|NCT02946580|8394914|P1|Overall Study|Did not undergo posterior spinal fusion|0
2442272|NCT02946580|8394913|P2|Overall Study|Adverse Event|2
2442273|NCT02946580|8394914|P1|Overall Study|Adverse Event|0
2442274|NCT02946580|8394913|P2|Overall Study|Withdrawal by Subject|2
2442275|NCT02946580|8394914|P1|Overall Study|Withdrawal by Subject|1
2442276|NCT02946515|8394932|P2|Overall Study|Lost to Follow-up|1
2442277|NCT02946515|8394933|P1|Overall Study|Lost to Follow-up|2
2442278|NCT02946463|8394946|P2|Primary Evaluation Period|Withdrawal by Subject|1
2442279|NCT02946463|8394947|P1|Primary Evaluation Period|Withdrawal by Subject|0
2442280|NCT02946463|8394946|P2|Primary Evaluation Period|Physician Decision|1
2442281|NCT02946463|8394947|P1|Primary Evaluation Period|Physician Decision|0
2442282|NCT02946385|8394969|P6|Overall Study|Lost to Follow-up|1
2442283|NCT02946385|8394970|P5|Overall Study|Lost to Follow-up|2
2442284|NCT02946385|8394971|P4|Overall Study|Lost to Follow-up|0
2442285|NCT02946385|8394972|P3|Overall Study|Lost to Follow-up|3
2442286|NCT02946385|8394973|P2|Overall Study|Lost to Follow-up|0
2442287|NCT02946385|8394974|P1|Overall Study|Lost to Follow-up|0
2442288|NCT02945657|8395077|P1|Overall Study|Withdrawal by Parent/Guardian|3
2442289|NCT02945657|8395077|P1|Overall Study|Adverse Event|1
2442290|NCT02945410|8395100|P6|Washout 1 (14 Days)|Withdrawal by Subject|0
2442291|NCT02945410|8395101|P5|Washout 1 (14 Days)|Withdrawal by Subject|1
2442292|NCT02945410|8395102|P4|Washout 1 (14 Days)|Withdrawal by Subject|0
2442293|NCT02945410|8395103|P3|Washout 1 (14 Days)|Withdrawal by Subject|2
2442294|NCT02945410|8395104|P2|Washout 1 (14 Days)|Withdrawal by Subject|0
2442295|NCT02945410|8395105|P1|Washout 1 (14 Days)|Withdrawal by Subject|0
2442296|NCT02945410|8395100|P6|Intervention 1 (5 Days)|Adverse Event|1
2442297|NCT02945410|8395101|P5|Intervention 1 (5 Days)|Adverse Event|0
2442298|NCT02945410|8395102|P4|Intervention 1 (5 Days)|Adverse Event|0
2442299|NCT02945410|8395103|P3|Intervention 1 (5 Days)|Adverse Event|0
2442300|NCT02945410|8395104|P2|Intervention 1 (5 Days)|Adverse Event|0
2442301|NCT02945410|8395105|P1|Intervention 1 (5 Days)|Adverse Event|1
2442302|NCT02945410|8395100|P6|Intervention 1 (5 Days)|Withdrawal by Subject|0
2442303|NCT02945410|8395101|P5|Intervention 1 (5 Days)|Withdrawal by Subject|0
2442304|NCT02945410|8395102|P4|Intervention 1 (5 Days)|Withdrawal by Subject|0
2442305|NCT02945410|8395103|P3|Intervention 1 (5 Days)|Withdrawal by Subject|0
2442306|NCT02945410|8395104|P2|Intervention 1 (5 Days)|Withdrawal by Subject|3
2442307|NCT02945410|8395105|P1|Intervention 1 (5 Days)|Withdrawal by Subject|0
2442308|NCT02945254|8395136|P2|Overall Study|Withdrawal by Subject|0
2442309|NCT02945254|8395137|P1|Overall Study|Withdrawal by Subject|1
2442310|NCT02945254|8395136|P2|Overall Study|Lost to Follow-up|0
2442311|NCT02945254|8395137|P1|Overall Study|Lost to Follow-up|1
2442312|NCT02945046|8395153|P3|Overall Study|Other than specified|7
2442313|NCT02945046|8395154|P2|Overall Study|Other than specified|4
2442314|NCT02945046|8395155|P1|Overall Study|Other than specified|5
2442315|NCT02945046|8395153|P3|Overall Study|Lack of Efficacy|1
2442316|NCT02945046|8395154|P2|Overall Study|Lack of Efficacy|2
2442317|NCT02945046|8395155|P1|Overall Study|Lack of Efficacy|1
2442318|NCT02945046|8395153|P3|Overall Study|Lost to Follow-up|0
2442319|NCT02945046|8395154|P2|Overall Study|Lost to Follow-up|1
2442320|NCT02945046|8395155|P1|Overall Study|Lost to Follow-up|1
2442321|NCT02945046|8395153|P3|Overall Study|Protocol Violation|2
2442322|NCT02945046|8395154|P2|Overall Study|Protocol Violation|3
2442323|NCT02945046|8395155|P1|Overall Study|Protocol Violation|2
2442324|NCT02945046|8395153|P3|Overall Study|Withdrawal by Subject|3
2442325|NCT02945046|8395154|P2|Overall Study|Withdrawal by Subject|3
2442326|NCT02945046|8395155|P1|Overall Study|Withdrawal by Subject|3
2442327|NCT02945046|8395153|P3|Overall Study|Adverse Event|2
2442328|NCT02945046|8395154|P2|Overall Study|Adverse Event|0
2442329|NCT02945046|8395155|P1|Overall Study|Adverse Event|1
2442330|NCT02944968|8395208|P1|Overall Study|Subject didn't meet eligibility criteria|2
2442331|NCT02944968|8395208|P1|Overall Study|Subject excluded before study procedure|1
2442332|NCT02944656|8395215|P2|Overall Study|Lost to Follow-up|10
2442333|NCT02944656|8395216|P1|Overall Study|Lost to Follow-up|7
2442334|NCT02944656|8395215|P2|Overall Study|No longer eligible|0
2442335|NCT02944656|8395216|P1|Overall Study|No longer eligible|3
2442336|NCT02944513|8395252|P2|Overall Study|Withdrawal by Subject|1
2442337|NCT02944513|8395253|P1|Overall Study|Withdrawal by Subject|4
2442338|NCT02943577|8395284|P2|Overall Study|Pregnancy|0
2442339|NCT02943577|8395285|P1|Overall Study|Pregnancy|1
2442340|NCT02943577|8395284|P2|Overall Study|Withdrawal by Subject|1
2442341|NCT02943577|8395285|P1|Overall Study|Withdrawal by Subject|1
2442342|NCT02943577|8395284|P2|Overall Study|Lost to Follow-up|1
2442343|NCT02943577|8395285|P1|Overall Study|Lost to Follow-up|0
2442344|NCT02943577|8395284|P2|Overall Study|Adverse Event|2
2442345|NCT02943577|8395285|P1|Overall Study|Adverse Event|3
2442346|NCT02943577|8395284|P2|Overall Study|Protocol Violation|1
2442347|NCT02943577|8395285|P1|Overall Study|Protocol Violation|0
2442348|NCT02943564|8395300|P3|Overall Study|Lack of Efficacy|0
2442349|NCT02943564|8395301|P2|Overall Study|Lack of Efficacy|1
2442350|NCT02943564|8395302|P1|Overall Study|Lack of Efficacy|0
2442351|NCT02943564|8395300|P3|Overall Study|Adverse Event|1
2442352|NCT02943564|8395301|P2|Overall Study|Adverse Event|2
2442353|NCT02943564|8395302|P1|Overall Study|Adverse Event|1
2442354|NCT02943564|8395300|P3|Overall Study|Withdrawal by Subject|2
2442355|NCT02943564|8395301|P2|Overall Study|Withdrawal by Subject|5
2442356|NCT02943564|8395302|P1|Overall Study|Withdrawal by Subject|6
2442357|NCT02943564|8395300|P3|Overall Study|Lost to Follow-up|0
2442358|NCT02943564|8395301|P2|Overall Study|Lost to Follow-up|0
2442359|NCT02943564|8395302|P1|Overall Study|Lost to Follow-up|1
2442360|NCT02943564|8395300|P3|Overall Study|Protocol Violation|2
2442361|NCT02943564|8395301|P2|Overall Study|Protocol Violation|2
2442362|NCT02943564|8395302|P1|Overall Study|Protocol Violation|2
2442363|NCT02943564|8395300|P3|Overall Study|Pregnancy|1
2442364|NCT02943564|8395301|P2|Overall Study|Pregnancy|1
2442365|NCT02943564|8395302|P1|Overall Study|Pregnancy|0
2442366|NCT02943564|8395300|P3|Overall Study|Non-compliance with study drug|0
2442367|NCT02943564|8395301|P2|Overall Study|Non-compliance with study drug|1
2442368|NCT02943564|8395302|P1|Overall Study|Non-compliance with study drug|0
2442369|NCT02943564|8395300|P3|Overall Study|Site terminated by sponsor|0
2442370|NCT02943564|8395301|P2|Overall Study|Site terminated by sponsor|1
2442371|NCT02943564|8395302|P1|Overall Study|Site terminated by sponsor|0
2442372|NCT02943564|8395300|P3|Overall Study|Miscellaneous Reasons|3
2442373|NCT02943564|8395301|P2|Overall Study|Miscellaneous Reasons|0
2442374|NCT02943564|8395302|P1|Overall Study|Miscellaneous Reasons|0
2442375|NCT02943460|8395325|P3|Open Label Extension (OLE)|Still in Open Label Extension Phase|8
2442376|NCT02943460|8395326|P2|Open Label Extension (OLE)|Still in Open Label Extension Phase|14
2442377|NCT02943460|8395327|P1|Open Label Extension (OLE)|Still in Open Label Extension Phase|18
2442378|NCT02943460|8395325|P3|Open Label Extension (OLE)|Investigator's Discretion|0
2442379|NCT02943460|8395326|P2|Open Label Extension (OLE)|Investigator's Discretion|1
2442380|NCT02943460|8395327|P1|Open Label Extension (OLE)|Investigator's Discretion|0
2442381|NCT02943460|8395325|P3|Open Label Extension (OLE)|Withdrew Consent|0
2442382|NCT02943460|8395326|P2|Open Label Extension (OLE)|Withdrew Consent|1
2442383|NCT02943460|8395327|P1|Open Label Extension (OLE)|Withdrew Consent|1
2442384|NCT02943460|8395325|P3|Open Label Extension (OLE)|Adverse Event|1
2442385|NCT02943460|8395326|P2|Open Label Extension (OLE)|Adverse Event|2
2442386|NCT02943460|8395327|P1|Open Label Extension (OLE)|Adverse Event|0
2442387|NCT02943460|8395325|P3|Blinded Study|Withdrew Consent|0
2442388|NCT02943460|8395326|P2|Blinded Study|Withdrew Consent|1
2442389|NCT02943460|8395327|P1|Blinded Study|Withdrew Consent|0
2442390|NCT02943460|8395325|P3|Blinded Study|Adverse Event|0
2442391|NCT02943460|8395326|P2|Blinded Study|Adverse Event|0
2442392|NCT02943460|8395327|P1|Blinded Study|Adverse Event|3
2442393|NCT02943447|8395345|P3|Overall Study|Still on Study|11
2442394|NCT02943447|8395346|P2|Overall Study|Still on Study|22
2442395|NCT02943447|8395347|P1|Overall Study|Still on Study|21
2442396|NCT02943447|8395345|P3|Overall Study|Withdrew Consent|1
2442397|NCT02943447|8395346|P2|Overall Study|Withdrew Consent|2
2442398|NCT02943447|8395347|P1|Overall Study|Withdrew Consent|1
2442399|NCT02943447|8395345|P3|Overall Study|Lack of Efficacy|0
2442400|NCT02943447|8395346|P2|Overall Study|Lack of Efficacy|2
2442401|NCT02943447|8395347|P1|Overall Study|Lack of Efficacy|2
2442402|NCT02943447|8395345|P3|Overall Study|Adverse Event|1
2442403|NCT02943447|8395346|P2|Overall Study|Adverse Event|4
2442404|NCT02943447|8395347|P1|Overall Study|Adverse Event|4
2442405|NCT02943096|8395416|P2|Overall Study|Lack of Efficacy|1
2442406|NCT02943096|8395417|P1|Overall Study|Lack of Efficacy|0
2442407|NCT02942576|8395442|P2|Overall Study|Other|8
2442408|NCT02942576|8395443|P1|Overall Study|Other|10
2442409|NCT02942576|8395442|P2|Overall Study|Physician Decision|4
2442410|NCT02942576|8395443|P1|Overall Study|Physician Decision|1
2442411|NCT02942576|8395442|P2|Overall Study|Withdrawal by Subject|5
2442412|NCT02942576|8395443|P1|Overall Study|Withdrawal by Subject|7
2442413|NCT02942576|8395442|P2|Overall Study|Adverse Event|6
2442414|NCT02942576|8395443|P1|Overall Study|Adverse Event|28
2442415|NCT02942017|8395457|P2|Overall Study|Randomized but not dosed|3
2442416|NCT02942017|8395458|P1|Overall Study|Randomized but not dosed|1
2442417|NCT02942017|8395457|P2|Overall Study|Lost to Follow-up|1
2442418|NCT02942017|8395458|P1|Overall Study|Lost to Follow-up|1
2442419|NCT02942017|8395457|P2|Overall Study|Withdrawal by Subject|1
2442420|NCT02942017|8395458|P1|Overall Study|Withdrawal by Subject|0
2442421|NCT02942017|8395457|P2|Overall Study|Adverse Event|1
2442422|NCT02942017|8395458|P1|Overall Study|Adverse Event|0
2442423|NCT02942004|8395489|P3|Overall Study|Randomized but not dosed|4
2442424|NCT02942004|8395490|P2|Overall Study|Randomized but not dosed|9
2442425|NCT02942004|8395491|P1|Overall Study|Randomized but not dosed|3
2442426|NCT02942004|8395489|P3|Overall Study|Lost to Follow-up|2
2442427|NCT02942004|8395490|P2|Overall Study|Lost to Follow-up|1
2442428|NCT02942004|8395491|P1|Overall Study|Lost to Follow-up|1
2442429|NCT02942004|8395489|P3|Overall Study|Withdrawal by Subject|3
2442430|NCT02942004|8395490|P2|Overall Study|Withdrawal by Subject|2
2442431|NCT02942004|8395491|P1|Overall Study|Withdrawal by Subject|0
2442432|NCT02940886|8395582|P2|Overall Study|Enrolment error|1
2442433|NCT02940886|8395583|P1|Overall Study|Enrolment error|0
2442434|NCT02940886|8395582|P2|Overall Study|No treatment|2
2442435|NCT02940886|8395583|P1|Overall Study|No treatment|7
2442436|NCT02940886|8395582|P2|Overall Study|Sponsor decision|1
2442437|NCT02940886|8395583|P1|Overall Study|Sponsor decision|0
2442438|NCT02940886|8395582|P2|Overall Study|Physician Decision|4
2442439|NCT02940886|8395583|P1|Overall Study|Physician Decision|9
2442440|NCT02940886|8395582|P2|Overall Study|Lost to Follow-up|21
2442441|NCT02940886|8395583|P1|Overall Study|Lost to Follow-up|49
2442442|NCT02940886|8395582|P2|Overall Study|Lack of Efficacy|0
2442443|NCT02940886|8395583|P1|Overall Study|Lack of Efficacy|1
2442444|NCT02940886|8395582|P2|Overall Study|Death|0
2442445|NCT02940886|8395583|P1|Overall Study|Death|1
2442446|NCT02940886|8395582|P2|Overall Study|Withdrawal by Subject|20
2442447|NCT02940886|8395583|P1|Overall Study|Withdrawal by Subject|28
2442448|NCT02940886|8395582|P2|Overall Study|Protocol Violation|2
2442449|NCT02940886|8395583|P1|Overall Study|Protocol Violation|0
2442450|NCT02940886|8395582|P2|Overall Study|Adverse Event|3
2442451|NCT02940886|8395583|P1|Overall Study|Adverse Event|7
2442452|NCT02940860|8395629|P2|Overall Study|Not treated|2
2442453|NCT02940860|8395630|P1|Overall Study|Not treated|2
2442454|NCT02940860|8395629|P2|Overall Study|Moved, poor venous access, transport|4
2442455|NCT02940860|8395630|P1|Overall Study|Moved, poor venous access, transport|6
2442456|NCT02940860|8395629|P2|Overall Study|Death|2
2442457|NCT02940860|8395630|P1|Overall Study|Death|3
2442458|NCT02940860|8395629|P2|Overall Study|Protocol Violation|2
2442459|NCT02940860|8395630|P1|Overall Study|Protocol Violation|0
2442460|NCT02940860|8395629|P2|Overall Study|Sponsor Decision|1
2442461|NCT02940860|8395630|P1|Overall Study|Sponsor Decision|0
2442462|NCT02940860|8395629|P2|Overall Study|Physician Decision|3
2442463|NCT02940860|8395630|P1|Overall Study|Physician Decision|5
2442464|NCT02940860|8395629|P2|Overall Study|Lost to Follow-up|7
2442465|NCT02940860|8395630|P1|Overall Study|Lost to Follow-up|13
2442466|NCT02940860|8395629|P2|Overall Study|Withdrawal by Subject|9
2442467|NCT02940860|8395630|P1|Overall Study|Withdrawal by Subject|19
2442468|NCT02940860|8395629|P2|Overall Study|Serious AE|3
2442469|NCT02940860|8395630|P1|Overall Study|Serious AE|7
2442470|NCT02940860|8395629|P2|Overall Study|Non-serious AE|2
2442471|NCT02940860|8395630|P1|Overall Study|Non-serious AE|1
2442472|NCT02940691|8395674|P1|Overall Study|Incarceration|1
2442473|NCT02940691|8395674|P1|Overall Study|Lost to Follow-up|5
2442474|NCT02940626|8395683|P2|Overall Study|Prohibited Concomitant Medication|1
2442475|NCT02940626|8395684|P1|Overall Study|Prohibited Concomitant Medication|0
2442476|NCT02940626|8395683|P2|Overall Study|Transfer to Hospice Care|0
2442477|NCT02940626|8395684|P1|Overall Study|Transfer to Hospice Care|1
2442478|NCT02940626|8395683|P2|Overall Study|Withdrawal by Subject|0
2442479|NCT02940626|8395684|P1|Overall Study|Withdrawal by Subject|1
2442480|NCT02940626|8395683|P2|Overall Study|Lost to Follow-up|2
2442481|NCT02940626|8395684|P1|Overall Study|Lost to Follow-up|5
2442482|NCT02940626|8395683|P2|Overall Study|Death|32
2442483|NCT02940626|8395684|P1|Overall Study|Death|40
2442484|NCT02940574|8395706|P2|1-year Follow-up|Lost to Follow-up|4
2442485|NCT02940574|8395707|P1|1-year Follow-up|Lost to Follow-up|3
2442486|NCT02940574|8395706|P2|From Study Start to 1-month Follow-up|Withdrawal by Subject|0
2442487|NCT02940574|8395707|P1|From Study Start to 1-month Follow-up|Withdrawal by Subject|1
2442488|NCT02940522|8395745|P2|Overall Study|Withdrawal by Subject|0
2442489|NCT02940522|8395746|P1|Overall Study|Withdrawal by Subject|1
2442490|NCT02940522|8395745|P2|Overall Study|Lost to Follow-up|2
2442491|NCT02940522|8395746|P1|Overall Study|Lost to Follow-up|1
2442492|NCT02939950|8395827|P2|Overall Study|Ineligible at Baseline|8
2442493|NCT02939950|8395828|P1|Overall Study|Ineligible at Baseline|2
2442494|NCT02939950|8395827|P2|Overall Study|Randomized, not dispensed|0
2442495|NCT02939950|8395828|P1|Overall Study|Randomized, not dispensed|1
2442496|NCT02939950|8395827|P2|Overall Study|Adverse Event|3
2442497|NCT02939950|8395828|P1|Overall Study|Adverse Event|7
2442498|NCT02939950|8395827|P2|Overall Study|Withdrawal by Subject|28
2442499|NCT02939950|8395828|P1|Overall Study|Withdrawal by Subject|12
2442500|NCT02939950|8395827|P2|Overall Study|Pregnancy|7
2442501|NCT02939950|8395828|P1|Overall Study|Pregnancy|6
2442502|NCT02939950|8395827|P2|Overall Study|Physician Decision|0
2442503|NCT02939950|8395828|P1|Overall Study|Physician Decision|2
2442504|NCT02939950|8395827|P2|Overall Study|Protocol Violation|3
2442505|NCT02939950|8395828|P1|Overall Study|Protocol Violation|6
2442506|NCT02939950|8395827|P2|Overall Study|Unacceptable lens movement|0
2442507|NCT02939950|8395828|P1|Overall Study|Unacceptable lens movement|2
2442508|NCT02939950|8395827|P2|Overall Study|Study related symptoms|8
2442509|NCT02939950|8395828|P1|Overall Study|Study related symptoms|8
2442510|NCT02939950|8395827|P2|Overall Study|Participant Relocated|3
2442511|NCT02939950|8395828|P1|Overall Study|Participant Relocated|5
2442512|NCT02939950|8395827|P2|Overall Study|Military orders|0
2442513|NCT02939950|8395828|P1|Overall Study|Military orders|1
2442514|NCT02939950|8395827|P2|Overall Study|Unacceptable distance lens visual acuity|1
2442515|NCT02939950|8395828|P1|Overall Study|Unacceptable distance lens visual acuity|1
2442516|NCT02939950|8395827|P2|Overall Study|Lack of motivation|2
2442517|NCT02939950|8395828|P1|Overall Study|Lack of motivation|0
2442518|NCT02939950|8395827|P2|Overall Study|Chalazion upper lid|1
2442519|NCT02939950|8395828|P1|Overall Study|Chalazion upper lid|0
2442520|NCT02939950|8395827|P2|Overall Study|Positive slit lamp findings|1
2442521|NCT02939950|8395828|P1|Overall Study|Positive slit lamp findings|0
2442522|NCT02939950|8395827|P2|Overall Study|Lost to Follow-up|16
2442523|NCT02939950|8395828|P1|Overall Study|Lost to Follow-up|13
2442524|NCT02939937|8395838|P2|Overall Study|Lost to Follow-up|3
2442525|NCT02939937|8395839|P1|Overall Study|Lost to Follow-up|1
2442526|NCT02939937|8395838|P2|Overall Study|Adverse Event|0
2442527|NCT02939937|8395839|P1|Overall Study|Adverse Event|5
2442528|NCT02939599|8395855|P2|Overall Study|Study Terminated By Sponsor|2
2442529|NCT02939599|8395856|P1|Overall Study|Study Terminated By Sponsor|2
2442530|NCT02939599|8395855|P2|Overall Study|Adverse Event|0
2442531|NCT02939599|8395856|P1|Overall Study|Adverse Event|1
2442532|NCT02939560|8395870|P1|Overall Study|Protocol Violation|1
2442533|NCT02939560|8395870|P1|Overall Study|Withdrawal by Subject|2
2442534|NCT02939079|8395928|P2|Overall Study|relapse during the study|1
2442535|NCT02939079|8395929|P1|Overall Study|relapse during the study|1
2442536|NCT02939079|8395928|P2|Overall Study|Withdrawal by Subject|1
2442537|NCT02939079|8395929|P1|Overall Study|Withdrawal by Subject|0
2442538|NCT02939079|8395928|P2|Overall Study|Protocol Violation|0
2442539|NCT02939079|8395929|P1|Overall Study|Protocol Violation|1
2442540|NCT02939079|8395928|P2|Overall Study|Lost to Follow-up|2
2442541|NCT02939079|8395929|P1|Overall Study|Lost to Follow-up|0
2442542|NCT02939079|8395928|P2|Overall Study|Adverse Event|1
2442543|NCT02939079|8395929|P1|Overall Study|Adverse Event|2
2442544|NCT02939014|8395959|P2|Overall Study|In Overall Survival Follow-up|4
2442545|NCT02939014|8395960|P1|Overall Study|In Overall Survival Follow-up|22
2442546|NCT02939014|8395959|P2|Overall Study|In Progression-Free Survival Follow-up|2
2442547|NCT02939014|8395960|P1|Overall Study|In Progression-Free Survival Follow-up|5
2442548|NCT02939014|8395959|P2|Overall Study|Death|3
2442549|NCT02939014|8395960|P1|Overall Study|Death|3
2442550|NCT02938585|8396004|P4|Overall Study|Withdrawal by Subject|5
2442551|NCT02938585|8396005|P3|Overall Study|Withdrawal by Subject|0
2442552|NCT02938585|8396006|P2|Overall Study|Withdrawal by Subject|0
2442553|NCT02938585|8396007|P1|Overall Study|Withdrawal by Subject|0
2442554|NCT02938585|8396004|P4|Overall Study|Withdrawal by parent or guardian|0
2442555|NCT02938585|8396005|P3|Overall Study|Withdrawal by parent or guardian|0
2442556|NCT02938585|8396006|P2|Overall Study|Withdrawal by parent or guardian|1
2442557|NCT02938585|8396007|P1|Overall Study|Withdrawal by parent or guardian|0
2442558|NCT02938520|8396171|P2|Overall Study|Adverse Event|4
2442559|NCT02938520|8396172|P1|Overall Study|Adverse Event|9
2442560|NCT02938520|8396171|P2|Overall Study|Lack of Efficacy|3
2442561|NCT02938520|8396172|P1|Overall Study|Lack of Efficacy|5
2442562|NCT02938520|8396171|P2|Overall Study|Protocol Violation|1
2442563|NCT02938520|8396172|P1|Overall Study|Protocol Violation|0
2442564|NCT02938520|8396171|P2|Overall Study|Withdrawal by Subject|7
2442565|NCT02938520|8396172|P1|Overall Study|Withdrawal by Subject|7
2442566|NCT02938520|8396171|P2|Overall Study|Lost to Follow-up|2
2442567|NCT02938520|8396172|P1|Overall Study|Lost to Follow-up|2
2442568|NCT02938520|8396171|P2|Overall Study|Physician Decision|5
2442569|NCT02938520|8396172|P1|Overall Study|Physician Decision|2
2442570|NCT02938520|8396171|P2|Overall Study|On-going at the time of analysis|261
2442571|NCT02938520|8396172|P1|Overall Study|On-going at the time of analysis|258
2442572|NCT02937870|8396317|P1|Overall Study|Protocol Deviation|2
2442573|NCT02937870|8396317|P1|Overall Study|Adverse Event|1
2442574|NCT02937740|8396348|P2|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1
2442575|NCT02937740|8396349|P1|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0
2442576|NCT02937740|8396348|P2|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1
2442577|NCT02937740|8396349|P1|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0
2442578|NCT02937740|8396348|P2|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0
2442579|NCT02937740|8396349|P1|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1
2442580|NCT02937740|8396348|P2|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7
2442581|NCT02937740|8396349|P1|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2
2442582|NCT02937740|8396348|P2|BID for 90 Days, 22 mg/Day|Adverse Event|10
2442583|NCT02937740|8396349|P1|BID for 90 Days, 22 mg/Day|Adverse Event|0
2442584|NCT02937740|8396348|P2|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14
2442585|NCT02937740|8396349|P1|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3
2442586|NCT02937701|8396365|P5|Week 22 to Week 50|Other|1
2442587|NCT02937701|8396366|P4|Week 22 to Week 50|Other|0
2442588|NCT02937701|8396367|P3|Week 22 to Week 50|Other|0
2442589|NCT02937701|8396368|P2|Week 22 to Week 50|Other|0
2442590|NCT02937701|8396369|P1|Week 22 to Week 50|Other|0
2442591|NCT02937701|8396365|P5|Week 22 to Week 50|Physician Decision|1
2442592|NCT02937701|8396366|P4|Week 22 to Week 50|Physician Decision|0
2442593|NCT02937701|8396367|P3|Week 22 to Week 50|Physician Decision|2
2442594|NCT02937701|8396368|P2|Week 22 to Week 50|Physician Decision|0
2442595|NCT02937701|8396369|P1|Week 22 to Week 50|Physician Decision|0
2442596|NCT02937701|8396365|P5|Week 22 to Week 50|Lost to Follow-up|1
2442597|NCT02937701|8396366|P4|Week 22 to Week 50|Lost to Follow-up|0
2442598|NCT02937701|8396367|P3|Week 22 to Week 50|Lost to Follow-up|2
2442599|NCT02937701|8396368|P2|Week 22 to Week 50|Lost to Follow-up|0
2442600|NCT02937701|8396369|P1|Week 22 to Week 50|Lost to Follow-up|0
2442601|NCT02937701|8396365|P5|Week 22 to Week 50|Withdrawal by Subject|1
2442602|NCT02937701|8396366|P4|Week 22 to Week 50|Withdrawal by Subject|2
2442603|NCT02937701|8396367|P3|Week 22 to Week 50|Withdrawal by Subject|8
2442604|NCT02937701|8396368|P2|Week 22 to Week 50|Withdrawal by Subject|0
2442605|NCT02937701|8396369|P1|Week 22 to Week 50|Withdrawal by Subject|0
2442606|NCT02937701|8396365|P5|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2
2442607|NCT02937701|8396366|P4|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3
2442608|NCT02937701|8396367|P3|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10
2442609|NCT02937701|8396368|P2|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0
2442610|NCT02937701|8396369|P1|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0
2442611|NCT02937701|8396365|P5|Week 22 to Week 50|Adverse Event|3
2442612|NCT02937701|8396366|P4|Week 22 to Week 50|Adverse Event|3
2442613|NCT02937701|8396367|P3|Week 22 to Week 50|Adverse Event|10
2442614|NCT02937701|8396368|P2|Week 22 to Week 50|Adverse Event|0
2442615|NCT02937701|8396369|P1|Week 22 to Week 50|Adverse Event|0
2442616|NCT02937701|8396365|P5|Day 1 to Week 22|Other|0
2442617|NCT02937701|8396366|P4|Day 1 to Week 22|Other|0
2442618|NCT02937701|8396367|P3|Day 1 to Week 22|Other|0
2442619|NCT02937701|8396368|P2|Day 1 to Week 22|Other|0
2442620|NCT02937701|8396369|P1|Day 1 to Week 22|Other|1
2442621|NCT02937701|8396365|P5|Day 1 to Week 22|Physician Decision|0
2442622|NCT02937701|8396366|P4|Day 1 to Week 22|Physician Decision|0
2442623|NCT02937701|8396367|P3|Day 1 to Week 22|Physician Decision|0
2442624|NCT02937701|8396368|P2|Day 1 to Week 22|Physician Decision|0
2442625|NCT02937701|8396369|P1|Day 1 to Week 22|Physician Decision|2
2442626|NCT02937701|8396365|P5|Day 1 to Week 22|Lost to Follow-up|0
2442627|NCT02937701|8396366|P4|Day 1 to Week 22|Lost to Follow-up|0
2442628|NCT02937701|8396367|P3|Day 1 to Week 22|Lost to Follow-up|0
2442629|NCT02937701|8396368|P2|Day 1 to Week 22|Lost to Follow-up|1
2442630|NCT02937701|8396369|P1|Day 1 to Week 22|Lost to Follow-up|1
2442631|NCT02937701|8396365|P5|Day 1 to Week 22|Protocol Violation|0
2442632|NCT02937701|8396366|P4|Day 1 to Week 22|Protocol Violation|0
2442633|NCT02937701|8396367|P3|Day 1 to Week 22|Protocol Violation|0
2442634|NCT02937701|8396368|P2|Day 1 to Week 22|Protocol Violation|1
2442635|NCT02937701|8396369|P1|Day 1 to Week 22|Protocol Violation|1
2442636|NCT02937701|8396365|P5|Day 1 to Week 22|Death|0
2442637|NCT02937701|8396366|P4|Day 1 to Week 22|Death|0
2442638|NCT02937701|8396367|P3|Day 1 to Week 22|Death|0
2442639|NCT02937701|8396368|P2|Day 1 to Week 22|Death|1
2442640|NCT02937701|8396369|P1|Day 1 to Week 22|Death|1
2442641|NCT02937701|8396365|P5|Day 1 to Week 22|Withdrawal by Subject|0
2442642|NCT02937701|8396366|P4|Day 1 to Week 22|Withdrawal by Subject|0
2442643|NCT02937701|8396367|P3|Day 1 to Week 22|Withdrawal by Subject|0
2442644|NCT02937701|8396368|P2|Day 1 to Week 22|Withdrawal by Subject|6
2442645|NCT02937701|8396369|P1|Day 1 to Week 22|Withdrawal by Subject|6
2442646|NCT02937701|8396365|P5|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
2442647|NCT02937701|8396366|P4|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
2442648|NCT02937701|8396367|P3|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
2442649|NCT02937701|8396368|P2|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9
2442650|NCT02937701|8396369|P1|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5
2442651|NCT02937701|8396365|P5|Day 1 to Week 22|Protocol Specified Criteria|0
2442652|NCT02937701|8396366|P4|Day 1 to Week 22|Protocol Specified Criteria|0
2442653|NCT02937701|8396367|P3|Day 1 to Week 22|Protocol Specified Criteria|0
2442654|NCT02937701|8396368|P2|Day 1 to Week 22|Protocol Specified Criteria|7
2442655|NCT02937701|8396369|P1|Day 1 to Week 22|Protocol Specified Criteria|7
2442656|NCT02937701|8396365|P5|Day 1 to Week 22|Adverse Event|0
2442657|NCT02937701|8396366|P4|Day 1 to Week 22|Adverse Event|0
2442658|NCT02937701|8396367|P3|Day 1 to Week 22|Adverse Event|0
2442659|NCT02937701|8396368|P2|Day 1 to Week 22|Adverse Event|14
2442660|NCT02937701|8396369|P1|Day 1 to Week 22|Adverse Event|11
2442661|NCT02937636|8396400|P2|Overall Study|Other (Not specified)|2
2442662|NCT02937636|8396401|P1|Overall Study|Other (Not specified)|3
2442663|NCT02937584|8396428|P2|Washout|Adverse Event|1
2442664|NCT02937584|8396429|P1|Washout|Adverse Event|0
2442665|NCT02937584|8396428|P2|Period 1|Adverse Event|2
2442666|NCT02937584|8396429|P1|Period 1|Adverse Event|1
2442667|NCT02936869|8396492|P2|Overall Study|Protocol Violation|0
2442668|NCT02936869|8396493|P1|Overall Study|Protocol Violation|1
2442669|NCT02936869|8396492|P2|Overall Study|Legal Case|1
2442670|NCT02936869|8396493|P1|Overall Study|Legal Case|0
2442671|NCT02936869|8396492|P2|Overall Study|Death|1
2442672|NCT02936869|8396493|P1|Overall Study|Death|0
2442673|NCT02936869|8396492|P2|Overall Study|Lost to Follow-up|3
2442674|NCT02936869|8396493|P1|Overall Study|Lost to Follow-up|1
2442675|NCT02935894|8396524|P1|Overall Study|Subject dismissed|1
2442676|NCT02935673|8396553|P3|Overall Study|Withdrawal by Subject|0
2442677|NCT02935673|8396554|P2|Overall Study|Withdrawal by Subject|2
2442678|NCT02935673|8396555|P1|Overall Study|Withdrawal by Subject|1
2442679|NCT02935673|8396553|P3|Overall Study|Adverse Event|0
2442680|NCT02935673|8396554|P2|Overall Study|Adverse Event|1
2442681|NCT02935673|8396555|P1|Overall Study|Adverse Event|0
2442682|NCT02935192|8396689|P2|Overall Study|Withdrawal by Subject|4
2442683|NCT02935192|8396690|P1|Overall Study|Withdrawal by Subject|8
2442684|NCT02934178|8396807|P2|Received Vaccination 3|Withdrawal by Subject|0
2442685|NCT02934178|8396808|P1|Received Vaccination 3|Withdrawal by Subject|1
2442686|NCT02934178|8396807|P2|Received Vaccination 2|Death|1
2442687|NCT02934178|8396808|P1|Received Vaccination 2|Death|0
2442688|NCT02933528|8396948|P1|Overall Study|Lost to Follow-up|2
2442689|NCT02933060|8396976|P2|Overall Study|Withdrawal by Subject|1
2442690|NCT02933060|8396977|P1|Overall Study|Withdrawal by Subject|0
2442691|NCT02932943|8397018|P2|Overall Study|Withdrawal by Subject|3
2442692|NCT02932943|8397019|P1|Overall Study|Withdrawal by Subject|3
2442693|NCT02932943|8397018|P2|Overall Study|Adverse Event|2
2442694|NCT02932943|8397019|P1|Overall Study|Adverse Event|2
2442695|NCT02932943|8397018|P2|Overall Study|Lost to Follow-up|2
2442696|NCT02932943|8397019|P1|Overall Study|Lost to Follow-up|0
2442697|NCT02932904|8397035|P4|Overall Study|Randomized But Not Treated|2
2442698|NCT02932904|8397036|P3|Overall Study|Randomized But Not Treated|0
2442699|NCT02932904|8397037|P2|Overall Study|Randomized But Not Treated|1
2442700|NCT02932904|8397038|P1|Overall Study|Randomized But Not Treated|1
2442701|NCT02932904|8397035|P4|Overall Study|Pretreatment Event/Adverse Event|3
2442702|NCT02932904|8397036|P3|Overall Study|Pretreatment Event/Adverse Event|1
2442703|NCT02932904|8397037|P2|Overall Study|Pretreatment Event/Adverse Event|5
2442704|NCT02932904|8397038|P1|Overall Study|Pretreatment Event/Adverse Event|3
2442705|NCT02932904|8397035|P4|Overall Study|Significant Protocol Deviation|1
2442706|NCT02932904|8397036|P3|Overall Study|Significant Protocol Deviation|6
2442707|NCT02932904|8397037|P2|Overall Study|Significant Protocol Deviation|3
2442708|NCT02932904|8397038|P1|Overall Study|Significant Protocol Deviation|2
2442709|NCT02932904|8397035|P4|Overall Study|Lost to Follow-up|0
2442710|NCT02932904|8397036|P3|Overall Study|Lost to Follow-up|6
2442711|NCT02932904|8397037|P2|Overall Study|Lost to Follow-up|3
2442712|NCT02932904|8397038|P1|Overall Study|Lost to Follow-up|5
2442713|NCT02932904|8397035|P4|Overall Study|Voluntary Withdrawal|2
2442714|NCT02932904|8397036|P3|Overall Study|Voluntary Withdrawal|4
2442715|NCT02932904|8397037|P2|Overall Study|Voluntary Withdrawal|1
2442716|NCT02932904|8397038|P1|Overall Study|Voluntary Withdrawal|2
2442717|NCT02932904|8397035|P4|Overall Study|Study Termination|0
2442718|NCT02932904|8397036|P3|Overall Study|Study Termination|0
2442719|NCT02932904|8397037|P2|Overall Study|Study Termination|1
2442720|NCT02932904|8397038|P1|Overall Study|Study Termination|0
2442721|NCT02932904|8397035|P4|Overall Study|Pregnancy|0
2442722|NCT02932904|8397036|P3|Overall Study|Pregnancy|1
2442723|NCT02932904|8397037|P2|Overall Study|Pregnancy|1
2442724|NCT02932904|8397038|P1|Overall Study|Pregnancy|0
2442725|NCT02932904|8397035|P4|Overall Study|Noncompliance with Study Drug|4
2442726|NCT02932904|8397036|P3|Overall Study|Noncompliance with Study Drug|3
2442727|NCT02932904|8397037|P2|Overall Study|Noncompliance with Study Drug|3
2442728|NCT02932904|8397038|P1|Overall Study|Noncompliance with Study Drug|2
2442729|NCT02932904|8397035|P4|Overall Study|Reason not Specified|2
2442730|NCT02932904|8397036|P3|Overall Study|Reason not Specified|2
2442731|NCT02932904|8397037|P2|Overall Study|Reason not Specified|0
2442732|NCT02932904|8397038|P1|Overall Study|Reason not Specified|1
2442733|NCT02932891|8397073|P1|Overall Study|HPA Suppress|2
2442734|NCT02932891|8397073|P1|Overall Study|Lost to Follow-up|2
2442735|NCT02932878|8397079|P2|Overall Study|Due to Lab Results|1
2442736|NCT02932878|8397080|P1|Overall Study|Due to Lab Results|2
2442737|NCT02932462|8397101|P2|Overall Study|Progressive Disease|0
2442738|NCT02932462|8397102|P1|Overall Study|Progressive Disease|1
2442739|NCT02932462|8397101|P2|Overall Study|Non-Compliance With Study Drug|1
2442740|NCT02932462|8397102|P1|Overall Study|Non-Compliance With Study Drug|0
2442741|NCT02932462|8397101|P2|Overall Study|Withdrawal by Subject|4
2442742|NCT02932462|8397102|P1|Overall Study|Withdrawal by Subject|1
2442743|NCT02932462|8397101|P2|Overall Study|Protocol Violation|5
2442744|NCT02932462|8397102|P1|Overall Study|Protocol Violation|0
2442745|NCT02932462|8397101|P2|Overall Study|Lost to Follow-up|1
2442746|NCT02932462|8397102|P1|Overall Study|Lost to Follow-up|4
2442747|NCT02932462|8397101|P2|Overall Study|Adverse Event|2
2442748|NCT02932462|8397102|P1|Overall Study|Adverse Event|1
2442749|NCT02932306|8397114|P2|Overall Study|Withdrew due to burning,itching,stinging|0
2442750|NCT02932306|8397115|P1|Overall Study|Withdrew due to burning,itching,stinging|1
2442751|NCT02932306|8397114|P2|Overall Study|Worsening condition|0
2442752|NCT02932306|8397115|P1|Overall Study|Worsening condition|2
2442753|NCT02932306|8397114|P2|Overall Study|Lack of Efficacy|2
2442754|NCT02932306|8397115|P1|Overall Study|Lack of Efficacy|0
2442755|NCT02932306|8397114|P2|Overall Study|Withdrawal by Parent or Guardian|8
2442756|NCT02932306|8397115|P1|Overall Study|Withdrawal by Parent or Guardian|6
2442757|NCT02932306|8397114|P2|Overall Study|Lost to Follow-up|40
2442758|NCT02932306|8397115|P1|Overall Study|Lost to Follow-up|36
2442759|NCT02932306|8397114|P2|Overall Study|Noncompliance with Study Drug|1
2442760|NCT02932306|8397115|P1|Overall Study|Noncompliance with Study Drug|1
2442761|NCT02932306|8397114|P2|Overall Study|Protocol Violation|1
2442762|NCT02932306|8397115|P1|Overall Study|Protocol Violation|1
2442763|NCT02932306|8397114|P2|Overall Study|Pregnancy|0
2442764|NCT02932306|8397115|P1|Overall Study|Pregnancy|2
2442765|NCT02932306|8397114|P2|Overall Study|Adverse Event|0
2442766|NCT02932306|8397115|P1|Overall Study|Adverse Event|3
2442767|NCT02932306|8397114|P2|Overall Study|Withdrawal by Subject|25
2442768|NCT02932306|8397115|P1|Overall Study|Withdrawal by Subject|16
2442769|NCT02932267|8397129|P1|Overall Study|Pregnancy|1
2442770|NCT02932267|8397129|P1|Overall Study|Lost to Follow-up|4
2442771|NCT02932267|8397129|P1|Overall Study|Withdrawal by Subject|3
2442772|NCT02932228|8397135|P2|Overall Study|not eligible upon chart review|5
2442773|NCT02932228|8397136|P1|Overall Study|not eligible upon chart review|2
2442774|NCT02932228|8397135|P2|Overall Study|Death|23
2442775|NCT02932228|8397136|P1|Overall Study|Death|8
2442776|NCT02931396|8397157|P2|Overall Study|Withdrawal by Subject|0
2442777|NCT02931396|8397158|P1|Overall Study|Withdrawal by Subject|2
2442778|NCT02931396|8397157|P2|Overall Study|Lost to Follow-up|0
2442779|NCT02931396|8397158|P1|Overall Study|Lost to Follow-up|3
2442780|NCT02930837|8397172|P1|Overall Study|Withdrawal by Subject|1
2442781|NCT02930837|8397172|P1|Overall Study|Lost to Follow-up|5
2442782|NCT02930837|8397172|P1|Overall Study|Adverse Event|6
2442783|NCT02930226|8397468|P6|Overall Study|Technical Problems: Leak in plasma bag|0
2442784|NCT02930226|8397469|P5|Overall Study|Technical Problems: Leak in plasma bag|1
2442785|NCT02930226|8397470|P4|Overall Study|Technical Problems: Leak in plasma bag|0
2442786|NCT02930226|8397471|P3|Overall Study|Technical Problems: Leak in plasma bag|0
2442787|NCT02930226|8397472|P2|Overall Study|Technical Problems: Leak in plasma bag|0
2442788|NCT02930226|8397473|P1|Overall Study|Technical Problems: Leak in plasma bag|0
2442789|NCT02930005|8397527|P2|Overall Study|Lost to Follow-up|5
2442790|NCT02930005|8397528|P1|Overall Study|Lost to Follow-up|1
2442791|NCT02929498|8397552|P3|Part 1: Dose Confirmation (Upto 2 Years)|Death|0
2442792|NCT02929498|8397553|P2|Part 1: Dose Confirmation (Upto 2 Years)|Death|0
2442793|NCT02929498|8397554|P1|Part 1: Dose Confirmation (Upto 2 Years)|Death|2
2442794|NCT02929498|8397552|P3|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0
2442795|NCT02929498|8397553|P2|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0
2442796|NCT02929498|8397554|P1|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3
2442797|NCT02929407|8397648|P1|Overall Study|Adverse Event|1
2442798|NCT02928770|8397663|P1|Overall Study|Withdrawal by Subject|2
2442799|NCT02928029|8397701|P2|Overall Study|AE not related to clinical progression|1
2442800|NCT02928029|8397702|P1|Overall Study|AE not related to clinical progression|1
2442801|NCT02928029|8397701|P2|Overall Study|Clinical progression|2
2442802|NCT02928029|8397702|P1|Overall Study|Clinical progression|1
2442803|NCT02928029|8397701|P2|Overall Study|Radiological progression|0
2442804|NCT02928029|8397702|P1|Overall Study|Radiological progression|1
2442805|NCT02928029|8397701|P2|Overall Study|Withdrawal by Subject|1
2442806|NCT02928029|8397702|P1|Overall Study|Withdrawal by Subject|0
2442807|NCT02927938|8397716|P4|Overall Study|Early Study Termination|3
2442808|NCT02927938|8397717|P3|Overall Study|Early Study Termination|4
2442809|NCT02927938|8397718|P2|Overall Study|Early Study Termination|5
2442810|NCT02927938|8397719|P1|Overall Study|Early Study Termination|1
2442811|NCT02927938|8397716|P4|Overall Study|Death|4
2442812|NCT02927938|8397717|P3|Overall Study|Death|0
2442813|NCT02927938|8397718|P2|Overall Study|Death|1
2442814|NCT02927938|8397719|P1|Overall Study|Death|0
2442815|NCT02927795|8397727|P1|Overall Study|Not Treated|4
2442816|NCT02927795|8397727|P1|Overall Study|Non-evaluable PF10 quest. at visit 2|19
2442817|NCT02927431|8397774|P3|Overall Study|Withdrawal by Subject|1
2442818|NCT02927431|8397775|P2|Overall Study|Withdrawal by Subject|0
2442819|NCT02927431|8397776|P1|Overall Study|Withdrawal by Subject|0
2442820|NCT02927366|8397854|P2|Overall Study|Patient schedule|0
2442821|NCT02927366|8397855|P1|Overall Study|Patient schedule|1
2442822|NCT02927366|8397854|P2|Overall Study|Adverse Event|0
2442823|NCT02927366|8397855|P1|Overall Study|Adverse Event|1
2442824|NCT02927171|8397910|P2|Overall Study|Lost to Follow-up|1
2442825|NCT02927171|8397911|P1|Overall Study|Lost to Follow-up|0
2442826|NCT02926638|8397923|P2|Overall Study|Not protocol specified|0
2442827|NCT02926638|8397924|P1|Overall Study|Not protocol specified|1
2442828|NCT02926638|8397923|P2|Overall Study|Ineligible|0
2442829|NCT02926638|8397924|P1|Overall Study|Ineligible|1
2442830|NCT02926638|8397923|P2|Overall Study|Progression|5
2442831|NCT02926638|8397924|P1|Overall Study|Progression|2
2442832|NCT02926573|8397938|P2|Overall Study|Delirium|1
2442833|NCT02926573|8397939|P1|Overall Study|Delirium|0
2442834|NCT02926573|8397938|P2|Overall Study|Return to operating room|2
2442835|NCT02926573|8397939|P1|Overall Study|Return to operating room|0
2442836|NCT02926573|8397938|P2|Overall Study|Withdrawal by Subject|2
2442837|NCT02926573|8397939|P1|Overall Study|Withdrawal by Subject|0
2442838|NCT02926573|8397938|P2|Overall Study|Change to outpatient status|1
2442839|NCT02926573|8397939|P1|Overall Study|Change to outpatient status|5
2442840|NCT02926573|8397938|P2|Overall Study|Change in surgery plan|1
2442841|NCT02926573|8397939|P1|Overall Study|Change in surgery plan|3
2442842|NCT02926573|8397938|P2|Overall Study|Remain intubated|2
2442843|NCT02926573|8397939|P1|Overall Study|Remain intubated|2
2442844|NCT02926573|8397938|P2|Overall Study|Nausea|0
2442845|NCT02926573|8397939|P1|Overall Study|Nausea|1
2442846|NCT02926209|8397957|P2|Study Cohort|Poor Bowel Preparation|0
2442847|NCT02926209|8397958|P1|Study Cohort|Poor Bowel Preparation|1
2442848|NCT02925403|8398030|P2|Overall Study|Lost to Follow-up|1
2442849|NCT02925403|8398031|P1|Overall Study|Lost to Follow-up|0
2442850|NCT02924883|8398045|P2|Overall Study|Ongoing in Study|115
2442851|NCT02924883|8398046|P1|Overall Study|Ongoing in Study|56
2442852|NCT02924883|8398045|P2|Overall Study|Death|13
2442853|NCT02924883|8398046|P1|Overall Study|Death|8
2442854|NCT02924883|8398045|P2|Overall Study|Protocol Violation|1
2442855|NCT02924883|8398046|P1|Overall Study|Protocol Violation|0
2442856|NCT02924883|8398045|P2|Overall Study|Withdrawal by Subject|4
2442857|NCT02924883|8398046|P1|Overall Study|Withdrawal by Subject|5
2442858|NCT02924688|8398071|P6|Overall Study|Withdrawal by Subject|14
2442859|NCT02924688|8398072|P5|Overall Study|Withdrawal by Subject|13
2442860|NCT02924688|8398073|P4|Overall Study|Withdrawal by Subject|12
2442861|NCT02924688|8398074|P3|Overall Study|Withdrawal by Subject|9
2442862|NCT02924688|8398075|P2|Overall Study|Withdrawal by Subject|13
2442863|NCT02924688|8398076|P1|Overall Study|Withdrawal by Subject|14
2442864|NCT02924688|8398071|P6|Overall Study|Physician Decision|1
2442865|NCT02924688|8398072|P5|Overall Study|Physician Decision|1
2442866|NCT02924688|8398073|P4|Overall Study|Physician Decision|1
2442867|NCT02924688|8398074|P3|Overall Study|Physician Decision|0
2442868|NCT02924688|8398075|P2|Overall Study|Physician Decision|1
2442869|NCT02924688|8398076|P1|Overall Study|Physician Decision|2
2442870|NCT02924688|8398071|P6|Overall Study|Lost to Follow-up|4
2442871|NCT02924688|8398072|P5|Overall Study|Lost to Follow-up|2
2442872|NCT02924688|8398073|P4|Overall Study|Lost to Follow-up|4
2442873|NCT02924688|8398074|P3|Overall Study|Lost to Follow-up|2
2442874|NCT02924688|8398075|P2|Overall Study|Lost to Follow-up|4
2442875|NCT02924688|8398076|P1|Overall Study|Lost to Follow-up|2
2442876|NCT02924688|8398071|P6|Overall Study|Protocol defined withdrawal criteria met|0
2442877|NCT02924688|8398072|P5|Overall Study|Protocol defined withdrawal criteria met|1
2442878|NCT02924688|8398073|P4|Overall Study|Protocol defined withdrawal criteria met|1
2442879|NCT02924688|8398074|P3|Overall Study|Protocol defined withdrawal criteria met|1
2442880|NCT02924688|8398075|P2|Overall Study|Protocol defined withdrawal criteria met|0
2442881|NCT02924688|8398076|P1|Overall Study|Protocol defined withdrawal criteria met|1
2442882|NCT02924688|8398071|P6|Overall Study|Protocol Violation|2
2442883|NCT02924688|8398072|P5|Overall Study|Protocol Violation|2
2442884|NCT02924688|8398073|P4|Overall Study|Protocol Violation|6
2442885|NCT02924688|8398074|P3|Overall Study|Protocol Violation|5
2442886|NCT02924688|8398075|P2|Overall Study|Protocol Violation|7
2442887|NCT02924688|8398076|P1|Overall Study|Protocol Violation|3
2442888|NCT02924688|8398071|P6|Overall Study|Lack of Efficacy|1
2442889|NCT02924688|8398072|P5|Overall Study|Lack of Efficacy|1
2442890|NCT02924688|8398073|P4|Overall Study|Lack of Efficacy|2
2442891|NCT02924688|8398074|P3|Overall Study|Lack of Efficacy|4
2442892|NCT02924688|8398075|P2|Overall Study|Lack of Efficacy|3
2442893|NCT02924688|8398076|P1|Overall Study|Lack of Efficacy|2
2442894|NCT02924688|8398071|P6|Overall Study|Adverse Event|2
2442895|NCT02924688|8398072|P5|Overall Study|Adverse Event|3
2442896|NCT02924688|8398073|P4|Overall Study|Adverse Event|2
2442897|NCT02924688|8398074|P3|Overall Study|Adverse Event|2
2442898|NCT02924688|8398075|P2|Overall Study|Adverse Event|3
2442899|NCT02924688|8398076|P1|Overall Study|Adverse Event|9
2442900|NCT02924051|8398159|P2|Overall Study|Withdrawal by Subject|9
2442901|NCT02924051|8398160|P1|Overall Study|Withdrawal by Subject|1
2442902|NCT02923830|8398187|P2|Overall Study|Physician Decision|15
2442903|NCT02923830|8398188|P1|Overall Study|Physician Decision|13
2442904|NCT02923245|8398219|P2|Overall Study|ultrasound order was cancelled|1
2442905|NCT02923245|8398220|P1|Overall Study|ultrasound order was cancelled|2
2442906|NCT02921425|8398342|P1|Overall Study|Protocol Violation|9
2442907|NCT02921087|8398414|P2|Overall Study|Withdrawal by Subject|1
2442908|NCT02921087|8398415|P1|Overall Study|Withdrawal by Subject|0
2442909|NCT02920983|8398444|P6|Dispense 3|Unacceptable Lens Fit|0
2442910|NCT02920983|8398445|P5|Dispense 3|Unacceptable Lens Fit|1
2442911|NCT02920983|8398446|P4|Dispense 3|Unacceptable Lens Fit|0
2442912|NCT02920983|8398447|P3|Dispense 3|Unacceptable Lens Fit|0
2442913|NCT02920983|8398448|P2|Dispense 3|Unacceptable Lens Fit|1
2442914|NCT02920983|8398449|P1|Dispense 3|Unacceptable Lens Fit|1
2442915|NCT02920983|8398444|P6|Dispense 2|Unscceptable lens fit|0
2442916|NCT02920983|8398445|P5|Dispense 2|Unscceptable lens fit|1
2442917|NCT02920983|8398446|P4|Dispense 2|Unscceptable lens fit|0
2442918|NCT02920983|8398447|P3|Dispense 2|Unscceptable lens fit|0
2442919|NCT02920983|8398448|P2|Dispense 2|Unscceptable lens fit|0
2442920|NCT02920983|8398449|P1|Dispense 2|Unscceptable lens fit|1
2442921|NCT02920983|8398444|P6|Dispense 1|Unacceptable Lens Fit|0
2442922|NCT02920983|8398445|P5|Dispense 1|Unacceptable Lens Fit|1
2442923|NCT02920983|8398446|P4|Dispense 1|Unacceptable Lens Fit|0
2442924|NCT02920983|8398447|P3|Dispense 1|Unacceptable Lens Fit|0
2442925|NCT02920983|8398448|P2|Dispense 1|Unacceptable Lens Fit|0
2442926|NCT02920983|8398449|P1|Dispense 1|Unacceptable Lens Fit|0
2442927|NCT02920970|8398478|P2|Second Intervention|Poor Lens Fit|0
2442928|NCT02920970|8398479|P1|Second Intervention|Poor Lens Fit|1
2442929|NCT02920970|8398478|P2|First Intervention|Adverse Event|1
2442930|NCT02920970|8398479|P1|First Intervention|Adverse Event|0
2442931|NCT02920970|8398478|P2|First Intervention|Protocol Violation|1
2442932|NCT02920970|8398479|P1|First Intervention|Protocol Violation|0
2442933|NCT02920957|8398505|P2|Second Intervention: 1 Month|Lost to Follow-up|1
2442934|NCT02920957|8398506|P1|Second Intervention: 1 Month|Lost to Follow-up|0
2442935|NCT02920957|8398505|P2|First Intervention : 1 Month|Adverse Event|0
2442936|NCT02920957|8398506|P1|First Intervention : 1 Month|Adverse Event|1
2442937|NCT02920957|8398505|P2|First Intervention : 1 Month|Lost to Follow-up|0
2442938|NCT02920957|8398506|P1|First Intervention : 1 Month|Lost to Follow-up|1
2442939|NCT02920957|8398505|P2|First Intervention : 1 Month|Withdrawal by Subject|0
2442940|NCT02920957|8398506|P1|First Intervention : 1 Month|Withdrawal by Subject|2
2442941|NCT02920450|8398595|P4|Overall Study|Withdrawal by Subject|0
2442942|NCT02920450|8398596|P3|Overall Study|Withdrawal by Subject|0
2442943|NCT02920450|8398597|P2|Overall Study|Withdrawal by Subject|0
2442944|NCT02920450|8398598|P1|Overall Study|Withdrawal by Subject|1
2442945|NCT02920450|8398595|P4|Overall Study|Death|0
2442946|NCT02920450|8398596|P3|Overall Study|Death|0
2442947|NCT02920450|8398597|P2|Overall Study|Death|0
2442948|NCT02920450|8398598|P1|Overall Study|Death|1
2442949|NCT02920242|8398609|P3|Overall Study|Did not meet inc./exc. criteria|0
2442950|NCT02920242|8398610|P2|Overall Study|Did not meet inc./exc. criteria|0
2442951|NCT02920242|8398611|P1|Overall Study|Did not meet inc./exc. criteria|1
2442952|NCT02920242|8398609|P3|Overall Study|Withdrawal by Subject|1
2442953|NCT02920242|8398610|P2|Overall Study|Withdrawal by Subject|0
2442954|NCT02920242|8398611|P1|Overall Study|Withdrawal by Subject|1
2442955|NCT02920177|8398639|P2|Overall Study|Lost to Follow-up|1
2442956|NCT02920177|8398640|P1|Overall Study|Lost to Follow-up|0
2442957|NCT02920177|8398639|P2|Overall Study|Physician Decision|0
2442958|NCT02920177|8398640|P1|Overall Study|Physician Decision|1
2442959|NCT02920177|8398639|P2|Overall Study|Withdrawal by Subject|1
2442960|NCT02920177|8398640|P1|Overall Study|Withdrawal by Subject|1
2442961|NCT02919995|8398660|P6|Overall Study|Adverse Event|1
2442962|NCT02919995|8398661|P5|Overall Study|Adverse Event|0
2442963|NCT02919995|8398662|P4|Overall Study|Adverse Event|0
2442964|NCT02919995|8398663|P3|Overall Study|Adverse Event|0
2442965|NCT02919995|8398664|P2|Overall Study|Adverse Event|0
2442966|NCT02919995|8398665|P1|Overall Study|Adverse Event|0
2442967|NCT02919761|8398711|P3|Part 2: Double-blind|Discontinued exclusion 16|2
2442968|NCT02919761|8398712|P2|Part 2: Double-blind|Discontinued exclusion 16|0
2442969|NCT02919761|8398713|P1|Part 2: Double-blind|Discontinued exclusion 16|0
2442970|NCT02919761|8398711|P3|Part 2: Double-blind|Did not meet LDA at Week 20|1
2442971|NCT02919761|8398712|P2|Part 2: Double-blind|Did not meet LDA at Week 20|0
2442972|NCT02919761|8398713|P1|Part 2: Double-blind|Did not meet LDA at Week 20|0
2442973|NCT02919761|8398711|P3|Part 2: Double-blind|Did not meet LDA at Week 16|1
2442974|NCT02919761|8398712|P2|Part 2: Double-blind|Did not meet LDA at Week 16|0
2442975|NCT02919761|8398713|P1|Part 2: Double-blind|Did not meet LDA at Week 16|0
2442976|NCT02919761|8398711|P3|Part 2: Double-blind|Worsening of disease activity|10
2442977|NCT02919761|8398712|P2|Part 2: Double-blind|Worsening of disease activity|4
2442978|NCT02919761|8398713|P1|Part 2: Double-blind|Worsening of disease activity|0
2442979|NCT02919761|8398711|P3|Part 2: Double-blind|Met withdrawal criteria|2
2442980|NCT02919761|8398712|P2|Part 2: Double-blind|Met withdrawal criteria|1
2442981|NCT02919761|8398713|P1|Part 2: Double-blind|Met withdrawal criteria|0
2442982|NCT02919761|8398711|P3|Part 2: Double-blind|Lost to Follow-up|3
2442983|NCT02919761|8398712|P2|Part 2: Double-blind|Lost to Follow-up|0
2442984|NCT02919761|8398713|P1|Part 2: Double-blind|Lost to Follow-up|0
2442985|NCT02919761|8398711|P3|Part 2: Double-blind|Adverse Event|0
2442986|NCT02919761|8398712|P2|Part 2: Double-blind|Adverse Event|1
2442987|NCT02919761|8398713|P1|Part 2: Double-blind|Adverse Event|0
2442988|NCT02919761|8398711|P3|Part 2: Double-blind|Withdrawal by Subject|2
2442989|NCT02919761|8398712|P2|Part 2: Double-blind|Withdrawal by Subject|0
2442990|NCT02919761|8398713|P1|Part 2: Double-blind|Withdrawal by Subject|0
2442991|NCT02919761|8398711|P3|Part 1: Open Label|Termination by Sponsor|0
2442992|NCT02919761|8398712|P2|Part 1: Open Label|Termination by Sponsor|0
2442993|NCT02919761|8398713|P1|Part 1: Open Label|Termination by Sponsor|1
2442994|NCT02919761|8398711|P3|Part 1: Open Label|did not meet inclusion criteria 8|0
2442995|NCT02919761|8398712|P2|Part 1: Open Label|did not meet inclusion criteria 8|0
2442996|NCT02919761|8398713|P1|Part 1: Open Label|did not meet inclusion criteria 8|1
2442997|NCT02919761|8398711|P3|Part 1: Open Label|Dose Greater Than 20mg/Week|0
2442998|NCT02919761|8398712|P2|Part 1: Open Label|Dose Greater Than 20mg/Week|0
2442999|NCT02919761|8398713|P1|Part 1: Open Label|Dose Greater Than 20mg/Week|1
2443000|NCT02919761|8398711|P3|Part 1: Open Label|Did Not Achieve Lda At Week 12|0
2443001|NCT02919761|8398712|P2|Part 1: Open Label|Did Not Achieve Lda At Week 12|0
2443002|NCT02919761|8398713|P1|Part 1: Open Label|Did Not Achieve Lda At Week 12|2
2443003|NCT02919761|8398711|P3|Part 1: Open Label|Met withdrawal criteria|0
2443004|NCT02919761|8398712|P2|Part 1: Open Label|Met withdrawal criteria|0
2443005|NCT02919761|8398713|P1|Part 1: Open Label|Met withdrawal criteria|5
2443006|NCT02919761|8398711|P3|Part 1: Open Label|Lost to Follow-up|0
2443007|NCT02919761|8398712|P2|Part 1: Open Label|Lost to Follow-up|0
2443008|NCT02919761|8398713|P1|Part 1: Open Label|Lost to Follow-up|1
2443009|NCT02919761|8398711|P3|Part 1: Open Label|Adverse Event|0
2443010|NCT02919761|8398712|P2|Part 1: Open Label|Adverse Event|0
2443011|NCT02919761|8398713|P1|Part 1: Open Label|Adverse Event|1
2443012|NCT02919761|8398711|P3|Part 1: Open Label|Withdrawal by Subject|0
2443013|NCT02919761|8398712|P2|Part 1: Open Label|Withdrawal by Subject|0
2443014|NCT02919761|8398713|P1|Part 1: Open Label|Withdrawal by Subject|12
2443015|NCT02919618|8398746|P1|Overall Study|Death|1
2443016|NCT02919267|8398776|P4|Overall Study|Protocol Violation|4
2443017|NCT02919267|8398777|P3|Overall Study|Protocol Violation|3
2443018|NCT02919267|8398778|P2|Overall Study|Protocol Violation|3
2443019|NCT02919267|8398779|P1|Overall Study|Protocol Violation|0
2443020|NCT02918552|8398919|P2|Overall Study|Lost to Follow-up|1
2443021|NCT02918552|8398920|P1|Overall Study|Lost to Follow-up|0
2443022|NCT02918552|8398919|P2|Overall Study|Withdrawal by Subject|1
2443023|NCT02918552|8398920|P1|Overall Study|Withdrawal by Subject|0
2443024|NCT02918552|8398919|P2|Overall Study|Failed Pharmacokinetics|0
2443025|NCT02918552|8398920|P1|Overall Study|Failed Pharmacokinetics|1
2443026|NCT02918279|8398994|P2|Overall Study|Other|1
2443027|NCT02918279|8398995|P1|Overall Study|Other|3
2443028|NCT02918279|8398994|P2|Overall Study|Withdrawal by parent/guardian|1
2443029|NCT02918279|8398995|P1|Overall Study|Withdrawal by parent/guardian|2
2443030|NCT02918279|8398994|P2|Overall Study|Withdrawal by Subject|15
2443031|NCT02918279|8398995|P1|Overall Study|Withdrawal by Subject|5
2443032|NCT02918279|8398994|P2|Overall Study|Lost to Follow-up|6
2443033|NCT02918279|8398995|P1|Overall Study|Lost to Follow-up|3
2443034|NCT02918266|8399131|P11|Part 2: Intervention Period 1 (2 Days)|Study termination|1
2443035|NCT02918266|8399132|P10|Part 2: Intervention Period 1 (2 Days)|Study termination|1
2443036|NCT02918266|8399133|P9|Part 2: Intervention Period 1 (2 Days)|Study termination|2
2443037|NCT02918266|8399134|P8|Part 2: Intervention Period 1 (2 Days)|Study termination|1
2443038|NCT02918266|8399135|P7|Part 2: Intervention Period 1 (2 Days)|Study termination|2
2443039|NCT02918266|8399136|P6|Part 2: Intervention Period 1 (2 Days)|Study termination|1
2443040|NCT02918266|8399137|P5|Part 2: Intervention Period 1 (2 Days)|Study termination|1
2443041|NCT02918266|8399138|P4|Part 2: Intervention Period 1 (2 Days)|Study termination|1
2443042|NCT02918266|8399139|P3|Part 2: Intervention Period 1 (2 Days)|Study termination|1
2443043|NCT02918266|8399140|P2|Part 2: Intervention Period 1 (2 Days)|Study termination|1
2443044|NCT02918266|8399141|P1|Part 2: Intervention Period 1 (2 Days)|Study termination|0
2443045|NCT02918071|8399240|P1|Overall Study|Lost to Follow-up|1
2443046|NCT02918071|8399240|P1|Overall Study|Withdrawal by Subject|2
2443047|NCT02917265|8399278|P2|Overall Study|Withdrawal by Subject|0
2443048|NCT02917265|8399279|P1|Overall Study|Withdrawal by Subject|1
2443049|NCT02917265|8399278|P2|Overall Study|Physician Decision|0
2443050|NCT02917265|8399279|P1|Overall Study|Physician Decision|1
2443051|NCT02916927|8399295|P2|Overall Study|Withdrawal before first time point|0
2443052|NCT02916927|8399296|P1|Overall Study|Withdrawal before first time point|1
2443053|NCT02916927|8399295|P2|Overall Study|At radiology for 45 & 60 min time points|1
2443054|NCT02916927|8399296|P1|Overall Study|At radiology for 45 & 60 min time points|0
2443055|NCT02916927|8399295|P2|Overall Study|Discharged prior to study drug receipt|2
2443056|NCT02916927|8399296|P1|Overall Study|Discharged prior to study drug receipt|0
2443057|NCT02915978|8399363|P3|Overall Study|Adverse Event|0
2443058|NCT02915978|8399364|P2|Overall Study|Adverse Event|1
2443059|NCT02915978|8399365|P1|Overall Study|Adverse Event|2
2443060|NCT02915874|8399417|P2|Overall Study|Started New Anxiety Medication|1
2443061|NCT02915874|8399418|P1|Overall Study|Started New Anxiety Medication|0
2443062|NCT02915874|8399417|P2|Overall Study|Withdrawal by Subject|1
2443063|NCT02915874|8399418|P1|Overall Study|Withdrawal by Subject|1
2443064|NCT02915874|8399417|P2|Overall Study|Lost to Follow-up|4
2443065|NCT02915874|8399418|P1|Overall Study|Lost to Follow-up|5
2443066|NCT02915835|8399438|P2|Overall Study|Withdrawal by Subject|1
2443067|NCT02915835|8399439|P1|Overall Study|Withdrawal by Subject|0
2443068|NCT02915835|8399438|P2|Overall Study|Physician Decision|0
2443069|NCT02915835|8399439|P1|Overall Study|Physician Decision|1
2443070|NCT02915302|8399639|P2|Overall Study|Other|0
2443071|NCT02915302|8399640|P1|Overall Study|Other|1
2443072|NCT02915302|8399639|P2|Overall Study|Withdrawal by Subject|29
2443073|NCT02915302|8399640|P1|Overall Study|Withdrawal by Subject|22
2443074|NCT02915302|8399639|P2|Overall Study|Lost to Follow-up|22
2443075|NCT02915302|8399640|P1|Overall Study|Lost to Follow-up|19
2443076|NCT02915302|8399639|P2|Overall Study|Protocol Violation|27
2443077|NCT02915302|8399640|P1|Overall Study|Protocol Violation|20
2443078|NCT02915302|8399639|P2|Overall Study|Adverse Event|0
2443079|NCT02915302|8399640|P1|Overall Study|Adverse Event|3
2443080|NCT02915159|8399652|P2|Overall Study|Lack of Efficacy|3
2443081|NCT02915159|8399653|P1|Overall Study|Lack of Efficacy|0
2443082|NCT02915159|8399652|P2|Overall Study|Adverse Event|2
2443083|NCT02915159|8399653|P1|Overall Study|Adverse Event|2
2443084|NCT02915159|8399652|P2|Overall Study|Request to discontinue treatment|2
2443085|NCT02915159|8399653|P1|Overall Study|Request to discontinue treatment|1
2443086|NCT02915159|8399652|P2|Overall Study|Participant withdrew consent|1
2443087|NCT02915159|8399653|P1|Overall Study|Participant withdrew consent|5
2443088|NCT02915159|8399652|P2|Overall Study|poor/non-compliance|0
2443089|NCT02915159|8399653|P1|Overall Study|poor/non-compliance|1
2443090|NCT02915159|8399652|P2|Overall Study|Participant no longer meets criteria|0
2443091|NCT02915159|8399653|P1|Overall Study|Participant no longer meets criteria|2
2443092|NCT02914275|8399782|P2|Overall Study|Excluded due to invalid informed consent|0
2443093|NCT02914275|8399783|P1|Overall Study|Excluded due to invalid informed consent|3
2443094|NCT02914275|8399782|P2|Overall Study|Other|1
2443095|NCT02914275|8399783|P1|Overall Study|Other|4
2443096|NCT02914275|8399782|P2|Overall Study|Physician Decision|1
2443097|NCT02914275|8399783|P1|Overall Study|Physician Decision|3
2443098|NCT02914275|8399782|P2|Overall Study|Protocol Violation|1
2443099|NCT02914275|8399783|P1|Overall Study|Protocol Violation|1
2443100|NCT02914275|8399782|P2|Overall Study|Withdrawal by Subject|10
2443101|NCT02914275|8399783|P1|Overall Study|Withdrawal by Subject|26
2443102|NCT02914275|8399782|P2|Overall Study|Lost to Follow-up|29
2443103|NCT02914275|8399783|P1|Overall Study|Lost to Follow-up|84
2443104|NCT02914236|8399815|P1|Overall Study|Lost to Follow-up|1
2443105|NCT02914184|8399861|P4|Overall Study|Migrated/moved from the study area|1
2443106|NCT02914184|8399862|P3|Overall Study|Migrated/moved from the study area|2
2443107|NCT02914184|8399863|P2|Overall Study|Migrated/moved from the study area|1
2443108|NCT02914184|8399864|P1|Overall Study|Migrated/moved from the study area|2
2443109|NCT02914184|8399861|P4|Overall Study|Other|0
2443110|NCT02914184|8399862|P3|Overall Study|Other|0
2443111|NCT02914184|8399863|P2|Overall Study|Other|0
2443112|NCT02914184|8399864|P1|Overall Study|Other|1
2443113|NCT02914184|8399861|P4|Overall Study|Withdrawal by Subject|3
2443114|NCT02914184|8399862|P3|Overall Study|Withdrawal by Subject|7
2443115|NCT02914184|8399863|P2|Overall Study|Withdrawal by Subject|2
2443116|NCT02914184|8399864|P1|Overall Study|Withdrawal by Subject|4
2443117|NCT02914184|8399861|P4|Overall Study|Lost to Follow-up|7
2443118|NCT02914184|8399862|P3|Overall Study|Lost to Follow-up|8
2443119|NCT02914184|8399863|P2|Overall Study|Lost to Follow-up|10
2443120|NCT02914184|8399864|P1|Overall Study|Lost to Follow-up|7
2443121|NCT02913326|8399921|P2|Overall Study|Adverse Event|0
2443122|NCT02913326|8399922|P1|Overall Study|Adverse Event|1
2443123|NCT02913326|8399921|P2|Overall Study|Lost to Follow-up|1
2443124|NCT02913326|8399922|P1|Overall Study|Lost to Follow-up|0
2443125|NCT02913326|8399921|P2|Overall Study|Reason not listed|1
2443126|NCT02913326|8399922|P1|Overall Study|Reason not listed|0
2443127|NCT02913105|8399945|P3|Overall Study|Withdrawal by Subject|1
2443128|NCT02913105|8399946|P2|Overall Study|Withdrawal by Subject|3
2443129|NCT02913105|8399947|P1|Overall Study|Withdrawal by Subject|0
2443130|NCT02913105|8399945|P3|Overall Study|Physician Decision|0
2443131|NCT02913105|8399946|P2|Overall Study|Physician Decision|1
2443132|NCT02913105|8399947|P1|Overall Study|Physician Decision|1
2443133|NCT02913105|8399945|P3|Overall Study|Reason Not Specified|1
2443134|NCT02913105|8399946|P2|Overall Study|Reason Not Specified|1
2443135|NCT02913105|8399947|P1|Overall Study|Reason Not Specified|3
2443136|NCT02913105|8399945|P3|Overall Study|Non-Compliance With Study Drug|1
2443137|NCT02913105|8399946|P2|Overall Study|Non-Compliance With Study Drug|0
2443138|NCT02913105|8399947|P1|Overall Study|Non-Compliance With Study Drug|0
2443139|NCT02913105|8399945|P3|Overall Study|Adverse Event|4
2443140|NCT02913105|8399946|P2|Overall Study|Adverse Event|0
2443141|NCT02913105|8399947|P1|Overall Study|Adverse Event|11
2443142|NCT02912650|8400000|P4|Overall Study|Adverse Event|0
2443143|NCT02912650|8400001|P3|Overall Study|Adverse Event|1
2443144|NCT02912650|8400002|P2|Overall Study|Adverse Event|0
2443145|NCT02912650|8400003|P1|Overall Study|Adverse Event|0
2443146|NCT02912650|8400000|P4|Overall Study|Withdrawal by Subject|5
2443147|NCT02912650|8400001|P3|Overall Study|Withdrawal by Subject|1
2443148|NCT02912650|8400002|P2|Overall Study|Withdrawal by Subject|0
2443149|NCT02912650|8400003|P1|Overall Study|Withdrawal by Subject|1
2443150|NCT02912468|8400087|P2|Overall Study|Randomized and not treated|1
2443151|NCT02912468|8400088|P1|Overall Study|Randomized and not treated|0
2443152|NCT02912468|8400087|P2|Overall Study|Withdrawal by Subject|2
2443153|NCT02912468|8400088|P1|Overall Study|Withdrawal by Subject|6
2443154|NCT02912468|8400087|P2|Overall Study|Adverse Event|2
2443155|NCT02912468|8400088|P1|Overall Study|Adverse Event|3
2443156|NCT02911948|8400222|P2|Overall Study|Unclassified|3
2443157|NCT02911948|8400223|P1|Overall Study|Unclassified|0
2443158|NCT02911948|8400222|P2|Overall Study|Lack of Efficacy|1
2443159|NCT02911948|8400223|P1|Overall Study|Lack of Efficacy|0
2443160|NCT02911948|8400222|P2|Overall Study|Withdrawal by Subject|2
2443161|NCT02911948|8400223|P1|Overall Study|Withdrawal by Subject|0
2443162|NCT02911948|8400222|P2|Overall Study|Protocol Violation|1
2443163|NCT02911948|8400223|P1|Overall Study|Protocol Violation|0
2443164|NCT02911688|8400485|P2|Washout|Withdrawal by Subject|1
2443165|NCT02911688|8400486|P1|Washout|Withdrawal by Subject|0
2443166|NCT02911688|8400485|P2|Washout|Lost to Follow-up|1
2443167|NCT02911688|8400486|P1|Washout|Lost to Follow-up|1
2443168|NCT02910739|8400520|P4|Overall Study|Adverse Event|0
2443169|NCT02910739|8400521|P3|Overall Study|Adverse Event|0
2443170|NCT02910739|8400522|P2|Overall Study|Adverse Event|0
2443171|NCT02910739|8400523|P1|Overall Study|Adverse Event|1
2443172|NCT02910713|8400549|P1|Overall Study|Investigator Discretion|1
2443173|NCT02910713|8400549|P1|Overall Study|Enrollment cap|7
2443174|NCT02910713|8400549|P1|Overall Study|Received Neither Application|18
2443175|NCT02910713|8400549|P1|Overall Study|Received One Application|10
2443176|NCT02910713|8400549|P1|Overall Study|Subject Choice|4
2443177|NCT02910713|8400549|P1|Overall Study|Protocol Violation|2
2443178|NCT02910167|8400565|P1|Overall Study|Lost to Follow-up|18
2443179|NCT02910167|8400565|P1|Overall Study|Adverse Event|1
2443180|NCT02910089|8400590|P2|Overall Study|Lost insurance eligibility|16
2443181|NCT02910089|8400591|P1|Overall Study|Lost insurance eligibility|22
2443182|NCT02910011|8400603|P1|Overall Study|Physician Decision|2
2443183|NCT02909907|8400611|P2|Overall Study|Withdrawal by Subject|1
2443184|NCT02909907|8400612|P1|Overall Study|Withdrawal by Subject|0
2443185|NCT02909153|8400658|P5|Overall Study|Withdrawal by Subject|0
2443186|NCT02909153|8400659|P4|Overall Study|Withdrawal by Subject|0
2443187|NCT02909153|8400660|P3|Overall Study|Withdrawal by Subject|0
2443188|NCT02909153|8400661|P2|Overall Study|Withdrawal by Subject|1
2443189|NCT02909153|8400662|P1|Overall Study|Withdrawal by Subject|0
2443190|NCT02909101|8400752|P2|Overall Study|Lost to Follow-up|1
2443191|NCT02909101|8400753|P1|Overall Study|Lost to Follow-up|1
2443192|NCT02908880|8400771|P1|Overall Study|Death|5
2443193|NCT02908880|8400771|P1|Overall Study|Withdrawal by Subject|17
2443194|NCT02908880|8400771|P1|Overall Study|Explantation of the device|1
2443195|NCT02908880|8400771|P1|Overall Study|Lost to Follow-up|4
2443196|NCT02908529|8400820|P2|Overall Study|Lost to Follow-up|2
2443197|NCT02908529|8400821|P1|Overall Study|Lost to Follow-up|0
2443198|NCT02908516|8400831|P2|Overall Study|Study Terminated|3
2443199|NCT02908516|8400832|P1|Overall Study|Study Terminated|3
2443200|NCT02908347|8400848|P2|Overall Study|Lost to Follow-up|0
2443201|NCT02908347|8400849|P1|Overall Study|Lost to Follow-up|1
2443202|NCT02908347|8400848|P2|Overall Study|Adverse Event|1
2443203|NCT02908347|8400849|P1|Overall Study|Adverse Event|0
2443204|NCT02907892|8400944|P2|Overall Study|Lost to Follow-up|40
2443205|NCT02907892|8400945|P1|Overall Study|Lost to Follow-up|27
2443206|NCT02907619|8400965|P3|Overall Study|Other|0
2443207|NCT02907619|8400966|P2|Overall Study|Other|1
2443208|NCT02907619|8400967|P1|Overall Study|Other|0
2443209|NCT02907619|8400965|P3|Overall Study|Withdrawal by Subject|0
2443210|NCT02907619|8400966|P2|Overall Study|Withdrawal by Subject|1
2443211|NCT02907619|8400967|P1|Overall Study|Withdrawal by Subject|1
2443212|NCT02907619|8400965|P3|Overall Study|Death|1
2443213|NCT02907619|8400966|P2|Overall Study|Death|0
2443214|NCT02907619|8400967|P1|Overall Study|Death|0
2443215|NCT02907619|8400965|P3|Overall Study|Study terminated by sponsor|19
2443216|NCT02907619|8400966|P2|Overall Study|Study terminated by sponsor|18
2443217|NCT02907619|8400967|P1|Overall Study|Study terminated by sponsor|18
2443218|NCT02907463|8401183|P1|Overall Study|Missing Exit Form|1
2443219|NCT02907463|8401183|P1|Overall Study|Device Explanted|1
2443220|NCT02907463|8401183|P1|Overall Study|Not Implanted with Study Device|2
2443221|NCT02907463|8401183|P1|Overall Study|MIS Approach was not used|2
2443222|NCT02907463|8401183|P1|Overall Study|Withdrawal by Subject|4
2443223|NCT02907463|8401183|P1|Overall Study|Death|10
2443224|NCT02907463|8401183|P1|Overall Study|Lost to Follow-up|17
2443225|NCT02907216|8401265|P2|Overall Study|Withdrawal by Subject|0
2443226|NCT02907216|8401266|P1|Overall Study|Withdrawal by Subject|1
2443227|NCT02907216|8401265|P2|Overall Study|No benefit to be obtained by continuing|1
2443228|NCT02907216|8401266|P1|Overall Study|No benefit to be obtained by continuing|0
2443229|NCT02906930|8401318|P4|Overall Study|Other|2
2443230|NCT02906930|8401319|P3|Overall Study|Other|1
2443231|NCT02906930|8401320|P2|Overall Study|Other|2
2443232|NCT02906930|8401321|P1|Overall Study|Other|1
2443233|NCT02906930|8401318|P4|Overall Study|Death|0
2443234|NCT02906930|8401319|P3|Overall Study|Death|1
2443235|NCT02906930|8401320|P2|Overall Study|Death|0
2443236|NCT02906930|8401321|P1|Overall Study|Death|0
2443237|NCT02906930|8401318|P4|Overall Study|Lost to Follow-up|2
2443238|NCT02906930|8401319|P3|Overall Study|Lost to Follow-up|5
2443239|NCT02906930|8401320|P2|Overall Study|Lost to Follow-up|7
2443240|NCT02906930|8401321|P1|Overall Study|Lost to Follow-up|5
2443241|NCT02906930|8401318|P4|Overall Study|Withdrawal by Subject|4
2443242|NCT02906930|8401319|P3|Overall Study|Withdrawal by Subject|5
2443243|NCT02906930|8401320|P2|Overall Study|Withdrawal by Subject|5
2443244|NCT02906930|8401321|P1|Overall Study|Withdrawal by Subject|0
2443245|NCT02906917|8401514|P2|Intensification Period (Week 26-38)|Withdrawal by Subject|2
2443246|NCT02906917|8401515|P1|Intensification Period (Week 26-38)|Withdrawal by Subject|3
2443247|NCT02906917|8401514|P2|Intensification Period (Week 26-38)|Lost to Follow-up|1
2443248|NCT02906917|8401515|P1|Intensification Period (Week 26-38)|Lost to Follow-up|3
2443249|NCT02906917|8401514|P2|Intensification Period (Week 26-38)|Adverse Event|2
2443250|NCT02906917|8401515|P1|Intensification Period (Week 26-38)|Adverse Event|0
2443251|NCT02906917|8401514|P2|Intensification Period (Week 26-38)|Unclassified|2
2443252|NCT02906917|8401515|P1|Intensification Period (Week 26-38)|Unclassified|3
2443253|NCT02906917|8401514|P2|Initiation Period (Week 0-26)|Withdrawal by Subject|4
2443254|NCT02906917|8401515|P1|Initiation Period (Week 0-26)|Withdrawal by Subject|3
2443255|NCT02906917|8401514|P2|Initiation Period (Week 0-26)|Lost to Follow-up|4
2443256|NCT02906917|8401515|P1|Initiation Period (Week 0-26)|Lost to Follow-up|1
2443257|NCT02906917|8401514|P2|Initiation Period (Week 0-26)|Adverse Event|0
2443258|NCT02906917|8401515|P1|Initiation Period (Week 0-26)|Adverse Event|1
2443259|NCT02906917|8401514|P2|Initiation Period (Week 0-26)|Unclassified|3
2443260|NCT02906917|8401515|P1|Initiation Period (Week 0-26)|Unclassified|1
2443261|NCT02906709|8401576|P2|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0
2443262|NCT02906709|8401577|P1|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2
2443263|NCT02906709|8401576|P2|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0
2443264|NCT02906709|8401577|P1|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3
2443265|NCT02906709|8401576|P2|Phase A (Week 0 to Week 16)|Death|1
2443266|NCT02906709|8401577|P1|Phase A (Week 0 to Week 16)|Death|0
2443267|NCT02906709|8401576|P2|Phase A (Week 0 to Week 16)|Adverse Event|2
2443268|NCT02906709|8401577|P1|Phase A (Week 0 to Week 16)|Adverse Event|1
2443269|NCT02906644|8401623|P2|Weeks 3 to 14|Lost to Follow-up|4
2443270|NCT02906644|8401624|P1|Weeks 3 to 14|Lost to Follow-up|3
2443271|NCT02906644|8401623|P2|Weeks 3 to 14|Withdrawal by Subject|7
2443272|NCT02906644|8401624|P1|Weeks 3 to 14|Withdrawal by Subject|13
2443273|NCT02906644|8401623|P2|First 2 Weeks|Physician Decision|1
2443274|NCT02906644|8401624|P1|First 2 Weeks|Physician Decision|1
2443275|NCT02906644|8401623|P2|First 2 Weeks|Withdrawal by Subject|2
2443276|NCT02906644|8401624|P1|First 2 Weeks|Withdrawal by Subject|0
2443277|NCT02906579|8401640|P1|Overall Study|Physician Decision|1
2443278|NCT02906579|8401640|P1|Overall Study|Adverse Event|1
2443279|NCT02906358|8401844|P2|Overall Study|Lost to Follow-up|15
2443280|NCT02906358|8401845|P1|Overall Study|Lost to Follow-up|12
2443281|NCT02906358|8401844|P2|Overall Study|Withdrawal by Subject|7
2443282|NCT02906358|8401845|P1|Overall Study|Withdrawal by Subject|10
2443283|NCT02905825|8401873|P1|Overall Study|Device Malfunction|1
2443284|NCT02905825|8401873|P1|Overall Study|Protocol Violation|11
2443285|NCT02905331|8401881|P3|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
2443286|NCT02905331|8401882|P2|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2
2443287|NCT02905331|8401883|P1|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
2443288|NCT02905331|8401881|P3|Active Treatment and Follow up (wk16-40)|Other|0
2443289|NCT02905331|8401882|P2|Active Treatment and Follow up (wk16-40)|Other|6
2443290|NCT02905331|8401883|P1|Active Treatment and Follow up (wk16-40)|Other|0
2443291|NCT02905331|8401881|P3|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
2443292|NCT02905331|8401882|P2|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1
2443293|NCT02905331|8401883|P1|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
2443294|NCT02905331|8401881|P3|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
2443295|NCT02905331|8401882|P2|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
2443296|NCT02905331|8401883|P1|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2
2443297|NCT02905331|8401881|P3|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
2443298|NCT02905331|8401882|P2|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
2443299|NCT02905331|8401883|P1|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1
2443300|NCT02905266|8401911|P2|Maintenance Phase Part 2|Not Reported|17
2443301|NCT02905266|8401912|P1|Maintenance Phase Part 2|Not Reported|10
2443302|NCT02905266|8401911|P2|Maintenance Phase Part 2|Maximum Clinical Benefit|1
2443303|NCT02905266|8401912|P1|Maintenance Phase Part 2|Maximum Clinical Benefit|0
2443304|NCT02905266|8401911|P2|Maintenance Phase Part 2|Study Drug Toxicity|2
2443305|NCT02905266|8401912|P1|Maintenance Phase Part 2|Study Drug Toxicity|1
2443306|NCT02905266|8401911|P2|Maintenance Phase Part 2|Disease Progression|2
2443307|NCT02905266|8401912|P1|Maintenance Phase Part 2|Disease Progression|8
2443308|NCT02905266|8401911|P2|Treatment Period Part 1|Maximum Clinical Benefit|1
2443309|NCT02905266|8401912|P1|Treatment Period Part 1|Maximum Clinical Benefit|0
2443310|NCT02905266|8401911|P2|Treatment Period Part 1|Study Drug Toxicity|15
2443311|NCT02905266|8401912|P1|Treatment Period Part 1|Study Drug Toxicity|22
2443312|NCT02905266|8401911|P2|Treatment Period Part 1|Disease Progression|7
2443313|NCT02905266|8401912|P1|Treatment Period Part 1|Disease Progression|6
2443314|NCT02905266|8401911|P2|Treatment Period Part 1|Subject Withdrew Consent|0
2443315|NCT02905266|8401912|P1|Treatment Period Part 1|Subject Withdrew Consent|1
2443316|NCT02905149|8401934|P2|Overall Study|Lost to Follow-up|0
2443317|NCT02905149|8401935|P1|Overall Study|Lost to Follow-up|2
2443318|NCT02904902|8401960|P1|Overall Study|Withdrawal by Subject|1
2443319|NCT02904096|8401973|P2|Overall Study|Sponsor instructed|0
2443320|NCT02904096|8401974|P1|Overall Study|Sponsor instructed|1
2443321|NCT02904096|8401973|P2|Overall Study|Non-compliant|1
2443322|NCT02904096|8401974|P1|Overall Study|Non-compliant|3
2443323|NCT02904096|8401973|P2|Overall Study|Lost to Follow-up|17
2443324|NCT02904096|8401974|P1|Overall Study|Lost to Follow-up|10
2443325|NCT02904096|8401973|P2|Overall Study|Withdrawal by Subject|3
2443326|NCT02904096|8401974|P1|Overall Study|Withdrawal by Subject|4
2443327|NCT02904096|8401973|P2|Overall Study|Adverse Event|0
2443328|NCT02904096|8401974|P1|Overall Study|Adverse Event|1
2443329|NCT02903238|8402027|P1|Overall Study|Lost to Follow-up|4
2443330|NCT02903030|8402038|P2|First Intervention (8 Weeks)|Withdrawal by Subject|1
2443331|NCT02903030|8402039|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
2443332|NCT02902965|8402057|P1|Overall Study|Withdrawal by Subject|10
2443333|NCT02902809|8402075|P1|Overall Study|Discontinuation of asthma program|28
2443334|NCT02901054|8402143|P1|Overall Study|Withdrawal by Subject|3
2443335|NCT02901054|8402143|P1|Overall Study|Physician Decision|1
2443336|NCT02900378|8402158|P2|Randomization (Visit 2)|Withdrawal of Informed Consent|2
2443337|NCT02900378|8402159|P1|Randomization (Visit 2)|Withdrawal of Informed Consent|0
2443338|NCT02900378|8402158|P2|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3
2443339|NCT02900378|8402159|P1|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5
2443340|NCT02900378|8402158|P2|Randomization (Visit 2)|Protocol Deviation|7
2443341|NCT02900378|8402159|P1|Randomization (Visit 2)|Protocol Deviation|1
2443342|NCT02900378|8402158|P2|Randomization (Visit 2)|Non-compliance with Study Drug|1
2443343|NCT02900378|8402159|P1|Randomization (Visit 2)|Non-compliance with Study Drug|1
2443344|NCT02900378|8402158|P2|Randomization (Visit 2)|Lost to Follow-up|0
2443345|NCT02900378|8402159|P1|Randomization (Visit 2)|Lost to Follow-up|1
2443346|NCT02900378|8402158|P2|Randomization (Visit 2)|Death|4
2443347|NCT02900378|8402159|P1|Randomization (Visit 2)|Death|1
2443348|NCT02900378|8402158|P2|Randomization (Visit 2)|Adverse Event|11
2443349|NCT02900378|8402159|P1|Randomization (Visit 2)|Adverse Event|14
2443350|NCT02900092|8402203|P1|Overall Study|Adverse Event|1
2443351|NCT02899377|8402221|P2|Overall Study|Adverse Event|0
2443352|NCT02899377|8402222|P1|Overall Study|Adverse Event|1
2443353|NCT02899338|8402255|P2|Overall Study|Withdrawal by Subject|0
2443354|NCT02899338|8402256|P1|Overall Study|Withdrawal by Subject|2
2443355|NCT02899338|8402255|P2|Overall Study|Adverse Event|2
2443356|NCT02899338|8402256|P1|Overall Study|Adverse Event|1
2443357|NCT02898662|8402292|P2|Overall Study|Other|1
2443358|NCT02898662|8402293|P1|Overall Study|Other|0
2443359|NCT02898662|8402292|P2|Overall Study|Subject decision|0
2443360|NCT02898662|8402293|P1|Overall Study|Subject decision|1
2443361|NCT02898662|8402292|P2|Overall Study|Randomized in error|1
2443362|NCT02898662|8402293|P1|Overall Study|Randomized in error|0
2443363|NCT02898662|8402292|P2|Overall Study|Technical issue|1
2443364|NCT02898662|8402293|P1|Overall Study|Technical issue|0
2443365|NCT02898662|8402292|P2|Overall Study|Withdrawal by Subject|1
2443366|NCT02898662|8402293|P1|Overall Study|Withdrawal by Subject|4
2443367|NCT02898662|8402292|P2|Overall Study|Loss of asthma control|24
2443368|NCT02898662|8402293|P1|Overall Study|Loss of asthma control|23
2443369|NCT02898662|8402292|P2|Overall Study|Adverse Event|0
2443370|NCT02898662|8402293|P1|Overall Study|Adverse Event|1
2443371|NCT02898597|8402317|P2|Overall Study|Death|1
2443372|NCT02898597|8402318|P1|Overall Study|Death|0
2443373|NCT02898597|8402317|P2|Overall Study|Lost to Follow-up|9
2443374|NCT02898597|8402318|P1|Overall Study|Lost to Follow-up|0
2443375|NCT02898597|8402317|P2|Overall Study|Protocol Violation|2
2443376|NCT02898597|8402318|P1|Overall Study|Protocol Violation|4
2443377|NCT02898454|8402327|P3|Overall Study|Did Not Met Eligibility Criteria|0
2443378|NCT02898454|8402328|P2|Overall Study|Did Not Met Eligibility Criteria|0
2443379|NCT02898454|8402329|P1|Overall Study|Did Not Met Eligibility Criteria|1
2443380|NCT02898454|8402327|P3|Overall Study|Lost to Follow-up|0
2443381|NCT02898454|8402328|P2|Overall Study|Lost to Follow-up|0
2443382|NCT02898454|8402329|P1|Overall Study|Lost to Follow-up|1
2443383|NCT02898454|8402327|P3|Overall Study|Withdrawal by Subject|3
2443384|NCT02898454|8402328|P2|Overall Study|Withdrawal by Subject|3
2443385|NCT02898454|8402329|P1|Overall Study|Withdrawal by Subject|6
2443386|NCT02898454|8402327|P3|Overall Study|Lack of Efficacy|0
2443387|NCT02898454|8402328|P2|Overall Study|Lack of Efficacy|1
2443388|NCT02898454|8402329|P1|Overall Study|Lack of Efficacy|4
2443389|NCT02898454|8402327|P3|Overall Study|Protocol Violation|1
2443390|NCT02898454|8402328|P2|Overall Study|Protocol Violation|0
2443391|NCT02898454|8402329|P1|Overall Study|Protocol Violation|1
2443392|NCT02898454|8402327|P3|Overall Study|Adverse Event|2
2443393|NCT02898454|8402328|P2|Overall Study|Adverse Event|1
2443394|NCT02898454|8402329|P1|Overall Study|Adverse Event|4
2443395|NCT02898116|8402442|P1|Overall Study|Progressive disease|1
2443396|NCT02898116|8402442|P1|Overall Study|Adverse Event|1
2443397|NCT02897349|8402450|P2|Overall Study|Other than listed above|1
2443398|NCT02897349|8402451|P1|Overall Study|Other than listed above|0
2443399|NCT02897349|8402450|P2|Overall Study|Adverse Event|3
2443400|NCT02897349|8402451|P1|Overall Study|Adverse Event|3
2443401|NCT02897349|8402450|P2|Overall Study|Lost to Follow-up|2
2443402|NCT02897349|8402451|P1|Overall Study|Lost to Follow-up|2
2443403|NCT02897115|8402493|P2|Overall Study|Early termination of study by sponsor|8
2443404|NCT02897115|8402494|P1|Overall Study|Early termination of study by sponsor|11
2443405|NCT02896855|8402571|P2|Overall Study|Withdrawal by Subject|1
2443406|NCT02896855|8402572|P1|Overall Study|Withdrawal by Subject|1
2443407|NCT02896855|8402571|P2|Overall Study|Lost to Follow-up|0
2443408|NCT02896855|8402572|P1|Overall Study|Lost to Follow-up|5
2443409|NCT02896855|8402571|P2|Overall Study|Death|12
2443410|NCT02896855|8402572|P1|Overall Study|Death|13
2443411|NCT02896855|8402571|P2|Overall Study|In Follow-Up|49
2443412|NCT02896855|8402572|P1|Overall Study|In Follow-Up|61
2443413|NCT02896855|8402571|P2|Overall Study|On Study Treatment|60
2443414|NCT02896855|8402572|P1|Overall Study|On Study Treatment|41
2443415|NCT02896361|8402653|P3|Third Intervention (2 Weeks)|emergenge of several new painful regions|0
2443416|NCT02896361|8402654|P2|Third Intervention (2 Weeks)|emergenge of several new painful regions|1
2443417|NCT02896361|8402655|P1|Third Intervention (2 Weeks)|emergenge of several new painful regions|0
2443418|NCT02896361|8402653|P3|Third Intervention (2 Weeks)|Protocol Violation|0
2443419|NCT02896361|8402654|P2|Third Intervention (2 Weeks)|Protocol Violation|0
2443420|NCT02896361|8402655|P1|Third Intervention (2 Weeks)|Protocol Violation|1
2443421|NCT02896296|8402673|P1|Overall Study|Relocation|1
2443422|NCT02896296|8402673|P1|Overall Study|Incarceration|1
2443423|NCT02896296|8402673|P1|Overall Study|Site closing|7
2443424|NCT02896296|8402673|P1|Overall Study|Withdrawal by Subject|10
2443425|NCT02896296|8402673|P1|Overall Study|Physician Decision|2
2443426|NCT02896296|8402673|P1|Overall Study|Pregnancy|1
2443427|NCT02896296|8402673|P1|Overall Study|Lost to Follow-up|19
2443428|NCT02896296|8402673|P1|Overall Study|Adverse Event|1
2443429|NCT02895347|8402681|P2|Overall Study|Withdrawal by Subject|1
2443430|NCT02895347|8402682|P1|Overall Study|Withdrawal by Subject|3
2443431|NCT02895295|8402694|P3|Overall Study|Survey Non-response|92
2443432|NCT02895295|8402695|P2|Overall Study|Survey Non-response|94
2443433|NCT02895295|8402696|P1|Overall Study|Survey Non-response|71
2443434|NCT02894840|8402730|P4|Overall Study|Lost to Follow-up|0
2443435|NCT02894840|8402731|P3|Overall Study|Lost to Follow-up|3
2443436|NCT02894840|8402732|P2|Overall Study|Lost to Follow-up|0
2443437|NCT02894840|8402733|P1|Overall Study|Lost to Follow-up|1
2443438|NCT02892734|8403005|P1|Follow up for 2 Years|Study closed early|1
2443439|NCT02892734|8403005|P1|Follow up for 2 Years|Death|2
2443440|NCT02892734|8403005|P1|Treatment on Study|Progressive Disease|2
2443441|NCT02892513|8403011|P2|Overall Study|Withdrawal by Subject|1
2443442|NCT02892513|8403012|P1|Overall Study|Withdrawal by Subject|0
2443443|NCT02892409|8403020|P2|Overall Study|Withdrawal by Subject|1
2443444|NCT02892409|8403021|P1|Overall Study|Withdrawal by Subject|2
2443445|NCT02892409|8403020|P2|Overall Study|Adverse Event|0
2443446|NCT02892409|8403021|P1|Overall Study|Adverse Event|1
2443447|NCT02892344|8403043|P2|Overall Study|Technical problems|1
2443448|NCT02892344|8403044|P1|Overall Study|Technical problems|0
2443449|NCT02892344|8403043|P2|Overall Study|Subject/guardian decision|4
2443450|NCT02892344|8403044|P1|Overall Study|Subject/guardian decision|0
2443451|NCT02892344|8403043|P2|Overall Study|Physician Decision|2
2443452|NCT02892344|8403044|P1|Overall Study|Physician Decision|0
2443453|NCT02892344|8403043|P2|Overall Study|Non-compliance with study treatment|1
2443454|NCT02892344|8403044|P1|Overall Study|Non-compliance with study treatment|0
2443455|NCT02892344|8403043|P2|Overall Study|Lost to Follow-up|1
2443456|NCT02892344|8403044|P1|Overall Study|Lost to Follow-up|0
2443457|NCT02892344|8403043|P2|Overall Study|Adverse Event|8
2443458|NCT02892344|8403044|P1|Overall Study|Adverse Event|1
2443459|NCT02892344|8403043|P2|Overall Study|Protocol deviation|4
2443460|NCT02892344|8403044|P1|Overall Study|Protocol deviation|3
2443461|NCT02892019|8403093|P2|Overall Study|Adverse Event|1
2443462|NCT02892019|8403094|P1|Overall Study|Adverse Event|1
2443463|NCT02892019|8403093|P2|Overall Study|Withdrawal by Subject|1
2443464|NCT02892019|8403094|P1|Overall Study|Withdrawal by Subject|0
2443465|NCT02892019|8403093|P2|Overall Study|randomized but not treated|1
2443466|NCT02892019|8403094|P1|Overall Study|randomized but not treated|0
2443467|NCT02891200|8403134|P2|Overall Study|Withdrawal by Subject|4
2443468|NCT02891200|8403135|P1|Overall Study|Withdrawal by Subject|1
2443469|NCT02891200|8403134|P2|Overall Study|Death|9
2443470|NCT02891200|8403135|P1|Overall Study|Death|10
2443471|NCT02891200|8403134|P2|Overall Study|Lost to Follow-up|36
2443472|NCT02891200|8403135|P1|Overall Study|Lost to Follow-up|31
2443473|NCT02891174|8403163|P2|Second Intervention (24 Hours)|Protocol Violation|1
2443474|NCT02891174|8403164|P1|Second Intervention (24 Hours)|Protocol Violation|0
2443475|NCT02891174|8403163|P2|Second Intervention (24 Hours)|Withdrew after receiving study drug|1
2443476|NCT02891174|8403164|P1|Second Intervention (24 Hours)|Withdrew after receiving study drug|2
2443477|NCT02891174|8403163|P2|Second Intervention (24 Hours)|Discharged during second intervention|5
2443478|NCT02891174|8403164|P1|Second Intervention (24 Hours)|Discharged during second intervention|3
2443479|NCT02891174|8403163|P2|Second Intervention (24 Hours)|No blood pressure after cross-over|0
2443480|NCT02891174|8403164|P1|Second Intervention (24 Hours)|No blood pressure after cross-over|1
2443481|NCT02891174|8403163|P2|First Intervention (24 Hours)|Withdrew after receiving study drug|6
2443482|NCT02891174|8403164|P1|First Intervention (24 Hours)|Withdrew after receiving study drug|2
2443483|NCT02891174|8403163|P2|First Intervention (24 Hours)|Discharged prior to cross-over|2
2443484|NCT02891174|8403164|P1|First Intervention (24 Hours)|Discharged prior to cross-over|0
2443485|NCT02891174|8403163|P2|First Intervention (24 Hours)|Declined any study medication|5
2443486|NCT02891174|8403164|P1|First Intervention (24 Hours)|Declined any study medication|1
2443487|NCT02891070|8403178|P2|Overall Study|Death|0
2443488|NCT02891070|8403179|P1|Overall Study|Death|3
2443489|NCT02891070|8403178|P2|Overall Study|Withdrawal by Subject|2
2443490|NCT02891070|8403179|P1|Overall Study|Withdrawal by Subject|1
2443491|NCT02891070|8403178|P2|Overall Study|Protocol Violation|1
2443492|NCT02891070|8403179|P1|Overall Study|Protocol Violation|0
2443493|NCT02891070|8403178|P2|Overall Study|Other|0
2443494|NCT02891070|8403179|P1|Overall Study|Other|1
2443495|NCT02891070|8403178|P2|Overall Study|Lost to Follow-up|4
2443496|NCT02891070|8403179|P1|Overall Study|Lost to Follow-up|4
2443497|NCT02891070|8403178|P2|Overall Study|Physician Decision|1
2443498|NCT02891070|8403179|P1|Overall Study|Physician Decision|0
2443499|NCT02891070|8403178|P2|Overall Study|Adverse Event|0
2443500|NCT02891070|8403179|P1|Overall Study|Adverse Event|1
2443501|NCT02890992|8403205|P8|130 Weeks Open-Label Extension Period|Other than specified|0
2443502|NCT02890992|8403206|P7|130 Weeks Open-Label Extension Period|Other than specified|0
2443503|NCT02890992|8403207|P6|130 Weeks Open-Label Extension Period|Other than specified|0
2443504|NCT02890992|8403208|P5|130 Weeks Open-Label Extension Period|Other than specified|0
2443505|NCT02890992|8403209|P4|130 Weeks Open-Label Extension Period|Other than specified|0
2443506|NCT02890992|8403210|P3|130 Weeks Open-Label Extension Period|Other than specified|0
2443507|NCT02890992|8403211|P2|130 Weeks Open-Label Extension Period|Other than specified|2
2443508|NCT02890992|8403212|P1|130 Weeks Open-Label Extension Period|Other than specified|0
2443509|NCT02890992|8403205|P8|130 Weeks Open-Label Extension Period|Included but not treated|1
2443510|NCT02890992|8403206|P7|130 Weeks Open-Label Extension Period|Included but not treated|1
2443511|NCT02890992|8403207|P6|130 Weeks Open-Label Extension Period|Included but not treated|0
2443512|NCT02890992|8403208|P5|130 Weeks Open-Label Extension Period|Included but not treated|0
2443513|NCT02890992|8403209|P4|130 Weeks Open-Label Extension Period|Included but not treated|0
2443514|NCT02890992|8403210|P3|130 Weeks Open-Label Extension Period|Included but not treated|0
2443515|NCT02890992|8403211|P2|130 Weeks Open-Label Extension Period|Included but not treated|0
2443516|NCT02890992|8403212|P1|130 Weeks Open-Label Extension Period|Included but not treated|0
2443517|NCT02890992|8403205|P8|130 Weeks Open-Label Extension Period|Adverse Event|0
2443518|NCT02890992|8403206|P7|130 Weeks Open-Label Extension Period|Adverse Event|0
2443519|NCT02890992|8403207|P6|130 Weeks Open-Label Extension Period|Adverse Event|0
2443520|NCT02890992|8403208|P5|130 Weeks Open-Label Extension Period|Adverse Event|0
2443521|NCT02890992|8403209|P4|130 Weeks Open-Label Extension Period|Adverse Event|0
2443522|NCT02890992|8403210|P3|130 Weeks Open-Label Extension Period|Adverse Event|0
2443523|NCT02890992|8403211|P2|130 Weeks Open-Label Extension Period|Adverse Event|1
2443524|NCT02890992|8403212|P1|130 Weeks Open-Label Extension Period|Adverse Event|0
2443525|NCT02888756|8403423|P3|Analytical Treatment Interruption|Physician Decision|5
2443526|NCT02888756|8403424|P2|Analytical Treatment Interruption|Physician Decision|6
2443527|NCT02888756|8403425|P1|Analytical Treatment Interruption|Physician Decision|10
2443528|NCT02888171|8403468|P2|Overall Study|Adverse Event|1
2443529|NCT02888171|8403469|P1|Overall Study|Adverse Event|0
2443530|NCT02888171|8403468|P2|Overall Study|Withdrawal by Subject|2
2443531|NCT02888171|8403469|P1|Overall Study|Withdrawal by Subject|3
2443532|NCT02888171|8403468|P2|Overall Study|Lost to Follow-up|1
2443533|NCT02888171|8403469|P1|Overall Study|Lost to Follow-up|2
2443534|NCT02888080|8403498|P2|Overall Study|Adverse Event|1
2443535|NCT02888080|8403499|P1|Overall Study|Adverse Event|0
2443536|NCT02888080|8403498|P2|Overall Study|Lack of Efficacy|1
2443537|NCT02888080|8403499|P1|Overall Study|Lack of Efficacy|0
2443538|NCT02888080|8403498|P2|Overall Study|New Therapy for study indication|0
2443539|NCT02888080|8403499|P1|Overall Study|New Therapy for study indication|1
2443540|NCT02888080|8403498|P2|Overall Study|Subject / Guardian decision|3
2443541|NCT02888080|8403499|P1|Overall Study|Subject / Guardian decision|1
2443542|NCT02887989|8403525|P2|Overall Study|Death|0
2443543|NCT02887989|8403526|P1|Overall Study|Death|1
2443544|NCT02887989|8403525|P2|Overall Study|Withdrawal by Subject|11
2443545|NCT02887989|8403526|P1|Overall Study|Withdrawal by Subject|8
2443546|NCT02887183|8403536|P1|Overall Study|Withdrawal by Subject|35
2443547|NCT02887183|8403536|P1|Overall Study|Physician Decision|10
2443548|NCT02887183|8403536|P1|Overall Study|Lost to Follow-up|13
2443549|NCT02887183|8403536|P1|Overall Study|Technical Problems|2
2443550|NCT02887183|8403536|P1|Overall Study|Protocol Violation|6
2443551|NCT02887183|8403536|P1|Overall Study|Pregnancy|1
2443552|NCT02887183|8403536|P1|Overall Study|Death|30
2443553|NCT02887183|8403536|P1|Overall Study|Adverse Event|44
2443554|NCT02886715|8403563|P3|Overall Study|missing|2
2443555|NCT02886715|8403564|P2|Overall Study|missing|2
2443556|NCT02886715|8403565|P1|Overall Study|missing|7
2443557|NCT02886715|8403563|P3|Overall Study|Withdrawal by Subject|5
2443558|NCT02886715|8403564|P2|Overall Study|Withdrawal by Subject|18
2443559|NCT02886715|8403565|P1|Overall Study|Withdrawal by Subject|20
2443560|NCT02886715|8403563|P3|Overall Study|Protocol Violation|1
2443561|NCT02886715|8403564|P2|Overall Study|Protocol Violation|2
2443562|NCT02886715|8403565|P1|Overall Study|Protocol Violation|3
2443563|NCT02886715|8403563|P3|Overall Study|Pregnancy|1
2443564|NCT02886715|8403564|P2|Overall Study|Pregnancy|1
2443565|NCT02886715|8403565|P1|Overall Study|Pregnancy|1
2443566|NCT02886715|8403563|P3|Overall Study|Lost to Follow-up|10
2443567|NCT02886715|8403564|P2|Overall Study|Lost to Follow-up|26
2443568|NCT02886715|8403565|P1|Overall Study|Lost to Follow-up|29
2443569|NCT02886715|8403563|P3|Overall Study|Lack of Efficacy|1
2443570|NCT02886715|8403564|P2|Overall Study|Lack of Efficacy|2
2443571|NCT02886715|8403565|P1|Overall Study|Lack of Efficacy|0
2443572|NCT02886715|8403563|P3|Overall Study|Adverse Event|0
2443573|NCT02886715|8403564|P2|Overall Study|Adverse Event|2
2443574|NCT02886715|8403565|P1|Overall Study|Adverse Event|4
2443575|NCT02886715|8403563|P3|Overall Study|Non-Compliance With Study Drug|0
2443576|NCT02886715|8403564|P2|Overall Study|Non-Compliance With Study Drug|2
2443577|NCT02886715|8403565|P1|Overall Study|Non-Compliance With Study Drug|0
2443578|NCT02886702|8403582|P3|Overall Study|Administrative Reasons|1
2443579|NCT02886702|8403583|P2|Overall Study|Administrative Reasons|0
2443580|NCT02886702|8403584|P1|Overall Study|Administrative Reasons|0
2443581|NCT02886702|8403582|P3|Overall Study|Adverse Event|3
2443582|NCT02886702|8403583|P2|Overall Study|Adverse Event|9
2443583|NCT02886702|8403584|P1|Overall Study|Adverse Event|4
2443584|NCT02886702|8403582|P3|Overall Study|Lack of Efficacy|5
2443585|NCT02886702|8403583|P2|Overall Study|Lack of Efficacy|4
2443586|NCT02886702|8403584|P1|Overall Study|Lack of Efficacy|3
2443587|NCT02886702|8403582|P3|Overall Study|Lost to Follow-up|8
2443588|NCT02886702|8403583|P2|Overall Study|Lost to Follow-up|13
2443589|NCT02886702|8403584|P1|Overall Study|Lost to Follow-up|11
2443590|NCT02886702|8403582|P3|Overall Study|Non-Compliance With Study Drug|4
2443591|NCT02886702|8403583|P2|Overall Study|Non-Compliance With Study Drug|1
2443592|NCT02886702|8403584|P1|Overall Study|Non-Compliance With Study Drug|0
2443593|NCT02886702|8403582|P3|Overall Study|Protocol Violation|1
2443594|NCT02886702|8403583|P2|Overall Study|Protocol Violation|2
2443595|NCT02886702|8403584|P1|Overall Study|Protocol Violation|2
2443596|NCT02886702|8403582|P3|Overall Study|Significant Worsening of Condition|0
2443597|NCT02886702|8403583|P2|Overall Study|Significant Worsening of Condition|1
2443598|NCT02886702|8403584|P1|Overall Study|Significant Worsening of Condition|0
2443599|NCT02886702|8403582|P3|Overall Study|Withdrawal by Subject|22
2443600|NCT02886702|8403583|P2|Overall Study|Withdrawal by Subject|18
2443601|NCT02886702|8403584|P1|Overall Study|Withdrawal by Subject|24
2443602|NCT02886702|8403582|P3|Overall Study|Other|9
2443603|NCT02886702|8403583|P2|Overall Study|Other|3
2443604|NCT02886702|8403584|P1|Overall Study|Other|4
2443605|NCT02886624|8403598|P1|48-week Post Treatment Follow-up|Lost to Follow-up|1
2443606|NCT02886624|8403598|P1|12-week Post Treatment Follow-up|Death|1
2443607|NCT02886338|8403607|P1|Overall Study|Withdrawal by Subject|1
2443608|NCT02885181|8403796|P4|Overall Study|Withdrawal by Subject|1
2443609|NCT02885181|8403797|P3|Overall Study|Withdrawal by Subject|0
2443610|NCT02885181|8403798|P2|Overall Study|Withdrawal by Subject|0
2443611|NCT02885181|8403799|P1|Overall Study|Withdrawal by Subject|0
2443612|NCT02885181|8403796|P4|Overall Study|Adverse Event|1
2443613|NCT02885181|8403797|P3|Overall Study|Adverse Event|0
2443614|NCT02885181|8403798|P2|Overall Study|Adverse Event|0
2443615|NCT02885181|8403799|P1|Overall Study|Adverse Event|0
2443616|NCT02885181|8403796|P4|Overall Study|Investigator's Discretion|1
2443617|NCT02885181|8403797|P3|Overall Study|Investigator's Discretion|0
2443618|NCT02885181|8403798|P2|Overall Study|Investigator's Discretion|1
2443619|NCT02885181|8403799|P1|Overall Study|Investigator's Discretion|0
2443620|NCT02884089|8403866|P4|Follow-up Visit|Withdrawal by Subject|1
2443621|NCT02884089|8403867|P3|Follow-up Visit|Withdrawal by Subject|0
2443622|NCT02884089|8403868|P2|Follow-up Visit|Withdrawal by Subject|0
2443623|NCT02884089|8403869|P1|Follow-up Visit|Withdrawal by Subject|1
2443624|NCT02884089|8403866|P4|Period 4|Lost to Follow-up|0
2443625|NCT02884089|8403867|P3|Period 4|Lost to Follow-up|0
2443626|NCT02884089|8403868|P2|Period 4|Lost to Follow-up|0
2443627|NCT02884089|8403869|P1|Period 4|Lost to Follow-up|1
2443628|NCT02884089|8403866|P4|Period 4|Withdrawal by Subject|0
2443629|NCT02884089|8403867|P3|Period 4|Withdrawal by Subject|0
2443630|NCT02884089|8403868|P2|Period 4|Withdrawal by Subject|1
2443631|NCT02884089|8403869|P1|Period 4|Withdrawal by Subject|0
2443632|NCT02884089|8403866|P4|Washout Period 3|Lost to Follow-up|1
2443633|NCT02884089|8403867|P3|Washout Period 3|Lost to Follow-up|0
2443634|NCT02884089|8403868|P2|Washout Period 3|Lost to Follow-up|0
2443635|NCT02884089|8403869|P1|Washout Period 3|Lost to Follow-up|0
2443636|NCT02884089|8403866|P4|Washout Period 3|Withdrawal by Subject|0
2443637|NCT02884089|8403867|P3|Washout Period 3|Withdrawal by Subject|1
2443638|NCT02884089|8403868|P2|Washout Period 3|Withdrawal by Subject|0
2443639|NCT02884089|8403869|P1|Washout Period 3|Withdrawal by Subject|0
2443640|NCT02884089|8403866|P4|Period 3|Withdrawal by Subject|0
2443641|NCT02884089|8403867|P3|Period 3|Withdrawal by Subject|1
2443642|NCT02884089|8403868|P2|Period 3|Withdrawal by Subject|0
2443643|NCT02884089|8403869|P1|Period 3|Withdrawal by Subject|0
2443644|NCT02884089|8403866|P4|Period 2|Adverse Event|0
2443645|NCT02884089|8403867|P3|Period 2|Adverse Event|0
2443646|NCT02884089|8403868|P2|Period 2|Adverse Event|0
2443647|NCT02884089|8403869|P1|Period 2|Adverse Event|1
2443648|NCT02884089|8403866|P4|Washout Period 1|Withdrawal by Subject|0
2443649|NCT02884089|8403867|P3|Washout Period 1|Withdrawal by Subject|0
2443650|NCT02884089|8403868|P2|Washout Period 1|Withdrawal by Subject|1
2443651|NCT02884089|8403869|P1|Washout Period 1|Withdrawal by Subject|0
2443652|NCT02884089|8403866|P4|Washout Period 1|Lost to Follow-up|1
2443653|NCT02884089|8403867|P3|Washout Period 1|Lost to Follow-up|0
2443654|NCT02884089|8403868|P2|Washout Period 1|Lost to Follow-up|1
2443655|NCT02884089|8403869|P1|Washout Period 1|Lost to Follow-up|0
2443656|NCT02884089|8403866|P4|Period 1|Dosing error|0
2443657|NCT02884089|8403867|P3|Period 1|Dosing error|0
2443658|NCT02884089|8403868|P2|Period 1|Dosing error|2
2443659|NCT02884089|8403869|P1|Period 1|Dosing error|2
2443660|NCT02883244|8403885|P2|Overall Study|Lost to Follow-up|1
2443661|NCT02883244|8403886|P1|Overall Study|Lost to Follow-up|0
2443662|NCT02882854|8403904|P2|Overall Study|Physician Decision|1
2443663|NCT02882854|8403905|P1|Overall Study|Physician Decision|0
2443664|NCT02882854|8403904|P2|Overall Study|Lost to Follow-up|2
2443665|NCT02882854|8403905|P1|Overall Study|Lost to Follow-up|1
2443666|NCT02882152|8403942|P2|Overall Study|Lost to Follow-up|0
2443667|NCT02882152|8403943|P1|Overall Study|Lost to Follow-up|1
2443668|NCT02881567|8404013|P1|Overall Study|Reason not Specified|3
2443669|NCT02881567|8404013|P1|Overall Study|Study terminated by sponsor|9
2443670|NCT02881567|8404013|P1|Overall Study|Investigator decision|1
2443671|NCT02881567|8404013|P1|Overall Study|Consent withdrawn|1
2443672|NCT02881567|8404013|P1|Overall Study|Lost to Follow-up|3
2443673|NCT02881567|8404013|P1|Overall Study|Adverse Event|1
2443674|NCT02881047|8404029|P1|Overall Study|Withdrawal by Subject|1
2443675|NCT02881047|8404029|P1|Overall Study|Adverse Event|1
2443676|NCT02880761|8404107|P2|Overall Study|Lost to Follow-up|4
2443677|NCT02880761|8404108|P1|Overall Study|Lost to Follow-up|3
2443678|NCT02880761|8404107|P2|Overall Study|Protocol Violation|3
2443679|NCT02880761|8404108|P1|Overall Study|Protocol Violation|4
2443680|NCT02880761|8404107|P2|Overall Study|Withdrawal by Subject|6
2443681|NCT02880761|8404108|P1|Overall Study|Withdrawal by Subject|3
2443682|NCT02880761|8404107|P2|Overall Study|Death|8
2443683|NCT02880761|8404108|P1|Overall Study|Death|6
2443684|NCT02878590|8404317|P1|Overall Study|Withdrawal by Subject|2
2443685|NCT02878330|8404342|P2|Overall Study|Other|7
2443686|NCT02878330|8404343|P1|Overall Study|Other|4
2443687|NCT02878330|8404342|P2|Overall Study|Withdrawal by Subject|21
2443688|NCT02878330|8404343|P1|Overall Study|Withdrawal by Subject|11
2443689|NCT02878330|8404342|P2|Overall Study|Lost to Follow-up|26
2443690|NCT02878330|8404343|P1|Overall Study|Lost to Follow-up|11
2443691|NCT02878330|8404342|P2|Overall Study|Death|2
2443692|NCT02878330|8404343|P1|Overall Study|Death|3
2443693|NCT02878213|8404359|P1|Overall Study|Adverse Event|1
2443694|NCT02878213|8404359|P1|Overall Study|Withdrawal by Subject|2
2443695|NCT02877927|8404366|P2|Overall Study|Missed EOT/PTE Visit|6
2443696|NCT02877927|8404367|P1|Overall Study|Missed EOT/PTE Visit|5
2443697|NCT02877927|8404366|P2|Overall Study|Physician Decision|1
2443698|NCT02877927|8404367|P1|Overall Study|Physician Decision|0
2443699|NCT02877927|8404366|P2|Overall Study|Withdrawal by Subject|12
2443700|NCT02877927|8404367|P1|Overall Study|Withdrawal by Subject|11
2443701|NCT02877927|8404366|P2|Overall Study|Lost to Follow-up|38
2443702|NCT02877927|8404367|P1|Overall Study|Lost to Follow-up|37
2443703|NCT02877927|8404366|P2|Overall Study|Adverse Event|0
2443704|NCT02877927|8404367|P1|Overall Study|Adverse Event|1
2443705|NCT02877082|8404405|P1|Overall Study|Trial was closed early|5
2443706|NCT02877004|8404416|P3|Overall Study|Pregnancy|1
2443707|NCT02877004|8404417|P2|Overall Study|Pregnancy|0
2443708|NCT02877004|8404418|P1|Overall Study|Pregnancy|0
2443709|NCT02876601|8404481|P4|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
2443710|NCT02876601|8404482|P3|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1
2443711|NCT02876601|8404483|P2|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
2443712|NCT02876601|8404484|P1|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
2443713|NCT02875977|8404582|P2|Overall Study|Lost to Follow-up|29
2443714|NCT02875977|8404583|P1|Overall Study|Lost to Follow-up|42
2443715|NCT02875613|8404597|P1|Overall Study|Withdrawal by Subject|1
2443716|NCT02875366|8404603|P2|Overall Study|Noncompliance|1
2443717|NCT02875366|8404604|P1|Overall Study|Noncompliance|0
2443718|NCT02875366|8404603|P2|Overall Study|Adverse Event|2
2443719|NCT02875366|8404604|P1|Overall Study|Adverse Event|0
2443720|NCT02875340|8404656|P1|Overall Study|Adverse Event|1
2443721|NCT02875340|8404656|P1|Overall Study|Physician Decision|3
2443722|NCT02875340|8404656|P1|Overall Study|Withdrawal by Subject|2
2443723|NCT02875340|8404656|P1|Overall Study|Death|2
2443724|NCT02875028|8404680|P2|Washout Period|Withdrawal by Subject|1
2443725|NCT02875028|8404681|P1|Washout Period|Withdrawal by Subject|0
2443726|NCT02874924|8404712|P3|Overall Study|Withdrawal by Subject|0
2443727|NCT02874924|8404713|P2|Overall Study|Withdrawal by Subject|0
2443728|NCT02874924|8404714|P1|Overall Study|Withdrawal by Subject|1
2443729|NCT02874924|8404712|P3|Overall Study|Adverse Event|0
2443730|NCT02874924|8404713|P2|Overall Study|Adverse Event|0
2443731|NCT02874924|8404714|P1|Overall Study|Adverse Event|2
2443732|NCT02874794|8404747|P2|Overall Study|Death|1
2443733|NCT02874794|8404748|P1|Overall Study|Death|2
2443734|NCT02874794|8404747|P2|Overall Study|Withdrawal by Subject|8
2443735|NCT02874794|8404748|P1|Overall Study|Withdrawal by Subject|2
2443736|NCT02874794|8404747|P2|Overall Study|Physician Decision|2
2443737|NCT02874794|8404748|P1|Overall Study|Physician Decision|3
2443738|NCT02874742|8404780|P3|Overall Study|Ongoing|15
2443739|NCT02874742|8404781|P2|Overall Study|Ongoing|98
2443740|NCT02874742|8404782|P1|Overall Study|Ongoing|87
2443741|NCT02874742|8404780|P3|Overall Study|Other|0
2443742|NCT02874742|8404781|P2|Overall Study|Other|1
2443743|NCT02874742|8404782|P1|Overall Study|Other|3
2443744|NCT02874742|8404780|P3|Overall Study|Withdrawal by Subject|0
2443745|NCT02874742|8404781|P2|Overall Study|Withdrawal by Subject|4
2443746|NCT02874742|8404782|P1|Overall Study|Withdrawal by Subject|8
2443747|NCT02874742|8404780|P3|Overall Study|Lost to Follow-up|0
2443748|NCT02874742|8404781|P2|Overall Study|Lost to Follow-up|0
2443749|NCT02874742|8404782|P1|Overall Study|Lost to Follow-up|2
2443750|NCT02874742|8404780|P3|Overall Study|Death|1
2443751|NCT02874742|8404781|P2|Overall Study|Death|1
2443752|NCT02874742|8404782|P1|Overall Study|Death|3
2443753|NCT02874534|8404836|P2|Overall Study|Ongoing in study|1
2443754|NCT02874534|8404837|P1|Overall Study|Ongoing in study|1
2443755|NCT02874534|8404836|P2|Overall Study|Lost to Follow-up|2
2443756|NCT02874534|8404837|P1|Overall Study|Lost to Follow-up|2
2443757|NCT02874534|8404836|P2|Overall Study|Withdrawal by Subject|8
2443758|NCT02874534|8404837|P1|Overall Study|Withdrawal by Subject|5
2443759|NCT02873754|8404859|P1|Overall Study|Couldn't complete study procedures|1
2443760|NCT02873754|8404859|P1|Overall Study|Lost to Follow-up|5
2443761|NCT02873702|8404876|P4|Maintenance Period (up to Month 6)|Withdrawal by Subject|1
2443762|NCT02873702|8404877|P3|Maintenance Period (up to Month 6)|Withdrawal by Subject|2
2443763|NCT02873702|8404878|P2|Maintenance Period (up to Month 6)|Withdrawal by Subject|0
2443764|NCT02873702|8404879|P1|Maintenance Period (up to Month 6)|Withdrawal by Subject|0
2443765|NCT02873702|8404876|P4|Maintenance Period (up to Month 6)|Relapse of EE|1
2443766|NCT02873702|8404877|P3|Maintenance Period (up to Month 6)|Relapse of EE|4
2443767|NCT02873702|8404878|P2|Maintenance Period (up to Month 6)|Relapse of EE|0
2443768|NCT02873702|8404879|P1|Maintenance Period (up to Month 6)|Relapse of EE|0
2443769|NCT02873702|8404876|P4|Maintenance Period (up to Month 6)|Adverse Event|0
2443770|NCT02873702|8404877|P3|Maintenance Period (up to Month 6)|Adverse Event|1
2443771|NCT02873702|8404878|P2|Maintenance Period (up to Month 6)|Adverse Event|0
2443772|NCT02873702|8404879|P1|Maintenance Period (up to Month 6)|Adverse Event|0
2443773|NCT02873702|8404876|P4|Healing Period (up to Week 8)|Withdrawal by Subject|0
2443774|NCT02873702|8404877|P3|Healing Period (up to Week 8)|Withdrawal by Subject|0
2443775|NCT02873702|8404878|P2|Healing Period (up to Week 8)|Withdrawal by Subject|1
2443776|NCT02873702|8404879|P1|Healing Period (up to Week 8)|Withdrawal by Subject|0
2443777|NCT02873702|8404876|P4|Healing Period (up to Week 8)|Adverse Event|0
2443778|NCT02873702|8404877|P3|Healing Period (up to Week 8)|Adverse Event|0
2443779|NCT02873702|8404878|P2|Healing Period (up to Week 8)|Adverse Event|0
2443780|NCT02873702|8404879|P1|Healing Period (up to Week 8)|Adverse Event|1
2443781|NCT02873689|8404891|P2|Overall Study|Randomized but not Treated|1
2443782|NCT02873689|8404892|P1|Overall Study|Randomized but not Treated|1
2443783|NCT02873689|8404891|P2|Overall Study|Adverse Event|2
2443784|NCT02873689|8404892|P1|Overall Study|Adverse Event|2
2443785|NCT02873689|8404891|P2|Overall Study|Protocol Violation|0
2443786|NCT02873689|8404892|P1|Overall Study|Protocol Violation|1
2443787|NCT02873689|8404891|P2|Overall Study|Withdrawal by Subject|2
2443788|NCT02873689|8404892|P1|Overall Study|Withdrawal by Subject|2
2443789|NCT02873689|8404891|P2|Overall Study|Lack of Efficacy|0
2443790|NCT02873689|8404892|P1|Overall Study|Lack of Efficacy|1
2443791|NCT02873429|8404920|P2|16 Weeks|Lost to Follow-up|0
2443792|NCT02873429|8404921|P1|16 Weeks|Lost to Follow-up|3
2443793|NCT02873429|8404920|P2|16 Weeks|Completed 6-8 week, missed 16 week|2
2443794|NCT02873429|8404921|P1|16 Weeks|Completed 6-8 week, missed 16 week|2
2443795|NCT02873429|8404920|P2|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1
2443796|NCT02873429|8404921|P1|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10
2443797|NCT02873377|8404933|P2|Period Title 3: 6 Months Follow up|Lost to Follow-up|23
2443798|NCT02873377|8404934|P1|Period Title 3: 6 Months Follow up|Lost to Follow-up|15
2443799|NCT02873377|8404933|P2|Period Title 2: 3 Months Follow up|Lost to Follow-up|22
2443800|NCT02873377|8404934|P1|Period Title 2: 3 Months Follow up|Lost to Follow-up|22
2443801|NCT02873221|8404956|P3|Safety Follow-up Period|Withdrawal of Consent|8
2443802|NCT02873221|8404957|P2|Safety Follow-up Period|Withdrawal of Consent|10
2443803|NCT02873221|8404958|P1|Safety Follow-up Period|Withdrawal of Consent|4
2443804|NCT02873221|8404956|P3|Safety Follow-up Period|Lost to Follow-up|5
2443805|NCT02873221|8404957|P2|Safety Follow-up Period|Lost to Follow-up|5
2443806|NCT02873221|8404958|P1|Safety Follow-up Period|Lost to Follow-up|3
2443807|NCT02873221|8404956|P3|Safety Follow-up Period|Protocol Violation|1
2443808|NCT02873221|8404957|P2|Safety Follow-up Period|Protocol Violation|0
2443809|NCT02873221|8404958|P1|Safety Follow-up Period|Protocol Violation|0
2443810|NCT02873221|8404956|P3|Safety Follow-up Period|Other Miscellaneous Reasons|0
2443811|NCT02873221|8404957|P2|Safety Follow-up Period|Other Miscellaneous Reasons|2
2443812|NCT02873221|8404958|P1|Safety Follow-up Period|Other Miscellaneous Reasons|0
2443813|NCT02873221|8404956|P3|Treatment Period|Lost to Follow-up|26
2443814|NCT02873221|8404957|P2|Treatment Period|Lost to Follow-up|30
2443815|NCT02873221|8404958|P1|Treatment Period|Lost to Follow-up|26
2443816|NCT02873221|8404956|P3|Treatment Period|Adverse Event|11
2443817|NCT02873221|8404957|P2|Treatment Period|Adverse Event|9
2443818|NCT02873221|8404958|P1|Treatment Period|Adverse Event|4
2443819|NCT02873221|8404956|P3|Treatment Period|Lack of Efficacy|12
2443820|NCT02873221|8404957|P2|Treatment Period|Lack of Efficacy|17
2443821|NCT02873221|8404958|P1|Treatment Period|Lack of Efficacy|0
2443822|NCT02873221|8404956|P3|Treatment Period|Withdrawal of Consent|41
2443823|NCT02873221|8404957|P2|Treatment Period|Withdrawal of Consent|51
2443824|NCT02873221|8404958|P1|Treatment Period|Withdrawal of Consent|52
2443825|NCT02873221|8404956|P3|Treatment Period|Lack of Qualifying Event|1
2443826|NCT02873221|8404957|P2|Treatment Period|Lack of Qualifying Event|3
2443827|NCT02873221|8404958|P1|Treatment Period|Lack of Qualifying Event|0
2443828|NCT02873221|8404956|P3|Treatment Period|Pregnancy|3
2443829|NCT02873221|8404957|P2|Treatment Period|Pregnancy|6
2443830|NCT02873221|8404958|P1|Treatment Period|Pregnancy|4
2443831|NCT02873221|8404956|P3|Treatment Period|Protocol Violation|8
2443832|NCT02873221|8404957|P2|Treatment Period|Protocol Violation|5
2443833|NCT02873221|8404958|P1|Treatment Period|Protocol Violation|2
2443834|NCT02873221|8404956|P3|Treatment Period|Non-Compliance with Study Drug|2
2443835|NCT02873221|8404957|P2|Treatment Period|Non-Compliance with Study Drug|3
2443836|NCT02873221|8404958|P1|Treatment Period|Non-Compliance with Study Drug|0
2443837|NCT02873221|8404956|P3|Treatment Period|Other Miscellaneous Reasons|1
2443838|NCT02873221|8404957|P2|Treatment Period|Other Miscellaneous Reasons|2
2443839|NCT02873221|8404958|P1|Treatment Period|Other Miscellaneous Reasons|0
2443840|NCT02873195|8404980|P2|Overall Study|Ineligible|0
2443841|NCT02873195|8404981|P1|Overall Study|Ineligible|5
2443842|NCT02872311|8405028|P5|Overall Study|Protocol Violation|0
2443843|NCT02872311|8405029|P4|Overall Study|Protocol Violation|0
2443844|NCT02872311|8405030|P3|Overall Study|Protocol Violation|1
2443845|NCT02872311|8405031|P2|Overall Study|Protocol Violation|2
2443846|NCT02872311|8405032|P1|Overall Study|Protocol Violation|0
2443847|NCT02872311|8405028|P5|Overall Study|Lost to Follow-up|0
2443848|NCT02872311|8405029|P4|Overall Study|Lost to Follow-up|0
2443849|NCT02872311|8405030|P3|Overall Study|Lost to Follow-up|0
2443850|NCT02872311|8405031|P2|Overall Study|Lost to Follow-up|0
2443851|NCT02872311|8405032|P1|Overall Study|Lost to Follow-up|2
2443852|NCT02872311|8405028|P5|Overall Study|Death|0
2443853|NCT02872311|8405029|P4|Overall Study|Death|0
2443854|NCT02872311|8405030|P3|Overall Study|Death|0
2443855|NCT02872311|8405031|P2|Overall Study|Death|0
2443856|NCT02872311|8405032|P1|Overall Study|Death|2
2443857|NCT02872285|8405093|P2|Overall Study|Discontinued due to back surgery|0
2443858|NCT02872285|8405094|P1|Overall Study|Discontinued due to back surgery|1
2443859|NCT02872285|8405093|P2|Overall Study|Lost to Follow-up|2
2443860|NCT02872285|8405094|P1|Overall Study|Lost to Follow-up|2
2443861|NCT02872285|8405093|P2|Overall Study|Withdrawal by Subject|0
2443862|NCT02872285|8405094|P1|Overall Study|Withdrawal by Subject|2
2443863|NCT02872012|8405140|P5|Overall Study|Withdrawal by Subject|0
2443864|NCT02872012|8405141|P4|Overall Study|Withdrawal by Subject|0
2443865|NCT02872012|8405142|P3|Overall Study|Withdrawal by Subject|0
2443866|NCT02872012|8405143|P2|Overall Study|Withdrawal by Subject|0
2443867|NCT02872012|8405144|P1|Overall Study|Withdrawal by Subject|1
2443868|NCT02871739|8405162|P4|Overall Study|Lost to Follow-up|2
2443869|NCT02871739|8405163|P3|Overall Study|Lost to Follow-up|0
2443870|NCT02871739|8405164|P2|Overall Study|Lost to Follow-up|2
2443871|NCT02871739|8405165|P1|Overall Study|Lost to Follow-up|3
2443872|NCT02871375|8405222|P2|Period 1, First 14 Days of Wear|Inclusion criteria not met|1
2443873|NCT02871375|8405223|P1|Period 1, First 14 Days of Wear|Inclusion criteria not met|0
2443874|NCT02870933|8405253|P2|Overall Study|Withdrawal by Subject|1
2443875|NCT02870933|8405254|P1|Overall Study|Withdrawal by Subject|0
2443876|NCT02870933|8405253|P2|Overall Study|Death|1
2443877|NCT02870933|8405254|P1|Overall Study|Death|2
2443878|NCT02869438|8405332|P2|Overall Study|Withdrawal by Subject|2
2443879|NCT02869438|8405333|P1|Overall Study|Withdrawal by Subject|1
2443880|NCT02869438|8405332|P2|Overall Study|Adverse Event|0
2443881|NCT02869438|8405333|P1|Overall Study|Adverse Event|1
2443882|NCT02869438|8405332|P2|Overall Study|Lost to Follow-up|0
2443883|NCT02869438|8405333|P1|Overall Study|Lost to Follow-up|1
2443884|NCT02868892|8405381|P1|Overall Study|Investigator left site and no follow-up|6
2443885|NCT02868554|8405390|P3|Overall Study|Lost to Follow-up|1
2443886|NCT02868554|8405391|P2|Overall Study|Lost to Follow-up|0
2443887|NCT02868554|8405392|P1|Overall Study|Lost to Follow-up|3
2443888|NCT02868216|8405427|P2|Overall Study|Withdrawal by Subject|5
2443889|NCT02868216|8405428|P1|Overall Study|Withdrawal by Subject|7
2443890|NCT02868216|8405427|P2|Overall Study|coronary artery bypass|0
2443891|NCT02868216|8405428|P1|Overall Study|coronary artery bypass|1
2443892|NCT02868216|8405427|P2|Overall Study|Death|1
2443893|NCT02868216|8405428|P1|Overall Study|Death|0
2443894|NCT02867995|8405436|P2|Overall Study|Lost to Follow-up|2
2443895|NCT02867995|8405437|P1|Overall Study|Lost to Follow-up|0
2443896|NCT02867995|8405436|P2|Overall Study|Withdrawal by Subject|1
2443897|NCT02867995|8405437|P1|Overall Study|Withdrawal by Subject|0
2443898|NCT02867709|8405456|P3|Safety Follow-up Period|Protocol Violation|1
2443899|NCT02867709|8405457|P2|Safety Follow-up Period|Protocol Violation|1
2443900|NCT02867709|8405458|P1|Safety Follow-up Period|Protocol Violation|0
2443901|NCT02867709|8405456|P3|Safety Follow-up Period|Pregnancy|0
2443902|NCT02867709|8405457|P2|Safety Follow-up Period|Pregnancy|1
2443903|NCT02867709|8405458|P1|Safety Follow-up Period|Pregnancy|0
2443904|NCT02867709|8405456|P3|Safety Follow-up Period|Lost to Follow-up|7
2443905|NCT02867709|8405457|P2|Safety Follow-up Period|Lost to Follow-up|5
2443906|NCT02867709|8405458|P1|Safety Follow-up Period|Lost to Follow-up|10
2443907|NCT02867709|8405456|P3|Safety Follow-up Period|Withdrawal of Consent|6
2443908|NCT02867709|8405457|P2|Safety Follow-up Period|Withdrawal of Consent|8
2443909|NCT02867709|8405458|P1|Safety Follow-up Period|Withdrawal of Consent|1
2443910|NCT02867709|8405456|P3|Treatment Period|Protocol Violation|3
2443911|NCT02867709|8405457|P2|Treatment Period|Protocol Violation|2
2443912|NCT02867709|8405458|P1|Treatment Period|Protocol Violation|3
2443913|NCT02867709|8405456|P3|Treatment Period|Lack of Qualifying Event|42
2443914|NCT02867709|8405457|P2|Treatment Period|Lack of Qualifying Event|55
2443915|NCT02867709|8405458|P1|Treatment Period|Lack of Qualifying Event|42
2443916|NCT02867709|8405456|P3|Treatment Period|Lost to Follow-up|20
2443917|NCT02867709|8405457|P2|Treatment Period|Lost to Follow-up|20
2443918|NCT02867709|8405458|P1|Treatment Period|Lost to Follow-up|17
2443919|NCT02867709|8405456|P3|Treatment Period|Withdrawal of Consent|8
2443920|NCT02867709|8405457|P2|Treatment Period|Withdrawal of Consent|9
2443921|NCT02867709|8405458|P1|Treatment Period|Withdrawal of Consent|7
2443922|NCT02867709|8405456|P3|Treatment Period|Adverse Event|2
2443923|NCT02867709|8405457|P2|Treatment Period|Adverse Event|1
2443924|NCT02867709|8405458|P1|Treatment Period|Adverse Event|1
2443925|NCT02866942|8405515|P1|Overall Study|Invalid consent|1
2443926|NCT02866695|8405520|P1|Overall Study|Lost to Follow-up|1
2443927|NCT02866695|8405520|P1|Overall Study|Adverse Event|1
2443928|NCT02865499|8405561|P1|Baseline|Withdrawal by Subject|1
2443929|NCT02865499|8405561|P1|Baseline|Adverse Event|1
2443930|NCT02865395|8405568|P3|Overall Study|Physician Decision|7
2443931|NCT02865395|8405569|P2|Overall Study|Physician Decision|10
2443932|NCT02865395|8405570|P1|Overall Study|Physician Decision|6
2443933|NCT02865083|8405583|P2|Overall Study|Early Termination|1
2443934|NCT02865083|8405584|P1|Overall Study|Early Termination|3
2443935|NCT02864342|8405645|P2|Overall Study|Adverse Event|0
2443936|NCT02864342|8405646|P1|Overall Study|Adverse Event|1
2443937|NCT02864342|8405645|P2|Overall Study|Lost Device|0
2443938|NCT02864342|8405646|P1|Overall Study|Lost Device|1
2443939|NCT02864342|8405645|P2|Overall Study|Lost to Follow-up|5
2443940|NCT02864342|8405646|P1|Overall Study|Lost to Follow-up|1
2443941|NCT02864342|8405645|P2|Overall Study|Did Not Start Treatment with Symbicort|1
2443942|NCT02864342|8405646|P1|Overall Study|Did Not Start Treatment with Symbicort|0
2443943|NCT02864342|8405645|P2|Overall Study|Death|1
2443944|NCT02864342|8405646|P1|Overall Study|Death|0
2443945|NCT02864342|8405645|P2|Overall Study|Device Technology Issue|7
2443946|NCT02864342|8405646|P1|Overall Study|Device Technology Issue|6
2443947|NCT02864342|8405645|P2|Overall Study|Withdrawal by Subject|2
2443948|NCT02864342|8405646|P1|Overall Study|Withdrawal by Subject|4
2443949|NCT02864342|8405645|P2|Overall Study|Eligibility Criteria Deviation|3
2443950|NCT02864342|8405646|P1|Overall Study|Eligibility Criteria Deviation|2
2443951|NCT02864316|8405663|P2|Overall Study|Adverse Event|1
2443952|NCT02864316|8405664|P1|Overall Study|Adverse Event|0
2443953|NCT02864316|8405663|P2|Overall Study|Progressive Disease|1
2443954|NCT02864316|8405664|P1|Overall Study|Progressive Disease|2
2443955|NCT02863575|8405702|P3|Overall Study|Adverse Event|0
2443956|NCT02863575|8405703|P2|Overall Study|Adverse Event|1
2443957|NCT02863575|8405704|P1|Overall Study|Adverse Event|0
2443958|NCT02863575|8405702|P3|Overall Study|Withdrawal by Subject|1
2443959|NCT02863575|8405703|P2|Overall Study|Withdrawal by Subject|1
2443960|NCT02863575|8405704|P1|Overall Study|Withdrawal by Subject|0
2443961|NCT02863575|8405702|P3|Overall Study|Participants Unable To Swallow Capsule|0
2443962|NCT02863575|8405703|P2|Overall Study|Participants Unable To Swallow Capsule|0
2443963|NCT02863575|8405704|P1|Overall Study|Participants Unable To Swallow Capsule|1
2443964|NCT02863419|8405756|P3|Overall Study|Died|1
2443965|NCT02863419|8405757|P2|Overall Study|Died|4
2443966|NCT02863419|8405758|P1|Overall Study|Died|3
2443967|NCT02863419|8405756|P3|Overall Study|Withdrawal by Subject|3
2443968|NCT02863419|8405757|P2|Overall Study|Withdrawal by Subject|5
2443969|NCT02863419|8405758|P1|Overall Study|Withdrawal by Subject|5
2443970|NCT02863419|8405756|P3|Overall Study|Lost to Follow-up|4
2443971|NCT02863419|8405757|P2|Overall Study|Lost to Follow-up|1
2443972|NCT02863419|8405758|P1|Overall Study|Lost to Follow-up|0
2443973|NCT02863328|8405875|P2|Overall Study|Died|1
2443974|NCT02863328|8405876|P1|Overall Study|Died|0
2443975|NCT02863328|8405875|P2|Overall Study|Withdrawal by Subject|12
2443976|NCT02863328|8405876|P1|Overall Study|Withdrawal by Subject|7
2443977|NCT02863328|8405875|P2|Overall Study|Lost to Follow-up|10
2443978|NCT02863328|8405876|P1|Overall Study|Lost to Follow-up|4
2443979|NCT02862730|8406020|P7|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
2443980|NCT02862730|8406021|P6|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
2443981|NCT02862730|8406022|P5|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
2443982|NCT02862730|8406023|P4|Third Intervention (84 Hours)|diagnosis of gastroparesis|1
2443983|NCT02862730|8406024|P3|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
2443984|NCT02862730|8406025|P2|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
2443985|NCT02862730|8406026|P1|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
2443986|NCT02862730|8406020|P7|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
2443987|NCT02862730|8406021|P6|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
2443988|NCT02862730|8406022|P5|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
2443989|NCT02862730|8406023|P4|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
2443990|NCT02862730|8406024|P3|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
2443991|NCT02862730|8406025|P2|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
2443992|NCT02862730|8406026|P1|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
2443993|NCT02862730|8406020|P7|Second Intervention (84 Hours)|Withdrawal by Subject|0
2443994|NCT02862730|8406021|P6|Second Intervention (84 Hours)|Withdrawal by Subject|0
2443995|NCT02862730|8406022|P5|Second Intervention (84 Hours)|Withdrawal by Subject|0
2443996|NCT02862730|8406023|P4|Second Intervention (84 Hours)|Withdrawal by Subject|0
2443997|NCT02862730|8406024|P3|Second Intervention (84 Hours)|Withdrawal by Subject|0
2443998|NCT02862730|8406025|P2|Second Intervention (84 Hours)|Withdrawal by Subject|0
2443999|NCT02862730|8406026|P1|Second Intervention (84 Hours)|Withdrawal by Subject|1
2444000|NCT02862730|8406020|P7|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
2444001|NCT02862730|8406021|P6|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
2444002|NCT02862730|8406022|P5|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
2444003|NCT02862730|8406023|P4|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
2444004|NCT02862730|8406024|P3|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1
2444005|NCT02862730|8406025|P2|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
2444006|NCT02862730|8406026|P1|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
2444007|NCT02862600|8406081|P1|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7
2444008|NCT02862600|8406081|P1|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1
2444009|NCT02862600|8406081|P1|Period 1--Perhexiline-low Target Range|Protocol Violation|3
2444010|NCT02862600|8406081|P1|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9
2444011|NCT02862574|8406091|P3|Open-Label Treatment Period|Study Terminated by Sponsor|1
2444012|NCT02862574|8406092|P2|Open-Label Treatment Period|Study Terminated by Sponsor|3
2444013|NCT02862574|8406093|P1|Open-Label Treatment Period|Study Terminated by Sponsor|2
2444014|NCT02862574|8406091|P3|Double-Blind Treatment Period|Study Terminated by Sponsor|4
2444015|NCT02862574|8406092|P2|Double-Blind Treatment Period|Study Terminated by Sponsor|1
2444016|NCT02862574|8406093|P1|Double-Blind Treatment Period|Study Terminated by Sponsor|3
2444017|NCT02862574|8406091|P3|Double-Blind Treatment Period|Adverse Event|0
2444018|NCT02862574|8406092|P2|Double-Blind Treatment Period|Adverse Event|1
2444019|NCT02862574|8406093|P1|Double-Blind Treatment Period|Adverse Event|0
2444020|NCT02862548|8406113|P2|Open-Label Extension Phase|Still on Study|24
2444021|NCT02862548|8406114|P1|Open-Label Extension Phase|Still on Study|26
2444022|NCT02862548|8406113|P2|Open-Label Phase|Death|1
2444023|NCT02862548|8406114|P1|Open-Label Phase|Death|0
2444024|NCT02862106|8406144|P2|Overall Study|Subjects moved to other city|0
2444025|NCT02862106|8406145|P1|Overall Study|Subjects moved to other city|1
2444026|NCT02862106|8406144|P2|Overall Study|Withdrawal by Subject|0
2444027|NCT02862106|8406145|P1|Overall Study|Withdrawal by Subject|2
2444028|NCT02862106|8406144|P2|Overall Study|Lost to Follow-up|5
2444029|NCT02862106|8406145|P1|Overall Study|Lost to Follow-up|15
2444030|NCT02862106|8406144|P2|Overall Study|Protocol Violation|1
2444031|NCT02862106|8406145|P1|Overall Study|Protocol Violation|16
2444032|NCT02862106|8406144|P2|Overall Study|Adverse Event|0
2444033|NCT02862106|8406145|P1|Overall Study|Adverse Event|4
2444034|NCT02861807|8406205|P2|Overall Study|Withdrawal by Subject|8
2444035|NCT02861807|8406206|P1|Overall Study|Withdrawal by Subject|5
2444036|NCT02861807|8406205|P2|Overall Study|Lost to Follow-up|6
2444037|NCT02861807|8406206|P1|Overall Study|Lost to Follow-up|7
2444038|NCT02861664|8406222|P2|Overall Study|Withdrawal of Consent|1
2444039|NCT02861664|8406223|P1|Overall Study|Withdrawal of Consent|0
2444040|NCT02860169|8406297|P1|Part C|Other (Screening failure)|1
2444041|NCT02860169|8406297|P1|Part B|Withdrawal by Subject|1
2444042|NCT02860169|8406297|P1|Part B|Other (Screening failure)|10
2444043|NCT02860169|8406297|P1|Part A|Other (did not completed consent)|1
2444044|NCT02860169|8406297|P1|Part A|Other (Survey not completed)|3
2444045|NCT02860169|8406297|P1|Part A|Other (Screening failure)|6
2444046|NCT02860169|8406297|P1|Part A|Withdrawal by Subject|1
2444047|NCT02859454|8406326|P1|Overall Study|PI discretion/off study prior to trtmt|1
2444048|NCT02859246|8406337|P1|Overall Study|Withdrawal by Subject|1
2444049|NCT02859246|8406337|P1|Overall Study|Adverse Event|1
2444050|NCT02859246|8406337|P1|Overall Study|Screen fails|3
2444051|NCT02858492|8406359|P4|Overall Study|Protocol defined stopping criteria|1
2444052|NCT02858492|8406360|P3|Overall Study|Protocol defined stopping criteria|0
2444053|NCT02858492|8406361|P2|Overall Study|Protocol defined stopping criteria|0
2444054|NCT02858492|8406362|P1|Overall Study|Protocol defined stopping criteria|0
2444055|NCT02858492|8406359|P4|Overall Study|Lack of Efficacy|1
2444056|NCT02858492|8406360|P3|Overall Study|Lack of Efficacy|0
2444057|NCT02858492|8406361|P2|Overall Study|Lack of Efficacy|0
2444058|NCT02858492|8406362|P1|Overall Study|Lack of Efficacy|0
2444059|NCT02858492|8406359|P4|Overall Study|Adverse Event|3
2444060|NCT02858492|8406360|P3|Overall Study|Adverse Event|0
2444061|NCT02858492|8406361|P2|Overall Study|Adverse Event|0
2444062|NCT02858492|8406362|P1|Overall Study|Adverse Event|0
2444063|NCT02858492|8406359|P4|Overall Study|Withdrawal by Subject|1
2444064|NCT02858492|8406360|P3|Overall Study|Withdrawal by Subject|0
2444065|NCT02858492|8406361|P2|Overall Study|Withdrawal by Subject|1
2444066|NCT02858492|8406362|P1|Overall Study|Withdrawal by Subject|0
2444067|NCT02858440|8406538|P1|Overall Study|Migrated/moved from study area|4
2444068|NCT02858440|8406538|P1|Overall Study|Consent withdrawal|3
2444069|NCT02858440|8406538|P1|Overall Study|Protocol Violation|2
2444070|NCT02858440|8406538|P1|Overall Study|Lost to Follow-up|3
2444071|NCT02858401|8406571|P7|Overall Study|Lost to Follow-up|0
2444072|NCT02858401|8406572|P6|Overall Study|Lost to Follow-up|0
2444073|NCT02858401|8406573|P5|Overall Study|Lost to Follow-up|0
2444074|NCT02858401|8406574|P4|Overall Study|Lost to Follow-up|0
2444075|NCT02858401|8406575|P3|Overall Study|Lost to Follow-up|0
2444076|NCT02858401|8406576|P2|Overall Study|Lost to Follow-up|1
2444077|NCT02858401|8406577|P1|Overall Study|Lost to Follow-up|0
2444078|NCT02858401|8406571|P7|Overall Study|Withdrew Consent|0
2444079|NCT02858401|8406572|P6|Overall Study|Withdrew Consent|1
2444080|NCT02858401|8406573|P5|Overall Study|Withdrew Consent|0
2444081|NCT02858401|8406574|P4|Overall Study|Withdrew Consent|0
2444082|NCT02858401|8406575|P3|Overall Study|Withdrew Consent|0
2444083|NCT02858401|8406576|P2|Overall Study|Withdrew Consent|0
2444084|NCT02858401|8406577|P1|Overall Study|Withdrew Consent|0
2444085|NCT02858362|8406988|P3|Overall Study|Lost to Follow-up|0
2444086|NCT02858362|8406989|P2|Overall Study|Lost to Follow-up|0
2444087|NCT02858362|8406990|P1|Overall Study|Lost to Follow-up|1
2444088|NCT02858362|8406988|P3|Overall Study|Early Study Termination|3
2444089|NCT02858362|8406989|P2|Overall Study|Early Study Termination|0
2444090|NCT02858362|8406990|P1|Overall Study|Early Study Termination|0
2444091|NCT02858362|8406988|P3|Overall Study|Withdrawal by Subject|0
2444092|NCT02858362|8406989|P2|Overall Study|Withdrawal by Subject|0
2444093|NCT02858362|8406990|P1|Overall Study|Withdrawal by Subject|1
2444094|NCT02858362|8406988|P3|Overall Study|Protocol Violation|0
2444095|NCT02858362|8406989|P2|Overall Study|Protocol Violation|1
2444096|NCT02858362|8406990|P1|Overall Study|Protocol Violation|0
2444097|NCT02858180|8407031|P2|Overall Study|Lost to Follow-up|2
2444098|NCT02858180|8407032|P1|Overall Study|Lost to Follow-up|0
2444099|NCT02857816|8407053|P1|Overall Study|Lost to Follow-up|1
2444100|NCT02857816|8407053|P1|Overall Study|Withdrawal by Subject|4
2444101|NCT02857816|8407053|P1|Overall Study|Screen Failure|33
2444102|NCT02857283|8407061|P2|First Exposure|Withdrawal by Subject|0
2444103|NCT02857283|8407062|P1|First Exposure|Withdrawal by Subject|1
2444104|NCT02856880|8407088|P1|Overall Study|Withdrawal of consent|1
2444105|NCT02856282|8407129|P1|Overall Study|Withdrawal by Subject|1
2444106|NCT02855541|8407156|P1|Overall Study|Withdrawal by Subject|2
2444107|NCT02855541|8407156|P1|Overall Study|Change in health status|2
2444108|NCT02855411|8407176|P1|Overall Study|Does not meet entrance criteria|14
2444109|NCT02855411|8407176|P1|Overall Study|Study terminated by sponsor|21
2444110|NCT02855359|8407198|P4|Overall Study|Study Termination by Sponsor|0
2444111|NCT02855359|8407199|P3|Overall Study|Study Termination by Sponsor|0
2444112|NCT02855359|8407200|P2|Overall Study|Study Termination by Sponsor|11
2444113|NCT02855359|8407201|P1|Overall Study|Study Termination by Sponsor|9
2444114|NCT02855359|8407198|P4|Overall Study|Death|0
2444115|NCT02855359|8407199|P3|Overall Study|Death|0
2444116|NCT02855359|8407200|P2|Overall Study|Death|2
2444117|NCT02855359|8407201|P1|Overall Study|Death|2
2444118|NCT02854631|8407246|P2|Overall Study|Lost to Follow-up|2
2444119|NCT02854631|8407247|P1|Overall Study|Lost to Follow-up|4
2444120|NCT02854631|8407246|P2|Overall Study|Subjects Randomized but Never Treated|0
2444121|NCT02854631|8407247|P1|Overall Study|Subjects Randomized but Never Treated|2
2444122|NCT02854631|8407246|P2|Overall Study|Protocol Violation|1
2444123|NCT02854631|8407247|P1|Overall Study|Protocol Violation|0
2444124|NCT02854631|8407246|P2|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0
2444125|NCT02854631|8407247|P1|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2
2444126|NCT02854631|8407246|P2|Overall Study|Death|8
2444127|NCT02854631|8407247|P1|Overall Study|Death|12
2444128|NCT02854631|8407246|P2|Overall Study|Investigator's Discretion|0
2444129|NCT02854631|8407247|P1|Overall Study|Investigator's Discretion|2
2444130|NCT02854631|8407246|P2|Overall Study|Withdrew Consent|2
2444131|NCT02854631|8407247|P1|Overall Study|Withdrew Consent|3
2444132|NCT02854631|8407246|P2|Overall Study|Adverse Event|2
2444133|NCT02854631|8407247|P1|Overall Study|Adverse Event|1
2444134|NCT02854605|8407308|P3|Overall Study|Protocol Violation|1
2444135|NCT02854605|8407309|P2|Overall Study|Protocol Violation|0
2444136|NCT02854605|8407310|P1|Overall Study|Protocol Violation|0
2444137|NCT02854605|8407308|P3|Overall Study|Investigator's Discretion|0
2444138|NCT02854605|8407309|P2|Overall Study|Investigator's Discretion|0
2444139|NCT02854605|8407310|P1|Overall Study|Investigator's Discretion|1
2444140|NCT02854605|8407308|P3|Overall Study|Withdrew Consent|1
2444141|NCT02854605|8407309|P2|Overall Study|Withdrew Consent|0
2444142|NCT02854605|8407310|P1|Overall Study|Withdrew Consent|1
2444143|NCT02854605|8407308|P3|Overall Study|Lost to Follow-up|0
2444144|NCT02854605|8407309|P2|Overall Study|Lost to Follow-up|2
2444145|NCT02854605|8407310|P1|Overall Study|Lost to Follow-up|0
2444146|NCT02854605|8407308|P3|Overall Study|Adverse Event|2
2444147|NCT02854605|8407309|P2|Overall Study|Adverse Event|5
2444148|NCT02854605|8407310|P1|Overall Study|Adverse Event|1
2444149|NCT02854527|8407340|P10|Overall Study|Lost to Follow-up|0
2444150|NCT02854527|8407341|P9|Overall Study|Lost to Follow-up|0
2444151|NCT02854527|8407342|P8|Overall Study|Lost to Follow-up|0
2444152|NCT02854527|8407343|P7|Overall Study|Lost to Follow-up|0
2444153|NCT02854527|8407344|P6|Overall Study|Lost to Follow-up|0
2444154|NCT02854527|8407345|P5|Overall Study|Lost to Follow-up|0
2444155|NCT02854527|8407346|P4|Overall Study|Lost to Follow-up|1
2444156|NCT02854527|8407347|P3|Overall Study|Lost to Follow-up|0
2444157|NCT02854527|8407348|P2|Overall Study|Lost to Follow-up|0
2444158|NCT02854527|8407349|P1|Overall Study|Lost to Follow-up|0
2444159|NCT02854527|8407340|P10|Overall Study|Adverse Event|0
2444160|NCT02854527|8407341|P9|Overall Study|Adverse Event|0
2444161|NCT02854527|8407342|P8|Overall Study|Adverse Event|0
2444162|NCT02854527|8407343|P7|Overall Study|Adverse Event|0
2444163|NCT02854527|8407344|P6|Overall Study|Adverse Event|0
2444164|NCT02854527|8407345|P5|Overall Study|Adverse Event|1
2444165|NCT02854527|8407346|P4|Overall Study|Adverse Event|0
2444166|NCT02854527|8407347|P3|Overall Study|Adverse Event|0
2444167|NCT02854527|8407348|P2|Overall Study|Adverse Event|0
2444168|NCT02854527|8407349|P1|Overall Study|Adverse Event|0
2444169|NCT02853929|8407407|P2|Overall Study|Subjects enrolled but not vaccinated|4
2444170|NCT02853929|8407408|P1|Overall Study|Subjects enrolled but not vaccinated|7
2444171|NCT02853929|8407407|P2|Overall Study|Withdrawal by Subject|0
2444172|NCT02853929|8407408|P1|Overall Study|Withdrawal by Subject|1
2444173|NCT02853929|8407407|P2|Overall Study|Lost to Follow-up|0
2444174|NCT02853929|8407408|P1|Overall Study|Lost to Follow-up|3
2444175|NCT02853435|8407449|P6|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
2444176|NCT02853435|8407450|P5|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1
2444177|NCT02853435|8407451|P4|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
2444178|NCT02853435|8407452|P3|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
2444179|NCT02853435|8407453|P2|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
2444180|NCT02853435|8407454|P1|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
2444181|NCT02853331|8407764|P2|Overall Study|Ongoing in study|325
2444182|NCT02853331|8407765|P1|Overall Study|Ongoing in study|368
2444183|NCT02853331|8407764|P2|Overall Study|Withdrawal by Subject|9
2444184|NCT02853331|8407765|P1|Overall Study|Withdrawal by Subject|5
2444185|NCT02853331|8407764|P2|Overall Study|Death|95
2444186|NCT02853331|8407765|P1|Overall Study|Death|59
2444187|NCT02853123|8407797|P2|Washout Period|Adverse Event|0
2444188|NCT02853123|8407798|P1|Washout Period|Adverse Event|1
2444189|NCT02853123|8407797|P2|Washout Period|Worsening of COPD|3
2444190|NCT02853123|8407798|P1|Washout Period|Worsening of COPD|0
2444191|NCT02853123|8407797|P2|Treatment Period 1|Adverse Event|3
2444192|NCT02853123|8407798|P1|Treatment Period 1|Adverse Event|0
2444193|NCT02852434|8407821|P2|Overall Study|Unsuccessful Dilator Procedure|0
2444194|NCT02852434|8407822|P1|Overall Study|Unsuccessful Dilator Procedure|2
2444195|NCT02852434|8407821|P2|Overall Study|Withdrawal by Subject|1
2444196|NCT02852434|8407822|P1|Overall Study|Withdrawal by Subject|0
2444197|NCT02852265|8407838|P2|3-month Follow-up|Lost to Follow-up|1
2444198|NCT02852265|8407839|P1|3-month Follow-up|Lost to Follow-up|1
2444199|NCT02851069|8407872|P1|Overall Study|Other|3
2444200|NCT02851069|8407872|P1|Overall Study|Failure to Return|3
2444201|NCT02850978|8407894|P1|Overall Study|Reason not listed|88
2444202|NCT02850978|8407894|P1|Overall Study|Lost to Follow-up|121
2444203|NCT02850978|8407894|P1|Overall Study|Improvement in condition|34
2444204|NCT02850978|8407894|P1|Overall Study|Lack of Efficacy|40
2444205|NCT02850978|8407894|P1|Overall Study|Adverse Event|81
2444206|NCT02850978|8407894|P1|Overall Study|No visit since the first visit|35
2444207|NCT02850978|8407894|P1|Overall Study|Uncollectable CRF|27
2444208|NCT02850965|8407901|P2|Overall Study|Randomized but not treated|1
2444209|NCT02850965|8407902|P1|Overall Study|Randomized but not treated|0
2444210|NCT02850965|8407901|P2|Overall Study|Physician Decision|1
2444211|NCT02850965|8407902|P1|Overall Study|Physician Decision|0
2444212|NCT02850965|8407901|P2|Overall Study|Withdrawal by Subject|4
2444213|NCT02850965|8407902|P1|Overall Study|Withdrawal by Subject|3
2444214|NCT02850965|8407901|P2|Overall Study|Adverse Event|2
2444215|NCT02850965|8407902|P1|Overall Study|Adverse Event|3
2444216|NCT02850965|8407901|P2|Overall Study|Lack of Efficacy|8
2444217|NCT02850965|8407902|P1|Overall Study|Lack of Efficacy|4
2444218|NCT02850965|8407901|P2|Overall Study|Lost to Follow-up|3
2444219|NCT02850965|8407902|P1|Overall Study|Lost to Follow-up|5
2444220|NCT02850965|8407901|P2|Overall Study|Protocol Violation|2
2444221|NCT02850965|8407902|P1|Overall Study|Protocol Violation|0
2444222|NCT02850965|8407901|P2|Overall Study|Other than listed|4
2444223|NCT02850965|8407902|P1|Overall Study|Other than listed|3
2444224|NCT02850276|8407918|P1|Overall Study|Lost to Follow-up|2
2444225|NCT02850276|8407918|P1|Overall Study|Physician Decision|2
2444226|NCT02850276|8407918|P1|Overall Study|Withdrawal by Subject|14
2444227|NCT02850276|8407918|P1|Overall Study|screen failure|43
2444228|NCT02849990|8407945|P1|Overall Study|Withdrawal by Subject|1
2444229|NCT02849990|8407945|P1|Overall Study|Adverse Event|1
2444230|NCT02849704|8407970|P2|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0
2444231|NCT02849704|8407971|P1|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1
2444232|NCT02849704|8407970|P2|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0
2444233|NCT02849704|8407971|P1|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1
2444234|NCT02849704|8407970|P2|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0
2444235|NCT02849704|8407971|P1|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1
2444236|NCT02849678|8407986|P2|Overall Study|Protocol Violation|6
2444237|NCT02849678|8407987|P1|Overall Study|Protocol Violation|3
2444238|NCT02849626|8408007|P2|Extension Phase A (up to 29 Weeks)|Non-specified|0
2444239|NCT02849626|8408008|P1|Extension Phase A (up to 29 Weeks)|Non-specified|1
2444240|NCT02849626|8408007|P2|Extension Phase A (up to 29 Weeks)|Inadequate therapeutic effect|1
2444241|NCT02849626|8408008|P1|Extension Phase A (up to 29 Weeks)|Inadequate therapeutic effect|3
2444242|NCT02849626|8408007|P2|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0
2444243|NCT02849626|8408008|P1|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4
2444244|NCT02849626|8408007|P2|Extension Phase A (up to 29 Weeks)|Adverse Event|2
2444245|NCT02849626|8408008|P1|Extension Phase A (up to 29 Weeks)|Adverse Event|3
2444246|NCT02849626|8408007|P2|Core Phase (up to 23 Weeks)|Non-specified|0
2444247|NCT02849626|8408008|P1|Core Phase (up to 23 Weeks)|Non-specified|3
2444248|NCT02849626|8408007|P2|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2
2444249|NCT02849626|8408008|P1|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6
2444250|NCT02849626|8408007|P2|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2
2444251|NCT02849626|8408008|P1|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7
2444252|NCT02849626|8408007|P2|Core Phase (up to 23 Weeks)|Adverse Event|3
2444253|NCT02849626|8408008|P1|Core Phase (up to 23 Weeks)|Adverse Event|11
2444254|NCT02849509|8408071|P3|Overall Study|No inform. on termination of Pradaxa/VKA|1
2444255|NCT02849509|8408072|P2|Overall Study|No inform. on termination of Pradaxa/VKA|10
2444256|NCT02849509|8408073|P1|Overall Study|No inform. on termination of Pradaxa/VKA|6
2444257|NCT02849509|8408071|P3|Overall Study|Other, reason not specified|25
2444258|NCT02849509|8408072|P2|Overall Study|Other, reason not specified|29
2444259|NCT02849509|8408073|P1|Overall Study|Other, reason not specified|14
2444260|NCT02849509|8408071|P3|Overall Study|Lost to Follow-up|36
2444261|NCT02849509|8408072|P2|Overall Study|Lost to Follow-up|67
2444262|NCT02849509|8408073|P1|Overall Study|Lost to Follow-up|27
2444263|NCT02849509|8408071|P3|Overall Study|Withdrawal by Subject|12
2444264|NCT02849509|8408072|P2|Overall Study|Withdrawal by Subject|17
2444265|NCT02849509|8408073|P1|Overall Study|Withdrawal by Subject|6
2444266|NCT02849509|8408071|P3|Overall Study|Other adverse event|8
2444267|NCT02849509|8408072|P2|Overall Study|Other adverse event|41
2444268|NCT02849509|8408073|P1|Overall Study|Other adverse event|36
2444269|NCT02849509|8408071|P3|Overall Study|Worsening of other pre-existing disease|2
2444270|NCT02849509|8408072|P2|Overall Study|Worsening of other pre-existing disease|1
2444271|NCT02849509|8408073|P1|Overall Study|Worsening of other pre-existing disease|0
2444272|NCT02849509|8408071|P3|Overall Study|Worsening of disease under study|1
2444273|NCT02849509|8408072|P2|Overall Study|Worsening of disease under study|1
2444274|NCT02849509|8408073|P1|Overall Study|Worsening of disease under study|1
2444275|NCT02849080|8408280|P4|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
2444276|NCT02849080|8408281|P3|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
2444277|NCT02849080|8408282|P2|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
2444278|NCT02849080|8408283|P1|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1
2444279|NCT02849080|8408280|P4|Extension Phase: 53 - 104 Weeks|Other|0
2444280|NCT02849080|8408281|P3|Extension Phase: 53 - 104 Weeks|Other|1
2444281|NCT02849080|8408282|P2|Extension Phase: 53 - 104 Weeks|Other|0
2444282|NCT02849080|8408283|P1|Extension Phase: 53 - 104 Weeks|Other|0
2444283|NCT02849080|8408280|P4|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
2444284|NCT02849080|8408281|P3|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
2444285|NCT02849080|8408282|P2|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
2444286|NCT02849080|8408283|P1|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2
2444287|NCT02849080|8408280|P4|Main Phase: 0 - 52 Weeks|Death|0
2444288|NCT02849080|8408281|P3|Main Phase: 0 - 52 Weeks|Death|0
2444289|NCT02849080|8408282|P2|Main Phase: 0 - 52 Weeks|Death|2
2444290|NCT02849080|8408283|P1|Main Phase: 0 - 52 Weeks|Death|0
2444291|NCT02849080|8408280|P4|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0
2444292|NCT02849080|8408281|P3|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0
2444293|NCT02849080|8408282|P2|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1
2444294|NCT02849080|8408283|P1|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5
2444295|NCT02849080|8408280|P4|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0
2444296|NCT02849080|8408281|P3|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0
2444297|NCT02849080|8408282|P2|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4
2444298|NCT02849080|8408283|P1|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7
2444299|NCT02848729|8408410|P2|Overall Study|Emesis|11
2444300|NCT02848729|8408411|P1|Overall Study|Emesis|15
2444301|NCT02848729|8408410|P2|Overall Study|Withdrawal by Subject|0
2444302|NCT02848729|8408411|P1|Overall Study|Withdrawal by Subject|1
2444303|NCT02848664|8408428|P1|Overall Study|no assistance for device training|1
2444304|NCT02848664|8408428|P1|Overall Study|Adverse Event|1
2444305|NCT02848664|8408428|P1|Overall Study|Withdrawal by Subject|2
2444306|NCT02848651|8408436|P1|Overall Study|Withdrawal by Subject|14
2444307|NCT02848651|8408436|P1|Overall Study|Physician Decision|4
2444308|NCT02848651|8408436|P1|Overall Study|Symptomatic Deterioration|1
2444309|NCT02848651|8408436|P1|Overall Study|Non-Compliance|1
2444310|NCT02848651|8408436|P1|Overall Study|Lost to Follow-up|1
2444311|NCT02848651|8408436|P1|Overall Study|Death|85
2444312|NCT02848326|8408469|P6|Safety Follow-up Period|Lost to Follow-up|3
2444313|NCT02848326|8408470|P5|Safety Follow-up Period|Lost to Follow-up|1
2444314|NCT02848326|8408471|P4|Safety Follow-up Period|Lost to Follow-up|0
2444315|NCT02848326|8408472|P3|Safety Follow-up Period|Lost to Follow-up|2
2444316|NCT02848326|8408473|P2|Safety Follow-up Period|Lost to Follow-up|0
2444317|NCT02848326|8408474|P1|Safety Follow-up Period|Lost to Follow-up|4
2444318|NCT02848326|8408469|P6|Safety Follow-up Period|Withdrawal of Consent|2
2444319|NCT02848326|8408470|P5|Safety Follow-up Period|Withdrawal of Consent|0
2444320|NCT02848326|8408471|P4|Safety Follow-up Period|Withdrawal of Consent|0
2444321|NCT02848326|8408472|P3|Safety Follow-up Period|Withdrawal of Consent|1
2444322|NCT02848326|8408473|P2|Safety Follow-up Period|Withdrawal of Consent|1
2444323|NCT02848326|8408474|P1|Safety Follow-up Period|Withdrawal of Consent|0
2444324|NCT02848326|8408469|P6|Treatment Period|Non-compliance with Study Drug|0
2444325|NCT02848326|8408470|P5|Treatment Period|Non-compliance with Study Drug|0
2444326|NCT02848326|8408471|P4|Treatment Period|Non-compliance with Study Drug|1
2444327|NCT02848326|8408472|P3|Treatment Period|Non-compliance with Study Drug|0
2444328|NCT02848326|8408473|P2|Treatment Period|Non-compliance with Study Drug|0
2444329|NCT02848326|8408474|P1|Treatment Period|Non-compliance with Study Drug|4
2444330|NCT02848326|8408469|P6|Treatment Period|Protocol Violation|3
2444331|NCT02848326|8408470|P5|Treatment Period|Protocol Violation|3
2444332|NCT02848326|8408471|P4|Treatment Period|Protocol Violation|2
2444333|NCT02848326|8408472|P3|Treatment Period|Protocol Violation|4
2444334|NCT02848326|8408473|P2|Treatment Period|Protocol Violation|3
2444335|NCT02848326|8408474|P1|Treatment Period|Protocol Violation|4
2444336|NCT02848326|8408469|P6|Treatment Period|Pregnancy|1
2444337|NCT02848326|8408470|P5|Treatment Period|Pregnancy|0
2444338|NCT02848326|8408471|P4|Treatment Period|Pregnancy|1
2444339|NCT02848326|8408472|P3|Treatment Period|Pregnancy|1
2444340|NCT02848326|8408473|P2|Treatment Period|Pregnancy|0
2444341|NCT02848326|8408474|P1|Treatment Period|Pregnancy|0
2444342|NCT02848326|8408469|P6|Treatment Period|Lost to Follow-up|3
2444343|NCT02848326|8408470|P5|Treatment Period|Lost to Follow-up|2
2444344|NCT02848326|8408471|P4|Treatment Period|Lost to Follow-up|7
2444345|NCT02848326|8408472|P3|Treatment Period|Lost to Follow-up|11
2444346|NCT02848326|8408473|P2|Treatment Period|Lost to Follow-up|1
2444347|NCT02848326|8408474|P1|Treatment Period|Lost to Follow-up|5
2444348|NCT02848326|8408469|P6|Treatment Period|Withdrawal of Consent|6
2444349|NCT02848326|8408470|P5|Treatment Period|Withdrawal of Consent|9
2444350|NCT02848326|8408471|P4|Treatment Period|Withdrawal of Consent|6
2444351|NCT02848326|8408472|P3|Treatment Period|Withdrawal of Consent|9
2444352|NCT02848326|8408473|P2|Treatment Period|Withdrawal of Consent|6
2444353|NCT02848326|8408474|P1|Treatment Period|Withdrawal of Consent|20
2444354|NCT02848326|8408469|P6|Treatment Period|Adverse Event|7
2444355|NCT02848326|8408470|P5|Treatment Period|Adverse Event|5
2444356|NCT02848326|8408471|P4|Treatment Period|Adverse Event|6
2444357|NCT02848326|8408472|P3|Treatment Period|Adverse Event|11
2444358|NCT02848326|8408473|P2|Treatment Period|Adverse Event|4
2444359|NCT02848326|8408474|P1|Treatment Period|Adverse Event|5
2444360|NCT02847858|8408521|P2|Overall Study|Lost to Follow-up|269
2444361|NCT02847858|8408522|P1|Overall Study|Lost to Follow-up|401
2444362|NCT02847650|8408548|P2|Overall Study|Withdrawal by Subject|1
2444363|NCT02847650|8408549|P1|Overall Study|Withdrawal by Subject|1
2444364|NCT02847650|8408548|P2|Overall Study|Protocol Violation|1
2444365|NCT02847650|8408549|P1|Overall Study|Protocol Violation|0
2444366|NCT02847650|8408548|P2|Overall Study|Lost to Follow-up|0
2444367|NCT02847650|8408549|P1|Overall Study|Lost to Follow-up|1
2444368|NCT02847650|8408548|P2|Overall Study|Adverse Event|4
2444369|NCT02847650|8408549|P1|Overall Study|Adverse Event|2
2444370|NCT02847637|8408573|P4|Overall Study|First emicizumab dose delayed|0
2444371|NCT02847637|8408574|P3|Overall Study|First emicizumab dose delayed|0
2444372|NCT02847637|8408575|P2|Overall Study|First emicizumab dose delayed|0
2444373|NCT02847637|8408576|P1|Overall Study|First emicizumab dose delayed|1
2444374|NCT02847637|8408573|P4|Overall Study|Ongoing treatment with emicizumab|63
2444375|NCT02847637|8408574|P3|Overall Study|Ongoing treatment with emicizumab|34
2444376|NCT02847637|8408575|P2|Overall Study|Ongoing treatment with emicizumab|35
2444377|NCT02847637|8408576|P1|Overall Study|Ongoing treatment with emicizumab|16
2444378|NCT02847637|8408573|P4|Overall Study|Withdrew from treatment due to AE|0
2444379|NCT02847637|8408574|P3|Overall Study|Withdrew from treatment due to AE|1
2444380|NCT02847637|8408575|P2|Overall Study|Withdrew from treatment due to AE|0
2444381|NCT02847637|8408576|P1|Overall Study|Withdrew from treatment due to AE|0
2444382|NCT02847494|8408690|P2|Overall Study|Lost to Follow-up|5
2444383|NCT02847494|8408691|P1|Overall Study|Lost to Follow-up|8
2444384|NCT02847260|8408701|P1|Overall Study|Physician Decision|1
2444385|NCT02847260|8408701|P1|Overall Study|Clinical Deterioration|1
2444386|NCT02847260|8408701|P1|Overall Study|Withdrawal by Subject|2
2444387|NCT02847260|8408701|P1|Overall Study|Adverse Event|3
2444388|NCT02847182|8408715|P2|Overall Study|Withdrawal by Subject|1
2444389|NCT02847182|8408716|P1|Overall Study|Withdrawal by Subject|0
2444390|NCT02846779|8408816|P3|Overall Study|Less than 31 days of follow-up|52
2444391|NCT02846779|8408817|P2|Overall Study|Less than 31 days of follow-up|45
2444392|NCT02846779|8408818|P1|Overall Study|Less than 31 days of follow-up|56
2444393|NCT02846779|8408816|P3|Overall Study|Lost Enrollment|86
2444394|NCT02846779|8408817|P2|Overall Study|Lost Enrollment|82
2444395|NCT02846779|8408818|P1|Overall Study|Lost Enrollment|83
2444396|NCT02846558|8408874|P4|Overall Study|Lost to Follow-up|0
2444397|NCT02846558|8408875|P3|Overall Study|Lost to Follow-up|0
2444398|NCT02846558|8408876|P2|Overall Study|Lost to Follow-up|0
2444399|NCT02846558|8408877|P1|Overall Study|Lost to Follow-up|2
2444400|NCT02846558|8408874|P4|Overall Study|Withdrawal by Subject|2
2444401|NCT02846558|8408875|P3|Overall Study|Withdrawal by Subject|2
2444402|NCT02846558|8408876|P2|Overall Study|Withdrawal by Subject|4
2444403|NCT02846558|8408877|P1|Overall Study|Withdrawal by Subject|5
2444404|NCT02846558|8408874|P4|Overall Study|Adverse Event|0
2444405|NCT02846558|8408875|P3|Overall Study|Adverse Event|0
2444406|NCT02846558|8408876|P2|Overall Study|Adverse Event|0
2444407|NCT02846558|8408877|P1|Overall Study|Adverse Event|1
2444408|NCT02845375|8408942|P3|Overall Study|upper airway obstruction|1
2444409|NCT02845375|8408943|P2|Overall Study|upper airway obstruction|2
2444410|NCT02845375|8408944|P1|Overall Study|upper airway obstruction|1
2444411|NCT02844946|8408973|P2|Overall Study|Lost to Follow-up|0
2444412|NCT02844946|8408974|P1|Overall Study|Lost to Follow-up|7
2444413|NCT02844920|8408992|P1|Overall Study|Lost to Follow-up|2
2444414|NCT02844543|8409010|P1|Overall Study|Did not meet eligibility criteria|1
2444415|NCT02844543|8409010|P1|Overall Study|Withdrawal by Subject|4
2444416|NCT02843659|8409020|P3|Overall Study|Adverse Event|0
2444417|NCT02843659|8409021|P2|Overall Study|Adverse Event|1
2444418|NCT02843659|8409022|P1|Overall Study|Adverse Event|0
2444419|NCT02843659|8409020|P3|Overall Study|Administrative Reason by Sponsor|4
2444420|NCT02843659|8409021|P2|Overall Study|Administrative Reason by Sponsor|5
2444421|NCT02843659|8409022|P1|Overall Study|Administrative Reason by Sponsor|4
2444422|NCT02843659|8409020|P3|Overall Study|Subject Withdrew Consent|1
2444423|NCT02843659|8409021|P2|Overall Study|Subject Withdrew Consent|0
2444424|NCT02843659|8409022|P1|Overall Study|Subject Withdrew Consent|0
2444425|NCT02843178|8409091|P4|Overall Study|Withdrawal by Subject|1
2444426|NCT02843178|8409092|P3|Overall Study|Withdrawal by Subject|1
2444427|NCT02843178|8409093|P2|Overall Study|Withdrawal by Subject|0
2444428|NCT02843178|8409094|P1|Overall Study|Withdrawal by Subject|0
2444429|NCT02843178|8409091|P4|Overall Study|Lost to Follow-up|3
2444430|NCT02843178|8409092|P3|Overall Study|Lost to Follow-up|6
2444431|NCT02843178|8409093|P2|Overall Study|Lost to Follow-up|8
2444432|NCT02843178|8409094|P1|Overall Study|Lost to Follow-up|8
2444433|NCT02842866|8409134|P2|Overall Study|Withdrawal by Subject|0
2444434|NCT02842866|8409135|P1|Overall Study|Withdrawal by Subject|1
2444435|NCT02842866|8409134|P2|Overall Study|Lost to Follow-up|0
2444436|NCT02842866|8409135|P1|Overall Study|Lost to Follow-up|2
2444437|NCT02842866|8409134|P2|Overall Study|Protocol Violation|2
2444438|NCT02842866|8409135|P1|Overall Study|Protocol Violation|4
2444439|NCT02842866|8409134|P2|Overall Study|Serious Adverse Event|1
2444440|NCT02842866|8409135|P1|Overall Study|Serious Adverse Event|0
2444441|NCT02842853|8409147|P4|Overall Study|Lost to Follow-up|11
2444442|NCT02842853|8409148|P3|Overall Study|Lost to Follow-up|10
2444443|NCT02842853|8409149|P2|Overall Study|Lost to Follow-up|13
2444444|NCT02842853|8409150|P1|Overall Study|Lost to Follow-up|9
2444445|NCT02842853|8409147|P4|Overall Study|Withdrawal by Subject|8
2444446|NCT02842853|8409148|P3|Overall Study|Withdrawal by Subject|9
2444447|NCT02842853|8409149|P2|Overall Study|Withdrawal by Subject|13
2444448|NCT02842853|8409150|P1|Overall Study|Withdrawal by Subject|11
2444449|NCT02842853|8409147|P4|Overall Study|Subject met exclusion criteria|0
2444450|NCT02842853|8409148|P3|Overall Study|Subject met exclusion criteria|0
2444451|NCT02842853|8409149|P2|Overall Study|Subject met exclusion criteria|1
2444452|NCT02842853|8409150|P1|Overall Study|Subject met exclusion criteria|0
2444453|NCT02842853|8409147|P4|Overall Study|Non-compliance with the protocol|5
2444454|NCT02842853|8409148|P3|Overall Study|Non-compliance with the protocol|2
2444455|NCT02842853|8409149|P2|Overall Study|Non-compliance with the protocol|7
2444456|NCT02842853|8409150|P1|Overall Study|Non-compliance with the protocol|3
2444457|NCT02842736|8409170|P1|Overall Study|Diary or safety evaluation not available|1
2444458|NCT02842736|8409170|P1|Overall Study|Intervention for menstrual bleeding|4
2444459|NCT02842736|8409170|P1|Overall Study|Lost to Follow-up|7
2444460|NCT02842151|8409200|P1|Overall Study|Subject moved too far away|1
2444461|NCT02842151|8409200|P1|Overall Study|Adverse Event|1
2444462|NCT02842086|8409208|P2|Overall Study|HIV-1 Infection|6
2444463|NCT02842086|8409209|P1|Overall Study|HIV-1 Infection|4
2444464|NCT02842086|8409208|P2|Overall Study|Lost to Follow-up|172
2444465|NCT02842086|8409209|P1|Overall Study|Lost to Follow-up|206
2444466|NCT02842086|8409208|P2|Overall Study|Withdrew Consent|146
2444467|NCT02842086|8409209|P1|Overall Study|Withdrew Consent|157
2444468|NCT02842086|8409208|P2|Overall Study|Protocol Violation|2
2444469|NCT02842086|8409209|P1|Overall Study|Protocol Violation|4
2444470|NCT02842086|8409208|P2|Overall Study|Non-Compliance with Study Drug|7
2444471|NCT02842086|8409209|P1|Overall Study|Non-Compliance with Study Drug|6
2444472|NCT02842086|8409208|P2|Overall Study|Investigator's Discretion|10
2444473|NCT02842086|8409209|P1|Overall Study|Investigator's Discretion|6
2444474|NCT02842086|8409208|P2|Overall Study|Death|2
2444475|NCT02842086|8409209|P1|Overall Study|Death|1
2444476|NCT02842086|8409208|P2|Overall Study|Adverse Event|20
2444477|NCT02842086|8409209|P1|Overall Study|Adverse Event|15
2444478|NCT02842086|8409208|P2|Overall Study|Still on Study|2328
2444479|NCT02842086|8409209|P1|Overall Study|Still on Study|2295
2444480|NCT02842086|8409208|P2|Overall Study|Randomized but Never Treated|6
2444481|NCT02842086|8409209|P1|Overall Study|Randomized but Never Treated|6
2444482|NCT02842073|8409243|P1|Overall Study|Withdrawal by Subject|1
2444483|NCT02841787|8409269|P3|Overall Study|Withdrawal by Subject|0
2444484|NCT02841787|8409270|P2|Overall Study|Withdrawal by Subject|4
2444485|NCT02841787|8409271|P1|Overall Study|Withdrawal by Subject|1
2444486|NCT02841787|8409269|P3|Overall Study|Symptoms dropped below threshold|0
2444487|NCT02841787|8409270|P2|Overall Study|Symptoms dropped below threshold|0
2444488|NCT02841787|8409271|P1|Overall Study|Symptoms dropped below threshold|1
2444489|NCT02841787|8409269|P3|Overall Study|Lost to Follow-up|0
2444490|NCT02841787|8409270|P2|Overall Study|Lost to Follow-up|0
2444491|NCT02841787|8409271|P1|Overall Study|Lost to Follow-up|1
2444492|NCT02841709|8409285|P5|5th Intervention|Adverse Event|2
2444493|NCT02841709|8409286|P4|5th Intervention|Adverse Event|0
2444494|NCT02841709|8409287|P3|5th Intervention|Adverse Event|0
2444495|NCT02841709|8409288|P2|5th Intervention|Adverse Event|0
2444496|NCT02841709|8409289|P1|5th Intervention|Adverse Event|2
2444497|NCT02840721|8409340|P1|Follow-Up|Withdrawal of Consent|2
2444498|NCT02840721|8409340|P1|Follow-Up|Withdrawal by Subject|4
2444499|NCT02840721|8409340|P1|Follow-Up|Lack of Efficacy|1
2444500|NCT02840721|8409340|P1|Treatment Period|Adverse Event|1
2444501|NCT02840253|8409359|P1|Overall Study|Unsuccessful block|4
2444502|NCT02839876|8409444|P2|Overall Study|Protocol Violation|11
2444503|NCT02839876|8409445|P1|Overall Study|Protocol Violation|10
2444504|NCT02839798|8409507|P1|Overall Study|Withdrawal by Subject|2
2444505|NCT02839746|8409553|P1|Overall Study|Not met selection criteria|12
2444506|NCT02839681|8409567|P1|Overall Study|Death|2
2444507|NCT02839330|8409580|P4|Overall Study|Other reason, not specified|6
2444508|NCT02839330|8409581|P3|Overall Study|Other reason, not specified|3
2444509|NCT02839330|8409582|P2|Overall Study|Other reason, not specified|3
2444510|NCT02839330|8409583|P1|Overall Study|Other reason, not specified|4
2444511|NCT02839330|8409580|P4|Overall Study|Protocol Violation|3
2444512|NCT02839330|8409581|P3|Overall Study|Protocol Violation|2
2444513|NCT02839330|8409582|P2|Overall Study|Protocol Violation|2
2444514|NCT02839330|8409583|P1|Overall Study|Protocol Violation|1
2444515|NCT02839330|8409580|P4|Overall Study|Administrative Reason|1
2444516|NCT02839330|8409581|P3|Overall Study|Administrative Reason|0
2444517|NCT02839330|8409582|P2|Overall Study|Administrative Reason|0
2444518|NCT02839330|8409583|P1|Overall Study|Administrative Reason|0
2444519|NCT02839330|8409580|P4|Overall Study|Lost to Follow-up|25
2444520|NCT02839330|8409581|P3|Overall Study|Lost to Follow-up|29
2444521|NCT02839330|8409582|P2|Overall Study|Lost to Follow-up|27
2444522|NCT02839330|8409583|P1|Overall Study|Lost to Follow-up|22
2444523|NCT02839330|8409580|P4|Overall Study|Withdrawal by Subject|13
2444524|NCT02839330|8409581|P3|Overall Study|Withdrawal by Subject|11
2444525|NCT02839330|8409582|P2|Overall Study|Withdrawal by Subject|19
2444526|NCT02839330|8409583|P1|Overall Study|Withdrawal by Subject|27
2444527|NCT02839330|8409580|P4|Overall Study|Death|1
2444528|NCT02839330|8409581|P3|Overall Study|Death|1
2444529|NCT02839330|8409582|P2|Overall Study|Death|6
2444530|NCT02839330|8409583|P1|Overall Study|Death|4
2444531|NCT02839330|8409580|P4|Overall Study|Adverse Event|2
2444532|NCT02839330|8409581|P3|Overall Study|Adverse Event|2
2444533|NCT02839330|8409582|P2|Overall Study|Adverse Event|1
2444534|NCT02839330|8409583|P1|Overall Study|Adverse Event|0
2444535|NCT02839200|8409618|P6|Overall Study|Randomized in error|0
2444536|NCT02839200|8409619|P5|Overall Study|Randomized in error|0
2444537|NCT02839200|8409620|P4|Overall Study|Randomized in error|0
2444538|NCT02839200|8409621|P3|Overall Study|Randomized in error|0
2444539|NCT02839200|8409622|P2|Overall Study|Randomized in error|1
2444540|NCT02839200|8409623|P1|Overall Study|Randomized in error|0
2444541|NCT02839200|8409618|P6|Overall Study|Adverse Event|0
2444542|NCT02839200|8409619|P5|Overall Study|Adverse Event|1
2444543|NCT02839200|8409620|P4|Overall Study|Adverse Event|0
2444544|NCT02839200|8409621|P3|Overall Study|Adverse Event|0
2444545|NCT02839200|8409622|P2|Overall Study|Adverse Event|0
2444546|NCT02839200|8409623|P1|Overall Study|Adverse Event|0
2444547|NCT02839200|8409618|P6|Overall Study|Lost to Follow-up|0
2444548|NCT02839200|8409619|P5|Overall Study|Lost to Follow-up|1
2444549|NCT02839200|8409620|P4|Overall Study|Lost to Follow-up|0
2444550|NCT02839200|8409621|P3|Overall Study|Lost to Follow-up|0
2444551|NCT02839200|8409622|P2|Overall Study|Lost to Follow-up|0
2444552|NCT02839200|8409623|P1|Overall Study|Lost to Follow-up|2
2444553|NCT02839200|8409618|P6|Overall Study|Withdrawal by Subject|1
2444554|NCT02839200|8409619|P5|Overall Study|Withdrawal by Subject|0
2444555|NCT02839200|8409620|P4|Overall Study|Withdrawal by Subject|0
2444556|NCT02839200|8409621|P3|Overall Study|Withdrawal by Subject|1
2444557|NCT02839200|8409622|P2|Overall Study|Withdrawal by Subject|0
2444558|NCT02839200|8409623|P1|Overall Study|Withdrawal by Subject|2
2444559|NCT02838901|8409657|P2|Overall Study|Lost to Follow-up|1
2444560|NCT02838901|8409658|P1|Overall Study|Lost to Follow-up|1
2444561|NCT02838901|8409657|P2|Overall Study|Withdrawal by Subject|1
2444562|NCT02838901|8409658|P1|Overall Study|Withdrawal by Subject|1
2444563|NCT02838420|8409688|P2|Overall Study|Death|13
2444564|NCT02838420|8409689|P1|Overall Study|Death|8
2444565|NCT02838420|8409688|P2|Overall Study|Withdrawal by Subject|4
2444566|NCT02838420|8409689|P1|Overall Study|Withdrawal by Subject|3
2444567|NCT02838420|8409688|P2|Overall Study|Lost to Follow-up|0
2444568|NCT02838420|8409689|P1|Overall Study|Lost to Follow-up|1
2444569|NCT02838420|8409688|P2|Overall Study|Ongoing in Study|45
2444570|NCT02838420|8409689|P1|Overall Study|Ongoing in Study|113
2444571|NCT02838134|8409752|P2|Overall Study|logistic problems|1
2444572|NCT02838134|8409753|P1|Overall Study|logistic problems|1
2444573|NCT02838134|8409752|P2|Overall Study|Lost to Follow-up|2
2444574|NCT02838134|8409753|P1|Overall Study|Lost to Follow-up|1
2444575|NCT02838017|8409785|P2|Overall Study|Lost to Follow-up|11
2444576|NCT02838017|8409786|P1|Overall Study|Lost to Follow-up|14
2444577|NCT02837952|8409804|P2|Overall Study|Medication Error|0
2444578|NCT02837952|8409805|P1|Overall Study|Medication Error|1
2444579|NCT02837952|8409804|P2|Overall Study|Withdrawal by Subject|5
2444580|NCT02837952|8409805|P1|Overall Study|Withdrawal by Subject|4
2444581|NCT02837952|8409804|P2|Overall Study|Adverse Event|1
2444582|NCT02837952|8409805|P1|Overall Study|Adverse Event|0
2444583|NCT02836613|8409857|P2|Overall Study|Withdrawal by Subject|2
2444584|NCT02836613|8409858|P1|Overall Study|Withdrawal by Subject|0
2444585|NCT02836613|8409857|P2|Overall Study|Lost to Follow-up|1
2444586|NCT02836613|8409858|P1|Overall Study|Lost to Follow-up|0
2444587|NCT02836613|8409857|P2|Overall Study|Accidental drowning|0
2444588|NCT02836613|8409858|P1|Overall Study|Accidental drowning|1
2444589|NCT02836496|8409872|P2|Overall Study|Withdrawal by Subject|1
2444590|NCT02836496|8409873|P1|Overall Study|Withdrawal by Subject|0
2444591|NCT02836496|8409872|P2|Overall Study|Adverse Event|1
2444592|NCT02836496|8409873|P1|Overall Study|Adverse Event|2
2444593|NCT02836249|8409889|P2|Overall Study|Still on Study|55
2444594|NCT02836249|8409890|P1|Overall Study|Still on Study|121
2444595|NCT02836249|8409889|P2|Overall Study|Lost to Follow-up|1
2444596|NCT02836249|8409890|P1|Overall Study|Lost to Follow-up|0
2444597|NCT02836249|8409889|P2|Overall Study|Withdrew Consent|1
2444598|NCT02836249|8409890|P1|Overall Study|Withdrew Consent|0
2444599|NCT02836249|8409889|P2|Overall Study|Pregnancy|0
2444600|NCT02836249|8409890|P1|Overall Study|Pregnancy|2
2444601|NCT02836249|8409889|P2|Overall Study|Randomized but Never Treated|1
2444602|NCT02836249|8409890|P1|Overall Study|Randomized but Never Treated|0
2444603|NCT02836236|8409908|P2|Overall Study|Still on Study|49
2444604|NCT02836236|8409909|P1|Overall Study|Still on Study|101
2444605|NCT02836236|8409908|P2|Overall Study|Investigator's Discretion|0
2444606|NCT02836236|8409909|P1|Overall Study|Investigator's Discretion|1
2444607|NCT02836236|8409908|P2|Overall Study|Adverse Event|1
2444608|NCT02836236|8409909|P1|Overall Study|Adverse Event|0
2444609|NCT02836236|8409908|P2|Overall Study|Withdrew Consent|0
2444610|NCT02836236|8409909|P1|Overall Study|Withdrew Consent|2
2444611|NCT02836236|8409908|P2|Overall Study|Randomized but Never Treated|0
2444612|NCT02836236|8409909|P1|Overall Study|Randomized but Never Treated|1
2444613|NCT02835820|8409925|P2|Overall Study|Baseline Screen Failure|3
2444614|NCT02835820|8409926|P1|Overall Study|Baseline Screen Failure|0
2444615|NCT02835690|8409973|P3|Overall Study|Not Treated|0
2444616|NCT02835690|8409974|P2|Overall Study|Not Treated|2
2444617|NCT02835690|8409975|P1|Overall Study|Not Treated|0
2444618|NCT02835690|8409973|P3|Overall Study|Ongoing in Study (Follow-up)|9
2444619|NCT02835690|8409974|P2|Overall Study|Ongoing in Study (Follow-up)|7
2444620|NCT02835690|8409975|P1|Overall Study|Ongoing in Study (Follow-up)|10
2444621|NCT02835690|8409973|P3|Overall Study|Death|6
2444622|NCT02835690|8409974|P2|Overall Study|Death|6
2444623|NCT02835690|8409975|P1|Overall Study|Death|4
2444624|NCT02835092|8410048|P3|Overall Study|Lost to Follow-up|0
2444625|NCT02835092|8410049|P2|Overall Study|Lost to Follow-up|2
2444626|NCT02835092|8410050|P1|Overall Study|Lost to Follow-up|0
2444627|NCT02835092|8410048|P3|Overall Study|Withdrawal by Subject|3
2444628|NCT02835092|8410049|P2|Overall Study|Withdrawal by Subject|6
2444629|NCT02835092|8410050|P1|Overall Study|Withdrawal by Subject|3
2444630|NCT02834819|8410060|P2|Overall Study|Did not complete 7 day follow up call.|0
2444631|NCT02834819|8410061|P1|Overall Study|Did not complete 7 day follow up call.|5
2444632|NCT02834247|8410116|P4|Dose Expansion Phase|Withdrawal by Subject|1
2444633|NCT02834247|8410117|P3|Dose Expansion Phase|Withdrawal by Subject|0
2444634|NCT02834247|8410118|P2|Dose Expansion Phase|Withdrawal by Subject|0
2444635|NCT02834247|8410119|P1|Dose Expansion Phase|Withdrawal by Subject|0
2444636|NCT02834247|8410116|P4|Dose Expansion Phase|Lost to Follow-up|1
2444637|NCT02834247|8410117|P3|Dose Expansion Phase|Lost to Follow-up|0
2444638|NCT02834247|8410118|P2|Dose Expansion Phase|Lost to Follow-up|0
2444639|NCT02834247|8410119|P1|Dose Expansion Phase|Lost to Follow-up|0
2444640|NCT02834247|8410116|P4|Dose Expansion Phase|Death|8
2444641|NCT02834247|8410117|P3|Dose Expansion Phase|Death|0
2444642|NCT02834247|8410118|P2|Dose Expansion Phase|Death|0
2444643|NCT02834247|8410119|P1|Dose Expansion Phase|Death|0
2444644|NCT02834247|8410116|P4|Dose Expansion Phase|Study Terminated by Sponsor|7
2444645|NCT02834247|8410117|P3|Dose Expansion Phase|Study Terminated by Sponsor|0
2444646|NCT02834247|8410118|P2|Dose Expansion Phase|Study Terminated by Sponsor|0
2444647|NCT02834247|8410119|P1|Dose Expansion Phase|Study Terminated by Sponsor|0
2444648|NCT02834247|8410116|P4|Dose Escalation Phase|Withdrawal by Subject|0
2444649|NCT02834247|8410117|P3|Dose Escalation Phase|Withdrawal by Subject|0
2444650|NCT02834247|8410118|P2|Dose Escalation Phase|Withdrawal by Subject|2
2444651|NCT02834247|8410119|P1|Dose Escalation Phase|Withdrawal by Subject|2
2444652|NCT02834247|8410116|P4|Dose Escalation Phase|Lost to Follow-up|0
2444653|NCT02834247|8410117|P3|Dose Escalation Phase|Lost to Follow-up|0
2444654|NCT02834247|8410118|P2|Dose Escalation Phase|Lost to Follow-up|1
2444655|NCT02834247|8410119|P1|Dose Escalation Phase|Lost to Follow-up|0
2444656|NCT02834247|8410116|P4|Dose Escalation Phase|Death|0
2444657|NCT02834247|8410117|P3|Dose Escalation Phase|Death|5
2444658|NCT02834247|8410118|P2|Dose Escalation Phase|Death|6
2444659|NCT02834247|8410119|P1|Dose Escalation Phase|Death|5
2444660|NCT02834247|8410116|P4|Dose Escalation Phase|Study Terminated by Sponsor|0
2444661|NCT02834247|8410117|P3|Dose Escalation Phase|Study Terminated by Sponsor|0
2444662|NCT02834247|8410118|P2|Dose Escalation Phase|Study Terminated by Sponsor|2
2444663|NCT02834247|8410119|P1|Dose Escalation Phase|Study Terminated by Sponsor|1
2444664|NCT02833974|8410148|P2|Overall Study|Adverse Event|3
2444665|NCT02833974|8410149|P1|Overall Study|Adverse Event|0
2444666|NCT02833974|8410148|P2|Overall Study|Lost to Follow-up|0
2444667|NCT02833974|8410149|P1|Overall Study|Lost to Follow-up|1
2444668|NCT02833948|8410175|P2|Overall Study|scans could not be evaluated|2
2444669|NCT02833948|8410176|P1|Overall Study|scans could not be evaluated|5
2444670|NCT02833948|8410175|P2|Overall Study|were not scanned|13
2444671|NCT02833948|8410176|P1|Overall Study|were not scanned|8
2444672|NCT02833948|8410175|P2|Overall Study|Death|3
2444673|NCT02833948|8410176|P1|Overall Study|Death|2
2444674|NCT02833350|8410249|P7|Overall Study|Withdrawal by Subject|2
2444675|NCT02833350|8410250|P6|Overall Study|Withdrawal by Subject|0
2444676|NCT02833350|8410251|P5|Overall Study|Withdrawal by Subject|2
2444677|NCT02833350|8410252|P4|Overall Study|Withdrawal by Subject|0
2444678|NCT02833350|8410253|P3|Overall Study|Withdrawal by Subject|2
2444679|NCT02833350|8410254|P2|Overall Study|Withdrawal by Subject|3
2444680|NCT02833350|8410255|P1|Overall Study|Withdrawal by Subject|3
2444681|NCT02833350|8410249|P7|Overall Study|Lost to Follow-up|1
2444682|NCT02833350|8410250|P6|Overall Study|Lost to Follow-up|0
2444683|NCT02833350|8410251|P5|Overall Study|Lost to Follow-up|0
2444684|NCT02833350|8410252|P4|Overall Study|Lost to Follow-up|0
2444685|NCT02833350|8410253|P3|Overall Study|Lost to Follow-up|0
2444686|NCT02833350|8410254|P2|Overall Study|Lost to Follow-up|1
2444687|NCT02833350|8410255|P1|Overall Study|Lost to Follow-up|0
2444688|NCT02833350|8410249|P7|Overall Study|Lack of Efficacy|1
2444689|NCT02833350|8410250|P6|Overall Study|Lack of Efficacy|1
2444690|NCT02833350|8410251|P5|Overall Study|Lack of Efficacy|0
2444691|NCT02833350|8410252|P4|Overall Study|Lack of Efficacy|4
2444692|NCT02833350|8410253|P3|Overall Study|Lack of Efficacy|1
2444693|NCT02833350|8410254|P2|Overall Study|Lack of Efficacy|2
2444694|NCT02833350|8410255|P1|Overall Study|Lack of Efficacy|0
2444695|NCT02833350|8410249|P7|Overall Study|Death|0
2444696|NCT02833350|8410250|P6|Overall Study|Death|0
2444697|NCT02833350|8410251|P5|Overall Study|Death|0
2444698|NCT02833350|8410252|P4|Overall Study|Death|0
2444699|NCT02833350|8410253|P3|Overall Study|Death|1
2444700|NCT02833350|8410254|P2|Overall Study|Death|0
2444701|NCT02833350|8410255|P1|Overall Study|Death|0
2444702|NCT02833350|8410249|P7|Overall Study|Adverse Event|1
2444703|NCT02833350|8410250|P6|Overall Study|Adverse Event|0
2444704|NCT02833350|8410251|P5|Overall Study|Adverse Event|1
2444705|NCT02833350|8410252|P4|Overall Study|Adverse Event|4
2444706|NCT02833350|8410253|P3|Overall Study|Adverse Event|4
2444707|NCT02833350|8410254|P2|Overall Study|Adverse Event|3
2444708|NCT02833350|8410255|P1|Overall Study|Adverse Event|0
2444709|NCT02832375|8410467|P2|Overall Study|Withdrawal of Consent|0
2444710|NCT02832375|8410468|P1|Overall Study|Withdrawal of Consent|1
2444711|NCT02832375|8410467|P2|Overall Study|Lost to Follow-up|0
2444712|NCT02832375|8410468|P1|Overall Study|Lost to Follow-up|1
2444713|NCT02831855|8410486|P3|Double Blind Phase (24 Weeks)|Randomized but not Treated|0
2444714|NCT02831855|8410487|P2|Double Blind Phase (24 Weeks)|Randomized but not Treated|3
2444715|NCT02831855|8410488|P1|Double Blind Phase (24 Weeks)|Randomized but not Treated|0
2444716|NCT02831855|8410486|P3|Double Blind Phase (24 Weeks)|Protocol Violation|2
2444717|NCT02831855|8410487|P2|Double Blind Phase (24 Weeks)|Protocol Violation|5
2444718|NCT02831855|8410488|P1|Double Blind Phase (24 Weeks)|Protocol Violation|0
2444719|NCT02831855|8410486|P3|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1
2444720|NCT02831855|8410487|P2|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6
2444721|NCT02831855|8410488|P1|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0
2444722|NCT02831855|8410486|P3|Double Blind Phase (24 Weeks)|Other|5
2444723|NCT02831855|8410487|P2|Double Blind Phase (24 Weeks)|Other|2
2444724|NCT02831855|8410488|P1|Double Blind Phase (24 Weeks)|Other|0
2444725|NCT02831855|8410486|P3|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2
2444726|NCT02831855|8410487|P2|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5
2444727|NCT02831855|8410488|P1|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0
2444728|NCT02831855|8410486|P3|Double Blind Phase (24 Weeks)|Screen Failure|0
2444729|NCT02831855|8410487|P2|Double Blind Phase (24 Weeks)|Screen Failure|1
2444730|NCT02831855|8410488|P1|Double Blind Phase (24 Weeks)|Screen Failure|0
2444731|NCT02831855|8410486|P3|Double Blind Phase (24 Weeks)|Lost to Follow-up|1
2444732|NCT02831855|8410487|P2|Double Blind Phase (24 Weeks)|Lost to Follow-up|1
2444733|NCT02831855|8410488|P1|Double Blind Phase (24 Weeks)|Lost to Follow-up|0
2444734|NCT02831855|8410486|P3|Double Blind Phase (24 Weeks)|Death|2
2444735|NCT02831855|8410487|P2|Double Blind Phase (24 Weeks)|Death|0
2444736|NCT02831855|8410488|P1|Double Blind Phase (24 Weeks)|Death|0
2444737|NCT02831855|8410486|P3|Double Blind Phase (24 Weeks)|Adverse Event|6
2444738|NCT02831855|8410487|P2|Double Blind Phase (24 Weeks)|Adverse Event|6
2444739|NCT02831855|8410488|P1|Double Blind Phase (24 Weeks)|Adverse Event|0
2444740|NCT02831855|8410486|P3|Open Label Phase (24 Weeks)|Other|0
2444741|NCT02831855|8410487|P2|Open Label Phase (24 Weeks)|Other|0
2444742|NCT02831855|8410488|P1|Open Label Phase (24 Weeks)|Other|4
2444743|NCT02831855|8410486|P3|Open Label Phase (24 Weeks)|Withdrawal by Subject|0
2444744|NCT02831855|8410487|P2|Open Label Phase (24 Weeks)|Withdrawal by Subject|0
2444745|NCT02831855|8410488|P1|Open Label Phase (24 Weeks)|Withdrawal by Subject|6
2444746|NCT02831855|8410486|P3|Open Label Phase (24 Weeks)|Protocol Violation|0
2444747|NCT02831855|8410487|P2|Open Label Phase (24 Weeks)|Protocol Violation|0
2444748|NCT02831855|8410488|P1|Open Label Phase (24 Weeks)|Protocol Violation|5
2444749|NCT02831855|8410486|P3|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0
2444750|NCT02831855|8410487|P2|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0
2444751|NCT02831855|8410488|P1|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2
2444752|NCT02831855|8410486|P3|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0
2444753|NCT02831855|8410487|P2|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0
2444754|NCT02831855|8410488|P1|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7
2444755|NCT02831855|8410486|P3|Open Label Phase (24 Weeks)|Lost to Follow-up|0
2444756|NCT02831855|8410487|P2|Open Label Phase (24 Weeks)|Lost to Follow-up|0
2444757|NCT02831855|8410488|P1|Open Label Phase (24 Weeks)|Lost to Follow-up|8
2444758|NCT02831855|8410486|P3|Open Label Phase (24 Weeks)|Adverse Event|0
2444759|NCT02831855|8410487|P2|Open Label Phase (24 Weeks)|Adverse Event|0
2444760|NCT02831855|8410488|P1|Open Label Phase (24 Weeks)|Adverse Event|39
2444761|NCT02831764|8410549|P2|Overall Study|Ongoing at the time of the analysis|335
2444762|NCT02831764|8410550|P1|Overall Study|Ongoing at the time of the analysis|330
2444763|NCT02831764|8410549|P2|Overall Study|Protocol Violation|2
2444764|NCT02831764|8410550|P1|Overall Study|Protocol Violation|5
2444765|NCT02831764|8410549|P2|Overall Study|Lack of Efficacy|2
2444766|NCT02831764|8410550|P1|Overall Study|Lack of Efficacy|2
2444767|NCT02831764|8410549|P2|Overall Study|Adverse Event|5
2444768|NCT02831764|8410550|P1|Overall Study|Adverse Event|8
2444769|NCT02831764|8410549|P2|Overall Study|Lost to Follow-up|5
2444770|NCT02831764|8410550|P1|Overall Study|Lost to Follow-up|6
2444771|NCT02831764|8410549|P2|Overall Study|Physician Decision|2
2444772|NCT02831764|8410550|P1|Overall Study|Physician Decision|2
2444773|NCT02831764|8410549|P2|Overall Study|Withdrawal by Subject|6
2444774|NCT02831764|8410550|P1|Overall Study|Withdrawal by Subject|7
2444775|NCT02831764|8410549|P2|Overall Study|Protocol specific withdrawal criteria|2
2444776|NCT02831764|8410550|P1|Overall Study|Protocol specific withdrawal criteria|0
2444777|NCT02831673|8410614|P2|Overall Study|Ongoing at Week 48 primary analysis.|330
2444778|NCT02831673|8410615|P1|Overall Study|Ongoing at Week 48 primary analysis.|320
2444779|NCT02831673|8410614|P2|Overall Study|Withdrawal by Subject|4
2444780|NCT02831673|8410615|P1|Overall Study|Withdrawal by Subject|6
2444781|NCT02831673|8410614|P2|Overall Study|Physician Decision|3
2444782|NCT02831673|8410615|P1|Overall Study|Physician Decision|6
2444783|NCT02831673|8410614|P2|Overall Study|Lost to Follow-up|6
2444784|NCT02831673|8410615|P1|Overall Study|Lost to Follow-up|9
2444785|NCT02831673|8410614|P2|Overall Study|Protocol Withdrawal Criterion Met|6
2444786|NCT02831673|8410615|P1|Overall Study|Protocol Withdrawal Criterion Met|1
2444787|NCT02831673|8410614|P2|Overall Study|Protocol Violation|4
2444788|NCT02831673|8410615|P1|Overall Study|Protocol Violation|5
2444789|NCT02831673|8410614|P2|Overall Study|Lack of Efficacy|1
2444790|NCT02831673|8410615|P1|Overall Study|Lack of Efficacy|3
2444791|NCT02831673|8410614|P2|Overall Study|Adverse Event|4
2444792|NCT02831673|8410615|P1|Overall Study|Adverse Event|6
2444793|NCT02831387|8410688|P2|Overall Study|Discontinued due to stock recovery|1
2444794|NCT02831387|8410689|P1|Overall Study|Discontinued due to stock recovery|0
2444795|NCT02831387|8410688|P2|Overall Study|Withdrawal by Subject|1
2444796|NCT02831387|8410689|P1|Overall Study|Withdrawal by Subject|1
2444797|NCT02830880|8410707|P1|Overall Study|Physician Decision|1
2444798|NCT02830880|8410707|P1|Overall Study|Death|1
2444799|NCT02830880|8410707|P1|Overall Study|Adverse reaction to chemotherapy|1
2444800|NCT02830087|8410722|P6|Overall Study|No study staff to follow-up patients|3
2444801|NCT02830087|8410723|P5|Overall Study|No study staff to follow-up patients|3
2444802|NCT02830087|8410724|P4|Overall Study|No study staff to follow-up patients|3
2444803|NCT02830087|8410725|P3|Overall Study|No study staff to follow-up patients|4
2444804|NCT02830087|8410726|P2|Overall Study|No study staff to follow-up patients|4
2444805|NCT02830087|8410727|P1|Overall Study|No study staff to follow-up patients|4
2444806|NCT02829996|8410794|P5|Overall Study|Withdrawal by Subject|0
2444807|NCT02829996|8410795|P4|Overall Study|Withdrawal by Subject|0
2444808|NCT02829996|8410796|P3|Overall Study|Withdrawal by Subject|0
2444809|NCT02829996|8410797|P2|Overall Study|Withdrawal by Subject|0
2444810|NCT02829996|8410798|P1|Overall Study|Withdrawal by Subject|1
2444811|NCT02829944|8410823|P2|Overall Study|Staff unavailable|1
2444812|NCT02829944|8410824|P1|Overall Study|Staff unavailable|0
2444813|NCT02829944|8410823|P2|Overall Study|Catheter broke|1
2444814|NCT02829944|8410824|P1|Overall Study|Catheter broke|0
2444815|NCT02829944|8410823|P2|Overall Study|Catheter Displacement|0
2444816|NCT02829944|8410824|P1|Overall Study|Catheter Displacement|1
2444817|NCT02829944|8410823|P2|Overall Study|Withdrawal by Subject|1
2444818|NCT02829944|8410824|P1|Overall Study|Withdrawal by Subject|2
2444819|NCT02829944|8410823|P2|Overall Study|Inadequate Neuraxial Block|1
2444820|NCT02829944|8410824|P1|Overall Study|Inadequate Neuraxial Block|1
2444821|NCT02829944|8410823|P2|Overall Study|Screen Failure|2
2444822|NCT02829944|8410824|P1|Overall Study|Screen Failure|2
2444823|NCT02829944|8410823|P2|Overall Study|Physician Decision|1
2444824|NCT02829944|8410824|P1|Overall Study|Physician Decision|0
2444825|NCT02829918|8410874|P1|Overall Study|Progression|1
2444826|NCT02829918|8410874|P1|Overall Study|Adverse Event|1
2444827|NCT02829918|8410874|P1|Overall Study|Withdrawal by Subject|4
2444828|NCT02829918|8410874|P1|Overall Study|Death|2
2444829|NCT02829775|8410879|P1|Overall Study|Disease remission|1
2444830|NCT02829775|8410879|P1|Overall Study|Withdrawal by Subject|3
2444831|NCT02829775|8410879|P1|Overall Study|Death|1
2444832|NCT02829138|8410961|P2|Overall Study|Withdrawal by Subject|0
2444833|NCT02829138|8410962|P1|Overall Study|Withdrawal by Subject|1
2444834|NCT02828644|8410987|P2|Overall Study|Lost to Follow-up|22
2444835|NCT02828644|8410988|P1|Overall Study|Lost to Follow-up|23
2444836|NCT02828241|8410997|P2|Overall Study|Protocol Violation|0
2444837|NCT02828241|8410998|P1|Overall Study|Protocol Violation|1
2444838|NCT02828241|8410997|P2|Overall Study|Adverse Event|2
2444839|NCT02828241|8410998|P1|Overall Study|Adverse Event|7
2444840|NCT02828124|8411025|P4|Overall Study|Subject Withdrew Consent|1
2444841|NCT02828124|8411026|P3|Overall Study|Subject Withdrew Consent|0
2444842|NCT02828124|8411027|P2|Overall Study|Subject Withdrew Consent|0
2444843|NCT02828124|8411028|P1|Overall Study|Subject Withdrew Consent|0
2444844|NCT02828124|8411025|P4|Overall Study|AE Unrelated to Study Drug|1
2444845|NCT02828124|8411026|P3|Overall Study|AE Unrelated to Study Drug|0
2444846|NCT02828124|8411027|P2|Overall Study|AE Unrelated to Study Drug|0
2444847|NCT02828124|8411028|P1|Overall Study|AE Unrelated to Study Drug|0
2444848|NCT02828124|8411025|P4|Overall Study|Disease Progression|4
2444849|NCT02828124|8411026|P3|Overall Study|Disease Progression|1
2444850|NCT02828124|8411027|P2|Overall Study|Disease Progression|2
2444851|NCT02828124|8411028|P1|Overall Study|Disease Progression|1
2444852|NCT02828111|8411143|P5|Overall Study|Lost to Follow-up|1
2444853|NCT02828111|8411144|P4|Overall Study|Lost to Follow-up|1
2444854|NCT02828111|8411145|P3|Overall Study|Lost to Follow-up|0
2444855|NCT02828111|8411146|P2|Overall Study|Lost to Follow-up|0
2444856|NCT02828111|8411147|P1|Overall Study|Lost to Follow-up|0
2444857|NCT02828111|8411143|P5|Overall Study|Withdrawal by Subject|0
2444858|NCT02828111|8411144|P4|Overall Study|Withdrawal by Subject|0
2444859|NCT02828111|8411145|P3|Overall Study|Withdrawal by Subject|2
2444860|NCT02828111|8411146|P2|Overall Study|Withdrawal by Subject|0
2444861|NCT02828111|8411147|P1|Overall Study|Withdrawal by Subject|0
2444862|NCT02828020|8411208|P3|Safety Follow-up Period|Other Miscellaneous Reasons|0
2444863|NCT02828020|8411209|P2|Safety Follow-up Period|Other Miscellaneous Reasons|0
2444864|NCT02828020|8411210|P1|Safety Follow-up Period|Other Miscellaneous Reasons|1
2444865|NCT02828020|8411208|P3|Safety Follow-up Period|Protocol Violation|1
2444866|NCT02828020|8411209|P2|Safety Follow-up Period|Protocol Violation|2
2444867|NCT02828020|8411210|P1|Safety Follow-up Period|Protocol Violation|0
2444868|NCT02828020|8411208|P3|Safety Follow-up Period|Lost to Follow-up|11
2444869|NCT02828020|8411209|P2|Safety Follow-up Period|Lost to Follow-up|8
2444870|NCT02828020|8411210|P1|Safety Follow-up Period|Lost to Follow-up|9
2444871|NCT02828020|8411208|P3|Safety Follow-up Period|Withdrawal of Consent|7
2444872|NCT02828020|8411209|P2|Safety Follow-up Period|Withdrawal of Consent|8
2444873|NCT02828020|8411210|P1|Safety Follow-up Period|Withdrawal of Consent|10
2444874|NCT02828020|8411208|P3|Treatment Period|Other Miscellaneous Reasons|0
2444875|NCT02828020|8411209|P2|Treatment Period|Other Miscellaneous Reasons|1
2444876|NCT02828020|8411210|P1|Treatment Period|Other Miscellaneous Reasons|0
2444877|NCT02828020|8411208|P3|Treatment Period|Protocol Violation|7
2444878|NCT02828020|8411209|P2|Treatment Period|Protocol Violation|4
2444879|NCT02828020|8411210|P1|Treatment Period|Protocol Violation|2
2444880|NCT02828020|8411208|P3|Treatment Period|Pregnancy|0
2444881|NCT02828020|8411209|P2|Treatment Period|Pregnancy|2
2444882|NCT02828020|8411210|P1|Treatment Period|Pregnancy|0
2444883|NCT02828020|8411208|P3|Treatment Period|Lack of Qualifying Event|43
2444884|NCT02828020|8411209|P2|Treatment Period|Lack of Qualifying Event|53
2444885|NCT02828020|8411210|P1|Treatment Period|Lack of Qualifying Event|44
2444886|NCT02828020|8411208|P3|Treatment Period|Lost to Follow-up|18
2444887|NCT02828020|8411209|P2|Treatment Period|Lost to Follow-up|24
2444888|NCT02828020|8411210|P1|Treatment Period|Lost to Follow-up|21
2444889|NCT02828020|8411208|P3|Treatment Period|Withdrawal of Consent|9
2444890|NCT02828020|8411209|P2|Treatment Period|Withdrawal of Consent|14
2444891|NCT02828020|8411210|P1|Treatment Period|Withdrawal of Consent|10
2444892|NCT02828020|8411208|P3|Treatment Period|Adverse Event|1
2444893|NCT02828020|8411209|P2|Treatment Period|Adverse Event|1
2444894|NCT02828020|8411210|P1|Treatment Period|Adverse Event|3
2444895|NCT02827708|8411241|P2|Overall Study|Death|2
2444896|NCT02827708|8411242|P1|Overall Study|Death|1
2444897|NCT02827708|8411241|P2|Overall Study|Withdrawal by Subject|2
2444898|NCT02827708|8411242|P1|Overall Study|Withdrawal by Subject|1
2444899|NCT02827708|8411241|P2|Overall Study|Lost to Follow-up|1
2444900|NCT02827708|8411242|P1|Overall Study|Lost to Follow-up|3
2444901|NCT02827500|8411321|P2|Overall Study|Other|1
2444902|NCT02827500|8411322|P1|Overall Study|Other|5
2444903|NCT02827500|8411321|P2|Overall Study|Missing primary endpoint data|1
2444904|NCT02827500|8411322|P1|Overall Study|Missing primary endpoint data|3
2444905|NCT02827500|8411321|P2|Overall Study|Withdrawal by Subject|1
2444906|NCT02827500|8411322|P1|Overall Study|Withdrawal by Subject|3
2444907|NCT02827500|8411321|P2|Overall Study|Lost to Follow-up|1
2444908|NCT02827500|8411322|P1|Overall Study|Lost to Follow-up|1
2444909|NCT02827500|8411321|P2|Overall Study|Death|3
2444910|NCT02827500|8411322|P1|Overall Study|Death|7
2444911|NCT02826798|8411343|P5|Overall Study|Withdrawal by Subject|0
2444912|NCT02826798|8411344|P4|Overall Study|Withdrawal by Subject|1
2444913|NCT02826798|8411345|P3|Overall Study|Withdrawal by Subject|0
2444914|NCT02826798|8411346|P2|Overall Study|Withdrawal by Subject|1
2444915|NCT02826798|8411347|P1|Overall Study|Withdrawal by Subject|0
2444916|NCT02826603|8411396|P2|Overall Study|New therapy for study indication|1
2444917|NCT02826603|8411397|P1|Overall Study|New therapy for study indication|0
2444918|NCT02826603|8411396|P2|Overall Study|Death|0
2444919|NCT02826603|8411397|P1|Overall Study|Death|2
2444920|NCT02826603|8411396|P2|Overall Study|Withdrawal by Subject|19
2444921|NCT02826603|8411397|P1|Overall Study|Withdrawal by Subject|20
2444922|NCT02826603|8411396|P2|Overall Study|Protocol Violation|3
2444923|NCT02826603|8411397|P1|Overall Study|Protocol Violation|3
2444924|NCT02826603|8411396|P2|Overall Study|Pregnancy|2
2444925|NCT02826603|8411397|P1|Overall Study|Pregnancy|1
2444926|NCT02826603|8411396|P2|Overall Study|Physician Decision|7
2444927|NCT02826603|8411397|P1|Overall Study|Physician Decision|1
2444928|NCT02826603|8411396|P2|Overall Study|Noncompliance with treatment|2
2444929|NCT02826603|8411397|P1|Overall Study|Noncompliance with treatment|0
2444930|NCT02826603|8411396|P2|Overall Study|Lost to Follow-up|12
2444931|NCT02826603|8411397|P1|Overall Study|Lost to Follow-up|13
2444932|NCT02826603|8411396|P2|Overall Study|Lack of Efficacy|9
2444933|NCT02826603|8411397|P1|Overall Study|Lack of Efficacy|4
2444934|NCT02826603|8411396|P2|Overall Study|Adverse Event|9
2444935|NCT02826603|8411397|P1|Overall Study|Adverse Event|17
2444936|NCT02826421|8411437|P4|Overall Study|Reason not given|0
2444937|NCT02826421|8411438|P3|Overall Study|Reason not given|1
2444938|NCT02826421|8411439|P2|Overall Study|Reason not given|0
2444939|NCT02826421|8411440|P1|Overall Study|Reason not given|1
2444940|NCT02826421|8411437|P4|Overall Study|Withdrawal by Subject|1
2444941|NCT02826421|8411438|P3|Overall Study|Withdrawal by Subject|1
2444942|NCT02826421|8411439|P2|Overall Study|Withdrawal by Subject|3
2444943|NCT02826421|8411440|P1|Overall Study|Withdrawal by Subject|1
2444944|NCT02826421|8411437|P4|Overall Study|Adverse Event|1
2444945|NCT02826421|8411438|P3|Overall Study|Adverse Event|0
2444946|NCT02826421|8411439|P2|Overall Study|Adverse Event|0
2444947|NCT02826421|8411440|P1|Overall Study|Adverse Event|1
2444948|NCT02825550|8411452|P1|Overall Study|Physician Decision|1
2444949|NCT02825251|8411460|P2|Overall Study|Unclassified|0
2444950|NCT02825251|8411461|P1|Overall Study|Unclassified|2
2444951|NCT02825251|8411460|P2|Overall Study|Withdrawal by Subject|4
2444952|NCT02825251|8411461|P1|Overall Study|Withdrawal by Subject|1
2444953|NCT02825251|8411460|P2|Overall Study|Lost to Follow-up|1
2444954|NCT02825251|8411461|P1|Overall Study|Lost to Follow-up|0
2444955|NCT02825251|8411460|P2|Overall Study|Adverse Event|1
2444956|NCT02825251|8411461|P1|Overall Study|Adverse Event|0
2444957|NCT02824562|8411664|P2|Overall Study|Death|1
2444958|NCT02824562|8411665|P1|Overall Study|Death|0
2444959|NCT02824562|8411664|P2|Overall Study|Lost to Follow-up|4
2444960|NCT02824562|8411665|P1|Overall Study|Lost to Follow-up|3
2444961|NCT02824432|8411674|P2|Overall Study|Major Protocol Deviation|0
2444962|NCT02824432|8411675|P1|Overall Study|Major Protocol Deviation|1
2444963|NCT02824224|8411751|P2|Overall Study|Did not show up for allocation visit|0
2444964|NCT02824224|8411752|P1|Overall Study|Did not show up for allocation visit|2
2444965|NCT02824224|8411751|P2|Overall Study|Discontinued, IUS expulsion|1
2444966|NCT02824224|8411752|P1|Overall Study|Discontinued, IUS expulsion|0
2444967|NCT02824198|8411772|P2|Overall Study|Withdrawal by Subject|0
2444968|NCT02824198|8411773|P1|Overall Study|Withdrawal by Subject|5
2444969|NCT02824198|8411772|P2|Overall Study|Lost to Follow-up|2
2444970|NCT02824198|8411773|P1|Overall Study|Lost to Follow-up|5
2444971|NCT02824198|8411772|P2|Overall Study|Non-compliance with the protocol|1
2444972|NCT02824198|8411773|P1|Overall Study|Non-compliance with the protocol|5
2444973|NCT02823964|8411803|P1|Overall Study|Withdrawal by Subject|1
2444974|NCT02823964|8411803|P1|Overall Study|Lack of Efficacy|1
2444975|NCT02823964|8411803|P1|Overall Study|Physician Decision|1
2444976|NCT02823964|8411803|P1|Overall Study|Adverse Event|2
2444977|NCT02823470|8411817|P2|Overall Study|Study terminated by sponsor|15
2444978|NCT02823470|8411818|P1|Overall Study|Study terminated by sponsor|8
2444979|NCT02823470|8411817|P2|Overall Study|Adverse Event|0
2444980|NCT02823470|8411818|P1|Overall Study|Adverse Event|1
2444981|NCT02822794|8411886|P2|Overall Study|Withdrew Consent|0
2444982|NCT02822794|8411887|P1|Overall Study|Withdrew Consent|1
2444983|NCT02822235|8411988|P2|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1
2444984|NCT02822235|8411989|P1|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6
2444985|NCT02822235|8411988|P2|Prospective Phase (Day 1 up to Month 12)|Death|0
2444986|NCT02822235|8411989|P1|Prospective Phase (Day 1 up to Month 12)|Death|1
2444987|NCT02822235|8411988|P2|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0
2444988|NCT02822235|8411989|P1|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4
2444989|NCT02822235|8411988|P2|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1
2444990|NCT02822235|8411989|P1|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0
2444991|NCT02822235|8411988|P2|Cross-sectional Phase (Day 1)|Reason Not Specified|0
2444992|NCT02822235|8411989|P1|Cross-sectional Phase (Day 1)|Reason Not Specified|2
2444993|NCT02822235|8411988|P2|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107
2444994|NCT02822235|8411989|P1|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144
2444995|NCT02821962|8412044|P2|Overall Study|Lost to Follow-up|0
2444996|NCT02821962|8412045|P1|Overall Study|Lost to Follow-up|2
2444997|NCT02821910|8412089|P6|Overall Study|Other than specified|0
2444998|NCT02821910|8412090|P5|Overall Study|Other than specified|0
2444999|NCT02821910|8412091|P4|Overall Study|Other than specified|0
2445000|NCT02821910|8412092|P3|Overall Study|Other than specified|1
2445001|NCT02821910|8412093|P2|Overall Study|Other than specified|0
2445002|NCT02821910|8412094|P1|Overall Study|Other than specified|1
2445003|NCT02821910|8412089|P6|Overall Study|Withdrawal by Subject|1
2445004|NCT02821910|8412090|P5|Overall Study|Withdrawal by Subject|0
2445005|NCT02821910|8412091|P4|Overall Study|Withdrawal by Subject|0
2445006|NCT02821910|8412092|P3|Overall Study|Withdrawal by Subject|1
2445007|NCT02821910|8412093|P2|Overall Study|Withdrawal by Subject|0
2445008|NCT02821910|8412094|P1|Overall Study|Withdrawal by Subject|0
2445009|NCT02821819|8412156|P1|Overall Study|Protocol Violation|1
2445010|NCT02821000|8412187|P1|Overall Study|Ongoing in Study|58
2445011|NCT02821000|8412187|P1|Overall Study|Withdrawal by Subject|1
2445012|NCT02821000|8412187|P1|Overall Study|Death|44
2445013|NCT02820844|8412225|P6|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1
2445014|NCT02820844|8412226|P5|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
2445015|NCT02820844|8412227|P4|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
2445016|NCT02820844|8412228|P3|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
2445017|NCT02820844|8412229|P2|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
2445018|NCT02820844|8412230|P1|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
2445019|NCT02820844|8412225|P6|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
2445020|NCT02820844|8412226|P5|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2
2445021|NCT02820844|8412227|P4|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
2445022|NCT02820844|8412228|P3|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
2445023|NCT02820844|8412229|P2|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
2445024|NCT02820844|8412230|P1|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
2445025|NCT02820844|8412225|P6|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
2445026|NCT02820844|8412226|P5|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
2445027|NCT02820844|8412227|P4|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2
2445028|NCT02820844|8412228|P3|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7
2445029|NCT02820844|8412229|P2|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
2445030|NCT02820844|8412230|P1|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
2445031|NCT02820844|8412225|P6|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
2445032|NCT02820844|8412226|P5|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
2445033|NCT02820844|8412227|P4|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
2445034|NCT02820844|8412228|P3|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1
2445035|NCT02820844|8412229|P2|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
2445036|NCT02820844|8412230|P1|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
2445037|NCT02820844|8412225|P6|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
2445038|NCT02820844|8412226|P5|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
2445117|NCT02818998|8412740|P2|Overall Study|Missing information|0
2445039|NCT02820844|8412227|P4|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2
2445040|NCT02820844|8412228|P3|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1
2445041|NCT02820844|8412229|P2|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
2445042|NCT02820844|8412230|P1|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
2445043|NCT02820844|8412225|P6|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
2445044|NCT02820844|8412226|P5|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
2445045|NCT02820844|8412227|P4|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
2445046|NCT02820844|8412228|P3|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
2445047|NCT02820844|8412229|P2|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
2445048|NCT02820844|8412230|P1|Double-blinded (Up to 48 Weeks)|Investigator discretion|1
2445049|NCT02820844|8412225|P6|Double-blinded (Up to 48 Weeks)|Adverse Event|0
2445050|NCT02820844|8412226|P5|Double-blinded (Up to 48 Weeks)|Adverse Event|0
2445051|NCT02820844|8412227|P4|Double-blinded (Up to 48 Weeks)|Adverse Event|0
2445052|NCT02820844|8412228|P3|Double-blinded (Up to 48 Weeks)|Adverse Event|0
2445053|NCT02820844|8412229|P2|Double-blinded (Up to 48 Weeks)|Adverse Event|1
2445054|NCT02820844|8412230|P1|Double-blinded (Up to 48 Weeks)|Adverse Event|2
2445055|NCT02820844|8412225|P6|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
2445056|NCT02820844|8412226|P5|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
2445057|NCT02820844|8412227|P4|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
2445058|NCT02820844|8412228|P3|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
2445059|NCT02820844|8412229|P2|Double-blinded (Up to 48 Weeks)|Protocol Violation|3
2445060|NCT02820844|8412230|P1|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
2445061|NCT02820844|8412225|P6|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
2445062|NCT02820844|8412226|P5|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
2445063|NCT02820844|8412227|P4|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
2445064|NCT02820844|8412228|P3|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
2445065|NCT02820844|8412229|P2|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2
2445066|NCT02820844|8412230|P1|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1
2445067|NCT02820844|8412225|P6|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
2445068|NCT02820844|8412226|P5|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
2445069|NCT02820844|8412227|P4|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
2445070|NCT02820844|8412228|P3|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
2445071|NCT02820844|8412229|P2|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3
2445072|NCT02820844|8412230|P1|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1
2445073|NCT02820597|8412444|P1|Overall Study|Lost to Follow-up|12
2445074|NCT02820038|8412456|P4|Overall Study|Withdrawal by Subject|13
2445075|NCT02820038|8412457|P3|Overall Study|Withdrawal by Subject|3
2445076|NCT02820038|8412458|P2|Overall Study|Withdrawal by Subject|14
2445077|NCT02820038|8412459|P1|Overall Study|Withdrawal by Subject|3
2445078|NCT02820038|8412456|P4|Overall Study|Lost to Follow-up|9
2445079|NCT02820038|8412457|P3|Overall Study|Lost to Follow-up|2
2445080|NCT02820038|8412458|P2|Overall Study|Lost to Follow-up|11
2445081|NCT02820038|8412459|P1|Overall Study|Lost to Follow-up|7
2445082|NCT02819804|8412586|P1|Complete Cycle 1 (28 Days)|Progressive disease/no response|1
2445083|NCT02819726|8412593|P4|Part B (All Participants)|Protocol non-compliance|0
2445084|NCT02819726|8412594|P3|Part B (All Participants)|Protocol non-compliance|1
2445085|NCT02819726|8412595|P2|Part B (All Participants)|Protocol non-compliance|0
2445086|NCT02819726|8412596|P1|Part B (All Participants)|Protocol non-compliance|0
2445087|NCT02819726|8412593|P4|Part B (All Participants)|Withdrawal by Subject|0
2445088|NCT02819726|8412594|P3|Part B (All Participants)|Withdrawal by Subject|1
2445089|NCT02819726|8412595|P2|Part B (All Participants)|Withdrawal by Subject|1
2445090|NCT02819726|8412596|P1|Part B (All Participants)|Withdrawal by Subject|2
2445091|NCT02819726|8412593|P4|Part B (All Participants)|Lost to Follow-up|2
2445092|NCT02819726|8412594|P3|Part B (All Participants)|Lost to Follow-up|2
2445093|NCT02819726|8412595|P2|Part B (All Participants)|Lost to Follow-up|1
2445094|NCT02819726|8412596|P1|Part B (All Participants)|Lost to Follow-up|1
2445095|NCT02819726|8412593|P4|Part A (All Participants)|Protocol non-compliance|0
2445096|NCT02819726|8412594|P3|Part A (All Participants)|Protocol non-compliance|5
2445097|NCT02819726|8412595|P2|Part A (All Participants)|Protocol non-compliance|4
2445098|NCT02819726|8412596|P1|Part A (All Participants)|Protocol non-compliance|3
2445099|NCT02819726|8412593|P4|Part A (All Participants)|Withdrawal by Subject|0
2445100|NCT02819726|8412594|P3|Part A (All Participants)|Withdrawal by Subject|6
2445101|NCT02819726|8412595|P2|Part A (All Participants)|Withdrawal by Subject|5
2445102|NCT02819726|8412596|P1|Part A (All Participants)|Withdrawal by Subject|3
2445103|NCT02819726|8412593|P4|Part A (All Participants)|Lost to Follow-up|0
2445104|NCT02819726|8412594|P3|Part A (All Participants)|Lost to Follow-up|0
2445105|NCT02819726|8412595|P2|Part A (All Participants)|Lost to Follow-up|1
2445106|NCT02819726|8412596|P1|Part A (All Participants)|Lost to Follow-up|0
2445107|NCT02818998|8412739|P3|Overall Study|Withdrawal by Subject|5
2445108|NCT02818998|8412740|P2|Overall Study|Withdrawal by Subject|4
2445109|NCT02818998|8412741|P1|Overall Study|Withdrawal by Subject|4
2445110|NCT02818998|8412739|P3|Overall Study|Death|4
2445111|NCT02818998|8412740|P2|Overall Study|Death|3
2445112|NCT02818998|8412741|P1|Overall Study|Death|2
2445113|NCT02818998|8412739|P3|Overall Study|Other|1
2445114|NCT02818998|8412740|P2|Overall Study|Other|1
2445115|NCT02818998|8412741|P1|Overall Study|Other|0
2445116|NCT02818998|8412739|P3|Overall Study|Missing information|2
2445118|NCT02818998|8412741|P1|Overall Study|Missing information|0
2445119|NCT02818998|8412739|P3|Overall Study|Lost to Follow-up|2
2445120|NCT02818998|8412740|P2|Overall Study|Lost to Follow-up|0
2445121|NCT02818998|8412741|P1|Overall Study|Lost to Follow-up|2
2445122|NCT02818998|8412739|P3|Overall Study|Adverse Event|0
2445123|NCT02818998|8412740|P2|Overall Study|Adverse Event|0
2445124|NCT02818998|8412741|P1|Overall Study|Adverse Event|3
2445125|NCT02818920|8412762|P1|Overall Study|Refused Further Treatment|1
2445126|NCT02818920|8412762|P1|Overall Study|Developed Other Disease|1
2445127|NCT02818920|8412762|P1|Overall Study|Adverse Event|3
2445128|NCT02818920|8412762|P1|Overall Study|Went Off Study Prior to Adjuvant Therapy|8
2445129|NCT02818920|8412762|P1|Overall Study|Progressed After Neoadjuvant Therapy|1
2445130|NCT02818920|8412762|P1|Overall Study|Unresectable|4
2445131|NCT02818777|8412766|P1|Overall Study|Adverse Event|3
2445132|NCT02818036|8412833|P2|Overall Study|Withdrawal by Subject|0
2445133|NCT02818036|8412834|P1|Overall Study|Withdrawal by Subject|1
2445134|NCT02818036|8412833|P2|Overall Study|head did not fit in fMRI scanner headres|0
2445135|NCT02818036|8412834|P1|Overall Study|head did not fit in fMRI scanner headres|1
2445136|NCT02817841|8412842|P1|Overall Study|Protocol Violation|94
2445137|NCT02817841|8412842|P1|Overall Study|Other reasons|53
2445138|NCT02817841|8412842|P1|Overall Study|Pregnancy wish|17
2445139|NCT02817841|8412842|P1|Overall Study|Pregnancy|32
2445140|NCT02817841|8412842|P1|Overall Study|Adverse event related to bleeding|51
2445141|NCT02817841|8412842|P1|Overall Study|Adverse event not related to bleeding|131
2445142|NCT02817841|8412842|P1|Overall Study|Withdrawal by Subject|183
2445143|NCT02817841|8412842|P1|Overall Study|Lost to Follow-up|287
2445144|NCT02817828|8412869|P1|Overall Study|Other|26
2445145|NCT02817828|8412869|P1|Overall Study|Withdrawal by Subject|78
2445146|NCT02817828|8412869|P1|Overall Study|Pregnancy wish|15
2445147|NCT02817828|8412869|P1|Overall Study|Pregnancy|7
2445148|NCT02817828|8412869|P1|Overall Study|Protocol Violation|11
2445149|NCT02817828|8412869|P1|Overall Study|Adverse event related to bleeding|53
2445150|NCT02817828|8412869|P1|Overall Study|Adverse event not related to bleeding|104
2445151|NCT02817828|8412869|P1|Overall Study|Lost to Follow-up|41
2445152|NCT02817594|8412904|P1|Overall Study|Did Not Receive Treatment|1
2445153|NCT02817594|8412904|P1|Overall Study|Other|1
2445154|NCT02817594|8412904|P1|Overall Study|Withdrawal by Subject|1
2445155|NCT02817555|8412925|P2|Overall Study|changed to Peritoneal Dialysis|1
2445156|NCT02817555|8412926|P1|Overall Study|changed to Peritoneal Dialysis|0
2445157|NCT02817555|8412925|P2|Overall Study|transplant|1
2445158|NCT02817555|8412926|P1|Overall Study|transplant|1
2445159|NCT02817555|8412925|P2|Overall Study|moved away|0
2445160|NCT02817555|8412926|P1|Overall Study|moved away|1
2445161|NCT02817555|8412925|P2|Overall Study|Death|3
2445162|NCT02817555|8412926|P1|Overall Study|Death|1
2445163|NCT02817516|8412946|P4|Overall Study|Other|0
2445164|NCT02817516|8412947|P3|Overall Study|Other|1
2445165|NCT02817516|8412948|P2|Overall Study|Other|0
2445166|NCT02817516|8412949|P1|Overall Study|Other|0
2445167|NCT02816138|8413088|P1|Overall Study|Adverse Event|1
2445168|NCT02815735|8413134|P2|Second Intervention (4 Weeks)|Protocol Violation|0
2445169|NCT02815735|8413135|P1|Second Intervention (4 Weeks)|Protocol Violation|1
2445170|NCT02815735|8413134|P2|First Intervention (4 Weeks)|Poor fitting characteristics|1
2445171|NCT02815735|8413135|P1|First Intervention (4 Weeks)|Poor fitting characteristics|0
2445172|NCT02815735|8413134|P2|First Intervention (4 Weeks)|Lost to Follow-up|0
2445173|NCT02815735|8413135|P1|First Intervention (4 Weeks)|Lost to Follow-up|1
2445174|NCT02815735|8413134|P2|First Intervention (4 Weeks)|Discomfort|0
2445175|NCT02815735|8413135|P1|First Intervention (4 Weeks)|Discomfort|1
2445176|NCT02815670|8413150|P1|Overall Study|Prematurely discontinued of the trial|1
2445177|NCT02815397|8413182|P1|Overall Study|Physician Decision|2
2445178|NCT02815293|8413192|P3|Overall Study|Adverse Event|0
2445179|NCT02815293|8413193|P2|Overall Study|Adverse Event|1
2445180|NCT02815293|8413194|P1|Overall Study|Adverse Event|0
2445181|NCT02815293|8413192|P3|Overall Study|Participants not randomized|18
2445182|NCT02815293|8413193|P2|Overall Study|Participants not randomized|0
2445183|NCT02815293|8413194|P1|Overall Study|Participants not randomized|0
2445184|NCT02815293|8413192|P3|Overall Study|Study termination by sponsor|0
2445185|NCT02815293|8413193|P2|Overall Study|Study termination by sponsor|7
2445186|NCT02815293|8413194|P1|Overall Study|Study termination by sponsor|10
2445187|NCT02814643|8413309|P2|Overall Study|Withdrawal by Subject|2
2445188|NCT02814643|8413310|P1|Overall Study|Withdrawal by Subject|1
2445189|NCT02814643|8413309|P2|Overall Study|Lost to Follow-up|1
2445190|NCT02814643|8413310|P1|Overall Study|Lost to Follow-up|0
2445191|NCT02814565|8413334|P2|Overall Study|Subject decision, caused by AE Influenza|1
2445192|NCT02814565|8413335|P1|Overall Study|Subject decision, caused by AE Influenza|1
2445193|NCT02814565|8413334|P2|Overall Study|Lack of Efficacy|1
2445194|NCT02814565|8413335|P1|Overall Study|Lack of Efficacy|0
2445195|NCT02813694|8413405|P2|Overall Study|Patient hospitalized|0
2445196|NCT02813694|8413406|P1|Overall Study|Patient hospitalized|1
2445197|NCT02813694|8413405|P2|Overall Study|Randomized- did not receive study drug|0
2445198|NCT02813694|8413406|P1|Overall Study|Randomized- did not receive study drug|2
2445199|NCT02813694|8413405|P2|Overall Study|Death|3
2445200|NCT02813694|8413406|P1|Overall Study|Death|3
2445201|NCT02813694|8413405|P2|Overall Study|Lost to Follow-up|1
2445202|NCT02813694|8413406|P1|Overall Study|Lost to Follow-up|1
2445203|NCT02813694|8413405|P2|Overall Study|Withdrawal by Subject|9
2445204|NCT02813694|8413406|P1|Overall Study|Withdrawal by Subject|10
2445205|NCT02813694|8413405|P2|Overall Study|Physician Decision|1
2445206|NCT02813694|8413406|P1|Overall Study|Physician Decision|0
2445207|NCT02813681|8413419|P3|Overall Study|Lost to Follow-up|0
2445208|NCT02813681|8413420|P2|Overall Study|Lost to Follow-up|1
2445209|NCT02813681|8413421|P1|Overall Study|Lost to Follow-up|0
2445210|NCT02813681|8413419|P3|Overall Study|Physician Decision|0
2445211|NCT02813681|8413420|P2|Overall Study|Physician Decision|5
2445212|NCT02813681|8413421|P1|Overall Study|Physician Decision|5
2445213|NCT02813577|8413442|P1|Overall Study|Study terminated|4
2445214|NCT02812186|8413519|P2|Period 1|nonevaluable data sets|6
2445215|NCT02812186|8413520|P1|Period 1|nonevaluable data sets|6
2445216|NCT02812186|8413519|P2|Period 1|Post randomization screen failure|9
2445217|NCT02812186|8413520|P1|Period 1|Post randomization screen failure|5
2445218|NCT02811159|8413569|P1|Treatment Course 1|Lost to Follow-up|1
2445219|NCT02810457|8413608|P2|Overall Study|Physician Decision|1
2445220|NCT02810457|8413609|P1|Overall Study|Physician Decision|0
2445221|NCT02810457|8413608|P2|Overall Study|Miscalculated PD|0
2445222|NCT02810457|8413609|P1|Overall Study|Miscalculated PD|1
2445223|NCT02810457|8413608|P2|Overall Study|Patient ineligibility|0
2445224|NCT02810457|8413609|P1|Overall Study|Patient ineligibility|3
2445225|NCT02810457|8413608|P2|Overall Study|Investigator decision|2
2445226|NCT02810457|8413609|P1|Overall Study|Investigator decision|3
2445227|NCT02810457|8413608|P2|Overall Study|Clinical progression|16
2445228|NCT02810457|8413609|P1|Overall Study|Clinical progression|15
2445229|NCT02810457|8413608|P2|Overall Study|Ongoing at data cutoff and discontinued|2
2445230|NCT02810457|8413609|P1|Overall Study|Ongoing at data cutoff and discontinued|3
2445231|NCT02810457|8413608|P2|Overall Study|Death|28
2445232|NCT02810457|8413609|P1|Overall Study|Death|39
2445233|NCT02810457|8413608|P2|Overall Study|Patient lost to follow-up|2
2445234|NCT02810457|8413609|P1|Overall Study|Patient lost to follow-up|2
2445235|NCT02810457|8413608|P2|Overall Study|Patient decision|35
2445236|NCT02810457|8413609|P1|Overall Study|Patient decision|31
2445237|NCT02810457|8413608|P2|Overall Study|Adverse Event|43
2445238|NCT02810457|8413609|P1|Overall Study|Adverse Event|37
2445239|NCT02810457|8413608|P2|Overall Study|Objective PD assessed by RECIST v1.1|199
2445240|NCT02810457|8413609|P1|Overall Study|Objective PD assessed by RECIST v1.1|191
2445241|NCT02810457|8413608|P2|Overall Study|Randomised but no treatment received|1
2445242|NCT02810457|8413609|P1|Overall Study|Randomised but no treatment received|2
2445243|NCT02809833|8413666|P1|Overall Study|Missing Information|52
2445244|NCT02809833|8413666|P1|Overall Study|Other|5
2445245|NCT02809833|8413666|P1|Overall Study|Adverse Event (AE)|24
2445246|NCT02809833|8413666|P1|Overall Study|Lost to Follow-up|35
2445247|NCT02809833|8413666|P1|Overall Study|Withdrawal by Subject|34
2445248|NCT02809833|8413666|P1|Overall Study|Noncompliance|1
2445249|NCT02809833|8413666|P1|Overall Study|Remission/Treatment No Longer Needed|3
2445250|NCT02809833|8413666|P1|Overall Study|Lack of Efficacy|89
2445251|NCT02809833|8413666|P1|Overall Study|Intolerance|54
2445252|NCT02809833|8413666|P1|Overall Study|Death|3
2445253|NCT02808338|8413797|P1|Overnight In-lab Polysomonography|Reason not given|1
2445254|NCT02808338|8413797|P1|Overnight In-lab Polysomonography|Withdrawal by Subject|1
2445255|NCT02808338|8413797|P1|Screening|Screen Failure|10
2445256|NCT02807948|8413858|P2|Overall Study|Physician Decision|0
2445257|NCT02807948|8413859|P1|Overall Study|Physician Decision|1
2445258|NCT02807402|8413864|P1|Overall Study|Other|2
2445259|NCT02807402|8413864|P1|Overall Study|Death|3
2445260|NCT02807402|8413864|P1|Overall Study|Failure to Return|1
2445261|NCT02807376|8413902|P2|Overall Study|Lost to Follow-up|1
2445262|NCT02807376|8413903|P1|Overall Study|Lost to Follow-up|0
2445263|NCT02807376|8413902|P2|Overall Study|Intra-operative exclusion criteria|0
2445264|NCT02807376|8413903|P1|Overall Study|Intra-operative exclusion criteria|3
2445265|NCT02807259|8413913|P2|Endline (3 Months)|migration, refusal, not available|87
2445266|NCT02807259|8413914|P1|Endline (3 Months)|migration, refusal, not available|35
2445267|NCT02807259|8413913|P2|Midline (3 Months)|migration, refusal, not available|34
2445268|NCT02807259|8413914|P1|Midline (3 Months)|migration, refusal, not available|30
2445269|NCT02807259|8413913|P2|Baseline (3 Months)|migration, refusal, not available|112
2445270|NCT02807259|8413914|P1|Baseline (3 Months)|migration, refusal, not available|77
2445271|NCT02806973|8413932|P4|Period 3|Adverse Event|0
2445272|NCT02806973|8413933|P3|Period 3|Adverse Event|1
2445273|NCT02806973|8413934|P2|Period 3|Adverse Event|0
2445274|NCT02806973|8413935|P1|Period 3|Adverse Event|0
2445275|NCT02806973|8413932|P4|Period 3|Withdrawal by Subject|3
2445276|NCT02806973|8413933|P3|Period 3|Withdrawal by Subject|0
2445277|NCT02806973|8413934|P2|Period 3|Withdrawal by Subject|0
2445278|NCT02806973|8413935|P1|Period 3|Withdrawal by Subject|0
2445279|NCT02806973|8413932|P4|Period 1|Adverse Event|1
2445280|NCT02806973|8413933|P3|Period 1|Adverse Event|0
2445281|NCT02806973|8413934|P2|Period 1|Adverse Event|0
2445282|NCT02806973|8413935|P1|Period 1|Adverse Event|0
2445283|NCT02806973|8413932|P4|Period 1|Withdrawal by Subject|1
2445284|NCT02806973|8413933|P3|Period 1|Withdrawal by Subject|1
2445285|NCT02806973|8413934|P2|Period 1|Withdrawal by Subject|2
2445286|NCT02806973|8413935|P1|Period 1|Withdrawal by Subject|0
2445287|NCT02806960|8413969|P4|Period 1|Study Terminated (withdrawn by sponsor)|3
2445288|NCT02806960|8413970|P3|Period 1|Study Terminated (withdrawn by sponsor)|3
2445289|NCT02806960|8413971|P2|Period 1|Study Terminated (withdrawn by sponsor)|3
2445290|NCT02806960|8413972|P1|Period 1|Study Terminated (withdrawn by sponsor)|3
2445291|NCT02806947|8414008|P2|Overall Study|Withdrawal by Subject|1
2445292|NCT02806947|8414009|P1|Overall Study|Withdrawal by Subject|5
2445293|NCT02806726|8414050|P1|Overall Study|Lost to Follow-up|1
2445294|NCT02806713|8414059|P2|Overall Study|cancelled surgery|2
2445295|NCT02806713|8414060|P1|Overall Study|cancelled surgery|1
2445296|NCT02806713|8414059|P2|Overall Study|Urethral injury during procedure|0
2445297|NCT02806713|8414060|P1|Overall Study|Urethral injury during procedure|1
2445298|NCT02806505|8414079|P2|Overall Study|Insufficient therapeutic response|4
2445299|NCT02806505|8414080|P1|Overall Study|Insufficient therapeutic response|2
2445300|NCT02806505|8414079|P2|Overall Study|Failure to return|1
2445301|NCT02806505|8414080|P1|Overall Study|Failure to return|0
2445302|NCT02806505|8414079|P2|Overall Study|Did not cooperate/refused treatment|3
2445303|NCT02806505|8414080|P1|Overall Study|Did not cooperate/refused treatment|3
2445304|NCT02806505|8414079|P2|Overall Study|Death|0
2445305|NCT02806505|8414080|P1|Overall Study|Death|4
2445306|NCT02806505|8414079|P2|Overall Study|Adverse event/intercurrent illness|3
2445307|NCT02806505|8414080|P1|Overall Study|Adverse event/intercurrent illness|1
2445308|NCT02806232|8414099|P9|Overall Study|Withdrawal by Subject|0
2445309|NCT02806232|8414100|P8|Overall Study|Withdrawal by Subject|0
2445310|NCT02806232|8414101|P7|Overall Study|Withdrawal by Subject|0
2445311|NCT02806232|8414102|P6|Overall Study|Withdrawal by Subject|1
2445312|NCT02806232|8414103|P5|Overall Study|Withdrawal by Subject|2
2445313|NCT02806232|8414104|P4|Overall Study|Withdrawal by Subject|0
2445314|NCT02806232|8414105|P3|Overall Study|Withdrawal by Subject|0
2445315|NCT02806232|8414106|P2|Overall Study|Withdrawal by Subject|2
2445316|NCT02806232|8414107|P1|Overall Study|Withdrawal by Subject|0
2445317|NCT02806232|8414099|P9|Overall Study|Lost to Follow-up|0
2445318|NCT02806232|8414100|P8|Overall Study|Lost to Follow-up|0
2445319|NCT02806232|8414101|P7|Overall Study|Lost to Follow-up|0
2445320|NCT02806232|8414102|P6|Overall Study|Lost to Follow-up|1
2445321|NCT02806232|8414103|P5|Overall Study|Lost to Follow-up|0
2445322|NCT02806232|8414104|P4|Overall Study|Lost to Follow-up|0
2445323|NCT02806232|8414105|P3|Overall Study|Lost to Follow-up|1
2445324|NCT02806232|8414106|P2|Overall Study|Lost to Follow-up|2
2445325|NCT02806232|8414107|P1|Overall Study|Lost to Follow-up|1
2445326|NCT02806024|8414147|P2|Overall Study|DVT during antepartum admission|1
2445327|NCT02806024|8414148|P1|Overall Study|DVT during antepartum admission|0
2445328|NCT02806024|8414147|P2|Overall Study|Night Delivery|1
2445329|NCT02806024|8414148|P1|Overall Study|Night Delivery|1
2445330|NCT02805907|8414158|P2|Overall Study|Lost to Follow-up|3
2445331|NCT02805907|8414159|P1|Overall Study|Lost to Follow-up|3
2445332|NCT02804750|8414182|P2|Period 4|Adverse Event|5
2445333|NCT02804750|8414183|P1|Period 4|Adverse Event|0
2445334|NCT02804750|8414182|P2|Period 3|Adverse Event|2
2445335|NCT02804750|8414183|P1|Period 3|Adverse Event|0
2445336|NCT02804750|8414182|P2|Period 2|Adverse Event|0
2445337|NCT02804750|8414183|P1|Period 2|Adverse Event|1
2445338|NCT02804750|8414182|P2|Period 1|Withdrawal by Subject|1
2445339|NCT02804750|8414183|P1|Period 1|Withdrawal by Subject|0
2445340|NCT02804750|8414182|P2|Period 1|Adverse Event|2
2445341|NCT02804750|8414183|P1|Period 1|Adverse Event|0
2445342|NCT02804399|8414210|P2|Period 2|Adverse Event|1
2445343|NCT02804399|8414211|P1|Period 2|Adverse Event|0
2445344|NCT02803580|8414283|P1|Overall Study|Inclusion in clinical trial|1
2445345|NCT02803580|8414283|P1|Overall Study|Withdrawal by Subject|3
2445346|NCT02803580|8414283|P1|Overall Study|Lost to Follow-up|19
2445347|NCT02803580|8414283|P1|Overall Study|Death|13
2445348|NCT02803138|8414322|P1|Overall Study|Other, not specified|28
2445349|NCT02803138|8414322|P1|Overall Study|Death|1
2445350|NCT02803138|8414322|P1|Overall Study|Withdrawn consent|1
2445351|NCT02803138|8414322|P1|Overall Study|Insufficient virological response|2
2445352|NCT02803138|8414322|P1|Overall Study|Failure to return|38
2445353|NCT02802878|8414338|P2|Overall Study|Protocol Violation|0
2445354|NCT02802878|8414339|P1|Overall Study|Protocol Violation|1
2445355|NCT02802878|8414338|P2|Overall Study|Withdrawal by Subject|3
2445356|NCT02802878|8414339|P1|Overall Study|Withdrawal by Subject|3
2445357|NCT02802865|8414355|P2|Overall Study|Ineliegible due to tuberculosis|1
2445358|NCT02802865|8414356|P1|Overall Study|Ineliegible due to tuberculosis|0
2445359|NCT02802865|8414355|P2|Overall Study|Pregnancy|1
2445360|NCT02802865|8414356|P1|Overall Study|Pregnancy|1
2445361|NCT02802592|8414378|P1|Overall Study|Study terminated due to loss of funding|4
2445362|NCT02802345|8414410|P2|Overall Study|Other than listed|5
2445363|NCT02802345|8414411|P1|Overall Study|Other than listed|1
2445364|NCT02802345|8414410|P2|Overall Study|Protocol Violation|1
2445365|NCT02802345|8414411|P1|Overall Study|Protocol Violation|0
2445366|NCT02802345|8414410|P2|Overall Study|Withdrawal by Subject|3
2445367|NCT02802345|8414411|P1|Overall Study|Withdrawal by Subject|3
2445368|NCT02802345|8414410|P2|Overall Study|Adverse Event|20
2445369|NCT02802345|8414411|P1|Overall Study|Adverse Event|28
2445370|NCT02802345|8414410|P2|Overall Study|Not Treated|1
2445371|NCT02802345|8414411|P1|Overall Study|Not Treated|0
2445372|NCT02802319|8414427|P2|Overall Study|Lost to Follow-up|4
2445373|NCT02802319|8414428|P1|Overall Study|Lost to Follow-up|0
2445374|NCT02802319|8414427|P2|Overall Study|Physician Decision|1
2445375|NCT02802319|8414428|P1|Overall Study|Physician Decision|2
2445376|NCT02801877|8414563|P4|Overall Study|Never Started Treatment|0
2445377|NCT02801877|8414564|P3|Overall Study|Never Started Treatment|4
2445378|NCT02801877|8414565|P2|Overall Study|Never Started Treatment|0
2445379|NCT02801877|8414566|P1|Overall Study|Never Started Treatment|2
2445380|NCT02801877|8414563|P4|Overall Study|Lost to Follow-up|0
2445381|NCT02801877|8414564|P3|Overall Study|Lost to Follow-up|2
2445382|NCT02801877|8414565|P2|Overall Study|Lost to Follow-up|1
2445383|NCT02801877|8414566|P1|Overall Study|Lost to Follow-up|1
2445384|NCT02801617|8414586|P2|Overall Study|Protocol Violation|6
2445385|NCT02801617|8414587|P1|Overall Study|Protocol Violation|2
2445386|NCT02801578|8414605|P1|Overall Study|Adverse Event|2
2445387|NCT02801396|8414609|P6|Period 1|Withdrawal by Subject|0
2445388|NCT02801396|8414610|P5|Period 1|Withdrawal by Subject|1
2445389|NCT02801396|8414611|P4|Period 1|Withdrawal by Subject|0
2445390|NCT02801396|8414612|P3|Period 1|Withdrawal by Subject|0
2445391|NCT02801396|8414613|P2|Period 1|Withdrawal by Subject|0
2445392|NCT02801396|8414614|P1|Period 1|Withdrawal by Subject|0
2445393|NCT02800928|8414648|P2|Overall Study|Protocol Violation|1
2445394|NCT02800928|8414649|P1|Overall Study|Protocol Violation|1
2445395|NCT02800928|8414648|P2|Overall Study|Withdrawal by Subject|1
2445396|NCT02800928|8414649|P1|Overall Study|Withdrawal by Subject|1
2445397|NCT02799784|8414675|P2|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1
2445398|NCT02799784|8414676|P1|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0
2445399|NCT02799784|8414675|P2|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1
2445400|NCT02799784|8414676|P1|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0
2445401|NCT02799784|8414675|P2|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0
2445402|NCT02799784|8414676|P1|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1
2445403|NCT02799784|8414675|P2|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1
2445404|NCT02799784|8414676|P1|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0
2445405|NCT02799784|8414675|P2|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0
2445406|NCT02799784|8414676|P1|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5
2445407|NCT02799784|8414675|P2|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
2445408|NCT02799784|8414676|P1|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
2445409|NCT02799472|8414684|P2|Overall Study|Lost to Follow-up|1
2445410|NCT02799472|8414685|P1|Overall Study|Lost to Follow-up|0
2445411|NCT02799472|8414684|P2|Overall Study|Lack of Efficacy|0
2445412|NCT02799472|8414685|P1|Overall Study|Lack of Efficacy|2
2445413|NCT02799472|8414684|P2|Overall Study|Withdrawal by Subject|4
2445414|NCT02799472|8414685|P1|Overall Study|Withdrawal by Subject|2
2445415|NCT02799082|8414745|P2|Overall Study|Protocol Violation|1
2445416|NCT02799082|8414746|P1|Overall Study|Protocol Violation|0
2445417|NCT02799082|8414745|P2|Overall Study|Refused second PDT or withdraw consent|3
2445418|NCT02799082|8414746|P1|Overall Study|Refused second PDT or withdraw consent|4
2445419|NCT02799069|8414783|P3|Overall Study|Protocol Violation|2
2445420|NCT02799069|8414784|P2|Overall Study|Protocol Violation|0
2445421|NCT02799069|8414785|P1|Overall Study|Protocol Violation|1
2445422|NCT02799069|8414783|P3|Overall Study|Withdrawal by Subject|3
2445423|NCT02799069|8414784|P2|Overall Study|Withdrawal by Subject|4
2445424|NCT02799069|8414785|P1|Overall Study|Withdrawal by Subject|4
2445425|NCT02799069|8414783|P3|Overall Study|Lost to Follow-up|0
2445426|NCT02799069|8414784|P2|Overall Study|Lost to Follow-up|1
2445427|NCT02799069|8414785|P1|Overall Study|Lost to Follow-up|1
2445428|NCT02799069|8414783|P3|Overall Study|Lack of Efficacy|0
2445429|NCT02799069|8414784|P2|Overall Study|Lack of Efficacy|0
2445430|NCT02799069|8414785|P1|Overall Study|Lack of Efficacy|2
2445431|NCT02799069|8414783|P3|Overall Study|Adverse Event|2
2445432|NCT02799069|8414784|P2|Overall Study|Adverse Event|2
2445433|NCT02799069|8414785|P1|Overall Study|Adverse Event|0
2445434|NCT02798315|8415154|P1|Overall Study|Failure to return|1
2445435|NCT02797678|8415188|P4|Second Intervention (5 Nights)|study/device use non-compliance|0
2445436|NCT02797678|8415189|P3|Second Intervention (5 Nights)|study/device use non-compliance|1
2445437|NCT02797678|8415190|P2|Second Intervention (5 Nights)|study/device use non-compliance|0
2445438|NCT02797678|8415191|P1|Second Intervention (5 Nights)|study/device use non-compliance|0
2445439|NCT02797678|8415188|P4|First Intervention (5 Nights)|study/device use non-compliance|0
2445440|NCT02797678|8415189|P3|First Intervention (5 Nights)|study/device use non-compliance|0
2445441|NCT02797678|8415190|P2|First Intervention (5 Nights)|study/device use non-compliance|1
2445442|NCT02797678|8415191|P1|First Intervention (5 Nights)|study/device use non-compliance|0
2445443|NCT02797678|8415188|P4|Screening Phase|Meeting Inclusion/Exclusion criteria|0
2445444|NCT02797678|8415189|P3|Screening Phase|Meeting Inclusion/Exclusion criteria|0
2445445|NCT02797678|8415190|P2|Screening Phase|Meeting Inclusion/Exclusion criteria|0
2445446|NCT02797678|8415191|P1|Screening Phase|Meeting Inclusion/Exclusion criteria|25
2445447|NCT02797522|8415226|P11|Overall Study|Study Terminated by Sponsor|1
2445448|NCT02797522|8415227|P10|Overall Study|Study Terminated by Sponsor|4
2445449|NCT02797522|8415228|P9|Overall Study|Study Terminated by Sponsor|2
2445450|NCT02797522|8415229|P8|Overall Study|Study Terminated by Sponsor|4
2445451|NCT02797522|8415230|P7|Overall Study|Study Terminated by Sponsor|0
2445452|NCT02797522|8415231|P6|Overall Study|Study Terminated by Sponsor|0
2445453|NCT02797522|8415232|P5|Overall Study|Study Terminated by Sponsor|0
2445454|NCT02797522|8415233|P4|Overall Study|Study Terminated by Sponsor|0
2445455|NCT02797522|8415234|P3|Overall Study|Study Terminated by Sponsor|0
2445456|NCT02797522|8415235|P2|Overall Study|Study Terminated by Sponsor|0
2445457|NCT02797522|8415236|P1|Overall Study|Study Terminated by Sponsor|0
2445458|NCT02797132|8415342|P1|Part B (24 Weeks)|Adverse Event|3
2445459|NCT02797132|8415342|P1|Part A (15 Days)|Adverse Event|1
2445460|NCT02797080|8415394|P1|Overall Study|Withdrawal by Subject|1
2445461|NCT02797080|8415394|P1|Overall Study|Lost to Follow-up|1
2445462|NCT02796963|8415436|P4|Overall Study|Lost to Follow-up|72
2445463|NCT02796963|8415437|P3|Overall Study|Lost to Follow-up|69
2445464|NCT02796963|8415438|P2|Overall Study|Lost to Follow-up|76
2445465|NCT02796963|8415439|P1|Overall Study|Lost to Follow-up|89
2445466|NCT02796677|8415505|P4|Overall Study|Reason not mentioned|5
2445467|NCT02796677|8415506|P3|Overall Study|Reason not mentioned|0
2445468|NCT02796677|8415507|P2|Overall Study|Reason not mentioned|3
2445469|NCT02796677|8415508|P1|Overall Study|Reason not mentioned|2
2445470|NCT02796677|8415505|P4|Overall Study|Progressive disease|18
2445471|NCT02796677|8415506|P3|Overall Study|Progressive disease|13
2445472|NCT02796677|8415507|P2|Overall Study|Progressive disease|15
2445473|NCT02796677|8415508|P1|Overall Study|Progressive disease|6
2445474|NCT02796677|8415505|P4|Overall Study|Withdrawal by Subject|7
2445475|NCT02796677|8415506|P3|Overall Study|Withdrawal by Subject|6
2445476|NCT02796677|8415507|P2|Overall Study|Withdrawal by Subject|14
2445477|NCT02796677|8415508|P1|Overall Study|Withdrawal by Subject|4
2445478|NCT02796677|8415505|P4|Overall Study|Lack of Efficacy|20
2445479|NCT02796677|8415506|P3|Overall Study|Lack of Efficacy|14
2445480|NCT02796677|8415507|P2|Overall Study|Lack of Efficacy|9
2445481|NCT02796677|8415508|P1|Overall Study|Lack of Efficacy|7
2445482|NCT02796677|8415505|P4|Overall Study|Lost to Follow-up|2
2445483|NCT02796677|8415506|P3|Overall Study|Lost to Follow-up|2
2445484|NCT02796677|8415507|P2|Overall Study|Lost to Follow-up|5
2445485|NCT02796677|8415508|P1|Overall Study|Lost to Follow-up|1
2445486|NCT02796677|8415505|P4|Overall Study|Protocol Violation|8
2445487|NCT02796677|8415506|P3|Overall Study|Protocol Violation|4
2445488|NCT02796677|8415507|P2|Overall Study|Protocol Violation|5
2445489|NCT02796677|8415508|P1|Overall Study|Protocol Violation|7
2445490|NCT02796677|8415505|P4|Overall Study|Adverse Event|14
2445491|NCT02796677|8415506|P3|Overall Study|Adverse Event|14
2445492|NCT02796677|8415507|P2|Overall Study|Adverse Event|22
2445493|NCT02796677|8415508|P1|Overall Study|Adverse Event|11
2445494|NCT02796651|8415532|P1|Overall Study|Other|10
2445495|NCT02796651|8415532|P1|Overall Study|Lack of Efficacy|1
2445496|NCT02796651|8415532|P1|Overall Study|Protocol Violation|4
2445497|NCT02796651|8415532|P1|Overall Study|Withdrawal by Subject|4
2445498|NCT02796651|8415532|P1|Overall Study|Lost to Follow-up|1
2445499|NCT02796651|8415532|P1|Overall Study|Adverse Event|6
2445500|NCT02795832|8415626|P6|Overall Study|Adverse Event|3
2445501|NCT02795832|8415627|P5|Overall Study|Adverse Event|0
2445502|NCT02795832|8415628|P4|Overall Study|Adverse Event|0
2445503|NCT02795832|8415629|P3|Overall Study|Adverse Event|0
2445504|NCT02795832|8415630|P2|Overall Study|Adverse Event|0
2445505|NCT02795832|8415631|P1|Overall Study|Adverse Event|0
2445506|NCT02795767|8415698|P3|Overall Study|Lack of Efficacy|1
2445507|NCT02795767|8415699|P2|Overall Study|Lack of Efficacy|0
2445508|NCT02795767|8415700|P1|Overall Study|Lack of Efficacy|0
2445509|NCT02795767|8415698|P3|Overall Study|Ongoing Study Treatment|9
2445510|NCT02795767|8415699|P2|Overall Study|Ongoing Study Treatment|10
2445511|NCT02795767|8415700|P1|Overall Study|Ongoing Study Treatment|66
2445512|NCT02795767|8415698|P3|Overall Study|Received Commercial Emicizumab|0
2445513|NCT02795767|8415699|P2|Overall Study|Received Commercial Emicizumab|0
2445514|NCT02795767|8415700|P1|Overall Study|Received Commercial Emicizumab|2
2445515|NCT02794974|8415821|P2|Overall Study|Physician Decision|1
2445516|NCT02794974|8415822|P1|Overall Study|Physician Decision|0
2445517|NCT02794870|8415838|P2|Overall Study|Withdrawal by Subject|0
2445518|NCT02794870|8415839|P1|Overall Study|Withdrawal by Subject|2
2445519|NCT02794480|8415887|P4|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
2445520|NCT02794480|8415888|P3|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2445521|NCT02794480|8415889|P2|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2445522|NCT02794480|8415890|P1|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
2445523|NCT02794480|8415887|P4|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1
2445524|NCT02794480|8415888|P3|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2445525|NCT02794480|8415889|P2|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2
2445526|NCT02794480|8415890|P1|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2445527|NCT02794480|8415887|P4|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2
2445528|NCT02794480|8415888|P3|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
2445529|NCT02794480|8415889|P2|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
2445530|NCT02794480|8415890|P1|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
2445531|NCT02794480|8415887|P4|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
2445532|NCT02794480|8415888|P3|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1
2445533|NCT02794480|8415889|P2|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
2445534|NCT02794480|8415890|P1|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
2445535|NCT02794480|8415887|P4|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
2445536|NCT02794480|8415888|P3|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1
2445537|NCT02794480|8415889|P2|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
2445538|NCT02794480|8415890|P1|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
2445539|NCT02794246|8415933|P1|Overall Study|Physician Decision|4
2445540|NCT02794246|8415933|P1|Overall Study|Withdrawal by Subject|2
2445541|NCT02794103|8415945|P1|Overall Study|Loss to follow up due to high sedation|3
2445542|NCT02793947|8415956|P2|Overall Study|Physician Decision|5
2445543|NCT02793947|8415957|P1|Overall Study|Physician Decision|1
2445544|NCT02793947|8415956|P2|Overall Study|Death|0
2445545|NCT02793947|8415957|P1|Overall Study|Death|1
2445546|NCT02793232|8416012|P9|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
2445547|NCT02793232|8416013|P8|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
2445548|NCT02793232|8416014|P7|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
2445549|NCT02793232|8416015|P6|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
2445550|NCT02793232|8416016|P5|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
2445551|NCT02793232|8416017|P4|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
2445552|NCT02793232|8416018|P3|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
2445553|NCT02793232|8416019|P2|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
2445554|NCT02793232|8416020|P1|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
2445555|NCT02792829|8416281|P8|Treatment Period 2|Use of proscribed medications|1
2445556|NCT02792829|8416282|P7|Treatment Period 2|Use of proscribed medications|0
2445557|NCT02792829|8416283|P6|Treatment Period 2|Use of proscribed medications|0
2445558|NCT02792829|8416284|P5|Treatment Period 2|Use of proscribed medications|0
2445559|NCT02792829|8416285|P4|Treatment Period 2|Use of proscribed medications|0
2445560|NCT02792829|8416286|P3|Treatment Period 2|Use of proscribed medications|0
2445561|NCT02792829|8416287|P2|Treatment Period 2|Use of proscribed medications|0
2445562|NCT02792829|8416288|P1|Treatment Period 2|Use of proscribed medications|0
2445563|NCT02792829|8416281|P8|Treatment Period 2|Adverse Event|1
2445564|NCT02792829|8416282|P7|Treatment Period 2|Adverse Event|1
2445565|NCT02792829|8416283|P6|Treatment Period 2|Adverse Event|0
2445566|NCT02792829|8416284|P5|Treatment Period 2|Adverse Event|1
2445567|NCT02792829|8416285|P4|Treatment Period 2|Adverse Event|0
2445568|NCT02792829|8416286|P3|Treatment Period 2|Adverse Event|0
2445569|NCT02792829|8416287|P2|Treatment Period 2|Adverse Event|0
2445570|NCT02792829|8416288|P1|Treatment Period 2|Adverse Event|0
2445571|NCT02792829|8416281|P8|Treatment Period 2|Non compliance with alcohol prohibition|0
2445572|NCT02792829|8416282|P7|Treatment Period 2|Non compliance with alcohol prohibition|0
2445573|NCT02792829|8416283|P6|Treatment Period 2|Non compliance with alcohol prohibition|0
2445574|NCT02792829|8416284|P5|Treatment Period 2|Non compliance with alcohol prohibition|0
2445575|NCT02792829|8416285|P4|Treatment Period 2|Non compliance with alcohol prohibition|0
2445576|NCT02792829|8416286|P3|Treatment Period 2|Non compliance with alcohol prohibition|0
2445577|NCT02792829|8416287|P2|Treatment Period 2|Non compliance with alcohol prohibition|1
2445578|NCT02792829|8416288|P1|Treatment Period 2|Non compliance with alcohol prohibition|0
2445579|NCT02792777|8416396|P2|Overall Study|Participant interviewed twice|0
2445580|NCT02792777|8416397|P1|Overall Study|Participant interviewed twice|1
2445581|NCT02792777|8416396|P2|Overall Study|Later determined to be ineligible|0
2445582|NCT02792777|8416397|P1|Overall Study|Later determined to be ineligible|2
2445583|NCT02792777|8416396|P2|Overall Study|Recording malfunction|0
2445584|NCT02792777|8416397|P1|Overall Study|Recording malfunction|2
2445585|NCT02792777|8416396|P2|Overall Study|Withdrawal by Subject|0
2445586|NCT02792777|8416397|P1|Overall Study|Withdrawal by Subject|2
2445587|NCT02792699|8416413|P3|Overall Study|Other|0
2445588|NCT02792699|8416414|P2|Overall Study|Other|0
2445589|NCT02792699|8416415|P1|Overall Study|Other|1
2445590|NCT02792699|8416413|P3|Overall Study|Dissatisfaction with Treatment Efficacy|1
2445591|NCT02792699|8416414|P2|Overall Study|Dissatisfaction with Treatment Efficacy|3
2445592|NCT02792699|8416415|P1|Overall Study|Dissatisfaction with Treatment Efficacy|1
2445593|NCT02792699|8416413|P3|Overall Study|Physician Decision|0
2445594|NCT02792699|8416414|P2|Overall Study|Physician Decision|0
2445595|NCT02792699|8416415|P1|Overall Study|Physician Decision|2
2445596|NCT02792699|8416413|P3|Overall Study|Lost to Follow-up|2
2445597|NCT02792699|8416414|P2|Overall Study|Lost to Follow-up|1
2445598|NCT02792699|8416415|P1|Overall Study|Lost to Follow-up|0
2445599|NCT02792699|8416413|P3|Overall Study|Withdrawal by Subject|3
2445600|NCT02792699|8416414|P2|Overall Study|Withdrawal by Subject|4
2445601|NCT02792699|8416415|P1|Overall Study|Withdrawal by Subject|4
2445602|NCT02792699|8416413|P3|Overall Study|Adverse Event|4
2445603|NCT02792699|8416414|P2|Overall Study|Adverse Event|2
2445604|NCT02792699|8416415|P1|Overall Study|Adverse Event|1
2445605|NCT02792517|8416496|P1|Overall Study|Lost to Follow-up|3
2445606|NCT02792517|8416496|P1|Overall Study|Decision by Sponsor|7
2445607|NCT02792517|8416496|P1|Overall Study|Withdrawal by Subject|10
2445608|NCT02792062|8416516|P6|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
2445609|NCT02792062|8416517|P5|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
2445610|NCT02792062|8416518|P4|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
2445611|NCT02792062|8416519|P3|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
2445612|NCT02792062|8416520|P2|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
2445613|NCT02792062|8416521|P1|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1
2445614|NCT02791763|8416573|P3|Overall Study|Adverse Event|7
2445615|NCT02791763|8416574|P2|Overall Study|Adverse Event|13
2445616|NCT02791763|8416575|P1|Overall Study|Adverse Event|12
2445617|NCT02791763|8416573|P3|Overall Study|Met hemoglobin stopping criteria|0
2445618|NCT02791763|8416574|P2|Overall Study|Met hemoglobin stopping criteria|0
2445619|NCT02791763|8416575|P1|Overall Study|Met hemoglobin stopping criteria|1
2445620|NCT02791763|8416573|P3|Overall Study|Participant had renal transplant|0
2445621|NCT02791763|8416574|P2|Overall Study|Participant had renal transplant|0
2445622|NCT02791763|8416575|P1|Overall Study|Participant had renal transplant|3
2445623|NCT02791763|8416573|P3|Overall Study|Cancer event|0
2445624|NCT02791763|8416574|P2|Overall Study|Cancer event|3
2445625|NCT02791763|8416575|P1|Overall Study|Cancer event|1
2445626|NCT02791763|8416573|P3|Overall Study|Needs maintenance/changes in dialysis|5
2445627|NCT02791763|8416574|P2|Overall Study|Needs maintenance/changes in dialysis|19
2445628|NCT02791763|8416575|P1|Overall Study|Needs maintenance/changes in dialysis|16
2445629|NCT02791763|8416573|P3|Overall Study|Physician Decision|0
2445630|NCT02791763|8416574|P2|Overall Study|Physician Decision|1
2445631|NCT02791763|8416575|P1|Overall Study|Physician Decision|0
2445632|NCT02791763|8416573|P3|Overall Study|Withdrawal by Subject|0
2445633|NCT02791763|8416574|P2|Overall Study|Withdrawal by Subject|1
2445634|NCT02791763|8416575|P1|Overall Study|Withdrawal by Subject|5
2445635|NCT02791763|8416573|P3|Overall Study|Protocol Violation|1
2445636|NCT02791763|8416574|P2|Overall Study|Protocol Violation|0
2445637|NCT02791763|8416575|P1|Overall Study|Protocol Violation|0
2445638|NCT02791659|8416694|P2|Overall Study|Protocol Violation|1
2445639|NCT02791659|8416695|P1|Overall Study|Protocol Violation|0
2445640|NCT02791516|8416703|P2|Overall Study|Withdrawal by Subject|1
2445641|NCT02791516|8416704|P1|Overall Study|Withdrawal by Subject|1
2445642|NCT02791490|8416716|P2|Overall Study|Withdrawal by Subject|6
2445643|NCT02791490|8416717|P1|Overall Study|Withdrawal by Subject|2
2445644|NCT02791490|8416716|P2|Overall Study|Lost to Follow-up|2
2445645|NCT02791490|8416717|P1|Overall Study|Lost to Follow-up|1
2445646|NCT02791438|8416737|P2|Treatment Period|Withdrawal by Parent/Guardian|0
2445647|NCT02791438|8416738|P1|Treatment Period|Withdrawal by Parent/Guardian|2
2445648|NCT02791438|8416737|P2|Treatment Period|Withdrawal by Subject|1
2445649|NCT02791438|8416738|P1|Treatment Period|Withdrawal by Subject|0
2445650|NCT02791438|8416737|P2|Treatment Period|Adverse Event|0
2445651|NCT02791438|8416738|P1|Treatment Period|Adverse Event|1
2445652|NCT02791269|8416779|P2|Overall Study|Lost to Follow-up|1
2445653|NCT02791269|8416780|P1|Overall Study|Lost to Follow-up|0
2445654|NCT02790606|8416858|P1|Overall Study|Withdrawal by Subject|1
2445655|NCT02790606|8416858|P1|Overall Study|Physician Decision|3
2445656|NCT02790606|8416858|P1|Overall Study|Lost to Follow-up|4
2445657|NCT02790606|8416858|P1|Overall Study|Death|27
2445658|NCT02790073|8416890|P1|Overall Study|Withdrawal by Subject|1
2445659|NCT02790073|8416890|P1|Overall Study|Withdrawal from HD|1
2445660|NCT02790073|8416890|P1|Overall Study|Death|1
2445661|NCT02788747|8416912|P3|Overall Study|Adverse Event|0
2445662|NCT02788747|8416913|P2|Overall Study|Adverse Event|0
2445663|NCT02788747|8416914|P1|Overall Study|Adverse Event|1
2445664|NCT02788656|8416984|P2|Overall Study|Withdrawal by Subject|0
2445665|NCT02788656|8416985|P1|Overall Study|Withdrawal by Subject|1
2445666|NCT02788474|8417007|P2|Open Label Treatment Period|Non-compliance|0
2445667|NCT02788474|8417008|P1|Open Label Treatment Period|Non-compliance|1
2445668|NCT02788474|8417007|P2|Open Label Treatment Period|Patient's refusal|3
2445669|NCT02788474|8417008|P1|Open Label Treatment Period|Patient's refusal|1
2445670|NCT02788474|8417007|P2|Open Label Treatment Period|Other than reason specified|0
2445671|NCT02788474|8417008|P1|Open Label Treatment Period|Other than reason specified|1
2445672|NCT02788474|8417007|P2|Open Label Treatment Period|Adverse Event|9
2445673|NCT02788474|8417008|P1|Open Label Treatment Period|Adverse Event|29
2445674|NCT02788474|8417007|P2|Double Blind Treatment Period|Adverse Event|4
2445675|NCT02788474|8417008|P1|Double Blind Treatment Period|Adverse Event|6
2445676|NCT02788474|8417007|P2|Double Blind Treatment Period|Patient's refusal|0
2445677|NCT02788474|8417008|P1|Double Blind Treatment Period|Patient's refusal|3
2445678|NCT02788474|8417007|P2|Double Blind Treatment Period|Not treated|0
2445679|NCT02788474|8417008|P1|Double Blind Treatment Period|Not treated|1
2445680|NCT02788357|8417023|P2|Overall Study|Lost to Follow-up|0
2445681|NCT02788357|8417024|P1|Overall Study|Lost to Follow-up|3
2445682|NCT02788279|8417039|P3|Overall Study|Sponsor decision|11
2445683|NCT02788279|8417040|P2|Overall Study|Sponsor decision|29
2445684|NCT02788279|8417041|P1|Overall Study|Sponsor decision|18
2445685|NCT02788279|8417039|P3|Overall Study|Lost to Follow-up|2
2445686|NCT02788279|8417040|P2|Overall Study|Lost to Follow-up|3
2445687|NCT02788279|8417041|P1|Overall Study|Lost to Follow-up|0
2445688|NCT02788279|8417039|P3|Overall Study|Withdrawal by Subject|5
2445689|NCT02788279|8417040|P2|Overall Study|Withdrawal by Subject|15
2445690|NCT02788279|8417041|P1|Overall Study|Withdrawal by Subject|10
2445691|NCT02788279|8417039|P3|Overall Study|Death|72
2445692|NCT02788279|8417040|P2|Overall Study|Death|136
2445693|NCT02788279|8417041|P1|Overall Study|Death|62
2445694|NCT02788175|8417101|P1|Overall Study|Ineligible prior to study agent|6
2445695|NCT02788175|8417101|P1|Overall Study|Withdrawal by Subject|4
2445696|NCT02788175|8417101|P1|Overall Study|Protocol Violation|3
2445697|NCT02787863|8417123|P8|Overall Study|Withdrawal by Subject|0
2445698|NCT02787863|8417124|P7|Overall Study|Withdrawal by Subject|0
2445699|NCT02787863|8417125|P6|Overall Study|Withdrawal by Subject|0
2445700|NCT02787863|8417126|P5|Overall Study|Withdrawal by Subject|0
2445701|NCT02787863|8417127|P4|Overall Study|Withdrawal by Subject|0
2445702|NCT02787863|8417128|P3|Overall Study|Withdrawal by Subject|1
2445703|NCT02787863|8417129|P2|Overall Study|Withdrawal by Subject|1
2445704|NCT02787863|8417130|P1|Overall Study|Withdrawal by Subject|0
2445705|NCT02787863|8417123|P8|Overall Study|Death|0
2445706|NCT02787863|8417124|P7|Overall Study|Death|0
2445707|NCT02787863|8417125|P6|Overall Study|Death|0
2445708|NCT02787863|8417126|P5|Overall Study|Death|0
2445709|NCT02787863|8417127|P4|Overall Study|Death|0
2445710|NCT02787863|8417128|P3|Overall Study|Death|1
2445711|NCT02787863|8417129|P2|Overall Study|Death|0
2445712|NCT02787863|8417130|P1|Overall Study|Death|1
2445713|NCT02787551|8417215|P2|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0
2445714|NCT02787551|8417216|P1|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5
2445715|NCT02787551|8417215|P2|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0
2445716|NCT02787551|8417216|P1|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3
2445717|NCT02787551|8417215|P2|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0
2445718|NCT02787551|8417216|P1|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1
2445719|NCT02787551|8417215|P2|Core Period: 26 Weeks|Other than specified|1
2445720|NCT02787551|8417216|P1|Core Period: 26 Weeks|Other than specified|3
2445721|NCT02787551|8417215|P2|Core Period: 26 Weeks|Randomized but not treated|1
2445722|NCT02787551|8417216|P1|Core Period: 26 Weeks|Randomized but not treated|2
2445723|NCT02787551|8417215|P2|Core Period: 26 Weeks|Withdrawal by Subject|9
2445724|NCT02787551|8417216|P1|Core Period: 26 Weeks|Withdrawal by Subject|9
2445725|NCT02787551|8417215|P2|Core Period: 26 Weeks|Poor compliance to protocol|0
2445726|NCT02787551|8417216|P1|Core Period: 26 Weeks|Poor compliance to protocol|2
2445727|NCT02787551|8417215|P2|Core Period: 26 Weeks|Lack of Efficacy|0
2445728|NCT02787551|8417216|P1|Core Period: 26 Weeks|Lack of Efficacy|1
2445729|NCT02787551|8417215|P2|Core Period: 26 Weeks|Adverse Event|0
2445730|NCT02787551|8417216|P1|Core Period: 26 Weeks|Adverse Event|10
2445731|NCT02787304|8417252|P4|Overall Study|Study terminated by sponsor|32
2445732|NCT02787304|8417253|P3|Overall Study|Study terminated by sponsor|31
2445733|NCT02787304|8417254|P2|Overall Study|Study terminated by sponsor|31
2445734|NCT02787304|8417255|P1|Overall Study|Study terminated by sponsor|25
2445735|NCT02787304|8417252|P4|Overall Study|Physician Decision|0
2445736|NCT02787304|8417253|P3|Overall Study|Physician Decision|1
2445737|NCT02787304|8417254|P2|Overall Study|Physician Decision|0
2445738|NCT02787304|8417255|P1|Overall Study|Physician Decision|0
2445739|NCT02787304|8417252|P4|Overall Study|Noncompliance with study drug|0
2445740|NCT02787304|8417253|P3|Overall Study|Noncompliance with study drug|1
2445741|NCT02787304|8417254|P2|Overall Study|Noncompliance with study drug|0
2445742|NCT02787304|8417255|P1|Overall Study|Noncompliance with study drug|0
2445743|NCT02787304|8417252|P4|Overall Study|Lost to Follow-up|1
2445744|NCT02787304|8417253|P3|Overall Study|Lost to Follow-up|0
2445745|NCT02787304|8417254|P2|Overall Study|Lost to Follow-up|0
2445746|NCT02787304|8417255|P1|Overall Study|Lost to Follow-up|1
2445747|NCT02787304|8417252|P4|Overall Study|Withdrawal by Subject|0
2445748|NCT02787304|8417253|P3|Overall Study|Withdrawal by Subject|0
2445749|NCT02787304|8417254|P2|Overall Study|Withdrawal by Subject|4
2445750|NCT02787304|8417255|P1|Overall Study|Withdrawal by Subject|1
2445751|NCT02787304|8417252|P4|Overall Study|Adverse Event|1
2445752|NCT02787304|8417253|P3|Overall Study|Adverse Event|8
2445753|NCT02787304|8417254|P2|Overall Study|Adverse Event|3
2445754|NCT02787304|8417255|P1|Overall Study|Adverse Event|9
2445755|NCT02787083|8417303|P2|Overall Study|Withdrawal by Subject|2
2445756|NCT02787083|8417304|P1|Overall Study|Withdrawal by Subject|2
2445757|NCT02787083|8417303|P2|Overall Study|Adverse Event|0
2445758|NCT02787083|8417304|P1|Overall Study|Adverse Event|1
2445759|NCT02786953|8417329|P2|Overall Study|Physician Decision|1
2445760|NCT02786953|8417330|P1|Overall Study|Physician Decision|0
2445761|NCT02786953|8417329|P2|Overall Study|Withdrawal by Subject|0
2445762|NCT02786953|8417330|P1|Overall Study|Withdrawal by Subject|3
2445763|NCT02786927|8417352|P1|Overall Study|Protocol Violation|4
2445764|NCT02786927|8417352|P1|Overall Study|Adverse Event|1
2445765|NCT02786901|8417362|P3|Overall Study|Randomized in error|1
2445766|NCT02786901|8417363|P2|Overall Study|Randomized in error|0
2445767|NCT02786901|8417364|P1|Overall Study|Randomized in error|2
2445768|NCT02786901|8417362|P3|Overall Study|Disallowed medication|0
2445769|NCT02786901|8417363|P2|Overall Study|Disallowed medication|1
2445770|NCT02786901|8417364|P1|Overall Study|Disallowed medication|1
2445771|NCT02786901|8417362|P3|Overall Study|Subject Request/Lost to Follow up|5
2445772|NCT02786901|8417363|P2|Overall Study|Subject Request/Lost to Follow up|5
2445773|NCT02786901|8417364|P1|Overall Study|Subject Request/Lost to Follow up|1
2445774|NCT02786901|8417362|P3|Overall Study|Rescue Therapy Use|33
2445775|NCT02786901|8417363|P2|Overall Study|Rescue Therapy Use|49
2445776|NCT02786901|8417364|P1|Overall Study|Rescue Therapy Use|71
2445777|NCT02786901|8417362|P3|Overall Study|Physician Decision|0
2445778|NCT02786901|8417363|P2|Overall Study|Physician Decision|0
2445779|NCT02786901|8417364|P1|Overall Study|Physician Decision|1
2445780|NCT02786901|8417362|P3|Overall Study|Adverse Event|2
2445781|NCT02786901|8417363|P2|Overall Study|Adverse Event|1
2445782|NCT02786901|8417364|P1|Overall Study|Adverse Event|1
2445783|NCT02786004|8417422|P2|Overall Study|Withdrawal by Subject|1
2445784|NCT02786004|8417423|P1|Overall Study|Withdrawal by Subject|0
2445785|NCT02785913|8417431|P1|Overall Study|Ineligible|4
2445786|NCT02785913|8417431|P1|Overall Study|Never Received Treatment|1
2445787|NCT02785913|8417431|P1|Overall Study|Not protocol specified|1
2445788|NCT02785913|8417431|P1|Overall Study|Progression|18
2445789|NCT02785913|8417431|P1|Overall Study|Death|2
2445790|NCT02785913|8417431|P1|Overall Study|Adverse Event|5
2445791|NCT02785900|8417440|P2|Overall Study|Physician Decision|2
2445792|NCT02785900|8417441|P1|Overall Study|Physician Decision|3
2445793|NCT02785900|8417440|P2|Overall Study|Withdrawal by Subject|8
2445794|NCT02785900|8417441|P1|Overall Study|Withdrawal by Subject|4
2445795|NCT02785900|8417440|P2|Overall Study|Death|32
2445796|NCT02785900|8417441|P1|Overall Study|Death|46
2445797|NCT02785900|8417440|P2|Overall Study|Study Termination by Sponsor|81
2445798|NCT02785900|8417441|P1|Overall Study|Study Termination by Sponsor|64
2445799|NCT02785770|8417465|P4|Intervention Period 3 (1 Day)|Adverse Event|1
2445800|NCT02785770|8417466|P3|Intervention Period 3 (1 Day)|Adverse Event|0
2445801|NCT02785770|8417467|P2|Intervention Period 3 (1 Day)|Adverse Event|0
2445802|NCT02785770|8417468|P1|Intervention Period 3 (1 Day)|Adverse Event|0
2445803|NCT02785770|8417465|P4|Intervention Period 2 (1 Day)|Family related obligations|0
2445804|NCT02785770|8417466|P3|Intervention Period 2 (1 Day)|Family related obligations|1
2445805|NCT02785770|8417467|P2|Intervention Period 2 (1 Day)|Family related obligations|0
2445806|NCT02785770|8417468|P1|Intervention Period 2 (1 Day)|Family related obligations|0
2445807|NCT02785770|8417465|P4|Intervention Period 2 (1 Day)|Adverse Event|0
2445808|NCT02785770|8417466|P3|Intervention Period 2 (1 Day)|Adverse Event|0
2445809|NCT02785770|8417467|P2|Intervention Period 2 (1 Day)|Adverse Event|1
2445810|NCT02785770|8417468|P1|Intervention Period 2 (1 Day)|Adverse Event|0
2445811|NCT02785588|8417535|P1|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1
2445812|NCT02785588|8417535|P1|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1
2445813|NCT02784834|8417662|P1|Overall Study|Lack of Efficacy|1
2445814|NCT02784704|8417668|P2|Overall Study|Subject Non Compliance|0
2445815|NCT02784704|8417669|P1|Overall Study|Subject Non Compliance|2
2445816|NCT02784704|8417668|P2|Overall Study|Withdrawal by Subject|3
2445817|NCT02784704|8417669|P1|Overall Study|Withdrawal by Subject|1
2445818|NCT02784704|8417668|P2|Overall Study|Lost to Follow-up|4
2445819|NCT02784704|8417669|P1|Overall Study|Lost to Follow-up|6
2445820|NCT02784704|8417668|P2|Overall Study|Adverse Event|2
2445821|NCT02784704|8417669|P1|Overall Study|Adverse Event|4
2445822|NCT02784106|8417745|P4|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
2445823|NCT02784106|8417746|P3|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
2445824|NCT02784106|8417747|P2|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
2445825|NCT02784106|8417748|P1|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
2445826|NCT02784106|8417745|P4|Open-Label Extension Period (26 Weeks)|Adverse Event|1
2445827|NCT02784106|8417746|P3|Open-Label Extension Period (26 Weeks)|Adverse Event|2
2445828|NCT02784106|8417747|P2|Open-Label Extension Period (26 Weeks)|Adverse Event|0
2445829|NCT02784106|8417748|P1|Open-Label Extension Period (26 Weeks)|Adverse Event|0
2445830|NCT02784106|8417745|P4|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
2445831|NCT02784106|8417746|P3|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
2445832|NCT02784106|8417747|P2|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
2445833|NCT02784106|8417748|P1|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1
2445834|NCT02784106|8417745|P4|Double-Blind Treatment Period (12 Weeks)|Other|0
2445835|NCT02784106|8417746|P3|Double-Blind Treatment Period (12 Weeks)|Other|0
2445836|NCT02784106|8417747|P2|Double-Blind Treatment Period (12 Weeks)|Other|0
2445837|NCT02784106|8417748|P1|Double-Blind Treatment Period (12 Weeks)|Other|2
2445838|NCT02784106|8417745|P4|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
2445839|NCT02784106|8417746|P3|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
2445840|NCT02784106|8417747|P2|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1
2445841|NCT02784106|8417748|P1|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2
2445842|NCT02784106|8417745|P4|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
2445843|NCT02784106|8417746|P3|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
2445844|NCT02784106|8417747|P2|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5
2445845|NCT02784106|8417748|P1|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3
2445846|NCT02783729|8417836|P4|Overall Study|Lost to Follow-up|0
2445847|NCT02783729|8417837|P3|Overall Study|Lost to Follow-up|1
2445848|NCT02783729|8417838|P2|Overall Study|Lost to Follow-up|1
2445849|NCT02783729|8417839|P1|Overall Study|Lost to Follow-up|2
2445850|NCT02783729|8417836|P4|Overall Study|Participant's choice|1
2445851|NCT02783729|8417837|P3|Overall Study|Participant's choice|2
2445852|NCT02783729|8417838|P2|Overall Study|Participant's choice|1
2445853|NCT02783729|8417839|P1|Overall Study|Participant's choice|2
2445854|NCT02783729|8417836|P4|Overall Study|Withdrawal by Subject|2
2445855|NCT02783729|8417837|P3|Overall Study|Withdrawal by Subject|1
2445856|NCT02783729|8417838|P2|Overall Study|Withdrawal by Subject|3
2445857|NCT02783729|8417839|P1|Overall Study|Withdrawal by Subject|2
2445858|NCT02783729|8417836|P4|Overall Study|Other|3
2445859|NCT02783729|8417837|P3|Overall Study|Other|2
2445860|NCT02783729|8417838|P2|Overall Study|Other|6
2445861|NCT02783729|8417839|P1|Overall Study|Other|1
2445862|NCT02783729|8417836|P4|Overall Study|Adverse Event|3
2445863|NCT02783729|8417837|P3|Overall Study|Adverse Event|2
2445864|NCT02783729|8417838|P2|Overall Study|Adverse Event|6
2445865|NCT02783729|8417839|P1|Overall Study|Adverse Event|2
2445866|NCT02783729|8417836|P4|Overall Study|Lack of Efficacy|0
2445867|NCT02783729|8417837|P3|Overall Study|Lack of Efficacy|0
2445868|NCT02783729|8417838|P2|Overall Study|Lack of Efficacy|0
2445869|NCT02783729|8417839|P1|Overall Study|Lack of Efficacy|1
2445870|NCT02783599|8417905|P1|Overall Study|Death|1
2445871|NCT02783599|8417905|P1|Overall Study|Physician Decision|2
2445872|NCT02783599|8417905|P1|Overall Study|Adverse Event|4
2445873|NCT02783599|8417905|P1|Overall Study|Surgical Resection|10
2445874|NCT02783599|8417905|P1|Overall Study|Progressive disease|23
2445875|NCT02783573|8417921|P3|Delayed-Start Period|Sponsor Decision|12
2445876|NCT02783573|8417922|P2|Delayed-Start Period|Sponsor Decision|17
2445877|NCT02783573|8417923|P1|Delayed-Start Period|Sponsor Decision|0
2445878|NCT02783573|8417921|P3|Placebo-Controlled Treatment Period|Sponsor Decision|492
2445879|NCT02783573|8417922|P2|Placebo-Controlled Treatment Period|Sponsor Decision|512
2445880|NCT02783573|8417923|P1|Placebo-Controlled Treatment Period|Sponsor Decision|494
2445881|NCT02783573|8417921|P3|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9
2445882|NCT02783573|8417922|P2|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3
2445883|NCT02783573|8417923|P1|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3
2445884|NCT02783573|8417921|P3|Placebo-Controlled Treatment Period|Withdrawal by Subject|23
2445885|NCT02783573|8417922|P2|Placebo-Controlled Treatment Period|Withdrawal by Subject|20
2445886|NCT02783573|8417923|P1|Placebo-Controlled Treatment Period|Withdrawal by Subject|15
2445887|NCT02783573|8417921|P3|Placebo-Controlled Treatment Period|Protocol Violation|0
2445888|NCT02783573|8417922|P2|Placebo-Controlled Treatment Period|Protocol Violation|2
2445889|NCT02783573|8417923|P1|Placebo-Controlled Treatment Period|Protocol Violation|1
2445890|NCT02783573|8417921|P3|Placebo-Controlled Treatment Period|Physician Decision|3
2445891|NCT02783573|8417922|P2|Placebo-Controlled Treatment Period|Physician Decision|1
2445892|NCT02783573|8417923|P1|Placebo-Controlled Treatment Period|Physician Decision|3
2445893|NCT02783573|8417921|P3|Placebo-Controlled Treatment Period|Other-determined by Investigator|2
2445894|NCT02783573|8417922|P2|Placebo-Controlled Treatment Period|Other-determined by Investigator|1
2445895|NCT02783573|8417923|P1|Placebo-Controlled Treatment Period|Other-determined by Investigator|0
2445896|NCT02783573|8417921|P3|Placebo-Controlled Treatment Period|Non-Compliance|0
2445897|NCT02783573|8417922|P2|Placebo-Controlled Treatment Period|Non-Compliance|1
2445898|NCT02783573|8417923|P1|Placebo-Controlled Treatment Period|Non-Compliance|0
2445899|NCT02783573|8417921|P3|Placebo-Controlled Treatment Period|Lost to Follow-up|1
2445900|NCT02783573|8417922|P2|Placebo-Controlled Treatment Period|Lost to Follow-up|3
2445901|NCT02783573|8417923|P1|Placebo-Controlled Treatment Period|Lost to Follow-up|3
2445902|NCT02783573|8417921|P3|Placebo-Controlled Treatment Period|Lack of Efficacy|2
2445903|NCT02783573|8417922|P2|Placebo-Controlled Treatment Period|Lack of Efficacy|0
2445904|NCT02783573|8417923|P1|Placebo-Controlled Treatment Period|Lack of Efficacy|0
2445905|NCT02783573|8417921|P3|Placebo-Controlled Treatment Period|Death|3
2445906|NCT02783573|8417922|P2|Placebo-Controlled Treatment Period|Death|2
2445907|NCT02783573|8417923|P1|Placebo-Controlled Treatment Period|Death|4
2445908|NCT02783573|8417921|P3|Placebo-Controlled Treatment Period|Adverse Event|13
2445909|NCT02783573|8417922|P2|Placebo-Controlled Treatment Period|Adverse Event|17
2445910|NCT02783573|8417923|P1|Placebo-Controlled Treatment Period|Adverse Event|13
2445911|NCT02783170|8417988|P2|Overall Study|Randomized but not Vaccinated|0
2445912|NCT02783170|8417989|P1|Overall Study|Randomized but not Vaccinated|1
2445913|NCT02782923|8418047|P1|Overall Study|Lost to Follow-up|15
2445914|NCT02782676|8418053|P2|Overall Study|Lost to Follow-up|1
2445915|NCT02782676|8418054|P1|Overall Study|Lost to Follow-up|0
2445916|NCT02782377|8418082|P1|Overall Study|Physician Decision|5
2445917|NCT02782325|8418097|P3|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4
2445918|NCT02782325|8418098|P2|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0
2445919|NCT02782325|8418099|P1|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0
2445920|NCT02782325|8418097|P3|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0
2445921|NCT02782325|8418098|P2|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2
2445922|NCT02782325|8418099|P1|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4
2445923|NCT02782169|8418127|P2|Overall Study|Lost to Follow-up|2
2445924|NCT02782169|8418128|P1|Overall Study|Lost to Follow-up|1
2445925|NCT02781844|8418146|P8|Treatment Period 1|Adverse Event|0
2445926|NCT02781844|8418147|P7|Treatment Period 1|Adverse Event|0
2445927|NCT02781844|8418148|P6|Treatment Period 1|Adverse Event|1
2445928|NCT02781844|8418149|P5|Treatment Period 1|Adverse Event|0
2445929|NCT02781844|8418150|P4|Treatment Period 1|Adverse Event|0
2445930|NCT02781844|8418151|P3|Treatment Period 1|Adverse Event|0
2445931|NCT02781844|8418152|P2|Treatment Period 1|Adverse Event|0
2445932|NCT02781844|8418153|P1|Treatment Period 1|Adverse Event|0
2445933|NCT02781818|8418286|P3|Overall Study|Lost to Follow-up|1
2445934|NCT02781818|8418287|P2|Overall Study|Lost to Follow-up|2
2445935|NCT02781818|8418288|P1|Overall Study|Lost to Follow-up|4
2445936|NCT02781558|8418354|P2|Overall Study|Adverse Event|0
2445937|NCT02781558|8418355|P1|Overall Study|Adverse Event|1
2445938|NCT02781558|8418354|P2|Overall Study|Lost to Follow-up|2
2445939|NCT02781558|8418355|P1|Overall Study|Lost to Follow-up|2
2445940|NCT02781324|8418442|P2|Overall Study|Physician Decision|2
2445941|NCT02781324|8418443|P1|Overall Study|Physician Decision|1
2445942|NCT02781324|8418442|P2|Overall Study|Withdrawal by Subject|0
2445943|NCT02781324|8418443|P1|Overall Study|Withdrawal by Subject|1
2445944|NCT02781311|8418472|P3|Overall Study|Non-Compliance with Study Drug|0
2445945|NCT02781311|8418473|P2|Overall Study|Non-Compliance with Study Drug|0
2445946|NCT02781311|8418474|P1|Overall Study|Non-Compliance with Study Drug|2
2445947|NCT02781311|8418472|P3|Overall Study|Lost to Follow-up|1
2445948|NCT02781311|8418473|P2|Overall Study|Lost to Follow-up|8
2445949|NCT02781311|8418474|P1|Overall Study|Lost to Follow-up|11
2445950|NCT02781311|8418472|P3|Overall Study|Withdrawal of Consent|2
2445951|NCT02781311|8418473|P2|Overall Study|Withdrawal of Consent|12
2445952|NCT02781311|8418474|P1|Overall Study|Withdrawal of Consent|11
2445953|NCT02781311|8418472|P3|Overall Study|Adverse Event|1
2445954|NCT02781311|8418473|P2|Overall Study|Adverse Event|6
2445955|NCT02781311|8418474|P1|Overall Study|Adverse Event|2
2445956|NCT02780856|8418501|P1|Overall Study|Lost to Follow-up|1
2445957|NCT02780700|8418520|P1|Overall Study|Progressive disease|1
2445958|NCT02780388|8418589|P5|Overall Study|Withdrawal by Subject|0
2445959|NCT02780388|8418590|P4|Overall Study|Withdrawal by Subject|0
2445960|NCT02780388|8418591|P3|Overall Study|Withdrawal by Subject|0
2445961|NCT02780388|8418592|P2|Overall Study|Withdrawal by Subject|1
2445962|NCT02780388|8418593|P1|Overall Study|Withdrawal by Subject|1
2445963|NCT02780388|8418589|P5|Overall Study|Lost to Follow-up|0
2445964|NCT02780388|8418590|P4|Overall Study|Lost to Follow-up|0
2445965|NCT02780388|8418591|P3|Overall Study|Lost to Follow-up|0
2445966|NCT02780388|8418592|P2|Overall Study|Lost to Follow-up|1
2445967|NCT02780388|8418593|P1|Overall Study|Lost to Follow-up|0
2445968|NCT02780167|8418659|P5|Overall Study|Other|2
2445969|NCT02780167|8418660|P4|Overall Study|Other|1
2445970|NCT02780167|8418661|P3|Overall Study|Other|3
2445971|NCT02780167|8418662|P2|Overall Study|Other|0
2445972|NCT02780167|8418663|P1|Overall Study|Other|0
2445973|NCT02780167|8418659|P5|Overall Study|Withdrawal by Subject|4
2445974|NCT02780167|8418660|P4|Overall Study|Withdrawal by Subject|3
2445975|NCT02780167|8418661|P3|Overall Study|Withdrawal by Subject|4
2445976|NCT02780167|8418662|P2|Overall Study|Withdrawal by Subject|4
2445977|NCT02780167|8418663|P1|Overall Study|Withdrawal by Subject|6
2445978|NCT02780167|8418659|P5|Overall Study|Protocol Violation|2
2445979|NCT02780167|8418660|P4|Overall Study|Protocol Violation|1
2445980|NCT02780167|8418661|P3|Overall Study|Protocol Violation|1
2445981|NCT02780167|8418662|P2|Overall Study|Protocol Violation|5
2445982|NCT02780167|8418663|P1|Overall Study|Protocol Violation|5
2445983|NCT02780167|8418659|P5|Overall Study|No longer meets eligibility criteria|1
2445984|NCT02780167|8418660|P4|Overall Study|No longer meets eligibility criteria|1
2445985|NCT02780167|8418661|P3|Overall Study|No longer meets eligibility criteria|0
2445986|NCT02780167|8418662|P2|Overall Study|No longer meets eligibility criteria|0
2445987|NCT02780167|8418663|P1|Overall Study|No longer meets eligibility criteria|0
2445988|NCT02780167|8418659|P5|Overall Study|Does not meet entrance criteria|0
2445989|NCT02780167|8418660|P4|Overall Study|Does not meet entrance criteria|0
2445990|NCT02780167|8418661|P3|Overall Study|Does not meet entrance criteria|1
2445991|NCT02780167|8418662|P2|Overall Study|Does not meet entrance criteria|0
2445992|NCT02780167|8418663|P1|Overall Study|Does not meet entrance criteria|0
2445993|NCT02780167|8418659|P5|Overall Study|Lost to Follow-up|0
2445994|NCT02780167|8418660|P4|Overall Study|Lost to Follow-up|0
2445995|NCT02780167|8418661|P3|Overall Study|Lost to Follow-up|1
2445996|NCT02780167|8418662|P2|Overall Study|Lost to Follow-up|0
2445997|NCT02780167|8418663|P1|Overall Study|Lost to Follow-up|2
2445998|NCT02780167|8418659|P5|Overall Study|Lack of Efficacy|0
2445999|NCT02780167|8418660|P4|Overall Study|Lack of Efficacy|1
2446000|NCT02780167|8418661|P3|Overall Study|Lack of Efficacy|6
2446001|NCT02780167|8418662|P2|Overall Study|Lack of Efficacy|5
2446002|NCT02780167|8418663|P1|Overall Study|Lack of Efficacy|6
2446003|NCT02780167|8418659|P5|Overall Study|Adverse Event|8
2446004|NCT02780167|8418660|P4|Overall Study|Adverse Event|12
2446005|NCT02780167|8418661|P3|Overall Study|Adverse Event|8
2446006|NCT02780167|8418662|P2|Overall Study|Adverse Event|8
2446007|NCT02780167|8418663|P1|Overall Study|Adverse Event|9
2446008|NCT02778555|8418851|P3|Overall Study|Withdrawal by Subject|107
2446009|NCT02778555|8418852|P2|Overall Study|Withdrawal by Subject|32
2446010|NCT02778555|8418853|P1|Overall Study|Withdrawal by Subject|55
2446011|NCT02778100|8418909|P2|Period 1 (Common Cold)|Withdrawal by Subject|0
2446012|NCT02778100|8418910|P1|Period 1 (Common Cold)|Withdrawal by Subject|1
2446013|NCT02778074|8418941|P2|Overall Study|Lost to Follow-up|10
2446014|NCT02778074|8418942|P1|Overall Study|Lost to Follow-up|7
2446015|NCT02777918|8418974|P2|Overall Study|Withdrawal by Subject|1
2446016|NCT02777918|8418975|P1|Overall Study|Withdrawal by Subject|1
2446017|NCT02777918|8418974|P2|Overall Study|Too busy / stressed|1
2446018|NCT02777918|8418975|P1|Overall Study|Too busy / stressed|1
2446019|NCT02777918|8418974|P2|Overall Study|Medical reasons|2
2446020|NCT02777918|8418975|P1|Overall Study|Medical reasons|1
2446021|NCT02777827|8418993|P6|Washout Between Periods 3 and 4|Protocol Violation|0
2446022|NCT02777827|8418994|P5|Washout Between Periods 3 and 4|Protocol Violation|0
2446023|NCT02777827|8418995|P4|Washout Between Periods 3 and 4|Protocol Violation|0
2446024|NCT02777827|8418996|P3|Washout Between Periods 3 and 4|Protocol Violation|1
2446025|NCT02777827|8418997|P2|Washout Between Periods 3 and 4|Protocol Violation|0
2446026|NCT02777827|8418998|P1|Washout Between Periods 3 and 4|Protocol Violation|0
2446027|NCT02777242|8419201|P1|Overall Study|Withdrawal by Subject|1
2446028|NCT02777242|8419201|P1|Overall Study|Sponsor's request|1
2446029|NCT02777242|8419201|P1|Overall Study|Multiple|1
2446030|NCT02777242|8419201|P1|Overall Study|Lost to Follow-up|1
2446031|NCT02777242|8419201|P1|Overall Study|Other|2
2446032|NCT02777125|8419207|P2|Overall Study|Protocol Violation|12
2446033|NCT02777125|8419208|P1|Overall Study|Protocol Violation|8
2446034|NCT02777125|8419207|P2|Overall Study|Assent form violation|23
2446035|NCT02777125|8419208|P1|Overall Study|Assent form violation|21
2446036|NCT02777125|8419207|P2|Overall Study|Consent form violation|12
2446037|NCT02777125|8419208|P1|Overall Study|Consent form violation|14
2446038|NCT02776683|8419253|P2|Post-switch Period|Other than listed|15
2446039|NCT02776683|8419254|P1|Post-switch Period|Other than listed|0
2446040|NCT02776683|8419253|P2|Post-switch Period|Progressive disease|20
2446041|NCT02776683|8419254|P1|Post-switch Period|Progressive disease|0
2446042|NCT02776683|8419253|P2|Post-switch Period|Physician Decision|3
2446043|NCT02776683|8419254|P1|Post-switch Period|Physician Decision|0
2446044|NCT02776683|8419253|P2|Post-switch Period|Withdrawal by Subject|2
2446045|NCT02776683|8419254|P1|Post-switch Period|Withdrawal by Subject|0
2446046|NCT02776683|8419253|P2|Post-switch Period|Adverse Event|3
2446047|NCT02776683|8419254|P1|Post-switch Period|Adverse Event|0
2446048|NCT02776683|8419253|P2|Pre-switch Period|Other than listed|0
2446049|NCT02776683|8419254|P1|Pre-switch Period|Other than listed|3
2446050|NCT02776683|8419253|P2|Pre-switch Period|Progressive disease|0
2446051|NCT02776683|8419254|P1|Pre-switch Period|Progressive disease|39
2446052|NCT02776683|8419253|P2|Pre-switch Period|Physician Decision|0
2446053|NCT02776683|8419254|P1|Pre-switch Period|Physician Decision|7
2446054|NCT02776683|8419253|P2|Pre-switch Period|Withdrawal by Subject|0
2446055|NCT02776683|8419254|P1|Pre-switch Period|Withdrawal by Subject|9
2446056|NCT02776683|8419253|P2|Pre-switch Period|Adverse Event|0
2446057|NCT02776683|8419254|P1|Pre-switch Period|Adverse Event|21
2446058|NCT02776683|8419253|P2|Pre-switch Period|Protocol Violation|0
2446059|NCT02776683|8419254|P1|Pre-switch Period|Protocol Violation|1
2446060|NCT02776670|8419265|P2|Overall Study|Other - Reason not given|1
2446061|NCT02776670|8419266|P1|Overall Study|Other - Reason not given|0
2446062|NCT02776670|8419265|P2|Overall Study|Withdrawal by Subject|1
2446063|NCT02776670|8419266|P1|Overall Study|Withdrawal by Subject|0
2446064|NCT02776670|8419265|P2|Overall Study|Protocol Violation|2
2446065|NCT02776670|8419266|P1|Overall Study|Protocol Violation|0
2446066|NCT02776670|8419265|P2|Overall Study|Adverse Event|2
2446067|NCT02776670|8419266|P1|Overall Study|Adverse Event|0
2446068|NCT02776033|8419324|P3|Overall Study|Adverse Event|0
2446069|NCT02776033|8419325|P2|Overall Study|Adverse Event|2
2446070|NCT02776033|8419326|P1|Overall Study|Adverse Event|1
2446071|NCT02776033|8419324|P3|Overall Study|Lost to Follow-up|0
2446072|NCT02776033|8419325|P2|Overall Study|Lost to Follow-up|0
2446073|NCT02776033|8419326|P1|Overall Study|Lost to Follow-up|1
2446074|NCT02776033|8419324|P3|Overall Study|Physician Decision|0
2446075|NCT02776033|8419325|P2|Overall Study|Physician Decision|0
2446076|NCT02776033|8419326|P1|Overall Study|Physician Decision|2
2446077|NCT02776033|8419324|P3|Overall Study|Withdrawal by Subject|2
2446078|NCT02776033|8419325|P2|Overall Study|Withdrawal by Subject|0
2446079|NCT02776033|8419326|P1|Overall Study|Withdrawal by Subject|0
2446080|NCT02775916|8419391|P2|Overall Study|Subject/Guardian Decision|0
2446081|NCT02775916|8419392|P1|Overall Study|Subject/Guardian Decision|2
2446082|NCT02775916|8419391|P2|Overall Study|Adverse Event|0
2446083|NCT02775916|8419392|P1|Overall Study|Adverse Event|1
2446084|NCT02775864|8419414|P4|Overall Study|Medicaid eligibility discontinued|890
2446085|NCT02775864|8419415|P3|Overall Study|Medicaid eligibility discontinued|720
2446086|NCT02775864|8419416|P2|Overall Study|Medicaid eligibility discontinued|2019
2446087|NCT02775864|8419417|P1|Overall Study|Medicaid eligibility discontinued|1478
2446088|NCT02775864|8419414|P4|Overall Study|Data ended end of 2010|1194
2446089|NCT02775864|8419415|P3|Overall Study|Data ended end of 2010|1140
2446090|NCT02775864|8419416|P2|Overall Study|Data ended end of 2010|2880
2446091|NCT02775864|8419417|P1|Overall Study|Data ended end of 2010|1764
2446092|NCT02775435|8419450|P2|Overall Study|Not Treated|1
2446093|NCT02775435|8419451|P1|Overall Study|Not Treated|0
2446094|NCT02775435|8419450|P2|Overall Study|Ongoing in Study|72
2446095|NCT02775435|8419451|P1|Overall Study|Ongoing in Study|121
2446096|NCT02775435|8419450|P2|Overall Study|Clinical Progression|26
2446097|NCT02775435|8419451|P1|Overall Study|Clinical Progression|13
2446098|NCT02775435|8419450|P2|Overall Study|Progressive Disease|140
2446099|NCT02775435|8419451|P1|Overall Study|Progressive Disease|86
2446100|NCT02775435|8419450|P2|Overall Study|Withdrawal by Subject|9
2446101|NCT02775435|8419451|P1|Overall Study|Withdrawal by Subject|5
2446102|NCT02775435|8419450|P2|Overall Study|Physician Decision|6
2446103|NCT02775435|8419451|P1|Overall Study|Physician Decision|5
2446104|NCT02775435|8419450|P2|Overall Study|Lost to Follow-up|2
2446105|NCT02775435|8419451|P1|Overall Study|Lost to Follow-up|0
2446106|NCT02775435|8419450|P2|Overall Study|Adverse Event|25
2446107|NCT02775435|8419451|P1|Overall Study|Adverse Event|48
2446108|NCT02775344|8419469|P2|Overall Study|No ovarian cyst identified|2
2446109|NCT02775344|8419470|P1|Overall Study|No ovarian cyst identified|3
2446110|NCT02774681|8419603|P1|Follow-Up for 3 Years|Withdrawal by Subject|1
2446111|NCT02774681|8419603|P1|Follow-Up for 3 Years|Death|11
2446112|NCT02774681|8419603|P1|Treatment on Study|Progressive Disease|7
2446113|NCT02774278|8419667|P1|Overall Study|Protocol Violation|2
2446114|NCT02774278|8419667|P1|Overall Study|Withdrawal by Subject|3
2446115|NCT02774278|8419667|P1|Overall Study|Administrative reasons|6
2446116|NCT02774278|8419667|P1|Overall Study|Refused treatment/did not cooperate|9
2446117|NCT02774278|8419667|P1|Overall Study|Adverse event/intercurrent illness|16
2446118|NCT02774278|8419667|P1|Overall Study|Death|29
2446119|NCT02774278|8419667|P1|Overall Study|Lack of Efficacy|199
2446120|NCT02773537|8419842|P3|Overall Study|Lost to Follow-up|4
2446121|NCT02773537|8419843|P2|Overall Study|Lost to Follow-up|1
2446122|NCT02773537|8419844|P1|Overall Study|Lost to Follow-up|0
2446123|NCT02773446|8419879|P6|First Admission|Lost to Follow-up|0
2446124|NCT02773446|8419880|P5|First Admission|Lost to Follow-up|0
2446125|NCT02773446|8419881|P4|First Admission|Lost to Follow-up|0
2446126|NCT02773446|8419882|P3|First Admission|Lost to Follow-up|0
2446127|NCT02773446|8419883|P2|First Admission|Lost to Follow-up|0
2446128|NCT02773446|8419884|P1|First Admission|Lost to Follow-up|1
2446129|NCT02773446|8419879|P6|First Admission|Withdrawal by Subject|0
2446130|NCT02773446|8419880|P5|First Admission|Withdrawal by Subject|0
2446131|NCT02773446|8419881|P4|First Admission|Withdrawal by Subject|1
2446132|NCT02773446|8419882|P3|First Admission|Withdrawal by Subject|0
2446133|NCT02773446|8419883|P2|First Admission|Withdrawal by Subject|0
2446134|NCT02773446|8419884|P1|First Admission|Withdrawal by Subject|0
2446135|NCT02773368|8419925|P2|Overall Study|Missing|1
2446136|NCT02773368|8419926|P1|Overall Study|Missing|0
2446137|NCT02773368|8419925|P2|Overall Study|Unclassified|1
2446138|NCT02773368|8419926|P1|Overall Study|Unclassified|1
2446139|NCT02773368|8419925|P2|Overall Study|Withdrawal by Subject|1
2446140|NCT02773368|8419926|P1|Overall Study|Withdrawal by Subject|5
2446141|NCT02773368|8419925|P2|Overall Study|Lost to Follow-up|1
2446142|NCT02773368|8419926|P1|Overall Study|Lost to Follow-up|4
2446143|NCT02772757|8419999|P3|Overall Study|Physician Decision|3
2446144|NCT02772757|8420000|P2|Overall Study|Physician Decision|3
2446145|NCT02772757|8420001|P1|Overall Study|Physician Decision|0
2446146|NCT02772757|8419999|P3|Overall Study|Protocol Violation|1
2446147|NCT02772757|8420000|P2|Overall Study|Protocol Violation|0
2446148|NCT02772757|8420001|P1|Overall Study|Protocol Violation|0
2446149|NCT02772757|8419999|P3|Overall Study|Withdrawal by Subject|1
2446150|NCT02772757|8420000|P2|Overall Study|Withdrawal by Subject|0
2446151|NCT02772757|8420001|P1|Overall Study|Withdrawal by Subject|1
2446152|NCT02771522|8420036|P1|Overall Study|No white spot lesions|3
2446153|NCT02771522|8420036|P1|Overall Study|Withdrawal by Subject|2
2446154|NCT02771522|8420036|P1|Overall Study|Lost to Follow-up|3
2446155|NCT02771366|8420047|P2|Period 2 (Crossover)|Withdrawal by Subject|0
2446156|NCT02771366|8420048|P1|Period 2 (Crossover)|Withdrawal by Subject|2
2446157|NCT02771366|8420047|P2|Period 1|Withdrawal by Subject|2
2446158|NCT02771366|8420048|P1|Period 1|Withdrawal by Subject|0
2446159|NCT02771275|8420055|P1|Overall Study|On Study|11
2446160|NCT02771275|8420055|P1|Overall Study|Reoperation|2
2446161|NCT02771145|8420063|P1|Overall Study|Lost to Follow-up|1
2446162|NCT02771145|8420063|P1|Overall Study|Adverse Event|3
2446163|NCT02770612|8420197|P1|Overall Study|Met exclusion criteria (postop LOS>7d)|1
2446164|NCT02770547|8420203|P2|Overall Study|Adverse Event|1
2446165|NCT02770547|8420204|P1|Overall Study|Adverse Event|0
2446166|NCT02770547|8420203|P2|Overall Study|Patient non-compliant|0
2446167|NCT02770547|8420204|P1|Overall Study|Patient non-compliant|1
2446168|NCT02770248|8420233|P2|Overall Study|Randomized in error, prior to treatment|1
2446169|NCT02770248|8420234|P1|Overall Study|Randomized in error, prior to treatment|0
2446170|NCT02770248|8420233|P2|Overall Study|Adverse Event|1
2446171|NCT02770248|8420234|P1|Overall Study|Adverse Event|0
2446172|NCT02769858|8420252|P1|Overall Study|Withdrawal by Subject|2
2446173|NCT02769312|8420276|P2|Follow-up|Lost to Follow-up|1
2446174|NCT02769312|8420277|P1|Follow-up|Lost to Follow-up|1
2446175|NCT02769312|8420276|P2|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1
2446176|NCT02769312|8420277|P1|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0
2446177|NCT02769312|8420276|P2|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0
2446178|NCT02769312|8420277|P1|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1
2446179|NCT02769312|8420276|P2|Double-Blind (0-2 Weeks)|Adverse Event|0
2446180|NCT02769312|8420277|P1|Double-Blind (0-2 Weeks)|Adverse Event|1
2446181|NCT02769312|8420276|P2|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1
2446182|NCT02769312|8420277|P1|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1
2446183|NCT02769247|8420294|P4|Overall Study|Physician Decision|0
2446184|NCT02769247|8420295|P3|Overall Study|Physician Decision|0
2446185|NCT02769247|8420296|P2|Overall Study|Physician Decision|0
2446186|NCT02769247|8420297|P1|Overall Study|Physician Decision|1
2446187|NCT02769247|8420294|P4|Overall Study|Protocol Violation|0
2446188|NCT02769247|8420295|P3|Overall Study|Protocol Violation|1
2446189|NCT02769247|8420296|P2|Overall Study|Protocol Violation|0
2446190|NCT02769247|8420297|P1|Overall Study|Protocol Violation|0
2446191|NCT02769247|8420294|P4|Overall Study|Withdrawal by Subject|1
2446192|NCT02769247|8420295|P3|Overall Study|Withdrawal by Subject|0
2446193|NCT02769247|8420296|P2|Overall Study|Withdrawal by Subject|0
2446194|NCT02769247|8420297|P1|Overall Study|Withdrawal by Subject|1
2446195|NCT02769065|8420365|P30|Overall Study|Pre-treatment Event/Adverse Event|0
2446196|NCT02769065|8420366|P29|Overall Study|Pre-treatment Event/Adverse Event|0
2446197|NCT02769065|8420367|P28|Overall Study|Pre-treatment Event/Adverse Event|0
2446198|NCT02769065|8420368|P27|Overall Study|Pre-treatment Event/Adverse Event|0
2446199|NCT02769065|8420369|P26|Overall Study|Pre-treatment Event/Adverse Event|0
2446200|NCT02769065|8420370|P25|Overall Study|Pre-treatment Event/Adverse Event|0
2446201|NCT02769065|8420371|P24|Overall Study|Pre-treatment Event/Adverse Event|0
2446202|NCT02769065|8420372|P23|Overall Study|Pre-treatment Event/Adverse Event|0
2446203|NCT02769065|8420373|P22|Overall Study|Pre-treatment Event/Adverse Event|0
2446204|NCT02769065|8420374|P21|Overall Study|Pre-treatment Event/Adverse Event|0
2446205|NCT02769065|8420375|P20|Overall Study|Pre-treatment Event/Adverse Event|0
2446206|NCT02769065|8420376|P19|Overall Study|Pre-treatment Event/Adverse Event|0
2446207|NCT02769065|8420377|P18|Overall Study|Pre-treatment Event/Adverse Event|0
2446208|NCT02769065|8420378|P17|Overall Study|Pre-treatment Event/Adverse Event|0
2446209|NCT02769065|8420379|P16|Overall Study|Pre-treatment Event/Adverse Event|0
2446210|NCT02769065|8420380|P15|Overall Study|Pre-treatment Event/Adverse Event|0
2446211|NCT02769065|8420381|P14|Overall Study|Pre-treatment Event/Adverse Event|0
2446212|NCT02769065|8420382|P13|Overall Study|Pre-treatment Event/Adverse Event|0
2446213|NCT02769065|8420383|P12|Overall Study|Pre-treatment Event/Adverse Event|0
2446214|NCT02769065|8420384|P11|Overall Study|Pre-treatment Event/Adverse Event|1
2446215|NCT02769065|8420385|P10|Overall Study|Pre-treatment Event/Adverse Event|0
2446216|NCT02769065|8420386|P9|Overall Study|Pre-treatment Event/Adverse Event|0
2446217|NCT02769065|8420387|P8|Overall Study|Pre-treatment Event/Adverse Event|0
2446218|NCT02769065|8420388|P7|Overall Study|Pre-treatment Event/Adverse Event|0
2446219|NCT02769065|8420389|P6|Overall Study|Pre-treatment Event/Adverse Event|0
2446220|NCT02769065|8420390|P5|Overall Study|Pre-treatment Event/Adverse Event|0
2446221|NCT02769065|8420391|P4|Overall Study|Pre-treatment Event/Adverse Event|0
2446222|NCT02769065|8420392|P3|Overall Study|Pre-treatment Event/Adverse Event|0
2446223|NCT02769065|8420393|P2|Overall Study|Pre-treatment Event/Adverse Event|0
2446224|NCT02769065|8420394|P1|Overall Study|Pre-treatment Event/Adverse Event|0
2446225|NCT02769065|8420365|P30|Overall Study|Reason Not Specified|0
2446226|NCT02769065|8420366|P29|Overall Study|Reason Not Specified|0
2446227|NCT02769065|8420367|P28|Overall Study|Reason Not Specified|0
2446228|NCT02769065|8420368|P27|Overall Study|Reason Not Specified|0
2446229|NCT02769065|8420369|P26|Overall Study|Reason Not Specified|0
2446230|NCT02769065|8420370|P25|Overall Study|Reason Not Specified|0
2446231|NCT02769065|8420371|P24|Overall Study|Reason Not Specified|0
2446232|NCT02769065|8420372|P23|Overall Study|Reason Not Specified|0
2446233|NCT02769065|8420373|P22|Overall Study|Reason Not Specified|0
2446234|NCT02769065|8420374|P21|Overall Study|Reason Not Specified|0
2446235|NCT02769065|8420375|P20|Overall Study|Reason Not Specified|0
2446236|NCT02769065|8420376|P19|Overall Study|Reason Not Specified|0
2446237|NCT02769065|8420377|P18|Overall Study|Reason Not Specified|0
2446238|NCT02769065|8420378|P17|Overall Study|Reason Not Specified|0
2446239|NCT02769065|8420379|P16|Overall Study|Reason Not Specified|0
2446240|NCT02769065|8420380|P15|Overall Study|Reason Not Specified|0
2446241|NCT02769065|8420381|P14|Overall Study|Reason Not Specified|0
2446242|NCT02769065|8420382|P13|Overall Study|Reason Not Specified|0
2446243|NCT02769065|8420383|P12|Overall Study|Reason Not Specified|0
2446244|NCT02769065|8420384|P11|Overall Study|Reason Not Specified|0
2446245|NCT02769065|8420385|P10|Overall Study|Reason Not Specified|0
2446246|NCT02769065|8420386|P9|Overall Study|Reason Not Specified|0
2446247|NCT02769065|8420387|P8|Overall Study|Reason Not Specified|0
2446248|NCT02769065|8420388|P7|Overall Study|Reason Not Specified|1
2446249|NCT02769065|8420389|P6|Overall Study|Reason Not Specified|0
2446250|NCT02769065|8420390|P5|Overall Study|Reason Not Specified|0
2446251|NCT02769065|8420391|P4|Overall Study|Reason Not Specified|0
2446252|NCT02769065|8420392|P3|Overall Study|Reason Not Specified|0
2446253|NCT02769065|8420393|P2|Overall Study|Reason Not Specified|0
2446254|NCT02769065|8420394|P1|Overall Study|Reason Not Specified|0
2446255|NCT02769065|8420365|P30|Overall Study|Voluntary Withdrawal|0
2446256|NCT02769065|8420366|P29|Overall Study|Voluntary Withdrawal|0
2446257|NCT02769065|8420367|P28|Overall Study|Voluntary Withdrawal|0
2446258|NCT02769065|8420368|P27|Overall Study|Voluntary Withdrawal|0
2446259|NCT02769065|8420369|P26|Overall Study|Voluntary Withdrawal|0
2446260|NCT02769065|8420370|P25|Overall Study|Voluntary Withdrawal|0
2446261|NCT02769065|8420371|P24|Overall Study|Voluntary Withdrawal|0
2446262|NCT02769065|8420372|P23|Overall Study|Voluntary Withdrawal|0
2446263|NCT02769065|8420373|P22|Overall Study|Voluntary Withdrawal|0
2446264|NCT02769065|8420374|P21|Overall Study|Voluntary Withdrawal|0
2446265|NCT02769065|8420375|P20|Overall Study|Voluntary Withdrawal|0
2446266|NCT02769065|8420376|P19|Overall Study|Voluntary Withdrawal|0
2446267|NCT02769065|8420377|P18|Overall Study|Voluntary Withdrawal|0
2446268|NCT02769065|8420378|P17|Overall Study|Voluntary Withdrawal|0
2446269|NCT02769065|8420379|P16|Overall Study|Voluntary Withdrawal|0
2446270|NCT02769065|8420380|P15|Overall Study|Voluntary Withdrawal|0
2446271|NCT02769065|8420381|P14|Overall Study|Voluntary Withdrawal|0
2446272|NCT02769065|8420382|P13|Overall Study|Voluntary Withdrawal|0
2446273|NCT02769065|8420383|P12|Overall Study|Voluntary Withdrawal|0
2446274|NCT02769065|8420384|P11|Overall Study|Voluntary Withdrawal|0
2446275|NCT02769065|8420385|P10|Overall Study|Voluntary Withdrawal|0
2446276|NCT02769065|8420386|P9|Overall Study|Voluntary Withdrawal|0
2446277|NCT02769065|8420387|P8|Overall Study|Voluntary Withdrawal|0
2446278|NCT02769065|8420388|P7|Overall Study|Voluntary Withdrawal|0
2446279|NCT02769065|8420389|P6|Overall Study|Voluntary Withdrawal|0
2446280|NCT02769065|8420390|P5|Overall Study|Voluntary Withdrawal|0
2446281|NCT02769065|8420391|P4|Overall Study|Voluntary Withdrawal|0
2446282|NCT02769065|8420392|P3|Overall Study|Voluntary Withdrawal|0
2446283|NCT02769065|8420393|P2|Overall Study|Voluntary Withdrawal|0
2446284|NCT02769065|8420394|P1|Overall Study|Voluntary Withdrawal|1
2446285|NCT02768870|8420804|P1|Overall Study|On Study|19
2446286|NCT02768870|8420804|P1|Overall Study|Reoperation|4
2446287|NCT02768870|8420804|P1|Overall Study|Death|1
2446288|NCT02768870|8420804|P1|Overall Study|Not Implanted with Device|2
2446289|NCT02768194|8420846|P6|Period 3|Other (Reason not specified)|0
2446290|NCT02768194|8420847|P5|Period 3|Other (Reason not specified)|0
2446291|NCT02768194|8420848|P4|Period 3|Other (Reason not specified)|0
2446292|NCT02768194|8420849|P3|Period 3|Other (Reason not specified)|0
2446293|NCT02768194|8420850|P2|Period 3|Other (Reason not specified)|1
2446294|NCT02768194|8420851|P1|Period 3|Other (Reason not specified)|0
2446295|NCT02768194|8420846|P6|Period 2|Other (Reason not specified)|0
2446296|NCT02768194|8420847|P5|Period 2|Other (Reason not specified)|0
2446297|NCT02768194|8420848|P4|Period 2|Other (Reason not specified)|0
2446298|NCT02768194|8420849|P3|Period 2|Other (Reason not specified)|0
2446299|NCT02768194|8420850|P2|Period 2|Other (Reason not specified)|0
2446300|NCT02768194|8420851|P1|Period 2|Other (Reason not specified)|1
2446301|NCT02768194|8420846|P6|Period 1|Adverse Event|0
2446302|NCT02768194|8420847|P5|Period 1|Adverse Event|0
2446303|NCT02768194|8420848|P4|Period 1|Adverse Event|1
2446304|NCT02768194|8420849|P3|Period 1|Adverse Event|0
2446305|NCT02768194|8420850|P2|Period 1|Adverse Event|0
2446306|NCT02768194|8420851|P1|Period 1|Adverse Event|0
2446307|NCT02768103|8420873|P1|Overall Study|1 participant did not fit in the fMRI|1
2446308|NCT02767765|8420895|P1|Overall Study|Withdrawal by Subject|1
2446309|NCT02767765|8420895|P1|Overall Study|Non-Compliance|1
2446310|NCT02767765|8420895|P1|Overall Study|Investigator decision|1
2446311|NCT02767765|8420895|P1|Overall Study|Lost to Follow-up|2
2446312|NCT02767765|8420895|P1|Overall Study|Insufficient response|1
2446313|NCT02767765|8420895|P1|Overall Study|Death|1
2446314|NCT02767765|8420895|P1|Overall Study|Adverse Event|4
2446315|NCT02766608|8421042|P5|Overall Study|Administrative Reasons|0
2446316|NCT02766608|8421043|P4|Overall Study|Administrative Reasons|0
2446317|NCT02766608|8421044|P3|Overall Study|Administrative Reasons|1
2446318|NCT02766608|8421045|P2|Overall Study|Administrative Reasons|1
2446319|NCT02766608|8421046|P1|Overall Study|Administrative Reasons|3
2446320|NCT02766608|8421042|P5|Overall Study|Protocol Violation|1
2446321|NCT02766608|8421043|P4|Overall Study|Protocol Violation|0
2446322|NCT02766608|8421044|P3|Overall Study|Protocol Violation|4
2446323|NCT02766608|8421045|P2|Overall Study|Protocol Violation|4
2446324|NCT02766608|8421046|P1|Overall Study|Protocol Violation|0
2446325|NCT02766608|8421042|P5|Overall Study|Protocol disc criteria|0
2446326|NCT02766608|8421043|P4|Overall Study|Protocol disc criteria|0
2446327|NCT02766608|8421044|P3|Overall Study|Protocol disc criteria|4
2446328|NCT02766608|8421045|P2|Overall Study|Protocol disc criteria|3
2446329|NCT02766608|8421046|P1|Overall Study|Protocol disc criteria|3
2446330|NCT02766608|8421042|P5|Overall Study|Physician Decision|2
2446331|NCT02766608|8421043|P4|Overall Study|Physician Decision|1
2446332|NCT02766608|8421044|P3|Overall Study|Physician Decision|3
2446333|NCT02766608|8421045|P2|Overall Study|Physician Decision|2
2446334|NCT02766608|8421046|P1|Overall Study|Physician Decision|3
2446335|NCT02766608|8421042|P5|Overall Study|Lost to Follow-up|2
2446336|NCT02766608|8421043|P4|Overall Study|Lost to Follow-up|2
2446337|NCT02766608|8421044|P3|Overall Study|Lost to Follow-up|5
2446338|NCT02766608|8421045|P2|Overall Study|Lost to Follow-up|3
2446339|NCT02766608|8421046|P1|Overall Study|Lost to Follow-up|6
2446340|NCT02766608|8421042|P5|Overall Study|Lack of Efficacy|2
2446341|NCT02766608|8421043|P4|Overall Study|Lack of Efficacy|8
2446342|NCT02766608|8421044|P3|Overall Study|Lack of Efficacy|32
2446343|NCT02766608|8421045|P2|Overall Study|Lack of Efficacy|15
2446344|NCT02766608|8421046|P1|Overall Study|Lack of Efficacy|16
2446345|NCT02766608|8421042|P5|Overall Study|Withdrawal by Subject|10
2446346|NCT02766608|8421043|P4|Overall Study|Withdrawal by Subject|13
2446347|NCT02766608|8421044|P3|Overall Study|Withdrawal by Subject|24
2446348|NCT02766608|8421045|P2|Overall Study|Withdrawal by Subject|20
2446349|NCT02766608|8421046|P1|Overall Study|Withdrawal by Subject|21
2446350|NCT02766608|8421042|P5|Overall Study|Adverse Event|12
2446351|NCT02766608|8421043|P4|Overall Study|Adverse Event|13
2446352|NCT02766608|8421044|P3|Overall Study|Adverse Event|17
2446353|NCT02766608|8421045|P2|Overall Study|Adverse Event|22
2446354|NCT02766608|8421046|P1|Overall Study|Adverse Event|27
2446355|NCT02766400|8421138|P2|Overall Study|Withdrawal by Subject|0
2446356|NCT02766400|8421139|P1|Overall Study|Withdrawal by Subject|1
2446357|NCT02766400|8421138|P2|Overall Study|Death|2
2446358|NCT02766400|8421139|P1|Overall Study|Death|1
2446359|NCT02766283|8421154|P1|Overall Study|Lost to Follow-up|27
2446360|NCT02766088|8421187|P1|Overall Study|Death|1
2446361|NCT02766088|8421187|P1|Overall Study|Other|1
2446362|NCT02766088|8421187|P1|Overall Study|Lost to Follow-up|5
2446363|NCT02766088|8421187|P1|Overall Study|Migrated/moved from the study area|1
2446364|NCT02766088|8421187|P1|Overall Study|Sponsor study termination|498
2446365|NCT02766023|8421202|P2|Overall Study|Not Eligible at Enrollment|1
2446366|NCT02766023|8421203|P1|Overall Study|Not Eligible at Enrollment|0
2446367|NCT02766023|8421202|P2|Overall Study|Physician Decision|0
2446368|NCT02766023|8421203|P1|Overall Study|Physician Decision|1
2446369|NCT02766023|8421202|P2|Overall Study|Withdrawal by Subject|5
2446370|NCT02766023|8421203|P1|Overall Study|Withdrawal by Subject|4
2446371|NCT02766023|8421202|P2|Overall Study|Adverse Event|0
2446372|NCT02766023|8421203|P1|Overall Study|Adverse Event|1
2446373|NCT02766023|8421202|P2|Overall Study|Pregnancy|0
2446374|NCT02766023|8421203|P1|Overall Study|Pregnancy|1
2446375|NCT02766023|8421202|P2|Overall Study|Lost to Follow-up|11
2446376|NCT02766023|8421203|P1|Overall Study|Lost to Follow-up|23
2446377|NCT02765490|8421253|P2|Overall Study|Death|1
2446378|NCT02765490|8421254|P1|Overall Study|Death|0
2446379|NCT02765490|8421253|P2|Overall Study|Other|1
2446380|NCT02765490|8421254|P1|Overall Study|Other|0
2446381|NCT02765490|8421253|P2|Overall Study|Lost to Follow-up|1
2446382|NCT02765490|8421254|P1|Overall Study|Lost to Follow-up|1
2446383|NCT02764775|8421300|P1|Overall Study|Withdrawal by Subject|3
2446384|NCT02764775|8421300|P1|Overall Study|Lost to Follow-up|2
2446385|NCT02764775|8421300|P1|Overall Study|Death|1
2446386|NCT02764697|8421304|P1|Overall Study|Lack of Efficacy|3
2446387|NCT02764229|8421309|P1|Overall Study|Study Stopped by Sponsor|69
2446388|NCT02764229|8421309|P1|Overall Study|Lack of Efficacy|1
2446389|NCT02764229|8421309|P1|Overall Study|Lost to Follow-up|3
2446390|NCT02764229|8421309|P1|Overall Study|Physician Decision|5
2446391|NCT02764229|8421309|P1|Overall Study|Adverse Event|9
2446392|NCT02764229|8421309|P1|Overall Study|Withdrawal by Subject|15
2446393|NCT02764190|8421315|P2|Overall Study|Lost to Follow-up|13
2446394|NCT02764190|8421316|P1|Overall Study|Lost to Follow-up|17
2446395|NCT02764151|8421364|P4|Overall Study|Other|2
2446396|NCT02764151|8421365|P3|Overall Study|Other|0
2446397|NCT02764151|8421366|P2|Overall Study|Other|0
2446398|NCT02764151|8421367|P1|Overall Study|Other|0
2446399|NCT02764151|8421364|P4|Overall Study|Subject refused further follow-up|1
2446400|NCT02764151|8421365|P3|Overall Study|Subject refused further follow-up|0
2446401|NCT02764151|8421366|P2|Overall Study|Subject refused further follow-up|0
2446402|NCT02764151|8421367|P1|Overall Study|Subject refused further follow-up|0
2446403|NCT02763644|8421506|P2|Overall Study|Adverse Event|1
2446404|NCT02763644|8421507|P1|Overall Study|Adverse Event|1
2446405|NCT02763644|8421506|P2|Overall Study|Death|1
2446406|NCT02763644|8421507|P1|Overall Study|Death|1
2446407|NCT02763644|8421506|P2|Overall Study|Patient/guardian decision|0
2446408|NCT02763644|8421507|P1|Overall Study|Patient/guardian decision|1
2446409|NCT02763579|8421527|P2|Overall Study|On-going in study|60
2446410|NCT02763579|8421528|P1|Overall Study|On-going in study|77
2446411|NCT02763579|8421527|P2|Overall Study|Physician Decision|0
2446412|NCT02763579|8421528|P1|Overall Study|Physician Decision|2
2446413|NCT02763579|8421527|P2|Overall Study|Withdrawal by Subject|9
2446414|NCT02763579|8421528|P1|Overall Study|Withdrawal by Subject|18
2446415|NCT02763579|8421527|P2|Overall Study|Lost to Follow-up|1
2446416|NCT02763579|8421528|P1|Overall Study|Lost to Follow-up|3
2446417|NCT02763579|8421527|P2|Overall Study|Death|132
2446418|NCT02763579|8421528|P1|Overall Study|Death|101
2446419|NCT02763566|8421540|P4|Overall Study|Withdrawal by Subject|0
2446420|NCT02763566|8421541|P3|Overall Study|Withdrawal by Subject|0
2446421|NCT02763566|8421542|P2|Overall Study|Withdrawal by Subject|1
2446422|NCT02763566|8421543|P1|Overall Study|Withdrawal by Subject|3
2446423|NCT02763566|8421540|P4|Overall Study|On study treatment at study conclusion|13
2446424|NCT02763566|8421541|P3|Overall Study|On study treatment at study conclusion|54
2446425|NCT02763566|8421542|P2|Overall Study|On study treatment at study conclusion|34
2446426|NCT02763566|8421543|P1|Overall Study|On study treatment at study conclusion|114
2446427|NCT02763566|8421540|P4|Overall Study|Lost to Follow-up|1
2446428|NCT02763566|8421541|P3|Overall Study|Lost to Follow-up|0
2446429|NCT02763566|8421542|P2|Overall Study|Lost to Follow-up|4
2446430|NCT02763566|8421543|P1|Overall Study|Lost to Follow-up|1
2446431|NCT02763254|8421571|P1|Overall Study|Adverse Event|1
2446432|NCT02763189|8421578|P2|Overall Study|Device failure|2
2446433|NCT02763189|8421579|P1|Overall Study|Device failure|0
2446434|NCT02762578|8421683|P2|Overall Study|Unclassified|0
2446435|NCT02762578|8421684|P1|Overall Study|Unclassified|6
2446436|NCT02762578|8421683|P2|Overall Study|Withdrawal by Subject|2
2446437|NCT02762578|8421684|P1|Overall Study|Withdrawal by Subject|4
2446438|NCT02762578|8421683|P2|Overall Study|Protocol Violation|2
2446439|NCT02762578|8421684|P1|Overall Study|Protocol Violation|4
2446440|NCT02762578|8421683|P2|Overall Study|Adverse Event|6
2446441|NCT02762578|8421684|P1|Overall Study|Adverse Event|1
2446442|NCT02762500|8421786|P2|Overall Study|Adverse Event|2
2446443|NCT02762500|8421787|P1|Overall Study|Adverse Event|0
2446444|NCT02762500|8421786|P2|Overall Study|Withdrawal by Subject|1
2446445|NCT02762500|8421787|P1|Overall Study|Withdrawal by Subject|1
2446446|NCT02762500|8421786|P2|Overall Study|Lack of Efficacy|0
2446447|NCT02762500|8421787|P1|Overall Study|Lack of Efficacy|1
2446448|NCT02762370|8421807|P2|Overall Study|Protocol Violation|0
2446449|NCT02762370|8421808|P1|Overall Study|Protocol Violation|1
2446450|NCT02762084|8421848|P3|Overall Study|Adverse Event|1
2446451|NCT02762084|8421849|P2|Overall Study|Adverse Event|0
2446452|NCT02762084|8421850|P1|Overall Study|Adverse Event|0
2446453|NCT02762084|8421848|P3|Overall Study|Withdrawal by Subject|0
2446454|NCT02762084|8421849|P2|Overall Study|Withdrawal by Subject|0
2446455|NCT02762084|8421850|P1|Overall Study|Withdrawal by Subject|1
2446456|NCT02761980|8421911|P4|Overall Study|Other|0
2446457|NCT02761980|8421912|P3|Overall Study|Other|1
2446458|NCT02761980|8421913|P2|Overall Study|Other|0
2446459|NCT02761980|8421914|P1|Overall Study|Other|0
2446460|NCT02761980|8421911|P4|Overall Study|Withdrawal by Subject|0
2446461|NCT02761980|8421912|P3|Overall Study|Withdrawal by Subject|0
2446462|NCT02761980|8421913|P2|Overall Study|Withdrawal by Subject|1
2446463|NCT02761980|8421914|P1|Overall Study|Withdrawal by Subject|0
2446464|NCT02761980|8421911|P4|Overall Study|Adverse Event|6
2446465|NCT02761980|8421912|P3|Overall Study|Adverse Event|5
2446466|NCT02761980|8421913|P2|Overall Study|Adverse Event|6
2446467|NCT02761980|8421914|P1|Overall Study|Adverse Event|4
2446468|NCT02761733|8421961|P4|Overall Study|Cognitive Impairment|0
2446469|NCT02761733|8421962|P3|Overall Study|Cognitive Impairment|1
2446470|NCT02761733|8421963|P2|Overall Study|Cognitive Impairment|0
2446471|NCT02761733|8421964|P1|Overall Study|Cognitive Impairment|5
2446472|NCT02761733|8421961|P4|Overall Study|Discharged from Study Site|11
2446473|NCT02761733|8421962|P3|Overall Study|Discharged from Study Site|25
2446474|NCT02761733|8421963|P2|Overall Study|Discharged from Study Site|9
2446475|NCT02761733|8421964|P1|Overall Study|Discharged from Study Site|10
2446476|NCT02761733|8421961|P4|Overall Study|Withdrawal by Subject|0
2446477|NCT02761733|8421962|P3|Overall Study|Withdrawal by Subject|0
2446478|NCT02761733|8421963|P2|Overall Study|Withdrawal by Subject|0
2446479|NCT02761733|8421964|P1|Overall Study|Withdrawal by Subject|2
2446480|NCT02761733|8421961|P4|Overall Study|Physician Decision|0
2446481|NCT02761733|8421962|P3|Overall Study|Physician Decision|0
2446482|NCT02761733|8421963|P2|Overall Study|Physician Decision|0
2446483|NCT02761733|8421964|P1|Overall Study|Physician Decision|4
2446484|NCT02761733|8421961|P4|Overall Study|Lost to Follow-up|3
2446485|NCT02761733|8421962|P3|Overall Study|Lost to Follow-up|0
2446486|NCT02761733|8421963|P2|Overall Study|Lost to Follow-up|7
2446487|NCT02761733|8421964|P1|Overall Study|Lost to Follow-up|6
2446488|NCT02761733|8421961|P4|Overall Study|Death|1
2446489|NCT02761733|8421962|P3|Overall Study|Death|1
2446490|NCT02761733|8421963|P2|Overall Study|Death|5
2446491|NCT02761733|8421964|P1|Overall Study|Death|3
2446492|NCT02761642|8421994|P1|Overall Study|Reason Unspecified|21
2446493|NCT02761642|8421994|P1|Overall Study|Physician Decision|1
2446494|NCT02761642|8421994|P1|Overall Study|Lack of Efficacy|20
2446495|NCT02761642|8421994|P1|Overall Study|Death|3
2446496|NCT02761642|8421994|P1|Overall Study|Non-compliant|7
2446497|NCT02761642|8421994|P1|Overall Study|Withdrawal by Subject|2
2446498|NCT02761642|8421994|P1|Overall Study|Adverse Event|13
2446499|NCT02761642|8421994|P1|Overall Study|Did not Receive Study Treatment|3
2446500|NCT02761629|8422007|P2|Overall Study|Randomized But Not Treated|4
2446501|NCT02761629|8422008|P1|Overall Study|Randomized But Not Treated|8
2446502|NCT02761629|8422007|P2|Overall Study|Lost to Follow-up|1
2446503|NCT02761629|8422008|P1|Overall Study|Lost to Follow-up|4
2446504|NCT02761629|8422007|P2|Overall Study|Other|2
2446505|NCT02761629|8422008|P1|Overall Study|Other|0
2446506|NCT02761629|8422007|P2|Overall Study|Withdrawal by Subject|3
2446507|NCT02761629|8422008|P1|Overall Study|Withdrawal by Subject|0
2446508|NCT02761629|8422007|P2|Overall Study|Protocol Violation|2
2446509|NCT02761629|8422008|P1|Overall Study|Protocol Violation|2
2446510|NCT02761629|8422007|P2|Overall Study|Did not Cooperate/Refused Treatment|4
2446511|NCT02761629|8422008|P1|Overall Study|Did not Cooperate/Refused Treatment|2
2446512|NCT02761629|8422007|P2|Overall Study|Failure to Return|4
2446513|NCT02761629|8422008|P1|Overall Study|Failure to Return|2
2446514|NCT02761629|8422007|P2|Overall Study|Insufficient Therapeutic Response|7
2446515|NCT02761629|8422008|P1|Overall Study|Insufficient Therapeutic Response|2
2446516|NCT02761629|8422007|P2|Overall Study|Adverse Event/Intercurrent Illness|5
2446517|NCT02761629|8422008|P1|Overall Study|Adverse Event/Intercurrent Illness|7
2446518|NCT02760927|8422055|P1|Overall Study|Tube Slippage from Device|1
2446519|NCT02760810|8422063|P1|Overall Study|Protocol Violation|1
2446520|NCT02760654|8422071|P2|Overall Study|Withdrawal by Subject|3
2446521|NCT02760654|8422072|P1|Overall Study|Withdrawal by Subject|4
2446522|NCT02760654|8422071|P2|Overall Study|Lost to Follow-up|3
2446523|NCT02760654|8422072|P1|Overall Study|Lost to Follow-up|3
2446524|NCT02760602|8422098|P2|Overall Study|Terminated by sponsor|13
2446525|NCT02760602|8422099|P1|Overall Study|Terminated by sponsor|12
2446526|NCT02760602|8422098|P2|Overall Study|Withdrawal by Subject|0
2446527|NCT02760602|8422099|P1|Overall Study|Withdrawal by Subject|1
2446528|NCT02759939|8422311|P4|Overall Study|Lost to Follow-up|650
2446529|NCT02759939|8422312|P3|Overall Study|Lost to Follow-up|783
2446530|NCT02759939|8422313|P2|Overall Study|Lost to Follow-up|791
2446531|NCT02759939|8422314|P1|Overall Study|Lost to Follow-up|735
2446532|NCT02759939|8422311|P4|Overall Study|Ineligible for T2 and T3|391
2446533|NCT02759939|8422312|P3|Overall Study|Ineligible for T2 and T3|366
2446534|NCT02759939|8422313|P2|Overall Study|Ineligible for T2 and T3|179
2446535|NCT02759939|8422314|P1|Overall Study|Ineligible for T2 and T3|310
2446536|NCT02759939|8422311|P4|Overall Study|Missing data on first outcome assessed|2
2446537|NCT02759939|8422312|P3|Overall Study|Missing data on first outcome assessed|5
2446538|NCT02759939|8422313|P2|Overall Study|Missing data on first outcome assessed|2
2446539|NCT02759939|8422314|P1|Overall Study|Missing data on first outcome assessed|11
2446540|NCT02759692|8422324|P2|Period 2|Test article no longer available|1
2446541|NCT02759692|8422325|P1|Period 2|Test article no longer available|0
2446542|NCT02759692|8422324|P2|Period 2|Lost to Follow-up|0
2446543|NCT02759692|8422325|P1|Period 2|Lost to Follow-up|1
2446544|NCT02759692|8422324|P2|Period 1|Miss-Randomized|1
2446545|NCT02759692|8422325|P1|Period 1|Miss-Randomized|1
2446546|NCT02759692|8422324|P2|Period 1|No longer meets eligibility criteria.|0
2446547|NCT02759692|8422325|P1|Period 1|No longer meets eligibility criteria.|1
2446548|NCT02759692|8422324|P2|Period 1|Test article no longer available|1
2446549|NCT02759692|8422325|P1|Period 1|Test article no longer available|1
2446550|NCT02759562|8422343|P2|Open-Label Treatment Period|Study Terminated by Sponsor|2
2446551|NCT02759562|8422344|P1|Open-Label Treatment Period|Study Terminated by Sponsor|1
2446552|NCT02759562|8422343|P2|Open-Label Treatment Period|Withdrew Consent|0
2446553|NCT02759562|8422344|P1|Open-Label Treatment Period|Withdrew Consent|1
2446554|NCT02759471|8422357|P1|Overall Study|discomfort|2
2446555|NCT02759315|8422413|P5|Overall Study|Study terminated prior to completion|1
2446556|NCT02759315|8422414|P4|Overall Study|Study terminated prior to completion|0
2446557|NCT02759315|8422415|P3|Overall Study|Study terminated prior to completion|5
2446558|NCT02759315|8422416|P2|Overall Study|Study terminated prior to completion|0
2446559|NCT02759315|8422417|P1|Overall Study|Study terminated prior to completion|2
2446560|NCT02759315|8422413|P5|Overall Study|Protocol Violation|0
2446561|NCT02759315|8422414|P4|Overall Study|Protocol Violation|0
2446562|NCT02759315|8422415|P3|Overall Study|Protocol Violation|0
2446563|NCT02759315|8422416|P2|Overall Study|Protocol Violation|1
2446564|NCT02759315|8422417|P1|Overall Study|Protocol Violation|0
2446565|NCT02759315|8422413|P5|Overall Study|Lost to Follow-up|0
2446566|NCT02759315|8422414|P4|Overall Study|Lost to Follow-up|0
2446567|NCT02759315|8422415|P3|Overall Study|Lost to Follow-up|4
2446568|NCT02759315|8422416|P2|Overall Study|Lost to Follow-up|0
2446569|NCT02759315|8422417|P1|Overall Study|Lost to Follow-up|2
2446570|NCT02759315|8422413|P5|Overall Study|Death|0
2446571|NCT02759315|8422414|P4|Overall Study|Death|0
2446572|NCT02759315|8422415|P3|Overall Study|Death|1
2446573|NCT02759315|8422416|P2|Overall Study|Death|0
2446574|NCT02759315|8422417|P1|Overall Study|Death|0
2446575|NCT02759315|8422413|P5|Overall Study|Adverse Event|0
2446576|NCT02759315|8422414|P4|Overall Study|Adverse Event|1
2446577|NCT02759315|8422415|P3|Overall Study|Adverse Event|0
2446578|NCT02759315|8422416|P2|Overall Study|Adverse Event|0
2446579|NCT02759315|8422417|P1|Overall Study|Adverse Event|0
2446580|NCT02758613|8422465|P4|Treatment|Withdrawal by Subject|0
2446581|NCT02758613|8422466|P3|Treatment|Withdrawal by Subject|1
2446582|NCT02758613|8422467|P2|Treatment|Withdrawal by Subject|0
2446583|NCT02758613|8422468|P1|Treatment|Withdrawal by Subject|1
2446584|NCT02758613|8422465|P4|Treatment|Physician and Sponsor Decision|0
2446585|NCT02758613|8422466|P3|Treatment|Physician and Sponsor Decision|0
2446586|NCT02758613|8422467|P2|Treatment|Physician and Sponsor Decision|0
2446587|NCT02758613|8422468|P1|Treatment|Physician and Sponsor Decision|1
2446588|NCT02758301|8422486|P2|Overall Study|Protocol Violation|1
2446589|NCT02758301|8422487|P1|Overall Study|Protocol Violation|0
2446590|NCT02758301|8422486|P2|Overall Study|Lost to Follow-up|0
2446591|NCT02758301|8422487|P1|Overall Study|Lost to Follow-up|7
2446592|NCT02758301|8422486|P2|Overall Study|Withdrawal by Subject|6
2446593|NCT02758301|8422487|P1|Overall Study|Withdrawal by Subject|5
2446594|NCT02758301|8422486|P2|Overall Study|Physician Decision|1
2446595|NCT02758301|8422487|P1|Overall Study|Physician Decision|10
2446596|NCT02758301|8422486|P2|Overall Study|Death|0
2446597|NCT02758301|8422487|P1|Overall Study|Death|12
2446598|NCT02758171|8422506|P2|Wash-out|Other reason|0
2446599|NCT02758171|8422507|P1|Wash-out|Other reason|1
2446600|NCT02758171|8422506|P2|Wash-out|Withdrawal by Subject|0
2446601|NCT02758171|8422507|P1|Wash-out|Withdrawal by Subject|1
2446602|NCT02757963|8422561|P1|Overall Study|Withdrawal by Subject|34
2446603|NCT02757963|8422561|P1|Overall Study|Physician Decision|1
2446604|NCT02757963|8422561|P1|Overall Study|Lost to Follow-up|5
2446605|NCT02757963|8422561|P1|Overall Study|Reached Stopping Criteria|1054
2446606|NCT02757963|8422561|P1|Overall Study|Adverse Event|3
2446607|NCT02757768|8422601|P2|Overall Study|Miscellaneous|2
2446608|NCT02757768|8422602|P1|Overall Study|Miscellaneous|4
2446609|NCT02757768|8422601|P2|Overall Study|Withdrawal by Subject|9
2446610|NCT02757768|8422602|P1|Overall Study|Withdrawal by Subject|16
2446611|NCT02757768|8422601|P2|Overall Study|Protocol Deviation|9
2446612|NCT02757768|8422602|P1|Overall Study|Protocol Deviation|2
2446613|NCT02757768|8422601|P2|Overall Study|Lost to Follow-up|0
2446614|NCT02757768|8422602|P1|Overall Study|Lost to Follow-up|1
2446615|NCT02757768|8422601|P2|Overall Study|Lack of Efficacy|1
2446616|NCT02757768|8422602|P1|Overall Study|Lack of Efficacy|2
2446617|NCT02757768|8422601|P2|Overall Study|Adverse Event|3
2446618|NCT02757768|8422602|P1|Overall Study|Adverse Event|5
2446619|NCT02757768|8422601|P2|Overall Study|Randomized Never Received Study Drug|4
2446620|NCT02757768|8422602|P1|Overall Study|Randomized Never Received Study Drug|3
2446621|NCT02757625|8422652|P4|Overall Study|Adverse Event|0
2446622|NCT02757625|8422653|P3|Overall Study|Adverse Event|1
2446623|NCT02757625|8422654|P2|Overall Study|Adverse Event|0
2446624|NCT02757625|8422655|P1|Overall Study|Adverse Event|0
2446625|NCT02757625|8422652|P4|Overall Study|Investigator’s discretion|0
2446626|NCT02757625|8422653|P3|Overall Study|Investigator’s discretion|1
2446627|NCT02757625|8422654|P2|Overall Study|Investigator’s discretion|0
2446628|NCT02757625|8422655|P1|Overall Study|Investigator’s discretion|0
2446629|NCT02757521|8422814|P2|Overall Study|Adverse Event|0
2446630|NCT02757521|8422815|P1|Overall Study|Adverse Event|1
2446631|NCT02757430|8422821|P1|Overall Study|No procedure performed|2
2446632|NCT02757430|8422821|P1|Overall Study|No informed consent|1
2446633|NCT02757430|8422821|P1|Overall Study|Inclusion/Exclusion criteria not met|3
2446634|NCT02757430|8422821|P1|Overall Study|Physician Decision|6
2446635|NCT02757352|8422840|P10|Follow-Up Period|Withdrawal by Subject|2
2446636|NCT02757352|8422841|P9|Follow-Up Period|Withdrawal by Subject|6
2446637|NCT02757352|8422842|P8|Follow-Up Period|Withdrawal by Subject|1
2446638|NCT02757352|8422843|P7|Follow-Up Period|Withdrawal by Subject|0
2446639|NCT02757352|8422844|P6|Follow-Up Period|Withdrawal by Subject|0
2446640|NCT02757352|8422845|P5|Follow-Up Period|Withdrawal by Subject|0
2446641|NCT02757352|8422846|P4|Follow-Up Period|Withdrawal by Subject|0
2446642|NCT02757352|8422847|P3|Follow-Up Period|Withdrawal by Subject|0
2446643|NCT02757352|8422848|P2|Follow-Up Period|Withdrawal by Subject|0
2446644|NCT02757352|8422849|P1|Follow-Up Period|Withdrawal by Subject|0
2446645|NCT02757352|8422840|P10|Follow-Up Period|Lack of Efficacy|1
2446646|NCT02757352|8422841|P9|Follow-Up Period|Lack of Efficacy|1
2446647|NCT02757352|8422842|P8|Follow-Up Period|Lack of Efficacy|0
2446648|NCT02757352|8422843|P7|Follow-Up Period|Lack of Efficacy|0
2446649|NCT02757352|8422844|P6|Follow-Up Period|Lack of Efficacy|0
2446650|NCT02757352|8422845|P5|Follow-Up Period|Lack of Efficacy|0
2446651|NCT02757352|8422846|P4|Follow-Up Period|Lack of Efficacy|0
2446652|NCT02757352|8422847|P3|Follow-Up Period|Lack of Efficacy|0
2446653|NCT02757352|8422848|P2|Follow-Up Period|Lack of Efficacy|0
2446654|NCT02757352|8422849|P1|Follow-Up Period|Lack of Efficacy|0
2446655|NCT02757352|8422840|P10|Follow-Up Period|Lost to Follow-up|0
2446656|NCT02757352|8422841|P9|Follow-Up Period|Lost to Follow-up|1
2446657|NCT02757352|8422842|P8|Follow-Up Period|Lost to Follow-up|0
2446658|NCT02757352|8422843|P7|Follow-Up Period|Lost to Follow-up|0
2446659|NCT02757352|8422844|P6|Follow-Up Period|Lost to Follow-up|0
2446660|NCT02757352|8422845|P5|Follow-Up Period|Lost to Follow-up|0
2446661|NCT02757352|8422846|P4|Follow-Up Period|Lost to Follow-up|0
2446662|NCT02757352|8422847|P3|Follow-Up Period|Lost to Follow-up|0
2446663|NCT02757352|8422848|P2|Follow-Up Period|Lost to Follow-up|0
2446664|NCT02757352|8422849|P1|Follow-Up Period|Lost to Follow-up|0
2446665|NCT02757352|8422840|P10|Follow-Up Period|Adverse Event|0
2446666|NCT02757352|8422841|P9|Follow-Up Period|Adverse Event|2
2446667|NCT02757352|8422842|P8|Follow-Up Period|Adverse Event|0
2446668|NCT02757352|8422843|P7|Follow-Up Period|Adverse Event|1
2446669|NCT02757352|8422844|P6|Follow-Up Period|Adverse Event|0
2446670|NCT02757352|8422845|P5|Follow-Up Period|Adverse Event|0
2446671|NCT02757352|8422846|P4|Follow-Up Period|Adverse Event|0
2446672|NCT02757352|8422847|P3|Follow-Up Period|Adverse Event|0
2446673|NCT02757352|8422848|P2|Follow-Up Period|Adverse Event|0
2446674|NCT02757352|8422849|P1|Follow-Up Period|Adverse Event|0
2446675|NCT02757352|8422840|P10|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
2446676|NCT02757352|8422841|P9|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
2446677|NCT02757352|8422842|P8|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
2446678|NCT02757352|8422843|P7|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
2446679|NCT02757352|8422844|P6|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1
2446680|NCT02757352|8422845|P5|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1
2446681|NCT02757352|8422846|P4|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2
2446682|NCT02757352|8422847|P3|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
2446683|NCT02757352|8422848|P2|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
2446684|NCT02757352|8422849|P1|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
2446685|NCT02757352|8422840|P10|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
2446686|NCT02757352|8422841|P9|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
2446687|NCT02757352|8422842|P8|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
2446688|NCT02757352|8422843|P7|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
2446689|NCT02757352|8422844|P6|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1
2446690|NCT02757352|8422845|P5|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
2446691|NCT02757352|8422846|P4|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
2446692|NCT02757352|8422847|P3|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
2446693|NCT02757352|8422848|P2|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
2446694|NCT02757352|8422849|P1|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
2446695|NCT02757352|8422840|P10|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
2446696|NCT02757352|8422841|P9|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
2446697|NCT02757352|8422842|P8|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
2446698|NCT02757352|8422843|P7|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
2446699|NCT02757352|8422844|P6|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
2446700|NCT02757352|8422845|P5|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1
2446701|NCT02757352|8422846|P4|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
2446702|NCT02757352|8422847|P3|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
2446703|NCT02757352|8422848|P2|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
2446704|NCT02757352|8422849|P1|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
2446705|NCT02757352|8422840|P10|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
2446706|NCT02757352|8422841|P9|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
2446707|NCT02757352|8422842|P8|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
2446708|NCT02757352|8422843|P7|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
2446709|NCT02757352|8422844|P6|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4
2446710|NCT02757352|8422845|P5|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1
2446711|NCT02757352|8422846|P4|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2
2446712|NCT02757352|8422847|P3|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
2446713|NCT02757352|8422848|P2|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
2446714|NCT02757352|8422849|P1|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
2446715|NCT02757352|8422840|P10|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
2446716|NCT02757352|8422841|P9|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
2446717|NCT02757352|8422842|P8|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
2446718|NCT02757352|8422843|P7|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
2446719|NCT02757352|8422844|P6|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1
2446720|NCT02757352|8422845|P5|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
2446721|NCT02757352|8422846|P4|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3
2446722|NCT02757352|8422847|P3|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
2446723|NCT02757352|8422848|P2|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
2446724|NCT02757352|8422849|P1|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
2446725|NCT02757352|8422840|P10|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
2446726|NCT02757352|8422841|P9|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
2446727|NCT02757352|8422842|P8|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
2446728|NCT02757352|8422843|P7|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
2446729|NCT02757352|8422844|P6|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
2446730|NCT02757352|8422845|P5|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
2446731|NCT02757352|8422846|P4|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
2446732|NCT02757352|8422847|P3|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42
2446733|NCT02757352|8422848|P2|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40
2446734|NCT02757352|8422849|P1|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62
2446735|NCT02757352|8422840|P10|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
2446736|NCT02757352|8422841|P9|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
2446737|NCT02757352|8422842|P8|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
2446738|NCT02757352|8422843|P7|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
2446739|NCT02757352|8422844|P6|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
2446740|NCT02757352|8422845|P5|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
2446741|NCT02757352|8422846|P4|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
2446742|NCT02757352|8422847|P3|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4
2446743|NCT02757352|8422848|P2|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1
2446744|NCT02757352|8422849|P1|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1
2446745|NCT02757352|8422840|P10|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
2446746|NCT02757352|8422841|P9|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
2446747|NCT02757352|8422842|P8|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
2446748|NCT02757352|8422843|P7|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
2446749|NCT02757352|8422844|P6|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
2446750|NCT02757352|8422845|P5|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
2446751|NCT02757352|8422846|P4|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
2446752|NCT02757352|8422847|P3|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
2446753|NCT02757352|8422848|P2|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1
2446754|NCT02757352|8422849|P1|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
2446755|NCT02757352|8422840|P10|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
2446756|NCT02757352|8422841|P9|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
2446757|NCT02757352|8422842|P8|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
2446758|NCT02757352|8422843|P7|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
2446759|NCT02757352|8422844|P6|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
2446760|NCT02757352|8422845|P5|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
2446761|NCT02757352|8422846|P4|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
2446762|NCT02757352|8422847|P3|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
2446763|NCT02757352|8422848|P2|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1
2446764|NCT02757352|8422849|P1|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
2446765|NCT02757352|8422840|P10|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
2446766|NCT02757352|8422841|P9|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
2446767|NCT02757352|8422842|P8|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
2446768|NCT02757352|8422843|P7|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
2446769|NCT02757352|8422844|P6|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
2446770|NCT02757352|8422845|P5|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
2446771|NCT02757352|8422846|P4|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
2446772|NCT02757352|8422847|P3|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2
2446773|NCT02757352|8422848|P2|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1
2446774|NCT02757352|8422849|P1|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6
2446775|NCT02757352|8422840|P10|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
2446776|NCT02757352|8422841|P9|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
2446777|NCT02757352|8422842|P8|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
2446778|NCT02757352|8422843|P7|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
2446779|NCT02757352|8422844|P6|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
2446780|NCT02757352|8422845|P5|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
2446781|NCT02757352|8422846|P4|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
2446782|NCT02757352|8422847|P3|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1
2446783|NCT02757352|8422848|P2|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
2446784|NCT02757352|8422849|P1|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
2446785|NCT02757352|8422840|P10|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
2446786|NCT02757352|8422841|P9|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
2446787|NCT02757352|8422842|P8|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
2446788|NCT02757352|8422843|P7|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
2446789|NCT02757352|8422844|P6|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
2446790|NCT02757352|8422845|P5|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
2446791|NCT02757352|8422846|P4|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
2446792|NCT02757352|8422847|P3|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1
2446793|NCT02757352|8422848|P2|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
2446794|NCT02757352|8422849|P1|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2
2446795|NCT02756832|8423005|P1|Overall Study|Protocol Deviation|10
2446796|NCT02756832|8423005|P1|Overall Study|Reason not Specified|9
2446797|NCT02756832|8423005|P1|Overall Study|Sponsor Decision/Regulatory Requirement|1
2446798|NCT02756832|8423005|P1|Overall Study|Insufficient Efficacy|2
2446799|NCT02756832|8423005|P1|Overall Study|Patient’s Unwillingness|12
2446800|NCT02756832|8423005|P1|Overall Study|Lost for Observation|13
2446801|NCT02756832|8423005|P1|Overall Study|Lost for Observation after Baseline|6
2446802|NCT02756819|8423019|P1|Overall Study|Reason not Specified|9
2446803|NCT02756819|8423019|P1|Overall Study|Adverse Event|2
2446804|NCT02756819|8423019|P1|Overall Study|Insufficient efficacy|2
2446805|NCT02756819|8423019|P1|Overall Study|Patient’s unwillingness|16
2446806|NCT02756819|8423019|P1|Overall Study|Lost for observation|23
2446807|NCT02756637|8423120|P2|Overall Study|Did not complete curative therapy|0
2446808|NCT02756637|8423121|P1|Overall Study|Did not complete curative therapy|33
2446809|NCT02756637|8423120|P2|Overall Study|No available NLR value|44
2446810|NCT02756637|8423121|P1|Overall Study|No available NLR value|44
2446811|NCT02756637|8423120|P2|Overall Study|Not eligible for initial SWOG study|10
2446812|NCT02756637|8423121|P1|Overall Study|Not eligible for initial SWOG study|10
2446813|NCT02756338|8423153|P1|Overall Study|Device Replaced with Pacemaker|4
2446814|NCT02756338|8423153|P1|Overall Study|Withdrawn by Investigator|1
2446815|NCT02756182|8423162|P1|Overall Study|StudyTechnical Difficulties|4
2446816|NCT02756078|8423177|P2|Period 2|Withdrawal by Subject|1
2446817|NCT02756078|8423178|P1|Period 2|Withdrawal by Subject|3
2446818|NCT02756078|8423177|P2|Period 2|Unsatisfactory Lens Fitting|1
2446819|NCT02756078|8423178|P1|Period 2|Unsatisfactory Lens Fitting|0
2446820|NCT02756078|8423177|P2|Period 2|Adverse Event|5
2446821|NCT02756078|8423178|P1|Period 2|Adverse Event|3
2446822|NCT02756078|8423177|P2|Period 1|Lens Discomfort|2
2446823|NCT02756078|8423178|P1|Period 1|Lens Discomfort|2
2446824|NCT02756078|8423177|P2|Period 1|Withdrawal by Subject|6
2446825|NCT02756078|8423178|P1|Period 1|Withdrawal by Subject|6
2446826|NCT02756078|8423177|P2|Period 1|Adverse Event|10
2446827|NCT02756078|8423178|P1|Period 1|Adverse Event|1
2446828|NCT02756078|8423177|P2|Period 1|Protocol Violation|1
2446829|NCT02756078|8423178|P1|Period 1|Protocol Violation|0
2446830|NCT02756078|8423177|P2|Period 1|Lost to Follow-up|2
2446831|NCT02756078|8423178|P1|Period 1|Lost to Follow-up|0
2446832|NCT02756078|8423177|P2|Period 1|Unsatisfactory Lens Fitting|1
2446833|NCT02756078|8423178|P1|Period 1|Unsatisfactory Lens Fitting|0
2446834|NCT02755831|8423203|P2|Overall Study|Lost to Follow-up|3
2446835|NCT02755831|8423204|P1|Overall Study|Lost to Follow-up|3
2446836|NCT02755818|8423220|P4|Overall Study|withdrawal by PI|1
2446837|NCT02755818|8423221|P3|Overall Study|withdrawal by PI|1
2446838|NCT02755818|8423222|P2|Overall Study|withdrawal by PI|0
2446839|NCT02755818|8423223|P1|Overall Study|withdrawal by PI|0
2446840|NCT02755818|8423220|P4|Overall Study|Withdrawal by Subject|2
2446841|NCT02755818|8423221|P3|Overall Study|Withdrawal by Subject|0
2446842|NCT02755818|8423222|P2|Overall Study|Withdrawal by Subject|0
2446843|NCT02755818|8423223|P1|Overall Study|Withdrawal by Subject|0
2446844|NCT02755805|8423259|P2|Overall Study|Withdrawal by Subject|2
2446845|NCT02755805|8423260|P1|Overall Study|Withdrawal by Subject|0
2446846|NCT02755805|8423259|P2|Overall Study|Refused assessments|0
2446847|NCT02755805|8423260|P1|Overall Study|Refused assessments|1
2446848|NCT02755805|8423259|P2|Overall Study|Lost to Follow-up|2
2446849|NCT02755805|8423260|P1|Overall Study|Lost to Follow-up|1
2446850|NCT02755090|8423281|P2|Overall Study|equipment malfunction|0
2446851|NCT02755090|8423282|P1|Overall Study|equipment malfunction|1
2446852|NCT02754492|8423334|P4|Overall Study|Venous access issues not resulting in AE|4
2446853|NCT02754492|8423335|P3|Overall Study|Venous access issues not resulting in AE|0
2446854|NCT02754492|8423336|P2|Overall Study|Venous access issues not resulting in AE|0
2446855|NCT02754492|8423337|P1|Overall Study|Venous access issues not resulting in AE|0
2446856|NCT02754492|8423334|P4|Overall Study|Adverse Event|13
2446857|NCT02754492|8423335|P3|Overall Study|Adverse Event|0
2446858|NCT02754492|8423336|P2|Overall Study|Adverse Event|0
2446859|NCT02754492|8423337|P1|Overall Study|Adverse Event|0
2446860|NCT02754492|8423334|P4|Overall Study|Equipment malfuntion|5
2446861|NCT02754492|8423335|P3|Overall Study|Equipment malfuntion|2
2446862|NCT02754492|8423336|P2|Overall Study|Equipment malfuntion|0
2446863|NCT02754492|8423337|P1|Overall Study|Equipment malfuntion|0
2446864|NCT02754492|8423334|P4|Overall Study|Withdrawal by Subject|0
2446865|NCT02754492|8423335|P3|Overall Study|Withdrawal by Subject|0
2446866|NCT02754492|8423336|P2|Overall Study|Withdrawal by Subject|0
2446867|NCT02754492|8423337|P1|Overall Study|Withdrawal by Subject|2
2446868|NCT02754492|8423334|P4|Overall Study|Protocol Violation|1
2446869|NCT02754492|8423335|P3|Overall Study|Protocol Violation|0
2446870|NCT02754492|8423336|P2|Overall Study|Protocol Violation|2
2446871|NCT02754492|8423337|P1|Overall Study|Protocol Violation|2
2446872|NCT02754440|8423353|P4|Overall Study|Subject issues not resulting in AE|12
2446873|NCT02754440|8423354|P3|Overall Study|Subject issues not resulting in AE|0
2446874|NCT02754440|8423355|P2|Overall Study|Subject issues not resulting in AE|0
2446875|NCT02754440|8423356|P1|Overall Study|Subject issues not resulting in AE|0
2446876|NCT02754440|8423353|P4|Overall Study|Equipment failure|7
2446877|NCT02754440|8423354|P3|Overall Study|Equipment failure|5
2446878|NCT02754440|8423355|P2|Overall Study|Equipment failure|5
2446879|NCT02754440|8423356|P1|Overall Study|Equipment failure|0
2446880|NCT02754440|8423353|P4|Overall Study|Withdrawal by Subject|1
2446881|NCT02754440|8423354|P3|Overall Study|Withdrawal by Subject|0
2446882|NCT02754440|8423355|P2|Overall Study|Withdrawal by Subject|0
2446883|NCT02754440|8423356|P1|Overall Study|Withdrawal by Subject|0
2446884|NCT02754440|8423353|P4|Overall Study|Adverse Event|9
2446885|NCT02754440|8423354|P3|Overall Study|Adverse Event|0
2446886|NCT02754440|8423355|P2|Overall Study|Adverse Event|1
2446887|NCT02754440|8423356|P1|Overall Study|Adverse Event|3
2446888|NCT02754440|8423353|P4|Overall Study|Protocol Violation|6
2446889|NCT02754440|8423354|P3|Overall Study|Protocol Violation|2
2446890|NCT02754440|8423355|P2|Overall Study|Protocol Violation|2
2446891|NCT02754440|8423356|P1|Overall Study|Protocol Violation|3
2446892|NCT02753946|8423408|P2|Overall Study|Physician Decision|2
2446893|NCT02753946|8423409|P1|Overall Study|Physician Decision|0
2446894|NCT02753946|8423408|P2|Overall Study|Lack of Efficacy|0
2446895|NCT02753946|8423409|P1|Overall Study|Lack of Efficacy|1
2446896|NCT02753946|8423408|P2|Overall Study|Withdrawal by Subject|1
2446897|NCT02753946|8423409|P1|Overall Study|Withdrawal by Subject|6
2446898|NCT02753946|8423408|P2|Overall Study|Adverse Event|6
2446899|NCT02753946|8423409|P1|Overall Study|Adverse Event|7
2446900|NCT02753075|8423489|P3|Overall Study|Physician Decision|0
2446901|NCT02753075|8423490|P2|Overall Study|Physician Decision|1
2446902|NCT02753075|8423491|P1|Overall Study|Physician Decision|3
2446903|NCT02753075|8423489|P3|Overall Study|Withdrawal of Consent|3
2446904|NCT02753075|8423490|P2|Overall Study|Withdrawal of Consent|1
2446905|NCT02753075|8423491|P1|Overall Study|Withdrawal of Consent|1
2446906|NCT02753075|8423489|P3|Overall Study|Lost to Follow-up|0
2446907|NCT02753075|8423490|P2|Overall Study|Lost to Follow-up|0
2446908|NCT02753075|8423491|P1|Overall Study|Lost to Follow-up|2
2446909|NCT02753075|8423489|P3|Overall Study|Adverse Event|0
2446910|NCT02753075|8423490|P2|Overall Study|Adverse Event|1
2446911|NCT02753075|8423491|P1|Overall Study|Adverse Event|2
2446912|NCT02752958|8423516|P1|Overall Study|Other (Reason not specified)|2
2446913|NCT02752958|8423516|P1|Overall Study|Withdrawal by Subject|2
2446914|NCT02752958|8423516|P1|Overall Study|Protocol Violation|1
2446915|NCT02752958|8423516|P1|Overall Study|Lost to Follow-up|1
2446916|NCT02752958|8423516|P1|Overall Study|Adverse Event|3
2446917|NCT02752802|8423598|P2|Overall Study|Contrast Volume Not Collected|0
2446918|NCT02752802|8423599|P1|Overall Study|Contrast Volume Not Collected|1
2446919|NCT02752776|8423611|P3|Overall Study|Withdrawal by Subject|2
2446920|NCT02752776|8423612|P2|Overall Study|Withdrawal by Subject|4
2446921|NCT02752776|8423613|P1|Overall Study|Withdrawal by Subject|3
2446922|NCT02752776|8423611|P3|Overall Study|Death|1
2446923|NCT02752776|8423612|P2|Overall Study|Death|0
2446924|NCT02752776|8423613|P1|Overall Study|Death|0
2446925|NCT02752776|8423611|P3|Overall Study|Subject/guardian decision|4
2446926|NCT02752776|8423612|P2|Overall Study|Subject/guardian decision|6
2446927|NCT02752776|8423613|P1|Overall Study|Subject/guardian decision|8
2446928|NCT02752776|8423611|P3|Overall Study|Protocol Violation|6
2446929|NCT02752776|8423612|P2|Overall Study|Protocol Violation|13
2446930|NCT02752776|8423613|P1|Overall Study|Protocol Violation|10
2446931|NCT02752776|8423611|P3|Overall Study|Pregnancy|3
2446932|NCT02752776|8423612|P2|Overall Study|Pregnancy|6
2446933|NCT02752776|8423613|P1|Overall Study|Pregnancy|1
2446934|NCT02752776|8423611|P3|Overall Study|Physician Decision|2
2446935|NCT02752776|8423612|P2|Overall Study|Physician Decision|6
2446936|NCT02752776|8423613|P1|Overall Study|Physician Decision|2
2446937|NCT02752776|8423611|P3|Overall Study|Non-compliance with study treatment|1
2446938|NCT02752776|8423612|P2|Overall Study|Non-compliance with study treatment|0
2446939|NCT02752776|8423613|P1|Overall Study|Non-compliance with study treatment|0
2446940|NCT02752776|8423611|P3|Overall Study|Lost to Follow-up|4
2446941|NCT02752776|8423612|P2|Overall Study|Lost to Follow-up|12
2446942|NCT02752776|8423613|P1|Overall Study|Lost to Follow-up|11
2446943|NCT02752776|8423611|P3|Overall Study|Lack of Efficacy|14
2446944|NCT02752776|8423612|P2|Overall Study|Lack of Efficacy|6
2446945|NCT02752776|8423613|P1|Overall Study|Lack of Efficacy|2
2446946|NCT02752776|8423611|P3|Overall Study|Adverse Event|11
2446947|NCT02752776|8423612|P2|Overall Study|Adverse Event|23
2446948|NCT02752776|8423613|P1|Overall Study|Adverse Event|15
2446949|NCT02752633|8423659|P1|Overall Study|Withdrawal by Subject|1
2446950|NCT02752074|8423699|P2|Overall Study|Status not Recorded|251
2446951|NCT02752074|8423700|P1|Overall Study|Status not Recorded|244
2446952|NCT02752074|8423699|P2|Overall Study|Withdrawal by Subject|8
2446953|NCT02752074|8423700|P1|Overall Study|Withdrawal by Subject|6
2446954|NCT02752074|8423699|P2|Overall Study|Death|91
2446955|NCT02752074|8423700|P1|Overall Study|Death|104
2446956|NCT02752074|8423699|P2|Overall Study|Lost to Follow-up|2
2446957|NCT02752074|8423700|P1|Overall Study|Lost to Follow-up|0
2446958|NCT02752048|8423725|P3|Overall Study|Withdrawal by Subject|3
2446959|NCT02752048|8423726|P2|Overall Study|Withdrawal by Subject|0
2446960|NCT02752048|8423727|P1|Overall Study|Withdrawal by Subject|0
2446961|NCT02751983|8423746|P2|Three-Month Follow-Up Assessments|Lost to Follow-up|16
2446962|NCT02751983|8423747|P1|Three-Month Follow-Up Assessments|Lost to Follow-up|12
2446963|NCT02751983|8423746|P2|One-Month Follow-Up Assessments|Lost to Follow-up|12
2446964|NCT02751983|8423747|P1|One-Month Follow-Up Assessments|Lost to Follow-up|14
2446965|NCT02751983|8423746|P2|Post-Treatment Assessment|Lost to Follow-up|0
2446966|NCT02751983|8423747|P1|Post-Treatment Assessment|Lost to Follow-up|5
2446967|NCT02751983|8423746|P2|Treatment|Discharged prior to beginning ACT|0
2446968|NCT02751983|8423747|P1|Treatment|Discharged prior to beginning ACT|2
2446969|NCT02751983|8423746|P2|Treatment|Stopped ACT, but Remained in study|0
2446970|NCT02751983|8423747|P1|Treatment|Stopped ACT, but Remained in study|2
2446971|NCT02751450|8423784|P2|Overall Study|Adverse Event|0
2446972|NCT02751450|8423785|P1|Overall Study|Adverse Event|1
2446973|NCT02751424|8423806|P9|Part 2|Adverse Event|0
2446974|NCT02751424|8423807|P8|Part 2|Adverse Event|5
2446975|NCT02751424|8423808|P7|Part 2|Adverse Event|0
2446976|NCT02751424|8423809|P6|Part 2|Adverse Event|0
2446977|NCT02751424|8423810|P5|Part 2|Adverse Event|0
2446978|NCT02751424|8423811|P4|Part 2|Adverse Event|0
2446979|NCT02751424|8423812|P3|Part 2|Adverse Event|0
2446980|NCT02751424|8423813|P2|Part 2|Adverse Event|0
2446981|NCT02751424|8423814|P1|Part 2|Adverse Event|0
2446982|NCT02751320|8423970|P1|Overall Study|Withdrawal by Subject|1
2446983|NCT02751320|8423970|P1|Overall Study|Adverse Event|2
2446984|NCT02750943|8424008|P2|Overall Study|Withdrawal by Subject|7
2446985|NCT02750943|8424009|P1|Overall Study|Withdrawal by Subject|5
2446986|NCT02750943|8424008|P2|Overall Study|Lost to Follow-up|2
2446987|NCT02750943|8424009|P1|Overall Study|Lost to Follow-up|1
2446988|NCT02750930|8424023|P1|Overall Study|Study closed/terminated|8
2446989|NCT02750813|8424035|P2|Period 1, First 14 Days of Wear|Reason not given|1
2446990|NCT02750813|8424036|P1|Period 1, First 14 Days of Wear|Reason not given|0
2446991|NCT02750813|8424035|P2|Period 1, First 14 Days of Wear|Withdrawal by Subject|0
2446992|NCT02750813|8424036|P1|Period 1, First 14 Days of Wear|Withdrawal by Subject|1
2446993|NCT02750800|8424051|P1|Overall Study|Other, not specified|3
2446994|NCT02750800|8424051|P1|Overall Study|Patient request|12
2446995|NCT02750800|8424051|P1|Overall Study|Investigator decision|53
2446996|NCT02750800|8424051|P1|Overall Study|Lost to Follow-up|12
2446997|NCT02750800|8424051|P1|Overall Study|Adverse Event|18
2446998|NCT02750761|8424156|P6|Overall Study|Lost to Follow-up|0
2446999|NCT02750761|8424157|P5|Overall Study|Lost to Follow-up|0
2447000|NCT02750761|8424158|P4|Overall Study|Lost to Follow-up|0
2447001|NCT02750761|8424159|P3|Overall Study|Lost to Follow-up|1
2447002|NCT02750761|8424160|P2|Overall Study|Lost to Follow-up|0
2447003|NCT02750761|8424161|P1|Overall Study|Lost to Follow-up|0
2447004|NCT02750709|8424257|P6|Treatment Period 1|Adverse Event|1
2447005|NCT02750709|8424258|P5|Treatment Period 1|Adverse Event|0
2447006|NCT02750709|8424259|P4|Treatment Period 1|Adverse Event|0
2447007|NCT02750709|8424260|P3|Treatment Period 1|Adverse Event|0
2447008|NCT02750709|8424261|P2|Treatment Period 1|Adverse Event|0
2447009|NCT02750709|8424262|P1|Treatment Period 1|Adverse Event|0
2447010|NCT02750618|8424288|P1|Overall Study|Withdrawal by Subject|1
2447011|NCT02750592|8424304|P1|Overall Study|Lack of Efficacy|2
2447012|NCT02750592|8424304|P1|Overall Study|Adverse Event|3
2447013|NCT02750501|8424323|P1|Overall Study|Non-compliant use of PERT|1
2447014|NCT02750501|8424323|P1|Overall Study|G-tube came out|1
2447015|NCT02750501|8424323|P1|Overall Study|Protocol Violation|1
2447016|NCT02750501|8424323|P1|Overall Study|Physician Decision|1
2447017|NCT02750501|8424323|P1|Overall Study|Adverse Event|4
2447018|NCT02750410|8424337|P2|Open-Label Extension Period|Withdrawal by Subject|2
2447019|NCT02750410|8424338|P1|Open-Label Extension Period|Withdrawal by Subject|1
2447020|NCT02750410|8424337|P2|Open-Label Extension Period|Protocol Violation|1
2447021|NCT02750410|8424338|P1|Open-Label Extension Period|Protocol Violation|0
2447022|NCT02750410|8424337|P2|Open-Label Extension Period|Adverse Event|3
2447023|NCT02750410|8424338|P1|Open-Label Extension Period|Adverse Event|5
2447024|NCT02750410|8424337|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
2447025|NCT02750410|8424338|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
2447026|NCT02750410|8424337|P2|Double-Blind Treatment Period|Adverse Event|2
2447027|NCT02750410|8424338|P1|Double-Blind Treatment Period|Adverse Event|2
2447028|NCT02750345|8424356|P6|Intervention 1|Adverse Event|0
2447029|NCT02750345|8424357|P5|Intervention 1|Adverse Event|1
2447030|NCT02750345|8424358|P4|Intervention 1|Adverse Event|0
2447031|NCT02750345|8424359|P3|Intervention 1|Adverse Event|0
2447032|NCT02750345|8424360|P2|Intervention 1|Adverse Event|0
2447033|NCT02750345|8424361|P1|Intervention 1|Adverse Event|0
2447034|NCT02750332|8424387|P2|Treatment Period 1|Withdrawal by Subject|1
2447035|NCT02750332|8424388|P1|Treatment Period 1|Withdrawal by Subject|0
2447036|NCT02750306|8424408|P2|Overall Study|Protocol Violation|0
2447037|NCT02750306|8424409|P1|Overall Study|Protocol Violation|1
2447038|NCT02750306|8424408|P2|Overall Study|Withdrawal by Subject|2
2447039|NCT02750306|8424409|P1|Overall Study|Withdrawal by Subject|5
2447040|NCT02749370|8424468|P1|Overall Study|Lost to Follow-up|3
2447041|NCT02749370|8424468|P1|Overall Study|Withdrawal by Subject|11
2447042|NCT02748863|8424514|P5|Treatment Period 2|Pregnancy|1
2447043|NCT02748863|8424515|P4|Treatment Period 2|Pregnancy|0
2447044|NCT02748863|8424516|P3|Treatment Period 2|Pregnancy|0
2447045|NCT02748863|8424517|P2|Treatment Period 2|Pregnancy|0
2447046|NCT02748863|8424518|P1|Treatment Period 2|Pregnancy|0
2447047|NCT02748863|8424514|P5|Treatment Period 2|Lack of Efficacy|0
2447048|NCT02748863|8424515|P4|Treatment Period 2|Lack of Efficacy|0
2447049|NCT02748863|8424516|P3|Treatment Period 2|Lack of Efficacy|0
2447050|NCT02748863|8424517|P2|Treatment Period 2|Lack of Efficacy|1
2447051|NCT02748863|8424518|P1|Treatment Period 2|Lack of Efficacy|0
2447052|NCT02748863|8424514|P5|Treatment Period 2|Adverse Event|0
2447053|NCT02748863|8424515|P4|Treatment Period 2|Adverse Event|2
2447054|NCT02748863|8424516|P3|Treatment Period 2|Adverse Event|0
2447055|NCT02748863|8424517|P2|Treatment Period 2|Adverse Event|2
2447056|NCT02748863|8424518|P1|Treatment Period 2|Adverse Event|3
2447057|NCT02748863|8424514|P5|Treatment Period 2|Lost to Follow-up|0
2447058|NCT02748863|8424515|P4|Treatment Period 2|Lost to Follow-up|0
2447059|NCT02748863|8424516|P3|Treatment Period 2|Lost to Follow-up|0
2447060|NCT02748863|8424517|P2|Treatment Period 2|Lost to Follow-up|0
2447061|NCT02748863|8424518|P1|Treatment Period 2|Lost to Follow-up|2
2447062|NCT02748863|8424514|P5|Treatment Period 1|Withdrawal by Subject|0
2447063|NCT02748863|8424515|P4|Treatment Period 1|Withdrawal by Subject|0
2447064|NCT02748863|8424516|P3|Treatment Period 1|Withdrawal by Subject|1
2447065|NCT02748863|8424517|P2|Treatment Period 1|Withdrawal by Subject|1
2447066|NCT02748863|8424518|P1|Treatment Period 1|Withdrawal by Subject|0
2447067|NCT02748863|8424514|P5|Treatment Period 1|Lack of Efficacy|0
2447068|NCT02748863|8424515|P4|Treatment Period 1|Lack of Efficacy|0
2447069|NCT02748863|8424516|P3|Treatment Period 1|Lack of Efficacy|1
2447070|NCT02748863|8424517|P2|Treatment Period 1|Lack of Efficacy|0
2447071|NCT02748863|8424518|P1|Treatment Period 1|Lack of Efficacy|0
2447072|NCT02748863|8424514|P5|Treatment Period 1|Adverse Event|0
2447073|NCT02748863|8424515|P4|Treatment Period 1|Adverse Event|0
2447074|NCT02748863|8424516|P3|Treatment Period 1|Adverse Event|0
2447075|NCT02748863|8424517|P2|Treatment Period 1|Adverse Event|1
2447076|NCT02748863|8424518|P1|Treatment Period 1|Adverse Event|0
2447077|NCT02748356|8424600|P1|Overall Study|Withdrawal by Subject|1
2447078|NCT02748213|8424607|P2|Overall Study|Other|29
2447079|NCT02748213|8424608|P1|Overall Study|Other|30
2447080|NCT02748213|8424607|P2|Overall Study|Failure to Return|0
2447081|NCT02748213|8424608|P1|Overall Study|Failure to Return|1
2447082|NCT02748213|8424607|P2|Overall Study|Refused Treatment*|6
2447083|NCT02748213|8424608|P1|Overall Study|Refused Treatment*|6
2447084|NCT02748213|8424607|P2|Overall Study|Protocol Violation|4
2447085|NCT02748213|8424608|P1|Overall Study|Protocol Violation|6
2447086|NCT02748213|8424607|P2|Overall Study|Violation of Selection Criteria|0
2447087|NCT02748213|8424608|P1|Overall Study|Violation of Selection Criteria|2
2447088|NCT02748213|8424607|P2|Overall Study|Insufficient Therapeutic Response|57
2447089|NCT02748213|8424608|P1|Overall Study|Insufficient Therapeutic Response|56
2447090|NCT02748213|8424607|P2|Overall Study|Death|3
2447091|NCT02748213|8424608|P1|Overall Study|Death|5
2447092|NCT02748213|8424607|P2|Overall Study|Adverse Event or Intercurrent Illness|11
2447093|NCT02748213|8424608|P1|Overall Study|Adverse Event or Intercurrent Illness|5
2447094|NCT02748213|8424607|P2|Overall Study|Abnormal Laboratory Test|0
2447095|NCT02748213|8424608|P1|Overall Study|Abnormal Laboratory Test|1
2447096|NCT02748213|8424607|P2|Overall Study|Withdrawal Prior to Treatment|2
2447097|NCT02748213|8424608|P1|Overall Study|Withdrawal Prior to Treatment|1
2447098|NCT02748057|8424626|P2|Overall Study|Withdrawal by Subject|0
2447099|NCT02748057|8424627|P1|Overall Study|Withdrawal by Subject|1
2447100|NCT02748057|8424626|P2|Overall Study|Participant Moved|0
2447101|NCT02748057|8424627|P1|Overall Study|Participant Moved|1
2447102|NCT02748057|8424626|P2|Overall Study|Protocol Violation|1
2447103|NCT02748057|8424627|P1|Overall Study|Protocol Violation|2
2447104|NCT02748057|8424626|P2|Overall Study|Physician Decision|1
2447105|NCT02748057|8424627|P1|Overall Study|Physician Decision|0
2447106|NCT02748057|8424626|P2|Overall Study|Adverse Event|0
2447107|NCT02748057|8424627|P1|Overall Study|Adverse Event|1
2447108|NCT02747004|8424682|P3|Overall Study|on study treatment/follow-up|41
2447109|NCT02747004|8424683|P2|Overall Study|on study treatment/follow-up|42
2447110|NCT02747004|8424684|P1|Overall Study|on study treatment/follow-up|48
2447111|NCT02747004|8424682|P3|Overall Study|Lost to Follow-up|2
2447112|NCT02747004|8424683|P2|Overall Study|Lost to Follow-up|2
2447113|NCT02747004|8424684|P1|Overall Study|Lost to Follow-up|1
2447114|NCT02747004|8424682|P3|Overall Study|Withdrawal by Subject|4
2447115|NCT02747004|8424683|P2|Overall Study|Withdrawal by Subject|5
2447116|NCT02747004|8424684|P1|Overall Study|Withdrawal by Subject|8
2447117|NCT02746679|8424732|P2|Overall Study|Lost to Follow-up|6
2447118|NCT02746679|8424733|P1|Overall Study|Lost to Follow-up|4
2447119|NCT02746627|8424766|P3|Overall Study|Withdrawal by Subject|1
2447120|NCT02746627|8424767|P2|Overall Study|Withdrawal by Subject|1
2447121|NCT02746627|8424768|P1|Overall Study|Withdrawal by Subject|1
2447122|NCT02746575|8424791|P1|Overall Study|Unknown history of CVA|1
2447123|NCT02746575|8424791|P1|Overall Study|PI unavailable|1
2447124|NCT02746575|8424791|P1|Overall Study|typ of surgery|1
2447125|NCT02746575|8424791|P1|Overall Study|type of surgery|1
2447126|NCT02746575|8424791|P1|Overall Study|put on beta-blocker|3
2447127|NCT02746575|8424791|P1|Overall Study|Study paused|8
2447128|NCT02746575|8424791|P1|Overall Study|Bradycardia/hypotension|9
2447129|NCT02746575|8424791|P1|Overall Study|Withdrawal by Subject|3
2447130|NCT02746575|8424791|P1|Overall Study|Received epidural|10
2447131|NCT02746575|8424791|P1|Overall Study|Surgery cancelled or time chaned|13
2447132|NCT02745535|8424854|P1|Overall Study|Lost to Follow-up|2
2447133|NCT02745535|8424854|P1|Overall Study|Adverse Event|3
2447134|NCT02745535|8424854|P1|Overall Study|Death|1
2447135|NCT02745392|8424866|P4|Overall Study|Lost to Follow-up|0
2447136|NCT02745392|8424867|P3|Overall Study|Lost to Follow-up|0
2447137|NCT02745392|8424868|P2|Overall Study|Lost to Follow-up|1
2447138|NCT02745392|8424869|P1|Overall Study|Lost to Follow-up|0
2447139|NCT02745145|8424895|P3|Overall Study|Study Termination|7
2447140|NCT02745145|8424896|P2|Overall Study|Study Termination|3
2447141|NCT02745145|8424897|P1|Overall Study|Study Termination|8
2447142|NCT02745145|8424895|P3|Overall Study|Withdrew consent|1
2447143|NCT02745145|8424896|P2|Overall Study|Withdrew consent|1
2447144|NCT02745145|8424897|P1|Overall Study|Withdrew consent|1
2447145|NCT02745145|8424895|P3|Overall Study|Progressive disease|1
2447146|NCT02745145|8424896|P2|Overall Study|Progressive disease|0
2447147|NCT02745145|8424897|P1|Overall Study|Progressive disease|0
2447148|NCT02745145|8424895|P3|Overall Study|Death|0
2447149|NCT02745145|8424896|P2|Overall Study|Death|1
2447150|NCT02745145|8424897|P1|Overall Study|Death|0
2447151|NCT02745145|8424895|P3|Overall Study|Adverse Event|0
2447152|NCT02745145|8424896|P2|Overall Study|Adverse Event|0
2447153|NCT02745145|8424897|P1|Overall Study|Adverse Event|1
2447154|NCT02745119|8424936|P4|Overall Study|Reason Not Specified|1
2447155|NCT02745119|8424937|P3|Overall Study|Reason Not Specified|0
2447156|NCT02745119|8424938|P2|Overall Study|Reason Not Specified|2
2447157|NCT02745119|8424939|P1|Overall Study|Reason Not Specified|0
2447158|NCT02745119|8424936|P4|Overall Study|Physician Decision|2
2447159|NCT02745119|8424937|P3|Overall Study|Physician Decision|2
2447160|NCT02745119|8424938|P2|Overall Study|Physician Decision|2
2447161|NCT02745119|8424939|P1|Overall Study|Physician Decision|0
2447162|NCT02745119|8424936|P4|Overall Study|Study Terminated by Sponsor|251
2447163|NCT02745119|8424937|P3|Overall Study|Study Terminated by Sponsor|135
2447164|NCT02745119|8424938|P2|Overall Study|Study Terminated by Sponsor|252
2447165|NCT02745119|8424939|P1|Overall Study|Study Terminated by Sponsor|134
2447166|NCT02745119|8424936|P4|Overall Study|Withdrawal by Subject|14
2447167|NCT02745119|8424937|P3|Overall Study|Withdrawal by Subject|8
2447168|NCT02745119|8424938|P2|Overall Study|Withdrawal by Subject|15
2447169|NCT02745119|8424939|P1|Overall Study|Withdrawal by Subject|7
2447170|NCT02745119|8424936|P4|Overall Study|Protocol Deviation|1
2447171|NCT02745119|8424937|P3|Overall Study|Protocol Deviation|0
2447172|NCT02745119|8424938|P2|Overall Study|Protocol Deviation|0
2447173|NCT02745119|8424939|P1|Overall Study|Protocol Deviation|0
2447174|NCT02745119|8424936|P4|Overall Study|Lost to Follow-up|1
2447175|NCT02745119|8424937|P3|Overall Study|Lost to Follow-up|0
2447176|NCT02745119|8424938|P2|Overall Study|Lost to Follow-up|0
2447177|NCT02745119|8424939|P1|Overall Study|Lost to Follow-up|0
2447178|NCT02745119|8424936|P4|Overall Study|Death|4
2447179|NCT02745119|8424937|P3|Overall Study|Death|0
2447180|NCT02745119|8424938|P2|Overall Study|Death|3
2447181|NCT02745119|8424939|P1|Overall Study|Death|3
2447182|NCT02745119|8424936|P4|Overall Study|Adverse Event|3
2447183|NCT02745119|8424937|P3|Overall Study|Adverse Event|1
2447184|NCT02745119|8424938|P2|Overall Study|Adverse Event|0
2447185|NCT02745119|8424939|P1|Overall Study|Adverse Event|1
2447186|NCT02744898|8424961|P1|Overall Study|Toxicity|1
2447187|NCT02744898|8424961|P1|Overall Study|Physician Decision|1
2447188|NCT02744898|8424961|P1|Overall Study|Progressive Disease|2
2447189|NCT02744755|8424975|P2|Study Period 2|Lack of Efficacy|2
2447190|NCT02744755|8424976|P1|Study Period 2|Lack of Efficacy|3
2447191|NCT02744755|8424975|P2|Study Period 2|Withdrawal by Subject|2
2447192|NCT02744755|8424976|P1|Study Period 2|Withdrawal by Subject|2
2447193|NCT02744755|8424975|P2|Study Period 2|Lost to Follow-up|2
2447194|NCT02744755|8424976|P1|Study Period 2|Lost to Follow-up|0
2447195|NCT02744755|8424975|P2|Study Period 2|not defined|2
2447196|NCT02744755|8424976|P1|Study Period 2|not defined|3
2447197|NCT02744755|8424975|P2|Study Period 2|Protocol Violation|0
2447198|NCT02744755|8424976|P1|Study Period 2|Protocol Violation|1
2447199|NCT02744755|8424975|P2|Study Period 2|Adverse Event|0
2447200|NCT02744755|8424976|P1|Study Period 2|Adverse Event|5
2447201|NCT02744755|8424975|P2|Study Period 1|Withdrawal by Subject|4
2447202|NCT02744755|8424976|P1|Study Period 1|Withdrawal by Subject|8
2447203|NCT02744755|8424975|P2|Study Period 1|Lack of Efficacy|0
2447204|NCT02744755|8424976|P1|Study Period 1|Lack of Efficacy|1
2447205|NCT02744755|8424975|P2|Study Period 1|Lost to Follow-up|1
2447206|NCT02744755|8424976|P1|Study Period 1|Lost to Follow-up|1
2447207|NCT02744755|8424975|P2|Study Period 1|Adverse Event|1
2447208|NCT02744755|8424976|P1|Study Period 1|Adverse Event|1
2447209|NCT02744755|8424975|P2|Study Period 1|Pregnancy|0
2447210|NCT02744755|8424976|P1|Study Period 1|Pregnancy|1
2447211|NCT02744755|8424975|P2|Study Period 1|not defined|1
2447212|NCT02744755|8424976|P1|Study Period 1|not defined|0
2447213|NCT02744755|8424975|P2|Study Period 1|Protocol Violation|1
2447214|NCT02744755|8424976|P1|Study Period 1|Protocol Violation|2
2447215|NCT02744391|8425036|P1|Overall Study|Withdrawal by Subject|3
2447216|NCT02744391|8425036|P1|Overall Study|Physician Decision|2
2447217|NCT02744391|8425036|P1|Overall Study|Lost to Follow-up|9
2447218|NCT02744066|8425077|P2|Overall Study|Discharged from NICU prior to completion|4
2447219|NCT02744066|8425078|P1|Overall Study|Discharged from NICU prior to completion|0
2447220|NCT02744066|8425077|P2|Overall Study|Withdrawal by parent|1
2447221|NCT02744066|8425078|P1|Overall Study|Withdrawal by parent|0
2447222|NCT02743962|8425088|P2|Overall Study|Atrophic vaginitis diagnosed|0
2447223|NCT02743962|8425089|P1|Overall Study|Atrophic vaginitis diagnosed|1
2447224|NCT02743949|8425111|P3|Overall Study|Voluntary Withdrawal|0
2447225|NCT02743949|8425112|P2|Overall Study|Voluntary Withdrawal|1
2447226|NCT02743949|8425113|P1|Overall Study|Voluntary Withdrawal|2
2447227|NCT02743949|8425111|P3|Overall Study|Significant Protocol Deviation|1
2447228|NCT02743949|8425112|P2|Overall Study|Significant Protocol Deviation|0
2447229|NCT02743949|8425113|P1|Overall Study|Significant Protocol Deviation|2
2447230|NCT02743949|8425111|P3|Overall Study|Adverse Event|2
2447231|NCT02743949|8425112|P2|Overall Study|Adverse Event|0
2447232|NCT02743949|8425113|P1|Overall Study|Adverse Event|0
2447233|NCT02743780|8425140|P5|Part 3 (7 Days)|Adverse Event|0
2447234|NCT02743780|8425141|P4|Part 3 (7 Days)|Adverse Event|0
2447235|NCT02743780|8425142|P3|Part 3 (7 Days)|Adverse Event|1
2447236|NCT02743780|8425143|P2|Part 3 (7 Days)|Adverse Event|0
2447237|NCT02743780|8425144|P1|Part 3 (7 Days)|Adverse Event|0
2447238|NCT02743221|8425234|P2|Overall Study|Patient not eligible, not treated|1
2447239|NCT02743221|8425235|P1|Overall Study|Patient not eligible, not treated|0
2447240|NCT02743221|8425234|P2|Overall Study|Physician Decision|5
2447241|NCT02743221|8425235|P1|Overall Study|Physician Decision|2
2447242|NCT02743221|8425234|P2|Overall Study|non medical reason|2
2447243|NCT02743221|8425235|P1|Overall Study|non medical reason|8
2447244|NCT02743221|8425234|P2|Overall Study|Adverse Event|14
2447245|NCT02743221|8425235|P1|Overall Study|Adverse Event|17
2447246|NCT02743221|8425234|P2|Overall Study|Progressive disease|38
2447247|NCT02743221|8425235|P1|Overall Study|Progressive disease|29
2447248|NCT02743117|8425251|P2|Overall Study|Other|0
2447249|NCT02743117|8425252|P1|Overall Study|Other|1
2447250|NCT02743117|8425251|P2|Overall Study|Lost to Follow-up|1
2447251|NCT02743117|8425252|P1|Overall Study|Lost to Follow-up|0
2447252|NCT02742818|8425277|P2|Overall Study|Protocol Violation|1
2447253|NCT02742818|8425278|P1|Overall Study|Protocol Violation|0
2447254|NCT02742818|8425277|P2|Overall Study|Adverse Event|1
2447255|NCT02742818|8425278|P1|Overall Study|Adverse Event|0
2447256|NCT02742766|8425311|P19|Part 2 (Up to 22 Days)|Physician Decision|0
2447257|NCT02742766|8425312|P18|Part 2 (Up to 22 Days)|Physician Decision|0
2447258|NCT02742766|8425313|P17|Part 2 (Up to 22 Days)|Physician Decision|0
2447259|NCT02742766|8425314|P16|Part 2 (Up to 22 Days)|Physician Decision|1
2447260|NCT02742766|8425315|P15|Part 2 (Up to 22 Days)|Physician Decision|0
2447261|NCT02742766|8425316|P14|Part 2 (Up to 22 Days)|Physician Decision|5
2447262|NCT02742766|8425317|P13|Part 2 (Up to 22 Days)|Physician Decision|2
2447263|NCT02742766|8425318|P12|Part 2 (Up to 22 Days)|Physician Decision|0
2447264|NCT02742766|8425319|P11|Part 2 (Up to 22 Days)|Physician Decision|0
2447265|NCT02742766|8425320|P10|Part 2 (Up to 22 Days)|Physician Decision|0
2447266|NCT02742766|8425321|P9|Part 2 (Up to 22 Days)|Physician Decision|0
2447267|NCT02742766|8425322|P8|Part 2 (Up to 22 Days)|Physician Decision|0
2447268|NCT02742766|8425323|P7|Part 2 (Up to 22 Days)|Physician Decision|0
2447269|NCT02742766|8425324|P6|Part 2 (Up to 22 Days)|Physician Decision|0
2447270|NCT02742766|8425325|P5|Part 2 (Up to 22 Days)|Physician Decision|0
2447271|NCT02742766|8425326|P4|Part 2 (Up to 22 Days)|Physician Decision|0
2447272|NCT02742766|8425327|P3|Part 2 (Up to 22 Days)|Physician Decision|0
2447273|NCT02742766|8425328|P2|Part 2 (Up to 22 Days)|Physician Decision|0
2447274|NCT02742766|8425329|P1|Part 2 (Up to 22 Days)|Physician Decision|0
2447275|NCT02742766|8425311|P19|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2447276|NCT02742766|8425312|P18|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2447277|NCT02742766|8425313|P17|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2447278|NCT02742766|8425314|P16|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2447279|NCT02742766|8425315|P15|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2447280|NCT02742766|8425316|P14|Part 2 (Up to 22 Days)|Withdrawal by Subject|1
2447281|NCT02742766|8425317|P13|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2447282|NCT02742766|8425318|P12|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2447283|NCT02742766|8425319|P11|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2447284|NCT02742766|8425320|P10|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2447285|NCT02742766|8425321|P9|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2447286|NCT02742766|8425322|P8|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2447287|NCT02742766|8425323|P7|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2447288|NCT02742766|8425324|P6|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2447289|NCT02742766|8425325|P5|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2447290|NCT02742766|8425326|P4|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2447291|NCT02742766|8425327|P3|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2447292|NCT02742766|8425328|P2|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2447293|NCT02742766|8425329|P1|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
2447294|NCT02742649|8425589|P5|Open-Label Period|Lost to Follow-up|1
2447295|NCT02742649|8425590|P4|Open-Label Period|Lost to Follow-up|0
2447296|NCT02742649|8425591|P3|Open-Label Period|Lost to Follow-up|0
2447297|NCT02742649|8425592|P2|Open-Label Period|Lost to Follow-up|0
2447298|NCT02742649|8425593|P1|Open-Label Period|Lost to Follow-up|0
2447299|NCT02742649|8425589|P5|Double-Blind Treatment Period|Adverse Event|0
2447300|NCT02742649|8425590|P4|Double-Blind Treatment Period|Adverse Event|0
2447301|NCT02742649|8425591|P3|Double-Blind Treatment Period|Adverse Event|0
2447302|NCT02742649|8425592|P2|Double-Blind Treatment Period|Adverse Event|1
2447303|NCT02742649|8425593|P1|Double-Blind Treatment Period|Adverse Event|0
2447304|NCT02742649|8425589|P5|Pre-Randomization Washout Period|Washout/Randomization Failure|0
2447305|NCT02742649|8425590|P4|Pre-Randomization Washout Period|Washout/Randomization Failure|0
2447306|NCT02742649|8425591|P3|Pre-Randomization Washout Period|Washout/Randomization Failure|0
2447307|NCT02742649|8425592|P2|Pre-Randomization Washout Period|Washout/Randomization Failure|0
2447308|NCT02742649|8425593|P1|Pre-Randomization Washout Period|Washout/Randomization Failure|5
2447309|NCT02742519|8425621|P3|Part 2 Open Label Period (32 Weeks)|Other|1
2447310|NCT02742519|8425622|P2|Part 2 Open Label Period (32 Weeks)|Other|0
2447311|NCT02742519|8425623|P1|Part 2 Open Label Period (32 Weeks)|Other|0
2447312|NCT02742519|8425621|P3|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9
2447313|NCT02742519|8425622|P2|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
2447314|NCT02742519|8425623|P1|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
2447315|NCT02742519|8425621|P3|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0
2447316|NCT02742519|8425622|P2|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
2447317|NCT02742519|8425623|P1|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
2447318|NCT02742441|8425643|P2|Overall Study|Adverse Event|2
2447319|NCT02742441|8425644|P1|Overall Study|Adverse Event|0
2447320|NCT02742441|8425643|P2|Overall Study|Withdrawal by Subject|2
2447321|NCT02742441|8425644|P1|Overall Study|Withdrawal by Subject|2
2447322|NCT02742441|8425643|P2|Overall Study|Lost to Follow-up|4
2447323|NCT02742441|8425644|P1|Overall Study|Lost to Follow-up|4
2447324|NCT02741713|8425691|P2|Overall Study|Surgery type changed intra-operatively|1
2447325|NCT02741713|8425692|P1|Overall Study|Surgery type changed intra-operatively|2
2447326|NCT02741518|8425734|P2|Overall Study|Withdrawal by Subject|1
2447327|NCT02741518|8425735|P1|Overall Study|Withdrawal by Subject|1
2447328|NCT02741310|8425745|P2|Overall Study|Sponsor Decision|2
2447329|NCT02741310|8425746|P1|Overall Study|Sponsor Decision|2
2447330|NCT02741271|8425791|P2|Overall Study|Withdrawal by Parent/Guardian|2
2447331|NCT02741271|8425792|P1|Overall Study|Withdrawal by Parent/Guardian|0
2447332|NCT02741271|8425791|P2|Overall Study|Lost to Follow-up|0
2447333|NCT02741271|8425792|P1|Overall Study|Lost to Follow-up|2
2447334|NCT02741245|8425825|P5|Overall Study|Withdrawal by Subject|0
2447335|NCT02741245|8425826|P4|Overall Study|Withdrawal by Subject|1
2447336|NCT02741245|8425827|P3|Overall Study|Withdrawal by Subject|0
2447337|NCT02741245|8425828|P2|Overall Study|Withdrawal by Subject|0
2447338|NCT02741245|8425829|P1|Overall Study|Withdrawal by Subject|0
2447339|NCT02741245|8425825|P5|Overall Study|Protocol Violation|0
2447340|NCT02741245|8425826|P4|Overall Study|Protocol Violation|1
2447341|NCT02741245|8425827|P3|Overall Study|Protocol Violation|0
2447342|NCT02741245|8425828|P2|Overall Study|Protocol Violation|1
2447343|NCT02741245|8425829|P1|Overall Study|Protocol Violation|0
2447344|NCT02741245|8425825|P5|Overall Study|Adverse Event|2
2447345|NCT02741245|8425826|P4|Overall Study|Adverse Event|2
2447346|NCT02741245|8425827|P3|Overall Study|Adverse Event|0
2447347|NCT02741245|8425828|P2|Overall Study|Adverse Event|0
2447348|NCT02741245|8425829|P1|Overall Study|Adverse Event|0
2447349|NCT02741076|8425935|P4|Overall Study|No additional information available|1
2447350|NCT02741076|8425936|P3|Overall Study|No additional information available|1
2447351|NCT02741076|8425937|P2|Overall Study|No additional information available|0
2447352|NCT02741076|8425938|P1|Overall Study|No additional information available|0
2447353|NCT02741076|8425935|P4|Overall Study|Sponsor Request|1
2447354|NCT02741076|8425936|P3|Overall Study|Sponsor Request|0
2447355|NCT02741076|8425937|P2|Overall Study|Sponsor Request|3
2447356|NCT02741076|8425938|P1|Overall Study|Sponsor Request|2
2447357|NCT02741076|8425935|P4|Overall Study|Withdrawal by Subject|0
2447358|NCT02741076|8425936|P3|Overall Study|Withdrawal by Subject|0
2447359|NCT02741076|8425937|P2|Overall Study|Withdrawal by Subject|1
2447360|NCT02741076|8425938|P1|Overall Study|Withdrawal by Subject|0
2447361|NCT02741076|8425935|P4|Overall Study|Lack of Efficacy|0
2447362|NCT02741076|8425936|P3|Overall Study|Lack of Efficacy|0
2447363|NCT02741076|8425937|P2|Overall Study|Lack of Efficacy|0
2447364|NCT02741076|8425938|P1|Overall Study|Lack of Efficacy|1
2447365|NCT02741076|8425935|P4|Overall Study|Adverse Event|0
2447366|NCT02741076|8425936|P3|Overall Study|Adverse Event|1
2447367|NCT02741076|8425937|P2|Overall Study|Adverse Event|1
2447368|NCT02741076|8425938|P1|Overall Study|Adverse Event|0
2447369|NCT02740049|8426054|P1|Overall Study|Isolated cells did not grow sufficiently|1
2447370|NCT02739997|8426060|P1|Overall Study|Withdrawal by Subject|1
2447371|NCT02739997|8426060|P1|Overall Study|Death|1
2447372|NCT02739984|8426074|P2|Overall Study|Lost to Follow-up|0
2447373|NCT02739984|8426075|P1|Overall Study|Lost to Follow-up|3
2447374|NCT02739984|8426074|P2|Overall Study|Death|1
2447375|NCT02739984|8426075|P1|Overall Study|Death|0
2447376|NCT02739984|8426074|P2|Overall Study|Withdrawal by Subject|1
2447377|NCT02739984|8426075|P1|Overall Study|Withdrawal by Subject|1
2447378|NCT02739984|8426074|P2|Overall Study|Sponsor Decision|0
2447379|NCT02739984|8426075|P1|Overall Study|Sponsor Decision|1
2447380|NCT02739828|8426123|P1|Overall Study|Lost to Follow-up|4
2447381|NCT02739828|8426123|P1|Overall Study|Adverse Event|1
2447382|NCT02739594|8426168|P2|Overall Study|Other|2
2447383|NCT02739594|8426169|P1|Overall Study|Other|6
2447384|NCT02739594|8426168|P2|Overall Study|Elevated Serum Creatinine|1
2447385|NCT02739594|8426169|P1|Overall Study|Elevated Serum Creatinine|0
2447386|NCT02739594|8426168|P2|Overall Study|Lost to Follow-up|1
2447387|NCT02739594|8426169|P1|Overall Study|Lost to Follow-up|0
2447388|NCT02739594|8426168|P2|Overall Study|Withdrawal by Subject|1
2447389|NCT02739594|8426169|P1|Overall Study|Withdrawal by Subject|1
2447390|NCT02739594|8426168|P2|Overall Study|Administrative Reasons|3
2447391|NCT02739594|8426169|P1|Overall Study|Administrative Reasons|1
2447392|NCT02739594|8426168|P2|Overall Study|Renal Insufficiency|6
2447393|NCT02739594|8426169|P1|Overall Study|Renal Insufficiency|4
2447394|NCT02739594|8426168|P2|Overall Study|Death|2
2447395|NCT02739594|8426169|P1|Overall Study|Death|4
2447396|NCT02739594|8426168|P2|Overall Study|Protocol Violation|6
2447397|NCT02739594|8426169|P1|Overall Study|Protocol Violation|5
2447398|NCT02739594|8426168|P2|Overall Study|Violation of Eligibility Criteria|2
2447399|NCT02739594|8426169|P1|Overall Study|Violation of Eligibility Criteria|1
2447400|NCT02739594|8426168|P2|Overall Study|Undesired Event|4
2447401|NCT02739594|8426169|P1|Overall Study|Undesired Event|3
2447402|NCT02739360|8426199|P1|Overall Study|Study terminated by Sponsor|2
2447403|NCT02739360|8426199|P1|Overall Study|Adverse Event|1
2447404|NCT02739321|8426205|P2|Overall Study|Withdrawal by Subject|2
2447405|NCT02739321|8426206|P1|Overall Study|Withdrawal by Subject|1
2447406|NCT02739321|8426205|P2|Overall Study|Lost to Follow-up|1
2447407|NCT02739321|8426206|P1|Overall Study|Lost to Follow-up|1
2447408|NCT02739321|8426205|P2|Overall Study|Lack of Efficacy|1
2447409|NCT02739321|8426206|P1|Overall Study|Lack of Efficacy|1
2447410|NCT02739269|8426252|P2|Overall Study|Withdrawal by Subject|2
2447411|NCT02739269|8426253|P1|Overall Study|Withdrawal by Subject|0
2447412|NCT02739269|8426252|P2|Overall Study|Cycle cancellation|2
2447413|NCT02739269|8426253|P1|Overall Study|Cycle cancellation|2
2447414|NCT02739269|8426252|P2|Overall Study|Protocol Violation|0
2447415|NCT02739269|8426253|P1|Overall Study|Protocol Violation|5
2447416|NCT02738879|8426280|P2|Overall Study|Withdrawal by Subject|7
2447417|NCT02738879|8426281|P1|Overall Study|Withdrawal by Subject|5
2447418|NCT02738879|8426280|P2|Overall Study|Site Discontinued Study Participation|0
2447419|NCT02738879|8426281|P1|Overall Study|Site Discontinued Study Participation|1
2447420|NCT02738879|8426280|P2|Overall Study|Screen Failure|2
2447421|NCT02738879|8426281|P1|Overall Study|Screen Failure|1
2447422|NCT02738879|8426280|P2|Overall Study|Pregnancy|1
2447423|NCT02738879|8426281|P1|Overall Study|Pregnancy|0
2447424|NCT02738879|8426280|P2|Overall Study|Physician Decision|4
2447425|NCT02738879|8426281|P1|Overall Study|Physician Decision|3
2447426|NCT02738879|8426280|P2|Overall Study|Protocol Violation|3
2447427|NCT02738879|8426281|P1|Overall Study|Protocol Violation|1
2447428|NCT02738879|8426280|P2|Overall Study|Lost to Follow-up|5
2447429|NCT02738879|8426281|P1|Overall Study|Lost to Follow-up|1
2447430|NCT02738879|8426280|P2|Overall Study|Death|2
2447431|NCT02738879|8426281|P1|Overall Study|Death|0
2447432|NCT02738879|8426280|P2|Overall Study|Adverse Event|1
2447433|NCT02738879|8426281|P1|Overall Study|Adverse Event|1
2447434|NCT02738580|8426333|P2|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1
2447435|NCT02738580|8426334|P1|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0
2447436|NCT02738580|8426333|P2|Overall Study|Withdrawal by Subject|1
2447437|NCT02738580|8426334|P1|Overall Study|Withdrawal by Subject|0
2447438|NCT02738580|8426333|P2|Overall Study|Lack of Efficacy|2
2447439|NCT02738580|8426334|P1|Overall Study|Lack of Efficacy|3
2447440|NCT02738580|8426333|P2|Overall Study|Adverse Event|0
2447441|NCT02738580|8426334|P1|Overall Study|Adverse Event|1
2447442|NCT02738333|8426345|P3|Overall Study|Lost to Follow-up|0
2447443|NCT02738333|8426346|P2|Overall Study|Lost to Follow-up|0
2447444|NCT02738333|8426347|P1|Overall Study|Lost to Follow-up|1
2447445|NCT02738333|8426345|P3|Overall Study|Death|0
2447446|NCT02738333|8426346|P2|Overall Study|Death|0
2447447|NCT02738333|8426347|P1|Overall Study|Death|1
2447448|NCT02738203|8426436|P2|Overall Study|Protocol Violation|1
2447449|NCT02738203|8426437|P1|Overall Study|Protocol Violation|0
2447450|NCT02738203|8426436|P2|Overall Study|Failed IUD Insertion|2
2447451|NCT02738203|8426437|P1|Overall Study|Failed IUD Insertion|2
2447452|NCT02738151|8426453|P2|Overall Study|Other than specified above|21
2447453|NCT02738151|8426454|P1|Overall Study|Other than specified above|11
2447454|NCT02738151|8426453|P2|Overall Study|Poor Compliance to Protocol|3
2447455|NCT02738151|8426454|P1|Overall Study|Poor Compliance to Protocol|4
2447456|NCT02738151|8426453|P2|Overall Study|Hypoglycemia|1
2447457|NCT02738151|8426454|P1|Overall Study|Hypoglycemia|0
2447458|NCT02738151|8426453|P2|Overall Study|Adverse Event|5
2447459|NCT02738151|8426454|P1|Overall Study|Adverse Event|4
2447460|NCT02738151|8426453|P2|Overall Study|Randomized but not treated|1
2447461|NCT02738151|8426454|P1|Overall Study|Randomized but not treated|4
2447462|NCT02738138|8426498|P2|Overall Study|Other - not further specified|0
2447463|NCT02738138|8426499|P1|Overall Study|Other - not further specified|1
2447464|NCT02738138|8426498|P2|Overall Study|Lost to Follow-up|0
2447465|NCT02738138|8426499|P1|Overall Study|Lost to Follow-up|2
2447466|NCT02738138|8426498|P2|Overall Study|Adverse Event|1
2447467|NCT02738138|8426499|P1|Overall Study|Adverse Event|0
2447468|NCT02738008|8426536|P3|Overall Study|Adverse Event|2
2447469|NCT02738008|8426537|P2|Overall Study|Adverse Event|1
2447470|NCT02738008|8426538|P1|Overall Study|Adverse Event|0
2447471|NCT02738008|8426536|P3|Overall Study|Study Terminated by Sponsor|3
2447472|NCT02738008|8426537|P2|Overall Study|Study Terminated by Sponsor|5
2447473|NCT02738008|8426538|P1|Overall Study|Study Terminated by Sponsor|1
2447474|NCT02737852|8426563|P1|Overall Study|Withdrawal by Subject|2
2447475|NCT02737722|8426572|P4|Overall Study|Physician Decision|0
2447476|NCT02737722|8426573|P3|Overall Study|Physician Decision|1
2447477|NCT02737722|8426574|P2|Overall Study|Physician Decision|0
2447478|NCT02737722|8426575|P1|Overall Study|Physician Decision|0
2447479|NCT02737618|8426626|P1|Overall Study|Withdrawal by Subject|9
2447480|NCT02737592|8426631|P1|Overall Study|Withdrawal by Subject|1
2447481|NCT02736890|8426704|P2|Crossover Next 12 Weeks|Withdrawal by Subject|0
2447482|NCT02736890|8426705|P1|Crossover Next 12 Weeks|Withdrawal by Subject|1
2447483|NCT02736890|8426704|P2|Crossover Next 12 Weeks|Lost to Follow-up|2
2447484|NCT02736890|8426705|P1|Crossover Next 12 Weeks|Lost to Follow-up|1
2447485|NCT02736825|8426727|P2|Overall Study|Early Termination|1
2447486|NCT02736825|8426728|P1|Overall Study|Early Termination|0
2447487|NCT02736825|8426727|P2|Overall Study|Lost to Follow-up|11
2447488|NCT02736825|8426728|P1|Overall Study|Lost to Follow-up|10
2447489|NCT02736721|8426768|P1|Overall Study|Other|5
2447490|NCT02736721|8426768|P1|Overall Study|Lost to Follow-up|3
2447491|NCT02736721|8426768|P1|Overall Study|Adverse Event|8
2447492|NCT02736578|8426779|P2|Overall Study|Adverse Event|0
2447493|NCT02736578|8426780|P1|Overall Study|Adverse Event|1
2447494|NCT02736188|8426798|P1|Overall Study|Other|6
2447495|NCT02736188|8426798|P1|Overall Study|Withdrawal by Subject|1
2447496|NCT02736188|8426798|P1|Overall Study|Adverse Event|1
2447497|NCT02736188|8426798|P1|Overall Study|Discontinuation of Study by Sponsor|134
2447498|NCT02735980|8426836|P3|Overall Study|Withdrawal by Subject|0
2447499|NCT02735980|8426837|P2|Overall Study|Withdrawal by Subject|2
2447500|NCT02735980|8426838|P1|Overall Study|Withdrawal by Subject|1
2447501|NCT02735980|8426836|P3|Overall Study|Screen failure|0
2447502|NCT02735980|8426837|P2|Overall Study|Screen failure|0
2447503|NCT02735980|8426838|P1|Overall Study|Screen failure|1
2447504|NCT02735980|8426836|P3|Overall Study|Physician Decision|0
2447505|NCT02735980|8426837|P2|Overall Study|Physician Decision|1
2447506|NCT02735980|8426838|P1|Overall Study|Physician Decision|3
2447507|NCT02735980|8426836|P3|Overall Study|Death|0
2447508|NCT02735980|8426837|P2|Overall Study|Death|4
2447509|NCT02735980|8426838|P1|Overall Study|Death|5
2447510|NCT02735980|8426836|P3|Overall Study|Adverse Event|1
2447511|NCT02735980|8426837|P2|Overall Study|Adverse Event|4
2447512|NCT02735980|8426838|P1|Overall Study|Adverse Event|0
2447513|NCT02735915|8426867|P1|Overall Study|Withdrawal by Subject|1
2447514|NCT02735915|8426867|P1|Overall Study|Withdrawal following SAE|2
2447515|NCT02735915|8426867|P1|Overall Study|Not vaccinated but subject ID assigned|8
2447516|NCT02735421|8426899|P1|Overall Study|Pregnancy|1
2447517|NCT02735421|8426899|P1|Overall Study|Inadequate compliance to treatment|1
2447518|NCT02735421|8426899|P1|Overall Study|Lost to Follow-up|3
2447519|NCT02735421|8426899|P1|Overall Study|Withdrawal by Subject|6
2447520|NCT02735421|8426899|P1|Overall Study|Adverse Event|2
2447521|NCT02735200|8426929|P2|Overall Study|Withdrawal by Subject|0
2447522|NCT02735200|8426930|P1|Overall Study|Withdrawal by Subject|8
2447523|NCT02735200|8426929|P2|Overall Study|Lost to Follow-up|5
2447524|NCT02735200|8426930|P1|Overall Study|Lost to Follow-up|0
2447525|NCT02735096|8426969|P1|Overall Study|No symptoms in clinic/personal leave|1
2447526|NCT02735044|8426978|P2|Overall Study|Other, not specified above|11
2447527|NCT02735044|8426979|P1|Overall Study|Other, not specified above|5
2447528|NCT02735044|8426978|P2|Overall Study|Randomized and not treated|2
2447529|NCT02735044|8426979|P1|Overall Study|Randomized and not treated|0
2447530|NCT02735044|8426978|P2|Overall Study|Poor compliance to protocol|7
2447531|NCT02735044|8426979|P1|Overall Study|Poor compliance to protocol|7
2447532|NCT02735044|8426978|P2|Overall Study|Lack of Efficacy|0
2447533|NCT02735044|8426979|P1|Overall Study|Lack of Efficacy|1
2447534|NCT02735044|8426978|P2|Overall Study|Adverse Event|3
2447535|NCT02735044|8426979|P1|Overall Study|Adverse Event|3
2447536|NCT02734810|8427047|P2|Overall Study|Lack of Efficacy|0
2447537|NCT02734810|8427048|P1|Overall Study|Lack of Efficacy|1
2447538|NCT02734810|8427047|P2|Overall Study|Adverse Event|0
2447539|NCT02734810|8427048|P1|Overall Study|Adverse Event|1
2447540|NCT02734693|8427057|P3|Overall Study|Withdrawal by Subject|0
2447541|NCT02734693|8427058|P2|Overall Study|Withdrawal by Subject|0
2447542|NCT02734693|8427059|P1|Overall Study|Withdrawal by Subject|1
2447543|NCT02734693|8427057|P3|Overall Study|Protocol Violation|0
2447544|NCT02734693|8427058|P2|Overall Study|Protocol Violation|0
2447545|NCT02734693|8427059|P1|Overall Study|Protocol Violation|1
2447546|NCT02734693|8427057|P3|Overall Study|Lost to Follow-up|0
2447547|NCT02734693|8427058|P2|Overall Study|Lost to Follow-up|0
2447548|NCT02734693|8427059|P1|Overall Study|Lost to Follow-up|2
2447549|NCT02734693|8427057|P3|Overall Study|Lack of Efficacy|0
2447550|NCT02734693|8427058|P2|Overall Study|Lack of Efficacy|0
2447551|NCT02734693|8427059|P1|Overall Study|Lack of Efficacy|1
2447552|NCT02734693|8427057|P3|Overall Study|Adverse Event|3
2447553|NCT02734693|8427058|P2|Overall Study|Adverse Event|3
2447554|NCT02734693|8427059|P1|Overall Study|Adverse Event|1
2447555|NCT02734433|8427100|P2|Overall Study|Withdrawal by Subject|2
2447556|NCT02734433|8427101|P1|Overall Study|Withdrawal by Subject|1
2447557|NCT02734433|8427100|P2|Overall Study|Clinical progression|1
2447558|NCT02734433|8427101|P1|Overall Study|Clinical progression|0
2447559|NCT02734433|8427100|P2|Overall Study|Disease progression|5
2447560|NCT02734433|8427101|P1|Overall Study|Disease progression|1
2447561|NCT02734212|8427177|P2|Overall Study|Lost to Follow-up|10
2447562|NCT02734212|8427178|P1|Overall Study|Lost to Follow-up|5
2447563|NCT02733991|8427199|P2|Overall Study|Withdrawal by Subject|5
2447564|NCT02733991|8427200|P1|Overall Study|Withdrawal by Subject|0
2447565|NCT02733991|8427199|P2|Overall Study|Adverse Event|0
2447566|NCT02733991|8427200|P1|Overall Study|Adverse Event|1
2447567|NCT02733367|8427223|P1|Overall Study|Withdrawal by Subject|6
2447568|NCT02733042|8427249|P19|Follow-up Period|Withdrawal by Subject|0
2447569|NCT02733042|8427250|P18|Follow-up Period|Withdrawal by Subject|0
2447570|NCT02733042|8427251|P17|Follow-up Period|Withdrawal by Subject|0
2447571|NCT02733042|8427252|P16|Follow-up Period|Withdrawal by Subject|1
2447572|NCT02733042|8427253|P15|Follow-up Period|Withdrawal by Subject|0
2447573|NCT02733042|8427254|P14|Follow-up Period|Withdrawal by Subject|0
2447574|NCT02733042|8427255|P13|Follow-up Period|Withdrawal by Subject|0
2447575|NCT02733042|8427256|P12|Follow-up Period|Withdrawal by Subject|0
2447576|NCT02733042|8427257|P11|Follow-up Period|Withdrawal by Subject|1
2447577|NCT02733042|8427258|P10|Follow-up Period|Withdrawal by Subject|0
2447578|NCT02733042|8427259|P9|Follow-up Period|Withdrawal by Subject|1
2447579|NCT02733042|8427260|P8|Follow-up Period|Withdrawal by Subject|0
2447580|NCT02733042|8427261|P7|Follow-up Period|Withdrawal by Subject|0
2447581|NCT02733042|8427262|P6|Follow-up Period|Withdrawal by Subject|0
2447582|NCT02733042|8427263|P5|Follow-up Period|Withdrawal by Subject|0
2447583|NCT02733042|8427264|P4|Follow-up Period|Withdrawal by Subject|0
2447584|NCT02733042|8427265|P3|Follow-up Period|Withdrawal by Subject|0
2447585|NCT02733042|8427266|P2|Follow-up Period|Withdrawal by Subject|0
2447586|NCT02733042|8427267|P1|Follow-up Period|Withdrawal by Subject|0
2447587|NCT02733042|8427249|P19|Follow-up Period|Other|0
2447588|NCT02733042|8427250|P18|Follow-up Period|Other|0
2447589|NCT02733042|8427251|P17|Follow-up Period|Other|0
2447590|NCT02733042|8427252|P16|Follow-up Period|Other|0
2447591|NCT02733042|8427253|P15|Follow-up Period|Other|0
2447592|NCT02733042|8427254|P14|Follow-up Period|Other|0
2447593|NCT02733042|8427255|P13|Follow-up Period|Other|0
2447594|NCT02733042|8427256|P12|Follow-up Period|Other|0
2447595|NCT02733042|8427257|P11|Follow-up Period|Other|0
2447596|NCT02733042|8427258|P10|Follow-up Period|Other|0
2447597|NCT02733042|8427259|P9|Follow-up Period|Other|0
2447598|NCT02733042|8427260|P8|Follow-up Period|Other|0
2447599|NCT02733042|8427261|P7|Follow-up Period|Other|0
2447600|NCT02733042|8427262|P6|Follow-up Period|Other|0
2447601|NCT02733042|8427263|P5|Follow-up Period|Other|0
2447602|NCT02733042|8427264|P4|Follow-up Period|Other|1
2447603|NCT02733042|8427265|P3|Follow-up Period|Other|0
2447604|NCT02733042|8427266|P2|Follow-up Period|Other|0
2447605|NCT02733042|8427267|P1|Follow-up Period|Other|0
2447606|NCT02733042|8427249|P19|Follow-up Period|Death|2
2447607|NCT02733042|8427250|P18|Follow-up Period|Death|1
2447608|NCT02733042|8427251|P17|Follow-up Period|Death|0
2447609|NCT02733042|8427252|P16|Follow-up Period|Death|4
2447610|NCT02733042|8427253|P15|Follow-up Period|Death|1
2447611|NCT02733042|8427254|P14|Follow-up Period|Death|1
2447612|NCT02733042|8427255|P13|Follow-up Period|Death|8
2447613|NCT02733042|8427256|P12|Follow-up Period|Death|0
2447614|NCT02733042|8427257|P11|Follow-up Period|Death|0
2447615|NCT02733042|8427258|P10|Follow-up Period|Death|0
2447616|NCT02733042|8427259|P9|Follow-up Period|Death|3
2447617|NCT02733042|8427260|P8|Follow-up Period|Death|3
2447618|NCT02733042|8427261|P7|Follow-up Period|Death|0
2447619|NCT02733042|8427262|P6|Follow-up Period|Death|2
2447620|NCT02733042|8427263|P5|Follow-up Period|Death|1
2447621|NCT02733042|8427264|P4|Follow-up Period|Death|0
2447622|NCT02733042|8427265|P3|Follow-up Period|Death|2
2447623|NCT02733042|8427266|P2|Follow-up Period|Death|1
2447624|NCT02733042|8427267|P1|Follow-up Period|Death|1
2447625|NCT02733042|8427249|P19|Follow-up Period|Ongoing on Follow-up|0
2447626|NCT02733042|8427250|P18|Follow-up Period|Ongoing on Follow-up|1
2447627|NCT02733042|8427251|P17|Follow-up Period|Ongoing on Follow-up|0
2447628|NCT02733042|8427252|P16|Follow-up Period|Ongoing on Follow-up|0
2447629|NCT02733042|8427253|P15|Follow-up Period|Ongoing on Follow-up|0
2447630|NCT02733042|8427254|P14|Follow-up Period|Ongoing on Follow-up|3
2447631|NCT02733042|8427255|P13|Follow-up Period|Ongoing on Follow-up|1
2447632|NCT02733042|8427256|P12|Follow-up Period|Ongoing on Follow-up|9
2447633|NCT02733042|8427257|P11|Follow-up Period|Ongoing on Follow-up|4
2447634|NCT02733042|8427258|P10|Follow-up Period|Ongoing on Follow-up|2
2447635|NCT02733042|8427259|P9|Follow-up Period|Ongoing on Follow-up|0
2447636|NCT02733042|8427260|P8|Follow-up Period|Ongoing on Follow-up|1
2447637|NCT02733042|8427261|P7|Follow-up Period|Ongoing on Follow-up|0
2447638|NCT02733042|8427262|P6|Follow-up Period|Ongoing on Follow-up|0
2447639|NCT02733042|8427263|P5|Follow-up Period|Ongoing on Follow-up|0
2447640|NCT02733042|8427264|P4|Follow-up Period|Ongoing on Follow-up|2
2447641|NCT02733042|8427265|P3|Follow-up Period|Ongoing on Follow-up|4
2447642|NCT02733042|8427266|P2|Follow-up Period|Ongoing on Follow-up|2
2447643|NCT02733042|8427267|P1|Follow-up Period|Ongoing on Follow-up|2
2447644|NCT02733042|8427249|P19|Treatment Period|Death|0
2447645|NCT02733042|8427250|P18|Treatment Period|Death|0
2447646|NCT02733042|8427251|P17|Treatment Period|Death|0
2447647|NCT02733042|8427252|P16|Treatment Period|Death|2
2447648|NCT02733042|8427253|P15|Treatment Period|Death|1
2447649|NCT02733042|8427254|P14|Treatment Period|Death|0
2447650|NCT02733042|8427255|P13|Treatment Period|Death|0
2447651|NCT02733042|8427256|P12|Treatment Period|Death|0
2447652|NCT02733042|8427257|P11|Treatment Period|Death|1
2447653|NCT02733042|8427258|P10|Treatment Period|Death|0
2447654|NCT02733042|8427259|P9|Treatment Period|Death|1
2447655|NCT02733042|8427260|P8|Treatment Period|Death|0
2447656|NCT02733042|8427261|P7|Treatment Period|Death|1
2447657|NCT02733042|8427262|P6|Treatment Period|Death|0
2447658|NCT02733042|8427263|P5|Treatment Period|Death|0
2447659|NCT02733042|8427264|P4|Treatment Period|Death|0
2447660|NCT02733042|8427265|P3|Treatment Period|Death|0
2447661|NCT02733042|8427266|P2|Treatment Period|Death|0
2447662|NCT02733042|8427267|P1|Treatment Period|Death|0
2447663|NCT02733042|8427249|P19|Treatment Period|Ongoing on Assigned Treatment|1
2447664|NCT02733042|8427250|P18|Treatment Period|Ongoing on Assigned Treatment|0
2447665|NCT02733042|8427251|P17|Treatment Period|Ongoing on Assigned Treatment|0
2447666|NCT02733042|8427252|P16|Treatment Period|Ongoing on Assigned Treatment|0
2447667|NCT02733042|8427253|P15|Treatment Period|Ongoing on Assigned Treatment|0
2447668|NCT02733042|8427254|P14|Treatment Period|Ongoing on Assigned Treatment|0
2447669|NCT02733042|8427255|P13|Treatment Period|Ongoing on Assigned Treatment|0
2447670|NCT02733042|8427256|P12|Treatment Period|Ongoing on Assigned Treatment|0
2447671|NCT02733042|8427257|P11|Treatment Period|Ongoing on Assigned Treatment|4
2447672|NCT02733042|8427258|P10|Treatment Period|Ongoing on Assigned Treatment|8
2447759|NCT02732951|8427473|P1|Overall Study|Protocol Violation|0
2447673|NCT02733042|8427259|P9|Treatment Period|Ongoing on Assigned Treatment|0
2447674|NCT02733042|8427260|P8|Treatment Period|Ongoing on Assigned Treatment|0
2447675|NCT02733042|8427261|P7|Treatment Period|Ongoing on Assigned Treatment|0
2447676|NCT02733042|8427262|P6|Treatment Period|Ongoing on Assigned Treatment|0
2447677|NCT02733042|8427263|P5|Treatment Period|Ongoing on Assigned Treatment|3
2447678|NCT02733042|8427264|P4|Treatment Period|Ongoing on Assigned Treatment|0
2447679|NCT02733042|8427265|P3|Treatment Period|Ongoing on Assigned Treatment|0
2447680|NCT02733042|8427266|P2|Treatment Period|Ongoing on Assigned Treatment|0
2447681|NCT02733042|8427267|P1|Treatment Period|Ongoing on Assigned Treatment|0
2447682|NCT02733042|8427249|P19|Treatment Period|Other|0
2447683|NCT02733042|8427250|P18|Treatment Period|Other|1
2447684|NCT02733042|8427251|P17|Treatment Period|Other|0
2447685|NCT02733042|8427252|P16|Treatment Period|Other|1
2447686|NCT02733042|8427253|P15|Treatment Period|Other|0
2447687|NCT02733042|8427254|P14|Treatment Period|Other|0
2447688|NCT02733042|8427255|P13|Treatment Period|Other|0
2447689|NCT02733042|8427256|P12|Treatment Period|Other|0
2447690|NCT02733042|8427257|P11|Treatment Period|Other|1
2447691|NCT02733042|8427258|P10|Treatment Period|Other|1
2447692|NCT02733042|8427259|P9|Treatment Period|Other|0
2447693|NCT02733042|8427260|P8|Treatment Period|Other|0
2447694|NCT02733042|8427261|P7|Treatment Period|Other|0
2447695|NCT02733042|8427262|P6|Treatment Period|Other|0
2447696|NCT02733042|8427263|P5|Treatment Period|Other|0
2447697|NCT02733042|8427264|P4|Treatment Period|Other|0
2447698|NCT02733042|8427265|P3|Treatment Period|Other|1
2447699|NCT02733042|8427266|P2|Treatment Period|Other|0
2447700|NCT02733042|8427267|P1|Treatment Period|Other|0
2447701|NCT02733042|8427249|P19|Treatment Period|Withdrawal by Subject|0
2447702|NCT02733042|8427250|P18|Treatment Period|Withdrawal by Subject|0
2447703|NCT02733042|8427251|P17|Treatment Period|Withdrawal by Subject|0
2447704|NCT02733042|8427252|P16|Treatment Period|Withdrawal by Subject|0
2447705|NCT02733042|8427253|P15|Treatment Period|Withdrawal by Subject|0
2447706|NCT02733042|8427254|P14|Treatment Period|Withdrawal by Subject|1
2447707|NCT02733042|8427255|P13|Treatment Period|Withdrawal by Subject|1
2447708|NCT02733042|8427256|P12|Treatment Period|Withdrawal by Subject|2
2447709|NCT02733042|8427257|P11|Treatment Period|Withdrawal by Subject|0
2447710|NCT02733042|8427258|P10|Treatment Period|Withdrawal by Subject|1
2447711|NCT02733042|8427259|P9|Treatment Period|Withdrawal by Subject|1
2447712|NCT02733042|8427260|P8|Treatment Period|Withdrawal by Subject|0
2447713|NCT02733042|8427261|P7|Treatment Period|Withdrawal by Subject|0
2447714|NCT02733042|8427262|P6|Treatment Period|Withdrawal by Subject|0
2447715|NCT02733042|8427263|P5|Treatment Period|Withdrawal by Subject|0
2447716|NCT02733042|8427264|P4|Treatment Period|Withdrawal by Subject|1
2447717|NCT02733042|8427265|P3|Treatment Period|Withdrawal by Subject|2
2447718|NCT02733042|8427266|P2|Treatment Period|Withdrawal by Subject|1
2447719|NCT02733042|8427267|P1|Treatment Period|Withdrawal by Subject|0
2447720|NCT02733042|8427249|P19|Treatment Period|Progressive Disease|4
2447721|NCT02733042|8427250|P18|Treatment Period|Progressive Disease|3
2447722|NCT02733042|8427251|P17|Treatment Period|Progressive Disease|2
2447723|NCT02733042|8427252|P16|Treatment Period|Progressive Disease|7
2447724|NCT02733042|8427253|P15|Treatment Period|Progressive Disease|4
2447725|NCT02733042|8427254|P14|Treatment Period|Progressive Disease|1
2447726|NCT02733042|8427255|P13|Treatment Period|Progressive Disease|8
2447727|NCT02733042|8427256|P12|Treatment Period|Progressive Disease|2
2447728|NCT02733042|8427257|P11|Treatment Period|Progressive Disease|2
2447729|NCT02733042|8427258|P10|Treatment Period|Progressive Disease|0
2447730|NCT02733042|8427259|P9|Treatment Period|Progressive Disease|3
2447731|NCT02733042|8427260|P8|Treatment Period|Progressive Disease|3
2447732|NCT02733042|8427261|P7|Treatment Period|Progressive Disease|0
2447733|NCT02733042|8427262|P6|Treatment Period|Progressive Disease|3
2447734|NCT02733042|8427263|P5|Treatment Period|Progressive Disease|1
2447735|NCT02733042|8427264|P4|Treatment Period|Progressive Disease|1
2447736|NCT02733042|8427265|P3|Treatment Period|Progressive Disease|3
2447737|NCT02733042|8427266|P2|Treatment Period|Progressive Disease|1
2447738|NCT02733042|8427267|P1|Treatment Period|Progressive Disease|2
2447739|NCT02733042|8427249|P19|Treatment Period|Adverse Event|0
2447740|NCT02733042|8427250|P18|Treatment Period|Adverse Event|1
2447741|NCT02733042|8427251|P17|Treatment Period|Adverse Event|0
2447742|NCT02733042|8427252|P16|Treatment Period|Adverse Event|0
2447743|NCT02733042|8427253|P15|Treatment Period|Adverse Event|0
2447744|NCT02733042|8427254|P14|Treatment Period|Adverse Event|2
2447745|NCT02733042|8427255|P13|Treatment Period|Adverse Event|0
2447746|NCT02733042|8427256|P12|Treatment Period|Adverse Event|2
2447747|NCT02733042|8427257|P11|Treatment Period|Adverse Event|2
2447748|NCT02733042|8427258|P10|Treatment Period|Adverse Event|0
2447749|NCT02733042|8427259|P9|Treatment Period|Adverse Event|0
2447750|NCT02733042|8427260|P8|Treatment Period|Adverse Event|0
2447751|NCT02733042|8427261|P7|Treatment Period|Adverse Event|0
2447752|NCT02733042|8427262|P6|Treatment Period|Adverse Event|0
2447753|NCT02733042|8427263|P5|Treatment Period|Adverse Event|0
2447754|NCT02733042|8427264|P4|Treatment Period|Adverse Event|1
2447755|NCT02733042|8427265|P3|Treatment Period|Adverse Event|1
2447756|NCT02733042|8427266|P2|Treatment Period|Adverse Event|0
2447757|NCT02733042|8427267|P1|Treatment Period|Adverse Event|1
2447758|NCT02732951|8427472|P2|Overall Study|Protocol Violation|1
2447760|NCT02732951|8427472|P2|Overall Study|Adverse Event|4
2447761|NCT02732951|8427473|P1|Overall Study|Adverse Event|4
2447762|NCT02732951|8427472|P2|Overall Study|Lost to Follow-up|1
2447763|NCT02732951|8427473|P1|Overall Study|Lost to Follow-up|0
2447764|NCT02732951|8427472|P2|Overall Study|Other than listed|0
2447765|NCT02732951|8427473|P1|Overall Study|Other than listed|1
2447766|NCT02732938|8427483|P3|Overall Study|Study terminated by sponsor|0
2447767|NCT02732938|8427484|P2|Overall Study|Study terminated by sponsor|6
2447768|NCT02732938|8427485|P1|Overall Study|Study terminated by sponsor|3
2447769|NCT02732938|8427483|P3|Overall Study|Refused further follow-up|0
2447770|NCT02732938|8427484|P2|Overall Study|Refused further follow-up|0
2447771|NCT02732938|8427485|P1|Overall Study|Refused further follow-up|1
2447772|NCT02732938|8427483|P3|Overall Study|Randomized but did not receive treatment|0
2447773|NCT02732938|8427484|P2|Overall Study|Randomized but did not receive treatment|1
2447774|NCT02732938|8427485|P1|Overall Study|Randomized but did not receive treatment|0
2447775|NCT02732938|8427483|P3|Overall Study|Death|0
2447776|NCT02732938|8427484|P2|Overall Study|Death|11
2447777|NCT02732938|8427485|P1|Overall Study|Death|0
2447778|NCT02732912|8427531|P2|Overall Study|No outcome; discharged or refused|9
2447779|NCT02732912|8427532|P1|Overall Study|No outcome; discharged or refused|6
2447780|NCT02732912|8427531|P2|Overall Study|Incomplete completion of questionnaire|3
2447781|NCT02732912|8427532|P1|Overall Study|Incomplete completion of questionnaire|2
2447782|NCT02732912|8427531|P2|Overall Study|Discharged before night|6
2447783|NCT02732912|8427532|P1|Overall Study|Discharged before night|2
2447784|NCT02732639|8427557|P1|Overall Study|Lost to Follow-up|1
2447785|NCT02732561|8427574|P2|Overall Study|Withdrawal by Subject|0
2447786|NCT02732561|8427575|P1|Overall Study|Withdrawal by Subject|1
2447787|NCT02732561|8427574|P2|Overall Study|Lost to Follow-up|1
2447788|NCT02732561|8427575|P1|Overall Study|Lost to Follow-up|1
2447789|NCT02732327|8427585|P2|Overall Study|Protocol Violation|1
2447790|NCT02732327|8427586|P1|Overall Study|Protocol Violation|0
2447791|NCT02732210|8427594|P2|Overall Study|Missing|8
2447792|NCT02732210|8427595|P1|Overall Study|Missing|0
2447793|NCT02732210|8427594|P2|Overall Study|Other|103
2447794|NCT02732210|8427595|P1|Overall Study|Other|35
2447795|NCT02732210|8427594|P2|Overall Study|Death|15
2447796|NCT02732210|8427595|P1|Overall Study|Death|4
2447797|NCT02732210|8427594|P2|Overall Study|Lost to Follow-up|57
2447798|NCT02732210|8427595|P1|Overall Study|Lost to Follow-up|5
2447799|NCT02732210|8427594|P2|Overall Study|Withdrawal by Subject|87
2447800|NCT02732210|8427595|P1|Overall Study|Withdrawal by Subject|28
2447801|NCT02732210|8427594|P2|Overall Study|Study Ended|13
2447802|NCT02732210|8427595|P1|Overall Study|Study Ended|13
2447803|NCT02732210|8427594|P2|Overall Study|Site Closed|11
2447804|NCT02732210|8427595|P1|Overall Study|Site Closed|0
2447805|NCT02731755|8427774|P2|First Intervention|Withdrawal by Subject|2
2447806|NCT02731755|8427775|P1|First Intervention|Withdrawal by Subject|0
2447807|NCT02731742|8427799|P4|Overall Study|Study Terminated by Sponsor|1
2447808|NCT02731742|8427800|P3|Overall Study|Study Terminated by Sponsor|1
2447809|NCT02731742|8427801|P2|Overall Study|Study Terminated by Sponsor|1
2447810|NCT02731742|8427802|P1|Overall Study|Study Terminated by Sponsor|2
2447811|NCT02731742|8427799|P4|Overall Study|Physician Decision|1
2447812|NCT02731742|8427800|P3|Overall Study|Physician Decision|0
2447813|NCT02731742|8427801|P2|Overall Study|Physician Decision|0
2447814|NCT02731742|8427802|P1|Overall Study|Physician Decision|0
2447815|NCT02731742|8427799|P4|Overall Study|Death|0
2447816|NCT02731742|8427800|P3|Overall Study|Death|5
2447817|NCT02731742|8427801|P2|Overall Study|Death|2
2447818|NCT02731742|8427802|P1|Overall Study|Death|1
2447819|NCT02731690|8427820|P1|Overall Study|Discontinuation of Study by Sponsor|26
2447820|NCT02731690|8427820|P1|Overall Study|Withdrawal by Subject|3
2447821|NCT02731690|8427820|P1|Overall Study|Adverse Event|1
2447822|NCT02731638|8427840|P2|Overall Study|Lost to Follow-up|9
2447823|NCT02731638|8427841|P1|Overall Study|Lost to Follow-up|6
2447824|NCT02731157|8428084|P1|First Rejuvenated RCE|Withdrawal by Subject|1
2447825|NCT02731131|8428102|P2|Overall Study|Refused Therapy|1
2447826|NCT02731131|8428103|P1|Overall Study|Refused Therapy|0
2447827|NCT02731131|8428102|P2|Overall Study|Psychiatric Disorder|1
2447828|NCT02731131|8428103|P1|Overall Study|Psychiatric Disorder|0
2447829|NCT02730871|8428132|P2|Overall Study|Adverse Event|0
2447830|NCT02730871|8428133|P1|Overall Study|Adverse Event|6
2447831|NCT02730819|8428147|P1|Overall Study|Lost to Follow-up|9
2447832|NCT02730728|8428156|P3|Overall Study|Lack of Efficacy|1
2447833|NCT02730728|8428157|P2|Overall Study|Lack of Efficacy|1
2447834|NCT02730728|8428158|P1|Overall Study|Lack of Efficacy|0
2447835|NCT02730728|8428156|P3|Overall Study|Withdrawal by Subject|0
2447836|NCT02730728|8428157|P2|Overall Study|Withdrawal by Subject|1
2447837|NCT02730728|8428158|P1|Overall Study|Withdrawal by Subject|0
2447838|NCT02730598|8428187|P2|Overall Study|Unrelated Injury affecting outcomes.|0
2447839|NCT02730598|8428188|P1|Overall Study|Unrelated Injury affecting outcomes.|1
2447840|NCT02730598|8428187|P2|Overall Study|Protocol Violation|1
2447841|NCT02730598|8428188|P1|Overall Study|Protocol Violation|0
2447842|NCT02730598|8428187|P2|Overall Study|Withdrawal by Subject|3
2447843|NCT02730598|8428188|P1|Overall Study|Withdrawal by Subject|3
2447844|NCT02730455|8428211|P3|Overall Study|Other|0
2447845|NCT02730455|8428212|P2|Overall Study|Other|2
2447846|NCT02730455|8428213|P1|Overall Study|Other|2
2447847|NCT02730455|8428211|P3|Overall Study|Other|2
2447848|NCT02730455|8428212|P2|Overall Study|Other|1
2447849|NCT02730455|8428213|P1|Overall Study|Other|1
2447850|NCT02730455|8428211|P3|Overall Study|Lost to Follow-up|4
2447851|NCT02730455|8428212|P2|Overall Study|Lost to Follow-up|1
2447852|NCT02730455|8428213|P1|Overall Study|Lost to Follow-up|3
2447853|NCT02730455|8428211|P3|Overall Study|Consent withdrawn|1
2447854|NCT02730455|8428212|P2|Overall Study|Consent withdrawn|4
2447855|NCT02730455|8428213|P1|Overall Study|Consent withdrawn|2
2447856|NCT02730455|8428211|P3|Overall Study|Death|4
2447857|NCT02730455|8428212|P2|Overall Study|Death|6
2447858|NCT02730455|8428213|P1|Overall Study|Death|5
2447859|NCT02730351|8428261|P2|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0
2447860|NCT02730351|8428262|P1|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1
2447861|NCT02730351|8428261|P2|Treatment Period 2 (2 Weeks)|Adverse Event|0
2447862|NCT02730351|8428262|P1|Treatment Period 2 (2 Weeks)|Adverse Event|1
2447863|NCT02730351|8428261|P2|Wash-out Period (2 Weeks)|Withdrawal by Subject|0
2447864|NCT02730351|8428262|P1|Wash-out Period (2 Weeks)|Withdrawal by Subject|1
2447865|NCT02730351|8428261|P2|Wash-out Period (2 Weeks)|Protocol Violation|1
2447866|NCT02730351|8428262|P1|Wash-out Period (2 Weeks)|Protocol Violation|0
2447867|NCT02730351|8428261|P2|Treatment Period 1 (2 Weeks)|Adverse Event|0
2447868|NCT02730351|8428262|P1|Treatment Period 1 (2 Weeks)|Adverse Event|1
2447869|NCT02730208|8428285|P2|Overall Study|Withdrawal of consent (not due to AE)|1
2447870|NCT02730208|8428286|P1|Overall Study|Withdrawal of consent (not due to AE)|0
2447871|NCT02730195|8428294|P1|Overall Study|Withdrawal by Subject|1
2447872|NCT02729909|8428308|P2|Overall Study|Voluntary Withdrawal|0
2447873|NCT02729909|8428309|P1|Overall Study|Voluntary Withdrawal|1
2447874|NCT02729909|8428308|P2|Overall Study|Significant Protocol Deviation|2
2447875|NCT02729909|8428309|P1|Overall Study|Significant Protocol Deviation|0
2447876|NCT02729909|8428308|P2|Overall Study|Lack of Efficacy|2
2447877|NCT02729909|8428309|P1|Overall Study|Lack of Efficacy|0
2447878|NCT02729909|8428308|P2|Overall Study|Lost to Follow-up|1
2447879|NCT02729909|8428309|P1|Overall Study|Lost to Follow-up|0
2447880|NCT02729896|8428328|P3|Overall Study|Progressive Disease|1
2447881|NCT02729896|8428329|P2|Overall Study|Progressive Disease|0
2447882|NCT02729896|8428330|P1|Overall Study|Progressive Disease|0
2447883|NCT02729896|8428328|P3|Overall Study|Physician Decision|5
2447884|NCT02729896|8428329|P2|Overall Study|Physician Decision|0
2447885|NCT02729896|8428330|P1|Overall Study|Physician Decision|0
2447886|NCT02729896|8428328|P3|Overall Study|Death|10
2447887|NCT02729896|8428329|P2|Overall Study|Death|2
2447888|NCT02729896|8428330|P1|Overall Study|Death|0
2447889|NCT02729831|8428351|P4|6 Month Follow-up|Death|1
2447890|NCT02729831|8428352|P3|6 Month Follow-up|Death|0
2447891|NCT02729831|8428353|P2|6 Month Follow-up|Death|3
2447892|NCT02729831|8428354|P1|6 Month Follow-up|Death|1
2447893|NCT02729831|8428351|P4|6 Month Follow-up|Lost to Follow-up|42
2447894|NCT02729831|8428352|P3|6 Month Follow-up|Lost to Follow-up|48
2447895|NCT02729831|8428353|P2|6 Month Follow-up|Lost to Follow-up|51
2447896|NCT02729831|8428354|P1|6 Month Follow-up|Lost to Follow-up|54
2447897|NCT02729831|8428351|P4|1 Week Post-visit|Lost to Follow-up|36
2447898|NCT02729831|8428352|P3|1 Week Post-visit|Lost to Follow-up|38
2447899|NCT02729831|8428353|P2|1 Week Post-visit|Lost to Follow-up|40
2447900|NCT02729831|8428354|P1|1 Week Post-visit|Lost to Follow-up|43
2447901|NCT02729831|8428351|P4|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17
2447902|NCT02729831|8428352|P3|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18
2447903|NCT02729831|8428353|P2|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23
2447904|NCT02729831|8428354|P1|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38
2447905|NCT02729753|8428382|P2|Overall Study|Device Malfunction. No units in stock.|1
2447906|NCT02729753|8428383|P1|Overall Study|Device Malfunction. No units in stock.|0
2447907|NCT02729545|8428397|P2|Overall Study|Withdrawal by Subject|3
2447908|NCT02729545|8428398|P1|Overall Study|Withdrawal by Subject|2
2447909|NCT02729545|8428397|P2|Overall Study|Lost to Follow-up|1
2447910|NCT02729545|8428398|P1|Overall Study|Lost to Follow-up|0
2447911|NCT02729545|8428397|P2|Overall Study|Pregnancy|1
2447912|NCT02729545|8428398|P1|Overall Study|Pregnancy|1
2447913|NCT02729194|8428420|P1|Overall Study|Withdrawal by Subject|3
2447914|NCT02729051|8428432|P2|Overall Study|Withdrawal by Subject|17
2447915|NCT02729051|8428433|P1|Overall Study|Withdrawal by Subject|6
2447916|NCT02729051|8428432|P2|Overall Study|Physician Decision|1
2447917|NCT02729051|8428433|P1|Overall Study|Physician Decision|1
2447918|NCT02729051|8428432|P2|Overall Study|Lost to Follow-up|2
2447919|NCT02729051|8428433|P1|Overall Study|Lost to Follow-up|1
2447920|NCT02729051|8428432|P2|Overall Study|Lack of Efficacy|1
2447921|NCT02729051|8428433|P1|Overall Study|Lack of Efficacy|1
2447922|NCT02729051|8428432|P2|Overall Study|Adverse Event|11
2447923|NCT02729051|8428433|P1|Overall Study|Adverse Event|21
2447924|NCT02729025|8428577|P2|Overall Study|Sponsor Decision|1
2447925|NCT02729025|8428578|P1|Overall Study|Sponsor Decision|0
2447926|NCT02728895|8428592|P2|Overall Study|Withdrawal by Subject|3
2447927|NCT02728895|8428593|P1|Overall Study|Withdrawal by Subject|0
2447928|NCT02728895|8428592|P2|Overall Study|Other|2
2447929|NCT02728895|8428593|P1|Overall Study|Other|1
2447930|NCT02728206|8428621|P1|Overall Study|Death|1
2447931|NCT02728089|8428629|P1|Overall Study|Withdrawal by Subject|1
2447932|NCT02728089|8428629|P1|Overall Study|Physician Decision|2
2447933|NCT02727777|8428717|P3|Overall Study|Progressive disease|0
2447934|NCT02727777|8428718|P2|Overall Study|Progressive disease|0
2447935|NCT02727777|8428719|P1|Overall Study|Progressive disease|2
2447936|NCT02727777|8428717|P3|Overall Study|Screen Failure|0
2447937|NCT02727777|8428718|P2|Overall Study|Screen Failure|0
2447938|NCT02727777|8428719|P1|Overall Study|Screen Failure|2
2447939|NCT02727660|8428740|P3|Overall Study|Administrative Reasons|4
2447940|NCT02727660|8428741|P2|Overall Study|Administrative Reasons|3
2447941|NCT02727660|8428742|P1|Overall Study|Administrative Reasons|2
2447942|NCT02727660|8428740|P3|Overall Study|Protocol Specified Disc. Criteria|2
2447943|NCT02727660|8428741|P2|Overall Study|Protocol Specified Disc. Criteria|5
2447944|NCT02727660|8428742|P1|Overall Study|Protocol Specified Disc. Criteria|5
2447945|NCT02727660|8428740|P3|Overall Study|Protocol Violation|5
2447946|NCT02727660|8428741|P2|Overall Study|Protocol Violation|5
2447947|NCT02727660|8428742|P1|Overall Study|Protocol Violation|7
2447948|NCT02727660|8428740|P3|Overall Study|Lost to Follow-up|8
2447949|NCT02727660|8428741|P2|Overall Study|Lost to Follow-up|9
2447950|NCT02727660|8428742|P1|Overall Study|Lost to Follow-up|5
2447951|NCT02727660|8428740|P3|Overall Study|Physician Decision|14
2447952|NCT02727660|8428741|P2|Overall Study|Physician Decision|8
2447953|NCT02727660|8428742|P1|Overall Study|Physician Decision|3
2447954|NCT02727660|8428740|P3|Overall Study|Withdrawal by Subject|30
2447955|NCT02727660|8428741|P2|Overall Study|Withdrawal by Subject|25
2447956|NCT02727660|8428742|P1|Overall Study|Withdrawal by Subject|26
2447957|NCT02727660|8428740|P3|Overall Study|Adverse Event|32
2447958|NCT02727660|8428741|P2|Overall Study|Adverse Event|21
2447959|NCT02727660|8428742|P1|Overall Study|Adverse Event|28
2447960|NCT02727660|8428740|P3|Overall Study|Lack of Efficacy|70
2447961|NCT02727660|8428741|P2|Overall Study|Lack of Efficacy|40
2447962|NCT02727660|8428742|P1|Overall Study|Lack of Efficacy|40
2447963|NCT02727322|8428761|P2|Overall Study|Protocol Violation|0
2447964|NCT02727322|8428762|P1|Overall Study|Protocol Violation|1
2447965|NCT02727322|8428761|P2|Overall Study|Withdrawal by Subject|1
2447966|NCT02727322|8428762|P1|Overall Study|Withdrawal by Subject|1
2447967|NCT02726945|8428788|P3|Overall Study|Elected to have total knee replacement|0
2447968|NCT02726945|8428789|P2|Overall Study|Elected to have total knee replacement|1
2447969|NCT02726945|8428790|P1|Overall Study|Elected to have total knee replacement|0
2447970|NCT02726945|8428788|P3|Overall Study|Withdrawal by Subject|1
2447971|NCT02726945|8428789|P2|Overall Study|Withdrawal by Subject|0
2447972|NCT02726945|8428790|P1|Overall Study|Withdrawal by Subject|0
2447973|NCT02726399|8428907|P1|Overall Study|Progression of disease|4
2447974|NCT02726399|8428907|P1|Overall Study|Adverse Event|2
2447975|NCT02726399|8428907|P1|Overall Study|Participant Non-Compliance|1
2447976|NCT02726113|8428924|P2|Genomic Analysis|Insurance non-coverage for surgery|1
2447977|NCT02726113|8428925|P1|Genomic Analysis|Insurance non-coverage for surgery|1
2447978|NCT02726113|8428924|P2|Genomic Analysis|Withdrawal by Subject|1
2447979|NCT02726113|8428925|P1|Genomic Analysis|Withdrawal by Subject|2
2447980|NCT02726113|8428924|P2|Genomic Analysis|Protocol Violation|0
2447981|NCT02726113|8428925|P1|Genomic Analysis|Protocol Violation|1
2447982|NCT02726113|8428924|P2|Total Enrollment|Insurance non-coverage for surgery|1
2447983|NCT02726113|8428925|P1|Total Enrollment|Insurance non-coverage for surgery|1
2447984|NCT02726113|8428924|P2|Total Enrollment|Withdrawal by Subject|1
2447985|NCT02726113|8428925|P1|Total Enrollment|Withdrawal by Subject|2
2447986|NCT02726113|8428924|P2|Total Enrollment|Protocol Violation|0
2447987|NCT02726113|8428925|P1|Total Enrollment|Protocol Violation|1
2447988|NCT02726113|8428924|P2|Total Enrollment|Physician Decision|1
2447989|NCT02726113|8428925|P1|Total Enrollment|Physician Decision|0
2447990|NCT02726074|8428932|P1|Overall Study|Others|3
2447991|NCT02726074|8428932|P1|Overall Study|Lost to Follow-up|2
2447992|NCT02726074|8428932|P1|Overall Study|Protocol Violation|3
2447993|NCT02726074|8428932|P1|Overall Study|Adverse Event|14
2447994|NCT02726074|8428932|P1|Overall Study|Withdrawal by Subject|4
2447995|NCT02726022|8428944|P1|Overall Study|Treatment Failure and Poor Compliance|1
2447996|NCT02726022|8428944|P1|Overall Study|Poor Compliance|13
2447997|NCT02726022|8428944|P1|Overall Study|Treatment Failure|8
2447998|NCT02726022|8428944|P1|Overall Study|Adverse Event|14
2447999|NCT02725866|8428953|P1|Overall Study|Other, not specified|4
2448000|NCT02725866|8428953|P1|Overall Study|Insufficient virological response|1
2448001|NCT02725866|8428953|P1|Overall Study|Withdrew consent|3
2448002|NCT02725866|8428953|P1|Overall Study|Failure to return|6
2448003|NCT02725788|8428966|P2|Overall Study|Protocol Violation|1
2448004|NCT02725788|8428967|P1|Overall Study|Protocol Violation|0
2448005|NCT02725788|8428966|P2|Overall Study|Lost to Follow-up|1
2448006|NCT02725788|8428967|P1|Overall Study|Lost to Follow-up|1
2448007|NCT02725710|8428975|P2|Overall Study|Lost to Follow-up|0
2448008|NCT02725710|8428976|P1|Overall Study|Lost to Follow-up|1
2448009|NCT02725671|8429004|P1|Overall Study|Lost to Follow-up|1
2448010|NCT02725515|8429014|P2|Overall Study|Lack of Response|1
2448011|NCT02725515|8429015|P1|Overall Study|Lack of Response|0
2448012|NCT02725515|8429014|P2|Overall Study|Completed Study Under Original Protocol|1
2448013|NCT02725515|8429015|P1|Overall Study|Completed Study Under Original Protocol|0
2448014|NCT02725515|8429014|P2|Overall Study|No Documented Disease Improvement|1
2448015|NCT02725515|8429015|P1|Overall Study|No Documented Disease Improvement|0
2448016|NCT02725515|8429014|P2|Overall Study|Adverse Event|2
2448017|NCT02725515|8429015|P1|Overall Study|Adverse Event|7
2448018|NCT02725515|8429014|P2|Overall Study|Lost to Follow-up|1
2448019|NCT02725515|8429015|P1|Overall Study|Lost to Follow-up|1
2448020|NCT02725515|8429014|P2|Overall Study|Non-Compliance With Study Drug|3
2448021|NCT02725515|8429015|P1|Overall Study|Non-Compliance With Study Drug|0
2448022|NCT02725515|8429014|P2|Overall Study|Withdrawal by Subject|1
2448023|NCT02725515|8429015|P1|Overall Study|Withdrawal by Subject|2
2448024|NCT02725515|8429014|P2|Overall Study|Loss of Improvement per Protocol|25
2448025|NCT02725515|8429015|P1|Overall Study|Loss of Improvement per Protocol|14
2448026|NCT02725515|8429014|P2|Overall Study|Refused infusion (no study treatment)|0
2448027|NCT02725515|8429015|P1|Overall Study|Refused infusion (no study treatment)|1
2448028|NCT02725476|8429027|P2|Overall Study|Adverse Event|1
2448029|NCT02725476|8429028|P1|Overall Study|Adverse Event|1
2448030|NCT02725476|8429027|P2|Overall Study|Physician Decision|0
2448031|NCT02725476|8429028|P1|Overall Study|Physician Decision|2
2448032|NCT02725008|8429038|P2|Overall Study|Admitted to hospital|1
2448033|NCT02725008|8429039|P1|Overall Study|Admitted to hospital|0
2448034|NCT02725008|8429038|P2|Overall Study|Withdrawal by Subject|2
2448035|NCT02725008|8429039|P1|Overall Study|Withdrawal by Subject|2
2448036|NCT02725008|8429038|P2|Overall Study|Lost to Follow-up|9
2448037|NCT02725008|8429039|P1|Overall Study|Lost to Follow-up|7
2448038|NCT02724644|8429057|P2|Overall Study|Administrative|0
2448039|NCT02724644|8429058|P1|Overall Study|Administrative|1
2448040|NCT02724644|8429057|P2|Overall Study|Withdrawal by Subject|1
2448041|NCT02724644|8429058|P1|Overall Study|Withdrawal by Subject|7
2448042|NCT02724644|8429057|P2|Overall Study|Lost to Follow-up|2
2448043|NCT02724644|8429058|P1|Overall Study|Lost to Follow-up|6
2448044|NCT02724644|8429057|P2|Overall Study|Adverse Event|1
2448045|NCT02724644|8429058|P1|Overall Study|Adverse Event|7
2448046|NCT02724111|8429092|P2|Overall Study|Protocol Violation|5
2448047|NCT02724111|8429093|P1|Overall Study|Protocol Violation|2
2448048|NCT02723786|8429113|P1|Overall Study|Lost to Follow-up|1
2448049|NCT02723630|8429141|P6|Intervention Period 3|consumption of restricted item|0
2448050|NCT02723630|8429142|P5|Intervention Period 3|consumption of restricted item|0
2448051|NCT02723630|8429143|P4|Intervention Period 3|consumption of restricted item|0
2448052|NCT02723630|8429144|P3|Intervention Period 3|consumption of restricted item|0
2448053|NCT02723630|8429145|P2|Intervention Period 3|consumption of restricted item|1
2448054|NCT02723630|8429146|P1|Intervention Period 3|consumption of restricted item|0
2448055|NCT02723630|8429141|P6|Intervention Period 1|Adverse Event|0
2448056|NCT02723630|8429142|P5|Intervention Period 1|Adverse Event|0
2448057|NCT02723630|8429143|P4|Intervention Period 1|Adverse Event|0
2448058|NCT02723630|8429144|P3|Intervention Period 1|Adverse Event|0
2448059|NCT02723630|8429145|P2|Intervention Period 1|Adverse Event|0
2448060|NCT02723630|8429146|P1|Intervention Period 1|Adverse Event|1
2448061|NCT02723201|8429178|P3|Second Intervention Period|Adverse Event|0
2448062|NCT02723201|8429179|P2|Second Intervention Period|Adverse Event|0
2448063|NCT02723201|8429180|P1|Second Intervention Period|Adverse Event|1
2448064|NCT02723201|8429178|P3|Second Intervention Period|Protocol Violation|0
2448065|NCT02723201|8429179|P2|Second Intervention Period|Protocol Violation|0
2448066|NCT02723201|8429180|P1|Second Intervention Period|Protocol Violation|1
2448067|NCT02723188|8429239|P3|Overall Study|Withdrawal by Subject|0
2448068|NCT02723188|8429240|P2|Overall Study|Withdrawal by Subject|0
2448069|NCT02723188|8429241|P1|Overall Study|Withdrawal by Subject|1
2448070|NCT02723175|8429254|P2|Overall Study|Lost to 3 Month Follow Up|1
2448071|NCT02723175|8429255|P1|Overall Study|Lost to 3 Month Follow Up|1
2448072|NCT02723175|8429254|P2|Overall Study|Lost to 1 Month Follow Up|2
2448073|NCT02723175|8429255|P1|Overall Study|Lost to 1 Month Follow Up|3
2448074|NCT02723084|8429297|P2|Overall Study|Lost to Follow-up|0
2448075|NCT02723084|8429298|P1|Overall Study|Lost to Follow-up|3
2448076|NCT02723084|8429297|P2|Overall Study|Withdrawal by Subject|1
2448077|NCT02723084|8429298|P1|Overall Study|Withdrawal by Subject|1
2448078|NCT02722967|8429312|P3|Overall Study|Non-adherence of the patch to the skin|2
2448079|NCT02722967|8429313|P2|Overall Study|Non-adherence of the patch to the skin|0
2448080|NCT02722967|8429314|P1|Overall Study|Non-adherence of the patch to the skin|0
2448081|NCT02722967|8429312|P3|Overall Study|Physician Decision|0
2448082|NCT02722967|8429313|P2|Overall Study|Physician Decision|0
2448083|NCT02722967|8429314|P1|Overall Study|Physician Decision|1
2448084|NCT02722967|8429312|P3|Overall Study|Withdrawal by Subject|1
2448085|NCT02722967|8429313|P2|Overall Study|Withdrawal by Subject|0
2448086|NCT02722967|8429314|P1|Overall Study|Withdrawal by Subject|1
2448087|NCT02722967|8429312|P3|Overall Study|Non-compliance with patch wearing|1
2448088|NCT02722967|8429313|P2|Overall Study|Non-compliance with patch wearing|1
2448089|NCT02722967|8429314|P1|Overall Study|Non-compliance with patch wearing|2
2448090|NCT02722967|8429312|P3|Overall Study|Lost to Follow-up|0
2448091|NCT02722967|8429313|P2|Overall Study|Lost to Follow-up|1
2448092|NCT02722967|8429314|P1|Overall Study|Lost to Follow-up|0
2448093|NCT02722967|8429312|P3|Overall Study|Adverse Event|0
2448094|NCT02722967|8429313|P2|Overall Study|Adverse Event|0
2448095|NCT02722967|8429314|P1|Overall Study|Adverse Event|1
2448096|NCT02722928|8429324|P2|Overall Study|Required Intraoperative MRI|7
2448097|NCT02722928|8429325|P1|Overall Study|Required Intraoperative MRI|5
2448098|NCT02722928|8429324|P2|Overall Study|Standard CT was not as required per prot|13
2448099|NCT02722928|8429325|P1|Overall Study|Standard CT was not as required per prot|5
2448100|NCT02722304|8429401|P5|Overall Study|Other|1
2448101|NCT02722304|8429402|P4|Overall Study|Other|1
2448102|NCT02722304|8429403|P3|Overall Study|Other|0
2448103|NCT02722304|8429404|P2|Overall Study|Other|0
2448104|NCT02722304|8429405|P1|Overall Study|Other|0
2448105|NCT02722304|8429401|P5|Overall Study|Study Terminated by Sponsor|1
2448106|NCT02722304|8429402|P4|Overall Study|Study Terminated by Sponsor|1
2448107|NCT02722304|8429403|P3|Overall Study|Study Terminated by Sponsor|2
2448108|NCT02722304|8429404|P2|Overall Study|Study Terminated by Sponsor|0
2448109|NCT02722304|8429405|P1|Overall Study|Study Terminated by Sponsor|1
2448110|NCT02722278|8429457|P2|Overall Study|Site closure not study related|1
2448111|NCT02722278|8429458|P1|Overall Study|Site closure not study related|0
2448112|NCT02722278|8429457|P2|Overall Study|Subject declined after tx assignment|1
2448113|NCT02722278|8429458|P1|Overall Study|Subject declined after tx assignment|0
2448114|NCT02722278|8429457|P2|Overall Study|High PSA pre-study/ not eligible|1
2448115|NCT02722278|8429458|P1|Overall Study|High PSA pre-study/ not eligible|0
2448116|NCT02722278|8429457|P2|Overall Study|Protocol Violation|0
2448117|NCT02722278|8429458|P1|Overall Study|Protocol Violation|1
2448118|NCT02722278|8429457|P2|Overall Study|Lost to Follow-up|0
2448119|NCT02722278|8429458|P1|Overall Study|Lost to Follow-up|2
2448120|NCT02722278|8429457|P2|Overall Study|Adverse Event|1
2448121|NCT02722278|8429458|P1|Overall Study|Adverse Event|4
2448122|NCT02722278|8429457|P2|Overall Study|Withdrawal by Subject|3
2448123|NCT02722278|8429458|P1|Overall Study|Withdrawal by Subject|5
2448124|NCT02722148|8429482|P1|Overall Study|Non compliant with treatment regimen|3
2448125|NCT02722148|8429482|P1|Overall Study|Lost to Follow-up|2
2448126|NCT02722044|8429489|P1|Overall Study|Did Not Meet Criteria at Week 14|1
2448127|NCT02722044|8429489|P1|Overall Study|Withdrawal by Subject|1
2448128|NCT02722044|8429489|P1|Overall Study|Physician Decision|1
2448129|NCT02722044|8429489|P1|Overall Study|Adverse Event|2
2448130|NCT02721875|8429518|P2|Overall Study|Progressive disease/relapse|0
2448131|NCT02721875|8429519|P1|Overall Study|Progressive disease/relapse|1
2448132|NCT02721147|8429570|P3|Overall Study|Lost to Follow-up|0
2448133|NCT02721147|8429571|P2|Overall Study|Lost to Follow-up|0
2448134|NCT02721147|8429572|P1|Overall Study|Lost to Follow-up|2
2448135|NCT02720757|8429616|P1|Overall Study|General exclusion|3
2448136|NCT02720757|8429616|P1|Overall Study|Missing|3
2448137|NCT02720757|8429616|P1|Overall Study|Patients wish to withdraw|2
2448138|NCT02720757|8429616|P1|Overall Study|Informed consent withdrawal|1
2448139|NCT02720757|8429616|P1|Overall Study|Loss of contact|4
2448140|NCT02720757|8429616|P1|Overall Study|Other reason|5
2448141|NCT02720536|8429625|P1|Overall Study|PR- unwilling to comply with procedures|1
2448142|NCT02720536|8429625|P1|Overall Study|PR - abnormal lab value(s)|1
2448143|NCT02720536|8429625|P1|Overall Study|PR - adverse event|1
2448144|NCT02720536|8429625|P1|Overall Study|PR - death|1
2448145|NCT02720536|8429625|P1|Overall Study|PR - unsatisfactory therapeutic effect|2
2448146|NCT02720536|8429625|P1|Overall Study|PR - pregnancy|2
2448147|NCT02720536|8429625|P1|Overall Study|Primary reason (PR) - subject withdrawal|11
2448148|NCT02720523|8429660|P7|Period 2: Long-term Extension Period|Other|3
2448149|NCT02720523|8429661|P6|Period 2: Long-term Extension Period|Other|0
2448150|NCT02720523|8429662|P5|Period 2: Long-term Extension Period|Other|2
2448151|NCT02720523|8429663|P4|Period 2: Long-term Extension Period|Other|0
2448152|NCT02720523|8429664|P3|Period 2: Long-term Extension Period|Other|0
2448153|NCT02720523|8429665|P2|Period 2: Long-term Extension Period|Other|0
2448154|NCT02720523|8429666|P1|Period 2: Long-term Extension Period|Other|0
2448155|NCT02720523|8429660|P7|Period 2: Long-term Extension Period|Withdrawal by Subject|1
2448156|NCT02720523|8429661|P6|Period 2: Long-term Extension Period|Withdrawal by Subject|1
2448157|NCT02720523|8429662|P5|Period 2: Long-term Extension Period|Withdrawal by Subject|2
2448158|NCT02720523|8429663|P4|Period 2: Long-term Extension Period|Withdrawal by Subject|0
2448159|NCT02720523|8429664|P3|Period 2: Long-term Extension Period|Withdrawal by Subject|0
2448160|NCT02720523|8429665|P2|Period 2: Long-term Extension Period|Withdrawal by Subject|0
2448161|NCT02720523|8429666|P1|Period 2: Long-term Extension Period|Withdrawal by Subject|0
2448162|NCT02720523|8429660|P7|Period 2: Long-term Extension Period|Adverse Event|11
2448163|NCT02720523|8429661|P6|Period 2: Long-term Extension Period|Adverse Event|7
2448164|NCT02720523|8429662|P5|Period 2: Long-term Extension Period|Adverse Event|4
2448165|NCT02720523|8429663|P4|Period 2: Long-term Extension Period|Adverse Event|0
2448166|NCT02720523|8429664|P3|Period 2: Long-term Extension Period|Adverse Event|0
2448167|NCT02720523|8429665|P2|Period 2: Long-term Extension Period|Adverse Event|0
2448168|NCT02720523|8429666|P1|Period 2: Long-term Extension Period|Adverse Event|0
2448169|NCT02720523|8429660|P7|Period 2: Long-term Extension Period|Ongoing|45
2448170|NCT02720523|8429661|P6|Period 2: Long-term Extension Period|Ongoing|54
2448171|NCT02720523|8429662|P5|Period 2: Long-term Extension Period|Ongoing|57
2448172|NCT02720523|8429663|P4|Period 2: Long-term Extension Period|Ongoing|0
2448173|NCT02720523|8429664|P3|Period 2: Long-term Extension Period|Ongoing|0
2448174|NCT02720523|8429665|P2|Period 2: Long-term Extension Period|Ongoing|0
2448175|NCT02720523|8429666|P1|Period 2: Long-term Extension Period|Ongoing|0
2448176|NCT02720523|8429660|P7|Period 1: Placebo-controlled Period|Other|0
2448177|NCT02720523|8429661|P6|Period 1: Placebo-controlled Period|Other|0
2448178|NCT02720523|8429662|P5|Period 1: Placebo-controlled Period|Other|0
2448179|NCT02720523|8429663|P4|Period 1: Placebo-controlled Period|Other|1
2448180|NCT02720523|8429664|P3|Period 1: Placebo-controlled Period|Other|1
2448181|NCT02720523|8429665|P2|Period 1: Placebo-controlled Period|Other|0
2448182|NCT02720523|8429666|P1|Period 1: Placebo-controlled Period|Other|0
2448183|NCT02720523|8429660|P7|Period 1: Placebo-controlled Period|Lack of Efficacy|0
2448184|NCT02720523|8429661|P6|Period 1: Placebo-controlled Period|Lack of Efficacy|0
2448185|NCT02720523|8429662|P5|Period 1: Placebo-controlled Period|Lack of Efficacy|0
2448186|NCT02720523|8429663|P4|Period 1: Placebo-controlled Period|Lack of Efficacy|0
2448187|NCT02720523|8429664|P3|Period 1: Placebo-controlled Period|Lack of Efficacy|0
2448188|NCT02720523|8429665|P2|Period 1: Placebo-controlled Period|Lack of Efficacy|0
2448189|NCT02720523|8429666|P1|Period 1: Placebo-controlled Period|Lack of Efficacy|1
2448190|NCT02720523|8429660|P7|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
2448191|NCT02720523|8429661|P6|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
2448192|NCT02720523|8429662|P5|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
2448193|NCT02720523|8429663|P4|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
2448194|NCT02720523|8429664|P3|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
2448195|NCT02720523|8429665|P2|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
2448196|NCT02720523|8429666|P1|Period 1: Placebo-controlled Period|Withdrawal by Subject|1
2448197|NCT02720523|8429660|P7|Period 1: Placebo-controlled Period|Adverse Event|0
2448198|NCT02720523|8429661|P6|Period 1: Placebo-controlled Period|Adverse Event|0
2448199|NCT02720523|8429662|P5|Period 1: Placebo-controlled Period|Adverse Event|0
2448200|NCT02720523|8429663|P4|Period 1: Placebo-controlled Period|Adverse Event|5
2448201|NCT02720523|8429664|P3|Period 1: Placebo-controlled Period|Adverse Event|1
2448202|NCT02720523|8429665|P2|Period 1: Placebo-controlled Period|Adverse Event|0
2448203|NCT02720523|8429666|P1|Period 1: Placebo-controlled Period|Adverse Event|0
2448204|NCT02720510|8429725|P2|Overall Study|Physician Decision|2
2448205|NCT02720510|8429726|P1|Overall Study|Physician Decision|1
2448206|NCT02720510|8429725|P2|Overall Study|Adverse Event|1
2448207|NCT02720510|8429726|P1|Overall Study|Adverse Event|0
2448208|NCT02720510|8429725|P2|Overall Study|Study Terminated by the sponsor|0
2448209|NCT02720510|8429726|P1|Overall Study|Study Terminated by the sponsor|2
2448210|NCT02720484|8429744|P1|Follow Up for 2 Years|Lost to Follow-up|2
2448211|NCT02720484|8429744|P1|Follow Up for 2 Years|Death|3
2448212|NCT02720484|8429744|P1|Follow Up for 2 Years|Withdrawal by Subject|1
2448213|NCT02720484|8429744|P1|Treatment on Study|Progressive Disease|4
2448214|NCT02720484|8429744|P1|Treatment on Study|Withdrawal by Subject|1
2448215|NCT02720484|8429744|P1|Treatment on Study|Adverse Event|1
2448216|NCT02720198|8429776|P2|Overall Study|Withdrawal by Subject|1
2448217|NCT02720198|8429777|P1|Overall Study|Withdrawal by Subject|0
2448218|NCT02720081|8429812|P2|Overall Study|Protocol Violation|1
2448219|NCT02720081|8429813|P1|Overall Study|Protocol Violation|4
2448220|NCT02720081|8429812|P2|Overall Study|Adverse Event|3
2448221|NCT02720081|8429813|P1|Overall Study|Adverse Event|0
2448222|NCT02719743|8429895|P5|Overall Study|Lost to Follow-up|0
2448223|NCT02719743|8429896|P4|Overall Study|Lost to Follow-up|0
2448224|NCT02719743|8429897|P3|Overall Study|Lost to Follow-up|0
2448225|NCT02719743|8429898|P2|Overall Study|Lost to Follow-up|1
2448226|NCT02719743|8429899|P1|Overall Study|Lost to Follow-up|1
2448227|NCT02719743|8429895|P5|Overall Study|Migrated/moved from study area|2
2448228|NCT02719743|8429896|P4|Overall Study|Migrated/moved from study area|0
2448229|NCT02719743|8429897|P3|Overall Study|Migrated/moved from study area|0
2448230|NCT02719743|8429898|P2|Overall Study|Migrated/moved from study area|0
2448231|NCT02719743|8429899|P1|Overall Study|Migrated/moved from study area|0
2448232|NCT02719743|8429895|P5|Overall Study|Consent withdrawal|0
2448233|NCT02719743|8429896|P4|Overall Study|Consent withdrawal|1
2448234|NCT02719743|8429897|P3|Overall Study|Consent withdrawal|0
2448235|NCT02719743|8429898|P2|Overall Study|Consent withdrawal|2
2448236|NCT02719743|8429899|P1|Overall Study|Consent withdrawal|0
2448237|NCT02719171|8430045|P5|Overall Study|Other|0
2448238|NCT02719171|8430046|P4|Overall Study|Other|1
2448239|NCT02719171|8430047|P3|Overall Study|Other|0
2448240|NCT02719171|8430048|P2|Overall Study|Other|0
2448241|NCT02719171|8430049|P1|Overall Study|Other|0
2448242|NCT02719171|8430045|P5|Overall Study|Subject Withdrawal|0
2448243|NCT02719171|8430046|P4|Overall Study|Subject Withdrawal|1
2448244|NCT02719171|8430047|P3|Overall Study|Subject Withdrawal|2
2448245|NCT02719171|8430048|P2|Overall Study|Subject Withdrawal|2
2448246|NCT02719171|8430049|P1|Overall Study|Subject Withdrawal|0
2448247|NCT02719171|8430045|P5|Overall Study|Lost to Follow-up|0
2448248|NCT02719171|8430046|P4|Overall Study|Lost to Follow-up|0
2448249|NCT02719171|8430047|P3|Overall Study|Lost to Follow-up|1
2448250|NCT02719171|8430048|P2|Overall Study|Lost to Follow-up|0
2448251|NCT02719171|8430049|P1|Overall Study|Lost to Follow-up|0
2448252|NCT02719171|8430045|P5|Overall Study|Adverse Event|2
2448253|NCT02719171|8430046|P4|Overall Study|Adverse Event|0
2448254|NCT02719171|8430047|P3|Overall Study|Adverse Event|0
2448255|NCT02719171|8430048|P2|Overall Study|Adverse Event|2
2448256|NCT02719171|8430049|P1|Overall Study|Adverse Event|1
2448257|NCT02719028|8430144|P4|Overall Study|Protocol Violation|1
2448258|NCT02719028|8430145|P3|Overall Study|Protocol Violation|0
2448259|NCT02719028|8430146|P2|Overall Study|Protocol Violation|0
2448260|NCT02719028|8430147|P1|Overall Study|Protocol Violation|0
2448261|NCT02719028|8430144|P4|Overall Study|Use of prohibited medication|0
2448262|NCT02719028|8430145|P3|Overall Study|Use of prohibited medication|1
2448263|NCT02719028|8430146|P2|Overall Study|Use of prohibited medication|0
2448264|NCT02719028|8430147|P1|Overall Study|Use of prohibited medication|0
2448265|NCT02719028|8430144|P4|Overall Study|Physician Decision|1
2448266|NCT02719028|8430145|P3|Overall Study|Physician Decision|1
2448267|NCT02719028|8430146|P2|Overall Study|Physician Decision|1
2448268|NCT02719028|8430147|P1|Overall Study|Physician Decision|0
2448269|NCT02719028|8430144|P4|Overall Study|Adverse Event|8
2448270|NCT02719028|8430145|P3|Overall Study|Adverse Event|4
2448271|NCT02719028|8430146|P2|Overall Study|Adverse Event|1
2448272|NCT02719028|8430147|P1|Overall Study|Adverse Event|2
2448273|NCT02718898|8430171|P7|Post Treatment Follow-up Period|Withdrawal by Subject|3
2448274|NCT02718898|8430172|P6|Post Treatment Follow-up Period|Withdrawal by Subject|5
2448275|NCT02718898|8430173|P5|Post Treatment Follow-up Period|Withdrawal by Subject|0
2448276|NCT02718898|8430174|P4|Post Treatment Follow-up Period|Withdrawal by Subject|0
2448277|NCT02718898|8430175|P3|Post Treatment Follow-up Period|Withdrawal by Subject|0
2448278|NCT02718898|8430176|P2|Post Treatment Follow-up Period|Withdrawal by Subject|0
2448279|NCT02718898|8430177|P1|Post Treatment Follow-up Period|Withdrawal by Subject|0
2448280|NCT02718898|8430171|P7|Post Treatment Follow-up Period|Lost to Follow-up|1
2448281|NCT02718898|8430172|P6|Post Treatment Follow-up Period|Lost to Follow-up|5
2448282|NCT02718898|8430173|P5|Post Treatment Follow-up Period|Lost to Follow-up|1
2448283|NCT02718898|8430174|P4|Post Treatment Follow-up Period|Lost to Follow-up|0
2448284|NCT02718898|8430175|P3|Post Treatment Follow-up Period|Lost to Follow-up|0
2448285|NCT02718898|8430176|P2|Post Treatment Follow-up Period|Lost to Follow-up|0
2448286|NCT02718898|8430177|P1|Post Treatment Follow-up Period|Lost to Follow-up|0
2448287|NCT02718898|8430171|P7|Post Treatment Follow-up Period|Adverse Event|1
2448288|NCT02718898|8430172|P6|Post Treatment Follow-up Period|Adverse Event|1
2448289|NCT02718898|8430173|P5|Post Treatment Follow-up Period|Adverse Event|0
2448290|NCT02718898|8430174|P4|Post Treatment Follow-up Period|Adverse Event|0
2448291|NCT02718898|8430175|P3|Post Treatment Follow-up Period|Adverse Event|0
2448292|NCT02718898|8430176|P2|Post Treatment Follow-up Period|Adverse Event|0
2448293|NCT02718898|8430177|P1|Post Treatment Follow-up Period|Adverse Event|0
2448294|NCT02718898|8430171|P7|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
2448295|NCT02718898|8430172|P6|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
2448296|NCT02718898|8430173|P5|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
2448297|NCT02718898|8430174|P4|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1
2448298|NCT02718898|8430175|P3|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
2448299|NCT02718898|8430176|P2|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
2448300|NCT02718898|8430177|P1|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
2448301|NCT02718898|8430171|P7|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
2448302|NCT02718898|8430172|P6|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
2448303|NCT02718898|8430173|P5|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
2448304|NCT02718898|8430174|P4|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1
2448305|NCT02718898|8430175|P3|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
2448306|NCT02718898|8430176|P2|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
2448307|NCT02718898|8430177|P1|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
2448308|NCT02718898|8430171|P7|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
2448309|NCT02718898|8430172|P6|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
2448310|NCT02718898|8430173|P5|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
2448311|NCT02718898|8430174|P4|Open Label Treatment Period (OLTP)|Lack of Efficacy|2
2448312|NCT02718898|8430175|P3|Open Label Treatment Period (OLTP)|Lack of Efficacy|1
2448313|NCT02718898|8430176|P2|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
2448314|NCT02718898|8430177|P1|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
2448315|NCT02718898|8430171|P7|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
2448316|NCT02718898|8430172|P6|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
2448317|NCT02718898|8430173|P5|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
2448318|NCT02718898|8430174|P4|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3
2448319|NCT02718898|8430175|P3|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1
2448320|NCT02718898|8430176|P2|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
2448321|NCT02718898|8430177|P1|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
2448322|NCT02718898|8430171|P7|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
2448323|NCT02718898|8430172|P6|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
2448324|NCT02718898|8430173|P5|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
2448325|NCT02718898|8430174|P4|Open Label Treatment Period (OLTP)|Lost to Follow-up|2
2448326|NCT02718898|8430175|P3|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
2448327|NCT02718898|8430176|P2|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
2448328|NCT02718898|8430177|P1|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
2448329|NCT02718898|8430171|P7|Open Label Treatment Period (OLTP)|Adverse Event|0
2448330|NCT02718898|8430172|P6|Open Label Treatment Period (OLTP)|Adverse Event|0
2448331|NCT02718898|8430173|P5|Open Label Treatment Period (OLTP)|Adverse Event|0
2448332|NCT02718898|8430174|P4|Open Label Treatment Period (OLTP)|Adverse Event|1
2448333|NCT02718898|8430175|P3|Open Label Treatment Period (OLTP)|Adverse Event|1
2448334|NCT02718898|8430176|P2|Open Label Treatment Period (OLTP)|Adverse Event|0
2448335|NCT02718898|8430177|P1|Open Label Treatment Period (OLTP)|Adverse Event|0
2448336|NCT02718898|8430171|P7|Blinded Treatment Period|Lost to Follow-up|0
2448337|NCT02718898|8430172|P6|Blinded Treatment Period|Lost to Follow-up|0
2448338|NCT02718898|8430173|P5|Blinded Treatment Period|Lost to Follow-up|0
2448339|NCT02718898|8430174|P4|Blinded Treatment Period|Lost to Follow-up|0
2448340|NCT02718898|8430175|P3|Blinded Treatment Period|Lost to Follow-up|0
2448341|NCT02718898|8430176|P2|Blinded Treatment Period|Lost to Follow-up|0
2448342|NCT02718898|8430177|P1|Blinded Treatment Period|Lost to Follow-up|2
2448343|NCT02718898|8430171|P7|Blinded Treatment Period|Lack of Efficacy|0
2448344|NCT02718898|8430172|P6|Blinded Treatment Period|Lack of Efficacy|0
2448345|NCT02718898|8430173|P5|Blinded Treatment Period|Lack of Efficacy|0
2448346|NCT02718898|8430174|P4|Blinded Treatment Period|Lack of Efficacy|0
2448347|NCT02718898|8430175|P3|Blinded Treatment Period|Lack of Efficacy|0
2448348|NCT02718898|8430176|P2|Blinded Treatment Period|Lack of Efficacy|0
2448349|NCT02718898|8430177|P1|Blinded Treatment Period|Lack of Efficacy|1
2448350|NCT02718898|8430171|P7|Blinded Treatment Period|Physician Decision|0
2448351|NCT02718898|8430172|P6|Blinded Treatment Period|Physician Decision|0
2448352|NCT02718898|8430173|P5|Blinded Treatment Period|Physician Decision|0
2448353|NCT02718898|8430174|P4|Blinded Treatment Period|Physician Decision|0
2448354|NCT02718898|8430175|P3|Blinded Treatment Period|Physician Decision|0
2448355|NCT02718898|8430176|P2|Blinded Treatment Period|Physician Decision|0
2448356|NCT02718898|8430177|P1|Blinded Treatment Period|Physician Decision|1
2448357|NCT02718898|8430171|P7|Blinded Treatment Period|Adverse Event|0
2448358|NCT02718898|8430172|P6|Blinded Treatment Period|Adverse Event|0
2448359|NCT02718898|8430173|P5|Blinded Treatment Period|Adverse Event|0
2448360|NCT02718898|8430174|P4|Blinded Treatment Period|Adverse Event|0
2448361|NCT02718898|8430175|P3|Blinded Treatment Period|Adverse Event|0
2448362|NCT02718898|8430176|P2|Blinded Treatment Period|Adverse Event|1
2448363|NCT02718898|8430177|P1|Blinded Treatment Period|Adverse Event|5
2448364|NCT02718625|8430212|P2|Overall Study|Termination of Study by Sponsor|1
2448365|NCT02718625|8430213|P1|Overall Study|Termination of Study by Sponsor|0
2448366|NCT02718625|8430212|P2|Overall Study|Adverse Event|1
2448367|NCT02718625|8430213|P1|Overall Study|Adverse Event|0
2448368|NCT02718417|8430232|P3|Maintenance Phase|Ongoing|172
2448369|NCT02718417|8430233|P2|Maintenance Phase|Ongoing|180
2448370|NCT02718417|8430234|P1|Maintenance Phase|Ongoing|155
2448371|NCT02718417|8430232|P3|Maintenance Phase|Lost to Follow-up|2
2448372|NCT02718417|8430233|P2|Maintenance Phase|Lost to Follow-up|0
2448373|NCT02718417|8430234|P1|Maintenance Phase|Lost to Follow-up|0
2448374|NCT02718417|8430232|P3|Maintenance Phase|Study terminated by sponsor|1
2448375|NCT02718417|8430233|P2|Maintenance Phase|Study terminated by sponsor|0
2448376|NCT02718417|8430234|P1|Maintenance Phase|Study terminated by sponsor|0
2448377|NCT02718417|8430232|P3|Maintenance Phase|Withdrawal by Subject|27
2448378|NCT02718417|8430233|P2|Maintenance Phase|Withdrawal by Subject|10
2448379|NCT02718417|8430234|P1|Maintenance Phase|Withdrawal by Subject|13
2448380|NCT02718417|8430232|P3|Maintenance Phase|Other|5
2448381|NCT02718417|8430233|P2|Maintenance Phase|Other|1
2448382|NCT02718417|8430234|P1|Maintenance Phase|Other|2
2448383|NCT02718417|8430232|P3|Maintenance Phase|Progressive disease|66
2448384|NCT02718417|8430233|P2|Maintenance Phase|Progressive disease|64
2448385|NCT02718417|8430234|P1|Maintenance Phase|Progressive disease|72
2448386|NCT02718417|8430232|P3|Maintenance Phase|Physician's decision|9
2448387|NCT02718417|8430233|P2|Maintenance Phase|Physician's decision|5
2448388|NCT02718417|8430234|P1|Maintenance Phase|Physician's decision|4
2448389|NCT02718417|8430232|P3|Maintenance Phase|No longer met eligibility criteria|0
2448390|NCT02718417|8430233|P2|Maintenance Phase|No longer met eligibility criteria|1
2448391|NCT02718417|8430234|P1|Maintenance Phase|No longer met eligibility criteria|0
2448392|NCT02718417|8430232|P3|Maintenance Phase|Global deterioration of health status|1
2448393|NCT02718417|8430233|P2|Maintenance Phase|Global deterioration of health status|2
2448394|NCT02718417|8430234|P1|Maintenance Phase|Global deterioration of health status|5
2448395|NCT02718417|8430232|P3|Maintenance Phase|Death leading to discontinuation|2
2448396|NCT02718417|8430233|P2|Maintenance Phase|Death leading to discontinuation|1
2448397|NCT02718417|8430234|P1|Maintenance Phase|Death leading to discontinuation|0
2448398|NCT02718417|8430232|P3|Maintenance Phase|Adverse Event|1
2448399|NCT02718417|8430233|P2|Maintenance Phase|Adverse Event|23
2448400|NCT02718417|8430234|P1|Maintenance Phase|Adverse Event|16
2448401|NCT02718417|8430232|P3|Chemotherapy Phase|Other|0
2448402|NCT02718417|8430233|P2|Chemotherapy Phase|Other|0
2448403|NCT02718417|8430234|P1|Chemotherapy Phase|Other|2
2448404|NCT02718417|8430232|P3|Chemotherapy Phase|Withdrawal by Subject|15
2448405|NCT02718417|8430233|P2|Chemotherapy Phase|Withdrawal by Subject|8
2448406|NCT02718417|8430234|P1|Chemotherapy Phase|Withdrawal by Subject|13
2448407|NCT02718417|8430232|P3|Chemotherapy Phase|Progressive disease|10
2448408|NCT02718417|8430233|P2|Chemotherapy Phase|Progressive disease|7
2448409|NCT02718417|8430234|P1|Chemotherapy Phase|Progressive disease|11
2448410|NCT02718417|8430232|P3|Chemotherapy Phase|Physician's decision|4
2448411|NCT02718417|8430233|P2|Chemotherapy Phase|Physician's decision|0
2448412|NCT02718417|8430234|P1|Chemotherapy Phase|Physician's decision|5
2448413|NCT02718417|8430232|P3|Chemotherapy Phase|No longer met eligibility criteria|1
2448414|NCT02718417|8430233|P2|Chemotherapy Phase|No longer met eligibility criteria|2
2448415|NCT02718417|8430234|P1|Chemotherapy Phase|No longer met eligibility criteria|4
2448416|NCT02718417|8430232|P3|Chemotherapy Phase|Global deterioration of health status|1
2448417|NCT02718417|8430233|P2|Chemotherapy Phase|Global deterioration of health status|2
2448418|NCT02718417|8430234|P1|Chemotherapy Phase|Global deterioration of health status|3
2448419|NCT02718417|8430232|P3|Chemotherapy Phase|Death leading to discontinuation|1
2448420|NCT02718417|8430233|P2|Chemotherapy Phase|Death leading to discontinuation|4
2448421|NCT02718417|8430234|P1|Chemotherapy Phase|Death leading to discontinuation|5
2448422|NCT02718417|8430232|P3|Chemotherapy Phase|Adverse Event|13
2448423|NCT02718417|8430233|P2|Chemotherapy Phase|Adverse Event|14
2448424|NCT02718417|8430234|P1|Chemotherapy Phase|Adverse Event|9
2448425|NCT02718326|8430296|P3|Overall Study|Un-specified|0
2448426|NCT02718326|8430297|P2|Overall Study|Un-specified|0
2448427|NCT02718326|8430298|P1|Overall Study|Un-specified|1
2448428|NCT02718326|8430296|P3|Overall Study|Protocol Deviation|0
2448429|NCT02718326|8430297|P2|Overall Study|Protocol Deviation|0
2448430|NCT02718326|8430298|P1|Overall Study|Protocol Deviation|1
2448431|NCT02718326|8430296|P3|Overall Study|Lost to Follow-up|5
2448432|NCT02718326|8430297|P2|Overall Study|Lost to Follow-up|4
2448433|NCT02718326|8430298|P1|Overall Study|Lost to Follow-up|12
2448434|NCT02718326|8430296|P3|Overall Study|Withdrawal by Subject|4
2448435|NCT02718326|8430297|P2|Overall Study|Withdrawal by Subject|5
2448436|NCT02718326|8430298|P1|Overall Study|Withdrawal by Subject|2
2448437|NCT02718326|8430296|P3|Overall Study|Death|1
2448438|NCT02718326|8430297|P2|Overall Study|Death|0
2448439|NCT02718326|8430298|P1|Overall Study|Death|6
2448440|NCT02718326|8430296|P3|Overall Study|Adverse Event|0
2448441|NCT02718326|8430297|P2|Overall Study|Adverse Event|4
2448442|NCT02718326|8430298|P1|Overall Study|Adverse Event|2
2448443|NCT02717754|8430419|P6|Overall Study|Incorrect Infusion Duration|20
2448444|NCT02717754|8430420|P5|Overall Study|Incorrect Infusion Duration|20
2448445|NCT02717754|8430421|P4|Overall Study|Incorrect Infusion Duration|10
2448446|NCT02717754|8430422|P3|Overall Study|Incorrect Infusion Duration|0
2448447|NCT02717754|8430423|P2|Overall Study|Incorrect Infusion Duration|0
2448448|NCT02717754|8430424|P1|Overall Study|Incorrect Infusion Duration|0
2448449|NCT02717494|8430455|P3|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4
2448450|NCT02717494|8430456|P2|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0
2448451|NCT02717494|8430457|P1|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0
2448452|NCT02717494|8430455|P3|First Intervention (Step 1)|Death|1
2448453|NCT02717494|8430456|P2|First Intervention (Step 1)|Death|0
2448454|NCT02717494|8430457|P1|First Intervention (Step 1)|Death|0
2448455|NCT02717494|8430455|P3|First Intervention (Step 1)|Withdrawal by Subject|1
2448456|NCT02717494|8430456|P2|First Intervention (Step 1)|Withdrawal by Subject|0
2448457|NCT02717494|8430457|P1|First Intervention (Step 1)|Withdrawal by Subject|2
2448458|NCT02717494|8430455|P3|First Intervention (Step 1)|Lost to Follow-up|3
2448459|NCT02717494|8430456|P2|First Intervention (Step 1)|Lost to Follow-up|7
2448460|NCT02717494|8430457|P1|First Intervention (Step 1)|Lost to Follow-up|4
2448461|NCT02717195|8430519|P5|Double-blind Treatment (DBT) Period|Patient missed required visits|1
2448462|NCT02717195|8430520|P4|Double-blind Treatment (DBT) Period|Patient missed required visits|1
2448463|NCT02717195|8430521|P3|Double-blind Treatment (DBT) Period|Patient missed required visits|0
2448464|NCT02717195|8430522|P2|Double-blind Treatment (DBT) Period|Patient missed required visits|0
2448465|NCT02717195|8430523|P1|Double-blind Treatment (DBT) Period|Patient missed required visits|0
2448466|NCT02717195|8430519|P5|Double-blind Treatment (DBT) Period|Psychosocial issues|0
2448467|NCT02717195|8430520|P4|Double-blind Treatment (DBT) Period|Psychosocial issues|0
2448468|NCT02717195|8430521|P3|Double-blind Treatment (DBT) Period|Psychosocial issues|1
2448469|NCT02717195|8430522|P2|Double-blind Treatment (DBT) Period|Psychosocial issues|0
2448470|NCT02717195|8430523|P1|Double-blind Treatment (DBT) Period|Psychosocial issues|0
2448471|NCT02717195|8430519|P5|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1
2448472|NCT02717195|8430520|P4|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
2448473|NCT02717195|8430521|P3|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
2448474|NCT02717195|8430522|P2|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
2448475|NCT02717195|8430523|P1|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
2448476|NCT02717195|8430519|P5|Double-blind Treatment (DBT) Period|Change of residence|1
2448477|NCT02717195|8430520|P4|Double-blind Treatment (DBT) Period|Change of residence|1
2448478|NCT02717195|8430521|P3|Double-blind Treatment (DBT) Period|Change of residence|0
2448479|NCT02717195|8430522|P2|Double-blind Treatment (DBT) Period|Change of residence|0
2448480|NCT02717195|8430523|P1|Double-blind Treatment (DBT) Period|Change of residence|0
2448481|NCT02717195|8430519|P5|Double-blind Treatment (DBT) Period|Family circumstances|1
2448482|NCT02717195|8430520|P4|Double-blind Treatment (DBT) Period|Family circumstances|0
2448483|NCT02717195|8430521|P3|Double-blind Treatment (DBT) Period|Family circumstances|0
2448484|NCT02717195|8430522|P2|Double-blind Treatment (DBT) Period|Family circumstances|0
2448485|NCT02717195|8430523|P1|Double-blind Treatment (DBT) Period|Family circumstances|0
2448486|NCT02717195|8430519|P5|Double-blind Treatment (DBT) Period|Investigator decision|1
2448487|NCT02717195|8430520|P4|Double-blind Treatment (DBT) Period|Investigator decision|1
2448488|NCT02717195|8430521|P3|Double-blind Treatment (DBT) Period|Investigator decision|0
2448489|NCT02717195|8430522|P2|Double-blind Treatment (DBT) Period|Investigator decision|0
2448490|NCT02717195|8430523|P1|Double-blind Treatment (DBT) Period|Investigator decision|0
2448491|NCT02717195|8430519|P5|Double-blind Treatment (DBT) Period|Patient decision|2
2448492|NCT02717195|8430520|P4|Double-blind Treatment (DBT) Period|Patient decision|2
2448493|NCT02717195|8430521|P3|Double-blind Treatment (DBT) Period|Patient decision|0
2448494|NCT02717195|8430522|P2|Double-blind Treatment (DBT) Period|Patient decision|0
2448495|NCT02717195|8430523|P1|Double-blind Treatment (DBT) Period|Patient decision|0
2448496|NCT02717195|8430519|P5|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
2448497|NCT02717195|8430520|P4|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
2448498|NCT02717195|8430521|P3|Double-blind Treatment (DBT) Period|Enrolled but not treated|1
2448499|NCT02717195|8430522|P2|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
2448500|NCT02717195|8430523|P1|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
2448501|NCT02717195|8430519|P5|Double-blind Treatment (DBT) Period|Lost to Follow-up|2
2448502|NCT02717195|8430520|P4|Double-blind Treatment (DBT) Period|Lost to Follow-up|3
2448503|NCT02717195|8430521|P3|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
2448504|NCT02717195|8430522|P2|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
2448505|NCT02717195|8430523|P1|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
2448506|NCT02717195|8430519|P5|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8
2448507|NCT02717195|8430520|P4|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13
2448508|NCT02717195|8430521|P3|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14
2448509|NCT02717195|8430522|P2|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0
2448510|NCT02717195|8430523|P1|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0
2448511|NCT02717195|8430519|P5|Double-blind Treatment (DBT) Period|Protocol Violation|1
2448512|NCT02717195|8430520|P4|Double-blind Treatment (DBT) Period|Protocol Violation|0
2448513|NCT02717195|8430521|P3|Double-blind Treatment (DBT) Period|Protocol Violation|1
2448514|NCT02717195|8430522|P2|Double-blind Treatment (DBT) Period|Protocol Violation|0
2448515|NCT02717195|8430523|P1|Double-blind Treatment (DBT) Period|Protocol Violation|0
2448516|NCT02717195|8430519|P5|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2
2448517|NCT02717195|8430520|P4|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3
2448518|NCT02717195|8430521|P3|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4
2448519|NCT02717195|8430522|P2|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0
2448520|NCT02717195|8430523|P1|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0
2448521|NCT02717195|8430519|P5|Double-blind Treatment (DBT) Period|Lack of Efficacy|2
2448522|NCT02717195|8430520|P4|Double-blind Treatment (DBT) Period|Lack of Efficacy|9
2448523|NCT02717195|8430521|P3|Double-blind Treatment (DBT) Period|Lack of Efficacy|6
2448524|NCT02717195|8430522|P2|Double-blind Treatment (DBT) Period|Lack of Efficacy|0
2448525|NCT02717195|8430523|P1|Double-blind Treatment (DBT) Period|Lack of Efficacy|0
2448526|NCT02717195|8430519|P5|Double-blind Treatment (DBT) Period|Adverse Event|8
2448527|NCT02717195|8430520|P4|Double-blind Treatment (DBT) Period|Adverse Event|11
2448528|NCT02717195|8430521|P3|Double-blind Treatment (DBT) Period|Adverse Event|10
2448529|NCT02717195|8430522|P2|Double-blind Treatment (DBT) Period|Adverse Event|0
2448530|NCT02717195|8430523|P1|Double-blind Treatment (DBT) Period|Adverse Event|0
2448531|NCT02717195|8430519|P5|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
2448532|NCT02717195|8430520|P4|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
2448533|NCT02717195|8430521|P3|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
2448534|NCT02717195|8430522|P2|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
2448535|NCT02717195|8430523|P1|Prospective Confirmation (PC) Period|Noncompliance with protocol|1
2448536|NCT02717195|8430519|P5|Prospective Confirmation (PC) Period|Patient fraud with payment|0
2448537|NCT02717195|8430520|P4|Prospective Confirmation (PC) Period|Patient fraud with payment|0
2448538|NCT02717195|8430521|P3|Prospective Confirmation (PC) Period|Patient fraud with payment|0
2448539|NCT02717195|8430522|P2|Prospective Confirmation (PC) Period|Patient fraud with payment|0
2448540|NCT02717195|8430523|P1|Prospective Confirmation (PC) Period|Patient fraud with payment|1
2448541|NCT02717195|8430519|P5|Prospective Confirmation (PC) Period|Sponsor requested|0
2448542|NCT02717195|8430520|P4|Prospective Confirmation (PC) Period|Sponsor requested|0
2448543|NCT02717195|8430521|P3|Prospective Confirmation (PC) Period|Sponsor requested|0
2448544|NCT02717195|8430522|P2|Prospective Confirmation (PC) Period|Sponsor requested|1
2448545|NCT02717195|8430523|P1|Prospective Confirmation (PC) Period|Sponsor requested|0
2448546|NCT02717195|8430519|P5|Prospective Confirmation (PC) Period|Duplicate subject|0
2448547|NCT02717195|8430520|P4|Prospective Confirmation (PC) Period|Duplicate subject|0
2448548|NCT02717195|8430521|P3|Prospective Confirmation (PC) Period|Duplicate subject|0
2448549|NCT02717195|8430522|P2|Prospective Confirmation (PC) Period|Duplicate subject|0
2448550|NCT02717195|8430523|P1|Prospective Confirmation (PC) Period|Duplicate subject|1
2448551|NCT02717195|8430519|P5|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
2448552|NCT02717195|8430520|P4|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
2448553|NCT02717195|8430521|P3|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
2448554|NCT02717195|8430522|P2|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1
2448555|NCT02717195|8430523|P1|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
2448556|NCT02717195|8430519|P5|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
2448557|NCT02717195|8430520|P4|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
2448558|NCT02717195|8430521|P3|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
2448559|NCT02717195|8430522|P2|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
2448560|NCT02717195|8430523|P1|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1
2448561|NCT02717195|8430519|P5|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
2448562|NCT02717195|8430520|P4|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
2448563|NCT02717195|8430521|P3|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
2448564|NCT02717195|8430522|P2|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1
2448565|NCT02717195|8430523|P1|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
2448566|NCT02717195|8430519|P5|Prospective Confirmation (PC) Period|Investigator decision|0
2448567|NCT02717195|8430520|P4|Prospective Confirmation (PC) Period|Investigator decision|0
2448568|NCT02717195|8430521|P3|Prospective Confirmation (PC) Period|Investigator decision|0
2448569|NCT02717195|8430522|P2|Prospective Confirmation (PC) Period|Investigator decision|1
2448570|NCT02717195|8430523|P1|Prospective Confirmation (PC) Period|Investigator decision|2
2448571|NCT02717195|8430519|P5|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
2448572|NCT02717195|8430520|P4|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
2448573|NCT02717195|8430521|P3|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
2448574|NCT02717195|8430522|P2|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1
2448575|NCT02717195|8430523|P1|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
2448576|NCT02717195|8430519|P5|Prospective Confirmation (PC) Period|Change of place of residence|0
2448577|NCT02717195|8430520|P4|Prospective Confirmation (PC) Period|Change of place of residence|0
2448578|NCT02717195|8430521|P3|Prospective Confirmation (PC) Period|Change of place of residence|0
2448579|NCT02717195|8430522|P2|Prospective Confirmation (PC) Period|Change of place of residence|0
2448580|NCT02717195|8430523|P1|Prospective Confirmation (PC) Period|Change of place of residence|1
2448581|NCT02717195|8430519|P5|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
2448582|NCT02717195|8430520|P4|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
2448583|NCT02717195|8430521|P3|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
2448584|NCT02717195|8430522|P2|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
2448585|NCT02717195|8430523|P1|Prospective Confirmation (PC) Period|Low level of drug in the blood|1
2448586|NCT02717195|8430519|P5|Prospective Confirmation (PC) Period|Patient decision|0
2448587|NCT02717195|8430520|P4|Prospective Confirmation (PC) Period|Patient decision|0
2448588|NCT02717195|8430521|P3|Prospective Confirmation (PC) Period|Patient decision|0
2448589|NCT02717195|8430522|P2|Prospective Confirmation (PC) Period|Patient decision|2
2448590|NCT02717195|8430523|P1|Prospective Confirmation (PC) Period|Patient decision|5
2448591|NCT02717195|8430519|P5|Prospective Confirmation (PC) Period|Technical error|0
2448592|NCT02717195|8430520|P4|Prospective Confirmation (PC) Period|Technical error|0
2448593|NCT02717195|8430521|P3|Prospective Confirmation (PC) Period|Technical error|0
2448594|NCT02717195|8430522|P2|Prospective Confirmation (PC) Period|Technical error|0
2448595|NCT02717195|8430523|P1|Prospective Confirmation (PC) Period|Technical error|1
2448596|NCT02717195|8430519|P5|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
2448597|NCT02717195|8430520|P4|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
2448598|NCT02717195|8430521|P3|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
2448599|NCT02717195|8430522|P2|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
2448600|NCT02717195|8430523|P1|Prospective Confirmation (PC) Period|Lack of results for blood levels|1
2448601|NCT02717195|8430519|P5|Prospective Confirmation (PC) Period|Enrolled but not treated|0
2448602|NCT02717195|8430520|P4|Prospective Confirmation (PC) Period|Enrolled but not treated|0
2448603|NCT02717195|8430521|P3|Prospective Confirmation (PC) Period|Enrolled but not treated|0
2448604|NCT02717195|8430522|P2|Prospective Confirmation (PC) Period|Enrolled but not treated|3
2448605|NCT02717195|8430523|P1|Prospective Confirmation (PC) Period|Enrolled but not treated|3
2448606|NCT02717195|8430519|P5|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
2448607|NCT02717195|8430520|P4|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
2448608|NCT02717195|8430521|P3|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
2448609|NCT02717195|8430522|P2|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75
2448610|NCT02717195|8430523|P1|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189
2448611|NCT02717195|8430519|P5|Prospective Confirmation (PC) Period|Lost to Follow-up|0
2448612|NCT02717195|8430520|P4|Prospective Confirmation (PC) Period|Lost to Follow-up|0
2448613|NCT02717195|8430521|P3|Prospective Confirmation (PC) Period|Lost to Follow-up|0
2448614|NCT02717195|8430522|P2|Prospective Confirmation (PC) Period|Lost to Follow-up|4
2448615|NCT02717195|8430523|P1|Prospective Confirmation (PC) Period|Lost to Follow-up|9
2448616|NCT02717195|8430519|P5|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
2448617|NCT02717195|8430520|P4|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
2448618|NCT02717195|8430521|P3|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
2448619|NCT02717195|8430522|P2|Prospective Confirmation (PC) Period|Withdrawal by Subject|12
2448620|NCT02717195|8430523|P1|Prospective Confirmation (PC) Period|Withdrawal by Subject|43
2448621|NCT02717195|8430519|P5|Prospective Confirmation (PC) Period|Protocol Violation|0
2448622|NCT02717195|8430520|P4|Prospective Confirmation (PC) Period|Protocol Violation|0
2448623|NCT02717195|8430521|P3|Prospective Confirmation (PC) Period|Protocol Violation|0
2448624|NCT02717195|8430522|P2|Prospective Confirmation (PC) Period|Protocol Violation|1
2448625|NCT02717195|8430523|P1|Prospective Confirmation (PC) Period|Protocol Violation|3
2448626|NCT02717195|8430519|P5|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
2448627|NCT02717195|8430520|P4|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
2448628|NCT02717195|8430521|P3|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
2448629|NCT02717195|8430522|P2|Prospective Confirmation (PC) Period|Non-compliance with IMP|1
2448630|NCT02717195|8430523|P1|Prospective Confirmation (PC) Period|Non-compliance with IMP|7
2448631|NCT02717195|8430519|P5|Prospective Confirmation (PC) Period|Lack of Efficacy|0
2448632|NCT02717195|8430520|P4|Prospective Confirmation (PC) Period|Lack of Efficacy|0
2448633|NCT02717195|8430521|P3|Prospective Confirmation (PC) Period|Lack of Efficacy|0
2448634|NCT02717195|8430522|P2|Prospective Confirmation (PC) Period|Lack of Efficacy|1
2448635|NCT02717195|8430523|P1|Prospective Confirmation (PC) Period|Lack of Efficacy|2
2448636|NCT02717195|8430519|P5|Prospective Confirmation (PC) Period|Adverse Event|0
2448637|NCT02717195|8430520|P4|Prospective Confirmation (PC) Period|Adverse Event|0
2448638|NCT02717195|8430521|P3|Prospective Confirmation (PC) Period|Adverse Event|0
2448639|NCT02717195|8430522|P2|Prospective Confirmation (PC) Period|Adverse Event|7
2448640|NCT02717195|8430523|P1|Prospective Confirmation (PC) Period|Adverse Event|19
2448641|NCT02717130|8430554|P1|Overall Study|Study Closure|4
2448642|NCT02717130|8430554|P1|Overall Study|Physician Decision|1
2448643|NCT02717130|8430554|P1|Overall Study|Adverse Event|1
2448644|NCT02717130|8430554|P1|Overall Study|Withdrawal by Subject|1
2448645|NCT02716896|8430560|P2|Overall Study|Physician Decision|1
2448646|NCT02716896|8430561|P1|Overall Study|Physician Decision|0
2448647|NCT02716805|8430612|P4|Overall Study|Progressive disease|0
2448648|NCT02716805|8430613|P3|Overall Study|Progressive disease|0
2448649|NCT02716805|8430614|P2|Overall Study|Progressive disease|0
2448650|NCT02716805|8430615|P1|Overall Study|Progressive disease|2
2448651|NCT02716779|8430623|P3|Combination Therapy|Adverse Event|1
2448652|NCT02716779|8430624|P2|Combination Therapy|Adverse Event|2
2448653|NCT02716779|8430625|P1|Combination Therapy|Adverse Event|0
2448654|NCT02716779|8430623|P3|Monotherapy|Adverse Event|1
2448655|NCT02716779|8430624|P2|Monotherapy|Adverse Event|1
2448656|NCT02716779|8430625|P1|Monotherapy|Adverse Event|0
2448657|NCT02716584|8430700|P2|Overall Study|Lost to Follow-up|5
2448658|NCT02716584|8430701|P1|Overall Study|Lost to Follow-up|8
2448659|NCT02716298|8430757|P2|First Intervention (1 Month)|Lens discomfort|1
2448660|NCT02716298|8430758|P1|First Intervention (1 Month)|Lens discomfort|1
2448661|NCT02716194|8430776|P3|Period 1 - ADVATE|Withdrawal by Subject|0
2448662|NCT02716194|8430777|P2|Period 1 - ADVATE|Withdrawal by Subject|1
2448663|NCT02716194|8430778|P1|Period 1 - ADVATE|Withdrawal by Subject|1
2448664|NCT02715726|8430858|P2|Overall Study|Randomized but not treated|2
2448665|NCT02715726|8430859|P1|Overall Study|Randomized but not treated|1
2448666|NCT02715726|8430858|P2|Overall Study|Other than specified above|15
2448667|NCT02715726|8430859|P1|Overall Study|Other than specified above|11
2448668|NCT02715726|8430858|P2|Overall Study|Participant moved|3
2448669|NCT02715726|8430859|P1|Overall Study|Participant moved|1
2448670|NCT02715726|8430858|P2|Overall Study|Death|1
2448671|NCT02715726|8430859|P1|Overall Study|Death|2
2448672|NCT02715726|8430858|P2|Overall Study|Protocol Violation|0
2448673|NCT02715726|8430859|P1|Overall Study|Protocol Violation|1
2448674|NCT02715726|8430858|P2|Overall Study|Adverse Event|6
2448675|NCT02715726|8430859|P1|Overall Study|Adverse Event|2
2448676|NCT02714868|8430939|P2|Overall Study|PI withdraw did not meet inclusion|0
2448677|NCT02714868|8430940|P1|Overall Study|PI withdraw did not meet inclusion|1
2448678|NCT02714868|8430939|P2|Overall Study|PI withdrawal safety risk self/others|0
2448679|NCT02714868|8430940|P1|Overall Study|PI withdrawal safety risk self/others|1
2448680|NCT02714868|8430939|P2|Overall Study|Withdrawal by Subject|0
2448681|NCT02714868|8430940|P1|Overall Study|Withdrawal by Subject|3
2448682|NCT02714426|8430967|P2|Overall Study|Withdrawal by Subject|2
2448683|NCT02714426|8430968|P1|Overall Study|Withdrawal by Subject|2
2448684|NCT02714218|8431029|P3|Overall Study|Stop treatment, but will do follow up|0
2448685|NCT02714218|8431030|P2|Overall Study|Stop treatment, but will do follow up|1
2448686|NCT02714218|8431031|P1|Overall Study|Stop treatment, but will do follow up|0
2448687|NCT02714218|8431029|P3|Overall Study|Complete Response|0
2448688|NCT02714218|8431030|P2|Overall Study|Complete Response|0
2448689|NCT02714218|8431031|P1|Overall Study|Complete Response|1
2448690|NCT02714218|8431029|P3|Overall Study|Dose Delayed > 6 weeks|0
2448691|NCT02714218|8431030|P2|Overall Study|Dose Delayed > 6 weeks|0
2448692|NCT02714218|8431031|P1|Overall Study|Dose Delayed > 6 weeks|1
2448693|NCT02714218|8431029|P3|Overall Study|Completed|0
2448694|NCT02714218|8431030|P2|Overall Study|Completed|0
2448695|NCT02714218|8431031|P1|Overall Study|Completed|2
2448696|NCT02714218|8431029|P3|Overall Study|Not Reported|0
2448697|NCT02714218|8431030|P2|Overall Study|Not Reported|5
2448698|NCT02714218|8431031|P1|Overall Study|Not Reported|9
2448699|NCT02714218|8431029|P3|Overall Study|Medical Decision|0
2448700|NCT02714218|8431030|P2|Overall Study|Medical Decision|1
2448701|NCT02714218|8431031|P1|Overall Study|Medical Decision|0
2448702|NCT02714218|8431029|P3|Overall Study|Maximum Clinical Benefit|0
2448703|NCT02714218|8431030|P2|Overall Study|Maximum Clinical Benefit|2
2448704|NCT02714218|8431031|P1|Overall Study|Maximum Clinical Benefit|2
2448705|NCT02714218|8431029|P3|Overall Study|Participant Withdrew Consent|0
2448706|NCT02714218|8431030|P2|Overall Study|Participant Withdrew Consent|3
2448707|NCT02714218|8431031|P1|Overall Study|Participant Withdrew Consent|2
2448708|NCT02714218|8431029|P3|Overall Study|Request to Discontinue Treatment|1
2448709|NCT02714218|8431030|P2|Overall Study|Request to Discontinue Treatment|5
2448710|NCT02714218|8431031|P1|Overall Study|Request to Discontinue Treatment|1
2448711|NCT02714218|8431029|P3|Overall Study|Study Drug Toxicity|4
2448712|NCT02714218|8431030|P2|Overall Study|Study Drug Toxicity|69
2448713|NCT02714218|8431031|P1|Overall Study|Study Drug Toxicity|46
2448714|NCT02714218|8431029|P3|Overall Study|Adverse Event Unrelated to Study Drug|0
2448715|NCT02714218|8431030|P2|Overall Study|Adverse Event Unrelated to Study Drug|6
2448716|NCT02714218|8431031|P1|Overall Study|Adverse Event Unrelated to Study Drug|10
2448717|NCT02714218|8431029|P3|Overall Study|Disease Progression|14
2448718|NCT02714218|8431030|P2|Overall Study|Disease Progression|51
2448719|NCT02714218|8431031|P1|Overall Study|Disease Progression|56
2448720|NCT02714062|8431081|P3|Overall Study|Protocol Violation|0
2448721|NCT02714062|8431082|P2|Overall Study|Protocol Violation|1
2448722|NCT02714062|8431083|P1|Overall Study|Protocol Violation|0
2448723|NCT02714062|8431081|P3|Overall Study|Withdrawal by Subject|1
2448724|NCT02714062|8431082|P2|Overall Study|Withdrawal by Subject|0
2448725|NCT02714062|8431083|P1|Overall Study|Withdrawal by Subject|1
2448726|NCT02714062|8431081|P3|Overall Study|Adverse Event|2
2448727|NCT02714062|8431082|P2|Overall Study|Adverse Event|0
2448728|NCT02714062|8431083|P1|Overall Study|Adverse Event|0
2448729|NCT02713828|8431129|P2|Overall Study|study terminated but patient allowed to|0
2448730|NCT02713828|8431130|P1|Overall Study|study terminated but patient allowed to|2
2448731|NCT02713828|8431129|P2|Overall Study|Withdrawal by Subject|0
2448732|NCT02713828|8431130|P1|Overall Study|Withdrawal by Subject|1
2448733|NCT02713828|8431129|P2|Overall Study|Death|0
2448734|NCT02713828|8431130|P1|Overall Study|Death|2
2448735|NCT02713789|8431142|P3|Overall Study|Lost to Follow-up|1
2448736|NCT02713789|8431143|P2|Overall Study|Lost to Follow-up|1
2448737|NCT02713789|8431144|P1|Overall Study|Lost to Follow-up|0
2448738|NCT02713594|8431207|P2|Overall Study|Lost to Follow-up|374
2448739|NCT02713594|8431208|P1|Overall Study|Lost to Follow-up|358
2448740|NCT02713594|8431207|P2|Overall Study|Withdrawal by Subject|22
2448741|NCT02713594|8431208|P1|Overall Study|Withdrawal by Subject|32
2448742|NCT02713542|8431220|P2|Overall Study|Withdrawal by Subject|1
2448743|NCT02713542|8431221|P1|Overall Study|Withdrawal by Subject|4
2448744|NCT02713542|8431220|P2|Overall Study|Use of prohibited medication|5
2448745|NCT02713542|8431221|P1|Overall Study|Use of prohibited medication|14
2448746|NCT02713243|8431240|P2|Overall Study|Protocol deviation|1
2448747|NCT02713243|8431241|P1|Overall Study|Protocol deviation|0
2448748|NCT02713243|8431240|P2|Overall Study|Administrative problems|1
2448749|NCT02713243|8431241|P1|Overall Study|Administrative problems|0
2448750|NCT02713243|8431240|P2|Overall Study|Abnormal laboratory value(s)#|0
2448751|NCT02713243|8431241|P1|Overall Study|Abnormal laboratory value(s)#|1
2448752|NCT02713204|8431259|P8|From Week 12 up to Week 36|Participant Re-located|0
2448753|NCT02713204|8431260|P7|From Week 12 up to Week 36|Participant Re-located|0
2448754|NCT02713204|8431261|P6|From Week 12 up to Week 36|Participant Re-located|0
2448755|NCT02713204|8431262|P5|From Week 12 up to Week 36|Participant Re-located|1
2448756|NCT02713204|8431263|P4|From Week 12 up to Week 36|Participant Re-located|0
2448757|NCT02713204|8431264|P3|From Week 12 up to Week 36|Participant Re-located|0
2448758|NCT02713204|8431265|P2|From Week 12 up to Week 36|Participant Re-located|0
2448759|NCT02713204|8431266|P1|From Week 12 up to Week 36|Participant Re-located|0
2448760|NCT02713204|8431259|P8|From Week 12 up to Week 36|Lost to Follow-up|0
2448761|NCT02713204|8431260|P7|From Week 12 up to Week 36|Lost to Follow-up|0
2448762|NCT02713204|8431261|P6|From Week 12 up to Week 36|Lost to Follow-up|0
2448763|NCT02713204|8431262|P5|From Week 12 up to Week 36|Lost to Follow-up|0
2448764|NCT02713204|8431263|P4|From Week 12 up to Week 36|Lost to Follow-up|2
2448765|NCT02713204|8431264|P3|From Week 12 up to Week 36|Lost to Follow-up|0
2448766|NCT02713204|8431265|P2|From Week 12 up to Week 36|Lost to Follow-up|0
2448767|NCT02713204|8431266|P1|From Week 12 up to Week 36|Lost to Follow-up|0
2448768|NCT02713204|8431259|P8|From Week 12 up to Week 36|Death|3
2448769|NCT02713204|8431260|P7|From Week 12 up to Week 36|Death|0
2448770|NCT02713204|8431261|P6|From Week 12 up to Week 36|Death|1
2448771|NCT02713204|8431262|P5|From Week 12 up to Week 36|Death|0
2448772|NCT02713204|8431263|P4|From Week 12 up to Week 36|Death|1
2448773|NCT02713204|8431264|P3|From Week 12 up to Week 36|Death|0
2448774|NCT02713204|8431265|P2|From Week 12 up to Week 36|Death|0
2448775|NCT02713204|8431266|P1|From Week 12 up to Week 36|Death|0
2448776|NCT02713204|8431259|P8|From Week 12 up to Week 36|Adverse Event|1
2448777|NCT02713204|8431260|P7|From Week 12 up to Week 36|Adverse Event|2
2448778|NCT02713204|8431261|P6|From Week 12 up to Week 36|Adverse Event|0
2448779|NCT02713204|8431262|P5|From Week 12 up to Week 36|Adverse Event|1
2448780|NCT02713204|8431263|P4|From Week 12 up to Week 36|Adverse Event|1
2448781|NCT02713204|8431264|P3|From Week 12 up to Week 36|Adverse Event|0
2448782|NCT02713204|8431265|P2|From Week 12 up to Week 36|Adverse Event|0
2448783|NCT02713204|8431266|P1|From Week 12 up to Week 36|Adverse Event|1
2448784|NCT02713204|8431259|P8|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2448785|NCT02713204|8431260|P7|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2448786|NCT02713204|8431261|P6|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2448787|NCT02713204|8431262|P5|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2448788|NCT02713204|8431263|P4|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2448789|NCT02713204|8431264|P3|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2448790|NCT02713204|8431265|P2|Baseline (Day 1) up to Week 12|Lost to Follow-up|1
2448791|NCT02713204|8431266|P1|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2448792|NCT02713204|8431259|P8|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2448793|NCT02713204|8431260|P7|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2448794|NCT02713204|8431261|P6|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2448795|NCT02713204|8431262|P5|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2448796|NCT02713204|8431263|P4|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2448797|NCT02713204|8431264|P3|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1
2448798|NCT02713204|8431265|P2|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2448799|NCT02713204|8431266|P1|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2448800|NCT02713204|8431259|P8|Baseline (Day 1) up to Week 12|Adverse Event|0
2448801|NCT02713204|8431260|P7|Baseline (Day 1) up to Week 12|Adverse Event|0
2448802|NCT02713204|8431261|P6|Baseline (Day 1) up to Week 12|Adverse Event|0
2448803|NCT02713204|8431262|P5|Baseline (Day 1) up to Week 12|Adverse Event|0
2448804|NCT02713204|8431263|P4|Baseline (Day 1) up to Week 12|Adverse Event|0
2448805|NCT02713204|8431264|P3|Baseline (Day 1) up to Week 12|Adverse Event|1
2448806|NCT02713204|8431265|P2|Baseline (Day 1) up to Week 12|Adverse Event|0
2448807|NCT02713204|8431266|P1|Baseline (Day 1) up to Week 12|Adverse Event|1
2448808|NCT02712788|8431325|P2|Overall Study|Protocol Violation|0
2448809|NCT02712788|8431326|P1|Overall Study|Protocol Violation|1
2448810|NCT02712788|8431325|P2|Overall Study|Physician Decision|0
2448811|NCT02712788|8431326|P1|Overall Study|Physician Decision|1
2448812|NCT02712554|8431336|P2|Part B: Treatment Phase|Other|1
2448813|NCT02712554|8431337|P1|Part B: Treatment Phase|Other|0
2448814|NCT02712554|8431336|P2|Part B: Treatment Phase|Withdrawal by Subject|1
2448815|NCT02712554|8431337|P1|Part B: Treatment Phase|Withdrawal by Subject|0
2448816|NCT02712554|8431336|P2|Part B: Treatment Phase|Adverse Event|1
2448817|NCT02712554|8431337|P1|Part B: Treatment Phase|Adverse Event|0
2448818|NCT02712554|8431336|P2|Part B: Qualification Phase|Adverse Event|1
2448819|NCT02712554|8431337|P1|Part B: Qualification Phase|Adverse Event|0
2448820|NCT02712554|8431336|P2|Part B: Qualification Phase|Withdrawal by Subject|3
2448821|NCT02712554|8431337|P1|Part B: Qualification Phase|Withdrawal by Subject|0
2448822|NCT02712554|8431336|P2|Part B: Qualification Phase|Sponsor Decision|4
2448823|NCT02712554|8431337|P1|Part B: Qualification Phase|Sponsor Decision|0
2448824|NCT02712554|8431336|P2|Part B: Qualification Phase|Drug Discrimination Failure|13
2448825|NCT02712554|8431337|P1|Part B: Qualification Phase|Drug Discrimination Failure|0
2448826|NCT02712333|8431482|P2|First Period|Withdrawal by Subject|2
2448827|NCT02712333|8431483|P1|First Period|Withdrawal by Subject|3
2448828|NCT02712320|8431501|P1|Overall Study|Treating with the prohibited medications|2
2448829|NCT02712320|8431501|P1|Overall Study|Transferred to another facility|1
2448830|NCT02712320|8431501|P1|Overall Study|Withdrawal by Subject|1
2448831|NCT02712320|8431501|P1|Overall Study|Lost to Follow-up|1
2448832|NCT02712008|8431544|P8|From Week 12 up to Week 36|Withdrawal by Subject|2
2448833|NCT02712008|8431545|P7|From Week 12 up to Week 36|Withdrawal by Subject|3
2448834|NCT02712008|8431546|P6|From Week 12 up to Week 36|Withdrawal by Subject|0
2448835|NCT02712008|8431547|P5|From Week 12 up to Week 36|Withdrawal by Subject|0
2448836|NCT02712008|8431548|P4|From Week 12 up to Week 36|Withdrawal by Subject|0
2448837|NCT02712008|8431549|P3|From Week 12 up to Week 36|Withdrawal by Subject|0
2448838|NCT02712008|8431550|P2|From Week 12 up to Week 36|Withdrawal by Subject|0
2448839|NCT02712008|8431551|P1|From Week 12 up to Week 36|Withdrawal by Subject|0
2448840|NCT02712008|8431544|P8|From Week 12 up to Week 36|Physician Decision|0
2448841|NCT02712008|8431545|P7|From Week 12 up to Week 36|Physician Decision|0
2448842|NCT02712008|8431546|P6|From Week 12 up to Week 36|Physician Decision|0
2448843|NCT02712008|8431547|P5|From Week 12 up to Week 36|Physician Decision|1
2448844|NCT02712008|8431548|P4|From Week 12 up to Week 36|Physician Decision|1
2448845|NCT02712008|8431549|P3|From Week 12 up to Week 36|Physician Decision|0
2448846|NCT02712008|8431550|P2|From Week 12 up to Week 36|Physician Decision|0
2448847|NCT02712008|8431551|P1|From Week 12 up to Week 36|Physician Decision|0
2448848|NCT02712008|8431544|P8|From Week 12 up to Week 36|Lost to Follow-up|0
2448849|NCT02712008|8431545|P7|From Week 12 up to Week 36|Lost to Follow-up|1
2448850|NCT02712008|8431546|P6|From Week 12 up to Week 36|Lost to Follow-up|0
2448851|NCT02712008|8431547|P5|From Week 12 up to Week 36|Lost to Follow-up|0
2448852|NCT02712008|8431548|P4|From Week 12 up to Week 36|Lost to Follow-up|1
2448853|NCT02712008|8431549|P3|From Week 12 up to Week 36|Lost to Follow-up|0
2448854|NCT02712008|8431550|P2|From Week 12 up to Week 36|Lost to Follow-up|0
2448855|NCT02712008|8431551|P1|From Week 12 up to Week 36|Lost to Follow-up|0
2448856|NCT02712008|8431544|P8|From Week 12 up to Week 36|Death|0
2448857|NCT02712008|8431545|P7|From Week 12 up to Week 36|Death|1
2448858|NCT02712008|8431546|P6|From Week 12 up to Week 36|Death|0
2448859|NCT02712008|8431547|P5|From Week 12 up to Week 36|Death|0
2448860|NCT02712008|8431548|P4|From Week 12 up to Week 36|Death|0
2448861|NCT02712008|8431549|P3|From Week 12 up to Week 36|Death|0
2448862|NCT02712008|8431550|P2|From Week 12 up to Week 36|Death|0
2448863|NCT02712008|8431551|P1|From Week 12 up to Week 36|Death|1
2448864|NCT02712008|8431544|P8|From Week 12 up to Week 36|Adverse Event|2
2448865|NCT02712008|8431545|P7|From Week 12 up to Week 36|Adverse Event|0
2448866|NCT02712008|8431546|P6|From Week 12 up to Week 36|Adverse Event|0
2448867|NCT02712008|8431547|P5|From Week 12 up to Week 36|Adverse Event|1
2448868|NCT02712008|8431548|P4|From Week 12 up to Week 36|Adverse Event|0
2448869|NCT02712008|8431549|P3|From Week 12 up to Week 36|Adverse Event|0
2448870|NCT02712008|8431550|P2|From Week 12 up to Week 36|Adverse Event|0
2448871|NCT02712008|8431551|P1|From Week 12 up to Week 36|Adverse Event|0
2448872|NCT02712008|8431544|P8|Baseline (Day 1) up to Week 12|Other Unspecified|0
2448873|NCT02712008|8431545|P7|Baseline (Day 1) up to Week 12|Other Unspecified|0
2448874|NCT02712008|8431546|P6|Baseline (Day 1) up to Week 12|Other Unspecified|0
2448875|NCT02712008|8431547|P5|Baseline (Day 1) up to Week 12|Other Unspecified|0
2448876|NCT02712008|8431548|P4|Baseline (Day 1) up to Week 12|Other Unspecified|0
2448877|NCT02712008|8431549|P3|Baseline (Day 1) up to Week 12|Other Unspecified|0
2448878|NCT02712008|8431550|P2|Baseline (Day 1) up to Week 12|Other Unspecified|1
2448879|NCT02712008|8431551|P1|Baseline (Day 1) up to Week 12|Other Unspecified|0
2448880|NCT02712008|8431544|P8|Baseline (Day 1) up to Week 12|Protocol Violation|0
2448881|NCT02712008|8431545|P7|Baseline (Day 1) up to Week 12|Protocol Violation|0
2448882|NCT02712008|8431546|P6|Baseline (Day 1) up to Week 12|Protocol Violation|0
2448883|NCT02712008|8431547|P5|Baseline (Day 1) up to Week 12|Protocol Violation|0
2448884|NCT02712008|8431548|P4|Baseline (Day 1) up to Week 12|Protocol Violation|0
2448885|NCT02712008|8431549|P3|Baseline (Day 1) up to Week 12|Protocol Violation|1
2448886|NCT02712008|8431550|P2|Baseline (Day 1) up to Week 12|Protocol Violation|0
2448887|NCT02712008|8431551|P1|Baseline (Day 1) up to Week 12|Protocol Violation|0
2448888|NCT02712008|8431544|P8|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2448889|NCT02712008|8431545|P7|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2448890|NCT02712008|8431546|P6|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2448891|NCT02712008|8431547|P5|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2448892|NCT02712008|8431548|P4|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2448893|NCT02712008|8431549|P3|Baseline (Day 1) up to Week 12|Lost to Follow-up|2
2448894|NCT02712008|8431550|P2|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
2448895|NCT02712008|8431551|P1|Baseline (Day 1) up to Week 12|Lost to Follow-up|1
2448896|NCT02712008|8431544|P8|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2448897|NCT02712008|8431545|P7|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2448898|NCT02712008|8431546|P6|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2448899|NCT02712008|8431547|P5|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2448900|NCT02712008|8431548|P4|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2448901|NCT02712008|8431549|P3|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1
2448902|NCT02712008|8431550|P2|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2
2448903|NCT02712008|8431551|P1|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
2448904|NCT02712008|8431544|P8|Baseline (Day 1) up to Week 12|Death|0
2448905|NCT02712008|8431545|P7|Baseline (Day 1) up to Week 12|Death|0
2448906|NCT02712008|8431546|P6|Baseline (Day 1) up to Week 12|Death|0
2448907|NCT02712008|8431547|P5|Baseline (Day 1) up to Week 12|Death|0
2448908|NCT02712008|8431548|P4|Baseline (Day 1) up to Week 12|Death|0
2448909|NCT02712008|8431549|P3|Baseline (Day 1) up to Week 12|Death|0
2448910|NCT02712008|8431550|P2|Baseline (Day 1) up to Week 12|Death|0
2448911|NCT02712008|8431551|P1|Baseline (Day 1) up to Week 12|Death|3
2448912|NCT02711995|8431583|P1|Washout (90 Days)|Conflicting medication|1
2448913|NCT02711800|8431622|P1|Overall Study|Withdrawal by Subject|1
2448914|NCT02711800|8431622|P1|Overall Study|Lost to Follow-up|1
2448915|NCT02711345|8431641|P10|Overall Study|Death|0
2448916|NCT02711345|8431642|P9|Overall Study|Death|0
2448917|NCT02711345|8431643|P8|Overall Study|Death|1
2448918|NCT02711345|8431644|P7|Overall Study|Death|0
2448919|NCT02711345|8431645|P6|Overall Study|Death|0
2448920|NCT02711345|8431646|P5|Overall Study|Death|0
2448921|NCT02711345|8431647|P4|Overall Study|Death|0
2448922|NCT02711345|8431648|P3|Overall Study|Death|0
2448923|NCT02711345|8431649|P2|Overall Study|Death|0
2448924|NCT02711345|8431650|P1|Overall Study|Death|1
2448925|NCT02711345|8431641|P10|Overall Study|Subject/guardian decision|4
2448926|NCT02711345|8431642|P9|Overall Study|Subject/guardian decision|0
2448927|NCT02711345|8431643|P8|Overall Study|Subject/guardian decision|1
2448928|NCT02711345|8431644|P7|Overall Study|Subject/guardian decision|3
2448929|NCT02711345|8431645|P6|Overall Study|Subject/guardian decision|2
2448930|NCT02711345|8431646|P5|Overall Study|Subject/guardian decision|0
2448931|NCT02711345|8431647|P4|Overall Study|Subject/guardian decision|0
2448932|NCT02711345|8431648|P3|Overall Study|Subject/guardian decision|0
2448933|NCT02711345|8431649|P2|Overall Study|Subject/guardian decision|0
2448934|NCT02711345|8431650|P1|Overall Study|Subject/guardian decision|0
2448935|NCT02711345|8431641|P10|Overall Study|Progressive disease|6
2448936|NCT02711345|8431642|P9|Overall Study|Progressive disease|5
2448937|NCT02711345|8431643|P8|Overall Study|Progressive disease|4
2448938|NCT02711345|8431644|P7|Overall Study|Progressive disease|8
2448939|NCT02711345|8431645|P6|Overall Study|Progressive disease|2
2448940|NCT02711345|8431646|P5|Overall Study|Progressive disease|7
2448941|NCT02711345|8431647|P4|Overall Study|Progressive disease|3
2448942|NCT02711345|8431648|P3|Overall Study|Progressive disease|5
2448943|NCT02711345|8431649|P2|Overall Study|Progressive disease|3
2448944|NCT02711345|8431650|P1|Overall Study|Progressive disease|1
2448945|NCT02711345|8431641|P10|Overall Study|Physician Decision|0
2448946|NCT02711345|8431642|P9|Overall Study|Physician Decision|1
2448947|NCT02711345|8431643|P8|Overall Study|Physician Decision|0
2448948|NCT02711345|8431644|P7|Overall Study|Physician Decision|0
2448949|NCT02711345|8431645|P6|Overall Study|Physician Decision|0
2448950|NCT02711345|8431646|P5|Overall Study|Physician Decision|0
2448951|NCT02711345|8431647|P4|Overall Study|Physician Decision|0
2448952|NCT02711345|8431648|P3|Overall Study|Physician Decision|1
2448953|NCT02711345|8431649|P2|Overall Study|Physician Decision|0
2448954|NCT02711345|8431650|P1|Overall Study|Physician Decision|0
2448955|NCT02711345|8431641|P10|Overall Study|Adverse Event|2
2448956|NCT02711345|8431642|P9|Overall Study|Adverse Event|0
2448957|NCT02711345|8431643|P8|Overall Study|Adverse Event|0
2448958|NCT02711345|8431644|P7|Overall Study|Adverse Event|1
2448959|NCT02711345|8431645|P6|Overall Study|Adverse Event|2
2448960|NCT02711345|8431646|P5|Overall Study|Adverse Event|1
2448961|NCT02711345|8431647|P4|Overall Study|Adverse Event|1
2448962|NCT02711345|8431648|P3|Overall Study|Adverse Event|0
2448963|NCT02711345|8431649|P2|Overall Study|Adverse Event|0
2448964|NCT02711345|8431650|P1|Overall Study|Adverse Event|0
2448965|NCT02711306|8431836|P2|Overall Study|Withdrawal by Subject|2
2448966|NCT02711306|8431837|P1|Overall Study|Withdrawal by Subject|2
2448967|NCT02710422|8432008|P2|Overall Study|Termination of study|9
2448968|NCT02710422|8432009|P1|Overall Study|Termination of study|9
2448969|NCT02710292|8432025|P2|Period 1, First 10 Days of Wear|Withdrawal by Subject|2
2448970|NCT02710292|8432026|P1|Period 1, First 10 Days of Wear|Withdrawal by Subject|1
2448971|NCT02710292|8432025|P2|Period 1, First 10 Days of Wear|Adverse Event|1
2448972|NCT02710292|8432026|P1|Period 1, First 10 Days of Wear|Adverse Event|0
2448973|NCT02710136|8432035|P2|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0
2448974|NCT02710136|8432036|P1|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1
2448975|NCT02710045|8432062|P3|Overall Study|Poor Attendance|0
2448976|NCT02710045|8432063|P2|Overall Study|Poor Attendance|1
2448977|NCT02710045|8432064|P1|Overall Study|Poor Attendance|0
2448978|NCT02710045|8432062|P3|Overall Study|Physician Decision|1
2448979|NCT02710045|8432063|P2|Overall Study|Physician Decision|0
2448980|NCT02710045|8432064|P1|Overall Study|Physician Decision|0
2448981|NCT02710045|8432062|P3|Overall Study|Lost to Follow-up|7
2448982|NCT02710045|8432063|P2|Overall Study|Lost to Follow-up|6
2448983|NCT02710045|8432064|P1|Overall Study|Lost to Follow-up|3
2448984|NCT02710045|8432062|P3|Overall Study|Protocol Violation|3
2448985|NCT02710045|8432063|P2|Overall Study|Protocol Violation|2
2448986|NCT02710045|8432064|P1|Overall Study|Protocol Violation|1
2448987|NCT02710045|8432062|P3|Overall Study|Withdrawal by Subject|2
2448988|NCT02710045|8432063|P2|Overall Study|Withdrawal by Subject|6
2448989|NCT02710045|8432064|P1|Overall Study|Withdrawal by Subject|6
2448990|NCT02710045|8432062|P3|Overall Study|Death|0
2448991|NCT02710045|8432063|P2|Overall Study|Death|2
2448992|NCT02710045|8432064|P1|Overall Study|Death|1
2448993|NCT02709785|8432093|P3|Overall Study|Withdrawal by Subject|1
2448994|NCT02709785|8432094|P2|Overall Study|Withdrawal by Subject|2
2448995|NCT02709785|8432095|P1|Overall Study|Withdrawal by Subject|1
2448996|NCT02709577|8432117|P4|Overall Study|Withdrawal by Subject|0
2448997|NCT02709577|8432118|P3|Overall Study|Withdrawal by Subject|2
2448998|NCT02709577|8432119|P2|Overall Study|Withdrawal by Subject|3
2448999|NCT02709577|8432120|P1|Overall Study|Withdrawal by Subject|2
2449000|NCT02709577|8432117|P4|Overall Study|procedural complication|0
2449001|NCT02709577|8432118|P3|Overall Study|procedural complication|0
2449002|NCT02709577|8432119|P2|Overall Study|procedural complication|1
2449003|NCT02709577|8432120|P1|Overall Study|procedural complication|0
2449004|NCT02709577|8432117|P4|Overall Study|non-accommodating anatomy|0
2449005|NCT02709577|8432118|P3|Overall Study|non-accommodating anatomy|0
2449006|NCT02709577|8432119|P2|Overall Study|non-accommodating anatomy|1
2449007|NCT02709577|8432120|P1|Overall Study|non-accommodating anatomy|0
2449008|NCT02709538|8432135|P3|Overall Study|Other|5
2449009|NCT02709538|8432136|P2|Overall Study|Other|7
2449010|NCT02709538|8432137|P1|Overall Study|Other|16
2449011|NCT02709538|8432135|P3|Overall Study|Withdrawal by Parent or Legal Guardian|0
2449012|NCT02709538|8432136|P2|Overall Study|Withdrawal by Parent or Legal Guardian|0
2449013|NCT02709538|8432137|P1|Overall Study|Withdrawal by Parent or Legal Guardian|1
2449014|NCT02709538|8432135|P3|Overall Study|Protocol deviation|4
2449015|NCT02709538|8432136|P2|Overall Study|Protocol deviation|4
2449016|NCT02709538|8432137|P1|Overall Study|Protocol deviation|10
2449017|NCT02709538|8432135|P3|Overall Study|Non-compliance with study drug|0
2449018|NCT02709538|8432136|P2|Overall Study|Non-compliance with study drug|0
2449019|NCT02709538|8432137|P1|Overall Study|Non-compliance with study drug|2
2449020|NCT02709538|8432135|P3|Overall Study|Non-compliance with study procedures|0
2449021|NCT02709538|8432136|P2|Overall Study|Non-compliance with study procedures|0
2449022|NCT02709538|8432137|P1|Overall Study|Non-compliance with study procedures|5
2449023|NCT02709538|8432135|P3|Overall Study|Withdrawal by Subject|4
2449024|NCT02709538|8432136|P2|Overall Study|Withdrawal by Subject|7
2449025|NCT02709538|8432137|P1|Overall Study|Withdrawal by Subject|40
2449026|NCT02709538|8432135|P3|Overall Study|Physician Decision|0
2449027|NCT02709538|8432136|P2|Overall Study|Physician Decision|0
2449028|NCT02709538|8432137|P1|Overall Study|Physician Decision|1
2449029|NCT02709538|8432135|P3|Overall Study|Lost to Follow-up|4
2449030|NCT02709538|8432136|P2|Overall Study|Lost to Follow-up|8
2449031|NCT02709538|8432137|P1|Overall Study|Lost to Follow-up|24
2449032|NCT02709538|8432135|P3|Overall Study|Lack of Efficacy|0
2449033|NCT02709538|8432136|P2|Overall Study|Lack of Efficacy|0
2449034|NCT02709538|8432137|P1|Overall Study|Lack of Efficacy|1
2449035|NCT02709538|8432135|P3|Overall Study|Adverse Event|3
2449036|NCT02709538|8432136|P2|Overall Study|Adverse Event|2
2449037|NCT02709538|8432137|P1|Overall Study|Adverse Event|13
2449038|NCT02709486|8432148|P3|Overall Study|Withdrawal by Subject|32
2449039|NCT02709486|8432149|P2|Overall Study|Withdrawal by Subject|22
2449040|NCT02709486|8432150|P1|Overall Study|Withdrawal by Subject|32
2449041|NCT02709486|8432148|P3|Overall Study|Other|3
2449042|NCT02709486|8432149|P2|Overall Study|Other|2
2449043|NCT02709486|8432150|P1|Overall Study|Other|0
2449044|NCT02709486|8432148|P3|Overall Study|Lost to Follow-up|2
2449045|NCT02709486|8432149|P2|Overall Study|Lost to Follow-up|2
2449046|NCT02709486|8432150|P1|Overall Study|Lost to Follow-up|3
2449047|NCT02709486|8432148|P3|Overall Study|Insufficient clinical response|3
2449048|NCT02709486|8432149|P2|Overall Study|Insufficient clinical response|3
2449049|NCT02709486|8432150|P1|Overall Study|Insufficient clinical response|7
2449050|NCT02709486|8432148|P3|Overall Study|Death|2
2449051|NCT02709486|8432149|P2|Overall Study|Death|0
2449052|NCT02709486|8432150|P1|Overall Study|Death|0
2449053|NCT02709486|8432148|P3|Overall Study|Adverse Event|3
2449054|NCT02709486|8432149|P2|Overall Study|Adverse Event|5
2449055|NCT02709486|8432150|P1|Overall Study|Adverse Event|2
2449056|NCT02709369|8432341|P1|Overall Study|Did not received intervention|2
2449057|NCT02709369|8432341|P1|Overall Study|Withdrawal by Subject|10
2449058|NCT02709369|8432341|P1|Overall Study|Lost to Follow-up|15
2449059|NCT02709330|8432375|P2|Overall Study|Withdrawal by Subject|0
2449060|NCT02709330|8432376|P1|Overall Study|Withdrawal by Subject|4
2449061|NCT02709330|8432375|P2|Overall Study|Physician Decision|0
2449062|NCT02709330|8432376|P1|Overall Study|Physician Decision|2
2449063|NCT02709330|8432375|P2|Overall Study|Lost to Follow-up|0
2449064|NCT02709330|8432376|P1|Overall Study|Lost to Follow-up|2
2449065|NCT02709330|8432375|P2|Overall Study|Death|0
2449066|NCT02709330|8432376|P1|Overall Study|Death|5
2449067|NCT02709096|8432390|P2|Overall Study|non-compliance|1
2449068|NCT02709096|8432391|P1|Overall Study|non-compliance|1
2449069|NCT02709083|8432397|P1|Overall Study|Original PI left institution|7
2449070|NCT02709005|8432410|P2|Overall Study|Withdrawal by Subject|0
2449071|NCT02709005|8432411|P1|Overall Study|Withdrawal by Subject|3
2449072|NCT02709005|8432410|P2|Overall Study|Lost to Follow-up|1
2449073|NCT02709005|8432411|P1|Overall Study|Lost to Follow-up|1
2449074|NCT02708524|8432469|P4|Overall Study|Subject lost study lens|0
2449075|NCT02708524|8432470|P3|Overall Study|Subject lost study lens|0
2449076|NCT02708524|8432471|P2|Overall Study|Subject lost study lens|0
2449077|NCT02708524|8432472|P1|Overall Study|Subject lost study lens|1
2449078|NCT02708524|8432469|P4|Overall Study|Did not wear lens at final visit|0
2449079|NCT02708524|8432470|P3|Overall Study|Did not wear lens at final visit|0
2449080|NCT02708524|8432471|P2|Overall Study|Did not wear lens at final visit|1
2449081|NCT02708524|8432472|P1|Overall Study|Did not wear lens at final visit|0
2449082|NCT02708524|8432469|P4|Overall Study|Dispensed incorrect study lens|0
2449083|NCT02708524|8432470|P3|Overall Study|Dispensed incorrect study lens|1
2449084|NCT02708524|8432471|P2|Overall Study|Dispensed incorrect study lens|1
2449085|NCT02708524|8432472|P1|Overall Study|Dispensed incorrect study lens|0
2449086|NCT02708524|8432469|P4|Overall Study|Withdrawal by Subject|0
2449087|NCT02708524|8432470|P3|Overall Study|Withdrawal by Subject|0
2449088|NCT02708524|8432471|P2|Overall Study|Withdrawal by Subject|1
2449089|NCT02708524|8432472|P1|Overall Study|Withdrawal by Subject|1
2449090|NCT02708524|8432469|P4|Overall Study|Protocol Violation|0
2449091|NCT02708524|8432470|P3|Overall Study|Protocol Violation|0
2449092|NCT02708524|8432471|P2|Overall Study|Protocol Violation|1
2449093|NCT02708524|8432472|P1|Overall Study|Protocol Violation|0
2449094|NCT02708524|8432469|P4|Overall Study|Lost to Follow-up|0
2449095|NCT02708524|8432470|P3|Overall Study|Lost to Follow-up|1
2449096|NCT02708524|8432471|P2|Overall Study|Lost to Follow-up|1
2449097|NCT02708524|8432472|P1|Overall Study|Lost to Follow-up|1
2449098|NCT02708524|8432469|P4|Overall Study|Lens Discomfort|0
2449099|NCT02708524|8432470|P3|Overall Study|Lens Discomfort|1
2449100|NCT02708524|8432471|P2|Overall Study|Lens Discomfort|0
2449101|NCT02708524|8432472|P1|Overall Study|Lens Discomfort|1
2449102|NCT02708524|8432469|P4|Overall Study|Adverse Event|0
2449103|NCT02708524|8432470|P3|Overall Study|Adverse Event|0
2449104|NCT02708524|8432471|P2|Overall Study|Adverse Event|1
2449105|NCT02708524|8432472|P1|Overall Study|Adverse Event|0
2449106|NCT02708485|8432520|P2|Overall Study|Withdrawal by Subject|2
2449107|NCT02708485|8432521|P1|Overall Study|Withdrawal by Subject|3
2449108|NCT02708355|8432541|P3|Overall Study|Adverse Event|0
2449109|NCT02708355|8432542|P2|Overall Study|Adverse Event|0
2449110|NCT02708355|8432543|P1|Overall Study|Adverse Event|1
2449111|NCT02708277|8432567|P2|Overall Study|Lost to Follow-up|4
2449112|NCT02708277|8432568|P1|Overall Study|Lost to Follow-up|7
2449113|NCT02708121|8432611|P2|Overall Study|Withdrawal by Subject|4
2449114|NCT02708121|8432612|P1|Overall Study|Withdrawal by Subject|0
2449115|NCT02708121|8432611|P2|Overall Study|Withdrawn by Study Team|1
2449116|NCT02708121|8432612|P1|Overall Study|Withdrawn by Study Team|1
2449117|NCT02708095|8432624|P3|Overall Study|Withdrawal by Subject|4
2449118|NCT02708095|8432625|P2|Overall Study|Withdrawal by Subject|3
2449119|NCT02708095|8432626|P1|Overall Study|Withdrawal by Subject|5
2449120|NCT02708095|8432624|P3|Overall Study|Protocol Violation|1
2449121|NCT02708095|8432625|P2|Overall Study|Protocol Violation|0
2449122|NCT02708095|8432626|P1|Overall Study|Protocol Violation|0
2449123|NCT02708095|8432624|P3|Overall Study|Physician Decision|2
2449124|NCT02708095|8432625|P2|Overall Study|Physician Decision|3
2449125|NCT02708095|8432626|P1|Overall Study|Physician Decision|2
2449126|NCT02708095|8432624|P3|Overall Study|Lost to Follow-up|0
2449127|NCT02708095|8432625|P2|Overall Study|Lost to Follow-up|0
2449128|NCT02708095|8432626|P1|Overall Study|Lost to Follow-up|2
2449129|NCT02708095|8432624|P3|Overall Study|Lack of Efficacy|0
2449130|NCT02708095|8432625|P2|Overall Study|Lack of Efficacy|3
2449131|NCT02708095|8432626|P1|Overall Study|Lack of Efficacy|9
2449132|NCT02708095|8432624|P3|Overall Study|Adverse Event|11
2449133|NCT02708095|8432625|P2|Overall Study|Adverse Event|10
2449134|NCT02708095|8432626|P1|Overall Study|Adverse Event|4
2449135|NCT02707991|8432649|P2|Overall Study|Became ineligible|1
2449136|NCT02707991|8432650|P1|Overall Study|Became ineligible|0
2449137|NCT02707991|8432649|P2|Overall Study|Protocol Violation|0
2449138|NCT02707991|8432650|P1|Overall Study|Protocol Violation|1
2449139|NCT02707965|8432667|P16|Overall Study|Protocol deviation|0
2449140|NCT02707965|8432668|P15|Overall Study|Protocol deviation|0
2449141|NCT02707965|8432669|P14|Overall Study|Protocol deviation|0
2449142|NCT02707965|8432670|P13|Overall Study|Protocol deviation|0
2449143|NCT02707965|8432671|P12|Overall Study|Protocol deviation|0
2449144|NCT02707965|8432672|P11|Overall Study|Protocol deviation|0
2449145|NCT02707965|8432673|P10|Overall Study|Protocol deviation|0
2449146|NCT02707965|8432674|P9|Overall Study|Protocol deviation|0
2449147|NCT02707965|8432675|P8|Overall Study|Protocol deviation|1
2449148|NCT02707965|8432676|P7|Overall Study|Protocol deviation|0
2449149|NCT02707965|8432677|P6|Overall Study|Protocol deviation|0
2449150|NCT02707965|8432678|P5|Overall Study|Protocol deviation|0
2449151|NCT02707965|8432679|P4|Overall Study|Protocol deviation|0
2449152|NCT02707965|8432680|P3|Overall Study|Protocol deviation|0
2449153|NCT02707965|8432681|P2|Overall Study|Protocol deviation|1
2449154|NCT02707965|8432682|P1|Overall Study|Protocol deviation|1
2449155|NCT02707965|8432667|P16|Overall Study|PI decisions|0
2449156|NCT02707965|8432668|P15|Overall Study|PI decisions|2
2449157|NCT02707965|8432669|P14|Overall Study|PI decisions|0
2449158|NCT02707965|8432670|P13|Overall Study|PI decisions|0
2449159|NCT02707965|8432671|P12|Overall Study|PI decisions|0
2449160|NCT02707965|8432672|P11|Overall Study|PI decisions|0
2449161|NCT02707965|8432673|P10|Overall Study|PI decisions|0
2449162|NCT02707965|8432674|P9|Overall Study|PI decisions|0
2449163|NCT02707965|8432675|P8|Overall Study|PI decisions|0
2449164|NCT02707965|8432676|P7|Overall Study|PI decisions|0
2449165|NCT02707965|8432677|P6|Overall Study|PI decisions|0
2449166|NCT02707965|8432678|P5|Overall Study|PI decisions|0
2449167|NCT02707965|8432679|P4|Overall Study|PI decisions|0
2449168|NCT02707965|8432680|P3|Overall Study|PI decisions|0
2449169|NCT02707965|8432681|P2|Overall Study|PI decisions|0
2449170|NCT02707965|8432682|P1|Overall Study|PI decisions|0
2449171|NCT02707965|8432667|P16|Overall Study|Withdrawal by Subject|0
2449172|NCT02707965|8432668|P15|Overall Study|Withdrawal by Subject|0
2449173|NCT02707965|8432669|P14|Overall Study|Withdrawal by Subject|0
2449174|NCT02707965|8432670|P13|Overall Study|Withdrawal by Subject|0
2449175|NCT02707965|8432671|P12|Overall Study|Withdrawal by Subject|0
2449176|NCT02707965|8432672|P11|Overall Study|Withdrawal by Subject|0
2449177|NCT02707965|8432673|P10|Overall Study|Withdrawal by Subject|0
2449178|NCT02707965|8432674|P9|Overall Study|Withdrawal by Subject|0
2449179|NCT02707965|8432675|P8|Overall Study|Withdrawal by Subject|2
2449180|NCT02707965|8432676|P7|Overall Study|Withdrawal by Subject|0
2449181|NCT02707965|8432677|P6|Overall Study|Withdrawal by Subject|0
2449182|NCT02707965|8432678|P5|Overall Study|Withdrawal by Subject|0
2449183|NCT02707965|8432679|P4|Overall Study|Withdrawal by Subject|0
2449184|NCT02707965|8432680|P3|Overall Study|Withdrawal by Subject|1
2449185|NCT02707965|8432681|P2|Overall Study|Withdrawal by Subject|0
2449186|NCT02707965|8432682|P1|Overall Study|Withdrawal by Subject|0
2449187|NCT02707952|8432734|P4|Overall Study|Withdrawal by Subject|0
2449188|NCT02707952|8432735|P3|Overall Study|Withdrawal by Subject|2
2449189|NCT02707952|8432736|P2|Overall Study|Withdrawal by Subject|1
2449190|NCT02707952|8432737|P1|Overall Study|Withdrawal by Subject|0
2449191|NCT02707952|8432734|P4|Overall Study|Lost to Follow-up|0
2449192|NCT02707952|8432735|P3|Overall Study|Lost to Follow-up|0
2449193|NCT02707952|8432736|P2|Overall Study|Lost to Follow-up|0
2449194|NCT02707952|8432737|P1|Overall Study|Lost to Follow-up|1
2449195|NCT02707952|8432734|P4|Overall Study|Adverse Event|0
2449196|NCT02707952|8432735|P3|Overall Study|Adverse Event|0
2449197|NCT02707952|8432736|P2|Overall Study|Adverse Event|0
2449198|NCT02707952|8432737|P1|Overall Study|Adverse Event|1
2449199|NCT02707640|8432758|P2|Overall Study|Sponsor Discretion|0
2449200|NCT02707640|8432759|P1|Overall Study|Sponsor Discretion|1
2449201|NCT02707640|8432758|P2|Overall Study|Participant's Personal Decision|2
2449202|NCT02707640|8432759|P1|Overall Study|Participant's Personal Decision|1
2449203|NCT02707640|8432758|P2|Overall Study|Withdrawal by Subject|1
2449204|NCT02707640|8432759|P1|Overall Study|Withdrawal by Subject|0
2449205|NCT02707640|8432758|P2|Overall Study|Physician Decision|0
2449206|NCT02707640|8432759|P1|Overall Study|Physician Decision|2
2449207|NCT02707640|8432758|P2|Overall Study|Death|2
2449208|NCT02707640|8432759|P1|Overall Study|Death|1
2449209|NCT02707640|8432758|P2|Overall Study|Adverse Event|2
2449210|NCT02707640|8432759|P1|Overall Study|Adverse Event|4
2449211|NCT02707601|8432779|P2|Overall Study|Participants Randomized but Not Treated|0
2449212|NCT02707601|8432780|P1|Overall Study|Participants Randomized but Not Treated|2
2449213|NCT02707601|8432779|P2|Overall Study|Lost to Follow-up|1
2449214|NCT02707601|8432780|P1|Overall Study|Lost to Follow-up|1
2449215|NCT02707601|8432779|P2|Overall Study|Withdrew Consent|1
2449216|NCT02707601|8432780|P1|Overall Study|Withdrew Consent|0
2449217|NCT02707601|8432779|P2|Overall Study|Investigator's Discretion|0
2449218|NCT02707601|8432780|P1|Overall Study|Investigator's Discretion|1
2449219|NCT02707601|8432779|P2|Overall Study|Lack of Efficacy|1
2449220|NCT02707601|8432780|P1|Overall Study|Lack of Efficacy|0
2449221|NCT02707601|8432779|P2|Overall Study|Death|1
2449222|NCT02707601|8432780|P1|Overall Study|Death|0
2449223|NCT02706951|8432826|P3|Overall Study|Other|0
2449224|NCT02706951|8432827|P2|Overall Study|Other|1
2449225|NCT02706951|8432828|P1|Overall Study|Other|2
2449226|NCT02706951|8432826|P3|Overall Study|Lost to Follow-up|1
2449227|NCT02706951|8432827|P2|Overall Study|Lost to Follow-up|4
2449228|NCT02706951|8432828|P1|Overall Study|Lost to Follow-up|0
2449229|NCT02706951|8432826|P3|Overall Study|Withdrawal by Subject|6
2449230|NCT02706951|8432827|P2|Overall Study|Withdrawal by Subject|6
2449231|NCT02706951|8432828|P1|Overall Study|Withdrawal by Subject|11
2449232|NCT02706951|8432826|P3|Overall Study|Adverse Event|3
2449233|NCT02706951|8432827|P2|Overall Study|Adverse Event|5
2449234|NCT02706951|8432828|P1|Overall Study|Adverse Event|1
2449235|NCT02706938|8432862|P2|Second Period, 6 Weeks|Withdrawal by Subject|3
2449236|NCT02706938|8432863|P1|Second Period, 6 Weeks|Withdrawal by Subject|0
2449237|NCT02706938|8432862|P2|Second Period, 6 Weeks|Adverse Event|7
2449238|NCT02706938|8432863|P1|Second Period, 6 Weeks|Adverse Event|0
2449239|NCT02706938|8432862|P2|First Period, 6 Weeks|Withdrawal by Subject|0
2449240|NCT02706938|8432863|P1|First Period, 6 Weeks|Withdrawal by Subject|1
2449241|NCT02706938|8432862|P2|First Period, 6 Weeks|Lost to Follow-up|2
2449242|NCT02706938|8432863|P1|First Period, 6 Weeks|Lost to Follow-up|2
2449243|NCT02706938|8432862|P2|First Period, 6 Weeks|Adverse Event|0
2449244|NCT02706938|8432863|P1|First Period, 6 Weeks|Adverse Event|8
2449245|NCT02706899|8432927|P2|Overall Study|Study Termination by Sponsor|6
2449246|NCT02706899|8432928|P1|Overall Study|Study Termination by Sponsor|4
2449247|NCT02706899|8432927|P2|Overall Study|Death|0
2449248|NCT02706899|8432928|P1|Overall Study|Death|8
2449249|NCT02706899|8432927|P2|Overall Study|Withdrawal by Subject|0
2449250|NCT02706899|8432928|P1|Overall Study|Withdrawal by Subject|1
2449251|NCT02706886|8432959|P9|Part A: SAD Period|Withdrawal by Subject|0
2449252|NCT02706886|8432960|P8|Part A: SAD Period|Withdrawal by Subject|0
2449253|NCT02706886|8432961|P7|Part A: SAD Period|Withdrawal by Subject|0
2449254|NCT02706886|8432962|P6|Part A: SAD Period|Withdrawal by Subject|0
2449255|NCT02706886|8432963|P5|Part A: SAD Period|Withdrawal by Subject|0
2449256|NCT02706886|8432964|P4|Part A: SAD Period|Withdrawal by Subject|2
2449257|NCT02706886|8432965|P3|Part A: SAD Period|Withdrawal by Subject|0
2449258|NCT02706886|8432966|P2|Part A: SAD Period|Withdrawal by Subject|0
2449259|NCT02706886|8432967|P1|Part A: SAD Period|Withdrawal by Subject|0
2449260|NCT02706873|8433084|P4|Overall Study|Ongoing|1
2449261|NCT02706873|8433085|P3|Overall Study|Ongoing|0
2449262|NCT02706873|8433086|P2|Overall Study|Ongoing|0
2449263|NCT02706873|8433087|P1|Overall Study|Ongoing|0
2449264|NCT02706873|8433084|P4|Overall Study|Not Dosed|1
2449265|NCT02706873|8433085|P3|Overall Study|Not Dosed|0
2449266|NCT02706873|8433086|P2|Overall Study|Not Dosed|0
2449267|NCT02706873|8433087|P1|Overall Study|Not Dosed|1
2449268|NCT02706873|8433084|P4|Overall Study|Other|3
2449269|NCT02706873|8433085|P3|Overall Study|Other|2
2449270|NCT02706873|8433086|P2|Overall Study|Other|1
2449271|NCT02706873|8433087|P1|Overall Study|Other|5
2449272|NCT02706873|8433084|P4|Overall Study|Lack of Efficacy|3
2449273|NCT02706873|8433085|P3|Overall Study|Lack of Efficacy|0
2449274|NCT02706873|8433086|P2|Overall Study|Lack of Efficacy|0
2449275|NCT02706873|8433087|P1|Overall Study|Lack of Efficacy|10
2449276|NCT02706873|8433084|P4|Overall Study|Lost to Follow-up|2
2449277|NCT02706873|8433085|P3|Overall Study|Lost to Follow-up|4
2449278|NCT02706873|8433086|P2|Overall Study|Lost to Follow-up|0
2449279|NCT02706873|8433087|P1|Overall Study|Lost to Follow-up|3
2449280|NCT02706873|8433084|P4|Overall Study|Withdrawal by Subject|11
2449281|NCT02706873|8433085|P3|Overall Study|Withdrawal by Subject|8
2449282|NCT02706873|8433086|P2|Overall Study|Withdrawal by Subject|0
2449283|NCT02706873|8433087|P1|Overall Study|Withdrawal by Subject|15
2449284|NCT02706873|8433084|P4|Overall Study|Adverse Event|12
2449285|NCT02706873|8433085|P3|Overall Study|Adverse Event|13
2449286|NCT02706873|8433086|P2|Overall Study|Adverse Event|3
2449287|NCT02706873|8433087|P1|Overall Study|Adverse Event|13
2449288|NCT02706847|8433187|P4|Week 12 to Week 24|Other|4
2449289|NCT02706847|8433188|P3|Week 12 to Week 24|Other|1
2449290|NCT02706847|8433189|P2|Week 12 to Week 24|Other|0
2449291|NCT02706847|8433190|P1|Week 12 to Week 24|Other|1
2449292|NCT02706847|8433187|P4|Week 12 to Week 24|Lost to Follow-up|1
2449293|NCT02706847|8433188|P3|Week 12 to Week 24|Lost to Follow-up|0
2449294|NCT02706847|8433189|P2|Week 12 to Week 24|Lost to Follow-up|0
2449295|NCT02706847|8433190|P1|Week 12 to Week 24|Lost to Follow-up|0
2449296|NCT02706847|8433187|P4|Week 12 to Week 24|Withdrawal by Subject|4
2449297|NCT02706847|8433188|P3|Week 12 to Week 24|Withdrawal by Subject|1
2449298|NCT02706847|8433189|P2|Week 12 to Week 24|Withdrawal by Subject|0
2449299|NCT02706847|8433190|P1|Week 12 to Week 24|Withdrawal by Subject|1
2449300|NCT02706847|8433187|P4|Week 12 to Week 24|Adverse Event|5
2449301|NCT02706847|8433188|P3|Week 12 to Week 24|Adverse Event|2
2449302|NCT02706847|8433189|P2|Week 12 to Week 24|Adverse Event|2
2449303|NCT02706847|8433190|P1|Week 12 to Week 24|Adverse Event|1
2449304|NCT02706847|8433187|P4|Day 1 to Week 12|Randomized in Error|0
2449305|NCT02706847|8433188|P3|Day 1 to Week 12|Randomized in Error|1
2449306|NCT02706847|8433189|P2|Day 1 to Week 12|Randomized in Error|0
2449307|NCT02706847|8433190|P1|Day 1 to Week 12|Randomized in Error|0
2449308|NCT02706847|8433187|P4|Day 1 to Week 12|Other|2
2449309|NCT02706847|8433188|P3|Day 1 to Week 12|Other|2
2449310|NCT02706847|8433189|P2|Day 1 to Week 12|Other|4
2449311|NCT02706847|8433190|P1|Day 1 to Week 12|Other|4
2449312|NCT02706847|8433187|P4|Day 1 to Week 12|Lost to Follow-up|0
2449313|NCT02706847|8433188|P3|Day 1 to Week 12|Lost to Follow-up|0
2449314|NCT02706847|8433189|P2|Day 1 to Week 12|Lost to Follow-up|1
2449315|NCT02706847|8433190|P1|Day 1 to Week 12|Lost to Follow-up|2
2449316|NCT02706847|8433187|P4|Day 1 to Week 12|Withdrawal by Subject|2
2449317|NCT02706847|8433188|P3|Day 1 to Week 12|Withdrawal by Subject|4
2449318|NCT02706847|8433189|P2|Day 1 to Week 12|Withdrawal by Subject|1
2449319|NCT02706847|8433190|P1|Day 1 to Week 12|Withdrawal by Subject|2
2449320|NCT02706847|8433187|P4|Day 1 to Week 12|Adverse Event|12
2449321|NCT02706847|8433188|P3|Day 1 to Week 12|Adverse Event|1
2449322|NCT02706847|8433189|P2|Day 1 to Week 12|Adverse Event|2
2449323|NCT02706847|8433190|P1|Day 1 to Week 12|Adverse Event|2
2449324|NCT02706834|8433232|P11|Overall Study|Other Reason Not Specified|0
2449325|NCT02706834|8433233|P10|Overall Study|Other Reason Not Specified|0
2449326|NCT02706834|8433234|P9|Overall Study|Other Reason Not Specified|0
2449327|NCT02706834|8433235|P8|Overall Study|Other Reason Not Specified|0
2449328|NCT02706834|8433236|P7|Overall Study|Other Reason Not Specified|0
2449329|NCT02706834|8433237|P6|Overall Study|Other Reason Not Specified|0
2449330|NCT02706834|8433238|P5|Overall Study|Other Reason Not Specified|1
2449331|NCT02706834|8433239|P4|Overall Study|Other Reason Not Specified|0
2449332|NCT02706834|8433240|P3|Overall Study|Other Reason Not Specified|0
2449333|NCT02706834|8433241|P2|Overall Study|Other Reason Not Specified|0
2449334|NCT02706834|8433242|P1|Overall Study|Other Reason Not Specified|1
2449335|NCT02706834|8433232|P11|Overall Study|Voluntary Withdrawal|0
2449336|NCT02706834|8433233|P10|Overall Study|Voluntary Withdrawal|1
2449337|NCT02706834|8433234|P9|Overall Study|Voluntary Withdrawal|0
2449338|NCT02706834|8433235|P8|Overall Study|Voluntary Withdrawal|0
2449339|NCT02706834|8433236|P7|Overall Study|Voluntary Withdrawal|0
2449340|NCT02706834|8433237|P6|Overall Study|Voluntary Withdrawal|0
2449341|NCT02706834|8433238|P5|Overall Study|Voluntary Withdrawal|0
2449342|NCT02706834|8433239|P4|Overall Study|Voluntary Withdrawal|0
2449343|NCT02706834|8433240|P3|Overall Study|Voluntary Withdrawal|0
2449344|NCT02706834|8433241|P2|Overall Study|Voluntary Withdrawal|0
2449345|NCT02706834|8433242|P1|Overall Study|Voluntary Withdrawal|1
2449346|NCT02706834|8433232|P11|Overall Study|Lost to Follow-up|0
2449347|NCT02706834|8433233|P10|Overall Study|Lost to Follow-up|0
2449348|NCT02706834|8433234|P9|Overall Study|Lost to Follow-up|0
2449349|NCT02706834|8433235|P8|Overall Study|Lost to Follow-up|0
2449350|NCT02706834|8433236|P7|Overall Study|Lost to Follow-up|0
2449351|NCT02706834|8433237|P6|Overall Study|Lost to Follow-up|0
2449352|NCT02706834|8433238|P5|Overall Study|Lost to Follow-up|0
2449353|NCT02706834|8433239|P4|Overall Study|Lost to Follow-up|0
2449354|NCT02706834|8433240|P3|Overall Study|Lost to Follow-up|1
2449355|NCT02706834|8433241|P2|Overall Study|Lost to Follow-up|0
2449356|NCT02706834|8433242|P1|Overall Study|Lost to Follow-up|0
2449357|NCT02706834|8433232|P11|Overall Study|Pretreatment Event/Adverse Event|1
2449358|NCT02706834|8433233|P10|Overall Study|Pretreatment Event/Adverse Event|0
2449359|NCT02706834|8433234|P9|Overall Study|Pretreatment Event/Adverse Event|0
2449360|NCT02706834|8433235|P8|Overall Study|Pretreatment Event/Adverse Event|0
2449361|NCT02706834|8433236|P7|Overall Study|Pretreatment Event/Adverse Event|0
2449362|NCT02706834|8433237|P6|Overall Study|Pretreatment Event/Adverse Event|0
2449363|NCT02706834|8433238|P5|Overall Study|Pretreatment Event/Adverse Event|0
2449364|NCT02706834|8433239|P4|Overall Study|Pretreatment Event/Adverse Event|0
2449365|NCT02706834|8433240|P3|Overall Study|Pretreatment Event/Adverse Event|0
2449366|NCT02706834|8433241|P2|Overall Study|Pretreatment Event/Adverse Event|1
2449367|NCT02706834|8433242|P1|Overall Study|Pretreatment Event/Adverse Event|0
2449368|NCT02706717|8433386|P2|Overall Study|Death|1
2449369|NCT02706717|8433387|P1|Overall Study|Death|0
2449370|NCT02706717|8433386|P2|Overall Study|Physician Decision|1
2449371|NCT02706717|8433387|P1|Overall Study|Physician Decision|0
2449372|NCT02706717|8433386|P2|Overall Study|Lost to Follow-up|1
2449373|NCT02706717|8433387|P1|Overall Study|Lost to Follow-up|0
2449374|NCT02706717|8433386|P2|Overall Study|Withdrawal by Subject|8
2449375|NCT02706717|8433387|P1|Overall Study|Withdrawal by Subject|1
2449376|NCT02706691|8433451|P1|Overall Study|Adverse Event|1
2449377|NCT02706327|8433461|P3|Overall Study|Lost to Follow-up|2
2449378|NCT02706327|8433462|P2|Overall Study|Lost to Follow-up|1
2449379|NCT02706327|8433463|P1|Overall Study|Lost to Follow-up|1
2449380|NCT02705716|8433515|P2|Overall Study|Withdrawal of Consent|1
2449381|NCT02705716|8433516|P1|Overall Study|Withdrawal of Consent|1
2449382|NCT02705716|8433515|P2|Overall Study|Protocol Violation|0
2449383|NCT02705716|8433516|P1|Overall Study|Protocol Violation|3
2449384|NCT02705716|8433515|P2|Overall Study|Adverse Event|1
2449385|NCT02705716|8433516|P1|Overall Study|Adverse Event|0
2449386|NCT02705625|8433529|P3|Overall Study|Overdosing|1
2449387|NCT02705625|8433530|P2|Overall Study|Overdosing|0
2449388|NCT02705625|8433531|P1|Overall Study|Overdosing|0
2449389|NCT02705625|8433529|P3|Overall Study|Non-compliance|1
2449390|NCT02705625|8433530|P2|Overall Study|Non-compliance|1
2449391|NCT02705625|8433531|P1|Overall Study|Non-compliance|0
2449392|NCT02705625|8433529|P3|Overall Study|Lost to Follow-up|1
2449393|NCT02705625|8433530|P2|Overall Study|Lost to Follow-up|0
2449394|NCT02705625|8433531|P1|Overall Study|Lost to Follow-up|0
2449395|NCT02705625|8433529|P3|Overall Study|Withdrawal by Subject|5
2449396|NCT02705625|8433530|P2|Overall Study|Withdrawal by Subject|4
2449397|NCT02705625|8433531|P1|Overall Study|Withdrawal by Subject|1
2449398|NCT02705625|8433529|P3|Overall Study|Death|1
2449399|NCT02705625|8433530|P2|Overall Study|Death|0
2449400|NCT02705625|8433531|P1|Overall Study|Death|0
2449401|NCT02705625|8433529|P3|Overall Study|Adverse Event|2
2449402|NCT02705625|8433530|P2|Overall Study|Adverse Event|5
2449403|NCT02705625|8433531|P1|Overall Study|Adverse Event|6
2449404|NCT02705625|8433529|P3|Overall Study|Protocol Violation|0
2449405|NCT02705625|8433530|P2|Overall Study|Protocol Violation|0
2449406|NCT02705625|8433531|P1|Overall Study|Protocol Violation|1
2449407|NCT02705586|8433560|P1|Overall Study|Vacation/Planned Absence|1
2449408|NCT02705586|8433560|P1|Overall Study|Transportation Difficulties|5
2449409|NCT02705586|8433560|P1|Overall Study|Health Issues|2
2449410|NCT02704689|8433633|P1|Overall Study|Study device not implanted|2
2449411|NCT02704689|8433633|P1|Overall Study|Physician Decision|1
2449412|NCT02704091|8433666|P2|Overall Study|Other|8
2449413|NCT02704091|8433667|P1|Overall Study|Other|2
2449414|NCT02704091|8433666|P2|Overall Study|Lost to Follow-up|5
2449415|NCT02704091|8433667|P1|Overall Study|Lost to Follow-up|13
2449416|NCT02704091|8433666|P2|Overall Study|Consent withdrawn|4
2449417|NCT02704091|8433667|P1|Overall Study|Consent withdrawn|4
2449418|NCT02704091|8433666|P2|Overall Study|Protocol Violation|3
2449419|NCT02704091|8433667|P1|Overall Study|Protocol Violation|5
2449420|NCT02704091|8433666|P2|Overall Study|Adverse Event|3
2449421|NCT02704091|8433667|P1|Overall Study|Adverse Event|4
2449422|NCT02703636|8433727|P1|Overall Study|Withdrawal by Subject|1
2449423|NCT02703636|8433727|P1|Overall Study|Study stopped by sponsor|1
2449424|NCT02703636|8433727|P1|Overall Study|Adverse Event|14
2449425|NCT02703532|8433742|P4|Overall Study|Lost to Follow-up|0
2449426|NCT02703532|8433743|P3|Overall Study|Lost to Follow-up|2
2449427|NCT02703532|8433744|P2|Overall Study|Lost to Follow-up|0
2449428|NCT02703532|8433745|P1|Overall Study|Lost to Follow-up|2
2449429|NCT02703532|8433742|P4|Overall Study|Withdrawal by Subject|1
2449430|NCT02703532|8433743|P3|Overall Study|Withdrawal by Subject|0
2449431|NCT02703532|8433744|P2|Overall Study|Withdrawal by Subject|1
2449432|NCT02703532|8433745|P1|Overall Study|Withdrawal by Subject|0
2449433|NCT02703454|8433807|P2|Overall Study|Study discontinuation|8
2449434|NCT02703454|8433808|P1|Overall Study|Study discontinuation|5
2449435|NCT02703454|8433807|P2|Overall Study|Lost to Follow-up|2
2449436|NCT02703454|8433808|P1|Overall Study|Lost to Follow-up|1
2449437|NCT02703454|8433807|P2|Overall Study|Withdrawal by Subject|3
2449438|NCT02703454|8433808|P1|Overall Study|Withdrawal by Subject|4
2449439|NCT02703454|8433807|P2|Overall Study|Not treated|3
2449440|NCT02703454|8433808|P1|Overall Study|Not treated|1
2449441|NCT02703337|8433843|P8|Period One (Part A)|Withdrawal by Subject|0
2449442|NCT02703337|8433844|P7|Period One (Part A)|Withdrawal by Subject|0
2449443|NCT02703337|8433845|P6|Period One (Part A)|Withdrawal by Subject|0
2449444|NCT02703337|8433846|P5|Period One (Part A)|Withdrawal by Subject|1
2449445|NCT02703337|8433847|P4|Period One (Part A)|Withdrawal by Subject|0
2449446|NCT02703337|8433848|P3|Period One (Part A)|Withdrawal by Subject|0
2449447|NCT02703337|8433849|P2|Period One (Part A)|Withdrawal by Subject|0
2449448|NCT02703337|8433850|P1|Period One (Part A)|Withdrawal by Subject|0
2449449|NCT02703324|8433870|P6|Period Two|Withdrawal by Subject|0
2449450|NCT02703324|8433871|P5|Period Two|Withdrawal by Subject|0
2449451|NCT02703324|8433872|P4|Period Two|Withdrawal by Subject|0
2449452|NCT02703324|8433873|P3|Period Two|Withdrawal by Subject|1
2449453|NCT02703324|8433874|P2|Period Two|Withdrawal by Subject|0
2449454|NCT02703324|8433875|P1|Period Two|Withdrawal by Subject|0
2449455|NCT02703259|8433886|P2|2 Weeks Postoperative Assessment|Lost to Follow-up|10
2449456|NCT02703259|8433887|P1|2 Weeks Postoperative Assessment|Lost to Follow-up|10
2449457|NCT02703259|8433886|P2|24 Hours Postoperative Assessment|excluded from analysis per protocol|2
2449458|NCT02703259|8433887|P1|24 Hours Postoperative Assessment|excluded from analysis per protocol|1
2449459|NCT02703259|8433886|P2|24 Hours Postoperative Assessment|Lost to Follow-up|4
2449460|NCT02703259|8433887|P1|24 Hours Postoperative Assessment|Lost to Follow-up|1
2449461|NCT02702401|8433935|P2|Overall Study|Ongoing in study|34
2449462|NCT02702401|8433936|P1|Overall Study|Ongoing in study|94
2449463|NCT02702401|8433935|P2|Overall Study|Withdrawal by Subject|0
2449464|NCT02702401|8433936|P1|Overall Study|Withdrawal by Subject|4
2449465|NCT02702401|8433935|P2|Overall Study|Death|101
2449466|NCT02702401|8433936|P1|Overall Study|Death|180
2449467|NCT02702193|8433958|P2|12 Month Follow up|Lost to Follow-up|18
2449468|NCT02702193|8433959|P1|12 Month Follow up|Lost to Follow-up|16
2449469|NCT02702193|8433958|P2|12 Month Follow up|Withdrawal by Subject|0
2449470|NCT02702193|8433959|P1|12 Month Follow up|Withdrawal by Subject|1
2449471|NCT02702193|8433958|P2|8 Month Follow up|Lost to Follow-up|18
2449472|NCT02702193|8433959|P1|8 Month Follow up|Lost to Follow-up|14
2449473|NCT02702193|8433958|P2|8 Month Follow up|Withdrawal by Subject|0
2449474|NCT02702193|8433959|P1|8 Month Follow up|Withdrawal by Subject|1
2449475|NCT02702193|8433958|P2|4 Month Follow up|Lost to Follow-up|18
2449476|NCT02702193|8433959|P1|4 Month Follow up|Lost to Follow-up|17
2449477|NCT02702193|8433958|P2|4 Month Follow up|Withdrawal by Subject|0
2449478|NCT02702193|8433959|P1|4 Month Follow up|Withdrawal by Subject|1
2449479|NCT02702193|8433958|P2|Baseline Assessment/Randomization|Withdrawal by Subject|0
2449480|NCT02702193|8433959|P1|Baseline Assessment/Randomization|Withdrawal by Subject|1
2449481|NCT02702011|8433987|P4|Overall Study|Withdrawal by Subject|0
2449482|NCT02702011|8433988|P3|Overall Study|Withdrawal by Subject|0
2449483|NCT02702011|8433989|P2|Overall Study|Withdrawal by Subject|1
2449484|NCT02702011|8433990|P1|Overall Study|Withdrawal by Subject|0
2449485|NCT02701985|8434002|P2|Overall Study|Adverse Event|5
2449486|NCT02701985|8434003|P1|Overall Study|Adverse Event|0
2449487|NCT02701985|8434002|P2|Overall Study|Death|0
2449488|NCT02701985|8434003|P1|Overall Study|Death|1
2449489|NCT02701985|8434002|P2|Overall Study|Lost to Follow-up|0
2449490|NCT02701985|8434003|P1|Overall Study|Lost to Follow-up|1
2449491|NCT02701985|8434002|P2|Overall Study|Withdrawal by Subject|1
2449492|NCT02701985|8434003|P1|Overall Study|Withdrawal by Subject|1
2449493|NCT02701764|8434046|P2|Overall Study|Lost to Follow-up|1
2449494|NCT02701764|8434047|P1|Overall Study|Lost to Follow-up|0
2449495|NCT02701634|8434106|P2|Overall Study|Randomized but not treated|0
2449496|NCT02701634|8434107|P1|Overall Study|Randomized but not treated|1
2449497|NCT02701634|8434106|P2|Overall Study|Withdrew Consent|7
2449498|NCT02701634|8434107|P1|Overall Study|Withdrew Consent|6
2449499|NCT02701634|8434106|P2|Overall Study|Study terminated by Sponsor|17
2449500|NCT02701634|8434107|P1|Overall Study|Study terminated by Sponsor|15
2449501|NCT02701634|8434106|P2|Overall Study|Investigator's Discretion|4
2449502|NCT02701634|8434107|P1|Overall Study|Investigator's Discretion|7
2449503|NCT02701634|8434106|P2|Overall Study|Death|0
2449504|NCT02701634|8434107|P1|Overall Study|Death|1
2449505|NCT02701634|8434106|P2|Overall Study|Adverse Event|3
2449506|NCT02701634|8434107|P1|Overall Study|Adverse Event|2
2449507|NCT02701361|8434177|P3|Overall Study|incarceration|1
2449508|NCT02701361|8434178|P2|Overall Study|incarceration|0
2449509|NCT02701361|8434179|P1|Overall Study|incarceration|0
2449510|NCT02701361|8434177|P3|Overall Study|timed out in rehab center|0
2449511|NCT02701361|8434178|P2|Overall Study|timed out in rehab center|1
2449512|NCT02701361|8434179|P1|Overall Study|timed out in rehab center|0
2449513|NCT02701361|8434177|P3|Overall Study|Withdrawal by Subject|0
2449514|NCT02701361|8434178|P2|Overall Study|Withdrawal by Subject|0
2449515|NCT02701361|8434179|P1|Overall Study|Withdrawal by Subject|4
2449516|NCT02701361|8434177|P3|Overall Study|Lost to Follow-up|1
2449517|NCT02701361|8434178|P2|Overall Study|Lost to Follow-up|2
2449518|NCT02701361|8434179|P1|Overall Study|Lost to Follow-up|5
2449519|NCT02701296|8434220|P2|Overall Study|Incomplete Data|2
2449520|NCT02701296|8434221|P1|Overall Study|Incomplete Data|0
2449521|NCT02700997|8434467|P1|Overall Study|No CT measurement - pelvic calcification|1
2449522|NCT02700997|8434467|P1|Overall Study|Did not undergo CT imaging|1
2449523|NCT02700984|8434473|P2|Overall Study|Reason not specified|2
2449524|NCT02700984|8434474|P1|Overall Study|Reason not specified|3
2449525|NCT02700984|8434473|P2|Overall Study|Withdrawal by Subject|9
2449526|NCT02700984|8434474|P1|Overall Study|Withdrawal by Subject|8
2449527|NCT02700984|8434473|P2|Overall Study|Physician Decision|1
2449528|NCT02700984|8434474|P1|Overall Study|Physician Decision|0
2449529|NCT02700984|8434473|P2|Overall Study|Lost to Follow-up|1
2449530|NCT02700984|8434474|P1|Overall Study|Lost to Follow-up|2
2449531|NCT02700984|8434473|P2|Overall Study|Death|1
2449532|NCT02700984|8434474|P1|Overall Study|Death|2
2449533|NCT02700815|8434527|P4|Overall Study|Withdrawal by Subject|0
2449534|NCT02700815|8434528|P3|Overall Study|Withdrawal by Subject|1
2449535|NCT02700815|8434529|P2|Overall Study|Withdrawal by Subject|0
2449536|NCT02700815|8434530|P1|Overall Study|Withdrawal by Subject|0
2449537|NCT02700815|8434527|P4|Overall Study|Refusal to continue medication|1
2449538|NCT02700815|8434528|P3|Overall Study|Refusal to continue medication|0
2449539|NCT02700815|8434529|P2|Overall Study|Refusal to continue medication|1
2449540|NCT02700815|8434530|P1|Overall Study|Refusal to continue medication|0
2449541|NCT02700815|8434527|P4|Overall Study|Lost to Follow-up|1
2449542|NCT02700815|8434528|P3|Overall Study|Lost to Follow-up|0
2449543|NCT02700815|8434529|P2|Overall Study|Lost to Follow-up|0
2449544|NCT02700815|8434530|P1|Overall Study|Lost to Follow-up|1
2449545|NCT02700815|8434527|P4|Overall Study|Lack of Efficacy|2
2449546|NCT02700815|8434528|P3|Overall Study|Lack of Efficacy|1
2449547|NCT02700815|8434529|P2|Overall Study|Lack of Efficacy|0
2449548|NCT02700815|8434530|P1|Overall Study|Lack of Efficacy|0
2449549|NCT02700815|8434527|P4|Overall Study|Adverse Event|3
2449550|NCT02700815|8434528|P3|Overall Study|Adverse Event|2
2449551|NCT02700815|8434529|P2|Overall Study|Adverse Event|6
2449552|NCT02700815|8434530|P1|Overall Study|Adverse Event|0
2449553|NCT02699983|8434570|P2|Overall Study|Withdrawal by Subject|0
2449554|NCT02699983|8434571|P1|Overall Study|Withdrawal by Subject|1
2449555|NCT02699892|8434636|P1|Overall Study|Other|36
2449556|NCT02699684|8434641|P2|Period 2, Second 30 Days of Wear|Adverse Event|0
2449557|NCT02699684|8434642|P1|Period 2, Second 30 Days of Wear|Adverse Event|1
2449558|NCT02699593|8434659|P2|Period 2|Torn Contact Lens|0
2449559|NCT02699593|8434660|P1|Period 2|Torn Contact Lens|1
2449560|NCT02699593|8434659|P2|Period 2|Lost Contact Lens|1
2449561|NCT02699593|8434660|P1|Period 2|Lost Contact Lens|0
2449562|NCT02699593|8434659|P2|Period 2|Adverse Event|1
2449563|NCT02699593|8434660|P1|Period 2|Adverse Event|1
2449564|NCT02699593|8434659|P2|Period 1|Adverse Event|1
2449565|NCT02699593|8434660|P1|Period 1|Adverse Event|1
2449566|NCT02699593|8434659|P2|Period 1|Withdrawal by Subject|1
2449567|NCT02699593|8434660|P1|Period 1|Withdrawal by Subject|0
2449568|NCT02699593|8434659|P2|Period 1|Protocol Violation|1
2449569|NCT02699593|8434660|P1|Period 1|Protocol Violation|0
2449570|NCT02699593|8434659|P2|Period 1|Torn Contact Len|3
2449571|NCT02699593|8434660|P1|Period 1|Torn Contact Len|4
2449572|NCT02699593|8434659|P2|Period 1|Unsatisfactory Visual Response|1
2449573|NCT02699593|8434660|P1|Period 1|Unsatisfactory Visual Response|0
2449574|NCT02699099|8434671|P3|Overall Study|Withdrawal by Subject|2
2449575|NCT02699099|8434672|P2|Overall Study|Withdrawal by Subject|1
2449576|NCT02699099|8434673|P1|Overall Study|Withdrawal by Subject|6
2449577|NCT02699099|8434671|P3|Overall Study|Lost to Follow-up|0
2449578|NCT02699099|8434672|P2|Overall Study|Lost to Follow-up|1
2449579|NCT02699099|8434673|P1|Overall Study|Lost to Follow-up|0
2449580|NCT02699099|8434671|P3|Overall Study|Adverse Event|1
2449581|NCT02699099|8434672|P2|Overall Study|Adverse Event|0
2449582|NCT02699099|8434673|P1|Overall Study|Adverse Event|1
2449583|NCT02698865|8434749|P2|Overall Study|Lost to Follow-up|2
2449584|NCT02698865|8434750|P1|Overall Study|Lost to Follow-up|4
2449585|NCT02698865|8434749|P2|Overall Study|Physician Decision|4
2449586|NCT02698865|8434750|P1|Overall Study|Physician Decision|0
2449587|NCT02698865|8434749|P2|Overall Study|Withdrawal by Subject|16
2449588|NCT02698865|8434750|P1|Overall Study|Withdrawal by Subject|20
2449589|NCT02698865|8434749|P2|Overall Study|Other|11
2449590|NCT02698865|8434750|P1|Overall Study|Other|11
2449591|NCT02698436|8434790|P2|Overall Study|Non-compliance with study regimen|0
2449592|NCT02698436|8434791|P1|Overall Study|Non-compliance with study regimen|1
2449593|NCT02698436|8434790|P2|Overall Study|Lost to Follow-up|4
2449594|NCT02698436|8434791|P1|Overall Study|Lost to Follow-up|2
2449595|NCT02698436|8434790|P2|Overall Study|Withdrawal by Subject|3
2449596|NCT02698436|8434791|P1|Overall Study|Withdrawal by Subject|3
2449597|NCT02698436|8434790|P2|Overall Study|Adverse Event|0
2449598|NCT02698436|8434791|P1|Overall Study|Adverse Event|1
2449599|NCT02698423|8434831|P2|Overall Study|Lost to Follow-up|24
2449600|NCT02698423|8434832|P1|Overall Study|Lost to Follow-up|19
2449601|NCT02698371|8434840|P1|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2
2449602|NCT02698371|8434840|P1|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3
2449603|NCT02698371|8434840|P1|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3
2449604|NCT02698371|8434840|P1|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3
2449605|NCT02698371|8434840|P1|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3
2449606|NCT02698371|8434840|P1|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3
2449607|NCT02698371|8434840|P1|All Participants Flow|Lost to Follow-up|3
2449608|NCT02698241|8434962|P1|Overall Study|Death|2
2449609|NCT02698241|8434962|P1|Overall Study|geographic and licensing issue|1
2449610|NCT02698241|8434962|P1|Overall Study|Subject on inodrip not safe to continue|6
2449611|NCT02698241|8434962|P1|Overall Study|Lost to Follow-up|3
2449612|NCT02698241|8434962|P1|Overall Study|Subject underwent system modification|2
2449613|NCT02698241|8434962|P1|Overall Study|Physician Decision|2
2449614|NCT02698241|8434962|P1|Overall Study|Withdrawal by Subject|7
2449615|NCT02698241|8434962|P1|Overall Study|Screening not met|7
2449616|NCT02698241|8434962|P1|Overall Study|Inclusion/exclusion criteria not met|4
2449617|NCT02698189|8434969|P2|Overall Study|Still ongoing in the study|1
2449618|NCT02698189|8434970|P1|Overall Study|Still ongoing in the study|0
2449619|NCT02698189|8434969|P2|Overall Study|Progressive disease|5
2449620|NCT02698189|8434970|P1|Overall Study|Progressive disease|3
2449621|NCT02698176|8435000|P4|Overall Study|Clinical progression|0
2449622|NCT02698176|8435001|P3|Overall Study|Clinical progression|0
2449623|NCT02698176|8435002|P2|Overall Study|Clinical progression|0
2449624|NCT02698176|8435003|P1|Overall Study|Clinical progression|3
2449625|NCT02698176|8435000|P4|Overall Study|Adverse Event|0
2449626|NCT02698176|8435001|P3|Overall Study|Adverse Event|0
2449627|NCT02698176|8435002|P2|Overall Study|Adverse Event|0
2449628|NCT02698176|8435003|P1|Overall Study|Adverse Event|2
2449629|NCT02698176|8435000|P4|Overall Study|Progressive disease|0
2449630|NCT02698176|8435001|P3|Overall Study|Progressive disease|1
2449631|NCT02698176|8435002|P2|Overall Study|Progressive disease|3
2449632|NCT02698176|8435003|P1|Overall Study|Progressive disease|4
2449633|NCT02697773|8435060|P3|Overall Study|Randomized but not treated|0
2449634|NCT02697773|8435061|P2|Overall Study|Randomized but not treated|1
2449635|NCT02697773|8435062|P1|Overall Study|Randomized but not treated|1
2449636|NCT02697773|8435060|P3|Overall Study|Withdrawal by Subject|13
2449637|NCT02697773|8435061|P2|Overall Study|Withdrawal by Subject|13
2449638|NCT02697773|8435062|P1|Overall Study|Withdrawal by Subject|10
2449639|NCT02697773|8435060|P3|Overall Study|Protocol Violation|0
2449640|NCT02697773|8435061|P2|Overall Study|Protocol Violation|1
2449641|NCT02697773|8435062|P1|Overall Study|Protocol Violation|1
2449642|NCT02697773|8435060|P3|Overall Study|Other|10
2449643|NCT02697773|8435061|P2|Overall Study|Other|11
2449644|NCT02697773|8435062|P1|Overall Study|Other|15
2449645|NCT02697773|8435060|P3|Overall Study|Lost to Follow-up|7
2449646|NCT02697773|8435061|P2|Overall Study|Lost to Follow-up|5
2449647|NCT02697773|8435062|P1|Overall Study|Lost to Follow-up|5
2449648|NCT02697773|8435060|P3|Overall Study|Lack of Efficacy|6
2449649|NCT02697773|8435061|P2|Overall Study|Lack of Efficacy|6
2449650|NCT02697773|8435062|P1|Overall Study|Lack of Efficacy|4
2449651|NCT02697773|8435060|P3|Overall Study|Death|2
2449652|NCT02697773|8435061|P2|Overall Study|Death|0
2449653|NCT02697773|8435062|P1|Overall Study|Death|0
2449654|NCT02697773|8435060|P3|Overall Study|Adverse Event|2
2449655|NCT02697773|8435061|P2|Overall Study|Adverse Event|1
2449656|NCT02697773|8435062|P1|Overall Study|Adverse Event|2
2449657|NCT02697435|8435243|P2|Overall Study|Physician Decision|4
2449658|NCT02697435|8435244|P1|Overall Study|Physician Decision|0
2449659|NCT02697435|8435243|P2|Overall Study|Withdrawal by Subject|0
2449660|NCT02697435|8435244|P1|Overall Study|Withdrawal by Subject|1
2449661|NCT02696850|8435352|P2|Overall Study|Lost to Follow-up|5
2449662|NCT02696850|8435353|P1|Overall Study|Lost to Follow-up|8
2449663|NCT02696850|8435352|P2|Overall Study|Withdrawal by Subject|3
2449664|NCT02696850|8435353|P1|Overall Study|Withdrawal by Subject|3
2449665|NCT02696798|8435366|P3|Post-treatment Follow-up Period|No progressive improvement|0
2449666|NCT02696798|8435367|P2|Post-treatment Follow-up Period|No progressive improvement|1
2449667|NCT02696798|8435368|P1|Post-treatment Follow-up Period|No progressive improvement|0
2449668|NCT02696798|8435366|P3|Post-treatment Follow-up Period|Physician Decision|0
2449669|NCT02696798|8435367|P2|Post-treatment Follow-up Period|Physician Decision|2
2449670|NCT02696798|8435368|P1|Post-treatment Follow-up Period|Physician Decision|0
2449671|NCT02696798|8435366|P3|Post-treatment Follow-up Period|Withdrawal by Subject|12
2449672|NCT02696798|8435367|P2|Post-treatment Follow-up Period|Withdrawal by Subject|8
2449673|NCT02696798|8435368|P1|Post-treatment Follow-up Period|Withdrawal by Subject|2
2449674|NCT02696798|8435366|P3|Post-treatment Follow-up Period|Lack of Efficacy|0
2449675|NCT02696798|8435367|P2|Post-treatment Follow-up Period|Lack of Efficacy|2
2449676|NCT02696798|8435368|P1|Post-treatment Follow-up Period|Lack of Efficacy|1
2449677|NCT02696798|8435366|P3|Post-treatment Follow-up Period|Lost to Follow-up|1
2449678|NCT02696798|8435367|P2|Post-treatment Follow-up Period|Lost to Follow-up|1
2449679|NCT02696798|8435368|P1|Post-treatment Follow-up Period|Lost to Follow-up|0
2449680|NCT02696798|8435366|P3|Post-treatment Follow-up Period|Adverse Event|6
2449681|NCT02696798|8435367|P2|Post-treatment Follow-up Period|Adverse Event|12
2449682|NCT02696798|8435368|P1|Post-treatment Follow-up Period|Adverse Event|2
2449683|NCT02696798|8435366|P3|Extended Treatment Period|Withdrawal by Subject|3
2449684|NCT02696798|8435367|P2|Extended Treatment Period|Withdrawal by Subject|2
2449685|NCT02696798|8435368|P1|Extended Treatment Period|Withdrawal by Subject|3
2449686|NCT02696798|8435366|P3|Extended Treatment Period|Physician Decision|0
2449687|NCT02696798|8435367|P2|Extended Treatment Period|Physician Decision|1
2449688|NCT02696798|8435368|P1|Extended Treatment Period|Physician Decision|0
2449689|NCT02696798|8435366|P3|Extended Treatment Period|Lost to Follow-up|0
2449690|NCT02696798|8435367|P2|Extended Treatment Period|Lost to Follow-up|0
2449691|NCT02696798|8435368|P1|Extended Treatment Period|Lost to Follow-up|1
2449692|NCT02696798|8435366|P3|Extended Treatment Period|Lack of Efficacy|2
2449693|NCT02696798|8435367|P2|Extended Treatment Period|Lack of Efficacy|2
2449694|NCT02696798|8435368|P1|Extended Treatment Period|Lack of Efficacy|7
2449695|NCT02696798|8435366|P3|Extended Treatment Period|Adverse Event|5
2449696|NCT02696798|8435367|P2|Extended Treatment Period|Adverse Event|4
2449697|NCT02696798|8435368|P1|Extended Treatment Period|Adverse Event|1
2449698|NCT02696798|8435366|P3|Blinded Treatment Dosing Period|Withdrawal by Subject|4
2449699|NCT02696798|8435367|P2|Blinded Treatment Dosing Period|Withdrawal by Subject|3
2449700|NCT02696798|8435368|P1|Blinded Treatment Dosing Period|Withdrawal by Subject|7
2449701|NCT02696798|8435366|P3|Blinded Treatment Dosing Period|Physician Decision|0
2449702|NCT02696798|8435367|P2|Blinded Treatment Dosing Period|Physician Decision|1
2449703|NCT02696798|8435368|P1|Blinded Treatment Dosing Period|Physician Decision|0
2449704|NCT02696798|8435366|P3|Blinded Treatment Dosing Period|Lost to Follow-up|0
2449705|NCT02696798|8435367|P2|Blinded Treatment Dosing Period|Lost to Follow-up|1
2449706|NCT02696798|8435368|P1|Blinded Treatment Dosing Period|Lost to Follow-up|0
2449707|NCT02696798|8435366|P3|Blinded Treatment Dosing Period|Lack of Efficacy|1
2449708|NCT02696798|8435367|P2|Blinded Treatment Dosing Period|Lack of Efficacy|1
2449709|NCT02696798|8435368|P1|Blinded Treatment Dosing Period|Lack of Efficacy|2
2449710|NCT02696798|8435366|P3|Blinded Treatment Dosing Period|Death|1
2449711|NCT02696798|8435367|P2|Blinded Treatment Dosing Period|Death|0
2449712|NCT02696798|8435368|P1|Blinded Treatment Dosing Period|Death|0
2449713|NCT02696798|8435366|P3|Blinded Treatment Dosing Period|Adverse Event|2
2449714|NCT02696798|8435367|P2|Blinded Treatment Dosing Period|Adverse Event|9
2449715|NCT02696798|8435368|P1|Blinded Treatment Dosing Period|Adverse Event|2
2449716|NCT02696785|8435465|P4|Follow-up Period|Withdrawal by Subject|4
2449717|NCT02696785|8435466|P3|Follow-up Period|Withdrawal by Subject|5
2449718|NCT02696785|8435467|P2|Follow-up Period|Withdrawal by Subject|0
2449719|NCT02696785|8435468|P1|Follow-up Period|Withdrawal by Subject|1
2449720|NCT02696785|8435465|P4|Follow-up Period|Lack of Efficacy|1
2449721|NCT02696785|8435466|P3|Follow-up Period|Lack of Efficacy|0
2449722|NCT02696785|8435467|P2|Follow-up Period|Lack of Efficacy|0
2449723|NCT02696785|8435468|P1|Follow-up Period|Lack of Efficacy|0
2449724|NCT02696785|8435465|P4|Follow-up Period|Lost to Follow-up|1
2449725|NCT02696785|8435466|P3|Follow-up Period|Lost to Follow-up|0
2449726|NCT02696785|8435467|P2|Follow-up Period|Lost to Follow-up|0
2449727|NCT02696785|8435468|P1|Follow-up Period|Lost to Follow-up|0
2449728|NCT02696785|8435465|P4|Follow-up Period|Adverse Event|2
2449729|NCT02696785|8435466|P3|Follow-up Period|Adverse Event|8
2449730|NCT02696785|8435467|P2|Follow-up Period|Adverse Event|0
2449731|NCT02696785|8435468|P1|Follow-up Period|Adverse Event|0
2449732|NCT02696785|8435465|P4|Extended Treatment Period|Withdrawal by Subject|5
2449733|NCT02696785|8435466|P3|Extended Treatment Period|Withdrawal by Subject|3
2449734|NCT02696785|8435467|P2|Extended Treatment Period|Withdrawal by Subject|2
2449735|NCT02696785|8435468|P1|Extended Treatment Period|Withdrawal by Subject|1
2449736|NCT02696785|8435465|P4|Extended Treatment Period|Lack of Efficacy|0
2449737|NCT02696785|8435466|P3|Extended Treatment Period|Lack of Efficacy|0
2449738|NCT02696785|8435467|P2|Extended Treatment Period|Lack of Efficacy|1
2449739|NCT02696785|8435468|P1|Extended Treatment Period|Lack of Efficacy|0
2449740|NCT02696785|8435465|P4|Extended Treatment Period|Adverse Event|1
2449741|NCT02696785|8435466|P3|Extended Treatment Period|Adverse Event|2
2449742|NCT02696785|8435467|P2|Extended Treatment Period|Adverse Event|3
2449743|NCT02696785|8435468|P1|Extended Treatment Period|Adverse Event|2
2449744|NCT02696785|8435465|P4|Washout Period|Lack of Efficacy|0
2449745|NCT02696785|8435466|P3|Washout Period|Lack of Efficacy|0
2449746|NCT02696785|8435467|P2|Washout Period|Lack of Efficacy|1
2449747|NCT02696785|8435468|P1|Washout Period|Lack of Efficacy|0
2449748|NCT02696785|8435465|P4|Washout Period|Withdrawal by Subject|0
2449749|NCT02696785|8435466|P3|Washout Period|Withdrawal by Subject|0
2449750|NCT02696785|8435467|P2|Washout Period|Withdrawal by Subject|1
2449751|NCT02696785|8435468|P1|Washout Period|Withdrawal by Subject|0
2449752|NCT02696785|8435465|P4|Blinded Treatment Period|Screen Failure|0
2449753|NCT02696785|8435466|P3|Blinded Treatment Period|Screen Failure|0
2449754|NCT02696785|8435467|P2|Blinded Treatment Period|Screen Failure|0
2449755|NCT02696785|8435468|P1|Blinded Treatment Period|Screen Failure|1
2449756|NCT02696785|8435465|P4|Blinded Treatment Period|Lack of Efficacy|1
2449757|NCT02696785|8435466|P3|Blinded Treatment Period|Lack of Efficacy|0
2449758|NCT02696785|8435467|P2|Blinded Treatment Period|Lack of Efficacy|0
2449759|NCT02696785|8435468|P1|Blinded Treatment Period|Lack of Efficacy|0
2449760|NCT02696785|8435465|P4|Blinded Treatment Period|Withdrawal by Subject|2
2449761|NCT02696785|8435466|P3|Blinded Treatment Period|Withdrawal by Subject|1
2449762|NCT02696785|8435467|P2|Blinded Treatment Period|Withdrawal by Subject|1
2449763|NCT02696785|8435468|P1|Blinded Treatment Period|Withdrawal by Subject|0
2449764|NCT02696785|8435465|P4|Blinded Treatment Period|Adverse Event|0
2449765|NCT02696785|8435466|P3|Blinded Treatment Period|Adverse Event|3
2449766|NCT02696785|8435467|P2|Blinded Treatment Period|Adverse Event|1
2449767|NCT02696785|8435468|P1|Blinded Treatment Period|Adverse Event|0
2449768|NCT02696434|8435588|P2|Overall Study|Physician Decision|1
2449769|NCT02696434|8435589|P1|Overall Study|Physician Decision|0
2449770|NCT02696434|8435588|P2|Overall Study|Withdrawal by Subject|12
2449771|NCT02696434|8435589|P1|Overall Study|Withdrawal by Subject|14
2449772|NCT02696434|8435588|P2|Overall Study|Lost to Follow-up|4
2449773|NCT02696434|8435589|P1|Overall Study|Lost to Follow-up|5
2449774|NCT02696434|8435588|P2|Overall Study|Adverse Event|1
2449775|NCT02696434|8435589|P1|Overall Study|Adverse Event|3
2449776|NCT02696317|8435607|P2|Period 2, 10 Days of Wear|Withdrawal by Subject|0
2449777|NCT02696317|8435608|P1|Period 2, 10 Days of Wear|Withdrawal by Subject|1
2449778|NCT02696317|8435607|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|4
2449779|NCT02696317|8435608|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|2
2449780|NCT02696226|8435652|P4|Overall Study|Study terminated - lack of enrollment|0
2449781|NCT02696226|8435653|P3|Overall Study|Study terminated - lack of enrollment|2
2449782|NCT02696226|8435654|P2|Overall Study|Study terminated - lack of enrollment|0
2449783|NCT02696226|8435655|P1|Overall Study|Study terminated - lack of enrollment|1
2449784|NCT02695719|8435685|P2|Overall Study|Voluntary Withdrawal|0
2449785|NCT02695719|8435686|P1|Overall Study|Voluntary Withdrawal|1
2449786|NCT02695719|8435685|P2|Overall Study|Significant Protocol Deviation|1
2449787|NCT02695719|8435686|P1|Overall Study|Significant Protocol Deviation|0
2449788|NCT02695719|8435685|P2|Overall Study|Pretreatment Event/Adverse Event|9
2449789|NCT02695719|8435686|P1|Overall Study|Pretreatment Event/Adverse Event|2
2449790|NCT02695628|8435704|P1|Overall Study|Withdrawal by Subject|1
2449791|NCT02695537|8435710|P1|Overall Study|Protocol Violation|3
2449792|NCT02695537|8435710|P1|Overall Study|Withdrawal by Subject|4
2449793|NCT02695537|8435710|P1|Overall Study|Lack of Efficacy|28
2449794|NCT02695537|8435710|P1|Overall Study|Adverse Event|3
2449795|NCT02695524|8435720|P2|Overall Study|Death|1
2449796|NCT02695524|8435721|P1|Overall Study|Death|0
2449797|NCT02695524|8435720|P2|Overall Study|Lost to Follow-up|2
2449798|NCT02695524|8435721|P1|Overall Study|Lost to Follow-up|3
2449799|NCT02695420|8435750|P4|Overall Study|Death|0
2449800|NCT02695420|8435751|P3|Overall Study|Death|0
2449801|NCT02695420|8435752|P2|Overall Study|Death|1
2449802|NCT02695420|8435753|P1|Overall Study|Death|0
2449803|NCT02695329|8435775|P2|Overall Study|Poor X-ray quality for measurement|5
2449804|NCT02695329|8435776|P1|Overall Study|Poor X-ray quality for measurement|4
2449805|NCT02695329|8435775|P2|Overall Study|Adverse Event|0
2449806|NCT02695329|8435776|P1|Overall Study|Adverse Event|1
2449807|NCT02694978|8435796|P2|Overall Study|Other-Withdrew prior to dosing|8
2449808|NCT02694978|8435797|P1|Overall Study|Other-Withdrew prior to dosing|9
2449809|NCT02694978|8435796|P2|Overall Study|Other-Personal reasons|3
2449810|NCT02694978|8435797|P1|Overall Study|Other-Personal reasons|3
2449811|NCT02694978|8435796|P2|Overall Study|Other-Protocol noncompliant|1
2449812|NCT02694978|8435797|P1|Overall Study|Other-Protocol noncompliant|2
2449813|NCT02694978|8435796|P2|Overall Study|Other-Unable to be reached|1
2449814|NCT02694978|8435797|P1|Overall Study|Other-Unable to be reached|0
2449815|NCT02694978|8435796|P2|Overall Study|Other-Investigator’s decision|0
2449816|NCT02694978|8435797|P1|Overall Study|Other-Investigator’s decision|1
2449817|NCT02694978|8435796|P2|Overall Study|Other-Decision of Participant|1
2449818|NCT02694978|8435797|P1|Overall Study|Other-Decision of Participant|6
2449819|NCT02694978|8435796|P2|Overall Study|Death|1
2449820|NCT02694978|8435797|P1|Overall Study|Death|4
2449821|NCT02694978|8435796|P2|Overall Study|Lost to Follow-up|17
2449822|NCT02694978|8435797|P1|Overall Study|Lost to Follow-up|14
2449823|NCT02694978|8435796|P2|Overall Study|Withdrawal by Subject|19
2449824|NCT02694978|8435797|P1|Overall Study|Withdrawal by Subject|22
2449825|NCT02694978|8435796|P2|Overall Study|Adverse Event|9
2449826|NCT02694978|8435797|P1|Overall Study|Adverse Event|10
2449827|NCT02694757|8435818|P1|Overall Study|Lack of Efficacy|3
2449828|NCT02694744|8435824|P2|Overall Study|Taking potassium supplement: exclusion 6|1
2449829|NCT02694744|8435825|P1|Overall Study|Taking potassium supplement: exclusion 6|0
2449830|NCT02694744|8435824|P2|Overall Study|Lost to Follow-up|0
2449831|NCT02694744|8435825|P1|Overall Study|Lost to Follow-up|1
2449832|NCT02694744|8435824|P2|Overall Study|Physician Decision|2
2449833|NCT02694744|8435825|P1|Overall Study|Physician Decision|1
2449834|NCT02694744|8435824|P2|Overall Study|Withdrawal by Subject|1
2449835|NCT02694744|8435825|P1|Overall Study|Withdrawal by Subject|2
2449836|NCT02694744|8435824|P2|Overall Study|Adverse Event|1
2449837|NCT02694744|8435825|P1|Overall Study|Adverse Event|2
2449838|NCT02694718|8435833|P1|Overall Study|Withdrawal by Subject|1
2449839|NCT02694718|8435833|P1|Overall Study|Death|1
2449840|NCT02694562|8435851|P1|Overall Study|Physician Decision|1
2449841|NCT02694562|8435851|P1|Overall Study|Screen Failure|2
2449842|NCT02694562|8435851|P1|Overall Study|Lost to Follow-up|3
2449843|NCT02694562|8435851|P1|Overall Study|Protocol Violation|4
2449844|NCT02694562|8435851|P1|Overall Study|Death|8
2449845|NCT02694549|8435860|P1|Overall Study|screen failures|2
2449846|NCT02694536|8435866|P1|Overall Study|Other|22
2449847|NCT02694536|8435866|P1|Overall Study|Death|8
2449848|NCT02694536|8435866|P1|Overall Study|Withdrawal by Subject|8
2449849|NCT02694536|8435866|P1|Overall Study|Study Drug-Related Adverse Event|1
2449850|NCT02694536|8435866|P1|Overall Study|Lost to Follow-up|1
2449851|NCT02694536|8435866|P1|Overall Study|Progressive Disease|40
2449852|NCT02694523|8435877|P7|Part B|Other|1
2449853|NCT02694523|8435878|P6|Part B|Other|0
2449854|NCT02694523|8435879|P5|Part B|Other|0
2449855|NCT02694523|8435880|P4|Part B|Other|0
2449856|NCT02694523|8435881|P3|Part B|Other|1
2449857|NCT02694523|8435882|P2|Part B|Other|0
2449858|NCT02694523|8435883|P1|Part B|Other|0
2449859|NCT02694523|8435877|P7|Part B|Withdrawal by Subject|0
2449860|NCT02694523|8435878|P6|Part B|Withdrawal by Subject|3
2449861|NCT02694523|8435879|P5|Part B|Withdrawal by Subject|1
2449862|NCT02694523|8435880|P4|Part B|Withdrawal by Subject|0
2449863|NCT02694523|8435881|P3|Part B|Withdrawal by Subject|9
2449864|NCT02694523|8435882|P2|Part B|Withdrawal by Subject|0
2449865|NCT02694523|8435883|P1|Part B|Withdrawal by Subject|0
2449866|NCT02694523|8435877|P7|Part B|Lost to Follow-up|1
2449867|NCT02694523|8435878|P6|Part B|Lost to Follow-up|0
2449868|NCT02694523|8435879|P5|Part B|Lost to Follow-up|2
2449869|NCT02694523|8435880|P4|Part B|Lost to Follow-up|3
2449870|NCT02694523|8435881|P3|Part B|Lost to Follow-up|2
2449871|NCT02694523|8435882|P2|Part B|Lost to Follow-up|0
2449872|NCT02694523|8435883|P1|Part B|Lost to Follow-up|0
2449873|NCT02694523|8435877|P7|Part B|Protocol Violation|0
2449874|NCT02694523|8435878|P6|Part B|Protocol Violation|0
2449875|NCT02694523|8435879|P5|Part B|Protocol Violation|0
2449876|NCT02694523|8435880|P4|Part B|Protocol Violation|0
2449877|NCT02694523|8435881|P3|Part B|Protocol Violation|1
2449878|NCT02694523|8435882|P2|Part B|Protocol Violation|0
2449879|NCT02694523|8435883|P1|Part B|Protocol Violation|0
2449880|NCT02694523|8435877|P7|Part B|Adverse Event|0
2449881|NCT02694523|8435878|P6|Part B|Adverse Event|2
2449882|NCT02694523|8435879|P5|Part B|Adverse Event|1
2449883|NCT02694523|8435880|P4|Part B|Adverse Event|1
2449884|NCT02694523|8435881|P3|Part B|Adverse Event|7
2449885|NCT02694523|8435882|P2|Part B|Adverse Event|0
2449886|NCT02694523|8435883|P1|Part B|Adverse Event|0
2449887|NCT02694523|8435877|P7|Part A|Other|0
2449888|NCT02694523|8435878|P6|Part A|Other|0
2449889|NCT02694523|8435879|P5|Part A|Other|0
2449890|NCT02694523|8435880|P4|Part A|Other|0
2449891|NCT02694523|8435881|P3|Part A|Other|0
2449892|NCT02694523|8435882|P2|Part A|Other|1
2449893|NCT02694523|8435883|P1|Part A|Other|1
2449894|NCT02694523|8435877|P7|Part A|Withdrawal by Subject|0
2449895|NCT02694523|8435878|P6|Part A|Withdrawal by Subject|0
2449896|NCT02694523|8435879|P5|Part A|Withdrawal by Subject|0
2449897|NCT02694523|8435880|P4|Part A|Withdrawal by Subject|0
2449898|NCT02694523|8435881|P3|Part A|Withdrawal by Subject|0
2449899|NCT02694523|8435882|P2|Part A|Withdrawal by Subject|1
2449900|NCT02694523|8435883|P1|Part A|Withdrawal by Subject|3
2449901|NCT02694523|8435877|P7|Part A|Lost to Follow-up|0
2449902|NCT02694523|8435878|P6|Part A|Lost to Follow-up|0
2449903|NCT02694523|8435879|P5|Part A|Lost to Follow-up|0
2449904|NCT02694523|8435880|P4|Part A|Lost to Follow-up|0
2449905|NCT02694523|8435881|P3|Part A|Lost to Follow-up|0
2449906|NCT02694523|8435882|P2|Part A|Lost to Follow-up|2
2449907|NCT02694523|8435883|P1|Part A|Lost to Follow-up|1
2449908|NCT02694523|8435877|P7|Part A|Protocol Violation|0
2449909|NCT02694523|8435878|P6|Part A|Protocol Violation|0
2449910|NCT02694523|8435879|P5|Part A|Protocol Violation|0
2449911|NCT02694523|8435880|P4|Part A|Protocol Violation|0
2449912|NCT02694523|8435881|P3|Part A|Protocol Violation|0
2449913|NCT02694523|8435882|P2|Part A|Protocol Violation|0
2449914|NCT02694523|8435883|P1|Part A|Protocol Violation|1
2449915|NCT02694523|8435877|P7|Part A|Adverse Event|0
2449916|NCT02694523|8435878|P6|Part A|Adverse Event|0
2449917|NCT02694523|8435879|P5|Part A|Adverse Event|0
2449918|NCT02694523|8435880|P4|Part A|Adverse Event|0
2449919|NCT02694523|8435881|P3|Part A|Adverse Event|0
2449920|NCT02694523|8435882|P2|Part A|Adverse Event|3
2449921|NCT02694523|8435883|P1|Part A|Adverse Event|7
2449922|NCT02694328|8435909|P2|Overall Study|Abnormal Laboratory Value|3
2449923|NCT02694328|8435910|P1|Overall Study|Abnormal Laboratory Value|0
2449924|NCT02694328|8435909|P2|Overall Study|Protocol Violation|5
2449925|NCT02694328|8435910|P1|Overall Study|Protocol Violation|6
2449926|NCT02694328|8435909|P2|Overall Study|Pregnancy|1
2449927|NCT02694328|8435910|P1|Overall Study|Pregnancy|1
2449928|NCT02694328|8435909|P2|Overall Study|Lack of Efficacy|2
2449929|NCT02694328|8435910|P1|Overall Study|Lack of Efficacy|1
2449930|NCT02694328|8435909|P2|Overall Study|Incarceration|1
2449931|NCT02694328|8435910|P1|Overall Study|Incarceration|1
2449932|NCT02694328|8435909|P2|Overall Study|Noncompliant with study drug|8
2449933|NCT02694328|8435910|P1|Overall Study|Noncompliant with study drug|11
2449934|NCT02694328|8435909|P2|Overall Study|Lost to Follow-up|22
2449935|NCT02694328|8435910|P1|Overall Study|Lost to Follow-up|26
2449936|NCT02694328|8435909|P2|Overall Study|Withdrawal by Subject|23
2449937|NCT02694328|8435910|P1|Overall Study|Withdrawal by Subject|27
2449938|NCT02694328|8435909|P2|Overall Study|Adverse Event|33
2449939|NCT02694328|8435910|P1|Overall Study|Adverse Event|27
2449940|NCT02693834|8435932|P2|Week 2 Practice|Adverse Event|1
2449941|NCT02693834|8435933|P1|Week 2 Practice|Adverse Event|0
2449942|NCT02693834|8435932|P2|Baseline Measurement|Adverse Event|0
2449943|NCT02693834|8435933|P1|Baseline Measurement|Adverse Event|1
2449944|NCT02693834|8435932|P2|Baseline Measurement|Withdrawal by Subject|0
2449945|NCT02693834|8435933|P1|Baseline Measurement|Withdrawal by Subject|1
2449946|NCT02693743|8435943|P2|Overall Study|Physician Decision|0
2449947|NCT02693743|8435944|P1|Overall Study|Physician Decision|1
2449948|NCT02693171|8435975|P1|Overall Study|Discontinuation of Study by Sponsor|8
2449949|NCT02693171|8435975|P1|Overall Study|Adverse Event|1
2449950|NCT02693106|8436007|P1|Overall Study|No time|3
2449951|NCT02693002|8436019|P2|Overall Study|Withdrawal by Subject|0
2449952|NCT02693002|8436020|P1|Overall Study|Withdrawal by Subject|1
2449953|NCT02692716|8436043|P2|Overall Study|Withdrawal by Subject|1
2449954|NCT02692716|8436044|P1|Overall Study|Withdrawal by Subject|3
2449955|NCT02692716|8436043|P2|Overall Study|Lost to Follow-up|5
2449956|NCT02692716|8436044|P1|Overall Study|Lost to Follow-up|2
2449957|NCT02692703|8436084|P1|Overall Study|Other|1
2449958|NCT02692703|8436084|P1|Overall Study|Lost to Follow-up|1
2449959|NCT02692560|8436092|P2|Overall Study|Withdrawal by Subject|6
2449960|NCT02692560|8436093|P1|Overall Study|Withdrawal by Subject|0
2449961|NCT02692482|8436133|P2|Overall Study|Withdrawal by Subject|2
2449962|NCT02692482|8436134|P1|Overall Study|Withdrawal by Subject|1
2449963|NCT02692482|8436133|P2|Overall Study|Death|2
2449964|NCT02692482|8436134|P1|Overall Study|Death|2
2449965|NCT02692417|8436148|P2|Overall Study|Adverse Event|0
2449966|NCT02692417|8436149|P1|Overall Study|Adverse Event|1
2449967|NCT02692417|8436148|P2|Overall Study|Withdrawal by Subject|1
2449968|NCT02692417|8436149|P1|Overall Study|Withdrawal by Subject|5
2449969|NCT02692235|8436161|P2|Overall Study|Adverse Event|2
2449970|NCT02692235|8436162|P1|Overall Study|Adverse Event|1
2449971|NCT02692235|8436161|P2|Overall Study|Withdrawal by Subject|1
2449972|NCT02692235|8436162|P1|Overall Study|Withdrawal by Subject|2
2449973|NCT02691936|8436172|P2|Overall Study|Withdrawal by Subject|5
2449974|NCT02691936|8436173|P1|Overall Study|Withdrawal by Subject|2
2449975|NCT02691741|8436195|P2|Overall Study|Withdrawal by Subject|4
2449976|NCT02691741|8436196|P1|Overall Study|Withdrawal by Subject|0
2449977|NCT02691741|8436195|P2|Overall Study|Physician Decision|1
2449978|NCT02691741|8436196|P1|Overall Study|Physician Decision|0
2449979|NCT02691741|8436195|P2|Overall Study|Lost to Follow-up|0
2449980|NCT02691741|8436196|P1|Overall Study|Lost to Follow-up|1
2449981|NCT02691741|8436195|P2|Overall Study|Adverse Event|2
2449982|NCT02691741|8436196|P1|Overall Study|Adverse Event|0
2449983|NCT02691702|8436236|P11|Overall Study|Protocol Violation|0
2449984|NCT02691702|8436237|P10|Overall Study|Protocol Violation|2
2449985|NCT02691702|8436238|P9|Overall Study|Protocol Violation|0
2449986|NCT02691702|8436239|P8|Overall Study|Protocol Violation|0
2449987|NCT02691702|8436240|P7|Overall Study|Protocol Violation|0
2449988|NCT02691702|8436241|P6|Overall Study|Protocol Violation|0
2449989|NCT02691702|8436242|P5|Overall Study|Protocol Violation|0
2449990|NCT02691702|8436243|P4|Overall Study|Protocol Violation|0
2449991|NCT02691702|8436244|P3|Overall Study|Protocol Violation|0
2449992|NCT02691702|8436245|P2|Overall Study|Protocol Violation|0
2449993|NCT02691702|8436246|P1|Overall Study|Protocol Violation|0
2449994|NCT02691702|8436236|P11|Overall Study|Other|0
2449995|NCT02691702|8436237|P10|Overall Study|Other|0
2449996|NCT02691702|8436238|P9|Overall Study|Other|1
2449997|NCT02691702|8436239|P8|Overall Study|Other|0
2449998|NCT02691702|8436240|P7|Overall Study|Other|1
2449999|NCT02691702|8436241|P6|Overall Study|Other|0
2450000|NCT02691702|8436242|P5|Overall Study|Other|0
2450001|NCT02691702|8436243|P4|Overall Study|Other|0
2450002|NCT02691702|8436244|P3|Overall Study|Other|0
2450003|NCT02691702|8436245|P2|Overall Study|Other|0
2450004|NCT02691702|8436246|P1|Overall Study|Other|0
2450005|NCT02691702|8436236|P11|Overall Study|Withdrawal by Subject|0
2450006|NCT02691702|8436237|P10|Overall Study|Withdrawal by Subject|0
2450007|NCT02691702|8436238|P9|Overall Study|Withdrawal by Subject|0
2450008|NCT02691702|8436239|P8|Overall Study|Withdrawal by Subject|0
2450009|NCT02691702|8436240|P7|Overall Study|Withdrawal by Subject|2
2450010|NCT02691702|8436241|P6|Overall Study|Withdrawal by Subject|1
2450011|NCT02691702|8436242|P5|Overall Study|Withdrawal by Subject|0
2450012|NCT02691702|8436243|P4|Overall Study|Withdrawal by Subject|0
2450013|NCT02691702|8436244|P3|Overall Study|Withdrawal by Subject|0
2450014|NCT02691702|8436245|P2|Overall Study|Withdrawal by Subject|1
2450015|NCT02691702|8436246|P1|Overall Study|Withdrawal by Subject|1
2450016|NCT02691702|8436236|P11|Overall Study|Lost to Follow-up|1
2450017|NCT02691702|8436237|P10|Overall Study|Lost to Follow-up|0
2450018|NCT02691702|8436238|P9|Overall Study|Lost to Follow-up|0
2450019|NCT02691702|8436239|P8|Overall Study|Lost to Follow-up|0
2450020|NCT02691702|8436240|P7|Overall Study|Lost to Follow-up|0
2450021|NCT02691702|8436241|P6|Overall Study|Lost to Follow-up|2
2450022|NCT02691702|8436242|P5|Overall Study|Lost to Follow-up|0
2450023|NCT02691702|8436243|P4|Overall Study|Lost to Follow-up|0
2450024|NCT02691702|8436244|P3|Overall Study|Lost to Follow-up|1
2450025|NCT02691702|8436245|P2|Overall Study|Lost to Follow-up|0
2450026|NCT02691702|8436246|P1|Overall Study|Lost to Follow-up|0
2450027|NCT02691702|8436236|P11|Overall Study|Adverse Event|1
2450028|NCT02691702|8436237|P10|Overall Study|Adverse Event|0
2450029|NCT02691702|8436238|P9|Overall Study|Adverse Event|1
2450030|NCT02691702|8436239|P8|Overall Study|Adverse Event|0
2450031|NCT02691702|8436240|P7|Overall Study|Adverse Event|0
2450032|NCT02691702|8436241|P6|Overall Study|Adverse Event|0
2450033|NCT02691702|8436242|P5|Overall Study|Adverse Event|0
2450034|NCT02691702|8436243|P4|Overall Study|Adverse Event|0
2450035|NCT02691702|8436244|P3|Overall Study|Adverse Event|0
2450036|NCT02691702|8436245|P2|Overall Study|Adverse Event|0
2450037|NCT02691702|8436246|P1|Overall Study|Adverse Event|1
2450038|NCT02691572|8436532|P2|Overall Study|Protocol Violation|1
2450039|NCT02691572|8436533|P1|Overall Study|Protocol Violation|0
2450040|NCT02691572|8436532|P2|Overall Study|Withdrawal by Subject|0
2450041|NCT02691572|8436533|P1|Overall Study|Withdrawal by Subject|1
2450042|NCT02691507|8436541|P2|Overall Study|Missed Visit 3|1
2450043|NCT02691507|8436542|P1|Overall Study|Missed Visit 3|0
2450044|NCT02691468|8436674|P2|Overall Study|Failure to advance FOB|0
2450045|NCT02691468|8436675|P1|Overall Study|Failure to advance FOB|2
2450046|NCT02691468|8436674|P2|Overall Study|Lost to Follow-up|1
2450047|NCT02691468|8436675|P1|Overall Study|Lost to Follow-up|2
2450048|NCT02691468|8436674|P2|Overall Study|Bronchial blocker use|1
2450049|NCT02691468|8436675|P1|Overall Study|Bronchial blocker use|2
2450050|NCT02691013|8436736|P2|Overall Study|Withdrawal by Subject|0
2450051|NCT02691013|8436737|P1|Overall Study|Withdrawal by Subject|3
2450052|NCT02690974|8436751|P1|Overall Study|Protocol Deviation|1
2450053|NCT02690974|8436751|P1|Overall Study|Protocol-defined stopping criteria|1
2450054|NCT02690974|8436751|P1|Overall Study|Non-compliance with study treatment|1
2450055|NCT02690974|8436751|P1|Overall Study|Physician Decision|2
2450056|NCT02690974|8436751|P1|Overall Study|Withdrawal of Informed Consent|3
2450057|NCT02690974|8436751|P1|Overall Study|Lost to Follow-up|3
2450058|NCT02690974|8436751|P1|Overall Study|Subject/guardian decision|4
2450059|NCT02690974|8436751|P1|Overall Study|Death|9
2450060|NCT02690974|8436751|P1|Overall Study|Adverse Event|16
2450061|NCT02690727|8436792|P2|Overall Study|Adverse Event|2
2450062|NCT02690727|8436793|P1|Overall Study|Adverse Event|2
2450063|NCT02690701|8436805|P2|Treatment Period 2|Protocol Violation|1
2450064|NCT02690701|8436806|P1|Treatment Period 2|Protocol Violation|0
2450065|NCT02690701|8436805|P2|Treatment Period 2|Withdrawal by Subject|2
2450066|NCT02690701|8436806|P1|Treatment Period 2|Withdrawal by Subject|0
2450067|NCT02690701|8436805|P2|Treatment Period 2|Lost to Follow-up|2
2450068|NCT02690701|8436806|P1|Treatment Period 2|Lost to Follow-up|0
2450069|NCT02690701|8436805|P2|Treatment Period 2|Lack of Efficacy|0
2450070|NCT02690701|8436806|P1|Treatment Period 2|Lack of Efficacy|1
2450071|NCT02690701|8436805|P2|Treatment Period 2|Adverse Event|0
2450072|NCT02690701|8436806|P1|Treatment Period 2|Adverse Event|2
2450073|NCT02690701|8436805|P2|Treatment Period 1|Withdrawal by Subject|1
2450074|NCT02690701|8436806|P1|Treatment Period 1|Withdrawal by Subject|0
2450075|NCT02690701|8436805|P2|Treatment Period 1|Adverse Event|2
2450076|NCT02690701|8436806|P1|Treatment Period 1|Adverse Event|2
2450077|NCT02690207|8436871|P1|Overall Study|Other reasons for withdrawal|23
2450078|NCT02690207|8436871|P1|Overall Study|Suspected HZ Episode|1
2450079|NCT02690207|8436871|P1|Overall Study|Migrated/moved from study area|5
2450080|NCT02690207|8436871|P1|Overall Study|Non-serious Adverse Event|18
2450081|NCT02690207|8436871|P1|Overall Study|Serious adverse event|110
2450082|NCT02690207|8436871|P1|Overall Study|Protocol Violation|2
2450083|NCT02690207|8436871|P1|Overall Study|Withdrawal by Subject|46
2450084|NCT02690207|8436871|P1|Overall Study|Lost to Follow-up|48
2450085|NCT02690194|8436881|P3|Overall Study|Withdrawal by Subject|0
2450086|NCT02690194|8436882|P2|Overall Study|Withdrawal by Subject|4
2450087|NCT02690194|8436883|P1|Overall Study|Withdrawal by Subject|1
2450088|NCT02689804|8437090|P2|Overall Study|Withdrawal by Subject|0
2450089|NCT02689804|8437091|P1|Overall Study|Withdrawal by Subject|2
2450090|NCT02689492|8437117|P1|Overall Study|Other than listed|1
2450091|NCT02689492|8437117|P1|Overall Study|Withdrawal/ Physician’s Decision|1
2450092|NCT02689492|8437117|P1|Overall Study|Withdrawal/Loss To Follow-Up|1
2450093|NCT02689492|8437117|P1|Overall Study|Physician Decision|2
2450094|NCT02689492|8437117|P1|Overall Study|Death|9
2450095|NCT02689492|8437117|P1|Overall Study|Withdrawal by Subject|11
2450096|NCT02689492|8437117|P1|Overall Study|Lost to Follow-up|61
2450097|NCT02689219|8437133|P2|Overall Study|Disease Progression|6
2450098|NCT02689219|8437134|P1|Overall Study|Disease Progression|10
2450099|NCT02689219|8437133|P2|Overall Study|Death|1
2450100|NCT02689219|8437134|P1|Overall Study|Death|1
2450101|NCT02689206|8437151|P5|Overall Study|Withdrawal by Subject|0
2450102|NCT02689206|8437152|P4|Overall Study|Withdrawal by Subject|0
2450103|NCT02689206|8437153|P3|Overall Study|Withdrawal by Subject|1
2450104|NCT02689206|8437154|P2|Overall Study|Withdrawal by Subject|0
2450105|NCT02689206|8437155|P1|Overall Study|Withdrawal by Subject|1
2450106|NCT02689206|8437151|P5|Overall Study|Physician Decision|0
2450107|NCT02689206|8437152|P4|Overall Study|Physician Decision|0
2450108|NCT02689206|8437153|P3|Overall Study|Physician Decision|0
2450109|NCT02689206|8437154|P2|Overall Study|Physician Decision|0
2450110|NCT02689206|8437155|P1|Overall Study|Physician Decision|1
2450111|NCT02689206|8437151|P5|Overall Study|Other: Reached stopping criteria|4
2450112|NCT02689206|8437152|P4|Overall Study|Other: Reached stopping criteria|3
2450113|NCT02689206|8437153|P3|Overall Study|Other: Reached stopping criteria|2
2450114|NCT02689206|8437154|P2|Overall Study|Other: Reached stopping criteria|1
2450115|NCT02689206|8437155|P1|Overall Study|Other: Reached stopping criteria|0
2450116|NCT02689206|8437151|P5|Overall Study|Protocol Violation|2
2450117|NCT02689206|8437152|P4|Overall Study|Protocol Violation|1
2450118|NCT02689206|8437153|P3|Overall Study|Protocol Violation|0
2450119|NCT02689206|8437154|P2|Overall Study|Protocol Violation|0
2450120|NCT02689206|8437155|P1|Overall Study|Protocol Violation|1
2450121|NCT02689206|8437151|P5|Overall Study|Adverse Event|2
2450122|NCT02689206|8437152|P4|Overall Study|Adverse Event|0
2450123|NCT02689206|8437153|P3|Overall Study|Adverse Event|1
2450124|NCT02689206|8437154|P2|Overall Study|Adverse Event|0
2450125|NCT02689206|8437155|P1|Overall Study|Adverse Event|0
2450126|NCT02688933|8437368|P2|Overall Study|Lost to Follow-up|5
2450127|NCT02688933|8437369|P1|Overall Study|Lost to Follow-up|1
2450128|NCT02688933|8437368|P2|Overall Study|Other than Specified|25
2450129|NCT02688933|8437369|P1|Overall Study|Other than Specified|14
2450130|NCT02688933|8437368|P2|Overall Study|Hypoglycemia|0
2450131|NCT02688933|8437369|P1|Overall Study|Hypoglycemia|2
2450132|NCT02688933|8437368|P2|Overall Study|Poor compliance to protocol|4
2450133|NCT02688933|8437369|P1|Overall Study|Poor compliance to protocol|7
2450134|NCT02688933|8437368|P2|Overall Study|Lack of Efficacy|2
2450135|NCT02688933|8437369|P1|Overall Study|Lack of Efficacy|2
2450136|NCT02688933|8437368|P2|Overall Study|Adverse Event|1
2450137|NCT02688933|8437369|P1|Overall Study|Adverse Event|3
2450138|NCT02688764|8437429|P2|Overall Study|Withdrawal by parent|0
2450139|NCT02688764|8437430|P1|Overall Study|Withdrawal by parent|3
2450140|NCT02688764|8437429|P2|Overall Study|Subject taken off dialysis|0
2450141|NCT02688764|8437430|P1|Overall Study|Subject taken off dialysis|1
2450142|NCT02688764|8437429|P2|Overall Study|Subject moving out|0
2450143|NCT02688764|8437430|P1|Overall Study|Subject moving out|2
2450144|NCT02688764|8437429|P2|Overall Study|Study drug taste/Withd. parent|0
2450145|NCT02688764|8437430|P1|Overall Study|Study drug taste/Withd. parent|1
2450146|NCT02688764|8437429|P2|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0
2450147|NCT02688764|8437430|P1|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1
2450148|NCT02688764|8437429|P2|Overall Study|Phosphorus level outside safe range|1
2450149|NCT02688764|8437430|P1|Overall Study|Phosphorus level outside safe range|0
2450150|NCT02688764|8437429|P2|Overall Study|Non-compl./Withd. subject|2
2450151|NCT02688764|8437430|P1|Overall Study|Non-compl./Withd. subject|0
2450152|NCT02688764|8437429|P2|Overall Study|Non-compl./Ph. decision/Withd. subject|1
2450153|NCT02688764|8437430|P1|Overall Study|Non-compl./Ph. decision/Withd. subject|1
2450154|NCT02688764|8437429|P2|Overall Study|Non-compl./Physician decision|0
2450155|NCT02688764|8437430|P1|Overall Study|Non-compl./Physician decision|2
2450156|NCT02688764|8437429|P2|Overall Study|Non-compliance with study drug|0
2450157|NCT02688764|8437430|P1|Overall Study|Non-compliance with study drug|4
2450158|NCT02688764|8437429|P2|Overall Study|Lack of efficacy/Physician decision|1
2450159|NCT02688764|8437430|P1|Overall Study|Lack of efficacy/Physician decision|0
2450160|NCT02688764|8437429|P2|Overall Study|Lack of Efficacy|2
2450161|NCT02688764|8437430|P1|Overall Study|Lack of Efficacy|3
2450162|NCT02688764|8437429|P2|Overall Study|Kidney transplant|4
2450163|NCT02688764|8437430|P1|Overall Study|Kidney transplant|10
2450164|NCT02688764|8437429|P2|Overall Study|AE/Withd. subject|0
2450165|NCT02688764|8437430|P1|Overall Study|AE/Withd. subject|1
2450166|NCT02688764|8437429|P2|Overall Study|AE/Withd. parent/Withd. subject|1
2450167|NCT02688764|8437430|P1|Overall Study|AE/Withd. parent/Withd. subject|1
2450168|NCT02688764|8437429|P2|Overall Study|AE/Withd. parent|0
2450169|NCT02688764|8437430|P1|Overall Study|AE/Withd. parent|3
2450170|NCT02688764|8437429|P2|Overall Study|AE/Physician decision|0
2450171|NCT02688764|8437430|P1|Overall Study|AE/Physician decision|1
2450172|NCT02688764|8437429|P2|Overall Study|AE/Other|1
2450173|NCT02688764|8437430|P1|Overall Study|AE/Other|0
2450174|NCT02688764|8437429|P2|Overall Study|AE/Non-compl./Withd. parent|1
2450175|NCT02688764|8437430|P1|Overall Study|AE/Non-compl./Withd. parent|0
2450176|NCT02688764|8437429|P2|Overall Study|AE/Non-compl.|0
2450177|NCT02688764|8437430|P1|Overall Study|AE/Non-compl.|1
2450178|NCT02688764|8437429|P2|Overall Study|AE/Lack of efficacy|0
2450179|NCT02688764|8437430|P1|Overall Study|AE/Lack of efficacy|1
2450180|NCT02688764|8437429|P2|Overall Study|AE/Kidney transplant|0
2450181|NCT02688764|8437430|P1|Overall Study|AE/Kidney transplant|1
2450182|NCT02688764|8437429|P2|Overall Study|Adverse Event|3
2450183|NCT02688764|8437430|P1|Overall Study|Adverse Event|3
2450184|NCT02688387|8437497|P22|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2450185|NCT02688387|8437498|P21|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2450186|NCT02688387|8437499|P20|Part 3B, Washout Period 3 (10 Days)|Study terminated|1
2450187|NCT02688387|8437500|P19|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2450188|NCT02688387|8437501|P18|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2450189|NCT02688387|8437502|P17|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2450190|NCT02688387|8437503|P16|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2450191|NCT02688387|8437504|P15|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2450192|NCT02688387|8437505|P14|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2450193|NCT02688387|8437506|P13|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2450194|NCT02688387|8437507|P12|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2450195|NCT02688387|8437508|P11|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2450196|NCT02688387|8437509|P10|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2450197|NCT02688387|8437510|P9|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2450198|NCT02688387|8437511|P8|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2450199|NCT02688387|8437512|P7|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2450200|NCT02688387|8437513|P6|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2450201|NCT02688387|8437514|P5|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2450202|NCT02688387|8437515|P4|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2450203|NCT02688387|8437516|P3|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2450204|NCT02688387|8437517|P2|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2450205|NCT02688387|8437518|P1|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
2450206|NCT02688387|8437497|P22|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2450207|NCT02688387|8437498|P21|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1
2450208|NCT02688387|8437499|P20|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2450209|NCT02688387|8437500|P19|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1
2450210|NCT02688387|8437501|P18|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2450211|NCT02688387|8437502|P17|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2450212|NCT02688387|8437503|P16|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2450213|NCT02688387|8437504|P15|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2450214|NCT02688387|8437505|P14|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2450215|NCT02688387|8437506|P13|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2450216|NCT02688387|8437507|P12|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2450217|NCT02688387|8437508|P11|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2450218|NCT02688387|8437509|P10|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2450219|NCT02688387|8437510|P9|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2450220|NCT02688387|8437511|P8|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2450221|NCT02688387|8437512|P7|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2450222|NCT02688387|8437513|P6|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2450223|NCT02688387|8437514|P5|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2450224|NCT02688387|8437515|P4|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2450225|NCT02688387|8437516|P3|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2450226|NCT02688387|8437517|P2|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2450227|NCT02688387|8437518|P1|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
2450228|NCT02688387|8437497|P22|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2450229|NCT02688387|8437498|P21|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1
2450230|NCT02688387|8437499|P20|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2450231|NCT02688387|8437500|P19|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2450232|NCT02688387|8437501|P18|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2450233|NCT02688387|8437502|P17|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2450234|NCT02688387|8437503|P16|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2450235|NCT02688387|8437504|P15|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2450236|NCT02688387|8437505|P14|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2450237|NCT02688387|8437506|P13|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2450238|NCT02688387|8437507|P12|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2450239|NCT02688387|8437508|P11|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2450240|NCT02688387|8437509|P10|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2450241|NCT02688387|8437510|P9|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2450242|NCT02688387|8437511|P8|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2450243|NCT02688387|8437512|P7|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2450244|NCT02688387|8437513|P6|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2450245|NCT02688387|8437514|P5|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2450246|NCT02688387|8437515|P4|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2450247|NCT02688387|8437516|P3|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2450248|NCT02688387|8437517|P2|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2450249|NCT02688387|8437518|P1|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
2450250|NCT02688387|8437497|P22|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450251|NCT02688387|8437498|P21|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450252|NCT02688387|8437499|P20|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450253|NCT02688387|8437500|P19|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450254|NCT02688387|8437501|P18|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450255|NCT02688387|8437502|P17|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450256|NCT02688387|8437503|P16|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450257|NCT02688387|8437504|P15|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1
2450258|NCT02688387|8437505|P14|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450259|NCT02688387|8437506|P13|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450260|NCT02688387|8437507|P12|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450261|NCT02688387|8437508|P11|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450262|NCT02688387|8437509|P10|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450263|NCT02688387|8437510|P9|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450264|NCT02688387|8437511|P8|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450265|NCT02688387|8437512|P7|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450266|NCT02688387|8437513|P6|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450267|NCT02688387|8437514|P5|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450268|NCT02688387|8437515|P4|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450269|NCT02688387|8437516|P3|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450270|NCT02688387|8437517|P2|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450271|NCT02688387|8437518|P1|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450272|NCT02688387|8437497|P22|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2450273|NCT02688387|8437498|P21|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2450274|NCT02688387|8437499|P20|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2450275|NCT02688387|8437500|P19|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2450276|NCT02688387|8437501|P18|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2450277|NCT02688387|8437502|P17|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2450278|NCT02688387|8437503|P16|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2450279|NCT02688387|8437504|P15|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2450280|NCT02688387|8437505|P14|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2450281|NCT02688387|8437506|P13|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2450282|NCT02688387|8437507|P12|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2450283|NCT02688387|8437508|P11|Part 2, Period 1 (up to 6 Days)|Adverse Event|1
2450284|NCT02688387|8437509|P10|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2450285|NCT02688387|8437510|P9|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2450286|NCT02688387|8437511|P8|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2450287|NCT02688387|8437512|P7|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2450288|NCT02688387|8437513|P6|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2450289|NCT02688387|8437514|P5|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2450290|NCT02688387|8437515|P4|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2450291|NCT02688387|8437516|P3|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2450292|NCT02688387|8437517|P2|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2450293|NCT02688387|8437518|P1|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
2450294|NCT02688387|8437497|P22|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2450295|NCT02688387|8437498|P21|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2450296|NCT02688387|8437499|P20|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2450297|NCT02688387|8437500|P19|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2450298|NCT02688387|8437501|P18|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2450299|NCT02688387|8437502|P17|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2450300|NCT02688387|8437503|P16|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2450301|NCT02688387|8437504|P15|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2450302|NCT02688387|8437505|P14|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2450303|NCT02688387|8437506|P13|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2450304|NCT02688387|8437507|P12|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2450305|NCT02688387|8437508|P11|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2450306|NCT02688387|8437509|P10|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2450307|NCT02688387|8437510|P9|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2450308|NCT02688387|8437511|P8|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2450309|NCT02688387|8437512|P7|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2450310|NCT02688387|8437513|P6|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2450311|NCT02688387|8437514|P5|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2450312|NCT02688387|8437515|P4|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2450313|NCT02688387|8437516|P3|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2450314|NCT02688387|8437517|P2|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
2450315|NCT02688387|8437518|P1|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1
2450316|NCT02688387|8437497|P22|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2450317|NCT02688387|8437498|P21|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2450318|NCT02688387|8437499|P20|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2450319|NCT02688387|8437500|P19|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2450320|NCT02688387|8437501|P18|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2450321|NCT02688387|8437502|P17|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2450322|NCT02688387|8437503|P16|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2450323|NCT02688387|8437504|P15|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2450324|NCT02688387|8437505|P14|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2450325|NCT02688387|8437506|P13|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2450326|NCT02688387|8437507|P12|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2450327|NCT02688387|8437508|P11|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2450328|NCT02688387|8437509|P10|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2450329|NCT02688387|8437510|P9|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2450330|NCT02688387|8437511|P8|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2450331|NCT02688387|8437512|P7|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2450332|NCT02688387|8437513|P6|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2450333|NCT02688387|8437514|P5|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1
2450334|NCT02688387|8437515|P4|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2450335|NCT02688387|8437516|P3|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1
2450336|NCT02688387|8437517|P2|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2450337|NCT02688387|8437518|P1|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
2450338|NCT02688387|8437497|P22|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2450339|NCT02688387|8437498|P21|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2450340|NCT02688387|8437499|P20|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2450341|NCT02688387|8437500|P19|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2450342|NCT02688387|8437501|P18|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2450343|NCT02688387|8437502|P17|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2450344|NCT02688387|8437503|P16|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2450345|NCT02688387|8437504|P15|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2450346|NCT02688387|8437505|P14|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2450347|NCT02688387|8437506|P13|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2450348|NCT02688387|8437507|P12|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2450349|NCT02688387|8437508|P11|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2450350|NCT02688387|8437509|P10|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2450351|NCT02688387|8437510|P9|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2450352|NCT02688387|8437511|P8|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2450353|NCT02688387|8437512|P7|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2450354|NCT02688387|8437513|P6|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2450355|NCT02688387|8437514|P5|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2450356|NCT02688387|8437515|P4|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2450357|NCT02688387|8437516|P3|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2450358|NCT02688387|8437517|P2|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1
2450359|NCT02688387|8437518|P1|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
2450360|NCT02688387|8437497|P22|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450361|NCT02688387|8437498|P21|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450362|NCT02688387|8437499|P20|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450363|NCT02688387|8437500|P19|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450364|NCT02688387|8437501|P18|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450365|NCT02688387|8437502|P17|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450366|NCT02688387|8437503|P16|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450367|NCT02688387|8437504|P15|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450368|NCT02688387|8437505|P14|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450369|NCT02688387|8437506|P13|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450370|NCT02688387|8437507|P12|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450371|NCT02688387|8437508|P11|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450372|NCT02688387|8437509|P10|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450373|NCT02688387|8437510|P9|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450374|NCT02688387|8437511|P8|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450375|NCT02688387|8437512|P7|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450376|NCT02688387|8437513|P6|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450377|NCT02688387|8437514|P5|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450378|NCT02688387|8437515|P4|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1
2450379|NCT02688387|8437516|P3|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450380|NCT02688387|8437517|P2|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450381|NCT02688387|8437518|P1|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
2450382|NCT02688387|8437497|P22|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2450383|NCT02688387|8437498|P21|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2450384|NCT02688387|8437499|P20|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2450385|NCT02688387|8437500|P19|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2450386|NCT02688387|8437501|P18|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2450387|NCT02688387|8437502|P17|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2450388|NCT02688387|8437503|P16|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2450389|NCT02688387|8437504|P15|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2450390|NCT02688387|8437505|P14|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2450391|NCT02688387|8437506|P13|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2450392|NCT02688387|8437507|P12|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2450393|NCT02688387|8437508|P11|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2450394|NCT02688387|8437509|P10|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2450395|NCT02688387|8437510|P9|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2450396|NCT02688387|8437511|P8|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2450397|NCT02688387|8437512|P7|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2450398|NCT02688387|8437513|P6|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2450399|NCT02688387|8437514|P5|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2450400|NCT02688387|8437515|P4|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2450401|NCT02688387|8437516|P3|Part 1, Period 1 (up to 6 Days)|Adverse Event|1
2450402|NCT02688387|8437517|P2|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2450403|NCT02688387|8437518|P1|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
2450404|NCT02688192|8437786|P2|Overall Study|Physician Decision|0
2450405|NCT02688192|8437787|P1|Overall Study|Physician Decision|1
2450406|NCT02688192|8437786|P2|Overall Study|Lost to Follow-up|5
2450407|NCT02688192|8437787|P1|Overall Study|Lost to Follow-up|10
2450408|NCT02688153|8437806|P2|Overall Study|Conversion to Commercial Valve|0
2450409|NCT02688153|8437807|P1|Overall Study|Conversion to Commercial Valve|3
2450410|NCT02688153|8437806|P2|Overall Study|Valve Explant|0
2450411|NCT02688153|8437807|P1|Overall Study|Valve Explant|1
2450412|NCT02688153|8437806|P2|Overall Study|Withdrawal by Subject|2
2450413|NCT02688153|8437807|P1|Overall Study|Withdrawal by Subject|4
2450414|NCT02688153|8437806|P2|Overall Study|Death|5
2450415|NCT02688153|8437807|P1|Overall Study|Death|7
2450416|NCT02687919|8437867|P2|Overall Study|Protocol Violation|0
2450417|NCT02687919|8437868|P1|Overall Study|Protocol Violation|2
2450418|NCT02687919|8437867|P2|Overall Study|Withdrawal by Subject|6
2450419|NCT02687919|8437868|P1|Overall Study|Withdrawal by Subject|6
2450420|NCT02687542|8437901|P5|Overall Study|Withdrawal by Subject|4
2450421|NCT02687542|8437902|P4|Overall Study|Withdrawal by Subject|2
2450422|NCT02687542|8437903|P3|Overall Study|Withdrawal by Subject|1
2450423|NCT02687542|8437904|P2|Overall Study|Withdrawal by Subject|1
2450424|NCT02687542|8437905|P1|Overall Study|Withdrawal by Subject|0
2450425|NCT02687542|8437901|P5|Overall Study|Adverse Event|9
2450426|NCT02687542|8437902|P4|Overall Study|Adverse Event|2
2450427|NCT02687542|8437903|P3|Overall Study|Adverse Event|3
2450428|NCT02687542|8437904|P2|Overall Study|Adverse Event|1
2450429|NCT02687542|8437905|P1|Overall Study|Adverse Event|3
2450430|NCT02687542|8437901|P5|Overall Study|Other|5
2450431|NCT02687542|8437902|P4|Overall Study|Other|6
2450432|NCT02687542|8437903|P3|Overall Study|Other|10
2450433|NCT02687542|8437904|P2|Overall Study|Other|9
2450434|NCT02687542|8437905|P1|Overall Study|Other|5
2450435|NCT02687542|8437901|P5|Overall Study|Protocol Violation|0
2450436|NCT02687542|8437902|P4|Overall Study|Protocol Violation|0
2450437|NCT02687542|8437903|P3|Overall Study|Protocol Violation|0
2450438|NCT02687542|8437904|P2|Overall Study|Protocol Violation|1
2450439|NCT02687542|8437905|P1|Overall Study|Protocol Violation|0
2450440|NCT02687542|8437901|P5|Overall Study|Lost to Follow-up|1
2450441|NCT02687542|8437902|P4|Overall Study|Lost to Follow-up|0
2450442|NCT02687542|8437903|P3|Overall Study|Lost to Follow-up|0
2450443|NCT02687542|8437904|P2|Overall Study|Lost to Follow-up|0
2450444|NCT02687542|8437905|P1|Overall Study|Lost to Follow-up|0
2450445|NCT02687542|8437901|P5|Overall Study|Medication error without associated AEs|1
2450446|NCT02687542|8437902|P4|Overall Study|Medication error without associated AEs|0
2450447|NCT02687542|8437903|P3|Overall Study|Medication error without associated AEs|0
2450448|NCT02687542|8437904|P2|Overall Study|Medication error without associated AEs|0
2450449|NCT02687542|8437905|P1|Overall Study|Medication error without associated AEs|0
2450450|NCT02687191|8438034|P6|Overall Study|Withdrawal by Subject|0
2450451|NCT02687191|8438035|P5|Overall Study|Withdrawal by Subject|0
2450452|NCT02687191|8438036|P4|Overall Study|Withdrawal by Subject|1
2450453|NCT02687191|8438037|P3|Overall Study|Withdrawal by Subject|0
2450454|NCT02687191|8438038|P2|Overall Study|Withdrawal by Subject|0
2450455|NCT02687191|8438039|P1|Overall Study|Withdrawal by Subject|0
2450456|NCT02687191|8438034|P6|Overall Study|Death|1
2450457|NCT02687191|8438035|P5|Overall Study|Death|1
2450458|NCT02687191|8438036|P4|Overall Study|Death|0
2450459|NCT02687191|8438037|P3|Overall Study|Death|1
2450460|NCT02687191|8438038|P2|Overall Study|Death|1
2450461|NCT02687191|8438039|P1|Overall Study|Death|0
2450462|NCT02686164|8438196|P1|Overall Study|Clinical progression|1
2450463|NCT02686164|8438196|P1|Overall Study|Withdrawal of consent|1
2450464|NCT02686164|8438196|P1|Overall Study|Adverse Event|1
2450465|NCT02686034|8438233|P2|Open Label Period 3|Lost to Follow-up|1
2450466|NCT02686034|8438234|P1|Open Label Period 3|Lost to Follow-up|0
2450467|NCT02686034|8438233|P2|Randomized Controlled Period 2|Spontaneous reduction in migraines|0
2450468|NCT02686034|8438234|P1|Randomized Controlled Period 2|Spontaneous reduction in migraines|1
2450469|NCT02686034|8438233|P2|Randomized Controlled Period 2|Adverse Event|2
2450470|NCT02686034|8438234|P1|Randomized Controlled Period 2|Adverse Event|0
2450471|NCT02686034|8438233|P2|Randomized Controlled Period 2|Withdrawal by Subject|0
2450472|NCT02686034|8438234|P1|Randomized Controlled Period 2|Withdrawal by Subject|3
2450473|NCT02686034|8438233|P2|Randomized Controlled Period 2|Lost to Follow-up|2
2450474|NCT02686034|8438234|P1|Randomized Controlled Period 2|Lost to Follow-up|1
2450475|NCT02686034|8438233|P2|Run-In Period 1|Lost to Follow-up|4
2450476|NCT02686034|8438234|P1|Run-In Period 1|Lost to Follow-up|4
2450477|NCT02686034|8438233|P2|Run-In Period 1|Withdrawal by Subject|3
2450478|NCT02686034|8438234|P1|Run-In Period 1|Withdrawal by Subject|4
2450479|NCT02686034|8438233|P2|Run-In Period 1|Eligibility|10
2450480|NCT02686034|8438234|P1|Run-In Period 1|Eligibility|12
2450481|NCT02685826|8438273|P3|Overall Study|Full Clinical Hold by FDA|20
2450482|NCT02685826|8438274|P2|Overall Study|Full Clinical Hold by FDA|9
2450483|NCT02685826|8438275|P1|Overall Study|Full Clinical Hold by FDA|19
2450484|NCT02685826|8438273|P3|Overall Study|Withdrawal by Subject|0
2450485|NCT02685826|8438274|P2|Overall Study|Withdrawal by Subject|0
2450486|NCT02685826|8438275|P1|Overall Study|Withdrawal by Subject|2
2450487|NCT02685826|8438273|P3|Overall Study|Progressive Disease|0
2450488|NCT02685826|8438274|P2|Overall Study|Progressive Disease|1
2450489|NCT02685826|8438275|P1|Overall Study|Progressive Disease|2
2450490|NCT02685826|8438273|P3|Overall Study|Adverse Event|1
2450491|NCT02685826|8438274|P2|Overall Study|Adverse Event|0
2450492|NCT02685826|8438275|P1|Overall Study|Adverse Event|2
2450493|NCT02685488|8438360|P2|Overall Study|Withdrawal by Subject|1
2450494|NCT02685488|8438361|P1|Overall Study|Withdrawal by Subject|0
2450495|NCT02685202|8438414|P1|Overall Study|Lost to Follow-up|9
2450496|NCT02685072|8438422|P2|1-Month Follow-Up|Withdrawal by Subject|0
2450497|NCT02685072|8438423|P1|1-Month Follow-Up|Withdrawal by Subject|1
2450498|NCT02685072|8438422|P2|Treatment Period|Withdrawal by Subject|3
2450499|NCT02685072|8438423|P1|Treatment Period|Withdrawal by Subject|1
2450500|NCT02685072|8438422|P2|Treatment Period|Lost to Follow-up|6
2450501|NCT02685072|8438423|P1|Treatment Period|Lost to Follow-up|12
2450502|NCT02685033|8438467|P2|Overall Study|Adverse Event|0
2450503|NCT02685033|8438468|P1|Overall Study|Adverse Event|1
2450504|NCT02685033|8438467|P2|Overall Study|Lost to Follow-up|1
2450505|NCT02685033|8438468|P1|Overall Study|Lost to Follow-up|2
2450506|NCT02685033|8438467|P2|Overall Study|Withdrawal of Consent|1
2450507|NCT02685033|8438468|P1|Overall Study|Withdrawal of Consent|0
2450508|NCT02684981|8438504|P3|Overall Study|Other|17
2450509|NCT02684981|8438505|P2|Overall Study|Other|49
2450510|NCT02684981|8438506|P1|Overall Study|Other|83
2450511|NCT02684981|8438504|P3|Overall Study|Permanently discontinued the treatment|110
2450512|NCT02684981|8438505|P2|Overall Study|Permanently discontinued the treatment|161
2450513|NCT02684981|8438506|P1|Overall Study|Permanently discontinued the treatment|157
2450514|NCT02684370|8438666|P6|Part B|Subject Withdrawal|2
2450515|NCT02684370|8438667|P5|Part B|Subject Withdrawal|1
2450516|NCT02684370|8438668|P4|Part B|Subject Withdrawal|1
2450517|NCT02684370|8438669|P3|Part B|Subject Withdrawal|0
2450518|NCT02684370|8438670|P2|Part B|Subject Withdrawal|0
2450519|NCT02684370|8438671|P1|Part B|Subject Withdrawal|0
2450520|NCT02684370|8438666|P6|Part B|Lost to Follow-up|5
2450521|NCT02684370|8438667|P5|Part B|Lost to Follow-up|2
2450522|NCT02684370|8438668|P4|Part B|Lost to Follow-up|1
2450523|NCT02684370|8438669|P3|Part B|Lost to Follow-up|0
2450524|NCT02684370|8438670|P2|Part B|Lost to Follow-up|0
2450525|NCT02684370|8438671|P1|Part B|Lost to Follow-up|0
2450526|NCT02684370|8438666|P6|Part B|Adverse Event|1
2450527|NCT02684370|8438667|P5|Part B|Adverse Event|2
2450528|NCT02684370|8438668|P4|Part B|Adverse Event|0
2450529|NCT02684370|8438669|P3|Part B|Adverse Event|0
2450530|NCT02684370|8438670|P2|Part B|Adverse Event|0
2450531|NCT02684370|8438671|P1|Part B|Adverse Event|0
2450532|NCT02684370|8438666|P6|Part A|Other|0
2450533|NCT02684370|8438667|P5|Part A|Other|0
2450534|NCT02684370|8438668|P4|Part A|Other|0
2450535|NCT02684370|8438669|P3|Part A|Other|1
2450536|NCT02684370|8438670|P2|Part A|Other|0
2450537|NCT02684370|8438671|P1|Part A|Other|0
2450538|NCT02684370|8438666|P6|Part A|Subject Withdrawal|0
2450539|NCT02684370|8438667|P5|Part A|Subject Withdrawal|0
2450540|NCT02684370|8438668|P4|Part A|Subject Withdrawal|0
2450541|NCT02684370|8438669|P3|Part A|Subject Withdrawal|3
2450542|NCT02684370|8438670|P2|Part A|Subject Withdrawal|0
2450543|NCT02684370|8438671|P1|Part A|Subject Withdrawal|1
2450544|NCT02684370|8438666|P6|Part A|Lost to Follow-up|0
2450545|NCT02684370|8438667|P5|Part A|Lost to Follow-up|0
2450546|NCT02684370|8438668|P4|Part A|Lost to Follow-up|0
2450547|NCT02684370|8438669|P3|Part A|Lost to Follow-up|0
2450548|NCT02684370|8438670|P2|Part A|Lost to Follow-up|1
2450549|NCT02684370|8438671|P1|Part A|Lost to Follow-up|1
2450550|NCT02684370|8438666|P6|Part A|Adverse Event|0
2450551|NCT02684370|8438667|P5|Part A|Adverse Event|0
2450552|NCT02684370|8438668|P4|Part A|Adverse Event|0
2450553|NCT02684370|8438669|P3|Part A|Adverse Event|1
2450554|NCT02684370|8438670|P2|Part A|Adverse Event|0
2450555|NCT02684370|8438671|P1|Part A|Adverse Event|2
2450556|NCT02684357|8438716|P6|Part B|Other|1
2450557|NCT02684357|8438717|P5|Part B|Other|0
2450558|NCT02684357|8438718|P4|Part B|Other|1
2450559|NCT02684357|8438719|P3|Part B|Other|0
2450560|NCT02684357|8438720|P2|Part B|Other|0
2450561|NCT02684357|8438721|P1|Part B|Other|0
2450562|NCT02684357|8438716|P6|Part B|Withdrawal by Subject|4
2450563|NCT02684357|8438717|P5|Part B|Withdrawal by Subject|2
2450564|NCT02684357|8438718|P4|Part B|Withdrawal by Subject|0
2450565|NCT02684357|8438719|P3|Part B|Withdrawal by Subject|0
2450566|NCT02684357|8438720|P2|Part B|Withdrawal by Subject|0
2450567|NCT02684357|8438721|P1|Part B|Withdrawal by Subject|0
2450568|NCT02684357|8438716|P6|Part B|Lost to Follow-up|7
2450569|NCT02684357|8438717|P5|Part B|Lost to Follow-up|1
2450570|NCT02684357|8438718|P4|Part B|Lost to Follow-up|1
2450571|NCT02684357|8438719|P3|Part B|Lost to Follow-up|0
2450572|NCT02684357|8438720|P2|Part B|Lost to Follow-up|0
2450573|NCT02684357|8438721|P1|Part B|Lost to Follow-up|0
2450574|NCT02684357|8438716|P6|Part B|Adverse Event (Other)|1
2450575|NCT02684357|8438717|P5|Part B|Adverse Event (Other)|1
2450576|NCT02684357|8438718|P4|Part B|Adverse Event (Other)|1
2450577|NCT02684357|8438719|P3|Part B|Adverse Event (Other)|0
2450578|NCT02684357|8438720|P2|Part B|Adverse Event (Other)|0
2450579|NCT02684357|8438721|P1|Part B|Adverse Event (Other)|0
2450580|NCT02684357|8438716|P6|Part A|Other|0
2450581|NCT02684357|8438717|P5|Part A|Other|0
2450582|NCT02684357|8438718|P4|Part A|Other|0
2450583|NCT02684357|8438719|P3|Part A|Other|0
2450584|NCT02684357|8438720|P2|Part A|Other|1
2450585|NCT02684357|8438721|P1|Part A|Other|0
2450586|NCT02684357|8438716|P6|Part A|Withdrawal by Subject|0
2450587|NCT02684357|8438717|P5|Part A|Withdrawal by Subject|0
2450588|NCT02684357|8438718|P4|Part A|Withdrawal by Subject|0
2450589|NCT02684357|8438719|P3|Part A|Withdrawal by Subject|0
2450590|NCT02684357|8438720|P2|Part A|Withdrawal by Subject|0
2450591|NCT02684357|8438721|P1|Part A|Withdrawal by Subject|3
2450592|NCT02684357|8438716|P6|Part A|Lost to Follow-up|0
2450593|NCT02684357|8438717|P5|Part A|Lost to Follow-up|0
2450594|NCT02684357|8438718|P4|Part A|Lost to Follow-up|0
2450595|NCT02684357|8438719|P3|Part A|Lost to Follow-up|2
2450596|NCT02684357|8438720|P2|Part A|Lost to Follow-up|2
2450597|NCT02684357|8438721|P1|Part A|Lost to Follow-up|0
2450598|NCT02684357|8438716|P6|Part A|Adverse Event (Worsening of Disease)|0
2450599|NCT02684357|8438717|P5|Part A|Adverse Event (Worsening of Disease)|0
2450600|NCT02684357|8438718|P4|Part A|Adverse Event (Worsening of Disease)|0
2450601|NCT02684357|8438719|P3|Part A|Adverse Event (Worsening of Disease)|0
2450602|NCT02684357|8438720|P2|Part A|Adverse Event (Worsening of Disease)|0
2450603|NCT02684357|8438721|P1|Part A|Adverse Event (Worsening of Disease)|1
2450604|NCT02684344|8438771|P2|Overall Study|Withdrawal by Subject|1
2450605|NCT02684344|8438772|P1|Overall Study|Withdrawal by Subject|0
2450606|NCT02684097|8438807|P2|Overall Study|Lack of Efficacy|6
2450607|NCT02684097|8438808|P1|Overall Study|Lack of Efficacy|13
2450608|NCT02683889|8438833|P1|Overall Study|Withdrawal by Subject|1
2450609|NCT02683785|8438841|P2|Overall Study|Adverse Event|2
2450610|NCT02683785|8438842|P1|Overall Study|Adverse Event|0
2450611|NCT02683785|8438841|P2|Overall Study|Lost to Follow-up|1
2450612|NCT02683785|8438842|P1|Overall Study|Lost to Follow-up|0
2450613|NCT02683785|8438841|P2|Overall Study|Withdrawal by Subject|1
2450614|NCT02683785|8438842|P1|Overall Study|Withdrawal by Subject|1
2450615|NCT02683746|8438899|P2|Overall Study|Physician Decision|1
2450616|NCT02683746|8438900|P1|Overall Study|Physician Decision|2
2450617|NCT02683746|8438899|P2|Overall Study|Withdrawal by Subject|5
2450618|NCT02683746|8438900|P1|Overall Study|Withdrawal by Subject|6
2450619|NCT02683746|8438899|P2|Overall Study|Lost to Follow-up|6
2450620|NCT02683746|8438900|P1|Overall Study|Lost to Follow-up|5
2450621|NCT02683746|8438899|P2|Overall Study|Adverse Event|2
2450622|NCT02683746|8438900|P1|Overall Study|Adverse Event|3
2450623|NCT02683668|8438943|P3|Period 2|Withdrawal by Subject|0
2450624|NCT02683668|8438944|P2|Period 2|Withdrawal by Subject|1
2450625|NCT02683668|8438945|P1|Period 2|Withdrawal by Subject|0
2450626|NCT02683109|8439052|P2|Overall Study|Adverse Event|0
2450627|NCT02683109|8439053|P1|Overall Study|Adverse Event|1
2450628|NCT02682823|8439074|P5|Overall Study|Adverse Event|0
2450629|NCT02682823|8439075|P4|Overall Study|Adverse Event|1
2450630|NCT02682823|8439076|P3|Overall Study|Adverse Event|0
2450631|NCT02682823|8439077|P2|Overall Study|Adverse Event|0
2450632|NCT02682823|8439078|P1|Overall Study|Adverse Event|0
2450633|NCT02682823|8439074|P5|Overall Study|Protocol Deviation|0
2450634|NCT02682823|8439075|P4|Overall Study|Protocol Deviation|0
2450635|NCT02682823|8439076|P3|Overall Study|Protocol Deviation|0
2450636|NCT02682823|8439077|P2|Overall Study|Protocol Deviation|1
2450637|NCT02682823|8439078|P1|Overall Study|Protocol Deviation|0
2450638|NCT02682823|8439074|P5|Overall Study|Withdrawal by Subject|1
2450639|NCT02682823|8439075|P4|Overall Study|Withdrawal by Subject|0
2450640|NCT02682823|8439076|P3|Overall Study|Withdrawal by Subject|1
2450641|NCT02682823|8439077|P2|Overall Study|Withdrawal by Subject|0
2450642|NCT02682823|8439078|P1|Overall Study|Withdrawal by Subject|0
2450643|NCT02682602|8439114|P2|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0
2450644|NCT02682602|8439115|P1|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3
2450645|NCT02682602|8439114|P2|Pre-operative Diseased & Normal Hips|Unusable images|0
2450646|NCT02682602|8439115|P1|Pre-operative Diseased & Normal Hips|Unusable images|1
2450647|NCT02681510|8439250|P1|Overall Study|Lost to Follow-up|9
2450648|NCT02681510|8439250|P1|Overall Study|Withdrawal by Subject|1
2450649|NCT02681094|8439280|P3|2 - Enrolled Participants Set|No treatment given|1
2450650|NCT02681094|8439281|P2|2 - Enrolled Participants Set|No treatment given|1
2450651|NCT02681094|8439282|P1|2 - Enrolled Participants Set|No treatment given|0
2450652|NCT02681094|8439280|P3|2 - Enrolled Participants Set|Other|7
2450653|NCT02681094|8439281|P2|2 - Enrolled Participants Set|Other|6
2450654|NCT02681094|8439282|P1|2 - Enrolled Participants Set|Other|6
2450655|NCT02681094|8439280|P3|2 - Enrolled Participants Set|Study specific discontinuation criteria|21
2450656|NCT02681094|8439281|P2|2 - Enrolled Participants Set|Study specific discontinuation criteria|15
2450657|NCT02681094|8439282|P1|2 - Enrolled Participants Set|Study specific discontinuation criteria|14
2450658|NCT02681094|8439280|P3|2 - Enrolled Participants Set|Lack of therapeutic response|14
2450659|NCT02681094|8439281|P2|2 - Enrolled Participants Set|Lack of therapeutic response|5
2450660|NCT02681094|8439282|P1|2 - Enrolled Participants Set|Lack of therapeutic response|1
2450661|NCT02681094|8439280|P3|2 - Enrolled Participants Set|Severe non-compliance to protocol|1
2450662|NCT02681094|8439281|P2|2 - Enrolled Participants Set|Severe non-compliance to protocol|0
2450663|NCT02681094|8439282|P1|2 - Enrolled Participants Set|Severe non-compliance to protocol|2
2450664|NCT02681094|8439280|P3|2 - Enrolled Participants Set|Adverse Event|1
2450665|NCT02681094|8439281|P2|2 - Enrolled Participants Set|Adverse Event|4
2450666|NCT02681094|8439282|P1|2 - Enrolled Participants Set|Adverse Event|10
2450667|NCT02681094|8439280|P3|2 - Enrolled Participants Set|Participant decision|9
2450668|NCT02681094|8439281|P2|2 - Enrolled Participants Set|Participant decision|10
2450669|NCT02681094|8439282|P1|2 - Enrolled Participants Set|Participant decision|7
2450670|NCT02681094|8439280|P3|1 -Modified Enrolled Participants Set|No treatment given|1
2450671|NCT02681094|8439281|P2|1 -Modified Enrolled Participants Set|No treatment given|1
2450672|NCT02681094|8439282|P1|1 -Modified Enrolled Participants Set|No treatment given|0
2450673|NCT02681094|8439280|P3|1 -Modified Enrolled Participants Set|Other|7
2450674|NCT02681094|8439281|P2|1 -Modified Enrolled Participants Set|Other|6
2450675|NCT02681094|8439282|P1|1 -Modified Enrolled Participants Set|Other|6
2450676|NCT02681094|8439280|P3|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20
2450677|NCT02681094|8439281|P2|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13
2450678|NCT02681094|8439282|P1|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11
2450679|NCT02681094|8439280|P3|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14
2450680|NCT02681094|8439281|P2|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5
2450681|NCT02681094|8439282|P1|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1
2450682|NCT02681094|8439280|P3|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1
2450683|NCT02681094|8439281|P2|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0
2450684|NCT02681094|8439282|P1|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2
2450685|NCT02681094|8439280|P3|1 -Modified Enrolled Participants Set|Adverse Event|1
2450686|NCT02681094|8439281|P2|1 -Modified Enrolled Participants Set|Adverse Event|4
2450687|NCT02681094|8439282|P1|1 -Modified Enrolled Participants Set|Adverse Event|10
2450688|NCT02681094|8439280|P3|1 -Modified Enrolled Participants Set|Participant decision|9
2450689|NCT02681094|8439281|P2|1 -Modified Enrolled Participants Set|Participant decision|10
2450690|NCT02681094|8439282|P1|1 -Modified Enrolled Participants Set|Participant decision|7
2450691|NCT02680847|8439301|P3|Overall Study|Adverse Event|1
2450692|NCT02680847|8439302|P2|Overall Study|Adverse Event|0
2450693|NCT02680847|8439303|P1|Overall Study|Adverse Event|0
2450694|NCT02680847|8439301|P3|Overall Study|Lack of Efficacy|2
2450695|NCT02680847|8439302|P2|Overall Study|Lack of Efficacy|0
2450696|NCT02680847|8439303|P1|Overall Study|Lack of Efficacy|0
2450697|NCT02680847|8439301|P3|Overall Study|Unwilling to participate in study|0
2450698|NCT02680847|8439302|P2|Overall Study|Unwilling to participate in study|1
2450699|NCT02680847|8439303|P1|Overall Study|Unwilling to participate in study|1
2450700|NCT02680847|8439301|P3|Overall Study|No longer met eligibility criteria|0
2450701|NCT02680847|8439302|P2|Overall Study|No longer met eligibility criteria|2
2450702|NCT02680847|8439303|P1|Overall Study|No longer met eligibility criteria|2
2450703|NCT02680847|8439301|P3|Overall Study|Other|0
2450704|NCT02680847|8439302|P2|Overall Study|Other|0
2450705|NCT02680847|8439303|P1|Overall Study|Other|2
2450706|NCT02680834|8439340|P2|Overall Study|Lost to Follow-up|1
2450707|NCT02680834|8439341|P1|Overall Study|Lost to Follow-up|0
2450708|NCT02680834|8439340|P2|Overall Study|Withdrawal by Subject|0
2450709|NCT02680834|8439341|P1|Overall Study|Withdrawal by Subject|6
2450710|NCT02680834|8439340|P2|Overall Study|Physician Decision|2
2450711|NCT02680834|8439341|P1|Overall Study|Physician Decision|5
2450712|NCT02680756|8439353|P2|Overall Study|None of above or not recorded|2
2450713|NCT02680756|8439354|P1|Overall Study|None of above or not recorded|3
2450714|NCT02680756|8439353|P2|Overall Study|TSAT above 60% or a ferritin above 800 m|0
2450715|NCT02680756|8439354|P1|Overall Study|TSAT above 60% or a ferritin above 800 m|1
2450716|NCT02680756|8439353|P2|Overall Study|Protocol Violation|0
2450717|NCT02680756|8439354|P1|Overall Study|Protocol Violation|1
2450718|NCT02680756|8439353|P2|Overall Study|Death|0
2450719|NCT02680756|8439354|P1|Overall Study|Death|1
2450720|NCT02680756|8439353|P2|Overall Study|Blood transfusion for any reason|1
2450721|NCT02680756|8439354|P1|Overall Study|Blood transfusion for any reason|0
2450722|NCT02680756|8439353|P2|Overall Study|Hb ≤7.5 g/dL|2
2450723|NCT02680756|8439354|P1|Overall Study|Hb ≤7.5 g/dL|0
2450724|NCT02680756|8439353|P2|Overall Study|Physician Decision|1
2450725|NCT02680756|8439354|P1|Overall Study|Physician Decision|4
2450726|NCT02680756|8439353|P2|Overall Study|Withdrawal by Subject|5
2450727|NCT02680756|8439354|P1|Overall Study|Withdrawal by Subject|5
2450728|NCT02680756|8439353|P2|Overall Study|Lost to Follow-up|6
2450729|NCT02680756|8439354|P1|Overall Study|Lost to Follow-up|7
2450730|NCT02680756|8439353|P2|Overall Study|Adverse Event|2
2450731|NCT02680756|8439354|P1|Overall Study|Adverse Event|10
2450732|NCT02680665|8439402|P1|Overall Study|No visit after the first prescription|5
2450733|NCT02680639|8439408|P3|Screening Period|Screen Failure|0
2450734|NCT02680639|8439409|P2|Screening Period|Screen Failure|0
2450735|NCT02680639|8439410|P1|Screening Period|Screen Failure|7
2450736|NCT02680041|8439476|P1|Overall Study|Lost to Follow-up|2
2450737|NCT02680041|8439476|P1|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8
2450738|NCT02679729|8439519|P9|Overall Study|Participant decision|0
2450739|NCT02679729|8439520|P8|Overall Study|Participant decision|0
2450740|NCT02679729|8439521|P7|Overall Study|Participant decision|1
2450741|NCT02679729|8439522|P6|Overall Study|Participant decision|0
2450742|NCT02679729|8439523|P5|Overall Study|Participant decision|0
2450743|NCT02679729|8439524|P4|Overall Study|Participant decision|0
2450744|NCT02679729|8439525|P3|Overall Study|Participant decision|0
2450745|NCT02679729|8439526|P2|Overall Study|Participant decision|1
2450746|NCT02679729|8439527|P1|Overall Study|Participant decision|0
2450747|NCT02679729|8439519|P9|Overall Study|Lost to Follow-up|0
2450748|NCT02679729|8439520|P8|Overall Study|Lost to Follow-up|0
2450749|NCT02679729|8439521|P7|Overall Study|Lost to Follow-up|0
2450750|NCT02679729|8439522|P6|Overall Study|Lost to Follow-up|0
2450751|NCT02679729|8439523|P5|Overall Study|Lost to Follow-up|1
2450752|NCT02679729|8439524|P4|Overall Study|Lost to Follow-up|0
2450753|NCT02679729|8439525|P3|Overall Study|Lost to Follow-up|0
2450754|NCT02679729|8439526|P2|Overall Study|Lost to Follow-up|1
2450755|NCT02679729|8439527|P1|Overall Study|Lost to Follow-up|0
2450756|NCT02679573|8439639|P2|Overall Study|Lost to Follow-up|3
2450757|NCT02679573|8439640|P1|Overall Study|Lost to Follow-up|0
2450758|NCT02679573|8439639|P2|Overall Study|Physician Decision|4
2450759|NCT02679573|8439640|P1|Overall Study|Physician Decision|2
2450760|NCT02679573|8439639|P2|Overall Study|Death|0
2450761|NCT02679573|8439640|P1|Overall Study|Death|2
2450762|NCT02679573|8439639|P2|Overall Study|Withdrawal by Subject|9
2450763|NCT02679573|8439640|P1|Overall Study|Withdrawal by Subject|2
2450764|NCT02679573|8439639|P2|Overall Study|Could not complete required study visits|2
2450765|NCT02679573|8439640|P1|Overall Study|Could not complete required study visits|6
2450766|NCT02679573|8439639|P2|Overall Study|Lack of Efficacy|15
2450767|NCT02679573|8439640|P1|Overall Study|Lack of Efficacy|12
2450768|NCT02679573|8439639|P2|Overall Study|Adverse Event|6
2450769|NCT02679573|8439640|P1|Overall Study|Adverse Event|13
2450770|NCT02679274|8439664|P2|Overall Study|Withdrawal by Subject|0
2450771|NCT02679274|8439665|P1|Overall Study|Withdrawal by Subject|1
2450772|NCT02679235|8439695|P1|Overall Study|Adverse Event|1
2450773|NCT02679235|8439695|P1|Overall Study|Withdrawal by Subject|3
2450774|NCT02679222|8439702|P1|Overall Study|No time for project|1
2450775|NCT02678923|8439732|P2|Overall Study|Did Not Return for Study Visits|0
2450776|NCT02678923|8439733|P1|Overall Study|Did Not Return for Study Visits|1
2450777|NCT02678923|8439732|P2|Overall Study|Lost to Follow-up|0
2450778|NCT02678923|8439733|P1|Overall Study|Lost to Follow-up|1
2450779|NCT02678923|8439732|P2|Overall Study|Withdrawal by Subject|2
2450780|NCT02678923|8439733|P1|Overall Study|Withdrawal by Subject|3
2450781|NCT02678923|8439732|P2|Overall Study|Protocol Deviation (Not Dosed)|3
2450782|NCT02678923|8439733|P1|Overall Study|Protocol Deviation (Not Dosed)|1
2450783|NCT02678676|8439749|P2|Overall Study|Unconfirmed for lost to follow-up|67
2450784|NCT02678676|8439750|P1|Overall Study|Unconfirmed for lost to follow-up|85
2450785|NCT02678676|8439749|P2|Overall Study|Lost to Follow-up|151
2450786|NCT02678676|8439750|P1|Overall Study|Lost to Follow-up|171
2450787|NCT02678676|8439749|P2|Overall Study|Withdrawal by Subject|5
2450788|NCT02678676|8439750|P1|Overall Study|Withdrawal by Subject|13
2450789|NCT02678676|8439749|P2|Overall Study|Death|649
2450790|NCT02678676|8439750|P1|Overall Study|Death|619
2450791|NCT02678416|8439781|P1|Part 2|Withdrawal by Subject|1
2450792|NCT02678416|8439781|P1|Part 2|Adverse Event|2
2450793|NCT02678416|8439781|P1|Part 1|Withdrawal by Subject|1
2450794|NCT02678390|8439801|P2|AE (1 Day)|Withdrawal by Subject|1
2450795|NCT02678390|8439802|P1|AE (1 Day)|Withdrawal by Subject|0
2450796|NCT02678286|8439818|P2|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
2450797|NCT02678286|8439819|P1|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
2450798|NCT02678286|8439818|P2|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2
2450799|NCT02678286|8439819|P1|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3
2450800|NCT02678286|8439818|P2|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0
2450801|NCT02678286|8439819|P1|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1
2450802|NCT02678286|8439818|P2|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1
2450803|NCT02678286|8439819|P1|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0
2450804|NCT02678286|8439818|P2|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1
2450805|NCT02678286|8439819|P1|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2
2450806|NCT02678000|8439871|P5|PART 2|Withdrawal by Subject|0
2450807|NCT02678000|8439872|P4|PART 2|Withdrawal by Subject|0
2450808|NCT02678000|8439873|P3|PART 2|Withdrawal by Subject|1
2450809|NCT02678000|8439874|P2|PART 2|Withdrawal by Subject|0
2450810|NCT02678000|8439875|P1|PART 2|Withdrawal by Subject|0
2450811|NCT02678000|8439871|P5|PART 2|Adverse Event|0
2450812|NCT02678000|8439872|P4|PART 2|Adverse Event|1
2450813|NCT02678000|8439873|P3|PART 2|Adverse Event|2
2450814|NCT02678000|8439874|P2|PART 2|Adverse Event|0
2450815|NCT02678000|8439875|P1|PART 2|Adverse Event|0
2450816|NCT02677896|8439913|P2|Overall Study|Did not receive study drug|2
2450817|NCT02677896|8439914|P1|Overall Study|Did not receive study drug|2
2450818|NCT02677896|8439913|P2|Overall Study|Miscellaneous|11
2450819|NCT02677896|8439914|P1|Overall Study|Miscellaneous|6
2450820|NCT02677896|8439913|P2|Overall Study|Withdrawal by patient:|30
2450821|NCT02677896|8439914|P1|Overall Study|Withdrawal by patient:|25
2450822|NCT02677896|8439913|P2|Overall Study|Protocol deviation|1
2450823|NCT02677896|8439914|P1|Overall Study|Protocol deviation|2
2450824|NCT02677896|8439913|P2|Overall Study|Progressive disease:|171
2450825|NCT02677896|8439914|P1|Overall Study|Progressive disease:|65
2450826|NCT02677896|8439913|P2|Overall Study|Lost to Follow-up|1
2450827|NCT02677896|8439914|P1|Overall Study|Lost to Follow-up|0
2450828|NCT02677896|8439913|P2|Overall Study|Death|7
2450829|NCT02677896|8439914|P1|Overall Study|Death|9
2450830|NCT02677896|8439913|P2|Overall Study|Adverse Event|21
2450831|NCT02677896|8439914|P1|Overall Study|Adverse Event|28
2450832|NCT02677844|8439942|P7|Period 3|Withdrawal by Subject|0
2450833|NCT02677844|8439943|P6|Period 3|Withdrawal by Subject|0
2450834|NCT02677844|8439944|P5|Period 3|Withdrawal by Subject|0
2450835|NCT02677844|8439945|P4|Period 3|Withdrawal by Subject|1
2450836|NCT02677844|8439946|P3|Period 3|Withdrawal by Subject|0
2450837|NCT02677844|8439947|P2|Period 3|Withdrawal by Subject|0
2450838|NCT02677844|8439948|P1|Period 3|Withdrawal by Subject|0
2450839|NCT02677220|8440050|P1|Overall Study|Adverse Event|1
2450840|NCT02676895|8440059|P3|Overall Study|Withdrawal by Subject|1
2450841|NCT02676895|8440060|P2|Overall Study|Withdrawal by Subject|0
2450842|NCT02676895|8440061|P1|Overall Study|Withdrawal by Subject|0
2450843|NCT02676895|8440059|P3|Overall Study|Lost to Follow-up|1
2450844|NCT02676895|8440060|P2|Overall Study|Lost to Follow-up|0
2450845|NCT02676895|8440061|P1|Overall Study|Lost to Follow-up|0
2450846|NCT02676895|8440059|P3|Overall Study|Adverse Event|1
2450847|NCT02676895|8440060|P2|Overall Study|Adverse Event|3
2450848|NCT02676895|8440061|P1|Overall Study|Adverse Event|0
2450849|NCT02676895|8440059|P3|Overall Study|Protocol Violation|0
2450850|NCT02676895|8440060|P2|Overall Study|Protocol Violation|0
2450851|NCT02676895|8440061|P1|Overall Study|Protocol Violation|1
2450852|NCT02676895|8440059|P3|Overall Study|Administrative reason|0
2450853|NCT02676895|8440060|P2|Overall Study|Administrative reason|0
2450854|NCT02676895|8440061|P1|Overall Study|Administrative reason|1
2450855|NCT02676882|8440104|P2|Overall Study|Withdrawal by Subject|2
2450856|NCT02676882|8440105|P1|Overall Study|Withdrawal by Subject|1
2450857|NCT02676882|8440104|P2|Overall Study|Lost to Follow-up|0
2450858|NCT02676882|8440105|P1|Overall Study|Lost to Follow-up|1
2450859|NCT02676882|8440104|P2|Overall Study|Adverse Event|0
2450860|NCT02676882|8440105|P1|Overall Study|Adverse Event|1
2450861|NCT02676466|8440124|P8|Overall Study|Withdrawal by Subject|1
2450862|NCT02676466|8440125|P7|Overall Study|Withdrawal by Subject|1
2450863|NCT02676466|8440126|P6|Overall Study|Withdrawal by Subject|1
2450864|NCT02676466|8440127|P5|Overall Study|Withdrawal by Subject|3
2450865|NCT02676466|8440128|P4|Overall Study|Withdrawal by Subject|0
2450866|NCT02676466|8440129|P3|Overall Study|Withdrawal by Subject|1
2450867|NCT02676466|8440130|P2|Overall Study|Withdrawal by Subject|3
2450868|NCT02676466|8440131|P1|Overall Study|Withdrawal by Subject|4
2450869|NCT02676466|8440124|P8|Overall Study|Death|0
2450870|NCT02676466|8440125|P7|Overall Study|Death|0
2450871|NCT02676466|8440126|P6|Overall Study|Death|0
2450872|NCT02676466|8440127|P5|Overall Study|Death|0
2450873|NCT02676466|8440128|P4|Overall Study|Death|0
2450874|NCT02676466|8440129|P3|Overall Study|Death|1
2450875|NCT02676466|8440130|P2|Overall Study|Death|2
2450876|NCT02676466|8440131|P1|Overall Study|Death|0
2450877|NCT02675907|8440212|P2|Study Overall|Lost to Follow-up|2
2450878|NCT02675907|8440213|P1|Study Overall|Lost to Follow-up|0
2450879|NCT02675907|8440212|P2|Study Overall|Withdrawal by Subject|2
2450880|NCT02675907|8440213|P1|Study Overall|Withdrawal by Subject|2
2450881|NCT02675907|8440212|P2|Study Overall|Lack of Efficacy|0
2450882|NCT02675907|8440213|P1|Study Overall|Lack of Efficacy|1
2450883|NCT02675907|8440212|P2|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
2450884|NCT02675907|8440213|P1|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
2450885|NCT02675907|8440212|P2|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
2450886|NCT02675907|8440213|P1|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
2450887|NCT02675751|8440258|P1|Overall Study|Lost to Follow-up|16
2450888|NCT02675634|8440262|P6|Test Period 2|Adverse Event|1
2450889|NCT02675634|8440263|P5|Test Period 2|Adverse Event|0
2450890|NCT02675634|8440264|P4|Test Period 2|Adverse Event|0
2450891|NCT02675634|8440265|P3|Test Period 2|Adverse Event|0
2450892|NCT02675634|8440266|P2|Test Period 2|Adverse Event|0
2450893|NCT02675634|8440267|P1|Test Period 2|Adverse Event|0
2450894|NCT02675634|8440262|P6|Test Period 2|Lack of Efficacy|0
2450895|NCT02675634|8440263|P5|Test Period 2|Lack of Efficacy|0
2450896|NCT02675634|8440264|P4|Test Period 2|Lack of Efficacy|0
2450897|NCT02675634|8440265|P3|Test Period 2|Lack of Efficacy|0
2450898|NCT02675634|8440266|P2|Test Period 2|Lack of Efficacy|0
2450899|NCT02675634|8440267|P1|Test Period 2|Lack of Efficacy|1
2450900|NCT02675634|8440262|P6|Test Period 1|Device deficiency that did not lead to A|0
2450901|NCT02675634|8440263|P5|Test Period 1|Device deficiency that did not lead to A|0
2450902|NCT02675634|8440264|P4|Test Period 1|Device deficiency that did not lead to A|0
2450903|NCT02675634|8440265|P3|Test Period 1|Device deficiency that did not lead to A|1
2450904|NCT02675634|8440266|P2|Test Period 1|Device deficiency that did not lead to A|0
2450905|NCT02675634|8440267|P1|Test Period 1|Device deficiency that did not lead to A|0
2450906|NCT02675634|8440262|P6|Test Period 1|Adverse Event|0
2450907|NCT02675634|8440263|P5|Test Period 1|Adverse Event|0
2450908|NCT02675634|8440264|P4|Test Period 1|Adverse Event|1
2450909|NCT02675634|8440265|P3|Test Period 1|Adverse Event|0
2450910|NCT02675634|8440266|P2|Test Period 1|Adverse Event|1
2450911|NCT02675634|8440267|P1|Test Period 1|Adverse Event|0
2450912|NCT02675517|8440284|P1|Overall Study|Evaluable PF-10 questionnaire at visit1|151
2450913|NCT02675517|8440284|P1|Overall Study|No evaluable PF-10 questionnaire at all|8
2450914|NCT02675426|8440296|P3|Overall Study|Other|2
2450915|NCT02675426|8440297|P2|Overall Study|Other|1
2450916|NCT02675426|8440298|P1|Overall Study|Other|3
2450917|NCT02675426|8440296|P3|Overall Study|Lost to Follow-up|2
2450918|NCT02675426|8440297|P2|Overall Study|Lost to Follow-up|0
2450919|NCT02675426|8440298|P1|Overall Study|Lost to Follow-up|1
2450920|NCT02675426|8440296|P3|Overall Study|Withdrawal by Subject|5
2450921|NCT02675426|8440297|P2|Overall Study|Withdrawal by Subject|5
2450922|NCT02675426|8440298|P1|Overall Study|Withdrawal by Subject|3
2450923|NCT02675426|8440296|P3|Overall Study|Adverse Event|9
2450924|NCT02675426|8440297|P2|Overall Study|Adverse Event|2
2450925|NCT02675426|8440298|P1|Overall Study|Adverse Event|6
2450926|NCT02674854|8440342|P3|Overall Study|Subject missed V6.2|0
2450927|NCT02674854|8440343|P2|Overall Study|Subject missed V6.2|0
2450928|NCT02674854|8440344|P1|Overall Study|Subject missed V6.2|1
2450929|NCT02674854|8440342|P3|Overall Study|Death|0
2450930|NCT02674854|8440343|P2|Overall Study|Death|1
2450931|NCT02674854|8440344|P1|Overall Study|Death|0
2450932|NCT02674854|8440342|P3|Overall Study|Protocol Violation|2
2450933|NCT02674854|8440343|P2|Overall Study|Protocol Violation|1
2450934|NCT02674854|8440344|P1|Overall Study|Protocol Violation|1
2450935|NCT02674854|8440342|P3|Overall Study|Disallowed Concurrent Medication|0
2450936|NCT02674854|8440343|P2|Overall Study|Disallowed Concurrent Medication|2
2450937|NCT02674854|8440344|P1|Overall Study|Disallowed Concurrent Medication|2
2450938|NCT02674854|8440342|P3|Overall Study|Lack of Efficacy|0
2450939|NCT02674854|8440343|P2|Overall Study|Lack of Efficacy|3
2450940|NCT02674854|8440344|P1|Overall Study|Lack of Efficacy|0
2450941|NCT02674854|8440342|P3|Overall Study|Lost to Follow-up|2
2450942|NCT02674854|8440343|P2|Overall Study|Lost to Follow-up|0
2450943|NCT02674854|8440344|P1|Overall Study|Lost to Follow-up|1
2450944|NCT02674854|8440342|P3|Overall Study|No-compliant subject|1
2450945|NCT02674854|8440343|P2|Overall Study|No-compliant subject|0
2450946|NCT02674854|8440344|P1|Overall Study|No-compliant subject|1
2450947|NCT02674854|8440342|P3|Overall Study|Withdrawal by Subject|4
2450948|NCT02674854|8440343|P2|Overall Study|Withdrawal by Subject|5
2450949|NCT02674854|8440344|P1|Overall Study|Withdrawal by Subject|1
2450950|NCT02674854|8440342|P3|Overall Study|Adverse Event|5
2450951|NCT02674854|8440343|P2|Overall Study|Adverse Event|15
2450952|NCT02674854|8440344|P1|Overall Study|Adverse Event|17
2450953|NCT02674568|8440377|P1|Overall Study|Other, Not Specified|20
2450954|NCT02674568|8440377|P1|Overall Study|Lost to Follow-up|9
2450955|NCT02674568|8440377|P1|Overall Study|Physician Decision|2
2450956|NCT02674568|8440377|P1|Overall Study|Death|303
2450957|NCT02674568|8440377|P1|Overall Study|Withdrawal by Subject|5
2450958|NCT02674477|8440402|P2|Overall Study|Protocol Violation|2
2450959|NCT02674477|8440403|P1|Overall Study|Protocol Violation|8
2450960|NCT02674334|8440426|P2|Overall Study|NIRS not recording|0
2450961|NCT02674334|8440427|P1|Overall Study|NIRS not recording|1
2450962|NCT02674334|8440426|P2|Overall Study|participant difficulty breathing|0
2450963|NCT02674334|8440427|P1|Overall Study|participant difficulty breathing|1
2450964|NCT02674334|8440426|P2|Overall Study|Lost to Follow-up|3
2450965|NCT02674334|8440427|P1|Overall Study|Lost to Follow-up|5
2450966|NCT02674204|8440437|P2|Overall Study|Adverse Event|0
2450967|NCT02674204|8440438|P1|Overall Study|Adverse Event|1
2450968|NCT02673619|8440510|P4|Overall Study|Lack of Efficacy|0
2450969|NCT02673619|8440511|P3|Overall Study|Lack of Efficacy|1
2450970|NCT02673619|8440512|P2|Overall Study|Lack of Efficacy|0
2450971|NCT02673619|8440513|P1|Overall Study|Lack of Efficacy|0
2450972|NCT02673619|8440510|P4|Overall Study|Adverse Event|0
2450973|NCT02673619|8440511|P3|Overall Study|Adverse Event|1
2450974|NCT02673619|8440512|P2|Overall Study|Adverse Event|0
2450975|NCT02673619|8440513|P1|Overall Study|Adverse Event|0
2450976|NCT02673619|8440510|P4|Overall Study|Withdrawal by Subject|0
2450977|NCT02673619|8440511|P3|Overall Study|Withdrawal by Subject|1
2450978|NCT02673619|8440512|P2|Overall Study|Withdrawal by Subject|1
2450979|NCT02673619|8440513|P1|Overall Study|Withdrawal by Subject|1
2450980|NCT02673619|8440510|P4|Overall Study|Lost to Follow-up|0
2450981|NCT02673619|8440511|P3|Overall Study|Lost to Follow-up|0
2450982|NCT02673619|8440512|P2|Overall Study|Lost to Follow-up|0
2450983|NCT02673619|8440513|P1|Overall Study|Lost to Follow-up|1
2450984|NCT02673489|8440624|P2|Follow Up Period|Unable to return for follow-up|1
2450985|NCT02673489|8440625|P1|Follow Up Period|Unable to return for follow-up|0
2450986|NCT02673489|8440624|P2|Follow Up Period|Unable to return for week 24 follow-up|1
2450987|NCT02673489|8440625|P1|Follow Up Period|Unable to return for week 24 follow-up|0
2450988|NCT02673489|8440624|P2|Treatment Period|Adverse Event|1
2450989|NCT02673489|8440625|P1|Treatment Period|Adverse Event|0
2450990|NCT02673489|8440624|P2|Treatment Period|Participant was incarcerated|1
2450991|NCT02673489|8440625|P1|Treatment Period|Participant was incarcerated|0
2450992|NCT02673489|8440624|P2|Treatment Period|Participant moved to another province|0
2450993|NCT02673489|8440625|P1|Treatment Period|Participant moved to another province|1
2450994|NCT02673489|8440624|P2|Treatment Period|Participant request to discontinue|1
2450995|NCT02673489|8440625|P1|Treatment Period|Participant request to discontinue|1
2450996|NCT02673489|8440624|P2|Treatment Period|Lost to Follow-up|0
2450997|NCT02673489|8440625|P1|Treatment Period|Lost to Follow-up|3
2450998|NCT02672852|8440690|P7|Part B|Other|2
2450999|NCT02672852|8440691|P6|Part B|Other|1
2451000|NCT02672852|8440692|P5|Part B|Other|4
2451001|NCT02672852|8440693|P4|Part B|Other|0
2451002|NCT02672852|8440694|P3|Part B|Other|0
2451003|NCT02672852|8440695|P2|Part B|Other|0
2451004|NCT02672852|8440696|P1|Part B|Other|0
2451005|NCT02672852|8440690|P7|Part B|Withdrawal by Subject|7
2451006|NCT02672852|8440691|P6|Part B|Withdrawal by Subject|0
2451007|NCT02672852|8440692|P5|Part B|Withdrawal by Subject|5
2451008|NCT02672852|8440693|P4|Part B|Withdrawal by Subject|0
2451009|NCT02672852|8440694|P3|Part B|Withdrawal by Subject|0
2451010|NCT02672852|8440695|P2|Part B|Withdrawal by Subject|0
2451011|NCT02672852|8440696|P1|Part B|Withdrawal by Subject|0
2451012|NCT02672852|8440690|P7|Part B|Lost to Follow-up|1
2451013|NCT02672852|8440691|P6|Part B|Lost to Follow-up|4
2451014|NCT02672852|8440692|P5|Part B|Lost to Follow-up|3
2451015|NCT02672852|8440693|P4|Part B|Lost to Follow-up|0
2451016|NCT02672852|8440694|P3|Part B|Lost to Follow-up|0
2451017|NCT02672852|8440695|P2|Part B|Lost to Follow-up|0
2451018|NCT02672852|8440696|P1|Part B|Lost to Follow-up|0
2451019|NCT02672852|8440690|P7|Part B|Other adverse event|1
2451020|NCT02672852|8440691|P6|Part B|Other adverse event|5
2451021|NCT02672852|8440692|P5|Part B|Other adverse event|3
2451022|NCT02672852|8440693|P4|Part B|Other adverse event|0
2451023|NCT02672852|8440694|P3|Part B|Other adverse event|0
2451024|NCT02672852|8440695|P2|Part B|Other adverse event|0
2451025|NCT02672852|8440696|P1|Part B|Other adverse event|0
2451026|NCT02672852|8440690|P7|Part B|Worsening pre-existing condition|0
2451027|NCT02672852|8440691|P6|Part B|Worsening pre-existing condition|1
2451028|NCT02672852|8440692|P5|Part B|Worsening pre-existing condition|0
2451029|NCT02672852|8440693|P4|Part B|Worsening pre-existing condition|0
2451030|NCT02672852|8440694|P3|Part B|Worsening pre-existing condition|0
2451031|NCT02672852|8440695|P2|Part B|Worsening pre-existing condition|0
2451032|NCT02672852|8440696|P1|Part B|Worsening pre-existing condition|0
2451033|NCT02672852|8440690|P7|Part B|Disease worsening|1
2451034|NCT02672852|8440691|P6|Part B|Disease worsening|0
2451035|NCT02672852|8440692|P5|Part B|Disease worsening|1
2451036|NCT02672852|8440693|P4|Part B|Disease worsening|0
2451037|NCT02672852|8440694|P3|Part B|Disease worsening|0
2451038|NCT02672852|8440695|P2|Part B|Disease worsening|0
2451039|NCT02672852|8440696|P1|Part B|Disease worsening|0
2451040|NCT02672852|8440690|P7|Part A2|Not entered in Part B|0
2451041|NCT02672852|8440691|P6|Part A2|Not entered in Part B|0
2451042|NCT02672852|8440692|P5|Part A2|Not entered in Part B|0
2451043|NCT02672852|8440693|P4|Part A2|Not entered in Part B|4
2451044|NCT02672852|8440694|P3|Part A2|Not entered in Part B|0
2451045|NCT02672852|8440695|P2|Part A2|Not entered in Part B|0
2451046|NCT02672852|8440696|P1|Part A2|Not entered in Part B|0
2451047|NCT02672852|8440690|P7|Part A2|Other|0
2451048|NCT02672852|8440691|P6|Part A2|Other|0
2451049|NCT02672852|8440692|P5|Part A2|Other|0
2451050|NCT02672852|8440693|P4|Part A2|Other|0
2451051|NCT02672852|8440694|P3|Part A2|Other|3
2451052|NCT02672852|8440695|P2|Part A2|Other|0
2451053|NCT02672852|8440696|P1|Part A2|Other|0
2451054|NCT02672852|8440690|P7|Part A2|Withdrawal by Subject|0
2451055|NCT02672852|8440691|P6|Part A2|Withdrawal by Subject|0
2451056|NCT02672852|8440692|P5|Part A2|Withdrawal by Subject|0
2451057|NCT02672852|8440693|P4|Part A2|Withdrawal by Subject|0
2451058|NCT02672852|8440694|P3|Part A2|Withdrawal by Subject|1
2451059|NCT02672852|8440695|P2|Part A2|Withdrawal by Subject|0
2451060|NCT02672852|8440696|P1|Part A2|Withdrawal by Subject|0
2451061|NCT02672852|8440690|P7|Part A2|Lost to Follow-up|0
2451062|NCT02672852|8440691|P6|Part A2|Lost to Follow-up|0
2451063|NCT02672852|8440692|P5|Part A2|Lost to Follow-up|0
2451064|NCT02672852|8440693|P4|Part A2|Lost to Follow-up|0
2451065|NCT02672852|8440694|P3|Part A2|Lost to Follow-up|2
2451066|NCT02672852|8440695|P2|Part A2|Lost to Follow-up|0
2451067|NCT02672852|8440696|P1|Part A2|Lost to Follow-up|0
2451068|NCT02672852|8440690|P7|Part A2|Adverse Event|0
2451069|NCT02672852|8440691|P6|Part A2|Adverse Event|0
2451070|NCT02672852|8440692|P5|Part A2|Adverse Event|0
2451071|NCT02672852|8440693|P4|Part A2|Adverse Event|0
2451072|NCT02672852|8440694|P3|Part A2|Adverse Event|3
2451073|NCT02672852|8440695|P2|Part A2|Adverse Event|0
2451074|NCT02672852|8440696|P1|Part A2|Adverse Event|0
2451075|NCT02672852|8440690|P7|Part A2|Disease worsening|0
2451076|NCT02672852|8440691|P6|Part A2|Disease worsening|0
2451077|NCT02672852|8440692|P5|Part A2|Disease worsening|0
2451078|NCT02672852|8440693|P4|Part A2|Disease worsening|0
2451079|NCT02672852|8440694|P3|Part A2|Disease worsening|1
2451080|NCT02672852|8440695|P2|Part A2|Disease worsening|0
2451081|NCT02672852|8440696|P1|Part A2|Disease worsening|0
2451082|NCT02672852|8440690|P7|Part A1|Withdrawal by Subject|0
2451083|NCT02672852|8440691|P6|Part A1|Withdrawal by Subject|0
2451084|NCT02672852|8440692|P5|Part A1|Withdrawal by Subject|0
2451085|NCT02672852|8440693|P4|Part A1|Withdrawal by Subject|0
2451086|NCT02672852|8440694|P3|Part A1|Withdrawal by Subject|0
2451087|NCT02672852|8440695|P2|Part A1|Withdrawal by Subject|1
2451088|NCT02672852|8440696|P1|Part A1|Withdrawal by Subject|1
2451089|NCT02672852|8440690|P7|Part A1|Lost to Follow-up|0
2451090|NCT02672852|8440691|P6|Part A1|Lost to Follow-up|0
2451091|NCT02672852|8440692|P5|Part A1|Lost to Follow-up|0
2451092|NCT02672852|8440693|P4|Part A1|Lost to Follow-up|0
2451093|NCT02672852|8440694|P3|Part A1|Lost to Follow-up|0
2451094|NCT02672852|8440695|P2|Part A1|Lost to Follow-up|2
2451095|NCT02672852|8440696|P1|Part A1|Lost to Follow-up|1
2451096|NCT02672852|8440690|P7|Part A1|Adverse Event|0
2451097|NCT02672852|8440691|P6|Part A1|Adverse Event|0
2451098|NCT02672852|8440692|P5|Part A1|Adverse Event|0
2451099|NCT02672852|8440693|P4|Part A1|Adverse Event|0
2451100|NCT02672852|8440694|P3|Part A1|Adverse Event|0
2451101|NCT02672852|8440695|P2|Part A1|Adverse Event|1
2451102|NCT02672852|8440696|P1|Part A1|Adverse Event|0
2451103|NCT02672852|8440690|P7|Part A1|Disease Worsening|0
2451104|NCT02672852|8440691|P6|Part A1|Disease Worsening|0
2451105|NCT02672852|8440692|P5|Part A1|Disease Worsening|0
2451106|NCT02672852|8440693|P4|Part A1|Disease Worsening|0
2451107|NCT02672852|8440694|P3|Part A1|Disease Worsening|0
2451108|NCT02672852|8440695|P2|Part A1|Disease Worsening|0
2451109|NCT02672852|8440696|P1|Part A1|Disease Worsening|1
2451110|NCT02672553|8440727|P2|Overall Study|Intraoperative screen failure|0
2451111|NCT02672553|8440728|P1|Overall Study|Intraoperative screen failure|2
2451112|NCT02672553|8440727|P2|Overall Study|Withdrawal by Subject|3
2451113|NCT02672553|8440728|P1|Overall Study|Withdrawal by Subject|3
2451114|NCT02672553|8440727|P2|Overall Study|Conversion to Commercial Valve|0
2451115|NCT02672553|8440728|P1|Overall Study|Conversion to Commercial Valve|3
2451116|NCT02672553|8440727|P2|Overall Study|Valve Explant|0
2451117|NCT02672553|8440728|P1|Overall Study|Valve Explant|1
2451118|NCT02672553|8440727|P2|Overall Study|Death|5
2451119|NCT02672553|8440728|P1|Overall Study|Death|3
2451120|NCT02672423|8440800|P10|Period 3|Physician Decision|0
2451121|NCT02672423|8440801|P9|Period 3|Physician Decision|0
2451122|NCT02672423|8440802|P8|Period 3|Physician Decision|0
2451123|NCT02672423|8440803|P7|Period 3|Physician Decision|0
2451124|NCT02672423|8440804|P6|Period 3|Physician Decision|1
2451125|NCT02672423|8440805|P5|Period 3|Physician Decision|0
2451126|NCT02672423|8440806|P4|Period 3|Physician Decision|0
2451127|NCT02672423|8440807|P3|Period 3|Physician Decision|0
2451128|NCT02672423|8440808|P2|Period 3|Physician Decision|0
2451129|NCT02672423|8440809|P1|Period 3|Physician Decision|0
2451130|NCT02672423|8440800|P10|Period 3|Withdrawal by Subject|0
2451131|NCT02672423|8440801|P9|Period 3|Withdrawal by Subject|0
2451132|NCT02672423|8440802|P8|Period 3|Withdrawal by Subject|1
2451133|NCT02672423|8440803|P7|Period 3|Withdrawal by Subject|0
2451134|NCT02672423|8440804|P6|Period 3|Withdrawal by Subject|0
2451135|NCT02672423|8440805|P5|Period 3|Withdrawal by Subject|0
2451136|NCT02672423|8440806|P4|Period 3|Withdrawal by Subject|0
2451137|NCT02672423|8440807|P3|Period 3|Withdrawal by Subject|0
2451138|NCT02672423|8440808|P2|Period 3|Withdrawal by Subject|0
2451139|NCT02672423|8440809|P1|Period 3|Withdrawal by Subject|0
2451140|NCT02672423|8440800|P10|Period 2|Withdrawal by Subject|0
2451141|NCT02672423|8440801|P9|Period 2|Withdrawal by Subject|0
2451142|NCT02672423|8440802|P8|Period 2|Withdrawal by Subject|0
2451143|NCT02672423|8440803|P7|Period 2|Withdrawal by Subject|0
2451144|NCT02672423|8440804|P6|Period 2|Withdrawal by Subject|0
2451145|NCT02672423|8440805|P5|Period 2|Withdrawal by Subject|0
2451146|NCT02672423|8440806|P4|Period 2|Withdrawal by Subject|0
2451147|NCT02672423|8440807|P3|Period 2|Withdrawal by Subject|1
2451148|NCT02672423|8440808|P2|Period 2|Withdrawal by Subject|0
2451149|NCT02672423|8440809|P1|Period 2|Withdrawal by Subject|0
2451150|NCT02672423|8440800|P10|Period 1|Adverse Event|0
2451151|NCT02672423|8440801|P9|Period 1|Adverse Event|0
2451152|NCT02672423|8440802|P8|Period 1|Adverse Event|0
2451153|NCT02672423|8440803|P7|Period 1|Adverse Event|0
2451154|NCT02672423|8440804|P6|Period 1|Adverse Event|0
2451155|NCT02672423|8440805|P5|Period 1|Adverse Event|1
2451156|NCT02672423|8440806|P4|Period 1|Adverse Event|0
2451157|NCT02672423|8440807|P3|Period 1|Adverse Event|0
2451158|NCT02672423|8440808|P2|Period 1|Adverse Event|0
2451159|NCT02672423|8440809|P1|Period 1|Adverse Event|0
2451160|NCT02671760|8440904|P3|Overall Study|Lost to Follow-up|0
2451161|NCT02671760|8440905|P2|Overall Study|Lost to Follow-up|1
2451162|NCT02671760|8440906|P1|Overall Study|Lost to Follow-up|0
2451163|NCT02671500|8440932|P1|Overall Study|Lost to Follow-up|2
2451164|NCT02671500|8440932|P1|Overall Study|Lack of Efficacy|12
2451165|NCT02671461|8440947|P3|Follow-up|Administrative Reason by Sponsor|0
2451166|NCT02671461|8440948|P2|Follow-up|Administrative Reason by Sponsor|1
2451167|NCT02671461|8440949|P1|Follow-up|Administrative Reason by Sponsor|0
2451168|NCT02671461|8440947|P3|Follow-up|Lost to Follow-up|1
2451169|NCT02671461|8440948|P2|Follow-up|Lost to Follow-up|0
2451170|NCT02671461|8440949|P1|Follow-up|Lost to Follow-up|0
2451171|NCT02671461|8440947|P3|Follow-up|Withdrawal by Subject|0
2451172|NCT02671461|8440948|P2|Follow-up|Withdrawal by Subject|0
2451173|NCT02671461|8440949|P1|Follow-up|Withdrawal by Subject|1
2451174|NCT02671461|8440947|P3|Treatment|Randomized, not treated|0
2451175|NCT02671461|8440948|P2|Treatment|Randomized, not treated|0
2451176|NCT02671461|8440949|P1|Treatment|Randomized, not treated|1
2451177|NCT02671461|8440947|P3|Treatment|Administrative Reason by Sponsor|4
2451178|NCT02671461|8440948|P2|Treatment|Administrative Reason by Sponsor|3
2451179|NCT02671461|8440949|P1|Treatment|Administrative Reason by Sponsor|1
2451180|NCT02671461|8440947|P3|Treatment|Adverse Event|1
2451181|NCT02671461|8440948|P2|Treatment|Adverse Event|0
2451182|NCT02671461|8440949|P1|Treatment|Adverse Event|0
2451183|NCT02671266|8440974|P2|Overall Study|Withdrawal by Subject|1
2451184|NCT02671266|8440975|P1|Overall Study|Withdrawal by Subject|1
2451185|NCT02670928|8440998|P2|Overall Study|Miss 3 classes in a row in first 12 wks|0
2451186|NCT02670928|8440999|P1|Overall Study|Miss 3 classes in a row in first 12 wks|2
2451187|NCT02670928|8440998|P2|Overall Study|Lost to Follow-up|0
2451188|NCT02670928|8440999|P1|Overall Study|Lost to Follow-up|1
2451189|NCT02670928|8440998|P2|Overall Study|Withdrawal by Subject|0
2451190|NCT02670928|8440999|P1|Overall Study|Withdrawal by Subject|4
2451191|NCT02670928|8440998|P2|Overall Study|Adverse Event|1
2451192|NCT02670928|8440999|P1|Overall Study|Adverse Event|3
2451193|NCT02670915|8441026|P3|Overall Study|Unclassified|0
2451194|NCT02670915|8441027|P2|Overall Study|Unclassified|3
2451195|NCT02670915|8441028|P1|Overall Study|Unclassified|0
2451196|NCT02670915|8441026|P3|Overall Study|Withdrawal by parent/guardian|1
2451197|NCT02670915|8441027|P2|Overall Study|Withdrawal by parent/guardian|4
2451198|NCT02670915|8441028|P1|Overall Study|Withdrawal by parent/guardian|4
2451199|NCT02670915|8441026|P3|Overall Study|Withdrawal by Subject|4
2451200|NCT02670915|8441027|P2|Overall Study|Withdrawal by Subject|1
2451201|NCT02670915|8441028|P1|Overall Study|Withdrawal by Subject|0
2451202|NCT02670551|8441312|P3|Overall Study|Did Not Receive Treatment|0
2451203|NCT02670551|8441313|P2|Overall Study|Did Not Receive Treatment|3
2451204|NCT02670551|8441314|P1|Overall Study|Did Not Receive Treatment|5
2451205|NCT02670551|8441312|P3|Overall Study|Other Miscellaneous Reasons|3
2451206|NCT02670551|8441313|P2|Overall Study|Other Miscellaneous Reasons|3
2451207|NCT02670551|8441314|P1|Overall Study|Other Miscellaneous Reasons|2
2451208|NCT02670551|8441312|P3|Overall Study|Noncompliance with study drug|2
2451209|NCT02670551|8441313|P2|Overall Study|Noncompliance with study drug|3
2451210|NCT02670551|8441314|P1|Overall Study|Noncompliance with study drug|3
2451211|NCT02670551|8441312|P3|Overall Study|Protocol Violation|0
2451212|NCT02670551|8441313|P2|Overall Study|Protocol Violation|0
2451213|NCT02670551|8441314|P1|Overall Study|Protocol Violation|1
2451214|NCT02670551|8441312|P3|Overall Study|Lost to Follow-up|6
2451215|NCT02670551|8441313|P2|Overall Study|Lost to Follow-up|7
2451216|NCT02670551|8441314|P1|Overall Study|Lost to Follow-up|5
2451217|NCT02670551|8441312|P3|Overall Study|Withdrawal of Consent|8
2451218|NCT02670551|8441313|P2|Overall Study|Withdrawal of Consent|3
2451219|NCT02670551|8441314|P1|Overall Study|Withdrawal of Consent|6
2451220|NCT02670551|8441312|P3|Overall Study|Lack of Efficacy|3
2451221|NCT02670551|8441313|P2|Overall Study|Lack of Efficacy|0
2451222|NCT02670551|8441314|P1|Overall Study|Lack of Efficacy|2
2451223|NCT02670551|8441312|P3|Overall Study|Adverse Event|9
2451224|NCT02670551|8441313|P2|Overall Study|Adverse Event|7
2451225|NCT02670551|8441314|P1|Overall Study|Adverse Event|4
2451226|NCT02670538|8441328|P3|Overall Study|Other Miscellaneous Reasons|2
2451227|NCT02670538|8441329|P2|Overall Study|Other Miscellaneous Reasons|1
2451228|NCT02670538|8441330|P1|Overall Study|Other Miscellaneous Reasons|0
2451229|NCT02670538|8441328|P3|Overall Study|Noncompliance with Study Drug|2
2451230|NCT02670538|8441329|P2|Overall Study|Noncompliance with Study Drug|3
2451231|NCT02670538|8441330|P1|Overall Study|Noncompliance with Study Drug|1
2451232|NCT02670538|8441328|P3|Overall Study|Protocol Violation|1
2451233|NCT02670538|8441329|P2|Overall Study|Protocol Violation|4
2451234|NCT02670538|8441330|P1|Overall Study|Protocol Violation|3
2451235|NCT02670538|8441328|P3|Overall Study|Lack of Efficacy|2
2451236|NCT02670538|8441329|P2|Overall Study|Lack of Efficacy|1
2451237|NCT02670538|8441330|P1|Overall Study|Lack of Efficacy|7
2451238|NCT02670538|8441328|P3|Overall Study|Adverse Event|11
2451239|NCT02670538|8441329|P2|Overall Study|Adverse Event|5
2451240|NCT02670538|8441330|P1|Overall Study|Adverse Event|5
2451241|NCT02670538|8441328|P3|Overall Study|Lost to Follow-up|7
2451242|NCT02670538|8441329|P2|Overall Study|Lost to Follow-up|12
2451243|NCT02670538|8441330|P1|Overall Study|Lost to Follow-up|8
2451244|NCT02670538|8441328|P3|Overall Study|Withdrawal of Consent|5
2451245|NCT02670538|8441329|P2|Overall Study|Withdrawal of Consent|6
2451246|NCT02670538|8441330|P1|Overall Study|Withdrawal of Consent|8
2451247|NCT02670473|8441341|P1|Overall Study|Withdrawal by Subject|1
2451248|NCT02670330|8441400|P2|Overall Study|Lost to Follow-up|2
2451249|NCT02670330|8441401|P1|Overall Study|Lost to Follow-up|3
2451250|NCT02670330|8441400|P2|Overall Study|Withdrawal by Subject|29
2451251|NCT02670330|8441401|P1|Overall Study|Withdrawal by Subject|34
2451252|NCT02670330|8441400|P2|Overall Study|Adverse Event|3
2451253|NCT02670330|8441401|P1|Overall Study|Adverse Event|1
2451254|NCT02670330|8441400|P2|Overall Study|Study Terminated By Sponsor|43
2451255|NCT02670330|8441401|P1|Overall Study|Study Terminated By Sponsor|36
2451256|NCT02670330|8441400|P2|Overall Study|Protocol Deviation|0
2451257|NCT02670330|8441401|P1|Overall Study|Protocol Deviation|1
2451258|NCT02669940|8441413|P2|Overall Study|Insufficient follow-up data|0
2451259|NCT02669940|8441414|P1|Overall Study|Insufficient follow-up data|1
2451260|NCT02669940|8441413|P2|Overall Study|Failure to return|3
2451261|NCT02669940|8441414|P1|Overall Study|Failure to return|0
2451262|NCT02669862|8441516|P3|Overall Study|Protocol Violation|1
2451263|NCT02669862|8441517|P2|Overall Study|Protocol Violation|0
2451264|NCT02669862|8441518|P1|Overall Study|Protocol Violation|0
2451265|NCT02669862|8441516|P3|Overall Study|moved|0
2451266|NCT02669862|8441517|P2|Overall Study|moved|1
2451267|NCT02669862|8441518|P1|Overall Study|moved|0
2451268|NCT02669862|8441516|P3|Overall Study|Withdrawal by Subject|3
2451269|NCT02669862|8441517|P2|Overall Study|Withdrawal by Subject|2
2451270|NCT02669862|8441518|P1|Overall Study|Withdrawal by Subject|2
2451271|NCT02669862|8441516|P3|Overall Study|Lost to Follow-up|1
2451272|NCT02669862|8441517|P2|Overall Study|Lost to Follow-up|2
2451273|NCT02669862|8441518|P1|Overall Study|Lost to Follow-up|0
2451274|NCT02669849|8441534|P3|Overall Study|Other|2
2451275|NCT02669849|8441535|P2|Overall Study|Other|0
2451276|NCT02669849|8441536|P1|Overall Study|Other|0
2451277|NCT02669849|8441534|P3|Overall Study|Study terminated by sponsor|14
2451278|NCT02669849|8441535|P2|Overall Study|Study terminated by sponsor|1
2451279|NCT02669849|8441536|P1|Overall Study|Study terminated by sponsor|16
2451280|NCT02669849|8441534|P3|Overall Study|Death|2
2451281|NCT02669849|8441535|P2|Overall Study|Death|1
2451282|NCT02669849|8441536|P1|Overall Study|Death|1
2451283|NCT02669849|8441534|P3|Overall Study|Lost to Follow-up|3
2451284|NCT02669849|8441535|P2|Overall Study|Lost to Follow-up|0
2451285|NCT02669849|8441536|P1|Overall Study|Lost to Follow-up|1
2451286|NCT02669849|8441534|P3|Overall Study|Withdrawal of Consent (not due to AE)|3
2451287|NCT02669849|8441535|P2|Overall Study|Withdrawal of Consent (not due to AE)|0
2451288|NCT02669849|8441536|P1|Overall Study|Withdrawal of Consent (not due to AE)|0
2451289|NCT02669758|8441579|P1|Overall Study|Protocol Violation|1
2451290|NCT02669758|8441579|P1|Overall Study|Study noncompliance|1
2451291|NCT02669758|8441579|P1|Overall Study|Pregnancy|1
2451292|NCT02669758|8441579|P1|Overall Study|Lack of Efficacy|5
2451293|NCT02669758|8441579|P1|Overall Study|Non-Compliance with Study Drug|8
2451294|NCT02669758|8441579|P1|Overall Study|Adverse Event|16
2451295|NCT02669758|8441579|P1|Overall Study|Lost to Follow-up|19
2451296|NCT02669758|8441579|P1|Overall Study|Withdrawal by Subject|43
2451297|NCT02669667|8441590|P7|Overall Study|Lost to Follow-up|0
2451298|NCT02669667|8441591|P6|Overall Study|Lost to Follow-up|1
2451299|NCT02669667|8441592|P5|Overall Study|Lost to Follow-up|0
2451300|NCT02669667|8441593|P4|Overall Study|Lost to Follow-up|0
2451301|NCT02669667|8441594|P3|Overall Study|Lost to Follow-up|0
2451302|NCT02669667|8441595|P2|Overall Study|Lost to Follow-up|0
2451303|NCT02669667|8441596|P1|Overall Study|Lost to Follow-up|0
2451304|NCT02669433|8441699|P3|Overall Study|Death|1
2451305|NCT02669433|8441700|P2|Overall Study|Death|1
2451306|NCT02669433|8441701|P1|Overall Study|Death|0
2451307|NCT02669433|8441699|P3|Overall Study|Withdrawal by Caregiver|2
2451308|NCT02669433|8441700|P2|Overall Study|Withdrawal by Caregiver|0
2451309|NCT02669433|8441701|P1|Overall Study|Withdrawal by Caregiver|1
2451310|NCT02669433|8441699|P3|Overall Study|Withdrawal by Subject|0
2451311|NCT02669433|8441700|P2|Overall Study|Withdrawal by Subject|1
2451312|NCT02669433|8441701|P1|Overall Study|Withdrawal by Subject|5
2451313|NCT02669433|8441699|P3|Overall Study|Sponsor Termination|1
2451314|NCT02669433|8441700|P2|Overall Study|Sponsor Termination|0
2451315|NCT02669433|8441701|P1|Overall Study|Sponsor Termination|1
2451316|NCT02669433|8441699|P3|Overall Study|Adverse Event|10
2451317|NCT02669433|8441700|P2|Overall Study|Adverse Event|7
2451318|NCT02669433|8441701|P1|Overall Study|Adverse Event|6
2451319|NCT02669433|8441699|P3|Overall Study|Physician Decision|0
2451320|NCT02669433|8441700|P2|Overall Study|Physician Decision|1
2451321|NCT02669433|8441701|P1|Overall Study|Physician Decision|1
2451322|NCT02669433|8441699|P3|Overall Study|Disease Progression|0
2451323|NCT02669433|8441700|P2|Overall Study|Disease Progression|0
2451324|NCT02669433|8441701|P1|Overall Study|Disease Progression|1
2451325|NCT02669433|8441699|P3|Overall Study|Protocol Violation|1
2451326|NCT02669433|8441700|P2|Overall Study|Protocol Violation|4
2451327|NCT02669433|8441701|P1|Overall Study|Protocol Violation|0
2451328|NCT02669407|8441715|P1|Overall Study|Physician Decision|3
2451329|NCT02669264|8441739|P7|Overall Study|Miscellaneous|2
2451330|NCT02669264|8441740|P6|Overall Study|Miscellaneous|0
2451331|NCT02669264|8441741|P5|Overall Study|Miscellaneous|0
2451332|NCT02669264|8441742|P4|Overall Study|Miscellaneous|0
2451333|NCT02669264|8441743|P3|Overall Study|Miscellaneous|0
2451334|NCT02669264|8441744|P2|Overall Study|Miscellaneous|0
2451335|NCT02669264|8441745|P1|Overall Study|Miscellaneous|0
2451336|NCT02669264|8441739|P7|Overall Study|Lost to Follow-up|0
2451337|NCT02669264|8441740|P6|Overall Study|Lost to Follow-up|0
2451338|NCT02669264|8441741|P5|Overall Study|Lost to Follow-up|1
2451339|NCT02669264|8441742|P4|Overall Study|Lost to Follow-up|0
2451340|NCT02669264|8441743|P3|Overall Study|Lost to Follow-up|0
2451341|NCT02669264|8441744|P2|Overall Study|Lost to Follow-up|0
2451342|NCT02669264|8441745|P1|Overall Study|Lost to Follow-up|0
2451343|NCT02669264|8441739|P7|Overall Study|Withdrawal by Subject|0
2451344|NCT02669264|8441740|P6|Overall Study|Withdrawal by Subject|0
2451345|NCT02669264|8441741|P5|Overall Study|Withdrawal by Subject|1
2451346|NCT02669264|8441742|P4|Overall Study|Withdrawal by Subject|0
2451347|NCT02669264|8441743|P3|Overall Study|Withdrawal by Subject|0
2451348|NCT02669264|8441744|P2|Overall Study|Withdrawal by Subject|1
2451349|NCT02669264|8441745|P1|Overall Study|Withdrawal by Subject|0
2451350|NCT02669264|8441739|P7|Overall Study|Death|3
2451351|NCT02669264|8441740|P6|Overall Study|Death|6
2451352|NCT02669264|8441741|P5|Overall Study|Death|3
2451353|NCT02669264|8441742|P4|Overall Study|Death|3
2451354|NCT02669264|8441743|P3|Overall Study|Death|3
2451355|NCT02669264|8441744|P2|Overall Study|Death|5
2451356|NCT02669264|8441745|P1|Overall Study|Death|5
2451357|NCT02669095|8441891|P2|Overall Study|Visit 5 assessments not completed|1
2451358|NCT02669095|8441892|P1|Overall Study|Visit 5 assessments not completed|0
2451359|NCT02669095|8441891|P2|Overall Study|Torn Lens|1
2451360|NCT02669095|8441892|P1|Overall Study|Torn Lens|0
2451361|NCT02669095|8441891|P2|Overall Study|Unsatisfactory Lens Fitting|1
2451362|NCT02669095|8441892|P1|Overall Study|Unsatisfactory Lens Fitting|0
2451363|NCT02669095|8441891|P2|Overall Study|Adverse Event|0
2451364|NCT02669095|8441892|P1|Overall Study|Adverse Event|1
2451365|NCT02669082|8441900|P1|Overall Study|Adverse Event|1
2451366|NCT02669043|8441912|P1|Overall Study|Didn't meet I/E criteria|4
2451367|NCT02669017|8441925|P9|Overall Study|Miscellaneous|2
2451368|NCT02669017|8441926|P8|Overall Study|Miscellaneous|13
2451369|NCT02669017|8441927|P7|Overall Study|Miscellaneous|1
2451370|NCT02669017|8441928|P6|Overall Study|Miscellaneous|1
2451371|NCT02669017|8441929|P5|Overall Study|Miscellaneous|2
2451372|NCT02669017|8441930|P4|Overall Study|Miscellaneous|0
2451373|NCT02669017|8441931|P3|Overall Study|Miscellaneous|0
2451374|NCT02669017|8441932|P2|Overall Study|Miscellaneous|0
2451375|NCT02669017|8441933|P1|Overall Study|Miscellaneous|0
2451376|NCT02669017|8441925|P9|Overall Study|Lost to Follow-up|1
2451377|NCT02669017|8441926|P8|Overall Study|Lost to Follow-up|0
2451378|NCT02669017|8441927|P7|Overall Study|Lost to Follow-up|0
2451379|NCT02669017|8441928|P6|Overall Study|Lost to Follow-up|0
2451380|NCT02669017|8441929|P5|Overall Study|Lost to Follow-up|0
2451381|NCT02669017|8441930|P4|Overall Study|Lost to Follow-up|0
2451382|NCT02669017|8441931|P3|Overall Study|Lost to Follow-up|0
2451383|NCT02669017|8441932|P2|Overall Study|Lost to Follow-up|0
2451384|NCT02669017|8441933|P1|Overall Study|Lost to Follow-up|0
2451385|NCT02669017|8441925|P9|Overall Study|Withdrawal by Subject|2
2451386|NCT02669017|8441926|P8|Overall Study|Withdrawal by Subject|2
2451387|NCT02669017|8441927|P7|Overall Study|Withdrawal by Subject|0
2451388|NCT02669017|8441928|P6|Overall Study|Withdrawal by Subject|0
2451389|NCT02669017|8441929|P5|Overall Study|Withdrawal by Subject|2
2451390|NCT02669017|8441930|P4|Overall Study|Withdrawal by Subject|1
2451391|NCT02669017|8441931|P3|Overall Study|Withdrawal by Subject|0
2451392|NCT02669017|8441932|P2|Overall Study|Withdrawal by Subject|0
2451393|NCT02669017|8441933|P1|Overall Study|Withdrawal by Subject|0
2451394|NCT02669017|8441925|P9|Overall Study|Death|20
2451395|NCT02669017|8441926|P8|Overall Study|Death|47
2451396|NCT02669017|8441927|P7|Overall Study|Death|10
2451397|NCT02669017|8441928|P6|Overall Study|Death|18
2451398|NCT02669017|8441929|P5|Overall Study|Death|8
2451399|NCT02669017|8441930|P4|Overall Study|Death|3
2451400|NCT02669017|8441931|P3|Overall Study|Death|2
2451401|NCT02669017|8441932|P2|Overall Study|Death|2
2451402|NCT02669017|8441933|P1|Overall Study|Death|1
2451403|NCT02668822|8442078|P2|Overall Study|Study Terminated by Sponsor|9
2451404|NCT02668822|8442079|P1|Overall Study|Study Terminated by Sponsor|7
2451405|NCT02668822|8442078|P2|Overall Study|Protocol Violation|0
2451406|NCT02668822|8442079|P1|Overall Study|Protocol Violation|2
2451407|NCT02668783|8442101|P2|Overall Study|Withdrawal by Subject|0
2451408|NCT02668783|8442102|P1|Overall Study|Withdrawal by Subject|1
2451409|NCT02668783|8442101|P2|Overall Study|Subject moved|0
2451410|NCT02668783|8442102|P1|Overall Study|Subject moved|1
2451411|NCT02668783|8442101|P2|Overall Study|Study terminated by sponsor|10
2451412|NCT02668783|8442102|P1|Overall Study|Study terminated by sponsor|9
2451413|NCT02668783|8442101|P2|Overall Study|Protocol Violation|1
2451414|NCT02668783|8442102|P1|Overall Study|Protocol Violation|2
2451415|NCT02668783|8442101|P2|Overall Study|Pregnancy|1
2451416|NCT02668783|8442102|P1|Overall Study|Pregnancy|0
2451417|NCT02668640|8442122|P1|Overall Study|Other, not specified|1
2451418|NCT02668640|8442122|P1|Overall Study|Lost to Follow-up|13
2451419|NCT02668302|8442174|P2|Overall Study|Withdrawal by Subject|0
2451420|NCT02668302|8442175|P1|Overall Study|Withdrawal by Subject|1
2451421|NCT02667912|8442195|P2|Overall Study|Withdrawal by Subject|0
2451422|NCT02667912|8442196|P1|Overall Study|Withdrawal by Subject|1
2451423|NCT02667912|8442195|P2|Overall Study|Withdrawal by Subject|2
2451424|NCT02667912|8442196|P1|Overall Study|Withdrawal by Subject|1
2451425|NCT02667912|8442195|P2|Overall Study|Death|1
2451426|NCT02667912|8442196|P1|Overall Study|Death|3
2451427|NCT02667626|8442296|P2|Overall Study|Withdrawal by Subject|1
2451428|NCT02667626|8442297|P1|Overall Study|Withdrawal by Subject|0
2451429|NCT02667288|8442311|P1|Overall Study|Withdrawal by Subject|5
2451430|NCT02667288|8442311|P1|Overall Study|Lost to Follow-up|3
2451431|NCT02667288|8442311|P1|Overall Study|Protocol Violation|5
2451432|NCT02667275|8442318|P2|Overall Study|Discontinued early without completing|1
2451433|NCT02667275|8442319|P1|Overall Study|Discontinued early without completing|0
2451434|NCT02667275|8442318|P2|Overall Study|Withdrawal by Subject|5
2451435|NCT02667275|8442319|P1|Overall Study|Withdrawal by Subject|0
2451436|NCT02667275|8442318|P2|Overall Study|Lost to Follow-up|2
2451437|NCT02667275|8442319|P1|Overall Study|Lost to Follow-up|0
2451438|NCT02667275|8442318|P2|Overall Study|Protocol Violation|7
2451439|NCT02667275|8442319|P1|Overall Study|Protocol Violation|11
2451440|NCT02667236|8442329|P2|Overall Study|Withdrawal by Subject|0
2451441|NCT02667236|8442330|P1|Overall Study|Withdrawal by Subject|2
2451442|NCT02667236|8442329|P2|Overall Study|Adverse Event|1
2451443|NCT02667236|8442330|P1|Overall Study|Adverse Event|1
2451444|NCT02666664|8442350|P2|Overall Study|Lost to Follow-up|2
2451445|NCT02666664|8442351|P1|Overall Study|Lost to Follow-up|1
2451446|NCT02666664|8442350|P2|Overall Study|Sponsor decision|1
2451447|NCT02666664|8442351|P1|Overall Study|Sponsor decision|0
2451448|NCT02666664|8442350|P2|Overall Study|Withdrawal by participant|40
2451449|NCT02666664|8442351|P1|Overall Study|Withdrawal by participant|23
2451450|NCT02666664|8442350|P2|Overall Study|Adverse Event|37
2451451|NCT02666664|8442351|P1|Overall Study|Adverse Event|12
2451452|NCT02666664|8442350|P2|Overall Study|Other|1
2451453|NCT02666664|8442351|P1|Overall Study|Other|0
2451454|NCT02666664|8442350|P2|Overall Study|Protocol Violation|2
2451455|NCT02666664|8442351|P1|Overall Study|Protocol Violation|0
2451456|NCT02666664|8442350|P2|Overall Study|Physician Decision|1
2451457|NCT02666664|8442351|P1|Overall Study|Physician Decision|0
2451458|NCT02666222|8442541|P1|Overall Study|Death|2
2451459|NCT02665689|8442551|P2|Overall Study|Lost to Follow-up|1
2451460|NCT02665689|8442552|P1|Overall Study|Lost to Follow-up|0
2451461|NCT02665689|8442551|P2|Overall Study|Trial termination|1
2451462|NCT02665689|8442552|P1|Overall Study|Trial termination|1
2451463|NCT02665689|8442551|P2|Overall Study|Adverse Event|0
2451464|NCT02665689|8442552|P1|Overall Study|Adverse Event|1
2451465|NCT02665455|8442587|P1|Overall Study|Protocol Violation|1
2451466|NCT02665455|8442587|P1|Overall Study|Adverse Event|1
2451467|NCT02665455|8442587|P1|Overall Study|Lost to Follow-up|1
2451468|NCT02665455|8442587|P1|Overall Study|Withdrawal by Subject|6
2451469|NCT02665286|8442631|P3|Overall Study|Lost to Follow-up|1
2451470|NCT02665286|8442632|P2|Overall Study|Lost to Follow-up|2
2451471|NCT02665286|8442633|P1|Overall Study|Lost to Follow-up|3
2451472|NCT02664415|8442732|P2|Overall Study|Adverse Event|0
2451473|NCT02664415|8442733|P1|Overall Study|Adverse Event|1
2451474|NCT02664272|8442774|P1|Overall Study|Fluoroscopic images not made available|2
2451475|NCT02663817|8442795|P1|Overall Study|Screen failure|2
2451476|NCT02663687|8442815|P5|Overall Study|Other|0
2451477|NCT02663687|8442816|P4|Overall Study|Other|0
2451478|NCT02663687|8442817|P3|Overall Study|Other|1
2451479|NCT02663687|8442818|P2|Overall Study|Other|0
2451480|NCT02663687|8442819|P1|Overall Study|Other|1
2451481|NCT02663687|8442815|P5|Overall Study|Adverse Event|0
2451482|NCT02663687|8442816|P4|Overall Study|Adverse Event|0
2451483|NCT02663687|8442817|P3|Overall Study|Adverse Event|0
2451484|NCT02663687|8442818|P2|Overall Study|Adverse Event|0
2451485|NCT02663687|8442819|P1|Overall Study|Adverse Event|1
2451486|NCT02663674|8442873|P2|Overall Study|Other Event (Health Related)|1
2451487|NCT02663674|8442874|P1|Overall Study|Other Event (Health Related)|0
2451488|NCT02663674|8442873|P2|Overall Study|Physician Decision|1
2451489|NCT02663674|8442874|P1|Overall Study|Physician Decision|1
2451490|NCT02663674|8442873|P2|Overall Study|Withdrawal by Subject|4
2451491|NCT02663674|8442874|P1|Overall Study|Withdrawal by Subject|1
2451492|NCT02663674|8442873|P2|Overall Study|Lost to Follow-up|4
2451493|NCT02663674|8442874|P1|Overall Study|Lost to Follow-up|5
2451494|NCT02663453|8443138|P2|Overall Study|Withdrawal by Subject|0
2451495|NCT02663453|8443139|P1|Overall Study|Withdrawal by Subject|1
2451496|NCT02663453|8443138|P2|Overall Study|Death|4
2451497|NCT02663453|8443139|P1|Overall Study|Death|4
2451498|NCT02663128|8443184|P6|Period 2|Physician Decision|0
2451499|NCT02663128|8443185|P5|Period 2|Physician Decision|1
2451500|NCT02663128|8443186|P4|Period 2|Physician Decision|0
2451501|NCT02663128|8443187|P3|Period 2|Physician Decision|0
2451502|NCT02663128|8443188|P2|Period 2|Physician Decision|0
2451503|NCT02663128|8443189|P1|Period 2|Physician Decision|0
2451504|NCT02662764|8443203|P1|Overall Study|Patient discharged prior to 24 hrs|5
2451505|NCT02662764|8443203|P1|Overall Study|Patient changed treatment|1
2451506|NCT02662764|8443203|P1|Overall Study|Device failure|4
2451507|NCT02662764|8443203|P1|Overall Study|Withdrawal by Subject|5
2451508|NCT02662764|8443203|P1|Overall Study|Protocol Violation|1
2451509|NCT02662764|8443203|P1|Overall Study|Lack of Efficacy|8
2451510|NCT02662764|8443203|P1|Overall Study|Adverse Event|6
2451511|NCT02662569|8443271|P4|Overall Study|Lost to Follow-up|0
2451512|NCT02662569|8443272|P3|Overall Study|Lost to Follow-up|0
2451513|NCT02662569|8443273|P2|Overall Study|Lost to Follow-up|0
2451514|NCT02662569|8443274|P1|Overall Study|Lost to Follow-up|1
2451515|NCT02662569|8443271|P4|Overall Study|Withdrawal by Subject|4
2451516|NCT02662569|8443272|P3|Overall Study|Withdrawal by Subject|6
2451517|NCT02662569|8443273|P2|Overall Study|Withdrawal by Subject|1
2451518|NCT02662569|8443274|P1|Overall Study|Withdrawal by Subject|6
2451519|NCT02662556|8443372|P1|Overall Study|Lack of Efficacy|4
2451520|NCT02662556|8443372|P1|Overall Study|Adverse Event|4
2451521|NCT02661815|8443441|P4|Overall Study|Withdrawal by Subject|0
2451522|NCT02661815|8443442|P3|Overall Study|Withdrawal by Subject|0
2451523|NCT02661815|8443443|P2|Overall Study|Withdrawal by Subject|0
2451524|NCT02661815|8443444|P1|Overall Study|Withdrawal by Subject|1
2451525|NCT02661594|8443466|P4|Overall Study|Protocol Violation|0
2451526|NCT02661594|8443467|P3|Overall Study|Protocol Violation|1
2451527|NCT02661594|8443468|P2|Overall Study|Protocol Violation|0
2451528|NCT02661594|8443469|P1|Overall Study|Protocol Violation|1
2451529|NCT02661178|8443510|P15|Part 1|Protocol Violation|0
2451530|NCT02661178|8443511|P14|Part 1|Protocol Violation|0
2451531|NCT02661178|8443512|P13|Part 1|Protocol Violation|0
2451532|NCT02661178|8443513|P12|Part 1|Protocol Violation|0
2451533|NCT02661178|8443514|P11|Part 1|Protocol Violation|0
2451534|NCT02661178|8443515|P10|Part 1|Protocol Violation|0
2451535|NCT02661178|8443516|P9|Part 1|Protocol Violation|0
2451536|NCT02661178|8443517|P8|Part 1|Protocol Violation|0
2451537|NCT02661178|8443518|P7|Part 1|Protocol Violation|0
2451538|NCT02661178|8443519|P6|Part 1|Protocol Violation|0
2451539|NCT02661178|8443520|P5|Part 1|Protocol Violation|0
2451540|NCT02661178|8443521|P4|Part 1|Protocol Violation|0
2451541|NCT02661178|8443522|P3|Part 1|Protocol Violation|0
2451542|NCT02661178|8443523|P2|Part 1|Protocol Violation|0
2451543|NCT02661178|8443524|P1|Part 1|Protocol Violation|1
2451544|NCT02661061|8443882|P2|Overall Study|Withdrawal by Subject|1
2451545|NCT02661061|8443883|P1|Overall Study|Withdrawal by Subject|1
2451546|NCT02661061|8443882|P2|Overall Study|Lack of Efficacy|1
2451547|NCT02661061|8443883|P1|Overall Study|Lack of Efficacy|1
2451548|NCT02660983|8443893|P2|Open Label Extension Phase (24 Weeks)|Other|1
2451549|NCT02660983|8443894|P1|Open Label Extension Phase (24 Weeks)|Other|0
2451550|NCT02660983|8443893|P2|Open Label Extension Phase (24 Weeks)|Adverse Event|3
2451551|NCT02660983|8443894|P1|Open Label Extension Phase (24 Weeks)|Adverse Event|1
2451552|NCT02660983|8443893|P2|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4
2451553|NCT02660983|8443894|P1|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1
2451554|NCT02660983|8443893|P2|Open Label Extension Phase (24 Weeks)|Protocol Violation|1
2451555|NCT02660983|8443894|P1|Open Label Extension Phase (24 Weeks)|Protocol Violation|1
2451556|NCT02660983|8443893|P2|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9
2451557|NCT02660983|8443894|P1|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8
2451558|NCT02660983|8443893|P2|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12
2451559|NCT02660983|8443894|P1|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15
2451560|NCT02660983|8443893|P2|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5
2451561|NCT02660983|8443894|P1|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1
2451562|NCT02660580|8443970|P5|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1
2451563|NCT02660580|8443971|P4|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1
2451564|NCT02660580|8443972|P3|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
2451565|NCT02660580|8443973|P2|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
2451566|NCT02660580|8443974|P1|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
2451567|NCT02660580|8443970|P5|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2
2451568|NCT02660580|8443971|P4|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2
2451569|NCT02660580|8443972|P3|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3
2451570|NCT02660580|8443973|P2|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0
2451571|NCT02660580|8443974|P1|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0
2451572|NCT02660580|8443970|P5|Extended Treatment Period(Week 16 to 52)|Adverse Event|4
2451573|NCT02660580|8443971|P4|Extended Treatment Period(Week 16 to 52)|Adverse Event|6
2451574|NCT02660580|8443972|P3|Extended Treatment Period(Week 16 to 52)|Adverse Event|8
2451575|NCT02660580|8443973|P2|Extended Treatment Period(Week 16 to 52)|Adverse Event|0
2451576|NCT02660580|8443974|P1|Extended Treatment Period(Week 16 to 52)|Adverse Event|0
2451577|NCT02660580|8443970|P5|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2
2451578|NCT02660580|8443971|P4|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2
2451579|NCT02660580|8443972|P3|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4
2451580|NCT02660580|8443973|P2|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0
2451581|NCT02660580|8443974|P1|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0
2451582|NCT02660580|8443970|P5|Extended Treatment Period(Week 16 to 52)|Other un-specified|1
2451583|NCT02660580|8443971|P4|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
2451584|NCT02660580|8443972|P3|Extended Treatment Period(Week 16 to 52)|Other un-specified|1
2451585|NCT02660580|8443973|P2|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
2451586|NCT02660580|8443974|P1|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
2451587|NCT02660580|8443970|P5|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1
2451588|NCT02660580|8443971|P4|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
2451589|NCT02660580|8443972|P3|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2
2451590|NCT02660580|8443973|P2|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
2451591|NCT02660580|8443974|P1|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
2451592|NCT02660580|8443970|P5|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
2451593|NCT02660580|8443971|P4|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
2451594|NCT02660580|8443972|P3|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
2451595|NCT02660580|8443973|P2|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2
2451596|NCT02660580|8443974|P1|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1
2451597|NCT02660580|8443970|P5|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
2451598|NCT02660580|8443971|P4|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
2451599|NCT02660580|8443972|P3|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
2451600|NCT02660580|8443973|P2|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4
2451601|NCT02660580|8443974|P1|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1
2451602|NCT02660580|8443970|P5|Core Treatment Period (Week 1 to 16)|Adverse Event|0
2451603|NCT02660580|8443971|P4|Core Treatment Period (Week 1 to 16)|Adverse Event|0
2451604|NCT02660580|8443972|P3|Core Treatment Period (Week 1 to 16)|Adverse Event|0
2451605|NCT02660580|8443973|P2|Core Treatment Period (Week 1 to 16)|Adverse Event|9
2451606|NCT02660580|8443974|P1|Core Treatment Period (Week 1 to 16)|Adverse Event|2
2451607|NCT02660580|8443970|P5|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
2451608|NCT02660580|8443971|P4|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
2451609|NCT02660580|8443972|P3|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
2451610|NCT02660580|8443973|P2|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2
2451611|NCT02660580|8443974|P1|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
2451612|NCT02660580|8443970|P5|Core Treatment Period (Week 1 to 16)|Other un-specified|0
2451613|NCT02660580|8443971|P4|Core Treatment Period (Week 1 to 16)|Other un-specified|0
2451614|NCT02660580|8443972|P3|Core Treatment Period (Week 1 to 16)|Other un-specified|0
2451615|NCT02660580|8443973|P2|Core Treatment Period (Week 1 to 16)|Other un-specified|0
2451616|NCT02660580|8443974|P1|Core Treatment Period (Week 1 to 16)|Other un-specified|1
2451617|NCT02660580|8443970|P5|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
2451618|NCT02660580|8443971|P4|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
2451619|NCT02660580|8443972|P3|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
2451620|NCT02660580|8443973|P2|Core Treatment Period (Week 1 to 16)|Protocol Violation|1
2451621|NCT02660580|8443974|P1|Core Treatment Period (Week 1 to 16)|Protocol Violation|3
2451622|NCT02660580|8443970|P5|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
2451623|NCT02660580|8443971|P4|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
2451624|NCT02660580|8443972|P3|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
2451625|NCT02660580|8443973|P2|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1
2451626|NCT02660580|8443974|P1|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1
2451627|NCT02660242|8444083|P1|Glucagon Injection|Lost to Follow-up|1
2451628|NCT02660242|8444083|P1|Glucose Tabs|Lost to Follow-up|1
2451629|NCT02660229|8444139|P2|Overall Study|Withdrawal by Subject|1
2451630|NCT02660229|8444140|P1|Overall Study|Withdrawal by Subject|0
2451631|NCT02660229|8444139|P2|Overall Study|Adverse Event|0
2451632|NCT02660229|8444140|P1|Overall Study|Adverse Event|2
2451633|NCT02659540|8444173|P2|Overall Study|Progressive disease|6
2451634|NCT02659540|8444174|P1|Overall Study|Progressive disease|2
2451635|NCT02659540|8444173|P2|Overall Study|Death|0
2451636|NCT02659540|8444174|P1|Overall Study|Death|1
2451637|NCT02659540|8444173|P2|Overall Study|Adverse Event|2
2451638|NCT02659540|8444174|P1|Overall Study|Adverse Event|3
2451639|NCT02658149|8444295|P2|Overall Study|Physician Decision|0
2451640|NCT02658149|8444296|P1|Overall Study|Physician Decision|1
2451641|NCT02658084|8444312|P2|Overall Study|Study Termination|0
2451642|NCT02658084|8444313|P1|Overall Study|Study Termination|1
2451643|NCT02658084|8444312|P2|Overall Study|Withdrawal by Subject|0
2451644|NCT02658084|8444313|P1|Overall Study|Withdrawal by Subject|1
2451645|NCT02657889|8444366|P4|Overall Study|Ongoing in Study|19
2451646|NCT02657889|8444367|P3|Overall Study|Ongoing in Study|24
2451647|NCT02657889|8444368|P2|Overall Study|Ongoing in Study|5
2451648|NCT02657889|8444369|P1|Overall Study|Ongoing in Study|0
2451649|NCT02657889|8444366|P4|Overall Study|Withdrawal by Subject|0
2451650|NCT02657889|8444367|P3|Overall Study|Withdrawal by Subject|8
2451651|NCT02657889|8444368|P2|Overall Study|Withdrawal by Subject|0
2451652|NCT02657889|8444369|P1|Overall Study|Withdrawal by Subject|0
2451653|NCT02657889|8444366|P4|Overall Study|Lost to Follow-up|2
2451654|NCT02657889|8444367|P3|Overall Study|Lost to Follow-up|1
2451655|NCT02657889|8444368|P2|Overall Study|Lost to Follow-up|0
2451656|NCT02657889|8444369|P1|Overall Study|Lost to Follow-up|2
2451657|NCT02657889|8444366|P4|Overall Study|Death|34
2451658|NCT02657889|8444367|P3|Overall Study|Death|20
2451659|NCT02657889|8444368|P2|Overall Study|Death|2
2451660|NCT02657889|8444369|P1|Overall Study|Death|5
2451661|NCT02657408|8444410|P2|Overall Study|Adverse Event|7
2451662|NCT02657408|8444411|P1|Overall Study|Adverse Event|3
2451663|NCT02657369|8444435|P1|Overall Study|Study terminated by sponsor|7
2451664|NCT02657369|8444435|P1|Overall Study|Death|27
2451665|NCT02657031|8444466|P2|Overall Study|Adverse Event|2
2451666|NCT02657031|8444467|P1|Overall Study|Adverse Event|1
2451667|NCT02656693|8444495|P3|Overall Study|Bariatric surgery|2
2451668|NCT02656693|8444496|P2|Overall Study|Bariatric surgery|1
2451669|NCT02656693|8444497|P1|Overall Study|Bariatric surgery|0
2451670|NCT02656693|8444495|P3|Overall Study|Pregnancy|1
2451671|NCT02656693|8444496|P2|Overall Study|Pregnancy|1
2451672|NCT02656693|8444497|P1|Overall Study|Pregnancy|1
2451673|NCT02656329|8444580|P2|Overall Study|Other than specified above|6
2451674|NCT02656329|8444581|P1|Overall Study|Other than specified above|5
2451675|NCT02656329|8444580|P2|Overall Study|Study termination by Sponsor|142
2451676|NCT02656329|8444581|P1|Overall Study|Study termination by Sponsor|150
2451677|NCT02656329|8444580|P2|Overall Study|Withdrawal by Subject|6
2451678|NCT02656329|8444581|P1|Overall Study|Withdrawal by Subject|7
2451679|NCT02656329|8444580|P2|Overall Study|Lost to Follow-up|3
2451680|NCT02656329|8444581|P1|Overall Study|Lost to Follow-up|2
2451681|NCT02656290|8444604|P1|Overall Study|Subjects Remain On Study|26
2451682|NCT02656173|8444614|P2|Overall Study|Miscellaneous|0
2451683|NCT02656173|8444615|P1|Overall Study|Miscellaneous|2
2451684|NCT02656173|8444614|P2|Overall Study|Protocol Violation|1
2451685|NCT02656173|8444615|P1|Overall Study|Protocol Violation|0
2451686|NCT02656173|8444614|P2|Overall Study|Withdrawal by Subject|3
2451687|NCT02656173|8444615|P1|Overall Study|Withdrawal by Subject|1
2451688|NCT02656173|8444614|P2|Overall Study|Adverse Event|5
2451689|NCT02656173|8444615|P1|Overall Study|Adverse Event|7
2451690|NCT02656173|8444614|P2|Overall Study|Deviation from the Eligible Criteria|2
2451691|NCT02656173|8444615|P1|Overall Study|Deviation from the Eligible Criteria|3
2451692|NCT02655887|8444687|P1|Overall Study|Missed 12-month follow-up visit|4
2451693|NCT02655887|8444687|P1|Overall Study|Withdrawal by Subject|3
2451694|NCT02655887|8444687|P1|Overall Study|Death|4
2451695|NCT02655887|8444687|P1|Overall Study|Lost to Follow-up|3
2451696|NCT02655679|8444706|P5|Overall Study|Other Miscellaneous Reasons|0
2451697|NCT02655679|8444707|P4|Overall Study|Other Miscellaneous Reasons|0
2451698|NCT02655679|8444708|P3|Overall Study|Other Miscellaneous Reasons|0
2451699|NCT02655679|8444709|P2|Overall Study|Other Miscellaneous Reasons|0
2451700|NCT02655679|8444710|P1|Overall Study|Other Miscellaneous Reasons|1
2451701|NCT02655679|8444706|P5|Overall Study|Lost to Follow-up|0
2451702|NCT02655679|8444707|P4|Overall Study|Lost to Follow-up|1
2451703|NCT02655679|8444708|P3|Overall Study|Lost to Follow-up|1
2451704|NCT02655679|8444709|P2|Overall Study|Lost to Follow-up|1
2451705|NCT02655679|8444710|P1|Overall Study|Lost to Follow-up|0
2451706|NCT02655679|8444706|P5|Overall Study|Inability to Comply with the Protocol|0
2451707|NCT02655679|8444707|P4|Overall Study|Inability to Comply with the Protocol|0
2451708|NCT02655679|8444708|P3|Overall Study|Inability to Comply with the Protocol|0
2451709|NCT02655679|8444709|P2|Overall Study|Inability to Comply with the Protocol|0
2451710|NCT02655679|8444710|P1|Overall Study|Inability to Comply with the Protocol|1
2451711|NCT02655679|8444706|P5|Overall Study|Withdrawal by Subject|1
2451712|NCT02655679|8444707|P4|Overall Study|Withdrawal by Subject|3
2451713|NCT02655679|8444708|P3|Overall Study|Withdrawal by Subject|0
2451714|NCT02655679|8444709|P2|Overall Study|Withdrawal by Subject|1
2451715|NCT02655679|8444710|P1|Overall Study|Withdrawal by Subject|1
2451716|NCT02655679|8444706|P5|Overall Study|Adverse Event|0
2451717|NCT02655679|8444707|P4|Overall Study|Adverse Event|0
2451718|NCT02655679|8444708|P3|Overall Study|Adverse Event|0
2451719|NCT02655679|8444709|P2|Overall Study|Adverse Event|1
2451720|NCT02655679|8444710|P1|Overall Study|Adverse Event|0
2451721|NCT02655666|8444782|P1|Overall Study|Sponsor stopped this clinical research.|12
2451722|NCT02655419|8444811|P2|Overall Study|Other|1
2451723|NCT02655419|8444812|P1|Overall Study|Other|0
2451724|NCT02655419|8444811|P2|Overall Study|Withdrawal by Subject|1
2451725|NCT02655419|8444812|P1|Overall Study|Withdrawal by Subject|4
2451726|NCT02655419|8444811|P2|Overall Study|Enrolled but not treated|5
2451727|NCT02655419|8444812|P1|Overall Study|Enrolled but not treated|1
2451728|NCT02655237|8444932|P2|Overall Study|Randomized but Not Treated|0
2451729|NCT02655237|8444933|P1|Overall Study|Randomized but Not Treated|1
2451730|NCT02655237|8444932|P2|Overall Study|Reduction of Hemoglobin Concentration|0
2451731|NCT02655237|8444933|P1|Overall Study|Reduction of Hemoglobin Concentration|1
2451732|NCT02655237|8444932|P2|Overall Study|Recovery Leading to Surgery|1
2451733|NCT02655237|8444933|P1|Overall Study|Recovery Leading to Surgery|2
2451734|NCT02655237|8444932|P2|Overall Study|Lack of Efficacy|1
2451735|NCT02655237|8444933|P1|Overall Study|Lack of Efficacy|0
2451736|NCT02655237|8444932|P2|Overall Study|Withdrawal by Participant|2
2451737|NCT02655237|8444933|P1|Overall Study|Withdrawal by Participant|1
2451738|NCT02655237|8444932|P2|Overall Study|Protocol Deviation|0
2451739|NCT02655237|8444933|P1|Overall Study|Protocol Deviation|2
2451740|NCT02655237|8444932|P2|Overall Study|Adverse Event|7
2451741|NCT02655237|8444933|P1|Overall Study|Adverse Event|10
2451742|NCT02655224|8444973|P2|Overall Study|Adverse Event|1
2451743|NCT02655224|8444974|P1|Overall Study|Adverse Event|1
2451744|NCT02654717|8445017|P2|Overall Study|Non-permitted medication|0
2451745|NCT02654717|8445018|P1|Overall Study|Non-permitted medication|3
2451746|NCT02654717|8445017|P2|Overall Study|Withdrawal by Subject|1
2451747|NCT02654717|8445018|P1|Overall Study|Withdrawal by Subject|0
2451748|NCT02654717|8445017|P2|Overall Study|Protocol Violation|2
2451749|NCT02654717|8445018|P1|Overall Study|Protocol Violation|1
2451750|NCT02654717|8445017|P2|Overall Study|Adverse Event|2
2451751|NCT02654717|8445018|P1|Overall Study|Adverse Event|2
2451752|NCT02654145|8445069|P1|Overall Study|Withdrawal by Subject|5
2451753|NCT02654145|8445069|P1|Overall Study|Protocol Violation|1
2451754|NCT02654145|8445069|P1|Overall Study|Lack of Efficacy|1
2451755|NCT02654132|8445078|P2|Overall Study|Never treated|2
2451756|NCT02654132|8445079|P1|Overall Study|Never treated|0
2451757|NCT02654132|8445078|P2|Overall Study|Clinical Progression (not protocol)|1
2451758|NCT02654132|8445079|P1|Overall Study|Clinical Progression (not protocol)|0
2451759|NCT02654132|8445078|P2|Overall Study|Inadequate response to therapy|0
2451760|NCT02654132|8445079|P1|Overall Study|Inadequate response to therapy|1
2451761|NCT02654132|8445078|P2|Overall Study|Subject Withdrew Consent|1
2451762|NCT02654132|8445079|P1|Overall Study|Subject Withdrew Consent|2
2451763|NCT02654132|8445078|P2|Overall Study|Not Reported|1
2451764|NCT02654132|8445079|P1|Overall Study|Not Reported|0
2451765|NCT02654132|8445078|P2|Overall Study|Subj Request to Discontinue Treatment|0
2451766|NCT02654132|8445079|P1|Overall Study|Subj Request to Discontinue Treatment|1
2451767|NCT02654132|8445078|P2|Overall Study|Maximum Clinical Benefit|2
2451768|NCT02654132|8445079|P1|Overall Study|Maximum Clinical Benefit|0
2451769|NCT02654132|8445078|P2|Overall Study|Study Drug Toxicity|2
2451770|NCT02654132|8445079|P1|Overall Study|Study Drug Toxicity|1
2451771|NCT02654132|8445078|P2|Overall Study|Switched to another tx|1
2451772|NCT02654132|8445079|P1|Overall Study|Switched to another tx|0
2451773|NCT02654132|8445078|P2|Overall Study|Adverse Event Unrelated to Study Drug|5
2451774|NCT02654132|8445079|P1|Overall Study|Adverse Event Unrelated to Study Drug|5
2451775|NCT02654132|8445078|P2|Overall Study|Disease Progression|31
2451776|NCT02654132|8445079|P1|Overall Study|Disease Progression|26
2451777|NCT02653625|8445135|P1|Overall Study|Suspected Drug Induced Liver Injury|1
2451778|NCT02653625|8445135|P1|Overall Study|Protocol Violation|1
2451779|NCT02653625|8445135|P1|Overall Study|Non-compliance with Study Drug|1
2451780|NCT02653625|8445135|P1|Overall Study|Adverse Event|1
2451781|NCT02653495|8445159|P2|Overall Study|Screening Failure|0
2451782|NCT02653495|8445160|P1|Overall Study|Screening Failure|10
2451783|NCT02653495|8445159|P2|Overall Study|Lost to Follow-up|0
2451784|NCT02653495|8445160|P1|Overall Study|Lost to Follow-up|2
2451785|NCT02653326|8445212|P2|Overall Study|Lost to Follow-up|7
2451786|NCT02653326|8445213|P1|Overall Study|Lost to Follow-up|10
2451787|NCT02653170|8445251|P3|Overall Study|Lost to Follow-up|10
2451788|NCT02653170|8445252|P2|Overall Study|Lost to Follow-up|4
2451789|NCT02653170|8445253|P1|Overall Study|Lost to Follow-up|12
2451790|NCT02653170|8445251|P3|Overall Study|withdrawn by study team|5
2451791|NCT02653170|8445252|P2|Overall Study|withdrawn by study team|4
2451792|NCT02653170|8445253|P1|Overall Study|withdrawn by study team|2
2451793|NCT02653170|8445251|P3|Overall Study|Withdrawal by Subject|3
2451794|NCT02653170|8445252|P2|Overall Study|Withdrawal by Subject|8
2451795|NCT02653170|8445253|P1|Overall Study|Withdrawal by Subject|3
2451796|NCT02652949|8445273|P1|12-Month Follow-up Secondary Endpoint|Death|4
2451797|NCT02652949|8445273|P1|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1
2451798|NCT02652949|8445273|P1|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2
2451799|NCT02652949|8445273|P1|6-Month Follow-up Secondary Endpoint|Death|5
2451800|NCT02652949|8445273|P1|30-Day Follow-up for Secondary Endpoint|Death|1
2451801|NCT02652949|8445273|P1|30-Day Follow-up for Primary Endpoint|Death|1
2451802|NCT02652767|8445308|P1|Overall Study|Withdrawal by Subject|1
2451803|NCT02652767|8445308|P1|Overall Study|Lost to Follow-up|1
2451804|NCT02652767|8445308|P1|Overall Study|Death|2
2451805|NCT02652624|8445336|P2|Extension Phase|Withdrew Consent|1
2451806|NCT02652624|8445337|P1|Extension Phase|Withdrew Consent|0
2451807|NCT02652624|8445336|P2|Extension Phase|Adverse Event|1
2451808|NCT02652624|8445337|P1|Extension Phase|Adverse Event|0
2451809|NCT02652624|8445336|P2|Extension Phase|Pregnancy|1
2451810|NCT02652624|8445337|P1|Extension Phase|Pregnancy|1
2451811|NCT02652624|8445336|P2|Extension Phase|Lost to Follow-up|1
2451812|NCT02652624|8445337|P1|Extension Phase|Lost to Follow-up|3
2451813|NCT02652624|8445336|P2|Randomized Phase|Lost to Follow-up|1
2451814|NCT02652624|8445337|P1|Randomized Phase|Lost to Follow-up|0
2451815|NCT02652624|8445336|P2|Randomized Phase|Death|1
2451816|NCT02652624|8445337|P1|Randomized Phase|Death|0
2451817|NCT02652624|8445336|P2|Randomized Phase|Investigator's Discretion|2
2451818|NCT02652624|8445337|P1|Randomized Phase|Investigator's Discretion|0
2451819|NCT02652624|8445336|P2|Randomized Phase|Pregnancy|1
2451820|NCT02652624|8445337|P1|Randomized Phase|Pregnancy|3
2451821|NCT02652260|8445425|P2|Overall Study|Withdrawal by Subject|1
2451822|NCT02652260|8445426|P1|Overall Study|Withdrawal by Subject|0
2451823|NCT02652260|8445425|P2|Overall Study|Pregnancy|1
2451824|NCT02652260|8445426|P1|Overall Study|Pregnancy|0
2451825|NCT02652156|8445485|P3|Overall Study|Physician Decision|0
2451826|NCT02652156|8445486|P2|Overall Study|Physician Decision|0
2451827|NCT02652156|8445487|P1|Overall Study|Physician Decision|1
2451828|NCT02651922|8445513|P1|Overall Study|due to exclusion criteria|2
2451829|NCT02651688|8445533|P3|Overall Study|Withdrawal by Subject|2
2451830|NCT02651688|8445534|P2|Overall Study|Withdrawal by Subject|0
2451831|NCT02651688|8445535|P1|Overall Study|Withdrawal by Subject|1
2451832|NCT02651688|8445533|P3|Overall Study|Lost to Follow-up|0
2451833|NCT02651688|8445534|P2|Overall Study|Lost to Follow-up|3
2451834|NCT02651688|8445535|P1|Overall Study|Lost to Follow-up|1
2451835|NCT02651688|8445533|P3|Overall Study|Principal Investigator (PI) decision|0
2451836|NCT02651688|8445534|P2|Overall Study|Principal Investigator (PI) decision|2
2451837|NCT02651688|8445535|P1|Overall Study|Principal Investigator (PI) decision|0
2451838|NCT02651688|8445533|P3|Overall Study|Non-compliance|1
2451839|NCT02651688|8445534|P2|Overall Study|Non-compliance|0
2451840|NCT02651688|8445535|P1|Overall Study|Non-compliance|0
2451841|NCT02651467|8445618|P3|Overall Study|Other (Not specified)|2
2451842|NCT02651467|8445619|P2|Overall Study|Other (Not specified)|0
2451843|NCT02651467|8445620|P1|Overall Study|Other (Not specified)|1
2451844|NCT02651467|8445618|P3|Overall Study|Withdrawal by Subject|2
2451845|NCT02651467|8445619|P2|Overall Study|Withdrawal by Subject|0
2451846|NCT02651467|8445620|P1|Overall Study|Withdrawal by Subject|0
2451847|NCT02651194|8445648|P1|Overall Study|Other|2
2451848|NCT02651194|8445648|P1|Overall Study|Lost to Follow-up|3
2451849|NCT02651155|8445656|P2|Overall Study|Voluntary Withdrawal|0
2451850|NCT02651155|8445657|P1|Overall Study|Voluntary Withdrawal|5
2451851|NCT02651155|8445656|P2|Overall Study|Pretreatment Event/Adverse Event|2
2451852|NCT02651155|8445657|P1|Overall Study|Pretreatment Event/Adverse Event|1
2451853|NCT02650921|8445677|P1|Overall Study|Due to Medical Condition|1
2451854|NCT02650921|8445677|P1|Overall Study|Adverse Event|1
2451855|NCT02650921|8445677|P1|Overall Study|Lost to Follow-up|2
2451856|NCT02650921|8445677|P1|Overall Study|Withdrawal by Subject|4
2451857|NCT02650895|8445731|P6|Overall Study|Withdrawal by Subject|0
2451858|NCT02650895|8445732|P5|Overall Study|Withdrawal by Subject|0
2451859|NCT02650895|8445733|P4|Overall Study|Withdrawal by Subject|0
2451860|NCT02650895|8445734|P3|Overall Study|Withdrawal by Subject|0
2451861|NCT02650895|8445735|P2|Overall Study|Withdrawal by Subject|1
2451862|NCT02650895|8445736|P1|Overall Study|Withdrawal by Subject|0
2451863|NCT02650466|8445783|P1|Overall Study|Lost to Follow-up|1
2451864|NCT02650466|8445783|P1|Overall Study|Withdrawal by Subject|5
2451865|NCT02650466|8445783|P1|Overall Study|Physician Decision|1
2451866|NCT02650128|8445913|P1|Overall Study|Death|2
2451867|NCT02649946|8445922|P2|Overall Study|Missed 6-month follow-up visit|4
2451868|NCT02649946|8445923|P1|Overall Study|Missed 6-month follow-up visit|0
2451869|NCT02649946|8445922|P2|Overall Study|Erroneously enrolled|0
2451870|NCT02649946|8445923|P1|Overall Study|Erroneously enrolled|1
2451871|NCT02649946|8445922|P2|Overall Study|Lost to Follow-up|1
2451872|NCT02649946|8445923|P1|Overall Study|Lost to Follow-up|2
2451873|NCT02649946|8445922|P2|Overall Study|Physician Decision|0
2451874|NCT02649946|8445923|P1|Overall Study|Physician Decision|1
2451875|NCT02649946|8445922|P2|Overall Study|Death|9
2451876|NCT02649946|8445923|P1|Overall Study|Death|7
2451877|NCT02649946|8445922|P2|Overall Study|Withdrawal by Subject|1
2451878|NCT02649946|8445923|P1|Overall Study|Withdrawal by Subject|1
2451879|NCT02649634|8445958|P2|Overall Study|Lost to Follow-up|1
2451880|NCT02649634|8445959|P1|Overall Study|Lost to Follow-up|0
2451881|NCT02649634|8445958|P2|Overall Study|Withdrawal by Subject|5
2451882|NCT02649634|8445959|P1|Overall Study|Withdrawal by Subject|3
2451883|NCT02648438|8446194|P3|Overall Study|Withdrawal by Subject|0
2451884|NCT02648438|8446195|P2|Overall Study|Withdrawal by Subject|1
2451885|NCT02648438|8446196|P1|Overall Study|Withdrawal by Subject|1
2451886|NCT02648438|8446194|P3|Overall Study|Protocol Violation|0
2451887|NCT02648438|8446195|P2|Overall Study|Protocol Violation|0
2451888|NCT02648438|8446196|P1|Overall Study|Protocol Violation|2
2451889|NCT02648438|8446194|P3|Overall Study|Eligibility criteria not fulfilled|0
2451890|NCT02648438|8446195|P2|Overall Study|Eligibility criteria not fulfilled|2
2451891|NCT02648438|8446196|P1|Overall Study|Eligibility criteria not fulfilled|0
2451892|NCT02648217|8446242|P2|Overall Study|Unclassified|0
2451893|NCT02648217|8446243|P1|Overall Study|Unclassified|5
2451894|NCT02648217|8446242|P2|Overall Study|Withdrawal by Subject|3
2451895|NCT02648217|8446243|P1|Overall Study|Withdrawal by Subject|4
2451896|NCT02648217|8446242|P2|Overall Study|Lost to Follow-up|1
2451897|NCT02648217|8446243|P1|Overall Study|Lost to Follow-up|1
2451898|NCT02648217|8446242|P2|Overall Study|Adverse Event|1
2451899|NCT02648217|8446243|P1|Overall Study|Adverse Event|0
2451900|NCT02648204|8446265|P4|Overall Study|Adverse Event|0
2451901|NCT02648204|8446266|P3|Overall Study|Adverse Event|1
2451902|NCT02648204|8446267|P2|Overall Study|Adverse Event|0
2451903|NCT02648204|8446268|P1|Overall Study|Adverse Event|0
2451904|NCT02648204|8446265|P4|Overall Study|Death|2
2451905|NCT02648204|8446266|P3|Overall Study|Death|2
2451906|NCT02648204|8446267|P2|Overall Study|Death|1
2451907|NCT02648204|8446268|P1|Overall Study|Death|1
2451908|NCT02648204|8446265|P4|Overall Study|Missing follow-up information|2
2451909|NCT02648204|8446266|P3|Overall Study|Missing follow-up information|4
2451910|NCT02648204|8446267|P2|Overall Study|Missing follow-up information|4
2451911|NCT02648204|8446268|P1|Overall Study|Missing follow-up information|4
2451912|NCT02648204|8446265|P4|Overall Study|Lost to Follow-up|6
2451913|NCT02648204|8446266|P3|Overall Study|Lost to Follow-up|4
2451914|NCT02648204|8446267|P2|Overall Study|Lost to Follow-up|8
2451915|NCT02648204|8446268|P1|Overall Study|Lost to Follow-up|5
2451916|NCT02648204|8446265|P4|Overall Study|Withdrawal by Subject|6
2451917|NCT02648204|8446266|P3|Overall Study|Withdrawal by Subject|2
2451918|NCT02648204|8446267|P2|Overall Study|Withdrawal by Subject|8
2451919|NCT02648204|8446268|P1|Overall Study|Withdrawal by Subject|12
2451920|NCT02647944|8446406|P2|Overall Study|Adverse Event|0
2451921|NCT02647944|8446407|P1|Overall Study|Adverse Event|2
2451922|NCT02647944|8446406|P2|Overall Study|Withdrawal by Subject|3
2451923|NCT02647944|8446407|P1|Overall Study|Withdrawal by Subject|0
2451924|NCT02647905|8446431|P1|Overall Study|Withdrawal by Subject|2
2451925|NCT02647905|8446431|P1|Overall Study|Lost to Follow-up|1
2451926|NCT02647866|8446441|P5|Overall Study|Subject moved to different country|0
2451927|NCT02647866|8446442|P4|Overall Study|Subject moved to different country|0
2451928|NCT02647866|8446443|P3|Overall Study|Subject moved to different country|0
2451929|NCT02647866|8446444|P2|Overall Study|Subject moved to different country|0
2451930|NCT02647866|8446445|P1|Overall Study|Subject moved to different country|1
2451931|NCT02647866|8446441|P5|Overall Study|Death|0
2451932|NCT02647866|8446442|P4|Overall Study|Death|0
2451933|NCT02647866|8446443|P3|Overall Study|Death|0
2451934|NCT02647866|8446444|P2|Overall Study|Death|1
2451935|NCT02647866|8446445|P1|Overall Study|Death|0
2451936|NCT02647866|8446441|P5|Overall Study|Physician Decision|2
2451937|NCT02647866|8446442|P4|Overall Study|Physician Decision|0
2451938|NCT02647866|8446443|P3|Overall Study|Physician Decision|1
2451939|NCT02647866|8446444|P2|Overall Study|Physician Decision|1
2451940|NCT02647866|8446445|P1|Overall Study|Physician Decision|0
2451941|NCT02647866|8446441|P5|Overall Study|Withdrawal by Subject|4
2451942|NCT02647866|8446442|P4|Overall Study|Withdrawal by Subject|4
2451943|NCT02647866|8446443|P3|Overall Study|Withdrawal by Subject|2
2451944|NCT02647866|8446444|P2|Overall Study|Withdrawal by Subject|1
2451945|NCT02647866|8446445|P1|Overall Study|Withdrawal by Subject|1
2451946|NCT02647866|8446441|P5|Overall Study|Disease Worsening|1
2451947|NCT02647866|8446442|P4|Overall Study|Disease Worsening|0
2451948|NCT02647866|8446443|P3|Overall Study|Disease Worsening|0
2451949|NCT02647866|8446444|P2|Overall Study|Disease Worsening|1
2451950|NCT02647866|8446445|P1|Overall Study|Disease Worsening|3
2451951|NCT02647866|8446441|P5|Overall Study|Adverse Event|1
2451952|NCT02647866|8446442|P4|Overall Study|Adverse Event|2
2451953|NCT02647866|8446443|P3|Overall Study|Adverse Event|2
2451954|NCT02647866|8446444|P2|Overall Study|Adverse Event|0
2451955|NCT02647866|8446445|P1|Overall Study|Adverse Event|0
2451956|NCT02647788|8446522|P2|Overall Study|Felt nauseous with assigned medication|1
2451957|NCT02647788|8446523|P1|Overall Study|Felt nauseous with assigned medication|1
2451958|NCT02647788|8446522|P2|Overall Study|Felt itchy with assigned medication|0
2451959|NCT02647788|8446523|P1|Overall Study|Felt itchy with assigned medication|1
2451960|NCT02647788|8446522|P2|Overall Study|Withdrawal by Subject|0
2451961|NCT02647788|8446523|P1|Overall Study|Withdrawal by Subject|1
2451962|NCT02647788|8446522|P2|Overall Study|Did not want opiate|1
2451963|NCT02647788|8446523|P1|Overall Study|Did not want opiate|0
2451964|NCT02647788|8446522|P2|Overall Study|Lost to Follow-up|11
2451965|NCT02647788|8446523|P1|Overall Study|Lost to Follow-up|13
2451966|NCT02647658|8446535|P2|Overall Study|Consent refusal|24
2451967|NCT02647658|8446536|P1|Overall Study|Consent refusal|15
2451968|NCT02647645|8446564|P2|Overall Study|Lost to Follow-up|1
2451969|NCT02647645|8446565|P1|Overall Study|Lost to Follow-up|2
2451970|NCT02647320|8446587|P5|Overall Study|Disposition Missing Due to Fire at Site|4
2451971|NCT02647320|8446588|P4|Overall Study|Disposition Missing Due to Fire at Site|3
2451972|NCT02647320|8446589|P3|Overall Study|Disposition Missing Due to Fire at Site|4
2451973|NCT02647320|8446590|P2|Overall Study|Disposition Missing Due to Fire at Site|3
2451974|NCT02647320|8446591|P1|Overall Study|Disposition Missing Due to Fire at Site|2
2451975|NCT02647320|8446587|P5|Overall Study|Lack of Efficacy|0
2451976|NCT02647320|8446588|P4|Overall Study|Lack of Efficacy|1
2451977|NCT02647320|8446589|P3|Overall Study|Lack of Efficacy|0
2451978|NCT02647320|8446590|P2|Overall Study|Lack of Efficacy|0
2451979|NCT02647320|8446591|P1|Overall Study|Lack of Efficacy|0
2451980|NCT02647320|8446587|P5|Overall Study|Develop anemia|0
2451981|NCT02647320|8446588|P4|Overall Study|Develop anemia|0
2451982|NCT02647320|8446589|P3|Overall Study|Develop anemia|0
2451983|NCT02647320|8446590|P2|Overall Study|Develop anemia|0
2451984|NCT02647320|8446591|P1|Overall Study|Develop anemia|1
2451985|NCT02647320|8446587|P5|Overall Study|Lost to Follow-up|0
2451986|NCT02647320|8446588|P4|Overall Study|Lost to Follow-up|0
2451987|NCT02647320|8446589|P3|Overall Study|Lost to Follow-up|0
2451988|NCT02647320|8446590|P2|Overall Study|Lost to Follow-up|1
2451989|NCT02647320|8446591|P1|Overall Study|Lost to Follow-up|1
2451990|NCT02647320|8446587|P5|Overall Study|Reason not provided|2
2451991|NCT02647320|8446588|P4|Overall Study|Reason not provided|0
2451992|NCT02647320|8446589|P3|Overall Study|Reason not provided|1
2451993|NCT02647320|8446590|P2|Overall Study|Reason not provided|0
2451994|NCT02647320|8446591|P1|Overall Study|Reason not provided|0
2451995|NCT02647320|8446587|P5|Overall Study|Study terminated by sponsor|2
2451996|NCT02647320|8446588|P4|Overall Study|Study terminated by sponsor|1
2451997|NCT02647320|8446589|P3|Overall Study|Study terminated by sponsor|1
2451998|NCT02647320|8446590|P2|Overall Study|Study terminated by sponsor|1
2451999|NCT02647320|8446591|P1|Overall Study|Study terminated by sponsor|1
2452000|NCT02647320|8446587|P5|Overall Study|Persistent hyperglycemia|1
2452001|NCT02647320|8446588|P4|Overall Study|Persistent hyperglycemia|1
2452002|NCT02647320|8446589|P3|Overall Study|Persistent hyperglycemia|1
2452003|NCT02647320|8446590|P2|Overall Study|Persistent hyperglycemia|1
2452004|NCT02647320|8446591|P1|Overall Study|Persistent hyperglycemia|0
2452005|NCT02647320|8446587|P5|Overall Study|Withdrawal by Subject|7
2452006|NCT02647320|8446588|P4|Overall Study|Withdrawal by Subject|2
2452007|NCT02647320|8446589|P3|Overall Study|Withdrawal by Subject|2
2452008|NCT02647320|8446590|P2|Overall Study|Withdrawal by Subject|4
2452009|NCT02647320|8446591|P1|Overall Study|Withdrawal by Subject|7
2452010|NCT02647320|8446587|P5|Overall Study|Protocol Violation|0
2452011|NCT02647320|8446588|P4|Overall Study|Protocol Violation|0
2452012|NCT02647320|8446589|P3|Overall Study|Protocol Violation|3
2452013|NCT02647320|8446590|P2|Overall Study|Protocol Violation|0
2452014|NCT02647320|8446591|P1|Overall Study|Protocol Violation|0
2452015|NCT02647320|8446587|P5|Overall Study|Adverse Event|1
2452016|NCT02647320|8446588|P4|Overall Study|Adverse Event|2
2452017|NCT02647320|8446589|P3|Overall Study|Adverse Event|3
2452018|NCT02647320|8446590|P2|Overall Study|Adverse Event|1
2452019|NCT02647320|8446591|P1|Overall Study|Adverse Event|0
2452020|NCT02647281|8446682|P9|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1
2452021|NCT02647281|8446683|P8|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
2452022|NCT02647281|8446684|P7|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
2452023|NCT02647281|8446685|P6|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
2452024|NCT02647281|8446686|P5|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
2452025|NCT02647281|8446687|P4|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
2452026|NCT02647281|8446688|P3|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
2452027|NCT02647281|8446689|P2|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
2452028|NCT02647281|8446690|P1|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
2452029|NCT02646891|8446878|P10|Overall Study|Death|0
2452030|NCT02646891|8446879|P9|Overall Study|Death|1
2452031|NCT02646891|8446880|P8|Overall Study|Death|1
2452032|NCT02646891|8446881|P7|Overall Study|Death|1
2452033|NCT02646891|8446882|P6|Overall Study|Death|0
2452034|NCT02646891|8446883|P5|Overall Study|Death|0
2452035|NCT02646891|8446884|P4|Overall Study|Death|0
2452036|NCT02646891|8446885|P3|Overall Study|Death|0
2452037|NCT02646891|8446886|P2|Overall Study|Death|0
2452038|NCT02646891|8446887|P1|Overall Study|Death|0
2452039|NCT02646891|8446878|P10|Overall Study|Withdrawal by Subject|3
2452040|NCT02646891|8446879|P9|Overall Study|Withdrawal by Subject|7
2452041|NCT02646891|8446880|P8|Overall Study|Withdrawal by Subject|9
2452042|NCT02646891|8446881|P7|Overall Study|Withdrawal by Subject|5
2452043|NCT02646891|8446882|P6|Overall Study|Withdrawal by Subject|0
2452044|NCT02646891|8446883|P5|Overall Study|Withdrawal by Subject|0
2452045|NCT02646891|8446884|P4|Overall Study|Withdrawal by Subject|0
2452046|NCT02646891|8446885|P3|Overall Study|Withdrawal by Subject|1
2452047|NCT02646891|8446886|P2|Overall Study|Withdrawal by Subject|0
2452048|NCT02646891|8446887|P1|Overall Study|Withdrawal by Subject|2
2452049|NCT02646891|8446878|P10|Overall Study|Protocol Violation|0
2452050|NCT02646891|8446879|P9|Overall Study|Protocol Violation|0
2452051|NCT02646891|8446880|P8|Overall Study|Protocol Violation|1
2452052|NCT02646891|8446881|P7|Overall Study|Protocol Violation|1
2452053|NCT02646891|8446882|P6|Overall Study|Protocol Violation|0
2452054|NCT02646891|8446883|P5|Overall Study|Protocol Violation|0
2452055|NCT02646891|8446884|P4|Overall Study|Protocol Violation|0
2452056|NCT02646891|8446885|P3|Overall Study|Protocol Violation|0
2452057|NCT02646891|8446886|P2|Overall Study|Protocol Violation|0
2452058|NCT02646891|8446887|P1|Overall Study|Protocol Violation|0
2452059|NCT02646891|8446878|P10|Overall Study|Lost to Follow-up|2
2452060|NCT02646891|8446879|P9|Overall Study|Lost to Follow-up|2
2452061|NCT02646891|8446880|P8|Overall Study|Lost to Follow-up|2
2452062|NCT02646891|8446881|P7|Overall Study|Lost to Follow-up|2
2452063|NCT02646891|8446882|P6|Overall Study|Lost to Follow-up|0
2452064|NCT02646891|8446883|P5|Overall Study|Lost to Follow-up|0
2452065|NCT02646891|8446884|P4|Overall Study|Lost to Follow-up|0
2452066|NCT02646891|8446885|P3|Overall Study|Lost to Follow-up|0
2452067|NCT02646891|8446886|P2|Overall Study|Lost to Follow-up|0
2452068|NCT02646891|8446887|P1|Overall Study|Lost to Follow-up|0
2452069|NCT02646891|8446878|P10|Overall Study|Adverse Event|0
2452070|NCT02646891|8446879|P9|Overall Study|Adverse Event|0
2452071|NCT02646891|8446880|P8|Overall Study|Adverse Event|0
2452072|NCT02646891|8446881|P7|Overall Study|Adverse Event|0
2452073|NCT02646891|8446882|P6|Overall Study|Adverse Event|0
2452074|NCT02646891|8446883|P5|Overall Study|Adverse Event|0
2452075|NCT02646891|8446884|P4|Overall Study|Adverse Event|0
2452076|NCT02646891|8446885|P3|Overall Study|Adverse Event|0
2452077|NCT02646891|8446886|P2|Overall Study|Adverse Event|1
2452078|NCT02646891|8446887|P1|Overall Study|Adverse Event|0
2452079|NCT02646566|8447061|P3|Overall Study|Treatment failure|0
2452080|NCT02646566|8447062|P2|Overall Study|Treatment failure|0
2452081|NCT02646566|8447063|P1|Overall Study|Treatment failure|1
2452082|NCT02646566|8447061|P3|Overall Study|Lost to Follow-up|5
2452083|NCT02646566|8447062|P2|Overall Study|Lost to Follow-up|4
2452084|NCT02646566|8447063|P1|Overall Study|Lost to Follow-up|5
2452085|NCT02646124|8447114|P2|Overall Study|Lost to Follow-up|2
2452086|NCT02646124|8447115|P1|Overall Study|Lost to Follow-up|0
2452087|NCT02645409|8447151|P2|Overall Study|Physician Decision|0
2452088|NCT02645409|8447152|P1|Overall Study|Physician Decision|1
2452089|NCT02645409|8447151|P2|Overall Study|Withdrawal by Subject|0
2452090|NCT02645409|8447152|P1|Overall Study|Withdrawal by Subject|3
2452091|NCT02644356|8447336|P1|Overall Study|Withdrawal by Subject|2
2452092|NCT02644122|8447419|P1|Overall Study|Withdrawal by Subject|1
2452093|NCT02644109|8447429|P2|Overall Study|Adverse Event|4
2452094|NCT02644109|8447430|P1|Overall Study|Adverse Event|0
2452095|NCT02644096|8447438|P2|Overall Study|Withdrawal by Subject|25
2452096|NCT02644096|8447439|P1|Overall Study|Withdrawal by Subject|28
2452097|NCT02643693|8447477|P6|Overall Study|Protocol Adherence Issues|1
2452098|NCT02643693|8447478|P5|Overall Study|Protocol Adherence Issues|0
2452099|NCT02643693|8447479|P4|Overall Study|Protocol Adherence Issues|0
2452100|NCT02643693|8447480|P3|Overall Study|Protocol Adherence Issues|1
2452101|NCT02643693|8447481|P2|Overall Study|Protocol Adherence Issues|0
2452102|NCT02643693|8447482|P1|Overall Study|Protocol Adherence Issues|2
2452103|NCT02643693|8447477|P6|Overall Study|Withdrawal by Subject|0
2452104|NCT02643693|8447478|P5|Overall Study|Withdrawal by Subject|0
2452105|NCT02643693|8447479|P4|Overall Study|Withdrawal by Subject|0
2452106|NCT02643693|8447480|P3|Overall Study|Withdrawal by Subject|0
2452107|NCT02643693|8447481|P2|Overall Study|Withdrawal by Subject|1
2452108|NCT02643693|8447482|P1|Overall Study|Withdrawal by Subject|0
2452109|NCT02643693|8447477|P6|Overall Study|Physician Decision|0
2452110|NCT02643693|8447478|P5|Overall Study|Physician Decision|0
2452111|NCT02643693|8447479|P4|Overall Study|Physician Decision|0
2452112|NCT02643693|8447480|P3|Overall Study|Physician Decision|0
2452113|NCT02643693|8447481|P2|Overall Study|Physician Decision|1
2452114|NCT02643693|8447482|P1|Overall Study|Physician Decision|0
2452115|NCT02643628|8447495|P2|Overall Study|Relocated out of state|1
2452116|NCT02643628|8447496|P1|Overall Study|Relocated out of state|0
2452117|NCT02643628|8447495|P2|Overall Study|Withdrawal by Subject|1
2452118|NCT02643628|8447496|P1|Overall Study|Withdrawal by Subject|0
2452119|NCT02643628|8447495|P2|Overall Study|Lost to Follow-up|4
2452120|NCT02643628|8447496|P1|Overall Study|Lost to Follow-up|1
2452121|NCT02643472|8447527|P2|Overall Study|Lost to Follow-up|26
2452122|NCT02643472|8447528|P1|Overall Study|Lost to Follow-up|22
2452123|NCT02643472|8447527|P2|Overall Study|Protocol Violation|1
2452124|NCT02643472|8447528|P1|Overall Study|Protocol Violation|0
2452125|NCT02643472|8447527|P2|Overall Study|Withdrawal by Subject|2
2452126|NCT02643472|8447528|P1|Overall Study|Withdrawal by Subject|3
2452127|NCT02643472|8447527|P2|Overall Study|Death|5
2452128|NCT02643472|8447528|P1|Overall Study|Death|2
2452129|NCT02643394|8447554|P2|Overall Study|Protocol Violation|5
2452130|NCT02643394|8447555|P1|Overall Study|Protocol Violation|4
2452131|NCT02643355|8447565|P2|Overall Study|Protocol Violation|2
2452132|NCT02643355|8447566|P1|Overall Study|Protocol Violation|0
2452133|NCT02643355|8447565|P2|Overall Study|Withdrawal by Subject|3
2452134|NCT02643355|8447566|P1|Overall Study|Withdrawal by Subject|1
2452135|NCT02643251|8447580|P2|Overall Study|PI Decision to terminate patient|0
2452136|NCT02643251|8447581|P1|Overall Study|PI Decision to terminate patient|1
2452137|NCT02643251|8447580|P2|Overall Study|Protocol Violation|0
2452138|NCT02643251|8447581|P1|Overall Study|Protocol Violation|1
2452139|NCT02643251|8447580|P2|Overall Study|Lost to Follow-up|1
2452140|NCT02643251|8447581|P1|Overall Study|Lost to Follow-up|4
2452141|NCT02643251|8447580|P2|Overall Study|Withdrawal by Subject|0
2452142|NCT02643251|8447581|P1|Overall Study|Withdrawal by Subject|2
2452143|NCT02643251|8447580|P2|Overall Study|Adverse Event|1
2452144|NCT02643251|8447581|P1|Overall Study|Adverse Event|3
2452145|NCT02643082|8447613|P2|Period 1|Adverse Event|0
2452146|NCT02643082|8447614|P1|Period 1|Adverse Event|1
2452147|NCT02642965|8447672|P1|Overall Study|Physician Decision|9
2452148|NCT02642965|8447672|P1|Overall Study|Lack of Efficacy|4
2452149|NCT02642679|8447716|P1|Overall Study|Physician Decision|1
2452150|NCT02642679|8447716|P1|Overall Study|Physician Decision|1
2452151|NCT02642679|8447716|P1|Overall Study|Withdrawal by Subject|1
2452152|NCT02642653|8447724|P2|Overall Study|Adverse Event|0
2452153|NCT02642653|8447725|P1|Overall Study|Adverse Event|2
2452154|NCT02642614|8447766|P4|Overall Study|Withdrawal by Subject|0
2452155|NCT02642614|8447767|P3|Overall Study|Withdrawal by Subject|0
2452156|NCT02642614|8447768|P2|Overall Study|Withdrawal by Subject|1
2452157|NCT02642614|8447769|P1|Overall Study|Withdrawal by Subject|1
2452158|NCT02642614|8447766|P4|Overall Study|Lost to Follow-up|0
2452159|NCT02642614|8447767|P3|Overall Study|Lost to Follow-up|0
2452160|NCT02642614|8447768|P2|Overall Study|Lost to Follow-up|0
2452161|NCT02642614|8447769|P1|Overall Study|Lost to Follow-up|1
2452162|NCT02642614|8447766|P4|Overall Study|Adverse Event|2
2452163|NCT02642614|8447767|P3|Overall Study|Adverse Event|2
2452164|NCT02642614|8447768|P2|Overall Study|Adverse Event|1
2452165|NCT02642614|8447769|P1|Overall Study|Adverse Event|1
2452166|NCT02642432|8447836|P1|Overall Study|Other|3
2452167|NCT02642432|8447836|P1|Overall Study|Lost to Follow-up|2
2452168|NCT02642432|8447836|P1|Overall Study|Withdrew Consent|1
2452169|NCT02642432|8447836|P1|Overall Study|Adverse Event|2
2452170|NCT02642159|8447853|P2|Overall Study|Other than specified above|3
2452171|NCT02642159|8447854|P1|Overall Study|Other than specified above|10
2452172|NCT02642159|8447853|P2|Overall Study|Poor compliance to study protocol|0
2452173|NCT02642159|8447854|P1|Overall Study|Poor compliance to study protocol|1
2452174|NCT02642159|8447853|P2|Overall Study|Withdrawal by Subject|1
2452175|NCT02642159|8447854|P1|Overall Study|Withdrawal by Subject|9
2452176|NCT02642159|8447853|P2|Overall Study|Adverse Event|4
2452177|NCT02642159|8447854|P1|Overall Study|Adverse Event|10
2452178|NCT02642159|8447853|P2|Overall Study|Randomized but not treated|0
2452179|NCT02642159|8447854|P1|Overall Study|Randomized but not treated|1
2452180|NCT02641730|8447978|P5|Observational Period (Week 60 - Week 84)|Other|1
2452181|NCT02641730|8447979|P4|Observational Period (Week 60 - Week 84)|Other|0
2452182|NCT02641730|8447980|P3|Observational Period (Week 60 - Week 84)|Other|0
2452183|NCT02641730|8447981|P2|Observational Period (Week 60 - Week 84)|Other|0
2452184|NCT02641730|8447982|P1|Observational Period (Week 60 - Week 84)|Other|0
2452185|NCT02641730|8447978|P5|After Controlled Period (Week 16 – 52)|Other|1
2452186|NCT02641730|8447979|P4|After Controlled Period (Week 16 – 52)|Other|0
2452187|NCT02641730|8447980|P3|After Controlled Period (Week 16 – 52)|Other|1
2452188|NCT02641730|8447981|P2|After Controlled Period (Week 16 – 52)|Other|1
2452189|NCT02641730|8447982|P1|After Controlled Period (Week 16 – 52)|Other|0
2452190|NCT02641730|8447978|P5|After Controlled Period (Week 16 – 52)|Pregnancy|1
2452191|NCT02641730|8447979|P4|After Controlled Period (Week 16 – 52)|Pregnancy|1
2452192|NCT02641730|8447980|P3|After Controlled Period (Week 16 – 52)|Pregnancy|0
2452193|NCT02641730|8447981|P2|After Controlled Period (Week 16 – 52)|Pregnancy|0
2452194|NCT02641730|8447982|P1|After Controlled Period (Week 16 – 52)|Pregnancy|0
2452195|NCT02641730|8447978|P5|After Controlled Period (Week 16 – 52)|Lack of Efficacy|0
2452196|NCT02641730|8447979|P4|After Controlled Period (Week 16 – 52)|Lack of Efficacy|2
2452197|NCT02641730|8447980|P3|After Controlled Period (Week 16 – 52)|Lack of Efficacy|0
2452198|NCT02641730|8447981|P2|After Controlled Period (Week 16 – 52)|Lack of Efficacy|2
2452199|NCT02641730|8447982|P1|After Controlled Period (Week 16 – 52)|Lack of Efficacy|0
2452200|NCT02641730|8447978|P5|After Controlled Period (Week 16 – 52)|Adverse Event|4
2452201|NCT02641730|8447979|P4|After Controlled Period (Week 16 – 52)|Adverse Event|5
2452202|NCT02641730|8447980|P3|After Controlled Period (Week 16 – 52)|Adverse Event|1
2452203|NCT02641730|8447981|P2|After Controlled Period (Week 16 – 52)|Adverse Event|1
2452204|NCT02641730|8447982|P1|After Controlled Period (Week 16 – 52)|Adverse Event|0
2452205|NCT02641730|8447978|P5|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2
2452206|NCT02641730|8447979|P4|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1
2452207|NCT02641730|8447980|P3|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
2452208|NCT02641730|8447981|P2|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
2452209|NCT02641730|8447982|P1|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2
2452210|NCT02641587|8448086|P2|Ambulatory Period|Withdrawal by Subject|0
2452211|NCT02641587|8448087|P1|Ambulatory Period|Withdrawal by Subject|1
2452212|NCT02641587|8448086|P2|Confinement Period|Withdrawal by Subject|1
2452213|NCT02641587|8448087|P1|Confinement Period|Withdrawal by Subject|2
2452214|NCT02641587|8448086|P2|Confinement Period|Adverse Event|0
2452215|NCT02641587|8448087|P1|Confinement Period|Adverse Event|1
2452216|NCT02641392|8448208|P3|Overall Study|Death|1
2452217|NCT02641392|8448209|P2|Overall Study|Death|0
2452218|NCT02641392|8448210|P1|Overall Study|Death|0
2452219|NCT02641392|8448208|P3|Overall Study|Miscellaneous|3
2452220|NCT02641392|8448209|P2|Overall Study|Miscellaneous|0
2452221|NCT02641392|8448210|P1|Overall Study|Miscellaneous|0
2452222|NCT02641392|8448208|P3|Overall Study|Lack of Efficacy|101
2452223|NCT02641392|8448209|P2|Overall Study|Lack of Efficacy|0
2452224|NCT02641392|8448210|P1|Overall Study|Lack of Efficacy|0
2452225|NCT02641392|8448208|P3|Overall Study|Study Terminated by Sponsor|144
2452226|NCT02641392|8448209|P2|Overall Study|Study Terminated by Sponsor|12
2452227|NCT02641392|8448210|P1|Overall Study|Study Terminated by Sponsor|4
2452228|NCT02641392|8448208|P3|Overall Study|Adverse Event|25
2452229|NCT02641392|8448209|P2|Overall Study|Adverse Event|1
2452230|NCT02641392|8448210|P1|Overall Study|Adverse Event|0
2452231|NCT02641392|8448208|P3|Overall Study|Withdrawal by Subject|17
2452232|NCT02641392|8448209|P2|Overall Study|Withdrawal by Subject|0
2452233|NCT02641392|8448210|P1|Overall Study|Withdrawal by Subject|0
2452234|NCT02641392|8448208|P3|Overall Study|Lost to Follow-up|2
2452235|NCT02641392|8448209|P2|Overall Study|Lost to Follow-up|0
2452236|NCT02641392|8448210|P1|Overall Study|Lost to Follow-up|0
2452237|NCT02641379|8448229|P11|Overall Study|PCR positive|0
2452238|NCT02641379|8448230|P10|Overall Study|PCR positive|0
2452239|NCT02641379|8448231|P9|Overall Study|PCR positive|0
2452240|NCT02641379|8448232|P8|Overall Study|PCR positive|0
2452241|NCT02641379|8448233|P7|Overall Study|PCR positive|1
2452242|NCT02641379|8448234|P6|Overall Study|PCR positive|0
2452243|NCT02641379|8448235|P5|Overall Study|PCR positive|0
2452244|NCT02641379|8448236|P4|Overall Study|PCR positive|0
2452245|NCT02641379|8448237|P3|Overall Study|PCR positive|0
2452246|NCT02641379|8448238|P2|Overall Study|PCR positive|0
2452247|NCT02641379|8448239|P1|Overall Study|PCR positive|0
2452248|NCT02641379|8448229|P11|Overall Study|Missing PCR result at Week 8|0
2452249|NCT02641379|8448230|P10|Overall Study|Missing PCR result at Week 8|1
2452250|NCT02641379|8448231|P9|Overall Study|Missing PCR result at Week 8|0
2452251|NCT02641379|8448232|P8|Overall Study|Missing PCR result at Week 8|0
2452252|NCT02641379|8448233|P7|Overall Study|Missing PCR result at Week 8|0
2452253|NCT02641379|8448234|P6|Overall Study|Missing PCR result at Week 8|0
2452254|NCT02641379|8448235|P5|Overall Study|Missing PCR result at Week 8|0
2452255|NCT02641379|8448236|P4|Overall Study|Missing PCR result at Week 8|0
2452256|NCT02641379|8448237|P3|Overall Study|Missing PCR result at Week 8|0
2452257|NCT02641379|8448238|P2|Overall Study|Missing PCR result at Week 8|0
2452258|NCT02641379|8448239|P1|Overall Study|Missing PCR result at Week 8|0
2452259|NCT02641379|8448229|P11|Overall Study|Participant treated after Week 24|0
2452260|NCT02641379|8448230|P10|Overall Study|Participant treated after Week 24|0
2452261|NCT02641379|8448231|P9|Overall Study|Participant treated after Week 24|1
2452262|NCT02641379|8448232|P8|Overall Study|Participant treated after Week 24|0
2452263|NCT02641379|8448233|P7|Overall Study|Participant treated after Week 24|0
2452264|NCT02641379|8448234|P6|Overall Study|Participant treated after Week 24|0
2452265|NCT02641379|8448235|P5|Overall Study|Participant treated after Week 24|0
2452266|NCT02641379|8448236|P4|Overall Study|Participant treated after Week 24|0
2452267|NCT02641379|8448237|P3|Overall Study|Participant treated after Week 24|0
2452268|NCT02641379|8448238|P2|Overall Study|Participant treated after Week 24|0
2452269|NCT02641379|8448239|P1|Overall Study|Participant treated after Week 24|0
2452270|NCT02641379|8448229|P11|Overall Study|Participant’s PCR high|0
2452271|NCT02641379|8448230|P10|Overall Study|Participant’s PCR high|0
2452272|NCT02641379|8448231|P9|Overall Study|Participant’s PCR high|0
2452273|NCT02641379|8448232|P8|Overall Study|Participant’s PCR high|1
2452274|NCT02641379|8448233|P7|Overall Study|Participant’s PCR high|0
2452275|NCT02641379|8448234|P6|Overall Study|Participant’s PCR high|0
2452276|NCT02641379|8448235|P5|Overall Study|Participant’s PCR high|0
2452277|NCT02641379|8448236|P4|Overall Study|Participant’s PCR high|0
2452278|NCT02641379|8448237|P3|Overall Study|Participant’s PCR high|0
2452279|NCT02641379|8448238|P2|Overall Study|Participant’s PCR high|0
2452280|NCT02641379|8448239|P1|Overall Study|Participant’s PCR high|0
2452281|NCT02641379|8448229|P11|Overall Study|Negative PCR result|0
2452282|NCT02641379|8448230|P10|Overall Study|Negative PCR result|1
2452283|NCT02641379|8448231|P9|Overall Study|Negative PCR result|0
2452284|NCT02641379|8448232|P8|Overall Study|Negative PCR result|0
2452285|NCT02641379|8448233|P7|Overall Study|Negative PCR result|0
2452286|NCT02641379|8448234|P6|Overall Study|Negative PCR result|0
2452287|NCT02641379|8448235|P5|Overall Study|Negative PCR result|0
2452288|NCT02641379|8448236|P4|Overall Study|Negative PCR result|0
2452289|NCT02641379|8448237|P3|Overall Study|Negative PCR result|0
2452290|NCT02641379|8448238|P2|Overall Study|Negative PCR result|0
2452291|NCT02641379|8448239|P1|Overall Study|Negative PCR result|0
2452292|NCT02641379|8448229|P11|Overall Study|No 2 Log drop at Week 12|1
2452293|NCT02641379|8448230|P10|Overall Study|No 2 Log drop at Week 12|0
2452294|NCT02641379|8448231|P9|Overall Study|No 2 Log drop at Week 12|0
2452295|NCT02641379|8448232|P8|Overall Study|No 2 Log drop at Week 12|0
2452296|NCT02641379|8448233|P7|Overall Study|No 2 Log drop at Week 12|0
2452297|NCT02641379|8448234|P6|Overall Study|No 2 Log drop at Week 12|0
2452298|NCT02641379|8448235|P5|Overall Study|No 2 Log drop at Week 12|0
2452299|NCT02641379|8448236|P4|Overall Study|No 2 Log drop at Week 12|0
2452300|NCT02641379|8448237|P3|Overall Study|No 2 Log drop at Week 12|0
2452301|NCT02641379|8448238|P2|Overall Study|No 2 Log drop at Week 12|0
2452302|NCT02641379|8448239|P1|Overall Study|No 2 Log drop at Week 12|0
2452303|NCT02641379|8448229|P11|Overall Study|Non-response Week 12|0
2452304|NCT02641379|8448230|P10|Overall Study|Non-response Week 12|0
2452305|NCT02641379|8448231|P9|Overall Study|Non-response Week 12|0
2452306|NCT02641379|8448232|P8|Overall Study|Non-response Week 12|1
2452307|NCT02641379|8448233|P7|Overall Study|Non-response Week 12|0
2452308|NCT02641379|8448234|P6|Overall Study|Non-response Week 12|0
2452309|NCT02641379|8448235|P5|Overall Study|Non-response Week 12|0
2452310|NCT02641379|8448236|P4|Overall Study|Non-response Week 12|0
2452311|NCT02641379|8448237|P3|Overall Study|Non-response Week 12|0
2452312|NCT02641379|8448238|P2|Overall Study|Non-response Week 12|0
2452313|NCT02641379|8448239|P1|Overall Study|Non-response Week 12|0
2452314|NCT02641379|8448229|P11|Overall Study|Participant showed weight reduction|0
2452315|NCT02641379|8448230|P10|Overall Study|Participant showed weight reduction|0
2452316|NCT02641379|8448231|P9|Overall Study|Participant showed weight reduction|0
2452317|NCT02641379|8448232|P8|Overall Study|Participant showed weight reduction|1
2452318|NCT02641379|8448233|P7|Overall Study|Participant showed weight reduction|0
2452319|NCT02641379|8448234|P6|Overall Study|Participant showed weight reduction|0
2452320|NCT02641379|8448235|P5|Overall Study|Participant showed weight reduction|0
2452321|NCT02641379|8448236|P4|Overall Study|Participant showed weight reduction|0
2452322|NCT02641379|8448237|P3|Overall Study|Participant showed weight reduction|0
2452323|NCT02641379|8448238|P2|Overall Study|Participant showed weight reduction|0
2452324|NCT02641379|8448239|P1|Overall Study|Participant showed weight reduction|0
2452325|NCT02641379|8448229|P11|Overall Study|Source data not found|0
2452326|NCT02641379|8448230|P10|Overall Study|Source data not found|0
2452327|NCT02641379|8448231|P9|Overall Study|Source data not found|0
2452328|NCT02641379|8448232|P8|Overall Study|Source data not found|0
2452329|NCT02641379|8448233|P7|Overall Study|Source data not found|0
2452330|NCT02641379|8448234|P6|Overall Study|Source data not found|1
2452331|NCT02641379|8448235|P5|Overall Study|Source data not found|0
2452332|NCT02641379|8448236|P4|Overall Study|Source data not found|0
2452333|NCT02641379|8448237|P3|Overall Study|Source data not found|0
2452334|NCT02641379|8448238|P2|Overall Study|Source data not found|0
2452335|NCT02641379|8448239|P1|Overall Study|Source data not found|0
2452336|NCT02641379|8448229|P11|Overall Study|Lost to Follow-up|0
2452337|NCT02641379|8448230|P10|Overall Study|Lost to Follow-up|0
2452338|NCT02641379|8448231|P9|Overall Study|Lost to Follow-up|1
2452339|NCT02641379|8448232|P8|Overall Study|Lost to Follow-up|0
2452340|NCT02641379|8448233|P7|Overall Study|Lost to Follow-up|0
2452341|NCT02641379|8448234|P6|Overall Study|Lost to Follow-up|0
2452342|NCT02641379|8448235|P5|Overall Study|Lost to Follow-up|0
2452343|NCT02641379|8448236|P4|Overall Study|Lost to Follow-up|0
2452344|NCT02641379|8448237|P3|Overall Study|Lost to Follow-up|0
2452345|NCT02641379|8448238|P2|Overall Study|Lost to Follow-up|0
2452346|NCT02641379|8448239|P1|Overall Study|Lost to Follow-up|0
2452347|NCT02641379|8448229|P11|Overall Study|Participation in sili rescue study|0
2452348|NCT02641379|8448230|P10|Overall Study|Participation in sili rescue study|0
2452349|NCT02641379|8448231|P9|Overall Study|Participation in sili rescue study|0
2452350|NCT02641379|8448232|P8|Overall Study|Participation in sili rescue study|0
2452351|NCT02641379|8448233|P7|Overall Study|Participation in sili rescue study|0
2452352|NCT02641379|8448234|P6|Overall Study|Participation in sili rescue study|1
2452353|NCT02641379|8448235|P5|Overall Study|Participation in sili rescue study|0
2452354|NCT02641379|8448236|P4|Overall Study|Participation in sili rescue study|0
2452355|NCT02641379|8448237|P3|Overall Study|Participation in sili rescue study|0
2452356|NCT02641379|8448238|P2|Overall Study|Participation in sili rescue study|0
2452357|NCT02641379|8448239|P1|Overall Study|Participation in sili rescue study|0
2452358|NCT02641379|8448229|P11|Overall Study|Protocol Violation|0
2452359|NCT02641379|8448230|P10|Overall Study|Protocol Violation|0
2452360|NCT02641379|8448231|P9|Overall Study|Protocol Violation|1
2452361|NCT02641379|8448232|P8|Overall Study|Protocol Violation|0
2452362|NCT02641379|8448233|P7|Overall Study|Protocol Violation|0
2452363|NCT02641379|8448234|P6|Overall Study|Protocol Violation|0
2452364|NCT02641379|8448235|P5|Overall Study|Protocol Violation|2
2452365|NCT02641379|8448236|P4|Overall Study|Protocol Violation|0
2452366|NCT02641379|8448237|P3|Overall Study|Protocol Violation|0
2452367|NCT02641379|8448238|P2|Overall Study|Protocol Violation|0
2452368|NCT02641379|8448239|P1|Overall Study|Protocol Violation|0
2452369|NCT02641379|8448229|P11|Overall Study|Blood could not be drawn|0
2452370|NCT02641379|8448230|P10|Overall Study|Blood could not be drawn|0
2452371|NCT02641379|8448231|P9|Overall Study|Blood could not be drawn|0
2452372|NCT02641379|8448232|P8|Overall Study|Blood could not be drawn|0
2452373|NCT02641379|8448233|P7|Overall Study|Blood could not be drawn|0
2452374|NCT02641379|8448234|P6|Overall Study|Blood could not be drawn|0
2452375|NCT02641379|8448235|P5|Overall Study|Blood could not be drawn|1
2452376|NCT02641379|8448236|P4|Overall Study|Blood could not be drawn|0
2452377|NCT02641379|8448237|P3|Overall Study|Blood could not be drawn|0
2452378|NCT02641379|8448238|P2|Overall Study|Blood could not be drawn|0
2452379|NCT02641379|8448239|P1|Overall Study|Blood could not be drawn|0
2452380|NCT02641379|8448229|P11|Overall Study|Baseline viral load unavailable|0
2452381|NCT02641379|8448230|P10|Overall Study|Baseline viral load unavailable|0
2452382|NCT02641379|8448231|P9|Overall Study|Baseline viral load unavailable|0
2452383|NCT02641379|8448232|P8|Overall Study|Baseline viral load unavailable|0
2452384|NCT02641379|8448233|P7|Overall Study|Baseline viral load unavailable|0
2452385|NCT02641379|8448234|P6|Overall Study|Baseline viral load unavailable|0
2452386|NCT02641379|8448235|P5|Overall Study|Baseline viral load unavailable|0
2452387|NCT02641379|8448236|P4|Overall Study|Baseline viral load unavailable|1
2452388|NCT02641379|8448237|P3|Overall Study|Baseline viral load unavailable|0
2452389|NCT02641379|8448238|P2|Overall Study|Baseline viral load unavailable|0
2452390|NCT02641379|8448239|P1|Overall Study|Baseline viral load unavailable|0
2452391|NCT02641379|8448229|P11|Overall Study|Inclusion criteria not fulfilled|0
2452392|NCT02641379|8448230|P10|Overall Study|Inclusion criteria not fulfilled|0
2452393|NCT02641379|8448231|P9|Overall Study|Inclusion criteria not fulfilled|0
2452394|NCT02641379|8448232|P8|Overall Study|Inclusion criteria not fulfilled|0
2452395|NCT02641379|8448233|P7|Overall Study|Inclusion criteria not fulfilled|0
2452396|NCT02641379|8448234|P6|Overall Study|Inclusion criteria not fulfilled|0
2452397|NCT02641379|8448235|P5|Overall Study|Inclusion criteria not fulfilled|0
2452398|NCT02641379|8448236|P4|Overall Study|Inclusion criteria not fulfilled|1
2452399|NCT02641379|8448237|P3|Overall Study|Inclusion criteria not fulfilled|0
2452400|NCT02641379|8448238|P2|Overall Study|Inclusion criteria not fulfilled|0
2452401|NCT02641379|8448239|P1|Overall Study|Inclusion criteria not fulfilled|0
2452402|NCT02641379|8448229|P11|Overall Study|PCR sample for Week 4 not drawn|0
2452403|NCT02641379|8448230|P10|Overall Study|PCR sample for Week 4 not drawn|0
2452404|NCT02641379|8448231|P9|Overall Study|PCR sample for Week 4 not drawn|0
2452405|NCT02641379|8448232|P8|Overall Study|PCR sample for Week 4 not drawn|0
2452406|NCT02641379|8448233|P7|Overall Study|PCR sample for Week 4 not drawn|0
2452407|NCT02641379|8448234|P6|Overall Study|PCR sample for Week 4 not drawn|0
2452408|NCT02641379|8448235|P5|Overall Study|PCR sample for Week 4 not drawn|0
2452409|NCT02641379|8448236|P4|Overall Study|PCR sample for Week 4 not drawn|1
2452410|NCT02641379|8448237|P3|Overall Study|PCR sample for Week 4 not drawn|0
2452411|NCT02641379|8448238|P2|Overall Study|PCR sample for Week 4 not drawn|0
2452412|NCT02641379|8448239|P1|Overall Study|PCR sample for Week 4 not drawn|0
2452413|NCT02641379|8448229|P11|Overall Study|PCR positive at Week 28|0
2452414|NCT02641379|8448230|P10|Overall Study|PCR positive at Week 28|0
2452415|NCT02641379|8448231|P9|Overall Study|PCR positive at Week 28|0
2452416|NCT02641379|8448232|P8|Overall Study|PCR positive at Week 28|0
2452417|NCT02641379|8448233|P7|Overall Study|PCR positive at Week 28|0
2452418|NCT02641379|8448234|P6|Overall Study|PCR positive at Week 28|0
2452419|NCT02641379|8448235|P5|Overall Study|PCR positive at Week 28|0
2452420|NCT02641379|8448236|P4|Overall Study|PCR positive at Week 28|0
2452421|NCT02641379|8448237|P3|Overall Study|PCR positive at Week 28|1
2452422|NCT02641379|8448238|P2|Overall Study|PCR positive at Week 28|0
2452423|NCT02641379|8448239|P1|Overall Study|PCR positive at Week 28|0
2452424|NCT02641379|8448229|P11|Overall Study|No PCR at baseline|0
2452425|NCT02641379|8448230|P10|Overall Study|No PCR at baseline|0
2452426|NCT02641379|8448231|P9|Overall Study|No PCR at baseline|0
2452427|NCT02641379|8448232|P8|Overall Study|No PCR at baseline|0
2452428|NCT02641379|8448233|P7|Overall Study|No PCR at baseline|0
2452429|NCT02641379|8448234|P6|Overall Study|No PCR at baseline|0
2452430|NCT02641379|8448235|P5|Overall Study|No PCR at baseline|0
2452431|NCT02641379|8448236|P4|Overall Study|No PCR at baseline|0
2452432|NCT02641379|8448237|P3|Overall Study|No PCR at baseline|1
2452433|NCT02641379|8448238|P2|Overall Study|No PCR at baseline|0
2452434|NCT02641379|8448239|P1|Overall Study|No PCR at baseline|0
2452435|NCT02641379|8448229|P11|Overall Study|PCR not performed at Week 12|0
2452436|NCT02641379|8448230|P10|Overall Study|PCR not performed at Week 12|0
2452437|NCT02641379|8448231|P9|Overall Study|PCR not performed at Week 12|0
2452438|NCT02641379|8448232|P8|Overall Study|PCR not performed at Week 12|0
2452439|NCT02641379|8448233|P7|Overall Study|PCR not performed at Week 12|0
2452440|NCT02641379|8448234|P6|Overall Study|PCR not performed at Week 12|0
2452441|NCT02641379|8448235|P5|Overall Study|PCR not performed at Week 12|0
2452442|NCT02641379|8448236|P4|Overall Study|PCR not performed at Week 12|0
2452443|NCT02641379|8448237|P3|Overall Study|PCR not performed at Week 12|1
2452444|NCT02641379|8448238|P2|Overall Study|PCR not performed at Week 12|0
2452445|NCT02641379|8448239|P1|Overall Study|PCR not performed at Week 12|0
2452446|NCT02641379|8448229|P11|Overall Study|PCR positive at Week 48|0
2452447|NCT02641379|8448230|P10|Overall Study|PCR positive at Week 48|0
2452448|NCT02641379|8448231|P9|Overall Study|PCR positive at Week 48|0
2452449|NCT02641379|8448232|P8|Overall Study|PCR positive at Week 48|0
2452450|NCT02641379|8448233|P7|Overall Study|PCR positive at Week 48|0
2452451|NCT02641379|8448234|P6|Overall Study|PCR positive at Week 48|0
2452452|NCT02641379|8448235|P5|Overall Study|PCR positive at Week 48|0
2452453|NCT02641379|8448236|P4|Overall Study|PCR positive at Week 48|0
2452454|NCT02641379|8448237|P3|Overall Study|PCR positive at Week 48|0
2452455|NCT02641379|8448238|P2|Overall Study|PCR positive at Week 48|1
2452456|NCT02641379|8448239|P1|Overall Study|PCR positive at Week 48|0
2452457|NCT02641379|8448229|P11|Overall Study|PCR positive at Week 68|0
2452458|NCT02641379|8448230|P10|Overall Study|PCR positive at Week 68|0
2452459|NCT02641379|8448231|P9|Overall Study|PCR positive at Week 68|0
2452460|NCT02641379|8448232|P8|Overall Study|PCR positive at Week 68|0
2452461|NCT02641379|8448233|P7|Overall Study|PCR positive at Week 68|0
2452462|NCT02641379|8448234|P6|Overall Study|PCR positive at Week 68|0
2452463|NCT02641379|8448235|P5|Overall Study|PCR positive at Week 68|0
2452464|NCT02641379|8448236|P4|Overall Study|PCR positive at Week 68|0
2452465|NCT02641379|8448237|P3|Overall Study|PCR positive at Week 68|0
2452466|NCT02641379|8448238|P2|Overall Study|PCR positive at Week 68|1
2452467|NCT02641379|8448239|P1|Overall Study|PCR positive at Week 68|0
2452468|NCT02641379|8448229|P11|Overall Study|Financial problems|0
2452469|NCT02641379|8448230|P10|Overall Study|Financial problems|0
2452470|NCT02641379|8448231|P9|Overall Study|Financial problems|0
2452471|NCT02641379|8448232|P8|Overall Study|Financial problems|0
2452472|NCT02641379|8448233|P7|Overall Study|Financial problems|0
2452473|NCT02641379|8448234|P6|Overall Study|Financial problems|0
2452474|NCT02641379|8448235|P5|Overall Study|Financial problems|0
2452475|NCT02641379|8448236|P4|Overall Study|Financial problems|0
2452476|NCT02641379|8448237|P3|Overall Study|Financial problems|0
2452477|NCT02641379|8448238|P2|Overall Study|Financial problems|1
2452478|NCT02641379|8448239|P1|Overall Study|Financial problems|0
2452479|NCT02641379|8448229|P11|Overall Study|Therapy stopped due to misunderstanding|0
2452480|NCT02641379|8448230|P10|Overall Study|Therapy stopped due to misunderstanding|0
2452481|NCT02641379|8448231|P9|Overall Study|Therapy stopped due to misunderstanding|0
2452482|NCT02641379|8448232|P8|Overall Study|Therapy stopped due to misunderstanding|0
2452483|NCT02641379|8448233|P7|Overall Study|Therapy stopped due to misunderstanding|0
2452484|NCT02641379|8448234|P6|Overall Study|Therapy stopped due to misunderstanding|0
2452485|NCT02641379|8448235|P5|Overall Study|Therapy stopped due to misunderstanding|0
2452486|NCT02641379|8448236|P4|Overall Study|Therapy stopped due to misunderstanding|0
2452487|NCT02641379|8448237|P3|Overall Study|Therapy stopped due to misunderstanding|0
2452488|NCT02641379|8448238|P2|Overall Study|Therapy stopped due to misunderstanding|0
2452489|NCT02641379|8448239|P1|Overall Study|Therapy stopped due to misunderstanding|1
2452490|NCT02641379|8448229|P11|Overall Study|Participant stopped study/treatment|0
2452491|NCT02641379|8448230|P10|Overall Study|Participant stopped study/treatment|0
2452492|NCT02641379|8448231|P9|Overall Study|Participant stopped study/treatment|1
2452493|NCT02641379|8448232|P8|Overall Study|Participant stopped study/treatment|0
2452494|NCT02641379|8448233|P7|Overall Study|Participant stopped study/treatment|2
2452495|NCT02641379|8448234|P6|Overall Study|Participant stopped study/treatment|1
2452496|NCT02641379|8448235|P5|Overall Study|Participant stopped study/treatment|0
2452497|NCT02641379|8448236|P4|Overall Study|Participant stopped study/treatment|0
2452498|NCT02641379|8448237|P3|Overall Study|Participant stopped study/treatment|1
2452499|NCT02641379|8448238|P2|Overall Study|Participant stopped study/treatment|3
2452500|NCT02641379|8448239|P1|Overall Study|Participant stopped study/treatment|1
2452501|NCT02641379|8448229|P11|Overall Study|Participant showed relapse|0
2452502|NCT02641379|8448230|P10|Overall Study|Participant showed relapse|0
2452503|NCT02641379|8448231|P9|Overall Study|Participant showed relapse|0
2452504|NCT02641379|8448232|P8|Overall Study|Participant showed relapse|0
2452505|NCT02641379|8448233|P7|Overall Study|Participant showed relapse|1
2452506|NCT02641379|8448234|P6|Overall Study|Participant showed relapse|0
2452507|NCT02641379|8448235|P5|Overall Study|Participant showed relapse|0
2452508|NCT02641379|8448236|P4|Overall Study|Participant showed relapse|0
2452509|NCT02641379|8448237|P3|Overall Study|Participant showed relapse|0
2452510|NCT02641379|8448238|P2|Overall Study|Participant showed relapse|0
2452511|NCT02641379|8448239|P1|Overall Study|Participant showed relapse|1
2452512|NCT02641379|8448229|P11|Overall Study|PCR positive at follow up 2|0
2452513|NCT02641379|8448230|P10|Overall Study|PCR positive at follow up 2|0
2452514|NCT02641379|8448231|P9|Overall Study|PCR positive at follow up 2|0
2452515|NCT02641379|8448232|P8|Overall Study|PCR positive at follow up 2|0
2452516|NCT02641379|8448233|P7|Overall Study|PCR positive at follow up 2|0
2452517|NCT02641379|8448234|P6|Overall Study|PCR positive at follow up 2|0
2452518|NCT02641379|8448235|P5|Overall Study|PCR positive at follow up 2|0
2452519|NCT02641379|8448236|P4|Overall Study|PCR positive at follow up 2|0
2452520|NCT02641379|8448237|P3|Overall Study|PCR positive at follow up 2|0
2452521|NCT02641379|8448238|P2|Overall Study|PCR positive at follow up 2|0
2452522|NCT02641379|8448239|P1|Overall Study|PCR positive at follow up 2|1
2452523|NCT02641379|8448229|P11|Overall Study|PCR positive at Week 24|0
2452524|NCT02641379|8448230|P10|Overall Study|PCR positive at Week 24|1
2452525|NCT02641379|8448231|P9|Overall Study|PCR positive at Week 24|0
2452526|NCT02641379|8448232|P8|Overall Study|PCR positive at Week 24|8
2452527|NCT02641379|8448233|P7|Overall Study|PCR positive at Week 24|3
2452528|NCT02641379|8448234|P6|Overall Study|PCR positive at Week 24|6
2452529|NCT02641379|8448235|P5|Overall Study|PCR positive at Week 24|0
2452530|NCT02641379|8448236|P4|Overall Study|PCR positive at Week 24|0
2452531|NCT02641379|8448237|P3|Overall Study|PCR positive at Week 24|62
2452532|NCT02641379|8448238|P2|Overall Study|PCR positive at Week 24|21
2452533|NCT02641379|8448239|P1|Overall Study|PCR positive at Week 24|15
2452534|NCT02641379|8448229|P11|Overall Study|Participant cannot be reached|1
2452535|NCT02641379|8448230|P10|Overall Study|Participant cannot be reached|2
2452536|NCT02641379|8448231|P9|Overall Study|Participant cannot be reached|0
2452537|NCT02641379|8448232|P8|Overall Study|Participant cannot be reached|1
2452538|NCT02641379|8448233|P7|Overall Study|Participant cannot be reached|0
2452539|NCT02641379|8448234|P6|Overall Study|Participant cannot be reached|1
2452540|NCT02641379|8448235|P5|Overall Study|Participant cannot be reached|2
2452541|NCT02641379|8448236|P4|Overall Study|Participant cannot be reached|8
2452542|NCT02641379|8448237|P3|Overall Study|Participant cannot be reached|0
2452543|NCT02641379|8448238|P2|Overall Study|Participant cannot be reached|4
2452544|NCT02641379|8448239|P1|Overall Study|Participant cannot be reached|4
2452545|NCT02641379|8448229|P11|Overall Study|Participant’s compliance|1
2452546|NCT02641379|8448230|P10|Overall Study|Participant’s compliance|1
2452547|NCT02641379|8448231|P9|Overall Study|Participant’s compliance|1
2452548|NCT02641379|8448232|P8|Overall Study|Participant’s compliance|0
2452549|NCT02641379|8448233|P7|Overall Study|Participant’s compliance|0
2452550|NCT02641379|8448234|P6|Overall Study|Participant’s compliance|2
2452551|NCT02641379|8448235|P5|Overall Study|Participant’s compliance|0
2452552|NCT02641379|8448236|P4|Overall Study|Participant’s compliance|1
2452553|NCT02641379|8448237|P3|Overall Study|Participant’s compliance|0
2452554|NCT02641379|8448238|P2|Overall Study|Participant’s compliance|1
2452555|NCT02641379|8448239|P1|Overall Study|Participant’s compliance|0
2452556|NCT02641379|8448229|P11|Overall Study|Participant unable to attend study visit|0
2452557|NCT02641379|8448230|P10|Overall Study|Participant unable to attend study visit|2
2452558|NCT02641379|8448231|P9|Overall Study|Participant unable to attend study visit|0
2452559|NCT02641379|8448232|P8|Overall Study|Participant unable to attend study visit|1
2452560|NCT02641379|8448233|P7|Overall Study|Participant unable to attend study visit|1
2452561|NCT02641379|8448234|P6|Overall Study|Participant unable to attend study visit|1
2452562|NCT02641379|8448235|P5|Overall Study|Participant unable to attend study visit|5
2452563|NCT02641379|8448236|P4|Overall Study|Participant unable to attend study visit|2
2452564|NCT02641379|8448237|P3|Overall Study|Participant unable to attend study visit|1
2452565|NCT02641379|8448238|P2|Overall Study|Participant unable to attend study visit|10
2452566|NCT02641379|8448239|P1|Overall Study|Participant unable to attend study visit|4
2452567|NCT02641379|8448229|P11|Overall Study|Lack of Efficacy|0
2452568|NCT02641379|8448230|P10|Overall Study|Lack of Efficacy|0
2452569|NCT02641379|8448231|P9|Overall Study|Lack of Efficacy|0
2452570|NCT02641379|8448232|P8|Overall Study|Lack of Efficacy|5
2452571|NCT02641379|8448233|P7|Overall Study|Lack of Efficacy|0
2452572|NCT02641379|8448234|P6|Overall Study|Lack of Efficacy|2
2452573|NCT02641379|8448235|P5|Overall Study|Lack of Efficacy|0
2452574|NCT02641379|8448236|P4|Overall Study|Lack of Efficacy|0
2452575|NCT02641379|8448237|P3|Overall Study|Lack of Efficacy|2
2452576|NCT02641379|8448238|P2|Overall Study|Lack of Efficacy|0
2452577|NCT02641379|8448239|P1|Overall Study|Lack of Efficacy|0
2452578|NCT02641379|8448229|P11|Overall Study|Adverse Event|5
2452579|NCT02641379|8448230|P10|Overall Study|Adverse Event|1
2452580|NCT02641379|8448231|P9|Overall Study|Adverse Event|1
2452581|NCT02641379|8448232|P8|Overall Study|Adverse Event|0
2452582|NCT02641379|8448233|P7|Overall Study|Adverse Event|5
2452583|NCT02641379|8448234|P6|Overall Study|Adverse Event|1
2452584|NCT02641379|8448235|P5|Overall Study|Adverse Event|5
2452585|NCT02641379|8448236|P4|Overall Study|Adverse Event|2
2452586|NCT02641379|8448237|P3|Overall Study|Adverse Event|2
2452587|NCT02641379|8448238|P2|Overall Study|Adverse Event|8
2452588|NCT02641379|8448239|P1|Overall Study|Adverse Event|7
2452589|NCT02641379|8448229|P11|Overall Study|Withdrawal of informed consent|0
2452590|NCT02641379|8448230|P10|Overall Study|Withdrawal of informed consent|0
2452591|NCT02641379|8448231|P9|Overall Study|Withdrawal of informed consent|0
2452592|NCT02641379|8448232|P8|Overall Study|Withdrawal of informed consent|1
2452593|NCT02641379|8448233|P7|Overall Study|Withdrawal of informed consent|0
2452594|NCT02641379|8448234|P6|Overall Study|Withdrawal of informed consent|0
2452595|NCT02641379|8448235|P5|Overall Study|Withdrawal of informed consent|0
2452596|NCT02641379|8448236|P4|Overall Study|Withdrawal of informed consent|0
2452597|NCT02641379|8448237|P3|Overall Study|Withdrawal of informed consent|0
2452598|NCT02641379|8448238|P2|Overall Study|Withdrawal of informed consent|1
2452599|NCT02641379|8448239|P1|Overall Study|Withdrawal of informed consent|0
2452600|NCT02641379|8448229|P11|Overall Study|Exclusion criterion during screening|0
2452601|NCT02641379|8448230|P10|Overall Study|Exclusion criterion during screening|0
2452602|NCT02641379|8448231|P9|Overall Study|Exclusion criterion during screening|0
2452603|NCT02641379|8448232|P8|Overall Study|Exclusion criterion during screening|0
2452604|NCT02641379|8448233|P7|Overall Study|Exclusion criterion during screening|0
2452605|NCT02641379|8448234|P6|Overall Study|Exclusion criterion during screening|0
2452606|NCT02641379|8448235|P5|Overall Study|Exclusion criterion during screening|2
2452607|NCT02641379|8448236|P4|Overall Study|Exclusion criterion during screening|1
2452608|NCT02641379|8448237|P3|Overall Study|Exclusion criterion during screening|0
2452609|NCT02641379|8448238|P2|Overall Study|Exclusion criterion during screening|0
2452610|NCT02641379|8448239|P1|Overall Study|Exclusion criterion during screening|1
2452611|NCT02640755|8448338|P2|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0
2452612|NCT02640755|8448339|P1|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1
2452613|NCT02640755|8448338|P2|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0
2452614|NCT02640755|8448339|P1|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1
2452615|NCT02640755|8448338|P2|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1
2452616|NCT02640755|8448339|P1|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0
2452617|NCT02640625|8448374|P1|Overall Study|Adverse Event|1
2452618|NCT02640612|8448383|P3|Overall Study|Lack of Efficacy|0
2452619|NCT02640612|8448384|P2|Overall Study|Lack of Efficacy|1
2452620|NCT02640612|8448385|P1|Overall Study|Lack of Efficacy|1
2452621|NCT02640612|8448383|P3|Overall Study|Protocol Violation|0
2452622|NCT02640612|8448384|P2|Overall Study|Protocol Violation|2
2452623|NCT02640612|8448385|P1|Overall Study|Protocol Violation|0
2452624|NCT02640612|8448383|P3|Overall Study|Lost to Follow-up|1
2452625|NCT02640612|8448384|P2|Overall Study|Lost to Follow-up|1
2452626|NCT02640612|8448385|P1|Overall Study|Lost to Follow-up|4
2452627|NCT02640612|8448383|P3|Overall Study|Withdrawal by Subject|3
2452628|NCT02640612|8448384|P2|Overall Study|Withdrawal by Subject|3
2452629|NCT02640612|8448385|P1|Overall Study|Withdrawal by Subject|10
2452630|NCT02640612|8448383|P3|Overall Study|Death|0
2452631|NCT02640612|8448384|P2|Overall Study|Death|0
2452632|NCT02640612|8448385|P1|Overall Study|Death|1
2452633|NCT02640612|8448383|P3|Overall Study|Adverse Event|2
2452634|NCT02640612|8448384|P2|Overall Study|Adverse Event|7
2452635|NCT02640612|8448385|P1|Overall Study|Adverse Event|6
2452636|NCT02640547|8448409|P1|Overall Study|Miscellaneous|3
2452637|NCT02640547|8448409|P1|Overall Study|Death|6
2452638|NCT02640547|8448409|P1|Overall Study|Withdrawal by Subject|1
2452639|NCT02640547|8448409|P1|Overall Study|Failure to Return|1
2452640|NCT02640482|8448486|P2|Overall Study|Lost to Follow-up|0
2452641|NCT02640482|8448487|P1|Overall Study|Lost to Follow-up|3
2452642|NCT02640404|8448499|P2|Overall Study|Withdrawal by Subject|0
2452643|NCT02640404|8448500|P1|Overall Study|Withdrawal by Subject|1
2452644|NCT02640404|8448499|P2|Overall Study|Protocol Violation|0
2452645|NCT02640404|8448500|P1|Overall Study|Protocol Violation|1
2452646|NCT02640157|8448511|P3|Overall Study|Randomized in error; did not receive Tx|0
2452647|NCT02640157|8448512|P2|Overall Study|Randomized in error; did not receive Tx|1
2452648|NCT02640157|8448513|P1|Overall Study|Randomized in error; did not receive Tx|0
2452649|NCT02640157|8448511|P3|Overall Study|Lost to Follow-up|7
2452650|NCT02640157|8448512|P2|Overall Study|Lost to Follow-up|2
2452651|NCT02640157|8448513|P1|Overall Study|Lost to Follow-up|9
2452652|NCT02640157|8448511|P3|Overall Study|Withdrew consent|2
2452653|NCT02640157|8448512|P2|Overall Study|Withdrew consent|0
2452654|NCT02640157|8448513|P1|Overall Study|Withdrew consent|2
2452655|NCT02640157|8448511|P3|Overall Study|Adverse Event|1
2452656|NCT02640157|8448512|P2|Overall Study|Adverse Event|2
2452657|NCT02640157|8448513|P1|Overall Study|Adverse Event|2
2452658|NCT02640053|8448532|P2|Overall Study|Chemo regimen changed after 1st Rx|1
2452659|NCT02640053|8448533|P1|Overall Study|Chemo regimen changed after 1st Rx|0
2452660|NCT02640053|8448532|P2|Overall Study|Alternative Therapy|1
2452661|NCT02640053|8448533|P1|Overall Study|Alternative Therapy|1
2452662|NCT02640053|8448532|P2|Overall Study|Adverse Event|1
2452663|NCT02640053|8448533|P1|Overall Study|Adverse Event|1
2452664|NCT02640053|8448532|P2|Overall Study|Withdrawal by Subject|1
2452665|NCT02640053|8448533|P1|Overall Study|Withdrawal by Subject|2
2452666|NCT02639559|8448640|P2|Overall Study|Issues with vascular acess|0
2452667|NCT02639559|8448641|P1|Overall Study|Issues with vascular acess|1
2452668|NCT02639559|8448640|P2|Overall Study|Mobilization failure|3
2452669|NCT02639559|8448641|P1|Overall Study|Mobilization failure|0
2452670|NCT02639338|8449077|P2|Overall Study|Randomized but Not Treated|1
2452671|NCT02639338|8449078|P1|Overall Study|Randomized but Not Treated|0
2452672|NCT02639338|8449077|P2|Overall Study|Death|0
2452673|NCT02639338|8449078|P1|Overall Study|Death|1
2452674|NCT02639338|8449077|P2|Overall Study|Withdrew Consent|2
2452675|NCT02639338|8449078|P1|Overall Study|Withdrew Consent|1
2452676|NCT02639338|8449077|P2|Overall Study|Lost to Follow-up|2
2452677|NCT02639338|8449078|P1|Overall Study|Lost to Follow-up|2
2452678|NCT02639247|8449096|P2|Overall Study|Protocol Violation|0
2452679|NCT02639247|8449097|P1|Overall Study|Protocol Violation|1
2452680|NCT02639247|8449096|P2|Overall Study|Withdrew Consent|1
2452681|NCT02639247|8449097|P1|Overall Study|Withdrew Consent|0
2452682|NCT02639247|8449096|P2|Overall Study|Death|0
2452683|NCT02639247|8449097|P1|Overall Study|Death|2
2452684|NCT02639247|8449096|P2|Overall Study|Lost to Follow-up|1
2452685|NCT02639247|8449097|P1|Overall Study|Lost to Follow-up|2
2452686|NCT02639052|8449113|P1|Overall Study|Lost to Follow-up|1
2452687|NCT02638948|8449150|P4|Overall Study|Other than specified above|1
2452688|NCT02638948|8449151|P3|Overall Study|Other than specified above|1
2452689|NCT02638948|8449152|P2|Overall Study|Other than specified above|1
2452690|NCT02638948|8449153|P1|Overall Study|Other than specified above|4
2452691|NCT02638948|8449150|P4|Overall Study|Participant no longer met study criteria|0
2452692|NCT02638948|8449151|P3|Overall Study|Participant no longer met study criteria|0
2452693|NCT02638948|8449152|P2|Overall Study|Participant no longer met study criteria|1
2452694|NCT02638948|8449153|P1|Overall Study|Participant no longer met study criteria|0
2452695|NCT02638948|8449150|P4|Overall Study|Poor/Non-Compliance|0
2452696|NCT02638948|8449151|P3|Overall Study|Poor/Non-Compliance|1
2452697|NCT02638948|8449152|P2|Overall Study|Poor/Non-Compliance|2
2452698|NCT02638948|8449153|P1|Overall Study|Poor/Non-Compliance|0
2452699|NCT02638948|8449150|P4|Overall Study|Lost to Follow-up|1
2452700|NCT02638948|8449151|P3|Overall Study|Lost to Follow-up|1
2452701|NCT02638948|8449152|P2|Overall Study|Lost to Follow-up|0
2452702|NCT02638948|8449153|P1|Overall Study|Lost to Follow-up|0
2452703|NCT02638948|8449150|P4|Overall Study|Lack of Efficacy|0
2452704|NCT02638948|8449151|P3|Overall Study|Lack of Efficacy|0
2452705|NCT02638948|8449152|P2|Overall Study|Lack of Efficacy|1
2452706|NCT02638948|8449153|P1|Overall Study|Lack of Efficacy|1
2452707|NCT02638948|8449150|P4|Overall Study|Adverse Event|1
2452708|NCT02638948|8449151|P3|Overall Study|Adverse Event|1
2452709|NCT02638948|8449152|P2|Overall Study|Adverse Event|0
2452710|NCT02638948|8449153|P1|Overall Study|Adverse Event|0
2452711|NCT02638948|8449150|P4|Overall Study|Administrative Reason by Sponsor|4
2452712|NCT02638948|8449151|P3|Overall Study|Administrative Reason by Sponsor|0
2452713|NCT02638948|8449152|P2|Overall Study|Administrative Reason by Sponsor|1
2452714|NCT02638948|8449153|P1|Overall Study|Administrative Reason by Sponsor|0
2452715|NCT02638948|8449150|P4|Overall Study|Withdrawal by Subject|1
2452716|NCT02638948|8449151|P3|Overall Study|Withdrawal by Subject|3
2452717|NCT02638948|8449152|P2|Overall Study|Withdrawal by Subject|5
2452718|NCT02638948|8449153|P1|Overall Study|Withdrawal by Subject|4
2452719|NCT02638493|8449252|P3|Overall Study|Inability to provide semen samples|0
2452720|NCT02638493|8449253|P2|Overall Study|Inability to provide semen samples|0
2452721|NCT02638493|8449254|P1|Overall Study|Inability to provide semen samples|2
2452722|NCT02638337|8449285|P2|Overall Study|Other - Miscellaneous|3
2452723|NCT02638337|8449286|P1|Overall Study|Other - Miscellaneous|4
2452724|NCT02638337|8449285|P2|Overall Study|Lost to Follow-up|7
2452725|NCT02638337|8449286|P1|Overall Study|Lost to Follow-up|7
2452726|NCT02638337|8449285|P2|Overall Study|Withdrawal by Subject|16
2452727|NCT02638337|8449286|P1|Overall Study|Withdrawal by Subject|13
2452728|NCT02638337|8449285|P2|Overall Study|Protocol Violation|0
2452729|NCT02638337|8449286|P1|Overall Study|Protocol Violation|3
2452730|NCT02638337|8449285|P2|Overall Study|Adverse Event|10
2452731|NCT02638337|8449286|P1|Overall Study|Adverse Event|6
2452732|NCT02638259|8449370|P2|Treatment Period 2|Withdrawal by Subject|7
2452733|NCT02638259|8449371|P1|Treatment Period 2|Withdrawal by Subject|1
2452734|NCT02638259|8449370|P2|Treatment Period 2|Adverse Event|4
2452735|NCT02638259|8449371|P1|Treatment Period 2|Adverse Event|5
2452736|NCT02638259|8449370|P2|Treatment Period 1|Withdrawn per sponsor decision|2
2452737|NCT02638259|8449371|P1|Treatment Period 1|Withdrawn per sponsor decision|0
2452738|NCT02638259|8449370|P2|Treatment Period 1|Withdrawal by Subject|6
2452739|NCT02638259|8449371|P1|Treatment Period 1|Withdrawal by Subject|4
2452740|NCT02638259|8449370|P2|Treatment Period 1|Protocol Violation|3
2452741|NCT02638259|8449371|P1|Treatment Period 1|Protocol Violation|0
2452742|NCT02638259|8449370|P2|Treatment Period 1|Lack of Efficacy|1
2452743|NCT02638259|8449371|P1|Treatment Period 1|Lack of Efficacy|0
2452744|NCT02638259|8449370|P2|Treatment Period 1|Death|1
2452745|NCT02638259|8449371|P1|Treatment Period 1|Death|0
2452746|NCT02638259|8449370|P2|Treatment Period 1|Adverse Event|5
2452747|NCT02638259|8449371|P1|Treatment Period 1|Adverse Event|1
2452748|NCT02638129|8449463|P2|Overall Study|Study terminated|30
2452749|NCT02638129|8449464|P1|Overall Study|Study terminated|28
2452750|NCT02638103|8449480|P4|Overall Study|Other than specified|4
2452751|NCT02638103|8449481|P3|Overall Study|Other than specified|2
2452752|NCT02638103|8449482|P2|Overall Study|Other than specified|4
2452753|NCT02638103|8449483|P1|Overall Study|Other than specified|5
2452754|NCT02638103|8449480|P4|Overall Study|Lack of Efficacy|22
2452755|NCT02638103|8449481|P3|Overall Study|Lack of Efficacy|12
2452756|NCT02638103|8449482|P2|Overall Study|Lack of Efficacy|10
2452757|NCT02638103|8449483|P1|Overall Study|Lack of Efficacy|14
2452758|NCT02638103|8449480|P4|Overall Study|Lost to Follow-up|37
2452759|NCT02638103|8449481|P3|Overall Study|Lost to Follow-up|20
2452760|NCT02638103|8449482|P2|Overall Study|Lost to Follow-up|33
2452761|NCT02638103|8449483|P1|Overall Study|Lost to Follow-up|26
2452762|NCT02638103|8449480|P4|Overall Study|Non-compliance to Study Procedures|1
2452763|NCT02638103|8449481|P3|Overall Study|Non-compliance to Study Procedures|1
2452764|NCT02638103|8449482|P2|Overall Study|Non-compliance to Study Procedures|1
2452765|NCT02638103|8449483|P1|Overall Study|Non-compliance to Study Procedures|2
2452766|NCT02638103|8449480|P4|Overall Study|Pregnancy|1
2452767|NCT02638103|8449481|P3|Overall Study|Pregnancy|0
2452768|NCT02638103|8449482|P2|Overall Study|Pregnancy|3
2452769|NCT02638103|8449483|P1|Overall Study|Pregnancy|2
2452770|NCT02638103|8449480|P4|Overall Study|Protocol Violation|4
2452771|NCT02638103|8449481|P3|Overall Study|Protocol Violation|1
2452772|NCT02638103|8449482|P2|Overall Study|Protocol Violation|2
2452773|NCT02638103|8449483|P1|Overall Study|Protocol Violation|1
2452774|NCT02638103|8449480|P4|Overall Study|Withdrawal by Subject|61
2452775|NCT02638103|8449481|P3|Overall Study|Withdrawal by Subject|30
2452776|NCT02638103|8449482|P2|Overall Study|Withdrawal by Subject|53
2452777|NCT02638103|8449483|P1|Overall Study|Withdrawal by Subject|43
2452778|NCT02638103|8449480|P4|Overall Study|Adverse Event|12
2452779|NCT02638103|8449481|P3|Overall Study|Adverse Event|19
2452780|NCT02638103|8449482|P2|Overall Study|Adverse Event|12
2452781|NCT02638103|8449483|P1|Overall Study|Adverse Event|13
2452782|NCT02637557|8449720|P4|Overall Study|Withdrawal by Subject|2
2452783|NCT02637557|8449721|P3|Overall Study|Withdrawal by Subject|4
2452784|NCT02637557|8449722|P2|Overall Study|Withdrawal by Subject|3
2452785|NCT02637557|8449723|P1|Overall Study|Withdrawal by Subject|1
2452786|NCT02637557|8449720|P4|Overall Study|Protocol Violation|1
2452787|NCT02637557|8449721|P3|Overall Study|Protocol Violation|2
2452788|NCT02637557|8449722|P2|Overall Study|Protocol Violation|0
2452789|NCT02637557|8449723|P1|Overall Study|Protocol Violation|2
2452790|NCT02637557|8449720|P4|Overall Study|Physician Decision|0
2452791|NCT02637557|8449721|P3|Overall Study|Physician Decision|0
2452792|NCT02637557|8449722|P2|Overall Study|Physician Decision|0
2452793|NCT02637557|8449723|P1|Overall Study|Physician Decision|1
2452794|NCT02637557|8449720|P4|Overall Study|Lost to Follow-up|1
2452795|NCT02637557|8449721|P3|Overall Study|Lost to Follow-up|0
2452796|NCT02637557|8449722|P2|Overall Study|Lost to Follow-up|1
2452797|NCT02637557|8449723|P1|Overall Study|Lost to Follow-up|1
2452798|NCT02637557|8449720|P4|Overall Study|Adverse Event|3
2452799|NCT02637557|8449721|P3|Overall Study|Adverse Event|3
2452800|NCT02637557|8449722|P2|Overall Study|Adverse Event|1
2452801|NCT02637557|8449723|P1|Overall Study|Adverse Event|3
2452802|NCT02637323|8449815|P2|Overall Study|Protocol Violation|1
2452803|NCT02637323|8449816|P1|Overall Study|Protocol Violation|0
2452804|NCT02637323|8449815|P2|Overall Study|Lost to Follow-up|0
2452805|NCT02637323|8449816|P1|Overall Study|Lost to Follow-up|2
2452806|NCT02637141|8449827|P3|Overall Study|Withdrawal by Subject|1
2452807|NCT02637141|8449828|P2|Overall Study|Withdrawal by Subject|1
2452808|NCT02637141|8449829|P1|Overall Study|Withdrawal by Subject|1
2452809|NCT02637141|8449827|P3|Overall Study|Adverse Event|0
2452810|NCT02637141|8449828|P2|Overall Study|Adverse Event|1
2452811|NCT02637141|8449829|P1|Overall Study|Adverse Event|1
2452812|NCT02637063|8449864|P3|Overall Study|Withdrawal by Subject|3
2452813|NCT02637063|8449865|P2|Overall Study|Withdrawal by Subject|2
2452814|NCT02637063|8449866|P1|Overall Study|Withdrawal by Subject|2
2452815|NCT02637063|8449864|P3|Overall Study|Lost to Follow-up|3
2452816|NCT02637063|8449865|P2|Overall Study|Lost to Follow-up|2
2452817|NCT02637063|8449866|P1|Overall Study|Lost to Follow-up|3
2452818|NCT02637037|8449894|P2|Overall Study|Adverse Event|0
2452819|NCT02637037|8449895|P1|Overall Study|Adverse Event|1
2452820|NCT02637037|8449894|P2|Overall Study|Withdrawal by Subject|1
2452821|NCT02637037|8449895|P1|Overall Study|Withdrawal by Subject|2
2452822|NCT02637037|8449894|P2|Overall Study|Positive drug screen at admission|0
2452823|NCT02637037|8449895|P1|Overall Study|Positive drug screen at admission|1
2452824|NCT02636907|8449961|P1|Extension Phase|Lack of Efficacy|1
2452825|NCT02636907|8449961|P1|Extension Phase|Lost to Follow-up|2
2452826|NCT02636907|8449961|P1|Extension Phase|Physician Decision|1
2452827|NCT02636907|8449961|P1|Extension Phase|Withdrawal by Subject|4
2452828|NCT02636907|8449961|P1|Extension Phase|Adverse Event|2
2452829|NCT02636907|8449961|P1|Autoinjector Assessment Period|Withdrawal by Subject|2
2452830|NCT02636907|8449961|P1|Autoinjector Assessment Period|Adverse Event|2
2452831|NCT02636608|8449978|P1|Overall Study|Did Not Receive Treatment|1
2452832|NCT02636608|8449978|P1|Overall Study|Other|2
2452833|NCT02636608|8449978|P1|Overall Study|Death|3
2452834|NCT02636608|8449978|P1|Overall Study|Insufficient Virological Response|1
2452835|NCT02636608|8449978|P1|Overall Study|Failure to Return|4
2452836|NCT02636595|8450006|P1|Overall Study|Other|1
2452837|NCT02636595|8450006|P1|Overall Study|Lost to Follow-up|1
2452838|NCT02636283|8450014|P2|Overall Study|Trial Terminated Prematurely|3
2452839|NCT02636283|8450015|P1|Overall Study|Trial Terminated Prematurely|0
2452840|NCT02636283|8450014|P2|Overall Study|Adverse Event|0
2452841|NCT02636283|8450015|P1|Overall Study|Adverse Event|2
2452842|NCT02635984|8450043|P2|Overall Study|Study Arm Closed|0
2452843|NCT02635984|8450044|P1|Overall Study|Study Arm Closed|1
2452844|NCT02635984|8450043|P2|Overall Study|Lost to Follow-up|4
2452845|NCT02635984|8450044|P1|Overall Study|Lost to Follow-up|2
2452846|NCT02635646|8450076|P2|Overall Study|Pregnancy|1
2452847|NCT02635646|8450077|P1|Overall Study|Pregnancy|1
2452848|NCT02635646|8450076|P2|Overall Study|Lost to Follow-up|25
2452849|NCT02635646|8450077|P1|Overall Study|Lost to Follow-up|24
2452850|NCT02635347|8450113|P2|Overall Study|Failed screening|7
2452851|NCT02635347|8450114|P1|Overall Study|Failed screening|20
2452852|NCT02635204|8450145|P2|Overall Study|Lost to Follow-up|1
2452853|NCT02635204|8450146|P1|Overall Study|Lost to Follow-up|1
2452854|NCT02635204|8450145|P2|Overall Study|Adverse Event|0
2452855|NCT02635204|8450146|P1|Overall Study|Adverse Event|1
2452856|NCT02634983|8450156|P2|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0
2452857|NCT02634983|8450157|P1|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2
2452858|NCT02634801|8450216|P3|Follow-up Period|Adverse Event|0
2452859|NCT02634801|8450217|P2|Follow-up Period|Adverse Event|5
2452860|NCT02634801|8450218|P1|Follow-up Period|Adverse Event|1
2452861|NCT02634801|8450216|P3|Follow-up Period|Withdrawal by Subject|5
2452862|NCT02634801|8450217|P2|Follow-up Period|Withdrawal by Subject|2
2452863|NCT02634801|8450218|P1|Follow-up Period|Withdrawal by Subject|1
2452864|NCT02634801|8450216|P3|Follow-up Period|Physician Decision|1
2452865|NCT02634801|8450217|P2|Follow-up Period|Physician Decision|0
2452866|NCT02634801|8450218|P1|Follow-up Period|Physician Decision|0
2452867|NCT02634801|8450216|P3|Follow-up Period|Lost to Follow-up|2
2452868|NCT02634801|8450217|P2|Follow-up Period|Lost to Follow-up|1
2452869|NCT02634801|8450218|P1|Follow-up Period|Lost to Follow-up|3
2452870|NCT02634801|8450216|P3|Extension Period (Weeks 24 to 36)|Missing|0
2452871|NCT02634801|8450217|P2|Extension Period (Weeks 24 to 36)|Missing|0
2452872|NCT02634801|8450218|P1|Extension Period (Weeks 24 to 36)|Missing|1
2452873|NCT02634801|8450216|P3|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
2452874|NCT02634801|8450217|P2|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
2452875|NCT02634801|8450218|P1|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
2452876|NCT02634801|8450216|P3|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0
2452877|NCT02634801|8450217|P2|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0
2452878|NCT02634801|8450218|P1|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1
2452879|NCT02634801|8450216|P3|Extension Period (Weeks 24 to 36)|Adverse Event|1
2452880|NCT02634801|8450217|P2|Extension Period (Weeks 24 to 36)|Adverse Event|0
2452881|NCT02634801|8450218|P1|Extension Period (Weeks 24 to 36)|Adverse Event|0
2452882|NCT02634801|8450216|P3|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3
2452883|NCT02634801|8450217|P2|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8
2452884|NCT02634801|8450218|P1|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0
2452885|NCT02634801|8450216|P3|Treatment Period (Weeks 0 to 24)|Protocol Violation|1
2452886|NCT02634801|8450217|P2|Treatment Period (Weeks 0 to 24)|Protocol Violation|0
2452887|NCT02634801|8450218|P1|Treatment Period (Weeks 0 to 24)|Protocol Violation|0
2452888|NCT02634801|8450216|P3|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1
2452889|NCT02634801|8450217|P2|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1
2452890|NCT02634801|8450218|P1|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2
2452891|NCT02634801|8450216|P3|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0
2452892|NCT02634801|8450217|P2|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2
2452893|NCT02634801|8450218|P1|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0
2452894|NCT02634801|8450216|P3|Treatment Period (Weeks 0 to 24)|Adverse Event|0
2452895|NCT02634801|8450217|P2|Treatment Period (Weeks 0 to 24)|Adverse Event|20
2452896|NCT02634801|8450218|P1|Treatment Period (Weeks 0 to 24)|Adverse Event|2
2452897|NCT02634788|8450318|P4|Overall Study|Withdrawal by Subject|0
2452898|NCT02634788|8450319|P3|Overall Study|Withdrawal by Subject|1
2452899|NCT02634788|8450320|P2|Overall Study|Withdrawal by Subject|1
2452900|NCT02634788|8450321|P1|Overall Study|Withdrawal by Subject|0
2452901|NCT02634788|8450318|P4|Overall Study|Lost to Follow-up|0
2452902|NCT02634788|8450319|P3|Overall Study|Lost to Follow-up|0
2452903|NCT02634788|8450320|P2|Overall Study|Lost to Follow-up|1
2452904|NCT02634788|8450321|P1|Overall Study|Lost to Follow-up|0
2452905|NCT02634788|8450318|P4|Overall Study|Lack of Efficacy|4
2452906|NCT02634788|8450319|P3|Overall Study|Lack of Efficacy|1
2452907|NCT02634788|8450320|P2|Overall Study|Lack of Efficacy|0
2452908|NCT02634788|8450321|P1|Overall Study|Lack of Efficacy|4
2452909|NCT02634788|8450318|P4|Overall Study|Adverse Event|1
2452910|NCT02634788|8450319|P3|Overall Study|Adverse Event|3
2452911|NCT02634788|8450320|P2|Overall Study|Adverse Event|8
2452912|NCT02634788|8450321|P1|Overall Study|Adverse Event|0
2452913|NCT02634606|8450387|P1|Overall Study|unable to obtain the drug at start|13
2452914|NCT02634580|8450399|P4|Overall Study|Subject Request|1
2452915|NCT02634580|8450400|P3|Overall Study|Subject Request|1
2452916|NCT02634580|8450401|P2|Overall Study|Subject Request|0
2452917|NCT02634580|8450402|P1|Overall Study|Subject Request|1
2452918|NCT02634346|8450459|P3|Overall Study|Protocol Violation|0
2452919|NCT02634346|8450460|P2|Overall Study|Protocol Violation|1
2452920|NCT02634346|8450461|P1|Overall Study|Protocol Violation|0
2452921|NCT02634346|8450459|P3|Overall Study|Lost to Follow-up|0
2452922|NCT02634346|8450460|P2|Overall Study|Lost to Follow-up|0
2452923|NCT02634346|8450461|P1|Overall Study|Lost to Follow-up|1
2452924|NCT02634346|8450459|P3|Overall Study|Lack of Efficacy|8
2452925|NCT02634346|8450460|P2|Overall Study|Lack of Efficacy|2
2452926|NCT02634346|8450461|P1|Overall Study|Lack of Efficacy|1
2452927|NCT02634346|8450459|P3|Overall Study|Adverse Event|7
2452928|NCT02634346|8450460|P2|Overall Study|Adverse Event|2
2452929|NCT02634346|8450461|P1|Overall Study|Adverse Event|2
2452930|NCT02634346|8450459|P3|Overall Study|Withdrawal by Subject|8
2452931|NCT02634346|8450460|P2|Overall Study|Withdrawal by Subject|9
2452932|NCT02634346|8450461|P1|Overall Study|Withdrawal by Subject|8
2452933|NCT02634320|8450475|P1|Overall Study|Lack of Efficacy|2
2452934|NCT02634320|8450475|P1|Overall Study|Withdrawal by Subject|5
2452935|NCT02634320|8450475|P1|Overall Study|Protocol Violation|1
2452936|NCT02634320|8450475|P1|Overall Study|Out of window for study visits|1
2452937|NCT02634320|8450475|P1|Overall Study|Moved out of area|2
2452938|NCT02634320|8450475|P1|Overall Study|Lost to Follow-up|3
2452939|NCT02634320|8450475|P1|Overall Study|Adverse Event|2
2452940|NCT02633800|8450600|P2|Overall Study|Patient Request|1
2452941|NCT02633800|8450601|P1|Overall Study|Patient Request|1
2452942|NCT02633800|8450600|P2|Overall Study|Withdrawal by Subject|3
2452943|NCT02633800|8450601|P1|Overall Study|Withdrawal by Subject|0
2452944|NCT02633800|8450600|P2|Overall Study|Adverse event, non-fatal|2
2452945|NCT02633800|8450601|P1|Overall Study|Adverse event, non-fatal|7
2452946|NCT02633800|8450600|P2|Overall Study|Study terminated by sponsor|5
2452947|NCT02633800|8450601|P1|Overall Study|Study terminated by sponsor|6
2452948|NCT02633800|8450600|P2|Overall Study|Clinical progression|6
2452949|NCT02633800|8450601|P1|Overall Study|Clinical progression|3
2452950|NCT02633800|8450600|P2|Overall Study|Radiologic(al) progression|23
2452951|NCT02633800|8450601|P1|Overall Study|Radiologic(al) progression|23
2452952|NCT02633800|8450600|P2|Overall Study|Reason not provided|0
2452953|NCT02633800|8450601|P1|Overall Study|Reason not provided|1
2452954|NCT02633800|8450600|P2|Overall Study|Death|3
2452955|NCT02633800|8450601|P1|Overall Study|Death|3
2452956|NCT02633787|8450611|P1|Overall Study|Withdrawal by Subject|1
2452957|NCT02633501|8450623|P6|Overall Study|Lost to Follow-up|0
2452958|NCT02633501|8450624|P5|Overall Study|Lost to Follow-up|2
2452959|NCT02633501|8450625|P4|Overall Study|Lost to Follow-up|1
2452960|NCT02633501|8450626|P3|Overall Study|Lost to Follow-up|0
2452961|NCT02633501|8450627|P2|Overall Study|Lost to Follow-up|0
2452962|NCT02633501|8450628|P1|Overall Study|Lost to Follow-up|0
2452963|NCT02633501|8450623|P6|Overall Study|Various other reasons|11
2452964|NCT02633501|8450624|P5|Overall Study|Various other reasons|7
2452965|NCT02633501|8450625|P4|Overall Study|Various other reasons|1
2452966|NCT02633501|8450626|P3|Overall Study|Various other reasons|4
2452967|NCT02633501|8450627|P2|Overall Study|Various other reasons|2
2452968|NCT02633501|8450628|P1|Overall Study|Various other reasons|0
2452969|NCT02633501|8450623|P6|Overall Study|Withdrawal by Subject|3
2452970|NCT02633501|8450624|P5|Overall Study|Withdrawal by Subject|1
2452971|NCT02633501|8450625|P4|Overall Study|Withdrawal by Subject|2
2452972|NCT02633501|8450626|P3|Overall Study|Withdrawal by Subject|2
2452973|NCT02633501|8450627|P2|Overall Study|Withdrawal by Subject|1
2452974|NCT02633501|8450628|P1|Overall Study|Withdrawal by Subject|2
2452975|NCT02633501|8450623|P6|Overall Study|Adverse Event|1
2452976|NCT02633501|8450624|P5|Overall Study|Adverse Event|1
2452977|NCT02633501|8450625|P4|Overall Study|Adverse Event|0
2452978|NCT02633501|8450626|P3|Overall Study|Adverse Event|1
2452979|NCT02633501|8450627|P2|Overall Study|Adverse Event|0
2452980|NCT02633501|8450628|P1|Overall Study|Adverse Event|0
2452981|NCT02633215|8450690|P2|Overall Study|Lost to Follow-up|3
2452982|NCT02633215|8450691|P1|Overall Study|Lost to Follow-up|2
2452983|NCT02633020|8450703|P2|Overall Study|Adverse Event|0
2452984|NCT02633020|8450704|P1|Overall Study|Adverse Event|1
2452985|NCT02632838|8450728|P2|Overall Study|Lost to Follow-up|2
2452986|NCT02632838|8450729|P1|Overall Study|Lost to Follow-up|0
2452987|NCT02632838|8450728|P2|Overall Study|Withdrawal by Subject|0
2452988|NCT02632838|8450729|P1|Overall Study|Withdrawal by Subject|3
2452989|NCT02632786|8450766|P2|Overall Study|Withdrawal by Subject|0
2452990|NCT02632786|8450767|P1|Overall Study|Withdrawal by Subject|1
2452991|NCT02632786|8450766|P2|Overall Study|Physician Decision|4
2452992|NCT02632786|8450767|P1|Overall Study|Physician Decision|5
2452993|NCT02632786|8450766|P2|Overall Study|Death|2
2452994|NCT02632786|8450767|P1|Overall Study|Death|3
2452995|NCT02632786|8450766|P2|Overall Study|Adverse Event|1
2452996|NCT02632786|8450767|P1|Overall Study|Adverse Event|2
2452997|NCT02632110|8450977|P10|Overall Study|Withdrawal by Subject|1
2452998|NCT02632110|8450978|P9|Overall Study|Withdrawal by Subject|1
2452999|NCT02632110|8450979|P8|Overall Study|Withdrawal by Subject|3
2453000|NCT02632110|8450980|P7|Overall Study|Withdrawal by Subject|3
2453001|NCT02632110|8450981|P6|Overall Study|Withdrawal by Subject|1
2453002|NCT02632110|8450982|P5|Overall Study|Withdrawal by Subject|1
2453003|NCT02632110|8450983|P4|Overall Study|Withdrawal by Subject|0
2453004|NCT02632110|8450984|P3|Overall Study|Withdrawal by Subject|0
2453005|NCT02632110|8450985|P2|Overall Study|Withdrawal by Subject|1
2453006|NCT02632110|8450986|P1|Overall Study|Withdrawal by Subject|1
2453007|NCT02631746|8451487|P1|Overall Study|Lack of Efficacy|3
2453008|NCT02631577|8451500|P2|Overall Study|Withdrawal by Subject|1
2453009|NCT02631577|8451501|P1|Overall Study|Withdrawal by Subject|0
2453010|NCT02631577|8451500|P2|Overall Study|Death|3
2453011|NCT02631577|8451501|P1|Overall Study|Death|1
2453012|NCT02631551|8451519|P4|Overall Study|Other, specific reasons not collected|2
2453013|NCT02631551|8451520|P3|Overall Study|Other, specific reasons not collected|2
2453014|NCT02631551|8451521|P2|Overall Study|Other, specific reasons not collected|7
2453015|NCT02631551|8451522|P1|Overall Study|Other, specific reasons not collected|5
2453016|NCT02631551|8451519|P4|Overall Study|Non-compliance with study drug|0
2453017|NCT02631551|8451520|P3|Overall Study|Non-compliance with study drug|0
2453018|NCT02631551|8451521|P2|Overall Study|Non-compliance with study drug|0
2453019|NCT02631551|8451522|P1|Overall Study|Non-compliance with study drug|1
2453020|NCT02631551|8451519|P4|Overall Study|Non-compliance with study procedures|1
2453021|NCT02631551|8451520|P3|Overall Study|Non-compliance with study procedures|1
2453022|NCT02631551|8451521|P2|Overall Study|Non-compliance with study procedures|0
2453023|NCT02631551|8451522|P1|Overall Study|Non-compliance with study procedures|0
2453024|NCT02631551|8451519|P4|Overall Study|Protocol deviation|0
2453025|NCT02631551|8451520|P3|Overall Study|Protocol deviation|3
2453026|NCT02631551|8451521|P2|Overall Study|Protocol deviation|6
2453027|NCT02631551|8451522|P1|Overall Study|Protocol deviation|3
2453028|NCT02631551|8451519|P4|Overall Study|Withdrawal by Subject|5
2453029|NCT02631551|8451520|P3|Overall Study|Withdrawal by Subject|0
2453030|NCT02631551|8451521|P2|Overall Study|Withdrawal by Subject|2
2453031|NCT02631551|8451522|P1|Overall Study|Withdrawal by Subject|2
2453032|NCT02631551|8451519|P4|Overall Study|Lost to Follow-up|3
2453033|NCT02631551|8451520|P3|Overall Study|Lost to Follow-up|0
2453034|NCT02631551|8451521|P2|Overall Study|Lost to Follow-up|2
2453035|NCT02631551|8451522|P1|Overall Study|Lost to Follow-up|1
2453036|NCT02631551|8451519|P4|Overall Study|Lack of Efficacy|0
2453037|NCT02631551|8451520|P3|Overall Study|Lack of Efficacy|1
2453038|NCT02631551|8451521|P2|Overall Study|Lack of Efficacy|0
2453039|NCT02631551|8451522|P1|Overall Study|Lack of Efficacy|0
2453040|NCT02631551|8451519|P4|Overall Study|Adverse Event|0
2453041|NCT02631551|8451520|P3|Overall Study|Adverse Event|4
2453042|NCT02631551|8451521|P2|Overall Study|Adverse Event|2
2453043|NCT02631551|8451522|P1|Overall Study|Adverse Event|1
2453044|NCT02630966|8451560|P2|Overall Study|Lack of Efficacy|2
2453045|NCT02630966|8451561|P1|Overall Study|Lack of Efficacy|0
2453046|NCT02630966|8451560|P2|Overall Study|Voluntary Withdrawal|1
2453047|NCT02630966|8451561|P1|Overall Study|Voluntary Withdrawal|1
2453048|NCT02630966|8451560|P2|Overall Study|Significant Protocol Deviation|2
2453049|NCT02630966|8451561|P1|Overall Study|Significant Protocol Deviation|0
2453050|NCT02630966|8451560|P2|Overall Study|Adverse Event|3
2453051|NCT02630966|8451561|P1|Overall Study|Adverse Event|1
2453052|NCT02630706|8451589|P3|Overall Study|Withdrawal by Subject|7
2453053|NCT02630706|8451590|P2|Overall Study|Withdrawal by Subject|5
2453054|NCT02630706|8451591|P1|Overall Study|Withdrawal by Subject|4
2453055|NCT02630706|8451589|P3|Overall Study|Pregnancy|0
2453056|NCT02630706|8451590|P2|Overall Study|Pregnancy|1
2453057|NCT02630706|8451591|P1|Overall Study|Pregnancy|0
2453058|NCT02630706|8451589|P3|Overall Study|Physician Decision|0
2453059|NCT02630706|8451590|P2|Overall Study|Physician Decision|1
2453060|NCT02630706|8451591|P1|Overall Study|Physician Decision|1
2453061|NCT02630706|8451589|P3|Overall Study|Lost to Follow-up|2
2453062|NCT02630706|8451590|P2|Overall Study|Lost to Follow-up|1
2453063|NCT02630706|8451591|P1|Overall Study|Lost to Follow-up|0
2453064|NCT02630706|8451589|P3|Overall Study|Adverse Event|1
2453065|NCT02630706|8451590|P2|Overall Study|Adverse Event|1
2453066|NCT02630706|8451591|P1|Overall Study|Adverse Event|2
2453067|NCT02630693|8451700|P2|Overall Study|No receive treatment|1
2453068|NCT02630693|8451701|P1|Overall Study|No receive treatment|0
2453069|NCT02630563|8451713|P1|Overall Study|Administrative|1
2453070|NCT02630472|8451724|P2|Overall Study|Physician Decision|0
2453071|NCT02630472|8451725|P1|Overall Study|Physician Decision|10
2453072|NCT02630459|8451743|P4|Overall Study|Subject missed week 24 assessment|0
2453073|NCT02630459|8451744|P3|Overall Study|Subject missed week 24 assessment|0
2453074|NCT02630459|8451745|P2|Overall Study|Subject missed week 24 assessment|0
2453075|NCT02630459|8451746|P1|Overall Study|Subject missed week 24 assessment|1
2453076|NCT02630459|8451743|P4|Overall Study|Withdrawal by Subject|1
2453077|NCT02630459|8451744|P3|Overall Study|Withdrawal by Subject|4
2453078|NCT02630459|8451745|P2|Overall Study|Withdrawal by Subject|1
2453079|NCT02630459|8451746|P1|Overall Study|Withdrawal by Subject|2
2453080|NCT02630459|8451743|P4|Overall Study|Sponsor decision|0
2453081|NCT02630459|8451744|P3|Overall Study|Sponsor decision|1
2453082|NCT02630459|8451745|P2|Overall Study|Sponsor decision|0
2453083|NCT02630459|8451746|P1|Overall Study|Sponsor decision|0
2453084|NCT02630459|8451743|P4|Overall Study|Protocol-specified criteria|2
2453085|NCT02630459|8451744|P3|Overall Study|Protocol-specified criteria|0
2453086|NCT02630459|8451745|P2|Overall Study|Protocol-specified criteria|1
2453087|NCT02630459|8451746|P1|Overall Study|Protocol-specified criteria|0
2453088|NCT02630251|8451768|P4|Overall Study|Physician Decision|0
2453089|NCT02630251|8451769|P3|Overall Study|Physician Decision|1
2453090|NCT02630251|8451770|P2|Overall Study|Physician Decision|0
2453091|NCT02630251|8451771|P1|Overall Study|Physician Decision|0
2453092|NCT02630186|8451885|P1|Overall Study|Withdrawal by Subject|1
2453093|NCT02629965|8451901|P2|Period 2|Adverse Event|0
2453094|NCT02629965|8451902|P1|Period 2|Adverse Event|1
2453095|NCT02629965|8451901|P2|Period 1|Other than listed above|2
2453096|NCT02629965|8451902|P1|Period 1|Other than listed above|1
2453097|NCT02629965|8451901|P2|Period 1|Unexpected worsening of disease|0
2453098|NCT02629965|8451902|P1|Period 1|Unexpected worsening of disease|2
2453099|NCT02629965|8451901|P2|Period 1|Adverse Event|0
2453100|NCT02629965|8451902|P1|Period 1|Adverse Event|1
2453101|NCT02629861|8451941|P3|Overall Study|Pregnancy|0
2453102|NCT02629861|8451942|P2|Overall Study|Pregnancy|1
2453103|NCT02629861|8451943|P1|Overall Study|Pregnancy|2
2453104|NCT02629861|8451941|P3|Overall Study|Other|0
2453105|NCT02629861|8451942|P2|Overall Study|Other|1
2453106|NCT02629861|8451943|P1|Overall Study|Other|1
2453107|NCT02629861|8451941|P3|Overall Study|Lost to Follow-up|4
2453108|NCT02629861|8451942|P2|Overall Study|Lost to Follow-up|9
2453109|NCT02629861|8451943|P1|Overall Study|Lost to Follow-up|12
2453110|NCT02629861|8451941|P3|Overall Study|Protocol Violation|7
2453111|NCT02629861|8451942|P2|Overall Study|Protocol Violation|3
2453112|NCT02629861|8451943|P1|Overall Study|Protocol Violation|2
2453113|NCT02629861|8451941|P3|Overall Study|Withdrawal by Subject|13
2453114|NCT02629861|8451942|P2|Overall Study|Withdrawal by Subject|8
2453115|NCT02629861|8451943|P1|Overall Study|Withdrawal by Subject|5
2453116|NCT02629861|8451941|P3|Overall Study|Adverse Event|4
2453117|NCT02629861|8451942|P2|Overall Study|Adverse Event|5
2453118|NCT02629861|8451943|P1|Overall Study|Adverse Event|7
2453119|NCT02629822|8451990|P1|Extension Study|Extension Period is Ongoing|6
2453120|NCT02629822|8451990|P1|Base Study|Non-Compliance With Study Drug|1
2453121|NCT02629822|8451990|P1|Base Study|Lost to Follow-up|2
2453122|NCT02629159|8452032|P3|Overall Study|Other|8
2453123|NCT02629159|8452033|P2|Overall Study|Other|4
2453124|NCT02629159|8452034|P1|Overall Study|Other|6
2453125|NCT02629159|8452032|P3|Overall Study|Lack of Efficacy|1
2453126|NCT02629159|8452033|P2|Overall Study|Lack of Efficacy|0
2453127|NCT02629159|8452034|P1|Overall Study|Lack of Efficacy|4
2453128|NCT02629159|8452032|P3|Overall Study|Lost to Follow-up|5
2453129|NCT02629159|8452033|P2|Overall Study|Lost to Follow-up|4
2453130|NCT02629159|8452034|P1|Overall Study|Lost to Follow-up|7
2453131|NCT02629159|8452032|P3|Overall Study|Withdrawal by Subject|15
2453132|NCT02629159|8452033|P2|Overall Study|Withdrawal by Subject|11
2453133|NCT02629159|8452034|P1|Overall Study|Withdrawal by Subject|22
2453134|NCT02629159|8452032|P3|Overall Study|Adverse Event|22
2453135|NCT02629159|8452033|P2|Overall Study|Adverse Event|20
2453136|NCT02629159|8452034|P1|Overall Study|Adverse Event|17
2453137|NCT02629133|8452086|P2|Overall Study|Withdrawal by Subject|1
2453138|NCT02629133|8452087|P1|Overall Study|Withdrawal by Subject|1
2453139|NCT02629133|8452086|P2|Overall Study|Lost to Follow-up|1
2453140|NCT02629133|8452087|P1|Overall Study|Lost to Follow-up|3
2453141|NCT02628938|8452130|P3|Overall Study|Failure to comply with the instructions|3
2453142|NCT02628938|8452131|P2|Overall Study|Failure to comply with the instructions|0
2453143|NCT02628938|8452132|P1|Overall Study|Failure to comply with the instructions|3
2453144|NCT02628938|8452130|P3|Overall Study|Did not attend the follow up recall|1
2453145|NCT02628938|8452131|P2|Overall Study|Did not attend the follow up recall|2
2453146|NCT02628938|8452132|P1|Overall Study|Did not attend the follow up recall|2
2453147|NCT02628769|8452146|P2|Second Intervention|Physician Decision|1
2453148|NCT02628769|8452147|P1|Second Intervention|Physician Decision|0
2453149|NCT02628769|8452146|P2|Second Intervention|Adverse Event|0
2453150|NCT02628769|8452147|P1|Second Intervention|Adverse Event|2
2453151|NCT02628769|8452146|P2|First Intervention|Withdrawal by Subject|1
2453152|NCT02628769|8452147|P1|First Intervention|Withdrawal by Subject|0
2453153|NCT02628769|8452146|P2|First Intervention|Adverse Event|0
2453154|NCT02628769|8452147|P1|First Intervention|Adverse Event|1
2453155|NCT02628743|8452185|P1|Overall Study|Physician Decision|2
2453156|NCT02628743|8452185|P1|Overall Study|Study Terminated by Sponsor|76
2453157|NCT02628743|8452185|P1|Overall Study|Withdrawal by Subject|50
2453158|NCT02628743|8452185|P1|Overall Study|Other|3
2453159|NCT02628600|8452211|P2|Overall Study|Other not specified|0
2453160|NCT02628600|8452212|P1|Overall Study|Other not specified|1
2453161|NCT02628600|8452211|P2|Overall Study|Physician Decision|2
2453162|NCT02628600|8452212|P1|Overall Study|Physician Decision|2
2453163|NCT02628600|8452211|P2|Overall Study|Lost to Follow-up|0
2453164|NCT02628600|8452212|P1|Overall Study|Lost to Follow-up|1
2453165|NCT02628600|8452211|P2|Overall Study|Withdrawal by Subject|8
2453166|NCT02628600|8452212|P1|Overall Study|Withdrawal by Subject|13
2453167|NCT02628600|8452211|P2|Overall Study|Lack of Efficacy|0
2453168|NCT02628600|8452212|P1|Overall Study|Lack of Efficacy|2
2453169|NCT02628600|8452211|P2|Overall Study|Protocol Violation|1
2453170|NCT02628600|8452212|P1|Overall Study|Protocol Violation|0
2453171|NCT02628600|8452211|P2|Overall Study|Adverse Event|20
2453172|NCT02628600|8452212|P1|Overall Study|Adverse Event|3
2453173|NCT02628600|8452211|P2|Overall Study|Death|1
2453174|NCT02628600|8452212|P1|Overall Study|Death|2
2453175|NCT02628418|8452226|P2|Overall Study|Lost to Follow-up|2
2453176|NCT02628418|8452227|P1|Overall Study|Lost to Follow-up|1
2453177|NCT02628028|8452318|P8|Long-term Extension (LTE) Period|Other|3
2453178|NCT02628028|8452319|P7|Long-term Extension (LTE) Period|Other|4
2453179|NCT02628028|8452320|P6|Long-term Extension (LTE) Period|Other|3
2453180|NCT02628028|8452321|P5|Long-term Extension (LTE) Period|Other|0
2453181|NCT02628028|8452322|P4|Long-term Extension (LTE) Period|Other|0
2453182|NCT02628028|8452323|P3|Long-term Extension (LTE) Period|Other|0
2453183|NCT02628028|8452324|P2|Long-term Extension (LTE) Period|Other|0
2453184|NCT02628028|8452325|P1|Long-term Extension (LTE) Period|Other|0
2453185|NCT02628028|8452318|P8|Long-term Extension (LTE) Period|Withdrawal by Subject|3
2453186|NCT02628028|8452319|P7|Long-term Extension (LTE) Period|Withdrawal by Subject|3
2453187|NCT02628028|8452320|P6|Long-term Extension (LTE) Period|Withdrawal by Subject|2
2453188|NCT02628028|8452321|P5|Long-term Extension (LTE) Period|Withdrawal by Subject|0
2453189|NCT02628028|8452322|P4|Long-term Extension (LTE) Period|Withdrawal by Subject|0
2453190|NCT02628028|8452323|P3|Long-term Extension (LTE) Period|Withdrawal by Subject|0
2453191|NCT02628028|8452324|P2|Long-term Extension (LTE) Period|Withdrawal by Subject|0
2453192|NCT02628028|8452325|P1|Long-term Extension (LTE) Period|Withdrawal by Subject|0
2453193|NCT02628028|8452318|P8|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51
2453194|NCT02628028|8452319|P7|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51
2453195|NCT02628028|8452320|P6|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52
2453196|NCT02628028|8452321|P5|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
2453197|NCT02628028|8452322|P4|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
2453198|NCT02628028|8452323|P3|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
2453199|NCT02628028|8452324|P2|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
2453200|NCT02628028|8452325|P1|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
2453201|NCT02628028|8452318|P8|Long-term Extension (LTE) Period|Lack of Efficacy|1
2453202|NCT02628028|8452319|P7|Long-term Extension (LTE) Period|Lack of Efficacy|0
2453203|NCT02628028|8452320|P6|Long-term Extension (LTE) Period|Lack of Efficacy|2
2453204|NCT02628028|8452321|P5|Long-term Extension (LTE) Period|Lack of Efficacy|0
2453205|NCT02628028|8452322|P4|Long-term Extension (LTE) Period|Lack of Efficacy|0
2453206|NCT02628028|8452323|P3|Long-term Extension (LTE) Period|Lack of Efficacy|0
2453207|NCT02628028|8452324|P2|Long-term Extension (LTE) Period|Lack of Efficacy|0
2453208|NCT02628028|8452325|P1|Long-term Extension (LTE) Period|Lack of Efficacy|0
2453209|NCT02628028|8452318|P8|Long-term Extension (LTE) Period|Adverse Event|3
2453210|NCT02628028|8452319|P7|Long-term Extension (LTE) Period|Adverse Event|0
2453211|NCT02628028|8452320|P6|Long-term Extension (LTE) Period|Adverse Event|1
2453212|NCT02628028|8452321|P5|Long-term Extension (LTE) Period|Adverse Event|0
2453213|NCT02628028|8452322|P4|Long-term Extension (LTE) Period|Adverse Event|0
2453214|NCT02628028|8452323|P3|Long-term Extension (LTE) Period|Adverse Event|0
2453215|NCT02628028|8452324|P2|Long-term Extension (LTE) Period|Adverse Event|0
2453216|NCT02628028|8452325|P1|Long-term Extension (LTE) Period|Adverse Event|0
2453217|NCT02628028|8452318|P8|Dosing Period|Other|4
2453218|NCT02628028|8452319|P7|Dosing Period|Other|2
2453219|NCT02628028|8452320|P6|Dosing Period|Other|1
2453220|NCT02628028|8452321|P5|Dosing Period|Other|2
2453221|NCT02628028|8452322|P4|Dosing Period|Other|0
2453222|NCT02628028|8452323|P3|Dosing Period|Other|0
2453223|NCT02628028|8452324|P2|Dosing Period|Other|0
2453224|NCT02628028|8452325|P1|Dosing Period|Other|0
2453225|NCT02628028|8452318|P8|Dosing Period|Lost to Follow-up|0
2453226|NCT02628028|8452319|P7|Dosing Period|Lost to Follow-up|1
2453227|NCT02628028|8452320|P6|Dosing Period|Lost to Follow-up|0
2453228|NCT02628028|8452321|P5|Dosing Period|Lost to Follow-up|0
2453229|NCT02628028|8452322|P4|Dosing Period|Lost to Follow-up|0
2453230|NCT02628028|8452323|P3|Dosing Period|Lost to Follow-up|0
2453231|NCT02628028|8452324|P2|Dosing Period|Lost to Follow-up|0
2453232|NCT02628028|8452325|P1|Dosing Period|Lost to Follow-up|0
2453233|NCT02628028|8452318|P8|Dosing Period|Site Terminated by Sponsor|0
2453234|NCT02628028|8452319|P7|Dosing Period|Site Terminated by Sponsor|1
2453235|NCT02628028|8452320|P6|Dosing Period|Site Terminated by Sponsor|1
2453236|NCT02628028|8452321|P5|Dosing Period|Site Terminated by Sponsor|0
2453237|NCT02628028|8452322|P4|Dosing Period|Site Terminated by Sponsor|0
2453238|NCT02628028|8452323|P3|Dosing Period|Site Terminated by Sponsor|0
2453239|NCT02628028|8452324|P2|Dosing Period|Site Terminated by Sponsor|0
2453240|NCT02628028|8452325|P1|Dosing Period|Site Terminated by Sponsor|0
2453241|NCT02628028|8452318|P8|Dosing Period|Physician Decision|0
2453242|NCT02628028|8452319|P7|Dosing Period|Physician Decision|0
2453243|NCT02628028|8452320|P6|Dosing Period|Physician Decision|1
2453244|NCT02628028|8452321|P5|Dosing Period|Physician Decision|0
2453245|NCT02628028|8452322|P4|Dosing Period|Physician Decision|0
2453246|NCT02628028|8452323|P3|Dosing Period|Physician Decision|0
2453247|NCT02628028|8452324|P2|Dosing Period|Physician Decision|0
2453248|NCT02628028|8452325|P1|Dosing Period|Physician Decision|0
2453249|NCT02628028|8452318|P8|Dosing Period|Study Terminated by Sponsor|7
2453250|NCT02628028|8452319|P7|Dosing Period|Study Terminated by Sponsor|7
2453251|NCT02628028|8452320|P6|Dosing Period|Study Terminated by Sponsor|6
2453252|NCT02628028|8452321|P5|Dosing Period|Study Terminated by Sponsor|7
2453253|NCT02628028|8452322|P4|Dosing Period|Study Terminated by Sponsor|0
2453254|NCT02628028|8452323|P3|Dosing Period|Study Terminated by Sponsor|0
2453255|NCT02628028|8452324|P2|Dosing Period|Study Terminated by Sponsor|0
2453256|NCT02628028|8452325|P1|Dosing Period|Study Terminated by Sponsor|0
2453257|NCT02628028|8452318|P8|Dosing Period|Lack of Efficacy|0
2453258|NCT02628028|8452319|P7|Dosing Period|Lack of Efficacy|1
2453259|NCT02628028|8452320|P6|Dosing Period|Lack of Efficacy|0
2453260|NCT02628028|8452321|P5|Dosing Period|Lack of Efficacy|3
2453261|NCT02628028|8452322|P4|Dosing Period|Lack of Efficacy|0
2453262|NCT02628028|8452323|P3|Dosing Period|Lack of Efficacy|0
2453263|NCT02628028|8452324|P2|Dosing Period|Lack of Efficacy|0
2453264|NCT02628028|8452325|P1|Dosing Period|Lack of Efficacy|0
2453265|NCT02628028|8452318|P8|Dosing Period|Death|1
2453266|NCT02628028|8452319|P7|Dosing Period|Death|0
2453267|NCT02628028|8452320|P6|Dosing Period|Death|0
2453268|NCT02628028|8452321|P5|Dosing Period|Death|0
2453269|NCT02628028|8452322|P4|Dosing Period|Death|0
2453270|NCT02628028|8452323|P3|Dosing Period|Death|0
2453271|NCT02628028|8452324|P2|Dosing Period|Death|0
2453272|NCT02628028|8452325|P1|Dosing Period|Death|0
2453273|NCT02628028|8452318|P8|Dosing Period|Adverse Event|2
2453274|NCT02628028|8452319|P7|Dosing Period|Adverse Event|3
2453275|NCT02628028|8452320|P6|Dosing Period|Adverse Event|1
2453276|NCT02628028|8452321|P5|Dosing Period|Adverse Event|2
2453277|NCT02628028|8452322|P4|Dosing Period|Adverse Event|0
2453278|NCT02628028|8452323|P3|Dosing Period|Adverse Event|0
2453279|NCT02628028|8452324|P2|Dosing Period|Adverse Event|0
2453280|NCT02628028|8452325|P1|Dosing Period|Adverse Event|0
2453281|NCT02628028|8452318|P8|Dosing Period|Withdrawal by Subject|1
2453282|NCT02628028|8452319|P7|Dosing Period|Withdrawal by Subject|1
2453283|NCT02628028|8452320|P6|Dosing Period|Withdrawal by Subject|4
2453284|NCT02628028|8452321|P5|Dosing Period|Withdrawal by Subject|2
2453285|NCT02628028|8452322|P4|Dosing Period|Withdrawal by Subject|0
2453286|NCT02628028|8452323|P3|Dosing Period|Withdrawal by Subject|1
2453287|NCT02628028|8452324|P2|Dosing Period|Withdrawal by Subject|0
2453288|NCT02628028|8452325|P1|Dosing Period|Withdrawal by Subject|0
2453289|NCT02627144|8452410|P1|Overall Study|Other|17
2453290|NCT02627144|8452410|P1|Overall Study|Enrolled, not treated|6
2453291|NCT02627144|8452410|P1|Overall Study|Lost to Follow-up|8
2453292|NCT02627144|8452410|P1|Overall Study|Administrative reasons|65
2453293|NCT02627144|8452410|P1|Overall Study|Refusal of treatment / poor cooperation|38
2453294|NCT02627144|8452410|P1|Overall Study|Death from other cause|8
2453295|NCT02627144|8452410|P1|Overall Study|Death from cancer|20
2453296|NCT02627144|8452410|P1|Overall Study|Cancer progression|171
2453297|NCT02627144|8452410|P1|Overall Study|Serious adverse event|32
2453298|NCT02626819|8452451|P2|Overall Study|Diagnosed w/ catastrophic illness|1
2453299|NCT02626819|8452452|P1|Overall Study|Diagnosed w/ catastrophic illness|0
2453300|NCT02626819|8452451|P2|Overall Study|Withdrawal by Subject|0
2453301|NCT02626819|8452452|P1|Overall Study|Withdrawal by Subject|1
2453302|NCT02626819|8452451|P2|Overall Study|Lost to Follow-up|2
2453303|NCT02626819|8452452|P1|Overall Study|Lost to Follow-up|3
2453304|NCT02626780|8452472|P1|Overall Study|Withdrawal by Subject|3
2453305|NCT02626520|8452505|P2|Overall Study|Study terminated|1
2453306|NCT02626520|8452506|P1|Overall Study|Study terminated|0
2453307|NCT02626520|8452505|P2|Overall Study|Did not start protocol therapy|2
2453308|NCT02626520|8452506|P1|Overall Study|Did not start protocol therapy|0
2453309|NCT02626520|8452505|P2|Overall Study|Lack of Efficacy|2
2453310|NCT02626520|8452506|P1|Overall Study|Lack of Efficacy|0
2453311|NCT02626520|8452505|P2|Overall Study|Adverse Event|4
2453312|NCT02626520|8452506|P1|Overall Study|Adverse Event|0
2453313|NCT02626520|8452505|P2|Overall Study|Physician Decision|1
2453314|NCT02626520|8452506|P1|Overall Study|Physician Decision|1
2453315|NCT02626182|8452518|P2|Overall Study|Adverse Event|0
2453316|NCT02626182|8452519|P1|Overall Study|Adverse Event|2
2453317|NCT02626000|8452529|P1|Overall Study|Death|23
2453318|NCT02626000|8452529|P1|Overall Study|Continuing Study|13
2453319|NCT02625974|8452543|P2|Overall Study|Protocol Violation|1
2453320|NCT02625974|8452544|P1|Overall Study|Protocol Violation|0
2453321|NCT02625974|8452543|P2|Overall Study|non-compliance with study drug|2
2453322|NCT02625974|8452544|P1|Overall Study|non-compliance with study drug|0
2453323|NCT02625974|8452543|P2|Overall Study|positive parasitemia|0
2453324|NCT02625974|8452544|P1|Overall Study|positive parasitemia|1
2453325|NCT02625974|8452543|P2|Overall Study|Withdrawal by Subject|1
2453326|NCT02625974|8452544|P1|Overall Study|Withdrawal by Subject|3
2453327|NCT02625974|8452543|P2|Overall Study|Adverse Event|2
2453328|NCT02625974|8452544|P1|Overall Study|Adverse Event|12
2453329|NCT02625922|8452652|P2|Overall Study|Systolic blood pressure < 125 mmHg|1
2453330|NCT02625922|8452653|P1|Overall Study|Systolic blood pressure < 125 mmHg|1
2453331|NCT02625922|8452652|P2|Overall Study|Non-availability of IMP|1
2453332|NCT02625922|8452653|P1|Overall Study|Non-availability of IMP|1
2453333|NCT02625623|8452672|P2|Overall Study|Off-Treatment, but follow up ongoing|24
2453334|NCT02625623|8452673|P1|Overall Study|Off-Treatment, but follow up ongoing|30
2453335|NCT02625623|8452672|P2|Overall Study|Still on Treatment|10
2453336|NCT02625623|8452673|P1|Overall Study|Still on Treatment|10
2453337|NCT02625623|8452672|P2|Overall Study|Participants randomized but not treated|1
2453338|NCT02625623|8452673|P1|Overall Study|Participants randomized but not treated|9
2453339|NCT02625324|8452736|P1|12-Month Follow-up Secondary Endpoint|Death|4
2453340|NCT02625324|8452736|P1|6-Month Follow-up Subject Accountability|Lost to Follow-up|1
2453341|NCT02625324|8452736|P1|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2
2453342|NCT02625324|8452736|P1|6-Month Follow-up Subject Accountability|Death|5
2453343|NCT02625324|8452736|P1|30-Day Follow-up for Secondary Endpoint|Death|1
2453344|NCT02625324|8452736|P1|30-Day Follow-up for Primary Endpoint|Death|1
2453345|NCT02625259|8452761|P5|First Intervention (Day 1)|Withdrawal by Subject|0
2453346|NCT02625259|8452762|P4|First Intervention (Day 1)|Withdrawal by Subject|1
2453347|NCT02625259|8452763|P3|First Intervention (Day 1)|Withdrawal by Subject|0
2453348|NCT02625259|8452764|P2|First Intervention (Day 1)|Withdrawal by Subject|0
2453349|NCT02625259|8452765|P1|First Intervention (Day 1)|Withdrawal by Subject|0
2453350|NCT02625259|8452761|P5|First Intervention (Day 1)|Adverse Event|0
2453351|NCT02625259|8452762|P4|First Intervention (Day 1)|Adverse Event|0
2453352|NCT02625259|8452763|P3|First Intervention (Day 1)|Adverse Event|0
2453353|NCT02625259|8452764|P2|First Intervention (Day 1)|Adverse Event|1
2453354|NCT02625259|8452765|P1|First Intervention (Day 1)|Adverse Event|2
2453355|NCT02625259|8452761|P5|First Intervention (Day 1)|Other|0
2453356|NCT02625259|8452762|P4|First Intervention (Day 1)|Other|0
2453357|NCT02625259|8452763|P3|First Intervention (Day 1)|Other|1
2453358|NCT02625259|8452764|P2|First Intervention (Day 1)|Other|0
2453359|NCT02625259|8452765|P1|First Intervention (Day 1)|Other|0
2453360|NCT02625233|8452802|P2|Overall Study|Adverse Event|0
2453361|NCT02625233|8452803|P1|Overall Study|Adverse Event|2
2453362|NCT02625220|8452811|P1|Overall Study|Study discontinued at site|2
2453363|NCT02625220|8452811|P1|Overall Study|Protocol Violation|1
2453364|NCT02625220|8452811|P1|Overall Study|Lost to Follow-up|2
2453365|NCT02625220|8452811|P1|Overall Study|Adverse Event|2
2453366|NCT02624986|8452939|P8|Overall Study|Withdrawal by Subject|1
2453367|NCT02624986|8452940|P7|Overall Study|Withdrawal by Subject|0
2453368|NCT02624986|8452941|P6|Overall Study|Withdrawal by Subject|0
2453369|NCT02624986|8452942|P5|Overall Study|Withdrawal by Subject|0
2453370|NCT02624986|8452943|P4|Overall Study|Withdrawal by Subject|0
2453371|NCT02624986|8452944|P3|Overall Study|Withdrawal by Subject|0
2453372|NCT02624986|8452945|P2|Overall Study|Withdrawal by Subject|0
2453373|NCT02624986|8452946|P1|Overall Study|Withdrawal by Subject|0
2453374|NCT02624986|8452939|P8|Overall Study|Protocol Violation|0
2453375|NCT02624986|8452940|P7|Overall Study|Protocol Violation|0
2453376|NCT02624986|8452941|P6|Overall Study|Protocol Violation|0
2453377|NCT02624986|8452942|P5|Overall Study|Protocol Violation|0
2453378|NCT02624986|8452943|P4|Overall Study|Protocol Violation|0
2453379|NCT02624986|8452944|P3|Overall Study|Protocol Violation|0
2453380|NCT02624986|8452945|P2|Overall Study|Protocol Violation|0
2453381|NCT02624986|8452946|P1|Overall Study|Protocol Violation|1
2453382|NCT02624986|8452939|P8|Overall Study|Progressive Disease|0
2453383|NCT02624986|8452940|P7|Overall Study|Progressive Disease|0
2453384|NCT02624986|8452941|P6|Overall Study|Progressive Disease|0
2453385|NCT02624986|8452942|P5|Overall Study|Progressive Disease|0
2453386|NCT02624986|8452943|P4|Overall Study|Progressive Disease|0
2453387|NCT02624986|8452944|P3|Overall Study|Progressive Disease|0
2453388|NCT02624986|8452945|P2|Overall Study|Progressive Disease|1
2453389|NCT02624986|8452946|P1|Overall Study|Progressive Disease|0
2453390|NCT02624986|8452939|P8|Overall Study|Study Terminated by Sponsor|3
2453391|NCT02624986|8452940|P7|Overall Study|Study Terminated by Sponsor|4
2453392|NCT02624986|8452941|P6|Overall Study|Study Terminated by Sponsor|2
2453393|NCT02624986|8452942|P5|Overall Study|Study Terminated by Sponsor|2
2453394|NCT02624986|8452943|P4|Overall Study|Study Terminated by Sponsor|1
2453395|NCT02624986|8452944|P3|Overall Study|Study Terminated by Sponsor|0
2453396|NCT02624986|8452945|P2|Overall Study|Study Terminated by Sponsor|1
2453397|NCT02624986|8452946|P1|Overall Study|Study Terminated by Sponsor|1
2453398|NCT02624986|8452939|P8|Overall Study|Death|1
2453399|NCT02624986|8452940|P7|Overall Study|Death|0
2453400|NCT02624986|8452941|P6|Overall Study|Death|0
2453401|NCT02624986|8452942|P5|Overall Study|Death|2
2453402|NCT02624986|8452943|P4|Overall Study|Death|2
2453403|NCT02624986|8452944|P3|Overall Study|Death|2
2453404|NCT02624986|8452945|P2|Overall Study|Death|1
2453405|NCT02624986|8452946|P1|Overall Study|Death|0
2453406|NCT02624791|8453123|P6|Overall Study|Withdrawal by Subject|0
2453407|NCT02624791|8453124|P5|Overall Study|Withdrawal by Subject|0
2453408|NCT02624791|8453125|P4|Overall Study|Withdrawal by Subject|0
2453409|NCT02624791|8453126|P3|Overall Study|Withdrawal by Subject|0
2453410|NCT02624791|8453127|P2|Overall Study|Withdrawal by Subject|0
2453411|NCT02624791|8453128|P1|Overall Study|Withdrawal by Subject|2
2453412|NCT02624713|8453135|P2|Overall Study|Lost to Follow-up|0
2453413|NCT02624713|8453136|P1|Overall Study|Lost to Follow-up|14
2453414|NCT02624687|8453145|P2|Overall Study|medical leave from work|1
2453415|NCT02624687|8453146|P1|Overall Study|medical leave from work|0
2453416|NCT02624687|8453145|P2|Overall Study|Withdrawal by Subject|1
2453417|NCT02624687|8453146|P1|Overall Study|Withdrawal by Subject|1
2453418|NCT02624492|8453177|P3|Overall Study|Progressive disease|3
2453419|NCT02624492|8453178|P2|Overall Study|Progressive disease|2
2453420|NCT02624492|8453179|P1|Overall Study|Progressive disease|0
2453421|NCT02624492|8453177|P3|Overall Study|Adverse Event|2
2453422|NCT02624492|8453178|P2|Overall Study|Adverse Event|2
2453423|NCT02624492|8453179|P1|Overall Study|Adverse Event|2
2453424|NCT02624284|8453214|P3|Overall Study|Adverse Event|1
2453425|NCT02624284|8453215|P2|Overall Study|Adverse Event|0
2453426|NCT02624284|8453216|P1|Overall Study|Adverse Event|0
2453427|NCT02624284|8453214|P3|Overall Study|Revealed exclusionary condition|0
2453428|NCT02624284|8453215|P2|Overall Study|Revealed exclusionary condition|2
2453429|NCT02624284|8453216|P1|Overall Study|Revealed exclusionary condition|2
2453430|NCT02624284|8453214|P3|Overall Study|Protocol Violation|7
2453431|NCT02624284|8453215|P2|Overall Study|Protocol Violation|10
2453432|NCT02624284|8453216|P1|Overall Study|Protocol Violation|9
2453433|NCT02624284|8453214|P3|Overall Study|Withdrawal by Subject|3
2453434|NCT02624284|8453215|P2|Overall Study|Withdrawal by Subject|6
2453435|NCT02624284|8453216|P1|Overall Study|Withdrawal by Subject|3
2453436|NCT02624050|8453235|P2|Overall Study|Protocol Violation|0
2453437|NCT02624050|8453236|P1|Overall Study|Protocol Violation|2
2453438|NCT02624050|8453235|P2|Overall Study|Physician Decision|0
2453439|NCT02624050|8453236|P1|Overall Study|Physician Decision|4
2453440|NCT02623959|8453264|P2|Overall Study|Progression|1
2453441|NCT02623959|8453265|P1|Overall Study|Progression|0
2453442|NCT02623725|8453345|P2|Overall Study|Withdrawal by Subject|1
2453443|NCT02623725|8453346|P1|Overall Study|Withdrawal by Subject|7
2453444|NCT02623725|8453345|P2|Overall Study|Serious adverse event|2
2453445|NCT02623725|8453346|P1|Overall Study|Serious adverse event|0
2453446|NCT02623725|8453345|P2|Overall Study|Non compliance with protocol|3
2453447|NCT02623725|8453346|P1|Overall Study|Non compliance with protocol|9
2453448|NCT02623361|8453380|P2|Overall Study|Withdrawal by Subject|1
2453449|NCT02623361|8453381|P1|Overall Study|Withdrawal by Subject|0
2453450|NCT02623361|8453380|P2|Overall Study|Protocol Violation|1
2453451|NCT02623361|8453381|P1|Overall Study|Protocol Violation|0
2453452|NCT02623335|8453420|P2|Overall Study|Protocol Violation|1
2453453|NCT02623335|8453421|P1|Overall Study|Protocol Violation|2
2453454|NCT02623335|8453420|P2|Overall Study|Withdrawal by Subject|5
2453455|NCT02623335|8453421|P1|Overall Study|Withdrawal by Subject|2
2453456|NCT02623335|8453420|P2|Overall Study|Lost to Follow-up|23
2453457|NCT02623335|8453421|P1|Overall Study|Lost to Follow-up|15
2453458|NCT02623335|8453420|P2|Overall Study|Death|7
2453459|NCT02623335|8453421|P1|Overall Study|Death|8
2453460|NCT02623322|8453448|P3|Overall Study|Lost to Follow-up|0
2453461|NCT02623322|8453449|P2|Overall Study|Lost to Follow-up|1
2453462|NCT02623322|8453450|P1|Overall Study|Lost to Follow-up|2
2453463|NCT02623218|8453488|P5|Overall Study|Lost to Follow-up|0
2453464|NCT02623218|8453489|P4|Overall Study|Lost to Follow-up|0
2453465|NCT02623218|8453490|P3|Overall Study|Lost to Follow-up|0
2453466|NCT02623218|8453491|P2|Overall Study|Lost to Follow-up|1
2453467|NCT02623218|8453492|P1|Overall Study|Lost to Follow-up|0
2453468|NCT02622828|8453514|P1|Overall Study|participant withdrew|3
2453469|NCT02622724|8453521|P2|Overall Study|Early termination of study|43
2453470|NCT02622724|8453522|P1|Overall Study|Early termination of study|38
2453471|NCT02622724|8453521|P2|Overall Study|Lost to Follow-UP, withdrawal of consent|7
2453472|NCT02622724|8453522|P1|Overall Study|Lost to Follow-UP, withdrawal of consent|4
2453473|NCT02622724|8453521|P2|Overall Study|Death|53
2453474|NCT02622724|8453522|P1|Overall Study|Death|51
2453475|NCT02622568|8453600|P2|Overall Study|Lost to Follow-up|5
2453476|NCT02622568|8453601|P1|Overall Study|Lost to Follow-up|5
2453477|NCT02622321|8453611|P4|Overall Study|Withdrawal by Subject|0
2453478|NCT02622321|8453612|P3|Overall Study|Withdrawal by Subject|0
2453479|NCT02622321|8453613|P2|Overall Study|Withdrawal by Subject|0
2453480|NCT02622321|8453614|P1|Overall Study|Withdrawal by Subject|1
2453481|NCT02622321|8453611|P4|Overall Study|Ongoing treatment with emicizumab|7
2453482|NCT02622321|8453612|P3|Overall Study|Ongoing treatment with emicizumab|49
2453483|NCT02622321|8453613|P2|Overall Study|Ongoing treatment with emicizumab|13
2453484|NCT02622321|8453614|P1|Overall Study|Ongoing treatment with emicizumab|31
2453485|NCT02622321|8453611|P4|Overall Study|Ongoing in safety follow-up|0
2453486|NCT02622321|8453612|P3|Overall Study|Ongoing in safety follow-up|0
2453487|NCT02622321|8453613|P2|Overall Study|Ongoing in safety follow-up|0
2453488|NCT02622321|8453614|P1|Overall Study|Ongoing in safety follow-up|3
2453489|NCT02622321|8453611|P4|Overall Study|Ongoing treatment with no emicizumab|0
2453490|NCT02622321|8453612|P3|Overall Study|Ongoing treatment with no emicizumab|0
2453491|NCT02622321|8453613|P2|Overall Study|Ongoing treatment with no emicizumab|5
2453492|NCT02622321|8453614|P1|Overall Study|Ongoing treatment with no emicizumab|0
2453493|NCT02622113|8453685|P2|Overall Study|Stopping Criteria|3
2453494|NCT02622113|8453686|P1|Overall Study|Stopping Criteria|1
2453495|NCT02622113|8453685|P2|Overall Study|Withdrawal by Subject|2
2453496|NCT02622113|8453686|P1|Overall Study|Withdrawal by Subject|0
2453497|NCT02622113|8453685|P2|Overall Study|Physician Decision|1
2453498|NCT02622113|8453686|P1|Overall Study|Physician Decision|0
2453499|NCT02622113|8453685|P2|Overall Study|Adverse Event|4
2453500|NCT02622113|8453686|P1|Overall Study|Adverse Event|4
2453501|NCT02622074|8453704|P6|Overall Study|Ongoing in Study|10
2453502|NCT02622074|8453705|P5|Overall Study|Ongoing in Study|10
2453503|NCT02622074|8453706|P4|Overall Study|Ongoing in Study|9
2453504|NCT02622074|8453707|P3|Overall Study|Ongoing in Study|10
2453505|NCT02622074|8453708|P2|Overall Study|Ongoing in Study|9
2453506|NCT02622074|8453709|P1|Overall Study|Ongoing in Study|6
2453507|NCT02622074|8453704|P6|Overall Study|Withdrawal by Subject|0
2453508|NCT02622074|8453705|P5|Overall Study|Withdrawal by Subject|0
2453509|NCT02622074|8453706|P4|Overall Study|Withdrawal by Subject|0
2453510|NCT02622074|8453707|P3|Overall Study|Withdrawal by Subject|0
2453511|NCT02622074|8453708|P2|Overall Study|Withdrawal by Subject|1
2453512|NCT02622074|8453709|P1|Overall Study|Withdrawal by Subject|0
2453513|NCT02622074|8453704|P6|Overall Study|Death|0
2453514|NCT02622074|8453705|P5|Overall Study|Death|0
2453515|NCT02622074|8453706|P4|Overall Study|Death|1
2453516|NCT02622074|8453707|P3|Overall Study|Death|0
2453517|NCT02622074|8453708|P2|Overall Study|Death|0
2453518|NCT02622074|8453709|P1|Overall Study|Death|4
2453519|NCT02621931|8453801|P3|Overall Study|Other|3
2453520|NCT02621931|8453802|P2|Overall Study|Other|1
2453521|NCT02621931|8453803|P1|Overall Study|Other|1
2453522|NCT02621931|8453801|P3|Overall Study|Lack of Efficacy|1
2453523|NCT02621931|8453802|P2|Overall Study|Lack of Efficacy|0
2453524|NCT02621931|8453803|P1|Overall Study|Lack of Efficacy|0
2453525|NCT02621931|8453801|P3|Overall Study|Lost to Follow-up|10
2453526|NCT02621931|8453802|P2|Overall Study|Lost to Follow-up|7
2453527|NCT02621931|8453803|P1|Overall Study|Lost to Follow-up|8
2453528|NCT02621931|8453801|P3|Overall Study|Noncompliance to study procedures|2
2453529|NCT02621931|8453802|P2|Overall Study|Noncompliance to study procedures|1
2453530|NCT02621931|8453803|P1|Overall Study|Noncompliance to study procedures|0
2453531|NCT02621931|8453801|P3|Overall Study|Pregnancy|0
2453532|NCT02621931|8453802|P2|Overall Study|Pregnancy|0
2453533|NCT02621931|8453803|P1|Overall Study|Pregnancy|2
2453534|NCT02621931|8453801|P3|Overall Study|Protocol Violation|2
2453535|NCT02621931|8453802|P2|Overall Study|Protocol Violation|2
2453536|NCT02621931|8453803|P1|Overall Study|Protocol Violation|2
2453537|NCT02621931|8453801|P3|Overall Study|Withdrawal by Subject|11
2453538|NCT02621931|8453802|P2|Overall Study|Withdrawal by Subject|10
2453539|NCT02621931|8453803|P1|Overall Study|Withdrawal by Subject|12
2453540|NCT02621931|8453801|P3|Overall Study|Adverse Event|7
2453541|NCT02621931|8453802|P2|Overall Study|Adverse Event|5
2453542|NCT02621931|8453803|P1|Overall Study|Adverse Event|8
2453543|NCT02621931|8453801|P3|Overall Study|Death|0
2453544|NCT02621931|8453802|P2|Overall Study|Death|1
2453545|NCT02621931|8453803|P1|Overall Study|Death|0
2453546|NCT02621606|8453885|P3|Overall Study|Withdrawal by Subject|0
2453547|NCT02621606|8453886|P2|Overall Study|Withdrawal by Subject|1
2453548|NCT02621606|8453887|P1|Overall Study|Withdrawal by Subject|0
2453549|NCT02621073|8453915|P2|Overall Study|Physician Decision|2
2453550|NCT02621073|8453916|P1|Overall Study|Physician Decision|3
2453551|NCT02621073|8453915|P2|Overall Study|Lost to Follow-up|1
2453552|NCT02621073|8453916|P1|Overall Study|Lost to Follow-up|0
2453553|NCT02621047|8453978|P3|Overall Study|Adverse Event|1
2453554|NCT02621047|8453979|P2|Overall Study|Adverse Event|0
2453555|NCT02621047|8453980|P1|Overall Study|Adverse Event|0
2453556|NCT02621034|8454096|P3|Overall Study|Lost to Follow-up|5
2453557|NCT02621034|8454097|P2|Overall Study|Lost to Follow-up|2
2453558|NCT02621034|8454098|P1|Overall Study|Lost to Follow-up|3
2453559|NCT02620787|8454132|P2|Overall Study|Eligibility Criteria Not Met|0
2453560|NCT02620787|8454133|P1|Overall Study|Eligibility Criteria Not Met|1
2453561|NCT02620787|8454132|P2|Overall Study|Adverse Event|0
2453562|NCT02620787|8454133|P1|Overall Study|Adverse Event|1
2453563|NCT02620384|8454175|P2|Overall Study|Drug shortage prevented 2nd dose|1
2453564|NCT02620384|8454176|P1|Overall Study|Drug shortage prevented 2nd dose|0
2453565|NCT02620384|8454175|P2|Overall Study|Discharged prior to 2nd dose|5
2453566|NCT02620384|8454176|P1|Overall Study|Discharged prior to 2nd dose|2
2453567|NCT02620384|8454175|P2|Overall Study|Adverse Event|1
2453568|NCT02620384|8454176|P1|Overall Study|Adverse Event|2
2453569|NCT02620020|8454208|P4|Overall Study|Death|0
2453570|NCT02620020|8454209|P3|Overall Study|Death|0
2453571|NCT02620020|8454210|P2|Overall Study|Death|1
2453572|NCT02620020|8454211|P1|Overall Study|Death|0
2453573|NCT02620020|8454208|P4|Overall Study|Withdrawal by Subject|12
2453574|NCT02620020|8454209|P3|Overall Study|Withdrawal by Subject|17
2453575|NCT02620020|8454210|P2|Overall Study|Withdrawal by Subject|16
2453576|NCT02620020|8454211|P1|Overall Study|Withdrawal by Subject|20
2453577|NCT02620020|8454208|P4|Overall Study|Protocol Violation|1
2453578|NCT02620020|8454209|P3|Overall Study|Protocol Violation|1
2453579|NCT02620020|8454210|P2|Overall Study|Protocol Violation|2
2453580|NCT02620020|8454211|P1|Overall Study|Protocol Violation|5
2453581|NCT02620020|8454208|P4|Overall Study|Physician Decision|4
2453582|NCT02620020|8454209|P3|Overall Study|Physician Decision|3
2453583|NCT02620020|8454210|P2|Overall Study|Physician Decision|4
2453584|NCT02620020|8454211|P1|Overall Study|Physician Decision|7
2453585|NCT02620020|8454208|P4|Overall Study|Lost to Follow-up|4
2453586|NCT02620020|8454209|P3|Overall Study|Lost to Follow-up|1
2453587|NCT02620020|8454210|P2|Overall Study|Lost to Follow-up|8
2453588|NCT02620020|8454211|P1|Overall Study|Lost to Follow-up|4
2453589|NCT02620020|8454208|P4|Overall Study|Adverse Event|5
2453590|NCT02620020|8454209|P3|Overall Study|Adverse Event|3
2453591|NCT02620020|8454210|P2|Overall Study|Adverse Event|4
2453592|NCT02620020|8454211|P1|Overall Study|Adverse Event|8
2453593|NCT02619812|8454237|P4|Overall Study|Withdrawal by Subject|2
2453594|NCT02619812|8454238|P3|Overall Study|Withdrawal by Subject|1
2453595|NCT02619812|8454239|P2|Overall Study|Withdrawal by Subject|0
2453596|NCT02619812|8454240|P1|Overall Study|Withdrawal by Subject|0
2453597|NCT02619617|8454273|P2|Period 2 SOM230 - 2nd Attack|Physician Decision|3
2453598|NCT02619617|8454274|P1|Period 2 SOM230 - 2nd Attack|Physician Decision|0
2453599|NCT02619617|8454273|P2|Period 2 SOM230 - 2nd Attack|Protocol Violation|1
2453600|NCT02619617|8454274|P1|Period 2 SOM230 - 2nd Attack|Protocol Violation|0
2453601|NCT02619175|8454321|P2|Overall Study|foot pain|0
2453602|NCT02619175|8454322|P1|Overall Study|foot pain|1
2453603|NCT02619175|8454321|P2|Overall Study|Withdrawal by Subject|0
2453604|NCT02619175|8454322|P1|Overall Study|Withdrawal by Subject|1
2453605|NCT02618928|8454336|P1|Overall Study|Treatment Never Started|7
2453606|NCT02618928|8454336|P1|Overall Study|Missing|6
2453607|NCT02618928|8454336|P1|Overall Study|Other|11
2453608|NCT02618928|8454336|P1|Overall Study|Death|3
2453609|NCT02618928|8454336|P1|Overall Study|Withdrawal by Subject|2
2453610|NCT02618928|8454336|P1|Overall Study|Insufficient Virological Response|1
2453611|NCT02618928|8454336|P1|Overall Study|Failure to Return|28
2453612|NCT02618759|8454431|P2|Overall Study|Other Reasons|4
2453613|NCT02618759|8454432|P1|Overall Study|Other Reasons|1
2453614|NCT02618759|8454431|P2|Overall Study|Withdrawal by Subject|0
2453615|NCT02618759|8454432|P1|Overall Study|Withdrawal by Subject|1
2453616|NCT02618759|8454431|P2|Overall Study|Lost to Follow-up|1
2453617|NCT02618759|8454432|P1|Overall Study|Lost to Follow-up|0
2453618|NCT02617628|8454620|P2|Overall Study|Withdr, Transfers-other prisons, dropout|61
2453619|NCT02617628|8454621|P1|Overall Study|Withdr, Transfers-other prisons, dropout|62
2453620|NCT02616900|8454629|P1|Overall Study|Incomplete data|6
2453621|NCT02616900|8454629|P1|Overall Study|Withdrawal by Subject|3
2453622|NCT02616900|8454629|P1|Overall Study|Protocol Violation|5
2453623|NCT02616900|8454629|P1|Overall Study|Lost to Follow-up|2
2453624|NCT02616900|8454629|P1|Overall Study|Lack of Efficacy|7
2453625|NCT02616783|8454637|P2|Overall Study|Withdrew Consent|1
2453626|NCT02616783|8454638|P1|Overall Study|Withdrew Consent|1
2453627|NCT02616783|8454637|P2|Overall Study|Protocol Violation|1
2453628|NCT02616783|8454638|P1|Overall Study|Protocol Violation|1
2453629|NCT02616783|8454637|P2|Overall Study|Non-Compliance with Study Drug|0
2453630|NCT02616783|8454638|P1|Overall Study|Non-Compliance with Study Drug|1
2453631|NCT02616783|8454637|P2|Overall Study|Death|0
2453632|NCT02616783|8454638|P1|Overall Study|Death|1
2453633|NCT02616783|8454637|P2|Overall Study|Adverse Event|0
2453634|NCT02616783|8454638|P1|Overall Study|Adverse Event|1
2453635|NCT02616783|8454637|P2|Overall Study|Randomized but Not Treated|0
2453636|NCT02616783|8454638|P1|Overall Study|Randomized but Not Treated|1
2453637|NCT02616601|8454661|P3|Overall Study|Non-Compliance with Test Article|1
2453638|NCT02616601|8454662|P2|Overall Study|Non-Compliance with Test Article|0
2453639|NCT02616601|8454663|P1|Overall Study|Non-Compliance with Test Article|1
2453640|NCT02616601|8454661|P3|Overall Study|Lost to Follow-up|1
2453641|NCT02616601|8454662|P2|Overall Study|Lost to Follow-up|0
2453642|NCT02616601|8454663|P1|Overall Study|Lost to Follow-up|1
2453643|NCT02616601|8454661|P3|Overall Study|Death|0
2453644|NCT02616601|8454662|P2|Overall Study|Death|0
2453645|NCT02616601|8454663|P1|Overall Study|Death|1
2453646|NCT02616601|8454661|P3|Overall Study|Adverse Event|2
2453647|NCT02616601|8454662|P2|Overall Study|Adverse Event|0
2453648|NCT02616601|8454663|P1|Overall Study|Adverse Event|2
2453649|NCT02616601|8454661|P3|Overall Study|Withdrawal by Subject|3
2453650|NCT02616601|8454662|P2|Overall Study|Withdrawal by Subject|4
2453651|NCT02616601|8454663|P1|Overall Study|Withdrawal by Subject|4
2453652|NCT02616380|8454690|P1|Overall Study|Other|2
2453653|NCT02616380|8454690|P1|Overall Study|Lost to Follow-up|1
2453654|NCT02616146|8454714|P2|Overall Study|Physician Decision|1
2453655|NCT02616146|8454715|P1|Overall Study|Physician Decision|2
2453656|NCT02616146|8454714|P2|Overall Study|Withdrawal by Subject|24
2453657|NCT02616146|8454715|P1|Overall Study|Withdrawal by Subject|30
2453658|NCT02616146|8454714|P2|Overall Study|Participant moved|3
2453659|NCT02616146|8454715|P1|Overall Study|Participant moved|4
2453660|NCT02616146|8454714|P2|Overall Study|Study terminated by sponsor|432
2453661|NCT02616146|8454715|P1|Overall Study|Study terminated by sponsor|1372
2453662|NCT02616146|8454714|P2|Overall Study|Protocol Violation|3
2453663|NCT02616146|8454715|P1|Overall Study|Protocol Violation|6
2453664|NCT02616146|8454714|P2|Overall Study|Pregnancy wish|0
2453665|NCT02616146|8454715|P1|Overall Study|Pregnancy wish|3
2453666|NCT02616146|8454714|P2|Overall Study|Pregnancy|2
2453667|NCT02616146|8454715|P1|Overall Study|Pregnancy|2
2453668|NCT02616146|8454714|P2|Overall Study|Non-compliance with study drug|2
2453669|NCT02616146|8454715|P1|Overall Study|Non-compliance with study drug|4
2453670|NCT02616146|8454714|P2|Overall Study|Non-compliance with study protocol|0
2453671|NCT02616146|8454715|P1|Overall Study|Non-compliance with study protocol|2
2453672|NCT02616146|8454714|P2|Overall Study|Lost to Follow-up|13
2453673|NCT02616146|8454715|P1|Overall Study|Lost to Follow-up|23
2453674|NCT02616146|8454714|P2|Overall Study|Adverse Event|24
2453675|NCT02616146|8454715|P1|Overall Study|Adverse Event|64
2453676|NCT02616029|8454731|P2|Overall Study|Still on Study|8
2453677|NCT02616029|8454732|P1|Overall Study|Still on Study|0
2453678|NCT02616029|8454731|P2|Overall Study|Withdrew Consent|0
2453679|NCT02616029|8454732|P1|Overall Study|Withdrew Consent|1
2453680|NCT02616029|8454731|P2|Overall Study|Protocol Violation|0
2453681|NCT02616029|8454732|P1|Overall Study|Protocol Violation|1
2453682|NCT02616029|8454731|P2|Overall Study|Adverse Event|0
2453683|NCT02616029|8454732|P1|Overall Study|Adverse Event|1
2453684|NCT02616029|8454731|P2|Overall Study|Enrolled and Never Treated|1
2453685|NCT02616029|8454732|P1|Overall Study|Enrolled and Never Treated|1
2453686|NCT02615990|8454755|P2|Overall Study|study terminated|1
2453687|NCT02615990|8454756|P1|Overall Study|study terminated|1
2453688|NCT02615470|8454855|P2|Overall Study|Lost to Follow-up|32
2453689|NCT02615470|8454856|P1|Overall Study|Lost to Follow-up|21
2453690|NCT02615145|8454869|P4|Overall Study|Other, Not Specified|0
2453691|NCT02615145|8454870|P3|Overall Study|Other, Not Specified|0
2453692|NCT02615145|8454871|P2|Overall Study|Other, Not Specified|2
2453693|NCT02615145|8454872|P1|Overall Study|Other, Not Specified|5
2453694|NCT02615145|8454869|P4|Overall Study|Death|0
2453695|NCT02615145|8454870|P3|Overall Study|Death|0
2453696|NCT02615145|8454871|P2|Overall Study|Death|3
2453697|NCT02615145|8454872|P1|Overall Study|Death|2
2453698|NCT02615145|8454869|P4|Overall Study|Failure to Return|0
2453699|NCT02615145|8454870|P3|Overall Study|Failure to Return|7
2453700|NCT02615145|8454871|P2|Overall Study|Failure to Return|10
2453701|NCT02615145|8454872|P1|Overall Study|Failure to Return|20
2453702|NCT02615145|8454869|P4|Overall Study|Did Not Start Treatment|1
2453703|NCT02615145|8454870|P3|Overall Study|Did Not Start Treatment|1
2453704|NCT02615145|8454871|P2|Overall Study|Did Not Start Treatment|0
2453705|NCT02615145|8454872|P1|Overall Study|Did Not Start Treatment|0
2453706|NCT02614898|8454959|P2|Overall Study|Missing|1
2453707|NCT02614898|8454960|P1|Overall Study|Missing|0
2453708|NCT02614898|8454959|P2|Overall Study|Other-Additional Information Unavailable|11
2453709|NCT02614898|8454960|P1|Overall Study|Other-Additional Information Unavailable|0
2453710|NCT02614898|8454959|P2|Overall Study|Withdrawal by Parent/Guardian|1
2453711|NCT02614898|8454960|P1|Overall Study|Withdrawal by Parent/Guardian|1
2453712|NCT02614898|8454959|P2|Overall Study|Withdrawal by Subject|2
2453713|NCT02614898|8454960|P1|Overall Study|Withdrawal by Subject|0
2453714|NCT02614898|8454959|P2|Overall Study|Study Terminated by Sponsor|0
2453715|NCT02614898|8454960|P1|Overall Study|Study Terminated by Sponsor|3
2453716|NCT02614898|8454959|P2|Overall Study|Physician Decision|8
2453717|NCT02614898|8454960|P1|Overall Study|Physician Decision|1
2453718|NCT02614898|8454959|P2|Overall Study|Lost to Follow-up|2
2453719|NCT02614898|8454960|P1|Overall Study|Lost to Follow-up|0
2453720|NCT02614898|8454959|P2|Overall Study|Participated until study termination|26
2453721|NCT02614898|8454960|P1|Overall Study|Participated until study termination|10
2453722|NCT02614729|8454972|P2|Overall Study|Withdrawal by Subject|0
2453723|NCT02614729|8454973|P1|Overall Study|Withdrawal by Subject|1
2453724|NCT02614703|8454993|P2|Overall Study|Withdrawal by Subject|1
2453725|NCT02614703|8454994|P1|Overall Study|Withdrawal by Subject|7
2453726|NCT02614560|8455038|P2|Overall Study|Death|2
2453727|NCT02614560|8455039|P1|Overall Study|Death|6
2453728|NCT02614287|8455087|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|3
2453729|NCT02614287|8455088|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|6
2453730|NCT02614287|8455087|P2|Post Treatment Follow-up Phase|Lost to Follow-up|2
2453731|NCT02614287|8455088|P1|Post Treatment Follow-up Phase|Lost to Follow-up|2
2453732|NCT02614287|8455087|P2|Post Treatment Follow-up Phase|Adverse Event|0
2453733|NCT02614287|8455088|P1|Post Treatment Follow-up Phase|Adverse Event|1
2453734|NCT02614287|8455087|P2|Open Label (OL) Treatment Phase|Withdrawal by Subject|7
2453735|NCT02614287|8455088|P1|Open Label (OL) Treatment Phase|Withdrawal by Subject|10
2453736|NCT02614287|8455087|P2|Open Label (OL) Treatment Phase|Physician Decision|0
2453737|NCT02614287|8455088|P1|Open Label (OL) Treatment Phase|Physician Decision|1
2453738|NCT02614287|8455087|P2|Open Label (OL) Treatment Phase|Lost to Follow-up|4
2453739|NCT02614287|8455088|P1|Open Label (OL) Treatment Phase|Lost to Follow-up|7
2453740|NCT02614287|8455087|P2|Open Label (OL) Treatment Phase|Lack of Efficacy|5
2453741|NCT02614287|8455088|P1|Open Label (OL) Treatment Phase|Lack of Efficacy|13
2453742|NCT02614287|8455087|P2|Open Label (OL) Treatment Phase|Adverse Event|6
2453743|NCT02614287|8455088|P1|Open Label (OL) Treatment Phase|Adverse Event|7
2453744|NCT02614261|8455134|P3|Overall Study|Withdrawal by Subject|7
2453745|NCT02614261|8455135|P2|Overall Study|Withdrawal by Subject|4
2453746|NCT02614261|8455136|P1|Overall Study|Withdrawal by Subject|19
2453747|NCT02614261|8455134|P3|Overall Study|Protocol Violation|0
2453748|NCT02614261|8455135|P2|Overall Study|Protocol Violation|1
2453749|NCT02614261|8455136|P1|Overall Study|Protocol Violation|6
2453750|NCT02614261|8455134|P3|Overall Study|Pregnancy|0
2453751|NCT02614261|8455135|P2|Overall Study|Pregnancy|2
2453752|NCT02614261|8455136|P1|Overall Study|Pregnancy|2
2453753|NCT02614261|8455134|P3|Overall Study|Physician Decision|1
2453754|NCT02614261|8455135|P2|Overall Study|Physician Decision|1
2453755|NCT02614261|8455136|P1|Overall Study|Physician Decision|2
2453756|NCT02614261|8455134|P3|Overall Study|Lost to Follow-up|1
2453757|NCT02614261|8455135|P2|Overall Study|Lost to Follow-up|4
2453758|NCT02614261|8455136|P1|Overall Study|Lost to Follow-up|10
2453759|NCT02614261|8455134|P3|Overall Study|Lack of Efficacy|0
2453760|NCT02614261|8455135|P2|Overall Study|Lack of Efficacy|0
2453761|NCT02614261|8455136|P1|Overall Study|Lack of Efficacy|4
2453762|NCT02614261|8455134|P3|Overall Study|Adverse Event|2
2453763|NCT02614261|8455135|P2|Overall Study|Adverse Event|3
2453764|NCT02614261|8455136|P1|Overall Study|Adverse Event|6
2453765|NCT02614196|8455202|P6|Post Treatment Follow-up Phase|Withdrawal by Subject|0
2453766|NCT02614196|8455203|P5|Post Treatment Follow-up Phase|Withdrawal by Subject|0
2453767|NCT02614196|8455204|P4|Post Treatment Follow-up Phase|Withdrawal by Subject|1
2453768|NCT02614196|8455205|P3|Post Treatment Follow-up Phase|Withdrawal by Subject|5
2453769|NCT02614196|8455206|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|1
2453770|NCT02614196|8455207|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|10
2453771|NCT02614196|8455202|P6|Post Treatment Follow-up Phase|Protocol Violation|0
2453772|NCT02614196|8455203|P5|Post Treatment Follow-up Phase|Protocol Violation|1
2453773|NCT02614196|8455204|P4|Post Treatment Follow-up Phase|Protocol Violation|0
2453774|NCT02614196|8455205|P3|Post Treatment Follow-up Phase|Protocol Violation|0
2453775|NCT02614196|8455206|P2|Post Treatment Follow-up Phase|Protocol Violation|1
2453776|NCT02614196|8455207|P1|Post Treatment Follow-up Phase|Protocol Violation|0
2453777|NCT02614196|8455202|P6|Post Treatment Follow-up Phase|Pregnancy|0
2453778|NCT02614196|8455203|P5|Post Treatment Follow-up Phase|Pregnancy|0
2453779|NCT02614196|8455204|P4|Post Treatment Follow-up Phase|Pregnancy|0
2453780|NCT02614196|8455205|P3|Post Treatment Follow-up Phase|Pregnancy|0
2453781|NCT02614196|8455206|P2|Post Treatment Follow-up Phase|Pregnancy|0
2453782|NCT02614196|8455207|P1|Post Treatment Follow-up Phase|Pregnancy|2
2453783|NCT02614196|8455202|P6|Post Treatment Follow-up Phase|Lost to Follow-up|0
2453784|NCT02614196|8455203|P5|Post Treatment Follow-up Phase|Lost to Follow-up|1
2453785|NCT02614196|8455204|P4|Post Treatment Follow-up Phase|Lost to Follow-up|0
2453786|NCT02614196|8455205|P3|Post Treatment Follow-up Phase|Lost to Follow-up|3
2453787|NCT02614196|8455206|P2|Post Treatment Follow-up Phase|Lost to Follow-up|3
2453788|NCT02614196|8455207|P1|Post Treatment Follow-up Phase|Lost to Follow-up|8
2453789|NCT02614196|8455202|P6|Double Blind Treatment Phase|Did not receive study drug|0
2453790|NCT02614196|8455203|P5|Double Blind Treatment Phase|Did not receive study drug|0
2453791|NCT02614196|8455204|P4|Double Blind Treatment Phase|Did not receive study drug|0
2453792|NCT02614196|8455205|P3|Double Blind Treatment Phase|Did not receive study drug|3
2453793|NCT02614196|8455206|P2|Double Blind Treatment Phase|Did not receive study drug|2
2453794|NCT02614196|8455207|P1|Double Blind Treatment Phase|Did not receive study drug|2
2453795|NCT02614196|8455202|P6|Double Blind Treatment Phase|Withdrawal by Subject|0
2453796|NCT02614196|8455203|P5|Double Blind Treatment Phase|Withdrawal by Subject|0
2453797|NCT02614196|8455204|P4|Double Blind Treatment Phase|Withdrawal by Subject|4
2453798|NCT02614196|8455205|P3|Double Blind Treatment Phase|Withdrawal by Subject|14
2453799|NCT02614196|8455206|P2|Double Blind Treatment Phase|Withdrawal by Subject|11
2453800|NCT02614196|8455207|P1|Double Blind Treatment Phase|Withdrawal by Subject|39
2453801|NCT02614196|8455202|P6|Double Blind Treatment Phase|Terminated by sponsor|0
2453802|NCT02614196|8455203|P5|Double Blind Treatment Phase|Terminated by sponsor|0
2453803|NCT02614196|8455204|P4|Double Blind Treatment Phase|Terminated by sponsor|0
2453804|NCT02614196|8455205|P3|Double Blind Treatment Phase|Terminated by sponsor|0
2453805|NCT02614196|8455206|P2|Double Blind Treatment Phase|Terminated by sponsor|0
2453806|NCT02614196|8455207|P1|Double Blind Treatment Phase|Terminated by sponsor|1
2453807|NCT02614196|8455202|P6|Double Blind Treatment Phase|Protocol Violation|0
2453808|NCT02614196|8455203|P5|Double Blind Treatment Phase|Protocol Violation|1
2453809|NCT02614196|8455204|P4|Double Blind Treatment Phase|Protocol Violation|0
2453810|NCT02614196|8455205|P3|Double Blind Treatment Phase|Protocol Violation|1
2453811|NCT02614196|8455206|P2|Double Blind Treatment Phase|Protocol Violation|2
2453812|NCT02614196|8455207|P1|Double Blind Treatment Phase|Protocol Violation|5
2453813|NCT02614196|8455202|P6|Double Blind Treatment Phase|Pregnancy|0
2453814|NCT02614196|8455203|P5|Double Blind Treatment Phase|Pregnancy|0
2453815|NCT02614196|8455204|P4|Double Blind Treatment Phase|Pregnancy|0
2453816|NCT02614196|8455205|P3|Double Blind Treatment Phase|Pregnancy|0
2453817|NCT02614196|8455206|P2|Double Blind Treatment Phase|Pregnancy|2
2453818|NCT02614196|8455207|P1|Double Blind Treatment Phase|Pregnancy|1
2453819|NCT02614196|8455202|P6|Double Blind Treatment Phase|Physician Decision|0
2453820|NCT02614196|8455203|P5|Double Blind Treatment Phase|Physician Decision|0
2453821|NCT02614196|8455204|P4|Double Blind Treatment Phase|Physician Decision|0
2453822|NCT02614196|8455205|P3|Double Blind Treatment Phase|Physician Decision|2
2453823|NCT02614196|8455206|P2|Double Blind Treatment Phase|Physician Decision|0
2453824|NCT02614196|8455207|P1|Double Blind Treatment Phase|Physician Decision|4
2453825|NCT02614196|8455202|P6|Double Blind Treatment Phase|Lost to Follow-up|0
2453826|NCT02614196|8455203|P5|Double Blind Treatment Phase|Lost to Follow-up|0
2453827|NCT02614196|8455204|P4|Double Blind Treatment Phase|Lost to Follow-up|0
2453828|NCT02614196|8455205|P3|Double Blind Treatment Phase|Lost to Follow-up|1
2453829|NCT02614196|8455206|P2|Double Blind Treatment Phase|Lost to Follow-up|7
2453830|NCT02614196|8455207|P1|Double Blind Treatment Phase|Lost to Follow-up|10
2453831|NCT02614196|8455202|P6|Double Blind Treatment Phase|Lack of Efficacy|0
2453832|NCT02614196|8455203|P5|Double Blind Treatment Phase|Lack of Efficacy|0
2453833|NCT02614196|8455204|P4|Double Blind Treatment Phase|Lack of Efficacy|0
2453834|NCT02614196|8455205|P3|Double Blind Treatment Phase|Lack of Efficacy|1
2453835|NCT02614196|8455206|P2|Double Blind Treatment Phase|Lack of Efficacy|1
2453836|NCT02614196|8455207|P1|Double Blind Treatment Phase|Lack of Efficacy|6
2453837|NCT02614196|8455202|P6|Double Blind Treatment Phase|Adverse Event|0
2453838|NCT02614196|8455203|P5|Double Blind Treatment Phase|Adverse Event|0
2453839|NCT02614196|8455204|P4|Double Blind Treatment Phase|Adverse Event|0
2453840|NCT02614196|8455205|P3|Double Blind Treatment Phase|Adverse Event|9
2453841|NCT02614196|8455206|P2|Double Blind Treatment Phase|Adverse Event|5
2453842|NCT02614196|8455207|P1|Double Blind Treatment Phase|Adverse Event|8
2453843|NCT02614183|8455253|P3|Post Treatment Follow-up Phase|Withdrawal by Subject|5
2453844|NCT02614183|8455254|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|2
2453845|NCT02614183|8455255|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|7
2453846|NCT02614183|8455253|P3|Post Treatment Follow-up Phase|Protocol Violation|0
2453847|NCT02614183|8455254|P2|Post Treatment Follow-up Phase|Protocol Violation|0
2453848|NCT02614183|8455255|P1|Post Treatment Follow-up Phase|Protocol Violation|1
2453849|NCT02614183|8455253|P3|Post Treatment Follow-up Phase|Physician Decision|2
2453850|NCT02614183|8455254|P2|Post Treatment Follow-up Phase|Physician Decision|1
2453851|NCT02614183|8455255|P1|Post Treatment Follow-up Phase|Physician Decision|5
2453852|NCT02614183|8455253|P3|Post Treatment Follow-up Phase|Lost to Follow-up|5
2453853|NCT02614183|8455254|P2|Post Treatment Follow-up Phase|Lost to Follow-up|3
2453854|NCT02614183|8455255|P1|Post Treatment Follow-up Phase|Lost to Follow-up|5
2453855|NCT02614183|8455253|P3|Double Blind Treatment Phase|Did not receive study drug|2
2453856|NCT02614183|8455254|P2|Double Blind Treatment Phase|Did not receive study drug|1
2453857|NCT02614183|8455255|P1|Double Blind Treatment Phase|Did not receive study drug|1
2453858|NCT02614183|8455253|P3|Double Blind Treatment Phase|Withdrawal by Subject|16
2453859|NCT02614183|8455254|P2|Double Blind Treatment Phase|Withdrawal by Subject|11
2453860|NCT02614183|8455255|P1|Double Blind Treatment Phase|Withdrawal by Subject|33
2453861|NCT02614183|8455253|P3|Double Blind Treatment Phase|Protocol Violation|2
2453862|NCT02614183|8455254|P2|Double Blind Treatment Phase|Protocol Violation|2
2453863|NCT02614183|8455255|P1|Double Blind Treatment Phase|Protocol Violation|2
2453864|NCT02614183|8455253|P3|Double Blind Treatment Phase|Pregnancy|3
2453865|NCT02614183|8455254|P2|Double Blind Treatment Phase|Pregnancy|1
2453866|NCT02614183|8455255|P1|Double Blind Treatment Phase|Pregnancy|2
2453867|NCT02614183|8455253|P3|Double Blind Treatment Phase|Physician Decision|2
2453868|NCT02614183|8455254|P2|Double Blind Treatment Phase|Physician Decision|3
2453869|NCT02614183|8455255|P1|Double Blind Treatment Phase|Physician Decision|7
2453870|NCT02614183|8455253|P3|Double Blind Treatment Phase|Lost to Follow-up|5
2453871|NCT02614183|8455254|P2|Double Blind Treatment Phase|Lost to Follow-up|9
2453872|NCT02614183|8455255|P1|Double Blind Treatment Phase|Lost to Follow-up|18
2453873|NCT02614183|8455253|P3|Double Blind Treatment Phase|Lack of Efficacy|2
2453874|NCT02614183|8455254|P2|Double Blind Treatment Phase|Lack of Efficacy|1
2453875|NCT02614183|8455255|P1|Double Blind Treatment Phase|Lack of Efficacy|10
2453876|NCT02614183|8455253|P3|Double Blind Treatment Phase|Adverse Event|7
2453877|NCT02614183|8455254|P2|Double Blind Treatment Phase|Adverse Event|9
2453878|NCT02614183|8455255|P1|Double Blind Treatment Phase|Adverse Event|10
2453879|NCT02614131|8455299|P7|Overall Study|Adverse Event|1
2453880|NCT02614131|8455300|P6|Overall Study|Adverse Event|0
2453881|NCT02614131|8455301|P5|Overall Study|Adverse Event|0
2453882|NCT02614131|8455302|P4|Overall Study|Adverse Event|0
2453883|NCT02614131|8455303|P3|Overall Study|Adverse Event|0
2453884|NCT02614131|8455304|P2|Overall Study|Adverse Event|0
2453885|NCT02614131|8455305|P1|Overall Study|Adverse Event|0
2453886|NCT02614131|8455299|P7|Overall Study|Withdrawal by Subject|0
2453887|NCT02614131|8455300|P6|Overall Study|Withdrawal by Subject|0
2453888|NCT02614131|8455301|P5|Overall Study|Withdrawal by Subject|0
2453889|NCT02614131|8455302|P4|Overall Study|Withdrawal by Subject|0
2453890|NCT02614131|8455303|P3|Overall Study|Withdrawal by Subject|0
2453891|NCT02614131|8455304|P2|Overall Study|Withdrawal by Subject|0
2453892|NCT02614131|8455305|P1|Overall Study|Withdrawal by Subject|1
2453893|NCT02614079|8455336|P1|Overall Study|Withdrawal by Subject|1
2453894|NCT02613910|8455340|P1|Overall Study|Termination of study|1
2453895|NCT02613871|8455426|P1|Overall Study|Withdrew Consent|1
2453896|NCT02613871|8455426|P1|Overall Study|Death|2
2453897|NCT02613507|8455447|P2|Overall Study|Randomized but not Treated|10
2453898|NCT02613507|8455448|P1|Overall Study|Randomized but not Treated|1
2453899|NCT02613507|8455447|P2|Overall Study|Subject no Longer Meets Study Criteria|0
2453900|NCT02613507|8455448|P1|Overall Study|Subject no Longer Meets Study Criteria|1
2453901|NCT02613507|8455447|P2|Overall Study|Brain Radiotherapy Activity Limited|0
2453902|NCT02613507|8455448|P1|Overall Study|Brain Radiotherapy Activity Limited|1
2453903|NCT02613507|8455447|P2|Overall Study|Maximum Clinical Benefit|10
2453904|NCT02613507|8455448|P1|Overall Study|Maximum Clinical Benefit|4
2453905|NCT02613507|8455447|P2|Overall Study|Lost to Follow-up|0
2453906|NCT02613507|8455448|P1|Overall Study|Lost to Follow-up|1
2453907|NCT02613507|8455447|P2|Overall Study|Participant Withdrew Consent|2
2453908|NCT02613507|8455448|P1|Overall Study|Participant Withdrew Consent|0
2453909|NCT02613507|8455447|P2|Overall Study|Request to Discontinue Study Treatment|17
2453910|NCT02613507|8455448|P1|Overall Study|Request to Discontinue Study Treatment|8
2453911|NCT02613507|8455447|P2|Overall Study|Adverse Event Unrelated to Study Drug|2
2453912|NCT02613507|8455448|P1|Overall Study|Adverse Event Unrelated to Study Drug|17
2453913|NCT02613507|8455447|P2|Overall Study|Death|0
2453914|NCT02613507|8455448|P1|Overall Study|Death|3
2453915|NCT02613507|8455447|P2|Overall Study|Study Drug Toxicity|14
2453916|NCT02613507|8455448|P1|Overall Study|Study Drug Toxicity|15
2453917|NCT02613507|8455447|P2|Overall Study|Disease Progression|109
2453918|NCT02613507|8455448|P1|Overall Study|Disease Progression|237
2453919|NCT02613481|8455464|P1|Overall Study|Withdrawal by Subject|2
2453920|NCT02613481|8455464|P1|Overall Study|Lost to Follow-up|7
2453921|NCT02613403|8455475|P5|Overall Study|Withdrawal by Subject|0
2453922|NCT02613403|8455476|P4|Overall Study|Withdrawal by Subject|0
2453923|NCT02613403|8455477|P3|Overall Study|Withdrawal by Subject|0
2453924|NCT02613403|8455478|P2|Overall Study|Withdrawal by Subject|0
2453925|NCT02613403|8455479|P1|Overall Study|Withdrawal by Subject|2
2453926|NCT02613403|8455475|P5|Overall Study|Lost to Follow-up|0
2453927|NCT02613403|8455476|P4|Overall Study|Lost to Follow-up|0
2453928|NCT02613403|8455477|P3|Overall Study|Lost to Follow-up|0
2453929|NCT02613403|8455478|P2|Overall Study|Lost to Follow-up|1
2453930|NCT02613403|8455479|P1|Overall Study|Lost to Follow-up|0
2453931|NCT02613221|8455531|P1|Overall Study|Enrolled but Not Treated|1
2453932|NCT02613221|8455531|P1|Overall Study|Delayed Treatment|1
2453933|NCT02613221|8455531|P1|Overall Study|Voluntary Discontinuation|1
2453934|NCT02613221|8455531|P1|Overall Study|Adverse Event|2
2453935|NCT02613221|8455531|P1|Overall Study|Lack of efficacy (exacerbation)|50
2453936|NCT02613208|8455543|P1|Overall Study|Death|37
2453937|NCT02613208|8455543|P1|Overall Study|Lost to Follow-up|5
2453938|NCT02613208|8455543|P1|Overall Study|Physician Decision|2
2453939|NCT02613208|8455543|P1|Overall Study|Change of address|2
2453940|NCT02613208|8455543|P1|Overall Study|Withdrawal by Subject|1
2453941|NCT02613182|8455557|P1|Overall Study|Withdrawal by Subject|6
2453942|NCT02613182|8455557|P1|Overall Study|Study Terminated by Sponsor|21
2453943|NCT02613182|8455557|P1|Overall Study|Physician Decision|1
2453944|NCT02613182|8455557|P1|Overall Study|Death|6
2453945|NCT02612909|8455566|P5|Phase 3|Withdrawal by Subject|0
2453946|NCT02612909|8455567|P4|Phase 3|Withdrawal by Subject|1
2453947|NCT02612909|8455568|P3|Phase 3|Withdrawal by Subject|0
2453948|NCT02612909|8455569|P2|Phase 3|Withdrawal by Subject|0
2453949|NCT02612909|8455570|P1|Phase 3|Withdrawal by Subject|0
2453950|NCT02612909|8455566|P5|Phase 2|Pregnancy|0
2453951|NCT02612909|8455567|P4|Phase 2|Pregnancy|0
2453952|NCT02612909|8455568|P3|Phase 2|Pregnancy|1
2453953|NCT02612909|8455569|P2|Phase 2|Pregnancy|0
2453954|NCT02612909|8455570|P1|Phase 2|Pregnancy|0
2453955|NCT02612909|8455566|P5|Phase 2|Withdrawal by Subject|0
2453956|NCT02612909|8455567|P4|Phase 2|Withdrawal by Subject|0
2453957|NCT02612909|8455568|P3|Phase 2|Withdrawal by Subject|0
2453958|NCT02612909|8455569|P2|Phase 2|Withdrawal by Subject|5
2453959|NCT02612909|8455570|P1|Phase 2|Withdrawal by Subject|2
2453960|NCT02612727|8455653|P2|Overall Study|Direct hyperbilirubinemia|2
2453961|NCT02612727|8455654|P1|Overall Study|Direct hyperbilirubinemia|0
2453962|NCT02612727|8455653|P2|Overall Study|Needed treatment incompatible with PT|1
2453963|NCT02612727|8455654|P1|Overall Study|Needed treatment incompatible with PT|1
2453964|NCT02612727|8455653|P2|Overall Study|Parent request|1
2453965|NCT02612727|8455654|P1|Overall Study|Parent request|4
2453966|NCT02612623|8455666|P4|Overall Study|Adverse Event|0
2453967|NCT02612623|8455667|P3|Overall Study|Adverse Event|1
2453968|NCT02612623|8455668|P2|Overall Study|Adverse Event|0
2453969|NCT02612623|8455669|P1|Overall Study|Adverse Event|1
2453970|NCT02612623|8455666|P4|Overall Study|Withdrawal by Subject|0
2453971|NCT02612623|8455667|P3|Overall Study|Withdrawal by Subject|0
2453972|NCT02612623|8455668|P2|Overall Study|Withdrawal by Subject|1
2453973|NCT02612623|8455669|P1|Overall Study|Withdrawal by Subject|0
2453974|NCT02612610|8455683|P4|Overall Study|Cough Improvement|0
2453975|NCT02612610|8455684|P3|Overall Study|Cough Improvement|1
2453976|NCT02612610|8455685|P2|Overall Study|Cough Improvement|0
2453977|NCT02612610|8455686|P1|Overall Study|Cough Improvement|0
2453978|NCT02612610|8455683|P4|Overall Study|Noncompliance|0
2453979|NCT02612610|8455684|P3|Overall Study|Noncompliance|0
2453980|NCT02612610|8455685|P2|Overall Study|Noncompliance|0
2453981|NCT02612610|8455686|P1|Overall Study|Noncompliance|1
2453982|NCT02612610|8455683|P4|Overall Study|Physician Decision|0
2453983|NCT02612610|8455684|P3|Overall Study|Physician Decision|0
2453984|NCT02612610|8455685|P2|Overall Study|Physician Decision|1
2453985|NCT02612610|8455686|P1|Overall Study|Physician Decision|0
2453986|NCT02612610|8455683|P4|Overall Study|Lack of Efficacy|1
2453987|NCT02612610|8455684|P3|Overall Study|Lack of Efficacy|0
2453988|NCT02612610|8455685|P2|Overall Study|Lack of Efficacy|2
2453989|NCT02612610|8455686|P1|Overall Study|Lack of Efficacy|1
2453990|NCT02612610|8455683|P4|Overall Study|Protocol Violation|0
2453991|NCT02612610|8455684|P3|Overall Study|Protocol Violation|1
2453992|NCT02612610|8455685|P2|Overall Study|Protocol Violation|1
2453993|NCT02612610|8455686|P1|Overall Study|Protocol Violation|0
2453994|NCT02612610|8455683|P4|Overall Study|Lost to Follow-up|0
2453995|NCT02612610|8455684|P3|Overall Study|Lost to Follow-up|0
2453996|NCT02612610|8455685|P2|Overall Study|Lost to Follow-up|1
2453997|NCT02612610|8455686|P1|Overall Study|Lost to Follow-up|0
2453998|NCT02612610|8455683|P4|Overall Study|Adverse Event|10
2453999|NCT02612610|8455684|P3|Overall Study|Adverse Event|3
2454000|NCT02612610|8455685|P2|Overall Study|Adverse Event|2
2454001|NCT02612610|8455686|P1|Overall Study|Adverse Event|2
2454002|NCT02612610|8455683|P4|Overall Study|Withdrawal by Subject|2
2454003|NCT02612610|8455684|P3|Overall Study|Withdrawal by Subject|0
2454004|NCT02612610|8455685|P2|Overall Study|Withdrawal by Subject|1
2454005|NCT02612610|8455686|P1|Overall Study|Withdrawal by Subject|1
2454006|NCT02612428|8455930|P2|VTL-308E|Lost to Follow-up|0
2454007|NCT02612428|8455931|P1|VTL-308E|Lost to Follow-up|2
2454008|NCT02612428|8455930|P2|VTL-308E|Death|7
2454009|NCT02612428|8455931|P1|VTL-308E|Death|9
2454010|NCT02612428|8455930|P2|VTL-308|Withdrawal by Subject|1
2454011|NCT02612428|8455931|P1|VTL-308|Withdrawal by Subject|0
2454012|NCT02612428|8455930|P2|VTL-308|Death|16
2454013|NCT02612428|8455931|P1|VTL-308|Death|14
2454014|NCT02612285|8455941|P1|Overall Study|Withdrawal by Subject|1
2454015|NCT02612077|8455945|P1|Overall Study|Unknown reason|2
2454016|NCT02612077|8455945|P1|Overall Study|Disease Progression|3
2454017|NCT02612077|8455945|P1|Overall Study|Enrollment in a Clinical Trial|1
2454018|NCT02612077|8455945|P1|Overall Study|Moved or Changed Medical Team|23
2454019|NCT02612077|8455945|P1|Overall Study|Death|377
2454020|NCT02612077|8455945|P1|Overall Study|Lost to Follow-up|20
2454021|NCT02612077|8455945|P1|Overall Study|Protocol Violation|28
2454022|NCT02612077|8455945|P1|Overall Study|Withdrawal by Subject|9
2454023|NCT02612077|8455945|P1|Overall Study|Adverse Event|3
2454024|NCT02612064|8455957|P2|Overall Study|Other|2
2454025|NCT02612064|8455958|P1|Overall Study|Other|0
2454026|NCT02612064|8455957|P2|Overall Study|Withdrawal by Subject|1
2454027|NCT02612064|8455958|P1|Overall Study|Withdrawal by Subject|1
2454028|NCT02611830|8455972|P4|Maintenance Phase|Reason not specified|0
2454029|NCT02611830|8455973|P3|Maintenance Phase|Reason not specified|4
2454030|NCT02611830|8455974|P2|Maintenance Phase|Reason not specified|1
2454031|NCT02611830|8455975|P1|Maintenance Phase|Reason not specified|0
2454032|NCT02611830|8455972|P4|Maintenance Phase|Pregnancy|0
2454033|NCT02611830|8455973|P3|Maintenance Phase|Pregnancy|1
2454034|NCT02611830|8455974|P2|Maintenance Phase|Pregnancy|0
2454035|NCT02611830|8455975|P1|Maintenance Phase|Pregnancy|0
2454036|NCT02611830|8455972|P4|Maintenance Phase|Voluntary Withdrawal|5
2454037|NCT02611830|8455973|P3|Maintenance Phase|Voluntary Withdrawal|2
2454038|NCT02611830|8455974|P2|Maintenance Phase|Voluntary Withdrawal|1
2454039|NCT02611830|8455975|P1|Maintenance Phase|Voluntary Withdrawal|0
2454040|NCT02611830|8455972|P4|Maintenance Phase|Lost to Follow-up|1
2454041|NCT02611830|8455973|P3|Maintenance Phase|Lost to Follow-up|0
2454042|NCT02611830|8455974|P2|Maintenance Phase|Lost to Follow-up|0
2454043|NCT02611830|8455975|P1|Maintenance Phase|Lost to Follow-up|0
2454044|NCT02611830|8455972|P4|Maintenance Phase|Significant Protocol Deviation|1
2454045|NCT02611830|8455973|P3|Maintenance Phase|Significant Protocol Deviation|1
2454046|NCT02611830|8455974|P2|Maintenance Phase|Significant Protocol Deviation|0
2454047|NCT02611830|8455975|P1|Maintenance Phase|Significant Protocol Deviation|0
2454048|NCT02611830|8455972|P4|Maintenance Phase|Pretreatment Event/Adverse Event|2
2454049|NCT02611830|8455973|P3|Maintenance Phase|Pretreatment Event/Adverse Event|5
2454050|NCT02611830|8455974|P2|Maintenance Phase|Pretreatment Event/Adverse Event|5
2454051|NCT02611830|8455975|P1|Maintenance Phase|Pretreatment Event/Adverse Event|0
2454052|NCT02611830|8455972|P4|Maintenance Phase|Lack of Efficacy|6
2454053|NCT02611830|8455973|P3|Maintenance Phase|Lack of Efficacy|18
2454054|NCT02611830|8455974|P2|Maintenance Phase|Lack of Efficacy|29
2454055|NCT02611830|8455975|P1|Maintenance Phase|Lack of Efficacy|0
2454056|NCT02611830|8455972|P4|OL Induction Phase|Reason not specified|0
2454057|NCT02611830|8455973|P3|OL Induction Phase|Reason not specified|0
2454058|NCT02611830|8455974|P2|OL Induction Phase|Reason not specified|0
2454059|NCT02611830|8455975|P1|OL Induction Phase|Reason not specified|3
2454060|NCT02611830|8455972|P4|OL Induction Phase|Lack of Efficacy|0
2454061|NCT02611830|8455973|P3|OL Induction Phase|Lack of Efficacy|0
2454062|NCT02611830|8455974|P2|OL Induction Phase|Lack of Efficacy|0
2454063|NCT02611830|8455975|P1|OL Induction Phase|Lack of Efficacy|9
2454064|NCT02611830|8455972|P4|OL Induction Phase|Voluntary Withdrawal|0
2454065|NCT02611830|8455973|P3|OL Induction Phase|Voluntary Withdrawal|0
2454066|NCT02611830|8455974|P2|OL Induction Phase|Voluntary Withdrawal|0
2454067|NCT02611830|8455975|P1|OL Induction Phase|Voluntary Withdrawal|5
2454068|NCT02611830|8455972|P4|OL Induction Phase|Significant Protocol Deviation|0
2454069|NCT02611830|8455973|P3|OL Induction Phase|Significant Protocol Deviation|0
2454070|NCT02611830|8455974|P2|OL Induction Phase|Significant Protocol Deviation|0
2454071|NCT02611830|8455975|P1|OL Induction Phase|Significant Protocol Deviation|4
2454072|NCT02611830|8455972|P4|OL Induction Phase|Pretreatment Event/Adverse Event|0
2454073|NCT02611830|8455973|P3|OL Induction Phase|Pretreatment Event/Adverse Event|0
2454074|NCT02611830|8455974|P2|OL Induction Phase|Pretreatment Event/Adverse Event|0
2454075|NCT02611830|8455975|P1|OL Induction Phase|Pretreatment Event/Adverse Event|9
2454076|NCT02611752|8456007|P2|Overall Study|Adverse Event|1
2454077|NCT02611752|8456008|P1|Overall Study|Adverse Event|0
2454078|NCT02611479|8456040|P1|Data Cleaning|No baseline function or pain metrics|2
2454079|NCT02611479|8456040|P1|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18
2454080|NCT02611479|8456040|P1|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2
2454081|NCT02611479|8456040|P1|Baseline Enrollment|Exited study|13
2454082|NCT02610842|8456172|P1|Overall Study|Lost to Follow-up|5
2454083|NCT02610816|8456181|P4|Phase 2|Pregnancy|1
2454084|NCT02610816|8456182|P3|Phase 2|Pregnancy|0
2454085|NCT02610816|8456183|P2|Phase 2|Pregnancy|0
2454086|NCT02610816|8456184|P1|Phase 2|Pregnancy|0
2454087|NCT02610816|8456181|P4|Phase 2|Physician Decision|2
2454088|NCT02610816|8456182|P3|Phase 2|Physician Decision|0
2454089|NCT02610816|8456183|P2|Phase 2|Physician Decision|0
2454090|NCT02610816|8456184|P1|Phase 2|Physician Decision|0
2454091|NCT02610816|8456181|P4|Phase 2|Lost to Follow-up|0
2454092|NCT02610816|8456182|P3|Phase 2|Lost to Follow-up|2
2454093|NCT02610816|8456183|P2|Phase 2|Lost to Follow-up|0
2454094|NCT02610816|8456184|P1|Phase 2|Lost to Follow-up|0
2454095|NCT02610816|8456181|P4|Phase 2|Withdrawal by Subject|3
2454096|NCT02610816|8456182|P3|Phase 2|Withdrawal by Subject|9
2454097|NCT02610816|8456183|P2|Phase 2|Withdrawal by Subject|0
2454098|NCT02610816|8456184|P1|Phase 2|Withdrawal by Subject|0
2454099|NCT02610816|8456181|P4|Phase 1|Physician Decision|0
2454100|NCT02610816|8456182|P3|Phase 1|Physician Decision|0
2454101|NCT02610816|8456183|P2|Phase 1|Physician Decision|1
2454102|NCT02610816|8456184|P1|Phase 1|Physician Decision|0
2454103|NCT02610816|8456181|P4|Phase 1|Lost to Follow-up|0
2454104|NCT02610816|8456182|P3|Phase 1|Lost to Follow-up|0
2454105|NCT02610816|8456183|P2|Phase 1|Lost to Follow-up|1
2454106|NCT02610816|8456184|P1|Phase 1|Lost to Follow-up|2
2454107|NCT02610816|8456181|P4|Phase 1|Withdrawal by Subject|0
2454108|NCT02610816|8456182|P3|Phase 1|Withdrawal by Subject|0
2454109|NCT02610816|8456183|P2|Phase 1|Withdrawal by Subject|6
2454110|NCT02610816|8456184|P1|Phase 1|Withdrawal by Subject|2
2454111|NCT02610725|8456205|P1|Overall Study|self-reported contraindication|9
2454112|NCT02610725|8456205|P1|Overall Study|Lost to Follow-up|197
2454113|NCT02610231|8456220|P1|Overall Study|Other|3
2454114|NCT02610231|8456220|P1|Overall Study|Non Compliance|2
2454115|NCT02610231|8456220|P1|Overall Study|Physician Decision|1
2454116|NCT02610231|8456220|P1|Overall Study|Surgery|2
2454117|NCT02610231|8456220|P1|Overall Study|Death|5
2454118|NCT02610231|8456220|P1|Overall Study|Adverse Event|20
2454119|NCT02610231|8456220|P1|Overall Study|Withdrawal by Subject|27
2454120|NCT02610192|8456227|P1|Overall Study|Physician Decision|1
2454121|NCT02610192|8456227|P1|Overall Study|Received other treatment|8
2454122|NCT02609672|8456250|P2|Overall Study|Lost to Follow-up|1
2454123|NCT02609672|8456251|P1|Overall Study|Lost to Follow-up|3
2454124|NCT02609659|8456285|P1|Overall Study|Other|1
2454125|NCT02609659|8456285|P1|Overall Study|Lost to Follow-up|6
2454126|NCT02609659|8456285|P1|Overall Study|Adverse Event|1
2454127|NCT02609633|8456295|P2|Overall Study|Reason not Specified|1
2454128|NCT02609633|8456296|P1|Overall Study|Reason not Specified|2
2454129|NCT02609633|8456295|P2|Overall Study|Non-Compliant with Study Procedures|0
2454130|NCT02609633|8456296|P1|Overall Study|Non-Compliant with Study Procedures|2
2454131|NCT02609633|8456295|P2|Overall Study|Protocol Deviation|0
2454132|NCT02609633|8456296|P1|Overall Study|Protocol Deviation|1
2454133|NCT02609633|8456295|P2|Overall Study|Consent Withdrawn|1
2454134|NCT02609633|8456296|P1|Overall Study|Consent Withdrawn|0
2454135|NCT02609607|8456323|P2|Overall Study|Lost to Follow-up|1
2454136|NCT02609607|8456324|P1|Overall Study|Lost to Follow-up|0
2454137|NCT02609399|8456348|P2|Influenza Season 2016-2017|Found ineligible after randomization|0
2454138|NCT02609399|8456349|P1|Influenza Season 2016-2017|Found ineligible after randomization|1
2454139|NCT02609399|8456348|P2|Influenza Season 2016-2017|Lost to Follow-up|5
2454140|NCT02609399|8456349|P1|Influenza Season 2016-2017|Lost to Follow-up|8
2454141|NCT02609399|8456348|P2|Influenza Season 2015-2016|Lost to Follow-up|2
2454142|NCT02609399|8456349|P1|Influenza Season 2015-2016|Lost to Follow-up|3
2454143|NCT02609178|8456379|P6|First Crown|Withdrawal by Subject|0
2454144|NCT02609178|8456380|P5|First Crown|Withdrawal by Subject|0
2454145|NCT02609178|8456381|P4|First Crown|Withdrawal by Subject|1
2454146|NCT02609178|8456382|P3|First Crown|Withdrawal by Subject|1
2454147|NCT02609178|8456383|P2|First Crown|Withdrawal by Subject|0
2454148|NCT02609178|8456384|P1|First Crown|Withdrawal by Subject|0
2454149|NCT02608892|8456446|P2|Overall Study|Lost to Follow-up|0
2454150|NCT02608892|8456447|P1|Overall Study|Lost to Follow-up|1
2454151|NCT02608684|8456456|P1|Overall Study|Withdrawal by Subject|1
2454152|NCT02608684|8456456|P1|Overall Study|Physician Decision|2
2454153|NCT02608099|8456514|P2|Overall Study|Ablation procedure not initiated|2
2454154|NCT02608099|8456515|P1|Overall Study|Ablation procedure not initiated|3
2454155|NCT02607956|8456553|P2|Overall Study|Lost to Follow-up|15
2454156|NCT02607956|8456554|P1|Overall Study|Lost to Follow-up|18
2454157|NCT02607956|8456553|P2|Overall Study|Withdrew Consent|16
2454158|NCT02607956|8456554|P1|Overall Study|Withdrew Consent|16
2454159|NCT02607956|8456553|P2|Overall Study|Protocol Violation|1
2454160|NCT02607956|8456554|P1|Overall Study|Protocol Violation|3
2454161|NCT02607956|8456553|P2|Overall Study|Non-Compliance with Study Drug|3
2454162|NCT02607956|8456554|P1|Overall Study|Non-Compliance with Study Drug|0
2454163|NCT02607956|8456553|P2|Overall Study|Investigator's Discretion|2
2454164|NCT02607956|8456554|P1|Overall Study|Investigator's Discretion|7
2454165|NCT02607956|8456553|P2|Overall Study|Death|4
2454166|NCT02607956|8456554|P1|Overall Study|Death|4
2454167|NCT02607956|8456553|P2|Overall Study|Adverse Event|3
2454168|NCT02607956|8456554|P1|Overall Study|Adverse Event|4
2454169|NCT02607956|8456553|P2|Overall Study|Still on Study|281
2454170|NCT02607956|8456554|P1|Overall Study|Still on Study|268
2454171|NCT02607956|8456553|P2|Overall Study|Randomized and Never Treated|5
2454172|NCT02607956|8456554|P1|Overall Study|Randomized and Never Treated|7
2454173|NCT02607930|8456584|P2|Overall Study|Lost to Follow-up|16
2454174|NCT02607930|8456585|P1|Overall Study|Lost to Follow-up|24
2454175|NCT02607930|8456584|P2|Overall Study|Withdrew Consent|15
2454176|NCT02607930|8456585|P1|Overall Study|Withdrew Consent|14
2454177|NCT02607930|8456584|P2|Overall Study|Protocol Violation|3
2454178|NCT02607930|8456585|P1|Overall Study|Protocol Violation|2
2454179|NCT02607930|8456584|P2|Overall Study|Non-Compliance with Study Drug|5
2454180|NCT02607930|8456585|P1|Overall Study|Non-Compliance with Study Drug|3
2454181|NCT02607930|8456584|P2|Overall Study|Investigator's Discretion|2
2454182|NCT02607930|8456585|P1|Overall Study|Investigator's Discretion|6
2454183|NCT02607930|8456584|P2|Overall Study|Death|1
2454184|NCT02607930|8456585|P1|Overall Study|Death|2
2454185|NCT02607930|8456584|P2|Overall Study|Adverse Event|4
2454186|NCT02607930|8456585|P1|Overall Study|Adverse Event|0
2454187|NCT02607930|8456584|P2|Overall Study|Still in Study|269
2454188|NCT02607930|8456585|P1|Overall Study|Still in Study|263
2454189|NCT02607930|8456584|P2|Overall Study|Randomized and Never Treated|0
2454190|NCT02607930|8456585|P1|Overall Study|Randomized and Never Treated|2
2454191|NCT02607865|8456629|P4|Overall Study|Unclassified|0
2454192|NCT02607865|8456630|P3|Overall Study|Unclassified|2
2454193|NCT02607865|8456631|P2|Overall Study|Unclassified|1
2454194|NCT02607865|8456632|P1|Overall Study|Unclassified|1
2454195|NCT02607865|8456629|P4|Overall Study|Death|3
2454196|NCT02607865|8456630|P3|Overall Study|Death|1
2454197|NCT02607865|8456631|P2|Overall Study|Death|4
2454198|NCT02607865|8456632|P1|Overall Study|Death|5
2454199|NCT02607865|8456629|P4|Overall Study|Withdrawal by Subject|8
2454200|NCT02607865|8456630|P3|Overall Study|Withdrawal by Subject|17
2454201|NCT02607865|8456631|P2|Overall Study|Withdrawal by Subject|18
2454202|NCT02607865|8456632|P1|Overall Study|Withdrawal by Subject|18
2454203|NCT02607865|8456629|P4|Overall Study|Lost to Follow-up|5
2454204|NCT02607865|8456630|P3|Overall Study|Lost to Follow-up|7
2454205|NCT02607865|8456631|P2|Overall Study|Lost to Follow-up|7
2454206|NCT02607865|8456632|P1|Overall Study|Lost to Follow-up|9
2454207|NCT02607800|8456806|P2|Overall Study|Randomized/Enrolled but Not Treated|1
2454208|NCT02607800|8456807|P1|Overall Study|Randomized/Enrolled but Not Treated|1
2454209|NCT02607800|8456806|P2|Overall Study|Withdrew Consent|0
2454210|NCT02607800|8456807|P1|Overall Study|Withdrew Consent|2
2454211|NCT02607800|8456806|P2|Overall Study|Lost to Follow-up|10
2454212|NCT02607800|8456807|P1|Overall Study|Lost to Follow-up|7
2454213|NCT02607735|8456825|P3|Deferred Treatment Substudy|Withdrew Consent|1
2454214|NCT02607735|8456826|P2|Deferred Treatment Substudy|Withdrew Consent|0
2454215|NCT02607735|8456827|P1|Deferred Treatment Substudy|Withdrew Consent|0
2454216|NCT02607735|8456825|P3|Deferred Treatment Substudy|Lost to Follow-up|4
2454217|NCT02607735|8456826|P2|Deferred Treatment Substudy|Lost to Follow-up|0
2454218|NCT02607735|8456827|P1|Deferred Treatment Substudy|Lost to Follow-up|0
2454219|NCT02607735|8456825|P3|Primary Study|Withdrew Consent|0
2454220|NCT02607735|8456826|P2|Primary Study|Withdrew Consent|0
2454221|NCT02607735|8456827|P1|Primary Study|Withdrew Consent|2
2454222|NCT02607735|8456825|P3|Primary Study|Lost to Follow-up|0
2454223|NCT02607735|8456826|P2|Primary Study|Lost to Follow-up|0
2454224|NCT02607735|8456827|P1|Primary Study|Lost to Follow-up|4
2454225|NCT02607735|8456825|P3|Primary Study|Randomized but Never Treated|0
2454226|NCT02607735|8456826|P2|Primary Study|Randomized but Never Treated|0
2454227|NCT02607735|8456827|P1|Primary Study|Randomized but Never Treated|1
2454228|NCT02607306|8456861|P3|Overall Study|Protocol Violation|1
2454229|NCT02607306|8456862|P2|Overall Study|Protocol Violation|2
2454230|NCT02607306|8456863|P1|Overall Study|Protocol Violation|4
2454231|NCT02607306|8456861|P3|Overall Study|Lack of Efficacy|1
2454232|NCT02607306|8456862|P2|Overall Study|Lack of Efficacy|1
2454233|NCT02607306|8456863|P1|Overall Study|Lack of Efficacy|0
2454234|NCT02607306|8456861|P3|Overall Study|Withdrawal by Subject|2
2454235|NCT02607306|8456862|P2|Overall Study|Withdrawal by Subject|10
2454236|NCT02607306|8456863|P1|Overall Study|Withdrawal by Subject|8
2454237|NCT02607306|8456861|P3|Overall Study|Unclassified|0
2454238|NCT02607306|8456862|P2|Overall Study|Unclassified|4
2454239|NCT02607306|8456863|P1|Overall Study|Unclassified|1
2454240|NCT02607306|8456861|P3|Overall Study|Adverse Event|6
2454241|NCT02607306|8456862|P2|Overall Study|Adverse Event|6
2454242|NCT02607306|8456863|P1|Overall Study|Adverse Event|8
2454243|NCT02606877|8457022|P2|Overall Study|Other than listed above|0
2454244|NCT02606877|8457023|P1|Overall Study|Other than listed above|1
2454245|NCT02606877|8457022|P2|Overall Study|Non-compliance with protocol|1
2454246|NCT02606877|8457023|P1|Overall Study|Non-compliance with protocol|0
2454247|NCT02606877|8457022|P2|Overall Study|Adverse Event|0
2454248|NCT02606877|8457023|P1|Overall Study|Adverse Event|3
2454249|NCT02606643|8457051|P2|Overall Study|did not meet inclusion criteria|3
2454250|NCT02606643|8457052|P1|Overall Study|did not meet inclusion criteria|1
2454251|NCT02606279|8457110|P2|Overall Study|Lost to Follow-up|1
2454252|NCT02606279|8457111|P1|Overall Study|Lost to Follow-up|0
2454253|NCT02606253|8457126|P3|Overall Study|Physician Decision|0
2454254|NCT02606253|8457127|P2|Overall Study|Physician Decision|1
2454255|NCT02606253|8457128|P1|Overall Study|Physician Decision|1
2454256|NCT02606253|8457126|P3|Overall Study|Protocol Violation|0
2454257|NCT02606253|8457127|P2|Overall Study|Protocol Violation|1
2454258|NCT02606253|8457128|P1|Overall Study|Protocol Violation|2
2454259|NCT02606253|8457126|P3|Overall Study|Adverse Event|0
2454260|NCT02606253|8457127|P2|Overall Study|Adverse Event|0
2454261|NCT02606253|8457128|P1|Overall Study|Adverse Event|2
2454262|NCT02605954|8457230|P2|Overall Study|Randomized but not treated|1
2454263|NCT02605954|8457231|P1|Overall Study|Randomized but not treated|0
2454264|NCT02605954|8457230|P2|Overall Study|Lost to Follow-up|0
2454265|NCT02605954|8457231|P1|Overall Study|Lost to Follow-up|3
2454266|NCT02605954|8457230|P2|Overall Study|Withdrew Consent|2
2454267|NCT02605954|8457231|P1|Overall Study|Withdrew Consent|2
2454268|NCT02605954|8457230|P2|Overall Study|Non-Compliance with Study Drug|0
2454269|NCT02605954|8457231|P1|Overall Study|Non-Compliance with Study Drug|1
2454270|NCT02605954|8457230|P2|Overall Study|Investigator's Discretion|0
2454271|NCT02605954|8457231|P1|Overall Study|Investigator's Discretion|1
2454272|NCT02605954|8457230|P2|Overall Study|Adverse Event|1
2454273|NCT02605954|8457231|P1|Overall Study|Adverse Event|5
2454274|NCT02605928|8457248|P1|Overall Study|Lack of Efficacy|5
2454275|NCT02605928|8457248|P1|Overall Study|Model tuning phase|28
2454276|NCT02605837|8457291|P2|Overall Study|Physician Decision|1
2454277|NCT02605837|8457292|P1|Overall Study|Physician Decision|0
2454278|NCT02605837|8457291|P2|Overall Study|Withdrawal by Subject|8
2454279|NCT02605837|8457292|P1|Overall Study|Withdrawal by Subject|8
2454280|NCT02605837|8457291|P2|Overall Study|Non-Compliance with Study Drug|1
2454281|NCT02605837|8457292|P1|Overall Study|Non-Compliance with Study Drug|0
2454282|NCT02605837|8457291|P2|Overall Study|Adverse Event|1
2454283|NCT02605837|8457292|P1|Overall Study|Adverse Event|3
2454284|NCT02605824|8457331|P2|Overall Study|Physician Decision|0
2454285|NCT02605824|8457332|P1|Overall Study|Physician Decision|1
2454286|NCT02605642|8457342|P2|Overall Study|Lack of response|11
2454287|NCT02605642|8457343|P1|Overall Study|Lack of response|24
2454288|NCT02605642|8457342|P2|Overall Study|Withdrawal by Subject|2
2454289|NCT02605642|8457343|P1|Overall Study|Withdrawal by Subject|23
2454290|NCT02605642|8457342|P2|Overall Study|Adverse Event|2
2454291|NCT02605642|8457343|P1|Overall Study|Adverse Event|14
2454292|NCT02605642|8457342|P2|Overall Study|Lost to Follow-up|1
2454293|NCT02605642|8457343|P1|Overall Study|Lost to Follow-up|12
2454294|NCT02605642|8457342|P2|Overall Study|Physician Decision|0
2454295|NCT02605642|8457343|P1|Overall Study|Physician Decision|10
2454296|NCT02605642|8457342|P2|Overall Study|Participant non-compliance|4
2454297|NCT02605642|8457343|P1|Overall Study|Participant non-compliance|2
2454298|NCT02605642|8457342|P2|Overall Study|Other|1
2454299|NCT02605642|8457343|P1|Overall Study|Other|11
2454300|NCT02605174|8457490|P7|Overall Study|Randomization Failure|30
2454301|NCT02605174|8457491|P6|Overall Study|Randomization Failure|11
2454302|NCT02605174|8457492|P5|Overall Study|Randomization Failure|16
2454303|NCT02605174|8457493|P4|Overall Study|Randomization Failure|7
2454304|NCT02605174|8457494|P3|Overall Study|Randomization Failure|20
2454305|NCT02605174|8457495|P2|Overall Study|Randomization Failure|6
2454306|NCT02605174|8457496|P1|Overall Study|Randomization Failure|22
2454307|NCT02605174|8457490|P7|Overall Study|Physician Decision|3
2454308|NCT02605174|8457491|P6|Overall Study|Physician Decision|0
2454309|NCT02605174|8457492|P5|Overall Study|Physician Decision|0
2454310|NCT02605174|8457493|P4|Overall Study|Physician Decision|0
2454311|NCT02605174|8457494|P3|Overall Study|Physician Decision|0
2454312|NCT02605174|8457495|P2|Overall Study|Physician Decision|0
2454313|NCT02605174|8457496|P1|Overall Study|Physician Decision|2
2454314|NCT02605174|8457490|P7|Overall Study|Withdrawal by Subject|15
2454315|NCT02605174|8457491|P6|Overall Study|Withdrawal by Subject|4
2454316|NCT02605174|8457492|P5|Overall Study|Withdrawal by Subject|6
2454317|NCT02605174|8457493|P4|Overall Study|Withdrawal by Subject|11
2454318|NCT02605174|8457494|P3|Overall Study|Withdrawal by Subject|14
2454319|NCT02605174|8457495|P2|Overall Study|Withdrawal by Subject|6
2454320|NCT02605174|8457496|P1|Overall Study|Withdrawal by Subject|9
2454321|NCT02605174|8457490|P7|Overall Study|Pregnancy|0
2454322|NCT02605174|8457491|P6|Overall Study|Pregnancy|0
2454323|NCT02605174|8457492|P5|Overall Study|Pregnancy|0
2454324|NCT02605174|8457493|P4|Overall Study|Pregnancy|2
2454325|NCT02605174|8457494|P3|Overall Study|Pregnancy|0
2454326|NCT02605174|8457495|P2|Overall Study|Pregnancy|0
2454327|NCT02605174|8457496|P1|Overall Study|Pregnancy|1
2454328|NCT02605174|8457490|P7|Overall Study|Protocol Violation|12
2454329|NCT02605174|8457491|P6|Overall Study|Protocol Violation|7
2454330|NCT02605174|8457492|P5|Overall Study|Protocol Violation|7
2454331|NCT02605174|8457493|P4|Overall Study|Protocol Violation|6
2454332|NCT02605174|8457494|P3|Overall Study|Protocol Violation|14
2454333|NCT02605174|8457495|P2|Overall Study|Protocol Violation|4
2454334|NCT02605174|8457496|P1|Overall Study|Protocol Violation|10
2454335|NCT02605174|8457490|P7|Overall Study|Lost to Follow-up|29
2454336|NCT02605174|8457491|P6|Overall Study|Lost to Follow-up|10
2454337|NCT02605174|8457492|P5|Overall Study|Lost to Follow-up|20
2454338|NCT02605174|8457493|P4|Overall Study|Lost to Follow-up|10
2454339|NCT02605174|8457494|P3|Overall Study|Lost to Follow-up|27
2454340|NCT02605174|8457495|P2|Overall Study|Lost to Follow-up|7
2454341|NCT02605174|8457496|P1|Overall Study|Lost to Follow-up|20
2454342|NCT02605174|8457490|P7|Overall Study|Adverse Event|0
2454343|NCT02605174|8457491|P6|Overall Study|Adverse Event|0
2454344|NCT02605174|8457492|P5|Overall Study|Adverse Event|4
2454345|NCT02605174|8457493|P4|Overall Study|Adverse Event|0
2454346|NCT02605174|8457494|P3|Overall Study|Adverse Event|1
2454347|NCT02605174|8457495|P2|Overall Study|Adverse Event|0
2454348|NCT02605174|8457496|P1|Overall Study|Adverse Event|0
2454349|NCT02605122|8457558|P2|Overall Study|Lost to Follow-up|1
2454350|NCT02605122|8457559|P1|Overall Study|Lost to Follow-up|1
2454351|NCT02605122|8457558|P2|Overall Study|Withdrawal by Subject|1
2454352|NCT02605122|8457559|P1|Overall Study|Withdrawal by Subject|4
2454353|NCT02604589|8457582|P3|Overall Study|catheter dislodgement|1
2454354|NCT02604589|8457583|P2|Overall Study|catheter dislodgement|0
2454355|NCT02604589|8457584|P1|Overall Study|catheter dislodgement|0
2454356|NCT02604550|8457612|P2|Overall Study|Incomplete data using paper journal|19
2454357|NCT02604550|8457613|P1|Overall Study|Incomplete data using paper journal|18
2454358|NCT02604550|8457612|P2|Overall Study|Withdrawal by Subject|1
2454359|NCT02604550|8457613|P1|Overall Study|Withdrawal by Subject|0
2454360|NCT02604550|8457612|P2|Overall Study|Lost to Follow-up|6
2454361|NCT02604550|8457613|P1|Overall Study|Lost to Follow-up|7
2454362|NCT02604433|8457639|P2|Post Treatment Follow-up Period|Follow-up is ongoing|24
2454363|NCT02604433|8457640|P1|Post Treatment Follow-up Period|Follow-up is ongoing|42
2454364|NCT02604433|8457639|P2|Double-blind Treatment Period|Study is ongoing|74
2454365|NCT02604433|8457640|P1|Double-blind Treatment Period|Study is ongoing|156
2454366|NCT02604433|8457639|P2|Double-blind Treatment Period|D/C TRT: protocol violation|0
2454367|NCT02604433|8457640|P1|Double-blind Treatment Period|D/C TRT: protocol violation|1
2454368|NCT02604433|8457639|P2|Double-blind Treatment Period|D/C TRT: other, e.g. moved, personal|3
2454369|NCT02604433|8457640|P1|Double-blind Treatment Period|D/C TRT: other, e.g. moved, personal|3
2454370|NCT02604433|8457639|P2|Double-blind Treatment Period|D/C TRT: lack of efficacy|8
2454371|NCT02604433|8457640|P1|Double-blind Treatment Period|D/C TRT: lack of efficacy|2
2454372|NCT02604433|8457639|P2|Double-blind Treatment Period|D/C TRT: adverse event|1
2454373|NCT02604433|8457640|P1|Double-blind Treatment Period|D/C TRT: adverse event|10
2454374|NCT02604433|8457639|P2|Double-blind Treatment Period|D/C TRT: withdrawal by subject|12
2454375|NCT02604433|8457640|P1|Double-blind Treatment Period|D/C TRT: withdrawal by subject|26
2454376|NCT02604433|8457639|P2|Double-blind Treatment Period|Death|1
2454377|NCT02604433|8457640|P1|Double-blind Treatment Period|Death|1
2454378|NCT02604433|8457639|P2|Double-blind Treatment Period|Personal reasons or moved|1
2454379|NCT02604433|8457640|P1|Double-blind Treatment Period|Personal reasons or moved|2
2454380|NCT02604433|8457639|P2|Double-blind Treatment Period|Adverse Event|0
2454381|NCT02604433|8457640|P1|Double-blind Treatment Period|Adverse Event|4
2454382|NCT02604433|8457639|P2|Double-blind Treatment Period|Withdrawal by Subject|6
2454383|NCT02604433|8457640|P1|Double-blind Treatment Period|Withdrawal by Subject|13
2454384|NCT02604407|8457709|P3|Overall Study|Other|4
2454385|NCT02604407|8457710|P2|Overall Study|Other|1
2454386|NCT02604407|8457711|P1|Overall Study|Other|3
2454387|NCT02604407|8457709|P3|Overall Study|Lack of Efficacy|0
2454388|NCT02604407|8457710|P2|Overall Study|Lack of Efficacy|0
2454389|NCT02604407|8457711|P1|Overall Study|Lack of Efficacy|1
2454390|NCT02604407|8457709|P3|Overall Study|Lost to Follow-up|2
2454391|NCT02604407|8457710|P2|Overall Study|Lost to Follow-up|1
2454392|NCT02604407|8457711|P1|Overall Study|Lost to Follow-up|2
2454393|NCT02604407|8457709|P3|Overall Study|Withdrawal by Subject|5
2454394|NCT02604407|8457710|P2|Overall Study|Withdrawal by Subject|3
2454395|NCT02604407|8457711|P1|Overall Study|Withdrawal by Subject|3
2454396|NCT02604407|8457709|P3|Overall Study|Protocol Violation|0
2454397|NCT02604407|8457710|P2|Overall Study|Protocol Violation|0
2454398|NCT02604407|8457711|P1|Overall Study|Protocol Violation|2
2454399|NCT02604407|8457709|P3|Overall Study|Adverse Event|5
2454400|NCT02604407|8457710|P2|Overall Study|Adverse Event|7
2454401|NCT02604407|8457711|P1|Overall Study|Adverse Event|0
2454402|NCT02604342|8457724|P2|Overall Study|Physician Decision|0
2454403|NCT02604342|8457725|P1|Overall Study|Physician Decision|2
2454404|NCT02604342|8457724|P2|Overall Study|Lost to Follow-up|1
2454405|NCT02604342|8457725|P1|Overall Study|Lost to Follow-up|1
2454406|NCT02604342|8457724|P2|Overall Study|Study Termination by Sponsor|0
2454407|NCT02604342|8457725|P1|Overall Study|Study Termination by Sponsor|1
2454408|NCT02604342|8457724|P2|Overall Study|Other|0
2454409|NCT02604342|8457725|P1|Overall Study|Other|1
2454410|NCT02604342|8457724|P2|Overall Study|Withdrawal by Subject|6
2454411|NCT02604342|8457725|P1|Overall Study|Withdrawal by Subject|5
2454412|NCT02604342|8457724|P2|Overall Study|Progression of disease|0
2454413|NCT02604342|8457725|P1|Overall Study|Progression of disease|1
2454414|NCT02604342|8457724|P2|Overall Study|Death|16
2454415|NCT02604342|8457725|P1|Overall Study|Death|32
2454416|NCT02604264|8457777|P2|Intervention|Didn't use CVC for at least 21 days|242
2454417|NCT02604264|8457778|P1|Intervention|Didn't use CVC for at least 21 days|200
2454418|NCT02604212|8457788|P4|Overall Study|Withdrawal by Subject|0
2454419|NCT02604212|8457789|P3|Overall Study|Withdrawal by Subject|1
2454420|NCT02604212|8457790|P2|Overall Study|Withdrawal by Subject|0
2454421|NCT02604212|8457791|P1|Overall Study|Withdrawal by Subject|0
2454422|NCT02604212|8457788|P4|Overall Study|Study Terminated by Sponsor|3
2454423|NCT02604212|8457789|P3|Overall Study|Study Terminated by Sponsor|3
2454424|NCT02604212|8457790|P2|Overall Study|Study Terminated by Sponsor|1
2454425|NCT02604212|8457791|P1|Overall Study|Study Terminated by Sponsor|2
2454426|NCT02604199|8457859|P4|Overall Study|Withdrawal by Subject|0
2454427|NCT02604199|8457860|P3|Overall Study|Withdrawal by Subject|0
2454428|NCT02604199|8457861|P2|Overall Study|Withdrawal by Subject|1
2454429|NCT02604199|8457862|P1|Overall Study|Withdrawal by Subject|0
2454430|NCT02604199|8457859|P4|Overall Study|Study terminated by sponsor|2
2454431|NCT02604199|8457860|P3|Overall Study|Study terminated by sponsor|0
2454432|NCT02604199|8457861|P2|Overall Study|Study terminated by sponsor|2
2454433|NCT02604199|8457862|P1|Overall Study|Study terminated by sponsor|0
2454434|NCT02604199|8457859|P4|Overall Study|Pregnancy|1
2454435|NCT02604199|8457860|P3|Overall Study|Pregnancy|0
2454436|NCT02604199|8457861|P2|Overall Study|Pregnancy|0
2454437|NCT02604199|8457862|P1|Overall Study|Pregnancy|0
2454438|NCT02604160|8457931|P2|Overall Study|Physician Decision|1
2454439|NCT02604160|8457932|P1|Overall Study|Physician Decision|0
2454440|NCT02604160|8457931|P2|Overall Study|Protocol Violation|1
2454441|NCT02604160|8457932|P1|Overall Study|Protocol Violation|0
2454442|NCT02604017|8457946|P2|Overall Study|Other|0
2454443|NCT02604017|8457947|P1|Overall Study|Other|1
2454444|NCT02604017|8457946|P2|Overall Study|Lost to Follow-up|6
2454445|NCT02604017|8457947|P1|Overall Study|Lost to Follow-up|5
2454446|NCT02604017|8457946|P2|Overall Study|Withdrew Consent|2
2454447|NCT02604017|8457947|P1|Overall Study|Withdrew Consent|0
2454448|NCT02603952|8457976|P4|Overall Study|Received oseltamivir by error|1
2454449|NCT02603952|8457977|P3|Overall Study|Received oseltamivir by error|0
2454450|NCT02603952|8457978|P2|Overall Study|Received oseltamivir by error|0
2454451|NCT02603952|8457979|P1|Overall Study|Received oseltamivir by error|0
2454452|NCT02603952|8457976|P4|Overall Study|Withdrawal by Subject|0
2454453|NCT02603952|8457977|P3|Overall Study|Withdrawal by Subject|0
2454454|NCT02603952|8457978|P2|Overall Study|Withdrawal by Subject|0
2454455|NCT02603952|8457979|P1|Overall Study|Withdrawal by Subject|1
2454456|NCT02603887|8458027|P1|Overall Study|Disease progression|1
2454457|NCT02603887|8458027|P1|Overall Study|Adverse Event|4
2454458|NCT02603887|8458027|P1|Overall Study|FDA Guidance|1
2454459|NCT02603809|8458040|P6|Overall Study|Lack of Efficacy|1
2454460|NCT02603809|8458041|P5|Overall Study|Lack of Efficacy|0
2454461|NCT02603809|8458042|P4|Overall Study|Lack of Efficacy|0
2454462|NCT02603809|8458043|P3|Overall Study|Lack of Efficacy|0
2454463|NCT02603809|8458044|P2|Overall Study|Lack of Efficacy|1
2454464|NCT02603809|8458045|P1|Overall Study|Lack of Efficacy|0
2454465|NCT02603809|8458040|P6|Overall Study|Adverse Event|1
2454466|NCT02603809|8458041|P5|Overall Study|Adverse Event|1
2454467|NCT02603809|8458042|P4|Overall Study|Adverse Event|2
2454468|NCT02603809|8458043|P3|Overall Study|Adverse Event|2
2454469|NCT02603809|8458044|P2|Overall Study|Adverse Event|0
2454470|NCT02603809|8458045|P1|Overall Study|Adverse Event|3
2454471|NCT02603809|8458040|P6|Overall Study|Physician Decision|1
2454472|NCT02603809|8458041|P5|Overall Study|Physician Decision|2
2454473|NCT02603809|8458042|P4|Overall Study|Physician Decision|1
2454474|NCT02603809|8458043|P3|Overall Study|Physician Decision|0
2454475|NCT02603809|8458044|P2|Overall Study|Physician Decision|0
2454476|NCT02603809|8458045|P1|Overall Study|Physician Decision|0
2454477|NCT02603809|8458040|P6|Overall Study|Pre-specified discontinuation criteria|1
2454478|NCT02603809|8458041|P5|Overall Study|Pre-specified discontinuation criteria|3
2454479|NCT02603809|8458042|P4|Overall Study|Pre-specified discontinuation criteria|2
2454480|NCT02603809|8458043|P3|Overall Study|Pre-specified discontinuation criteria|2
2454481|NCT02603809|8458044|P2|Overall Study|Pre-specified discontinuation criteria|3
2454482|NCT02603809|8458045|P1|Overall Study|Pre-specified discontinuation criteria|3
2454483|NCT02603809|8458040|P6|Overall Study|Lost to Follow-up|2
2454484|NCT02603809|8458041|P5|Overall Study|Lost to Follow-up|2
2454485|NCT02603809|8458042|P4|Overall Study|Lost to Follow-up|4
2454486|NCT02603809|8458043|P3|Overall Study|Lost to Follow-up|1
2454487|NCT02603809|8458044|P2|Overall Study|Lost to Follow-up|3
2454488|NCT02603809|8458045|P1|Overall Study|Lost to Follow-up|2
2454489|NCT02603809|8458040|P6|Overall Study|Withdrawal by Subject|4
2454490|NCT02603809|8458041|P5|Overall Study|Withdrawal by Subject|3
2454491|NCT02603809|8458042|P4|Overall Study|Withdrawal by Subject|3
2454492|NCT02603809|8458043|P3|Overall Study|Withdrawal by Subject|2
2454493|NCT02603809|8458044|P2|Overall Study|Withdrawal by Subject|1
2454494|NCT02603809|8458045|P1|Overall Study|Withdrawal by Subject|4
2454495|NCT02603419|8458111|P6|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1
2454496|NCT02603419|8458112|P5|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
2454497|NCT02603419|8458113|P4|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
2454498|NCT02603419|8458114|P3|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
2454499|NCT02603419|8458115|P2|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
2454500|NCT02603419|8458116|P1|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
2454501|NCT02603419|8458111|P6|Expansion Phase:Maximum Exposure:48Weeks|Death|1
2454502|NCT02603419|8458112|P5|Expansion Phase:Maximum Exposure:48Weeks|Death|0
2454503|NCT02603419|8458113|P4|Expansion Phase:Maximum Exposure:48Weeks|Death|0
2454504|NCT02603419|8458114|P3|Expansion Phase:Maximum Exposure:48Weeks|Death|0
2454505|NCT02603419|8458115|P2|Expansion Phase:Maximum Exposure:48Weeks|Death|0
2454506|NCT02603419|8458116|P1|Expansion Phase:Maximum Exposure:48Weeks|Death|0
2454507|NCT02603419|8458111|P6|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1
2454508|NCT02603419|8458112|P5|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
2454509|NCT02603419|8458113|P4|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
2454510|NCT02603419|8458114|P3|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
2454511|NCT02603419|8458115|P2|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
2454512|NCT02603419|8458116|P1|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
2454513|NCT02603419|8458111|P6|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
2454514|NCT02603419|8458112|P5|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
2454515|NCT02603419|8458113|P4|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2
2454516|NCT02603419|8458114|P3|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
2454517|NCT02603419|8458115|P2|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
2454518|NCT02603419|8458116|P1|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
2454519|NCT02603419|8458111|P6|Lead-in Phase:Maximum Exposure:123Weeks|Other|0
2454520|NCT02603419|8458112|P5|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
2454521|NCT02603419|8458113|P4|Lead-in Phase:Maximum Exposure:123Weeks|Other|0
2454522|NCT02603419|8458114|P3|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
2454523|NCT02603419|8458115|P2|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
2454524|NCT02603419|8458116|P1|Lead-in Phase:Maximum Exposure:123Weeks|Other|2
2454525|NCT02603419|8458111|P6|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
2454526|NCT02603419|8458112|P5|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
2454527|NCT02603419|8458113|P4|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
2454528|NCT02603419|8458114|P3|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
2454529|NCT02603419|8458115|P2|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1
2454530|NCT02603419|8458116|P1|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
2454531|NCT02603419|8458111|P6|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
2454532|NCT02603419|8458112|P5|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1
2454533|NCT02603419|8458113|P4|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
2454534|NCT02603419|8458114|P3|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
2454535|NCT02603419|8458115|P2|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
2454536|NCT02603419|8458116|P1|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
2454537|NCT02603419|8458111|P6|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
2454538|NCT02603419|8458112|P5|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1
2454539|NCT02603419|8458113|P4|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
2454540|NCT02603419|8458114|P3|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3
2454541|NCT02603419|8458115|P2|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
2454542|NCT02603419|8458116|P1|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2
2454543|NCT02603419|8458111|P6|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0
2454544|NCT02603419|8458112|P5|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3
2454545|NCT02603419|8458113|P4|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4
2454546|NCT02603419|8458114|P3|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2
2454547|NCT02603419|8458115|P2|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4
2454548|NCT02603419|8458116|P1|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2
2454549|NCT02603419|8458111|P6|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
2454550|NCT02603419|8458112|P5|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
2454551|NCT02603419|8458113|P4|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
2454552|NCT02603419|8458114|P3|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
2454553|NCT02603419|8458115|P2|Lead-in Phase:Maximum Exposure:123Weeks|Death|1
2454554|NCT02603419|8458116|P1|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
2454555|NCT02603393|8458303|P2|Overall Study|Sponsor decision|0
2454556|NCT02603393|8458304|P1|Overall Study|Sponsor decision|1
2454557|NCT02603393|8458303|P2|Overall Study|Non-compliance with study treatment|0
2454558|NCT02603393|8458304|P1|Overall Study|Non-compliance with study treatment|1
2454559|NCT02603393|8458303|P2|Overall Study|Lost to Follow-up|2
2454560|NCT02603393|8458304|P1|Overall Study|Lost to Follow-up|1
2454561|NCT02603393|8458303|P2|Overall Study|Protocol deviation|3
2454562|NCT02603393|8458304|P1|Overall Study|Protocol deviation|2
2454563|NCT02603393|8458303|P2|Overall Study|Physician Decision|3
2454564|NCT02603393|8458304|P1|Overall Study|Physician Decision|3
2454565|NCT02603393|8458303|P2|Overall Study|Death|4
2454566|NCT02603393|8458304|P1|Overall Study|Death|3
2454567|NCT02603393|8458303|P2|Overall Study|Lack of Efficacy|2
2454568|NCT02603393|8458304|P1|Overall Study|Lack of Efficacy|7
2454569|NCT02603393|8458303|P2|Overall Study|Technical problems|7
2454570|NCT02603393|8458304|P1|Overall Study|Technical problems|4
2454571|NCT02603393|8458303|P2|Overall Study|Adverse Event|15
2454572|NCT02603393|8458304|P1|Overall Study|Adverse Event|17
2454573|NCT02603393|8458303|P2|Overall Study|Patient/guardian decision|18
2454574|NCT02603393|8458304|P1|Overall Study|Patient/guardian decision|32
2454575|NCT02603172|8458343|P8|Part A (Approximately 16 Weeks)|Adverse Event|0
2454576|NCT02603172|8458344|P7|Part A (Approximately 16 Weeks)|Adverse Event|0
2454577|NCT02603172|8458345|P6|Part A (Approximately 16 Weeks)|Adverse Event|0
2454578|NCT02603172|8458346|P5|Part A (Approximately 16 Weeks)|Adverse Event|0
2454579|NCT02603172|8458347|P4|Part A (Approximately 16 Weeks)|Adverse Event|0
2454580|NCT02603172|8458348|P3|Part A (Approximately 16 Weeks)|Adverse Event|1
2454581|NCT02603172|8458349|P2|Part A (Approximately 16 Weeks)|Adverse Event|0
2454582|NCT02603172|8458350|P1|Part A (Approximately 16 Weeks)|Adverse Event|0
2454583|NCT02603120|8458478|P2|Overall Study|Lost to Follow-up|2
2454584|NCT02603120|8458479|P1|Overall Study|Lost to Follow-up|2
2454585|NCT02603120|8458478|P2|Overall Study|Withdrew Consent|7
2454586|NCT02603120|8458479|P1|Overall Study|Withdrew Consent|3
2454587|NCT02603120|8458478|P2|Overall Study|Pregnancy|1
2454588|NCT02603120|8458479|P1|Overall Study|Pregnancy|0
2454589|NCT02603120|8458478|P2|Overall Study|Death|0
2454590|NCT02603120|8458479|P1|Overall Study|Death|2
2454591|NCT02603120|8458478|P2|Overall Study|Adverse Event|2
2454592|NCT02603120|8458479|P1|Overall Study|Adverse Event|3
2454593|NCT02603120|8458478|P2|Overall Study|Still in Study|269
2454594|NCT02603120|8458479|P1|Overall Study|Still in Study|272
2454595|NCT02603120|8458478|P2|Overall Study|Randomized but Never Treated|2
2454596|NCT02603120|8458479|P1|Overall Study|Randomized but Never Treated|2
2454597|NCT02603107|8458499|P2|Optional Extension Phase|Still in Study|213
2454598|NCT02603107|8458500|P1|Optional Extension Phase|Still in Study|241
2454599|NCT02603107|8458499|P2|Randomized Phase|Lost to Follow-up|3
2454600|NCT02603107|8458500|P1|Randomized Phase|Lost to Follow-up|0
2454601|NCT02603107|8458499|P2|Randomized Phase|Withdrew Consent|14
2454602|NCT02603107|8458500|P1|Randomized Phase|Withdrew Consent|8
2454603|NCT02603107|8458499|P2|Randomized Phase|Protocol Violation|0
2454604|NCT02603107|8458500|P1|Randomized Phase|Protocol Violation|1
2454605|NCT02603107|8458499|P2|Randomized Phase|Non-Compliance with Study Drug|1
2454606|NCT02603107|8458500|P1|Randomized Phase|Non-Compliance with Study Drug|1
2454607|NCT02603107|8458499|P2|Randomized Phase|Investigator's Discretion|1
2454608|NCT02603107|8458500|P1|Randomized Phase|Investigator's Discretion|0
2454609|NCT02603107|8458499|P2|Randomized Phase|Death|1
2454610|NCT02603107|8458500|P1|Randomized Phase|Death|1
2454611|NCT02603107|8458499|P2|Randomized Phase|Adverse Event|0
2454612|NCT02603107|8458500|P1|Randomized Phase|Adverse Event|2
2454613|NCT02603107|8458499|P2|Randomized Phase|Still in Study|27
2454614|NCT02603107|8458500|P1|Randomized Phase|Still in Study|32
2454615|NCT02603107|8458499|P2|Randomized Phase|Randomized and Never Treated|1
2454616|NCT02603107|8458500|P1|Randomized Phase|Randomized and Never Treated|0
2454617|NCT02602080|8458563|P3|Overall Study|Protocol Violation|3
2454618|NCT02602080|8458564|P2|Overall Study|Protocol Violation|1
2454619|NCT02602080|8458565|P1|Overall Study|Protocol Violation|6
2454620|NCT02601820|8458608|P1|1-Yr Post-Treatment (T5)|Missing T5 Record|88
2454621|NCT02601820|8458608|P1|12 Weeks Post-Treatment (T4)|Missing T4 record|3
2454622|NCT02601820|8458608|P1|Late On-Treatment (T3)|missing T3 Record|49
2454623|NCT02601820|8458608|P1|Early On-Treatment (T2)|Missing T2 Record|51
2454624|NCT02601625|8458637|P4|Overall Study|Lost to Follow-up|1
2454625|NCT02601625|8458638|P3|Overall Study|Lost to Follow-up|1
2454626|NCT02601625|8458639|P2|Overall Study|Lost to Follow-up|0
2454627|NCT02601625|8458640|P1|Overall Study|Lost to Follow-up|0
2454628|NCT02601573|8458693|P5|Overall Study|Withdrawal by Subject|0
2454629|NCT02601573|8458694|P4|Overall Study|Withdrawal by Subject|1
2454630|NCT02601573|8458695|P3|Overall Study|Withdrawal by Subject|0
2454631|NCT02601573|8458696|P2|Overall Study|Withdrawal by Subject|1
2454632|NCT02601573|8458697|P1|Overall Study|Withdrawal by Subject|0
2454633|NCT02601573|8458693|P5|Overall Study|Lost to Follow-up|2
2454634|NCT02601573|8458694|P4|Overall Study|Lost to Follow-up|0
2454635|NCT02601573|8458695|P3|Overall Study|Lost to Follow-up|1
2454636|NCT02601573|8458696|P2|Overall Study|Lost to Follow-up|3
2454637|NCT02601573|8458697|P1|Overall Study|Lost to Follow-up|0
2454638|NCT02601560|8458732|P8|Overall Study|Other|0
2454639|NCT02601560|8458733|P7|Overall Study|Other|1
2454640|NCT02601560|8458734|P6|Overall Study|Other|0
2454641|NCT02601560|8458735|P5|Overall Study|Other|0
2454642|NCT02601560|8458736|P4|Overall Study|Other|0
2454643|NCT02601560|8458737|P3|Overall Study|Other|0
2454644|NCT02601560|8458738|P2|Overall Study|Other|0
2454645|NCT02601560|8458739|P1|Overall Study|Other|0
2454646|NCT02601469|8458923|P2|Overall Study|Enrolled in Error|0
2454647|NCT02601469|8458924|P1|Overall Study|Enrolled in Error|1
2454648|NCT02601300|8458930|P1|Extension Phase|Lack of Efficacy|10
2454649|NCT02601300|8458930|P1|Extension Phase|Adverse Event|4
2454650|NCT02601300|8458930|P1|Extension Phase|Withdrawal by Subject|3
2454651|NCT02601300|8458930|P1|Induction Phase|Protocol Violation|1
2454652|NCT02601300|8458930|P1|Induction Phase|Lack of Efficacy|2
2454653|NCT02601209|8458950|P9|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
2454654|NCT02601209|8458951|P8|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
2454655|NCT02601209|8458952|P7|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1
2454656|NCT02601209|8458953|P6|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2
2454657|NCT02601209|8458954|P5|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1
2454658|NCT02601209|8458955|P4|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
2454659|NCT02601209|8458956|P3|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
2454660|NCT02601209|8458957|P2|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
2454661|NCT02601209|8458958|P1|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
2454662|NCT02601209|8458950|P9|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
2454663|NCT02601209|8458951|P8|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
2454664|NCT02601209|8458952|P7|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
2454665|NCT02601209|8458953|P6|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
2454666|NCT02601209|8458954|P5|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
2454667|NCT02601209|8458955|P4|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
2454668|NCT02601209|8458956|P3|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
2454669|NCT02601209|8458957|P2|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
2454670|NCT02601209|8458958|P1|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
2454671|NCT02600871|8458986|P2|Overall Study|Lost to Follow-up|10
2454672|NCT02600871|8458987|P1|Overall Study|Lost to Follow-up|13
2454673|NCT02600845|8458997|P1|Overall Study|Consent Withdrawal|5
2454674|NCT02600845|8458997|P1|Overall Study|Non-compliance with Study Procedures|10
2454675|NCT02600845|8458997|P1|Overall Study|Reason Not Specified|3
2454676|NCT02600819|8459012|P2|Open-Label Extension (OLE) (B/F/TAF)|Still on B/F/TAF Study Drug|7
2454677|NCT02600819|8459013|P1|Open-Label Extension (OLE) (B/F/TAF)|Still on B/F/TAF Study Drug|0
2454678|NCT02600819|8459012|P2|Main Study (E/C/F/TAF)|Still on E/C/F/TAF Study Drug|0
2454679|NCT02600819|8459013|P1|Main Study (E/C/F/TAF)|Still on E/C/F/TAF Study Drug|3
2454680|NCT02600819|8459012|P2|Main Study (E/C/F/TAF)|Lost to Follow-up|0
2454681|NCT02600819|8459013|P1|Main Study (E/C/F/TAF)|Lost to Follow-up|2
2454682|NCT02600819|8459012|P2|Main Study (E/C/F/TAF)|Withdrew Consent|0
2454683|NCT02600819|8459013|P1|Main Study (E/C/F/TAF)|Withdrew Consent|5
2454684|NCT02600819|8459012|P2|Main Study (E/C/F/TAF)|Non-Compliance with Study Drug|0
2454685|NCT02600819|8459013|P1|Main Study (E/C/F/TAF)|Non-Compliance with Study Drug|1
2454686|NCT02600819|8459012|P2|Main Study (E/C/F/TAF)|Investigator's Discretion|0
2454687|NCT02600819|8459013|P1|Main Study (E/C/F/TAF)|Investigator's Discretion|4
2454688|NCT02600819|8459012|P2|Main Study (E/C/F/TAF)|Death|0
2454689|NCT02600819|8459013|P1|Main Study (E/C/F/TAF)|Death|2
2454690|NCT02600819|8459012|P2|Main Study (E/C/F/TAF)|Adverse Event|0
2454691|NCT02600819|8459013|P1|Main Study (E/C/F/TAF)|Adverse Event|2
2454692|NCT02600351|8459117|P4|Overall Study|Randomized but Not Treated|3
2454693|NCT02600351|8459118|P3|Overall Study|Randomized but Not Treated|1
2454694|NCT02600351|8459119|P2|Overall Study|Randomized but Not Treated|0
2454695|NCT02600351|8459120|P1|Overall Study|Randomized but Not Treated|1
2454696|NCT02600351|8459117|P4|Overall Study|Lost to Follow-up|0
2454697|NCT02600351|8459118|P3|Overall Study|Lost to Follow-up|0
2454698|NCT02600351|8459119|P2|Overall Study|Lost to Follow-up|0
2454699|NCT02600351|8459120|P1|Overall Study|Lost to Follow-up|1
2454700|NCT02600351|8459117|P4|Overall Study|Lack of Efficacy|2
2454701|NCT02600351|8459118|P3|Overall Study|Lack of Efficacy|5
2454702|NCT02600351|8459119|P2|Overall Study|Lack of Efficacy|0
2454703|NCT02600351|8459120|P1|Overall Study|Lack of Efficacy|3
2454704|NCT02599961|8459155|P1|Overall Study|Other, Not Specified|3
2454705|NCT02599961|8459155|P1|Overall Study|Discontinuation of Study by Sponsor|9
2454706|NCT02599961|8459155|P1|Overall Study|Subject Non-Compliance|2
2454707|NCT02599961|8459155|P1|Overall Study|Withdrawal by Subject|1
2454708|NCT02599129|8459229|P2|Overall Study|Withdrawal by Subject|1
2454709|NCT02599129|8459230|P1|Overall Study|Withdrawal by Subject|2
2454710|NCT02599129|8459229|P2|Overall Study|Lost to Follow-up|0
2454711|NCT02599129|8459230|P1|Overall Study|Lost to Follow-up|1
2454712|NCT02599129|8459229|P2|Overall Study|Lack of Efficacy|2
2454713|NCT02599129|8459230|P1|Overall Study|Lack of Efficacy|2
2454714|NCT02598934|8459246|P2|Overall Study|Protocol Violation|2
2454715|NCT02598934|8459247|P1|Overall Study|Protocol Violation|1
2454716|NCT02598934|8459246|P2|Overall Study|Administrative|1
2454717|NCT02598934|8459247|P1|Overall Study|Administrative|2
2454718|NCT02598934|8459246|P2|Overall Study|Withdrawal by Subject|3
2454719|NCT02598934|8459247|P1|Overall Study|Withdrawal by Subject|2
2454720|NCT02598934|8459246|P2|Overall Study|Failure to Return|3
2454721|NCT02598934|8459247|P1|Overall Study|Failure to Return|3
2454722|NCT02598934|8459246|P2|Overall Study|Adverse Event|13
2454723|NCT02598934|8459247|P1|Overall Study|Adverse Event|11
2454724|NCT02598622|8459259|P2|Overall Study|Physician Decision|0
2454725|NCT02598622|8459260|P1|Overall Study|Physician Decision|3
2454726|NCT02598622|8459259|P2|Overall Study|Withdrawal by Subject|0
2454727|NCT02598622|8459260|P1|Overall Study|Withdrawal by Subject|3
2454728|NCT02598297|8459289|P2|Overall Study|Followed for survival|0
2454729|NCT02598297|8459290|P1|Overall Study|Followed for survival|1
2454730|NCT02598297|8459289|P2|Overall Study|Subject/guardian decision|0
2454731|NCT02598297|8459290|P1|Overall Study|Subject/guardian decision|1
2454732|NCT02598297|8459289|P2|Overall Study|Physician Decision|0
2454733|NCT02598297|8459290|P1|Overall Study|Physician Decision|1
2454734|NCT02598297|8459289|P2|Overall Study|Adverse Event|1
2454735|NCT02598297|8459290|P1|Overall Study|Adverse Event|1
2454736|NCT02598297|8459289|P2|Overall Study|Study terminated by Sponsor|23
2454737|NCT02598297|8459290|P1|Overall Study|Study terminated by Sponsor|21
2454738|NCT02598193|8459316|P1|Overall Study|Does not want to take Nintedanib|1
2454739|NCT02598193|8459316|P1|Overall Study|Listed in active lung transplant list|1
2454740|NCT02598193|8459316|P1|Overall Study|Withdrawal by Subject|1
2454741|NCT02598193|8459316|P1|Overall Study|Adverse Event|13
2454742|NCT02598128|8459324|P4|Period A: Days -7 to -1|Adverse Event|0
2454743|NCT02598128|8459325|P3|Period A: Days -7 to -1|Adverse Event|0
2454744|NCT02598128|8459326|P2|Period A: Days -7 to -1|Adverse Event|0
2454745|NCT02598128|8459327|P1|Period A: Days -7 to -1|Adverse Event|1
2454746|NCT02598076|8459370|P2|Overall Study|Lost to Follow-up|3
2454747|NCT02598076|8459371|P1|Overall Study|Lost to Follow-up|2
2454748|NCT02597946|8459385|P1|Overall Study|Other than above|1
2454749|NCT02597946|8459385|P1|Overall Study|Progressive disease|16
2454750|NCT02597946|8459385|P1|Overall Study|Withdrawal by Subject|1
2454751|NCT02597933|8459396|P2|Overall Study|Other than stated above|14
2454752|NCT02597933|8459397|P1|Overall Study|Other than stated above|7
2454753|NCT02597933|8459396|P2|Overall Study|Not treated|2
2454754|NCT02597933|8459397|P1|Overall Study|Not treated|2
2454755|NCT02597933|8459396|P2|Overall Study|Adverse Event|28
2454756|NCT02597933|8459397|P1|Overall Study|Adverse Event|20
2454757|NCT02597933|8459396|P2|Overall Study|Protocol Violation|2
2454758|NCT02597933|8459397|P1|Overall Study|Protocol Violation|2
2454759|NCT02597933|8459396|P2|Overall Study|Withdrawal by Subject|5
2454760|NCT02597933|8459397|P1|Overall Study|Withdrawal by Subject|7
2454761|NCT02597920|8459428|P3|Overall Study|Other|0
2454762|NCT02597920|8459429|P2|Overall Study|Other|0
2454763|NCT02597920|8459430|P1|Overall Study|Other|1
2454764|NCT02597920|8459428|P3|Overall Study|Other than specified|5
2454765|NCT02597920|8459429|P2|Overall Study|Other than specified|31
2454766|NCT02597920|8459430|P1|Overall Study|Other than specified|10
2454767|NCT02597920|8459428|P3|Overall Study|Refuse to continue in the study|1
2454768|NCT02597920|8459429|P2|Overall Study|Refuse to continue in the study|13
2454769|NCT02597920|8459430|P1|Overall Study|Refuse to continue in the study|3
2454770|NCT02597920|8459428|P3|Overall Study|Lost to Follow-up|0
2454771|NCT02597920|8459429|P2|Overall Study|Lost to Follow-up|9
2454772|NCT02597920|8459430|P1|Overall Study|Lost to Follow-up|7
2454773|NCT02597920|8459428|P3|Overall Study|Other adverse event|0
2454774|NCT02597920|8459429|P2|Overall Study|Other adverse event|30
2454775|NCT02597920|8459430|P1|Overall Study|Other adverse event|20
2454776|NCT02597920|8459428|P3|Overall Study|Worsening of other pre-existing disease|0
2454777|NCT02597920|8459429|P2|Overall Study|Worsening of other pre-existing disease|1
2454778|NCT02597920|8459430|P1|Overall Study|Worsening of other pre-existing disease|0
2454779|NCT02597855|8459464|P2|Overall Study|Lost to Follow-up|1
2454780|NCT02597855|8459465|P1|Overall Study|Lost to Follow-up|2
2454781|NCT02597452|8459511|P1|Overall Study|testing incomplete|30
2454782|NCT02597062|8459623|P1|Overall Study|Ineligible|1
2454783|NCT02597049|8459632|P3|Overall Study|Noncompliant with Study Visits|0
2454784|NCT02597049|8459633|P2|Overall Study|Noncompliant with Study Visits|0
2454785|NCT02597049|8459634|P1|Overall Study|Noncompliant with Study Visits|1
2454786|NCT02597049|8459632|P3|Overall Study|Death|0
2454787|NCT02597049|8459633|P2|Overall Study|Death|0
2454788|NCT02597049|8459634|P1|Overall Study|Death|2
2454789|NCT02597049|8459632|P3|Overall Study|Adverse Event|0
2454790|NCT02597049|8459633|P2|Overall Study|Adverse Event|0
2454791|NCT02597049|8459634|P1|Overall Study|Adverse Event|2
2454792|NCT02597049|8459632|P3|Overall Study|Withdrawal by Subject|1
2454793|NCT02597049|8459633|P2|Overall Study|Withdrawal by Subject|2
2454794|NCT02597049|8459634|P1|Overall Study|Withdrawal by Subject|2
2454795|NCT02597049|8459632|P3|Overall Study|Lost to Follow-up|2
2454796|NCT02597049|8459633|P2|Overall Study|Lost to Follow-up|3
2454797|NCT02597049|8459634|P1|Overall Study|Lost to Follow-up|0
2454798|NCT02596971|8459675|P3|Overall Study|Death|0
2454799|NCT02596971|8459676|P2|Overall Study|Death|0
2454800|NCT02596971|8459677|P1|Overall Study|Death|2
2454801|NCT02596971|8459675|P3|Overall Study|In Follow-up|15
2454802|NCT02596971|8459676|P2|Overall Study|In Follow-up|0
2454803|NCT02596971|8459677|P1|Overall Study|In Follow-up|4
2454804|NCT02596971|8459675|P3|Overall Study|Ongoing|24
2454805|NCT02596971|8459676|P2|Overall Study|Ongoing|6
2454806|NCT02596971|8459677|P1|Overall Study|Ongoing|36
2454807|NCT02596971|8459675|P3|Overall Study|Withdrawal by Subject|2
2454808|NCT02596971|8459676|P2|Overall Study|Withdrawal by Subject|0
2454809|NCT02596971|8459677|P1|Overall Study|Withdrawal by Subject|0
2454810|NCT02596971|8459675|P3|Overall Study|Physician Decision|1
2454811|NCT02596971|8459676|P2|Overall Study|Physician Decision|0
2454812|NCT02596971|8459677|P1|Overall Study|Physician Decision|0
2454813|NCT02596971|8459675|P3|Overall Study|Disease Progression|0
2454814|NCT02596971|8459676|P2|Overall Study|Disease Progression|1
2454815|NCT02596971|8459677|P1|Overall Study|Disease Progression|0
2454816|NCT02596958|8459706|P1|Overall Study|Excluded Due to Second Line Treatment|9
2454817|NCT02596958|8459706|P1|Overall Study|Missing|32
2454818|NCT02596958|8459706|P1|Overall Study|Lost to Follow-up|33
2454819|NCT02596958|8459706|P1|Overall Study|Administrative Reasons/Other|231
2454820|NCT02596958|8459706|P1|Overall Study|Refusal of Treatment/Poor Cooperation|61
2454821|NCT02596958|8459706|P1|Overall Study|Death From Other Cause|33
2454822|NCT02596958|8459706|P1|Overall Study|Death From Cancer|112
2454823|NCT02596958|8459706|P1|Overall Study|Cancer Progression|441
2454824|NCT02596958|8459706|P1|Overall Study|Serious Adverse Drug Reactions|44
2454825|NCT02596945|8459718|P1|Overall Study|Missing|1
2454826|NCT02596945|8459718|P1|Overall Study|Withdrawal by Subject|1
2454827|NCT02596945|8459718|P1|Overall Study|Other Erythropoietin stimulating agent|4
2454828|NCT02596945|8459718|P1|Overall Study|Change to hemodialysis|15
2454829|NCT02596945|8459718|P1|Overall Study|Other|32
2454830|NCT02596945|8459718|P1|Overall Study|No documentation of study drug dosing|3
2454831|NCT02596893|8459728|P4|Overall Double-Blind Period Weeks 0-52|Early Escape|70
2454832|NCT02596893|8459729|P3|Overall Double-Blind Period Weeks 0-52|Early Escape|69
2454833|NCT02596893|8459730|P2|Overall Double-Blind Period Weeks 0-52|Early Escape|76
2454834|NCT02596893|8459731|P1|Overall Double-Blind Period Weeks 0-52|Early Escape|66
2454835|NCT02596893|8459728|P4|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2
2454836|NCT02596893|8459729|P3|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
2454837|NCT02596893|8459730|P2|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
2454838|NCT02596893|8459731|P1|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
2454839|NCT02596893|8459728|P4|Overall Double-Blind Period Weeks 0-52|Death|0
2454840|NCT02596893|8459729|P3|Overall Double-Blind Period Weeks 0-52|Death|1
2454841|NCT02596893|8459730|P2|Overall Double-Blind Period Weeks 0-52|Death|0
2454842|NCT02596893|8459731|P1|Overall Double-Blind Period Weeks 0-52|Death|0
2454843|NCT02596893|8459728|P4|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2
2454844|NCT02596893|8459729|P3|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1
2454845|NCT02596893|8459730|P2|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0
2454846|NCT02596893|8459731|P1|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0
2454847|NCT02596893|8459728|P4|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
2454848|NCT02596893|8459729|P3|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
2454849|NCT02596893|8459730|P2|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
2454850|NCT02596893|8459731|P1|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0
2454851|NCT02596893|8459728|P4|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2
2454852|NCT02596893|8459729|P3|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0
2454853|NCT02596893|8459730|P2|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2
2454854|NCT02596893|8459731|P1|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1
2454855|NCT02596893|8459728|P4|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5
2454856|NCT02596893|8459729|P3|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13
2454857|NCT02596893|8459730|P2|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4
2454858|NCT02596893|8459731|P1|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10
2454859|NCT02596893|8459728|P4|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13
2454860|NCT02596893|8459729|P3|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14
2454861|NCT02596893|8459730|P2|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14
2454862|NCT02596893|8459731|P1|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15
2454863|NCT02596893|8459728|P4|Overall Double-Blind Period Weeks 0-52|Pregnancy|1
2454864|NCT02596893|8459729|P3|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
2454865|NCT02596893|8459730|P2|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
2454866|NCT02596893|8459731|P1|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
2454867|NCT02596893|8459728|P4|Overall Double-Blind Period Weeks 0-52|Adverse Event|12
2454868|NCT02596893|8459729|P3|Overall Double-Blind Period Weeks 0-52|Adverse Event|15
2454869|NCT02596893|8459730|P2|Overall Double-Blind Period Weeks 0-52|Adverse Event|15
2454870|NCT02596893|8459731|P1|Overall Double-Blind Period Weeks 0-52|Adverse Event|11
2454871|NCT02596893|8459728|P4|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58
2454872|NCT02596893|8459729|P3|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48
2454873|NCT02596893|8459730|P2|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56
2454874|NCT02596893|8459731|P1|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61
2454875|NCT02596854|8459790|P1|Overall Study|Withdrawn|8
2454876|NCT02596711|8459812|P3|Overall Study|Lost to Follow-up|3
2454877|NCT02596711|8459813|P2|Overall Study|Lost to Follow-up|2
2454878|NCT02596711|8459814|P1|Overall Study|Lost to Follow-up|1
2454879|NCT02596620|8459830|P2|Overall Study|Lost to Follow-up|1
2454880|NCT02596620|8459831|P1|Overall Study|Lost to Follow-up|1
2454881|NCT02596230|8459869|P5|Objective 2, One Year|Other|0
2454882|NCT02596230|8459870|P4|Objective 2, One Year|Other|0
2454883|NCT02596230|8459871|P3|Objective 2, One Year|Other|2
2454884|NCT02596230|8459872|P2|Objective 2, One Year|Other|3
2454885|NCT02596230|8459873|P1|Objective 2, One Year|Other|0
2454886|NCT02596230|8459869|P5|Objective 2, One Year|Death|30
2454887|NCT02596230|8459870|P4|Objective 2, One Year|Death|21
2454888|NCT02596230|8459871|P3|Objective 2, One Year|Death|41
2454889|NCT02596230|8459872|P2|Objective 2, One Year|Death|12
2454890|NCT02596230|8459873|P1|Objective 2, One Year|Death|0
2454891|NCT02596230|8459869|P5|Objective 2, One Year|Adverse drug reaction|0
2454892|NCT02596230|8459870|P4|Objective 2, One Year|Adverse drug reaction|0
2454893|NCT02596230|8459871|P3|Objective 2, One Year|Adverse drug reaction|0
2454894|NCT02596230|8459872|P2|Objective 2, One Year|Adverse drug reaction|1
2454895|NCT02596230|8459873|P1|Objective 2, One Year|Adverse drug reaction|0
2454896|NCT02596230|8459869|P5|Objective 2, One Year|Withdrawal by Subject|2
2454897|NCT02596230|8459870|P4|Objective 2, One Year|Withdrawal by Subject|5
2454898|NCT02596230|8459871|P3|Objective 2, One Year|Withdrawal by Subject|14
2454899|NCT02596230|8459872|P2|Objective 2, One Year|Withdrawal by Subject|11
2454900|NCT02596230|8459873|P1|Objective 2, One Year|Withdrawal by Subject|0
2454901|NCT02596230|8459869|P5|Objective 2, One Year|Lost to Follow-up|46
2454902|NCT02596230|8459870|P4|Objective 2, One Year|Lost to Follow-up|32
2454903|NCT02596230|8459871|P3|Objective 2, One Year|Lost to Follow-up|41
2454904|NCT02596230|8459872|P2|Objective 2, One Year|Lost to Follow-up|41
2454905|NCT02596230|8459873|P1|Objective 2, One Year|Lost to Follow-up|0
2454906|NCT02596230|8459869|P5|Screening Period for Objective 2|Participants not participating in obj 2|0
2454907|NCT02596230|8459870|P4|Screening Period for Objective 2|Participants not participating in obj 2|846
2454908|NCT02596230|8459871|P3|Screening Period for Objective 2|Participants not participating in obj 2|0
2454909|NCT02596230|8459872|P2|Screening Period for Objective 2|Participants not participating in obj 2|228
2454910|NCT02596230|8459873|P1|Screening Period for Objective 2|Participants not participating in obj 2|3714
2454911|NCT02596035|8459897|P3|Overall Study|Other Reasons|0
2454912|NCT02596035|8459898|P2|Overall Study|Other Reasons|4
2454913|NCT02596035|8459899|P1|Overall Study|Other Reasons|3
2454914|NCT02596035|8459897|P3|Overall Study|Poor/Non-Compliance|0
2454915|NCT02596035|8459898|P2|Overall Study|Poor/Non-Compliance|1
2454916|NCT02596035|8459899|P1|Overall Study|Poor/Non-Compliance|0
2454917|NCT02596035|8459897|P3|Overall Study|Withdrawal by Subject|0
2454918|NCT02596035|8459898|P2|Overall Study|Withdrawal by Subject|2
2454919|NCT02596035|8459899|P1|Overall Study|Withdrawal by Subject|4
2454920|NCT02596035|8459897|P3|Overall Study|Adverse Event|0
2454921|NCT02596035|8459898|P2|Overall Study|Adverse Event|2
2454922|NCT02596035|8459899|P1|Overall Study|Adverse Event|6
2454923|NCT02596035|8459897|P3|Overall Study|Study Drug Toxicity|0
2454924|NCT02596035|8459898|P2|Overall Study|Study Drug Toxicity|3
2454925|NCT02596035|8459899|P1|Overall Study|Study Drug Toxicity|11
2454926|NCT02596035|8459897|P3|Overall Study|Disease Progression|1
2454927|NCT02596035|8459898|P2|Overall Study|Disease Progression|32
2454928|NCT02596035|8459899|P1|Overall Study|Disease Progression|62
2454929|NCT02596009|8459935|P6|Overall Study|Administrative problems|0
2454930|NCT02596009|8459936|P5|Overall Study|Administrative problems|0
2454931|NCT02596009|8459937|P4|Overall Study|Administrative problems|0
2454932|NCT02596009|8459938|P3|Overall Study|Administrative problems|0
2454933|NCT02596009|8459939|P2|Overall Study|Administrative problems|1
2454934|NCT02596009|8459940|P1|Overall Study|Administrative problems|0
2454935|NCT02595970|8459957|P1|Overall Study|Lack of Efficacy|7
2454936|NCT02595970|8459957|P1|Overall Study|Adverse Event|5
2454937|NCT02595970|8459957|P1|Overall Study|Protocol Violation|4
2454938|NCT02595970|8459957|P1|Overall Study|Physician Decision|2
2454939|NCT02595970|8459957|P1|Overall Study|Withdrawal by Subject|2
2454940|NCT02595723|8459974|P3|First Washout (21 Days)|Lost to Follow-up|0
2454941|NCT02595723|8459975|P2|First Washout (21 Days)|Lost to Follow-up|0
2454942|NCT02595723|8459976|P1|First Washout (21 Days)|Lost to Follow-up|1
2454943|NCT02595723|8459974|P3|First Washout (21 Days)|Withdrawal by Subject|0
2454944|NCT02595723|8459975|P2|First Washout (21 Days)|Withdrawal by Subject|0
2454945|NCT02595723|8459976|P1|First Washout (21 Days)|Withdrawal by Subject|1
2454946|NCT02595502|8459988|P2|Period 3|Received Incorrect Treatment at period 3|1
2454947|NCT02595502|8459989|P1|Period 3|Received Incorrect Treatment at period 3|0
2454948|NCT02595502|8459988|P2|Period 3|Lost to Follow-up|0
2454949|NCT02595502|8459989|P1|Period 3|Lost to Follow-up|1
2454950|NCT02595502|8459988|P2|Period 3|Protocol Violation|1
2454951|NCT02595502|8459989|P1|Period 3|Protocol Violation|0
2454952|NCT02595502|8459988|P2|Period 2|Received incorrect lens at Period 1|1
2454953|NCT02595502|8459989|P1|Period 2|Received incorrect lens at Period 1|0
2454954|NCT02595502|8459988|P2|Period 2|Adverse Event|1
2454955|NCT02595502|8459989|P1|Period 2|Adverse Event|1
2454956|NCT02595502|8459988|P2|Period 1|Lost to Follow-up|1
2454957|NCT02595502|8459989|P1|Period 1|Lost to Follow-up|0
2454958|NCT02595502|8459988|P2|Period 1|Withdrawal by Subject|0
2454959|NCT02595502|8459989|P1|Period 1|Withdrawal by Subject|1
2454960|NCT02595502|8459988|P2|Period 1|Adverse Event|1
2454961|NCT02595502|8459989|P1|Period 1|Adverse Event|0
2454962|NCT02595450|8459995|P1|Overall Study|Enrolled, but not treated|8
2454963|NCT02595450|8459995|P1|Overall Study|Unspecified (only completed 1 cycle)|73
2454964|NCT02595437|8460001|P1|Triferic Via IV|Withdrawal by Subject|1
2454965|NCT02595073|8460021|P2|Overall Study|Protocol Violation|0
2454966|NCT02595073|8460022|P1|Overall Study|Protocol Violation|2
2454967|NCT02595073|8460021|P2|Overall Study|Progressive Disease|1
2454968|NCT02595073|8460022|P1|Overall Study|Progressive Disease|0
2454969|NCT02595008|8460032|P2|Overall Study|Enrolled In Error|0
2454970|NCT02595008|8460033|P1|Overall Study|Enrolled In Error|1
2454971|NCT02594163|8460071|P2|Follow-up Period|Physician Decision|1
2454972|NCT02594163|8460072|P1|Follow-up Period|Physician Decision|0
2454973|NCT02594163|8460071|P2|Follow-up Period|Progressive Disease|0
2454974|NCT02594163|8460072|P1|Follow-up Period|Progressive Disease|2
2454975|NCT02594163|8460071|P2|Follow-up Period|Adverse Event|1
2454976|NCT02594163|8460072|P1|Follow-up Period|Adverse Event|0
2454977|NCT02594163|8460071|P2|Follow-up Period|Death|5
2454978|NCT02594163|8460072|P1|Follow-up Period|Death|2
2454979|NCT02594163|8460071|P2|Follow-up Period|Lost to Follow-up|0
2454980|NCT02594163|8460072|P1|Follow-up Period|Lost to Follow-up|1
2454981|NCT02594163|8460071|P2|Follow-up Period|Study Termination by Sponsor|4
2454982|NCT02594163|8460072|P1|Follow-up Period|Study Termination by Sponsor|6
2454983|NCT02594163|8460071|P2|Follow-up Period|Withdrawal by Subject|1
2454984|NCT02594163|8460072|P1|Follow-up Period|Withdrawal by Subject|0
2454985|NCT02594163|8460071|P2|Treatment Period|Other, Non-AE|0
2454986|NCT02594163|8460072|P1|Treatment Period|Other, Non-AE|1
2454987|NCT02594163|8460071|P2|Treatment Period|Study termination by sponsor|1
2454988|NCT02594163|8460072|P1|Treatment Period|Study termination by sponsor|2
2454989|NCT02594163|8460071|P2|Treatment Period|Physician Decision|3
2454990|NCT02594163|8460072|P1|Treatment Period|Physician Decision|1
2454991|NCT02594163|8460071|P2|Treatment Period|Adverse Event|5
2454992|NCT02594163|8460072|P1|Treatment Period|Adverse Event|1
2454993|NCT02594163|8460071|P2|Treatment Period|Progressive disease|3
2454994|NCT02594163|8460072|P1|Treatment Period|Progressive disease|2
2454995|NCT02594098|8460090|P2|Overall Study|Other|1
2454996|NCT02594098|8460091|P1|Overall Study|Other|0
2454997|NCT02594098|8460090|P2|Overall Study|Seek alternative treatment|1
2454998|NCT02594098|8460091|P1|Overall Study|Seek alternative treatment|2
2454999|NCT02594098|8460090|P2|Overall Study|Terminated participation|2
2455000|NCT02594098|8460091|P1|Overall Study|Terminated participation|6
2455001|NCT02594098|8460090|P2|Overall Study|Withdrawal by Subject|3
2455002|NCT02594098|8460091|P1|Overall Study|Withdrawal by Subject|1
2455003|NCT02594098|8460090|P2|Overall Study|Lack of Efficacy|6
2455004|NCT02594098|8460091|P1|Overall Study|Lack of Efficacy|17
2455005|NCT02593864|8460160|P1|Overall Study|Lost to Follow-up|3
2455006|NCT02593864|8460160|P1|Overall Study|Withdrawal by Subject|3
2455007|NCT02593773|8460165|P1|Overall Study|Death|1
2455008|NCT02593773|8460165|P1|Overall Study|Study Terminated by Sponsor|31
2455009|NCT02593773|8460165|P1|Overall Study|Voluntary Withdrawal|3
2455010|NCT02593305|8460197|P3|Post 1|Comparison only group. No intervention.|10
2455011|NCT02593305|8460198|P2|Post 1|Comparison only group. No intervention.|0
2455012|NCT02593305|8460199|P1|Post 1|Comparison only group. No intervention.|0
2455013|NCT02593149|8460214|P2|Intervention|Didn't use CVC for at least 21 day|115
2455014|NCT02593149|8460215|P1|Intervention|Didn't use CVC for at least 21 day|116
2455015|NCT02593149|8460214|P2|Run-In|Didn't use CVC for at least 21 days|38
2455016|NCT02593149|8460215|P1|Run-In|Didn't use CVC for at least 21 days|36
2455017|NCT02592876|8460223|P2|Overall Study|Death|9
2455018|NCT02592876|8460224|P1|Overall Study|Death|6
2455019|NCT02592876|8460223|P2|Overall Study|Lost to Follow-up|1
2455020|NCT02592876|8460224|P1|Overall Study|Lost to Follow-up|0
2455021|NCT02592876|8460223|P2|Overall Study|Study Termination by Sponsor|27
2455022|NCT02592876|8460224|P1|Overall Study|Study Termination by Sponsor|32
2455023|NCT02592876|8460223|P2|Overall Study|Withdrawal by Subject|3
2455024|NCT02592876|8460224|P1|Overall Study|Withdrawal by Subject|3
2455025|NCT02592447|8460295|P2|Overall Study|Withdrawal by Subject|1
2455026|NCT02592447|8460296|P1|Overall Study|Withdrawal by Subject|0
2455027|NCT02592447|8460295|P2|Overall Study|Ineligible after randomization|0
2455028|NCT02592447|8460296|P1|Overall Study|Ineligible after randomization|1
2455029|NCT02592447|8460295|P2|Overall Study|Lost to Follow-up|0
2455030|NCT02592447|8460296|P1|Overall Study|Lost to Follow-up|1
2455031|NCT02592434|8460304|P3|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0
2455032|NCT02592434|8460305|P2|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1
2455033|NCT02592434|8460306|P1|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0
2455034|NCT02592434|8460304|P3|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0
2455035|NCT02592434|8460305|P2|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1
2455036|NCT02592434|8460306|P1|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0
2455037|NCT02592434|8460304|P3|Double Blind Phase (26 Weeks)|Protocol Deviation|1
2455038|NCT02592434|8460305|P2|Double Blind Phase (26 Weeks)|Protocol Deviation|0
2455039|NCT02592434|8460306|P1|Double Blind Phase (26 Weeks)|Protocol Deviation|0
2455040|NCT02592434|8460304|P3|Double Blind Phase (26 Weeks)|Other|0
2455041|NCT02592434|8460305|P2|Double Blind Phase (26 Weeks)|Other|1
2455042|NCT02592434|8460306|P1|Double Blind Phase (26 Weeks)|Other|0
2455043|NCT02592434|8460304|P3|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44
2455044|NCT02592434|8460305|P2|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22
2455045|NCT02592434|8460306|P1|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0
2455046|NCT02592434|8460304|P3|Double Blind Phase (26 Weeks)|Adverse Event|2
2455047|NCT02592434|8460305|P2|Double Blind Phase (26 Weeks)|Adverse Event|2
2455048|NCT02592434|8460306|P1|Double Blind Phase (26 Weeks)|Adverse Event|0
2455049|NCT02592434|8460304|P3|Open-Label Phase (18 Weeks)|Protocol Deviation|0
2455050|NCT02592434|8460305|P2|Open-Label Phase (18 Weeks)|Protocol Deviation|0
2455051|NCT02592434|8460306|P1|Open-Label Phase (18 Weeks)|Protocol Deviation|4
2455052|NCT02592434|8460304|P3|Open-Label Phase (18 Weeks)|Other|0
2455053|NCT02592434|8460305|P2|Open-Label Phase (18 Weeks)|Other|0
2455054|NCT02592434|8460306|P1|Open-Label Phase (18 Weeks)|Other|3
2455055|NCT02592434|8460304|P3|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0
2455056|NCT02592434|8460305|P2|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0
2455057|NCT02592434|8460306|P1|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21
2455058|NCT02592434|8460304|P3|Open-Label Phase (18 Weeks)|Adverse Event|0
2455059|NCT02592434|8460305|P2|Open-Label Phase (18 Weeks)|Adverse Event|0
2455060|NCT02592434|8460306|P1|Open-Label Phase (18 Weeks)|Adverse Event|12
2455061|NCT02591290|8460469|P1|Overall Study|Withdrawal by Subject|2
2455062|NCT02591238|8460479|P4|Overall Study|personal circumstances|0
2455063|NCT02591238|8460480|P3|Overall Study|personal circumstances|0
2455064|NCT02591238|8460481|P2|Overall Study|personal circumstances|1
2455065|NCT02591238|8460482|P1|Overall Study|personal circumstances|0
2455066|NCT02591238|8460479|P4|Overall Study|personal circumstances|1
2455067|NCT02591238|8460480|P3|Overall Study|personal circumstances|0
2455068|NCT02591238|8460481|P2|Overall Study|personal circumstances|0
2455069|NCT02591238|8460482|P1|Overall Study|personal circumstances|0
2455070|NCT02591238|8460479|P4|Overall Study|influenza|1
2455071|NCT02591238|8460480|P3|Overall Study|influenza|0
2455072|NCT02591238|8460481|P2|Overall Study|influenza|0
2455073|NCT02591238|8460482|P1|Overall Study|influenza|0
2455074|NCT02591238|8460479|P4|Overall Study|Withdrawal by Subject|1
2455075|NCT02591238|8460480|P3|Overall Study|Withdrawal by Subject|0
2455076|NCT02591238|8460481|P2|Overall Study|Withdrawal by Subject|0
2455077|NCT02591238|8460482|P1|Overall Study|Withdrawal by Subject|0
2455078|NCT02591238|8460479|P4|Overall Study|Pregnancy|0
2455079|NCT02591238|8460480|P3|Overall Study|Pregnancy|0
2455080|NCT02591238|8460481|P2|Overall Study|Pregnancy|0
2455081|NCT02591238|8460482|P1|Overall Study|Pregnancy|1
2455082|NCT02590939|8460518|P2|Overall Study|Failed the nociceptive test|1
2455083|NCT02590939|8460519|P1|Overall Study|Failed the nociceptive test|2
2455084|NCT02590939|8460518|P2|Overall Study|Withdrawal by Subject|1
2455085|NCT02590939|8460519|P1|Overall Study|Withdrawal by Subject|3
2455086|NCT02590588|8460539|P1|Overall Study|Adverse Event|1
2455087|NCT02590562|8460547|P1|Overall Study|Did Not Meet the Inclusion Criteria|6
2455088|NCT02590432|8460606|P9|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
2455089|NCT02590432|8460607|P8|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1
2455090|NCT02590432|8460608|P7|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
2455091|NCT02590432|8460609|P6|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
2455092|NCT02590432|8460610|P5|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
2455093|NCT02590432|8460611|P4|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
2455094|NCT02590432|8460612|P3|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
2455095|NCT02590432|8460613|P2|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
2455096|NCT02590432|8460614|P1|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
2455097|NCT02590432|8460606|P9|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
2455098|NCT02590432|8460607|P8|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1
2455099|NCT02590432|8460608|P7|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
2455100|NCT02590432|8460609|P6|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
2455101|NCT02590432|8460610|P5|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
2455102|NCT02590432|8460611|P4|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
2455103|NCT02590432|8460612|P3|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
2455104|NCT02590432|8460613|P2|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
2455105|NCT02590432|8460614|P1|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
2455106|NCT02590432|8460606|P9|Dose-reduced Open Label Treatment Period|Protocol Violation|1
2455107|NCT02590432|8460607|P8|Dose-reduced Open Label Treatment Period|Protocol Violation|0
2455108|NCT02590432|8460608|P7|Dose-reduced Open Label Treatment Period|Protocol Violation|0
2455109|NCT02590432|8460609|P6|Dose-reduced Open Label Treatment Period|Protocol Violation|0
2455110|NCT02590432|8460610|P5|Dose-reduced Open Label Treatment Period|Protocol Violation|0
2455111|NCT02590432|8460611|P4|Dose-reduced Open Label Treatment Period|Protocol Violation|0
2455112|NCT02590432|8460612|P3|Dose-reduced Open Label Treatment Period|Protocol Violation|0
2455113|NCT02590432|8460613|P2|Dose-reduced Open Label Treatment Period|Protocol Violation|0
2455114|NCT02590432|8460614|P1|Dose-reduced Open Label Treatment Period|Protocol Violation|0
2455115|NCT02590432|8460606|P9|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1
2455116|NCT02590432|8460607|P8|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
2455117|NCT02590432|8460608|P7|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
2455118|NCT02590432|8460609|P6|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
2455119|NCT02590432|8460610|P5|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
2455120|NCT02590432|8460611|P4|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
2455121|NCT02590432|8460612|P3|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
2455122|NCT02590432|8460613|P2|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
2455123|NCT02590432|8460614|P1|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
2455124|NCT02590432|8460606|P9|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1
2455125|NCT02590432|8460607|P8|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3
2455126|NCT02590432|8460608|P7|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
2455127|NCT02590432|8460609|P6|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
2455128|NCT02590432|8460610|P5|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
2455129|NCT02590432|8460611|P4|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
2455130|NCT02590432|8460612|P3|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
2455131|NCT02590432|8460613|P2|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
2455132|NCT02590432|8460614|P1|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
2455133|NCT02590432|8460606|P9|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
2455134|NCT02590432|8460607|P8|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1
2455135|NCT02590432|8460608|P7|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
2455136|NCT02590432|8460609|P6|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
2455137|NCT02590432|8460610|P5|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
2455138|NCT02590432|8460611|P4|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
2455139|NCT02590432|8460612|P3|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
2455140|NCT02590432|8460613|P2|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
2455141|NCT02590432|8460614|P1|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
2455142|NCT02590432|8460606|P9|Dose-reduced Open Label Treatment Period|Adverse Event|15
2455143|NCT02590432|8460607|P8|Dose-reduced Open Label Treatment Period|Adverse Event|12
2455144|NCT02590432|8460608|P7|Dose-reduced Open Label Treatment Period|Adverse Event|0
2455145|NCT02590432|8460609|P6|Dose-reduced Open Label Treatment Period|Adverse Event|0
2455146|NCT02590432|8460610|P5|Dose-reduced Open Label Treatment Period|Adverse Event|0
2455147|NCT02590432|8460611|P4|Dose-reduced Open Label Treatment Period|Adverse Event|0
2455148|NCT02590432|8460612|P3|Dose-reduced Open Label Treatment Period|Adverse Event|0
2455149|NCT02590432|8460613|P2|Dose-reduced Open Label Treatment Period|Adverse Event|0
2455150|NCT02590432|8460614|P1|Dose-reduced Open Label Treatment Period|Adverse Event|0
2455151|NCT02590432|8460606|P9|Double-blind Treatment Period|Non-compliance with Study Drug|0
2455152|NCT02590432|8460607|P8|Double-blind Treatment Period|Non-compliance with Study Drug|0
2455153|NCT02590432|8460608|P7|Double-blind Treatment Period|Non-compliance with Study Drug|0
2455154|NCT02590432|8460609|P6|Double-blind Treatment Period|Non-compliance with Study Drug|1
2455155|NCT02590432|8460610|P5|Double-blind Treatment Period|Non-compliance with Study Drug|0
2455156|NCT02590432|8460611|P4|Double-blind Treatment Period|Non-compliance with Study Drug|0
2455157|NCT02590432|8460612|P3|Double-blind Treatment Period|Non-compliance with Study Drug|0
2455158|NCT02590432|8460613|P2|Double-blind Treatment Period|Non-compliance with Study Drug|0
2455159|NCT02590432|8460614|P1|Double-blind Treatment Period|Non-compliance with Study Drug|0
2455160|NCT02590432|8460606|P9|Double-blind Treatment Period|Lost to Follow-up|0
2455161|NCT02590432|8460607|P8|Double-blind Treatment Period|Lost to Follow-up|0
2455162|NCT02590432|8460608|P7|Double-blind Treatment Period|Lost to Follow-up|0
2455163|NCT02590432|8460609|P6|Double-blind Treatment Period|Lost to Follow-up|2
2455164|NCT02590432|8460610|P5|Double-blind Treatment Period|Lost to Follow-up|0
2455165|NCT02590432|8460611|P4|Double-blind Treatment Period|Lost to Follow-up|0
2455166|NCT02590432|8460612|P3|Double-blind Treatment Period|Lost to Follow-up|1
2455167|NCT02590432|8460613|P2|Double-blind Treatment Period|Lost to Follow-up|0
2455168|NCT02590432|8460614|P1|Double-blind Treatment Period|Lost to Follow-up|0
2455169|NCT02590432|8460606|P9|Double-blind Treatment Period|Withdrawal of Consent|0
2455170|NCT02590432|8460607|P8|Double-blind Treatment Period|Withdrawal of Consent|0
2455171|NCT02590432|8460608|P7|Double-blind Treatment Period|Withdrawal of Consent|1
2455172|NCT02590432|8460609|P6|Double-blind Treatment Period|Withdrawal of Consent|1
2455173|NCT02590432|8460610|P5|Double-blind Treatment Period|Withdrawal of Consent|3
2455174|NCT02590432|8460611|P4|Double-blind Treatment Period|Withdrawal of Consent|3
2455175|NCT02590432|8460612|P3|Double-blind Treatment Period|Withdrawal of Consent|1
2455176|NCT02590432|8460613|P2|Double-blind Treatment Period|Withdrawal of Consent|0
2455177|NCT02590432|8460614|P1|Double-blind Treatment Period|Withdrawal of Consent|0
2455178|NCT02590432|8460606|P9|Double-blind Treatment Period|Lack of Efficacy|0
2455179|NCT02590432|8460607|P8|Double-blind Treatment Period|Lack of Efficacy|0
2455180|NCT02590432|8460608|P7|Double-blind Treatment Period|Lack of Efficacy|0
2455181|NCT02590432|8460609|P6|Double-blind Treatment Period|Lack of Efficacy|0
2455182|NCT02590432|8460610|P5|Double-blind Treatment Period|Lack of Efficacy|0
2455183|NCT02590432|8460611|P4|Double-blind Treatment Period|Lack of Efficacy|0
2455184|NCT02590432|8460612|P3|Double-blind Treatment Period|Lack of Efficacy|1
2455185|NCT02590432|8460613|P2|Double-blind Treatment Period|Lack of Efficacy|0
2455186|NCT02590432|8460614|P1|Double-blind Treatment Period|Lack of Efficacy|0
2455187|NCT02590432|8460606|P9|Double-blind Treatment Period|Adverse Event|0
2455188|NCT02590432|8460607|P8|Double-blind Treatment Period|Adverse Event|0
2455189|NCT02590432|8460608|P7|Double-blind Treatment Period|Adverse Event|20
2455190|NCT02590432|8460609|P6|Double-blind Treatment Period|Adverse Event|22
2455191|NCT02590432|8460610|P5|Double-blind Treatment Period|Adverse Event|6
2455192|NCT02590432|8460611|P4|Double-blind Treatment Period|Adverse Event|12
2455193|NCT02590432|8460612|P3|Double-blind Treatment Period|Adverse Event|14
2455194|NCT02590432|8460613|P2|Double-blind Treatment Period|Adverse Event|0
2455195|NCT02590432|8460614|P1|Double-blind Treatment Period|Adverse Event|0
2455196|NCT02590432|8460606|P9|Open-label Treatment Period|Other Miscellaneous Reasons|0
2455197|NCT02590432|8460607|P8|Open-label Treatment Period|Other Miscellaneous Reasons|0
2455198|NCT02590432|8460608|P7|Open-label Treatment Period|Other Miscellaneous Reasons|0
2455199|NCT02590432|8460609|P6|Open-label Treatment Period|Other Miscellaneous Reasons|0
2455200|NCT02590432|8460610|P5|Open-label Treatment Period|Other Miscellaneous Reasons|0
2455201|NCT02590432|8460611|P4|Open-label Treatment Period|Other Miscellaneous Reasons|0
2455202|NCT02590432|8460612|P3|Open-label Treatment Period|Other Miscellaneous Reasons|0
2455203|NCT02590432|8460613|P2|Open-label Treatment Period|Other Miscellaneous Reasons|6
2455204|NCT02590432|8460614|P1|Open-label Treatment Period|Other Miscellaneous Reasons|10
2455205|NCT02590432|8460606|P9|Open-label Treatment Period|Non-compliance with Study Drug|0
2455206|NCT02590432|8460607|P8|Open-label Treatment Period|Non-compliance with Study Drug|0
2455207|NCT02590432|8460608|P7|Open-label Treatment Period|Non-compliance with Study Drug|0
2455208|NCT02590432|8460609|P6|Open-label Treatment Period|Non-compliance with Study Drug|0
2455209|NCT02590432|8460610|P5|Open-label Treatment Period|Non-compliance with Study Drug|0
2455210|NCT02590432|8460611|P4|Open-label Treatment Period|Non-compliance with Study Drug|0
2455211|NCT02590432|8460612|P3|Open-label Treatment Period|Non-compliance with Study Drug|0
2455212|NCT02590432|8460613|P2|Open-label Treatment Period|Non-compliance with Study Drug|1
2455213|NCT02590432|8460614|P1|Open-label Treatment Period|Non-compliance with Study Drug|7
2455214|NCT02590432|8460606|P9|Open-label Treatment Period|Protocol Violation|0
2455215|NCT02590432|8460607|P8|Open-label Treatment Period|Protocol Violation|0
2455216|NCT02590432|8460608|P7|Open-label Treatment Period|Protocol Violation|0
2455217|NCT02590432|8460609|P6|Open-label Treatment Period|Protocol Violation|0
2455218|NCT02590432|8460610|P5|Open-label Treatment Period|Protocol Violation|0
2455219|NCT02590432|8460611|P4|Open-label Treatment Period|Protocol Violation|0
2455220|NCT02590432|8460612|P3|Open-label Treatment Period|Protocol Violation|0
2455221|NCT02590432|8460613|P2|Open-label Treatment Period|Protocol Violation|4
2455222|NCT02590432|8460614|P1|Open-label Treatment Period|Protocol Violation|10
2455223|NCT02590432|8460606|P9|Open-label Treatment Period|Lost to Follow-up|0
2455224|NCT02590432|8460607|P8|Open-label Treatment Period|Lost to Follow-up|0
2455225|NCT02590432|8460608|P7|Open-label Treatment Period|Lost to Follow-up|0
2455226|NCT02590432|8460609|P6|Open-label Treatment Period|Lost to Follow-up|0
2455227|NCT02590432|8460610|P5|Open-label Treatment Period|Lost to Follow-up|0
2455228|NCT02590432|8460611|P4|Open-label Treatment Period|Lost to Follow-up|0
2455229|NCT02590432|8460612|P3|Open-label Treatment Period|Lost to Follow-up|0
2455230|NCT02590432|8460613|P2|Open-label Treatment Period|Lost to Follow-up|29
2455231|NCT02590432|8460614|P1|Open-label Treatment Period|Lost to Follow-up|51
2455232|NCT02590432|8460606|P9|Open-label Treatment Period|Withdrawal of Consent|0
2455233|NCT02590432|8460607|P8|Open-label Treatment Period|Withdrawal of Consent|0
2455234|NCT02590432|8460608|P7|Open-label Treatment Period|Withdrawal of Consent|0
2455235|NCT02590432|8460609|P6|Open-label Treatment Period|Withdrawal of Consent|0
2455236|NCT02590432|8460610|P5|Open-label Treatment Period|Withdrawal of Consent|0
2455237|NCT02590432|8460611|P4|Open-label Treatment Period|Withdrawal of Consent|0
2455238|NCT02590432|8460612|P3|Open-label Treatment Period|Withdrawal of Consent|0
2455239|NCT02590432|8460613|P2|Open-label Treatment Period|Withdrawal of Consent|28
2455240|NCT02590432|8460614|P1|Open-label Treatment Period|Withdrawal of Consent|43
2455241|NCT02590432|8460606|P9|Open-label Treatment Period|Lack of Efficacy|0
2455242|NCT02590432|8460607|P8|Open-label Treatment Period|Lack of Efficacy|0
2455243|NCT02590432|8460608|P7|Open-label Treatment Period|Lack of Efficacy|0
2455244|NCT02590432|8460609|P6|Open-label Treatment Period|Lack of Efficacy|0
2455245|NCT02590432|8460610|P5|Open-label Treatment Period|Lack of Efficacy|0
2455246|NCT02590432|8460611|P4|Open-label Treatment Period|Lack of Efficacy|0
2455247|NCT02590432|8460612|P3|Open-label Treatment Period|Lack of Efficacy|0
2455248|NCT02590432|8460613|P2|Open-label Treatment Period|Lack of Efficacy|5
2455249|NCT02590432|8460614|P1|Open-label Treatment Period|Lack of Efficacy|14
2455250|NCT02590432|8460606|P9|Open-label Treatment Period|Adverse Event|0
2455251|NCT02590432|8460607|P8|Open-label Treatment Period|Adverse Event|0
2455252|NCT02590432|8460608|P7|Open-label Treatment Period|Adverse Event|0
2455253|NCT02590432|8460609|P6|Open-label Treatment Period|Adverse Event|0
2455254|NCT02590432|8460610|P5|Open-label Treatment Period|Adverse Event|0
2455255|NCT02590432|8460611|P4|Open-label Treatment Period|Adverse Event|0
2455256|NCT02590432|8460612|P3|Open-label Treatment Period|Adverse Event|0
2455257|NCT02590432|8460613|P2|Open-label Treatment Period|Adverse Event|79
2455258|NCT02590432|8460614|P1|Open-label Treatment Period|Adverse Event|97
2455259|NCT02590406|8460650|P2|Overall Study|Saturometer malfunction|1
2455260|NCT02590406|8460651|P1|Overall Study|Saturometer malfunction|0
2455261|NCT02590406|8460650|P2|Overall Study|Adverse Event|0
2455262|NCT02590406|8460651|P1|Overall Study|Adverse Event|1
2455263|NCT02590354|8460665|P1|Phase 2 - Treatment Interruption|Lost to Follow-up|2
2455264|NCT02590354|8460665|P1|Phase 1|Lost to Follow-up|1
2455265|NCT02590354|8460665|P1|Phase 1|Subject does not want to participate|20
2455266|NCT02590354|8460665|P1|Phase 1|Detectable level of HIV DNA or caRNA|75
2455267|NCT02590354|8460665|P1|Phase 1|Confirmed neutrophil count <1200/µl|1
2455268|NCT02590354|8460665|P1|Phase 1|Active hepatitis B or C infection|1
2455269|NCT02590003|8460692|P2|Overall Study|Death|2
2455270|NCT02590003|8460693|P1|Overall Study|Death|1
2455271|NCT02589639|8460720|P3|Overall Study|Not Treated|0
2455272|NCT02589639|8460721|P2|Overall Study|Not Treated|3
2455273|NCT02589639|8460722|P1|Overall Study|Not Treated|0
2455274|NCT02589639|8460720|P3|Overall Study|Other reason than specified above|1
2455275|NCT02589639|8460721|P2|Overall Study|Other reason than specified above|2
2455276|NCT02589639|8460722|P1|Overall Study|Other reason than specified above|1
2455277|NCT02589639|8460720|P3|Overall Study|Adverse Event|3
2455278|NCT02589639|8460721|P2|Overall Study|Adverse Event|5
2455279|NCT02589639|8460722|P1|Overall Study|Adverse Event|4
2455280|NCT02589639|8460720|P3|Overall Study|Patient withdrawal, not due to AE|0
2455281|NCT02589639|8460721|P2|Overall Study|Patient withdrawal, not due to AE|0
2455282|NCT02589639|8460722|P1|Overall Study|Patient withdrawal, not due to AE|3
2455283|NCT02589639|8460720|P3|Overall Study|Protocol Violation|0
2455284|NCT02589639|8460721|P2|Overall Study|Protocol Violation|0
2455285|NCT02589639|8460722|P1|Overall Study|Protocol Violation|1
2455286|NCT02589639|8460720|P3|Overall Study|Lost to Follow-up|0
2455287|NCT02589639|8460721|P2|Overall Study|Lost to Follow-up|0
2455288|NCT02589639|8460722|P1|Overall Study|Lost to Follow-up|1
2455289|NCT02589626|8460735|P2|Overall Study|Adverse Event|1
2455290|NCT02589626|8460736|P1|Overall Study|Adverse Event|1
2455291|NCT02589626|8460735|P2|Overall Study|Withdrawal by Subject|1
2455292|NCT02589626|8460736|P1|Overall Study|Withdrawal by Subject|1
2455293|NCT02589626|8460735|P2|Overall Study|Other than the reason specified|0
2455294|NCT02589626|8460736|P1|Overall Study|Other than the reason specified|1
2455295|NCT02589405|8460744|P1|Overall Study|Withdrawal by Subject|1
2455296|NCT02589405|8460744|P1|Overall Study|Adverse Event|3
2455297|NCT02588339|8460882|P1|Overall Study|GVHD Progression prior to treatment|2
2455298|NCT02588339|8460882|P1|Overall Study|Withdrawal by Subject|1
2455299|NCT02588261|8460894|P2|Overall Study|Lost to Follow-up|0
2455300|NCT02588261|8460895|P1|Overall Study|Lost to Follow-up|1
2455301|NCT02588261|8460894|P2|Overall Study|Adverse Event|24
2455302|NCT02588261|8460895|P1|Overall Study|Adverse Event|29
2455303|NCT02588261|8460894|P2|Overall Study|Progressive Disease|82
2455304|NCT02588261|8460895|P1|Overall Study|Progressive Disease|61
2455305|NCT02588261|8460894|P2|Overall Study|Miscellaneous|4
2455306|NCT02588261|8460895|P1|Overall Study|Miscellaneous|5
2455307|NCT02588261|8460894|P2|Overall Study|Noncompliance with Study Drug|1
2455308|NCT02588261|8460895|P1|Overall Study|Noncompliance with Study Drug|0
2455309|NCT02588261|8460894|P2|Overall Study|Withdrawal by Subject|8
2455310|NCT02588261|8460895|P1|Overall Study|Withdrawal by Subject|12
2455311|NCT02588261|8460894|P2|Overall Study|Death|2
2455312|NCT02588261|8460895|P1|Overall Study|Death|1
2455313|NCT02588261|8460894|P2|Overall Study|Protocol Deviation|0
2455314|NCT02588261|8460895|P1|Overall Study|Protocol Deviation|1
2455315|NCT02588261|8460894|P2|Overall Study|Study Terminated by Sponsor|142
2455316|NCT02588261|8460895|P1|Overall Study|Study Terminated by Sponsor|157
2455317|NCT02588092|8460931|P10|Overall Study|Sponsor Decision|1
2455318|NCT02588092|8460932|P9|Overall Study|Sponsor Decision|1
2455319|NCT02588092|8460933|P8|Overall Study|Sponsor Decision|0
2455320|NCT02588092|8460934|P7|Overall Study|Sponsor Decision|0
2455321|NCT02588092|8460935|P6|Overall Study|Sponsor Decision|0
2455322|NCT02588092|8460936|P5|Overall Study|Sponsor Decision|0
2455323|NCT02588092|8460937|P4|Overall Study|Sponsor Decision|0
2455324|NCT02588092|8460938|P3|Overall Study|Sponsor Decision|0
2455325|NCT02588092|8460939|P2|Overall Study|Sponsor Decision|0
2455326|NCT02588092|8460940|P1|Overall Study|Sponsor Decision|0
2455327|NCT02588092|8460931|P10|Overall Study|Started Another Treatment|0
2455328|NCT02588092|8460932|P9|Overall Study|Started Another Treatment|0
2455329|NCT02588092|8460933|P8|Overall Study|Started Another Treatment|1
2455330|NCT02588092|8460934|P7|Overall Study|Started Another Treatment|0
2455331|NCT02588092|8460935|P6|Overall Study|Started Another Treatment|0
2455332|NCT02588092|8460936|P5|Overall Study|Started Another Treatment|1
2455333|NCT02588092|8460937|P4|Overall Study|Started Another Treatment|0
2455334|NCT02588092|8460938|P3|Overall Study|Started Another Treatment|0
2455335|NCT02588092|8460939|P2|Overall Study|Started Another Treatment|0
2455336|NCT02588092|8460940|P1|Overall Study|Started Another Treatment|0
2455337|NCT02588092|8460931|P10|Overall Study|Withdrawal by Subject|0
2455338|NCT02588092|8460932|P9|Overall Study|Withdrawal by Subject|0
2455339|NCT02588092|8460933|P8|Overall Study|Withdrawal by Subject|2
2455340|NCT02588092|8460934|P7|Overall Study|Withdrawal by Subject|1
2455341|NCT02588092|8460935|P6|Overall Study|Withdrawal by Subject|1
2455342|NCT02588092|8460936|P5|Overall Study|Withdrawal by Subject|0
2455343|NCT02588092|8460937|P4|Overall Study|Withdrawal by Subject|0
2455344|NCT02588092|8460938|P3|Overall Study|Withdrawal by Subject|0
2455345|NCT02588092|8460939|P2|Overall Study|Withdrawal by Subject|0
2455346|NCT02588092|8460940|P1|Overall Study|Withdrawal by Subject|0
2455347|NCT02588092|8460931|P10|Overall Study|Death|2
2455348|NCT02588092|8460932|P9|Overall Study|Death|5
2455349|NCT02588092|8460933|P8|Overall Study|Death|1
2455350|NCT02588092|8460934|P7|Overall Study|Death|2
2455351|NCT02588092|8460935|P6|Overall Study|Death|2
2455352|NCT02588092|8460936|P5|Overall Study|Death|2
2455353|NCT02588092|8460937|P4|Overall Study|Death|3
2455354|NCT02588092|8460938|P3|Overall Study|Death|3
2455355|NCT02588092|8460939|P2|Overall Study|Death|3
2455356|NCT02588092|8460940|P1|Overall Study|Death|4
2455357|NCT02587819|8461134|P1|Overall Study|Lost to Follow-up|1
2455358|NCT02587819|8461134|P1|Overall Study|Adverse Event|1
2455359|NCT02587520|8461170|P18|Overall Study|Lost to Follow-up|0
2455360|NCT02587520|8461171|P17|Overall Study|Lost to Follow-up|0
2455361|NCT02587520|8461172|P16|Overall Study|Lost to Follow-up|0
2455362|NCT02587520|8461173|P15|Overall Study|Lost to Follow-up|0
2455363|NCT02587520|8461174|P14|Overall Study|Lost to Follow-up|0
2455364|NCT02587520|8461175|P13|Overall Study|Lost to Follow-up|0
2455365|NCT02587520|8461176|P12|Overall Study|Lost to Follow-up|1
2455366|NCT02587520|8461177|P11|Overall Study|Lost to Follow-up|2
2455367|NCT02587520|8461178|P10|Overall Study|Lost to Follow-up|2
2455368|NCT02587520|8461179|P9|Overall Study|Lost to Follow-up|0
2455369|NCT02587520|8461180|P8|Overall Study|Lost to Follow-up|1
2455370|NCT02587520|8461181|P7|Overall Study|Lost to Follow-up|1
2455371|NCT02587520|8461182|P6|Overall Study|Lost to Follow-up|1
2455372|NCT02587520|8461183|P5|Overall Study|Lost to Follow-up|0
2455373|NCT02587520|8461184|P4|Overall Study|Lost to Follow-up|2
2455374|NCT02587520|8461185|P3|Overall Study|Lost to Follow-up|0
2455375|NCT02587520|8461186|P2|Overall Study|Lost to Follow-up|2
2455376|NCT02587520|8461187|P1|Overall Study|Lost to Follow-up|0
2455377|NCT02587520|8461170|P18|Overall Study|Withdrawal by Subject|0
2455378|NCT02587520|8461171|P17|Overall Study|Withdrawal by Subject|0
2455379|NCT02587520|8461172|P16|Overall Study|Withdrawal by Subject|0
2455380|NCT02587520|8461173|P15|Overall Study|Withdrawal by Subject|0
2455381|NCT02587520|8461174|P14|Overall Study|Withdrawal by Subject|1
2455382|NCT02587520|8461175|P13|Overall Study|Withdrawal by Subject|0
2455383|NCT02587520|8461176|P12|Overall Study|Withdrawal by Subject|0
2455384|NCT02587520|8461177|P11|Overall Study|Withdrawal by Subject|0
2455385|NCT02587520|8461178|P10|Overall Study|Withdrawal by Subject|0
2455386|NCT02587520|8461179|P9|Overall Study|Withdrawal by Subject|0
2455387|NCT02587520|8461180|P8|Overall Study|Withdrawal by Subject|0
2455388|NCT02587520|8461181|P7|Overall Study|Withdrawal by Subject|1
2455389|NCT02587520|8461182|P6|Overall Study|Withdrawal by Subject|1
2455390|NCT02587520|8461183|P5|Overall Study|Withdrawal by Subject|0
2455391|NCT02587520|8461184|P4|Overall Study|Withdrawal by Subject|1
2455392|NCT02587520|8461185|P3|Overall Study|Withdrawal by Subject|1
2455393|NCT02587520|8461186|P2|Overall Study|Withdrawal by Subject|0
2455394|NCT02587520|8461187|P1|Overall Study|Withdrawal by Subject|0
2455395|NCT02587520|8461170|P18|Overall Study|Adverse Event|0
2455396|NCT02587520|8461171|P17|Overall Study|Adverse Event|0
2455397|NCT02587520|8461172|P16|Overall Study|Adverse Event|0
2455398|NCT02587520|8461173|P15|Overall Study|Adverse Event|0
2455399|NCT02587520|8461174|P14|Overall Study|Adverse Event|0
2455400|NCT02587520|8461175|P13|Overall Study|Adverse Event|0
2455401|NCT02587520|8461176|P12|Overall Study|Adverse Event|1
2455402|NCT02587520|8461177|P11|Overall Study|Adverse Event|0
2455403|NCT02587520|8461178|P10|Overall Study|Adverse Event|0
2455404|NCT02587520|8461179|P9|Overall Study|Adverse Event|0
2455405|NCT02587520|8461180|P8|Overall Study|Adverse Event|0
2455406|NCT02587520|8461181|P7|Overall Study|Adverse Event|0
2455407|NCT02587520|8461182|P6|Overall Study|Adverse Event|0
2455408|NCT02587520|8461183|P5|Overall Study|Adverse Event|0
2455409|NCT02587520|8461184|P4|Overall Study|Adverse Event|0
2455410|NCT02587520|8461185|P3|Overall Study|Adverse Event|0
2455411|NCT02587520|8461186|P2|Overall Study|Adverse Event|0
2455412|NCT02587520|8461187|P1|Overall Study|Adverse Event|0
2455413|NCT02587520|8461170|P18|Overall Study|Protocol Violation|0
2455414|NCT02587520|8461171|P17|Overall Study|Protocol Violation|0
2455415|NCT02587520|8461172|P16|Overall Study|Protocol Violation|0
2455416|NCT02587520|8461173|P15|Overall Study|Protocol Violation|0
2455417|NCT02587520|8461174|P14|Overall Study|Protocol Violation|0
2455418|NCT02587520|8461175|P13|Overall Study|Protocol Violation|0
2455419|NCT02587520|8461176|P12|Overall Study|Protocol Violation|2
2455420|NCT02587520|8461177|P11|Overall Study|Protocol Violation|1
2455421|NCT02587520|8461178|P10|Overall Study|Protocol Violation|3
2455422|NCT02587520|8461179|P9|Overall Study|Protocol Violation|3
2455423|NCT02587520|8461180|P8|Overall Study|Protocol Violation|1
2455424|NCT02587520|8461181|P7|Overall Study|Protocol Violation|1
2455425|NCT02587520|8461182|P6|Overall Study|Protocol Violation|1
2455426|NCT02587520|8461183|P5|Overall Study|Protocol Violation|0
2455427|NCT02587520|8461184|P4|Overall Study|Protocol Violation|2
2455428|NCT02587520|8461185|P3|Overall Study|Protocol Violation|0
2455429|NCT02587520|8461186|P2|Overall Study|Protocol Violation|0
2455430|NCT02587520|8461187|P1|Overall Study|Protocol Violation|2
2455431|NCT02587234|8461227|P2|Overall Study|Lost to Follow-up|2
2455432|NCT02587234|8461228|P1|Overall Study|Lost to Follow-up|0
2455433|NCT02587234|8461227|P2|Overall Study|Withdrawal by Subject|1
2455434|NCT02587234|8461228|P1|Overall Study|Withdrawal by Subject|1
2455435|NCT02587143|8461240|P2|Overall Study|Adverse Event|0
2455436|NCT02587143|8461241|P1|Overall Study|Adverse Event|1
2455437|NCT02587065|8461258|P1|Overall Study|Reason not Specified|3
2455438|NCT02587065|8461258|P1|Overall Study|Discontinuation of Study Medication|2
2455439|NCT02587065|8461258|P1|Overall Study|Non-adherence to the Protocol|3
2455440|NCT02587065|8461258|P1|Overall Study|Withdrawal of Informed Consent (IC)|5
2455441|NCT02587065|8461258|P1|Overall Study|Adverse Event|14
2455442|NCT02586805|8461314|P4|Overall Study|Physician Decision|0
2455443|NCT02586805|8461315|P3|Overall Study|Physician Decision|0
2455444|NCT02586805|8461316|P2|Overall Study|Physician Decision|0
2455445|NCT02586805|8461317|P1|Overall Study|Physician Decision|1
2455446|NCT02586805|8461314|P4|Overall Study|Lost to Follow-up|0
2455447|NCT02586805|8461315|P3|Overall Study|Lost to Follow-up|1
2455448|NCT02586805|8461316|P2|Overall Study|Lost to Follow-up|0
2455449|NCT02586805|8461317|P1|Overall Study|Lost to Follow-up|0
2455450|NCT02586805|8461314|P4|Overall Study|Adverse Event|0
2455451|NCT02586805|8461315|P3|Overall Study|Adverse Event|1
2455452|NCT02586805|8461316|P2|Overall Study|Adverse Event|0
2455453|NCT02586805|8461317|P1|Overall Study|Adverse Event|2
2455454|NCT02586805|8461314|P4|Overall Study|Withdrawal by Subject|2
2455455|NCT02586805|8461315|P3|Overall Study|Withdrawal by Subject|1
2455456|NCT02586805|8461316|P2|Overall Study|Withdrawal by Subject|1
2455457|NCT02586805|8461317|P1|Overall Study|Withdrawal by Subject|3
2455458|NCT02586506|8461345|P1|Overall Study|Other Reason|2
2455459|NCT02586506|8461345|P1|Overall Study|Lost to Follow-up|1
2455460|NCT02586506|8461345|P1|Overall Study|Protocol Violation|6
2455461|NCT02586493|8461351|P1|Overall Study|Withdrawal by Subject|1
2455462|NCT02586493|8461351|P1|Overall Study|Lost to Follow-up|1
2455463|NCT02586493|8461351|P1|Overall Study|Protocol Violation|6
2455464|NCT02586493|8461351|P1|Overall Study|Adverse Event|4
2455465|NCT02586415|8461359|P2|Overall Study|Lost to Follow-up|2
2455466|NCT02586415|8461360|P1|Overall Study|Lost to Follow-up|1
2455467|NCT02586415|8461359|P2|Overall Study|Death|23
2455468|NCT02586415|8461360|P1|Overall Study|Death|13
2455469|NCT02586025|8461372|P2|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|35
2455470|NCT02586025|8461373|P1|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|56
2455471|NCT02586025|8461372|P2|Adjuvant Treatment|Recurrent Disease|4
2455472|NCT02586025|8461373|P1|Adjuvant Treatment|Recurrent Disease|1
2455473|NCT02586025|8461372|P2|Adjuvant Treatment|Physician Decision|1
2455474|NCT02586025|8461373|P1|Adjuvant Treatment|Physician Decision|0
2455475|NCT02586025|8461372|P2|Adjuvant Treatment|Withdrawal by Subject|3
2455476|NCT02586025|8461373|P1|Adjuvant Treatment|Withdrawal by Subject|5
2455477|NCT02586025|8461372|P2|Adjuvant Treatment|Remain in Adjuvant Treatment|61
2455478|NCT02586025|8461373|P1|Adjuvant Treatment|Remain in Adjuvant Treatment|133
2455479|NCT02586025|8461372|P2|Neoadjuvant Treatment|Progressive Disease|3
2455480|NCT02586025|8461373|P1|Neoadjuvant Treatment|Progressive Disease|2
2455481|NCT02586025|8461372|P2|Neoadjuvant Treatment|Physician Decision|1
2455482|NCT02586025|8461373|P1|Neoadjuvant Treatment|Physician Decision|2
2455483|NCT02586025|8461372|P2|Neoadjuvant Treatment|Withdrawal by Subject|3
2455484|NCT02586025|8461373|P1|Neoadjuvant Treatment|Withdrawal by Subject|4
2455485|NCT02586025|8461372|P2|Neoadjuvant Treatment|Adverse Event|0
2455486|NCT02586025|8461373|P1|Neoadjuvant Treatment|Adverse Event|1
2455487|NCT02586025|8461372|P2|Neoadjuvant Treatment|Death|0
2455488|NCT02586025|8461373|P1|Neoadjuvant Treatment|Death|1
2455489|NCT02586025|8461372|P2|Neoadjuvant Treatment|Did Not Receive Study Drug|0
2455490|NCT02586025|8461373|P1|Neoadjuvant Treatment|Did Not Receive Study Drug|1
2455491|NCT02585999|8461409|P1|Overall Study|Protocol Violation|1
2455492|NCT02585999|8461409|P1|Overall Study|Lost to Follow-up|1
2455493|NCT02585960|8461417|P3|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0
2455494|NCT02585960|8461418|P2|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1
2455495|NCT02585960|8461419|P1|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0
2455496|NCT02585960|8461417|P3|Prophylactic Treatment Period|Major protocol deviation|0
2455497|NCT02585960|8461418|P2|Prophylactic Treatment Period|Major protocol deviation|4
2455498|NCT02585960|8461419|P1|Prophylactic Treatment Period|Major protocol deviation|0
2455499|NCT02585960|8461417|P3|PK/Safety Assessment Period|Screen Failure|1
2455500|NCT02585960|8461418|P2|PK/Safety Assessment Period|Screen Failure|0
2455501|NCT02585960|8461419|P1|PK/Safety Assessment Period|Screen Failure|0
2455502|NCT02585960|8461417|P3|PK/Safety Assessment Period|Withdrawn by sponsor|0
2455503|NCT02585960|8461418|P2|PK/Safety Assessment Period|Withdrawn by sponsor|1
2455504|NCT02585960|8461419|P1|PK/Safety Assessment Period|Withdrawn by sponsor|0
2455505|NCT02585960|8461417|P3|PK/Safety Assessment Period|Other|0
2455506|NCT02585960|8461418|P2|PK/Safety Assessment Period|Other|4
2455507|NCT02585960|8461419|P1|PK/Safety Assessment Period|Other|4
2455508|NCT02585960|8461417|P3|PK/Safety Assessment Period|Non-compliance to study procedures|0
2455509|NCT02585960|8461418|P2|PK/Safety Assessment Period|Non-compliance to study procedures|2
2455510|NCT02585960|8461419|P1|PK/Safety Assessment Period|Non-compliance to study procedures|0
2455511|NCT02585960|8461417|P3|PK/Safety Assessment Period|Withdrawal by Subject|5
2455512|NCT02585960|8461418|P2|PK/Safety Assessment Period|Withdrawal by Subject|2
2455513|NCT02585960|8461419|P1|PK/Safety Assessment Period|Withdrawal by Subject|1
2455514|NCT02585960|8461417|P3|PK/Safety Assessment Period|Physician Decision|0
2455515|NCT02585960|8461418|P2|PK/Safety Assessment Period|Physician Decision|1
2455516|NCT02585960|8461419|P1|PK/Safety Assessment Period|Physician Decision|0
2455517|NCT02585934|8461489|P2|Overall Study|Another Reason|5
2455518|NCT02585934|8461490|P1|Overall Study|Another Reason|10
2455519|NCT02585934|8461489|P2|Overall Study|Sponsor Termination|2
2455520|NCT02585934|8461490|P1|Overall Study|Sponsor Termination|1
2455521|NCT02585934|8461489|P2|Overall Study|Caregiver Withdrew Consent|7
2455522|NCT02585934|8461490|P1|Overall Study|Caregiver Withdrew Consent|7
2455523|NCT02585934|8461489|P2|Overall Study|Death|0
2455524|NCT02585934|8461490|P1|Overall Study|Death|2
2455525|NCT02585934|8461489|P2|Overall Study|Lack of Efficacy|1
2455526|NCT02585934|8461490|P1|Overall Study|Lack of Efficacy|2
2455527|NCT02585934|8461489|P2|Overall Study|Withdrawal by Subject|21
2455528|NCT02585934|8461490|P1|Overall Study|Withdrawal by Subject|7
2455529|NCT02585934|8461489|P2|Overall Study|Physician Decision|2
2455530|NCT02585934|8461490|P1|Overall Study|Physician Decision|3
2455531|NCT02585934|8461489|P2|Overall Study|Adverse Event|22
2455532|NCT02585934|8461490|P1|Overall Study|Adverse Event|21
2455533|NCT02585934|8461489|P2|Overall Study|Protocol Violation|11
2455534|NCT02585934|8461490|P1|Overall Study|Protocol Violation|14
2455535|NCT02585934|8461489|P2|Overall Study|Lost to Follow-up|2
2455536|NCT02585934|8461490|P1|Overall Study|Lost to Follow-up|2
2455537|NCT02585830|8461546|P1|Overall Study|Withdrawal by Subject|3
2455538|NCT02585778|8461555|P2|Overall Study|Other than specified above|2
2455539|NCT02585778|8461556|P1|Overall Study|Other than specified above|6
2455540|NCT02585778|8461555|P2|Overall Study|Randomized but not treated|2
2455541|NCT02585778|8461556|P1|Overall Study|Randomized but not treated|1
2455542|NCT02585778|8461555|P2|Overall Study|Death|1
2455543|NCT02585778|8461556|P1|Overall Study|Death|0
2455544|NCT02585778|8461555|P2|Overall Study|Poor compliance to study protocol|2
2455545|NCT02585778|8461556|P1|Overall Study|Poor compliance to study protocol|0
2455546|NCT02585778|8461555|P2|Overall Study|Participant did not wish to continue|4
2455547|NCT02585778|8461556|P1|Overall Study|Participant did not wish to continue|9
2455548|NCT02585778|8461555|P2|Overall Study|Adverse Event|4
2455549|NCT02585778|8461556|P1|Overall Study|Adverse Event|17
2455550|NCT02585713|8461672|P2|Overall Study|Other|1
2455551|NCT02585713|8461673|P1|Overall Study|Other|3
2455552|NCT02585713|8461672|P2|Overall Study|Withdrew prior to treatment|7
2455553|NCT02585713|8461673|P1|Overall Study|Withdrew prior to treatment|2
2455554|NCT02584959|8461736|P3|Period 2|Withdrawn from study|2
2455555|NCT02584959|8461737|P2|Period 2|Withdrawn from study|1
2455556|NCT02584959|8461738|P1|Period 2|Withdrawn from study|6
2455557|NCT02584959|8461736|P3|Period 1|Withdrawn from study|0
2455558|NCT02584959|8461737|P2|Period 1|Withdrawn from study|4
2455559|NCT02584959|8461738|P1|Period 1|Withdrawn from study|3
2455560|NCT02584855|8461793|P6|Post Treatment Follow-up Period|Protocol Violation|0
2455561|NCT02584855|8461794|P5|Post Treatment Follow-up Period|Protocol Violation|1
2455562|NCT02584855|8461795|P4|Post Treatment Follow-up Period|Protocol Violation|0
2455563|NCT02584855|8461796|P3|Post Treatment Follow-up Period|Protocol Violation|0
2455564|NCT02584855|8461797|P2|Post Treatment Follow-up Period|Protocol Violation|0
2455565|NCT02584855|8461798|P1|Post Treatment Follow-up Period|Protocol Violation|0
2455566|NCT02584855|8461793|P6|Post Treatment Follow-up Period|Withdrawal by Subject|0
2455567|NCT02584855|8461794|P5|Post Treatment Follow-up Period|Withdrawal by Subject|7
2455568|NCT02584855|8461795|P4|Post Treatment Follow-up Period|Withdrawal by Subject|0
2455569|NCT02584855|8461796|P3|Post Treatment Follow-up Period|Withdrawal by Subject|0
2455570|NCT02584855|8461797|P2|Post Treatment Follow-up Period|Withdrawal by Subject|0
2455571|NCT02584855|8461798|P1|Post Treatment Follow-up Period|Withdrawal by Subject|0
2455572|NCT02584855|8461793|P6|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
2455573|NCT02584855|8461794|P5|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
2455574|NCT02584855|8461795|P4|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
2455575|NCT02584855|8461796|P3|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
2455576|NCT02584855|8461797|P2|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1
2455577|NCT02584855|8461798|P1|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
2455578|NCT02584855|8461793|P6|Double-Blind Withdrawal Period|Lack of Efficacy|0
2455579|NCT02584855|8461794|P5|Double-Blind Withdrawal Period|Lack of Efficacy|0
2455580|NCT02584855|8461795|P4|Double-Blind Withdrawal Period|Lack of Efficacy|0
2455581|NCT02584855|8461796|P3|Double-Blind Withdrawal Period|Lack of Efficacy|0
2455582|NCT02584855|8461797|P2|Double-Blind Withdrawal Period|Lack of Efficacy|10
2455583|NCT02584855|8461798|P1|Double-Blind Withdrawal Period|Lack of Efficacy|0
2455584|NCT02584855|8461793|P6|Double-Blind Withdrawal Period|Adverse Event|0
2455585|NCT02584855|8461794|P5|Double-Blind Withdrawal Period|Adverse Event|0
2455586|NCT02584855|8461795|P4|Double-Blind Withdrawal Period|Adverse Event|1
2455587|NCT02584855|8461796|P3|Double-Blind Withdrawal Period|Adverse Event|0
2455588|NCT02584855|8461797|P2|Double-Blind Withdrawal Period|Adverse Event|4
2455589|NCT02584855|8461798|P1|Double-Blind Withdrawal Period|Adverse Event|0
2455590|NCT02584855|8461793|P6|Double-Blind Withdrawal Period|Withdrawal by Subject|0
2455591|NCT02584855|8461794|P5|Double-Blind Withdrawal Period|Withdrawal by Subject|0
2455592|NCT02584855|8461795|P4|Double-Blind Withdrawal Period|Withdrawal by Subject|0
2455593|NCT02584855|8461796|P3|Double-Blind Withdrawal Period|Withdrawal by Subject|2
2455594|NCT02584855|8461797|P2|Double-Blind Withdrawal Period|Withdrawal by Subject|0
2455595|NCT02584855|8461798|P1|Double-Blind Withdrawal Period|Withdrawal by Subject|0
2455596|NCT02584855|8461793|P6|Open-Label Treatment Period|Sponsor Decision|0
2455597|NCT02584855|8461794|P5|Open-Label Treatment Period|Sponsor Decision|0
2455598|NCT02584855|8461795|P4|Open-Label Treatment Period|Sponsor Decision|0
2455599|NCT02584855|8461796|P3|Open-Label Treatment Period|Sponsor Decision|0
2455600|NCT02584855|8461797|P2|Open-Label Treatment Period|Sponsor Decision|0
2455601|NCT02584855|8461798|P1|Open-Label Treatment Period|Sponsor Decision|1
2455602|NCT02584855|8461793|P6|Open-Label Treatment Period|No PI Available|0
2455603|NCT02584855|8461794|P5|Open-Label Treatment Period|No PI Available|0
2455604|NCT02584855|8461795|P4|Open-Label Treatment Period|No PI Available|0
2455605|NCT02584855|8461796|P3|Open-Label Treatment Period|No PI Available|0
2455606|NCT02584855|8461797|P2|Open-Label Treatment Period|No PI Available|0
2455607|NCT02584855|8461798|P1|Open-Label Treatment Period|No PI Available|2
2455608|NCT02584855|8461793|P6|Open-Label Treatment Period|Protocol Violation|0
2455609|NCT02584855|8461794|P5|Open-Label Treatment Period|Protocol Violation|0
2455610|NCT02584855|8461795|P4|Open-Label Treatment Period|Protocol Violation|0
2455611|NCT02584855|8461796|P3|Open-Label Treatment Period|Protocol Violation|0
2455612|NCT02584855|8461797|P2|Open-Label Treatment Period|Protocol Violation|0
2455613|NCT02584855|8461798|P1|Open-Label Treatment Period|Protocol Violation|1
2455614|NCT02584855|8461793|P6|Open-Label Treatment Period|Lost to Follow-up|0
2455615|NCT02584855|8461794|P5|Open-Label Treatment Period|Lost to Follow-up|0
2455616|NCT02584855|8461795|P4|Open-Label Treatment Period|Lost to Follow-up|0
2455617|NCT02584855|8461796|P3|Open-Label Treatment Period|Lost to Follow-up|0
2455618|NCT02584855|8461797|P2|Open-Label Treatment Period|Lost to Follow-up|0
2455619|NCT02584855|8461798|P1|Open-Label Treatment Period|Lost to Follow-up|1
2455620|NCT02584855|8461793|P6|Open-Label Treatment Period|Death|0
2455621|NCT02584855|8461794|P5|Open-Label Treatment Period|Death|0
2455622|NCT02584855|8461795|P4|Open-Label Treatment Period|Death|0
2455623|NCT02584855|8461796|P3|Open-Label Treatment Period|Death|0
2455624|NCT02584855|8461797|P2|Open-Label Treatment Period|Death|0
2455625|NCT02584855|8461798|P1|Open-Label Treatment Period|Death|2
2455626|NCT02584855|8461793|P6|Open-Label Treatment Period|Adverse Event|0
2455627|NCT02584855|8461794|P5|Open-Label Treatment Period|Adverse Event|0
2455628|NCT02584855|8461795|P4|Open-Label Treatment Period|Adverse Event|0
2455629|NCT02584855|8461796|P3|Open-Label Treatment Period|Adverse Event|0
2455630|NCT02584855|8461797|P2|Open-Label Treatment Period|Adverse Event|0
2455631|NCT02584855|8461798|P1|Open-Label Treatment Period|Adverse Event|14
2455632|NCT02584855|8461793|P6|Open-Label Treatment Period|Withdrawal by Subject|0
2455633|NCT02584855|8461794|P5|Open-Label Treatment Period|Withdrawal by Subject|0
2455634|NCT02584855|8461795|P4|Open-Label Treatment Period|Withdrawal by Subject|0
2455635|NCT02584855|8461796|P3|Open-Label Treatment Period|Withdrawal by Subject|0
2455636|NCT02584855|8461797|P2|Open-Label Treatment Period|Withdrawal by Subject|0
2455637|NCT02584855|8461798|P1|Open-Label Treatment Period|Withdrawal by Subject|21
2455638|NCT02584855|8461793|P6|Open-Label Treatment Period|Lack of Efficacy|0
2455639|NCT02584855|8461794|P5|Open-Label Treatment Period|Lack of Efficacy|0
2455640|NCT02584855|8461795|P4|Open-Label Treatment Period|Lack of Efficacy|0
2455641|NCT02584855|8461796|P3|Open-Label Treatment Period|Lack of Efficacy|0
2455642|NCT02584855|8461797|P2|Open-Label Treatment Period|Lack of Efficacy|0
2455643|NCT02584855|8461798|P1|Open-Label Treatment Period|Lack of Efficacy|61
2455644|NCT02584660|8461884|P2|Overall Study|Other|1
2455645|NCT02584660|8461885|P1|Overall Study|Other|0
2455646|NCT02584660|8461884|P2|Overall Study|Withdrawal by Subject|2
2455647|NCT02584660|8461885|P1|Overall Study|Withdrawal by Subject|0
2455648|NCT02584660|8461884|P2|Overall Study|Protocol Violation|1
2455649|NCT02584660|8461885|P1|Overall Study|Protocol Violation|0
2455650|NCT02584660|8461884|P2|Overall Study|Lost to Follow-up|4
2455651|NCT02584660|8461885|P1|Overall Study|Lost to Follow-up|3
2455652|NCT02584660|8461884|P2|Overall Study|Adverse Event|0
2455653|NCT02584660|8461885|P1|Overall Study|Adverse Event|4
2455654|NCT02584504|8461904|P3|Open-label Treatment|Entered but not treated|1
2455655|NCT02584504|8461905|P2|Open-label Treatment|Entered but not treated|1
2455656|NCT02584504|8461906|P1|Open-label Treatment|Entered but not treated|0
2455657|NCT02584504|8461904|P3|Open-label Treatment|Physician Decision|0
2455658|NCT02584504|8461905|P2|Open-label Treatment|Physician Decision|1
2455659|NCT02584504|8461906|P1|Open-label Treatment|Physician Decision|0
2455660|NCT02584504|8461904|P3|Open-label Treatment|Adverse Event|3
2455661|NCT02584504|8461905|P2|Open-label Treatment|Adverse Event|2
2455662|NCT02584504|8461906|P1|Open-label Treatment|Adverse Event|2
2455663|NCT02584504|8461904|P3|Open-label Treatment|Participant withdrew consent|4
2455664|NCT02584504|8461905|P2|Open-label Treatment|Participant withdrew consent|0
2455665|NCT02584504|8461906|P1|Open-label Treatment|Participant withdrew consent|0
2455666|NCT02584504|8461904|P3|Double-blind Treatment|Family Matter|0
2455667|NCT02584504|8461905|P2|Double-blind Treatment|Family Matter|1
2455668|NCT02584504|8461906|P1|Double-blind Treatment|Family Matter|0
2455669|NCT02584504|8461904|P3|Double-blind Treatment|Adverse Event|0
2455670|NCT02584504|8461905|P2|Double-blind Treatment|Adverse Event|1
2455671|NCT02584504|8461906|P1|Double-blind Treatment|Adverse Event|0
2455672|NCT02584504|8461904|P3|Double-blind Treatment|Participant withdrew consent|1
2455673|NCT02584504|8461905|P2|Double-blind Treatment|Participant withdrew consent|0
2455674|NCT02584504|8461906|P1|Double-blind Treatment|Participant withdrew consent|0
2455675|NCT02584452|8461962|P2|Overall Study|Lost to Follow-up|1
2455676|NCT02584452|8461963|P1|Overall Study|Lost to Follow-up|1
2455677|NCT02584452|8461962|P2|Overall Study|Physician Decision|1
2455678|NCT02584452|8461963|P1|Overall Study|Physician Decision|1
2455679|NCT02583477|8461993|P2|Overall Study|Study terminated|2
2455680|NCT02583477|8461994|P1|Overall Study|Study terminated|2
2455681|NCT02583477|8461993|P2|Overall Study|Death|16
2455682|NCT02583477|8461994|P1|Overall Study|Death|1
2455683|NCT02583477|8461993|P2|Overall Study|Adverse Event|2
2455684|NCT02583477|8461994|P1|Overall Study|Adverse Event|0
2455685|NCT02583425|8462014|P1|Treatment Period|Adverse Event|1
2455686|NCT02583425|8462014|P1|Baseline|Did not meet continued criteria|5
2455687|NCT02583425|8462014|P1|Screening|Did not meet entry criteria|12
2455688|NCT02583269|8462024|P5|Overall Study|Patient hospitalized prior to start|0
2455689|NCT02583269|8462025|P4|Overall Study|Patient hospitalized prior to start|0
2455690|NCT02583269|8462026|P3|Overall Study|Patient hospitalized prior to start|0
2455691|NCT02583269|8462027|P2|Overall Study|Patient hospitalized prior to start|0
2455692|NCT02583269|8462028|P1|Overall Study|Patient hospitalized prior to start|1
2455693|NCT02583256|8462057|P4|Overall Study|Administrative/Other|2
2455694|NCT02583256|8462058|P3|Overall Study|Administrative/Other|1
2455695|NCT02583256|8462059|P2|Overall Study|Administrative/Other|0
2455696|NCT02583256|8462060|P1|Overall Study|Administrative/Other|2
2455697|NCT02583256|8462057|P4|Overall Study|Lost to Follow-up|1
2455698|NCT02583256|8462058|P3|Overall Study|Lost to Follow-up|0
2455699|NCT02583256|8462059|P2|Overall Study|Lost to Follow-up|1
2455700|NCT02583256|8462060|P1|Overall Study|Lost to Follow-up|1
2455701|NCT02583256|8462057|P4|Overall Study|Withdrawal by Subject|0
2455702|NCT02583256|8462058|P3|Overall Study|Withdrawal by Subject|1
2455703|NCT02583256|8462059|P2|Overall Study|Withdrawal by Subject|1
2455704|NCT02583256|8462060|P1|Overall Study|Withdrawal by Subject|0
2455705|NCT02583048|8462157|P3|Overall Study|Failed to meet eligibility criterion|1
2455706|NCT02583048|8462158|P2|Overall Study|Failed to meet eligibility criterion|0
2455707|NCT02583048|8462159|P1|Overall Study|Failed to meet eligibility criterion|0
2455708|NCT02583048|8462157|P3|Overall Study|Withdrawal by Subject|0
2455709|NCT02583048|8462158|P2|Overall Study|Withdrawal by Subject|1
2455710|NCT02583048|8462159|P1|Overall Study|Withdrawal by Subject|0
2455711|NCT02582983|8462194|P1|Overall Study|Adverse Event|1
2455712|NCT02582983|8462194|P1|Overall Study|Withdrawal by Subject|2
2455713|NCT02582983|8462194|P1|Overall Study|Death|3
2455714|NCT02582814|8462257|P2|Overall Study|Adverse Event|4
2455715|NCT02582814|8462258|P1|Overall Study|Adverse Event|4
2455716|NCT02582814|8462257|P2|Overall Study|Withdrawal by Subject|3
2455717|NCT02582814|8462258|P1|Overall Study|Withdrawal by Subject|4
2455718|NCT02582814|8462257|P2|Overall Study|Study-specific withdrawal criteria|0
2455719|NCT02582814|8462258|P1|Overall Study|Study-specific withdrawal criteria|1
2455720|NCT02582749|8462298|P2|Overall Study|Withdrawal by Subject|1
2455721|NCT02582749|8462299|P1|Overall Study|Withdrawal by Subject|0
2455722|NCT02582749|8462298|P2|Overall Study|Study terminated by funder|10
2455723|NCT02582749|8462299|P1|Overall Study|Study terminated by funder|5
2455724|NCT02582684|8462329|P1|Overall Study|Found to be ineligible after enrollment|2
2455725|NCT02582684|8462329|P1|Overall Study|Subject withdrew consent|1
2455726|NCT02582684|8462329|P1|Overall Study|Subject not able to get to clinic|10
2455727|NCT02582684|8462329|P1|Overall Study|Unable to contact subject/parent|4
2455728|NCT02582671|8462348|P1|Overall Study|Other, not specified|1
2455729|NCT02582671|8462348|P1|Overall Study|Failure to return|1
2455730|NCT02582658|8462360|P1|Overall Study|Not further specified|11
2455731|NCT02582658|8462360|P1|Overall Study|Death|1
2455732|NCT02582658|8462360|P1|Overall Study|Withdrawn Consent|1
2455733|NCT02582658|8462360|P1|Overall Study|Insufficient Virological Response|2
2455734|NCT02582658|8462360|P1|Overall Study|Failure to Return|10
2455735|NCT02582632|8462378|P1|Overall Study|Other|1
2455736|NCT02582515|8462393|P2|Overall Study|Withdrawal by Subject|1
2455737|NCT02582515|8462394|P1|Overall Study|Withdrawal by Subject|0
2455738|NCT02582255|8462402|P2|Overall Study|Protocol Violation|3
2455739|NCT02582255|8462403|P1|Overall Study|Protocol Violation|0
2455740|NCT02582242|8462416|P2|Overall Study|Unclassified|1
2455741|NCT02582242|8462417|P1|Overall Study|Unclassified|2
2455742|NCT02582242|8462416|P2|Overall Study|Withdrawal by Subject|11
2455743|NCT02582242|8462417|P1|Overall Study|Withdrawal by Subject|11
2455744|NCT02582242|8462416|P2|Overall Study|Lost to Follow-up|1
2455745|NCT02582242|8462417|P1|Overall Study|Lost to Follow-up|0
2455746|NCT02582242|8462416|P2|Overall Study|Protocol Violation|1
2455747|NCT02582242|8462417|P1|Overall Study|Protocol Violation|3
2455748|NCT02582242|8462416|P2|Overall Study|Adverse Event|3
2455749|NCT02582242|8462417|P1|Overall Study|Adverse Event|4
2455750|NCT02581995|8462476|P1|Overall Study|Death|4
2455751|NCT02581995|8462476|P1|Overall Study|Physician Decision|1
2455752|NCT02581995|8462476|P1|Overall Study|Withdrawal by participant|12
2455753|NCT02581995|8462476|P1|Overall Study|Lost to Follow-up|5
2455754|NCT02581995|8462476|P1|Overall Study|Adverse Event|6
2455755|NCT02581995|8462476|P1|Overall Study|Unspecified other|3
2455756|NCT02581930|8462490|P1|Overall Study|patient declined further treatment|1
2455757|NCT02581930|8462490|P1|Overall Study|Withdrawal by Subject|1
2455758|NCT02581488|8462508|P2|Overall Study|Protocol Violation|4
2455759|NCT02581488|8462509|P1|Overall Study|Protocol Violation|0
2455760|NCT02581488|8462508|P2|Overall Study|Non-Compliance|0
2455761|NCT02581488|8462509|P1|Overall Study|Non-Compliance|1
2455762|NCT02581488|8462508|P2|Overall Study|Withdrawal by Subject|0
2455763|NCT02581488|8462509|P1|Overall Study|Withdrawal by Subject|1
2455764|NCT02581488|8462508|P2|Overall Study|Lost to Follow-up|0
2455765|NCT02581488|8462509|P1|Overall Study|Lost to Follow-up|1
2455766|NCT02581488|8462508|P2|Overall Study|Adverse Event|7
2455767|NCT02581488|8462509|P1|Overall Study|Adverse Event|6
2455768|NCT02581410|8462540|P2|End of Study Phase|Other-transfer of subject not completed|1
2455769|NCT02581410|8462541|P1|End of Study Phase|Other-transfer of subject not completed|0
2455770|NCT02581410|8462540|P2|End of Study Phase|Lost to Follow-up|2
2455771|NCT02581410|8462541|P1|End of Study Phase|Lost to Follow-up|0
2455772|NCT02581410|8462540|P2|End of Study Phase|Migrated/moved from study area|3
2455773|NCT02581410|8462541|P1|End of Study Phase|Migrated/moved from study area|0
2455774|NCT02581410|8462540|P2|End of Study Phase|Withdrawal by Subject|2
2455775|NCT02581410|8462541|P1|End of Study Phase|Withdrawal by Subject|1
2455776|NCT02581410|8462540|P2|End of Study Phase|Adverse Event|3
2455777|NCT02581410|8462541|P1|End of Study Phase|Adverse Event|4
2455778|NCT02581410|8462540|P2|Vaccination Phase|Migrated/moved from study area|1
2455779|NCT02581410|8462541|P1|Vaccination Phase|Migrated/moved from study area|0
2455780|NCT02581410|8462540|P2|Vaccination Phase|Withdrawal by Subject|1
2455781|NCT02581410|8462541|P1|Vaccination Phase|Withdrawal by Subject|0
2455782|NCT02581410|8462540|P2|Vaccination Phase|Adverse Event|1
2455783|NCT02581410|8462541|P1|Vaccination Phase|Adverse Event|2
2455784|NCT02581345|8462571|P4|Part 2: Week 17 to Week 47|Unspecified Reason|1
2455785|NCT02581345|8462572|P3|Part 2: Week 17 to Week 47|Unspecified Reason|1
2455786|NCT02581345|8462573|P2|Part 2: Week 17 to Week 47|Unspecified Reason|0
2455787|NCT02581345|8462574|P1|Part 2: Week 17 to Week 47|Unspecified Reason|2
2455788|NCT02581345|8462571|P4|Part 2: Week 17 to Week 47|Lost to Follow-up|1
2455789|NCT02581345|8462572|P3|Part 2: Week 17 to Week 47|Lost to Follow-up|0
2455790|NCT02581345|8462573|P2|Part 2: Week 17 to Week 47|Lost to Follow-up|0
2455791|NCT02581345|8462574|P1|Part 2: Week 17 to Week 47|Lost to Follow-up|2
2455792|NCT02581345|8462571|P4|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2
2455793|NCT02581345|8462572|P3|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3
2455794|NCT02581345|8462573|P2|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0
2455795|NCT02581345|8462574|P1|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8
2455796|NCT02581345|8462571|P4|Part 2: Week 17 to Week 47|Withdrawal by Subject|5
2455797|NCT02581345|8462572|P3|Part 2: Week 17 to Week 47|Withdrawal by Subject|7
2455798|NCT02581345|8462573|P2|Part 2: Week 17 to Week 47|Withdrawal by Subject|0
2455799|NCT02581345|8462574|P1|Part 2: Week 17 to Week 47|Withdrawal by Subject|9
2455800|NCT02581345|8462571|P4|Part 2: Week 17 to Week 47|Physician Decision|1
2455801|NCT02581345|8462572|P3|Part 2: Week 17 to Week 47|Physician Decision|2
2455802|NCT02581345|8462573|P2|Part 2: Week 17 to Week 47|Physician Decision|0
2455803|NCT02581345|8462574|P1|Part 2: Week 17 to Week 47|Physician Decision|3
2455804|NCT02581345|8462571|P4|Part 2: Week 17 to Week 47|Adverse Event|2
2455805|NCT02581345|8462572|P3|Part 2: Week 17 to Week 47|Adverse Event|2
2455806|NCT02581345|8462573|P2|Part 2: Week 17 to Week 47|Adverse Event|0
2455807|NCT02581345|8462574|P1|Part 2: Week 17 to Week 47|Adverse Event|5
2455808|NCT02581345|8462571|P4|Part 1: up to Week 16|Did Not Receive Treatment|0
2455809|NCT02581345|8462572|P3|Part 1: up to Week 16|Did Not Receive Treatment|0
2455810|NCT02581345|8462573|P2|Part 1: up to Week 16|Did Not Receive Treatment|1
2455811|NCT02581345|8462574|P1|Part 1: up to Week 16|Did Not Receive Treatment|1
2455812|NCT02581345|8462571|P4|Part 1: up to Week 16|Unspecified Reason|0
2455813|NCT02581345|8462572|P3|Part 1: up to Week 16|Unspecified Reason|0
2455814|NCT02581345|8462573|P2|Part 1: up to Week 16|Unspecified Reason|3
2455815|NCT02581345|8462574|P1|Part 1: up to Week 16|Unspecified Reason|3
2455816|NCT02581345|8462571|P4|Part 1: up to Week 16|Lost to Follow-up|0
2455817|NCT02581345|8462572|P3|Part 1: up to Week 16|Lost to Follow-up|0
2455818|NCT02581345|8462573|P2|Part 1: up to Week 16|Lost to Follow-up|0
2455819|NCT02581345|8462574|P1|Part 1: up to Week 16|Lost to Follow-up|2
2455820|NCT02581345|8462571|P4|Part 1: up to Week 16|Withdrawal by Subject|0
2455821|NCT02581345|8462572|P3|Part 1: up to Week 16|Withdrawal by Subject|0
2455822|NCT02581345|8462573|P2|Part 1: up to Week 16|Withdrawal by Subject|7
2455823|NCT02581345|8462574|P1|Part 1: up to Week 16|Withdrawal by Subject|4
2455824|NCT02581345|8462571|P4|Part 1: up to Week 16|Physician Decision|0
2455825|NCT02581345|8462572|P3|Part 1: up to Week 16|Physician Decision|0
2455826|NCT02581345|8462573|P2|Part 1: up to Week 16|Physician Decision|4
2455827|NCT02581345|8462574|P1|Part 1: up to Week 16|Physician Decision|2
2455828|NCT02581345|8462571|P4|Part 1: up to Week 16|Adverse Event|0
2455829|NCT02581345|8462572|P3|Part 1: up to Week 16|Adverse Event|0
2455830|NCT02581345|8462573|P2|Part 1: up to Week 16|Adverse Event|8
2455831|NCT02581345|8462574|P1|Part 1: up to Week 16|Adverse Event|3
2455832|NCT02581202|8462676|P1|Overall Study|Pregnancy|3
2455833|NCT02581202|8462676|P1|Overall Study|Lost to Follow-up|5
2455834|NCT02581202|8462676|P1|Overall Study|Withdrawal by Subject|4
2455835|NCT02581202|8462676|P1|Overall Study|Lack of Efficacy|2
2455836|NCT02581189|8462715|P1|Overall Study|Other, not specified|7
2455837|NCT02581189|8462715|P1|Overall Study|Insufficient virological response|2
2455838|NCT02581189|8462715|P1|Overall Study|Death|3
2455839|NCT02581189|8462715|P1|Overall Study|Withdrew consent|5
2455840|NCT02581189|8462715|P1|Overall Study|Failure to return|36
2455841|NCT02581163|8462729|P1|Overall Study|Other, not specified|9
2455842|NCT02581163|8462729|P1|Overall Study|Death|1
2455843|NCT02581163|8462729|P1|Overall Study|Withdrew consent|1
2455844|NCT02581163|8462729|P1|Overall Study|Insufficient virological response|3
2455845|NCT02581163|8462729|P1|Overall Study|Failure to return|15
2455846|NCT02580591|8462787|P4|Overall Study|Other than specified|2
2455847|NCT02580591|8462788|P3|Overall Study|Other than specified|5
2455848|NCT02580591|8462789|P2|Overall Study|Other than specified|2
2455849|NCT02580591|8462790|P1|Overall Study|Other than specified|3
2455850|NCT02580591|8462787|P4|Overall Study|Not treated|0
2455851|NCT02580591|8462788|P3|Overall Study|Not treated|0
2455852|NCT02580591|8462789|P2|Overall Study|Not treated|1
2455853|NCT02580591|8462790|P1|Overall Study|Not treated|1
2455854|NCT02580591|8462787|P4|Overall Study|Withdrawal by Subject|3
2455855|NCT02580591|8462788|P3|Overall Study|Withdrawal by Subject|2
2455856|NCT02580591|8462789|P2|Overall Study|Withdrawal by Subject|1
2455857|NCT02580591|8462790|P1|Overall Study|Withdrawal by Subject|6
2455858|NCT02580591|8462787|P4|Overall Study|Lost to Follow-up|1
2455859|NCT02580591|8462788|P3|Overall Study|Lost to Follow-up|3
2455860|NCT02580591|8462789|P2|Overall Study|Lost to Follow-up|3
2455861|NCT02580591|8462790|P1|Overall Study|Lost to Follow-up|5
2455862|NCT02580591|8462787|P4|Overall Study|Protocol Violation|1
2455863|NCT02580591|8462788|P3|Overall Study|Protocol Violation|1
2455864|NCT02580591|8462789|P2|Overall Study|Protocol Violation|2
2455865|NCT02580591|8462790|P1|Overall Study|Protocol Violation|3
2455866|NCT02580591|8462787|P4|Overall Study|Adverse Event|5
2455867|NCT02580591|8462788|P3|Overall Study|Adverse Event|2
2455868|NCT02580591|8462789|P2|Overall Study|Adverse Event|1
2455869|NCT02580591|8462790|P1|Overall Study|Adverse Event|0
2455870|NCT02580357|8462823|P3|Overall Study|Protocol Violation|0
2455871|NCT02580357|8462824|P2|Overall Study|Protocol Violation|0
2455872|NCT02580357|8462825|P1|Overall Study|Protocol Violation|1
2455873|NCT02580357|8462823|P3|Overall Study|Lost to Follow-up|0
2455874|NCT02580357|8462824|P2|Overall Study|Lost to Follow-up|0
2455875|NCT02580357|8462825|P1|Overall Study|Lost to Follow-up|2
2455876|NCT02580240|8462842|P2|Overall Study|Physician Decision|0
2455877|NCT02580240|8462843|P1|Overall Study|Physician Decision|2
2455878|NCT02580058|8462867|P3|Overall Study|Withdrawal by Subject|36
2455879|NCT02580058|8462868|P2|Overall Study|Withdrawal by Subject|26
2455880|NCT02580058|8462869|P1|Overall Study|Withdrawal by Subject|24
2455881|NCT02580058|8462867|P3|Overall Study|Ongoing|46
2455882|NCT02580058|8462868|P2|Overall Study|Ongoing|55
2455883|NCT02580058|8462869|P1|Overall Study|Ongoing|51
2455884|NCT02580058|8462867|P3|Overall Study|Lost to Follow-up|4
2455885|NCT02580058|8462868|P2|Overall Study|Lost to Follow-up|5
2455886|NCT02580058|8462869|P1|Overall Study|Lost to Follow-up|4
2455887|NCT02579928|8462936|P2|Overall Study|Withdrawal by Subject|0
2455888|NCT02579928|8462937|P1|Overall Study|Withdrawal by Subject|1
2455889|NCT02579863|8462977|P2|Overall Study|Withdrawal by Subject|19
2455890|NCT02579863|8462978|P1|Overall Study|Withdrawal by Subject|17
2455891|NCT02579863|8462977|P2|Overall Study|Study Terminated at Selected Sites|3
2455892|NCT02579863|8462978|P1|Overall Study|Study Terminated at Selected Sites|3
2455893|NCT02579863|8462977|P2|Overall Study|Screen Failure|2
2455894|NCT02579863|8462978|P1|Overall Study|Screen Failure|1
2455895|NCT02579863|8462977|P2|Overall Study|Physician Decision|2
2455896|NCT02579863|8462978|P1|Overall Study|Physician Decision|0
2455897|NCT02579863|8462977|P2|Overall Study|Lost to Follow-up|1
2455898|NCT02579863|8462978|P1|Overall Study|Lost to Follow-up|2
2455899|NCT02579863|8462977|P2|Overall Study|Death|3
2455900|NCT02579863|8462978|P1|Overall Study|Death|11
2455901|NCT02579863|8462977|P2|Overall Study|Adverse Event|12
2455902|NCT02579863|8462978|P1|Overall Study|Adverse Event|17
2455903|NCT02579863|8462977|P2|Overall Study|Ongoing in Trial|112
2455904|NCT02579863|8462978|P1|Overall Study|Ongoing in Trial|105
2455905|NCT02579772|8462998|P2|Overall Study|flu-like illness, orthopedic trauma|1
2455906|NCT02579772|8462999|P1|Overall Study|flu-like illness, orthopedic trauma|1
2455907|NCT02579772|8462998|P2|Overall Study|Usage of additional antioxidants|0
2455908|NCT02579772|8462999|P1|Overall Study|Usage of additional antioxidants|1
2455909|NCT02579772|8462998|P2|Overall Study|Withdrawal by Subject|1
2455910|NCT02579772|8462999|P1|Overall Study|Withdrawal by Subject|0
2455911|NCT02579759|8463020|P3|Overall Study|Lost to Follow-up|2
2455912|NCT02579759|8463021|P2|Overall Study|Lost to Follow-up|2
2455913|NCT02579759|8463022|P1|Overall Study|Lost to Follow-up|2
2455914|NCT02579759|8463020|P3|Overall Study|Withdrawal by Subject|5
2455915|NCT02579759|8463021|P2|Overall Study|Withdrawal by Subject|3
2455916|NCT02579759|8463022|P1|Overall Study|Withdrawal by Subject|3
2455917|NCT02579759|8463020|P3|Overall Study|Adverse Event|1
2455918|NCT02579759|8463021|P2|Overall Study|Adverse Event|3
2455919|NCT02579759|8463022|P1|Overall Study|Adverse Event|4
2455920|NCT02579759|8463020|P3|Overall Study|Inclusion/exclusion criteria|1
2455921|NCT02579759|8463021|P2|Overall Study|Inclusion/exclusion criteria|0
2455922|NCT02579759|8463022|P1|Overall Study|Inclusion/exclusion criteria|0
2455923|NCT02579759|8463020|P3|Overall Study|Pregnancy|0
2455924|NCT02579759|8463021|P2|Overall Study|Pregnancy|1
2455925|NCT02579759|8463022|P1|Overall Study|Pregnancy|0
2455926|NCT02579759|8463020|P3|Overall Study|Non compliance|0
2455927|NCT02579759|8463021|P2|Overall Study|Non compliance|1
2455928|NCT02579759|8463022|P1|Overall Study|Non compliance|0
2455929|NCT02579759|8463020|P3|Overall Study|Sponsor stopped Dose 2|0
2455930|NCT02579759|8463021|P2|Overall Study|Sponsor stopped Dose 2|41
2455931|NCT02579759|8463022|P1|Overall Study|Sponsor stopped Dose 2|0
2455932|NCT02579759|8463020|P3|Overall Study|BfArM hold|12
2455933|NCT02579759|8463021|P2|Overall Study|BfArM hold|12
2455934|NCT02579759|8463022|P1|Overall Study|BfArM hold|13
2455935|NCT02579759|8463020|P3|Overall Study|Other (Sponsor stopped Dose 2)|0
2455936|NCT02579759|8463021|P2|Overall Study|Other (Sponsor stopped Dose 2)|1
2455937|NCT02579759|8463022|P1|Overall Study|Other (Sponsor stopped Dose 2)|0
2455938|NCT02579759|8463020|P3|Overall Study|Protocol Violation|0
2455939|NCT02579759|8463021|P2|Overall Study|Protocol Violation|0
2455940|NCT02579759|8463022|P1|Overall Study|Protocol Violation|2
2455941|NCT02579603|8463068|P2|Overall Study|Other than stated|0
2455942|NCT02579603|8463069|P1|Overall Study|Other than stated|1
2455943|NCT02579603|8463068|P2|Overall Study|Adverse Event|2
2455944|NCT02579603|8463069|P1|Overall Study|Adverse Event|2
2455945|NCT02579603|8463068|P2|Overall Study|Not treated|0
2455946|NCT02579603|8463069|P1|Overall Study|Not treated|1
2455947|NCT02578992|8463124|P2|Overall Study|equipment not available or malfunction|3
2455948|NCT02578992|8463125|P1|Overall Study|equipment not available or malfunction|3
2455949|NCT02578940|8463137|P1|Overall Study|Lost to Follow-up|1
2455950|NCT02578940|8463137|P1|Overall Study|Screening failure|5
2455951|NCT02578862|8463146|P2|Overall Study|Unplanned unilateral procedure|1
2455952|NCT02578862|8463147|P1|Overall Study|Unplanned unilateral procedure|0
2455953|NCT02578862|8463146|P2|Overall Study|Withdrawal by Subject|1
2455954|NCT02578862|8463147|P1|Overall Study|Withdrawal by Subject|0
2455955|NCT02578706|8463185|P3|Overall Study|Physician Decision|0
2455956|NCT02578706|8463186|P2|Overall Study|Physician Decision|1
2455957|NCT02578706|8463187|P1|Overall Study|Physician Decision|0
2455958|NCT02578706|8463185|P3|Overall Study|Lost to Follow-up|0
2455959|NCT02578706|8463186|P2|Overall Study|Lost to Follow-up|4
2455960|NCT02578706|8463187|P1|Overall Study|Lost to Follow-up|0
2455961|NCT02578706|8463185|P3|Overall Study|Withdrawal by Subject|0
2455962|NCT02578706|8463186|P2|Overall Study|Withdrawal by Subject|0
2455963|NCT02578706|8463187|P1|Overall Study|Withdrawal by Subject|1
2455964|NCT02578680|8463266|P2|Overall Study|Ongoing in Study|96
2455965|NCT02578680|8463267|P1|Overall Study|Ongoing in Study|276
2455966|NCT02578680|8463266|P2|Overall Study|Withdrawal by Subject|5
2455967|NCT02578680|8463267|P1|Overall Study|Withdrawal by Subject|8
2455968|NCT02578680|8463266|P2|Overall Study|Withdrawal by Parent/Guardian|0
2455969|NCT02578680|8463267|P1|Overall Study|Withdrawal by Parent/Guardian|1
2455970|NCT02578680|8463266|P2|Overall Study|Protocol Violation|1
2455971|NCT02578680|8463267|P1|Overall Study|Protocol Violation|1
2455972|NCT02578680|8463266|P2|Overall Study|Death|104
2455973|NCT02578680|8463267|P1|Overall Study|Death|124
2455974|NCT02578316|8463283|P1|Extension Phase|Progression of disease|6
2455975|NCT02578186|8463316|P2|Period 1 (First of Crossover)|Withdrawal by Subject|1
2455976|NCT02578186|8463317|P1|Period 1 (First of Crossover)|Withdrawal by Subject|1
2455977|NCT02578186|8463316|P2|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
2455978|NCT02578186|8463317|P1|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
2455979|NCT02577887|8463406|P1|Overall Study|Withdrawal by Subject|80
2455980|NCT02577887|8463406|P1|Overall Study|Protocol Violation|125
2455981|NCT02577887|8463406|P1|Overall Study|Death|93
2455982|NCT02577718|8463432|P1|Overall Study|Withdrawal by Subject|2
2455983|NCT02577718|8463432|P1|Overall Study|Death|6
2455984|NCT02577315|8463474|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
2455985|NCT02577315|8463475|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
2455986|NCT02577146|8463491|P1|Overall Study|Screen Failure|17
2455987|NCT02577146|8463491|P1|Overall Study|Physician Decision|3
2455988|NCT02577146|8463491|P1|Overall Study|Lost to Follow-up|8
2455989|NCT02577107|8463498|P2|Overall Study|Protocol deviation|1
2455990|NCT02577107|8463499|P1|Overall Study|Protocol deviation|0
2455991|NCT02577029|8463519|P8|Overall Study|Sponsor Termination of the Study|12
2455992|NCT02577029|8463520|P7|Overall Study|Sponsor Termination of the Study|12
2455993|NCT02577029|8463521|P6|Overall Study|Sponsor Termination of the Study|12
2455994|NCT02577029|8463522|P5|Overall Study|Sponsor Termination of the Study|10
2455995|NCT02577029|8463523|P4|Overall Study|Sponsor Termination of the Study|12
2455996|NCT02577029|8463524|P3|Overall Study|Sponsor Termination of the Study|5
2455997|NCT02577029|8463525|P2|Overall Study|Sponsor Termination of the Study|2
2455998|NCT02577029|8463526|P1|Overall Study|Sponsor Termination of the Study|9
2455999|NCT02577029|8463519|P8|Overall Study|Withdrawal by Subject|0
2456000|NCT02577029|8463520|P7|Overall Study|Withdrawal by Subject|0
2456001|NCT02577029|8463521|P6|Overall Study|Withdrawal by Subject|1
2456002|NCT02577029|8463522|P5|Overall Study|Withdrawal by Subject|0
2456003|NCT02577029|8463523|P4|Overall Study|Withdrawal by Subject|0
2456004|NCT02577029|8463524|P3|Overall Study|Withdrawal by Subject|0
2456005|NCT02577029|8463525|P2|Overall Study|Withdrawal by Subject|0
2456006|NCT02577029|8463526|P1|Overall Study|Withdrawal by Subject|0
2456007|NCT02577029|8463519|P8|Overall Study|Adverse Event|0
2456008|NCT02577029|8463520|P7|Overall Study|Adverse Event|0
2456009|NCT02577029|8463521|P6|Overall Study|Adverse Event|0
2456010|NCT02577029|8463522|P5|Overall Study|Adverse Event|1
2456011|NCT02577029|8463523|P4|Overall Study|Adverse Event|0
2456012|NCT02577029|8463524|P3|Overall Study|Adverse Event|2
2456013|NCT02577029|8463525|P2|Overall Study|Adverse Event|0
2456014|NCT02577029|8463526|P1|Overall Study|Adverse Event|1
2456015|NCT02577016|8463634|P2|Overall Study|Physician Decision|1
2456016|NCT02577016|8463635|P1|Overall Study|Physician Decision|0
2456017|NCT02577016|8463634|P2|Overall Study|Adverse Event|1
2456018|NCT02577016|8463635|P1|Overall Study|Adverse Event|2
2456019|NCT02577003|8463653|P2|Overall Study|Withdrawal by Subject|1
2456020|NCT02577003|8463654|P1|Overall Study|Withdrawal by Subject|0
2456021|NCT02577003|8463653|P2|Overall Study|Adverse Event|4
2456022|NCT02577003|8463654|P1|Overall Study|Adverse Event|2
2456023|NCT02576977|8463674|P2|Overall Study|Ongoing in trial|77
2456024|NCT02576977|8463675|P1|Overall Study|Ongoing in trial|53
2456025|NCT02576977|8463674|P2|Overall Study|Withdrawal by Subject|9
2456026|NCT02576977|8463675|P1|Overall Study|Withdrawal by Subject|9
2456027|NCT02576977|8463674|P2|Overall Study|Study Terminated at Selected Sites|2
2456028|NCT02576977|8463675|P1|Overall Study|Study Terminated at Selected Sites|3
2456029|NCT02576977|8463674|P2|Overall Study|Screen failure|0
2456030|NCT02576977|8463675|P1|Overall Study|Screen failure|1
2456031|NCT02576977|8463674|P2|Overall Study|Death|35
2456032|NCT02576977|8463675|P1|Overall Study|Death|47
2456033|NCT02576977|8463674|P2|Overall Study|Adverse Event|2
2456034|NCT02576977|8463675|P1|Overall Study|Adverse Event|13
2456035|NCT02576951|8463697|P4|Overall Study|Protocol Violation|1
2456036|NCT02576951|8463698|P3|Overall Study|Protocol Violation|0
2456037|NCT02576951|8463699|P2|Overall Study|Protocol Violation|0
2456038|NCT02576951|8463700|P1|Overall Study|Protocol Violation|0
2456039|NCT02576951|8463697|P4|Overall Study|Withdrawal by Subject|2
2456040|NCT02576951|8463698|P3|Overall Study|Withdrawal by Subject|0
2456041|NCT02576951|8463699|P2|Overall Study|Withdrawal by Subject|0
2456042|NCT02576951|8463700|P1|Overall Study|Withdrawal by Subject|1
2456043|NCT02576951|8463697|P4|Overall Study|Lost to Follow-up|2
2456044|NCT02576951|8463698|P3|Overall Study|Lost to Follow-up|2
2456045|NCT02576951|8463699|P2|Overall Study|Lost to Follow-up|0
2456046|NCT02576951|8463700|P1|Overall Study|Lost to Follow-up|0
2456047|NCT02576938|8463724|P3|Overall Study|Met Exclusion Criteria|0
2456048|NCT02576938|8463725|P2|Overall Study|Met Exclusion Criteria|1
2456049|NCT02576938|8463726|P1|Overall Study|Met Exclusion Criteria|0
2456050|NCT02576938|8463724|P3|Overall Study|Physician Decision|0
2456051|NCT02576938|8463725|P2|Overall Study|Physician Decision|1
2456052|NCT02576938|8463726|P1|Overall Study|Physician Decision|0
2456053|NCT02576938|8463724|P3|Overall Study|Lost to Follow-up|1
2456054|NCT02576938|8463725|P2|Overall Study|Lost to Follow-up|0
2456055|NCT02576938|8463726|P1|Overall Study|Lost to Follow-up|2
2456056|NCT02576938|8463724|P3|Overall Study|Lack of Efficacy|0
2456057|NCT02576938|8463725|P2|Overall Study|Lack of Efficacy|4
2456058|NCT02576938|8463726|P1|Overall Study|Lack of Efficacy|9
2456059|NCT02576938|8463724|P3|Overall Study|Withdrawal by Subject|4
2456060|NCT02576938|8463725|P2|Overall Study|Withdrawal by Subject|2
2456061|NCT02576938|8463726|P1|Overall Study|Withdrawal by Subject|3
2456062|NCT02576938|8463724|P3|Overall Study|Protocol Violation|1
2456063|NCT02576938|8463725|P2|Overall Study|Protocol Violation|1
2456064|NCT02576938|8463726|P1|Overall Study|Protocol Violation|1
2456065|NCT02576938|8463724|P3|Overall Study|Adverse Event|6
2456066|NCT02576938|8463725|P2|Overall Study|Adverse Event|3
2456067|NCT02576938|8463726|P1|Overall Study|Adverse Event|5
2456068|NCT02576678|8463772|P3|Overall Study|Miscellaneous|0
2456069|NCT02576678|8463773|P2|Overall Study|Miscellaneous|0
2456070|NCT02576678|8463774|P1|Overall Study|Miscellaneous|2
2456071|NCT02576678|8463772|P3|Overall Study|Lost to Follow-up|1
2456072|NCT02576678|8463773|P2|Overall Study|Lost to Follow-up|0
2456073|NCT02576678|8463774|P1|Overall Study|Lost to Follow-up|0
2456074|NCT02576678|8463772|P3|Overall Study|Withdrawal by Subject|2
2456075|NCT02576678|8463773|P2|Overall Study|Withdrawal by Subject|1
2456076|NCT02576678|8463774|P1|Overall Study|Withdrawal by Subject|3
2456077|NCT02576678|8463772|P3|Overall Study|Adverse Event|2
2456078|NCT02576678|8463773|P2|Overall Study|Adverse Event|0
2456079|NCT02576678|8463774|P1|Overall Study|Adverse Event|0
2456080|NCT02576652|8463806|P1|Overall Study|Withdrawal by Subject|2
2456081|NCT02576639|8463818|P5|Overall Study|Physician Decision|1
2456082|NCT02576639|8463819|P4|Overall Study|Physician Decision|0
2456083|NCT02576639|8463820|P3|Overall Study|Physician Decision|0
2456084|NCT02576639|8463821|P2|Overall Study|Physician Decision|0
2456085|NCT02576639|8463822|P1|Overall Study|Physician Decision|0
2456086|NCT02576639|8463818|P5|Overall Study|Adverse Event|2
2456087|NCT02576639|8463819|P4|Overall Study|Adverse Event|1
2456088|NCT02576639|8463820|P3|Overall Study|Adverse Event|1
2456089|NCT02576639|8463821|P2|Overall Study|Adverse Event|0
2456090|NCT02576639|8463822|P1|Overall Study|Adverse Event|1
2456091|NCT02576639|8463818|P5|Overall Study|Withdrawal by Subject|1
2456092|NCT02576639|8463819|P4|Overall Study|Withdrawal by Subject|0
2456093|NCT02576639|8463820|P3|Overall Study|Withdrawal by Subject|1
2456094|NCT02576639|8463821|P2|Overall Study|Withdrawal by Subject|2
2456095|NCT02576639|8463822|P1|Overall Study|Withdrawal by Subject|1
2456096|NCT02576587|8463881|P2|Follow up Period (Case Only)|Controls not eligible for followup|155
2456097|NCT02576587|8463882|P1|Follow up Period (Case Only)|Controls not eligible for followup|0
2456098|NCT02576587|8463881|P2|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0
2456099|NCT02576587|8463882|P1|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92
2456100|NCT02576587|8463881|P2|Follow up Period (Case Only)|Withdrawal by Subject|0
2456101|NCT02576587|8463882|P1|Follow up Period (Case Only)|Withdrawal by Subject|25
2456102|NCT02576587|8463881|P2|Baseline|Equipment failure|1
2456103|NCT02576587|8463882|P1|Baseline|Equipment failure|0
2456104|NCT02576535|8463900|P1|Overall Study|Withdrawal by Subject|2
2456105|NCT02576145|8463924|P2|Overall Study|Tetanus Titers Decreased|1
2456106|NCT02576145|8463925|P1|Overall Study|Tetanus Titers Decreased|0
2456107|NCT02576145|8463924|P2|Overall Study|Acute rejection|0
2456108|NCT02576145|8463925|P1|Overall Study|Acute rejection|1
2456109|NCT02576145|8463924|P2|Overall Study|Withdrawal by Subject|0
2456110|NCT02576145|8463925|P1|Overall Study|Withdrawal by Subject|1
2456111|NCT02576145|8463924|P2|Overall Study|Adverse Event|0
2456112|NCT02576145|8463925|P1|Overall Study|Adverse Event|1
2456113|NCT02576067|8463963|P2|Overall Study|Physician Decision|0
2456114|NCT02576067|8463964|P1|Overall Study|Physician Decision|4
2456115|NCT02576067|8463963|P2|Overall Study|screen failure/ re-enrolled|25
2456116|NCT02576067|8463964|P1|Overall Study|screen failure/ re-enrolled|0
2456117|NCT02576067|8463963|P2|Overall Study|not randomized, failed run-in|0
2456118|NCT02576067|8463964|P1|Overall Study|not randomized, failed run-in|7
2456119|NCT02576067|8463963|P2|Overall Study|study closure of main CIRT trial)|8
2456120|NCT02576067|8463964|P1|Overall Study|study closure of main CIRT trial)|0
2456121|NCT02576067|8463963|P2|Overall Study|Withdrawal by Subject|2
2456122|NCT02576067|8463964|P1|Overall Study|Withdrawal by Subject|11
2456123|NCT02576067|8463963|P2|Overall Study|Lost to Follow-up|0
2456124|NCT02576067|8463964|P1|Overall Study|Lost to Follow-up|11
2456125|NCT02576067|8463963|P2|Overall Study|Lack of Efficacy|0
2456126|NCT02576067|8463964|P1|Overall Study|Lack of Efficacy|1
2456127|NCT02576067|8463963|P2|Overall Study|Death|1
2456128|NCT02576067|8463964|P1|Overall Study|Death|0
2456129|NCT02576054|8463974|P1|Overall Study|Withdrawal by Subject|1
2456130|NCT02575950|8463995|P4|Overall Study|Lost to Follow-up|3
2456131|NCT02575950|8463996|P3|Overall Study|Lost to Follow-up|0
2456132|NCT02575950|8463997|P2|Overall Study|Lost to Follow-up|1
2456133|NCT02575950|8463998|P1|Overall Study|Lost to Follow-up|0
2456134|NCT02575950|8463995|P4|Overall Study|Withdrawal by Subject|2
2456135|NCT02575950|8463996|P3|Overall Study|Withdrawal by Subject|0
2456136|NCT02575950|8463997|P2|Overall Study|Withdrawal by Subject|0
2456137|NCT02575950|8463998|P1|Overall Study|Withdrawal by Subject|0
2456138|NCT02575911|8464027|P1|Overall Study|Lost to Follow-up|1
2456139|NCT02575833|8464047|P2|Overall Study|Lost to Follow-up|0
2456140|NCT02575833|8464048|P1|Overall Study|Lost to Follow-up|1
2456141|NCT02575833|8464047|P2|Overall Study|Withdrawal by Subject|1
2456142|NCT02575833|8464048|P1|Overall Study|Withdrawal by Subject|0
2456143|NCT02575807|8464063|P5|Overall Study|Withdrawal by Subject|2
2456144|NCT02575807|8464064|P4|Overall Study|Withdrawal by Subject|1
2456145|NCT02575807|8464065|P3|Overall Study|Withdrawal by Subject|1
2456146|NCT02575807|8464066|P2|Overall Study|Withdrawal by Subject|0
2456147|NCT02575807|8464067|P1|Overall Study|Withdrawal by Subject|0
2456148|NCT02575807|8464063|P5|Overall Study|Subject ineligible - medical implant|0
2456149|NCT02575807|8464064|P4|Overall Study|Subject ineligible - medical implant|1
2456150|NCT02575807|8464065|P3|Overall Study|Subject ineligible - medical implant|0
2456151|NCT02575807|8464066|P2|Overall Study|Subject ineligible - medical implant|0
2456152|NCT02575807|8464067|P1|Overall Study|Subject ineligible - medical implant|0
2456153|NCT02575807|8464063|P5|Overall Study|Terminated due to physician decision|0
2456154|NCT02575807|8464064|P4|Overall Study|Terminated due to physician decision|0
2456155|NCT02575807|8464065|P3|Overall Study|Terminated due to physician decision|1
2456156|NCT02575807|8464066|P2|Overall Study|Terminated due to physician decision|0
2456157|NCT02575807|8464067|P1|Overall Study|Terminated due to physician decision|0
2456158|NCT02575807|8464063|P5|Overall Study|Terminated due to FDA clinical hold|0
2456159|NCT02575807|8464064|P4|Overall Study|Terminated due to FDA clinical hold|0
2456160|NCT02575807|8464065|P3|Overall Study|Terminated due to FDA clinical hold|0
2456161|NCT02575807|8464066|P2|Overall Study|Terminated due to FDA clinical hold|0
2456162|NCT02575807|8464067|P1|Overall Study|Terminated due to FDA clinical hold|1
2456163|NCT02575807|8464063|P5|Overall Study|Study terminated by Sponsor|1
2456164|NCT02575807|8464064|P4|Overall Study|Study terminated by Sponsor|0
2456165|NCT02575807|8464065|P3|Overall Study|Study terminated by Sponsor|7
2456166|NCT02575807|8464066|P2|Overall Study|Study terminated by Sponsor|1
2456167|NCT02575807|8464067|P1|Overall Study|Study terminated by Sponsor|0
2456168|NCT02575807|8464063|P5|Overall Study|Death|1
2456169|NCT02575807|8464064|P4|Overall Study|Death|0
2456170|NCT02575807|8464065|P3|Overall Study|Death|7
2456171|NCT02575807|8464066|P2|Overall Study|Death|3
2456172|NCT02575807|8464067|P1|Overall Study|Death|8
2456173|NCT02575365|8464107|P1|Overall Study|Lost to Follow-up|4
2456174|NCT02575079|8464127|P2|Overall Study|Withdrawal by Subject|0
2456175|NCT02575079|8464128|P1|Overall Study|Withdrawal by Subject|3
2456176|NCT02575079|8464127|P2|Overall Study|Death|0
2456177|NCT02575079|8464128|P1|Overall Study|Death|3
2456178|NCT02574845|8464153|P6|Overall Study|Adverse Event|1
2456179|NCT02574845|8464154|P5|Overall Study|Adverse Event|0
2456180|NCT02574845|8464155|P4|Overall Study|Adverse Event|0
2456181|NCT02574845|8464156|P3|Overall Study|Adverse Event|0
2456182|NCT02574845|8464157|P2|Overall Study|Adverse Event|1
2456183|NCT02574845|8464158|P1|Overall Study|Adverse Event|0
2456184|NCT02574845|8464153|P6|Overall Study|Consent withdrawn further participation|0
2456185|NCT02574845|8464154|P5|Overall Study|Consent withdrawn further participation|1
2456186|NCT02574845|8464155|P4|Overall Study|Consent withdrawn further participation|0
2456187|NCT02574845|8464156|P3|Overall Study|Consent withdrawn further participation|0
2456188|NCT02574845|8464157|P2|Overall Study|Consent withdrawn further participation|0
2456189|NCT02574845|8464158|P1|Overall Study|Consent withdrawn further participation|0
2456190|NCT02574481|8464192|P4|Overall Study|Death|0
2456191|NCT02574481|8464193|P3|Overall Study|Death|0
2456192|NCT02574481|8464194|P2|Overall Study|Death|6
2456193|NCT02574481|8464195|P1|Overall Study|Death|6
2456194|NCT02574481|8464192|P4|Overall Study|Other|0
2456195|NCT02574481|8464193|P3|Overall Study|Other|0
2456196|NCT02574481|8464194|P2|Overall Study|Other|0
2456197|NCT02574481|8464195|P1|Overall Study|Other|1
2456198|NCT02574481|8464192|P4|Overall Study|Visit Missed|0
2456199|NCT02574481|8464193|P3|Overall Study|Visit Missed|2
2456200|NCT02574481|8464194|P2|Overall Study|Visit Missed|4
2456201|NCT02574481|8464195|P1|Overall Study|Visit Missed|12
2456202|NCT02574481|8464192|P4|Overall Study|Adverse Event|0
2456203|NCT02574481|8464193|P3|Overall Study|Adverse Event|0
2456204|NCT02574481|8464194|P2|Overall Study|Adverse Event|0
2456205|NCT02574481|8464195|P1|Overall Study|Adverse Event|2
2456206|NCT02574481|8464192|P4|Overall Study|Withdrawal by Subject|0
2456207|NCT02574481|8464193|P3|Overall Study|Withdrawal by Subject|1
2456208|NCT02574481|8464194|P2|Overall Study|Withdrawal by Subject|4
2456209|NCT02574481|8464195|P1|Overall Study|Withdrawal by Subject|6
2456210|NCT02574312|8464235|P2|3 Months Follow-up|Withdrawal by Subject|0
2456211|NCT02574312|8464236|P1|3 Months Follow-up|Withdrawal by Subject|1
2456212|NCT02574260|8464252|P1|Overall Study|Disease Progression|1
2456213|NCT02574247|8464261|P3|Overall Study|Did not meet inclusion criteria|5
2456214|NCT02574247|8464262|P2|Overall Study|Did not meet inclusion criteria|3
2456215|NCT02574247|8464263|P1|Overall Study|Did not meet inclusion criteria|4
2456216|NCT02574247|8464261|P3|Overall Study|Withdrawal by Subject|0
2456217|NCT02574247|8464262|P2|Overall Study|Withdrawal by Subject|0
2456218|NCT02574247|8464263|P1|Overall Study|Withdrawal by Subject|1
2456219|NCT02573948|8464275|P1|Longitudinal Cohort|Incarcerated|25
2456220|NCT02573948|8464275|P1|Longitudinal Cohort|Lost to Follow-up|22
2456221|NCT02573948|8464275|P1|Longitudinal Cohort|Death|9
2456222|NCT02573870|8464285|P2|Overall Study|Other: Fail to Meet Visit|2
2456223|NCT02573870|8464286|P1|Overall Study|Other: Fail to Meet Visit|0
2456224|NCT02573870|8464285|P2|Overall Study|Lost to Follow-up|1
2456225|NCT02573870|8464286|P1|Overall Study|Lost to Follow-up|0
2456226|NCT02573870|8464285|P2|Overall Study|Other: Reached defined stopping criteria|1
2456227|NCT02573870|8464286|P1|Overall Study|Other: Reached defined stopping criteria|0
2456228|NCT02573870|8464285|P2|Overall Study|Lack of Efficacy|1
2456229|NCT02573870|8464286|P1|Overall Study|Lack of Efficacy|0
2456230|NCT02573870|8464285|P2|Overall Study|Adverse Event|2
2456231|NCT02573870|8464286|P1|Overall Study|Adverse Event|0
2456232|NCT02573467|8464321|P4|Post-treatment Follow up Epoch|Technical problems|0
2456233|NCT02573467|8464322|P3|Post-treatment Follow up Epoch|Technical problems|1
2456234|NCT02573467|8464323|P2|Post-treatment Follow up Epoch|Technical problems|0
2456235|NCT02573467|8464324|P1|Post-treatment Follow up Epoch|Technical problems|0
2456236|NCT02573467|8464321|P4|Post-treatment Follow up Epoch|Withdrawal by Subject|2
2456237|NCT02573467|8464322|P3|Post-treatment Follow up Epoch|Withdrawal by Subject|9
2456238|NCT02573467|8464323|P2|Post-treatment Follow up Epoch|Withdrawal by Subject|4
2456239|NCT02573467|8464324|P1|Post-treatment Follow up Epoch|Withdrawal by Subject|5
2456240|NCT02573467|8464321|P4|Post-treatment Follow up Epoch|Death|1
2456241|NCT02573467|8464322|P3|Post-treatment Follow up Epoch|Death|0
2456242|NCT02573467|8464323|P2|Post-treatment Follow up Epoch|Death|1
2456243|NCT02573467|8464324|P1|Post-treatment Follow up Epoch|Death|1
2456244|NCT02573467|8464321|P4|Double-blind Treatment Epoch|Study Terminated by sponsor|55
2456245|NCT02573467|8464322|P3|Double-blind Treatment Epoch|Study Terminated by sponsor|48
2456246|NCT02573467|8464323|P2|Double-blind Treatment Epoch|Study Terminated by sponsor|51
2456247|NCT02573467|8464324|P1|Double-blind Treatment Epoch|Study Terminated by sponsor|50
2456248|NCT02573467|8464321|P4|Double-blind Treatment Epoch|Withdrawal by Subject|0
2456249|NCT02573467|8464322|P3|Double-blind Treatment Epoch|Withdrawal by Subject|1
2456250|NCT02573467|8464323|P2|Double-blind Treatment Epoch|Withdrawal by Subject|1
2456251|NCT02573467|8464324|P1|Double-blind Treatment Epoch|Withdrawal by Subject|2
2456252|NCT02573467|8464321|P4|Double-blind Treatment Epoch|Adverse Event|0
2456253|NCT02573467|8464322|P3|Double-blind Treatment Epoch|Adverse Event|1
2456254|NCT02573467|8464323|P2|Double-blind Treatment Epoch|Adverse Event|0
2456255|NCT02573467|8464324|P1|Double-blind Treatment Epoch|Adverse Event|1
2456256|NCT02573467|8464321|P4|Double-blind Treatment Epoch|Lack of Efficacy|0
2456257|NCT02573467|8464322|P3|Double-blind Treatment Epoch|Lack of Efficacy|1
2456258|NCT02573467|8464323|P2|Double-blind Treatment Epoch|Lack of Efficacy|0
2456259|NCT02573467|8464324|P1|Double-blind Treatment Epoch|Lack of Efficacy|0
2456260|NCT02573311|8464388|P2|Disposition for Part 2|Other than specified above|3
2456261|NCT02573311|8464389|P1|Disposition for Part 2|Other than specified above|13
2456262|NCT02573311|8464388|P2|Disposition for Part 2|Investigator decision|1
2456263|NCT02573311|8464389|P1|Disposition for Part 2|Investigator decision|0
2456264|NCT02573311|8464388|P2|Disposition for Part 2|Withdrawal by Subject|3
2456265|NCT02573311|8464389|P1|Disposition for Part 2|Withdrawal by Subject|60
2456266|NCT02573311|8464388|P2|Disposition for Part 2|Lost to Follow-up|7
2456267|NCT02573311|8464389|P1|Disposition for Part 2|Lost to Follow-up|76
2456268|NCT02573311|8464388|P2|Disposition for Part 2|Adverse Event|5
2456269|NCT02573311|8464389|P1|Disposition for Part 2|Adverse Event|36
2456270|NCT02573311|8464388|P2|Disposition for Part 2|Physician Decision|7
2456271|NCT02573311|8464389|P1|Disposition for Part 2|Physician Decision|25
2456272|NCT02573311|8464388|P2|Disposition for Part 1|Withdrawal by Subject|3
2456273|NCT02573311|8464389|P1|Disposition for Part 1|Withdrawal by Subject|7
2456274|NCT02573155|8464458|P2|Washout Between Treatment Period 4 and 5|Adverse Event|1
2456275|NCT02573155|8464459|P1|Washout Between Treatment Period 4 and 5|Adverse Event|0
2456276|NCT02573155|8464458|P2|Washout Between Treatment Period 3 and 4|Adverse Event|1
2456277|NCT02573155|8464459|P1|Washout Between Treatment Period 3 and 4|Adverse Event|0
2456278|NCT02573155|8464458|P2|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1
2456279|NCT02573155|8464459|P1|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0
2456280|NCT02573155|8464458|P2|Washout Between Treatment Period 2 and 3|Adverse Event|2
2456281|NCT02573155|8464459|P1|Washout Between Treatment Period 2 and 3|Adverse Event|0
2456282|NCT02573155|8464458|P2|Washout Between Treatment Period 2 and 3|Sponsor's decision|0
2456283|NCT02573155|8464459|P1|Washout Between Treatment Period 2 and 3|Sponsor's decision|1
2456284|NCT02573155|8464458|P2|Washout Between Treatment Period 1 and 2|Adverse Event|3
2456285|NCT02573155|8464459|P1|Washout Between Treatment Period 1 and 2|Adverse Event|0
2456286|NCT02573155|8464458|P2|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1
2456287|NCT02573155|8464459|P1|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0
2456288|NCT02573155|8464458|P2|Washout Between Treatment Period 1 and 2|Physician Decision|1
2456289|NCT02573155|8464459|P1|Washout Between Treatment Period 1 and 2|Physician Decision|0
2456290|NCT02573012|8464607|P2|Overall Study|Physician Decision|2
2456291|NCT02573012|8464608|P1|Overall Study|Physician Decision|1
2456292|NCT02573012|8464607|P2|Overall Study|Study Ended per Protocol|0
2456293|NCT02573012|8464608|P1|Overall Study|Study Ended per Protocol|1
2456294|NCT02573012|8464607|P2|Overall Study|Withdrawal by Subject|2
2456295|NCT02573012|8464608|P1|Overall Study|Withdrawal by Subject|2
2456296|NCT02573012|8464607|P2|Overall Study|Non-compliance|2
2456297|NCT02573012|8464608|P1|Overall Study|Non-compliance|1
2456298|NCT02573012|8464607|P2|Overall Study|Lack of Efficacy|4
2456299|NCT02573012|8464608|P1|Overall Study|Lack of Efficacy|5
2456300|NCT02573012|8464607|P2|Overall Study|Adverse Event|5
2456301|NCT02573012|8464608|P1|Overall Study|Adverse Event|5
2456302|NCT02572817|8464660|P2|Overall Study|Lost to Follow-up|3
2456303|NCT02572817|8464661|P1|Overall Study|Lost to Follow-up|3
2456304|NCT02572817|8464660|P2|Overall Study|Death|3
2456305|NCT02572817|8464661|P1|Overall Study|Death|6
2456306|NCT02572401|8464769|P4|Overall Study|Death|1
2456307|NCT02572401|8464770|P3|Overall Study|Death|0
2456308|NCT02572401|8464771|P2|Overall Study|Death|0
2456309|NCT02572401|8464772|P1|Overall Study|Death|0
2456310|NCT02572401|8464769|P4|Overall Study|Lost to Follow-up|9
2456311|NCT02572401|8464770|P3|Overall Study|Lost to Follow-up|9
2456312|NCT02572401|8464771|P2|Overall Study|Lost to Follow-up|8
2456313|NCT02572401|8464772|P1|Overall Study|Lost to Follow-up|5
2456314|NCT02572388|8464802|P4|Overall Study|Withdrawal by Subject|2
2456315|NCT02572388|8464803|P3|Overall Study|Withdrawal by Subject|2
2456316|NCT02572388|8464804|P2|Overall Study|Withdrawal by Subject|1
2456317|NCT02572388|8464805|P1|Overall Study|Withdrawal by Subject|1
2456318|NCT02572167|8464830|P3|Overall Study|Did not meet inclusion criteria|1
2456319|NCT02572167|8464831|P2|Overall Study|Did not meet inclusion criteria|0
2456320|NCT02572167|8464832|P1|Overall Study|Did not meet inclusion criteria|0
2456321|NCT02572167|8464830|P3|Overall Study|Death|1
2456322|NCT02572167|8464831|P2|Overall Study|Death|3
2456323|NCT02572167|8464832|P1|Overall Study|Death|0
2456324|NCT02572167|8464830|P3|Overall Study|Lost to Follow-up|1
2456325|NCT02572167|8464831|P2|Overall Study|Lost to Follow-up|2
2456326|NCT02572167|8464832|P1|Overall Study|Lost to Follow-up|0
2456327|NCT02572167|8464830|P3|Overall Study|Withdrawal by Subject|1
2456328|NCT02572167|8464831|P2|Overall Study|Withdrawal by Subject|3
2456329|NCT02572167|8464832|P1|Overall Study|Withdrawal by Subject|0
2456330|NCT02572167|8464830|P3|Overall Study|In follow up|27
2456331|NCT02572167|8464831|P2|Overall Study|In follow up|48
2456332|NCT02572167|8464832|P1|Overall Study|In follow up|6
2456333|NCT02572076|8464846|P1|Overall Study|Protocol Violation|1
2456334|NCT02571972|8464850|P1|Overall Study|Withdrawal by Subject|2
2456335|NCT02571972|8464850|P1|Overall Study|Protocol Violation|2
2456336|NCT02571452|8464867|P2|Overall Study 6-Month Follow-up|Protocol Violation|0
2456337|NCT02571452|8464868|P1|Overall Study 6-Month Follow-up|Protocol Violation|1
2456338|NCT02571452|8464867|P2|Overall Study 6-Month Follow-up|Lost to Follow-up|0
2456339|NCT02571452|8464868|P1|Overall Study 6-Month Follow-up|Lost to Follow-up|4
2456340|NCT02571452|8464867|P2|Overall Study Treatment|Protocol Violation|1
2456341|NCT02571452|8464868|P1|Overall Study Treatment|Protocol Violation|0
2456342|NCT02571244|8464909|P2|Overall Study|Unable to reach out post discharge|0
2456343|NCT02571244|8464910|P1|Overall Study|Unable to reach out post discharge|3
2456344|NCT02571244|8464909|P2|Overall Study|Lost to Follow-up|1
2456345|NCT02571244|8464910|P1|Overall Study|Lost to Follow-up|0
2456346|NCT02571075|8464968|P2|Overall Study|Lost to Follow-up|24
2456347|NCT02571075|8464969|P1|Overall Study|Lost to Follow-up|20
2456348|NCT02571049|8464983|P2|Randomization|Adverse Event|1
2456349|NCT02571049|8464984|P1|Randomization|Adverse Event|0
2456350|NCT02571049|8464983|P2|Randomization|No migraine attack|1
2456351|NCT02571049|8464984|P1|Randomization|No migraine attack|0
2456352|NCT02571049|8464983|P2|Screening|Did not meet entry criteria|2
2456353|NCT02571049|8464984|P1|Screening|Did not meet entry criteria|2
2456354|NCT02570750|8464992|P2|Overall Study|Adverse Event|1
2456355|NCT02570750|8464993|P1|Overall Study|Adverse Event|2
2456356|NCT02570750|8464992|P2|Overall Study|Lost to Follow-up|2
2456357|NCT02570750|8464993|P1|Overall Study|Lost to Follow-up|2
2456358|NCT02570750|8464992|P2|Overall Study|Withdrawal by Subject|0
2456359|NCT02570750|8464993|P1|Overall Study|Withdrawal by Subject|5
2456360|NCT02570750|8464992|P2|Overall Study|Protocol deviation|2
2456361|NCT02570750|8464993|P1|Overall Study|Protocol deviation|4
2456362|NCT02570750|8464992|P2|Overall Study|Inclusion/exclusion criteria deviation|0
2456363|NCT02570750|8464993|P1|Overall Study|Inclusion/exclusion criteria deviation|1
2456364|NCT02570711|8465011|P2|Overall Study|Early Termination of Study by Sponsor|2
2456365|NCT02570711|8465012|P1|Overall Study|Early Termination of Study by Sponsor|0
2456366|NCT02570711|8465011|P2|Overall Study|Death|0
2456367|NCT02570711|8465012|P1|Overall Study|Death|1
2456368|NCT02570165|8465100|P7|Overall Study|Withdrawal Request by GSK|0
2456369|NCT02570165|8465101|P6|Overall Study|Withdrawal Request by GSK|0
2456370|NCT02570165|8465102|P5|Overall Study|Withdrawal Request by GSK|0
2456371|NCT02570165|8465103|P4|Overall Study|Withdrawal Request by GSK|0
2456372|NCT02570165|8465104|P3|Overall Study|Withdrawal Request by GSK|2
2456373|NCT02570165|8465105|P2|Overall Study|Withdrawal Request by GSK|0
2456374|NCT02570165|8465106|P1|Overall Study|Withdrawal Request by GSK|0
2456375|NCT02570165|8465100|P7|Overall Study|Par. did not Meet Continuation Criteria|0
2456376|NCT02570165|8465101|P6|Overall Study|Par. did not Meet Continuation Criteria|1
2456377|NCT02570165|8465102|P5|Overall Study|Par. did not Meet Continuation Criteria|0
2456378|NCT02570165|8465103|P4|Overall Study|Par. did not Meet Continuation Criteria|0
2456379|NCT02570165|8465104|P3|Overall Study|Par. did not Meet Continuation Criteria|0
2456380|NCT02570165|8465105|P2|Overall Study|Par. did not Meet Continuation Criteria|0
2456381|NCT02570165|8465106|P1|Overall Study|Par. did not Meet Continuation Criteria|0
2456382|NCT02570165|8465100|P7|Overall Study|Withdrawal by Subject|0
2456383|NCT02570165|8465101|P6|Overall Study|Withdrawal by Subject|0
2456384|NCT02570165|8465102|P5|Overall Study|Withdrawal by Subject|1
2456385|NCT02570165|8465103|P4|Overall Study|Withdrawal by Subject|2
2456386|NCT02570165|8465104|P3|Overall Study|Withdrawal by Subject|0
2456387|NCT02570165|8465105|P2|Overall Study|Withdrawal by Subject|0
2456388|NCT02570165|8465106|P1|Overall Study|Withdrawal by Subject|0
2456389|NCT02570165|8465100|P7|Overall Study|Physician Decision|0
2456390|NCT02570165|8465101|P6|Overall Study|Physician Decision|0
2456391|NCT02570165|8465102|P5|Overall Study|Physician Decision|0
2456392|NCT02570165|8465103|P4|Overall Study|Physician Decision|0
2456393|NCT02570165|8465104|P3|Overall Study|Physician Decision|0
2456394|NCT02570165|8465105|P2|Overall Study|Physician Decision|1
2456395|NCT02570165|8465106|P1|Overall Study|Physician Decision|0
2456396|NCT02570165|8465100|P7|Overall Study|Lost to Follow-up|0
2456397|NCT02570165|8465101|P6|Overall Study|Lost to Follow-up|0
2456398|NCT02570165|8465102|P5|Overall Study|Lost to Follow-up|0
2456399|NCT02570165|8465103|P4|Overall Study|Lost to Follow-up|1
2456400|NCT02570165|8465104|P3|Overall Study|Lost to Follow-up|1
2456401|NCT02570165|8465105|P2|Overall Study|Lost to Follow-up|0
2456402|NCT02570165|8465106|P1|Overall Study|Lost to Follow-up|0
2456403|NCT02570165|8465100|P7|Overall Study|Par. Reached Stopping Criteria|0
2456404|NCT02570165|8465101|P6|Overall Study|Par. Reached Stopping Criteria|1
2456405|NCT02570165|8465102|P5|Overall Study|Par. Reached Stopping Criteria|1
2456406|NCT02570165|8465103|P4|Overall Study|Par. Reached Stopping Criteria|2
2456407|NCT02570165|8465104|P3|Overall Study|Par. Reached Stopping Criteria|0
2456408|NCT02570165|8465105|P2|Overall Study|Par. Reached Stopping Criteria|1
2456409|NCT02570165|8465106|P1|Overall Study|Par. Reached Stopping Criteria|1
2456410|NCT02570165|8465100|P7|Overall Study|Lack of Efficacy|0
2456411|NCT02570165|8465101|P6|Overall Study|Lack of Efficacy|0
2456412|NCT02570165|8465102|P5|Overall Study|Lack of Efficacy|4
2456413|NCT02570165|8465103|P4|Overall Study|Lack of Efficacy|0
2456414|NCT02570165|8465104|P3|Overall Study|Lack of Efficacy|0
2456415|NCT02570165|8465105|P2|Overall Study|Lack of Efficacy|1
2456416|NCT02570165|8465106|P1|Overall Study|Lack of Efficacy|0
2456417|NCT02570165|8465100|P7|Overall Study|Adverse Event|0
2456418|NCT02570165|8465101|P6|Overall Study|Adverse Event|0
2456419|NCT02570165|8465102|P5|Overall Study|Adverse Event|0
2456420|NCT02570165|8465103|P4|Overall Study|Adverse Event|0
2456421|NCT02570165|8465104|P3|Overall Study|Adverse Event|2
2456422|NCT02570165|8465105|P2|Overall Study|Adverse Event|0
2456423|NCT02570165|8465106|P1|Overall Study|Adverse Event|1
2456424|NCT02570126|8465146|P2|Overall Study|Withdrawal by Subject|7
2456425|NCT02570126|8465147|P1|Overall Study|Withdrawal by Subject|3
2456426|NCT02570126|8465146|P2|Overall Study|Protocol Violation|1
2456427|NCT02570126|8465147|P1|Overall Study|Protocol Violation|0
2456428|NCT02570126|8465146|P2|Overall Study|Violation Of Procedures GSK|1
2456429|NCT02570126|8465147|P1|Overall Study|Violation Of Procedures GSK|0
2456430|NCT02570126|8465146|P2|Overall Study|Unable To Arrange Visit 3|0
2456431|NCT02570126|8465147|P1|Overall Study|Unable To Arrange Visit 3|1
2456432|NCT02570126|8465146|P2|Overall Study|Lost to Follow-up|0
2456433|NCT02570126|8465147|P1|Overall Study|Lost to Follow-up|2
2456434|NCT02570074|8465173|P2|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0
2456435|NCT02570074|8465174|P1|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1
2456436|NCT02569996|8465243|P1|Overall Study|Unknown reason|1
2456437|NCT02569996|8465243|P1|Overall Study|Complete remission|7
2456438|NCT02569996|8465243|P1|Overall Study|Lost to Follow-up|5
2456439|NCT02569996|8465243|P1|Overall Study|Withdrawal by Subject|5
2456440|NCT02569996|8465243|P1|Overall Study|Non-compliance|9
2456441|NCT02569996|8465243|P1|Overall Study|New anti-lymphoma treatment|1
2456442|NCT02569996|8465243|P1|Overall Study|Progression of the disease|18
2456443|NCT02569996|8465243|P1|Overall Study|Physician Decision|3
2456444|NCT02569996|8465243|P1|Overall Study|Adverse Event|6
2456445|NCT02569957|8465255|P2|Overall Study|Withdrawal by Subject|1
2456446|NCT02569957|8465256|P1|Overall Study|Withdrawal by Subject|0
2456447|NCT02569853|8465288|P2|Overall Study|Physician Decision|1
2456448|NCT02569853|8465289|P1|Overall Study|Physician Decision|1
2456449|NCT02569853|8465288|P2|Overall Study|Did not experience migraine attack|7
2456450|NCT02569853|8465289|P1|Overall Study|Did not experience migraine attack|10
2456451|NCT02569853|8465288|P2|Overall Study|Protocol Violation|1
2456452|NCT02569853|8465289|P1|Overall Study|Protocol Violation|1
2456453|NCT02569853|8465288|P2|Overall Study|Lost to Follow-up|3
2456454|NCT02569853|8465289|P1|Overall Study|Lost to Follow-up|3
2456455|NCT02569853|8465288|P2|Overall Study|Withdrawal by Subject|2
2456456|NCT02569853|8465289|P1|Overall Study|Withdrawal by Subject|3
2456457|NCT02569853|8465288|P2|Overall Study|Adverse Event|0
2456458|NCT02569853|8465289|P1|Overall Study|Adverse Event|2
2456459|NCT02569710|8465307|P10|Overall Study|Withdrawal by Subject|0
2456460|NCT02569710|8465308|P9|Overall Study|Withdrawal by Subject|0
2456461|NCT02569710|8465309|P8|Overall Study|Withdrawal by Subject|0
2456462|NCT02569710|8465310|P7|Overall Study|Withdrawal by Subject|0
2456463|NCT02569710|8465311|P6|Overall Study|Withdrawal by Subject|1
2456464|NCT02569710|8465312|P5|Overall Study|Withdrawal by Subject|0
2456465|NCT02569710|8465313|P4|Overall Study|Withdrawal by Subject|0
2456466|NCT02569710|8465314|P3|Overall Study|Withdrawal by Subject|0
2456467|NCT02569710|8465315|P2|Overall Study|Withdrawal by Subject|0
2456468|NCT02569710|8465316|P1|Overall Study|Withdrawal by Subject|0
2456469|NCT02569710|8465307|P10|Overall Study|Virologic failure|0
2456470|NCT02569710|8465308|P9|Overall Study|Virologic failure|0
2456471|NCT02569710|8465309|P8|Overall Study|Virologic failure|0
2456472|NCT02569710|8465310|P7|Overall Study|Virologic failure|1
2456473|NCT02569710|8465311|P6|Overall Study|Virologic failure|0
2456474|NCT02569710|8465312|P5|Overall Study|Virologic failure|1
2456475|NCT02569710|8465313|P4|Overall Study|Virologic failure|0
2456476|NCT02569710|8465314|P3|Overall Study|Virologic failure|0
2456477|NCT02569710|8465315|P2|Overall Study|Virologic failure|0
2456478|NCT02569710|8465316|P1|Overall Study|Virologic failure|0
2456479|NCT02569710|8465307|P10|Overall Study|Lost to Follow-up|0
2456480|NCT02569710|8465308|P9|Overall Study|Lost to Follow-up|1
2456481|NCT02569710|8465309|P8|Overall Study|Lost to Follow-up|0
2456482|NCT02569710|8465310|P7|Overall Study|Lost to Follow-up|1
2456483|NCT02569710|8465311|P6|Overall Study|Lost to Follow-up|0
2456484|NCT02569710|8465312|P5|Overall Study|Lost to Follow-up|0
2456485|NCT02569710|8465313|P4|Overall Study|Lost to Follow-up|0
2456486|NCT02569710|8465314|P3|Overall Study|Lost to Follow-up|0
2456487|NCT02569710|8465315|P2|Overall Study|Lost to Follow-up|0
2456488|NCT02569710|8465316|P1|Overall Study|Lost to Follow-up|0
2456489|NCT02569710|8465307|P10|Overall Study|Adverse Event|0
2456490|NCT02569710|8465308|P9|Overall Study|Adverse Event|0
2456491|NCT02569710|8465309|P8|Overall Study|Adverse Event|0
2456492|NCT02569710|8465310|P7|Overall Study|Adverse Event|0
2456493|NCT02569710|8465311|P6|Overall Study|Adverse Event|0
2456494|NCT02569710|8465312|P5|Overall Study|Adverse Event|0
2456495|NCT02569710|8465313|P4|Overall Study|Adverse Event|0
2456496|NCT02569710|8465314|P3|Overall Study|Adverse Event|0
2456497|NCT02569710|8465315|P2|Overall Study|Adverse Event|0
2456498|NCT02569710|8465316|P1|Overall Study|Adverse Event|1
2456499|NCT02569437|8465656|P2|Overall Study|Lost to Follow-up|14
2456500|NCT02569437|8465657|P1|Overall Study|Lost to Follow-up|12
2456501|NCT02569398|8465674|P3|Overall Study|Other|13
2456502|NCT02569398|8465675|P2|Overall Study|Other|14
2456503|NCT02569398|8465676|P1|Overall Study|Other|12
2456504|NCT02569398|8465674|P3|Overall Study|Study terminated by sponsor|134
2456505|NCT02569398|8465675|P2|Overall Study|Study terminated by sponsor|131
2456506|NCT02569398|8465676|P1|Overall Study|Study terminated by sponsor|130
2456507|NCT02569398|8465674|P3|Overall Study|Withdrawal by Subject|30
2456508|NCT02569398|8465675|P2|Overall Study|Withdrawal by Subject|43
2456509|NCT02569398|8465676|P1|Overall Study|Withdrawal by Subject|43
2456510|NCT02569398|8465674|P3|Overall Study|Adverse Event|6
2456511|NCT02569398|8465675|P2|Overall Study|Adverse Event|1
2456512|NCT02569398|8465676|P1|Overall Study|Adverse Event|0
2456513|NCT02568683|8465751|P2|Overall Study|Study Terminated By Sponsor|2
2456514|NCT02568683|8465752|P1|Overall Study|Study Terminated By Sponsor|5
2456515|NCT02568683|8465751|P2|Overall Study|Withdrew Consent|0
2456516|NCT02568683|8465752|P1|Overall Study|Withdrew Consent|1
2456517|NCT02568683|8465751|P2|Overall Study|Death|2
2456518|NCT02568683|8465752|P1|Overall Study|Death|0
2456519|NCT02568397|8465779|P2|Period 2|Physician Decision|1
2456520|NCT02568397|8465780|P1|Period 2|Physician Decision|0
2456521|NCT02568397|8465779|P2|Period 2|Withdrawal by Subject|1
2456522|NCT02568397|8465780|P1|Period 2|Withdrawal by Subject|0
2456523|NCT02568384|8465804|P1|Overall Study|Mobile devices incompatible with App|2
2456524|NCT02568254|8465818|P6|Period 3|Unstatisfactory Lens fitting|0
2456525|NCT02568254|8465819|P5|Period 3|Unstatisfactory Lens fitting|1
2456526|NCT02568254|8465820|P4|Period 3|Unstatisfactory Lens fitting|0
2456527|NCT02568254|8465821|P3|Period 3|Unstatisfactory Lens fitting|0
2456528|NCT02568254|8465822|P2|Period 3|Unstatisfactory Lens fitting|0
2456529|NCT02568254|8465823|P1|Period 3|Unstatisfactory Lens fitting|0
2456530|NCT02568254|8465818|P6|Period 2|Adverse Event|0
2456531|NCT02568254|8465819|P5|Period 2|Adverse Event|0
2456532|NCT02568254|8465820|P4|Period 2|Adverse Event|0
2456533|NCT02568254|8465821|P3|Period 2|Adverse Event|1
2456534|NCT02568254|8465822|P2|Period 2|Adverse Event|0
2456535|NCT02568254|8465823|P1|Period 2|Adverse Event|0
2456536|NCT02568046|8465833|P2|Overall Study|Other Events|1
2456537|NCT02568046|8465834|P1|Overall Study|Other Events|0
2456538|NCT02568046|8465833|P2|Overall Study|Withdrawal by Subject|1
2456539|NCT02568046|8465834|P1|Overall Study|Withdrawal by Subject|2
2456540|NCT02568046|8465833|P2|Overall Study|Progressive Disease|0
2456541|NCT02568046|8465834|P1|Overall Study|Progressive Disease|1
2456542|NCT02568046|8465833|P2|Overall Study|Death|0
2456543|NCT02568046|8465834|P1|Overall Study|Death|2
2456544|NCT02568046|8465833|P2|Overall Study|Adverse Event|1
2456545|NCT02568046|8465834|P1|Overall Study|Adverse Event|0
2456546|NCT02567708|8465897|P2|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3
2456547|NCT02567708|8465898|P1|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0
2456548|NCT02567708|8465897|P2|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0
2456549|NCT02567708|8465898|P1|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2
2456550|NCT02567708|8465897|P2|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1
2456551|NCT02567708|8465898|P1|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0
2456552|NCT02567708|8465897|P2|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2
2456553|NCT02567708|8465898|P1|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
2456554|NCT02567656|8465943|P6|Overall Study|Premature discontinuation due to PD|0
2456555|NCT02567656|8465944|P5|Overall Study|Premature discontinuation due to PD|0
2456556|NCT02567656|8465945|P4|Overall Study|Premature discontinuation due to PD|0
2456557|NCT02567656|8465946|P3|Overall Study|Premature discontinuation due to PD|2
2456558|NCT02567656|8465947|P2|Overall Study|Premature discontinuation due to PD|1
2456559|NCT02567656|8465948|P1|Overall Study|Premature discontinuation due to PD|1
2456560|NCT02567552|8465980|P2|Overall Study|Adverse Event|1
2456561|NCT02567552|8465981|P1|Overall Study|Adverse Event|0
2456562|NCT02567188|8466011|P1|Overall Study|Protocol Violation|5
2456563|NCT02567188|8466011|P1|Overall Study|Started Hemodialysis|2
2456564|NCT02567188|8466011|P1|Overall Study|Moved and Changed Clinic|1
2456565|NCT02567188|8466011|P1|Overall Study|Refused Treatment/ Did not Cooperate|1
2456566|NCT02567188|8466011|P1|Overall Study|Withdrawal by Subject|1
2456567|NCT02567188|8466011|P1|Overall Study|Adverse Event|1
2456568|NCT02567188|8466011|P1|Overall Study|Lost to Follow-up|5
2456569|NCT02567188|8466011|P1|Overall Study|Terminated Mircera Treatment|9
2456570|NCT02567188|8466011|P1|Overall Study|Death|10
2456571|NCT02566785|8466042|P2|Overall Study|Worsening condition|1
2456572|NCT02566785|8466043|P1|Overall Study|Worsening condition|1
2456573|NCT02566785|8466042|P2|Overall Study|Lost to Follow-up|2
2456574|NCT02566785|8466043|P1|Overall Study|Lost to Follow-up|0
2456575|NCT02566759|8466070|P17|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1
2456576|NCT02566759|8466071|P16|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2456577|NCT02566759|8466072|P15|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2456578|NCT02566759|8466073|P14|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2456579|NCT02566759|8466074|P13|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2456580|NCT02566759|8466075|P12|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2456581|NCT02566759|8466076|P11|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2456582|NCT02566759|8466077|P10|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2456583|NCT02566759|8466078|P9|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2456584|NCT02566759|8466079|P8|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2456585|NCT02566759|8466080|P7|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2456586|NCT02566759|8466081|P6|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2456587|NCT02566759|8466082|P5|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2456588|NCT02566759|8466083|P4|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2456589|NCT02566759|8466084|P3|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2456590|NCT02566759|8466085|P2|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2456591|NCT02566759|8466086|P1|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
2456592|NCT02566759|8466070|P17|All Parts|Other|0
2456593|NCT02566759|8466071|P16|All Parts|Other|0
2456594|NCT02566759|8466072|P15|All Parts|Other|0
2456595|NCT02566759|8466073|P14|All Parts|Other|2
2456596|NCT02566759|8466074|P13|All Parts|Other|0
2456597|NCT02566759|8466075|P12|All Parts|Other|0
2456598|NCT02566759|8466076|P11|All Parts|Other|0
2456599|NCT02566759|8466077|P10|All Parts|Other|0
2456600|NCT02566759|8466078|P9|All Parts|Other|0
2456601|NCT02566759|8466079|P8|All Parts|Other|0
2456602|NCT02566759|8466080|P7|All Parts|Other|0
2456603|NCT02566759|8466081|P6|All Parts|Other|0
2456604|NCT02566759|8466082|P5|All Parts|Other|0
2456605|NCT02566759|8466083|P4|All Parts|Other|0
2456606|NCT02566759|8466084|P3|All Parts|Other|0
2456607|NCT02566759|8466085|P2|All Parts|Other|0
2456608|NCT02566759|8466086|P1|All Parts|Other|0
2456609|NCT02566759|8466070|P17|All Parts|Adverse Event|0
2456610|NCT02566759|8466071|P16|All Parts|Adverse Event|0
2456611|NCT02566759|8466072|P15|All Parts|Adverse Event|0
2456612|NCT02566759|8466073|P14|All Parts|Adverse Event|3
2456613|NCT02566759|8466074|P13|All Parts|Adverse Event|1
2456614|NCT02566759|8466075|P12|All Parts|Adverse Event|0
2456615|NCT02566759|8466076|P11|All Parts|Adverse Event|0
2456616|NCT02566759|8466077|P10|All Parts|Adverse Event|0
2456617|NCT02566759|8466078|P9|All Parts|Adverse Event|0
2456618|NCT02566759|8466079|P8|All Parts|Adverse Event|0
2456619|NCT02566759|8466080|P7|All Parts|Adverse Event|0
2456620|NCT02566759|8466081|P6|All Parts|Adverse Event|0
2456621|NCT02566759|8466082|P5|All Parts|Adverse Event|0
2456622|NCT02566759|8466083|P4|All Parts|Adverse Event|0
2456623|NCT02566759|8466084|P3|All Parts|Adverse Event|0
2456624|NCT02566759|8466085|P2|All Parts|Adverse Event|0
2456625|NCT02566759|8466086|P1|All Parts|Adverse Event|0
2456626|NCT02566759|8466070|P17|All Parts|Withdrawal by Subject|0
2456627|NCT02566759|8466071|P16|All Parts|Withdrawal by Subject|0
2456628|NCT02566759|8466072|P15|All Parts|Withdrawal by Subject|0
2456629|NCT02566759|8466073|P14|All Parts|Withdrawal by Subject|0
2456630|NCT02566759|8466074|P13|All Parts|Withdrawal by Subject|0
2456631|NCT02566759|8466075|P12|All Parts|Withdrawal by Subject|0
2456632|NCT02566759|8466076|P11|All Parts|Withdrawal by Subject|0
2456633|NCT02566759|8466077|P10|All Parts|Withdrawal by Subject|0
2456634|NCT02566759|8466078|P9|All Parts|Withdrawal by Subject|0
2456635|NCT02566759|8466079|P8|All Parts|Withdrawal by Subject|0
2456636|NCT02566759|8466080|P7|All Parts|Withdrawal by Subject|0
2456637|NCT02566759|8466081|P6|All Parts|Withdrawal by Subject|0
2456638|NCT02566759|8466082|P5|All Parts|Withdrawal by Subject|0
2456639|NCT02566759|8466083|P4|All Parts|Withdrawal by Subject|0
2456640|NCT02566759|8466084|P3|All Parts|Withdrawal by Subject|0
2456641|NCT02566759|8466085|P2|All Parts|Withdrawal by Subject|1
2456642|NCT02566759|8466086|P1|All Parts|Withdrawal by Subject|0
2456643|NCT02566577|8466248|P2|Overall Study|Physical limitation|0
2456644|NCT02566577|8466249|P1|Overall Study|Physical limitation|1
2456645|NCT02566577|8466248|P2|Overall Study|Equipment failure|1
2456646|NCT02566577|8466249|P1|Overall Study|Equipment failure|1
2456647|NCT02566577|8466248|P2|Overall Study|Withdrawal by Subject|1
2456648|NCT02566577|8466249|P1|Overall Study|Withdrawal by Subject|1
2456649|NCT02566109|8466329|P1|Overall Study|Withdrawal by Subject|1
2456650|NCT02566031|8466393|P2|Overall Study|Lost to Follow-up|1
2456651|NCT02566031|8466394|P1|Overall Study|Lost to Follow-up|1
2456652|NCT02566031|8466393|P2|Overall Study|Adverse Event|1
2456653|NCT02566031|8466394|P1|Overall Study|Adverse Event|3
2456654|NCT02566031|8466393|P2|Overall Study|Protocol deviation|3
2456655|NCT02566031|8466394|P1|Overall Study|Protocol deviation|2
2456656|NCT02566031|8466393|P2|Overall Study|Patient/guardian decision|7
2456657|NCT02566031|8466394|P1|Overall Study|Patient/guardian decision|14
2456658|NCT02566005|8466411|P2|Overall Study|labor after randomization|4
2456659|NCT02566005|8466412|P1|Overall Study|labor after randomization|0
2456660|NCT02566005|8466411|P2|Overall Study|did not receive foley|1
2456661|NCT02566005|8466412|P1|Overall Study|did not receive foley|0
2456662|NCT02566005|8466411|P2|Overall Study|received foley|0
2456663|NCT02566005|8466412|P1|Overall Study|received foley|8
2456664|NCT02566005|8466411|P2|Overall Study|vaginal bleeding|1
2456665|NCT02566005|8466412|P1|Overall Study|vaginal bleeding|0
2456666|NCT02565810|8466440|P1|Overall Study|Withdrawal by Subject|1
2456667|NCT02565784|8466449|P1|Second Treatment|Withdrawal by Subject|2
2456668|NCT02565784|8466449|P1|First Treatment|Withdrawal by Subject|1
2456669|NCT02565784|8466449|P1|First Treatment|Adverse Event|1
2456670|NCT02565706|8466461|P4|Overall Study|Lost to Follow-up|74
2456671|NCT02565706|8466462|P3|Overall Study|Lost to Follow-up|82
2456672|NCT02565706|8466463|P2|Overall Study|Lost to Follow-up|75
2456673|NCT02565706|8466464|P1|Overall Study|Lost to Follow-up|72
2456674|NCT02565706|8466461|P4|Overall Study|Withdrawal by Subject|11
2456675|NCT02565706|8466462|P3|Overall Study|Withdrawal by Subject|7
2456676|NCT02565706|8466463|P2|Overall Study|Withdrawal by Subject|7
2456677|NCT02565706|8466464|P1|Overall Study|Withdrawal by Subject|5
2456678|NCT02565615|8466570|P5|Overall Study|Untreated|567
2456679|NCT02565615|8466571|P4|Overall Study|Untreated|0
2456680|NCT02565615|8466572|P3|Overall Study|Untreated|0
2456681|NCT02565615|8466573|P2|Overall Study|Untreated|0
2456682|NCT02565615|8466574|P1|Overall Study|Untreated|0
2456683|NCT02565615|8466570|P5|Overall Study|Adverse Event|9
2456684|NCT02565615|8466571|P4|Overall Study|Adverse Event|0
2456685|NCT02565615|8466572|P3|Overall Study|Adverse Event|0
2456686|NCT02565615|8466573|P2|Overall Study|Adverse Event|1
2456687|NCT02565615|8466574|P1|Overall Study|Adverse Event|1
2456688|NCT02565615|8466570|P5|Overall Study|Reason not defined|62
2456689|NCT02565615|8466571|P4|Overall Study|Reason not defined|1
2456690|NCT02565615|8466572|P3|Overall Study|Reason not defined|0
2456691|NCT02565615|8466573|P2|Overall Study|Reason not defined|2
2456692|NCT02565615|8466574|P1|Overall Study|Reason not defined|0
2456693|NCT02565615|8466570|P5|Overall Study|Not meeting eligibility criteria|25
2456694|NCT02565615|8466571|P4|Overall Study|Not meeting eligibility criteria|0
2456695|NCT02565615|8466572|P3|Overall Study|Not meeting eligibility criteria|0
2456696|NCT02565615|8466573|P2|Overall Study|Not meeting eligibility criteria|7
2456697|NCT02565615|8466574|P1|Overall Study|Not meeting eligibility criteria|0
2456698|NCT02565615|8466570|P5|Overall Study|Lost to Follow-up|765
2456699|NCT02565615|8466571|P4|Overall Study|Lost to Follow-up|1
2456700|NCT02565615|8466572|P3|Overall Study|Lost to Follow-up|0
2456701|NCT02565615|8466573|P2|Overall Study|Lost to Follow-up|4
2456702|NCT02565615|8466574|P1|Overall Study|Lost to Follow-up|0
2456703|NCT02565615|8466570|P5|Overall Study|Not willing to participate in study|169
2456704|NCT02565615|8466571|P4|Overall Study|Not willing to participate in study|1
2456705|NCT02565615|8466572|P3|Overall Study|Not willing to participate in study|0
2456706|NCT02565615|8466573|P2|Overall Study|Not willing to participate in study|21
2456707|NCT02565615|8466574|P1|Overall Study|Not willing to participate in study|2
2456708|NCT02565615|8466570|P5|Overall Study|Death|4
2456709|NCT02565615|8466571|P4|Overall Study|Death|0
2456710|NCT02565615|8466572|P3|Overall Study|Death|0
2456711|NCT02565615|8466573|P2|Overall Study|Death|1
2456712|NCT02565615|8466574|P1|Overall Study|Death|0
2456713|NCT02565576|8466688|P2|Overall Study|Adverse Event|0
2456714|NCT02565576|8466689|P1|Overall Study|Adverse Event|1
2456715|NCT02565576|8466688|P2|Overall Study|Death|2
2456716|NCT02565576|8466689|P1|Overall Study|Death|0
2456717|NCT02565576|8466688|P2|Overall Study|Lost to Follow-up|0
2456718|NCT02565576|8466689|P1|Overall Study|Lost to Follow-up|1
2456719|NCT02565576|8466688|P2|Overall Study|subject / guardian decision|3
2456720|NCT02565576|8466689|P1|Overall Study|subject / guardian decision|1
2456721|NCT02565576|8466688|P2|Overall Study|abnormal lab value|0
2456722|NCT02565576|8466689|P1|Overall Study|abnormal lab value|2
2456723|NCT02565381|8466732|P3|Overall Study|Lost to Follow-up|1
2456724|NCT02565381|8466733|P2|Overall Study|Lost to Follow-up|0
2456725|NCT02565381|8466734|P1|Overall Study|Lost to Follow-up|1
2456726|NCT02565147|8466774|P2|Overall Study|Death|1
2456727|NCT02565147|8466775|P1|Overall Study|Death|1
2456728|NCT02565147|8466774|P2|Overall Study|Lost to Follow-up|1
2456729|NCT02565147|8466775|P1|Overall Study|Lost to Follow-up|0
2456730|NCT02565147|8466774|P2|Overall Study|Withdrawal by Subject|1
2456731|NCT02565147|8466775|P1|Overall Study|Withdrawal by Subject|5
2456732|NCT02565108|8466799|P2|Overall Study|Withdrew Consent|0
2456733|NCT02565108|8466800|P1|Overall Study|Withdrew Consent|1
2456734|NCT02565108|8466799|P2|Overall Study|Adverse Event|0
2456735|NCT02565108|8466800|P1|Overall Study|Adverse Event|1
2456736|NCT02564952|8466816|P1|Overall Study|Participant Met Withdrawal Criteria|1
2456737|NCT02564952|8466816|P1|Overall Study|Low Efficacy|1
2456738|NCT02564952|8466816|P1|Overall Study|Withdrawal by Subject|1
2456739|NCT02564952|8466816|P1|Overall Study|Participant Withdrawn by Investigator|1
2456740|NCT02564952|8466816|P1|Overall Study|Lost to Follow-up|1
2456741|NCT02564952|8466816|P1|Overall Study|Adverse Event|6
2456742|NCT02564887|8466861|P2|Overall Study|Lost to Follow-up|0
2456743|NCT02564887|8466862|P1|Overall Study|Lost to Follow-up|6
2456744|NCT02564718|8466880|P2|Overall Study|Withdrew from treatment|1
2456745|NCT02564718|8466881|P1|Overall Study|Withdrew from treatment|0
2456746|NCT02564263|8466938|P2|Overall Study|Ongoing in Study|25
2456747|NCT02564263|8466939|P1|Overall Study|Ongoing in Study|42
2456748|NCT02564263|8466938|P2|Overall Study|Withdrawal by Subject|18
2456749|NCT02564263|8466939|P1|Overall Study|Withdrawal by Subject|5
2456750|NCT02564263|8466938|P2|Overall Study|Death|242
2456751|NCT02564263|8466939|P1|Overall Study|Death|236
2456752|NCT02564263|8466938|P2|Overall Study|Adverse Event|29
2456753|NCT02564263|8466939|P1|Overall Study|Adverse Event|31
2456754|NCT02564211|8466961|P1|Overall Study|Adverse Event|4
2456755|NCT02564120|8466972|P1|Overall Study|Other medical condition|24
2456756|NCT02564120|8466972|P1|Overall Study|Withdrawal by Subject|204
2456757|NCT02564120|8466972|P1|Overall Study|Death|58
2456758|NCT02564120|8466972|P1|Overall Study|Did not return release forms|160
2456759|NCT02564055|8467020|P6|Overall Study|Withdrawal by Subject|10
2456760|NCT02564055|8467021|P5|Overall Study|Withdrawal by Subject|10
2456761|NCT02564055|8467022|P4|Overall Study|Withdrawal by Subject|3
2456762|NCT02564055|8467023|P3|Overall Study|Withdrawal by Subject|3
2456763|NCT02564055|8467024|P2|Overall Study|Withdrawal by Subject|4
2456764|NCT02564055|8467025|P1|Overall Study|Withdrawal by Subject|4
2456765|NCT02564055|8467020|P6|Overall Study|Physician Decision|0
2456766|NCT02564055|8467021|P5|Overall Study|Physician Decision|0
2456767|NCT02564055|8467022|P4|Overall Study|Physician Decision|0
2456768|NCT02564055|8467023|P3|Overall Study|Physician Decision|1
2456769|NCT02564055|8467024|P2|Overall Study|Physician Decision|0
2456770|NCT02564055|8467025|P1|Overall Study|Physician Decision|0
2456771|NCT02564055|8467020|P6|Overall Study|Lost to Follow-up|0
2456772|NCT02564055|8467021|P5|Overall Study|Lost to Follow-up|1
2456773|NCT02564055|8467022|P4|Overall Study|Lost to Follow-up|2
2456774|NCT02564055|8467023|P3|Overall Study|Lost to Follow-up|4
2456775|NCT02564055|8467024|P2|Overall Study|Lost to Follow-up|1
2456776|NCT02564055|8467025|P1|Overall Study|Lost to Follow-up|0
2456777|NCT02564055|8467020|P6|Overall Study|Reached stopping criteria|1
2456778|NCT02564055|8467021|P5|Overall Study|Reached stopping criteria|0
2456779|NCT02564055|8467022|P4|Overall Study|Reached stopping criteria|0
2456780|NCT02564055|8467023|P3|Overall Study|Reached stopping criteria|0
2456781|NCT02564055|8467024|P2|Overall Study|Reached stopping criteria|0
2456782|NCT02564055|8467025|P1|Overall Study|Reached stopping criteria|0
2456783|NCT02564055|8467020|P6|Overall Study|Protocol Violation|0
2456784|NCT02564055|8467021|P5|Overall Study|Protocol Violation|0
2456785|NCT02564055|8467022|P4|Overall Study|Protocol Violation|0
2456786|NCT02564055|8467023|P3|Overall Study|Protocol Violation|0
2456787|NCT02564055|8467024|P2|Overall Study|Protocol Violation|0
2456788|NCT02564055|8467025|P1|Overall Study|Protocol Violation|1
2456789|NCT02564055|8467020|P6|Overall Study|Adverse Event|1
2456790|NCT02564055|8467021|P5|Overall Study|Adverse Event|4
2456791|NCT02564055|8467022|P4|Overall Study|Adverse Event|1
2456792|NCT02564055|8467023|P3|Overall Study|Adverse Event|4
2456793|NCT02564055|8467024|P2|Overall Study|Adverse Event|0
2456794|NCT02564055|8467025|P1|Overall Study|Adverse Event|1
2456795|NCT02564042|8467279|P6|Overall Study|Withdrawal by Subject|12
2456796|NCT02564042|8467280|P5|Overall Study|Withdrawal by Subject|10
2456797|NCT02564042|8467281|P4|Overall Study|Withdrawal by Subject|2
2456798|NCT02564042|8467282|P3|Overall Study|Withdrawal by Subject|2
2456799|NCT02564042|8467283|P2|Overall Study|Withdrawal by Subject|3
2456800|NCT02564042|8467284|P1|Overall Study|Withdrawal by Subject|5
2456801|NCT02564042|8467279|P6|Overall Study|Physician Decision|0
2456802|NCT02564042|8467280|P5|Overall Study|Physician Decision|0
2456803|NCT02564042|8467281|P4|Overall Study|Physician Decision|1
2456804|NCT02564042|8467282|P3|Overall Study|Physician Decision|0
2456805|NCT02564042|8467283|P2|Overall Study|Physician Decision|0
2456806|NCT02564042|8467284|P1|Overall Study|Physician Decision|1
2456807|NCT02564042|8467279|P6|Overall Study|Lost to Follow-up|1
2456808|NCT02564042|8467280|P5|Overall Study|Lost to Follow-up|1
2456809|NCT02564042|8467281|P4|Overall Study|Lost to Follow-up|0
2456810|NCT02564042|8467282|P3|Overall Study|Lost to Follow-up|1
2456811|NCT02564042|8467283|P2|Overall Study|Lost to Follow-up|1
2456812|NCT02564042|8467284|P1|Overall Study|Lost to Follow-up|1
2456813|NCT02564042|8467279|P6|Overall Study|Adverse Event|1
2456814|NCT02564042|8467280|P5|Overall Study|Adverse Event|0
2456815|NCT02564042|8467281|P4|Overall Study|Adverse Event|0
2456816|NCT02564042|8467282|P3|Overall Study|Adverse Event|3
2456817|NCT02564042|8467283|P2|Overall Study|Adverse Event|4
2456818|NCT02564042|8467284|P1|Overall Study|Adverse Event|4
2456819|NCT02563899|8467579|P4|Overall Study|Withdrawal by Subject|0
2456820|NCT02563899|8467580|P3|Overall Study|Withdrawal by Subject|1
2456821|NCT02563899|8467581|P2|Overall Study|Withdrawal by Subject|0
2456822|NCT02563899|8467582|P1|Overall Study|Withdrawal by Subject|0
2456823|NCT02563899|8467579|P4|Overall Study|Protocol Violation|0
2456824|NCT02563899|8467580|P3|Overall Study|Protocol Violation|0
2456825|NCT02563899|8467581|P2|Overall Study|Protocol Violation|0
2456826|NCT02563899|8467582|P1|Overall Study|Protocol Violation|1
2456827|NCT02563548|8467658|P6|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
2456828|NCT02563548|8467659|P5|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1
2456829|NCT02563548|8467660|P4|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
2456830|NCT02563548|8467661|P3|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
2456831|NCT02563548|8467662|P2|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
2456832|NCT02563548|8467663|P1|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
2456833|NCT02563548|8467658|P6|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1
2456834|NCT02563548|8467659|P5|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
2456835|NCT02563548|8467660|P4|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
2456836|NCT02563548|8467661|P3|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
2456837|NCT02563548|8467662|P2|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
2456838|NCT02563548|8467663|P1|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
2456839|NCT02563548|8467658|P6|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2
2456840|NCT02563548|8467659|P5|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
2456841|NCT02563548|8467660|P4|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
2456842|NCT02563548|8467661|P3|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
2456843|NCT02563548|8467662|P2|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
2456844|NCT02563548|8467663|P1|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
2456845|NCT02563548|8467658|P6|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2
2456846|NCT02563548|8467659|P5|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
2456847|NCT02563548|8467660|P4|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
2456848|NCT02563548|8467661|P3|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
2456849|NCT02563548|8467662|P2|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
2456850|NCT02563548|8467663|P1|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
2456851|NCT02563548|8467658|P6|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1
2456852|NCT02563548|8467659|P5|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2
2456853|NCT02563548|8467660|P4|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
2456854|NCT02563548|8467661|P3|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
2456855|NCT02563548|8467662|P2|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
2456856|NCT02563548|8467663|P1|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
2456857|NCT02563548|8467658|P6|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
2456858|NCT02563548|8467659|P5|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6
2456859|NCT02563548|8467660|P4|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
2456860|NCT02563548|8467661|P3|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
2456861|NCT02563548|8467662|P2|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
2456862|NCT02563548|8467663|P1|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
2456863|NCT02563548|8467658|P6|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3
2456864|NCT02563548|8467659|P5|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15
2456865|NCT02563548|8467660|P4|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
2456866|NCT02563548|8467661|P3|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
2456867|NCT02563548|8467662|P2|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
2456868|NCT02563548|8467663|P1|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
2456869|NCT02563548|8467658|P6|Dose Expansion (Up to 60 Weeks)|Adverse Event|8
2456870|NCT02563548|8467659|P5|Dose Expansion (Up to 60 Weeks)|Adverse Event|1
2456871|NCT02563548|8467660|P4|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
2456872|NCT02563548|8467661|P3|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
2456873|NCT02563548|8467662|P2|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
2456874|NCT02563548|8467663|P1|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
2456875|NCT02563548|8467658|P6|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
2456876|NCT02563548|8467659|P5|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
2456877|NCT02563548|8467660|P4|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1
2456878|NCT02563548|8467661|P3|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2
2456879|NCT02563548|8467662|P2|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
2456880|NCT02563548|8467663|P1|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
2456881|NCT02563548|8467658|P6|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
2456882|NCT02563548|8467659|P5|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
2456883|NCT02563548|8467660|P4|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
2456884|NCT02563548|8467661|P3|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3
2456885|NCT02563548|8467662|P2|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
2456886|NCT02563548|8467663|P1|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
2456887|NCT02563548|8467658|P6|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
2456888|NCT02563548|8467659|P5|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
2456889|NCT02563548|8467660|P4|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
2456890|NCT02563548|8467661|P3|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2
2456891|NCT02563548|8467662|P2|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2
2456892|NCT02563548|8467663|P1|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1
2456893|NCT02563548|8467658|P6|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
2456894|NCT02563548|8467659|P5|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
2456895|NCT02563548|8467660|P4|Dose Escalation (Up to 46 Weeks)|Adverse Event|1
2456896|NCT02563548|8467661|P3|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
2456897|NCT02563548|8467662|P2|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
2456898|NCT02563548|8467663|P1|Dose Escalation (Up to 46 Weeks)|Adverse Event|2
2456899|NCT02563106|8467727|P2|Overall Study|Other reason - not specified|1
2456900|NCT02563106|8467728|P1|Overall Study|Other reason - not specified|2
2456901|NCT02563106|8467727|P2|Overall Study|Physician Decision|1
2456902|NCT02563106|8467728|P1|Overall Study|Physician Decision|3
2456903|NCT02563106|8467727|P2|Overall Study|Lost to Follow-up|2
2456904|NCT02563106|8467728|P1|Overall Study|Lost to Follow-up|3
2456905|NCT02563106|8467727|P2|Overall Study|Use of non-permitted concurrent therapy|2
2456906|NCT02563106|8467728|P1|Overall Study|Use of non-permitted concurrent therapy|1
2456907|NCT02563106|8467727|P2|Overall Study|Protocol Violation|0
2456908|NCT02563106|8467728|P1|Overall Study|Protocol Violation|1
2456909|NCT02563106|8467727|P2|Overall Study|Adverse Event|15
2456910|NCT02563106|8467728|P1|Overall Study|Adverse Event|17
2456911|NCT02563106|8467727|P2|Overall Study|Withdrawal by Subject|8
2456912|NCT02563106|8467728|P1|Overall Study|Withdrawal by Subject|7
2456913|NCT02563028|8467767|P1|Overall Study|Unable to elicit VEP post induction|1
2456914|NCT02563028|8467767|P1|Overall Study|Lack of equipment|1
2456915|NCT02562482|8467843|P2|Overall Study|Illness/Injury unrelated to product|1
2456916|NCT02562482|8467844|P1|Overall Study|Illness/Injury unrelated to product|0
2456917|NCT02562482|8467843|P2|Overall Study|Physician Decision|3
2456918|NCT02562482|8467844|P1|Overall Study|Physician Decision|1
2456919|NCT02562482|8467843|P2|Overall Study|Withdrawal by Subject|3
2456920|NCT02562482|8467844|P1|Overall Study|Withdrawal by Subject|5
2456921|NCT02562482|8467843|P2|Overall Study|Moved from area|3
2456922|NCT02562482|8467844|P1|Overall Study|Moved from area|2
2456923|NCT02562482|8467843|P2|Overall Study|Lost to Follow-up|6
2456924|NCT02562482|8467844|P1|Overall Study|Lost to Follow-up|9
2456925|NCT02562482|8467843|P2|Overall Study|Enrolled, but did not receive product|0
2456926|NCT02562482|8467844|P1|Overall Study|Enrolled, but did not receive product|4
2456927|NCT02561832|8467879|P2|Overall Study|Disease progression|3
2456928|NCT02561832|8467880|P1|Overall Study|Disease progression|3
2456929|NCT02561832|8467879|P2|Overall Study|Adverse Event|0
2456930|NCT02561832|8467880|P1|Overall Study|Adverse Event|3
2456931|NCT02561832|8467879|P2|Overall Study|Withdrawal by Subject|1
2456932|NCT02561832|8467880|P1|Overall Study|Withdrawal by Subject|1
2456933|NCT02561806|8467888|P2|Post-Treatment Follow-up|Withdrawal by Subject|0
2456934|NCT02561806|8467889|P1|Post-Treatment Follow-up|Withdrawal by Subject|1
2456935|NCT02561806|8467888|P2|Post-Treatment Follow-up|Lost to Follow-up|1
2456936|NCT02561806|8467889|P1|Post-Treatment Follow-up|Lost to Follow-up|1
2456937|NCT02561806|8467888|P2|Maintenance Period|Site staff became unblinded|1
2456938|NCT02561806|8467889|P1|Maintenance Period|Site staff became unblinded|0
2456939|NCT02561806|8467888|P2|Maintenance Period|Withdrawal by Subject|3
2456940|NCT02561806|8467889|P1|Maintenance Period|Withdrawal by Subject|5
2456941|NCT02561806|8467888|P2|Maintenance Period|Protocol Violation|0
2456942|NCT02561806|8467889|P1|Maintenance Period|Protocol Violation|1
2456943|NCT02561806|8467888|P2|Maintenance Period|Lost to Follow-up|2
2456944|NCT02561806|8467889|P1|Maintenance Period|Lost to Follow-up|2
2456945|NCT02561806|8467888|P2|Maintenance Period|Lack of Efficacy|1
2456946|NCT02561806|8467889|P1|Maintenance Period|Lack of Efficacy|3
2456947|NCT02561806|8467888|P2|Maintenance Period|Adverse Event|1
2456948|NCT02561806|8467889|P1|Maintenance Period|Adverse Event|2
2456949|NCT02561806|8467888|P2|Induction Period|Randomized but not treated|1
2456950|NCT02561806|8467889|P1|Induction Period|Randomized but not treated|0
2456951|NCT02561806|8467888|P2|Induction Period|Site staff became unblinded|0
2456952|NCT02561806|8467889|P1|Induction Period|Site staff became unblinded|1
2456953|NCT02561806|8467888|P2|Induction Period|Withdrawal by Subject|2
2456954|NCT02561806|8467889|P1|Induction Period|Withdrawal by Subject|0
2456955|NCT02561806|8467888|P2|Induction Period|Lack of Efficacy|0
2456956|NCT02561806|8467889|P1|Induction Period|Lack of Efficacy|1
2456957|NCT02561806|8467888|P2|Induction Period|Adverse Event|2
2456958|NCT02561806|8467889|P1|Induction Period|Adverse Event|0
2456959|NCT02561572|8467993|P2|Overall Study|Protocol Violation|1
2456960|NCT02561572|8467994|P1|Overall Study|Protocol Violation|0
2456961|NCT02561572|8467993|P2|Overall Study|Inadequate time before surgery|1
2456962|NCT02561572|8467994|P1|Overall Study|Inadequate time before surgery|2
2456963|NCT02561195|8468052|P6|Overall Study|Randomized but not treated|0
2456964|NCT02561195|8468053|P5|Overall Study|Randomized but not treated|0
2456965|NCT02561195|8468054|P4|Overall Study|Randomized but not treated|0
2456966|NCT02561195|8468055|P3|Overall Study|Randomized but not treated|0
2456967|NCT02561195|8468056|P2|Overall Study|Randomized but not treated|0
2456968|NCT02561195|8468057|P1|Overall Study|Randomized but not treated|1
2456969|NCT02561195|8468052|P6|Overall Study|Withdrawal by Subject|0
2456970|NCT02561195|8468053|P5|Overall Study|Withdrawal by Subject|6
2456971|NCT02561195|8468054|P4|Overall Study|Withdrawal by Subject|2
2456972|NCT02561195|8468055|P3|Overall Study|Withdrawal by Subject|4
2456973|NCT02561195|8468056|P2|Overall Study|Withdrawal by Subject|4
2456974|NCT02561195|8468057|P1|Overall Study|Withdrawal by Subject|3
2456975|NCT02561195|8468052|P6|Overall Study|Death|0
2456976|NCT02561195|8468053|P5|Overall Study|Death|0
2456977|NCT02561195|8468054|P4|Overall Study|Death|2
2456978|NCT02561195|8468055|P3|Overall Study|Death|0
2456979|NCT02561195|8468056|P2|Overall Study|Death|1
2456980|NCT02561195|8468057|P1|Overall Study|Death|2
2456981|NCT02561195|8468052|P6|Overall Study|Protocol Violation|2
2456982|NCT02561195|8468053|P5|Overall Study|Protocol Violation|5
2456983|NCT02561195|8468054|P4|Overall Study|Protocol Violation|2
2456984|NCT02561195|8468055|P3|Overall Study|Protocol Violation|1
2456985|NCT02561195|8468056|P2|Overall Study|Protocol Violation|0
2456986|NCT02561195|8468057|P1|Overall Study|Protocol Violation|1
2456987|NCT02561195|8468052|P6|Overall Study|Other|1
2456988|NCT02561195|8468053|P5|Overall Study|Other|5
2456989|NCT02561195|8468054|P4|Overall Study|Other|7
2456990|NCT02561195|8468055|P3|Overall Study|Other|1
2456991|NCT02561195|8468056|P2|Overall Study|Other|3
2456992|NCT02561195|8468057|P1|Overall Study|Other|7
2456993|NCT02561195|8468052|P6|Overall Study|No longer willing to participate|3
2456994|NCT02561195|8468053|P5|Overall Study|No longer willing to participate|1
2456995|NCT02561195|8468054|P4|Overall Study|No longer willing to participate|4
2456996|NCT02561195|8468055|P3|Overall Study|No longer willing to participate|0
2456997|NCT02561195|8468056|P2|Overall Study|No longer willing to participate|4
2456998|NCT02561195|8468057|P1|Overall Study|No longer willing to participate|2
2456999|NCT02561195|8468052|P6|Overall Study|No longer meets eligibility criteria|1
2457000|NCT02561195|8468053|P5|Overall Study|No longer meets eligibility criteria|4
2457001|NCT02561195|8468054|P4|Overall Study|No longer meets eligibility criteria|4
2457002|NCT02561195|8468055|P3|Overall Study|No longer meets eligibility criteria|0
2457003|NCT02561195|8468056|P2|Overall Study|No longer meets eligibility criteria|1
2457004|NCT02561195|8468057|P1|Overall Study|No longer meets eligibility criteria|0
2457005|NCT02561195|8468052|P6|Overall Study|Lost to Follow-up|3
2457006|NCT02561195|8468053|P5|Overall Study|Lost to Follow-up|3
2457007|NCT02561195|8468054|P4|Overall Study|Lost to Follow-up|2
2457008|NCT02561195|8468055|P3|Overall Study|Lost to Follow-up|0
2457009|NCT02561195|8468056|P2|Overall Study|Lost to Follow-up|4
2457010|NCT02561195|8468057|P1|Overall Study|Lost to Follow-up|3
2457011|NCT02561195|8468052|P6|Overall Study|Adverse Event|0
2457012|NCT02561195|8468053|P5|Overall Study|Adverse Event|4
2457013|NCT02561195|8468054|P4|Overall Study|Adverse Event|3
2457014|NCT02561195|8468055|P3|Overall Study|Adverse Event|0
2457015|NCT02561195|8468056|P2|Overall Study|Adverse Event|5
2457016|NCT02561195|8468057|P1|Overall Study|Adverse Event|4
2457017|NCT02561156|8468218|P13|Part 2|Adverse Event|0
2457018|NCT02561156|8468219|P12|Part 2|Adverse Event|1
2457019|NCT02561156|8468220|P11|Part 2|Adverse Event|0
2457020|NCT02561156|8468221|P10|Part 2|Adverse Event|0
2457021|NCT02561156|8468222|P9|Part 2|Adverse Event|0
2457022|NCT02561156|8468223|P8|Part 2|Adverse Event|0
2457023|NCT02561156|8468224|P7|Part 2|Adverse Event|0
2457024|NCT02561156|8468225|P6|Part 2|Adverse Event|0
2457025|NCT02561156|8468226|P5|Part 2|Adverse Event|0
2457026|NCT02561156|8468227|P4|Part 2|Adverse Event|0
2457027|NCT02561156|8468228|P3|Part 2|Adverse Event|0
2457028|NCT02561156|8468229|P2|Part 2|Adverse Event|0
2457029|NCT02561156|8468230|P1|Part 2|Adverse Event|0
2457030|NCT02560389|8468512|P3|Overall Study|Tested positive for illicit substance|0
2457031|NCT02560389|8468513|P2|Overall Study|Tested positive for illicit substance|1
2457032|NCT02560389|8468514|P1|Overall Study|Tested positive for illicit substance|0
2457033|NCT02560389|8468512|P3|Overall Study|Lost to Follow-up|2
2457034|NCT02560389|8468513|P2|Overall Study|Lost to Follow-up|2
2457035|NCT02560389|8468514|P1|Overall Study|Lost to Follow-up|1
2457036|NCT02560025|8468612|P1|Overall Study|Ineligible after consent/ registration|3
2457037|NCT02560012|8468618|P1|Overall Study|Study Terminated|2
2457038|NCT02559713|8468622|P1|Overall Study|Pretreatment Event/ Adverse Event|1
2457039|NCT02559687|8468632|P1|Overall Study|Ongoing Follow-Up|14
2457040|NCT02559687|8468632|P1|Overall Study|Withdrawal by Subject|4
2457041|NCT02559687|8468632|P1|Overall Study|Death|103
2457042|NCT02559622|8468645|P4|Overall Study|Patient/guardian decision|1
2457043|NCT02559622|8468646|P3|Overall Study|Patient/guardian decision|0
2457044|NCT02559622|8468647|P2|Overall Study|Patient/guardian decision|2
2457045|NCT02559622|8468648|P1|Overall Study|Patient/guardian decision|1
2457046|NCT02559622|8468645|P4|Overall Study|Adverse Event|2
2457047|NCT02559622|8468646|P3|Overall Study|Adverse Event|2
2457048|NCT02559622|8468647|P2|Overall Study|Adverse Event|2
2457049|NCT02559622|8468648|P1|Overall Study|Adverse Event|0
2457050|NCT02559622|8468645|P4|Overall Study|Progressive disease|0
2457051|NCT02559622|8468646|P3|Overall Study|Progressive disease|0
2457052|NCT02559622|8468647|P2|Overall Study|Progressive disease|1
2457053|NCT02559622|8468648|P1|Overall Study|Progressive disease|0
2457054|NCT02559570|8468732|P5|Overall Study|Other Miscellaneous Reasons|0
2457055|NCT02559570|8468733|P4|Overall Study|Other Miscellaneous Reasons|0
2457056|NCT02559570|8468734|P3|Overall Study|Other Miscellaneous Reasons|1
2457057|NCT02559570|8468735|P2|Overall Study|Other Miscellaneous Reasons|0
2457058|NCT02559570|8468736|P1|Overall Study|Other Miscellaneous Reasons|0
2457059|NCT02559570|8468732|P5|Overall Study|Protocol Violation|1
2457060|NCT02559570|8468733|P4|Overall Study|Protocol Violation|0
2457061|NCT02559570|8468734|P3|Overall Study|Protocol Violation|0
2457062|NCT02559570|8468735|P2|Overall Study|Protocol Violation|0
2457063|NCT02559570|8468736|P1|Overall Study|Protocol Violation|1
2457064|NCT02559570|8468732|P5|Overall Study|Lost to Follow-up|0
2457065|NCT02559570|8468733|P4|Overall Study|Lost to Follow-up|0
2457066|NCT02559570|8468734|P3|Overall Study|Lost to Follow-up|0
2457067|NCT02559570|8468735|P2|Overall Study|Lost to Follow-up|0
2457068|NCT02559570|8468736|P1|Overall Study|Lost to Follow-up|1
2457069|NCT02559570|8468732|P5|Overall Study|Withdrawal of Consent|1
2457070|NCT02559570|8468733|P4|Overall Study|Withdrawal of Consent|2
2457071|NCT02559570|8468734|P3|Overall Study|Withdrawal of Consent|1
2457072|NCT02559570|8468735|P2|Overall Study|Withdrawal of Consent|0
2457073|NCT02559570|8468736|P1|Overall Study|Withdrawal of Consent|0
2457074|NCT02559570|8468732|P5|Overall Study|Adverse Event|0
2457075|NCT02559570|8468733|P4|Overall Study|Adverse Event|1
2457076|NCT02559570|8468734|P3|Overall Study|Adverse Event|0
2457077|NCT02559570|8468735|P2|Overall Study|Adverse Event|2
2457078|NCT02559570|8468736|P1|Overall Study|Adverse Event|0
2457079|NCT02559414|8468774|P3|Overall Study|Other|1
2457080|NCT02559414|8468775|P2|Overall Study|Other|1
2457081|NCT02559414|8468776|P1|Overall Study|Other|0
2457082|NCT02559414|8468774|P3|Overall Study|Withdrawal by Subject|1
2457083|NCT02559414|8468775|P2|Overall Study|Withdrawal by Subject|0
2457084|NCT02559414|8468776|P1|Overall Study|Withdrawal by Subject|1
2457085|NCT02559414|8468774|P3|Overall Study|Lost to Follow-up|0
2457086|NCT02559414|8468775|P2|Overall Study|Lost to Follow-up|1
2457087|NCT02559414|8468776|P1|Overall Study|Lost to Follow-up|0
2457088|NCT02559310|8468816|P2|Overall Study|Randomized but not treated|2
2457089|NCT02559310|8468817|P1|Overall Study|Randomized but not treated|3
2457090|NCT02559310|8468816|P2|Overall Study|Sponsor Decision|1
2457091|NCT02559310|8468817|P1|Overall Study|Sponsor Decision|0
2457092|NCT02559310|8468816|P2|Overall Study|Withdrawal by Subject|9
2457093|NCT02559310|8468817|P1|Overall Study|Withdrawal by Subject|13
2457094|NCT02559310|8468816|P2|Overall Study|Physician Decision|1
2457095|NCT02559310|8468817|P1|Overall Study|Physician Decision|2
2457096|NCT02559310|8468816|P2|Overall Study|Lost to Follow-up|3
2457097|NCT02559310|8468817|P1|Overall Study|Lost to Follow-up|5
2457098|NCT02559310|8468816|P2|Overall Study|Death|3
2457099|NCT02559310|8468817|P1|Overall Study|Death|4
2457100|NCT02559206|8468835|P8|Overall Study|Other Not Specified|0
2457101|NCT02559206|8468836|P7|Overall Study|Other Not Specified|0
2457102|NCT02559206|8468837|P6|Overall Study|Other Not Specified|0
2457103|NCT02559206|8468838|P5|Overall Study|Other Not Specified|0
2457104|NCT02559206|8468839|P4|Overall Study|Other Not Specified|1
2457105|NCT02559206|8468840|P3|Overall Study|Other Not Specified|0
2457106|NCT02559206|8468841|P2|Overall Study|Other Not Specified|0
2457107|NCT02559206|8468842|P1|Overall Study|Other Not Specified|0
2457108|NCT02559206|8468835|P8|Overall Study|Lack of Efficacy|3
2457109|NCT02559206|8468836|P7|Overall Study|Lack of Efficacy|3
2457110|NCT02559206|8468837|P6|Overall Study|Lack of Efficacy|3
2457111|NCT02559206|8468838|P5|Overall Study|Lack of Efficacy|2
2457112|NCT02559206|8468839|P4|Overall Study|Lack of Efficacy|2
2457113|NCT02559206|8468840|P3|Overall Study|Lack of Efficacy|3
2457114|NCT02559206|8468841|P2|Overall Study|Lack of Efficacy|0
2457115|NCT02559206|8468842|P1|Overall Study|Lack of Efficacy|1
2457116|NCT02559206|8468835|P8|Overall Study|Lost to Follow-up|4
2457117|NCT02559206|8468836|P7|Overall Study|Lost to Follow-up|1
2457118|NCT02559206|8468837|P6|Overall Study|Lost to Follow-up|5
2457119|NCT02559206|8468838|P5|Overall Study|Lost to Follow-up|2
2457120|NCT02559206|8468839|P4|Overall Study|Lost to Follow-up|3
2457121|NCT02559206|8468840|P3|Overall Study|Lost to Follow-up|3
2457122|NCT02559206|8468841|P2|Overall Study|Lost to Follow-up|5
2457123|NCT02559206|8468842|P1|Overall Study|Lost to Follow-up|3
2457124|NCT02559206|8468835|P8|Overall Study|Withdrawal by Subject|2
2457125|NCT02559206|8468836|P7|Overall Study|Withdrawal by Subject|1
2457126|NCT02559206|8468837|P6|Overall Study|Withdrawal by Subject|4
2457127|NCT02559206|8468838|P5|Overall Study|Withdrawal by Subject|5
2457128|NCT02559206|8468839|P4|Overall Study|Withdrawal by Subject|3
2457129|NCT02559206|8468840|P3|Overall Study|Withdrawal by Subject|1
2457130|NCT02559206|8468841|P2|Overall Study|Withdrawal by Subject|3
2457131|NCT02559206|8468842|P1|Overall Study|Withdrawal by Subject|3
2457132|NCT02559206|8468835|P8|Overall Study|Protocol Violation|0
2457133|NCT02559206|8468836|P7|Overall Study|Protocol Violation|0
2457134|NCT02559206|8468837|P6|Overall Study|Protocol Violation|2
2457135|NCT02559206|8468838|P5|Overall Study|Protocol Violation|0
2457136|NCT02559206|8468839|P4|Overall Study|Protocol Violation|0
2457137|NCT02559206|8468840|P3|Overall Study|Protocol Violation|1
2457138|NCT02559206|8468841|P2|Overall Study|Protocol Violation|0
2457139|NCT02559206|8468842|P1|Overall Study|Protocol Violation|1
2457140|NCT02559206|8468835|P8|Overall Study|Adverse Event|0
2457141|NCT02559206|8468836|P7|Overall Study|Adverse Event|1
2457142|NCT02559206|8468837|P6|Overall Study|Adverse Event|0
2457143|NCT02559206|8468838|P5|Overall Study|Adverse Event|3
2457144|NCT02559206|8468839|P4|Overall Study|Adverse Event|5
2457145|NCT02559206|8468840|P3|Overall Study|Adverse Event|1
2457146|NCT02559206|8468841|P2|Overall Study|Adverse Event|4
2457147|NCT02559206|8468842|P1|Overall Study|Adverse Event|0
2457148|NCT02558894|8468884|P2|Overall Study|Closure of Part A|1
2457149|NCT02558894|8468885|P1|Overall Study|Closure of Part A|2
2457150|NCT02558894|8468884|P2|Overall Study|Withdrawal by Subject|1
2457151|NCT02558894|8468885|P1|Overall Study|Withdrawal by Subject|2
2457152|NCT02558894|8468884|P2|Overall Study|Death; any cause, entire study duration|31
2457153|NCT02558894|8468885|P1|Overall Study|Death; any cause, entire study duration|28
2457154|NCT02558790|8468946|P1|Overall Study|Screen Fail|3
2457155|NCT02558790|8468946|P1|Overall Study|Withdrawal by Subject|1
2457156|NCT02558790|8468946|P1|Overall Study|Physician Decision|1
2457157|NCT02558790|8468946|P1|Overall Study|Lost to Follow-up|2
2457158|NCT02558400|8468953|P3|Overall Study|Ineligible for the study|0
2457159|NCT02558400|8468954|P2|Overall Study|Ineligible for the study|2
2457160|NCT02558400|8468955|P1|Overall Study|Ineligible for the study|0
2457161|NCT02558400|8468953|P3|Overall Study|Death|0
2457162|NCT02558400|8468954|P2|Overall Study|Death|1
2457163|NCT02558400|8468955|P1|Overall Study|Death|0
2457164|NCT02558400|8468953|P3|Overall Study|Protocol Violation|8
2457165|NCT02558400|8468954|P2|Overall Study|Protocol Violation|3
2457166|NCT02558400|8468955|P1|Overall Study|Protocol Violation|6
2457167|NCT02558400|8468953|P3|Overall Study|Physician Decision|0
2457168|NCT02558400|8468954|P2|Overall Study|Physician Decision|2
2457169|NCT02558400|8468955|P1|Overall Study|Physician Decision|2
2457170|NCT02558400|8468953|P3|Overall Study|Disallowed Concurrent Medication|5
2457171|NCT02558400|8468954|P2|Overall Study|Disallowed Concurrent Medication|7
2457172|NCT02558400|8468955|P1|Overall Study|Disallowed Concurrent Medication|6
2457173|NCT02558400|8468953|P3|Overall Study|Lack of Efficacy|1
2457174|NCT02558400|8468954|P2|Overall Study|Lack of Efficacy|13
2457175|NCT02558400|8468955|P1|Overall Study|Lack of Efficacy|0
2457176|NCT02558400|8468953|P3|Overall Study|Lost to Follow-up|4
2457177|NCT02558400|8468954|P2|Overall Study|Lost to Follow-up|5
2457178|NCT02558400|8468955|P1|Overall Study|Lost to Follow-up|5
2457179|NCT02558400|8468953|P3|Overall Study|Non-Compliant|3
2457180|NCT02558400|8468954|P2|Overall Study|Non-Compliant|1
2457181|NCT02558400|8468955|P1|Overall Study|Non-Compliant|0
2457182|NCT02558400|8468953|P3|Overall Study|Withdrawal by Subject|8
2457183|NCT02558400|8468954|P2|Overall Study|Withdrawal by Subject|9
2457184|NCT02558400|8468955|P1|Overall Study|Withdrawal by Subject|13
2457185|NCT02558400|8468953|P3|Overall Study|Adverse Event|4
2457186|NCT02558400|8468954|P2|Overall Study|Adverse Event|53
2457187|NCT02558400|8468955|P1|Overall Study|Adverse Event|47
2457188|NCT02557646|8469044|P1|Overall Study|Other|14
2457189|NCT02557646|8469044|P1|Overall Study|Lost to Follow-up|17
2457190|NCT02557646|8469044|P1|Overall Study|Withdrawal by Subject|18
2457191|NCT02557646|8469044|P1|Overall Study|Lack of Efficacy|186
2457192|NCT02557646|8469044|P1|Overall Study|Death|1
2457193|NCT02557646|8469044|P1|Overall Study|Adverse Event|40
2457194|NCT02557516|8469071|P4|Overall Study|Sponsor decision|8
2457195|NCT02557516|8469072|P3|Overall Study|Sponsor decision|2
2457196|NCT02557516|8469073|P2|Overall Study|Sponsor decision|1
2457197|NCT02557516|8469074|P1|Overall Study|Sponsor decision|0
2457198|NCT02557516|8469071|P4|Overall Study|Physician Decision|0
2457199|NCT02557516|8469072|P3|Overall Study|Physician Decision|0
2457200|NCT02557516|8469073|P2|Overall Study|Physician Decision|2
2457201|NCT02557516|8469074|P1|Overall Study|Physician Decision|0
2457202|NCT02557516|8469071|P4|Overall Study|Disease progression|0
2457203|NCT02557516|8469072|P3|Overall Study|Disease progression|0
2457204|NCT02557516|8469073|P2|Overall Study|Disease progression|2
2457205|NCT02557516|8469074|P1|Overall Study|Disease progression|0
2457206|NCT02557516|8469071|P4|Overall Study|Adverse Event|1
2457207|NCT02557516|8469072|P3|Overall Study|Adverse Event|2
2457208|NCT02557516|8469073|P2|Overall Study|Adverse Event|0
2457209|NCT02557516|8469074|P1|Overall Study|Adverse Event|1
2457210|NCT02557399|8469095|P2|Overall Study|Withdrawal by Subject|1
2457211|NCT02557399|8469096|P1|Overall Study|Withdrawal by Subject|1
2457212|NCT02557399|8469095|P2|Overall Study|Protocol-defined stopping criteria|1
2457213|NCT02557399|8469096|P1|Overall Study|Protocol-defined stopping criteria|0
2457214|NCT02557399|8469095|P2|Overall Study|Protocol Violation|1
2457215|NCT02557399|8469096|P1|Overall Study|Protocol Violation|0
2457216|NCT02557399|8469095|P2|Overall Study|Adverse Event|5
2457217|NCT02557399|8469096|P1|Overall Study|Adverse Event|6
2457218|NCT02556918|8469155|P2|Overall Study|Withdrawal by Subject|4
2457219|NCT02556918|8469156|P1|Overall Study|Withdrawal by Subject|4
2457220|NCT02556918|8469155|P2|Overall Study|Protocol Violation|6
2457221|NCT02556918|8469156|P1|Overall Study|Protocol Violation|5
2457222|NCT02556801|8469216|P4|Overall Study|Personal reasons patient|1
2457223|NCT02556801|8469217|P3|Overall Study|Personal reasons patient|0
2457224|NCT02556801|8469218|P2|Overall Study|Personal reasons patient|0
2457225|NCT02556801|8469219|P1|Overall Study|Personal reasons patient|0
2457226|NCT02556801|8469216|P4|Overall Study|Pregnancy|0
2457227|NCT02556801|8469217|P3|Overall Study|Pregnancy|0
2457228|NCT02556801|8469218|P2|Overall Study|Pregnancy|1
2457229|NCT02556801|8469219|P1|Overall Study|Pregnancy|0
2457230|NCT02556801|8469216|P4|Overall Study|Adverse Event|3
2457231|NCT02556801|8469217|P3|Overall Study|Adverse Event|0
2457232|NCT02556801|8469218|P2|Overall Study|Adverse Event|2
2457233|NCT02556801|8469219|P1|Overall Study|Adverse Event|0
2457234|NCT02556801|8469216|P4|Overall Study|Protocol Violation|1
2457235|NCT02556801|8469217|P3|Overall Study|Protocol Violation|1
2457236|NCT02556801|8469218|P2|Overall Study|Protocol Violation|3
2457237|NCT02556801|8469219|P1|Overall Study|Protocol Violation|0
2457238|NCT02556801|8469216|P4|Overall Study|Withdrawal by Subject|0
2457239|NCT02556801|8469217|P3|Overall Study|Withdrawal by Subject|1
2457240|NCT02556801|8469218|P2|Overall Study|Withdrawal by Subject|1
2457241|NCT02556801|8469219|P1|Overall Study|Withdrawal by Subject|1
2457242|NCT02556801|8469216|P4|Overall Study|Lost to Follow-up|0
2457243|NCT02556801|8469217|P3|Overall Study|Lost to Follow-up|2
2457244|NCT02556801|8469218|P2|Overall Study|Lost to Follow-up|0
2457245|NCT02556801|8469219|P1|Overall Study|Lost to Follow-up|1
2457246|NCT02556632|8469281|P3|Overall Study|Treatment or Change Delay|1
2457247|NCT02556632|8469282|P2|Overall Study|Treatment or Change Delay|0
2457248|NCT02556632|8469283|P1|Overall Study|Treatment or Change Delay|0
2457249|NCT02556632|8469281|P3|Overall Study|Disliked Study Procedures|1
2457250|NCT02556632|8469282|P2|Overall Study|Disliked Study Procedures|0
2457251|NCT02556632|8469283|P1|Overall Study|Disliked Study Procedures|0
2457252|NCT02556632|8469281|P3|Overall Study|Ineligible|0
2457253|NCT02556632|8469282|P2|Overall Study|Ineligible|1
2457254|NCT02556632|8469283|P1|Overall Study|Ineligible|0
2457255|NCT02556632|8469281|P3|Overall Study|Did Not Start RT|0
2457256|NCT02556632|8469282|P2|Overall Study|Did Not Start RT|1
2457257|NCT02556632|8469283|P1|Overall Study|Did Not Start RT|0
2457258|NCT02556632|8469281|P3|Overall Study|Possibly Related Adverse Event|1
2457259|NCT02556632|8469282|P2|Overall Study|Possibly Related Adverse Event|0
2457260|NCT02556632|8469283|P1|Overall Study|Possibly Related Adverse Event|0
2457261|NCT02556632|8469281|P3|Overall Study|Related Adverse Event|0
2457262|NCT02556632|8469282|P2|Overall Study|Related Adverse Event|1
2457263|NCT02556632|8469283|P1|Overall Study|Related Adverse Event|0
2457264|NCT02556632|8469281|P3|Overall Study|Unrelated Adverse Event|3
2457265|NCT02556632|8469282|P2|Overall Study|Unrelated Adverse Event|0
2457266|NCT02556632|8469283|P1|Overall Study|Unrelated Adverse Event|1
2457267|NCT02556632|8469281|P3|Overall Study|Withdrew (Unrelated Medical)|0
2457268|NCT02556632|8469282|P2|Overall Study|Withdrew (Unrelated Medical)|0
2457269|NCT02556632|8469283|P1|Overall Study|Withdrew (Unrelated Medical)|1
2457270|NCT02556632|8469281|P3|Overall Study|Changed Mind|0
2457271|NCT02556632|8469282|P2|Overall Study|Changed Mind|1
2457272|NCT02556632|8469283|P1|Overall Study|Changed Mind|0
2457273|NCT02556632|8469281|P3|Overall Study|Personal Issues|1
2457274|NCT02556632|8469282|P2|Overall Study|Personal Issues|1
2457275|NCT02556632|8469283|P1|Overall Study|Personal Issues|0
2457276|NCT02556632|8469281|P3|Overall Study|No Reason|1
2457277|NCT02556632|8469282|P2|Overall Study|No Reason|0
2457278|NCT02556632|8469283|P1|Overall Study|No Reason|1
2457279|NCT02556632|8469281|P3|Overall Study|Disliked Intervention|1
2457280|NCT02556632|8469282|P2|Overall Study|Disliked Intervention|1
2457281|NCT02556632|8469283|P1|Overall Study|Disliked Intervention|1
2457282|NCT02556632|8469281|P3|Overall Study|Lost to Follow-up|0
2457283|NCT02556632|8469282|P2|Overall Study|Lost to Follow-up|0
2457284|NCT02556632|8469283|P1|Overall Study|Lost to Follow-up|1
2457285|NCT02556307|8469301|P1|Overall Study|Enrolled but not treated|2
2457286|NCT02556307|8469301|P1|Overall Study|Change to triple therapy|4
2457287|NCT02556307|8469301|P1|Overall Study|Lost to Follow-up|36
2457288|NCT02556307|8469301|P1|Overall Study|Premature treatment interruption|11
2457289|NCT02556255|8469311|P1|Overall Study|Lost to Follow-up|4
2457290|NCT02556203|8469326|P2|Overall Study|Adverse Event|0
2457291|NCT02556203|8469327|P1|Overall Study|Adverse Event|1
2457292|NCT02556203|8469326|P2|Overall Study|Lost to Follow-up|5
2457293|NCT02556203|8469327|P1|Overall Study|Lost to Follow-up|5
2457294|NCT02556203|8469326|P2|Overall Study|Withdrawal by Subject|21
2457295|NCT02556203|8469327|P1|Overall Study|Withdrawal by Subject|21
2457296|NCT02556177|8469349|P2|Overall Study|Subjects did not complete all 4 visits|61
2457297|NCT02556177|8469350|P1|Overall Study|Subjects did not complete all 4 visits|283
2457298|NCT02556138|8469358|P1|Overall Study|Withdrawal by Subject|1
2457299|NCT02555878|8469366|P2|Overall Study|Other|17
2457300|NCT02555878|8469367|P1|Overall Study|Other|17
2457301|NCT02555878|8469366|P2|Overall Study|Physician Decision|13
2457302|NCT02555878|8469367|P1|Overall Study|Physician Decision|12
2457303|NCT02555878|8469366|P2|Overall Study|Protocol Violation|2
2457304|NCT02555878|8469367|P1|Overall Study|Protocol Violation|1
2457305|NCT02555878|8469366|P2|Overall Study|Death|59
2457306|NCT02555878|8469367|P1|Overall Study|Death|74
2457307|NCT02555878|8469366|P2|Overall Study|Adverse Event|8
2457308|NCT02555878|8469367|P1|Overall Study|Adverse Event|12
2457309|NCT02555878|8469366|P2|Overall Study|Withdrawal by Subject|48
2457310|NCT02555878|8469367|P1|Overall Study|Withdrawal by Subject|48
2457311|NCT02555878|8469366|P2|Overall Study|Lost to Follow-up|3
2457312|NCT02555878|8469367|P1|Overall Study|Lost to Follow-up|2
2457313|NCT02555722|8469399|P2|Month 2|Lost to Follow-up|0
2457314|NCT02555722|8469400|P1|Month 2|Lost to Follow-up|1
2457315|NCT02555722|8469399|P2|Month 2|Withdrawal by Subject|0
2457316|NCT02555722|8469400|P1|Month 2|Withdrawal by Subject|3
2457317|NCT02555722|8469399|P2|Month 1|Lens Discomfort|0
2457318|NCT02555722|8469400|P1|Month 1|Lens Discomfort|1
2457319|NCT02555722|8469399|P2|Week 2|Withdrawal by Subject|0
2457320|NCT02555722|8469400|P1|Week 2|Withdrawal by Subject|1
2457321|NCT02555722|8469399|P2|Week 2|Adverse Event|1
2457322|NCT02555722|8469400|P1|Week 2|Adverse Event|0
2457323|NCT02555618|8469591|P2|Overall Study|Sponsor's Circumstances|0
2457324|NCT02555618|8469592|P1|Overall Study|Sponsor's Circumstances|1
2457325|NCT02555371|8469634|P5|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
2457326|NCT02555371|8469635|P4|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1
2457327|NCT02555371|8469636|P3|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
2457328|NCT02555371|8469637|P2|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
2457329|NCT02555371|8469638|P1|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
2457330|NCT02555371|8469634|P5|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1
2457331|NCT02555371|8469635|P4|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
2457332|NCT02555371|8469636|P3|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
2457333|NCT02555371|8469637|P2|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
2457334|NCT02555371|8469638|P1|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
2457335|NCT02555371|8469634|P5|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2
2457336|NCT02555371|8469635|P4|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
2457337|NCT02555371|8469636|P3|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
2457338|NCT02555371|8469637|P2|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
2457339|NCT02555371|8469638|P1|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
2457340|NCT02555371|8469634|P5|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
2457341|NCT02555371|8469635|P4|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2
2457342|NCT02555371|8469636|P3|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
2457343|NCT02555371|8469637|P2|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
2457344|NCT02555371|8469638|P1|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
2457345|NCT02555371|8469634|P5|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
2457346|NCT02555371|8469635|P4|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1
2457347|NCT02555371|8469636|P3|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
2457348|NCT02555371|8469637|P2|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
2457349|NCT02555371|8469638|P1|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
2457350|NCT02555371|8469634|P5|Part C (DB Period: Up to 52W)|Adverse Event|0
2457351|NCT02555371|8469635|P4|Part C (DB Period: Up to 52W)|Adverse Event|0
2457352|NCT02555371|8469636|P3|Part C (DB Period: Up to 52W)|Adverse Event|1
2457353|NCT02555371|8469637|P2|Part C (DB Period: Up to 52W)|Adverse Event|2
2457354|NCT02555371|8469638|P1|Part C (DB Period: Up to 52W)|Adverse Event|0
2457355|NCT02555371|8469634|P5|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
2457356|NCT02555371|8469635|P4|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
2457357|NCT02555371|8469636|P3|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
2457358|NCT02555371|8469637|P2|Part C (DB Period: Up to 52W)|Lack of Efficacy|1
2457359|NCT02555371|8469638|P1|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
2457360|NCT02555371|8469634|P5|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
2457361|NCT02555371|8469635|P4|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
2457362|NCT02555371|8469636|P3|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2
2457363|NCT02555371|8469637|P2|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2
2457364|NCT02555371|8469638|P1|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
2457365|NCT02555371|8469634|P5|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
2457366|NCT02555371|8469635|P4|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
2457367|NCT02555371|8469636|P3|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45
2457368|NCT02555371|8469637|P2|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84
2457369|NCT02555371|8469638|P1|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
2457370|NCT02555371|8469634|P5|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
2457371|NCT02555371|8469635|P4|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
2457372|NCT02555371|8469636|P3|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
2457373|NCT02555371|8469637|P2|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
2457374|NCT02555371|8469638|P1|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2
2457375|NCT02555371|8469634|P5|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
2457376|NCT02555371|8469635|P4|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
2457377|NCT02555371|8469636|P3|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
2457378|NCT02555371|8469637|P2|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
2457379|NCT02555371|8469638|P1|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1
2457380|NCT02555371|8469634|P5|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
2457381|NCT02555371|8469635|P4|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
2457382|NCT02555371|8469636|P3|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
2457383|NCT02555371|8469637|P2|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
2457384|NCT02555371|8469638|P1|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5
2457385|NCT02555371|8469634|P5|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
2457386|NCT02555371|8469635|P4|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
2457387|NCT02555371|8469636|P3|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
2457388|NCT02555371|8469637|P2|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
2457389|NCT02555371|8469638|P1|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2
2457390|NCT02555371|8469634|P5|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
2457391|NCT02555371|8469635|P4|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
2457392|NCT02555371|8469636|P3|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
2457393|NCT02555371|8469637|P2|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
2457394|NCT02555371|8469638|P1|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1
2457395|NCT02555215|8469689|P1|Overall Study|Investigator Decision|2
2457396|NCT02555215|8469689|P1|Overall Study|Other|1
2457397|NCT02554981|8469700|P1|Overall Study|Other Miscellaneous Reasons|3
2457398|NCT02554981|8469700|P1|Overall Study|Administrative Reasons|1
2457399|NCT02554981|8469700|P1|Overall Study|Adverse Event|1
2457400|NCT02554929|8469726|P2|Overall Study|Withdrawal by Subject|8
2457401|NCT02554929|8469727|P1|Overall Study|Withdrawal by Subject|2
2457402|NCT02554929|8469726|P2|Overall Study|Lost to Follow-up|4
2457403|NCT02554929|8469727|P1|Overall Study|Lost to Follow-up|4
2457404|NCT02554890|8469745|P2|Open-label|Withdrawal by Subject|1
2457405|NCT02554890|8469746|P1|Open-label|Withdrawal by Subject|0
2457406|NCT02554890|8469745|P2|Open-label|Technical problems|1
2457407|NCT02554890|8469746|P1|Open-label|Technical problems|0
2457408|NCT02554890|8469745|P2|Open-label|Lost to Follow-up|7
2457409|NCT02554890|8469746|P1|Open-label|Lost to Follow-up|0
2457410|NCT02554890|8469745|P2|Open-label|Subject/Guardian decision|11
2457411|NCT02554890|8469746|P1|Open-label|Subject/Guardian decision|0
2457412|NCT02554890|8469745|P2|Open-label|Physician Decision|1
2457413|NCT02554890|8469746|P1|Open-label|Physician Decision|0
2457414|NCT02554890|8469745|P2|Open-label|Death|1
2457415|NCT02554890|8469746|P1|Open-label|Death|0
2457416|NCT02554890|8469745|P2|Open-label|Adverse Event|30
2457417|NCT02554890|8469746|P1|Open-label|Adverse Event|0
2457418|NCT02554890|8469745|P2|Double-blind|Noncompliance with study treatment|5
2457419|NCT02554890|8469746|P1|Double-blind|Noncompliance with study treatment|6
2457420|NCT02554890|8469745|P2|Double-blind|Withdrawal by Subject|6
2457421|NCT02554890|8469746|P1|Double-blind|Withdrawal by Subject|5
2457422|NCT02554890|8469745|P2|Double-blind|Technical problems|0
2457423|NCT02554890|8469746|P1|Double-blind|Technical problems|1
2457424|NCT02554890|8469745|P2|Double-blind|Lost to Follow-up|5
2457425|NCT02554890|8469746|P1|Double-blind|Lost to Follow-up|7
2457426|NCT02554890|8469745|P2|Double-blind|Subject/Guardian decision|16
2457427|NCT02554890|8469746|P1|Double-blind|Subject/Guardian decision|21
2457428|NCT02554890|8469745|P2|Double-blind|Physician Decision|3
2457429|NCT02554890|8469746|P1|Double-blind|Physician Decision|4
2457430|NCT02554890|8469745|P2|Double-blind|Protocol Violation|1
2457431|NCT02554890|8469746|P1|Double-blind|Protocol Violation|1
2457432|NCT02554890|8469745|P2|Double-blind|Death|4
2457433|NCT02554890|8469746|P1|Double-blind|Death|6
2457434|NCT02554890|8469745|P2|Double-blind|Adverse Event|51
2457435|NCT02554890|8469746|P1|Double-blind|Adverse Event|45
2457436|NCT02554877|8469774|P4|Overall Study|No longer willing to participate|0
2457437|NCT02554877|8469775|P3|Overall Study|No longer willing to participate|2
2457438|NCT02554877|8469776|P2|Overall Study|No longer willing to participate|2
2457439|NCT02554877|8469777|P1|Overall Study|No longer willing to participate|0
2457440|NCT02554877|8469774|P4|Overall Study|Insufficient clinical response|0
2457441|NCT02554877|8469775|P3|Overall Study|Insufficient clinical response|0
2457442|NCT02554877|8469776|P2|Overall Study|Insufficient clinical response|0
2457443|NCT02554877|8469777|P1|Overall Study|Insufficient clinical response|4
2457444|NCT02554877|8469774|P4|Overall Study|Other|3
2457445|NCT02554877|8469775|P3|Overall Study|Other|0
2457446|NCT02554877|8469776|P2|Overall Study|Other|3
2457447|NCT02554877|8469777|P1|Overall Study|Other|1
2457448|NCT02554877|8469774|P4|Overall Study|Protocol Violation|0
2457449|NCT02554877|8469775|P3|Overall Study|Protocol Violation|1
2457450|NCT02554877|8469776|P2|Overall Study|Protocol Violation|1
2457451|NCT02554877|8469777|P1|Overall Study|Protocol Violation|3
2457452|NCT02554877|8469774|P4|Overall Study|No longer met eligibility criteria|1
2457453|NCT02554877|8469775|P3|Overall Study|No longer met eligibility criteria|1
2457454|NCT02554877|8469776|P2|Overall Study|No longer met eligibility criteria|0
2457455|NCT02554877|8469777|P1|Overall Study|No longer met eligibility criteria|1
2457456|NCT02554877|8469774|P4|Overall Study|Did not meet entrance criteria|0
2457457|NCT02554877|8469775|P3|Overall Study|Did not meet entrance criteria|1
2457458|NCT02554877|8469776|P2|Overall Study|Did not meet entrance criteria|0
2457459|NCT02554877|8469777|P1|Overall Study|Did not meet entrance criteria|0
2457460|NCT02554877|8469774|P4|Overall Study|Lost to Follow-up|2
2457461|NCT02554877|8469775|P3|Overall Study|Lost to Follow-up|1
2457462|NCT02554877|8469776|P2|Overall Study|Lost to Follow-up|1
2457463|NCT02554877|8469777|P1|Overall Study|Lost to Follow-up|1
2457464|NCT02554877|8469774|P4|Overall Study|Adverse Event|1
2457465|NCT02554877|8469775|P3|Overall Study|Adverse Event|0
2457466|NCT02554877|8469776|P2|Overall Study|Adverse Event|0
2457467|NCT02554877|8469777|P1|Overall Study|Adverse Event|2
2457468|NCT02554786|8469865|P5|Overall Study|Pregnancy|1
2457469|NCT02554786|8469866|P4|Overall Study|Pregnancy|1
2457470|NCT02554786|8469867|P3|Overall Study|Pregnancy|0
2457471|NCT02554786|8469868|P2|Overall Study|Pregnancy|0
2457472|NCT02554786|8469869|P1|Overall Study|Pregnancy|0
2457473|NCT02554786|8469865|P5|Overall Study|Physician Decision|1
2457474|NCT02554786|8469866|P4|Overall Study|Physician Decision|1
2457475|NCT02554786|8469867|P3|Overall Study|Physician Decision|4
2457476|NCT02554786|8469868|P2|Overall Study|Physician Decision|1
2457477|NCT02554786|8469869|P1|Overall Study|Physician Decision|0
2457478|NCT02554786|8469865|P5|Overall Study|Non-compliance with study treatment|1
2457479|NCT02554786|8469866|P4|Overall Study|Non-compliance with study treatment|0
2457480|NCT02554786|8469867|P3|Overall Study|Non-compliance with study treatment|1
2457481|NCT02554786|8469868|P2|Overall Study|Non-compliance with study treatment|1
2457482|NCT02554786|8469869|P1|Overall Study|Non-compliance with study treatment|0
2457483|NCT02554786|8469865|P5|Overall Study|Death|0
2457484|NCT02554786|8469866|P4|Overall Study|Death|1
2457485|NCT02554786|8469867|P3|Overall Study|Death|0
2457486|NCT02554786|8469868|P2|Overall Study|Death|0
2457487|NCT02554786|8469869|P1|Overall Study|Death|0
2457488|NCT02554786|8469865|P5|Overall Study|Adverse Event|2
2457489|NCT02554786|8469866|P4|Overall Study|Adverse Event|0
2457490|NCT02554786|8469867|P3|Overall Study|Adverse Event|0
2457491|NCT02554786|8469868|P2|Overall Study|Adverse Event|0
2457492|NCT02554786|8469869|P1|Overall Study|Adverse Event|0
2457493|NCT02554786|8469865|P5|Overall Study|Technical problems|1
2457494|NCT02554786|8469866|P4|Overall Study|Technical problems|2
2457495|NCT02554786|8469867|P3|Overall Study|Technical problems|0
2457496|NCT02554786|8469868|P2|Overall Study|Technical problems|1
2457497|NCT02554786|8469869|P1|Overall Study|Technical problems|1
2457498|NCT02554786|8469865|P5|Overall Study|Protocol deviation|2
2457499|NCT02554786|8469866|P4|Overall Study|Protocol deviation|4
2457500|NCT02554786|8469867|P3|Overall Study|Protocol deviation|3
2457501|NCT02554786|8469868|P2|Overall Study|Protocol deviation|3
2457502|NCT02554786|8469869|P1|Overall Study|Protocol deviation|1
2457503|NCT02554786|8469865|P5|Overall Study|Lost to Follow-up|2
2457504|NCT02554786|8469866|P4|Overall Study|Lost to Follow-up|2
2457505|NCT02554786|8469867|P3|Overall Study|Lost to Follow-up|4
2457506|NCT02554786|8469868|P2|Overall Study|Lost to Follow-up|3
2457507|NCT02554786|8469869|P1|Overall Study|Lost to Follow-up|4
2457508|NCT02554786|8469865|P5|Overall Study|Subject/guardian decision|20
2457509|NCT02554786|8469866|P4|Overall Study|Subject/guardian decision|30
2457510|NCT02554786|8469867|P3|Overall Study|Subject/guardian decision|18
2457511|NCT02554786|8469868|P2|Overall Study|Subject/guardian decision|17
2457512|NCT02554786|8469869|P1|Overall Study|Subject/guardian decision|29
2457513|NCT02554682|8470021|P10|Overall Study|Physician Decision|0
2457514|NCT02554682|8470022|P9|Overall Study|Physician Decision|0
2457515|NCT02554682|8470023|P8|Overall Study|Physician Decision|0
2457516|NCT02554682|8470024|P7|Overall Study|Physician Decision|0
2457517|NCT02554682|8470025|P6|Overall Study|Physician Decision|0
2457518|NCT02554682|8470026|P5|Overall Study|Physician Decision|0
2457519|NCT02554682|8470027|P4|Overall Study|Physician Decision|0
2457520|NCT02554682|8470028|P3|Overall Study|Physician Decision|0
2457521|NCT02554682|8470029|P2|Overall Study|Physician Decision|2
2457522|NCT02554682|8470030|P1|Overall Study|Physician Decision|2
2457523|NCT02554682|8470021|P10|Overall Study|Withdrawal by Subject|0
2457524|NCT02554682|8470022|P9|Overall Study|Withdrawal by Subject|0
2457525|NCT02554682|8470023|P8|Overall Study|Withdrawal by Subject|0
2457526|NCT02554682|8470024|P7|Overall Study|Withdrawal by Subject|0
2457527|NCT02554682|8470025|P6|Overall Study|Withdrawal by Subject|0
2457528|NCT02554682|8470026|P5|Overall Study|Withdrawal by Subject|0
2457529|NCT02554682|8470027|P4|Overall Study|Withdrawal by Subject|0
2457530|NCT02554682|8470028|P3|Overall Study|Withdrawal by Subject|0
2457531|NCT02554682|8470029|P2|Overall Study|Withdrawal by Subject|1
2457532|NCT02554682|8470030|P1|Overall Study|Withdrawal by Subject|2
2457533|NCT02554682|8470021|P10|Overall Study|Lost to Follow-up|2
2457534|NCT02554682|8470022|P9|Overall Study|Lost to Follow-up|2
2457535|NCT02554682|8470023|P8|Overall Study|Lost to Follow-up|6
2457536|NCT02554682|8470024|P7|Overall Study|Lost to Follow-up|6
2457537|NCT02554682|8470025|P6|Overall Study|Lost to Follow-up|1
2457538|NCT02554682|8470026|P5|Overall Study|Lost to Follow-up|2
2457539|NCT02554682|8470027|P4|Overall Study|Lost to Follow-up|3
2457540|NCT02554682|8470028|P3|Overall Study|Lost to Follow-up|4
2457541|NCT02554682|8470029|P2|Overall Study|Lost to Follow-up|9
2457542|NCT02554682|8470030|P1|Overall Study|Lost to Follow-up|11
2457543|NCT02554656|8470079|P1|Overall Study|Protocol Violation|3
2457544|NCT02554279|8470124|P2|Overall Study|Other reason|6
2457545|NCT02554279|8470125|P1|Overall Study|Other reason|19
2457546|NCT02554279|8470124|P2|Overall Study|Protocol Violation|1
2457547|NCT02554279|8470125|P1|Overall Study|Protocol Violation|2
2457548|NCT02554279|8470124|P2|Overall Study|Withdrawal by Subject|4
2457549|NCT02554279|8470125|P1|Overall Study|Withdrawal by Subject|6
2457550|NCT02554279|8470124|P2|Overall Study|Lost to Follow-up|2
2457551|NCT02554279|8470125|P1|Overall Study|Lost to Follow-up|3
2457552|NCT02554279|8470124|P2|Overall Study|Adverse Event|5
2457553|NCT02554279|8470125|P1|Overall Study|Adverse Event|2
2457554|NCT02554019|8470160|P3|Overall Study|Adverse Event|0
2457555|NCT02554019|8470161|P2|Overall Study|Adverse Event|0
2457556|NCT02554019|8470162|P1|Overall Study|Adverse Event|1
2457557|NCT02554019|8470160|P3|Overall Study|Withdrawal by Subject|2
2457558|NCT02554019|8470161|P2|Overall Study|Withdrawal by Subject|0
2457559|NCT02554019|8470162|P1|Overall Study|Withdrawal by Subject|1
2457560|NCT02553928|8470184|P2|Overall Study|Administrative reason(s)|1
2457561|NCT02553928|8470185|P1|Overall Study|Administrative reason(s)|0
2457562|NCT02553928|8470184|P2|Overall Study|Lost to Follow-up|1
2457563|NCT02553928|8470185|P1|Overall Study|Lost to Follow-up|0
2457564|NCT02553928|8470184|P2|Overall Study|Adverse Event|1
2457565|NCT02553928|8470185|P1|Overall Study|Adverse Event|2
2457566|NCT02553772|8470239|P2|Overall Study|Other Miscellaneous Reasons|1
2457567|NCT02553772|8470240|P1|Overall Study|Other Miscellaneous Reasons|0
2457568|NCT02553772|8470239|P2|Overall Study|Lack of Efficacy|0
2457569|NCT02553772|8470240|P1|Overall Study|Lack of Efficacy|1
2457570|NCT02553772|8470239|P2|Overall Study|Withdrawal of Consent|1
2457571|NCT02553772|8470240|P1|Overall Study|Withdrawal of Consent|1
2457572|NCT02553772|8470239|P2|Overall Study|Lost to Follow-up|1
2457573|NCT02553772|8470240|P1|Overall Study|Lost to Follow-up|2
2457574|NCT02553772|8470239|P2|Overall Study|Adverse Event|3
2457575|NCT02553772|8470240|P1|Overall Study|Adverse Event|2
2457576|NCT02553629|8470285|P2|Overall Study|Logistic reasons|6
2457577|NCT02553629|8470286|P1|Overall Study|Logistic reasons|3
2457578|NCT02553538|8470302|P2|Overall Study|Died or Left Network|56
2457579|NCT02553538|8470303|P1|Overall Study|Died or Left Network|54
2457580|NCT02553538|8470302|P2|Overall Study|Could Not Reach by Telephone|0
2457581|NCT02553538|8470303|P1|Overall Study|Could Not Reach by Telephone|133
2457582|NCT02553499|8470337|P14|Overall Study|Withdrawal by Subject|0
2457583|NCT02553499|8470338|P13|Overall Study|Withdrawal by Subject|0
2457584|NCT02553499|8470339|P12|Overall Study|Withdrawal by Subject|0
2457585|NCT02553499|8470340|P11|Overall Study|Withdrawal by Subject|1
2457586|NCT02553499|8470341|P10|Overall Study|Withdrawal by Subject|0
2457587|NCT02553499|8470342|P9|Overall Study|Withdrawal by Subject|1
2457588|NCT02553499|8470343|P8|Overall Study|Withdrawal by Subject|1
2457589|NCT02553499|8470344|P7|Overall Study|Withdrawal by Subject|0
2457590|NCT02553499|8470345|P6|Overall Study|Withdrawal by Subject|0
2457591|NCT02553499|8470346|P5|Overall Study|Withdrawal by Subject|0
2457592|NCT02553499|8470347|P4|Overall Study|Withdrawal by Subject|0
2457593|NCT02553499|8470348|P3|Overall Study|Withdrawal by Subject|0
2457594|NCT02553499|8470349|P2|Overall Study|Withdrawal by Subject|0
2457595|NCT02553499|8470350|P1|Overall Study|Withdrawal by Subject|2
2457596|NCT02553499|8470337|P14|Overall Study|Study Terminated by Sponsor|0
2457597|NCT02553499|8470338|P13|Overall Study|Study Terminated by Sponsor|0
2457598|NCT02553499|8470339|P12|Overall Study|Study Terminated by Sponsor|0
2457599|NCT02553499|8470340|P11|Overall Study|Study Terminated by Sponsor|0
2457600|NCT02553499|8470341|P10|Overall Study|Study Terminated by Sponsor|0
2457601|NCT02553499|8470342|P9|Overall Study|Study Terminated by Sponsor|1
2457602|NCT02553499|8470343|P8|Overall Study|Study Terminated by Sponsor|0
2457603|NCT02553499|8470344|P7|Overall Study|Study Terminated by Sponsor|0
2457604|NCT02553499|8470345|P6|Overall Study|Study Terminated by Sponsor|0
2457605|NCT02553499|8470346|P5|Overall Study|Study Terminated by Sponsor|0
2457606|NCT02553499|8470347|P4|Overall Study|Study Terminated by Sponsor|0
2457607|NCT02553499|8470348|P3|Overall Study|Study Terminated by Sponsor|0
2457608|NCT02553499|8470349|P2|Overall Study|Study Terminated by Sponsor|0
2457609|NCT02553499|8470350|P1|Overall Study|Study Terminated by Sponsor|0
2457610|NCT02553499|8470337|P14|Overall Study|Progressive Disease|1
2457611|NCT02553499|8470338|P13|Overall Study|Progressive Disease|2
2457612|NCT02553499|8470339|P12|Overall Study|Progressive Disease|0
2457613|NCT02553499|8470340|P11|Overall Study|Progressive Disease|0
2457614|NCT02553499|8470341|P10|Overall Study|Progressive Disease|1
2457615|NCT02553499|8470342|P9|Overall Study|Progressive Disease|0
2457616|NCT02553499|8470343|P8|Overall Study|Progressive Disease|0
2457617|NCT02553499|8470344|P7|Overall Study|Progressive Disease|1
2457618|NCT02553499|8470345|P6|Overall Study|Progressive Disease|1
2457619|NCT02553499|8470346|P5|Overall Study|Progressive Disease|1
2457620|NCT02553499|8470347|P4|Overall Study|Progressive Disease|2
2457621|NCT02553499|8470348|P3|Overall Study|Progressive Disease|0
2457622|NCT02553499|8470349|P2|Overall Study|Progressive Disease|0
2457623|NCT02553499|8470350|P1|Overall Study|Progressive Disease|0
2457624|NCT02553499|8470337|P14|Overall Study|Physician Decision|0
2457625|NCT02553499|8470338|P13|Overall Study|Physician Decision|1
2457626|NCT02553499|8470339|P12|Overall Study|Physician Decision|3
2457627|NCT02553499|8470340|P11|Overall Study|Physician Decision|1
2457628|NCT02553499|8470341|P10|Overall Study|Physician Decision|2
2457629|NCT02553499|8470342|P9|Overall Study|Physician Decision|1
2457630|NCT02553499|8470343|P8|Overall Study|Physician Decision|1
2457631|NCT02553499|8470344|P7|Overall Study|Physician Decision|0
2457632|NCT02553499|8470345|P6|Overall Study|Physician Decision|0
2457633|NCT02553499|8470346|P5|Overall Study|Physician Decision|1
2457634|NCT02553499|8470347|P4|Overall Study|Physician Decision|0
2457635|NCT02553499|8470348|P3|Overall Study|Physician Decision|1
2457636|NCT02553499|8470349|P2|Overall Study|Physician Decision|1
2457637|NCT02553499|8470350|P1|Overall Study|Physician Decision|0
2457638|NCT02553499|8470337|P14|Overall Study|Lost to Follow-up|0
2457639|NCT02553499|8470338|P13|Overall Study|Lost to Follow-up|0
2457640|NCT02553499|8470339|P12|Overall Study|Lost to Follow-up|0
2457641|NCT02553499|8470340|P11|Overall Study|Lost to Follow-up|0
2457642|NCT02553499|8470341|P10|Overall Study|Lost to Follow-up|0
2457643|NCT02553499|8470342|P9|Overall Study|Lost to Follow-up|0
2457644|NCT02553499|8470343|P8|Overall Study|Lost to Follow-up|0
2457645|NCT02553499|8470344|P7|Overall Study|Lost to Follow-up|1
2457646|NCT02553499|8470345|P6|Overall Study|Lost to Follow-up|0
2457647|NCT02553499|8470346|P5|Overall Study|Lost to Follow-up|0
2457648|NCT02553499|8470347|P4|Overall Study|Lost to Follow-up|0
2457649|NCT02553499|8470348|P3|Overall Study|Lost to Follow-up|0
2457650|NCT02553499|8470349|P2|Overall Study|Lost to Follow-up|0
2457651|NCT02553499|8470350|P1|Overall Study|Lost to Follow-up|0
2457652|NCT02553499|8470337|P14|Overall Study|Death|0
2457653|NCT02553499|8470338|P13|Overall Study|Death|0
2457654|NCT02553499|8470339|P12|Overall Study|Death|0
2457655|NCT02553499|8470340|P11|Overall Study|Death|1
2457656|NCT02553499|8470341|P10|Overall Study|Death|0
2457657|NCT02553499|8470342|P9|Overall Study|Death|0
2457658|NCT02553499|8470343|P8|Overall Study|Death|0
2457659|NCT02553499|8470344|P7|Overall Study|Death|0
2457660|NCT02553499|8470345|P6|Overall Study|Death|2
2457661|NCT02553499|8470346|P5|Overall Study|Death|1
2457662|NCT02553499|8470347|P4|Overall Study|Death|0
2457663|NCT02553499|8470348|P3|Overall Study|Death|1
2457664|NCT02553499|8470349|P2|Overall Study|Death|1
2457665|NCT02553499|8470350|P1|Overall Study|Death|0
2457666|NCT02553499|8470337|P14|Overall Study|Adverse Event|1
2457667|NCT02553499|8470338|P13|Overall Study|Adverse Event|0
2457668|NCT02553499|8470339|P12|Overall Study|Adverse Event|0
2457669|NCT02553499|8470340|P11|Overall Study|Adverse Event|0
2457670|NCT02553499|8470341|P10|Overall Study|Adverse Event|0
2457671|NCT02553499|8470342|P9|Overall Study|Adverse Event|0
2457672|NCT02553499|8470343|P8|Overall Study|Adverse Event|1
2457673|NCT02553499|8470344|P7|Overall Study|Adverse Event|1
2457674|NCT02553499|8470345|P6|Overall Study|Adverse Event|0
2457675|NCT02553499|8470346|P5|Overall Study|Adverse Event|0
2457676|NCT02553499|8470347|P4|Overall Study|Adverse Event|0
2457677|NCT02553499|8470348|P3|Overall Study|Adverse Event|0
2457678|NCT02553499|8470349|P2|Overall Study|Adverse Event|0
2457679|NCT02553499|8470350|P1|Overall Study|Adverse Event|0
2457680|NCT02553421|8470452|P2|Overall Study|Improper Device Placement|0
2457681|NCT02553421|8470453|P1|Overall Study|Improper Device Placement|3
2457682|NCT02553421|8470452|P2|Overall Study|Incomplete or Insufficient Data Collecte|0
2457683|NCT02553421|8470453|P1|Overall Study|Incomplete or Insufficient Data Collecte|5
2457684|NCT02553421|8470452|P2|Overall Study|Lost to Follow-up|1
2457685|NCT02553421|8470453|P1|Overall Study|Lost to Follow-up|21
2457686|NCT02553317|8470463|P2|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1
2457687|NCT02553317|8470464|P1|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0
2457688|NCT02553317|8470463|P2|Overall Treatment Period + Follow-up|Protocol Violation|1
2457689|NCT02553317|8470464|P1|Overall Treatment Period + Follow-up|Protocol Violation|0
2457690|NCT02553317|8470463|P2|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1
2457691|NCT02553317|8470464|P1|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1
2457692|NCT02553317|8470463|P2|Overall Treatment Period + Follow-up|Lost to Follow-up|1
2457693|NCT02553317|8470464|P1|Overall Treatment Period + Follow-up|Lost to Follow-up|0
2457694|NCT02553317|8470463|P2|Overall Treatment Period + Follow-up|Withdrawal by Subject|5
2457695|NCT02553317|8470464|P1|Overall Treatment Period + Follow-up|Withdrawal by Subject|4
2457696|NCT02553317|8470463|P2|Overall Treatment Period + Follow-up|Adverse Event|5
2457697|NCT02553317|8470464|P1|Overall Treatment Period + Follow-up|Adverse Event|6
2457698|NCT02553317|8470463|P2|Overall Treatment Period + Follow-up|Death|3
2457699|NCT02553317|8470464|P1|Overall Treatment Period + Follow-up|Death|1
2457700|NCT02553317|8470463|P2|Overall Treatment Period + Follow-up|Non-compliance with study drug|1
2457701|NCT02553317|8470464|P1|Overall Treatment Period + Follow-up|Non-compliance with study drug|0
2457702|NCT02553317|8470463|P2|Overall Treatment Period + Follow-up|Physician Decision|4
2457703|NCT02553317|8470464|P1|Overall Treatment Period + Follow-up|Physician Decision|2
2457704|NCT02553317|8470463|P2|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1
2457705|NCT02553317|8470464|P1|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0
2457706|NCT02552966|8470494|P1|Overall Study|Withdrawal by Subject|3
2457707|NCT02552966|8470494|P1|Overall Study|Lost to Follow-up|2
2457708|NCT02552355|8470529|P4|Overall Study|Withdrawal by Subject|1
2457709|NCT02552355|8470530|P3|Overall Study|Withdrawal by Subject|0
2457710|NCT02552355|8470531|P2|Overall Study|Withdrawal by Subject|0
2457711|NCT02552355|8470532|P1|Overall Study|Withdrawal by Subject|0
2457712|NCT02552355|8470529|P4|Overall Study|Adverse Event|0
2457713|NCT02552355|8470530|P3|Overall Study|Adverse Event|2
2457714|NCT02552355|8470531|P2|Overall Study|Adverse Event|2
2457715|NCT02552355|8470532|P1|Overall Study|Adverse Event|0
2457716|NCT02552303|8470578|P4|Follow-Up|ineligible|0
2457717|NCT02552303|8470579|P3|Follow-Up|ineligible|0
2457718|NCT02552303|8470580|P2|Follow-Up|ineligible|2
2457719|NCT02552303|8470581|P1|Follow-Up|ineligible|0
2457720|NCT02552303|8470578|P4|Follow-Up|Lost to Follow-up|0
2457721|NCT02552303|8470579|P3|Follow-Up|Lost to Follow-up|1
2457722|NCT02552303|8470580|P2|Follow-Up|Lost to Follow-up|0
2457723|NCT02552303|8470581|P1|Follow-Up|Lost to Follow-up|0
2457724|NCT02552303|8470578|P4|Allocation|ineligible|0
2457725|NCT02552303|8470579|P3|Allocation|ineligible|0
2457726|NCT02552303|8470580|P2|Allocation|ineligible|1
2457727|NCT02552303|8470581|P1|Allocation|ineligible|1
2457728|NCT02552303|8470578|P4|Allocation|Withdrawal by Subject|1
2457729|NCT02552303|8470579|P3|Allocation|Withdrawal by Subject|1
2457730|NCT02552303|8470580|P2|Allocation|Withdrawal by Subject|1
2457731|NCT02552303|8470581|P1|Allocation|Withdrawal by Subject|2
2457732|NCT02552147|8470595|P2|Second Intervention (7 Days)|Protocol Violation|0
2457733|NCT02552147|8470596|P1|Second Intervention (7 Days)|Protocol Violation|2
2457734|NCT02552147|8470595|P2|First Intervention (7 Days)|Protocol Violation|0
2457735|NCT02552147|8470596|P1|First Intervention (7 Days)|Protocol Violation|1
2457736|NCT02552121|8470630|P8|Part 2: Cohort Expansion|Death|0
2457737|NCT02552121|8470631|P7|Part 2: Cohort Expansion|Death|0
2457738|NCT02552121|8470632|P6|Part 2: Cohort Expansion|Death|0
2457739|NCT02552121|8470633|P5|Part 2: Cohort Expansion|Death|0
2457740|NCT02552121|8470634|P4|Part 2: Cohort Expansion|Death|0
2457741|NCT02552121|8470635|P3|Part 2: Cohort Expansion|Death|1
2457742|NCT02552121|8470636|P2|Part 2: Cohort Expansion|Death|0
2457743|NCT02552121|8470637|P1|Part 2: Cohort Expansion|Death|0
2457744|NCT02552121|8470630|P8|Part 2: Cohort Expansion|Adverse Event|0
2457745|NCT02552121|8470631|P7|Part 2: Cohort Expansion|Adverse Event|0
2457746|NCT02552121|8470632|P6|Part 2: Cohort Expansion|Adverse Event|0
2457747|NCT02552121|8470633|P5|Part 2: Cohort Expansion|Adverse Event|0
2457748|NCT02552121|8470634|P4|Part 2: Cohort Expansion|Adverse Event|1
2457749|NCT02552121|8470635|P3|Part 2: Cohort Expansion|Adverse Event|6
2457750|NCT02552121|8470636|P2|Part 2: Cohort Expansion|Adverse Event|0
2457751|NCT02552121|8470637|P1|Part 2: Cohort Expansion|Adverse Event|0
2457752|NCT02552121|8470630|P8|Part 2: Cohort Expansion|Disease Progression|3
2457753|NCT02552121|8470631|P7|Part 2: Cohort Expansion|Disease Progression|0
2457754|NCT02552121|8470632|P6|Part 2: Cohort Expansion|Disease Progression|4
2457755|NCT02552121|8470633|P5|Part 2: Cohort Expansion|Disease Progression|1
2457756|NCT02552121|8470634|P4|Part 2: Cohort Expansion|Disease Progression|2
2457757|NCT02552121|8470635|P3|Part 2: Cohort Expansion|Disease Progression|3
2457758|NCT02552121|8470636|P2|Part 2: Cohort Expansion|Disease Progression|0
2457759|NCT02552121|8470637|P1|Part 2: Cohort Expansion|Disease Progression|0
2457760|NCT02552121|8470630|P8|Part 2: Cohort Expansion|Patient Choice|0
2457761|NCT02552121|8470631|P7|Part 2: Cohort Expansion|Patient Choice|1
2457762|NCT02552121|8470632|P6|Part 2: Cohort Expansion|Patient Choice|0
2457763|NCT02552121|8470633|P5|Part 2: Cohort Expansion|Patient Choice|0
2457764|NCT02552121|8470634|P4|Part 2: Cohort Expansion|Patient Choice|0
2457765|NCT02552121|8470635|P3|Part 2: Cohort Expansion|Patient Choice|1
2457766|NCT02552121|8470636|P2|Part 2: Cohort Expansion|Patient Choice|0
2457767|NCT02552121|8470637|P1|Part 2: Cohort Expansion|Patient Choice|0
2457768|NCT02552121|8470630|P8|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
2457769|NCT02552121|8470631|P7|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
2457770|NCT02552121|8470632|P6|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
2457771|NCT02552121|8470633|P5|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
2457772|NCT02552121|8470634|P4|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
2457773|NCT02552121|8470635|P3|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
2457774|NCT02552121|8470636|P2|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1
2457775|NCT02552121|8470637|P1|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
2457776|NCT02552121|8470630|P8|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
2457777|NCT02552121|8470631|P7|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
2457778|NCT02552121|8470632|P6|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
2457779|NCT02552121|8470633|P5|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
2457780|NCT02552121|8470634|P4|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
2457781|NCT02552121|8470635|P3|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
2457782|NCT02552121|8470636|P2|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2
2457783|NCT02552121|8470637|P1|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
2457784|NCT02552121|8470630|P8|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
2457785|NCT02552121|8470631|P7|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
2457786|NCT02552121|8470632|P6|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
2457787|NCT02552121|8470633|P5|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
2457788|NCT02552121|8470634|P4|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
2457789|NCT02552121|8470635|P3|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
2457790|NCT02552121|8470636|P2|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2
2457791|NCT02552121|8470637|P1|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
2457792|NCT02552121|8470630|P8|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
2457793|NCT02552121|8470631|P7|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
2457794|NCT02552121|8470632|P6|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
2457795|NCT02552121|8470633|P5|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
2457796|NCT02552121|8470634|P4|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
2457797|NCT02552121|8470635|P3|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
2457798|NCT02552121|8470636|P2|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1
2457799|NCT02552121|8470637|P1|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
2457800|NCT02552121|8470630|P8|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
2457801|NCT02552121|8470631|P7|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
2457802|NCT02552121|8470632|P6|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
2457803|NCT02552121|8470633|P5|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
2457804|NCT02552121|8470634|P4|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
2457805|NCT02552121|8470635|P3|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
2457806|NCT02552121|8470636|P2|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
2457807|NCT02552121|8470637|P1|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1
2457808|NCT02552121|8470630|P8|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
2457809|NCT02552121|8470631|P7|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
2457810|NCT02552121|8470632|P6|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
2457811|NCT02552121|8470633|P5|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
2457812|NCT02552121|8470634|P4|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
2457813|NCT02552121|8470635|P3|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
2457814|NCT02552121|8470636|P2|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
2457815|NCT02552121|8470637|P1|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2
2457816|NCT02551874|8470898|P2|Overall Study|Did not enter long-term study|25
2457817|NCT02551874|8470899|P1|Overall Study|Did not enter long-term study|18
2457818|NCT02551874|8470898|P2|Overall Study|Did not receive randomized treatment|7
2457819|NCT02551874|8470899|P1|Overall Study|Did not receive randomized treatment|0
2457820|NCT02551874|8470898|P2|Overall Study|Reason not reported|4
2457821|NCT02551874|8470899|P1|Overall Study|Reason not reported|10
2457822|NCT02551874|8470898|P2|Overall Study|Pregnancy|1
2457823|NCT02551874|8470899|P1|Overall Study|Pregnancy|0
2457824|NCT02551874|8470898|P2|Overall Study|Lost to Follow-up|2
2457825|NCT02551874|8470899|P1|Overall Study|Lost to Follow-up|0
2457826|NCT02551731|8470968|P1|Overall Study|Withdrawal by Subject|2
2457827|NCT02551692|8470988|P3|Overall Study|Withdrawal by Subject|1
2457828|NCT02551692|8470989|P2|Overall Study|Withdrawal by Subject|0
2457829|NCT02551692|8470990|P1|Overall Study|Withdrawal by Subject|1
2457830|NCT02551692|8470988|P3|Overall Study|Lost to Follow-up|4
2457831|NCT02551692|8470989|P2|Overall Study|Lost to Follow-up|1
2457832|NCT02551692|8470990|P1|Overall Study|Lost to Follow-up|0
2457833|NCT02551055|8471037|P8|Overall Study|Reason not specified|0
2457834|NCT02551055|8471038|P7|Overall Study|Reason not specified|1
2457835|NCT02551055|8471039|P6|Overall Study|Reason not specified|0
2457836|NCT02551055|8471040|P5|Overall Study|Reason not specified|1
2457837|NCT02551055|8471041|P4|Overall Study|Reason not specified|0
2457838|NCT02551055|8471042|P3|Overall Study|Reason not specified|0
2457839|NCT02551055|8471043|P2|Overall Study|Reason not specified|0
2457840|NCT02551055|8471044|P1|Overall Study|Reason not specified|0
2457841|NCT02551055|8471037|P8|Overall Study|Withdrawal by Subject|0
2457842|NCT02551055|8471038|P7|Overall Study|Withdrawal by Subject|0
2457843|NCT02551055|8471039|P6|Overall Study|Withdrawal by Subject|0
2457844|NCT02551055|8471040|P5|Overall Study|Withdrawal by Subject|2
2457845|NCT02551055|8471041|P4|Overall Study|Withdrawal by Subject|1
2457846|NCT02551055|8471042|P3|Overall Study|Withdrawal by Subject|0
2457847|NCT02551055|8471043|P2|Overall Study|Withdrawal by Subject|1
2457848|NCT02551055|8471044|P1|Overall Study|Withdrawal by Subject|1
2457849|NCT02551055|8471037|P8|Overall Study|Study Terminated by Sponsor|0
2457850|NCT02551055|8471038|P7|Overall Study|Study Terminated by Sponsor|0
2457851|NCT02551055|8471039|P6|Overall Study|Study Terminated by Sponsor|0
2457852|NCT02551055|8471040|P5|Overall Study|Study Terminated by Sponsor|2
2457853|NCT02551055|8471041|P4|Overall Study|Study Terminated by Sponsor|2
2457854|NCT02551055|8471042|P3|Overall Study|Study Terminated by Sponsor|0
2457855|NCT02551055|8471043|P2|Overall Study|Study Terminated by Sponsor|1
2457856|NCT02551055|8471044|P1|Overall Study|Study Terminated by Sponsor|1
2457857|NCT02551055|8471037|P8|Overall Study|Death|0
2457858|NCT02551055|8471038|P7|Overall Study|Death|2
2457859|NCT02551055|8471039|P6|Overall Study|Death|1
2457860|NCT02551055|8471040|P5|Overall Study|Death|2
2457861|NCT02551055|8471041|P4|Overall Study|Death|2
2457862|NCT02551055|8471042|P3|Overall Study|Death|2
2457863|NCT02551055|8471043|P2|Overall Study|Death|4
2457864|NCT02551055|8471044|P1|Overall Study|Death|2
2457865|NCT02550873|8471119|P3|Open Label Extension|Study ongoing|111
2457866|NCT02550873|8471120|P2|Open Label Extension|Study ongoing|0
2457867|NCT02550873|8471121|P1|Open Label Extension|Study ongoing|0
2457868|NCT02550873|8471119|P3|Randomized Double Blind|Disease progression|0
2457869|NCT02550873|8471120|P2|Randomized Double Blind|Disease progression|1
2457870|NCT02550873|8471121|P1|Randomized Double Blind|Disease progression|1
2457871|NCT02550873|8471119|P3|Randomized Double Blind|Adverse Event|0
2457872|NCT02550873|8471120|P2|Randomized Double Blind|Adverse Event|1
2457873|NCT02550873|8471121|P1|Randomized Double Blind|Adverse Event|3
2457874|NCT02550652|8471201|P2|Overall Study|Ongoing in study|56
2457875|NCT02550652|8471202|P1|Overall Study|Ongoing in study|59
2457876|NCT02550652|8471201|P2|Overall Study|Withdrawal by Subject|4
2457877|NCT02550652|8471202|P1|Overall Study|Withdrawal by Subject|3
2457878|NCT02550652|8471201|P2|Overall Study|Lack of Efficacy|0
2457879|NCT02550652|8471202|P1|Overall Study|Lack of Efficacy|1
2457880|NCT02550652|8471201|P2|Overall Study|Death|2
2457881|NCT02550652|8471202|P1|Overall Study|Death|0
2457882|NCT02550288|8471249|P5|Overall Study|Withdrawal by Subject|0
2457883|NCT02550288|8471250|P4|Overall Study|Withdrawal by Subject|1
2457884|NCT02550288|8471251|P3|Overall Study|Withdrawal by Subject|0
2457885|NCT02550288|8471252|P2|Overall Study|Withdrawal by Subject|0
2457886|NCT02550288|8471253|P1|Overall Study|Withdrawal by Subject|0
2457887|NCT02550288|8471249|P5|Overall Study|Participant moved|0
2457888|NCT02550288|8471250|P4|Overall Study|Participant moved|1
2457889|NCT02550288|8471251|P3|Overall Study|Participant moved|0
2457890|NCT02550288|8471252|P2|Overall Study|Participant moved|0
2457891|NCT02550288|8471253|P1|Overall Study|Participant moved|0
2457892|NCT02550288|8471249|P5|Overall Study|Protocol Violation|3
2457893|NCT02550288|8471250|P4|Overall Study|Protocol Violation|0
2457894|NCT02550288|8471251|P3|Overall Study|Protocol Violation|1
2457895|NCT02550288|8471252|P2|Overall Study|Protocol Violation|2
2457896|NCT02550288|8471253|P1|Overall Study|Protocol Violation|2
2457897|NCT02550288|8471249|P5|Overall Study|Physician Decision|0
2457898|NCT02550288|8471250|P4|Overall Study|Physician Decision|1
2457899|NCT02550288|8471251|P3|Overall Study|Physician Decision|0
2457900|NCT02550288|8471252|P2|Overall Study|Physician Decision|0
2457901|NCT02550288|8471253|P1|Overall Study|Physician Decision|0
2457902|NCT02550288|8471249|P5|Overall Study|Adverse Event|0
2457903|NCT02550288|8471250|P4|Overall Study|Adverse Event|0
2457904|NCT02550288|8471251|P3|Overall Study|Adverse Event|0
2457905|NCT02550288|8471252|P2|Overall Study|Adverse Event|1
2457906|NCT02550288|8471253|P1|Overall Study|Adverse Event|0
2457907|NCT02550106|8471409|P1|Overall Study|Withdrawal by Subject|2
2457908|NCT02550106|8471409|P1|Overall Study|Protocol Violation|6
2457909|NCT02550106|8471409|P1|Overall Study|Lack of Efficacy|3
2457910|NCT02550106|8471409|P1|Overall Study|Adverse Event|1
2457911|NCT02549573|8471454|P2|Overall Study|Protocol Violation|1
2457912|NCT02549573|8471455|P1|Overall Study|Protocol Violation|0
2457913|NCT02549573|8471454|P2|Overall Study|Withdrawal by Subject|2
2457914|NCT02549573|8471455|P1|Overall Study|Withdrawal by Subject|0
2457915|NCT02549352|8471509|P2|12-month Follow-up|Other|3
2457916|NCT02549352|8471510|P1|12-month Follow-up|Other|1
2457917|NCT02549352|8471509|P2|12-month Follow-up|Protocol Violation|1
2457918|NCT02549352|8471510|P1|12-month Follow-up|Protocol Violation|0
2457919|NCT02549352|8471509|P2|12-month Follow-up|Death|1
2457920|NCT02549352|8471510|P1|12-month Follow-up|Death|0
2457921|NCT02549352|8471509|P2|12-month Follow-up|Lost to Follow-up|2
2457922|NCT02549352|8471510|P1|12-month Follow-up|Lost to Follow-up|3
2457923|NCT02549352|8471509|P2|12-month Follow-up|Withdrawal by Subject|5
2457924|NCT02549352|8471510|P1|12-month Follow-up|Withdrawal by Subject|4
2457925|NCT02549352|8471509|P2|3-day Treatment and 8-week Follow-up|Other|2
2457926|NCT02549352|8471510|P1|3-day Treatment and 8-week Follow-up|Other|0
2457927|NCT02549352|8471509|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
2457928|NCT02549352|8471510|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2
2457929|NCT02549352|8471509|P2|3-day Treatment and 8-week Follow-up|Adverse Event|1
2457930|NCT02549352|8471510|P1|3-day Treatment and 8-week Follow-up|Adverse Event|0
2457931|NCT02549339|8471526|P2|12-month Follow-up|Other|3
2457932|NCT02549339|8471527|P1|12-month Follow-up|Other|0
2457933|NCT02549339|8471526|P2|12-month Follow-up|Lost to Follow-up|3
2457934|NCT02549339|8471527|P1|12-month Follow-up|Lost to Follow-up|1
2457935|NCT02549339|8471526|P2|12-month Follow-up|Withdrawal by Subject|3
2457936|NCT02549339|8471527|P1|12-month Follow-up|Withdrawal by Subject|8
2457937|NCT02549339|8471526|P2|12-month Follow-up|Lack of Efficacy|2
2457938|NCT02549339|8471527|P1|12-month Follow-up|Lack of Efficacy|0
2457939|NCT02549339|8471526|P2|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2
2457940|NCT02549339|8471527|P1|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
2457941|NCT02549339|8471526|P2|3-day Treatment and 8-week Follow-up|Other|0
2457942|NCT02549339|8471527|P1|3-day Treatment and 8-week Follow-up|Other|1
2457943|NCT02549339|8471526|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
2457944|NCT02549339|8471527|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1
2457945|NCT02549339|8471526|P2|3-day Treatment and 8-week Follow-up|Protocol Violation|0
2457946|NCT02549339|8471527|P1|3-day Treatment and 8-week Follow-up|Protocol Violation|2
2457947|NCT02549287|8471543|P2|Overall Study|Withdrawal by Subject|6
2457948|NCT02549287|8471544|P1|Overall Study|Withdrawal by Subject|15
2457949|NCT02549287|8471543|P2|Overall Study|Lost to Follow-up|26
2457950|NCT02549287|8471544|P1|Overall Study|Lost to Follow-up|65
2457951|NCT02549196|8471578|P4|Overall Study|Withdrawal by Subject|0
2457952|NCT02549196|8471579|P3|Overall Study|Withdrawal by Subject|1
2457953|NCT02549196|8471580|P2|Overall Study|Withdrawal by Subject|0
2457954|NCT02549196|8471581|P1|Overall Study|Withdrawal by Subject|1
2457955|NCT02549196|8471578|P4|Overall Study|Protocol Violation|1
2457956|NCT02549196|8471579|P3|Overall Study|Protocol Violation|0
2457957|NCT02549196|8471580|P2|Overall Study|Protocol Violation|0
2457958|NCT02549196|8471581|P1|Overall Study|Protocol Violation|0
2457959|NCT02549027|8471637|P6|Period 5 - MK-6096 or Placebo|Protocol Violation|0
2457960|NCT02549027|8471638|P5|Period 5 - MK-6096 or Placebo|Protocol Violation|2
2457961|NCT02549027|8471639|P4|Period 5 - MK-6096 or Placebo|Protocol Violation|0
2457962|NCT02549027|8471640|P3|Period 5 - MK-6096 or Placebo|Protocol Violation|0
2457963|NCT02549027|8471641|P2|Period 5 - MK-6096 or Placebo|Protocol Violation|0
2457964|NCT02549027|8471642|P1|Period 5 - MK-6096 or Placebo|Protocol Violation|0
2457965|NCT02549027|8471637|P6|Washout After Period 4|Withdrawal by Subject|0
2457966|NCT02549027|8471638|P5|Washout After Period 4|Withdrawal by Subject|0
2457967|NCT02549027|8471639|P4|Washout After Period 4|Withdrawal by Subject|1
2457968|NCT02549027|8471640|P3|Washout After Period 4|Withdrawal by Subject|1
2457969|NCT02549027|8471641|P2|Washout After Period 4|Withdrawal by Subject|1
2457970|NCT02549027|8471642|P1|Washout After Period 4|Withdrawal by Subject|0
2457971|NCT02548962|8471772|P2|Overall Study|Withdrawal by Subject|0
2457972|NCT02548962|8471773|P1|Overall Study|Withdrawal by Subject|1
2457973|NCT02548650|8471825|P2|Double Therapy|Withdrawal by Subject|1
2457974|NCT02548650|8471826|P1|Double Therapy|Withdrawal by Subject|0
2457975|NCT02548650|8471825|P2|Double Therapy|Adverse Event|1
2457976|NCT02548650|8471826|P1|Double Therapy|Adverse Event|1
2457977|NCT02548650|8471825|P2|Triple Therapy|Withdrawal by Subject|4
2457978|NCT02548650|8471826|P1|Triple Therapy|Withdrawal by Subject|0
2457979|NCT02548650|8471825|P2|Triple Therapy|Adverse Event|0
2457980|NCT02548650|8471826|P1|Triple Therapy|Adverse Event|1
2457981|NCT02548585|8471841|P7|Overall Study|Randomized but not treated|0
2457982|NCT02548585|8471842|P6|Overall Study|Randomized but not treated|1
2457983|NCT02548585|8471843|P5|Overall Study|Randomized but not treated|0
2457984|NCT02548585|8471844|P4|Overall Study|Randomized but not treated|0
2457985|NCT02548585|8471845|P3|Overall Study|Randomized but not treated|0
2457986|NCT02548585|8471846|P2|Overall Study|Randomized but not treated|0
2457987|NCT02548585|8471847|P1|Overall Study|Randomized but not treated|0
2457988|NCT02548585|8471841|P7|Overall Study|Other|1
2457989|NCT02548585|8471842|P6|Overall Study|Other|0
2457990|NCT02548585|8471843|P5|Overall Study|Other|3
2457991|NCT02548585|8471844|P4|Overall Study|Other|2
2457992|NCT02548585|8471845|P3|Overall Study|Other|0
2457993|NCT02548585|8471846|P2|Overall Study|Other|0
2457994|NCT02548585|8471847|P1|Overall Study|Other|1
2457995|NCT02548585|8471841|P7|Overall Study|Lost to Follow-up|0
2457996|NCT02548585|8471842|P6|Overall Study|Lost to Follow-up|0
2457997|NCT02548585|8471843|P5|Overall Study|Lost to Follow-up|0
2457998|NCT02548585|8471844|P4|Overall Study|Lost to Follow-up|0
2457999|NCT02548585|8471845|P3|Overall Study|Lost to Follow-up|0
2458000|NCT02548585|8471846|P2|Overall Study|Lost to Follow-up|0
2458001|NCT02548585|8471847|P1|Overall Study|Lost to Follow-up|1
2458002|NCT02548585|8471841|P7|Overall Study|Withdrawal by Subject|0
2458003|NCT02548585|8471842|P6|Overall Study|Withdrawal by Subject|1
2458004|NCT02548585|8471843|P5|Overall Study|Withdrawal by Subject|0
2458005|NCT02548585|8471844|P4|Overall Study|Withdrawal by Subject|0
2458006|NCT02548585|8471845|P3|Overall Study|Withdrawal by Subject|0
2458007|NCT02548585|8471846|P2|Overall Study|Withdrawal by Subject|0
2458008|NCT02548585|8471847|P1|Overall Study|Withdrawal by Subject|0
2458009|NCT02548455|8472065|P1|Overall Study|Visit not completed|173
2458010|NCT02548455|8472065|P1|Overall Study|Lost to Follow-up|14
2458011|NCT02548455|8472065|P1|Overall Study|Death|26
2458012|NCT02548455|8472065|P1|Overall Study|Withdrawal by Subject|27
2458013|NCT02548156|8472126|P6|Washout Period 1|Lost to Follow-up|0
2458014|NCT02548156|8472127|P5|Washout Period 1|Lost to Follow-up|1
2458015|NCT02548156|8472128|P4|Washout Period 1|Lost to Follow-up|0
2458016|NCT02548156|8472129|P3|Washout Period 1|Lost to Follow-up|0
2458017|NCT02548156|8472130|P2|Washout Period 1|Lost to Follow-up|0
2458018|NCT02548156|8472131|P1|Washout Period 1|Lost to Follow-up|0
2458019|NCT02548143|8472150|P2|Overall Study|Withdrawal by Subject|1
2458020|NCT02548143|8472151|P1|Overall Study|Withdrawal by Subject|0
2458021|NCT02548143|8472150|P2|Overall Study|Adverse Event|0
2458022|NCT02548143|8472151|P1|Overall Study|Adverse Event|1
2458023|NCT02548078|8472163|P2|Overall Study|Lost to Follow-up|3
2458024|NCT02548078|8472164|P1|Overall Study|Lost to Follow-up|1
2458025|NCT02548078|8472163|P2|Overall Study|Moved from study area|3
2458026|NCT02548078|8472164|P1|Overall Study|Moved from study area|3
2458027|NCT02548078|8472163|P2|Overall Study|Serious adverse event/Adverse event|0
2458028|NCT02548078|8472164|P1|Overall Study|Serious adverse event/Adverse event|1
2458029|NCT02547987|8472352|P1|Overall Study|Adverse Event|2
2458030|NCT02547987|8472352|P1|Overall Study|Withdrawal by Subject|1
2458031|NCT02547974|8472360|P4|Overall Study|Withdrawal by Subject|0
2458032|NCT02547974|8472361|P3|Overall Study|Withdrawal by Subject|0
2458033|NCT02547974|8472362|P2|Overall Study|Withdrawal by Subject|0
2458034|NCT02547974|8472363|P1|Overall Study|Withdrawal by Subject|1
2458035|NCT02547935|8472450|P3|Overall Study|Death|0
2458036|NCT02547935|8472451|P2|Overall Study|Death|1
2458037|NCT02547935|8472452|P1|Overall Study|Death|1
2458038|NCT02547935|8472450|P3|Overall Study|Lost to Follow-up|1
2458039|NCT02547935|8472451|P2|Overall Study|Lost to Follow-up|2
2458040|NCT02547935|8472452|P1|Overall Study|Lost to Follow-up|0
2458041|NCT02547935|8472450|P3|Overall Study|Physician Decision|0
2458042|NCT02547935|8472451|P2|Overall Study|Physician Decision|1
2458043|NCT02547935|8472452|P1|Overall Study|Physician Decision|0
2458044|NCT02547935|8472450|P3|Overall Study|Screen Failure|0
2458045|NCT02547935|8472451|P2|Overall Study|Screen Failure|0
2458046|NCT02547935|8472452|P1|Overall Study|Screen Failure|2
2458047|NCT02547935|8472450|P3|Overall Study|Withdrawal by Subject|4
2458048|NCT02547935|8472451|P2|Overall Study|Withdrawal by Subject|3
2458049|NCT02547935|8472452|P1|Overall Study|Withdrawal by Subject|2
2458050|NCT02547935|8472450|P3|Overall Study|Other|0
2458051|NCT02547935|8472451|P2|Overall Study|Other|1
2458052|NCT02547935|8472452|P1|Overall Study|Other|0
2458053|NCT02547766|8472490|P1|Overall Study|Withdrawal by Subject|1
2458054|NCT02547649|8472510|P3|Overall Study|Withdrawal by Subject|2
2458055|NCT02547649|8472511|P2|Overall Study|Withdrawal by Subject|4
2458056|NCT02547649|8472512|P1|Overall Study|Withdrawal by Subject|0
2458057|NCT02547649|8472510|P3|Overall Study|Not vaccinated|1
2458058|NCT02547649|8472511|P2|Overall Study|Not vaccinated|0
2458059|NCT02547649|8472512|P1|Overall Study|Not vaccinated|0
2458060|NCT02547649|8472510|P3|Overall Study|Lost to Follow-up|1
2458061|NCT02547649|8472511|P2|Overall Study|Lost to Follow-up|1
2458062|NCT02547649|8472512|P1|Overall Study|Lost to Follow-up|3
2458063|NCT02547454|8472577|P1|Overall Study|No data|11
2458064|NCT02547454|8472577|P1|Overall Study|Other|39
2458065|NCT02547454|8472577|P1|Overall Study|Lost to Follow-up|26
2458066|NCT02547454|8472577|P1|Overall Study|Death|38
2458067|NCT02547454|8472577|P1|Overall Study|Due to no further need to treat|4
2458068|NCT02547454|8472577|P1|Overall Study|Due to transplantation|1
2458069|NCT02547454|8472577|P1|Overall Study|Due to hemodialysis|53
2458070|NCT02547363|8472607|P2|12-month Follow-up|Other|0
2458071|NCT02547363|8472608|P1|12-month Follow-up|Other|1
2458072|NCT02547363|8472607|P2|12-month Follow-up|Lack of Efficacy|1
2458073|NCT02547363|8472608|P1|12-month Follow-up|Lack of Efficacy|1
2458074|NCT02547363|8472607|P2|12-month Follow-up|Lost to Follow-up|1
2458075|NCT02547363|8472608|P1|12-month Follow-up|Lost to Follow-up|4
2458076|NCT02547363|8472607|P2|12-month Follow-up|Withdrawal by Subject|3
2458077|NCT02547363|8472608|P1|12-month Follow-up|Withdrawal by Subject|4
2458078|NCT02547363|8472607|P2|3-day Treatment and 8-week Follow-up|Other|1
2458079|NCT02547363|8472608|P1|3-day Treatment and 8-week Follow-up|Other|1
2458080|NCT02547363|8472607|P2|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
2458081|NCT02547363|8472608|P1|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
2458082|NCT02547363|8472607|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8
2458083|NCT02547363|8472608|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2
2458084|NCT02547363|8472607|P2|3-day Treatment and 8-week Follow-up|Adverse Event|1
2458085|NCT02547363|8472608|P1|3-day Treatment and 8-week Follow-up|Adverse Event|0
2458086|NCT02547233|8472624|P2|12-month Follow-up|Other|1
2458087|NCT02547233|8472625|P1|12-month Follow-up|Other|0
2458088|NCT02547233|8472624|P2|12-month Follow-up|Protocol Violation|1
2458089|NCT02547233|8472625|P1|12-month Follow-up|Protocol Violation|0
2458090|NCT02547233|8472624|P2|12-month Follow-up|Lack of Efficacy|2
2458091|NCT02547233|8472625|P1|12-month Follow-up|Lack of Efficacy|1
2458092|NCT02547233|8472624|P2|12-month Follow-up|Lost to Follow-up|3
2458093|NCT02547233|8472625|P1|12-month Follow-up|Lost to Follow-up|3
2458094|NCT02547233|8472624|P2|12-month Follow-up|Withdrawal by Subject|10
2458095|NCT02547233|8472625|P1|12-month Follow-up|Withdrawal by Subject|10
2458096|NCT02547233|8472624|P2|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
2458097|NCT02547233|8472625|P1|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
2458098|NCT02547233|8472624|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9
2458099|NCT02547233|8472625|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0
2458100|NCT02547233|8472624|P2|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0
2458101|NCT02547233|8472625|P1|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1
2458102|NCT02547233|8472624|P2|3-day Treatment and 8-week Follow-up|Adverse Event|0
2458103|NCT02547233|8472625|P1|3-day Treatment and 8-week Follow-up|Adverse Event|1
2458104|NCT02547129|8472641|P2|Overall Study|Difficulty with ongoing infection|0
2458105|NCT02547129|8472642|P1|Overall Study|Difficulty with ongoing infection|1
2458106|NCT02547038|8472685|P2|Overall Study|Lost to Follow-up|2
2458107|NCT02547038|8472686|P1|Overall Study|Lost to Follow-up|3
2458108|NCT02546986|8472703|P2|Survival Follow-Up Phase|Lost to Follow-up|2
2458109|NCT02546986|8472704|P1|Survival Follow-Up Phase|Lost to Follow-up|2
2458110|NCT02546986|8472703|P2|Survival Follow-Up Phase|Alive|16
2458111|NCT02546986|8472704|P1|Survival Follow-Up Phase|Alive|13
2458112|NCT02546986|8472703|P2|Survival Follow-Up Phase|Death|12
2458113|NCT02546986|8472704|P1|Survival Follow-Up Phase|Death|18
2458114|NCT02546986|8472703|P2|Survival Follow-Up Phase|Missing Status|5
2458115|NCT02546986|8472704|P1|Survival Follow-Up Phase|Missing Status|3
2458116|NCT02546986|8472703|P2|Treatment Period|Miscellaneous|9
2458117|NCT02546986|8472704|P1|Treatment Period|Miscellaneous|7
2458118|NCT02546986|8472703|P2|Treatment Period|Study Terminated by Sponsor|1
2458119|NCT02546986|8472704|P1|Treatment Period|Study Terminated by Sponsor|0
2458120|NCT02546986|8472703|P2|Treatment Period|Non-compliance with Study Drug|1
2458121|NCT02546986|8472704|P1|Treatment Period|Non-compliance with Study Drug|0
2458122|NCT02546986|8472703|P2|Treatment Period|Withdrawal by Subject|1
2458123|NCT02546986|8472704|P1|Treatment Period|Withdrawal by Subject|1
2458124|NCT02546986|8472703|P2|Treatment Period|Protocol Violation|0
2458125|NCT02546986|8472704|P1|Treatment Period|Protocol Violation|1
2458126|NCT02546986|8472703|P2|Treatment Period|Physician Decision|2
2458127|NCT02546986|8472704|P1|Treatment Period|Physician Decision|1
2458128|NCT02546986|8472703|P2|Treatment Period|Death|4
2458129|NCT02546986|8472704|P1|Treatment Period|Death|3
2458130|NCT02546986|8472703|P2|Treatment Period|Symptomatic Deterioration|3
2458131|NCT02546986|8472704|P1|Treatment Period|Symptomatic Deterioration|4
2458132|NCT02546986|8472703|P2|Treatment Period|Adverse Event|6
2458133|NCT02546986|8472704|P1|Treatment Period|Adverse Event|14
2458134|NCT02546986|8472703|P2|Treatment Period|Progressive Disease|22
2458135|NCT02546986|8472704|P1|Treatment Period|Progressive Disease|20
2458136|NCT02546765|8472731|P4|Overall Study|Withdrawal by Subject|0
2458137|NCT02546765|8472732|P3|Overall Study|Withdrawal by Subject|0
2458138|NCT02546765|8472733|P2|Overall Study|Withdrawal by Subject|1
2458139|NCT02546765|8472734|P1|Overall Study|Withdrawal by Subject|0
2458140|NCT02546609|8472775|P3|Overall Study|travel or work schedule restriction|2
2458141|NCT02546609|8472776|P2|Overall Study|travel or work schedule restriction|0
2458142|NCT02546609|8472777|P1|Overall Study|travel or work schedule restriction|0
2458143|NCT02546609|8472775|P3|Overall Study|Lost to Follow-up|1
2458144|NCT02546609|8472776|P2|Overall Study|Lost to Follow-up|3
2458145|NCT02546609|8472777|P1|Overall Study|Lost to Follow-up|2
2458146|NCT02546609|8472775|P3|Overall Study|Protocol Violation|1
2458147|NCT02546609|8472776|P2|Overall Study|Protocol Violation|1
2458148|NCT02546609|8472777|P1|Overall Study|Protocol Violation|0
2458149|NCT02546609|8472775|P3|Overall Study|Adverse Event|1
2458150|NCT02546609|8472776|P2|Overall Study|Adverse Event|6
2458151|NCT02546609|8472777|P1|Overall Study|Adverse Event|0
2458152|NCT02546609|8472775|P3|Overall Study|Withdrawal by Subject|2
2458153|NCT02546609|8472776|P2|Overall Study|Withdrawal by Subject|1
2458154|NCT02546609|8472777|P1|Overall Study|Withdrawal by Subject|0
2458155|NCT02546544|8472857|P1|Overall Study|Withdrawal by Subject|1
2458156|NCT02546544|8472857|P1|Overall Study|Adverse Event|1
2458157|NCT02546544|8472857|P1|Overall Study|Disease Progression|14
2458158|NCT02546362|8472898|P1|12-week Treatment Period|Change in medication|1
2458159|NCT02546362|8472898|P1|12-week Treatment Period|Lost to Follow-up|2
2458160|NCT02546362|8472898|P1|12-week Treatment Period|Withdrawal by Subject|6
2458161|NCT02546362|8472898|P1|4-week Treatment Period|Change in medication|2
2458162|NCT02546362|8472898|P1|4-week Treatment Period|Lost to Follow-up|1
2458163|NCT02546323|8472919|P2|Overall Study|Met Withdrawal Criteria|14
2458164|NCT02546323|8472920|P1|Overall Study|Met Withdrawal Criteria|2
2458165|NCT02546323|8472919|P2|Overall Study|Non-compliance with Study Drug|2
2458166|NCT02546323|8472920|P1|Overall Study|Non-compliance with Study Drug|2
2458167|NCT02546323|8472919|P2|Overall Study|Lost to Follow-up|3
2458168|NCT02546323|8472920|P1|Overall Study|Lost to Follow-up|2
2458169|NCT02546323|8472919|P2|Overall Study|Patient Specific Reasons|2
2458170|NCT02546323|8472920|P1|Overall Study|Patient Specific Reasons|1
2458171|NCT02546323|8472919|P2|Overall Study|Adverse Event|11
2458172|NCT02546323|8472920|P1|Overall Study|Adverse Event|17
2458173|NCT02546323|8472919|P2|Overall Study|Eligibility Criteria not Fulfilled|1
2458174|NCT02546323|8472920|P1|Overall Study|Eligibility Criteria not Fulfilled|0
2458175|NCT02546323|8472919|P2|Overall Study|Withdrawal by Subject|33
2458176|NCT02546323|8472920|P1|Overall Study|Withdrawal by Subject|36
2458177|NCT02546193|8472940|P4|Overall Study|Not eligible at time of induction|0
2458178|NCT02546193|8472941|P3|Overall Study|Not eligible at time of induction|1
2458179|NCT02546193|8472942|P2|Overall Study|Not eligible at time of induction|6
2458180|NCT02546193|8472943|P1|Overall Study|Not eligible at time of induction|4
2458181|NCT02546193|8472940|P4|Overall Study|Withdrawal by Subject|0
2458182|NCT02546193|8472941|P3|Overall Study|Withdrawal by Subject|1
2458183|NCT02546193|8472942|P2|Overall Study|Withdrawal by Subject|0
2458184|NCT02546193|8472943|P1|Overall Study|Withdrawal by Subject|2
2458185|NCT02545868|8472980|P3|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|34
2458186|NCT02545868|8472981|P2|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|35
2458187|NCT02545868|8472982|P1|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|33
2458188|NCT02545543|8473065|P2|Overall Study|Enrolment of subject at >1 study site|1
2458189|NCT02545543|8473066|P1|Overall Study|Enrolment of subject at >1 study site|1
2458190|NCT02545543|8473065|P2|Overall Study|Noncomplaince|0
2458191|NCT02545543|8473066|P1|Overall Study|Noncomplaince|1
2458192|NCT02545543|8473065|P2|Overall Study|Withdrawal by Subject|8
2458193|NCT02545543|8473066|P1|Overall Study|Withdrawal by Subject|9
2458194|NCT02545543|8473065|P2|Overall Study|Physician Decision|0
2458195|NCT02545543|8473066|P1|Overall Study|Physician Decision|3
2458196|NCT02545543|8473065|P2|Overall Study|Lost to Follow-up|25
2458197|NCT02545543|8473066|P1|Overall Study|Lost to Follow-up|67
2458198|NCT02545504|8473092|P2|Overall Study|Lost to Follow-up|2
2458199|NCT02545504|8473093|P1|Overall Study|Lost to Follow-up|2
2458200|NCT02545504|8473092|P2|Overall Study|Investigator's discretion|1
2458201|NCT02545504|8473093|P1|Overall Study|Investigator's discretion|3
2458202|NCT02545504|8473092|P2|Overall Study|Withdrew consent|11
2458203|NCT02545504|8473093|P1|Overall Study|Withdrew consent|9
2458204|NCT02545504|8473092|P2|Overall Study|Unknown reason|32
2458205|NCT02545504|8473093|P1|Overall Study|Unknown reason|30
2458206|NCT02545504|8473092|P2|Overall Study|Death|168
2458207|NCT02545504|8473093|P1|Overall Study|Death|174
2458208|NCT02545322|8473107|P1|Overall Study|Withdrawal by Subject|3
2458209|NCT02545270|8473115|P3|Overall Study|Videos being too similar to other|2
2458210|NCT02545270|8473116|P2|Overall Study|Videos being too similar to other|0
2458211|NCT02545270|8473117|P1|Overall Study|Videos being too similar to other|0
2458212|NCT02545270|8473115|P3|Overall Study|technical difficulties|0
2458213|NCT02545270|8473116|P2|Overall Study|technical difficulties|1
2458214|NCT02545270|8473117|P1|Overall Study|technical difficulties|0
2458215|NCT02544633|8473161|P4|Survival Follow-up Period|Study Terminated by Sponsor|3
2458216|NCT02544633|8473162|P3|Survival Follow-up Period|Study Terminated by Sponsor|2
2458217|NCT02544633|8473163|P2|Survival Follow-up Period|Study Terminated by Sponsor|4
2458218|NCT02544633|8473164|P1|Survival Follow-up Period|Study Terminated by Sponsor|12
2458219|NCT02544633|8473161|P4|Survival Follow-up Period|Withdrawal by Subject|0
2458220|NCT02544633|8473162|P3|Survival Follow-up Period|Withdrawal by Subject|1
2458221|NCT02544633|8473163|P2|Survival Follow-up Period|Withdrawal by Subject|0
2458222|NCT02544633|8473164|P1|Survival Follow-up Period|Withdrawal by Subject|4
2458223|NCT02544633|8473161|P4|Survival Follow-up Period|Lost to Follow-up|0
2458224|NCT02544633|8473162|P3|Survival Follow-up Period|Lost to Follow-up|1
2458225|NCT02544633|8473163|P2|Survival Follow-up Period|Lost to Follow-up|1
2458226|NCT02544633|8473164|P1|Survival Follow-up Period|Lost to Follow-up|0
2458227|NCT02544633|8473161|P4|Survival Follow-up Period|Death|9
2458228|NCT02544633|8473162|P3|Survival Follow-up Period|Death|3
2458229|NCT02544633|8473163|P2|Survival Follow-up Period|Death|14
2458230|NCT02544633|8473164|P1|Survival Follow-up Period|Death|12
2458231|NCT02544633|8473161|P4|Treatment Period|Clinical Disease Progression|1
2458232|NCT02544633|8473162|P3|Treatment Period|Clinical Disease Progression|0
2458233|NCT02544633|8473163|P2|Treatment Period|Clinical Disease Progression|0
2458234|NCT02544633|8473164|P1|Treatment Period|Clinical Disease Progression|0
2458235|NCT02544633|8473161|P4|Treatment Period|Non-compliance|0
2458236|NCT02544633|8473162|P3|Treatment Period|Non-compliance|1
2458237|NCT02544633|8473163|P2|Treatment Period|Non-compliance|0
2458238|NCT02544633|8473164|P1|Treatment Period|Non-compliance|0
2458239|NCT02544633|8473161|P4|Treatment Period|Death|0
2458240|NCT02544633|8473162|P3|Treatment Period|Death|1
2458241|NCT02544633|8473163|P2|Treatment Period|Death|0
2458242|NCT02544633|8473164|P1|Treatment Period|Death|0
2458243|NCT02544633|8473161|P4|Treatment Period|Lost to Follow-up|0
2458244|NCT02544633|8473162|P3|Treatment Period|Lost to Follow-up|0
2458245|NCT02544633|8473163|P2|Treatment Period|Lost to Follow-up|1
2458246|NCT02544633|8473164|P1|Treatment Period|Lost to Follow-up|0
2458247|NCT02544633|8473161|P4|Treatment Period|Withdrawal by Subject|0
2458248|NCT02544633|8473162|P3|Treatment Period|Withdrawal by Subject|0
2458249|NCT02544633|8473163|P2|Treatment Period|Withdrawal by Subject|0
2458250|NCT02544633|8473164|P1|Treatment Period|Withdrawal by Subject|1
2458251|NCT02544633|8473161|P4|Treatment Period|Global Deterioration of Health|1
2458252|NCT02544633|8473162|P3|Treatment Period|Global Deterioration of Health|0
2458253|NCT02544633|8473163|P2|Treatment Period|Global Deterioration of Health|3
2458254|NCT02544633|8473164|P1|Treatment Period|Global Deterioration of Health|3
2458255|NCT02544633|8473161|P4|Treatment Period|Lack of Efficacy|5
2458256|NCT02544633|8473162|P3|Treatment Period|Lack of Efficacy|5
2458257|NCT02544633|8473163|P2|Treatment Period|Lack of Efficacy|11
2458258|NCT02544633|8473164|P1|Treatment Period|Lack of Efficacy|17
2458259|NCT02544633|8473161|P4|Treatment Period|Adverse Event|5
2458260|NCT02544633|8473162|P3|Treatment Period|Adverse Event|0
2458261|NCT02544633|8473163|P2|Treatment Period|Adverse Event|4
2458262|NCT02544633|8473164|P1|Treatment Period|Adverse Event|7
2458263|NCT02544633|8473161|P4|Treatment Period|Patient Still on Treatment/Study|0
2458264|NCT02544633|8473162|P3|Treatment Period|Patient Still on Treatment/Study|1
2458265|NCT02544633|8473163|P2|Treatment Period|Patient Still on Treatment/Study|1
2458266|NCT02544633|8473164|P1|Treatment Period|Patient Still on Treatment/Study|0
2458267|NCT02544451|8473248|P3|Overall Study|Other|0
2458268|NCT02544451|8473249|P2|Overall Study|Other|4
2458269|NCT02544451|8473250|P1|Overall Study|Other|4
2458270|NCT02544451|8473248|P3|Overall Study|Physician Decision|0
2458271|NCT02544451|8473249|P2|Overall Study|Physician Decision|0
2458272|NCT02544451|8473250|P1|Overall Study|Physician Decision|4
2458273|NCT02544451|8473248|P3|Overall Study|Lost to Follow-up|0
2458274|NCT02544451|8473249|P2|Overall Study|Lost to Follow-up|0
2458275|NCT02544451|8473250|P1|Overall Study|Lost to Follow-up|2
2458276|NCT02544451|8473248|P3|Overall Study|Withdrawal of consent (not due to AE)|1
2458277|NCT02544451|8473249|P2|Overall Study|Withdrawal of consent (not due to AE)|2
2458278|NCT02544451|8473250|P1|Overall Study|Withdrawal of consent (not due to AE)|3
2458279|NCT02544451|8473248|P3|Overall Study|Adverse Event|0
2458280|NCT02544451|8473249|P2|Overall Study|Adverse Event|6
2458281|NCT02544451|8473250|P1|Overall Study|Adverse Event|1
2458282|NCT02544152|8473295|P2|Overall Study|Other|0
2458283|NCT02544152|8473296|P1|Overall Study|Other|1
2458284|NCT02544152|8473295|P2|Overall Study|Withdrawal by Subject|3
2458285|NCT02544152|8473296|P1|Overall Study|Withdrawal by Subject|0
2458286|NCT02544152|8473295|P2|Overall Study|Adverse Event|4
2458287|NCT02544152|8473296|P1|Overall Study|Adverse Event|0
2458288|NCT02544074|8473339|P21|Overall Study|Tablet error|0
2458289|NCT02544074|8473340|P20|Overall Study|Tablet error|0
2458290|NCT02544074|8473341|P19|Overall Study|Tablet error|0
2458291|NCT02544074|8473342|P18|Overall Study|Tablet error|0
2458292|NCT02544074|8473343|P17|Overall Study|Tablet error|0
2458293|NCT02544074|8473344|P16|Overall Study|Tablet error|0
2458294|NCT02544074|8473345|P15|Overall Study|Tablet error|0
2458295|NCT02544074|8473346|P14|Overall Study|Tablet error|0
2458296|NCT02544074|8473347|P13|Overall Study|Tablet error|0
2458297|NCT02544074|8473348|P12|Overall Study|Tablet error|0
2458298|NCT02544074|8473349|P11|Overall Study|Tablet error|0
2458299|NCT02544074|8473350|P10|Overall Study|Tablet error|1
2458300|NCT02544074|8473351|P9|Overall Study|Tablet error|0
2458301|NCT02544074|8473352|P8|Overall Study|Tablet error|0
2458302|NCT02544074|8473353|P7|Overall Study|Tablet error|0
2458303|NCT02544074|8473354|P6|Overall Study|Tablet error|1
2458304|NCT02544074|8473355|P5|Overall Study|Tablet error|0
2458305|NCT02544074|8473356|P4|Overall Study|Tablet error|0
2458306|NCT02544074|8473357|P3|Overall Study|Tablet error|0
2458307|NCT02544074|8473358|P2|Overall Study|Tablet error|0
2458308|NCT02544074|8473359|P1|Overall Study|Tablet error|0
2458309|NCT02544074|8473339|P21|Overall Study|Withdrawal by Subject|0
2458310|NCT02544074|8473340|P20|Overall Study|Withdrawal by Subject|0
2458311|NCT02544074|8473341|P19|Overall Study|Withdrawal by Subject|0
2458312|NCT02544074|8473342|P18|Overall Study|Withdrawal by Subject|0
2458313|NCT02544074|8473343|P17|Overall Study|Withdrawal by Subject|0
2458314|NCT02544074|8473344|P16|Overall Study|Withdrawal by Subject|0
2458315|NCT02544074|8473345|P15|Overall Study|Withdrawal by Subject|0
2458316|NCT02544074|8473346|P14|Overall Study|Withdrawal by Subject|0
2458317|NCT02544074|8473347|P13|Overall Study|Withdrawal by Subject|0
2458318|NCT02544074|8473348|P12|Overall Study|Withdrawal by Subject|0
2458319|NCT02544074|8473349|P11|Overall Study|Withdrawal by Subject|0
2458320|NCT02544074|8473350|P10|Overall Study|Withdrawal by Subject|0
2458321|NCT02544074|8473351|P9|Overall Study|Withdrawal by Subject|0
2458322|NCT02544074|8473352|P8|Overall Study|Withdrawal by Subject|0
2458323|NCT02544074|8473353|P7|Overall Study|Withdrawal by Subject|0
2458324|NCT02544074|8473354|P6|Overall Study|Withdrawal by Subject|0
2458325|NCT02544074|8473355|P5|Overall Study|Withdrawal by Subject|0
2458326|NCT02544074|8473356|P4|Overall Study|Withdrawal by Subject|0
2458327|NCT02544074|8473357|P3|Overall Study|Withdrawal by Subject|0
2458328|NCT02544074|8473358|P2|Overall Study|Withdrawal by Subject|1
2458329|NCT02544074|8473359|P1|Overall Study|Withdrawal by Subject|0
2458330|NCT02543918|8473395|P2|Overall Study|Adverse Event|1
2458331|NCT02543918|8473396|P1|Overall Study|Adverse Event|1
2458332|NCT02543918|8473395|P2|Overall Study|Withdrawal by Subject|1
2458333|NCT02543918|8473396|P1|Overall Study|Withdrawal by Subject|1
2458334|NCT02543918|8473395|P2|Overall Study|Lost to Follow-up|1
2458335|NCT02543918|8473396|P1|Overall Study|Lost to Follow-up|1
2458336|NCT02543918|8473395|P2|Overall Study|Never treated|1
2458337|NCT02543918|8473396|P1|Overall Study|Never treated|0
2458338|NCT02543892|8473410|P8|Had Immunology Data|Withdrawal by Subject|0
2458339|NCT02543892|8473411|P7|Had Immunology Data|Withdrawal by Subject|1
2458340|NCT02543892|8473412|P6|Had Immunology Data|Withdrawal by Subject|0
2458341|NCT02543892|8473413|P5|Had Immunology Data|Withdrawal by Subject|0
2458342|NCT02543892|8473414|P4|Had Immunology Data|Withdrawal by Subject|0
2458343|NCT02543892|8473415|P3|Had Immunology Data|Withdrawal by Subject|0
2458344|NCT02543892|8473416|P2|Had Immunology Data|Withdrawal by Subject|0
2458345|NCT02543892|8473417|P1|Had Immunology Data|Withdrawal by Subject|0
2458346|NCT02543892|8473410|P8|Received Vaccination 2|Adverse Event|0
2458347|NCT02543892|8473411|P7|Received Vaccination 2|Adverse Event|0
2458348|NCT02543892|8473412|P6|Received Vaccination 2|Adverse Event|0
2458349|NCT02543892|8473413|P5|Received Vaccination 2|Adverse Event|0
2458350|NCT02543892|8473414|P4|Received Vaccination 2|Adverse Event|0
2458351|NCT02543892|8473415|P3|Received Vaccination 2|Adverse Event|0
2458352|NCT02543892|8473416|P2|Received Vaccination 2|Adverse Event|1
2458353|NCT02543892|8473417|P1|Received Vaccination 2|Adverse Event|0
2458354|NCT02543892|8473410|P8|Received Vaccination 2|Physician Decision|0
2458355|NCT02543892|8473411|P7|Received Vaccination 2|Physician Decision|0
2458356|NCT02543892|8473412|P6|Received Vaccination 2|Physician Decision|1
2458357|NCT02543892|8473413|P5|Received Vaccination 2|Physician Decision|0
2458358|NCT02543892|8473414|P4|Received Vaccination 2|Physician Decision|0
2458359|NCT02543892|8473415|P3|Received Vaccination 2|Physician Decision|0
2458360|NCT02543892|8473416|P2|Received Vaccination 2|Physician Decision|0
2458361|NCT02543892|8473417|P1|Received Vaccination 2|Physician Decision|0
2458362|NCT02543892|8473410|P8|Received Vaccination 2|Withdrawal by Subject|1
2458363|NCT02543892|8473411|P7|Received Vaccination 2|Withdrawal by Subject|0
2458364|NCT02543892|8473412|P6|Received Vaccination 2|Withdrawal by Subject|0
2458365|NCT02543892|8473413|P5|Received Vaccination 2|Withdrawal by Subject|0
2458366|NCT02543892|8473414|P4|Received Vaccination 2|Withdrawal by Subject|0
2458367|NCT02543892|8473415|P3|Received Vaccination 2|Withdrawal by Subject|0
2458368|NCT02543892|8473416|P2|Received Vaccination 2|Withdrawal by Subject|0
2458369|NCT02543892|8473417|P1|Received Vaccination 2|Withdrawal by Subject|1
2458370|NCT02543801|8473467|P4|Overall Study|Protocol Violation|0
2458371|NCT02543801|8473468|P3|Overall Study|Protocol Violation|0
2458372|NCT02543801|8473469|P2|Overall Study|Protocol Violation|2
2458373|NCT02543801|8473470|P1|Overall Study|Protocol Violation|1
2458374|NCT02543528|8473499|P5|Extended Wear Period|Withdrawal by Subject|0
2458375|NCT02543528|8473500|P4|Extended Wear Period|Withdrawal by Subject|5
2458376|NCT02543528|8473501|P3|Extended Wear Period|Withdrawal by Subject|4
2458377|NCT02543528|8473502|P2|Extended Wear Period|Withdrawal by Subject|9
2458378|NCT02543528|8473503|P1|Extended Wear Period|Withdrawal by Subject|10
2458379|NCT02543528|8473499|P5|Extended Wear Period|Lost to Follow-up|0
2458380|NCT02543528|8473500|P4|Extended Wear Period|Lost to Follow-up|1
2458381|NCT02543528|8473501|P3|Extended Wear Period|Lost to Follow-up|2
2458382|NCT02543528|8473502|P2|Extended Wear Period|Lost to Follow-up|1
2458383|NCT02543528|8473503|P1|Extended Wear Period|Lost to Follow-up|0
2458384|NCT02543528|8473499|P5|Extended Wear Period|Unsatisfactory Lens Fitting|0
2458385|NCT02543528|8473500|P4|Extended Wear Period|Unsatisfactory Lens Fitting|0
2458386|NCT02543528|8473501|P3|Extended Wear Period|Unsatisfactory Lens Fitting|0
2458387|NCT02543528|8473502|P2|Extended Wear Period|Unsatisfactory Lens Fitting|0
2458388|NCT02543528|8473503|P1|Extended Wear Period|Unsatisfactory Lens Fitting|1
2458389|NCT02543528|8473499|P5|Extended Wear Period|Missed too many scheduled visits|0
2458390|NCT02543528|8473500|P4|Extended Wear Period|Missed too many scheduled visits|3
2458391|NCT02543528|8473501|P3|Extended Wear Period|Missed too many scheduled visits|1
2458392|NCT02543528|8473502|P2|Extended Wear Period|Missed too many scheduled visits|0
2458393|NCT02543528|8473503|P1|Extended Wear Period|Missed too many scheduled visits|0
2458394|NCT02543528|8473499|P5|Extended Wear Period|Adverse Event|0
2458395|NCT02543528|8473500|P4|Extended Wear Period|Adverse Event|3
2458396|NCT02543528|8473501|P3|Extended Wear Period|Adverse Event|16
2458397|NCT02543528|8473502|P2|Extended Wear Period|Adverse Event|11
2458398|NCT02543528|8473503|P1|Extended Wear Period|Adverse Event|17
2458399|NCT02543528|8473499|P5|Adaptation Period|Adverse Event|2
2458400|NCT02543528|8473500|P4|Adaptation Period|Adverse Event|0
2458401|NCT02543528|8473501|P3|Adaptation Period|Adverse Event|0
2458402|NCT02543528|8473502|P2|Adaptation Period|Adverse Event|0
2458403|NCT02543528|8473503|P1|Adaptation Period|Adverse Event|0
2458404|NCT02543528|8473499|P5|Adaptation Period|Lost to Follow-up|14
2458405|NCT02543528|8473500|P4|Adaptation Period|Lost to Follow-up|0
2458406|NCT02543528|8473501|P3|Adaptation Period|Lost to Follow-up|0
2458407|NCT02543528|8473502|P2|Adaptation Period|Lost to Follow-up|0
2458408|NCT02543528|8473503|P1|Adaptation Period|Lost to Follow-up|0
2458409|NCT02543528|8473499|P5|Adaptation Period|Lens Handling Difficultes|8
2458410|NCT02543528|8473500|P4|Adaptation Period|Lens Handling Difficultes|0
2458411|NCT02543528|8473501|P3|Adaptation Period|Lens Handling Difficultes|0
2458412|NCT02543528|8473502|P2|Adaptation Period|Lens Handling Difficultes|0
2458413|NCT02543528|8473503|P1|Adaptation Period|Lens Handling Difficultes|0
2458414|NCT02543528|8473499|P5|Adaptation Period|Unsatisfactory Lens Fitting|2
2458415|NCT02543528|8473500|P4|Adaptation Period|Unsatisfactory Lens Fitting|0
2458416|NCT02543528|8473501|P3|Adaptation Period|Unsatisfactory Lens Fitting|0
2458417|NCT02543528|8473502|P2|Adaptation Period|Unsatisfactory Lens Fitting|0
2458418|NCT02543528|8473503|P1|Adaptation Period|Unsatisfactory Lens Fitting|0
2458419|NCT02543346|8473536|P4|Second Priming Visit|Adverse Event|0
2458420|NCT02543346|8473537|P3|Second Priming Visit|Adverse Event|0
2458421|NCT02543346|8473538|P2|Second Priming Visit|Adverse Event|0
2458422|NCT02543346|8473539|P1|Second Priming Visit|Adverse Event|1
2458423|NCT02543346|8473536|P4|Second Priming Visit|Withdrawal by Subject|2
2458424|NCT02543346|8473537|P3|Second Priming Visit|Withdrawal by Subject|2
2458425|NCT02543346|8473538|P2|Second Priming Visit|Withdrawal by Subject|2
2458426|NCT02543346|8473539|P1|Second Priming Visit|Withdrawal by Subject|0
2458427|NCT02543294|8473565|P1|Overall Study|Withdrawal by Subject|7
2458428|NCT02543294|8473565|P1|Overall Study|Physician Decision|2
2458429|NCT02543294|8473565|P1|Overall Study|Lost to Follow-up|3
2458430|NCT02542943|8473573|P3|Overall Study|Withdrawal by Subject|0
2458431|NCT02542943|8473574|P2|Overall Study|Withdrawal by Subject|1
2458432|NCT02542943|8473575|P1|Overall Study|Withdrawal by Subject|0
2458433|NCT02542943|8473573|P3|Overall Study|Lost to Follow-up|0
2458434|NCT02542943|8473574|P2|Overall Study|Lost to Follow-up|0
2458435|NCT02542943|8473575|P1|Overall Study|Lost to Follow-up|1
2458436|NCT02542865|8473602|P2|Overall Study|Withdrawal by Subject|0
2458437|NCT02542865|8473603|P1|Overall Study|Withdrawal by Subject|16
2458438|NCT02542865|8473602|P2|Overall Study|Identified as screen failure|0
2458439|NCT02542865|8473603|P1|Overall Study|Identified as screen failure|1
2458440|NCT02542631|8473666|P2|Overall Study|Used Prohibited Medication|1
2458441|NCT02542631|8473667|P1|Overall Study|Used Prohibited Medication|2
2458442|NCT02542631|8473666|P2|Overall Study|Other|1
2458443|NCT02542631|8473667|P1|Overall Study|Other|2
2458444|NCT02542631|8473666|P2|Overall Study|Death|2
2458445|NCT02542631|8473667|P1|Overall Study|Death|1
2458446|NCT02542631|8473666|P2|Overall Study|Lost to Follow-up|5
2458447|NCT02542631|8473667|P1|Overall Study|Lost to Follow-up|6
2458448|NCT02542631|8473666|P2|Overall Study|Physician Decision|4
2458449|NCT02542631|8473667|P1|Overall Study|Physician Decision|6
2458450|NCT02542631|8473666|P2|Overall Study|Protocol Violation|1
2458451|NCT02542631|8473667|P1|Overall Study|Protocol Violation|1
2458452|NCT02542631|8473666|P2|Overall Study|Withdrawal by Subject|16
2458453|NCT02542631|8473667|P1|Overall Study|Withdrawal by Subject|11
2458454|NCT02542631|8473666|P2|Overall Study|Sponsor Termination|0
2458455|NCT02542631|8473667|P1|Overall Study|Sponsor Termination|1
2458456|NCT02542631|8473666|P2|Overall Study|Adverse Event|1
2458457|NCT02542631|8473667|P1|Overall Study|Adverse Event|1
2458458|NCT02542605|8473689|P3|Part B: Randomization Phase|Withdrawal by Subject|1
2458459|NCT02542605|8473690|P2|Part B: Randomization Phase|Withdrawal by Subject|0
2458460|NCT02542605|8473691|P1|Part B: Randomization Phase|Withdrawal by Subject|0
2458461|NCT02542605|8473689|P3|Part B: Challenge Phase|Sponsor decision|0
2458462|NCT02542605|8473690|P2|Part B: Challenge Phase|Sponsor decision|0
2458463|NCT02542605|8473691|P1|Part B: Challenge Phase|Sponsor decision|1
2458464|NCT02542072|8473781|P2|Second Intervention (1 Month)|Lens discomfort|0
2458465|NCT02542072|8473782|P1|Second Intervention (1 Month)|Lens discomfort|1
2458466|NCT02542072|8473781|P2|Second Intervention (1 Month)|Lost to Follow-up|0
2458467|NCT02542072|8473782|P1|Second Intervention (1 Month)|Lost to Follow-up|1
2458468|NCT02542072|8473781|P2|First Intervention (1 Month)|Protocol Violation|0
2458469|NCT02542072|8473782|P1|First Intervention (1 Month)|Protocol Violation|1
2458470|NCT02542072|8473781|P2|First Intervention (1 Month)|Lens discomfort|2
2458471|NCT02542072|8473782|P1|First Intervention (1 Month)|Lens discomfort|1
2458472|NCT02542072|8473781|P2|First Intervention (1 Month)|Lost to Follow-up|0
2458473|NCT02542072|8473782|P1|First Intervention (1 Month)|Lost to Follow-up|2
2458474|NCT02542072|8473781|P2|First Intervention (1 Month)|Adverse Event|1
2458475|NCT02542072|8473782|P1|First Intervention (1 Month)|Adverse Event|1
2458476|NCT02541903|8473906|P1|Overall Study|Death|1
2458477|NCT02541669|8473927|P5|Double-Blinded Treatment Period|Withdrawal by Subject|1
2458478|NCT02541669|8473928|P4|Double-Blinded Treatment Period|Withdrawal by Subject|0
2458479|NCT02541669|8473929|P3|Double-Blinded Treatment Period|Withdrawal by Subject|1
2458480|NCT02541669|8473930|P2|Double-Blinded Treatment Period|Withdrawal by Subject|0
2458481|NCT02541669|8473931|P1|Double-Blinded Treatment Period|Withdrawal by Subject|0
2458482|NCT02541604|8473978|P12|Overall Study|Medical condition may jeopardize safety|0
2458483|NCT02541604|8473979|P11|Overall Study|Medical condition may jeopardize safety|0
2458484|NCT02541604|8473980|P10|Overall Study|Medical condition may jeopardize safety|0
2458485|NCT02541604|8473981|P9|Overall Study|Medical condition may jeopardize safety|0
2458486|NCT02541604|8473982|P8|Overall Study|Medical condition may jeopardize safety|1
2458487|NCT02541604|8473983|P7|Overall Study|Medical condition may jeopardize safety|0
2458488|NCT02541604|8473984|P6|Overall Study|Medical condition may jeopardize safety|0
2458489|NCT02541604|8473985|P5|Overall Study|Medical condition may jeopardize safety|0
2458490|NCT02541604|8473986|P4|Overall Study|Medical condition may jeopardize safety|0
2458491|NCT02541604|8473987|P3|Overall Study|Medical condition may jeopardize safety|0
2458492|NCT02541604|8473988|P2|Overall Study|Medical condition may jeopardize safety|0
2458493|NCT02541604|8473989|P1|Overall Study|Medical condition may jeopardize safety|0
2458494|NCT02541604|8473978|P12|Overall Study|Study Terminated by Sponsor|0
2458495|NCT02541604|8473979|P11|Overall Study|Study Terminated by Sponsor|0
2458496|NCT02541604|8473980|P10|Overall Study|Study Terminated by Sponsor|0
2458497|NCT02541604|8473981|P9|Overall Study|Study Terminated by Sponsor|0
2458498|NCT02541604|8473982|P8|Overall Study|Study Terminated by Sponsor|0
2458499|NCT02541604|8473983|P7|Overall Study|Study Terminated by Sponsor|0
2458500|NCT02541604|8473984|P6|Overall Study|Study Terminated by Sponsor|0
2458501|NCT02541604|8473985|P5|Overall Study|Study Terminated by Sponsor|0
2458502|NCT02541604|8473986|P4|Overall Study|Study Terminated by Sponsor|1
2458503|NCT02541604|8473987|P3|Overall Study|Study Terminated by Sponsor|2
2458504|NCT02541604|8473988|P2|Overall Study|Study Terminated by Sponsor|4
2458505|NCT02541604|8473989|P1|Overall Study|Study Terminated by Sponsor|1
2458506|NCT02541604|8473978|P12|Overall Study|Withdrawal by Subject|0
2458507|NCT02541604|8473979|P11|Overall Study|Withdrawal by Subject|0
2458508|NCT02541604|8473980|P10|Overall Study|Withdrawal by Subject|0
2458509|NCT02541604|8473981|P9|Overall Study|Withdrawal by Subject|1
2458510|NCT02541604|8473982|P8|Overall Study|Withdrawal by Subject|0
2458511|NCT02541604|8473983|P7|Overall Study|Withdrawal by Subject|0
2458512|NCT02541604|8473984|P6|Overall Study|Withdrawal by Subject|1
2458513|NCT02541604|8473985|P5|Overall Study|Withdrawal by Subject|1
2458514|NCT02541604|8473986|P4|Overall Study|Withdrawal by Subject|0
2458515|NCT02541604|8473987|P3|Overall Study|Withdrawal by Subject|1
2458516|NCT02541604|8473988|P2|Overall Study|Withdrawal by Subject|0
2458517|NCT02541604|8473989|P1|Overall Study|Withdrawal by Subject|2
2458518|NCT02541604|8473978|P12|Overall Study|Lost to Follow-up|0
2458519|NCT02541604|8473979|P11|Overall Study|Lost to Follow-up|0
2458520|NCT02541604|8473980|P10|Overall Study|Lost to Follow-up|0
2458521|NCT02541604|8473981|P9|Overall Study|Lost to Follow-up|0
2458522|NCT02541604|8473982|P8|Overall Study|Lost to Follow-up|0
2458523|NCT02541604|8473983|P7|Overall Study|Lost to Follow-up|1
2458524|NCT02541604|8473984|P6|Overall Study|Lost to Follow-up|1
2458525|NCT02541604|8473985|P5|Overall Study|Lost to Follow-up|0
2458526|NCT02541604|8473986|P4|Overall Study|Lost to Follow-up|0
2458527|NCT02541604|8473987|P3|Overall Study|Lost to Follow-up|1
2458528|NCT02541604|8473988|P2|Overall Study|Lost to Follow-up|0
2458529|NCT02541604|8473989|P1|Overall Study|Lost to Follow-up|2
2458530|NCT02541604|8473978|P12|Overall Study|Death|3
2458531|NCT02541604|8473979|P11|Overall Study|Death|2
2458532|NCT02541604|8473980|P10|Overall Study|Death|4
2458533|NCT02541604|8473981|P9|Overall Study|Death|3
2458534|NCT02541604|8473982|P8|Overall Study|Death|9
2458535|NCT02541604|8473983|P7|Overall Study|Death|9
2458536|NCT02541604|8473984|P6|Overall Study|Death|8
2458537|NCT02541604|8473985|P5|Overall Study|Death|9
2458538|NCT02541604|8473986|P4|Overall Study|Death|2
2458539|NCT02541604|8473987|P3|Overall Study|Death|7
2458540|NCT02541604|8473988|P2|Overall Study|Death|5
2458541|NCT02541604|8473989|P1|Overall Study|Death|6
2458542|NCT02540850|8474104|P3|Overall Study|Lost to Follow-up|34
2458543|NCT02540850|8474105|P2|Overall Study|Lost to Follow-up|66
2458544|NCT02540850|8474106|P1|Overall Study|Lost to Follow-up|69
2458545|NCT02540668|8474147|P2|Period 2 - LY3314814 and Warfarin|Physician Decision|1
2458546|NCT02540668|8474148|P1|Period 2 - LY3314814 and Warfarin|Physician Decision|0
2458547|NCT02540538|8474179|P3|Overall Study|Pregnancy|0
2458548|NCT02540538|8474180|P2|Overall Study|Pregnancy|1
2458549|NCT02540538|8474181|P1|Overall Study|Pregnancy|0
2458550|NCT02540356|8474249|P2|Overall Study|Terminated due to disease progression|0
2458551|NCT02540356|8474250|P1|Overall Study|Terminated due to disease progression|1
2458552|NCT02540291|8474285|P4|Overall Study|Other|0
2458553|NCT02540291|8474286|P3|Overall Study|Other|1
2458554|NCT02540291|8474287|P2|Overall Study|Other|0
2458555|NCT02540291|8474288|P1|Overall Study|Other|0
2458556|NCT02540291|8474285|P4|Overall Study|Study Terminated By Sponsor|0
2458557|NCT02540291|8474286|P3|Overall Study|Study Terminated By Sponsor|0
2458558|NCT02540291|8474287|P2|Overall Study|Study Terminated By Sponsor|0
2458559|NCT02540291|8474288|P1|Overall Study|Study Terminated By Sponsor|1
2458560|NCT02540291|8474285|P4|Overall Study|Withdrawal Of Consent|0
2458561|NCT02540291|8474286|P3|Overall Study|Withdrawal Of Consent|0
2458562|NCT02540291|8474287|P2|Overall Study|Withdrawal Of Consent|1
2458563|NCT02540291|8474288|P1|Overall Study|Withdrawal Of Consent|0
2458564|NCT02540291|8474285|P4|Overall Study|Lost to Follow-up|0
2458565|NCT02540291|8474286|P3|Overall Study|Lost to Follow-up|1
2458566|NCT02540291|8474287|P2|Overall Study|Lost to Follow-up|0
2458567|NCT02540291|8474288|P1|Overall Study|Lost to Follow-up|0
2458568|NCT02540291|8474285|P4|Overall Study|Death|7
2458569|NCT02540291|8474286|P3|Overall Study|Death|5
2458570|NCT02540291|8474287|P2|Overall Study|Death|7
2458571|NCT02540291|8474288|P1|Overall Study|Death|7
2458572|NCT02540265|8474323|P3|Overall Study|Lost to Follow-up|1
2458573|NCT02540265|8474324|P2|Overall Study|Lost to Follow-up|0
2458574|NCT02540265|8474325|P1|Overall Study|Lost to Follow-up|0
2458575|NCT02540213|8474380|P1|Overall Study|Enrolled but not treated|2
2458576|NCT02540213|8474380|P1|Overall Study|Consent withdrawn|7
2458577|NCT02540213|8474380|P1|Overall Study|Lack of Efficacy|6
2458578|NCT02540213|8474380|P1|Overall Study|Kidney transplant|3
2458579|NCT02540213|8474380|P1|Overall Study|Administrative reasons|3
2458580|NCT02540213|8474380|P1|Overall Study|Death/adverse event|18
2458581|NCT02540083|8474401|P1|Overall Study|Withdrawal by Subject|16
2458582|NCT02539797|8474442|P3|Overall Study|Lost to Follow-up|0
2458583|NCT02539797|8474443|P2|Overall Study|Lost to Follow-up|1
2458584|NCT02539797|8474444|P1|Overall Study|Lost to Follow-up|0
2458585|NCT02539368|8474496|P5|Overall Study|Missing|0
2458586|NCT02539368|8474497|P4|Overall Study|Missing|0
2458587|NCT02539368|8474498|P3|Overall Study|Missing|0
2458588|NCT02539368|8474499|P2|Overall Study|Missing|3
2458589|NCT02539368|8474500|P1|Overall Study|Missing|10
2458590|NCT02539368|8474496|P5|Overall Study|Other|3
2458591|NCT02539368|8474497|P4|Overall Study|Other|1
2458592|NCT02539368|8474498|P3|Overall Study|Other|24
2458593|NCT02539368|8474499|P2|Overall Study|Other|18
2458594|NCT02539368|8474500|P1|Overall Study|Other|145
2458595|NCT02539368|8474496|P5|Overall Study|Participant Non-compliant|0
2458596|NCT02539368|8474497|P4|Overall Study|Participant Non-compliant|1
2458597|NCT02539368|8474498|P3|Overall Study|Participant Non-compliant|1
2458598|NCT02539368|8474499|P2|Overall Study|Participant Non-compliant|2
2458599|NCT02539368|8474500|P1|Overall Study|Participant Non-compliant|13
2458600|NCT02539368|8474496|P5|Overall Study|Adverse Event|3
2458601|NCT02539368|8474497|P4|Overall Study|Adverse Event|0
2458602|NCT02539368|8474498|P3|Overall Study|Adverse Event|9
2458603|NCT02539368|8474499|P2|Overall Study|Adverse Event|5
2458604|NCT02539368|8474500|P1|Overall Study|Adverse Event|44
2458605|NCT02539368|8474496|P5|Overall Study|Lost to Follow-up|3
2458606|NCT02539368|8474497|P4|Overall Study|Lost to Follow-up|4
2458607|NCT02539368|8474498|P3|Overall Study|Lost to Follow-up|16
2458608|NCT02539368|8474499|P2|Overall Study|Lost to Follow-up|21
2458609|NCT02539368|8474500|P1|Overall Study|Lost to Follow-up|96
2458610|NCT02539368|8474496|P5|Overall Study|Physician Decision|2
2458611|NCT02539368|8474497|P4|Overall Study|Physician Decision|0
2458612|NCT02539368|8474498|P3|Overall Study|Physician Decision|7
2458613|NCT02539368|8474499|P2|Overall Study|Physician Decision|15
2458614|NCT02539368|8474500|P1|Overall Study|Physician Decision|49
2458615|NCT02539368|8474496|P5|Overall Study|Withdrawal by Subject|3
2458616|NCT02539368|8474497|P4|Overall Study|Withdrawal by Subject|1
2458617|NCT02539368|8474498|P3|Overall Study|Withdrawal by Subject|9
2458618|NCT02539368|8474499|P2|Overall Study|Withdrawal by Subject|35
2458619|NCT02539368|8474500|P1|Overall Study|Withdrawal by Subject|44
2458620|NCT02539368|8474496|P5|Overall Study|Death|0
2458621|NCT02539368|8474497|P4|Overall Study|Death|0
2458622|NCT02539368|8474498|P3|Overall Study|Death|1
2458623|NCT02539368|8474499|P2|Overall Study|Death|2
2458624|NCT02539368|8474500|P1|Overall Study|Death|4
2458625|NCT02539225|8474633|P2|Part B|Physician Decision|9
2458626|NCT02539225|8474634|P1|Part B|Physician Decision|0
2458627|NCT02539225|8474633|P2|Part B|Withdrawal by Subject|3
2458628|NCT02539225|8474634|P1|Part B|Withdrawal by Subject|0
2458629|NCT02539225|8474633|P2|Part B|Adverse Event|4
2458630|NCT02539225|8474634|P1|Part B|Adverse Event|4
2458631|NCT02539225|8474633|P2|Pre Treatment for Part B|Physician Decision|0
2458632|NCT02539225|8474634|P1|Pre Treatment for Part B|Physician Decision|2
2458633|NCT02539225|8474633|P2|Pre Treatment for Part B|Withdrawal by Subject|0
2458634|NCT02539225|8474634|P1|Pre Treatment for Part B|Withdrawal by Subject|1
2458635|NCT02539225|8474633|P2|Pre Treatment for Part B|Adverse Event|1
2458636|NCT02539225|8474634|P1|Pre Treatment for Part B|Adverse Event|1
2458637|NCT02539225|8474633|P2|Pre Treatment for Part B|Progressive disease|1
2458638|NCT02539225|8474634|P1|Pre Treatment for Part B|Progressive disease|1
2458639|NCT02539225|8474633|P2|Part A|Did Not Receive study Drug|1
2458640|NCT02539225|8474634|P1|Part A|Did Not Receive study Drug|1
2458641|NCT02539225|8474633|P2|Part A|Physician Decision|7
2458642|NCT02539225|8474634|P1|Part A|Physician Decision|4
2458643|NCT02539225|8474633|P2|Part A|Withdrawal by Subject|4
2458644|NCT02539225|8474634|P1|Part A|Withdrawal by Subject|2
2458645|NCT02539225|8474633|P2|Part A|Adverse Event|4
2458646|NCT02539225|8474634|P1|Part A|Adverse Event|13
2458647|NCT02539134|8474661|P6|Overall Study|Lost to Follow-up|0
2458648|NCT02539134|8474662|P5|Overall Study|Lost to Follow-up|0
2458649|NCT02539134|8474663|P4|Overall Study|Lost to Follow-up|0
2458650|NCT02539134|8474664|P3|Overall Study|Lost to Follow-up|0
2458651|NCT02539134|8474665|P2|Overall Study|Lost to Follow-up|0
2458652|NCT02539134|8474666|P1|Overall Study|Lost to Follow-up|1
2458653|NCT02538965|8474735|P1|Follow-Up Period|Withdrawal by Parent|4
2458654|NCT02538965|8474735|P1|Follow-Up Period|Other = Death due to disease progression|13
2458655|NCT02538965|8474735|P1|Treatment Period|Physician Decision|2
2458656|NCT02538965|8474735|P1|Treatment Period|Disease Progression|1
2458657|NCT02538965|8474735|P1|Treatment Period|Treatment Failure|9
2458658|NCT02538965|8474735|P1|Treatment Period|Withdrawal by Parent/Guardian|2
2458659|NCT02538965|8474735|P1|Treatment Period|Adverse Event|2
2458660|NCT02538965|8474735|P1|Treatment Period|Other = Death due to disease progression|1
2458661|NCT02538666|8474781|P3|Overall Study|Withdrew Consent|1
2458662|NCT02538666|8474782|P2|Overall Study|Withdrew Consent|1
2458663|NCT02538666|8474783|P1|Overall Study|Withdrew Consent|0
2458664|NCT02538666|8474781|P3|Overall Study|no longer meets study criteria|0
2458665|NCT02538666|8474782|P2|Overall Study|no longer meets study criteria|0
2458666|NCT02538666|8474783|P1|Overall Study|no longer meets study criteria|1
2458667|NCT02538666|8474781|P3|Overall Study|Disease progression|0
2458668|NCT02538666|8474782|P2|Overall Study|Disease progression|0
2458669|NCT02538666|8474783|P1|Overall Study|Disease progression|1
2458670|NCT02538471|8474813|P1|Overall Study|Progression of disease|2
2458671|NCT02538107|8474849|P1|Overall Study|Not recorded|7
2458672|NCT02538107|8474849|P1|Overall Study|Other|7
2458673|NCT02538107|8474849|P1|Overall Study|Surgery|1
2458674|NCT02538107|8474849|P1|Overall Study|Adverse Event|4
2458675|NCT02538107|8474849|P1|Overall Study|Administrative reason|5
2458676|NCT02538107|8474849|P1|Overall Study|Death|4
2458677|NCT02538107|8474849|P1|Overall Study|Withdrawal by Subject|17
2458678|NCT02538107|8474849|P1|Overall Study|No further treatment necessary|18
2458679|NCT02538107|8474849|P1|Overall Study|Administration of other ESA|11
2458680|NCT02538107|8474849|P1|Overall Study|Necessity of dialysis|20
2458681|NCT02538107|8474849|P1|Overall Study|Missing|5
2458682|NCT02538107|8474849|P1|Overall Study|Did not receive any Mircera dose|11
2458683|NCT02538094|8474869|P2|Washout (4 Weeks)|Withdrawal by Subject|1
2458684|NCT02538094|8474870|P1|Washout (4 Weeks)|Withdrawal by Subject|0
2458685|NCT02538094|8474869|P2|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1
2458686|NCT02538094|8474870|P1|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0
2458687|NCT02538029|8474900|P3|Overall Study|unable to complete cognitive assessments|1
2458688|NCT02538029|8474901|P2|Overall Study|unable to complete cognitive assessments|0
2458689|NCT02538029|8474902|P1|Overall Study|unable to complete cognitive assessments|1
2458690|NCT02537574|8474948|P3|Overall Study|Noncompliance with Protocol|1
2458691|NCT02537574|8474949|P2|Overall Study|Noncompliance with Protocol|0
2458692|NCT02537574|8474950|P1|Overall Study|Noncompliance with Protocol|0
2458693|NCT02537574|8474948|P3|Overall Study|Subject did not want last Vivitrol Injec|1
2458694|NCT02537574|8474949|P2|Overall Study|Subject did not want last Vivitrol Injec|0
2458695|NCT02537574|8474950|P1|Overall Study|Subject did not want last Vivitrol Injec|0
2458696|NCT02537574|8474948|P3|Overall Study|Transportation Issues|1
2458697|NCT02537574|8474949|P2|Overall Study|Transportation Issues|0
2458698|NCT02537574|8474950|P1|Overall Study|Transportation Issues|0
2458699|NCT02537574|8474948|P3|Overall Study|Failed Naloxone Challenge|0
2458700|NCT02537574|8474949|P2|Overall Study|Failed Naloxone Challenge|1
2458701|NCT02537574|8474950|P1|Overall Study|Failed Naloxone Challenge|0
2458702|NCT02537574|8474948|P3|Overall Study|Incarceration|0
2458703|NCT02537574|8474949|P2|Overall Study|Incarceration|1
2458704|NCT02537574|8474950|P1|Overall Study|Incarceration|0
2458705|NCT02537574|8474948|P3|Overall Study|Patient not Stable|0
2458706|NCT02537574|8474949|P2|Overall Study|Patient not Stable|1
2458707|NCT02537574|8474950|P1|Overall Study|Patient not Stable|0
2458708|NCT02537574|8474948|P3|Overall Study|Duplicate Patient|0
2458709|NCT02537574|8474949|P2|Overall Study|Duplicate Patient|0
2458710|NCT02537574|8474950|P1|Overall Study|Duplicate Patient|1
2458711|NCT02537574|8474948|P3|Overall Study|Lack of Efficacy|15
2458712|NCT02537574|8474949|P2|Overall Study|Lack of Efficacy|16
2458713|NCT02537574|8474950|P1|Overall Study|Lack of Efficacy|14
2458714|NCT02537574|8474948|P3|Overall Study|Withdrawal by Subject|29
2458715|NCT02537574|8474949|P2|Overall Study|Withdrawal by Subject|27
2458716|NCT02537574|8474950|P1|Overall Study|Withdrawal by Subject|37
2458717|NCT02537574|8474948|P3|Overall Study|Protocol Violation|3
2458718|NCT02537574|8474949|P2|Overall Study|Protocol Violation|2
2458719|NCT02537574|8474950|P1|Overall Study|Protocol Violation|4
2458720|NCT02537574|8474948|P3|Overall Study|Physician Decision|0
2458721|NCT02537574|8474949|P2|Overall Study|Physician Decision|0
2458722|NCT02537574|8474950|P1|Overall Study|Physician Decision|2
2458723|NCT02537574|8474948|P3|Overall Study|Noncompliance with study drug|1
2458724|NCT02537574|8474949|P2|Overall Study|Noncompliance with study drug|1
2458725|NCT02537574|8474950|P1|Overall Study|Noncompliance with study drug|0
2458726|NCT02537574|8474948|P3|Overall Study|Lost to Follow-up|55
2458727|NCT02537574|8474949|P2|Overall Study|Lost to Follow-up|51
2458728|NCT02537574|8474950|P1|Overall Study|Lost to Follow-up|40
2458729|NCT02537574|8474948|P3|Overall Study|Adverse Event|2
2458730|NCT02537574|8474949|P2|Overall Study|Adverse Event|3
2458731|NCT02537574|8474950|P1|Overall Study|Adverse Event|1
2458732|NCT02537522|8474976|P4|Phase II - Period 1 Bilateral|Adverse Event|1
2458733|NCT02537522|8474977|P3|Phase II - Period 1 Bilateral|Adverse Event|0
2458734|NCT02537522|8474978|P2|Phase II - Period 1 Bilateral|Adverse Event|0
2458735|NCT02537522|8474979|P1|Phase II - Period 1 Bilateral|Adverse Event|0
2458736|NCT02537522|8474976|P4|Phase I - Contralateral|unsatisfactory lens fitting|0
2458737|NCT02537522|8474977|P3|Phase I - Contralateral|unsatisfactory lens fitting|0
2458738|NCT02537522|8474978|P2|Phase I - Contralateral|unsatisfactory lens fitting|1
2458739|NCT02537522|8474979|P1|Phase I - Contralateral|unsatisfactory lens fitting|0
2458740|NCT02537522|8474976|P4|Phase I - Contralateral|incorrect randomization|0
2458741|NCT02537522|8474977|P3|Phase I - Contralateral|incorrect randomization|0
2458742|NCT02537522|8474978|P2|Phase I - Contralateral|incorrect randomization|1
2458743|NCT02537522|8474979|P1|Phase I - Contralateral|incorrect randomization|0
2458744|NCT02537522|8474976|P4|Phase I - Contralateral|Withdrawal by Subject|0
2458745|NCT02537522|8474977|P3|Phase I - Contralateral|Withdrawal by Subject|0
2458746|NCT02537522|8474978|P2|Phase I - Contralateral|Withdrawal by Subject|1
2458747|NCT02537522|8474979|P1|Phase I - Contralateral|Withdrawal by Subject|0
2458748|NCT02537522|8474976|P4|Phase I - Contralateral|Subject no longer eligible|0
2458749|NCT02537522|8474977|P3|Phase I - Contralateral|Subject no longer eligible|0
2458750|NCT02537522|8474978|P2|Phase I - Contralateral|Subject no longer eligible|7
2458751|NCT02537522|8474979|P1|Phase I - Contralateral|Subject no longer eligible|15
2458752|NCT02537431|8474996|P1|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1
2458753|NCT02537015|8475025|P1|Overall Study|Other Miscellaneous Reasons|1
2458754|NCT02537015|8475025|P1|Overall Study|Withdrawal by Subject|2
2458755|NCT02537015|8475025|P1|Overall Study|Adverse Event|3
2458756|NCT02536976|8475031|P2|Overall Study|Physician Decision|1
2458757|NCT02536976|8475032|P1|Overall Study|Physician Decision|0
2458758|NCT02536781|8475044|P2|Overall Study|Lost to Follow-up|0
2458759|NCT02536781|8475045|P1|Overall Study|Lost to Follow-up|2
2458760|NCT02536664|8475055|P2|Overall Study|Missing|20
2458761|NCT02536664|8475056|P1|Overall Study|Missing|53
2458762|NCT02536664|8475055|P2|Overall Study|Other|24
2458763|NCT02536664|8475056|P1|Overall Study|Other|18
2458764|NCT02536664|8475055|P2|Overall Study|Withdrawal by Subject|5
2458765|NCT02536664|8475056|P1|Overall Study|Withdrawal by Subject|8
2458766|NCT02536664|8475055|P2|Overall Study|Intolerability|6
2458767|NCT02536664|8475056|P1|Overall Study|Intolerability|8
2458768|NCT02536664|8475055|P2|Overall Study|Death due to other reason|2
2458769|NCT02536664|8475056|P1|Overall Study|Death due to other reason|3
2458770|NCT02536664|8475055|P2|Overall Study|Death due to lymphoma|1
2458771|NCT02536664|8475056|P1|Overall Study|Death due to lymphoma|2
2458772|NCT02536664|8475055|P2|Overall Study|Progression|18
2458773|NCT02536664|8475056|P1|Overall Study|Progression|13
2458774|NCT02536664|8475055|P2|Overall Study|Inadequate completion of documentation|4
2458775|NCT02536664|8475056|P1|Overall Study|Inadequate completion of documentation|2
2458776|NCT02536339|8475074|P1|Overall Study|Death|20
2458777|NCT02536339|8475074|P1|Overall Study|Withdrawal by Subject|3
2458778|NCT02536339|8475074|P1|Overall Study|Lost to Follow-up|2
2458779|NCT02536339|8475074|P1|Overall Study|Treatment Ongoing|2
2458780|NCT02536339|8475074|P1|Overall Study|In Survival Follow-Up|4
2458781|NCT02536313|8475100|P2|Overall Study|Lack of Efficacy|1
2458782|NCT02536313|8475101|P1|Overall Study|Lack of Efficacy|0
2458783|NCT02535741|8475155|P1|Overall Study|Missing data|6
2458784|NCT02535741|8475155|P1|Overall Study|Exclusion criteria: Bilateral implant|4
2458785|NCT02535741|8475155|P1|Overall Study|Lost to Follow-up|10
2458786|NCT02535741|8475155|P1|Overall Study|Withdrawal by Subject|9
2458787|NCT02535741|8475155|P1|Overall Study|Adverse Event|3
2458788|NCT02535715|8475163|P3|Overall Study|Withdrawal by Subject|1
2458789|NCT02535715|8475164|P2|Overall Study|Withdrawal by Subject|0
2458790|NCT02535715|8475165|P1|Overall Study|Withdrawal by Subject|0
2458791|NCT02535416|8475194|P9|Overall Study|Family bereavement overseas|0
2458792|NCT02535416|8475195|P8|Overall Study|Family bereavement overseas|0
2458793|NCT02535416|8475196|P7|Overall Study|Family bereavement overseas|0
2458794|NCT02535416|8475197|P6|Overall Study|Family bereavement overseas|0
2458795|NCT02535416|8475198|P5|Overall Study|Family bereavement overseas|0
2458796|NCT02535416|8475199|P4|Overall Study|Family bereavement overseas|0
2458797|NCT02535416|8475200|P3|Overall Study|Family bereavement overseas|0
2458798|NCT02535416|8475201|P2|Overall Study|Family bereavement overseas|0
2458799|NCT02535416|8475202|P1|Overall Study|Family bereavement overseas|1
2458800|NCT02535364|8475254|P1|12-Month Follow-up Period|Subject transferred to hospice|1
2458801|NCT02535364|8475254|P1|12-Month Follow-up Period|Subject received alternative therapy|2
2458802|NCT02535364|8475254|P1|12-Month Follow-up Period|Underwent stem cell transplant|5
2458803|NCT02535364|8475254|P1|12-Month Follow-up Period|Death|5
2458804|NCT02535364|8475254|P1|12-Month Follow-up Period|Disease progression|22
2458805|NCT02535364|8475254|P1|Study Treatment|Study placed on clinical hold by FDA|1
2458806|NCT02535364|8475254|P1|Study Treatment|Death|1
2458807|NCT02535364|8475254|P1|Part B Screening|Change in diagnosis, no longer eligible|2
2458808|NCT02535364|8475254|P1|Part B Screening|Adverse Event|1
2458809|NCT02535364|8475254|P1|Part B Screening|Withdrawal by Subject|1
2458810|NCT02535364|8475254|P1|Part B Screening|Physician Decision|1
2458811|NCT02535364|8475254|P1|Part B Screening|Death|2
2458812|NCT02535364|8475254|P1|Part B Screening|Unable to manufacture JCAR015|3
2458813|NCT02535364|8475254|P1|Part B Screening|Study placed on clinical hold by FDA|7
2458814|NCT02535364|8475254|P1|Part A Screening Through Leukapheresis|Disease progression|1
2458815|NCT02535364|8475254|P1|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2
2458816|NCT02535364|8475254|P1|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22
2458817|NCT02534935|8475339|P3|Overall Study|Lost to Follow-up|1
2458818|NCT02534935|8475340|P2|Overall Study|Lost to Follow-up|1
2458819|NCT02534935|8475341|P1|Overall Study|Lost to Follow-up|0
2458820|NCT02534935|8475339|P3|Overall Study|Adverse Event|0
2458821|NCT02534935|8475340|P2|Overall Study|Adverse Event|2
2458822|NCT02534935|8475341|P1|Overall Study|Adverse Event|0
2458823|NCT02534935|8475339|P3|Overall Study|No longer meets the eligibility criteria|0
2458824|NCT02534935|8475340|P2|Overall Study|No longer meets the eligibility criteria|3
2458825|NCT02534935|8475341|P1|Overall Study|No longer meets the eligibility criteria|0
2458826|NCT02534935|8475339|P3|Overall Study|Withdrawal by Subject|3
2458827|NCT02534935|8475340|P2|Overall Study|Withdrawal by Subject|3
2458828|NCT02534935|8475341|P1|Overall Study|Withdrawal by Subject|0
2458829|NCT02534935|8475339|P3|Overall Study|No longer willing to participate|1
2458830|NCT02534935|8475340|P2|Overall Study|No longer willing to participate|1
2458831|NCT02534935|8475341|P1|Overall Study|No longer willing to participate|0
2458832|NCT02534896|8475502|P3|Overall Study|Insufficient therapeutic response|0
2458833|NCT02534896|8475503|P2|Overall Study|Insufficient therapeutic response|0
2458834|NCT02534896|8475504|P1|Overall Study|Insufficient therapeutic response|2
2458835|NCT02534896|8475502|P3|Overall Study|Adverse Event|1
2458836|NCT02534896|8475503|P2|Overall Study|Adverse Event|1
2458837|NCT02534896|8475504|P1|Overall Study|Adverse Event|2
2458838|NCT02534883|8475523|P2|Overall Study|Early Termination|3
2458839|NCT02534883|8475524|P1|Overall Study|Early Termination|8
2458840|NCT02534493|8475540|P1|Overall Study|Withdrawal by Subject|1
2458841|NCT02534493|8475540|P1|Overall Study|Lost to Follow-up|1
2458842|NCT02534350|8475551|P2|Overall Study|Withdrew Consent|0
2458843|NCT02534350|8475552|P1|Overall Study|Withdrew Consent|2
2458844|NCT02534350|8475551|P2|Overall Study|Protocol Violation|0
2458845|NCT02534350|8475552|P1|Overall Study|Protocol Violation|1
2458846|NCT02534350|8475551|P2|Overall Study|Randomized But Not Treated|0
2458847|NCT02534350|8475552|P1|Overall Study|Randomized But Not Treated|1
2458848|NCT02534324|8475566|P2|Overall Study|Adverse Event|0
2458849|NCT02534324|8475567|P1|Overall Study|Adverse Event|1
2458850|NCT02534324|8475566|P2|Overall Study|Lost to Follow-up|7
2458851|NCT02534324|8475567|P1|Overall Study|Lost to Follow-up|20
2458852|NCT02534324|8475566|P2|Overall Study|Protocol Violation|1
2458853|NCT02534324|8475567|P1|Overall Study|Protocol Violation|4
2458854|NCT02533999|8475586|P2|Overall Study|Randomized but intervention not received|1
2458855|NCT02533999|8475587|P1|Overall Study|Randomized but intervention not received|0
2458856|NCT02533999|8475586|P2|Overall Study|Adverse Event|1
2458857|NCT02533999|8475587|P1|Overall Study|Adverse Event|0
2458858|NCT02533999|8475586|P2|Overall Study|Protocol Violation|0
2458859|NCT02533999|8475587|P1|Overall Study|Protocol Violation|3
2458860|NCT02533999|8475586|P2|Overall Study|Lost to Follow-up|5
2458861|NCT02533999|8475587|P1|Overall Study|Lost to Follow-up|3
2458862|NCT02533570|8475638|P3|Overall Study|Adverse Event|1
2458863|NCT02533570|8475639|P2|Overall Study|Adverse Event|1
2458864|NCT02533570|8475640|P1|Overall Study|Adverse Event|0
2458865|NCT02533531|8475651|P1|Overall Study|Device did not turn on|1
2458866|NCT02533453|8475714|P1|Overall Study|Withdrawal by Subject|2
2458867|NCT02533453|8475714|P1|Overall Study|Protocol Violation|1
2458868|NCT02533453|8475714|P1|Overall Study|Adverse Event|6
2458869|NCT02533401|8475723|P1|Overall Study|Violation of Selection Criteria|1
2458870|NCT02533401|8475723|P1|Overall Study|Lost to Follow-up|1
2458871|NCT02533401|8475723|P1|Overall Study|Insufficient Response/Progressed Disease|1
2458872|NCT02533401|8475723|P1|Overall Study|Death|5
2458873|NCT02533401|8475723|P1|Overall Study|Adverse Event/Intercurrent Disease|3
2458874|NCT02533375|8475731|P1|Overall Study|Adverse Event|2
2458875|NCT02533375|8475731|P1|Overall Study|Lack of Efficacy|3
2458876|NCT02533258|8475763|P1|Overall Study|Lack of Efficacy|2
2458877|NCT02533258|8475763|P1|Overall Study|Progression of pleural effusion|1
2458878|NCT02533258|8475763|P1|Overall Study|Economic factor|1
2458879|NCT02533258|8475763|P1|Overall Study|Other|1
2458880|NCT02533258|8475763|P1|Overall Study|Death|2
2458881|NCT02533258|8475763|P1|Overall Study|Adverse Event|1
2458882|NCT02532972|8475904|P1|Overall Study|Withdrawal by Subject|1
2458883|NCT02532855|8475921|P2|Overall Study|Withdrawal by Subject|8
2458884|NCT02532855|8475922|P1|Overall Study|Withdrawal by Subject|4
2458885|NCT02532855|8475921|P2|Overall Study|Lost to Follow-up|3
2458886|NCT02532855|8475922|P1|Overall Study|Lost to Follow-up|4
2458887|NCT02532764|8475956|P10|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
2458888|NCT02532764|8475957|P9|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
2458889|NCT02532764|8475958|P8|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
2458890|NCT02532764|8475959|P7|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
2458891|NCT02532764|8475960|P6|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
2458892|NCT02532764|8475961|P5|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
2458893|NCT02532764|8475962|P4|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
2458894|NCT02532764|8475963|P3|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
2458895|NCT02532764|8475964|P2|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
2458896|NCT02532764|8475965|P1|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
2458897|NCT02532647|8476116|P3|Overall Study|Did not receive trial medication|1
2458898|NCT02532647|8476117|P2|Overall Study|Did not receive trial medication|0
2458899|NCT02532647|8476118|P1|Overall Study|Did not receive trial medication|1
2458900|NCT02532543|8476136|P4|Overall Study|Lost to Follow-up|0
2458901|NCT02532543|8476137|P3|Overall Study|Lost to Follow-up|1
2458902|NCT02532543|8476138|P2|Overall Study|Lost to Follow-up|0
2458903|NCT02532543|8476139|P1|Overall Study|Lost to Follow-up|0
2458904|NCT02532465|8476175|P2|Overall Study|Lack of Efficacy|1
2458905|NCT02532465|8476176|P1|Overall Study|Lack of Efficacy|0
2458906|NCT02532465|8476175|P2|Overall Study|Protocol Violation|0
2458907|NCT02532465|8476176|P1|Overall Study|Protocol Violation|1
2458908|NCT02532374|8476186|P1|Overall Study|Physician Decision|1
2458909|NCT02532374|8476186|P1|Overall Study|Withdrawal by Subject|1
2458910|NCT02532283|8476212|P2|Overall Study|Withdrawal by Subject|3
2458911|NCT02532283|8476213|P1|Overall Study|Withdrawal by Subject|8
2458912|NCT02532283|8476212|P2|Overall Study|Lost to Follow-up|1
2458913|NCT02532283|8476213|P1|Overall Study|Lost to Follow-up|0
2458914|NCT02532283|8476212|P2|Overall Study|Death|0
2458915|NCT02532283|8476213|P1|Overall Study|Death|1
2458916|NCT02532283|8476212|P2|Overall Study|Adverse Event|1
2458917|NCT02532283|8476213|P1|Overall Study|Adverse Event|0
2458918|NCT02532179|8476255|P1|Overall Study|Subject received depot steroid injection|1
2458919|NCT02532179|8476255|P1|Overall Study|Pregnancy|1
2458920|NCT02532179|8476255|P1|Overall Study|Lost to Follow-up|1
2458921|NCT02531802|8476320|P21|Received Vaccination 2|Withdrawal by Subject|0
2458922|NCT02531802|8476321|P20|Received Vaccination 2|Withdrawal by Subject|1
2458923|NCT02531802|8476322|P19|Received Vaccination 2|Withdrawal by Subject|1
2458924|NCT02531802|8476323|P18|Received Vaccination 2|Withdrawal by Subject|1
2458925|NCT02531802|8476324|P17|Received Vaccination 2|Withdrawal by Subject|0
2458926|NCT02531802|8476325|P16|Received Vaccination 2|Withdrawal by Subject|0
2458927|NCT02531802|8476326|P15|Received Vaccination 2|Withdrawal by Subject|1
2458928|NCT02531802|8476327|P14|Received Vaccination 2|Withdrawal by Subject|1
2458929|NCT02531802|8476328|P13|Received Vaccination 2|Withdrawal by Subject|1
2458930|NCT02531802|8476329|P12|Received Vaccination 2|Withdrawal by Subject|0
2458931|NCT02531802|8476330|P11|Received Vaccination 2|Withdrawal by Subject|1
2458932|NCT02531802|8476331|P10|Received Vaccination 2|Withdrawal by Subject|0
2458933|NCT02531802|8476332|P9|Received Vaccination 2|Withdrawal by Subject|0
2458934|NCT02531802|8476333|P8|Received Vaccination 2|Withdrawal by Subject|0
2458935|NCT02531802|8476334|P7|Received Vaccination 2|Withdrawal by Subject|0
2458936|NCT02531802|8476335|P6|Received Vaccination 2|Withdrawal by Subject|0
2458937|NCT02531802|8476336|P5|Received Vaccination 2|Withdrawal by Subject|0
2458938|NCT02531802|8476337|P4|Received Vaccination 2|Withdrawal by Subject|0
2458939|NCT02531802|8476338|P3|Received Vaccination 2|Withdrawal by Subject|0
2458940|NCT02531802|8476339|P2|Received Vaccination 2|Withdrawal by Subject|0
2458941|NCT02531802|8476340|P1|Received Vaccination 2|Withdrawal by Subject|0
2458942|NCT02531802|8476320|P21|Received Vaccination 2|Adverse Event|1
2458943|NCT02531802|8476321|P20|Received Vaccination 2|Adverse Event|0
2458944|NCT02531802|8476322|P19|Received Vaccination 2|Adverse Event|1
2458945|NCT02531802|8476323|P18|Received Vaccination 2|Adverse Event|2
2458946|NCT02531802|8476324|P17|Received Vaccination 2|Adverse Event|0
2458947|NCT02531802|8476325|P16|Received Vaccination 2|Adverse Event|0
2458948|NCT02531802|8476326|P15|Received Vaccination 2|Adverse Event|0
2458949|NCT02531802|8476327|P14|Received Vaccination 2|Adverse Event|0
2458950|NCT02531802|8476328|P13|Received Vaccination 2|Adverse Event|0
2458951|NCT02531802|8476329|P12|Received Vaccination 2|Adverse Event|0
2458952|NCT02531802|8476330|P11|Received Vaccination 2|Adverse Event|0
2458953|NCT02531802|8476331|P10|Received Vaccination 2|Adverse Event|0
2458954|NCT02531802|8476332|P9|Received Vaccination 2|Adverse Event|0
2458955|NCT02531802|8476333|P8|Received Vaccination 2|Adverse Event|0
2458956|NCT02531802|8476334|P7|Received Vaccination 2|Adverse Event|0
2458957|NCT02531802|8476335|P6|Received Vaccination 2|Adverse Event|2
2458958|NCT02531802|8476336|P5|Received Vaccination 2|Adverse Event|0
2458959|NCT02531802|8476337|P4|Received Vaccination 2|Adverse Event|0
2458960|NCT02531802|8476338|P3|Received Vaccination 2|Adverse Event|0
2458961|NCT02531802|8476339|P2|Received Vaccination 2|Adverse Event|0
2458962|NCT02531802|8476340|P1|Received Vaccination 2|Adverse Event|0
2458963|NCT02531802|8476320|P21|Received Vaccination 2|Physician Decision|0
2458964|NCT02531802|8476321|P20|Received Vaccination 2|Physician Decision|0
2458965|NCT02531802|8476322|P19|Received Vaccination 2|Physician Decision|0
2458966|NCT02531802|8476323|P18|Received Vaccination 2|Physician Decision|1
2458967|NCT02531802|8476324|P17|Received Vaccination 2|Physician Decision|0
2458968|NCT02531802|8476325|P16|Received Vaccination 2|Physician Decision|0
2458969|NCT02531802|8476326|P15|Received Vaccination 2|Physician Decision|0
2458970|NCT02531802|8476327|P14|Received Vaccination 2|Physician Decision|1
2458971|NCT02531802|8476328|P13|Received Vaccination 2|Physician Decision|0
2458972|NCT02531802|8476329|P12|Received Vaccination 2|Physician Decision|0
2458973|NCT02531802|8476330|P11|Received Vaccination 2|Physician Decision|0
2458974|NCT02531802|8476331|P10|Received Vaccination 2|Physician Decision|2
2458975|NCT02531802|8476332|P9|Received Vaccination 2|Physician Decision|0
2458976|NCT02531802|8476333|P8|Received Vaccination 2|Physician Decision|0
2458977|NCT02531802|8476334|P7|Received Vaccination 2|Physician Decision|0
2458978|NCT02531802|8476335|P6|Received Vaccination 2|Physician Decision|1
2458979|NCT02531802|8476336|P5|Received Vaccination 2|Physician Decision|0
2458980|NCT02531802|8476337|P4|Received Vaccination 2|Physician Decision|0
2458981|NCT02531802|8476338|P3|Received Vaccination 2|Physician Decision|0
2458982|NCT02531802|8476339|P2|Received Vaccination 2|Physician Decision|0
2458983|NCT02531802|8476340|P1|Received Vaccination 2|Physician Decision|0
2458984|NCT02531802|8476320|P21|Received Vaccination 2|Medication interfering with study taken|0
2458985|NCT02531802|8476321|P20|Received Vaccination 2|Medication interfering with study taken|0
2458986|NCT02531802|8476322|P19|Received Vaccination 2|Medication interfering with study taken|1
2458987|NCT02531802|8476323|P18|Received Vaccination 2|Medication interfering with study taken|0
2458988|NCT02531802|8476324|P17|Received Vaccination 2|Medication interfering with study taken|0
2458989|NCT02531802|8476325|P16|Received Vaccination 2|Medication interfering with study taken|0
2458990|NCT02531802|8476326|P15|Received Vaccination 2|Medication interfering with study taken|0
2458991|NCT02531802|8476327|P14|Received Vaccination 2|Medication interfering with study taken|0
2458992|NCT02531802|8476328|P13|Received Vaccination 2|Medication interfering with study taken|1
2458993|NCT02531802|8476329|P12|Received Vaccination 2|Medication interfering with study taken|0
2458994|NCT02531802|8476330|P11|Received Vaccination 2|Medication interfering with study taken|1
2458995|NCT02531802|8476331|P10|Received Vaccination 2|Medication interfering with study taken|1
2458996|NCT02531802|8476332|P9|Received Vaccination 2|Medication interfering with study taken|0
2458997|NCT02531802|8476333|P8|Received Vaccination 2|Medication interfering with study taken|0
2458998|NCT02531802|8476334|P7|Received Vaccination 2|Medication interfering with study taken|0
2458999|NCT02531802|8476335|P6|Received Vaccination 2|Medication interfering with study taken|0
2459000|NCT02531802|8476336|P5|Received Vaccination 2|Medication interfering with study taken|0
2459001|NCT02531802|8476337|P4|Received Vaccination 2|Medication interfering with study taken|0
2459002|NCT02531802|8476338|P3|Received Vaccination 2|Medication interfering with study taken|1
2459003|NCT02531802|8476339|P2|Received Vaccination 2|Medication interfering with study taken|0
2459004|NCT02531802|8476340|P1|Received Vaccination 2|Medication interfering with study taken|0
2459005|NCT02531698|8476772|P2|Overall Study|Lost to Follow-up|0
2459006|NCT02531698|8476773|P1|Overall Study|Lost to Follow-up|1
2459007|NCT02531698|8476772|P2|Overall Study|Protocol Violation|0
2459008|NCT02531698|8476773|P1|Overall Study|Protocol Violation|2
2459009|NCT02531698|8476772|P2|Overall Study|Withdrawal by Subject|1
2459010|NCT02531698|8476773|P1|Overall Study|Withdrawal by Subject|6
2459011|NCT02531698|8476772|P2|Overall Study|Adverse Event|1
2459012|NCT02531698|8476773|P1|Overall Study|Adverse Event|2
2459013|NCT02531646|8477020|P3|Overall Study|equip. image processing issue|0
2459014|NCT02531646|8477021|P2|Overall Study|equip. image processing issue|1
2459015|NCT02531646|8477022|P1|Overall Study|equip. image processing issue|5
2459016|NCT02531633|8477041|P10|Part B (104 Weeks)|Lost to Follow-up|0
2459017|NCT02531633|8477042|P9|Part B (104 Weeks)|Lost to Follow-up|0
2459018|NCT02531633|8477043|P8|Part B (104 Weeks)|Lost to Follow-up|1
2459019|NCT02531633|8477044|P7|Part B (104 Weeks)|Lost to Follow-up|0
2459020|NCT02531633|8477045|P6|Part B (104 Weeks)|Lost to Follow-up|0
2459021|NCT02531633|8477046|P5|Part B (104 Weeks)|Lost to Follow-up|0
2459022|NCT02531633|8477047|P4|Part B (104 Weeks)|Lost to Follow-up|0
2459023|NCT02531633|8477048|P3|Part B (104 Weeks)|Lost to Follow-up|0
2459024|NCT02531633|8477049|P2|Part B (104 Weeks)|Lost to Follow-up|0
2459025|NCT02531633|8477050|P1|Part B (104 Weeks)|Lost to Follow-up|0
2459026|NCT02531633|8477041|P10|Part B (104 Weeks)|Sponsor request|4
2459027|NCT02531633|8477042|P9|Part B (104 Weeks)|Sponsor request|5
2459028|NCT02531633|8477043|P8|Part B (104 Weeks)|Sponsor request|3
2459029|NCT02531633|8477044|P7|Part B (104 Weeks)|Sponsor request|5
2459030|NCT02531633|8477045|P6|Part B (104 Weeks)|Sponsor request|8
2459031|NCT02531633|8477046|P5|Part B (104 Weeks)|Sponsor request|0
2459032|NCT02531633|8477047|P4|Part B (104 Weeks)|Sponsor request|0
2459033|NCT02531633|8477048|P3|Part B (104 Weeks)|Sponsor request|0
2459034|NCT02531633|8477049|P2|Part B (104 Weeks)|Sponsor request|0
2459035|NCT02531633|8477050|P1|Part B (104 Weeks)|Sponsor request|0
2459036|NCT02531633|8477041|P10|Part A (52 Weeks)|Other|0
2459037|NCT02531633|8477042|P9|Part A (52 Weeks)|Other|0
2459038|NCT02531633|8477043|P8|Part A (52 Weeks)|Other|0
2459039|NCT02531633|8477044|P7|Part A (52 Weeks)|Other|0
2459040|NCT02531633|8477045|P6|Part A (52 Weeks)|Other|0
2459041|NCT02531633|8477046|P5|Part A (52 Weeks)|Other|0
2459042|NCT02531633|8477047|P4|Part A (52 Weeks)|Other|0
2459043|NCT02531633|8477048|P3|Part A (52 Weeks)|Other|0
2459044|NCT02531633|8477049|P2|Part A (52 Weeks)|Other|0
2459045|NCT02531633|8477050|P1|Part A (52 Weeks)|Other|2
2459046|NCT02531633|8477041|P10|Part A (52 Weeks)|Withdrawal by Subject|0
2459047|NCT02531633|8477042|P9|Part A (52 Weeks)|Withdrawal by Subject|0
2459048|NCT02531633|8477043|P8|Part A (52 Weeks)|Withdrawal by Subject|0
2459049|NCT02531633|8477044|P7|Part A (52 Weeks)|Withdrawal by Subject|0
2459050|NCT02531633|8477045|P6|Part A (52 Weeks)|Withdrawal by Subject|0
2459051|NCT02531633|8477046|P5|Part A (52 Weeks)|Withdrawal by Subject|3
2459052|NCT02531633|8477047|P4|Part A (52 Weeks)|Withdrawal by Subject|3
2459053|NCT02531633|8477048|P3|Part A (52 Weeks)|Withdrawal by Subject|1
2459054|NCT02531633|8477049|P2|Part A (52 Weeks)|Withdrawal by Subject|6
2459055|NCT02531633|8477050|P1|Part A (52 Weeks)|Withdrawal by Subject|6
2459056|NCT02531633|8477041|P10|Part A (52 Weeks)|Physician Decision|0
2459057|NCT02531633|8477042|P9|Part A (52 Weeks)|Physician Decision|0
2459058|NCT02531633|8477043|P8|Part A (52 Weeks)|Physician Decision|0
2459059|NCT02531633|8477044|P7|Part A (52 Weeks)|Physician Decision|0
2459060|NCT02531633|8477045|P6|Part A (52 Weeks)|Physician Decision|0
2459061|NCT02531633|8477046|P5|Part A (52 Weeks)|Physician Decision|0
2459062|NCT02531633|8477047|P4|Part A (52 Weeks)|Physician Decision|1
2459063|NCT02531633|8477048|P3|Part A (52 Weeks)|Physician Decision|3
2459064|NCT02531633|8477049|P2|Part A (52 Weeks)|Physician Decision|4
2459065|NCT02531633|8477050|P1|Part A (52 Weeks)|Physician Decision|1
2459066|NCT02531633|8477041|P10|Part A (52 Weeks)|Lost to Follow-up|0
2459067|NCT02531633|8477042|P9|Part A (52 Weeks)|Lost to Follow-up|0
2459068|NCT02531633|8477043|P8|Part A (52 Weeks)|Lost to Follow-up|0
2459069|NCT02531633|8477044|P7|Part A (52 Weeks)|Lost to Follow-up|0
2459070|NCT02531633|8477045|P6|Part A (52 Weeks)|Lost to Follow-up|0
2459071|NCT02531633|8477046|P5|Part A (52 Weeks)|Lost to Follow-up|1
2459072|NCT02531633|8477047|P4|Part A (52 Weeks)|Lost to Follow-up|0
2459073|NCT02531633|8477048|P3|Part A (52 Weeks)|Lost to Follow-up|0
2459074|NCT02531633|8477049|P2|Part A (52 Weeks)|Lost to Follow-up|0
2459075|NCT02531633|8477050|P1|Part A (52 Weeks)|Lost to Follow-up|0
2459076|NCT02531633|8477041|P10|Part A (52 Weeks)|Protocol Violation|0
2459077|NCT02531633|8477042|P9|Part A (52 Weeks)|Protocol Violation|0
2459078|NCT02531633|8477043|P8|Part A (52 Weeks)|Protocol Violation|0
2459079|NCT02531633|8477044|P7|Part A (52 Weeks)|Protocol Violation|0
2459080|NCT02531633|8477045|P6|Part A (52 Weeks)|Protocol Violation|0
2459081|NCT02531633|8477046|P5|Part A (52 Weeks)|Protocol Violation|0
2459082|NCT02531633|8477047|P4|Part A (52 Weeks)|Protocol Violation|0
2459083|NCT02531633|8477048|P3|Part A (52 Weeks)|Protocol Violation|0
2459084|NCT02531633|8477049|P2|Part A (52 Weeks)|Protocol Violation|0
2459085|NCT02531633|8477050|P1|Part A (52 Weeks)|Protocol Violation|1
2459086|NCT02531633|8477041|P10|Part A (52 Weeks)|Sponsor request|0
2459087|NCT02531633|8477042|P9|Part A (52 Weeks)|Sponsor request|0
2459088|NCT02531633|8477043|P8|Part A (52 Weeks)|Sponsor request|0
2459089|NCT02531633|8477044|P7|Part A (52 Weeks)|Sponsor request|0
2459090|NCT02531633|8477045|P6|Part A (52 Weeks)|Sponsor request|0
2459091|NCT02531633|8477046|P5|Part A (52 Weeks)|Sponsor request|19
2459092|NCT02531633|8477047|P4|Part A (52 Weeks)|Sponsor request|18
2459093|NCT02531633|8477048|P3|Part A (52 Weeks)|Sponsor request|18
2459094|NCT02531633|8477049|P2|Part A (52 Weeks)|Sponsor request|24
2459095|NCT02531633|8477050|P1|Part A (52 Weeks)|Sponsor request|24
2459096|NCT02531438|8477529|P2|Overall Study|Randomized with Exclusion Criteria|0
2459097|NCT02531438|8477530|P1|Overall Study|Randomized with Exclusion Criteria|1
2459098|NCT02531438|8477529|P2|Overall Study|Missed EOT/PTE Visit|2
2459099|NCT02531438|8477530|P1|Overall Study|Missed EOT/PTE Visit|5
2459100|NCT02531438|8477529|P2|Overall Study|Randomized, but Not Treated|0
2459101|NCT02531438|8477530|P1|Overall Study|Randomized, but Not Treated|4
2459102|NCT02531438|8477529|P2|Overall Study|Death|3
2459103|NCT02531438|8477530|P1|Overall Study|Death|6
2459104|NCT02531438|8477529|P2|Overall Study|Physician Decision|1
2459105|NCT02531438|8477530|P1|Overall Study|Physician Decision|0
2459106|NCT02531438|8477529|P2|Overall Study|Withdrawal by Subject|8
2459107|NCT02531438|8477530|P1|Overall Study|Withdrawal by Subject|7
2459108|NCT02531438|8477529|P2|Overall Study|Lost to Follow-up|3
2459109|NCT02531438|8477530|P1|Overall Study|Lost to Follow-up|0
2459110|NCT02531438|8477529|P2|Overall Study|Adverse Event|9
2459111|NCT02531438|8477530|P1|Overall Study|Adverse Event|7
2459112|NCT02531373|8477549|P9|Overall Study|Withdrawal by Subject|0
2459113|NCT02531373|8477550|P8|Overall Study|Withdrawal by Subject|0
2459114|NCT02531373|8477551|P7|Overall Study|Withdrawal by Subject|0
2459115|NCT02531373|8477552|P6|Overall Study|Withdrawal by Subject|0
2459116|NCT02531373|8477553|P5|Overall Study|Withdrawal by Subject|3
2459117|NCT02531373|8477554|P4|Overall Study|Withdrawal by Subject|0
2459118|NCT02531373|8477555|P3|Overall Study|Withdrawal by Subject|0
2459119|NCT02531373|8477556|P2|Overall Study|Withdrawal by Subject|0
2459120|NCT02531373|8477557|P1|Overall Study|Withdrawal by Subject|0
2459121|NCT02531373|8477549|P9|Overall Study|Withdrawal by Parent/Guardian|3
2459122|NCT02531373|8477550|P8|Overall Study|Withdrawal by Parent/Guardian|1
2459123|NCT02531373|8477551|P7|Overall Study|Withdrawal by Parent/Guardian|4
2459124|NCT02531373|8477552|P6|Overall Study|Withdrawal by Parent/Guardian|3
2459125|NCT02531373|8477553|P5|Overall Study|Withdrawal by Parent/Guardian|0
2459126|NCT02531373|8477554|P4|Overall Study|Withdrawal by Parent/Guardian|0
2459127|NCT02531373|8477555|P3|Overall Study|Withdrawal by Parent/Guardian|0
2459128|NCT02531373|8477556|P2|Overall Study|Withdrawal by Parent/Guardian|0
2459129|NCT02531373|8477557|P1|Overall Study|Withdrawal by Parent/Guardian|0
2459130|NCT02531373|8477549|P9|Overall Study|Protocol Violation|1
2459131|NCT02531373|8477550|P8|Overall Study|Protocol Violation|0
2459132|NCT02531373|8477551|P7|Overall Study|Protocol Violation|1
2459133|NCT02531373|8477552|P6|Overall Study|Protocol Violation|1
2459134|NCT02531373|8477553|P5|Overall Study|Protocol Violation|0
2459135|NCT02531373|8477554|P4|Overall Study|Protocol Violation|0
2459136|NCT02531373|8477555|P3|Overall Study|Protocol Violation|0
2459137|NCT02531373|8477556|P2|Overall Study|Protocol Violation|0
2459138|NCT02531373|8477557|P1|Overall Study|Protocol Violation|0
2459139|NCT02531373|8477549|P9|Overall Study|Physician Decision|0
2459140|NCT02531373|8477550|P8|Overall Study|Physician Decision|0
2459141|NCT02531373|8477551|P7|Overall Study|Physician Decision|0
2459142|NCT02531373|8477552|P6|Overall Study|Physician Decision|1
2459143|NCT02531373|8477553|P5|Overall Study|Physician Decision|2
2459144|NCT02531373|8477554|P4|Overall Study|Physician Decision|0
2459145|NCT02531373|8477555|P3|Overall Study|Physician Decision|0
2459146|NCT02531373|8477556|P2|Overall Study|Physician Decision|0
2459147|NCT02531373|8477557|P1|Overall Study|Physician Decision|0
2459148|NCT02531373|8477549|P9|Overall Study|Lost to Follow-up|0
2459149|NCT02531373|8477550|P8|Overall Study|Lost to Follow-up|0
2459150|NCT02531373|8477551|P7|Overall Study|Lost to Follow-up|2
2459151|NCT02531373|8477552|P6|Overall Study|Lost to Follow-up|2
2459152|NCT02531373|8477553|P5|Overall Study|Lost to Follow-up|0
2459153|NCT02531373|8477554|P4|Overall Study|Lost to Follow-up|0
2459154|NCT02531373|8477555|P3|Overall Study|Lost to Follow-up|0
2459155|NCT02531373|8477556|P2|Overall Study|Lost to Follow-up|0
2459156|NCT02531373|8477557|P1|Overall Study|Lost to Follow-up|0
2459157|NCT02531373|8477549|P9|Overall Study|Lack of Efficacy|5
2459158|NCT02531373|8477550|P8|Overall Study|Lack of Efficacy|8
2459159|NCT02531373|8477551|P7|Overall Study|Lack of Efficacy|4
2459160|NCT02531373|8477552|P6|Overall Study|Lack of Efficacy|2
2459161|NCT02531373|8477553|P5|Overall Study|Lack of Efficacy|3
2459162|NCT02531373|8477554|P4|Overall Study|Lack of Efficacy|0
2459163|NCT02531373|8477555|P3|Overall Study|Lack of Efficacy|0
2459164|NCT02531373|8477556|P2|Overall Study|Lack of Efficacy|0
2459165|NCT02531373|8477557|P1|Overall Study|Lack of Efficacy|0
2459166|NCT02531035|8477631|P2|Overall Study|Randomized, not treated|1
2459167|NCT02531035|8477632|P1|Overall Study|Randomized, not treated|2
2459168|NCT02531035|8477631|P2|Overall Study|Lost to Follow-up|10
2459169|NCT02531035|8477632|P1|Overall Study|Lost to Follow-up|8
2459170|NCT02531035|8477631|P2|Overall Study|Withdrawal by Subject|32
2459171|NCT02531035|8477632|P1|Overall Study|Withdrawal by Subject|42
2459172|NCT02531035|8477631|P2|Overall Study|Other|2
2459173|NCT02531035|8477632|P1|Overall Study|Other|3
2459174|NCT02531035|8477631|P2|Overall Study|Adverse Event|45
2459175|NCT02531035|8477632|P1|Overall Study|Adverse Event|16
2459176|NCT02531035|8477631|P2|Overall Study|Physician Decision|0
2459177|NCT02531035|8477632|P1|Overall Study|Physician Decision|1
2459178|NCT02531035|8477631|P2|Overall Study|Noncompliance with study drug|3
2459179|NCT02531035|8477632|P1|Overall Study|Noncompliance with study drug|8
2459180|NCT02531035|8477631|P2|Overall Study|Protocol Violation|1
2459181|NCT02531035|8477632|P1|Overall Study|Protocol Violation|1
2459182|NCT02531035|8477631|P2|Overall Study|Death|1
2459183|NCT02531035|8477632|P1|Overall Study|Death|0
2459184|NCT02530970|8477657|P1|Overall Study|Relocation|3
2459185|NCT02530970|8477657|P1|Overall Study|Change in Provider|5
2459186|NCT02530970|8477657|P1|Overall Study|Explant|2
2459187|NCT02530970|8477657|P1|Overall Study|Insurance|2
2459188|NCT02530970|8477657|P1|Overall Study|Hospitalization|1
2459189|NCT02530970|8477657|P1|Overall Study|Death|6
2459190|NCT02530970|8477657|P1|Overall Study|Withdrawal by Subject|14
2459191|NCT02530970|8477657|P1|Overall Study|Physician Decision|5
2459192|NCT02530970|8477657|P1|Overall Study|Lost to Follow-up|88
2459193|NCT02530970|8477657|P1|Overall Study|Adverse Event|8
2459194|NCT02530671|8477664|P2|Overall Study|Withdrawal by Subject|0
2459195|NCT02530671|8477665|P1|Overall Study|Withdrawal by Subject|1
2459196|NCT02530671|8477664|P2|Overall Study|Lost to Follow-up|0
2459197|NCT02530671|8477665|P1|Overall Study|Lost to Follow-up|2
2459198|NCT02530385|8477743|P2|Overall Study|Withdrawal by Subject|1
2459199|NCT02530385|8477744|P1|Overall Study|Withdrawal by Subject|0
2459200|NCT02530125|8477807|P1|Followed for Survival for 2 Years|Early termination of study|3
2459201|NCT02530125|8477807|P1|Completed Treatment|Early termination of study|1
2459202|NCT02529995|8477821|P2|Part B|Discontinued Study|5
2459203|NCT02529995|8477822|P1|Part B|Discontinued Study|6
2459204|NCT02529995|8477821|P2|Part B|Ongoing Study at Data Cut-off|7
2459205|NCT02529995|8477822|P1|Part B|Ongoing Study at Data Cut-off|0
2459206|NCT02529995|8477821|P2|Part A|Discontinued Study|0
2459207|NCT02529995|8477822|P1|Part A|Discontinued Study|1
2459208|NCT02529995|8477821|P2|Part A|Ongoing Study at Data Cut-off|16
2459209|NCT02529995|8477822|P1|Part A|Ongoing Study at Data Cut-off|14
2459210|NCT02529553|8477865|P9|Overall Study|Withdrawal by Subject|0
2459211|NCT02529553|8477866|P8|Overall Study|Withdrawal by Subject|1
2459212|NCT02529553|8477867|P7|Overall Study|Withdrawal by Subject|0
2459213|NCT02529553|8477868|P6|Overall Study|Withdrawal by Subject|1
2459214|NCT02529553|8477869|P5|Overall Study|Withdrawal by Subject|0
2459215|NCT02529553|8477870|P4|Overall Study|Withdrawal by Subject|0
2459216|NCT02529553|8477871|P3|Overall Study|Withdrawal by Subject|0
2459217|NCT02529553|8477872|P2|Overall Study|Withdrawal by Subject|0
2459218|NCT02529553|8477873|P1|Overall Study|Withdrawal by Subject|0
2459219|NCT02529553|8477865|P9|Overall Study|Physician Decision|0
2459220|NCT02529553|8477866|P8|Overall Study|Physician Decision|0
2459221|NCT02529553|8477867|P7|Overall Study|Physician Decision|0
2459222|NCT02529553|8477868|P6|Overall Study|Physician Decision|0
2459223|NCT02529553|8477869|P5|Overall Study|Physician Decision|1
2459224|NCT02529553|8477870|P4|Overall Study|Physician Decision|0
2459225|NCT02529553|8477871|P3|Overall Study|Physician Decision|0
2459226|NCT02529553|8477872|P2|Overall Study|Physician Decision|1
2459227|NCT02529553|8477873|P1|Overall Study|Physician Decision|0
2459228|NCT02529553|8477865|P9|Overall Study|Progressive Disease|3
2459229|NCT02529553|8477866|P8|Overall Study|Progressive Disease|5
2459230|NCT02529553|8477867|P7|Overall Study|Progressive Disease|3
2459231|NCT02529553|8477868|P6|Overall Study|Progressive Disease|3
2459232|NCT02529553|8477869|P5|Overall Study|Progressive Disease|2
2459233|NCT02529553|8477870|P4|Overall Study|Progressive Disease|3
2459234|NCT02529553|8477871|P3|Overall Study|Progressive Disease|1
2459235|NCT02529553|8477872|P2|Overall Study|Progressive Disease|0
2459236|NCT02529553|8477873|P1|Overall Study|Progressive Disease|1
2459237|NCT02529488|8477912|P1|Overall Study|Death|3
2459238|NCT02529488|8477912|P1|Overall Study|Adverse Event|1
2459239|NCT02529137|8477920|P1|Overall Study|Discontinuation for different reasons|8
2459240|NCT02528643|8477957|P2|Overall Study|No End of Study Information Available|0
2459241|NCT02528643|8477958|P1|Overall Study|No End of Study Information Available|1
2459242|NCT02528643|8477957|P2|Overall Study|Miscellaneous|1
2459243|NCT02528643|8477958|P1|Overall Study|Miscellaneous|0
2459244|NCT02528643|8477957|P2|Overall Study|Withdrawal by Subject|7
2459245|NCT02528643|8477958|P1|Overall Study|Withdrawal by Subject|0
2459246|NCT02528643|8477957|P2|Overall Study|Lost to Follow-up|1
2459247|NCT02528643|8477958|P1|Overall Study|Lost to Follow-up|0
2459248|NCT02528643|8477957|P2|Overall Study|Death|76
2459249|NCT02528643|8477958|P1|Overall Study|Death|38
2459250|NCT02528331|8477975|P1|Overall Study|Withdrawal by Subject|2
2459251|NCT02528305|8478043|P1|Overall Study|Physician Decision|1
2459252|NCT02528305|8478043|P1|Overall Study|Adverse Event|1
2459253|NCT02528305|8478043|P1|Overall Study|Withdrawal by Subject|1
2459254|NCT02528253|8478090|P5|Overall Study|Withdrawn Due to Pregnancy|1
2459255|NCT02528253|8478091|P4|Overall Study|Withdrawn Due to Pregnancy|0
2459256|NCT02528253|8478092|P3|Overall Study|Withdrawn Due to Pregnancy|0
2459257|NCT02528253|8478093|P2|Overall Study|Withdrawn Due to Pregnancy|1
2459258|NCT02528253|8478094|P1|Overall Study|Withdrawn Due to Pregnancy|0
2459259|NCT02528253|8478090|P5|Overall Study|Protocol Violation|4
2459260|NCT02528253|8478091|P4|Overall Study|Protocol Violation|0
2459261|NCT02528253|8478092|P3|Overall Study|Protocol Violation|4
2459262|NCT02528253|8478093|P2|Overall Study|Protocol Violation|2
2459263|NCT02528253|8478094|P1|Overall Study|Protocol Violation|1
2459264|NCT02528253|8478090|P5|Overall Study|Withdrawal by Subject|73
2459265|NCT02528253|8478091|P4|Overall Study|Withdrawal by Subject|48
2459266|NCT02528253|8478092|P3|Overall Study|Withdrawal by Subject|29
2459267|NCT02528253|8478093|P2|Overall Study|Withdrawal by Subject|20
2459268|NCT02528253|8478094|P1|Overall Study|Withdrawal by Subject|25
2459269|NCT02528253|8478090|P5|Overall Study|Other|76
2459270|NCT02528253|8478091|P4|Overall Study|Other|52
2459271|NCT02528253|8478092|P3|Overall Study|Other|58
2459272|NCT02528253|8478093|P2|Overall Study|Other|22
2459273|NCT02528253|8478094|P1|Overall Study|Other|21
2459274|NCT02528253|8478090|P5|Overall Study|Lost to Follow-up|34
2459275|NCT02528253|8478091|P4|Overall Study|Lost to Follow-up|16
2459276|NCT02528253|8478092|P3|Overall Study|Lost to Follow-up|31
2459277|NCT02528253|8478093|P2|Overall Study|Lost to Follow-up|9
2459278|NCT02528253|8478094|P1|Overall Study|Lost to Follow-up|16
2459279|NCT02528253|8478090|P5|Overall Study|Insufficient clinical response|16
2459280|NCT02528253|8478091|P4|Overall Study|Insufficient clinical response|12
2459281|NCT02528253|8478092|P3|Overall Study|Insufficient clinical response|13
2459282|NCT02528253|8478093|P2|Overall Study|Insufficient clinical response|10
2459283|NCT02528253|8478094|P1|Overall Study|Insufficient clinical response|7
2459284|NCT02528253|8478090|P5|Overall Study|Death|1
2459285|NCT02528253|8478091|P4|Overall Study|Death|0
2459286|NCT02528253|8478092|P3|Overall Study|Death|1
2459287|NCT02528253|8478093|P2|Overall Study|Death|2
2459288|NCT02528253|8478094|P1|Overall Study|Death|2
2459289|NCT02528253|8478090|P5|Overall Study|Adverse Event|18
2459290|NCT02528253|8478091|P4|Overall Study|Adverse Event|8
2459291|NCT02528253|8478092|P3|Overall Study|Adverse Event|4
2459292|NCT02528253|8478093|P2|Overall Study|Adverse Event|4
2459293|NCT02528253|8478094|P1|Overall Study|Adverse Event|3
2459294|NCT02528214|8478387|P2|Overall Study|Other than specified above|1
2459295|NCT02528214|8478388|P1|Overall Study|Other than specified above|0
2459296|NCT02528214|8478387|P2|Overall Study|Adverse Event|1
2459297|NCT02528214|8478388|P1|Overall Study|Adverse Event|0
2459298|NCT02528214|8478387|P2|Overall Study|Protocol Violation|1
2459299|NCT02528214|8478388|P1|Overall Study|Protocol Violation|0
2459300|NCT02528188|8478423|P3|Overall Study|Randomized but not treated|12
2459301|NCT02528188|8478424|P2|Overall Study|Randomized but not treated|7
2459302|NCT02528188|8478425|P1|Overall Study|Randomized but not treated|6
2459303|NCT02528188|8478423|P3|Overall Study|Other|74
2459304|NCT02528188|8478424|P2|Overall Study|Other|91
2459305|NCT02528188|8478425|P1|Overall Study|Other|89
2459306|NCT02528188|8478423|P3|Overall Study|Death|0
2459307|NCT02528188|8478424|P2|Overall Study|Death|4
2459308|NCT02528188|8478425|P1|Overall Study|Death|4
2459309|NCT02528188|8478423|P3|Overall Study|Lost to Follow-up|31
2459310|NCT02528188|8478424|P2|Overall Study|Lost to Follow-up|21
2459311|NCT02528188|8478425|P1|Overall Study|Lost to Follow-up|25
2459312|NCT02528188|8478423|P3|Overall Study|Withdrawal by Subject|100
2459313|NCT02528188|8478424|P2|Overall Study|Withdrawal by Subject|104
2459314|NCT02528188|8478425|P1|Overall Study|Withdrawal by Subject|97
2459315|NCT02528188|8478423|P3|Overall Study|Lack of Efficacy|22
2459316|NCT02528188|8478424|P2|Overall Study|Lack of Efficacy|21
2459317|NCT02528188|8478425|P1|Overall Study|Lack of Efficacy|19
2459318|NCT02528188|8478423|P3|Overall Study|Protocol Violation|4
2459319|NCT02528188|8478424|P2|Overall Study|Protocol Violation|6
2459320|NCT02528188|8478425|P1|Overall Study|Protocol Violation|4
2459321|NCT02528188|8478423|P3|Overall Study|Adverse Event|8
2459322|NCT02528188|8478424|P2|Overall Study|Adverse Event|22
2459323|NCT02528188|8478425|P1|Overall Study|Adverse Event|23
2459324|NCT02527434|8478700|P3|Overall Study|Site closure|0
2459325|NCT02527434|8478701|P2|Overall Study|Site closure|0
2459326|NCT02527434|8478702|P1|Overall Study|Site closure|1
2459327|NCT02527434|8478700|P3|Overall Study|Reason Not Specified|0
2459328|NCT02527434|8478701|P2|Overall Study|Reason Not Specified|0
2459329|NCT02527434|8478702|P1|Overall Study|Reason Not Specified|1
2459330|NCT02527434|8478700|P3|Overall Study|Withdrawal by Subject|3
2459331|NCT02527434|8478701|P2|Overall Study|Withdrawal by Subject|3
2459332|NCT02527434|8478702|P1|Overall Study|Withdrawal by Subject|5
2459333|NCT02527434|8478700|P3|Overall Study|Death|17
2459334|NCT02527434|8478701|P2|Overall Study|Death|6
2459335|NCT02527434|8478702|P1|Overall Study|Death|19
2459336|NCT02527434|8478700|P3|Overall Study|Lost to Follow-up|0
2459337|NCT02527434|8478701|P2|Overall Study|Lost to Follow-up|2
2459338|NCT02527434|8478702|P1|Overall Study|Lost to Follow-up|2
2459339|NCT02527161|8478760|P1|Overall Study|Consent violation|4
2459340|NCT02527161|8478760|P1|Overall Study|MRI contraindication|2
2459341|NCT02527161|8478760|P1|Overall Study|Delay in or unfit for surgery|5
2459342|NCT02527161|8478760|P1|Overall Study|Exclusion RA diagnosis|1
2459343|NCT02527161|8478760|P1|Overall Study|Exclusion for excessive deformity|1
2459344|NCT02527161|8478760|P1|Overall Study|Exclusion for BMI|2
2459345|NCT02527161|8478760|P1|Overall Study|Shape Match not used in surgery|2
2459346|NCT02527161|8478760|P1|Overall Study|Withdrawal by Subject|6
2459347|NCT02527161|8478760|P1|Overall Study|Failed MRI|39
2459348|NCT02527148|8478779|P2|Overall Study|Did not receive study intervention|0
2459349|NCT02527148|8478780|P1|Overall Study|Did not receive study intervention|1
2459350|NCT02526693|8478800|P2|Overall Study|Physician Decision|1
2459351|NCT02526693|8478801|P1|Overall Study|Physician Decision|3
2459352|NCT02526550|8478830|P1|Overall Study|Lost to Follow-up|1
2459353|NCT02526524|8478842|P6|Overall Study|Sponsor Decision|0
2459354|NCT02526524|8478843|P5|Overall Study|Sponsor Decision|0
2459355|NCT02526524|8478844|P4|Overall Study|Sponsor Decision|0
2459356|NCT02526524|8478845|P3|Overall Study|Sponsor Decision|0
2459357|NCT02526524|8478846|P2|Overall Study|Sponsor Decision|0
2459358|NCT02526524|8478847|P1|Overall Study|Sponsor Decision|1
2459359|NCT02526524|8478842|P6|Overall Study|Physician Decision|0
2459360|NCT02526524|8478843|P5|Overall Study|Physician Decision|1
2459361|NCT02526524|8478844|P4|Overall Study|Physician Decision|0
2459362|NCT02526524|8478845|P3|Overall Study|Physician Decision|0
2459363|NCT02526524|8478846|P2|Overall Study|Physician Decision|0
2459364|NCT02526524|8478847|P1|Overall Study|Physician Decision|0
2459365|NCT02526524|8478842|P6|Overall Study|Loss of Glucose Control|0
2459366|NCT02526524|8478843|P5|Overall Study|Loss of Glucose Control|2
2459367|NCT02526524|8478844|P4|Overall Study|Loss of Glucose Control|0
2459368|NCT02526524|8478845|P3|Overall Study|Loss of Glucose Control|3
2459369|NCT02526524|8478846|P2|Overall Study|Loss of Glucose Control|0
2459370|NCT02526524|8478847|P1|Overall Study|Loss of Glucose Control|0
2459371|NCT02526524|8478842|P6|Overall Study|Protocol Violation|3
2459372|NCT02526524|8478843|P5|Overall Study|Protocol Violation|4
2459373|NCT02526524|8478844|P4|Overall Study|Protocol Violation|3
2459374|NCT02526524|8478845|P3|Overall Study|Protocol Violation|5
2459375|NCT02526524|8478846|P2|Overall Study|Protocol Violation|1
2459376|NCT02526524|8478847|P1|Overall Study|Protocol Violation|3
2459377|NCT02526524|8478842|P6|Overall Study|Lost to Follow-up|5
2459378|NCT02526524|8478843|P5|Overall Study|Lost to Follow-up|2
2459379|NCT02526524|8478844|P4|Overall Study|Lost to Follow-up|1
2459380|NCT02526524|8478845|P3|Overall Study|Lost to Follow-up|8
2459381|NCT02526524|8478846|P2|Overall Study|Lost to Follow-up|3
2459382|NCT02526524|8478847|P1|Overall Study|Lost to Follow-up|2
2459383|NCT02526524|8478842|P6|Overall Study|Adverse Event|8
2459384|NCT02526524|8478843|P5|Overall Study|Adverse Event|6
2459385|NCT02526524|8478844|P4|Overall Study|Adverse Event|2
2459386|NCT02526524|8478845|P3|Overall Study|Adverse Event|4
2459387|NCT02526524|8478846|P2|Overall Study|Adverse Event|2
2459388|NCT02526524|8478847|P1|Overall Study|Adverse Event|3
2459389|NCT02526524|8478842|P6|Overall Study|Withdrawal by Subject|5
2459390|NCT02526524|8478843|P5|Overall Study|Withdrawal by Subject|9
2459391|NCT02526524|8478844|P4|Overall Study|Withdrawal by Subject|1
2459392|NCT02526524|8478845|P3|Overall Study|Withdrawal by Subject|6
2459393|NCT02526524|8478846|P2|Overall Study|Withdrawal by Subject|3
2459394|NCT02526524|8478847|P1|Overall Study|Withdrawal by Subject|3
2459395|NCT02526290|8478861|P1|Overall Study|Physician Decision|1
2459396|NCT02526290|8478861|P1|Overall Study|Withdrawal by Subject|4
2459397|NCT02526290|8478861|P1|Overall Study|Adverse Event|3
2459398|NCT02525874|8478893|P1|Overall Study|New lesions in Brain|1
2459399|NCT02525874|8478893|P1|Overall Study|Alternative Treatment for MS|2
2459400|NCT02525874|8478893|P1|Overall Study|Disease relapse|4
2459401|NCT02525874|8478893|P1|Overall Study|Disease progression, defined by protocol|2
2459402|NCT02525874|8478893|P1|Overall Study|Lost to Follow-up|7
2459403|NCT02525874|8478893|P1|Overall Study|Adverse Event|17
2459404|NCT02525874|8478893|P1|Overall Study|Non-compliance with study drug|3
2459405|NCT02525874|8478893|P1|Overall Study|Consent withdrawn|22
2459406|NCT02525874|8478893|P1|Overall Study|Investigator Decision|1
2459407|NCT02525874|8478893|P1|Overall Study|Other|1
2459408|NCT02525627|8478923|P2|Overall Study|Site terminated|10
2459409|NCT02525627|8478924|P1|Overall Study|Site terminated|11
2459410|NCT02525627|8478923|P2|Overall Study|Death|0
2459411|NCT02525627|8478924|P1|Overall Study|Death|1
2459412|NCT02525627|8478923|P2|Overall Study|Withdrawal by Subject|2
2459413|NCT02525627|8478924|P1|Overall Study|Withdrawal by Subject|1
2459414|NCT02525627|8478923|P2|Overall Study|Revision|1
2459415|NCT02525627|8478924|P1|Overall Study|Revision|1
2459416|NCT02525588|8478936|P2|Overall Study|Adverse Event|1
2459417|NCT02525588|8478937|P1|Overall Study|Adverse Event|0
2459418|NCT02525588|8478936|P2|Overall Study|Withdrawal by Subject|1
2459419|NCT02525588|8478937|P1|Overall Study|Withdrawal by Subject|1
2459420|NCT02525588|8478936|P2|Overall Study|Lost to Follow-up|0
2459421|NCT02525588|8478937|P1|Overall Study|Lost to Follow-up|2
2459422|NCT02525588|8478936|P2|Overall Study|Death|1
2459423|NCT02525588|8478937|P1|Overall Study|Death|3
2459424|NCT02525094|8479049|P2|Overall Study|Not Treated|1
2459425|NCT02525094|8479050|P1|Overall Study|Not Treated|1
2459426|NCT02525094|8479049|P2|Overall Study|Withdrawal by Subject|6
2459427|NCT02525094|8479050|P1|Overall Study|Withdrawal by Subject|5
2459428|NCT02525094|8479049|P2|Overall Study|Lost to Follow-up|1
2459429|NCT02525094|8479050|P1|Overall Study|Lost to Follow-up|2
2459430|NCT02524665|8479113|P1|Overall Study|Lost to Follow-up|1
2459431|NCT02524288|8479164|P1|Overall Study|Physician Decision|2
2459432|NCT02524288|8479164|P1|Overall Study|Pregnancy|22
2459433|NCT02524288|8479164|P1|Overall Study|Withdrawal by Subject|76
2459434|NCT02524288|8479164|P1|Overall Study|Subject Moved|32
2459435|NCT02524288|8479164|P1|Overall Study|Study Terminated By Sponsor|1417
2459436|NCT02524288|8479164|P1|Overall Study|Site Discontinued Study Participation|1
2459437|NCT02524288|8479164|P1|Overall Study|Screen Failure|2
2459438|NCT02524288|8479164|P1|Overall Study|Protocol Violation|6
2459439|NCT02524288|8479164|P1|Overall Study|Pregnancy Wish|6
2459440|NCT02524288|8479164|P1|Overall Study|Non-Compliance With Study Drug|14
2459441|NCT02524288|8479164|P1|Overall Study|Non-Compliance With Protocol|32
2459442|NCT02524288|8479164|P1|Overall Study|Lost to Follow-up|216
2459443|NCT02524288|8479164|P1|Overall Study|Adverse Event|115
2459444|NCT02524158|8479174|P2|6-month Assessment|Lost to Follow-up|20
2459445|NCT02524158|8479175|P1|6-month Assessment|Lost to Follow-up|21
2459446|NCT02524158|8479174|P2|6-month Assessment|Withdrawal by Subject|1
2459447|NCT02524158|8479175|P1|6-month Assessment|Withdrawal by Subject|1
2459448|NCT02524158|8479174|P2|12-weeks Assessment|Lost to Follow-up|12
2459449|NCT02524158|8479175|P1|12-weeks Assessment|Lost to Follow-up|18
2459450|NCT02524158|8479174|P2|12-weeks Assessment|Withdrawal by Subject|1
2459451|NCT02524158|8479175|P1|12-weeks Assessment|Withdrawal by Subject|1
2459452|NCT02524145|8479217|P3|Overall Study|Withdrawal by Subject|3
2459453|NCT02524145|8479218|P2|Overall Study|Withdrawal by Subject|2
2459454|NCT02524145|8479219|P1|Overall Study|Withdrawal by Subject|2
2459455|NCT02522884|8479316|P1|Overall Study|Missed 12-month Follow-up|9
2459456|NCT02522884|8479316|P1|Overall Study|Death|3
2459457|NCT02522884|8479316|P1|Overall Study|Withdrawal by Subject|6
2459458|NCT02522728|8479323|P2|Overall Study|Did not receive randomized study device|1
2459459|NCT02522728|8479324|P1|Overall Study|Did not receive randomized study device|0
2459460|NCT02522728|8479323|P2|Overall Study|Adverse Event|1
2459461|NCT02522728|8479324|P1|Overall Study|Adverse Event|2
2459462|NCT02522728|8479323|P2|Overall Study|Death|3
2459463|NCT02522728|8479324|P1|Overall Study|Death|4
2459464|NCT02522728|8479323|P2|Overall Study|Withdrawal by Subject|6
2459465|NCT02522728|8479324|P1|Overall Study|Withdrawal by Subject|6
2459466|NCT02522624|8479340|P2|Overall Study|Technical failure|0
2459467|NCT02522624|8479341|P1|Overall Study|Technical failure|1
2459468|NCT02522403|8479376|P2|Overall Study|Withdrawal by Subject|4
2459469|NCT02522403|8479377|P1|Overall Study|Withdrawal by Subject|2
2459470|NCT02522403|8479376|P2|Overall Study|Lost to Follow-up|2
2459471|NCT02522403|8479377|P1|Overall Study|Lost to Follow-up|2
2459472|NCT02522377|8479389|P2|Overall Study|Remission Achieved|0
2459473|NCT02522377|8479390|P1|Overall Study|Remission Achieved|3
2459474|NCT02522377|8479389|P2|Overall Study|Withdrawal by Subject|0
2459475|NCT02522377|8479390|P1|Overall Study|Withdrawal by Subject|1
2459476|NCT02522325|8479406|P2|Overall Study|Adverse Event|1
2459477|NCT02522325|8479407|P1|Overall Study|Adverse Event|0
2459478|NCT02522299|8479415|P2|Overall Study|Withdrawal by Subject|0
2459479|NCT02522299|8479416|P1|Overall Study|Withdrawal by Subject|2
2459480|NCT02522299|8479415|P2|Overall Study|Physician Decision|1
2459481|NCT02522299|8479416|P1|Overall Study|Physician Decision|0
2459482|NCT02522299|8479415|P2|Overall Study|Adverse Event|0
2459483|NCT02522299|8479416|P1|Overall Study|Adverse Event|2
2459484|NCT02522286|8479499|P4|Overall Study|Withdrawal by Subject|3
2459485|NCT02522286|8479500|P3|Overall Study|Withdrawal by Subject|0
2459486|NCT02522286|8479501|P2|Overall Study|Withdrawal by Subject|0
2459487|NCT02522286|8479502|P1|Overall Study|Withdrawal by Subject|3
2459488|NCT02521948|8479528|P1|Overall Study|Did not attend one or both follow-ups|6
2459489|NCT02521948|8479528|P1|Overall Study|Lost to Follow-up|1
2459490|NCT02521948|8479528|P1|Overall Study|Death|4
2459491|NCT02521948|8479528|P1|Overall Study|Adverse Event|2
2459492|NCT02521376|8479574|P4|Overall Study|Enrolled, But Not Treated|0
2459493|NCT02521376|8479575|P3|Overall Study|Enrolled, But Not Treated|0
2459494|NCT02521376|8479576|P2|Overall Study|Enrolled, But Not Treated|0
2459495|NCT02521376|8479577|P1|Overall Study|Enrolled, But Not Treated|1
2459496|NCT02520726|8479618|P2|Overall Study|Lost to Follow-up|2
2459497|NCT02520726|8479619|P1|Overall Study|Lost to Follow-up|3
2459498|NCT02520531|8479629|P2|Overall Study|Not study device|0
2459499|NCT02520531|8479630|P1|Overall Study|Not study device|1
2459500|NCT02520531|8479629|P2|Overall Study|Withdrawal by Subject|0
2459501|NCT02520531|8479630|P1|Overall Study|Withdrawal by Subject|1
2459502|NCT02520531|8479629|P2|Overall Study|Meet exclusion criterion|1
2459503|NCT02520531|8479630|P1|Overall Study|Meet exclusion criterion|0
2459504|NCT02520531|8479629|P2|Overall Study|Lost to Follow-up|1
2459505|NCT02520531|8479630|P1|Overall Study|Lost to Follow-up|1
2459506|NCT02520531|8479629|P2|Overall Study|Death|2
2459507|NCT02520531|8479630|P1|Overall Study|Death|1
2459508|NCT02520531|8479629|P2|Overall Study|Revision of study device components|2
2459509|NCT02520531|8479630|P1|Overall Study|Revision of study device components|2
2459510|NCT02520388|8479715|P2|Overall Study|Other (reason not defined)|4
2459511|NCT02520388|8479716|P1|Overall Study|Other (reason not defined)|4
2459512|NCT02520388|8479715|P2|Overall Study|Lost to Follow-up|2
2459513|NCT02520388|8479716|P1|Overall Study|Lost to Follow-up|3
2459514|NCT02520388|8479715|P2|Overall Study|Adverse Event|4
2459515|NCT02520388|8479716|P1|Overall Study|Adverse Event|1
2459516|NCT02520388|8479715|P2|Overall Study|Subject or parent/guardian request|6
2459517|NCT02520388|8479716|P1|Overall Study|Subject or parent/guardian request|0
2459518|NCT02520388|8479715|P2|Overall Study|Physician Decision|0
2459519|NCT02520388|8479716|P1|Overall Study|Physician Decision|1
2459520|NCT02520310|8479724|P1|At 1 Year Clinical Follow-up|Withdrawal by Subject|1
2459521|NCT02520310|8479724|P1|At 6 Months Clinical Follow-up|Death|1
2459522|NCT02520284|8479859|P3|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1
2459523|NCT02520284|8479860|P2|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1
2459524|NCT02520284|8479861|P1|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2
2459525|NCT02520284|8479859|P3|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3
2459526|NCT02520284|8479860|P2|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1
2459527|NCT02520284|8479861|P1|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2
2459528|NCT02520284|8479859|P3|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2
2459529|NCT02520284|8479860|P2|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4
2459530|NCT02520284|8479861|P1|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3
2459531|NCT02520284|8479859|P3|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28
2459532|NCT02520284|8479860|P2|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29
2459533|NCT02520284|8479861|P1|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25
2459534|NCT02520284|8479859|P3|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0
2459535|NCT02520284|8479860|P2|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2
2459536|NCT02520284|8479861|P1|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0
2459537|NCT02520284|8479859|P3|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0
2459538|NCT02520284|8479860|P2|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1
2459539|NCT02520284|8479861|P1|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1
2459540|NCT02520284|8479859|P3|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3
2459541|NCT02520284|8479860|P2|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2
2459542|NCT02520284|8479861|P1|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2
2459543|NCT02520284|8479859|P3|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15
2459544|NCT02520284|8479860|P2|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11
2459545|NCT02520284|8479861|P1|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17
2459546|NCT02520284|8479859|P3|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1
2459547|NCT02520284|8479860|P2|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0
2459548|NCT02520284|8479861|P1|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0
2459549|NCT02520284|8479859|P3|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
2459550|NCT02520284|8479860|P2|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
2459551|NCT02520284|8479861|P1|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
2459552|NCT02520284|8479859|P3|Blinded Induction Phase: Up to Week 8|Adverse Event|0
2459553|NCT02520284|8479860|P2|Blinded Induction Phase: Up to Week 8|Adverse Event|3
2459554|NCT02520284|8479861|P1|Blinded Induction Phase: Up to Week 8|Adverse Event|1
2459555|NCT02520089|8479895|P2|Overall Study|Lost to Follow-up|4
2459556|NCT02520089|8479896|P1|Overall Study|Lost to Follow-up|3
2459557|NCT02519855|8479906|P2|Overall Study|Lost to Follow-up|3
2459558|NCT02519855|8479907|P1|Overall Study|Lost to Follow-up|3
2459559|NCT02519855|8479906|P2|Overall Study|Adverse Event|1
2459560|NCT02519855|8479907|P1|Overall Study|Adverse Event|0
2459561|NCT02519842|8479925|P3|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2
2459562|NCT02519842|8479926|P2|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
2459563|NCT02519842|8479927|P1|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
2459564|NCT02519842|8479925|P3|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1
2459565|NCT02519842|8479926|P2|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
2459566|NCT02519842|8479927|P1|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
2459567|NCT02519842|8479925|P3|Optional Extension: Cycles 2-6|Completed Chemotherapy|13
2459568|NCT02519842|8479926|P2|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
2459569|NCT02519842|8479927|P1|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
2459570|NCT02519842|8479925|P3|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2
2459571|NCT02519842|8479926|P2|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
2459572|NCT02519842|8479927|P1|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
2459573|NCT02519842|8479925|P3|Optional Extension: Cycles 2-6|Death|1
2459574|NCT02519842|8479926|P2|Optional Extension: Cycles 2-6|Death|0
2459575|NCT02519842|8479927|P1|Optional Extension: Cycles 2-6|Death|0
2459576|NCT02519842|8479925|P3|Optional Extension: Cycles 2-6|Withdrawal by Subject|1
2459577|NCT02519842|8479926|P2|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
2459578|NCT02519842|8479927|P1|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
2459579|NCT02519842|8479925|P3|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3
2459580|NCT02519842|8479926|P2|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
2459581|NCT02519842|8479927|P1|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
2459582|NCT02519842|8479925|P3|Optional Extension: Cycles 2-6|Adverse Event|1
2459583|NCT02519842|8479926|P2|Optional Extension: Cycles 2-6|Adverse Event|0
2459584|NCT02519842|8479927|P1|Optional Extension: Cycles 2-6|Adverse Event|0
2459585|NCT02519842|8479925|P3|Optional Extension: Cycles 2-6|Physician Decision|5
2459586|NCT02519842|8479926|P2|Optional Extension: Cycles 2-6|Physician Decision|0
2459587|NCT02519842|8479927|P1|Optional Extension: Cycles 2-6|Physician Decision|0
2459588|NCT02519842|8479925|P3|Base Study: Cycle 1|Non-compliance with Study Drug|0
2459589|NCT02519842|8479926|P2|Base Study: Cycle 1|Non-compliance with Study Drug|1
2459590|NCT02519842|8479927|P1|Base Study: Cycle 1|Non-compliance with Study Drug|0
2459591|NCT02519842|8479925|P3|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
2459592|NCT02519842|8479926|P2|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1
2459593|NCT02519842|8479927|P1|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
2459594|NCT02519842|8479925|P3|Base Study: Cycle 1|Adverse Event|0
2459595|NCT02519842|8479926|P2|Base Study: Cycle 1|Adverse Event|0
2459596|NCT02519842|8479927|P1|Base Study: Cycle 1|Adverse Event|1
2459597|NCT02519842|8479925|P3|Base Study: Cycle 1|Screening Failure|0
2459598|NCT02519842|8479926|P2|Base Study: Cycle 1|Screening Failure|1
2459599|NCT02519842|8479927|P1|Base Study: Cycle 1|Screening Failure|1
2459600|NCT02519712|8479946|P1|Overall Study|Accruals are donors|2
2459601|NCT02519712|8479946|P1|Overall Study|Disease Progression|1
2459602|NCT02519712|8479946|P1|Overall Study|Disease Relapse|1
2459603|NCT02519595|8479953|P3|Overall Study|Protocol Violation|16
2459604|NCT02519595|8479954|P2|Overall Study|Protocol Violation|22
2459605|NCT02519595|8479955|P1|Overall Study|Protocol Violation|8
2459606|NCT02519504|8479980|P2|Overall Study|Did not participate in direct testing|86
2459607|NCT02519504|8479981|P1|Overall Study|Did not participate in direct testing|95
2459608|NCT02519504|8479980|P2|Overall Study|Ineligible for direct testing|12
2459609|NCT02519504|8479981|P1|Overall Study|Ineligible for direct testing|12
2459610|NCT02519504|8479980|P2|Overall Study|Protocol Violation|5
2459611|NCT02519504|8479981|P1|Overall Study|Protocol Violation|6
2459612|NCT02518971|8480186|P2|Overall Study|eligibility criteria no longer met|3
2459613|NCT02518971|8480187|P1|Overall Study|eligibility criteria no longer met|6
2459614|NCT02518971|8480186|P2|Overall Study|medication lost in mail|1
2459615|NCT02518971|8480187|P1|Overall Study|medication lost in mail|0
2459616|NCT02518971|8480186|P2|Overall Study|Side effects|0
2459617|NCT02518971|8480187|P1|Overall Study|Side effects|1
2459618|NCT02518971|8480186|P2|Overall Study|Withdrawal by Subject|5
2459619|NCT02518971|8480187|P1|Overall Study|Withdrawal by Subject|4
2459620|NCT02518971|8480186|P2|Overall Study|Protocol Violation|4
2459621|NCT02518971|8480187|P1|Overall Study|Protocol Violation|6
2459622|NCT02518971|8480186|P2|Overall Study|Physician Decision|6
2459623|NCT02518971|8480187|P1|Overall Study|Physician Decision|6
2459624|NCT02518971|8480186|P2|Overall Study|Lost to Follow-up|1
2459625|NCT02518971|8480187|P1|Overall Study|Lost to Follow-up|0
2459626|NCT02518919|8480207|P3|Overall Study|Protocol Violation|2
2459627|NCT02518919|8480208|P2|Overall Study|Protocol Violation|1
2459628|NCT02518919|8480209|P1|Overall Study|Protocol Violation|1
2459629|NCT02518685|8480239|P2|Overall Study|Lost to Follow-up|4
2459630|NCT02518685|8480240|P1|Overall Study|Lost to Follow-up|1
2459631|NCT02518685|8480239|P2|Overall Study|Physician Decision|0
2459632|NCT02518685|8480240|P1|Overall Study|Physician Decision|1
2459633|NCT02518685|8480239|P2|Overall Study|Pregnancy|0
2459634|NCT02518685|8480240|P1|Overall Study|Pregnancy|1
2459635|NCT02518685|8480239|P2|Overall Study|relocation, study fatigue|2
2459636|NCT02518685|8480240|P1|Overall Study|relocation, study fatigue|7
2459637|NCT02518685|8480239|P2|Overall Study|Withdrawal by Subject|3
2459638|NCT02518685|8480240|P1|Overall Study|Withdrawal by Subject|10
2459639|NCT02518685|8480239|P2|Overall Study|Adverse Event|1
2459640|NCT02518685|8480240|P1|Overall Study|Adverse Event|29
2459641|NCT02518620|8480249|P2|Overall Study|Relocation|1
2459642|NCT02518620|8480250|P1|Overall Study|Relocation|2
2459643|NCT02518620|8480249|P2|Overall Study|Pregnancy|0
2459644|NCT02518620|8480250|P1|Overall Study|Pregnancy|1
2459645|NCT02518620|8480249|P2|Overall Study|Pregnancy Wish|0
2459646|NCT02518620|8480250|P1|Overall Study|Pregnancy Wish|3
2459647|NCT02518620|8480249|P2|Overall Study|Death|0
2459648|NCT02518620|8480250|P1|Overall Study|Death|1
2459649|NCT02518620|8480249|P2|Overall Study|Withdrawal by Subject|9
2459650|NCT02518620|8480250|P1|Overall Study|Withdrawal by Subject|17
2459651|NCT02518620|8480249|P2|Overall Study|Lost to Follow-up|1
2459652|NCT02518620|8480250|P1|Overall Study|Lost to Follow-up|1
2459653|NCT02518620|8480249|P2|Overall Study|Sponsor's Decision|3
2459654|NCT02518620|8480250|P1|Overall Study|Sponsor's Decision|0
2459655|NCT02518620|8480249|P2|Overall Study|Physician Decision|1
2459656|NCT02518620|8480250|P1|Overall Study|Physician Decision|1
2459657|NCT02518620|8480249|P2|Overall Study|Non-Compliance with Study Drug|0
2459658|NCT02518620|8480250|P1|Overall Study|Non-Compliance with Study Drug|1
2459659|NCT02518620|8480249|P2|Overall Study|Lack of Efficacy|0
2459660|NCT02518620|8480250|P1|Overall Study|Lack of Efficacy|2
2459661|NCT02518620|8480249|P2|Overall Study|Adverse Event|11
2459662|NCT02518620|8480250|P1|Overall Study|Adverse Event|23
2459663|NCT02518464|8480273|P1|Overall Study|Adverse Event|2
2459664|NCT02518113|8480294|P4|Overall Study|Progressive Disease|0
2459665|NCT02518113|8480295|P3|Overall Study|Progressive Disease|3
2459666|NCT02518113|8480296|P2|Overall Study|Progressive Disease|2
2459667|NCT02518113|8480297|P1|Overall Study|Progressive Disease|1
2459668|NCT02518113|8480294|P4|Overall Study|Physician Decision|0
2459669|NCT02518113|8480295|P3|Overall Study|Physician Decision|0
2459670|NCT02518113|8480296|P2|Overall Study|Physician Decision|1
2459671|NCT02518113|8480297|P1|Overall Study|Physician Decision|0
2459672|NCT02518113|8480294|P4|Overall Study|Death|0
2459673|NCT02518113|8480295|P3|Overall Study|Death|0
2459674|NCT02518113|8480296|P2|Overall Study|Death|2
2459675|NCT02518113|8480297|P1|Overall Study|Death|1
2459676|NCT02518113|8480294|P4|Overall Study|Adverse Event|0
2459677|NCT02518113|8480295|P3|Overall Study|Adverse Event|1
2459678|NCT02518113|8480296|P2|Overall Study|Adverse Event|0
2459679|NCT02518113|8480297|P1|Overall Study|Adverse Event|1
2459680|NCT02518048|8480338|P1|Overall Study|Withdrawal by Subject|1
2459681|NCT02517866|8480364|P3|Overall Study|Reason not specified|0
2459682|NCT02517866|8480365|P2|Overall Study|Reason not specified|0
2459683|NCT02517866|8480366|P1|Overall Study|Reason not specified|2
2459684|NCT02517866|8480364|P3|Overall Study|Investigator Decision|0
2459685|NCT02517866|8480365|P2|Overall Study|Investigator Decision|1
2459686|NCT02517866|8480366|P1|Overall Study|Investigator Decision|2
2459687|NCT02517866|8480364|P3|Overall Study|Voluntary Withdrawal|0
2459688|NCT02517866|8480365|P2|Overall Study|Voluntary Withdrawal|2
2459689|NCT02517866|8480366|P1|Overall Study|Voluntary Withdrawal|2
2459690|NCT02517866|8480364|P3|Overall Study|Lost to Follow-up|0
2459691|NCT02517866|8480365|P2|Overall Study|Lost to Follow-up|0
2459692|NCT02517866|8480366|P1|Overall Study|Lost to Follow-up|1
2459693|NCT02517866|8480364|P3|Overall Study|Significant Protocol Deviation|0
2459694|NCT02517866|8480365|P2|Overall Study|Significant Protocol Deviation|1
2459695|NCT02517866|8480366|P1|Overall Study|Significant Protocol Deviation|4
2459696|NCT02517866|8480364|P3|Overall Study|Pretreatment Event/Adverse Event|0
2459697|NCT02517866|8480365|P2|Overall Study|Pretreatment Event/Adverse Event|2
2459698|NCT02517866|8480366|P1|Overall Study|Pretreatment Event/Adverse Event|9
2459699|NCT02517541|8480437|P1|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2
2459700|NCT02517541|8480437|P1|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4
2459701|NCT02517541|8480437|P1|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1
2459702|NCT02517541|8480437|P1|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2
2459703|NCT02517541|8480437|P1|Test Period (SenSura Mio Convex Soft)|Adverse Event|3
2459704|NCT02517541|8480437|P1|Baseline Period (Own Product)|Protocol Violation|1
2459705|NCT02517528|8480443|P1|Overall Study|Withdrawal by Subject|1
2459706|NCT02517515|8480453|P2|Overall Study|Other|0
2459707|NCT02517515|8480454|P1|Overall Study|Other|1
2459708|NCT02517515|8480453|P2|Overall Study|Lost to Follow-up|0
2459709|NCT02517515|8480454|P1|Overall Study|Lost to Follow-up|1
2459710|NCT02517515|8480453|P2|Overall Study|Withdrew Consent|1
2459711|NCT02517515|8480454|P1|Overall Study|Withdrew Consent|0
2459712|NCT02517515|8480453|P2|Overall Study|Adverse Event|1
2459713|NCT02517515|8480454|P1|Overall Study|Adverse Event|0
2459714|NCT02517463|8480471|P2|Overall Study|Lost to Follow-up|2
2459715|NCT02517463|8480472|P1|Overall Study|Lost to Follow-up|5
2459716|NCT02517268|8480484|P2|Overall Study|Withdrawal by Subject|0
2459717|NCT02517268|8480485|P1|Overall Study|Withdrawal by Subject|1
2459718|NCT02516982|8480537|P4|Overall Study|Did not install the app|47
2459719|NCT02516982|8480538|P3|Overall Study|Did not install the app|46
2459720|NCT02516982|8480539|P2|Overall Study|Did not install the app|0
2459721|NCT02516982|8480540|P1|Overall Study|Did not install the app|0
2459722|NCT02516982|8480537|P4|Overall Study|Protocol Violation|1
2459723|NCT02516982|8480538|P3|Overall Study|Protocol Violation|1
2459724|NCT02516982|8480539|P2|Overall Study|Protocol Violation|0
2459725|NCT02516982|8480540|P1|Overall Study|Protocol Violation|0
2459726|NCT02516982|8480537|P4|Overall Study|Withdrawal by Subject|2
2459727|NCT02516982|8480538|P3|Overall Study|Withdrawal by Subject|1
2459728|NCT02516982|8480539|P2|Overall Study|Withdrawal by Subject|0
2459729|NCT02516982|8480540|P1|Overall Study|Withdrawal by Subject|0
2459730|NCT02516982|8480537|P4|Overall Study|Called in to antenatal appointment|0
2459731|NCT02516982|8480538|P3|Overall Study|Called in to antenatal appointment|0
2459732|NCT02516982|8480539|P2|Overall Study|Called in to antenatal appointment|35
2459733|NCT02516982|8480540|P1|Overall Study|Called in to antenatal appointment|32
2459734|NCT02516605|8480567|P5|Overall Study|Withdrawal by Subject|0
2459735|NCT02516605|8480568|P4|Overall Study|Withdrawal by Subject|1
2459736|NCT02516605|8480569|P3|Overall Study|Withdrawal by Subject|0
2459737|NCT02516605|8480570|P2|Overall Study|Withdrawal by Subject|0
2459738|NCT02516605|8480571|P1|Overall Study|Withdrawal by Subject|0
2459739|NCT02516605|8480567|P5|Overall Study|Protocol Violation|1
2459740|NCT02516605|8480568|P4|Overall Study|Protocol Violation|0
2459741|NCT02516605|8480569|P3|Overall Study|Protocol Violation|0
2459742|NCT02516605|8480570|P2|Overall Study|Protocol Violation|0
2459743|NCT02516605|8480571|P1|Overall Study|Protocol Violation|0
2459744|NCT02516592|8480642|P2|Overall Study|Death|1
2459745|NCT02516592|8480643|P1|Overall Study|Death|1
2459746|NCT02516592|8480642|P2|Overall Study|Abnormal test procedure result|0
2459747|NCT02516592|8480643|P1|Overall Study|Abnormal test procedure result|1
2459748|NCT02516592|8480642|P2|Overall Study|Adverse Event|2
2459749|NCT02516592|8480643|P1|Overall Study|Adverse Event|1
2459750|NCT02516592|8480642|P2|Overall Study|Patient/guardian decision|1
2459751|NCT02516592|8480643|P1|Overall Study|Patient/guardian decision|2
2459752|NCT02516592|8480642|P2|Overall Study|Lost to Follow-up|3
2459753|NCT02516592|8480643|P1|Overall Study|Lost to Follow-up|2
2459754|NCT02516592|8480642|P2|Overall Study|Protocol deviation|4
2459755|NCT02516592|8480643|P1|Overall Study|Protocol deviation|4
2459756|NCT02516592|8480642|P2|Overall Study|Patient withdrew consent|2
2459757|NCT02516592|8480643|P1|Overall Study|Patient withdrew consent|5
2459758|NCT02516410|8480665|P2|Overall Study|Withdrawal by Subject|1
2459759|NCT02516410|8480666|P1|Overall Study|Withdrawal by Subject|0
2459760|NCT02516410|8480665|P2|Overall Study|Adverse Event|1
2459761|NCT02516410|8480666|P1|Overall Study|Adverse Event|0
2459762|NCT02516306|8480695|P2|Period 2: Day 8 - 91|Protocol Violation|2
2459763|NCT02516306|8480696|P1|Period 2: Day 8 - 91|Protocol Violation|1
2459764|NCT02516202|8480705|P3|Overall Study|Stopped Follow-up|1
2459765|NCT02516202|8480706|P2|Overall Study|Stopped Follow-up|0
2459766|NCT02516202|8480707|P1|Overall Study|Stopped Follow-up|0
2459767|NCT02516202|8480705|P3|Overall Study|Lost to Follow-up|1
2459768|NCT02516202|8480706|P2|Overall Study|Lost to Follow-up|1
2459769|NCT02516202|8480707|P1|Overall Study|Lost to Follow-up|1
2459770|NCT02516202|8480705|P3|Overall Study|Withdrawal by Subject|1
2459771|NCT02516202|8480706|P2|Overall Study|Withdrawal by Subject|0
2459772|NCT02516202|8480707|P1|Overall Study|Withdrawal by Subject|1
2459773|NCT02516163|8480733|P1|Overall Study|MRI contraindication exclusion|6
2459774|NCT02516163|8480733|P1|Overall Study|Data not recorded|2
2459775|NCT02516163|8480733|P1|Overall Study|Use of incorrect measurement technique|5
2459776|NCT02516163|8480733|P1|Overall Study|Unfit/delay in surgery|3
2459777|NCT02516163|8480733|P1|Overall Study|Failed MRI/incorrect MRI protocol|11
2459778|NCT02516163|8480733|P1|Overall Study|Withdrawal by Subject|1
2459779|NCT02516098|8480747|P2|Period 2|Withdrawal by Subject|1
2459780|NCT02516098|8480748|P1|Period 2|Withdrawal by Subject|0
2459781|NCT02516098|8480747|P2|Washout After Period 1|Adverse Event|1
2459782|NCT02516098|8480748|P1|Washout After Period 1|Adverse Event|0
2459783|NCT02516098|8480747|P2|Period 1|Protocol Violation|0
2459784|NCT02516098|8480748|P1|Period 1|Protocol Violation|1
2459785|NCT02515994|8480762|P2|Overall Study|Withdrawal by Subject|0
2459786|NCT02515994|8480763|P1|Overall Study|Withdrawal by Subject|2
2459787|NCT02515994|8480762|P2|Overall Study|Adverse Event|1
2459788|NCT02515994|8480763|P1|Overall Study|Adverse Event|3
2459789|NCT02515994|8480762|P2|Overall Study|No Longer Meets Eligibility Criteria|1
2459790|NCT02515994|8480763|P1|Overall Study|No Longer Meets Eligibility Criteria|2
2459791|NCT02515994|8480762|P2|Overall Study|Protocol Violation|5
2459792|NCT02515994|8480763|P1|Overall Study|Protocol Violation|3
2459793|NCT02515942|8480778|P3|Overall Study|Withdrawal by Subject|2
2459794|NCT02515942|8480779|P2|Overall Study|Withdrawal by Subject|3
2459795|NCT02515942|8480780|P1|Overall Study|Withdrawal by Subject|0
2459796|NCT02515942|8480778|P3|Overall Study|Lost to Follow-up|0
2459797|NCT02515942|8480779|P2|Overall Study|Lost to Follow-up|0
2459798|NCT02515942|8480780|P1|Overall Study|Lost to Follow-up|2
2459799|NCT02515942|8480778|P3|Overall Study|Lack of Efficacy|1
2459800|NCT02515942|8480779|P2|Overall Study|Lack of Efficacy|0
2459801|NCT02515942|8480780|P1|Overall Study|Lack of Efficacy|0
2459802|NCT02515942|8480778|P3|Overall Study|Death|1
2459803|NCT02515942|8480779|P2|Overall Study|Death|0
2459804|NCT02515942|8480780|P1|Overall Study|Death|0
2459805|NCT02515942|8480778|P3|Overall Study|Adverse Event|0
2459806|NCT02515942|8480779|P2|Overall Study|Adverse Event|0
2459807|NCT02515942|8480780|P1|Overall Study|Adverse Event|5
2459808|NCT02515669|8480846|P4|48 Week Open-Label Phase|Other|0
2459809|NCT02515669|8480847|P3|48 Week Open-Label Phase|Other|1
2459810|NCT02515669|8480848|P2|48 Week Open-Label Phase|Other|0
2459811|NCT02515669|8480849|P1|48 Week Open-Label Phase|Other|0
2459812|NCT02515331|8480934|P3|Overall Study|Adverse Event|0
2459813|NCT02515331|8480935|P2|Overall Study|Adverse Event|0
2459814|NCT02515331|8480936|P1|Overall Study|Adverse Event|2
2459815|NCT02515331|8480934|P3|Overall Study|Protocol deviation|3
2459816|NCT02515331|8480935|P2|Overall Study|Protocol deviation|0
2459817|NCT02515331|8480936|P1|Overall Study|Protocol deviation|0
2459818|NCT02515331|8480934|P3|Overall Study|Withdrawal by Subject|1
2459819|NCT02515331|8480935|P2|Overall Study|Withdrawal by Subject|0
2459820|NCT02515331|8480936|P1|Overall Study|Withdrawal by Subject|0
2459821|NCT02515279|8480957|P1|Overall Study|Other|22
2459822|NCT02515279|8480957|P1|Overall Study|End-of-treatment visit not attended|17
2459823|NCT02515279|8480957|P1|Overall Study|Withdrawal by Subject|18
2459824|NCT02515279|8480957|P1|Overall Study|Lost to Follow-up|9
2459825|NCT02515279|8480957|P1|Overall Study|Lack of Efficacy|31
2459826|NCT02515279|8480957|P1|Overall Study|Adverse Event|7
2459827|NCT02515097|8480976|P2|Overall Study|Adverse Event|1
2459828|NCT02515097|8480977|P1|Overall Study|Adverse Event|2
2459829|NCT02515097|8480976|P2|Overall Study|Withdrawal by Subject|3
2459830|NCT02515097|8480977|P1|Overall Study|Withdrawal by Subject|1
2459831|NCT02515097|8480976|P2|Overall Study|Lost to Follow-up|2
2459832|NCT02515097|8480977|P1|Overall Study|Lost to Follow-up|4
2459833|NCT02515045|8480998|P3|Overall Study|Lost to Follow-up|1
2459834|NCT02515045|8480999|P2|Overall Study|Lost to Follow-up|1
2459835|NCT02515045|8481000|P1|Overall Study|Lost to Follow-up|0
2459836|NCT02515045|8480998|P3|Overall Study|Adverse Event|3
2459837|NCT02515045|8480999|P2|Overall Study|Adverse Event|3
2459838|NCT02515045|8481000|P1|Overall Study|Adverse Event|0
2459839|NCT02514772|8481037|P2|Overall Study|Withdrawal by Subject|1
2459840|NCT02514772|8481038|P1|Overall Study|Withdrawal by Subject|2
2459841|NCT02514772|8481037|P2|Overall Study|Death|1
2459842|NCT02514772|8481038|P1|Overall Study|Death|0
2459843|NCT02514772|8481037|P2|Overall Study|Adverse Event|0
2459844|NCT02514772|8481038|P1|Overall Study|Adverse Event|1
2459845|NCT02514577|8481052|P2|Overall Study|Adverse Event|1
2459846|NCT02514577|8481053|P1|Overall Study|Adverse Event|1
2459847|NCT02514577|8481052|P2|Overall Study|Withdrawal by Subject|6
2459848|NCT02514577|8481053|P1|Overall Study|Withdrawal by Subject|6
2459849|NCT02514577|8481052|P2|Overall Study|Protocol Violation|0
2459850|NCT02514577|8481053|P1|Overall Study|Protocol Violation|1
2459851|NCT02514577|8481052|P2|Overall Study|Lost to Follow-up|6
2459852|NCT02514577|8481053|P1|Overall Study|Lost to Follow-up|6
2459853|NCT02514551|8481063|P2|Overall Study|Participant Never Treated|2
2459854|NCT02514551|8481064|P1|Overall Study|Participant Never Treated|0
2459855|NCT02514551|8481063|P2|Overall Study|Lost to Follow-up|1
2459856|NCT02514551|8481064|P1|Overall Study|Lost to Follow-up|0
2459857|NCT02514473|8481081|P2|Overall Study|Other|1
2459858|NCT02514473|8481082|P1|Overall Study|Other|1
2459859|NCT02514473|8481081|P2|Overall Study|Lost to Follow-up|1
2459860|NCT02514473|8481082|P1|Overall Study|Lost to Follow-up|0
2459861|NCT02514473|8481081|P2|Overall Study|Withdrawal by Subject|1
2459862|NCT02514473|8481082|P1|Overall Study|Withdrawal by Subject|2
2459863|NCT02514473|8481081|P2|Overall Study|Adverse Event|2
2459864|NCT02514473|8481082|P1|Overall Study|Adverse Event|0
2459865|NCT02514174|8481123|P1|Overall Study|Treated off study with Afatinib.|1
2459866|NCT02514174|8481123|P1|Overall Study|Treatment change|1
2459867|NCT02514174|8481123|P1|Overall Study|Progressive disease|11
2459868|NCT02514174|8481123|P1|Overall Study|Study closed by sponsor|9
2459869|NCT02514174|8481123|P1|Overall Study|Adverse Event|2
2459870|NCT02514174|8481123|P1|Overall Study|Patient refused to continue medication|1
2459871|NCT02514122|8481134|P2|Overall Study|Withdrawal by Subject|0
2459872|NCT02514122|8481135|P1|Overall Study|Withdrawal by Subject|2
2459873|NCT02513823|8481182|P1|Overall Study|Physician Decision|1
2459874|NCT02513823|8481182|P1|Overall Study|Lost to Follow-up|4
2459875|NCT02513771|8481189|P2|Overall Study|Not being able to get to clinic|0
2459876|NCT02513771|8481190|P1|Overall Study|Not being able to get to clinic|1
2459877|NCT02513771|8481189|P2|Overall Study|Lost to Follow-up|1
2459878|NCT02513771|8481190|P1|Overall Study|Lost to Follow-up|1
2459879|NCT02513745|8481228|P2|Overall Study|Criteria at time of surgery not met.|3
2459880|NCT02513745|8481229|P1|Overall Study|Criteria at time of surgery not met.|3
2459881|NCT02513550|8481483|P6|Post-Treatment Follow-up Period|Labor Reasons|0
2459882|NCT02513550|8481484|P5|Post-Treatment Follow-up Period|Labor Reasons|0
2459883|NCT02513550|8481485|P4|Post-Treatment Follow-up Period|Labor Reasons|0
2459884|NCT02513550|8481486|P3|Post-Treatment Follow-up Period|Labor Reasons|1
2459885|NCT02513550|8481487|P2|Post-Treatment Follow-up Period|Labor Reasons|0
2459886|NCT02513550|8481488|P1|Post-Treatment Follow-up Period|Labor Reasons|0
2459887|NCT02513550|8481483|P6|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
2459888|NCT02513550|8481484|P5|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
2459889|NCT02513550|8481485|P4|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
2459890|NCT02513550|8481486|P3|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3
2459891|NCT02513550|8481487|P2|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
2459892|NCT02513550|8481488|P1|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
2459893|NCT02513550|8481483|P6|Post-Treatment Follow-up Period|Subject move out of town|0
2459894|NCT02513550|8481484|P5|Post-Treatment Follow-up Period|Subject move out of town|0
2459895|NCT02513550|8481485|P4|Post-Treatment Follow-up Period|Subject move out of town|0
2459896|NCT02513550|8481486|P3|Post-Treatment Follow-up Period|Subject move out of town|1
2459897|NCT02513550|8481487|P2|Post-Treatment Follow-up Period|Subject move out of town|0
2459898|NCT02513550|8481488|P1|Post-Treatment Follow-up Period|Subject move out of town|0
2459899|NCT02513550|8481483|P6|Post-Treatment Follow-up Period|Death|0
2459900|NCT02513550|8481484|P5|Post-Treatment Follow-up Period|Death|0
2459901|NCT02513550|8481485|P4|Post-Treatment Follow-up Period|Death|0
2459902|NCT02513550|8481486|P3|Post-Treatment Follow-up Period|Death|1
2459903|NCT02513550|8481487|P2|Post-Treatment Follow-up Period|Death|0
2459904|NCT02513550|8481488|P1|Post-Treatment Follow-up Period|Death|0
2459905|NCT02513550|8481483|P6|Post-Treatment Follow-up Period|Physician Decision|0
2459906|NCT02513550|8481484|P5|Post-Treatment Follow-up Period|Physician Decision|0
2459907|NCT02513550|8481485|P4|Post-Treatment Follow-up Period|Physician Decision|0
2459908|NCT02513550|8481486|P3|Post-Treatment Follow-up Period|Physician Decision|0
2459909|NCT02513550|8481487|P2|Post-Treatment Follow-up Period|Physician Decision|0
2459910|NCT02513550|8481488|P1|Post-Treatment Follow-up Period|Physician Decision|2
2459911|NCT02513550|8481483|P6|Post-Treatment Follow-up Period|Adverse Event|0
2459912|NCT02513550|8481484|P5|Post-Treatment Follow-up Period|Adverse Event|0
2459913|NCT02513550|8481485|P4|Post-Treatment Follow-up Period|Adverse Event|0
2459914|NCT02513550|8481486|P3|Post-Treatment Follow-up Period|Adverse Event|4
2459915|NCT02513550|8481487|P2|Post-Treatment Follow-up Period|Adverse Event|1
2459916|NCT02513550|8481488|P1|Post-Treatment Follow-up Period|Adverse Event|1
2459917|NCT02513550|8481483|P6|Post-Treatment Follow-up Period|Lost to Follow-up|0
2459918|NCT02513550|8481484|P5|Post-Treatment Follow-up Period|Lost to Follow-up|0
2459919|NCT02513550|8481485|P4|Post-Treatment Follow-up Period|Lost to Follow-up|0
2459920|NCT02513550|8481486|P3|Post-Treatment Follow-up Period|Lost to Follow-up|7
2459921|NCT02513550|8481487|P2|Post-Treatment Follow-up Period|Lost to Follow-up|2
2459922|NCT02513550|8481488|P1|Post-Treatment Follow-up Period|Lost to Follow-up|4
2459923|NCT02513550|8481483|P6|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
2459924|NCT02513550|8481484|P5|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
2459925|NCT02513550|8481485|P4|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
2459926|NCT02513550|8481486|P3|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20
2459927|NCT02513550|8481487|P2|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16
2459928|NCT02513550|8481488|P1|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12
2459929|NCT02513550|8481483|P6|Post-Treatment Follow-up Period|Withdrawal by Subject|0
2459930|NCT02513550|8481484|P5|Post-Treatment Follow-up Period|Withdrawal by Subject|0
2459931|NCT02513550|8481485|P4|Post-Treatment Follow-up Period|Withdrawal by Subject|0
2459932|NCT02513550|8481486|P3|Post-Treatment Follow-up Period|Withdrawal by Subject|26
2459933|NCT02513550|8481487|P2|Post-Treatment Follow-up Period|Withdrawal by Subject|20
2459934|NCT02513550|8481488|P1|Post-Treatment Follow-up Period|Withdrawal by Subject|12
2459935|NCT02513550|8481483|P6|Double Blind Treatment Period|Death|0
2459936|NCT02513550|8481484|P5|Double Blind Treatment Period|Death|0
2459937|NCT02513550|8481485|P4|Double Blind Treatment Period|Death|0
2459938|NCT02513550|8481486|P3|Double Blind Treatment Period|Death|2
2459939|NCT02513550|8481487|P2|Double Blind Treatment Period|Death|0
2459940|NCT02513550|8481488|P1|Double Blind Treatment Period|Death|1
2459941|NCT02513550|8481483|P6|Double Blind Treatment Period|Due to personal business|0
2459942|NCT02513550|8481484|P5|Double Blind Treatment Period|Due to personal business|0
2459943|NCT02513550|8481485|P4|Double Blind Treatment Period|Due to personal business|0
2459944|NCT02513550|8481486|P3|Double Blind Treatment Period|Due to personal business|1
2459945|NCT02513550|8481487|P2|Double Blind Treatment Period|Due to personal business|0
2459946|NCT02513550|8481488|P1|Double Blind Treatment Period|Due to personal business|2
2459947|NCT02513550|8481483|P6|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
2459948|NCT02513550|8481484|P5|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
2459949|NCT02513550|8481485|P4|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
2459950|NCT02513550|8481486|P3|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1
2459951|NCT02513550|8481487|P2|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
2459952|NCT02513550|8481488|P1|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
2459953|NCT02513550|8481483|P6|Double Blind Treatment Period|Site terminated by sponsor|0
2459954|NCT02513550|8481484|P5|Double Blind Treatment Period|Site terminated by sponsor|0
2459955|NCT02513550|8481485|P4|Double Blind Treatment Period|Site terminated by sponsor|0
2459956|NCT02513550|8481486|P3|Double Blind Treatment Period|Site terminated by sponsor|3
2459957|NCT02513550|8481487|P2|Double Blind Treatment Period|Site terminated by sponsor|1
2459958|NCT02513550|8481488|P1|Double Blind Treatment Period|Site terminated by sponsor|1
2459959|NCT02513550|8481483|P6|Double Blind Treatment Period|Physician Decision|0
2459960|NCT02513550|8481484|P5|Double Blind Treatment Period|Physician Decision|0
2459961|NCT02513550|8481485|P4|Double Blind Treatment Period|Physician Decision|0
2459962|NCT02513550|8481486|P3|Double Blind Treatment Period|Physician Decision|4
2459963|NCT02513550|8481487|P2|Double Blind Treatment Period|Physician Decision|0
2459964|NCT02513550|8481488|P1|Double Blind Treatment Period|Physician Decision|2
2459965|NCT02513550|8481483|P6|Double Blind Treatment Period|Protocol Violation|0
2459966|NCT02513550|8481484|P5|Double Blind Treatment Period|Protocol Violation|0
2459967|NCT02513550|8481485|P4|Double Blind Treatment Period|Protocol Violation|0
2459968|NCT02513550|8481486|P3|Double Blind Treatment Period|Protocol Violation|4
2459969|NCT02513550|8481487|P2|Double Blind Treatment Period|Protocol Violation|1
2459970|NCT02513550|8481488|P1|Double Blind Treatment Period|Protocol Violation|1
2459971|NCT02513550|8481483|P6|Double Blind Treatment Period|Lack of Efficacy|0
2459972|NCT02513550|8481484|P5|Double Blind Treatment Period|Lack of Efficacy|0
2459973|NCT02513550|8481485|P4|Double Blind Treatment Period|Lack of Efficacy|0
2459974|NCT02513550|8481486|P3|Double Blind Treatment Period|Lack of Efficacy|6
2459975|NCT02513550|8481487|P2|Double Blind Treatment Period|Lack of Efficacy|5
2459976|NCT02513550|8481488|P1|Double Blind Treatment Period|Lack of Efficacy|4
2459977|NCT02513550|8481483|P6|Double Blind Treatment Period|Lost to Follow-up|1
2459978|NCT02513550|8481484|P5|Double Blind Treatment Period|Lost to Follow-up|0
2459979|NCT02513550|8481485|P4|Double Blind Treatment Period|Lost to Follow-up|0
2459980|NCT02513550|8481486|P3|Double Blind Treatment Period|Lost to Follow-up|11
2459981|NCT02513550|8481487|P2|Double Blind Treatment Period|Lost to Follow-up|7
2459982|NCT02513550|8481488|P1|Double Blind Treatment Period|Lost to Follow-up|9
2459983|NCT02513550|8481483|P6|Double Blind Treatment Period|Adverse Event|0
2459984|NCT02513550|8481484|P5|Double Blind Treatment Period|Adverse Event|1
2459985|NCT02513550|8481485|P4|Double Blind Treatment Period|Adverse Event|0
2459986|NCT02513550|8481486|P3|Double Blind Treatment Period|Adverse Event|17
2459987|NCT02513550|8481487|P2|Double Blind Treatment Period|Adverse Event|13
2459988|NCT02513550|8481488|P1|Double Blind Treatment Period|Adverse Event|5
2459989|NCT02513550|8481483|P6|Double Blind Treatment Period|Withdrawal by Subject|0
2459990|NCT02513550|8481484|P5|Double Blind Treatment Period|Withdrawal by Subject|0
2459991|NCT02513550|8481485|P4|Double Blind Treatment Period|Withdrawal by Subject|0
2459992|NCT02513550|8481486|P3|Double Blind Treatment Period|Withdrawal by Subject|25
2459993|NCT02513550|8481487|P2|Double Blind Treatment Period|Withdrawal by Subject|11
2459994|NCT02513550|8481488|P1|Double Blind Treatment Period|Withdrawal by Subject|11
2459995|NCT02513459|8481580|P1|Overall Study|Surgery planned-- not done|1
2459996|NCT02513459|8481580|P1|Overall Study|Reproductive plans|1
2459997|NCT02513459|8481580|P1|Overall Study|Lack of response|1
2459998|NCT02513459|8481580|P1|Overall Study|Subject decision|2
2459999|NCT02513459|8481580|P1|Overall Study|Pregnancy|2
2460000|NCT02513459|8481580|P1|Overall Study|Loss of efficacy|2
2460001|NCT02513459|8481580|P1|Overall Study|Withdrew consent|5
2460002|NCT02513459|8481580|P1|Overall Study|Adverse Event|7
2460003|NCT02513160|8481637|P4|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
2460004|NCT02513160|8481638|P3|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
2460005|NCT02513160|8481639|P2|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1
2460006|NCT02513160|8481640|P1|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
2460007|NCT02513160|8481637|P4|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
2460008|NCT02513160|8481638|P3|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
2460009|NCT02513160|8481639|P2|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
2460010|NCT02513160|8481640|P1|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1
2460011|NCT02513160|8481637|P4|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
2460012|NCT02513160|8481638|P3|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
2460013|NCT02513160|8481639|P2|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
2460014|NCT02513160|8481640|P1|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2
2460015|NCT02513160|8481637|P4|Treatment Period (Day 0 to Week 6)|Noncompliance|0
2460016|NCT02513160|8481638|P3|Treatment Period (Day 0 to Week 6)|Noncompliance|0
2460017|NCT02513160|8481639|P2|Treatment Period (Day 0 to Week 6)|Noncompliance|0
2460018|NCT02513160|8481640|P1|Treatment Period (Day 0 to Week 6)|Noncompliance|1
2460019|NCT02513160|8481637|P4|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1
2460020|NCT02513160|8481638|P3|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0
2460021|NCT02513160|8481639|P2|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
2460022|NCT02513160|8481640|P1|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
2460023|NCT02513160|8481637|P4|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
2460024|NCT02513160|8481638|P3|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
2460025|NCT02513160|8481639|P2|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
2460026|NCT02513160|8481640|P1|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10
2460027|NCT02513160|8481637|P4|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
2460028|NCT02513160|8481638|P3|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
2460029|NCT02513160|8481639|P2|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
2460030|NCT02513160|8481640|P1|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1
2460031|NCT02513160|8481637|P4|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
2460032|NCT02513160|8481638|P3|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
2460033|NCT02513160|8481639|P2|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
2460034|NCT02513160|8481640|P1|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20
2460035|NCT02513160|8481637|P4|Run-In Period (Days -14 to Day -1)|Adverse Event|0
2460036|NCT02513160|8481638|P3|Run-In Period (Days -14 to Day -1)|Adverse Event|0
2460037|NCT02513160|8481639|P2|Run-In Period (Days -14 to Day -1)|Adverse Event|0
2460038|NCT02513160|8481640|P1|Run-In Period (Days -14 to Day -1)|Adverse Event|4
2460039|NCT02513160|8481637|P4|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
2460040|NCT02513160|8481638|P3|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
2460041|NCT02513160|8481639|P2|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
2460042|NCT02513160|8481640|P1|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6
2460043|NCT02513160|8481637|P4|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
2460044|NCT02513160|8481638|P3|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
2460045|NCT02513160|8481639|P2|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
2460046|NCT02513160|8481640|P1|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214
2460047|NCT02513160|8481637|P4|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
2460048|NCT02513160|8481638|P3|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
2460049|NCT02513160|8481639|P2|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
2460050|NCT02513160|8481640|P1|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33
2460051|NCT02513095|8481698|P2|Overall Study|Stampede resulted in transfers out of ER|16
2460052|NCT02513095|8481699|P1|Overall Study|Stampede resulted in transfers out of ER|14
2460053|NCT02512861|8481745|P2|Overall Study|Withdrawal by Subject|1
2460054|NCT02512861|8481746|P1|Overall Study|Withdrawal by Subject|0
2460055|NCT02512861|8481745|P2|Overall Study|Physician Decision|1
2460056|NCT02512861|8481746|P1|Overall Study|Physician Decision|3
2460057|NCT02512861|8481745|P2|Overall Study|Protocol Violation|7
2460058|NCT02512861|8481746|P1|Overall Study|Protocol Violation|3
2460059|NCT02512302|8482024|P10|Period 4|Adverse Event|0
2460060|NCT02512302|8482025|P9|Period 4|Adverse Event|0
2460061|NCT02512302|8482026|P8|Period 4|Adverse Event|0
2460062|NCT02512302|8482027|P7|Period 4|Adverse Event|1
2460063|NCT02512302|8482028|P6|Period 4|Adverse Event|0
2460064|NCT02512302|8482029|P5|Period 4|Adverse Event|0
2460065|NCT02512302|8482030|P4|Period 4|Adverse Event|0
2460066|NCT02512302|8482031|P3|Period 4|Adverse Event|0
2460067|NCT02512302|8482032|P2|Period 4|Adverse Event|0
2460068|NCT02512302|8482033|P1|Period 4|Adverse Event|0
2460069|NCT02512302|8482024|P10|Period 3|Lost to Follow-up|0
2460070|NCT02512302|8482025|P9|Period 3|Lost to Follow-up|0
2460071|NCT02512302|8482026|P8|Period 3|Lost to Follow-up|0
2460072|NCT02512302|8482027|P7|Period 3|Lost to Follow-up|0
2460073|NCT02512302|8482028|P6|Period 3|Lost to Follow-up|0
2460074|NCT02512302|8482029|P5|Period 3|Lost to Follow-up|0
2460075|NCT02512302|8482030|P4|Period 3|Lost to Follow-up|0
2460076|NCT02512302|8482031|P3|Period 3|Lost to Follow-up|1
2460077|NCT02512302|8482032|P2|Period 3|Lost to Follow-up|0
2460078|NCT02512302|8482033|P1|Period 3|Lost to Follow-up|0
2460079|NCT02512302|8482024|P10|Period 2|Adverse Event|1
2460080|NCT02512302|8482025|P9|Period 2|Adverse Event|0
2460081|NCT02512302|8482026|P8|Period 2|Adverse Event|0
2460082|NCT02512302|8482027|P7|Period 2|Adverse Event|0
2460083|NCT02512302|8482028|P6|Period 2|Adverse Event|0
2460084|NCT02512302|8482029|P5|Period 2|Adverse Event|0
2460085|NCT02512302|8482030|P4|Period 2|Adverse Event|0
2460086|NCT02512302|8482031|P3|Period 2|Adverse Event|0
2460087|NCT02512302|8482032|P2|Period 2|Adverse Event|0
2460088|NCT02512302|8482033|P1|Period 2|Adverse Event|0
2460089|NCT02512302|8482024|P10|Period 1|Adverse Event|0
2460090|NCT02512302|8482025|P9|Period 1|Adverse Event|0
2460091|NCT02512302|8482026|P8|Period 1|Adverse Event|0
2460092|NCT02512302|8482027|P7|Period 1|Adverse Event|0
2460093|NCT02512302|8482028|P6|Period 1|Adverse Event|0
2460094|NCT02512302|8482029|P5|Period 1|Adverse Event|0
2460095|NCT02512302|8482030|P4|Period 1|Adverse Event|0
2460096|NCT02512302|8482031|P3|Period 1|Adverse Event|0
2460097|NCT02512302|8482032|P2|Period 1|Adverse Event|1
2460098|NCT02512302|8482033|P1|Period 1|Adverse Event|0
2460099|NCT02512068|8482149|P2|Overall Study|Reason Not Specified|5
2460100|NCT02512068|8482150|P1|Overall Study|Reason Not Specified|3
2460101|NCT02512068|8482149|P2|Overall Study|Lack of Efficacy|1
2460102|NCT02512068|8482150|P1|Overall Study|Lack of Efficacy|0
2460103|NCT02512068|8482149|P2|Overall Study|Voluntary Withdrawal|1
2460104|NCT02512068|8482150|P1|Overall Study|Voluntary Withdrawal|0
2460105|NCT02512068|8482149|P2|Overall Study|Major Protocol Deviation|0
2460106|NCT02512068|8482150|P1|Overall Study|Major Protocol Deviation|1
2460107|NCT02512068|8482149|P2|Overall Study|Pretreatment Event/Adverse Event|6
2460108|NCT02512068|8482150|P1|Overall Study|Pretreatment Event/Adverse Event|8
2460109|NCT02512042|8482176|P2|Overall Study|Other|11
2460110|NCT02512042|8482177|P1|Overall Study|Other|11
2460111|NCT02512042|8482176|P2|Overall Study|Lost to Follow-up|2
2460112|NCT02512042|8482177|P1|Overall Study|Lost to Follow-up|5
2460113|NCT02512042|8482176|P2|Overall Study|Non-compliance with study drug|2
2460114|NCT02512042|8482177|P1|Overall Study|Non-compliance with study drug|1
2460115|NCT02512042|8482176|P2|Overall Study|Withdrawal by Subject|6
2460116|NCT02512042|8482177|P1|Overall Study|Withdrawal by Subject|6
2460117|NCT02512042|8482176|P2|Overall Study|Adverse Event|4
2460118|NCT02512042|8482177|P1|Overall Study|Adverse Event|0
2460119|NCT02511782|8482186|P3|Overall Study|Withdrawal by Subject|0
2460120|NCT02511782|8482187|P2|Overall Study|Withdrawal by Subject|0
2460121|NCT02511782|8482188|P1|Overall Study|Withdrawal by Subject|1
2460122|NCT02511678|8482207|P1|Overall Study|Received Radiation Treatment|1
2460123|NCT02511678|8482207|P1|Overall Study|Protocol Violation|1
2460124|NCT02511678|8482207|P1|Overall Study|Biopsy was Negative|1
2460125|NCT02511678|8482207|P1|Overall Study|Required Radiofrequency Ablation|1
2460126|NCT02511678|8482207|P1|Overall Study|Oncologist Cancelled Study Cryoablation|1
2460127|NCT02511678|8482207|P1|Overall Study|Targeted Therapy to Index Tumor Required|5
2460128|NCT02511678|8482207|P1|Overall Study|Adverse Event|1
2460129|NCT02511678|8482207|P1|Overall Study|Death|19
2460130|NCT02511678|8482207|P1|Overall Study|Lost to Follow-up|4
2460131|NCT02511678|8482207|P1|Overall Study|Withdrawal by Subject|2
2460132|NCT02511431|8482261|P6|Treatment|Lost to Follow-up|1
2460133|NCT02511431|8482262|P5|Treatment|Lost to Follow-up|0
2460134|NCT02511431|8482263|P4|Treatment|Lost to Follow-up|0
2460135|NCT02511431|8482264|P3|Treatment|Lost to Follow-up|1
2460136|NCT02511431|8482265|P2|Treatment|Lost to Follow-up|0
2460137|NCT02511431|8482266|P1|Treatment|Lost to Follow-up|0
2460138|NCT02511184|8482293|P2|Overall Study|Withdrawal by Subject|1
2460139|NCT02511184|8482294|P1|Overall Study|Withdrawal by Subject|0
2460140|NCT02511184|8482293|P2|Overall Study|Study terminated by sponsor|5
2460141|NCT02511184|8482294|P1|Overall Study|Study terminated by sponsor|1
2460142|NCT02511184|8482293|P2|Overall Study|Lost to Follow-up|1
2460143|NCT02511184|8482294|P1|Overall Study|Lost to Follow-up|0
2460144|NCT02511184|8482293|P2|Overall Study|Death|0
2460145|NCT02511184|8482294|P1|Overall Study|Death|1
2460146|NCT02510820|8482344|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
2460147|NCT02510820|8482345|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
2460148|NCT02510820|8482344|P2|First Intervention (4 Weeks)|Withdrawal by Subject|1
2460149|NCT02510820|8482345|P1|First Intervention (4 Weeks)|Withdrawal by Subject|0
2460150|NCT02510664|8482386|P3|Overall Study|Time Constraints|0
2460151|NCT02510664|8482387|P2|Overall Study|Time Constraints|1
2460152|NCT02510664|8482388|P1|Overall Study|Time Constraints|1
2460153|NCT02510664|8482386|P3|Overall Study|Provider Retired/No Time to Reschedule|0
2460154|NCT02510664|8482387|P2|Overall Study|Provider Retired/No Time to Reschedule|10
2460155|NCT02510664|8482388|P1|Overall Study|Provider Retired/No Time to Reschedule|10
2460156|NCT02510664|8482386|P3|Overall Study|Transferred Care|0
2460157|NCT02510664|8482387|P2|Overall Study|Transferred Care|9
2460158|NCT02510664|8482388|P1|Overall Study|Transferred Care|9
2460159|NCT02510014|8482430|P2|Treatment Period|Incarceration, pregnancy, misc|5
2460160|NCT02510014|8482431|P1|Treatment Period|Incarceration, pregnancy, misc|29
2460161|NCT02510014|8482430|P2|Treatment Period|Protocol Violation|4
2460162|NCT02510014|8482431|P1|Treatment Period|Protocol Violation|4
2460163|NCT02510014|8482430|P2|Treatment Period|Withdrawn by the investigator|1
2460164|NCT02510014|8482431|P1|Treatment Period|Withdrawn by the investigator|7
2460165|NCT02510014|8482430|P2|Treatment Period|Withdrawal by Subject|24
2460166|NCT02510014|8482431|P1|Treatment Period|Withdrawal by Subject|67
2460167|NCT02510014|8482430|P2|Treatment Period|Physician Decision|0
2460168|NCT02510014|8482431|P1|Treatment Period|Physician Decision|5
2460169|NCT02510014|8482430|P2|Treatment Period|Lost to Follow-up|19
2460170|NCT02510014|8482431|P1|Treatment Period|Lost to Follow-up|80
2460171|NCT02510014|8482430|P2|Treatment Period|Withdrawal symptoms|0
2460172|NCT02510014|8482431|P1|Treatment Period|Withdrawal symptoms|3
2460173|NCT02510014|8482430|P2|Treatment Period|Adverse Event|4
2460174|NCT02510014|8482431|P1|Treatment Period|Adverse Event|11
2460175|NCT02510014|8482430|P2|Run-In Period (Days -14 to Day -1)|Other|1
2460176|NCT02510014|8482431|P1|Run-In Period (Days -14 to Day -1)|Other|19
2460177|NCT02510014|8482430|P2|Run-In Period (Days -14 to Day -1)|Protocol Violation|0
2460178|NCT02510014|8482431|P1|Run-In Period (Days -14 to Day -1)|Protocol Violation|2
2460179|NCT02510014|8482430|P2|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1
2460180|NCT02510014|8482431|P1|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7
2460181|NCT02510014|8482430|P2|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3
2460182|NCT02510014|8482431|P1|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22
2460183|NCT02510014|8482430|P2|Run-In Period (Days -14 to Day -1)|Physician Decision|1
2460184|NCT02510014|8482431|P1|Run-In Period (Days -14 to Day -1)|Physician Decision|0
2460185|NCT02510014|8482430|P2|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3
2460186|NCT02510014|8482431|P1|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44
2460187|NCT02510014|8482430|P2|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0
2460188|NCT02510014|8482431|P1|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1
2460189|NCT02510014|8482430|P2|Run-In Period (Days -14 to Day -1)|Adverse Event|1
2460190|NCT02510014|8482431|P1|Run-In Period (Days -14 to Day -1)|Adverse Event|1
2460191|NCT02509117|8482534|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1
2460192|NCT02509117|8482535|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
2460193|NCT02509117|8482536|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
2460194|NCT02509117|8482537|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
2460195|NCT02509117|8482538|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
2460196|NCT02509117|8482539|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
2460197|NCT02509117|8482540|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
2460198|NCT02509117|8482541|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
2460199|NCT02509117|8482542|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
2460200|NCT02509117|8482543|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
2460201|NCT02509117|8482534|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1
2460202|NCT02509117|8482535|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
2460440|NCT02505334|8483604|P1|Main Treatment Period|Adverse Event|3
2460203|NCT02509117|8482536|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
2460204|NCT02509117|8482537|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
2460205|NCT02509117|8482538|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
2460206|NCT02509117|8482539|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
2460207|NCT02509117|8482540|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
2460208|NCT02509117|8482541|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
2460209|NCT02509117|8482542|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
2460210|NCT02509117|8482543|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
2460211|NCT02509117|8482534|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
2460212|NCT02509117|8482535|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
2460213|NCT02509117|8482536|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
2460214|NCT02509117|8482537|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
2460215|NCT02509117|8482538|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
2460216|NCT02509117|8482539|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
2460217|NCT02509117|8482540|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
2460218|NCT02509117|8482541|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
2460219|NCT02509117|8482542|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1
2460220|NCT02509117|8482543|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
2460221|NCT02509078|8482754|P2|Overall Study|Protocol Violation|1
2460222|NCT02509078|8482755|P1|Overall Study|Protocol Violation|1
2460223|NCT02508935|8482898|P1|Overall Study|Trial terminated by sponsor|5
2460224|NCT02508935|8482898|P1|Overall Study|Physician Decision|1
2460225|NCT02508935|8482898|P1|Overall Study|Protocol Violation|1
2460226|NCT02508935|8482898|P1|Overall Study|Adverse Event|3
2460227|NCT02508935|8482898|P1|Overall Study|Emesis|3
2460228|NCT02508935|8482898|P1|Overall Study|Pain Score <4|1
2460229|NCT02508935|8482898|P1|Overall Study|Withdrawal by Caregiver|8
2460230|NCT02508935|8482898|P1|Overall Study|Withdrawal by Subject|1
2460231|NCT02508701|8482914|P4|Overall Study|Lost to Follow-up|3
2460232|NCT02508701|8482915|P3|Overall Study|Lost to Follow-up|5
2460233|NCT02508701|8482916|P2|Overall Study|Lost to Follow-up|5
2460234|NCT02508701|8482917|P1|Overall Study|Lost to Follow-up|9
2460235|NCT02508194|8483002|P2|Overall Study|Principal Investigator Decision|2
2460236|NCT02508194|8483003|P1|Overall Study|Principal Investigator Decision|1
2460237|NCT02508194|8483002|P2|Overall Study|Error in Randomization|3
2460238|NCT02508194|8483003|P1|Overall Study|Error in Randomization|1
2460239|NCT02508194|8483002|P2|Overall Study|Withdrawal by Subject|18
2460240|NCT02508194|8483003|P1|Overall Study|Withdrawal by Subject|20
2460241|NCT02508194|8483002|P2|Overall Study|Lost to Follow-up|18
2460242|NCT02508194|8483003|P1|Overall Study|Lost to Follow-up|25
2460243|NCT02508194|8483002|P2|Overall Study|Death|3
2460244|NCT02508194|8483003|P1|Overall Study|Death|5
2460245|NCT02508116|8483043|P2|Overall Study|Physician Decision|0
2460246|NCT02508116|8483044|P1|Overall Study|Physician Decision|2
2460247|NCT02508116|8483043|P2|Overall Study|Protocol Violation|2
2460248|NCT02508116|8483044|P1|Overall Study|Protocol Violation|1
2460249|NCT02508116|8483043|P2|Overall Study|Withdrawal by Subject|2
2460250|NCT02508116|8483044|P1|Overall Study|Withdrawal by Subject|3
2460251|NCT02508116|8483043|P2|Overall Study|Lost to Follow-up|3
2460252|NCT02508116|8483044|P1|Overall Study|Lost to Follow-up|2
2460253|NCT02507973|8483071|P1|Overall Study|Adverse Event|1
2460254|NCT02507752|8483077|P1|Overall Study|Participant didn't perform visit Week 24|1
2460255|NCT02507752|8483077|P1|Overall Study|Participant didn't perform visit Week 12|1
2460256|NCT02507752|8483077|P1|Overall Study|Infusion reaction at first infusion|1
2460257|NCT02507752|8483077|P1|Overall Study|Lost to Follow-up|7
2460258|NCT02507752|8483077|P1|Overall Study|Protocol Violation|6
2460259|NCT02507752|8483077|P1|Overall Study|Adverse Event|1
2460260|NCT02507375|8483121|P2|Overall Study|Adverse Event|1
2460261|NCT02507375|8483122|P1|Overall Study|Adverse Event|0
2460262|NCT02507375|8483121|P2|Overall Study|Refused treatment|1
2460263|NCT02507375|8483122|P1|Overall Study|Refused treatment|0
2460264|NCT02507375|8483121|P2|Overall Study|Death|1
2460265|NCT02507375|8483122|P1|Overall Study|Death|0
2460266|NCT02507375|8483121|P2|Overall Study|Progressive Disease|5
2460267|NCT02507375|8483122|P1|Overall Study|Progressive Disease|4
2460268|NCT02507349|8483141|P2|Overall Study|Lost to Follow-up|144
2460269|NCT02507349|8483142|P1|Overall Study|Lost to Follow-up|174
2460270|NCT02507349|8483141|P2|Overall Study|Withdrawal by Subject|1
2460271|NCT02507349|8483142|P1|Overall Study|Withdrawal by Subject|1
2460272|NCT02507349|8483141|P2|Overall Study|Death|16
2460273|NCT02507349|8483142|P1|Overall Study|Death|12
2460274|NCT02507219|8483166|P6|Overall Study|Withdrawal by Subject|0
2460275|NCT02507219|8483167|P5|Overall Study|Withdrawal by Subject|1
2460276|NCT02507219|8483168|P4|Overall Study|Withdrawal by Subject|0
2460277|NCT02507219|8483169|P3|Overall Study|Withdrawal by Subject|0
2460278|NCT02507219|8483170|P2|Overall Study|Withdrawal by Subject|0
2460279|NCT02507219|8483171|P1|Overall Study|Withdrawal by Subject|0
2460280|NCT02507219|8483166|P6|Overall Study|Physician Decision|0
2460281|NCT02507219|8483167|P5|Overall Study|Physician Decision|0
2460282|NCT02507219|8483168|P4|Overall Study|Physician Decision|0
2460283|NCT02507219|8483169|P3|Overall Study|Physician Decision|0
2460284|NCT02507219|8483170|P2|Overall Study|Physician Decision|0
2460285|NCT02507219|8483171|P1|Overall Study|Physician Decision|1
2460286|NCT02506881|8483200|P4|First Intervention (Day 1)|Violation of blood storage conditions|12
2460287|NCT02506881|8483201|P3|First Intervention (Day 1)|Violation of blood storage conditions|12
2460288|NCT02506881|8483202|P2|First Intervention (Day 1)|Violation of blood storage conditions|0
2460289|NCT02506881|8483203|P1|First Intervention (Day 1)|Violation of blood storage conditions|0
2460290|NCT02506881|8483200|P4|First Intervention (Day 1)|Withdrawal by Subject|0
2460291|NCT02506881|8483201|P3|First Intervention (Day 1)|Withdrawal by Subject|0
2460292|NCT02506881|8483202|P2|First Intervention (Day 1)|Withdrawal by Subject|0
2460293|NCT02506881|8483203|P1|First Intervention (Day 1)|Withdrawal by Subject|1
2460294|NCT02506881|8483200|P4|First Intervention (Day 1)|Protocol Violation|0
2460295|NCT02506881|8483201|P3|First Intervention (Day 1)|Protocol Violation|1
2460296|NCT02506881|8483202|P2|First Intervention (Day 1)|Protocol Violation|0
2460297|NCT02506881|8483203|P1|First Intervention (Day 1)|Protocol Violation|0
2460298|NCT02506816|8483276|P1|Overall Study|Adverse Event|3
2460299|NCT02506257|8483402|P4|Overall Study|Protocol Violation|0
2460300|NCT02506257|8483403|P3|Overall Study|Protocol Violation|1
2460301|NCT02506257|8483404|P2|Overall Study|Protocol Violation|0
2460302|NCT02506257|8483405|P1|Overall Study|Protocol Violation|0
2460303|NCT02506257|8483402|P4|Overall Study|Adverse Event|0
2460304|NCT02506257|8483403|P3|Overall Study|Adverse Event|3
2460305|NCT02506257|8483404|P2|Overall Study|Adverse Event|2
2460306|NCT02506257|8483405|P1|Overall Study|Adverse Event|0
2460307|NCT02506101|8483437|P2|Overall Study|No enrollment and staff unavailability|0
2460308|NCT02506101|8483438|P1|Overall Study|No enrollment and staff unavailability|1
2460309|NCT02506101|8483437|P2|Overall Study|Transportation issues|0
2460310|NCT02506101|8483438|P1|Overall Study|Transportation issues|1
2460311|NCT02506036|8483454|P2|First Intervention (4-6 Weeks)|Withdrawal by Subject|1
2460312|NCT02506036|8483455|P1|First Intervention (4-6 Weeks)|Withdrawal by Subject|0
2460313|NCT02506036|8483454|P2|First Intervention (4-6 Weeks)|Lost to Follow-up|1
2460314|NCT02506036|8483455|P1|First Intervention (4-6 Weeks)|Lost to Follow-up|0
2460315|NCT02506036|8483454|P2|First Intervention (4-6 Weeks)|Death|0
2460316|NCT02506036|8483455|P1|First Intervention (4-6 Weeks)|Death|1
2460317|NCT02505945|8483463|P2|Overall Study|Lost to Follow-up|1
2460318|NCT02505945|8483464|P1|Overall Study|Lost to Follow-up|6
2460319|NCT02505945|8483463|P2|Overall Study|Physician Decision|1
2460320|NCT02505945|8483464|P1|Overall Study|Physician Decision|2
2460321|NCT02505945|8483463|P2|Overall Study|Adverse Event|0
2460322|NCT02505945|8483464|P1|Overall Study|Adverse Event|1
2460323|NCT02505945|8483463|P2|Overall Study|Withdrawal by Subject|2
2460324|NCT02505945|8483464|P1|Overall Study|Withdrawal by Subject|13
2460325|NCT02505867|8483485|P2|Overall Study|Lack of Efficacy|6
2460326|NCT02505867|8483486|P1|Overall Study|Lack of Efficacy|6
2460327|NCT02505542|8483492|P4|Part B: Double-Blind Period|Subject did not complete all visits|0
2460328|NCT02505542|8483493|P3|Part B: Double-Blind Period|Subject did not complete all visits|0
2460329|NCT02505542|8483494|P2|Part B: Double-Blind Period|Subject did not complete all visits|1
2460330|NCT02505542|8483495|P1|Part B: Double-Blind Period|Subject did not complete all visits|0
2460331|NCT02505542|8483492|P4|Part B: Double-Blind Period|Miscalculation|0
2460332|NCT02505542|8483493|P3|Part B: Double-Blind Period|Miscalculation|0
2460333|NCT02505542|8483494|P2|Part B: Double-Blind Period|Miscalculation|1
2460334|NCT02505542|8483495|P1|Part B: Double-Blind Period|Miscalculation|0
2460335|NCT02505542|8483492|P4|Part B: Double-Blind Period|Lack of Efficacy|0
2460336|NCT02505542|8483493|P3|Part B: Double-Blind Period|Lack of Efficacy|0
2460337|NCT02505542|8483494|P2|Part B: Double-Blind Period|Lack of Efficacy|1
2460338|NCT02505542|8483495|P1|Part B: Double-Blind Period|Lack of Efficacy|0
2460339|NCT02505542|8483492|P4|Part B: Double-Blind Period|Patient was moved from the country|1
2460340|NCT02505542|8483493|P3|Part B: Double-Blind Period|Patient was moved from the country|0
2460341|NCT02505542|8483494|P2|Part B: Double-Blind Period|Patient was moved from the country|0
2460342|NCT02505542|8483495|P1|Part B: Double-Blind Period|Patient was moved from the country|0
2460343|NCT02505542|8483492|P4|Part B: Double-Blind Period|Week 94 missed|0
2460344|NCT02505542|8483493|P3|Part B: Double-Blind Period|Week 94 missed|1
2460345|NCT02505542|8483494|P2|Part B: Double-Blind Period|Week 94 missed|0
2460346|NCT02505542|8483495|P1|Part B: Double-Blind Period|Week 94 missed|0
2460347|NCT02505542|8483492|P4|Part B: Double-Blind Period|Planning pregnancy|0
2460348|NCT02505542|8483493|P3|Part B: Double-Blind Period|Planning pregnancy|0
2460349|NCT02505542|8483494|P2|Part B: Double-Blind Period|Planning pregnancy|1
2460350|NCT02505542|8483495|P1|Part B: Double-Blind Period|Planning pregnancy|0
2460351|NCT02505542|8483492|P4|Part B: Double-Blind Period|Withdrawal by Subject|2
2460352|NCT02505542|8483493|P3|Part B: Double-Blind Period|Withdrawal by Subject|7
2460353|NCT02505542|8483494|P2|Part B: Double-Blind Period|Withdrawal by Subject|8
2460354|NCT02505542|8483495|P1|Part B: Double-Blind Period|Withdrawal by Subject|0
2460355|NCT02505542|8483492|P4|Part B: Double-Blind Period|Lost to Follow-up|1
2460356|NCT02505542|8483493|P3|Part B: Double-Blind Period|Lost to Follow-up|0
2460357|NCT02505542|8483494|P2|Part B: Double-Blind Period|Lost to Follow-up|0
2460358|NCT02505542|8483495|P1|Part B: Double-Blind Period|Lost to Follow-up|0
2460359|NCT02505542|8483492|P4|Part B: Double-Blind Period|Adverse Event|3
2460360|NCT02505542|8483493|P3|Part B: Double-Blind Period|Adverse Event|1
2460361|NCT02505542|8483494|P2|Part B: Double-Blind Period|Adverse Event|0
2460362|NCT02505542|8483495|P1|Part B: Double-Blind Period|Adverse Event|0
2460363|NCT02505542|8483492|P4|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
2460364|NCT02505542|8483493|P3|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
2460365|NCT02505542|8483494|P2|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
2460366|NCT02505542|8483495|P1|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341
2460367|NCT02505542|8483492|P4|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
2460368|NCT02505542|8483493|P3|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
2460369|NCT02505542|8483494|P2|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
2460370|NCT02505542|8483495|P1|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3
2460371|NCT02505542|8483492|P4|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
2460372|NCT02505542|8483493|P3|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
2460373|NCT02505542|8483494|P2|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
2460374|NCT02505542|8483495|P1|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2
2460375|NCT02505542|8483492|P4|Part A: Open-Label Period|Non-compliance|0
2460376|NCT02505542|8483493|P3|Part A: Open-Label Period|Non-compliance|0
2460377|NCT02505542|8483494|P2|Part A: Open-Label Period|Non-compliance|0
2460378|NCT02505542|8483495|P1|Part A: Open-Label Period|Non-compliance|1
2460379|NCT02505542|8483492|P4|Part A: Open-Label Period|Screening failure (detected too late)|0
2460380|NCT02505542|8483493|P3|Part A: Open-Label Period|Screening failure (detected too late)|0
2460381|NCT02505542|8483494|P2|Part A: Open-Label Period|Screening failure (detected too late)|0
2460382|NCT02505542|8483495|P1|Part A: Open-Label Period|Screening failure (detected too late)|1
2460383|NCT02505542|8483492|P4|Part A: Open-Label Period|Medical monitor decision|0
2460384|NCT02505542|8483493|P3|Part A: Open-Label Period|Medical monitor decision|0
2460385|NCT02505542|8483494|P2|Part A: Open-Label Period|Medical monitor decision|0
2460386|NCT02505542|8483495|P1|Part A: Open-Label Period|Medical monitor decision|1
2460387|NCT02505542|8483492|P4|Part A: Open-Label Period|Sponsor directive|0
2460388|NCT02505542|8483493|P3|Part A: Open-Label Period|Sponsor directive|0
2460389|NCT02505542|8483494|P2|Part A: Open-Label Period|Sponsor directive|0
2460390|NCT02505542|8483495|P1|Part A: Open-Label Period|Sponsor directive|1
2460391|NCT02505542|8483492|P4|Part A: Open-Label Period|Pregnancy|0
2460392|NCT02505542|8483493|P3|Part A: Open-Label Period|Pregnancy|0
2460393|NCT02505542|8483494|P2|Part A: Open-Label Period|Pregnancy|0
2460394|NCT02505542|8483495|P1|Part A: Open-Label Period|Pregnancy|2
2460395|NCT02505542|8483492|P4|Part A: Open-Label Period|Participant did not attend week 48 visit|0
2460396|NCT02505542|8483493|P3|Part A: Open-Label Period|Participant did not attend week 48 visit|0
2460397|NCT02505542|8483494|P2|Part A: Open-Label Period|Participant did not attend week 48 visit|0
2460398|NCT02505542|8483495|P1|Part A: Open-Label Period|Participant did not attend week 48 visit|1
2460399|NCT02505542|8483492|P4|Part A: Open-Label Period|New medical history available|0
2460400|NCT02505542|8483493|P3|Part A: Open-Label Period|New medical history available|0
2460401|NCT02505542|8483494|P2|Part A: Open-Label Period|New medical history available|0
2460402|NCT02505542|8483495|P1|Part A: Open-Label Period|New medical history available|1
2460403|NCT02505542|8483492|P4|Part A: Open-Label Period|Withdrawal by Subject|0
2460404|NCT02505542|8483493|P3|Part A: Open-Label Period|Withdrawal by Subject|0
2460405|NCT02505542|8483494|P2|Part A: Open-Label Period|Withdrawal by Subject|0
2460406|NCT02505542|8483495|P1|Part A: Open-Label Period|Withdrawal by Subject|27
2460407|NCT02505542|8483492|P4|Part A: Open-Label Period|Lost to Follow-up|0
2460408|NCT02505542|8483493|P3|Part A: Open-Label Period|Lost to Follow-up|0
2460409|NCT02505542|8483494|P2|Part A: Open-Label Period|Lost to Follow-up|0
2460410|NCT02505542|8483495|P1|Part A: Open-Label Period|Lost to Follow-up|5
2460411|NCT02505542|8483492|P4|Part A: Open-Label Period|Protocol Violation|0
2460412|NCT02505542|8483493|P3|Part A: Open-Label Period|Protocol Violation|0
2460413|NCT02505542|8483494|P2|Part A: Open-Label Period|Protocol Violation|0
2460414|NCT02505542|8483495|P1|Part A: Open-Label Period|Protocol Violation|1
2460415|NCT02505542|8483492|P4|Part A: Open-Label Period|Lack of Efficacy|0
2460416|NCT02505542|8483493|P3|Part A: Open-Label Period|Lack of Efficacy|0
2460417|NCT02505542|8483494|P2|Part A: Open-Label Period|Lack of Efficacy|0
2460418|NCT02505542|8483495|P1|Part A: Open-Label Period|Lack of Efficacy|5
2460419|NCT02505542|8483492|P4|Part A: Open-Label Period|Adverse Event|0
2460420|NCT02505542|8483493|P3|Part A: Open-Label Period|Adverse Event|0
2460421|NCT02505542|8483494|P2|Part A: Open-Label Period|Adverse Event|0
2460422|NCT02505542|8483495|P1|Part A: Open-Label Period|Adverse Event|31
2460423|NCT02505334|8483603|P2|Extension Treatment Period|Unclassified|0
2460424|NCT02505334|8483604|P1|Extension Treatment Period|Unclassified|3
2460425|NCT02505334|8483603|P2|Extension Treatment Period|Withdrawal by Subject|0
2460426|NCT02505334|8483604|P1|Extension Treatment Period|Withdrawal by Subject|6
2460427|NCT02505334|8483603|P2|Extension Treatment Period|Lack of Efficacy|0
2460428|NCT02505334|8483604|P1|Extension Treatment Period|Lack of Efficacy|4
2460429|NCT02505334|8483603|P2|Extension Treatment Period|Adverse Event|0
2460430|NCT02505334|8483604|P1|Extension Treatment Period|Adverse Event|5
2460431|NCT02505334|8483603|P2|Main Treatment Period|Unclassified|10
2460432|NCT02505334|8483604|P1|Main Treatment Period|Unclassified|4
2460433|NCT02505334|8483603|P2|Main Treatment Period|Withdrawal by Subject|8
2460434|NCT02505334|8483604|P1|Main Treatment Period|Withdrawal by Subject|1
2460435|NCT02505334|8483603|P2|Main Treatment Period|Protocol Violation|1
2460436|NCT02505334|8483604|P1|Main Treatment Period|Protocol Violation|0
2460437|NCT02505334|8483603|P2|Main Treatment Period|Lack of Efficacy|17
2460438|NCT02505334|8483604|P1|Main Treatment Period|Lack of Efficacy|7
2460439|NCT02505334|8483603|P2|Main Treatment Period|Adverse Event|3
2460441|NCT02504892|8483740|P1|Overall Study|Adverse event-pneumonitis|2
2460442|NCT02504827|8483747|P1|Overall Study|Could not produce sputum|1
2460443|NCT02504671|8483786|P6|Overall Study|Protocol defined stopping criteria|3
2460444|NCT02504671|8483787|P5|Overall Study|Protocol defined stopping criteria|3
2460445|NCT02504671|8483788|P4|Overall Study|Protocol defined stopping criteria|5
2460446|NCT02504671|8483789|P3|Overall Study|Protocol defined stopping criteria|3
2460447|NCT02504671|8483790|P2|Overall Study|Protocol defined stopping criteria|4
2460448|NCT02504671|8483791|P1|Overall Study|Protocol defined stopping criteria|7
2460449|NCT02504671|8483786|P6|Overall Study|Lost to Follow-up|1
2460450|NCT02504671|8483787|P5|Overall Study|Lost to Follow-up|0
2460451|NCT02504671|8483788|P4|Overall Study|Lost to Follow-up|0
2460452|NCT02504671|8483789|P3|Overall Study|Lost to Follow-up|2
2460453|NCT02504671|8483790|P2|Overall Study|Lost to Follow-up|0
2460454|NCT02504671|8483791|P1|Overall Study|Lost to Follow-up|0
2460455|NCT02504671|8483786|P6|Overall Study|Protocol Violation|1
2460456|NCT02504671|8483787|P5|Overall Study|Protocol Violation|0
2460457|NCT02504671|8483788|P4|Overall Study|Protocol Violation|0
2460458|NCT02504671|8483789|P3|Overall Study|Protocol Violation|0
2460459|NCT02504671|8483790|P2|Overall Study|Protocol Violation|1
2460460|NCT02504671|8483791|P1|Overall Study|Protocol Violation|2
2460461|NCT02504671|8483786|P6|Overall Study|Adverse Event|2
2460462|NCT02504671|8483787|P5|Overall Study|Adverse Event|0
2460463|NCT02504671|8483788|P4|Overall Study|Adverse Event|1
2460464|NCT02504671|8483789|P3|Overall Study|Adverse Event|0
2460465|NCT02504671|8483790|P2|Overall Study|Adverse Event|1
2460466|NCT02504671|8483791|P1|Overall Study|Adverse Event|1
2460467|NCT02504671|8483786|P6|Overall Study|Lack of Efficacy|4
2460468|NCT02504671|8483787|P5|Overall Study|Lack of Efficacy|4
2460469|NCT02504671|8483788|P4|Overall Study|Lack of Efficacy|0
2460470|NCT02504671|8483789|P3|Overall Study|Lack of Efficacy|1
2460471|NCT02504671|8483790|P2|Overall Study|Lack of Efficacy|3
2460472|NCT02504671|8483791|P1|Overall Study|Lack of Efficacy|1
2460473|NCT02504671|8483786|P6|Overall Study|Withdrawal by Subject|3
2460474|NCT02504671|8483787|P5|Overall Study|Withdrawal by Subject|5
2460475|NCT02504671|8483788|P4|Overall Study|Withdrawal by Subject|4
2460476|NCT02504671|8483789|P3|Overall Study|Withdrawal by Subject|4
2460477|NCT02504671|8483790|P2|Overall Study|Withdrawal by Subject|5
2460478|NCT02504671|8483791|P1|Overall Study|Withdrawal by Subject|1
2460479|NCT02504541|8483963|P1|Overall Study|Multiple|5
2460480|NCT02504541|8483963|P1|Overall Study|Other|2
2460481|NCT02504541|8483963|P1|Overall Study|Termination by Sponsor|1
2460482|NCT02504541|8483963|P1|Overall Study|Protocol Violation|2
2460483|NCT02504541|8483963|P1|Overall Study|Met Stopping Criteria|1
2460484|NCT02504541|8483963|P1|Overall Study|Lost to Follow-up|1
2460485|NCT02504541|8483963|P1|Overall Study|Withdrawal by Subject|4
2460486|NCT02504541|8483963|P1|Overall Study|Adverse Event|4
2460487|NCT02504502|8483969|P2|Crossover to Enhanced Report|Lost to Follow-up|0
2460488|NCT02504502|8483970|P1|Crossover to Enhanced Report|Lost to Follow-up|5
2460489|NCT02504502|8483969|P2|Routine Care vs. Enhanced Report|Lost to Follow-up|7
2460490|NCT02504502|8483970|P1|Routine Care vs. Enhanced Report|Lost to Follow-up|4
2460491|NCT02504424|8483976|P1|Overall Study|Withdrawal by Subject|2
2460492|NCT02504320|8483985|P4|Treatment Period 3|Adverse Event|0
2460493|NCT02504320|8483986|P3|Treatment Period 3|Adverse Event|1
2460494|NCT02504320|8483987|P2|Treatment Period 3|Adverse Event|0
2460495|NCT02504320|8483988|P1|Treatment Period 3|Adverse Event|0
2460496|NCT02504320|8483985|P4|Treatment Period 3|Positive Drug Screen|1
2460497|NCT02504320|8483986|P3|Treatment Period 3|Positive Drug Screen|0
2460498|NCT02504320|8483987|P2|Treatment Period 3|Positive Drug Screen|0
2460499|NCT02504320|8483988|P1|Treatment Period 3|Positive Drug Screen|0
2460500|NCT02504320|8483985|P4|Treatment Period 2|Positive Drug Screen|0
2460501|NCT02504320|8483986|P3|Treatment Period 2|Positive Drug Screen|0
2460502|NCT02504320|8483987|P2|Treatment Period 2|Positive Drug Screen|1
2460503|NCT02504320|8483988|P1|Treatment Period 2|Positive Drug Screen|0
2460504|NCT02504320|8483985|P4|Treatment Period 1|Positive Drug Screen|0
2460505|NCT02504320|8483986|P3|Treatment Period 1|Positive Drug Screen|1
2460506|NCT02504320|8483987|P2|Treatment Period 1|Positive Drug Screen|0
2460507|NCT02504320|8483988|P1|Treatment Period 1|Positive Drug Screen|0
2460508|NCT02504294|8484008|P2|Overall Study|Lost to Follow-up|7
2460509|NCT02504294|8484009|P1|Overall Study|Lost to Follow-up|6
2460510|NCT02504294|8484008|P2|Overall Study|Physician Decision|2
2460511|NCT02504294|8484009|P1|Overall Study|Physician Decision|1
2460512|NCT02504294|8484008|P2|Overall Study|Protocol Violation|26
2460513|NCT02504294|8484009|P1|Overall Study|Protocol Violation|27
2460514|NCT02504294|8484008|P2|Overall Study|Withdrawal by Subject|1
2460515|NCT02504294|8484009|P1|Overall Study|Withdrawal by Subject|7
2460516|NCT02504294|8484008|P2|Overall Study|Adverse Event|12
2460517|NCT02504294|8484009|P1|Overall Study|Adverse Event|15
2460518|NCT02504268|8484019|P2|Overall Study|Not Disclosed|0
2460519|NCT02504268|8484020|P1|Overall Study|Not Disclosed|1
2460520|NCT02504268|8484019|P2|Overall Study|Poor/Non-Compliance|2
2460521|NCT02504268|8484020|P1|Overall Study|Poor/Non-Compliance|3
2460522|NCT02504268|8484019|P2|Overall Study|Lack of Efficacy|35
2460523|NCT02504268|8484020|P1|Overall Study|Lack of Efficacy|11
2460524|NCT02504268|8484019|P2|Overall Study|No Longer Meets Study Criteria|3
2460525|NCT02504268|8484020|P1|Overall Study|No Longer Meets Study Criteria|2
2460526|NCT02504268|8484019|P2|Overall Study|Subject Request to Discontinue|3
2460527|NCT02504268|8484020|P1|Overall Study|Subject Request to Discontinue|11
2460528|NCT02504268|8484019|P2|Overall Study|Death|1
2460529|NCT02504268|8484020|P1|Overall Study|Death|1
2460530|NCT02504268|8484019|P2|Overall Study|Lost to Follow-up|6
2460531|NCT02504268|8484020|P1|Overall Study|Lost to Follow-up|3
2460532|NCT02504268|8484019|P2|Overall Study|Pregnancy|0
2460533|NCT02504268|8484020|P1|Overall Study|Pregnancy|2
2460534|NCT02504268|8484019|P2|Overall Study|Withdrawal of Consent|10
2460535|NCT02504268|8484020|P1|Overall Study|Withdrawal of Consent|11
2460536|NCT02504268|8484019|P2|Overall Study|Adverse Event|8
2460537|NCT02504268|8484020|P1|Overall Study|Adverse Event|18
2460538|NCT02503865|8484055|P3|Overall Study|Refused treatment|2
2460539|NCT02503865|8484056|P2|Overall Study|Refused treatment|39
2460540|NCT02503865|8484057|P1|Overall Study|Refused treatment|4
2460541|NCT02503865|8484055|P3|Overall Study|Moved out of area|0
2460542|NCT02503865|8484056|P2|Overall Study|Moved out of area|8
2460543|NCT02503865|8484057|P1|Overall Study|Moved out of area|1
2460544|NCT02503787|8484102|P1|Implant to 3 Month Endpoint|Withdrawal by Subject|1
2460545|NCT02503787|8484102|P1|Implant to 3 Month Endpoint|Adverse Event|2
2460546|NCT02503787|8484102|P1|Successful Trial (≥50% Pain Relief)|Physician Decision|2
2460547|NCT02503787|8484102|P1|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3
2460548|NCT02503787|8484102|P1|Device Trial (HD Programming Trial)|Withdrawal by Subject|1
2460549|NCT02503787|8484102|P1|Device Trial (HD Programming Trial)|Lack of Efficacy|6
2460550|NCT02503787|8484102|P1|Enrollment|Unable to be programmed|1
2460551|NCT02503787|8484102|P1|Enrollment|Inability to implant system|1
2460552|NCT02503787|8484102|P1|Enrollment|Protocol Violation|1
2460553|NCT02503787|8484102|P1|Enrollment|Adverse Event|1
2460554|NCT02503787|8484102|P1|Enrollment|Study closure|1
2460555|NCT02503787|8484102|P1|Enrollment|Lost to Follow-up|1
2460556|NCT02503787|8484102|P1|Enrollment|Insurance issue|2
2460557|NCT02503787|8484102|P1|Enrollment|Physician Decision|2
2460558|NCT02503787|8484102|P1|Enrollment|Inclusion/exclusion criteria not met|4
2460559|NCT02503787|8484102|P1|Enrollment|Withdrawal by Subject|6
2460560|NCT02503540|8484119|P1|Overall Study|Withdrawal by Subject|1
2460561|NCT02503540|8484119|P1|Overall Study|Death|2
2460562|NCT02503501|8484140|P2|Overall Study|Withdrawal by Subject|2
2460563|NCT02503501|8484141|P1|Overall Study|Withdrawal by Subject|0
2460564|NCT02503501|8484140|P2|Overall Study|Protocol Violation|1
2460565|NCT02503501|8484141|P1|Overall Study|Protocol Violation|0
2460566|NCT02503501|8484140|P2|Overall Study|Physician Decision|0
2460567|NCT02503501|8484141|P1|Overall Study|Physician Decision|1
2460568|NCT02503215|8484190|P1|Overall Study|Unable to use positive airway pressure|2
2460569|NCT02503215|8484190|P1|Overall Study|Unable to wear compression stockings|1
2460570|NCT02503202|8484201|P5|Extension: Month 6 to 24|Withdrawal by Subject|0
2460571|NCT02503202|8484202|P4|Extension: Month 6 to 24|Withdrawal by Subject|4
2460572|NCT02503202|8484203|P3|Extension: Month 6 to 24|Withdrawal by Subject|2
2460573|NCT02503202|8484204|P2|Extension: Month 6 to 24|Withdrawal by Subject|8
2460574|NCT02503202|8484205|P1|Extension: Month 6 to 24|Withdrawal by Subject|5
2460575|NCT02503202|8484201|P5|Extension: Month 6 to 24|Physician Decision|0
2460576|NCT02503202|8484202|P4|Extension: Month 6 to 24|Physician Decision|3
2460577|NCT02503202|8484203|P3|Extension: Month 6 to 24|Physician Decision|1
2460578|NCT02503202|8484204|P2|Extension: Month 6 to 24|Physician Decision|0
2460579|NCT02503202|8484205|P1|Extension: Month 6 to 24|Physician Decision|1
2460580|NCT02503202|8484201|P5|Extension: Month 6 to 24|Lost to Follow-up|1
2460581|NCT02503202|8484202|P4|Extension: Month 6 to 24|Lost to Follow-up|10
2460582|NCT02503202|8484203|P3|Extension: Month 6 to 24|Lost to Follow-up|6
2460583|NCT02503202|8484204|P2|Extension: Month 6 to 24|Lost to Follow-up|8
2460584|NCT02503202|8484205|P1|Extension: Month 6 to 24|Lost to Follow-up|4
2460585|NCT02503202|8484201|P5|Extension: Month 6 to 24|Death|0
2460586|NCT02503202|8484202|P4|Extension: Month 6 to 24|Death|0
2460587|NCT02503202|8484203|P3|Extension: Month 6 to 24|Death|0
2460588|NCT02503202|8484204|P2|Extension: Month 6 to 24|Death|0
2460589|NCT02503202|8484205|P1|Extension: Month 6 to 24|Death|1
2460590|NCT02503202|8484201|P5|Extension: Month 6 to 24|Protocol Violation|0
2460591|NCT02503202|8484202|P4|Extension: Month 6 to 24|Protocol Violation|1
2460592|NCT02503202|8484203|P3|Extension: Month 6 to 24|Protocol Violation|0
2460593|NCT02503202|8484204|P2|Extension: Month 6 to 24|Protocol Violation|0
2460594|NCT02503202|8484205|P1|Extension: Month 6 to 24|Protocol Violation|0
2460595|NCT02503202|8484201|P5|Base Study: Up to Month 6|Randomized not vaccinated|0
2460596|NCT02503202|8484202|P4|Base Study: Up to Month 6|Randomized not vaccinated|2
2460597|NCT02503202|8484203|P3|Base Study: Up to Month 6|Randomized not vaccinated|1
2460598|NCT02503202|8484204|P2|Base Study: Up to Month 6|Randomized not vaccinated|0
2460599|NCT02503202|8484205|P1|Base Study: Up to Month 6|Randomized not vaccinated|0
2460600|NCT02503202|8484201|P5|Base Study: Up to Month 6|Withdrawal by Subject|1
2460601|NCT02503202|8484202|P4|Base Study: Up to Month 6|Withdrawal by Subject|4
2460602|NCT02503202|8484203|P3|Base Study: Up to Month 6|Withdrawal by Subject|4
2460603|NCT02503202|8484204|P2|Base Study: Up to Month 6|Withdrawal by Subject|3
2460604|NCT02503202|8484205|P1|Base Study: Up to Month 6|Withdrawal by Subject|6
2460605|NCT02503202|8484201|P5|Base Study: Up to Month 6|Physician Decision|1
2460606|NCT02503202|8484202|P4|Base Study: Up to Month 6|Physician Decision|0
2460607|NCT02503202|8484203|P3|Base Study: Up to Month 6|Physician Decision|0
2460608|NCT02503202|8484204|P2|Base Study: Up to Month 6|Physician Decision|0
2460609|NCT02503202|8484205|P1|Base Study: Up to Month 6|Physician Decision|0
2460610|NCT02503202|8484201|P5|Base Study: Up to Month 6|Lost to Follow-up|1
2460611|NCT02503202|8484202|P4|Base Study: Up to Month 6|Lost to Follow-up|5
2460612|NCT02503202|8484203|P3|Base Study: Up to Month 6|Lost to Follow-up|10
2460613|NCT02503202|8484204|P2|Base Study: Up to Month 6|Lost to Follow-up|8
2460614|NCT02503202|8484205|P1|Base Study: Up to Month 6|Lost to Follow-up|11
2460615|NCT02503202|8484201|P5|Base Study: Up to Month 6|Death|0
2460616|NCT02503202|8484202|P4|Base Study: Up to Month 6|Death|0
2460617|NCT02503202|8484203|P3|Base Study: Up to Month 6|Death|0
2460618|NCT02503202|8484204|P2|Base Study: Up to Month 6|Death|1
2460619|NCT02503202|8484205|P1|Base Study: Up to Month 6|Death|1
2460620|NCT02503085|8484247|P4|Period 2: Washout (3 to 7 Days)|Adverse Event|0
2460621|NCT02503085|8484248|P3|Period 2: Washout (3 to 7 Days)|Adverse Event|1
2460622|NCT02503085|8484249|P2|Period 2: Washout (3 to 7 Days)|Adverse Event|0
2460623|NCT02503085|8484250|P1|Period 2: Washout (3 to 7 Days)|Adverse Event|1
2460624|NCT02502864|8484289|P1|Overall Study|Withdrawal by Subject|1
2460625|NCT02502734|8484298|P2|Washout Period|Adverse Event|0
2460626|NCT02502734|8484299|P1|Washout Period|Adverse Event|1
2460627|NCT02502734|8484298|P2|Double-blind Treatment Period 1|Adverse Event|0
2460628|NCT02502734|8484299|P1|Double-blind Treatment Period 1|Adverse Event|1
2460629|NCT02502526|8484310|P3|Overall Study|Enrollment suspension|1
2460630|NCT02502526|8484311|P2|Overall Study|Enrollment suspension|1
2460631|NCT02502526|8484312|P1|Overall Study|Enrollment suspension|4
2460632|NCT02502526|8484310|P3|Overall Study|Disqualified due to cataract grading|1
2460633|NCT02502526|8484311|P2|Overall Study|Disqualified due to cataract grading|0
2460634|NCT02502526|8484312|P1|Overall Study|Disqualified due to cataract grading|0
2460635|NCT02502526|8484310|P3|Overall Study|Withdrawal by Subject|1
2460636|NCT02502526|8484311|P2|Overall Study|Withdrawal by Subject|1
2460637|NCT02502526|8484312|P1|Overall Study|Withdrawal by Subject|0
2460638|NCT02502526|8484310|P3|Overall Study|Lost to Follow-up|3
2460639|NCT02502526|8484311|P2|Overall Study|Lost to Follow-up|2
2460640|NCT02502526|8484312|P1|Overall Study|Lost to Follow-up|2
2460641|NCT02502149|8484409|P5|Intermediate|Discontinued prematurely|0
2460642|NCT02502149|8484410|P4|Intermediate|Discontinued prematurely|0
2460643|NCT02502149|8484411|P3|Intermediate|Discontinued prematurely|0
2460644|NCT02502149|8484412|P2|Intermediate|Discontinued prematurely|0
2460645|NCT02502149|8484413|P1|Intermediate|Discontinued prematurely|1
2460646|NCT02501629|8484553|P2|Overall Study|Subject did not return to site|1
2460647|NCT02501629|8484554|P1|Overall Study|Subject did not return to site|0
2460648|NCT02501629|8484553|P2|Overall Study|Withdrawal by Subject|5
2460649|NCT02501629|8484554|P1|Overall Study|Withdrawal by Subject|3
2460650|NCT02501629|8484553|P2|Overall Study|Early termination by sponsor|0
2460651|NCT02501629|8484554|P1|Overall Study|Early termination by sponsor|1
2460652|NCT02501629|8484553|P2|Overall Study|Withdrawn from study by sponsor|0
2460653|NCT02501629|8484554|P1|Overall Study|Withdrawn from study by sponsor|1
2460654|NCT02501629|8484553|P2|Overall Study|Death|1
2460655|NCT02501629|8484554|P1|Overall Study|Death|0
2460656|NCT02501161|8484587|P2|Overall Study|Other|0
2460657|NCT02501161|8484588|P1|Overall Study|Other|3
2460658|NCT02501161|8484587|P2|Overall Study|Withdrawal by Subject|15
2460659|NCT02501161|8484588|P1|Overall Study|Withdrawal by Subject|10
2460660|NCT02501161|8484587|P2|Overall Study|Lost to Follow-up|4
2460661|NCT02501161|8484588|P1|Overall Study|Lost to Follow-up|7
2460662|NCT02501161|8484587|P2|Overall Study|Adverse Event|6
2460663|NCT02501161|8484588|P1|Overall Study|Adverse Event|2
2460664|NCT02500979|8484712|P2|Period 2|Change in risk|0
2460665|NCT02500979|8484713|P1|Period 2|Change in risk|1
2460666|NCT02500979|8484712|P2|Period 1|Subject decision|0
2460667|NCT02500979|8484713|P1|Period 1|Subject decision|2
2460668|NCT02500979|8484712|P2|Period 1|Adverse Event|0
2460669|NCT02500979|8484713|P1|Period 1|Adverse Event|1
2460670|NCT02500979|8484712|P2|Period 1|Severe non-compliance to protocol|1
2460671|NCT02500979|8484713|P1|Period 1|Severe non-compliance to protocol|0
2460672|NCT02500979|8484712|P2|Period 1|Hyperglycemia|0
2460673|NCT02500979|8484713|P1|Period 1|Hyperglycemia|1
2460674|NCT02500901|8484747|P1|Overall Study|Disease ProgressionDD|2
2460675|NCT02500758|8484769|P2|Second Intervention (2 Minutes)|Protocol Violation|1
2460676|NCT02500758|8484770|P1|Second Intervention (2 Minutes)|Protocol Violation|1
2460677|NCT02500758|8484769|P2|Second Intervention (2 Minutes)|Lost to Follow-up|1
2460678|NCT02500758|8484770|P1|Second Intervention (2 Minutes)|Lost to Follow-up|0
2460679|NCT02500758|8484769|P2|Second Intervention (2 Minutes)|Withdrawal by Subject|0
2460680|NCT02500758|8484770|P1|Second Intervention (2 Minutes)|Withdrawal by Subject|2
2460681|NCT02500758|8484769|P2|Washout (1 Week)|Lost to Follow-up|2
2460682|NCT02500758|8484770|P1|Washout (1 Week)|Lost to Follow-up|2
2460683|NCT02500758|8484769|P2|First Intervention (2 Minutes)|Withdrawal by Subject|1
2460684|NCT02500758|8484770|P1|First Intervention (2 Minutes)|Withdrawal by Subject|0
2460685|NCT02500732|8484780|P2|Overall Study|Physician Decision|1
2460686|NCT02500732|8484781|P1|Overall Study|Physician Decision|0
2460687|NCT02500706|8484798|P3|Overall Study|Unclassified|1
2460688|NCT02500706|8484799|P2|Overall Study|Unclassified|0
2460689|NCT02500706|8484800|P1|Overall Study|Unclassified|0
2460690|NCT02500706|8484798|P3|Overall Study|Withdrawal by Subject|4
2460691|NCT02500706|8484799|P2|Overall Study|Withdrawal by Subject|6
2460692|NCT02500706|8484800|P1|Overall Study|Withdrawal by Subject|4
2460693|NCT02500706|8484798|P3|Overall Study|Lost to Follow-up|1
2460694|NCT02500706|8484799|P2|Overall Study|Lost to Follow-up|1
2460695|NCT02500706|8484800|P1|Overall Study|Lost to Follow-up|0
2460696|NCT02500706|8484798|P3|Overall Study|Adverse Event|1
2460697|NCT02500706|8484799|P2|Overall Study|Adverse Event|0
2460698|NCT02500706|8484800|P1|Overall Study|Adverse Event|0
2460699|NCT02500641|8484954|P2|Overall Study|Non compliance to study drug|1
2460700|NCT02500641|8484955|P1|Overall Study|Non compliance to study drug|0
2460701|NCT02500641|8484954|P2|Overall Study|Sponsor decision|0
2460702|NCT02500641|8484955|P1|Overall Study|Sponsor decision|1
2460703|NCT02500641|8484954|P2|Overall Study|Lost to Follow-up|0
2460704|NCT02500641|8484955|P1|Overall Study|Lost to Follow-up|1
2460705|NCT02500641|8484954|P2|Overall Study|Protocol Violation|2
2460706|NCT02500641|8484955|P1|Overall Study|Protocol Violation|1
2460707|NCT02500641|8484954|P2|Overall Study|Unable to follow study procedures|2
2460708|NCT02500641|8484955|P1|Overall Study|Unable to follow study procedures|3
2460709|NCT02500641|8484954|P2|Overall Study|Withdrawal by Subject|5
2460710|NCT02500641|8484955|P1|Overall Study|Withdrawal by Subject|4
2460711|NCT02500641|8484954|P2|Overall Study|Adverse Event|2
2460712|NCT02500641|8484955|P1|Overall Study|Adverse Event|0
2460713|NCT02500537|8484976|P2|Overall Study|Withdrawal by Subject|0
2460714|NCT02500537|8484977|P1|Overall Study|Withdrawal by Subject|1
2460715|NCT02500537|8484976|P2|Overall Study|Lost to Follow-up|1
2460716|NCT02500537|8484977|P1|Overall Study|Lost to Follow-up|0
2460717|NCT02500537|8484976|P2|Overall Study|Death|0
2460718|NCT02500537|8484977|P1|Overall Study|Death|2
2460719|NCT02500056|8485046|P2|Overall Study|Death|1
2460720|NCT02500056|8485047|P1|Overall Study|Death|3
2460721|NCT02500056|8485046|P2|Overall Study|Recurrence|0
2460722|NCT02500056|8485047|P1|Overall Study|Recurrence|1
2460723|NCT02500056|8485046|P2|Overall Study|Lost to Follow-up|7
2460724|NCT02500056|8485047|P1|Overall Study|Lost to Follow-up|3
2460725|NCT02499952|8485057|P1|Overall Study|Death|9
2460726|NCT02499952|8485057|P1|Overall Study|Lost to Follow-up|1
2460727|NCT02499900|8485066|P2|Extension Study Period|Other|2
2460728|NCT02499900|8485067|P1|Extension Study Period|Other|0
2460729|NCT02499900|8485066|P2|Extension Study Period|Lost to Follow-up|5
2460730|NCT02499900|8485067|P1|Extension Study Period|Lost to Follow-up|2
2460731|NCT02499900|8485066|P2|Extension Study Period|Pregnancy|2
2460732|NCT02499900|8485067|P1|Extension Study Period|Pregnancy|1
2460733|NCT02499900|8485066|P2|Extension Study Period|Physician Decision|5
2460734|NCT02499900|8485067|P1|Extension Study Period|Physician Decision|2
2460735|NCT02499900|8485066|P2|Extension Study Period|Withdrawal by Subject|2
2460736|NCT02499900|8485067|P1|Extension Study Period|Withdrawal by Subject|5
2460737|NCT02499900|8485066|P2|Extension Study Period|Adverse Event|4
2460738|NCT02499900|8485067|P1|Extension Study Period|Adverse Event|2
2460739|NCT02499900|8485066|P2|Completed Core, Continued Into Extension|Personal motivation|0
2460740|NCT02499900|8485067|P1|Completed Core, Continued Into Extension|Personal motivation|1
2460741|NCT02499900|8485066|P2|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0
2460742|NCT02499900|8485067|P1|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1
2460743|NCT02499900|8485066|P2|Completed Core, Continued Into Extension|Withdrawal by Subject|2
2460744|NCT02499900|8485067|P1|Completed Core, Continued Into Extension|Withdrawal by Subject|0
2460745|NCT02499900|8485066|P2|Completed Core, Continued Into Extension|Physician Decision|0
2460746|NCT02499900|8485067|P1|Completed Core, Continued Into Extension|Physician Decision|1
2460747|NCT02499900|8485066|P2|Core Study Period|Death|1
2460748|NCT02499900|8485067|P1|Core Study Period|Death|0
2460749|NCT02499900|8485066|P2|Core Study Period|Adverse Event|14
2460750|NCT02499900|8485067|P1|Core Study Period|Adverse Event|18
2460751|NCT02499900|8485066|P2|Core Study Period|Withdrawal by Subject|10
2460752|NCT02499900|8485067|P1|Core Study Period|Withdrawal by Subject|11
2460753|NCT02499900|8485066|P2|Core Study Period|Protocol Violation|0
2460754|NCT02499900|8485067|P1|Core Study Period|Protocol Violation|3
2460755|NCT02499900|8485066|P2|Core Study Period|Pregnancy|0
2460756|NCT02499900|8485067|P1|Core Study Period|Pregnancy|1
2460757|NCT02499900|8485066|P2|Core Study Period|Per sponsor request|1
2460758|NCT02499900|8485067|P1|Core Study Period|Per sponsor request|0
2460759|NCT02499900|8485066|P2|Core Study Period|Lost to Follow-up|2
2460760|NCT02499900|8485067|P1|Core Study Period|Lost to Follow-up|1
2460761|NCT02499900|8485066|P2|Core Study Period|Other|4
2460762|NCT02499900|8485067|P1|Core Study Period|Other|1
2460763|NCT02499783|8485098|P3|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2
2460764|NCT02499783|8485099|P2|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0
2460765|NCT02499783|8485100|P1|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0
2460766|NCT02499783|8485098|P3|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9
2460767|NCT02499783|8485099|P2|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0
2460768|NCT02499783|8485100|P1|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0
2460769|NCT02499783|8485098|P3|Open Label Period: Weeks 8 to 26|Withdrew Consent|2
2460770|NCT02499783|8485099|P2|Open Label Period: Weeks 8 to 26|Withdrew Consent|0
2460771|NCT02499783|8485100|P1|Open Label Period: Weeks 8 to 26|Withdrew Consent|0
2460772|NCT02499783|8485098|P3|Open Label Period: Weeks 8 to 26|Adverse Event|16
2460773|NCT02499783|8485099|P2|Open Label Period: Weeks 8 to 26|Adverse Event|0
2460774|NCT02499783|8485100|P1|Open Label Period: Weeks 8 to 26|Adverse Event|0
2460775|NCT02499783|8485098|P3|DB Period: Weeks 0-8|Other|0
2460776|NCT02499783|8485099|P2|DB Period: Weeks 0-8|Other|1
2460777|NCT02499783|8485100|P1|DB Period: Weeks 0-8|Other|1
2460778|NCT02499783|8485098|P3|DB Period: Weeks 0-8|Withdrew Consent|0
2460779|NCT02499783|8485099|P2|DB Period: Weeks 0-8|Withdrew Consent|0
2460780|NCT02499783|8485100|P1|DB Period: Weeks 0-8|Withdrew Consent|1
2460781|NCT02499783|8485098|P3|DB Period: Weeks 0-8|Adverse Event|0
2460782|NCT02499783|8485099|P2|DB Period: Weeks 0-8|Adverse Event|6
2460783|NCT02499783|8485100|P1|DB Period: Weeks 0-8|Adverse Event|8
2460784|NCT02499783|8485098|P3|DB Period/Placebo-Controlled: Weeks 0-4|Other|0
2460785|NCT02499783|8485099|P2|DB Period/Placebo-Controlled: Weeks 0-4|Other|1
2460786|NCT02499783|8485100|P1|DB Period/Placebo-Controlled: Weeks 0-4|Other|1
2460787|NCT02499783|8485098|P3|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0
2460788|NCT02499783|8485099|P2|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0
2460789|NCT02499783|8485100|P1|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1
2460790|NCT02499783|8485098|P3|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0
2460791|NCT02499783|8485099|P2|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4
2460792|NCT02499783|8485100|P1|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2
2460793|NCT02499575|8485158|P2|Overall Study|Protocol Violation|1
2460794|NCT02499575|8485159|P1|Overall Study|Protocol Violation|0
2460795|NCT02499406|8485169|P1|Overall Study|missed 3 treatment sessions|4
2460796|NCT02499263|8485190|P1|Overall Study|Pregnancy|1
2460797|NCT02499263|8485190|P1|Overall Study|Participant's decision|3
2460798|NCT02499263|8485190|P1|Overall Study|Adverse Events/Serious Adverse Events|11
2460799|NCT02499263|8485190|P1|Overall Study|investigator's judgment|12
2460800|NCT02499263|8485190|P1|Overall Study|Lack of Efficacy|22
2460801|NCT02499263|8485190|P1|Overall Study|Participant's withdrawal of consent|4
2460802|NCT02499263|8485190|P1|Overall Study|Lost to Follow-up|9
2460803|NCT02499172|8485227|P4|Overall Study|Lost to Follow-up|0
2460804|NCT02499172|8485228|P3|Overall Study|Lost to Follow-up|0
2460805|NCT02499172|8485229|P2|Overall Study|Lost to Follow-up|64
2460806|NCT02499172|8485230|P1|Overall Study|Lost to Follow-up|65
2460807|NCT02499172|8485227|P4|Overall Study|Financial reason|436
2460808|NCT02499172|8485228|P3|Overall Study|Financial reason|523
2460809|NCT02499172|8485229|P2|Overall Study|Financial reason|0
2460810|NCT02499172|8485230|P1|Overall Study|Financial reason|0
2460811|NCT02499159|8485242|P2|30-Day Follow-Up Phone Call|Other|0
2460812|NCT02499159|8485243|P1|30-Day Follow-Up Phone Call|Other|1
2460813|NCT02499159|8485242|P2|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0
2460814|NCT02499159|8485243|P1|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2
2460815|NCT02499159|8485242|P2|30-Day Follow-Up Phone Call|Lost to Follow-up|1
2460816|NCT02499159|8485243|P1|30-Day Follow-Up Phone Call|Lost to Follow-up|3
2460817|NCT02499159|8485242|P2|30-Day Follow-Up Phone Call|Withdrawal by Subject|1
2460818|NCT02499159|8485243|P1|30-Day Follow-Up Phone Call|Withdrawal by Subject|1
2460819|NCT02499159|8485242|P2|Randomization|Protocol Violation|1
2460820|NCT02499159|8485243|P1|Randomization|Protocol Violation|1
2460821|NCT02499146|8485267|P1|Overall Study|Began other treatment/therapy|13
2460822|NCT02499146|8485267|P1|Overall Study|Ongoing at date of cut-off|9
2460823|NCT02499146|8485267|P1|Overall Study|Other|2
2460824|NCT02499146|8485267|P1|Overall Study|Withdrawal by Subject|1
2460825|NCT02499146|8485267|P1|Overall Study|Lost to Follow-up|1
2460826|NCT02499120|8485307|P2|Overall Study|Ongoing on study|11
2460827|NCT02499120|8485308|P1|Overall Study|Ongoing on study|15
2460828|NCT02499120|8485307|P2|Overall Study|Other|0
2460829|NCT02499120|8485308|P1|Overall Study|Other|1
2460830|NCT02499120|8485307|P2|Overall Study|Withdrawal by Subject|5
2460831|NCT02499120|8485308|P1|Overall Study|Withdrawal by Subject|2
2460832|NCT02499120|8485307|P2|Overall Study|Participant refused further follow-up|0
2460833|NCT02499120|8485308|P1|Overall Study|Participant refused further follow-up|1
2460834|NCT02499120|8485307|P2|Overall Study|Lost to Follow-up|2
2460835|NCT02499120|8485308|P1|Overall Study|Lost to Follow-up|1
2460836|NCT02499120|8485307|P2|Overall Study|Death|42
2460837|NCT02499120|8485308|P1|Overall Study|Death|45
2460838|NCT02499029|8485339|P2|Overall Study|Death|0
2460839|NCT02499029|8485340|P1|Overall Study|Death|1
2460840|NCT02499029|8485339|P2|Overall Study|Physician Decision|1
2460841|NCT02499029|8485340|P1|Overall Study|Physician Decision|2
2460842|NCT02499029|8485339|P2|Overall Study|Lost to Follow-up|2
2460843|NCT02499029|8485340|P1|Overall Study|Lost to Follow-up|2
2460844|NCT02498821|8485367|P2|Overall Study|Screen failure|5
2460845|NCT02498821|8485368|P1|Overall Study|Screen failure|3
2460846|NCT02498678|8485412|P2|Overall Study|interference from the surgical team|2
2460847|NCT02498678|8485413|P1|Overall Study|interference from the surgical team|0
2460848|NCT02498652|8485429|P2|Overall Study|Protocol Violation|1
2460849|NCT02498652|8485430|P1|Overall Study|Protocol Violation|0
2460850|NCT02498418|8485558|P3|Overall Study|Participant taken prohibited medication|1
2460851|NCT02498418|8485559|P2|Overall Study|Participant taken prohibited medication|1
2460852|NCT02498418|8485560|P1|Overall Study|Participant taken prohibited medication|0
2460853|NCT02498418|8485558|P3|Overall Study|Lost to Follow-up|1
2460854|NCT02498418|8485559|P2|Overall Study|Lost to Follow-up|1
2460855|NCT02498418|8485560|P1|Overall Study|Lost to Follow-up|0
2460856|NCT02498418|8485558|P3|Overall Study|Withdrawal by Subject|3
2460857|NCT02498418|8485559|P2|Overall Study|Withdrawal by Subject|0
2460858|NCT02498418|8485560|P1|Overall Study|Withdrawal by Subject|2
2460859|NCT02498418|8485558|P3|Overall Study|Lack of Efficacy|1
2460860|NCT02498418|8485559|P2|Overall Study|Lack of Efficacy|0
2460861|NCT02498418|8485560|P1|Overall Study|Lack of Efficacy|0
2460862|NCT02498236|8485584|P8|Overall Study|Withdrawal by Subject|0
2460863|NCT02498236|8485585|P7|Overall Study|Withdrawal by Subject|0
2460864|NCT02498236|8485586|P6|Overall Study|Withdrawal by Subject|0
2460865|NCT02498236|8485587|P5|Overall Study|Withdrawal by Subject|1
2460866|NCT02498236|8485588|P4|Overall Study|Withdrawal by Subject|0
2460867|NCT02498236|8485589|P3|Overall Study|Withdrawal by Subject|0
2460868|NCT02498236|8485590|P2|Overall Study|Withdrawal by Subject|0
2460869|NCT02498236|8485591|P1|Overall Study|Withdrawal by Subject|0
2460870|NCT02498236|8485584|P8|Overall Study|Equipment failure|0
2460871|NCT02498236|8485585|P7|Overall Study|Equipment failure|1
2460872|NCT02498236|8485586|P6|Overall Study|Equipment failure|0
2460873|NCT02498236|8485587|P5|Overall Study|Equipment failure|0
2460874|NCT02498236|8485588|P4|Overall Study|Equipment failure|0
2460875|NCT02498236|8485589|P3|Overall Study|Equipment failure|0
2460876|NCT02498236|8485590|P2|Overall Study|Equipment failure|0
2460877|NCT02498236|8485591|P1|Overall Study|Equipment failure|0
2460878|NCT02498236|8485584|P8|Overall Study|Did not show for testing|1
2460879|NCT02498236|8485585|P7|Overall Study|Did not show for testing|0
2460880|NCT02498236|8485586|P6|Overall Study|Did not show for testing|0
2460881|NCT02498236|8485587|P5|Overall Study|Did not show for testing|0
2460882|NCT02498236|8485588|P4|Overall Study|Did not show for testing|0
2460883|NCT02498236|8485589|P3|Overall Study|Did not show for testing|0
2460884|NCT02498236|8485590|P2|Overall Study|Did not show for testing|0
2460885|NCT02498236|8485591|P1|Overall Study|Did not show for testing|1
2460886|NCT02497976|8485622|P2|Overall Study|Moved out of area|1
2460887|NCT02497976|8485623|P1|Overall Study|Moved out of area|0
2460888|NCT02497976|8485622|P2|Overall Study|Withdrawal by Subject|0
2460889|NCT02497976|8485623|P1|Overall Study|Withdrawal by Subject|2
2460890|NCT02497781|8485718|P2|Overall Study|Lost to Follow-up|1
2460891|NCT02497781|8485719|P1|Overall Study|Lost to Follow-up|1
2460892|NCT02497781|8485718|P2|Overall Study|Randomised but not treated|1
2460893|NCT02497781|8485719|P1|Overall Study|Randomised but not treated|1
2460894|NCT02497781|8485718|P2|Overall Study|Lack of Efficacy|1
2460895|NCT02497781|8485719|P1|Overall Study|Lack of Efficacy|0
2460896|NCT02497781|8485718|P2|Overall Study|Withdrawal by Subject|0
2460897|NCT02497781|8485719|P1|Overall Study|Withdrawal by Subject|2
2460898|NCT02497755|8485782|P2|Overall Study|Protocol Violation|0
2460899|NCT02497755|8485783|P1|Overall Study|Protocol Violation|1
2460900|NCT02497469|8485798|P2|Overall Study|Reason not Specified|6
2460901|NCT02497469|8485799|P1|Overall Study|Reason not Specified|6
2460902|NCT02497469|8485798|P2|Overall Study|Lack of Efficacy|40
2460903|NCT02497469|8485799|P1|Overall Study|Lack of Efficacy|86
2460904|NCT02497469|8485798|P2|Overall Study|Pregnancy|1
2460905|NCT02497469|8485799|P1|Overall Study|Pregnancy|1
2460906|NCT02497469|8485798|P2|Overall Study|Voluntary Withdrawal|41
2460907|NCT02497469|8485799|P1|Overall Study|Voluntary Withdrawal|39
2460908|NCT02497469|8485798|P2|Overall Study|Lost to Follow-up|4
2460909|NCT02497469|8485799|P1|Overall Study|Lost to Follow-up|14
2460910|NCT02497469|8485798|P2|Overall Study|Significant Protocol Deviation|5
2460911|NCT02497469|8485799|P1|Overall Study|Significant Protocol Deviation|4
2460912|NCT02497469|8485798|P2|Overall Study|Leukopenia or Lymphopenia|0
2460913|NCT02497469|8485799|P1|Overall Study|Leukopenia or Lymphopenia|1
2460914|NCT02497469|8485798|P2|Overall Study|Pretreatment Event/Adverse Event|16
2460915|NCT02497469|8485799|P1|Overall Study|Pretreatment Event/Adverse Event|18
2460916|NCT02497469|8485798|P2|Overall Study|Randomized but not Treated|2
2460917|NCT02497469|8485799|P1|Overall Study|Randomized but not Treated|0
2460918|NCT02497391|8485809|P6|Period 3 (14 Days)|Withdrawal by Subject|0
2460919|NCT02497391|8485810|P5|Period 3 (14 Days)|Withdrawal by Subject|0
2460920|NCT02497391|8485811|P4|Period 3 (14 Days)|Withdrawal by Subject|0
2460921|NCT02497391|8485812|P3|Period 3 (14 Days)|Withdrawal by Subject|1
2460922|NCT02497391|8485813|P2|Period 3 (14 Days)|Withdrawal by Subject|0
2460923|NCT02497391|8485814|P1|Period 3 (14 Days)|Withdrawal by Subject|0
2460924|NCT02497391|8485809|P6|Period 3 (14 Days)|Sponsor Decision|0
2460925|NCT02497391|8485810|P5|Period 3 (14 Days)|Sponsor Decision|1
2460926|NCT02497391|8485811|P4|Period 3 (14 Days)|Sponsor Decision|0
2460927|NCT02497391|8485812|P3|Period 3 (14 Days)|Sponsor Decision|0
2460928|NCT02497391|8485813|P2|Period 3 (14 Days)|Sponsor Decision|0
2460929|NCT02497391|8485814|P1|Period 3 (14 Days)|Sponsor Decision|0
2460930|NCT02497391|8485809|P6|Period 3 (14 Days)|Adverse Event|0
2460931|NCT02497391|8485810|P5|Period 3 (14 Days)|Adverse Event|0
2460932|NCT02497391|8485811|P4|Period 3 (14 Days)|Adverse Event|0
2460933|NCT02497391|8485812|P3|Period 3 (14 Days)|Adverse Event|0
2460934|NCT02497391|8485813|P2|Period 3 (14 Days)|Adverse Event|1
2460935|NCT02497391|8485814|P1|Period 3 (14 Days)|Adverse Event|0
2460936|NCT02497391|8485809|P6|Period 2 (14 Days)|Sponsor Decision|3
2460937|NCT02497391|8485810|P5|Period 2 (14 Days)|Sponsor Decision|2
2460938|NCT02497391|8485811|P4|Period 2 (14 Days)|Sponsor Decision|3
2460939|NCT02497391|8485812|P3|Period 2 (14 Days)|Sponsor Decision|2
2460940|NCT02497391|8485813|P2|Period 2 (14 Days)|Sponsor Decision|1
2460941|NCT02497391|8485814|P1|Period 2 (14 Days)|Sponsor Decision|3
2460942|NCT02497391|8485809|P6|Period 2 (14 Days)|Withdrawal by Subject|0
2460943|NCT02497391|8485810|P5|Period 2 (14 Days)|Withdrawal by Subject|0
2460944|NCT02497391|8485811|P4|Period 2 (14 Days)|Withdrawal by Subject|0
2460945|NCT02497391|8485812|P3|Period 2 (14 Days)|Withdrawal by Subject|1
2460946|NCT02497391|8485813|P2|Period 2 (14 Days)|Withdrawal by Subject|0
2460947|NCT02497391|8485814|P1|Period 2 (14 Days)|Withdrawal by Subject|1
2460948|NCT02497287|8485825|P1|Follow-up Phase (4 Week)|Other|1
2460949|NCT02497287|8485825|P1|Follow-up Phase (4 Week)|Adverse Event|3
2460950|NCT02497287|8485825|P1|Follow-up Phase (4 Week)|Lost to Follow-up|5
2460951|NCT02497287|8485825|P1|Follow-up Phase (4 Week)|Withdrawal by Subject|10
2460952|NCT02497287|8485825|P1|Follow-up Phase (4 Week)|PI Decision|12
2460953|NCT02497287|8485825|P1|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1
2460954|NCT02497287|8485825|P1|Optimization/Maintenance (48 Weeks)|Death|2
2460955|NCT02497287|8485825|P1|Optimization/Maintenance (48 Weeks)|Pregnancy|2
2460956|NCT02497287|8485825|P1|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3
2460957|NCT02497287|8485825|P1|Optimization/Maintenance (48 Weeks)|Protocol Violation|3
2460958|NCT02497287|8485825|P1|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10
2460959|NCT02497287|8485825|P1|Optimization/Maintenance (48 Weeks)|Other|21
2460960|NCT02497287|8485825|P1|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25
2460961|NCT02497287|8485825|P1|Optimization/Maintenance (48 Weeks)|Adverse Event|25
2460962|NCT02497287|8485825|P1|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30
2460963|NCT02497287|8485825|P1|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331
2460964|NCT02497287|8485825|P1|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1
2460965|NCT02497287|8485825|P1|Induction Phase (4 Weeks)|Protocol Violation|1
2460966|NCT02497287|8485825|P1|Induction Phase (4 Weeks)|Lost to Follow-up|5
2460967|NCT02497287|8485825|P1|Induction Phase (4 Weeks)|Other|13
2460968|NCT02497287|8485825|P1|Induction Phase (4 Weeks)|Lack of Efficacy|21
2460969|NCT02497287|8485825|P1|Induction Phase (4 Weeks)|Withdrawal by Subject|22
2460970|NCT02497287|8485825|P1|Induction Phase (4 Weeks)|Adverse Event|52
2460971|NCT02497287|8485825|P1|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84
2460972|NCT02496702|8485918|P2|Overall Study|Only partially tested|2
2460973|NCT02496702|8485919|P1|Overall Study|Only partially tested|0
2460974|NCT02496702|8485918|P2|Overall Study|Lost to Follow-up|6
2460975|NCT02496702|8485919|P1|Overall Study|Lost to Follow-up|8
2460976|NCT02496533|8485941|P2|Overall Study|Late for radiologic testing|2
2460977|NCT02496533|8485942|P1|Overall Study|Late for radiologic testing|0
2460978|NCT02496533|8485941|P2|Overall Study|Patient did not complete all measures|4
2460979|NCT02496533|8485942|P1|Overall Study|Patient did not complete all measures|0
2460980|NCT02496533|8485941|P2|Overall Study|Lack of data on outcome|0
2460981|NCT02496533|8485942|P1|Overall Study|Lack of data on outcome|3
2460982|NCT02496221|8485954|P2|Treatment Period 2 - 4 Days|Physician Decision|0
2460983|NCT02496221|8485955|P1|Treatment Period 2 - 4 Days|Physician Decision|1
2460984|NCT02496221|8485954|P2|Treatment Period 2 - 4 Days|Protocol Violation|0
2460985|NCT02496221|8485955|P1|Treatment Period 2 - 4 Days|Protocol Violation|1
2460986|NCT02496221|8485954|P2|Treatment Period 2 - 4 Days|Adverse Event|1
2460987|NCT02496221|8485955|P1|Treatment Period 2 - 4 Days|Adverse Event|0
2460988|NCT02496091|8485989|P1|Overall Study|Eligibility criteria not fulfilled|2
2460989|NCT02496039|8485998|P1|Overall Study|Protocol Violation|1
2460990|NCT02496039|8485998|P1|Overall Study|Adverse Event|3
2460991|NCT02496000|8486013|P3|Overall Study|undetermined|0
2460992|NCT02496000|8486014|P2|Overall Study|undetermined|1
2460993|NCT02496000|8486015|P1|Overall Study|undetermined|0
2460994|NCT02496000|8486013|P3|Overall Study|Non-compliance or lack of cooperation|0
2460995|NCT02496000|8486014|P2|Overall Study|Non-compliance or lack of cooperation|2
2460996|NCT02496000|8486015|P1|Overall Study|Non-compliance or lack of cooperation|0
2460997|NCT02496000|8486013|P3|Overall Study|Protocol Violation|1
2460998|NCT02496000|8486014|P2|Overall Study|Protocol Violation|0
2460999|NCT02496000|8486015|P1|Overall Study|Protocol Violation|0
2461000|NCT02496000|8486013|P3|Overall Study|Lost to Follow-up|1
2461001|NCT02496000|8486014|P2|Overall Study|Lost to Follow-up|0
2461002|NCT02496000|8486015|P1|Overall Study|Lost to Follow-up|1
2461003|NCT02496000|8486013|P3|Overall Study|Withdrawal by Subject|0
2461004|NCT02496000|8486014|P2|Overall Study|Withdrawal by Subject|2
2461005|NCT02496000|8486015|P1|Overall Study|Withdrawal by Subject|1
2461006|NCT02495948|8486036|P2|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
2461007|NCT02495948|8486037|P1|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
2461008|NCT02495948|8486036|P2|Period 1, First 30 Days of Wear|Adverse Event|1
2461009|NCT02495948|8486037|P1|Period 1, First 30 Days of Wear|Adverse Event|0
2461010|NCT02495844|8486046|P2|Overall Study|Hepatitis Positivity|1
2461011|NCT02495844|8486047|P1|Overall Study|Hepatitis Positivity|0
2461012|NCT02495844|8486046|P2|Overall Study|AE, non-fatal|1
2461013|NCT02495844|8486047|P1|Overall Study|AE, non-fatal|0
2461014|NCT02495844|8486046|P2|Overall Study|Lack of Efficacy|2
2461015|NCT02495844|8486047|P1|Overall Study|Lack of Efficacy|1
2461016|NCT02495233|8486170|P2|Overall Study|Miscellaneous|1
2461017|NCT02495233|8486171|P1|Overall Study|Miscellaneous|0
2461018|NCT02495168|8486200|P3|Overall Study|Lack of Efficacy|3
2461019|NCT02495168|8486201|P2|Overall Study|Lack of Efficacy|0
2461020|NCT02495168|8486202|P1|Overall Study|Lack of Efficacy|0
2461021|NCT02495168|8486200|P3|Overall Study|Adverse Event|3
2461022|NCT02495168|8486201|P2|Overall Study|Adverse Event|8
2461023|NCT02495168|8486202|P1|Overall Study|Adverse Event|4
2461024|NCT02495168|8486200|P3|Overall Study|Protocol Violation|1
2461025|NCT02495168|8486201|P2|Overall Study|Protocol Violation|10
2461026|NCT02495168|8486202|P1|Overall Study|Protocol Violation|0
2461027|NCT02495168|8486200|P3|Overall Study|Withdrawal by Subject|2
2461028|NCT02495168|8486201|P2|Overall Study|Withdrawal by Subject|4
2461029|NCT02495168|8486202|P1|Overall Study|Withdrawal by Subject|1
2461030|NCT02495168|8486200|P3|Overall Study|Lost to Follow-up|1
2461031|NCT02495168|8486201|P2|Overall Study|Lost to Follow-up|6
2461032|NCT02495168|8486202|P1|Overall Study|Lost to Follow-up|10
2461033|NCT02495168|8486200|P3|Overall Study|Physician Decision|0
2461034|NCT02495168|8486201|P2|Overall Study|Physician Decision|1
2461035|NCT02495168|8486202|P1|Overall Study|Physician Decision|1
2461036|NCT02495168|8486200|P3|Overall Study|Did not Complete Final Visit On Time|2
2461037|NCT02495168|8486201|P2|Overall Study|Did not Complete Final Visit On Time|3
2461038|NCT02495168|8486202|P1|Overall Study|Did not Complete Final Visit On Time|4
2461039|NCT02495168|8486200|P3|Overall Study|Other than Specified|5
2461040|NCT02495168|8486201|P2|Overall Study|Other than Specified|22
2461041|NCT02495168|8486202|P1|Overall Study|Other than Specified|18
2461042|NCT02495025|8486261|P2|Overall Study|Withdrawal by Subject|0
2461043|NCT02495025|8486262|P1|Overall Study|Withdrawal by Subject|5
2461044|NCT02495025|8486261|P2|Overall Study|Lost to Follow-up|14
2461045|NCT02495025|8486262|P1|Overall Study|Lost to Follow-up|21
2461046|NCT02494596|8486314|P3|Overall Study|Refused Treatment|0
2461047|NCT02494596|8486315|P2|Overall Study|Refused Treatment|1
2461048|NCT02494596|8486316|P1|Overall Study|Refused Treatment|0
2461049|NCT02494596|8486314|P3|Overall Study|Adverse Event|0
2461050|NCT02494596|8486315|P2|Overall Study|Adverse Event|1
2461051|NCT02494596|8486316|P1|Overall Study|Adverse Event|0
2461052|NCT02494596|8486314|P3|Overall Study|Insufficient Therapeutic Response|1
2461053|NCT02494596|8486315|P2|Overall Study|Insufficient Therapeutic Response|3
2461054|NCT02494596|8486316|P1|Overall Study|Insufficient Therapeutic Response|3
2461055|NCT02494583|8486344|P3|Overall Study|Ongoing in Study|34
2461056|NCT02494583|8486345|P2|Overall Study|Ongoing in Study|51
2461057|NCT02494583|8486346|P1|Overall Study|Ongoing in Study|56
2461058|NCT02494583|8486344|P3|Overall Study|Withdrawal by Subject|15
2461059|NCT02494583|8486345|P2|Overall Study|Withdrawal by Subject|15
2461060|NCT02494583|8486346|P1|Overall Study|Withdrawal by Subject|3
2461061|NCT02494583|8486344|P3|Overall Study|Protocol Violation|0
2461062|NCT02494583|8486345|P2|Overall Study|Protocol Violation|2
2461063|NCT02494583|8486346|P1|Overall Study|Protocol Violation|1
2461064|NCT02494583|8486344|P3|Overall Study|Lost to Follow-up|0
2461065|NCT02494583|8486345|P2|Overall Study|Lost to Follow-up|0
2461066|NCT02494583|8486346|P1|Overall Study|Lost to Follow-up|1
2461067|NCT02494583|8486344|P3|Overall Study|Death|201
2461068|NCT02494583|8486345|P2|Overall Study|Death|189
2461069|NCT02494583|8486346|P1|Overall Study|Death|195
2461070|NCT02494401|8486444|P2|Overall Study|Withdrawal by Subject|2
2461071|NCT02494401|8486445|P1|Overall Study|Withdrawal by Subject|3
2461072|NCT02494401|8486444|P2|Overall Study|Lost to Follow-up|25
2461073|NCT02494401|8486445|P1|Overall Study|Lost to Follow-up|22
2461074|NCT02494206|8486497|P1|Overall Study|Disease Progression|1
2461075|NCT02494206|8486497|P1|Overall Study|Adverse Event|1
2461076|NCT02493946|8486551|P3|Open Label Period|Site error|1
2461077|NCT02493946|8486552|P2|Open Label Period|Site error|0
2461078|NCT02493946|8486553|P1|Open Label Period|Site error|0
2461079|NCT02493946|8486551|P3|Open Label Period|Pregnancy|3
2461080|NCT02493946|8486552|P2|Open Label Period|Pregnancy|0
2461081|NCT02493946|8486553|P1|Open Label Period|Pregnancy|0
2461082|NCT02493946|8486551|P3|Open Label Period|Investigator decision, non-availability|1
2461083|NCT02493946|8486552|P2|Open Label Period|Investigator decision, non-availability|0
2461084|NCT02493946|8486553|P1|Open Label Period|Investigator decision, non-availability|0
2461085|NCT02493946|8486551|P3|Open Label Period|Investigator decision, non-compliance|2
2461086|NCT02493946|8486552|P2|Open Label Period|Investigator decision, non-compliance|0
2461087|NCT02493946|8486553|P1|Open Label Period|Investigator decision, non-compliance|0
2461088|NCT02493946|8486551|P3|Open Label Period|Lost to Follow-up|1
2461089|NCT02493946|8486552|P2|Open Label Period|Lost to Follow-up|0
2461090|NCT02493946|8486553|P1|Open Label Period|Lost to Follow-up|0
2461091|NCT02493946|8486551|P3|Open Label Period|Adverse Event|4
2461092|NCT02493946|8486552|P2|Open Label Period|Adverse Event|0
2461093|NCT02493946|8486553|P1|Open Label Period|Adverse Event|0
2461094|NCT02493946|8486551|P3|Open Label Period|Withdrawal by Subject|74
2461095|NCT02493946|8486552|P2|Open Label Period|Withdrawal by Subject|0
2461096|NCT02493946|8486553|P1|Open Label Period|Withdrawal by Subject|0
2461097|NCT02493946|8486551|P3|DB Period|Withdrawal by Subject|0
2461098|NCT02493946|8486552|P2|DB Period|Withdrawal by Subject|5
2461099|NCT02493946|8486553|P1|DB Period|Withdrawal by Subject|8
2461100|NCT02493868|8486586|P2|Follow-up Phase|Other|1
2461101|NCT02493868|8486587|P1|Follow-up Phase|Other|2
2461102|NCT02493868|8486586|P2|Follow-up Phase|Investigator Decision|1
2461103|NCT02493868|8486587|P1|Follow-up Phase|Investigator Decision|5
2461104|NCT02493868|8486586|P2|Follow-up Phase|Withdrawal by Subject|0
2461105|NCT02493868|8486587|P1|Follow-up Phase|Withdrawal by Subject|3
2461106|NCT02493868|8486586|P2|Follow-up Phase|Lost to Follow-up|0
2461107|NCT02493868|8486587|P1|Follow-up Phase|Lost to Follow-up|1
2461108|NCT02493868|8486586|P2|Maintenance Phase: DE+TE Participants|Other|9
2461109|NCT02493868|8486587|P1|Maintenance Phase: DE+TE Participants|Other|4
2461110|NCT02493868|8486586|P2|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1
2461111|NCT02493868|8486587|P1|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0
2461112|NCT02493868|8486586|P2|Maintenance Phase: DE+TE Participants|Pregnancy|0
2461113|NCT02493868|8486587|P1|Maintenance Phase: DE+TE Participants|Pregnancy|1
2461114|NCT02493868|8486586|P2|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7
2461115|NCT02493868|8486587|P1|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5
2461116|NCT02493868|8486586|P2|Maintenance Phase: DE+TE Participants|Protocol Violation|1
2461117|NCT02493868|8486587|P1|Maintenance Phase: DE+TE Participants|Protocol Violation|1
2461118|NCT02493868|8486586|P2|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0
2461119|NCT02493868|8486587|P1|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1
2461120|NCT02493868|8486586|P2|Maintenance Phase: DE+TE Participants|Adverse Event|4
2461121|NCT02493868|8486587|P1|Maintenance Phase: DE+TE Participants|Adverse Event|1
2461122|NCT02493868|8486586|P2|Optimization Phase: DE+TE Participants|Other|2
2461123|NCT02493868|8486587|P1|Optimization Phase: DE+TE Participants|Other|10
2461124|NCT02493868|8486586|P2|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20
2461125|NCT02493868|8486587|P1|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107
2461126|NCT02493868|8486586|P2|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5
2461127|NCT02493868|8486587|P1|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14
2461128|NCT02493868|8486586|P2|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3
2461129|NCT02493868|8486587|P1|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8
2461130|NCT02493868|8486586|P2|Optimization Phase: DE+TE Participants|Protocol Violation|1
2461131|NCT02493868|8486587|P1|Optimization Phase: DE+TE Participants|Protocol Violation|4
2461132|NCT02493868|8486586|P2|Optimization Phase: DE+TE Participants|Lack of Efficacy|0
2461133|NCT02493868|8486587|P1|Optimization Phase: DE+TE Participants|Lack of Efficacy|8
2461134|NCT02493868|8486586|P2|Optimization Phase: DE+TE Participants|Lost to Follow-up|1
2461135|NCT02493868|8486587|P1|Optimization Phase: DE+TE Participants|Lost to Follow-up|2
2461136|NCT02493868|8486586|P2|Optimization Phase: DE+TE Participants|Adverse Event|0
2461137|NCT02493868|8486587|P1|Optimization Phase: DE+TE Participants|Adverse Event|5
2461138|NCT02493868|8486586|P2|Induction Phase: DE Participants|Other|0
2461139|NCT02493868|8486587|P1|Induction Phase: DE Participants|Other|8
2461140|NCT02493868|8486586|P2|Induction Phase: DE Participants|Not meet criteria to continue next phase|0
2461141|NCT02493868|8486587|P1|Induction Phase: DE Participants|Not meet criteria to continue next phase|114
2461142|NCT02493868|8486586|P2|Induction Phase: DE Participants|Withdrawal by Subject|0
2461143|NCT02493868|8486587|P1|Induction Phase: DE Participants|Withdrawal by Subject|15
2461144|NCT02493868|8486586|P2|Induction Phase: DE Participants|Protocol Violation|0
2461145|NCT02493868|8486587|P1|Induction Phase: DE Participants|Protocol Violation|2
2461146|NCT02493868|8486586|P2|Induction Phase: DE Participants|Lack of Efficacy|0
2461147|NCT02493868|8486587|P1|Induction Phase: DE Participants|Lack of Efficacy|2
2461148|NCT02493868|8486586|P2|Induction Phase: DE Participants|Lost to Follow-up|0
2461149|NCT02493868|8486587|P1|Induction Phase: DE Participants|Lost to Follow-up|1
2461150|NCT02493868|8486586|P2|Induction Phase: DE Participants|Adverse Event|0
2461151|NCT02493868|8486587|P1|Induction Phase: DE Participants|Adverse Event|22
2461152|NCT02493855|8486636|P3|Overall Study|Withdrawal by Subject|0
2461153|NCT02493855|8486637|P2|Overall Study|Withdrawal by Subject|0
2461154|NCT02493855|8486638|P1|Overall Study|Withdrawal by Subject|1
2461155|NCT02493855|8486636|P3|Overall Study|Adverse Event|0
2461156|NCT02493855|8486637|P2|Overall Study|Adverse Event|1
2461157|NCT02493855|8486638|P1|Overall Study|Adverse Event|0
2461158|NCT02493855|8486636|P3|Overall Study|Non-compliance|0
2461159|NCT02493855|8486637|P2|Overall Study|Non-compliance|0
2461160|NCT02493855|8486638|P1|Overall Study|Non-compliance|1
2461161|NCT02493777|8486648|P2|Overall Study|Lost to Follow-up|1
2461162|NCT02493777|8486649|P1|Overall Study|Lost to Follow-up|0
2461163|NCT02493764|8486659|P2|Overall Study|Withdrawal by Subject|7
2461164|NCT02493764|8486660|P1|Overall Study|Withdrawal by Subject|11
2461165|NCT02493764|8486659|P2|Overall Study|Withdrawal parent/guardian|1
2461166|NCT02493764|8486660|P1|Overall Study|Withdrawal parent/guardian|0
2461167|NCT02493764|8486659|P2|Overall Study|Participant moved|5
2461168|NCT02493764|8486660|P1|Overall Study|Participant moved|17
2461169|NCT02493764|8486659|P2|Overall Study|Physician Decision|1
2461170|NCT02493764|8486660|P1|Overall Study|Physician Decision|1
2461171|NCT02493764|8486659|P2|Overall Study|Protocol Violation|7
2461172|NCT02493764|8486660|P1|Overall Study|Protocol Violation|6
2461173|NCT02493764|8486659|P2|Overall Study|Lost to Follow-up|1
2461174|NCT02493764|8486660|P1|Overall Study|Lost to Follow-up|2
2461175|NCT02493764|8486659|P2|Overall Study|Death|58
2461176|NCT02493764|8486660|P1|Overall Study|Death|44
2461177|NCT02493764|8486659|P2|Overall Study|Adverse Event|2
2461178|NCT02493764|8486660|P1|Overall Study|Adverse Event|2
2461179|NCT02493751|8486710|P2|Overall Study|Ongoing|23
2461180|NCT02493751|8486711|P1|Overall Study|Ongoing|11
2461181|NCT02493751|8486710|P2|Overall Study|Withdrawal by Subject|5
2461182|NCT02493751|8486711|P1|Overall Study|Withdrawal by Subject|2
2461183|NCT02493751|8486710|P2|Overall Study|Lost to Follow-up|1
2461184|NCT02493751|8486711|P1|Overall Study|Lost to Follow-up|0
2461185|NCT02493517|8486742|P2|Overall Study|Missed study visit|1
2461186|NCT02493517|8486743|P1|Overall Study|Missed study visit|0
2461187|NCT02493517|8486742|P2|Overall Study|Adverse Event|2
2461188|NCT02493517|8486743|P1|Overall Study|Adverse Event|0
2461189|NCT02493517|8486742|P2|Overall Study|Withdrawal by Subject|2
2461190|NCT02493517|8486743|P1|Overall Study|Withdrawal by Subject|1
2461191|NCT02493517|8486742|P2|Overall Study|Protocol Violation|2
2461192|NCT02493517|8486743|P1|Overall Study|Protocol Violation|1
2461193|NCT02493127|8486808|P2|Overall Study|Lost to Follow-up|1
2461194|NCT02493127|8486809|P1|Overall Study|Lost to Follow-up|1
2461195|NCT02493062|8486827|P1|Overall Study|Physician Decision|12
2461196|NCT02492984|8486850|P2|Overall Study|Withdrawal by Subject|0
2461197|NCT02492984|8486851|P1|Overall Study|Withdrawal by Subject|1
2461198|NCT02492984|8486850|P2|Overall Study|Protocol Violation|0
2461199|NCT02492984|8486851|P1|Overall Study|Protocol Violation|1
2461200|NCT02492984|8486850|P2|Overall Study|Adverse Event|0
2461201|NCT02492984|8486851|P1|Overall Study|Adverse Event|1
2461202|NCT02492958|8486875|P4|Overall Study|Adverse Event|0
2461203|NCT02492958|8486876|P3|Overall Study|Adverse Event|1
2461204|NCT02492958|8486877|P2|Overall Study|Adverse Event|0
2461205|NCT02492958|8486878|P1|Overall Study|Adverse Event|1
2461206|NCT02492958|8486875|P4|Overall Study|Withdrawal by Subject|0
2461207|NCT02492958|8486876|P3|Overall Study|Withdrawal by Subject|1
2461208|NCT02492958|8486877|P2|Overall Study|Withdrawal by Subject|0
2461209|NCT02492958|8486878|P1|Overall Study|Withdrawal by Subject|0
2461210|NCT02492880|8486964|P1|Overall Study|Protocol Violation|1
2461211|NCT02492880|8486964|P1|Overall Study|Lost to Follow-up|1
2461212|NCT02492841|8486971|P3|Overall Study|Lost to Follow-up|35
2461213|NCT02492841|8486972|P2|Overall Study|Lost to Follow-up|31
2461214|NCT02492841|8486973|P1|Overall Study|Lost to Follow-up|34
2461215|NCT02492763|8486992|P4|Overall Study|Study Terminated by Sponsor|10
2461216|NCT02492763|8486993|P3|Overall Study|Study Terminated by Sponsor|6
2461217|NCT02492763|8486994|P2|Overall Study|Study Terminated by Sponsor|10
2461218|NCT02492763|8486995|P1|Overall Study|Study Terminated by Sponsor|13
2461219|NCT02492763|8486992|P4|Overall Study|Screen Failure|1
2461220|NCT02492763|8486993|P3|Overall Study|Screen Failure|0
2461221|NCT02492763|8486994|P2|Overall Study|Screen Failure|0
2461222|NCT02492763|8486995|P1|Overall Study|Screen Failure|0
2461223|NCT02492763|8486992|P4|Overall Study|Non-Compliance With Study Drug|0
2461224|NCT02492763|8486993|P3|Overall Study|Non-Compliance With Study Drug|0
2461225|NCT02492763|8486994|P2|Overall Study|Non-Compliance With Study Drug|1
2461226|NCT02492763|8486995|P1|Overall Study|Non-Compliance With Study Drug|0
2461227|NCT02492763|8486992|P4|Overall Study|Lost to Follow-up|0
2461228|NCT02492763|8486993|P3|Overall Study|Lost to Follow-up|1
2461229|NCT02492763|8486994|P2|Overall Study|Lost to Follow-up|0
2461230|NCT02492763|8486995|P1|Overall Study|Lost to Follow-up|0
2461231|NCT02492763|8486992|P4|Overall Study|Hyperglycemia Discontinuation Criteria|0
2461232|NCT02492763|8486993|P3|Overall Study|Hyperglycemia Discontinuation Criteria|0
2461233|NCT02492763|8486994|P2|Overall Study|Hyperglycemia Discontinuation Criteria|1
2461234|NCT02492763|8486995|P1|Overall Study|Hyperglycemia Discontinuation Criteria|0
2461235|NCT02492763|8486992|P4|Overall Study|Death|0
2461236|NCT02492763|8486993|P3|Overall Study|Death|1
2461237|NCT02492763|8486994|P2|Overall Study|Death|0
2461238|NCT02492763|8486995|P1|Overall Study|Death|0
2461239|NCT02492763|8486992|P4|Overall Study|Adverse Event|2
2461240|NCT02492763|8486993|P3|Overall Study|Adverse Event|1
2461241|NCT02492763|8486994|P2|Overall Study|Adverse Event|1
2461242|NCT02492763|8486995|P1|Overall Study|Adverse Event|3
2461243|NCT02492763|8486992|P4|Overall Study|Withdrawal by Subject|0
2461244|NCT02492763|8486993|P3|Overall Study|Withdrawal by Subject|1
2461245|NCT02492763|8486994|P2|Overall Study|Withdrawal by Subject|2
2461246|NCT02492763|8486995|P1|Overall Study|Withdrawal by Subject|0
2461247|NCT02492165|8487100|P4|Overall Study|Withdrawal by Subject|0
2461248|NCT02492165|8487101|P3|Overall Study|Withdrawal by Subject|0
2461249|NCT02492165|8487102|P2|Overall Study|Withdrawal by Subject|1
2461250|NCT02492165|8487103|P1|Overall Study|Withdrawal by Subject|0
2461251|NCT02492100|8487125|P1|Overall Study|Death|1
2461252|NCT02491892|8487154|P2|Overall Study|Lost to Follow-up|0
2461253|NCT02491892|8487155|P1|Overall Study|Lost to Follow-up|1
2461254|NCT02491892|8487154|P2|Overall Study|Refused Treatment|0
2461255|NCT02491892|8487155|P1|Overall Study|Refused Treatment|1
2461256|NCT02491892|8487154|P2|Overall Study|Lack of Efficacy|36
2461257|NCT02491892|8487155|P1|Overall Study|Lack of Efficacy|37
2461258|NCT02491892|8487154|P2|Overall Study|Death|1
2461259|NCT02491892|8487155|P1|Overall Study|Death|1
2461260|NCT02491892|8487154|P2|Overall Study|Adverse Event|1
2461261|NCT02491892|8487155|P1|Overall Study|Adverse Event|1
2461262|NCT02491684|8487201|P2|Treatment Phase|Investigator and Sponsor decision|1
2461263|NCT02491684|8487202|P1|Treatment Phase|Investigator and Sponsor decision|0
2461264|NCT02491684|8487201|P2|Treatment Phase|Incorrect randomisation|0
2461265|NCT02491684|8487202|P1|Treatment Phase|Incorrect randomisation|1
2461266|NCT02491684|8487201|P2|Treatment Phase|Adverse Event|2
2461267|NCT02491684|8487202|P1|Treatment Phase|Adverse Event|2
2461268|NCT02491463|8487240|P4|Overall Study|Lost to Follow-up|0
2461269|NCT02491463|8487241|P3|Overall Study|Lost to Follow-up|3
2461270|NCT02491463|8487242|P2|Overall Study|Lost to Follow-up|3
2461271|NCT02491463|8487243|P1|Overall Study|Lost to Follow-up|0
2461272|NCT02491463|8487240|P4|Overall Study|Migrated/moved from study area|1
2461273|NCT02491463|8487241|P3|Overall Study|Migrated/moved from study area|1
2461274|NCT02491463|8487242|P2|Overall Study|Migrated/moved from study area|5
2461275|NCT02491463|8487243|P1|Overall Study|Migrated/moved from study area|1
2461276|NCT02491463|8487240|P4|Overall Study|Withdrawal by Subject|0
2461277|NCT02491463|8487241|P3|Overall Study|Withdrawal by Subject|0
2461278|NCT02491463|8487242|P2|Overall Study|Withdrawal by Subject|2
2461279|NCT02491463|8487243|P1|Overall Study|Withdrawal by Subject|1
2461280|NCT02491411|8487346|P1|Overall Study|Physician Decision|4
2461281|NCT02491073|8487377|P2|Overall Study|screen failure|0
2461282|NCT02491073|8487378|P1|Overall Study|screen failure|1
2461283|NCT02490475|8487430|P4|Period 2: Extension Phase|Adverse Event|0
2461284|NCT02490475|8487431|P3|Period 2: Extension Phase|Adverse Event|1
2461285|NCT02490475|8487432|P2|Period 2: Extension Phase|Adverse Event|0
2461286|NCT02490475|8487433|P1|Period 2: Extension Phase|Adverse Event|0
2461287|NCT02490475|8487430|P4|Period 2: Extension Phase|Refused Treatment|1
2461288|NCT02490475|8487431|P3|Period 2: Extension Phase|Refused Treatment|0
2461289|NCT02490475|8487432|P2|Period 2: Extension Phase|Refused Treatment|0
2461290|NCT02490475|8487433|P1|Period 2: Extension Phase|Refused Treatment|0
2461291|NCT02490475|8487430|P4|Period 2: Extension Phase|Insufficient Therapeutic Response|0
2461292|NCT02490475|8487431|P3|Period 2: Extension Phase|Insufficient Therapeutic Response|2
2461293|NCT02490475|8487432|P2|Period 2: Extension Phase|Insufficient Therapeutic Response|0
2461294|NCT02490475|8487433|P1|Period 2: Extension Phase|Insufficient Therapeutic Response|1
2461295|NCT02490475|8487430|P4|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2
2461296|NCT02490475|8487431|P3|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4
2461297|NCT02490475|8487432|P2|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
2461298|NCT02490475|8487433|P1|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
2461299|NCT02490475|8487430|P4|Period 1: First 6 Cycles|Refused Treatment|0
2461300|NCT02490475|8487431|P3|Period 1: First 6 Cycles|Refused Treatment|0
2461301|NCT02490475|8487432|P2|Period 1: First 6 Cycles|Refused Treatment|0
2461302|NCT02490475|8487433|P1|Period 1: First 6 Cycles|Refused Treatment|1
2461303|NCT02490475|8487430|P4|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
2461304|NCT02490475|8487431|P3|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
2461305|NCT02490475|8487432|P2|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0
2461306|NCT02490475|8487433|P1|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
2461307|NCT02490475|8487430|P4|Period 1: First 6 Cycles|Adverse Event|1
2461308|NCT02490475|8487431|P3|Period 1: First 6 Cycles|Adverse Event|0
2461309|NCT02490475|8487432|P2|Period 1: First 6 Cycles|Adverse Event|1
2461310|NCT02490475|8487433|P1|Period 1: First 6 Cycles|Adverse Event|2
2461311|NCT02490371|8487511|P2|Overall Study|Lost to Follow-up|1
2461312|NCT02490371|8487512|P1|Overall Study|Lost to Follow-up|1
2461313|NCT02489981|8487539|P1|Overall Study|Other than listed|28
2461314|NCT02489981|8487539|P1|Overall Study|Lost to Follow-up|31
2461315|NCT02489981|8487539|P1|Overall Study|Improved|31
2461316|NCT02489981|8487539|P1|Overall Study|Insufficient effectiveness|16
2461317|NCT02489981|8487539|P1|Overall Study|Adverse Event|21
2461318|NCT02489968|8487546|P6|Double-blind Treatment Period|Other than specified above|0
2461319|NCT02489968|8487547|P5|Double-blind Treatment Period|Other than specified above|1
2461320|NCT02489968|8487548|P4|Double-blind Treatment Period|Other than specified above|0
2461321|NCT02489968|8487549|P3|Double-blind Treatment Period|Other than specified above|0
2461322|NCT02489968|8487550|P2|Double-blind Treatment Period|Other than specified above|0
2461323|NCT02489968|8487551|P1|Double-blind Treatment Period|Other than specified above|0
2461324|NCT02489968|8487546|P6|Double-blind Treatment Period|Withdrawal by Subject|2
2461325|NCT02489968|8487547|P5|Double-blind Treatment Period|Withdrawal by Subject|0
2461326|NCT02489968|8487548|P4|Double-blind Treatment Period|Withdrawal by Subject|2
2461327|NCT02489968|8487549|P3|Double-blind Treatment Period|Withdrawal by Subject|0
2461328|NCT02489968|8487550|P2|Double-blind Treatment Period|Withdrawal by Subject|0
2461329|NCT02489968|8487551|P1|Double-blind Treatment Period|Withdrawal by Subject|0
2461330|NCT02489968|8487546|P6|Double-blind Treatment Period|Protocol Violation|1
2461331|NCT02489968|8487547|P5|Double-blind Treatment Period|Protocol Violation|1
2461332|NCT02489968|8487548|P4|Double-blind Treatment Period|Protocol Violation|0
2461333|NCT02489968|8487549|P3|Double-blind Treatment Period|Protocol Violation|0
2461334|NCT02489968|8487550|P2|Double-blind Treatment Period|Protocol Violation|0
2461335|NCT02489968|8487551|P1|Double-blind Treatment Period|Protocol Violation|0
2461336|NCT02489968|8487546|P6|Double-blind Treatment Period|Adverse Event|5
2461337|NCT02489968|8487547|P5|Double-blind Treatment Period|Adverse Event|4
2461338|NCT02489968|8487548|P4|Double-blind Treatment Period|Adverse Event|6
2461339|NCT02489968|8487549|P3|Double-blind Treatment Period|Adverse Event|2
2461340|NCT02489968|8487550|P2|Double-blind Treatment Period|Adverse Event|0
2461341|NCT02489968|8487551|P1|Double-blind Treatment Period|Adverse Event|0
2461342|NCT02489968|8487546|P6|Open-label Treatment Period|Other than specified above|0
2461343|NCT02489968|8487547|P5|Open-label Treatment Period|Other than specified above|0
2461344|NCT02489968|8487548|P4|Open-label Treatment Period|Other than specified above|0
2461345|NCT02489968|8487549|P3|Open-label Treatment Period|Other than specified above|0
2461346|NCT02489968|8487550|P2|Open-label Treatment Period|Other than specified above|189
2461347|NCT02489968|8487551|P1|Open-label Treatment Period|Other than specified above|204
2461348|NCT02489968|8487546|P6|Open-label Treatment Period|Withdrawal by Subject|0
2461349|NCT02489968|8487547|P5|Open-label Treatment Period|Withdrawal by Subject|0
2461350|NCT02489968|8487548|P4|Open-label Treatment Period|Withdrawal by Subject|0
2461351|NCT02489968|8487549|P3|Open-label Treatment Period|Withdrawal by Subject|0
2461352|NCT02489968|8487550|P2|Open-label Treatment Period|Withdrawal by Subject|7
2461353|NCT02489968|8487551|P1|Open-label Treatment Period|Withdrawal by Subject|4
2461354|NCT02489968|8487546|P6|Open-label Treatment Period|Lost to Follow-up|0
2461355|NCT02489968|8487547|P5|Open-label Treatment Period|Lost to Follow-up|0
2461356|NCT02489968|8487548|P4|Open-label Treatment Period|Lost to Follow-up|0
2461357|NCT02489968|8487549|P3|Open-label Treatment Period|Lost to Follow-up|0
2461358|NCT02489968|8487550|P2|Open-label Treatment Period|Lost to Follow-up|3
2461359|NCT02489968|8487551|P1|Open-label Treatment Period|Lost to Follow-up|0
2461360|NCT02489968|8487546|P6|Open-label Treatment Period|Protocol Violation|0
2461361|NCT02489968|8487547|P5|Open-label Treatment Period|Protocol Violation|0
2461362|NCT02489968|8487548|P4|Open-label Treatment Period|Protocol Violation|0
2461363|NCT02489968|8487549|P3|Open-label Treatment Period|Protocol Violation|0
2461364|NCT02489968|8487550|P2|Open-label Treatment Period|Protocol Violation|2
2461365|NCT02489968|8487551|P1|Open-label Treatment Period|Protocol Violation|2
2461366|NCT02489968|8487546|P6|Open-label Treatment Period|Adverse Event|0
2461367|NCT02489968|8487547|P5|Open-label Treatment Period|Adverse Event|0
2461368|NCT02489968|8487548|P4|Open-label Treatment Period|Adverse Event|0
2461369|NCT02489968|8487549|P3|Open-label Treatment Period|Adverse Event|0
2461370|NCT02489968|8487550|P2|Open-label Treatment Period|Adverse Event|7
2461371|NCT02489968|8487551|P1|Open-label Treatment Period|Adverse Event|14
2461372|NCT02489799|8487565|P2|Overall Study|Death|1
2461373|NCT02489799|8487566|P1|Overall Study|Death|0
2461374|NCT02489799|8487565|P2|Overall Study|Withdrawal by Subject|1
2461375|NCT02489799|8487566|P1|Overall Study|Withdrawal by Subject|1
2461376|NCT02489799|8487565|P2|Overall Study|Failure to Maintain Eligibility|6
2461377|NCT02489799|8487566|P1|Overall Study|Failure to Maintain Eligibility|4
2461378|NCT02489799|8487565|P2|Overall Study|Lost to Follow-up|1
2461379|NCT02489799|8487566|P1|Overall Study|Lost to Follow-up|4
2461380|NCT02489773|8487592|P2|Overall Study|Leave the country or the state|1
2461381|NCT02489773|8487593|P1|Overall Study|Leave the country or the state|1
2461382|NCT02489773|8487592|P2|Overall Study|Withdrawal by Subject|0
2461383|NCT02489773|8487593|P1|Overall Study|Withdrawal by Subject|1
2461384|NCT02489773|8487592|P2|Overall Study|Physician Decision|0
2461385|NCT02489773|8487593|P1|Overall Study|Physician Decision|1
2461386|NCT02489773|8487592|P2|Overall Study|Lost to Follow-up|1
2461387|NCT02489773|8487593|P1|Overall Study|Lost to Follow-up|4
2461388|NCT02489500|8487603|P2|Overall Study|Death|1
2461389|NCT02489500|8487604|P1|Overall Study|Death|1
2461390|NCT02489344|8487622|P1|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2
2461391|NCT02489344|8487622|P1|LTS14116 (Extension Study): 31 Months|Adverse Event|1
2461392|NCT02489344|8487622|P1|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1
2461393|NCT02489344|8487622|P1|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1
2461394|NCT02489279|8487664|P2|Overall Study|Lost to Follow-up|10
2461395|NCT02489279|8487665|P1|Overall Study|Lost to Follow-up|12
2461396|NCT02488980|8487706|P3|Overall Study|Protocol Violation|2
2461397|NCT02488980|8487707|P2|Overall Study|Protocol Violation|2
2461398|NCT02488980|8487708|P1|Overall Study|Protocol Violation|2
2461399|NCT02488915|8487725|P1|Overall Study|Withdrawal by Subject|1
2461400|NCT02488915|8487725|P1|Overall Study|Lost to Follow-up|4
2461401|NCT02488915|8487725|P1|Overall Study|Death|21
2461402|NCT02488824|8487743|P2|Overall Study|Adverse Event|1
2461403|NCT02488824|8487744|P1|Overall Study|Adverse Event|1
2461404|NCT02488681|8487758|P1|Overall Study|Implant unsuccessful|7
2461405|NCT02488330|8487762|P1|Overall Study|Study Termination by Sponsor|4
2461406|NCT02488330|8487762|P1|Overall Study|Disease Progression|3
2461407|NCT02488330|8487762|P1|Overall Study|Death|2
2461408|NCT02488330|8487762|P1|Overall Study|Physician Decision|2
2461409|NCT02488330|8487762|P1|Overall Study|Adverse Event|1
2461410|NCT02488239|8487783|P1|Overall Study|Did not undergo implant procedure|1
2461411|NCT02488239|8487783|P1|Overall Study|Consent ineligible|1
2461412|NCT02488239|8487783|P1|Overall Study|Physician Decision|2
2461413|NCT02488239|8487783|P1|Overall Study|Withdrawal by Subject|3
2461414|NCT02488239|8487783|P1|Overall Study|Death|3
2461415|NCT02488005|8487800|P1|Overall Study|Lost to Follow-up|2
2461416|NCT02487979|8487810|P1|Overall Study|Progressive Disease|17
2461417|NCT02487979|8487810|P1|Overall Study|Withdrawal by Subject|2
2461418|NCT02487979|8487810|P1|Overall Study|Physician Decision|2
2461419|NCT02487810|8487822|P2|Overall Study|Withdrawal by Subject|0
2461420|NCT02487810|8487823|P1|Overall Study|Withdrawal by Subject|1
2461421|NCT02487771|8487855|P2|Overall Study|Withdrawal by Subject|5
2461422|NCT02487771|8487856|P1|Overall Study|Withdrawal by Subject|3
2461423|NCT02487771|8487855|P2|Overall Study|Moved out of area|6
2461424|NCT02487771|8487856|P1|Overall Study|Moved out of area|5
2461425|NCT02487771|8487855|P2|Overall Study|Lost to Follow-up|3
2461426|NCT02487771|8487856|P1|Overall Study|Lost to Follow-up|2
2461427|NCT02487498|8488006|P2|Period: Period 2|Physician Decision|0
2461428|NCT02487498|8488007|P1|Period: Period 2|Physician Decision|1
2461429|NCT02487498|8488006|P2|Period: Period 2|Death|1
2461430|NCT02487498|8488007|P1|Period: Period 2|Death|0
2461431|NCT02487498|8488006|P2|Period: Period 2|Lost to Follow-up|1
2461432|NCT02487498|8488007|P1|Period: Period 2|Lost to Follow-up|1
2461433|NCT02487498|8488006|P2|Period: Period 2|Subject/guardian decision|1
2461434|NCT02487498|8488007|P1|Period: Period 2|Subject/guardian decision|2
2461435|NCT02487498|8488006|P2|Period: Period 2|Adverse Event|2
2461436|NCT02487498|8488007|P1|Period: Period 2|Adverse Event|2
2461437|NCT02487498|8488006|P2|Period: Washout|Non-compliance with study treatment|1
2461438|NCT02487498|8488007|P1|Period: Washout|Non-compliance with study treatment|0
2461439|NCT02487498|8488006|P2|Period: Washout|Physician Decision|0
2461440|NCT02487498|8488007|P1|Period: Washout|Physician Decision|1
2461441|NCT02487498|8488006|P2|Period: Washout|Lack of Efficacy|1
2461442|NCT02487498|8488007|P1|Period: Washout|Lack of Efficacy|1
2461443|NCT02487498|8488006|P2|Period: Washout|Subject/guardian decision|5
2461444|NCT02487498|8488007|P1|Period: Washout|Subject/guardian decision|0
2461445|NCT02487498|8488006|P2|Period: Period 1|Protocol deviation|0
2461446|NCT02487498|8488007|P1|Period: Period 1|Protocol deviation|1
2461447|NCT02487498|8488006|P2|Period: Period 1|Physician Decision|1
2461448|NCT02487498|8488007|P1|Period: Period 1|Physician Decision|0
2461449|NCT02487498|8488006|P2|Period: Period 1|Lack of Efficacy|0
2461450|NCT02487498|8488007|P1|Period: Period 1|Lack of Efficacy|1
2461451|NCT02487498|8488006|P2|Period: Period 1|Lost to Follow-up|2
2461452|NCT02487498|8488007|P1|Period: Period 1|Lost to Follow-up|0
2461453|NCT02487498|8488006|P2|Period: Period 1|Subject/guardian decision|4
2461454|NCT02487498|8488007|P1|Period: Period 1|Subject/guardian decision|2
2461455|NCT02487498|8488006|P2|Period: Period 1|Adverse Event|4
2461456|NCT02487498|8488007|P1|Period: Period 1|Adverse Event|2
2461457|NCT02487472|8488030|P1|Overall Study|Other|2
2461458|NCT02487472|8488030|P1|Overall Study|Did not complete telephonic interviews|9
2461459|NCT02487446|8488046|P2|Period 2|Adverse Event|2
2461460|NCT02487446|8488047|P1|Period 2|Adverse Event|6
2461461|NCT02487446|8488046|P2|Period 2|Withdrawal by Subject|1
2461462|NCT02487446|8488047|P1|Period 2|Withdrawal by Subject|1
2461463|NCT02487446|8488046|P2|Period 2|Lost to Follow-up|1
2461464|NCT02487446|8488047|P1|Period 2|Lost to Follow-up|1
2461465|NCT02487446|8488046|P2|Period 2|Protocol deviation|1
2461466|NCT02487446|8488047|P1|Period 2|Protocol deviation|0
2461467|NCT02487446|8488046|P2|Washout|Adverse Event|2
2461468|NCT02487446|8488047|P1|Washout|Adverse Event|2
2461469|NCT02487446|8488046|P2|Washout|Withdrawal by Subject|4
2461470|NCT02487446|8488047|P1|Washout|Withdrawal by Subject|1
2461471|NCT02487446|8488046|P2|Washout|Lost to Follow-up|2
2461472|NCT02487446|8488047|P1|Washout|Lost to Follow-up|0
2461473|NCT02487446|8488046|P2|Period 1|Adverse Event|5
2461474|NCT02487446|8488047|P1|Period 1|Adverse Event|5
2461475|NCT02487446|8488046|P2|Period 1|Withdrawal by Subject|0
2461476|NCT02487446|8488047|P1|Period 1|Withdrawal by Subject|2
2461477|NCT02487446|8488046|P2|Period 1|Lost to Follow-up|0
2461478|NCT02487446|8488047|P1|Period 1|Lost to Follow-up|2
2461479|NCT02487446|8488046|P2|Period 1|Protocol deviation|2
2461480|NCT02487446|8488047|P1|Period 1|Protocol deviation|3
2461481|NCT02487446|8488046|P2|Period 1|Lack of Efficacy|0
2461482|NCT02487446|8488047|P1|Period 1|Lack of Efficacy|1
2461483|NCT02487446|8488046|P2|Period 1|Physician Decision|1
2461484|NCT02487446|8488047|P1|Period 1|Physician Decision|0
2461485|NCT02487199|8488127|P2|Overall Study|Withdrew Consent|1
2461486|NCT02487199|8488128|P1|Overall Study|Withdrew Consent|0
2461487|NCT02487030|8488153|P7|Overall Study|Death|0
2461488|NCT02487030|8488154|P6|Overall Study|Death|0
2461489|NCT02487030|8488155|P5|Overall Study|Death|1
2461490|NCT02487030|8488156|P4|Overall Study|Death|0
2461491|NCT02487030|8488157|P3|Overall Study|Death|0
2461492|NCT02487030|8488158|P2|Overall Study|Death|0
2461493|NCT02487030|8488159|P1|Overall Study|Death|0
2461494|NCT02487030|8488153|P7|Overall Study|Adverse Event|0
2461495|NCT02487030|8488154|P6|Overall Study|Adverse Event|0
2461496|NCT02487030|8488155|P5|Overall Study|Adverse Event|0
2461497|NCT02487030|8488156|P4|Overall Study|Adverse Event|1
2461498|NCT02487030|8488157|P3|Overall Study|Adverse Event|0
2461499|NCT02487030|8488158|P2|Overall Study|Adverse Event|0
2461500|NCT02487030|8488159|P1|Overall Study|Adverse Event|0
2461501|NCT02487030|8488153|P7|Overall Study|Lost to Follow-up|0
2461502|NCT02487030|8488154|P6|Overall Study|Lost to Follow-up|1
2461503|NCT02487030|8488155|P5|Overall Study|Lost to Follow-up|0
2461504|NCT02487030|8488156|P4|Overall Study|Lost to Follow-up|1
2461505|NCT02487030|8488157|P3|Overall Study|Lost to Follow-up|1
2461506|NCT02487030|8488158|P2|Overall Study|Lost to Follow-up|0
2461507|NCT02487030|8488159|P1|Overall Study|Lost to Follow-up|0
2461508|NCT02487030|8488153|P7|Overall Study|Lack of Efficacy|0
2461509|NCT02487030|8488154|P6|Overall Study|Lack of Efficacy|0
2461510|NCT02487030|8488155|P5|Overall Study|Lack of Efficacy|1
2461511|NCT02487030|8488156|P4|Overall Study|Lack of Efficacy|0
2461512|NCT02487030|8488157|P3|Overall Study|Lack of Efficacy|1
2461513|NCT02487030|8488158|P2|Overall Study|Lack of Efficacy|4
2461514|NCT02487030|8488159|P1|Overall Study|Lack of Efficacy|2
2461515|NCT02486952|8488190|P1|Overall Study|Other|2
2461516|NCT02486952|8488190|P1|Overall Study|Lost to Follow-up|26
2461517|NCT02486952|8488190|P1|Overall Study|Lack of Efficacy|3
2461518|NCT02486952|8488190|P1|Overall Study|Death|15
2461519|NCT02486952|8488190|P1|Overall Study|Adverse Event|1
2461520|NCT02486952|8488190|P1|Overall Study|Not Started Induction Therapy|3
2461521|NCT02486796|8488208|P2|Overall Study|Physician Decision|0
2461522|NCT02486796|8488209|P1|Overall Study|Physician Decision|1
2461523|NCT02486796|8488208|P2|Overall Study|Withdrawal by Subject|1
2461524|NCT02486796|8488209|P1|Overall Study|Withdrawal by Subject|1
2461525|NCT02486757|8488221|P1|Overall Study|Lost to Follow-up|1
2461526|NCT02486692|8488227|P2|Overall Study|did not login for randomization|7
2461527|NCT02486692|8488228|P1|Overall Study|did not login for randomization|4
2461528|NCT02486653|8488240|P2|Overall Study|surgery cancelled|1
2461529|NCT02486653|8488241|P1|Overall Study|surgery cancelled|4
2461530|NCT02486653|8488240|P2|Overall Study|Protocol Violation|0
2461531|NCT02486653|8488241|P1|Overall Study|Protocol Violation|1
2461532|NCT02486653|8488240|P2|Overall Study|Withdrawal by Subject|3
2461533|NCT02486653|8488241|P1|Overall Study|Withdrawal by Subject|1
2461534|NCT02486627|8488265|P2|Overall Study|Lost to Follow-up|3
2461535|NCT02486627|8488266|P1|Overall Study|Lost to Follow-up|1
2461536|NCT02486627|8488265|P2|Overall Study|Significant Participant Noncompliance|1
2461537|NCT02486627|8488266|P1|Overall Study|Significant Participant Noncompliance|1
2461538|NCT02486627|8488265|P2|Overall Study|Consent Withdrawn by Participant|3
2461539|NCT02486627|8488266|P1|Overall Study|Consent Withdrawn by Participant|4
2461540|NCT02486627|8488265|P2|Overall Study|Other Unspecified|2
2461541|NCT02486627|8488266|P1|Overall Study|Other Unspecified|0
2461542|NCT02486627|8488265|P2|Overall Study|Death|0
2461543|NCT02486627|8488266|P1|Overall Study|Death|1
2461544|NCT02486302|8488283|P1|Overall Study|Not treated|3
2461545|NCT02486302|8488283|P1|Overall Study|Excluded due to legal reasons|8
2461546|NCT02486302|8488283|P1|Overall Study|Documentation not completed|255
2461547|NCT02486302|8488283|P1|Overall Study|Discontinued prematurely|410
2461548|NCT02485925|8488363|P1|Overall Study|Lost to Follow-up|11
2461549|NCT02485925|8488363|P1|Overall Study|Death|1
2461550|NCT02485925|8488363|P1|Overall Study|Withdrawal by Subject|3
2461551|NCT02485717|8488395|P3|Overall Study|Did Not Meet Exclusion Criteria #12|0
2461552|NCT02485717|8488396|P2|Overall Study|Did Not Meet Exclusion Criteria #12|1
2461553|NCT02485717|8488397|P1|Overall Study|Did Not Meet Exclusion Criteria #12|0
2461554|NCT02485717|8488395|P3|Overall Study|Did Not Meet Exclusion Criteria #2|0
2461555|NCT02485717|8488396|P2|Overall Study|Did Not Meet Exclusion Criteria #2|1
2461556|NCT02485717|8488397|P1|Overall Study|Did Not Meet Exclusion Criteria #2|0
2461557|NCT02485717|8488395|P3|Overall Study|Withdrawal by Subject|1
2461558|NCT02485717|8488396|P2|Overall Study|Withdrawal by Subject|0
2461559|NCT02485717|8488397|P1|Overall Study|Withdrawal by Subject|0
2461560|NCT02485717|8488395|P3|Overall Study|Lost to Follow-up|0
2461561|NCT02485717|8488396|P2|Overall Study|Lost to Follow-up|0
2461562|NCT02485717|8488397|P1|Overall Study|Lost to Follow-up|6
2461563|NCT02485704|8488412|P2|Overall Study|Did Not Meet Inclusion Criteria #2|0
2461564|NCT02485704|8488413|P1|Overall Study|Did Not Meet Inclusion Criteria #2|1
2461565|NCT02485704|8488412|P2|Overall Study|Withdrawal by Subject|3
2461566|NCT02485704|8488413|P1|Overall Study|Withdrawal by Subject|0
2461567|NCT02485704|8488412|P2|Overall Study|Lost to Follow-up|5
2461568|NCT02485704|8488413|P1|Overall Study|Lost to Follow-up|4
2461569|NCT02485483|8488461|P2|Overall Study|Discontinued after baseline|0
2461570|NCT02485483|8488462|P1|Overall Study|Discontinued after baseline|39
2461571|NCT02485483|8488461|P2|Overall Study|Depression at baseline|0
2461572|NCT02485483|8488462|P1|Overall Study|Depression at baseline|15
2461573|NCT02485353|8488477|P1|Overall Study|Disease Progression|1
2461574|NCT02485353|8488477|P1|Overall Study|Death|1
2461575|NCT02485301|8488484|P2|Overall Study|Other|4
2461576|NCT02485301|8488485|P1|Overall Study|Other|3
2461577|NCT02485301|8488484|P2|Overall Study|Lost to Follow-up|17
2461578|NCT02485301|8488485|P1|Overall Study|Lost to Follow-up|17
2461579|NCT02485301|8488484|P2|Overall Study|Migrated/moved from study area|19
2461580|NCT02485301|8488485|P1|Overall Study|Migrated/moved from study area|10
2461581|NCT02485301|8488484|P2|Overall Study|Withdrawal by Subject|7
2461582|NCT02485301|8488485|P1|Overall Study|Withdrawal by Subject|6
2461583|NCT02485301|8488484|P2|Overall Study|Protocol Violation|1
2461584|NCT02485301|8488485|P1|Overall Study|Protocol Violation|0
2461585|NCT02485301|8488484|P2|Overall Study|Serious Adverse Events|1
2461586|NCT02485301|8488485|P1|Overall Study|Serious Adverse Events|2
2461587|NCT02485158|8488535|P1|Overall Study|expected drug side effect|1
2461588|NCT02485158|8488535|P1|Overall Study|Withdrawal by Subject|3
2461589|NCT02484911|8488624|P2|Overall Study|Protocol Violation|1
2461590|NCT02484911|8488625|P1|Overall Study|Protocol Violation|2
2461591|NCT02484911|8488624|P2|Overall Study|Withdrawal by Subject|1
2461592|NCT02484911|8488625|P1|Overall Study|Withdrawal by Subject|2
2461593|NCT02484729|8488715|P10|Overall Study|Failure of IntelliCap Error|1
2461594|NCT02484729|8488716|P9|Overall Study|Failure of IntelliCap Error|0
2461595|NCT02484729|8488717|P8|Overall Study|Failure of IntelliCap Error|0
2461596|NCT02484729|8488718|P7|Overall Study|Failure of IntelliCap Error|0
2461597|NCT02484729|8488719|P6|Overall Study|Failure of IntelliCap Error|0
2461598|NCT02484729|8488720|P5|Overall Study|Failure of IntelliCap Error|0
2461599|NCT02484729|8488721|P4|Overall Study|Failure of IntelliCap Error|0
2461600|NCT02484729|8488722|P3|Overall Study|Failure of IntelliCap Error|0
2461601|NCT02484729|8488723|P2|Overall Study|Failure of IntelliCap Error|0
2461602|NCT02484729|8488724|P1|Overall Study|Failure of IntelliCap Error|0
2461603|NCT02484651|8488922|P2|Overall Study|Time of the procedure less than 90 min.|2
2461604|NCT02484651|8488923|P1|Overall Study|Time of the procedure less than 90 min.|1
2461605|NCT02484651|8488922|P2|Overall Study|BIS monitoring failed.|1
2461606|NCT02484651|8488923|P1|Overall Study|BIS monitoring failed.|1
2461607|NCT02484651|8488922|P2|Overall Study|Patients' data files were corrupted.|1
2461608|NCT02484651|8488923|P1|Overall Study|Patients' data files were corrupted.|1
2461609|NCT02483975|8488944|P2|Overall Study|Physician Decision|0
2461610|NCT02483975|8488945|P1|Overall Study|Physician Decision|2
2461611|NCT02483975|8488944|P2|Overall Study|Lost to Follow-up|1
2461612|NCT02483975|8488945|P1|Overall Study|Lost to Follow-up|0
2461613|NCT02483975|8488944|P2|Overall Study|Adverse Event|1
2461614|NCT02483975|8488945|P1|Overall Study|Adverse Event|0
2461615|NCT02483611|8488962|P3|Overall Study|Protocol Violation|1
2461616|NCT02483611|8488963|P2|Overall Study|Protocol Violation|0
2461617|NCT02483611|8488964|P1|Overall Study|Protocol Violation|0
2461618|NCT02483585|8489061|P2|Open-label Treatment Phase|Lost to Follow-up|5
2461619|NCT02483585|8489062|P1|Open-label Treatment Phase|Lost to Follow-up|3
2461620|NCT02483585|8489061|P2|Open-label Treatment Phase|Withdrawal by Subject|14
2461621|NCT02483585|8489062|P1|Open-label Treatment Phase|Withdrawal by Subject|18
2461622|NCT02483585|8489061|P2|Open-label Treatment Phase|Decision by Sponsor|1
2461623|NCT02483585|8489062|P1|Open-label Treatment Phase|Decision by Sponsor|0
2461624|NCT02483585|8489061|P2|Open-label Treatment Phase|Protocol-specified Criteria|5
2461625|NCT02483585|8489062|P1|Open-label Treatment Phase|Protocol-specified Criteria|6
2461626|NCT02483585|8489061|P2|Double-blind Treatment Phase|Lost to Follow-up|2
2461627|NCT02483585|8489062|P1|Double-blind Treatment Phase|Lost to Follow-up|3
2461628|NCT02483585|8489061|P2|Double-blind Treatment Phase|Withdrawal by Subject|12
2461629|NCT02483585|8489062|P1|Double-blind Treatment Phase|Withdrawal by Subject|12
2461630|NCT02483585|8489061|P2|Double-blind Treatment Phase|Decision by Sponsor|1
2461631|NCT02483585|8489062|P1|Double-blind Treatment Phase|Decision by Sponsor|1
2461632|NCT02483572|8489084|P2|Overall Study|Physician Decision|1
2461633|NCT02483572|8489085|P1|Overall Study|Physician Decision|0
2461634|NCT02483572|8489084|P2|Overall Study|Lost to Follow-up|0
2461635|NCT02483572|8489085|P1|Overall Study|Lost to Follow-up|1
2461636|NCT02483572|8489084|P2|Overall Study|Withdrawal by Subject|0
2461637|NCT02483572|8489085|P1|Overall Study|Withdrawal by Subject|1
2461638|NCT02483533|8489099|P2|Overall Study|Lack of Efficacy|50
2461639|NCT02483533|8489100|P1|Overall Study|Lack of Efficacy|50
2461640|NCT02483416|8489110|P2|Overall Study|Treatment stop|0
2461641|NCT02483416|8489111|P1|Overall Study|Treatment stop|3
2461642|NCT02483416|8489110|P2|Overall Study|Other reason|1
2461643|NCT02483416|8489111|P1|Overall Study|Other reason|0
2461644|NCT02482935|8489166|P2|Period 1|Withdrawal by Subject|0
2461645|NCT02482935|8489167|P1|Period 1|Withdrawal by Subject|1
2461646|NCT02482805|8489195|P3|Overall Study|Lost to Follow-up|0
2461647|NCT02482805|8489196|P2|Overall Study|Lost to Follow-up|4
2461648|NCT02482805|8489197|P1|Overall Study|Lost to Follow-up|4
2461649|NCT02482571|8489316|P1|Overall Study|Withdrawal by Subject|4
2461650|NCT02482571|8489316|P1|Overall Study|Scanner or Respiract failure|3
2461651|NCT02482571|8489316|P1|Overall Study|Adverse Event|1
2461652|NCT02482428|8489328|P5|Overall Study|subject/guardian decision|2
2461653|NCT02482428|8489329|P4|Overall Study|subject/guardian decision|0
2461654|NCT02482428|8489330|P3|Overall Study|subject/guardian decision|0
2461655|NCT02482428|8489331|P2|Overall Study|subject/guardian decision|2
2461656|NCT02482428|8489332|P1|Overall Study|subject/guardian decision|4
2461657|NCT02482428|8489328|P5|Overall Study|protocol deviation|0
2461658|NCT02482428|8489329|P4|Overall Study|protocol deviation|0
2461659|NCT02482428|8489330|P3|Overall Study|protocol deviation|0
2461660|NCT02482428|8489331|P2|Overall Study|protocol deviation|1
2461661|NCT02482428|8489332|P1|Overall Study|protocol deviation|1
2461662|NCT02482428|8489328|P5|Overall Study|Physician Decision|1
2461663|NCT02482428|8489329|P4|Overall Study|Physician Decision|0
2461664|NCT02482428|8489330|P3|Overall Study|Physician Decision|0
2461665|NCT02482428|8489331|P2|Overall Study|Physician Decision|0
2461666|NCT02482428|8489332|P1|Overall Study|Physician Decision|0
2461667|NCT02482428|8489328|P5|Overall Study|Lost to Follow-up|4
2461668|NCT02482428|8489329|P4|Overall Study|Lost to Follow-up|2
2461669|NCT02482428|8489330|P3|Overall Study|Lost to Follow-up|1
2461670|NCT02482428|8489331|P2|Overall Study|Lost to Follow-up|9
2461671|NCT02482428|8489332|P1|Overall Study|Lost to Follow-up|4
2461672|NCT02482298|8489355|P3|Overall Study|Lost to Follow-up|0
2461673|NCT02482298|8489356|P2|Overall Study|Lost to Follow-up|1
2461674|NCT02482298|8489357|P1|Overall Study|Lost to Follow-up|0
2461675|NCT02482298|8489355|P3|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1
2461676|NCT02482298|8489356|P2|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
2461677|NCT02482298|8489357|P1|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
2461678|NCT02482298|8489355|P3|Overall Study|Did Not Fulfill Randomization Criteria|0
2461679|NCT02482298|8489356|P2|Overall Study|Did Not Fulfill Randomization Criteria|1
2461680|NCT02482298|8489357|P1|Overall Study|Did Not Fulfill Randomization Criteria|0
2461681|NCT02482298|8489355|P3|Overall Study|Withdrawal by Subject|2
2461682|NCT02482298|8489356|P2|Overall Study|Withdrawal by Subject|1
2461683|NCT02482298|8489357|P1|Overall Study|Withdrawal by Subject|2
2461684|NCT02482233|8489379|P2|Overall Study|Lost to Follow-up|1
2461685|NCT02482233|8489380|P1|Overall Study|Lost to Follow-up|1
2461686|NCT02482129|8489416|P2|Overall Study|Criteria not met|0
2461687|NCT02482129|8489417|P1|Overall Study|Criteria not met|1
2461688|NCT02482129|8489416|P2|Overall Study|Withdrawal by Subject|0
2461689|NCT02482129|8489417|P1|Overall Study|Withdrawal by Subject|2
2461690|NCT02482129|8489416|P2|Overall Study|Adverse Event|0
2461691|NCT02482129|8489417|P1|Overall Study|Adverse Event|1
2461692|NCT02482129|8489416|P2|Overall Study|Criteria not met-prior to treatment|0
2461693|NCT02482129|8489417|P1|Overall Study|Criteria not met-prior to treatment|1
2461694|NCT02482129|8489416|P2|Overall Study|Unable to draw blood-prior to treatment|0
2461695|NCT02482129|8489417|P1|Overall Study|Unable to draw blood-prior to treatment|1
2461696|NCT02482129|8489416|P2|Overall Study|Withdrawal by subject-prior to treatment|1
2461697|NCT02482129|8489417|P1|Overall Study|Withdrawal by subject-prior to treatment|0
2461698|NCT02482129|8489416|P2|Overall Study|Adverse Event-prior to treatment|1
2461699|NCT02482129|8489417|P1|Overall Study|Adverse Event-prior to treatment|0
2461700|NCT02481934|8489444|P1|Overall Study|Death|2
2461701|NCT02481830|8489451|P2|Overall Study|Participant not eligible for trial|1
2461702|NCT02481830|8489452|P1|Overall Study|Participant not eligible for trial|0
2461703|NCT02481830|8489451|P2|Overall Study|Disease Progression|1
2461704|NCT02481830|8489452|P1|Overall Study|Disease Progression|1
2461705|NCT02481830|8489451|P2|Overall Study|Withdrawal by Subject|14
2461706|NCT02481830|8489452|P1|Overall Study|Withdrawal by Subject|0
2461707|NCT02481830|8489451|P2|Overall Study|No longer meets Study Criteria|4
2461708|NCT02481830|8489452|P1|Overall Study|No longer meets Study Criteria|1
2461709|NCT02481050|8489601|P1|Overall Study|Other|3
2461710|NCT02481050|8489601|P1|Overall Study|Withdrawal by Subject|7
2461711|NCT02481050|8489601|P1|Overall Study|Disease Progression|47
2461712|NCT02481050|8489601|P1|Overall Study|Adverse Event|1
2461713|NCT02480764|8489628|P3|Overall Study|Reason not Specified|0
2461714|NCT02480764|8489629|P2|Overall Study|Reason not Specified|1
2461715|NCT02480764|8489630|P1|Overall Study|Reason not Specified|0
2461716|NCT02480764|8489628|P3|Overall Study|Lack of Efficacy|3
2461717|NCT02480764|8489629|P2|Overall Study|Lack of Efficacy|3
2461718|NCT02480764|8489630|P1|Overall Study|Lack of Efficacy|0
2461719|NCT02480764|8489628|P3|Overall Study|Voluntary Withdrawal|10
2461720|NCT02480764|8489629|P2|Overall Study|Voluntary Withdrawal|5
2461721|NCT02480764|8489630|P1|Overall Study|Voluntary Withdrawal|6
2461722|NCT02480764|8489628|P3|Overall Study|Lost to Follow-up|2
2461723|NCT02480764|8489629|P2|Overall Study|Lost to Follow-up|1
2461724|NCT02480764|8489630|P1|Overall Study|Lost to Follow-up|0
2461725|NCT02480764|8489628|P3|Overall Study|Major Protocol Deviation|3
2461726|NCT02480764|8489629|P2|Overall Study|Major Protocol Deviation|4
2461727|NCT02480764|8489630|P1|Overall Study|Major Protocol Deviation|1
2461728|NCT02480764|8489628|P3|Overall Study|Pretreatment Event/Adverse Event|3
2461729|NCT02480764|8489629|P2|Overall Study|Pretreatment Event/Adverse Event|6
2461730|NCT02480764|8489630|P1|Overall Study|Pretreatment Event/Adverse Event|3
2461731|NCT02480712|8489656|P1|Overall Study|Lack of Efficacy|1
2461732|NCT02480712|8489656|P1|Overall Study|Death|1
2461733|NCT02480712|8489656|P1|Overall Study|Withdrew Consent|3
2461734|NCT02480712|8489656|P1|Overall Study|Lost to Follow-up|5
2461735|NCT02480712|8489656|P1|Overall Study|Enrolled but Never Treated|1
2461736|NCT02480621|8489675|P2|Follow Up|Lost to Follow-up|2
2461737|NCT02480621|8489676|P1|Follow Up|Lost to Follow-up|4
2461738|NCT02480621|8489675|P2|Randomization|Surgeon did not give intervention|1
2461739|NCT02480621|8489676|P1|Randomization|Surgeon did not give intervention|0
2461740|NCT02480621|8489675|P2|Randomization|Withdrawal by Subject|0
2461741|NCT02480621|8489676|P1|Randomization|Withdrawal by Subject|1
2461742|NCT02480153|8489753|P3|Period 3: Week 52 Dosing to Week 78|Death|0
2461743|NCT02480153|8489754|P2|Period 3: Week 52 Dosing to Week 78|Death|1
2461744|NCT02480153|8489755|P1|Period 3: Week 52 Dosing to Week 78|Death|0
2461745|NCT02480153|8489753|P3|Period 3: Week 52 Dosing to Week 78|Adverse Event|1
2461746|NCT02480153|8489754|P2|Period 3: Week 52 Dosing to Week 78|Adverse Event|0
2461747|NCT02480153|8489755|P1|Period 3: Week 52 Dosing to Week 78|Adverse Event|0
2461748|NCT02480153|8489753|P3|Period 3: Week 52 Dosing to Week 78|Other|1
2461749|NCT02480153|8489754|P2|Period 3: Week 52 Dosing to Week 78|Other|0
2461750|NCT02480153|8489755|P1|Period 3: Week 52 Dosing to Week 78|Other|0
2461751|NCT02480153|8489753|P3|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1
2461752|NCT02480153|8489754|P2|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0
2461753|NCT02480153|8489755|P1|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4
2461754|NCT02480153|8489753|P3|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1
2461755|NCT02480153|8489754|P2|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2
2461756|NCT02480153|8489755|P1|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3
2461757|NCT02480153|8489753|P3|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0
2461758|NCT02480153|8489754|P2|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1
2461759|NCT02480153|8489755|P1|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0
2461760|NCT02480153|8489753|P3|Period 2: Week 26 to Week 52 Pre-dose|Other|0
2461761|NCT02480153|8489754|P2|Period 2: Week 26 to Week 52 Pre-dose|Other|0
2461762|NCT02480153|8489755|P1|Period 2: Week 26 to Week 52 Pre-dose|Other|2
2461763|NCT02480153|8489753|P3|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3
2461764|NCT02480153|8489754|P2|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7
2461765|NCT02480153|8489755|P1|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6
2461766|NCT02480153|8489753|P3|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1
2461767|NCT02480153|8489754|P2|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3
2461768|NCT02480153|8489755|P1|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8
2461769|NCT02480153|8489753|P3|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0
2461770|NCT02480153|8489754|P2|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1
2461771|NCT02480153|8489755|P1|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0
2461772|NCT02480153|8489753|P3|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3
2461773|NCT02480153|8489754|P2|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1
2461774|NCT02480153|8489755|P1|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4
2461775|NCT02480153|8489753|P3|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0
2461776|NCT02480153|8489754|P2|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2
2461777|NCT02480153|8489755|P1|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0
2461778|NCT02480153|8489753|P3|Period 1: First Dose to Week 26 Pre-dose|Death|0
2461779|NCT02480153|8489754|P2|Period 1: First Dose to Week 26 Pre-dose|Death|1
2461780|NCT02480153|8489755|P1|Period 1: First Dose to Week 26 Pre-dose|Death|0
2461781|NCT02480153|8489753|P3|Period 1: First Dose to Week 26 Pre-dose|Other|0
2461782|NCT02480153|8489754|P2|Period 1: First Dose to Week 26 Pre-dose|Other|1
2461783|NCT02480153|8489755|P1|Period 1: First Dose to Week 26 Pre-dose|Other|0
2461784|NCT02480153|8489753|P3|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0
2461785|NCT02480153|8489754|P2|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8
2461786|NCT02480153|8489755|P1|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3
2461787|NCT02480153|8489753|P3|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0
2461788|NCT02480153|8489754|P2|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2
2461789|NCT02480153|8489755|P1|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1
2461790|NCT02480153|8489753|P3|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0
2461791|NCT02480153|8489754|P2|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1
2461792|NCT02480153|8489755|P1|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0
2461793|NCT02480153|8489753|P3|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0
2461794|NCT02480153|8489754|P2|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1
2461795|NCT02480153|8489755|P1|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0
2461796|NCT02480010|8489932|P2|Overall Study|Refused Treatment|3
2461797|NCT02480010|8489933|P1|Overall Study|Refused Treatment|0
2461798|NCT02480010|8489932|P2|Overall Study|Insufficient therapeutic response|29
2461799|NCT02480010|8489933|P1|Overall Study|Insufficient therapeutic response|31
2461800|NCT02480010|8489932|P2|Overall Study|Death|0
2461801|NCT02480010|8489933|P1|Overall Study|Death|1
2461802|NCT02480010|8489932|P2|Overall Study|Adverse Event|1
2461803|NCT02480010|8489933|P1|Overall Study|Adverse Event|3
2461804|NCT02479880|8489979|P2|Overall Study|Pregnancy|1
2461805|NCT02479880|8489980|P1|Overall Study|Pregnancy|0
2461806|NCT02479880|8489979|P2|Overall Study|Study Terminated by Sponsor|12
2461807|NCT02479880|8489980|P1|Overall Study|Study Terminated by Sponsor|13
2461808|NCT02479412|8490004|P9|Overall Study|Randomization to wrong PK sampling group|0
2461809|NCT02479412|8490005|P8|Overall Study|Randomization to wrong PK sampling group|0
2461810|NCT02479412|8490006|P7|Overall Study|Randomization to wrong PK sampling group|0
2461811|NCT02479412|8490007|P6|Overall Study|Randomization to wrong PK sampling group|0
2461812|NCT02479412|8490008|P5|Overall Study|Randomization to wrong PK sampling group|1
2461813|NCT02479412|8490009|P4|Overall Study|Randomization to wrong PK sampling group|0
2461814|NCT02479412|8490010|P3|Overall Study|Randomization to wrong PK sampling group|0
2461815|NCT02479412|8490011|P2|Overall Study|Randomization to wrong PK sampling group|0
2461816|NCT02479412|8490012|P1|Overall Study|Randomization to wrong PK sampling group|0
2461817|NCT02479412|8490004|P9|Overall Study|Study-specific withdrawal criteria|1
2461818|NCT02479412|8490005|P8|Overall Study|Study-specific withdrawal criteria|1
2461819|NCT02479412|8490006|P7|Overall Study|Study-specific withdrawal criteria|0
2461820|NCT02479412|8490007|P6|Overall Study|Study-specific withdrawal criteria|0
2461821|NCT02479412|8490008|P5|Overall Study|Study-specific withdrawal criteria|0
2461822|NCT02479412|8490009|P4|Overall Study|Study-specific withdrawal criteria|1
2461823|NCT02479412|8490010|P3|Overall Study|Study-specific withdrawal criteria|1
2461824|NCT02479412|8490011|P2|Overall Study|Study-specific withdrawal criteria|0
2461825|NCT02479412|8490012|P1|Overall Study|Study-specific withdrawal criteria|0
2461826|NCT02479412|8490004|P9|Overall Study|Adverse Event|0
2461827|NCT02479412|8490005|P8|Overall Study|Adverse Event|0
2461828|NCT02479412|8490006|P7|Overall Study|Adverse Event|0
2461829|NCT02479412|8490007|P6|Overall Study|Adverse Event|0
2461830|NCT02479412|8490008|P5|Overall Study|Adverse Event|0
2461831|NCT02479412|8490009|P4|Overall Study|Adverse Event|0
2461832|NCT02479412|8490010|P3|Overall Study|Adverse Event|1
2461833|NCT02479412|8490011|P2|Overall Study|Adverse Event|0
2461834|NCT02479412|8490012|P1|Overall Study|Adverse Event|0
2461835|NCT02479139|8490089|P6|Overall Study|Other Miscellaneous Reasons|0
2461836|NCT02479139|8490090|P5|Overall Study|Other Miscellaneous Reasons|1
2461837|NCT02479139|8490091|P4|Overall Study|Other Miscellaneous Reasons|1
2461838|NCT02479139|8490092|P3|Overall Study|Other Miscellaneous Reasons|1
2461839|NCT02479139|8490093|P2|Overall Study|Other Miscellaneous Reasons|0
2461840|NCT02479139|8490094|P1|Overall Study|Other Miscellaneous Reasons|1
2461841|NCT02479139|8490089|P6|Overall Study|Treatment Failure/Lack of Efficacy|0
2461842|NCT02479139|8490090|P5|Overall Study|Treatment Failure/Lack of Efficacy|0
2461843|NCT02479139|8490091|P4|Overall Study|Treatment Failure/Lack of Efficacy|0
2461844|NCT02479139|8490092|P3|Overall Study|Treatment Failure/Lack of Efficacy|1
2461845|NCT02479139|8490093|P2|Overall Study|Treatment Failure/Lack of Efficacy|0
2461846|NCT02479139|8490094|P1|Overall Study|Treatment Failure/Lack of Efficacy|0
2461847|NCT02479139|8490089|P6|Overall Study|Withdrew Consent|1
2461848|NCT02479139|8490090|P5|Overall Study|Withdrew Consent|1
2461849|NCT02479139|8490091|P4|Overall Study|Withdrew Consent|4
2461850|NCT02479139|8490092|P3|Overall Study|Withdrew Consent|1
2461851|NCT02479139|8490093|P2|Overall Study|Withdrew Consent|6
2461852|NCT02479139|8490094|P1|Overall Study|Withdrew Consent|5
2461853|NCT02479139|8490089|P6|Overall Study|Lost to Follow-up|5
2461854|NCT02479139|8490090|P5|Overall Study|Lost to Follow-up|3
2461855|NCT02479139|8490091|P4|Overall Study|Lost to Follow-up|2
2461856|NCT02479139|8490092|P3|Overall Study|Lost to Follow-up|4
2461857|NCT02479139|8490093|P2|Overall Study|Lost to Follow-up|4
2461858|NCT02479139|8490094|P1|Overall Study|Lost to Follow-up|2
2461859|NCT02478632|8490127|P2|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1
2461860|NCT02478632|8490128|P1|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5
2461861|NCT02478632|8490127|P2|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3
2461862|NCT02478632|8490128|P1|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2
2461863|NCT02478632|8490127|P2|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5
2461864|NCT02478632|8490128|P1|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4
2461865|NCT02478398|8490165|P2|Overall Study|Withdrawal By Participant|4
2461866|NCT02478398|8490166|P1|Overall Study|Withdrawal By Participant|10
2461867|NCT02478398|8490165|P2|Overall Study|Withdrawal By Parent/Guardian|6
2461868|NCT02478398|8490166|P1|Overall Study|Withdrawal By Parent/Guardian|9
2461869|NCT02478398|8490165|P2|Overall Study|Protocol Violation|1
2461870|NCT02478398|8490166|P1|Overall Study|Protocol Violation|3
2461871|NCT02478398|8490165|P2|Overall Study|Non-Compliance With Study Drug|1
2461872|NCT02478398|8490166|P1|Overall Study|Non-Compliance With Study Drug|5
2461873|NCT02478398|8490165|P2|Overall Study|Lost to Follow-up|4
2461874|NCT02478398|8490166|P1|Overall Study|Lost to Follow-up|5
2461875|NCT02478398|8490165|P2|Overall Study|Adverse Event|5
2461876|NCT02478398|8490166|P1|Overall Study|Adverse Event|20
2461877|NCT02478372|8490186|P2|Overall Study|Death|2
2461878|NCT02478372|8490187|P1|Overall Study|Death|0
2461879|NCT02478372|8490186|P2|Overall Study|Lost to Follow-up|4
2461880|NCT02478372|8490187|P1|Overall Study|Lost to Follow-up|1
2461881|NCT02478372|8490186|P2|Overall Study|Protocol Violation|8
2461882|NCT02478372|8490187|P1|Overall Study|Protocol Violation|12
2461883|NCT02478359|8490211|P2|Overall Study|Disenrolled from health plan|65
2461884|NCT02478359|8490212|P1|Overall Study|Disenrolled from health plan|106
2461885|NCT02478164|8490284|P1|Overall Study|Withdrawal by Subject|1
2461886|NCT02478164|8490284|P1|Overall Study|Adverse Event|1
2461887|NCT02478164|8490284|P1|Overall Study|Lack of Efficacy|13
2461888|NCT02477618|8490297|P2|Overall Study|Left Study Site for Rehabilitation|1
2461889|NCT02477618|8490298|P1|Overall Study|Left Study Site for Rehabilitation|0
2461890|NCT02477618|8490297|P2|Overall Study|Transferred Away from Study Site|0
2461891|NCT02477618|8490298|P1|Overall Study|Transferred Away from Study Site|1
2461892|NCT02477618|8490297|P2|Overall Study|Adverse Event|1
2461893|NCT02477618|8490298|P1|Overall Study|Adverse Event|1
2461894|NCT02477618|8490297|P2|Overall Study|Died in Double-Blind Treatment Period|11
2461895|NCT02477618|8490298|P1|Overall Study|Died in Double-Blind Treatment Period|11
2461896|NCT02477618|8490297|P2|Overall Study|Completed Visits but Discontinued Drug|1
2461897|NCT02477618|8490298|P1|Overall Study|Completed Visits but Discontinued Drug|2
2461898|NCT02477605|8490322|P2|Overall Study|Administered gas during surgery|1
2461899|NCT02477605|8490323|P1|Overall Study|Administered gas during surgery|0
2461900|NCT02477605|8490322|P2|Overall Study|Withdrawal by Subject|1
2461901|NCT02477605|8490323|P1|Overall Study|Withdrawal by Subject|0
2461902|NCT02477605|8490322|P2|Overall Study|Lost to Follow-up|2
2461903|NCT02477605|8490323|P1|Overall Study|Lost to Follow-up|0
2461904|NCT02477605|8490322|P2|Overall Study|Discontinued prior to treatment|0
2461905|NCT02477605|8490323|P1|Overall Study|Discontinued prior to treatment|1
2461906|NCT02477553|8490339|P2|Overall Study|patient deceased|0
2461907|NCT02477553|8490340|P1|Overall Study|patient deceased|1
2461908|NCT02477553|8490339|P2|Overall Study|MD advised against screening|3
2461909|NCT02477553|8490340|P1|Overall Study|MD advised against screening|1
2461910|NCT02477553|8490339|P2|Overall Study|Elevated risk for CRC|2
2461911|NCT02477553|8490340|P1|Overall Study|Elevated risk for CRC|2
2461912|NCT02477553|8490339|P2|Overall Study|Technical issues with intervention|0
2461913|NCT02477553|8490340|P1|Overall Study|Technical issues with intervention|2
2461914|NCT02477553|8490339|P2|Overall Study|Workup consistent w/CRC|1
2461915|NCT02477553|8490340|P1|Overall Study|Workup consistent w/CRC|1
2461916|NCT02477553|8490339|P2|Overall Study|No MD visit|1
2461917|NCT02477553|8490340|P1|Overall Study|No MD visit|1
2461918|NCT02477553|8490339|P2|Overall Study|Screening up-to-date|13
2461919|NCT02477553|8490340|P1|Overall Study|Screening up-to-date|12
2461920|NCT02477527|8490360|P1|Overall Study|Screen Failure|3
2461921|NCT02477527|8490360|P1|Overall Study|Withdrawal by Subject|1
2461922|NCT02477527|8490360|P1|Overall Study|Lost to Follow-up|2
2461923|NCT02477332|8490374|P6|Overall Study|Withdrawal by Subject|0
2461924|NCT02477332|8490375|P5|Overall Study|Withdrawal by Subject|1
2461925|NCT02477332|8490376|P4|Overall Study|Withdrawal by Subject|2
2461926|NCT02477332|8490377|P3|Overall Study|Withdrawal by Subject|1
2461927|NCT02477332|8490378|P2|Overall Study|Withdrawal by Subject|3
2461928|NCT02477332|8490379|P1|Overall Study|Withdrawal by Subject|0
2461929|NCT02477332|8490374|P6|Overall Study|Physician Decision|1
2461930|NCT02477332|8490375|P5|Overall Study|Physician Decision|0
2461931|NCT02477332|8490376|P4|Overall Study|Physician Decision|3
2461932|NCT02477332|8490377|P3|Overall Study|Physician Decision|1
2461933|NCT02477332|8490378|P2|Overall Study|Physician Decision|0
2461934|NCT02477332|8490379|P1|Overall Study|Physician Decision|0
2461935|NCT02477332|8490374|P6|Overall Study|Lost to Follow-up|0
2461936|NCT02477332|8490375|P5|Overall Study|Lost to Follow-up|0
2461937|NCT02477332|8490376|P4|Overall Study|Lost to Follow-up|0
2461938|NCT02477332|8490377|P3|Overall Study|Lost to Follow-up|2
2461939|NCT02477332|8490378|P2|Overall Study|Lost to Follow-up|0
2461940|NCT02477332|8490379|P1|Overall Study|Lost to Follow-up|0
2461941|NCT02477332|8490374|P6|Overall Study|Technical problems|0
2461942|NCT02477332|8490375|P5|Overall Study|Technical problems|0
2461943|NCT02477332|8490376|P4|Overall Study|Technical problems|0
2461944|NCT02477332|8490377|P3|Overall Study|Technical problems|1
2461945|NCT02477332|8490378|P2|Overall Study|Technical problems|0
2461946|NCT02477332|8490379|P1|Overall Study|Technical problems|0
2461947|NCT02477332|8490374|P6|Overall Study|Protocol Violation|1
2461948|NCT02477332|8490375|P5|Overall Study|Protocol Violation|1
2461949|NCT02477332|8490376|P4|Overall Study|Protocol Violation|3
2461950|NCT02477332|8490377|P3|Overall Study|Protocol Violation|3
2461951|NCT02477332|8490378|P2|Overall Study|Protocol Violation|0
2461952|NCT02477332|8490379|P1|Overall Study|Protocol Violation|2
2461953|NCT02477332|8490374|P6|Overall Study|Pregnancy|0
2461954|NCT02477332|8490375|P5|Overall Study|Pregnancy|0
2461955|NCT02477332|8490376|P4|Overall Study|Pregnancy|1
2461956|NCT02477332|8490377|P3|Overall Study|Pregnancy|0
2461957|NCT02477332|8490378|P2|Overall Study|Pregnancy|0
2461958|NCT02477332|8490379|P1|Overall Study|Pregnancy|0
2461959|NCT02477332|8490374|P6|Overall Study|Non-compliance with study treatment|0
2461960|NCT02477332|8490375|P5|Overall Study|Non-compliance with study treatment|0
2461961|NCT02477332|8490376|P4|Overall Study|Non-compliance with study treatment|0
2461962|NCT02477332|8490377|P3|Overall Study|Non-compliance with study treatment|2
2461963|NCT02477332|8490378|P2|Overall Study|Non-compliance with study treatment|1
2461964|NCT02477332|8490379|P1|Overall Study|Non-compliance with study treatment|0
2461965|NCT02477332|8490374|P6|Overall Study|Lack of Efficacy|1
2461966|NCT02477332|8490375|P5|Overall Study|Lack of Efficacy|1
2461967|NCT02477332|8490376|P4|Overall Study|Lack of Efficacy|2
2461968|NCT02477332|8490377|P3|Overall Study|Lack of Efficacy|1
2461969|NCT02477332|8490378|P2|Overall Study|Lack of Efficacy|2
2461970|NCT02477332|8490379|P1|Overall Study|Lack of Efficacy|1
2461971|NCT02477332|8490374|P6|Overall Study|Adverse Event|2
2461972|NCT02477332|8490375|P5|Overall Study|Adverse Event|1
2461973|NCT02477332|8490376|P4|Overall Study|Adverse Event|2
2461974|NCT02477332|8490377|P3|Overall Study|Adverse Event|1
2461975|NCT02477332|8490378|P2|Overall Study|Adverse Event|1
2461976|NCT02477332|8490379|P1|Overall Study|Adverse Event|0
2461977|NCT02477215|8490457|P3|Fixed Dose Phase|Physician Decision|0
2461978|NCT02477215|8490458|P2|Fixed Dose Phase|Physician Decision|7
2461979|NCT02477215|8490459|P1|Fixed Dose Phase|Physician Decision|0
2461980|NCT02477215|8490457|P3|Dose Escalation Phase|Physician Decision|0
2461981|NCT02477215|8490458|P2|Dose Escalation Phase|Physician Decision|2
2461982|NCT02477215|8490459|P1|Dose Escalation Phase|Physician Decision|1
2461983|NCT02477020|8490475|P2|Overall Study|Lack of Efficacy|5
2461984|NCT02477020|8490476|P1|Overall Study|Lack of Efficacy|14
2461985|NCT02477020|8490475|P2|Overall Study|Reason not Specified|1
2461986|NCT02477020|8490476|P1|Overall Study|Reason not Specified|3
2461987|NCT02477020|8490475|P2|Overall Study|Voluntary Withdrawal|16
2461988|NCT02477020|8490476|P1|Overall Study|Voluntary Withdrawal|7
2461989|NCT02477020|8490475|P2|Overall Study|Pretreatment Event/Adverse Event|6
2461990|NCT02477020|8490476|P1|Overall Study|Pretreatment Event/Adverse Event|6
2461991|NCT02476994|8490506|P2|Overall Study|Based on feedback from FDA|0
2461992|NCT02476994|8490507|P1|Overall Study|Based on feedback from FDA|1
2461993|NCT02476617|8490576|P1|Overall Study|Lost to Follow-up|1
2461994|NCT02476617|8490576|P1|Overall Study|Adverse Event|1
2461995|NCT02476578|8490582|P2|Overall Study|Lost to Follow-up|13
2461996|NCT02476578|8490583|P1|Overall Study|Lost to Follow-up|6
2461997|NCT02476578|8490582|P2|Overall Study|Died before Email was sent (<9.11.2015)|43
2461998|NCT02476578|8490583|P1|Overall Study|Died before Email was sent (<9.11.2015)|35
2461999|NCT02476422|8490645|P2|Overall Study|Subject/guardian decision|1
2462000|NCT02476422|8490646|P1|Overall Study|Subject/guardian decision|0
2462001|NCT02476175|8490687|P1|Overall Study|Adverse Event|2
2462002|NCT02476006|8490711|P1|Overall Study|Enrolled but not treated|4
2462003|NCT02476006|8490711|P1|Overall Study|Protocol Violation|1
2462004|NCT02476006|8490711|P1|Overall Study|Excluded from study|1
2462005|NCT02476006|8490711|P1|Overall Study|Switched to commercial drug|4
2462006|NCT02476006|8490711|P1|Overall Study|Study ended treatment not available|4
2462007|NCT02476006|8490711|P1|Overall Study|Physician Decision|5
2462008|NCT02476006|8490711|P1|Overall Study|Lost to Follow-up|5
2462009|NCT02476006|8490711|P1|Overall Study|Sponsor decision|6
2462010|NCT02476006|8490711|P1|Overall Study|Poor compliance to study protocol|3
2462011|NCT02476006|8490711|P1|Overall Study|Adverse Event|41
2462012|NCT02476006|8490711|P1|Overall Study|Participant did not wish to continue|39
2462013|NCT02476006|8490711|P1|Overall Study|Pregnancy|1
2462014|NCT02476006|8490711|P1|Overall Study|Lack of treatment efficacy|2
2462015|NCT02476006|8490711|P1|Overall Study|Death|4
2462016|NCT02475980|8490725|P1|Overall Study|Withdrawal by Subject|1
2462017|NCT02475980|8490725|P1|Overall Study|Lost to Follow-up|4
2462018|NCT02475733|8490751|P2|Overall Study|Physician Decision|0
2462019|NCT02475733|8490752|P1|Overall Study|Physician Decision|1
2462020|NCT02475733|8490751|P2|Overall Study|Withdrawal by Subject|0
2462021|NCT02475733|8490752|P1|Overall Study|Withdrawal by Subject|1
2462022|NCT02475655|8490809|P2|Overall Study|Lost to Follow-up|1
2462023|NCT02475655|8490810|P1|Overall Study|Lost to Follow-up|0
2462024|NCT02475629|8490869|P1|Overall Study|Subject non-compliance|1
2462025|NCT02475629|8490869|P1|Overall Study|Lost to Follow-up|1
2462026|NCT02475629|8490869|P1|Overall Study|Withdrawal by Subject|1
2462027|NCT02475629|8490869|P1|Overall Study|Physician Decision|1
2462028|NCT02475629|8490869|P1|Overall Study|Death|4
2462029|NCT02475629|8490869|P1|Overall Study|Adverse Event|1
2462030|NCT02475564|8490892|P2|Overall Study|Intense Menstrual bleeding|0
2462031|NCT02475564|8490893|P1|Overall Study|Intense Menstrual bleeding|1
2462032|NCT02475564|8490892|P2|Overall Study|Lost to Follow-up|1
2462033|NCT02475564|8490893|P1|Overall Study|Lost to Follow-up|2
2462034|NCT02475564|8490892|P2|Overall Study|Withdrawal by Subject|0
2462035|NCT02475564|8490893|P1|Overall Study|Withdrawal by Subject|1
2462036|NCT02475395|8490905|P2|Overall Study|Protocol Violation|3
2462037|NCT02475395|8490906|P1|Overall Study|Protocol Violation|30
2462038|NCT02475278|8490916|P1|Overall Study|Reason Not Specified|1
2462039|NCT02475278|8490916|P1|Overall Study|Lost to Follow-up|1
2462040|NCT02475265|8490927|P1|Overall Study|Withdrawal by Subject|2
2462041|NCT02475265|8490927|P1|Overall Study|Physician Decision|1
2462042|NCT02474589|8490978|P2|Overall Study|Inability to complete study procedures|1
2462043|NCT02474589|8490979|P1|Overall Study|Inability to complete study procedures|5
2462044|NCT02474589|8490978|P2|Overall Study|Withdrawal by Subject|0
2462045|NCT02474589|8490979|P1|Overall Study|Withdrawal by Subject|4
2462046|NCT02474589|8490978|P2|Overall Study|Protocol Violation|1
2462047|NCT02474589|8490979|P1|Overall Study|Protocol Violation|4
2462048|NCT02474589|8490978|P2|Overall Study|Lost to Follow-up|1
2462049|NCT02474589|8490979|P1|Overall Study|Lost to Follow-up|6
2462050|NCT02474589|8490978|P2|Overall Study|Adverse Event|2
2462051|NCT02474589|8490979|P1|Overall Study|Adverse Event|6
2462052|NCT02474082|8491038|P2|Overall Study|Protocol deviation|1
2462053|NCT02474082|8491039|P1|Overall Study|Protocol deviation|0
2462054|NCT02474082|8491038|P2|Overall Study|Non-compliance with study treatment|2
2462055|NCT02474082|8491039|P1|Overall Study|Non-compliance with study treatment|0
2462056|NCT02474082|8491038|P2|Overall Study|Participant/guardian decision|2
2462057|NCT02474082|8491039|P1|Overall Study|Participant/guardian decision|1
2462058|NCT02474082|8491038|P2|Overall Study|Dose tapering not achieved|4
2462059|NCT02474082|8491039|P1|Overall Study|Dose tapering not achieved|0
2462060|NCT02474082|8491038|P2|Overall Study|Lost to Follow-up|2
2462061|NCT02474082|8491039|P1|Overall Study|Lost to Follow-up|2
2462062|NCT02474082|8491038|P2|Overall Study|Withdrawal of informed consent|11
2462063|NCT02474082|8491039|P1|Overall Study|Withdrawal of informed consent|1
2462064|NCT02474082|8491038|P2|Overall Study|Adverse Event|32
2462065|NCT02474082|8491039|P1|Overall Study|Adverse Event|2
2462066|NCT02474069|8491073|P3|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2
2462067|NCT02474069|8491074|P2|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2
2462068|NCT02474069|8491075|P1|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0
2462069|NCT02474069|8491073|P3|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1
2462070|NCT02474069|8491074|P2|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0
2462071|NCT02474069|8491075|P1|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0
2462072|NCT02474069|8491073|P3|Comparative Dosing Phase (CDP)|Lost to Follow-up|1
2462073|NCT02474069|8491074|P2|Comparative Dosing Phase (CDP)|Lost to Follow-up|4
2462074|NCT02474069|8491075|P1|Comparative Dosing Phase (CDP)|Lost to Follow-up|0
2462075|NCT02474069|8491073|P3|Comparative Dosing Phase (CDP)|Adverse Event|2
2462076|NCT02474069|8491074|P2|Comparative Dosing Phase (CDP)|Adverse Event|3
2462077|NCT02474069|8491075|P1|Comparative Dosing Phase (CDP)|Adverse Event|0
2462078|NCT02474069|8491073|P3|Selection Phase (SP)|Withdrawal of Informed Consent|0
2462079|NCT02474069|8491074|P2|Selection Phase (SP)|Withdrawal of Informed Consent|0
2462080|NCT02474069|8491075|P1|Selection Phase (SP)|Withdrawal of Informed Consent|3
2462081|NCT02474069|8491073|P3|Selection Phase (SP)|Withdrawal by Subject|0
2462082|NCT02474069|8491074|P2|Selection Phase (SP)|Withdrawal by Subject|0
2462083|NCT02474069|8491075|P1|Selection Phase (SP)|Withdrawal by Subject|3
2462084|NCT02474069|8491073|P3|Selection Phase (SP)|Technical Problem|0
2462085|NCT02474069|8491074|P2|Selection Phase (SP)|Technical Problem|0
2462086|NCT02474069|8491075|P1|Selection Phase (SP)|Technical Problem|1
2462087|NCT02474069|8491073|P3|Selection Phase (SP)|No longer requires treatment|0
2462088|NCT02474069|8491074|P2|Selection Phase (SP)|No longer requires treatment|0
2462089|NCT02474069|8491075|P1|Selection Phase (SP)|No longer requires treatment|1
2462090|NCT02474069|8491073|P3|Selection Phase (SP)|Protocol Violation|0
2462091|NCT02474069|8491074|P2|Selection Phase (SP)|Protocol Violation|0
2462092|NCT02474069|8491075|P1|Selection Phase (SP)|Protocol Violation|1
2462093|NCT02474069|8491073|P3|Selection Phase (SP)|Physician Decision|0
2462094|NCT02474069|8491074|P2|Selection Phase (SP)|Physician Decision|0
2462095|NCT02474069|8491075|P1|Selection Phase (SP)|Physician Decision|1
2462096|NCT02474069|8491073|P3|Selection Phase (SP)|Lost to Follow-up|0
2462097|NCT02474069|8491074|P2|Selection Phase (SP)|Lost to Follow-up|0
2462098|NCT02474069|8491075|P1|Selection Phase (SP)|Lost to Follow-up|4
2462099|NCT02474069|8491073|P3|Selection Phase (SP)|Lack of Efficacy|0
2462100|NCT02474069|8491074|P2|Selection Phase (SP)|Lack of Efficacy|0
2462101|NCT02474069|8491075|P1|Selection Phase (SP)|Lack of Efficacy|1
2462102|NCT02474069|8491073|P3|Selection Phase (SP)|Adverse Event|0
2462103|NCT02474069|8491074|P2|Selection Phase (SP)|Adverse Event|0
2462104|NCT02474069|8491075|P1|Selection Phase (SP)|Adverse Event|8
2462105|NCT02473965|8491108|P2|Overall Study|Physician Decision|2
2462106|NCT02473965|8491109|P1|Overall Study|Physician Decision|0
2462107|NCT02473965|8491108|P2|Overall Study|Withdrawal by Subject|3
2462108|NCT02473965|8491109|P1|Overall Study|Withdrawal by Subject|2
2462109|NCT02473965|8491108|P2|Overall Study|MG worsening|1
2462110|NCT02473965|8491109|P1|Overall Study|MG worsening|4
2462111|NCT02473965|8491108|P2|Overall Study|Adverse Event|4
2462112|NCT02473965|8491109|P1|Overall Study|Adverse Event|6
2462113|NCT02473952|8491121|P2|Overall Study|Withdrawal by Subject|6
2462114|NCT02473952|8491122|P1|Overall Study|Withdrawal by Subject|0
2462115|NCT02473952|8491121|P2|Overall Study|Adverse Event|2
2462116|NCT02473952|8491122|P1|Overall Study|Adverse Event|2
2462117|NCT02473640|8491162|P1|Treatment Period 1|Adverse Event|1
2462118|NCT02473523|8491171|P1|Overall Study|Lost to Follow-up|1
2462119|NCT02473523|8491171|P1|Overall Study|Death|1
2462120|NCT02473510|8491192|P2|Overall Study|Lost to Follow-up|2
2462121|NCT02473510|8491193|P1|Overall Study|Lost to Follow-up|1
2462122|NCT02473471|8491207|P1|Overall Study|Lost to Follow-up|1
2462123|NCT02473471|8491207|P1|Overall Study|poor oral hygiene|2
2462124|NCT02473445|8491238|P1|Overall Study|Sponsor Decision|20
2462125|NCT02473445|8491238|P1|Overall Study|Withdrawal by Subject|2
2462126|NCT02473367|8491244|P1|Period 4|Lost to Follow-up|1
2462127|NCT02473367|8491244|P1|Wait 1|Withdrawal by Subject|1
2462128|NCT02473289|8491264|P2|Overall Study|Other|0
2462129|NCT02473289|8491265|P1|Overall Study|Other|2
2462130|NCT02473289|8491264|P2|Overall Study|Treatment Unblinded + Adverse event|1
2462131|NCT02473289|8491265|P1|Overall Study|Treatment Unblinded + Adverse event|0
2462132|NCT02473289|8491264|P2|Overall Study|Withdrawal of consent|7
2462133|NCT02473289|8491265|P1|Overall Study|Withdrawal of consent|6
2462134|NCT02473289|8491264|P2|Overall Study|Protocol Violation|1
2462135|NCT02473289|8491265|P1|Overall Study|Protocol Violation|0
2462136|NCT02473289|8491264|P2|Overall Study|Lost to Follow-up|1
2462137|NCT02473289|8491265|P1|Overall Study|Lost to Follow-up|1
2462138|NCT02473289|8491264|P2|Overall Study|Adverse Event|3
2462139|NCT02473289|8491265|P1|Overall Study|Adverse Event|2
2462140|NCT02472977|8491290|P3|Overall Study|Subject request to discontinue treatment|0
2462141|NCT02472977|8491291|P2|Overall Study|Subject request to discontinue treatment|1
2462142|NCT02472977|8491292|P1|Overall Study|Subject request to discontinue treatment|0
2462143|NCT02472977|8491290|P3|Overall Study|Study drug toxicity|2
2462144|NCT02472977|8491291|P2|Overall Study|Study drug toxicity|0
2462145|NCT02472977|8491292|P1|Overall Study|Study drug toxicity|2
2462146|NCT02472977|8491290|P3|Overall Study|Withdrawal by Subject|0
2462147|NCT02472977|8491291|P2|Overall Study|Withdrawal by Subject|1
2462148|NCT02472977|8491292|P1|Overall Study|Withdrawal by Subject|0
2462149|NCT02472977|8491290|P3|Overall Study|Disease progression|6
2462150|NCT02472977|8491291|P2|Overall Study|Disease progression|25
2462151|NCT02472977|8491292|P1|Overall Study|Disease progression|4
2462152|NCT02472964|8491317|P2|Part 2 (Week 24-week 48)|Protocol Violation|1
2462153|NCT02472964|8491318|P1|Part 2 (Week 24-week 48)|Protocol Violation|3
2462154|NCT02472964|8491317|P2|Part 2 (Week 24-week 48)|Withdrawal by Subject|1
2462155|NCT02472964|8491318|P1|Part 2 (Week 24-week 48)|Withdrawal by Subject|3
2462156|NCT02472964|8491317|P2|Part 2 (Week 24-week 48)|Lost to Follow-up|1
2462157|NCT02472964|8491318|P1|Part 2 (Week 24-week 48)|Lost to Follow-up|2
2462158|NCT02472964|8491317|P2|Part 2 (Week 24-week 48)|Physician Decision|1
2462159|NCT02472964|8491318|P1|Part 2 (Week 24-week 48)|Physician Decision|1
2462160|NCT02472964|8491317|P2|Part 2 (Week 24-week 48)|Death|1
2462161|NCT02472964|8491318|P1|Part 2 (Week 24-week 48)|Death|0
2462162|NCT02472964|8491317|P2|Part 2 (Week 24-week 48)|Disease Progression|56
2462163|NCT02472964|8491318|P1|Part 2 (Week 24-week 48)|Disease Progression|52
2462164|NCT02472964|8491317|P2|Part 2 (Week 24-week 48)|Adverse Event|2
2462165|NCT02472964|8491318|P1|Part 2 (Week 24-week 48)|Adverse Event|4
2462166|NCT02472964|8491317|P2|Part 1 (up to Week 24)|Other|1
2462167|NCT02472964|8491318|P1|Part 1 (up to Week 24)|Other|2
2462168|NCT02472964|8491317|P2|Part 1 (up to Week 24)|Withdrawal by Subject|2
2462169|NCT02472964|8491318|P1|Part 1 (up to Week 24)|Withdrawal by Subject|7
2462170|NCT02472964|8491317|P2|Part 1 (up to Week 24)|Lost to Follow-up|1
2462171|NCT02472964|8491318|P1|Part 1 (up to Week 24)|Lost to Follow-up|0
2462172|NCT02472964|8491317|P2|Part 1 (up to Week 24)|Physician Decision|1
2462173|NCT02472964|8491318|P1|Part 1 (up to Week 24)|Physician Decision|3
2462174|NCT02472964|8491317|P2|Part 1 (up to Week 24)|Death|6
2462175|NCT02472964|8491318|P1|Part 1 (up to Week 24)|Death|3
2462176|NCT02472964|8491317|P2|Part 1 (up to Week 24)|disease progression|47
2462177|NCT02472964|8491318|P1|Part 1 (up to Week 24)|disease progression|58
2462178|NCT02472964|8491317|P2|Part 1 (up to Week 24)|Adverse Event|4
2462179|NCT02472964|8491318|P1|Part 1 (up to Week 24)|Adverse Event|2
2462180|NCT02472886|8491327|P3|Overall Study|Lack of Efficacy|1
2462181|NCT02472886|8491328|P2|Overall Study|Lack of Efficacy|2
2462182|NCT02472886|8491329|P1|Overall Study|Lack of Efficacy|0
2462183|NCT02472847|8491357|P2|Overall Study|Withdrawal by Subject|5
2462184|NCT02472847|8491358|P1|Overall Study|Withdrawal by Subject|1
2462185|NCT02472795|8491369|P5|Overall Study|Withdrawal by Subject|1
2462186|NCT02472795|8491370|P4|Overall Study|Withdrawal by Subject|0
2462187|NCT02472795|8491371|P3|Overall Study|Withdrawal by Subject|0
2462188|NCT02472795|8491372|P2|Overall Study|Withdrawal by Subject|0
2462189|NCT02472795|8491373|P1|Overall Study|Withdrawal by Subject|0
2462190|NCT02472795|8491369|P5|Overall Study|Adverse Event|2
2462191|NCT02472795|8491370|P4|Overall Study|Adverse Event|0
2462192|NCT02472795|8491371|P3|Overall Study|Adverse Event|0
2462193|NCT02472795|8491372|P2|Overall Study|Adverse Event|1
2462194|NCT02472795|8491373|P1|Overall Study|Adverse Event|0
2462195|NCT02472756|8491405|P1|Maintenance (Approximately 2 Years)|Adverse Event|1
2462196|NCT02472756|8491405|P1|Maintenance (Approximately 2 Years)|Progression Disease|2
2462197|NCT02472756|8491405|P1|Maintenance (Approximately 2 Years)|Lack of Drug|7
2462198|NCT02472756|8491405|P1|Induction (Approximately 6 Months)|Enrolled But Not Treated|1
2462199|NCT02472756|8491405|P1|Induction (Approximately 6 Months)|Adverse Event|1
2462200|NCT02472652|8491426|P1|Overall Study|Lost to Follow-up|1
2462201|NCT02472639|8491433|P2|Overall Study|Physician Decision|3
2462202|NCT02472639|8491434|P1|Overall Study|Physician Decision|4
2462203|NCT02472405|8491481|P1|Overall Study|Adverse Event|1
2462204|NCT02472405|8491481|P1|Overall Study|Lost to Follow-up|9
2462205|NCT02472366|8491489|P2|Overall Study|Lost to Follow-up|0
2462206|NCT02472366|8491490|P1|Overall Study|Lost to Follow-up|1
2462207|NCT02472353|8491506|P2|Overall Study|Study Termination|4
2462208|NCT02472353|8491507|P1|Overall Study|Study Termination|1
2462209|NCT02472353|8491506|P2|Overall Study|Withdrawal by Subject|1
2462210|NCT02472353|8491507|P1|Overall Study|Withdrawal by Subject|2
2462211|NCT02472353|8491506|P2|Overall Study|Lost to Follow-up|1
2462212|NCT02472353|8491507|P1|Overall Study|Lost to Follow-up|1
2462213|NCT02472145|8491544|P3|Overall Study|Other|43
2462214|NCT02472145|8491545|P2|Overall Study|Other|45
2462215|NCT02472145|8491546|P1|Overall Study|Other|0
2462216|NCT02472145|8491544|P3|Overall Study|Sponsor decision|2
2462217|NCT02472145|8491545|P2|Overall Study|Sponsor decision|3
2462218|NCT02472145|8491546|P1|Overall Study|Sponsor decision|0
2462219|NCT02472145|8491544|P3|Overall Study|Withdrawal by Subject|13
2462220|NCT02472145|8491545|P2|Overall Study|Withdrawal by Subject|9
2462221|NCT02472145|8491546|P1|Overall Study|Withdrawal by Subject|0
2462222|NCT02472145|8491544|P3|Overall Study|Lost to Follow-up|0
2462223|NCT02472145|8491545|P2|Overall Study|Lost to Follow-up|1
2462224|NCT02472145|8491546|P1|Overall Study|Lost to Follow-up|0
2462225|NCT02472145|8491544|P3|Overall Study|Death|99
2462226|NCT02472145|8491545|P2|Overall Study|Death|101
2462227|NCT02472145|8491546|P1|Overall Study|Death|10
2462228|NCT02471755|8491567|P2|Overall Study|Lost to Follow-up|1
2462229|NCT02471755|8491568|P1|Overall Study|Lost to Follow-up|0
2462230|NCT02471755|8491567|P2|Overall Study|Withdrawal by Subject|0
2462231|NCT02471755|8491568|P1|Overall Study|Withdrawal by Subject|1
2462232|NCT02471612|8491597|P1|Overall Study|Lost to Follow-up|2
2462233|NCT02471404|8491628|P3|Overall Study|Other reasons not specified|12
2462234|NCT02471404|8491629|P2|Overall Study|Other reasons not specified|7
2462235|NCT02471404|8491630|P1|Overall Study|Other reasons not specified|10
2462236|NCT02471404|8491628|P3|Overall Study|Withdrawal by Subject|5
2462237|NCT02471404|8491629|P2|Overall Study|Withdrawal by Subject|4
2462238|NCT02471404|8491630|P1|Overall Study|Withdrawal by Subject|8
2462239|NCT02471404|8491628|P3|Overall Study|Protocol Violation|0
2462240|NCT02471404|8491629|P2|Overall Study|Protocol Violation|0
2462241|NCT02471404|8491630|P1|Overall Study|Protocol Violation|1
2462242|NCT02471404|8491628|P3|Overall Study|Lost to Follow-up|3
2462243|NCT02471404|8491629|P2|Overall Study|Lost to Follow-up|1
2462244|NCT02471404|8491630|P1|Overall Study|Lost to Follow-up|1
2462245|NCT02471404|8491628|P3|Overall Study|Failure to Meet Randomization Criteria|1
2462246|NCT02471404|8491629|P2|Overall Study|Failure to Meet Randomization Criteria|0
2462247|NCT02471404|8491630|P1|Overall Study|Failure to Meet Randomization Criteria|2
2462248|NCT02471404|8491628|P3|Overall Study|Developed Study Withdrawal Criteria|2
2462249|NCT02471404|8491629|P2|Overall Study|Developed Study Withdrawal Criteria|1
2462250|NCT02471404|8491630|P1|Overall Study|Developed Study Withdrawal Criteria|4
2462251|NCT02471404|8491628|P3|Overall Study|Adverse Event|2
2462252|NCT02471404|8491629|P2|Overall Study|Adverse Event|1
2462253|NCT02471404|8491630|P1|Overall Study|Adverse Event|7
2462254|NCT02471183|8491662|P1|Extended Treatment Period|Lack of Efficacy|1
2462255|NCT02471183|8491662|P1|Main Treatment Period|Withdrawal by Subject|1
2462256|NCT02471183|8491662|P1|Main Treatment Period|Adverse Event|1
2462257|NCT02470806|8491697|P2|Overall Study|Lack of Efficacy|15
2462258|NCT02470806|8491698|P1|Overall Study|Lack of Efficacy|5
2462259|NCT02470806|8491697|P2|Overall Study|Withdrawal by Subject|10
2462260|NCT02470806|8491698|P1|Overall Study|Withdrawal by Subject|3
2462261|NCT02470806|8491697|P2|Overall Study|Physician Decision|3
2462262|NCT02470806|8491698|P1|Overall Study|Physician Decision|0
2462263|NCT02470806|8491697|P2|Overall Study|Protocol Violation|11
2462264|NCT02470806|8491698|P1|Overall Study|Protocol Violation|4
2462265|NCT02470806|8491697|P2|Overall Study|Adverse Event|2
2462266|NCT02470806|8491698|P1|Overall Study|Adverse Event|5
2462267|NCT02470806|8491697|P2|Overall Study|Lost to Follow-up|1
2462268|NCT02470806|8491698|P1|Overall Study|Lost to Follow-up|1
2462269|NCT02470429|8491758|P2|Overall Study|Withdrawal by Subject|0
2462270|NCT02470429|8491759|P1|Overall Study|Withdrawal by Subject|1
2462271|NCT02470429|8491758|P2|Overall Study|Adverse Event|0
2462272|NCT02470429|8491759|P1|Overall Study|Adverse Event|1
2462273|NCT02470403|8491777|P5|Overall Study|Subject/guardian decision|0
2462274|NCT02470403|8491778|P4|Overall Study|Subject/guardian decision|4
2462275|NCT02470403|8491779|P3|Overall Study|Subject/guardian decision|0
2462276|NCT02470403|8491780|P2|Overall Study|Subject/guardian decision|0
2462277|NCT02470403|8491781|P1|Overall Study|Subject/guardian decision|1
2462278|NCT02470403|8491777|P5|Overall Study|Lost to Follow-up|0
2462279|NCT02470403|8491778|P4|Overall Study|Lost to Follow-up|0
2462280|NCT02470403|8491779|P3|Overall Study|Lost to Follow-up|0
2462281|NCT02470403|8491780|P2|Overall Study|Lost to Follow-up|1
2462282|NCT02470403|8491781|P1|Overall Study|Lost to Follow-up|0
2462283|NCT02470403|8491777|P5|Overall Study|Adverse Event|0
2462284|NCT02470403|8491778|P4|Overall Study|Adverse Event|0
2462285|NCT02470403|8491779|P3|Overall Study|Adverse Event|0
2462286|NCT02470403|8491780|P2|Overall Study|Adverse Event|0
2462287|NCT02470403|8491781|P1|Overall Study|Adverse Event|1
2462288|NCT02469961|8491861|P2|Overall Study|Physician Decision|1
2462289|NCT02469961|8491862|P1|Overall Study|Physician Decision|4
2462290|NCT02469896|8491876|P2|Overall Study|Withdrawal by Subject|0
2462291|NCT02469896|8491877|P1|Overall Study|Withdrawal by Subject|2
2462292|NCT02469623|8491947|P1|Overall Study|Death|3
2462293|NCT02469623|8491947|P1|Overall Study|Withdrawal by Subject|2
2462294|NCT02469623|8491947|P1|Overall Study|Lost to Follow-up|4
2462295|NCT02469623|8491947|P1|Overall Study|Not consented for long-term follow-up|4
2462296|NCT02469610|8491954|P2|Overall Study|exclusion criteria|1
2462297|NCT02469610|8491955|P1|Overall Study|exclusion criteria|2
2462298|NCT02469610|8491954|P2|Overall Study|Lost to Follow-up|0
2462299|NCT02469610|8491955|P1|Overall Study|Lost to Follow-up|1
2462300|NCT02469610|8491954|P2|Overall Study|Death|0
2462301|NCT02469610|8491955|P1|Overall Study|Death|1
2462302|NCT02469415|8491982|P1|Overall Study|Investigational agent placed on hold|2
2462303|NCT02469415|8491982|P1|Overall Study|Withdrawal by Subject|1
2462304|NCT02469298|8491990|P4|Overall Study|Withdrawal by Subject|1
2462305|NCT02469298|8491991|P3|Overall Study|Withdrawal by Subject|0
2462306|NCT02469298|8491992|P2|Overall Study|Withdrawal by Subject|0
2462307|NCT02469298|8491993|P1|Overall Study|Withdrawal by Subject|0
2462308|NCT02469298|8491990|P4|Overall Study|Physician Decision|1
2462309|NCT02469298|8491991|P3|Overall Study|Physician Decision|0
2462310|NCT02469298|8491992|P2|Overall Study|Physician Decision|0
2462311|NCT02469298|8491993|P1|Overall Study|Physician Decision|0
2462312|NCT02469298|8491990|P4|Overall Study|Lost to Follow-up|0
2462313|NCT02469298|8491991|P3|Overall Study|Lost to Follow-up|1
2462314|NCT02469298|8491992|P2|Overall Study|Lost to Follow-up|0
2462315|NCT02469298|8491993|P1|Overall Study|Lost to Follow-up|1
2462316|NCT02469298|8491990|P4|Overall Study|Protocol Violation|0
2462317|NCT02469298|8491991|P3|Overall Study|Protocol Violation|1
2462318|NCT02469298|8491992|P2|Overall Study|Protocol Violation|1
2462319|NCT02469298|8491993|P1|Overall Study|Protocol Violation|0
2462320|NCT02469246|8492133|P2|Double-Blind Phase|Lost to Follow-up|5
2462321|NCT02469246|8492134|P1|Double-Blind Phase|Lost to Follow-up|9
2462322|NCT02469246|8492133|P2|Double-Blind Phase|Withdrew Consent|25
2462323|NCT02469246|8492134|P1|Double-Blind Phase|Withdrew Consent|25
2462324|NCT02469246|8492133|P2|Double-Blind Phase|Protocol Violation|1
2462325|NCT02469246|8492134|P1|Double-Blind Phase|Protocol Violation|1
2462326|NCT02469246|8492133|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
2462327|NCT02469246|8492134|P1|Double-Blind Phase|Non-Compliance with Study Drug|3
2462328|NCT02469246|8492133|P2|Double-Blind Phase|Investigator's Discretion|8
2462329|NCT02469246|8492134|P1|Double-Blind Phase|Investigator's Discretion|8
2462330|NCT02469246|8492133|P2|Double-Blind Phase|Lack of Efficacy|1
2462331|NCT02469246|8492134|P1|Double-Blind Phase|Lack of Efficacy|2
2462332|NCT02469246|8492133|P2|Double-Blind Phase|Death|0
2462333|NCT02469246|8492134|P1|Double-Blind Phase|Death|2
2462334|NCT02469246|8492133|P2|Double-Blind Phase|Adverse Event|9
2462335|NCT02469246|8492134|P1|Double-Blind Phase|Adverse Event|12
2462336|NCT02469246|8492133|P2|Double-Blind Phase|Randomized and Never Treated|6
2462337|NCT02469246|8492134|P1|Double-Blind Phase|Randomized and Never Treated|5
2462338|NCT02469168|8492166|P2|Overall Study|Trial closed|0
2462339|NCT02469168|8492167|P1|Overall Study|Trial closed|1
2462340|NCT02469064|8492187|P2|Overall Study|Request not to receive intervention.|3
2462341|NCT02469064|8492188|P1|Overall Study|Request not to receive intervention.|1
2462342|NCT02468934|8492196|P1|Overall Study|Screen Failure|3
2462343|NCT02468934|8492196|P1|Overall Study|Withdrawal by Subject|4
2462344|NCT02468674|8492247|P9|Overall Study|Protocol Deviation|1
2462345|NCT02468674|8492248|P8|Overall Study|Protocol Deviation|1
2462346|NCT02468674|8492249|P7|Overall Study|Protocol Deviation|0
2462347|NCT02468674|8492250|P6|Overall Study|Protocol Deviation|0
2462348|NCT02468674|8492251|P5|Overall Study|Protocol Deviation|0
2462349|NCT02468674|8492252|P4|Overall Study|Protocol Deviation|0
2462350|NCT02468674|8492253|P3|Overall Study|Protocol Deviation|0
2462351|NCT02468674|8492254|P2|Overall Study|Protocol Deviation|0
2462352|NCT02468674|8492255|P1|Overall Study|Protocol Deviation|0
2462353|NCT02468674|8492247|P9|Overall Study|Patient/Guardian Decision|1
2462354|NCT02468674|8492248|P8|Overall Study|Patient/Guardian Decision|2
2462355|NCT02468674|8492249|P7|Overall Study|Patient/Guardian Decision|0
2462356|NCT02468674|8492250|P6|Overall Study|Patient/Guardian Decision|0
2462357|NCT02468674|8492251|P5|Overall Study|Patient/Guardian Decision|1
2462358|NCT02468674|8492252|P4|Overall Study|Patient/Guardian Decision|0
2462359|NCT02468674|8492253|P3|Overall Study|Patient/Guardian Decision|0
2462360|NCT02468674|8492254|P2|Overall Study|Patient/Guardian Decision|0
2462361|NCT02468674|8492255|P1|Overall Study|Patient/Guardian Decision|0
2462362|NCT02468674|8492247|P9|Overall Study|Physician Decision|0
2462363|NCT02468674|8492248|P8|Overall Study|Physician Decision|0
2462364|NCT02468674|8492249|P7|Overall Study|Physician Decision|1
2462365|NCT02468674|8492250|P6|Overall Study|Physician Decision|0
2462366|NCT02468674|8492251|P5|Overall Study|Physician Decision|0
2462367|NCT02468674|8492252|P4|Overall Study|Physician Decision|0
2462368|NCT02468674|8492253|P3|Overall Study|Physician Decision|0
2462369|NCT02468674|8492254|P2|Overall Study|Physician Decision|0
2462370|NCT02468674|8492255|P1|Overall Study|Physician Decision|0
2462371|NCT02468674|8492247|P9|Overall Study|Lost to Follow-up|1
2462372|NCT02468674|8492248|P8|Overall Study|Lost to Follow-up|1
2462373|NCT02468674|8492249|P7|Overall Study|Lost to Follow-up|0
2462374|NCT02468674|8492250|P6|Overall Study|Lost to Follow-up|0
2462375|NCT02468674|8492251|P5|Overall Study|Lost to Follow-up|0
2462376|NCT02468674|8492252|P4|Overall Study|Lost to Follow-up|0
2462377|NCT02468674|8492253|P3|Overall Study|Lost to Follow-up|0
2462378|NCT02468674|8492254|P2|Overall Study|Lost to Follow-up|0
2462379|NCT02468674|8492255|P1|Overall Study|Lost to Follow-up|1
2462380|NCT02468674|8492247|P9|Overall Study|Adverse Event|0
2462381|NCT02468674|8492248|P8|Overall Study|Adverse Event|0
2462382|NCT02468674|8492249|P7|Overall Study|Adverse Event|0
2462383|NCT02468674|8492250|P6|Overall Study|Adverse Event|1
2462384|NCT02468674|8492251|P5|Overall Study|Adverse Event|0
2462385|NCT02468674|8492252|P4|Overall Study|Adverse Event|1
2462386|NCT02468674|8492253|P3|Overall Study|Adverse Event|0
2462387|NCT02468674|8492254|P2|Overall Study|Adverse Event|0
2462388|NCT02468674|8492255|P1|Overall Study|Adverse Event|0
2462389|NCT02468648|8492311|P1|Overall Study|Death|1
2462390|NCT02468414|8492359|P2|Overall Study|Screen Failure|0
2462391|NCT02468414|8492360|P1|Overall Study|Screen Failure|1
2462392|NCT02468414|8492359|P2|Overall Study|Poor in-vitro secreting TARGTs|0
2462393|NCT02468414|8492360|P1|Overall Study|Poor in-vitro secreting TARGTs|1
2462394|NCT02468414|8492359|P2|Overall Study|Early Study Termination by Sponsor|0
2462395|NCT02468414|8492360|P1|Overall Study|Early Study Termination by Sponsor|1
2462396|NCT02468193|8492366|P1|Overall Study|Subject/ Guardian decision|2
2462397|NCT02468193|8492366|P1|Overall Study|Adverse Event|4
2462398|NCT02466659|8492613|P2|Overall Study|Lost to Follow-up|2
2462399|NCT02466659|8492614|P1|Overall Study|Lost to Follow-up|5
2462400|NCT02466555|8492622|P1|Overall Study|Lost to Follow-up|2
2462401|NCT02466516|8492634|P5|Overall Study|Lost to Follow-up|0
2462402|NCT02466516|8492635|P4|Overall Study|Lost to Follow-up|0
2462403|NCT02466516|8492636|P3|Overall Study|Lost to Follow-up|1
2462404|NCT02466516|8492637|P2|Overall Study|Lost to Follow-up|0
2462405|NCT02466516|8492638|P1|Overall Study|Lost to Follow-up|2
2462406|NCT02466516|8492634|P5|Overall Study|Withdrew Consent|0
2462407|NCT02466516|8492635|P4|Overall Study|Withdrew Consent|0
2462408|NCT02466516|8492636|P3|Overall Study|Withdrew Consent|0
2462409|NCT02466516|8492637|P2|Overall Study|Withdrew Consent|0
2462410|NCT02466516|8492638|P1|Overall Study|Withdrew Consent|1
2462411|NCT02466516|8492634|P5|Overall Study|Adverse Event|0
2462412|NCT02466516|8492635|P4|Overall Study|Adverse Event|0
2462413|NCT02466516|8492636|P3|Overall Study|Adverse Event|0
2462414|NCT02466516|8492637|P2|Overall Study|Adverse Event|1
2462415|NCT02466516|8492638|P1|Overall Study|Adverse Event|1
2462416|NCT02466425|8492657|P2|Overall Study|Withdrawal by Parent/Guardian|0
2462417|NCT02466425|8492658|P1|Overall Study|Withdrawal by Parent/Guardian|2
2462418|NCT02466425|8492657|P2|Overall Study|Other|3
2462419|NCT02466425|8492658|P1|Overall Study|Other|1
2462420|NCT02466425|8492657|P2|Overall Study|Withdrawal by Subject|1
2462421|NCT02466425|8492658|P1|Overall Study|Withdrawal by Subject|0
2462422|NCT02466425|8492657|P2|Overall Study|Protocol Violation|0
2462423|NCT02466425|8492658|P1|Overall Study|Protocol Violation|1
2462424|NCT02466425|8492657|P2|Overall Study|Lost to Follow-up|0
2462425|NCT02466425|8492658|P1|Overall Study|Lost to Follow-up|3
2462426|NCT02466425|8492657|P2|Overall Study|Lack of Efficacy|1
2462427|NCT02466425|8492658|P1|Overall Study|Lack of Efficacy|4
2462428|NCT02466425|8492657|P2|Overall Study|Adverse Event|11
2462429|NCT02466425|8492658|P1|Overall Study|Adverse Event|3
2462430|NCT02465931|8492696|P2|Overall Study|Withdrawal by Subject|0
2462431|NCT02465931|8492697|P1|Overall Study|Withdrawal by Subject|1
2462432|NCT02465931|8492696|P2|Overall Study|Protocol Violation|0
2462433|NCT02465931|8492697|P1|Overall Study|Protocol Violation|1
2462434|NCT02465931|8492696|P2|Overall Study|Lost to Follow-up|11
2462435|NCT02465931|8492697|P1|Overall Study|Lost to Follow-up|9
2462436|NCT02465866|8492703|P4|Period 3|Withdrawal by Subject|0
2462437|NCT02465866|8492704|P3|Period 3|Withdrawal by Subject|0
2462438|NCT02465866|8492705|P2|Period 3|Withdrawal by Subject|1
2462439|NCT02465866|8492706|P1|Period 3|Withdrawal by Subject|0
2462440|NCT02465528|8492796|P4|Overall Study|Physician Decision|0
2462441|NCT02465528|8492797|P3|Overall Study|Physician Decision|1
2462442|NCT02465528|8492798|P2|Overall Study|Physician Decision|0
2462443|NCT02465528|8492799|P1|Overall Study|Physician Decision|0
2462444|NCT02465528|8492796|P4|Overall Study|Adverse Event|1
2462445|NCT02465528|8492797|P3|Overall Study|Adverse Event|0
2462446|NCT02465528|8492798|P2|Overall Study|Adverse Event|0
2462447|NCT02465528|8492799|P1|Overall Study|Adverse Event|0
2462448|NCT02465528|8492796|P4|Overall Study|Withdrawal by Subject|0
2462449|NCT02465528|8492797|P3|Overall Study|Withdrawal by Subject|2
2462450|NCT02465528|8492798|P2|Overall Study|Withdrawal by Subject|0
2462451|NCT02465528|8492799|P1|Overall Study|Withdrawal by Subject|0
2462452|NCT02465528|8492796|P4|Overall Study|Study terminated by sponsor|0
2462453|NCT02465528|8492797|P3|Overall Study|Study terminated by sponsor|0
2462454|NCT02465528|8492798|P2|Overall Study|Study terminated by sponsor|2
2462455|NCT02465528|8492799|P1|Overall Study|Study terminated by sponsor|1
2462456|NCT02465528|8492796|P4|Overall Study|Progressive disease|4
2462457|NCT02465528|8492797|P3|Overall Study|Progressive disease|9
2462458|NCT02465528|8492798|P2|Overall Study|Progressive disease|2
2462459|NCT02465528|8492799|P1|Overall Study|Progressive disease|0
2462460|NCT02465515|8492832|P2|Overall Study|Lost to Follow-up|51
2462461|NCT02465515|8492833|P1|Overall Study|Lost to Follow-up|68
2462462|NCT02465515|8492832|P2|Overall Study|Physician Decision|12
2462463|NCT02465515|8492833|P1|Overall Study|Physician Decision|8
2462464|NCT02465515|8492832|P2|Overall Study|Withdrawal by Subject|43
2462465|NCT02465515|8492833|P1|Overall Study|Withdrawal by Subject|74
2462466|NCT02465515|8492832|P2|Overall Study|Investigator site closed|5
2462467|NCT02465515|8492833|P1|Overall Study|Investigator site closed|4
2462468|NCT02465489|8492879|P1|Overall Study|Adverse Event|5
2462469|NCT02465463|8492908|P2|Overall Study|Protocol Violation|0
2462470|NCT02465463|8492909|P1|Overall Study|Protocol Violation|1
2462471|NCT02465463|8492908|P2|Overall Study|Death|0
2462472|NCT02465463|8492909|P1|Overall Study|Death|1
2462473|NCT02465463|8492908|P2|Overall Study|Lost to Follow-up|1
2462474|NCT02465463|8492909|P1|Overall Study|Lost to Follow-up|2
2462475|NCT02465437|8492957|P4|Overall Study|Adverse Event|0
2462476|NCT02465437|8492958|P3|Overall Study|Adverse Event|0
2462477|NCT02465437|8492959|P2|Overall Study|Adverse Event|1
2462478|NCT02465437|8492960|P1|Overall Study|Adverse Event|0
2462479|NCT02465437|8492957|P4|Overall Study|Withdrawal by Subject|1
2462480|NCT02465437|8492958|P3|Overall Study|Withdrawal by Subject|0
2462481|NCT02465437|8492959|P2|Overall Study|Withdrawal by Subject|0
2462482|NCT02465437|8492960|P1|Overall Study|Withdrawal by Subject|1
2462483|NCT02465437|8492957|P4|Overall Study|Physician Decision|0
2462484|NCT02465437|8492958|P3|Overall Study|Physician Decision|1
2462485|NCT02465437|8492959|P2|Overall Study|Physician Decision|0
2462486|NCT02465437|8492960|P1|Overall Study|Physician Decision|0
2462487|NCT02465203|8493020|P3|Overall Study|Patient/guardian decision|1
2462488|NCT02465203|8493021|P2|Overall Study|Patient/guardian decision|1
2462489|NCT02465203|8493022|P1|Overall Study|Patient/guardian decision|1
2462490|NCT02465203|8493020|P3|Overall Study|New therapy for study indication|0
2462491|NCT02465203|8493021|P2|Overall Study|New therapy for study indication|0
2462492|NCT02465203|8493022|P1|Overall Study|New therapy for study indication|4
2462493|NCT02465203|8493020|P3|Overall Study|Study terminated by sponsor|11
2462494|NCT02465203|8493021|P2|Overall Study|Study terminated by sponsor|34
2462495|NCT02465203|8493022|P1|Overall Study|Study terminated by sponsor|50
2462496|NCT02465203|8493020|P3|Overall Study|Protocol Violation|1
2462497|NCT02465203|8493021|P2|Overall Study|Protocol Violation|1
2462498|NCT02465203|8493022|P1|Overall Study|Protocol Violation|1
2462499|NCT02463409|8493182|P1|Overall Study|Screen failure|1
2462500|NCT02463409|8493182|P1|Overall Study|Withdrawal by Subject|1
2462501|NCT02463331|8493190|P2|Overall Study|Physician Decision|0
2462502|NCT02463331|8493191|P1|Overall Study|Physician Decision|3
2462503|NCT02463331|8493190|P2|Overall Study|Lack of Efficacy|0
2462504|NCT02463331|8493191|P1|Overall Study|Lack of Efficacy|6
2462505|NCT02463331|8493190|P2|Overall Study|Pregnancy|3
2462506|NCT02463331|8493191|P1|Overall Study|Pregnancy|2
2462507|NCT02463331|8493190|P2|Overall Study|Lost to Follow-up|1
2462508|NCT02463331|8493191|P1|Overall Study|Lost to Follow-up|1
2462509|NCT02463331|8493190|P2|Overall Study|Adverse Event|2
2462510|NCT02463331|8493191|P1|Overall Study|Adverse Event|4
2462511|NCT02463097|8493207|P1|Overall Study|Withdrawal by Subject|1
2462512|NCT02463071|8493216|P3|Overall Study|Lost to Follow-up|1
2462513|NCT02463071|8493217|P2|Overall Study|Lost to Follow-up|0
2462514|NCT02463071|8493218|P1|Overall Study|Lost to Follow-up|0
2462515|NCT02463071|8493216|P3|Overall Study|Protocol Violation|0
2462516|NCT02463071|8493217|P2|Overall Study|Protocol Violation|2
2462517|NCT02463071|8493218|P1|Overall Study|Protocol Violation|0
2462518|NCT02463071|8493216|P3|Overall Study|Reason not specified|4
2462519|NCT02463071|8493217|P2|Overall Study|Reason not specified|9
2462520|NCT02463071|8493218|P1|Overall Study|Reason not specified|7
2462521|NCT02463071|8493216|P3|Overall Study|Eligibility criteria not fulfilled|0
2462522|NCT02463071|8493217|P2|Overall Study|Eligibility criteria not fulfilled|0
2462523|NCT02463071|8493218|P1|Overall Study|Eligibility criteria not fulfilled|1
2462524|NCT02463071|8493216|P3|Overall Study|Death|0
2462525|NCT02463071|8493217|P2|Overall Study|Death|0
2462526|NCT02463071|8493218|P1|Overall Study|Death|1
2462527|NCT02463071|8493216|P3|Overall Study|Adverse Event|1
2462528|NCT02463071|8493217|P2|Overall Study|Adverse Event|5
2462529|NCT02463071|8493218|P1|Overall Study|Adverse Event|3
2462530|NCT02462759|8493246|P3|Part 1: Double Blind|Death|0
2462531|NCT02462759|8493247|P2|Part 1: Double Blind|Death|0
2462532|NCT02462759|8493248|P1|Part 1: Double Blind|Death|1
2462533|NCT02462720|8493296|P2|Part 2|Protocol Violation|1
2462534|NCT02462720|8493297|P1|Part 2|Protocol Violation|0
2462535|NCT02462720|8493296|P2|Part 2|Withdrawal by Subject|0
2462536|NCT02462720|8493297|P1|Part 2|Withdrawal by Subject|1
2462537|NCT02462473|8493307|P1|Overall Study|Other|3
2462538|NCT02462473|8493307|P1|Overall Study|Death|1
2462539|NCT02462083|8493387|P1|Overall Study|Other than specified|45
2462540|NCT02462083|8493387|P1|Overall Study|Worsening condition|16
2462541|NCT02462083|8493387|P1|Overall Study|Adverse Event|33
2462542|NCT02462083|8493387|P1|Overall Study|Protocol Violation|6
2462543|NCT02462083|8493387|P1|Overall Study|Pregnancy|1
2462544|NCT02462083|8493387|P1|Overall Study|Lack of Efficacy|151
2462545|NCT02462083|8493387|P1|Overall Study|Lost to Follow-up|41
2462546|NCT02462083|8493387|P1|Overall Study|Withdrawal by Subject|87
2462547|NCT02462083|8493387|P1|Overall Study|Sponsor request|39
2462548|NCT02462057|8493396|P5|Overall Study|Joined HealthyFood Before Intervention|17
2462549|NCT02462057|8493397|P4|Overall Study|Joined HealthyFood Before Intervention|16
2462550|NCT02462057|8493398|P3|Overall Study|Joined HealthyFood Before Intervention|23
2462551|NCT02462057|8493399|P2|Overall Study|Joined HealthyFood Before Intervention|13
2462552|NCT02462057|8493400|P1|Overall Study|Joined HealthyFood Before Intervention|22
2462553|NCT02462057|8493396|P5|Overall Study|Left Vitality|33
2462554|NCT02462057|8493397|P4|Overall Study|Left Vitality|35
2462555|NCT02462057|8493398|P3|Overall Study|Left Vitality|23
2462556|NCT02462057|8493399|P2|Overall Study|Left Vitality|27
2462557|NCT02462057|8493400|P1|Overall Study|Left Vitality|32
2462558|NCT02461758|8493446|P4|Overall Study|Lost to Follow-up|0
2462559|NCT02461758|8493447|P3|Overall Study|Lost to Follow-up|1
2462560|NCT02461758|8493448|P2|Overall Study|Lost to Follow-up|1
2462561|NCT02461758|8493449|P1|Overall Study|Lost to Follow-up|0
2462562|NCT02461628|8493490|P2|Overall Study|Refused to complete survey|7
2462563|NCT02461628|8493491|P1|Overall Study|Refused to complete survey|4
2462564|NCT02461589|8493515|P10|Overall Study|Withdrawal from trial before exposure|1
2462565|NCT02461589|8493516|P9|Overall Study|Withdrawal from trial before exposure|0
2462566|NCT02461589|8493517|P8|Overall Study|Withdrawal from trial before exposure|0
2462567|NCT02461589|8493518|P7|Overall Study|Withdrawal from trial before exposure|0
2462568|NCT02461589|8493519|P6|Overall Study|Withdrawal from trial before exposure|0
2462569|NCT02461589|8493520|P5|Overall Study|Withdrawal from trial before exposure|0
2462570|NCT02461589|8493521|P4|Overall Study|Withdrawal from trial before exposure|0
2462571|NCT02461589|8493522|P3|Overall Study|Withdrawal from trial before exposure|0
2462572|NCT02461589|8493523|P2|Overall Study|Withdrawal from trial before exposure|0
2462573|NCT02461589|8493524|P1|Overall Study|Withdrawal from trial before exposure|0
2462574|NCT02461589|8493515|P10|Overall Study|Missing follow-up information|0
2462575|NCT02461589|8493516|P9|Overall Study|Missing follow-up information|0
2462576|NCT02461589|8493517|P8|Overall Study|Missing follow-up information|0
2462577|NCT02461589|8493518|P7|Overall Study|Missing follow-up information|1
2462578|NCT02461589|8493519|P6|Overall Study|Missing follow-up information|0
2462579|NCT02461589|8493520|P5|Overall Study|Missing follow-up information|0
2462580|NCT02461589|8493521|P4|Overall Study|Missing follow-up information|0
2462581|NCT02461589|8493522|P3|Overall Study|Missing follow-up information|0
2462582|NCT02461589|8493523|P2|Overall Study|Missing follow-up information|1
2462583|NCT02461589|8493524|P1|Overall Study|Missing follow-up information|1
2462584|NCT02461589|8493515|P10|Overall Study|Unclassified|2
2462585|NCT02461589|8493516|P9|Overall Study|Unclassified|0
2462586|NCT02461589|8493517|P8|Overall Study|Unclassified|0
2462587|NCT02461589|8493518|P7|Overall Study|Unclassified|1
2462588|NCT02461589|8493519|P6|Overall Study|Unclassified|0
2462589|NCT02461589|8493520|P5|Overall Study|Unclassified|0
2462590|NCT02461589|8493521|P4|Overall Study|Unclassified|0
2462591|NCT02461589|8493522|P3|Overall Study|Unclassified|0
2462592|NCT02461589|8493523|P2|Overall Study|Unclassified|0
2462593|NCT02461589|8493524|P1|Overall Study|Unclassified|0
2462594|NCT02461589|8493515|P10|Overall Study|Death|0
2462595|NCT02461589|8493516|P9|Overall Study|Death|0
2462596|NCT02461589|8493517|P8|Overall Study|Death|1
2462597|NCT02461589|8493518|P7|Overall Study|Death|0
2462598|NCT02461589|8493519|P6|Overall Study|Death|0
2462599|NCT02461589|8493520|P5|Overall Study|Death|0
2462600|NCT02461589|8493521|P4|Overall Study|Death|0
2462601|NCT02461589|8493522|P3|Overall Study|Death|0
2462602|NCT02461589|8493523|P2|Overall Study|Death|0
2462603|NCT02461589|8493524|P1|Overall Study|Death|0
2462604|NCT02461589|8493515|P10|Overall Study|Lost to Follow-up|1
2462605|NCT02461589|8493516|P9|Overall Study|Lost to Follow-up|3
2462606|NCT02461589|8493517|P8|Overall Study|Lost to Follow-up|1
2462607|NCT02461589|8493518|P7|Overall Study|Lost to Follow-up|3
2462608|NCT02461589|8493519|P6|Overall Study|Lost to Follow-up|1
2462609|NCT02461589|8493520|P5|Overall Study|Lost to Follow-up|1
2462610|NCT02461589|8493521|P4|Overall Study|Lost to Follow-up|3
2462611|NCT02461589|8493522|P3|Overall Study|Lost to Follow-up|2
2462612|NCT02461589|8493523|P2|Overall Study|Lost to Follow-up|0
2462613|NCT02461589|8493524|P1|Overall Study|Lost to Follow-up|0
2462614|NCT02461589|8493515|P10|Overall Study|Withdrawal by Subject|1
2462615|NCT02461589|8493516|P9|Overall Study|Withdrawal by Subject|3
2462616|NCT02461589|8493517|P8|Overall Study|Withdrawal by Subject|3
2462617|NCT02461589|8493518|P7|Overall Study|Withdrawal by Subject|1
2462618|NCT02461589|8493519|P6|Overall Study|Withdrawal by Subject|2
2462619|NCT02461589|8493520|P5|Overall Study|Withdrawal by Subject|1
2462620|NCT02461589|8493521|P4|Overall Study|Withdrawal by Subject|2
2462621|NCT02461589|8493522|P3|Overall Study|Withdrawal by Subject|3
2462622|NCT02461589|8493523|P2|Overall Study|Withdrawal by Subject|1
2462623|NCT02461589|8493524|P1|Overall Study|Withdrawal by Subject|5
2462624|NCT02461290|8493657|P1|Overall Study|Lost to Follow-up|3
2462625|NCT02461290|8493657|P1|Overall Study|Withdrawn for Inadequate Clinical Stage|7
2462626|NCT02461160|8493677|P13|Overall Study|Lost to Follow-up|0
2462627|NCT02461160|8493678|P12|Overall Study|Lost to Follow-up|0
2462628|NCT02461160|8493679|P11|Overall Study|Lost to Follow-up|0
2462629|NCT02461160|8493680|P10|Overall Study|Lost to Follow-up|0
2462630|NCT02461160|8493681|P9|Overall Study|Lost to Follow-up|0
2462631|NCT02461160|8493682|P8|Overall Study|Lost to Follow-up|1
2462632|NCT02461160|8493683|P7|Overall Study|Lost to Follow-up|0
2462633|NCT02461160|8493684|P6|Overall Study|Lost to Follow-up|0
2462634|NCT02461160|8493685|P5|Overall Study|Lost to Follow-up|0
2462635|NCT02461160|8493686|P4|Overall Study|Lost to Follow-up|0
2462636|NCT02461160|8493687|P3|Overall Study|Lost to Follow-up|0
2462637|NCT02461160|8493688|P2|Overall Study|Lost to Follow-up|0
2462638|NCT02461160|8493689|P1|Overall Study|Lost to Follow-up|0
2462639|NCT02461134|8493900|P1|Overall Study|Adverse Event|1
2462640|NCT02460991|8493908|P2|Overall Study|Withdrawal by Subject|2
2462641|NCT02460991|8493909|P1|Overall Study|Withdrawal by Subject|0
2462642|NCT02460978|8493926|P3|Overall Study|Pregnancy|2
2462643|NCT02460978|8493927|P2|Overall Study|Pregnancy|0
2462644|NCT02460978|8493928|P1|Overall Study|Pregnancy|0
2462645|NCT02460978|8493926|P3|Overall Study|Discontinued due to DKA/hypoglycemia|4
2462646|NCT02460978|8493927|P2|Overall Study|Discontinued due to DKA/hypoglycemia|5
2462647|NCT02460978|8493928|P1|Overall Study|Discontinued due to DKA/hypoglycemia|2
2462648|NCT02460978|8493926|P3|Overall Study|Protocol Violation|1
2462649|NCT02460978|8493927|P2|Overall Study|Protocol Violation|1
2462650|NCT02460978|8493928|P1|Overall Study|Protocol Violation|1
2462651|NCT02460978|8493926|P3|Overall Study|Lost to Follow-up|1
2462652|NCT02460978|8493927|P2|Overall Study|Lost to Follow-up|3
2462653|NCT02460978|8493928|P1|Overall Study|Lost to Follow-up|2
2462654|NCT02460978|8493926|P3|Overall Study|Withdrawal by Subject|14
2462655|NCT02460978|8493927|P2|Overall Study|Withdrawal by Subject|5
2462656|NCT02460978|8493928|P1|Overall Study|Withdrawal by Subject|5
2462657|NCT02460978|8493926|P3|Overall Study|Adverse Event|11
2462658|NCT02460978|8493927|P2|Overall Study|Adverse Event|11
2462659|NCT02460978|8493928|P1|Overall Study|Adverse Event|17
2462660|NCT02460822|8493954|P1|Overall Study|Withdrawal by Subject|1
2462661|NCT02460562|8493965|P2|Overall Study|Lost to Follow-up|16
2462662|NCT02460562|8493966|P1|Overall Study|Lost to Follow-up|15
2462663|NCT02460380|8493982|P2|Overall Study|Withdrawal by Subject|5
2462664|NCT02460380|8493983|P1|Overall Study|Withdrawal by Subject|10
2462665|NCT02460159|8494019|P2|Overall Study|Withdrawal by Subject|0
2462666|NCT02460159|8494020|P1|Overall Study|Withdrawal by Subject|2
2462667|NCT02460159|8494019|P2|Overall Study|Adverse Event|1
2462668|NCT02460159|8494020|P1|Overall Study|Adverse Event|4
2462669|NCT02459951|8494048|P1|Overall Study|Unable to meet holding requirement|1
2462670|NCT02459899|8494059|P4|Overall Study|Withdrawal by Subject|0
2462671|NCT02459899|8494060|P3|Overall Study|Withdrawal by Subject|0
2462672|NCT02459899|8494061|P2|Overall Study|Withdrawal by Subject|3
2462673|NCT02459899|8494062|P1|Overall Study|Withdrawal by Subject|1
2462674|NCT02459899|8494059|P4|Overall Study|Non-compliance with the treatment|1
2462675|NCT02459899|8494060|P3|Overall Study|Non-compliance with the treatment|0
2462676|NCT02459899|8494061|P2|Overall Study|Non-compliance with the treatment|0
2462677|NCT02459899|8494062|P1|Overall Study|Non-compliance with the treatment|0
2462678|NCT02459899|8494059|P4|Overall Study|Lost to Follow-up|1
2462679|NCT02459899|8494060|P3|Overall Study|Lost to Follow-up|0
2462680|NCT02459899|8494061|P2|Overall Study|Lost to Follow-up|2
2462681|NCT02459899|8494062|P1|Overall Study|Lost to Follow-up|1
2462682|NCT02459899|8494059|P4|Overall Study|Adverse Event|0
2462683|NCT02459899|8494060|P3|Overall Study|Adverse Event|0
2462684|NCT02459899|8494061|P2|Overall Study|Adverse Event|1
2462685|NCT02459899|8494062|P1|Overall Study|Adverse Event|1
2462686|NCT02459665|8494096|P4|Overall Study|Withdrawal by Subject|2
2462687|NCT02459665|8494097|P3|Overall Study|Withdrawal by Subject|1
2462688|NCT02459665|8494098|P2|Overall Study|Withdrawal by Subject|1
2462689|NCT02459665|8494099|P1|Overall Study|Withdrawal by Subject|0
2462690|NCT02459418|8494130|P2|Overall Study|Abnormal Transvaginal Ultrasound|0
2462691|NCT02459418|8494131|P1|Overall Study|Abnormal Transvaginal Ultrasound|1
2462692|NCT02459418|8494130|P2|Overall Study|Elevated Creatine Kinase|0
2462693|NCT02459418|8494131|P1|Overall Study|Elevated Creatine Kinase|1
2462694|NCT02459418|8494130|P2|Overall Study|Withdrawal by Subject|1
2462695|NCT02459418|8494131|P1|Overall Study|Withdrawal by Subject|1
2462696|NCT02459418|8494130|P2|Overall Study|Adverse Event|1
2462697|NCT02459418|8494131|P1|Overall Study|Adverse Event|0
2462698|NCT02459418|8494130|P2|Overall Study|Endometrial thickness of >5 mm|0
2462699|NCT02459418|8494131|P1|Overall Study|Endometrial thickness of >5 mm|1
2462700|NCT02459418|8494130|P2|Overall Study|Physician Decision|2
2462701|NCT02459418|8494131|P1|Overall Study|Physician Decision|0
2462702|NCT02459418|8494130|P2|Overall Study|Protocol Violation|2
2462703|NCT02459418|8494131|P1|Overall Study|Protocol Violation|0
2462704|NCT02459418|8494130|P2|Overall Study|Exclusion Criteria|0
2462705|NCT02459418|8494131|P1|Overall Study|Exclusion Criteria|4
2462706|NCT02459093|8494178|P2|Overall Study|Lost to Follow-up|7
2462707|NCT02459093|8494179|P1|Overall Study|Lost to Follow-up|6
2462708|NCT02459093|8494178|P2|Overall Study|Protocol Violation|11
2462709|NCT02459093|8494179|P1|Overall Study|Protocol Violation|6
2462710|NCT02458469|8494224|P6|Second Intervention (2 Weeks)|Withdrawal by Subject|1
2462711|NCT02458469|8494225|P5|Second Intervention (2 Weeks)|Withdrawal by Subject|0
2462712|NCT02458469|8494226|P4|Second Intervention (2 Weeks)|Withdrawal by Subject|0
2462713|NCT02458469|8494227|P3|Second Intervention (2 Weeks)|Withdrawal by Subject|0
2462714|NCT02458469|8494228|P2|Second Intervention (2 Weeks)|Withdrawal by Subject|0
2462715|NCT02458469|8494229|P1|Second Intervention (2 Weeks)|Withdrawal by Subject|0
2462716|NCT02458469|8494224|P6|First Intervention (2 Weeks)|Physician Decision|0
2462717|NCT02458469|8494225|P5|First Intervention (2 Weeks)|Physician Decision|0
2462718|NCT02458469|8494226|P4|First Intervention (2 Weeks)|Physician Decision|0
2462719|NCT02458469|8494227|P3|First Intervention (2 Weeks)|Physician Decision|0
2462720|NCT02458469|8494228|P2|First Intervention (2 Weeks)|Physician Decision|0
2462721|NCT02458469|8494229|P1|First Intervention (2 Weeks)|Physician Decision|1
2462722|NCT02458469|8494224|P6|First Intervention (2 Weeks)|Lost to Follow-up|0
2462723|NCT02458469|8494225|P5|First Intervention (2 Weeks)|Lost to Follow-up|0
2462724|NCT02458469|8494226|P4|First Intervention (2 Weeks)|Lost to Follow-up|0
2462725|NCT02458469|8494227|P3|First Intervention (2 Weeks)|Lost to Follow-up|1
2462726|NCT02458469|8494228|P2|First Intervention (2 Weeks)|Lost to Follow-up|0
2462727|NCT02458469|8494229|P1|First Intervention (2 Weeks)|Lost to Follow-up|0
2462728|NCT02458287|8494275|P4|Overall Study|Relocated Out of State|1
2462729|NCT02458287|8494276|P3|Overall Study|Relocated Out of State|0
2462730|NCT02458287|8494277|P2|Overall Study|Relocated Out of State|0
2462731|NCT02458287|8494278|P1|Overall Study|Relocated Out of State|0
2462732|NCT02458287|8494275|P4|Overall Study|Withdrawal by Subject|1
2462733|NCT02458287|8494276|P3|Overall Study|Withdrawal by Subject|2
2462734|NCT02458287|8494277|P2|Overall Study|Withdrawal by Subject|2
2462735|NCT02458287|8494278|P1|Overall Study|Withdrawal by Subject|0
2462736|NCT02458287|8494275|P4|Overall Study|Protocol Violation|0
2462737|NCT02458287|8494276|P3|Overall Study|Protocol Violation|0
2462738|NCT02458287|8494277|P2|Overall Study|Protocol Violation|1
2462739|NCT02458287|8494278|P1|Overall Study|Protocol Violation|0
2462740|NCT02458287|8494275|P4|Overall Study|Lost to Follow-up|0
2462741|NCT02458287|8494276|P3|Overall Study|Lost to Follow-up|1
2462742|NCT02458287|8494277|P2|Overall Study|Lost to Follow-up|1
2462743|NCT02458287|8494278|P1|Overall Study|Lost to Follow-up|0
2462744|NCT02458287|8494275|P4|Overall Study|Adverse Event|1
2462745|NCT02458287|8494276|P3|Overall Study|Adverse Event|0
2462746|NCT02458287|8494277|P2|Overall Study|Adverse Event|0
2462747|NCT02458287|8494278|P1|Overall Study|Adverse Event|0
2462748|NCT02457819|8494330|P1|Overall Study|Adverse Event|33
2462749|NCT02457819|8494330|P1|Overall Study|Lack of Efficacy|19
2462750|NCT02457819|8494330|P1|Overall Study|Lost to Follow-up|10
2462751|NCT02457819|8494330|P1|Overall Study|non compliance with study drug|4
2462752|NCT02457819|8494330|P1|Overall Study|Protocol Violation|1
2462753|NCT02457819|8494330|P1|Overall Study|Withdrawal by Subject|24
2462754|NCT02457819|8494330|P1|Overall Study|reason not given|8
2462755|NCT02457793|8494342|P6|Overall Study|Physician Decision|3
2462756|NCT02457793|8494343|P5|Overall Study|Physician Decision|1
2462757|NCT02457793|8494344|P4|Overall Study|Physician Decision|1
2462758|NCT02457793|8494345|P3|Overall Study|Physician Decision|1
2462759|NCT02457793|8494346|P2|Overall Study|Physician Decision|0
2462760|NCT02457793|8494347|P1|Overall Study|Physician Decision|1
2462761|NCT02457793|8494342|P6|Overall Study|Adverse Event|0
2462762|NCT02457793|8494343|P5|Overall Study|Adverse Event|0
2462763|NCT02457793|8494344|P4|Overall Study|Adverse Event|1
2462764|NCT02457793|8494345|P3|Overall Study|Adverse Event|0
2462765|NCT02457793|8494346|P2|Overall Study|Adverse Event|0
2462766|NCT02457793|8494347|P1|Overall Study|Adverse Event|0
2462767|NCT02457793|8494342|P6|Overall Study|Withdrawal by Subject|2
2462768|NCT02457793|8494343|P5|Overall Study|Withdrawal by Subject|2
2462769|NCT02457793|8494344|P4|Overall Study|Withdrawal by Subject|2
2462770|NCT02457793|8494345|P3|Overall Study|Withdrawal by Subject|2
2462771|NCT02457793|8494346|P2|Overall Study|Withdrawal by Subject|4
2462772|NCT02457793|8494347|P1|Overall Study|Withdrawal by Subject|0
2462773|NCT02457793|8494342|P6|Overall Study|Reason not specified|1
2462774|NCT02457793|8494343|P5|Overall Study|Reason not specified|1
2462775|NCT02457793|8494344|P4|Overall Study|Reason not specified|1
2462776|NCT02457793|8494345|P3|Overall Study|Reason not specified|0
2462777|NCT02457793|8494346|P2|Overall Study|Reason not specified|0
2462778|NCT02457793|8494347|P1|Overall Study|Reason not specified|0
2462779|NCT02457637|8494491|P1|Clinic or Telephone Follow-up|Lost to Follow-up|71
2462780|NCT02457611|8494498|P1|Overall Study|Lost to Follow-up|3
2462781|NCT02457546|8494512|P2|Overall Study|Adverse Event|1
2462782|NCT02457546|8494513|P1|Overall Study|Adverse Event|0
2462783|NCT02457546|8494512|P2|Overall Study|Lost to Follow-up|1
2462784|NCT02457546|8494513|P1|Overall Study|Lost to Follow-up|4
2462785|NCT02457546|8494512|P2|Overall Study|Refused to complete study/procedures|1
2462786|NCT02457546|8494513|P1|Overall Study|Refused to complete study/procedures|1
2462787|NCT02457546|8494512|P2|Overall Study|Other reasons|1
2462788|NCT02457546|8494513|P1|Overall Study|Other reasons|4
2462789|NCT02457247|8494568|P4|Period 2|Voluntary Withdrawal|0
2462790|NCT02457247|8494569|P3|Period 2|Voluntary Withdrawal|0
2462791|NCT02457247|8494570|P2|Period 2|Voluntary Withdrawal|1
2462792|NCT02457247|8494571|P1|Period 2|Voluntary Withdrawal|1
2462793|NCT02457247|8494568|P4|Period 2|Lost to Follow-up|0
2462794|NCT02457247|8494569|P3|Period 2|Lost to Follow-up|0
2462795|NCT02457247|8494570|P2|Period 2|Lost to Follow-up|1
2462796|NCT02457247|8494571|P1|Period 2|Lost to Follow-up|0
2462797|NCT02457247|8494568|P4|Period 2|Significant Protocol Deviation|0
2462798|NCT02457247|8494569|P3|Period 2|Significant Protocol Deviation|0
2462799|NCT02457247|8494570|P2|Period 2|Significant Protocol Deviation|0
2462800|NCT02457247|8494571|P1|Period 2|Significant Protocol Deviation|1
2462801|NCT02457247|8494568|P4|Period 2|Pretreatment Event/Adverse Event|0
2462802|NCT02457247|8494569|P3|Period 2|Pretreatment Event/Adverse Event|0
2462803|NCT02457247|8494570|P2|Period 2|Pretreatment Event/Adverse Event|1
2462804|NCT02457247|8494571|P1|Period 2|Pretreatment Event/Adverse Event|0
2462805|NCT02457247|8494568|P4|Period 1|Voluntary Withdrawal|0
2462806|NCT02457247|8494569|P3|Period 1|Voluntary Withdrawal|0
2462807|NCT02457247|8494570|P2|Period 1|Voluntary Withdrawal|0
2462808|NCT02457247|8494571|P1|Period 1|Voluntary Withdrawal|1
2462809|NCT02457247|8494568|P4|Period 1|Significant Protocol Deviation|0
2462810|NCT02457247|8494569|P3|Period 1|Significant Protocol Deviation|0
2462811|NCT02457247|8494570|P2|Period 1|Significant Protocol Deviation|1
2462812|NCT02457247|8494571|P1|Period 1|Significant Protocol Deviation|1
2462813|NCT02457247|8494568|P4|Period 1|Pretreatment Event/Adverse Event|0
2462814|NCT02457247|8494569|P3|Period 1|Pretreatment Event/Adverse Event|0
2462815|NCT02457247|8494570|P2|Period 1|Pretreatment Event/Adverse Event|1
2462816|NCT02457247|8494571|P1|Period 1|Pretreatment Event/Adverse Event|0
2462817|NCT02457195|8494591|P1|Overall Study|Withdrawal by Subject|4
2462818|NCT02457195|8494591|P1|Overall Study|Protocol Violation|2
2462819|NCT02457195|8494591|P1|Overall Study|Adverse Event|3
2462820|NCT02457182|8494597|P2|Overall Study|Lost to Follow-up|0
2462821|NCT02457182|8494598|P1|Overall Study|Lost to Follow-up|1
2462822|NCT02457065|8494616|P2|Overall Study|Lost to Follow-up|11
2462823|NCT02457065|8494617|P1|Overall Study|Lost to Follow-up|9
2462824|NCT02456740|8494639|P9|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
2462825|NCT02456740|8494640|P8|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
2462826|NCT02456740|8494641|P7|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
2462827|NCT02456740|8494642|P6|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
2462828|NCT02456740|8494643|P5|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2
2462829|NCT02456740|8494644|P4|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
2462830|NCT02456740|8494645|P3|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
2462831|NCT02456740|8494646|P2|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
2462832|NCT02456740|8494647|P1|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
2462833|NCT02456740|8494639|P9|Active Treatment Phase (Weeks 24 - 52)|Death|0
2462834|NCT02456740|8494640|P8|Active Treatment Phase (Weeks 24 - 52)|Death|1
2462835|NCT02456740|8494641|P7|Active Treatment Phase (Weeks 24 - 52)|Death|0
2462836|NCT02456740|8494642|P6|Active Treatment Phase (Weeks 24 - 52)|Death|0
2462837|NCT02456740|8494643|P5|Active Treatment Phase (Weeks 24 - 52)|Death|0
2462838|NCT02456740|8494644|P4|Active Treatment Phase (Weeks 24 - 52)|Death|0
2462839|NCT02456740|8494645|P3|Active Treatment Phase (Weeks 24 - 52)|Death|0
2462840|NCT02456740|8494646|P2|Active Treatment Phase (Weeks 24 - 52)|Death|0
2462841|NCT02456740|8494647|P1|Active Treatment Phase (Weeks 24 - 52)|Death|0
2462842|NCT02456740|8494639|P9|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
2462843|NCT02456740|8494640|P8|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
2462844|NCT02456740|8494641|P7|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
2462845|NCT02456740|8494642|P6|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
2462846|NCT02456740|8494643|P5|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11
2462847|NCT02456740|8494644|P4|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10
2462848|NCT02456740|8494645|P3|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
2462849|NCT02456740|8494646|P2|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
2462850|NCT02456740|8494647|P1|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
2462851|NCT02456740|8494639|P9|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5
2462852|NCT02456740|8494640|P8|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
2462853|NCT02456740|8494641|P7|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
2462854|NCT02456740|8494642|P6|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
2462855|NCT02456740|8494643|P5|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4
2462856|NCT02456740|8494644|P4|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1
2462857|NCT02456740|8494645|P3|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
2462858|NCT02456740|8494646|P2|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
2462859|NCT02456740|8494647|P1|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
2462860|NCT02456740|8494639|P9|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
2462861|NCT02456740|8494640|P8|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
2462862|NCT02456740|8494641|P7|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
2462863|NCT02456740|8494642|P6|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
2462864|NCT02456740|8494643|P5|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
2462865|NCT02456740|8494644|P4|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
2462866|NCT02456740|8494645|P3|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5
2462867|NCT02456740|8494646|P2|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4
2462868|NCT02456740|8494647|P1|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9
2462869|NCT02456740|8494639|P9|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
2462870|NCT02456740|8494640|P8|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
2462871|NCT02456740|8494641|P7|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
2462872|NCT02456740|8494642|P6|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
2462873|NCT02456740|8494643|P5|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
2462874|NCT02456740|8494644|P4|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
2462875|NCT02456740|8494645|P3|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21
2462876|NCT02456740|8494646|P2|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28
2462877|NCT02456740|8494647|P1|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27
2462878|NCT02456740|8494639|P9|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
2462879|NCT02456740|8494640|P8|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
2462880|NCT02456740|8494641|P7|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
2462881|NCT02456740|8494642|P6|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
2462882|NCT02456740|8494643|P5|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
2462883|NCT02456740|8494644|P4|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
2462884|NCT02456740|8494645|P3|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
2462885|NCT02456740|8494646|P2|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
2462886|NCT02456740|8494647|P1|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
2462887|NCT02456662|8494671|P2|Overall Study|Lost to Follow-up|1
2462888|NCT02456662|8494672|P1|Overall Study|Lost to Follow-up|2
2462889|NCT02456103|8494678|P1|Overall Study|Withdrawal by Subject|24
2462890|NCT02456103|8494678|P1|Overall Study|Lost to Follow-up|1
2462891|NCT02456103|8494678|P1|Overall Study|Abnormal Laboratory Value|2
2462892|NCT02456103|8494678|P1|Overall Study|Adverse Event|5
2462893|NCT02456103|8494678|P1|Overall Study|Protocol Violation|1
2462894|NCT02456103|8494678|P1|Overall Study|Required prohibited medications|5
2462895|NCT02456103|8494678|P1|Overall Study|Physician Decision|1
2462896|NCT02456103|8494678|P1|Overall Study|Study Closure|207
2462897|NCT02455518|8494691|P4|Overall Study|Protocol Violation|3
2462898|NCT02455518|8494692|P3|Overall Study|Protocol Violation|1
2462899|NCT02455518|8494693|P2|Overall Study|Protocol Violation|1
2462900|NCT02455518|8494694|P1|Overall Study|Protocol Violation|0
2462901|NCT02455388|8494716|P3|Overall Study|Withdrawal by Subject|7
2462902|NCT02455388|8494717|P2|Overall Study|Withdrawal by Subject|0
2462903|NCT02455388|8494718|P1|Overall Study|Withdrawal by Subject|0
2462904|NCT02455388|8494716|P3|Overall Study|Protocol Violation|4
2462905|NCT02455388|8494717|P2|Overall Study|Protocol Violation|0
2462906|NCT02455388|8494718|P1|Overall Study|Protocol Violation|1
2462907|NCT02455336|8494729|P2|Overall Study|Non-responder to treatment|0
2462908|NCT02455336|8494730|P1|Overall Study|Non-responder to treatment|2
2462909|NCT02455336|8494729|P2|Overall Study|Adverse Event|0
2462910|NCT02455336|8494730|P1|Overall Study|Adverse Event|3
2462911|NCT02455336|8494729|P2|Overall Study|Withdrawal by Subject|2
2462912|NCT02455336|8494730|P1|Overall Study|Withdrawal by Subject|0
2462913|NCT02455076|8494745|P5|Outpatient|Lost to Follow-up|12
2462914|NCT02455076|8494746|P4|Outpatient|Lost to Follow-up|1
2462915|NCT02455076|8494747|P3|Outpatient|Lost to Follow-up|0
2462916|NCT02455076|8494748|P2|Outpatient|Lost to Follow-up|0
2462917|NCT02455076|8494749|P1|Outpatient|Lost to Follow-up|0
2462918|NCT02455076|8494745|P5|Outpatient|Adverse Event|0
2462919|NCT02455076|8494746|P4|Outpatient|Adverse Event|5
2462920|NCT02455076|8494747|P3|Outpatient|Adverse Event|0
2462921|NCT02455076|8494748|P2|Outpatient|Adverse Event|0
2462922|NCT02455076|8494749|P1|Outpatient|Adverse Event|0
2462923|NCT02455076|8494745|P5|Inpatient|Adverse Event|0
2462924|NCT02455076|8494746|P4|Inpatient|Adverse Event|0
2462925|NCT02455076|8494747|P3|Inpatient|Adverse Event|0
2462926|NCT02455076|8494748|P2|Inpatient|Adverse Event|0
2462927|NCT02455076|8494749|P1|Inpatient|Adverse Event|3
2462928|NCT02455076|8494745|P5|Inpatient|Discharged <24 h after admission|0
2462929|NCT02455076|8494746|P4|Inpatient|Discharged <24 h after admission|0
2462930|NCT02455076|8494747|P3|Inpatient|Discharged <24 h after admission|0
2462931|NCT02455076|8494748|P2|Inpatient|Discharged <24 h after admission|1
2462932|NCT02455076|8494749|P1|Inpatient|Discharged <24 h after admission|0
2462933|NCT02455076|8494745|P5|Inpatient|Withdrawal by Subject|0
2462934|NCT02455076|8494746|P4|Inpatient|Withdrawal by Subject|0
2462935|NCT02455076|8494747|P3|Inpatient|Withdrawal by Subject|0
2462936|NCT02455076|8494748|P2|Inpatient|Withdrawal by Subject|0
2462937|NCT02455076|8494749|P1|Inpatient|Withdrawal by Subject|1
2462938|NCT02455050|8494835|P4|Treatment Period 2|Lost to Follow-up|1
2462939|NCT02455050|8494836|P3|Treatment Period 2|Lost to Follow-up|2
2462940|NCT02455050|8494837|P2|Treatment Period 2|Lost to Follow-up|0
2462941|NCT02455050|8494838|P1|Treatment Period 2|Lost to Follow-up|1
2462942|NCT02455050|8494835|P4|Treatment Period 1|Lost to Follow-up|2
2462943|NCT02455050|8494836|P3|Treatment Period 1|Lost to Follow-up|1
2462944|NCT02455050|8494837|P2|Treatment Period 1|Lost to Follow-up|1
2462945|NCT02455050|8494838|P1|Treatment Period 1|Lost to Follow-up|1
2462946|NCT02454959|8494902|P1|Overall Study|Adverse Event|2
2462947|NCT02454959|8494902|P1|Overall Study|Withdrawal by Subject|3
2462948|NCT02454959|8494902|P1|Overall Study|Physician Decision|1
2462949|NCT02454959|8494902|P1|Overall Study|Protocol-Specified Criteria|3
2462950|NCT02454933|8494922|P2|Overall Study|Withdrawal by Subject|2
2462951|NCT02454933|8494923|P1|Overall Study|Withdrawal by Subject|0
2462952|NCT02454933|8494922|P2|Overall Study|Adverse Event|1
2462953|NCT02454933|8494923|P1|Overall Study|Adverse Event|1
2462954|NCT02454933|8494922|P2|Overall Study|Progressive disease|5
2462955|NCT02454933|8494923|P1|Overall Study|Progressive disease|7
2462956|NCT02454608|8494931|P3|Open Label Period|Withdrawal by Subject|8
2462957|NCT02454608|8494932|P2|Open Label Period|Withdrawal by Subject|0
2462958|NCT02454608|8494933|P1|Open Label Period|Withdrawal by Subject|0
2462959|NCT02454608|8494931|P3|Open Label Period|Lost to Follow-up|11
2462960|NCT02454608|8494932|P2|Open Label Period|Lost to Follow-up|0
2462961|NCT02454608|8494933|P1|Open Label Period|Lost to Follow-up|0
2462962|NCT02454608|8494931|P3|Double-Blind Period|Lack of Efficacy|0
2462963|NCT02454608|8494932|P2|Double-Blind Period|Lack of Efficacy|2
2462964|NCT02454608|8494933|P1|Double-Blind Period|Lack of Efficacy|0
2462965|NCT02454530|8494956|P2|Overall Study|Lost to Follow-up|4
2462966|NCT02454530|8494957|P1|Overall Study|Lost to Follow-up|4
2462967|NCT02454530|8494956|P2|Overall Study|Death|41
2462968|NCT02454530|8494957|P1|Overall Study|Death|2
2462969|NCT02454530|8494956|P2|Overall Study|Missing information|69
2462970|NCT02454530|8494957|P1|Overall Study|Missing information|56
2462971|NCT02454530|8494956|P2|Overall Study|Other|13
2462972|NCT02454530|8494957|P1|Overall Study|Other|8
2462973|NCT02454478|8494994|P1|Overall Study|Incomplete DLT Evaluation|1
2462974|NCT02454101|8495088|P2|Overall Study|Lost to Follow-up|4
2462975|NCT02454101|8495089|P1|Overall Study|Lost to Follow-up|3
2462976|NCT02454101|8495088|P2|Overall Study|Adverse Event|3
2462977|NCT02454101|8495089|P1|Overall Study|Adverse Event|2
2462978|NCT02453841|8495111|P1|Overall Study|Unable to obtain blood samples|2
2462979|NCT02453841|8495111|P1|Overall Study|Protocol Violation|1
2462980|NCT02453711|8495134|P9|Overall Study|Unclassified|0
2462981|NCT02453711|8495135|P8|Overall Study|Unclassified|0
2462982|NCT02453711|8495136|P7|Overall Study|Unclassified|0
2462983|NCT02453711|8495137|P6|Overall Study|Unclassified|0
2462984|NCT02453711|8495138|P5|Overall Study|Unclassified|0
2462985|NCT02453711|8495139|P4|Overall Study|Unclassified|0
2462986|NCT02453711|8495140|P3|Overall Study|Unclassified|1
2462987|NCT02453711|8495141|P2|Overall Study|Unclassified|0
2462988|NCT02453711|8495142|P1|Overall Study|Unclassified|1
2462989|NCT02453711|8495134|P9|Overall Study|Death|0
2462990|NCT02453711|8495135|P8|Overall Study|Death|0
2462991|NCT02453711|8495136|P7|Overall Study|Death|1
2462992|NCT02453711|8495137|P6|Overall Study|Death|0
2462993|NCT02453711|8495138|P5|Overall Study|Death|0
2462994|NCT02453711|8495139|P4|Overall Study|Death|0
2462995|NCT02453711|8495140|P3|Overall Study|Death|0
2462996|NCT02453711|8495141|P2|Overall Study|Death|0
2462997|NCT02453711|8495142|P1|Overall Study|Death|0
2462998|NCT02453711|8495134|P9|Overall Study|Lost to Follow-up|6
2462999|NCT02453711|8495135|P8|Overall Study|Lost to Follow-up|6
2463000|NCT02453711|8495136|P7|Overall Study|Lost to Follow-up|2
2463001|NCT02453711|8495137|P6|Overall Study|Lost to Follow-up|5
2463002|NCT02453711|8495138|P5|Overall Study|Lost to Follow-up|1
2463003|NCT02453711|8495139|P4|Overall Study|Lost to Follow-up|3
2463004|NCT02453711|8495140|P3|Overall Study|Lost to Follow-up|2
2463005|NCT02453711|8495141|P2|Overall Study|Lost to Follow-up|3
2463006|NCT02453711|8495142|P1|Overall Study|Lost to Follow-up|5
2463007|NCT02453711|8495134|P9|Overall Study|Withdrawal by Subject|7
2463008|NCT02453711|8495135|P8|Overall Study|Withdrawal by Subject|1
2463009|NCT02453711|8495136|P7|Overall Study|Withdrawal by Subject|0
2463010|NCT02453711|8495137|P6|Overall Study|Withdrawal by Subject|1
2463011|NCT02453711|8495138|P5|Overall Study|Withdrawal by Subject|1
2463012|NCT02453711|8495139|P4|Overall Study|Withdrawal by Subject|4
2463013|NCT02453711|8495140|P3|Overall Study|Withdrawal by Subject|6
2463014|NCT02453711|8495141|P2|Overall Study|Withdrawal by Subject|4
2463015|NCT02453711|8495142|P1|Overall Study|Withdrawal by Subject|5
2463016|NCT02453685|8495486|P2|Overall Study|Unclassified|2
2463017|NCT02453685|8495487|P1|Overall Study|Unclassified|4
2463018|NCT02453685|8495486|P2|Overall Study|Withdrawal by Subject|4
2463019|NCT02453685|8495487|P1|Overall Study|Withdrawal by Subject|8
2463020|NCT02453685|8495486|P2|Overall Study|Lost to Follow-up|1
2463021|NCT02453685|8495487|P1|Overall Study|Lost to Follow-up|0
2463022|NCT02453685|8495486|P2|Overall Study|Protocol Violation|4
2463023|NCT02453685|8495487|P1|Overall Study|Protocol Violation|7
2463024|NCT02453685|8495486|P2|Overall Study|Adverse Event|1
2463025|NCT02453685|8495487|P1|Overall Study|Adverse Event|0
2463026|NCT02453555|8495545|P6|Extension Period|Withdrawal by Subject|0
2463027|NCT02453555|8495546|P5|Extension Period|Withdrawal by Subject|0
2463028|NCT02453555|8495547|P4|Extension Period|Withdrawal by Subject|0
2463029|NCT02453555|8495548|P3|Extension Period|Withdrawal by Subject|1
2463030|NCT02453555|8495549|P2|Extension Period|Withdrawal by Subject|0
2463031|NCT02453555|8495550|P1|Extension Period|Withdrawal by Subject|0
2463032|NCT02453555|8495545|P6|Extension Period|Protocol Violation|0
2463033|NCT02453555|8495546|P5|Extension Period|Protocol Violation|0
2463034|NCT02453555|8495547|P4|Extension Period|Protocol Violation|0
2463035|NCT02453555|8495548|P3|Extension Period|Protocol Violation|1
2463036|NCT02453555|8495549|P2|Extension Period|Protocol Violation|0
2463037|NCT02453555|8495550|P1|Extension Period|Protocol Violation|0
2463038|NCT02453555|8495545|P6|Extension Period|Adverse Event|1
2463039|NCT02453555|8495546|P5|Extension Period|Adverse Event|1
2463040|NCT02453555|8495547|P4|Extension Period|Adverse Event|2
2463041|NCT02453555|8495548|P3|Extension Period|Adverse Event|1
2463042|NCT02453555|8495549|P2|Extension Period|Adverse Event|0
2463043|NCT02453555|8495550|P1|Extension Period|Adverse Event|0
2463044|NCT02453555|8495545|P6|24-week Double-blind Treatment Period|Other than specified above|0
2463045|NCT02453555|8495546|P5|24-week Double-blind Treatment Period|Other than specified above|0
2463046|NCT02453555|8495547|P4|24-week Double-blind Treatment Period|Other than specified above|0
2463047|NCT02453555|8495548|P3|24-week Double-blind Treatment Period|Other than specified above|0
2463048|NCT02453555|8495549|P2|24-week Double-blind Treatment Period|Other than specified above|3
2463049|NCT02453555|8495550|P1|24-week Double-blind Treatment Period|Other than specified above|0
2463050|NCT02453555|8495545|P6|24-week Double-blind Treatment Period|Withdrawal by Subject|0
2463051|NCT02453555|8495546|P5|24-week Double-blind Treatment Period|Withdrawal by Subject|0
2463052|NCT02453555|8495547|P4|24-week Double-blind Treatment Period|Withdrawal by Subject|0
2463053|NCT02453555|8495548|P3|24-week Double-blind Treatment Period|Withdrawal by Subject|0
2463054|NCT02453555|8495549|P2|24-week Double-blind Treatment Period|Withdrawal by Subject|4
2463055|NCT02453555|8495550|P1|24-week Double-blind Treatment Period|Withdrawal by Subject|2
2463056|NCT02453555|8495545|P6|24-week Double-blind Treatment Period|Lost to Follow-up|0
2463057|NCT02453555|8495546|P5|24-week Double-blind Treatment Period|Lost to Follow-up|0
2463058|NCT02453555|8495547|P4|24-week Double-blind Treatment Period|Lost to Follow-up|0
2463059|NCT02453555|8495548|P3|24-week Double-blind Treatment Period|Lost to Follow-up|0
2463060|NCT02453555|8495549|P2|24-week Double-blind Treatment Period|Lost to Follow-up|0
2463061|NCT02453555|8495550|P1|24-week Double-blind Treatment Period|Lost to Follow-up|1
2463062|NCT02453555|8495545|P6|24-week Double-blind Treatment Period|Adverse Event|0
2463063|NCT02453555|8495546|P5|24-week Double-blind Treatment Period|Adverse Event|0
2463064|NCT02453555|8495547|P4|24-week Double-blind Treatment Period|Adverse Event|0
2463065|NCT02453555|8495548|P3|24-week Double-blind Treatment Period|Adverse Event|0
2463066|NCT02453555|8495549|P2|24-week Double-blind Treatment Period|Adverse Event|0
2463067|NCT02453555|8495550|P1|24-week Double-blind Treatment Period|Adverse Event|2
2463068|NCT02453386|8495566|P3|Overall Study|Other|1
2463069|NCT02453386|8495567|P2|Overall Study|Other|0
2463070|NCT02453386|8495568|P1|Overall Study|Other|1
2463071|NCT02453386|8495566|P3|Overall Study|Lost to Follow-up|1
2463072|NCT02453386|8495567|P2|Overall Study|Lost to Follow-up|0
2463073|NCT02453386|8495568|P1|Overall Study|Lost to Follow-up|0
2463074|NCT02453386|8495566|P3|Overall Study|Sponsor Terminated by Investigator|2
2463075|NCT02453386|8495567|P2|Overall Study|Sponsor Terminated by Investigator|1
2463076|NCT02453386|8495568|P1|Overall Study|Sponsor Terminated by Investigator|0
2463077|NCT02453386|8495566|P3|Overall Study|Subject Terminated by Sponsor|1
2463078|NCT02453386|8495567|P2|Overall Study|Subject Terminated by Sponsor|1
2463079|NCT02453386|8495568|P1|Overall Study|Subject Terminated by Sponsor|1
2463080|NCT02453386|8495566|P3|Overall Study|Sponsor Terminated Study|11
2463081|NCT02453386|8495567|P2|Overall Study|Sponsor Terminated Study|8
2463082|NCT02453386|8495568|P1|Overall Study|Sponsor Terminated Study|14
2463083|NCT02453386|8495566|P3|Overall Study|Withdrawal by Subject|9
2463084|NCT02453386|8495567|P2|Overall Study|Withdrawal by Subject|9
2463085|NCT02453386|8495568|P1|Overall Study|Withdrawal by Subject|10
2463086|NCT02453386|8495566|P3|Overall Study|Protocol Violation|1
2463087|NCT02453386|8495567|P2|Overall Study|Protocol Violation|0
2463088|NCT02453386|8495568|P1|Overall Study|Protocol Violation|1
2463089|NCT02453386|8495566|P3|Overall Study|Adverse Event|15
2463090|NCT02453386|8495567|P2|Overall Study|Adverse Event|30
2463091|NCT02453386|8495568|P1|Overall Study|Adverse Event|22
2463092|NCT02453321|8495632|P3|Overall Study|Deep Venous Thrombosis|0
2463093|NCT02453321|8495633|P2|Overall Study|Deep Venous Thrombosis|1
2463094|NCT02453321|8495634|P1|Overall Study|Deep Venous Thrombosis|0
2463095|NCT02453321|8495632|P3|Overall Study|Weakness|2
2463096|NCT02453321|8495633|P2|Overall Study|Weakness|1
2463097|NCT02453321|8495634|P1|Overall Study|Weakness|1
2463098|NCT02453282|8495654|P3|Overall Study|Other|1
2463099|NCT02453282|8495655|P2|Overall Study|Other|1
2463100|NCT02453282|8495656|P1|Overall Study|Other|1
2463101|NCT02453282|8495654|P3|Overall Study|Participants ongoing at data cut-off|62
2463102|NCT02453282|8495655|P2|Overall Study|Participants ongoing at data cut-off|84
2463103|NCT02453282|8495656|P1|Overall Study|Participants ongoing at data cut-off|85
2463104|NCT02453282|8495654|P3|Overall Study|Withdrawal by Subject|11
2463105|NCT02453282|8495655|P2|Overall Study|Withdrawal by Subject|10
2463106|NCT02453282|8495656|P1|Overall Study|Withdrawal by Subject|12
2463107|NCT02453282|8495654|P3|Overall Study|Lost to Follow-up|2
2463108|NCT02453282|8495655|P2|Overall Study|Lost to Follow-up|0
2463109|NCT02453282|8495656|P1|Overall Study|Lost to Follow-up|1
2463110|NCT02453282|8495654|P3|Overall Study|Death|296
2463111|NCT02453282|8495655|P2|Overall Study|Death|277
2463112|NCT02453282|8495656|P1|Overall Study|Death|275
2463113|NCT02453256|8495737|P2|Open Label Period|Withdrawal by Subject|1
2463114|NCT02453256|8495738|P1|Open Label Period|Withdrawal by Subject|5
2463115|NCT02453256|8495737|P2|Open Label Period|Other|2
2463116|NCT02453256|8495738|P1|Open Label Period|Other|0
2463117|NCT02453256|8495737|P2|Open Label Period|Lost to Follow-up|0
2463118|NCT02453256|8495738|P1|Open Label Period|Lost to Follow-up|1
2463119|NCT02453256|8495737|P2|Open Label Period|Death|1
2463120|NCT02453256|8495738|P1|Open Label Period|Death|0
2463121|NCT02453256|8495737|P2|Open Label Period|Adverse Event|3
2463122|NCT02453256|8495738|P1|Open Label Period|Adverse Event|1
2463123|NCT02453256|8495737|P2|Double Blind Period|Other|1
2463124|NCT02453256|8495738|P1|Double Blind Period|Other|0
2463125|NCT02453256|8495737|P2|Double Blind Period|Withdrawal by Subject|5
2463126|NCT02453256|8495738|P1|Double Blind Period|Withdrawal by Subject|9
2463127|NCT02453256|8495737|P2|Double Blind Period|Adverse Event|2
2463128|NCT02453256|8495738|P1|Double Blind Period|Adverse Event|3
2463129|NCT02453256|8495737|P2|Double Blind Period|Death|1
2463130|NCT02453256|8495738|P1|Double Blind Period|Death|1
2463131|NCT02453048|8495863|P5|Overall Study|Lost to Follow-up|0
2463132|NCT02453048|8495864|P4|Overall Study|Lost to Follow-up|0
2463133|NCT02453048|8495865|P3|Overall Study|Lost to Follow-up|2
2463134|NCT02453048|8495866|P2|Overall Study|Lost to Follow-up|1
2463135|NCT02453048|8495867|P1|Overall Study|Lost to Follow-up|0
2463136|NCT02453048|8495863|P5|Overall Study|Only part of initial 6 mo. study|6
2463137|NCT02453048|8495864|P4|Overall Study|Only part of initial 6 mo. study|0
2463138|NCT02453048|8495865|P3|Overall Study|Only part of initial 6 mo. study|0
2463139|NCT02453048|8495866|P2|Overall Study|Only part of initial 6 mo. study|0
2463140|NCT02453048|8495867|P1|Overall Study|Only part of initial 6 mo. study|0
2463141|NCT02452892|8495904|P4|Follow-up|Subject left town on Day 42|0
2463142|NCT02452892|8495905|P3|Follow-up|Subject left town on Day 42|0
2463143|NCT02452892|8495906|P2|Follow-up|Subject left town on Day 42|0
2463144|NCT02452892|8495907|P1|Follow-up|Subject left town on Day 42|1
2463145|NCT02452892|8495904|P4|Follow-up|Withdrawal by Subject|1
2463146|NCT02452892|8495905|P3|Follow-up|Withdrawal by Subject|0
2463147|NCT02452892|8495906|P2|Follow-up|Withdrawal by Subject|0
2463148|NCT02452892|8495907|P1|Follow-up|Withdrawal by Subject|0
2463149|NCT02452892|8495904|P4|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
2463150|NCT02452892|8495905|P3|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
2463151|NCT02452892|8495906|P2|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
2463152|NCT02452892|8495907|P1|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2
2463153|NCT02452892|8495904|P4|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2
2463154|NCT02452892|8495905|P3|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
2463155|NCT02452892|8495906|P2|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
2463156|NCT02452892|8495907|P1|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
2463157|NCT02452892|8495904|P4|Week 1 Initial Randommization|Lost to Follow-up|0
2463158|NCT02452892|8495905|P3|Week 1 Initial Randommization|Lost to Follow-up|1
2463159|NCT02452892|8495906|P2|Week 1 Initial Randommization|Lost to Follow-up|0
2463160|NCT02452892|8495907|P1|Week 1 Initial Randommization|Lost to Follow-up|0
2463161|NCT02452892|8495904|P4|Week 1 Initial Randommization|Adverse Event|0
2463162|NCT02452892|8495905|P3|Week 1 Initial Randommization|Adverse Event|0
2463163|NCT02452892|8495906|P2|Week 1 Initial Randommization|Adverse Event|0
2463164|NCT02452892|8495907|P1|Week 1 Initial Randommization|Adverse Event|1
2463165|NCT02452554|8495942|P6|Overall Study|Never Received Treatment|0
2463166|NCT02452554|8495943|P5|Overall Study|Never Received Treatment|0
2463167|NCT02452554|8495944|P4|Overall Study|Never Received Treatment|0
2463168|NCT02452554|8495945|P3|Overall Study|Never Received Treatment|0
2463169|NCT02452554|8495946|P2|Overall Study|Never Received Treatment|0
2463170|NCT02452554|8495947|P1|Overall Study|Never Received Treatment|1
2463171|NCT02452554|8495942|P6|Overall Study|Ineligible|0
2463172|NCT02452554|8495943|P5|Overall Study|Ineligible|0
2463173|NCT02452554|8495944|P4|Overall Study|Ineligible|0
2463174|NCT02452554|8495945|P3|Overall Study|Ineligible|0
2463175|NCT02452554|8495946|P2|Overall Study|Ineligible|1
2463176|NCT02452554|8495947|P1|Overall Study|Ineligible|0
2463177|NCT02452554|8495942|P6|Overall Study|Withdrawal by Subject|1
2463178|NCT02452554|8495943|P5|Overall Study|Withdrawal by Subject|0
2463179|NCT02452554|8495944|P4|Overall Study|Withdrawal by Subject|0
2463180|NCT02452554|8495945|P3|Overall Study|Withdrawal by Subject|2
2463181|NCT02452554|8495946|P2|Overall Study|Withdrawal by Subject|0
2463182|NCT02452554|8495947|P1|Overall Study|Withdrawal by Subject|1
2463183|NCT02452554|8495942|P6|Overall Study|Physician Decision|0
2463184|NCT02452554|8495943|P5|Overall Study|Physician Decision|0
2463185|NCT02452554|8495944|P4|Overall Study|Physician Decision|0
2463186|NCT02452554|8495945|P3|Overall Study|Physician Decision|0
2463187|NCT02452554|8495946|P2|Overall Study|Physician Decision|1
2463188|NCT02452554|8495947|P1|Overall Study|Physician Decision|0
2463189|NCT02452554|8495942|P6|Overall Study|Lack of Efficacy|8
2463190|NCT02452554|8495943|P5|Overall Study|Lack of Efficacy|5
2463191|NCT02452554|8495944|P4|Overall Study|Lack of Efficacy|1
2463192|NCT02452554|8495945|P3|Overall Study|Lack of Efficacy|9
2463193|NCT02452554|8495946|P2|Overall Study|Lack of Efficacy|14
2463194|NCT02452554|8495947|P1|Overall Study|Lack of Efficacy|13
2463195|NCT02452554|8495942|P6|Overall Study|Death|0
2463196|NCT02452554|8495943|P5|Overall Study|Death|0
2463197|NCT02452554|8495944|P4|Overall Study|Death|0
2463198|NCT02452554|8495945|P3|Overall Study|Death|0
2463199|NCT02452554|8495946|P2|Overall Study|Death|1
2463200|NCT02452554|8495947|P1|Overall Study|Death|2
2463201|NCT02452463|8496000|P3|Overall Study|Withdrawal by Subject|0
2463202|NCT02452463|8496001|P2|Overall Study|Withdrawal by Subject|1
2463203|NCT02452463|8496002|P1|Overall Study|Withdrawal by Subject|0
2463204|NCT02452463|8496000|P3|Overall Study|Recommended by DSMB|0
2463205|NCT02452463|8496001|P2|Overall Study|Recommended by DSMB|1
2463206|NCT02452463|8496002|P1|Overall Study|Recommended by DSMB|0
2463207|NCT02452463|8496000|P3|Overall Study|Study Suspended|0
2463208|NCT02452463|8496001|P2|Overall Study|Study Suspended|0
2463209|NCT02452463|8496002|P1|Overall Study|Study Suspended|1
2463210|NCT02452463|8496000|P3|Overall Study|Death|0
2463211|NCT02452463|8496001|P2|Overall Study|Death|0
2463212|NCT02452463|8496002|P1|Overall Study|Death|1
2463213|NCT02452424|8496045|P11|Overall Study|Adverse Event|1
2463214|NCT02452424|8496046|P10|Overall Study|Adverse Event|0
2463215|NCT02452424|8496047|P9|Overall Study|Adverse Event|0
2463216|NCT02452424|8496048|P8|Overall Study|Adverse Event|0
2463217|NCT02452424|8496049|P7|Overall Study|Adverse Event|0
2463218|NCT02452424|8496050|P6|Overall Study|Adverse Event|0
2463219|NCT02452424|8496051|P5|Overall Study|Adverse Event|0
2463220|NCT02452424|8496052|P4|Overall Study|Adverse Event|0
2463221|NCT02452424|8496053|P3|Overall Study|Adverse Event|0
2463222|NCT02452424|8496054|P2|Overall Study|Adverse Event|0
2463223|NCT02452424|8496055|P1|Overall Study|Adverse Event|0
2463224|NCT02452424|8496045|P11|Overall Study|Progressive disease (per RECIST)|0
2463225|NCT02452424|8496046|P10|Overall Study|Progressive disease (per RECIST)|0
2463226|NCT02452424|8496047|P9|Overall Study|Progressive disease (per RECIST)|2
2463227|NCT02452424|8496048|P8|Overall Study|Progressive disease (per RECIST)|0
2463228|NCT02452424|8496049|P7|Overall Study|Progressive disease (per RECIST)|0
2463229|NCT02452424|8496050|P6|Overall Study|Progressive disease (per RECIST)|0
2463230|NCT02452424|8496051|P5|Overall Study|Progressive disease (per RECIST)|0
2463231|NCT02452424|8496052|P4|Overall Study|Progressive disease (per RECIST)|0
2463232|NCT02452424|8496053|P3|Overall Study|Progressive disease (per RECIST)|0
2463233|NCT02452424|8496054|P2|Overall Study|Progressive disease (per RECIST)|0
2463234|NCT02452424|8496055|P1|Overall Study|Progressive disease (per RECIST)|0
2463235|NCT02452424|8496045|P11|Overall Study|Other|1
2463236|NCT02452424|8496046|P10|Overall Study|Other|0
2463237|NCT02452424|8496047|P9|Overall Study|Other|0
2463238|NCT02452424|8496048|P8|Overall Study|Other|3
2463239|NCT02452424|8496049|P7|Overall Study|Other|4
2463240|NCT02452424|8496050|P6|Overall Study|Other|1
2463241|NCT02452424|8496051|P5|Overall Study|Other|0
2463242|NCT02452424|8496052|P4|Overall Study|Other|0
2463243|NCT02452424|8496053|P3|Overall Study|Other|1
2463244|NCT02452424|8496054|P2|Overall Study|Other|0
2463245|NCT02452424|8496055|P1|Overall Study|Other|0
2463246|NCT02452424|8496045|P11|Overall Study|Withdrawal by Subject|0
2463247|NCT02452424|8496046|P10|Overall Study|Withdrawal by Subject|1
2463248|NCT02452424|8496047|P9|Overall Study|Withdrawal by Subject|1
2463249|NCT02452424|8496048|P8|Overall Study|Withdrawal by Subject|0
2463250|NCT02452424|8496049|P7|Overall Study|Withdrawal by Subject|1
2463251|NCT02452424|8496050|P6|Overall Study|Withdrawal by Subject|0
2463252|NCT02452424|8496051|P5|Overall Study|Withdrawal by Subject|0
2463253|NCT02452424|8496052|P4|Overall Study|Withdrawal by Subject|2
2463254|NCT02452424|8496053|P3|Overall Study|Withdrawal by Subject|3
2463255|NCT02452424|8496054|P2|Overall Study|Withdrawal by Subject|0
2463256|NCT02452424|8496055|P1|Overall Study|Withdrawal by Subject|0
2463257|NCT02452424|8496045|P11|Overall Study|Lost to Follow-up|0
2463258|NCT02452424|8496046|P10|Overall Study|Lost to Follow-up|0
2463259|NCT02452424|8496047|P9|Overall Study|Lost to Follow-up|0
2463260|NCT02452424|8496048|P8|Overall Study|Lost to Follow-up|0
2463261|NCT02452424|8496049|P7|Overall Study|Lost to Follow-up|0
2463262|NCT02452424|8496050|P6|Overall Study|Lost to Follow-up|0
2463263|NCT02452424|8496051|P5|Overall Study|Lost to Follow-up|0
2463264|NCT02452424|8496052|P4|Overall Study|Lost to Follow-up|0
2463265|NCT02452424|8496053|P3|Overall Study|Lost to Follow-up|1
2463266|NCT02452424|8496054|P2|Overall Study|Lost to Follow-up|1
2463267|NCT02452424|8496055|P1|Overall Study|Lost to Follow-up|0
2463268|NCT02452424|8496045|P11|Overall Study|Death|0
2463269|NCT02452424|8496046|P10|Overall Study|Death|1
2463270|NCT02452424|8496047|P9|Overall Study|Death|3
2463271|NCT02452424|8496048|P8|Overall Study|Death|1
2463272|NCT02452424|8496049|P7|Overall Study|Death|5
2463273|NCT02452424|8496050|P6|Overall Study|Death|0
2463274|NCT02452424|8496051|P5|Overall Study|Death|2
2463275|NCT02452424|8496052|P4|Overall Study|Death|6
2463276|NCT02452424|8496053|P3|Overall Study|Death|2
2463277|NCT02452424|8496054|P2|Overall Study|Death|2
2463278|NCT02452424|8496055|P1|Overall Study|Death|2
2463279|NCT02452320|8496098|P2|Overall Study|Adverse Event|1
2463280|NCT02452320|8496099|P1|Overall Study|Adverse Event|0
2463281|NCT02452190|8496111|P2|Overall Study|Death|1
2463282|NCT02452190|8496112|P1|Overall Study|Death|0
2463283|NCT02452190|8496111|P2|Overall Study|Participant traveled abroad|0
2463284|NCT02452190|8496112|P1|Overall Study|Participant traveled abroad|1
2463285|NCT02452190|8496111|P2|Overall Study|Noncompliance with study drug|0
2463286|NCT02452190|8496112|P1|Overall Study|Noncompliance with study drug|1
2463287|NCT02452190|8496111|P2|Overall Study|Withdrawal by Subject|11
2463288|NCT02452190|8496112|P1|Overall Study|Withdrawal by Subject|20
2463289|NCT02452190|8496111|P2|Overall Study|Adverse Event|5
2463290|NCT02452190|8496112|P1|Overall Study|Adverse Event|2
2463291|NCT02452190|8496111|P2|Overall Study|Lost to Follow-up|3
2463292|NCT02452190|8496112|P1|Overall Study|Lost to Follow-up|4
2463293|NCT02452190|8496111|P2|Overall Study|Lack of Efficacy|1
2463294|NCT02452190|8496112|P1|Overall Study|Lack of Efficacy|3
2463295|NCT02452190|8496111|P2|Overall Study|Investigator's Decision|0
2463296|NCT02452190|8496112|P1|Overall Study|Investigator's Decision|2
2463297|NCT02452190|8496111|P2|Overall Study|Pregnancy|0
2463298|NCT02452190|8496112|P1|Overall Study|Pregnancy|1
2463299|NCT02452190|8496111|P2|Overall Study|Withdrawal by Sponsor|3
2463300|NCT02452190|8496112|P1|Overall Study|Withdrawal by Sponsor|1
2463301|NCT02452047|8496150|P3|Overall Study|Withdrawal by Subject|0
2463302|NCT02452047|8496151|P2|Overall Study|Withdrawal by Subject|0
2463303|NCT02452047|8496152|P1|Overall Study|Withdrawal by Subject|1
2463304|NCT02452047|8496150|P3|Overall Study|Lost to Follow-up|0
2463305|NCT02452047|8496151|P2|Overall Study|Lost to Follow-up|1
2463306|NCT02452047|8496152|P1|Overall Study|Lost to Follow-up|1
2463307|NCT02452047|8496150|P3|Overall Study|Physician Decision|0
2463308|NCT02452047|8496151|P2|Overall Study|Physician Decision|0
2463309|NCT02452047|8496152|P1|Overall Study|Physician Decision|1
2463310|NCT02452047|8496150|P3|Overall Study|Death|1
2463311|NCT02452047|8496151|P2|Overall Study|Death|3
2463312|NCT02452047|8496152|P1|Overall Study|Death|1
2463313|NCT02452047|8496150|P3|Overall Study|Adverse Event|1
2463314|NCT02452047|8496151|P2|Overall Study|Adverse Event|1
2463315|NCT02452047|8496152|P1|Overall Study|Adverse Event|0
2463316|NCT02452034|8496217|P6|Overall Study|Withdrawn by Parent/Guardian|0
2463317|NCT02452034|8496218|P5|Overall Study|Withdrawn by Parent/Guardian|0
2463318|NCT02452034|8496219|P4|Overall Study|Withdrawn by Parent/Guardian|0
2463319|NCT02452034|8496220|P3|Overall Study|Withdrawn by Parent/Guardian|0
2463320|NCT02452034|8496221|P2|Overall Study|Withdrawn by Parent/Guardian|0
2463321|NCT02452034|8496222|P1|Overall Study|Withdrawn by Parent/Guardian|1
2463322|NCT02452034|8496217|P6|Overall Study|Screen Failure|0
2463323|NCT02452034|8496218|P5|Overall Study|Screen Failure|0
2463324|NCT02452034|8496219|P4|Overall Study|Screen Failure|1
2463325|NCT02452034|8496220|P3|Overall Study|Screen Failure|0
2463326|NCT02452034|8496221|P2|Overall Study|Screen Failure|0
2463327|NCT02452034|8496222|P1|Overall Study|Screen Failure|1
2463328|NCT02452034|8496217|P6|Overall Study|Protocol Violation|1
2463329|NCT02452034|8496218|P5|Overall Study|Protocol Violation|0
2463330|NCT02452034|8496219|P4|Overall Study|Protocol Violation|0
2463331|NCT02452034|8496220|P3|Overall Study|Protocol Violation|0
2463332|NCT02452034|8496221|P2|Overall Study|Protocol Violation|0
2463333|NCT02452034|8496222|P1|Overall Study|Protocol Violation|0
2463334|NCT02452034|8496217|P6|Overall Study|Physician Decision|0
2463335|NCT02452034|8496218|P5|Overall Study|Physician Decision|0
2463336|NCT02452034|8496219|P4|Overall Study|Physician Decision|0
2463337|NCT02452034|8496220|P3|Overall Study|Physician Decision|1
2463338|NCT02452034|8496221|P2|Overall Study|Physician Decision|1
2463339|NCT02452034|8496222|P1|Overall Study|Physician Decision|0
2463340|NCT02452034|8496217|P6|Overall Study|Death|1
2463341|NCT02452034|8496218|P5|Overall Study|Death|1
2463342|NCT02452034|8496219|P4|Overall Study|Death|0
2463343|NCT02452034|8496220|P3|Overall Study|Death|0
2463344|NCT02452034|8496221|P2|Overall Study|Death|0
2463345|NCT02452034|8496222|P1|Overall Study|Death|0
2463346|NCT02452034|8496217|P6|Overall Study|Adverse Event|1
2463347|NCT02452034|8496218|P5|Overall Study|Adverse Event|0
2463348|NCT02452034|8496219|P4|Overall Study|Adverse Event|0
2463349|NCT02452034|8496220|P3|Overall Study|Adverse Event|0
2463350|NCT02452034|8496221|P2|Overall Study|Adverse Event|0
2463351|NCT02452034|8496222|P1|Overall Study|Adverse Event|0
2463352|NCT02451943|8496295|P2|Overall Study|Lost to Follow-up|4
2463353|NCT02451943|8496296|P1|Overall Study|Lost to Follow-up|3
2463354|NCT02451943|8496295|P2|Overall Study|Withdrawal by Subject|16
2463355|NCT02451943|8496296|P1|Overall Study|Withdrawal by Subject|13
2463356|NCT02451943|8496295|P2|Overall Study|On Treatment|4
2463357|NCT02451943|8496296|P1|Overall Study|On Treatment|4
2463358|NCT02451917|8496324|P2|First Intervention (24 Weeks)|Adverse Event|2
2463359|NCT02451917|8496325|P1|First Intervention (24 Weeks)|Adverse Event|0
2463360|NCT02451917|8496324|P2|First Intervention (24 Weeks)|Death|1
2463361|NCT02451917|8496325|P1|First Intervention (24 Weeks)|Death|0
2463362|NCT02451917|8496324|P2|First Intervention (24 Weeks)|Lost to Follow-up|0
2463363|NCT02451917|8496325|P1|First Intervention (24 Weeks)|Lost to Follow-up|2
2463364|NCT02451670|8496367|P2|Overall Study|Did not have qualifying follow-up visit.|696
2463365|NCT02451670|8496368|P1|Overall Study|Did not have qualifying follow-up visit.|714
2463366|NCT02451358|8496387|P4|Overall Study|Protocol Violation|0
2463367|NCT02451358|8496388|P3|Overall Study|Protocol Violation|1
2463368|NCT02451358|8496389|P2|Overall Study|Protocol Violation|1
2463369|NCT02451358|8496390|P1|Overall Study|Protocol Violation|0
2463370|NCT02451358|8496387|P4|Overall Study|Withdrawal by Subject|0
2463371|NCT02451358|8496388|P3|Overall Study|Withdrawal by Subject|0
2463372|NCT02451358|8496389|P2|Overall Study|Withdrawal by Subject|1
2463373|NCT02451358|8496390|P1|Overall Study|Withdrawal by Subject|1
2463374|NCT02451137|8496478|P2|Overall Study|Other than specified above|3
2463375|NCT02451137|8496479|P1|Overall Study|Other than specified above|2
2463376|NCT02451137|8496478|P2|Overall Study|Withdrawal by Subject|63
2463377|NCT02451137|8496479|P1|Overall Study|Withdrawal by Subject|40
2463378|NCT02451137|8496478|P2|Overall Study|Sponsor decision|25
2463379|NCT02451137|8496479|P1|Overall Study|Sponsor decision|13
2463380|NCT02451137|8496478|P2|Overall Study|Physician Decision|5
2463381|NCT02451137|8496479|P1|Overall Study|Physician Decision|6
2463382|NCT02451137|8496478|P2|Overall Study|Lost to Follow-up|61
2463383|NCT02451137|8496479|P1|Overall Study|Lost to Follow-up|53
2463384|NCT02451137|8496478|P2|Overall Study|Investigator's decision|19
2463385|NCT02451137|8496479|P1|Overall Study|Investigator's decision|23
2463386|NCT02451137|8496478|P2|Overall Study|Hypoglycemia|1
2463387|NCT02451137|8496479|P1|Overall Study|Hypoglycemia|2
2463388|NCT02451137|8496478|P2|Overall Study|Participant decision:discontinue insulin|43
2463389|NCT02451137|8496479|P1|Overall Study|Participant decision:discontinue insulin|41
2463390|NCT02451137|8496478|P2|Overall Study|Lack of Efficacy|9
2463391|NCT02451137|8496479|P1|Overall Study|Lack of Efficacy|4
2463392|NCT02451137|8496478|P2|Overall Study|Adverse Event|42
2463393|NCT02451137|8496479|P1|Overall Study|Adverse Event|43
2463394|NCT02451137|8496478|P2|Overall Study|Randomized but not treated|27
2463395|NCT02451137|8496479|P1|Overall Study|Randomized but not treated|19
2463396|NCT02451124|8496509|P1|Overall Study|Withdrawal by Subject|1
2463397|NCT02451007|8496520|P1|Overall Study|Disease Progression|2
2463398|NCT02451007|8496520|P1|Overall Study|Adverse Event|1
2463399|NCT02451007|8496520|P1|Overall Study|Withdrawal by Subject|4
2463400|NCT02450552|8496559|P3|Overall Study|Physician Decision|1
2463401|NCT02450552|8496560|P2|Overall Study|Physician Decision|0
2463402|NCT02450552|8496561|P1|Overall Study|Physician Decision|1
2463403|NCT02450552|8496559|P3|Overall Study|Withdrawal by Subject|4
2463404|NCT02450552|8496560|P2|Overall Study|Withdrawal by Subject|0
2463405|NCT02450552|8496561|P1|Overall Study|Withdrawal by Subject|4
2463406|NCT02450539|8496604|P2|Overall Study|On study treatment/follow up|25
2463407|NCT02450539|8496605|P1|Overall Study|On study treatment/follow up|27
2463408|NCT02450539|8496604|P2|Overall Study|Lost to Follow-up|1
2463409|NCT02450539|8496605|P1|Overall Study|Lost to Follow-up|4
2463410|NCT02450539|8496604|P2|Overall Study|Withdrawal by Subject|7
2463411|NCT02450539|8496605|P1|Overall Study|Withdrawal by Subject|19
2463412|NCT02450526|8496629|P5|OL Period (Cycles 2-5)|Protocol Violation|7
2463413|NCT02450526|8496630|P4|OL Period (Cycles 2-5)|Protocol Violation|0
2463414|NCT02450526|8496631|P3|OL Period (Cycles 2-5)|Protocol Violation|0
2463415|NCT02450526|8496632|P2|OL Period (Cycles 2-5)|Protocol Violation|0
2463416|NCT02450526|8496633|P1|OL Period (Cycles 2-5)|Protocol Violation|0
2463417|NCT02450526|8496629|P5|OL Period (Cycles 2-5)|Lack of Efficacy|1
2463418|NCT02450526|8496630|P4|OL Period (Cycles 2-5)|Lack of Efficacy|0
2463419|NCT02450526|8496631|P3|OL Period (Cycles 2-5)|Lack of Efficacy|0
2463420|NCT02450526|8496632|P2|OL Period (Cycles 2-5)|Lack of Efficacy|0
2463421|NCT02450526|8496633|P1|OL Period (Cycles 2-5)|Lack of Efficacy|0
2463422|NCT02450526|8496629|P5|OL Period (Cycles 2-5)|Withdrawal by Subject|31
2463423|NCT02450526|8496630|P4|OL Period (Cycles 2-5)|Withdrawal by Subject|0
2463424|NCT02450526|8496631|P3|OL Period (Cycles 2-5)|Withdrawal by Subject|0
2463425|NCT02450526|8496632|P2|OL Period (Cycles 2-5)|Withdrawal by Subject|0
2463426|NCT02450526|8496633|P1|OL Period (Cycles 2-5)|Withdrawal by Subject|0
2463427|NCT02450526|8496629|P5|OL Period (Cycles 2-5)|Adverse Event|2
2463428|NCT02450526|8496630|P4|OL Period (Cycles 2-5)|Adverse Event|0
2463429|NCT02450526|8496631|P3|OL Period (Cycles 2-5)|Adverse Event|0
2463430|NCT02450526|8496632|P2|OL Period (Cycles 2-5)|Adverse Event|0
2463431|NCT02450526|8496633|P1|OL Period (Cycles 2-5)|Adverse Event|0
2463432|NCT02450526|8496629|P5|DB Period (Cycle 1)|Protocol Violation|0
2463433|NCT02450526|8496630|P4|DB Period (Cycle 1)|Protocol Violation|1
2463434|NCT02450526|8496631|P3|DB Period (Cycle 1)|Protocol Violation|0
2463435|NCT02450526|8496632|P2|DB Period (Cycle 1)|Protocol Violation|0
2463436|NCT02450526|8496633|P1|DB Period (Cycle 1)|Protocol Violation|2
2463437|NCT02450526|8496629|P5|DB Period (Cycle 1)|Lost to Follow-up|0
2463438|NCT02450526|8496630|P4|DB Period (Cycle 1)|Lost to Follow-up|0
2463439|NCT02450526|8496631|P3|DB Period (Cycle 1)|Lost to Follow-up|0
2463440|NCT02450526|8496632|P2|DB Period (Cycle 1)|Lost to Follow-up|0
2463441|NCT02450526|8496633|P1|DB Period (Cycle 1)|Lost to Follow-up|1
2463442|NCT02450526|8496629|P5|DB Period (Cycle 1)|Withdrawal by Subject|0
2463443|NCT02450526|8496630|P4|DB Period (Cycle 1)|Withdrawal by Subject|1
2463444|NCT02450526|8496631|P3|DB Period (Cycle 1)|Withdrawal by Subject|8
2463445|NCT02450526|8496632|P2|DB Period (Cycle 1)|Withdrawal by Subject|3
2463446|NCT02450526|8496633|P1|DB Period (Cycle 1)|Withdrawal by Subject|28
2463447|NCT02450526|8496629|P5|DB Period (Cycle 1)|Adverse Event|0
2463448|NCT02450526|8496630|P4|DB Period (Cycle 1)|Adverse Event|0
2463449|NCT02450526|8496631|P3|DB Period (Cycle 1)|Adverse Event|2
2463450|NCT02450526|8496632|P2|DB Period (Cycle 1)|Adverse Event|0
2463451|NCT02450526|8496633|P1|DB Period (Cycle 1)|Adverse Event|0
2463452|NCT02449915|8496735|P2|Overall Study|Abnormal preop lab|1
2463453|NCT02449915|8496736|P1|Overall Study|Abnormal preop lab|0
2463454|NCT02449915|8496735|P2|Overall Study|Intraoperative surgical findings|1
2463455|NCT02449915|8496736|P1|Overall Study|Intraoperative surgical findings|1
2463456|NCT02449915|8496735|P2|Overall Study|Withdrawal by Subject|2
2463457|NCT02449915|8496736|P1|Overall Study|Withdrawal by Subject|0
2463458|NCT02449915|8496735|P2|Overall Study|Exclusion criteria - drug use|0
2463459|NCT02449915|8496736|P1|Overall Study|Exclusion criteria - drug use|1
2463460|NCT02449902|8496744|P2|Overall Study|Withdrawal by Subject|1
2463461|NCT02449902|8496745|P1|Overall Study|Withdrawal by Subject|0
2463462|NCT02449902|8496744|P2|Overall Study|Adverse Event|1
2463463|NCT02449902|8496745|P1|Overall Study|Adverse Event|0
2463464|NCT02449889|8496772|P3|Overall Study|Protocol Violation|1
2463465|NCT02449889|8496773|P2|Overall Study|Protocol Violation|4
2463466|NCT02449889|8496774|P1|Overall Study|Protocol Violation|0
2463467|NCT02449889|8496772|P3|Overall Study|Adverse Event|0
2463468|NCT02449889|8496773|P2|Overall Study|Adverse Event|2
2463469|NCT02449889|8496774|P1|Overall Study|Adverse Event|1
2463470|NCT02449044|8496899|P1|Overall Study|Sponsor Discontinued Trial|3
2463471|NCT02449044|8496899|P1|Overall Study|Physician Decision|9
2463472|NCT02449044|8496899|P1|Overall Study|Met Withdrawal Criteria|7
2463473|NCT02449044|8496899|P1|Overall Study|Adverse Event|30
2463474|NCT02449044|8496899|P1|Overall Study|Withdrawal by Subject|13
2463475|NCT02449044|8496899|P1|Overall Study|Lost to Follow-up|2
2463476|NCT02449018|8496920|P2|Overall Study|Patient decision|0
2463477|NCT02449018|8496921|P1|Overall Study|Patient decision|2
2463478|NCT02449018|8496920|P2|Overall Study|Protocol deviation|0
2463479|NCT02449018|8496921|P1|Overall Study|Protocol deviation|4
2463480|NCT02449018|8496920|P2|Overall Study|Adverse Event|1
2463481|NCT02449018|8496921|P1|Overall Study|Adverse Event|5
2463482|NCT02449018|8496920|P2|Overall Study|Administrative problems|0
2463483|NCT02449018|8496921|P1|Overall Study|Administrative problems|1
2463484|NCT02449018|8496920|P2|Overall Study|Abnormal laboratory value|1
2463485|NCT02449018|8496921|P1|Overall Study|Abnormal laboratory value|0
2463486|NCT02448875|8496968|P3|Overall Study|Withdrawal by Subject|0
2463487|NCT02448875|8496969|P2|Overall Study|Withdrawal by Subject|0
2463488|NCT02448875|8496970|P1|Overall Study|Withdrawal by Subject|1
2463489|NCT02448875|8496968|P3|Overall Study|Investigator Decision|1
2463490|NCT02448875|8496969|P2|Overall Study|Investigator Decision|0
2463491|NCT02448875|8496970|P1|Overall Study|Investigator Decision|3
2463492|NCT02448875|8496968|P3|Overall Study|Lost to Follow-up|0
2463493|NCT02448875|8496969|P2|Overall Study|Lost to Follow-up|0
2463494|NCT02448875|8496970|P1|Overall Study|Lost to Follow-up|1
2463495|NCT02448875|8496968|P3|Overall Study|Adverse Event|0
2463496|NCT02448875|8496969|P2|Overall Study|Adverse Event|1
2463497|NCT02448875|8496970|P1|Overall Study|Adverse Event|2
2463498|NCT02448810|8497018|P8|Overall Study|Other (unspecified)|0
2463499|NCT02448810|8497019|P7|Overall Study|Other (unspecified)|2
2463500|NCT02448810|8497020|P6|Overall Study|Other (unspecified)|0
2463501|NCT02448810|8497021|P5|Overall Study|Other (unspecified)|0
2463502|NCT02448810|8497022|P4|Overall Study|Other (unspecified)|0
2463503|NCT02448810|8497023|P3|Overall Study|Other (unspecified)|0
2463504|NCT02448810|8497024|P2|Overall Study|Other (unspecified)|0
2463505|NCT02448810|8497025|P1|Overall Study|Other (unspecified)|0
2463506|NCT02448810|8497018|P8|Overall Study|Lost to Follow-up|0
2463507|NCT02448810|8497019|P7|Overall Study|Lost to Follow-up|0
2463508|NCT02448810|8497020|P6|Overall Study|Lost to Follow-up|0
2463509|NCT02448810|8497021|P5|Overall Study|Lost to Follow-up|0
2463510|NCT02448810|8497022|P4|Overall Study|Lost to Follow-up|0
2463511|NCT02448810|8497023|P3|Overall Study|Lost to Follow-up|0
2463512|NCT02448810|8497024|P2|Overall Study|Lost to Follow-up|1
2463513|NCT02448810|8497025|P1|Overall Study|Lost to Follow-up|0
2463514|NCT02448810|8497018|P8|Overall Study|Other (Progressive disease)|5
2463515|NCT02448810|8497019|P7|Overall Study|Other (Progressive disease)|14
2463516|NCT02448810|8497020|P6|Overall Study|Other (Progressive disease)|9
2463517|NCT02448810|8497021|P5|Overall Study|Other (Progressive disease)|23
2463518|NCT02448810|8497022|P4|Overall Study|Other (Progressive disease)|3
2463519|NCT02448810|8497023|P3|Overall Study|Other (Progressive disease)|0
2463520|NCT02448810|8497024|P2|Overall Study|Other (Progressive disease)|2
2463521|NCT02448810|8497025|P1|Overall Study|Other (Progressive disease)|2
2463522|NCT02448810|8497018|P8|Overall Study|Death|0
2463523|NCT02448810|8497019|P7|Overall Study|Death|0
2463524|NCT02448810|8497020|P6|Overall Study|Death|0
2463525|NCT02448810|8497021|P5|Overall Study|Death|1
2463526|NCT02448810|8497022|P4|Overall Study|Death|0
2463527|NCT02448810|8497023|P3|Overall Study|Death|1
2463528|NCT02448810|8497024|P2|Overall Study|Death|0
2463529|NCT02448810|8497025|P1|Overall Study|Death|1
2463530|NCT02448810|8497018|P8|Overall Study|Other (study terminated by sponsor)|1
2463531|NCT02448810|8497019|P7|Overall Study|Other (study terminated by sponsor)|2
2463532|NCT02448810|8497020|P6|Overall Study|Other (study terminated by sponsor)|2
2463533|NCT02448810|8497021|P5|Overall Study|Other (study terminated by sponsor)|4
2463534|NCT02448810|8497022|P4|Overall Study|Other (study terminated by sponsor)|0
2463535|NCT02448810|8497023|P3|Overall Study|Other (study terminated by sponsor)|0
2463536|NCT02448810|8497024|P2|Overall Study|Other (study terminated by sponsor)|0
2463537|NCT02448810|8497025|P1|Overall Study|Other (study terminated by sponsor)|0
2463538|NCT02448810|8497018|P8|Overall Study|Withdrawal by Subject|2
2463539|NCT02448810|8497019|P7|Overall Study|Withdrawal by Subject|0
2463540|NCT02448810|8497020|P6|Overall Study|Withdrawal by Subject|5
2463541|NCT02448810|8497021|P5|Overall Study|Withdrawal by Subject|3
2463542|NCT02448810|8497022|P4|Overall Study|Withdrawal by Subject|0
2463543|NCT02448810|8497023|P3|Overall Study|Withdrawal by Subject|1
2463544|NCT02448810|8497024|P2|Overall Study|Withdrawal by Subject|0
2463545|NCT02448810|8497025|P1|Overall Study|Withdrawal by Subject|0
2463546|NCT02448810|8497018|P8|Overall Study|Adverse Event|0
2463547|NCT02448810|8497019|P7|Overall Study|Adverse Event|0
2463548|NCT02448810|8497020|P6|Overall Study|Adverse Event|0
2463549|NCT02448810|8497021|P5|Overall Study|Adverse Event|0
2463550|NCT02448810|8497022|P4|Overall Study|Adverse Event|0
2463551|NCT02448810|8497023|P3|Overall Study|Adverse Event|1
2463552|NCT02448810|8497024|P2|Overall Study|Adverse Event|0
2463553|NCT02448810|8497025|P1|Overall Study|Adverse Event|0
2463554|NCT02448719|8497102|P11|Overall Study|Withdrawal by Subject|0
2463555|NCT02448719|8497103|P10|Overall Study|Withdrawal by Subject|0
2463556|NCT02448719|8497104|P9|Overall Study|Withdrawal by Subject|0
2463557|NCT02448719|8497105|P8|Overall Study|Withdrawal by Subject|0
2463558|NCT02448719|8497106|P7|Overall Study|Withdrawal by Subject|0
2463559|NCT02448719|8497107|P6|Overall Study|Withdrawal by Subject|0
2463560|NCT02448719|8497108|P5|Overall Study|Withdrawal by Subject|1
2463561|NCT02448719|8497109|P4|Overall Study|Withdrawal by Subject|0
2463562|NCT02448719|8497110|P3|Overall Study|Withdrawal by Subject|0
2463563|NCT02448719|8497111|P2|Overall Study|Withdrawal by Subject|0
2463564|NCT02448719|8497112|P1|Overall Study|Withdrawal by Subject|0
2463565|NCT02448706|8497336|P2|Overall Study|Protocol Violation|1
2463566|NCT02448706|8497337|P1|Overall Study|Protocol Violation|1
2463567|NCT02448706|8497336|P2|Overall Study|Withdrawal by Subject|3
2463568|NCT02448706|8497337|P1|Overall Study|Withdrawal by Subject|4
2463569|NCT02448563|8497387|P2|Overall Study|Withdrawal by Subject|1
2463570|NCT02448563|8497388|P1|Overall Study|Withdrawal by Subject|0
2463571|NCT02448563|8497387|P2|Overall Study|Lost to Follow-up|10
2463572|NCT02448563|8497388|P1|Overall Study|Lost to Follow-up|16
2463573|NCT02448537|8497410|P3|Overall Study|Withdrawal by Subject|1
2463574|NCT02448537|8497411|P2|Overall Study|Withdrawal by Subject|1
2463575|NCT02448537|8497412|P1|Overall Study|Withdrawal by Subject|1
2463576|NCT02448043|8497526|P2|Overall Study|Protocol Violation|2
2463577|NCT02448043|8497527|P1|Overall Study|Protocol Violation|1
2463578|NCT02448043|8497526|P2|Overall Study|Withdrawal by Subject|2
2463579|NCT02448043|8497527|P1|Overall Study|Withdrawal by Subject|2
2463580|NCT02447952|8497545|P1|Overall Study|Withdrawal by Subject|4
2463581|NCT02447952|8497545|P1|Overall Study|Physician Decision|1
2463582|NCT02447952|8497545|P1|Overall Study|Adverse Event|2
2463583|NCT02447887|8497602|P1|Overall Study|Study was terminated|3
2463584|NCT02447848|8497615|P1|Overall Study|Withdrawal by Subject|4
2463585|NCT02447848|8497615|P1|Overall Study|Lack of Efficacy|4
2463586|NCT02447848|8497615|P1|Overall Study|Patient discharged|3
2463587|NCT02447458|8497627|P6|Overall Study|Other|0
2463588|NCT02447458|8497628|P5|Overall Study|Other|0
2463589|NCT02447458|8497629|P4|Overall Study|Other|0
2463590|NCT02447458|8497630|P3|Overall Study|Other|1
2463591|NCT02447458|8497631|P2|Overall Study|Other|0
2463592|NCT02447458|8497632|P1|Overall Study|Other|0
2463593|NCT02447432|8497730|P2|Epoch 001|Lost to Follow-up|3
2463594|NCT02447432|8497731|P1|Epoch 001|Lost to Follow-up|1
2463595|NCT02447432|8497730|P2|Epoch 001|Migrated/moved from study area|5
2463596|NCT02447432|8497731|P1|Epoch 001|Migrated/moved from study area|3
2463597|NCT02447432|8497730|P2|Epoch 001|Withdrawal by Subject|4
2463598|NCT02447432|8497731|P1|Epoch 001|Withdrawal by Subject|0
2463599|NCT02447432|8497730|P2|Epoch 001|Adverse Event|1
2463600|NCT02447432|8497731|P1|Epoch 001|Adverse Event|1
2463601|NCT02447328|8497763|P1|Overall Study|Withdrawal by Subject|1
2463602|NCT02447250|8497767|P1|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4
2463603|NCT02447250|8497767|P1|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1
2463604|NCT02447250|8497767|P1|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1
2463605|NCT02447081|8497784|P1|Overall Study|unsuccessful implant procedure|10
2463606|NCT02447081|8497784|P1|Overall Study|Visit not completed|17
2463607|NCT02447081|8497784|P1|Overall Study|Lost to Follow-up|36
2463608|NCT02447081|8497784|P1|Overall Study|Death|161
2463609|NCT02447029|8497800|P2|Overall Study|Withdrawal by Subject|2
2463610|NCT02447029|8497801|P1|Overall Study|Withdrawal by Subject|3
2463611|NCT02446990|8497821|P2|Overall Study|Withdrawal by Subject|199
2463612|NCT02446990|8497822|P1|Overall Study|Withdrawal by Subject|231
2463613|NCT02446990|8497821|P2|Overall Study|Physician Decision|0
2463614|NCT02446990|8497822|P1|Overall Study|Physician Decision|1
2463615|NCT02446990|8497821|P2|Overall Study|Lost to Follow-up|1
2463616|NCT02446990|8497822|P1|Overall Study|Lost to Follow-up|3
2463617|NCT02446990|8497821|P2|Overall Study|Death|458
2463618|NCT02446990|8497822|P1|Overall Study|Death|485
2463619|NCT02446912|8497857|P3|Overall Study|Miscellaneous|4
2463620|NCT02446912|8497858|P2|Overall Study|Miscellaneous|2
2463621|NCT02446912|8497859|P1|Overall Study|Miscellaneous|2
2463622|NCT02446912|8497857|P3|Overall Study|Withdrawal by Subject|15
2463623|NCT02446912|8497858|P2|Overall Study|Withdrawal by Subject|15
2463624|NCT02446912|8497859|P1|Overall Study|Withdrawal by Subject|10
2463625|NCT02446912|8497857|P3|Overall Study|Severe non-compliance to protocol|1
2463626|NCT02446912|8497858|P2|Overall Study|Severe non-compliance to protocol|0
2463627|NCT02446912|8497859|P1|Overall Study|Severe non-compliance to protocol|1
2463628|NCT02446912|8497857|P3|Overall Study|Lost to Follow-up|2
2463629|NCT02446912|8497858|P2|Overall Study|Lost to Follow-up|0
2463630|NCT02446912|8497859|P1|Overall Study|Lost to Follow-up|0
2463631|NCT02446912|8497857|P3|Overall Study|Lack of Efficacy|7
2463632|NCT02446912|8497858|P2|Overall Study|Lack of Efficacy|4
2463633|NCT02446912|8497859|P1|Overall Study|Lack of Efficacy|1
2463634|NCT02446912|8497857|P3|Overall Study|Study-specific withdrawal criteria|0
2463635|NCT02446912|8497858|P2|Overall Study|Study-specific withdrawal criteria|0
2463636|NCT02446912|8497859|P1|Overall Study|Study-specific withdrawal criteria|1
2463637|NCT02446912|8497857|P3|Overall Study|Condition under investigation worsened|1
2463638|NCT02446912|8497858|P2|Overall Study|Condition under investigation worsened|1
2463639|NCT02446912|8497859|P1|Overall Study|Condition under investigation worsened|0
2463640|NCT02446912|8497857|P3|Overall Study|Adverse Event|5
2463641|NCT02446912|8497858|P2|Overall Study|Adverse Event|13
2463642|NCT02446912|8497859|P1|Overall Study|Adverse Event|3
2463643|NCT02446899|8497932|P2|Overall Study|Failure to Meet Randomization Criteria|2
2463644|NCT02446899|8497933|P1|Overall Study|Failure to Meet Randomization Criteria|0
2463645|NCT02446899|8497932|P2|Overall Study|Miscellaneous|4
2463646|NCT02446899|8497933|P1|Overall Study|Miscellaneous|5
2463647|NCT02446899|8497932|P2|Overall Study|Withdrawal by Subject|19
2463648|NCT02446899|8497933|P1|Overall Study|Withdrawal by Subject|11
2463649|NCT02446899|8497932|P2|Overall Study|Severe Non-Compliance to Protocol|1
2463650|NCT02446899|8497933|P1|Overall Study|Severe Non-Compliance to Protocol|0
2463651|NCT02446899|8497932|P2|Overall Study|Lost to Follow-up|3
2463652|NCT02446899|8497933|P1|Overall Study|Lost to Follow-up|1
2463653|NCT02446899|8497932|P2|Overall Study|Lack of Efficacy|8
2463654|NCT02446899|8497933|P1|Overall Study|Lack of Efficacy|2
2463655|NCT02446899|8497932|P2|Overall Study|Study Specific Withdrawal Criteria|0
2463656|NCT02446899|8497933|P1|Overall Study|Study Specific Withdrawal Criteria|1
2463657|NCT02446899|8497932|P2|Overall Study|Condition Under Investigation Worsened|4
2463658|NCT02446899|8497933|P1|Overall Study|Condition Under Investigation Worsened|1
2463659|NCT02446899|8497932|P2|Overall Study|Adverse Event|7
2463660|NCT02446899|8497933|P1|Overall Study|Adverse Event|4
2463661|NCT02446769|8497957|P3|Study Period|Randomized in Error|0
2463662|NCT02446769|8497958|P2|Study Period|Randomized in Error|2
2463663|NCT02446769|8497959|P1|Study Period|Randomized in Error|0
2463664|NCT02446769|8497957|P3|Screening Period|Screen Failure|0
2463665|NCT02446769|8497958|P2|Screening Period|Screen Failure|0
2463666|NCT02446769|8497959|P1|Screening Period|Screen Failure|11
2463667|NCT02446743|8497980|P2|Overall Study|Other|3
2463668|NCT02446743|8497981|P1|Overall Study|Other|2
2463669|NCT02446743|8497980|P2|Overall Study|Adverse Event|1
2463670|NCT02446743|8497981|P1|Overall Study|Adverse Event|1
2463671|NCT02446743|8497980|P2|Overall Study|Lost to Follow-up|0
2463672|NCT02446743|8497981|P1|Overall Study|Lost to Follow-up|1
2463673|NCT02446743|8497980|P2|Overall Study|Withdrawal by Subject|1
2463674|NCT02446743|8497981|P1|Overall Study|Withdrawal by Subject|1
2463675|NCT02446717|8498136|P5|Overall Study|Withdrew consent|0
2463676|NCT02446717|8498137|P4|Overall Study|Withdrew consent|1
2463677|NCT02446717|8498138|P3|Overall Study|Withdrew consent|0
2463678|NCT02446717|8498139|P2|Overall Study|Withdrew consent|0
2463679|NCT02446717|8498140|P1|Overall Study|Withdrew consent|0
2463680|NCT02446717|8498136|P5|Overall Study|Lost to Follow-up|1
2463681|NCT02446717|8498137|P4|Overall Study|Lost to Follow-up|0
2463682|NCT02446717|8498138|P3|Overall Study|Lost to Follow-up|1
2463683|NCT02446717|8498139|P2|Overall Study|Lost to Follow-up|1
2463684|NCT02446717|8498140|P1|Overall Study|Lost to Follow-up|0
2463685|NCT02446717|8498136|P5|Overall Study|Adverse Event|0
2463686|NCT02446717|8498137|P4|Overall Study|Adverse Event|0
2463687|NCT02446717|8498138|P3|Overall Study|Adverse Event|1
2463688|NCT02446717|8498139|P2|Overall Study|Adverse Event|0
2463689|NCT02446717|8498140|P1|Overall Study|Adverse Event|0
2463690|NCT02446691|8498167|P1|Overall Study|Protocol Violation|1
2463691|NCT02446691|8498167|P1|Overall Study|Lost to Follow-up|8
2463692|NCT02446691|8498167|P1|Overall Study|Withdrawal by Subject|2
2463693|NCT02446418|8498237|P2|Overall Study|Protocol defined stopping criteria reach|0
2463694|NCT02446418|8498238|P1|Overall Study|Protocol defined stopping criteria reach|1
2463695|NCT02446418|8498237|P2|Overall Study|Lack of Efficacy|0
2463696|NCT02446418|8498238|P1|Overall Study|Lack of Efficacy|2
2463697|NCT02446418|8498237|P2|Overall Study|Protocol Violation|2
2463698|NCT02446418|8498238|P1|Overall Study|Protocol Violation|1
2463699|NCT02446418|8498237|P2|Overall Study|Lost to Follow-up|2
2463700|NCT02446418|8498238|P1|Overall Study|Lost to Follow-up|2
2463701|NCT02446418|8498237|P2|Overall Study|Withdrawal by Subject|3
2463702|NCT02446418|8498238|P1|Overall Study|Withdrawal by Subject|3
2463703|NCT02446418|8498237|P2|Overall Study|Physician Decision|1
2463704|NCT02446418|8498238|P1|Overall Study|Physician Decision|5
2463705|NCT02446418|8498237|P2|Overall Study|Adverse Event|8
2463706|NCT02446418|8498238|P1|Overall Study|Adverse Event|4
2463707|NCT02446171|8498309|P4|Overall Study|Withdrawal by Subject|0
2463708|NCT02446171|8498310|P3|Overall Study|Withdrawal by Subject|2
2463709|NCT02446171|8498311|P2|Overall Study|Withdrawal by Subject|0
2463710|NCT02446171|8498312|P1|Overall Study|Withdrawal by Subject|0
2463711|NCT02446015|8498383|P2|Overall Study|Withdrawal by Subject|0
2463712|NCT02446015|8498384|P1|Overall Study|Withdrawal by Subject|1
2463713|NCT02446015|8498383|P2|Overall Study|Adverse Event|1
2463714|NCT02446015|8498384|P1|Overall Study|Adverse Event|0
2463715|NCT02445755|8498494|P1|Overall Study|Screen Failure|5
2463716|NCT02445755|8498494|P1|Overall Study|Protocol Violation|6
2463717|NCT02445755|8498494|P1|Overall Study|Withdrawal by Subject|2
2463718|NCT02445586|8498508|P1|Overall Study|Medical Condition|1
2463719|NCT02445586|8498508|P1|Overall Study|Protocol Violation|1
2463720|NCT02445586|8498508|P1|Overall Study|Disease Progression|10
2463721|NCT02445586|8498508|P1|Overall Study|Withdrawal by Subject|13
2463722|NCT02445586|8498508|P1|Overall Study|Death|14
2463723|NCT02445573|8498548|P2|Overall Study|Lost to Follow-up|1
2463724|NCT02445573|8498549|P1|Overall Study|Lost to Follow-up|0
2463725|NCT02445573|8498548|P2|Overall Study|Withdrawal by Subject|1
2463726|NCT02445573|8498549|P1|Overall Study|Withdrawal by Subject|1
2463727|NCT02444793|8498646|P4|Overall Study|Objective progression or relapse|3
2463728|NCT02444793|8498647|P3|Overall Study|Objective progression or relapse|2
2463729|NCT02444793|8498648|P2|Overall Study|Objective progression or relapse|1
2463730|NCT02444793|8498649|P1|Overall Study|Objective progression or relapse|9
2463731|NCT02444793|8498646|P4|Overall Study|Other|0
2463732|NCT02444793|8498647|P3|Overall Study|Other|2
2463733|NCT02444793|8498648|P2|Overall Study|Other|0
2463734|NCT02444793|8498649|P1|Overall Study|Other|0
2463735|NCT02444793|8498646|P4|Overall Study|Death|0
2463736|NCT02444793|8498647|P3|Overall Study|Death|0
2463737|NCT02444793|8498648|P2|Overall Study|Death|3
2463738|NCT02444793|8498649|P1|Overall Study|Death|0
2463739|NCT02444793|8498646|P4|Overall Study|Lost to Follow-up|0
2463740|NCT02444793|8498647|P3|Overall Study|Lost to Follow-up|0
2463741|NCT02444793|8498648|P2|Overall Study|Lost to Follow-up|2
2463742|NCT02444793|8498649|P1|Overall Study|Lost to Follow-up|2
2463743|NCT02444533|8498808|P2|Overall Study|Only gave post-procedure complications|2
2463744|NCT02444533|8498809|P1|Overall Study|Only gave post-procedure complications|2
2463745|NCT02444533|8498808|P2|Overall Study|Not able to complete forms|2
2463746|NCT02444533|8498809|P1|Overall Study|Not able to complete forms|0
2463747|NCT02444182|8498842|P2|Overall Study|Lost to Follow-up|4
2463748|NCT02444182|8498843|P1|Overall Study|Lost to Follow-up|0
2463749|NCT02444182|8498842|P2|Overall Study|non-compliance|1
2463750|NCT02444182|8498843|P1|Overall Study|non-compliance|2
2463751|NCT02443883|8498866|P4|Overall Study|Randomized, but never treated|1
2463752|NCT02443883|8498867|P3|Overall Study|Randomized, but never treated|1
2463753|NCT02443883|8498868|P2|Overall Study|Randomized, but never treated|0
2463754|NCT02443883|8498869|P1|Overall Study|Randomized, but never treated|2
2463755|NCT02443883|8498866|P4|Overall Study|Withdrawal by Subject|1
2463756|NCT02443883|8498867|P3|Overall Study|Withdrawal by Subject|2
2463757|NCT02443883|8498868|P2|Overall Study|Withdrawal by Subject|0
2463758|NCT02443883|8498869|P1|Overall Study|Withdrawal by Subject|1
2463759|NCT02443883|8498866|P4|Overall Study|Physician Decision|3
2463760|NCT02443883|8498867|P3|Overall Study|Physician Decision|0
2463761|NCT02443883|8498868|P2|Overall Study|Physician Decision|1
2463762|NCT02443883|8498869|P1|Overall Study|Physician Decision|2
2463763|NCT02443883|8498866|P4|Overall Study|Lost to Follow-up|0
2463764|NCT02443883|8498867|P3|Overall Study|Lost to Follow-up|0
2463765|NCT02443883|8498868|P2|Overall Study|Lost to Follow-up|2
2463766|NCT02443883|8498869|P1|Overall Study|Lost to Follow-up|1
2463767|NCT02443883|8498866|P4|Overall Study|Adverse Event|2
2463768|NCT02443883|8498867|P3|Overall Study|Adverse Event|1
2463769|NCT02443883|8498868|P2|Overall Study|Adverse Event|2
2463770|NCT02443883|8498869|P1|Overall Study|Adverse Event|0
2463771|NCT02443805|8498889|P2|Overall Study|Any other reason not above-mentioned|2
2463772|NCT02443805|8498890|P1|Overall Study|Any other reason not above-mentioned|3
2463773|NCT02443805|8498889|P2|Overall Study|Withdrawal by parent/guardian|5
2463774|NCT02443805|8498890|P1|Overall Study|Withdrawal by parent/guardian|3
2463775|NCT02443805|8498889|P2|Overall Study|Non-compliance with study drug|4
2463776|NCT02443805|8498890|P1|Overall Study|Non-compliance with study drug|6
2463777|NCT02443805|8498889|P2|Overall Study|Lack of Efficacy|1
2463778|NCT02443805|8498890|P1|Overall Study|Lack of Efficacy|1
2463779|NCT02443805|8498889|P2|Overall Study|Protocol Violation|4
2463780|NCT02443805|8498890|P1|Overall Study|Protocol Violation|2
2463781|NCT02443805|8498889|P2|Overall Study|Pregnancy|5
2463782|NCT02443805|8498890|P1|Overall Study|Pregnancy|6
2463783|NCT02443805|8498889|P2|Overall Study|Lost to Follow-up|14
2463784|NCT02443805|8498890|P1|Overall Study|Lost to Follow-up|19
2463785|NCT02443805|8498889|P2|Overall Study|Withdrawal by Subject|74
2463786|NCT02443805|8498890|P1|Overall Study|Withdrawal by Subject|73
2463787|NCT02443805|8498889|P2|Overall Study|Adverse Event|18
2463788|NCT02443805|8498890|P1|Overall Study|Adverse Event|100
2463789|NCT02443740|8498921|P11|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
2463790|NCT02443740|8498922|P10|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
2463791|NCT02443740|8498923|P9|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
2463792|NCT02443740|8498924|P8|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
2463793|NCT02443740|8498925|P7|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
2463794|NCT02443740|8498926|P6|Intervention Period 1 (3 Days)|Withdrawal by Subject|1
2463795|NCT02443740|8498927|P5|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
2463796|NCT02443740|8498928|P4|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
2463797|NCT02443740|8498929|P3|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
2463798|NCT02443740|8498930|P2|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
2463799|NCT02443740|8498931|P1|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
2463800|NCT02443740|8498921|P11|Intervention Period 1 (3 Days)|Protocol Violation|0
2463801|NCT02443740|8498922|P10|Intervention Period 1 (3 Days)|Protocol Violation|0
2463802|NCT02443740|8498923|P9|Intervention Period 1 (3 Days)|Protocol Violation|0
2463803|NCT02443740|8498924|P8|Intervention Period 1 (3 Days)|Protocol Violation|0
2463804|NCT02443740|8498925|P7|Intervention Period 1 (3 Days)|Protocol Violation|1
2463805|NCT02443740|8498926|P6|Intervention Period 1 (3 Days)|Protocol Violation|0
2463806|NCT02443740|8498927|P5|Intervention Period 1 (3 Days)|Protocol Violation|0
2463807|NCT02443740|8498928|P4|Intervention Period 1 (3 Days)|Protocol Violation|0
2463808|NCT02443740|8498929|P3|Intervention Period 1 (3 Days)|Protocol Violation|0
2463809|NCT02443740|8498930|P2|Intervention Period 1 (3 Days)|Protocol Violation|0
2463810|NCT02443740|8498931|P1|Intervention Period 1 (3 Days)|Protocol Violation|1
2463811|NCT02443740|8498921|P11|Intervention Period 1 (3 Days)|Adverse Event|0
2463812|NCT02443740|8498922|P10|Intervention Period 1 (3 Days)|Adverse Event|0
2463813|NCT02443740|8498923|P9|Intervention Period 1 (3 Days)|Adverse Event|0
2463814|NCT02443740|8498924|P8|Intervention Period 1 (3 Days)|Adverse Event|0
2463815|NCT02443740|8498925|P7|Intervention Period 1 (3 Days)|Adverse Event|0
2463816|NCT02443740|8498926|P6|Intervention Period 1 (3 Days)|Adverse Event|1
2463817|NCT02443740|8498927|P5|Intervention Period 1 (3 Days)|Adverse Event|0
2463818|NCT02443740|8498928|P4|Intervention Period 1 (3 Days)|Adverse Event|0
2463819|NCT02443740|8498929|P3|Intervention Period 1 (3 Days)|Adverse Event|0
2463820|NCT02443740|8498930|P2|Intervention Period 1 (3 Days)|Adverse Event|0
2463821|NCT02443740|8498931|P1|Intervention Period 1 (3 Days)|Adverse Event|0
2463822|NCT02443688|8499113|P3|Overall Study|Sponsor Request|0
2463823|NCT02443688|8499114|P2|Overall Study|Sponsor Request|1
2463824|NCT02443688|8499115|P1|Overall Study|Sponsor Request|2
2463825|NCT02443688|8499113|P3|Overall Study|Non-compliance with study drug|4
2463826|NCT02443688|8499114|P2|Overall Study|Non-compliance with study drug|2
2463827|NCT02443688|8499115|P1|Overall Study|Non-compliance with study drug|1
2463828|NCT02443688|8499113|P3|Overall Study|Withdrawal by Subject|4
2463829|NCT02443688|8499114|P2|Overall Study|Withdrawal by Subject|3
2463830|NCT02443688|8499115|P1|Overall Study|Withdrawal by Subject|3
2463831|NCT02443688|8499113|P3|Overall Study|Pregnancy|1
2463832|NCT02443688|8499114|P2|Overall Study|Pregnancy|0
2463833|NCT02443688|8499115|P1|Overall Study|Pregnancy|0
2463834|NCT02443688|8499113|P3|Overall Study|Physician Decision|1
2463835|NCT02443688|8499114|P2|Overall Study|Physician Decision|0
2463836|NCT02443688|8499115|P1|Overall Study|Physician Decision|3
2463837|NCT02443688|8499113|P3|Overall Study|Lost to Follow-up|0
2463838|NCT02443688|8499114|P2|Overall Study|Lost to Follow-up|0
2463839|NCT02443688|8499115|P1|Overall Study|Lost to Follow-up|1
2463840|NCT02443688|8499113|P3|Overall Study|Adverse Event|2
2463841|NCT02443688|8499114|P2|Overall Study|Adverse Event|3
2463842|NCT02443688|8499115|P1|Overall Study|Adverse Event|2
2463843|NCT02443402|8499194|P2|Overall Study|Screen Failure|2
2463844|NCT02443402|8499195|P1|Overall Study|Screen Failure|1
2463845|NCT02443402|8499194|P2|Overall Study|Withdrawal by Subject|1
2463846|NCT02443402|8499195|P1|Overall Study|Withdrawal by Subject|3
2463847|NCT02443298|8499257|P2|Overall Study|Withdrawal by Subject|2
2463848|NCT02443298|8499258|P1|Overall Study|Withdrawal by Subject|1
2463849|NCT02443298|8499257|P2|Overall Study|Adverse Event|3
2463850|NCT02443298|8499258|P1|Overall Study|Adverse Event|3
2463851|NCT02443103|8499278|P1|Overall Study|Noncompliance|1
2463852|NCT02443103|8499278|P1|Overall Study|Adverse Event|2
2463853|NCT02442830|8499291|P2|Overall Study|Technical Failure|1
2463854|NCT02442830|8499292|P1|Overall Study|Technical Failure|0
2463855|NCT02442804|8499302|P2|Overall Study|Adverse Event|0
2463856|NCT02442804|8499303|P1|Overall Study|Adverse Event|1
2463857|NCT02442804|8499302|P2|Overall Study|Withdrawal by Subject|1
2463858|NCT02442804|8499303|P1|Overall Study|Withdrawal by Subject|0
2463859|NCT02442349|8499408|P1|Overall Study|On-going Study at Data Cut-off|149
2463860|NCT02442349|8499408|P1|Overall Study|Withdrawal by Subject|8
2463861|NCT02442349|8499408|P1|Overall Study|Death|14
2463862|NCT02442310|8499413|P1|Overall Study|Withdrawal by Subject|1
2463863|NCT02442310|8499413|P1|Overall Study|Adverse Event|2
2463864|NCT02442284|8499435|P1|Overall Study|Other|1
2463865|NCT02442284|8499435|P1|Overall Study|Lost to Follow-up|3
2463866|NCT02442284|8499435|P1|Overall Study|Withdrew Consent|2
2463867|NCT02442284|8499435|P1|Overall Study|Adverse Event|1
2463868|NCT02442271|8499442|P1|Overall Study|Other|1
2463869|NCT02442271|8499442|P1|Overall Study|Lost to Follow-up|1
2463870|NCT02442271|8499442|P1|Overall Study|Withdrew Consent|1
2463871|NCT02442271|8499442|P1|Overall Study|Adverse Event|1
2463872|NCT02442206|8499468|P2|Period 2|Adverse Event|0
2463873|NCT02442206|8499469|P1|Period 2|Adverse Event|1
2463874|NCT02442206|8499468|P2|Period 1|COPD exacerbation|1
2463875|NCT02442206|8499469|P1|Period 1|COPD exacerbation|0
2463876|NCT02442206|8499468|P2|Period 1|withdrew consent|1
2463877|NCT02442206|8499469|P1|Period 1|withdrew consent|0
2463878|NCT02442206|8499468|P2|Period 1|Adverse Event|1
2463879|NCT02442206|8499469|P1|Period 1|Adverse Event|1
2463880|NCT02441946|8499501|P3|Extension Period (8 Weeks)|Withdrawal by Subject|0
2463881|NCT02441946|8499502|P2|Extension Period (8 Weeks)|Withdrawal by Subject|0
2463882|NCT02441946|8499503|P1|Extension Period (8 Weeks)|Withdrawal by Subject|1
2463883|NCT02441946|8499501|P3|Extension Period (8 Weeks)|Adverse Event|0
2463884|NCT02441946|8499502|P2|Extension Period (8 Weeks)|Adverse Event|0
2463885|NCT02441946|8499503|P1|Extension Period (8 Weeks)|Adverse Event|1
2463886|NCT02441946|8499501|P3|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
2463887|NCT02441946|8499502|P2|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
2463888|NCT02441946|8499503|P1|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9
2463889|NCT02441946|8499501|P3|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
2463890|NCT02441946|8499502|P2|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
2463891|NCT02441946|8499503|P1|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1
2463892|NCT02441946|8499501|P3|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
2463893|NCT02441946|8499502|P2|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
2463894|NCT02441946|8499503|P1|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1
2463895|NCT02441946|8499501|P3|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
2463896|NCT02441946|8499502|P2|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
2463897|NCT02441946|8499503|P1|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1
2463898|NCT02441946|8499501|P3|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
2463899|NCT02441946|8499502|P2|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
2463900|NCT02441946|8499503|P1|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15
2463901|NCT02441946|8499501|P3|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
2463902|NCT02441946|8499502|P2|Cycle 1 Period 1 (2 Weeks)|Never Treated|1
2463903|NCT02441946|8499503|P1|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
2463904|NCT02441946|8499501|P3|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
2463905|NCT02441946|8499502|P2|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3
2463906|NCT02441946|8499503|P1|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
2463907|NCT02441946|8499501|P3|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
2463908|NCT02441946|8499502|P2|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
2463909|NCT02441946|8499503|P1|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1
2463910|NCT02441946|8499501|P3|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0
2463911|NCT02441946|8499502|P2|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
2463912|NCT02441946|8499503|P1|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
2463913|NCT02441517|8499524|P1|Overall Study|Study Terminated by Sponsor|1
2463914|NCT02441517|8499524|P1|Overall Study|Withdrawal by Subject|2
2463915|NCT02441517|8499524|P1|Overall Study|Lost to Follow-up|1
2463916|NCT02441309|8499537|P3|Overall Study|Withdrawal by Subject|1
2463917|NCT02441309|8499538|P2|Overall Study|Withdrawal by Subject|0
2463918|NCT02441309|8499539|P1|Overall Study|Withdrawal by Subject|1
2463919|NCT02441309|8499537|P3|Overall Study|Adverse Event|0
2463920|NCT02441309|8499538|P2|Overall Study|Adverse Event|1
2463921|NCT02441309|8499539|P1|Overall Study|Adverse Event|0
2463922|NCT02441309|8499537|P3|Overall Study|Disease progression|2
2463923|NCT02441309|8499538|P2|Overall Study|Disease progression|1
2463924|NCT02441309|8499539|P1|Overall Study|Disease progression|2
2463925|NCT02441218|8499570|P2|Overall Study|Lost to Follow-up|1
2463926|NCT02441218|8499571|P1|Overall Study|Lost to Follow-up|2
2463927|NCT02441218|8499570|P2|Overall Study|Withdrawal by Subject|58
2463928|NCT02441218|8499571|P1|Overall Study|Withdrawal by Subject|73
2463929|NCT02441218|8499570|P2|Overall Study|Death|553
2463930|NCT02441218|8499571|P1|Overall Study|Death|503
2463931|NCT02441179|8499597|P2|Overall Study|Withdrawal by Subject|1
2463932|NCT02441179|8499598|P1|Overall Study|Withdrawal by Subject|1
2463933|NCT02441114|8499616|P1|Washout2|Withdrawal by Subject|4
2463934|NCT02441036|8499627|P5|Overall Study|No tissue resected|0
2463935|NCT02441036|8499628|P4|Overall Study|No tissue resected|1
2463936|NCT02441036|8499629|P3|Overall Study|No tissue resected|0
2463937|NCT02441036|8499630|P2|Overall Study|No tissue resected|1
2463938|NCT02441036|8499631|P1|Overall Study|No tissue resected|0
2463939|NCT02440789|8499658|P1|Overall Study|Not willing to adhere to reqs|1
2463940|NCT02440789|8499658|P1|Overall Study|Withdrawal by Subject|3
2463941|NCT02440594|8499733|P8|Overall Study|Administratively w/drawn|1
2463942|NCT02440594|8499734|P7|Overall Study|Administratively w/drawn|2
2463943|NCT02440594|8499735|P6|Overall Study|Administratively w/drawn|0
2463944|NCT02440594|8499736|P5|Overall Study|Administratively w/drawn|0
2463945|NCT02440594|8499737|P4|Overall Study|Administratively w/drawn|0
2463946|NCT02440594|8499738|P3|Overall Study|Administratively w/drawn|0
2463947|NCT02440594|8499739|P2|Overall Study|Administratively w/drawn|2
2463948|NCT02440594|8499740|P1|Overall Study|Administratively w/drawn|3
2463949|NCT02440594|8499733|P8|Overall Study|Withdrawal by Subject|7
2463950|NCT02440594|8499734|P7|Overall Study|Withdrawal by Subject|7
2463951|NCT02440594|8499735|P6|Overall Study|Withdrawal by Subject|2
2463952|NCT02440594|8499736|P5|Overall Study|Withdrawal by Subject|2
2463953|NCT02440594|8499737|P4|Overall Study|Withdrawal by Subject|38
2463954|NCT02440594|8499738|P3|Overall Study|Withdrawal by Subject|59
2463955|NCT02440594|8499739|P2|Overall Study|Withdrawal by Subject|67
2463956|NCT02440594|8499740|P1|Overall Study|Withdrawal by Subject|81
2463957|NCT02440594|8499733|P8|Overall Study|Cognitive Impairment/Communication Issue|0
2463958|NCT02440594|8499734|P7|Overall Study|Cognitive Impairment/Communication Issue|0
2463959|NCT02440594|8499735|P6|Overall Study|Cognitive Impairment/Communication Issue|1
2463960|NCT02440594|8499736|P5|Overall Study|Cognitive Impairment/Communication Issue|2
2463961|NCT02440594|8499737|P4|Overall Study|Cognitive Impairment/Communication Issue|4
2463962|NCT02440594|8499738|P3|Overall Study|Cognitive Impairment/Communication Issue|4
2463963|NCT02440594|8499739|P2|Overall Study|Cognitive Impairment/Communication Issue|6
2463964|NCT02440594|8499740|P1|Overall Study|Cognitive Impairment/Communication Issue|14
2463965|NCT02440594|8499733|P8|Overall Study|Lost to Follow-up|48
2463966|NCT02440594|8499734|P7|Overall Study|Lost to Follow-up|28
2463967|NCT02440594|8499735|P6|Overall Study|Lost to Follow-up|4
2463968|NCT02440594|8499736|P5|Overall Study|Lost to Follow-up|5
2463969|NCT02440594|8499737|P4|Overall Study|Lost to Follow-up|47
2463970|NCT02440594|8499738|P3|Overall Study|Lost to Follow-up|54
2463971|NCT02440594|8499739|P2|Overall Study|Lost to Follow-up|33
2463972|NCT02440594|8499740|P1|Overall Study|Lost to Follow-up|34
2463973|NCT02439320|8499830|P3|Overall Study|Randomization Failure|34
2463974|NCT02439320|8499831|P2|Overall Study|Randomization Failure|46
2463975|NCT02439320|8499832|P1|Overall Study|Randomization Failure|35
2463976|NCT02439320|8499830|P3|Overall Study|Sponsor Request|1
2463977|NCT02439320|8499831|P2|Overall Study|Sponsor Request|2
2463978|NCT02439320|8499832|P1|Overall Study|Sponsor Request|0
2463979|NCT02439320|8499830|P3|Overall Study|Physician Decision|0
2463980|NCT02439320|8499831|P2|Overall Study|Physician Decision|1
2463981|NCT02439320|8499832|P1|Overall Study|Physician Decision|2
2463982|NCT02439320|8499830|P3|Overall Study|Withdrawal by Subject|14
2463983|NCT02439320|8499831|P2|Overall Study|Withdrawal by Subject|16
2463984|NCT02439320|8499832|P1|Overall Study|Withdrawal by Subject|12
2463985|NCT02439320|8499830|P3|Overall Study|Pregnancy|1
2463986|NCT02439320|8499831|P2|Overall Study|Pregnancy|1
2463987|NCT02439320|8499832|P1|Overall Study|Pregnancy|0
2463988|NCT02439320|8499830|P3|Overall Study|Noncompliance with Protocol|7
2463989|NCT02439320|8499831|P2|Overall Study|Noncompliance with Protocol|11
2463990|NCT02439320|8499832|P1|Overall Study|Noncompliance with Protocol|10
2463991|NCT02439320|8499830|P3|Overall Study|Death|0
2463992|NCT02439320|8499831|P2|Overall Study|Death|1
2463993|NCT02439320|8499832|P1|Overall Study|Death|0
2463994|NCT02439320|8499830|P3|Overall Study|Lost to Follow-up|42
2463995|NCT02439320|8499831|P2|Overall Study|Lost to Follow-up|34
2463996|NCT02439320|8499832|P1|Overall Study|Lost to Follow-up|37
2463997|NCT02439320|8499830|P3|Overall Study|Adverse Event|0
2463998|NCT02439320|8499831|P2|Overall Study|Adverse Event|2
2463999|NCT02439320|8499832|P1|Overall Study|Adverse Event|0
2464000|NCT02439138|8499912|P1|Overall Study|PI decision to terminate the study|2
2464001|NCT02439138|8499912|P1|Overall Study|Adverse Event|1
2464002|NCT02438826|8499925|P2|Overall Study|Screen Failure|0
2464003|NCT02438826|8499926|P1|Overall Study|Screen Failure|2
2464004|NCT02438826|8499925|P2|Overall Study|Protocol Violation|2
2464005|NCT02438826|8499926|P1|Overall Study|Protocol Violation|1
2464006|NCT02438826|8499925|P2|Overall Study|Withdrawal by Subject|1
2464007|NCT02438826|8499926|P1|Overall Study|Withdrawal by Subject|1
2464008|NCT02438826|8499925|P2|Overall Study|Lack of Efficacy|0
2464009|NCT02438826|8499926|P1|Overall Study|Lack of Efficacy|1
2464010|NCT02438826|8499925|P2|Overall Study|Adverse Event|1
2464011|NCT02438826|8499926|P1|Overall Study|Adverse Event|1
2464012|NCT02438813|8499954|P1|Overall Study|Patients Not Treated/No EOT Visit|249
2464013|NCT02438813|8499954|P1|Overall Study|Study Ended by Sponsor|80
2464014|NCT02438813|8499954|P1|Overall Study|Patient Lost to Follow-Up|137
2464015|NCT02438813|8499954|P1|Overall Study|Patient Decision|59
2464016|NCT02438787|8500006|P3|Overall Study|Site terminated by sponsor|1
2464017|NCT02438787|8500007|P2|Overall Study|Site terminated by sponsor|0
2464018|NCT02438787|8500008|P1|Overall Study|Site terminated by sponsor|0
2464019|NCT02438787|8500006|P3|Overall Study|Other|0
2464020|NCT02438787|8500007|P2|Overall Study|Other|1
2464021|NCT02438787|8500008|P1|Overall Study|Other|0
2464022|NCT02438787|8500006|P3|Overall Study|Study discontinued by sponsor|69
2464023|NCT02438787|8500007|P2|Overall Study|Study discontinued by sponsor|72
2464024|NCT02438787|8500008|P1|Overall Study|Study discontinued by sponsor|64
2464025|NCT02438787|8500006|P3|Overall Study|Withdrawal by Subject|10
2464026|NCT02438787|8500007|P2|Overall Study|Withdrawal by Subject|7
2464027|NCT02438787|8500008|P1|Overall Study|Withdrawal by Subject|15
2464028|NCT02438787|8500006|P3|Overall Study|Protocol Violation|1
2464029|NCT02438787|8500007|P2|Overall Study|Protocol Violation|0
2464030|NCT02438787|8500008|P1|Overall Study|Protocol Violation|0
2464031|NCT02438787|8500006|P3|Overall Study|Lost to Follow-up|0
2464032|NCT02438787|8500007|P2|Overall Study|Lost to Follow-up|1
2464033|NCT02438787|8500008|P1|Overall Study|Lost to Follow-up|0
2464034|NCT02438787|8500006|P3|Overall Study|Lack of Efficacy|0
2464035|NCT02438787|8500007|P2|Overall Study|Lack of Efficacy|2
2464036|NCT02438787|8500008|P1|Overall Study|Lack of Efficacy|1
2464037|NCT02438787|8500006|P3|Overall Study|Adverse Event|2
2464038|NCT02438787|8500007|P2|Overall Study|Adverse Event|0
2464039|NCT02438787|8500008|P1|Overall Study|Adverse Event|1
2464040|NCT02438384|8500128|P3|Overall Study|Lost to Follow-up|4
2464041|NCT02438384|8500129|P2|Overall Study|Lost to Follow-up|6
2464042|NCT02438384|8500130|P1|Overall Study|Lost to Follow-up|8
2464043|NCT02438280|8500149|P2|Overall Study|Physician Decision|0
2464044|NCT02438280|8500150|P1|Overall Study|Physician Decision|1
2464045|NCT02438137|8500160|P2|Overall Study|Physician Decision|1
2464046|NCT02438137|8500161|P1|Overall Study|Physician Decision|0
2464047|NCT02438137|8500160|P2|Overall Study|Withdrawal by Subject|3
2464048|NCT02438137|8500161|P1|Overall Study|Withdrawal by Subject|4
2464049|NCT02438137|8500160|P2|Overall Study|Adverse Event|0
2464050|NCT02438137|8500161|P1|Overall Study|Adverse Event|1
2464051|NCT02438137|8500160|P2|Overall Study|Lost to Follow-up|2
2464052|NCT02438137|8500161|P1|Overall Study|Lost to Follow-up|3
2464053|NCT02437903|8500169|P1|Overall Study|Lost to Follow-up|3
2464054|NCT02437903|8500169|P1|Overall Study|Withdrawal by Subject|1
2464055|NCT02437903|8500169|P1|Overall Study|Adverse Event|1
2464056|NCT02437890|8500182|P5|Overall Study|Death|0
2464057|NCT02437890|8500183|P4|Overall Study|Death|2
2464058|NCT02437890|8500184|P3|Overall Study|Death|0
2464059|NCT02437890|8500185|P2|Overall Study|Death|0
2464060|NCT02437890|8500186|P1|Overall Study|Death|0
2464061|NCT02437890|8500182|P5|Overall Study|Withdrawal by Subject|5
2464062|NCT02437890|8500183|P4|Overall Study|Withdrawal by Subject|5
2464063|NCT02437890|8500184|P3|Overall Study|Withdrawal by Subject|6
2464064|NCT02437890|8500185|P2|Overall Study|Withdrawal by Subject|2
2464065|NCT02437890|8500186|P1|Overall Study|Withdrawal by Subject|1
2464066|NCT02437890|8500182|P5|Overall Study|Adverse Event|7
2464067|NCT02437890|8500183|P4|Overall Study|Adverse Event|11
2464068|NCT02437890|8500184|P3|Overall Study|Adverse Event|5
2464069|NCT02437890|8500185|P2|Overall Study|Adverse Event|9
2464070|NCT02437890|8500186|P1|Overall Study|Adverse Event|4
2464071|NCT02437890|8500182|P5|Overall Study|Lack of Efficacy|1
2464072|NCT02437890|8500183|P4|Overall Study|Lack of Efficacy|3
2464073|NCT02437890|8500184|P3|Overall Study|Lack of Efficacy|0
2464074|NCT02437890|8500185|P2|Overall Study|Lack of Efficacy|3
2464075|NCT02437890|8500186|P1|Overall Study|Lack of Efficacy|1
2464076|NCT02437890|8500182|P5|Overall Study|Unable to attend visit(s)|0
2464077|NCT02437890|8500183|P4|Overall Study|Unable to attend visit(s)|0
2464078|NCT02437890|8500184|P3|Overall Study|Unable to attend visit(s)|0
2464079|NCT02437890|8500185|P2|Overall Study|Unable to attend visit(s)|0
2464080|NCT02437890|8500186|P1|Overall Study|Unable to attend visit(s)|1
2464081|NCT02437890|8500182|P5|Overall Study|Physician Decision|0
2464082|NCT02437890|8500183|P4|Overall Study|Physician Decision|1
2464083|NCT02437890|8500184|P3|Overall Study|Physician Decision|0
2464084|NCT02437890|8500185|P2|Overall Study|Physician Decision|0
2464085|NCT02437890|8500186|P1|Overall Study|Physician Decision|0
2464086|NCT02437890|8500182|P5|Overall Study|Sponsor's decision|2
2464087|NCT02437890|8500183|P4|Overall Study|Sponsor's decision|0
2464088|NCT02437890|8500184|P3|Overall Study|Sponsor's decision|4
2464089|NCT02437890|8500185|P2|Overall Study|Sponsor's decision|1
2464090|NCT02437890|8500186|P1|Overall Study|Sponsor's decision|1
2464091|NCT02437890|8500182|P5|Overall Study|Non-compliance to study drug|1
2464092|NCT02437890|8500183|P4|Overall Study|Non-compliance to study drug|0
2464093|NCT02437890|8500184|P3|Overall Study|Non-compliance to study drug|0
2464094|NCT02437890|8500185|P2|Overall Study|Non-compliance to study drug|1
2464095|NCT02437890|8500186|P1|Overall Study|Non-compliance to study drug|0
2464096|NCT02437864|8500399|P2|Overall Study|Protocol Violation|0
2464097|NCT02437864|8500400|P1|Overall Study|Protocol Violation|4
2464098|NCT02437513|8500421|P1|Overall Study|Withdrawal by Subject|2
2464099|NCT02437409|8500446|P1|Overall Study|Screening failure|12
2464100|NCT02437409|8500446|P1|Overall Study|Withdrawal by Subject|3
2464101|NCT02437318|8500539|P2|Overall Study|Untreated|1
2464102|NCT02437318|8500540|P1|Overall Study|Untreated|0
2464103|NCT02437318|8500539|P2|Overall Study|Protocol Violation|6
2464104|NCT02437318|8500540|P1|Overall Study|Protocol Violation|5
2464105|NCT02437318|8500539|P2|Overall Study|Death|4
2464106|NCT02437318|8500540|P1|Overall Study|Death|4
2464107|NCT02437318|8500539|P2|Overall Study|Adverse Event|3
2464108|NCT02437318|8500540|P1|Overall Study|Adverse Event|14
2464109|NCT02437318|8500539|P2|Overall Study|Physician Decision|10
2464110|NCT02437318|8500540|P1|Overall Study|Physician Decision|11
2464111|NCT02437318|8500539|P2|Overall Study|Subject/guardian decision|10
2464112|NCT02437318|8500540|P1|Overall Study|Subject/guardian decision|22
2464113|NCT02437318|8500539|P2|Overall Study|Progressive disease|208
2464114|NCT02437318|8500540|P1|Overall Study|Progressive disease|173
2464115|NCT02437305|8500548|P2|Overall Study|Lost to Follow-up|12
2464116|NCT02437305|8500549|P1|Overall Study|Lost to Follow-up|18
2464117|NCT02437188|8500576|P2|Overall Study|Adverse Event|1
2464118|NCT02437188|8500577|P1|Overall Study|Adverse Event|0
2464119|NCT02437188|8500576|P2|Overall Study|Randomized but did not receive surgery|8
2464120|NCT02437188|8500577|P1|Overall Study|Randomized but did not receive surgery|4
2464121|NCT02437162|8500594|P3|Overall Study|Other|1
2464122|NCT02437162|8500595|P2|Overall Study|Other|0
2464123|NCT02437162|8500596|P1|Overall Study|Other|0
2464124|NCT02437162|8500594|P3|Overall Study|Death|0
2464125|NCT02437162|8500595|P2|Overall Study|Death|1
2464126|NCT02437162|8500596|P1|Overall Study|Death|0
2464127|NCT02437162|8500594|P3|Overall Study|Lost to Follow-up|1
2464128|NCT02437162|8500595|P2|Overall Study|Lost to Follow-up|0
2464129|NCT02437162|8500596|P1|Overall Study|Lost to Follow-up|1
2464130|NCT02437162|8500594|P3|Overall Study|Adverse Event|0
2464131|NCT02437162|8500595|P2|Overall Study|Adverse Event|1
2464132|NCT02437162|8500596|P1|Overall Study|Adverse Event|0
2464133|NCT02437162|8500594|P3|Overall Study|Withdrawal by Subject|9
2464134|NCT02437162|8500595|P2|Overall Study|Withdrawal by Subject|7
2464135|NCT02437162|8500596|P1|Overall Study|Withdrawal by Subject|13
2464136|NCT02437162|8500594|P3|Overall Study|Study discontinued by Sponsor|97
2464137|NCT02437162|8500595|P2|Overall Study|Study discontinued by Sponsor|98
2464138|NCT02437162|8500596|P1|Overall Study|Study discontinued by Sponsor|93
2464139|NCT02437162|8500594|P3|Overall Study|Randomized but not treated|1
2464140|NCT02437162|8500595|P2|Overall Study|Randomized but not treated|0
2464141|NCT02437162|8500596|P1|Overall Study|Randomized but not treated|0
2464142|NCT02437162|8500594|P3|Overall Study|Protocol Violation|0
2464143|NCT02437162|8500595|P2|Overall Study|Protocol Violation|1
2464144|NCT02437162|8500596|P1|Overall Study|Protocol Violation|0
2464145|NCT02436915|8500716|P2|Overall Study|Withdrawal by Subject|1
2464146|NCT02436915|8500717|P1|Overall Study|Withdrawal by Subject|0
2464147|NCT02436889|8500739|P2|Overall Study|Does not like/could not tolerate medicat|1
2464148|NCT02436889|8500740|P1|Overall Study|Does not like/could not tolerate medicat|0
2464149|NCT02436889|8500739|P2|Overall Study|No improvement in symptoms|0
2464150|NCT02436889|8500740|P1|Overall Study|No improvement in symptoms|1
2464151|NCT02436811|8500759|P3|Overall Study|Lost to Follow-up|7
2464152|NCT02436811|8500760|P2|Overall Study|Lost to Follow-up|9
2464153|NCT02436811|8500761|P1|Overall Study|Lost to Follow-up|2
2464154|NCT02436681|8500769|P1|Overall Study|Death|2
2464155|NCT02436681|8500769|P1|Overall Study|Withdrawal by Subject|2
2464156|NCT02436681|8500769|P1|Overall Study|Lost to Follow-up|10
2464157|NCT02436577|8500786|P6|Overall Study|Protocol Deviation|0
2464158|NCT02436577|8500787|P5|Overall Study|Protocol Deviation|0
2464159|NCT02436577|8500788|P4|Overall Study|Protocol Deviation|0
2464160|NCT02436577|8500789|P3|Overall Study|Protocol Deviation|0
2464161|NCT02436577|8500790|P2|Overall Study|Protocol Deviation|1
2464162|NCT02436577|8500791|P1|Overall Study|Protocol Deviation|0
2464163|NCT02436330|8500846|P2|Cohort 6|Withdrawal by Subject|1
2464164|NCT02436330|8500847|P1|Cohort 6|Withdrawal by Subject|1
2464165|NCT02436330|8500846|P2|Cohort 6|Lost to Follow-up|0
2464166|NCT02436330|8500847|P1|Cohort 6|Lost to Follow-up|2
2464167|NCT02436330|8500846|P2|Cohort 5|Withdrawal by Subject|2
2464168|NCT02436330|8500847|P1|Cohort 5|Withdrawal by Subject|3
2464169|NCT02436330|8500846|P2|Cohort 5|Lost to Follow-up|2
2464170|NCT02436330|8500847|P1|Cohort 5|Lost to Follow-up|3
2464171|NCT02436330|8500846|P2|Cohort 4|Withdrawal by Subject|0
2464172|NCT02436330|8500847|P1|Cohort 4|Withdrawal by Subject|1
2464173|NCT02436330|8500846|P2|Cohort 4|Lost to Follow-up|0
2464174|NCT02436330|8500847|P1|Cohort 4|Lost to Follow-up|1
2464175|NCT02436330|8500846|P2|Cohort 3|Withdrawal by Subject|0
2464176|NCT02436330|8500847|P1|Cohort 3|Withdrawal by Subject|4
2464177|NCT02436330|8500846|P2|Cohort 3|Lost to Follow-up|0
2464178|NCT02436330|8500847|P1|Cohort 3|Lost to Follow-up|1
2464179|NCT02436330|8500846|P2|Cohort 2|Withdrawal by Subject|3
2464180|NCT02436330|8500847|P1|Cohort 2|Withdrawal by Subject|2
2464181|NCT02436330|8500846|P2|Cohort 2|Lost to Follow-up|0
2464182|NCT02436330|8500847|P1|Cohort 2|Lost to Follow-up|2
2464183|NCT02436330|8500846|P2|Cohort 1|Withdrawal by Subject|1
2464184|NCT02436330|8500847|P1|Cohort 1|Withdrawal by Subject|0
2464185|NCT02436330|8500846|P2|Cohort 1|Lost to Follow-up|2
2464186|NCT02436330|8500847|P1|Cohort 1|Lost to Follow-up|5
2464187|NCT02436304|8500892|P3|Overall Study|Randomized in error didn’t meet I/E crit|1
2464188|NCT02436304|8500893|P2|Overall Study|Randomized in error didn’t meet I/E crit|0
2464189|NCT02436304|8500894|P1|Overall Study|Randomized in error didn’t meet I/E crit|0
2464190|NCT02436304|8500892|P3|Overall Study|Withdrawal by Subject|0
2464191|NCT02436304|8500893|P2|Overall Study|Withdrawal by Subject|1
2464192|NCT02436304|8500894|P1|Overall Study|Withdrawal by Subject|0
2464193|NCT02436304|8500892|P3|Overall Study|Lost to Follow-up|0
2464194|NCT02436304|8500893|P2|Overall Study|Lost to Follow-up|1
2464195|NCT02436304|8500894|P1|Overall Study|Lost to Follow-up|0
2464196|NCT02436239|8500913|P4|Down-Taper Period|Withdrawal by Subject|2
2464197|NCT02436239|8500914|P3|Down-Taper Period|Withdrawal by Subject|1
2464198|NCT02436239|8500915|P2|Down-Taper Period|Withdrawal by Subject|4
2464199|NCT02436239|8500916|P1|Down-Taper Period|Withdrawal by Subject|4
2464200|NCT02436239|8500913|P4|Open-Lable Treatment Period|Other Reason|0
2464201|NCT02436239|8500914|P3|Open-Lable Treatment Period|Other Reason|0
2464202|NCT02436239|8500915|P2|Open-Lable Treatment Period|Other Reason|1
2464203|NCT02436239|8500916|P1|Open-Lable Treatment Period|Other Reason|1
2464204|NCT02436239|8500913|P4|Open-Lable Treatment Period|Noncompliance with Study Drug|1
2464205|NCT02436239|8500914|P3|Open-Lable Treatment Period|Noncompliance with Study Drug|3
2464206|NCT02436239|8500915|P2|Open-Lable Treatment Period|Noncompliance with Study Drug|6
2464207|NCT02436239|8500916|P1|Open-Lable Treatment Period|Noncompliance with Study Drug|5
2464208|NCT02436239|8500913|P4|Open-Lable Treatment Period|Protocol Violation|0
2464209|NCT02436239|8500914|P3|Open-Lable Treatment Period|Protocol Violation|1
2464210|NCT02436239|8500915|P2|Open-Lable Treatment Period|Protocol Violation|1
2464211|NCT02436239|8500916|P1|Open-Lable Treatment Period|Protocol Violation|0
2464212|NCT02436239|8500913|P4|Open-Lable Treatment Period|Lost to Follow-up|1
2464213|NCT02436239|8500914|P3|Open-Lable Treatment Period|Lost to Follow-up|4
2464214|NCT02436239|8500915|P2|Open-Lable Treatment Period|Lost to Follow-up|2
2464215|NCT02436239|8500916|P1|Open-Lable Treatment Period|Lost to Follow-up|4
2464216|NCT02436239|8500913|P4|Open-Lable Treatment Period|Withdrawal by Subject|0
2464217|NCT02436239|8500914|P3|Open-Lable Treatment Period|Withdrawal by Subject|9
2464218|NCT02436239|8500915|P2|Open-Lable Treatment Period|Withdrawal by Subject|15
2464219|NCT02436239|8500916|P1|Open-Lable Treatment Period|Withdrawal by Subject|10
2464220|NCT02436239|8500913|P4|Open-Lable Treatment Period|Lack of Efficacy|1
2464221|NCT02436239|8500914|P3|Open-Lable Treatment Period|Lack of Efficacy|6
2464222|NCT02436239|8500915|P2|Open-Lable Treatment Period|Lack of Efficacy|6
2464223|NCT02436239|8500916|P1|Open-Lable Treatment Period|Lack of Efficacy|1
2464224|NCT02436239|8500913|P4|Open-Lable Treatment Period|Adverse Event|2
2464225|NCT02436239|8500914|P3|Open-Lable Treatment Period|Adverse Event|4
2464226|NCT02436239|8500915|P2|Open-Lable Treatment Period|Adverse Event|3
2464227|NCT02436239|8500916|P1|Open-Lable Treatment Period|Adverse Event|12
2464228|NCT02436200|8500938|P1|Overall Study|Significant outlier|1
2464229|NCT02435966|8500957|P3|Overall Study|Withdrawal by Subject|0
2464230|NCT02435966|8500958|P2|Overall Study|Withdrawal by Subject|1
2464231|NCT02435966|8500959|P1|Overall Study|Withdrawal by Subject|0
2464232|NCT02435914|8500971|P4|Overall Study|Other Miscellaneous Reason|0
2464233|NCT02435914|8500972|P3|Overall Study|Other Miscellaneous Reason|1
2464234|NCT02435914|8500973|P2|Overall Study|Other Miscellaneous Reason|0
2464235|NCT02435914|8500974|P1|Overall Study|Other Miscellaneous Reason|0
2464236|NCT02435914|8500971|P4|Overall Study|Withdrawal by Subject|0
2464237|NCT02435914|8500972|P3|Overall Study|Withdrawal by Subject|0
2464238|NCT02435914|8500973|P2|Overall Study|Withdrawal by Subject|1
2464239|NCT02435914|8500974|P1|Overall Study|Withdrawal by Subject|0
2464240|NCT02435914|8500971|P4|Overall Study|Ocular Adverse Event|0
2464241|NCT02435914|8500972|P3|Overall Study|Ocular Adverse Event|0
2464242|NCT02435914|8500973|P2|Overall Study|Ocular Adverse Event|0
2464243|NCT02435914|8500974|P1|Overall Study|Ocular Adverse Event|1
2464244|NCT02435836|8500996|P1|Overall Study|AE of Worsening Schizophrenia|96
2464245|NCT02435836|8500996|P1|Overall Study|Met Withdrawal Criteria|7
2464246|NCT02435836|8500996|P1|Overall Study|Protocol Violation|6
2464247|NCT02435836|8500996|P1|Overall Study|Noncompliance|27
2464248|NCT02435836|8500996|P1|Overall Study|Sponsor discontinued trial|167
2464249|NCT02435836|8500996|P1|Overall Study|Adverse Event|44
2464250|NCT02435836|8500996|P1|Overall Study|Insufficient Clinical Response|26
2464251|NCT02435836|8500996|P1|Overall Study|Withdrawal by Subject|236
2464252|NCT02435836|8500996|P1|Overall Study|Lack of Efficacy|1
2464253|NCT02435836|8500996|P1|Overall Study|Lost to Follow-up|21
2464254|NCT02435433|8501055|P5|Overall Study|Lost to Follow-up|0
2464255|NCT02435433|8501056|P4|Overall Study|Lost to Follow-up|0
2464256|NCT02435433|8501057|P3|Overall Study|Lost to Follow-up|0
2464257|NCT02435433|8501058|P2|Overall Study|Lost to Follow-up|2
2464258|NCT02435433|8501059|P1|Overall Study|Lost to Follow-up|2
2464259|NCT02435433|8501055|P5|Overall Study|Withdrawal by Subject|0
2464260|NCT02435433|8501056|P4|Overall Study|Withdrawal by Subject|0
2464261|NCT02435433|8501057|P3|Overall Study|Withdrawal by Subject|0
2464262|NCT02435433|8501058|P2|Overall Study|Withdrawal by Subject|3
2464263|NCT02435433|8501059|P1|Overall Study|Withdrawal by Subject|2
2464264|NCT02435433|8501055|P5|Overall Study|On Treatment|0
2464265|NCT02435433|8501056|P4|Overall Study|On Treatment|0
2464266|NCT02435433|8501057|P3|Overall Study|On Treatment|0
2464267|NCT02435433|8501058|P2|Overall Study|On Treatment|0
2464268|NCT02435433|8501059|P1|Overall Study|On Treatment|11
2464269|NCT02435277|8501085|P4|Overall Study|Withdrawal by Subject|0
2464270|NCT02435277|8501086|P3|Overall Study|Withdrawal by Subject|0
2464271|NCT02435277|8501087|P2|Overall Study|Withdrawal by Subject|0
2464272|NCT02435277|8501088|P1|Overall Study|Withdrawal by Subject|1
2464273|NCT02435277|8501085|P4|Overall Study|Adverse Event|0
2464274|NCT02435277|8501086|P3|Overall Study|Adverse Event|0
2464275|NCT02435277|8501087|P2|Overall Study|Adverse Event|1
2464276|NCT02435277|8501088|P1|Overall Study|Adverse Event|1
2464277|NCT02435147|8501102|P1|Overall Study|non-evaluable DXA scan|11
2464278|NCT02435069|8501107|P5|Effectiveness - Second Intervention|Lack of Efficacy|1
2464279|NCT02435069|8501108|P4|Effectiveness - Second Intervention|Lack of Efficacy|0
2464280|NCT02435069|8501109|P3|Effectiveness - Second Intervention|Lack of Efficacy|0
2464281|NCT02435069|8501110|P2|Effectiveness - Second Intervention|Lack of Efficacy|0
2464282|NCT02435069|8501111|P1|Effectiveness - Second Intervention|Lack of Efficacy|0
2464283|NCT02435069|8501107|P5|Dose Response - First Intervention|Adverse Event|0
2464284|NCT02435069|8501108|P4|Dose Response - First Intervention|Adverse Event|0
2464285|NCT02435069|8501109|P3|Dose Response - First Intervention|Adverse Event|1
2464286|NCT02435069|8501110|P2|Dose Response - First Intervention|Adverse Event|1
2464287|NCT02435069|8501111|P1|Dose Response - First Intervention|Adverse Event|0
2464288|NCT02434939|8501133|P2|Overall Study|Adverse Event|1
2464289|NCT02434939|8501134|P1|Overall Study|Adverse Event|0
2464290|NCT02434939|8501133|P2|Overall Study|Withdrawal by Subject|0
2464291|NCT02434939|8501134|P1|Overall Study|Withdrawal by Subject|3
2464292|NCT02434939|8501133|P2|Overall Study|Lack of Efficacy|48
2464293|NCT02434939|8501134|P1|Overall Study|Lack of Efficacy|34
2464294|NCT02434770|8501149|P3|Week 18 to Week|Received Non-study Polio Vaccine|3
2464295|NCT02434770|8501150|P2|Week 18 to Week|Received Non-study Polio Vaccine|6
2464296|NCT02434770|8501151|P1|Week 18 to Week|Received Non-study Polio Vaccine|6
2464297|NCT02434770|8501149|P3|Week 18 to Week|Withdrawal by Subject|2
2464298|NCT02434770|8501150|P2|Week 18 to Week|Withdrawal by Subject|0
2464299|NCT02434770|8501151|P1|Week 18 to Week|Withdrawal by Subject|0
2464300|NCT02434770|8501149|P3|Week 18 to Week|Lost to Follow-up|1
2464301|NCT02434770|8501150|P2|Week 18 to Week|Lost to Follow-up|2
2464302|NCT02434770|8501151|P1|Week 18 to Week|Lost to Follow-up|2
2464303|NCT02434770|8501149|P3|Week 1 to Week 18|Death|0
2464304|NCT02434770|8501150|P2|Week 1 to Week 18|Death|0
2464305|NCT02434770|8501151|P1|Week 1 to Week 18|Death|1
2464306|NCT02434770|8501149|P3|Week 1 to Week 18|Relocated Out of Study Area|1
2464307|NCT02434770|8501150|P2|Week 1 to Week 18|Relocated Out of Study Area|0
2464308|NCT02434770|8501151|P1|Week 1 to Week 18|Relocated Out of Study Area|0
2464309|NCT02434770|8501149|P3|Week 1 to Week 18|Received Non-study Polio Vaccine|9
2464310|NCT02434770|8501150|P2|Week 1 to Week 18|Received Non-study Polio Vaccine|10
2464311|NCT02434770|8501151|P1|Week 1 to Week 18|Received Non-study Polio Vaccine|8
2464312|NCT02434770|8501149|P3|Week 1 to Week 18|Withdrawal by Subject|5
2464313|NCT02434770|8501150|P2|Week 1 to Week 18|Withdrawal by Subject|12
2464314|NCT02434770|8501151|P1|Week 1 to Week 18|Withdrawal by Subject|6
2464315|NCT02434770|8501149|P3|Week 1 to Week 18|Lost to Follow-up|2
2464316|NCT02434770|8501150|P2|Week 1 to Week 18|Lost to Follow-up|0
2464317|NCT02434770|8501151|P1|Week 1 to Week 18|Lost to Follow-up|0
2464318|NCT02434471|8501301|P1|Overall Study|Physician Decision|9
2464319|NCT02434328|8501310|P2|Overall Study|Other|1
2464320|NCT02434328|8501311|P1|Overall Study|Other|4
2464321|NCT02434328|8501310|P2|Overall Study|Lost to Follow-up|6
2464322|NCT02434328|8501311|P1|Overall Study|Lost to Follow-up|1
2464323|NCT02434328|8501310|P2|Overall Study|Death|7
2464324|NCT02434328|8501311|P1|Overall Study|Death|4
2464325|NCT02434328|8501310|P2|Overall Study|Withdrawal by Subject|21
2464326|NCT02434328|8501311|P1|Overall Study|Withdrawal by Subject|12
2464327|NCT02434328|8501310|P2|Overall Study|Physician Decision|1
2464328|NCT02434328|8501311|P1|Overall Study|Physician Decision|0
2464329|NCT02434328|8501310|P2|Overall Study|Lack of Efficacy|2
2464330|NCT02434328|8501311|P1|Overall Study|Lack of Efficacy|0
2464331|NCT02434328|8501310|P2|Overall Study|Adverse Event|4
2464332|NCT02434328|8501311|P1|Overall Study|Adverse Event|9
2464333|NCT02433834|8501386|P1|Overall Study|Physician Decision|1
2464334|NCT02433834|8501386|P1|Overall Study|Adverse Event|6
2464335|NCT02433834|8501386|P1|Overall Study|Withdrawal by Subject|14
2464336|NCT02433834|8501386|P1|Overall Study|Lost to Follow-up|6
2464337|NCT02433834|8501386|P1|Overall Study|Protocol Violation|3
2464338|NCT02433834|8501386|P1|Overall Study|Protocol-specified criteria|7
2464339|NCT02433678|8501446|P2|Overall Study|Lost to Follow-up|2
2464340|NCT02433678|8501447|P1|Overall Study|Lost to Follow-up|1
2464341|NCT02433483|8501514|P1|Overall Study|Other antineoplastic therapy/HSCT|1
2464342|NCT02433483|8501514|P1|Overall Study|Unacceptable toxicity|1
2464343|NCT02433340|8501541|P4|Overall Study|Other|0
2464344|NCT02433340|8501542|P3|Overall Study|Other|0
2464345|NCT02433340|8501543|P2|Overall Study|Other|1
2464346|NCT02433340|8501544|P1|Overall Study|Other|0
2464347|NCT02433340|8501541|P4|Overall Study|Required Alternative/Prohibited Therapy|0
2464348|NCT02433340|8501542|P3|Overall Study|Required Alternative/Prohibited Therapy|0
2464349|NCT02433340|8501543|P2|Overall Study|Required Alternative/Prohibited Therapy|0
2464350|NCT02433340|8501544|P1|Overall Study|Required Alternative/Prohibited Therapy|1
2464351|NCT02433340|8501541|P4|Overall Study|Lost to Follow-up|0
2464352|NCT02433340|8501542|P3|Overall Study|Lost to Follow-up|0
2464353|NCT02433340|8501543|P2|Overall Study|Lost to Follow-up|1
2464354|NCT02433340|8501544|P1|Overall Study|Lost to Follow-up|0
2464355|NCT02433340|8501541|P4|Overall Study|Withdrawal by Subject|2
2464356|NCT02433340|8501542|P3|Overall Study|Withdrawal by Subject|1
2464357|NCT02433340|8501543|P2|Overall Study|Withdrawal by Subject|0
2464358|NCT02433340|8501544|P1|Overall Study|Withdrawal by Subject|1
2464359|NCT02433340|8501541|P4|Overall Study|Adverse Event|0
2464360|NCT02433340|8501542|P3|Overall Study|Adverse Event|1
2464361|NCT02433340|8501543|P2|Overall Study|Adverse Event|0
2464362|NCT02433340|8501544|P1|Overall Study|Adverse Event|0
2464363|NCT02433288|8502438|P2|Overall Study|Death|3
2464364|NCT02433288|8502439|P1|Overall Study|Death|0
2464365|NCT02433288|8502438|P2|Overall Study|Lost to Follow-up|14
2464366|NCT02433288|8502439|P1|Overall Study|Lost to Follow-up|2
2464367|NCT02433288|8502438|P2|Overall Study|Withdrawal by Subject|99
2464368|NCT02433288|8502439|P1|Overall Study|Withdrawal by Subject|101
2464369|NCT02433288|8502438|P2|Overall Study|Eligibility criteria not fullfilled|3
2464370|NCT02433288|8502439|P1|Overall Study|Eligibility criteria not fullfilled|7
2464371|NCT02433288|8502438|P2|Overall Study|Severe non-compliance to protocol|7
2464372|NCT02433288|8502439|P1|Overall Study|Severe non-compliance to protocol|13
2464373|NCT02432196|8502539|P1|Overall Study|On Study|20
2464374|NCT02432196|8502539|P1|Overall Study|Reoperation|3
2464375|NCT02432196|8502539|P1|Overall Study|Death|2
2464376|NCT02432196|8502539|P1|Overall Study|Not Implanted with Device|1
2464377|NCT02432144|8502547|P1|Overall Study|Participant Non-Compliance|1
2464378|NCT02432105|8502555|P3|Overall Study|Randomized in error|2
2464379|NCT02432105|8502556|P2|Overall Study|Randomized in error|0
2464380|NCT02432105|8502557|P1|Overall Study|Randomized in error|0
2464381|NCT02432105|8502555|P3|Overall Study|Culture positive for yeast|0
2464382|NCT02432105|8502556|P2|Overall Study|Culture positive for yeast|1
2464383|NCT02432105|8502557|P1|Overall Study|Culture positive for yeast|0
2464384|NCT02432105|8502555|P3|Overall Study|Withdrawal by Subject|1
2464385|NCT02432105|8502556|P2|Overall Study|Withdrawal by Subject|0
2464386|NCT02432105|8502557|P1|Overall Study|Withdrawal by Subject|1
2464387|NCT02432105|8502555|P3|Overall Study|Lost to Follow-up|0
2464388|NCT02432105|8502556|P2|Overall Study|Lost to Follow-up|1
2464389|NCT02432105|8502557|P1|Overall Study|Lost to Follow-up|1
2464390|NCT02432040|8502574|P2|Overall Study|Physician Decision|1
2464391|NCT02432040|8502575|P1|Overall Study|Physician Decision|1
2464392|NCT02432040|8502574|P2|Overall Study|Lost to Follow-up|5
2464393|NCT02432040|8502575|P1|Overall Study|Lost to Follow-up|4
2464394|NCT02432040|8502574|P2|Overall Study|Lack of Efficacy|0
2464395|NCT02432040|8502575|P1|Overall Study|Lack of Efficacy|3
2464396|NCT02431793|8502598|P3|Overall Study|Lost to Follow-up|104
2464397|NCT02431793|8502599|P2|Overall Study|Lost to Follow-up|122
2464398|NCT02431793|8502600|P1|Overall Study|Lost to Follow-up|101
2464399|NCT02431793|8502598|P3|Overall Study|Withdrawal by Subject|5
2464400|NCT02431793|8502599|P2|Overall Study|Withdrawal by Subject|5
2464401|NCT02431793|8502600|P1|Overall Study|Withdrawal by Subject|7
2464402|NCT02431793|8502598|P3|Overall Study|Ineligible doe to not filling Rx|8
2464403|NCT02431793|8502599|P2|Overall Study|Ineligible doe to not filling Rx|7
2464404|NCT02431793|8502600|P1|Overall Study|Ineligible doe to not filling Rx|11
2464405|NCT02431559|8502691|P4|Overall Study|Physician Decision|1
2464406|NCT02431559|8502692|P3|Overall Study|Physician Decision|0
2464407|NCT02431559|8502693|P2|Overall Study|Physician Decision|0
2464408|NCT02431559|8502694|P1|Overall Study|Physician Decision|0
2464409|NCT02431559|8502691|P4|Overall Study|Withdrawal by Subject|4
2464410|NCT02431559|8502692|P3|Overall Study|Withdrawal by Subject|0
2464411|NCT02431559|8502693|P2|Overall Study|Withdrawal by Subject|1
2464412|NCT02431559|8502694|P1|Overall Study|Withdrawal by Subject|0
2464413|NCT02431559|8502691|P4|Overall Study|Progressive disease|22
2464414|NCT02431559|8502692|P3|Overall Study|Progressive disease|4
2464415|NCT02431559|8502693|P2|Overall Study|Progressive disease|1
2464416|NCT02431559|8502694|P1|Overall Study|Progressive disease|2
2464417|NCT02431559|8502691|P4|Overall Study|Adverse Event|4
2464418|NCT02431559|8502692|P3|Overall Study|Adverse Event|0
2464419|NCT02431559|8502693|P2|Overall Study|Adverse Event|1
2464420|NCT02431559|8502694|P1|Overall Study|Adverse Event|0
2464421|NCT02431533|8502718|P2|Overall Study|Developed Exclusionary criteria|0
2464422|NCT02431533|8502719|P1|Overall Study|Developed Exclusionary criteria|1
2464423|NCT02431533|8502718|P2|Overall Study|Withdrawal by Subject|3
2464424|NCT02431533|8502719|P1|Overall Study|Withdrawal by Subject|1
2464425|NCT02431468|8502785|P3|Overall Study|noncompliance, investigator termination,|2
2464426|NCT02431468|8502786|P2|Overall Study|noncompliance, investigator termination,|2
2464427|NCT02431468|8502787|P1|Overall Study|noncompliance, investigator termination,|2
2464428|NCT02431468|8502785|P3|Overall Study|Withdrawal by Subject|2
2464429|NCT02431468|8502786|P2|Overall Study|Withdrawal by Subject|12
2464430|NCT02431468|8502787|P1|Overall Study|Withdrawal by Subject|4
2464431|NCT02431468|8502785|P3|Overall Study|Adverse Event|5
2464432|NCT02431468|8502786|P2|Overall Study|Adverse Event|4
2464433|NCT02431468|8502787|P1|Overall Study|Adverse Event|2
2464434|NCT02431260|8502878|P14|Overall Study|Other Unspecified|0
2464435|NCT02431260|8502879|P13|Overall Study|Other Unspecified|1
2464436|NCT02431260|8502880|P12|Overall Study|Other Unspecified|1
2464437|NCT02431260|8502881|P11|Overall Study|Other Unspecified|0
2464438|NCT02431260|8502882|P10|Overall Study|Other Unspecified|0
2464439|NCT02431260|8502883|P9|Overall Study|Other Unspecified|0
2464440|NCT02431260|8502884|P8|Overall Study|Other Unspecified|0
2464441|NCT02431260|8502885|P7|Overall Study|Other Unspecified|0
2464442|NCT02431260|8502886|P6|Overall Study|Other Unspecified|0
2464443|NCT02431260|8502887|P5|Overall Study|Other Unspecified|0
2464444|NCT02431260|8502888|P4|Overall Study|Other Unspecified|0
2464445|NCT02431260|8502889|P3|Overall Study|Other Unspecified|0
2464446|NCT02431260|8502890|P2|Overall Study|Other Unspecified|0
2464447|NCT02431260|8502891|P1|Overall Study|Other Unspecified|0
2464448|NCT02431260|8502878|P14|Overall Study|Physician Decision|0
2464449|NCT02431260|8502879|P13|Overall Study|Physician Decision|0
2464450|NCT02431260|8502880|P12|Overall Study|Physician Decision|0
2464451|NCT02431260|8502881|P11|Overall Study|Physician Decision|0
2464452|NCT02431260|8502882|P10|Overall Study|Physician Decision|0
2464453|NCT02431260|8502883|P9|Overall Study|Physician Decision|0
2464454|NCT02431260|8502884|P8|Overall Study|Physician Decision|0
2464455|NCT02431260|8502885|P7|Overall Study|Physician Decision|0
2464456|NCT02431260|8502886|P6|Overall Study|Physician Decision|1
2464457|NCT02431260|8502887|P5|Overall Study|Physician Decision|0
2464458|NCT02431260|8502888|P4|Overall Study|Physician Decision|0
2464459|NCT02431260|8502889|P3|Overall Study|Physician Decision|0
2464460|NCT02431260|8502890|P2|Overall Study|Physician Decision|0
2464461|NCT02431260|8502891|P1|Overall Study|Physician Decision|0
2464462|NCT02431260|8502878|P14|Overall Study|Study Terminated by the Sponsor|0
2464463|NCT02431260|8502879|P13|Overall Study|Study Terminated by the Sponsor|4
2464464|NCT02431260|8502880|P12|Overall Study|Study Terminated by the Sponsor|0
2464465|NCT02431260|8502881|P11|Overall Study|Study Terminated by the Sponsor|1
2464466|NCT02431260|8502882|P10|Overall Study|Study Terminated by the Sponsor|1
2464467|NCT02431260|8502883|P9|Overall Study|Study Terminated by the Sponsor|1
2464468|NCT02431260|8502884|P8|Overall Study|Study Terminated by the Sponsor|2
2464469|NCT02431260|8502885|P7|Overall Study|Study Terminated by the Sponsor|1
2464470|NCT02431260|8502886|P6|Overall Study|Study Terminated by the Sponsor|0
2464471|NCT02431260|8502887|P5|Overall Study|Study Terminated by the Sponsor|1
2464472|NCT02431260|8502888|P4|Overall Study|Study Terminated by the Sponsor|1
2464473|NCT02431260|8502889|P3|Overall Study|Study Terminated by the Sponsor|2
2464474|NCT02431260|8502890|P2|Overall Study|Study Terminated by the Sponsor|0
2464475|NCT02431260|8502891|P1|Overall Study|Study Terminated by the Sponsor|0
2464476|NCT02431260|8502878|P14|Overall Study|Lost to Follow-up|0
2464477|NCT02431260|8502879|P13|Overall Study|Lost to Follow-up|0
2464478|NCT02431260|8502880|P12|Overall Study|Lost to Follow-up|0
2464479|NCT02431260|8502881|P11|Overall Study|Lost to Follow-up|0
2464480|NCT02431260|8502882|P10|Overall Study|Lost to Follow-up|0
2464481|NCT02431260|8502883|P9|Overall Study|Lost to Follow-up|0
2464482|NCT02431260|8502884|P8|Overall Study|Lost to Follow-up|0
2464483|NCT02431260|8502885|P7|Overall Study|Lost to Follow-up|0
2464484|NCT02431260|8502886|P6|Overall Study|Lost to Follow-up|1
2464485|NCT02431260|8502887|P5|Overall Study|Lost to Follow-up|0
2464486|NCT02431260|8502888|P4|Overall Study|Lost to Follow-up|0
2464487|NCT02431260|8502889|P3|Overall Study|Lost to Follow-up|0
2464488|NCT02431260|8502890|P2|Overall Study|Lost to Follow-up|0
2464489|NCT02431260|8502891|P1|Overall Study|Lost to Follow-up|0
2464490|NCT02431260|8502878|P14|Overall Study|Death|1
2464491|NCT02431260|8502879|P13|Overall Study|Death|5
2464492|NCT02431260|8502880|P12|Overall Study|Death|2
2464493|NCT02431260|8502881|P11|Overall Study|Death|3
2464494|NCT02431260|8502882|P10|Overall Study|Death|6
2464495|NCT02431260|8502883|P9|Overall Study|Death|6
2464496|NCT02431260|8502884|P8|Overall Study|Death|1
2464497|NCT02431260|8502885|P7|Overall Study|Death|3
2464498|NCT02431260|8502886|P6|Overall Study|Death|2
2464499|NCT02431260|8502887|P5|Overall Study|Death|2
2464500|NCT02431260|8502888|P4|Overall Study|Death|4
2464501|NCT02431260|8502889|P3|Overall Study|Death|3
2464502|NCT02431260|8502890|P2|Overall Study|Death|4
2464503|NCT02431260|8502891|P1|Overall Study|Death|4
2464504|NCT02431260|8502878|P14|Overall Study|Subject Decision|0
2464505|NCT02431260|8502879|P13|Overall Study|Subject Decision|0
2464506|NCT02431260|8502880|P12|Overall Study|Subject Decision|1
2464507|NCT02431260|8502881|P11|Overall Study|Subject Decision|0
2464508|NCT02431260|8502882|P10|Overall Study|Subject Decision|1
2464509|NCT02431260|8502883|P9|Overall Study|Subject Decision|1
2464510|NCT02431260|8502884|P8|Overall Study|Subject Decision|0
2464511|NCT02431260|8502885|P7|Overall Study|Subject Decision|0
2464512|NCT02431260|8502886|P6|Overall Study|Subject Decision|0
2464513|NCT02431260|8502887|P5|Overall Study|Subject Decision|0
2464514|NCT02431260|8502888|P4|Overall Study|Subject Decision|0
2464515|NCT02431260|8502889|P3|Overall Study|Subject Decision|1
2464516|NCT02431260|8502890|P2|Overall Study|Subject Decision|1
2464517|NCT02431260|8502891|P1|Overall Study|Subject Decision|0
2464518|NCT02431247|8502984|P2|Overall Study|Non-compliance with study drug|0
2464519|NCT02431247|8502985|P1|Overall Study|Non-compliance with study drug|1
2464520|NCT02431247|8502984|P2|Overall Study|Ongoing|336
2464521|NCT02431247|8502985|P1|Overall Study|Ongoing|339
2464522|NCT02431247|8502984|P2|Overall Study|Other|1
2464523|NCT02431247|8502985|P1|Overall Study|Other|2
2464524|NCT02431247|8502984|P2|Overall Study|Withdrawal by Subject|6
2464525|NCT02431247|8502985|P1|Overall Study|Withdrawal by Subject|4
2464526|NCT02431247|8502984|P2|Overall Study|Physician Decision|0
2464527|NCT02431247|8502985|P1|Overall Study|Physician Decision|3
2464528|NCT02431247|8502984|P2|Overall Study|Adverse Event|15
2464529|NCT02431247|8502985|P1|Overall Study|Adverse Event|8
2464530|NCT02431247|8502984|P2|Overall Study|Lost to Follow-up|5
2464531|NCT02431247|8502985|P1|Overall Study|Lost to Follow-up|5
2464532|NCT02430870|8503078|P8|Part 2|Other Reason Not Specified|1
2464533|NCT02430870|8503079|P7|Part 2|Other Reason Not Specified|0
2464534|NCT02430870|8503080|P6|Part 2|Other Reason Not Specified|0
2464535|NCT02430870|8503081|P5|Part 2|Other Reason Not Specified|0
2464536|NCT02430870|8503082|P4|Part 2|Other Reason Not Specified|0
2464537|NCT02430870|8503083|P3|Part 2|Other Reason Not Specified|0
2464538|NCT02430870|8503084|P2|Part 2|Other Reason Not Specified|0
2464539|NCT02430870|8503085|P1|Part 2|Other Reason Not Specified|0
2464540|NCT02430870|8503078|P8|Part 2|Voluntary Withdrawal|0
2464541|NCT02430870|8503079|P7|Part 2|Voluntary Withdrawal|1
2464542|NCT02430870|8503080|P6|Part 2|Voluntary Withdrawal|0
2464543|NCT02430870|8503081|P5|Part 2|Voluntary Withdrawal|0
2464544|NCT02430870|8503082|P4|Part 2|Voluntary Withdrawal|0
2464545|NCT02430870|8503083|P3|Part 2|Voluntary Withdrawal|0
2464546|NCT02430870|8503084|P2|Part 2|Voluntary Withdrawal|0
2464547|NCT02430870|8503085|P1|Part 2|Voluntary Withdrawal|0
2464548|NCT02430532|8503172|P2|Overall Study|Adverse Event|1
2464549|NCT02430532|8503173|P1|Overall Study|Adverse Event|0
2464550|NCT02430532|8503172|P2|Overall Study|Consent Withdrawn|2
2464551|NCT02430532|8503173|P1|Overall Study|Consent Withdrawn|0
2464552|NCT02430532|8503172|P2|Overall Study|Sponsor Decision to Stop Study Early|25
2464553|NCT02430532|8503173|P1|Overall Study|Sponsor Decision to Stop Study Early|30
2464554|NCT02430311|8503214|P2|Part B|Death|0
2464555|NCT02430311|8503215|P1|Part B|Death|1
2464556|NCT02430311|8503214|P2|Part B|Adverse Event|0
2464557|NCT02430311|8503215|P1|Part B|Adverse Event|1
2464558|NCT02430311|8503214|P2|Part B|Withdrawal by Subject|2
2464559|NCT02430311|8503215|P1|Part B|Withdrawal by Subject|2
2464560|NCT02430311|8503214|P2|Part B|Meet study-specific withdrawal criteria|6
2464561|NCT02430311|8503215|P1|Part B|Meet study-specific withdrawal criteria|6
2464562|NCT02430311|8503214|P2|Part A|Withdrawal by Subject|0
2464563|NCT02430311|8503215|P1|Part A|Withdrawal by Subject|1
2464564|NCT02430311|8503214|P2|Part A|Adverse Event|1
2464565|NCT02430311|8503215|P1|Part A|Adverse Event|0
2464566|NCT02429856|8503269|P2|Overall Study|Withdrawal by Subject|1
2464567|NCT02429856|8503270|P1|Overall Study|Withdrawal by Subject|1
2464568|NCT02429856|8503269|P2|Overall Study|Lost to Follow-up|5
2464569|NCT02429856|8503270|P1|Overall Study|Lost to Follow-up|6
2464570|NCT02429856|8503269|P2|Overall Study|Death|13
2464571|NCT02429856|8503270|P1|Overall Study|Death|12
2464572|NCT02429791|8503288|P2|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5
2464573|NCT02429791|8503289|P1|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7
2464574|NCT02429791|8503288|P2|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
2464575|NCT02429791|8503289|P1|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
2464576|NCT02429791|8503288|P2|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1
2464577|NCT02429791|8503289|P1|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0
2464578|NCT02429791|8503288|P2|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3
2464579|NCT02429791|8503289|P1|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4
2464580|NCT02429791|8503288|P2|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4
2464581|NCT02429791|8503289|P1|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0
2464582|NCT02429791|8503288|P2|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12
2464583|NCT02429791|8503289|P1|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11
2464584|NCT02429791|8503288|P2|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7
2464585|NCT02429791|8503289|P1|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3
2464586|NCT02429791|8503288|P2|Early Switch Phase (Up to Week 52)|Protocol Violation|4
2464587|NCT02429791|8503289|P1|Early Switch Phase (Up to Week 52)|Protocol Violation|1
2464588|NCT02429791|8503288|P2|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2
2464589|NCT02429791|8503289|P1|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
2464590|NCT02429791|8503288|P2|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1
2464591|NCT02429791|8503289|P1|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2
2464592|NCT02429791|8503288|P2|Early Switch Phase (Up to Week 52)|Physician Decision|2
2464593|NCT02429791|8503289|P1|Early Switch Phase (Up to Week 52)|Physician Decision|0
2464594|NCT02429791|8503288|P2|Early Switch Phase (Up to Week 52)|Adverse Event|2
2464595|NCT02429791|8503289|P1|Early Switch Phase (Up to Week 52)|Adverse Event|6
2464596|NCT02429778|8503377|P2|Overall Study|Withdrawal by Subject|0
2464597|NCT02429778|8503378|P1|Overall Study|Withdrawal by Subject|5
2464598|NCT02429778|8503377|P2|Overall Study|Lost to Follow-up|0
2464599|NCT02429778|8503378|P1|Overall Study|Lost to Follow-up|2
2464600|NCT02429310|8503409|P2|Overall Study|Protocol Violation|1
2464601|NCT02429310|8503410|P1|Overall Study|Protocol Violation|1
2464602|NCT02429310|8503409|P2|Overall Study|Lost to Follow-up|2
2464603|NCT02429310|8503410|P1|Overall Study|Lost to Follow-up|1
2464604|NCT02429258|8503420|P2|Overall Study|Protocol Violation|1
2464605|NCT02429258|8503421|P1|Overall Study|Protocol Violation|0
2464606|NCT02429258|8503420|P2|Overall Study|Withdrawal by Subject|0
2464607|NCT02429258|8503421|P1|Overall Study|Withdrawal by Subject|2
2464608|NCT02428699|8503475|P2|Washout Period 1|Screen Failure|2
2464609|NCT02428699|8503476|P1|Washout Period 1|Screen Failure|1
2464610|NCT02428608|8503504|P1|Overall Study|various|16
2464611|NCT02428608|8503504|P1|Overall Study|Death|1
2464612|NCT02428608|8503504|P1|Overall Study|moved away|10
2464613|NCT02428608|8503504|P1|Overall Study|scheduling conflicts|15
2464614|NCT02428608|8503504|P1|Overall Study|Withdrawal by Subject|2
2464615|NCT02428608|8503504|P1|Overall Study|Lost to Follow-up|37
2464616|NCT02428608|8503504|P1|Overall Study|Pregnancy|2
2464617|NCT02428413|8503536|P2|Overall Study|Nurse Refusal|0
2464618|NCT02428413|8503537|P1|Overall Study|Nurse Refusal|1
2464619|NCT02428413|8503536|P2|Overall Study|Missed Cases|2
2464620|NCT02428413|8503537|P1|Overall Study|Missed Cases|1
2464621|NCT02428413|8503536|P2|Overall Study|Case Cancelled|0
2464622|NCT02428413|8503537|P1|Overall Study|Case Cancelled|2
2464623|NCT02428413|8503536|P2|Overall Study|Protocol Violation|2
2464624|NCT02428413|8503537|P1|Overall Study|Protocol Violation|1
2464625|NCT02428413|8503536|P2|Overall Study|Device to measure WAG malfunctioned|5
2464626|NCT02428413|8503537|P1|Overall Study|Device to measure WAG malfunctioned|3
2464627|NCT02428296|8503572|P1|Overall Study|Withdrawal by Subject|2
2464628|NCT02428296|8503572|P1|Overall Study|Adverse Event|7
2464629|NCT02428231|8503584|P2|Overall Study|Adverse Event|0
2464630|NCT02428231|8503585|P1|Overall Study|Adverse Event|3
2464631|NCT02428231|8503584|P2|Overall Study|Required Symptomatic Therapy|1
2464632|NCT02428231|8503585|P1|Overall Study|Required Symptomatic Therapy|0
2464633|NCT02428231|8503584|P2|Overall Study|Other|16
2464634|NCT02428231|8503585|P1|Overall Study|Other|10
2464635|NCT02427984|8503602|P3|Overall Study|Lost to Follow-up|18
2464636|NCT02427984|8503603|P2|Overall Study|Lost to Follow-up|5
2464637|NCT02427984|8503604|P1|Overall Study|Lost to Follow-up|13
2464638|NCT02427958|8503618|P1|Overall Study|Lack of Efficacy|1
2464639|NCT02427958|8503618|P1|Overall Study|Withdrawal by Subject|14
2464640|NCT02427958|8503618|P1|Overall Study|Lost to Follow-up|6
2464641|NCT02427958|8503618|P1|Overall Study|Pretreatment Event (PTE) or AE|3
2464642|NCT02427646|8503711|P2|Overall Study|Bothersome hand weakness|4
2464643|NCT02427646|8503712|P1|Overall Study|Bothersome hand weakness|2
2464644|NCT02427646|8503711|P2|Overall Study|Protocol Violation|3
2464645|NCT02427646|8503712|P1|Overall Study|Protocol Violation|3
2464646|NCT02427646|8503711|P2|Overall Study|Physician Decision|4
2464647|NCT02427646|8503712|P1|Overall Study|Physician Decision|1
2464648|NCT02427646|8503711|P2|Overall Study|Lack of Efficacy|3
2464649|NCT02427646|8503712|P1|Overall Study|Lack of Efficacy|2
2464650|NCT02427607|8503720|P1|Overall Study|Withdrawal by Subject|1
2464651|NCT02427477|8503726|P2|Period 1|Adverse Event|0
2464652|NCT02427477|8503727|P1|Period 1|Adverse Event|1
2464653|NCT02427399|8503740|P5|Overall Study|Protocol Violation|15
2464654|NCT02427399|8503741|P4|Overall Study|Protocol Violation|18
2464655|NCT02427399|8503742|P3|Overall Study|Protocol Violation|12
2464656|NCT02427399|8503743|P2|Overall Study|Protocol Violation|16
2464657|NCT02427399|8503744|P1|Overall Study|Protocol Violation|14
2464658|NCT02427100|8503768|P2|Overall Study|Lost to Follow-up|2
2464659|NCT02427100|8503769|P1|Overall Study|Lost to Follow-up|0
2464660|NCT02426918|8503780|P3|Overall Study|Other|9
2464661|NCT02426918|8503781|P2|Overall Study|Other|11
2464662|NCT02426918|8503782|P1|Overall Study|Other|9
2464663|NCT02426918|8503780|P3|Overall Study|Withdrawal by Subject|4
2464664|NCT02426918|8503781|P2|Overall Study|Withdrawal by Subject|5
2464665|NCT02426918|8503782|P1|Overall Study|Withdrawal by Subject|5
2464666|NCT02426918|8503780|P3|Overall Study|Physician Decision|1
2464667|NCT02426918|8503781|P2|Overall Study|Physician Decision|1
2464668|NCT02426918|8503782|P1|Overall Study|Physician Decision|1
2464669|NCT02426918|8503780|P3|Overall Study|Adverse Event|0
2464670|NCT02426918|8503781|P2|Overall Study|Adverse Event|2
2464671|NCT02426918|8503782|P1|Overall Study|Adverse Event|2
2464672|NCT02426658|8503817|P1|Overall Study|Patient expired before treatment|2
2464673|NCT02426658|8503817|P1|Overall Study|Withdrawal by Subject|1
2464674|NCT02426580|8503824|P2|Overall Study|Allergic to egg white|0
2464675|NCT02426580|8503825|P1|Overall Study|Allergic to egg white|1
2464676|NCT02426580|8503824|P2|Overall Study|Kidney transplant|0
2464677|NCT02426580|8503825|P1|Overall Study|Kidney transplant|3
2464678|NCT02426580|8503824|P2|Overall Study|transfer to hemodialysis|5
2464679|NCT02426580|8503825|P1|Overall Study|transfer to hemodialysis|5
2464680|NCT02426580|8503824|P2|Overall Study|Lost to Follow-up|9
2464681|NCT02426580|8503825|P1|Overall Study|Lost to Follow-up|0
2464682|NCT02426580|8503824|P2|Overall Study|Death|2
2464683|NCT02426580|8503825|P1|Overall Study|Death|2
2464684|NCT02426541|8503833|P2|Overall Study|Protocol Violation|0
2464685|NCT02426541|8503834|P1|Overall Study|Protocol Violation|1
2464686|NCT02426138|8503846|P2|First Intervention (12 Weeks)|Withdrawal by Subject|1
2464687|NCT02426138|8503847|P1|First Intervention (12 Weeks)|Withdrawal by Subject|1
2464688|NCT02426125|8503887|P2|Overall Study|Withdrawal by Subject|16
2464689|NCT02426125|8503888|P1|Overall Study|Withdrawal by Subject|16
2464690|NCT02426125|8503887|P2|Overall Study|Protocol Violation|0
2464691|NCT02426125|8503888|P1|Overall Study|Protocol Violation|1
2464692|NCT02426125|8503887|P2|Overall Study|Lost to Follow-up|10
2464693|NCT02426125|8503888|P1|Overall Study|Lost to Follow-up|12
2464694|NCT02425826|8503919|P3|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1
2464695|NCT02425826|8503920|P2|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
2464696|NCT02425826|8503921|P1|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
2464697|NCT02425826|8503919|P3|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1
2464698|NCT02425826|8503920|P2|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0
2464699|NCT02425826|8503921|P1|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8
2464700|NCT02425826|8503919|P3|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4
2464701|NCT02425826|8503920|P2|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0
2464702|NCT02425826|8503921|P1|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12
2464703|NCT02425826|8503919|P3|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6
2464704|NCT02425826|8503920|P2|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0
2464705|NCT02425826|8503921|P1|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8
2464706|NCT02425826|8503919|P3|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2
2464707|NCT02425826|8503920|P2|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0
2464708|NCT02425826|8503921|P1|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7
2464709|NCT02425826|8503919|P3|Placebo-controlled Phase (Week 0 - 16)|Other|0
2464710|NCT02425826|8503920|P2|Placebo-controlled Phase (Week 0 - 16)|Other|1
2464711|NCT02425826|8503921|P1|Placebo-controlled Phase (Week 0 - 16)|Other|3
2464712|NCT02425826|8503919|P3|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0
2464713|NCT02425826|8503920|P2|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4
2464714|NCT02425826|8503921|P1|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10
2464715|NCT02425826|8503919|P3|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0
2464716|NCT02425826|8503920|P2|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1
2464717|NCT02425826|8503921|P1|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9
2464882|NCT02421588|8504750|P2|Overall Study|Treatment-related AE|14
2464718|NCT02425826|8503919|P3|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
2464719|NCT02425826|8503920|P2|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1
2464720|NCT02425826|8503921|P1|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
2464721|NCT02425826|8503919|P3|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0
2464722|NCT02425826|8503920|P2|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2
2464723|NCT02425826|8503921|P1|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5
2464724|NCT02425111|8503975|P1|Part B: Treatment Extension Period|Lack of Efficacy|7
2464725|NCT02425111|8503975|P1|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3
2464726|NCT02425111|8503975|P1|Part A: Treatment Period|Lost to Follow-up|2
2464727|NCT02425111|8503975|P1|Part A: Treatment Period|Voluntary Withdrawal|4
2464728|NCT02425111|8503975|P1|Part A: Treatment Period|Lack of Efficacy|15
2464729|NCT02425111|8503975|P1|Part A: Treatment Period|Pretreatment Event/Adverse Event|2
2464730|NCT02425098|8503996|P2|Overall Study|Reason not Specified|1
2464731|NCT02425098|8503997|P1|Overall Study|Reason not Specified|0
2464732|NCT02425098|8503996|P2|Overall Study|Pregnancy|0
2464733|NCT02425098|8503997|P1|Overall Study|Pregnancy|2
2464734|NCT02425098|8503996|P2|Overall Study|Withdrawal by Subject|8
2464735|NCT02425098|8503997|P1|Overall Study|Withdrawal by Subject|4
2464736|NCT02425098|8503996|P2|Overall Study|Lost to Follow-up|7
2464737|NCT02425098|8503997|P1|Overall Study|Lost to Follow-up|7
2464738|NCT02424734|8504149|P3|Overall Study|Treatment stopped to be discharged home|0
2464739|NCT02424734|8504150|P2|Overall Study|Treatment stopped to be discharged home|2
2464740|NCT02424734|8504151|P1|Overall Study|Treatment stopped to be discharged home|2
2464741|NCT02424591|8504170|P2|Overall Study|Protocol Violation|3
2464742|NCT02424591|8504171|P1|Overall Study|Protocol Violation|2
2464743|NCT02424578|8504183|P2|Overall Study|Withdrawal by Subject|1
2464744|NCT02424578|8504184|P1|Overall Study|Withdrawal by Subject|0
2464745|NCT02424565|8504190|P2|Period 1 (D0)|Protocol Violation|1
2464746|NCT02424565|8504191|P1|Period 1 (D0)|Protocol Violation|0
2464747|NCT02424539|8504200|P3|Overall Study|Other: Reached stopping criteria|6
2464748|NCT02424539|8504201|P2|Overall Study|Other: Reached stopping criteria|7
2464749|NCT02424539|8504202|P1|Overall Study|Other: Reached stopping criteria|11
2464750|NCT02424539|8504200|P3|Overall Study|Withdrawal by Subject|0
2464751|NCT02424539|8504201|P2|Overall Study|Withdrawal by Subject|1
2464752|NCT02424539|8504202|P1|Overall Study|Withdrawal by Subject|3
2464753|NCT02424539|8504200|P3|Overall Study|Physician Decision|1
2464754|NCT02424539|8504201|P2|Overall Study|Physician Decision|0
2464755|NCT02424539|8504202|P1|Overall Study|Physician Decision|0
2464756|NCT02424539|8504200|P3|Overall Study|Adverse Event|1
2464757|NCT02424539|8504201|P2|Overall Study|Adverse Event|0
2464758|NCT02424539|8504202|P1|Overall Study|Adverse Event|0
2464759|NCT02424344|8504277|P2|Overall Study|Adverse Event|8
2464760|NCT02424344|8504278|P1|Overall Study|Adverse Event|4
2464761|NCT02424344|8504277|P2|Overall Study|Lost to Follow-up|0
2464762|NCT02424344|8504278|P1|Overall Study|Lost to Follow-up|1
2464763|NCT02424344|8504277|P2|Overall Study|Withdrawal by Subject|1
2464764|NCT02424344|8504278|P1|Overall Study|Withdrawal by Subject|2
2464765|NCT02424344|8504277|P2|Overall Study|Lack of Efficacy|1
2464766|NCT02424344|8504278|P1|Overall Study|Lack of Efficacy|0
2464767|NCT02424149|8504296|P2|Overall Study|Withdrawal by Subject|1
2464768|NCT02424149|8504297|P1|Overall Study|Withdrawal by Subject|0
2464769|NCT02424149|8504296|P2|Overall Study|surgery cancelled|0
2464770|NCT02424149|8504297|P1|Overall Study|surgery cancelled|2
2464771|NCT02424097|8504313|P2|Overall Study|Lost to Follow-up|2
2464772|NCT02424097|8504314|P1|Overall Study|Lost to Follow-up|1
2464773|NCT02423798|8504369|P1|Overall Study|Withdrawal by Subject|3
2464774|NCT02423291|8504435|P1|Overall Study|Adverse Event|1
2464775|NCT02423291|8504435|P1|Overall Study|Lack of Efficacy|14
2464776|NCT02423109|8504465|P2|Lens 1|Adverse Event|0
2464777|NCT02423109|8504466|P1|Lens 1|Adverse Event|1
2464778|NCT02422797|8504499|P2|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0
2464779|NCT02422797|8504500|P1|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
2464780|NCT02422797|8504499|P2|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0
2464781|NCT02422797|8504500|P1|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1
2464782|NCT02422797|8504499|P2|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6
2464783|NCT02422797|8504500|P1|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2
2464784|NCT02422797|8504499|P2|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2
2464785|NCT02422797|8504500|P1|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2
2464786|NCT02422797|8504499|P2|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3
2464787|NCT02422797|8504500|P1|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5
2464788|NCT02422797|8504499|P2|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6
2464789|NCT02422797|8504500|P1|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10
2464790|NCT02422797|8504499|P2|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1
2464791|NCT02422797|8504500|P1|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0
2464792|NCT02422797|8504499|P2|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7
2464793|NCT02422797|8504500|P1|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2
2464794|NCT02422797|8504499|P2|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1
2464795|NCT02422797|8504500|P1|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1
2464796|NCT02422797|8504499|P2|Early Switch Phase (Up to Week 52)|Protocol Violation|3
2464797|NCT02422797|8504500|P1|Early Switch Phase (Up to Week 52)|Protocol Violation|0
2464798|NCT02422797|8504499|P2|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
2464799|NCT02422797|8504500|P1|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
2464800|NCT02422797|8504499|P2|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2
2464801|NCT02422797|8504500|P1|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1
2464802|NCT02422797|8504499|P2|Early Switch Phase (Up to Week 52)|Physician Decision|1
2464803|NCT02422797|8504500|P1|Early Switch Phase (Up to Week 52)|Physician Decision|0
2464804|NCT02422797|8504499|P2|Early Switch Phase (Up to Week 52)|Adverse Event|1
2464805|NCT02422797|8504500|P1|Early Switch Phase (Up to Week 52)|Adverse Event|11
2464806|NCT02422615|8504588|P2|Overall Study|Technical problems|1
2464807|NCT02422615|8504589|P1|Overall Study|Technical problems|0
2464808|NCT02422615|8504588|P2|Overall Study|Protocol Violation|1
2464809|NCT02422615|8504589|P1|Overall Study|Protocol Violation|1
2464810|NCT02422615|8504588|P2|Overall Study|Death|0
2464811|NCT02422615|8504589|P1|Overall Study|Death|2
2464812|NCT02422615|8504588|P2|Overall Study|Subject/guardian decision|5
2464813|NCT02422615|8504589|P1|Overall Study|Subject/guardian decision|21
2464814|NCT02422615|8504588|P2|Overall Study|Physician Decision|7
2464815|NCT02422615|8504589|P1|Overall Study|Physician Decision|22
2464816|NCT02422615|8504588|P2|Overall Study|Adverse Event|10
2464817|NCT02422615|8504589|P1|Overall Study|Adverse Event|41
2464818|NCT02422615|8504588|P2|Overall Study|Progressive disease|142
2464819|NCT02422615|8504589|P1|Overall Study|Progressive disease|193
2464820|NCT02422303|8504606|P2|Overall Study|Lost to Follow-up|1
2464821|NCT02422303|8504607|P1|Overall Study|Lost to Follow-up|1
2464822|NCT02422264|8504615|P2|Overall Study|Subject vaccinated outside of the study|1
2464823|NCT02422264|8504616|P1|Overall Study|Subject vaccinated outside of the study|0
2464824|NCT02422264|8504615|P2|Overall Study|Migrated/moved from study area|1
2464825|NCT02422264|8504616|P1|Overall Study|Migrated/moved from study area|3
2464826|NCT02422264|8504615|P2|Overall Study|Withdrawal by Subject|2
2464827|NCT02422264|8504616|P1|Overall Study|Withdrawal by Subject|1
2464828|NCT02422264|8504615|P2|Overall Study|Serious Adverse Event|0
2464829|NCT02422264|8504616|P1|Overall Study|Serious Adverse Event|1
2464830|NCT02422186|8504662|P2|Follow-up Phase (2 Weeks)|Other|0
2464831|NCT02422186|8504663|P1|Follow-up Phase (2 Weeks)|Other|3
2464832|NCT02422186|8504662|P2|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0
2464833|NCT02422186|8504663|P1|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1
2464834|NCT02422186|8504662|P2|Double-blind Induction Phase (4 Weeks)|Other|0
2464835|NCT02422186|8504663|P1|Double-blind Induction Phase (4 Weeks)|Other|1
2464836|NCT02422186|8504662|P2|Double-blind Induction Phase (4 Weeks)|Adverse Event|2
2464837|NCT02422186|8504663|P1|Double-blind Induction Phase (4 Weeks)|Adverse Event|4
2464838|NCT02422186|8504662|P2|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
2464839|NCT02422186|8504663|P1|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3
2464840|NCT02422186|8504662|P2|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2
2464841|NCT02422186|8504663|P1|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
2464842|NCT02422186|8504662|P2|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
2464843|NCT02422186|8504663|P1|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0
2464844|NCT02422186|8504662|P2|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
2464845|NCT02422186|8504663|P1|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1
2464846|NCT02421952|8504685|P1|Overall Study|Surgery cancelled|1
2464847|NCT02421952|8504685|P1|Overall Study|Subject uncooperative for baseline test|2
2464848|NCT02421952|8504685|P1|Overall Study|Failed seriation task|13
2464849|NCT02421952|8504685|P1|Overall Study|Diary Not Returned|93
2464850|NCT02421939|8504694|P2|Overall Study|Protocol deviation|1
2464851|NCT02421939|8504695|P1|Overall Study|Protocol deviation|1
2464852|NCT02421939|8504694|P2|Overall Study|Miscellaneous|5
2464853|NCT02421939|8504695|P1|Overall Study|Miscellaneous|4
2464854|NCT02421939|8504694|P2|Overall Study|Completed 1 or 2 chemo cycles with CRs|19
2464855|NCT02421939|8504695|P1|Overall Study|Completed 1 or 2 chemo cycles with CRs|0
2464856|NCT02421939|8504694|P2|Overall Study|Physician Decision|11
2464857|NCT02421939|8504695|P1|Overall Study|Physician Decision|11
2464858|NCT02421939|8504694|P2|Overall Study|Withdrawal by Subject|24
2464859|NCT02421939|8504695|P1|Overall Study|Withdrawal by Subject|5
2464860|NCT02421939|8504694|P2|Overall Study|Adverse Event|5
2464861|NCT02421939|8504695|P1|Overall Study|Adverse Event|28
2464862|NCT02421939|8504694|P2|Overall Study|Disease relapse|2
2464863|NCT02421939|8504695|P1|Overall Study|Disease relapse|33
2464864|NCT02421939|8504694|P2|Overall Study|Death|10
2464865|NCT02421939|8504695|P1|Overall Study|Death|36
2464866|NCT02421939|8504694|P2|Overall Study|Lack of Efficacy|31
2464867|NCT02421939|8504695|P1|Overall Study|Lack of Efficacy|21
2464868|NCT02421939|8504694|P2|Overall Study|Progressive disease|16
2464869|NCT02421939|8504695|P1|Overall Study|Progressive disease|70
2464870|NCT02421887|8504723|P2|Overall Study|Adverse Event|0
2464871|NCT02421887|8504724|P1|Overall Study|Adverse Event|2
2464872|NCT02421887|8504723|P2|Overall Study|Physician Decision|4
2464873|NCT02421887|8504724|P1|Overall Study|Physician Decision|2
2464874|NCT02421887|8504723|P2|Overall Study|Withdrawal by Subject|5
2464875|NCT02421887|8504724|P1|Overall Study|Withdrawal by Subject|8
2464876|NCT02421887|8504723|P2|Overall Study|Lost to Follow-up|0
2464877|NCT02421887|8504724|P1|Overall Study|Lost to Follow-up|5
2464878|NCT02421588|8504750|P2|Overall Study|Not treated|8
2464879|NCT02421588|8504751|P1|Overall Study|Not treated|2
2464880|NCT02421588|8504750|P2|Overall Study|Withdrawal by Subject|16
2464881|NCT02421588|8504751|P1|Overall Study|Withdrawal by Subject|14
2464883|NCT02421588|8504751|P1|Overall Study|Treatment-related AE|10
2464884|NCT02421588|8504750|P2|Overall Study|Symptomatic deterioration|19
2464885|NCT02421588|8504751|P1|Overall Study|Symptomatic deterioration|13
2464886|NCT02421588|8504750|P2|Overall Study|Other reason not specified|1
2464887|NCT02421588|8504751|P1|Overall Study|Other reason not specified|3
2464888|NCT02421588|8504750|P2|Overall Study|Physician Decision|17
2464889|NCT02421588|8504751|P1|Overall Study|Physician Decision|8
2464890|NCT02421588|8504750|P2|Overall Study|Death|3
2464891|NCT02421588|8504751|P1|Overall Study|Death|11
2464892|NCT02421588|8504750|P2|Overall Study|Progressive disease|135
2464893|NCT02421588|8504751|P1|Overall Study|Progressive disease|152
2464894|NCT02421588|8504750|P2|Overall Study|Non-treatment-related AE|8
2464895|NCT02421588|8504751|P1|Overall Study|Non-treatment-related AE|8
2464896|NCT02421510|8504774|P3|Overall Study|Lost to Follow-up|0
2464897|NCT02421510|8504775|P2|Overall Study|Lost to Follow-up|1
2464898|NCT02421510|8504776|P1|Overall Study|Lost to Follow-up|1
2464899|NCT02421510|8504774|P3|Overall Study|Withdrawal by Subject|12
2464900|NCT02421510|8504775|P2|Overall Study|Withdrawal by Subject|18
2464901|NCT02421510|8504776|P1|Overall Study|Withdrawal by Subject|14
2464902|NCT02421510|8504774|P3|Overall Study|Pregnancy|0
2464903|NCT02421510|8504775|P2|Overall Study|Pregnancy|1
2464904|NCT02421510|8504776|P1|Overall Study|Pregnancy|1
2464905|NCT02421510|8504774|P3|Overall Study|Adverse Event|18
2464906|NCT02421510|8504775|P2|Overall Study|Adverse Event|10
2464907|NCT02421510|8504776|P1|Overall Study|Adverse Event|9
2464908|NCT02421510|8504774|P3|Overall Study|Physician Decision|3
2464909|NCT02421510|8504775|P2|Overall Study|Physician Decision|1
2464910|NCT02421510|8504776|P1|Overall Study|Physician Decision|1
2464911|NCT02421510|8504774|P3|Overall Study|Noncompliance with study drug|0
2464912|NCT02421510|8504775|P2|Overall Study|Noncompliance with study drug|0
2464913|NCT02421510|8504776|P1|Overall Study|Noncompliance with study drug|1
2464914|NCT02421510|8504774|P3|Overall Study|Death|0
2464915|NCT02421510|8504775|P2|Overall Study|Death|0
2464916|NCT02421510|8504776|P1|Overall Study|Death|1
2464917|NCT02421510|8504774|P3|Overall Study|Protocol Violation|0
2464918|NCT02421510|8504775|P2|Overall Study|Protocol Violation|2
2464919|NCT02421510|8504776|P1|Overall Study|Protocol Violation|1
2464920|NCT02421510|8504774|P3|Overall Study|Other|3
2464921|NCT02421510|8504775|P2|Overall Study|Other|2
2464922|NCT02421510|8504776|P1|Overall Study|Other|4
2464923|NCT02421419|8504808|P3|Overall Study|Physician Decision|1
2464924|NCT02421419|8504809|P2|Overall Study|Physician Decision|0
2464925|NCT02421419|8504810|P1|Overall Study|Physician Decision|0
2464926|NCT02421172|8504880|P5|Period 2|Patient/guardian decision|1
2464927|NCT02421172|8504881|P4|Period 2|Patient/guardian decision|2
2464928|NCT02421172|8504882|P3|Period 2|Patient/guardian decision|3
2464929|NCT02421172|8504883|P2|Period 2|Patient/guardian decision|0
2464930|NCT02421172|8504884|P1|Period 2|Patient/guardian decision|0
2464931|NCT02421172|8504880|P5|Period 2|Lost to Follow-up|0
2464932|NCT02421172|8504881|P4|Period 2|Lost to Follow-up|1
2464933|NCT02421172|8504882|P3|Period 2|Lost to Follow-up|0
2464934|NCT02421172|8504883|P2|Period 2|Lost to Follow-up|0
2464935|NCT02421172|8504884|P1|Period 2|Lost to Follow-up|0
2464936|NCT02421172|8504880|P5|Period 2|Adverse Event|0
2464937|NCT02421172|8504881|P4|Period 2|Adverse Event|0
2464938|NCT02421172|8504882|P3|Period 2|Adverse Event|4
2464939|NCT02421172|8504883|P2|Period 2|Adverse Event|0
2464940|NCT02421172|8504884|P1|Period 2|Adverse Event|0
2464941|NCT02421172|8504880|P5|Period 1|Patient/guardian decision|0
2464942|NCT02421172|8504881|P4|Period 1|Patient/guardian decision|0
2464943|NCT02421172|8504882|P3|Period 1|Patient/guardian decision|0
2464944|NCT02421172|8504883|P2|Period 1|Patient/guardian decision|1
2464945|NCT02421172|8504884|P1|Period 1|Patient/guardian decision|0
2464946|NCT02421172|8504880|P5|Period 1|Lost to Follow-up|0
2464947|NCT02421172|8504881|P4|Period 1|Lost to Follow-up|0
2464948|NCT02421172|8504882|P3|Period 1|Lost to Follow-up|0
2464949|NCT02421172|8504883|P2|Period 1|Lost to Follow-up|1
2464950|NCT02421172|8504884|P1|Period 1|Lost to Follow-up|3
2464951|NCT02421172|8504880|P5|Period 1|Adverse Event|0
2464952|NCT02421172|8504881|P4|Period 1|Adverse Event|0
2464953|NCT02421172|8504882|P3|Period 1|Adverse Event|0
2464954|NCT02421172|8504883|P2|Period 1|Adverse Event|0
2464955|NCT02421172|8504884|P1|Period 1|Adverse Event|1
2464956|NCT02421120|8504928|P1|Overall Study|Adverse Event|1
2464957|NCT02420821|8504970|P2|Overall Study|Death|116
2464958|NCT02420821|8504971|P1|Overall Study|Death|129
2464959|NCT02420821|8504970|P2|Overall Study|Withdrawal by Subject|17
2464960|NCT02420821|8504971|P1|Overall Study|Withdrawal by Subject|31
2464961|NCT02420821|8504970|P2|Overall Study|Physician Decision|2
2464962|NCT02420821|8504971|P1|Overall Study|Physician Decision|5
2464963|NCT02420821|8504970|P2|Overall Study|Non-compliance|2
2464964|NCT02420821|8504971|P1|Overall Study|Non-compliance|1
2464965|NCT02420821|8504970|P2|Overall Study|Lost to Follow-up|0
2464966|NCT02420821|8504971|P1|Overall Study|Lost to Follow-up|2
2464967|NCT02420353|8505041|P2|Overall Study|Withdrawal by Subject|1
2464968|NCT02420353|8505042|P1|Overall Study|Withdrawal by Subject|0
2464969|NCT02420327|8505134|P1|Overall Study|Protocol Violation|1
2464970|NCT02420327|8505134|P1|Overall Study|Lost to Follow-up|1
2464971|NCT02420327|8505134|P1|Overall Study|Withdrawal by Subject|6
2464972|NCT02420327|8505134|P1|Overall Study|Pregnancy|1
2464973|NCT02420327|8505134|P1|Overall Study|Adverse Event|7
2464974|NCT02420262|8505170|P2|Overall Study|Unclassified|1
2464975|NCT02420262|8505171|P1|Overall Study|Unclassified|0
2464976|NCT02420262|8505170|P2|Overall Study|Withdrawal by Subject|4
2464977|NCT02420262|8505171|P1|Overall Study|Withdrawal by Subject|1
2464978|NCT02420262|8505170|P2|Overall Study|Adverse Event|0
2464979|NCT02420262|8505171|P1|Overall Study|Adverse Event|1
2464980|NCT02420093|8505197|P2|Overall Study|Withdrawal by Subject|1
2464981|NCT02420093|8505198|P1|Overall Study|Withdrawal by Subject|1
2464982|NCT02419937|8505260|P2|Overall Study|Lost to Follow-up|0
2464983|NCT02419937|8505261|P1|Overall Study|Lost to Follow-up|1
2464984|NCT02419755|8505269|P2|Overall Study|Withdrawal by Subject|0
2464985|NCT02419755|8505270|P1|Overall Study|Withdrawal by Subject|1
2464986|NCT02419755|8505269|P2|Overall Study|Ineligible|0
2464987|NCT02419755|8505270|P1|Overall Study|Ineligible|1
2464988|NCT02419755|8505269|P2|Overall Study|Relapse|1
2464989|NCT02419755|8505270|P1|Overall Study|Relapse|0
2464990|NCT02419755|8505269|P2|Overall Study|Death|3
2464991|NCT02419755|8505270|P1|Overall Study|Death|1
2464992|NCT02419612|8505296|P2|Overall Study|Subject moved out of state|1
2464993|NCT02419612|8505297|P1|Overall Study|Subject moved out of state|0
2464994|NCT02419612|8505296|P2|Overall Study|Worsening of liver function|1
2464995|NCT02419612|8505297|P1|Overall Study|Worsening of liver function|0
2464996|NCT02419612|8505296|P2|Overall Study|Noncompliance With Study Drug|2
2464997|NCT02419612|8505297|P1|Overall Study|Noncompliance With Study Drug|0
2464998|NCT02419612|8505296|P2|Overall Study|Subject Request To Discontinue Treatment|1
2464999|NCT02419612|8505297|P1|Overall Study|Subject Request To Discontinue Treatment|1
2465000|NCT02419612|8505296|P2|Overall Study|Withdrawal by Subject|9
2465001|NCT02419612|8505297|P1|Overall Study|Withdrawal by Subject|9
2465002|NCT02419612|8505296|P2|Overall Study|Lost to Follow-up|6
2465003|NCT02419612|8505297|P1|Overall Study|Lost to Follow-up|6
2465004|NCT02419612|8505296|P2|Overall Study|Death|2
2465005|NCT02419612|8505297|P1|Overall Study|Death|0
2465006|NCT02419612|8505296|P2|Overall Study|Adverse Event|1
2465007|NCT02419612|8505297|P1|Overall Study|Adverse Event|1
2465008|NCT02419573|8505313|P2|Overall Study|Withdrawal by Subject|0
2465009|NCT02419573|8505314|P1|Overall Study|Withdrawal by Subject|1
2465010|NCT02419573|8505313|P2|Overall Study|Lost to Follow-up|0
2465011|NCT02419573|8505314|P1|Overall Study|Lost to Follow-up|3
2465012|NCT02419508|8505344|P2|Overall Study|Other - Reason not specified|1
2465013|NCT02419508|8505345|P1|Overall Study|Other - Reason not specified|0
2465014|NCT02419508|8505344|P2|Overall Study|Withdrawal by Subject|0
2465015|NCT02419508|8505345|P1|Overall Study|Withdrawal by Subject|1
2465016|NCT02419508|8505344|P2|Overall Study|Adverse Event|3
2465017|NCT02419508|8505345|P1|Overall Study|Adverse Event|9
2465018|NCT02419469|8505363|P1|Overall Study|Withdrawal by Subject|1
2465019|NCT02419313|8505367|P2|Second Intervention|Lost to Follow-up|0
2465020|NCT02419313|8505368|P1|Second Intervention|Lost to Follow-up|1
2465021|NCT02419313|8505367|P2|First Intervention|Lost to Follow-up|0
2465022|NCT02419313|8505368|P1|First Intervention|Lost to Follow-up|2
2465023|NCT02419001|8505380|P2|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0
2465024|NCT02419001|8505381|P1|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1
2465025|NCT02418910|8505391|P1|Overall Study|Withdrawal by Subject|4
2465026|NCT02418910|8505391|P1|Overall Study|Lost to Follow-up|3
2465027|NCT02418819|8505399|P4|Overall Study|No longer willing to participate|1
2465028|NCT02418819|8505400|P3|Overall Study|No longer willing to participate|2
2465029|NCT02418819|8505401|P2|Overall Study|No longer willing to participate|0
2465030|NCT02418819|8505402|P1|Overall Study|No longer willing to participate|0
2465031|NCT02418819|8505399|P4|Overall Study|No longer meets eligibility criteria|0
2465032|NCT02418819|8505400|P3|Overall Study|No longer meets eligibility criteria|1
2465033|NCT02418819|8505401|P2|Overall Study|No longer meets eligibility criteria|0
2465034|NCT02418819|8505402|P1|Overall Study|No longer meets eligibility criteria|0
2465035|NCT02418819|8505399|P4|Overall Study|Lost to Follow-up|0
2465036|NCT02418819|8505400|P3|Overall Study|Lost to Follow-up|0
2465037|NCT02418819|8505401|P2|Overall Study|Lost to Follow-up|0
2465038|NCT02418819|8505402|P1|Overall Study|Lost to Follow-up|1
2465039|NCT02418819|8505399|P4|Overall Study|Adverse Event|0
2465040|NCT02418819|8505400|P3|Overall Study|Adverse Event|1
2465041|NCT02418819|8505401|P2|Overall Study|Adverse Event|0
2465042|NCT02418819|8505402|P1|Overall Study|Adverse Event|0
2465043|NCT02418585|8505460|P2|Follow-up Phase (24 Weeks)|Other|2
2465044|NCT02418585|8505461|P1|Follow-up Phase (24 Weeks)|Other|3
2465045|NCT02418585|8505460|P2|Follow-up Phase (24 Weeks)|Investigator Decision|17
2465046|NCT02418585|8505461|P1|Follow-up Phase (24 Weeks)|Investigator Decision|6
2465047|NCT02418585|8505460|P2|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3
2465048|NCT02418585|8505461|P1|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6
2465049|NCT02418585|8505460|P2|Follow-up Phase (24 Weeks)|Lost to Follow-up|3
2465050|NCT02418585|8505461|P1|Follow-up Phase (24 Weeks)|Lost to Follow-up|3
2465051|NCT02418585|8505460|P2|Double Blind (DB) Phase (4 Weeks)|Other|1
2465052|NCT02418585|8505461|P1|Double Blind (DB) Phase (4 Weeks)|Other|0
2465053|NCT02418585|8505460|P2|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1
2465054|NCT02418585|8505461|P1|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9
2465055|NCT02418585|8505460|P2|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0
2465056|NCT02418585|8505461|P1|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2
2465057|NCT02418585|8505460|P2|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7
2465058|NCT02418585|8505461|P1|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4
2465059|NCT02418585|8505460|P2|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2
2465060|NCT02418585|8505461|P1|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2
2465061|NCT02418585|8505460|P2|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1
2465062|NCT02418585|8505461|P1|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1
2465063|NCT02418468|8505517|P2|Overall Study|Withdrawal of informed consent|1
2465064|NCT02418468|8505518|P1|Overall Study|Withdrawal of informed consent|1
2465065|NCT02418468|8505517|P2|Overall Study|Adverse Event|0
2465066|NCT02418468|8505518|P1|Overall Study|Adverse Event|1
2465067|NCT02418455|8505524|P1|Continuation Period|Sponsor Decision|7
2465068|NCT02418455|8505524|P1|48-Week Treatment Period|Other- Not Specified|1
2465069|NCT02418182|8505567|P2|Overall Study|Lost to Follow-up|2
2465070|NCT02418182|8505568|P1|Overall Study|Lost to Follow-up|0
2465071|NCT02418182|8505567|P2|Overall Study|Unable to re-consent|15
2465072|NCT02418182|8505568|P1|Overall Study|Unable to re-consent|18
2465073|NCT02418156|8505580|P1|Overall Study|Subject refused to return|1
2465074|NCT02418156|8505580|P1|Overall Study|Withdrawal by Subject|1
2465075|NCT02418156|8505580|P1|Overall Study|Physician Decision|1
2465076|NCT02418156|8505580|P1|Overall Study|Death|2
2465077|NCT02418156|8505580|P1|Overall Study|Lost to Follow-up|12
2465078|NCT02418000|8505622|P5|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3
2465079|NCT02418000|8505623|P4|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
2465080|NCT02418000|8505624|P3|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
2465081|NCT02418000|8505625|P2|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
2465082|NCT02418000|8505626|P1|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
2465083|NCT02418000|8505622|P5|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1
2465084|NCT02418000|8505623|P4|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
2465085|NCT02418000|8505624|P3|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
2465086|NCT02418000|8505625|P2|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
2465087|NCT02418000|8505626|P1|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
2465088|NCT02418000|8505622|P5|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
2465089|NCT02418000|8505623|P4|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3
2465090|NCT02418000|8505624|P3|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
2465091|NCT02418000|8505625|P2|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
2465092|NCT02418000|8505626|P1|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
2465093|NCT02418000|8505622|P5|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
2465094|NCT02418000|8505623|P4|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
2465095|NCT02418000|8505624|P3|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3
2465096|NCT02418000|8505625|P2|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
2465097|NCT02418000|8505626|P1|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
2465098|NCT02418000|8505622|P5|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
2465099|NCT02418000|8505623|P4|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
2465100|NCT02418000|8505624|P3|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
2465101|NCT02418000|8505625|P2|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9
2465102|NCT02418000|8505626|P1|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
2465103|NCT02418000|8505622|P5|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
2465104|NCT02418000|8505623|P4|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
2465105|NCT02418000|8505624|P3|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
2465106|NCT02418000|8505625|P2|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1
2465107|NCT02418000|8505626|P1|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
2465108|NCT02418000|8505622|P5|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
2465109|NCT02418000|8505623|P4|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
2465110|NCT02418000|8505624|P3|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
2465111|NCT02418000|8505625|P2|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
2465112|NCT02418000|8505626|P1|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1
2465113|NCT02418000|8505622|P5|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
2465114|NCT02418000|8505623|P4|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
2465115|NCT02418000|8505624|P3|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
2465116|NCT02418000|8505625|P2|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
2465117|NCT02418000|8505626|P1|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4
2465118|NCT02418000|8505622|P5|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
2465119|NCT02418000|8505623|P4|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
2465120|NCT02418000|8505624|P3|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
2465121|NCT02418000|8505625|P2|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
2465122|NCT02418000|8505626|P1|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2
2465123|NCT02417961|8505744|P1|Overall Study|Withdrawal by Subject|2
2465124|NCT02417961|8505744|P1|Overall Study|Lost to Follow-up|1
2465125|NCT02417961|8505744|P1|Overall Study|Adverse Event|1
2465126|NCT02417935|8505756|P2|Treatment Period|Physician Decision|1
2465127|NCT02417935|8505757|P1|Treatment Period|Physician Decision|3
2465128|NCT02417935|8505756|P2|Treatment Period|Withdrawal by Subject|3
2465129|NCT02417935|8505757|P1|Treatment Period|Withdrawal by Subject|3
2465130|NCT02417935|8505756|P2|Treatment Period|Protocol Violation|1
2465131|NCT02417935|8505757|P1|Treatment Period|Protocol Violation|2
2465132|NCT02417935|8505756|P2|Treatment Period|Entry Criteria not met|1
2465133|NCT02417935|8505757|P1|Treatment Period|Entry Criteria not met|0
2465134|NCT02417935|8505756|P2|Treatment Period|Lost to Follow-up|0
2465135|NCT02417935|8505757|P1|Treatment Period|Lost to Follow-up|1
2465136|NCT02417935|8505756|P2|Treatment Period|Adverse Event|10
2465137|NCT02417935|8505757|P1|Treatment Period|Adverse Event|12
2465138|NCT02417753|8505815|P1|Overall Study|Death|1
2465139|NCT02417441|8505835|P2|Overall Study|Inconclusive due to missing data|19
2465140|NCT02417441|8505836|P1|Overall Study|Inconclusive due to missing data|52
2465141|NCT02417246|8505904|P2|Phase 2 1st Generic Administered|Physician Decision|0
2465142|NCT02417246|8505905|P1|Phase 2 1st Generic Administered|Physician Decision|1
2465143|NCT02417246|8505904|P2|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3
2465144|NCT02417246|8505905|P1|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2
2465145|NCT02417246|8505904|P2|Phase 1 Brand Name Metoprolol ER|Physician Decision|0
2465146|NCT02417246|8505905|P1|Phase 1 Brand Name Metoprolol ER|Physician Decision|1
2465147|NCT02417246|8505904|P2|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1
2465148|NCT02417246|8505905|P1|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1
2465149|NCT02417233|8505928|P3|Overall Study|Mentally unstable|0
2465150|NCT02417233|8505929|P2|Overall Study|Mentally unstable|1
2465151|NCT02417233|8505930|P1|Overall Study|Mentally unstable|0
2465152|NCT02417233|8505928|P3|Overall Study|Relocation out of study area|1
2465153|NCT02417233|8505929|P2|Overall Study|Relocation out of study area|0
2465154|NCT02417233|8505930|P1|Overall Study|Relocation out of study area|1
2465155|NCT02417233|8505928|P3|Overall Study|Withdrawal by Subject|8
2465156|NCT02417233|8505929|P2|Overall Study|Withdrawal by Subject|1
2465157|NCT02417233|8505930|P1|Overall Study|Withdrawal by Subject|2
2465158|NCT02417233|8505928|P3|Overall Study|Protocol Violation|2
2465159|NCT02417233|8505929|P2|Overall Study|Protocol Violation|0
2465160|NCT02417233|8505930|P1|Overall Study|Protocol Violation|2
2465161|NCT02417233|8505928|P3|Overall Study|Lost to Follow-up|34
2465162|NCT02417233|8505929|P2|Overall Study|Lost to Follow-up|39
2465163|NCT02417233|8505930|P1|Overall Study|Lost to Follow-up|27
2465164|NCT02417233|8505928|P3|Overall Study|Death|14
2465165|NCT02417233|8505929|P2|Overall Study|Death|10
2465166|NCT02417233|8505930|P1|Overall Study|Death|4
2465167|NCT02417064|8505967|P3|Follow-up Phase (24 Weeks)|Other|3
2465168|NCT02417064|8505968|P2|Follow-up Phase (24 Weeks)|Other|2
2465169|NCT02417064|8505969|P1|Follow-up Phase (24 Weeks)|Other|2
2465170|NCT02417064|8505967|P3|Follow-up Phase (24 Weeks)|PI Decision|44
2465171|NCT02417064|8505968|P2|Follow-up Phase (24 Weeks)|PI Decision|29
2465172|NCT02417064|8505969|P1|Follow-up Phase (24 Weeks)|PI Decision|34
2465173|NCT02417064|8505967|P3|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2
2465174|NCT02417064|8505968|P2|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9
2465175|NCT02417064|8505969|P1|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3
2465176|NCT02417064|8505967|P3|Follow-up Phase (24 Weeks)|Protocol Violation|1
2465177|NCT02417064|8505968|P2|Follow-up Phase (24 Weeks)|Protocol Violation|0
2465178|NCT02417064|8505969|P1|Follow-up Phase (24 Weeks)|Protocol Violation|0
2465179|NCT02417064|8505967|P3|Follow-up Phase (24 Weeks)|Lost to Follow-up|1
2465180|NCT02417064|8505968|P2|Follow-up Phase (24 Weeks)|Lost to Follow-up|2
2465181|NCT02417064|8505969|P1|Follow-up Phase (24 Weeks)|Lost to Follow-up|0
2465182|NCT02417064|8505967|P3|Double-blind Induction Phase (4 Weeks)|Other|2
2465183|NCT02417064|8505968|P2|Double-blind Induction Phase (4 Weeks)|Other|4
2465184|NCT02417064|8505969|P1|Double-blind Induction Phase (4 Weeks)|Other|1
2465185|NCT02417064|8505967|P3|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
2465186|NCT02417064|8505968|P2|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5
2465187|NCT02417064|8505969|P1|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
2465188|NCT02417064|8505967|P3|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
2465189|NCT02417064|8505968|P2|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
2465190|NCT02417064|8505969|P1|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2
2465191|NCT02417064|8505967|P3|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
2465192|NCT02417064|8505968|P2|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1
2465193|NCT02417064|8505969|P1|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
2465194|NCT02417064|8505967|P3|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0
2465195|NCT02417064|8505968|P2|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
2465196|NCT02417064|8505969|P1|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
2465197|NCT02417064|8505967|P3|Double-blind Induction Phase (4 Weeks)|Adverse Event|2
2465198|NCT02417064|8505968|P2|Double-blind Induction Phase (4 Weeks)|Adverse Event|7
2465199|NCT02417064|8505969|P1|Double-blind Induction Phase (4 Weeks)|Adverse Event|1
2465200|NCT02416934|8506040|P2|Overall Study|re-operation|0
2465201|NCT02416934|8506041|P1|Overall Study|re-operation|1
2465202|NCT02416934|8506040|P2|Overall Study|surgery started late|1
2465203|NCT02416934|8506041|P1|Overall Study|surgery started late|0
2465204|NCT02416934|8506040|P2|Overall Study|Protocol Violation|1
2465205|NCT02416934|8506041|P1|Overall Study|Protocol Violation|0
2465206|NCT02416934|8506040|P2|Overall Study|recruited during continuing renewal proc|1
2465207|NCT02416934|8506041|P1|Overall Study|recruited during continuing renewal proc|0
2465208|NCT02416934|8506040|P2|Overall Study|Withdrawal by Subject|0
2465209|NCT02416934|8506041|P1|Overall Study|Withdrawal by Subject|1
2465210|NCT02416934|8506040|P2|Overall Study|Lost to Follow-up|2
2465211|NCT02416934|8506041|P1|Overall Study|Lost to Follow-up|0
2465212|NCT02416934|8506040|P2|Overall Study|given steroids|2
2465213|NCT02416934|8506041|P1|Overall Study|given steroids|1
2465214|NCT02416908|8506056|P4|Dose Escalation Phase|Withdrawal by Subject|0
2465215|NCT02416908|8506057|P3|Dose Escalation Phase|Withdrawal by Subject|1
2465216|NCT02416908|8506058|P2|Dose Escalation Phase|Withdrawal by Subject|0
2465217|NCT02416908|8506059|P1|Dose Escalation Phase|Withdrawal by Subject|0
2465218|NCT02416908|8506056|P4|Dose Escalation Phase|Adverse Event|0
2465219|NCT02416908|8506057|P3|Dose Escalation Phase|Adverse Event|3
2465220|NCT02416908|8506058|P2|Dose Escalation Phase|Adverse Event|0
2465221|NCT02416908|8506059|P1|Dose Escalation Phase|Adverse Event|0
2465222|NCT02416180|8506091|P1|Overall Study|Withdrawal by Subject|1
2465223|NCT02415959|8506103|P5|Overall Study|Protocol Violation|0
2465224|NCT02415959|8506104|P4|Overall Study|Protocol Violation|1
2465225|NCT02415959|8506105|P3|Overall Study|Protocol Violation|0
2465226|NCT02415959|8506106|P2|Overall Study|Protocol Violation|0
2465227|NCT02415959|8506107|P1|Overall Study|Protocol Violation|0
2465228|NCT02415959|8506103|P5|Overall Study|Adverse Event|0
2465229|NCT02415959|8506104|P4|Overall Study|Adverse Event|0
2465230|NCT02415959|8506105|P3|Overall Study|Adverse Event|0
2465231|NCT02415959|8506106|P2|Overall Study|Adverse Event|1
2465232|NCT02415959|8506107|P1|Overall Study|Adverse Event|0
2465233|NCT02415595|8506536|P4|Overall Study|Other|0
2465234|NCT02415595|8506537|P3|Overall Study|Other|1
2465235|NCT02415595|8506538|P2|Overall Study|Other|1
2465236|NCT02415595|8506539|P1|Overall Study|Other|0
2465237|NCT02415595|8506536|P4|Overall Study|Withdrawal by Subject|3
2465238|NCT02415595|8506537|P3|Overall Study|Withdrawal by Subject|1
2465239|NCT02415595|8506538|P2|Overall Study|Withdrawal by Subject|0
2465240|NCT02415595|8506539|P1|Overall Study|Withdrawal by Subject|4
2465241|NCT02415595|8506536|P4|Overall Study|Reached stopping criteria|0
2465242|NCT02415595|8506537|P3|Overall Study|Reached stopping criteria|1
2465243|NCT02415595|8506538|P2|Overall Study|Reached stopping criteria|1
2465244|NCT02415595|8506539|P1|Overall Study|Reached stopping criteria|0
2465245|NCT02415595|8506536|P4|Overall Study|Poor/Non-compliance|0
2465246|NCT02415595|8506537|P3|Overall Study|Poor/Non-compliance|1
2465247|NCT02415595|8506538|P2|Overall Study|Poor/Non-compliance|0
2465248|NCT02415595|8506539|P1|Overall Study|Poor/Non-compliance|1
2465249|NCT02415595|8506536|P4|Overall Study|Lost to Follow-up|1
2465250|NCT02415595|8506537|P3|Overall Study|Lost to Follow-up|1
2465251|NCT02415595|8506538|P2|Overall Study|Lost to Follow-up|3
2465252|NCT02415595|8506539|P1|Overall Study|Lost to Follow-up|1
2465253|NCT02415595|8506536|P4|Overall Study|Lack of Efficacy|0
2465254|NCT02415595|8506537|P3|Overall Study|Lack of Efficacy|0
2465255|NCT02415595|8506538|P2|Overall Study|Lack of Efficacy|4
2465256|NCT02415595|8506539|P1|Overall Study|Lack of Efficacy|4
2465257|NCT02415595|8506536|P4|Overall Study|Adverse Event|10
2465258|NCT02415595|8506537|P3|Overall Study|Adverse Event|5
2465259|NCT02415595|8506538|P2|Overall Study|Adverse Event|3
2465260|NCT02415595|8506539|P1|Overall Study|Adverse Event|1
2465261|NCT02415595|8506536|P4|Overall Study|Administrative reason by sponsor|39
2465262|NCT02415595|8506537|P3|Overall Study|Administrative reason by sponsor|41
2465263|NCT02415595|8506538|P2|Overall Study|Administrative reason by sponsor|40
2465264|NCT02415595|8506539|P1|Overall Study|Administrative reason by sponsor|39
2465265|NCT02415400|8506681|P4|Overall Study|Site closure; participant won't transfer|1
2465266|NCT02415400|8506682|P3|Overall Study|Site closure; participant won't transfer|0
2465267|NCT02415400|8506683|P2|Overall Study|Site closure; participant won't transfer|0
2465268|NCT02415400|8506684|P1|Overall Study|Site closure; participant won't transfer|0
2465269|NCT02415400|8506681|P4|Overall Study|Investigator decision|1
2465270|NCT02415400|8506682|P3|Overall Study|Investigator decision|1
2465271|NCT02415400|8506683|P2|Overall Study|Investigator decision|0
2465272|NCT02415400|8506684|P1|Overall Study|Investigator decision|0
2465273|NCT02415400|8506681|P4|Overall Study|Participant in jail|0
2465274|NCT02415400|8506682|P3|Overall Study|Participant in jail|1
2465275|NCT02415400|8506683|P2|Overall Study|Participant in jail|0
2465276|NCT02415400|8506684|P1|Overall Study|Participant in jail|0
2465277|NCT02415400|8506681|P4|Overall Study|Poor treatment monitoring|0
2465278|NCT02415400|8506682|P3|Overall Study|Poor treatment monitoring|1
2465279|NCT02415400|8506683|P2|Overall Study|Poor treatment monitoring|0
2465280|NCT02415400|8506684|P1|Overall Study|Poor treatment monitoring|0
2465281|NCT02415400|8506681|P4|Overall Study|State regulations prevent participation|0
2465282|NCT02415400|8506682|P3|Overall Study|State regulations prevent participation|1
2465283|NCT02415400|8506683|P2|Overall Study|State regulations prevent participation|0
2465284|NCT02415400|8506684|P1|Overall Study|State regulations prevent participation|0
2465285|NCT02415400|8506681|P4|Overall Study|Coagulation values cannot be set|0
2465286|NCT02415400|8506682|P3|Overall Study|Coagulation values cannot be set|1
2465287|NCT02415400|8506683|P2|Overall Study|Coagulation values cannot be set|0
2465288|NCT02415400|8506684|P1|Overall Study|Coagulation values cannot be set|0
2465289|NCT02415400|8506681|P4|Overall Study|Stroke and stroke rehabilitation|0
2465290|NCT02415400|8506682|P3|Overall Study|Stroke and stroke rehabilitation|1
2465291|NCT02415400|8506683|P2|Overall Study|Stroke and stroke rehabilitation|0
2465292|NCT02415400|8506684|P1|Overall Study|Stroke and stroke rehabilitation|0
2465293|NCT02415400|8506681|P4|Overall Study|No study drug on site|0
2465294|NCT02415400|8506682|P3|Overall Study|No study drug on site|0
2465295|NCT02415400|8506683|P2|Overall Study|No study drug on site|1
2465296|NCT02415400|8506684|P1|Overall Study|No study drug on site|0
2465297|NCT02415400|8506681|P4|Overall Study|Randomized in error|0
2465298|NCT02415400|8506682|P3|Overall Study|Randomized in error|0
2465299|NCT02415400|8506683|P2|Overall Study|Randomized in error|0
2465300|NCT02415400|8506684|P1|Overall Study|Randomized in error|2
2465301|NCT02415400|8506681|P4|Overall Study|Participant wanted home visits|0
2465302|NCT02415400|8506682|P3|Overall Study|Participant wanted home visits|0
2465303|NCT02415400|8506683|P2|Overall Study|Participant wanted home visits|0
2465304|NCT02415400|8506684|P1|Overall Study|Participant wanted home visits|1
2465305|NCT02415400|8506681|P4|Overall Study|Participant doesn't answer phone|0
2465306|NCT02415400|8506682|P3|Overall Study|Participant doesn't answer phone|0
2465307|NCT02415400|8506683|P2|Overall Study|Participant doesn't answer phone|0
2465308|NCT02415400|8506684|P1|Overall Study|Participant doesn't answer phone|1
2465309|NCT02415400|8506681|P4|Overall Study|Participant no longer meets criteria|1
2465310|NCT02415400|8506682|P3|Overall Study|Participant no longer meets criteria|0
2465311|NCT02415400|8506683|P2|Overall Study|Participant no longer meets criteria|0
2465312|NCT02415400|8506684|P1|Overall Study|Participant no longer meets criteria|2
2465313|NCT02415400|8506681|P4|Overall Study|Poor/Non-Compliance|4
2465314|NCT02415400|8506682|P3|Overall Study|Poor/Non-Compliance|3
2465315|NCT02415400|8506683|P2|Overall Study|Poor/Non-Compliance|1
2465316|NCT02415400|8506684|P1|Overall Study|Poor/Non-Compliance|0
2465317|NCT02415400|8506681|P4|Overall Study|Lost to Follow-up|5
2465318|NCT02415400|8506682|P3|Overall Study|Lost to Follow-up|2
2465319|NCT02415400|8506683|P2|Overall Study|Lost to Follow-up|3
2465320|NCT02415400|8506684|P1|Overall Study|Lost to Follow-up|3
2465321|NCT02415400|8506681|P4|Overall Study|Death|42
2465322|NCT02415400|8506682|P3|Overall Study|Death|35
2465323|NCT02415400|8506683|P2|Overall Study|Death|41
2465324|NCT02415400|8506684|P1|Overall Study|Death|39
2465325|NCT02415400|8506681|P4|Overall Study|Participant withdrew consent|21
2465326|NCT02415400|8506682|P3|Overall Study|Participant withdrew consent|30
2465327|NCT02415400|8506683|P2|Overall Study|Participant withdrew consent|12
2465328|NCT02415400|8506684|P1|Overall Study|Participant withdrew consent|14
2465329|NCT02415400|8506681|P4|Overall Study|Participant request to stop therapy|6
2465330|NCT02415400|8506682|P3|Overall Study|Participant request to stop therapy|8
2465331|NCT02415400|8506683|P2|Overall Study|Participant request to stop therapy|3
2465332|NCT02415400|8506684|P1|Overall Study|Participant request to stop therapy|4
2465333|NCT02415400|8506681|P4|Overall Study|Adverse Event|2
2465334|NCT02415400|8506682|P3|Overall Study|Adverse Event|1
2465335|NCT02415400|8506683|P2|Overall Study|Adverse Event|1
2465336|NCT02415400|8506684|P1|Overall Study|Adverse Event|0
2465337|NCT02415127|8506752|P2|Overall Study|Adverse Event|0
2465338|NCT02415127|8506753|P1|Overall Study|Adverse Event|1
2465339|NCT02414958|8506770|P3|Overall Study|Other than specified|5
2465340|NCT02414958|8506771|P2|Overall Study|Other than specified|4
2465341|NCT02414958|8506772|P1|Overall Study|Other than specified|4
2465342|NCT02414958|8506770|P3|Overall Study|Withdrawal by Subject|5
2465343|NCT02414958|8506771|P2|Overall Study|Withdrawal by Subject|3
2465344|NCT02414958|8506772|P1|Overall Study|Withdrawal by Subject|5
2465345|NCT02414958|8506770|P3|Overall Study|Lost to Follow-up|0
2465346|NCT02414958|8506771|P2|Overall Study|Lost to Follow-up|4
2465347|NCT02414958|8506772|P1|Overall Study|Lost to Follow-up|7
2465348|NCT02414958|8506770|P3|Overall Study|Protocol Violation|1
2465349|NCT02414958|8506771|P2|Overall Study|Protocol Violation|3
2465350|NCT02414958|8506772|P1|Overall Study|Protocol Violation|10
2465351|NCT02414958|8506770|P3|Overall Study|Adverse Event|3
2465352|NCT02414958|8506771|P2|Overall Study|Adverse Event|6
2465353|NCT02414958|8506772|P1|Overall Study|Adverse Event|6
2465354|NCT02414854|8506805|P4|Overall Study|Other than specified above|37
2465355|NCT02414854|8506806|P3|Overall Study|Other than specified above|17
2465356|NCT02414854|8506807|P2|Overall Study|Other than specified above|37
2465357|NCT02414854|8506808|P1|Overall Study|Other than specified above|12
2465358|NCT02414854|8506805|P4|Overall Study|Poor compliance to protocol|2
2465359|NCT02414854|8506806|P3|Overall Study|Poor compliance to protocol|2
2465360|NCT02414854|8506807|P2|Overall Study|Poor compliance to protocol|1
2465361|NCT02414854|8506808|P1|Overall Study|Poor compliance to protocol|1
2465362|NCT02414854|8506805|P4|Overall Study|Adverse Event|12
2465363|NCT02414854|8506806|P3|Overall Study|Adverse Event|1
2465364|NCT02414854|8506807|P2|Overall Study|Adverse Event|7
2465365|NCT02414854|8506808|P1|Overall Study|Adverse Event|9
2465366|NCT02414841|8506972|P2|Overall Study|Randomized But Not Treated|4
2465367|NCT02414841|8506973|P1|Overall Study|Randomized But Not Treated|6
2465368|NCT02414841|8506972|P2|Overall Study|Received a Kidney Transplant|4
2465369|NCT02414841|8506973|P1|Overall Study|Received a Kidney Transplant|13
2465370|NCT02414841|8506972|P2|Overall Study|Death|14
2465371|NCT02414841|8506973|P1|Overall Study|Death|17
2465372|NCT02414841|8506972|P2|Overall Study|Lost to Follow-up|6
2465373|NCT02414841|8506973|P1|Overall Study|Lost to Follow-up|13
2465374|NCT02414841|8506972|P2|Overall Study|Withdrawal by Subject|5
2465375|NCT02414841|8506973|P1|Overall Study|Withdrawal by Subject|7
2465376|NCT02414828|8506985|P4|Overall Study|Lost to Follow-up|2
2465377|NCT02414828|8506986|P3|Overall Study|Lost to Follow-up|1
2465378|NCT02414828|8506987|P2|Overall Study|Lost to Follow-up|1
2465379|NCT02414828|8506988|P1|Overall Study|Lost to Follow-up|0
2465380|NCT02414152|8507081|P1|Overall Study|Lack of Efficacy|1
2465381|NCT02414152|8507081|P1|Overall Study|Withdrawal by Subject|1
2465382|NCT02413996|8507087|P2|Overall Study|not comfortable with the intervention|2
2465383|NCT02413996|8507088|P1|Overall Study|not comfortable with the intervention|9
2465384|NCT02413593|8507133|P1|Overall Study|Adverse Event|1
2465385|NCT02413593|8507133|P1|Overall Study|Lost to Follow-up|3
2465386|NCT02413489|8507152|P3|Overall Study|Study Terminated By Sponsor|1
2465387|NCT02413489|8507153|P2|Overall Study|Study Terminated By Sponsor|13
2465388|NCT02413489|8507154|P1|Overall Study|Study Terminated By Sponsor|2
2465389|NCT02413489|8507152|P3|Overall Study|Withdrawal by Subject|0
2465390|NCT02413489|8507153|P2|Overall Study|Withdrawal by Subject|0
2465391|NCT02413489|8507154|P1|Overall Study|Withdrawal by Subject|2
2465392|NCT02413489|8507152|P3|Overall Study|Death|4
2465393|NCT02413489|8507153|P2|Overall Study|Death|3
2465394|NCT02413489|8507154|P1|Overall Study|Death|11
2465395|NCT02413398|8507195|P2|Overall Study|Other Eligibility criteria|2
2465396|NCT02413398|8507196|P1|Overall Study|Other Eligibility criteria|1
2465397|NCT02413398|8507195|P2|Overall Study|Withdrawal by Subject|1
2465398|NCT02413398|8507196|P1|Overall Study|Withdrawal by Subject|1
2465399|NCT02413398|8507195|P2|Overall Study|Lost to Follow-up|4
2465400|NCT02413398|8507196|P1|Overall Study|Lost to Follow-up|2
2465401|NCT02413372|8507211|P3|Follow-up|Subject unable to return for visit|1
2465402|NCT02413372|8507212|P2|Follow-up|Subject unable to return for visit|0
2465403|NCT02413372|8507213|P1|Follow-up|Subject unable to return for visit|0
2465404|NCT02413372|8507211|P3|Follow-up|Subject Withdrew Consent|1
2465405|NCT02413372|8507212|P2|Follow-up|Subject Withdrew Consent|0
2465406|NCT02413372|8507213|P1|Follow-up|Subject Withdrew Consent|1
2465407|NCT02413372|8507211|P3|Follow-up|Lost to Follow-up|0
2465408|NCT02413372|8507212|P2|Follow-up|Lost to Follow-up|1
2465409|NCT02413372|8507213|P1|Follow-up|Lost to Follow-up|1
2465410|NCT02413372|8507211|P3|Treatment|Withdrawal by Subject|0
2465411|NCT02413372|8507212|P2|Treatment|Withdrawal by Subject|0
2465412|NCT02413372|8507213|P1|Treatment|Withdrawal by Subject|1
2465413|NCT02413372|8507211|P3|Treatment|Lost to Follow-up|1
2465414|NCT02413372|8507212|P2|Treatment|Lost to Follow-up|2
2465415|NCT02413372|8507213|P1|Treatment|Lost to Follow-up|0
2465416|NCT02413346|8507262|P2|Overall Study|Other Miscellaneous Reasons|3
2465417|NCT02413346|8507263|P1|Overall Study|Other Miscellaneous Reasons|4
2465418|NCT02413346|8507262|P2|Overall Study|Protocol Violation|0
2465419|NCT02413346|8507263|P1|Overall Study|Protocol Violation|2
2465420|NCT02413346|8507262|P2|Overall Study|Lost to Follow-up|21
2465421|NCT02413346|8507263|P1|Overall Study|Lost to Follow-up|17
2465422|NCT02413346|8507262|P2|Overall Study|Withdrawal by Subject|40
2465423|NCT02413346|8507263|P1|Overall Study|Withdrawal by Subject|30
2465424|NCT02413346|8507262|P2|Overall Study|Adverse Event|6
2465425|NCT02413346|8507263|P1|Overall Study|Adverse Event|6
2465426|NCT02413333|8507273|P2|Period 2|Protocol Deviation|0
2465427|NCT02413333|8507274|P1|Period 2|Protocol Deviation|1
2465428|NCT02413333|8507273|P2|Period 1|Reason Not Specified|1
2465429|NCT02413333|8507274|P1|Period 1|Reason Not Specified|0
2465430|NCT02413333|8507273|P2|Period 1|Adverse Event|0
2465431|NCT02413333|8507274|P1|Period 1|Adverse Event|1
2465432|NCT02413294|8507282|P1|Overall Study|Withdrawal by Subject|1
2465433|NCT02413255|8507317|P17|Overall Study|Voluntary Withdrawal|0
2465434|NCT02413255|8507318|P16|Overall Study|Voluntary Withdrawal|0
2465435|NCT02413255|8507319|P15|Overall Study|Voluntary Withdrawal|1
2465436|NCT02413255|8507320|P14|Overall Study|Voluntary Withdrawal|0
2465437|NCT02413255|8507321|P13|Overall Study|Voluntary Withdrawal|0
2465438|NCT02413255|8507322|P12|Overall Study|Voluntary Withdrawal|0
2465439|NCT02413255|8507323|P11|Overall Study|Voluntary Withdrawal|0
2465440|NCT02413255|8507324|P10|Overall Study|Voluntary Withdrawal|0
2465441|NCT02413255|8507325|P9|Overall Study|Voluntary Withdrawal|0
2465442|NCT02413255|8507326|P8|Overall Study|Voluntary Withdrawal|0
2465443|NCT02413255|8507327|P7|Overall Study|Voluntary Withdrawal|0
2465444|NCT02413255|8507328|P6|Overall Study|Voluntary Withdrawal|0
2465445|NCT02413255|8507329|P5|Overall Study|Voluntary Withdrawal|0
2465446|NCT02413255|8507330|P4|Overall Study|Voluntary Withdrawal|0
2465447|NCT02413255|8507331|P3|Overall Study|Voluntary Withdrawal|0
2465448|NCT02413255|8507332|P2|Overall Study|Voluntary Withdrawal|0
2465449|NCT02413255|8507333|P1|Overall Study|Voluntary Withdrawal|0
2465450|NCT02413229|8507689|P8|Overall Study|Progressive Disease|1
2465451|NCT02413229|8507690|P7|Overall Study|Progressive Disease|0
2465452|NCT02413229|8507691|P6|Overall Study|Progressive Disease|0
2465453|NCT02413229|8507692|P5|Overall Study|Progressive Disease|0
2465454|NCT02413229|8507693|P4|Overall Study|Progressive Disease|0
2465455|NCT02413229|8507694|P3|Overall Study|Progressive Disease|0
2465456|NCT02413229|8507695|P2|Overall Study|Progressive Disease|0
2465457|NCT02413229|8507696|P1|Overall Study|Progressive Disease|0
2465458|NCT02413229|8507689|P8|Overall Study|Withdrawal by Subject|2
2465459|NCT02413229|8507690|P7|Overall Study|Withdrawal by Subject|0
2465460|NCT02413229|8507691|P6|Overall Study|Withdrawal by Subject|0
2465461|NCT02413229|8507692|P5|Overall Study|Withdrawal by Subject|1
2465462|NCT02413229|8507693|P4|Overall Study|Withdrawal by Subject|0
2465463|NCT02413229|8507694|P3|Overall Study|Withdrawal by Subject|0
2465464|NCT02413229|8507695|P2|Overall Study|Withdrawal by Subject|1
2465465|NCT02413229|8507696|P1|Overall Study|Withdrawal by Subject|1
2465466|NCT02413229|8507689|P8|Overall Study|Lost to Follow-up|0
2465467|NCT02413229|8507690|P7|Overall Study|Lost to Follow-up|0
2465468|NCT02413229|8507691|P6|Overall Study|Lost to Follow-up|0
2465469|NCT02413229|8507692|P5|Overall Study|Lost to Follow-up|2
2465470|NCT02413229|8507693|P4|Overall Study|Lost to Follow-up|0
2465471|NCT02413229|8507694|P3|Overall Study|Lost to Follow-up|1
2465472|NCT02413229|8507695|P2|Overall Study|Lost to Follow-up|0
2465473|NCT02413229|8507696|P1|Overall Study|Lost to Follow-up|0
2465474|NCT02413229|8507689|P8|Overall Study|Adverse Event|1
2465475|NCT02413229|8507690|P7|Overall Study|Adverse Event|0
2465476|NCT02413229|8507691|P6|Overall Study|Adverse Event|0
2465477|NCT02413229|8507692|P5|Overall Study|Adverse Event|0
2465478|NCT02413229|8507693|P4|Overall Study|Adverse Event|1
2465479|NCT02413229|8507694|P3|Overall Study|Adverse Event|0
2465480|NCT02413229|8507695|P2|Overall Study|Adverse Event|0
2465481|NCT02413229|8507696|P1|Overall Study|Adverse Event|0
2465482|NCT02412878|8507835|P2|Overall Study|Lost to Follow-up|3
2465483|NCT02412878|8507836|P1|Overall Study|Lost to Follow-up|2
2465484|NCT02412878|8507835|P2|Overall Study|Withdrawal by Subject|10
2465485|NCT02412878|8507836|P1|Overall Study|Withdrawal by Subject|19
2465486|NCT02412852|8507854|P4|Overall Study|Physician Decision|1
2465487|NCT02412852|8507855|P3|Overall Study|Physician Decision|0
2465488|NCT02412852|8507856|P2|Overall Study|Physician Decision|0
2465489|NCT02412852|8507857|P1|Overall Study|Physician Decision|0
2465490|NCT02412852|8507854|P4|Overall Study|Withdrawal by Subject|0
2465491|NCT02412852|8507855|P3|Overall Study|Withdrawal by Subject|0
2465492|NCT02412852|8507856|P2|Overall Study|Withdrawal by Subject|1
2465493|NCT02412852|8507857|P1|Overall Study|Withdrawal by Subject|0
2465494|NCT02412761|8507883|P6|First Intervention (2 Weeks)|Withdrawal by Subject|1
2465495|NCT02412761|8507884|P5|First Intervention (2 Weeks)|Withdrawal by Subject|0
2465496|NCT02412761|8507885|P4|First Intervention (2 Weeks)|Withdrawal by Subject|0
2465497|NCT02412761|8507886|P3|First Intervention (2 Weeks)|Withdrawal by Subject|1
2465498|NCT02412761|8507887|P2|First Intervention (2 Weeks)|Withdrawal by Subject|1
2465499|NCT02412761|8507888|P1|First Intervention (2 Weeks)|Withdrawal by Subject|0
2465500|NCT02412722|8507902|P6|Overall Study|Reason not Specified|6
2465501|NCT02412722|8507903|P5|Overall Study|Reason not Specified|2
2465502|NCT02412722|8507904|P4|Overall Study|Reason not Specified|1
2465503|NCT02412722|8507905|P3|Overall Study|Reason not Specified|2
2465504|NCT02412722|8507906|P2|Overall Study|Reason not Specified|0
2465505|NCT02412722|8507907|P1|Overall Study|Reason not Specified|3
2465506|NCT02412722|8507902|P6|Overall Study|Received drug in run-in and discontinued|0
2465507|NCT02412722|8507903|P5|Overall Study|Received drug in run-in and discontinued|0
2465508|NCT02412722|8507904|P4|Overall Study|Received drug in run-in and discontinued|0
2465509|NCT02412722|8507905|P3|Overall Study|Received drug in run-in and discontinued|0
2465510|NCT02412722|8507906|P2|Overall Study|Received drug in run-in and discontinued|2
2465511|NCT02412722|8507907|P1|Overall Study|Received drug in run-in and discontinued|0
2465512|NCT02412722|8507902|P6|Overall Study|Lost to Follow-up|0
2465513|NCT02412722|8507903|P5|Overall Study|Lost to Follow-up|1
2465514|NCT02412722|8507904|P4|Overall Study|Lost to Follow-up|0
2465515|NCT02412722|8507905|P3|Overall Study|Lost to Follow-up|0
2465516|NCT02412722|8507906|P2|Overall Study|Lost to Follow-up|0
2465517|NCT02412722|8507907|P1|Overall Study|Lost to Follow-up|0
2465518|NCT02412722|8507902|P6|Overall Study|Withdrawal by Subject|1
2465519|NCT02412722|8507903|P5|Overall Study|Withdrawal by Subject|1
2465520|NCT02412722|8507904|P4|Overall Study|Withdrawal by Subject|2
2465521|NCT02412722|8507905|P3|Overall Study|Withdrawal by Subject|1
2465522|NCT02412722|8507906|P2|Overall Study|Withdrawal by Subject|0
2465523|NCT02412722|8507907|P1|Overall Study|Withdrawal by Subject|2
2465524|NCT02412722|8507902|P6|Overall Study|Progressive Disease|3
2465525|NCT02412722|8507903|P5|Overall Study|Progressive Disease|3
2465526|NCT02412722|8507904|P4|Overall Study|Progressive Disease|9
2465527|NCT02412722|8507905|P3|Overall Study|Progressive Disease|4
2465528|NCT02412722|8507906|P2|Overall Study|Progressive Disease|4
2465529|NCT02412722|8507907|P1|Overall Study|Progressive Disease|6
2465530|NCT02412722|8507902|P6|Overall Study|Adverse Event|3
2465531|NCT02412722|8507903|P5|Overall Study|Adverse Event|0
2465532|NCT02412722|8507904|P4|Overall Study|Adverse Event|3
2465533|NCT02412722|8507905|P3|Overall Study|Adverse Event|0
2465534|NCT02412722|8507906|P2|Overall Study|Adverse Event|2
2465535|NCT02412722|8507907|P1|Overall Study|Adverse Event|0
2465536|NCT02412657|8507978|P3|Overall Study|Protocol Violation|3
2465537|NCT02412657|8507979|P2|Overall Study|Protocol Violation|2
2465538|NCT02412657|8507980|P1|Overall Study|Protocol Violation|0
2465539|NCT02412657|8507978|P3|Overall Study|Lost to Follow-up|0
2465540|NCT02412657|8507979|P2|Overall Study|Lost to Follow-up|0
2465541|NCT02412657|8507980|P1|Overall Study|Lost to Follow-up|1
2465542|NCT02412488|8508024|P1|Overall Study|Reveal LINQ explant|1
2465543|NCT02412488|8508024|P1|Overall Study|No Reveal LINQ Insertion Attempt|1
2465544|NCT02412488|8508024|P1|Overall Study|Physician Decision|1
2465545|NCT02412488|8508024|P1|Overall Study|Withdrawal by Subject|5
2465546|NCT02412488|8508024|P1|Overall Study|Lost to Follow-up|10
2465547|NCT02412436|8508028|P1|Overall Study|Not Willing to Adhere to Requirements|1
2465548|NCT02412436|8508028|P1|Overall Study|Death|1
2465549|NCT02412436|8508028|P1|Overall Study|Unable to get to clinic|3
2465550|NCT02412436|8508028|P1|Overall Study|Lost to Follow-up|6
2465551|NCT02412436|8508028|P1|Overall Study|Protocol-mandated Discontinuation|7
2465552|NCT02412306|8508047|P5|Overall Study|Death|2
2465553|NCT02412306|8508048|P4|Overall Study|Death|0
2465554|NCT02412306|8508049|P3|Overall Study|Death|15
2465555|NCT02412306|8508050|P2|Overall Study|Death|7
2465556|NCT02412306|8508051|P1|Overall Study|Death|5
2465557|NCT02412306|8508047|P5|Overall Study|Withdrawal by Subject|0
2465558|NCT02412306|8508048|P4|Overall Study|Withdrawal by Subject|0
2465559|NCT02412306|8508049|P3|Overall Study|Withdrawal by Subject|1
2465560|NCT02412306|8508050|P2|Overall Study|Withdrawal by Subject|0
2465561|NCT02412306|8508051|P1|Overall Study|Withdrawal by Subject|0
2465562|NCT02412306|8508047|P5|Overall Study|Lost to Follow-up|0
2465563|NCT02412306|8508048|P4|Overall Study|Lost to Follow-up|0
2465564|NCT02412306|8508049|P3|Overall Study|Lost to Follow-up|0
2465565|NCT02412306|8508050|P2|Overall Study|Lost to Follow-up|1
2465566|NCT02412306|8508051|P1|Overall Study|Lost to Follow-up|0
2465567|NCT02412111|8508113|P3|Active Comparator Period (8 Weeks)|Other|2
2465568|NCT02412111|8508114|P2|Active Comparator Period (8 Weeks)|Other|0
2465569|NCT02412111|8508115|P1|Active Comparator Period (8 Weeks)|Other|0
2465570|NCT02412111|8508113|P3|Active Comparator Period (8 Weeks)|Other non-compliance|0
2465571|NCT02412111|8508114|P2|Active Comparator Period (8 Weeks)|Other non-compliance|1
2465572|NCT02412111|8508115|P1|Active Comparator Period (8 Weeks)|Other non-compliance|0
2465573|NCT02412111|8508113|P3|Active Comparator Period (8 Weeks)|Lost to Follow-up|1
2465574|NCT02412111|8508114|P2|Active Comparator Period (8 Weeks)|Lost to Follow-up|0
2465575|NCT02412111|8508115|P1|Active Comparator Period (8 Weeks)|Lost to Follow-up|0
2465576|NCT02412111|8508113|P3|Active Comparator Period (8 Weeks)|Participants refused further dosing|1
2465577|NCT02412111|8508114|P2|Active Comparator Period (8 Weeks)|Participants refused further dosing|0
2465578|NCT02412111|8508115|P1|Active Comparator Period (8 Weeks)|Participants refused further dosing|0
2465579|NCT02412111|8508113|P3|Active Comparator Period (8 Weeks)|Adverse Event|2
2465580|NCT02412111|8508114|P2|Active Comparator Period (8 Weeks)|Adverse Event|0
2465581|NCT02412111|8508115|P1|Active Comparator Period (8 Weeks)|Adverse Event|0
2465582|NCT02412111|8508113|P3|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0
2465583|NCT02412111|8508114|P2|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0
2465584|NCT02412111|8508115|P1|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2
2465585|NCT02412111|8508113|P3|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0
2465586|NCT02412111|8508114|P2|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0
2465587|NCT02412111|8508115|P1|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1
2465588|NCT02411747|8508198|P2|Overall Study|Protocol Violation|4
2465589|NCT02411747|8508199|P1|Overall Study|Protocol Violation|2
2465590|NCT02411747|8508198|P2|Overall Study|Withdrawal by Subject|0
2465591|NCT02411747|8508199|P1|Overall Study|Withdrawal by Subject|1
2465592|NCT02411578|8508214|P2|Crossover Trial Phase|Pregnancy|1
2465593|NCT02411578|8508215|P1|Crossover Trial Phase|Pregnancy|0
2465594|NCT02411539|8508272|P2|Overall Study|Confounding medical condition|1
2465595|NCT02411539|8508273|P1|Overall Study|Confounding medical condition|0
2465596|NCT02411539|8508272|P2|Overall Study|Lost to Follow-up|0
2465597|NCT02411539|8508273|P1|Overall Study|Lost to Follow-up|2
2465598|NCT02411448|8508364|P3|Overall Study|Alive on study treatment|43
2465599|NCT02411448|8508365|P2|Overall Study|Alive on study treatment|64
2465600|NCT02411448|8508366|P1|Overall Study|Alive on study treatment|3
2465601|NCT02411448|8508364|P3|Overall Study|Did not receive study treatment|0
2465602|NCT02411448|8508365|P2|Overall Study|Did not receive study treatment|3
2465603|NCT02411448|8508366|P1|Overall Study|Did not receive study treatment|0
2465604|NCT02411448|8508364|P3|Overall Study|Other|0
2465605|NCT02411448|8508365|P2|Overall Study|Other|2
2465606|NCT02411448|8508366|P1|Overall Study|Other|0
2465607|NCT02411448|8508364|P3|Overall Study|Withdrawal by Subject|9
2465608|NCT02411448|8508365|P2|Overall Study|Withdrawal by Subject|14
2465609|NCT02411448|8508366|P1|Overall Study|Withdrawal by Subject|1
2465610|NCT02411396|8508395|P1|Overall Study|Death|10
2465611|NCT02411396|8508395|P1|Overall Study|Lost to Follow-up|31
2465612|NCT02411292|8508408|P1|Overall Study|Lost to Follow-up|3
2465613|NCT02411292|8508408|P1|Overall Study|Death|2
2465614|NCT02411292|8508408|P1|Overall Study|Discharged before 3rd enoxaparin dose|16
2465615|NCT02411201|8508414|P1|Overall Study|Age group completed|2
2465616|NCT02411201|8508414|P1|Overall Study|Withdrawal by Subject|2
2465617|NCT02411201|8508414|P1|Overall Study|Adverse Event|2
2465618|NCT02411110|8508427|P2|Treatment Period 2|Personal Reasons|2
2465619|NCT02411110|8508428|P1|Treatment Period 2|Personal Reasons|0
2465620|NCT02411110|8508427|P2|Treatment Period 2|Lost to Follow-up|2
2465621|NCT02411110|8508428|P1|Treatment Period 2|Lost to Follow-up|0
2465622|NCT02411110|8508427|P2|Treatment Period 2|Adverse Event|0
2465623|NCT02411110|8508428|P1|Treatment Period 2|Adverse Event|1
2465624|NCT02411110|8508427|P2|Treatment Period 1|Other Miscellaneous Reasons|0
2465625|NCT02411110|8508428|P1|Treatment Period 1|Other Miscellaneous Reasons|2
2465626|NCT02411110|8508427|P2|Treatment Period 1|Personal Reasons|5
2465627|NCT02411110|8508428|P1|Treatment Period 1|Personal Reasons|2
2465628|NCT02411110|8508427|P2|Treatment Period 1|Lost to Follow-up|0
2465629|NCT02411110|8508428|P1|Treatment Period 1|Lost to Follow-up|1
2465630|NCT02411110|8508427|P2|Treatment Period 1|Adverse Event|2
2465631|NCT02411110|8508428|P1|Treatment Period 1|Adverse Event|4
2465632|NCT02411084|8508438|P2|Overall Study|Other reasons|5
2465633|NCT02411084|8508439|P1|Overall Study|Other reasons|0
2465634|NCT02411084|8508438|P2|Overall Study|Adverse Event|1
2465635|NCT02411084|8508439|P1|Overall Study|Adverse Event|2
2465636|NCT02411084|8508438|P2|Overall Study|Death|4
2465637|NCT02411084|8508439|P1|Overall Study|Death|5
2465638|NCT02411084|8508438|P2|Overall Study|Lack of Efficacy|3
2465639|NCT02411084|8508439|P1|Overall Study|Lack of Efficacy|6
2465640|NCT02410824|8508471|P2|First Intervention (One Week)|Headache|1
2465641|NCT02410824|8508472|P1|First Intervention (One Week)|Headache|0
2465642|NCT02410629|8508517|P2|Overall Study|Subject underwent heart surgery|1
2465643|NCT02410629|8508518|P1|Overall Study|Subject underwent heart surgery|0
2465644|NCT02410629|8508517|P2|Overall Study|Subject moved back to home country|1
2465645|NCT02410629|8508518|P1|Overall Study|Subject moved back to home country|0
2465646|NCT02410629|8508517|P2|Overall Study|Subject returned to work|0
2465647|NCT02410629|8508518|P1|Overall Study|Subject returned to work|1
2465648|NCT02410629|8508517|P2|Overall Study|Family cannot commit to the study|1
2465649|NCT02410629|8508518|P1|Overall Study|Family cannot commit to the study|2
2465650|NCT02410551|8508534|P1|Overall Study|FDA Clinical hold-patients taken off|2
2465651|NCT02410551|8508534|P1|Overall Study|Withdrawal by Subject|1
2465652|NCT02410551|8508534|P1|Overall Study|Adverse Event|1
2465653|NCT02410343|8508552|P2|Extension Period (12 Months)|Early termination of study by sponsor|1
2465654|NCT02410343|8508553|P1|Extension Period (12 Months)|Early termination of study by sponsor|0
2465655|NCT02410343|8508552|P2|Extension Period (12 Months)|Adverse Event|0
2465656|NCT02410343|8508553|P1|Extension Period (12 Months)|Adverse Event|1
2465657|NCT02410343|8508552|P2|Core Period (24 Weeks)|Early termination of study by sponsor|7
2465658|NCT02410343|8508553|P1|Core Period (24 Weeks)|Early termination of study by sponsor|4
2465659|NCT02410343|8508552|P2|Core Period (24 Weeks)|Adverse Event|0
2465660|NCT02410343|8508553|P1|Core Period (24 Weeks)|Adverse Event|1
2465661|NCT02410278|8508599|P3|Study Treatment Period|GSRS Threshold Not Met|0
2465662|NCT02410278|8508600|P2|Study Treatment Period|GSRS Threshold Not Met|1
2465663|NCT02410278|8508601|P1|Study Treatment Period|GSRS Threshold Not Met|0
2465664|NCT02410278|8508599|P3|Study Treatment Period|Other|0
2465665|NCT02410278|8508600|P2|Study Treatment Period|Other|3
2465666|NCT02410278|8508601|P1|Study Treatment Period|Other|0
2465667|NCT02410278|8508599|P3|Study Treatment Period|Withdrawal by Subject|0
2465668|NCT02410278|8508600|P2|Study Treatment Period|Withdrawal by Subject|1
2465669|NCT02410278|8508601|P1|Study Treatment Period|Withdrawal by Subject|0
2465670|NCT02410278|8508599|P3|Study Treatment Period|Physician Decision|1
2465671|NCT02410278|8508600|P2|Study Treatment Period|Physician Decision|0
2465672|NCT02410278|8508601|P1|Study Treatment Period|Physician Decision|0
2465673|NCT02410278|8508599|P3|Study Treatment Period|Adverse Event|3
2465674|NCT02410278|8508600|P2|Study Treatment Period|Adverse Event|6
2465675|NCT02410278|8508601|P1|Study Treatment Period|Adverse Event|0
2465676|NCT02410278|8508599|P3|Run-in Period|Pregnancy|0
2465677|NCT02410278|8508600|P2|Run-in Period|Pregnancy|0
2465678|NCT02410278|8508601|P1|Run-in Period|Pregnancy|1
2465679|NCT02410278|8508599|P3|Run-in Period|Withdrawal by Subject|0
2465680|NCT02410278|8508600|P2|Run-in Period|Withdrawal by Subject|0
2465681|NCT02410278|8508601|P1|Run-in Period|Withdrawal by Subject|1
2465682|NCT02410278|8508599|P3|Run-in Period|Lost to Follow-up|0
2465683|NCT02410278|8508600|P2|Run-in Period|Lost to Follow-up|0
2465684|NCT02410278|8508601|P1|Run-in Period|Lost to Follow-up|1
2465685|NCT02410278|8508599|P3|Run-in Period|GSRS Threshold Not Met|0
2465686|NCT02410278|8508600|P2|Run-in Period|GSRS Threshold Not Met|0
2465687|NCT02410278|8508601|P1|Run-in Period|GSRS Threshold Not Met|30
2465688|NCT02410278|8508599|P3|Run-in Period|Adverse Event|0
2465689|NCT02410278|8508600|P2|Run-in Period|Adverse Event|0
2465690|NCT02410278|8508601|P1|Run-in Period|Adverse Event|5
2465691|NCT02410252|8508626|P1|Overall Study|Physician Decision|2
2465692|NCT02410252|8508626|P1|Overall Study|Withdrawal by Subject|4
2465693|NCT02410200|8508639|P1|Overall Study|Adverse Event|2
2465694|NCT02409732|8508709|P1|Overall Study|Lost to Follow-up|2
2465695|NCT02409732|8508709|P1|Overall Study|Withdrawal by Subject|4
2465696|NCT02409719|8508719|P2|Overall Study|Lost to Follow-up|3
2465697|NCT02409719|8508720|P1|Overall Study|Lost to Follow-up|3
2465698|NCT02409667|8508730|P5|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
2465699|NCT02409667|8508731|P4|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
2465700|NCT02409667|8508732|P3|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3
2465701|NCT02409667|8508733|P2|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
2465702|NCT02409667|8508734|P1|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
2465703|NCT02409667|8508730|P5|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1
2465704|NCT02409667|8508731|P4|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
2465705|NCT02409667|8508732|P3|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1
2465706|NCT02409667|8508733|P2|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
2465707|NCT02409667|8508734|P1|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
2465708|NCT02409667|8508730|P5|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0
2465709|NCT02409667|8508731|P4|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2
2465710|NCT02409667|8508732|P3|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5
2465711|NCT02409667|8508733|P2|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4
2465712|NCT02409667|8508734|P1|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0
2465713|NCT02409667|8508730|P5|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
2465714|NCT02409667|8508731|P4|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
2465715|NCT02409667|8508732|P3|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4
2465716|NCT02409667|8508733|P2|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5
2465717|NCT02409667|8508734|P1|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
2465718|NCT02409667|8508730|P5|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2
2465719|NCT02409667|8508731|P4|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1
2465720|NCT02409667|8508732|P3|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4
2465721|NCT02409667|8508733|P2|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7
2465722|NCT02409667|8508734|P1|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0
2465723|NCT02409667|8508730|P5|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
2465724|NCT02409667|8508731|P4|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2
2465725|NCT02409667|8508732|P3|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
2465726|NCT02409667|8508733|P2|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
2465727|NCT02409667|8508734|P1|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
2465728|NCT02409667|8508730|P5|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0
2465729|NCT02409667|8508731|P4|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3
2465730|NCT02409667|8508732|P3|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4
2465731|NCT02409667|8508733|P2|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7
2465732|NCT02409667|8508734|P1|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0
2465733|NCT02409667|8508730|P5|Treatment Period 1, Baseline to Week 24|Adverse Event|0
2465734|NCT02409667|8508731|P4|Treatment Period 1, Baseline to Week 24|Adverse Event|0
2465735|NCT02409667|8508732|P3|Treatment Period 1, Baseline to Week 24|Adverse Event|0
2465736|NCT02409667|8508733|P2|Treatment Period 1, Baseline to Week 24|Adverse Event|0
2465737|NCT02409667|8508734|P1|Treatment Period 1, Baseline to Week 24|Adverse Event|25
2465738|NCT02409667|8508730|P5|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
2465739|NCT02409667|8508731|P4|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
2465740|NCT02409667|8508732|P3|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
2465741|NCT02409667|8508733|P2|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
2465742|NCT02409667|8508734|P1|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48
2465743|NCT02409667|8508730|P5|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
2465744|NCT02409667|8508731|P4|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
2465745|NCT02409667|8508732|P3|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
2465746|NCT02409667|8508733|P2|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
2465747|NCT02409667|8508734|P1|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6
2465748|NCT02409667|8508730|P5|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
2465749|NCT02409667|8508731|P4|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
2465750|NCT02409667|8508732|P3|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
2465751|NCT02409667|8508733|P2|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
2465752|NCT02409667|8508734|P1|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5
2465753|NCT02409667|8508730|P5|Treatment Period 1, Baseline to Week 24|Physician Decision|0
2465754|NCT02409667|8508731|P4|Treatment Period 1, Baseline to Week 24|Physician Decision|0
2465755|NCT02409667|8508732|P3|Treatment Period 1, Baseline to Week 24|Physician Decision|0
2465756|NCT02409667|8508733|P2|Treatment Period 1, Baseline to Week 24|Physician Decision|0
2465757|NCT02409667|8508734|P1|Treatment Period 1, Baseline to Week 24|Physician Decision|4
2465758|NCT02409667|8508730|P5|Treatment Period 1, Baseline to Week 24|Pregnancy|0
2465759|NCT02409667|8508731|P4|Treatment Period 1, Baseline to Week 24|Pregnancy|0
2465760|NCT02409667|8508732|P3|Treatment Period 1, Baseline to Week 24|Pregnancy|0
2465761|NCT02409667|8508733|P2|Treatment Period 1, Baseline to Week 24|Pregnancy|0
2465762|NCT02409667|8508734|P1|Treatment Period 1, Baseline to Week 24|Pregnancy|1
2465763|NCT02409667|8508730|P5|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
2465764|NCT02409667|8508731|P4|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
2465765|NCT02409667|8508732|P3|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
2465766|NCT02409667|8508733|P2|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
2465767|NCT02409667|8508734|P1|Treatment Period 1, Baseline to Week 24|Protocol deviation|20
2465768|NCT02409667|8508730|P5|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
2465769|NCT02409667|8508731|P4|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
2465770|NCT02409667|8508732|P3|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
2465771|NCT02409667|8508733|P2|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
2465772|NCT02409667|8508734|P1|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6
2465773|NCT02409667|8508730|P5|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
2465774|NCT02409667|8508731|P4|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
2465775|NCT02409667|8508732|P3|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
2465776|NCT02409667|8508733|P2|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
2465777|NCT02409667|8508734|P1|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6
2465778|NCT02409355|8508796|P2|Overall Study|Study terminated by Sponsor|3
2465779|NCT02409355|8508797|P1|Overall Study|Study terminated by Sponsor|2
2465780|NCT02409355|8508796|P2|Overall Study|Death|1
2465781|NCT02409355|8508797|P1|Overall Study|Death|1
2465782|NCT02409355|8508796|P2|Overall Study|Withdrawal by Subject|0
2465783|NCT02409355|8508797|P1|Overall Study|Withdrawal by Subject|1
2465784|NCT02408523|8508889|P2|Overall Study|Did not satisfy extension conditions|1
2465785|NCT02408523|8508890|P1|Overall Study|Did not satisfy extension conditions|0
2465786|NCT02408523|8508889|P2|Overall Study|Sponsor request|0
2465787|NCT02408523|8508890|P1|Overall Study|Sponsor request|1
2465788|NCT02408523|8508889|P2|Overall Study|Withdrawal by Subject|1
2465789|NCT02408523|8508890|P1|Overall Study|Withdrawal by Subject|3
2465790|NCT02408523|8508889|P2|Overall Study|Lost to Follow-up|3
2465791|NCT02408523|8508890|P1|Overall Study|Lost to Follow-up|2
2465792|NCT02408523|8508889|P2|Overall Study|Protocol Violation|2
2465793|NCT02408523|8508890|P1|Overall Study|Protocol Violation|1
2465794|NCT02408523|8508889|P2|Overall Study|Lack of Efficacy|1
2465795|NCT02408523|8508890|P1|Overall Study|Lack of Efficacy|0
2465796|NCT02408523|8508889|P2|Overall Study|Adverse Event|10
2465797|NCT02408523|8508890|P1|Overall Study|Adverse Event|4
2465798|NCT02408068|8508975|P6|Treatment 3 (1.5 Days)|Adverse Event|0
2465799|NCT02408068|8508976|P5|Treatment 3 (1.5 Days)|Adverse Event|0
2465800|NCT02408068|8508977|P4|Treatment 3 (1.5 Days)|Adverse Event|0
2465801|NCT02408068|8508978|P3|Treatment 3 (1.5 Days)|Adverse Event|1
2465802|NCT02408068|8508979|P2|Treatment 3 (1.5 Days)|Adverse Event|0
2465803|NCT02408068|8508980|P1|Treatment 3 (1.5 Days)|Adverse Event|0
2465804|NCT02407704|8509007|P4|Overall Study|Withdrawal by Subject|0
2465805|NCT02407704|8509008|P3|Overall Study|Withdrawal by Subject|1
2465806|NCT02407704|8509009|P2|Overall Study|Withdrawal by Subject|0
2465807|NCT02407704|8509010|P1|Overall Study|Withdrawal by Subject|0
2465808|NCT02407704|8509007|P4|Overall Study|Protocol Violation|1
2465809|NCT02407704|8509008|P3|Overall Study|Protocol Violation|0
2465810|NCT02407704|8509009|P2|Overall Study|Protocol Violation|0
2465811|NCT02407704|8509010|P1|Overall Study|Protocol Violation|0
2465812|NCT02407704|8509007|P4|Overall Study|Lost to Follow-up|2
2465813|NCT02407704|8509008|P3|Overall Study|Lost to Follow-up|0
2465814|NCT02407704|8509009|P2|Overall Study|Lost to Follow-up|0
2465815|NCT02407704|8509010|P1|Overall Study|Lost to Follow-up|0
2465816|NCT02407249|8509044|P1|Overall Study|Not treated|13
2465817|NCT02407249|8509044|P1|Overall Study|Did not complete 12-month follow-up|13
2465818|NCT02407236|8509060|P8|Maintenance Study (44 Weeks)|Other|1
2465819|NCT02407236|8509061|P7|Maintenance Study (44 Weeks)|Other|2
2465820|NCT02407236|8509062|P6|Maintenance Study (44 Weeks)|Other|1
2465821|NCT02407236|8509063|P5|Maintenance Study (44 Weeks)|Other|1
2465822|NCT02407236|8509064|P4|Maintenance Study (44 Weeks)|Other|0
2465823|NCT02407236|8509065|P3|Maintenance Study (44 Weeks)|Other|0
2465824|NCT02407236|8509066|P2|Maintenance Study (44 Weeks)|Other|0
2465825|NCT02407236|8509067|P1|Maintenance Study (44 Weeks)|Other|0
2465826|NCT02407236|8509060|P8|Maintenance Study (44 Weeks)|Sponsor decision|0
2465827|NCT02407236|8509061|P7|Maintenance Study (44 Weeks)|Sponsor decision|0
2465828|NCT02407236|8509062|P6|Maintenance Study (44 Weeks)|Sponsor decision|1
2465829|NCT02407236|8509063|P5|Maintenance Study (44 Weeks)|Sponsor decision|0
2465830|NCT02407236|8509064|P4|Maintenance Study (44 Weeks)|Sponsor decision|1
2465831|NCT02407236|8509065|P3|Maintenance Study (44 Weeks)|Sponsor decision|0
2465832|NCT02407236|8509066|P2|Maintenance Study (44 Weeks)|Sponsor decision|0
2465833|NCT02407236|8509067|P1|Maintenance Study (44 Weeks)|Sponsor decision|0
2465834|NCT02407236|8509060|P8|Maintenance Study (44 Weeks)|Withdraw of consent|5
2465835|NCT02407236|8509061|P7|Maintenance Study (44 Weeks)|Withdraw of consent|7
2465836|NCT02407236|8509062|P6|Maintenance Study (44 Weeks)|Withdraw of consent|5
2465837|NCT02407236|8509063|P5|Maintenance Study (44 Weeks)|Withdraw of consent|10
2465838|NCT02407236|8509064|P4|Maintenance Study (44 Weeks)|Withdraw of consent|8
2465839|NCT02407236|8509065|P3|Maintenance Study (44 Weeks)|Withdraw of consent|0
2465840|NCT02407236|8509066|P2|Maintenance Study (44 Weeks)|Withdraw of consent|0
2465841|NCT02407236|8509067|P1|Maintenance Study (44 Weeks)|Withdraw of consent|0
2465842|NCT02407236|8509060|P8|Maintenance Study (44 Weeks)|Death|1
2465843|NCT02407236|8509061|P7|Maintenance Study (44 Weeks)|Death|0
2465844|NCT02407236|8509062|P6|Maintenance Study (44 Weeks)|Death|0
2465845|NCT02407236|8509063|P5|Maintenance Study (44 Weeks)|Death|0
2465846|NCT02407236|8509064|P4|Maintenance Study (44 Weeks)|Death|0
2465847|NCT02407236|8509065|P3|Maintenance Study (44 Weeks)|Death|0
2465848|NCT02407236|8509066|P2|Maintenance Study (44 Weeks)|Death|0
2465849|NCT02407236|8509067|P1|Maintenance Study (44 Weeks)|Death|0
2465850|NCT02407236|8509060|P8|Maintenance Study (44 Weeks)|Lost to Follow-up|1
2465851|NCT02407236|8509061|P7|Maintenance Study (44 Weeks)|Lost to Follow-up|0
2465852|NCT02407236|8509062|P6|Maintenance Study (44 Weeks)|Lost to Follow-up|1
2465853|NCT02407236|8509063|P5|Maintenance Study (44 Weeks)|Lost to Follow-up|0
2465854|NCT02407236|8509064|P4|Maintenance Study (44 Weeks)|Lost to Follow-up|1
2465855|NCT02407236|8509065|P3|Maintenance Study (44 Weeks)|Lost to Follow-up|0
2465856|NCT02407236|8509066|P2|Maintenance Study (44 Weeks)|Lost to Follow-up|0
2465857|NCT02407236|8509067|P1|Maintenance Study (44 Weeks)|Lost to Follow-up|0
2465858|NCT02407236|8509060|P8|Induction Study (8 Weeks)|Other|0
2465859|NCT02407236|8509061|P7|Induction Study (8 Weeks)|Other|0
2465860|NCT02407236|8509062|P6|Induction Study (8 Weeks)|Other|0
2465861|NCT02407236|8509063|P5|Induction Study (8 Weeks)|Other|0
2465862|NCT02407236|8509064|P4|Induction Study (8 Weeks)|Other|0
2465863|NCT02407236|8509065|P3|Induction Study (8 Weeks)|Other|5
2465864|NCT02407236|8509066|P2|Induction Study (8 Weeks)|Other|1
2465865|NCT02407236|8509067|P1|Induction Study (8 Weeks)|Other|2
2465866|NCT02407236|8509060|P8|Induction Study (8 Weeks)|Physician Decision|0
2465867|NCT02407236|8509061|P7|Induction Study (8 Weeks)|Physician Decision|0
2465868|NCT02407236|8509062|P6|Induction Study (8 Weeks)|Physician Decision|0
2465869|NCT02407236|8509063|P5|Induction Study (8 Weeks)|Physician Decision|0
2465870|NCT02407236|8509064|P4|Induction Study (8 Weeks)|Physician Decision|0
2465871|NCT02407236|8509065|P3|Induction Study (8 Weeks)|Physician Decision|0
2465872|NCT02407236|8509066|P2|Induction Study (8 Weeks)|Physician Decision|1
2465873|NCT02407236|8509067|P1|Induction Study (8 Weeks)|Physician Decision|1
2465874|NCT02407236|8509060|P8|Induction Study (8 Weeks)|Lost to Follow-up|0
2465875|NCT02407236|8509061|P7|Induction Study (8 Weeks)|Lost to Follow-up|0
2465876|NCT02407236|8509062|P6|Induction Study (8 Weeks)|Lost to Follow-up|0
2465877|NCT02407236|8509063|P5|Induction Study (8 Weeks)|Lost to Follow-up|0
2465878|NCT02407236|8509064|P4|Induction Study (8 Weeks)|Lost to Follow-up|0
2465879|NCT02407236|8509065|P3|Induction Study (8 Weeks)|Lost to Follow-up|1
2465880|NCT02407236|8509066|P2|Induction Study (8 Weeks)|Lost to Follow-up|0
2465881|NCT02407236|8509067|P1|Induction Study (8 Weeks)|Lost to Follow-up|0
2465882|NCT02407236|8509060|P8|Induction Study (8 Weeks)|Withdrawal by Subject|0
2465883|NCT02407236|8509061|P7|Induction Study (8 Weeks)|Withdrawal by Subject|0
2465884|NCT02407236|8509062|P6|Induction Study (8 Weeks)|Withdrawal by Subject|0
2465885|NCT02407236|8509063|P5|Induction Study (8 Weeks)|Withdrawal by Subject|0
2465886|NCT02407236|8509064|P4|Induction Study (8 Weeks)|Withdrawal by Subject|0
2465887|NCT02407236|8509065|P3|Induction Study (8 Weeks)|Withdrawal by Subject|7
2465888|NCT02407236|8509066|P2|Induction Study (8 Weeks)|Withdrawal by Subject|9
2465889|NCT02407236|8509067|P1|Induction Study (8 Weeks)|Withdrawal by Subject|17
2465890|NCT02407236|8509060|P8|Induction Study (8 Weeks)|Death|0
2465891|NCT02407236|8509061|P7|Induction Study (8 Weeks)|Death|0
2465892|NCT02407236|8509062|P6|Induction Study (8 Weeks)|Death|0
2465893|NCT02407236|8509063|P5|Induction Study (8 Weeks)|Death|0
2465894|NCT02407236|8509064|P4|Induction Study (8 Weeks)|Death|0
2465895|NCT02407236|8509065|P3|Induction Study (8 Weeks)|Death|1
2465896|NCT02407236|8509066|P2|Induction Study (8 Weeks)|Death|0
2465897|NCT02407236|8509067|P1|Induction Study (8 Weeks)|Death|0
2465898|NCT02407236|8509060|P8|Induction Study (8 Weeks)|Adverse Event|0
2465899|NCT02407236|8509061|P7|Induction Study (8 Weeks)|Adverse Event|0
2465900|NCT02407236|8509062|P6|Induction Study (8 Weeks)|Adverse Event|0
2465901|NCT02407236|8509063|P5|Induction Study (8 Weeks)|Adverse Event|0
2465902|NCT02407236|8509064|P4|Induction Study (8 Weeks)|Adverse Event|0
2465903|NCT02407236|8509065|P3|Induction Study (8 Weeks)|Adverse Event|1
2465904|NCT02407236|8509066|P2|Induction Study (8 Weeks)|Adverse Event|0
2465905|NCT02407236|8509067|P1|Induction Study (8 Weeks)|Adverse Event|3
2465906|NCT02407223|8509307|P3|Overall Study|Other|25
2465907|NCT02407223|8509308|P2|Overall Study|Other|27
2465908|NCT02407223|8509309|P1|Overall Study|Other|29
2465909|NCT02407223|8509307|P3|Overall Study|Subject Refused Further Study Treatment|0
2465910|NCT02407223|8509308|P2|Overall Study|Subject Refused Further Study Treatment|1
2465911|NCT02407223|8509309|P1|Overall Study|Subject Refused Further Study Treatment|0
2465912|NCT02407223|8509307|P3|Overall Study|Study Terminated by Sponsor|86
2465913|NCT02407223|8509308|P2|Overall Study|Study Terminated by Sponsor|80
2465914|NCT02407223|8509309|P1|Overall Study|Study Terminated by Sponsor|77
2465915|NCT02407223|8509307|P3|Overall Study|Withdrawal by Subject|4
2465916|NCT02407223|8509308|P2|Overall Study|Withdrawal by Subject|4
2465917|NCT02407223|8509309|P1|Overall Study|Withdrawal by Subject|2
2465918|NCT02407223|8509307|P3|Overall Study|Lost to Follow-up|2
2465919|NCT02407223|8509308|P2|Overall Study|Lost to Follow-up|0
2465920|NCT02407223|8509309|P1|Overall Study|Lost to Follow-up|1
2465921|NCT02407223|8509307|P3|Overall Study|Lack of Efficacy|4
2465922|NCT02407223|8509308|P2|Overall Study|Lack of Efficacy|6
2465923|NCT02407223|8509309|P1|Overall Study|Lack of Efficacy|6
2465924|NCT02407223|8509307|P3|Overall Study|Adverse Event|1
2465925|NCT02407223|8509308|P2|Overall Study|Adverse Event|0
2465926|NCT02407223|8509309|P1|Overall Study|Adverse Event|1
2465927|NCT02406677|8509442|P2|Overall Study|Withdrawal by Subject|0
2465928|NCT02406677|8509443|P1|Overall Study|Withdrawal by Subject|1
2465929|NCT02406677|8509442|P2|Overall Study|Discharged on prasugrel|587
2465930|NCT02406677|8509443|P1|Overall Study|Discharged on prasugrel|283
2465931|NCT02406677|8509442|P2|Overall Study|Discharged without P2Y12|3
2465932|NCT02406677|8509443|P1|Overall Study|Discharged without P2Y12|1
2465933|NCT02406677|8509442|P2|Overall Study|Death|8
2465934|NCT02406677|8509443|P1|Overall Study|Death|16
2465935|NCT02406612|8509457|P2|Overall Study|Guidewire Failure|1
2465936|NCT02406612|8509458|P1|Overall Study|Guidewire Failure|0
2465937|NCT02406612|8509457|P2|Overall Study|Intra-procedural Exclusion|3
2465938|NCT02406612|8509458|P1|Overall Study|Intra-procedural Exclusion|1
2465939|NCT02406612|8509457|P2|Overall Study|Screening Failure|0
2465940|NCT02406612|8509458|P1|Overall Study|Screening Failure|3
2465941|NCT02406586|8509473|P3|Overall Study|Withdrawal by Subject|0
2465942|NCT02406586|8509474|P2|Overall Study|Withdrawal by Subject|0
2465943|NCT02406586|8509475|P1|Overall Study|Withdrawal by Subject|1
2465944|NCT02406586|8509473|P3|Overall Study|Lost to Follow-up|2
2465945|NCT02406586|8509474|P2|Overall Study|Lost to Follow-up|4
2465946|NCT02406586|8509475|P1|Overall Study|Lost to Follow-up|0
2465947|NCT02406261|8509617|P2|Period 2|Withdrawal by Subject|1
2465948|NCT02406261|8509618|P1|Period 2|Withdrawal by Subject|0
2465949|NCT02406261|8509617|P2|Period 2|Protocol Violation|1
2465950|NCT02406261|8509618|P1|Period 2|Protocol Violation|0
2465951|NCT02406261|8509617|P2|Period 2|Physician Decision|1
2465952|NCT02406261|8509618|P1|Period 2|Physician Decision|0
2465953|NCT02406261|8509617|P2|Period 1|Adverse Event|0
2465954|NCT02406261|8509618|P1|Period 1|Adverse Event|1
2465955|NCT02406261|8509617|P2|Period 1|Lost to Follow-up|0
2465956|NCT02406261|8509618|P1|Period 1|Lost to Follow-up|2
2465957|NCT02406248|8509630|P1|Overall Study|Withdrawal by Subject|2
2465958|NCT02406248|8509630|P1|Overall Study|Death|7
2465959|NCT02406027|8509641|P7|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
2465960|NCT02406027|8509642|P6|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
2465961|NCT02406027|8509643|P5|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1
2465962|NCT02406027|8509644|P4|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
2465963|NCT02406027|8509645|P3|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
2465964|NCT02406027|8509646|P2|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
2465965|NCT02406027|8509647|P1|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
2465966|NCT02406027|8509641|P7|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
2465967|NCT02406027|8509642|P6|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1
2465968|NCT02406027|8509643|P5|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
2465969|NCT02406027|8509644|P4|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
2465970|NCT02406027|8509645|P3|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
2465971|NCT02406027|8509646|P2|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
2465972|NCT02406027|8509647|P1|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
2465973|NCT02406027|8509641|P7|Open-label Phase (Period 2)|Study Terminated by Sponsor|19
2465974|NCT02406027|8509642|P6|Open-label Phase (Period 2)|Study Terminated by Sponsor|24
2465975|NCT02406027|8509643|P5|Open-label Phase (Period 2)|Study Terminated by Sponsor|7
2465976|NCT02406027|8509644|P4|Open-label Phase (Period 2)|Study Terminated by Sponsor|11
2465977|NCT02406027|8509645|P3|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
2465978|NCT02406027|8509646|P2|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
2465979|NCT02406027|8509647|P1|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
2465980|NCT02406027|8509641|P7|Open-label Phase (Period 2)|Withdrawal by Subject|2
2465981|NCT02406027|8509642|P6|Open-label Phase (Period 2)|Withdrawal by Subject|0
2465982|NCT02406027|8509643|P5|Open-label Phase (Period 2)|Withdrawal by Subject|4
2465983|NCT02406027|8509644|P4|Open-label Phase (Period 2)|Withdrawal by Subject|2
2465984|NCT02406027|8509645|P3|Open-label Phase (Period 2)|Withdrawal by Subject|0
2465985|NCT02406027|8509646|P2|Open-label Phase (Period 2)|Withdrawal by Subject|0
2465986|NCT02406027|8509647|P1|Open-label Phase (Period 2)|Withdrawal by Subject|0
2465987|NCT02406027|8509641|P7|Open-label Phase (Period 2)|Physician Decision|1
2465988|NCT02406027|8509642|P6|Open-label Phase (Period 2)|Physician Decision|1
2465989|NCT02406027|8509643|P5|Open-label Phase (Period 2)|Physician Decision|0
2465990|NCT02406027|8509644|P4|Open-label Phase (Period 2)|Physician Decision|0
2465991|NCT02406027|8509645|P3|Open-label Phase (Period 2)|Physician Decision|0
2465992|NCT02406027|8509646|P2|Open-label Phase (Period 2)|Physician Decision|0
2465993|NCT02406027|8509647|P1|Open-label Phase (Period 2)|Physician Decision|0
2465994|NCT02406027|8509641|P7|Open-label Phase (Period 2)|Adverse Event|0
2465995|NCT02406027|8509642|P6|Open-label Phase (Period 2)|Adverse Event|0
2465996|NCT02406027|8509643|P5|Open-label Phase (Period 2)|Adverse Event|2
2465997|NCT02406027|8509644|P4|Open-label Phase (Period 2)|Adverse Event|2
2465998|NCT02406027|8509645|P3|Open-label Phase (Period 2)|Adverse Event|0
2465999|NCT02406027|8509646|P2|Open-label Phase (Period 2)|Adverse Event|0
2466000|NCT02406027|8509647|P1|Open-label Phase (Period 2)|Adverse Event|0
2466001|NCT02406027|8509641|P7|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
2466002|NCT02406027|8509642|P6|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
2466003|NCT02406027|8509643|P5|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
2466004|NCT02406027|8509644|P4|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
2466005|NCT02406027|8509645|P3|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1
2466006|NCT02406027|8509646|P2|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
2466007|NCT02406027|8509647|P1|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1
2466008|NCT02406027|8509641|P7|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
2466009|NCT02406027|8509642|P6|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
2466010|NCT02406027|8509643|P5|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
2466011|NCT02406027|8509644|P4|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
2466012|NCT02406027|8509645|P3|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1
2466013|NCT02406027|8509646|P2|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1
2466014|NCT02406027|8509647|P1|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2
2466015|NCT02406027|8509641|P7|Double-blind Treatment Phase (Period 1)|Physician Decision|0
2466016|NCT02406027|8509642|P6|Double-blind Treatment Phase (Period 1)|Physician Decision|0
2466017|NCT02406027|8509643|P5|Double-blind Treatment Phase (Period 1)|Physician Decision|0
2466018|NCT02406027|8509644|P4|Double-blind Treatment Phase (Period 1)|Physician Decision|0
2466019|NCT02406027|8509645|P3|Double-blind Treatment Phase (Period 1)|Physician Decision|1
2466020|NCT02406027|8509646|P2|Double-blind Treatment Phase (Period 1)|Physician Decision|0
2466021|NCT02406027|8509647|P1|Double-blind Treatment Phase (Period 1)|Physician Decision|3
2466022|NCT02406027|8509641|P7|Double-blind Treatment Phase (Period 1)|Adverse Event|0
2466023|NCT02406027|8509642|P6|Double-blind Treatment Phase (Period 1)|Adverse Event|0
2466024|NCT02406027|8509643|P5|Double-blind Treatment Phase (Period 1)|Adverse Event|0
2466025|NCT02406027|8509644|P4|Double-blind Treatment Phase (Period 1)|Adverse Event|0
2466026|NCT02406027|8509645|P3|Double-blind Treatment Phase (Period 1)|Adverse Event|1
2466027|NCT02406027|8509646|P2|Double-blind Treatment Phase (Period 1)|Adverse Event|2
2466028|NCT02406027|8509647|P1|Double-blind Treatment Phase (Period 1)|Adverse Event|0
2466029|NCT02405962|8509677|P2|Overall Study|A participant has moved to another place|1
2466030|NCT02405962|8509678|P1|Overall Study|A participant has moved to another place|0
2466031|NCT02405962|8509677|P2|Overall Study|Lost to Follow-up|4
2466032|NCT02405962|8509678|P1|Overall Study|Lost to Follow-up|1
2466033|NCT02405780|8509716|P4|Period II|Non-compliance with study procedures|4
2466034|NCT02405780|8509717|P3|Period II|Non-compliance with study procedures|7
2466035|NCT02405780|8509718|P2|Period II|Non-compliance with study procedures|2
2466036|NCT02405780|8509719|P1|Period II|Non-compliance with study procedures|5
2466037|NCT02405780|8509716|P4|Period II|Withdrawal by Subject|3
2466038|NCT02405780|8509717|P3|Period II|Withdrawal by Subject|0
2466039|NCT02405780|8509718|P2|Period II|Withdrawal by Subject|4
2466040|NCT02405780|8509719|P1|Period II|Withdrawal by Subject|7
2466041|NCT02405780|8509716|P4|Period II|Pregnancy|0
2466042|NCT02405780|8509717|P3|Period II|Pregnancy|1
2466043|NCT02405780|8509718|P2|Period II|Pregnancy|0
2466044|NCT02405780|8509719|P1|Period II|Pregnancy|0
2466045|NCT02405780|8509716|P4|Period II|Medical reason|0
2466046|NCT02405780|8509717|P3|Period II|Medical reason|0
2466047|NCT02405780|8509718|P2|Period II|Medical reason|1
2466048|NCT02405780|8509719|P1|Period II|Medical reason|0
2466049|NCT02405780|8509716|P4|Period II|Adverse Event|11
2466050|NCT02405780|8509717|P3|Period II|Adverse Event|4
2466051|NCT02405780|8509718|P2|Period II|Adverse Event|5
2466052|NCT02405780|8509719|P1|Period II|Adverse Event|3
2466053|NCT02405780|8509716|P4|Period I|Non-compliance with study procedures|11
2466054|NCT02405780|8509717|P3|Period I|Non-compliance with study procedures|8
2466055|NCT02405780|8509718|P2|Period I|Non-compliance with study procedures|6
2466056|NCT02405780|8509719|P1|Period I|Non-compliance with study procedures|8
2466057|NCT02405780|8509716|P4|Period I|Withdrawal by Subject|4
2466058|NCT02405780|8509717|P3|Period I|Withdrawal by Subject|3
2466059|NCT02405780|8509718|P2|Period I|Withdrawal by Subject|1
2466060|NCT02405780|8509719|P1|Period I|Withdrawal by Subject|9
2466061|NCT02405780|8509716|P4|Period I|Screening Failure|0
2466062|NCT02405780|8509717|P3|Period I|Screening Failure|1
2466063|NCT02405780|8509718|P2|Period I|Screening Failure|0
2466064|NCT02405780|8509719|P1|Period I|Screening Failure|1
2466065|NCT02405780|8509716|P4|Period I|Medical reasons|1
2466066|NCT02405780|8509717|P3|Period I|Medical reasons|0
2466067|NCT02405780|8509718|P2|Period I|Medical reasons|1
2466068|NCT02405780|8509719|P1|Period I|Medical reasons|1
2466069|NCT02405780|8509716|P4|Period I|Adverse Event|7
2466070|NCT02405780|8509717|P3|Period I|Adverse Event|3
2466071|NCT02405780|8509718|P2|Period I|Adverse Event|0
2466072|NCT02405780|8509719|P1|Period I|Adverse Event|8
2466073|NCT02405442|8509782|P4|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
2466074|NCT02405442|8509783|P3|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
2466075|NCT02405442|8509784|P2|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
2466076|NCT02405442|8509785|P1|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1
2466077|NCT02405442|8509782|P4|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
2466078|NCT02405442|8509783|P3|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
2466079|NCT02405442|8509784|P2|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1
2466080|NCT02405442|8509785|P1|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
2466081|NCT02405442|8509782|P4|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
2466082|NCT02405442|8509783|P3|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
2466083|NCT02405442|8509784|P2|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1
2466084|NCT02405442|8509785|P1|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
2466085|NCT02405442|8509782|P4|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
2466086|NCT02405442|8509783|P3|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
2466087|NCT02405442|8509784|P2|Open-Label Phase (up to Week 52)|Lost to Follow-up|1
2466088|NCT02405442|8509785|P1|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
2466089|NCT02405442|8509782|P4|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
2466090|NCT02405442|8509783|P3|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
2466091|NCT02405442|8509784|P2|Open-Label Phase (up to Week 52)|Lack of Efficacy|1
2466092|NCT02405442|8509785|P1|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
2466093|NCT02405442|8509782|P4|Open-Label Phase (up to Week 52)|Withdrew Consent|1
2466094|NCT02405442|8509783|P3|Open-Label Phase (up to Week 52)|Withdrew Consent|1
2466095|NCT02405442|8509784|P2|Open-Label Phase (up to Week 52)|Withdrew Consent|2
2466096|NCT02405442|8509785|P1|Open-Label Phase (up to Week 52)|Withdrew Consent|1
2466097|NCT02405442|8509782|P4|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2
2466098|NCT02405442|8509783|P3|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3
2466099|NCT02405442|8509784|P2|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1
2466100|NCT02405442|8509785|P1|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0
2466101|NCT02405442|8509782|P4|Open-Label Phase (up to Week 52)|Adverse Event|6
2466102|NCT02405442|8509783|P3|Open-Label Phase (up to Week 52)|Adverse Event|2
2466103|NCT02405442|8509784|P2|Open-Label Phase (up to Week 52)|Adverse Event|1
2466104|NCT02405442|8509785|P1|Open-Label Phase (up to Week 52)|Adverse Event|6
2466105|NCT02405442|8509782|P4|Open-Label Phase (up to Week 52)|Investigator's Discretion|2
2466106|NCT02405442|8509783|P3|Open-Label Phase (up to Week 52)|Investigator's Discretion|11
2466107|NCT02405442|8509784|P2|Open-Label Phase (up to Week 52)|Investigator's Discretion|11
2466108|NCT02405442|8509785|P1|Open-Label Phase (up to Week 52)|Investigator's Discretion|14
2466109|NCT02405442|8509782|P4|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13
2466110|NCT02405442|8509783|P3|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28
2466111|NCT02405442|8509784|P2|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28
2466112|NCT02405442|8509785|P1|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27
2466113|NCT02405442|8509782|P4|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
2466114|NCT02405442|8509783|P3|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
2466115|NCT02405442|8509784|P2|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1
2466116|NCT02405442|8509785|P1|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
2466117|NCT02405442|8509782|P4|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0
2466118|NCT02405442|8509783|P3|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0
2466119|NCT02405442|8509784|P2|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1
2466120|NCT02405442|8509785|P1|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1
2466121|NCT02405442|8509782|P4|Double-Blind Phase (up to Week 8)|Withdrew Consent|0
2466122|NCT02405442|8509783|P3|Double-Blind Phase (up to Week 8)|Withdrew Consent|2
2466123|NCT02405442|8509784|P2|Double-Blind Phase (up to Week 8)|Withdrew Consent|1
2466124|NCT02405442|8509785|P1|Double-Blind Phase (up to Week 8)|Withdrew Consent|0
2466125|NCT02405442|8509782|P4|Double-Blind Phase (up to Week 8)|Adverse Event|1
2466126|NCT02405442|8509783|P3|Double-Blind Phase (up to Week 8)|Adverse Event|4
2466127|NCT02405442|8509784|P2|Double-Blind Phase (up to Week 8)|Adverse Event|2
2466128|NCT02405442|8509785|P1|Double-Blind Phase (up to Week 8)|Adverse Event|0
2466129|NCT02405091|8509839|P3|Overall Study|Physician Decision|0
2466130|NCT02405091|8509840|P2|Overall Study|Physician Decision|2
2466131|NCT02405091|8509841|P1|Overall Study|Physician Decision|2
2466132|NCT02405091|8509839|P3|Overall Study|Lost to Follow-up|0
2466133|NCT02405091|8509840|P2|Overall Study|Lost to Follow-up|6
2466134|NCT02405091|8509841|P1|Overall Study|Lost to Follow-up|5
2466135|NCT02405091|8509839|P3|Overall Study|Death|0
2466136|NCT02405091|8509840|P2|Overall Study|Death|1
2466137|NCT02405091|8509841|P1|Overall Study|Death|0
2466138|NCT02405091|8509839|P3|Overall Study|Withdrawal by Subject|0
2466139|NCT02405091|8509840|P2|Overall Study|Withdrawal by Subject|8
2466140|NCT02405091|8509841|P1|Overall Study|Withdrawal by Subject|4
2466141|NCT02405091|8509839|P3|Overall Study|Noncompliance|2
2466142|NCT02405091|8509840|P2|Overall Study|Noncompliance|6
2466143|NCT02405091|8509841|P1|Overall Study|Noncompliance|1
2466144|NCT02405091|8509839|P3|Overall Study|Protocol Violation|0
2466145|NCT02405091|8509840|P2|Overall Study|Protocol Violation|0
2466146|NCT02405091|8509841|P1|Overall Study|Protocol Violation|1
2466147|NCT02405091|8509839|P3|Overall Study|Adverse Event|0
2466148|NCT02405091|8509840|P2|Overall Study|Adverse Event|10
2466149|NCT02405091|8509841|P1|Overall Study|Adverse Event|16
2466150|NCT02404649|8509877|P2|Overall Study|Adverse Event|2
2466151|NCT02404649|8509878|P1|Overall Study|Adverse Event|1
2466152|NCT02404545|8509895|P2|Overall Study|Sponsor Termination|6
2466153|NCT02404545|8509896|P1|Overall Study|Sponsor Termination|6
2466154|NCT02404493|8509915|P2|Overall Study|Adverse Event|1
2466155|NCT02404493|8509916|P1|Overall Study|Adverse Event|1
2466156|NCT02404389|8510161|P5|Overall Study|Subject/guardian decision|1
2466157|NCT02404389|8510162|P4|Overall Study|Subject/guardian decision|1
2466158|NCT02404389|8510163|P3|Overall Study|Subject/guardian decision|0
2466159|NCT02404389|8510164|P2|Overall Study|Subject/guardian decision|0
2466160|NCT02404389|8510165|P1|Overall Study|Subject/guardian decision|1
2466161|NCT02404389|8510161|P5|Overall Study|Adverse Event|2
2466162|NCT02404389|8510162|P4|Overall Study|Adverse Event|0
2466163|NCT02404389|8510163|P3|Overall Study|Adverse Event|1
2466164|NCT02404389|8510164|P2|Overall Study|Adverse Event|0
2466165|NCT02404389|8510165|P1|Overall Study|Adverse Event|1
2466166|NCT02404350|8510205|P4|Overall Study|Due to Technical problems|1
2466167|NCT02404350|8510206|P3|Overall Study|Due to Technical problems|0
2466168|NCT02404350|8510207|P2|Overall Study|Due to Technical problems|0
2466169|NCT02404350|8510208|P1|Overall Study|Due to Technical problems|0
2466170|NCT02404350|8510205|P4|Overall Study|Due to Non-compliance with treatment|1
2466171|NCT02404350|8510206|P3|Overall Study|Due to Non-compliance with treatment|0
2466172|NCT02404350|8510207|P2|Overall Study|Due to Non-compliance with treatment|0
2466173|NCT02404350|8510208|P1|Overall Study|Due to Non-compliance with treatment|0
2466174|NCT02404350|8510205|P4|Overall Study|Withdrawal by Subject|19
2466175|NCT02404350|8510206|P3|Overall Study|Withdrawal by Subject|3
2466176|NCT02404350|8510207|P2|Overall Study|Withdrawal by Subject|3
2466177|NCT02404350|8510208|P1|Overall Study|Withdrawal by Subject|7
2466178|NCT02404350|8510205|P4|Overall Study|Pregnancy|1
2466179|NCT02404350|8510206|P3|Overall Study|Pregnancy|0
2466180|NCT02404350|8510207|P2|Overall Study|Pregnancy|0
2466181|NCT02404350|8510208|P1|Overall Study|Pregnancy|0
2466182|NCT02404350|8510205|P4|Overall Study|Physician Decision|2
2466183|NCT02404350|8510206|P3|Overall Study|Physician Decision|0
2466184|NCT02404350|8510207|P2|Overall Study|Physician Decision|0
2466185|NCT02404350|8510208|P1|Overall Study|Physician Decision|1
2466186|NCT02404350|8510205|P4|Overall Study|Lost to Follow-up|1
2466187|NCT02404350|8510206|P3|Overall Study|Lost to Follow-up|0
2466188|NCT02404350|8510207|P2|Overall Study|Lost to Follow-up|0
2466189|NCT02404350|8510208|P1|Overall Study|Lost to Follow-up|2
2466190|NCT02404350|8510205|P4|Overall Study|Lack of Efficacy|3
2466191|NCT02404350|8510206|P3|Overall Study|Lack of Efficacy|0
2466192|NCT02404350|8510207|P2|Overall Study|Lack of Efficacy|1
2466193|NCT02404350|8510208|P1|Overall Study|Lack of Efficacy|3
2466194|NCT02404350|8510205|P4|Overall Study|Adverse Event|9
2466195|NCT02404350|8510206|P3|Overall Study|Adverse Event|3
2466196|NCT02404350|8510207|P2|Overall Study|Adverse Event|2
2466197|NCT02404350|8510208|P1|Overall Study|Adverse Event|2
2466198|NCT02404220|8510290|P4|Overall Study|Enrolled but Never Treated|0
2466199|NCT02404220|8510291|P3|Overall Study|Enrolled but Never Treated|0
2466200|NCT02404220|8510292|P2|Overall Study|Enrolled but Never Treated|2
2466201|NCT02404220|8510293|P1|Overall Study|Enrolled but Never Treated|0
2466202|NCT02404220|8510290|P4|Overall Study|Withdrawal by Subject|0
2466203|NCT02404220|8510291|P3|Overall Study|Withdrawal by Subject|0
2466204|NCT02404220|8510292|P2|Overall Study|Withdrawal by Subject|1
2466205|NCT02404220|8510293|P1|Overall Study|Withdrawal by Subject|0
2466206|NCT02404220|8510290|P4|Overall Study|Study Terminated by Sponsor|1
2466207|NCT02404220|8510291|P3|Overall Study|Study Terminated by Sponsor|2
2466208|NCT02404220|8510292|P2|Overall Study|Study Terminated by Sponsor|0
2466209|NCT02404220|8510293|P1|Overall Study|Study Terminated by Sponsor|0
2466210|NCT02404220|8510290|P4|Overall Study|Progressive Disease|1
2466211|NCT02404220|8510291|P3|Overall Study|Progressive Disease|1
2466212|NCT02404220|8510292|P2|Overall Study|Progressive Disease|0
2466213|NCT02404220|8510293|P1|Overall Study|Progressive Disease|0
2466214|NCT02404220|8510290|P4|Overall Study|Death|8
2466215|NCT02404220|8510291|P3|Overall Study|Death|3
2466216|NCT02404220|8510292|P2|Overall Study|Death|5
2466217|NCT02404220|8510293|P1|Overall Study|Death|5
2466218|NCT02404220|8510290|P4|Overall Study|Adverse Event|0
2466219|NCT02404220|8510291|P3|Overall Study|Adverse Event|1
2466220|NCT02404220|8510292|P2|Overall Study|Adverse Event|0
2466221|NCT02404220|8510293|P1|Overall Study|Adverse Event|0
2466222|NCT02404103|8510329|P2|Overall Study|Lost to Follow-up|3
2466223|NCT02404103|8510330|P1|Overall Study|Lost to Follow-up|3
2466224|NCT02404103|8510329|P2|Overall Study|Adverse Event|0
2466225|NCT02404103|8510330|P1|Overall Study|Adverse Event|1
2466226|NCT02404025|8510350|P1|Overall Study|Lack of Efficacy|3
2466227|NCT02404025|8510350|P1|Overall Study|Adverse Event|1
2466228|NCT02403817|8510432|P2|Overall Study|Withdrawal by Subject|0
2466229|NCT02403817|8510433|P1|Overall Study|Withdrawal by Subject|5
2466230|NCT02403674|8510464|P2|Overall Study|Protocol Violation|2
2466231|NCT02403674|8510465|P1|Overall Study|Protocol Violation|4
2466232|NCT02403674|8510464|P2|Overall Study|Pregnancy|1
2466233|NCT02403674|8510465|P1|Overall Study|Pregnancy|1
2466234|NCT02403674|8510464|P2|Overall Study|Not treated with study drug|2
2466235|NCT02403674|8510465|P1|Overall Study|Not treated with study drug|4
2466236|NCT02403674|8510464|P2|Overall Study|Physician Decision|2
2466237|NCT02403674|8510465|P1|Overall Study|Physician Decision|2
2466238|NCT02403674|8510464|P2|Overall Study|Withdrawal by Subject|11
2466239|NCT02403674|8510465|P1|Overall Study|Withdrawal by Subject|8
2466240|NCT02403674|8510464|P2|Overall Study|Noncompliance with study drug|2
2466241|NCT02403674|8510465|P1|Overall Study|Noncompliance with study drug|1
2466242|NCT02403674|8510464|P2|Overall Study|Lost to Follow-up|7
2466243|NCT02403674|8510465|P1|Overall Study|Lost to Follow-up|6
2466244|NCT02403674|8510464|P2|Overall Study|Lack of Efficacy|10
2466245|NCT02403674|8510465|P1|Overall Study|Lack of Efficacy|18
2466246|NCT02403674|8510464|P2|Overall Study|Death|3
2466247|NCT02403674|8510465|P1|Overall Study|Death|1
2466248|NCT02403674|8510464|P2|Overall Study|Adverse Event|23
2466249|NCT02403674|8510465|P1|Overall Study|Adverse Event|10
2466250|NCT02403635|8510504|P1|Overall Study|Not eligible|9
2466251|NCT02403271|8510581|P2|Period 2|Other varied reasons|10
2466252|NCT02403271|8510582|P1|Period 2|Other varied reasons|0
2466253|NCT02403271|8510581|P2|Period 2|Study Terminated by Sponsor|14
2466254|NCT02403271|8510582|P1|Period 2|Study Terminated by Sponsor|0
2466255|NCT02403271|8510581|P2|Period 2|Lost to Follow-up|2
2466256|NCT02403271|8510582|P1|Period 2|Lost to Follow-up|0
2466257|NCT02403271|8510581|P2|Period 2|Death|84
2466258|NCT02403271|8510582|P1|Period 2|Death|0
2466259|NCT02403271|8510581|P2|Period 2|Withdrawal by Subject|14
2466260|NCT02403271|8510582|P1|Period 2|Withdrawal by Subject|0
2466261|NCT02403271|8510581|P2|Period 1|Other varied reasons|0
2466262|NCT02403271|8510582|P1|Period 1|Other varied reasons|1
2466263|NCT02403206|8510596|P2|Overall Study|Reason not given|4
2466264|NCT02403206|8510597|P1|Overall Study|Reason not given|2
2466265|NCT02403206|8510596|P2|Overall Study|Withdrawal by Subject|3
2466266|NCT02403206|8510597|P1|Overall Study|Withdrawal by Subject|3
2466267|NCT02403206|8510596|P2|Overall Study|Physician Decision|0
2466268|NCT02403206|8510597|P1|Overall Study|Physician Decision|2
2466269|NCT02403206|8510596|P2|Overall Study|Lost to Follow-up|3
2466270|NCT02403206|8510597|P1|Overall Study|Lost to Follow-up|4
2466271|NCT02403180|8510608|P2|Period 2 (5 Days)|Withdrawal by Subject|1
2466272|NCT02403180|8510609|P1|Period 2 (5 Days)|Withdrawal by Subject|0
2466273|NCT02403180|8510608|P2|Pre-Treatment Period|Withdrawal by subject prior to treatment|1
2466274|NCT02403180|8510609|P1|Pre-Treatment Period|Withdrawal by subject prior to treatment|0
2466275|NCT02402933|8510638|P1|Overall Study|Discontinued; Site Termination|10
2466276|NCT02402933|8510638|P1|Overall Study|Withdrawal by Subject|4
2466277|NCT02402322|8510682|P3|Follow-up|Withdrawal by Subject|24
2466278|NCT02402322|8510683|P2|Follow-up|Withdrawal by Subject|3
2466279|NCT02402322|8510684|P1|Follow-up|Withdrawal by Subject|6
2466280|NCT02402322|8510682|P3|Pretreatment|Withdrawal by Subject|1
2466281|NCT02402322|8510683|P2|Pretreatment|Withdrawal by Subject|1
2466282|NCT02402322|8510684|P1|Pretreatment|Withdrawal by Subject|3
2466283|NCT02402218|8510734|P3|Overall Study|Withdrawal by Subject|1
2466284|NCT02402218|8510735|P2|Overall Study|Withdrawal by Subject|1
2466285|NCT02402218|8510736|P1|Overall Study|Withdrawal by Subject|1
2466286|NCT02402218|8510734|P3|Overall Study|Adverse Event|1
2466287|NCT02402218|8510735|P2|Overall Study|Adverse Event|2
2466288|NCT02402218|8510736|P1|Overall Study|Adverse Event|0
2466289|NCT02402218|8510734|P3|Overall Study|Reinfection|1
2466290|NCT02402218|8510735|P2|Overall Study|Reinfection|0
2466291|NCT02402218|8510736|P1|Overall Study|Reinfection|0
2466292|NCT02402218|8510734|P3|Overall Study|Death|0
2466293|NCT02402218|8510735|P2|Overall Study|Death|0
2466294|NCT02402218|8510736|P1|Overall Study|Death|1
2466295|NCT02402218|8510734|P3|Overall Study|Lack of Efficacy|1
2466296|NCT02402218|8510735|P2|Overall Study|Lack of Efficacy|1
2466297|NCT02402218|8510736|P1|Overall Study|Lack of Efficacy|0
2466298|NCT02402218|8510734|P3|Overall Study|Did not pickup study medication|13
2466299|NCT02402218|8510735|P2|Overall Study|Did not pickup study medication|9
2466300|NCT02402218|8510736|P1|Overall Study|Did not pickup study medication|12
2466301|NCT02402166|8510759|P1|Overall Study|Lost to Follow-up|1
2466302|NCT02402166|8510759|P1|Overall Study|Withdrawal by Subject|2
2466303|NCT02402166|8510759|P1|Overall Study|Adverse Event|2
2466304|NCT02401867|8510816|P1|Analysis|Cervical assay could not be conducted|9
2466305|NCT02401867|8510816|P1|Specimen Collection|Didn't receive 1 or more tests|10
2466306|NCT02401529|8510851|P2|Overall Study|Protocol Violation|0
2466307|NCT02401529|8510852|P1|Overall Study|Protocol Violation|5
2466308|NCT02401529|8510851|P2|Overall Study|Physician Decision|6
2466309|NCT02401529|8510852|P1|Overall Study|Physician Decision|2
2466310|NCT02401529|8510851|P2|Overall Study|Lost to Follow-up|1
2466311|NCT02401529|8510852|P1|Overall Study|Lost to Follow-up|2
2466312|NCT02401412|8510919|P2|Overall Study|Improper Enrollment per In/Ex Criteria|6
2466313|NCT02401412|8510920|P1|Overall Study|Improper Enrollment per In/Ex Criteria|10
2466314|NCT02401412|8510919|P2|Overall Study|Subject withdrawal prior to intervention|1
2466315|NCT02401412|8510920|P1|Overall Study|Subject withdrawal prior to intervention|0
2466316|NCT02401412|8510919|P2|Overall Study|Withdrawal by Subject|4
2466317|NCT02401412|8510920|P1|Overall Study|Withdrawal by Subject|4
2466318|NCT02401412|8510919|P2|Overall Study|Discontinued Intervention|21
2466319|NCT02401412|8510920|P1|Overall Study|Discontinued Intervention|15
2466320|NCT02401412|8510919|P2|Overall Study|Lost to Follow-up|0
2466321|NCT02401412|8510920|P1|Overall Study|Lost to Follow-up|1
2466322|NCT02401256|8510928|P1|Overall Study|Withdrawal by Subject|12
2466323|NCT02401256|8510928|P1|Overall Study|Adverse Event|5
2466324|NCT02401230|8510937|P3|Overall Study|Lost to Follow-up|3
2466325|NCT02401230|8510938|P2|Overall Study|Lost to Follow-up|3
2466326|NCT02401230|8510939|P1|Overall Study|Lost to Follow-up|1
2466327|NCT02401230|8510937|P3|Overall Study|Withdrawal by Subject|1
2466328|NCT02401230|8510938|P2|Overall Study|Withdrawal by Subject|1
2466329|NCT02401230|8510939|P1|Overall Study|Withdrawal by Subject|2
2466330|NCT02401230|8510937|P3|Overall Study|Adverse Event|0
2466331|NCT02401230|8510938|P2|Overall Study|Adverse Event|2
2466332|NCT02401230|8510939|P1|Overall Study|Adverse Event|3
2466333|NCT02400905|8511018|P1|Overall Study|Subject refused visit|1
2466334|NCT02400905|8511018|P1|Overall Study|Death|3
2466335|NCT02400905|8511018|P1|Overall Study|Withdrawal by Subject|5
2466336|NCT02400905|8511018|P1|Overall Study|Lost to Follow-up|6
2466337|NCT02400905|8511018|P1|Overall Study|Ongoing Follow-up|256
2466338|NCT02400749|8511028|P2|Week 17 - 32|Adverse Event|1
2466339|NCT02400749|8511029|P1|Week 17 - 32|Adverse Event|2
2466340|NCT02400749|8511028|P2|Week 17 - 32|Withdrawal by Subject|2
2466341|NCT02400749|8511029|P1|Week 17 - 32|Withdrawal by Subject|3
2466342|NCT02400749|8511028|P2|Week 0 -16|Protocol Violation|0
2466343|NCT02400749|8511029|P1|Week 0 -16|Protocol Violation|1
2466344|NCT02400749|8511028|P2|Week 0 -16|Lost to Follow-up|0
2466345|NCT02400749|8511029|P1|Week 0 -16|Lost to Follow-up|2
2466346|NCT02400749|8511028|P2|Week 0 -16|Adverse Event|1
2466347|NCT02400749|8511029|P1|Week 0 -16|Adverse Event|3
2466348|NCT02400749|8511028|P2|Week 0 -16|Withdrawal by Subject|5
2466349|NCT02400749|8511029|P1|Week 0 -16|Withdrawal by Subject|5
2466350|NCT02400580|8511056|P2|Overall Study|Adverse Event|0
2466351|NCT02400580|8511057|P1|Overall Study|Adverse Event|1
2466352|NCT02400580|8511056|P2|Overall Study|Withdrawal by Subject|1
2466353|NCT02400580|8511057|P1|Overall Study|Withdrawal by Subject|1
2466354|NCT02400346|8511073|P1|Overall Study|Lost to Follow-up|1
2466355|NCT02400346|8511073|P1|Overall Study|Administrative or other reason(s)|2
2466356|NCT02400346|8511073|P1|Overall Study|Withdrawal by Subject|7
2466357|NCT02400346|8511073|P1|Overall Study|Non-compliance with IMP|1
2466358|NCT02400346|8511073|P1|Overall Study|Lack of Efficacy|9
2466359|NCT02400346|8511073|P1|Overall Study|Adverse Event|24
2466360|NCT02400333|8511081|P4|Overall Study|Protocol Violation|1
2466361|NCT02400333|8511082|P3|Overall Study|Protocol Violation|2
2466362|NCT02400333|8511083|P2|Overall Study|Protocol Violation|0
2466363|NCT02400333|8511084|P1|Overall Study|Protocol Violation|1
2466364|NCT02400333|8511081|P4|Overall Study|Withdrawal by Subject|1
2466365|NCT02400333|8511082|P3|Overall Study|Withdrawal by Subject|0
2466366|NCT02400333|8511083|P2|Overall Study|Withdrawal by Subject|1
2466367|NCT02400333|8511084|P1|Overall Study|Withdrawal by Subject|0
2466368|NCT02400307|8511144|P2|Overall Study|Enrolled and Never Dosed|0
2466369|NCT02400307|8511145|P1|Overall Study|Enrolled and Never Dosed|1
2466370|NCT02399254|8511199|P1|Overall Study|Physician Decision|2
2466371|NCT02399163|8511206|P1|Overall Study|Withdrawal by Participant|5
2466372|NCT02399163|8511206|P1|Overall Study|Protocol Deviation|2
2466373|NCT02399163|8511206|P1|Overall Study|Adverse Event|2
2466374|NCT02398227|8511261|P2|Overall Study|Removed from treatment and dropped out|0
2466375|NCT02398227|8511262|P1|Overall Study|Removed from treatment and dropped out|1
2466376|NCT02398227|8511261|P2|Overall Study|Withdrawal by Subject|6
2466377|NCT02398227|8511262|P1|Overall Study|Withdrawal by Subject|5
2466378|NCT02398227|8511261|P2|Overall Study|Lost to Follow-up|12
2466379|NCT02398227|8511262|P1|Overall Study|Lost to Follow-up|21
2466380|NCT02398188|8511272|P2|Overall Study|Withdrawal by Subject|16
2466381|NCT02398188|8511273|P1|Overall Study|Withdrawal by Subject|7
2466382|NCT02398188|8511272|P2|Overall Study|Pregnancy|0
2466383|NCT02398188|8511273|P1|Overall Study|Pregnancy|1
2466384|NCT02398188|8511272|P2|Overall Study|Sponsor Decision|1
2466385|NCT02398188|8511273|P1|Overall Study|Sponsor Decision|2
2466386|NCT02398188|8511272|P2|Overall Study|Protocol Violation|10
2466387|NCT02398188|8511273|P1|Overall Study|Protocol Violation|6
2466388|NCT02398188|8511272|P2|Overall Study|Non-compliance|4
2466389|NCT02398188|8511273|P1|Overall Study|Non-compliance|4
2466390|NCT02398188|8511272|P2|Overall Study|Lost to Follow-up|0
2466391|NCT02398188|8511273|P1|Overall Study|Lost to Follow-up|5
2466392|NCT02398188|8511272|P2|Overall Study|Adverse Event|3
2466393|NCT02398188|8511273|P1|Overall Study|Adverse Event|2
2466394|NCT02397915|8511291|P4|Period 1|Physician Decision|0
2466395|NCT02397915|8511292|P3|Period 1|Physician Decision|0
2466396|NCT02397915|8511293|P2|Period 1|Physician Decision|0
2466397|NCT02397915|8511294|P1|Period 1|Physician Decision|1
2466398|NCT02397915|8511291|P4|Period 1|Protocol Violation|0
2466399|NCT02397915|8511292|P3|Period 1|Protocol Violation|0
2466400|NCT02397915|8511293|P2|Period 1|Protocol Violation|1
2466401|NCT02397915|8511294|P1|Period 1|Protocol Violation|0
2466402|NCT02397837|8511346|P2|Overall Study|Physician Decision|1
2466403|NCT02397837|8511347|P1|Overall Study|Physician Decision|1
2466404|NCT02397837|8511346|P2|Overall Study|Withdrawal by Subject|5
2466405|NCT02397837|8511347|P1|Overall Study|Withdrawal by Subject|6
2466406|NCT02397694|8511442|P2|Open Label Extension Phase|Lost to Follow-up|0
2466407|NCT02397694|8511443|P1|Open Label Extension Phase|Lost to Follow-up|4
2466408|NCT02397694|8511442|P2|Open Label Extension Phase|Withdrew Consent|1
2466409|NCT02397694|8511443|P1|Open Label Extension Phase|Withdrew Consent|3
2466410|NCT02397694|8511442|P2|Open Label Extension Phase|Protocol Violation|0
2466411|NCT02397694|8511443|P1|Open Label Extension Phase|Protocol Violation|1
2466412|NCT02397694|8511442|P2|Double-Blinded Phase|Lost to Follow-up|1
2466413|NCT02397694|8511443|P1|Double-Blinded Phase|Lost to Follow-up|1
2466414|NCT02397694|8511442|P2|Double-Blinded Phase|Withdrawal by Subject|0
2466415|NCT02397694|8511443|P1|Double-Blinded Phase|Withdrawal by Subject|1
2466416|NCT02397694|8511442|P2|Double-Blinded Phase|Non-compliance with study drug|2
2466417|NCT02397694|8511443|P1|Double-Blinded Phase|Non-compliance with study drug|0
2466418|NCT02397694|8511442|P2|Double-Blinded Phase|Adverse Event|0
2466419|NCT02397694|8511443|P1|Double-Blinded Phase|Adverse Event|1
2466420|NCT02397655|8511481|P1|Overall Study|data not completed|1301
2466421|NCT02397473|8511492|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|1
2466422|NCT02397473|8511493|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|0
2466423|NCT02397473|8511492|P2|Post Treatment Follow-up Phase|Protocol Violation|0
2466424|NCT02397473|8511493|P1|Post Treatment Follow-up Phase|Protocol Violation|1
2466425|NCT02397473|8511492|P2|Post Treatment Follow-up Phase|Lost to Follow-up|0
2466426|NCT02397473|8511493|P1|Post Treatment Follow-up Phase|Lost to Follow-up|1
2466427|NCT02397473|8511492|P2|Post Treatment Follow-up Phase|Lack of Efficacy|1
2466428|NCT02397473|8511493|P1|Post Treatment Follow-up Phase|Lack of Efficacy|1
2466429|NCT02397473|8511492|P2|Treatment Phase|Protocol Violation(did not receive drug)|3
2466430|NCT02397473|8511493|P1|Treatment Phase|Protocol Violation(did not receive drug)|0
2466431|NCT02397473|8511492|P2|Treatment Phase|Withdrawal by Subject|1
2466432|NCT02397473|8511493|P1|Treatment Phase|Withdrawal by Subject|2
2466433|NCT02397473|8511492|P2|Treatment Phase|Lost to Follow-up|0
2466434|NCT02397473|8511493|P1|Treatment Phase|Lost to Follow-up|1
2466435|NCT02397473|8511492|P2|Treatment Phase|Lack of Efficacy|1
2466436|NCT02397473|8511493|P1|Treatment Phase|Lack of Efficacy|8
2466437|NCT02397473|8511492|P2|Treatment Phase|Adverse Event|2
2466438|NCT02397473|8511493|P1|Treatment Phase|Adverse Event|1
2466439|NCT02397096|8511552|P2|Study Extensions|Ongoing|202
2466440|NCT02397096|8511553|P1|Study Extensions|Ongoing|399
2466441|NCT02397096|8511552|P2|Week 24 to Week 48|Lost to Follow-up|0
2466442|NCT02397096|8511553|P1|Week 24 to Week 48|Lost to Follow-up|2
2466443|NCT02397096|8511552|P2|Week 24 to Week 48|Withdrawal by Subject|2
2466444|NCT02397096|8511553|P1|Week 24 to Week 48|Withdrawal by Subject|5
2466445|NCT02397096|8511552|P2|Week 24 to Week 48|Physician Decision|1
2466446|NCT02397096|8511553|P1|Week 24 to Week 48|Physician Decision|2
2466447|NCT02397096|8511552|P2|Week 24 to Week 48|Non-Compliance With Study Drug|1
2466448|NCT02397096|8511553|P1|Week 24 to Week 48|Non-Compliance With Study Drug|0
2466449|NCT02397096|8511552|P2|Week 24 to Week 48|Lack of Efficacy|1
2466450|NCT02397096|8511553|P1|Week 24 to Week 48|Lack of Efficacy|5
2466451|NCT02397096|8511552|P2|Week 24 to Week 48|Adverse Event|2
2466452|NCT02397096|8511553|P1|Week 24 to Week 48|Adverse Event|6
2466453|NCT02397096|8511552|P2|Day 1 to Week 24|Withdrawal by Subject|1
2466454|NCT02397096|8511553|P1|Day 1 to Week 24|Withdrawal by Subject|6
2466455|NCT02397096|8511552|P2|Day 1 to Week 24|Protocol Violation|4
2466456|NCT02397096|8511553|P1|Day 1 to Week 24|Protocol Violation|1
2466457|NCT02397096|8511552|P2|Day 1 to Week 24|Physician Decision|3
2466458|NCT02397096|8511553|P1|Day 1 to Week 24|Physician Decision|2
2466459|NCT02397096|8511552|P2|Day 1 to Week 24|Lost to Follow-up|4
2466460|NCT02397096|8511553|P1|Day 1 to Week 24|Lost to Follow-up|3
2466461|NCT02397096|8511552|P2|Day 1 to Week 24|Lack of Efficacy|1
2466462|NCT02397096|8511553|P1|Day 1 to Week 24|Lack of Efficacy|0
2466463|NCT02397096|8511552|P2|Day 1 to Week 24|Death|0
2466464|NCT02397096|8511553|P1|Day 1 to Week 24|Death|1
2466465|NCT02397096|8511552|P2|Day 1 to Week 24|Adverse Event|1
2466466|NCT02397096|8511553|P1|Day 1 to Week 24|Adverse Event|7
2466467|NCT02396953|8511586|P3|Overall Study|Personal Reasons|0
2466468|NCT02396953|8511587|P2|Overall Study|Personal Reasons|1
2466469|NCT02396953|8511588|P1|Overall Study|Personal Reasons|1
2466470|NCT02396953|8511586|P3|Overall Study|Insulin like Growth Factor-1 increased|2
2466471|NCT02396953|8511587|P2|Overall Study|Insulin like Growth Factor-1 increased|2
2466472|NCT02396953|8511588|P1|Overall Study|Insulin like Growth Factor-1 increased|3
2466473|NCT02396953|8511586|P3|Overall Study|Withdrawal by Subject|1
2466474|NCT02396953|8511587|P2|Overall Study|Withdrawal by Subject|0
2466475|NCT02396953|8511588|P1|Overall Study|Withdrawal by Subject|0
2466476|NCT02396537|8511663|P2|Overall Study|Protocol Violation|1
2466477|NCT02396537|8511664|P1|Overall Study|Protocol Violation|0
2466478|NCT02396420|8511676|P1|Overall Study|Death|1
2466479|NCT02396381|8511700|P2|Overall Study|Randomization/Screening Error|1
2466480|NCT02396381|8511701|P1|Overall Study|Randomization/Screening Error|3
2466481|NCT02396381|8511700|P2|Overall Study|Possible conflict of interest|0
2466482|NCT02396381|8511701|P1|Overall Study|Possible conflict of interest|1
2466483|NCT02396381|8511700|P2|Overall Study|Could not complete visit|0
2466484|NCT02396381|8511701|P1|Overall Study|Could not complete visit|1
2466485|NCT02396381|8511700|P2|Overall Study|Moved out of town/state|3
2466486|NCT02396381|8511701|P1|Overall Study|Moved out of town/state|1
2466487|NCT02396381|8511700|P2|Overall Study|Non-compliance with study procedures|0
2466488|NCT02396381|8511701|P1|Overall Study|Non-compliance with study procedures|1
2466489|NCT02396381|8511700|P2|Overall Study|Pregnancy|0
2466490|NCT02396381|8511701|P1|Overall Study|Pregnancy|2
2466491|NCT02396381|8511700|P2|Overall Study|Physician Decision|5
2466492|NCT02396381|8511701|P1|Overall Study|Physician Decision|5
2466493|NCT02396381|8511700|P2|Overall Study|Site terminated by sponsor|8
2466494|NCT02396381|8511701|P1|Overall Study|Site terminated by sponsor|7
2466495|NCT02396381|8511700|P2|Overall Study|Protocol Violation|0
2466496|NCT02396381|8511701|P1|Overall Study|Protocol Violation|1
2466497|NCT02396381|8511700|P2|Overall Study|Lost to Follow-up|31
2466498|NCT02396381|8511701|P1|Overall Study|Lost to Follow-up|49
2466499|NCT02396381|8511700|P2|Overall Study|Withdrawal by Subject|24
2466500|NCT02396381|8511701|P1|Overall Study|Withdrawal by Subject|33
2466501|NCT02396381|8511700|P2|Overall Study|Adverse Event|2
2466502|NCT02396381|8511701|P1|Overall Study|Adverse Event|3
2466503|NCT02396316|8511740|P2|Overall Study|Treatment unblinded|1
2466504|NCT02396316|8511741|P1|Overall Study|Treatment unblinded|0
2466505|NCT02396316|8511740|P2|Overall Study|Protocol Violation|1
2466506|NCT02396316|8511741|P1|Overall Study|Protocol Violation|0
2466507|NCT02396316|8511740|P2|Overall Study|Progressive disease|3
2466508|NCT02396316|8511741|P1|Overall Study|Progressive disease|6
2466509|NCT02396316|8511740|P2|Overall Study|Physician Decision|0
2466510|NCT02396316|8511741|P1|Overall Study|Physician Decision|1
2466511|NCT02396212|8511760|P1|Overall Study|Lack of Efficacy|2
2466512|NCT02396212|8511760|P1|Overall Study|Adverse Event|1
2466513|NCT02395822|8511867|P1|Overall Study|Death|1
2466514|NCT02395822|8511867|P1|Overall Study|Withdrawal by Subject|1
2466515|NCT02395666|8511888|P2|Overall Study|Withdrawal by Subject|1
2466516|NCT02395666|8511889|P1|Overall Study|Withdrawal by Subject|2
2466517|NCT02395666|8511888|P2|Overall Study|Lost to Follow-up|0
2466518|NCT02395666|8511889|P1|Overall Study|Lost to Follow-up|1
2466519|NCT02395666|8511888|P2|Overall Study|Physician Decision|0
2466520|NCT02395666|8511889|P1|Overall Study|Physician Decision|3
2466521|NCT02395653|8511903|P1|Overall Study|Lost to Follow-up|1
2466522|NCT02395653|8511903|P1|Overall Study|Withdrawal by Subject|1
2466523|NCT02395653|8511903|P1|Overall Study|Inclusion Criteria Not Met at Screening|3
2466524|NCT02395653|8511903|P1|Overall Study|Investigator Decision at Screening|1
2466525|NCT02395653|8511903|P1|Overall Study|SSEC Application But With 0 Dose|1
2466526|NCT02395653|8511903|P1|Overall Study|Consent Withdrawn at Screening|1
2466527|NCT02395653|8511903|P1|Overall Study|Exclusion Criteria Met at Screening|4
2466528|NCT02395536|8511912|P2|Overall Study|Insurance issue|1
2466529|NCT02395536|8511913|P1|Overall Study|Insurance issue|0
2466530|NCT02395536|8511912|P2|Overall Study|Inclusion/Excusion Criteria Violation|2
2466531|NCT02395536|8511913|P1|Overall Study|Inclusion/Excusion Criteria Violation|1
2466532|NCT02395536|8511912|P2|Overall Study|Withdrawal by Subject|17
2466533|NCT02395536|8511913|P1|Overall Study|Withdrawal by Subject|9
2466534|NCT02395536|8511912|P2|Overall Study|Physician Decision|6
2466535|NCT02395536|8511913|P1|Overall Study|Physician Decision|4
2466536|NCT02395536|8511912|P2|Overall Study|Death|0
2466537|NCT02395536|8511913|P1|Overall Study|Death|2
2466538|NCT02395536|8511912|P2|Overall Study|Lost to Follow-up|4
2466539|NCT02395536|8511913|P1|Overall Study|Lost to Follow-up|4
2466540|NCT02395471|8511921|P2|Overall Study|Subject not eligible|0
2466541|NCT02395471|8511922|P1|Overall Study|Subject not eligible|1
2466542|NCT02395471|8511921|P2|Overall Study|Patient did not return for procedure|1
2466543|NCT02395471|8511922|P1|Overall Study|Patient did not return for procedure|0
2466544|NCT02395471|8511921|P2|Overall Study|Failure to swollow sponge twice|0
2466545|NCT02395471|8511922|P1|Overall Study|Failure to swollow sponge twice|1
2466546|NCT02395471|8511921|P2|Overall Study|Protocol Violation|1
2466547|NCT02395471|8511922|P1|Overall Study|Protocol Violation|0
2466548|NCT02395471|8511921|P2|Overall Study|Physician Decision|0
2466549|NCT02395471|8511922|P1|Overall Study|Physician Decision|1
2466550|NCT02395471|8511921|P2|Overall Study|Withdrawal by Subject|1
2466551|NCT02395471|8511922|P1|Overall Study|Withdrawal by Subject|2
2466552|NCT02395471|8511921|P2|Overall Study|Lost to Follow-up|0
2466553|NCT02395471|8511922|P1|Overall Study|Lost to Follow-up|2
2466554|NCT02395302|8511937|P1|Overall Study|Physician Decision|2
2466555|NCT02395302|8511937|P1|Overall Study|Withdrawal by Subject|2
2466556|NCT02395302|8511937|P1|Overall Study|Run In Failure|7
2466557|NCT02395302|8511937|P1|Overall Study|Screen Failure|3
2466558|NCT02395172|8511957|P2|Overall Study|Treatment ongoing|5
2466559|NCT02395172|8511958|P1|Overall Study|Treatment ongoing|49
2466560|NCT02395172|8511957|P2|Overall Study|Participants randomized but not treated|31
2466561|NCT02395172|8511958|P1|Overall Study|Participants randomized but not treated|3
2466562|NCT02395133|8511997|P4|Overall Study|Other than specified above|4
2466563|NCT02395133|8511998|P3|Overall Study|Other than specified above|2
2466564|NCT02395133|8511999|P2|Overall Study|Other than specified above|2
2466565|NCT02395133|8512000|P1|Overall Study|Other than specified above|5
2466566|NCT02395133|8511997|P4|Overall Study|Sponsor decision|1
2466567|NCT02395133|8511998|P3|Overall Study|Sponsor decision|0
2466568|NCT02395133|8511999|P2|Overall Study|Sponsor decision|0
2466569|NCT02395133|8512000|P1|Overall Study|Sponsor decision|2
2466570|NCT02395133|8511997|P4|Overall Study|Consent withdrawn with personal reason|3
2466571|NCT02395133|8511998|P3|Overall Study|Consent withdrawn with personal reason|0
2466572|NCT02395133|8511999|P2|Overall Study|Consent withdrawn with personal reason|1
2466573|NCT02395133|8512000|P1|Overall Study|Consent withdrawn with personal reason|0
2466574|NCT02395133|8511997|P4|Overall Study|Consent withdrawn with no reason given|2
2466575|NCT02395133|8511998|P3|Overall Study|Consent withdrawn with no reason given|0
2466576|NCT02395133|8511999|P2|Overall Study|Consent withdrawn with no reason given|3
2466577|NCT02395133|8512000|P1|Overall Study|Consent withdrawn with no reason given|1
2466578|NCT02395133|8511997|P4|Overall Study|Pregnancy|0
2466579|NCT02395133|8511998|P3|Overall Study|Pregnancy|3
2466580|NCT02395133|8511999|P2|Overall Study|Pregnancy|0
2466581|NCT02395133|8512000|P1|Overall Study|Pregnancy|0
2466582|NCT02395133|8511997|P4|Overall Study|Lost to Follow-up|0
2466583|NCT02395133|8511998|P3|Overall Study|Lost to Follow-up|1
2466584|NCT02395133|8511999|P2|Overall Study|Lost to Follow-up|1
2466585|NCT02395133|8512000|P1|Overall Study|Lost to Follow-up|0
2466586|NCT02395133|8511997|P4|Overall Study|Protocol Violation|3
2466587|NCT02395133|8511998|P3|Overall Study|Protocol Violation|0
2466588|NCT02395133|8511999|P2|Overall Study|Protocol Violation|1
2466589|NCT02395133|8512000|P1|Overall Study|Protocol Violation|1
2466590|NCT02395133|8511997|P4|Overall Study|Lack of Efficacy|1
2466591|NCT02395133|8511998|P3|Overall Study|Lack of Efficacy|1
2466592|NCT02395133|8511999|P2|Overall Study|Lack of Efficacy|0
2466593|NCT02395133|8512000|P1|Overall Study|Lack of Efficacy|1
2466594|NCT02395133|8511997|P4|Overall Study|Adverse Event|0
2466595|NCT02395133|8511998|P3|Overall Study|Adverse Event|3
2466596|NCT02395133|8511999|P2|Overall Study|Adverse Event|1
2466597|NCT02395133|8512000|P1|Overall Study|Adverse Event|4
2466598|NCT02395055|8512088|P2|Overall Study|Withdrawal by Subject|3
2466599|NCT02395055|8512089|P1|Overall Study|Withdrawal by Subject|7
2466600|NCT02395042|8512102|P3|Treatment 2 Period|Lack of Efficacy|0
2466601|NCT02395042|8512103|P2|Treatment 2 Period|Lack of Efficacy|1
2466602|NCT02395042|8512104|P1|Treatment 2 Period|Lack of Efficacy|1
2466603|NCT02395042|8512102|P3|Treatment 1 Period|Other Miscellaneous Reasons|1
2466604|NCT02395042|8512103|P2|Treatment 1 Period|Other Miscellaneous Reasons|2
2466605|NCT02395042|8512104|P1|Treatment 1 Period|Other Miscellaneous Reasons|0
2466606|NCT02395042|8512102|P3|Treatment 1 Period|Lost to Follow-up|0
2466607|NCT02395042|8512103|P2|Treatment 1 Period|Lost to Follow-up|0
2466608|NCT02395042|8512104|P1|Treatment 1 Period|Lost to Follow-up|1
2466609|NCT02395042|8512102|P3|Treatment 1 Period|Lack of Efficacy|0
2466610|NCT02395042|8512103|P2|Treatment 1 Period|Lack of Efficacy|1
2466611|NCT02395042|8512104|P1|Treatment 1 Period|Lack of Efficacy|1
2466612|NCT02395042|8512102|P3|Treatment 1 Period|Adverse Event|1
2466613|NCT02395042|8512103|P2|Treatment 1 Period|Adverse Event|3
2466614|NCT02395042|8512104|P1|Treatment 1 Period|Adverse Event|1
2466615|NCT02394925|8512142|P1|Overall Study|Unsatisfactory Visual Response|5
2466616|NCT02394925|8512142|P1|Overall Study|No longer meet eligibility criteria|1
2466617|NCT02394925|8512142|P1|Overall Study|Protocol Violation|5
2466618|NCT02394925|8512142|P1|Overall Study|Lost to Follow-up|9
2466619|NCT02394925|8512142|P1|Overall Study|Lens handling difficulities|5
2466620|NCT02394925|8512142|P1|Overall Study|Lens Discomfort|3
2466621|NCT02394925|8512142|P1|Overall Study|Adverse Event|1
2466622|NCT02394808|8512152|P2|Period 2|Lost to Follow-up|0
2466623|NCT02394808|8512153|P1|Period 2|Lost to Follow-up|1
2466624|NCT02394808|8512152|P2|Period 1|Unsatisfactory lens fitting|1
2466625|NCT02394808|8512153|P1|Period 1|Unsatisfactory lens fitting|0
2466626|NCT02394756|8512161|P6|Period 2|Unsatisfactory Visual Response|0
2466627|NCT02394756|8512162|P5|Period 2|Unsatisfactory Visual Response|1
2466628|NCT02394756|8512163|P4|Period 2|Unsatisfactory Visual Response|0
2466629|NCT02394756|8512164|P3|Period 2|Unsatisfactory Visual Response|0
2466630|NCT02394756|8512165|P2|Period 2|Unsatisfactory Visual Response|0
2466631|NCT02394756|8512166|P1|Period 2|Unsatisfactory Visual Response|0
2466632|NCT02394756|8512161|P6|Period 1|Withdrawal by Subject|0
2466633|NCT02394756|8512162|P5|Period 1|Withdrawal by Subject|0
2466634|NCT02394756|8512163|P4|Period 1|Withdrawal by Subject|1
2466635|NCT02394756|8512164|P3|Period 1|Withdrawal by Subject|1
2466636|NCT02394756|8512165|P2|Period 1|Withdrawal by Subject|1
2466637|NCT02394756|8512166|P1|Period 1|Withdrawal by Subject|0
2466638|NCT02394756|8512161|P6|Period 1|Lens Discomfort|1
2466639|NCT02394756|8512162|P5|Period 1|Lens Discomfort|0
2466640|NCT02394756|8512163|P4|Period 1|Lens Discomfort|0
2466641|NCT02394756|8512164|P3|Period 1|Lens Discomfort|0
2466642|NCT02394756|8512165|P2|Period 1|Lens Discomfort|0
2466643|NCT02394756|8512166|P1|Period 1|Lens Discomfort|0
2466644|NCT02394730|8512179|P2|Overall Study|Withdrawal by Subject|1
2466645|NCT02394730|8512180|P1|Overall Study|Withdrawal by Subject|0
2466646|NCT02394730|8512179|P2|Overall Study|Lost to Follow-up|0
2466647|NCT02394730|8512180|P1|Overall Study|Lost to Follow-up|1
2466648|NCT02394665|8512217|P3|Overall Study|Physician Decision|0
2466649|NCT02394665|8512218|P2|Overall Study|Physician Decision|0
2466650|NCT02394665|8512219|P1|Overall Study|Physician Decision|1
2466651|NCT02394600|8512241|P2|Overall Study|Protocol Violation|0
2466652|NCT02394600|8512242|P1|Overall Study|Protocol Violation|1
2466653|NCT02394600|8512241|P2|Overall Study|Withdrawal by Subject|1
2466654|NCT02394600|8512242|P1|Overall Study|Withdrawal by Subject|0
2466655|NCT02394600|8512241|P2|Overall Study|Lost to Follow-up|1
2466656|NCT02394600|8512242|P1|Overall Study|Lost to Follow-up|0
2466657|NCT02394600|8512241|P2|Overall Study|Adverse Event|0
2466658|NCT02394600|8512242|P1|Overall Study|Adverse Event|3
2466659|NCT02394561|8512252|P2|Extension Phase|Lack of Efficacy|3
2466660|NCT02394561|8512253|P1|Extension Phase|Lack of Efficacy|3
2466661|NCT02394561|8512252|P2|Extension Phase|Withdrawal by Subject|5
2466662|NCT02394561|8512253|P1|Extension Phase|Withdrawal by Subject|0
2466663|NCT02394561|8512252|P2|Extension Phase|Physician Decision|2
2466664|NCT02394561|8512253|P1|Extension Phase|Physician Decision|0
2466665|NCT02394561|8512252|P2|Extension Phase|Lost to Follow-up|0
2466666|NCT02394561|8512253|P1|Extension Phase|Lost to Follow-up|1
2466667|NCT02394561|8512252|P2|Extension Phase|Protocol Violation|0
2466668|NCT02394561|8512253|P1|Extension Phase|Protocol Violation|1
2466669|NCT02394561|8512252|P2|Extension Phase|Death|1
2466670|NCT02394561|8512253|P1|Extension Phase|Death|0
2466671|NCT02394561|8512252|P2|Extension Phase|Adverse Event|1
2466672|NCT02394561|8512253|P1|Extension Phase|Adverse Event|6
2466673|NCT02394561|8512252|P2|CORE Phase|Lack of Efficacy|6
2466674|NCT02394561|8512253|P1|CORE Phase|Lack of Efficacy|1
2466675|NCT02394561|8512252|P2|CORE Phase|Withdrawal by Subject|2
2466676|NCT02394561|8512253|P1|CORE Phase|Withdrawal by Subject|2
2466677|NCT02394561|8512252|P2|CORE Phase|Physician Decision|1
2466678|NCT02394561|8512253|P1|CORE Phase|Physician Decision|1
2466679|NCT02394561|8512252|P2|CORE Phase|Lost to Follow-up|0
2466680|NCT02394561|8512253|P1|CORE Phase|Lost to Follow-up|1
2466681|NCT02394561|8512252|P2|CORE Phase|Pregnancy|0
2466682|NCT02394561|8512253|P1|CORE Phase|Pregnancy|1
2466683|NCT02394561|8512252|P2|CORE Phase|Death|1
2466684|NCT02394561|8512253|P1|CORE Phase|Death|0
2466685|NCT02394561|8512252|P2|CORE Phase|Adverse Event|9
2466686|NCT02394561|8512253|P1|CORE Phase|Adverse Event|7
2466687|NCT02394340|8512300|P1|Overall Study|Adverse Event|1
2466688|NCT02394340|8512300|P1|Overall Study|Failed drug screen test|1
2466689|NCT02393950|8512307|P2|Overall Study|Withdrawal by Subject|1
2466690|NCT02393950|8512308|P1|Overall Study|Withdrawal by Subject|0
2466691|NCT02393950|8512307|P2|Overall Study|Adverse Event|0
2466692|NCT02393950|8512308|P1|Overall Study|Adverse Event|1
2466693|NCT02393547|8512382|P1|Overall Study|Lost to Follow-up|1
2466694|NCT02393547|8512382|P1|Overall Study|Withdrawal by Subject|3
2466695|NCT02393547|8512382|P1|Overall Study|Adverse Event|2
2466696|NCT02393209|8512473|P4|Overall Study|Lost to Follow-up|0
2466697|NCT02393209|8512474|P3|Overall Study|Lost to Follow-up|0
2466698|NCT02393209|8512475|P2|Overall Study|Lost to Follow-up|1
2466699|NCT02393209|8512476|P1|Overall Study|Lost to Follow-up|0
2466700|NCT02393209|8512473|P4|Overall Study|Patient Seen by Another Oncologist|0
2466701|NCT02393209|8512474|P3|Overall Study|Patient Seen by Another Oncologist|0
2466702|NCT02393209|8512475|P2|Overall Study|Patient Seen by Another Oncologist|1
2466703|NCT02393209|8512476|P1|Overall Study|Patient Seen by Another Oncologist|0
2466704|NCT02393209|8512473|P4|Overall Study|Death from Legionella Infection|0
2466705|NCT02393209|8512474|P3|Overall Study|Death from Legionella Infection|0
2466706|NCT02393209|8512475|P2|Overall Study|Death from Legionella Infection|1
2466707|NCT02393209|8512476|P1|Overall Study|Death from Legionella Infection|0
2466708|NCT02393209|8512473|P4|Overall Study|Death due to Disease Progression|0
2466709|NCT02393209|8512474|P3|Overall Study|Death due to Disease Progression|0
2466710|NCT02393209|8512475|P2|Overall Study|Death due to Disease Progression|2
2466711|NCT02393209|8512476|P1|Overall Study|Death due to Disease Progression|2
2466712|NCT02393209|8512473|P4|Overall Study|Death|0
2466713|NCT02393209|8512474|P3|Overall Study|Death|0
2466714|NCT02393209|8512475|P2|Overall Study|Death|2
2466715|NCT02393209|8512476|P1|Overall Study|Death|2
2466716|NCT02393209|8512473|P4|Overall Study|Withdrawal by Patient|0
2466717|NCT02393209|8512474|P3|Overall Study|Withdrawal by Patient|0
2466718|NCT02393209|8512475|P2|Overall Study|Withdrawal by Patient|0
2466719|NCT02393209|8512476|P1|Overall Study|Withdrawal by Patient|1
2466720|NCT02393209|8512473|P4|Overall Study|Study Terminated by Sponsor|0
2466721|NCT02393209|8512474|P3|Overall Study|Study Terminated by Sponsor|0
2466722|NCT02393209|8512475|P2|Overall Study|Study Terminated by Sponsor|1
2466723|NCT02393209|8512476|P1|Overall Study|Study Terminated by Sponsor|1
2466724|NCT02392624|8512565|P3|Overall Study|Other|1
2466725|NCT02392624|8512566|P2|Overall Study|Other|1
2466726|NCT02392624|8512567|P1|Overall Study|Other|49
2466727|NCT02392624|8512565|P3|Overall Study|Sponsor/Investigator Decision|0
2466728|NCT02392624|8512566|P2|Overall Study|Sponsor/Investigator Decision|1
2466729|NCT02392624|8512567|P1|Overall Study|Sponsor/Investigator Decision|2
2466730|NCT02392624|8512565|P3|Overall Study|Protocol Violation|1
2466731|NCT02392624|8512566|P2|Overall Study|Protocol Violation|0
2466732|NCT02392624|8512567|P1|Overall Study|Protocol Violation|0
2466733|NCT02392624|8512565|P3|Overall Study|Pregnancy|0
2466734|NCT02392624|8512566|P2|Overall Study|Pregnancy|0
2466735|NCT02392624|8512567|P1|Overall Study|Pregnancy|1
2466736|NCT02392624|8512565|P3|Overall Study|Adverse Event|2
2466737|NCT02392624|8512566|P2|Overall Study|Adverse Event|1
2466738|NCT02392624|8512567|P1|Overall Study|Adverse Event|4
2466739|NCT02392624|8512565|P3|Overall Study|Withdrawal by Subject|9
2466740|NCT02392624|8512566|P2|Overall Study|Withdrawal by Subject|12
2466741|NCT02392624|8512567|P1|Overall Study|Withdrawal by Subject|15
2466742|NCT02392507|8512580|P1|Maintenance Regimen|On Study Treatment at Study Conclusion|11
2466743|NCT02392507|8512580|P1|Maintenance Regimen|Death|1
2466744|NCT02392507|8512580|P1|Induction Regimen|Withdrawal by Subject|2
2466745|NCT02392507|8512580|P1|Induction Regimen|Physician Decision|1
2466746|NCT02392507|8512580|P1|Induction Regimen|On Study Treatment at Study Conclusion|11
2466747|NCT02392507|8512580|P1|Induction Regimen|Death|3
2466748|NCT02392481|8512619|P4|Overall Study|Withdrawal by Subject|0
2466749|NCT02392481|8512620|P3|Overall Study|Withdrawal by Subject|1
2466750|NCT02392481|8512621|P2|Overall Study|Withdrawal by Subject|0
2466751|NCT02392481|8512622|P1|Overall Study|Withdrawal by Subject|0
2466752|NCT02392481|8512619|P4|Overall Study|Adverse Event|2
2466753|NCT02392481|8512620|P3|Overall Study|Adverse Event|1
2466754|NCT02392481|8512621|P2|Overall Study|Adverse Event|0
2466755|NCT02392481|8512622|P1|Overall Study|Adverse Event|0
2466756|NCT02392403|8512644|P1|Overall Study|Withdrawal by Subject|1
2466757|NCT02392403|8512644|P1|Overall Study|Death|1
2466758|NCT02392403|8512644|P1|Overall Study|Adverse Event|1
2466759|NCT02392377|8512658|P2|Overall Study|Withdrawal by Subject|1
2466760|NCT02392377|8512659|P1|Overall Study|Withdrawal by Subject|0
2466761|NCT02392247|8512751|P1|Overall Study|Surgery cancelled; no data|1
2466762|NCT02392247|8512751|P1|Overall Study|Withdrawal by Subject|1
2466763|NCT02392234|8512762|P6|Treatment Period 2 (8 Weeks)|Adverse Event|0
2466764|NCT02392234|8512763|P5|Treatment Period 2 (8 Weeks)|Adverse Event|0
2466765|NCT02392234|8512764|P4|Treatment Period 2 (8 Weeks)|Adverse Event|0
2466766|NCT02392234|8512765|P3|Treatment Period 2 (8 Weeks)|Adverse Event|0
2466767|NCT02392234|8512766|P2|Treatment Period 2 (8 Weeks)|Adverse Event|0
2466768|NCT02392234|8512767|P1|Treatment Period 2 (8 Weeks)|Adverse Event|1
2466769|NCT02392234|8512762|P6|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
2466770|NCT02392234|8512763|P5|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
2466771|NCT02392234|8512764|P4|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
2466772|NCT02392234|8512765|P3|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
2466773|NCT02392234|8512766|P2|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
2466774|NCT02392234|8512767|P1|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
2466775|NCT02392234|8512762|P6|Treatment Period 1 (8 Weeks)|Other|0
2466776|NCT02392234|8512763|P5|Treatment Period 1 (8 Weeks)|Other|0
2466777|NCT02392234|8512764|P4|Treatment Period 1 (8 Weeks)|Other|0
2466778|NCT02392234|8512765|P3|Treatment Period 1 (8 Weeks)|Other|0
2466779|NCT02392234|8512766|P2|Treatment Period 1 (8 Weeks)|Other|0
2466780|NCT02392234|8512767|P1|Treatment Period 1 (8 Weeks)|Other|1
2466781|NCT02392234|8512762|P6|Treatment Period 1 (8 Weeks)|Noncompliance|1
2466782|NCT02392234|8512763|P5|Treatment Period 1 (8 Weeks)|Noncompliance|0
2466783|NCT02392234|8512764|P4|Treatment Period 1 (8 Weeks)|Noncompliance|0
2466784|NCT02392234|8512765|P3|Treatment Period 1 (8 Weeks)|Noncompliance|0
2466785|NCT02392234|8512766|P2|Treatment Period 1 (8 Weeks)|Noncompliance|0
2466786|NCT02392234|8512767|P1|Treatment Period 1 (8 Weeks)|Noncompliance|0
2466787|NCT02392234|8512762|P6|Treatment Period 1 (8 Weeks)|Pregnancy|0
2466788|NCT02392234|8512763|P5|Treatment Period 1 (8 Weeks)|Pregnancy|0
2466789|NCT02392234|8512764|P4|Treatment Period 1 (8 Weeks)|Pregnancy|1
2466790|NCT02392234|8512765|P3|Treatment Period 1 (8 Weeks)|Pregnancy|0
2466791|NCT02392234|8512766|P2|Treatment Period 1 (8 Weeks)|Pregnancy|0
2466792|NCT02392234|8512767|P1|Treatment Period 1 (8 Weeks)|Pregnancy|1
2466793|NCT02392234|8512762|P6|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
2466794|NCT02392234|8512763|P5|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
2466795|NCT02392234|8512764|P4|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
2466796|NCT02392234|8512765|P3|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
2466797|NCT02392234|8512766|P2|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
2466798|NCT02392234|8512767|P1|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
2466799|NCT02392234|8512762|P6|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
2466800|NCT02392234|8512763|P5|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2
2466801|NCT02392234|8512764|P4|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
2466802|NCT02392234|8512765|P3|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
2466803|NCT02392234|8512766|P2|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
2466804|NCT02392234|8512767|P1|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
2466805|NCT02392234|8512762|P6|Treatment Period 1 (8 Weeks)|Adverse Event|1
2466806|NCT02392234|8512763|P5|Treatment Period 1 (8 Weeks)|Adverse Event|1
2466807|NCT02392234|8512764|P4|Treatment Period 1 (8 Weeks)|Adverse Event|0
2466808|NCT02392234|8512765|P3|Treatment Period 1 (8 Weeks)|Adverse Event|1
2466809|NCT02392234|8512766|P2|Treatment Period 1 (8 Weeks)|Adverse Event|0
2466810|NCT02392234|8512767|P1|Treatment Period 1 (8 Weeks)|Adverse Event|1
2466811|NCT02392104|8512799|P1|Overall Study|INRs drawn by visiting nurse services|1
2466812|NCT02392104|8512799|P1|Overall Study|admitted to skilled nursing facility|3
2466813|NCT02392104|8512799|P1|Overall Study|INR goal range changed|1
2466814|NCT02392104|8512799|P1|Overall Study|transferred care to another doctor|2
2466815|NCT02392104|8512799|P1|Overall Study|bleeding event|1
2466816|NCT02392104|8512799|P1|Overall Study|discontinuation of warfarin|3
2466817|NCT02392000|8512810|P1|Overall Study|Lost to Follow-up|8
2466818|NCT02392000|8512810|P1|Overall Study|Withdrawal by Subject|1
2466819|NCT02392000|8512810|P1|Overall Study|Greater than mild sleep apnea exclusion|18
2466820|NCT02391948|8512836|P5|24-month Assessment|Not able to schedule visit in timeframe|8
2466821|NCT02391948|8512837|P4|24-month Assessment|Not able to schedule visit in timeframe|9
2466822|NCT02391948|8512838|P3|24-month Assessment|Not able to schedule visit in timeframe|2
2466823|NCT02391948|8512839|P2|24-month Assessment|Not able to schedule visit in timeframe|5
2466824|NCT02391948|8512840|P1|24-month Assessment|Not able to schedule visit in timeframe|8
2466825|NCT02391948|8512836|P5|24-month Assessment|Medical issue/illness|0
2466826|NCT02391948|8512837|P4|24-month Assessment|Medical issue/illness|0
2466827|NCT02391948|8512838|P3|24-month Assessment|Medical issue/illness|1
2466828|NCT02391948|8512839|P2|24-month Assessment|Medical issue/illness|0
2466829|NCT02391948|8512840|P1|24-month Assessment|Medical issue/illness|0
2466830|NCT02391948|8512836|P5|24-month Assessment|Lost to Follow-up|0
2466831|NCT02391948|8512837|P4|24-month Assessment|Lost to Follow-up|0
2466832|NCT02391948|8512838|P3|24-month Assessment|Lost to Follow-up|0
2466833|NCT02391948|8512839|P2|24-month Assessment|Lost to Follow-up|4
2466834|NCT02391948|8512840|P1|24-month Assessment|Lost to Follow-up|5
2466835|NCT02391948|8512836|P5|24-month Assessment|Withdrawal by Subject|1
2466836|NCT02391948|8512837|P4|24-month Assessment|Withdrawal by Subject|0
2466837|NCT02391948|8512838|P3|24-month Assessment|Withdrawal by Subject|0
2466838|NCT02391948|8512839|P2|24-month Assessment|Withdrawal by Subject|1
2466839|NCT02391948|8512840|P1|24-month Assessment|Withdrawal by Subject|1
2466840|NCT02391948|8512836|P5|24-month Assessment|Death|1
2466841|NCT02391948|8512837|P4|24-month Assessment|Death|0
2466842|NCT02391948|8512838|P3|24-month Assessment|Death|0
2466843|NCT02391948|8512839|P2|24-month Assessment|Death|0
2466844|NCT02391948|8512840|P1|24-month Assessment|Death|0
2466845|NCT02391948|8512836|P5|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22
2466846|NCT02391948|8512837|P4|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31
2466847|NCT02391948|8512838|P3|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22
2466848|NCT02391948|8512839|P2|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41
2466849|NCT02391948|8512840|P1|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66
2466850|NCT02391948|8512836|P5|18-month Assessment|Not able to schedule visit in timeframe|4
2466851|NCT02391948|8512837|P4|18-month Assessment|Not able to schedule visit in timeframe|1
2466852|NCT02391948|8512838|P3|18-month Assessment|Not able to schedule visit in timeframe|2
2466853|NCT02391948|8512839|P2|18-month Assessment|Not able to schedule visit in timeframe|3
2466854|NCT02391948|8512840|P1|18-month Assessment|Not able to schedule visit in timeframe|3
2466855|NCT02391948|8512836|P5|18-month Assessment|Lost to Follow-up|3
2466856|NCT02391948|8512837|P4|18-month Assessment|Lost to Follow-up|2
2466857|NCT02391948|8512838|P3|18-month Assessment|Lost to Follow-up|2
2466858|NCT02391948|8512839|P2|18-month Assessment|Lost to Follow-up|6
2466859|NCT02391948|8512840|P1|18-month Assessment|Lost to Follow-up|2
2466860|NCT02391948|8512836|P5|18-month Assessment|Withdrawal by Subject|0
2466861|NCT02391948|8512837|P4|18-month Assessment|Withdrawal by Subject|1
2466862|NCT02391948|8512838|P3|18-month Assessment|Withdrawal by Subject|0
2466863|NCT02391948|8512839|P2|18-month Assessment|Withdrawal by Subject|0
2466864|NCT02391948|8512840|P1|18-month Assessment|Withdrawal by Subject|1
2466865|NCT02391948|8512836|P5|18-month Assessment|Death|1
2466866|NCT02391948|8512837|P4|18-month Assessment|Death|1
2466867|NCT02391948|8512838|P3|18-month Assessment|Death|0
2466868|NCT02391948|8512839|P2|18-month Assessment|Death|0
2466869|NCT02391948|8512840|P1|18-month Assessment|Death|0
2466870|NCT02391948|8512836|P5|12-month Assessment|Not able to schedule visit in timeframe|1
2466871|NCT02391948|8512837|P4|12-month Assessment|Not able to schedule visit in timeframe|2
2466872|NCT02391948|8512838|P3|12-month Assessment|Not able to schedule visit in timeframe|0
2466873|NCT02391948|8512839|P2|12-month Assessment|Not able to schedule visit in timeframe|4
2466874|NCT02391948|8512840|P1|12-month Assessment|Not able to schedule visit in timeframe|2
2466875|NCT02391948|8512836|P5|12-month Assessment|Medical issue/illness|0
2466876|NCT02391948|8512837|P4|12-month Assessment|Medical issue/illness|1
2466877|NCT02391948|8512838|P3|12-month Assessment|Medical issue/illness|0
2466878|NCT02391948|8512839|P2|12-month Assessment|Medical issue/illness|1
2466879|NCT02391948|8512840|P1|12-month Assessment|Medical issue/illness|0
2466880|NCT02391948|8512836|P5|12-month Assessment|Lost to Follow-up|5
2466881|NCT02391948|8512837|P4|12-month Assessment|Lost to Follow-up|4
2466882|NCT02391948|8512838|P3|12-month Assessment|Lost to Follow-up|4
2466883|NCT02391948|8512839|P2|12-month Assessment|Lost to Follow-up|4
2466884|NCT02391948|8512840|P1|12-month Assessment|Lost to Follow-up|5
2466885|NCT02391948|8512836|P5|12-month Assessment|Withdrawal by Subject|0
2466886|NCT02391948|8512837|P4|12-month Assessment|Withdrawal by Subject|1
2466887|NCT02391948|8512838|P3|12-month Assessment|Withdrawal by Subject|0
2466888|NCT02391948|8512839|P2|12-month Assessment|Withdrawal by Subject|0
2466889|NCT02391948|8512840|P1|12-month Assessment|Withdrawal by Subject|1
2466890|NCT02391948|8512836|P5|12-month Assessment|Death|0
2466891|NCT02391948|8512837|P4|12-month Assessment|Death|1
2466892|NCT02391948|8512838|P3|12-month Assessment|Death|0
2466893|NCT02391948|8512839|P2|12-month Assessment|Death|0
2466894|NCT02391948|8512840|P1|12-month Assessment|Death|0
2466895|NCT02391948|8512836|P5|6-month Assessment|In 2-visit study (6-month N/A)|24
2466896|NCT02391948|8512837|P4|6-month Assessment|In 2-visit study (6-month N/A)|35
2466897|NCT02391948|8512838|P3|6-month Assessment|In 2-visit study (6-month N/A)|24
2466898|NCT02391948|8512839|P2|6-month Assessment|In 2-visit study (6-month N/A)|42
2466899|NCT02391948|8512840|P1|6-month Assessment|In 2-visit study (6-month N/A)|68
2466900|NCT02391948|8512836|P5|6-month Assessment|Not able to schedule visit in timeframe|0
2466901|NCT02391948|8512837|P4|6-month Assessment|Not able to schedule visit in timeframe|5
2466902|NCT02391948|8512838|P3|6-month Assessment|Not able to schedule visit in timeframe|4
2466903|NCT02391948|8512839|P2|6-month Assessment|Not able to schedule visit in timeframe|8
2466904|NCT02391948|8512840|P1|6-month Assessment|Not able to schedule visit in timeframe|6
2466905|NCT02391948|8512836|P5|6-month Assessment|Medical issue/illness|0
2466906|NCT02391948|8512837|P4|6-month Assessment|Medical issue/illness|0
2466907|NCT02391948|8512838|P3|6-month Assessment|Medical issue/illness|0
2466908|NCT02391948|8512839|P2|6-month Assessment|Medical issue/illness|1
2466909|NCT02391948|8512840|P1|6-month Assessment|Medical issue/illness|1
2466910|NCT02391948|8512836|P5|6-month Assessment|Lost to Follow-up|1
2466911|NCT02391948|8512837|P4|6-month Assessment|Lost to Follow-up|3
2466912|NCT02391948|8512838|P3|6-month Assessment|Lost to Follow-up|2
2466913|NCT02391948|8512839|P2|6-month Assessment|Lost to Follow-up|5
2466914|NCT02391948|8512840|P1|6-month Assessment|Lost to Follow-up|4
2466915|NCT02391948|8512836|P5|6-month Assessment|Withdrawal by Subject|0
2466916|NCT02391948|8512837|P4|6-month Assessment|Withdrawal by Subject|2
2466917|NCT02391948|8512838|P3|6-month Assessment|Withdrawal by Subject|1
2466918|NCT02391948|8512839|P2|6-month Assessment|Withdrawal by Subject|0
2466919|NCT02391948|8512840|P1|6-month Assessment|Withdrawal by Subject|0
2466920|NCT02391948|8512836|P5|6-month Assessment|Death|1
2466921|NCT02391948|8512837|P4|6-month Assessment|Death|0
2466922|NCT02391948|8512838|P3|6-month Assessment|Death|0
2466923|NCT02391948|8512839|P2|6-month Assessment|Death|0
2466924|NCT02391948|8512840|P1|6-month Assessment|Death|0
2466925|NCT02391584|8512964|P2|12 Month (End of Study)|Lost to Follow-up|0
2466926|NCT02391584|8512965|P1|12 Month (End of Study)|Lost to Follow-up|2
2466927|NCT02391584|8512964|P2|6 Month|Withdrawal by Subject|0
2466928|NCT02391584|8512965|P1|6 Month|Withdrawal by Subject|1
2466929|NCT02391584|8512964|P2|3 Month|Lost to Follow-up|0
2466930|NCT02391584|8512965|P1|3 Month|Lost to Follow-up|1
2466931|NCT02391584|8512964|P2|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0
2466932|NCT02391584|8512965|P1|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1
2466933|NCT02391584|8512964|P2|Primary Endpoint (6-weeks)|Lost to Follow-up|2
2466934|NCT02391584|8512965|P1|Primary Endpoint (6-weeks)|Lost to Follow-up|1
2466935|NCT02391545|8512982|P2|Overall Study|Other Reasons|4
2466936|NCT02391545|8512983|P1|Overall Study|Other Reasons|6
2466937|NCT02391545|8512982|P2|Overall Study|Withdrawal by Subject|1
2466938|NCT02391545|8512983|P1|Overall Study|Withdrawal by Subject|0
2466939|NCT02391545|8512982|P2|Overall Study|Termination of study by sponsor|20
2466940|NCT02391545|8512983|P1|Overall Study|Termination of study by sponsor|20
2466941|NCT02391545|8512982|P2|Overall Study|Lost to Follow-up|1
2466942|NCT02391545|8512983|P1|Overall Study|Lost to Follow-up|0
2466943|NCT02391545|8512982|P2|Overall Study|Death|2
2466944|NCT02391545|8512983|P1|Overall Study|Death|0
2466945|NCT02391363|8513003|P2|Overall Study|Withdrawal by Subject|3
2466946|NCT02391363|8513004|P1|Overall Study|Withdrawal by Subject|6
2466947|NCT02391363|8513003|P2|Overall Study|Lost to Follow-up|5
2466948|NCT02391363|8513004|P1|Overall Study|Lost to Follow-up|5
2466949|NCT02391311|8513070|P2|Overall Study|deemed ineligible after baseline|1
2466950|NCT02391311|8513071|P1|Overall Study|deemed ineligible after baseline|1
2466951|NCT02391311|8513070|P2|Overall Study|Lost to Follow-up|1
2466952|NCT02391311|8513071|P1|Overall Study|Lost to Follow-up|2
2466953|NCT02391116|8513079|P1|Survival Follow-up|Switching to Other Therapy|1
2466954|NCT02391116|8513079|P1|Survival Follow-up|Withdrawal by Subject|3
2466955|NCT02391116|8513079|P1|Active Follow-up|Switching to Other Therapy|2
2466956|NCT02391116|8513079|P1|Active Follow-up|Withdrawal by Subject|1
2466957|NCT02391116|8513079|P1|Safety Follow-up|Deterioration of General Conditions|3
2466958|NCT02391116|8513079|P1|Safety Follow-up|No Follow Up|1
2466959|NCT02391116|8513079|P1|Safety Follow-up|Switching to Other Therapy|4
2466960|NCT02391116|8513079|P1|Safety Follow-up|Withdrawal by Subject|4
2466961|NCT02391116|8513079|P1|Safety Follow-up|Adverse Event|1
2466962|NCT02391116|8513079|P1|Treatment|AE with Clinical PD|3
2466963|NCT02391116|8513079|P1|Treatment|Adverse Event (AE) Without Clinical PD|9
2466964|NCT02391116|8513079|P1|Treatment|Protocol Violation|1
2466965|NCT02391116|8513079|P1|Treatment|Withdrawal by Subject|1
2466966|NCT02391038|8513133|P3|Overall Study|Progressive disease|6
2466967|NCT02391038|8513134|P2|Overall Study|Progressive disease|3
2466968|NCT02391038|8513135|P1|Overall Study|Progressive disease|3
2466969|NCT02390557|8513279|P3|Wave 2|Survey non-respondent|23
2466970|NCT02390557|8513280|P2|Wave 2|Survey non-respondent|41
2466971|NCT02390557|8513281|P1|Wave 2|Survey non-respondent|72
2466972|NCT02390362|8513291|P2|Overall Study|Withdrawal by Subject|1
2466973|NCT02390362|8513292|P1|Overall Study|Withdrawal by Subject|0
2466974|NCT02390219|8513300|P1|Overall Study|Other|2
2466975|NCT02390219|8513300|P1|Overall Study|Lost to Follow-up|2
2466976|NCT02390219|8513300|P1|Overall Study|Withdrawal by Subject|1
2466977|NCT02390219|8513300|P1|Overall Study|Adverse Event|6
2466978|NCT02390219|8513300|P1|Overall Study|Physician Decision|1
2466979|NCT02390219|8513300|P1|Overall Study|Death|1
2466980|NCT02390167|8513310|P1|Overall Study|Lost to Follow-up|1
2466981|NCT02390076|8513332|P3|Overall Study|Lost to Follow-up|4
2466982|NCT02390076|8513333|P2|Overall Study|Lost to Follow-up|1
2466983|NCT02390076|8513334|P1|Overall Study|Lost to Follow-up|2
2466984|NCT02389894|8513363|P3|Overall Study|Lost to Follow-up|1
2466985|NCT02389894|8513364|P2|Overall Study|Lost to Follow-up|1
2466986|NCT02389894|8513365|P1|Overall Study|Lost to Follow-up|2
2466987|NCT02389894|8513363|P3|Overall Study|Withdrawal by Subject|5
2466988|NCT02389894|8513364|P2|Overall Study|Withdrawal by Subject|4
2466989|NCT02389894|8513365|P1|Overall Study|Withdrawal by Subject|2
2466990|NCT02389894|8513363|P3|Overall Study|Death|3
2466991|NCT02389894|8513364|P2|Overall Study|Death|5
2466992|NCT02389894|8513365|P1|Overall Study|Death|4
2466993|NCT02389829|8513497|P2|Overall Study|Lost to Follow-up|1
2466994|NCT02389829|8513498|P1|Overall Study|Lost to Follow-up|0
2466995|NCT02389816|8513513|P3|Overall Study|Reason not Specified|0
2466996|NCT02389816|8513514|P2|Overall Study|Reason not Specified|2
2466997|NCT02389816|8513515|P1|Overall Study|Reason not Specified|0
2466998|NCT02389816|8513513|P3|Overall Study|Non Compliance with Study Drug|1
2466999|NCT02389816|8513514|P2|Overall Study|Non Compliance with Study Drug|1
2467000|NCT02389816|8513515|P1|Overall Study|Non Compliance with Study Drug|1
2467001|NCT02389816|8513513|P3|Overall Study|Lack of Efficacy|0
2467002|NCT02389816|8513514|P2|Overall Study|Lack of Efficacy|0
2467003|NCT02389816|8513515|P1|Overall Study|Lack of Efficacy|1
2467004|NCT02389816|8513513|P3|Overall Study|Withdrawal of Consent|4
2467005|NCT02389816|8513514|P2|Overall Study|Withdrawal of Consent|4
2467006|NCT02389816|8513515|P1|Overall Study|Withdrawal of Consent|6
2467007|NCT02389816|8513513|P3|Overall Study|Lost to Follow-up|0
2467008|NCT02389816|8513514|P2|Overall Study|Lost to Follow-up|0
2467009|NCT02389816|8513515|P1|Overall Study|Lost to Follow-up|1
2467010|NCT02389816|8513513|P3|Overall Study|Major Protocol Deviation|0
2467011|NCT02389816|8513514|P2|Overall Study|Major Protocol Deviation|0
2467012|NCT02389816|8513515|P1|Overall Study|Major Protocol Deviation|1
2467013|NCT02389816|8513513|P3|Overall Study|Pretreatment Event or Adverse Event (AE)|7
2467014|NCT02389816|8513514|P2|Overall Study|Pretreatment Event or Adverse Event (AE)|6
2467015|NCT02389816|8513515|P1|Overall Study|Pretreatment Event or Adverse Event (AE)|4
2467016|NCT02389816|8513513|P3|Overall Study|Randomized but Not Treated|0
2467017|NCT02389816|8513514|P2|Overall Study|Randomized but Not Treated|0
2467018|NCT02389816|8513515|P1|Overall Study|Randomized but Not Treated|1
2467019|NCT02389764|8513547|P1|Overall Study|Lack of Efficacy|9
2467020|NCT02389621|8513582|P2|Posttreatment Period|Other - Miscellaneous|0
2467021|NCT02389621|8513583|P1|Posttreatment Period|Other - Miscellaneous|2
2467022|NCT02389621|8513582|P2|Posttreatment Period|Lost to Follow-up|1
2467023|NCT02389621|8513583|P1|Posttreatment Period|Lost to Follow-up|1
2467024|NCT02389621|8513582|P2|Posttreatment Period|Withdrawal by Subject|2
2467025|NCT02389621|8513583|P1|Posttreatment Period|Withdrawal by Subject|3
2467026|NCT02389621|8513582|P2|Posttreatment Period|Adverse Event|1
2467027|NCT02389621|8513583|P1|Posttreatment Period|Adverse Event|3
2467028|NCT02389621|8513582|P2|Treatment Period|Withdrawal by Subject|1
2467029|NCT02389621|8513583|P1|Treatment Period|Withdrawal by Subject|1
2467030|NCT02389452|8513613|P1|Overall Study|Enrolled but Not Eligible for Study|6
2467031|NCT02389452|8513613|P1|Overall Study|Withdrawal by Subject|5
2467032|NCT02389452|8513613|P1|Overall Study|Adverse Event|1
2467033|NCT02389452|8513613|P1|Overall Study|Lost to Follow-up|13
2467034|NCT02388997|8513725|P2|Overall Study|Tested positive for virus during run-in|1
2467035|NCT02388997|8513726|P1|Overall Study|Tested positive for virus during run-in|0
2467036|NCT02388997|8513725|P2|Overall Study|Lung function exclusion criteria|2
2467037|NCT02388997|8513726|P1|Overall Study|Lung function exclusion criteria|0
2467038|NCT02388997|8513725|P2|Overall Study|Withdrawal by Subject|1
2467039|NCT02388997|8513726|P1|Overall Study|Withdrawal by Subject|2
2467040|NCT02388997|8513725|P2|Overall Study|Adverse Event|2
2467041|NCT02388997|8513726|P1|Overall Study|Adverse Event|1
2467042|NCT02388932|8513744|P1|Overall Study|Death|1
2467043|NCT02388776|8513765|P1|Overall Study|Lost to Follow-up|1
2467044|NCT02388776|8513765|P1|Overall Study|Death|1
2467045|NCT02388763|8513770|P2|Period 1, 10 Days of Wear|Withdrawal by Subject|1
2467046|NCT02388763|8513771|P1|Period 1, 10 Days of Wear|Withdrawal by Subject|1
2467047|NCT02388763|8513770|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|1
2467048|NCT02388763|8513771|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|1
2467049|NCT02388737|8513785|P3|Overall Study|Reason Not Specified|4
2467050|NCT02388737|8513786|P2|Overall Study|Reason Not Specified|5
2467051|NCT02388737|8513787|P1|Overall Study|Reason Not Specified|5
2467052|NCT02388737|8513785|P3|Overall Study|Lack of Efficacy|3
2467053|NCT02388737|8513786|P2|Overall Study|Lack of Efficacy|0
2467054|NCT02388737|8513787|P1|Overall Study|Lack of Efficacy|3
2467055|NCT02388737|8513785|P3|Overall Study|Voluntary Withdrawal|17
2467056|NCT02388737|8513786|P2|Overall Study|Voluntary Withdrawal|18
2467057|NCT02388737|8513787|P1|Overall Study|Voluntary Withdrawal|10
2467058|NCT02388737|8513785|P3|Overall Study|Lost to Follow-up|4
2467059|NCT02388737|8513786|P2|Overall Study|Lost to Follow-up|1
2467060|NCT02388737|8513787|P1|Overall Study|Lost to Follow-up|5
2467061|NCT02388737|8513785|P3|Overall Study|Major Protocol Deviation|22
2467062|NCT02388737|8513786|P2|Overall Study|Major Protocol Deviation|25
2467063|NCT02388737|8513787|P1|Overall Study|Major Protocol Deviation|18
2467064|NCT02388737|8513785|P3|Overall Study|Pretreatment Event/Adverse Event|12
2467065|NCT02388737|8513786|P2|Overall Study|Pretreatment Event/Adverse Event|11
2467066|NCT02388737|8513787|P1|Overall Study|Pretreatment Event/Adverse Event|13
2467067|NCT02388724|8513821|P2|Overall Study|Randomized but not Treated|2
2467068|NCT02388724|8513822|P1|Overall Study|Randomized but not Treated|0
2467069|NCT02388724|8513821|P2|Overall Study|Voluntary Withdrawal|5
2467070|NCT02388724|8513822|P1|Overall Study|Voluntary Withdrawal|6
2467071|NCT02388724|8513821|P2|Overall Study|Pretreatment Event/Adverse Event|2
2467072|NCT02388724|8513822|P1|Overall Study|Pretreatment Event/Adverse Event|3
2467073|NCT02388724|8513821|P2|Overall Study|Major Protocol Deviation|3
2467074|NCT02388724|8513822|P1|Overall Study|Major Protocol Deviation|3
2467075|NCT02388724|8513821|P2|Overall Study|Reason not Specified|1
2467076|NCT02388724|8513822|P1|Overall Study|Reason not Specified|0
2467077|NCT02388347|8513868|P5|Overall Study|Withdrawal by Subject|0
2467078|NCT02388347|8513869|P4|Overall Study|Withdrawal by Subject|0
2467079|NCT02388347|8513870|P3|Overall Study|Withdrawal by Subject|1
2467080|NCT02388347|8513871|P2|Overall Study|Withdrawal by Subject|0
2467081|NCT02388347|8513872|P1|Overall Study|Withdrawal by Subject|0
2467082|NCT02388295|8513951|P3|Treatment Weeks 3 to 12|Adverse Event|0
2467083|NCT02388295|8513952|P2|Treatment Weeks 3 to 12|Adverse Event|1
2467084|NCT02388295|8513953|P1|Treatment Weeks 3 to 12|Adverse Event|1
2467085|NCT02388295|8513951|P3|Dose Escalation Week 2|Determined not eligible|1
2467086|NCT02388295|8513952|P2|Dose Escalation Week 2|Determined not eligible|1
2467087|NCT02388295|8513953|P1|Dose Escalation Week 2|Determined not eligible|1
2467088|NCT02388295|8513951|P3|Dose Escalation Week 2|Protocol Violation|0
2467089|NCT02388295|8513952|P2|Dose Escalation Week 2|Protocol Violation|1
2467090|NCT02388295|8513953|P1|Dose Escalation Week 2|Protocol Violation|0
2467091|NCT02388295|8513951|P3|Dose Escalation Week 1|Determined not eligible|1
2467092|NCT02388295|8513952|P2|Dose Escalation Week 1|Determined not eligible|1
2467093|NCT02388295|8513953|P1|Dose Escalation Week 1|Determined not eligible|1
2467094|NCT02388295|8513951|P3|Dose Escalation Week 1|Adverse Event|1
2467095|NCT02388295|8513952|P2|Dose Escalation Week 1|Adverse Event|2
2467096|NCT02388295|8513953|P1|Dose Escalation Week 1|Adverse Event|1
2467097|NCT02388269|8513971|P3|Overall Study|Screen Failure|10
2467098|NCT02388269|8513972|P2|Overall Study|Screen Failure|0
2467099|NCT02388269|8513973|P1|Overall Study|Screen Failure|0
2467100|NCT02388269|8513971|P3|Overall Study|Protocol Violation|0
2467101|NCT02388269|8513972|P2|Overall Study|Protocol Violation|0
2467102|NCT02388269|8513973|P1|Overall Study|Protocol Violation|2
2467103|NCT02388269|8513971|P3|Overall Study|no diary data|0
2467104|NCT02388269|8513972|P2|Overall Study|no diary data|0
2467105|NCT02388269|8513973|P1|Overall Study|no diary data|3
2467106|NCT02388269|8513971|P3|Overall Study|less than 50% stimulations|0
2467107|NCT02388269|8513972|P2|Overall Study|less than 50% stimulations|0
2467108|NCT02388269|8513973|P1|Overall Study|less than 50% stimulations|1
2467109|NCT02388269|8513971|P3|Overall Study|Withdrawal by Subject|0
2467110|NCT02388269|8513972|P2|Overall Study|Withdrawal by Subject|2
2467111|NCT02388269|8513973|P1|Overall Study|Withdrawal by Subject|1
2467112|NCT02388269|8513971|P3|Overall Study|Adverse Event|0
2467113|NCT02388269|8513972|P2|Overall Study|Adverse Event|0
2467114|NCT02388269|8513973|P1|Overall Study|Adverse Event|2
2467115|NCT02388191|8514005|P2|Overall Study|Patient did not receive IUD|0
2467116|NCT02388191|8514006|P1|Overall Study|Patient did not receive IUD|1
2467117|NCT02388074|8514020|P1|Overall Study|Sample Not Returned|1
2467118|NCT02388074|8514020|P1|Overall Study|Lost in Transit|2
2467119|NCT02387996|8514024|P1|Overall Study|Poor/Non-Compliance|1
2467120|NCT02387996|8514024|P1|Overall Study|Lost to Follow-up|1
2467121|NCT02387996|8514024|P1|Overall Study|Subject Withdrew Consent|1
2467122|NCT02387996|8514024|P1|Overall Study|Subject Request to Discontinue Treatment|9
2467123|NCT02387996|8514024|P1|Overall Study|Adverse Event Unrelated to Study Drug|34
2467124|NCT02387996|8514024|P1|Overall Study|Study Drug Toxicity|14
2467125|NCT02387996|8514024|P1|Overall Study|Disease Progression|144
2467126|NCT02387983|8514035|P1|Overall Study|Withdrawal by Subject|2
2467127|NCT02387983|8514035|P1|Overall Study|Protocol Violation|1
2467128|NCT02387983|8514035|P1|Overall Study|Adverse Event|4
2467129|NCT02387970|8514049|P2|Overall Study|Did not complete 1-year follow up|2
2467130|NCT02387970|8514050|P1|Overall Study|Did not complete 1-year follow up|1
2467131|NCT02387957|8514071|P3|Overall Study|The study was discontinued|20
2467132|NCT02387957|8514072|P2|Overall Study|The study was discontinued|21
2467133|NCT02387957|8514073|P1|Overall Study|The study was discontinued|21
2467134|NCT02387762|8514144|P2|Overall Study|Withdrawal by Subject|0
2467135|NCT02387762|8514145|P1|Overall Study|Withdrawal by Subject|1
2467136|NCT02387580|8514177|P6|Overall Study|Withdrawal by Subject|0
2467137|NCT02387580|8514178|P5|Overall Study|Withdrawal by Subject|0
2467138|NCT02387580|8514179|P4|Overall Study|Withdrawal by Subject|1
2467139|NCT02387580|8514180|P3|Overall Study|Withdrawal by Subject|0
2467140|NCT02387580|8514181|P2|Overall Study|Withdrawal by Subject|0
2467141|NCT02387580|8514182|P1|Overall Study|Withdrawal by Subject|0
2467142|NCT02387372|8514275|P2|Overall Study|Not Treated|0
2467143|NCT02387372|8514276|P1|Overall Study|Not Treated|1
2467144|NCT02386345|8514386|P1|Overall Study|Did not complete 12-month follow-up|72
2467145|NCT02386345|8514386|P1|Overall Study|Repeat Procedure|10
2467146|NCT02386345|8514386|P1|Overall Study|Adverse Event|5
2467147|NCT02386345|8514386|P1|Overall Study|Lost to Follow-up|1
2467148|NCT02386345|8514386|P1|Overall Study|Not treated|14
2467149|NCT02386189|8514396|P2|Overall Study|Death|0
2467150|NCT02386189|8514397|P1|Overall Study|Death|1
2467151|NCT02386189|8514396|P2|Overall Study|Withdrawal by Subject|0
2467152|NCT02386189|8514397|P1|Overall Study|Withdrawal by Subject|1
2467153|NCT02386189|8514396|P2|Overall Study|Lost to Follow-up|3
2467154|NCT02386189|8514397|P1|Overall Study|Lost to Follow-up|2
2467155|NCT02386098|8514420|P5|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
2467156|NCT02386098|8514421|P4|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
2467157|NCT02386098|8514422|P3|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
2467158|NCT02386098|8514423|P2|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8
2467159|NCT02386098|8514424|P1|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5
2467160|NCT02386098|8514420|P5|Stage 1 (96 Weeks)|Other|0
2467161|NCT02386098|8514421|P4|Stage 1 (96 Weeks)|Other|0
2467162|NCT02386098|8514422|P3|Stage 1 (96 Weeks)|Other|0
2467163|NCT02386098|8514423|P2|Stage 1 (96 Weeks)|Other|0
2467164|NCT02386098|8514424|P1|Stage 1 (96 Weeks)|Other|1
2467165|NCT02386098|8514420|P5|Stage 1 (96 Weeks)|Withdrawal by Subject|0
2467166|NCT02386098|8514421|P4|Stage 1 (96 Weeks)|Withdrawal by Subject|0
2467167|NCT02386098|8514422|P3|Stage 1 (96 Weeks)|Withdrawal by Subject|0
2467168|NCT02386098|8514423|P2|Stage 1 (96 Weeks)|Withdrawal by Subject|1
2467169|NCT02386098|8514424|P1|Stage 1 (96 Weeks)|Withdrawal by Subject|3
2467170|NCT02386098|8514420|P5|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
2467171|NCT02386098|8514421|P4|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
2467172|NCT02386098|8514422|P3|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
2467173|NCT02386098|8514423|P2|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2
2467174|NCT02386098|8514424|P1|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
2467175|NCT02386098|8514420|P5|Stage 1 (96 Weeks)|Lost to Follow-up|0
2467176|NCT02386098|8514421|P4|Stage 1 (96 Weeks)|Lost to Follow-up|0
2467177|NCT02386098|8514422|P3|Stage 1 (96 Weeks)|Lost to Follow-up|0
2467178|NCT02386098|8514423|P2|Stage 1 (96 Weeks)|Lost to Follow-up|2
2467179|NCT02386098|8514424|P1|Stage 1 (96 Weeks)|Lost to Follow-up|2
2467180|NCT02386098|8514420|P5|Stage 1 (96 Weeks)|Adverse Event|0
2467181|NCT02386098|8514421|P4|Stage 1 (96 Weeks)|Adverse Event|0
2467182|NCT02386098|8514422|P3|Stage 1 (96 Weeks)|Adverse Event|0
2467183|NCT02386098|8514423|P2|Stage 1 (96 Weeks)|Adverse Event|1
2467184|NCT02386098|8514424|P1|Stage 1 (96 Weeks)|Adverse Event|2
2467185|NCT02386098|8514420|P5|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
2467186|NCT02386098|8514421|P4|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
2467187|NCT02386098|8514422|P3|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
2467188|NCT02386098|8514423|P2|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29
2467189|NCT02386098|8514424|P1|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30
2467190|NCT02385799|8514503|P2|Overall Study|Withdrawal by Subject|4
2467191|NCT02385799|8514504|P1|Overall Study|Withdrawal by Subject|0
2467192|NCT02385799|8514503|P2|Overall Study|Adverse Event|2
2467193|NCT02385799|8514504|P1|Overall Study|Adverse Event|4
2467194|NCT02385799|8514503|P2|Overall Study|Lost to Follow-up|2
2467195|NCT02385799|8514504|P1|Overall Study|Lost to Follow-up|1
2467196|NCT02385708|8514545|P2|Overall Study|Protocol Violation|1
2467197|NCT02385708|8514546|P1|Overall Study|Protocol Violation|1
2467198|NCT02385708|8514545|P2|Overall Study|Investigator decision|7
2467199|NCT02385708|8514546|P1|Overall Study|Investigator decision|5
2467200|NCT02385708|8514545|P2|Overall Study|Withdrawn - surgery canceled|5
2467201|NCT02385708|8514546|P1|Overall Study|Withdrawn - surgery canceled|2
2467202|NCT02385708|8514545|P2|Overall Study|Withdrawal by Subject|2
2467203|NCT02385708|8514546|P1|Overall Study|Withdrawal by Subject|0
2467204|NCT02385669|8514552|P1|Overall Study|Adverse Event|2
2467205|NCT02385526|8514560|P3|Overall Study|Protocol Violation|0
2467206|NCT02385526|8514561|P2|Overall Study|Protocol Violation|0
2467207|NCT02385526|8514562|P1|Overall Study|Protocol Violation|1
2467208|NCT02385526|8514560|P3|Overall Study|Physician Decision|0
2467209|NCT02385526|8514561|P2|Overall Study|Physician Decision|0
2467210|NCT02385526|8514562|P1|Overall Study|Physician Decision|1
2467211|NCT02385526|8514560|P3|Overall Study|Lost to Follow-up|0
2467212|NCT02385526|8514561|P2|Overall Study|Lost to Follow-up|1
2467213|NCT02385526|8514562|P1|Overall Study|Lost to Follow-up|0
2467214|NCT02385526|8514560|P3|Overall Study|Withdrawal by Subject|0
2467215|NCT02385526|8514561|P2|Overall Study|Withdrawal by Subject|2
2467216|NCT02385526|8514562|P1|Overall Study|Withdrawal by Subject|0
2467217|NCT02385084|8514570|P6|Period 2|Protocol Violation|0
2467218|NCT02385084|8514571|P5|Period 2|Protocol Violation|0
2467219|NCT02385084|8514572|P4|Period 2|Protocol Violation|0
2467220|NCT02385084|8514573|P3|Period 2|Protocol Violation|1
2467221|NCT02385084|8514574|P2|Period 2|Protocol Violation|0
2467222|NCT02385084|8514575|P1|Period 2|Protocol Violation|0
2467223|NCT02384993|8514588|P2|Overall Study|Adverse Event|1
2467224|NCT02384993|8514589|P1|Overall Study|Adverse Event|0
2467225|NCT02384941|8514615|P3|Overall Study|Other than specified above|1
2467226|NCT02384941|8514616|P2|Overall Study|Other than specified above|0
2467227|NCT02384941|8514617|P1|Overall Study|Other than specified above|4
2467228|NCT02384941|8514615|P3|Overall Study|Pregnancy|1
2467229|NCT02384941|8514616|P2|Overall Study|Pregnancy|0
2467230|NCT02384941|8514617|P1|Overall Study|Pregnancy|0
2467231|NCT02384941|8514615|P3|Overall Study|Withdrawal by Subject|20
2467232|NCT02384941|8514616|P2|Overall Study|Withdrawal by Subject|19
2467233|NCT02384941|8514617|P1|Overall Study|Withdrawal by Subject|26
2467234|NCT02384941|8514615|P3|Overall Study|Protocol Violation|0
2467235|NCT02384941|8514616|P2|Overall Study|Protocol Violation|0
2467236|NCT02384941|8514617|P1|Overall Study|Protocol Violation|3
2467237|NCT02384941|8514615|P3|Overall Study|Physician Decision|0
2467238|NCT02384941|8514616|P2|Overall Study|Physician Decision|1
2467239|NCT02384941|8514617|P1|Overall Study|Physician Decision|1
2467240|NCT02384941|8514615|P3|Overall Study|Non-Compliance With Study Drug|1
2467241|NCT02384941|8514616|P2|Overall Study|Non-Compliance With Study Drug|0
2467242|NCT02384941|8514617|P1|Overall Study|Non-Compliance With Study Drug|2
2467243|NCT02384941|8514615|P3|Overall Study|Lost to Follow-up|1
2467244|NCT02384941|8514616|P2|Overall Study|Lost to Follow-up|2
2467245|NCT02384941|8514617|P1|Overall Study|Lost to Follow-up|3
2467246|NCT02384941|8514615|P3|Overall Study|Adverse Event|17
2467247|NCT02384941|8514616|P2|Overall Study|Adverse Event|13
2467248|NCT02384941|8514617|P1|Overall Study|Adverse Event|11
2467249|NCT02384538|8514648|P2|Overall Study|Other|3
2467250|NCT02384538|8514649|P1|Overall Study|Other|1
2467251|NCT02384538|8514648|P2|Overall Study|Withdrew Consent|4
2467252|NCT02384538|8514649|P1|Overall Study|Withdrew Consent|0
2467253|NCT02384538|8514648|P2|Overall Study|Lack of Efficacy|4
2467254|NCT02384538|8514649|P1|Overall Study|Lack of Efficacy|4
2467255|NCT02384538|8514648|P2|Overall Study|Adverse Event|4
2467256|NCT02384538|8514649|P1|Overall Study|Adverse Event|1
2467257|NCT02384460|8514669|P2|Overall Study|Non-compliance|0
2467258|NCT02384460|8514670|P1|Overall Study|Non-compliance|1
2467259|NCT02384460|8514669|P2|Overall Study|Elective medical treatment|0
2467260|NCT02384460|8514670|P1|Overall Study|Elective medical treatment|1
2467261|NCT02384460|8514669|P2|Overall Study|Withdrawal by Subject|3
2467262|NCT02384460|8514670|P1|Overall Study|Withdrawal by Subject|0
2467263|NCT02384460|8514669|P2|Overall Study|Adverse Event|2
2467264|NCT02384460|8514670|P1|Overall Study|Adverse Event|5
2467265|NCT02384460|8514669|P2|Overall Study|Returned to previous therapeutic regimen|1
2467266|NCT02384460|8514670|P1|Overall Study|Returned to previous therapeutic regimen|0
2467267|NCT02384460|8514669|P2|Overall Study|Protocol Violation|1
2467268|NCT02384460|8514670|P1|Overall Study|Protocol Violation|0
2467269|NCT02383966|8514755|P2|Overall Study|Randomized, but not treated|3
2467270|NCT02383966|8514756|P1|Overall Study|Randomized, but not treated|1
2467271|NCT02383966|8514755|P2|Overall Study|Ongoing at clinical cut-off date|4
2467272|NCT02383966|8514756|P1|Overall Study|Ongoing at clinical cut-off date|25
2467273|NCT02383940|8514776|P2|Overall Study|Other than specified above|0
2467274|NCT02383940|8514777|P1|Overall Study|Other than specified above|1
2467275|NCT02383940|8514776|P2|Overall Study|Randomized but not treated|0
2467276|NCT02383940|8514777|P1|Overall Study|Randomized but not treated|2
2467277|NCT02383940|8514776|P2|Overall Study|Withdrawal by Subject|1
2467278|NCT02383940|8514777|P1|Overall Study|Withdrawal by Subject|1
2467279|NCT02383940|8514776|P2|Overall Study|Physician Decision|0
2467280|NCT02383940|8514777|P1|Overall Study|Physician Decision|2
2467281|NCT02383940|8514776|P2|Overall Study|Lost to Follow-up|2
2467282|NCT02383940|8514777|P1|Overall Study|Lost to Follow-up|2
2467283|NCT02383940|8514776|P2|Overall Study|Adverse Event|0
2467284|NCT02383940|8514777|P1|Overall Study|Adverse Event|1
2467285|NCT02383862|8514793|P2|3 Month Follow up|Lost to Follow-up|21
2467286|NCT02383862|8514794|P1|3 Month Follow up|Lost to Follow-up|23
2467287|NCT02383758|8514827|P2|Overall Study|Withdrawal by Subject|2
2467288|NCT02383758|8514828|P1|Overall Study|Withdrawal by Subject|0
2467289|NCT02383589|8514856|P2|Overall Study|Non-compliance with study drug|1
2467290|NCT02383589|8514857|P1|Overall Study|Non-compliance with study drug|0
2467291|NCT02383589|8514856|P2|Overall Study|Withdrawal by Subject|5
2467292|NCT02383589|8514857|P1|Overall Study|Withdrawal by Subject|0
2467293|NCT02383589|8514856|P2|Overall Study|Lost to Follow-up|1
2467294|NCT02383589|8514857|P1|Overall Study|Lost to Follow-up|0
2467295|NCT02383589|8514856|P2|Overall Study|Adverse Event|3
2467296|NCT02383589|8514857|P1|Overall Study|Adverse Event|1
2467297|NCT02383576|8514880|P2|Overall Study|Administrative/Other|4
2467298|NCT02383576|8514881|P1|Overall Study|Administrative/Other|2
2467299|NCT02383576|8514880|P2|Overall Study|Investigator's Decision|1
2467300|NCT02383576|8514881|P1|Overall Study|Investigator's Decision|0
2467301|NCT02383576|8514880|P2|Overall Study|Withdrew Consent|6
2467302|NCT02383576|8514881|P1|Overall Study|Withdrew Consent|1
2467303|NCT02383576|8514880|P2|Overall Study|Lost to Follow-up|1
2467304|NCT02383576|8514881|P1|Overall Study|Lost to Follow-up|7
2467305|NCT02383576|8514880|P2|Overall Study|Death|33
2467306|NCT02383576|8514881|P1|Overall Study|Death|53
2467307|NCT02383472|8514897|P2|Overall Study|Withdrawal by Subject|1
2467308|NCT02383472|8514898|P1|Overall Study|Withdrawal by Subject|1
2467309|NCT02383433|8514912|P1|Overall Study|Disease progression|2
2467310|NCT02383355|8514931|P2|Overall Study|Adverse Event|0
2467311|NCT02383355|8514932|P1|Overall Study|Adverse Event|2
2467312|NCT02383056|8514948|P2|Overall Study|Lost to Follow-up|2
2467313|NCT02383056|8514949|P1|Overall Study|Lost to Follow-up|0
2467314|NCT02383056|8514948|P2|Overall Study|Adverse Event|0
2467315|NCT02383056|8514949|P1|Overall Study|Adverse Event|1
2467316|NCT02382991|8514975|P2|Overall Study|Withdrawal by Subject|1
2467317|NCT02382991|8514976|P1|Overall Study|Withdrawal by Subject|0
2467318|NCT02382991|8514975|P2|Overall Study|Lost to Follow-up|0
2467319|NCT02382991|8514976|P1|Overall Study|Lost to Follow-up|1
2467320|NCT02382991|8514975|P2|Overall Study|Adverse Event|2
2467321|NCT02382991|8514976|P1|Overall Study|Adverse Event|1
2467322|NCT02382640|8515103|P4|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
2467323|NCT02382640|8515104|P3|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
2467324|NCT02382640|8515105|P2|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
2467325|NCT02382640|8515106|P1|Intervention Period 4 (3 Days)|Laboratory Abnormality|1
2467326|NCT02382133|8515144|P1|Overall Study|pressure injury both sites|1
2467327|NCT02382133|8515144|P1|Overall Study|arterial catheter loss|4
2467328|NCT02382133|8515144|P1|Overall Study|Physician Decision|2
2467329|NCT02382133|8515144|P1|Overall Study|transfer out of ICU|4
2467330|NCT02382133|8515144|P1|Overall Study|Death|22
2467331|NCT02382016|8515151|P2|OL Extension Period|Withdrawal by Subject|0
2467332|NCT02382016|8515152|P1|OL Extension Period|Withdrawal by Subject|1
2467333|NCT02382016|8515151|P2|OL Extension Period|Death|0
2467334|NCT02382016|8515152|P1|OL Extension Period|Death|2
2467335|NCT02382016|8515151|P2|OL Extension Period|Physician Decision|0
2467336|NCT02382016|8515152|P1|OL Extension Period|Physician Decision|3
2467337|NCT02382016|8515151|P2|Open-label (OL) Treatment Period|Death|0
2467338|NCT02382016|8515152|P1|Open-label (OL) Treatment Period|Death|4
2467339|NCT02382016|8515151|P2|Open-label (OL) Treatment Period|Withdrawal by Subject|0
2467340|NCT02382016|8515152|P1|Open-label (OL) Treatment Period|Withdrawal by Subject|2
2467341|NCT02382016|8515151|P2|Open-label (OL) Treatment Period|Physician Decision|0
2467342|NCT02382016|8515152|P1|Open-label (OL) Treatment Period|Physician Decision|3
2467343|NCT02382016|8515151|P2|Double-blind (DB) Treatment Period|Withdrawal by Subject|1
2467344|NCT02382016|8515152|P1|Double-blind (DB) Treatment Period|Withdrawal by Subject|0
2467345|NCT02382016|8515151|P2|Double-blind (DB) Treatment Period|Lack of Efficacy|0
2467346|NCT02382016|8515152|P1|Double-blind (DB) Treatment Period|Lack of Efficacy|1
2467347|NCT02382016|8515151|P2|Double-blind (DB) Treatment Period|Physician Decision|0
2467348|NCT02382016|8515152|P1|Double-blind (DB) Treatment Period|Physician Decision|3
2467349|NCT02381795|8515176|P1|Overall Study|Study Terminated|2
2467350|NCT02381795|8515176|P1|Overall Study|Withdrawal by Subject|1
2467351|NCT02380859|8515284|P2|Overall Study|Withdrawal by Subject|0
2467352|NCT02380859|8515285|P1|Overall Study|Withdrawal by Subject|2
2467353|NCT02380742|8515321|P2|Overall Study|Withdrawal by Subject|0
2467354|NCT02380742|8515322|P1|Overall Study|Withdrawal by Subject|1
2467355|NCT02380287|8515342|P8|Overall Study|Adverse Event|0
2467356|NCT02380287|8515343|P7|Overall Study|Adverse Event|0
2467357|NCT02380287|8515344|P6|Overall Study|Adverse Event|0
2467358|NCT02380287|8515345|P5|Overall Study|Adverse Event|0
2467359|NCT02380287|8515346|P4|Overall Study|Adverse Event|0
2467360|NCT02380287|8515347|P3|Overall Study|Adverse Event|1
2467361|NCT02380287|8515348|P2|Overall Study|Adverse Event|0
2467362|NCT02380287|8515349|P1|Overall Study|Adverse Event|0
2467363|NCT02380248|8515365|P1|Overall Study|Withdrawal by Subject|3
2467364|NCT02380248|8515365|P1|Overall Study|Lost to Follow-up|11
2467365|NCT02379923|8515381|P1|Overall Study|Death|5
2467366|NCT02379728|8515410|P4|Overall Study|Protocol Violation|0
2467367|NCT02379728|8515411|P3|Overall Study|Protocol Violation|2
2467368|NCT02379728|8515412|P2|Overall Study|Protocol Violation|0
2467369|NCT02379728|8515413|P1|Overall Study|Protocol Violation|0
2467370|NCT02379728|8515410|P4|Overall Study|Withdrawal by Subject|3
2467371|NCT02379728|8515411|P3|Overall Study|Withdrawal by Subject|5
2467372|NCT02379728|8515412|P2|Overall Study|Withdrawal by Subject|0
2467373|NCT02379728|8515413|P1|Overall Study|Withdrawal by Subject|5
2467374|NCT02379728|8515410|P4|Overall Study|Lost to Follow-up|0
2467375|NCT02379728|8515411|P3|Overall Study|Lost to Follow-up|3
2467376|NCT02379728|8515412|P2|Overall Study|Lost to Follow-up|0
2467377|NCT02379728|8515413|P1|Overall Study|Lost to Follow-up|1
2467378|NCT02379637|8515469|P2|Overall Study|Withdrawal by Subject|0
2467379|NCT02379637|8515470|P1|Overall Study|Withdrawal by Subject|1
2467380|NCT02379637|8515469|P2|Overall Study|Adverse Event|0
2467381|NCT02379637|8515470|P1|Overall Study|Adverse Event|1
2467382|NCT02379637|8515469|P2|Overall Study|Protocol Violation|1
2467383|NCT02379637|8515470|P1|Overall Study|Protocol Violation|0
2467384|NCT02379390|8515509|P2|Overall Study|Study Termination|1
2467385|NCT02379390|8515510|P1|Overall Study|Study Termination|0
2467386|NCT02379390|8515509|P2|Overall Study|Investigator’s decision|0
2467387|NCT02379390|8515510|P1|Overall Study|Investigator’s decision|1
2467388|NCT02379390|8515509|P2|Overall Study|Adverse Event|1
2467389|NCT02379390|8515510|P1|Overall Study|Adverse Event|1
2467390|NCT02379221|8515538|P1|Overall Study|Lost to Follow-up|1
2467391|NCT02379091|8515574|P4|Overall Study|Lack of Efficacy|0
2467392|NCT02379091|8515575|P3|Overall Study|Lack of Efficacy|0
2467393|NCT02379091|8515576|P2|Overall Study|Lack of Efficacy|0
2467394|NCT02379091|8515577|P1|Overall Study|Lack of Efficacy|3
2467395|NCT02379091|8515574|P4|Overall Study|Study Termination|8
2467396|NCT02379091|8515575|P3|Overall Study|Study Termination|5
2467397|NCT02379091|8515576|P2|Overall Study|Study Termination|2
2467398|NCT02379091|8515577|P1|Overall Study|Study Termination|7
2467399|NCT02379091|8515574|P4|Overall Study|Voluntary Withdrawal|4
2467400|NCT02379091|8515575|P3|Overall Study|Voluntary Withdrawal|2
2467401|NCT02379091|8515576|P2|Overall Study|Voluntary Withdrawal|5
2467402|NCT02379091|8515577|P1|Overall Study|Voluntary Withdrawal|2
2467403|NCT02379091|8515574|P4|Overall Study|Lost to Follow-up|1
2467404|NCT02379091|8515575|P3|Overall Study|Lost to Follow-up|0
2467405|NCT02379091|8515576|P2|Overall Study|Lost to Follow-up|0
2467406|NCT02379091|8515577|P1|Overall Study|Lost to Follow-up|0
2467407|NCT02379091|8515574|P4|Overall Study|Principal Investigator Discretion|0
2467408|NCT02379091|8515575|P3|Overall Study|Principal Investigator Discretion|0
2467409|NCT02379091|8515576|P2|Overall Study|Principal Investigator Discretion|1
2467410|NCT02379091|8515577|P1|Overall Study|Principal Investigator Discretion|0
2467411|NCT02379091|8515574|P4|Overall Study|Pretreatment Event/Adverse Event|1
2467412|NCT02379091|8515575|P3|Overall Study|Pretreatment Event/Adverse Event|0
2467413|NCT02379091|8515576|P2|Overall Study|Pretreatment Event/Adverse Event|2
2467414|NCT02379091|8515577|P1|Overall Study|Pretreatment Event/Adverse Event|0
2467415|NCT02379052|8515615|P2|Overall Study|Subject was Incarcerated|1
2467416|NCT02379052|8515616|P1|Overall Study|Subject was Incarcerated|0
2467417|NCT02379052|8515615|P2|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0
2467418|NCT02379052|8515616|P1|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1
2467419|NCT02379052|8515615|P2|Overall Study|Lost to Follow-up|1
2467420|NCT02379052|8515616|P1|Overall Study|Lost to Follow-up|2
2467421|NCT02379052|8515615|P2|Overall Study|Withdrawal by Subject|0
2467422|NCT02379052|8515616|P1|Overall Study|Withdrawal by Subject|2
2467423|NCT02379052|8515615|P2|Overall Study|Physician Decision|1
2467424|NCT02379052|8515616|P1|Overall Study|Physician Decision|1
2467425|NCT02379052|8515615|P2|Overall Study|Adverse Event|1
2467426|NCT02379052|8515616|P1|Overall Study|Adverse Event|0
2467427|NCT02379052|8515615|P2|Overall Study|Protocol Violation|1
2467428|NCT02379052|8515616|P1|Overall Study|Protocol Violation|0
2467429|NCT02378961|8515658|P4|Overall Study|Death|0
2467430|NCT02378961|8515659|P3|Overall Study|Death|1
2467431|NCT02378961|8515660|P2|Overall Study|Death|0
2467432|NCT02378961|8515661|P1|Overall Study|Death|0
2467433|NCT02378961|8515658|P4|Overall Study|Lack of Efficacy|1
2467434|NCT02378961|8515659|P3|Overall Study|Lack of Efficacy|0
2467435|NCT02378961|8515660|P2|Overall Study|Lack of Efficacy|2
2467436|NCT02378961|8515661|P1|Overall Study|Lack of Efficacy|4
2467437|NCT02378935|8515698|P7|Overall Study|Death|0
2467438|NCT02378935|8515699|P6|Overall Study|Death|0
2467439|NCT02378935|8515700|P5|Overall Study|Death|0
2467440|NCT02378935|8515701|P4|Overall Study|Death|0
2467441|NCT02378935|8515702|P3|Overall Study|Death|1
2467442|NCT02378935|8515703|P2|Overall Study|Death|0
2467443|NCT02378935|8515704|P1|Overall Study|Death|0
2467444|NCT02378935|8515698|P7|Overall Study|Lack of Efficacy|0
2467445|NCT02378935|8515699|P6|Overall Study|Lack of Efficacy|0
2467446|NCT02378935|8515700|P5|Overall Study|Lack of Efficacy|0
2467447|NCT02378935|8515701|P4|Overall Study|Lack of Efficacy|6
2467448|NCT02378935|8515702|P3|Overall Study|Lack of Efficacy|2
2467449|NCT02378935|8515703|P2|Overall Study|Lack of Efficacy|0
2467450|NCT02378935|8515704|P1|Overall Study|Lack of Efficacy|10
2467451|NCT02378883|8515755|P1|12 Months Follow-Up|Death|2
2467452|NCT02378883|8515755|P1|12 Months Follow-Up|Lost to Follow-up|3
2467453|NCT02378883|8515755|P1|30 Day Follow-Up|Death|1
2467454|NCT02378883|8515755|P1|30 Day Follow-Up|Missed Visit|2
2467455|NCT02378883|8515755|P1|30 Day Follow-Up|Physician Decision|2
2467456|NCT02378883|8515755|P1|30 Day Follow-Up|Withdrawal by Subject|1
2467457|NCT02378883|8515755|P1|Enrollment|Attempt to use Apollo was not performed|3
2467458|NCT02378883|8515755|P1|Enrollment|Subject did not meet Inclusion criteria|6
2467459|NCT02378662|8515821|P2|Overall Study|Early Discontinuation|0
2467460|NCT02378662|8515822|P1|Overall Study|Early Discontinuation|2
2467461|NCT02378506|8515828|P1|Overall Study|Randomized But Not Treated|1
2467462|NCT02378506|8515828|P1|Overall Study|Adverse Event|14
2467463|NCT02378506|8515828|P1|Overall Study|Death|1
2467464|NCT02378506|8515828|P1|Overall Study|Protocol Violation|2
2467465|NCT02378506|8515828|P1|Overall Study|Withdrawal by Subject|4
2467466|NCT02378506|8515828|P1|Overall Study|Lack of Efficacy|3
2467467|NCT02378480|8515847|P2|Overall Study|Lost to Follow-up|18
2467468|NCT02378480|8515848|P1|Overall Study|Lost to Follow-up|10
2467469|NCT02378480|8515847|P2|Overall Study|Withdrawal by Subject|4
2467470|NCT02378480|8515848|P1|Overall Study|Withdrawal by Subject|9
2467471|NCT02378480|8515847|P2|Overall Study|Missed EOT/PTE Visit|2
2467472|NCT02378480|8515848|P1|Overall Study|Missed EOT/PTE Visit|1
2467473|NCT02378480|8515847|P2|Overall Study|Adverse Event|1
2467474|NCT02378480|8515848|P1|Overall Study|Adverse Event|0
2467475|NCT02378480|8515847|P2|Overall Study|Randomized, but Not Treated|4
2467476|NCT02378480|8515848|P1|Overall Study|Randomized, but Not Treated|6
2467477|NCT02378480|8515847|P2|Overall Study|Death|2
2467478|NCT02378480|8515848|P1|Overall Study|Death|1
2467479|NCT02378480|8515847|P2|Overall Study|Physician Decision|1
2467480|NCT02378480|8515848|P1|Overall Study|Physician Decision|1
2467481|NCT02378220|8515875|P2|Overall Study|Death|1
2467482|NCT02378220|8515876|P1|Overall Study|Death|6
2467483|NCT02377921|8515955|P2|Overall Study|Subject non-compliance|1
2467484|NCT02377921|8515956|P1|Overall Study|Subject non-compliance|1
2467485|NCT02377817|8515980|P2|Overall Study|Unrelated injury prevented lateral sleep|0
2467486|NCT02377817|8515981|P1|Overall Study|Unrelated injury prevented lateral sleep|1
2467487|NCT02377817|8515980|P2|Overall Study|Transportation/childcare barriers.|0
2467488|NCT02377817|8515981|P1|Overall Study|Transportation/childcare barriers.|2
2467489|NCT02377466|8516045|P2|Overall Study|Other: Randomized and not treated|2
2467490|NCT02377466|8516046|P1|Overall Study|Other: Randomized and not treated|0
2467491|NCT02377427|8516164|P5|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
2467492|NCT02377427|8516165|P4|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
2467493|NCT02377427|8516166|P3|Part B (From Week 20 and up to Week 80)|Protocol Violation|1
2467494|NCT02377427|8516167|P2|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
2467495|NCT02377427|8516168|P1|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
2467496|NCT02377427|8516164|P5|Part A (Up to Week 20)|Withdrawal by Subject|0
2467497|NCT02377427|8516165|P4|Part A (Up to Week 20)|Withdrawal by Subject|0
2467498|NCT02377427|8516166|P3|Part A (Up to Week 20)|Withdrawal by Subject|0
2467499|NCT02377427|8516167|P2|Part A (Up to Week 20)|Withdrawal by Subject|0
2467500|NCT02377427|8516168|P1|Part A (Up to Week 20)|Withdrawal by Subject|2
2467501|NCT02377427|8516164|P5|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
2467502|NCT02377427|8516165|P4|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
2467503|NCT02377427|8516166|P3|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
2467504|NCT02377427|8516167|P2|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
2467505|NCT02377427|8516168|P1|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1
2467506|NCT02377427|8516164|P5|Part A (Up to Week 20)|Physician Decision|0
2467507|NCT02377427|8516165|P4|Part A (Up to Week 20)|Physician Decision|0
2467508|NCT02377427|8516166|P3|Part A (Up to Week 20)|Physician Decision|0
2467509|NCT02377427|8516167|P2|Part A (Up to Week 20)|Physician Decision|0
2467510|NCT02377427|8516168|P1|Part A (Up to Week 20)|Physician Decision|1
2467511|NCT02377362|8516241|P13|Part B Overall|Withdrawal by Subject|0
2467512|NCT02377362|8516242|P12|Part B Overall|Withdrawal by Subject|1
2467513|NCT02377362|8516243|P11|Part B Overall|Withdrawal by Subject|0
2467514|NCT02377362|8516244|P10|Part B Overall|Withdrawal by Subject|0
2467515|NCT02377362|8516245|P9|Part B Overall|Withdrawal by Subject|0
2467516|NCT02377362|8516246|P8|Part B Overall|Withdrawal by Subject|0
2467517|NCT02377362|8516247|P7|Part B Overall|Withdrawal by Subject|1
2467518|NCT02377362|8516248|P6|Part B Overall|Withdrawal by Subject|0
2467519|NCT02377362|8516249|P5|Part B Overall|Withdrawal by Subject|0
2467520|NCT02377362|8516250|P4|Part B Overall|Withdrawal by Subject|0
2467521|NCT02377362|8516251|P3|Part B Overall|Withdrawal by Subject|0
2467522|NCT02377362|8516252|P2|Part B Overall|Withdrawal by Subject|0
2467523|NCT02377362|8516253|P1|Part B Overall|Withdrawal by Subject|0
2467524|NCT02377362|8516241|P13|Part B Overall|Adverse Event|0
2467525|NCT02377362|8516242|P12|Part B Overall|Adverse Event|0
2467526|NCT02377362|8516243|P11|Part B Overall|Adverse Event|0
2467527|NCT02377362|8516244|P10|Part B Overall|Adverse Event|0
2467528|NCT02377362|8516245|P9|Part B Overall|Adverse Event|0
2467529|NCT02377362|8516246|P8|Part B Overall|Adverse Event|1
2467530|NCT02377362|8516247|P7|Part B Overall|Adverse Event|1
2467531|NCT02377362|8516248|P6|Part B Overall|Adverse Event|0
2467532|NCT02377362|8516249|P5|Part B Overall|Adverse Event|0
2467533|NCT02377362|8516250|P4|Part B Overall|Adverse Event|0
2467534|NCT02377362|8516251|P3|Part B Overall|Adverse Event|0
2467535|NCT02377362|8516252|P2|Part B Overall|Adverse Event|0
2467536|NCT02377362|8516253|P1|Part B Overall|Adverse Event|0
2467537|NCT02377362|8516241|P13|Part B Overall|Protocol Violation|0
2467538|NCT02377362|8516242|P12|Part B Overall|Protocol Violation|0
2467539|NCT02377362|8516243|P11|Part B Overall|Protocol Violation|0
2467540|NCT02377362|8516244|P10|Part B Overall|Protocol Violation|1
2467541|NCT02377362|8516245|P9|Part B Overall|Protocol Violation|0
2467542|NCT02377362|8516246|P8|Part B Overall|Protocol Violation|0
2467543|NCT02377362|8516247|P7|Part B Overall|Protocol Violation|0
2467544|NCT02377362|8516248|P6|Part B Overall|Protocol Violation|0
2467545|NCT02377362|8516249|P5|Part B Overall|Protocol Violation|0
2467546|NCT02377362|8516250|P4|Part B Overall|Protocol Violation|0
2467547|NCT02377362|8516251|P3|Part B Overall|Protocol Violation|0
2467548|NCT02377362|8516252|P2|Part B Overall|Protocol Violation|0
2467549|NCT02377362|8516253|P1|Part B Overall|Protocol Violation|0
2467550|NCT02377362|8516241|P13|Part A Third Treatment|Highest dose level 1200 not used|0
2467551|NCT02377362|8516242|P12|Part A Third Treatment|Highest dose level 1200 not used|0
2467552|NCT02377362|8516243|P11|Part A Third Treatment|Highest dose level 1200 not used|0
2467553|NCT02377362|8516244|P10|Part A Third Treatment|Highest dose level 1200 not used|0
2467554|NCT02377362|8516245|P9|Part A Third Treatment|Highest dose level 1200 not used|0
2467555|NCT02377362|8516246|P8|Part A Third Treatment|Highest dose level 1200 not used|0
2467556|NCT02377362|8516247|P7|Part A Third Treatment|Highest dose level 1200 not used|0
2467557|NCT02377362|8516248|P6|Part A Third Treatment|Highest dose level 1200 not used|4
2467558|NCT02377362|8516249|P5|Part A Third Treatment|Highest dose level 1200 not used|3
2467559|NCT02377362|8516250|P4|Part A Third Treatment|Highest dose level 1200 not used|4
2467560|NCT02377362|8516251|P3|Part A Third Treatment|Highest dose level 1200 not used|0
2467561|NCT02377362|8516252|P2|Part A Third Treatment|Highest dose level 1200 not used|0
2467562|NCT02377362|8516253|P1|Part A Third Treatment|Highest dose level 1200 not used|0
2467563|NCT02377362|8516241|P13|Part A Second Treatment|Protocol Violation|0
2467564|NCT02377362|8516242|P12|Part A Second Treatment|Protocol Violation|0
2467565|NCT02377362|8516243|P11|Part A Second Treatment|Protocol Violation|0
2467566|NCT02377362|8516244|P10|Part A Second Treatment|Protocol Violation|0
2467567|NCT02377362|8516245|P9|Part A Second Treatment|Protocol Violation|0
2467568|NCT02377362|8516246|P8|Part A Second Treatment|Protocol Violation|0
2467569|NCT02377362|8516247|P7|Part A Second Treatment|Protocol Violation|0
2467570|NCT02377362|8516248|P6|Part A Second Treatment|Protocol Violation|0
2467571|NCT02377362|8516249|P5|Part A Second Treatment|Protocol Violation|1
2467572|NCT02377362|8516250|P4|Part A Second Treatment|Protocol Violation|0
2467573|NCT02377362|8516251|P3|Part A Second Treatment|Protocol Violation|0
2467574|NCT02377362|8516252|P2|Part A Second Treatment|Protocol Violation|0
2467575|NCT02377362|8516253|P1|Part A Second Treatment|Protocol Violation|0
2467576|NCT02377349|8516462|P2|Overall Study|Other|1
2467577|NCT02377349|8516463|P1|Overall Study|Other|0
2467578|NCT02377349|8516462|P2|Overall Study|Lost to follow-up (complete vaccination)|5
2467579|NCT02377349|8516463|P1|Overall Study|Lost to follow-up (complete vaccination)|6
2467580|NCT02377349|8516462|P2|Overall Study|Lost to follow-up (partial vaccination)|0
2467581|NCT02377349|8516463|P1|Overall Study|Lost to follow-up (partial vaccination)|1
2467582|NCT02377349|8516462|P2|Overall Study|Withdrawal by Subject|3
2467583|NCT02377349|8516463|P1|Overall Study|Withdrawal by Subject|5
2467584|NCT02377349|8516462|P2|Overall Study|Protocol Violation|2
2467585|NCT02377349|8516463|P1|Overall Study|Protocol Violation|3
2467586|NCT02377349|8516462|P2|Overall Study|Serious Adverse Event|0
2467587|NCT02377349|8516463|P1|Overall Study|Serious Adverse Event|1
2467588|NCT02377063|8516501|P1|Overall Study|Non-compliance|5
2467589|NCT02376790|8516519|P3|Overall Study|Lost to Follow-up|12
2467590|NCT02376790|8516520|P2|Overall Study|Lost to Follow-up|10
2467591|NCT02376790|8516521|P1|Overall Study|Lost to Follow-up|15
2467592|NCT02376790|8516519|P3|Overall Study|Decision by Sponsor|4
2467593|NCT02376790|8516520|P2|Overall Study|Decision by Sponsor|1
2467594|NCT02376790|8516521|P1|Overall Study|Decision by Sponsor|2
2467595|NCT02376790|8516519|P3|Overall Study|Withdrawal by Subject|37
2467596|NCT02376790|8516520|P2|Overall Study|Withdrawal by Subject|36
2467597|NCT02376790|8516521|P1|Overall Study|Withdrawal by Subject|43
2467598|NCT02376166|8516712|P1|Overall Study|Discontinued metformin early|2
2467599|NCT02376166|8516712|P1|Overall Study|Adverse Event|1
2467600|NCT02375971|8516740|P3|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0
2467601|NCT02375971|8516741|P2|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
2467602|NCT02375971|8516742|P1|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
2467603|NCT02375971|8516740|P3|Follow-Up Phase (up to Day 169)|Death|4
2467604|NCT02375971|8516741|P2|Follow-Up Phase (up to Day 169)|Death|4
2467605|NCT02375971|8516742|P1|Follow-Up Phase (up to Day 169)|Death|4
2467606|NCT02375971|8516740|P3|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
2467607|NCT02375971|8516741|P2|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0
2467608|NCT02375971|8516742|P1|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
2467609|NCT02375971|8516740|P3|Follow-Up Phase (up to Day 169)|Adverse Event|0
2467610|NCT02375971|8516741|P2|Follow-Up Phase (up to Day 169)|Adverse Event|0
2467611|NCT02375971|8516742|P1|Follow-Up Phase (up to Day 169)|Adverse Event|1
2467612|NCT02375971|8516740|P3|Treatment (Day 1 - Baseline)|Adverse Event|1
2467613|NCT02375971|8516741|P2|Treatment (Day 1 - Baseline)|Adverse Event|0
2467614|NCT02375971|8516742|P1|Treatment (Day 1 - Baseline)|Adverse Event|0
2467615|NCT02375971|8516740|P3|Treatment (Day 1 - Baseline)|Lost to Follow-up|1
2467616|NCT02375971|8516741|P2|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
2467617|NCT02375971|8516742|P1|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
2467618|NCT02375971|8516740|P3|Treatment (Day 1 - Baseline)|Physician Decision|1
2467619|NCT02375971|8516741|P2|Treatment (Day 1 - Baseline)|Physician Decision|1
2467620|NCT02375971|8516742|P1|Treatment (Day 1 - Baseline)|Physician Decision|1
2467621|NCT02375971|8516740|P3|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2
2467622|NCT02375971|8516741|P2|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
2467623|NCT02375971|8516742|P1|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
2467624|NCT02375724|8516784|P2|Overall Study|Adverse Event|4
2467625|NCT02375724|8516785|P1|Overall Study|Adverse Event|2
2467626|NCT02375724|8516784|P2|Overall Study|Protocol Violation|0
2467627|NCT02375724|8516785|P1|Overall Study|Protocol Violation|1
2467628|NCT02375724|8516784|P2|Overall Study|Lost to Follow-up|0
2467629|NCT02375724|8516785|P1|Overall Study|Lost to Follow-up|1
2467630|NCT02375724|8516784|P2|Overall Study|Withdrawal by Subject|1
2467631|NCT02375724|8516785|P1|Overall Study|Withdrawal by Subject|1
2467632|NCT02375724|8516784|P2|Overall Study|Lack of Efficacy|1
2467633|NCT02375724|8516785|P1|Overall Study|Lack of Efficacy|1
2467634|NCT02375698|8516797|P2|Overall Study|Physician Decision|0
2467635|NCT02375698|8516798|P1|Overall Study|Physician Decision|2
2467636|NCT02375698|8516797|P2|Overall Study|Withdrawal by Subject|2
2467637|NCT02375698|8516798|P1|Overall Study|Withdrawal by Subject|0
2467638|NCT02375373|8516806|P1|Overall Study|Withdrawal by Subject|11
2467639|NCT02375347|8516810|P1|Overall Study|Protocol Violation|1
2467640|NCT02374957|8516816|P2|Overall Study|Patient did not complete forms correctly|0
2467641|NCT02374957|8516817|P1|Overall Study|Patient did not complete forms correctly|1
2467642|NCT02374671|8516846|P3|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
2467643|NCT02374671|8516847|P2|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
2467644|NCT02374671|8516848|P1|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1
2467645|NCT02374671|8516846|P3|Implantation- Nonrandomized & Randomized|Adverse Event|1
2467646|NCT02374671|8516847|P2|Implantation- Nonrandomized & Randomized|Adverse Event|0
2467647|NCT02374671|8516848|P1|Implantation- Nonrandomized & Randomized|Adverse Event|7
2467648|NCT02374671|8516846|P3|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2
2467649|NCT02374671|8516847|P2|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1
2467650|NCT02374671|8516848|P1|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17
2467651|NCT02374671|8516846|P3|Observation (Deferred Implantation)|Adverse Event|1
2467652|NCT02374671|8516847|P2|Observation (Deferred Implantation)|Adverse Event|0
2467653|NCT02374671|8516848|P1|Observation (Deferred Implantation)|Adverse Event|0
2467654|NCT02374671|8516846|P3|Observation (Deferred Implantation)|Withdrawal by Subject|4
2467655|NCT02374671|8516847|P2|Observation (Deferred Implantation)|Withdrawal by Subject|0
2467656|NCT02374671|8516848|P1|Observation (Deferred Implantation)|Withdrawal by Subject|0
2467657|NCT02374593|8516856|P2|Overall Study|non-compliant|0
2467658|NCT02374593|8516857|P1|Overall Study|non-compliant|2
2467659|NCT02374463|8516869|P2|Overall Study|Withdrawal by Subject|3
2467660|NCT02374463|8516870|P1|Overall Study|Withdrawal by Subject|3
2467661|NCT02374346|8516919|P1|Overall Study|operated or discharged during weekend|48
2467662|NCT02374307|8516927|P2|6-months Follow-up|Withdrawal by Subject|3
2467663|NCT02374307|8516928|P1|6-months Follow-up|Withdrawal by Subject|0
2467664|NCT02374307|8516927|P2|6-months Follow-up|Death|1
2467665|NCT02374307|8516928|P1|6-months Follow-up|Death|2
2467666|NCT02374307|8516927|P2|6-months Follow-up|Lost to Follow-up|2
2467667|NCT02374307|8516928|P1|6-months Follow-up|Lost to Follow-up|1
2467668|NCT02374307|8516927|P2|3-months Follow-up|Missed first follow-up|1
2467669|NCT02374307|8516928|P1|3-months Follow-up|Missed first follow-up|5
2467670|NCT02374307|8516927|P2|3-months Follow-up|Death|2
2467671|NCT02374307|8516928|P1|3-months Follow-up|Death|1
2467672|NCT02374307|8516927|P2|3-months Follow-up|Withdrawal by Subject|4
2467673|NCT02374307|8516928|P1|3-months Follow-up|Withdrawal by Subject|1
2467674|NCT02374307|8516927|P2|3-months Follow-up|Lost to Follow-up|2
2467675|NCT02374307|8516928|P1|3-months Follow-up|Lost to Follow-up|1
2467676|NCT02374255|8516959|P4|Overall Study|Withdrawal by Subject|0
2467677|NCT02374255|8516960|P3|Overall Study|Withdrawal by Subject|0
2467678|NCT02374255|8516961|P2|Overall Study|Withdrawal by Subject|0
2467679|NCT02374255|8516962|P1|Overall Study|Withdrawal by Subject|2
2467680|NCT02374099|8517063|P2|Overall Study|Study Terminated by Sponsor|4
2467681|NCT02374099|8517064|P1|Overall Study|Study Terminated by Sponsor|3
2467682|NCT02374099|8517063|P2|Overall Study|Randomized, but not treated|1
2467683|NCT02374099|8517064|P1|Overall Study|Randomized, but not treated|2
2467684|NCT02374099|8517063|P2|Overall Study|Miscellaneous|3
2467685|NCT02374099|8517064|P1|Overall Study|Miscellaneous|2
2467686|NCT02374099|8517063|P2|Overall Study|Withdrawal by Subject|1
2467687|NCT02374099|8517064|P1|Overall Study|Withdrawal by Subject|5
2467688|NCT02374099|8517063|P2|Overall Study|Progressive Disease|40
2467689|NCT02374099|8517064|P1|Overall Study|Progressive Disease|35
2467690|NCT02374099|8517063|P2|Overall Study|Adverse Event|0
2467691|NCT02374099|8517064|P1|Overall Study|Adverse Event|1
2467692|NCT02373202|8517172|P4|Overall Study|Other|0
2467693|NCT02373202|8517173|P3|Overall Study|Other|0
2467694|NCT02373202|8517174|P2|Overall Study|Other|1
2467695|NCT02373202|8517175|P1|Overall Study|Other|0
2467696|NCT02373202|8517172|P4|Overall Study|Lack of Efficacy|0
2467697|NCT02373202|8517173|P3|Overall Study|Lack of Efficacy|1
2467698|NCT02373202|8517174|P2|Overall Study|Lack of Efficacy|0
2467699|NCT02373202|8517175|P1|Overall Study|Lack of Efficacy|0
2467700|NCT02373202|8517172|P4|Overall Study|Adverse Event|1
2467701|NCT02373202|8517173|P3|Overall Study|Adverse Event|2
2467702|NCT02373202|8517174|P2|Overall Study|Adverse Event|5
2467703|NCT02373202|8517175|P1|Overall Study|Adverse Event|2
2467704|NCT02373098|8517250|P2|Overall Study|Adverse Event|0
2467705|NCT02373098|8517251|P1|Overall Study|Adverse Event|3
2467706|NCT02373098|8517250|P2|Overall Study|Withdrawal by Subject|0
2467707|NCT02373098|8517251|P1|Overall Study|Withdrawal by Subject|5
2467708|NCT02373098|8517250|P2|Overall Study|Protocol Violation|0
2467709|NCT02373098|8517251|P1|Overall Study|Protocol Violation|3
2467710|NCT02373098|8517250|P2|Overall Study|Lost to Follow-up|0
2467711|NCT02373098|8517251|P1|Overall Study|Lost to Follow-up|1
2467712|NCT02372799|8517279|P3|Down-taper Period|Lost to Follow-up|2
2467713|NCT02372799|8517280|P2|Down-taper Period|Lost to Follow-up|2
2467714|NCT02372799|8517281|P1|Down-taper Period|Lost to Follow-up|1
2467715|NCT02372799|8517279|P3|Treatment Period|Miscellaneous Reasons|0
2467716|NCT02372799|8517280|P2|Treatment Period|Miscellaneous Reasons|1
2467717|NCT02372799|8517281|P1|Treatment Period|Miscellaneous Reasons|1
2467718|NCT02372799|8517279|P3|Treatment Period|Non-compliance with study drug|4
2467719|NCT02372799|8517280|P2|Treatment Period|Non-compliance with study drug|4
2467720|NCT02372799|8517281|P1|Treatment Period|Non-compliance with study drug|4
2467721|NCT02372799|8517279|P3|Treatment Period|Protocol Violation|0
2467722|NCT02372799|8517280|P2|Treatment Period|Protocol Violation|0
2467723|NCT02372799|8517281|P1|Treatment Period|Protocol Violation|3
2467724|NCT02372799|8517279|P3|Treatment Period|Lost to Follow-up|3
2467725|NCT02372799|8517280|P2|Treatment Period|Lost to Follow-up|5
2467726|NCT02372799|8517281|P1|Treatment Period|Lost to Follow-up|11
2467727|NCT02372799|8517279|P3|Treatment Period|Withdrawal by Subject|2
2467728|NCT02372799|8517280|P2|Treatment Period|Withdrawal by Subject|10
2467729|NCT02372799|8517281|P1|Treatment Period|Withdrawal by Subject|10
2467730|NCT02372799|8517279|P3|Treatment Period|Insufficient therapeutic response|0
2467731|NCT02372799|8517280|P2|Treatment Period|Insufficient therapeutic response|2
2467732|NCT02372799|8517281|P1|Treatment Period|Insufficient therapeutic response|2
2467733|NCT02372799|8517279|P3|Treatment Period|Adverse Event|6
2467734|NCT02372799|8517280|P2|Treatment Period|Adverse Event|10
2467735|NCT02372799|8517281|P1|Treatment Period|Adverse Event|3
2467736|NCT02372396|8517310|P2|Overall Study|Lost to Follow-up|9
2467737|NCT02372396|8517311|P1|Overall Study|Lost to Follow-up|7
2467738|NCT02372253|8517335|P2|Overall Study|Non Compliance|0
2467739|NCT02372253|8517336|P1|Overall Study|Non Compliance|2
2467740|NCT02372071|8517381|P1|Overall Study|Protocol Violation|18
2467741|NCT02372058|8517386|P1|Overall Study|Withdrawal by Subject|3
2467742|NCT02371980|8517392|P5|Double-blind Period|Missing|0
2467743|NCT02371980|8517393|P4|Double-blind Period|Missing|0
2467744|NCT02371980|8517394|P3|Double-blind Period|Missing|0
2467745|NCT02371980|8517395|P2|Double-blind Period|Missing|1
2467746|NCT02371980|8517396|P1|Double-blind Period|Missing|0
2467747|NCT02371980|8517392|P5|Double-blind Period|Reason not Specified|1
2467748|NCT02371980|8517393|P4|Double-blind Period|Reason not Specified|2
2467749|NCT02371980|8517394|P3|Double-blind Period|Reason not Specified|3
2467750|NCT02371980|8517395|P2|Double-blind Period|Reason not Specified|3
2467751|NCT02371980|8517396|P1|Double-blind Period|Reason not Specified|0
2467752|NCT02371980|8517392|P5|Double-blind Period|Relapse|26
2467753|NCT02371980|8517393|P4|Double-blind Period|Relapse|25
2467754|NCT02371980|8517394|P3|Double-blind Period|Relapse|25
2467755|NCT02371980|8517395|P2|Double-blind Period|Relapse|50
2467756|NCT02371980|8517396|P1|Double-blind Period|Relapse|0
2467757|NCT02371980|8517392|P5|Double-blind Period|Voluntary Withdrawal|11
2467758|NCT02371980|8517393|P4|Double-blind Period|Voluntary Withdrawal|9
2467759|NCT02371980|8517394|P3|Double-blind Period|Voluntary Withdrawal|8
2467760|NCT02371980|8517395|P2|Double-blind Period|Voluntary Withdrawal|12
2467761|NCT02371980|8517396|P1|Double-blind Period|Voluntary Withdrawal|0
2467762|NCT02371980|8517392|P5|Double-blind Period|Lost to Follow-up|5
2467763|NCT02371980|8517393|P4|Double-blind Period|Lost to Follow-up|6
2467764|NCT02371980|8517394|P3|Double-blind Period|Lost to Follow-up|8
2467765|NCT02371980|8517395|P2|Double-blind Period|Lost to Follow-up|8
2467766|NCT02371980|8517396|P1|Double-blind Period|Lost to Follow-up|0
2467767|NCT02371980|8517392|P5|Double-blind Period|Noncompliance with Study Drug|3
2467768|NCT02371980|8517393|P4|Double-blind Period|Noncompliance with Study Drug|2
2467769|NCT02371980|8517394|P3|Double-blind Period|Noncompliance with Study Drug|2
2467770|NCT02371980|8517395|P2|Double-blind Period|Noncompliance with Study Drug|1
2467771|NCT02371980|8517396|P1|Double-blind Period|Noncompliance with Study Drug|0
2467772|NCT02371980|8517392|P5|Double-blind Period|Significant Protocol Deviation|3
2467773|NCT02371980|8517393|P4|Double-blind Period|Significant Protocol Deviation|3
2467774|NCT02371980|8517394|P3|Double-blind Period|Significant Protocol Deviation|7
2467775|NCT02371980|8517395|P2|Double-blind Period|Significant Protocol Deviation|2
2467776|NCT02371980|8517396|P1|Double-blind Period|Significant Protocol Deviation|0
2467777|NCT02371980|8517392|P5|Double-blind Period|Pretreatment Event/Adverse Event|9
2467778|NCT02371980|8517393|P4|Double-blind Period|Pretreatment Event/Adverse Event|2
2467779|NCT02371980|8517394|P3|Double-blind Period|Pretreatment Event/Adverse Event|3
2467780|NCT02371980|8517395|P2|Double-blind Period|Pretreatment Event/Adverse Event|4
2467781|NCT02371980|8517396|P1|Double-blind Period|Pretreatment Event/Adverse Event|0
2467782|NCT02371980|8517392|P5|Open-label Period|Reason not Specified|0
2467783|NCT02371980|8517393|P4|Open-label Period|Reason not Specified|0
2467784|NCT02371980|8517394|P3|Open-label Period|Reason not Specified|0
2467785|NCT02371980|8517395|P2|Open-label Period|Reason not Specified|0
2467786|NCT02371980|8517396|P1|Open-label Period|Reason not Specified|9
2467787|NCT02371980|8517392|P5|Open-label Period|Did not Meet Randomization Criteria|0
2467788|NCT02371980|8517393|P4|Open-label Period|Did not Meet Randomization Criteria|0
2467789|NCT02371980|8517394|P3|Open-label Period|Did not Meet Randomization Criteria|0
2467790|NCT02371980|8517395|P2|Open-label Period|Did not Meet Randomization Criteria|0
2467791|NCT02371980|8517396|P1|Open-label Period|Did not Meet Randomization Criteria|162
2467792|NCT02371980|8517392|P5|Open-label Period|Lack of Efficacy|0
2467793|NCT02371980|8517393|P4|Open-label Period|Lack of Efficacy|0
2467794|NCT02371980|8517394|P3|Open-label Period|Lack of Efficacy|0
2467795|NCT02371980|8517395|P2|Open-label Period|Lack of Efficacy|0
2467796|NCT02371980|8517396|P1|Open-label Period|Lack of Efficacy|116
2467797|NCT02371980|8517392|P5|Open-label Period|Pregnancy|0
2467798|NCT02371980|8517393|P4|Open-label Period|Pregnancy|0
2467799|NCT02371980|8517394|P3|Open-label Period|Pregnancy|0
2467800|NCT02371980|8517395|P2|Open-label Period|Pregnancy|0
2467801|NCT02371980|8517396|P1|Open-label Period|Pregnancy|1
2467802|NCT02371980|8517392|P5|Open-label Period|Voluntary Withdrawal|0
2467803|NCT02371980|8517393|P4|Open-label Period|Voluntary Withdrawal|0
2467804|NCT02371980|8517394|P3|Open-label Period|Voluntary Withdrawal|0
2467805|NCT02371980|8517395|P2|Open-label Period|Voluntary Withdrawal|0
2467806|NCT02371980|8517396|P1|Open-label Period|Voluntary Withdrawal|91
2467807|NCT02371980|8517392|P5|Open-label Period|Lost to Follow-up|0
2467808|NCT02371980|8517393|P4|Open-label Period|Lost to Follow-up|0
2467809|NCT02371980|8517394|P3|Open-label Period|Lost to Follow-up|0
2467810|NCT02371980|8517395|P2|Open-label Period|Lost to Follow-up|0
2467811|NCT02371980|8517396|P1|Open-label Period|Lost to Follow-up|55
2467812|NCT02371980|8517392|P5|Open-label Period|Noncompliance with Study Drug|0
2467813|NCT02371980|8517393|P4|Open-label Period|Noncompliance with Study Drug|0
2467814|NCT02371980|8517394|P3|Open-label Period|Noncompliance with Study Drug|0
2467815|NCT02371980|8517395|P2|Open-label Period|Noncompliance with Study Drug|0
2467816|NCT02371980|8517396|P1|Open-label Period|Noncompliance with Study Drug|10
2467817|NCT02371980|8517392|P5|Open-label Period|Significant Protocol Deviation|0
2467818|NCT02371980|8517393|P4|Open-label Period|Significant Protocol Deviation|0
2467819|NCT02371980|8517394|P3|Open-label Period|Significant Protocol Deviation|0
2467820|NCT02371980|8517395|P2|Open-label Period|Significant Protocol Deviation|0
2467821|NCT02371980|8517396|P1|Open-label Period|Significant Protocol Deviation|19
2467822|NCT02371980|8517392|P5|Open-label Period|Pretreatment Event/Adverse Event|0
2467823|NCT02371980|8517393|P4|Open-label Period|Pretreatment Event/Adverse Event|0
2467824|NCT02371980|8517394|P3|Open-label Period|Pretreatment Event/Adverse Event|0
2467825|NCT02371980|8517395|P2|Open-label Period|Pretreatment Event/Adverse Event|0
2467826|NCT02371980|8517396|P1|Open-label Period|Pretreatment Event/Adverse Event|63
2467827|NCT02371759|8517456|P8|Overall Study|Withdrawal by Subject|1
2467828|NCT02371759|8517457|P7|Overall Study|Withdrawal by Subject|0
2467829|NCT02371759|8517458|P6|Overall Study|Withdrawal by Subject|0
2467830|NCT02371759|8517459|P5|Overall Study|Withdrawal by Subject|0
2467831|NCT02371759|8517460|P4|Overall Study|Withdrawal by Subject|0
2467832|NCT02371759|8517461|P3|Overall Study|Withdrawal by Subject|0
2467833|NCT02371759|8517462|P2|Overall Study|Withdrawal by Subject|0
2467834|NCT02371759|8517463|P1|Overall Study|Withdrawal by Subject|0
2467835|NCT02371759|8517456|P8|Overall Study|Protocol Violation|3
2467836|NCT02371759|8517457|P7|Overall Study|Protocol Violation|0
2467837|NCT02371759|8517458|P6|Overall Study|Protocol Violation|1
2467838|NCT02371759|8517459|P5|Overall Study|Protocol Violation|3
2467839|NCT02371759|8517460|P4|Overall Study|Protocol Violation|0
2467840|NCT02371759|8517461|P3|Overall Study|Protocol Violation|1
2467841|NCT02371759|8517462|P2|Overall Study|Protocol Violation|1
2467842|NCT02371759|8517463|P1|Overall Study|Protocol Violation|3
2467843|NCT02371746|8517680|P7|Overall Study|Consent withdrawn|1
2467844|NCT02371746|8517681|P6|Overall Study|Consent withdrawn|0
2467845|NCT02371746|8517682|P5|Overall Study|Consent withdrawn|0
2467846|NCT02371746|8517683|P4|Overall Study|Consent withdrawn|0
2467847|NCT02371746|8517684|P3|Overall Study|Consent withdrawn|0
2467848|NCT02371746|8517685|P2|Overall Study|Consent withdrawn|0
2467849|NCT02371746|8517686|P1|Overall Study|Consent withdrawn|0
2467850|NCT02371629|8517729|P2|Overall Study|Protocol deviation|1
2467851|NCT02371629|8517730|P1|Overall Study|Protocol deviation|0
2467852|NCT02371629|8517729|P2|Overall Study|Lack of Efficacy|2
2467853|NCT02371629|8517730|P1|Overall Study|Lack of Efficacy|0
2467854|NCT02371629|8517729|P2|Overall Study|Noncompliance with study treatment|0
2467855|NCT02371629|8517730|P1|Overall Study|Noncompliance with study treatment|1
2467856|NCT02371629|8517729|P2|Overall Study|Death|1
2467857|NCT02371629|8517730|P1|Overall Study|Death|1
2467858|NCT02371629|8517729|P2|Overall Study|Physician Decision|3
2467859|NCT02371629|8517730|P1|Overall Study|Physician Decision|2
2467860|NCT02371629|8517729|P2|Overall Study|Adverse Event|8
2467861|NCT02371629|8517730|P1|Overall Study|Adverse Event|8
2467862|NCT02371629|8517729|P2|Overall Study|Patient decision|10
2467863|NCT02371629|8517730|P1|Overall Study|Patient decision|14
2467864|NCT02371616|8517766|P2|Overall Study|Other (Not specified)|5
2467865|NCT02371616|8517767|P1|Overall Study|Other (Not specified)|1
2467866|NCT02371616|8517766|P2|Overall Study|Withdrawal of Consent|0
2467867|NCT02371616|8517767|P1|Overall Study|Withdrawal of Consent|1
2467868|NCT02371616|8517766|P2|Overall Study|Adverse Event|1
2467869|NCT02371616|8517767|P1|Overall Study|Adverse Event|0
2467870|NCT02371616|8517766|P2|Overall Study|Protocol Violation|1
2467871|NCT02371616|8517767|P1|Overall Study|Protocol Violation|2
2467872|NCT02371369|8517785|P2|Part 2|Death|1
2467873|NCT02371369|8517786|P1|Part 2|Death|0
2467874|NCT02371369|8517785|P2|Part 2|Physician Decision|0
2467875|NCT02371369|8517786|P1|Part 2|Physician Decision|1
2467876|NCT02371369|8517785|P2|Part 2|Withdrawal by Subject|1
2467877|NCT02371369|8517786|P1|Part 2|Withdrawal by Subject|5
2467878|NCT02371369|8517785|P2|Part 2|Adverse Event|2
2467879|NCT02371369|8517786|P1|Part 2|Adverse Event|3
2467880|NCT02371369|8517785|P2|Part 1|Protocol Violation|1
2467881|NCT02371369|8517786|P1|Part 1|Protocol Violation|0
2467882|NCT02371369|8517785|P2|Part 1|Disease progression|1
2467883|NCT02371369|8517786|P1|Part 1|Disease progression|0
2467884|NCT02371369|8517785|P2|Part 1|Withdrawal by Subject|6
2467885|NCT02371369|8517786|P1|Part 1|Withdrawal by Subject|1
2467886|NCT02371369|8517785|P2|Part 1|Adverse Event|0
2467887|NCT02371369|8517786|P1|Part 1|Adverse Event|8
2467888|NCT02371369|8517785|P2|Part 1|Physician Decision|3
2467889|NCT02371369|8517786|P1|Part 1|Physician Decision|0
2467890|NCT02370914|8517877|P1|Overall Study|Protocol Violation|2
2467891|NCT02370888|8517885|P1|Overall Study|did not meet chimerism criteria|6
2467892|NCT02370888|8517885|P1|Overall Study|disease progression|2
2467893|NCT02370667|8517896|P3|Overall Study|Lost to Follow-up|0
2467894|NCT02370667|8517897|P2|Overall Study|Lost to Follow-up|1
2467895|NCT02370667|8517898|P1|Overall Study|Lost to Follow-up|0
2467896|NCT02370641|8517962|P2|Overall Study|dropped study|2
2467897|NCT02370641|8517963|P1|Overall Study|dropped study|4
2467898|NCT02370615|8517971|P2|Overall Study|Adverse Event|0
2467899|NCT02370615|8517972|P1|Overall Study|Adverse Event|1
2467900|NCT02370602|8518015|P6|Overall Study|Pretreatment Event/Adverse Event|0
2467901|NCT02370602|8518016|P5|Overall Study|Pretreatment Event/Adverse Event|0
2467902|NCT02370602|8518017|P4|Overall Study|Pretreatment Event/Adverse Event|0
2467903|NCT02370602|8518018|P3|Overall Study|Pretreatment Event/Adverse Event|0
2467904|NCT02370602|8518019|P2|Overall Study|Pretreatment Event/Adverse Event|0
2467905|NCT02370602|8518020|P1|Overall Study|Pretreatment Event/Adverse Event|1
2467906|NCT02370537|8518114|P3|Part B|Withdrawal by Subject|0
2467907|NCT02370537|8518115|P2|Part B|Withdrawal by Subject|1
2467908|NCT02370537|8518116|P1|Part B|Withdrawal by Subject|0
2467909|NCT02370537|8518114|P3|Part B|Not randomised to receive treatment|259
2467910|NCT02370537|8518115|P2|Part B|Not randomised to receive treatment|2
2467911|NCT02370537|8518116|P1|Part B|Not randomised to receive treatment|1
2467912|NCT02370537|8518114|P3|Part A (Open-label Recruitment)|Adverse Event|1
2467913|NCT02370537|8518115|P2|Part A (Open-label Recruitment)|Adverse Event|0
2467914|NCT02370537|8518116|P1|Part A (Open-label Recruitment)|Adverse Event|0
2467915|NCT02370537|8518114|P3|Part A (Open-label Recruitment)|Withdrawal by Subject|0
2467916|NCT02370537|8518115|P2|Part A (Open-label Recruitment)|Withdrawal by Subject|1
2467917|NCT02370537|8518116|P1|Part A (Open-label Recruitment)|Withdrawal by Subject|0
2467918|NCT02370498|8518165|P2|Overall Study|Ongoing In Trial|33
2467919|NCT02370498|8518166|P1|Overall Study|Ongoing In Trial|56
2467920|NCT02370498|8518165|P2|Overall Study|Withdrawal by Subject|11
2467921|NCT02370498|8518166|P1|Overall Study|Withdrawal by Subject|6
2467922|NCT02370498|8518165|P2|Overall Study|Protocol Violation|2
2467923|NCT02370498|8518166|P1|Overall Study|Protocol Violation|1
2467924|NCT02370498|8518165|P2|Overall Study|Lost to Follow-up|0
2467925|NCT02370498|8518166|P1|Overall Study|Lost to Follow-up|1
2467926|NCT02370498|8518165|P2|Overall Study|Death|242
2467927|NCT02370498|8518166|P1|Overall Study|Death|222
2467928|NCT02370498|8518165|P2|Overall Study|Adverse Event|8
2467929|NCT02370498|8518166|P1|Overall Study|Adverse Event|10
2467930|NCT02370420|8518220|P2|Overall Study|Lost to Follow-up|9
2467931|NCT02370420|8518221|P1|Overall Study|Lost to Follow-up|11
2467932|NCT02370420|8518220|P2|Overall Study|Physician Decision|3
2467933|NCT02370420|8518221|P1|Overall Study|Physician Decision|3
2467934|NCT02370394|8518258|P2|Overall Study|Withdrawal by Subject|1
2467935|NCT02370394|8518259|P1|Overall Study|Withdrawal by Subject|0
2467936|NCT02370394|8518258|P2|Overall Study|Lost to Follow-up|1
2467937|NCT02370394|8518259|P1|Overall Study|Lost to Follow-up|2
2467938|NCT02370251|8518273|P1|Overall Study|Death|4
2467939|NCT02370251|8518273|P1|Overall Study|Received less than 8 days of Omegaven|7
2467940|NCT02370160|8518279|P3|Overall Study|Death|1
2467941|NCT02370160|8518280|P2|Overall Study|Death|4
2467942|NCT02370160|8518281|P1|Overall Study|Death|3
2467943|NCT02370121|8518305|P2|Overall Study|Lost to Follow-up|1
2467944|NCT02370121|8518306|P1|Overall Study|Lost to Follow-up|1
2467945|NCT02370095|8518346|P2|Overall Study|Withdrawal by Subject|1
2467946|NCT02370095|8518347|P1|Overall Study|Withdrawal by Subject|0
2467947|NCT02370043|8518377|P6|Overall Study|Withdrawal by Subject|1
2467948|NCT02370043|8518378|P5|Overall Study|Withdrawal by Subject|1
2467949|NCT02370043|8518379|P4|Overall Study|Withdrawal by Subject|0
2467950|NCT02370043|8518380|P3|Overall Study|Withdrawal by Subject|0
2467951|NCT02370043|8518381|P2|Overall Study|Withdrawal by Subject|0
2467952|NCT02370043|8518382|P1|Overall Study|Withdrawal by Subject|0
2467953|NCT02369874|8518514|P3|Overall Study|Participant Ongoing|32
2467954|NCT02369874|8518515|P2|Overall Study|Participant Ongoing|45
2467955|NCT02369874|8518516|P1|Overall Study|Participant Ongoing|34
2467956|NCT02369874|8518514|P3|Overall Study|Miscellaneous|0
2467957|NCT02369874|8518515|P2|Overall Study|Miscellaneous|1
2467958|NCT02369874|8518516|P1|Overall Study|Miscellaneous|1
2467959|NCT02369874|8518514|P3|Overall Study|Withdrawal by Subject|27
2467960|NCT02369874|8518515|P2|Overall Study|Withdrawal by Subject|9
2467961|NCT02369874|8518516|P1|Overall Study|Withdrawal by Subject|7
2467962|NCT02369874|8518514|P3|Overall Study|Lost to Follow-up|2
2467963|NCT02369874|8518515|P2|Overall Study|Lost to Follow-up|2
2467964|NCT02369874|8518516|P1|Overall Study|Lost to Follow-up|2
2467965|NCT02369848|8518563|P1|Overall Study|Lost to Follow-up|1
2467966|NCT02369848|8518563|P1|Overall Study|Withdrawal by Subject|2
2467967|NCT02369848|8518563|P1|Overall Study|Death|1
2467968|NCT02369510|8518656|P3|Overall Study|Epidural Activation|5
2467969|NCT02369510|8518657|P2|Overall Study|Epidural Activation|1
2467970|NCT02369510|8518658|P1|Overall Study|Epidural Activation|1
2467971|NCT02369510|8518656|P3|Overall Study|Spilled Medication|1
2467972|NCT02369510|8518657|P2|Overall Study|Spilled Medication|2
2467973|NCT02369510|8518658|P1|Overall Study|Spilled Medication|1
2467974|NCT02369341|8518697|P2|Overall Study|Migrated/moved from study area|0
2467975|NCT02369341|8518698|P1|Overall Study|Migrated/moved from study area|1
2467976|NCT02368886|8518874|P4|Overall Study|Ineligible|1
2467977|NCT02368886|8518875|P3|Overall Study|Ineligible|0
2467978|NCT02368886|8518876|P2|Overall Study|Ineligible|0
2467979|NCT02368886|8518877|P1|Overall Study|Ineligible|0
2467980|NCT02368886|8518874|P4|Overall Study|Cancel|3
2467981|NCT02368886|8518875|P3|Overall Study|Cancel|1
2467982|NCT02368886|8518876|P2|Overall Study|Cancel|1
2467983|NCT02368886|8518877|P1|Overall Study|Cancel|1
2467984|NCT02368314|8518908|P2|Overall Study|Adverse Event|2
2467985|NCT02368314|8518909|P1|Overall Study|Adverse Event|1
2467986|NCT02368314|8518908|P2|Overall Study|Withdrawal by Subject|1
2467987|NCT02368314|8518909|P1|Overall Study|Withdrawal by Subject|2
2467988|NCT02368210|8518921|P2|Overall Study|Adverse Event|1
2467989|NCT02368210|8518922|P1|Overall Study|Adverse Event|0
2467990|NCT02368210|8518921|P2|Overall Study|Withdrawal by Subject|0
2467991|NCT02368210|8518922|P1|Overall Study|Withdrawal by Subject|1
2467992|NCT02367911|8518949|P2|Overall Study|Lost to Follow-up|2
2467993|NCT02367911|8518950|P1|Overall Study|Lost to Follow-up|2
2467994|NCT02367911|8518949|P2|Overall Study|Withdrawal by Subject|2
2467995|NCT02367911|8518950|P1|Overall Study|Withdrawal by Subject|3
2467996|NCT02367885|8518961|P3|Overall Study|Withdrawal by Subject|0
2467997|NCT02367885|8518962|P2|Overall Study|Withdrawal by Subject|0
2467998|NCT02367885|8518963|P1|Overall Study|Withdrawal by Subject|1
2467999|NCT02367885|8518961|P3|Overall Study|Lost to Follow-up|0
2468000|NCT02367885|8518962|P2|Overall Study|Lost to Follow-up|0
2468001|NCT02367885|8518963|P1|Overall Study|Lost to Follow-up|1
2468002|NCT02367833|8519206|P3|Overall Study|Withdrawal by Subject|0
2468003|NCT02367833|8519207|P2|Overall Study|Withdrawal by Subject|1
2468004|NCT02367833|8519208|P1|Overall Study|Withdrawal by Subject|1
2468005|NCT02367794|8519225|P3|Overall Study|Hypercalcemia prior to C1D1|1
2468006|NCT02367794|8519226|P2|Overall Study|Hypercalcemia prior to C1D1|0
2468007|NCT02367794|8519227|P1|Overall Study|Hypercalcemia prior to C1D1|0
2468008|NCT02367794|8519225|P3|Overall Study|Patient unable to receive carboplatin|1
2468009|NCT02367794|8519226|P2|Overall Study|Patient unable to receive carboplatin|0
2468010|NCT02367794|8519227|P1|Overall Study|Patient unable to receive carboplatin|0
2468011|NCT02367794|8519225|P3|Overall Study|Randomized in error|1
2468012|NCT02367794|8519226|P2|Overall Study|Randomized in error|0
2468013|NCT02367794|8519227|P1|Overall Study|Randomized in error|0
2468014|NCT02367794|8519225|P3|Overall Study|Brain metastasis|0
2468015|NCT02367794|8519226|P2|Overall Study|Brain metastasis|0
2468016|NCT02367794|8519227|P1|Overall Study|Brain metastasis|1
2468017|NCT02367794|8519225|P3|Overall Study|Withdrawal by Subject|14
2468018|NCT02367794|8519226|P2|Overall Study|Withdrawal by Subject|12
2468019|NCT02367794|8519227|P1|Overall Study|Withdrawal by Subject|25
2468020|NCT02367794|8519225|P3|Overall Study|Protocol Violation|1
2468021|NCT02367794|8519226|P2|Overall Study|Protocol Violation|0
2468022|NCT02367794|8519227|P1|Overall Study|Protocol Violation|1
2468023|NCT02367794|8519225|P3|Overall Study|Physician Decision|1
2468024|NCT02367794|8519226|P2|Overall Study|Physician Decision|3
2468025|NCT02367794|8519227|P1|Overall Study|Physician Decision|0
2468026|NCT02367794|8519225|P3|Overall Study|Lost to Follow-up|1
2468027|NCT02367794|8519226|P2|Overall Study|Lost to Follow-up|2
2468028|NCT02367794|8519227|P1|Overall Study|Lost to Follow-up|1
2468029|NCT02367794|8519225|P3|Overall Study|Death|229
2468030|NCT02367794|8519226|P2|Overall Study|Death|223
2468031|NCT02367794|8519227|P1|Overall Study|Death|230
2468032|NCT02367781|8519240|P2|Overall Study|Administrative-Change Facility|0
2468033|NCT02367781|8519241|P1|Overall Study|Administrative-Change Facility|1
2468034|NCT02367781|8519240|P2|Overall Study|Death Prior First Dose|0
2468035|NCT02367781|8519241|P1|Overall Study|Death Prior First Dose|1
2468036|NCT02367781|8519240|P2|Overall Study|Prolonged Hospitalization|0
2468037|NCT02367781|8519241|P1|Overall Study|Prolonged Hospitalization|1
2468038|NCT02367781|8519240|P2|Overall Study|On-going in study|88
2468039|NCT02367781|8519241|P1|Overall Study|On-going in study|214
2468040|NCT02367781|8519240|P2|Overall Study|Death|136
2468041|NCT02367781|8519241|P1|Overall Study|Death|240
2468042|NCT02367781|8519240|P2|Overall Study|Lost to Follow-up|1
2468043|NCT02367781|8519241|P1|Overall Study|Lost to Follow-up|0
2468044|NCT02367781|8519240|P2|Overall Study|Non-Compliance|0
2468045|NCT02367781|8519241|P1|Overall Study|Non-Compliance|1
2468046|NCT02367781|8519240|P2|Overall Study|Randomized in Error|4
2468047|NCT02367781|8519241|P1|Overall Study|Randomized in Error|5
2468048|NCT02367781|8519240|P2|Overall Study|Physician Decision|0
2468049|NCT02367781|8519241|P1|Overall Study|Physician Decision|1
2468050|NCT02367781|8519240|P2|Overall Study|Protocol Violation|1
2468051|NCT02367781|8519241|P1|Overall Study|Protocol Violation|0
2468052|NCT02367781|8519240|P2|Overall Study|Withdrawal by Subject|10
2468053|NCT02367781|8519241|P1|Overall Study|Withdrawal by Subject|19
2468054|NCT02367729|8519251|P2|Overall Study|Withdrawal by Subject|5
2468055|NCT02367729|8519252|P1|Overall Study|Withdrawal by Subject|0
2468056|NCT02367729|8519251|P2|Overall Study|Adverse Event|2
2468057|NCT02367729|8519252|P1|Overall Study|Adverse Event|1
2468058|NCT02367729|8519251|P2|Overall Study|Organic disorder diagnosed|1
2468059|NCT02367729|8519252|P1|Overall Study|Organic disorder diagnosed|2
2468060|NCT02367521|8519270|P2|Overall Study|unable to find transportation|0
2468061|NCT02367521|8519271|P1|Overall Study|unable to find transportation|2
2468062|NCT02367521|8519270|P2|Overall Study|severe headache after intervention|0
2468063|NCT02367521|8519271|P1|Overall Study|severe headache after intervention|2
2468064|NCT02367352|8519349|P3|Overall Study|Adverse Event|0
2468065|NCT02367352|8519350|P2|Overall Study|Adverse Event|0
2468066|NCT02367352|8519351|P1|Overall Study|Adverse Event|1
2468067|NCT02367352|8519349|P3|Overall Study|Participant Received Alternative Therapy|0
2468068|NCT02367352|8519350|P2|Overall Study|Participant Received Alternative Therapy|0
2468069|NCT02367352|8519351|P1|Overall Study|Participant Received Alternative Therapy|1
2468070|NCT02367352|8519349|P3|Overall Study|Progressive disease|0
2468071|NCT02367352|8519350|P2|Overall Study|Progressive disease|0
2468072|NCT02367352|8519351|P1|Overall Study|Progressive disease|7
2468073|NCT02367131|8519401|P1|Overall Study|Other than stated above|20
2468074|NCT02367131|8519401|P1|Overall Study|No change/progressive disease|78
2468075|NCT02367131|8519401|P1|Overall Study|Improvement/remission|2
2468076|NCT02367131|8519401|P1|Overall Study|Request by patient|54
2468077|NCT02367131|8519401|P1|Overall Study|No visit since the first visit|4
2468078|NCT02367131|8519401|P1|Overall Study|Adverse Event|64
2468079|NCT02366936|8519593|P1|Overall Study|Physician Decision|2
2468080|NCT02366936|8519593|P1|Overall Study|Lost to Follow-up|4
2468081|NCT02366936|8519593|P1|Overall Study|Withdrawal by Subject|2
2468082|NCT02366923|8519598|P1|Overall Study|High Astigmatism|3
2468083|NCT02366923|8519598|P1|Overall Study|Positive Slit Lamp Findings|2
2468084|NCT02366923|8519598|P1|Overall Study|Withdrawal by Subject|1
2468085|NCT02366910|8519611|P1|Overall Study|Screen Failure|3
2468086|NCT02366910|8519611|P1|Overall Study|Withdrawal by Subject|2
2468087|NCT02366767|8519659|P2|Overall Study|left for home after 1 day at camp|0
2468088|NCT02366767|8519660|P1|Overall Study|left for home after 1 day at camp|1
2468089|NCT02366689|8519673|P3|Overall Study|Pregnancy|1
2468090|NCT02366689|8519674|P2|Overall Study|Pregnancy|1
2468091|NCT02366689|8519675|P1|Overall Study|Pregnancy|0
2468092|NCT02366689|8519673|P3|Overall Study|Lost to Follow-up|0
2468093|NCT02366689|8519674|P2|Overall Study|Lost to Follow-up|2
2468094|NCT02366689|8519675|P1|Overall Study|Lost to Follow-up|3
2468095|NCT02366689|8519673|P3|Overall Study|Withdrawal by Subject|1
2468096|NCT02366689|8519674|P2|Overall Study|Withdrawal by Subject|0
2468097|NCT02366689|8519675|P1|Overall Study|Withdrawal by Subject|1
2468098|NCT02366637|8519727|P2|Second Intervention Period|Study Terminated by Sponsor|1
2468099|NCT02366637|8519728|P1|Second Intervention Period|Study Terminated by Sponsor|1
2468100|NCT02366637|8519727|P2|First Intervention Period|Study Terminated by Sponsor|4
2468101|NCT02366637|8519728|P1|First Intervention Period|Study Terminated by Sponsor|6
2468102|NCT02366637|8519727|P2|First Intervention Period|Adverse Event|1
2468103|NCT02366637|8519728|P1|First Intervention Period|Adverse Event|0
2468104|NCT02366468|8519754|P2|Overall Study|Other|2
2468105|NCT02366468|8519755|P1|Overall Study|Other|0
2468106|NCT02366468|8519754|P2|Overall Study|Death|2
2468107|NCT02366468|8519755|P1|Overall Study|Death|1
2468108|NCT02366468|8519754|P2|Overall Study|Lost to Follow-up|0
2468109|NCT02366468|8519755|P1|Overall Study|Lost to Follow-up|2
2468110|NCT02366468|8519754|P2|Overall Study|Withdrawal by Subject|5
2468111|NCT02366468|8519755|P1|Overall Study|Withdrawal by Subject|1
2468112|NCT02366468|8519754|P2|Overall Study|Adverse Event|0
2468113|NCT02366468|8519755|P1|Overall Study|Adverse Event|2
2468114|NCT02366195|8519786|P1|Overall Study|Death|26
2468115|NCT02366195|8519786|P1|Overall Study|Lost to Follow-up|1
2468116|NCT02366195|8519786|P1|Overall Study|Withdrawal by Subject|6
2468117|NCT02366195|8519786|P1|Overall Study|Continuing Study|79
2468118|NCT02365636|8519845|P3|Overall Study|Other|0
2468119|NCT02365636|8519846|P2|Overall Study|Other|0
2468120|NCT02365636|8519847|P1|Overall Study|Other|2
2468121|NCT02365636|8519845|P3|Overall Study|Lost to Follow-up|1
2468122|NCT02365636|8519846|P2|Overall Study|Lost to Follow-up|0
2468123|NCT02365636|8519847|P1|Overall Study|Lost to Follow-up|0
2468124|NCT02365636|8519845|P3|Overall Study|Protocol Violation|0
2468125|NCT02365636|8519846|P2|Overall Study|Protocol Violation|4
2468126|NCT02365636|8519847|P1|Overall Study|Protocol Violation|1
2468127|NCT02365636|8519845|P3|Overall Study|Adverse Event|2
2468128|NCT02365636|8519846|P2|Overall Study|Adverse Event|3
2468129|NCT02365636|8519847|P1|Overall Study|Adverse Event|3
2468130|NCT02365584|8519893|P2|Overall Study|Disease Progression|12
2468131|NCT02365584|8519894|P1|Overall Study|Disease Progression|9
2468132|NCT02365584|8519893|P2|Overall Study|Withdrawal by Subject|0
2468133|NCT02365584|8519894|P1|Overall Study|Withdrawal by Subject|1
2468134|NCT02365584|8519893|P2|Overall Study|Adverse Event|2
2468135|NCT02365584|8519894|P1|Overall Study|Adverse Event|2
2468136|NCT02365558|8519918|P2|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1
2468137|NCT02365558|8519919|P1|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0
2468138|NCT02365558|8519918|P2|Period 1 (Day 1 Through Day 7)|Adverse Event|0
2468139|NCT02365558|8519919|P1|Period 1 (Day 1 Through Day 7)|Adverse Event|1
2468140|NCT02365519|8519932|P3|Randomized and Treated|Withdrawal by Subject|1
2468141|NCT02365519|8519933|P2|Randomized and Treated|Withdrawal by Subject|1
2468142|NCT02365519|8519934|P1|Randomized and Treated|Withdrawal by Subject|0
2468143|NCT02365519|8519932|P3|Randomized and Treated|Adverse Event|0
2468144|NCT02365519|8519933|P2|Randomized and Treated|Adverse Event|1
2468145|NCT02365519|8519934|P1|Randomized and Treated|Adverse Event|0
2468146|NCT02365298|8519955|P2|Period 2|Protocol Violation|1
2468147|NCT02365298|8519956|P1|Period 2|Protocol Violation|0
2468148|NCT02365298|8519955|P2|Period 2|Test Article longer available|1
2468149|NCT02365298|8519956|P1|Period 2|Test Article longer available|0
2468150|NCT02365298|8519955|P2|Period 2|Discontinued at request of Sponsor|0
2468151|NCT02365298|8519956|P1|Period 2|Discontinued at request of Sponsor|1
2468152|NCT02365298|8519955|P2|Period 2|incorrect Rx dispensed|0
2468153|NCT02365298|8519956|P1|Period 2|incorrect Rx dispensed|1
2468154|NCT02365285|8519976|P4|Overall Study|Adverse Event|2
2468155|NCT02365285|8519977|P3|Overall Study|Adverse Event|0
2468156|NCT02365285|8519978|P2|Overall Study|Adverse Event|0
2468157|NCT02365285|8519979|P1|Overall Study|Adverse Event|0
2468158|NCT02365285|8519976|P4|Overall Study|Physician Decision|0
2468159|NCT02365285|8519977|P3|Overall Study|Physician Decision|1
2468160|NCT02365285|8519978|P2|Overall Study|Physician Decision|1
2468161|NCT02365285|8519979|P1|Overall Study|Physician Decision|0
2468162|NCT02365233|8519996|P3|Overall Study|IRB withheld the data|2
2468163|NCT02365233|8519997|P2|Overall Study|IRB withheld the data|2
2468164|NCT02365233|8519998|P1|Overall Study|IRB withheld the data|1
2468165|NCT02365207|8520006|P1|Overall Study|Physician Decision|1
2468166|NCT02365207|8520006|P1|Overall Study|Withdrawal by Subject|1
2468167|NCT02364999|8520012|P2|Overall Study|Randomized but did not receive treatment|3
2468168|NCT02364999|8520013|P1|Overall Study|Randomized but did not receive treatment|2
2468169|NCT02364999|8520012|P2|Overall Study|Other|1
2468170|NCT02364999|8520013|P1|Overall Study|Other|0
2468171|NCT02364999|8520012|P2|Overall Study|Withdrawal by Subject|14
2468172|NCT02364999|8520013|P1|Overall Study|Withdrawal by Subject|14
2468173|NCT02364999|8520012|P2|Overall Study|Protocol Violation|2
2468174|NCT02364999|8520013|P1|Overall Study|Protocol Violation|3
2468175|NCT02364999|8520012|P2|Overall Study|Lost to Follow-up|15
2468176|NCT02364999|8520013|P1|Overall Study|Lost to Follow-up|10
2468177|NCT02364999|8520012|P2|Overall Study|Death|138
2468178|NCT02364999|8520013|P1|Overall Study|Death|136
2468179|NCT02364947|8520039|P3|Overall Study|Death|0
2468180|NCT02364947|8520040|P2|Overall Study|Death|1
2468181|NCT02364947|8520041|P1|Overall Study|Death|0
2468182|NCT02364947|8520039|P3|Overall Study|Physician Decision|5
2468183|NCT02364947|8520040|P2|Overall Study|Physician Decision|2
2468184|NCT02364947|8520041|P1|Overall Study|Physician Decision|3
2468185|NCT02364947|8520039|P3|Overall Study|Protocol Violation|1
2468186|NCT02364947|8520040|P2|Overall Study|Protocol Violation|1
2468187|NCT02364947|8520041|P1|Overall Study|Protocol Violation|1
2468188|NCT02364947|8520039|P3|Overall Study|Adverse Event|11
2468189|NCT02364947|8520040|P2|Overall Study|Adverse Event|33
2468190|NCT02364947|8520041|P1|Overall Study|Adverse Event|45
2468191|NCT02364947|8520039|P3|Overall Study|Withdrawal by Subject|9
2468192|NCT02364947|8520040|P2|Overall Study|Withdrawal by Subject|8
2468193|NCT02364947|8520041|P1|Overall Study|Withdrawal by Subject|10
2468194|NCT02364388|8520210|P1|Overall Study|No Biopsy|2
2468195|NCT02364388|8520210|P1|Overall Study|No OA/US data|2
2468196|NCT02364388|8520210|P1|Overall Study|Technical Failure|3
2468197|NCT02364388|8520210|P1|Overall Study|Protocol Violation|1
2468198|NCT02364336|8520217|P2|Overall Study|Adverse Event|1
2468199|NCT02364336|8520218|P1|Overall Study|Adverse Event|0
2468200|NCT02364180|8520231|P1|Overall Study|Screen Fail|1
2468201|NCT02364037|8520244|P2|Overall Study|Lost to Follow-up|49
2468202|NCT02364037|8520245|P1|Overall Study|Lost to Follow-up|37
2468203|NCT02364037|8520244|P2|Overall Study|Withdrawal by Subject|4
2468204|NCT02364037|8520245|P1|Overall Study|Withdrawal by Subject|7
2468205|NCT02363959|8520259|P2|Overall Study|Medical instability|0
2468206|NCT02363959|8520260|P1|Overall Study|Medical instability|1
2468207|NCT02363946|8520289|P13|Overall Study|Lost to Follow-up|0
2468208|NCT02363946|8520290|P12|Overall Study|Lost to Follow-up|0
2468209|NCT02363946|8520291|P11|Overall Study|Lost to Follow-up|0
2468210|NCT02363946|8520292|P10|Overall Study|Lost to Follow-up|0
2468211|NCT02363946|8520293|P9|Overall Study|Lost to Follow-up|0
2468212|NCT02363946|8520294|P8|Overall Study|Lost to Follow-up|1
2468213|NCT02363946|8520295|P7|Overall Study|Lost to Follow-up|0
2468214|NCT02363946|8520296|P6|Overall Study|Lost to Follow-up|0
2468215|NCT02363946|8520297|P5|Overall Study|Lost to Follow-up|0
2468216|NCT02363946|8520298|P4|Overall Study|Lost to Follow-up|0
2468217|NCT02363946|8520299|P3|Overall Study|Lost to Follow-up|0
2468218|NCT02363946|8520300|P2|Overall Study|Lost to Follow-up|0
2468219|NCT02363946|8520301|P1|Overall Study|Lost to Follow-up|0
2468220|NCT02363478|8520530|P1|Overall Study|Adverse Event|4
2468221|NCT02363478|8520530|P1|Overall Study|Lost to Follow-up|4
2468222|NCT02363439|8520537|P1|Overall Study|Lack of Efficacy|4
2468223|NCT02363322|8520543|P2|Overall Study|Lost to Follow-up|0
2468224|NCT02363322|8520544|P1|Overall Study|Lost to Follow-up|1
2468225|NCT02362789|8520565|P3|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2
2468226|NCT02362789|8520566|P2|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1
2468227|NCT02362789|8520567|P1|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0
2468228|NCT02362789|8520565|P3|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4
2468229|NCT02362789|8520566|P2|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1
2468230|NCT02362789|8520567|P1|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0
2468231|NCT02362789|8520565|P3|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6
2468232|NCT02362789|8520566|P2|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2
2468233|NCT02362789|8520567|P1|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0
2468234|NCT02362789|8520565|P3|Run-in Phase (Week 0 to 16)|Adverse Event|0
2468235|NCT02362789|8520566|P2|Run-in Phase (Week 0 to 16)|Adverse Event|0
2468236|NCT02362789|8520567|P1|Run-in Phase (Week 0 to 16)|Adverse Event|1
2468237|NCT02362789|8520565|P3|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0
2468238|NCT02362789|8520566|P2|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0
2468239|NCT02362789|8520567|P1|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1
2468240|NCT02362646|8520576|P2|Overall Study|received transplant|14
2468241|NCT02362646|8520577|P1|Overall Study|received transplant|21
2468242|NCT02362646|8520576|P2|Overall Study|Withdrawal by Subject|2
2468243|NCT02362646|8520577|P1|Overall Study|Withdrawal by Subject|2
2468244|NCT02362646|8520576|P2|Overall Study|Death|8
2468245|NCT02362646|8520577|P1|Overall Study|Death|15
2468246|NCT02362503|8520609|P3|Open Label Period-Up to Atleast 96 Weeks|Ongoing at the time of analysis|67
2468247|NCT02362503|8520610|P2|Open Label Period-Up to Atleast 96 Weeks|Ongoing at the time of analysis|160
2468248|NCT02362503|8520611|P1|Open Label Period-Up to Atleast 96 Weeks|Ongoing at the time of analysis|55
2468249|NCT02362503|8520609|P3|Open Label Period-Up to Atleast 96 Weeks|Progression of disease|0
2468250|NCT02362503|8520610|P2|Open Label Period-Up to Atleast 96 Weeks|Progression of disease|1
2468251|NCT02362503|8520611|P1|Open Label Period-Up to Atleast 96 Weeks|Progression of disease|0
2468252|NCT02362503|8520609|P3|Open Label Period-Up to Atleast 96 Weeks|No longer meets study criteria|2
2468253|NCT02362503|8520610|P2|Open Label Period-Up to Atleast 96 Weeks|No longer meets study criteria|2
2468254|NCT02362503|8520611|P1|Open Label Period-Up to Atleast 96 Weeks|No longer meets study criteria|0
2468255|NCT02362503|8520609|P3|Open Label Period-Up to Atleast 96 Weeks|Pregnancy|0
2468256|NCT02362503|8520610|P2|Open Label Period-Up to Atleast 96 Weeks|Pregnancy|1
2468257|NCT02362503|8520611|P1|Open Label Period-Up to Atleast 96 Weeks|Pregnancy|0
2468258|NCT02362503|8520609|P3|Open Label Period-Up to Atleast 96 Weeks|Non-compliance with study drug|5
2468259|NCT02362503|8520610|P2|Open Label Period-Up to Atleast 96 Weeks|Non-compliance with study drug|8
2468260|NCT02362503|8520611|P1|Open Label Period-Up to Atleast 96 Weeks|Non-compliance with study drug|3
2468261|NCT02362503|8520609|P3|Open Label Period-Up to Atleast 96 Weeks|Lost to Follow-up|1
2468262|NCT02362503|8520610|P2|Open Label Period-Up to Atleast 96 Weeks|Lost to Follow-up|3
2468263|NCT02362503|8520611|P1|Open Label Period-Up to Atleast 96 Weeks|Lost to Follow-up|3
2468264|NCT02362503|8520609|P3|Open Label Period-Up to Atleast 96 Weeks|Withdrawal by Subject|1
2468265|NCT02362503|8520610|P2|Open Label Period-Up to Atleast 96 Weeks|Withdrawal by Subject|5
2468266|NCT02362503|8520611|P1|Open Label Period-Up to Atleast 96 Weeks|Withdrawal by Subject|0
2468267|NCT02362503|8520609|P3|Open Label Period-Up to Atleast 96 Weeks|Death|12
2468268|NCT02362503|8520610|P2|Open Label Period-Up to Atleast 96 Weeks|Death|5
2468269|NCT02362503|8520611|P1|Open Label Period-Up to Atleast 96 Weeks|Death|1
2468270|NCT02362503|8520609|P3|Open Label Period-Up to Atleast 96 Weeks|Adverse Event|5
2468271|NCT02362503|8520610|P2|Open Label Period-Up to Atleast 96 Weeks|Adverse Event|4
2468272|NCT02362503|8520611|P1|Open Label Period-Up to Atleast 96 Weeks|Adverse Event|3
2468273|NCT02362503|8520609|P3|Open Label Period-Up to Atleast 96 Weeks|Lack of Efficacy|6
2468274|NCT02362503|8520610|P2|Open Label Period-Up to Atleast 96 Weeks|Lack of Efficacy|9
2468275|NCT02362503|8520611|P1|Open Label Period-Up to Atleast 96 Weeks|Lack of Efficacy|3
2468276|NCT02362503|8520609|P3|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
2468277|NCT02362503|8520610|P2|Double-blind Period-Up to 8 Days|No longer meets study criteria|1
2468278|NCT02362503|8520611|P1|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
2468279|NCT02362503|8520609|P3|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
2468280|NCT02362503|8520610|P2|Double-blind Period-Up to 8 Days|Lost to Follow-up|1
2468281|NCT02362503|8520611|P1|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
2468282|NCT02362503|8520609|P3|Double-blind Period-Up to 8 Days|Death|0
2468283|NCT02362503|8520610|P2|Double-blind Period-Up to 8 Days|Death|1
2468284|NCT02362503|8520611|P1|Double-blind Period-Up to 8 Days|Death|1
2468285|NCT02362503|8520609|P3|Double-blind Period-Up to 8 Days|Adverse Event|0
2468286|NCT02362503|8520610|P2|Double-blind Period-Up to 8 Days|Adverse Event|2
2468287|NCT02362503|8520611|P1|Double-blind Period-Up to 8 Days|Adverse Event|0
2468288|NCT02362425|8520640|P4|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
2468289|NCT02362425|8520641|P3|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1
2468290|NCT02362425|8520642|P2|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
2468291|NCT02362425|8520643|P1|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
2468292|NCT02362425|8520640|P4|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1
2468293|NCT02362425|8520641|P3|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
2468294|NCT02362425|8520642|P2|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
2468295|NCT02362425|8520643|P1|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
2468296|NCT02362425|8520640|P4|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2
2468297|NCT02362425|8520641|P3|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
2468298|NCT02362425|8520642|P2|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
2468299|NCT02362425|8520643|P1|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
2468300|NCT02362425|8520640|P4|Phase 1 (up to 6 Months)|Study closure|0
2468301|NCT02362425|8520641|P3|Phase 1 (up to 6 Months)|Study closure|0
2468302|NCT02362425|8520642|P2|Phase 1 (up to 6 Months)|Study closure|0
2468303|NCT02362425|8520643|P1|Phase 1 (up to 6 Months)|Study closure|9
2468304|NCT02362425|8520640|P4|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
2468305|NCT02362425|8520641|P3|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
2468306|NCT02362425|8520642|P2|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
2468307|NCT02362425|8520643|P1|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3
2468308|NCT02362425|8520640|P4|Phase 1 (up to 6 Months)|Screening failure|0
2468309|NCT02362425|8520641|P3|Phase 1 (up to 6 Months)|Screening failure|0
2468310|NCT02362425|8520642|P2|Phase 1 (up to 6 Months)|Screening failure|0
2468311|NCT02362425|8520643|P1|Phase 1 (up to 6 Months)|Screening failure|1
2468312|NCT02362425|8520640|P4|Phase 1 (up to 6 Months)|Medicinal contraindication|0
2468313|NCT02362425|8520641|P3|Phase 1 (up to 6 Months)|Medicinal contraindication|0
2468314|NCT02362425|8520642|P2|Phase 1 (up to 6 Months)|Medicinal contraindication|0
2468315|NCT02362425|8520643|P1|Phase 1 (up to 6 Months)|Medicinal contraindication|1
2468316|NCT02362425|8520640|P4|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
2468317|NCT02362425|8520641|P3|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
2468318|NCT02362425|8520642|P2|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
2468319|NCT02362425|8520643|P1|Phase 1 (up to 6 Months)|Withdrawal by Subject|2
2468320|NCT02362412|8520761|P2|Treatment Period III|Lost to Follow-up|1
2468321|NCT02362412|8520762|P1|Treatment Period III|Lost to Follow-up|0
2468322|NCT02362360|8520796|P2|Period 1|Withdrawal by Subject|1
2468323|NCT02362360|8520797|P1|Period 1|Withdrawal by Subject|2
2468324|NCT02362360|8520796|P2|Period 1|Lack of Efficacy|0
2468325|NCT02362360|8520797|P1|Period 1|Lack of Efficacy|1
2468326|NCT02362282|8520814|P2|Overall Study|Withdrawal by Subject|0
2468327|NCT02362282|8520815|P1|Overall Study|Withdrawal by Subject|1
2468328|NCT02361762|8520832|P2|Overall Study|Lost to Follow-up|1
2468329|NCT02361762|8520833|P1|Overall Study|Lost to Follow-up|0
2468330|NCT02361762|8520832|P2|Overall Study|Withdrawal by Subject|1
2468331|NCT02361762|8520833|P1|Overall Study|Withdrawal by Subject|0
2468332|NCT02361580|8520884|P2|Overall Study|Lost to Follow-up|3
2468333|NCT02361580|8520885|P1|Overall Study|Lost to Follow-up|6
2468334|NCT02361216|8520914|P2|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2
2468335|NCT02361216|8520915|P1|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0
2468336|NCT02361216|8520914|P2|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
2468337|NCT02361216|8520915|P1|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
2468338|NCT02361216|8520914|P2|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11
2468339|NCT02361216|8520915|P1|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6
2468340|NCT02361216|8520914|P2|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0
2468341|NCT02361216|8520915|P1|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1
2468342|NCT02361216|8520914|P2|3 Day Treatment and 8 Week Follow/up|Adverse Event|2
2468343|NCT02361216|8520915|P1|3 Day Treatment and 8 Week Follow/up|Adverse Event|1
2468344|NCT02361216|8520914|P2|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1
2468345|NCT02361216|8520915|P1|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0
2468346|NCT02360995|8520930|P3|Overall Study|Withdrawal by Subject|0
2468347|NCT02360995|8520931|P2|Overall Study|Withdrawal by Subject|1
2468348|NCT02360995|8520932|P1|Overall Study|Withdrawal by Subject|0
2468349|NCT02360995|8520930|P3|Overall Study|Lost to Follow-up|2
2468350|NCT02360995|8520931|P2|Overall Study|Lost to Follow-up|0
2468351|NCT02360995|8520932|P1|Overall Study|Lost to Follow-up|2
2468352|NCT02360475|8520996|P4|Overall Study|Migrated/moved from study area|1
2468353|NCT02360475|8520997|P3|Overall Study|Migrated/moved from study area|0
2468354|NCT02360475|8520998|P2|Overall Study|Migrated/moved from study area|0
2468355|NCT02360475|8520999|P1|Overall Study|Migrated/moved from study area|0
2468356|NCT02360475|8520996|P4|Overall Study|Withdrawal by Subject|0
2468357|NCT02360475|8520997|P3|Overall Study|Withdrawal by Subject|2
2468358|NCT02360475|8520998|P2|Overall Study|Withdrawal by Subject|1
2468359|NCT02360475|8520999|P1|Overall Study|Withdrawal by Subject|0
2468360|NCT02360475|8520996|P4|Overall Study|Lost to Follow-up|4
2468361|NCT02360475|8520997|P3|Overall Study|Lost to Follow-up|6
2468362|NCT02360475|8520998|P2|Overall Study|Lost to Follow-up|12
2468363|NCT02360475|8520999|P1|Overall Study|Lost to Follow-up|4
2468364|NCT02360397|8521057|P1|Overall Study|Adverse Event|1
2468365|NCT02360397|8521057|P1|Overall Study|Incomplete screening|3
2468366|NCT02360293|8521066|P2|Overall Study|Excluded|0
2468367|NCT02360293|8521067|P1|Overall Study|Excluded|1
2468368|NCT02360293|8521066|P2|Overall Study|Withdrawal by Subject|1
2468369|NCT02360293|8521067|P1|Overall Study|Withdrawal by Subject|2
2468370|NCT02360293|8521066|P2|Overall Study|Lost to Follow-up|95
2468371|NCT02360293|8521067|P1|Overall Study|Lost to Follow-up|73
2468372|NCT02360280|8521081|P2|Overall Study|Lost to Follow-up|0
2468373|NCT02360280|8521082|P1|Overall Study|Lost to Follow-up|1
2468374|NCT02360280|8521081|P2|Overall Study|Adverse Event|1
2468375|NCT02360280|8521082|P1|Overall Study|Adverse Event|0
2468376|NCT02360280|8521081|P2|Overall Study|Withdrawal by Subject|0
2468377|NCT02360280|8521082|P1|Overall Study|Withdrawal by Subject|2
2468378|NCT02360228|8521097|P3|Overall Study|Unstable symptoms during screening|1
2468379|NCT02360228|8521098|P2|Overall Study|Unstable symptoms during screening|0
2468380|NCT02360228|8521099|P1|Overall Study|Unstable symptoms during screening|0
2468381|NCT02360228|8521097|P3|Overall Study|Self-discontinued medication|0
2468382|NCT02360228|8521098|P2|Overall Study|Self-discontinued medication|1
2468383|NCT02360228|8521099|P1|Overall Study|Self-discontinued medication|0
2468384|NCT02360228|8521097|P3|Overall Study|Withdrawal by Subject|0
2468385|NCT02360228|8521098|P2|Overall Study|Withdrawal by Subject|0
2468386|NCT02360228|8521099|P1|Overall Study|Withdrawal by Subject|1
2468387|NCT02360111|8521194|P1|Overall Study|Death|2
2468388|NCT02359903|8521265|P2|Overall Study|Adverse Event|2
2468389|NCT02359903|8521266|P1|Overall Study|Adverse Event|0
2468390|NCT02359890|8521274|P1|Overall Study|Never treated with study catheter|6
2468391|NCT02359890|8521274|P1|Overall Study|Not meeting eligibility|4
2468392|NCT02359877|8521285|P4|Overall Study|Adverse Event|1
2468393|NCT02359877|8521286|P3|Overall Study|Adverse Event|0
2468394|NCT02359877|8521287|P2|Overall Study|Adverse Event|0
2468395|NCT02359877|8521288|P1|Overall Study|Adverse Event|0
2468396|NCT02359877|8521285|P4|Overall Study|Withdrawal by Subject|2
2468397|NCT02359877|8521286|P3|Overall Study|Withdrawal by Subject|0
2468398|NCT02359877|8521287|P2|Overall Study|Withdrawal by Subject|0
2468399|NCT02359877|8521288|P1|Overall Study|Withdrawal by Subject|1
2468400|NCT02359851|8521338|P1|Overall Study|Disease progression|1
2468401|NCT02359851|8521338|P1|Overall Study|Death|1
2468402|NCT02359435|8521348|P2|Overall Study|Lost to Follow-up|4
2468403|NCT02359435|8521349|P1|Overall Study|Lost to Follow-up|4
2468404|NCT02359045|8521409|P2|Overall Study|Adverse Event|1
2468405|NCT02359045|8521410|P1|Overall Study|Adverse Event|0
2468406|NCT02359045|8521409|P2|Overall Study|Lost to Follow-up|1
2468407|NCT02359045|8521410|P1|Overall Study|Lost to Follow-up|1
2468408|NCT02359045|8521409|P2|Overall Study|Eligibility criteria not fulfilled|1
2468409|NCT02359045|8521410|P1|Overall Study|Eligibility criteria not fulfilled|3
2468410|NCT02358863|8521690|P1|Overall Study|Physician Decision|3
2468411|NCT02358668|8521697|P3|Overall Study|Withdrawal by Subject|0
2468412|NCT02358668|8521698|P2|Overall Study|Withdrawal by Subject|1
2468413|NCT02358668|8521699|P1|Overall Study|Withdrawal by Subject|0
2468414|NCT02358668|8521697|P3|Overall Study|Adverse Event|0
2468415|NCT02358668|8521698|P2|Overall Study|Adverse Event|0
2468416|NCT02358668|8521699|P1|Overall Study|Adverse Event|2
2468417|NCT02358473|8521848|P1|Overall Study|Physician Decision|2
2468418|NCT02358473|8521848|P1|Overall Study|Withdrawal by Subject|2
2468419|NCT02358473|8521848|P1|Overall Study|Adverse Event|3
2468420|NCT02358473|8521848|P1|Overall Study|Disease Progession|6
2468421|NCT02358343|8521862|P5|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
2468422|NCT02358343|8521863|P4|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
2468423|NCT02358343|8521864|P3|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1
2468424|NCT02358343|8521865|P2|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
2468425|NCT02358343|8521866|P1|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
2468426|NCT02358343|8521862|P5|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
2468427|NCT02358343|8521863|P4|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
2468428|NCT02358343|8521864|P3|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
2468429|NCT02358343|8521865|P2|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0
2468430|NCT02358343|8521866|P1|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0
2468431|NCT02358343|8521862|P5|Comparative Efficacy Trial / Observation|Death|0
2468432|NCT02358343|8521863|P4|Comparative Efficacy Trial / Observation|Death|0
2468433|NCT02358343|8521864|P3|Comparative Efficacy Trial / Observation|Death|2
2468434|NCT02358343|8521865|P2|Comparative Efficacy Trial / Observation|Death|0
2468435|NCT02358343|8521866|P1|Comparative Efficacy Trial / Observation|Death|0
2468436|NCT02358343|8521862|P5|Screening Intervention|Determined Ineligible|0
2468437|NCT02358343|8521863|P4|Screening Intervention|Determined Ineligible|0
2468438|NCT02358343|8521864|P3|Screening Intervention|Determined Ineligible|0
2468439|NCT02358343|8521865|P2|Screening Intervention|Determined Ineligible|6
2468440|NCT02358343|8521866|P1|Screening Intervention|Determined Ineligible|5
2468441|NCT02358343|8521862|P5|Screening Intervention|Withdrawal by Subject|0
2468442|NCT02358343|8521863|P4|Screening Intervention|Withdrawal by Subject|0
2468443|NCT02358343|8521864|P3|Screening Intervention|Withdrawal by Subject|0
2468444|NCT02358343|8521865|P2|Screening Intervention|Withdrawal by Subject|0
2468445|NCT02358343|8521866|P1|Screening Intervention|Withdrawal by Subject|1
2468446|NCT02358343|8521862|P5|Screening Intervention|Death|0
2468447|NCT02358343|8521863|P4|Screening Intervention|Death|0
2468448|NCT02358343|8521864|P3|Screening Intervention|Death|0
2468449|NCT02358343|8521865|P2|Screening Intervention|Death|2
2468450|NCT02358343|8521866|P1|Screening Intervention|Death|0
2468451|NCT02358044|8521922|P2|Overall Study|Withdrawal by Subject|4
2468452|NCT02358044|8521923|P1|Overall Study|Withdrawal by Subject|0
2468453|NCT02358044|8521922|P2|Overall Study|Physician Decision|1
2468454|NCT02358044|8521923|P1|Overall Study|Physician Decision|0
2468455|NCT02358044|8521922|P2|Overall Study|Lost to Follow-up|1
2468456|NCT02358044|8521923|P1|Overall Study|Lost to Follow-up|2
2468457|NCT02358044|8521922|P2|Overall Study|Adverse Event|1
2468458|NCT02358044|8521923|P1|Overall Study|Adverse Event|0
2468459|NCT02358031|8521942|P3|Overall Study|Ongoing in Study|33
2468460|NCT02358031|8521943|P2|Overall Study|Ongoing in Study|64
2468461|NCT02358031|8521944|P1|Overall Study|Ongoing in Study|61
2468462|NCT02358031|8521942|P3|Overall Study|Withdrawal by Subject|17
2468463|NCT02358031|8521943|P2|Overall Study|Withdrawal by Subject|12
2468464|NCT02358031|8521944|P1|Overall Study|Withdrawal by Subject|14
2468465|NCT02358031|8521942|P3|Overall Study|Lost to Follow-up|1
2468466|NCT02358031|8521943|P2|Overall Study|Lost to Follow-up|1
2468467|NCT02358031|8521944|P1|Overall Study|Lost to Follow-up|0
2468468|NCT02358031|8521942|P3|Overall Study|Death|249
2468469|NCT02358031|8521943|P2|Overall Study|Death|204
2468470|NCT02358031|8521944|P1|Overall Study|Death|226
2468471|NCT02357940|8522071|P2|Overall Study|Investigator's judgement|1
2468472|NCT02357940|8522072|P1|Overall Study|Investigator's judgement|0
2468473|NCT02357940|8522071|P2|Overall Study|Adverse Event|1
2468474|NCT02357940|8522072|P1|Overall Study|Adverse Event|0
2468475|NCT02357901|8522199|P4|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7
2468476|NCT02357901|8522200|P3|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6
2468477|NCT02357901|8522201|P2|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17
2468478|NCT02357901|8522202|P1|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0
2468479|NCT02357901|8522199|P4|Treatment Period (Day 1 to Week 24)|Physician Decision|1
2468480|NCT02357901|8522200|P3|Treatment Period (Day 1 to Week 24)|Physician Decision|1
2468481|NCT02357901|8522201|P2|Treatment Period (Day 1 to Week 24)|Physician Decision|0
2468482|NCT02357901|8522202|P1|Treatment Period (Day 1 to Week 24)|Physician Decision|0
2468483|NCT02357901|8522199|P4|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3
2468484|NCT02357901|8522200|P3|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
2468485|NCT02357901|8522201|P2|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1
2468486|NCT02357901|8522202|P1|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
2468487|NCT02357901|8522199|P4|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
2468488|NCT02357901|8522200|P3|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
2468489|NCT02357901|8522201|P2|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
2468490|NCT02357901|8522202|P1|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
2468491|NCT02357901|8522199|P4|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3
2468492|NCT02357901|8522200|P3|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
2468493|NCT02357901|8522201|P2|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
2468494|NCT02357901|8522202|P1|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0
2468495|NCT02357901|8522199|P4|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
2468496|NCT02357901|8522200|P3|Treatment Period (Day 1 to Week 24)|Protocol Violation|5
2468497|NCT02357901|8522201|P2|Treatment Period (Day 1 to Week 24)|Protocol Violation|2
2468498|NCT02357901|8522202|P1|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
2468499|NCT02357901|8522199|P4|Treatment Period (Day 1 to Week 24)|Adverse Event|2
2468500|NCT02357901|8522200|P3|Treatment Period (Day 1 to Week 24)|Adverse Event|10
2468501|NCT02357901|8522201|P2|Treatment Period (Day 1 to Week 24)|Adverse Event|6
2468502|NCT02357901|8522202|P1|Treatment Period (Day 1 to Week 24)|Adverse Event|0
2468503|NCT02357901|8522199|P4|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18
2468504|NCT02357901|8522200|P3|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5
2468505|NCT02357901|8522201|P2|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3
2468506|NCT02357901|8522202|P1|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0
2468507|NCT02357901|8522199|P4|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18
2468508|NCT02357901|8522200|P3|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21
2468509|NCT02357901|8522201|P2|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20
2468510|NCT02357901|8522202|P1|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0
2468511|NCT02357901|8522199|P4|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12
2468512|NCT02357901|8522200|P3|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23
2468513|NCT02357901|8522201|P2|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26
2468514|NCT02357901|8522202|P1|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0
2468515|NCT02357901|8522199|P4|Run-In Period (Days -14 to Day -1)|Run-In failures|0
2468516|NCT02357901|8522200|P3|Run-In Period (Days -14 to Day -1)|Run-In failures|0
2468517|NCT02357901|8522201|P2|Run-In Period (Days -14 to Day -1)|Run-In failures|0
2468518|NCT02357901|8522202|P1|Run-In Period (Days -14 to Day -1)|Run-In failures|161
2468519|NCT02357576|8522290|P2|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0
2468520|NCT02357576|8522291|P1|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2
2468521|NCT02357576|8522290|P2|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4
2468522|NCT02357576|8522291|P1|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1
2468523|NCT02357576|8522290|P2|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0
2468524|NCT02357576|8522291|P1|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1
2468525|NCT02357576|8522290|P2|Neurodevelopmental Outcome Follow Up|Scheduling error|1
2468526|NCT02357576|8522291|P1|Neurodevelopmental Outcome Follow Up|Scheduling error|1
2468527|NCT02357576|8522290|P2|Treatment Period|Physician Decision|1
2468528|NCT02357576|8522291|P1|Treatment Period|Physician Decision|0
2468529|NCT02357576|8522290|P2|Treatment Period|Withdrawal by Subject|1
2468530|NCT02357576|8522291|P1|Treatment Period|Withdrawal by Subject|0
2468531|NCT02357459|8522332|P3|Overall Study|Job Commitments|1
2468532|NCT02357459|8522333|P2|Overall Study|Job Commitments|0
2468533|NCT02357459|8522334|P1|Overall Study|Job Commitments|0
2468534|NCT02357459|8522332|P3|Overall Study|Pre-planned Knee surgery|2
2468535|NCT02357459|8522333|P2|Overall Study|Pre-planned Knee surgery|0
2468536|NCT02357459|8522334|P1|Overall Study|Pre-planned Knee surgery|0
2468537|NCT02357459|8522332|P3|Overall Study|Incarceration|1
2468538|NCT02357459|8522333|P2|Overall Study|Incarceration|0
2468539|NCT02357459|8522334|P1|Overall Study|Incarceration|0
2468540|NCT02357459|8522332|P3|Overall Study|Instruction from PCP|0
2468541|NCT02357459|8522333|P2|Overall Study|Instruction from PCP|0
2468542|NCT02357459|8522334|P1|Overall Study|Instruction from PCP|1
2468543|NCT02357459|8522332|P3|Overall Study|Patient Relocated|0
2468544|NCT02357459|8522333|P2|Overall Study|Patient Relocated|0
2468545|NCT02357459|8522334|P1|Overall Study|Patient Relocated|2
2468546|NCT02357459|8522332|P3|Overall Study|Lack of Efficacy|4
2468547|NCT02357459|8522333|P2|Overall Study|Lack of Efficacy|4
2468548|NCT02357459|8522334|P1|Overall Study|Lack of Efficacy|7
2468549|NCT02357459|8522332|P3|Overall Study|Lost to Follow-up|0
2468550|NCT02357459|8522333|P2|Overall Study|Lost to Follow-up|3
2468551|NCT02357459|8522334|P1|Overall Study|Lost to Follow-up|1
2468552|NCT02357459|8522332|P3|Overall Study|Protocol Violation|0
2468553|NCT02357459|8522333|P2|Overall Study|Protocol Violation|1
2468554|NCT02357459|8522334|P1|Overall Study|Protocol Violation|1
2468555|NCT02357459|8522332|P3|Overall Study|Physician Decision|0
2468556|NCT02357459|8522333|P2|Overall Study|Physician Decision|2
2468557|NCT02357459|8522334|P1|Overall Study|Physician Decision|0
2468558|NCT02357459|8522332|P3|Overall Study|Withdrawal by Subject|3
2468559|NCT02357459|8522333|P2|Overall Study|Withdrawal by Subject|3
2468560|NCT02357459|8522334|P1|Overall Study|Withdrawal by Subject|5
2468561|NCT02357459|8522332|P3|Overall Study|Adverse Event|1
2468562|NCT02357459|8522333|P2|Overall Study|Adverse Event|1
2468563|NCT02357459|8522334|P1|Overall Study|Adverse Event|0
2468564|NCT02357420|8522380|P4|Overall Study|Lost to Follow-up|3
2468565|NCT02357420|8522381|P3|Overall Study|Lost to Follow-up|2
2468566|NCT02357420|8522382|P2|Overall Study|Lost to Follow-up|0
2468567|NCT02357420|8522383|P1|Overall Study|Lost to Follow-up|3
2468568|NCT02357420|8522380|P4|Overall Study|Withdrawn Consent|6
2468569|NCT02357420|8522381|P3|Overall Study|Withdrawn Consent|6
2468570|NCT02357420|8522382|P2|Overall Study|Withdrawn Consent|8
2468571|NCT02357420|8522383|P1|Overall Study|Withdrawn Consent|4
2468572|NCT02357420|8522380|P4|Overall Study|Protocol Non-compliance|1
2468573|NCT02357420|8522381|P3|Overall Study|Protocol Non-compliance|0
2468574|NCT02357420|8522382|P2|Overall Study|Protocol Non-compliance|0
2468575|NCT02357420|8522383|P1|Overall Study|Protocol Non-compliance|0
2468576|NCT02357420|8522380|P4|Overall Study|Prohibited Medication|0
2468577|NCT02357420|8522381|P3|Overall Study|Prohibited Medication|0
2468578|NCT02357420|8522382|P2|Overall Study|Prohibited Medication|1
2468579|NCT02357420|8522383|P1|Overall Study|Prohibited Medication|1
2468580|NCT02357420|8522380|P4|Overall Study|Investigator Decision|0
2468581|NCT02357420|8522381|P3|Overall Study|Investigator Decision|0
2468582|NCT02357420|8522382|P2|Overall Study|Investigator Decision|0
2468583|NCT02357420|8522383|P1|Overall Study|Investigator Decision|1
2468584|NCT02357420|8522380|P4|Overall Study|Adverse Event|9
2468585|NCT02357420|8522381|P3|Overall Study|Adverse Event|8
2468586|NCT02357420|8522382|P2|Overall Study|Adverse Event|3
2468587|NCT02357420|8522383|P1|Overall Study|Adverse Event|3
2468588|NCT02357342|8522444|P2|First 6 Months|Death|0
2468589|NCT02357342|8522445|P1|First 6 Months|Death|2
2468590|NCT02357147|8522493|P2|Maintenance Treatment Phase|Not Treated|0
2468591|NCT02357147|8522494|P1|Maintenance Treatment Phase|Not Treated|1
2468592|NCT02357147|8522493|P2|Maintenance Treatment Phase|Sponsor Decision|15
2468593|NCT02357147|8522494|P1|Maintenance Treatment Phase|Sponsor Decision|0
2468594|NCT02357147|8522493|P2|Maintenance Treatment Phase|Adverse Event|3
2468595|NCT02357147|8522494|P1|Maintenance Treatment Phase|Adverse Event|0
2468596|NCT02357147|8522493|P2|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0
2468597|NCT02357147|8522494|P1|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10
2468598|NCT02357147|8522493|P2|Maintenance Treatment Phase|Withdrawal by Subject|1
2468599|NCT02357147|8522494|P1|Maintenance Treatment Phase|Withdrawal by Subject|0
2468600|NCT02357147|8522493|P2|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10
2468601|NCT02357147|8522494|P1|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15
2468602|NCT02357147|8522493|P2|Combination Treatment Phase|Not treated|2
2468603|NCT02357147|8522494|P1|Combination Treatment Phase|Not treated|0
2468604|NCT02357147|8522493|P2|Combination Treatment Phase|Other|0
2468605|NCT02357147|8522494|P1|Combination Treatment Phase|Other|1
2468606|NCT02357147|8522493|P2|Combination Treatment Phase|Sponsor Decision|12
2468607|NCT02357147|8522494|P1|Combination Treatment Phase|Sponsor Decision|0
2468608|NCT02357147|8522493|P2|Combination Treatment Phase|Death|1
2468609|NCT02357147|8522494|P1|Combination Treatment Phase|Death|1
2468610|NCT02357147|8522493|P2|Combination Treatment Phase|Adverse Event|4
2468611|NCT02357147|8522494|P1|Combination Treatment Phase|Adverse Event|12
2468612|NCT02357147|8522493|P2|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1
2468613|NCT02357147|8522494|P1|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4
2468614|NCT02357147|8522493|P2|Combination Treatment Phase|Withdrawal by Subject|2
2468615|NCT02357147|8522494|P1|Combination Treatment Phase|Withdrawal by Subject|4
2468616|NCT02357147|8522493|P2|Combination Treatment Phase|Investigator Discretion|1
2468617|NCT02357147|8522494|P1|Combination Treatment Phase|Investigator Discretion|1
2468618|NCT02357147|8522493|P2|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1
2468619|NCT02357147|8522494|P1|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0
2468620|NCT02357147|8522493|P2|Combination Treatment Phase|Progressive Disease (Radiographic test)|3
2468621|NCT02357147|8522494|P1|Combination Treatment Phase|Progressive Disease (Radiographic test)|3
2468622|NCT02356783|8522527|P2|Overall Study|Lost to Follow-up|3
2468623|NCT02356783|8522528|P1|Overall Study|Lost to Follow-up|1
2468624|NCT02356588|8522538|P2|Overall Study|Protocol Violation|1
2468625|NCT02356588|8522539|P1|Overall Study|Protocol Violation|0
2468626|NCT02356588|8522538|P2|Overall Study|Withdrawal by Subject|0
2468627|NCT02356588|8522539|P1|Overall Study|Withdrawal by Subject|1
2468628|NCT02356588|8522538|P2|Overall Study|Adverse Event|2
2468629|NCT02356588|8522539|P1|Overall Study|Adverse Event|0
2468630|NCT02356588|8522538|P2|Overall Study|Lack of Efficacy|10
2468631|NCT02356588|8522539|P1|Overall Study|Lack of Efficacy|4
2468632|NCT02356562|8522656|P2|Overall Study|site closure|0
2468633|NCT02356562|8522657|P1|Overall Study|site closure|1
2468634|NCT02356562|8522656|P2|Overall Study|Re-entered treatment in a previous study|0
2468635|NCT02356562|8522657|P1|Overall Study|Re-entered treatment in a previous study|1
2468636|NCT02356562|8522656|P2|Overall Study|Withdrawal by Subject|1
2468637|NCT02356562|8522657|P1|Overall Study|Withdrawal by Subject|0
2468638|NCT02356211|8522682|P2|Overall Study|ineligible|8
2468639|NCT02356211|8522683|P1|Overall Study|ineligible|1
2468640|NCT02356211|8522682|P2|Overall Study|Withdrawal by Subject|2
2468641|NCT02356211|8522683|P1|Overall Study|Withdrawal by Subject|2
2468642|NCT02355743|8522747|P1|Overall Study|Lost to Follow-up|1
2468643|NCT02355743|8522747|P1|Overall Study|Withdrawal by Subject|1
2468644|NCT02355691|8522755|P2|Overall Study|Loss of Research Personnel|9
2468645|NCT02355691|8522756|P1|Overall Study|Loss of Research Personnel|7
2468646|NCT02355665|8522766|P2|Overall Study|Compliance, PI decision, move, eligible|3
2468647|NCT02355665|8522767|P1|Overall Study|Compliance, PI decision, move, eligible|6
2468648|NCT02355665|8522766|P2|Overall Study|Death|2
2468649|NCT02355665|8522767|P1|Overall Study|Death|4
2468650|NCT02355665|8522766|P2|Overall Study|Lost to Follow-up|103
2468651|NCT02355665|8522767|P1|Overall Study|Lost to Follow-up|131
2468652|NCT02355665|8522766|P2|Overall Study|Withdrawal by Subject|100
2468653|NCT02355665|8522767|P1|Overall Study|Withdrawal by Subject|90
2468654|NCT02355665|8522766|P2|Overall Study|Protocol Violation|0
2468655|NCT02355665|8522767|P1|Overall Study|Protocol Violation|2
2468656|NCT02355665|8522766|P2|Overall Study|Adverse Event|24
2468657|NCT02355665|8522767|P1|Overall Study|Adverse Event|16
2468658|NCT02355028|8523225|P2|Overall Study|Deemed ineligible after randomization|4
2468659|NCT02355028|8523226|P1|Overall Study|Deemed ineligible after randomization|8
2468660|NCT02355028|8523225|P2|Overall Study|Withdrawal by Subject|1
2468661|NCT02355028|8523226|P1|Overall Study|Withdrawal by Subject|1
2468662|NCT02355028|8523225|P2|Overall Study|Adverse Event|0
2468663|NCT02355028|8523226|P1|Overall Study|Adverse Event|2
2468664|NCT02354976|8523262|P3|Overall Study|Adverse Event|2
2468665|NCT02354976|8523263|P2|Overall Study|Adverse Event|0
2468666|NCT02354976|8523264|P1|Overall Study|Adverse Event|1
2468667|NCT02354976|8523262|P3|Overall Study|Study-specifc withdrawal criteria|0
2468668|NCT02354976|8523263|P2|Overall Study|Study-specifc withdrawal criteria|1
2468669|NCT02354976|8523264|P1|Overall Study|Study-specifc withdrawal criteria|0
2468670|NCT02354976|8523262|P3|Overall Study|Other - reason not specified|1
2468671|NCT02354976|8523263|P2|Overall Study|Other - reason not specified|0
2468672|NCT02354976|8523264|P1|Overall Study|Other - reason not specified|1
2468673|NCT02354690|8523327|P1|Overall Study|Physician Decision|1
2468674|NCT02354599|8523341|P6|Overall Study|Withdrawal by Subject|0
2468675|NCT02354599|8523342|P5|Overall Study|Withdrawal by Subject|0
2468676|NCT02354599|8523343|P4|Overall Study|Withdrawal by Subject|0
2468677|NCT02354599|8523344|P3|Overall Study|Withdrawal by Subject|0
2468678|NCT02354599|8523345|P2|Overall Study|Withdrawal by Subject|1
2468679|NCT02354599|8523346|P1|Overall Study|Withdrawal by Subject|1
2468680|NCT02354599|8523341|P6|Overall Study|Pretreatment Event/Adverse Event|1
2468681|NCT02354599|8523342|P5|Overall Study|Pretreatment Event/Adverse Event|0
2468682|NCT02354599|8523343|P4|Overall Study|Pretreatment Event/Adverse Event|0
2468683|NCT02354599|8523344|P3|Overall Study|Pretreatment Event/Adverse Event|0
2468684|NCT02354599|8523345|P2|Overall Study|Pretreatment Event/Adverse Event|0
2468685|NCT02354599|8523346|P1|Overall Study|Pretreatment Event/Adverse Event|0
2468686|NCT02354586|8523416|P1|Overall Study|Disease progression|116
2468687|NCT02354586|8523416|P1|Overall Study|Lost to Follow-up|6
2468688|NCT02354586|8523416|P1|Overall Study|Withdrawal by Subject|51
2468689|NCT02354586|8523416|P1|Overall Study|Death|168
2468690|NCT02354508|8523435|P3|Period 3: Post-treatment Follow up Phase|Physician Decision|1
2468691|NCT02354508|8523436|P2|Period 3: Post-treatment Follow up Phase|Physician Decision|0
2468692|NCT02354508|8523437|P1|Period 3: Post-treatment Follow up Phase|Physician Decision|3
2468693|NCT02354508|8523435|P3|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0
2468694|NCT02354508|8523436|P2|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1
2468695|NCT02354508|8523437|P1|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0
2468696|NCT02354508|8523435|P3|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2
2468697|NCT02354508|8523436|P2|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2
2468698|NCT02354508|8523437|P1|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1
2468699|NCT02354508|8523435|P3|Period 2: Extension Phase|Physician Decision|1
2468700|NCT02354508|8523436|P2|Period 2: Extension Phase|Physician Decision|0
2468701|NCT02354508|8523437|P1|Period 2: Extension Phase|Physician Decision|5
2468702|NCT02354508|8523435|P3|Period 2: Extension Phase|Withdrawal by Subject|0
2468703|NCT02354508|8523436|P2|Period 2: Extension Phase|Withdrawal by Subject|1
2468704|NCT02354508|8523437|P1|Period 2: Extension Phase|Withdrawal by Subject|0
2468705|NCT02354508|8523435|P3|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2
2468706|NCT02354508|8523436|P2|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3
2468707|NCT02354508|8523437|P1|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1
2468708|NCT02354508|8523435|P3|Period 1: Core Phase|Withdrawal by Subject|2
2468709|NCT02354508|8523436|P2|Period 1: Core Phase|Withdrawal by Subject|1
2468710|NCT02354508|8523437|P1|Period 1: Core Phase|Withdrawal by Subject|0
2468711|NCT02354508|8523435|P3|Period 1: Core Phase|Unsatisfactory therapeutic effect|2
2468712|NCT02354508|8523436|P2|Period 1: Core Phase|Unsatisfactory therapeutic effect|0
2468713|NCT02354508|8523437|P1|Period 1: Core Phase|Unsatisfactory therapeutic effect|1
2468714|NCT02354508|8523435|P3|Period 1: Core Phase|Adverse Event|2
2468715|NCT02354508|8523436|P2|Period 1: Core Phase|Adverse Event|1
2468716|NCT02354508|8523437|P1|Period 1: Core Phase|Adverse Event|1
2468717|NCT02354417|8523539|P1|Overall Study|Physician Decision|1
2468718|NCT02354235|8523565|P2|Overall Study|Conflict with the stopping criteria|1
2468719|NCT02354235|8523566|P1|Overall Study|Conflict with the stopping criteria|0
2468720|NCT02354235|8523565|P2|Overall Study|Withdrawal by Subject|3
2468721|NCT02354235|8523566|P1|Overall Study|Withdrawal by Subject|1
2468722|NCT02354235|8523565|P2|Overall Study|Physician Decision|1
2468723|NCT02354235|8523566|P1|Overall Study|Physician Decision|0
2468724|NCT02354235|8523565|P2|Overall Study|Adverse Event|2
2468725|NCT02354235|8523566|P1|Overall Study|Adverse Event|2
2468726|NCT02354222|8523582|P2|Overall Study|Conflict with the stopping criteria|4
2468727|NCT02354222|8523583|P1|Overall Study|Conflict with the stopping criteria|0
2468728|NCT02354222|8523582|P2|Overall Study|Withdrawal by Subject|3
2468729|NCT02354222|8523583|P1|Overall Study|Withdrawal by Subject|2
2468730|NCT02354222|8523582|P2|Overall Study|Pregnancy|0
2468731|NCT02354222|8523583|P1|Overall Study|Pregnancy|1
2468732|NCT02354222|8523582|P2|Overall Study|Physician Decision|1
2468733|NCT02354222|8523583|P1|Overall Study|Physician Decision|1
2468734|NCT02354222|8523582|P2|Overall Study|Adverse Event|3
2468735|NCT02354222|8523583|P1|Overall Study|Adverse Event|0
2468736|NCT02353871|8523614|P2|Overall Study|Lost to Follow-up|0
2468737|NCT02353871|8523615|P1|Overall Study|Lost to Follow-up|2
2468738|NCT02353871|8523614|P2|Overall Study|Consent withdrawn|8
2468739|NCT02353871|8523615|P1|Overall Study|Consent withdrawn|1
2468740|NCT02353871|8523614|P2|Overall Study|Protocol deviation|1
2468741|NCT02353871|8523615|P1|Overall Study|Protocol deviation|0
2468742|NCT02353572|8523668|P1|Overall Study|Study terminated|2
2468743|NCT02353572|8523668|P1|Overall Study|Withdrawal by Subject|1
2468744|NCT02353468|8523672|P1|Overall Study|Study terminated|3
2468745|NCT02353442|8523678|P2|Overall Study|Withdrawal by Subject|4
2468746|NCT02353442|8523679|P1|Overall Study|Withdrawal by Subject|3
2468747|NCT02353169|8523734|P4|Overall Study|Pre-op medication|0
2468748|NCT02353169|8523735|P3|Overall Study|Pre-op medication|1
2468749|NCT02353169|8523736|P2|Overall Study|Pre-op medication|0
2468750|NCT02353169|8523737|P1|Overall Study|Pre-op medication|0
2468751|NCT02353169|8523734|P4|Overall Study|ECG data error|2
2468752|NCT02353169|8523735|P3|Overall Study|ECG data error|2
2468753|NCT02353169|8523736|P2|Overall Study|ECG data error|3
2468754|NCT02353169|8523737|P1|Overall Study|ECG data error|0
2468755|NCT02353169|8523734|P4|Overall Study|Inhalational induction|0
2468756|NCT02353169|8523735|P3|Overall Study|Inhalational induction|0
2468757|NCT02353169|8523736|P2|Overall Study|Inhalational induction|2
2468758|NCT02353169|8523737|P1|Overall Study|Inhalational induction|0
2468759|NCT02353169|8523734|P4|Overall Study|OR team declined|0
2468760|NCT02353169|8523735|P3|Overall Study|OR team declined|0
2468761|NCT02353169|8523736|P2|Overall Study|OR team declined|0
2468762|NCT02353169|8523737|P1|Overall Study|OR team declined|2
2468763|NCT02353169|8523734|P4|Overall Study|QTc > 450 msec|1
2468764|NCT02353169|8523735|P3|Overall Study|QTc > 450 msec|1
2468765|NCT02353169|8523736|P2|Overall Study|QTc > 450 msec|1
2468766|NCT02353169|8523737|P1|Overall Study|QTc > 450 msec|1
2468767|NCT02352948|8523829|P6|Overall Study|Other|0
2468768|NCT02352948|8523830|P5|Overall Study|Other|0
2468769|NCT02352948|8523831|P4|Overall Study|Other|0
2468770|NCT02352948|8523832|P3|Overall Study|Other|2
2468771|NCT02352948|8523833|P2|Overall Study|Other|0
2468772|NCT02352948|8523834|P1|Overall Study|Other|0
2468773|NCT02352948|8523829|P6|Overall Study|Eligibility criteria not fulfilled|0
2468774|NCT02352948|8523830|P5|Overall Study|Eligibility criteria not fulfilled|0
2468775|NCT02352948|8523831|P4|Overall Study|Eligibility criteria not fulfilled|1
2468776|NCT02352948|8523832|P3|Overall Study|Eligibility criteria not fulfilled|0
2468777|NCT02352948|8523833|P2|Overall Study|Eligibility criteria not fulfilled|1
2468778|NCT02352948|8523834|P1|Overall Study|Eligibility criteria not fulfilled|0
2468779|NCT02352948|8523829|P6|Overall Study|Withdrawal by Subject|4
2468780|NCT02352948|8523830|P5|Overall Study|Withdrawal by Subject|9
2468781|NCT02352948|8523831|P4|Overall Study|Withdrawal by Subject|23
2468782|NCT02352948|8523832|P3|Overall Study|Withdrawal by Subject|11
2468783|NCT02352948|8523833|P2|Overall Study|Withdrawal by Subject|10
2468784|NCT02352948|8523834|P1|Overall Study|Withdrawal by Subject|1
2468785|NCT02352948|8523829|P6|Overall Study|Lost to Follow-up|1
2468786|NCT02352948|8523830|P5|Overall Study|Lost to Follow-up|2
2468787|NCT02352948|8523831|P4|Overall Study|Lost to Follow-up|1
2468788|NCT02352948|8523832|P3|Overall Study|Lost to Follow-up|2
2468789|NCT02352948|8523833|P2|Overall Study|Lost to Follow-up|0
2468790|NCT02352948|8523834|P1|Overall Study|Lost to Follow-up|1
2468791|NCT02352948|8523829|P6|Overall Study|Death|44
2468792|NCT02352948|8523830|P5|Overall Study|Death|77
2468793|NCT02352948|8523831|P4|Overall Study|Death|74
2468794|NCT02352948|8523832|P3|Overall Study|Death|114
2468795|NCT02352948|8523833|P2|Overall Study|Death|48
2468796|NCT02352948|8523834|P1|Overall Study|Death|47
2468797|NCT02352779|8523922|P3|Overall Study|No Reason|1
2468798|NCT02352779|8523923|P2|Overall Study|No Reason|0
2468799|NCT02352779|8523924|P1|Overall Study|No Reason|0
2468800|NCT02352779|8523922|P3|Overall Study|Other Medical Reason|1
2468801|NCT02352779|8523923|P2|Overall Study|Other Medical Reason|0
2468802|NCT02352779|8523924|P1|Overall Study|Other Medical Reason|0
2468803|NCT02352779|8523922|P3|Overall Study|Absence of Symptoms|0
2468804|NCT02352779|8523923|P2|Overall Study|Absence of Symptoms|0
2468805|NCT02352779|8523924|P1|Overall Study|Absence of Symptoms|1
2468806|NCT02352779|8523922|P3|Overall Study|Study Related Symptoms|0
2468807|NCT02352779|8523923|P2|Overall Study|Study Related Symptoms|0
2468808|NCT02352779|8523924|P1|Overall Study|Study Related Symptoms|1
2468809|NCT02352779|8523922|P3|Overall Study|Changed Mind|0
2468810|NCT02352779|8523923|P2|Overall Study|Changed Mind|0
2468811|NCT02352779|8523924|P1|Overall Study|Changed Mind|1
2468812|NCT02352779|8523922|P3|Overall Study|Disliked Intervention|0
2468813|NCT02352779|8523923|P2|Overall Study|Disliked Intervention|0
2468814|NCT02352779|8523924|P1|Overall Study|Disliked Intervention|1
2468815|NCT02352779|8523922|P3|Overall Study|Feeling Overwhelmed|0
2468816|NCT02352779|8523923|P2|Overall Study|Feeling Overwhelmed|0
2468817|NCT02352779|8523924|P1|Overall Study|Feeling Overwhelmed|1
2468818|NCT02352779|8523922|P3|Overall Study|Too Many Forms|0
2468819|NCT02352779|8523923|P2|Overall Study|Too Many Forms|0
2468820|NCT02352779|8523924|P1|Overall Study|Too Many Forms|2
2468821|NCT02352779|8523922|P3|Overall Study|Personal Issues|0
2468822|NCT02352779|8523923|P2|Overall Study|Personal Issues|1
2468823|NCT02352779|8523924|P1|Overall Study|Personal Issues|1
2468824|NCT02352493|8523950|P18|Overall Study|Lost to Follow-up|0
2468825|NCT02352493|8523951|P17|Overall Study|Lost to Follow-up|0
2468826|NCT02352493|8523952|P16|Overall Study|Lost to Follow-up|0
2468827|NCT02352493|8523953|P15|Overall Study|Lost to Follow-up|0
2468828|NCT02352493|8523954|P14|Overall Study|Lost to Follow-up|2
2468829|NCT02352493|8523955|P13|Overall Study|Lost to Follow-up|1
2468830|NCT02352493|8523956|P12|Overall Study|Lost to Follow-up|0
2468831|NCT02352493|8523957|P11|Overall Study|Lost to Follow-up|0
2468832|NCT02352493|8523958|P10|Overall Study|Lost to Follow-up|1
2468833|NCT02352493|8523959|P9|Overall Study|Lost to Follow-up|0
2468834|NCT02352493|8523960|P8|Overall Study|Lost to Follow-up|0
2468835|NCT02352493|8523961|P7|Overall Study|Lost to Follow-up|0
2468836|NCT02352493|8523962|P6|Overall Study|Lost to Follow-up|0
2468837|NCT02352493|8523963|P5|Overall Study|Lost to Follow-up|0
2468838|NCT02352493|8523964|P4|Overall Study|Lost to Follow-up|0
2468839|NCT02352493|8523965|P3|Overall Study|Lost to Follow-up|0
2468840|NCT02352493|8523966|P2|Overall Study|Lost to Follow-up|0
2468841|NCT02352493|8523967|P1|Overall Study|Lost to Follow-up|0
2468842|NCT02352493|8523950|P18|Overall Study|Withdrawal by Subject|0
2468843|NCT02352493|8523951|P17|Overall Study|Withdrawal by Subject|0
2468844|NCT02352493|8523952|P16|Overall Study|Withdrawal by Subject|0
2468845|NCT02352493|8523953|P15|Overall Study|Withdrawal by Subject|1
2468846|NCT02352493|8523954|P14|Overall Study|Withdrawal by Subject|0
2468847|NCT02352493|8523955|P13|Overall Study|Withdrawal by Subject|0
2468848|NCT02352493|8523956|P12|Overall Study|Withdrawal by Subject|0
2468849|NCT02352493|8523957|P11|Overall Study|Withdrawal by Subject|0
2468850|NCT02352493|8523958|P10|Overall Study|Withdrawal by Subject|0
2468851|NCT02352493|8523959|P9|Overall Study|Withdrawal by Subject|1
2468852|NCT02352493|8523960|P8|Overall Study|Withdrawal by Subject|0
2468853|NCT02352493|8523961|P7|Overall Study|Withdrawal by Subject|0
2468854|NCT02352493|8523962|P6|Overall Study|Withdrawal by Subject|0
2468855|NCT02352493|8523963|P5|Overall Study|Withdrawal by Subject|0
2468856|NCT02352493|8523964|P4|Overall Study|Withdrawal by Subject|0
2468857|NCT02352493|8523965|P3|Overall Study|Withdrawal by Subject|0
2468858|NCT02352493|8523966|P2|Overall Study|Withdrawal by Subject|0
2468859|NCT02352493|8523967|P1|Overall Study|Withdrawal by Subject|0
2468860|NCT02352493|8523950|P18|Overall Study|Pregnancy|0
2468861|NCT02352493|8523951|P17|Overall Study|Pregnancy|0
2468862|NCT02352493|8523952|P16|Overall Study|Pregnancy|0
2468863|NCT02352493|8523953|P15|Overall Study|Pregnancy|0
2468864|NCT02352493|8523954|P14|Overall Study|Pregnancy|0
2468865|NCT02352493|8523955|P13|Overall Study|Pregnancy|0
2468866|NCT02352493|8523956|P12|Overall Study|Pregnancy|0
2468867|NCT02352493|8523957|P11|Overall Study|Pregnancy|0
2468868|NCT02352493|8523958|P10|Overall Study|Pregnancy|0
2468869|NCT02352493|8523959|P9|Overall Study|Pregnancy|1
2468870|NCT02352493|8523960|P8|Overall Study|Pregnancy|0
2468871|NCT02352493|8523961|P7|Overall Study|Pregnancy|1
2468872|NCT02352493|8523962|P6|Overall Study|Pregnancy|0
2468873|NCT02352493|8523963|P5|Overall Study|Pregnancy|0
2468874|NCT02352493|8523964|P4|Overall Study|Pregnancy|0
2468875|NCT02352493|8523965|P3|Overall Study|Pregnancy|0
2468876|NCT02352493|8523966|P2|Overall Study|Pregnancy|0
2468877|NCT02352493|8523967|P1|Overall Study|Pregnancy|0
2468878|NCT02351960|8524200|P2|Overall Study|Significant Protocol Deviation|5
2468879|NCT02351960|8524201|P1|Overall Study|Significant Protocol Deviation|0
2468880|NCT02351960|8524200|P2|Overall Study|Voluntary Withdrawal|4
2468881|NCT02351960|8524201|P1|Overall Study|Voluntary Withdrawal|5
2468882|NCT02351960|8524200|P2|Overall Study|Pretreatment Event/Adverse Event|3
2468883|NCT02351960|8524201|P1|Overall Study|Pretreatment Event/Adverse Event|6
2468884|NCT02351934|8524222|P2|Follow-Up|2 ERAS Components Noncompliant|4
2468885|NCT02351934|8524223|P1|Follow-Up|2 ERAS Components Noncompliant|0
2468886|NCT02351934|8524222|P2|Follow-Up|1 ERAS Component Noncompliant|6
2468887|NCT02351934|8524223|P1|Follow-Up|1 ERAS Component Noncompliant|0
2468888|NCT02351934|8524222|P2|Follow-Up|No documentation|0
2468889|NCT02351934|8524223|P1|Follow-Up|No documentation|2
2468890|NCT02351934|8524222|P2|Follow-Up|Hypotension|0
2468891|NCT02351934|8524223|P1|Follow-Up|Hypotension|3
2468892|NCT02351934|8524222|P2|Follow-Up|Early dismissal|0
2468893|NCT02351934|8524223|P1|Follow-Up|Early dismissal|3
2468894|NCT02351934|8524222|P2|Follow-Up|Acute Kidney Injury|0
2468895|NCT02351934|8524223|P1|Follow-Up|Acute Kidney Injury|1
2468896|NCT02351934|8524222|P2|Follow-Up|POD weight<pre-op weight|0
2468897|NCT02351934|8524223|P1|Follow-Up|POD weight<pre-op weight|3
2468898|NCT02351934|8524222|P2|Allocation|Acute Kidney Injury on Post Op Day 1|0
2468899|NCT02351934|8524223|P1|Allocation|Acute Kidney Injury on Post Op Day 1|1
2468900|NCT02351934|8524222|P2|Allocation|Hypotension preventing administration|0
2468901|NCT02351934|8524223|P1|Allocation|Hypotension preventing administration|2
2468902|NCT02351934|8524222|P2|Allocation|POD weight<pre-op weight|0
2468903|NCT02351934|8524223|P1|Allocation|POD weight<pre-op weight|3
2468904|NCT02351817|8524239|P2|Period 2|Protocol Violation|0
2468905|NCT02351817|8524240|P1|Period 2|Protocol Violation|1
2468906|NCT02351817|8524239|P2|Period 2|Adverse Event|2
2468907|NCT02351817|8524240|P1|Period 2|Adverse Event|0
2468908|NCT02351817|8524239|P2|Period 1|Lack of Efficacy|1
2468909|NCT02351817|8524240|P1|Period 1|Lack of Efficacy|0
2468910|NCT02351817|8524239|P2|Period 1|Adverse Event|2
2468911|NCT02351817|8524240|P1|Period 1|Adverse Event|1
2468912|NCT02351167|8524285|P3|Overall Study|Withdrawal by Subject|21
2468913|NCT02351167|8524286|P2|Overall Study|Withdrawal by Subject|18
2468914|NCT02351167|8524287|P1|Overall Study|Withdrawal by Subject|19
2468915|NCT02350478|8524428|P2|Overall Study|Lost to Follow-up|1
2468916|NCT02350478|8524429|P1|Overall Study|Lost to Follow-up|5
2468917|NCT02350309|8524451|P6|Treatment Period 4 (2 Days)|Death in the Family|1
2468918|NCT02350309|8524452|P5|Treatment Period 4 (2 Days)|Death in the Family|0
2468919|NCT02350309|8524453|P4|Treatment Period 4 (2 Days)|Death in the Family|0
2468920|NCT02350309|8524454|P3|Treatment Period 4 (2 Days)|Death in the Family|0
2468921|NCT02350309|8524455|P2|Treatment Period 4 (2 Days)|Death in the Family|0
2468922|NCT02350309|8524456|P1|Treatment Period 4 (2 Days)|Death in the Family|0
2468923|NCT02350309|8524451|P6|Treatment Period 1 (2 Days)|Physician Decision|0
2468924|NCT02350309|8524452|P5|Treatment Period 1 (2 Days)|Physician Decision|0
2468925|NCT02350309|8524453|P4|Treatment Period 1 (2 Days)|Physician Decision|0
2468926|NCT02350309|8524454|P3|Treatment Period 1 (2 Days)|Physician Decision|1
2468927|NCT02350309|8524455|P2|Treatment Period 1 (2 Days)|Physician Decision|0
2468928|NCT02350309|8524456|P1|Treatment Period 1 (2 Days)|Physician Decision|0
2468929|NCT02349789|8524495|P1|Overall Study|Withdrawal by Subject|2
2468930|NCT02349711|8524506|P2|Overall Study|Lost to Follow-up|1
2468931|NCT02349711|8524507|P1|Overall Study|Lost to Follow-up|1
2468932|NCT02349711|8524506|P2|Overall Study|Withdrawal by Subject|1
2468933|NCT02349711|8524507|P1|Overall Study|Withdrawal by Subject|2
2468934|NCT02349542|8524540|P1|Overall Study|Withdrawal by Subject|5
2468935|NCT02349451|8524564|P4|Overall Study|Withdrawal by Subject|1
2468936|NCT02349451|8524565|P3|Overall Study|Withdrawal by Subject|2
2468937|NCT02349451|8524566|P2|Overall Study|Withdrawal by Subject|1
2468938|NCT02349451|8524567|P1|Overall Study|Withdrawal by Subject|0
2468939|NCT02349412|8524616|P2|Overall Study|Withdrawal by Subject|7
2468940|NCT02349412|8524617|P1|Overall Study|Withdrawal by Subject|7
2468941|NCT02349360|8524633|P2|Overall Study|Withdrawal by Subject|1
2468942|NCT02349360|8524634|P1|Overall Study|Withdrawal by Subject|0
2468943|NCT02349295|8524645|P5|IR (Week 16-24)|Lack of Efficacy|1
2468944|NCT02349295|8524646|P4|IR (Week 16-24)|Lack of Efficacy|0
2468945|NCT02349295|8524647|P3|IR (Week 16-24)|Lack of Efficacy|0
2468946|NCT02349295|8524648|P2|IR (Week 16-24)|Lack of Efficacy|0
2468947|NCT02349295|8524649|P1|IR (Week 16-24)|Lack of Efficacy|0
2468948|NCT02349295|8524645|P5|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
2468949|NCT02349295|8524646|P4|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
2468950|NCT02349295|8524647|P3|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
2468951|NCT02349295|8524648|P2|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
2468952|NCT02349295|8524649|P1|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
2468953|NCT02349295|8524645|P5|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
2468954|NCT02349295|8524646|P4|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
2468955|NCT02349295|8524647|P3|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
2468956|NCT02349295|8524648|P2|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
2468957|NCT02349295|8524649|P1|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2
2468958|NCT02349295|8524645|P5|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
2468959|NCT02349295|8524646|P4|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
2468960|NCT02349295|8524647|P3|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
2468961|NCT02349295|8524648|P2|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
2468962|NCT02349295|8524649|P1|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7
2468963|NCT02349295|8524645|P5|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
2468964|NCT02349295|8524646|P4|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
2468965|NCT02349295|8524647|P3|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4
2468966|NCT02349295|8524648|P2|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2
2468967|NCT02349295|8524649|P1|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9
2468968|NCT02349295|8524645|P5|Double Blind Treatment (Week 0-24)|Adverse Event|0
2468969|NCT02349295|8524646|P4|Double Blind Treatment (Week 0-24)|Adverse Event|0
2468970|NCT02349295|8524647|P3|Double Blind Treatment (Week 0-24)|Adverse Event|7
2468971|NCT02349295|8524648|P2|Double Blind Treatment (Week 0-24)|Adverse Event|5
2468972|NCT02349295|8524649|P1|Double Blind Treatment (Week 0-24)|Adverse Event|5
2468973|NCT02349061|8524768|P3|Study Extension (Week 56 to Week 120)|Physician Decision|1
2468974|NCT02349061|8524769|P2|Study Extension (Week 56 to Week 120)|Physician Decision|0
2468975|NCT02349061|8524770|P1|Study Extension (Week 56 to Week 120)|Physician Decision|0
2468976|NCT02349061|8524768|P3|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1
2468977|NCT02349061|8524769|P2|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2
2468978|NCT02349061|8524770|P1|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0
2468979|NCT02349061|8524768|P3|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1
2468980|NCT02349061|8524769|P2|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0
2468981|NCT02349061|8524770|P1|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0
2468982|NCT02349061|8524768|P3|Study Extension (Week 56 to Week 120)|Adverse Event|0
2468983|NCT02349061|8524769|P2|Study Extension (Week 56 to Week 120)|Adverse Event|3
2468984|NCT02349061|8524770|P1|Study Extension (Week 56 to Week 120)|Adverse Event|0
2468985|NCT02349061|8524768|P3|Main Study: Week 24 to 56|Physician Decision|1
2468986|NCT02349061|8524769|P2|Main Study: Week 24 to 56|Physician Decision|0
2468987|NCT02349061|8524770|P1|Main Study: Week 24 to 56|Physician Decision|0
2468988|NCT02349061|8524768|P3|Main Study: Week 24 to 56|Withdrawal by Subject|1
2468989|NCT02349061|8524769|P2|Main Study: Week 24 to 56|Withdrawal by Subject|0
2468990|NCT02349061|8524770|P1|Main Study: Week 24 to 56|Withdrawal by Subject|0
2468991|NCT02349061|8524768|P3|Main Study: Week 24 to 56|Lack of Efficacy|0
2468992|NCT02349061|8524769|P2|Main Study: Week 24 to 56|Lack of Efficacy|1
2468993|NCT02349061|8524770|P1|Main Study: Week 24 to 56|Lack of Efficacy|0
2468994|NCT02349061|8524768|P3|Main Study: Week 24 to 56|Adverse Event|1
2468995|NCT02349061|8524769|P2|Main Study: Week 24 to 56|Adverse Event|2
2468996|NCT02349061|8524770|P1|Main Study: Week 24 to 56|Adverse Event|0
2468997|NCT02349061|8524768|P3|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0
2468998|NCT02349061|8524769|P2|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0
2468999|NCT02349061|8524770|P1|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2
2469000|NCT02349061|8524768|P3|Main Study: PCP (Up to Week 24)|Other|0
2469001|NCT02349061|8524769|P2|Main Study: PCP (Up to Week 24)|Other|1
2469002|NCT02349061|8524770|P1|Main Study: PCP (Up to Week 24)|Other|1
2469003|NCT02349061|8524768|P3|Main Study: PCP (Up to Week 24)|Physician Decision|0
2469004|NCT02349061|8524769|P2|Main Study: PCP (Up to Week 24)|Physician Decision|0
2469005|NCT02349061|8524770|P1|Main Study: PCP (Up to Week 24)|Physician Decision|1
2469006|NCT02349061|8524768|P3|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0
2469007|NCT02349061|8524769|P2|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0
2469008|NCT02349061|8524770|P1|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1
2469009|NCT02349061|8524768|P3|Main Study: PCP (Up to Week 24)|Adverse Event|0
2469010|NCT02349061|8524769|P2|Main Study: PCP (Up to Week 24)|Adverse Event|3
2469011|NCT02349061|8524770|P1|Main Study: PCP (Up to Week 24)|Adverse Event|4
2469012|NCT02349048|8524790|P2|Overall Study|Lost to Follow-up|0
2469013|NCT02349048|8524791|P1|Overall Study|Lost to Follow-up|1
2469014|NCT02349048|8524790|P2|Overall Study|Withdrawal by Subject|0
2469015|NCT02349048|8524791|P1|Overall Study|Withdrawal by Subject|4
2469016|NCT02348840|8524852|P4|Overall Study|Withdrawal by Subject|0
2469017|NCT02348840|8524853|P3|Overall Study|Withdrawal by Subject|0
2469018|NCT02348840|8524854|P2|Overall Study|Withdrawal by Subject|1
2469019|NCT02348840|8524855|P1|Overall Study|Withdrawal by Subject|2
2469020|NCT02348723|8524869|P2|Overall Study|Adverse Event|1
2469021|NCT02348723|8524870|P1|Overall Study|Adverse Event|3
2469022|NCT02348723|8524869|P2|Overall Study|Reason other than specified|1
2469023|NCT02348723|8524870|P1|Overall Study|Reason other than specified|1
2469024|NCT02348723|8524869|P2|Overall Study|Consent withdrawn|3
2469025|NCT02348723|8524870|P1|Overall Study|Consent withdrawn|1
2469026|NCT02348723|8524869|P2|Overall Study|Lost to Follow-up|1
2469027|NCT02348723|8524870|P1|Overall Study|Lost to Follow-up|1
2469028|NCT02348723|8524869|P2|Overall Study|Non-compliant with Protocol|0
2469029|NCT02348723|8524870|P1|Overall Study|Non-compliant with Protocol|1
2469030|NCT02348723|8524869|P2|Overall Study|No ablation|20
2469031|NCT02348723|8524870|P1|Overall Study|No ablation|21
2469032|NCT02347943|8525097|P3|Overall Study|Study was cancelled|45
2469033|NCT02347943|8525098|P2|Overall Study|Study was cancelled|67
2469034|NCT02347943|8525099|P1|Overall Study|Study was cancelled|140
2469035|NCT02347787|8525109|P2|9 Month Follow-Up|Withdrawal by Subject|12
2469036|NCT02347787|8525110|P1|9 Month Follow-Up|Withdrawal by Subject|9
2469037|NCT02347787|8525109|P2|9 Month Follow-Up|Lost to Follow-up|59
2469038|NCT02347787|8525110|P1|9 Month Follow-Up|Lost to Follow-up|52
2469039|NCT02347787|8525109|P2|6 Month Follow-Up|Withdrawal by Subject|9
2469040|NCT02347787|8525110|P1|6 Month Follow-Up|Withdrawal by Subject|3
2469041|NCT02347787|8525109|P2|6 Month Follow-Up|Lost to Follow-up|47
2469042|NCT02347787|8525110|P1|6 Month Follow-Up|Lost to Follow-up|63
2469043|NCT02347774|8525172|P3|On Study Treatment|ranomized in error|1
2469044|NCT02347774|8525173|P2|On Study Treatment|ranomized in error|0
2469045|NCT02347774|8525174|P1|On Study Treatment|ranomized in error|0
2469046|NCT02347774|8525172|P3|On Study Treatment|Met Prolonged QT criteria|0
2469047|NCT02347774|8525173|P2|On Study Treatment|Met Prolonged QT criteria|0
2469048|NCT02347774|8525174|P1|On Study Treatment|Met Prolonged QT criteria|1
2469049|NCT02347774|8525172|P3|On Study Treatment|Lost to Follow-up|1
2469050|NCT02347774|8525173|P2|On Study Treatment|Lost to Follow-up|6
2469051|NCT02347774|8525174|P1|On Study Treatment|Lost to Follow-up|2
2469052|NCT02347774|8525172|P3|On Study Treatment|withdrew consent|12
2469053|NCT02347774|8525173|P2|On Study Treatment|withdrew consent|8
2469054|NCT02347774|8525174|P1|On Study Treatment|withdrew consent|9
2469055|NCT02347774|8525172|P3|On Study Treatment|Protocol Violation|1
2469056|NCT02347774|8525173|P2|On Study Treatment|Protocol Violation|0
2469057|NCT02347774|8525174|P1|On Study Treatment|Protocol Violation|0
2469058|NCT02347774|8525172|P3|On Study Treatment|non-complicance with study medication|0
2469059|NCT02347774|8525173|P2|On Study Treatment|non-complicance with study medication|2
2469060|NCT02347774|8525174|P1|On Study Treatment|non-complicance with study medication|0
2469061|NCT02347774|8525172|P3|On Study Treatment|Lack of Efficacy|2
2469062|NCT02347774|8525173|P2|On Study Treatment|Lack of Efficacy|0
2469063|NCT02347774|8525174|P1|On Study Treatment|Lack of Efficacy|3
2469064|NCT02347774|8525172|P3|On Study Treatment|Adverse Event|19
2469065|NCT02347774|8525173|P2|On Study Treatment|Adverse Event|15
2469066|NCT02347774|8525174|P1|On Study Treatment|Adverse Event|9
2469067|NCT02347774|8525172|P3|Study Participation|randomized in error|1
2469068|NCT02347774|8525173|P2|Study Participation|randomized in error|0
2469069|NCT02347774|8525174|P1|Study Participation|randomized in error|0
2469070|NCT02347774|8525172|P3|Study Participation|incarceration|0
2469071|NCT02347774|8525173|P2|Study Participation|incarceration|0
2469072|NCT02347774|8525174|P1|Study Participation|incarceration|1
2469073|NCT02347774|8525172|P3|Study Participation|non-compliance with study drug|0
2469074|NCT02347774|8525173|P2|Study Participation|non-compliance with study drug|1
2469075|NCT02347774|8525174|P1|Study Participation|non-compliance with study drug|0
2469076|NCT02347774|8525172|P3|Study Participation|Met Prolonged QT criteria|0
2469163|NCT02347332|8525372|P2|Overall Study|Adverse Event|41
2469077|NCT02347774|8525173|P2|Study Participation|Met Prolonged QT criteria|0
2469078|NCT02347774|8525174|P1|Study Participation|Met Prolonged QT criteria|1
2469079|NCT02347774|8525172|P3|Study Participation|withdrew consent|1
2469080|NCT02347774|8525173|P2|Study Participation|withdrew consent|1
2469081|NCT02347774|8525174|P1|Study Participation|withdrew consent|1
2469082|NCT02347774|8525172|P3|Study Participation|Adverse Event|6
2469083|NCT02347774|8525173|P2|Study Participation|Adverse Event|4
2469084|NCT02347774|8525174|P1|Study Participation|Adverse Event|1
2469085|NCT02347774|8525172|P3|Study Participation|Withdrawal by Subject|15
2469086|NCT02347774|8525173|P2|Study Participation|Withdrawal by Subject|9
2469087|NCT02347774|8525174|P1|Study Participation|Withdrawal by Subject|8
2469088|NCT02347774|8525172|P3|Study Participation|Lost to Follow-up|2
2469089|NCT02347774|8525173|P2|Study Participation|Lost to Follow-up|6
2469090|NCT02347774|8525174|P1|Study Participation|Lost to Follow-up|3
2469091|NCT02347761|8525230|P3|On Study Treatment|Adverse Event|20
2469092|NCT02347761|8525231|P2|On Study Treatment|Adverse Event|8
2469093|NCT02347761|8525232|P1|On Study Treatment|Adverse Event|10
2469094|NCT02347761|8525230|P3|On Study Treatment|durg not working|1
2469095|NCT02347761|8525231|P2|On Study Treatment|durg not working|1
2469096|NCT02347761|8525232|P1|On Study Treatment|durg not working|0
2469097|NCT02347761|8525230|P3|On Study Treatment|investigator discretion|0
2469098|NCT02347761|8525231|P2|On Study Treatment|investigator discretion|0
2469099|NCT02347761|8525232|P1|On Study Treatment|investigator discretion|2
2469100|NCT02347761|8525230|P3|On Study Treatment|Lost to Follow-up|1
2469101|NCT02347761|8525231|P2|On Study Treatment|Lost to Follow-up|1
2469102|NCT02347761|8525232|P1|On Study Treatment|Lost to Follow-up|2
2469103|NCT02347761|8525230|P3|On Study Treatment|dissastisfaction with device|4
2469104|NCT02347761|8525231|P2|On Study Treatment|dissastisfaction with device|1
2469105|NCT02347761|8525232|P1|On Study Treatment|dissastisfaction with device|2
2469106|NCT02347761|8525230|P3|On Study Treatment|move/travel|5
2469107|NCT02347761|8525231|P2|On Study Treatment|move/travel|6
2469108|NCT02347761|8525232|P1|On Study Treatment|move/travel|2
2469109|NCT02347761|8525230|P3|On Study Treatment|Withdrawal by Subject|5
2469110|NCT02347761|8525231|P2|On Study Treatment|Withdrawal by Subject|3
2469111|NCT02347761|8525232|P1|On Study Treatment|Withdrawal by Subject|7
2469112|NCT02347761|8525230|P3|On Study Treatment|non-compliance with study medication|2
2469113|NCT02347761|8525231|P2|On Study Treatment|non-compliance with study medication|0
2469114|NCT02347761|8525232|P1|On Study Treatment|non-compliance with study medication|0
2469115|NCT02347761|8525230|P3|On Study Treatment|Lack of Efficacy|4
2469116|NCT02347761|8525231|P2|On Study Treatment|Lack of Efficacy|3
2469117|NCT02347761|8525232|P1|On Study Treatment|Lack of Efficacy|2
2469118|NCT02347761|8525230|P3|All Collected|moved/travel|0
2469119|NCT02347761|8525231|P2|All Collected|moved/travel|1
2469120|NCT02347761|8525232|P1|All Collected|moved/travel|0
2469121|NCT02347761|8525230|P3|All Collected|exacerbation of COPD|1
2469122|NCT02347761|8525231|P2|All Collected|exacerbation of COPD|0
2469123|NCT02347761|8525232|P1|All Collected|exacerbation of COPD|0
2469124|NCT02347761|8525230|P3|All Collected|instillation site pain|1
2469125|NCT02347761|8525231|P2|All Collected|instillation site pain|0
2469126|NCT02347761|8525232|P1|All Collected|instillation site pain|0
2469127|NCT02347761|8525230|P3|All Collected|invetigator disretion|0
2469128|NCT02347761|8525231|P2|All Collected|invetigator disretion|0
2469129|NCT02347761|8525232|P1|All Collected|invetigator disretion|2
2469130|NCT02347761|8525230|P3|All Collected|Withdrawal by Subject|22
2469131|NCT02347761|8525231|P2|All Collected|Withdrawal by Subject|11
2469132|NCT02347761|8525232|P1|All Collected|Withdrawal by Subject|11
2469133|NCT02347761|8525230|P3|All Collected|Lost to Follow-up|3
2469134|NCT02347761|8525231|P2|All Collected|Lost to Follow-up|2
2469135|NCT02347761|8525232|P1|All Collected|Lost to Follow-up|3
2469136|NCT02347761|8525230|P3|All Collected|Death|0
2469137|NCT02347761|8525231|P2|All Collected|Death|0
2469138|NCT02347761|8525232|P1|All Collected|Death|1
2469139|NCT02347657|8525293|P2|Overall Study|Other|3
2469140|NCT02347657|8525294|P1|Overall Study|Other|3
2469141|NCT02347657|8525293|P2|Overall Study|Randomized but not treated|0
2469142|NCT02347657|8525294|P1|Overall Study|Randomized but not treated|1
2469143|NCT02347657|8525293|P2|Overall Study|Withdrawal by Subject|7
2469144|NCT02347657|8525294|P1|Overall Study|Withdrawal by Subject|6
2469145|NCT02347657|8525293|P2|Overall Study|Adverse Event|4
2469146|NCT02347657|8525294|P1|Overall Study|Adverse Event|8
2469147|NCT02347657|8525293|P2|Overall Study|Physician Decision|1
2469148|NCT02347657|8525294|P1|Overall Study|Physician Decision|0
2469149|NCT02347332|8525372|P2|Overall Study|Switch Post-Trial program|1
2469150|NCT02347332|8525373|P1|Overall Study|Switch Post-Trial program|0
2469151|NCT02347332|8525372|P2|Overall Study|Protocol requirement|1
2469152|NCT02347332|8525373|P1|Overall Study|Protocol requirement|1
2469153|NCT02347332|8525372|P2|Overall Study|Withdrawal by Subject|14
2469154|NCT02347332|8525373|P1|Overall Study|Withdrawal by Subject|20
2469155|NCT02347332|8525372|P2|Overall Study|Physician Decision|3
2469156|NCT02347332|8525373|P1|Overall Study|Physician Decision|4
2469157|NCT02347332|8525372|P2|Overall Study|Lost to Follow-up|1
2469158|NCT02347332|8525373|P1|Overall Study|Lost to Follow-up|2
2469159|NCT02347332|8525372|P2|Overall Study|Protocol Violation|1
2469160|NCT02347332|8525373|P1|Overall Study|Protocol Violation|1
2469161|NCT02347332|8525372|P2|Overall Study|Death (Unknown, Various reasons)|6
2469162|NCT02347332|8525373|P1|Overall Study|Death (Unknown, Various reasons)|6
2469164|NCT02347332|8525373|P1|Overall Study|Adverse Event|50
2469165|NCT02347332|8525372|P2|Overall Study|Progressive disease|159
2469166|NCT02347332|8525373|P1|Overall Study|Progressive disease|141
2469167|NCT02347332|8525372|P2|Overall Study|Not treated|2
2469168|NCT02347332|8525373|P1|Overall Study|Not treated|5
2469169|NCT02347189|8525387|P1|Overall Study|No primary outcome data available|2
2469170|NCT02347189|8525387|P1|Overall Study|No implant attempted of study device|9
2469171|NCT02347176|8525406|P4|Overall Study|Other|0
2469172|NCT02347176|8525407|P3|Overall Study|Other|2
2469173|NCT02347176|8525408|P2|Overall Study|Other|2
2469174|NCT02347176|8525409|P1|Overall Study|Other|1
2469175|NCT02347176|8525406|P4|Overall Study|Withdrawal by Subject|3
2469176|NCT02347176|8525407|P3|Overall Study|Withdrawal by Subject|5
2469177|NCT02347176|8525408|P2|Overall Study|Withdrawal by Subject|5
2469178|NCT02347176|8525409|P1|Overall Study|Withdrawal by Subject|9
2469179|NCT02347176|8525406|P4|Overall Study|Lost to Follow-up|1
2469180|NCT02347176|8525407|P3|Overall Study|Lost to Follow-up|1
2469181|NCT02347176|8525408|P2|Overall Study|Lost to Follow-up|3
2469182|NCT02347176|8525409|P1|Overall Study|Lost to Follow-up|2
2469183|NCT02347098|8525494|P2|Overall Study|no visit due to illness|1
2469184|NCT02347098|8525495|P1|Overall Study|no visit due to illness|2
2469185|NCT02347098|8525494|P2|Overall Study|Refuse Follow-up Visit|5
2469186|NCT02347098|8525495|P1|Overall Study|Refuse Follow-up Visit|1
2469187|NCT02347098|8525494|P2|Overall Study|Lost to Follow-up|2
2469188|NCT02347098|8525495|P1|Overall Study|Lost to Follow-up|2
2469189|NCT02347098|8525494|P2|Overall Study|Withdrawal by Subject|0
2469190|NCT02347098|8525495|P1|Overall Study|Withdrawal by Subject|1
2469191|NCT02347098|8525494|P2|Overall Study|Death|0
2469192|NCT02347098|8525495|P1|Overall Study|Death|1
2469193|NCT02347085|8525507|P1|Overall Study|Protocol Criteria|2
2469194|NCT02347085|8525507|P1|Overall Study|Lost to Follow-up|1
2469195|NCT02347085|8525507|P1|Overall Study|Withdrawal by Subject|4
2469196|NCT02347085|8525507|P1|Overall Study|Lack of Efficacy|1
2469197|NCT02347085|8525507|P1|Overall Study|Adverse Event|2
2469198|NCT02347072|8525529|P1|Overall Study|Disc due to Protocol-specified Criteria|6
2469199|NCT02347072|8525529|P1|Overall Study|Protocol Violation|1
2469200|NCT02347072|8525529|P1|Overall Study|Lost to Follow-up|2
2469201|NCT02347072|8525529|P1|Overall Study|Physician Decision|1
2469202|NCT02347072|8525529|P1|Overall Study|Withdrawal by Subject|6
2469203|NCT02347072|8525529|P1|Overall Study|Adverse Event|2
2469204|NCT02346877|8525563|P2|Overall Study|Missing|0
2469205|NCT02346877|8525564|P1|Overall Study|Missing|5
2469206|NCT02346877|8525563|P2|Overall Study|Sponsor Decision|0
2469207|NCT02346877|8525564|P1|Overall Study|Sponsor Decision|12
2469208|NCT02346877|8525563|P2|Overall Study|Administrative Decision|0
2469209|NCT02346877|8525564|P1|Overall Study|Administrative Decision|1
2469210|NCT02346877|8525563|P2|Overall Study|Adverse Event|0
2469211|NCT02346877|8525564|P1|Overall Study|Adverse Event|1
2469212|NCT02346721|8525574|P1|Overall Study|Lack of Efficacy|1
2469213|NCT02346721|8525574|P1|Overall Study|Withdrew Consent|3
2469214|NCT02346370|8525613|P3|Overall Study|Physician Decision|0
2469215|NCT02346370|8525614|P2|Overall Study|Physician Decision|1
2469216|NCT02346370|8525615|P1|Overall Study|Physician Decision|0
2469217|NCT02346370|8525613|P3|Overall Study|Radiologic progression|1
2469218|NCT02346370|8525614|P2|Overall Study|Radiologic progression|0
2469219|NCT02346370|8525615|P1|Overall Study|Radiologic progression|0
2469220|NCT02346370|8525613|P3|Overall Study|Sponsor discontinued study|2
2469221|NCT02346370|8525614|P2|Overall Study|Sponsor discontinued study|0
2469222|NCT02346370|8525615|P1|Overall Study|Sponsor discontinued study|5
2469223|NCT02346370|8525613|P3|Overall Study|Death|1
2469224|NCT02346370|8525614|P2|Overall Study|Death|3
2469225|NCT02346370|8525615|P1|Overall Study|Death|1
2469226|NCT02346370|8525613|P3|Overall Study|Withdrawal of consent|0
2469227|NCT02346370|8525614|P2|Overall Study|Withdrawal of consent|0
2469228|NCT02346370|8525615|P1|Overall Study|Withdrawal of consent|1
2469229|NCT02346370|8525613|P3|Overall Study|Not treated|0
2469230|NCT02346370|8525614|P2|Overall Study|Not treated|0
2469231|NCT02346370|8525615|P1|Overall Study|Not treated|1
2469232|NCT02346240|8525664|P24|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2469233|NCT02346240|8525665|P23|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2469234|NCT02346240|8525666|P22|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2469235|NCT02346240|8525667|P21|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2469236|NCT02346240|8525668|P20|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2469237|NCT02346240|8525669|P19|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1
2469238|NCT02346240|8525670|P18|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2469239|NCT02346240|8525671|P17|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2469240|NCT02346240|8525672|P16|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2469241|NCT02346240|8525673|P15|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2469242|NCT02346240|8525674|P14|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2469243|NCT02346240|8525675|P13|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2469244|NCT02346240|8525676|P12|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2469245|NCT02346240|8525677|P11|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2469246|NCT02346240|8525678|P10|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2469247|NCT02346240|8525679|P9|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2469248|NCT02346240|8525680|P8|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2469249|NCT02346240|8525681|P7|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2469250|NCT02346240|8525682|P6|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2469251|NCT02346240|8525683|P5|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2469252|NCT02346240|8525684|P4|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2469253|NCT02346240|8525685|P3|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2469254|NCT02346240|8525686|P2|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2469255|NCT02346240|8525687|P1|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
2469256|NCT02346240|8525664|P24|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3
2469257|NCT02346240|8525665|P23|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2
2469258|NCT02346240|8525666|P22|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4
2469259|NCT02346240|8525667|P21|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2469260|NCT02346240|8525668|P20|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2469261|NCT02346240|8525669|P19|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2
2469262|NCT02346240|8525670|P18|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2469263|NCT02346240|8525671|P17|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2469264|NCT02346240|8525672|P16|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2469265|NCT02346240|8525673|P15|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2469266|NCT02346240|8525674|P14|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2469267|NCT02346240|8525675|P13|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2469268|NCT02346240|8525676|P12|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2469269|NCT02346240|8525677|P11|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2469270|NCT02346240|8525678|P10|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2469271|NCT02346240|8525679|P9|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2469272|NCT02346240|8525680|P8|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2469273|NCT02346240|8525681|P7|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2469274|NCT02346240|8525682|P6|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2469275|NCT02346240|8525683|P5|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2469276|NCT02346240|8525684|P4|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2469277|NCT02346240|8525685|P3|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2469278|NCT02346240|8525686|P2|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2469279|NCT02346240|8525687|P1|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
2469280|NCT02346240|8525664|P24|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
2469281|NCT02346240|8525665|P23|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
2469282|NCT02346240|8525666|P22|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10
2469283|NCT02346240|8525667|P21|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2469284|NCT02346240|8525668|P20|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
2469285|NCT02346240|8525669|P19|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4
2469286|NCT02346240|8525670|P18|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2469287|NCT02346240|8525671|P17|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2469288|NCT02346240|8525672|P16|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2469289|NCT02346240|8525673|P15|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2469290|NCT02346240|8525674|P14|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2469291|NCT02346240|8525675|P13|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2469292|NCT02346240|8525676|P12|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2469293|NCT02346240|8525677|P11|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2469294|NCT02346240|8525678|P10|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2469295|NCT02346240|8525679|P9|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2469296|NCT02346240|8525680|P8|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2469297|NCT02346240|8525681|P7|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2469298|NCT02346240|8525682|P6|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2469299|NCT02346240|8525683|P5|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2469300|NCT02346240|8525684|P4|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2469301|NCT02346240|8525685|P3|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2469302|NCT02346240|8525686|P2|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2469303|NCT02346240|8525687|P1|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2469304|NCT02346240|8525664|P24|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
2469305|NCT02346240|8525665|P23|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
2469306|NCT02346240|8525666|P22|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
2469307|NCT02346240|8525667|P21|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2469308|NCT02346240|8525668|P20|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3
2469309|NCT02346240|8525669|P19|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2
2469310|NCT02346240|8525670|P18|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2
2469311|NCT02346240|8525671|P17|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2469312|NCT02346240|8525672|P16|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2469313|NCT02346240|8525673|P15|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2469314|NCT02346240|8525674|P14|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2469315|NCT02346240|8525675|P13|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2469316|NCT02346240|8525676|P12|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2469317|NCT02346240|8525677|P11|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2469318|NCT02346240|8525678|P10|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2469319|NCT02346240|8525679|P9|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2469320|NCT02346240|8525680|P8|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2469321|NCT02346240|8525681|P7|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2469322|NCT02346240|8525682|P6|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2469323|NCT02346240|8525683|P5|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2469324|NCT02346240|8525684|P4|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2469325|NCT02346240|8525685|P3|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2469326|NCT02346240|8525686|P2|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2469327|NCT02346240|8525687|P1|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
2469328|NCT02346240|8525664|P24|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2469329|NCT02346240|8525665|P23|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2469330|NCT02346240|8525666|P22|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1
2469331|NCT02346240|8525667|P21|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2469332|NCT02346240|8525668|P20|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2469333|NCT02346240|8525669|P19|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2469334|NCT02346240|8525670|P18|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2469335|NCT02346240|8525671|P17|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2469336|NCT02346240|8525672|P16|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2469337|NCT02346240|8525673|P15|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2469338|NCT02346240|8525674|P14|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2469339|NCT02346240|8525675|P13|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2469340|NCT02346240|8525676|P12|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2469341|NCT02346240|8525677|P11|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2469342|NCT02346240|8525678|P10|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2469343|NCT02346240|8525679|P9|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2469344|NCT02346240|8525680|P8|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2469345|NCT02346240|8525681|P7|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2469346|NCT02346240|8525682|P6|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2469347|NCT02346240|8525683|P5|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2469348|NCT02346240|8525684|P4|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2469349|NCT02346240|8525685|P3|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2469350|NCT02346240|8525686|P2|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2469351|NCT02346240|8525687|P1|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
2469352|NCT02346240|8525664|P24|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2469353|NCT02346240|8525665|P23|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2469354|NCT02346240|8525666|P22|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1
2469355|NCT02346240|8525667|P21|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2469356|NCT02346240|8525668|P20|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2469357|NCT02346240|8525669|P19|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1
2469358|NCT02346240|8525670|P18|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2469359|NCT02346240|8525671|P17|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2469360|NCT02346240|8525672|P16|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2469361|NCT02346240|8525673|P15|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2469362|NCT02346240|8525674|P14|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2469363|NCT02346240|8525675|P13|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2469364|NCT02346240|8525676|P12|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2469365|NCT02346240|8525677|P11|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2469366|NCT02346240|8525678|P10|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2469367|NCT02346240|8525679|P9|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2469368|NCT02346240|8525680|P8|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2469369|NCT02346240|8525681|P7|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2469370|NCT02346240|8525682|P6|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2469371|NCT02346240|8525683|P5|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2469372|NCT02346240|8525684|P4|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2469373|NCT02346240|8525685|P3|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2469374|NCT02346240|8525686|P2|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2469375|NCT02346240|8525687|P1|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
2469376|NCT02346240|8525664|P24|Open-Label Period (Week 48 to Week 144)|Death|0
2469377|NCT02346240|8525665|P23|Open-Label Period (Week 48 to Week 144)|Death|0
2469378|NCT02346240|8525666|P22|Open-Label Period (Week 48 to Week 144)|Death|1
2469379|NCT02346240|8525667|P21|Open-Label Period (Week 48 to Week 144)|Death|0
2469380|NCT02346240|8525668|P20|Open-Label Period (Week 48 to Week 144)|Death|1
2469381|NCT02346240|8525669|P19|Open-Label Period (Week 48 to Week 144)|Death|1
2469382|NCT02346240|8525670|P18|Open-Label Period (Week 48 to Week 144)|Death|0
2469383|NCT02346240|8525671|P17|Open-Label Period (Week 48 to Week 144)|Death|0
2469384|NCT02346240|8525672|P16|Open-Label Period (Week 48 to Week 144)|Death|0
2469385|NCT02346240|8525673|P15|Open-Label Period (Week 48 to Week 144)|Death|0
2469386|NCT02346240|8525674|P14|Open-Label Period (Week 48 to Week 144)|Death|0
2469387|NCT02346240|8525675|P13|Open-Label Period (Week 48 to Week 144)|Death|0
2469388|NCT02346240|8525676|P12|Open-Label Period (Week 48 to Week 144)|Death|0
2469389|NCT02346240|8525677|P11|Open-Label Period (Week 48 to Week 144)|Death|0
2469390|NCT02346240|8525678|P10|Open-Label Period (Week 48 to Week 144)|Death|0
2469391|NCT02346240|8525679|P9|Open-Label Period (Week 48 to Week 144)|Death|0
2469392|NCT02346240|8525680|P8|Open-Label Period (Week 48 to Week 144)|Death|0
2469393|NCT02346240|8525681|P7|Open-Label Period (Week 48 to Week 144)|Death|0
2469394|NCT02346240|8525682|P6|Open-Label Period (Week 48 to Week 144)|Death|0
2469395|NCT02346240|8525683|P5|Open-Label Period (Week 48 to Week 144)|Death|0
2469396|NCT02346240|8525684|P4|Open-Label Period (Week 48 to Week 144)|Death|0
2469397|NCT02346240|8525685|P3|Open-Label Period (Week 48 to Week 144)|Death|0
2469398|NCT02346240|8525686|P2|Open-Label Period (Week 48 to Week 144)|Death|0
2469399|NCT02346240|8525687|P1|Open-Label Period (Week 48 to Week 144)|Death|0
2469400|NCT02346240|8525664|P24|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
2469401|NCT02346240|8525665|P23|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
2469402|NCT02346240|8525666|P22|Open-Label Period (Week 48 to Week 144)|Adverse Event|13
2469403|NCT02346240|8525667|P21|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
2469404|NCT02346240|8525668|P20|Open-Label Period (Week 48 to Week 144)|Adverse Event|2
2469405|NCT02346240|8525669|P19|Open-Label Period (Week 48 to Week 144)|Adverse Event|6
2469406|NCT02346240|8525670|P18|Open-Label Period (Week 48 to Week 144)|Adverse Event|1
2469407|NCT02346240|8525671|P17|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2469408|NCT02346240|8525672|P16|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2469409|NCT02346240|8525673|P15|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2469410|NCT02346240|8525674|P14|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2469411|NCT02346240|8525675|P13|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2469412|NCT02346240|8525676|P12|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2469413|NCT02346240|8525677|P11|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2469414|NCT02346240|8525678|P10|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2469415|NCT02346240|8525679|P9|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2469416|NCT02346240|8525680|P8|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2469417|NCT02346240|8525681|P7|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2469418|NCT02346240|8525682|P6|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2469419|NCT02346240|8525683|P5|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2469420|NCT02346240|8525684|P4|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2469421|NCT02346240|8525685|P3|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2469422|NCT02346240|8525686|P2|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2469423|NCT02346240|8525687|P1|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
2469424|NCT02346240|8525664|P24|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2469425|NCT02346240|8525665|P23|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2469426|NCT02346240|8525666|P22|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2469427|NCT02346240|8525667|P21|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2469428|NCT02346240|8525668|P20|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2469429|NCT02346240|8525669|P19|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2469430|NCT02346240|8525670|P18|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2469431|NCT02346240|8525671|P17|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2469432|NCT02346240|8525672|P16|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2469433|NCT02346240|8525673|P15|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1
2469434|NCT02346240|8525674|P14|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2469435|NCT02346240|8525675|P13|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2469436|NCT02346240|8525676|P12|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2469437|NCT02346240|8525677|P11|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2469438|NCT02346240|8525678|P10|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2469439|NCT02346240|8525679|P9|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2469440|NCT02346240|8525680|P8|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2469441|NCT02346240|8525681|P7|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2469442|NCT02346240|8525682|P6|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2469443|NCT02346240|8525683|P5|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2469444|NCT02346240|8525684|P4|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2469445|NCT02346240|8525685|P3|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2469446|NCT02346240|8525686|P2|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2469447|NCT02346240|8525687|P1|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
2469448|NCT02346240|8525664|P24|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2469449|NCT02346240|8525665|P23|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2469450|NCT02346240|8525666|P22|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2469451|NCT02346240|8525667|P21|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2469452|NCT02346240|8525668|P20|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2469453|NCT02346240|8525669|P19|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2469454|NCT02346240|8525670|P18|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2469455|NCT02346240|8525671|P17|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2469456|NCT02346240|8525672|P16|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2469457|NCT02346240|8525673|P15|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1
2469458|NCT02346240|8525674|P14|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2469459|NCT02346240|8525675|P13|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2469460|NCT02346240|8525676|P12|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2469461|NCT02346240|8525677|P11|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2469462|NCT02346240|8525678|P10|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2469463|NCT02346240|8525679|P9|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2469464|NCT02346240|8525680|P8|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2469465|NCT02346240|8525681|P7|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2469466|NCT02346240|8525682|P6|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2469467|NCT02346240|8525683|P5|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2469468|NCT02346240|8525684|P4|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2469469|NCT02346240|8525685|P3|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2469470|NCT02346240|8525686|P2|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2469471|NCT02346240|8525687|P1|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
2469472|NCT02346240|8525664|P24|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2469473|NCT02346240|8525665|P23|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2469474|NCT02346240|8525666|P22|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2469475|NCT02346240|8525667|P21|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2469476|NCT02346240|8525668|P20|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2469477|NCT02346240|8525669|P19|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2469478|NCT02346240|8525670|P18|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2469479|NCT02346240|8525671|P17|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2469480|NCT02346240|8525672|P16|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2469481|NCT02346240|8525673|P15|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1
2469482|NCT02346240|8525674|P14|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2469483|NCT02346240|8525675|P13|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2469484|NCT02346240|8525676|P12|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2469485|NCT02346240|8525677|P11|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2469486|NCT02346240|8525678|P10|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2469487|NCT02346240|8525679|P9|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2469488|NCT02346240|8525680|P8|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2469489|NCT02346240|8525681|P7|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2469490|NCT02346240|8525682|P6|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2469491|NCT02346240|8525683|P5|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2469492|NCT02346240|8525684|P4|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2469493|NCT02346240|8525685|P3|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2469494|NCT02346240|8525686|P2|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2469495|NCT02346240|8525687|P1|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
2469496|NCT02346240|8525664|P24|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2469497|NCT02346240|8525665|P23|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2469498|NCT02346240|8525666|P22|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2469499|NCT02346240|8525667|P21|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2469500|NCT02346240|8525668|P20|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2469501|NCT02346240|8525669|P19|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2469502|NCT02346240|8525670|P18|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2469503|NCT02346240|8525671|P17|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2469504|NCT02346240|8525672|P16|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2469505|NCT02346240|8525673|P15|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2469506|NCT02346240|8525674|P14|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2469507|NCT02346240|8525675|P13|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2469508|NCT02346240|8525676|P12|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2469509|NCT02346240|8525677|P11|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|1
2469510|NCT02346240|8525678|P10|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2469511|NCT02346240|8525679|P9|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2469512|NCT02346240|8525680|P8|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2469513|NCT02346240|8525681|P7|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2469514|NCT02346240|8525682|P6|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2469935|NCT02345226|8525989|P1|Double-Blind Phase|Withdrew Consent|41
2469515|NCT02346240|8525683|P5|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2469516|NCT02346240|8525684|P4|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2469517|NCT02346240|8525685|P3|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2469518|NCT02346240|8525686|P2|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2469519|NCT02346240|8525687|P1|Maintenance Period (Week 16 to Week 48)|Patient’s decisions|0
2469520|NCT02346240|8525664|P24|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2469521|NCT02346240|8525665|P23|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2469522|NCT02346240|8525666|P22|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2469523|NCT02346240|8525667|P21|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2469524|NCT02346240|8525668|P20|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2469525|NCT02346240|8525669|P19|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2469526|NCT02346240|8525670|P18|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2469527|NCT02346240|8525671|P17|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2469528|NCT02346240|8525672|P16|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2469529|NCT02346240|8525673|P15|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2469530|NCT02346240|8525674|P14|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2469531|NCT02346240|8525675|P13|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2469532|NCT02346240|8525676|P12|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2469533|NCT02346240|8525677|P11|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2469534|NCT02346240|8525678|P10|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1
2469535|NCT02346240|8525679|P9|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2469536|NCT02346240|8525680|P8|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2469537|NCT02346240|8525681|P7|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2469538|NCT02346240|8525682|P6|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2469539|NCT02346240|8525683|P5|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2469540|NCT02346240|8525684|P4|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2469541|NCT02346240|8525685|P3|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2469542|NCT02346240|8525686|P2|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2469543|NCT02346240|8525687|P1|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
2469544|NCT02346240|8525664|P24|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2469545|NCT02346240|8525665|P23|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2469546|NCT02346240|8525666|P22|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2469547|NCT02346240|8525667|P21|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2469548|NCT02346240|8525668|P20|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2469549|NCT02346240|8525669|P19|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2469550|NCT02346240|8525670|P18|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2469551|NCT02346240|8525671|P17|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2469552|NCT02346240|8525672|P16|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2469553|NCT02346240|8525673|P15|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
2469554|NCT02346240|8525674|P14|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
2469555|NCT02346240|8525675|P13|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2469556|NCT02346240|8525676|P12|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
2469557|NCT02346240|8525677|P11|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2469558|NCT02346240|8525678|P10|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2469559|NCT02346240|8525679|P9|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
2469560|NCT02346240|8525680|P8|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2469561|NCT02346240|8525681|P7|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2469562|NCT02346240|8525682|P6|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2469563|NCT02346240|8525683|P5|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2469564|NCT02346240|8525684|P4|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2469565|NCT02346240|8525685|P3|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2469566|NCT02346240|8525686|P2|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2469567|NCT02346240|8525687|P1|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
2469568|NCT02346240|8525664|P24|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2469569|NCT02346240|8525665|P23|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2469570|NCT02346240|8525666|P22|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2469571|NCT02346240|8525667|P21|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2469572|NCT02346240|8525668|P20|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2469573|NCT02346240|8525669|P19|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2469574|NCT02346240|8525670|P18|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2469575|NCT02346240|8525671|P17|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2469576|NCT02346240|8525672|P16|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2469577|NCT02346240|8525673|P15|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2469578|NCT02346240|8525674|P14|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2469579|NCT02346240|8525675|P13|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2469580|NCT02346240|8525676|P12|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2469581|NCT02346240|8525677|P11|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2469582|NCT02346240|8525678|P10|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2469583|NCT02346240|8525679|P9|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2469584|NCT02346240|8525680|P8|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2469585|NCT02346240|8525681|P7|Maintenance Period (Week 16 to Week 48)|Moved out of state|1
2469586|NCT02346240|8525682|P6|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2469587|NCT02346240|8525683|P5|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2469588|NCT02346240|8525684|P4|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2469589|NCT02346240|8525685|P3|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2469590|NCT02346240|8525686|P2|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2469591|NCT02346240|8525687|P1|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
2469592|NCT02346240|8525664|P24|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2469593|NCT02346240|8525665|P23|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2469594|NCT02346240|8525666|P22|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2469595|NCT02346240|8525667|P21|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2469596|NCT02346240|8525668|P20|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2469597|NCT02346240|8525669|P19|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2469598|NCT02346240|8525670|P18|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2469599|NCT02346240|8525671|P17|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4
2469600|NCT02346240|8525672|P16|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8
2469601|NCT02346240|8525673|P15|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3
2469602|NCT02346240|8525674|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3
2469603|NCT02346240|8525675|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2469604|NCT02346240|8525676|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2469605|NCT02346240|8525677|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2469606|NCT02346240|8525678|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2469607|NCT02346240|8525679|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2469608|NCT02346240|8525680|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2469609|NCT02346240|8525681|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2469610|NCT02346240|8525682|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2469611|NCT02346240|8525683|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2469612|NCT02346240|8525684|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2469613|NCT02346240|8525685|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2469614|NCT02346240|8525686|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2469615|NCT02346240|8525687|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2469616|NCT02346240|8525664|P24|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2469617|NCT02346240|8525665|P23|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2469618|NCT02346240|8525666|P22|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2469619|NCT02346240|8525667|P21|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2469620|NCT02346240|8525668|P20|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2469621|NCT02346240|8525669|P19|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2469622|NCT02346240|8525670|P18|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2469623|NCT02346240|8525671|P17|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2469624|NCT02346240|8525672|P16|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
2469625|NCT02346240|8525673|P15|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5
2469626|NCT02346240|8525674|P14|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
2469627|NCT02346240|8525675|P13|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2469628|NCT02346240|8525676|P12|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
2469629|NCT02346240|8525677|P11|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2469630|NCT02346240|8525678|P10|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2469631|NCT02346240|8525679|P9|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2469632|NCT02346240|8525680|P8|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2469633|NCT02346240|8525681|P7|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2469634|NCT02346240|8525682|P6|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2469635|NCT02346240|8525683|P5|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2469636|NCT02346240|8525684|P4|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2469637|NCT02346240|8525685|P3|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2469638|NCT02346240|8525686|P2|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2469639|NCT02346240|8525687|P1|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2469640|NCT02346240|8525664|P24|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2469641|NCT02346240|8525665|P23|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2469642|NCT02346240|8525666|P22|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2469643|NCT02346240|8525667|P21|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2469644|NCT02346240|8525668|P20|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2469645|NCT02346240|8525669|P19|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2469646|NCT02346240|8525670|P18|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2469647|NCT02346240|8525671|P17|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2469648|NCT02346240|8525672|P16|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2469649|NCT02346240|8525673|P15|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1
2469650|NCT02346240|8525674|P14|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2469651|NCT02346240|8525675|P13|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2469652|NCT02346240|8525676|P12|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2469653|NCT02346240|8525677|P11|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2469654|NCT02346240|8525678|P10|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2469655|NCT02346240|8525679|P9|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2469656|NCT02346240|8525680|P8|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2469657|NCT02346240|8525681|P7|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2469658|NCT02346240|8525682|P6|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2469659|NCT02346240|8525683|P5|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2469660|NCT02346240|8525684|P4|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2469661|NCT02346240|8525685|P3|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2469662|NCT02346240|8525686|P2|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2469663|NCT02346240|8525687|P1|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2469664|NCT02346240|8525664|P24|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2469665|NCT02346240|8525665|P23|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2469666|NCT02346240|8525666|P22|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2469667|NCT02346240|8525667|P21|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2469668|NCT02346240|8525668|P20|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2469669|NCT02346240|8525669|P19|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2469670|NCT02346240|8525670|P18|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2469671|NCT02346240|8525671|P17|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2469672|NCT02346240|8525672|P16|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3
2469673|NCT02346240|8525673|P15|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2469674|NCT02346240|8525674|P14|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
2469675|NCT02346240|8525675|P13|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2469676|NCT02346240|8525676|P12|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2469677|NCT02346240|8525677|P11|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2469678|NCT02346240|8525678|P10|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2469679|NCT02346240|8525679|P9|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2469680|NCT02346240|8525680|P8|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2469681|NCT02346240|8525681|P7|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2469682|NCT02346240|8525682|P6|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2469683|NCT02346240|8525683|P5|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2469684|NCT02346240|8525684|P4|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2469685|NCT02346240|8525685|P3|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2469686|NCT02346240|8525686|P2|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2469687|NCT02346240|8525687|P1|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2469688|NCT02346240|8525664|P24|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2469689|NCT02346240|8525665|P23|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2469690|NCT02346240|8525666|P22|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2469691|NCT02346240|8525667|P21|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2469692|NCT02346240|8525668|P20|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2469693|NCT02346240|8525669|P19|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2469694|NCT02346240|8525670|P18|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2469695|NCT02346240|8525671|P17|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
2469696|NCT02346240|8525672|P16|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
2469697|NCT02346240|8525673|P15|Maintenance Period (Week 16 to Week 48)|Adverse Event|4
2469698|NCT02346240|8525674|P14|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
2469699|NCT02346240|8525675|P13|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2469700|NCT02346240|8525676|P12|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2469701|NCT02346240|8525677|P11|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2469702|NCT02346240|8525678|P10|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2469703|NCT02346240|8525679|P9|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
2469704|NCT02346240|8525680|P8|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
2469705|NCT02346240|8525681|P7|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2469706|NCT02346240|8525682|P6|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2469707|NCT02346240|8525683|P5|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2469708|NCT02346240|8525684|P4|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2469709|NCT02346240|8525685|P3|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2469710|NCT02346240|8525686|P2|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2469711|NCT02346240|8525687|P1|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2469712|NCT02346240|8525664|P24|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2469713|NCT02346240|8525665|P23|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2469714|NCT02346240|8525666|P22|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2469715|NCT02346240|8525667|P21|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2469716|NCT02346240|8525668|P20|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2469717|NCT02346240|8525669|P19|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2469718|NCT02346240|8525670|P18|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2469719|NCT02346240|8525671|P17|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2469720|NCT02346240|8525672|P16|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2469721|NCT02346240|8525673|P15|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2469722|NCT02346240|8525674|P14|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2469723|NCT02346240|8525675|P13|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2469724|NCT02346240|8525676|P12|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2469725|NCT02346240|8525677|P11|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2469726|NCT02346240|8525678|P10|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2469727|NCT02346240|8525679|P9|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2469728|NCT02346240|8525680|P8|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2469729|NCT02346240|8525681|P7|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2469730|NCT02346240|8525682|P6|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2469731|NCT02346240|8525683|P5|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2469732|NCT02346240|8525684|P4|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2469733|NCT02346240|8525685|P3|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1
2469734|NCT02346240|8525686|P2|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2469735|NCT02346240|8525687|P1|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
2469736|NCT02346240|8525664|P24|Initial Period (Baseline to Week 16)|Non-compliance|0
2469737|NCT02346240|8525665|P23|Initial Period (Baseline to Week 16)|Non-compliance|0
2469738|NCT02346240|8525666|P22|Initial Period (Baseline to Week 16)|Non-compliance|0
2469739|NCT02346240|8525667|P21|Initial Period (Baseline to Week 16)|Non-compliance|0
2469740|NCT02346240|8525668|P20|Initial Period (Baseline to Week 16)|Non-compliance|0
2469741|NCT02346240|8525669|P19|Initial Period (Baseline to Week 16)|Non-compliance|0
2469742|NCT02346240|8525670|P18|Initial Period (Baseline to Week 16)|Non-compliance|0
2469743|NCT02346240|8525671|P17|Initial Period (Baseline to Week 16)|Non-compliance|0
2469744|NCT02346240|8525672|P16|Initial Period (Baseline to Week 16)|Non-compliance|0
2469745|NCT02346240|8525673|P15|Initial Period (Baseline to Week 16)|Non-compliance|0
2469746|NCT02346240|8525674|P14|Initial Period (Baseline to Week 16)|Non-compliance|0
2469747|NCT02346240|8525675|P13|Initial Period (Baseline to Week 16)|Non-compliance|0
2469748|NCT02346240|8525676|P12|Initial Period (Baseline to Week 16)|Non-compliance|0
2469749|NCT02346240|8525677|P11|Initial Period (Baseline to Week 16)|Non-compliance|0
2469750|NCT02346240|8525678|P10|Initial Period (Baseline to Week 16)|Non-compliance|0
2469751|NCT02346240|8525679|P9|Initial Period (Baseline to Week 16)|Non-compliance|0
2469752|NCT02346240|8525680|P8|Initial Period (Baseline to Week 16)|Non-compliance|0
2469753|NCT02346240|8525681|P7|Initial Period (Baseline to Week 16)|Non-compliance|0
2469754|NCT02346240|8525682|P6|Initial Period (Baseline to Week 16)|Non-compliance|0
2469755|NCT02346240|8525683|P5|Initial Period (Baseline to Week 16)|Non-compliance|0
2469756|NCT02346240|8525684|P4|Initial Period (Baseline to Week 16)|Non-compliance|1
2469757|NCT02346240|8525685|P3|Initial Period (Baseline to Week 16)|Non-compliance|0
2469758|NCT02346240|8525686|P2|Initial Period (Baseline to Week 16)|Non-compliance|1
2469759|NCT02346240|8525687|P1|Initial Period (Baseline to Week 16)|Non-compliance|0
2469760|NCT02346240|8525664|P24|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2469761|NCT02346240|8525665|P23|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2469762|NCT02346240|8525666|P22|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2469763|NCT02346240|8525667|P21|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2469764|NCT02346240|8525668|P20|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2469765|NCT02346240|8525669|P19|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2469766|NCT02346240|8525670|P18|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2469767|NCT02346240|8525671|P17|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2469768|NCT02346240|8525672|P16|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2469769|NCT02346240|8525673|P15|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2469770|NCT02346240|8525674|P14|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2469771|NCT02346240|8525675|P13|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2469772|NCT02346240|8525676|P12|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2469773|NCT02346240|8525677|P11|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2469774|NCT02346240|8525678|P10|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2469775|NCT02346240|8525679|P9|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2469776|NCT02346240|8525680|P8|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2469777|NCT02346240|8525681|P7|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2469778|NCT02346240|8525682|P6|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2469779|NCT02346240|8525683|P5|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
2469780|NCT02346240|8525684|P4|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
2469781|NCT02346240|8525685|P3|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3
2469782|NCT02346240|8525686|P2|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
2469783|NCT02346240|8525687|P1|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1
2469784|NCT02346240|8525664|P24|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2469785|NCT02346240|8525665|P23|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2469786|NCT02346240|8525666|P22|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2469787|NCT02346240|8525667|P21|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2469788|NCT02346240|8525668|P20|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2469789|NCT02346240|8525669|P19|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2469790|NCT02346240|8525670|P18|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2469791|NCT02346240|8525671|P17|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2469792|NCT02346240|8525672|P16|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2469793|NCT02346240|8525673|P15|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2469794|NCT02346240|8525674|P14|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2469795|NCT02346240|8525675|P13|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2469796|NCT02346240|8525676|P12|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2469797|NCT02346240|8525677|P11|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2469798|NCT02346240|8525678|P10|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2469799|NCT02346240|8525679|P9|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2469800|NCT02346240|8525680|P8|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2469801|NCT02346240|8525681|P7|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2469802|NCT02346240|8525682|P6|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2469803|NCT02346240|8525683|P5|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
2469804|NCT02346240|8525684|P4|Initial Period (Baseline to Week 16)|Lost to Follow-up|3
2469805|NCT02346240|8525685|P3|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
2469806|NCT02346240|8525686|P2|Initial Period (Baseline to Week 16)|Lost to Follow-up|2
2469807|NCT02346240|8525687|P1|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
2469808|NCT02346240|8525664|P24|Initial Period (Baseline to Week 16)|Protocol Violation|0
2469809|NCT02346240|8525665|P23|Initial Period (Baseline to Week 16)|Protocol Violation|0
2469810|NCT02346240|8525666|P22|Initial Period (Baseline to Week 16)|Protocol Violation|0
2469811|NCT02346240|8525667|P21|Initial Period (Baseline to Week 16)|Protocol Violation|0
2469812|NCT02346240|8525668|P20|Initial Period (Baseline to Week 16)|Protocol Violation|0
2469813|NCT02346240|8525669|P19|Initial Period (Baseline to Week 16)|Protocol Violation|0
2469814|NCT02346240|8525670|P18|Initial Period (Baseline to Week 16)|Protocol Violation|0
2469815|NCT02346240|8525671|P17|Initial Period (Baseline to Week 16)|Protocol Violation|0
2469816|NCT02346240|8525672|P16|Initial Period (Baseline to Week 16)|Protocol Violation|0
2469817|NCT02346240|8525673|P15|Initial Period (Baseline to Week 16)|Protocol Violation|0
2469818|NCT02346240|8525674|P14|Initial Period (Baseline to Week 16)|Protocol Violation|0
2469819|NCT02346240|8525675|P13|Initial Period (Baseline to Week 16)|Protocol Violation|0
2469820|NCT02346240|8525676|P12|Initial Period (Baseline to Week 16)|Protocol Violation|0
2469821|NCT02346240|8525677|P11|Initial Period (Baseline to Week 16)|Protocol Violation|0
2469822|NCT02346240|8525678|P10|Initial Period (Baseline to Week 16)|Protocol Violation|0
2469823|NCT02346240|8525679|P9|Initial Period (Baseline to Week 16)|Protocol Violation|0
2469824|NCT02346240|8525680|P8|Initial Period (Baseline to Week 16)|Protocol Violation|0
2469825|NCT02346240|8525681|P7|Initial Period (Baseline to Week 16)|Protocol Violation|0
2469826|NCT02346240|8525682|P6|Initial Period (Baseline to Week 16)|Protocol Violation|0
2469827|NCT02346240|8525683|P5|Initial Period (Baseline to Week 16)|Protocol Violation|0
2469828|NCT02346240|8525684|P4|Initial Period (Baseline to Week 16)|Protocol Violation|0
2469829|NCT02346240|8525685|P3|Initial Period (Baseline to Week 16)|Protocol Violation|0
2469830|NCT02346240|8525686|P2|Initial Period (Baseline to Week 16)|Protocol Violation|1
2469831|NCT02346240|8525687|P1|Initial Period (Baseline to Week 16)|Protocol Violation|0
2469832|NCT02346240|8525664|P24|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2469833|NCT02346240|8525665|P23|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2469834|NCT02346240|8525666|P22|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2469835|NCT02346240|8525667|P21|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2469836|NCT02346240|8525668|P20|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2469837|NCT02346240|8525669|P19|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2469838|NCT02346240|8525670|P18|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2469839|NCT02346240|8525671|P17|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2469840|NCT02346240|8525672|P16|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2469841|NCT02346240|8525673|P15|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2469842|NCT02346240|8525674|P14|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2469843|NCT02346240|8525675|P13|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2469844|NCT02346240|8525676|P12|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2469845|NCT02346240|8525677|P11|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2469846|NCT02346240|8525678|P10|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2469847|NCT02346240|8525679|P9|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2469848|NCT02346240|8525680|P8|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2469849|NCT02346240|8525681|P7|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2469850|NCT02346240|8525682|P6|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2469851|NCT02346240|8525683|P5|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2469852|NCT02346240|8525684|P4|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2469853|NCT02346240|8525685|P3|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2469854|NCT02346240|8525686|P2|Initial Period (Baseline to Week 16)|Lack of Efficacy|1
2469855|NCT02346240|8525687|P1|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
2469856|NCT02346240|8525664|P24|Initial Period (Baseline to Week 16)|Adverse Event|0
2469857|NCT02346240|8525665|P23|Initial Period (Baseline to Week 16)|Adverse Event|0
2469858|NCT02346240|8525666|P22|Initial Period (Baseline to Week 16)|Adverse Event|0
2469859|NCT02346240|8525667|P21|Initial Period (Baseline to Week 16)|Adverse Event|0
2469860|NCT02346240|8525668|P20|Initial Period (Baseline to Week 16)|Adverse Event|0
2469861|NCT02346240|8525669|P19|Initial Period (Baseline to Week 16)|Adverse Event|0
2469862|NCT02346240|8525670|P18|Initial Period (Baseline to Week 16)|Adverse Event|0
2469863|NCT02346240|8525671|P17|Initial Period (Baseline to Week 16)|Adverse Event|0
2469864|NCT02346240|8525672|P16|Initial Period (Baseline to Week 16)|Adverse Event|0
2469865|NCT02346240|8525673|P15|Initial Period (Baseline to Week 16)|Adverse Event|0
2469866|NCT02346240|8525674|P14|Initial Period (Baseline to Week 16)|Adverse Event|0
2469867|NCT02346240|8525675|P13|Initial Period (Baseline to Week 16)|Adverse Event|0
2469868|NCT02346240|8525676|P12|Initial Period (Baseline to Week 16)|Adverse Event|0
2469869|NCT02346240|8525677|P11|Initial Period (Baseline to Week 16)|Adverse Event|0
2469870|NCT02346240|8525678|P10|Initial Period (Baseline to Week 16)|Adverse Event|0
2469871|NCT02346240|8525679|P9|Initial Period (Baseline to Week 16)|Adverse Event|0
2469872|NCT02346240|8525680|P8|Initial Period (Baseline to Week 16)|Adverse Event|0
2469873|NCT02346240|8525681|P7|Initial Period (Baseline to Week 16)|Adverse Event|0
2469874|NCT02346240|8525682|P6|Initial Period (Baseline to Week 16)|Adverse Event|0
2469875|NCT02346240|8525683|P5|Initial Period (Baseline to Week 16)|Adverse Event|0
2469876|NCT02346240|8525684|P4|Initial Period (Baseline to Week 16)|Adverse Event|1
2469877|NCT02346240|8525685|P3|Initial Period (Baseline to Week 16)|Adverse Event|1
2469878|NCT02346240|8525686|P2|Initial Period (Baseline to Week 16)|Adverse Event|4
2469879|NCT02346240|8525687|P1|Initial Period (Baseline to Week 16)|Adverse Event|0
2469880|NCT02346136|8525726|P2|Overall Study|Study termination|18
2469881|NCT02346136|8525727|P1|Overall Study|Study termination|14
2469882|NCT02346136|8525726|P2|Overall Study|Death|0
2469883|NCT02346136|8525727|P1|Overall Study|Death|1
2469884|NCT02346136|8525726|P2|Overall Study|Withdrawal by Subject|5
2469885|NCT02346136|8525727|P1|Overall Study|Withdrawal by Subject|7
2469886|NCT02345889|8525763|P4|Overall Study|Cecum not intubated|0
2469887|NCT02345889|8525764|P3|Overall Study|Cecum not intubated|0
2469888|NCT02345889|8525765|P2|Overall Study|Cecum not intubated|0
2469889|NCT02345889|8525766|P1|Overall Study|Cecum not intubated|1
2469890|NCT02345889|8525763|P4|Overall Study|Ulcerative Colitis identified|0
2469891|NCT02345889|8525764|P3|Overall Study|Ulcerative Colitis identified|0
2469892|NCT02345889|8525765|P2|Overall Study|Ulcerative Colitis identified|0
2469893|NCT02345889|8525766|P1|Overall Study|Ulcerative Colitis identified|1
2469894|NCT02345889|8525763|P4|Overall Study|Recognized ineligible post-randomization|1
2469895|NCT02345889|8525764|P3|Overall Study|Recognized ineligible post-randomization|2
2469896|NCT02345889|8525765|P2|Overall Study|Recognized ineligible post-randomization|0
2469897|NCT02345889|8525766|P1|Overall Study|Recognized ineligible post-randomization|1
2469898|NCT02345889|8525763|P4|Overall Study|Polyposis identified during procedure|1
2469899|NCT02345889|8525764|P3|Overall Study|Polyposis identified during procedure|0
2469900|NCT02345889|8525765|P2|Overall Study|Polyposis identified during procedure|1
2469901|NCT02345889|8525766|P1|Overall Study|Polyposis identified during procedure|1
2469902|NCT02345889|8525763|P4|Overall Study|Inadequate Bowel Prep|14
2469903|NCT02345889|8525764|P3|Overall Study|Inadequate Bowel Prep|18
2469904|NCT02345889|8525765|P2|Overall Study|Inadequate Bowel Prep|16
2469905|NCT02345889|8525766|P1|Overall Study|Inadequate Bowel Prep|17
2469906|NCT02345512|8525853|P1|Overall Study|Withdrawal by Subject|1
2469907|NCT02345512|8525853|P1|Overall Study|Adverse Event|1
2469908|NCT02345330|8525947|P1|Overall Study|Progressive Disease|2
2469909|NCT02345330|8525947|P1|Overall Study|Death|1
2469910|NCT02345252|8525959|P2|Double-Blind Phase|Randomized but Never Treated|2
2469911|NCT02345252|8525960|P1|Double-Blind Phase|Randomized but Never Treated|0
2469912|NCT02345252|8525959|P2|Double-Blind Phase|Lost to Follow-up|10
2469913|NCT02345252|8525960|P1|Double-Blind Phase|Lost to Follow-up|8
2469914|NCT02345252|8525959|P2|Double-Blind Phase|Withdrew Consent|23
2469915|NCT02345252|8525960|P1|Double-Blind Phase|Withdrew Consent|21
2469916|NCT02345252|8525959|P2|Double-Blind Phase|Protocol Violation|1
2469917|NCT02345252|8525960|P1|Double-Blind Phase|Protocol Violation|2
2469918|NCT02345252|8525959|P2|Double-Blind Phase|Non-Compliance with Study Drug|2
2469919|NCT02345252|8525960|P1|Double-Blind Phase|Non-Compliance with Study Drug|1
2469920|NCT02345252|8525959|P2|Double-Blind Phase|Investigator's Discretion|6
2469921|NCT02345252|8525960|P1|Double-Blind Phase|Investigator's Discretion|4
2469922|NCT02345252|8525959|P2|Double-Blind Phase|Lack of Efficacy|0
2469923|NCT02345252|8525960|P1|Double-Blind Phase|Lack of Efficacy|1
2469924|NCT02345252|8525959|P2|Double-Blind Phase|Death|2
2469925|NCT02345252|8525960|P1|Double-Blind Phase|Death|1
2469926|NCT02345252|8525959|P2|Double-Blind Phase|Adverse Event|3
2469927|NCT02345252|8525960|P1|Double-Blind Phase|Adverse Event|2
2469928|NCT02345226|8525988|P2|Open-Label Extension Phase|Lost to Follow-up|1
2469929|NCT02345226|8525989|P1|Open-Label Extension Phase|Lost to Follow-up|0
2469930|NCT02345226|8525988|P2|Double-Blind Phase|Randomized but Never Treated|4
2469931|NCT02345226|8525989|P1|Double-Blind Phase|Randomized but Never Treated|2
2469932|NCT02345226|8525988|P2|Double-Blind Phase|Lost to Follow-up|16
2469933|NCT02345226|8525989|P1|Double-Blind Phase|Lost to Follow-up|12
2469934|NCT02345226|8525988|P2|Double-Blind Phase|Withdrew Consent|39
2469936|NCT02345226|8525988|P2|Double-Blind Phase|Non-Compliance with Study Drug|2
2469937|NCT02345226|8525989|P1|Double-Blind Phase|Non-Compliance with Study Drug|1
2469938|NCT02345226|8525988|P2|Double-Blind Phase|Investigator's Discretion|3
2469939|NCT02345226|8525989|P1|Double-Blind Phase|Investigator's Discretion|4
2469940|NCT02345226|8525988|P2|Double-Blind Phase|Lack of Efficacy|0
2469941|NCT02345226|8525989|P1|Double-Blind Phase|Lack of Efficacy|1
2469942|NCT02345226|8525988|P2|Double-Blind Phase|Pregnancy|1
2469943|NCT02345226|8525989|P1|Double-Blind Phase|Pregnancy|0
2469944|NCT02345226|8525988|P2|Double-Blind Phase|Death|0
2469945|NCT02345226|8525989|P1|Double-Blind Phase|Death|3
2469946|NCT02345226|8525988|P2|Double-Blind Phase|Adverse Event|6
2469947|NCT02345226|8525989|P1|Double-Blind Phase|Adverse Event|5
2469948|NCT02345161|8526021|P2|Overall Study|Lost to Follow-up|1
2469949|NCT02345161|8526022|P1|Overall Study|Lost to Follow-up|0
2469950|NCT02345161|8526021|P2|Overall Study|Physician Decision|4
2469951|NCT02345161|8526022|P1|Overall Study|Physician Decision|4
2469952|NCT02345161|8526021|P2|Overall Study|Adverse Event|19
2469953|NCT02345161|8526022|P1|Overall Study|Adverse Event|16
2469954|NCT02345161|8526021|P2|Overall Study|Withdrawal by Subject|33
2469955|NCT02345161|8526022|P1|Overall Study|Withdrawal by Subject|25
2469956|NCT02344745|8526143|P2|Overall Study|Data collection sheets were lost|0
2469957|NCT02344745|8526144|P1|Overall Study|Data collection sheets were lost|2
2469958|NCT02344576|8526173|P4|6-Month Follow-Up|Lost to Follow-up|6
2469959|NCT02344576|8526174|P3|6-Month Follow-Up|Lost to Follow-up|13
2469960|NCT02344576|8526175|P2|6-Month Follow-Up|Lost to Follow-up|5
2469961|NCT02344576|8526176|P1|6-Month Follow-Up|Lost to Follow-up|4
2469962|NCT02344576|8526173|P4|6-Month Follow-Up|Withdrawal by Subject|2
2469963|NCT02344576|8526174|P3|6-Month Follow-Up|Withdrawal by Subject|1
2469964|NCT02344576|8526175|P2|6-Month Follow-Up|Withdrawal by Subject|0
2469965|NCT02344576|8526176|P1|6-Month Follow-Up|Withdrawal by Subject|1
2469966|NCT02344576|8526173|P4|6-Month Follow-Up|Death|0
2469967|NCT02344576|8526174|P3|6-Month Follow-Up|Death|0
2469968|NCT02344576|8526175|P2|6-Month Follow-Up|Death|14
2469969|NCT02344576|8526176|P1|6-Month Follow-Up|Death|14
2469970|NCT02344576|8526173|P4|1-Month Follow-Up|Lost to Follow-up|3
2469971|NCT02344576|8526174|P3|1-Month Follow-Up|Lost to Follow-up|11
2469972|NCT02344576|8526175|P2|1-Month Follow-Up|Lost to Follow-up|5
2469973|NCT02344576|8526176|P1|1-Month Follow-Up|Lost to Follow-up|2
2469974|NCT02344576|8526173|P4|1-Month Follow-Up|Withdrawal by Subject|10
2469975|NCT02344576|8526174|P3|1-Month Follow-Up|Withdrawal by Subject|8
2469976|NCT02344576|8526175|P2|1-Month Follow-Up|Withdrawal by Subject|14
2469977|NCT02344576|8526176|P1|1-Month Follow-Up|Withdrawal by Subject|3
2469978|NCT02344576|8526173|P4|1-Month Follow-Up|Death|0
2469979|NCT02344576|8526174|P3|1-Month Follow-Up|Death|0
2469980|NCT02344576|8526175|P2|1-Month Follow-Up|Death|8
2469981|NCT02344576|8526176|P1|1-Month Follow-Up|Death|13
2469982|NCT02344576|8526173|P4|Enrollment|Agreed to Medical Record Review Only|0
2469983|NCT02344576|8526174|P3|Enrollment|Agreed to Medical Record Review Only|0
2469984|NCT02344576|8526175|P2|Enrollment|Agreed to Medical Record Review Only|8
2469985|NCT02344576|8526176|P1|Enrollment|Agreed to Medical Record Review Only|7
2469986|NCT02344342|8526239|P4|Overall Study|Industry partner dropped out|10
2469987|NCT02344342|8526240|P3|Overall Study|Industry partner dropped out|14
2469988|NCT02344342|8526241|P2|Overall Study|Industry partner dropped out|9
2469989|NCT02344342|8526242|P1|Overall Study|Industry partner dropped out|11
2469990|NCT02344173|8526289|P1|12-month Visit|Lost to Follow-up|58
2469991|NCT02344173|8526289|P1|12-month Visit|Withdrawal by Subject|30
2469992|NCT02344173|8526289|P1|12-month Visit|Death|8
2469993|NCT02344173|8526289|P1|Procedure|Ablation Procedure Not Performed|7
2469994|NCT02344004|8526297|P2|Overall Study|Protocol Violation|0
2469995|NCT02344004|8526298|P1|Overall Study|Protocol Violation|1
2469996|NCT02344004|8526297|P2|Overall Study|Other Not Specified|0
2469997|NCT02344004|8526298|P1|Overall Study|Other Not Specified|12
2469998|NCT02344004|8526297|P2|Overall Study|Rescue Medication|0
2469999|NCT02344004|8526298|P1|Overall Study|Rescue Medication|2
2470000|NCT02344004|8526297|P2|Overall Study|Withdrawal by Subject|5
2470001|NCT02344004|8526298|P1|Overall Study|Withdrawal by Subject|22
2470002|NCT02344004|8526297|P2|Overall Study|Physician Decision|1
2470003|NCT02344004|8526298|P1|Overall Study|Physician Decision|4
2470004|NCT02344004|8526297|P2|Overall Study|Death|7
2470005|NCT02344004|8526298|P1|Overall Study|Death|9
2470006|NCT02344004|8526297|P2|Overall Study|Adverse Event|1
2470007|NCT02344004|8526298|P1|Overall Study|Adverse Event|11
2470008|NCT02343939|8526325|P9|Overall Study|Never Treated With ENTO|0
2470009|NCT02343939|8526326|P8|Overall Study|Never Treated With ENTO|2
2470010|NCT02343939|8526327|P7|Overall Study|Never Treated With ENTO|1
2470011|NCT02343939|8526328|P6|Overall Study|Never Treated With ENTO|0
2470012|NCT02343939|8526329|P5|Overall Study|Never Treated With ENTO|0
2470013|NCT02343939|8526330|P4|Overall Study|Never Treated With ENTO|0
2470014|NCT02343939|8526331|P3|Overall Study|Never Treated With ENTO|0
2470015|NCT02343939|8526332|P2|Overall Study|Never Treated With ENTO|0
2470016|NCT02343939|8526333|P1|Overall Study|Never Treated With ENTO|0
2470017|NCT02343939|8526325|P9|Overall Study|Adverse Event|0
2470018|NCT02343939|8526326|P8|Overall Study|Adverse Event|0
2470019|NCT02343939|8526327|P7|Overall Study|Adverse Event|0
2470020|NCT02343939|8526328|P6|Overall Study|Adverse Event|1
2470021|NCT02343939|8526329|P5|Overall Study|Adverse Event|0
2470022|NCT02343939|8526330|P4|Overall Study|Adverse Event|0
2470023|NCT02343939|8526331|P3|Overall Study|Adverse Event|0
2470024|NCT02343939|8526332|P2|Overall Study|Adverse Event|0
2470025|NCT02343939|8526333|P1|Overall Study|Adverse Event|0
2470026|NCT02343939|8526325|P9|Overall Study|Investigator's discretion|0
2470027|NCT02343939|8526326|P8|Overall Study|Investigator's discretion|0
2470028|NCT02343939|8526327|P7|Overall Study|Investigator's discretion|1
2470029|NCT02343939|8526328|P6|Overall Study|Investigator's discretion|0
2470030|NCT02343939|8526329|P5|Overall Study|Investigator's discretion|0
2470031|NCT02343939|8526330|P4|Overall Study|Investigator's discretion|1
2470032|NCT02343939|8526331|P3|Overall Study|Investigator's discretion|0
2470033|NCT02343939|8526332|P2|Overall Study|Investigator's discretion|0
2470034|NCT02343939|8526333|P1|Overall Study|Investigator's discretion|0
2470035|NCT02343939|8526325|P9|Overall Study|Treatment failure|0
2470036|NCT02343939|8526326|P8|Overall Study|Treatment failure|1
2470037|NCT02343939|8526327|P7|Overall Study|Treatment failure|2
2470038|NCT02343939|8526328|P6|Overall Study|Treatment failure|0
2470039|NCT02343939|8526329|P5|Overall Study|Treatment failure|0
2470040|NCT02343939|8526330|P4|Overall Study|Treatment failure|0
2470041|NCT02343939|8526331|P3|Overall Study|Treatment failure|0
2470042|NCT02343939|8526332|P2|Overall Study|Treatment failure|0
2470043|NCT02343939|8526333|P1|Overall Study|Treatment failure|0
2470044|NCT02343939|8526325|P9|Overall Study|Withdrew consent|6
2470045|NCT02343939|8526326|P8|Overall Study|Withdrew consent|8
2470046|NCT02343939|8526327|P7|Overall Study|Withdrew consent|0
2470047|NCT02343939|8526328|P6|Overall Study|Withdrew consent|0
2470048|NCT02343939|8526329|P5|Overall Study|Withdrew consent|2
2470049|NCT02343939|8526330|P4|Overall Study|Withdrew consent|2
2470050|NCT02343939|8526331|P3|Overall Study|Withdrew consent|1
2470051|NCT02343939|8526332|P2|Overall Study|Withdrew consent|6
2470052|NCT02343939|8526333|P1|Overall Study|Withdrew consent|3
2470053|NCT02343939|8526325|P9|Overall Study|Study terminated by sponsor|0
2470054|NCT02343939|8526326|P8|Overall Study|Study terminated by sponsor|4
2470055|NCT02343939|8526327|P7|Overall Study|Study terminated by sponsor|3
2470056|NCT02343939|8526328|P6|Overall Study|Study terminated by sponsor|5
2470057|NCT02343939|8526329|P5|Overall Study|Study terminated by sponsor|1
2470058|NCT02343939|8526330|P4|Overall Study|Study terminated by sponsor|1
2470059|NCT02343939|8526331|P3|Overall Study|Study terminated by sponsor|0
2470060|NCT02343939|8526332|P2|Overall Study|Study terminated by sponsor|27
2470061|NCT02343939|8526333|P1|Overall Study|Study terminated by sponsor|0
2470062|NCT02343939|8526325|P9|Overall Study|Death|1
2470063|NCT02343939|8526326|P8|Overall Study|Death|22
2470064|NCT02343939|8526327|P7|Overall Study|Death|8
2470065|NCT02343939|8526328|P6|Overall Study|Death|11
2470066|NCT02343939|8526329|P5|Overall Study|Death|5
2470067|NCT02343939|8526330|P4|Overall Study|Death|2
2470068|NCT02343939|8526331|P3|Overall Study|Death|4
2470069|NCT02343939|8526332|P2|Overall Study|Death|15
2470070|NCT02343939|8526333|P1|Overall Study|Death|0
2470071|NCT02343458|8526475|P4|Overall Study|Protocol Specified Criteria|8
2470072|NCT02343458|8526476|P3|Overall Study|Protocol Specified Criteria|14
2470073|NCT02343458|8526477|P2|Overall Study|Protocol Specified Criteria|13
2470074|NCT02343458|8526478|P1|Overall Study|Protocol Specified Criteria|17
2470075|NCT02343458|8526475|P4|Overall Study|Protocol Violation|2
2470076|NCT02343458|8526476|P3|Overall Study|Protocol Violation|2
2470077|NCT02343458|8526477|P2|Overall Study|Protocol Violation|5
2470078|NCT02343458|8526478|P1|Overall Study|Protocol Violation|2
2470079|NCT02343458|8526475|P4|Overall Study|Lost to Follow-up|1
2470080|NCT02343458|8526476|P3|Overall Study|Lost to Follow-up|3
2470081|NCT02343458|8526477|P2|Overall Study|Lost to Follow-up|5
2470082|NCT02343458|8526478|P1|Overall Study|Lost to Follow-up|5
2470083|NCT02343458|8526475|P4|Overall Study|Physician Decision|2
2470084|NCT02343458|8526476|P3|Overall Study|Physician Decision|2
2470085|NCT02343458|8526477|P2|Overall Study|Physician Decision|4
2470086|NCT02343458|8526478|P1|Overall Study|Physician Decision|1
2470087|NCT02343458|8526475|P4|Overall Study|Withdrawal by Subject|14
2470088|NCT02343458|8526476|P3|Overall Study|Withdrawal by Subject|23
2470089|NCT02343458|8526477|P2|Overall Study|Withdrawal by Subject|17
2470090|NCT02343458|8526478|P1|Overall Study|Withdrawal by Subject|18
2470091|NCT02343458|8526475|P4|Overall Study|Lack of Efficacy|8
2470092|NCT02343458|8526476|P3|Overall Study|Lack of Efficacy|4
2470093|NCT02343458|8526477|P2|Overall Study|Lack of Efficacy|8
2470094|NCT02343458|8526478|P1|Overall Study|Lack of Efficacy|3
2470095|NCT02343458|8526475|P4|Overall Study|Adverse Event|3
2470096|NCT02343458|8526476|P3|Overall Study|Adverse Event|15
2470097|NCT02343458|8526477|P2|Overall Study|Adverse Event|14
2470098|NCT02343458|8526478|P1|Overall Study|Adverse Event|15
2470099|NCT02343263|8526587|P3|Overall Study|Physician Decision|1
2470100|NCT02343263|8526588|P2|Overall Study|Physician Decision|3
2470101|NCT02343263|8526589|P1|Overall Study|Physician Decision|5
2470102|NCT02343159|8526618|P3|Overall Study|Enrollment Error|0
2470103|NCT02343159|8526619|P2|Overall Study|Enrollment Error|0
2470104|NCT02343159|8526620|P1|Overall Study|Enrollment Error|1
2470105|NCT02343159|8526618|P3|Overall Study|Sponsor Decision|0
2470106|NCT02343159|8526619|P2|Overall Study|Sponsor Decision|1
2470107|NCT02343159|8526620|P1|Overall Study|Sponsor Decision|0
2470108|NCT02343159|8526618|P3|Overall Study|Adverse Event|2
2470109|NCT02343159|8526619|P2|Overall Study|Adverse Event|4
2470110|NCT02343159|8526620|P1|Overall Study|Adverse Event|4
2470111|NCT02343159|8526618|P3|Overall Study|Lost to Follow-up|2
2470112|NCT02343159|8526619|P2|Overall Study|Lost to Follow-up|2
2470113|NCT02343159|8526620|P1|Overall Study|Lost to Follow-up|0
2470114|NCT02343159|8526618|P3|Overall Study|Withdrawal by Subject|2
2470115|NCT02343159|8526619|P2|Overall Study|Withdrawal by Subject|0
2470116|NCT02343159|8526620|P1|Overall Study|Withdrawal by Subject|3
2470117|NCT02343159|8526618|P3|Overall Study|Physician Decision|1
2470118|NCT02343159|8526619|P2|Overall Study|Physician Decision|0
2470119|NCT02343159|8526620|P1|Overall Study|Physician Decision|2
2470120|NCT02343159|8526618|P3|Overall Study|Early Study Termination|23
2470121|NCT02343159|8526619|P2|Overall Study|Early Study Termination|19
2470122|NCT02343159|8526620|P1|Overall Study|Early Study Termination|16
2470123|NCT02343003|8526664|P2|Overall Study|terminated by sponsor|0
2470124|NCT02343003|8526665|P1|Overall Study|terminated by sponsor|2
2470125|NCT02343003|8526664|P2|Overall Study|exclusion criteria met|1
2470126|NCT02343003|8526665|P1|Overall Study|exclusion criteria met|1
2470127|NCT02343003|8526664|P2|Overall Study|Death|1
2470128|NCT02343003|8526665|P1|Overall Study|Death|0
2470129|NCT02343003|8526664|P2|Overall Study|Protocol Violation|0
2470130|NCT02343003|8526665|P1|Overall Study|Protocol Violation|1
2470131|NCT02343003|8526664|P2|Overall Study|Lost to Follow-up|1
2470132|NCT02343003|8526665|P1|Overall Study|Lost to Follow-up|5
2470133|NCT02343003|8526664|P2|Overall Study|Withdrawal by Subject|4
2470134|NCT02343003|8526665|P1|Overall Study|Withdrawal by Subject|9
2470135|NCT02342886|8526686|P5|Overall Study|Protocol Violation|0
2470136|NCT02342886|8526687|P4|Overall Study|Protocol Violation|2
2470137|NCT02342886|8526688|P3|Overall Study|Protocol Violation|0
2470138|NCT02342886|8526689|P2|Overall Study|Protocol Violation|0
2470139|NCT02342886|8526690|P1|Overall Study|Protocol Violation|0
2470140|NCT02342886|8526686|P5|Overall Study|Late exclusion: pyrazinamide resistance|0
2470141|NCT02342886|8526687|P4|Overall Study|Late exclusion: pyrazinamide resistance|0
2470142|NCT02342886|8526688|P3|Overall Study|Late exclusion: pyrazinamide resistance|1
2470143|NCT02342886|8526689|P2|Overall Study|Late exclusion: pyrazinamide resistance|0
2470144|NCT02342886|8526690|P1|Overall Study|Late exclusion: pyrazinamide resistance|0
2470145|NCT02342886|8526686|P5|Overall Study|Pregnancy|0
2470146|NCT02342886|8526687|P4|Overall Study|Pregnancy|0
2470147|NCT02342886|8526688|P3|Overall Study|Pregnancy|2
2470148|NCT02342886|8526689|P2|Overall Study|Pregnancy|0
2470149|NCT02342886|8526690|P1|Overall Study|Pregnancy|0
2470150|NCT02342886|8526686|P5|Overall Study|Investigator/sponsor decision|1
2470151|NCT02342886|8526687|P4|Overall Study|Investigator/sponsor decision|3
2470152|NCT02342886|8526688|P3|Overall Study|Investigator/sponsor decision|0
2470153|NCT02342886|8526689|P2|Overall Study|Investigator/sponsor decision|2
2470154|NCT02342886|8526690|P1|Overall Study|Investigator/sponsor decision|0
2470155|NCT02342886|8526686|P5|Overall Study|Withdrawal by Subject|0
2470156|NCT02342886|8526687|P4|Overall Study|Withdrawal by Subject|1
2470157|NCT02342886|8526688|P3|Overall Study|Withdrawal by Subject|0
2470158|NCT02342886|8526689|P2|Overall Study|Withdrawal by Subject|1
2470159|NCT02342886|8526690|P1|Overall Study|Withdrawal by Subject|0
2470160|NCT02342886|8526686|P5|Overall Study|Death|1
2470161|NCT02342886|8526687|P4|Overall Study|Death|0
2470162|NCT02342886|8526688|P3|Overall Study|Death|1
2470163|NCT02342886|8526689|P2|Overall Study|Death|2
2470164|NCT02342886|8526690|P1|Overall Study|Death|1
2470165|NCT02342886|8526686|P5|Overall Study|Lost to Follow-up|0
2470166|NCT02342886|8526687|P4|Overall Study|Lost to Follow-up|0
2470167|NCT02342886|8526688|P3|Overall Study|Lost to Follow-up|0
2470168|NCT02342886|8526689|P2|Overall Study|Lost to Follow-up|0
2470169|NCT02342886|8526690|P1|Overall Study|Lost to Follow-up|1
2470170|NCT02342886|8526686|P5|Overall Study|Adverse event/specific toxicity|1
2470171|NCT02342886|8526687|P4|Overall Study|Adverse event/specific toxicity|2
2470172|NCT02342886|8526688|P3|Overall Study|Adverse event/specific toxicity|11
2470173|NCT02342886|8526689|P2|Overall Study|Adverse event/specific toxicity|3
2470174|NCT02342886|8526690|P1|Overall Study|Adverse event/specific toxicity|4
2470175|NCT02342886|8526686|P5|Overall Study|Late exclusion: rifampicin resistance|0
2470176|NCT02342886|8526687|P4|Overall Study|Late exclusion: rifampicin resistance|0
2470177|NCT02342886|8526688|P3|Overall Study|Late exclusion: rifampicin resistance|0
2470178|NCT02342886|8526689|P2|Overall Study|Late exclusion: rifampicin resistance|0
2470179|NCT02342886|8526690|P1|Overall Study|Late exclusion: rifampicin resistance|1
2470180|NCT02342886|8526686|P5|Overall Study|Treatment non-compliance|0
2470181|NCT02342886|8526687|P4|Overall Study|Treatment non-compliance|1
2470182|NCT02342886|8526688|P3|Overall Study|Treatment non-compliance|0
2470183|NCT02342886|8526689|P2|Overall Study|Treatment non-compliance|0
2470184|NCT02342886|8526690|P1|Overall Study|Treatment non-compliance|1
2470185|NCT02342743|8526707|P1|Treatment Period|Change in prophylactic medication|1
2470186|NCT02342743|8526707|P1|Treatment Period|Lost to Follow-up|8
2470187|NCT02342743|8526707|P1|Treatment Period|Withdrawal by Subject|2
2470188|NCT02342743|8526707|P1|Baseline Period|Screening failure regarding baseline|7
2470189|NCT02342743|8526707|P1|Baseline Period|Change in prophylactic medication|3
2470190|NCT02342743|8526707|P1|Baseline Period|Lost to Follow-up|2
2470191|NCT02342743|8526707|P1|Baseline Period|Withdrawal by Subject|3
2470192|NCT02342704|8526720|P2|Overall Study|Adverse Event|3
2470193|NCT02342704|8526721|P1|Overall Study|Adverse Event|1
2470194|NCT02342704|8526720|P2|Overall Study|Lost to Follow-up|1
2470195|NCT02342704|8526721|P1|Overall Study|Lost to Follow-up|2
2470196|NCT02342704|8526720|P2|Overall Study|Withdrawal by Subject|0
2470197|NCT02342704|8526721|P1|Overall Study|Withdrawal by Subject|1
2470198|NCT02342704|8526720|P2|Overall Study|Other|1
2470199|NCT02342704|8526721|P1|Overall Study|Other|0
2470200|NCT02342704|8526720|P2|Overall Study|Sponsor Termination|43
2470201|NCT02342704|8526721|P1|Overall Study|Sponsor Termination|49
2470202|NCT02342704|8526720|P2|Overall Study|Physician Decision|3
2470203|NCT02342704|8526721|P1|Overall Study|Physician Decision|0
2470204|NCT02342678|8526749|P2|Overall Study|Illness/medical reason|1
2470205|NCT02342678|8526750|P1|Overall Study|Illness/medical reason|1
2470206|NCT02342678|8526749|P2|Overall Study|Family illness/emergency|1
2470207|NCT02342678|8526750|P1|Overall Study|Family illness/emergency|0
2470208|NCT02342678|8526749|P2|Overall Study|Too busy to complete study|2
2470209|NCT02342678|8526750|P1|Overall Study|Too busy to complete study|0
2470210|NCT02342678|8526749|P2|Overall Study|Lost to Follow-up|1
2470211|NCT02342678|8526750|P1|Overall Study|Lost to Follow-up|0
2470212|NCT02342548|8526781|P3|Overall Study|Other|1
2470213|NCT02342548|8526782|P2|Overall Study|Other|1
2470214|NCT02342548|8526783|P1|Overall Study|Other|1
2470215|NCT02342548|8526781|P3|Overall Study|Withdrawal by Subject|4
2470216|NCT02342548|8526782|P2|Overall Study|Withdrawal by Subject|3
2470217|NCT02342548|8526783|P1|Overall Study|Withdrawal by Subject|1
2470218|NCT02342548|8526781|P3|Overall Study|Protocol Violation|0
2470219|NCT02342548|8526782|P2|Overall Study|Protocol Violation|1
2470220|NCT02342548|8526783|P1|Overall Study|Protocol Violation|0
2470221|NCT02342548|8526781|P3|Overall Study|Study terminated by sponsor|25
2470222|NCT02342548|8526782|P2|Overall Study|Study terminated by sponsor|39
2470223|NCT02342548|8526783|P1|Overall Study|Study terminated by sponsor|20
2470224|NCT02342548|8526781|P3|Overall Study|Lost to Follow-up|0
2470225|NCT02342548|8526782|P2|Overall Study|Lost to Follow-up|1
2470226|NCT02342548|8526783|P1|Overall Study|Lost to Follow-up|0
2470227|NCT02342548|8526781|P3|Overall Study|Adverse Event|13
2470228|NCT02342548|8526782|P2|Overall Study|Adverse Event|17
2470229|NCT02342548|8526783|P1|Overall Study|Adverse Event|12
2470230|NCT02342418|8526827|P2|Overall Study|Adverse Event|1
2470231|NCT02342418|8526828|P1|Overall Study|Adverse Event|0
2470232|NCT02342288|8527007|P2|Overall Study|coordinator not available|2
2470233|NCT02342288|8527008|P1|Overall Study|coordinator not available|0
2470234|NCT02342288|8527007|P2|Overall Study|subject cannot tolerate numbing drops|1
2470235|NCT02342288|8527008|P1|Overall Study|subject cannot tolerate numbing drops|0
2470236|NCT02342288|8527007|P2|Overall Study|coordinator contaminated with blood|1
2470237|NCT02342288|8527008|P1|Overall Study|coordinator contaminated with blood|0
2470238|NCT02342288|8527007|P2|Overall Study|Withdrawal by Subject|0
2470239|NCT02342288|8527008|P1|Overall Study|Withdrawal by Subject|1
2470240|NCT02342288|8527007|P2|Overall Study|anesthesia leak in system|0
2470241|NCT02342288|8527008|P1|Overall Study|anesthesia leak in system|1
2470242|NCT02342288|8527007|P2|Overall Study|no protocol anesthesiologist available|2
2470243|NCT02342288|8527008|P1|Overall Study|no protocol anesthesiologist available|3
2470244|NCT02342223|8527014|P1|Overall Study|Lost to Follow-up|1
2470245|NCT02342171|8527034|P2|Overall Study|Missing age data|1
2470246|NCT02342171|8527035|P1|Overall Study|Missing age data|0
2470247|NCT02342171|8527034|P2|Overall Study|Unknown outcome|1
2470248|NCT02342171|8527035|P1|Overall Study|Unknown outcome|0
2470249|NCT02342171|8527034|P2|Overall Study|Missing cycle treshold value|0
2470250|NCT02342171|8527035|P1|Overall Study|Missing cycle treshold value|1
2470251|NCT02342171|8527034|P2|Overall Study|Received favipiravir|0
2470252|NCT02342171|8527035|P1|Overall Study|Received favipiravir|10
2470253|NCT02342171|8527034|P2|Overall Study|Death|87
2470254|NCT02342171|8527035|P1|Overall Study|Death|4
2470255|NCT02341482|8527289|P1|Overall Study|Adverse Event|1
2470256|NCT02341456|8527318|P3|Overall Study|Physician Decision|0
2470257|NCT02341456|8527319|P2|Overall Study|Physician Decision|0
2470258|NCT02341456|8527320|P1|Overall Study|Physician Decision|1
2470259|NCT02341456|8527318|P3|Overall Study|Moved to local access programme.|1
2470260|NCT02341456|8527319|P2|Overall Study|Moved to local access programme.|1
2470261|NCT02341456|8527320|P1|Overall Study|Moved to local access programme.|0
2470262|NCT02341456|8527318|P3|Overall Study|Withdrawal by Subject|1
2470263|NCT02341456|8527319|P2|Overall Study|Withdrawal by Subject|1
2470264|NCT02341456|8527320|P1|Overall Study|Withdrawal by Subject|0
2470265|NCT02341456|8527318|P3|Overall Study|Death|1
2470266|NCT02341456|8527319|P2|Overall Study|Death|1
2470267|NCT02341456|8527320|P1|Overall Study|Death|1
2470268|NCT02341456|8527318|P3|Overall Study|Disease progression|1
2470269|NCT02341456|8527319|P2|Overall Study|Disease progression|3
2470270|NCT02341456|8527320|P1|Overall Study|Disease progression|2
2470271|NCT02341417|8527445|P3|Overall Study|Death|1
2470272|NCT02341417|8527446|P2|Overall Study|Death|0
2470273|NCT02341417|8527447|P1|Overall Study|Death|0
2470274|NCT02341417|8527445|P3|Overall Study|Decision by sponsor|0
2470275|NCT02341417|8527446|P2|Overall Study|Decision by sponsor|0
2470276|NCT02341417|8527447|P1|Overall Study|Decision by sponsor|2
2470277|NCT02341417|8527445|P3|Overall Study|Withdrawal by Subject|0
2470278|NCT02341417|8527446|P2|Overall Study|Withdrawal by Subject|2
2470279|NCT02341417|8527447|P1|Overall Study|Withdrawal by Subject|0
2470280|NCT02340962|8527508|P2|Overall Study|Lost to Follow-up|0
2470281|NCT02340962|8527509|P1|Overall Study|Lost to Follow-up|1
2470282|NCT02340819|8527529|P1|Overall Study|Discontinued with other reason|1
2470283|NCT02340819|8527529|P1|Overall Study|Withdrawal by Subject|2
2470284|NCT02340819|8527529|P1|Overall Study|Adverse Event|1
2470285|NCT02340806|8527558|P2|Overall Study|re-dose < 90 min of CSE|3
2470286|NCT02340806|8527559|P1|Overall Study|re-dose < 90 min of CSE|1
2470287|NCT02340806|8527558|P2|Overall Study|history of chronic pain medication|0
2470288|NCT02340806|8527559|P1|Overall Study|history of chronic pain medication|1
2470289|NCT02340806|8527558|P2|Overall Study|epidural catheter replaced|1
2470290|NCT02340806|8527559|P1|Overall Study|epidural catheter replaced|2
2470291|NCT02340806|8527558|P2|Overall Study|Protocol Violation|0
2470292|NCT02340806|8527559|P1|Overall Study|Protocol Violation|2
2470293|NCT02340780|8527585|P1|Overall Study|Ineligible|1
2470294|NCT02340663|8527640|P2|Overall Study|Withdrawal by Subject|1
2470295|NCT02340663|8527641|P1|Overall Study|Withdrawal by Subject|3
2470296|NCT02340663|8527640|P2|Overall Study|Protocol Violation|0
2470297|NCT02340663|8527641|P1|Overall Study|Protocol Violation|1
2470298|NCT02340663|8527640|P2|Overall Study|Lost to Follow-up|0
2470299|NCT02340663|8527641|P1|Overall Study|Lost to Follow-up|1
2470300|NCT02340520|8527697|P1|Overall Study|Withdrawal by Subject|1
2470301|NCT02340520|8527697|P1|Overall Study|Patient did not take drug as specified|1
2470302|NCT02340520|8527697|P1|Overall Study|Lost to Follow-up|1
2470303|NCT02340221|8527740|P2|Overall Study|Continued on study|290
2470304|NCT02340221|8527741|P1|Overall Study|Continued on study|140
2470305|NCT02340221|8527740|P2|Overall Study|Reason Not Specified|1
2470306|NCT02340221|8527741|P1|Overall Study|Reason Not Specified|0
2470307|NCT02340221|8527740|P2|Overall Study|Lost to Follow-up|3
2470308|NCT02340221|8527741|P1|Overall Study|Lost to Follow-up|2
2470309|NCT02340221|8527740|P2|Overall Study|Withdrawal by Participant|22
2470310|NCT02340221|8527741|P1|Overall Study|Withdrawal by Participant|14
2470311|NCT02340221|8527740|P2|Overall Study|Death|101
2470312|NCT02340221|8527741|P1|Overall Study|Death|58
2470313|NCT02340078|8527775|P1|Overall Study|Protocol Violation|1
2470314|NCT02340000|8527782|P2|Time Period 2|Lost to Follow-up|8
2470315|NCT02340000|8527783|P1|Time Period 2|Lost to Follow-up|10
2470316|NCT02340000|8527782|P2|Time Period 2|Withdrawal by Subject|7
2470317|NCT02340000|8527783|P1|Time Period 2|Withdrawal by Subject|9
2470318|NCT02340000|8527782|P2|Time Period 1|Lost to Follow-up|7
2470319|NCT02340000|8527783|P1|Time Period 1|Lost to Follow-up|6
2470320|NCT02340000|8527782|P2|Time Period 1|Withdrawal by Subject|8
2470321|NCT02340000|8527783|P1|Time Period 1|Withdrawal by Subject|6
2470322|NCT02339909|8527813|P3|Overall Study|Became ineligible after randomisation|71
2470323|NCT02339909|8527814|P2|Overall Study|Became ineligible after randomisation|63
2470324|NCT02339909|8527815|P1|Overall Study|Became ineligible after randomisation|89
2470325|NCT02339584|8527853|P2|Overall Study|Withdrawal by Subject|4
2470326|NCT02339584|8527854|P1|Overall Study|Withdrawal by Subject|2
2470327|NCT02339584|8527853|P2|Overall Study|Protocol Violation|1
2470328|NCT02339584|8527854|P1|Overall Study|Protocol Violation|1
2470329|NCT02339584|8527853|P2|Overall Study|Physician Decision|2
2470330|NCT02339584|8527854|P1|Overall Study|Physician Decision|1
2470331|NCT02339584|8527853|P2|Overall Study|Lack of Efficacy|1
2470332|NCT02339584|8527854|P1|Overall Study|Lack of Efficacy|0
2470333|NCT02339584|8527853|P2|Overall Study|Adverse Event|7
2470334|NCT02339584|8527854|P1|Overall Study|Adverse Event|11
2470335|NCT02339506|8527874|P2|Washout (Period 2)|Withdrawal by Subject|0
2470336|NCT02339506|8527875|P1|Washout (Period 2)|Withdrawal by Subject|2
2470337|NCT02339506|8527874|P2|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1
2470338|NCT02339506|8527875|P1|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0
2470339|NCT02339285|8527904|P3|Overall Study|Protocol Deviation|0
2470340|NCT02339285|8527905|P2|Overall Study|Protocol Deviation|1
2470341|NCT02339285|8527906|P1|Overall Study|Protocol Deviation|0
2470342|NCT02339285|8527904|P3|Overall Study|Lost to Follow-up|1
2470343|NCT02339285|8527905|P2|Overall Study|Lost to Follow-up|1
2470344|NCT02339285|8527906|P1|Overall Study|Lost to Follow-up|1
2470345|NCT02339285|8527904|P3|Overall Study|Withdrawal by Subject|1
2470346|NCT02339285|8527905|P2|Overall Study|Withdrawal by Subject|1
2470347|NCT02339285|8527906|P1|Overall Study|Withdrawal by Subject|0
2470348|NCT02339155|8527952|P2|Overall Study|Withdrawal by Subject|4
2470349|NCT02339155|8527953|P1|Overall Study|Withdrawal by Subject|4
2470350|NCT02339155|8527952|P2|Overall Study|Physician Decision|1
2470351|NCT02339155|8527953|P1|Overall Study|Physician Decision|2
2470352|NCT02339155|8527952|P2|Overall Study|Lost to Follow-up|9
2470353|NCT02339155|8527953|P1|Overall Study|Lost to Follow-up|8
2470354|NCT02339155|8527952|P2|Overall Study|Death|1
2470355|NCT02339155|8527953|P1|Overall Study|Death|1
2470356|NCT02339155|8527952|P2|Overall Study|Adverse Event|6
2470357|NCT02339155|8527953|P1|Overall Study|Adverse Event|0
2470358|NCT02338882|8528159|P2|Overall Study|Lost to Follow-up|3
2470359|NCT02338882|8528160|P1|Overall Study|Lost to Follow-up|6
2470360|NCT02338882|8528159|P2|Overall Study|Death|0
2470361|NCT02338882|8528160|P1|Overall Study|Death|1
2470362|NCT02338843|8528198|P2|Overall Study|Discontinued prior to randomizat|0
2470363|NCT02338843|8528199|P1|Overall Study|Discontinued prior to randomizat|1
2470364|NCT02338843|8528198|P2|Overall Study|Subject Recovered|2
2470365|NCT02338843|8528199|P1|Overall Study|Subject Recovered|0
2470366|NCT02338843|8528198|P2|Overall Study|Withdrawal by Subject|2
2470367|NCT02338843|8528199|P1|Overall Study|Withdrawal by Subject|0
2470368|NCT02338843|8528198|P2|Overall Study|Physician Decision|0
2470369|NCT02338843|8528199|P1|Overall Study|Physician Decision|1
2470370|NCT02338843|8528198|P2|Overall Study|Death|53
2470371|NCT02338843|8528199|P1|Overall Study|Death|40
2470372|NCT02338843|8528198|P2|Overall Study|Adverse Event|1
2470373|NCT02338843|8528199|P1|Overall Study|Adverse Event|2
2470374|NCT02338492|8528227|P1|Overall Study|Reason not captured above|6
2470375|NCT02338492|8528227|P1|Overall Study|Lost to Follow-up|4
2470376|NCT02338492|8528227|P1|Overall Study|Adverse Event|3
2470377|NCT02338492|8528227|P1|Overall Study|Death|32
2470378|NCT02338362|8528243|P2|Overall Study|Withdrawal by Subject|1
2470379|NCT02338362|8528244|P1|Overall Study|Withdrawal by Subject|1
2470380|NCT02338193|8528274|P3|Overall Study|intolerant of side effects|0
2470381|NCT02338193|8528275|P2|Overall Study|intolerant of side effects|0
2470382|NCT02338193|8528276|P1|Overall Study|intolerant of side effects|1
2470383|NCT02338193|8528274|P3|Overall Study|moved out of state|0
2470384|NCT02338193|8528275|P2|Overall Study|moved out of state|1
2470385|NCT02338193|8528276|P1|Overall Study|moved out of state|0
2470386|NCT02338193|8528274|P3|Overall Study|Noncompliant with visits|7
2470387|NCT02338193|8528275|P2|Overall Study|Noncompliant with visits|2
2470388|NCT02338193|8528276|P1|Overall Study|Noncompliant with visits|2
2470389|NCT02338193|8528274|P3|Overall Study|Pregnancy|1
2470390|NCT02338193|8528275|P2|Overall Study|Pregnancy|1
2470391|NCT02338193|8528276|P1|Overall Study|Pregnancy|0
2470392|NCT02338193|8528274|P3|Overall Study|Withdrawal by Subject|2
2470393|NCT02338193|8528275|P2|Overall Study|Withdrawal by Subject|0
2470394|NCT02338193|8528276|P1|Overall Study|Withdrawal by Subject|0
2470395|NCT02338154|8528329|P1|Overall Study|Missing Exit Reason on Exit Form|1
2470396|NCT02338154|8528329|P1|Overall Study|Patients Without Exit Form|47
2470397|NCT02338154|8528329|P1|Overall Study|Other Reason|3
2470398|NCT02338154|8528329|P1|Overall Study|Lost to Follow-up|8
2470399|NCT02338154|8528329|P1|Overall Study|Withdrawal by Subject or by Investigator|10
2470400|NCT02338154|8528329|P1|Overall Study|Valve Explant|11
2470401|NCT02338154|8528329|P1|Overall Study|Valve Implant Failure|17
2470402|NCT02338154|8528329|P1|Overall Study|Death|46
2470403|NCT02337946|8528453|P3|Protocol Treatment 2 Period|Reason not specified|4
2470404|NCT02337946|8528454|P2|Protocol Treatment 2 Period|Reason not specified|4
2470405|NCT02337946|8528455|P1|Protocol Treatment 2 Period|Reason not specified|0
2470406|NCT02337946|8528453|P3|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7
2470407|NCT02337946|8528454|P2|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5
2470408|NCT02337946|8528455|P1|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0
2470409|NCT02337946|8528453|P3|Protocol Treatment 2 Period|Death During Protocol Treatment|0
2470410|NCT02337946|8528454|P2|Protocol Treatment 2 Period|Death During Protocol Treatment|1
2470411|NCT02337946|8528455|P1|Protocol Treatment 2 Period|Death During Protocol Treatment|0
2470412|NCT02337946|8528453|P3|Protocol Treatment 2 Period|Lack of Efficacy|29
2470413|NCT02337946|8528454|P2|Protocol Treatment 2 Period|Lack of Efficacy|29
2470414|NCT02337946|8528455|P1|Protocol Treatment 2 Period|Lack of Efficacy|0
2470415|NCT02337946|8528453|P3|Protocol Treatment 2 Period|Voluntary Withdrawal|1
2470416|NCT02337946|8528454|P2|Protocol Treatment 2 Period|Voluntary Withdrawal|3
2470417|NCT02337946|8528455|P1|Protocol Treatment 2 Period|Voluntary Withdrawal|0
2470418|NCT02337946|8528453|P3|Protocol Treatment 2 Period|Adverse Event|9
2470419|NCT02337946|8528454|P2|Protocol Treatment 2 Period|Adverse Event|9
2470420|NCT02337946|8528455|P1|Protocol Treatment 2 Period|Adverse Event|0
2470421|NCT02337946|8528453|P3|In-between Period|Without Informed Consent|0
2470422|NCT02337946|8528454|P2|In-between Period|Without Informed Consent|0
2470423|NCT02337946|8528455|P1|In-between Period|Without Informed Consent|1
2470424|NCT02337946|8528453|P3|Protocol Treatment 1 Period|Reason not specified|0
2470425|NCT02337946|8528454|P2|Protocol Treatment 1 Period|Reason not specified|0
2470426|NCT02337946|8528455|P1|Protocol Treatment 1 Period|Reason not specified|8
2470427|NCT02337946|8528453|P3|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0
2470428|NCT02337946|8528454|P2|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0
2470429|NCT02337946|8528455|P1|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1
2470430|NCT02337946|8528453|P3|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0
2470431|NCT02337946|8528454|P2|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0
2470432|NCT02337946|8528455|P1|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9
2470433|NCT02337946|8528453|P3|Protocol Treatment 1 Period|Death During Protocol Treatment|0
2470434|NCT02337946|8528454|P2|Protocol Treatment 1 Period|Death During Protocol Treatment|0
2470435|NCT02337946|8528455|P1|Protocol Treatment 1 Period|Death During Protocol Treatment|3
2470436|NCT02337946|8528453|P3|Protocol Treatment 1 Period|Lack of Efficacy|0
2470437|NCT02337946|8528454|P2|Protocol Treatment 1 Period|Lack of Efficacy|0
2470438|NCT02337946|8528455|P1|Protocol Treatment 1 Period|Lack of Efficacy|15
2470439|NCT02337946|8528453|P3|Protocol Treatment 1 Period|Voluntary Withdrawal|0
2470440|NCT02337946|8528454|P2|Protocol Treatment 1 Period|Voluntary Withdrawal|0
2470441|NCT02337946|8528455|P1|Protocol Treatment 1 Period|Voluntary Withdrawal|6
2470442|NCT02337946|8528453|P3|Protocol Treatment 1 Period|Major Protocol Deviation|0
2470443|NCT02337946|8528454|P2|Protocol Treatment 1 Period|Major Protocol Deviation|0
2470444|NCT02337946|8528455|P1|Protocol Treatment 1 Period|Major Protocol Deviation|1
2470445|NCT02337946|8528453|P3|Protocol Treatment 1 Period|Adverse Event|0
2470446|NCT02337946|8528454|P2|Protocol Treatment 1 Period|Adverse Event|0
2470447|NCT02337946|8528455|P1|Protocol Treatment 1 Period|Adverse Event|7
2470448|NCT02337907|8528483|P6|Overall Study|Adverse Event|0
2470449|NCT02337907|8528484|P5|Overall Study|Adverse Event|4
2470450|NCT02337907|8528485|P4|Overall Study|Adverse Event|1
2470451|NCT02337907|8528486|P3|Overall Study|Adverse Event|1
2470452|NCT02337907|8528487|P2|Overall Study|Adverse Event|1
2470453|NCT02337907|8528488|P1|Overall Study|Adverse Event|1
2470454|NCT02337907|8528483|P6|Overall Study|Lost to Follow-up|1
2470455|NCT02337907|8528484|P5|Overall Study|Lost to Follow-up|0
2470456|NCT02337907|8528485|P4|Overall Study|Lost to Follow-up|0
2470457|NCT02337907|8528486|P3|Overall Study|Lost to Follow-up|0
2470458|NCT02337907|8528487|P2|Overall Study|Lost to Follow-up|0
2470459|NCT02337907|8528488|P1|Overall Study|Lost to Follow-up|0
2470460|NCT02337907|8528483|P6|Overall Study|Withdrawal by Subject|0
2470461|NCT02337907|8528484|P5|Overall Study|Withdrawal by Subject|5
2470462|NCT02337907|8528485|P4|Overall Study|Withdrawal by Subject|2
2470463|NCT02337907|8528486|P3|Overall Study|Withdrawal by Subject|0
2470464|NCT02337907|8528487|P2|Overall Study|Withdrawal by Subject|3
2470465|NCT02337907|8528488|P1|Overall Study|Withdrawal by Subject|2
2470466|NCT02337907|8528483|P6|Overall Study|Other than listed|0
2470467|NCT02337907|8528484|P5|Overall Study|Other than listed|1
2470468|NCT02337907|8528485|P4|Overall Study|Other than listed|1
2470469|NCT02337907|8528486|P3|Overall Study|Other than listed|0
2470470|NCT02337907|8528487|P2|Overall Study|Other than listed|0
2470471|NCT02337907|8528488|P1|Overall Study|Other than listed|1
2470472|NCT02337764|8528523|P1|Overall Study|Lack of Efficacy|2
2470473|NCT02337764|8528523|P1|Overall Study|Voluntary Withdrawal|12
2470474|NCT02337764|8528523|P1|Overall Study|Pretreatment Event/Adverse Event|46
2470475|NCT02337751|8528536|P2|Overall Study|Investigator's Judgement|0
2470476|NCT02337751|8528537|P1|Overall Study|Investigator's Judgement|1
2470477|NCT02337751|8528536|P2|Overall Study|Lack of Efficacy|5
2470478|NCT02337751|8528537|P1|Overall Study|Lack of Efficacy|2
2470479|NCT02337751|8528536|P2|Overall Study|Voluntary Withdrawal|8
2470480|NCT02337751|8528537|P1|Overall Study|Voluntary Withdrawal|6
2470481|NCT02337751|8528536|P2|Overall Study|Pretreatment Event/Adverse Event|3
2470482|NCT02337751|8528537|P1|Overall Study|Pretreatment Event/Adverse Event|2
2470483|NCT02337738|8528556|P3|Overall Study|Investigator's Judgment|3
2470484|NCT02337738|8528557|P2|Overall Study|Investigator's Judgment|1
2470485|NCT02337738|8528558|P1|Overall Study|Investigator's Judgment|1
2470486|NCT02337738|8528556|P3|Overall Study|Lack of Efficacy|0
2470487|NCT02337738|8528557|P2|Overall Study|Lack of Efficacy|4
2470488|NCT02337738|8528558|P1|Overall Study|Lack of Efficacy|2
2470489|NCT02337738|8528556|P3|Overall Study|Voluntary Withdrawal|2
2470490|NCT02337738|8528557|P2|Overall Study|Voluntary Withdrawal|5
2470491|NCT02337738|8528558|P1|Overall Study|Voluntary Withdrawal|10
2470492|NCT02337738|8528556|P3|Overall Study|Major Protocol Deviation (in-Treatment)|0
2470493|NCT02337738|8528557|P2|Overall Study|Major Protocol Deviation (in-Treatment)|1
2470494|NCT02337738|8528558|P1|Overall Study|Major Protocol Deviation (in-Treatment)|0
2470495|NCT02337738|8528556|P3|Overall Study|Pretreatment Event/Adverse Event|21
2470496|NCT02337738|8528557|P2|Overall Study|Pretreatment Event/Adverse Event|18
2470497|NCT02337738|8528558|P1|Overall Study|Pretreatment Event/Adverse Event|9
2470498|NCT02337738|8528556|P3|Overall Study|Major Protocol Deviation (Pre-Treatment)|0
2470499|NCT02337738|8528557|P2|Overall Study|Major Protocol Deviation (Pre-Treatment)|1
2470500|NCT02337738|8528558|P1|Overall Study|Major Protocol Deviation (Pre-Treatment)|0
2470501|NCT02337725|8528598|P2|Overall Study|Lack of Efficacy|0
2470502|NCT02337725|8528599|P1|Overall Study|Lack of Efficacy|4
2470503|NCT02337725|8528598|P2|Overall Study|Voluntary Withdrawal|3
2470504|NCT02337725|8528599|P1|Overall Study|Voluntary Withdrawal|14
2470505|NCT02337725|8528598|P2|Overall Study|Major Protocol Deviation|1
2470506|NCT02337725|8528599|P1|Overall Study|Major Protocol Deviation|0
2470507|NCT02337725|8528598|P2|Overall Study|Pretreatment Event/AE in Treatment|3
2470508|NCT02337725|8528599|P1|Overall Study|Pretreatment Event/AE in Treatment|8
2470509|NCT02337725|8528598|P2|Overall Study|Pretreatment Event/AE before Treatment|1
2470510|NCT02337725|8528599|P1|Overall Study|Pretreatment Event/AE before Treatment|0
2470511|NCT02337491|8528623|P2|Overall Study|On Treatment|0
2470512|NCT02337491|8528624|P1|Overall Study|On Treatment|2
2470513|NCT02337491|8528623|P2|Overall Study|Progressive Disease|28
2470514|NCT02337491|8528624|P1|Overall Study|Progressive Disease|44
2470515|NCT02337491|8528623|P2|Overall Study|Withdrawal by Subject|0
2470516|NCT02337491|8528624|P1|Overall Study|Withdrawal by Subject|3
2470517|NCT02337491|8528623|P2|Overall Study|Adverse Event|1
2470518|NCT02337491|8528624|P1|Overall Study|Adverse Event|0
2470519|NCT02337491|8528623|P2|Overall Study|Death|1
2470520|NCT02337491|8528624|P1|Overall Study|Death|1
2470521|NCT02337478|8528638|P1|Overall Study|Lack of Efficacy|5
2470522|NCT02337387|8528648|P4|Overall Study|Sponsor Decision to Terminate Study|3
2470523|NCT02337387|8528649|P3|Overall Study|Sponsor Decision to Terminate Study|3
2470524|NCT02337387|8528650|P2|Overall Study|Sponsor Decision to Terminate Study|7
2470525|NCT02337387|8528651|P1|Overall Study|Sponsor Decision to Terminate Study|14
2470526|NCT02337387|8528648|P4|Overall Study|Adverse Event|0
2470527|NCT02337387|8528649|P3|Overall Study|Adverse Event|0
2470528|NCT02337387|8528650|P2|Overall Study|Adverse Event|1
2470529|NCT02337387|8528651|P1|Overall Study|Adverse Event|0
2470530|NCT02337361|8528669|P2|6-month Follow-up|Lost to Follow-up|4
2470531|NCT02337361|8528670|P1|6-month Follow-up|Lost to Follow-up|2
2470532|NCT02337361|8528669|P2|3-month Follow-up|Lost to Follow-up|14
2470533|NCT02337361|8528670|P1|3-month Follow-up|Lost to Follow-up|19
2470534|NCT02336607|8528732|P4|Overall Study|Withdrawal by Subject|20
2470535|NCT02336607|8528733|P3|Overall Study|Withdrawal by Subject|0
2470536|NCT02336607|8528734|P2|Overall Study|Withdrawal by Subject|2
2470537|NCT02336607|8528735|P1|Overall Study|Withdrawal by Subject|0
2470538|NCT02336607|8528732|P4|Overall Study|Adverse Event|26
2470539|NCT02336607|8528733|P3|Overall Study|Adverse Event|2
2470540|NCT02336607|8528734|P2|Overall Study|Adverse Event|2
2470541|NCT02336607|8528735|P1|Overall Study|Adverse Event|0
2470542|NCT02336607|8528732|P4|Overall Study|Protocol Violation|3
2470543|NCT02336607|8528733|P3|Overall Study|Protocol Violation|1
2470544|NCT02336607|8528734|P2|Overall Study|Protocol Violation|1
2470545|NCT02336607|8528735|P1|Overall Study|Protocol Violation|0
2470546|NCT02336607|8528732|P4|Overall Study|Lost to Follow-up|21
2470547|NCT02336607|8528733|P3|Overall Study|Lost to Follow-up|0
2470548|NCT02336607|8528734|P2|Overall Study|Lost to Follow-up|1
2470549|NCT02336607|8528735|P1|Overall Study|Lost to Follow-up|2
2470550|NCT02336607|8528732|P4|Overall Study|Lack of Efficacy|2
2470551|NCT02336607|8528733|P3|Overall Study|Lack of Efficacy|0
2470552|NCT02336607|8528734|P2|Overall Study|Lack of Efficacy|0
2470553|NCT02336607|8528735|P1|Overall Study|Lack of Efficacy|1
2470554|NCT02336607|8528732|P4|Overall Study|Physician Decision|15
2470555|NCT02336607|8528733|P3|Overall Study|Physician Decision|3
2470556|NCT02336607|8528734|P2|Overall Study|Physician Decision|4
2470557|NCT02336607|8528735|P1|Overall Study|Physician Decision|1
2470558|NCT02336555|8528838|P2|Treatment Period 2 (28 Days)|Adverse Event|1
2470559|NCT02336555|8528839|P1|Treatment Period 2 (28 Days)|Adverse Event|0
2470560|NCT02336555|8528838|P2|Treatment Period 1 (28 Days)|Physician Decision|0
2470561|NCT02336555|8528839|P1|Treatment Period 1 (28 Days)|Physician Decision|2
2470562|NCT02336555|8528838|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
2470563|NCT02336555|8528839|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2470564|NCT02336451|8528852|P5|Overall Study|Patient/guardian decision|1
2470565|NCT02336451|8528853|P4|Overall Study|Patient/guardian decision|2
2470566|NCT02336451|8528854|P3|Overall Study|Patient/guardian decision|0
2470567|NCT02336451|8528855|P2|Overall Study|Patient/guardian decision|4
2470568|NCT02336451|8528856|P1|Overall Study|Patient/guardian decision|2
2470569|NCT02336451|8528852|P5|Overall Study|Protocol Violation|0
2470570|NCT02336451|8528853|P4|Overall Study|Protocol Violation|0
2470571|NCT02336451|8528854|P3|Overall Study|Protocol Violation|0
2470572|NCT02336451|8528855|P2|Overall Study|Protocol Violation|0
2470573|NCT02336451|8528856|P1|Overall Study|Protocol Violation|1
2470574|NCT02336451|8528852|P5|Overall Study|Progressive disease|4
2470575|NCT02336451|8528853|P4|Overall Study|Progressive disease|14
2470576|NCT02336451|8528854|P3|Overall Study|Progressive disease|2
2470577|NCT02336451|8528855|P2|Overall Study|Progressive disease|26
2470578|NCT02336451|8528856|P1|Overall Study|Progressive disease|23
2470579|NCT02336451|8528852|P5|Overall Study|Physician Decision|3
2470580|NCT02336451|8528853|P4|Overall Study|Physician Decision|16
2470581|NCT02336451|8528854|P3|Overall Study|Physician Decision|7
2470582|NCT02336451|8528855|P2|Overall Study|Physician Decision|6
2470583|NCT02336451|8528856|P1|Overall Study|Physician Decision|9
2470584|NCT02336451|8528852|P5|Overall Study|Death|6
2470585|NCT02336451|8528853|P4|Overall Study|Death|6
2470586|NCT02336451|8528854|P3|Overall Study|Death|3
2470587|NCT02336451|8528855|P2|Overall Study|Death|2
2470588|NCT02336451|8528856|P1|Overall Study|Death|6
2470589|NCT02336451|8528852|P5|Overall Study|Adverse Event|4
2470590|NCT02336451|8528853|P4|Overall Study|Adverse Event|6
2470591|NCT02336451|8528854|P3|Overall Study|Adverse Event|0
2470592|NCT02336451|8528855|P2|Overall Study|Adverse Event|2
2470593|NCT02336451|8528856|P1|Overall Study|Adverse Event|1
2470594|NCT02336425|8529013|P4|Overall Study|Study terminated.|3
2470595|NCT02336425|8529014|P3|Overall Study|Study terminated.|3
2470596|NCT02336425|8529015|P2|Overall Study|Study terminated.|2
2470597|NCT02336425|8529016|P1|Overall Study|Study terminated.|2
2470598|NCT02336282|8529066|P1|Overall Study|Not enough time to complete sessions|2
2470599|NCT02336282|8529066|P1|Overall Study|Lost to Follow-up|1
2470600|NCT02336282|8529066|P1|Overall Study|Uncomfortable with technology|1
2470601|NCT02336282|8529066|P1|Overall Study|Unrelated illness|1
2470602|NCT02336178|8529090|P1|Overall Study|Other|1
2470603|NCT02336178|8529090|P1|Overall Study|Withdrawal by Subject|1
2470604|NCT02336178|8529090|P1|Overall Study|Protocol Violation|1
2470605|NCT02336178|8529090|P1|Overall Study|Lost to Follow-up|1
2470606|NCT02336165|8529181|P5|Overall Study|Other|0
2470607|NCT02336165|8529182|P4|Overall Study|Other|1
2470608|NCT02336165|8529183|P3|Overall Study|Other|0
2470609|NCT02336165|8529184|P2|Overall Study|Other|0
2470610|NCT02336165|8529185|P1|Overall Study|Other|1
2470611|NCT02336165|8529181|P5|Overall Study|Non-compliance|0
2470612|NCT02336165|8529182|P4|Overall Study|Non-compliance|1
2470613|NCT02336165|8529183|P3|Overall Study|Non-compliance|0
2470614|NCT02336165|8529184|P2|Overall Study|Non-compliance|0
2470615|NCT02336165|8529185|P1|Overall Study|Non-compliance|1
2470616|NCT02336165|8529181|P5|Overall Study|Progressive disease|19
2470617|NCT02336165|8529182|P4|Overall Study|Progressive disease|24
2470618|NCT02336165|8529183|P3|Overall Study|Progressive disease|27
2470619|NCT02336165|8529184|P2|Overall Study|Progressive disease|22
2470620|NCT02336165|8529185|P1|Overall Study|Progressive disease|23
2470621|NCT02336165|8529181|P5|Overall Study|Adverse Event|1
2470622|NCT02336165|8529182|P4|Overall Study|Adverse Event|4
2470623|NCT02336165|8529183|P3|Overall Study|Adverse Event|2
2470624|NCT02336165|8529184|P2|Overall Study|Adverse Event|1
2470625|NCT02336165|8529185|P1|Overall Study|Adverse Event|4
2470626|NCT02336165|8529181|P5|Overall Study|Withdrawal by Subject|1
2470627|NCT02336165|8529182|P4|Overall Study|Withdrawal by Subject|0
2470628|NCT02336165|8529183|P3|Overall Study|Withdrawal by Subject|1
2470629|NCT02336165|8529184|P2|Overall Study|Withdrawal by Subject|0
2470630|NCT02336165|8529185|P1|Overall Study|Withdrawal by Subject|0
2470631|NCT02336165|8529181|P5|Overall Study|Physician Decision|0
2470632|NCT02336165|8529182|P4|Overall Study|Physician Decision|1
2470633|NCT02336165|8529183|P3|Overall Study|Physician Decision|1
2470634|NCT02336165|8529184|P2|Overall Study|Physician Decision|2
2470635|NCT02336165|8529185|P1|Overall Study|Physician Decision|2
2470636|NCT02336165|8529181|P5|Overall Study|Death|1
2470637|NCT02336165|8529182|P4|Overall Study|Death|0
2470638|NCT02336165|8529183|P3|Overall Study|Death|0
2470639|NCT02336165|8529184|P2|Overall Study|Death|0
2470640|NCT02336165|8529185|P1|Overall Study|Death|3
2470641|NCT02336074|8529219|P2|Overall Study|Adverse Event|2
2470642|NCT02336074|8529220|P1|Overall Study|Adverse Event|0
2470643|NCT02335489|8529265|P1|Overall Study|Lack of Efficacy|1
2470644|NCT02335489|8529265|P1|Overall Study|Physician Decision|2
2470645|NCT02335489|8529265|P1|Overall Study|Withdrawal by Subject|2
2470646|NCT02335489|8529265|P1|Overall Study|Lost to Follow-up|1
2470647|NCT02335489|8529265|P1|Overall Study|Sponsor terminated study|4
2470648|NCT02335424|8529269|P1|Overall Study|Not treated|4
2470649|NCT02335424|8529269|P1|Overall Study|Physician Decision|3
2470650|NCT02335424|8529269|P1|Overall Study|Lost to Follow-up|2
2470651|NCT02335424|8529269|P1|Overall Study|Death|239
2470652|NCT02335424|8529269|P1|Overall Study|Adverse Event|25
2470653|NCT02335424|8529269|P1|Overall Study|Ongoing In Study|89
2470654|NCT02335424|8529269|P1|Overall Study|Withdrawal by Subject|12
2470655|NCT02335346|8529302|P1|Overall Study|Withdrawal by Subject|1
2470656|NCT02335346|8529302|P1|Overall Study|Adverse Event|11
2470657|NCT02334423|8529602|P2|Overall Study|Protocol Violation|3
2470658|NCT02334423|8529603|P1|Overall Study|Protocol Violation|10
2470659|NCT02334384|8529617|P2|Overall Study|Lost to Follow-up|1
2470660|NCT02334384|8529618|P1|Overall Study|Lost to Follow-up|1
2470661|NCT02334306|8529630|P2|Double-blind Period|Withdrawal by Subject|1
2470662|NCT02334306|8529631|P1|Double-blind Period|Withdrawal by Subject|1
2470663|NCT02334306|8529630|P2|Double-blind Period|Adverse Event|1
2470664|NCT02334306|8529631|P1|Double-blind Period|Adverse Event|0
2470665|NCT02333630|8529687|P2|Overall Study|Lost to Follow-up|2
2470666|NCT02333630|8529688|P1|Overall Study|Lost to Follow-up|5
2470667|NCT02333383|8529700|P1|Overall Study|Transfer to another hospital|2
2470668|NCT02333383|8529700|P1|Overall Study|Withdrawal by Subject|3
2470669|NCT02333383|8529700|P1|Overall Study|Lost to Follow-up|15
2470670|NCT02333383|8529700|P1|Overall Study|Adalimumab discontinuation|21
2470671|NCT02333331|8529714|P4|Overall Study|Patient/Guardian Decision|1
2470672|NCT02333331|8529715|P3|Overall Study|Patient/Guardian Decision|9
2470673|NCT02333331|8529716|P2|Overall Study|Patient/Guardian Decision|2
2470674|NCT02333331|8529717|P1|Overall Study|Patient/Guardian Decision|1
2470675|NCT02333331|8529714|P4|Overall Study|Protocol Deviation|1
2470676|NCT02333331|8529715|P3|Overall Study|Protocol Deviation|2
2470677|NCT02333331|8529716|P2|Overall Study|Protocol Deviation|3
2470678|NCT02333331|8529717|P1|Overall Study|Protocol Deviation|0
2470679|NCT02333331|8529714|P4|Overall Study|Physician Decision|0
2470680|NCT02333331|8529715|P3|Overall Study|Physician Decision|0
2470681|NCT02333331|8529716|P2|Overall Study|Physician Decision|1
2470682|NCT02333331|8529717|P1|Overall Study|Physician Decision|0
2470683|NCT02333331|8529714|P4|Overall Study|Lost to Follow-up|0
2470684|NCT02333331|8529715|P3|Overall Study|Lost to Follow-up|1
2470685|NCT02333331|8529716|P2|Overall Study|Lost to Follow-up|0
2470686|NCT02333331|8529717|P1|Overall Study|Lost to Follow-up|0
2470687|NCT02333331|8529714|P4|Overall Study|Death|0
2470688|NCT02333331|8529715|P3|Overall Study|Death|2
2470689|NCT02333331|8529716|P2|Overall Study|Death|0
2470690|NCT02333331|8529717|P1|Overall Study|Death|0
2470691|NCT02333331|8529714|P4|Overall Study|Adverse Event|1
2470692|NCT02333331|8529715|P3|Overall Study|Adverse Event|4
2470693|NCT02333331|8529716|P2|Overall Study|Adverse Event|0
2470694|NCT02333331|8529717|P1|Overall Study|Adverse Event|1
2470695|NCT02332889|8529761|P1|Overall Study|Physician Decision|1
2470696|NCT02332876|8529767|P2|Overall Study|Lost to Follow-up|1
2470697|NCT02332876|8529768|P1|Overall Study|Lost to Follow-up|1
2470698|NCT02332824|8529780|P6|Overall Study|Transfer|0
2470699|NCT02332824|8529781|P5|Overall Study|Transfer|0
2470700|NCT02332824|8529782|P4|Overall Study|Transfer|1
2470701|NCT02332824|8529783|P3|Overall Study|Transfer|1
2470702|NCT02332824|8529784|P2|Overall Study|Transfer|0
2470703|NCT02332824|8529785|P1|Overall Study|Transfer|0
2470704|NCT02332824|8529780|P6|Overall Study|Inconvenient schedule|0
2470705|NCT02332824|8529781|P5|Overall Study|Inconvenient schedule|0
2470706|NCT02332824|8529782|P4|Overall Study|Inconvenient schedule|0
2470707|NCT02332824|8529783|P3|Overall Study|Inconvenient schedule|0
2470708|NCT02332824|8529784|P2|Overall Study|Inconvenient schedule|1
2470709|NCT02332824|8529785|P1|Overall Study|Inconvenient schedule|1
2470710|NCT02332824|8529780|P6|Overall Study|Voluntary Withdrawal|0
2470711|NCT02332824|8529781|P5|Overall Study|Voluntary Withdrawal|0
2470712|NCT02332824|8529782|P4|Overall Study|Voluntary Withdrawal|0
2470713|NCT02332824|8529783|P3|Overall Study|Voluntary Withdrawal|0
2470714|NCT02332824|8529784|P2|Overall Study|Voluntary Withdrawal|0
2470715|NCT02332824|8529785|P1|Overall Study|Voluntary Withdrawal|1
2470716|NCT02332824|8529780|P6|Overall Study|Pretreatment Event/Adverse Event|1
2470717|NCT02332824|8529781|P5|Overall Study|Pretreatment Event/Adverse Event|4
2470718|NCT02332824|8529782|P4|Overall Study|Pretreatment Event/Adverse Event|1
2470719|NCT02332824|8529783|P3|Overall Study|Pretreatment Event/Adverse Event|1
2470720|NCT02332824|8529784|P2|Overall Study|Pretreatment Event/Adverse Event|0
2470721|NCT02332824|8529785|P1|Overall Study|Pretreatment Event/Adverse Event|4
2470722|NCT02332798|8529826|P3|Overall Study|Abnormal Laboratory Findings|0
2470723|NCT02332798|8529827|P2|Overall Study|Abnormal Laboratory Findings|0
2470724|NCT02332798|8529828|P1|Overall Study|Abnormal Laboratory Findings|1
2470725|NCT02332798|8529826|P3|Overall Study|Positive Urine Drug Test|0
2470726|NCT02332798|8529827|P2|Overall Study|Positive Urine Drug Test|1
2470727|NCT02332798|8529828|P1|Overall Study|Positive Urine Drug Test|0
2470728|NCT02332798|8529826|P3|Overall Study|Unwilling to Participate in Study|1
2470729|NCT02332798|8529827|P2|Overall Study|Unwilling to Participate in Study|1
2470730|NCT02332798|8529828|P1|Overall Study|Unwilling to Participate in Study|0
2470731|NCT02332720|8529901|P23|Part A and Part B|Withdrawal by Subject|0
2470732|NCT02332720|8529902|P22|Part A and Part B|Withdrawal by Subject|0
2470733|NCT02332720|8529903|P21|Part A and Part B|Withdrawal by Subject|0
2470734|NCT02332720|8529904|P20|Part A and Part B|Withdrawal by Subject|1
2470735|NCT02332720|8529905|P19|Part A and Part B|Withdrawal by Subject|0
2470736|NCT02332720|8529906|P18|Part A and Part B|Withdrawal by Subject|0
2470737|NCT02332720|8529907|P17|Part A and Part B|Withdrawal by Subject|0
2470738|NCT02332720|8529908|P16|Part A and Part B|Withdrawal by Subject|0
2470739|NCT02332720|8529909|P15|Part A and Part B|Withdrawal by Subject|0
2470740|NCT02332720|8529910|P14|Part A and Part B|Withdrawal by Subject|0
2470741|NCT02332720|8529911|P13|Part A and Part B|Withdrawal by Subject|0
2470742|NCT02332720|8529912|P12|Part A and Part B|Withdrawal by Subject|0
2470743|NCT02332720|8529913|P11|Part A and Part B|Withdrawal by Subject|0
2470744|NCT02332720|8529914|P10|Part A and Part B|Withdrawal by Subject|0
2470745|NCT02332720|8529915|P9|Part A and Part B|Withdrawal by Subject|0
2470746|NCT02332720|8529916|P8|Part A and Part B|Withdrawal by Subject|0
2470747|NCT02332720|8529917|P7|Part A and Part B|Withdrawal by Subject|0
2470748|NCT02332720|8529918|P6|Part A and Part B|Withdrawal by Subject|1
2470749|NCT02332720|8529919|P5|Part A and Part B|Withdrawal by Subject|0
2470750|NCT02332720|8529920|P4|Part A and Part B|Withdrawal by Subject|0
2470751|NCT02332720|8529921|P3|Part A and Part B|Withdrawal by Subject|0
2470752|NCT02332720|8529922|P2|Part A and Part B|Withdrawal by Subject|0
2470753|NCT02332720|8529923|P1|Part A and Part B|Withdrawal by Subject|0
2470754|NCT02332720|8529901|P23|Part A and Part B|Physician Decision|0
2470755|NCT02332720|8529902|P22|Part A and Part B|Physician Decision|0
2470756|NCT02332720|8529903|P21|Part A and Part B|Physician Decision|0
2470757|NCT02332720|8529904|P20|Part A and Part B|Physician Decision|0
2470758|NCT02332720|8529905|P19|Part A and Part B|Physician Decision|1
2470759|NCT02332720|8529906|P18|Part A and Part B|Physician Decision|0
2470760|NCT02332720|8529907|P17|Part A and Part B|Physician Decision|0
2470761|NCT02332720|8529908|P16|Part A and Part B|Physician Decision|0
2470762|NCT02332720|8529909|P15|Part A and Part B|Physician Decision|0
2470763|NCT02332720|8529910|P14|Part A and Part B|Physician Decision|0
2470764|NCT02332720|8529911|P13|Part A and Part B|Physician Decision|0
2470765|NCT02332720|8529912|P12|Part A and Part B|Physician Decision|0
2470766|NCT02332720|8529913|P11|Part A and Part B|Physician Decision|0
2470767|NCT02332720|8529914|P10|Part A and Part B|Physician Decision|0
2470768|NCT02332720|8529915|P9|Part A and Part B|Physician Decision|0
2470769|NCT02332720|8529916|P8|Part A and Part B|Physician Decision|0
2470770|NCT02332720|8529917|P7|Part A and Part B|Physician Decision|0
2470771|NCT02332720|8529918|P6|Part A and Part B|Physician Decision|0
2470772|NCT02332720|8529919|P5|Part A and Part B|Physician Decision|0
2470773|NCT02332720|8529920|P4|Part A and Part B|Physician Decision|0
2470774|NCT02332720|8529921|P3|Part A and Part B|Physician Decision|0
2470775|NCT02332720|8529922|P2|Part A and Part B|Physician Decision|0
2470776|NCT02332720|8529923|P1|Part A and Part B|Physician Decision|0
2470777|NCT02332720|8529901|P23|Part A and Part B|Adverse Event|0
2470778|NCT02332720|8529902|P22|Part A and Part B|Adverse Event|0
2470779|NCT02332720|8529903|P21|Part A and Part B|Adverse Event|0
2470780|NCT02332720|8529904|P20|Part A and Part B|Adverse Event|0
2470781|NCT02332720|8529905|P19|Part A and Part B|Adverse Event|0
2470782|NCT02332720|8529906|P18|Part A and Part B|Adverse Event|1
2470783|NCT02332720|8529907|P17|Part A and Part B|Adverse Event|0
2470784|NCT02332720|8529908|P16|Part A and Part B|Adverse Event|0
2470785|NCT02332720|8529909|P15|Part A and Part B|Adverse Event|0
2470786|NCT02332720|8529910|P14|Part A and Part B|Adverse Event|0
2470787|NCT02332720|8529911|P13|Part A and Part B|Adverse Event|0
2470788|NCT02332720|8529912|P12|Part A and Part B|Adverse Event|0
2470789|NCT02332720|8529913|P11|Part A and Part B|Adverse Event|0
2470790|NCT02332720|8529914|P10|Part A and Part B|Adverse Event|0
2470791|NCT02332720|8529915|P9|Part A and Part B|Adverse Event|0
2470792|NCT02332720|8529916|P8|Part A and Part B|Adverse Event|0
2470793|NCT02332720|8529917|P7|Part A and Part B|Adverse Event|0
2470794|NCT02332720|8529918|P6|Part A and Part B|Adverse Event|0
2470795|NCT02332720|8529919|P5|Part A and Part B|Adverse Event|0
2470796|NCT02332720|8529920|P4|Part A and Part B|Adverse Event|0
2470797|NCT02332720|8529921|P3|Part A and Part B|Adverse Event|0
2470798|NCT02332720|8529922|P2|Part A and Part B|Adverse Event|0
2470799|NCT02332720|8529923|P1|Part A and Part B|Adverse Event|0
2470800|NCT02332720|8529901|P23|Part A and Part B|Lost to Follow-up|0
2470801|NCT02332720|8529902|P22|Part A and Part B|Lost to Follow-up|0
2470802|NCT02332720|8529903|P21|Part A and Part B|Lost to Follow-up|0
2470803|NCT02332720|8529904|P20|Part A and Part B|Lost to Follow-up|0
2470804|NCT02332720|8529905|P19|Part A and Part B|Lost to Follow-up|0
2470805|NCT02332720|8529906|P18|Part A and Part B|Lost to Follow-up|0
2470806|NCT02332720|8529907|P17|Part A and Part B|Lost to Follow-up|0
2470807|NCT02332720|8529908|P16|Part A and Part B|Lost to Follow-up|1
2470808|NCT02332720|8529909|P15|Part A and Part B|Lost to Follow-up|0
2470809|NCT02332720|8529910|P14|Part A and Part B|Lost to Follow-up|0
2470810|NCT02332720|8529911|P13|Part A and Part B|Lost to Follow-up|0
2470811|NCT02332720|8529912|P12|Part A and Part B|Lost to Follow-up|0
2470812|NCT02332720|8529913|P11|Part A and Part B|Lost to Follow-up|0
2470813|NCT02332720|8529914|P10|Part A and Part B|Lost to Follow-up|0
2470814|NCT02332720|8529915|P9|Part A and Part B|Lost to Follow-up|0
2470815|NCT02332720|8529916|P8|Part A and Part B|Lost to Follow-up|1
2470816|NCT02332720|8529917|P7|Part A and Part B|Lost to Follow-up|1
2470817|NCT02332720|8529918|P6|Part A and Part B|Lost to Follow-up|2
2470818|NCT02332720|8529919|P5|Part A and Part B|Lost to Follow-up|0
2470819|NCT02332720|8529920|P4|Part A and Part B|Lost to Follow-up|0
2470820|NCT02332720|8529921|P3|Part A and Part B|Lost to Follow-up|0
2470821|NCT02332720|8529922|P2|Part A and Part B|Lost to Follow-up|0
2470822|NCT02332720|8529923|P1|Part A and Part B|Lost to Follow-up|1
2470823|NCT02332707|8530059|P18|Overall Study|Withdrawal by Subject|0
2470824|NCT02332707|8530060|P17|Overall Study|Withdrawal by Subject|0
2470825|NCT02332707|8530061|P16|Overall Study|Withdrawal by Subject|0
2470826|NCT02332707|8530062|P15|Overall Study|Withdrawal by Subject|0
2470827|NCT02332707|8530063|P14|Overall Study|Withdrawal by Subject|0
2470828|NCT02332707|8530064|P13|Overall Study|Withdrawal by Subject|0
2470829|NCT02332707|8530065|P12|Overall Study|Withdrawal by Subject|0
2470830|NCT02332707|8530066|P11|Overall Study|Withdrawal by Subject|0
2470831|NCT02332707|8530067|P10|Overall Study|Withdrawal by Subject|3
2470832|NCT02332707|8530068|P9|Overall Study|Withdrawal by Subject|0
2470833|NCT02332707|8530069|P8|Overall Study|Withdrawal by Subject|0
2470834|NCT02332707|8530070|P7|Overall Study|Withdrawal by Subject|0
2470835|NCT02332707|8530071|P6|Overall Study|Withdrawal by Subject|0
2470836|NCT02332707|8530072|P5|Overall Study|Withdrawal by Subject|0
2470837|NCT02332707|8530073|P4|Overall Study|Withdrawal by Subject|0
2470838|NCT02332707|8530074|P3|Overall Study|Withdrawal by Subject|1
2470839|NCT02332707|8530075|P2|Overall Study|Withdrawal by Subject|0
2470840|NCT02332707|8530076|P1|Overall Study|Withdrawal by Subject|0
2470841|NCT02332707|8530059|P18|Overall Study|Physician Decision|0
2470842|NCT02332707|8530060|P17|Overall Study|Physician Decision|0
2470843|NCT02332707|8530061|P16|Overall Study|Physician Decision|0
2470844|NCT02332707|8530062|P15|Overall Study|Physician Decision|0
2470845|NCT02332707|8530063|P14|Overall Study|Physician Decision|0
2470846|NCT02332707|8530064|P13|Overall Study|Physician Decision|1
2470847|NCT02332707|8530065|P12|Overall Study|Physician Decision|0
2470848|NCT02332707|8530066|P11|Overall Study|Physician Decision|0
2470849|NCT02332707|8530067|P10|Overall Study|Physician Decision|0
2470850|NCT02332707|8530068|P9|Overall Study|Physician Decision|0
2470851|NCT02332707|8530069|P8|Overall Study|Physician Decision|0
2470852|NCT02332707|8530070|P7|Overall Study|Physician Decision|0
2470853|NCT02332707|8530071|P6|Overall Study|Physician Decision|0
2470854|NCT02332707|8530072|P5|Overall Study|Physician Decision|0
2470855|NCT02332707|8530073|P4|Overall Study|Physician Decision|1
2470856|NCT02332707|8530074|P3|Overall Study|Physician Decision|0
2470857|NCT02332707|8530075|P2|Overall Study|Physician Decision|0
2470858|NCT02332707|8530076|P1|Overall Study|Physician Decision|0
2470859|NCT02332707|8530059|P18|Overall Study|Lost to Follow-up|0
2470860|NCT02332707|8530060|P17|Overall Study|Lost to Follow-up|0
2470861|NCT02332707|8530061|P16|Overall Study|Lost to Follow-up|0
2470862|NCT02332707|8530062|P15|Overall Study|Lost to Follow-up|0
2470863|NCT02332707|8530063|P14|Overall Study|Lost to Follow-up|0
2470864|NCT02332707|8530064|P13|Overall Study|Lost to Follow-up|3
2470865|NCT02332707|8530065|P12|Overall Study|Lost to Follow-up|0
2470866|NCT02332707|8530066|P11|Overall Study|Lost to Follow-up|2
2470867|NCT02332707|8530067|P10|Overall Study|Lost to Follow-up|0
2470868|NCT02332707|8530068|P9|Overall Study|Lost to Follow-up|0
2470869|NCT02332707|8530069|P8|Overall Study|Lost to Follow-up|0
2470870|NCT02332707|8530070|P7|Overall Study|Lost to Follow-up|0
2470871|NCT02332707|8530071|P6|Overall Study|Lost to Follow-up|1
2470872|NCT02332707|8530072|P5|Overall Study|Lost to Follow-up|0
2470873|NCT02332707|8530073|P4|Overall Study|Lost to Follow-up|0
2470874|NCT02332707|8530074|P3|Overall Study|Lost to Follow-up|0
2470875|NCT02332707|8530075|P2|Overall Study|Lost to Follow-up|0
2470876|NCT02332707|8530076|P1|Overall Study|Lost to Follow-up|0
2470877|NCT02332707|8530059|P18|Overall Study|Adverse Event|0
2470878|NCT02332707|8530060|P17|Overall Study|Adverse Event|0
2470879|NCT02332707|8530061|P16|Overall Study|Adverse Event|0
2470880|NCT02332707|8530062|P15|Overall Study|Adverse Event|0
2470881|NCT02332707|8530063|P14|Overall Study|Adverse Event|0
2470882|NCT02332707|8530064|P13|Overall Study|Adverse Event|1
2470883|NCT02332707|8530065|P12|Overall Study|Adverse Event|0
2470884|NCT02332707|8530066|P11|Overall Study|Adverse Event|0
2470885|NCT02332707|8530067|P10|Overall Study|Adverse Event|0
2470886|NCT02332707|8530068|P9|Overall Study|Adverse Event|0
2470887|NCT02332707|8530069|P8|Overall Study|Adverse Event|0
2470888|NCT02332707|8530070|P7|Overall Study|Adverse Event|0
2470889|NCT02332707|8530071|P6|Overall Study|Adverse Event|0
2470890|NCT02332707|8530072|P5|Overall Study|Adverse Event|0
2470891|NCT02332707|8530073|P4|Overall Study|Adverse Event|0
2470892|NCT02332707|8530074|P3|Overall Study|Adverse Event|0
2470893|NCT02332707|8530075|P2|Overall Study|Adverse Event|0
2470894|NCT02332707|8530076|P1|Overall Study|Adverse Event|0
2470895|NCT02332590|8530170|P2|Overall Study|Other than specified above|5
2470896|NCT02332590|8530171|P1|Overall Study|Other than specified above|6
2470897|NCT02332590|8530170|P2|Overall Study|Randomized but not treated|0
2470898|NCT02332590|8530171|P1|Overall Study|Randomized but not treated|1
2470899|NCT02332590|8530170|P2|Overall Study|Poor compliance to protocol|1
2470900|NCT02332590|8530171|P1|Overall Study|Poor compliance to protocol|3
2470901|NCT02332590|8530170|P2|Overall Study|Lack of Efficacy|2
2470902|NCT02332590|8530171|P1|Overall Study|Lack of Efficacy|4
2470903|NCT02332590|8530170|P2|Overall Study|Adverse Event|11
2470904|NCT02332590|8530171|P1|Overall Study|Adverse Event|15
2470905|NCT02332239|8530235|P2|Overall Study|Lost to Follow-up|6
2470906|NCT02332239|8530236|P1|Overall Study|Lost to Follow-up|4
2470907|NCT02331680|8530272|P3|Overall Study|Protocol Violation|3
2470908|NCT02331680|8530273|P2|Overall Study|Protocol Violation|0
2470909|NCT02331680|8530274|P1|Overall Study|Protocol Violation|0
2470910|NCT02331680|8530272|P3|Overall Study|Non-compliance with study drug|1
2470911|NCT02331680|8530273|P2|Overall Study|Non-compliance with study drug|0
2470912|NCT02331680|8530274|P1|Overall Study|Non-compliance with study drug|0
2470913|NCT02331680|8530272|P3|Overall Study|Met withdrawal criteria|5
2470914|NCT02331680|8530273|P2|Overall Study|Met withdrawal criteria|2
2470915|NCT02331680|8530274|P1|Overall Study|Met withdrawal criteria|2
2470916|NCT02331680|8530272|P3|Overall Study|Withdrawal by Subject|2
2470917|NCT02331680|8530273|P2|Overall Study|Withdrawal by Subject|1
2470918|NCT02331680|8530274|P1|Overall Study|Withdrawal by Subject|0
2470919|NCT02331680|8530272|P3|Overall Study|Physician Decision|2
2470920|NCT02331680|8530273|P2|Overall Study|Physician Decision|1
2470921|NCT02331680|8530274|P1|Overall Study|Physician Decision|1
2470922|NCT02331680|8530272|P3|Overall Study|Adverse Event|2
2470923|NCT02331680|8530273|P2|Overall Study|Adverse Event|0
2470924|NCT02331680|8530274|P1|Overall Study|Adverse Event|3
2470925|NCT02331446|8530304|P4|Overall Study|Lost before baseline analysis|0
2470926|NCT02331446|8530305|P3|Overall Study|Lost before baseline analysis|1
2470927|NCT02331446|8530306|P2|Overall Study|Lost before baseline analysis|1
2470928|NCT02331446|8530307|P1|Overall Study|Lost before baseline analysis|0
2470929|NCT02331446|8530304|P4|Overall Study|Physician Decision|1
2470930|NCT02331446|8530305|P3|Overall Study|Physician Decision|0
2470931|NCT02331446|8530306|P2|Overall Study|Physician Decision|1
2470932|NCT02331446|8530307|P1|Overall Study|Physician Decision|0
2470933|NCT02331446|8530304|P4|Overall Study|Disease|1
2470934|NCT02331446|8530305|P3|Overall Study|Disease|2
2470935|NCT02331446|8530306|P2|Overall Study|Disease|2
2470936|NCT02331446|8530307|P1|Overall Study|Disease|0
2470937|NCT02331446|8530304|P4|Overall Study|Personal Problem|0
2470938|NCT02331446|8530305|P3|Overall Study|Personal Problem|0
2470939|NCT02331446|8530306|P2|Overall Study|Personal Problem|0
2470940|NCT02331446|8530307|P1|Overall Study|Personal Problem|2
2470941|NCT02331446|8530304|P4|Overall Study|Lost to Follow-up|1
2470942|NCT02331446|8530305|P3|Overall Study|Lost to Follow-up|0
2470943|NCT02331446|8530306|P2|Overall Study|Lost to Follow-up|1
2470944|NCT02331446|8530307|P1|Overall Study|Lost to Follow-up|2
2470945|NCT02331368|8530383|P1|Overall Study|Withdrawal by Subject|3
2470946|NCT02330549|8530479|P2|Overall Study|Failure to meet randomization criteria|0
2470947|NCT02330549|8530480|P1|Overall Study|Failure to meet randomization criteria|1
2470948|NCT02330549|8530479|P2|Overall Study|Subject withdrew consent|1
2470949|NCT02330549|8530480|P1|Overall Study|Subject withdrew consent|2
2470950|NCT02330549|8530479|P2|Overall Study|Adverse Event|0
2470951|NCT02330549|8530480|P1|Overall Study|Adverse Event|1
2470952|NCT02330081|8530655|P1|Overall Study|Protocol Violation|6
2470953|NCT02330081|8530655|P1|Overall Study|Donation did not meet criteria|1
2470954|NCT02330081|8530655|P1|Overall Study|Adverse Event|1
2470955|NCT02330055|8530676|P2|Overall Study|participant did not sleep|1
2470956|NCT02330055|8530677|P1|Overall Study|participant did not sleep|0
2470957|NCT02330055|8530676|P2|Overall Study|data for less than 60 minutes|3
2470958|NCT02330055|8530677|P1|Overall Study|data for less than 60 minutes|3
2470959|NCT02330055|8530676|P2|Overall Study|participant forgot to wear device|5
2470960|NCT02330055|8530677|P1|Overall Study|participant forgot to wear device|5
2470961|NCT02330055|8530676|P2|Overall Study|technical issues|0
2470962|NCT02330055|8530677|P1|Overall Study|technical issues|2
2470963|NCT02329743|8530723|P3|Overall Study|Other|3
2470964|NCT02329743|8530724|P2|Overall Study|Other|2
2470965|NCT02329743|8530725|P1|Overall Study|Other|0
2470966|NCT02329743|8530723|P3|Overall Study|Withdrawal by Subject|1
2470967|NCT02329743|8530724|P2|Overall Study|Withdrawal by Subject|4
2470968|NCT02329743|8530725|P1|Overall Study|Withdrawal by Subject|4
2470969|NCT02329743|8530723|P3|Overall Study|Lost to Follow-up|1
2470970|NCT02329743|8530724|P2|Overall Study|Lost to Follow-up|0
2470971|NCT02329743|8530725|P1|Overall Study|Lost to Follow-up|1
2470972|NCT02329743|8530723|P3|Overall Study|Adverse Event|3
2470973|NCT02329743|8530724|P2|Overall Study|Adverse Event|1
2470974|NCT02329743|8530725|P1|Overall Study|Adverse Event|1
2470975|NCT02329730|8530740|P12|Overall Study|Withdrawal by Subject|0
2470976|NCT02329730|8530741|P11|Overall Study|Withdrawal by Subject|0
2470977|NCT02329730|8530742|P10|Overall Study|Withdrawal by Subject|1
2470978|NCT02329730|8530743|P9|Overall Study|Withdrawal by Subject|1
2470979|NCT02329730|8530744|P8|Overall Study|Withdrawal by Subject|1
2470980|NCT02329730|8530745|P7|Overall Study|Withdrawal by Subject|1
2470981|NCT02329730|8530746|P6|Overall Study|Withdrawal by Subject|0
2470982|NCT02329730|8530747|P5|Overall Study|Withdrawal by Subject|1
2470983|NCT02329730|8530748|P4|Overall Study|Withdrawal by Subject|0
2470984|NCT02329730|8530749|P3|Overall Study|Withdrawal by Subject|0
2470985|NCT02329730|8530750|P2|Overall Study|Withdrawal by Subject|0
2470986|NCT02329730|8530751|P1|Overall Study|Withdrawal by Subject|0
2470987|NCT02329730|8530740|P12|Overall Study|Protocol Violation|0
2470988|NCT02329730|8530741|P11|Overall Study|Protocol Violation|0
2470989|NCT02329730|8530742|P10|Overall Study|Protocol Violation|0
2470990|NCT02329730|8530743|P9|Overall Study|Protocol Violation|0
2470991|NCT02329730|8530744|P8|Overall Study|Protocol Violation|0
2470992|NCT02329730|8530745|P7|Overall Study|Protocol Violation|0
2470993|NCT02329730|8530746|P6|Overall Study|Protocol Violation|2
2470994|NCT02329730|8530747|P5|Overall Study|Protocol Violation|2
2470995|NCT02329730|8530748|P4|Overall Study|Protocol Violation|0
2470996|NCT02329730|8530749|P3|Overall Study|Protocol Violation|0
2470997|NCT02329730|8530750|P2|Overall Study|Protocol Violation|0
2470998|NCT02329730|8530751|P1|Overall Study|Protocol Violation|0
2470999|NCT02329431|8530862|P2|Overall Study|Lost to Follow-up|13
2471000|NCT02329431|8530863|P1|Overall Study|Lost to Follow-up|20
2471001|NCT02329223|8530882|P3|Overall Study|Adverse Event|0
2471002|NCT02329223|8530883|P2|Overall Study|Adverse Event|1
2471003|NCT02329223|8530884|P1|Overall Study|Adverse Event|0
2471004|NCT02329223|8530882|P3|Overall Study|Physician Decision|1
2471005|NCT02329223|8530883|P2|Overall Study|Physician Decision|0
2471006|NCT02329223|8530884|P1|Overall Study|Physician Decision|0
2471007|NCT02329223|8530882|P3|Overall Study|Withdrawal by Subject|5
2471008|NCT02329223|8530883|P2|Overall Study|Withdrawal by Subject|2
2471009|NCT02329223|8530884|P1|Overall Study|Withdrawal by Subject|1
2471010|NCT02328937|8530934|P6|Period 2|Adverse Event|0
2471011|NCT02328937|8530935|P5|Period 2|Adverse Event|0
2471012|NCT02328937|8530936|P4|Period 2|Adverse Event|0
2471013|NCT02328937|8530937|P3|Period 2|Adverse Event|1
2471014|NCT02328937|8530938|P2|Period 2|Adverse Event|0
2471015|NCT02328937|8530939|P1|Period 2|Adverse Event|0
2471016|NCT02328937|8530934|P6|Period 1|Lost to Follow-up|0
2471017|NCT02328937|8530935|P5|Period 1|Lost to Follow-up|0
2471018|NCT02328937|8530936|P4|Period 1|Lost to Follow-up|1
2471019|NCT02328937|8530937|P3|Period 1|Lost to Follow-up|0
2471020|NCT02328937|8530938|P2|Period 1|Lost to Follow-up|0
2471021|NCT02328937|8530939|P1|Period 1|Lost to Follow-up|0
2471022|NCT02328547|8530959|P2|First Intervention (12 Weeks)|Withdrawal by Subject|0
2471023|NCT02328547|8530960|P1|First Intervention (12 Weeks)|Withdrawal by Subject|2
2471024|NCT02328547|8530959|P2|First Intervention (12 Weeks)|Lost to Follow-up|0
2471025|NCT02328547|8530960|P1|First Intervention (12 Weeks)|Lost to Follow-up|1
2471026|NCT02328105|8531035|P1|Overall Study|Still On Study in Follow-Up|4
2471027|NCT02328105|8531035|P1|Overall Study|Withdrawal by Subject|1
2471028|NCT02328105|8531035|P1|Overall Study|Death|6
2471029|NCT02328040|8531040|P2|First Intervention (2 Days)|Withdrawal by Subject|1
2471030|NCT02328040|8531041|P1|First Intervention (2 Days)|Withdrawal by Subject|1
2471031|NCT02327325|8531093|P3|Overall Study|Excluded by Study Team|1
2471032|NCT02327325|8531094|P2|Overall Study|Excluded by Study Team|0
2471033|NCT02327325|8531095|P1|Overall Study|Excluded by Study Team|0
2471034|NCT02327325|8531093|P3|Overall Study|Withdrawal by Subject|4
2471035|NCT02327325|8531094|P2|Overall Study|Withdrawal by Subject|4
2471036|NCT02327325|8531095|P1|Overall Study|Withdrawal by Subject|1
2471037|NCT02327260|8531118|P3|Overall Study|cognitive concerns|0
2471038|NCT02327260|8531119|P2|Overall Study|cognitive concerns|0
2471039|NCT02327260|8531120|P1|Overall Study|cognitive concerns|1
2471040|NCT02327260|8531118|P3|Overall Study|non-adherence to protocol|0
2471041|NCT02327260|8531119|P2|Overall Study|non-adherence to protocol|0
2471042|NCT02327260|8531120|P1|Overall Study|non-adherence to protocol|2
2471043|NCT02327260|8531118|P3|Overall Study|invalid phone number|0
2471044|NCT02327260|8531119|P2|Overall Study|invalid phone number|1
2471045|NCT02327260|8531120|P1|Overall Study|invalid phone number|1
2471046|NCT02327260|8531118|P3|Overall Study|Lost to Follow-up|2
2471047|NCT02327260|8531119|P2|Overall Study|Lost to Follow-up|3
2471048|NCT02327260|8531120|P1|Overall Study|Lost to Follow-up|2
2471049|NCT02327169|8531167|P15|Overall Study|Lost to Follow-up|0
2471050|NCT02327169|8531168|P14|Overall Study|Lost to Follow-up|0
2471051|NCT02327169|8531169|P13|Overall Study|Lost to Follow-up|0
2471052|NCT02327169|8531170|P12|Overall Study|Lost to Follow-up|0
2471053|NCT02327169|8531171|P11|Overall Study|Lost to Follow-up|0
2471054|NCT02327169|8531172|P10|Overall Study|Lost to Follow-up|0
2471055|NCT02327169|8531173|P9|Overall Study|Lost to Follow-up|0
2471056|NCT02327169|8531174|P8|Overall Study|Lost to Follow-up|0
2471057|NCT02327169|8531175|P7|Overall Study|Lost to Follow-up|0
2471058|NCT02327169|8531176|P6|Overall Study|Lost to Follow-up|0
2471059|NCT02327169|8531177|P5|Overall Study|Lost to Follow-up|1
2471060|NCT02327169|8531178|P4|Overall Study|Lost to Follow-up|0
2471061|NCT02327169|8531179|P3|Overall Study|Lost to Follow-up|0
2471062|NCT02327169|8531180|P2|Overall Study|Lost to Follow-up|0
2471063|NCT02327169|8531181|P1|Overall Study|Lost to Follow-up|0
2471064|NCT02327169|8531167|P15|Overall Study|Withdrawal by Subject|3
2471065|NCT02327169|8531168|P14|Overall Study|Withdrawal by Subject|0
2471066|NCT02327169|8531169|P13|Overall Study|Withdrawal by Subject|0
2471067|NCT02327169|8531170|P12|Overall Study|Withdrawal by Subject|0
2471068|NCT02327169|8531171|P11|Overall Study|Withdrawal by Subject|0
2471069|NCT02327169|8531172|P10|Overall Study|Withdrawal by Subject|0
2471070|NCT02327169|8531173|P9|Overall Study|Withdrawal by Subject|0
2471071|NCT02327169|8531174|P8|Overall Study|Withdrawal by Subject|1
2471072|NCT02327169|8531175|P7|Overall Study|Withdrawal by Subject|0
2471073|NCT02327169|8531176|P6|Overall Study|Withdrawal by Subject|0
2471074|NCT02327169|8531177|P5|Overall Study|Withdrawal by Subject|1
2471075|NCT02327169|8531178|P4|Overall Study|Withdrawal by Subject|0
2471076|NCT02327169|8531179|P3|Overall Study|Withdrawal by Subject|0
2471077|NCT02327169|8531180|P2|Overall Study|Withdrawal by Subject|0
2471078|NCT02327169|8531181|P1|Overall Study|Withdrawal by Subject|1
2471079|NCT02327169|8531167|P15|Overall Study|Reason Not Specified|2
2471080|NCT02327169|8531168|P14|Overall Study|Reason Not Specified|0
2471081|NCT02327169|8531169|P13|Overall Study|Reason Not Specified|0
2471082|NCT02327169|8531170|P12|Overall Study|Reason Not Specified|1
2471083|NCT02327169|8531171|P11|Overall Study|Reason Not Specified|2
2471084|NCT02327169|8531172|P10|Overall Study|Reason Not Specified|1
2471085|NCT02327169|8531173|P9|Overall Study|Reason Not Specified|0
2471086|NCT02327169|8531174|P8|Overall Study|Reason Not Specified|0
2471087|NCT02327169|8531175|P7|Overall Study|Reason Not Specified|0
2471088|NCT02327169|8531176|P6|Overall Study|Reason Not Specified|0
2471089|NCT02327169|8531177|P5|Overall Study|Reason Not Specified|0
2471090|NCT02327169|8531178|P4|Overall Study|Reason Not Specified|0
2471091|NCT02327169|8531179|P3|Overall Study|Reason Not Specified|1
2471092|NCT02327169|8531180|P2|Overall Study|Reason Not Specified|0
2471093|NCT02327169|8531181|P1|Overall Study|Reason Not Specified|0
2471094|NCT02327169|8531167|P15|Overall Study|Symptomatic Deterioration|1
2471095|NCT02327169|8531168|P14|Overall Study|Symptomatic Deterioration|2
2471096|NCT02327169|8531169|P13|Overall Study|Symptomatic Deterioration|0
2471097|NCT02327169|8531170|P12|Overall Study|Symptomatic Deterioration|0
2471098|NCT02327169|8531171|P11|Overall Study|Symptomatic Deterioration|0
2471099|NCT02327169|8531172|P10|Overall Study|Symptomatic Deterioration|1
2471100|NCT02327169|8531173|P9|Overall Study|Symptomatic Deterioration|2
2471101|NCT02327169|8531174|P8|Overall Study|Symptomatic Deterioration|0
2471102|NCT02327169|8531175|P7|Overall Study|Symptomatic Deterioration|0
2471103|NCT02327169|8531176|P6|Overall Study|Symptomatic Deterioration|1
2471104|NCT02327169|8531177|P5|Overall Study|Symptomatic Deterioration|1
2471105|NCT02327169|8531178|P4|Overall Study|Symptomatic Deterioration|0
2471106|NCT02327169|8531179|P3|Overall Study|Symptomatic Deterioration|1
2471107|NCT02327169|8531180|P2|Overall Study|Symptomatic Deterioration|0
2471108|NCT02327169|8531181|P1|Overall Study|Symptomatic Deterioration|0
2471109|NCT02327169|8531167|P15|Overall Study|Adverse Event|1
2471110|NCT02327169|8531168|P14|Overall Study|Adverse Event|2
2471111|NCT02327169|8531169|P13|Overall Study|Adverse Event|0
2471112|NCT02327169|8531170|P12|Overall Study|Adverse Event|3
2471113|NCT02327169|8531171|P11|Overall Study|Adverse Event|0
2471114|NCT02327169|8531172|P10|Overall Study|Adverse Event|2
2471115|NCT02327169|8531173|P9|Overall Study|Adverse Event|0
2471116|NCT02327169|8531174|P8|Overall Study|Adverse Event|0
2471117|NCT02327169|8531175|P7|Overall Study|Adverse Event|0
2471118|NCT02327169|8531176|P6|Overall Study|Adverse Event|0
2471119|NCT02327169|8531177|P5|Overall Study|Adverse Event|1
2471120|NCT02327169|8531178|P4|Overall Study|Adverse Event|0
2471121|NCT02327169|8531179|P3|Overall Study|Adverse Event|1
2471122|NCT02327169|8531180|P2|Overall Study|Adverse Event|0
2471123|NCT02327169|8531181|P1|Overall Study|Adverse Event|2
2471124|NCT02327169|8531167|P15|Overall Study|Progressive Disease|3
2471125|NCT02327169|8531168|P14|Overall Study|Progressive Disease|3
2471126|NCT02327169|8531169|P13|Overall Study|Progressive Disease|1
2471127|NCT02327169|8531170|P12|Overall Study|Progressive Disease|3
2471128|NCT02327169|8531171|P11|Overall Study|Progressive Disease|4
2471129|NCT02327169|8531172|P10|Overall Study|Progressive Disease|4
2471130|NCT02327169|8531173|P9|Overall Study|Progressive Disease|4
2471131|NCT02327169|8531174|P8|Overall Study|Progressive Disease|3
2471132|NCT02327169|8531175|P7|Overall Study|Progressive Disease|3
2471133|NCT02327169|8531176|P6|Overall Study|Progressive Disease|3
2471134|NCT02327169|8531177|P5|Overall Study|Progressive Disease|4
2471135|NCT02327169|8531178|P4|Overall Study|Progressive Disease|3
2471136|NCT02327169|8531179|P3|Overall Study|Progressive Disease|4
2471137|NCT02327169|8531180|P2|Overall Study|Progressive Disease|3
2471138|NCT02327169|8531181|P1|Overall Study|Progressive Disease|1
2471139|NCT02327130|8531411|P1|Overall Study|Met exclusion criteria|3
2471140|NCT02327130|8531411|P1|Overall Study|Incorrectly place ventilator adaptor|1
2471141|NCT02327130|8531411|P1|Overall Study|Unable to provide breath sample|1
2471142|NCT02327130|8531411|P1|Overall Study|Physician Decision|2
2471143|NCT02327130|8531411|P1|Overall Study|Discharged in less than 5 days|5
2471144|NCT02327013|8531430|P5|Overall Study|Withdrawal before treatment|0
2471145|NCT02327013|8531431|P4|Overall Study|Withdrawal before treatment|0
2471146|NCT02327013|8531432|P3|Overall Study|Withdrawal before treatment|5
2471147|NCT02327013|8531433|P2|Overall Study|Withdrawal before treatment|1
2471148|NCT02327013|8531434|P1|Overall Study|Withdrawal before treatment|2
2471149|NCT02327013|8531430|P5|Overall Study|Protocol Violation|1
2471150|NCT02327013|8531431|P4|Overall Study|Protocol Violation|0
2471151|NCT02327013|8531432|P3|Overall Study|Protocol Violation|3
2471152|NCT02327013|8531433|P2|Overall Study|Protocol Violation|0
2471153|NCT02327013|8531434|P1|Overall Study|Protocol Violation|0
2471154|NCT02327013|8531430|P5|Overall Study|Administrative or other reason(s)|1
2471155|NCT02327013|8531431|P4|Overall Study|Administrative or other reason(s)|1
2471156|NCT02327013|8531432|P3|Overall Study|Administrative or other reason(s)|11
2471157|NCT02327013|8531433|P2|Overall Study|Administrative or other reason(s)|5
2471158|NCT02327013|8531434|P1|Overall Study|Administrative or other reason(s)|1
2471159|NCT02327013|8531430|P5|Overall Study|Lost to Follow-up|0
2471160|NCT02327013|8531431|P4|Overall Study|Lost to Follow-up|0
2471161|NCT02327013|8531432|P3|Overall Study|Lost to Follow-up|5
2471162|NCT02327013|8531433|P2|Overall Study|Lost to Follow-up|4
2471163|NCT02327013|8531434|P1|Overall Study|Lost to Follow-up|2
2471164|NCT02327013|8531430|P5|Overall Study|Withdrawal of Consent|0
2471165|NCT02327013|8531431|P4|Overall Study|Withdrawal of Consent|0
2471166|NCT02327013|8531432|P3|Overall Study|Withdrawal of Consent|3
2471167|NCT02327013|8531433|P2|Overall Study|Withdrawal of Consent|0
2471168|NCT02327013|8531434|P1|Overall Study|Withdrawal of Consent|1
2471169|NCT02327013|8531430|P5|Overall Study|Non-compliance with IMP|0
2471170|NCT02327013|8531431|P4|Overall Study|Non-compliance with IMP|0
2471171|NCT02327013|8531432|P3|Overall Study|Non-compliance with IMP|7
2471172|NCT02327013|8531433|P2|Overall Study|Non-compliance with IMP|2
2471173|NCT02327013|8531434|P1|Overall Study|Non-compliance with IMP|1
2471174|NCT02327013|8531430|P5|Overall Study|Lack of Efficacy|1
2471175|NCT02327013|8531431|P4|Overall Study|Lack of Efficacy|0
2471176|NCT02327013|8531432|P3|Overall Study|Lack of Efficacy|5
2471177|NCT02327013|8531433|P2|Overall Study|Lack of Efficacy|0
2471178|NCT02327013|8531434|P1|Overall Study|Lack of Efficacy|2
2471179|NCT02327013|8531430|P5|Overall Study|Adverse Event|1
2471180|NCT02327013|8531431|P4|Overall Study|Adverse Event|0
2471181|NCT02327013|8531432|P3|Overall Study|Adverse Event|3
2471182|NCT02327013|8531433|P2|Overall Study|Adverse Event|4
2471183|NCT02327013|8531434|P1|Overall Study|Adverse Event|4
2471184|NCT02326597|8531620|P2|Overall Study|Lost to Follow-up|32
2471185|NCT02326597|8531621|P1|Overall Study|Lost to Follow-up|42
2471186|NCT02326298|8531642|P14|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3
2471187|NCT02326298|8531643|P13|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6
2471188|NCT02326298|8531644|P12|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6
2471189|NCT02326298|8531645|P11|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2471190|NCT02326298|8531646|P10|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2471191|NCT02326298|8531647|P9|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2471192|NCT02326298|8531648|P8|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2471193|NCT02326298|8531649|P7|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2471194|NCT02326298|8531650|P6|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2471195|NCT02326298|8531651|P5|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2471196|NCT02326298|8531652|P4|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2471197|NCT02326298|8531653|P3|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2471198|NCT02326298|8531654|P2|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2471199|NCT02326298|8531655|P1|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2471200|NCT02326298|8531642|P14|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
2471201|NCT02326298|8531643|P13|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7
2471202|NCT02326298|8531644|P12|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2
2471203|NCT02326298|8531645|P11|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2471204|NCT02326298|8531646|P10|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2471205|NCT02326298|8531647|P9|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2471206|NCT02326298|8531648|P8|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2471207|NCT02326298|8531649|P7|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2471208|NCT02326298|8531650|P6|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2471209|NCT02326298|8531651|P5|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2471210|NCT02326298|8531652|P4|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2471211|NCT02326298|8531653|P3|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2471212|NCT02326298|8531654|P2|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2471213|NCT02326298|8531655|P1|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2471214|NCT02326298|8531642|P14|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1
2471215|NCT02326298|8531643|P13|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2
2471216|NCT02326298|8531644|P12|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7
2471217|NCT02326298|8531645|P11|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2471218|NCT02326298|8531646|P10|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2471219|NCT02326298|8531647|P9|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2471220|NCT02326298|8531648|P8|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2471221|NCT02326298|8531649|P7|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2471222|NCT02326298|8531650|P6|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2471223|NCT02326298|8531651|P5|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2471224|NCT02326298|8531652|P4|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2471225|NCT02326298|8531653|P3|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2471226|NCT02326298|8531654|P2|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2471227|NCT02326298|8531655|P1|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2471228|NCT02326298|8531642|P14|Open-label Period (Week 48 to Week 144)|Protocol Violation|2
2471229|NCT02326298|8531643|P13|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2471230|NCT02326298|8531644|P12|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2471231|NCT02326298|8531645|P11|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2471232|NCT02326298|8531646|P10|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2471233|NCT02326298|8531647|P9|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2471234|NCT02326298|8531648|P8|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2471235|NCT02326298|8531649|P7|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2471236|NCT02326298|8531650|P6|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2471237|NCT02326298|8531651|P5|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2471238|NCT02326298|8531652|P4|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2471239|NCT02326298|8531653|P3|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2471240|NCT02326298|8531654|P2|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2471241|NCT02326298|8531655|P1|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2471242|NCT02326298|8531642|P14|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2471243|NCT02326298|8531643|P13|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
2471244|NCT02326298|8531644|P12|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
2471245|NCT02326298|8531645|P11|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2471246|NCT02326298|8531646|P10|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2471247|NCT02326298|8531647|P9|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2471248|NCT02326298|8531648|P8|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2471249|NCT02326298|8531649|P7|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2471250|NCT02326298|8531650|P6|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2471251|NCT02326298|8531651|P5|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2471252|NCT02326298|8531652|P4|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2471253|NCT02326298|8531653|P3|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2471254|NCT02326298|8531654|P2|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2471255|NCT02326298|8531655|P1|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2471256|NCT02326298|8531642|P14|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2471257|NCT02326298|8531643|P13|Open-label Period (Week 48 to Week 144)|Adverse Event|3
2471258|NCT02326298|8531644|P12|Open-label Period (Week 48 to Week 144)|Adverse Event|3
2471259|NCT02326298|8531645|P11|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2471260|NCT02326298|8531646|P10|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2471261|NCT02326298|8531647|P9|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2471262|NCT02326298|8531648|P8|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2471263|NCT02326298|8531649|P7|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2471264|NCT02326298|8531650|P6|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2471265|NCT02326298|8531651|P5|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2471266|NCT02326298|8531652|P4|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2471267|NCT02326298|8531653|P3|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2471268|NCT02326298|8531654|P2|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2471269|NCT02326298|8531655|P1|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2471270|NCT02326298|8531642|P14|Open-label Period (Week 48 to Week 144)|Death|0
2471271|NCT02326298|8531643|P13|Open-label Period (Week 48 to Week 144)|Death|0
2471272|NCT02326298|8531644|P12|Open-label Period (Week 48 to Week 144)|Death|1
2471273|NCT02326298|8531645|P11|Open-label Period (Week 48 to Week 144)|Death|0
2471274|NCT02326298|8531646|P10|Open-label Period (Week 48 to Week 144)|Death|0
2471275|NCT02326298|8531647|P9|Open-label Period (Week 48 to Week 144)|Death|0
2471276|NCT02326298|8531648|P8|Open-label Period (Week 48 to Week 144)|Death|0
2471277|NCT02326298|8531649|P7|Open-label Period (Week 48 to Week 144)|Death|0
2471278|NCT02326298|8531650|P6|Open-label Period (Week 48 to Week 144)|Death|0
2471279|NCT02326298|8531651|P5|Open-label Period (Week 48 to Week 144)|Death|0
2471280|NCT02326298|8531652|P4|Open-label Period (Week 48 to Week 144)|Death|0
2471281|NCT02326298|8531653|P3|Open-label Period (Week 48 to Week 144)|Death|0
2471282|NCT02326298|8531654|P2|Open-label Period (Week 48 to Week 144)|Death|0
2471283|NCT02326298|8531655|P1|Open-label Period (Week 48 to Week 144)|Death|0
2471284|NCT02326298|8531642|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2471285|NCT02326298|8531643|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2471286|NCT02326298|8531644|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2471287|NCT02326298|8531645|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2471288|NCT02326298|8531646|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2471289|NCT02326298|8531647|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2471290|NCT02326298|8531648|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2471291|NCT02326298|8531649|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2471292|NCT02326298|8531650|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2
2471293|NCT02326298|8531651|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2471294|NCT02326298|8531652|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2471295|NCT02326298|8531653|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2471296|NCT02326298|8531654|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2471297|NCT02326298|8531655|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
2471298|NCT02326298|8531642|P14|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2471299|NCT02326298|8531643|P13|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2471300|NCT02326298|8531644|P12|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2471301|NCT02326298|8531645|P11|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2471302|NCT02326298|8531646|P10|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2471303|NCT02326298|8531647|P9|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2471304|NCT02326298|8531648|P8|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
2471305|NCT02326298|8531649|P7|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2471306|NCT02326298|8531650|P6|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2471307|NCT02326298|8531651|P5|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2471308|NCT02326298|8531652|P4|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2471309|NCT02326298|8531653|P3|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2471310|NCT02326298|8531654|P2|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2471311|NCT02326298|8531655|P1|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2471312|NCT02326298|8531642|P14|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2471313|NCT02326298|8531643|P13|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2471314|NCT02326298|8531644|P12|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2471315|NCT02326298|8531645|P11|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2471316|NCT02326298|8531646|P10|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2471317|NCT02326298|8531647|P9|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2471318|NCT02326298|8531648|P8|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
2471319|NCT02326298|8531649|P7|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1
2471320|NCT02326298|8531650|P6|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2471321|NCT02326298|8531651|P5|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2471322|NCT02326298|8531652|P4|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2471323|NCT02326298|8531653|P3|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2471324|NCT02326298|8531654|P2|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2471325|NCT02326298|8531655|P1|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2471326|NCT02326298|8531642|P14|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2471327|NCT02326298|8531643|P13|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2471328|NCT02326298|8531644|P12|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2471329|NCT02326298|8531645|P11|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2471330|NCT02326298|8531646|P10|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2471331|NCT02326298|8531647|P9|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2471332|NCT02326298|8531648|P8|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1
2471333|NCT02326298|8531649|P7|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2471334|NCT02326298|8531650|P6|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2471335|NCT02326298|8531651|P5|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2471336|NCT02326298|8531652|P4|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2471337|NCT02326298|8531653|P3|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2471338|NCT02326298|8531654|P2|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2471339|NCT02326298|8531655|P1|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
2471340|NCT02326298|8531642|P14|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2471341|NCT02326298|8531643|P13|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2471342|NCT02326298|8531644|P12|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2471343|NCT02326298|8531645|P11|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2471344|NCT02326298|8531646|P10|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2471345|NCT02326298|8531647|P9|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2471346|NCT02326298|8531648|P8|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2471347|NCT02326298|8531649|P7|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
2471348|NCT02326298|8531650|P6|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2471349|NCT02326298|8531651|P5|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2471350|NCT02326298|8531652|P4|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2471351|NCT02326298|8531653|P3|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2471352|NCT02326298|8531654|P2|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2471353|NCT02326298|8531655|P1|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2471354|NCT02326298|8531642|P14|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2471355|NCT02326298|8531643|P13|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2471356|NCT02326298|8531644|P12|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2471357|NCT02326298|8531645|P11|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2471358|NCT02326298|8531646|P10|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2471359|NCT02326298|8531647|P9|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2471360|NCT02326298|8531648|P8|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2471361|NCT02326298|8531649|P7|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2471362|NCT02326298|8531650|P6|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1
2471363|NCT02326298|8531651|P5|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2471364|NCT02326298|8531652|P4|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2471365|NCT02326298|8531653|P3|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2471366|NCT02326298|8531654|P2|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2471367|NCT02326298|8531655|P1|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
2471368|NCT02326298|8531642|P14|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2471369|NCT02326298|8531643|P13|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2471370|NCT02326298|8531644|P12|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2471371|NCT02326298|8531645|P11|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2471372|NCT02326298|8531646|P10|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2471373|NCT02326298|8531647|P9|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4
2471374|NCT02326298|8531648|P8|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2471375|NCT02326298|8531649|P7|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2
2471376|NCT02326298|8531650|P6|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1
2471377|NCT02326298|8531651|P5|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2471378|NCT02326298|8531652|P4|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2471379|NCT02326298|8531653|P3|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2471380|NCT02326298|8531654|P2|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2471381|NCT02326298|8531655|P1|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
2471382|NCT02326298|8531642|P14|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2471383|NCT02326298|8531643|P13|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2471384|NCT02326298|8531644|P12|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2471385|NCT02326298|8531645|P11|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2471386|NCT02326298|8531646|P10|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2471387|NCT02326298|8531647|P9|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2471388|NCT02326298|8531648|P8|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2471389|NCT02326298|8531649|P7|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
2471390|NCT02326298|8531650|P6|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2471391|NCT02326298|8531651|P5|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2471392|NCT02326298|8531652|P4|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2471393|NCT02326298|8531653|P3|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2471394|NCT02326298|8531654|P2|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2471395|NCT02326298|8531655|P1|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2471396|NCT02326298|8531642|P14|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2471397|NCT02326298|8531643|P13|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2471398|NCT02326298|8531644|P12|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2471399|NCT02326298|8531645|P11|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2471400|NCT02326298|8531646|P10|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2471401|NCT02326298|8531647|P9|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2471402|NCT02326298|8531648|P8|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2471403|NCT02326298|8531649|P7|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2471404|NCT02326298|8531650|P6|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2471405|NCT02326298|8531651|P5|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2471406|NCT02326298|8531652|P4|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2471407|NCT02326298|8531653|P3|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2
2471408|NCT02326298|8531654|P2|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2471409|NCT02326298|8531655|P1|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
2471410|NCT02326298|8531642|P14|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2471411|NCT02326298|8531643|P13|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2471412|NCT02326298|8531644|P12|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2471413|NCT02326298|8531645|P11|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2471414|NCT02326298|8531646|P10|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2471415|NCT02326298|8531647|P9|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2471416|NCT02326298|8531648|P8|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2471417|NCT02326298|8531649|P7|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2471418|NCT02326298|8531650|P6|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2471419|NCT02326298|8531651|P5|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2471420|NCT02326298|8531652|P4|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2471421|NCT02326298|8531653|P3|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2471422|NCT02326298|8531654|P2|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
2471423|NCT02326298|8531655|P1|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
2471424|NCT02326298|8531642|P14|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2471425|NCT02326298|8531643|P13|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2471426|NCT02326298|8531644|P12|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2471427|NCT02326298|8531645|P11|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2471428|NCT02326298|8531646|P10|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2471429|NCT02326298|8531647|P9|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2471430|NCT02326298|8531648|P8|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2471431|NCT02326298|8531649|P7|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2471432|NCT02326298|8531650|P6|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2471433|NCT02326298|8531651|P5|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2471434|NCT02326298|8531652|P4|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2471435|NCT02326298|8531653|P3|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2471436|NCT02326298|8531654|P2|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
2471437|NCT02326298|8531655|P1|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
2471438|NCT02326298|8531642|P14|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2471439|NCT02326298|8531643|P13|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2471440|NCT02326298|8531644|P12|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2471441|NCT02326298|8531645|P11|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2471442|NCT02326298|8531646|P10|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2471443|NCT02326298|8531647|P9|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2471444|NCT02326298|8531648|P8|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2471445|NCT02326298|8531649|P7|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2471446|NCT02326298|8531650|P6|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2471447|NCT02326298|8531651|P5|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2471448|NCT02326298|8531652|P4|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2471449|NCT02326298|8531653|P3|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2471450|NCT02326298|8531654|P2|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
2471451|NCT02326298|8531655|P1|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1
2471452|NCT02326298|8531642|P14|Initial Period (Week 0 to Week 16)|Adverse Event|0
2471453|NCT02326298|8531643|P13|Initial Period (Week 0 to Week 16)|Adverse Event|0
2471454|NCT02326298|8531644|P12|Initial Period (Week 0 to Week 16)|Adverse Event|0
2471455|NCT02326298|8531645|P11|Initial Period (Week 0 to Week 16)|Adverse Event|0
2471456|NCT02326298|8531646|P10|Initial Period (Week 0 to Week 16)|Adverse Event|0
2471457|NCT02326298|8531647|P9|Initial Period (Week 0 to Week 16)|Adverse Event|0
2471458|NCT02326298|8531648|P8|Initial Period (Week 0 to Week 16)|Adverse Event|0
2471459|NCT02326298|8531649|P7|Initial Period (Week 0 to Week 16)|Adverse Event|0
2471460|NCT02326298|8531650|P6|Initial Period (Week 0 to Week 16)|Adverse Event|0
2471461|NCT02326298|8531651|P5|Initial Period (Week 0 to Week 16)|Adverse Event|0
2471462|NCT02326298|8531652|P4|Initial Period (Week 0 to Week 16)|Adverse Event|0
2471463|NCT02326298|8531653|P3|Initial Period (Week 0 to Week 16)|Adverse Event|1
2471464|NCT02326298|8531654|P2|Initial Period (Week 0 to Week 16)|Adverse Event|0
2471465|NCT02326298|8531655|P1|Initial Period (Week 0 to Week 16)|Adverse Event|0
2471466|NCT02326272|8531678|P15|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2471467|NCT02326272|8531679|P14|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2471468|NCT02326272|8531680|P13|Open-label Period (Week 48 to Week 144)|Pregnancy|1
2471469|NCT02326272|8531681|P12|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2471470|NCT02326272|8531682|P11|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2471471|NCT02326272|8531683|P10|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2471472|NCT02326272|8531684|P9|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2471473|NCT02326272|8531685|P8|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2471474|NCT02326272|8531686|P7|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2471475|NCT02326272|8531687|P6|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2471476|NCT02326272|8531688|P5|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2471477|NCT02326272|8531689|P4|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2471478|NCT02326272|8531690|P3|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2471479|NCT02326272|8531691|P2|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2471480|NCT02326272|8531692|P1|Open-label Period (Week 48 to Week 144)|Pregnancy|0
2471481|NCT02326272|8531678|P15|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2471482|NCT02326272|8531679|P14|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2471483|NCT02326272|8531680|P13|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2471484|NCT02326272|8531681|P12|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1
2471485|NCT02326272|8531682|P11|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2471486|NCT02326272|8531683|P10|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2471487|NCT02326272|8531684|P9|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2471488|NCT02326272|8531685|P8|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2471489|NCT02326272|8531686|P7|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2471490|NCT02326272|8531687|P6|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2471491|NCT02326272|8531688|P5|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2471492|NCT02326272|8531689|P4|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2471493|NCT02326272|8531690|P3|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2471494|NCT02326272|8531691|P2|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2471495|NCT02326272|8531692|P1|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
2471496|NCT02326272|8531678|P15|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
2471497|NCT02326272|8531679|P14|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2471498|NCT02326272|8531680|P13|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
2471499|NCT02326272|8531681|P12|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1
2471500|NCT02326272|8531682|P11|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2471501|NCT02326272|8531683|P10|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2471502|NCT02326272|8531684|P9|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2471503|NCT02326272|8531685|P8|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2471504|NCT02326272|8531686|P7|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2471505|NCT02326272|8531687|P6|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2471506|NCT02326272|8531688|P5|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2471507|NCT02326272|8531689|P4|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2471508|NCT02326272|8531690|P3|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2471509|NCT02326272|8531691|P2|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2471510|NCT02326272|8531692|P1|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
2471511|NCT02326272|8531678|P15|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2
2471512|NCT02326272|8531679|P14|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2471513|NCT02326272|8531680|P13|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2471514|NCT02326272|8531681|P12|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4
2471515|NCT02326272|8531682|P11|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2471516|NCT02326272|8531683|P10|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2471517|NCT02326272|8531684|P9|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2471518|NCT02326272|8531685|P8|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2471519|NCT02326272|8531686|P7|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2471520|NCT02326272|8531687|P6|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2471521|NCT02326272|8531688|P5|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2471522|NCT02326272|8531689|P4|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2471523|NCT02326272|8531690|P3|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2471524|NCT02326272|8531691|P2|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2471525|NCT02326272|8531692|P1|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
2471526|NCT02326272|8531678|P15|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3
2471527|NCT02326272|8531679|P14|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2471528|NCT02326272|8531680|P13|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2
2471529|NCT02326272|8531681|P12|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2471530|NCT02326272|8531682|P11|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1
2471531|NCT02326272|8531683|P10|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2471532|NCT02326272|8531684|P9|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2471533|NCT02326272|8531685|P8|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2471534|NCT02326272|8531686|P7|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2471535|NCT02326272|8531687|P6|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2471536|NCT02326272|8531688|P5|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2471537|NCT02326272|8531689|P4|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2471538|NCT02326272|8531690|P3|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2471539|NCT02326272|8531691|P2|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2471540|NCT02326272|8531692|P1|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
2471541|NCT02326272|8531678|P15|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2471542|NCT02326272|8531679|P14|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2471543|NCT02326272|8531680|P13|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2471544|NCT02326272|8531681|P12|Open-label Period (Week 48 to Week 144)|Protocol Violation|1
2471545|NCT02326272|8531682|P11|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2471546|NCT02326272|8531683|P10|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2471547|NCT02326272|8531684|P9|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2471548|NCT02326272|8531685|P8|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2471549|NCT02326272|8531686|P7|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2471550|NCT02326272|8531687|P6|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2471551|NCT02326272|8531688|P5|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2471552|NCT02326272|8531689|P4|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2471553|NCT02326272|8531690|P3|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2471554|NCT02326272|8531691|P2|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2471555|NCT02326272|8531692|P1|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
2471556|NCT02326272|8531678|P15|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2471557|NCT02326272|8531679|P14|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2471558|NCT02326272|8531680|P13|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
2471559|NCT02326272|8531681|P12|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2471560|NCT02326272|8531682|P11|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
2471561|NCT02326272|8531683|P10|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2471562|NCT02326272|8531684|P9|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2471563|NCT02326272|8531685|P8|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2471564|NCT02326272|8531686|P7|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2471565|NCT02326272|8531687|P6|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2471566|NCT02326272|8531688|P5|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2471567|NCT02326272|8531689|P4|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2471568|NCT02326272|8531690|P3|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2471569|NCT02326272|8531691|P2|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2471570|NCT02326272|8531692|P1|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
2471571|NCT02326272|8531678|P15|Open-label Period (Week 48 to Week 144)|Adverse Event|1
2471572|NCT02326272|8531679|P14|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2471573|NCT02326272|8531680|P13|Open-label Period (Week 48 to Week 144)|Adverse Event|3
2471574|NCT02326272|8531681|P12|Open-label Period (Week 48 to Week 144)|Adverse Event|8
2471575|NCT02326272|8531682|P11|Open-label Period (Week 48 to Week 144)|Adverse Event|1
2471576|NCT02326272|8531683|P10|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2471577|NCT02326272|8531684|P9|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2471578|NCT02326272|8531685|P8|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2471579|NCT02326272|8531686|P7|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2471580|NCT02326272|8531687|P6|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2471581|NCT02326272|8531688|P5|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2471582|NCT02326272|8531689|P4|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2471583|NCT02326272|8531690|P3|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2471584|NCT02326272|8531691|P2|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2471585|NCT02326272|8531692|P1|Open-label Period (Week 48 to Week 144)|Adverse Event|0
2471586|NCT02326272|8531678|P15|Open-label Period (Week 48 to Week 144)|Death|0
2471587|NCT02326272|8531679|P14|Open-label Period (Week 48 to Week 144)|Death|0
2471588|NCT02326272|8531680|P13|Open-label Period (Week 48 to Week 144)|Death|1
2471589|NCT02326272|8531681|P12|Open-label Period (Week 48 to Week 144)|Death|0
2471590|NCT02326272|8531682|P11|Open-label Period (Week 48 to Week 144)|Death|0
2471591|NCT02326272|8531683|P10|Open-label Period (Week 48 to Week 144)|Death|0
2471592|NCT02326272|8531684|P9|Open-label Period (Week 48 to Week 144)|Death|0
2471593|NCT02326272|8531685|P8|Open-label Period (Week 48 to Week 144)|Death|0
2471594|NCT02326272|8531686|P7|Open-label Period (Week 48 to Week 144)|Death|0
2471595|NCT02326272|8531687|P6|Open-label Period (Week 48 to Week 144)|Death|0
2471596|NCT02326272|8531688|P5|Open-label Period (Week 48 to Week 144)|Death|0
2471597|NCT02326272|8531689|P4|Open-label Period (Week 48 to Week 144)|Death|0
2471598|NCT02326272|8531690|P3|Open-label Period (Week 48 to Week 144)|Death|0
2471599|NCT02326272|8531691|P2|Open-label Period (Week 48 to Week 144)|Death|0
2471600|NCT02326272|8531692|P1|Open-label Period (Week 48 to Week 144)|Death|0
2471601|NCT02326272|8531678|P15|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2471602|NCT02326272|8531679|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2471603|NCT02326272|8531680|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2471604|NCT02326272|8531681|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2471605|NCT02326272|8531682|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2471606|NCT02326272|8531683|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2471607|NCT02326272|8531684|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2471608|NCT02326272|8531685|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2471609|NCT02326272|8531686|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1
2471610|NCT02326272|8531687|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2471611|NCT02326272|8531688|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2471612|NCT02326272|8531689|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2471613|NCT02326272|8531690|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2471614|NCT02326272|8531691|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2471615|NCT02326272|8531692|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
2471616|NCT02326272|8531678|P15|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2471617|NCT02326272|8531679|P14|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2471618|NCT02326272|8531680|P13|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2471619|NCT02326272|8531681|P12|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2471620|NCT02326272|8531682|P11|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2471621|NCT02326272|8531683|P10|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2471622|NCT02326272|8531684|P9|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2471623|NCT02326272|8531685|P8|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2471624|NCT02326272|8531686|P7|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2471625|NCT02326272|8531687|P6|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1
2471626|NCT02326272|8531688|P5|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2471627|NCT02326272|8531689|P4|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2471628|NCT02326272|8531690|P3|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2471629|NCT02326272|8531691|P2|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2471630|NCT02326272|8531692|P1|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
2471631|NCT02326272|8531678|P15|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2471632|NCT02326272|8531679|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2471633|NCT02326272|8531680|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2471634|NCT02326272|8531681|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2471635|NCT02326272|8531682|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2472084|NCT02322775|8532441|P2|Overall Study|Adverse Event|0
2471636|NCT02326272|8531683|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2471637|NCT02326272|8531684|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
2471638|NCT02326272|8531685|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
2471639|NCT02326272|8531686|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
2471640|NCT02326272|8531687|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
2471641|NCT02326272|8531688|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2471642|NCT02326272|8531689|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2471643|NCT02326272|8531690|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2471644|NCT02326272|8531691|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2471645|NCT02326272|8531692|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
2471646|NCT02326272|8531678|P15|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2471647|NCT02326272|8531679|P14|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2471648|NCT02326272|8531680|P13|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2471649|NCT02326272|8531681|P12|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2471650|NCT02326272|8531682|P11|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2471651|NCT02326272|8531683|P10|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2471652|NCT02326272|8531684|P9|Maintenance Period (Week 16 to Week 48)|Non-compliance|1
2471653|NCT02326272|8531685|P8|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2471654|NCT02326272|8531686|P7|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2471655|NCT02326272|8531687|P6|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2471656|NCT02326272|8531688|P5|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2471657|NCT02326272|8531689|P4|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2471658|NCT02326272|8531690|P3|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2471659|NCT02326272|8531691|P2|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2471660|NCT02326272|8531692|P1|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
2471661|NCT02326272|8531678|P15|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2471662|NCT02326272|8531679|P14|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2471663|NCT02326272|8531680|P13|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2471664|NCT02326272|8531681|P12|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2471665|NCT02326272|8531682|P11|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2471666|NCT02326272|8531683|P10|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2471667|NCT02326272|8531684|P9|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2471668|NCT02326272|8531685|P8|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2471669|NCT02326272|8531686|P7|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
2471670|NCT02326272|8531687|P6|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2471671|NCT02326272|8531688|P5|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2471672|NCT02326272|8531689|P4|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2471673|NCT02326272|8531690|P3|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2471674|NCT02326272|8531691|P2|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2471675|NCT02326272|8531692|P1|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
2471676|NCT02326272|8531678|P15|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2471677|NCT02326272|8531679|P14|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2471678|NCT02326272|8531680|P13|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2471679|NCT02326272|8531681|P12|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2471680|NCT02326272|8531682|P11|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2471681|NCT02326272|8531683|P10|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2471682|NCT02326272|8531684|P9|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2471683|NCT02326272|8531685|P8|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1
2471684|NCT02326272|8531686|P7|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2471685|NCT02326272|8531687|P6|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2471686|NCT02326272|8531688|P5|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2471687|NCT02326272|8531689|P4|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2471688|NCT02326272|8531690|P3|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2471689|NCT02326272|8531691|P2|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2471690|NCT02326272|8531692|P1|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
2471691|NCT02326272|8531678|P15|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2471692|NCT02326272|8531679|P14|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2471693|NCT02326272|8531680|P13|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2471694|NCT02326272|8531681|P12|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2471695|NCT02326272|8531682|P11|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2471696|NCT02326272|8531683|P10|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2471697|NCT02326272|8531684|P9|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2471698|NCT02326272|8531685|P8|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2471699|NCT02326272|8531686|P7|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2471700|NCT02326272|8531687|P6|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
2471701|NCT02326272|8531688|P5|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2471702|NCT02326272|8531689|P4|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
2471703|NCT02326272|8531690|P3|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2471704|NCT02326272|8531691|P2|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2471705|NCT02326272|8531692|P1|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
2471706|NCT02326272|8531678|P15|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2471707|NCT02326272|8531679|P14|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2471708|NCT02326272|8531680|P13|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2471709|NCT02326272|8531681|P12|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2471710|NCT02326272|8531682|P11|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2471711|NCT02326272|8531683|P10|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2471712|NCT02326272|8531684|P9|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2471713|NCT02326272|8531685|P8|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
2471714|NCT02326272|8531686|P7|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2471715|NCT02326272|8531687|P6|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
2471716|NCT02326272|8531688|P5|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2471717|NCT02326272|8531689|P4|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2471718|NCT02326272|8531690|P3|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2471719|NCT02326272|8531691|P2|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2471720|NCT02326272|8531692|P1|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
2471721|NCT02326272|8531678|P15|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2471722|NCT02326272|8531679|P14|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2471723|NCT02326272|8531680|P13|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2471724|NCT02326272|8531681|P12|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2471725|NCT02326272|8531682|P11|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2471726|NCT02326272|8531683|P10|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
2471727|NCT02326272|8531684|P9|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
2471728|NCT02326272|8531685|P8|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2471729|NCT02326272|8531686|P7|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
2471730|NCT02326272|8531687|P6|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2
2471731|NCT02326272|8531688|P5|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2471732|NCT02326272|8531689|P4|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2471733|NCT02326272|8531690|P3|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2471734|NCT02326272|8531691|P2|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2471735|NCT02326272|8531692|P1|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
2471736|NCT02326272|8531678|P15|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2471737|NCT02326272|8531679|P14|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2471738|NCT02326272|8531680|P13|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2471739|NCT02326272|8531681|P12|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2471740|NCT02326272|8531682|P11|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2471741|NCT02326272|8531683|P10|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2471742|NCT02326272|8531684|P9|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
2471743|NCT02326272|8531685|P8|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
2471744|NCT02326272|8531686|P7|Maintenance Period (Week 16 to Week 48)|Adverse Event|4
2471745|NCT02326272|8531687|P6|Maintenance Period (Week 16 to Week 48)|Adverse Event|3
2471746|NCT02326272|8531688|P5|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
2471747|NCT02326272|8531689|P4|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2471748|NCT02326272|8531690|P3|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2471749|NCT02326272|8531691|P2|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2471750|NCT02326272|8531692|P1|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
2471751|NCT02326272|8531678|P15|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2471752|NCT02326272|8531679|P14|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2471753|NCT02326272|8531680|P13|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2471754|NCT02326272|8531681|P12|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2471755|NCT02326272|8531682|P11|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2471756|NCT02326272|8531683|P10|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2471757|NCT02326272|8531684|P9|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2471758|NCT02326272|8531685|P8|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2471759|NCT02326272|8531686|P7|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2471760|NCT02326272|8531687|P6|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2471761|NCT02326272|8531688|P5|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2471762|NCT02326272|8531689|P4|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2471763|NCT02326272|8531690|P3|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1
2471764|NCT02326272|8531691|P2|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2471765|NCT02326272|8531692|P1|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
2471766|NCT02326272|8531678|P15|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2471767|NCT02326272|8531679|P14|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2471768|NCT02326272|8531680|P13|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2471769|NCT02326272|8531681|P12|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2471770|NCT02326272|8531682|P11|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2471771|NCT02326272|8531683|P10|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2471772|NCT02326272|8531684|P9|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2471773|NCT02326272|8531685|P8|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2471774|NCT02326272|8531686|P7|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2471775|NCT02326272|8531687|P6|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2471776|NCT02326272|8531688|P5|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2471777|NCT02326272|8531689|P4|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2471778|NCT02326272|8531690|P3|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1
2471779|NCT02326272|8531691|P2|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2471780|NCT02326272|8531692|P1|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
2471781|NCT02326272|8531678|P15|Initial Period (Week 0 to Week 16)|Missed two doses|0
2471782|NCT02326272|8531679|P14|Initial Period (Week 0 to Week 16)|Missed two doses|0
2471783|NCT02326272|8531680|P13|Initial Period (Week 0 to Week 16)|Missed two doses|0
2471784|NCT02326272|8531681|P12|Initial Period (Week 0 to Week 16)|Missed two doses|0
2471785|NCT02326272|8531682|P11|Initial Period (Week 0 to Week 16)|Missed two doses|0
2471786|NCT02326272|8531683|P10|Initial Period (Week 0 to Week 16)|Missed two doses|0
2471787|NCT02326272|8531684|P9|Initial Period (Week 0 to Week 16)|Missed two doses|0
2471788|NCT02326272|8531685|P8|Initial Period (Week 0 to Week 16)|Missed two doses|0
2471789|NCT02326272|8531686|P7|Initial Period (Week 0 to Week 16)|Missed two doses|0
2471790|NCT02326272|8531687|P6|Initial Period (Week 0 to Week 16)|Missed two doses|0
2471791|NCT02326272|8531688|P5|Initial Period (Week 0 to Week 16)|Missed two doses|0
2471792|NCT02326272|8531689|P4|Initial Period (Week 0 to Week 16)|Missed two doses|0
2471793|NCT02326272|8531690|P3|Initial Period (Week 0 to Week 16)|Missed two doses|1
2471794|NCT02326272|8531691|P2|Initial Period (Week 0 to Week 16)|Missed two doses|0
2471795|NCT02326272|8531692|P1|Initial Period (Week 0 to Week 16)|Missed two doses|0
2471796|NCT02326272|8531678|P15|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2471797|NCT02326272|8531679|P14|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2471798|NCT02326272|8531680|P13|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2471799|NCT02326272|8531681|P12|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2471800|NCT02326272|8531682|P11|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2471801|NCT02326272|8531683|P10|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2471802|NCT02326272|8531684|P9|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2471803|NCT02326272|8531685|P8|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2471804|NCT02326272|8531686|P7|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2471805|NCT02326272|8531687|P6|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2471806|NCT02326272|8531688|P5|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2471807|NCT02326272|8531689|P4|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2471808|NCT02326272|8531690|P3|Initial Period (Week 0 to Week 16)|Moved from the study area|1
2471809|NCT02326272|8531691|P2|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2471810|NCT02326272|8531692|P1|Initial Period (Week 0 to Week 16)|Moved from the study area|0
2471811|NCT02326272|8531678|P15|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2471812|NCT02326272|8531679|P14|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2471813|NCT02326272|8531680|P13|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2471814|NCT02326272|8531681|P12|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2471815|NCT02326272|8531682|P11|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2471816|NCT02326272|8531683|P10|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2471817|NCT02326272|8531684|P9|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2471818|NCT02326272|8531685|P8|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2471819|NCT02326272|8531686|P7|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2471820|NCT02326272|8531687|P6|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2471821|NCT02326272|8531688|P5|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2471822|NCT02326272|8531689|P4|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
2471823|NCT02326272|8531690|P3|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
2471824|NCT02326272|8531691|P2|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
2471825|NCT02326272|8531692|P1|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
2471826|NCT02326272|8531678|P15|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2471827|NCT02326272|8531679|P14|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2471828|NCT02326272|8531680|P13|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2471829|NCT02326272|8531681|P12|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2471830|NCT02326272|8531682|P11|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2471831|NCT02326272|8531683|P10|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2471832|NCT02326272|8531684|P9|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2471833|NCT02326272|8531685|P8|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2471834|NCT02326272|8531686|P7|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2471835|NCT02326272|8531687|P6|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2471836|NCT02326272|8531688|P5|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2471837|NCT02326272|8531689|P4|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2471838|NCT02326272|8531690|P3|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
2471839|NCT02326272|8531691|P2|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2
2471840|NCT02326272|8531692|P1|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
2471841|NCT02326272|8531678|P15|Initial Period (Week 0 to Week 16)|Adverse Event|0
2471842|NCT02326272|8531679|P14|Initial Period (Week 0 to Week 16)|Adverse Event|0
2471843|NCT02326272|8531680|P13|Initial Period (Week 0 to Week 16)|Adverse Event|0
2471844|NCT02326272|8531681|P12|Initial Period (Week 0 to Week 16)|Adverse Event|0
2471845|NCT02326272|8531682|P11|Initial Period (Week 0 to Week 16)|Adverse Event|0
2471846|NCT02326272|8531683|P10|Initial Period (Week 0 to Week 16)|Adverse Event|0
2471847|NCT02326272|8531684|P9|Initial Period (Week 0 to Week 16)|Adverse Event|0
2471848|NCT02326272|8531685|P8|Initial Period (Week 0 to Week 16)|Adverse Event|0
2471849|NCT02326272|8531686|P7|Initial Period (Week 0 to Week 16)|Adverse Event|0
2471850|NCT02326272|8531687|P6|Initial Period (Week 0 to Week 16)|Adverse Event|0
2471851|NCT02326272|8531688|P5|Initial Period (Week 0 to Week 16)|Adverse Event|0
2471852|NCT02326272|8531689|P4|Initial Period (Week 0 to Week 16)|Adverse Event|0
2471853|NCT02326272|8531690|P3|Initial Period (Week 0 to Week 16)|Adverse Event|1
2471854|NCT02326272|8531691|P2|Initial Period (Week 0 to Week 16)|Adverse Event|3
2471855|NCT02326272|8531692|P1|Initial Period (Week 0 to Week 16)|Adverse Event|0
2471856|NCT02326025|8531729|P2|Overall Study|Protocol Violation|1
2471857|NCT02326025|8531730|P1|Overall Study|Protocol Violation|0
2471858|NCT02326025|8531729|P2|Overall Study|Withdrawal by Subject|2
2471859|NCT02326025|8531730|P1|Overall Study|Withdrawal by Subject|0
2471860|NCT02326025|8531729|P2|Overall Study|Physician and Participant Decision|0
2471861|NCT02326025|8531730|P1|Overall Study|Physician and Participant Decision|1
2471862|NCT02326025|8531729|P2|Overall Study|Physician Decision|2
2471863|NCT02326025|8531730|P1|Overall Study|Physician Decision|1
2471864|NCT02326025|8531729|P2|Overall Study|Adverse Event|0
2471865|NCT02326025|8531730|P1|Overall Study|Adverse Event|3
2471866|NCT02325791|8531777|P4|Overall Study|Withdrawal by Subject|16
2471867|NCT02325791|8531778|P3|Overall Study|Withdrawal by Subject|8
2471868|NCT02325791|8531779|P2|Overall Study|Withdrawal by Subject|5
2471869|NCT02325791|8531780|P1|Overall Study|Withdrawal by Subject|0
2471870|NCT02325791|8531777|P4|Overall Study|Protocol Violation|0
2471871|NCT02325791|8531778|P3|Overall Study|Protocol Violation|1
2471872|NCT02325791|8531779|P2|Overall Study|Protocol Violation|0
2471873|NCT02325791|8531780|P1|Overall Study|Protocol Violation|0
2471874|NCT02325791|8531777|P4|Overall Study|Physician Decision|0
2471875|NCT02325791|8531778|P3|Overall Study|Physician Decision|1
2471876|NCT02325791|8531779|P2|Overall Study|Physician Decision|1
2471877|NCT02325791|8531780|P1|Overall Study|Physician Decision|0
2471878|NCT02325791|8531777|P4|Overall Study|Lost to Follow-up|9
2471879|NCT02325791|8531778|P3|Overall Study|Lost to Follow-up|14
2471880|NCT02325791|8531779|P2|Overall Study|Lost to Follow-up|15
2471881|NCT02325791|8531780|P1|Overall Study|Lost to Follow-up|0
2471882|NCT02325791|8531777|P4|Overall Study|Death|1
2471883|NCT02325791|8531778|P3|Overall Study|Death|0
2471884|NCT02325791|8531779|P2|Overall Study|Death|3
2471885|NCT02325791|8531780|P1|Overall Study|Death|0
2471886|NCT02325791|8531777|P4|Overall Study|Adverse Event|0
2471887|NCT02325791|8531778|P3|Overall Study|Adverse Event|1
2471888|NCT02325791|8531779|P2|Overall Study|Adverse Event|1
2471889|NCT02325791|8531780|P1|Overall Study|Adverse Event|0
2471890|NCT02325713|8531815|P16|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2471891|NCT02325713|8531816|P15|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2471892|NCT02325713|8531817|P14|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2471893|NCT02325713|8531818|P13|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2471894|NCT02325713|8531819|P12|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2471895|NCT02325713|8531820|P11|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2471896|NCT02325713|8531821|P10|Intervention Period 3 (2 Days)|Withdrawal by Subject|1
2471897|NCT02325713|8531822|P9|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2471898|NCT02325713|8531823|P8|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2471899|NCT02325713|8531824|P7|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2471900|NCT02325713|8531825|P6|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2471901|NCT02325713|8531826|P5|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2471902|NCT02325713|8531827|P4|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2471903|NCT02325713|8531828|P3|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2471904|NCT02325713|8531829|P2|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2471905|NCT02325713|8531830|P1|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
2471906|NCT02325713|8531815|P16|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2471907|NCT02325713|8531816|P15|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2471908|NCT02325713|8531817|P14|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2471909|NCT02325713|8531818|P13|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2471910|NCT02325713|8531819|P12|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2471911|NCT02325713|8531820|P11|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2471912|NCT02325713|8531821|P10|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2471913|NCT02325713|8531822|P9|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2471914|NCT02325713|8531823|P8|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2471915|NCT02325713|8531824|P7|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2471916|NCT02325713|8531825|P6|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2471917|NCT02325713|8531826|P5|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2471918|NCT02325713|8531827|P4|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2471919|NCT02325713|8531828|P3|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2471920|NCT02325713|8531829|P2|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
2471921|NCT02325713|8531830|P1|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1
2471922|NCT02325713|8531815|P16|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2471923|NCT02325713|8531816|P15|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2471924|NCT02325713|8531817|P14|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2471925|NCT02325713|8531818|P13|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2471926|NCT02325713|8531819|P12|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2471927|NCT02325713|8531820|P11|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1
2471928|NCT02325713|8531821|P10|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2471929|NCT02325713|8531822|P9|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2471930|NCT02325713|8531823|P8|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2471931|NCT02325713|8531824|P7|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2471932|NCT02325713|8531825|P6|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2471933|NCT02325713|8531826|P5|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2471934|NCT02325713|8531827|P4|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2471935|NCT02325713|8531828|P3|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2471936|NCT02325713|8531829|P2|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2471937|NCT02325713|8531830|P1|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
2471938|NCT02325518|8531944|P2|Overall Study|Withdrawal by Subject|1
2471939|NCT02325518|8531945|P1|Overall Study|Withdrawal by Subject|0
2471940|NCT02325518|8531944|P2|Overall Study|Physician Decision|1
2471941|NCT02325518|8531945|P1|Overall Study|Physician Decision|0
2471942|NCT02325518|8531944|P2|Overall Study|Adverse Event|1
2471943|NCT02325518|8531945|P1|Overall Study|Adverse Event|4
2471944|NCT02324842|8531974|P3|Overall Study|Lost to Follow-up|2
2471945|NCT02324842|8531975|P2|Overall Study|Lost to Follow-up|1
2471946|NCT02324842|8531976|P1|Overall Study|Lost to Follow-up|1
2471947|NCT02324699|8532005|P1|Overall Study|study terminated|1
2471948|NCT02324569|8532125|P2|Overall Study|Inconvenient Schedule|0
2471949|NCT02324569|8532126|P1|Overall Study|Inconvenient Schedule|2
2471950|NCT02324569|8532125|P2|Overall Study|Change Insulin Dosage Exceeding Criteria|2
2471951|NCT02324569|8532126|P1|Overall Study|Change Insulin Dosage Exceeding Criteria|0
2471952|NCT02324569|8532125|P2|Overall Study|Lack of Efficacy|3
2471953|NCT02324569|8532126|P1|Overall Study|Lack of Efficacy|2
2471954|NCT02324569|8532125|P2|Overall Study|Voluntary Withdrawal|6
2471955|NCT02324569|8532126|P1|Overall Study|Voluntary Withdrawal|3
2471956|NCT02324569|8532125|P2|Overall Study|Pretreatment Event/Adverse Event|10
2471957|NCT02324569|8532126|P1|Overall Study|Pretreatment Event/Adverse Event|9
2471958|NCT02324465|8532159|P2|Overall Study|device failure|1
2471959|NCT02324465|8532160|P1|Overall Study|device failure|0
2471960|NCT02324205|8532187|P1|Overall Study|Withdrawal by Subject|37
2471961|NCT02324049|8532218|P1|Part C|Study terminated|11
2471962|NCT02323646|8532231|P3|Treatment Course 2|Non-compliance|1
2471963|NCT02323646|8532232|P2|Treatment Course 2|Non-compliance|1
2471964|NCT02323646|8532233|P1|Treatment Course 2|Non-compliance|0
2471965|NCT02323646|8532231|P3|Treatment Course 2|Lost to Follow-up|1
2471966|NCT02323646|8532232|P2|Treatment Course 2|Lost to Follow-up|0
2471967|NCT02323646|8532233|P1|Treatment Course 2|Lost to Follow-up|0
2471968|NCT02323646|8532231|P3|Treatment Course 2|Adverse Event|1
2471969|NCT02323646|8532232|P2|Treatment Course 2|Adverse Event|0
2471970|NCT02323646|8532233|P1|Treatment Course 2|Adverse Event|1
2471971|NCT02323646|8532231|P3|Treatment Course 1|Withdrawal by Subject|0
2471972|NCT02323646|8532232|P2|Treatment Course 1|Withdrawal by Subject|2
2471973|NCT02323646|8532233|P1|Treatment Course 1|Withdrawal by Subject|0
2471974|NCT02323646|8532231|P3|Treatment Course 1|Lost to Follow-up|2
2471975|NCT02323646|8532232|P2|Treatment Course 1|Lost to Follow-up|0
2471976|NCT02323646|8532233|P1|Treatment Course 1|Lost to Follow-up|1
2471977|NCT02323646|8532231|P3|Treatment Course 1|Heavy Bleeding|0
2471978|NCT02323646|8532232|P2|Treatment Course 1|Heavy Bleeding|1
2471979|NCT02323646|8532233|P1|Treatment Course 1|Heavy Bleeding|1
2471980|NCT02323646|8532231|P3|Treatment Course 1|Adverse Event|1
2471981|NCT02323646|8532232|P2|Treatment Course 1|Adverse Event|0
2471982|NCT02323646|8532233|P1|Treatment Course 1|Adverse Event|1
2471983|NCT02323204|8532281|P4|6-month Follow-up Survey Completion|Withdrawal by Subject|1
2471984|NCT02323204|8532282|P3|6-month Follow-up Survey Completion|Withdrawal by Subject|3
2471985|NCT02323204|8532283|P2|6-month Follow-up Survey Completion|Withdrawal by Subject|0
2471986|NCT02323204|8532284|P1|6-month Follow-up Survey Completion|Withdrawal by Subject|0
2471987|NCT02323204|8532281|P4|6-month Follow-up Survey Completion|Lost to Follow-up|43
2471988|NCT02323204|8532282|P3|6-month Follow-up Survey Completion|Lost to Follow-up|38
2471989|NCT02323204|8532283|P2|6-month Follow-up Survey Completion|Lost to Follow-up|50
2471990|NCT02323204|8532284|P1|6-month Follow-up Survey Completion|Lost to Follow-up|49
2471991|NCT02323204|8532281|P4|3-month Follow-up Survey Completion|Withdrawal by Subject|2
2471992|NCT02323204|8532282|P3|3-month Follow-up Survey Completion|Withdrawal by Subject|0
2471993|NCT02323204|8532283|P2|3-month Follow-up Survey Completion|Withdrawal by Subject|2
2471994|NCT02323204|8532284|P1|3-month Follow-up Survey Completion|Withdrawal by Subject|0
2471995|NCT02323204|8532281|P4|3-month Follow-up Survey Completion|Lost to Follow-up|42
2471996|NCT02323204|8532282|P3|3-month Follow-up Survey Completion|Lost to Follow-up|41
2471997|NCT02323204|8532283|P2|3-month Follow-up Survey Completion|Lost to Follow-up|45
2471998|NCT02323204|8532284|P1|3-month Follow-up Survey Completion|Lost to Follow-up|54
2471999|NCT02323204|8532281|P4|6-week Follow-up Intervention Booster|Withdrawal by Subject|2
2472000|NCT02323204|8532282|P3|6-week Follow-up Intervention Booster|Withdrawal by Subject|0
2472001|NCT02323204|8532283|P2|6-week Follow-up Intervention Booster|Withdrawal by Subject|8
2472002|NCT02323204|8532284|P1|6-week Follow-up Intervention Booster|Withdrawal by Subject|0
2472003|NCT02323204|8532281|P4|6-week Follow-up Intervention Booster|Lost to Follow-up|34
2472004|NCT02323204|8532282|P3|6-week Follow-up Intervention Booster|Lost to Follow-up|0
2472005|NCT02323204|8532283|P2|6-week Follow-up Intervention Booster|Lost to Follow-up|35
2472006|NCT02323204|8532284|P1|6-week Follow-up Intervention Booster|Lost to Follow-up|0
2472007|NCT02323204|8532281|P4|6-week Follow-up Survey Completion|Withdrawal by Subject|2
2472008|NCT02323204|8532282|P3|6-week Follow-up Survey Completion|Withdrawal by Subject|3
2472009|NCT02323204|8532283|P2|6-week Follow-up Survey Completion|Withdrawal by Subject|8
2472010|NCT02323204|8532284|P1|6-week Follow-up Survey Completion|Withdrawal by Subject|12
2472011|NCT02323204|8532281|P4|6-week Follow-up Survey Completion|Lost to Follow-up|35
2472012|NCT02323204|8532282|P3|6-week Follow-up Survey Completion|Lost to Follow-up|39
2472013|NCT02323204|8532283|P2|6-week Follow-up Survey Completion|Lost to Follow-up|28
2472014|NCT02323204|8532284|P1|6-week Follow-up Survey Completion|Lost to Follow-up|29
2472015|NCT02323204|8532281|P4|Baseline Survey Completion|Withdrawal by Subject|3
2472016|NCT02323204|8532282|P3|Baseline Survey Completion|Withdrawal by Subject|5
2472017|NCT02323204|8532283|P2|Baseline Survey Completion|Withdrawal by Subject|9
2472018|NCT02323204|8532284|P1|Baseline Survey Completion|Withdrawal by Subject|10
2472019|NCT02322892|8532357|P2|Overall Study|Protocol Violation|0
2472020|NCT02322892|8532358|P1|Overall Study|Protocol Violation|1
2472021|NCT02322892|8532357|P2|Overall Study|Met exclusion criteria|1
2472022|NCT02322892|8532358|P1|Overall Study|Met exclusion criteria|0
2472023|NCT02322892|8532357|P2|Overall Study|Surgery cancelled|2
2472024|NCT02322892|8532358|P1|Overall Study|Surgery cancelled|1
2472025|NCT02322879|8532374|P2|First Intervention|Physician Decision|0
2472026|NCT02322879|8532375|P1|First Intervention|Physician Decision|1
2472027|NCT02322866|8532383|P2|Overall Study|Other Miscellaneous Reasons|6
2472028|NCT02322866|8532384|P1|Overall Study|Other Miscellaneous Reasons|6
2472029|NCT02322866|8532383|P2|Overall Study|Lack of Efficacy|1
2472030|NCT02322866|8532384|P1|Overall Study|Lack of Efficacy|3
2472031|NCT02322866|8532383|P2|Overall Study|Noncompliance with Treatment|4
2472032|NCT02322866|8532384|P1|Overall Study|Noncompliance with Treatment|3
2472033|NCT02322866|8532383|P2|Overall Study|Protocol Violation|0
2472034|NCT02322866|8532384|P1|Overall Study|Protocol Violation|1
2472035|NCT02322866|8532383|P2|Overall Study|Lost to Follow-up|39
2472036|NCT02322866|8532384|P1|Overall Study|Lost to Follow-up|36
2472037|NCT02322866|8532383|P2|Overall Study|Withdrawal of Consent|25
2472038|NCT02322866|8532384|P1|Overall Study|Withdrawal of Consent|16
2472039|NCT02322866|8532383|P2|Overall Study|Adverse Event|11
2472040|NCT02322866|8532384|P1|Overall Study|Adverse Event|6
2472041|NCT02322814|8532411|P5|Overall Study|Withdrawal by Subject|3
2472042|NCT02322814|8532412|P4|Overall Study|Withdrawal by Subject|1
2472043|NCT02322814|8532413|P3|Overall Study|Withdrawal by Subject|2
2472044|NCT02322814|8532414|P2|Overall Study|Withdrawal by Subject|4
2472045|NCT02322814|8532415|P1|Overall Study|Withdrawal by Subject|5
2472046|NCT02322814|8532411|P5|Overall Study|Death|6
2472047|NCT02322814|8532412|P4|Overall Study|Death|10
2472048|NCT02322814|8532413|P3|Overall Study|Death|30
2472049|NCT02322814|8532414|P2|Overall Study|Death|22
2472050|NCT02322814|8532415|P1|Overall Study|Death|7
2472051|NCT02322814|8532411|P5|Overall Study|Protocol Violation|0
2472052|NCT02322814|8532412|P4|Overall Study|Protocol Violation|0
2472053|NCT02322814|8532413|P3|Overall Study|Protocol Violation|0
2472054|NCT02322814|8532414|P2|Overall Study|Protocol Violation|0
2472055|NCT02322814|8532415|P1|Overall Study|Protocol Violation|1
2472056|NCT02322814|8532411|P5|Overall Study|Other|0
2472057|NCT02322814|8532412|P4|Overall Study|Other|0
2472058|NCT02322814|8532413|P3|Overall Study|Other|0
2472059|NCT02322814|8532414|P2|Overall Study|Other|0
2472060|NCT02322814|8532415|P1|Overall Study|Other|2
2472061|NCT02322814|8532411|P5|Overall Study|Lost to Follow-up|0
2472062|NCT02322814|8532412|P4|Overall Study|Lost to Follow-up|0
2472063|NCT02322814|8532413|P3|Overall Study|Lost to Follow-up|1
2472064|NCT02322814|8532414|P2|Overall Study|Lost to Follow-up|2
2472065|NCT02322814|8532415|P1|Overall Study|Lost to Follow-up|1
2472066|NCT02322814|8532411|P5|Overall Study|Progressive Disease|0
2472067|NCT02322814|8532412|P4|Overall Study|Progressive Disease|1
2472068|NCT02322814|8532413|P3|Overall Study|Progressive Disease|0
2472069|NCT02322814|8532414|P2|Overall Study|Progressive Disease|2
2472070|NCT02322814|8532415|P1|Overall Study|Progressive Disease|0
2472071|NCT02322814|8532411|P5|Overall Study|Ongoing Study|22
2472072|NCT02322814|8532412|P4|Overall Study|Ongoing Study|20
2472073|NCT02322814|8532413|P3|Overall Study|Ongoing Study|14
2472074|NCT02322814|8532414|P2|Overall Study|Ongoing Study|13
2472075|NCT02322814|8532415|P1|Overall Study|Ongoing Study|0
2472076|NCT02322775|8532441|P2|Overall Study|Not willing to perform all FU visits|1
2472077|NCT02322775|8532442|P1|Overall Study|Not willing to perform all FU visits|0
2472078|NCT02322775|8532441|P2|Overall Study|Withdrawal by Subject|4
2472079|NCT02322775|8532442|P1|Overall Study|Withdrawal by Subject|3
2472080|NCT02322775|8532441|P2|Overall Study|Protocol Violation|0
2472081|NCT02322775|8532442|P1|Overall Study|Protocol Violation|1
2472082|NCT02322775|8532441|P2|Overall Study|Lost to Follow-up|1
2472083|NCT02322775|8532442|P1|Overall Study|Lost to Follow-up|0
2472085|NCT02322775|8532442|P1|Overall Study|Adverse Event|1
2472086|NCT02322749|8532468|P6|Period 3|Withdrawal by Subject|0
2472087|NCT02322749|8532469|P5|Period 3|Withdrawal by Subject|0
2472088|NCT02322749|8532470|P4|Period 3|Withdrawal by Subject|0
2472089|NCT02322749|8532471|P3|Period 3|Withdrawal by Subject|1
2472090|NCT02322749|8532472|P2|Period 3|Withdrawal by Subject|0
2472091|NCT02322749|8532473|P1|Period 3|Withdrawal by Subject|0
2472092|NCT02322749|8532468|P6|Period 2|Withdrawal by Subject|0
2472093|NCT02322749|8532469|P5|Period 2|Withdrawal by Subject|0
2472094|NCT02322749|8532470|P4|Period 2|Withdrawal by Subject|1
2472095|NCT02322749|8532471|P3|Period 2|Withdrawal by Subject|0
2472096|NCT02322749|8532472|P2|Period 2|Withdrawal by Subject|0
2472097|NCT02322749|8532473|P1|Period 2|Withdrawal by Subject|0
2472098|NCT02322749|8532468|P6|Period 2|Adverse Event|0
2472099|NCT02322749|8532469|P5|Period 2|Adverse Event|0
2472100|NCT02322749|8532470|P4|Period 2|Adverse Event|1
2472101|NCT02322749|8532471|P3|Period 2|Adverse Event|0
2472102|NCT02322749|8532472|P2|Period 2|Adverse Event|0
2472103|NCT02322749|8532473|P1|Period 2|Adverse Event|0
2472104|NCT02322710|8532498|P2|Overall Study|Protocol Violation|25
2472105|NCT02322710|8532499|P1|Overall Study|Protocol Violation|20
2472106|NCT02322710|8532498|P2|Overall Study|No efficacy assessment post-baseline|1
2472107|NCT02322710|8532499|P1|Overall Study|No efficacy assessment post-baseline|0
2472108|NCT02322411|8532512|P2|Overall Study|Lost to Follow-up|7
2472109|NCT02322411|8532513|P1|Overall Study|Lost to Follow-up|4
2472110|NCT02322281|8532532|P3|Overall Study|Miscellaneous|4
2472111|NCT02322281|8532533|P2|Overall Study|Miscellaneous|0
2472112|NCT02322281|8532534|P1|Overall Study|Miscellaneous|0
2472113|NCT02322281|8532532|P3|Overall Study|Missing|1
2472114|NCT02322281|8532533|P2|Overall Study|Missing|0
2472115|NCT02322281|8532534|P1|Overall Study|Missing|0
2472116|NCT02322281|8532532|P3|Overall Study|Study Terminated by Sponsor|0
2472117|NCT02322281|8532533|P2|Overall Study|Study Terminated by Sponsor|0
2472118|NCT02322281|8532534|P1|Overall Study|Study Terminated by Sponsor|2
2472119|NCT02322281|8532532|P3|Overall Study|Physician Decision|5
2472120|NCT02322281|8532533|P2|Overall Study|Physician Decision|0
2472121|NCT02322281|8532534|P1|Overall Study|Physician Decision|2
2472122|NCT02322281|8532532|P3|Overall Study|Withdrawal by Subject|6
2472123|NCT02322281|8532533|P2|Overall Study|Withdrawal by Subject|1
2472124|NCT02322281|8532534|P1|Overall Study|Withdrawal by Subject|1
2472125|NCT02322281|8532532|P3|Overall Study|Death|3
2472126|NCT02322281|8532533|P2|Overall Study|Death|3
2472127|NCT02322281|8532534|P1|Overall Study|Death|3
2472128|NCT02322281|8532532|P3|Overall Study|Adverse Event|6
2472129|NCT02322281|8532533|P2|Overall Study|Adverse Event|4
2472130|NCT02322281|8532534|P1|Overall Study|Adverse Event|3
2472131|NCT02322281|8532532|P3|Overall Study|Progressive Disease|49
2472132|NCT02322281|8532533|P2|Overall Study|Progressive Disease|14
2472133|NCT02322281|8532534|P1|Overall Study|Progressive Disease|42
2472134|NCT02322229|8532555|P1|Overall Study|Physician Decision|2
2472135|NCT02322216|8532567|P2|Overall Study|Withdrawal by Subject|4
2472136|NCT02322216|8532568|P1|Overall Study|Withdrawal by Subject|1
2472137|NCT02322216|8532567|P2|Overall Study|Adverse Event|0
2472138|NCT02322216|8532568|P1|Overall Study|Adverse Event|1
2472139|NCT02322190|8532575|P2|Overall Study|Death on study|0
2472140|NCT02322190|8532576|P1|Overall Study|Death on study|1
2472141|NCT02321930|8532584|P1|Overall Study|Lost to Follow-up|1
2472142|NCT02321800|8532594|P2|Overall Study|Other, Miscellaneous|1
2472143|NCT02321800|8532595|P1|Overall Study|Other, Miscellaneous|3
2472144|NCT02321800|8532594|P2|Overall Study|Adverse Event|3
2472145|NCT02321800|8532595|P1|Overall Study|Adverse Event|2
2472146|NCT02321800|8532594|P2|Overall Study|Lost to Follow-up|4
2472147|NCT02321800|8532595|P1|Overall Study|Lost to Follow-up|10
2472148|NCT02321800|8532594|P2|Overall Study|Protocol Violation|0
2472149|NCT02321800|8532595|P1|Overall Study|Protocol Violation|1
2472150|NCT02321800|8532594|P2|Overall Study|Death|0
2472151|NCT02321800|8532595|P1|Overall Study|Death|1
2472152|NCT02321800|8532594|P2|Overall Study|Withdrawal by Subject|3
2472153|NCT02321800|8532595|P1|Overall Study|Withdrawal by Subject|3
2472154|NCT02321462|8532684|P2|Overall Study|Subject withdrawn before any treatment|1
2472155|NCT02321462|8532685|P1|Overall Study|Subject withdrawn before any treatment|1
2472156|NCT02321462|8532684|P2|Overall Study|Withdrawal by Subject|2
2472157|NCT02321462|8532685|P1|Overall Study|Withdrawal by Subject|5
2472158|NCT02321436|8532707|P2|Overall Study|Lost to Follow-up|1
2472159|NCT02321436|8532708|P1|Overall Study|Lost to Follow-up|0
2472160|NCT02321436|8532707|P2|Overall Study|Withdrawal by Subject|0
2472161|NCT02321436|8532708|P1|Overall Study|Withdrawal by Subject|1
2472162|NCT02321098|8532752|P3|Additional 15 Months Treatment|Withdrawal by Subject|1
2472163|NCT02321098|8532753|P2|Additional 15 Months Treatment|Withdrawal by Subject|0
2472164|NCT02321098|8532754|P1|Additional 15 Months Treatment|Withdrawal by Subject|0
2472165|NCT02321098|8532752|P3|Additional 15 Months Treatment|Lost to Follow-up|1
2472166|NCT02321098|8532753|P2|Additional 15 Months Treatment|Lost to Follow-up|0
2472167|NCT02321098|8532754|P1|Additional 15 Months Treatment|Lost to Follow-up|0
2472168|NCT02321098|8532752|P3|Additional 15 Months Treatment|Lack of Efficacy|6
2472169|NCT02321098|8532753|P2|Additional 15 Months Treatment|Lack of Efficacy|0
2472170|NCT02321098|8532754|P1|Additional 15 Months Treatment|Lack of Efficacy|0
2472171|NCT02321098|8532752|P3|12 Weeks Treament|Lost to Follow-up|0
2472172|NCT02321098|8532753|P2|12 Weeks Treament|Lost to Follow-up|1
2472173|NCT02321098|8532754|P1|12 Weeks Treament|Lost to Follow-up|1
2472174|NCT02320903|8532766|P3|Overall Study|Lost to Follow-up|5
2472175|NCT02320903|8532767|P2|Overall Study|Lost to Follow-up|5
2472176|NCT02320903|8532768|P1|Overall Study|Lost to Follow-up|0
2472177|NCT02320903|8532766|P3|Overall Study|Exited therapy; no longer eligible|2
2472178|NCT02320903|8532767|P2|Overall Study|Exited therapy; no longer eligible|2
2472179|NCT02320903|8532768|P1|Overall Study|Exited therapy; no longer eligible|8
2472180|NCT02320903|8532766|P3|Overall Study|Withdrawal by Subject|9
2472181|NCT02320903|8532767|P2|Overall Study|Withdrawal by Subject|9
2472182|NCT02320903|8532768|P1|Overall Study|Withdrawal by Subject|0
2472183|NCT02320721|8532893|P2|Overall Study|Other than specified above|20
2472184|NCT02320721|8532894|P1|Overall Study|Other than specified above|15
2472185|NCT02320721|8532893|P2|Overall Study|Hypoglycemia|0
2472186|NCT02320721|8532894|P1|Overall Study|Hypoglycemia|1
2472187|NCT02320721|8532893|P2|Overall Study|Randomized but not treated|1
2472188|NCT02320721|8532894|P1|Overall Study|Randomized but not treated|0
2472189|NCT02320721|8532893|P2|Overall Study|Poor compliance to protocol|7
2472190|NCT02320721|8532894|P1|Overall Study|Poor compliance to protocol|3
2472191|NCT02320721|8532893|P2|Overall Study|Lack of Efficacy|0
2472192|NCT02320721|8532894|P1|Overall Study|Lack of Efficacy|2
2472193|NCT02320721|8532893|P2|Overall Study|Adverse Event|6
2472194|NCT02320721|8532894|P1|Overall Study|Adverse Event|6
2472195|NCT02320487|8532949|P1|Overall Study|Adverse Event|11
2472196|NCT02320487|8532949|P1|Overall Study|Death|3
2472197|NCT02320487|8532949|P1|Overall Study|Withdrawal by Subject|1
2472198|NCT02320487|8532949|P1|Overall Study|Physician Decision|5
2472199|NCT02320487|8532949|P1|Overall Study|Reason not Specified|1
2472200|NCT02320396|8532969|P2|Overall Study|Withdrawal by Subject|0
2472201|NCT02320396|8532970|P1|Overall Study|Withdrawal by Subject|2
2472202|NCT02320396|8532969|P2|Overall Study|Protocol Violation|1
2472203|NCT02320396|8532970|P1|Overall Study|Protocol Violation|0
2472204|NCT02320396|8532969|P2|Overall Study|Pregnancy|1
2472205|NCT02320396|8532970|P1|Overall Study|Pregnancy|0
2472206|NCT02320396|8532969|P2|Overall Study|Adverse Event|2
2472207|NCT02320396|8532970|P1|Overall Study|Adverse Event|2
2472208|NCT02320149|8533012|P2|Overall Study|Other Miscellaneous Reasons|3
2472209|NCT02320149|8533013|P1|Overall Study|Other Miscellaneous Reasons|2
2472210|NCT02320149|8533012|P2|Overall Study|Lack of Efficacy|1
2472211|NCT02320149|8533013|P1|Overall Study|Lack of Efficacy|0
2472212|NCT02320149|8533012|P2|Overall Study|Noncompliance with Study Treatment|2
2472213|NCT02320149|8533013|P1|Overall Study|Noncompliance with Study Treatment|7
2472214|NCT02320149|8533012|P2|Overall Study|Protocol Violation|1
2472215|NCT02320149|8533013|P1|Overall Study|Protocol Violation|2
2472216|NCT02320149|8533012|P2|Overall Study|Lost to Follow-up|34
2472217|NCT02320149|8533013|P1|Overall Study|Lost to Follow-up|21
2472218|NCT02320149|8533012|P2|Overall Study|Withdrawal of Consent|32
2472219|NCT02320149|8533013|P1|Overall Study|Withdrawal of Consent|28
2472220|NCT02320149|8533012|P2|Overall Study|Adverse Event|7
2472221|NCT02320149|8533013|P1|Overall Study|Adverse Event|3
2472222|NCT02319668|8533120|P2|Overall Study|Other (Not specified)|2
2472223|NCT02319668|8533121|P1|Overall Study|Other (Not specified)|0
2472224|NCT02319642|8533135|P2|Overall Study|Withdrawal by Subject|1
2472225|NCT02319642|8533136|P1|Overall Study|Withdrawal by Subject|1
2472226|NCT02319642|8533135|P2|Overall Study|Lack of Efficacy|1
2472227|NCT02319642|8533136|P1|Overall Study|Lack of Efficacy|1
2472228|NCT02319642|8533135|P2|Overall Study|Adverse Event|4
2472229|NCT02319642|8533136|P1|Overall Study|Adverse Event|2
2472230|NCT02319525|8533156|P2|Overall Study|Withdrawal by Subject|1
2472231|NCT02319525|8533157|P1|Overall Study|Withdrawal by Subject|2
2472232|NCT02319148|8533199|P4|Second Intervention Period|Other|1
2472233|NCT02319148|8533200|P3|Second Intervention Period|Other|0
2472234|NCT02319148|8533201|P2|Second Intervention Period|Other|0
2472235|NCT02319148|8533202|P1|Second Intervention Period|Other|0
2472236|NCT02319148|8533199|P4|Second Intervention Period|No longer willing to participate|0
2472237|NCT02319148|8533200|P3|Second Intervention Period|No longer willing to participate|0
2472238|NCT02319148|8533201|P2|Second Intervention Period|No longer willing to participate|1
2472239|NCT02319148|8533202|P1|Second Intervention Period|No longer willing to participate|0
2472240|NCT02319148|8533199|P4|Second Intervention Period|Adverse event (AE) related to study drug|1
2472241|NCT02319148|8533200|P3|Second Intervention Period|Adverse event (AE) related to study drug|1
2472242|NCT02319148|8533201|P2|Second Intervention Period|Adverse event (AE) related to study drug|0
2472243|NCT02319148|8533202|P1|Second Intervention Period|Adverse event (AE) related to study drug|0
2472244|NCT02319044|8533265|P3|Overall Study|Not treated|2
2472245|NCT02319044|8533266|P2|Overall Study|Not treated|2
2472246|NCT02319044|8533267|P1|Overall Study|Not treated|0
2472247|NCT02319044|8533265|P3|Overall Study|Study specific discontinuation criteria|1
2472248|NCT02319044|8533266|P2|Overall Study|Study specific discontinuation criteria|2
2472249|NCT02319044|8533267|P1|Overall Study|Study specific discontinuation criteria|2
2472250|NCT02319044|8533265|P3|Overall Study|Adverse Event|8
2472251|NCT02319044|8533266|P2|Overall Study|Adverse Event|2
2472252|NCT02319044|8533267|P1|Overall Study|Adverse Event|17
2472253|NCT02319044|8533265|P3|Overall Study|Condition under investigation worsened|46
2472254|NCT02319044|8533266|P2|Overall Study|Condition under investigation worsened|50
2472255|NCT02319044|8533267|P1|Overall Study|Condition under investigation worsened|100
2472256|NCT02319044|8533265|P3|Overall Study|Withdrawal by Subject|6
2472257|NCT02319044|8533266|P2|Overall Study|Withdrawal by Subject|3
2472258|NCT02319044|8533267|P1|Overall Study|Withdrawal by Subject|3
2472259|NCT02319044|8533265|P3|Overall Study|Death, PI/sponsor decision, med history|4
2472260|NCT02319044|8533266|P2|Overall Study|Death, PI/sponsor decision, med history|1
2472261|NCT02319044|8533267|P1|Overall Study|Death, PI/sponsor decision, med history|0
2472262|NCT02319031|8533323|P2|Treatment Period|Death|0
2472263|NCT02319031|8533324|P1|Treatment Period|Death|1
2472264|NCT02318940|8533388|P2|Overall Study|lost the record|0
2472265|NCT02318940|8533389|P1|Overall Study|lost the record|1
2472266|NCT02318797|8533431|P2|Overall Study|Lost to Follow-up|96
2472267|NCT02318797|8533432|P1|Overall Study|Lost to Follow-up|85
2472268|NCT02318797|8533431|P2|Overall Study|Death|6
2472269|NCT02318797|8533432|P1|Overall Study|Death|3
2472270|NCT02318693|8533472|P2|Overall Study|Protocol Violation|1
2472271|NCT02318693|8533473|P1|Overall Study|Protocol Violation|0
2472272|NCT02318667|8533487|P1|Overall Study|Protocol Violation|2
2472273|NCT02318667|8533487|P1|Overall Study|Lack of Efficacy|6
2472274|NCT02318667|8533487|P1|Overall Study|Adverse Event|1
2472275|NCT02318602|8533506|P3|Overall Study|Guardian decision to withdraw|1
2472276|NCT02318602|8533507|P2|Overall Study|Guardian decision to withdraw|0
2472277|NCT02318602|8533508|P1|Overall Study|Guardian decision to withdraw|0
2472278|NCT02318602|8533506|P3|Overall Study|Death|0
2472279|NCT02318602|8533507|P2|Overall Study|Death|0
2472280|NCT02318602|8533508|P1|Overall Study|Death|1
2472281|NCT02318602|8533506|P3|Overall Study|Withdrawal by Subject|0
2472282|NCT02318602|8533507|P2|Overall Study|Withdrawal by Subject|3
2472283|NCT02318602|8533508|P1|Overall Study|Withdrawal by Subject|0
2472284|NCT02318602|8533506|P3|Overall Study|Adverse Event|1
2472285|NCT02318602|8533507|P2|Overall Study|Adverse Event|1
2472286|NCT02318602|8533508|P1|Overall Study|Adverse Event|0
2472287|NCT02318329|8533549|P10|Overall Study|Other|1
2472288|NCT02318329|8533550|P9|Overall Study|Other|1
2472289|NCT02318329|8533551|P8|Overall Study|Other|0
2472290|NCT02318329|8533552|P7|Overall Study|Other|0
2472291|NCT02318329|8533553|P6|Overall Study|Other|0
2472292|NCT02318329|8533554|P5|Overall Study|Other|0
2472293|NCT02318329|8533555|P4|Overall Study|Other|0
2472294|NCT02318329|8533556|P3|Overall Study|Other|1
2472295|NCT02318329|8533557|P2|Overall Study|Other|1
2472296|NCT02318329|8533558|P1|Overall Study|Other|1
2472297|NCT02318329|8533549|P10|Overall Study|Withdrawal by Subject|6
2472298|NCT02318329|8533550|P9|Overall Study|Withdrawal by Subject|0
2472299|NCT02318329|8533551|P8|Overall Study|Withdrawal by Subject|0
2472300|NCT02318329|8533552|P7|Overall Study|Withdrawal by Subject|0
2472301|NCT02318329|8533553|P6|Overall Study|Withdrawal by Subject|0
2472302|NCT02318329|8533554|P5|Overall Study|Withdrawal by Subject|0
2472303|NCT02318329|8533555|P4|Overall Study|Withdrawal by Subject|0
2472304|NCT02318329|8533556|P3|Overall Study|Withdrawal by Subject|0
2472305|NCT02318329|8533557|P2|Overall Study|Withdrawal by Subject|0
2472306|NCT02318329|8533558|P1|Overall Study|Withdrawal by Subject|0
2472307|NCT02318329|8533549|P10|Overall Study|Lost to Follow-up|1
2472308|NCT02318329|8533550|P9|Overall Study|Lost to Follow-up|0
2472309|NCT02318329|8533551|P8|Overall Study|Lost to Follow-up|0
2472310|NCT02318329|8533552|P7|Overall Study|Lost to Follow-up|0
2472311|NCT02318329|8533553|P6|Overall Study|Lost to Follow-up|0
2472312|NCT02318329|8533554|P5|Overall Study|Lost to Follow-up|0
2472313|NCT02318329|8533555|P4|Overall Study|Lost to Follow-up|0
2472314|NCT02318329|8533556|P3|Overall Study|Lost to Follow-up|0
2472315|NCT02318329|8533557|P2|Overall Study|Lost to Follow-up|0
2472316|NCT02318329|8533558|P1|Overall Study|Lost to Follow-up|0
2472317|NCT02318329|8533549|P10|Overall Study|Death|5
2472318|NCT02318329|8533550|P9|Overall Study|Death|0
2472319|NCT02318329|8533551|P8|Overall Study|Death|0
2472320|NCT02318329|8533552|P7|Overall Study|Death|0
2472321|NCT02318329|8533553|P6|Overall Study|Death|0
2472322|NCT02318329|8533554|P5|Overall Study|Death|0
2472323|NCT02318329|8533555|P4|Overall Study|Death|0
2472324|NCT02318329|8533556|P3|Overall Study|Death|0
2472325|NCT02318329|8533557|P2|Overall Study|Death|0
2472326|NCT02318329|8533558|P1|Overall Study|Death|0
2472327|NCT02318329|8533549|P10|Overall Study|Progressive Disease|39
2472328|NCT02318329|8533550|P9|Overall Study|Progressive Disease|5
2472329|NCT02318329|8533551|P8|Overall Study|Progressive Disease|1
2472330|NCT02318329|8533552|P7|Overall Study|Progressive Disease|1
2472331|NCT02318329|8533553|P6|Overall Study|Progressive Disease|3
2472332|NCT02318329|8533554|P5|Overall Study|Progressive Disease|3
2472333|NCT02318329|8533555|P4|Overall Study|Progressive Disease|3
2472334|NCT02318329|8533556|P3|Overall Study|Progressive Disease|2
2472335|NCT02318329|8533557|P2|Overall Study|Progressive Disease|3
2472336|NCT02318329|8533558|P1|Overall Study|Progressive Disease|2
2472337|NCT02317809|8533643|P2|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0
2472338|NCT02317809|8533644|P1|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1
2472339|NCT02317809|8533643|P2|First Intervention Period (8 Days)|Protocol Non-Compliance|0
2472340|NCT02317809|8533644|P1|First Intervention Period (8 Days)|Protocol Non-Compliance|2
2472341|NCT02317614|8533732|P2|Overall Study|Death|1
2472342|NCT02317614|8533733|P1|Overall Study|Death|1
2472343|NCT02317614|8533732|P2|Overall Study|Withdrawal by Subject|0
2472344|NCT02317614|8533733|P1|Overall Study|Withdrawal by Subject|1
2472345|NCT02317614|8533732|P2|Overall Study|Lost to Follow-up|1
2472346|NCT02317614|8533733|P1|Overall Study|Lost to Follow-up|1
2472347|NCT02317510|8533760|P2|Overall Study|Adverse Event|1
2472348|NCT02317510|8533761|P1|Overall Study|Adverse Event|0
2472349|NCT02317016|8533793|P1|Part B: Day 35 to End Part B (AZD9291)|Death|5
2472350|NCT02317016|8533793|P1|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2
2472351|NCT02317016|8533793|P1|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1
2472352|NCT02317016|8533793|P1|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23
2472353|NCT02317016|8533793|P1|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1
2472354|NCT02317016|8533793|P1|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1
2472355|NCT02317016|8533793|P1|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1
2472356|NCT02316847|8533821|P2|Overall Study|Withdrawn due to termination by Sponsor|67
2472357|NCT02316847|8533822|P1|Overall Study|Withdrawn due to termination by Sponsor|7
2472358|NCT02316847|8533821|P2|Overall Study|Noncompliance with study drug|3
2472359|NCT02316847|8533822|P1|Overall Study|Noncompliance with study drug|0
2472360|NCT02316847|8533821|P2|Overall Study|Withdrawal by Subject|9
2472361|NCT02316847|8533822|P1|Overall Study|Withdrawal by Subject|2
2472362|NCT02316847|8533821|P2|Overall Study|Pregnancy|1
2472363|NCT02316847|8533822|P1|Overall Study|Pregnancy|0
2472364|NCT02316847|8533821|P2|Overall Study|Physician Decision|1
2472365|NCT02316847|8533822|P1|Overall Study|Physician Decision|0
2472366|NCT02316847|8533821|P2|Overall Study|Lost to Follow-up|2
2472367|NCT02316847|8533822|P1|Overall Study|Lost to Follow-up|0
2472368|NCT02316847|8533821|P2|Overall Study|Adverse Event|3
2472369|NCT02316847|8533822|P1|Overall Study|Adverse Event|0
2472370|NCT02316769|8533833|P2|Overall Study|Withdrawal by Subject|0
2472371|NCT02316769|8533834|P1|Overall Study|Withdrawal by Subject|1
2472372|NCT02316769|8533833|P2|Overall Study|Physician Decision|0
2472373|NCT02316769|8533834|P1|Overall Study|Physician Decision|1
2472374|NCT02316717|8533845|P3|Overall Study|TBC|0
2472375|NCT02316717|8533846|P2|Overall Study|TBC|0
2472376|NCT02316717|8533847|P1|Overall Study|TBC|1
2472377|NCT02316717|8533845|P3|Overall Study|Physician Decision|0
2472378|NCT02316717|8533846|P2|Overall Study|Physician Decision|1
2472379|NCT02316717|8533847|P1|Overall Study|Physician Decision|0
2472380|NCT02316717|8533845|P3|Overall Study|Death|1
2472381|NCT02316717|8533846|P2|Overall Study|Death|0
2472382|NCT02316717|8533847|P1|Overall Study|Death|0
2472383|NCT02316717|8533845|P3|Overall Study|Withdrawal by Subject|1
2472384|NCT02316717|8533846|P2|Overall Study|Withdrawal by Subject|1
2472385|NCT02316717|8533847|P1|Overall Study|Withdrawal by Subject|2
2472386|NCT02316717|8533845|P3|Overall Study|Protocol Violation|0
2472387|NCT02316717|8533846|P2|Overall Study|Protocol Violation|0
2472388|NCT02316717|8533847|P1|Overall Study|Protocol Violation|2
2472389|NCT02316717|8533845|P3|Overall Study|Non compliance|0
2472390|NCT02316717|8533846|P2|Overall Study|Non compliance|1
2472391|NCT02316717|8533847|P1|Overall Study|Non compliance|3
2472392|NCT02316717|8533845|P3|Overall Study|Lost to Follow-up|1
2472393|NCT02316717|8533846|P2|Overall Study|Lost to Follow-up|2
2472394|NCT02316717|8533847|P1|Overall Study|Lost to Follow-up|1
2472395|NCT02316717|8533845|P3|Overall Study|Adverse Event|0
2472396|NCT02316717|8533846|P2|Overall Study|Adverse Event|2
2472397|NCT02316717|8533847|P1|Overall Study|Adverse Event|2
2472398|NCT02316613|8533984|P1|Overall Study|Did not met selection criteria|14
2472399|NCT02316613|8533984|P1|Overall Study|No data and duplicate cases|5
2472400|NCT02316613|8533984|P1|Overall Study|Participant moved/changed medical team|11
2472401|NCT02316613|8533984|P1|Overall Study|Lymphoma transformation|2
2472402|NCT02316613|8533984|P1|Overall Study|Lost to Follow-up|9
2472403|NCT02316613|8533984|P1|Overall Study|Death|63
2472404|NCT02316548|8534023|P2|Overall Study|Protocol Violation|1
2472405|NCT02316548|8534024|P1|Overall Study|Protocol Violation|0
2472406|NCT02316353|8534154|P2|Overall Study|Withdrawal by Subject|2
2472407|NCT02316353|8534155|P1|Overall Study|Withdrawal by Subject|6
2472408|NCT02316353|8534154|P2|Overall Study|Adverse Event|3
2472409|NCT02316353|8534155|P1|Overall Study|Adverse Event|1
2472410|NCT02316353|8534154|P2|Overall Study|Pregnancy|3
2472411|NCT02316353|8534155|P1|Overall Study|Pregnancy|1
2472412|NCT02316171|8534175|P4|Overall Study|difficulties with urinary catheter|0
2472413|NCT02316171|8534176|P3|Overall Study|difficulties with urinary catheter|0
2472414|NCT02316171|8534177|P2|Overall Study|difficulties with urinary catheter|0
2472415|NCT02316171|8534178|P1|Overall Study|difficulties with urinary catheter|1
2472416|NCT02315664|8534242|P2|Overall Study|Withdrawal by Subject|3
2472417|NCT02315664|8534243|P1|Overall Study|Withdrawal by Subject|0
2472418|NCT02315664|8534242|P2|Overall Study|Lost to Follow-up|1
2472419|NCT02315664|8534243|P1|Overall Study|Lost to Follow-up|1
2472420|NCT02315560|8534263|P1|Overall Study|noncompliance by subjects|3
2472421|NCT02314923|8534522|P10|Overall Study|Participant relocation|0
2472422|NCT02314923|8534523|P9|Overall Study|Participant relocation|0
2472423|NCT02314923|8534524|P8|Overall Study|Participant relocation|1
2472424|NCT02314923|8534525|P7|Overall Study|Participant relocation|0
2472425|NCT02314923|8534526|P6|Overall Study|Participant relocation|0
2472426|NCT02314923|8534527|P5|Overall Study|Participant relocation|0
2472427|NCT02314923|8534528|P4|Overall Study|Participant relocation|0
2472428|NCT02314923|8534529|P3|Overall Study|Participant relocation|0
2472429|NCT02314923|8534530|P2|Overall Study|Participant relocation|0
2472430|NCT02314923|8534531|P1|Overall Study|Participant relocation|1
2472431|NCT02314923|8534522|P10|Overall Study|Screen failure|0
2472432|NCT02314923|8534523|P9|Overall Study|Screen failure|0
2472433|NCT02314923|8534524|P8|Overall Study|Screen failure|0
2472434|NCT02314923|8534525|P7|Overall Study|Screen failure|1
2472435|NCT02314923|8534526|P6|Overall Study|Screen failure|0
2472436|NCT02314923|8534527|P5|Overall Study|Screen failure|0
2472437|NCT02314923|8534528|P4|Overall Study|Screen failure|0
2472438|NCT02314923|8534529|P3|Overall Study|Screen failure|0
2472439|NCT02314923|8534530|P2|Overall Study|Screen failure|0
2472440|NCT02314923|8534531|P1|Overall Study|Screen failure|0
2472441|NCT02314923|8534522|P10|Overall Study|Participant unavailable|0
2472442|NCT02314923|8534523|P9|Overall Study|Participant unavailable|0
2472443|NCT02314923|8534524|P8|Overall Study|Participant unavailable|0
2472444|NCT02314923|8534525|P7|Overall Study|Participant unavailable|0
2472445|NCT02314923|8534526|P6|Overall Study|Participant unavailable|1
2472446|NCT02314923|8534527|P5|Overall Study|Participant unavailable|0
2472447|NCT02314923|8534528|P4|Overall Study|Participant unavailable|0
2472448|NCT02314923|8534529|P3|Overall Study|Participant unavailable|0
2472449|NCT02314923|8534530|P2|Overall Study|Participant unavailable|0
2472450|NCT02314923|8534531|P1|Overall Study|Participant unavailable|0
2472451|NCT02314923|8534522|P10|Overall Study|Physician Decision|0
2472452|NCT02314923|8534523|P9|Overall Study|Physician Decision|0
2472453|NCT02314923|8534524|P8|Overall Study|Physician Decision|0
2472454|NCT02314923|8534525|P7|Overall Study|Physician Decision|0
2472455|NCT02314923|8534526|P6|Overall Study|Physician Decision|0
2472456|NCT02314923|8534527|P5|Overall Study|Physician Decision|0
2472457|NCT02314923|8534528|P4|Overall Study|Physician Decision|0
2472458|NCT02314923|8534529|P3|Overall Study|Physician Decision|0
2472459|NCT02314923|8534530|P2|Overall Study|Physician Decision|1
2472460|NCT02314923|8534531|P1|Overall Study|Physician Decision|0
2472461|NCT02314923|8534522|P10|Overall Study|Withdrawal by Subject|0
2472462|NCT02314923|8534523|P9|Overall Study|Withdrawal by Subject|0
2472463|NCT02314923|8534524|P8|Overall Study|Withdrawal by Subject|0
2472464|NCT02314923|8534525|P7|Overall Study|Withdrawal by Subject|1
2472465|NCT02314923|8534526|P6|Overall Study|Withdrawal by Subject|0
2472466|NCT02314923|8534527|P5|Overall Study|Withdrawal by Subject|1
2472467|NCT02314923|8534528|P4|Overall Study|Withdrawal by Subject|0
2472468|NCT02314923|8534529|P3|Overall Study|Withdrawal by Subject|1
2472469|NCT02314923|8534530|P2|Overall Study|Withdrawal by Subject|0
2472470|NCT02314923|8534531|P1|Overall Study|Withdrawal by Subject|0
2472471|NCT02314923|8534522|P10|Overall Study|Lost to Follow-up|0
2472472|NCT02314923|8534523|P9|Overall Study|Lost to Follow-up|2
2472473|NCT02314923|8534524|P8|Overall Study|Lost to Follow-up|4
2472474|NCT02314923|8534525|P7|Overall Study|Lost to Follow-up|3
2472475|NCT02314923|8534526|P6|Overall Study|Lost to Follow-up|0
2472476|NCT02314923|8534527|P5|Overall Study|Lost to Follow-up|0
2472477|NCT02314923|8534528|P4|Overall Study|Lost to Follow-up|0
2472478|NCT02314923|8534529|P3|Overall Study|Lost to Follow-up|1
2472479|NCT02314923|8534530|P2|Overall Study|Lost to Follow-up|3
2472480|NCT02314923|8534531|P1|Overall Study|Lost to Follow-up|2
2472481|NCT02314923|8534522|P10|Overall Study|Death|0
2472482|NCT02314923|8534523|P9|Overall Study|Death|0
2472483|NCT02314923|8534524|P8|Overall Study|Death|0
2472484|NCT02314923|8534525|P7|Overall Study|Death|0
2472485|NCT02314923|8534526|P6|Overall Study|Death|0
2472486|NCT02314923|8534527|P5|Overall Study|Death|0
2472487|NCT02314923|8534528|P4|Overall Study|Death|1
2472488|NCT02314923|8534529|P3|Overall Study|Death|0
2472489|NCT02314923|8534530|P2|Overall Study|Death|0
2472490|NCT02314923|8534531|P1|Overall Study|Death|0
2472491|NCT02314637|8534630|P2|Overall Study|Other Reason|0
2472492|NCT02314637|8534631|P1|Overall Study|Other Reason|1
2472493|NCT02314637|8534630|P2|Overall Study|Withdrawal by Subject|4
2472494|NCT02314637|8534631|P1|Overall Study|Withdrawal by Subject|5
2472495|NCT02314637|8534630|P2|Overall Study|Physician Decision|2
2472496|NCT02314637|8534631|P1|Overall Study|Physician Decision|5
2472497|NCT02314637|8534630|P2|Overall Study|Lack of Efficacy|0
2472498|NCT02314637|8534631|P1|Overall Study|Lack of Efficacy|1
2472499|NCT02314637|8534630|P2|Overall Study|Adverse Event|8
2472500|NCT02314637|8534631|P1|Overall Study|Adverse Event|4
2472501|NCT02314247|8534702|P3|Overall Study|Progression of Disease|0
2472502|NCT02314247|8534703|P2|Overall Study|Progression of Disease|2
2472503|NCT02314247|8534704|P1|Overall Study|Progression of Disease|6
2472504|NCT02314247|8534702|P3|Overall Study|Withdrawal by Subject|1
2472505|NCT02314247|8534703|P2|Overall Study|Withdrawal by Subject|3
2472506|NCT02314247|8534704|P1|Overall Study|Withdrawal by Subject|1
2472507|NCT02314247|8534702|P3|Overall Study|Adverse Event|0
2472508|NCT02314247|8534703|P2|Overall Study|Adverse Event|1
2472509|NCT02314247|8534704|P1|Overall Study|Adverse Event|2
2472510|NCT02314143|8534729|P3|Overall Study|Withdrawal by Subject|1
2472511|NCT02314143|8534730|P2|Overall Study|Withdrawal by Subject|0
2472512|NCT02314143|8534731|P1|Overall Study|Withdrawal by Subject|1
2472513|NCT02314143|8534729|P3|Overall Study|Physician Decision|0
2472514|NCT02314143|8534730|P2|Overall Study|Physician Decision|1
2472515|NCT02314143|8534731|P1|Overall Study|Physician Decision|2
2472516|NCT02314143|8534729|P3|Overall Study|Other (Study Closed/Terminated)|4
2472517|NCT02314143|8534730|P2|Overall Study|Other (Study Closed/Terminated)|3
2472518|NCT02314143|8534731|P1|Overall Study|Other (Study Closed/Terminated)|5
2472519|NCT02314143|8534729|P3|Overall Study|Adverse Event|4
2472520|NCT02314143|8534730|P2|Overall Study|Adverse Event|6
2472521|NCT02314143|8534731|P1|Overall Study|Adverse Event|0
2472522|NCT02314117|8534777|P2|Overall Study|No post-discontinuation follow-up|19
2472523|NCT02314117|8534778|P1|Overall Study|No post-discontinuation follow-up|21
2472524|NCT02314117|8534777|P2|Overall Study|Withdrawal by Subject|2
2472525|NCT02314117|8534778|P1|Overall Study|Withdrawal by Subject|2
2472526|NCT02314117|8534777|P2|Overall Study|On Treatment|6
2472527|NCT02314117|8534778|P1|Overall Study|On Treatment|10
2472528|NCT02314117|8534777|P2|Overall Study|Lost to Follow-up|11
2472529|NCT02314117|8534778|P1|Overall Study|Lost to Follow-up|8
2472530|NCT02314052|8534831|P6|Cycle One|Adverse Event|0
2472531|NCT02314052|8534832|P5|Cycle One|Adverse Event|0
2472532|NCT02314052|8534833|P4|Cycle One|Adverse Event|1
2472533|NCT02314052|8534834|P3|Cycle One|Adverse Event|0
2472534|NCT02314052|8534835|P2|Cycle One|Adverse Event|0
2472535|NCT02314052|8534836|P1|Cycle One|Adverse Event|0
2472536|NCT02314026|8534904|P1|Overall Study|Protocol Violation|28
2472537|NCT02313909|8534922|P2|Overall Study|Lost to Follow-up|17
2472538|NCT02313909|8534923|P1|Overall Study|Lost to Follow-up|24
2472539|NCT02313909|8534922|P2|Overall Study|Consent withdrawn by participant|33
2472540|NCT02313909|8534923|P1|Overall Study|Consent withdrawn by participant|33
2472541|NCT02313766|8534946|P3|Overall Study|Adverse Event|0
2472542|NCT02313766|8534947|P2|Overall Study|Adverse Event|1
2472543|NCT02313766|8534948|P1|Overall Study|Adverse Event|0
2472544|NCT02313766|8534946|P3|Overall Study|Lost to Follow-up|0
2472545|NCT02313766|8534947|P2|Overall Study|Lost to Follow-up|2
2472546|NCT02313766|8534948|P1|Overall Study|Lost to Follow-up|0
2472547|NCT02313766|8534946|P3|Overall Study|surgery cancelled|0
2472548|NCT02313766|8534947|P2|Overall Study|surgery cancelled|0
2472549|NCT02313766|8534948|P1|Overall Study|surgery cancelled|1
2472550|NCT02313558|8534985|P2|Overall Study|Lost to Follow-up|4
2472551|NCT02313558|8534986|P1|Overall Study|Lost to Follow-up|4
2472552|NCT02313558|8534985|P2|Overall Study|Withdrawal by Subject|0
2472553|NCT02313558|8534986|P1|Overall Study|Withdrawal by Subject|2
2472554|NCT02313233|8535032|P2|Overall Study|Administrative reason|1
2472555|NCT02313233|8535033|P1|Overall Study|Administrative reason|1
2472556|NCT02313233|8535032|P2|Overall Study|Withdrawal by Subject|2
2472557|NCT02313233|8535033|P1|Overall Study|Withdrawal by Subject|1
2472558|NCT02313155|8535055|P2|Overall Study|Lost to Follow-up|1
2472559|NCT02313155|8535056|P1|Overall Study|Lost to Follow-up|0
2472560|NCT02312934|8535106|P2|Overall Study|Physician Decision|0
2472561|NCT02312934|8535107|P1|Overall Study|Physician Decision|1
2472562|NCT02312934|8535106|P2|Overall Study|Lost to Follow-up|0
2472563|NCT02312934|8535107|P1|Overall Study|Lost to Follow-up|1
2472564|NCT02312856|8535119|P1|Overall Study|Lost to Follow-up|3
2472565|NCT02312856|8535119|P1|Overall Study|Death|1
2472566|NCT02312687|8535203|P1|Overall Study|Other, Not Specified|1
2472567|NCT02312219|8535262|P2|Overall Study|Not randomized. Ineligible|1
2472568|NCT02312219|8535263|P1|Overall Study|Not randomized. Ineligible|0
2472569|NCT02312219|8535262|P2|Overall Study|Other|1
2472570|NCT02312219|8535263|P1|Overall Study|Other|0
2472571|NCT02312219|8535262|P2|Overall Study|could not schedule imaging in time|2
2472572|NCT02312219|8535263|P1|Overall Study|could not schedule imaging in time|0
2472573|NCT02312219|8535262|P2|Overall Study|Withdrawal by Subject|2
2472574|NCT02312219|8535263|P1|Overall Study|Withdrawal by Subject|1
2472575|NCT02312206|8535273|P2|Overall Study|Subject missed 3 consecutive tx visits|1
2472576|NCT02312206|8535274|P1|Overall Study|Subject missed 3 consecutive tx visits|0
2472577|NCT02312206|8535273|P2|Overall Study|Patient transferred to hospice|1
2472578|NCT02312206|8535274|P1|Overall Study|Patient transferred to hospice|0
2472579|NCT02312206|8535273|P2|Overall Study|Patient progression and new therapy|0
2472580|NCT02312206|8535274|P1|Overall Study|Patient progression and new therapy|1
2472581|NCT02312206|8535273|P2|Overall Study|Disease Progression|0
2472582|NCT02312206|8535274|P1|Overall Study|Disease Progression|1
2472583|NCT02312206|8535273|P2|Overall Study|Study Terminated by Sponsor|74
2472584|NCT02312206|8535274|P1|Overall Study|Study Terminated by Sponsor|81
2472585|NCT02312206|8535273|P2|Overall Study|Death|36
2472586|NCT02312206|8535274|P1|Overall Study|Death|30
2472587|NCT02312206|8535273|P2|Overall Study|Physician Decision|6
2472588|NCT02312206|8535274|P1|Overall Study|Physician Decision|7
2472589|NCT02312206|8535273|P2|Overall Study|Withdrawal by Subject|6
2472590|NCT02312206|8535274|P1|Overall Study|Withdrawal by Subject|7
2472591|NCT02312206|8535273|P2|Overall Study|Adverse Event|6
2472592|NCT02312206|8535274|P1|Overall Study|Adverse Event|3
2472593|NCT02312063|8535297|P2|Overall Study|Withdrawal by Subject|1
2472594|NCT02312063|8535298|P1|Overall Study|Withdrawal by Subject|0
2472595|NCT02311894|8535351|P1|Overall Study|Withdrawal by Subject|1
2472596|NCT02311894|8535351|P1|Overall Study|Adverse Event|1
2472597|NCT02311894|8535351|P1|Overall Study|Lost to Follow-up|1
2472598|NCT02311894|8535351|P1|Overall Study|Discontinued in error|1
2472599|NCT02311881|8535363|P3|Overall Study|Serious Adverse Event|0
2472600|NCT02311881|8535364|P2|Overall Study|Serious Adverse Event|1
2472601|NCT02311881|8535365|P1|Overall Study|Serious Adverse Event|0
2472602|NCT02311881|8535363|P3|Overall Study|Participant taking another medication|1
2472603|NCT02311881|8535364|P2|Overall Study|Participant taking another medication|0
2472604|NCT02311881|8535365|P1|Overall Study|Participant taking another medication|0
2472605|NCT02311881|8535363|P3|Overall Study|Medical Monitor Discretion|1
2472606|NCT02311881|8535364|P2|Overall Study|Medical Monitor Discretion|0
2472607|NCT02311881|8535365|P1|Overall Study|Medical Monitor Discretion|0
2472608|NCT02311881|8535363|P3|Overall Study|Physician Decision|1
2472609|NCT02311881|8535364|P2|Overall Study|Physician Decision|0
2472610|NCT02311881|8535365|P1|Overall Study|Physician Decision|0
2472611|NCT02311881|8535363|P3|Overall Study|Non-Compliance|2
2472612|NCT02311881|8535364|P2|Overall Study|Non-Compliance|0
2472613|NCT02311881|8535365|P1|Overall Study|Non-Compliance|1
2472614|NCT02311881|8535363|P3|Overall Study|Protocol Deviation|0
2472615|NCT02311881|8535364|P2|Overall Study|Protocol Deviation|0
2472616|NCT02311881|8535365|P1|Overall Study|Protocol Deviation|1
2472617|NCT02311881|8535363|P3|Overall Study|Sponsor Decision|1
2472618|NCT02311881|8535364|P2|Overall Study|Sponsor Decision|1
2472619|NCT02311881|8535365|P1|Overall Study|Sponsor Decision|1
2472620|NCT02311881|8535363|P3|Overall Study|Withdrawal by Subject|4
2472621|NCT02311881|8535364|P2|Overall Study|Withdrawal by Subject|1
2472622|NCT02311881|8535365|P1|Overall Study|Withdrawal by Subject|3
2472623|NCT02311881|8535363|P3|Overall Study|Subject has border line pregnancy test|0
2472624|NCT02311881|8535364|P2|Overall Study|Subject has border line pregnancy test|0
2472625|NCT02311881|8535365|P1|Overall Study|Subject has border line pregnancy test|1
2472626|NCT02311881|8535363|P3|Overall Study|Lack of Efficacy|0
2472627|NCT02311881|8535364|P2|Overall Study|Lack of Efficacy|2
2472628|NCT02311881|8535365|P1|Overall Study|Lack of Efficacy|1
2472629|NCT02311881|8535363|P3|Overall Study|Other|1
2472630|NCT02311881|8535364|P2|Overall Study|Other|0
2472631|NCT02311881|8535365|P1|Overall Study|Other|0
2472632|NCT02311881|8535363|P3|Overall Study|Withdrawal of consent|17
2472633|NCT02311881|8535364|P2|Overall Study|Withdrawal of consent|16
2472634|NCT02311881|8535365|P1|Overall Study|Withdrawal of consent|14
2472635|NCT02311881|8535363|P3|Overall Study|Protocol Violation|3
2472636|NCT02311881|8535364|P2|Overall Study|Protocol Violation|2
2472637|NCT02311881|8535365|P1|Overall Study|Protocol Violation|1
2472638|NCT02311881|8535363|P3|Overall Study|Lost to Follow-up|2
2472639|NCT02311881|8535364|P2|Overall Study|Lost to Follow-up|3
2472640|NCT02311881|8535365|P1|Overall Study|Lost to Follow-up|3
2472641|NCT02311881|8535363|P3|Overall Study|Adverse Event|8
2472642|NCT02311881|8535364|P2|Overall Study|Adverse Event|15
2472643|NCT02311881|8535365|P1|Overall Study|Adverse Event|7
2472644|NCT02311881|8535363|P3|Overall Study|Did not meet the study criteria|0
2472645|NCT02311881|8535364|P2|Overall Study|Did not meet the study criteria|2
2472646|NCT02311881|8535365|P1|Overall Study|Did not meet the study criteria|2
2472647|NCT02311478|8535400|P1|Overall Study|Failed IUD Insertion|1
2472648|NCT02311478|8535400|P1|Overall Study|Lost to Follow-up|5
2472649|NCT02311478|8535400|P1|Overall Study|Withdrawal by Subject|1
2472650|NCT02311153|8535423|P2|Overall Study|Lost to Follow-up|7
2472651|NCT02311153|8535424|P1|Overall Study|Lost to Follow-up|5
2472652|NCT02310789|8535440|P1|Overall Study|Adverse Event|1
2472653|NCT02310763|8535452|P3|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
2472654|NCT02310763|8535453|P2|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
2472655|NCT02310763|8535454|P1|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
2472656|NCT02310763|8535452|P3|Period 1 (Weeks 1 to 48)|Adverse Event|0
2472657|NCT02310763|8535453|P2|Period 1 (Weeks 1 to 48)|Adverse Event|0
2472658|NCT02310763|8535454|P1|Period 1 (Weeks 1 to 48)|Adverse Event|1
2472659|NCT02310763|8535452|P3|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0
2472660|NCT02310763|8535453|P2|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0
2472661|NCT02310763|8535454|P1|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1
2472662|NCT02310763|8535452|P3|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1
2472663|NCT02310763|8535453|P2|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1
2472664|NCT02310763|8535454|P1|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0
2472665|NCT02310763|8535452|P3|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
2472666|NCT02310763|8535453|P2|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
2472667|NCT02310763|8535454|P1|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
2472668|NCT02310750|8535657|P16|HP Washout 2|Lost to Follow-up|0
2472669|NCT02310750|8535658|P15|HP Washout 2|Lost to Follow-up|0
2472670|NCT02310750|8535659|P14|HP Washout 2|Lost to Follow-up|0
2472671|NCT02310750|8535660|P13|HP Washout 2|Lost to Follow-up|0
2472672|NCT02310750|8535661|P12|HP Washout 2|Lost to Follow-up|0
2472673|NCT02310750|8535662|P11|HP Washout 2|Lost to Follow-up|0
2472674|NCT02310750|8535663|P10|HP Washout 2|Lost to Follow-up|0
2472675|NCT02310750|8535664|P9|HP Washout 2|Lost to Follow-up|0
2472676|NCT02310750|8535665|P8|HP Washout 2|Lost to Follow-up|0
2472677|NCT02310750|8535666|P7|HP Washout 2|Lost to Follow-up|7
2472678|NCT02310750|8535667|P6|HP Washout 2|Lost to Follow-up|0
2472679|NCT02310750|8535668|P5|HP Washout 2|Lost to Follow-up|1
2472680|NCT02310750|8535669|P4|HP Washout 2|Lost to Follow-up|0
2472681|NCT02310750|8535670|P3|HP Washout 2|Lost to Follow-up|0
2472682|NCT02310750|8535671|P2|HP Washout 2|Lost to Follow-up|0
2472683|NCT02310750|8535672|P1|HP Washout 2|Lost to Follow-up|0
2472684|NCT02310750|8535657|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2472685|NCT02310750|8535658|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2472686|NCT02310750|8535659|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2472687|NCT02310750|8535660|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2472688|NCT02310750|8535661|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2472689|NCT02310750|8535662|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2472690|NCT02310750|8535663|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2472691|NCT02310750|8535664|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
2472692|NCT02310750|8535665|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
2472693|NCT02310750|8535666|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2472694|NCT02310750|8535667|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2472695|NCT02310750|8535668|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2472696|NCT02310750|8535669|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2472697|NCT02310750|8535670|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2472698|NCT02310750|8535671|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2472699|NCT02310750|8535672|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
2472700|NCT02310750|8535657|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2472701|NCT02310750|8535658|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2472702|NCT02310750|8535659|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2472703|NCT02310750|8535660|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2472704|NCT02310750|8535661|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2472705|NCT02310750|8535662|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2472706|NCT02310750|8535663|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
2472707|NCT02310750|8535664|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
2472708|NCT02310750|8535665|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
2472709|NCT02310750|8535666|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2472710|NCT02310750|8535667|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2472711|NCT02310750|8535668|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2472712|NCT02310750|8535669|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2472713|NCT02310750|8535670|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2472714|NCT02310750|8535671|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2472715|NCT02310750|8535672|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
2472716|NCT02310750|8535657|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2472717|NCT02310750|8535658|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2472718|NCT02310750|8535659|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2472719|NCT02310750|8535660|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2472720|NCT02310750|8535661|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2472721|NCT02310750|8535662|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2472722|NCT02310750|8535663|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1
2472723|NCT02310750|8535664|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2472724|NCT02310750|8535665|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2472725|NCT02310750|8535666|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2472726|NCT02310750|8535667|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2472727|NCT02310750|8535668|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2472728|NCT02310750|8535669|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2472729|NCT02310750|8535670|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2472730|NCT02310750|8535671|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2472731|NCT02310750|8535672|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
2472732|NCT02310750|8535657|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2472733|NCT02310750|8535658|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2472734|NCT02310750|8535659|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2472735|NCT02310750|8535660|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2472736|NCT02310750|8535661|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2472737|NCT02310750|8535662|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2472738|NCT02310750|8535663|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
2472739|NCT02310750|8535664|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6
2472740|NCT02310750|8535665|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2472741|NCT02310750|8535666|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2472742|NCT02310750|8535667|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2
2472743|NCT02310750|8535668|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2472744|NCT02310750|8535669|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
2472745|NCT02310750|8535670|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2472746|NCT02310750|8535671|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2472747|NCT02310750|8535672|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
2472748|NCT02310750|8535657|P16|HP Washout 1|Lost to Follow-up|0
2472749|NCT02310750|8535658|P15|HP Washout 1|Lost to Follow-up|0
2472750|NCT02310750|8535659|P14|HP Washout 1|Lost to Follow-up|0
2472751|NCT02310750|8535660|P13|HP Washout 1|Lost to Follow-up|0
2472752|NCT02310750|8535661|P12|HP Washout 1|Lost to Follow-up|0
2472753|NCT02310750|8535662|P11|HP Washout 1|Lost to Follow-up|0
2472754|NCT02310750|8535663|P10|HP Washout 1|Lost to Follow-up|0
2472755|NCT02310750|8535664|P9|HP Washout 1|Lost to Follow-up|0
2472756|NCT02310750|8535665|P8|HP Washout 1|Lost to Follow-up|0
2472757|NCT02310750|8535666|P7|HP Washout 1|Lost to Follow-up|3
2472758|NCT02310750|8535667|P6|HP Washout 1|Lost to Follow-up|2
2472759|NCT02310750|8535668|P5|HP Washout 1|Lost to Follow-up|2
2472760|NCT02310750|8535669|P4|HP Washout 1|Lost to Follow-up|1
2472761|NCT02310750|8535670|P3|HP Washout 1|Lost to Follow-up|1
2472762|NCT02310750|8535671|P2|HP Washout 1|Lost to Follow-up|0
2472763|NCT02310750|8535672|P1|HP Washout 1|Lost to Follow-up|0
2472764|NCT02310750|8535657|P16|HP Period 1|Withdrawal by Subject|0
2472765|NCT02310750|8535658|P15|HP Period 1|Withdrawal by Subject|0
2472766|NCT02310750|8535659|P14|HP Period 1|Withdrawal by Subject|0
2472767|NCT02310750|8535660|P13|HP Period 1|Withdrawal by Subject|0
2472768|NCT02310750|8535661|P12|HP Period 1|Withdrawal by Subject|0
2472769|NCT02310750|8535662|P11|HP Period 1|Withdrawal by Subject|0
2472770|NCT02310750|8535663|P10|HP Period 1|Withdrawal by Subject|0
2472771|NCT02310750|8535664|P9|HP Period 1|Withdrawal by Subject|0
2472772|NCT02310750|8535665|P8|HP Period 1|Withdrawal by Subject|0
2472773|NCT02310750|8535666|P7|HP Period 1|Withdrawal by Subject|0
2472774|NCT02310750|8535667|P6|HP Period 1|Withdrawal by Subject|0
2472775|NCT02310750|8535668|P5|HP Period 1|Withdrawal by Subject|0
2472776|NCT02310750|8535669|P4|HP Period 1|Withdrawal by Subject|1
2472777|NCT02310750|8535670|P3|HP Period 1|Withdrawal by Subject|0
2472778|NCT02310750|8535671|P2|HP Period 1|Withdrawal by Subject|0
2472779|NCT02310750|8535672|P1|HP Period 1|Withdrawal by Subject|1
2472780|NCT02310750|8535657|P16|HP Period 1|Lost to Follow-up|0
2472781|NCT02310750|8535658|P15|HP Period 1|Lost to Follow-up|0
2472782|NCT02310750|8535659|P14|HP Period 1|Lost to Follow-up|0
2472783|NCT02310750|8535660|P13|HP Period 1|Lost to Follow-up|0
2472784|NCT02310750|8535661|P12|HP Period 1|Lost to Follow-up|0
2472785|NCT02310750|8535662|P11|HP Period 1|Lost to Follow-up|0
2472786|NCT02310750|8535663|P10|HP Period 1|Lost to Follow-up|0
2472787|NCT02310750|8535664|P9|HP Period 1|Lost to Follow-up|0
2472788|NCT02310750|8535665|P8|HP Period 1|Lost to Follow-up|0
2472789|NCT02310750|8535666|P7|HP Period 1|Lost to Follow-up|1
2472790|NCT02310750|8535667|P6|HP Period 1|Lost to Follow-up|0
2472791|NCT02310750|8535668|P5|HP Period 1|Lost to Follow-up|0
2472792|NCT02310750|8535669|P4|HP Period 1|Lost to Follow-up|0
2472793|NCT02310750|8535670|P3|HP Period 1|Lost to Follow-up|0
2472794|NCT02310750|8535671|P2|HP Period 1|Lost to Follow-up|0
2472795|NCT02310750|8535672|P1|HP Period 1|Lost to Follow-up|0
2472796|NCT02310646|8536113|P2|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0
2472797|NCT02310646|8536114|P1|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1
2472798|NCT02310646|8536113|P2|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0
2472799|NCT02310646|8536114|P1|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1
2472800|NCT02310581|8536142|P4|Overall Study|Withdrawal by Subject|1
2472801|NCT02310581|8536143|P3|Overall Study|Withdrawal by Subject|0
2472802|NCT02310581|8536144|P2|Overall Study|Withdrawal by Subject|1
2472803|NCT02310581|8536145|P1|Overall Study|Withdrawal by Subject|2
2472804|NCT02310581|8536142|P4|Overall Study|Adverse Event|0
2472805|NCT02310581|8536143|P3|Overall Study|Adverse Event|1
2472806|NCT02310581|8536144|P2|Overall Study|Adverse Event|1
2472807|NCT02310581|8536145|P1|Overall Study|Adverse Event|1
2472808|NCT02310568|8536184|P5|Stage 2 (4 Weeks)|Lost to Follow-up|0
2472809|NCT02310568|8536185|P4|Stage 2 (4 Weeks)|Lost to Follow-up|2
2472810|NCT02310568|8536186|P3|Stage 2 (4 Weeks)|Lost to Follow-up|0
2472811|NCT02310568|8536187|P2|Stage 2 (4 Weeks)|Lost to Follow-up|0
2472812|NCT02310568|8536188|P1|Stage 2 (4 Weeks)|Lost to Follow-up|0
2472813|NCT02310568|8536184|P5|Stage 2 (4 Weeks)|Protocol Violation|0
2472814|NCT02310568|8536185|P4|Stage 2 (4 Weeks)|Protocol Violation|1
2472815|NCT02310568|8536186|P3|Stage 2 (4 Weeks)|Protocol Violation|0
2472816|NCT02310568|8536187|P2|Stage 2 (4 Weeks)|Protocol Violation|0
2472817|NCT02310568|8536188|P1|Stage 2 (4 Weeks)|Protocol Violation|0
2472818|NCT02310568|8536184|P5|Stage 2 (4 Weeks)|Adverse Event|1
2472819|NCT02310568|8536185|P4|Stage 2 (4 Weeks)|Adverse Event|1
2472820|NCT02310568|8536186|P3|Stage 2 (4 Weeks)|Adverse Event|0
2472821|NCT02310568|8536187|P2|Stage 2 (4 Weeks)|Adverse Event|0
2472822|NCT02310568|8536188|P1|Stage 2 (4 Weeks)|Adverse Event|0
2472823|NCT02310568|8536184|P5|Stage 2 (4 Weeks)|Other|0
2472824|NCT02310568|8536185|P4|Stage 2 (4 Weeks)|Other|0
2472825|NCT02310568|8536186|P3|Stage 2 (4 Weeks)|Other|1
2472826|NCT02310568|8536187|P2|Stage 2 (4 Weeks)|Other|1
2472827|NCT02310568|8536188|P1|Stage 2 (4 Weeks)|Other|0
2472828|NCT02310568|8536184|P5|Stage 2 (4 Weeks)|Withdrawal by Participants|0
2472829|NCT02310568|8536185|P4|Stage 2 (4 Weeks)|Withdrawal by Participants|1
2472830|NCT02310568|8536186|P3|Stage 2 (4 Weeks)|Withdrawal by Participants|0
2472831|NCT02310568|8536187|P2|Stage 2 (4 Weeks)|Withdrawal by Participants|0
2472832|NCT02310568|8536188|P1|Stage 2 (4 Weeks)|Withdrawal by Participants|1
2472833|NCT02310568|8536184|P5|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
2472834|NCT02310568|8536185|P4|Stage 1 ( 4 Weeks)|Lost to Follow-up|1
2472835|NCT02310568|8536186|P3|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
2472836|NCT02310568|8536187|P2|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
2472837|NCT02310568|8536188|P1|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
2472838|NCT02310568|8536184|P5|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
2472839|NCT02310568|8536185|P4|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1
2472840|NCT02310568|8536186|P3|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
2472841|NCT02310568|8536187|P2|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
2472842|NCT02310568|8536188|P1|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
2472843|NCT02310568|8536184|P5|Stage 1 ( 4 Weeks)|Adverse Event|0
2472844|NCT02310568|8536185|P4|Stage 1 ( 4 Weeks)|Adverse Event|0
2472845|NCT02310568|8536186|P3|Stage 1 ( 4 Weeks)|Adverse Event|1
2472846|NCT02310568|8536187|P2|Stage 1 ( 4 Weeks)|Adverse Event|1
2472847|NCT02310568|8536188|P1|Stage 1 ( 4 Weeks)|Adverse Event|1
2472848|NCT02310568|8536184|P5|Stage 1 ( 4 Weeks)|Other|0
2472849|NCT02310568|8536185|P4|Stage 1 ( 4 Weeks)|Other|0
2472850|NCT02310568|8536186|P3|Stage 1 ( 4 Weeks)|Other|0
2472851|NCT02310568|8536187|P2|Stage 1 ( 4 Weeks)|Other|1
2472852|NCT02310568|8536188|P1|Stage 1 ( 4 Weeks)|Other|1
2472853|NCT02310568|8536184|P5|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
2472854|NCT02310568|8536185|P4|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
2472855|NCT02310568|8536186|P3|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
2472856|NCT02310568|8536187|P2|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
2472857|NCT02310568|8536188|P1|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1
2472858|NCT02310568|8536184|P5|Stage 1 ( 4 Weeks)|Lack of Efficacy|1
2472859|NCT02310568|8536185|P4|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
2472860|NCT02310568|8536186|P3|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
2472861|NCT02310568|8536187|P2|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
2472862|NCT02310568|8536188|P1|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
2472863|NCT02310126|8536268|P2|Period 1 (15 Minutes)|Protocol Violation|1
2472864|NCT02310126|8536269|P1|Period 1 (15 Minutes)|Protocol Violation|0
2472865|NCT02310126|8536268|P2|Period 1 (15 Minutes)|Lost to Follow-up|1
2472866|NCT02310126|8536269|P1|Period 1 (15 Minutes)|Lost to Follow-up|0
2472867|NCT02310100|8536275|P1|Overall Study|Lost to Follow-up|2
2472868|NCT02310100|8536275|P1|Overall Study|Visit compliance|1
2472869|NCT02310100|8536275|P1|Overall Study|Unapproved ablation operator|1
2472870|NCT02310100|8536275|P1|Overall Study|Enrollment closure|1
2472871|NCT02310100|8536275|P1|Overall Study|Withdrawal by Subject|10
2472872|NCT02310100|8536275|P1|Overall Study|Physician Decision|3
2472873|NCT02309723|8536283|P3|Overall Study|Withdrawal by Subject|24
2472874|NCT02309723|8536284|P2|Overall Study|Withdrawal by Subject|23
2472875|NCT02309723|8536285|P1|Overall Study|Withdrawal by Subject|24
2472876|NCT02309411|8536328|P3|Overall Study|Withdrawal by Subject|0
2472877|NCT02309411|8536329|P2|Overall Study|Withdrawal by Subject|1
2472878|NCT02309411|8536330|P1|Overall Study|Withdrawal by Subject|1
2472879|NCT02309411|8536328|P3|Overall Study|Physician Decision|0
2472880|NCT02309411|8536329|P2|Overall Study|Physician Decision|0
2472881|NCT02309411|8536330|P1|Overall Study|Physician Decision|1
2472882|NCT02309359|8536354|P5|Overall Study|Other|2
2472883|NCT02309359|8536355|P4|Overall Study|Other|3
2472884|NCT02309359|8536356|P3|Overall Study|Other|2
2472885|NCT02309359|8536357|P2|Overall Study|Other|0
2472886|NCT02309359|8536358|P1|Overall Study|Other|2
2472887|NCT02309359|8536354|P5|Overall Study|Lost to Follow-up|0
2472888|NCT02309359|8536355|P4|Overall Study|Lost to Follow-up|1
2472889|NCT02309359|8536356|P3|Overall Study|Lost to Follow-up|0
2472890|NCT02309359|8536357|P2|Overall Study|Lost to Follow-up|0
2472891|NCT02309359|8536358|P1|Overall Study|Lost to Follow-up|0
2472892|NCT02309359|8536354|P5|Overall Study|Lack of Efficacy|3
2472893|NCT02309359|8536355|P4|Overall Study|Lack of Efficacy|0
2472894|NCT02309359|8536356|P3|Overall Study|Lack of Efficacy|0
2472895|NCT02309359|8536357|P2|Overall Study|Lack of Efficacy|1
2472896|NCT02309359|8536358|P1|Overall Study|Lack of Efficacy|3
2472897|NCT02309359|8536354|P5|Overall Study|Withdrawal by Subject|0
2472898|NCT02309359|8536355|P4|Overall Study|Withdrawal by Subject|4
2472899|NCT02309359|8536356|P3|Overall Study|Withdrawal by Subject|4
2472900|NCT02309359|8536357|P2|Overall Study|Withdrawal by Subject|2
2472901|NCT02309359|8536358|P1|Overall Study|Withdrawal by Subject|2
2472902|NCT02309359|8536354|P5|Overall Study|Death|0
2472903|NCT02309359|8536355|P4|Overall Study|Death|0
2472904|NCT02309359|8536356|P3|Overall Study|Death|0
2472905|NCT02309359|8536357|P2|Overall Study|Death|0
2472906|NCT02309359|8536358|P1|Overall Study|Death|1
2472907|NCT02309359|8536354|P5|Overall Study|Adverse Event|4
2472908|NCT02309359|8536355|P4|Overall Study|Adverse Event|4
2472909|NCT02309359|8536356|P3|Overall Study|Adverse Event|5
2472910|NCT02309359|8536357|P2|Overall Study|Adverse Event|5
2472911|NCT02309359|8536358|P1|Overall Study|Adverse Event|4
2472912|NCT02309294|8536485|P1|Overall Study|Withdrawal by Subject|2
2472913|NCT02309112|8536492|P3|Overall Study|Lost to Follow-up|0
2472914|NCT02309112|8536493|P2|Overall Study|Lost to Follow-up|1
2472915|NCT02309112|8536494|P1|Overall Study|Lost to Follow-up|0
2472916|NCT02309112|8536492|P3|Overall Study|Withdrawal by Subject|1
2472917|NCT02309112|8536493|P2|Overall Study|Withdrawal by Subject|0
2472918|NCT02309112|8536494|P1|Overall Study|Withdrawal by Subject|1
2472919|NCT02309099|8536517|P2|Overall Study|Adverse Event|0
2472920|NCT02309099|8536518|P1|Overall Study|Adverse Event|2
2472921|NCT02308748|8536579|P10|Period 5|Adverse Event|0
2472922|NCT02308748|8536580|P9|Period 5|Adverse Event|1
2472923|NCT02308748|8536581|P8|Period 5|Adverse Event|0
2472924|NCT02308748|8536582|P7|Period 5|Adverse Event|0
2472925|NCT02308748|8536583|P6|Period 5|Adverse Event|0
2472926|NCT02308748|8536584|P5|Period 5|Adverse Event|0
2472927|NCT02308748|8536585|P4|Period 5|Adverse Event|0
2472928|NCT02308748|8536586|P3|Period 5|Adverse Event|0
2472929|NCT02308748|8536587|P2|Period 5|Adverse Event|0
2472930|NCT02308748|8536588|P1|Period 5|Adverse Event|1
2472931|NCT02308748|8536579|P10|Period 3|Protocol Violation|1
2472932|NCT02308748|8536580|P9|Period 3|Protocol Violation|0
2472933|NCT02308748|8536581|P8|Period 3|Protocol Violation|0
2472934|NCT02308748|8536582|P7|Period 3|Protocol Violation|0
2472935|NCT02308748|8536583|P6|Period 3|Protocol Violation|0
2472936|NCT02308748|8536584|P5|Period 3|Protocol Violation|0
2472937|NCT02308748|8536585|P4|Period 3|Protocol Violation|0
2472938|NCT02308748|8536586|P3|Period 3|Protocol Violation|0
2472939|NCT02308748|8536587|P2|Period 3|Protocol Violation|0
2472940|NCT02308748|8536588|P1|Period 3|Protocol Violation|0
2472941|NCT02308748|8536579|P10|Period 2|Adverse Event|0
2472942|NCT02308748|8536580|P9|Period 2|Adverse Event|0
2472943|NCT02308748|8536581|P8|Period 2|Adverse Event|1
2472944|NCT02308748|8536582|P7|Period 2|Adverse Event|0
2472945|NCT02308748|8536583|P6|Period 2|Adverse Event|0
2472946|NCT02308748|8536584|P5|Period 2|Adverse Event|0
2472947|NCT02308748|8536585|P4|Period 2|Adverse Event|0
2472948|NCT02308748|8536586|P3|Period 2|Adverse Event|0
2472949|NCT02308748|8536587|P2|Period 2|Adverse Event|0
2472950|NCT02308748|8536588|P1|Period 2|Adverse Event|0
2472951|NCT02308748|8536579|P10|Period 1|Withdrawal by Subject|0
2472952|NCT02308748|8536580|P9|Period 1|Withdrawal by Subject|0
2472953|NCT02308748|8536581|P8|Period 1|Withdrawal by Subject|0
2472954|NCT02308748|8536582|P7|Period 1|Withdrawal by Subject|0
2472955|NCT02308748|8536583|P6|Period 1|Withdrawal by Subject|0
2472956|NCT02308748|8536584|P5|Period 1|Withdrawal by Subject|0
2472957|NCT02308748|8536585|P4|Period 1|Withdrawal by Subject|0
2472958|NCT02308748|8536586|P3|Period 1|Withdrawal by Subject|1
2472959|NCT02308748|8536587|P2|Period 1|Withdrawal by Subject|0
2472960|NCT02308748|8536588|P1|Period 1|Withdrawal by Subject|0
2472961|NCT02308696|8536602|P2|Overall Study|Moved to a Higher Level of Care|6
2472962|NCT02308696|8536603|P1|Overall Study|Moved to a Higher Level of Care|17
2472963|NCT02308696|8536602|P2|Overall Study|Death|4
2472964|NCT02308696|8536603|P1|Overall Study|Death|8
2472965|NCT02308696|8536602|P2|Overall Study|Lost to Follow-up|21
2472966|NCT02308696|8536603|P1|Overall Study|Lost to Follow-up|28
2472967|NCT02308540|8536637|P6|Overall Study|Lost to Follow-up|1
2472968|NCT02308540|8536638|P5|Overall Study|Lost to Follow-up|0
2472969|NCT02308540|8536639|P4|Overall Study|Lost to Follow-up|0
2472970|NCT02308540|8536640|P3|Overall Study|Lost to Follow-up|0
2472971|NCT02308540|8536641|P2|Overall Study|Lost to Follow-up|0
2472972|NCT02308540|8536642|P1|Overall Study|Lost to Follow-up|0
2472973|NCT02308228|8536731|P2|Overall Study|Withdrawal by Subject|3
2472974|NCT02308228|8536732|P1|Overall Study|Withdrawal by Subject|5
2472975|NCT02308228|8536731|P2|Overall Study|Adverse Event|4
2472976|NCT02308228|8536732|P1|Overall Study|Adverse Event|3
2472977|NCT02308163|8536761|P5|Overall Study|Miscellaneous|5
2472978|NCT02308163|8536762|P4|Overall Study|Miscellaneous|0
2472979|NCT02308163|8536763|P3|Overall Study|Miscellaneous|1
2472980|NCT02308163|8536764|P2|Overall Study|Miscellaneous|2
2472981|NCT02308163|8536765|P1|Overall Study|Miscellaneous|2
2472982|NCT02308163|8536761|P5|Overall Study|Lab data met discontinuation criteria|0
2472983|NCT02308163|8536762|P4|Overall Study|Lab data met discontinuation criteria|2
2472984|NCT02308163|8536763|P3|Overall Study|Lab data met discontinuation criteria|0
2472985|NCT02308163|8536764|P2|Overall Study|Lab data met discontinuation criteria|0
2472986|NCT02308163|8536765|P1|Overall Study|Lab data met discontinuation criteria|3
2472987|NCT02308163|8536761|P5|Overall Study|Protocol Violation|5
2472988|NCT02308163|8536762|P4|Overall Study|Protocol Violation|2
2472989|NCT02308163|8536763|P3|Overall Study|Protocol Violation|3
2472990|NCT02308163|8536764|P2|Overall Study|Protocol Violation|3
2472991|NCT02308163|8536765|P1|Overall Study|Protocol Violation|3
2472992|NCT02308163|8536761|P5|Overall Study|Withdrawal of consent|6
2472993|NCT02308163|8536762|P4|Overall Study|Withdrawal of consent|2
2472994|NCT02308163|8536763|P3|Overall Study|Withdrawal of consent|0
2472995|NCT02308163|8536764|P2|Overall Study|Withdrawal of consent|3
2472996|NCT02308163|8536765|P1|Overall Study|Withdrawal of consent|2
2472997|NCT02308163|8536761|P5|Overall Study|Lack of Efficacy|6
2472998|NCT02308163|8536762|P4|Overall Study|Lack of Efficacy|4
2472999|NCT02308163|8536763|P3|Overall Study|Lack of Efficacy|8
2473000|NCT02308163|8536764|P2|Overall Study|Lack of Efficacy|3
2473001|NCT02308163|8536765|P1|Overall Study|Lack of Efficacy|11
2473002|NCT02308163|8536761|P5|Overall Study|Adverse Event|11
2473003|NCT02308163|8536762|P4|Overall Study|Adverse Event|2
2473004|NCT02308163|8536763|P3|Overall Study|Adverse Event|2
2473005|NCT02308163|8536764|P2|Overall Study|Adverse Event|5
2473006|NCT02308163|8536765|P1|Overall Study|Adverse Event|9
2473007|NCT02308163|8536761|P5|Overall Study|Not fulfill eligible criteria|1
2473008|NCT02308163|8536762|P4|Overall Study|Not fulfill eligible criteria|1
2473009|NCT02308163|8536763|P3|Overall Study|Not fulfill eligible criteria|0
2473010|NCT02308163|8536764|P2|Overall Study|Not fulfill eligible criteria|2
2473011|NCT02308163|8536765|P1|Overall Study|Not fulfill eligible criteria|1
2473012|NCT02308124|8537075|P3|Overall Study|Adverse Event|2
2473013|NCT02308124|8537076|P2|Overall Study|Adverse Event|2
2473014|NCT02308124|8537077|P1|Overall Study|Adverse Event|0
2473015|NCT02308124|8537075|P3|Overall Study|Lost to Follow-up|6
2473016|NCT02308124|8537076|P2|Overall Study|Lost to Follow-up|6
2473017|NCT02308124|8537077|P1|Overall Study|Lost to Follow-up|6
2473018|NCT02308020|8537103|P6|Overall Study|On treatment|0
2473019|NCT02308020|8537104|P5|Overall Study|On treatment|0
2473020|NCT02308020|8537105|P4|Overall Study|On treatment|0
2473021|NCT02308020|8537106|P3|Overall Study|On treatment|0
2473022|NCT02308020|8537107|P2|Overall Study|On treatment|3
2473023|NCT02308020|8537108|P1|Overall Study|On treatment|0
2473024|NCT02308020|8537103|P6|Overall Study|Withdrawal by Subject|0
2473025|NCT02308020|8537104|P5|Overall Study|Withdrawal by Subject|2
2473026|NCT02308020|8537105|P4|Overall Study|Withdrawal by Subject|3
2473027|NCT02308020|8537106|P3|Overall Study|Withdrawal by Subject|0
2473028|NCT02308020|8537107|P2|Overall Study|Withdrawal by Subject|4
2473029|NCT02308020|8537108|P1|Overall Study|Withdrawal by Subject|0
2473030|NCT02308020|8537103|P6|Overall Study|Physician Decision|1
2473031|NCT02308020|8537104|P5|Overall Study|Physician Decision|0
2473032|NCT02308020|8537105|P4|Overall Study|Physician Decision|0
2473033|NCT02308020|8537106|P3|Overall Study|Physician Decision|0
2473034|NCT02308020|8537107|P2|Overall Study|Physician Decision|0
2473035|NCT02308020|8537108|P1|Overall Study|Physician Decision|0
2473036|NCT02308020|8537103|P6|Overall Study|Protocol Violation|0
2473037|NCT02308020|8537104|P5|Overall Study|Protocol Violation|0
2473038|NCT02308020|8537105|P4|Overall Study|Protocol Violation|0
2473039|NCT02308020|8537106|P3|Overall Study|Protocol Violation|1
2473040|NCT02308020|8537107|P2|Overall Study|Protocol Violation|0
2473041|NCT02308020|8537108|P1|Overall Study|Protocol Violation|0
2473042|NCT02308020|8537103|P6|Overall Study|Adverse Event|1
2473043|NCT02308020|8537104|P5|Overall Study|Adverse Event|0
2473044|NCT02308020|8537105|P4|Overall Study|Adverse Event|1
2473045|NCT02308020|8537106|P3|Overall Study|Adverse Event|0
2473046|NCT02308020|8537107|P2|Overall Study|Adverse Event|5
2473047|NCT02308020|8537108|P1|Overall Study|Adverse Event|3
2473048|NCT02307682|8537209|P3|Overall Study|Other|0
2473049|NCT02307682|8537210|P2|Overall Study|Other|1
2473050|NCT02307682|8537211|P1|Overall Study|Other|1
2473051|NCT02307682|8537209|P3|Overall Study|Protocol Deviation|2
2473052|NCT02307682|8537210|P2|Overall Study|Protocol Deviation|0
2473053|NCT02307682|8537211|P1|Overall Study|Protocol Deviation|0
2473054|NCT02307682|8537209|P3|Overall Study|Lost to Follow-up|6
2473055|NCT02307682|8537210|P2|Overall Study|Lost to Follow-up|5
2473056|NCT02307682|8537211|P1|Overall Study|Lost to Follow-up|1
2473057|NCT02307682|8537209|P3|Overall Study|Death|12
2473058|NCT02307682|8537210|P2|Overall Study|Death|7
2473059|NCT02307682|8537211|P1|Overall Study|Death|9
2473060|NCT02307682|8537209|P3|Overall Study|Withdrawal by Subject|23
2473061|NCT02307682|8537210|P2|Overall Study|Withdrawal by Subject|34
2473062|NCT02307682|8537211|P1|Overall Study|Withdrawal by Subject|26
2473063|NCT02307682|8537209|P3|Overall Study|Progressive Disease|0
2473064|NCT02307682|8537210|P2|Overall Study|Progressive Disease|0
2473065|NCT02307682|8537211|P1|Overall Study|Progressive Disease|1
2473066|NCT02307682|8537209|P3|Overall Study|Physician Decision|8
2473067|NCT02307682|8537210|P2|Overall Study|Physician Decision|2
2473068|NCT02307682|8537211|P1|Overall Study|Physician Decision|2
2473069|NCT02307682|8537209|P3|Overall Study|Lack of Efficacy|1
2473070|NCT02307682|8537210|P2|Overall Study|Lack of Efficacy|0
2473071|NCT02307682|8537211|P1|Overall Study|Lack of Efficacy|1
2473072|NCT02307682|8537209|P3|Overall Study|Adverse Event|12
2473073|NCT02307682|8537210|P2|Overall Study|Adverse Event|8
2473074|NCT02307682|8537211|P1|Overall Study|Adverse Event|9
2473075|NCT02307513|8537327|P2|Active Treatment Phase (Weeks 13-64)|Pregnancy|1
2473076|NCT02307513|8537328|P1|Active Treatment Phase (Weeks 13-64)|Pregnancy|0
2473077|NCT02307513|8537327|P2|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1
2473078|NCT02307513|8537328|P1|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1
2473079|NCT02307513|8537327|P2|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7
2473080|NCT02307513|8537328|P1|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7
2473081|NCT02307513|8537327|P2|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2
2473082|NCT02307513|8537328|P1|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2
2473083|NCT02307513|8537327|P2|Active Treatment Phase (Weeks 13-64)|Adverse Event|4
2473084|NCT02307513|8537328|P1|Active Treatment Phase (Weeks 13-64)|Adverse Event|9
2473085|NCT02307513|8537327|P2|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0
2473086|NCT02307513|8537328|P1|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1
2473087|NCT02307513|8537327|P2|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1
2473088|NCT02307513|8537328|P1|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1
2473089|NCT02307513|8537327|P2|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1
2473090|NCT02307513|8537328|P1|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0
2473091|NCT02307513|8537327|P2|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5
2473092|NCT02307513|8537328|P1|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4
2473093|NCT02307513|8537327|P2|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1
2473094|NCT02307513|8537328|P1|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0
2473095|NCT02307513|8537327|P2|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8
2473096|NCT02307513|8537328|P1|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0
2473097|NCT02307513|8537327|P2|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4
2473098|NCT02307513|8537328|P1|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3
2473099|NCT02307266|8537379|P3|Overall Study|Lost to Follow-up|0
2473100|NCT02307266|8537380|P2|Overall Study|Lost to Follow-up|0
2473101|NCT02307266|8537381|P1|Overall Study|Lost to Follow-up|3
2473102|NCT02307266|8537379|P3|Overall Study|Withdrawal by Subject|1
2473103|NCT02307266|8537380|P2|Overall Study|Withdrawal by Subject|0
2473104|NCT02307266|8537381|P1|Overall Study|Withdrawal by Subject|2
2473105|NCT02307266|8537379|P3|Overall Study|Adverse Event|5
2473106|NCT02307266|8537380|P2|Overall Study|Adverse Event|1
2473107|NCT02307266|8537381|P1|Overall Study|Adverse Event|3
2473108|NCT02306850|8537406|P1|Overall Study|Lack of Efficacy|2
2473109|NCT02306694|8537428|P1|Overall Study|Lost to Follow-up|1
2473110|NCT02306694|8537428|P1|Overall Study|Withdrawal by Subject|3
2473111|NCT02306265|8537438|P1|Overall Study|Withdrawal by Subject|1
2473112|NCT02305888|8537447|P3|Overall Study|Adverse Event|0
2473113|NCT02305888|8537448|P2|Overall Study|Adverse Event|1
2473114|NCT02305888|8537449|P1|Overall Study|Adverse Event|0
2473115|NCT02305888|8537447|P3|Overall Study|Lost to Follow-up|1
2473116|NCT02305888|8537448|P2|Overall Study|Lost to Follow-up|0
2473117|NCT02305888|8537449|P1|Overall Study|Lost to Follow-up|0
2473118|NCT02305797|8537468|P2|Overall Study|Reason not collected|1
2473119|NCT02305797|8537469|P1|Overall Study|Reason not collected|0
2473120|NCT02305797|8537468|P2|Overall Study|Noncompliance|12
2473121|NCT02305797|8537469|P1|Overall Study|Noncompliance|14
2473122|NCT02305797|8537468|P2|Overall Study|Pregnancy|2
2473123|NCT02305797|8537469|P1|Overall Study|Pregnancy|0
2473124|NCT02305797|8537468|P2|Overall Study|Lost to Follow-up|11
2473125|NCT02305797|8537469|P1|Overall Study|Lost to Follow-up|5
2473126|NCT02305797|8537468|P2|Overall Study|Lack of Efficacy|0
2473127|NCT02305797|8537469|P1|Overall Study|Lack of Efficacy|6
2473128|NCT02305797|8537468|P2|Overall Study|Withdrawal by Subject|10
2473129|NCT02305797|8537469|P1|Overall Study|Withdrawal by Subject|9
2473130|NCT02305797|8537468|P2|Overall Study|Adverse Event|2
2473131|NCT02305797|8537469|P1|Overall Study|Adverse Event|11
2473132|NCT02305758|8537479|P2|Overall Study|Other, not specified|1
2473133|NCT02305758|8537480|P1|Overall Study|Other, not specified|2
2473134|NCT02305758|8537479|P2|Overall Study|Study Terminated by Sponsor|34
2473135|NCT02305758|8537480|P1|Overall Study|Study Terminated by Sponsor|21
2473136|NCT02305758|8537479|P2|Overall Study|Lost to Follow-up|1
2473137|NCT02305758|8537480|P1|Overall Study|Lost to Follow-up|6
2473138|NCT02305758|8537479|P2|Overall Study|Withdrew consent|2
2473139|NCT02305758|8537480|P1|Overall Study|Withdrew consent|9
2473140|NCT02305758|8537479|P2|Overall Study|Death|27
2473141|NCT02305758|8537480|P1|Overall Study|Death|27
2473142|NCT02305446|8537498|P1|Overall Study|Adverse Event|1
2473143|NCT02305381|8537506|P3|Overall Study|Unclassified|7
2473144|NCT02305381|8537507|P2|Overall Study|Unclassified|5
2473145|NCT02305381|8537508|P1|Overall Study|Unclassified|5
2473146|NCT02305238|8537621|P3|Overall Study|Required procedure failed|0
2473147|NCT02305238|8537622|P2|Overall Study|Required procedure failed|1
2473148|NCT02305238|8537623|P1|Overall Study|Required procedure failed|0
2473149|NCT02305238|8537621|P3|Overall Study|Randomized failure|8
2473150|NCT02305238|8537622|P2|Overall Study|Randomized failure|0
2473151|NCT02305238|8537623|P1|Overall Study|Randomized failure|0
2473152|NCT02305238|8537621|P3|Overall Study|Withdrawal by Subject|0
2473153|NCT02305238|8537622|P2|Overall Study|Withdrawal by Subject|4
2473154|NCT02305238|8537623|P1|Overall Study|Withdrawal by Subject|3
2473155|NCT02305238|8537621|P3|Overall Study|Adverse Event|0
2473156|NCT02305238|8537622|P2|Overall Study|Adverse Event|2
2473157|NCT02305238|8537623|P1|Overall Study|Adverse Event|4
2473158|NCT02305238|8537621|P3|Overall Study|Physician Decision|0
2473159|NCT02305238|8537622|P2|Overall Study|Physician Decision|1
2473160|NCT02305238|8537623|P1|Overall Study|Physician Decision|2
2473161|NCT02305238|8537621|P3|Overall Study|Protocol Violation|0
2473162|NCT02305238|8537622|P2|Overall Study|Protocol Violation|3
2473163|NCT02305238|8537623|P1|Overall Study|Protocol Violation|0
2473164|NCT02305238|8537621|P3|Overall Study|Logistical difficulties|0
2473165|NCT02305238|8537622|P2|Overall Study|Logistical difficulties|3
2473166|NCT02305238|8537623|P1|Overall Study|Logistical difficulties|1
2473167|NCT02305238|8537621|P3|Overall Study|Progressive disease|0
2473168|NCT02305238|8537622|P2|Overall Study|Progressive disease|4
2473169|NCT02305238|8537623|P1|Overall Study|Progressive disease|4
2473170|NCT02305238|8537621|P3|Overall Study|Death|0
2473171|NCT02305238|8537622|P2|Overall Study|Death|1
2473172|NCT02305238|8537623|P1|Overall Study|Death|2
2473173|NCT02304926|8537655|P2|Overall Study|Lost to Follow-up|1
2473174|NCT02304926|8537656|P1|Overall Study|Lost to Follow-up|2
2473175|NCT02304705|8537702|P2|Overall Study|Lost to Follow-up|2
2473176|NCT02304705|8537703|P1|Overall Study|Lost to Follow-up|0
2473177|NCT02304705|8537702|P2|Overall Study|Death|1
2473178|NCT02304705|8537703|P1|Overall Study|Death|0
2473179|NCT02304705|8537702|P2|Overall Study|Physician Decision|4
2473180|NCT02304705|8537703|P1|Overall Study|Physician Decision|2
2473181|NCT02304705|8537702|P2|Overall Study|Withdrawal by Subject|0
2473182|NCT02304705|8537703|P1|Overall Study|Withdrawal by Subject|2
2473183|NCT02304484|8537709|P1|Overall Study|Lost to Follow-up|2
2473184|NCT02304484|8537709|P1|Overall Study|Withdrawal by Subject|14
2473185|NCT02304484|8537709|P1|Overall Study|Death|9
2473186|NCT02303704|8537792|P2|Overall Study|Protocol Violation|9
2473187|NCT02303704|8537793|P1|Overall Study|Protocol Violation|5
2473188|NCT02303574|8537821|P10|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
2473189|NCT02303574|8537822|P9|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
2473190|NCT02303574|8537823|P8|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1
2473191|NCT02303574|8537824|P7|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
2473192|NCT02303574|8537825|P6|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
2473193|NCT02303574|8537826|P5|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
2473194|NCT02303574|8537827|P4|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
2473195|NCT02303574|8537828|P3|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
2473196|NCT02303574|8537829|P2|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
2473197|NCT02303574|8537830|P1|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
2473198|NCT02303574|8537821|P10|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
2473199|NCT02303574|8537822|P9|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
2473200|NCT02303574|8537823|P8|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
2473201|NCT02303574|8537824|P7|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
2473202|NCT02303574|8537825|P6|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
2473203|NCT02303574|8537826|P5|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
2473204|NCT02303574|8537827|P4|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
2473205|NCT02303574|8537828|P3|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1
2473206|NCT02303574|8537829|P2|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
2473207|NCT02303574|8537830|P1|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
2473208|NCT02303262|8538051|P1|Overall Study|Withdrawal by Subject|2
2473209|NCT02303041|8538059|P2|Overall Study|Adverse Event|2
2473210|NCT02303041|8538060|P1|Overall Study|Adverse Event|1
2473211|NCT02302859|8538076|P2|Overall Study|Withdrawal by Subject|1
2473212|NCT02302859|8538077|P1|Overall Study|Withdrawal by Subject|0
2473213|NCT02302859|8538076|P2|Overall Study|Lost Phone|1
2473214|NCT02302859|8538077|P1|Overall Study|Lost Phone|1
2473215|NCT02302846|8538083|P1|Overall Study|Withdrawal by Subject|1
2473216|NCT02302807|8538089|P2|Overall Study|Physician Decision|1
2473217|NCT02302807|8538090|P1|Overall Study|Physician Decision|0
2473218|NCT02302807|8538089|P2|Overall Study|Study Terminated By Sponsor|64
2473219|NCT02302807|8538090|P1|Overall Study|Study Terminated By Sponsor|35
2473220|NCT02302807|8538089|P2|Overall Study|Death|385
2473221|NCT02302807|8538090|P1|Overall Study|Death|397
2473222|NCT02302807|8538089|P2|Overall Study|Lost to Follow-up|6
2473223|NCT02302807|8538090|P1|Overall Study|Lost to Follow-up|4
2473224|NCT02302807|8538089|P2|Overall Study|Withdrawal by Subject|11
2473225|NCT02302807|8538090|P1|Overall Study|Withdrawal by Subject|28
2473226|NCT02302716|8538137|P2|Overall Study|Protocol Violation|1
2473227|NCT02302716|8538138|P1|Overall Study|Protocol Violation|0
2473228|NCT02302716|8538137|P2|Overall Study|Withdrawal by Subject|7
2473229|NCT02302716|8538138|P1|Overall Study|Withdrawal by Subject|13
2473230|NCT02302716|8538137|P2|Overall Study|Physician Decision|4
2473231|NCT02302716|8538138|P1|Overall Study|Physician Decision|3
2473232|NCT02302716|8538137|P2|Overall Study|Lost to Follow-up|4
2473233|NCT02302716|8538138|P1|Overall Study|Lost to Follow-up|2
2473234|NCT02302716|8538137|P2|Overall Study|Lack of Efficacy|1
2473235|NCT02302716|8538138|P1|Overall Study|Lack of Efficacy|0
2473236|NCT02302716|8538137|P2|Overall Study|Death|1
2473237|NCT02302716|8538138|P1|Overall Study|Death|0
2473238|NCT02302716|8538137|P2|Overall Study|Adverse Event|1
2473239|NCT02302716|8538138|P1|Overall Study|Adverse Event|1
2473240|NCT02302339|8538186|P4|Overall Study|Withdrawal by Subject|0
2473241|NCT02302339|8538187|P3|Overall Study|Withdrawal by Subject|1
2473242|NCT02302339|8538188|P2|Overall Study|Withdrawal by Subject|2
2473243|NCT02302339|8538189|P1|Overall Study|Withdrawal by Subject|0
2473244|NCT02302339|8538186|P4|Overall Study|Lost to Follow-up|0
2473245|NCT02302339|8538187|P3|Overall Study|Lost to Follow-up|0
2473246|NCT02302339|8538188|P2|Overall Study|Lost to Follow-up|0
2473247|NCT02302339|8538189|P1|Overall Study|Lost to Follow-up|1
2473248|NCT02302222|8538222|P2|Overall Study|Withdrawn prior to any treatment|1
2473249|NCT02302222|8538223|P1|Overall Study|Withdrawn prior to any treatment|0
2473250|NCT02302222|8538222|P2|Overall Study|Treatment discontinued before day 5|1
2473251|NCT02302222|8538223|P1|Overall Study|Treatment discontinued before day 5|0
2473252|NCT02302222|8538222|P2|Overall Study|Lost to Follow-up|0
2473253|NCT02302222|8538223|P1|Overall Study|Lost to Follow-up|1
2473254|NCT02302222|8538222|P2|Overall Study|Physician Decision|4
2473255|NCT02302222|8538223|P1|Overall Study|Physician Decision|0
2473256|NCT02302066|8538262|P4|Overall Study|Reason Not Specified|1
2473257|NCT02302066|8538263|P3|Overall Study|Reason Not Specified|9
2473258|NCT02302066|8538264|P2|Overall Study|Reason Not Specified|1
2473259|NCT02302066|8538265|P1|Overall Study|Reason Not Specified|1
2473260|NCT02302066|8538262|P4|Overall Study|Pregnancy|0
2473261|NCT02302066|8538263|P3|Overall Study|Pregnancy|12
2473262|NCT02302066|8538264|P2|Overall Study|Pregnancy|10
2473263|NCT02302066|8538265|P1|Overall Study|Pregnancy|2
2473264|NCT02302066|8538262|P4|Overall Study|Withdrawal by Subject|33
2473265|NCT02302066|8538263|P3|Overall Study|Withdrawal by Subject|124
2473266|NCT02302066|8538264|P2|Overall Study|Withdrawal by Subject|58
2473267|NCT02302066|8538265|P1|Overall Study|Withdrawal by Subject|25
2473268|NCT02302066|8538262|P4|Overall Study|Lost to Follow-up|7
2473269|NCT02302066|8538263|P3|Overall Study|Lost to Follow-up|24
2473270|NCT02302066|8538264|P2|Overall Study|Lost to Follow-up|5
2473271|NCT02302066|8538265|P1|Overall Study|Lost to Follow-up|4
2473272|NCT02302066|8538262|P4|Overall Study|Adverse Event|0
2473273|NCT02302066|8538263|P3|Overall Study|Adverse Event|3
2473274|NCT02302066|8538264|P2|Overall Study|Adverse Event|1
2473275|NCT02302066|8538265|P1|Overall Study|Adverse Event|1
2473276|NCT02301988|8538309|P2|Overall Study|Adverse Event|1
2473277|NCT02301988|8538310|P1|Overall Study|Adverse Event|1
2473278|NCT02301988|8538309|P2|Overall Study|Death|0
2473279|NCT02301988|8538310|P1|Overall Study|Death|1
2473280|NCT02301988|8538309|P2|Overall Study|Lack of Efficacy|2
2473281|NCT02301988|8538310|P1|Overall Study|Lack of Efficacy|3
2473282|NCT02301988|8538309|P2|Overall Study|Unknown Reason|3
2473283|NCT02301988|8538310|P1|Overall Study|Unknown Reason|1
2473284|NCT02301988|8538309|P2|Overall Study|Physician Decision|2
2473285|NCT02301988|8538310|P1|Overall Study|Physician Decision|2
2473286|NCT02301988|8538309|P2|Overall Study|Withdrawal by Subject|1
2473287|NCT02301988|8538310|P1|Overall Study|Withdrawal by Subject|2
2473288|NCT02301975|8538343|P3|Overall Study|Withdrawal by Subject|11
2473289|NCT02301975|8538344|P2|Overall Study|Withdrawal by Subject|12
2473290|NCT02301975|8538345|P1|Overall Study|Withdrawal by Subject|15
2473291|NCT02301975|8538343|P3|Overall Study|Physician Decision|3
2473292|NCT02301975|8538344|P2|Overall Study|Physician Decision|2
2473293|NCT02301975|8538345|P1|Overall Study|Physician Decision|4
2473294|NCT02301975|8538343|P3|Overall Study|Lost to Follow-up|2
2473295|NCT02301975|8538344|P2|Overall Study|Lost to Follow-up|2
2473296|NCT02301975|8538345|P1|Overall Study|Lost to Follow-up|0
2473297|NCT02301975|8538343|P3|Overall Study|Protocol Violation|3
2473298|NCT02301975|8538344|P2|Overall Study|Protocol Violation|5
2473299|NCT02301975|8538345|P1|Overall Study|Protocol Violation|3
2473300|NCT02301975|8538343|P3|Overall Study|Lack of Efficacy|1
2473301|NCT02301975|8538344|P2|Overall Study|Lack of Efficacy|1
2473302|NCT02301975|8538345|P1|Overall Study|Lack of Efficacy|1
2473303|NCT02301975|8538343|P3|Overall Study|Adverse Event|2
2473304|NCT02301975|8538344|P2|Overall Study|Adverse Event|3
2473305|NCT02301975|8538345|P1|Overall Study|Adverse Event|8
2473306|NCT02301936|8538373|P2|Overall Study|Lost to Follow-up|0
2473307|NCT02301936|8538374|P1|Overall Study|Lost to Follow-up|1
2473308|NCT02301897|8538399|P3|Treatment Course 2|Other Miscellaneous Reasons|0
2473309|NCT02301897|8538400|P2|Treatment Course 2|Other Miscellaneous Reasons|0
2473310|NCT02301897|8538401|P1|Treatment Course 2|Other Miscellaneous Reasons|1
2473311|NCT02301897|8538399|P3|Treatment Course 2|Withdrawal by Subject|0
2473312|NCT02301897|8538400|P2|Treatment Course 2|Withdrawal by Subject|2
2473313|NCT02301897|8538401|P1|Treatment Course 2|Withdrawal by Subject|0
2473314|NCT02301897|8538399|P3|Treatment Course 2|Pregnancy|1
2473315|NCT02301897|8538400|P2|Treatment Course 2|Pregnancy|1
2473316|NCT02301897|8538401|P1|Treatment Course 2|Pregnancy|0
2473317|NCT02301897|8538399|P3|Treatment Course 2|Lost to Follow-up|0
2473318|NCT02301897|8538400|P2|Treatment Course 2|Lost to Follow-up|2
2473319|NCT02301897|8538401|P1|Treatment Course 2|Lost to Follow-up|0
2473320|NCT02301897|8538399|P3|Treatment Course 1|Other Miscellaneous Reasons|0
2473321|NCT02301897|8538400|P2|Treatment Course 1|Other Miscellaneous Reasons|0
2473322|NCT02301897|8538401|P1|Treatment Course 1|Other Miscellaneous Reasons|1
2473323|NCT02301897|8538399|P3|Treatment Course 1|Withdrawal by Subject|2
2473324|NCT02301897|8538400|P2|Treatment Course 1|Withdrawal by Subject|0
2473325|NCT02301897|8538401|P1|Treatment Course 1|Withdrawal by Subject|0
2473326|NCT02301897|8538399|P3|Treatment Course 1|Withdrawal by Sponsor|2
2473327|NCT02301897|8538400|P2|Treatment Course 1|Withdrawal by Sponsor|0
2473328|NCT02301897|8538401|P1|Treatment Course 1|Withdrawal by Sponsor|0
2473329|NCT02301897|8538399|P3|Treatment Course 1|Lost to Follow-up|1
2473330|NCT02301897|8538400|P2|Treatment Course 1|Lost to Follow-up|2
2473331|NCT02301897|8538401|P1|Treatment Course 1|Lost to Follow-up|1
2473332|NCT02301897|8538399|P3|Treatment Course 1|Adverse Event|0
2473333|NCT02301897|8538400|P2|Treatment Course 1|Adverse Event|1
2473334|NCT02301897|8538401|P1|Treatment Course 1|Adverse Event|1
2473335|NCT02301897|8538399|P3|Treatment Course 1|Non-Compliance|1
2473336|NCT02301897|8538400|P2|Treatment Course 1|Non-Compliance|0
2473337|NCT02301897|8538401|P1|Treatment Course 1|Non-Compliance|0
2473338|NCT02301624|8538467|P2|Open-label Maintenance Phase|Participant felt no change in condition|0
2473339|NCT02301624|8538468|P1|Open-label Maintenance Phase|Participant felt no change in condition|1
2473340|NCT02301624|8538467|P2|Open-label Maintenance Phase|Death|1
2473341|NCT02301624|8538468|P1|Open-label Maintenance Phase|Death|2
2473342|NCT02301624|8538467|P2|Open-label Maintenance Phase|Physician Decision|3
2473343|NCT02301624|8538468|P1|Open-label Maintenance Phase|Physician Decision|3
2473344|NCT02301624|8538467|P2|Open-label Maintenance Phase|Adverse Event|5
2473345|NCT02301624|8538468|P1|Open-label Maintenance Phase|Adverse Event|2
2473346|NCT02301624|8538467|P2|Open-label Maintenance Phase|Withdrawal by Subject|8
2473347|NCT02301624|8538468|P1|Open-label Maintenance Phase|Withdrawal by Subject|4
2473348|NCT02301624|8538467|P2|Blind Induction Phase|Withdrawal by Subject|0
2473349|NCT02301624|8538468|P1|Blind Induction Phase|Withdrawal by Subject|1
2473350|NCT02301429|8538477|P1|Overall Study|not acceptable vascular anatomy|3
2473351|NCT02301403|8538523|P2|Overall Study|Withdrawal by Subject|41
2473352|NCT02301403|8538524|P1|Overall Study|Withdrawal by Subject|28
2473353|NCT02301390|8538532|P2|Overall Study|study terminated|0
2473354|NCT02301390|8538533|P1|Overall Study|study terminated|2
2473355|NCT02301390|8538532|P2|Overall Study|Missed multiple visits|1
2473356|NCT02301390|8538533|P1|Overall Study|Missed multiple visits|1
2473357|NCT02301390|8538532|P2|Overall Study|Procedure not completed|4
2473358|NCT02301390|8538533|P1|Overall Study|Procedure not completed|0
2473359|NCT02301390|8538532|P2|Overall Study|Death|2
2473360|NCT02301390|8538533|P1|Overall Study|Death|2
2473361|NCT02301390|8538532|P2|Overall Study|Lost to Follow-up|1
2473362|NCT02301390|8538533|P1|Overall Study|Lost to Follow-up|0
2473363|NCT02301390|8538532|P2|Overall Study|Physician Decision|0
2473364|NCT02301390|8538533|P1|Overall Study|Physician Decision|1
2473365|NCT02301390|8538532|P2|Overall Study|Protocol Violation|0
2473366|NCT02301390|8538533|P1|Overall Study|Protocol Violation|1
2473367|NCT02301390|8538532|P2|Overall Study|Withdrawal by Subject|5
2473368|NCT02301390|8538533|P1|Overall Study|Withdrawal by Subject|3
2473369|NCT02301169|8538574|P2|Overall Study|Adverse Event|0
2473370|NCT02301169|8538575|P1|Overall Study|Adverse Event|1
2473371|NCT02301143|8538589|P2|Investigator's Choice|Unresectable Surgery|1
2473372|NCT02301143|8538590|P1|Investigator's Choice|Unresectable Surgery|0
2473373|NCT02301143|8538589|P2|Investigator's Choice|Other|1
2473374|NCT02301143|8538590|P1|Investigator's Choice|Other|0
2473375|NCT02301143|8538589|P2|Investigator's Choice|Symptomatic Deterioration|1
2473376|NCT02301143|8538590|P1|Investigator's Choice|Symptomatic Deterioration|0
2473377|NCT02301143|8538589|P2|Investigator's Choice|Noncompliance With Study Drug|1
2473378|NCT02301143|8538590|P1|Investigator's Choice|Noncompliance With Study Drug|0
2473379|NCT02301143|8538589|P2|Investigator's Choice|Progressive Disease|3
2473380|NCT02301143|8538590|P1|Investigator's Choice|Progressive Disease|0
2473381|NCT02301143|8538589|P2|Investigator's Choice|Adverse Event|3
2473382|NCT02301143|8538590|P1|Investigator's Choice|Adverse Event|0
2473383|NCT02301143|8538589|P2|Induction Period|Other|0
2473384|NCT02301143|8538590|P1|Induction Period|Other|1
2473385|NCT02301143|8538589|P2|Induction Period|Protocol Violation|0
2473386|NCT02301143|8538590|P1|Induction Period|Protocol Violation|2
2473387|NCT02301143|8538589|P2|Induction Period|Symptomatic Deterioration|0
2473388|NCT02301143|8538590|P1|Induction Period|Symptomatic Deterioration|2
2473389|NCT02301143|8538589|P2|Induction Period|Physician Decision|0
2473390|NCT02301143|8538590|P1|Induction Period|Physician Decision|4
2473391|NCT02301143|8538589|P2|Induction Period|Noncompliance with Study Drug|0
2473392|NCT02301143|8538590|P1|Induction Period|Noncompliance with Study Drug|1
2473393|NCT02301143|8538589|P2|Induction Period|Withdrawal by Subject|0
2473394|NCT02301143|8538590|P1|Induction Period|Withdrawal by Subject|3
2473395|NCT02301143|8538589|P2|Induction Period|Progressive Disease|0
2473396|NCT02301143|8538590|P1|Induction Period|Progressive Disease|8
2473397|NCT02301143|8538589|P2|Induction Period|Adverse Event|0
2473398|NCT02301143|8538590|P1|Induction Period|Adverse Event|22
2473399|NCT02301143|8538589|P2|Induction Period|Death|0
2473400|NCT02301143|8538590|P1|Induction Period|Death|1
2473401|NCT02301143|8538589|P2|Induction Period|Enrolled But Not Treated|0
2473402|NCT02301143|8538590|P1|Induction Period|Enrolled But Not Treated|1
2473403|NCT02300610|8538634|P3|Overall Study|Withdrawal by Subject|1
2473404|NCT02300610|8538635|P2|Overall Study|Withdrawal by Subject|0
2473405|NCT02300610|8538636|P1|Overall Study|Withdrawal by Subject|1
2473406|NCT02300558|8538651|P1|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29
2473407|NCT02300558|8538651|P1|Open-Label (OL) Extension Phase|Withdrew Consent|1
2473408|NCT02300558|8538651|P1|Open-Label (OL) Extension Phase|Lack of Efficacy|2
2473409|NCT02300558|8538651|P1|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6
2473410|NCT02300311|8538664|P2|Overall Study|Refused to continue taking medication|0
2473411|NCT02300311|8538665|P1|Overall Study|Refused to continue taking medication|18
2473412|NCT02300311|8538664|P2|Overall Study|Other than the reason specified|0
2473413|NCT02300311|8538665|P1|Overall Study|Other than the reason specified|1
2473414|NCT02300298|8538677|P2|Disposition for Docetaxel|other adverse event|4
2473415|NCT02300298|8538678|P1|Disposition for Docetaxel|other adverse event|0
2473416|NCT02300298|8538677|P2|Disposition for Docetaxel|Progressive disease|6
2473417|NCT02300298|8538678|P1|Disposition for Docetaxel|Progressive disease|0
2473418|NCT02300298|8538677|P2|Disposition for Nintedanib|Progressive disease|0
2473419|NCT02300298|8538678|P1|Disposition for Nintedanib|Progressive disease|10
2473420|NCT02300129|8538688|P4|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
2473421|NCT02300129|8538689|P3|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
2473422|NCT02300129|8538690|P2|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
2473423|NCT02300129|8538691|P1|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1
2473424|NCT02300129|8538688|P4|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1
2473425|NCT02300129|8538689|P3|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
2473426|NCT02300129|8538690|P2|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
2473427|NCT02300129|8538691|P1|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
2473428|NCT02300129|8538688|P4|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
2473429|NCT02300129|8538689|P3|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
2473430|NCT02300129|8538690|P2|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1
2473431|NCT02300129|8538691|P1|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
2473432|NCT02300103|8538701|P1|Overall Study|Withdrew Consent|2
2473433|NCT02300103|8538701|P1|Overall Study|Protocol Violation|1
2473434|NCT02300103|8538701|P1|Overall Study|Lack of Efficacy|3
2473435|NCT02299934|8538781|P1|Overall Study|Termination of study|13
2473436|NCT02299635|8538831|P1|Overall Study|Other|3
2473437|NCT02299635|8538831|P1|Overall Study|Withdrawal by Subject|2
2473438|NCT02299635|8538831|P1|Overall Study|Objective progression or relapse|10
2473439|NCT02299635|8538831|P1|Overall Study|Global deterioration of health status|1
2473440|NCT02299635|8538831|P1|Overall Study|Death|1
2473441|NCT02299635|8538831|P1|Overall Study|Adverse Event|2
2473442|NCT02299427|8538871|P2|Overall Study|not adherent to dog website use|0
2473443|NCT02299427|8538872|P1|Overall Study|not adherent to dog website use|21
2473444|NCT02299427|8538871|P2|Overall Study|Lost to Follow-up|3
2473445|NCT02299427|8538872|P1|Overall Study|Lost to Follow-up|1
2473446|NCT02299427|8538871|P2|Overall Study|Withdrawal by Subject|0
2473447|NCT02299427|8538872|P1|Overall Study|Withdrawal by Subject|1
2473448|NCT02299388|8538882|P2|Overall Study|Withdrawal by Subject|1
2473449|NCT02299388|8538883|P1|Overall Study|Withdrawal by Subject|0
2473450|NCT02299375|8538893|P2|Overall Study|Withdrawal by Subject|4
2473451|NCT02299375|8538894|P1|Overall Study|Withdrawal by Subject|1
2473452|NCT02299375|8538893|P2|Overall Study|Physician Decision|1
2473453|NCT02299375|8538894|P1|Overall Study|Physician Decision|1
2473454|NCT02299375|8538893|P2|Overall Study|Lost to Follow-up|2
2473455|NCT02299375|8538894|P1|Overall Study|Lost to Follow-up|0
2473456|NCT02299375|8538893|P2|Overall Study|Other: Study closed/terminated|55
2473457|NCT02299375|8538894|P1|Overall Study|Other: Study closed/terminated|66
2473458|NCT02299375|8538893|P2|Overall Study|Other: Met stopping criteria|0
2473459|NCT02299375|8538894|P1|Overall Study|Other: Met stopping criteria|1
2473460|NCT02299375|8538893|P2|Overall Study|Protocol Violation|3
2473461|NCT02299375|8538894|P1|Overall Study|Protocol Violation|1
2473462|NCT02299375|8538893|P2|Overall Study|Lack of Efficacy|3
2473463|NCT02299375|8538894|P1|Overall Study|Lack of Efficacy|1
2473464|NCT02299375|8538893|P2|Overall Study|Adverse Event, non-fatal|9
2473465|NCT02299375|8538894|P1|Overall Study|Adverse Event, non-fatal|8
2473466|NCT02299375|8538893|P2|Overall Study|Adverse Event, serious fatal|3
2473467|NCT02299375|8538894|P1|Overall Study|Adverse Event, serious fatal|1
2473468|NCT02299336|8538953|P1|Overall Study|Lost to Follow-up|1
2473469|NCT02299336|8538953|P1|Overall Study|Death|1
2473470|NCT02299336|8538953|P1|Overall Study|Adverse Event|1
2473471|NCT02299336|8538953|P1|Overall Study|Withdrawal by Subject|11
2473472|NCT02299206|8538988|P1|Overall Study|Withdrawal by Subject|1
2473473|NCT02299206|8538988|P1|Overall Study|Lost to Follow-up|1
2473474|NCT02299076|8539049|P2|Overall Study|Fraudulent Entries|14
2473475|NCT02299076|8539050|P1|Overall Study|Fraudulent Entries|20
2473476|NCT02298946|8539071|P2|Overall Study|Unevaluable|1
2473477|NCT02298946|8539072|P1|Overall Study|Unevaluable|2
2473478|NCT02298946|8539071|P2|Overall Study|Did not receive treatment|0
2473479|NCT02298946|8539072|P1|Overall Study|Did not receive treatment|2
2473480|NCT02298868|8539100|P1|Overall Study|Patient underwent transplant|1
2473481|NCT02298868|8539100|P1|Overall Study|Death|1
2473482|NCT02298868|8539100|P1|Overall Study|Adverse Event|1
2473483|NCT02298192|8539171|P2|Overall Study|Adverse Event|2
2473484|NCT02298192|8539172|P1|Overall Study|Adverse Event|6
2473485|NCT02298192|8539171|P2|Overall Study|Lost to Follow-up|1
2473486|NCT02298192|8539172|P1|Overall Study|Lost to Follow-up|2
2473487|NCT02298192|8539171|P2|Overall Study|Withdrawal by Subject|1
2473488|NCT02298192|8539172|P1|Overall Study|Withdrawal by Subject|6
2473489|NCT02298192|8539171|P2|Overall Study|Withdrawal criteria|0
2473490|NCT02298192|8539172|P1|Overall Study|Withdrawal criteria|2
2473491|NCT02298192|8539171|P2|Overall Study|Unclassified|2
2473492|NCT02298192|8539172|P1|Overall Study|Unclassified|3
2473493|NCT02298179|8539196|P12|Overall Study|Lost to Follow-up|0
2473494|NCT02298179|8539197|P11|Overall Study|Lost to Follow-up|0
2473495|NCT02298179|8539198|P10|Overall Study|Lost to Follow-up|0
2473496|NCT02298179|8539199|P9|Overall Study|Lost to Follow-up|0
2473497|NCT02298179|8539200|P8|Overall Study|Lost to Follow-up|1
2473498|NCT02298179|8539201|P7|Overall Study|Lost to Follow-up|0
2473499|NCT02298179|8539202|P6|Overall Study|Lost to Follow-up|0
2473500|NCT02298179|8539203|P5|Overall Study|Lost to Follow-up|0
2473501|NCT02298179|8539204|P4|Overall Study|Lost to Follow-up|0
2473502|NCT02298179|8539205|P3|Overall Study|Lost to Follow-up|1
2473503|NCT02298179|8539206|P2|Overall Study|Lost to Follow-up|0
2473504|NCT02298179|8539207|P1|Overall Study|Lost to Follow-up|0
2473505|NCT02297841|8539449|P1|Overall Study|Protocol Violation|7
2473506|NCT02297841|8539449|P1|Overall Study|Withdrawal by Subject|1
2473507|NCT02297815|8539455|P2|Overall Study|Lost to Follow-up|140
2473508|NCT02297815|8539456|P1|Overall Study|Lost to Follow-up|236
2473509|NCT02297516|8539474|P2|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1
2473510|NCT02297516|8539475|P1|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0
2473511|NCT02297516|8539474|P2|Single Treatment Phase (6 Months)|Protocol Violation|2
2473512|NCT02297516|8539475|P1|Single Treatment Phase (6 Months)|Protocol Violation|0
2473513|NCT02297516|8539474|P2|Single Treatment Phase (6 Months)|Medical reason|0
2473514|NCT02297516|8539475|P1|Single Treatment Phase (6 Months)|Medical reason|1
2473515|NCT02297503|8539496|P2|Overall Study|Medical reason|1
2473516|NCT02297503|8539497|P1|Overall Study|Medical reason|0
2473517|NCT02297503|8539496|P2|Overall Study|Lost to Follow-up|1
2473518|NCT02297503|8539497|P1|Overall Study|Lost to Follow-up|0
2473519|NCT02297503|8539496|P2|Overall Study|Pregnancy|1
2473520|NCT02297503|8539497|P1|Overall Study|Pregnancy|0
2473521|NCT02297503|8539496|P2|Overall Study|Protocol Violation|0
2473522|NCT02297503|8539497|P1|Overall Study|Protocol Violation|1
2473523|NCT02297503|8539496|P2|Overall Study|Withdrawal by Subject|1
2473524|NCT02297503|8539497|P1|Overall Study|Withdrawal by Subject|1
2473525|NCT02297412|8539524|P2|Overall Study|Canceled|1
2473526|NCT02297412|8539525|P1|Overall Study|Canceled|1
2473527|NCT02296931|8539586|P2|Overall Study|Protocol Violation|2
2473528|NCT02296931|8539587|P1|Overall Study|Protocol Violation|0
2473529|NCT02296892|8539596|P3|Overall Study|Lost to Follow-up|1
2473530|NCT02296892|8539597|P2|Overall Study|Lost to Follow-up|0
2473531|NCT02296892|8539598|P1|Overall Study|Lost to Follow-up|5
2473532|NCT02296892|8539596|P3|Overall Study|Exclusion Criteria at Day of Procedure|4
2473533|NCT02296892|8539597|P2|Overall Study|Exclusion Criteria at Day of Procedure|4
2473534|NCT02296892|8539598|P1|Overall Study|Exclusion Criteria at Day of Procedure|7
2473535|NCT02296840|8539617|P2|Overall Study|Lost to Follow-up|17
2473536|NCT02296840|8539618|P1|Overall Study|Lost to Follow-up|6
2473537|NCT02296840|8539617|P2|Overall Study|Protocol Violation|1
2473538|NCT02296840|8539618|P1|Overall Study|Protocol Violation|2
2473539|NCT02296840|8539617|P2|Overall Study|Adverse Event|1
2473540|NCT02296840|8539618|P1|Overall Study|Adverse Event|1
2473541|NCT02296476|8539726|P3|Overall Study|Disease Progression|2
2473542|NCT02296476|8539727|P2|Overall Study|Disease Progression|4
2473543|NCT02296476|8539728|P1|Overall Study|Disease Progression|6
2473544|NCT02296424|8539783|P4|Part 2|Lost to Follow-up|0
2473545|NCT02296424|8539784|P3|Part 2|Lost to Follow-up|1
2473546|NCT02296424|8539785|P2|Part 2|Lost to Follow-up|0
2473547|NCT02296424|8539786|P1|Part 2|Lost to Follow-up|0
2473548|NCT02296424|8539783|P4|Part 2|Adverse Event|0
2473549|NCT02296424|8539784|P3|Part 2|Adverse Event|1
2473550|NCT02296424|8539785|P2|Part 2|Adverse Event|0
2473551|NCT02296424|8539786|P1|Part 2|Adverse Event|0
2473552|NCT02296424|8539783|P4|Part 2|Lack of Efficacy|0
2473553|NCT02296424|8539784|P3|Part 2|Lack of Efficacy|1
2473554|NCT02296424|8539785|P2|Part 2|Lack of Efficacy|0
2473555|NCT02296424|8539786|P1|Part 2|Lack of Efficacy|0
2473556|NCT02296424|8539783|P4|Part 1|16 directly started part II|0
2473557|NCT02296424|8539784|P3|Part 1|16 directly started part II|0
2473558|NCT02296424|8539785|P2|Part 1|16 directly started part II|0
2473559|NCT02296424|8539786|P1|Part 1|16 directly started part II|16
2473560|NCT02296424|8539783|P4|Part 1|Lack of Efficacy|0
2473561|NCT02296424|8539784|P3|Part 1|Lack of Efficacy|0
2473562|NCT02296424|8539785|P2|Part 1|Lack of Efficacy|17
2473563|NCT02296424|8539786|P1|Part 1|Lack of Efficacy|5
2473564|NCT02296424|8539783|P4|Part 1|Adverse Event|0
2473565|NCT02296424|8539784|P3|Part 1|Adverse Event|0
2473566|NCT02296424|8539785|P2|Part 1|Adverse Event|11
2473567|NCT02296424|8539786|P1|Part 1|Adverse Event|2
2473568|NCT02296424|8539783|P4|Part 1|Study terminated by sponsor|0
2473569|NCT02296424|8539784|P3|Part 1|Study terminated by sponsor|0
2473570|NCT02296424|8539785|P2|Part 1|Study terminated by sponsor|1
2473571|NCT02296424|8539786|P1|Part 1|Study terminated by sponsor|0
2473572|NCT02296424|8539783|P4|Part 1|Withdrawal by Subject|0
2473573|NCT02296424|8539784|P3|Part 1|Withdrawal by Subject|0
2473574|NCT02296424|8539785|P2|Part 1|Withdrawal by Subject|2
2473575|NCT02296424|8539786|P1|Part 1|Withdrawal by Subject|0
2473576|NCT02296424|8539783|P4|Part 1|Protocol Violation|0
2473577|NCT02296424|8539784|P3|Part 1|Protocol Violation|0
2473578|NCT02296424|8539785|P2|Part 1|Protocol Violation|1
2473579|NCT02296424|8539786|P1|Part 1|Protocol Violation|0
2473580|NCT02296424|8539783|P4|Part 1|New therapy for study indication|0
2473581|NCT02296424|8539784|P3|Part 1|New therapy for study indication|0
2473582|NCT02296424|8539785|P2|Part 1|New therapy for study indication|1
2473583|NCT02296424|8539786|P1|Part 1|New therapy for study indication|0
2473584|NCT02296320|8539811|P3|Overall Study|Not - specified|1
2473585|NCT02296320|8539812|P2|Overall Study|Not - specified|0
2473586|NCT02296320|8539813|P1|Overall Study|Not - specified|0
2473587|NCT02296320|8539811|P3|Overall Study|Not treated|0
2473588|NCT02296320|8539812|P2|Overall Study|Not treated|0
2473589|NCT02296320|8539813|P1|Overall Study|Not treated|2
2473590|NCT02296320|8539811|P3|Overall Study|Lost to Follow-up|7
2473591|NCT02296320|8539812|P2|Overall Study|Lost to Follow-up|2
2473592|NCT02296320|8539813|P1|Overall Study|Lost to Follow-up|5
2473593|NCT02296320|8539811|P3|Overall Study|Death|27
2473594|NCT02296320|8539812|P2|Overall Study|Death|3
2473595|NCT02296320|8539813|P1|Overall Study|Death|24
2473596|NCT02296320|8539811|P3|Overall Study|Withdrawal by Subject|2
2473597|NCT02296320|8539812|P2|Overall Study|Withdrawal by Subject|0
2473598|NCT02296320|8539813|P1|Overall Study|Withdrawal by Subject|4
2473599|NCT02296242|8539852|P5|Overall Study|Lack of Efficacy|3
2473600|NCT02296242|8539853|P4|Overall Study|Lack of Efficacy|0
2473601|NCT02296242|8539854|P3|Overall Study|Lack of Efficacy|0
2473602|NCT02296242|8539855|P2|Overall Study|Lack of Efficacy|0
2473603|NCT02296242|8539856|P1|Overall Study|Lack of Efficacy|0
2473604|NCT02296242|8539852|P5|Overall Study|Adverse Event|0
2473605|NCT02296242|8539853|P4|Overall Study|Adverse Event|1
2473606|NCT02296242|8539854|P3|Overall Study|Adverse Event|0
2473607|NCT02296242|8539855|P2|Overall Study|Adverse Event|0
2473608|NCT02296242|8539856|P1|Overall Study|Adverse Event|0
2473609|NCT02296242|8539852|P5|Overall Study|Alternative Treatment|0
2473610|NCT02296242|8539853|P4|Overall Study|Alternative Treatment|1
2473611|NCT02296242|8539854|P3|Overall Study|Alternative Treatment|0
2473612|NCT02296242|8539855|P2|Overall Study|Alternative Treatment|0
2473613|NCT02296242|8539856|P1|Overall Study|Alternative Treatment|0
2473614|NCT02296242|8539852|P5|Overall Study|Physician Decision|0
2473615|NCT02296242|8539853|P4|Overall Study|Physician Decision|1
2473616|NCT02296242|8539854|P3|Overall Study|Physician Decision|0
2473617|NCT02296242|8539855|P2|Overall Study|Physician Decision|1
2473618|NCT02296242|8539856|P1|Overall Study|Physician Decision|0
2473619|NCT02296242|8539852|P5|Overall Study|Screened for Other Protocol|0
2473620|NCT02296242|8539853|P4|Overall Study|Screened for Other Protocol|0
2473621|NCT02296242|8539854|P3|Overall Study|Screened for Other Protocol|0
2473622|NCT02296242|8539855|P2|Overall Study|Screened for Other Protocol|1
2473623|NCT02296242|8539856|P1|Overall Study|Screened for Other Protocol|0
2473624|NCT02296242|8539852|P5|Overall Study|Need for Hydroxyurea|0
2473625|NCT02296242|8539853|P4|Overall Study|Need for Hydroxyurea|0
2473626|NCT02296242|8539854|P3|Overall Study|Need for Hydroxyurea|0
2473627|NCT02296242|8539855|P2|Overall Study|Need for Hydroxyurea|0
2473628|NCT02296242|8539856|P1|Overall Study|Need for Hydroxyurea|2
2473629|NCT02296242|8539852|P5|Overall Study|Lost to Follow-up|0
2473630|NCT02296242|8539853|P4|Overall Study|Lost to Follow-up|0
2473631|NCT02296242|8539854|P3|Overall Study|Lost to Follow-up|0
2473632|NCT02296242|8539855|P2|Overall Study|Lost to Follow-up|0
2473633|NCT02296242|8539856|P1|Overall Study|Lost to Follow-up|1
2473634|NCT02296242|8539852|P5|Overall Study|At Least 3 Drug Interruptions|1
2473635|NCT02296242|8539853|P4|Overall Study|At Least 3 Drug Interruptions|1
2473636|NCT02296242|8539854|P3|Overall Study|At Least 3 Drug Interruptions|1
2473637|NCT02296242|8539855|P2|Overall Study|At Least 3 Drug Interruptions|0
2473638|NCT02296242|8539856|P1|Overall Study|At Least 3 Drug Interruptions|0
2473639|NCT02296242|8539852|P5|Overall Study|Patient Condition Changed|1
2473640|NCT02296242|8539853|P4|Overall Study|Patient Condition Changed|0
2473641|NCT02296242|8539854|P3|Overall Study|Patient Condition Changed|2
2473642|NCT02296242|8539855|P2|Overall Study|Patient Condition Changed|0
2473643|NCT02296242|8539856|P1|Overall Study|Patient Condition Changed|0
2473644|NCT02296242|8539852|P5|Overall Study|Unacceptable Toxicity|1
2473645|NCT02296242|8539853|P4|Overall Study|Unacceptable Toxicity|0
2473646|NCT02296242|8539854|P3|Overall Study|Unacceptable Toxicity|0
2473647|NCT02296242|8539855|P2|Overall Study|Unacceptable Toxicity|0
2473648|NCT02296242|8539856|P1|Overall Study|Unacceptable Toxicity|0
2473649|NCT02296242|8539852|P5|Overall Study|Disease Progression|11
2473650|NCT02296242|8539853|P4|Overall Study|Disease Progression|8
2473651|NCT02296242|8539854|P3|Overall Study|Disease Progression|2
2473652|NCT02296242|8539855|P2|Overall Study|Disease Progression|3
2473653|NCT02296242|8539856|P1|Overall Study|Disease Progression|1
2473654|NCT02296242|8539852|P5|Overall Study|Withdrawal by Subject|3
2473655|NCT02296242|8539853|P4|Overall Study|Withdrawal by Subject|1
2473656|NCT02296242|8539854|P3|Overall Study|Withdrawal by Subject|1
2473657|NCT02296242|8539855|P2|Overall Study|Withdrawal by Subject|0
2473658|NCT02296242|8539856|P1|Overall Study|Withdrawal by Subject|0
2473659|NCT02296242|8539852|P5|Overall Study|Death|1
2473660|NCT02296242|8539853|P4|Overall Study|Death|1
2473661|NCT02296242|8539854|P3|Overall Study|Death|1
2473662|NCT02296242|8539855|P2|Overall Study|Death|1
2473663|NCT02296242|8539856|P1|Overall Study|Death|1
2473664|NCT02296138|8539884|P2|Overall Study|Other than specified|13
2473665|NCT02296138|8539885|P1|Overall Study|Other than specified|15
2473666|NCT02296138|8539884|P2|Overall Study|Patients with data irregularities|11
2473667|NCT02296138|8539885|P1|Overall Study|Patients with data irregularities|10
2473668|NCT02296138|8539884|P2|Overall Study|Not Treated|1
2473669|NCT02296138|8539885|P1|Overall Study|Not Treated|1
2473670|NCT02296138|8539884|P2|Overall Study|Withdrawal by Subject|131
2473671|NCT02296138|8539885|P1|Overall Study|Withdrawal by Subject|184
2473672|NCT02296138|8539884|P2|Overall Study|Lost to Follow-up|12
2473673|NCT02296138|8539885|P1|Overall Study|Lost to Follow-up|9
2473674|NCT02296138|8539884|P2|Overall Study|Protocol Violation|36
2473675|NCT02296138|8539885|P1|Overall Study|Protocol Violation|35
2473676|NCT02296138|8539884|P2|Overall Study|Lack of Efficacy|37
2473677|NCT02296138|8539885|P1|Overall Study|Lack of Efficacy|59
2473678|NCT02296138|8539884|P2|Overall Study|Adverse Event|259
2473679|NCT02296138|8539885|P1|Overall Study|Adverse Event|348
2473680|NCT02296125|8539901|P4|Overall Study|Any reason not specifically recorded|0
2473681|NCT02296125|8539902|P3|Overall Study|Any reason not specifically recorded|0
2473682|NCT02296125|8539903|P2|Overall Study|Any reason not specifically recorded|3
2473683|NCT02296125|8539904|P1|Overall Study|Any reason not specifically recorded|3
2473684|NCT02296125|8539901|P4|Overall Study|Condition under investigation worsened|39
2473685|NCT02296125|8539902|P3|Overall Study|Condition under investigation worsened|24
2473686|NCT02296125|8539903|P2|Overall Study|Condition under investigation worsened|151
2473687|NCT02296125|8539904|P1|Overall Study|Condition under investigation worsened|87
2473688|NCT02296125|8539901|P4|Overall Study|Severe non-compliance to protocol|0
2473689|NCT02296125|8539902|P3|Overall Study|Severe non-compliance to protocol|0
2473690|NCT02296125|8539903|P2|Overall Study|Severe non-compliance to protocol|1
2473691|NCT02296125|8539904|P1|Overall Study|Severe non-compliance to protocol|0
2473692|NCT02296125|8539901|P4|Overall Study|Adverse Event|4
2473693|NCT02296125|8539902|P3|Overall Study|Adverse Event|9
2473694|NCT02296125|8539903|P2|Overall Study|Adverse Event|50
2473695|NCT02296125|8539904|P1|Overall Study|Adverse Event|36
2473696|NCT02296125|8539901|P4|Overall Study|Withdrawal by Subject|1
2473697|NCT02296125|8539902|P3|Overall Study|Withdrawal by Subject|5
2473698|NCT02296125|8539903|P2|Overall Study|Withdrawal by Subject|8
2473699|NCT02296125|8539904|P1|Overall Study|Withdrawal by Subject|12
2473700|NCT02296112|8539956|P1|Overall Study|Began an alternate therapy|1
2473701|NCT02296112|8539956|P1|Overall Study|Toxicity|1
2473702|NCT02296112|8539956|P1|Overall Study|Disease progression|7
2473703|NCT02295995|8539998|P2|Overall Study|Lost to Follow-up|1
2473704|NCT02295995|8539999|P1|Overall Study|Lost to Follow-up|5
2473705|NCT02295774|8540010|P1|Overall Study|Withdrawal by Subject|2
2473706|NCT02295774|8540010|P1|Overall Study|Physician Decision|1
2473707|NCT02295644|8540019|P4|Overall Study|Did not meet inclusion criterion|2
2473708|NCT02295644|8540020|P3|Overall Study|Did not meet inclusion criterion|1
2473709|NCT02295644|8540021|P2|Overall Study|Did not meet inclusion criterion|0
2473710|NCT02295644|8540022|P1|Overall Study|Did not meet inclusion criterion|0
2473711|NCT02295280|8540071|P2|Overall Study|Adverse Event|1
2473712|NCT02295280|8540072|P1|Overall Study|Adverse Event|0
2473713|NCT02295020|8540080|P2|Overall Study|Withdrawal by Subject|2
2473714|NCT02295020|8540081|P1|Overall Study|Withdrawal by Subject|3
2473715|NCT02295020|8540080|P2|Overall Study|Adverse Event|1
2473716|NCT02295020|8540081|P1|Overall Study|Adverse Event|0
2473717|NCT02294786|8540113|P2|Overall Study|Death|3
2473718|NCT02294786|8540114|P1|Overall Study|Death|2
2473719|NCT02294786|8540113|P2|Overall Study|Adverse Event|1
2473720|NCT02294786|8540114|P1|Overall Study|Adverse Event|1
2473721|NCT02294786|8540113|P2|Overall Study|Protocol Violation|0
2473722|NCT02294786|8540114|P1|Overall Study|Protocol Violation|1
2473723|NCT02294786|8540113|P2|Overall Study|Lost to Follow-up|2
2473724|NCT02294786|8540114|P1|Overall Study|Lost to Follow-up|1
2473725|NCT02294786|8540113|P2|Overall Study|Physician Decision|7
2473726|NCT02294786|8540114|P1|Overall Study|Physician Decision|6
2473727|NCT02294786|8540113|P2|Overall Study|Withdrawal by Subject|1
2473728|NCT02294786|8540114|P1|Overall Study|Withdrawal by Subject|0
2473729|NCT02294773|8540161|P2|Overall Study|Withdrawal by Subject|2
2473730|NCT02294773|8540162|P1|Overall Study|Withdrawal by Subject|0
2473731|NCT02294734|8540178|P2|Overall Study|Withdrawal by Subject|2
2473732|NCT02294734|8540179|P1|Overall Study|Withdrawal by Subject|4
2473733|NCT02294734|8540178|P2|Overall Study|Physician Decision|1
2473734|NCT02294734|8540179|P1|Overall Study|Physician Decision|2
2473735|NCT02294734|8540178|P2|Overall Study|Lost to Follow-up|0
2473736|NCT02294734|8540179|P1|Overall Study|Lost to Follow-up|2
2473737|NCT02294734|8540178|P2|Overall Study|Met Protocol Defined Stopping Criteria|0
2473738|NCT02294734|8540179|P1|Overall Study|Met Protocol Defined Stopping Criteria|1
2473739|NCT02294734|8540178|P2|Overall Study|Adverse Event|5
2473740|NCT02294734|8540179|P1|Overall Study|Adverse Event|5
2473741|NCT02294682|8540231|P2|Overall Study|Could not swallow pills|0
2473742|NCT02294682|8540232|P1|Overall Study|Could not swallow pills|1
2473743|NCT02294604|8540275|P3|Overall Study|Culture contamination|0
2473744|NCT02294604|8540276|P2|Overall Study|Culture contamination|2
2473745|NCT02294604|8540277|P1|Overall Study|Culture contamination|1
2473746|NCT02294604|8540275|P3|Overall Study|Did not provide samples for culture|0
2473747|NCT02294604|8540276|P2|Overall Study|Did not provide samples for culture|1
2473748|NCT02294604|8540277|P1|Overall Study|Did not provide samples for culture|0
2473749|NCT02294474|8540296|P2|Overall Study|Other than specified above|12
2473750|NCT02294474|8540297|P1|Overall Study|Other than specified above|12
2473751|NCT02294474|8540296|P2|Overall Study|Protocol Violation|2
2473752|NCT02294474|8540297|P1|Overall Study|Protocol Violation|4
2473753|NCT02294474|8540296|P2|Overall Study|Lack of Efficacy|1
2473754|NCT02294474|8540297|P1|Overall Study|Lack of Efficacy|2
2473755|NCT02294474|8540296|P2|Overall Study|Adverse Event|7
2473756|NCT02294474|8540297|P1|Overall Study|Adverse Event|7
2473757|NCT02294461|8540321|P2|Overall Study|Miscellaneous|32
2473758|NCT02294461|8540322|P1|Overall Study|Miscellaneous|11
2473759|NCT02294461|8540321|P2|Overall Study|Adverse Event|10
2473760|NCT02294461|8540322|P1|Overall Study|Adverse Event|11
2473761|NCT02294461|8540321|P2|Overall Study|Disease Progression|39
2473762|NCT02294461|8540322|P1|Overall Study|Disease Progression|23
2473763|NCT02294461|8540321|P2|Overall Study|Withdrawal by Subject|45
2473764|NCT02294461|8540322|P1|Overall Study|Withdrawal by Subject|14
2473765|NCT02294461|8540321|P2|Overall Study|Protocol Violation|2
2473766|NCT02294461|8540322|P1|Overall Study|Protocol Violation|0
2473767|NCT02294461|8540321|P2|Overall Study|Death|3
2473768|NCT02294461|8540322|P1|Overall Study|Death|3
2473769|NCT02294396|8540378|P4|Overall Study|Miscellaneous|2
2473770|NCT02294396|8540379|P3|Overall Study|Miscellaneous|5
2473771|NCT02294396|8540380|P2|Overall Study|Miscellaneous|0
2473772|NCT02294396|8540381|P1|Overall Study|Miscellaneous|2
2473773|NCT02294396|8540378|P4|Overall Study|Protocol Deviation|1
2473774|NCT02294396|8540379|P3|Overall Study|Protocol Deviation|2
2473775|NCT02294396|8540380|P2|Overall Study|Protocol Deviation|2
2473776|NCT02294396|8540381|P1|Overall Study|Protocol Deviation|3
2473777|NCT02294396|8540378|P4|Overall Study|Lost to Follow-up|1
2473778|NCT02294396|8540379|P3|Overall Study|Lost to Follow-up|1
2473779|NCT02294396|8540380|P2|Overall Study|Lost to Follow-up|0
2473780|NCT02294396|8540381|P1|Overall Study|Lost to Follow-up|0
2473781|NCT02294396|8540378|P4|Overall Study|Withdrawal by Subject|8
2473782|NCT02294396|8540379|P3|Overall Study|Withdrawal by Subject|6
2473783|NCT02294396|8540380|P2|Overall Study|Withdrawal by Subject|6
2473784|NCT02294396|8540381|P1|Overall Study|Withdrawal by Subject|8
2473785|NCT02294396|8540378|P4|Overall Study|Electrocardiogram adviser's judgment|1
2473786|NCT02294396|8540379|P3|Overall Study|Electrocardiogram adviser's judgment|0
2473787|NCT02294396|8540380|P2|Overall Study|Electrocardiogram adviser's judgment|0
2473788|NCT02294396|8540381|P1|Overall Study|Electrocardiogram adviser's judgment|1
2473789|NCT02294396|8540378|P4|Overall Study|Adverse Event|24
2473790|NCT02294396|8540379|P3|Overall Study|Adverse Event|21
2473791|NCT02294396|8540380|P2|Overall Study|Adverse Event|25
2473792|NCT02294396|8540381|P1|Overall Study|Adverse Event|26
2473793|NCT02294318|8540453|P2|Overall Study|Not exposed to intervention|2
2473794|NCT02294318|8540454|P1|Overall Study|Not exposed to intervention|0
2473795|NCT02294318|8540453|P2|Overall Study|Worsening of drinking|0
2473796|NCT02294318|8540454|P1|Overall Study|Worsening of drinking|3
2473797|NCT02294227|8540473|P3|Overall Study|Adverse Event|2
2473798|NCT02294227|8540474|P2|Overall Study|Adverse Event|8
2473799|NCT02294227|8540475|P1|Overall Study|Adverse Event|6
2473800|NCT02294227|8540473|P3|Overall Study|Lack of Efficacy|8
2473801|NCT02294227|8540474|P2|Overall Study|Lack of Efficacy|12
2473802|NCT02294227|8540475|P1|Overall Study|Lack of Efficacy|11
2473803|NCT02294227|8540473|P3|Overall Study|Lost to Follow-up|0
2473804|NCT02294227|8540474|P2|Overall Study|Lost to Follow-up|0
2473805|NCT02294227|8540475|P1|Overall Study|Lost to Follow-up|1
2473806|NCT02294227|8540473|P3|Overall Study|Physician Decision|1
2473807|NCT02294227|8540474|P2|Overall Study|Physician Decision|2
2473808|NCT02294227|8540475|P1|Overall Study|Physician Decision|1
2473809|NCT02294227|8540473|P3|Overall Study|Subject/Guardian Decision|7
2473810|NCT02294227|8540474|P2|Overall Study|Subject/Guardian Decision|3
2473811|NCT02294227|8540475|P1|Overall Study|Subject/Guardian Decision|6
2473812|NCT02294227|8540473|P3|Overall Study|Death|1
2473813|NCT02294227|8540474|P2|Overall Study|Death|0
2473814|NCT02294227|8540475|P1|Overall Study|Death|0
2473815|NCT02294175|8540501|P2|Overall Study|wound healed|2
2473816|NCT02294175|8540502|P1|Overall Study|wound healed|0
2473817|NCT02294175|8540501|P2|Overall Study|Lost to Follow-up|1
2473818|NCT02294175|8540502|P1|Overall Study|Lost to Follow-up|0
2473819|NCT02294175|8540501|P2|Overall Study|Protocol Violation|0
2473820|NCT02294175|8540502|P1|Overall Study|Protocol Violation|1
2473821|NCT02294175|8540501|P2|Overall Study|pt taking excluded medication|1
2473822|NCT02294175|8540502|P1|Overall Study|pt taking excluded medication|3
2473823|NCT02294175|8540501|P2|Overall Study|Withdrawal by Subject|2
2473824|NCT02294175|8540502|P1|Overall Study|Withdrawal by Subject|1
2473825|NCT02294019|8540526|P1|Overall Study|Withdrawal by Subject|1
2473826|NCT02294019|8540526|P1|Overall Study|Other|1
2473827|NCT02294019|8540526|P1|Overall Study|Lost to Follow-up|31
2473828|NCT02294019|8540526|P1|Overall Study|Protocol Violation|68
2473829|NCT02294019|8540526|P1|Overall Study|Adverse Event|2
2473830|NCT02293902|8540534|P5|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
2473831|NCT02293902|8540535|P4|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
2473832|NCT02293902|8540536|P3|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
2473833|NCT02293902|8540537|P2|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
2473834|NCT02293902|8540538|P1|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
2473835|NCT02293902|8540534|P5|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6
2473836|NCT02293902|8540535|P4|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
2473837|NCT02293902|8540536|P3|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
2473838|NCT02293902|8540537|P2|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7
2473839|NCT02293902|8540538|P1|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0
2473840|NCT02293902|8540534|P5|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
2473841|NCT02293902|8540535|P4|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
2473842|NCT02293902|8540536|P3|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
2473843|NCT02293902|8540537|P2|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
2473844|NCT02293902|8540538|P1|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1
2473845|NCT02293902|8540534|P5|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
2473846|NCT02293902|8540535|P4|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
2473847|NCT02293902|8540536|P3|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2
2473848|NCT02293902|8540537|P2|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1
2473849|NCT02293902|8540538|P1|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5
2473850|NCT02293902|8540534|P5|Double-Blind Period (Up to Week 24)|Adverse Event|0
2473851|NCT02293902|8540535|P4|Double-Blind Period (Up to Week 24)|Adverse Event|0
2473852|NCT02293902|8540536|P3|Double-Blind Period (Up to Week 24)|Adverse Event|8
2473853|NCT02293902|8540537|P2|Double-Blind Period (Up to Week 24)|Adverse Event|6
2473854|NCT02293902|8540538|P1|Double-Blind Period (Up to Week 24)|Adverse Event|5
2473855|NCT02293863|8540600|P3|Overall Study|Reason Not Specified|2
2473856|NCT02293863|8540601|P2|Overall Study|Reason Not Specified|2
2473857|NCT02293863|8540602|P1|Overall Study|Reason Not Specified|0
2473858|NCT02293863|8540600|P3|Overall Study|Withdrawal by Subject|1
2473859|NCT02293863|8540601|P2|Overall Study|Withdrawal by Subject|3
2473860|NCT02293863|8540602|P1|Overall Study|Withdrawal by Subject|3
2473861|NCT02293863|8540600|P3|Overall Study|Lost to Follow-up|2
2473862|NCT02293863|8540601|P2|Overall Study|Lost to Follow-up|2
2473863|NCT02293863|8540602|P1|Overall Study|Lost to Follow-up|2
2473864|NCT02293863|8540600|P3|Overall Study|Death|4
2473865|NCT02293863|8540601|P2|Overall Study|Death|6
2473866|NCT02293863|8540602|P1|Overall Study|Death|4
2473867|NCT02293538|8540671|P2|Overall Study|Withdrawal by Subject|1
2473868|NCT02293538|8540672|P1|Overall Study|Withdrawal by Subject|0
2473869|NCT02293538|8540671|P2|Overall Study|Lost to Follow-up|0
2473870|NCT02293538|8540672|P1|Overall Study|Lost to Follow-up|1
2473871|NCT02293538|8540671|P2|Overall Study|Adverse Event|1
2473872|NCT02293538|8540672|P1|Overall Study|Adverse Event|0
2473873|NCT02293460|8540702|P1|Overall Study|Withdrawal by Subject|1
2473874|NCT02293460|8540702|P1|Overall Study|Adverse Event|2
2473875|NCT02293460|8540702|P1|Overall Study|Lack of Efficacy|2
2473876|NCT02293460|8540702|P1|Overall Study|Protocol Violation|1
2473877|NCT02293395|8540708|P2|Overall Study|Withdrawal by Subject|7
2473878|NCT02293395|8540709|P1|Overall Study|Withdrawal by Subject|8
2473879|NCT02293395|8540708|P2|Overall Study|Lost to Follow-up|0
2473880|NCT02293395|8540709|P1|Overall Study|Lost to Follow-up|1
2473881|NCT02292927|8540722|P2|Overall Study|Protocol Violation|7
2473882|NCT02292927|8540723|P1|Overall Study|Protocol Violation|13
2473883|NCT02292849|8540740|P3|Overall Study|Physician Decision|0
2473884|NCT02292849|8540741|P2|Overall Study|Physician Decision|0
2473885|NCT02292849|8540742|P1|Overall Study|Physician Decision|4
2473886|NCT02292849|8540740|P3|Overall Study|Lost to Follow-up|2
2473887|NCT02292849|8540741|P2|Overall Study|Lost to Follow-up|2
2473888|NCT02292849|8540742|P1|Overall Study|Lost to Follow-up|0
2473889|NCT02292771|8540752|P2|Overall Study|Lost to Follow-up|1
2473890|NCT02292771|8540753|P1|Overall Study|Lost to Follow-up|2
2473891|NCT02292771|8540752|P2|Overall Study|Withdrawal by Subject|1
2473892|NCT02292771|8540753|P1|Overall Study|Withdrawal by Subject|2
2473893|NCT02292719|8540876|P6|Overall Study|Subject enrolled in new study.|0
2473894|NCT02292719|8540877|P5|Overall Study|Subject enrolled in new study.|0
2473895|NCT02292719|8540878|P4|Overall Study|Subject enrolled in new study.|0
2473896|NCT02292719|8540879|P3|Overall Study|Subject enrolled in new study.|1
2473897|NCT02292719|8540880|P2|Overall Study|Subject enrolled in new study.|0
2473898|NCT02292719|8540881|P1|Overall Study|Subject enrolled in new study.|0
2473899|NCT02292719|8540876|P6|Overall Study|Withdrawal by Subject|0
2473900|NCT02292719|8540877|P5|Overall Study|Withdrawal by Subject|1
2473901|NCT02292719|8540878|P4|Overall Study|Withdrawal by Subject|1
2473902|NCT02292719|8540879|P3|Overall Study|Withdrawal by Subject|0
2473903|NCT02292719|8540880|P2|Overall Study|Withdrawal by Subject|0
2473904|NCT02292719|8540881|P1|Overall Study|Withdrawal by Subject|0
2473905|NCT02292446|8540944|P1|Overall Study|Withdrawal by Subject|3
2473906|NCT02292446|8540944|P1|Overall Study|Subject/guardian decision|2
2473907|NCT02292446|8540944|P1|Overall Study|Disease progression|2
2473908|NCT02292446|8540944|P1|Overall Study|Death|1
2473909|NCT02292446|8540944|P1|Overall Study|Adverse Event|12
2473910|NCT02292212|8541033|P1|ViE Phase|Protocol Violation|2
2473911|NCT02292212|8541033|P1|ViE Phase|Withdrawal by Subject|1
2473912|NCT02291913|8541102|P1|Overall Study|Protocol Violation|1
2473913|NCT02291913|8541102|P1|Overall Study|Withdrawal by Subject|1
2473914|NCT02291913|8541102|P1|Overall Study|Physician Decision|1
2473915|NCT02291913|8541102|P1|Overall Study|Death|2
2473916|NCT02291913|8541102|P1|Overall Study|Adverse Event|11
2473917|NCT02291913|8541102|P1|Overall Study|Progressive Disease|32
2473918|NCT02291861|8541115|P4|Overall Study|Other|1
2473919|NCT02291861|8541116|P3|Overall Study|Other|0
2473920|NCT02291861|8541117|P2|Overall Study|Other|0
2473921|NCT02291861|8541118|P1|Overall Study|Other|0
2473922|NCT02291861|8541115|P4|Overall Study|Lost to Follow-up|0
2473923|NCT02291861|8541116|P3|Overall Study|Lost to Follow-up|4
2473924|NCT02291861|8541117|P2|Overall Study|Lost to Follow-up|1
2473925|NCT02291861|8541118|P1|Overall Study|Lost to Follow-up|2
2473926|NCT02291861|8541115|P4|Overall Study|Noncompliance|1
2473927|NCT02291861|8541116|P3|Overall Study|Noncompliance|2
2473928|NCT02291861|8541117|P2|Overall Study|Noncompliance|1
2473929|NCT02291861|8541118|P1|Overall Study|Noncompliance|1
2473930|NCT02291861|8541115|P4|Overall Study|Withdrawal by Subject|4
2473931|NCT02291861|8541116|P3|Overall Study|Withdrawal by Subject|1
2473932|NCT02291861|8541117|P2|Overall Study|Withdrawal by Subject|2
2473933|NCT02291861|8541118|P1|Overall Study|Withdrawal by Subject|1
2473934|NCT02291861|8541115|P4|Overall Study|Protocol Violation|1
2473935|NCT02291861|8541116|P3|Overall Study|Protocol Violation|0
2473936|NCT02291861|8541117|P2|Overall Study|Protocol Violation|0
2473937|NCT02291861|8541118|P1|Overall Study|Protocol Violation|1
2473938|NCT02291861|8541115|P4|Overall Study|Death|1
2473939|NCT02291861|8541116|P3|Overall Study|Death|1
2473940|NCT02291861|8541117|P2|Overall Study|Death|0
2473941|NCT02291861|8541118|P1|Overall Study|Death|0
2473942|NCT02291861|8541115|P4|Overall Study|Adverse Event|2
2473943|NCT02291861|8541116|P3|Overall Study|Adverse Event|1
2473944|NCT02291861|8541117|P2|Overall Study|Adverse Event|4
2473945|NCT02291861|8541118|P1|Overall Study|Adverse Event|2
2473946|NCT02291679|8541181|P3|Overall Study|Other|2
2473947|NCT02291679|8541182|P2|Overall Study|Other|4
2473948|NCT02291679|8541183|P1|Overall Study|Other|2
2473949|NCT02291679|8541181|P3|Overall Study|Insufficient Therapeutic Response|7
2473950|NCT02291679|8541182|P2|Overall Study|Insufficient Therapeutic Response|5
2473951|NCT02291679|8541183|P1|Overall Study|Insufficient Therapeutic Response|5
2473952|NCT02291679|8541181|P3|Overall Study|Lost to Follow-up|9
2473953|NCT02291679|8541182|P2|Overall Study|Lost to Follow-up|10
2473954|NCT02291679|8541183|P1|Overall Study|Lost to Follow-up|12
2473955|NCT02291679|8541181|P3|Overall Study|Withdrew Consent|15
2473956|NCT02291679|8541182|P2|Overall Study|Withdrew Consent|10
2473957|NCT02291679|8541183|P1|Overall Study|Withdrew Consent|18
2473958|NCT02291679|8541181|P3|Overall Study|Protocol Violation|7
2473959|NCT02291679|8541182|P2|Overall Study|Protocol Violation|1
2473960|NCT02291679|8541183|P1|Overall Study|Protocol Violation|5
2473961|NCT02291679|8541181|P3|Overall Study|Adverse Event|19
2473962|NCT02291679|8541182|P2|Overall Study|Adverse Event|12
2473963|NCT02291679|8541183|P1|Overall Study|Adverse Event|2
2473964|NCT02291549|8541214|P2|Overall Study|Withdrawal by Subject|1
2473965|NCT02291549|8541215|P1|Overall Study|Withdrawal by Subject|0
2473966|NCT02291549|8541214|P2|Overall Study|Lost to Follow-up|0
2473967|NCT02291549|8541215|P1|Overall Study|Lost to Follow-up|1
2473968|NCT02291510|8541237|P4|Overall Study|Adverse Event|1
2473969|NCT02291510|8541238|P3|Overall Study|Adverse Event|0
2473970|NCT02291510|8541239|P2|Overall Study|Adverse Event|0
2473971|NCT02291510|8541240|P1|Overall Study|Adverse Event|0
2473972|NCT02291419|8541256|P2|Overall Study|Early study termination|5
2473973|NCT02291419|8541257|P1|Overall Study|Early study termination|1
2473974|NCT02291237|8541275|P2|Overall Study|Subject Required Prohibited Medication|0
2473975|NCT02291237|8541276|P1|Overall Study|Subject Required Prohibited Medication|2
2473976|NCT02291237|8541275|P2|Overall Study|Lost to Follow-up|2
2473977|NCT02291237|8541276|P1|Overall Study|Lost to Follow-up|0
2473978|NCT02291237|8541275|P2|Overall Study|Withdrew Consent|11
2473979|NCT02291237|8541276|P1|Overall Study|Withdrew Consent|11
2473980|NCT02291237|8541275|P2|Overall Study|Investigator's Discretion|3
2473981|NCT02291237|8541276|P1|Overall Study|Investigator's Discretion|0
2473982|NCT02291237|8541275|P2|Overall Study|Adverse Event|3
2473983|NCT02291237|8541276|P1|Overall Study|Adverse Event|1
2473984|NCT02291237|8541275|P2|Overall Study|Study Terminated by Sponsor|67
2473985|NCT02291237|8541276|P1|Overall Study|Study Terminated by Sponsor|72
2473986|NCT02291029|8541298|P6|Overall Study|Adverse Event|0
2473987|NCT02291029|8541299|P5|Overall Study|Adverse Event|0
2473988|NCT02291029|8541300|P4|Overall Study|Adverse Event|0
2473989|NCT02291029|8541301|P3|Overall Study|Adverse Event|0
2473990|NCT02291029|8541302|P2|Overall Study|Adverse Event|1
2473991|NCT02291029|8541303|P1|Overall Study|Adverse Event|0
2473992|NCT02291029|8541298|P6|Overall Study|Withdrawal by Subject|0
2473993|NCT02291029|8541299|P5|Overall Study|Withdrawal by Subject|0
2473994|NCT02291029|8541300|P4|Overall Study|Withdrawal by Subject|0
2473995|NCT02291029|8541301|P3|Overall Study|Withdrawal by Subject|1
2473996|NCT02291029|8541302|P2|Overall Study|Withdrawal by Subject|0
2473997|NCT02291029|8541303|P1|Overall Study|Withdrawal by Subject|0
2473998|NCT02290925|8541374|P2|Second Period of 3 Months|insulin started|1
2473999|NCT02290925|8541375|P1|Second Period of 3 Months|insulin started|0
2474000|NCT02290925|8541374|P2|Second Period of 3 Months|Lost to Follow-up|3
2474001|NCT02290925|8541375|P1|Second Period of 3 Months|Lost to Follow-up|1
2474002|NCT02290925|8541374|P2|First Period of Three Months|Insulin Started|1
2474003|NCT02290925|8541375|P1|First Period of Three Months|Insulin Started|1
2474004|NCT02290925|8541374|P2|First Period of Three Months|Death|0
2474005|NCT02290925|8541375|P1|First Period of Three Months|Death|1
2474006|NCT02290925|8541374|P2|First Period of Three Months|Lost to Follow-up|1
2474007|NCT02290925|8541375|P1|First Period of Three Months|Lost to Follow-up|2
2474008|NCT02290873|8541390|P3|Overall Study|Protocol Violation|1
2474009|NCT02290873|8541391|P2|Overall Study|Protocol Violation|0
2474010|NCT02290873|8541392|P1|Overall Study|Protocol Violation|0
2474011|NCT02290873|8541390|P3|Overall Study|Esophagogastroduodenoscopy was added|0
2474012|NCT02290873|8541391|P2|Overall Study|Esophagogastroduodenoscopy was added|0
2474013|NCT02290873|8541392|P1|Overall Study|Esophagogastroduodenoscopy was added|1
2474014|NCT02290873|8541390|P3|Overall Study|Nellcor device error|0
2474015|NCT02290873|8541391|P2|Overall Study|Nellcor device error|0
2474016|NCT02290873|8541392|P1|Overall Study|Nellcor device error|1
2474017|NCT02290873|8541390|P3|Overall Study|Withdrawal by Subject|1
2474018|NCT02290873|8541391|P2|Overall Study|Withdrawal by Subject|1
2474019|NCT02290873|8541392|P1|Overall Study|Withdrawal by Subject|0
2474020|NCT02290821|8541411|P2|Overall Study|Lost to Follow-up|2
2474021|NCT02290821|8541412|P1|Overall Study|Lost to Follow-up|3
2474022|NCT02290821|8541411|P2|Overall Study|Unable or unwilling to cooperate with|0
2474023|NCT02290821|8541412|P1|Overall Study|Unable or unwilling to cooperate with|2
2474024|NCT02290821|8541411|P2|Overall Study|Withdrawal by Subject|1
2474025|NCT02290821|8541412|P1|Overall Study|Withdrawal by Subject|1
2474026|NCT02290691|8541420|P2|Overall Study|Lost to Follow-up|7
2474027|NCT02290691|8541421|P1|Overall Study|Lost to Follow-up|7
2474028|NCT02290691|8541420|P2|Overall Study|Withdrawal by Subject|1
2474029|NCT02290691|8541421|P1|Overall Study|Withdrawal by Subject|1
2474030|NCT02290691|8541420|P2|Overall Study|Noncompliance|1
2474031|NCT02290691|8541421|P1|Overall Study|Noncompliance|0
2474032|NCT02290431|8541534|P1|Overall Study|Physician Decision|2
2474033|NCT02290431|8541534|P1|Overall Study|Study terminated by Sponsor|1
2474034|NCT02290431|8541534|P1|Overall Study|Progressive disease|4
2474035|NCT02290431|8541534|P1|Overall Study|Adverse Event|20
2474036|NCT02290340|8541557|P4|Overall Study|Other|1
2474037|NCT02290340|8541558|P3|Overall Study|Other|0
2474038|NCT02290340|8541559|P2|Overall Study|Other|0
2474039|NCT02290340|8541560|P1|Overall Study|Other|1
2474040|NCT02290340|8541557|P4|Overall Study|Withdrawal by Subject|0
2474041|NCT02290340|8541558|P3|Overall Study|Withdrawal by Subject|0
2474042|NCT02290340|8541559|P2|Overall Study|Withdrawal by Subject|0
2474043|NCT02290340|8541560|P1|Overall Study|Withdrawal by Subject|1
2474044|NCT02290340|8541557|P4|Overall Study|Lost to Follow-up|1
2474045|NCT02290340|8541558|P3|Overall Study|Lost to Follow-up|0
2474046|NCT02290340|8541559|P2|Overall Study|Lost to Follow-up|0
2474047|NCT02290340|8541560|P1|Overall Study|Lost to Follow-up|0
2474048|NCT02290223|8541605|P2|12 Months|Refusal|1
2474049|NCT02290223|8541606|P1|12 Months|Refusal|0
2474050|NCT02290223|8541605|P2|12 Months|Lost to Follow-up|10
2474051|NCT02290223|8541606|P1|12 Months|Lost to Follow-up|16
2474052|NCT02290223|8541605|P2|6 Months|deceased (not related to study)|0
2474053|NCT02290223|8541606|P1|6 Months|deceased (not related to study)|2
2474054|NCT02290223|8541605|P2|6 Months|Withdrawal by Subject|0
2474055|NCT02290223|8541606|P1|6 Months|Withdrawal by Subject|5
2474056|NCT02290223|8541605|P2|6 Months|Lost to Follow-up|6
2474057|NCT02290223|8541606|P1|6 Months|Lost to Follow-up|9
2474058|NCT02289963|8541721|P2|Overall Study|Other than specified above|2
2474059|NCT02289963|8541722|P1|Overall Study|Other than specified above|0
2474060|NCT02289963|8541721|P2|Overall Study|End treatment visit outside visit window|4
2474061|NCT02289963|8541722|P1|Overall Study|End treatment visit outside visit window|0
2474062|NCT02289963|8541721|P2|Overall Study|Last injection missed|2
2474063|NCT02289963|8541722|P1|Overall Study|Last injection missed|2
2474064|NCT02289963|8541721|P2|Overall Study|Withdrawal by Subject|0
2474065|NCT02289963|8541722|P1|Overall Study|Withdrawal by Subject|1
2474066|NCT02289963|8541721|P2|Overall Study|Poor compliance to protocol|0
2474067|NCT02289963|8541722|P1|Overall Study|Poor compliance to protocol|1
2474068|NCT02289963|8541721|P2|Overall Study|Adverse Event|2
2474069|NCT02289963|8541722|P1|Overall Study|Adverse Event|1
2474070|NCT02289898|8541773|P3|Overall Study|Other|10
2474071|NCT02289898|8541774|P2|Overall Study|Other|7
2474072|NCT02289898|8541775|P1|Overall Study|Other|8
2474073|NCT02289898|8541773|P3|Overall Study|Use of another anticancer therapy|1
2474074|NCT02289898|8541774|P2|Overall Study|Use of another anticancer therapy|0
2474075|NCT02289898|8541775|P1|Overall Study|Use of another anticancer therapy|0
2474076|NCT02289898|8541773|P3|Overall Study|Disease progression|34
2474077|NCT02289898|8541774|P2|Overall Study|Disease progression|28
2474078|NCT02289898|8541775|P1|Overall Study|Disease progression|34
2474079|NCT02289898|8541773|P3|Overall Study|Adverse Event|5
2474080|NCT02289898|8541774|P2|Overall Study|Adverse Event|5
2474081|NCT02289898|8541775|P1|Overall Study|Adverse Event|3
2474082|NCT02289898|8541773|P3|Overall Study|Withdrawal by Subject|1
2474083|NCT02289898|8541774|P2|Overall Study|Withdrawal by Subject|4
2474084|NCT02289898|8541775|P1|Overall Study|Withdrawal by Subject|0
2474085|NCT02289898|8541773|P3|Overall Study|Physician Decision|2
2474086|NCT02289898|8541774|P2|Overall Study|Physician Decision|5
2474087|NCT02289898|8541775|P1|Overall Study|Physician Decision|2
2474088|NCT02289898|8541773|P3|Overall Study|Death|3
2474089|NCT02289898|8541774|P2|Overall Study|Death|4
2474090|NCT02289898|8541775|P1|Overall Study|Death|5
2474091|NCT02289833|8541784|P2|Overall Study|Death|16
2474092|NCT02289833|8541785|P1|Overall Study|Death|23
2474093|NCT02289833|8541784|P2|Overall Study|Lost to Follow-up|0
2474094|NCT02289833|8541785|P1|Overall Study|Lost to Follow-up|4
2474095|NCT02289833|8541784|P2|Overall Study|Study discontinuation|1
2474096|NCT02289833|8541785|P1|Overall Study|Study discontinuation|0
2474097|NCT02289820|8541821|P7|Overall Study|withdrawal of consent|0
2474098|NCT02289820|8541822|P6|Overall Study|withdrawal of consent|0
2474099|NCT02289820|8541823|P5|Overall Study|withdrawal of consent|0
2474100|NCT02289820|8541824|P4|Overall Study|withdrawal of consent|0
2474101|NCT02289820|8541825|P3|Overall Study|withdrawal of consent|0
2474102|NCT02289820|8541826|P2|Overall Study|withdrawal of consent|1
2474103|NCT02289820|8541827|P1|Overall Study|withdrawal of consent|0
2474104|NCT02289820|8541821|P7|Overall Study|Lost to Follow-up|1
2474105|NCT02289820|8541822|P6|Overall Study|Lost to Follow-up|1
2474106|NCT02289820|8541823|P5|Overall Study|Lost to Follow-up|0
2474107|NCT02289820|8541824|P4|Overall Study|Lost to Follow-up|1
2474108|NCT02289820|8541825|P3|Overall Study|Lost to Follow-up|3
2474109|NCT02289820|8541826|P2|Overall Study|Lost to Follow-up|0
2474110|NCT02289820|8541827|P1|Overall Study|Lost to Follow-up|0
2474111|NCT02289820|8541821|P7|Overall Study|Death|0
2474112|NCT02289820|8541822|P6|Overall Study|Death|0
2474113|NCT02289820|8541823|P5|Overall Study|Death|0
2474114|NCT02289820|8541824|P4|Overall Study|Death|0
2474115|NCT02289820|8541825|P3|Overall Study|Death|1
2474116|NCT02289820|8541826|P2|Overall Study|Death|0
2474117|NCT02289820|8541827|P1|Overall Study|Death|0
2474118|NCT02289820|8541821|P7|Overall Study|Withdrawal by Subject|1
2474119|NCT02289820|8541822|P6|Overall Study|Withdrawal by Subject|0
2474120|NCT02289820|8541823|P5|Overall Study|Withdrawal by Subject|0
2474121|NCT02289820|8541824|P4|Overall Study|Withdrawal by Subject|1
2474122|NCT02289820|8541825|P3|Overall Study|Withdrawal by Subject|2
2474123|NCT02289820|8541826|P2|Overall Study|Withdrawal by Subject|1
2474124|NCT02289820|8541827|P1|Overall Study|Withdrawal by Subject|2
2474125|NCT02289742|8541945|P4|Third Wear Period|Reason not given|1
2474126|NCT02289742|8541946|P3|Third Wear Period|Reason not given|0
2474127|NCT02289742|8541947|P2|Third Wear Period|Reason not given|0
2474128|NCT02289742|8541948|P1|Third Wear Period|Reason not given|0
2474129|NCT02289742|8541945|P4|Third Wear Period|Adverse Event|0
2474130|NCT02289742|8541946|P3|Third Wear Period|Adverse Event|0
2474131|NCT02289742|8541947|P2|Third Wear Period|Adverse Event|1
2474132|NCT02289742|8541948|P1|Third Wear Period|Adverse Event|0
2474133|NCT02289742|8541945|P4|First Wear Period|Other prior to treatment|1
2474134|NCT02289742|8541946|P3|First Wear Period|Other prior to treatment|0
2474135|NCT02289742|8541947|P2|First Wear Period|Other prior to treatment|0
2474136|NCT02289742|8541948|P1|First Wear Period|Other prior to treatment|0
2474137|NCT02289742|8541945|P4|First Wear Period|Adverse Event|0
2474138|NCT02289742|8541946|P3|First Wear Period|Adverse Event|1
2474139|NCT02289742|8541947|P2|First Wear Period|Adverse Event|0
2474140|NCT02289742|8541948|P1|First Wear Period|Adverse Event|0
2474141|NCT02289742|8541945|P4|First Wear Period|Adverse event prior to treatment|0
2474142|NCT02289742|8541946|P3|First Wear Period|Adverse event prior to treatment|0
2474143|NCT02289742|8541947|P2|First Wear Period|Adverse event prior to treatment|1
2474144|NCT02289742|8541948|P1|First Wear Period|Adverse event prior to treatment|0
2474145|NCT02289729|8541965|P1|Overall Study|Death|1
2474146|NCT02289729|8541965|P1|Overall Study|Withdrawal by Subject|1
2474147|NCT02289729|8541965|P1|Overall Study|Very Narrow Therapeutic Margin|1
2474148|NCT02289729|8541965|P1|Overall Study|Lack of Efficacy|3
2474149|NCT02289469|8542021|P2|Overall Study|Unable to match a control|0
2474150|NCT02289469|8542022|P1|Overall Study|Unable to match a control|6
2474151|NCT02289456|8542030|P1|Monotherapy Period|Miscellaneous|1
2474152|NCT02289456|8542030|P1|Monotherapy Period|Study Terminated by Sponsor|2
2474153|NCT02289456|8542030|P1|Monotherapy Period|Withdrawal by Subject|2
2474154|NCT02289456|8542030|P1|Monotherapy Period|Symptomatic Deterioration|1
2474155|NCT02289456|8542030|P1|Monotherapy Period|Progressive Disease (PD)|8
2474156|NCT02289456|8542030|P1|Monotherapy Period|Adverse Event|1
2474157|NCT02289456|8542030|P1|Monotherapy Period|Death|1
2474158|NCT02289456|8542030|P1|Induction Period|Miscellaneous|1
2474159|NCT02289456|8542030|P1|Induction Period|Withdrawal by Subject|2
2474160|NCT02289456|8542030|P1|Induction Period|Symptomatic Deterioration|4
2474161|NCT02289456|8542030|P1|Induction Period|Progressive Disease (PD)|4
2474162|NCT02289456|8542030|P1|Induction Period|Adverse Event|11
2474163|NCT02289456|8542030|P1|Induction Period|Death|2
2474164|NCT02289417|8542053|P9|Extension Phase Weeks 52-104|Miscellaneous|0
2474165|NCT02289417|8542054|P8|Extension Phase Weeks 52-104|Miscellaneous|1
2474166|NCT02289417|8542055|P7|Extension Phase Weeks 52-104|Miscellaneous|0
2474167|NCT02289417|8542056|P6|Extension Phase Weeks 52-104|Miscellaneous|0
2474168|NCT02289417|8542057|P5|Extension Phase Weeks 52-104|Miscellaneous|0
2474169|NCT02289417|8542058|P4|Extension Phase Weeks 52-104|Miscellaneous|0
2474170|NCT02289417|8542059|P3|Extension Phase Weeks 52-104|Miscellaneous|0
2474171|NCT02289417|8542060|P2|Extension Phase Weeks 52-104|Miscellaneous|0
2474172|NCT02289417|8542061|P1|Extension Phase Weeks 52-104|Miscellaneous|0
2474173|NCT02289417|8542053|P9|Extension Phase Weeks 52-104|Withdrawal by Subject|1
2474174|NCT02289417|8542054|P8|Extension Phase Weeks 52-104|Withdrawal by Subject|2
2474175|NCT02289417|8542055|P7|Extension Phase Weeks 52-104|Withdrawal by Subject|0
2474176|NCT02289417|8542056|P6|Extension Phase Weeks 52-104|Withdrawal by Subject|0
2474177|NCT02289417|8542057|P5|Extension Phase Weeks 52-104|Withdrawal by Subject|0
2474178|NCT02289417|8542058|P4|Extension Phase Weeks 52-104|Withdrawal by Subject|0
2474179|NCT02289417|8542059|P3|Extension Phase Weeks 52-104|Withdrawal by Subject|0
2474180|NCT02289417|8542060|P2|Extension Phase Weeks 52-104|Withdrawal by Subject|0
2474181|NCT02289417|8542061|P1|Extension Phase Weeks 52-104|Withdrawal by Subject|0
2474182|NCT02289417|8542053|P9|Extension Phase Weeks 52-104|Lack of Efficacy|2
2474183|NCT02289417|8542054|P8|Extension Phase Weeks 52-104|Lack of Efficacy|2
2474184|NCT02289417|8542055|P7|Extension Phase Weeks 52-104|Lack of Efficacy|0
2474185|NCT02289417|8542056|P6|Extension Phase Weeks 52-104|Lack of Efficacy|0
2474186|NCT02289417|8542057|P5|Extension Phase Weeks 52-104|Lack of Efficacy|0
2474187|NCT02289417|8542058|P4|Extension Phase Weeks 52-104|Lack of Efficacy|0
2474188|NCT02289417|8542059|P3|Extension Phase Weeks 52-104|Lack of Efficacy|0
2474189|NCT02289417|8542060|P2|Extension Phase Weeks 52-104|Lack of Efficacy|0
2474190|NCT02289417|8542061|P1|Extension Phase Weeks 52-104|Lack of Efficacy|0
2474191|NCT02289417|8542053|P9|Extension Phase Weeks 52-104|Adverse Event|3
2474192|NCT02289417|8542054|P8|Extension Phase Weeks 52-104|Adverse Event|2
2474193|NCT02289417|8542055|P7|Extension Phase Weeks 52-104|Adverse Event|0
2474194|NCT02289417|8542056|P6|Extension Phase Weeks 52-104|Adverse Event|0
2474195|NCT02289417|8542057|P5|Extension Phase Weeks 52-104|Adverse Event|0
2474196|NCT02289417|8542058|P4|Extension Phase Weeks 52-104|Adverse Event|0
2474197|NCT02289417|8542059|P3|Extension Phase Weeks 52-104|Adverse Event|0
2474198|NCT02289417|8542060|P2|Extension Phase Weeks 52-104|Adverse Event|0
2474199|NCT02289417|8542061|P1|Extension Phase Weeks 52-104|Adverse Event|0
2474200|NCT02289417|8542053|P9|Active Treatment Phase Weeks 12-52|Miscellaneous|0
2474201|NCT02289417|8542054|P8|Active Treatment Phase Weeks 12-52|Miscellaneous|0
2474202|NCT02289417|8542055|P7|Active Treatment Phase Weeks 12-52|Miscellaneous|1
2474203|NCT02289417|8542056|P6|Active Treatment Phase Weeks 12-52|Miscellaneous|0
2474204|NCT02289417|8542057|P5|Active Treatment Phase Weeks 12-52|Miscellaneous|0
2474205|NCT02289417|8542058|P4|Active Treatment Phase Weeks 12-52|Miscellaneous|1
2474206|NCT02289417|8542059|P3|Active Treatment Phase Weeks 12-52|Miscellaneous|0
2474207|NCT02289417|8542060|P2|Active Treatment Phase Weeks 12-52|Miscellaneous|0
2474208|NCT02289417|8542061|P1|Active Treatment Phase Weeks 12-52|Miscellaneous|0
2474209|NCT02289417|8542053|P9|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
2474210|NCT02289417|8542054|P8|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
2474211|NCT02289417|8542055|P7|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1
2474212|NCT02289417|8542056|P6|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
2474213|NCT02289417|8542057|P5|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
2474214|NCT02289417|8542058|P4|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
2474215|NCT02289417|8542059|P3|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
2474216|NCT02289417|8542060|P2|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
2474217|NCT02289417|8542061|P1|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
2474218|NCT02289417|8542053|P9|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
2474219|NCT02289417|8542054|P8|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
2474220|NCT02289417|8542055|P7|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
2474221|NCT02289417|8542056|P6|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
2474222|NCT02289417|8542057|P5|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
2474223|NCT02289417|8542058|P4|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
2474224|NCT02289417|8542059|P3|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
2474225|NCT02289417|8542060|P2|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
2474226|NCT02289417|8542061|P1|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
2474227|NCT02289417|8542053|P9|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
2474228|NCT02289417|8542054|P8|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
2474229|NCT02289417|8542055|P7|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
2474230|NCT02289417|8542056|P6|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3
2474231|NCT02289417|8542057|P5|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2
2474232|NCT02289417|8542058|P4|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6
2474233|NCT02289417|8542059|P3|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4
2474234|NCT02289417|8542060|P2|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1
2474235|NCT02289417|8542061|P1|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
2474236|NCT02289417|8542053|P9|Active Treatment Phase Weeks 12-52|Pregnancy|0
2474237|NCT02289417|8542054|P8|Active Treatment Phase Weeks 12-52|Pregnancy|0
2474238|NCT02289417|8542055|P7|Active Treatment Phase Weeks 12-52|Pregnancy|0
2474239|NCT02289417|8542056|P6|Active Treatment Phase Weeks 12-52|Pregnancy|0
2474240|NCT02289417|8542057|P5|Active Treatment Phase Weeks 12-52|Pregnancy|0
2474241|NCT02289417|8542058|P4|Active Treatment Phase Weeks 12-52|Pregnancy|0
2474242|NCT02289417|8542059|P3|Active Treatment Phase Weeks 12-52|Pregnancy|1
2474243|NCT02289417|8542060|P2|Active Treatment Phase Weeks 12-52|Pregnancy|0
2474244|NCT02289417|8542061|P1|Active Treatment Phase Weeks 12-52|Pregnancy|0
2474245|NCT02289417|8542053|P9|Active Treatment Phase Weeks 12-52|Adverse Event|0
2474246|NCT02289417|8542054|P8|Active Treatment Phase Weeks 12-52|Adverse Event|0
2474247|NCT02289417|8542055|P7|Active Treatment Phase Weeks 12-52|Adverse Event|0
2474248|NCT02289417|8542056|P6|Active Treatment Phase Weeks 12-52|Adverse Event|1
2474249|NCT02289417|8542057|P5|Active Treatment Phase Weeks 12-52|Adverse Event|2
2474250|NCT02289417|8542058|P4|Active Treatment Phase Weeks 12-52|Adverse Event|2
2474251|NCT02289417|8542059|P3|Active Treatment Phase Weeks 12-52|Adverse Event|4
2474252|NCT02289417|8542060|P2|Active Treatment Phase Weeks 12-52|Adverse Event|1
2474253|NCT02289417|8542061|P1|Active Treatment Phase Weeks 12-52|Adverse Event|0
2474254|NCT02289417|8542053|P9|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
2474255|NCT02289417|8542054|P8|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
2474256|NCT02289417|8542055|P7|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
2474257|NCT02289417|8542056|P6|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
2474258|NCT02289417|8542057|P5|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
2474259|NCT02289417|8542058|P4|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
2474260|NCT02289417|8542059|P3|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
2474261|NCT02289417|8542060|P2|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
2474262|NCT02289417|8542061|P1|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3
2474263|NCT02289417|8542053|P9|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
2474264|NCT02289417|8542054|P8|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
2474265|NCT02289417|8542055|P7|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
2474266|NCT02289417|8542056|P6|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
2474267|NCT02289417|8542057|P5|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
2474268|NCT02289417|8542058|P4|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
2474269|NCT02289417|8542059|P3|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
2474270|NCT02289417|8542060|P2|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1
2474271|NCT02289417|8542061|P1|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
2474272|NCT02289417|8542053|P9|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
2474273|NCT02289417|8542054|P8|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
2474274|NCT02289417|8542055|P7|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
2474275|NCT02289417|8542056|P6|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
2474276|NCT02289417|8542057|P5|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
2474277|NCT02289417|8542058|P4|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
2474278|NCT02289417|8542059|P3|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2
2474279|NCT02289417|8542060|P2|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3
2474280|NCT02289417|8542061|P1|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1
2474281|NCT02289417|8542053|P9|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
2474282|NCT02289417|8542054|P8|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
2474283|NCT02289417|8542055|P7|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
2474284|NCT02289417|8542056|P6|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
2474285|NCT02289417|8542057|P5|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
2474286|NCT02289417|8542058|P4|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
2474287|NCT02289417|8542059|P3|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1
2474288|NCT02289417|8542060|P2|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
2474289|NCT02289417|8542061|P1|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3
2474290|NCT02289352|8542110|P3|Overall Study|Withdrawal by Subject|0
2474291|NCT02289352|8542111|P2|Overall Study|Withdrawal by Subject|1
2474292|NCT02289352|8542112|P1|Overall Study|Withdrawal by Subject|1
2474293|NCT02289079|8542179|P2|Overall Study|Lost to Follow-up|1
2474294|NCT02289079|8542180|P1|Overall Study|Lost to Follow-up|0
2474295|NCT02289079|8542179|P2|Overall Study|Physician Decision|0
2474296|NCT02289079|8542180|P1|Overall Study|Physician Decision|2
2474297|NCT02288559|8542209|P4|Overall Study|Reason Not Specified|0
2474298|NCT02288559|8542210|P3|Overall Study|Reason Not Specified|3
2474299|NCT02288559|8542211|P2|Overall Study|Reason Not Specified|0
2474300|NCT02288559|8542212|P1|Overall Study|Reason Not Specified|0
2474301|NCT02288559|8542209|P4|Overall Study|Withdrawal by Subject|1
2474302|NCT02288559|8542210|P3|Overall Study|Withdrawal by Subject|2
2474303|NCT02288559|8542211|P2|Overall Study|Withdrawal by Subject|0
2474304|NCT02288559|8542212|P1|Overall Study|Withdrawal by Subject|0
2474305|NCT02288559|8542209|P4|Overall Study|Lost to Follow-up|1
2474306|NCT02288559|8542210|P3|Overall Study|Lost to Follow-up|0
2474307|NCT02288559|8542211|P2|Overall Study|Lost to Follow-up|0
2474308|NCT02288559|8542212|P1|Overall Study|Lost to Follow-up|0
2474309|NCT02288559|8542209|P4|Overall Study|Death|0
2474310|NCT02288559|8542210|P3|Overall Study|Death|1
2474311|NCT02288559|8542211|P2|Overall Study|Death|0
2474312|NCT02288559|8542212|P1|Overall Study|Death|0
2474313|NCT02288559|8542209|P4|Overall Study|Adverse Event|0
2474314|NCT02288559|8542210|P3|Overall Study|Adverse Event|5
2474315|NCT02288559|8542211|P2|Overall Study|Adverse Event|1
2474316|NCT02288559|8542212|P1|Overall Study|Adverse Event|1
2474317|NCT02288325|8542263|P3|Double-blind Treatment Period|Multiple Reasons|2
2474318|NCT02288325|8542264|P2|Double-blind Treatment Period|Multiple Reasons|8
2474319|NCT02288325|8542265|P1|Double-blind Treatment Period|Multiple Reasons|0
2474320|NCT02288325|8542263|P3|Double-blind Treatment Period|Non-Compliance With Study Drug|4
2474321|NCT02288325|8542264|P2|Double-blind Treatment Period|Non-Compliance With Study Drug|1
2474322|NCT02288325|8542265|P1|Double-blind Treatment Period|Non-Compliance With Study Drug|0
2474323|NCT02288325|8542263|P3|Double-blind Treatment Period|Protocol Violation|2
2474324|NCT02288325|8542264|P2|Double-blind Treatment Period|Protocol Violation|1
2474325|NCT02288325|8542265|P1|Double-blind Treatment Period|Protocol Violation|0
2474326|NCT02288325|8542263|P3|Double-blind Treatment Period|Lost to Follow-up|5
2474327|NCT02288325|8542264|P2|Double-blind Treatment Period|Lost to Follow-up|4
2474328|NCT02288325|8542265|P1|Double-blind Treatment Period|Lost to Follow-up|0
2474329|NCT02288325|8542263|P3|Double-blind Treatment Period|Withdrawal of Consent|8
2474417|NCT02287610|8542675|P1|Overall Study|Withdrawal by Subject|8
2474330|NCT02288325|8542264|P2|Double-blind Treatment Period|Withdrawal of Consent|8
2474331|NCT02288325|8542265|P1|Double-blind Treatment Period|Withdrawal of Consent|0
2474332|NCT02288325|8542263|P3|Double-blind Treatment Period|Adverse Event|5
2474333|NCT02288325|8542264|P2|Double-blind Treatment Period|Adverse Event|2
2474334|NCT02288325|8542265|P1|Double-blind Treatment Period|Adverse Event|0
2474335|NCT02288325|8542263|P3|Stabilization Period|Reason not Specified|0
2474336|NCT02288325|8542264|P2|Stabilization Period|Reason not Specified|0
2474337|NCT02288325|8542265|P1|Stabilization Period|Reason not Specified|15
2474338|NCT02288325|8542263|P3|Stabilization Period|Non-Compliance With Study Drug|0
2474339|NCT02288325|8542264|P2|Stabilization Period|Non-Compliance With Study Drug|0
2474340|NCT02288325|8542265|P1|Stabilization Period|Non-Compliance With Study Drug|5
2474341|NCT02288325|8542263|P3|Stabilization Period|Protocol Violation|0
2474342|NCT02288325|8542264|P2|Stabilization Period|Protocol Violation|0
2474343|NCT02288325|8542265|P1|Stabilization Period|Protocol Violation|8
2474344|NCT02288325|8542263|P3|Stabilization Period|Lost to Follow-up|0
2474345|NCT02288325|8542264|P2|Stabilization Period|Lost to Follow-up|0
2474346|NCT02288325|8542265|P1|Stabilization Period|Lost to Follow-up|12
2474347|NCT02288325|8542263|P3|Stabilization Period|Withdrawal of Consent|0
2474348|NCT02288325|8542264|P2|Stabilization Period|Withdrawal of Consent|0
2474349|NCT02288325|8542265|P1|Stabilization Period|Withdrawal of Consent|23
2474350|NCT02288325|8542263|P3|Stabilization Period|Lack of Efficacy|0
2474351|NCT02288325|8542264|P2|Stabilization Period|Lack of Efficacy|0
2474352|NCT02288325|8542265|P1|Stabilization Period|Lack of Efficacy|22
2474353|NCT02288325|8542263|P3|Stabilization Period|Adverse Event|0
2474354|NCT02288325|8542264|P2|Stabilization Period|Adverse Event|0
2474355|NCT02288325|8542265|P1|Stabilization Period|Adverse Event|13
2474356|NCT02288325|8542263|P3|Run-in Period|Reason not Specified|0
2474357|NCT02288325|8542264|P2|Run-in Period|Reason not Specified|0
2474358|NCT02288325|8542265|P1|Run-in Period|Reason not Specified|8
2474359|NCT02288325|8542263|P3|Run-in Period|Non-Compliance With Study Drug|0
2474360|NCT02288325|8542264|P2|Run-in Period|Non-Compliance With Study Drug|0
2474361|NCT02288325|8542265|P1|Run-in Period|Non-Compliance With Study Drug|3
2474362|NCT02288325|8542263|P3|Run-in Period|Protocol Violation|0
2474363|NCT02288325|8542264|P2|Run-in Period|Protocol Violation|0
2474364|NCT02288325|8542265|P1|Run-in Period|Protocol Violation|17
2474365|NCT02288325|8542263|P3|Run-in Period|Lost to Follow-up|0
2474366|NCT02288325|8542264|P2|Run-in Period|Lost to Follow-up|0
2474367|NCT02288325|8542265|P1|Run-in Period|Lost to Follow-up|25
2474368|NCT02288325|8542263|P3|Run-in Period|Withdrawal of Consent|0
2474369|NCT02288325|8542264|P2|Run-in Period|Withdrawal of Consent|0
2474370|NCT02288325|8542265|P1|Run-in Period|Withdrawal of Consent|28
2474371|NCT02288325|8542263|P3|Run-in Period|Lack of Efficacy|0
2474372|NCT02288325|8542264|P2|Run-in Period|Lack of Efficacy|0
2474373|NCT02288325|8542265|P1|Run-in Period|Lack of Efficacy|16
2474374|NCT02288325|8542263|P3|Run-in Period|Adverse Event|0
2474375|NCT02288325|8542264|P2|Run-in Period|Adverse Event|0
2474376|NCT02288325|8542265|P1|Run-in Period|Adverse Event|48
2474377|NCT02288312|8542275|P3|Overall Study|Pregnancy|0
2474378|NCT02288312|8542276|P2|Overall Study|Pregnancy|0
2474379|NCT02288312|8542277|P1|Overall Study|Pregnancy|1
2474380|NCT02288182|8542317|P2|Overall Study|Lost to Follow-up|1
2474381|NCT02288182|8542318|P1|Overall Study|Lost to Follow-up|0
2474382|NCT02288182|8542317|P2|Overall Study|Adverse Event|1
2474383|NCT02288182|8542318|P1|Overall Study|Adverse Event|0
2474384|NCT02288091|8542330|P1|Overall Study|Screen fail|7
2474385|NCT02288091|8542330|P1|Overall Study|Lost to Follow-up|1
2474386|NCT02287922|8542342|P4|Overall Study|Other|0
2474387|NCT02287922|8542343|P3|Overall Study|Other|2
2474388|NCT02287922|8542344|P2|Overall Study|Other|0
2474389|NCT02287922|8542345|P1|Overall Study|Other|1
2474390|NCT02287922|8542342|P4|Overall Study|Sponsor's decision|1
2474391|NCT02287922|8542343|P3|Overall Study|Sponsor's decision|0
2474392|NCT02287922|8542344|P2|Overall Study|Sponsor's decision|0
2474393|NCT02287922|8542345|P1|Overall Study|Sponsor's decision|0
2474394|NCT02287922|8542342|P4|Overall Study|Lost to Follow-up|0
2474395|NCT02287922|8542343|P3|Overall Study|Lost to Follow-up|1
2474396|NCT02287922|8542344|P2|Overall Study|Lost to Follow-up|0
2474397|NCT02287922|8542345|P1|Overall Study|Lost to Follow-up|0
2474398|NCT02287922|8542342|P4|Overall Study|Withdrawal by Subject|2
2474399|NCT02287922|8542343|P3|Overall Study|Withdrawal by Subject|1
2474400|NCT02287922|8542344|P2|Overall Study|Withdrawal by Subject|1
2474401|NCT02287922|8542345|P1|Overall Study|Withdrawal by Subject|1
2474402|NCT02287922|8542342|P4|Overall Study|Adverse Event|4
2474403|NCT02287922|8542343|P3|Overall Study|Adverse Event|3
2474404|NCT02287922|8542344|P2|Overall Study|Adverse Event|1
2474405|NCT02287922|8542345|P1|Overall Study|Adverse Event|1
2474406|NCT02287896|8542436|P2|Second Injection Visit|Withdrawal by Subject|1
2474407|NCT02287896|8542437|P1|Second Injection Visit|Withdrawal by Subject|0
2474408|NCT02287883|8542455|P2|Overall Study|Non-response to survey|237
2474409|NCT02287883|8542456|P1|Overall Study|Non-response to survey|229
2474410|NCT02287883|8542455|P2|Overall Study|No longer eligible|182
2474411|NCT02287883|8542456|P1|Overall Study|No longer eligible|222
2474412|NCT02287883|8542455|P2|Overall Study|Death|7
2474413|NCT02287883|8542456|P1|Overall Study|Death|8
2474414|NCT02287623|8542658|P2|Overall Study|Protocol Violation|1
2474415|NCT02287623|8542659|P1|Overall Study|Protocol Violation|0
2474416|NCT02287610|8542675|P1|Overall Study|Excluded-investigator non-responsiveness|5
2474418|NCT02287610|8542675|P1|Overall Study|Lost to Follow-up|3
2474419|NCT02287467|8542710|P2|Overall Study|Protocol Violation|9
2474420|NCT02287467|8542711|P1|Overall Study|Protocol Violation|12
2474421|NCT02287402|8542759|P1|Follow-up|Voluntary Withdrawal|2
2474422|NCT02287402|8542759|P1|Follow-up|Lost to Follow-up|1
2474423|NCT02287402|8542759|P1|Treatment Period|Voluntary Withdrawal|10
2474424|NCT02287402|8542759|P1|Treatment Period|Adverse Event|17
2474425|NCT02287038|8542864|P2|Overall Study|Abnormal ECG after starting medication|0
2474426|NCT02287038|8542865|P1|Overall Study|Abnormal ECG after starting medication|1
2474427|NCT02287038|8542864|P2|Overall Study|Nausea after starting medication|0
2474428|NCT02287038|8542865|P1|Overall Study|Nausea after starting medication|1
2474429|NCT02287038|8542864|P2|Overall Study|Anxiety after starting medication|1
2474430|NCT02287038|8542865|P1|Overall Study|Anxiety after starting medication|0
2474431|NCT02287038|8542864|P2|Overall Study|Stopped attending appointments|2
2474432|NCT02287038|8542865|P1|Overall Study|Stopped attending appointments|3
2474433|NCT02287025|8542875|P2|Overall Study|Screening failed|1
2474434|NCT02287025|8542876|P1|Overall Study|Screening failed|1
2474435|NCT02287025|8542875|P2|Overall Study|Withdrawal by Subject|2
2474436|NCT02287025|8542876|P1|Overall Study|Withdrawal by Subject|2
2474437|NCT02287025|8542875|P2|Overall Study|Adverse Event|4
2474438|NCT02287025|8542876|P1|Overall Study|Adverse Event|2
2474439|NCT02287025|8542875|P2|Overall Study|Progression of disease|2
2474440|NCT02287025|8542876|P1|Overall Study|Progression of disease|3
2474441|NCT02287025|8542875|P2|Overall Study|Not treated|0
2474442|NCT02287025|8542876|P1|Overall Study|Not treated|2
2474443|NCT02286960|8542887|P2|Overall Study|Lost to Follow-up|3
2474444|NCT02286960|8542888|P1|Overall Study|Lost to Follow-up|3
2474445|NCT02286947|8542900|P1|Overall Study|Withdrawal by Subject|2
2474446|NCT02286895|8542942|P2|Assessed for Measles Seroconversion|Baseline measure non-negative|32
2474447|NCT02286895|8542943|P1|Assessed for Measles Seroconversion|Baseline measure non-negative|41
2474448|NCT02286895|8542942|P2|Assessed for Measles Seroconversion|Missing measurement|3
2474449|NCT02286895|8542943|P1|Assessed for Measles Seroconversion|Missing measurement|6
2474450|NCT02286895|8542942|P2|Assessed for Measles Seroconversion|Protocol Violation|4
2474451|NCT02286895|8542943|P1|Assessed for Measles Seroconversion|Protocol Violation|1
2474452|NCT02286713|8542987|P2|Six Month Follow-Up|Lost to Follow-up|27
2474453|NCT02286713|8542988|P1|Six Month Follow-Up|Lost to Follow-up|30
2474454|NCT02286713|8542987|P2|Six Month Follow-Up|Death|0
2474455|NCT02286713|8542988|P1|Six Month Follow-Up|Death|2
2474456|NCT02286713|8542987|P2|Three Month Follow-Up|Withdrawal by Subject|1
2474457|NCT02286713|8542988|P1|Three Month Follow-Up|Withdrawal by Subject|1
2474458|NCT02286713|8542987|P2|Three Month Follow-Up|Lost to Follow-up|24
2474459|NCT02286713|8542988|P1|Three Month Follow-Up|Lost to Follow-up|26
2474460|NCT02286713|8542987|P2|Three Month Follow-Up|Death|1
2474461|NCT02286713|8542988|P1|Three Month Follow-Up|Death|1
2474462|NCT02286713|8542987|P2|One Week Follow-Up|Withdrawal by Subject|3
2474463|NCT02286713|8542988|P1|One Week Follow-Up|Withdrawal by Subject|6
2474464|NCT02286713|8542987|P2|One Week Follow-Up|Lost to Follow-up|21
2474465|NCT02286713|8542988|P1|One Week Follow-Up|Lost to Follow-up|17
2474466|NCT02286713|8542987|P2|One Week Follow-Up|Death|0
2474467|NCT02286713|8542988|P1|One Week Follow-Up|Death|1
2474468|NCT02286466|8543169|P2|Overall Study|Declined Clinician Assessment|1
2474469|NCT02286466|8543170|P1|Overall Study|Declined Clinician Assessment|0
2474470|NCT02286466|8543169|P2|Overall Study|Lost to Follow-up|4
2474471|NCT02286466|8543170|P1|Overall Study|Lost to Follow-up|1
2474472|NCT02286466|8543169|P2|Overall Study|Withdrawal by Subject|2
2474473|NCT02286466|8543170|P1|Overall Study|Withdrawal by Subject|5
2474474|NCT02286466|8543169|P2|Overall Study|Death|3
2474475|NCT02286466|8543170|P1|Overall Study|Death|1
2474476|NCT02286193|8543182|P1|Overall Study|Referred: Declined service|38
2474477|NCT02286193|8543182|P1|Overall Study|Referred: unable to reach/resource sent|104
2474478|NCT02286193|8543182|P1|Overall Study|Referred: CRS unable to make contact|62
2474479|NCT02286102|8543189|P2|Overall Study|Screen Failure|1
2474480|NCT02286102|8543190|P1|Overall Study|Screen Failure|1
2474481|NCT02285998|8543202|P2|Overall Study|Other Reasons|10
2474482|NCT02285998|8543203|P1|Overall Study|Other Reasons|7
2474483|NCT02285998|8543202|P2|Overall Study|Withdrawal by Subject|61
2474484|NCT02285998|8543203|P1|Overall Study|Withdrawal by Subject|53
2474485|NCT02285998|8543202|P2|Overall Study|Lost to Follow-up|172
2474486|NCT02285998|8543203|P1|Overall Study|Lost to Follow-up|176
2474487|NCT02285998|8543202|P2|Overall Study|Physician Decision|2
2474488|NCT02285998|8543203|P1|Overall Study|Physician Decision|1
2474489|NCT02285998|8543202|P2|Overall Study|Adverse Event|8
2474490|NCT02285998|8543203|P1|Overall Study|Adverse Event|9
2474491|NCT02285920|8543231|P4|Overall Study|Death|1
2474492|NCT02285920|8543232|P3|Overall Study|Death|2
2474493|NCT02285920|8543233|P2|Overall Study|Death|0
2474494|NCT02285920|8543234|P1|Overall Study|Death|2
2474495|NCT02285920|8543231|P4|Overall Study|Dialysis discontinuation|0
2474496|NCT02285920|8543232|P3|Overall Study|Dialysis discontinuation|0
2474497|NCT02285920|8543233|P2|Overall Study|Dialysis discontinuation|1
2474498|NCT02285920|8543234|P1|Overall Study|Dialysis discontinuation|0
2474499|NCT02285920|8543231|P4|Overall Study|Transfer to non-participating unit|0
2474500|NCT02285920|8543232|P3|Overall Study|Transfer to non-participating unit|0
2474501|NCT02285920|8543233|P2|Overall Study|Transfer to non-participating unit|1
2474502|NCT02285920|8543234|P1|Overall Study|Transfer to non-participating unit|0
2474503|NCT02285920|8543231|P4|Overall Study|Change to peritoneal dialysis|0
2474504|NCT02285920|8543232|P3|Overall Study|Change to peritoneal dialysis|1
2474505|NCT02285920|8543233|P2|Overall Study|Change to peritoneal dialysis|0
2474506|NCT02285920|8543234|P1|Overall Study|Change to peritoneal dialysis|0
2474507|NCT02285920|8543231|P4|Overall Study|Kidney transplantation|0
2474508|NCT02285920|8543232|P3|Overall Study|Kidney transplantation|2
2474509|NCT02285920|8543233|P2|Overall Study|Kidney transplantation|2
2474510|NCT02285920|8543234|P1|Overall Study|Kidney transplantation|2
2474511|NCT02285855|8543324|P2|Overall Study|Withdrawal by Subject|1
2474512|NCT02285855|8543325|P1|Overall Study|Withdrawal by Subject|2
2474513|NCT02285777|8543333|P2|Overall Study|Lost to Follow-up|2
2474514|NCT02285777|8543334|P1|Overall Study|Lost to Follow-up|4
2474515|NCT02285777|8543333|P2|Overall Study|Withdrawal by Subject|1
2474516|NCT02285777|8543334|P1|Overall Study|Withdrawal by Subject|1
2474517|NCT02285270|8543415|P1|Overall Study|Determined to be ineligible|1
2474518|NCT02285270|8543415|P1|Overall Study|Physician Decision|3
2474519|NCT02285270|8543415|P1|Overall Study|Lost to Follow-up|1
2474520|NCT02285153|8543423|P2|Overall Study|Adverse Event|0
2474521|NCT02285153|8543424|P1|Overall Study|Adverse Event|1
2474522|NCT02285062|8543438|P2|Overall Study|Lost to Follow-up|5
2474523|NCT02285062|8543439|P1|Overall Study|Lost to Follow-up|8
2474524|NCT02285062|8543438|P2|Overall Study|Death|62
2474525|NCT02285062|8543439|P1|Overall Study|Death|58
2474526|NCT02285062|8543438|P2|Overall Study|Withdrawal by Subject|17
2474527|NCT02285062|8543439|P1|Overall Study|Withdrawal by Subject|12
2474528|NCT02285010|8543487|P2|Overall Study|Not spinal anesthesia|1
2474529|NCT02285010|8543488|P1|Overall Study|Not spinal anesthesia|3
2474530|NCT02285010|8543487|P2|Overall Study|not abdominal hysterectomy|0
2474531|NCT02285010|8543488|P1|Overall Study|not abdominal hysterectomy|2
2474532|NCT02284906|8543505|P3|Overall Study|Reason not Specified|0
2474533|NCT02284906|8543506|P2|Overall Study|Reason not Specified|1
2474534|NCT02284906|8543507|P1|Overall Study|Reason not Specified|1
2474535|NCT02284906|8543505|P3|Overall Study|Study Termination|14
2474536|NCT02284906|8543506|P2|Overall Study|Study Termination|11
2474537|NCT02284906|8543507|P1|Overall Study|Study Termination|0
2474538|NCT02284906|8543505|P3|Overall Study|Voluntary Withdrawal|5
2474539|NCT02284906|8543506|P2|Overall Study|Voluntary Withdrawal|4
2474540|NCT02284906|8543507|P1|Overall Study|Voluntary Withdrawal|2
2474541|NCT02284906|8543505|P3|Overall Study|Major Protocol Deviation|0
2474542|NCT02284906|8543506|P2|Overall Study|Major Protocol Deviation|1
2474543|NCT02284906|8543507|P1|Overall Study|Major Protocol Deviation|0
2474544|NCT02284906|8543505|P3|Overall Study|Pretreatment Event/Adverse Event|0
2474545|NCT02284906|8543506|P2|Overall Study|Pretreatment Event/Adverse Event|1
2474546|NCT02284906|8543507|P1|Overall Study|Pretreatment Event/Adverse Event|0
2474547|NCT02284893|8543520|P2|52 Week (Long Term)|Non-Compliance|3
2474548|NCT02284893|8543521|P1|52 Week (Long Term)|Non-Compliance|2
2474549|NCT02284893|8543520|P2|52 Week (Long Term)|Lost to Follow-up|2
2474550|NCT02284893|8543521|P1|52 Week (Long Term)|Lost to Follow-up|2
2474551|NCT02284893|8543520|P2|52 Week (Long Term)|Withrawal of the consent by the subject|6
2474552|NCT02284893|8543521|P1|52 Week (Long Term)|Withrawal of the consent by the subject|4
2474553|NCT02284893|8543520|P2|52 Week (Long Term)|Subject no longer meets study criteria|1
2474554|NCT02284893|8543521|P1|52 Week (Long Term)|Subject no longer meets study criteria|0
2474555|NCT02284893|8543520|P2|52 Week (Long Term)|Adverse Event|1
2474556|NCT02284893|8543521|P1|52 Week (Long Term)|Adverse Event|3
2474557|NCT02284893|8543520|P2|26 Week (Short Term)|Other|1
2474558|NCT02284893|8543521|P1|26 Week (Short Term)|Other|1
2474559|NCT02284893|8543520|P2|26 Week (Short Term)|Subject no longer meets study criteria|8
2474560|NCT02284893|8543521|P1|26 Week (Short Term)|Subject no longer meets study criteria|5
2474561|NCT02284893|8543520|P2|26 Week (Short Term)|Lost to Follow-up|1
2474562|NCT02284893|8543521|P1|26 Week (Short Term)|Lost to Follow-up|3
2474563|NCT02284893|8543520|P2|26 Week (Short Term)|Withrawal of the consent by the subject|10
2474564|NCT02284893|8543521|P1|26 Week (Short Term)|Withrawal of the consent by the subject|7
2474565|NCT02284893|8543520|P2|26 Week (Short Term)|Discontinuation by the subject|2
2474566|NCT02284893|8543521|P1|26 Week (Short Term)|Discontinuation by the subject|2
2474567|NCT02284893|8543520|P2|26 Week (Short Term)|Adverse Event|9
2474568|NCT02284893|8543521|P1|26 Week (Short Term)|Adverse Event|1
2474569|NCT02284568|8543598|P3|Overall Study|Withdrew before taking study drug|0
2474570|NCT02284568|8543599|P2|Overall Study|Withdrew before taking study drug|1
2474571|NCT02284568|8543600|P1|Overall Study|Withdrew before taking study drug|0
2474572|NCT02284568|8543598|P3|Overall Study|Other|0
2474573|NCT02284568|8543599|P2|Overall Study|Other|2
2474574|NCT02284568|8543600|P1|Overall Study|Other|1
2474575|NCT02284568|8543598|P3|Overall Study|Lack of Efficacy|0
2474576|NCT02284568|8543599|P2|Overall Study|Lack of Efficacy|7
2474577|NCT02284568|8543600|P1|Overall Study|Lack of Efficacy|4
2474578|NCT02284568|8543598|P3|Overall Study|Lost to Follow-up|0
2474579|NCT02284568|8543599|P2|Overall Study|Lost to Follow-up|3
2474580|NCT02284568|8543600|P1|Overall Study|Lost to Follow-up|0
2474581|NCT02284568|8543598|P3|Overall Study|Sponsor requested patient stop treatment|90
2474582|NCT02284568|8543599|P2|Overall Study|Sponsor requested patient stop treatment|0
2474583|NCT02284568|8543600|P1|Overall Study|Sponsor requested patient stop treatment|0
2474584|NCT02284568|8543598|P3|Overall Study|Protocol Violation|0
2474585|NCT02284568|8543599|P2|Overall Study|Protocol Violation|1
2474586|NCT02284568|8543600|P1|Overall Study|Protocol Violation|0
2474587|NCT02284568|8543598|P3|Overall Study|Noncompliance|0
2474588|NCT02284568|8543599|P2|Overall Study|Noncompliance|0
2474589|NCT02284568|8543600|P1|Overall Study|Noncompliance|1
2474590|NCT02284568|8543598|P3|Overall Study|Noncompliance with study drug admin|0
2474591|NCT02284568|8543599|P2|Overall Study|Noncompliance with study drug admin|2
2474592|NCT02284568|8543600|P1|Overall Study|Noncompliance with study drug admin|1
2474593|NCT02284568|8543598|P3|Overall Study|Withdrawal by Subject|1
2474594|NCT02284568|8543599|P2|Overall Study|Withdrawal by Subject|21
2474595|NCT02284568|8543600|P1|Overall Study|Withdrawal by Subject|22
2474596|NCT02284568|8543598|P3|Overall Study|Adverse Event|4
2474597|NCT02284568|8543599|P2|Overall Study|Adverse Event|9
2474598|NCT02284568|8543600|P1|Overall Study|Adverse Event|2
2474599|NCT02284373|8543694|P3|Overall Study|Lost to Follow-up|0
2474600|NCT02284373|8543695|P2|Overall Study|Lost to Follow-up|1
2474601|NCT02284373|8543696|P1|Overall Study|Lost to Follow-up|0
2474602|NCT02284373|8543694|P3|Overall Study|Other|0
2474603|NCT02284373|8543695|P2|Overall Study|Other|1
2474604|NCT02284373|8543696|P1|Overall Study|Other|0
2474605|NCT02284373|8543694|P3|Overall Study|Withdrawal by Subject|0
2474606|NCT02284373|8543695|P2|Overall Study|Withdrawal by Subject|1
2474607|NCT02284373|8543696|P1|Overall Study|Withdrawal by Subject|0
2474608|NCT02284347|8543704|P1|Overall Study|Withdrawn prior to treatment|1
2474609|NCT02284347|8543704|P1|Overall Study|Lost to Follow-up|2
2474610|NCT02284243|8543712|P2|Overall Study|Adverse Event|0
2474611|NCT02284243|8543713|P1|Overall Study|Adverse Event|1
2474612|NCT02284243|8543712|P2|Overall Study|Lack of Efficacy|3
2474613|NCT02284243|8543713|P1|Overall Study|Lack of Efficacy|3
2474614|NCT02284178|8543733|P2|Overall Study|Met exclusion criteria|54
2474615|NCT02284178|8543734|P1|Overall Study|Met exclusion criteria|49
2474616|NCT02284009|8543777|P2|Overall Study|Withdrawal by Subject|5
2474617|NCT02284009|8543778|P1|Overall Study|Withdrawal by Subject|2
2474618|NCT02284009|8543777|P2|Overall Study|Physician Decision|2
2474619|NCT02284009|8543778|P1|Overall Study|Physician Decision|0
2474620|NCT02284009|8543777|P2|Overall Study|Lost to Follow-up|3
2474621|NCT02284009|8543778|P1|Overall Study|Lost to Follow-up|1
2474622|NCT02284009|8543777|P2|Overall Study|Adverse Event|0
2474623|NCT02284009|8543778|P1|Overall Study|Adverse Event|3
2474624|NCT02283788|8543877|P4|Overall Study|Withdrawal by Subject|1
2474625|NCT02283788|8543878|P3|Overall Study|Withdrawal by Subject|0
2474626|NCT02283788|8543879|P2|Overall Study|Withdrawal by Subject|1
2474627|NCT02283788|8543880|P1|Overall Study|Withdrawal by Subject|0
2474628|NCT02283788|8543877|P4|Overall Study|Adverse Event|1
2474629|NCT02283788|8543878|P3|Overall Study|Adverse Event|5
2474630|NCT02283788|8543879|P2|Overall Study|Adverse Event|3
2474631|NCT02283788|8543880|P1|Overall Study|Adverse Event|1
2474632|NCT02283762|8543892|P2|Long-term Extension Phase (LTE)|Physician Decision|2
2474633|NCT02283762|8543893|P1|Long-term Extension Phase (LTE)|Physician Decision|1
2474634|NCT02283762|8543892|P2|Long-term Extension Phase (LTE)|Lost to Follow-up|1
2474635|NCT02283762|8543893|P1|Long-term Extension Phase (LTE)|Lost to Follow-up|0
2474636|NCT02283762|8543892|P2|Long-term Extension Phase (LTE)|Protocol Violation|1
2474637|NCT02283762|8543893|P1|Long-term Extension Phase (LTE)|Protocol Violation|1
2474638|NCT02283762|8543892|P2|Long-term Extension Phase (LTE)|Withdrawal by Subject|3
2474639|NCT02283762|8543893|P1|Long-term Extension Phase (LTE)|Withdrawal by Subject|4
2474640|NCT02283762|8543892|P2|Long-term Extension Phase (LTE)|Study terminated at site|0
2474641|NCT02283762|8543893|P1|Long-term Extension Phase (LTE)|Study terminated at site|1
2474642|NCT02283762|8543892|P2|Long-term Extension Phase (LTE)|Lack of Efficacy|1
2474643|NCT02283762|8543893|P1|Long-term Extension Phase (LTE)|Lack of Efficacy|1
2474644|NCT02283762|8543892|P2|Long-term Extension Phase (LTE)|Adverse Event|6
2474645|NCT02283762|8543893|P1|Long-term Extension Phase (LTE)|Adverse Event|2
2474646|NCT02283762|8543892|P2|Main Treatment Phase (MT)|Withdrawal by Subject|4
2474647|NCT02283762|8543893|P1|Main Treatment Phase (MT)|Withdrawal by Subject|7
2474648|NCT02283762|8543892|P2|Main Treatment Phase (MT)|Pregnancy|1
2474649|NCT02283762|8543893|P1|Main Treatment Phase (MT)|Pregnancy|0
2474650|NCT02283762|8543892|P2|Main Treatment Phase (MT)|Physician Decision|1
2474651|NCT02283762|8543893|P1|Main Treatment Phase (MT)|Physician Decision|1
2474652|NCT02283762|8543892|P2|Main Treatment Phase (MT)|Lack of Efficacy|0
2474653|NCT02283762|8543893|P1|Main Treatment Phase (MT)|Lack of Efficacy|1
2474654|NCT02283762|8543892|P2|Main Treatment Phase (MT)|Adverse Event|9
2474655|NCT02283762|8543893|P1|Main Treatment Phase (MT)|Adverse Event|9
2474656|NCT02283658|8543917|P1|Overall Study|Withdrawal by Subject|1
2474657|NCT02283411|8543939|P1|Overall Study|Screen Failed|28
2474658|NCT02283411|8543939|P1|Overall Study|Withdrawal by Subject|3
2474659|NCT02283268|8543947|P1|Overall Study|Withdrawal by Subject|1
2474660|NCT02282982|8544008|P1|Overall Study|Other, not specified|18
2474661|NCT02282982|8544008|P1|Overall Study|Palivizumab is ended|11
2474662|NCT02282982|8544008|P1|Overall Study|Lack of product|156
2474663|NCT02282982|8544008|P1|Overall Study|Death|4
2474664|NCT02282982|8544008|P1|Overall Study|Withdrew consent|2
2474665|NCT02282982|8544008|P1|Overall Study|Lost to Follow-up|15
2474666|NCT02282813|8544031|P3|Overall Study|Administrative reasons|0
2474667|NCT02282813|8544032|P2|Overall Study|Administrative reasons|1
2474668|NCT02282813|8544033|P1|Overall Study|Administrative reasons|0
2474669|NCT02282813|8544031|P3|Overall Study|Lack of Efficacy|0
2474670|NCT02282813|8544032|P2|Overall Study|Lack of Efficacy|0
2474671|NCT02282813|8544033|P1|Overall Study|Lack of Efficacy|1
2474672|NCT02282813|8544031|P3|Overall Study|Serum Ca >/=11.0mg/dL|0
2474673|NCT02282813|8544032|P2|Overall Study|Serum Ca >/=11.0mg/dL|0
2474674|NCT02282813|8544033|P1|Overall Study|Serum Ca >/=11.0mg/dL|1
2474675|NCT02282813|8544031|P3|Overall Study|Lost to Follow-up|1
2474676|NCT02282813|8544032|P2|Overall Study|Lost to Follow-up|0
2474677|NCT02282813|8544033|P1|Overall Study|Lost to Follow-up|2
2474678|NCT02282813|8544031|P3|Overall Study|Physician Decision|1
2474679|NCT02282813|8544032|P2|Overall Study|Physician Decision|3
2474680|NCT02282813|8544033|P1|Overall Study|Physician Decision|0
2474681|NCT02282813|8544031|P3|Overall Study|Subject non-compliance|0
2474682|NCT02282813|8544032|P2|Overall Study|Subject non-compliance|4
2474683|NCT02282813|8544033|P1|Overall Study|Subject non-compliance|1
2474684|NCT02282813|8544031|P3|Overall Study|Adverse Event|1
2474685|NCT02282813|8544032|P2|Overall Study|Adverse Event|10
2474686|NCT02282813|8544033|P1|Overall Study|Adverse Event|3
2474687|NCT02282813|8544031|P3|Overall Study|Withdrawal by Subject|0
2474688|NCT02282813|8544032|P2|Overall Study|Withdrawal by Subject|5
2474689|NCT02282813|8544033|P1|Overall Study|Withdrawal by Subject|4
2474690|NCT02282631|8544079|P2|Overall Study|Lost to Follow-up|0
2474691|NCT02282631|8544080|P1|Overall Study|Lost to Follow-up|2
2474692|NCT02282605|8544121|P3|Overall Study|negative SA result on Day -1|0
2474693|NCT02282605|8544122|P2|Overall Study|negative SA result on Day -1|0
2474694|NCT02282605|8544123|P1|Overall Study|negative SA result on Day -1|3
2474695|NCT02282527|8544145|P2|Overall Study|Lack of home health aid|0
2474696|NCT02282527|8544146|P1|Overall Study|Lack of home health aid|1
2474697|NCT02282527|8544145|P2|Overall Study|Lost to Follow-up|1
2474698|NCT02282527|8544146|P1|Overall Study|Lost to Follow-up|0
2474699|NCT02282293|8544158|P2|Overall Study|Moved out of study area|1
2474700|NCT02282293|8544159|P1|Overall Study|Moved out of study area|0
2474701|NCT02282293|8544158|P2|Overall Study|Unable to comply with study procedures|0
2474702|NCT02282293|8544159|P1|Overall Study|Unable to comply with study procedures|1
2474703|NCT02282293|8544158|P2|Overall Study|Lost to Follow-up|2
2474704|NCT02282293|8544159|P1|Overall Study|Lost to Follow-up|2
2474705|NCT02282020|8544196|P2|Overall Study|Withdrew Consent Prior to Dosing|12
2474706|NCT02282020|8544197|P1|Overall Study|Withdrew Consent Prior to Dosing|0
2474707|NCT02282020|8544196|P2|Overall Study|Developed Discontinuation Criteria|3
2474708|NCT02282020|8544197|P1|Overall Study|Developed Discontinuation Criteria|1
2474709|NCT02282020|8544196|P2|Overall Study|Severe Non-compliance to Protocol|0
2474710|NCT02282020|8544197|P1|Overall Study|Severe Non-compliance to Protocol|1
2474711|NCT02282020|8544196|P2|Overall Study|Miscellaneous|17
2474712|NCT02282020|8544197|P1|Overall Study|Miscellaneous|4
2474713|NCT02282020|8544196|P2|Overall Study|Withdrawal by Subject|10
2474714|NCT02282020|8544197|P1|Overall Study|Withdrawal by Subject|5
2474715|NCT02282020|8544196|P2|Overall Study|Adverse Event|15
2474716|NCT02282020|8544197|P1|Overall Study|Adverse Event|13
2474717|NCT02282020|8544196|P2|Overall Study|Objective Disease Progression|30
2474718|NCT02282020|8544197|P1|Overall Study|Objective Disease Progression|111
2474719|NCT02281773|8544256|P5|Overall Study|Other Reason|1
2474720|NCT02281773|8544257|P4|Overall Study|Other Reason|3
2474721|NCT02281773|8544258|P3|Overall Study|Other Reason|2
2474722|NCT02281773|8544259|P2|Overall Study|Other Reason|4
2474723|NCT02281773|8544260|P1|Overall Study|Other Reason|0
2474724|NCT02281773|8544256|P5|Overall Study|Withdrawal by Subject|8
2474725|NCT02281773|8544257|P4|Overall Study|Withdrawal by Subject|6
2474726|NCT02281773|8544258|P3|Overall Study|Withdrawal by Subject|6
2474727|NCT02281773|8544259|P2|Overall Study|Withdrawal by Subject|8
2474728|NCT02281773|8544260|P1|Overall Study|Withdrawal by Subject|2
2474729|NCT02281773|8544256|P5|Overall Study|Lost to Follow-up|10
2474730|NCT02281773|8544257|P4|Overall Study|Lost to Follow-up|2
2474731|NCT02281773|8544258|P3|Overall Study|Lost to Follow-up|6
2474732|NCT02281773|8544259|P2|Overall Study|Lost to Follow-up|2
2474733|NCT02281773|8544260|P1|Overall Study|Lost to Follow-up|2
2474734|NCT02281773|8544256|P5|Overall Study|Protocol Violation|2
2474735|NCT02281773|8544257|P4|Overall Study|Protocol Violation|2
2474736|NCT02281773|8544258|P3|Overall Study|Protocol Violation|0
2474737|NCT02281773|8544259|P2|Overall Study|Protocol Violation|0
2474738|NCT02281773|8544260|P1|Overall Study|Protocol Violation|1
2474739|NCT02281773|8544256|P5|Overall Study|Adverse Event|9
2474740|NCT02281773|8544257|P4|Overall Study|Adverse Event|8
2474741|NCT02281773|8544258|P3|Overall Study|Adverse Event|4
2474742|NCT02281773|8544259|P2|Overall Study|Adverse Event|1
2474743|NCT02281773|8544260|P1|Overall Study|Adverse Event|6
2474744|NCT02281552|8544348|P2|Overall Study|Adverse Event|9
2474745|NCT02281552|8544349|P1|Overall Study|Adverse Event|3
2474746|NCT02281552|8544348|P2|Overall Study|Insufficient clinical response|1
2474747|NCT02281552|8544349|P1|Overall Study|Insufficient clinical response|0
2474748|NCT02281552|8544348|P2|Overall Study|Medication error|0
2474749|NCT02281552|8544349|P1|Overall Study|Medication error|1
2474750|NCT02281357|8544442|P2|Overall Study|Withdrawal by Subject|3
2474751|NCT02281357|8544443|P1|Overall Study|Withdrawal by Subject|4
2474752|NCT02281357|8544442|P2|Overall Study|Lost to Follow-up|0
2474753|NCT02281357|8544443|P1|Overall Study|Lost to Follow-up|1
2474754|NCT02281357|8544442|P2|Overall Study|Adverse Event|1
2474755|NCT02281357|8544443|P1|Overall Study|Adverse Event|2
2474756|NCT02281318|8544457|P2|Overall Study|Withdrawal by Subject|2
2474757|NCT02281318|8544458|P1|Overall Study|Withdrawal by Subject|6
2474758|NCT02281318|8544457|P2|Overall Study|Physician Decision|0
2474759|NCT02281318|8544458|P1|Overall Study|Physician Decision|2
2474760|NCT02281318|8544457|P2|Overall Study|Lost to Follow-up|1
2474761|NCT02281318|8544458|P1|Overall Study|Lost to Follow-up|2
2474762|NCT02281318|8544457|P2|Overall Study|Lack of Efficacy|0
2474763|NCT02281318|8544458|P1|Overall Study|Lack of Efficacy|2
2474764|NCT02281318|8544457|P2|Overall Study|Adverse Event|2
2474765|NCT02281318|8544458|P1|Overall Study|Adverse Event|2
2474766|NCT02280863|8544504|P2|Integrated Platform|Met stopping criteria|1
2474767|NCT02280863|8544505|P1|Integrated Platform|Met stopping criteria|0
2474768|NCT02280499|8544589|P1|Overall Study|Adverse Event|5
2474769|NCT02280499|8544589|P1|Overall Study|Lost to Follow-up|42
2474770|NCT02280499|8544589|P1|Overall Study|Death|14
2474771|NCT02280473|8544597|P2|Overall Study|Lost to Follow-up|1
2474772|NCT02280473|8544598|P1|Overall Study|Lost to Follow-up|0
2474773|NCT02280473|8544597|P2|Overall Study|Lack of Efficacy|1
2474774|NCT02280473|8544598|P1|Overall Study|Lack of Efficacy|0
2474775|NCT02280473|8544597|P2|Overall Study|Adverse Event|1
2474776|NCT02280473|8544598|P1|Overall Study|Adverse Event|1
2474777|NCT02280421|8544614|P2|Washout (2 Weeks)|Withdrawal by Subject|0
2474778|NCT02280421|8544615|P1|Washout (2 Weeks)|Withdrawal by Subject|1
2474779|NCT02280421|8544614|P2|Washout (2 Weeks)|Adverse Event|1
2474780|NCT02280421|8544615|P1|Washout (2 Weeks)|Adverse Event|0
2474781|NCT02280408|8544681|P4|Overall Study|Lost to Follow-up|0
2474782|NCT02280408|8544682|P3|Overall Study|Lost to Follow-up|0
2474783|NCT02280408|8544683|P2|Overall Study|Lost to Follow-up|2
2474784|NCT02280408|8544684|P1|Overall Study|Lost to Follow-up|0
2474785|NCT02280304|8544756|P2|Overall Study|Lost to Follow-up|8
2474786|NCT02280304|8544757|P1|Overall Study|Lost to Follow-up|7
2474787|NCT02280291|8544778|P4|Overall Study|Other|0
2474788|NCT02280291|8544779|P3|Overall Study|Other|0
2474789|NCT02280291|8544780|P2|Overall Study|Other|1
2474790|NCT02280291|8544781|P1|Overall Study|Other|1
2474791|NCT02280291|8544778|P4|Overall Study|Protocol Violation|0
2474792|NCT02280291|8544779|P3|Overall Study|Protocol Violation|0
2474793|NCT02280291|8544780|P2|Overall Study|Protocol Violation|0
2474794|NCT02280291|8544781|P1|Overall Study|Protocol Violation|1
2474795|NCT02280291|8544778|P4|Overall Study|Lost to Follow-up|8
2474796|NCT02280291|8544779|P3|Overall Study|Lost to Follow-up|3
2474797|NCT02280291|8544780|P2|Overall Study|Lost to Follow-up|1
2474798|NCT02280291|8544781|P1|Overall Study|Lost to Follow-up|2
2474799|NCT02280187|8544815|P1|Overall Study|Lost to Follow-up|218
2474800|NCT02280096|8544843|P2|Overall Study|Lack of attachment|1
2474801|NCT02280096|8544844|P1|Overall Study|Lack of attachment|0
2474802|NCT02280096|8544843|P2|Overall Study|Functional neurological disorder|0
2474803|NCT02280096|8544844|P1|Overall Study|Functional neurological disorder|1
2474804|NCT02280096|8544843|P2|Overall Study|Pregnancy|0
2474805|NCT02280096|8544844|P1|Overall Study|Pregnancy|1
2474806|NCT02280044|8544874|P2|Overall Study|Planned alternate|2
2474807|NCT02280044|8544875|P1|Overall Study|Planned alternate|0
2474808|NCT02279862|8544885|P2|Overall Study|Withdrawal by Subject|0
2474809|NCT02279862|8544886|P1|Overall Study|Withdrawal by Subject|1
2474810|NCT02279862|8544885|P2|Overall Study|Other|2
2474811|NCT02279862|8544886|P1|Overall Study|Other|1
2474812|NCT02279862|8544885|P2|Overall Study|Study closed by sponsor|13
2474813|NCT02279862|8544886|P1|Overall Study|Study closed by sponsor|16
2474814|NCT02279862|8544885|P2|Overall Study|Disease progression|2
2474815|NCT02279862|8544886|P1|Overall Study|Disease progression|5
2474816|NCT02279862|8544885|P2|Overall Study|Administrative reason by sponsor|1
2474817|NCT02279862|8544886|P1|Overall Study|Administrative reason by sponsor|0
2474818|NCT02279862|8544885|P2|Overall Study|No longer meets criteria|1
2474819|NCT02279862|8544886|P1|Overall Study|No longer meets criteria|0
2474820|NCT02279862|8544885|P2|Overall Study|Study drug toxicity|6
2474821|NCT02279862|8544886|P1|Overall Study|Study drug toxicity|3
2474822|NCT02279732|8544904|P2|Overall Study|Other|3
2474823|NCT02279732|8544905|P1|Overall Study|Other|3
2474824|NCT02279732|8544904|P2|Overall Study|Other|67
2474825|NCT02279732|8544905|P1|Overall Study|Other|53
2474826|NCT02279732|8544904|P2|Overall Study|Subject Requested to Discontinue|1
2474827|NCT02279732|8544905|P1|Overall Study|Subject Requested to Discontinue|0
2474828|NCT02279732|8544904|P2|Overall Study|Maximum Clinical Benefit|0
2474829|NCT02279732|8544905|P1|Overall Study|Maximum Clinical Benefit|1
2474830|NCT02279732|8544904|P2|Overall Study|Lost to Follow-up|1
2474831|NCT02279732|8544905|P1|Overall Study|Lost to Follow-up|0
2474832|NCT02279732|8544904|P2|Overall Study|Study Drug Toxicity|0
2474833|NCT02279732|8544905|P1|Overall Study|Study Drug Toxicity|2
2474834|NCT02279732|8544904|P2|Overall Study|Administrative Reason By Sponsor|2
2474835|NCT02279732|8544905|P1|Overall Study|Administrative Reason By Sponsor|0
2474836|NCT02279732|8544904|P2|Overall Study|Adverse Event|2
2474837|NCT02279732|8544905|P1|Overall Study|Adverse Event|1
2474838|NCT02279732|8544904|P2|Overall Study|Withdrawal by Subject|7
2474839|NCT02279732|8544905|P1|Overall Study|Withdrawal by Subject|2
2474840|NCT02279732|8544904|P2|Overall Study|Disease Progression|3
2474841|NCT02279732|8544905|P1|Overall Study|Disease Progression|13
2474842|NCT02279732|8544904|P2|Overall Study|Death|20
2474843|NCT02279732|8544905|P1|Overall Study|Death|23
2474844|NCT02279498|8544997|P2|Overall Study|Undefined|1
2474845|NCT02279498|8544998|P1|Overall Study|Undefined|2
2474846|NCT02279498|8544997|P2|Overall Study|Withdrawal by Subject|2
2474847|NCT02279498|8544998|P1|Overall Study|Withdrawal by Subject|9
2474848|NCT02279498|8544997|P2|Overall Study|Lost to Follow-up|1
2474849|NCT02279498|8544998|P1|Overall Study|Lost to Follow-up|0
2474850|NCT02279498|8544997|P2|Overall Study|Lack of Efficacy|0
2474851|NCT02279498|8544998|P1|Overall Study|Lack of Efficacy|4
2474852|NCT02279498|8544997|P2|Overall Study|Adverse Event|0
2474853|NCT02279498|8544998|P1|Overall Study|Adverse Event|3
2474854|NCT02279420|8545007|P1|Overall Study|Lost to Follow-up|23
2474855|NCT02279407|8545015|P4|Overall Study|Adverse Event|0
2474856|NCT02279407|8545016|P3|Overall Study|Adverse Event|2
2474857|NCT02279407|8545017|P2|Overall Study|Adverse Event|1
2474858|NCT02279407|8545018|P1|Overall Study|Adverse Event|1
2474859|NCT02279407|8545015|P4|Overall Study|Withdrawal by Subject|1
2474860|NCT02279407|8545016|P3|Overall Study|Withdrawal by Subject|1
2474861|NCT02279407|8545017|P2|Overall Study|Withdrawal by Subject|0
2474862|NCT02279407|8545018|P1|Overall Study|Withdrawal by Subject|1
2474863|NCT02279407|8545015|P4|Overall Study|Couldn't swallow IP; noncompliance|0
2474864|NCT02279407|8545016|P3|Overall Study|Couldn't swallow IP; noncompliance|2
2474865|NCT02279407|8545017|P2|Overall Study|Couldn't swallow IP; noncompliance|0
2474866|NCT02279407|8545018|P1|Overall Study|Couldn't swallow IP; noncompliance|0
2474867|NCT02279173|8545029|P1|Overall Study|Enrolled But Did Not Receive Treatment|1
2474868|NCT02279173|8545029|P1|Overall Study|Lost to Follow-up|3
2474869|NCT02279173|8545029|P1|Overall Study|Decision by Sponsor|4
2474870|NCT02279173|8545029|P1|Overall Study|Withdrawal by Subject|17
2474871|NCT02279173|8545029|P1|Overall Study|Protocol-specified Criteria|64
2474872|NCT02279173|8545029|P1|Overall Study|Ongoing|78
2474873|NCT02279043|8545078|P3|Overall Study|Lost to Follow-up|0
2474874|NCT02279043|8545079|P2|Overall Study|Lost to Follow-up|88
2474875|NCT02279043|8545080|P1|Overall Study|Lost to Follow-up|46
2474876|NCT02279043|8545078|P3|Overall Study|Post-rand. exclusion - not eligible|0
2474877|NCT02279043|8545079|P2|Overall Study|Post-rand. exclusion - not eligible|1
2474878|NCT02279043|8545080|P1|Overall Study|Post-rand. exclusion - not eligible|1
2474879|NCT02278952|8545110|P1|Overall Study|Insufficient Sample|6
2474880|NCT02278939|8545122|P2|Overall Study|family emergency unable to commit|0
2474881|NCT02278939|8545123|P1|Overall Study|family emergency unable to commit|2
2474882|NCT02278939|8545122|P2|Overall Study|death in family|0
2474883|NCT02278939|8545123|P1|Overall Study|death in family|1
2474884|NCT02278939|8545122|P2|Overall Study|Lost to Follow-up|1
2474885|NCT02278939|8545123|P1|Overall Study|Lost to Follow-up|1
2474886|NCT02278939|8545122|P2|Overall Study|lack of time|0
2474887|NCT02278939|8545123|P1|Overall Study|lack of time|1
2474888|NCT02278614|8545151|P2|Overall Study|left eye was not eligible|0
2474889|NCT02278614|8545152|P1|Overall Study|left eye was not eligible|1
2474890|NCT02278614|8545151|P2|Overall Study|Adverse Event|0
2474891|NCT02278614|8545152|P1|Overall Study|Adverse Event|1
2474892|NCT02278614|8545151|P2|Overall Study|Withdrawal by Subject|5
2474893|NCT02278614|8545152|P1|Overall Study|Withdrawal by Subject|3
2474894|NCT02278471|8545186|P2|Overall Study|Withdrawal by Subject|3
2474895|NCT02278471|8545187|P1|Overall Study|Withdrawal by Subject|0
2474896|NCT02278471|8545186|P2|Overall Study|Death|2
2474897|NCT02278471|8545187|P1|Overall Study|Death|2
2474898|NCT02278471|8545186|P2|Overall Study|Lost to Follow-up|15
2474899|NCT02278471|8545187|P1|Overall Study|Lost to Follow-up|6
2474900|NCT02278328|8545203|P3|Neuropsych Screening|incomplete consent|2
2474901|NCT02278328|8545204|P2|Neuropsych Screening|incomplete consent|0
2474902|NCT02278328|8545205|P1|Neuropsych Screening|incomplete consent|0
2474903|NCT02278328|8545203|P3|Neuropsych Screening|Withdrawal by Subject|0
2474904|NCT02278328|8545204|P2|Neuropsych Screening|Withdrawal by Subject|1
2474905|NCT02278328|8545205|P1|Neuropsych Screening|Withdrawal by Subject|0
2474906|NCT02278328|8545203|P3|Neuropsych Screening|found ineligible on neuropsych|0
2474907|NCT02278328|8545204|P2|Neuropsych Screening|found ineligible on neuropsych|0
2474908|NCT02278328|8545205|P1|Neuropsych Screening|found ineligible on neuropsych|1
2474909|NCT02278120|8545234|P2|Overall Study|Protocol Violation|2
2474910|NCT02278120|8545235|P1|Overall Study|Protocol Violation|0
2474911|NCT02278120|8545234|P2|Overall Study|Lost to Follow-up|0
2474912|NCT02278120|8545235|P1|Overall Study|Lost to Follow-up|2
2474913|NCT02278120|8545234|P2|Overall Study|Death|3
2474914|NCT02278120|8545235|P1|Overall Study|Death|3
2474915|NCT02278120|8545234|P2|Overall Study|Physician Decision|19
2474916|NCT02278120|8545235|P1|Overall Study|Physician Decision|8
2474917|NCT02278120|8545234|P2|Overall Study|Adverse Event|10
2474918|NCT02278120|8545235|P1|Overall Study|Adverse Event|12
2474919|NCT02278120|8545234|P2|Overall Study|Patient/guardian decision|8
2474920|NCT02278120|8545235|P1|Overall Study|Patient/guardian decision|14
2474921|NCT02278120|8545234|P2|Overall Study|Progressive disease|174
2474922|NCT02278120|8545235|P1|Overall Study|Progressive disease|122
2474923|NCT02278003|8545251|P2|Overall Study|Recognition task improperly completed|0
2474924|NCT02278003|8545252|P1|Overall Study|Recognition task improperly completed|7
2474925|NCT02278003|8545251|P2|Overall Study|Not Treated|0
2474926|NCT02278003|8545252|P1|Overall Study|Not Treated|1
2474927|NCT02278003|8545251|P2|Overall Study|Withdrawal by Subject|0
2474928|NCT02278003|8545252|P1|Overall Study|Withdrawal by Subject|11
2474929|NCT02277990|8545262|P2|Overall Study|Had other reason|32
2474930|NCT02277990|8545263|P1|Overall Study|Had other reason|26
2474931|NCT02277990|8545262|P2|Overall Study|Lost to Follow-up|69
2474932|NCT02277990|8545263|P1|Overall Study|Lost to Follow-up|66
2474933|NCT02277990|8545262|P2|Overall Study|Physician Decision|34
2474934|NCT02277990|8545263|P1|Overall Study|Physician Decision|40
2474935|NCT02277990|8545262|P2|Overall Study|Withdrawal by Subject|53
2474936|NCT02277990|8545263|P1|Overall Study|Withdrawal by Subject|64
2474937|NCT02277990|8545262|P2|Overall Study|Death|188
2474938|NCT02277990|8545263|P1|Overall Study|Death|170
2474939|NCT02277769|8545291|P3|Overall Study|Other than specified above|5
2474940|NCT02277769|8545292|P2|Overall Study|Other than specified above|8
2474941|NCT02277769|8545293|P1|Overall Study|Other than specified above|12
2474942|NCT02277769|8545291|P3|Overall Study|Adverse Event|4
2474943|NCT02277769|8545292|P2|Overall Study|Adverse Event|2
2474944|NCT02277769|8545293|P1|Overall Study|Adverse Event|14
2474945|NCT02277769|8545291|P3|Overall Study|Lack of Efficacy|4
2474946|NCT02277769|8545292|P2|Overall Study|Lack of Efficacy|0
2474947|NCT02277769|8545293|P1|Overall Study|Lack of Efficacy|17
2474948|NCT02277769|8545291|P3|Overall Study|Protocol Violation|5
2474949|NCT02277769|8545292|P2|Overall Study|Protocol Violation|3
2474950|NCT02277769|8545293|P1|Overall Study|Protocol Violation|3
2474951|NCT02277743|8545364|P3|Overall Study|Other than specified above|16
2474952|NCT02277743|8545365|P2|Overall Study|Other than specified above|5
2474953|NCT02277743|8545366|P1|Overall Study|Other than specified above|18
2474954|NCT02277743|8545364|P3|Overall Study|Lack of Efficacy|3
2474955|NCT02277743|8545365|P2|Overall Study|Lack of Efficacy|4
2474956|NCT02277743|8545366|P1|Overall Study|Lack of Efficacy|11
2474957|NCT02277743|8545364|P3|Overall Study|Adverse Event|6
2474958|NCT02277743|8545365|P2|Overall Study|Adverse Event|6
2474959|NCT02277743|8545366|P1|Overall Study|Adverse Event|10
2474960|NCT02277743|8545364|P3|Overall Study|Protocol Violation|1
2474961|NCT02277743|8545365|P2|Overall Study|Protocol Violation|1
2474962|NCT02277743|8545366|P1|Overall Study|Protocol Violation|1
2474963|NCT02277691|8545434|P1|Overall Study|Used Other Antihypertensive Drug|1
2474964|NCT02277691|8545434|P1|Overall Study|Lack of Efficacy|5
2474965|NCT02277691|8545434|P1|Overall Study|Voluntary Withdrawal|7
2474966|NCT02277691|8545434|P1|Overall Study|Pretreatment Event/Adverse Event|33
2474967|NCT02277119|8545508|P3|Overall Study|Protocol Violation|7
2474968|NCT02277119|8545509|P2|Overall Study|Protocol Violation|3
2474969|NCT02277119|8545510|P1|Overall Study|Protocol Violation|2
2474970|NCT02277119|8545508|P3|Overall Study|Lack of Efficacy|1
2474971|NCT02277119|8545509|P2|Overall Study|Lack of Efficacy|1
2474972|NCT02277119|8545510|P1|Overall Study|Lack of Efficacy|1
2474973|NCT02276872|8545548|P3|Overall Study|Adverse Event|0
2474974|NCT02276872|8545549|P2|Overall Study|Adverse Event|0
2474975|NCT02276872|8545550|P1|Overall Study|Adverse Event|1
2474976|NCT02276807|8545626|P2|Overall Study|Lost to Follow-up|10
2474977|NCT02276807|8545627|P1|Overall Study|Lost to Follow-up|10
2474978|NCT02276807|8545626|P2|Overall Study|Withdrawal by Subject|7
2474979|NCT02276807|8545627|P1|Overall Study|Withdrawal by Subject|8
2474980|NCT02276612|8545662|P2|Overall Study|Lost to Follow-up|0
2474981|NCT02276612|8545663|P1|Overall Study|Lost to Follow-up|1
2474982|NCT02276612|8545662|P2|Overall Study|Withdrew Consent|0
2474983|NCT02276612|8545663|P1|Overall Study|Withdrew Consent|1
2474984|NCT02276612|8545662|P2|Overall Study|Pregnancy|0
2474985|NCT02276612|8545663|P1|Overall Study|Pregnancy|1
2474986|NCT02276612|8545662|P2|Overall Study|Death|0
2474987|NCT02276612|8545663|P1|Overall Study|Death|1
2474988|NCT02276560|8545686|P3|Overall Study|Adverse Event|0
2474989|NCT02276560|8545687|P2|Overall Study|Adverse Event|0
2474990|NCT02276560|8545688|P1|Overall Study|Adverse Event|1
2474991|NCT02276482|8545698|P2|Overall Study|Reason not specified|1
2474992|NCT02276482|8545699|P1|Overall Study|Reason not specified|0
2474993|NCT02276482|8545698|P2|Overall Study|Gram-negative infection|0
2474994|NCT02276482|8545699|P1|Overall Study|Gram-negative infection|1
2474995|NCT02276482|8545698|P2|Overall Study|Withdrawal by Subject|0
2474996|NCT02276482|8545699|P1|Overall Study|Withdrawal by Subject|1
2474997|NCT02276482|8545698|P2|Overall Study|Adverse Event|0
2474998|NCT02276482|8545699|P1|Overall Study|Adverse Event|1
2474999|NCT02276222|8545834|P2|Overall Study|subject withdrew after randomization|0
2475000|NCT02276222|8545835|P1|Overall Study|subject withdrew after randomization|1
2475001|NCT02276222|8545834|P2|Overall Study|sheduling conflict|0
2475002|NCT02276222|8545835|P1|Overall Study|sheduling conflict|1
2475003|NCT02276222|8545834|P2|Overall Study|Physician Decision|1
2475004|NCT02276222|8545835|P1|Overall Study|Physician Decision|2
2475005|NCT02276222|8545834|P2|Overall Study|Lost to Follow-up|5
2475006|NCT02276222|8545835|P1|Overall Study|Lost to Follow-up|15
2475007|NCT02276222|8545834|P2|Overall Study|sponsor decision|3
2475008|NCT02276222|8545835|P1|Overall Study|sponsor decision|0
2475009|NCT02276222|8545834|P2|Overall Study|non compliance with study medication|2
2475010|NCT02276222|8545835|P1|Overall Study|non compliance with study medication|6
2475011|NCT02276222|8545834|P2|Overall Study|Withdrawal by Subject|33
2475012|NCT02276222|8545835|P1|Overall Study|Withdrawal by Subject|79
2475013|NCT02276222|8545834|P2|Overall Study|Protocol Violation|2
2475014|NCT02276222|8545835|P1|Overall Study|Protocol Violation|3
2475015|NCT02276222|8545834|P2|Overall Study|Lack of Efficacy|3
2475016|NCT02276222|8545835|P1|Overall Study|Lack of Efficacy|13
2475017|NCT02276222|8545834|P2|Overall Study|Death|4
2475018|NCT02276222|8545835|P1|Overall Study|Death|3
2475019|NCT02276222|8545834|P2|Overall Study|Adverse Event|11
2475020|NCT02276222|8545835|P1|Overall Study|Adverse Event|62
2475021|NCT02276053|8545859|P1|Overall Study|Patient needs to increase baseline AED|1
2475022|NCT02276053|8545859|P1|Overall Study|Patient does not meet selection criteria|3
2475023|NCT02276053|8545859|P1|Overall Study|Withdrawal by Subject|1
2475024|NCT02276053|8545859|P1|Overall Study|Lack of Efficacy|2
2475025|NCT02276053|8545859|P1|Overall Study|Adverse Event|5
2475026|NCT02276053|8545859|P1|Overall Study|Death|2
2475027|NCT02276040|8545875|P1|Overall Study|Physician Decision|15
2475028|NCT02275780|8545886|P2|Extension Study: up to 192 Weeks|Ongoing|233
2475029|NCT02275780|8545887|P1|Extension Study: up to 192 Weeks|Ongoing|260
2475030|NCT02275780|8545886|P2|Base Study: 96 Weeks|Randomized not treated|1
2475031|NCT02275780|8545887|P1|Base Study: 96 Weeks|Randomized not treated|2
2475032|NCT02275780|8545886|P2|Base Study: 96 Weeks|Pregnancy|1
2475033|NCT02275780|8545887|P1|Base Study: 96 Weeks|Pregnancy|2
2475034|NCT02275780|8545886|P2|Base Study: 96 Weeks|Physician Decision|4
2475035|NCT02275780|8545887|P1|Base Study: 96 Weeks|Physician Decision|2
2475036|NCT02275780|8545886|P2|Base Study: 96 Weeks|Noncompliance with drug|6
2475037|NCT02275780|8545887|P1|Base Study: 96 Weeks|Noncompliance with drug|9
2475038|NCT02275780|8545886|P2|Base Study: 96 Weeks|Withdrawal by Subject|22
2475039|NCT02275780|8545887|P1|Base Study: 96 Weeks|Withdrawal by Subject|19
2475040|NCT02275780|8545886|P2|Base Study: 96 Weeks|Protocol Violation|6
2475041|NCT02275780|8545887|P1|Base Study: 96 Weeks|Protocol Violation|1
2475042|NCT02275780|8545886|P2|Base Study: 96 Weeks|Lost to Follow-up|24
2475043|NCT02275780|8545887|P1|Base Study: 96 Weeks|Lost to Follow-up|28
2475044|NCT02275780|8545886|P2|Base Study: 96 Weeks|Lack of Efficacy|32
2475045|NCT02275780|8545887|P1|Base Study: 96 Weeks|Lack of Efficacy|21
2475046|NCT02275780|8545886|P2|Base Study: 96 Weeks|Death|1
2475047|NCT02275780|8545887|P1|Base Study: 96 Weeks|Death|3
2475048|NCT02275780|8545886|P2|Base Study: 96 Weeks|Adverse Event|14
2475049|NCT02275780|8545887|P1|Base Study: 96 Weeks|Adverse Event|6
2475050|NCT02275611|8545943|P4|Inpatient Withdrawal|Withdrawal by Subject|0
2475051|NCT02275611|8545944|P3|Inpatient Withdrawal|Withdrawal by Subject|0
2475052|NCT02275611|8545945|P2|Inpatient Withdrawal|Withdrawal by Subject|0
2475053|NCT02275611|8545946|P1|Inpatient Withdrawal|Withdrawal by Subject|1
2475054|NCT02275546|8545958|P2|Treatment Period 2|Protocol Violation|1
2475055|NCT02275546|8545959|P1|Treatment Period 2|Protocol Violation|0
2475056|NCT02275546|8545958|P2|Treatment Period 2|Withdrawal by Subject|1
2475057|NCT02275546|8545959|P1|Treatment Period 2|Withdrawal by Subject|2
2475058|NCT02275481|8545969|P2|Overall Study|Physician Decision|1
2475059|NCT02275481|8545970|P1|Overall Study|Physician Decision|0
2475060|NCT02275481|8545969|P2|Overall Study|all other reasons combined|1
2475061|NCT02275481|8545970|P1|Overall Study|all other reasons combined|2
2475062|NCT02275481|8545969|P2|Overall Study|Withdrawal by Subject|0
2475063|NCT02275481|8545970|P1|Overall Study|Withdrawal by Subject|3
2475064|NCT02275481|8545969|P2|Overall Study|Lost to Follow-up|0
2475065|NCT02275481|8545970|P1|Overall Study|Lost to Follow-up|2
2475066|NCT02275481|8545969|P2|Overall Study|Death|1
2475067|NCT02275481|8545970|P1|Overall Study|Death|2
2475068|NCT02275364|8545976|P2|Period 1|Other reason|0
2475069|NCT02275364|8545977|P1|Period 1|Other reason|1
2475070|NCT02275364|8545976|P2|Period 1|Withdrawal by Subject|0
2475071|NCT02275364|8545977|P1|Period 1|Withdrawal by Subject|1
2475072|NCT02275338|8546006|P1|Overall Study|Does not meet entry criteria|1
2475073|NCT02275338|8546006|P1|Overall Study|Reason not specified|5
2475074|NCT02275338|8546006|P1|Overall Study|Ineligible to start Phase 2|4
2475075|NCT02275338|8546006|P1|Overall Study|Disease progression (death)|1
2475076|NCT02275338|8546006|P1|Overall Study|Withdrawal by Subject|4
2475077|NCT02275338|8546006|P1|Overall Study|Lack of Efficacy|3
2475078|NCT02275338|8546006|P1|Overall Study|Adverse Event|15
2475079|NCT02275117|8546055|P5|Overall Study|Other|2
2475080|NCT02275117|8546056|P4|Overall Study|Other|0
2475081|NCT02275117|8546057|P3|Overall Study|Other|0
2475082|NCT02275117|8546058|P2|Overall Study|Other|0
2475083|NCT02275117|8546059|P1|Overall Study|Other|1
2475084|NCT02275117|8546055|P5|Overall Study|Study Burden|7
2475085|NCT02275117|8546056|P4|Overall Study|Study Burden|5
2475086|NCT02275117|8546057|P3|Overall Study|Study Burden|7
2475087|NCT02275117|8546058|P2|Overall Study|Study Burden|4
2475088|NCT02275117|8546059|P1|Overall Study|Study Burden|5
2475089|NCT02275117|8546055|P5|Overall Study|Worsening of Study Indication|0
2475090|NCT02275117|8546056|P4|Overall Study|Worsening of Study Indication|0
2475091|NCT02275117|8546057|P3|Overall Study|Worsening of Study Indication|2
2475092|NCT02275117|8546058|P2|Overall Study|Worsening of Study Indication|1
2475093|NCT02275117|8546059|P1|Overall Study|Worsening of Study Indication|0
2475094|NCT02275117|8546055|P5|Overall Study|Terminated by Sponsor|4
2475095|NCT02275117|8546056|P4|Overall Study|Terminated by Sponsor|6
2475096|NCT02275117|8546057|P3|Overall Study|Terminated by Sponsor|4
2475097|NCT02275117|8546058|P2|Overall Study|Terminated by Sponsor|4
2475098|NCT02275117|8546059|P1|Overall Study|Terminated by Sponsor|4
2475099|NCT02275117|8546055|P5|Overall Study|Withdrawal by Subject|3
2475100|NCT02275117|8546056|P4|Overall Study|Withdrawal by Subject|3
2475101|NCT02275117|8546057|P3|Overall Study|Withdrawal by Subject|7
2475102|NCT02275117|8546058|P2|Overall Study|Withdrawal by Subject|4
2475103|NCT02275117|8546059|P1|Overall Study|Withdrawal by Subject|6
2475104|NCT02275117|8546055|P5|Overall Study|Protocol Violation|0
2475105|NCT02275117|8546056|P4|Overall Study|Protocol Violation|1
2475106|NCT02275117|8546057|P3|Overall Study|Protocol Violation|1
2475107|NCT02275117|8546058|P2|Overall Study|Protocol Violation|0
2475108|NCT02275117|8546059|P1|Overall Study|Protocol Violation|1
2475109|NCT02275117|8546055|P5|Overall Study|Physician Decision|1
2475110|NCT02275117|8546056|P4|Overall Study|Physician Decision|0
2475111|NCT02275117|8546057|P3|Overall Study|Physician Decision|1
2475112|NCT02275117|8546058|P2|Overall Study|Physician Decision|1
2475113|NCT02275117|8546059|P1|Overall Study|Physician Decision|0
2475114|NCT02275117|8546055|P5|Overall Study|Lost to Follow-up|8
2475115|NCT02275117|8546056|P4|Overall Study|Lost to Follow-up|16
2475116|NCT02275117|8546057|P3|Overall Study|Lost to Follow-up|15
2475117|NCT02275117|8546058|P2|Overall Study|Lost to Follow-up|16
2475118|NCT02275117|8546059|P1|Overall Study|Lost to Follow-up|11
2475119|NCT02275117|8546055|P5|Overall Study|Lack of Efficacy|10
2475120|NCT02275117|8546056|P4|Overall Study|Lack of Efficacy|2
2475121|NCT02275117|8546057|P3|Overall Study|Lack of Efficacy|5
2475122|NCT02275117|8546058|P2|Overall Study|Lack of Efficacy|7
2475123|NCT02275117|8546059|P1|Overall Study|Lack of Efficacy|6
2475124|NCT02275117|8546055|P5|Overall Study|Adverse Event|1
2475125|NCT02275117|8546056|P4|Overall Study|Adverse Event|0
2475126|NCT02275117|8546057|P3|Overall Study|Adverse Event|0
2475127|NCT02275117|8546058|P2|Overall Study|Adverse Event|0
2475128|NCT02275117|8546059|P1|Overall Study|Adverse Event|0
2475129|NCT02275052|8546166|P4|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2
2475130|NCT02275052|8546167|P3|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
2475131|NCT02275052|8546168|P2|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
2475132|NCT02275052|8546169|P1|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
2475133|NCT02275052|8546166|P4|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6
2475134|NCT02275052|8546167|P3|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
2475135|NCT02275052|8546168|P2|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
2475136|NCT02275052|8546169|P1|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
2475137|NCT02275052|8546166|P4|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4
2475138|NCT02275052|8546167|P3|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
2475139|NCT02275052|8546168|P2|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
2475140|NCT02275052|8546169|P1|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
2475141|NCT02275052|8546166|P4|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2
2475142|NCT02275052|8546167|P3|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3
2475143|NCT02275052|8546168|P2|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
2475144|NCT02275052|8546169|P1|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
2475145|NCT02275052|8546166|P4|Washout Period (12-17 Days)|Lack of Efficacy|0
2475146|NCT02275052|8546167|P3|Washout Period (12-17 Days)|Lack of Efficacy|0
2475147|NCT02275052|8546168|P2|Washout Period (12-17 Days)|Lack of Efficacy|0
2475148|NCT02275052|8546169|P1|Washout Period (12-17 Days)|Lack of Efficacy|1
2475149|NCT02275052|8546166|P4|Washout Period (12-17 Days)|Withdrawal by Subject|0
2475150|NCT02275052|8546167|P3|Washout Period (12-17 Days)|Withdrawal by Subject|0
2475151|NCT02275052|8546168|P2|Washout Period (12-17 Days)|Withdrawal by Subject|0
2475152|NCT02275052|8546169|P1|Washout Period (12-17 Days)|Withdrawal by Subject|3
2475153|NCT02275052|8546166|P4|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
2475154|NCT02275052|8546167|P3|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
2475155|NCT02275052|8546168|P2|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
2475156|NCT02275052|8546169|P1|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2
2475157|NCT02275052|8546166|P4|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
2475158|NCT02275052|8546167|P3|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
2475159|NCT02275052|8546168|P2|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
2475160|NCT02275052|8546169|P1|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1
2475161|NCT02275052|8546166|P4|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
2475162|NCT02275052|8546167|P3|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
2475163|NCT02275052|8546168|P2|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4
2475164|NCT02275052|8546169|P1|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6
2475165|NCT02275052|8546166|P4|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
2475166|NCT02275052|8546167|P3|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
2475167|NCT02275052|8546168|P2|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1
2475168|NCT02275052|8546169|P1|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
2475169|NCT02275052|8546166|P4|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2475170|NCT02275052|8546167|P3|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2475171|NCT02275052|8546168|P2|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
2475172|NCT02275052|8546169|P1|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2475173|NCT02274948|8546183|P2|Overall Study|Left the area|3
2475174|NCT02274948|8546184|P1|Overall Study|Left the area|4
2475175|NCT02274948|8546183|P2|Overall Study|Stopped on family Practitioner advice|5
2475176|NCT02274948|8546184|P1|Overall Study|Stopped on family Practitioner advice|2
2475177|NCT02274948|8546183|P2|Overall Study|Withdrawal by Subject|58
2475178|NCT02274948|8546184|P1|Overall Study|Withdrawal by Subject|64
2475179|NCT02274948|8546183|P2|Overall Study|Lost to Follow-up|25
2475180|NCT02274948|8546184|P1|Overall Study|Lost to Follow-up|28
2475181|NCT02274857|8546227|P2|Overall Study|Other|0
2475182|NCT02274857|8546228|P1|Overall Study|Other|2
2475183|NCT02274857|8546227|P2|Overall Study|Withdrawal by Subject|2
2475184|NCT02274857|8546228|P1|Overall Study|Withdrawal by Subject|11
2475185|NCT02274857|8546227|P2|Overall Study|Trial screen failure|2
2475186|NCT02274857|8546228|P1|Overall Study|Trial screen failure|0
2475187|NCT02274857|8546227|P2|Overall Study|Physician Decision|0
2475188|NCT02274857|8546228|P1|Overall Study|Physician Decision|2
2475189|NCT02274857|8546227|P2|Overall Study|Lost to Follow-up|0
2475190|NCT02274857|8546228|P1|Overall Study|Lost to Follow-up|3
2475191|NCT02274857|8546227|P2|Overall Study|Death|2
2475192|NCT02274857|8546228|P1|Overall Study|Death|1
2475193|NCT02274857|8546227|P2|Overall Study|Adverse Event|0
2475194|NCT02274857|8546228|P1|Overall Study|Adverse Event|1
2475195|NCT02274792|8546241|P1|Overall Study|Sponsor Decision|2
2475196|NCT02274792|8546241|P1|Overall Study|Protocol Specified Criteria|2
2475197|NCT02274792|8546241|P1|Overall Study|Lost to Follow-up|8
2475198|NCT02274792|8546241|P1|Overall Study|Withdrawal by Subject|13
2475199|NCT02274766|8546251|P2|Overall Study|Adverse Event|1
2475200|NCT02274766|8546252|P1|Overall Study|Adverse Event|0
2475201|NCT02274766|8546251|P2|Overall Study|Subject Unwilling to Proceed|1
2475202|NCT02274766|8546252|P1|Overall Study|Subject Unwilling to Proceed|0
2475203|NCT02274766|8546251|P2|Overall Study|Did Not Receive Study Drug|1
2475204|NCT02274766|8546252|P1|Overall Study|Did Not Receive Study Drug|1
2475205|NCT02274766|8546251|P2|Overall Study|Withdrawal by Subject|6
2475206|NCT02274766|8546252|P1|Overall Study|Withdrawal by Subject|3
2475207|NCT02274558|8546319|P3|Overall Study|Physician Decision|1
2475208|NCT02274558|8546320|P2|Overall Study|Physician Decision|2
2475209|NCT02274558|8546321|P1|Overall Study|Physician Decision|0
2475210|NCT02274558|8546319|P3|Overall Study|Lost to Follow-up|1
2475211|NCT02274558|8546320|P2|Overall Study|Lost to Follow-up|1
2475212|NCT02274558|8546321|P1|Overall Study|Lost to Follow-up|2
2475213|NCT02274558|8546319|P3|Overall Study|Death|1
2475214|NCT02274558|8546320|P2|Overall Study|Death|0
2475215|NCT02274558|8546321|P1|Overall Study|Death|0
2475216|NCT02274558|8546319|P3|Overall Study|Withdrawal by Subject|4
2475217|NCT02274558|8546320|P2|Overall Study|Withdrawal by Subject|5
2475218|NCT02274558|8546321|P1|Overall Study|Withdrawal by Subject|1
2475219|NCT02274558|8546319|P3|Overall Study|Non-compliance|0
2475220|NCT02274558|8546320|P2|Overall Study|Non-compliance|1
2475221|NCT02274558|8546321|P1|Overall Study|Non-compliance|2
2475222|NCT02274558|8546319|P3|Overall Study|Adverse Event|2
2475223|NCT02274558|8546320|P2|Overall Study|Adverse Event|4
2475224|NCT02274558|8546321|P1|Overall Study|Adverse Event|2
2475225|NCT02274493|8546335|P1|Overall Study|Withdrawal by Subject|1
2475226|NCT02274311|8546342|P1|Three Months of Clomiphene Wash-out|Lost to Follow-up|1
2475227|NCT02273973|8546350|P2|Overall Study|Reason not specified|1
2475228|NCT02273973|8546351|P1|Overall Study|Reason not specified|0
2475229|NCT02273973|8546350|P2|Overall Study|Physician Decision|1
2475230|NCT02273973|8546351|P1|Overall Study|Physician Decision|0
2475231|NCT02273973|8546350|P2|Overall Study|Lost to Follow-up|1
2475232|NCT02273973|8546351|P1|Overall Study|Lost to Follow-up|0
2475233|NCT02273973|8546350|P2|Overall Study|Progression of disease|2
2475234|NCT02273973|8546351|P1|Overall Study|Progression of disease|0
2475235|NCT02273973|8546350|P2|Overall Study|Protocol Violation|0
2475236|NCT02273973|8546351|P1|Overall Study|Protocol Violation|1
2475237|NCT02273973|8546350|P2|Overall Study|Non-compliance|0
2475238|NCT02273973|8546351|P1|Overall Study|Non-compliance|1
2475239|NCT02273973|8546350|P2|Overall Study|Death|0
2475240|NCT02273973|8546351|P1|Overall Study|Death|1
2475241|NCT02273973|8546350|P2|Overall Study|Withdrawal by Subject|3
2475242|NCT02273973|8546351|P1|Overall Study|Withdrawal by Subject|2
2475243|NCT02273973|8546350|P2|Overall Study|Adverse Event|0
2475244|NCT02273973|8546351|P1|Overall Study|Adverse Event|4
2475245|NCT02273960|8546395|P4|Long Term Extension|Death|1
2475246|NCT02273960|8546396|P3|Long Term Extension|Death|0
2475247|NCT02273960|8546397|P2|Long Term Extension|Death|0
2475248|NCT02273960|8546398|P1|Long Term Extension|Death|0
2475249|NCT02273960|8546395|P4|Short Term Period|ST complete, not entering LTE|5
2475250|NCT02273960|8546396|P3|Short Term Period|ST complete, not entering LTE|4
2475251|NCT02273960|8546397|P2|Short Term Period|ST complete, not entering LTE|6
2475252|NCT02273960|8546398|P1|Short Term Period|ST complete, not entering LTE|4
2475253|NCT02273960|8546395|P4|Short Term Period|Lack of Efficacy|1
2475254|NCT02273960|8546396|P3|Short Term Period|Lack of Efficacy|0
2475255|NCT02273960|8546397|P2|Short Term Period|Lack of Efficacy|0
2475256|NCT02273960|8546398|P1|Short Term Period|Lack of Efficacy|0
2475257|NCT02273960|8546395|P4|Short Term Period|Lost to Follow-up|0
2475258|NCT02273960|8546396|P3|Short Term Period|Lost to Follow-up|0
2475259|NCT02273960|8546397|P2|Short Term Period|Lost to Follow-up|0
2475260|NCT02273960|8546398|P1|Short Term Period|Lost to Follow-up|1
2475261|NCT02273908|8546442|P2|Overall Study|Withdrawal by Subject|2
2475262|NCT02273908|8546443|P1|Overall Study|Withdrawal by Subject|4
2475263|NCT02273908|8546442|P2|Overall Study|Did not meet entrance criteria|2
2475264|NCT02273908|8546443|P1|Overall Study|Did not meet entrance criteria|3
2475265|NCT02273908|8546442|P2|Overall Study|Lost to Follow-up|1
2475266|NCT02273908|8546443|P1|Overall Study|Lost to Follow-up|10
2475267|NCT02273908|8546442|P2|Overall Study|Adverse Event|0
2475268|NCT02273908|8546443|P1|Overall Study|Adverse Event|16
2475269|NCT02273752|8546465|P1|Overall Study|Trial was terminated early|2
2475270|NCT02273180|8546556|P2|Overall Study|Other than specified above|10
2475271|NCT02273180|8546557|P1|Overall Study|Other than specified above|21
2475272|NCT02273180|8546556|P2|Overall Study|Hypoglycemia(not reported as serious AE)|0
2475273|NCT02273180|8546557|P1|Overall Study|Hypoglycemia(not reported as serious AE)|1
2475274|NCT02273180|8546556|P2|Overall Study|Randomized but not treated|0
2475275|NCT02273180|8546557|P1|Overall Study|Randomized but not treated|1
2475276|NCT02273180|8546556|P2|Overall Study|Protocol Violation|7
2475277|NCT02273180|8546557|P1|Overall Study|Protocol Violation|1
2475278|NCT02273180|8546556|P2|Overall Study|Lack of Efficacy|0
2475279|NCT02273180|8546557|P1|Overall Study|Lack of Efficacy|1
2475280|NCT02273180|8546556|P2|Overall Study|Adverse Event|2
2475281|NCT02273180|8546557|P1|Overall Study|Adverse Event|2
2475282|NCT02273167|8546582|P3|Overall Study|Various|8
2475283|NCT02273167|8546583|P2|Overall Study|Various|9
2475284|NCT02273167|8546584|P1|Overall Study|Various|10
2475285|NCT02273167|8546582|P3|Overall Study|Withdrawal by Subject|11
2475286|NCT02273167|8546583|P2|Overall Study|Withdrawal by Subject|12
2475287|NCT02273167|8546584|P1|Overall Study|Withdrawal by Subject|10
2475288|NCT02273167|8546582|P3|Overall Study|Lost to Follow-up|1
2475289|NCT02273167|8546583|P2|Overall Study|Lost to Follow-up|1
2475290|NCT02273167|8546584|P1|Overall Study|Lost to Follow-up|0
2475291|NCT02273167|8546582|P3|Overall Study|Protocol Violation|1
2475292|NCT02273167|8546583|P2|Overall Study|Protocol Violation|1
2475293|NCT02273167|8546584|P1|Overall Study|Protocol Violation|3
2475294|NCT02273167|8546582|P3|Overall Study|Adverse Event|0
2475295|NCT02273167|8546583|P2|Overall Study|Adverse Event|0
2475296|NCT02273167|8546584|P1|Overall Study|Adverse Event|1
2475297|NCT02273141|8546609|P2|Overall Study|Various|6
2475298|NCT02273141|8546610|P1|Overall Study|Various|6
2475299|NCT02273141|8546609|P2|Overall Study|Withdrawal by Subject|15
2475300|NCT02273141|8546610|P1|Overall Study|Withdrawal by Subject|10
2475301|NCT02273141|8546609|P2|Overall Study|Lost to Follow-up|3
2475302|NCT02273141|8546610|P1|Overall Study|Lost to Follow-up|1
2475303|NCT02273141|8546609|P2|Overall Study|Adverse Event|1
2475304|NCT02273141|8546610|P1|Overall Study|Adverse Event|0
2475305|NCT02273050|8546683|P3|Overall Study|Protocol Violation|4
2475306|NCT02273050|8546684|P2|Overall Study|Protocol Violation|1
2475307|NCT02273050|8546685|P1|Overall Study|Protocol Violation|3
2475308|NCT02273050|8546683|P3|Overall Study|Lost to Follow-up|3
2475309|NCT02273050|8546684|P2|Overall Study|Lost to Follow-up|2
2475310|NCT02273050|8546685|P1|Overall Study|Lost to Follow-up|0
2475311|NCT02273050|8546683|P3|Overall Study|Withdrawal by Subject|16
2475312|NCT02273050|8546684|P2|Overall Study|Withdrawal by Subject|14
2475313|NCT02273050|8546685|P1|Overall Study|Withdrawal by Subject|17
2475314|NCT02273050|8546683|P3|Overall Study|Lack of Efficacy|1
2475315|NCT02273050|8546684|P2|Overall Study|Lack of Efficacy|1
2475316|NCT02273050|8546685|P1|Overall Study|Lack of Efficacy|0
2475317|NCT02273050|8546683|P3|Overall Study|Dev. of study spec. withdrawal criteria|1
2475318|NCT02273050|8546684|P2|Overall Study|Dev. of study spec. withdrawal criteria|1
2475319|NCT02273050|8546685|P1|Overall Study|Dev. of study spec. withdrawal criteria|0
2475320|NCT02273050|8546683|P3|Overall Study|Death|1
2475321|NCT02273050|8546684|P2|Overall Study|Death|0
2475322|NCT02273050|8546685|P1|Overall Study|Death|0
2475323|NCT02273050|8546683|P3|Overall Study|Adverse Event|3
2475324|NCT02273050|8546684|P2|Overall Study|Adverse Event|3
2475325|NCT02273050|8546685|P1|Overall Study|Adverse Event|4
2475326|NCT02273037|8546713|P2|Overall Study|Other complication|0
2475327|NCT02273037|8546714|P1|Overall Study|Other complication|2
2475328|NCT02273037|8546713|P2|Overall Study|Multiple delivery|2
2475329|NCT02273037|8546714|P1|Overall Study|Multiple delivery|2
2475330|NCT02273037|8546713|P2|Overall Study|Breech delivery|3
2475331|NCT02273037|8546714|P1|Overall Study|Breech delivery|2
2475332|NCT02273037|8546713|P2|Overall Study|Delivered before monitoring initiated|3
2475333|NCT02273037|8546714|P1|Overall Study|Delivered before monitoring initiated|1
2475334|NCT02273037|8546713|P2|Overall Study|Lost to Follow-up|0
2475335|NCT02273037|8546714|P1|Overall Study|Lost to Follow-up|1
2475336|NCT02272985|8546724|P1|Overall Study|kidney transplantation|1
2475337|NCT02272985|8546724|P1|Overall Study|hip fracture|1
2475338|NCT02272985|8546724|P1|Overall Study|Withdrawal by Subject|1
2475339|NCT02272816|8546729|P1|Overall Study|Adverse Event|1
2475340|NCT02272803|8546737|P2|Overall Study|Withdrawal by Subject|0
2475341|NCT02272803|8546738|P1|Overall Study|Withdrawal by Subject|1
2475342|NCT02272803|8546737|P2|Overall Study|Poor/non-compliance|1
2475343|NCT02272803|8546738|P1|Overall Study|Poor/non-compliance|0
2475344|NCT02272803|8546737|P2|Overall Study|Subject moved to care facility|1
2475345|NCT02272803|8546738|P1|Overall Study|Subject moved to care facility|0
2475346|NCT02272803|8546737|P2|Overall Study|Maximum clinical benefit|1
2475347|NCT02272803|8546738|P1|Overall Study|Maximum clinical benefit|1
2475348|NCT02272803|8546737|P2|Overall Study|Subj request to discontinue study trt|4
2475349|NCT02272803|8546738|P1|Overall Study|Subj request to discontinue study trt|1
2475350|NCT02272803|8546737|P2|Overall Study|Study drug toxicity|4
2475351|NCT02272803|8546738|P1|Overall Study|Study drug toxicity|1
2475352|NCT02272803|8546737|P2|Overall Study|Adverse Event unrelated to study drug|4
2475353|NCT02272803|8546738|P1|Overall Study|Adverse Event unrelated to study drug|1
2475354|NCT02272803|8546737|P2|Overall Study|Disease progression|2
2475355|NCT02272803|8546738|P1|Overall Study|Disease progression|4
2475356|NCT02272790|8546755|P6|Overall Study|Physician Decision|0
2475357|NCT02272790|8546756|P5|Overall Study|Physician Decision|0
2475358|NCT02272790|8546757|P4|Overall Study|Physician Decision|0
2475359|NCT02272790|8546758|P3|Overall Study|Physician Decision|0
2475360|NCT02272790|8546759|P2|Overall Study|Physician Decision|1
2475361|NCT02272790|8546760|P1|Overall Study|Physician Decision|0
2475362|NCT02272777|8546896|P2|Overall Study|Other|0
2475363|NCT02272777|8546897|P1|Overall Study|Other|2
2475364|NCT02272777|8546896|P2|Overall Study|Lost to Follow-up|0
2475365|NCT02272777|8546897|P1|Overall Study|Lost to Follow-up|2
2475366|NCT02272777|8546896|P2|Overall Study|Withdrawal by Subject|3
2475367|NCT02272777|8546897|P1|Overall Study|Withdrawal by Subject|0
2475368|NCT02272777|8546896|P2|Overall Study|Adverse Event|1
2475369|NCT02272777|8546897|P1|Overall Study|Adverse Event|0
2475370|NCT02272725|8546905|P2|Overall Study|equipment malfunction|0
2475371|NCT02272725|8546906|P1|Overall Study|equipment malfunction|2
2475372|NCT02272413|8546923|P2|Post-switch Period|Other than listed|5
2475373|NCT02272413|8546924|P1|Post-switch Period|Other than listed|4
2475374|NCT02272413|8546923|P2|Post-switch Period|Study terminated by sponsor|11
2475375|NCT02272413|8546924|P1|Post-switch Period|Study terminated by sponsor|8
2475376|NCT02272413|8546923|P2|Post-switch Period|Progressive disease|21
2475377|NCT02272413|8546924|P1|Post-switch Period|Progressive disease|21
2475378|NCT02272413|8546923|P2|Post-switch Period|Physician Decision|1
2475379|NCT02272413|8546924|P1|Post-switch Period|Physician Decision|1
2475380|NCT02272413|8546923|P2|Post-switch Period|Withdrawal by Subject|2
2475381|NCT02272413|8546924|P1|Post-switch Period|Withdrawal by Subject|1
2475382|NCT02272413|8546923|P2|Post-switch Period|Death|2
2475383|NCT02272413|8546924|P1|Post-switch Period|Death|3
2475384|NCT02272413|8546923|P2|Post-switch Period|Adverse Event|4
2475385|NCT02272413|8546924|P1|Post-switch Period|Adverse Event|4
2475386|NCT02272413|8546923|P2|Pre-switch Period|Other than listed|11
2475387|NCT02272413|8546924|P1|Pre-switch Period|Other than listed|10
2475388|NCT02272413|8546923|P2|Pre-switch Period|Protocol Violation|0
2475389|NCT02272413|8546924|P1|Pre-switch Period|Protocol Violation|1
2475390|NCT02272413|8546923|P2|Pre-switch Period|Lost to Follow-up|2
2475391|NCT02272413|8546924|P1|Pre-switch Period|Lost to Follow-up|0
2475392|NCT02272413|8546923|P2|Pre-switch Period|Progressive disease|173
2475393|NCT02272413|8546924|P1|Pre-switch Period|Progressive disease|185
2475394|NCT02272413|8546923|P2|Pre-switch Period|Physician Decision|18
2475395|NCT02272413|8546924|P1|Pre-switch Period|Physician Decision|6
2475396|NCT02272413|8546923|P2|Pre-switch Period|Withdrawal by Subject|15
2475397|NCT02272413|8546924|P1|Pre-switch Period|Withdrawal by Subject|27
2475398|NCT02272413|8546923|P2|Pre-switch Period|Death|26
2475399|NCT02272413|8546924|P1|Pre-switch Period|Death|26
2475400|NCT02272413|8546923|P2|Pre-switch Period|Adverse Event|37
2475401|NCT02272413|8546924|P1|Pre-switch Period|Adverse Event|38
2475402|NCT02272413|8546923|P2|Randomized Through Treatment Start|Not treated|5
2475403|NCT02272413|8546924|P1|Randomized Through Treatment Start|Not treated|3
2475404|NCT02271984|8546955|P12|Washout Period 4 (7 Days)|Withdrawal by Subject|0
2475405|NCT02271984|8546956|P11|Washout Period 4 (7 Days)|Withdrawal by Subject|0
2475406|NCT02271984|8546957|P10|Washout Period 4 (7 Days)|Withdrawal by Subject|0
2475407|NCT02271984|8546958|P9|Washout Period 4 (7 Days)|Withdrawal by Subject|0
2475408|NCT02271984|8546959|P8|Washout Period 4 (7 Days)|Withdrawal by Subject|1
2475409|NCT02271984|8546960|P7|Washout Period 4 (7 Days)|Withdrawal by Subject|0
2475410|NCT02271984|8546961|P6|Washout Period 4 (7 Days)|Withdrawal by Subject|1
2475411|NCT02271984|8546962|P5|Washout Period 4 (7 Days)|Withdrawal by Subject|0
2475412|NCT02271984|8546963|P4|Washout Period 4 (7 Days)|Withdrawal by Subject|0
2475413|NCT02271984|8546964|P3|Washout Period 4 (7 Days)|Withdrawal by Subject|0
2475414|NCT02271984|8546965|P2|Washout Period 4 (7 Days)|Withdrawal by Subject|0
2475415|NCT02271984|8546966|P1|Washout Period 4 (7 Days)|Withdrawal by Subject|0
2475416|NCT02271945|8547055|P2|Overall Study|Other|1
2475417|NCT02271945|8547056|P1|Overall Study|Other|1
2475418|NCT02271945|8547055|P2|Overall Study|Withdrawal by Subject|1
2475419|NCT02271945|8547056|P1|Overall Study|Withdrawal by Subject|1
2475420|NCT02271945|8547055|P2|Overall Study|Death|3
2475421|NCT02271945|8547056|P1|Overall Study|Death|3
2475422|NCT02271880|8547099|P2|Overall Study|Premature discontinuation of study|4
2475423|NCT02271880|8547100|P1|Overall Study|Premature discontinuation of study|3
2475424|NCT02271854|8547130|P1|Overall Study|Lost to Follow-up|1
2475425|NCT02271854|8547130|P1|Overall Study|Unable or unwilling to cooperate with st|1
2475426|NCT02271854|8547130|P1|Overall Study|Withdrawal by Subject|2
2475427|NCT02271529|8547170|P1|Overall Study|Withdrawal by Subject|1
2475428|NCT02270983|8547291|P3|Overall Study|moved away from study site|0
2475429|NCT02270983|8547292|P2|Overall Study|moved away from study site|1
2475430|NCT02270983|8547293|P1|Overall Study|moved away from study site|0
2475431|NCT02270983|8547291|P3|Overall Study|study procedure non-compliance|0
2475432|NCT02270983|8547292|P2|Overall Study|study procedure non-compliance|0
2475433|NCT02270983|8547293|P1|Overall Study|study procedure non-compliance|1
2475434|NCT02270983|8547291|P3|Overall Study|family emergency|0
2475435|NCT02270983|8547292|P2|Overall Study|family emergency|1
2475436|NCT02270983|8547293|P1|Overall Study|family emergency|0
2475437|NCT02270983|8547291|P3|Overall Study|Protocol Violation|1
2475438|NCT02270983|8547292|P2|Overall Study|Protocol Violation|1
2475439|NCT02270983|8547293|P1|Overall Study|Protocol Violation|1
2475440|NCT02270983|8547291|P3|Overall Study|Lost to Follow-up|2
2475441|NCT02270983|8547292|P2|Overall Study|Lost to Follow-up|1
2475442|NCT02270983|8547293|P1|Overall Study|Lost to Follow-up|1
2475443|NCT02270983|8547291|P3|Overall Study|Withdrawal by Subject|2
2475444|NCT02270983|8547292|P2|Overall Study|Withdrawal by Subject|0
2475445|NCT02270983|8547293|P1|Overall Study|Withdrawal by Subject|1
2475446|NCT02270983|8547291|P3|Overall Study|Lack of Efficacy|1
2475447|NCT02270983|8547292|P2|Overall Study|Lack of Efficacy|1
2475448|NCT02270983|8547293|P1|Overall Study|Lack of Efficacy|2
2475449|NCT02270983|8547291|P3|Overall Study|Adverse Event|6
2475450|NCT02270983|8547292|P2|Overall Study|Adverse Event|2
2475451|NCT02270983|8547293|P1|Overall Study|Adverse Event|3
2475452|NCT02270944|8547318|P2|Overall Study|Withdrawal by Subject|1
2475453|NCT02270944|8547319|P1|Overall Study|Withdrawal by Subject|2
2475454|NCT02270944|8547318|P2|Overall Study|Lost to Follow-up|4
2475455|NCT02270944|8547319|P1|Overall Study|Lost to Follow-up|9
2475456|NCT02270684|8547337|P2|Overall Study|Study terminated|0
2475457|NCT02270684|8547338|P1|Overall Study|Study terminated|1
2475458|NCT02270684|8547337|P2|Overall Study|Lost to Follow-up|3
2475459|NCT02270684|8547338|P1|Overall Study|Lost to Follow-up|0
2475460|NCT02270671|8547346|P2|Overall Study|Lost to Follow-up|1
2475461|NCT02270671|8547347|P1|Overall Study|Lost to Follow-up|2
2475462|NCT02270671|8547346|P2|Overall Study|Missed Post-intervention Data Collection|2
2475463|NCT02270671|8547347|P1|Overall Study|Missed Post-intervention Data Collection|2
2475464|NCT02270671|8547346|P2|Overall Study|Protocol Violation|1
2475465|NCT02270671|8547347|P1|Overall Study|Protocol Violation|0
2475466|NCT02270671|8547346|P2|Overall Study|Withdrawal by Subject|1
2475467|NCT02270671|8547347|P1|Overall Study|Withdrawal by Subject|1
2475468|NCT02270515|8547372|P1|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16
2475469|NCT02270515|8547372|P1|Intervention Period 3: 12-18 Months|Death|3
2475470|NCT02270515|8547372|P1|Intervention Period 3: 12-18 Months|Received transplant|2
2475471|NCT02270515|8547372|P1|Intervention Period 3: 12-18 Months|No longer patient at study site|2
2475472|NCT02270515|8547372|P1|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1
2475473|NCT02270515|8547372|P1|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17
2475474|NCT02270515|8547372|P1|Intervention Period 2: 6-12 Months|Death|5
2475475|NCT02270515|8547372|P1|Intervention Period 2: 6-12 Months|Received transplant|1
2475476|NCT02270515|8547372|P1|Intervention Period 2: 6-12 Months|No longer patient at study site|7
2475477|NCT02270515|8547372|P1|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2
2475478|NCT02270515|8547372|P1|Intervention Period 1: 0-6 Months|Death|7
2475479|NCT02270515|8547372|P1|Intervention Period 1: 0-6 Months|Received transplant|3
2475480|NCT02270515|8547372|P1|Intervention Period 1: 0-6 Months|No longer patient at study site|5
2475481|NCT02270515|8547372|P1|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1
2475482|NCT02269943|8547431|P2|Follow-Up Survival Period|Alive|8
2475483|NCT02269943|8547432|P1|Follow-Up Survival Period|Alive|2
2475484|NCT02269943|8547431|P2|Follow-Up Survival Period|Lost to Follow-up|2
2475485|NCT02269943|8547432|P1|Follow-Up Survival Period|Lost to Follow-up|0
2475486|NCT02269943|8547431|P2|Follow-Up Survival Period|Death|16
2475487|NCT02269943|8547432|P1|Follow-Up Survival Period|Death|3
2475488|NCT02269943|8547431|P2|Treatment Period|Symptomatic Deterioration|2
2475489|NCT02269943|8547432|P1|Treatment Period|Symptomatic Deterioration|0
2475490|NCT02269943|8547431|P2|Treatment Period|Progressive Disease|17
2475491|NCT02269943|8547432|P1|Treatment Period|Progressive Disease|5
2475492|NCT02269943|8547431|P2|Treatment Period|Adverse Event|10
2475493|NCT02269943|8547432|P1|Treatment Period|Adverse Event|1
2475494|NCT02269943|8547431|P2|Treatment Period|Death|1
2475495|NCT02269943|8547432|P1|Treatment Period|Death|0
2475496|NCT02269917|8547462|P2|Overall Study|Randomized but not treated|5
2475497|NCT02269917|8547463|P1|Overall Study|Randomized but not treated|3
2475498|NCT02269917|8547462|P2|Overall Study|Non-compliance with study drug|0
2475499|NCT02269917|8547463|P1|Overall Study|Non-compliance with study drug|2
2475500|NCT02269917|8547462|P2|Overall Study|Adverse Event|4
2475501|NCT02269917|8547463|P1|Overall Study|Adverse Event|11
2475502|NCT02269917|8547462|P2|Overall Study|Withdrawal by Subject|8
2475503|NCT02269917|8547463|P1|Overall Study|Withdrawal by Subject|9
2475504|NCT02269917|8547462|P2|Overall Study|Other|3
2475505|NCT02269917|8547463|P1|Overall Study|Other|6
2475506|NCT02269917|8547462|P2|Overall Study|Ongoing|360
2475507|NCT02269917|8547463|P1|Overall Study|Ongoing|731
2475508|NCT02269917|8547462|P2|Overall Study|Lost to Follow-up|3
2475509|NCT02269917|8547463|P1|Overall Study|Lost to Follow-up|4
2475510|NCT02269787|8547516|P2|Overall Study|Incapacitated|1
2475511|NCT02269787|8547517|P1|Overall Study|Incapacitated|0
2475512|NCT02269787|8547516|P2|Overall Study|Death|3
2475513|NCT02269787|8547517|P1|Overall Study|Death|2
2475514|NCT02269787|8547516|P2|Overall Study|Lost to Follow-up|6
2475515|NCT02269787|8547517|P1|Overall Study|Lost to Follow-up|20
2475516|NCT02269709|8547523|P1|Six Month Follow-up|Lost to Follow-up|12
2475517|NCT02269709|8547523|P1|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1
2475518|NCT02269709|8547523|P1|Time of Enrollment|Withdrawal by Subject|3
2475519|NCT02269657|8547528|P1|Overall Study|Protocol Violation|3
2475520|NCT02269475|8547565|P2|Overall Study|Withdrawal by Subject|1
2475521|NCT02269475|8547566|P1|Overall Study|Withdrawal by Subject|0
2475522|NCT02269475|8547565|P2|Overall Study|Meet Exclusion Criteria No. 17|0
2475523|NCT02269475|8547566|P1|Overall Study|Meet Exclusion Criteria No. 17|3
2475524|NCT02269423|8547581|P4|Overall Study|Discontinued due to change in residence|1
2475525|NCT02269423|8547582|P3|Overall Study|Discontinued due to change in residence|0
2475526|NCT02269423|8547583|P2|Overall Study|Discontinued due to change in residence|1
2475527|NCT02269423|8547584|P1|Overall Study|Discontinued due to change in residence|0
2475528|NCT02269241|8547646|P1|Overall Study|Screening failures|546
2475529|NCT02269241|8547646|P1|Overall Study|Several reasons not classified|53
2475530|NCT02269241|8547646|P1|Overall Study|At the specific request of the sponsor|20
2475531|NCT02269241|8547646|P1|Overall Study|Adverse Event|113
2475532|NCT02269241|8547646|P1|Overall Study|Development of an exclusion criteria|16
2475533|NCT02269241|8547646|P1|Overall Study|Wish for pregnancy|5
2475534|NCT02269241|8547646|P1|Overall Study|Pregnancy|15
2475535|NCT02269241|8547646|P1|Overall Study|Physician Decision|7
2475536|NCT02269241|8547646|P1|Overall Study|Protocol Violation|1
2475537|NCT02269241|8547646|P1|Overall Study|Withdrawal by Subject|155
2475538|NCT02269241|8547646|P1|Overall Study|Lost to Follow-up|269
2475539|NCT02269098|8547660|P2|Overall Study|Lost to Follow-up|9
2475540|NCT02269098|8547661|P1|Overall Study|Lost to Follow-up|14
2475541|NCT02268864|8547722|P3|Overall Study|Death|0
2475542|NCT02268864|8547723|P2|Overall Study|Death|1
2475543|NCT02268864|8547724|P1|Overall Study|Death|0
2475544|NCT02268864|8547722|P3|Overall Study|Withdrawal by Subject|0
2475545|NCT02268864|8547723|P2|Overall Study|Withdrawal by Subject|0
2475546|NCT02268864|8547724|P1|Overall Study|Withdrawal by Subject|2
2475547|NCT02268812|8547750|P4|Overall Study|Other|3
2475548|NCT02268812|8547751|P3|Overall Study|Other|1
2475549|NCT02268812|8547752|P2|Overall Study|Other|4
2475550|NCT02268812|8547753|P1|Overall Study|Other|5
2475551|NCT02268812|8547750|P4|Overall Study|Physician Decision|1
2475552|NCT02268812|8547751|P3|Overall Study|Physician Decision|0
2475553|NCT02268812|8547752|P2|Overall Study|Physician Decision|1
2475554|NCT02268812|8547753|P1|Overall Study|Physician Decision|3
2475555|NCT02268812|8547750|P4|Overall Study|Withdrawal by Subject|0
2475556|NCT02268812|8547751|P3|Overall Study|Withdrawal by Subject|0
2475557|NCT02268812|8547752|P2|Overall Study|Withdrawal by Subject|1
2475558|NCT02268812|8547753|P1|Overall Study|Withdrawal by Subject|0
2475559|NCT02268812|8547750|P4|Overall Study|Protocol deviation|0
2475560|NCT02268812|8547751|P3|Overall Study|Protocol deviation|1
2475561|NCT02268812|8547752|P2|Overall Study|Protocol deviation|0
2475562|NCT02268812|8547753|P1|Overall Study|Protocol deviation|0
2475563|NCT02268812|8547750|P4|Overall Study|Adverse Event|10
2475564|NCT02268812|8547751|P3|Overall Study|Adverse Event|7
2475565|NCT02268812|8547752|P2|Overall Study|Adverse Event|26
2475566|NCT02268812|8547753|P1|Overall Study|Adverse Event|8
2475567|NCT02268526|8547786|P3|Overall Study|Subject/guardian decision|3
2475568|NCT02268526|8547787|P2|Overall Study|Subject/guardian decision|7
2475569|NCT02268526|8547788|P1|Overall Study|Subject/guardian decision|0
2475570|NCT02268526|8547786|P3|Overall Study|Physician Decision|1
2475571|NCT02268526|8547787|P2|Overall Study|Physician Decision|0
2475572|NCT02268526|8547788|P1|Overall Study|Physician Decision|0
2475573|NCT02268526|8547786|P3|Overall Study|protocol deviation|0
2475574|NCT02268526|8547787|P2|Overall Study|protocol deviation|1
2475575|NCT02268526|8547788|P1|Overall Study|protocol deviation|0
2475576|NCT02268526|8547786|P3|Overall Study|Death|0
2475577|NCT02268526|8547787|P2|Overall Study|Death|11
2475578|NCT02268526|8547788|P1|Overall Study|Death|1
2475579|NCT02268526|8547786|P3|Overall Study|Adverse Event|1
2475580|NCT02268526|8547787|P2|Overall Study|Adverse Event|2
2475581|NCT02268526|8547788|P1|Overall Study|Adverse Event|0
2475582|NCT02268396|8547809|P1|Overall Study|2 Subjects no Day 29 Assessment|2
2475583|NCT02268396|8547809|P1|Overall Study|Protocol-Specified Criteria|2
2475584|NCT02268396|8547809|P1|Overall Study|Lost to Follow-up|2
2475585|NCT02268396|8547809|P1|Overall Study|Withdrawal by Subject|1
2475586|NCT02268396|8547809|P1|Overall Study|Administrative|2
2475587|NCT02268396|8547809|P1|Overall Study|Adverse Event|3
2475588|NCT02268214|8547821|P3|Overall Study|Not entering long-term period|5
2475589|NCT02268214|8547822|P2|Overall Study|Not entering long-term period|3
2475590|NCT02268214|8547823|P1|Overall Study|Not entering long-term period|2
2475591|NCT02268214|8547821|P3|Overall Study|Other reasons|3
2475592|NCT02268214|8547822|P2|Overall Study|Other reasons|3
2475593|NCT02268214|8547823|P1|Overall Study|Other reasons|7
2475594|NCT02268214|8547821|P3|Overall Study|Poor/non-compliance|2
2475595|NCT02268214|8547822|P2|Overall Study|Poor/non-compliance|1
2475596|NCT02268214|8547823|P1|Overall Study|Poor/non-compliance|2
2475597|NCT02268214|8547821|P3|Overall Study|Subject request to discontinue treatment|6
2475598|NCT02268214|8547822|P2|Overall Study|Subject request to discontinue treatment|8
2475599|NCT02268214|8547823|P1|Overall Study|Subject request to discontinue treatment|10
2475600|NCT02268214|8547821|P3|Overall Study|Withdrawal by Subject|10
2475601|NCT02268214|8547822|P2|Overall Study|Withdrawal by Subject|5
2475602|NCT02268214|8547823|P1|Overall Study|Withdrawal by Subject|4
2475603|NCT02268214|8547821|P3|Overall Study|Adverse Event|9
2475604|NCT02268214|8547822|P2|Overall Study|Adverse Event|14
2475605|NCT02268214|8547823|P1|Overall Study|Adverse Event|11
2475606|NCT02268214|8547821|P3|Overall Study|Lack of Efficacy|2
2475607|NCT02268214|8547822|P2|Overall Study|Lack of Efficacy|0
2475608|NCT02268214|8547823|P1|Overall Study|Lack of Efficacy|1
2475609|NCT02268214|8547821|P3|Overall Study|Lost to Follow-up|4
2475610|NCT02268214|8547822|P2|Overall Study|Lost to Follow-up|3
2475611|NCT02268214|8547823|P1|Overall Study|Lost to Follow-up|3
2475612|NCT02268214|8547821|P3|Overall Study|Pregnancy|1
2475613|NCT02268214|8547822|P2|Overall Study|Pregnancy|2
2475614|NCT02268214|8547823|P1|Overall Study|Pregnancy|2
2475615|NCT02268214|8547821|P3|Overall Study|Subject no longer meets study criteria|0
2475616|NCT02268214|8547822|P2|Overall Study|Subject no longer meets study criteria|2
2475617|NCT02268214|8547823|P1|Overall Study|Subject no longer meets study criteria|0
2475618|NCT02268058|8547870|P4|Overall Study|Protocol Violation|0
2475619|NCT02268058|8547871|P3|Overall Study|Protocol Violation|0
2475620|NCT02268058|8547872|P2|Overall Study|Protocol Violation|0
2475621|NCT02268058|8547873|P1|Overall Study|Protocol Violation|1
2475622|NCT02268045|8547897|P2|Overall Study|Protocol Violation|1
2475623|NCT02268045|8547898|P1|Overall Study|Protocol Violation|1
2475624|NCT02268045|8547897|P2|Overall Study|Physician Decision|1
2475625|NCT02268045|8547898|P1|Overall Study|Physician Decision|0
2475626|NCT02268045|8547897|P2|Overall Study|Withdrawal by Subject|6
2475627|NCT02268045|8547898|P1|Overall Study|Withdrawal by Subject|2
2475628|NCT02268045|8547897|P2|Overall Study|Adverse Event|7
2475629|NCT02268045|8547898|P1|Overall Study|Adverse Event|7
2475630|NCT02268045|8547897|P2|Overall Study|Disease Progression|1
2475631|NCT02268045|8547898|P1|Overall Study|Disease Progression|2
2475632|NCT02268045|8547897|P2|Overall Study|Death|4
2475633|NCT02268045|8547898|P1|Overall Study|Death|4
2475634|NCT02267824|8547940|P2|Overall Study|Did Not Meet Initial Dental Criteria|0
2475635|NCT02267824|8547941|P1|Overall Study|Did Not Meet Initial Dental Criteria|2
2475636|NCT02267824|8547940|P2|Overall Study|Protocol Violation|0
2475637|NCT02267824|8547941|P1|Overall Study|Protocol Violation|3
2475638|NCT02267824|8547940|P2|Overall Study|Lost to Follow-up|0
2475639|NCT02267824|8547941|P1|Overall Study|Lost to Follow-up|4
2475640|NCT02267824|8547940|P2|Overall Study|Pregnancy|1
2475641|NCT02267824|8547941|P1|Overall Study|Pregnancy|1
2475642|NCT02267317|8548030|P6|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
2475643|NCT02267317|8548031|P5|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
2475644|NCT02267317|8548032|P4|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
2475645|NCT02267317|8548033|P3|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
2475646|NCT02267317|8548034|P2|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
2475647|NCT02267317|8548035|P1|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1
2475648|NCT02267317|8548030|P6|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
2475649|NCT02267317|8548031|P5|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
2475650|NCT02267317|8548032|P4|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
2475651|NCT02267317|8548033|P3|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
2475652|NCT02267317|8548034|P2|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
2475653|NCT02267317|8548035|P1|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1
2475654|NCT02267278|8548085|P1|Overall Study|prescribed prohibited medication|1
2475655|NCT02267278|8548085|P1|Overall Study|Developed new cancer diagnoses|2
2475656|NCT02267278|8548085|P1|Overall Study|transformation to acute leukemia (AML)|1
2475657|NCT02267278|8548085|P1|Overall Study|Proceeded to transplantation (allo-HCT)|1
2475658|NCT02267187|8548109|P1|Overall Study|Screen fail|3
2475659|NCT02267187|8548109|P1|Overall Study|Physician Decision|2
2475660|NCT02267135|8548117|P2|Period 2 (Randomized Set)|Withdrawal by Subject|0
2475661|NCT02267135|8548118|P1|Period 2 (Randomized Set)|Withdrawal by Subject|1
2475662|NCT02267135|8548117|P2|Period 2 (Randomized Set)|Adverse Event|0
2475663|NCT02267135|8548118|P1|Period 2 (Randomized Set)|Adverse Event|2
2475664|NCT02267135|8548117|P2|Period 2 (Randomized Set)|Lost to Follow-up|1
2475665|NCT02267135|8548118|P1|Period 2 (Randomized Set)|Lost to Follow-up|1
2475666|NCT02267135|8548117|P2|Period 1 (Randomized Set)|Lost to Follow-up|1
2475667|NCT02267135|8548118|P1|Period 1 (Randomized Set)|Lost to Follow-up|0
2475668|NCT02267135|8548117|P2|Period 1 (Randomized Set)|Withdrawal by Subject|3
2475669|NCT02267135|8548118|P1|Period 1 (Randomized Set)|Withdrawal by Subject|1
2475670|NCT02266875|8548162|P2|Overall Study|Lost to Follow-up|0
2475671|NCT02266875|8548163|P1|Overall Study|Lost to Follow-up|2
2475672|NCT02266875|8548162|P2|Overall Study|Withdrawal by Subject|0
2475673|NCT02266875|8548163|P1|Overall Study|Withdrawal by Subject|9
2475674|NCT02266706|8548228|P9|Overall Study|Enrollment in another study|0
2475675|NCT02266706|8548229|P8|Overall Study|Enrollment in another study|0
2475676|NCT02266706|8548230|P7|Overall Study|Enrollment in another study|0
2475677|NCT02266706|8548231|P6|Overall Study|Enrollment in another study|0
2475678|NCT02266706|8548232|P5|Overall Study|Enrollment in another study|0
2475679|NCT02266706|8548233|P4|Overall Study|Enrollment in another study|1
2475680|NCT02266706|8548234|P3|Overall Study|Enrollment in another study|0
2475681|NCT02266706|8548235|P2|Overall Study|Enrollment in another study|0
2475682|NCT02266706|8548236|P1|Overall Study|Enrollment in another study|0
2475683|NCT02266706|8548228|P9|Overall Study|Screen failure|0
2475684|NCT02266706|8548229|P8|Overall Study|Screen failure|0
2475685|NCT02266706|8548230|P7|Overall Study|Screen failure|1
2475686|NCT02266706|8548231|P6|Overall Study|Screen failure|1
2475687|NCT02266706|8548232|P5|Overall Study|Screen failure|0
2475688|NCT02266706|8548233|P4|Overall Study|Screen failure|0
2475689|NCT02266706|8548234|P3|Overall Study|Screen failure|0
2475690|NCT02266706|8548235|P2|Overall Study|Screen failure|0
2475691|NCT02266706|8548236|P1|Overall Study|Screen failure|0
2475692|NCT02266706|8548228|P9|Overall Study|Withdrawal by Subject|0
2475693|NCT02266706|8548229|P8|Overall Study|Withdrawal by Subject|0
2475694|NCT02266706|8548230|P7|Overall Study|Withdrawal by Subject|0
2475695|NCT02266706|8548231|P6|Overall Study|Withdrawal by Subject|1
2475696|NCT02266706|8548232|P5|Overall Study|Withdrawal by Subject|0
2475697|NCT02266706|8548233|P4|Overall Study|Withdrawal by Subject|0
2475698|NCT02266706|8548234|P3|Overall Study|Withdrawal by Subject|1
2475699|NCT02266706|8548235|P2|Overall Study|Withdrawal by Subject|1
2475700|NCT02266706|8548236|P1|Overall Study|Withdrawal by Subject|0
2475701|NCT02266381|8548468|P3|Overall Study|Physician Decision|4
2475702|NCT02266381|8548469|P2|Overall Study|Physician Decision|5
2475703|NCT02266381|8548470|P1|Overall Study|Physician Decision|3
2475704|NCT02266225|8548520|P1|Overall Study|Withdrawal by Subject|13
2475705|NCT02266225|8548520|P1|Overall Study|Death|1
2475706|NCT02266225|8548520|P1|Overall Study|Lost to Follow-up|2
2475707|NCT02265952|8548554|P2|Open Label Extension (OLE) Period|Withdrawal by Subject|1
2475794|NCT02265705|8548802|P6|Follow-up Period|Sponsor Decision|1
2475708|NCT02265952|8548555|P1|Open Label Extension (OLE) Period|Withdrawal by Subject|0
2475709|NCT02265952|8548554|P2|Open Label Extension (OLE) Period|Physician Decision|7
2475710|NCT02265952|8548555|P1|Open Label Extension (OLE) Period|Physician Decision|0
2475711|NCT02265796|8548598|P2|Overall Study|Withdrawal by Subject|1
2475712|NCT02265796|8548599|P1|Overall Study|Withdrawal by Subject|1
2475713|NCT02265796|8548598|P2|Overall Study|started on excluded medication|0
2475714|NCT02265796|8548599|P1|Overall Study|started on excluded medication|1
2475715|NCT02265796|8548598|P2|Overall Study|Death|0
2475716|NCT02265796|8548599|P1|Overall Study|Death|1
2475717|NCT02265744|8548618|P5|Overall Study|Pregnancy|0
2475718|NCT02265744|8548619|P4|Overall Study|Pregnancy|1
2475719|NCT02265744|8548620|P3|Overall Study|Pregnancy|1
2475720|NCT02265744|8548621|P2|Overall Study|Pregnancy|2
2475721|NCT02265744|8548622|P1|Overall Study|Pregnancy|1
2475722|NCT02265744|8548618|P5|Overall Study|Subject no longer meets study criteria|1
2475723|NCT02265744|8548619|P4|Overall Study|Subject no longer meets study criteria|0
2475724|NCT02265744|8548620|P3|Overall Study|Subject no longer meets study criteria|0
2475725|NCT02265744|8548621|P2|Overall Study|Subject no longer meets study criteria|0
2475726|NCT02265744|8548622|P1|Overall Study|Subject no longer meets study criteria|0
2475727|NCT02265744|8548618|P5|Overall Study|Administrative reason by sponsor|3
2475728|NCT02265744|8548619|P4|Overall Study|Administrative reason by sponsor|3
2475729|NCT02265744|8548620|P3|Overall Study|Administrative reason by sponsor|2
2475730|NCT02265744|8548621|P2|Overall Study|Administrative reason by sponsor|2
2475731|NCT02265744|8548622|P1|Overall Study|Administrative reason by sponsor|3
2475732|NCT02265744|8548618|P5|Overall Study|Reason not provided by Investigator|0
2475733|NCT02265744|8548619|P4|Overall Study|Reason not provided by Investigator|2
2475734|NCT02265744|8548620|P3|Overall Study|Reason not provided by Investigator|0
2475735|NCT02265744|8548621|P2|Overall Study|Reason not provided by Investigator|0
2475736|NCT02265744|8548622|P1|Overall Study|Reason not provided by Investigator|1
2475737|NCT02265744|8548618|P5|Overall Study|Lack of Efficacy|5
2475738|NCT02265744|8548619|P4|Overall Study|Lack of Efficacy|4
2475739|NCT02265744|8548620|P3|Overall Study|Lack of Efficacy|3
2475740|NCT02265744|8548621|P2|Overall Study|Lack of Efficacy|4
2475741|NCT02265744|8548622|P1|Overall Study|Lack of Efficacy|2
2475742|NCT02265744|8548618|P5|Overall Study|Adverse Event|2
2475743|NCT02265744|8548619|P4|Overall Study|Adverse Event|8
2475744|NCT02265744|8548620|P3|Overall Study|Adverse Event|9
2475745|NCT02265744|8548621|P2|Overall Study|Adverse Event|4
2475746|NCT02265744|8548622|P1|Overall Study|Adverse Event|8
2475747|NCT02265744|8548618|P5|Overall Study|Participant request to discontinue|0
2475748|NCT02265744|8548619|P4|Overall Study|Participant request to discontinue|0
2475749|NCT02265744|8548620|P3|Overall Study|Participant request to discontinue|2
2475750|NCT02265744|8548621|P2|Overall Study|Participant request to discontinue|2
2475751|NCT02265744|8548622|P1|Overall Study|Participant request to discontinue|2
2475752|NCT02265744|8548618|P5|Overall Study|Withdrawal by Subject|0
2475753|NCT02265744|8548619|P4|Overall Study|Withdrawal by Subject|2
2475754|NCT02265744|8548620|P3|Overall Study|Withdrawal by Subject|0
2475755|NCT02265744|8548621|P2|Overall Study|Withdrawal by Subject|0
2475756|NCT02265744|8548622|P1|Overall Study|Withdrawal by Subject|2
2475757|NCT02265744|8548618|P5|Overall Study|Death|0
2475758|NCT02265744|8548619|P4|Overall Study|Death|2
2475759|NCT02265744|8548620|P3|Overall Study|Death|0
2475760|NCT02265744|8548621|P2|Overall Study|Death|0
2475761|NCT02265744|8548622|P1|Overall Study|Death|0
2475762|NCT02265744|8548618|P5|Overall Study|Lost to Follow-up|0
2475763|NCT02265744|8548619|P4|Overall Study|Lost to Follow-up|1
2475764|NCT02265744|8548620|P3|Overall Study|Lost to Follow-up|0
2475765|NCT02265744|8548621|P2|Overall Study|Lost to Follow-up|0
2475766|NCT02265744|8548622|P1|Overall Study|Lost to Follow-up|0
2475767|NCT02265744|8548618|P5|Overall Study|Poor/Non-compliance|2
2475768|NCT02265744|8548619|P4|Overall Study|Poor/Non-compliance|0
2475769|NCT02265744|8548620|P3|Overall Study|Poor/Non-compliance|0
2475770|NCT02265744|8548621|P2|Overall Study|Poor/Non-compliance|1
2475771|NCT02265744|8548622|P1|Overall Study|Poor/Non-compliance|1
2475772|NCT02265705|8548801|P7|Follow-up Period|Withdrawal by Subject|1
2475773|NCT02265705|8548802|P6|Follow-up Period|Withdrawal by Subject|0
2475774|NCT02265705|8548803|P5|Follow-up Period|Withdrawal by Subject|0
2475775|NCT02265705|8548804|P4|Follow-up Period|Withdrawal by Subject|0
2475776|NCT02265705|8548805|P3|Follow-up Period|Withdrawal by Subject|0
2475777|NCT02265705|8548806|P2|Follow-up Period|Withdrawal by Subject|0
2475778|NCT02265705|8548807|P1|Follow-up Period|Withdrawal by Subject|0
2475779|NCT02265705|8548801|P7|Follow-up Period|Physician Decision|1
2475780|NCT02265705|8548802|P6|Follow-up Period|Physician Decision|0
2475781|NCT02265705|8548803|P5|Follow-up Period|Physician Decision|0
2475782|NCT02265705|8548804|P4|Follow-up Period|Physician Decision|0
2475783|NCT02265705|8548805|P3|Follow-up Period|Physician Decision|0
2475784|NCT02265705|8548806|P2|Follow-up Period|Physician Decision|0
2475785|NCT02265705|8548807|P1|Follow-up Period|Physician Decision|0
2475786|NCT02265705|8548801|P7|Follow-up Period|Adverse Event|3
2475787|NCT02265705|8548802|P6|Follow-up Period|Adverse Event|0
2475788|NCT02265705|8548803|P5|Follow-up Period|Adverse Event|0
2475789|NCT02265705|8548804|P4|Follow-up Period|Adverse Event|0
2475790|NCT02265705|8548805|P3|Follow-up Period|Adverse Event|0
2475791|NCT02265705|8548806|P2|Follow-up Period|Adverse Event|0
2475792|NCT02265705|8548807|P1|Follow-up Period|Adverse Event|0
2475793|NCT02265705|8548801|P7|Follow-up Period|Sponsor Decision|6
2475795|NCT02265705|8548803|P5|Follow-up Period|Sponsor Decision|0
2475796|NCT02265705|8548804|P4|Follow-up Period|Sponsor Decision|0
2475797|NCT02265705|8548805|P3|Follow-up Period|Sponsor Decision|0
2475798|NCT02265705|8548806|P2|Follow-up Period|Sponsor Decision|0
2475799|NCT02265705|8548807|P1|Follow-up Period|Sponsor Decision|0
2475800|NCT02265705|8548801|P7|Open Label Period|Withdrawal by Subject|0
2475801|NCT02265705|8548802|P6|Open Label Period|Withdrawal by Subject|0
2475802|NCT02265705|8548803|P5|Open Label Period|Withdrawal by Subject|2
2475803|NCT02265705|8548804|P4|Open Label Period|Withdrawal by Subject|0
2475804|NCT02265705|8548805|P3|Open Label Period|Withdrawal by Subject|0
2475805|NCT02265705|8548806|P2|Open Label Period|Withdrawal by Subject|0
2475806|NCT02265705|8548807|P1|Open Label Period|Withdrawal by Subject|0
2475807|NCT02265705|8548801|P7|Open Label Period|Physician Decision|0
2475808|NCT02265705|8548802|P6|Open Label Period|Physician Decision|0
2475809|NCT02265705|8548803|P5|Open Label Period|Physician Decision|1
2475810|NCT02265705|8548804|P4|Open Label Period|Physician Decision|0
2475811|NCT02265705|8548805|P3|Open Label Period|Physician Decision|0
2475812|NCT02265705|8548806|P2|Open Label Period|Physician Decision|0
2475813|NCT02265705|8548807|P1|Open Label Period|Physician Decision|0
2475814|NCT02265705|8548801|P7|Open Label Period|Adverse Event|0
2475815|NCT02265705|8548802|P6|Open Label Period|Adverse Event|0
2475816|NCT02265705|8548803|P5|Open Label Period|Adverse Event|2
2475817|NCT02265705|8548804|P4|Open Label Period|Adverse Event|2
2475818|NCT02265705|8548805|P3|Open Label Period|Adverse Event|0
2475819|NCT02265705|8548806|P2|Open Label Period|Adverse Event|0
2475820|NCT02265705|8548807|P1|Open Label Period|Adverse Event|0
2475821|NCT02265705|8548801|P7|Rescue Period|Lack of Efficacy|0
2475822|NCT02265705|8548802|P6|Rescue Period|Lack of Efficacy|0
2475823|NCT02265705|8548803|P5|Rescue Period|Lack of Efficacy|0
2475824|NCT02265705|8548804|P4|Rescue Period|Lack of Efficacy|0
2475825|NCT02265705|8548805|P3|Rescue Period|Lack of Efficacy|1
2475826|NCT02265705|8548806|P2|Rescue Period|Lack of Efficacy|0
2475827|NCT02265705|8548807|P1|Rescue Period|Lack of Efficacy|0
2475828|NCT02265705|8548801|P7|Rescue Period|Death|0
2475829|NCT02265705|8548802|P6|Rescue Period|Death|0
2475830|NCT02265705|8548803|P5|Rescue Period|Death|0
2475831|NCT02265705|8548804|P4|Rescue Period|Death|0
2475832|NCT02265705|8548805|P3|Rescue Period|Death|1
2475833|NCT02265705|8548806|P2|Rescue Period|Death|0
2475834|NCT02265705|8548807|P1|Rescue Period|Death|0
2475835|NCT02265705|8548801|P7|Rescue Period|Withdrawal by Subject|0
2475836|NCT02265705|8548802|P6|Rescue Period|Withdrawal by Subject|0
2475837|NCT02265705|8548803|P5|Rescue Period|Withdrawal by Subject|0
2475838|NCT02265705|8548804|P4|Rescue Period|Withdrawal by Subject|0
2475839|NCT02265705|8548805|P3|Rescue Period|Withdrawal by Subject|1
2475840|NCT02265705|8548806|P2|Rescue Period|Withdrawal by Subject|0
2475841|NCT02265705|8548807|P1|Rescue Period|Withdrawal by Subject|0
2475842|NCT02265705|8548801|P7|Treatment Period Week 0-24|Lack of Efficacy|0
2475843|NCT02265705|8548802|P6|Treatment Period Week 0-24|Lack of Efficacy|0
2475844|NCT02265705|8548803|P5|Treatment Period Week 0-24|Lack of Efficacy|0
2475845|NCT02265705|8548804|P4|Treatment Period Week 0-24|Lack of Efficacy|0
2475846|NCT02265705|8548805|P3|Treatment Period Week 0-24|Lack of Efficacy|0
2475847|NCT02265705|8548806|P2|Treatment Period Week 0-24|Lack of Efficacy|1
2475848|NCT02265705|8548807|P1|Treatment Period Week 0-24|Lack of Efficacy|0
2475849|NCT02265705|8548801|P7|Treatment Period Week 0-24|Withdrawal by Subject|0
2475850|NCT02265705|8548802|P6|Treatment Period Week 0-24|Withdrawal by Subject|0
2475851|NCT02265705|8548803|P5|Treatment Period Week 0-24|Withdrawal by Subject|0
2475852|NCT02265705|8548804|P4|Treatment Period Week 0-24|Withdrawal by Subject|0
2475853|NCT02265705|8548805|P3|Treatment Period Week 0-24|Withdrawal by Subject|0
2475854|NCT02265705|8548806|P2|Treatment Period Week 0-24|Withdrawal by Subject|5
2475855|NCT02265705|8548807|P1|Treatment Period Week 0-24|Withdrawal by Subject|7
2475856|NCT02265705|8548801|P7|Treatment Period Week 0-24|Physician Decision|0
2475857|NCT02265705|8548802|P6|Treatment Period Week 0-24|Physician Decision|0
2475858|NCT02265705|8548803|P5|Treatment Period Week 0-24|Physician Decision|0
2475859|NCT02265705|8548804|P4|Treatment Period Week 0-24|Physician Decision|0
2475860|NCT02265705|8548805|P3|Treatment Period Week 0-24|Physician Decision|0
2475861|NCT02265705|8548806|P2|Treatment Period Week 0-24|Physician Decision|0
2475862|NCT02265705|8548807|P1|Treatment Period Week 0-24|Physician Decision|1
2475863|NCT02265705|8548801|P7|Treatment Period Week 0-24|Entry Criteria Not Met|0
2475864|NCT02265705|8548802|P6|Treatment Period Week 0-24|Entry Criteria Not Met|0
2475865|NCT02265705|8548803|P5|Treatment Period Week 0-24|Entry Criteria Not Met|0
2475866|NCT02265705|8548804|P4|Treatment Period Week 0-24|Entry Criteria Not Met|0
2475867|NCT02265705|8548805|P3|Treatment Period Week 0-24|Entry Criteria Not Met|0
2475868|NCT02265705|8548806|P2|Treatment Period Week 0-24|Entry Criteria Not Met|1
2475869|NCT02265705|8548807|P1|Treatment Period Week 0-24|Entry Criteria Not Met|1
2475870|NCT02265705|8548801|P7|Treatment Period Week 0-24|Adverse Event|0
2475871|NCT02265705|8548802|P6|Treatment Period Week 0-24|Adverse Event|0
2475872|NCT02265705|8548803|P5|Treatment Period Week 0-24|Adverse Event|0
2475873|NCT02265705|8548804|P4|Treatment Period Week 0-24|Adverse Event|0
2475874|NCT02265705|8548805|P3|Treatment Period Week 0-24|Adverse Event|0
2475875|NCT02265705|8548806|P2|Treatment Period Week 0-24|Adverse Event|2
2475876|NCT02265705|8548807|P1|Treatment Period Week 0-24|Adverse Event|3
2475877|NCT02265510|8548846|P14|Overall Study|Study Terminated by Sponsor|2
2475878|NCT02265510|8548847|P13|Overall Study|Study Terminated by Sponsor|1
2475879|NCT02265510|8548848|P12|Overall Study|Study Terminated by Sponsor|4
2475880|NCT02265510|8548849|P11|Overall Study|Study Terminated by Sponsor|1
2475881|NCT02265510|8548850|P10|Overall Study|Study Terminated by Sponsor|2
2475882|NCT02265510|8548851|P9|Overall Study|Study Terminated by Sponsor|1
2475883|NCT02265510|8548852|P8|Overall Study|Study Terminated by Sponsor|1
2475884|NCT02265510|8548853|P7|Overall Study|Study Terminated by Sponsor|1
2475885|NCT02265510|8548854|P6|Overall Study|Study Terminated by Sponsor|1
2475886|NCT02265510|8548855|P5|Overall Study|Study Terminated by Sponsor|0
2475887|NCT02265510|8548856|P4|Overall Study|Study Terminated by Sponsor|0
2475888|NCT02265510|8548857|P3|Overall Study|Study Terminated by Sponsor|0
2475889|NCT02265510|8548858|P2|Overall Study|Study Terminated by Sponsor|0
2475890|NCT02265510|8548859|P1|Overall Study|Study Terminated by Sponsor|0
2475891|NCT02265510|8548846|P14|Overall Study|Other|0
2475892|NCT02265510|8548847|P13|Overall Study|Other|0
2475893|NCT02265510|8548848|P12|Overall Study|Other|0
2475894|NCT02265510|8548849|P11|Overall Study|Other|0
2475895|NCT02265510|8548850|P10|Overall Study|Other|0
2475896|NCT02265510|8548851|P9|Overall Study|Other|0
2475897|NCT02265510|8548852|P8|Overall Study|Other|0
2475898|NCT02265510|8548853|P7|Overall Study|Other|0
2475899|NCT02265510|8548854|P6|Overall Study|Other|0
2475900|NCT02265510|8548855|P5|Overall Study|Other|0
2475901|NCT02265510|8548856|P4|Overall Study|Other|0
2475902|NCT02265510|8548857|P3|Overall Study|Other|0
2475903|NCT02265510|8548858|P2|Overall Study|Other|1
2475904|NCT02265510|8548859|P1|Overall Study|Other|0
2475905|NCT02265510|8548846|P14|Overall Study|Lost to Follow-up|2
2475906|NCT02265510|8548847|P13|Overall Study|Lost to Follow-up|0
2475907|NCT02265510|8548848|P12|Overall Study|Lost to Follow-up|0
2475908|NCT02265510|8548849|P11|Overall Study|Lost to Follow-up|0
2475909|NCT02265510|8548850|P10|Overall Study|Lost to Follow-up|2
2475910|NCT02265510|8548851|P9|Overall Study|Lost to Follow-up|0
2475911|NCT02265510|8548852|P8|Overall Study|Lost to Follow-up|0
2475912|NCT02265510|8548853|P7|Overall Study|Lost to Follow-up|0
2475913|NCT02265510|8548854|P6|Overall Study|Lost to Follow-up|0
2475914|NCT02265510|8548855|P5|Overall Study|Lost to Follow-up|1
2475915|NCT02265510|8548856|P4|Overall Study|Lost to Follow-up|0
2475916|NCT02265510|8548857|P3|Overall Study|Lost to Follow-up|0
2475917|NCT02265510|8548858|P2|Overall Study|Lost to Follow-up|0
2475918|NCT02265510|8548859|P1|Overall Study|Lost to Follow-up|0
2475919|NCT02265510|8548846|P14|Overall Study|Death|6
2475920|NCT02265510|8548847|P13|Overall Study|Death|7
2475921|NCT02265510|8548848|P12|Overall Study|Death|12
2475922|NCT02265510|8548849|P11|Overall Study|Death|4
2475923|NCT02265510|8548850|P10|Overall Study|Death|3
2475924|NCT02265510|8548851|P9|Overall Study|Death|3
2475925|NCT02265510|8548852|P8|Overall Study|Death|1
2475926|NCT02265510|8548853|P7|Overall Study|Death|2
2475927|NCT02265510|8548854|P6|Overall Study|Death|3
2475928|NCT02265510|8548855|P5|Overall Study|Death|1
2475929|NCT02265510|8548856|P4|Overall Study|Death|2
2475930|NCT02265510|8548857|P3|Overall Study|Death|2
2475931|NCT02265510|8548858|P2|Overall Study|Death|0
2475932|NCT02265510|8548859|P1|Overall Study|Death|2
2475933|NCT02265510|8548846|P14|Overall Study|Disease Progression|0
2475934|NCT02265510|8548847|P13|Overall Study|Disease Progression|0
2475935|NCT02265510|8548848|P12|Overall Study|Disease Progression|0
2475936|NCT02265510|8548849|P11|Overall Study|Disease Progression|0
2475937|NCT02265510|8548850|P10|Overall Study|Disease Progression|0
2475938|NCT02265510|8548851|P9|Overall Study|Disease Progression|0
2475939|NCT02265510|8548852|P8|Overall Study|Disease Progression|0
2475940|NCT02265510|8548853|P7|Overall Study|Disease Progression|0
2475941|NCT02265510|8548854|P6|Overall Study|Disease Progression|0
2475942|NCT02265510|8548855|P5|Overall Study|Disease Progression|1
2475943|NCT02265510|8548856|P4|Overall Study|Disease Progression|1
2475944|NCT02265510|8548857|P3|Overall Study|Disease Progression|2
2475945|NCT02265510|8548858|P2|Overall Study|Disease Progression|1
2475946|NCT02265510|8548859|P1|Overall Study|Disease Progression|0
2475947|NCT02265510|8548846|P14|Overall Study|Withdrawal by Subject|0
2475948|NCT02265510|8548847|P13|Overall Study|Withdrawal by Subject|1
2475949|NCT02265510|8548848|P12|Overall Study|Withdrawal by Subject|0
2475950|NCT02265510|8548849|P11|Overall Study|Withdrawal by Subject|0
2475951|NCT02265510|8548850|P10|Overall Study|Withdrawal by Subject|0
2475952|NCT02265510|8548851|P9|Overall Study|Withdrawal by Subject|0
2475953|NCT02265510|8548852|P8|Overall Study|Withdrawal by Subject|2
2475954|NCT02265510|8548853|P7|Overall Study|Withdrawal by Subject|0
2475955|NCT02265510|8548854|P6|Overall Study|Withdrawal by Subject|2
2475956|NCT02265510|8548855|P5|Overall Study|Withdrawal by Subject|0
2475957|NCT02265510|8548856|P4|Overall Study|Withdrawal by Subject|1
2475958|NCT02265510|8548857|P3|Overall Study|Withdrawal by Subject|2
2475959|NCT02265510|8548858|P2|Overall Study|Withdrawal by Subject|1
2475960|NCT02265510|8548859|P1|Overall Study|Withdrawal by Subject|1
2475961|NCT02265237|8548959|P4|As Treated (Overall Study)|Other|1
2475962|NCT02265237|8548960|P3|As Treated (Overall Study)|Other|3
2475963|NCT02265237|8548961|P2|As Treated (Overall Study)|Other|0
2475964|NCT02265237|8548962|P1|As Treated (Overall Study)|Other|2
2475965|NCT02265237|8548959|P4|As Treated (Overall Study)|Lost to Follow-up|0
2475966|NCT02265237|8548960|P3|As Treated (Overall Study)|Lost to Follow-up|6
2475967|NCT02265237|8548961|P2|As Treated (Overall Study)|Lost to Follow-up|2
2475968|NCT02265237|8548962|P1|As Treated (Overall Study)|Lost to Follow-up|1
2475969|NCT02265237|8548959|P4|As Treated (Overall Study)|Withdrawal by Subject|0
2476057|NCT02261493|8549448|P2|Overall Study|Lost to Follow-up|27
2475970|NCT02265237|8548960|P3|As Treated (Overall Study)|Withdrawal by Subject|1
2475971|NCT02265237|8548961|P2|As Treated (Overall Study)|Withdrawal by Subject|0
2475972|NCT02265237|8548962|P1|As Treated (Overall Study)|Withdrawal by Subject|1
2475973|NCT02265237|8548959|P4|As Treated (Overall Study)|Adverse Event|0
2475974|NCT02265237|8548960|P3|As Treated (Overall Study)|Adverse Event|0
2475975|NCT02265237|8548961|P2|As Treated (Overall Study)|Adverse Event|1
2475976|NCT02265237|8548962|P1|As Treated (Overall Study)|Adverse Event|1
2475977|NCT02264821|8548992|P3|Overall Study|Protocol Violation|6
2475978|NCT02264821|8548993|P2|Overall Study|Protocol Violation|3
2475979|NCT02264821|8548994|P1|Overall Study|Protocol Violation|1
2475980|NCT02264574|8549007|P2|Overall Study|various other reasons|3
2475981|NCT02264574|8549008|P1|Overall Study|various other reasons|0
2475982|NCT02264574|8549007|P2|Overall Study|Withdrawal by Subject|5
2475983|NCT02264574|8549008|P1|Overall Study|Withdrawal by Subject|6
2475984|NCT02263547|8549078|P1|Overall Study|Lost to Follow-up|2
2475985|NCT02263547|8549078|P1|Overall Study|Adverse Event|1
2475986|NCT02263365|8549085|P2|Overall Study|Physician Decision|18
2475987|NCT02263365|8549086|P1|Overall Study|Physician Decision|22
2475988|NCT02263326|8549100|P2|Overall Study|Lost to Follow-up|1
2475989|NCT02263326|8549101|P1|Overall Study|Lost to Follow-up|1
2475990|NCT02262754|8549195|P3|Overall Study|Other|2
2475991|NCT02262754|8549196|P2|Overall Study|Other|0
2475992|NCT02262754|8549197|P1|Overall Study|Other|4
2475993|NCT02262754|8549195|P3|Overall Study|Withdrawal by Subject|1
2475994|NCT02262754|8549196|P2|Overall Study|Withdrawal by Subject|0
2475995|NCT02262754|8549197|P1|Overall Study|Withdrawal by Subject|1
2475996|NCT02262754|8549195|P3|Overall Study|Protocol Violation|0
2475997|NCT02262754|8549196|P2|Overall Study|Protocol Violation|0
2475998|NCT02262754|8549197|P1|Overall Study|Protocol Violation|1
2475999|NCT02262754|8549195|P3|Overall Study|Study terminated by sponsor|4
2476000|NCT02262754|8549196|P2|Overall Study|Study terminated by sponsor|4
2476001|NCT02262754|8549197|P1|Overall Study|Study terminated by sponsor|5
2476002|NCT02262754|8549195|P3|Overall Study|No longer meets eligibility criteria|0
2476003|NCT02262754|8549196|P2|Overall Study|No longer meets eligibility criteria|1
2476004|NCT02262754|8549197|P1|Overall Study|No longer meets eligibility criteria|0
2476005|NCT02262754|8549195|P3|Overall Study|Lost to Follow-up|1
2476006|NCT02262754|8549196|P2|Overall Study|Lost to Follow-up|0
2476007|NCT02262754|8549197|P1|Overall Study|Lost to Follow-up|0
2476008|NCT02262754|8549195|P3|Overall Study|Lack of Efficacy|1
2476009|NCT02262754|8549196|P2|Overall Study|Lack of Efficacy|0
2476010|NCT02262754|8549197|P1|Overall Study|Lack of Efficacy|2
2476011|NCT02262754|8549195|P3|Overall Study|Adverse Event|0
2476012|NCT02262754|8549196|P2|Overall Study|Adverse Event|4
2476013|NCT02262754|8549197|P1|Overall Study|Adverse Event|3
2476014|NCT02262728|8549272|P2|Follow-up Phase (3 Years)|Withdrawal by Subject|1
2476015|NCT02262728|8549273|P1|Follow-up Phase (3 Years)|Withdrawal by Subject|0
2476016|NCT02262728|8549272|P2|Follow-up Phase (3 Years)|Lost to Follow-up|1
2476017|NCT02262728|8549273|P1|Follow-up Phase (3 Years)|Lost to Follow-up|4
2476018|NCT02262728|8549272|P2|Follow-up Phase (3 Years)|Death|1
2476019|NCT02262728|8549273|P1|Follow-up Phase (3 Years)|Death|0
2476020|NCT02262377|8549305|P2|Overall Study|Withdrawal by Subject|0
2476021|NCT02262377|8549306|P1|Overall Study|Withdrawal by Subject|4
2476022|NCT02262377|8549305|P2|Overall Study|Found ineligible after enrollment|0
2476023|NCT02262377|8549306|P1|Overall Study|Found ineligible after enrollment|3
2476024|NCT02262377|8549305|P2|Overall Study|Lost to Follow-up|6
2476025|NCT02262377|8549306|P1|Overall Study|Lost to Follow-up|5
2476026|NCT02262364|8549321|P1|Blood Draw for Device Processing|Insufficient blood could be drawn|1
2476027|NCT02262260|8549330|P2|Overall Study|Protocol deviation|5
2476028|NCT02262260|8549331|P1|Overall Study|Protocol deviation|2
2476029|NCT02262260|8549330|P2|Overall Study|Lost to Follow-up|2
2476030|NCT02262260|8549331|P1|Overall Study|Lost to Follow-up|1
2476031|NCT02262260|8549330|P2|Overall Study|Withdrawal of consent|2
2476032|NCT02262260|8549331|P1|Overall Study|Withdrawal of consent|4
2476033|NCT02262260|8549330|P2|Overall Study|Adverse Event|1
2476034|NCT02262260|8549331|P1|Overall Study|Adverse Event|4
2476035|NCT02261974|8549389|P2|Overall Study|Adverse Event|0
2476036|NCT02261974|8549390|P1|Overall Study|Adverse Event|1
2476037|NCT02261974|8549389|P2|Overall Study|Lost to Follow-up|0
2476038|NCT02261974|8549390|P1|Overall Study|Lost to Follow-up|2
2476039|NCT02261974|8549389|P2|Overall Study|Received partial treatment; FU to 1 mo|1
2476040|NCT02261974|8549390|P1|Overall Study|Received partial treatment; FU to 1 mo|3
2476041|NCT02261974|8549389|P2|Overall Study|Missed treatment cut-off date|3
2476042|NCT02261974|8549390|P1|Overall Study|Missed treatment cut-off date|6
2476043|NCT02261974|8549389|P2|Overall Study|Pregnancy|1
2476044|NCT02261974|8549390|P1|Overall Study|Pregnancy|0
2476045|NCT02261974|8549389|P2|Overall Study|Withdrawal by Subject|2
2476046|NCT02261974|8549390|P1|Overall Study|Withdrawal by Subject|3
2476047|NCT02261493|8549447|P3|Overall Study|Adverse Event|0
2476048|NCT02261493|8549448|P2|Overall Study|Adverse Event|1
2476049|NCT02261493|8549449|P1|Overall Study|Adverse Event|0
2476050|NCT02261493|8549447|P3|Overall Study|Lack of Efficacy|0
2476051|NCT02261493|8549448|P2|Overall Study|Lack of Efficacy|1
2476052|NCT02261493|8549449|P1|Overall Study|Lack of Efficacy|0
2476053|NCT02261493|8549447|P3|Overall Study|Pregnancy|0
2476054|NCT02261493|8549448|P2|Overall Study|Pregnancy|2
2476055|NCT02261493|8549449|P1|Overall Study|Pregnancy|1
2476056|NCT02261493|8549447|P3|Overall Study|Lost to Follow-up|8
2476058|NCT02261493|8549449|P1|Overall Study|Lost to Follow-up|14
2476059|NCT02261493|8549447|P3|Overall Study|Personal Reasons|16
2476060|NCT02261493|8549448|P2|Overall Study|Personal Reasons|14
2476061|NCT02261493|8549449|P1|Overall Study|Personal Reasons|14
2476062|NCT02261493|8549447|P3|Overall Study|Protocol Violation|0
2476063|NCT02261493|8549448|P2|Overall Study|Protocol Violation|0
2476064|NCT02261493|8549449|P1|Overall Study|Protocol Violation|1
2476065|NCT02261493|8549447|P3|Overall Study|Undisclosed alcohol abuse|0
2476066|NCT02261493|8549448|P2|Overall Study|Undisclosed alcohol abuse|1
2476067|NCT02261493|8549449|P1|Overall Study|Undisclosed alcohol abuse|0
2476068|NCT02261493|8549447|P3|Overall Study|Physician Decision|0
2476069|NCT02261493|8549448|P2|Overall Study|Physician Decision|1
2476070|NCT02261493|8549449|P1|Overall Study|Physician Decision|0
2476071|NCT02261493|8549447|P3|Overall Study|Noncompliance|2
2476072|NCT02261493|8549448|P2|Overall Study|Noncompliance|0
2476073|NCT02261493|8549449|P1|Overall Study|Noncompliance|0
2476074|NCT02261467|8549477|P2|Overall Study|Adverse Event|1
2476075|NCT02261467|8549478|P1|Overall Study|Adverse Event|1
2476076|NCT02261467|8549477|P2|Overall Study|Lost to Follow-up|13
2476077|NCT02261467|8549478|P1|Overall Study|Lost to Follow-up|2
2476078|NCT02261467|8549477|P2|Overall Study|Personal Reasons|22
2476079|NCT02261467|8549478|P1|Overall Study|Personal Reasons|17
2476080|NCT02261467|8549477|P2|Overall Study|Protocol Violation|1
2476081|NCT02261467|8549478|P1|Overall Study|Protocol Violation|0
2476082|NCT02261467|8549477|P2|Overall Study|Enrolled in Error|0
2476083|NCT02261467|8549478|P1|Overall Study|Enrolled in Error|1
2476084|NCT02260986|8549520|P3|Overall Study|Pregnancy|0
2476085|NCT02260986|8549521|P2|Overall Study|Pregnancy|0
2476086|NCT02260986|8549522|P1|Overall Study|Pregnancy|2
2476087|NCT02260986|8549520|P3|Overall Study|Lost to Follow-up|3
2476088|NCT02260986|8549521|P2|Overall Study|Lost to Follow-up|0
2476089|NCT02260986|8549522|P1|Overall Study|Lost to Follow-up|4
2476090|NCT02260986|8549520|P3|Overall Study|Lack of investigation product supply|1
2476091|NCT02260986|8549521|P2|Overall Study|Lack of investigation product supply|0
2476092|NCT02260986|8549522|P1|Overall Study|Lack of investigation product supply|2
2476093|NCT02260986|8549520|P3|Overall Study|Incorrect randomization|0
2476094|NCT02260986|8549521|P2|Overall Study|Incorrect randomization|1
2476095|NCT02260986|8549522|P1|Overall Study|Incorrect randomization|0
2476096|NCT02260986|8549520|P3|Overall Study|Withdrawal by Subject|9
2476097|NCT02260986|8549521|P2|Overall Study|Withdrawal by Subject|4
2476098|NCT02260986|8549522|P1|Overall Study|Withdrawal by Subject|17
2476099|NCT02260986|8549520|P3|Overall Study|Car accident|1
2476100|NCT02260986|8549521|P2|Overall Study|Car accident|0
2476101|NCT02260986|8549522|P1|Overall Study|Car accident|0
2476102|NCT02260986|8549520|P3|Overall Study|Protocol Violation|16
2476103|NCT02260986|8549521|P2|Overall Study|Protocol Violation|5
2476104|NCT02260986|8549522|P1|Overall Study|Protocol Violation|14
2476105|NCT02260986|8549520|P3|Overall Study|Lack of Efficacy|0
2476106|NCT02260986|8549521|P2|Overall Study|Lack of Efficacy|3
2476107|NCT02260986|8549522|P1|Overall Study|Lack of Efficacy|27
2476108|NCT02260986|8549520|P3|Overall Study|Adverse Event|11
2476109|NCT02260986|8549521|P2|Overall Study|Adverse Event|0
2476110|NCT02260986|8549522|P1|Overall Study|Adverse Event|24
2476111|NCT02260934|8549640|P2|Overall Study|Site error|1
2476112|NCT02260934|8549641|P1|Overall Study|Site error|0
2476113|NCT02260934|8549640|P2|Overall Study|Participant Relocated|0
2476114|NCT02260934|8549641|P1|Overall Study|Participant Relocated|1
2476115|NCT02260934|8549640|P2|Overall Study|Withdrawal by Subject|2
2476116|NCT02260934|8549641|P1|Overall Study|Withdrawal by Subject|0
2476117|NCT02260934|8549640|P2|Overall Study|Lost to Follow-up|1
2476118|NCT02260934|8549641|P1|Overall Study|Lost to Follow-up|2
2476119|NCT02260882|8549679|P2|Overall Study|Protocol Violation|1
2476120|NCT02260882|8549680|P1|Overall Study|Protocol Violation|0
2476121|NCT02260817|8549704|P2|Overall Study|Protocol Violation|14
2476122|NCT02260817|8549705|P1|Overall Study|Protocol Violation|0
2476123|NCT02260817|8549704|P2|Overall Study|Biopsy infeasible, ADT & rad. therapy|1
2476124|NCT02260817|8549705|P1|Overall Study|Biopsy infeasible, ADT & rad. therapy|0
2476125|NCT02260817|8549704|P2|Overall Study|Observation, no biopsy|1
2476126|NCT02260817|8549705|P1|Overall Study|Observation, no biopsy|0
2476127|NCT02260817|8549704|P2|Overall Study|Androgen deprivation therapy, no biopsy|7
2476128|NCT02260817|8549705|P1|Overall Study|Androgen deprivation therapy, no biopsy|0
2476129|NCT02260817|8549704|P2|Overall Study|Lost to Follow-up|14
2476130|NCT02260817|8549705|P1|Overall Study|Lost to Follow-up|0
2476131|NCT02260791|8549753|P2|Overall Study|Protocol deviation|3
2476132|NCT02260791|8549754|P1|Overall Study|Protocol deviation|2
2476133|NCT02260791|8549753|P2|Overall Study|Screen failure|1
2476134|NCT02260791|8549754|P1|Overall Study|Screen failure|0
2476135|NCT02260791|8549753|P2|Overall Study|Withdrawal by Subject|16
2476136|NCT02260791|8549754|P1|Overall Study|Withdrawal by Subject|11
2476137|NCT02260791|8549753|P2|Overall Study|Death|0
2476138|NCT02260791|8549754|P1|Overall Study|Death|1
2476139|NCT02260791|8549753|P2|Overall Study|Adverse Event|9
2476140|NCT02260791|8549754|P1|Overall Study|Adverse Event|13
2476141|NCT02260791|8549753|P2|Overall Study|Lack of Efficacy|1
2476142|NCT02260791|8549754|P1|Overall Study|Lack of Efficacy|2
2476143|NCT02260791|8549753|P2|Overall Study|Lost to Follow-up|4
2476144|NCT02260791|8549754|P1|Overall Study|Lost to Follow-up|4
2476145|NCT02260648|8549793|P3|Overall Study|Discontinue Due to Study Termination|7
2476146|NCT02260648|8549794|P2|Overall Study|Discontinue Due to Study Termination|12
2476147|NCT02260648|8549795|P1|Overall Study|Discontinue Due to Study Termination|13
2476148|NCT02260648|8549793|P3|Overall Study|Protocol Violation|0
2476149|NCT02260648|8549794|P2|Overall Study|Protocol Violation|0
2476150|NCT02260648|8549795|P1|Overall Study|Protocol Violation|1
2476151|NCT02260648|8549793|P3|Overall Study|Withdrawal by Subject|0
2476152|NCT02260648|8549794|P2|Overall Study|Withdrawal by Subject|1
2476153|NCT02260648|8549795|P1|Overall Study|Withdrawal by Subject|1
2476154|NCT02260648|8549793|P3|Overall Study|Adverse Event|1
2476155|NCT02260648|8549794|P2|Overall Study|Adverse Event|0
2476156|NCT02260648|8549795|P1|Overall Study|Adverse Event|3
2476157|NCT02260635|8549823|P2|Open-Label Extension|Withdrawal by Subject|0
2476158|NCT02260635|8549824|P1|Open-Label Extension|Withdrawal by Subject|1
2476159|NCT02260635|8549823|P2|Open-Label Extension|Study Termination|25
2476160|NCT02260635|8549824|P1|Open-Label Extension|Study Termination|25
2476161|NCT02260635|8549823|P2|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2
2476162|NCT02260635|8549824|P1|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1
2476163|NCT02260492|8549876|P3|Overall Study|Withdrawal by Subject|2
2476164|NCT02260492|8549877|P2|Overall Study|Withdrawal by Subject|2
2476165|NCT02260492|8549878|P1|Overall Study|Withdrawal by Subject|3
2476166|NCT02260492|8549876|P3|Overall Study|Physician Decision|1
2476167|NCT02260492|8549877|P2|Overall Study|Physician Decision|0
2476168|NCT02260492|8549878|P1|Overall Study|Physician Decision|2
2476169|NCT02260492|8549876|P3|Overall Study|Lost to Follow-up|0
2476170|NCT02260492|8549877|P2|Overall Study|Lost to Follow-up|9
2476171|NCT02260492|8549878|P1|Overall Study|Lost to Follow-up|12
2476172|NCT02260492|8549876|P3|Overall Study|Death|0
2476173|NCT02260492|8549877|P2|Overall Study|Death|1
2476174|NCT02260492|8549878|P1|Overall Study|Death|0
2476175|NCT02260492|8549876|P3|Overall Study|Adverse Event|2
2476176|NCT02260492|8549877|P2|Overall Study|Adverse Event|1
2476177|NCT02260492|8549878|P1|Overall Study|Adverse Event|6
2476178|NCT02260388|8549911|P4|Overall Study|Lost to Follow-up|4
2476179|NCT02260388|8549912|P3|Overall Study|Lost to Follow-up|3
2476180|NCT02260388|8549913|P2|Overall Study|Lost to Follow-up|8
2476181|NCT02260388|8549914|P1|Overall Study|Lost to Follow-up|2
2476182|NCT02260180|8549943|P3|Overall Study|Adverse Event|1
2476183|NCT02260180|8549944|P2|Overall Study|Adverse Event|0
2476184|NCT02260180|8549945|P1|Overall Study|Adverse Event|2
2476185|NCT02260154|8549956|P1|Overall Study|Screening failure|2
2476186|NCT02259582|8549996|P3|Overall Study|Lack of Subject Adherence to Protocol|1
2476187|NCT02259582|8549997|P2|Overall Study|Lack of Subject Adherence to Protocol|1
2476188|NCT02259582|8549998|P1|Overall Study|Lack of Subject Adherence to Protocol|1
2476189|NCT02259582|8549996|P3|Overall Study|Disease progression|17
2476190|NCT02259582|8549997|P2|Overall Study|Disease progression|15
2476191|NCT02259582|8549998|P1|Overall Study|Disease progression|14
2476192|NCT02259582|8549996|P3|Overall Study|Withdrawal by Subject|1
2476193|NCT02259582|8549997|P2|Overall Study|Withdrawal by Subject|0
2476194|NCT02259582|8549998|P1|Overall Study|Withdrawal by Subject|0
2476195|NCT02259582|8549996|P3|Overall Study|Adverse Event|1
2476196|NCT02259582|8549997|P2|Overall Study|Adverse Event|0
2476197|NCT02259582|8549998|P1|Overall Study|Adverse Event|1
2476198|NCT02259582|8549996|P3|Overall Study|Death|1
2476199|NCT02259582|8549997|P2|Overall Study|Death|0
2476200|NCT02259582|8549998|P1|Overall Study|Death|0
2476201|NCT02259582|8549996|P3|Overall Study|Physician Decision|0
2476202|NCT02259582|8549997|P2|Overall Study|Physician Decision|1
2476203|NCT02259582|8549998|P1|Overall Study|Physician Decision|0
2476204|NCT02259400|8550008|P2|Overall Study|Death|2
2476205|NCT02259400|8550009|P1|Overall Study|Death|0
2476206|NCT02259348|8550041|P1|Overall Study|Death|4
2476207|NCT02259348|8550041|P1|Overall Study|Donors|6
2476208|NCT02259114|8550058|P5|Overall Study|Not Treated|0
2476209|NCT02259114|8550059|P4|Overall Study|Not Treated|0
2476210|NCT02259114|8550060|P3|Overall Study|Not Treated|0
2476211|NCT02259114|8550061|P2|Overall Study|Not Treated|0
2476212|NCT02259114|8550062|P1|Overall Study|Not Treated|1
2476213|NCT02259114|8550058|P5|Overall Study|Treatment Delay >2 wks: Toxicity|0
2476214|NCT02259114|8550059|P4|Overall Study|Treatment Delay >2 wks: Toxicity|0
2476215|NCT02259114|8550060|P3|Overall Study|Treatment Delay >2 wks: Toxicity|0
2476216|NCT02259114|8550061|P2|Overall Study|Treatment Delay >2 wks: Toxicity|1
2476217|NCT02259114|8550062|P1|Overall Study|Treatment Delay >2 wks: Toxicity|1
2476218|NCT02259114|8550058|P5|Overall Study|Withdrawal by Subject|0
2476219|NCT02259114|8550059|P4|Overall Study|Withdrawal by Subject|1
2476220|NCT02259114|8550060|P3|Overall Study|Withdrawal by Subject|1
2476221|NCT02259114|8550061|P2|Overall Study|Withdrawal by Subject|0
2476222|NCT02259114|8550062|P1|Overall Study|Withdrawal by Subject|0
2476223|NCT02259114|8550058|P5|Overall Study|Treatment Delay >2 wks: Adverse Event|0
2476224|NCT02259114|8550059|P4|Overall Study|Treatment Delay >2 wks: Adverse Event|0
2476225|NCT02259114|8550060|P3|Overall Study|Treatment Delay >2 wks: Adverse Event|1
2476226|NCT02259114|8550061|P2|Overall Study|Treatment Delay >2 wks: Adverse Event|0
2476227|NCT02259114|8550062|P1|Overall Study|Treatment Delay >2 wks: Adverse Event|0
2476228|NCT02259114|8550058|P5|Overall Study|Death|0
2476229|NCT02259114|8550059|P4|Overall Study|Death|0
2476230|NCT02259114|8550060|P3|Overall Study|Death|1
2476231|NCT02259114|8550061|P2|Overall Study|Death|0
2476232|NCT02259114|8550062|P1|Overall Study|Death|3
2476233|NCT02259114|8550058|P5|Overall Study|Adverse Event|1
2476234|NCT02259114|8550059|P4|Overall Study|Adverse Event|0
2476235|NCT02259114|8550060|P3|Overall Study|Adverse Event|0
2476236|NCT02259114|8550061|P2|Overall Study|Adverse Event|1
2476237|NCT02259114|8550062|P1|Overall Study|Adverse Event|2
2476238|NCT02259114|8550058|P5|Overall Study|Progressive Disease|5
2476239|NCT02259114|8550059|P4|Overall Study|Progressive Disease|2
2476240|NCT02259114|8550060|P3|Overall Study|Progressive Disease|10
2476241|NCT02259114|8550061|P2|Overall Study|Progressive Disease|2
2476242|NCT02259114|8550062|P1|Overall Study|Progressive Disease|14
2476243|NCT02259088|8550121|P2|Overall Study|Subject/guardian decision|8
2476244|NCT02259088|8550122|P1|Overall Study|Subject/guardian decision|8
2476245|NCT02259088|8550121|P2|Overall Study|Protocol deviation|0
2476246|NCT02259088|8550122|P1|Overall Study|Protocol deviation|5
2476247|NCT02259088|8550121|P2|Overall Study|Physician Decision|2
2476248|NCT02259088|8550122|P1|Overall Study|Physician Decision|5
2476249|NCT02259088|8550121|P2|Overall Study|Death|0
2476250|NCT02259088|8550122|P1|Overall Study|Death|2
2476251|NCT02259088|8550121|P2|Overall Study|Lost to Follow-up|0
2476252|NCT02259088|8550122|P1|Overall Study|Lost to Follow-up|2
2476253|NCT02259088|8550121|P2|Overall Study|Adverse Event|4
2476254|NCT02259088|8550122|P1|Overall Study|Adverse Event|6
2476255|NCT02259010|8550167|P1|Overall Study|Didn't Completed Dosing; PK Assessment|5
2476256|NCT02258542|8550196|P4|Overall Study|Eligibility criteria not fulfilled|0
2476257|NCT02258542|8550197|P3|Overall Study|Eligibility criteria not fulfilled|0
2476258|NCT02258542|8550198|P2|Overall Study|Eligibility criteria not fulfilled|2
2476259|NCT02258542|8550199|P1|Overall Study|Eligibility criteria not fulfilled|0
2476260|NCT02258542|8550196|P4|Overall Study|Protocol Violation|0
2476261|NCT02258542|8550197|P3|Overall Study|Protocol Violation|0
2476262|NCT02258542|8550198|P2|Overall Study|Protocol Violation|2
2476263|NCT02258542|8550199|P1|Overall Study|Protocol Violation|1
2476264|NCT02258542|8550196|P4|Overall Study|Adverse Event|0
2476265|NCT02258542|8550197|P3|Overall Study|Adverse Event|0
2476266|NCT02258542|8550198|P2|Overall Study|Adverse Event|4
2476267|NCT02258542|8550199|P1|Overall Study|Adverse Event|3
2476268|NCT02258542|8550196|P4|Overall Study|Death|1
2476269|NCT02258542|8550197|P3|Overall Study|Death|0
2476270|NCT02258542|8550198|P2|Overall Study|Death|4
2476271|NCT02258542|8550199|P1|Overall Study|Death|5
2476272|NCT02258542|8550196|P4|Overall Study|Lost to Follow-up|2
2476273|NCT02258542|8550197|P3|Overall Study|Lost to Follow-up|1
2476274|NCT02258542|8550198|P2|Overall Study|Lost to Follow-up|12
2476275|NCT02258542|8550199|P1|Overall Study|Lost to Follow-up|5
2476276|NCT02258542|8550196|P4|Overall Study|Withdrawal by Subject|1
2476277|NCT02258542|8550197|P3|Overall Study|Withdrawal by Subject|7
2476278|NCT02258542|8550198|P2|Overall Study|Withdrawal by Subject|20
2476279|NCT02258542|8550199|P1|Overall Study|Withdrawal by Subject|20
2476280|NCT02258542|8550196|P4|Overall Study|study specific discount. criteria|0
2476281|NCT02258542|8550197|P3|Overall Study|study specific discount. criteria|0
2476282|NCT02258542|8550198|P2|Overall Study|study specific discount. criteria|1
2476283|NCT02258542|8550199|P1|Overall Study|study specific discount. criteria|1
2476284|NCT02258542|8550196|P4|Overall Study|eg. not made to the visit|1
2476285|NCT02258542|8550197|P3|Overall Study|eg. not made to the visit|0
2476286|NCT02258542|8550198|P2|Overall Study|eg. not made to the visit|4
2476287|NCT02258542|8550199|P1|Overall Study|eg. not made to the visit|7
2476288|NCT02258529|8550423|P1|Overall Study|Adverse Event|1
2476289|NCT02258529|8550423|P1|Overall Study|Study Terminated by Sponsor|9
2476290|NCT02258334|8550512|P4|Overall Study|Adverse Event|0
2476291|NCT02258334|8550513|P3|Overall Study|Adverse Event|0
2476292|NCT02258334|8550514|P2|Overall Study|Adverse Event|0
2476293|NCT02258334|8550515|P1|Overall Study|Adverse Event|1
2476294|NCT02257918|8550589|P3|Overall Study|Pregnancy|1
2476295|NCT02257918|8550590|P2|Overall Study|Pregnancy|0
2476296|NCT02257918|8550591|P1|Overall Study|Pregnancy|0
2476297|NCT02257918|8550589|P3|Overall Study|Withdrawal by Subject|1
2476298|NCT02257918|8550590|P2|Overall Study|Withdrawal by Subject|0
2476299|NCT02257918|8550591|P1|Overall Study|Withdrawal by Subject|0
2476300|NCT02257918|8550589|P3|Overall Study|Lost to Follow-up|0
2476301|NCT02257918|8550590|P2|Overall Study|Lost to Follow-up|1
2476302|NCT02257918|8550591|P1|Overall Study|Lost to Follow-up|4
2476303|NCT02257684|8550641|P1|Overall Study|Sponsor's Decision|1
2476304|NCT02257684|8550641|P1|Overall Study|Lack of Efficacy|1
2476305|NCT02257684|8550641|P1|Overall Study|Adverse Event|2
2476306|NCT02257632|8550651|P2|Overall Study|Adverse Event|2
2476307|NCT02257632|8550652|P1|Overall Study|Adverse Event|1
2476308|NCT02257632|8550651|P2|Overall Study|Withdrawal by Subject|1
2476309|NCT02257632|8550652|P1|Overall Study|Withdrawal by Subject|0
2476310|NCT02257489|8550701|P9|Overall Study|Withdrawal by Subject|0
2476311|NCT02257489|8550702|P8|Overall Study|Withdrawal by Subject|0
2476312|NCT02257489|8550703|P7|Overall Study|Withdrawal by Subject|0
2476313|NCT02257489|8550704|P6|Overall Study|Withdrawal by Subject|0
2476314|NCT02257489|8550705|P5|Overall Study|Withdrawal by Subject|0
2476315|NCT02257489|8550706|P4|Overall Study|Withdrawal by Subject|1
2476316|NCT02257489|8550707|P3|Overall Study|Withdrawal by Subject|0
2476317|NCT02257489|8550708|P2|Overall Study|Withdrawal by Subject|0
2476318|NCT02257489|8550709|P1|Overall Study|Withdrawal by Subject|0
2476319|NCT02257385|8550745|P2|Overall Study|Withdrawal by Subject|4
2476320|NCT02257385|8550746|P1|Overall Study|Withdrawal by Subject|4
2476321|NCT02257385|8550745|P2|Overall Study|Lost to Follow-up|1
2476322|NCT02257385|8550746|P1|Overall Study|Lost to Follow-up|0
2476323|NCT02257385|8550745|P2|Overall Study|Protocol Violation|7
2476324|NCT02257385|8550746|P1|Overall Study|Protocol Violation|5
2476325|NCT02257385|8550745|P2|Overall Study|Lack of Efficacy|2
2476326|NCT02257385|8550746|P1|Overall Study|Lack of Efficacy|1
2476327|NCT02257385|8550745|P2|Overall Study|Adverse Event|8
2476328|NCT02257385|8550746|P1|Overall Study|Adverse Event|12
2476329|NCT02257372|8550756|P2|Overall Study|Withdrew consent|0
2476330|NCT02257372|8550757|P1|Overall Study|Withdrew consent|1
2476331|NCT02257372|8550756|P2|Overall Study|Lost to Follow-up|1
2476332|NCT02257372|8550757|P1|Overall Study|Lost to Follow-up|0
2476333|NCT02257372|8550756|P2|Overall Study|Protocol Violation|1
2476334|NCT02257372|8550757|P1|Overall Study|Protocol Violation|1
2476335|NCT02257372|8550756|P2|Overall Study|Lack of Efficacy|1
2476336|NCT02257372|8550757|P1|Overall Study|Lack of Efficacy|2
2476337|NCT02257372|8550756|P2|Overall Study|Adverse Event|7
2476338|NCT02257372|8550757|P1|Overall Study|Adverse Event|3
2476339|NCT02256982|8550774|P2|Overall Study|Disease Progression|1
2476340|NCT02256982|8550775|P1|Overall Study|Disease Progression|0
2476341|NCT02256969|8550784|P3|Overall Study|Screenfailed or withdrew|1
2476342|NCT02256969|8550785|P2|Overall Study|Screenfailed or withdrew|1
2476343|NCT02256969|8550786|P1|Overall Study|Screenfailed or withdrew|2
2476344|NCT02256917|8550803|P1|Prophylactic Treatment Phase II|Discontinued medication|1
2476345|NCT02256917|8550803|P1|Prophylactic Treatment Phase II|Did not attend completion visit|1
2476346|NCT02256917|8550803|P1|Prophylactic Treatment Phase II|Withdrawn Consent|1
2476347|NCT02256917|8550803|P1|Prophylactic Treatment Phase II|Lost to Follow-up|1
2476348|NCT02256917|8550803|P1|Prophylactic Treatment Phase I|Lost to Follow-up|1
2476349|NCT02256891|8550824|P2|Overall Study|Equipment Malfunction|1
2476350|NCT02256891|8550825|P1|Overall Study|Equipment Malfunction|0
2476351|NCT02256891|8550824|P2|Overall Study|Screen Fail|4
2476352|NCT02256891|8550825|P1|Overall Study|Screen Fail|5
2476353|NCT02256891|8550824|P2|Overall Study|Physician Decision|3
2476354|NCT02256891|8550825|P1|Overall Study|Physician Decision|7
2476355|NCT02256891|8550824|P2|Overall Study|Lost to Follow-up|3
2476356|NCT02256891|8550825|P1|Overall Study|Lost to Follow-up|0
2476357|NCT02256891|8550824|P2|Overall Study|Death|2
2476358|NCT02256891|8550825|P1|Overall Study|Death|0
2476359|NCT02256839|8550851|P2|Overall Study|Did not meet Eligibility Criteria|3
2476360|NCT02256839|8550852|P1|Overall Study|Did not meet Eligibility Criteria|2
2476361|NCT02256553|8550858|P1|Period III|Adverse Event|3
2476362|NCT02256553|8550858|P1|Period II|Subject Moved|1
2476363|NCT02256553|8550858|P1|Period II|Adverse Event|1
2476364|NCT02256553|8550858|P1|Period I|Protocol Violation|1
2476365|NCT02256553|8550858|P1|Period I|Adverse Event|5
2476366|NCT02256540|8550867|P3|Overall Study|Back pain preventing exercise|1
2476367|NCT02256540|8550868|P2|Overall Study|Back pain preventing exercise|0
2476368|NCT02256540|8550869|P1|Overall Study|Back pain preventing exercise|0
2476369|NCT02256540|8550867|P3|Overall Study|Withdrawal by Subject|1
2476370|NCT02256540|8550868|P2|Overall Study|Withdrawal by Subject|1
2476371|NCT02256540|8550869|P1|Overall Study|Withdrawal by Subject|0
2476372|NCT02256488|8550887|P4|Overall Study|Withdrawal by Subject|2
2476373|NCT02256488|8550888|P3|Overall Study|Withdrawal by Subject|0
2476374|NCT02256488|8550889|P2|Overall Study|Withdrawal by Subject|0
2476375|NCT02256488|8550890|P1|Overall Study|Withdrawal by Subject|1
2476376|NCT02256488|8550887|P4|Overall Study|OTHER|1
2476377|NCT02256488|8550888|P3|Overall Study|OTHER|1
2476378|NCT02256488|8550889|P2|Overall Study|OTHER|0
2476379|NCT02256488|8550890|P1|Overall Study|OTHER|1
2476380|NCT02256488|8550887|P4|Overall Study|Lost to Follow-up|3
2476381|NCT02256488|8550888|P3|Overall Study|Lost to Follow-up|9
2476382|NCT02256488|8550889|P2|Overall Study|Lost to Follow-up|6
2476383|NCT02256488|8550890|P1|Overall Study|Lost to Follow-up|6
2476384|NCT02256436|8550906|P2|Overall Study|Ongoing in Study|67
2476385|NCT02256436|8550907|P1|Overall Study|Ongoing in Study|108
2476386|NCT02256436|8550906|P2|Overall Study|Withdrawal by Subject|30
2476387|NCT02256436|8550907|P1|Overall Study|Withdrawal by Subject|7
2476388|NCT02256436|8550906|P2|Overall Study|Protocol Violation|0
2476389|NCT02256436|8550907|P1|Overall Study|Protocol Violation|1
2476390|NCT02256436|8550906|P2|Overall Study|Physician Decision|3
2476391|NCT02256436|8550907|P1|Overall Study|Physician Decision|1
2476392|NCT02256436|8550906|P2|Overall Study|Lost to Follow-up|1
2476393|NCT02256436|8550907|P1|Overall Study|Lost to Follow-up|1
2476394|NCT02256436|8550906|P2|Overall Study|Death|158
2476395|NCT02256436|8550907|P1|Overall Study|Death|137
2476396|NCT02256436|8550906|P2|Overall Study|Adverse Event|13
2476397|NCT02256436|8550907|P1|Overall Study|Adverse Event|15
2476398|NCT02256267|8550967|P1|Period 2 (Day 7 to Day 14)|Adverse Event|1
2476399|NCT02256267|8550967|P1|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1
2476400|NCT02255981|8551040|P1|Overall Study|Withdrawal by Subject|1
2476401|NCT02255981|8551040|P1|Overall Study|Lost to Follow-up|3
2476402|NCT02255760|8551055|P5|Overall Study|Lost to Follow-up|0
2476403|NCT02255760|8551056|P4|Overall Study|Lost to Follow-up|0
2476404|NCT02255760|8551057|P3|Overall Study|Lost to Follow-up|0
2476405|NCT02255760|8551058|P2|Overall Study|Lost to Follow-up|1
2476406|NCT02255760|8551059|P1|Overall Study|Lost to Follow-up|0
2476407|NCT02255565|8551114|P3|Overall Study|Withdrawal by Subject|0
2476408|NCT02255565|8551115|P2|Overall Study|Withdrawal by Subject|1
2476409|NCT02255565|8551116|P1|Overall Study|Withdrawal by Subject|0
2476410|NCT02255461|8551180|P5|Overall Study|Not meet dose reduction BSA requirement|0
2476411|NCT02255461|8551181|P4|Overall Study|Not meet dose reduction BSA requirement|0
2476412|NCT02255461|8551182|P3|Overall Study|Not meet dose reduction BSA requirement|0
2476413|NCT02255461|8551183|P2|Overall Study|Not meet dose reduction BSA requirement|1
2476414|NCT02255461|8551184|P1|Overall Study|Not meet dose reduction BSA requirement|0
2476415|NCT02255461|8551180|P5|Overall Study|Withdrawal by Subject|1
2476416|NCT02255461|8551181|P4|Overall Study|Withdrawal by Subject|0
2476417|NCT02255461|8551182|P3|Overall Study|Withdrawal by Subject|1
2476418|NCT02255461|8551183|P2|Overall Study|Withdrawal by Subject|0
2476419|NCT02255461|8551184|P1|Overall Study|Withdrawal by Subject|0
2476420|NCT02255461|8551180|P5|Overall Study|Adverse Event|1
2476421|NCT02255461|8551181|P4|Overall Study|Adverse Event|0
2476422|NCT02255461|8551182|P3|Overall Study|Adverse Event|0
2476423|NCT02255461|8551183|P2|Overall Study|Adverse Event|1
2476424|NCT02255461|8551184|P1|Overall Study|Adverse Event|0
2476425|NCT02255279|8551267|P2|Overall Study|Withdrawal by Subject|6
2476426|NCT02255279|8551268|P1|Overall Study|Withdrawal by Subject|3
2476427|NCT02255279|8551267|P2|Overall Study|Protocol Violation|1
2476428|NCT02255279|8551268|P1|Overall Study|Protocol Violation|0
2476429|NCT02255279|8551267|P2|Overall Study|Lost to Follow-up|2
2476430|NCT02255279|8551268|P1|Overall Study|Lost to Follow-up|2
2476431|NCT02255149|8551321|P1|Overall Study|Implant Failure|1
2476432|NCT02255149|8551321|P1|Overall Study|Withdrawal by PI|1
2476433|NCT02255149|8551321|P1|Overall Study|Withdrawal by Subject|1
2476434|NCT02255149|8551321|P1|Overall Study|Lost to Follow-up|2
2476435|NCT02255097|8551337|P1|Overall Study|Treatment Ongoing|36
2476436|NCT02255097|8551337|P1|Overall Study|Allocated but not treated|1
2476437|NCT02255097|8551337|P1|Overall Study|Withdrawal by Subject|2
2476438|NCT02255097|8551337|P1|Overall Study|Progressive Disease|80
2476439|NCT02255097|8551337|P1|Overall Study|Physician Decision|1
2476440|NCT02255097|8551337|P1|Overall Study|Lost to Follow-up|1
2476441|NCT02255097|8551337|P1|Overall Study|Death|2
2476442|NCT02255097|8551337|P1|Overall Study|Excluded Medication|1
2476443|NCT02255097|8551337|P1|Overall Study|Complete Response|1
2476444|NCT02255097|8551337|P1|Overall Study|Clinical Progression|23
2476445|NCT02255097|8551337|P1|Overall Study|Adverse Event|24
2476446|NCT02254772|8551358|P1|Overall Study|Withdrawal by Subject|1
2476447|NCT02254772|8551358|P1|Overall Study|Ineligible|1
2476448|NCT02254681|8551364|P1|Overall Study|Lack of Efficacy|6
2476449|NCT02254551|8551374|P1|Dose Escalation|Dose-limiting toxicity|2
2476450|NCT02254551|8551374|P1|Dose Escalation|Physician Decision|1
2476451|NCT02254486|8551384|P2|Overall Study|Various|12
2476452|NCT02254486|8551385|P1|Overall Study|Various|12
2476453|NCT02254486|8551384|P2|Overall Study|GFR<60mL/min|21
2476454|NCT02254486|8551385|P1|Overall Study|GFR<60mL/min|16
2476455|NCT02254486|8551384|P2|Overall Study|Withdrawal by Subject|15
2476456|NCT02254486|8551385|P1|Overall Study|Withdrawal by Subject|17
2476457|NCT02254486|8551384|P2|Overall Study|Protocol Violation|2
2476458|NCT02254486|8551385|P1|Overall Study|Protocol Violation|1
2476459|NCT02254486|8551384|P2|Overall Study|Lost to Follow-up|4
2476460|NCT02254486|8551385|P1|Overall Study|Lost to Follow-up|2
2476461|NCT02254486|8551384|P2|Overall Study|Lack of Efficacy|0
2476462|NCT02254486|8551385|P1|Overall Study|Lack of Efficacy|1
2476463|NCT02254486|8551384|P2|Overall Study|Adverse Event|1
2476464|NCT02254486|8551385|P1|Overall Study|Adverse Event|1
2476465|NCT02254460|8551424|P2|Overall Study|Adverse Event|0
2476466|NCT02254460|8551425|P1|Overall Study|Adverse Event|1
2476467|NCT02254421|8551433|P2|Overall Study|Withdrew Consent|1
2476468|NCT02254421|8551434|P1|Overall Study|Withdrew Consent|1
2476469|NCT02254421|8551433|P2|Overall Study|Death|2
2476470|NCT02254421|8551434|P1|Overall Study|Death|0
2476471|NCT02254421|8551433|P2|Overall Study|Randomized but Not Treated|0
2476472|NCT02254421|8551434|P1|Overall Study|Randomized but Not Treated|1
2476473|NCT02254408|8551448|P2|Overall Study|Lost to Follow-up|0
2476474|NCT02254408|8551449|P1|Overall Study|Lost to Follow-up|1
2476475|NCT02254408|8551448|P2|Overall Study|Withdrawal by Subject|3
2476476|NCT02254408|8551449|P1|Overall Study|Withdrawal by Subject|3
2476477|NCT02254408|8551448|P2|Overall Study|Investigator's Discretion|1
2476478|NCT02254408|8551449|P1|Overall Study|Investigator's Discretion|0
2476479|NCT02254408|8551448|P2|Overall Study|Death|3
2476480|NCT02254408|8551449|P1|Overall Study|Death|2
2476481|NCT02254408|8551448|P2|Overall Study|Adverse Event|0
2476482|NCT02254408|8551449|P1|Overall Study|Adverse Event|1
2476483|NCT02254408|8551448|P2|Overall Study|Randomized But Not Treated|3
2476484|NCT02254408|8551449|P1|Overall Study|Randomized But Not Treated|1
2476485|NCT02254304|8551461|P2|Overall Study|Personal decision|0
2476486|NCT02254304|8551462|P1|Overall Study|Personal decision|1
2476487|NCT02254304|8551461|P2|Overall Study|Personal causes|1
2476488|NCT02254304|8551462|P1|Overall Study|Personal causes|4
2476489|NCT02254304|8551461|P2|Overall Study|Injection site pain and Injection fear|0
2476490|NCT02254304|8551462|P1|Overall Study|Injection site pain and Injection fear|1
2476491|NCT02254304|8551461|P2|Overall Study|Withdrawal by Subject|0
2476492|NCT02254304|8551462|P1|Overall Study|Withdrawal by Subject|3
2476493|NCT02254304|8551461|P2|Overall Study|Protocol Violation|0
2476494|NCT02254304|8551462|P1|Overall Study|Protocol Violation|1
2476495|NCT02254304|8551461|P2|Overall Study|Lost to Follow-up|2
2476496|NCT02254304|8551462|P1|Overall Study|Lost to Follow-up|2
2476497|NCT02254304|8551461|P2|Overall Study|Adverse Event|1
2476498|NCT02254304|8551462|P1|Overall Study|Adverse Event|2
2476499|NCT02254291|8551522|P3|Overall Study|Missing follow-up information|1
2476500|NCT02254291|8551523|P2|Overall Study|Missing follow-up information|0
2476501|NCT02254291|8551524|P1|Overall Study|Missing follow-up information|0
2476502|NCT02254291|8551522|P3|Overall Study|Withdrawal by Subject|1
2476503|NCT02254291|8551523|P2|Overall Study|Withdrawal by Subject|3
2476504|NCT02254291|8551524|P1|Overall Study|Withdrawal by Subject|0
2476505|NCT02253654|8551581|P2|Overall Study|Did Not Receive Study Treatment|1
2476506|NCT02253654|8551582|P1|Overall Study|Did Not Receive Study Treatment|4
2476507|NCT02253654|8551581|P2|Overall Study|Death|7
2476508|NCT02253654|8551582|P1|Overall Study|Death|4
2476509|NCT02253654|8551581|P2|Overall Study|Lost to Follow-up|5
2476510|NCT02253654|8551582|P1|Overall Study|Lost to Follow-up|2
2476511|NCT02253654|8551581|P2|Overall Study|Decision by Sponsor|1
2476512|NCT02253654|8551582|P1|Overall Study|Decision by Sponsor|1
2476513|NCT02253654|8551581|P2|Overall Study|Withdrawal by Subject|4
2476514|NCT02253654|8551582|P1|Overall Study|Withdrawal by Subject|12
2476515|NCT02253433|8551608|P2|Overall Study|Medical or Other Concerns|2
2476516|NCT02253433|8551609|P1|Overall Study|Medical or Other Concerns|1
2476517|NCT02253433|8551608|P2|Overall Study|Too Busy|4
2476518|NCT02253433|8551609|P1|Overall Study|Too Busy|0
2476519|NCT02253433|8551608|P2|Overall Study|Unstable Housing/Homeless|7
2476520|NCT02253433|8551609|P1|Overall Study|Unstable Housing/Homeless|0
2476521|NCT02253433|8551608|P2|Overall Study|Uncomfortable with home visitors|3
2476522|NCT02253433|8551609|P1|Overall Study|Uncomfortable with home visitors|0
2476523|NCT02253433|8551608|P2|Overall Study|Out of Study Area|7
2476524|NCT02253433|8551609|P1|Overall Study|Out of Study Area|2
2476525|NCT02253433|8551608|P2|Overall Study|No Longer Interested|15
2476526|NCT02253433|8551609|P1|Overall Study|No Longer Interested|3
2476527|NCT02253433|8551608|P2|Overall Study|Death|1
2476528|NCT02253433|8551609|P1|Overall Study|Death|1
2476529|NCT02253433|8551608|P2|Overall Study|Unable to Contact|16
2476530|NCT02253433|8551609|P1|Overall Study|Unable to Contact|9
2476531|NCT02253147|8551868|P1|Overall Study|Withdrawal by Subject|1
2476532|NCT02253147|8551868|P1|Overall Study|Lost to Follow-up|2
2476533|NCT02253147|8551868|P1|Overall Study|Conditional re-treatment at W52|5
2476534|NCT02253147|8551868|P1|Overall Study|Did not consent to study extension|9
2476535|NCT02253147|8551868|P1|Overall Study|Protocol Violation|30
2476536|NCT02252965|8551902|P2|Overall Study|Other|5
2476537|NCT02252965|8551903|P1|Overall Study|Other|4
2476538|NCT02252965|8551902|P2|Overall Study|Withdrawal by Subject|9
2476539|NCT02252965|8551903|P1|Overall Study|Withdrawal by Subject|7
2476540|NCT02252965|8551902|P2|Overall Study|Lack of Efficacy|2
2476541|NCT02252965|8551903|P1|Overall Study|Lack of Efficacy|0
2476542|NCT02252965|8551902|P2|Overall Study|Protocol Violation|5
2476543|NCT02252965|8551903|P1|Overall Study|Protocol Violation|4
2476544|NCT02252965|8551902|P2|Overall Study|Lost to Follow-up|8
2476545|NCT02252965|8551903|P1|Overall Study|Lost to Follow-up|16
2476546|NCT02252965|8551902|P2|Overall Study|Adverse Event|14
2476547|NCT02252965|8551903|P1|Overall Study|Adverse Event|9
2476548|NCT02252939|8551930|P1|Overall Study|Lost to Follow-up|3
2476549|NCT02252536|8551987|P2|Overall Study|Lost to Follow-up|3
2476550|NCT02252536|8551988|P1|Overall Study|Lost to Follow-up|5
2476551|NCT02252406|8552049|P2|Titrated to Ranolazine 1000mg BID|Adverse Event|0
2476552|NCT02252406|8552050|P1|Titrated to Ranolazine 1000mg BID|Adverse Event|2
2476553|NCT02252406|8552049|P2|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1
2476554|NCT02252406|8552050|P1|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1
2476555|NCT02252406|8552049|P2|Starting Dose Ranolazine 500 mg BID|Adverse Event|0
2476556|NCT02252406|8552050|P1|Starting Dose Ranolazine 500 mg BID|Adverse Event|1
2476557|NCT02252406|8552049|P2|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0
2476558|NCT02252406|8552050|P1|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1
2476559|NCT02252406|8552049|P2|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3
2476560|NCT02252406|8552050|P1|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2
2476561|NCT02252211|8552108|P3|Overall Study|Serious Adverse Event During Screening|1
2476562|NCT02252211|8552109|P2|Overall Study|Serious Adverse Event During Screening|0
2476563|NCT02252211|8552110|P1|Overall Study|Serious Adverse Event During Screening|1
2476564|NCT02252211|8552108|P3|Overall Study|Withdrawal by Subject|0
2476565|NCT02252211|8552109|P2|Overall Study|Withdrawal by Subject|0
2476566|NCT02252211|8552110|P1|Overall Study|Withdrawal by Subject|1
2476567|NCT02252211|8552108|P3|Overall Study|Progressive disease|0
2476568|NCT02252211|8552109|P2|Overall Study|Progressive disease|2
2476569|NCT02252211|8552110|P1|Overall Study|Progressive disease|3
2476570|NCT02252211|8552108|P3|Overall Study|Adverse Event|0
2476571|NCT02252211|8552109|P2|Overall Study|Adverse Event|1
2476572|NCT02252211|8552110|P1|Overall Study|Adverse Event|0
2476573|NCT02252172|8552147|P2|Overall Study|Ongoing|298
2476574|NCT02252172|8552148|P1|Overall Study|Ongoing|276
2476575|NCT02252172|8552147|P2|Overall Study|Lost to Follow-up|1
2476576|NCT02252172|8552148|P1|Overall Study|Lost to Follow-up|3
2476577|NCT02252146|8552160|P1|Overall Study|Inability to travel to study site|1
2476578|NCT02252146|8552160|P1|Overall Study|Entered hospice care|1
2476579|NCT02252146|8552160|P1|Overall Study|Lack of Efficacy|4
2476580|NCT02252042|8552173|P2|Overall Study|Ongoing in study|35
2476581|NCT02252042|8552174|P1|Overall Study|Ongoing in study|64
2476582|NCT02252042|8552173|P2|Overall Study|Withdrawal by Subject|20
2476583|NCT02252042|8552174|P1|Overall Study|Withdrawal by Subject|13
2476584|NCT02252042|8552173|P2|Overall Study|Physician Decision|1
2476585|NCT02252042|8552174|P1|Overall Study|Physician Decision|0
2476586|NCT02252042|8552173|P2|Overall Study|Death|192
2476587|NCT02252042|8552174|P1|Overall Study|Death|170
2476588|NCT02252016|8552214|P2|Overall Study|Withdrawal by Subject|2
2476589|NCT02252016|8552215|P1|Overall Study|Withdrawal by Subject|0
2476590|NCT02252016|8552214|P2|Overall Study|Physician Decision|0
2476591|NCT02252016|8552215|P1|Overall Study|Physician Decision|1
2476592|NCT02252016|8552214|P2|Overall Study|Lost to Follow-up|1
2476593|NCT02252016|8552215|P1|Overall Study|Lost to Follow-up|2
2476594|NCT02251990|8552229|P2|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2
2476595|NCT02251990|8552230|P1|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0
2476596|NCT02251990|8552229|P2|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1
2476597|NCT02251990|8552230|P1|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0
2476598|NCT02251990|8552229|P2|Period 1 (Double-blind [DB])|Not Treated|0
2476599|NCT02251990|8552230|P1|Period 1 (Double-blind [DB])|Not Treated|1
2476600|NCT02251990|8552229|P2|Period 1 (Double-blind [DB])|Withdrawal by Subject|0
2476601|NCT02251990|8552230|P1|Period 1 (Double-blind [DB])|Withdrawal by Subject|1
2476602|NCT02251990|8552229|P2|Period 1 (Double-blind [DB])|Lack of Efficacy|0
2476603|NCT02251990|8552230|P1|Period 1 (Double-blind [DB])|Lack of Efficacy|5
2476604|NCT02251990|8552229|P2|Period 1 (Double-blind [DB])|Adverse Event|1
2476605|NCT02251990|8552230|P1|Period 1 (Double-blind [DB])|Adverse Event|1
2476606|NCT02251912|8552258|P2|Overall Study|Adverse Event|2
2476607|NCT02251912|8552259|P1|Overall Study|Adverse Event|0
2476608|NCT02251912|8552258|P2|Overall Study|Withdrawal by Subject|3
2476609|NCT02251912|8552259|P1|Overall Study|Withdrawal by Subject|2
2476610|NCT02251717|8552288|P2|Overall Study|Withdrew Consent|0
2476611|NCT02251717|8552289|P1|Overall Study|Withdrew Consent|1
2476612|NCT02251717|8552288|P2|Overall Study|Adverse Event|1
2476613|NCT02251717|8552289|P1|Overall Study|Adverse Event|0
2476614|NCT02251652|8552301|P1|Overall Study|Withdrawal by Subject|1
2476615|NCT02251275|8552351|P5|Overall Study|Withdrawal by Subject|0
2476616|NCT02251275|8552352|P4|Overall Study|Withdrawal by Subject|1
2476617|NCT02251275|8552353|P3|Overall Study|Withdrawal by Subject|35
2476618|NCT02251275|8552354|P2|Overall Study|Withdrawal by Subject|51
2476619|NCT02251275|8552355|P1|Overall Study|Withdrawal by Subject|25
2476620|NCT02251275|8552351|P5|Overall Study|Protocol Deviation|0
2476621|NCT02251275|8552352|P4|Overall Study|Protocol Deviation|0
2476622|NCT02251275|8552353|P3|Overall Study|Protocol Deviation|1
2476623|NCT02251275|8552354|P2|Overall Study|Protocol Deviation|0
2476624|NCT02251275|8552355|P1|Overall Study|Protocol Deviation|0
2476625|NCT02251275|8552351|P5|Overall Study|Physician Decision|1
2476626|NCT02251275|8552352|P4|Overall Study|Physician Decision|0
2476627|NCT02251275|8552353|P3|Overall Study|Physician Decision|26
2476628|NCT02251275|8552354|P2|Overall Study|Physician Decision|30
2476629|NCT02251275|8552355|P1|Overall Study|Physician Decision|19
2476630|NCT02251275|8552351|P5|Overall Study|Lost to Follow-up|0
2476631|NCT02251275|8552352|P4|Overall Study|Lost to Follow-up|0
2476632|NCT02251275|8552353|P3|Overall Study|Lost to Follow-up|4
2476633|NCT02251275|8552354|P2|Overall Study|Lost to Follow-up|6
2476634|NCT02251275|8552355|P1|Overall Study|Lost to Follow-up|5
2476635|NCT02251275|8552351|P5|Overall Study|Adverse Event|0
2476636|NCT02251275|8552352|P4|Overall Study|Adverse Event|0
2476637|NCT02251275|8552353|P3|Overall Study|Adverse Event|28
2476638|NCT02251275|8552354|P2|Overall Study|Adverse Event|60
2476639|NCT02251275|8552355|P1|Overall Study|Adverse Event|23
2476640|NCT02250443|8552428|P1|Overall Study|Adverse Event|3
2476641|NCT02250443|8552428|P1|Overall Study|Administrative problems|7
2476642|NCT02250326|8552457|P3|Follow-Up Period|Lost to Follow-up|3
2476643|NCT02250326|8552458|P2|Follow-Up Period|Lost to Follow-up|1
2476644|NCT02250326|8552459|P1|Follow-Up Period|Lost to Follow-up|1
2476645|NCT02250326|8552457|P3|Follow-Up Period|Unknown or Missing|3
2476646|NCT02250326|8552458|P2|Follow-Up Period|Unknown or Missing|3
2476647|NCT02250326|8552459|P1|Follow-Up Period|Unknown or Missing|2
2476648|NCT02250326|8552457|P3|Follow-Up Period|Death|32
2476649|NCT02250326|8552458|P2|Follow-Up Period|Death|26
2476650|NCT02250326|8552459|P1|Follow-Up Period|Death|46
2476651|NCT02250326|8552457|P3|Treatment Period|Randomized or assigned; not treated|1
2476652|NCT02250326|8552458|P2|Treatment Period|Randomized or assigned; not treated|1
2476653|NCT02250326|8552459|P1|Treatment Period|Randomized or assigned; not treated|2
2476654|NCT02250326|8552457|P3|Treatment Period|Miscellaneous|7
2476655|NCT02250326|8552458|P2|Treatment Period|Miscellaneous|2
2476656|NCT02250326|8552459|P1|Treatment Period|Miscellaneous|8
2476657|NCT02250326|8552457|P3|Treatment Period|Withdrawal by Subject|4
2476658|NCT02250326|8552458|P2|Treatment Period|Withdrawal by Subject|5
2476659|NCT02250326|8552459|P1|Treatment Period|Withdrawal by Subject|11
2476660|NCT02250326|8552457|P3|Treatment Period|Symptomatic Deterioration|10
2476661|NCT02250326|8552458|P2|Treatment Period|Symptomatic Deterioration|4
2476662|NCT02250326|8552459|P1|Treatment Period|Symptomatic Deterioration|9
2476663|NCT02250326|8552457|P3|Treatment Period|Progressive Disease|45
2476664|NCT02250326|8552458|P2|Treatment Period|Progressive Disease|36
2476665|NCT02250326|8552459|P1|Treatment Period|Progressive Disease|42
2476666|NCT02250326|8552457|P3|Treatment Period|Adverse Event|8
2476667|NCT02250326|8552458|P2|Treatment Period|Adverse Event|4
2476668|NCT02250326|8552459|P1|Treatment Period|Adverse Event|8
2476669|NCT02250326|8552457|P3|Treatment Period|Death|2
2476670|NCT02250326|8552458|P2|Treatment Period|Death|12
2476671|NCT02250326|8552459|P1|Treatment Period|Death|1
2476672|NCT02250274|8552492|P2|Overall Study|Insufficient blood draw amount|6
2476673|NCT02250274|8552493|P1|Overall Study|Insufficient blood draw amount|7
2476674|NCT02250183|8552509|P1|Overall Study|Lost to Follow-up|1
2476675|NCT02250183|8552509|P1|Overall Study|Adverse Event|5
2476676|NCT02250183|8552509|P1|Overall Study|Withdrawal by Subject|2
2476677|NCT02249949|8552518|P1|Overall Study|Cancelled prior to treatment|2
2476678|NCT02249832|8552525|P1|Overall Study|Lost to Follow-up|10
2476679|NCT02249832|8552525|P1|Overall Study|Withdrawal by Subject|3
2476680|NCT02249767|8552569|P3|Overall Study|Did not use medication|8
2476681|NCT02249767|8552570|P2|Overall Study|Did not use medication|9
2476682|NCT02249767|8552571|P1|Overall Study|Did not use medication|8
2476683|NCT02249182|8552637|P5|Treatment Phase|Lost to Follow-up|0
2476684|NCT02249182|8552638|P4|Treatment Phase|Lost to Follow-up|0
2476685|NCT02249182|8552639|P3|Treatment Phase|Lost to Follow-up|0
2476686|NCT02249182|8552640|P2|Treatment Phase|Lost to Follow-up|0
2476687|NCT02249182|8552641|P1|Treatment Phase|Lost to Follow-up|4
2476688|NCT02248974|8552791|P2|1-Month Follow-Up|Lost to Follow-up|3
2476689|NCT02248974|8552792|P1|1-Month Follow-Up|Lost to Follow-up|2
2476690|NCT02248974|8552791|P2|1-Week Follow-Up|Lost to Follow-up|8
2476691|NCT02248974|8552792|P1|1-Week Follow-Up|Lost to Follow-up|0
2476692|NCT02248974|8552791|P2|1-Week Follow-Up|Withdrawal by Subject|2
2476693|NCT02248974|8552792|P1|1-Week Follow-Up|Withdrawal by Subject|0
2476694|NCT02248974|8552791|P2|1-Week Follow-Up|Timing: implanted before survey|2
2476695|NCT02248974|8552792|P1|1-Week Follow-Up|Timing: implanted before survey|0
2476696|NCT02248974|8552791|P2|1-Week Follow-Up|Noncompliant with terms of participation|1
2476697|NCT02248974|8552792|P1|1-Week Follow-Up|Noncompliant with terms of participation|0
2476698|NCT02248974|8552791|P2|1-Week Follow-Up|Excluded because of age|1
2476699|NCT02248974|8552792|P1|1-Week Follow-Up|Excluded because of age|0
2476700|NCT02248974|8552791|P2|1-Week Follow-Up|Death|1
2476701|NCT02248974|8552792|P1|1-Week Follow-Up|Death|1
2476702|NCT02248974|8552791|P2|1-Week Follow-Up|Cognitive Difficulty|0
2476703|NCT02248974|8552792|P1|1-Week Follow-Up|Cognitive Difficulty|1
2476704|NCT02248974|8552791|P2|1-Week Follow-Up|Transferred to another facility|0
2476705|NCT02248974|8552792|P1|1-Week Follow-Up|Transferred to another facility|1
2476706|NCT02248974|8552791|P2|1-Week Follow-Up|Enrolled in another study|1
2476707|NCT02248974|8552792|P1|1-Week Follow-Up|Enrolled in another study|1
2476708|NCT02248974|8552791|P2|1-Week Follow-Up|Became ineligible for LVAD|1
2476709|NCT02248974|8552792|P1|1-Week Follow-Up|Became ineligible for LVAD|4
2476710|NCT02248974|8552791|P2|1-Day Follow-Up|Enrolled in another study|0
2476711|NCT02248974|8552792|P1|1-Day Follow-Up|Enrolled in another study|1
2476712|NCT02248974|8552791|P2|1-Day Follow-Up|Withdrawal by Subject|0
2476713|NCT02248974|8552792|P1|1-Day Follow-Up|Withdrawal by Subject|5
2476714|NCT02248974|8552791|P2|1-Day Follow-Up|Lost to Follow-up|0
2476715|NCT02248974|8552792|P1|1-Day Follow-Up|Lost to Follow-up|4
2476716|NCT02248961|8552870|P2|Overall Study|Unmet inclusion/exclusion criteria|0
2476717|NCT02248961|8552871|P1|Overall Study|Unmet inclusion/exclusion criteria|1
2476718|NCT02248961|8552870|P2|Overall Study|Withdrawal by Subject|2
2476719|NCT02248961|8552871|P1|Overall Study|Withdrawal by Subject|1
2476720|NCT02248961|8552870|P2|Overall Study|Adverse Event|0
2476721|NCT02248961|8552871|P1|Overall Study|Adverse Event|1
2476722|NCT02248857|8552906|P3|6 Month|Death|0
2476723|NCT02248857|8552907|P2|6 Month|Death|0
2476724|NCT02248857|8552908|P1|6 Month|Death|1
2476725|NCT02248857|8552906|P3|6 Month|Withdrawal by Subject|2
2476726|NCT02248857|8552907|P2|6 Month|Withdrawal by Subject|2
2476727|NCT02248857|8552908|P1|6 Month|Withdrawal by Subject|0
2476728|NCT02248857|8552906|P3|6 Month|Partially completed, unable to finish|0
2476729|NCT02248857|8552907|P2|6 Month|Partially completed, unable to finish|1
2476730|NCT02248857|8552908|P1|6 Month|Partially completed, unable to finish|0
2476731|NCT02248857|8552906|P3|6 Month|Lost to Follow-up|15
2476732|NCT02248857|8552907|P2|6 Month|Lost to Follow-up|26
2476733|NCT02248857|8552908|P1|6 Month|Lost to Follow-up|27
2476734|NCT02248857|8552906|P3|3 Month|Partially completed, unable to finish|1
2476735|NCT02248857|8552907|P2|3 Month|Partially completed, unable to finish|2
2476736|NCT02248857|8552908|P1|3 Month|Partially completed, unable to finish|2
2476737|NCT02248857|8552906|P3|3 Month|Unable to reach for 3 month|26
2476738|NCT02248857|8552907|P2|3 Month|Unable to reach for 3 month|29
2476739|NCT02248857|8552908|P1|3 Month|Unable to reach for 3 month|35
2476740|NCT02248857|8552906|P3|3 Month|Withdrawal by Subject|4
2476741|NCT02248857|8552907|P2|3 Month|Withdrawal by Subject|3
2476742|NCT02248857|8552908|P1|3 Month|Withdrawal by Subject|9
2476743|NCT02248818|8552945|P9|Randomised Study|Administrative - randomization error|0
2476744|NCT02248818|8552946|P8|Randomised Study|Administrative - randomization error|0
2476745|NCT02248818|8552947|P7|Randomised Study|Administrative - randomization error|0
2476746|NCT02248818|8552948|P6|Randomised Study|Administrative - randomization error|8
2476747|NCT02248818|8552949|P5|Randomised Study|Administrative - randomization error|0
2476748|NCT02248818|8552950|P4|Randomised Study|Administrative - randomization error|0
2476749|NCT02248818|8552951|P3|Randomised Study|Administrative - randomization error|0
2476750|NCT02248818|8552952|P2|Randomised Study|Administrative - randomization error|0
2476751|NCT02248818|8552953|P1|Randomised Study|Administrative - randomization error|0
2476752|NCT02248818|8552945|P9|Screening|Lost to Follow-up|7
2476753|NCT02248818|8552946|P8|Screening|Lost to Follow-up|0
2476754|NCT02248818|8552947|P7|Screening|Lost to Follow-up|0
2476755|NCT02248818|8552948|P6|Screening|Lost to Follow-up|0
2476756|NCT02248818|8552949|P5|Screening|Lost to Follow-up|0
2476757|NCT02248818|8552950|P4|Screening|Lost to Follow-up|0
2476758|NCT02248818|8552951|P3|Screening|Lost to Follow-up|0
2476759|NCT02248818|8552952|P2|Screening|Lost to Follow-up|0
2476760|NCT02248818|8552953|P1|Screening|Lost to Follow-up|0
2476761|NCT02248818|8552945|P9|Screening|Withdrawal by Subject|6
2476762|NCT02248818|8552946|P8|Screening|Withdrawal by Subject|0
2476763|NCT02248818|8552947|P7|Screening|Withdrawal by Subject|0
2476764|NCT02248818|8552948|P6|Screening|Withdrawal by Subject|0
2476765|NCT02248818|8552949|P5|Screening|Withdrawal by Subject|0
2476766|NCT02248818|8552950|P4|Screening|Withdrawal by Subject|0
2476767|NCT02248818|8552951|P3|Screening|Withdrawal by Subject|0
2476768|NCT02248818|8552952|P2|Screening|Withdrawal by Subject|0
2476769|NCT02248818|8552953|P1|Screening|Withdrawal by Subject|0
2476770|NCT02248818|8552945|P9|Screening|Physician Decision|73
2476771|NCT02248818|8552946|P8|Screening|Physician Decision|0
2476772|NCT02248818|8552947|P7|Screening|Physician Decision|0
2476773|NCT02248818|8552948|P6|Screening|Physician Decision|0
2476774|NCT02248818|8552949|P5|Screening|Physician Decision|0
2476775|NCT02248818|8552950|P4|Screening|Physician Decision|0
2476776|NCT02248818|8552951|P3|Screening|Physician Decision|0
2476777|NCT02248818|8552952|P2|Screening|Physician Decision|0
2476778|NCT02248818|8552953|P1|Screening|Physician Decision|0
2476779|NCT02248818|8552945|P9|Screening|Study fully enrolled|14
2476780|NCT02248818|8552946|P8|Screening|Study fully enrolled|0
2476781|NCT02248818|8552947|P7|Screening|Study fully enrolled|0
2476782|NCT02248818|8552948|P6|Screening|Study fully enrolled|0
2476783|NCT02248818|8552949|P5|Screening|Study fully enrolled|0
2476784|NCT02248818|8552950|P4|Screening|Study fully enrolled|0
2476785|NCT02248818|8552951|P3|Screening|Study fully enrolled|0
2476786|NCT02248818|8552952|P2|Screening|Study fully enrolled|0
2476787|NCT02248818|8552953|P1|Screening|Study fully enrolled|0
2476788|NCT02248818|8552945|P9|Screening|Protocol Violation|7
2476789|NCT02248818|8552946|P8|Screening|Protocol Violation|0
2476790|NCT02248818|8552947|P7|Screening|Protocol Violation|0
2476791|NCT02248818|8552948|P6|Screening|Protocol Violation|0
2476792|NCT02248818|8552949|P5|Screening|Protocol Violation|0
2476793|NCT02248818|8552950|P4|Screening|Protocol Violation|0
2476794|NCT02248818|8552951|P3|Screening|Protocol Violation|0
2476795|NCT02248818|8552952|P2|Screening|Protocol Violation|0
2476796|NCT02248818|8552953|P1|Screening|Protocol Violation|0
2476797|NCT02248675|8553168|P2|Overall Study|Lost to Follow-up|1
2476798|NCT02248675|8553169|P1|Overall Study|Lost to Follow-up|3
2476799|NCT02248649|8553196|P2|Overall Study|Lost to Follow-up|10
2476800|NCT02248649|8553197|P1|Overall Study|Lost to Follow-up|14
2476801|NCT02248649|8553196|P2|Overall Study|Death|11
2476802|NCT02248649|8553197|P1|Overall Study|Death|7
2476803|NCT02248480|8553222|P2|Overall Study|Other:Physician Decision|1
2476804|NCT02248480|8553223|P1|Overall Study|Other:Physician Decision|0
2476805|NCT02248480|8553222|P2|Overall Study|Entry Criteria Not Met|1
2476806|NCT02248480|8553223|P1|Overall Study|Entry Criteria Not Met|0
2476807|NCT02248480|8553222|P2|Overall Study|Withdrawal by Subject|4
2476808|NCT02248480|8553223|P1|Overall Study|Withdrawal by Subject|2
2476809|NCT02248480|8553222|P2|Overall Study|Adverse Event|2
2476810|NCT02248480|8553223|P1|Overall Study|Adverse Event|11
2476811|NCT02248480|8553222|P2|Overall Study|Lack of Efficacy|6
2476812|NCT02248480|8553223|P1|Overall Study|Lack of Efficacy|4
2476813|NCT02247960|8553290|P2|Catheter Removed|Lost to Follow-up|10
2476814|NCT02247960|8553291|P1|Catheter Removed|Lost to Follow-up|7
2476815|NCT02247960|8553290|P2|Patient Consent and Randomization|Withdrawal by Subject|4
2476816|NCT02247960|8553291|P1|Patient Consent and Randomization|Withdrawal by Subject|0
2476817|NCT02247960|8553290|P2|Patient Consent and Randomization|Physician Decision|2
2476818|NCT02247960|8553291|P1|Patient Consent and Randomization|Physician Decision|2
2476819|NCT02247804|8553304|P3|Treatment Period 3|Reason not Specified|3
2476820|NCT02247804|8553305|P2|Treatment Period 3|Reason not Specified|1
2476821|NCT02247804|8553306|P1|Treatment Period 3|Reason not Specified|2
2476822|NCT02247804|8553304|P3|Treatment Period 3|Personal Reasons|2
2476823|NCT02247804|8553305|P2|Treatment Period 3|Personal Reasons|3
2476824|NCT02247804|8553306|P1|Treatment Period 3|Personal Reasons|4
2476825|NCT02247804|8553304|P3|Treatment Period 3|Lost to Follow-up|2
2476826|NCT02247804|8553305|P2|Treatment Period 3|Lost to Follow-up|2
2476827|NCT02247804|8553306|P1|Treatment Period 3|Lost to Follow-up|1
2476828|NCT02247804|8553304|P3|Treatment Period 3|Lack of Efficacy|0
2476829|NCT02247804|8553305|P2|Treatment Period 3|Lack of Efficacy|1
2476830|NCT02247804|8553306|P1|Treatment Period 3|Lack of Efficacy|0
2476831|NCT02247804|8553304|P3|Treatment Period 3|Adverse Event|3
2476832|NCT02247804|8553305|P2|Treatment Period 3|Adverse Event|3
2476833|NCT02247804|8553306|P1|Treatment Period 3|Adverse Event|4
2476834|NCT02247804|8553304|P3|Treatment Period 2|Reason not Specified|2
2476835|NCT02247804|8553305|P2|Treatment Period 2|Reason not Specified|0
2476836|NCT02247804|8553306|P1|Treatment Period 2|Reason not Specified|0
2476837|NCT02247804|8553304|P3|Treatment Period 2|Personal Reasons|1
2476838|NCT02247804|8553305|P2|Treatment Period 2|Personal Reasons|1
2476839|NCT02247804|8553306|P1|Treatment Period 2|Personal Reasons|2
2476840|NCT02247804|8553304|P3|Treatment Period 2|Lost to Follow-up|1
2476841|NCT02247804|8553305|P2|Treatment Period 2|Lost to Follow-up|1
2476842|NCT02247804|8553306|P1|Treatment Period 2|Lost to Follow-up|0
2476843|NCT02247804|8553304|P3|Treatment Period 2|Lack of Efficacy|1
2476844|NCT02247804|8553305|P2|Treatment Period 2|Lack of Efficacy|0
2476845|NCT02247804|8553306|P1|Treatment Period 2|Lack of Efficacy|0
2476846|NCT02247804|8553304|P3|Treatment Period 2|Adverse Event|3
2476847|NCT02247804|8553305|P2|Treatment Period 2|Adverse Event|3
2476848|NCT02247804|8553306|P1|Treatment Period 2|Adverse Event|6
2476849|NCT02247804|8553304|P3|Treatment Period 1|Randomized but not Treated|1
2476850|NCT02247804|8553305|P2|Treatment Period 1|Randomized but not Treated|1
2476851|NCT02247804|8553306|P1|Treatment Period 1|Randomized but not Treated|5
2476852|NCT02247804|8553304|P3|Treatment Period 1|Protocol Deviation|1
2476853|NCT02247804|8553305|P2|Treatment Period 1|Protocol Deviation|0
2476854|NCT02247804|8553306|P1|Treatment Period 1|Protocol Deviation|0
2476855|NCT02247804|8553304|P3|Treatment Period 1|Personal Reasons|2
2476856|NCT02247804|8553305|P2|Treatment Period 1|Personal Reasons|1
2476857|NCT02247804|8553306|P1|Treatment Period 1|Personal Reasons|7
2476858|NCT02247804|8553304|P3|Treatment Period 1|Lost to Follow-up|2
2476859|NCT02247804|8553305|P2|Treatment Period 1|Lost to Follow-up|0
2476860|NCT02247804|8553306|P1|Treatment Period 1|Lost to Follow-up|1
2476861|NCT02247804|8553304|P3|Treatment Period 1|Lack of Efficacy|2
2476862|NCT02247804|8553305|P2|Treatment Period 1|Lack of Efficacy|0
2476863|NCT02247804|8553306|P1|Treatment Period 1|Lack of Efficacy|0
2476864|NCT02247804|8553304|P3|Treatment Period 1|Adverse Event|0
2476865|NCT02247804|8553305|P2|Treatment Period 1|Adverse Event|2
2476866|NCT02247804|8553306|P1|Treatment Period 1|Adverse Event|9
2476867|NCT02247531|8553364|P3|Overall Study|Unspecified Reason|4
2476868|NCT02247531|8553365|P2|Overall Study|Unspecified Reason|3
2476869|NCT02247531|8553366|P1|Overall Study|Unspecified Reason|2
2476870|NCT02247531|8553364|P3|Overall Study|Physician Decision|2
2476871|NCT02247531|8553365|P2|Overall Study|Physician Decision|2
2476872|NCT02247531|8553366|P1|Overall Study|Physician Decision|0
2476873|NCT02247531|8553364|P3|Overall Study|Study Terminated by Sponsor|62
2476874|NCT02247531|8553365|P2|Overall Study|Study Terminated by Sponsor|66
2476875|NCT02247531|8553366|P1|Overall Study|Study Terminated by Sponsor|64
2476876|NCT02247531|8553364|P3|Overall Study|Withdrawal by Subject|25
2476877|NCT02247531|8553365|P2|Overall Study|Withdrawal by Subject|31
2476878|NCT02247531|8553366|P1|Overall Study|Withdrawal by Subject|26
2476879|NCT02247531|8553364|P3|Overall Study|Non-compliance|0
2476880|NCT02247531|8553365|P2|Overall Study|Non-compliance|2
2476881|NCT02247531|8553366|P1|Overall Study|Non-compliance|2
2476882|NCT02247531|8553364|P3|Overall Study|Lost to Follow-up|3
2476883|NCT02247531|8553365|P2|Overall Study|Lost to Follow-up|8
2476884|NCT02247531|8553366|P1|Overall Study|Lost to Follow-up|1
2476885|NCT02247531|8553364|P3|Overall Study|Death|5
2476886|NCT02247531|8553365|P2|Overall Study|Death|9
2476887|NCT02247531|8553366|P1|Overall Study|Death|8
2476888|NCT02247531|8553364|P3|Overall Study|Adverse Event|9
2476889|NCT02247531|8553365|P2|Overall Study|Adverse Event|4
2476890|NCT02247531|8553366|P1|Overall Study|Adverse Event|3
2476891|NCT02247479|8553416|P3|Overall Study|Unspecified Reason|2
2476892|NCT02247479|8553417|P2|Overall Study|Unspecified Reason|5
2476893|NCT02247479|8553418|P1|Overall Study|Unspecified Reason|2
2476894|NCT02247479|8553416|P3|Overall Study|Physician Decision|2
2476895|NCT02247479|8553417|P2|Overall Study|Physician Decision|0
2476896|NCT02247479|8553418|P1|Overall Study|Physician Decision|1
2476897|NCT02247479|8553416|P3|Overall Study|Study Terminated by Sponsor|94
2476898|NCT02247479|8553417|P2|Overall Study|Study Terminated by Sponsor|88
2476899|NCT02247479|8553418|P1|Overall Study|Study Terminated by Sponsor|98
2476900|NCT02247479|8553416|P3|Overall Study|Withdrawal by Subject|24
2476901|NCT02247479|8553417|P2|Overall Study|Withdrawal by Subject|29
2476902|NCT02247479|8553418|P1|Overall Study|Withdrawal by Subject|25
2476903|NCT02247479|8553416|P3|Overall Study|Non-compliance|1
2476904|NCT02247479|8553417|P2|Overall Study|Non-compliance|0
2476905|NCT02247479|8553418|P1|Overall Study|Non-compliance|0
2476906|NCT02247479|8553416|P3|Overall Study|Lost to Follow-up|1
2476907|NCT02247479|8553417|P2|Overall Study|Lost to Follow-up|3
2476908|NCT02247479|8553418|P1|Overall Study|Lost to Follow-up|3
2476909|NCT02247479|8553416|P3|Overall Study|Death|6
2476910|NCT02247479|8553417|P2|Overall Study|Death|4
2476911|NCT02247479|8553418|P1|Overall Study|Death|5
2476912|NCT02247479|8553416|P3|Overall Study|Adverse Event|8
2476913|NCT02247479|8553417|P2|Overall Study|Adverse Event|9
2476914|NCT02247479|8553418|P1|Overall Study|Adverse Event|8
2476915|NCT02247466|8553467|P2|Overall Study|Procedure changed to open surgery|3
2476916|NCT02247466|8553468|P1|Overall Study|Procedure changed to open surgery|0
2476917|NCT02247440|8553486|P1|Overall Study|Lack of Efficacy|3
2476918|NCT02247440|8553486|P1|Overall Study|Withdrawal by Subject|1
2476919|NCT02247401|8553499|P3|Overall Study|Lost to Follow-up|1
2476920|NCT02247401|8553500|P2|Overall Study|Lost to Follow-up|1
2476921|NCT02247401|8553501|P1|Overall Study|Lost to Follow-up|1
2476922|NCT02247401|8553499|P3|Overall Study|Withdrawal by Subject|1
2476923|NCT02247401|8553500|P2|Overall Study|Withdrawal by Subject|1
2476924|NCT02247401|8553501|P1|Overall Study|Withdrawal by Subject|4
2476925|NCT02247401|8553499|P3|Overall Study|Adverse Event|0
2476926|NCT02247401|8553500|P2|Overall Study|Adverse Event|0
2476927|NCT02247401|8553501|P1|Overall Study|Adverse Event|1
2476928|NCT02247011|8553548|P1|Overall Study|Poor quality of radiological results|125
2476929|NCT02246998|8553569|P4|Overall Study|Randomized but Never Dosed|1
2476930|NCT02246998|8553570|P3|Overall Study|Randomized but Never Dosed|2
2476931|NCT02246998|8553571|P2|Overall Study|Randomized but Never Dosed|2
2476932|NCT02246998|8553572|P1|Overall Study|Randomized but Never Dosed|1
2476933|NCT02246998|8553569|P4|Overall Study|Lost to Follow-up|1
2476934|NCT02246998|8553570|P3|Overall Study|Lost to Follow-up|0
2476935|NCT02246998|8553571|P2|Overall Study|Lost to Follow-up|0
2476936|NCT02246998|8553572|P1|Overall Study|Lost to Follow-up|1
2476937|NCT02246998|8553569|P4|Overall Study|Adverse Event|0
2476938|NCT02246998|8553570|P3|Overall Study|Adverse Event|1
2476939|NCT02246998|8553571|P2|Overall Study|Adverse Event|1
2476940|NCT02246998|8553572|P1|Overall Study|Adverse Event|0
2476941|NCT02246777|8553682|P1|Overall Study|Change of residence|1
2476942|NCT02246777|8553682|P1|Overall Study|Adverse Event|2
2476943|NCT02246764|8553698|P3|Overall Study|Protocol Violation|1
2476944|NCT02246764|8553699|P2|Overall Study|Protocol Violation|1
2476945|NCT02246764|8553700|P1|Overall Study|Protocol Violation|2
2476946|NCT02246764|8553698|P3|Overall Study|Physician Decision|1
2476947|NCT02246764|8553699|P2|Overall Study|Physician Decision|2
2476948|NCT02246764|8553700|P1|Overall Study|Physician Decision|0
2476949|NCT02246764|8553698|P3|Overall Study|Disallowed Concomitant Medication|0
2476950|NCT02246764|8553699|P2|Overall Study|Disallowed Concomitant Medication|0
2476951|NCT02246764|8553700|P1|Overall Study|Disallowed Concomitant Medication|1
2476952|NCT02246764|8553698|P3|Overall Study|Withdrawal by Subject|1
2476953|NCT02246764|8553699|P2|Overall Study|Withdrawal by Subject|0
2476954|NCT02246764|8553700|P1|Overall Study|Withdrawal by Subject|0
2476955|NCT02246764|8553698|P3|Overall Study|Adverse Event|1
2476956|NCT02246764|8553699|P2|Overall Study|Adverse Event|29
2476957|NCT02246764|8553700|P1|Overall Study|Adverse Event|15
2476958|NCT02246673|8553713|P5|Overall Study|Protocol Violation|0
2476959|NCT02246673|8553714|P4|Overall Study|Protocol Violation|1
2476960|NCT02246673|8553715|P3|Overall Study|Protocol Violation|0
2476961|NCT02246673|8553716|P2|Overall Study|Protocol Violation|0
2476962|NCT02246673|8553717|P1|Overall Study|Protocol Violation|0
2476963|NCT02246673|8553713|P5|Overall Study|Lost to Follow-up|0
2476964|NCT02246673|8553714|P4|Overall Study|Lost to Follow-up|1
2476965|NCT02246673|8553715|P3|Overall Study|Lost to Follow-up|0
2476966|NCT02246673|8553716|P2|Overall Study|Lost to Follow-up|0
2476967|NCT02246673|8553717|P1|Overall Study|Lost to Follow-up|0
2476968|NCT02246673|8553713|P5|Overall Study|Withdrawal by Subject|1
2476969|NCT02246673|8553714|P4|Overall Study|Withdrawal by Subject|0
2476970|NCT02246673|8553715|P3|Overall Study|Withdrawal by Subject|0
2476971|NCT02246673|8553716|P2|Overall Study|Withdrawal by Subject|0
2476972|NCT02246673|8553717|P1|Overall Study|Withdrawal by Subject|0
2476973|NCT02246673|8553713|P5|Overall Study|Sponsor Decision|0
2476974|NCT02246673|8553714|P4|Overall Study|Sponsor Decision|0
2476975|NCT02246673|8553715|P3|Overall Study|Sponsor Decision|0
2476976|NCT02246673|8553716|P2|Overall Study|Sponsor Decision|0
2476977|NCT02246673|8553717|P1|Overall Study|Sponsor Decision|1
2476978|NCT02246660|8553825|P3|Overall Study|Death|1
2476979|NCT02246660|8553826|P2|Overall Study|Death|0
2476980|NCT02246660|8553827|P1|Overall Study|Death|0
2476981|NCT02246660|8553825|P3|Overall Study|Withdrawal by Subject|0
2476982|NCT02246660|8553826|P2|Overall Study|Withdrawal by Subject|1
2476983|NCT02246660|8553827|P1|Overall Study|Withdrawal by Subject|0
2476984|NCT02246647|8553837|P2|Overall Study|Withdrawal by Subject|1
2476985|NCT02246647|8553838|P1|Overall Study|Withdrawal by Subject|1
2476986|NCT02246621|8553872|P2|Overall Study|On Study Treatment/ Follow Up|133
2476987|NCT02246621|8553873|P1|Overall Study|On Study Treatment/ Follow Up|257
2476988|NCT02246621|8553872|P2|Overall Study|Lost to Follow-up|1
2476989|NCT02246621|8553873|P1|Overall Study|Lost to Follow-up|3
2476990|NCT02246621|8553872|P2|Overall Study|Withdrawal by Subject|14
2476991|NCT02246621|8553873|P1|Overall Study|Withdrawal by Subject|36
2476992|NCT02246582|8553910|P2|Overall Study|Withdrawal by Subject|4
2476993|NCT02246582|8553911|P1|Overall Study|Withdrawal by Subject|3
2476994|NCT02246439|8553919|P2|Overall Study|Withdrawal by Subject|0
2476995|NCT02246439|8553920|P1|Overall Study|Withdrawal by Subject|1
2476996|NCT02246439|8553919|P2|Overall Study|Unkonwn|3
2476997|NCT02246439|8553920|P1|Overall Study|Unkonwn|1
2476998|NCT02246439|8553919|P2|Overall Study|Physician Decision|1
2476999|NCT02246439|8553920|P1|Overall Study|Physician Decision|0
2477000|NCT02246439|8553919|P2|Overall Study|Protocol Violation|2
2477001|NCT02246439|8553920|P1|Overall Study|Protocol Violation|0
2477002|NCT02246439|8553919|P2|Overall Study|Lost to Follow-up|5
2477003|NCT02246439|8553920|P1|Overall Study|Lost to Follow-up|7
2477004|NCT02246439|8553919|P2|Overall Study|Adverse Event|0
2477005|NCT02246439|8553920|P1|Overall Study|Adverse Event|3
2477006|NCT02246218|8553971|P2|Overall Study|Lost to Follow-up|0
2477007|NCT02246218|8553972|P1|Overall Study|Lost to Follow-up|1
2477008|NCT02246218|8553971|P2|Overall Study|Adverse Event|1
2477009|NCT02246218|8553972|P1|Overall Study|Adverse Event|1
2477010|NCT02246218|8553971|P2|Overall Study|Stopping Rule: Liver Transplant|4
2477011|NCT02246218|8553972|P1|Overall Study|Stopping Rule: Liver Transplant|2
2477012|NCT02246218|8553971|P2|Overall Study|Withdrawal by Parent/Guardian|1
2477013|NCT02246218|8553972|P1|Overall Study|Withdrawal by Parent/Guardian|0
2477014|NCT02246166|8554032|P2|Overall Study|Protocol Violation|0
2477015|NCT02246166|8554033|P1|Overall Study|Protocol Violation|1
2477016|NCT02246114|8554069|P2|Overall Study|miscarriage|0
2477017|NCT02246114|8554070|P1|Overall Study|miscarriage|1
2477018|NCT02245737|8554121|P3|Overall Study|Sponsor Decision|432
2477019|NCT02245737|8554122|P2|Overall Study|Sponsor Decision|430
2477020|NCT02245737|8554123|P1|Overall Study|Sponsor Decision|445
2477021|NCT02245737|8554121|P3|Overall Study|Withdrawal due to Caregiver Circumstance|22
2477185|NCT02243293|8554469|P9|Overall Study|Withdrawal by Subject|0
2477022|NCT02245737|8554122|P2|Overall Study|Withdrawal due to Caregiver Circumstance|20
2477023|NCT02245737|8554123|P1|Overall Study|Withdrawal due to Caregiver Circumstance|10
2477024|NCT02245737|8554121|P3|Overall Study|Withdrawal by Subject|44
2477025|NCT02245737|8554122|P2|Overall Study|Withdrawal by Subject|41
2477026|NCT02245737|8554123|P1|Overall Study|Withdrawal by Subject|40
2477027|NCT02245737|8554121|P3|Overall Study|Protocol Violation|3
2477028|NCT02245737|8554122|P2|Overall Study|Protocol Violation|2
2477029|NCT02245737|8554123|P1|Overall Study|Protocol Violation|3
2477030|NCT02245737|8554121|P3|Overall Study|Physician Decision|6
2477031|NCT02245737|8554122|P2|Overall Study|Physician Decision|3
2477032|NCT02245737|8554123|P1|Overall Study|Physician Decision|6
2477033|NCT02245737|8554121|P3|Overall Study|Other-determined by Investigator|10
2477034|NCT02245737|8554122|P2|Overall Study|Other-determined by Investigator|10
2477035|NCT02245737|8554123|P1|Overall Study|Other-determined by Investigator|9
2477036|NCT02245737|8554121|P3|Overall Study|Lost to Follow-up|4
2477037|NCT02245737|8554122|P2|Overall Study|Lost to Follow-up|5
2477038|NCT02245737|8554123|P1|Overall Study|Lost to Follow-up|2
2477039|NCT02245737|8554121|P3|Overall Study|Initiation of Symptomatic AD medication|0
2477040|NCT02245737|8554122|P2|Overall Study|Initiation of Symptomatic AD medication|0
2477041|NCT02245737|8554123|P1|Overall Study|Initiation of Symptomatic AD medication|2
2477042|NCT02245737|8554121|P3|Overall Study|Eligibility Criteria No Longer Met|4
2477043|NCT02245737|8554122|P2|Overall Study|Eligibility Criteria No Longer Met|4
2477044|NCT02245737|8554123|P1|Overall Study|Eligibility Criteria No Longer Met|2
2477045|NCT02245737|8554121|P3|Overall Study|Death|4
2477046|NCT02245737|8554122|P2|Overall Study|Death|4
2477047|NCT02245737|8554123|P1|Overall Study|Death|2
2477048|NCT02245737|8554121|P3|Overall Study|Condition Worsened|9
2477049|NCT02245737|8554122|P2|Overall Study|Condition Worsened|10
2477050|NCT02245737|8554123|P1|Overall Study|Condition Worsened|9
2477051|NCT02245737|8554121|P3|Overall Study|Adverse Event|33
2477052|NCT02245737|8554122|P2|Overall Study|Adverse Event|26
2477053|NCT02245737|8554123|P1|Overall Study|Adverse Event|23
2477054|NCT02245412|8554181|P3|Follow-Up Period|Other - Terminated by Sponsor|1
2477055|NCT02245412|8554182|P2|Follow-Up Period|Other - Terminated by Sponsor|0
2477056|NCT02245412|8554183|P1|Follow-Up Period|Other - Terminated by Sponsor|0
2477057|NCT02245412|8554181|P3|Follow-Up Period|Physician Decision|0
2477058|NCT02245412|8554182|P2|Follow-Up Period|Physician Decision|0
2477059|NCT02245412|8554183|P1|Follow-Up Period|Physician Decision|1
2477060|NCT02245412|8554181|P3|Follow-Up Period|Death|1
2477061|NCT02245412|8554182|P2|Follow-Up Period|Death|2
2477062|NCT02245412|8554183|P1|Follow-Up Period|Death|4
2477063|NCT02245412|8554181|P3|Treatment Period|Biopsy did not confirm GI GVHD|0
2477064|NCT02245412|8554182|P2|Treatment Period|Biopsy did not confirm GI GVHD|0
2477065|NCT02245412|8554183|P1|Treatment Period|Biopsy did not confirm GI GVHD|1
2477066|NCT02245412|8554181|P3|Treatment Period|Withdrawal by Subject|0
2477067|NCT02245412|8554182|P2|Treatment Period|Withdrawal by Subject|1
2477068|NCT02245412|8554183|P1|Treatment Period|Withdrawal by Subject|2
2477069|NCT02245412|8554181|P3|Treatment Period|Physician Decision|0
2477070|NCT02245412|8554182|P2|Treatment Period|Physician Decision|1
2477071|NCT02245412|8554183|P1|Treatment Period|Physician Decision|1
2477072|NCT02245412|8554181|P3|Treatment Period|Death|0
2477073|NCT02245412|8554182|P2|Treatment Period|Death|1
2477074|NCT02245412|8554183|P1|Treatment Period|Death|1
2477075|NCT02244996|8554230|P2|Overall Study|Lack of Efficacy|6
2477076|NCT02244996|8554231|P1|Overall Study|Lack of Efficacy|2
2477077|NCT02244944|8554243|P1|Overall Study|Study Terminated|1
2477078|NCT02244944|8554243|P1|Overall Study|Withdrawal by Subject|1
2477079|NCT02244619|8554274|P2|Overall Study|Did not receive study intervention|21
2477080|NCT02244619|8554275|P1|Overall Study|Did not receive study intervention|8
2477081|NCT02244580|8554293|P1|Overall Study|No cancer tissues available|241
2477082|NCT02244424|8554303|P2|Overall Study|Lost to Follow-up|10
2477083|NCT02244424|8554304|P1|Overall Study|Lost to Follow-up|20
2477084|NCT02243696|8554323|P1|Overall Study|Study Terminated for EP PASSION|961
2477085|NCT02243696|8554323|P1|Overall Study|Subject Withdrawn by Investigator|273
2477086|NCT02243696|8554323|P1|Overall Study|Subject No Longer has Study System|42
2477087|NCT02243696|8554323|P1|Overall Study|Lost to Follow-up|57
2477088|NCT02243696|8554323|P1|Overall Study|Withdrawal by Subject|79
2477089|NCT02243696|8554323|P1|Overall Study|Death|282
2477090|NCT02243371|8554359|P2|Overall Study|Withdrawal by Subject|2
2477091|NCT02243371|8554360|P1|Overall Study|Withdrawal by Subject|0
2477092|NCT02243371|8554359|P2|Overall Study|Lack of Clinical Benefit|1
2477093|NCT02243371|8554360|P1|Overall Study|Lack of Clinical Benefit|0
2477094|NCT02243371|8554359|P2|Overall Study|Adverse Event (unrelated)|1
2477095|NCT02243371|8554360|P1|Overall Study|Adverse Event (unrelated)|0
2477096|NCT02243371|8554359|P2|Overall Study|Death (unrelated)|4
2477097|NCT02243371|8554360|P1|Overall Study|Death (unrelated)|2
2477098|NCT02243371|8554359|P2|Overall Study|Progressive Disease (clinic & radio)|24
2477099|NCT02243371|8554360|P1|Overall Study|Progressive Disease (clinic & radio)|35
2477100|NCT02243306|8554380|P2|Overall Study|Physician Decision|1
2477101|NCT02243306|8554381|P1|Overall Study|Physician Decision|0
2477102|NCT02243306|8554380|P2|Overall Study|Other: Reached stopping criteria|1
2477103|NCT02243306|8554381|P1|Overall Study|Other: Reached stopping criteria|0
2477104|NCT02243306|8554380|P2|Overall Study|Adverse Event|1
2477105|NCT02243306|8554381|P1|Overall Study|Adverse Event|0
2477106|NCT02243293|8554456|P22|Overall Study|Randomized but did'nt receive study drug|0
2477107|NCT02243293|8554457|P21|Overall Study|Randomized but did'nt receive study drug|0
2477108|NCT02243293|8554458|P20|Overall Study|Randomized but did'nt receive study drug|1
2477109|NCT02243293|8554459|P19|Overall Study|Randomized but did'nt receive study drug|0
2477110|NCT02243293|8554460|P18|Overall Study|Randomized but did'nt receive study drug|0
2477111|NCT02243293|8554461|P17|Overall Study|Randomized but did'nt receive study drug|0
2477112|NCT02243293|8554462|P16|Overall Study|Randomized but did'nt receive study drug|0
2477113|NCT02243293|8554463|P15|Overall Study|Randomized but did'nt receive study drug|0
2477114|NCT02243293|8554464|P14|Overall Study|Randomized but did'nt receive study drug|0
2477115|NCT02243293|8554465|P13|Overall Study|Randomized but did'nt receive study drug|0
2477116|NCT02243293|8554466|P12|Overall Study|Randomized but did'nt receive study drug|0
2477117|NCT02243293|8554467|P11|Overall Study|Randomized but did'nt receive study drug|0
2477118|NCT02243293|8554468|P10|Overall Study|Randomized but did'nt receive study drug|1
2477119|NCT02243293|8554469|P9|Overall Study|Randomized but did'nt receive study drug|0
2477120|NCT02243293|8554470|P8|Overall Study|Randomized but did'nt receive study drug|0
2477121|NCT02243293|8554471|P7|Overall Study|Randomized but did'nt receive study drug|0
2477122|NCT02243293|8554472|P6|Overall Study|Randomized but did'nt receive study drug|0
2477123|NCT02243293|8554473|P5|Overall Study|Randomized but did'nt receive study drug|1
2477124|NCT02243293|8554474|P4|Overall Study|Randomized but did'nt receive study drug|0
2477125|NCT02243293|8554475|P3|Overall Study|Randomized but did'nt receive study drug|0
2477126|NCT02243293|8554476|P2|Overall Study|Randomized but did'nt receive study drug|0
2477127|NCT02243293|8554477|P1|Overall Study|Randomized but did'nt receive study drug|0
2477128|NCT02243293|8554456|P22|Overall Study|Enrolled into a Re-treatment Study|0
2477129|NCT02243293|8554457|P21|Overall Study|Enrolled into a Re-treatment Study|0
2477130|NCT02243293|8554458|P20|Overall Study|Enrolled into a Re-treatment Study|0
2477131|NCT02243293|8554459|P19|Overall Study|Enrolled into a Re-treatment Study|0
2477132|NCT02243293|8554460|P18|Overall Study|Enrolled into a Re-treatment Study|0
2477133|NCT02243293|8554461|P17|Overall Study|Enrolled into a Re-treatment Study|0
2477134|NCT02243293|8554462|P16|Overall Study|Enrolled into a Re-treatment Study|0
2477135|NCT02243293|8554463|P15|Overall Study|Enrolled into a Re-treatment Study|1
2477136|NCT02243293|8554464|P14|Overall Study|Enrolled into a Re-treatment Study|0
2477137|NCT02243293|8554465|P13|Overall Study|Enrolled into a Re-treatment Study|0
2477138|NCT02243293|8554466|P12|Overall Study|Enrolled into a Re-treatment Study|0
2477139|NCT02243293|8554467|P11|Overall Study|Enrolled into a Re-treatment Study|0
2477140|NCT02243293|8554468|P10|Overall Study|Enrolled into a Re-treatment Study|0
2477141|NCT02243293|8554469|P9|Overall Study|Enrolled into a Re-treatment Study|0
2477142|NCT02243293|8554470|P8|Overall Study|Enrolled into a Re-treatment Study|0
2477143|NCT02243293|8554471|P7|Overall Study|Enrolled into a Re-treatment Study|0
2477144|NCT02243293|8554472|P6|Overall Study|Enrolled into a Re-treatment Study|0
2477145|NCT02243293|8554473|P5|Overall Study|Enrolled into a Re-treatment Study|0
2477146|NCT02243293|8554474|P4|Overall Study|Enrolled into a Re-treatment Study|0
2477147|NCT02243293|8554475|P3|Overall Study|Enrolled into a Re-treatment Study|0
2477148|NCT02243293|8554476|P2|Overall Study|Enrolled into a Re-treatment Study|0
2477149|NCT02243293|8554477|P1|Overall Study|Enrolled into a Re-treatment Study|0
2477150|NCT02243293|8554456|P22|Overall Study|Lost to Follow-up|2
2477151|NCT02243293|8554457|P21|Overall Study|Lost to Follow-up|1
2477152|NCT02243293|8554458|P20|Overall Study|Lost to Follow-up|0
2477153|NCT02243293|8554459|P19|Overall Study|Lost to Follow-up|0
2477154|NCT02243293|8554460|P18|Overall Study|Lost to Follow-up|1
2477155|NCT02243293|8554461|P17|Overall Study|Lost to Follow-up|3
2477156|NCT02243293|8554462|P16|Overall Study|Lost to Follow-up|0
2477157|NCT02243293|8554463|P15|Overall Study|Lost to Follow-up|0
2477158|NCT02243293|8554464|P14|Overall Study|Lost to Follow-up|0
2477159|NCT02243293|8554465|P13|Overall Study|Lost to Follow-up|0
2477160|NCT02243293|8554466|P12|Overall Study|Lost to Follow-up|2
2477161|NCT02243293|8554467|P11|Overall Study|Lost to Follow-up|0
2477162|NCT02243293|8554468|P10|Overall Study|Lost to Follow-up|0
2477163|NCT02243293|8554469|P9|Overall Study|Lost to Follow-up|0
2477164|NCT02243293|8554470|P8|Overall Study|Lost to Follow-up|0
2477165|NCT02243293|8554471|P7|Overall Study|Lost to Follow-up|3
2477166|NCT02243293|8554472|P6|Overall Study|Lost to Follow-up|0
2477167|NCT02243293|8554473|P5|Overall Study|Lost to Follow-up|0
2477168|NCT02243293|8554474|P4|Overall Study|Lost to Follow-up|1
2477169|NCT02243293|8554475|P3|Overall Study|Lost to Follow-up|1
2477170|NCT02243293|8554476|P2|Overall Study|Lost to Follow-up|1
2477171|NCT02243293|8554477|P1|Overall Study|Lost to Follow-up|0
2477172|NCT02243293|8554456|P22|Overall Study|Withdrawal by Subject|1
2477173|NCT02243293|8554457|P21|Overall Study|Withdrawal by Subject|0
2477174|NCT02243293|8554458|P20|Overall Study|Withdrawal by Subject|0
2477175|NCT02243293|8554459|P19|Overall Study|Withdrawal by Subject|0
2477176|NCT02243293|8554460|P18|Overall Study|Withdrawal by Subject|0
2477177|NCT02243293|8554461|P17|Overall Study|Withdrawal by Subject|0
2477178|NCT02243293|8554462|P16|Overall Study|Withdrawal by Subject|0
2477179|NCT02243293|8554463|P15|Overall Study|Withdrawal by Subject|0
2477180|NCT02243293|8554464|P14|Overall Study|Withdrawal by Subject|0
2477181|NCT02243293|8554465|P13|Overall Study|Withdrawal by Subject|0
2477182|NCT02243293|8554466|P12|Overall Study|Withdrawal by Subject|1
2477183|NCT02243293|8554467|P11|Overall Study|Withdrawal by Subject|0
2477184|NCT02243293|8554468|P10|Overall Study|Withdrawal by Subject|1
2477186|NCT02243293|8554470|P8|Overall Study|Withdrawal by Subject|0
2477187|NCT02243293|8554471|P7|Overall Study|Withdrawal by Subject|0
2477188|NCT02243293|8554472|P6|Overall Study|Withdrawal by Subject|0
2477189|NCT02243293|8554473|P5|Overall Study|Withdrawal by Subject|0
2477190|NCT02243293|8554474|P4|Overall Study|Withdrawal by Subject|0
2477191|NCT02243293|8554475|P3|Overall Study|Withdrawal by Subject|0
2477192|NCT02243293|8554476|P2|Overall Study|Withdrawal by Subject|0
2477193|NCT02243293|8554477|P1|Overall Study|Withdrawal by Subject|1
2477194|NCT02243293|8554456|P22|Overall Study|Adverse Event|0
2477195|NCT02243293|8554457|P21|Overall Study|Adverse Event|1
2477196|NCT02243293|8554458|P20|Overall Study|Adverse Event|0
2477197|NCT02243293|8554459|P19|Overall Study|Adverse Event|0
2477198|NCT02243293|8554460|P18|Overall Study|Adverse Event|0
2477199|NCT02243293|8554461|P17|Overall Study|Adverse Event|0
2477200|NCT02243293|8554462|P16|Overall Study|Adverse Event|1
2477201|NCT02243293|8554463|P15|Overall Study|Adverse Event|0
2477202|NCT02243293|8554464|P14|Overall Study|Adverse Event|0
2477203|NCT02243293|8554465|P13|Overall Study|Adverse Event|0
2477204|NCT02243293|8554466|P12|Overall Study|Adverse Event|0
2477205|NCT02243293|8554467|P11|Overall Study|Adverse Event|0
2477206|NCT02243293|8554468|P10|Overall Study|Adverse Event|0
2477207|NCT02243293|8554469|P9|Overall Study|Adverse Event|0
2477208|NCT02243293|8554470|P8|Overall Study|Adverse Event|0
2477209|NCT02243293|8554471|P7|Overall Study|Adverse Event|0
2477210|NCT02243293|8554472|P6|Overall Study|Adverse Event|0
2477211|NCT02243293|8554473|P5|Overall Study|Adverse Event|0
2477212|NCT02243293|8554474|P4|Overall Study|Adverse Event|0
2477213|NCT02243293|8554475|P3|Overall Study|Adverse Event|0
2477214|NCT02243293|8554476|P2|Overall Study|Adverse Event|0
2477215|NCT02243293|8554477|P1|Overall Study|Adverse Event|1
2477216|NCT02243280|8554576|P11|Treated|Lost to Follow-up|2
2477217|NCT02243280|8554577|P10|Treated|Lost to Follow-up|0
2477218|NCT02243280|8554578|P9|Treated|Lost to Follow-up|1
2477219|NCT02243280|8554579|P8|Treated|Lost to Follow-up|0
2477220|NCT02243280|8554580|P7|Treated|Lost to Follow-up|0
2477221|NCT02243280|8554581|P6|Treated|Lost to Follow-up|0
2477222|NCT02243280|8554582|P5|Treated|Lost to Follow-up|0
2477223|NCT02243280|8554583|P4|Treated|Lost to Follow-up|0
2477224|NCT02243280|8554584|P3|Treated|Lost to Follow-up|0
2477225|NCT02243280|8554585|P2|Treated|Lost to Follow-up|0
2477226|NCT02243280|8554586|P1|Treated|Lost to Follow-up|0
2477227|NCT02243280|8554576|P11|Treated|Adverse Event|1
2477228|NCT02243280|8554577|P10|Treated|Adverse Event|0
2477229|NCT02243280|8554578|P9|Treated|Adverse Event|0
2477230|NCT02243280|8554579|P8|Treated|Adverse Event|0
2477231|NCT02243280|8554580|P7|Treated|Adverse Event|0
2477232|NCT02243280|8554581|P6|Treated|Adverse Event|0
2477233|NCT02243280|8554582|P5|Treated|Adverse Event|0
2477234|NCT02243280|8554583|P4|Treated|Adverse Event|0
2477235|NCT02243280|8554584|P3|Treated|Adverse Event|0
2477236|NCT02243280|8554585|P2|Treated|Adverse Event|0
2477237|NCT02243280|8554586|P1|Treated|Adverse Event|1
2477238|NCT02243202|8554641|P4|Overall Study|Randomized but not received treatment|1
2477239|NCT02243202|8554642|P3|Overall Study|Randomized but not received treatment|0
2477240|NCT02243202|8554643|P2|Overall Study|Randomized but not received treatment|0
2477241|NCT02243202|8554644|P1|Overall Study|Randomized but not received treatment|0
2477242|NCT02243202|8554641|P4|Overall Study|Other|2
2477243|NCT02243202|8554642|P3|Overall Study|Other|1
2477244|NCT02243202|8554643|P2|Overall Study|Other|3
2477245|NCT02243202|8554644|P1|Overall Study|Other|1
2477246|NCT02243202|8554641|P4|Overall Study|Withdrawal by Subject|4
2477247|NCT02243202|8554642|P3|Overall Study|Withdrawal by Subject|4
2477248|NCT02243202|8554643|P2|Overall Study|Withdrawal by Subject|6
2477249|NCT02243202|8554644|P1|Overall Study|Withdrawal by Subject|7
2477250|NCT02243202|8554641|P4|Overall Study|Protocol Violation|1
2477251|NCT02243202|8554642|P3|Overall Study|Protocol Violation|2
2477252|NCT02243202|8554643|P2|Overall Study|Protocol Violation|1
2477253|NCT02243202|8554644|P1|Overall Study|Protocol Violation|3
2477254|NCT02243202|8554641|P4|Overall Study|Lost to Follow-up|11
2477255|NCT02243202|8554642|P3|Overall Study|Lost to Follow-up|14
2477256|NCT02243202|8554643|P2|Overall Study|Lost to Follow-up|9
2477257|NCT02243202|8554644|P1|Overall Study|Lost to Follow-up|9
2477258|NCT02243202|8554641|P4|Overall Study|Adverse Event|4
2477259|NCT02243202|8554642|P3|Overall Study|Adverse Event|10
2477260|NCT02243202|8554643|P2|Overall Study|Adverse Event|6
2477261|NCT02243202|8554644|P1|Overall Study|Adverse Event|5
2477262|NCT02243176|8554680|P2|Overall Study|Adverse Event|2
2477263|NCT02243176|8554681|P1|Overall Study|Adverse Event|2
2477264|NCT02243176|8554680|P2|Overall Study|Withdrawal by Subject|7
2477265|NCT02243176|8554681|P1|Overall Study|Withdrawal by Subject|8
2477266|NCT02243176|8554680|P2|Overall Study|Protocol Violation|1
2477267|NCT02243176|8554681|P1|Overall Study|Protocol Violation|2
2477268|NCT02243176|8554680|P2|Overall Study|protocol specified withdrawal critera|3
2477269|NCT02243176|8554681|P1|Overall Study|protocol specified withdrawal critera|1
2477270|NCT02243176|8554680|P2|Overall Study|Other reason|2
2477271|NCT02243176|8554681|P1|Overall Study|Other reason|1
2477272|NCT02243046|8554706|P3|Overall Study|Lost to Follow-up|4
2477273|NCT02243046|8554707|P2|Overall Study|Lost to Follow-up|1
2477274|NCT02243046|8554708|P1|Overall Study|Lost to Follow-up|1
2477275|NCT02242942|8554775|P3|Overall Study|On-going in Study|11
2477276|NCT02242942|8554776|P2|Overall Study|On-going in Study|186
2477277|NCT02242942|8554777|P1|Overall Study|On-going in Study|190
2477278|NCT02242942|8554775|P3|Overall Study|Withdrawal by Subject|0
2477279|NCT02242942|8554776|P2|Overall Study|Withdrawal by Subject|10
2477280|NCT02242942|8554777|P1|Overall Study|Withdrawal by Subject|8
2477281|NCT02242942|8554775|P3|Overall Study|Physician Decision|0
2477282|NCT02242942|8554776|P2|Overall Study|Physician Decision|0
2477283|NCT02242942|8554777|P1|Overall Study|Physician Decision|1
2477284|NCT02242942|8554775|P3|Overall Study|Death|2
2477285|NCT02242942|8554776|P2|Overall Study|Death|20
2477286|NCT02242942|8554777|P1|Overall Study|Death|17
2477287|NCT02242903|8554811|P7|Overall Study|Withdrawal by Subject|0
2477288|NCT02242903|8554812|P6|Overall Study|Withdrawal by Subject|0
2477289|NCT02242903|8554813|P5|Overall Study|Withdrawal by Subject|0
2477290|NCT02242903|8554814|P4|Overall Study|Withdrawal by Subject|0
2477291|NCT02242903|8554815|P3|Overall Study|Withdrawal by Subject|0
2477292|NCT02242903|8554816|P2|Overall Study|Withdrawal by Subject|0
2477293|NCT02242903|8554817|P1|Overall Study|Withdrawal by Subject|1
2477294|NCT02242643|8554847|P2|Overall Study|Withdrawal by subject at Visit 2|1
2477295|NCT02242643|8554848|P1|Overall Study|Withdrawal by subject at Visit 2|0
2477296|NCT02242643|8554847|P2|Overall Study|Language barrier|0
2477297|NCT02242643|8554848|P1|Overall Study|Language barrier|1
2477298|NCT02242643|8554847|P2|Overall Study|Protocol requirements not followed|0
2477299|NCT02242643|8554848|P1|Overall Study|Protocol requirements not followed|1
2477300|NCT02242643|8554847|P2|Overall Study|Consent withdrawal by parent|0
2477301|NCT02242643|8554848|P1|Overall Study|Consent withdrawal by parent|1
2477302|NCT02242643|8554847|P2|Overall Study|Non-compliance|0
2477303|NCT02242643|8554848|P1|Overall Study|Non-compliance|1
2477304|NCT02242643|8554847|P2|Overall Study|Child placed in foster care by family|1
2477305|NCT02242643|8554848|P1|Overall Study|Child placed in foster care by family|0
2477306|NCT02242643|8554847|P2|Overall Study|Lost to Follow-up|61
2477307|NCT02242643|8554848|P1|Overall Study|Lost to Follow-up|54
2477308|NCT02242643|8554847|P2|Overall Study|Migrated/moved from study area|3
2477309|NCT02242643|8554848|P1|Overall Study|Migrated/moved from study area|1
2477310|NCT02242643|8554847|P2|Overall Study|Withdrawal by Subject|10
2477311|NCT02242643|8554848|P1|Overall Study|Withdrawal by Subject|15
2477312|NCT02242643|8554847|P2|Overall Study|Protocol Violation|2
2477313|NCT02242643|8554848|P1|Overall Study|Protocol Violation|1
2477314|NCT02242487|8554903|P2|Overall Study|Withdrawal by Subject|19
2477315|NCT02242487|8554904|P1|Overall Study|Withdrawal by Subject|37
2477316|NCT02242487|8554903|P2|Overall Study|Other - Miscellaneous|6
2477317|NCT02242487|8554904|P1|Overall Study|Other - Miscellaneous|4
2477318|NCT02242487|8554903|P2|Overall Study|Lost to Follow-up|1
2477319|NCT02242487|8554904|P1|Overall Study|Lost to Follow-up|2
2477320|NCT02242487|8554903|P2|Overall Study|Protocol Violation|0
2477321|NCT02242487|8554904|P1|Overall Study|Protocol Violation|2
2477322|NCT02242487|8554903|P2|Overall Study|Lack of Efficacy|6
2477323|NCT02242487|8554904|P1|Overall Study|Lack of Efficacy|4
2477324|NCT02242487|8554903|P2|Overall Study|Adverse Event|15
2477325|NCT02242487|8554904|P1|Overall Study|Adverse Event|13
2477326|NCT02242305|8554920|P2|Overall Study|Lost to Follow-up|0
2477327|NCT02242305|8554921|P1|Overall Study|Lost to Follow-up|2
2477328|NCT02242305|8554920|P2|Overall Study|Subject withdraws inform consent|4
2477329|NCT02242305|8554921|P1|Overall Study|Subject withdraws inform consent|0
2477330|NCT02242305|8554920|P2|Overall Study|Non-compliance dosing regimen or visit|2
2477331|NCT02242305|8554921|P1|Overall Study|Non-compliance dosing regimen or visit|2
2477332|NCT02242305|8554920|P2|Overall Study|Adverse Event|0
2477333|NCT02242305|8554921|P1|Overall Study|Adverse Event|1
2477334|NCT02242305|8554920|P2|Overall Study|Without spasm-like pain during 3 weeks|4
2477335|NCT02242305|8554921|P1|Overall Study|Without spasm-like pain during 3 weeks|1
2477336|NCT02242201|8554942|P3|Overall Study|preoperative opioid consumption|0
2477337|NCT02242201|8554943|P2|Overall Study|preoperative opioid consumption|1
2477338|NCT02242201|8554944|P1|Overall Study|preoperative opioid consumption|0
2477339|NCT02242201|8554942|P3|Overall Study|postponed surgery|1
2477340|NCT02242201|8554943|P2|Overall Study|postponed surgery|0
2477341|NCT02242201|8554944|P1|Overall Study|postponed surgery|0
2477342|NCT02242201|8554942|P3|Overall Study|changed surgical procedure|0
2477343|NCT02242201|8554943|P2|Overall Study|changed surgical procedure|0
2477344|NCT02242201|8554944|P1|Overall Study|changed surgical procedure|1
2477345|NCT02242201|8554942|P3|Overall Study|planned post-op anticoagulation|0
2477346|NCT02242201|8554943|P2|Overall Study|planned post-op anticoagulation|0
2477347|NCT02242201|8554944|P1|Overall Study|planned post-op anticoagulation|1
2477348|NCT02242201|8554942|P3|Overall Study|preoperative identified neuropathy|0
2477349|NCT02242201|8554943|P2|Overall Study|preoperative identified neuropathy|0
2477350|NCT02242201|8554944|P1|Overall Study|preoperative identified neuropathy|2
2477351|NCT02241889|8554982|P6|Overall Study|Withdrawal by Subject|1
2477352|NCT02241889|8554983|P5|Overall Study|Withdrawal by Subject|0
2477353|NCT02241889|8554984|P4|Overall Study|Withdrawal by Subject|0
2477354|NCT02241889|8554985|P3|Overall Study|Withdrawal by Subject|0
2477355|NCT02241889|8554986|P2|Overall Study|Withdrawal by Subject|0
2477356|NCT02241889|8554987|P1|Overall Study|Withdrawal by Subject|0
2477357|NCT02241889|8554982|P6|Overall Study|device issues|0
2477358|NCT02241889|8554983|P5|Overall Study|device issues|0
2477359|NCT02241889|8554984|P4|Overall Study|device issues|0
2477360|NCT02241889|8554985|P3|Overall Study|device issues|1
2477361|NCT02241889|8554986|P2|Overall Study|device issues|0
2477362|NCT02241889|8554987|P1|Overall Study|device issues|0
2477363|NCT02241785|8555022|P1|Overall Study|Adverse Event|1
2477364|NCT02241785|8555022|P1|Overall Study|Lost to Follow-up|2
2477365|NCT02241785|8555022|P1|Overall Study|Withdrawal by Subject|1
2477366|NCT02241785|8555022|P1|Overall Study|Sponsor Termination|43
2477367|NCT02241733|8555032|P2|Overall Study|Death|2
2477368|NCT02241733|8555033|P1|Overall Study|Death|0
2477369|NCT02241733|8555032|P2|Overall Study|Withdrawal by Subject|2
2477370|NCT02241733|8555033|P1|Overall Study|Withdrawal by Subject|0
2477371|NCT02241733|8555032|P2|Overall Study|Physician Decision|2
2477372|NCT02241733|8555033|P1|Overall Study|Physician Decision|6
2477373|NCT02241733|8555032|P2|Overall Study|Lost to Follow-up|4
2477374|NCT02241733|8555033|P1|Overall Study|Lost to Follow-up|9
2477375|NCT02241551|8555072|P2|Overall Study|Adverse Event|0
2477376|NCT02241551|8555073|P1|Overall Study|Adverse Event|1
2477377|NCT02241512|8555095|P2|Overall Study|Pump malfunction, drug not delivered|0
2477378|NCT02241512|8555096|P1|Overall Study|Pump malfunction, drug not delivered|1
2477379|NCT02241187|8555112|P1|Overall Study|Protocol closed due to lack of accrual.|2
2477380|NCT02240693|8555144|P5|Overall Study|Other than specified|0
2477381|NCT02240693|8555145|P4|Overall Study|Other than specified|0
2477382|NCT02240693|8555146|P3|Overall Study|Other than specified|2
2477383|NCT02240693|8555147|P2|Overall Study|Other than specified|0
2477384|NCT02240693|8555148|P1|Overall Study|Other than specified|0
2477385|NCT02240693|8555144|P5|Overall Study|Withdrawal by Subject|0
2477386|NCT02240693|8555145|P4|Overall Study|Withdrawal by Subject|1
2477387|NCT02240693|8555146|P3|Overall Study|Withdrawal by Subject|2
2477388|NCT02240693|8555147|P2|Overall Study|Withdrawal by Subject|0
2477389|NCT02240693|8555148|P1|Overall Study|Withdrawal by Subject|0
2477390|NCT02240693|8555144|P5|Overall Study|Adverse Event|1
2477391|NCT02240693|8555145|P4|Overall Study|Adverse Event|0
2477392|NCT02240693|8555146|P3|Overall Study|Adverse Event|0
2477393|NCT02240693|8555147|P2|Overall Study|Adverse Event|0
2477394|NCT02240693|8555148|P1|Overall Study|Adverse Event|0
2477395|NCT02240680|8555184|P4|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
2477396|NCT02240680|8555185|P3|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1
2477397|NCT02240680|8555186|P2|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
2477398|NCT02240680|8555187|P1|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
2477399|NCT02240680|8555184|P4|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
2477400|NCT02240680|8555185|P3|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1
2477401|NCT02240680|8555186|P2|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
2477402|NCT02240680|8555187|P1|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
2477403|NCT02240680|8555184|P4|Japanese Patients (Up to 52 Weeks)|Adverse Event|7
2477404|NCT02240680|8555185|P3|Japanese Patients (Up to 52 Weeks)|Adverse Event|6
2477405|NCT02240680|8555186|P2|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
2477406|NCT02240680|8555187|P1|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
2477407|NCT02240680|8555184|P4|Overall Study (Up to 24 Weeks)|Other than specified|0
2477408|NCT02240680|8555185|P3|Overall Study (Up to 24 Weeks)|Other than specified|0
2477409|NCT02240680|8555186|P2|Overall Study (Up to 24 Weeks)|Other than specified|0
2477410|NCT02240680|8555187|P1|Overall Study (Up to 24 Weeks)|Other than specified|1
2477411|NCT02240680|8555184|P4|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
2477412|NCT02240680|8555185|P3|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
2477413|NCT02240680|8555186|P2|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1
2477414|NCT02240680|8555187|P1|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3
2477415|NCT02240680|8555184|P4|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
2477416|NCT02240680|8555185|P3|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
2477417|NCT02240680|8555186|P2|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
2477418|NCT02240680|8555187|P1|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1
2477419|NCT02240680|8555184|P4|Overall Study (Up to 24 Weeks)|Protocol Violation|0
2477420|NCT02240680|8555185|P3|Overall Study (Up to 24 Weeks)|Protocol Violation|0
2477421|NCT02240680|8555186|P2|Overall Study (Up to 24 Weeks)|Protocol Violation|1
2477422|NCT02240680|8555187|P1|Overall Study (Up to 24 Weeks)|Protocol Violation|4
2477423|NCT02240680|8555184|P4|Overall Study (Up to 24 Weeks)|Adverse Event|0
2477424|NCT02240680|8555185|P3|Overall Study (Up to 24 Weeks)|Adverse Event|0
2477425|NCT02240680|8555186|P2|Overall Study (Up to 24 Weeks)|Adverse Event|6
2477426|NCT02240680|8555187|P1|Overall Study (Up to 24 Weeks)|Adverse Event|6
2477427|NCT02240628|8555241|P2|Overall Study|Physician Decision|5
2477428|NCT02240628|8555242|P1|Overall Study|Physician Decision|6
2477429|NCT02240368|8555276|P3|Overall Study|Entropy failed to detect more than 50%|1
2477430|NCT02240368|8555277|P2|Overall Study|Entropy failed to detect more than 50%|0
2477431|NCT02240368|8555278|P1|Overall Study|Entropy failed to detect more than 50%|0
2477432|NCT02240368|8555276|P3|Overall Study|Surgery lasted less then 20 minutes|0
2477433|NCT02240368|8555277|P2|Overall Study|Surgery lasted less then 20 minutes|0
2477434|NCT02240368|8555278|P1|Overall Study|Surgery lasted less then 20 minutes|1
2477435|NCT02240121|8555310|P2|Overall Study|Other than specified|3
2477436|NCT02240121|8555311|P1|Overall Study|Other than specified|1
2477437|NCT02240121|8555310|P2|Overall Study|Lost to Follow-up|4
2477438|NCT02240121|8555311|P1|Overall Study|Lost to Follow-up|3
2477439|NCT02240121|8555310|P2|Overall Study|Withdrawal by Subject|2
2477440|NCT02240121|8555311|P1|Overall Study|Withdrawal by Subject|6
2477441|NCT02240121|8555310|P2|Overall Study|Adverse Event|4
2477442|NCT02240121|8555311|P1|Overall Study|Adverse Event|2
2477443|NCT02240121|8555310|P2|Overall Study|Pregnancy|0
2477444|NCT02240121|8555311|P1|Overall Study|Pregnancy|1
2477445|NCT02240121|8555310|P2|Overall Study|Site closed|1
2477446|NCT02240121|8555311|P1|Overall Study|Site closed|1
2477447|NCT02240121|8555310|P2|Overall Study|Lack of Efficacy|3
2477448|NCT02240121|8555311|P1|Overall Study|Lack of Efficacy|2
2477449|NCT02240121|8555310|P2|Overall Study|Change in protocol interpretation|0
2477450|NCT02240121|8555311|P1|Overall Study|Change in protocol interpretation|1
2477451|NCT02240121|8555310|P2|Overall Study|Physician Decision|1
2477452|NCT02240121|8555311|P1|Overall Study|Physician Decision|0
2477453|NCT02240121|8555310|P2|Overall Study|Protocol Violation|2
2477454|NCT02240121|8555311|P1|Overall Study|Protocol Violation|1
2477455|NCT02240108|8555339|P2|Overall Study|StudyTerminated by Sponsor|1
2477456|NCT02240108|8555340|P1|Overall Study|StudyTerminated by Sponsor|0
2477457|NCT02240108|8555339|P2|Overall Study|Withdrawal by Subject|9
2477458|NCT02240108|8555340|P1|Overall Study|Withdrawal by Subject|4
2477459|NCT02240108|8555339|P2|Overall Study|Pregnancy|0
2477460|NCT02240108|8555340|P1|Overall Study|Pregnancy|1
2477461|NCT02240108|8555339|P2|Overall Study|Adverse Event|9
2477462|NCT02240108|8555340|P1|Overall Study|Adverse Event|1
2477463|NCT02240108|8555339|P2|Overall Study|Other than specified|6
2477464|NCT02240108|8555340|P1|Overall Study|Other than specified|8
2477465|NCT02239978|8555395|P2|Overall Study|Withdrawal by Subject|0
2477466|NCT02239978|8555396|P1|Overall Study|Withdrawal by Subject|2
2477467|NCT02239939|8555413|P2|Overall Study|Lost to Follow-up|1
2477468|NCT02239939|8555414|P1|Overall Study|Lost to Follow-up|0
2477469|NCT02239939|8555413|P2|Overall Study|Withdrawal by Subject|1
2477470|NCT02239939|8555414|P1|Overall Study|Withdrawal by Subject|1
2477471|NCT02239939|8555413|P2|Overall Study|Adverse Event|0
2477472|NCT02239939|8555414|P1|Overall Study|Adverse Event|1
2477473|NCT02239926|8555430|P2|Overall Study|Withdrawal by Subject|1
2477474|NCT02239926|8555431|P1|Overall Study|Withdrawal by Subject|0
2477475|NCT02239692|8555493|P2|Overall Study|Other reason|0
2477476|NCT02239692|8555494|P1|Overall Study|Other reason|1
2477477|NCT02239692|8555493|P2|Overall Study|Withdrawal by Subject|5
2477478|NCT02239692|8555494|P1|Overall Study|Withdrawal by Subject|3
2477479|NCT02239692|8555493|P2|Overall Study|Lost to Follow-up|4
2477480|NCT02239692|8555494|P1|Overall Study|Lost to Follow-up|1
2477481|NCT02239692|8555493|P2|Overall Study|Physician Decision|1
2477482|NCT02239692|8555494|P1|Overall Study|Physician Decision|0
2477483|NCT02239692|8555493|P2|Overall Study|Adverse Event|1
2477484|NCT02239692|8555494|P1|Overall Study|Adverse Event|0
2477485|NCT02239692|8555493|P2|Overall Study|Incomplete colonoscopy|2
2477486|NCT02239692|8555494|P1|Overall Study|Incomplete colonoscopy|1
2477487|NCT02239679|8555513|P3|Overall Study|Withdrawal by Subject|1
2477488|NCT02239679|8555514|P2|Overall Study|Withdrawal by Subject|3
2477489|NCT02239679|8555515|P1|Overall Study|Withdrawal by Subject|2
2477490|NCT02239679|8555513|P3|Overall Study|Lost to Follow-up|0
2477491|NCT02239679|8555514|P2|Overall Study|Lost to Follow-up|0
2477492|NCT02239679|8555515|P1|Overall Study|Lost to Follow-up|1
2477493|NCT02239640|8555727|P1|Overall Study|Death|142
2477494|NCT02239640|8555727|P1|Overall Study|Lost to Follow-up|72
2477495|NCT02239640|8555727|P1|Overall Study|Withdrawal by Subject|3
2477496|NCT02239601|8555739|P2|Overall Study|Protocol Violation|2
2477497|NCT02239601|8555740|P1|Overall Study|Protocol Violation|4
2477498|NCT02239601|8555739|P2|Overall Study|Withdrawal by Subject|4
2477499|NCT02239601|8555740|P1|Overall Study|Withdrawal by Subject|3
2477500|NCT02239536|8555793|P2|Overall Study|Non-neoplastic polyp|17
2477501|NCT02239536|8555794|P1|Overall Study|Non-neoplastic polyp|23
2477502|NCT02239510|8555804|P2|Overall Study|Lost to Follow-up|1
2477503|NCT02239510|8555805|P1|Overall Study|Lost to Follow-up|2
2477504|NCT02239328|8555827|P1|Overall Study|Equipment or website malfunction|2
2477505|NCT02239328|8555827|P1|Overall Study|Benign disease noted at time of surgery|6
2477506|NCT02239120|8555852|P2|Overall Study|Lost to Follow-up|14
2477507|NCT02239120|8555853|P1|Overall Study|Lost to Follow-up|19
2477508|NCT02239120|8555852|P2|Overall Study|Death|58
2477509|NCT02239120|8555853|P1|Overall Study|Death|56
2477510|NCT02239094|8555877|P1|Overall Study|Remitted before started|1
2477511|NCT02239094|8555877|P1|Overall Study|Withdrawal by Subject|1
2477512|NCT02238483|8555932|P2|Overall Study|Illness in family member|0
2477513|NCT02238483|8555933|P1|Overall Study|Illness in family member|1
2477514|NCT02238483|8555932|P2|Overall Study|Completion status not recorded|1
2477515|NCT02238483|8555933|P1|Overall Study|Completion status not recorded|1
2477516|NCT02238483|8555932|P2|Overall Study|Withdrawn due to physician decision|0
2477517|NCT02238483|8555933|P1|Overall Study|Withdrawn due to physician decision|1
2477518|NCT02238483|8555932|P2|Overall Study|Adverse Event|3
2477519|NCT02238483|8555933|P1|Overall Study|Adverse Event|7
2477520|NCT02238483|8555932|P2|Overall Study|Death|0
2477521|NCT02238483|8555933|P1|Overall Study|Death|1
2477522|NCT02238483|8555932|P2|Overall Study|Protocol Violation|2
2477523|NCT02238483|8555933|P1|Overall Study|Protocol Violation|1
2477524|NCT02238483|8555932|P2|Overall Study|Lost to Follow-up|1
2477525|NCT02238483|8555933|P1|Overall Study|Lost to Follow-up|1
2477526|NCT02238483|8555932|P2|Overall Study|Withdrawal by Subject|7
2477527|NCT02238483|8555933|P1|Overall Study|Withdrawal by Subject|2
2477528|NCT02238379|8555971|P2|Overall Study|Lost to Follow-up|0
2477529|NCT02238379|8555972|P1|Overall Study|Lost to Follow-up|1
2477530|NCT02238080|8555998|P1|Overall Study|Other|4
2477531|NCT02238080|8555998|P1|Overall Study|Withdrawal by Subject|2
2477532|NCT02238080|8555998|P1|Overall Study|Treatment interrupted|6
2477533|NCT02238080|8555998|P1|Overall Study|Death|13
2477534|NCT02238067|8556012|P1|Overall Study|Not completed survey at Month 6|45
2477535|NCT02237911|8556083|P3|Overall Study|Lost to Follow-up|1
2477536|NCT02237911|8556084|P2|Overall Study|Lost to Follow-up|1
2477537|NCT02237911|8556085|P1|Overall Study|Lost to Follow-up|3
2477538|NCT02237911|8556083|P3|Overall Study|Withdrawal by Subject|2
2477539|NCT02237911|8556084|P2|Overall Study|Withdrawal by Subject|7
2477540|NCT02237911|8556085|P1|Overall Study|Withdrawal by Subject|4
2477541|NCT02237118|8556101|P2|Overall Study|consent withdrawn|0
2477542|NCT02237118|8556102|P1|Overall Study|consent withdrawn|1
2477543|NCT02237118|8556101|P2|Overall Study|Protocol Violation|1
2477544|NCT02237118|8556102|P1|Overall Study|Protocol Violation|0
2477545|NCT02236611|8556139|P2|Overall Study|Withdrew consent|4
2477546|NCT02236611|8556140|P1|Overall Study|Withdrew consent|9
2477547|NCT02236611|8556139|P2|Overall Study|Protocol deviation|5
2477548|NCT02236611|8556140|P1|Overall Study|Protocol deviation|3
2477549|NCT02236611|8556139|P2|Overall Study|Lost to Follow-up|2
2477550|NCT02236611|8556140|P1|Overall Study|Lost to Follow-up|0
2477551|NCT02236611|8556139|P2|Overall Study|Lack of Efficacy|7
2477552|NCT02236611|8556140|P1|Overall Study|Lack of Efficacy|4
2477553|NCT02236611|8556139|P2|Overall Study|Adverse Event|16
2477554|NCT02236611|8556140|P1|Overall Study|Adverse Event|10
2477555|NCT02236598|8556148|P2|Overall Study|Withdrawal by Subject|1
2477556|NCT02236598|8556149|P1|Overall Study|Withdrawal by Subject|0
2477557|NCT02236598|8556148|P2|Overall Study|Adverse Event|1
2477558|NCT02236598|8556149|P1|Overall Study|Adverse Event|0
2477559|NCT02236559|8556163|P2|Overall Study|Withdrawal by Subject|0
2477560|NCT02236559|8556164|P1|Overall Study|Withdrawal by Subject|1
2477561|NCT02236559|8556163|P2|Overall Study|Physician Decision|1
2477562|NCT02236559|8556164|P1|Overall Study|Physician Decision|1
2477563|NCT02236559|8556163|P2|Overall Study|Subject Did Not Consent|2
2477564|NCT02236559|8556164|P1|Overall Study|Subject Did Not Consent|4
2477565|NCT02236559|8556163|P2|Overall Study|Did not Meet Inclusion|3
2477566|NCT02236559|8556164|P1|Overall Study|Did not Meet Inclusion|3
2477567|NCT02236559|8556163|P2|Overall Study|Met Exclusion|6
2477568|NCT02236559|8556164|P1|Overall Study|Met Exclusion|3
2477569|NCT02236520|8556201|P4|Overall Study|Pregnancy|0
2477570|NCT02236520|8556202|P3|Overall Study|Pregnancy|0
2477571|NCT02236520|8556203|P2|Overall Study|Pregnancy|0
2477572|NCT02236520|8556204|P1|Overall Study|Pregnancy|1
2477573|NCT02236520|8556201|P4|Overall Study|Withdrawal by Subject|1
2477574|NCT02236520|8556202|P3|Overall Study|Withdrawal by Subject|0
2477575|NCT02236520|8556203|P2|Overall Study|Withdrawal by Subject|0
2477576|NCT02236520|8556204|P1|Overall Study|Withdrawal by Subject|1
2477577|NCT02236520|8556201|P4|Overall Study|Physician Decision|0
2477578|NCT02236520|8556202|P3|Overall Study|Physician Decision|0
2477579|NCT02236520|8556203|P2|Overall Study|Physician Decision|5
2477580|NCT02236520|8556204|P1|Overall Study|Physician Decision|0
2477581|NCT02236130|8556231|P2|Overall Study|Lost to Follow-up|12
2477582|NCT02236130|8556232|P1|Overall Study|Lost to Follow-up|7
2477583|NCT02235454|8556282|P1|Overall Study|Withdrawal by Subject|2
2477584|NCT02235311|8556288|P2|Overall Study|Protocol Violation|1
2477585|NCT02235311|8556289|P1|Overall Study|Protocol Violation|0
2477586|NCT02235311|8556288|P2|Overall Study|Lost to Follow-up|1
2477587|NCT02235311|8556289|P1|Overall Study|Lost to Follow-up|0
2477588|NCT02235077|8556307|P2|Overall Study|Physician Decision|1
2477589|NCT02235077|8556308|P1|Overall Study|Physician Decision|0
2477590|NCT02235077|8556307|P2|Overall Study|Withdrawal by Subject|5
2477591|NCT02235077|8556308|P1|Overall Study|Withdrawal by Subject|8
2477592|NCT02235077|8556307|P2|Overall Study|Lost to Follow-up|6
2477593|NCT02235077|8556308|P1|Overall Study|Lost to Follow-up|5
2477594|NCT02235077|8556307|P2|Overall Study|Death|7
2477595|NCT02235077|8556308|P1|Overall Study|Death|5
2477596|NCT02234843|8556373|P10|Overall Study|Lost to Follow-up|0
2477597|NCT02234843|8556374|P9|Overall Study|Lost to Follow-up|0
2477598|NCT02234843|8556375|P8|Overall Study|Lost to Follow-up|0
2477599|NCT02234843|8556376|P7|Overall Study|Lost to Follow-up|1
2477600|NCT02234843|8556377|P6|Overall Study|Lost to Follow-up|0
2477601|NCT02234843|8556378|P5|Overall Study|Lost to Follow-up|0
2477602|NCT02234843|8556379|P4|Overall Study|Lost to Follow-up|0
2477603|NCT02234843|8556380|P3|Overall Study|Lost to Follow-up|0
2477604|NCT02234843|8556381|P2|Overall Study|Lost to Follow-up|1
2477605|NCT02234843|8556382|P1|Overall Study|Lost to Follow-up|0
2477606|NCT02234843|8556373|P10|Overall Study|Non-compliance with study drug|0
2477607|NCT02234843|8556374|P9|Overall Study|Non-compliance with study drug|0
2477608|NCT02234843|8556375|P8|Overall Study|Non-compliance with study drug|0
2477609|NCT02234843|8556376|P7|Overall Study|Non-compliance with study drug|1
2477610|NCT02234843|8556377|P6|Overall Study|Non-compliance with study drug|1
2477611|NCT02234843|8556378|P5|Overall Study|Non-compliance with study drug|0
2477612|NCT02234843|8556379|P4|Overall Study|Non-compliance with study drug|0
2477613|NCT02234843|8556380|P3|Overall Study|Non-compliance with study drug|0
2477614|NCT02234843|8556381|P2|Overall Study|Non-compliance with study drug|0
2477615|NCT02234843|8556382|P1|Overall Study|Non-compliance with study drug|1
2477616|NCT02234843|8556373|P10|Overall Study|Adverse Event|0
2477617|NCT02234843|8556374|P9|Overall Study|Adverse Event|1
2477618|NCT02234843|8556375|P8|Overall Study|Adverse Event|0
2477619|NCT02234843|8556376|P7|Overall Study|Adverse Event|0
2477620|NCT02234843|8556377|P6|Overall Study|Adverse Event|1
2477621|NCT02234843|8556378|P5|Overall Study|Adverse Event|2
2477622|NCT02234843|8556379|P4|Overall Study|Adverse Event|3
2477623|NCT02234843|8556380|P3|Overall Study|Adverse Event|1
2477624|NCT02234843|8556381|P2|Overall Study|Adverse Event|1
2477625|NCT02234843|8556382|P1|Overall Study|Adverse Event|5
2477626|NCT02234843|8556373|P10|Overall Study|Physician Decision|0
2477627|NCT02234843|8556374|P9|Overall Study|Physician Decision|0
2477628|NCT02234843|8556375|P8|Overall Study|Physician Decision|1
2477629|NCT02234843|8556376|P7|Overall Study|Physician Decision|0
2477630|NCT02234843|8556377|P6|Overall Study|Physician Decision|0
2477631|NCT02234843|8556378|P5|Overall Study|Physician Decision|0
2477632|NCT02234843|8556379|P4|Overall Study|Physician Decision|1
2477633|NCT02234843|8556380|P3|Overall Study|Physician Decision|0
2477634|NCT02234843|8556381|P2|Overall Study|Physician Decision|1
2477635|NCT02234843|8556382|P1|Overall Study|Physician Decision|4
2477636|NCT02234843|8556373|P10|Overall Study|Other|0
2477637|NCT02234843|8556374|P9|Overall Study|Other|0
2477638|NCT02234843|8556375|P8|Overall Study|Other|1
2477639|NCT02234843|8556376|P7|Overall Study|Other|0
2477640|NCT02234843|8556377|P6|Overall Study|Other|1
2477641|NCT02234843|8556378|P5|Overall Study|Other|0
2477642|NCT02234843|8556379|P4|Overall Study|Other|1
2477643|NCT02234843|8556380|P3|Overall Study|Other|0
2477644|NCT02234843|8556381|P2|Overall Study|Other|2
2477645|NCT02234843|8556382|P1|Overall Study|Other|0
2477646|NCT02234843|8556373|P10|Overall Study|Recovery|0
2477647|NCT02234843|8556374|P9|Overall Study|Recovery|0
2477648|NCT02234843|8556375|P8|Overall Study|Recovery|0
2477649|NCT02234843|8556376|P7|Overall Study|Recovery|0
2477650|NCT02234843|8556377|P6|Overall Study|Recovery|0
2477651|NCT02234843|8556378|P5|Overall Study|Recovery|0
2477652|NCT02234843|8556379|P4|Overall Study|Recovery|0
2477653|NCT02234843|8556380|P3|Overall Study|Recovery|0
2477654|NCT02234843|8556381|P2|Overall Study|Recovery|0
2477655|NCT02234843|8556382|P1|Overall Study|Recovery|1
2477656|NCT02234843|8556373|P10|Overall Study|Withdrawal by Subject|0
2477657|NCT02234843|8556374|P9|Overall Study|Withdrawal by Subject|0
2477658|NCT02234843|8556375|P8|Overall Study|Withdrawal by Subject|0
2477659|NCT02234843|8556376|P7|Overall Study|Withdrawal by Subject|0
2477660|NCT02234843|8556377|P6|Overall Study|Withdrawal by Subject|7
2477661|NCT02234843|8556378|P5|Overall Study|Withdrawal by Subject|0
2477662|NCT02234843|8556379|P4|Overall Study|Withdrawal by Subject|0
2477663|NCT02234843|8556380|P3|Overall Study|Withdrawal by Subject|1
2477664|NCT02234843|8556381|P2|Overall Study|Withdrawal by Subject|1
2477665|NCT02234843|8556382|P1|Overall Study|Withdrawal by Subject|5
2477666|NCT02234843|8556373|P10|Overall Study|Patient convenience|0
2477667|NCT02234843|8556374|P9|Overall Study|Patient convenience|0
2477668|NCT02234843|8556375|P8|Overall Study|Patient convenience|0
2477669|NCT02234843|8556376|P7|Overall Study|Patient convenience|0
2477670|NCT02234843|8556377|P6|Overall Study|Patient convenience|1
2477671|NCT02234843|8556378|P5|Overall Study|Patient convenience|0
2477672|NCT02234843|8556379|P4|Overall Study|Patient convenience|0
2477673|NCT02234843|8556380|P3|Overall Study|Patient convenience|0
2477674|NCT02234843|8556381|P2|Overall Study|Patient convenience|0
2477675|NCT02234843|8556382|P1|Overall Study|Patient convenience|2
2477676|NCT02234843|8556373|P10|Overall Study|Efficacy outcome reached|0
2477677|NCT02234843|8556374|P9|Overall Study|Efficacy outcome reached|0
2477678|NCT02234843|8556375|P8|Overall Study|Efficacy outcome reached|0
2477679|NCT02234843|8556376|P7|Overall Study|Efficacy outcome reached|0
2477680|NCT02234843|8556377|P6|Overall Study|Efficacy outcome reached|2
2477681|NCT02234843|8556378|P5|Overall Study|Efficacy outcome reached|0
2477682|NCT02234843|8556379|P4|Overall Study|Efficacy outcome reached|0
2477683|NCT02234843|8556380|P3|Overall Study|Efficacy outcome reached|0
2477684|NCT02234843|8556381|P2|Overall Study|Efficacy outcome reached|0
2477685|NCT02234843|8556382|P1|Overall Study|Efficacy outcome reached|2
2477686|NCT02234843|8556373|P10|Overall Study|Protocol Violation|0
2477687|NCT02234843|8556374|P9|Overall Study|Protocol Violation|0
2477688|NCT02234843|8556375|P8|Overall Study|Protocol Violation|0
2477689|NCT02234843|8556376|P7|Overall Study|Protocol Violation|0
2477690|NCT02234843|8556377|P6|Overall Study|Protocol Violation|0
2477691|NCT02234843|8556378|P5|Overall Study|Protocol Violation|0
2477692|NCT02234843|8556379|P4|Overall Study|Protocol Violation|0
2477693|NCT02234843|8556380|P3|Overall Study|Protocol Violation|1
2477694|NCT02234843|8556381|P2|Overall Study|Protocol Violation|0
2477695|NCT02234843|8556382|P1|Overall Study|Protocol Violation|1
2477696|NCT02234843|8556373|P10|Overall Study|Death|0
2477697|NCT02234843|8556374|P9|Overall Study|Death|0
2477698|NCT02234843|8556375|P8|Overall Study|Death|0
2477699|NCT02234843|8556376|P7|Overall Study|Death|0
2477700|NCT02234843|8556377|P6|Overall Study|Death|0
2477701|NCT02234843|8556378|P5|Overall Study|Death|0
2477702|NCT02234843|8556379|P4|Overall Study|Death|0
2477703|NCT02234843|8556380|P3|Overall Study|Death|0
2477704|NCT02234843|8556381|P2|Overall Study|Death|0
2477705|NCT02234843|8556382|P1|Overall Study|Death|1
2477706|NCT02234622|8556540|P2|Overall Study|Lost to Follow-up|14
2477707|NCT02234622|8556541|P1|Overall Study|Lost to Follow-up|27
2477708|NCT02234622|8556540|P2|Overall Study|Withdrawal by Subject|22
2477709|NCT02234622|8556541|P1|Overall Study|Withdrawal by Subject|16
2477710|NCT02234479|8556650|P2|Overall Study|Withdrawal by Subject|3
2477711|NCT02234479|8556651|P1|Overall Study|Withdrawal by Subject|1
2477712|NCT02234362|8556661|P1|Overall Study|Withdrawal by Subject|3
2477713|NCT02234362|8556661|P1|Overall Study|Lost to Follow-up|6
2477714|NCT02234362|8556661|P1|Overall Study|Not eligible after first screening visit|17
2477715|NCT02234284|8556680|P2|Overall Study|Lost to Follow-up|7
2477716|NCT02234284|8556681|P1|Overall Study|Lost to Follow-up|20
2477717|NCT02234284|8556680|P2|Overall Study|Withdrawal by Subject|0
2477718|NCT02234284|8556681|P1|Overall Study|Withdrawal by Subject|1
2477719|NCT02234284|8556680|P2|Overall Study|Death|2
2477720|NCT02234284|8556681|P1|Overall Study|Death|4
2477721|NCT02234141|8556740|P7|Long-Term Treatment Period|Study Discontinued by Sponsor|8
2477722|NCT02234141|8556741|P6|Long-Term Treatment Period|Study Discontinued by Sponsor|10
2477723|NCT02234141|8556742|P5|Long-Term Treatment Period|Study Discontinued by Sponsor|9
2477724|NCT02234141|8556743|P4|Long-Term Treatment Period|Study Discontinued by Sponsor|0
2477725|NCT02234141|8556744|P3|Long-Term Treatment Period|Study Discontinued by Sponsor|25
2477726|NCT02234141|8556745|P2|Long-Term Treatment Period|Study Discontinued by Sponsor|27
2477727|NCT02234141|8556746|P1|Long-Term Treatment Period|Study Discontinued by Sponsor|28
2477728|NCT02234141|8556740|P7|Long-Term Treatment Period|Withdrew Consent|0
2477729|NCT02234141|8556741|P6|Long-Term Treatment Period|Withdrew Consent|0
2477730|NCT02234141|8556742|P5|Long-Term Treatment Period|Withdrew Consent|0
2477731|NCT02234141|8556743|P4|Long-Term Treatment Period|Withdrew Consent|0
2477732|NCT02234141|8556744|P3|Long-Term Treatment Period|Withdrew Consent|1
2477733|NCT02234141|8556745|P2|Long-Term Treatment Period|Withdrew Consent|1
2477734|NCT02234141|8556746|P1|Long-Term Treatment Period|Withdrew Consent|0
2477735|NCT02234141|8556740|P7|Long-Term Treatment Period|Adverse Event|1
2477736|NCT02234141|8556741|P6|Long-Term Treatment Period|Adverse Event|1
2477737|NCT02234141|8556742|P5|Long-Term Treatment Period|Adverse Event|1
2477738|NCT02234141|8556743|P4|Long-Term Treatment Period|Adverse Event|0
2477739|NCT02234141|8556744|P3|Long-Term Treatment Period|Adverse Event|5
2477740|NCT02234141|8556745|P2|Long-Term Treatment Period|Adverse Event|0
2477741|NCT02234141|8556746|P1|Long-Term Treatment Period|Adverse Event|4
2477742|NCT02234141|8556740|P7|Long-Term Treatment Period|Investigator's discretion|1
2477743|NCT02234141|8556741|P6|Long-Term Treatment Period|Investigator's discretion|0
2477744|NCT02234141|8556742|P5|Long-Term Treatment Period|Investigator's discretion|0
2477745|NCT02234141|8556743|P4|Long-Term Treatment Period|Investigator's discretion|0
2477746|NCT02234141|8556744|P3|Long-Term Treatment Period|Investigator's discretion|2
2477747|NCT02234141|8556745|P2|Long-Term Treatment Period|Investigator's discretion|3
2477748|NCT02234141|8556746|P1|Long-Term Treatment Period|Investigator's discretion|1
2477749|NCT02234141|8556740|P7|Long-Term Treatment Period|Death|0
2477750|NCT02234141|8556741|P6|Long-Term Treatment Period|Death|1
2477751|NCT02234141|8556742|P5|Long-Term Treatment Period|Death|0
2477752|NCT02234141|8556743|P4|Long-Term Treatment Period|Death|0
2477753|NCT02234141|8556744|P3|Long-Term Treatment Period|Death|0
2477754|NCT02234141|8556745|P2|Long-Term Treatment Period|Death|0
2477755|NCT02234141|8556746|P1|Long-Term Treatment Period|Death|0
2477756|NCT02234141|8556740|P7|Treatment Period (24 Weeks)|Randomized but not treated|0
2477757|NCT02234141|8556741|P6|Treatment Period (24 Weeks)|Randomized but not treated|0
2477758|NCT02234141|8556742|P5|Treatment Period (24 Weeks)|Randomized but not treated|0
2477759|NCT02234141|8556743|P4|Treatment Period (24 Weeks)|Randomized but not treated|0
2477760|NCT02234141|8556744|P3|Treatment Period (24 Weeks)|Randomized but not treated|0
2477761|NCT02234141|8556745|P2|Treatment Period (24 Weeks)|Randomized but not treated|1
2477762|NCT02234141|8556746|P1|Treatment Period (24 Weeks)|Randomized but not treated|0
2477763|NCT02234141|8556740|P7|Treatment Period (24 Weeks)|Adverse Event|0
2477764|NCT02234141|8556741|P6|Treatment Period (24 Weeks)|Adverse Event|0
2477765|NCT02234141|8556742|P5|Treatment Period (24 Weeks)|Adverse Event|0
2477766|NCT02234141|8556743|P4|Treatment Period (24 Weeks)|Adverse Event|3
2477767|NCT02234141|8556744|P3|Treatment Period (24 Weeks)|Adverse Event|2
2477768|NCT02234141|8556745|P2|Treatment Period (24 Weeks)|Adverse Event|1
2477769|NCT02234141|8556746|P1|Treatment Period (24 Weeks)|Adverse Event|3
2477770|NCT02234141|8556740|P7|Treatment Period (24 Weeks)|Death|0
2477771|NCT02234141|8556741|P6|Treatment Period (24 Weeks)|Death|0
2477772|NCT02234141|8556742|P5|Treatment Period (24 Weeks)|Death|0
2477773|NCT02234141|8556743|P4|Treatment Period (24 Weeks)|Death|1
2477774|NCT02234141|8556744|P3|Treatment Period (24 Weeks)|Death|0
2477775|NCT02234141|8556745|P2|Treatment Period (24 Weeks)|Death|2
2477776|NCT02234141|8556746|P1|Treatment Period (24 Weeks)|Death|1
2477777|NCT02234141|8556740|P7|Treatment Period (24 Weeks)|Investigator's discretion|0
2477778|NCT02234141|8556741|P6|Treatment Period (24 Weeks)|Investigator's discretion|0
2477779|NCT02234141|8556742|P5|Treatment Period (24 Weeks)|Investigator's discretion|0
2477780|NCT02234141|8556743|P4|Treatment Period (24 Weeks)|Investigator's discretion|0
2477781|NCT02234141|8556744|P3|Treatment Period (24 Weeks)|Investigator's discretion|0
2477782|NCT02234141|8556745|P2|Treatment Period (24 Weeks)|Investigator's discretion|2
2477783|NCT02234141|8556746|P1|Treatment Period (24 Weeks)|Investigator's discretion|0
2477784|NCT02234141|8556740|P7|Treatment Period (24 Weeks)|Protocol Violation|0
2477785|NCT02234141|8556741|P6|Treatment Period (24 Weeks)|Protocol Violation|0
2477786|NCT02234141|8556742|P5|Treatment Period (24 Weeks)|Protocol Violation|0
2477787|NCT02234141|8556743|P4|Treatment Period (24 Weeks)|Protocol Violation|1
2477788|NCT02234141|8556744|P3|Treatment Period (24 Weeks)|Protocol Violation|0
2477789|NCT02234141|8556745|P2|Treatment Period (24 Weeks)|Protocol Violation|0
2477790|NCT02234141|8556746|P1|Treatment Period (24 Weeks)|Protocol Violation|0
2477791|NCT02233803|8556892|P2|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2
2477792|NCT02233803|8556893|P1|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1
2477793|NCT02233803|8556892|P2|Treatment Period 2 (4-Wks)|Lost to Follow-up|0
2477794|NCT02233803|8556893|P1|Treatment Period 2 (4-Wks)|Lost to Follow-up|1
2477795|NCT02233803|8556892|P2|Washout Period (4-Wks)|Withdrawal by Subject|1
2477796|NCT02233803|8556893|P1|Washout Period (4-Wks)|Withdrawal by Subject|1
2477797|NCT02233803|8556892|P2|Washout Period (4-Wks)|Physician Decision|0
2477798|NCT02233803|8556893|P1|Washout Period (4-Wks)|Physician Decision|1
2477799|NCT02233803|8556892|P2|Washout Period (4-Wks)|Lost to Follow-up|1
2477800|NCT02233803|8556893|P1|Washout Period (4-Wks)|Lost to Follow-up|0
2477801|NCT02233803|8556892|P2|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1
2477802|NCT02233803|8556893|P1|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0
2477803|NCT02233803|8556892|P2|Treatment Period 1 (4-Wks)|Protocol Violation|2
2477804|NCT02233803|8556893|P1|Treatment Period 1 (4-Wks)|Protocol Violation|2
2477805|NCT02233803|8556892|P2|Treatment Period 1 (4-Wks)|Adverse Event|1
2477806|NCT02233803|8556893|P1|Treatment Period 1 (4-Wks)|Adverse Event|0
2477807|NCT02233803|8556892|P2|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0
2477808|NCT02233803|8556893|P1|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1
2477809|NCT02233738|8556926|P2|Overall Study|Did not return after Baseline|2
2477810|NCT02233738|8556927|P1|Overall Study|Did not return after Baseline|3
2477811|NCT02233738|8556926|P2|Overall Study|Withdrawal by Subject|1
2477812|NCT02233738|8556927|P1|Overall Study|Withdrawal by Subject|0
2477813|NCT02233738|8556926|P2|Overall Study|Death|1
2477814|NCT02233738|8556927|P1|Overall Study|Death|0
2477815|NCT02233738|8556926|P2|Overall Study|Lost to Follow-up|12
2477816|NCT02233738|8556927|P1|Overall Study|Lost to Follow-up|5
2477817|NCT02233647|8557097|P1|Overall Study|Adverse Event|1
2477818|NCT02233543|8557126|P2|Period 2|COPD exacerbation|0
2477819|NCT02233543|8557127|P1|Period 2|COPD exacerbation|1
2477820|NCT02233543|8557126|P2|Period 2|Participant required other treatment.|1
2477821|NCT02233543|8557127|P1|Period 2|Participant required other treatment.|0
2477822|NCT02233543|8557126|P2|Period 2|Adverse Event|0
2477823|NCT02233543|8557127|P1|Period 2|Adverse Event|1
2477824|NCT02233543|8557126|P2|Period 1|Participants required other treatment.|3
2477825|NCT02233543|8557127|P1|Period 1|Participants required other treatment.|2
2477826|NCT02233543|8557126|P2|Period 1|Withdrawal by Subject|0
2477827|NCT02233543|8557127|P1|Period 1|Withdrawal by Subject|1
2477828|NCT02233309|8557177|P1|Overall Study|Physician Decision|5
2477829|NCT02232984|8557211|P1|Overall Study|Protocol Violation|1
2477830|NCT02232984|8557211|P1|Overall Study|not disclosed by site|7
2477831|NCT02232984|8557211|P1|Overall Study|Device implant unsuccessful|53
2477832|NCT02232984|8557211|P1|Overall Study|Investigator withdrawal|10
2477833|NCT02232984|8557211|P1|Overall Study|Death|1
2477834|NCT02232984|8557211|P1|Overall Study|Withdrawal by Subject|5
2477835|NCT02232880|8557220|P1|Overall Study|study stopped prior to randomization|1
2477836|NCT02232698|8557229|P2|Overall Study|Withdrawal by Subject|11
2477837|NCT02232698|8557230|P1|Overall Study|Withdrawal by Subject|0
2477838|NCT02232698|8557229|P2|Overall Study|Allocated to control group|3
2477839|NCT02232698|8557230|P1|Overall Study|Allocated to control group|0
2477840|NCT02232698|8557229|P2|Overall Study|Non-compliance with study device|4
2477841|NCT02232698|8557230|P1|Overall Study|Non-compliance with study device|1
2477842|NCT02232698|8557229|P2|Overall Study|Had device-associated symptoms|0
2477843|NCT02232698|8557230|P1|Overall Study|Had device-associated symptoms|7
2477844|NCT02232698|8557229|P2|Overall Study|Met exclusion criteria|1
2477845|NCT02232698|8557230|P1|Overall Study|Met exclusion criteria|1
2477846|NCT02232698|8557229|P2|Overall Study|Pregnancy|1
2477847|NCT02232698|8557230|P1|Overall Study|Pregnancy|1
2477848|NCT02232425|8557253|P2|Overall Study|Lack of Efficacy|0
2477849|NCT02232425|8557254|P1|Overall Study|Lack of Efficacy|1
2477850|NCT02232425|8557253|P2|Overall Study|Withdrawal by Subject|6
2477851|NCT02232425|8557254|P1|Overall Study|Withdrawal by Subject|5
2477852|NCT02232425|8557253|P2|Overall Study|Adverse Event|0
2477853|NCT02232425|8557254|P1|Overall Study|Adverse Event|2
2477854|NCT02232425|8557253|P2|Overall Study|Lost to Follow-up|2
2477855|NCT02232425|8557254|P1|Overall Study|Lost to Follow-up|6
2477856|NCT02232243|8557287|P3|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0
2477857|NCT02232243|8557288|P2|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1
2477858|NCT02232243|8557289|P1|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0
2477859|NCT02232178|8557301|P3|Overall Study|surgical complication|0
2477860|NCT02232178|8557302|P2|Overall Study|surgical complication|0
2477861|NCT02232178|8557303|P1|Overall Study|surgical complication|1
2477862|NCT02232178|8557301|P3|Overall Study|ineligibility|1
2477863|NCT02232178|8557302|P2|Overall Study|ineligibility|0
2477864|NCT02232178|8557303|P1|Overall Study|ineligibility|0
2477865|NCT02232178|8557301|P3|Overall Study|Lost to Follow-up|0
2477866|NCT02232178|8557302|P2|Overall Study|Lost to Follow-up|1
2477867|NCT02232178|8557303|P1|Overall Study|Lost to Follow-up|0
2477868|NCT02232074|8557333|P2|Overall Study|deemed ineligible|1
2477869|NCT02232074|8557334|P1|Overall Study|deemed ineligible|0
2477870|NCT02232074|8557333|P2|Overall Study|No legal concerns at baseline|41
2477871|NCT02232074|8557334|P1|Overall Study|No legal concerns at baseline|36
2477872|NCT02232074|8557333|P2|Overall Study|Withdrawal by Subject|3
2477873|NCT02232074|8557334|P1|Overall Study|Withdrawal by Subject|5
2477874|NCT02231918|8557401|P3|Overall Study|Adverse Event|1
2477875|NCT02231918|8557402|P2|Overall Study|Adverse Event|0
2477876|NCT02231918|8557403|P1|Overall Study|Adverse Event|0
2477877|NCT02231918|8557401|P3|Overall Study|Withdrawal by Subject|0
2477878|NCT02231918|8557402|P2|Overall Study|Withdrawal by Subject|1
2477879|NCT02231918|8557403|P1|Overall Study|Withdrawal by Subject|0
2477880|NCT02231892|8557468|P3|Overall Study|Could not find reliable motor hotspot|1
2477881|NCT02231892|8557469|P2|Overall Study|Could not find reliable motor hotspot|0
2477882|NCT02231892|8557470|P1|Overall Study|Could not find reliable motor hotspot|0
2477883|NCT02231892|8557468|P3|Overall Study|Could not find motor threshold|1
2477884|NCT02231892|8557469|P2|Overall Study|Could not find motor threshold|0
2477885|NCT02231892|8557470|P1|Overall Study|Could not find motor threshold|2
2477886|NCT02231892|8557468|P3|Overall Study|Participant motor threshold was >83%|9
2477887|NCT02231892|8557469|P2|Overall Study|Participant motor threshold was >83%|0
2477888|NCT02231892|8557470|P1|Overall Study|Participant motor threshold was >83%|0
2477889|NCT02231892|8557468|P3|Overall Study|Motor activity when stimulating ante ACC|12
2477890|NCT02231892|8557469|P2|Overall Study|Motor activity when stimulating ante ACC|7
2477891|NCT02231892|8557470|P1|Overall Study|Motor activity when stimulating ante ACC|4
2477892|NCT02231892|8557468|P3|Overall Study|Physician Decision|4
2477893|NCT02231892|8557469|P2|Overall Study|Physician Decision|2
2477894|NCT02231892|8557470|P1|Overall Study|Physician Decision|0
2477895|NCT02231892|8557468|P3|Overall Study|Withdrawal by Subject|15
2477896|NCT02231892|8557469|P2|Overall Study|Withdrawal by Subject|3
2477897|NCT02231892|8557470|P1|Overall Study|Withdrawal by Subject|4
2477898|NCT02231892|8557468|P3|Overall Study|Lost to Follow-up|3
2477899|NCT02231892|8557469|P2|Overall Study|Lost to Follow-up|0
2477900|NCT02231892|8557470|P1|Overall Study|Lost to Follow-up|1
2477901|NCT02231762|8557487|P4|Maintenance Phase|Adverse Event|2
2477902|NCT02231762|8557488|P3|Maintenance Phase|Adverse Event|1
2477903|NCT02231762|8557489|P2|Maintenance Phase|Adverse Event|0
2477904|NCT02231762|8557490|P1|Maintenance Phase|Adverse Event|0
2477905|NCT02231762|8557487|P4|Maintenance Phase|Disease progression|3
2477906|NCT02231762|8557488|P3|Maintenance Phase|Disease progression|4
2477907|NCT02231762|8557489|P2|Maintenance Phase|Disease progression|3
2477908|NCT02231762|8557490|P1|Maintenance Phase|Disease progression|0
2477909|NCT02231762|8557487|P4|Combination Phase|Protocol Violation|0
2477910|NCT02231762|8557488|P3|Combination Phase|Protocol Violation|0
2477911|NCT02231762|8557489|P2|Combination Phase|Protocol Violation|0
2477912|NCT02231762|8557490|P1|Combination Phase|Protocol Violation|1
2477913|NCT02231762|8557487|P4|Combination Phase|Did not meet inclusion criteria|0
2477914|NCT02231762|8557488|P3|Combination Phase|Did not meet inclusion criteria|0
2477915|NCT02231762|8557489|P2|Combination Phase|Did not meet inclusion criteria|0
2477916|NCT02231762|8557490|P1|Combination Phase|Did not meet inclusion criteria|1
2477917|NCT02231762|8557487|P4|Combination Phase|Disease Progression|0
2477918|NCT02231762|8557488|P3|Combination Phase|Disease Progression|0
2477919|NCT02231762|8557489|P2|Combination Phase|Disease Progression|0
2477920|NCT02231762|8557490|P1|Combination Phase|Disease Progression|6
2477921|NCT02231762|8557487|P4|Combination Phase|Withdrawal by Subject|0
2477922|NCT02231762|8557488|P3|Combination Phase|Withdrawal by Subject|0
2477923|NCT02231762|8557489|P2|Combination Phase|Withdrawal by Subject|0
2477924|NCT02231762|8557490|P1|Combination Phase|Withdrawal by Subject|2
2477925|NCT02231762|8557487|P4|Combination Phase|Adverse Event|0
2477926|NCT02231762|8557488|P3|Combination Phase|Adverse Event|0
2477927|NCT02231762|8557489|P2|Combination Phase|Adverse Event|0
2477928|NCT02231762|8557490|P1|Combination Phase|Adverse Event|10
2477929|NCT02231749|8557523|P2|Overall Study|No longer meets Study Criteria|0
2477930|NCT02231749|8557524|P1|Overall Study|No longer meets Study Criteria|1
2477931|NCT02231749|8557523|P2|Overall Study|other|8
2477932|NCT02231749|8557524|P1|Overall Study|other|0
2477933|NCT02231749|8557523|P2|Overall Study|Pregnancy|0
2477934|NCT02231749|8557524|P1|Overall Study|Pregnancy|1
2477935|NCT02231749|8557523|P2|Overall Study|Poor/Non-Compliance|3
2477936|NCT02231749|8557524|P1|Overall Study|Poor/Non-Compliance|0
2477937|NCT02231749|8557523|P2|Overall Study|Maximum Clinical Benefit|8
2477938|NCT02231749|8557524|P1|Overall Study|Maximum Clinical Benefit|5
2477939|NCT02231749|8557523|P2|Overall Study|Lost to Follow-up|2
2477940|NCT02231749|8557524|P1|Overall Study|Lost to Follow-up|1
2477941|NCT02231749|8557523|P2|Overall Study|Participant withdrew Consent|15
2477942|NCT02231749|8557524|P1|Overall Study|Participant withdrew Consent|8
2477943|NCT02231749|8557523|P2|Overall Study|Participant's request to discontinue|21
2477944|NCT02231749|8557524|P1|Overall Study|Participant's request to discontinue|10
2477945|NCT02231749|8557523|P2|Overall Study|AE unrelated to Study drug|31
2477946|NCT02231749|8557524|P1|Overall Study|AE unrelated to Study drug|32
2477947|NCT02231749|8557523|P2|Overall Study|Death|1
2477948|NCT02231749|8557524|P1|Overall Study|Death|1
2477949|NCT02231749|8557523|P2|Overall Study|Study Drug Toxicity|63
2477950|NCT02231749|8557524|P1|Overall Study|Study Drug Toxicity|134
2477951|NCT02231749|8557523|P2|Overall Study|Disease progression|297
2477952|NCT02231749|8557524|P1|Overall Study|Disease progression|229
2477953|NCT02231580|8557542|P2|Overall Study|Adverse Event|0
2477954|NCT02231580|8557543|P1|Overall Study|Adverse Event|5
2477955|NCT02231164|8557660|P2|Overall Study|Withdrawal by Subject|2
2477956|NCT02231164|8557661|P1|Overall Study|Withdrawal by Subject|1
2477957|NCT02231164|8557660|P2|Overall Study|Lack of Efficacy|3
2477958|NCT02231164|8557661|P1|Overall Study|Lack of Efficacy|4
2477959|NCT02231164|8557660|P2|Overall Study|Adverse Event|1
2477960|NCT02231164|8557661|P1|Overall Study|Adverse Event|1
2477961|NCT02230956|8557689|P3|Overall Study|Other Miscellaneous Reason|2
2477962|NCT02230956|8557690|P2|Overall Study|Other Miscellaneous Reason|1
2477963|NCT02230956|8557691|P1|Overall Study|Other Miscellaneous Reason|0
2477964|NCT02230956|8557689|P3|Overall Study|Protocol Violation|1
2477965|NCT02230956|8557690|P2|Overall Study|Protocol Violation|1
2477966|NCT02230956|8557691|P1|Overall Study|Protocol Violation|0
2477967|NCT02230956|8557689|P3|Overall Study|Personal Reasons|1
2477968|NCT02230956|8557690|P2|Overall Study|Personal Reasons|1
2477969|NCT02230956|8557691|P1|Overall Study|Personal Reasons|2
2477970|NCT02230956|8557689|P3|Overall Study|Lost to Follow-up|2
2477971|NCT02230956|8557690|P2|Overall Study|Lost to Follow-up|1
2477972|NCT02230956|8557691|P1|Overall Study|Lost to Follow-up|1
2477973|NCT02230956|8557689|P3|Overall Study|Lack of Efficacy|1
2477974|NCT02230956|8557690|P2|Overall Study|Lack of Efficacy|1
2477975|NCT02230956|8557691|P1|Overall Study|Lack of Efficacy|1
2477976|NCT02230956|8557689|P3|Overall Study|Adverse Event|0
2477977|NCT02230956|8557690|P2|Overall Study|Adverse Event|1
2477978|NCT02230956|8557691|P1|Overall Study|Adverse Event|1
2477979|NCT02230904|8557713|P2|Overall Study|Safety follow up could not take place|1
2477980|NCT02230904|8557714|P1|Overall Study|Safety follow up could not take place|0
2477981|NCT02230683|8557747|P1|Overall Study|Adverse Event|1
2477982|NCT02230670|8557764|P2|Overall Study|Progression to Child-Pugh C|2
2477983|NCT02230670|8557765|P1|Overall Study|Progression to Child-Pugh C|1
2477984|NCT02230670|8557764|P2|Overall Study|Protocol Violation|1
2477985|NCT02230670|8557765|P1|Overall Study|Protocol Violation|0
2477986|NCT02230670|8557764|P2|Overall Study|Physician Decision|1
2477987|NCT02230670|8557765|P1|Overall Study|Physician Decision|0
2477988|NCT02230670|8557764|P2|Overall Study|Withdrawal by Subject|2
2477989|NCT02230670|8557765|P1|Overall Study|Withdrawal by Subject|2
2477990|NCT02230670|8557764|P2|Overall Study|Adverse Event|2
2477991|NCT02230670|8557765|P1|Overall Study|Adverse Event|1
2477992|NCT02230384|8557851|P2|Phase 2 - Switch|Adverse Event|0
2477993|NCT02230384|8557852|P1|Phase 2 - Switch|Adverse Event|2
2477994|NCT02230384|8557851|P2|Phase 2 - Switch|Lost to Follow-up|0
2477995|NCT02230384|8557852|P1|Phase 2 - Switch|Lost to Follow-up|1
2477996|NCT02230384|8557851|P2|Phase 2 - Switch|Withdrawal by Subject|1
2477997|NCT02230384|8557852|P1|Phase 2 - Switch|Withdrawal by Subject|0
2477998|NCT02230384|8557851|P2|Phase 1|Physician Decision|1
2477999|NCT02230384|8557852|P1|Phase 1|Physician Decision|0
2478000|NCT02230384|8557851|P2|Phase 1|Lost to Follow-up|0
2478001|NCT02230384|8557852|P1|Phase 1|Lost to Follow-up|1
2478002|NCT02230332|8557872|P2|Overall Study|Protocol Violation|0
2478003|NCT02230332|8557873|P1|Overall Study|Protocol Violation|1
2478004|NCT02230332|8557872|P2|Overall Study|Lost to Follow-up|0
2478005|NCT02230332|8557873|P1|Overall Study|Lost to Follow-up|1
2478006|NCT02230332|8557872|P2|Overall Study|Adverse Event|1
2478007|NCT02230332|8557873|P1|Overall Study|Adverse Event|2
2478008|NCT02230306|8557889|P1|Overall Study|Did not receive study treatment|1
2478009|NCT02230085|8557900|P1|Overall Study|Withdrawal by Subject|3
2478010|NCT02230085|8557900|P1|Overall Study|Physician Decision|1
2478011|NCT02229864|8557904|P1|3 - Year Visit|Death|2
2478012|NCT02229864|8557904|P1|2 - Year Visit|Missed Visits|1
2478013|NCT02229539|8557959|P3|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0
2478014|NCT02229539|8557960|P2|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1
2478015|NCT02229539|8557961|P1|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2
2478016|NCT02229539|8557959|P3|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3
2478017|NCT02229539|8557960|P2|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
2478018|NCT02229539|8557961|P1|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
2478019|NCT02229539|8557959|P3|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
2478020|NCT02229539|8557960|P2|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
2478021|NCT02229539|8557961|P1|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0
2478022|NCT02229539|8557959|P3|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
2478023|NCT02229539|8557960|P2|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
2478024|NCT02229539|8557961|P1|Cycle 2 (Optional Continuation Phase)|Adverse Event|2
2478025|NCT02229539|8557959|P3|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6
2478026|NCT02229539|8557960|P2|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
2478027|NCT02229539|8557961|P1|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
2478028|NCT02229539|8557959|P3|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1
2478029|NCT02229539|8557960|P2|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4
2478030|NCT02229539|8557961|P1|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3
2478031|NCT02229539|8557959|P3|Cycle 1 (Treatment Per Protocol)|Medical Problems|1
2478032|NCT02229539|8557960|P2|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
2478033|NCT02229539|8557961|P1|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
2478034|NCT02229539|8557959|P3|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1
2478035|NCT02229539|8557960|P2|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
2478036|NCT02229539|8557961|P1|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
2478037|NCT02229539|8557959|P3|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
2478038|NCT02229539|8557960|P2|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1
2478039|NCT02229539|8557961|P1|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
2478040|NCT02229396|8558092|P3|Overall Study|Withdrew; No Record on Termination Page|1
2478041|NCT02229396|8558093|P2|Overall Study|Withdrew; No Record on Termination Page|0
2478042|NCT02229396|8558094|P1|Overall Study|Withdrew; No Record on Termination Page|2
2478043|NCT02229396|8558092|P3|Overall Study|Study-Specific Withdrawal Criteria|3
2478044|NCT02229396|8558093|P2|Overall Study|Study-Specific Withdrawal Criteria|1
2478045|NCT02229396|8558094|P1|Overall Study|Study-Specific Withdrawal Criteria|0
2478046|NCT02229396|8558092|P3|Overall Study|Withdrawal by Subject|41
2478047|NCT02229396|8558093|P2|Overall Study|Withdrawal by Subject|28
2478048|NCT02229396|8558094|P1|Overall Study|Withdrawal by Subject|42
2478049|NCT02229396|8558092|P3|Overall Study|Other|15
2478050|NCT02229396|8558093|P2|Overall Study|Other|18
2478051|NCT02229396|8558094|P1|Overall Study|Other|10
2478052|NCT02229396|8558092|P3|Overall Study|Patient Incorrectly Randomized|1
2478053|NCT02229396|8558093|P2|Overall Study|Patient Incorrectly Randomized|0
2478054|NCT02229396|8558094|P1|Overall Study|Patient Incorrectly Randomized|0
2478055|NCT02229396|8558092|P3|Overall Study|Protocol Violation|0
2478056|NCT02229396|8558093|P2|Overall Study|Protocol Violation|1
2478057|NCT02229396|8558094|P1|Overall Study|Protocol Violation|2
2478058|NCT02229396|8558092|P3|Overall Study|Lost to Follow-up|21
2478059|NCT02229396|8558093|P2|Overall Study|Lost to Follow-up|14
2478060|NCT02229396|8558094|P1|Overall Study|Lost to Follow-up|14
2478061|NCT02229396|8558092|P3|Overall Study|Death|1
2478062|NCT02229396|8558093|P2|Overall Study|Death|3
2478063|NCT02229396|8558094|P1|Overall Study|Death|2
2478064|NCT02229396|8558092|P3|Overall Study|Adverse Event|12
2478065|NCT02229396|8558093|P2|Overall Study|Adverse Event|12
2478066|NCT02229396|8558094|P1|Overall Study|Adverse Event|6
2478067|NCT02229383|8558125|P2|Overall Study|Other|8
2478068|NCT02229383|8558126|P1|Overall Study|Other|3
2478069|NCT02229383|8558125|P2|Overall Study|Did not receive treatment|0
2478070|NCT02229383|8558126|P1|Overall Study|Did not receive treatment|1
2478071|NCT02229383|8558125|P2|Overall Study|Withdrawal by Subject|6
2478072|NCT02229383|8558126|P1|Overall Study|Withdrawal by Subject|4
2478073|NCT02229383|8558125|P2|Overall Study|Lost to Follow-up|3
2478074|NCT02229383|8558126|P1|Overall Study|Lost to Follow-up|5
2478075|NCT02229383|8558125|P2|Overall Study|Death|1
2478076|NCT02229383|8558126|P1|Overall Study|Death|0
2478077|NCT02229383|8558125|P2|Overall Study|Adverse Event|4
2478078|NCT02229383|8558126|P1|Overall Study|Adverse Event|7
2478079|NCT02229227|8558151|P2|Overall Study|Physician Decision|12
2478080|NCT02229227|8558152|P1|Overall Study|Physician Decision|5
2478081|NCT02229227|8558151|P2|Overall Study|Other|1
2478082|NCT02229227|8558152|P1|Overall Study|Other|0
2478083|NCT02229227|8558151|P2|Overall Study|Withdrawal by Subject|12
2478084|NCT02229227|8558152|P1|Overall Study|Withdrawal by Subject|8
2478085|NCT02229227|8558151|P2|Overall Study|Study terminated by sponsor|11
2478086|NCT02229227|8558152|P1|Overall Study|Study terminated by sponsor|11
2478087|NCT02229227|8558151|P2|Overall Study|Lost to Follow-up|3
2478088|NCT02229227|8558152|P1|Overall Study|Lost to Follow-up|3
2478089|NCT02229227|8558151|P2|Overall Study|Protocol defined stopping criteria|3
2478090|NCT02229227|8558152|P1|Overall Study|Protocol defined stopping criteria|1
2478091|NCT02229227|8558151|P2|Overall Study|Protocol Violation|8
2478092|NCT02229227|8558152|P1|Overall Study|Protocol Violation|6
2478093|NCT02229227|8558151|P2|Overall Study|Lack of Efficacy|3
2478094|NCT02229227|8558152|P1|Overall Study|Lack of Efficacy|3
2478095|NCT02229227|8558151|P2|Overall Study|Adverse Event|9
2478096|NCT02229227|8558152|P1|Overall Study|Adverse Event|14
2478097|NCT02229214|8558237|P2|Overall Study|Withdrawal by Subject|0
2478098|NCT02229214|8558238|P1|Overall Study|Withdrawal by Subject|4
2478099|NCT02229214|8558237|P2|Overall Study|Adverse Event|0
2478100|NCT02229214|8558238|P1|Overall Study|Adverse Event|2
2478101|NCT02228980|8558262|P4|Overall Study|Withdrawal by Subject|3
2478102|NCT02228980|8558263|P3|Overall Study|Withdrawal by Subject|2
2478103|NCT02228980|8558264|P2|Overall Study|Withdrawal by Subject|3
2478104|NCT02228980|8558265|P1|Overall Study|Withdrawal by Subject|3
2478105|NCT02228980|8558262|P4|Overall Study|Protocol Violation|0
2478106|NCT02228980|8558263|P3|Overall Study|Protocol Violation|0
2478107|NCT02228980|8558264|P2|Overall Study|Protocol Violation|0
2478108|NCT02228980|8558265|P1|Overall Study|Protocol Violation|7
2478109|NCT02228980|8558262|P4|Overall Study|Adverse Event|0
2478110|NCT02228980|8558263|P3|Overall Study|Adverse Event|0
2478111|NCT02228980|8558264|P2|Overall Study|Adverse Event|0
2478112|NCT02228980|8558265|P1|Overall Study|Adverse Event|14
2478113|NCT02228967|8558289|P2|Overall Study|Withdrawal by Subject|18
2478114|NCT02228967|8558290|P1|Overall Study|Withdrawal by Subject|13
2478115|NCT02228967|8558289|P2|Overall Study|Lost to Follow-up|142
2478116|NCT02228967|8558290|P1|Overall Study|Lost to Follow-up|146
2478117|NCT02228720|8558335|P1|Open Label - Day 30|Lost to Follow-up|1
2478118|NCT02228460|8558367|P1|Overall Study|Lost to Follow-up|1
2478119|NCT02228460|8558367|P1|Overall Study|Adverse Event|1
2478120|NCT02228395|8558390|P3|First Intervention Period|Unable to comply with study dates|1
2478121|NCT02228395|8558391|P2|First Intervention Period|Unable to comply with study dates|1
2478122|NCT02228395|8558392|P1|First Intervention Period|Unable to comply with study dates|0
2478123|NCT02228395|8558390|P3|First Intervention Period|No longer willing to participate|0
2478124|NCT02228395|8558391|P2|First Intervention Period|No longer willing to participate|0
2478125|NCT02228395|8558392|P1|First Intervention Period|No longer willing to participate|1
2478126|NCT02227862|8558478|P2|Overall Study|Lost to Follow-up|2
2478127|NCT02227862|8558479|P1|Overall Study|Lost to Follow-up|1
2478128|NCT02227862|8558478|P2|Overall Study|Withdrawal by Subject|6
2478129|NCT02227862|8558479|P1|Overall Study|Withdrawal by Subject|7
2478130|NCT02227862|8558478|P2|Overall Study|Adverse Event|3
2478131|NCT02227862|8558479|P1|Overall Study|Adverse Event|4
2478132|NCT02227862|8558478|P2|Overall Study|Other|2
2478133|NCT02227862|8558479|P1|Overall Study|Other|0
2478134|NCT02227862|8558478|P2|Overall Study|Protocol Violation|9
2478135|NCT02227862|8558479|P1|Overall Study|Protocol Violation|7
2478136|NCT02227849|8558509|P1|Overall Study|Withdrawal by Subject|3
2478137|NCT02227849|8558509|P1|Overall Study|Physician Decision|1
2478138|NCT02227849|8558509|P1|Overall Study|Adverse Event|4
2478139|NCT02227784|8558540|P5|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3
2478140|NCT02227784|8558541|P4|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
2478141|NCT02227784|8558542|P3|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
2478142|NCT02227784|8558543|P2|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
2478143|NCT02227784|8558544|P1|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
2478144|NCT02227784|8558540|P5|Open-Label Extension Phase (OLE)|Sponsor Decision|243
2478145|NCT02227784|8558541|P4|Open-Label Extension Phase (OLE)|Sponsor Decision|0
2478146|NCT02227784|8558542|P3|Open-Label Extension Phase (OLE)|Sponsor Decision|0
2478147|NCT02227784|8558543|P2|Open-Label Extension Phase (OLE)|Sponsor Decision|0
2478148|NCT02227784|8558544|P1|Open-Label Extension Phase (OLE)|Sponsor Decision|0
2478149|NCT02227784|8558540|P5|Open-Label Extension Phase (OLE)|Death|1
2478150|NCT02227784|8558541|P4|Open-Label Extension Phase (OLE)|Death|0
2478151|NCT02227784|8558542|P3|Open-Label Extension Phase (OLE)|Death|0
2478152|NCT02227784|8558543|P2|Open-Label Extension Phase (OLE)|Death|0
2478153|NCT02227784|8558544|P1|Open-Label Extension Phase (OLE)|Death|0
2478154|NCT02227784|8558540|P5|Open-Label Extension Phase (OLE)|Adverse Event|1
2478155|NCT02227784|8558541|P4|Open-Label Extension Phase (OLE)|Adverse Event|0
2478156|NCT02227784|8558542|P3|Open-Label Extension Phase (OLE)|Adverse Event|0
2478157|NCT02227784|8558543|P2|Open-Label Extension Phase (OLE)|Adverse Event|0
2478158|NCT02227784|8558544|P1|Open-Label Extension Phase (OLE)|Adverse Event|0
2478159|NCT02227784|8558540|P5|Double-Blind Phase|Withdrawal by Subject|0
2478160|NCT02227784|8558541|P4|Double-Blind Phase|Withdrawal by Subject|2
2478161|NCT02227784|8558542|P3|Double-Blind Phase|Withdrawal by Subject|5
2478162|NCT02227784|8558543|P2|Double-Blind Phase|Withdrawal by Subject|1
2478163|NCT02227784|8558544|P1|Double-Blind Phase|Withdrawal by Subject|2
2478164|NCT02227784|8558540|P5|Double-Blind Phase|Sponsor Decision|0
2478165|NCT02227784|8558541|P4|Double-Blind Phase|Sponsor Decision|32
2478166|NCT02227784|8558542|P3|Double-Blind Phase|Sponsor Decision|14
2478167|NCT02227784|8558543|P2|Double-Blind Phase|Sponsor Decision|15
2478168|NCT02227784|8558544|P1|Double-Blind Phase|Sponsor Decision|34
2478169|NCT02227784|8558540|P5|Double-Blind Phase|Protocol Violation|0
2478170|NCT02227784|8558541|P4|Double-Blind Phase|Protocol Violation|1
2478171|NCT02227784|8558542|P3|Double-Blind Phase|Protocol Violation|1
2478172|NCT02227784|8558543|P2|Double-Blind Phase|Protocol Violation|0
2478173|NCT02227784|8558544|P1|Double-Blind Phase|Protocol Violation|0
2478174|NCT02227784|8558540|P5|Double-Blind Phase|Physician Decision|0
2478175|NCT02227784|8558541|P4|Double-Blind Phase|Physician Decision|1
2478176|NCT02227784|8558542|P3|Double-Blind Phase|Physician Decision|0
2478177|NCT02227784|8558543|P2|Double-Blind Phase|Physician Decision|0
2478178|NCT02227784|8558544|P1|Double-Blind Phase|Physician Decision|1
2478179|NCT02227784|8558540|P5|Double-Blind Phase|Adverse Event|0
2478180|NCT02227784|8558541|P4|Double-Blind Phase|Adverse Event|3
2478181|NCT02227784|8558542|P3|Double-Blind Phase|Adverse Event|1
2478182|NCT02227784|8558543|P2|Double-Blind Phase|Adverse Event|2
2478183|NCT02227784|8558544|P1|Double-Blind Phase|Adverse Event|3
2478184|NCT02227368|8558673|P2|Overall Study|Adverse Event|0
2478185|NCT02227368|8558674|P1|Overall Study|Adverse Event|1
2478186|NCT02227368|8558673|P2|Overall Study|Lost to Follow-up|0
2478187|NCT02227368|8558674|P1|Overall Study|Lost to Follow-up|1
2478188|NCT02227368|8558673|P2|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4
2478189|NCT02227368|8558674|P1|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0
2478190|NCT02227238|8558730|P2|Overall Study|Lost to Follow-up|5
2478191|NCT02227238|8558731|P1|Overall Study|Lost to Follow-up|7
2478192|NCT02227238|8558730|P2|Overall Study|Physician Decision|9
2478193|NCT02227238|8558731|P1|Overall Study|Physician Decision|0
2478194|NCT02227238|8558730|P2|Overall Study|Withdrawal by Subject|4
2478195|NCT02227238|8558731|P1|Overall Study|Withdrawal by Subject|5
2478196|NCT02227238|8558730|P2|Overall Study|Protocol Violation|8
2478197|NCT02227238|8558731|P1|Overall Study|Protocol Violation|7
2478198|NCT02227238|8558730|P2|Overall Study|Lack of Efficacy|22
2478199|NCT02227238|8558731|P1|Overall Study|Lack of Efficacy|10
2478200|NCT02227238|8558730|P2|Overall Study|Adverse Event|18
2478201|NCT02227238|8558731|P1|Overall Study|Adverse Event|8
2478202|NCT02227238|8558730|P2|Overall Study|Other: Reached stopping criteria|1
2478203|NCT02227238|8558731|P1|Overall Study|Other: Reached stopping criteria|0
2478204|NCT02227147|8558797|P2|Follow-up Period|Other|5
2478205|NCT02227147|8558798|P1|Follow-up Period|Other|3
2478206|NCT02227147|8558797|P2|Controlled Treatment Period|Other|0
2478207|NCT02227147|8558798|P1|Controlled Treatment Period|Other|2
2478208|NCT02227147|8558797|P2|Controlled Treatment Period|Adverse Event|3
2478209|NCT02227147|8558798|P1|Controlled Treatment Period|Adverse Event|4
2478210|NCT02227108|8558825|P1|Overall Study|Adverse Event|6
2478211|NCT02227108|8558825|P1|Overall Study|Investigator discretion|1
2478212|NCT02227108|8558825|P1|Overall Study|Initiation of alternative therapy|2
2478213|NCT02227108|8558825|P1|Overall Study|Progressive disease|17
2478214|NCT02227108|8558825|P1|Overall Study|Other|3
2478215|NCT02227108|8558825|P1|Overall Study|Did not receive treatment|2
2478216|NCT02226653|8558864|P2|Treatment Period 5 Fed State|Adverse Event|1
2478217|NCT02226653|8558865|P1|Treatment Period 5 Fed State|Adverse Event|0
2478218|NCT02226653|8558864|P2|Treatment Period 2 Fasted State|Lost to Follow-up|0
2478219|NCT02226653|8558865|P1|Treatment Period 2 Fasted State|Lost to Follow-up|1
2478220|NCT02226562|8558889|P2|Overall Study|Lost to Follow-up|1
2478221|NCT02226562|8558890|P1|Overall Study|Lost to Follow-up|0
2478222|NCT02226549|8558908|P2|Overall Study|Lost to Follow-up|1
2478223|NCT02226549|8558909|P1|Overall Study|Lost to Follow-up|0
2478224|NCT02226549|8558908|P2|Overall Study|Randomized but Never Treated|0
2478225|NCT02226549|8558909|P1|Overall Study|Randomized but Never Treated|1
2478226|NCT02226198|8558919|P3|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
2478227|NCT02226198|8558920|P2|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1
2478228|NCT02226198|8558921|P1|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
2478229|NCT02226198|8558919|P3|Lead-in Phase|Protocol Violation|0
2478230|NCT02226198|8558920|P2|Lead-in Phase|Protocol Violation|0
2478231|NCT02226198|8558921|P1|Lead-in Phase|Protocol Violation|1
2478232|NCT02226172|8558994|P1|Overall Study|Adverse Event|6
2478233|NCT02226172|8558994|P1|Overall Study|Study terminated by sponsor|1
2478234|NCT02226172|8558994|P1|Overall Study|Death|1
2478235|NCT02226172|8558994|P1|Overall Study|Other|5
2478236|NCT02226172|8558994|P1|Overall Study|Participant refused further follow-up|4
2478237|NCT02226120|8559025|P1|Overall Study|missing treatment disposition pages|2
2478238|NCT02226120|8559025|P1|Overall Study|Protocol deviation|1
2478239|NCT02226120|8559025|P1|Overall Study|Non-compliance with study drug|10
2478240|NCT02226120|8559025|P1|Overall Study|Withdrawal by parent/guardian|36
2478241|NCT02226120|8559025|P1|Overall Study|Physician Decision|21
2478242|NCT02226120|8559025|P1|Overall Study|Lost to Follow-up|13
2478243|NCT02226120|8559025|P1|Overall Study|Technical problems|4
2478244|NCT02226120|8559025|P1|Overall Study|Study terminated by sponsor|1
2478245|NCT02226120|8559025|P1|Overall Study|Death|172
2478246|NCT02226120|8559025|P1|Overall Study|Adverse Event|60
2478247|NCT02226003|8559032|P3|Overall Study|Withdrawal by Subject|3
2478248|NCT02226003|8559033|P2|Overall Study|Withdrawal by Subject|0
2478249|NCT02226003|8559034|P1|Overall Study|Withdrawal by Subject|0
2478250|NCT02226003|8559032|P3|Overall Study|Lost to Follow-up|3
2478251|NCT02226003|8559033|P2|Overall Study|Lost to Follow-up|1
2478252|NCT02226003|8559034|P1|Overall Study|Lost to Follow-up|2
2478253|NCT02225743|8559090|P1|Overall Study|Withdrawal by Subject|18
2478254|NCT02225587|8559096|P2|Overall Study|Withdrawal by Subject|28
2478255|NCT02225587|8559097|P1|Overall Study|Withdrawal by Subject|13
2478256|NCT02225587|8559096|P2|Overall Study|Participant Moved|0
2478257|NCT02225587|8559097|P1|Overall Study|Participant Moved|1
2478258|NCT02225587|8559096|P2|Overall Study|Protocol Violation|0
2478259|NCT02225587|8559097|P1|Overall Study|Protocol Violation|1
2478260|NCT02225587|8559096|P2|Overall Study|Physician Decision|0
2478261|NCT02225587|8559097|P1|Overall Study|Physician Decision|2
2478262|NCT02225587|8559096|P2|Overall Study|Non-Compliance With Study Drug|0
2478263|NCT02225587|8559097|P1|Overall Study|Non-Compliance With Study Drug|1
2478264|NCT02225587|8559096|P2|Overall Study|Lost to Follow-up|5
2478265|NCT02225587|8559097|P1|Overall Study|Lost to Follow-up|5
2478266|NCT02225587|8559096|P2|Overall Study|Adverse Event|5
2478267|NCT02225587|8559097|P1|Overall Study|Adverse Event|5
2478268|NCT02225353|8559126|P3|Overall Study|Protocol Violation|12
2478269|NCT02225353|8559127|P2|Overall Study|Protocol Violation|5
2478270|NCT02225353|8559128|P1|Overall Study|Protocol Violation|4
2478271|NCT02225353|8559126|P3|Overall Study|Lost to Follow-up|3
2478272|NCT02225353|8559127|P2|Overall Study|Lost to Follow-up|1
2478273|NCT02225353|8559128|P1|Overall Study|Lost to Follow-up|0
2478274|NCT02224846|8559169|P2|Period 2 (Month 12 to Month 24)|Sponsor Decision|1
2478275|NCT02224846|8559170|P1|Period 2 (Month 12 to Month 24)|Sponsor Decision|2
2478276|NCT02224846|8559169|P2|Period 2 (Month 12 to Month 24)|Physician Decision|2
2478277|NCT02224846|8559170|P1|Period 2 (Month 12 to Month 24)|Physician Decision|0
2478278|NCT02224846|8559169|P2|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43
2478279|NCT02224846|8559170|P1|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25
2478280|NCT02224846|8559169|P2|Period 2 (Month 12 to Month 24)|Protocol Violation|11
2478281|NCT02224846|8559170|P1|Period 2 (Month 12 to Month 24)|Protocol Violation|4
2478282|NCT02224846|8559169|P2|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13
2478283|NCT02224846|8559170|P1|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7
2478284|NCT02224846|8559169|P2|Period 2 (Month 12 to Month 24)|Death|0
2478285|NCT02224846|8559170|P1|Period 2 (Month 12 to Month 24)|Death|1
2478286|NCT02224846|8559169|P2|Period 2 (Month 12 to Month 24)|Adverse Event|4
2478287|NCT02224846|8559170|P1|Period 2 (Month 12 to Month 24)|Adverse Event|3
2478288|NCT02224846|8559169|P2|Period 2 (Month 3 to Month 12)|Physician Decision|2
2478289|NCT02224846|8559170|P1|Period 2 (Month 3 to Month 12)|Physician Decision|0
2478290|NCT02224846|8559169|P2|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19
2478291|NCT02224846|8559170|P1|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15
2478292|NCT02224846|8559169|P2|Period 2 (Month 3 to Month 12)|Protocol Violation|3
2478293|NCT02224846|8559170|P1|Period 2 (Month 3 to Month 12)|Protocol Violation|0
2478294|NCT02224846|8559169|P2|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5
2478295|NCT02224846|8559170|P1|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3
2478296|NCT02224846|8559169|P2|Period 2 (Month 3 to Month 12)|Adverse Event|2
2478297|NCT02224846|8559170|P1|Period 2 (Month 3 to Month 12)|Adverse Event|1
2478298|NCT02224846|8559169|P2|Period 1 (Month 3)|Sponsor Decision|1
2478299|NCT02224846|8559170|P1|Period 1 (Month 3)|Sponsor Decision|2
2478300|NCT02224846|8559169|P2|Period 1 (Month 3)|Withdrawal by Subject|18
2478301|NCT02224846|8559170|P1|Period 1 (Month 3)|Withdrawal by Subject|8
2478302|NCT02224846|8559169|P2|Period 1 (Month 3)|Protocol Violation|8
2478303|NCT02224846|8559170|P1|Period 1 (Month 3)|Protocol Violation|4
2478304|NCT02224846|8559169|P2|Period 1 (Month 3)|Lost to Follow-up|8
2478305|NCT02224846|8559170|P1|Period 1 (Month 3)|Lost to Follow-up|3
2478306|NCT02224846|8559169|P2|Period 1 (Month 3)|Adverse Event|1
2478307|NCT02224846|8559170|P1|Period 1 (Month 3)|Adverse Event|2
2478308|NCT02224755|8559200|P2|Two Year Follow up Post-implant|Withdrawn post-implant|6
2478309|NCT02224755|8559201|P1|Two Year Follow up Post-implant|Withdrawn post-implant|15
2478310|NCT02224755|8559200|P2|Two Year Follow up Post-implant|Device explant or permanent deactivation|3
2478311|NCT02224755|8559201|P1|Two Year Follow up Post-implant|Device explant or permanent deactivation|3
2478312|NCT02224755|8559200|P2|Two Year Follow up Post-implant|Heart transplant|119
2478313|NCT02224755|8559201|P1|Two Year Follow up Post-implant|Heart transplant|137
2478314|NCT02224755|8559200|P2|Two Year Follow up Post-implant|Death|98
2478315|NCT02224755|8559201|P1|Two Year Follow up Post-implant|Death|103
2478316|NCT02224755|8559200|P2|Randomization to Device Implant|Withdrawn prior to implant|1
2478317|NCT02224755|8559201|P1|Randomization to Device Implant|Withdrawn prior to implant|7
2478318|NCT02224703|8559236|P3|Overall Study|Lack of Efficacy|0
2478319|NCT02224703|8559237|P2|Overall Study|Lack of Efficacy|0
2478320|NCT02224703|8559238|P1|Overall Study|Lack of Efficacy|1
2478321|NCT02224703|8559236|P3|Overall Study|Withdrawn by parent/guardian|0
2478322|NCT02224703|8559237|P2|Overall Study|Withdrawn by parent/guardian|1
2478323|NCT02224703|8559238|P1|Overall Study|Withdrawn by parent/guardian|0
2478324|NCT02224703|8559236|P3|Overall Study|Advised by medical monitor|0
2478325|NCT02224703|8559237|P2|Overall Study|Advised by medical monitor|0
2478326|NCT02224703|8559238|P1|Overall Study|Advised by medical monitor|1
2478327|NCT02224703|8559236|P3|Overall Study|Withdrawn by investigator|0
2478328|NCT02224703|8559237|P2|Overall Study|Withdrawn by investigator|0
2478329|NCT02224703|8559238|P1|Overall Study|Withdrawn by investigator|1
2478330|NCT02224703|8559236|P3|Overall Study|Adverse Event|0
2478331|NCT02224703|8559237|P2|Overall Study|Adverse Event|5
2478332|NCT02224703|8559238|P1|Overall Study|Adverse Event|0
2478333|NCT02224690|8559257|P2|Overall Study|Did not meet eligibility criteria|0
2478334|NCT02224690|8559258|P1|Overall Study|Did not meet eligibility criteria|1
2478335|NCT02224690|8559257|P2|Overall Study|Use of G-tube|0
2478336|NCT02224690|8559258|P1|Overall Study|Use of G-tube|1
2478337|NCT02224690|8559257|P2|Overall Study|Met Withdrawal Criteria|0
2478338|NCT02224690|8559258|P1|Overall Study|Met Withdrawal Criteria|4
2478339|NCT02224690|8559257|P2|Overall Study|Adverse Event|1
2478340|NCT02224690|8559258|P1|Overall Study|Adverse Event|8
2478341|NCT02224664|8559270|P5|Dose Escalation Period (21 Days)|Withdrawal by Subject|4
2478342|NCT02224664|8559271|P4|Dose Escalation Period (21 Days)|Withdrawal by Subject|1
2478343|NCT02224664|8559272|P3|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
2478344|NCT02224664|8559273|P2|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
2478345|NCT02224664|8559274|P1|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
2478346|NCT02224664|8559270|P5|Dose Escalation Period (21 Days)|Adverse Event|7
2478347|NCT02224664|8559271|P4|Dose Escalation Period (21 Days)|Adverse Event|2
2478348|NCT02224664|8559272|P3|Dose Escalation Period (21 Days)|Adverse Event|2
2478349|NCT02224664|8559273|P2|Dose Escalation Period (21 Days)|Adverse Event|0
2478350|NCT02224664|8559274|P1|Dose Escalation Period (21 Days)|Adverse Event|0
2478351|NCT02224664|8559270|P5|Lead-in Period (3 Days)|Does not meet entrance criteria|0
2478352|NCT02224664|8559271|P4|Lead-in Period (3 Days)|Does not meet entrance criteria|0
2478353|NCT02224664|8559272|P3|Lead-in Period (3 Days)|Does not meet entrance criteria|0
2478354|NCT02224664|8559273|P2|Lead-in Period (3 Days)|Does not meet entrance criteria|0
2478355|NCT02224664|8559274|P1|Lead-in Period (3 Days)|Does not meet entrance criteria|5
2478356|NCT02224638|8559356|P2|Overall Study|Adverse Event|1
2478357|NCT02224638|8559357|P1|Overall Study|Adverse Event|1
2478358|NCT02224625|8559365|P1|Sensitization|Adverse Event|55
2478359|NCT02224625|8559365|P1|Irritation|Adverse Event|6
2478360|NCT02224599|8559386|P1|Overall Study|Progression of Disease|1
2478361|NCT02224599|8559386|P1|Overall Study|Physician Decision|1
2478362|NCT02224560|8559395|P3|Overall Study|Withdrawn by Investigator|0
2478363|NCT02224560|8559396|P2|Overall Study|Withdrawn by Investigator|1
2478364|NCT02224560|8559397|P1|Overall Study|Withdrawn by Investigator|1
2478365|NCT02224560|8559395|P3|Overall Study|Adverse Event|1
2478366|NCT02224560|8559396|P2|Overall Study|Adverse Event|1
2478367|NCT02224560|8559397|P1|Overall Study|Adverse Event|4
2478368|NCT02224560|8559395|P3|Overall Study|Met Withdrawal Criteria|0
2478369|NCT02224560|8559396|P2|Overall Study|Met Withdrawal Criteria|0
2478370|NCT02224560|8559397|P1|Overall Study|Met Withdrawal Criteria|1
2478371|NCT02224560|8559395|P3|Overall Study|Withdrawal by Subject|1
2478372|NCT02224560|8559396|P2|Overall Study|Withdrawal by Subject|0
2478373|NCT02224560|8559397|P1|Overall Study|Withdrawal by Subject|2
2478374|NCT02224560|8559395|P3|Overall Study|Protocol Deviation|0
2478375|NCT02224560|8559396|P2|Overall Study|Protocol Deviation|0
2478376|NCT02224560|8559397|P1|Overall Study|Protocol Deviation|1
2478377|NCT02224274|8559445|P2|Overall Study|Death|0
2478378|NCT02224274|8559446|P1|Overall Study|Death|1
2478379|NCT02224157|8559458|P2|Overall Study|Adverse Event|3
2478380|NCT02224157|8559459|P1|Overall Study|Adverse Event|1
2478381|NCT02224157|8559458|P2|Overall Study|Death|1
2478382|NCT02224157|8559459|P1|Overall Study|Death|1
2478383|NCT02224157|8559458|P2|Overall Study|Lost to Follow-up|35
2478384|NCT02224157|8559459|P1|Overall Study|Lost to Follow-up|27
2478385|NCT02224157|8559458|P2|Overall Study|Eligibility criteria not fulfilled|8
2478386|NCT02224157|8559459|P1|Overall Study|Eligibility criteria not fulfilled|4
2478387|NCT02224157|8559458|P2|Overall Study|Prematurely closed site|2
2478388|NCT02224157|8559459|P1|Overall Study|Prematurely closed site|4
2478389|NCT02224157|8559458|P2|Overall Study|Subject decision|50
2478390|NCT02224157|8559459|P1|Overall Study|Subject decision|58
2478391|NCT02224157|8559458|P2|Overall Study|Other|10
2478392|NCT02224157|8559459|P1|Overall Study|Other|13
2478393|NCT02224157|8559458|P2|Overall Study|Severe non-compliance to protocol|2
2478394|NCT02224157|8559459|P1|Overall Study|Severe non-compliance to protocol|2
2478395|NCT02224053|8559483|P1|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2
2478396|NCT02224053|8559483|P1|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1
2478397|NCT02224053|8559483|P1|AZD9291 and Omeprazole Co-administration|Adverse Event|3
2478398|NCT02224053|8559483|P1|AZD9291 and Omeprazole Co-administration|Protocol Violation|4
2478399|NCT02224053|8559483|P1|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11
2478400|NCT02223858|8559529|P2|Overall Study|Refused|9
2478401|NCT02223858|8559530|P1|Overall Study|Refused|9
2478402|NCT02223858|8559529|P2|Overall Study|Withdrawal by Subject|5
2478403|NCT02223858|8559530|P1|Overall Study|Withdrawal by Subject|8
2478404|NCT02223858|8559529|P2|Overall Study|Lost to Follow-up|11
2478405|NCT02223858|8559530|P1|Overall Study|Lost to Follow-up|6
2478406|NCT02223858|8559529|P2|Overall Study|Death|1
2478407|NCT02223858|8559530|P1|Overall Study|Death|1
2478408|NCT02223793|8559543|P3|Overall Study|Moved/studycenter unable to participate|8
2478409|NCT02223793|8559544|P2|Overall Study|Moved/studycenter unable to participate|6
2478410|NCT02223793|8559545|P1|Overall Study|Moved/studycenter unable to participate|4
2478411|NCT02223793|8559543|P3|Overall Study|Withdrawal by Subject|3
2478412|NCT02223793|8559544|P2|Overall Study|Withdrawal by Subject|2
2478413|NCT02223793|8559545|P1|Overall Study|Withdrawal by Subject|3
2478414|NCT02223793|8559543|P3|Overall Study|Lost to Follow-up|2
2478415|NCT02223793|8559544|P2|Overall Study|Lost to Follow-up|1
2478416|NCT02223793|8559545|P1|Overall Study|Lost to Follow-up|10
2478417|NCT02223754|8559558|P2|Period 2|Test Article No Longer Available|1
2478418|NCT02223754|8559559|P1|Period 2|Test Article No Longer Available|0
2478419|NCT02223754|8559558|P2|Period 2|Lost to Follow-up|0
2478420|NCT02223754|8559559|P1|Period 2|Lost to Follow-up|1
2478421|NCT02223754|8559558|P2|Period 2|Lens Discomfort|1
2478422|NCT02223754|8559559|P1|Period 2|Lens Discomfort|1
2478423|NCT02223754|8559558|P2|Period 2|Protocol Violation|0
2478424|NCT02223754|8559559|P1|Period 2|Protocol Violation|1
2478425|NCT02223754|8559558|P2|Period 2|Adverse Event|1
2478426|NCT02223754|8559559|P1|Period 2|Adverse Event|0
2478427|NCT02223754|8559558|P2|Period 1|Unsatisfactory Visual Response|1
2478428|NCT02223754|8559559|P1|Period 1|Unsatisfactory Visual Response|0
2478429|NCT02223754|8559558|P2|Period 1|Test Article No Longer Available|5
2478430|NCT02223754|8559559|P1|Period 1|Test Article No Longer Available|1
2478431|NCT02223754|8559558|P2|Period 1|Withdrawal by Subject|4
2478432|NCT02223754|8559559|P1|Period 1|Withdrawal by Subject|0
2478433|NCT02223754|8559558|P2|Period 1|Protocol Violation|4
2478434|NCT02223754|8559559|P1|Period 1|Protocol Violation|2
2478435|NCT02223754|8559558|P2|Period 1|Lost to Follow-up|1
2478436|NCT02223754|8559559|P1|Period 1|Lost to Follow-up|0
2478437|NCT02223754|8559558|P2|Period 1|Adverse Event|0
2478438|NCT02223754|8559559|P1|Period 1|Adverse Event|1
2478439|NCT02223715|8559579|P1|Overall Study|Lost to Follow-up|73
2478440|NCT02223715|8559579|P1|Overall Study|Death|31
2478441|NCT02223390|8559717|P2|Overall Study|Lost to Follow-up|4
2478442|NCT02223390|8559718|P1|Overall Study|Lost to Follow-up|9
2478443|NCT02223364|8559729|P3|Overall Study|Physician Decision|0
2478444|NCT02223364|8559730|P2|Overall Study|Physician Decision|0
2478445|NCT02223364|8559731|P1|Overall Study|Physician Decision|1
2478446|NCT02223364|8559729|P3|Overall Study|subject expired before surgery|0
2478447|NCT02223364|8559730|P2|Overall Study|subject expired before surgery|0
2478448|NCT02223364|8559731|P1|Overall Study|subject expired before surgery|1
2478449|NCT02223364|8559729|P3|Overall Study|Protocol Violation|3
2478450|NCT02223364|8559730|P2|Overall Study|Protocol Violation|0
2478451|NCT02223364|8559731|P1|Overall Study|Protocol Violation|3
2478452|NCT02222818|8559907|P2|Period 1|Eligibility criteria not met|3
2478453|NCT02222818|8559908|P1|Period 1|Eligibility criteria not met|0
2478454|NCT02222714|8559920|P5|Overall Study|Withdrawal by Subject|1
2478455|NCT02222714|8559921|P4|Overall Study|Withdrawal by Subject|0
2478456|NCT02222714|8559922|P3|Overall Study|Withdrawal by Subject|1
2478457|NCT02222714|8559923|P2|Overall Study|Withdrawal by Subject|0
2478458|NCT02222714|8559924|P1|Overall Study|Withdrawal by Subject|0
2478459|NCT02222714|8559920|P5|Overall Study|Death|6
2478460|NCT02222714|8559921|P4|Overall Study|Death|4
2478461|NCT02222714|8559922|P3|Overall Study|Death|3
2478462|NCT02222714|8559923|P2|Overall Study|Death|2
2478463|NCT02222714|8559924|P1|Overall Study|Death|0
2478464|NCT02222558|8559963|P6|Period 3|Withdrawal by Subject|1
2478465|NCT02222558|8559964|P5|Period 3|Withdrawal by Subject|0
2478466|NCT02222558|8559965|P4|Period 3|Withdrawal by Subject|0
2478467|NCT02222558|8559966|P3|Period 3|Withdrawal by Subject|0
2478468|NCT02222558|8559967|P2|Period 3|Withdrawal by Subject|0
2478469|NCT02222558|8559968|P1|Period 3|Withdrawal by Subject|0
2478470|NCT02222558|8559963|P6|Period 1: Single Dose|Withdrawal by Subject|0
2478471|NCT02222558|8559964|P5|Period 1: Single Dose|Withdrawal by Subject|0
2478472|NCT02222558|8559965|P4|Period 1: Single Dose|Withdrawal by Subject|0
2478473|NCT02222558|8559966|P3|Period 1: Single Dose|Withdrawal by Subject|0
2478474|NCT02222558|8559967|P2|Period 1: Single Dose|Withdrawal by Subject|0
2478475|NCT02222558|8559968|P1|Period 1: Single Dose|Withdrawal by Subject|4
2478476|NCT02222493|8559984|P2|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0
2478477|NCT02222493|8559985|P1|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9
2478478|NCT02222493|8559984|P2|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0
2478479|NCT02222493|8559985|P1|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1
2478480|NCT02222493|8559984|P2|Period 3: Week 54 Dosing-Week 78 Visit|Other|0
2478481|NCT02222493|8559985|P1|Period 3: Week 54 Dosing-Week 78 Visit|Other|4
2478482|NCT02222493|8559984|P2|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0
2478483|NCT02222493|8559985|P1|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14
2478484|NCT02222493|8559984|P2|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0
2478485|NCT02222493|8559985|P1|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3
2478486|NCT02222493|8559984|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3
2478487|NCT02222493|8559985|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9
2478488|NCT02222493|8559984|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
2478489|NCT02222493|8559985|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
2478490|NCT02222493|8559984|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4
2478491|NCT02222493|8559985|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6
2478492|NCT02222493|8559984|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0
2478493|NCT02222493|8559985|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1
2478494|NCT02222493|8559984|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0
2478495|NCT02222493|8559985|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3
2478496|NCT02222493|8559984|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9
2478497|NCT02222493|8559985|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22
2478498|NCT02222493|8559984|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0
2478499|NCT02222493|8559985|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1
2478500|NCT02222493|8559984|P2|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0
2478501|NCT02222493|8559985|P1|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1
2478502|NCT02222493|8559984|P2|Period 1: First Dose-Week 30 (Pre-dose)|Other|0
2478503|NCT02222493|8559985|P1|Period 1: First Dose-Week 30 (Pre-dose)|Other|4
2478504|NCT02222493|8559984|P2|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20
2478505|NCT02222493|8559985|P1|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18
2478506|NCT02222493|8559984|P2|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0
2478507|NCT02222493|8559985|P1|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2
2478508|NCT02222493|8559984|P2|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0
2478509|NCT02222493|8559985|P1|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1
2478510|NCT02222493|8559984|P2|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7
2478511|NCT02222493|8559985|P1|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0
2478512|NCT02222493|8559984|P2|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1
2478513|NCT02222493|8559985|P1|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5
2478514|NCT02222493|8559984|P2|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9
2478515|NCT02222493|8559985|P1|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11
2478516|NCT02222493|8559984|P2|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1
2478517|NCT02222493|8559985|P1|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0
2478518|NCT02222493|8559984|P2|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
2478519|NCT02222493|8559985|P1|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
2478520|NCT02222246|8560136|P2|Overall Study|Physician Decision|1
2478521|NCT02222246|8560137|P1|Overall Study|Physician Decision|0
2478522|NCT02222246|8560136|P2|Overall Study|No Emergency Department Visits|26
2478523|NCT02222246|8560137|P1|Overall Study|No Emergency Department Visits|27
2478524|NCT02222207|8560165|P1|Overall Study|Adverse Event|1
2478525|NCT02222207|8560165|P1|Overall Study|Other reasons|2
2478526|NCT02222207|8560165|P1|Overall Study|Death|1
2478527|NCT02221882|8560212|P6|Overall Study|Death|0
2478528|NCT02221882|8560213|P5|Overall Study|Death|0
2478529|NCT02221882|8560214|P4|Overall Study|Death|0
2478530|NCT02221882|8560215|P3|Overall Study|Death|0
2478531|NCT02221882|8560216|P2|Overall Study|Death|1
2478532|NCT02221882|8560217|P1|Overall Study|Death|0
2478533|NCT02221882|8560212|P6|Overall Study|Withdrawal by Subject|2
2478534|NCT02221882|8560213|P5|Overall Study|Withdrawal by Subject|2
2478535|NCT02221882|8560214|P4|Overall Study|Withdrawal by Subject|2
2478536|NCT02221882|8560215|P3|Overall Study|Withdrawal by Subject|4
2478537|NCT02221882|8560216|P2|Overall Study|Withdrawal by Subject|0
2478538|NCT02221882|8560217|P1|Overall Study|Withdrawal by Subject|0
2478539|NCT02221674|8560284|P3|Overall Study|Lost to Follow-up|0
2478540|NCT02221674|8560285|P2|Overall Study|Lost to Follow-up|0
2478541|NCT02221674|8560286|P1|Overall Study|Lost to Follow-up|1
2478542|NCT02221648|8560302|P2|Overall Study|Withdrawal by Subject|3
2478543|NCT02221648|8560303|P1|Overall Study|Withdrawal by Subject|3
2478544|NCT02221284|8560321|P1|Overall Study|Protocol Deviation|5
2478545|NCT02221284|8560321|P1|Overall Study|Case Report Forms Uncollected|56
2478546|NCT02221037|8560353|P4|Overall Study|Physician Decision|0
2478547|NCT02221037|8560354|P3|Overall Study|Physician Decision|1
2478548|NCT02221037|8560355|P2|Overall Study|Physician Decision|0
2478549|NCT02221037|8560356|P1|Overall Study|Physician Decision|0
2478550|NCT02220998|8560442|P2|Overall Study|Lost to Follow-up|4
2478551|NCT02220998|8560443|P1|Overall Study|Lost to Follow-up|4
2478552|NCT02220998|8560442|P2|Overall Study|Lack of Efficacy|5
2478553|NCT02220998|8560443|P1|Overall Study|Lack of Efficacy|0
2478554|NCT02220998|8560442|P2|Overall Study|Death|0
2478555|NCT02220998|8560443|P1|Overall Study|Death|2
2478556|NCT02220998|8560442|P2|Overall Study|Randomized but Never Treated|2
2478557|NCT02220998|8560443|P1|Overall Study|Randomized but Never Treated|1
2478558|NCT02220920|8560461|P2|Overall Study|Conflict with the stopping criteria|2
2478559|NCT02220920|8560462|P1|Overall Study|Conflict with the stopping criteria|1
2478560|NCT02220920|8560461|P2|Overall Study|Withdrawal by Subject|0
2478561|NCT02220920|8560462|P1|Overall Study|Withdrawal by Subject|1
2478562|NCT02220920|8560461|P2|Overall Study|Lack of Efficacy|1
2478563|NCT02220920|8560462|P1|Overall Study|Lack of Efficacy|0
2478564|NCT02220920|8560461|P2|Overall Study|Adverse Event|0
2478565|NCT02220920|8560462|P1|Overall Study|Adverse Event|1
2478566|NCT02220907|8560476|P1|Overall Study|Conflict with the stopping criteria|1
2478567|NCT02220907|8560476|P1|Overall Study|Withdrawal by Subject|2
2478568|NCT02220907|8560476|P1|Overall Study|Physician Decision|1
2478569|NCT02220907|8560476|P1|Overall Study|Adverse Event|7
2478570|NCT02220894|8560485|P2|Overall Study|Ongoing in Study|183
2478571|NCT02220894|8560486|P1|Overall Study|Ongoing in Study|265
2478572|NCT02220894|8560485|P2|Overall Study|Withdrawal by Subject|13
2478573|NCT02220894|8560486|P1|Overall Study|Withdrawal by Subject|2
2478574|NCT02220894|8560485|P2|Overall Study|Withdrawal by Parent/Guardian|1
2478575|NCT02220894|8560486|P1|Overall Study|Withdrawal by Parent/Guardian|0
2478576|NCT02220894|8560485|P2|Overall Study|Lost to Follow-up|2
2478577|NCT02220894|8560486|P1|Overall Study|Lost to Follow-up|0
2478578|NCT02220894|8560485|P2|Overall Study|Death|368
2478579|NCT02220894|8560486|P1|Overall Study|Death|252
2478580|NCT02220894|8560485|P2|Overall Study|Adverse Event|70
2478581|NCT02220894|8560486|P1|Overall Study|Adverse Event|118
2478582|NCT02220855|8560512|P1|Overall Study|Withdrawal by Subject|1
2478583|NCT02220855|8560512|P1|Overall Study|Disease Progression|5
2478584|NCT02220855|8560512|P1|Overall Study|Adverse Event|8
2478585|NCT02220764|8560522|P2|Overall Study|Death|0
2478586|NCT02220764|8560523|P1|Overall Study|Death|1
2478587|NCT02220764|8560522|P2|Overall Study|Lost to Follow-up|1
2478588|NCT02220764|8560523|P1|Overall Study|Lost to Follow-up|3
2478589|NCT02220725|8560537|P4|Overall Study|Withdrawal by Subject|1
2478590|NCT02220725|8560538|P3|Overall Study|Withdrawal by Subject|0
2478591|NCT02220725|8560539|P2|Overall Study|Withdrawal by Subject|0
2478592|NCT02220725|8560540|P1|Overall Study|Withdrawal by Subject|0
2478593|NCT02220725|8560537|P4|Overall Study|Lost to Follow-up|1
2478594|NCT02220725|8560538|P3|Overall Study|Lost to Follow-up|0
2478595|NCT02220725|8560539|P2|Overall Study|Lost to Follow-up|0
2478596|NCT02220725|8560540|P1|Overall Study|Lost to Follow-up|0
2478597|NCT02220205|8560570|P2|Overall Study|Withdrawal by Subject|0
2478598|NCT02220205|8560571|P1|Overall Study|Withdrawal by Subject|1
2478599|NCT02219932|8560596|P2|Overall Study|Adverse Event|21
2478600|NCT02219932|8560597|P1|Overall Study|Adverse Event|23
2478601|NCT02219932|8560596|P2|Overall Study|Lost to Follow-up|2
2478602|NCT02219932|8560597|P1|Overall Study|Lost to Follow-up|4
2478603|NCT02219932|8560596|P2|Overall Study|Pregnancy|0
2478604|NCT02219932|8560597|P1|Overall Study|Pregnancy|1
2478605|NCT02219932|8560596|P2|Overall Study|Protocol Violation|6
2478606|NCT02219932|8560597|P1|Overall Study|Protocol Violation|10
2478607|NCT02219932|8560596|P2|Overall Study|Lack of Efficacy (Subject Perception)|2
2478608|NCT02219932|8560597|P1|Overall Study|Lack of Efficacy (Subject Perception)|10
2478609|NCT02219932|8560596|P2|Overall Study|Consent Withdrawn|7
2478610|NCT02219932|8560597|P1|Overall Study|Consent Withdrawn|11
2478611|NCT02219932|8560596|P2|Overall Study|Investigator Decision|1
2478612|NCT02219932|8560597|P1|Overall Study|Investigator Decision|0
2478613|NCT02219932|8560596|P2|Overall Study|Death|1
2478614|NCT02219932|8560597|P1|Overall Study|Death|1
2478615|NCT02219932|8560596|P2|Overall Study|Other|11
2478616|NCT02219932|8560597|P1|Overall Study|Other|5
2478617|NCT02219685|8560613|P2|Blinded Treatment Phase|Withdrew Consent|0
2478618|NCT02219685|8560614|P1|Blinded Treatment Phase|Withdrew Consent|1
2478619|NCT02219685|8560613|P2|Blinded Treatment Phase|Lost to Follow-up|0
2478620|NCT02219685|8560614|P1|Blinded Treatment Phase|Lost to Follow-up|1
2478621|NCT02219477|8560720|P3|Overall Study|Withdrawal by Subject|0
2478622|NCT02219477|8560721|P2|Overall Study|Withdrawal by Subject|1
2478623|NCT02219477|8560722|P1|Overall Study|Withdrawal by Subject|0
2478624|NCT02219477|8560720|P3|Overall Study|Adverse Event|1
2478625|NCT02219477|8560721|P2|Overall Study|Adverse Event|1
2478626|NCT02219477|8560722|P1|Overall Study|Adverse Event|0
2478627|NCT02219464|8560750|P2|Overall Study|catheter malfunction|0
2478628|NCT02219464|8560751|P1|Overall Study|catheter malfunction|1
2478629|NCT02219464|8560750|P2|Overall Study|case cancelled|0
2478630|NCT02219464|8560751|P1|Overall Study|case cancelled|1
2478631|NCT02219464|8560750|P2|Overall Study|Withdrawal by Subject|0
2478632|NCT02219464|8560751|P1|Overall Study|Withdrawal by Subject|1
2478633|NCT02219308|8560772|P2|Overall Study|Withdrawal by Subject|2
2478634|NCT02219308|8560773|P1|Overall Study|Withdrawal by Subject|1
2478635|NCT02219087|8560933|P2|Overall Study|Randomization envelope pulled out of seq|1
2478636|NCT02219087|8560934|P1|Overall Study|Randomization envelope pulled out of seq|0
2478637|NCT02219048|8560954|P2|Overall Study|Other|1
2478638|NCT02219048|8560955|P1|Overall Study|Other|0
2478639|NCT02219048|8560954|P2|Overall Study|Withdrawal by Subject|0
2478640|NCT02219048|8560955|P1|Overall Study|Withdrawal by Subject|2
2478641|NCT02219048|8560954|P2|Overall Study|Study terminated by sponsor|15
2478642|NCT02219048|8560955|P1|Overall Study|Study terminated by sponsor|16
2478643|NCT02219048|8560954|P2|Overall Study|No longer meets eligibility criteria|0
2478644|NCT02219048|8560955|P1|Overall Study|No longer meets eligibility criteria|1
2478645|NCT02219048|8560954|P2|Overall Study|Adverse Event|5
2478646|NCT02219048|8560955|P1|Overall Study|Adverse Event|2
2478647|NCT02219009|8560981|P2|Overall Study|Physician Decision|1
2478648|NCT02219009|8560982|P1|Overall Study|Physician Decision|0
2478649|NCT02219009|8560981|P2|Overall Study|Protocol deviation|0
2478650|NCT02219009|8560982|P1|Overall Study|Protocol deviation|1
2478651|NCT02219009|8560981|P2|Overall Study|Lost to Follow-up|2
2478652|NCT02219009|8560982|P1|Overall Study|Lost to Follow-up|2
2478653|NCT02219009|8560981|P2|Overall Study|Adverse Event|4
2478654|NCT02219009|8560982|P1|Overall Study|Adverse Event|2
2478655|NCT02219009|8560981|P2|Overall Study|Withdrawal by Subject|1
2478656|NCT02219009|8560982|P1|Overall Study|Withdrawal by Subject|5
2478657|NCT02218736|8560994|P2|Overall Study|Protocol Violation|0
2478658|NCT02218736|8560995|P1|Overall Study|Protocol Violation|2
2478659|NCT02218736|8560994|P2|Overall Study|Withdrawal by Subject|9
2478660|NCT02218736|8560995|P1|Overall Study|Withdrawal by Subject|10
2478661|NCT02218697|8561007|P2|Overall Study|Withdrawal by Subject|3
2478662|NCT02218697|8561008|P1|Overall Study|Withdrawal by Subject|2
2478663|NCT02218697|8561007|P2|Overall Study|Unwilling to be vaccinated in left arm|1
2478664|NCT02218697|8561008|P1|Overall Study|Unwilling to be vaccinated in left arm|0
2478665|NCT02218697|8561007|P2|Overall Study|Adverse Event|2
2478666|NCT02218697|8561008|P1|Overall Study|Adverse Event|0
2478667|NCT02218541|8561048|P2|Overall Study|Implant Failure|1
2478668|NCT02218541|8561049|P1|Overall Study|Implant Failure|4
2478669|NCT02218541|8561048|P2|Overall Study|Lost to Follow-up|1
2478670|NCT02218541|8561049|P1|Overall Study|Lost to Follow-up|2
2478671|NCT02218372|8561095|P2|Overall Study|Withdrawal by Parent/Guardian|1
2478672|NCT02218372|8561096|P1|Overall Study|Withdrawal by Parent/Guardian|0
2478673|NCT02218372|8561095|P2|Overall Study|Randomized but did not receive treatment|3
2478674|NCT02218372|8561096|P1|Overall Study|Randomized but did not receive treatment|2
2478675|NCT02218372|8561095|P2|Overall Study|Miscellaneous|1
2478676|NCT02218372|8561096|P1|Overall Study|Miscellaneous|2
2478677|NCT02218372|8561095|P2|Overall Study|Adverse Event|1
2478678|NCT02218372|8561096|P1|Overall Study|Adverse Event|1
2478679|NCT02218268|8561176|P2|24 Hour Washout|Physician Decision|9
2478680|NCT02218268|8561177|P1|24 Hour Washout|Physician Decision|11
2478681|NCT02218216|8561189|P3|Overall Study|Study terminated before completed|0
2478682|NCT02218216|8561190|P2|Overall Study|Study terminated before completed|0
2478683|NCT02218216|8561191|P1|Overall Study|Study terminated before completed|6
2478684|NCT02218008|8561244|P6|Stage 2 (S2)|Lost to Follow-up|1
2478685|NCT02218008|8561245|P5|Stage 2 (S2)|Lost to Follow-up|0
2478686|NCT02218008|8561246|P4|Stage 2 (S2)|Lost to Follow-up|0
2478687|NCT02218008|8561247|P3|Stage 2 (S2)|Lost to Follow-up|0
2478688|NCT02218008|8561248|P2|Stage 2 (S2)|Lost to Follow-up|0
2478689|NCT02218008|8561249|P1|Stage 2 (S2)|Lost to Follow-up|0
2478690|NCT02218008|8561244|P6|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
2478691|NCT02218008|8561245|P5|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
2478692|NCT02218008|8561246|P4|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1
2478693|NCT02218008|8561247|P3|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
2478694|NCT02218008|8561248|P2|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
2478695|NCT02218008|8561249|P1|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
2478696|NCT02218008|8561244|P6|Stage 2 (S2)|Lack of Efficacy|2
2478697|NCT02218008|8561245|P5|Stage 2 (S2)|Lack of Efficacy|0
2478698|NCT02218008|8561246|P4|Stage 2 (S2)|Lack of Efficacy|0
2478699|NCT02218008|8561247|P3|Stage 2 (S2)|Lack of Efficacy|0
2478700|NCT02218008|8561248|P2|Stage 2 (S2)|Lack of Efficacy|0
2478701|NCT02218008|8561249|P1|Stage 2 (S2)|Lack of Efficacy|0
2478702|NCT02218008|8561244|P6|Stage 2 (S2)|Withdrawal by Subject|0
2478703|NCT02218008|8561245|P5|Stage 2 (S2)|Withdrawal by Subject|1
2478704|NCT02218008|8561246|P4|Stage 2 (S2)|Withdrawal by Subject|1
2478705|NCT02218008|8561247|P3|Stage 2 (S2)|Withdrawal by Subject|0
2478706|NCT02218008|8561248|P2|Stage 2 (S2)|Withdrawal by Subject|0
2478707|NCT02218008|8561249|P1|Stage 2 (S2)|Withdrawal by Subject|0
2478708|NCT02218008|8561244|P6|Stage 2 (S2)|Adverse Event|3
2478709|NCT02218008|8561245|P5|Stage 2 (S2)|Adverse Event|3
2478710|NCT02218008|8561246|P4|Stage 2 (S2)|Adverse Event|2
2478711|NCT02218008|8561247|P3|Stage 2 (S2)|Adverse Event|0
2478712|NCT02218008|8561248|P2|Stage 2 (S2)|Adverse Event|0
2478713|NCT02218008|8561249|P1|Stage 2 (S2)|Adverse Event|0
2478714|NCT02218008|8561244|P6|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
2478715|NCT02218008|8561245|P5|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
2478716|NCT02218008|8561246|P4|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
2478717|NCT02218008|8561247|P3|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
2478718|NCT02218008|8561248|P2|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
2478719|NCT02218008|8561249|P1|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1
2478720|NCT02218008|8561244|P6|Stage 1 (S1)|Protocol Violation|0
2478721|NCT02218008|8561245|P5|Stage 1 (S1)|Protocol Violation|0
2478722|NCT02218008|8561246|P4|Stage 1 (S1)|Protocol Violation|0
2478723|NCT02218008|8561247|P3|Stage 1 (S1)|Protocol Violation|1
2478724|NCT02218008|8561248|P2|Stage 1 (S1)|Protocol Violation|0
2478725|NCT02218008|8561249|P1|Stage 1 (S1)|Protocol Violation|0
2478726|NCT02218008|8561244|P6|Stage 1 (S1)|Pregnancy|0
2478727|NCT02218008|8561245|P5|Stage 1 (S1)|Pregnancy|0
2478728|NCT02218008|8561246|P4|Stage 1 (S1)|Pregnancy|0
2478729|NCT02218008|8561247|P3|Stage 1 (S1)|Pregnancy|1
2478730|NCT02218008|8561248|P2|Stage 1 (S1)|Pregnancy|0
2478731|NCT02218008|8561249|P1|Stage 1 (S1)|Pregnancy|0
2478732|NCT02218008|8561244|P6|Stage 1 (S1)|Non-compliance; drug use|0
2478733|NCT02218008|8561245|P5|Stage 1 (S1)|Non-compliance; drug use|0
2478734|NCT02218008|8561246|P4|Stage 1 (S1)|Non-compliance; drug use|0
2478735|NCT02218008|8561247|P3|Stage 1 (S1)|Non-compliance; drug use|0
2478736|NCT02218008|8561248|P2|Stage 1 (S1)|Non-compliance; drug use|0
2478737|NCT02218008|8561249|P1|Stage 1 (S1)|Non-compliance; drug use|1
2478738|NCT02218008|8561244|P6|Stage 1 (S1)|Non-compliance with Study Drug|0
2478739|NCT02218008|8561245|P5|Stage 1 (S1)|Non-compliance with Study Drug|0
2478740|NCT02218008|8561246|P4|Stage 1 (S1)|Non-compliance with Study Drug|0
2478741|NCT02218008|8561247|P3|Stage 1 (S1)|Non-compliance with Study Drug|0
2478742|NCT02218008|8561248|P2|Stage 1 (S1)|Non-compliance with Study Drug|1
2478743|NCT02218008|8561249|P1|Stage 1 (S1)|Non-compliance with Study Drug|2
2478744|NCT02218008|8561244|P6|Stage 1 (S1)|Lost to Follow-up|0
2478745|NCT02218008|8561245|P5|Stage 1 (S1)|Lost to Follow-up|0
2478746|NCT02218008|8561246|P4|Stage 1 (S1)|Lost to Follow-up|0
2478747|NCT02218008|8561247|P3|Stage 1 (S1)|Lost to Follow-up|1
2478748|NCT02218008|8561248|P2|Stage 1 (S1)|Lost to Follow-up|0
2478749|NCT02218008|8561249|P1|Stage 1 (S1)|Lost to Follow-up|3
2478750|NCT02218008|8561244|P6|Stage 1 (S1)|Lack of Efficacy|0
2478751|NCT02218008|8561245|P5|Stage 1 (S1)|Lack of Efficacy|0
2478752|NCT02218008|8561246|P4|Stage 1 (S1)|Lack of Efficacy|0
2478753|NCT02218008|8561247|P3|Stage 1 (S1)|Lack of Efficacy|0
2478754|NCT02218008|8561248|P2|Stage 1 (S1)|Lack of Efficacy|0
2478755|NCT02218008|8561249|P1|Stage 1 (S1)|Lack of Efficacy|3
2478756|NCT02218008|8561244|P6|Stage 1 (S1)|Withdrawal by Subject|0
2478757|NCT02218008|8561245|P5|Stage 1 (S1)|Withdrawal by Subject|0
2478758|NCT02218008|8561246|P4|Stage 1 (S1)|Withdrawal by Subject|0
2478759|NCT02218008|8561247|P3|Stage 1 (S1)|Withdrawal by Subject|1
2478760|NCT02218008|8561248|P2|Stage 1 (S1)|Withdrawal by Subject|1
2478761|NCT02218008|8561249|P1|Stage 1 (S1)|Withdrawal by Subject|6
2478762|NCT02218008|8561244|P6|Stage 1 (S1)|Adverse Event|0
2478763|NCT02218008|8561245|P5|Stage 1 (S1)|Adverse Event|0
2478764|NCT02218008|8561246|P4|Stage 1 (S1)|Adverse Event|0
2478765|NCT02218008|8561247|P3|Stage 1 (S1)|Adverse Event|11
2478766|NCT02218008|8561248|P2|Stage 1 (S1)|Adverse Event|5
2478767|NCT02218008|8561249|P1|Stage 1 (S1)|Adverse Event|6
2478768|NCT02217982|8561295|P2|Overall Study|Adverse Event|1
2478769|NCT02217982|8561296|P1|Overall Study|Adverse Event|0
2478770|NCT02217982|8561295|P2|Overall Study|Trial discontinued|0
2478771|NCT02217982|8561296|P1|Overall Study|Trial discontinued|1
2478772|NCT02217878|8561379|P2|Overall Study|initial diagnosis of STEMI not confirmed|0
2478773|NCT02217878|8561380|P1|Overall Study|initial diagnosis of STEMI not confirmed|1
2478774|NCT02217878|8561379|P2|Overall Study|required morphine due to chest pain|2
2478775|NCT02217878|8561380|P1|Overall Study|required morphine due to chest pain|1
2478776|NCT02217566|8561478|P1|Overall Study|Early study termination|6
2478777|NCT02217566|8561478|P1|Overall Study|Death|3
2478778|NCT02217566|8561478|P1|Overall Study|Lost to Follow-up|2
2478779|NCT02217527|8561489|P2|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1
2478780|NCT02217527|8561490|P1|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0
2478781|NCT02217527|8561489|P2|Drug Condition 1: First Study Phase|Withdrawal by Subject|3
2478782|NCT02217527|8561490|P1|Drug Condition 1: First Study Phase|Withdrawal by Subject|1
2478783|NCT02217475|8561503|P3|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1
2478784|NCT02217475|8561504|P2|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0
2478785|NCT02217475|8561505|P1|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0
2478786|NCT02217475|8561503|P3|Treatment Period 2 (Year 2)|Physician Decision|2
2478787|NCT02217475|8561504|P2|Treatment Period 2 (Year 2)|Physician Decision|0
2478788|NCT02217475|8561505|P1|Treatment Period 2 (Year 2)|Physician Decision|0
2478789|NCT02217475|8561503|P3|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2
2478790|NCT02217475|8561504|P2|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0
2478791|NCT02217475|8561505|P1|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2
2478792|NCT02217475|8561503|P3|Treatment Period 2 (Year 2)|Lost to Follow-up|2
2478793|NCT02217475|8561504|P2|Treatment Period 2 (Year 2)|Lost to Follow-up|1
2478794|NCT02217475|8561505|P1|Treatment Period 2 (Year 2)|Lost to Follow-up|0
2478795|NCT02217475|8561503|P3|Treatment Period 2 (Year 2)|Adverse Event|5
2478796|NCT02217475|8561504|P2|Treatment Period 2 (Year 2)|Adverse Event|1
2478797|NCT02217475|8561505|P1|Treatment Period 2 (Year 2)|Adverse Event|0
2478798|NCT02217475|8561503|P3|Discontinued After Period 1|Physician Decision|1
2478799|NCT02217475|8561504|P2|Discontinued After Period 1|Physician Decision|0
2478800|NCT02217475|8561505|P1|Discontinued After Period 1|Physician Decision|0
2478801|NCT02217475|8561503|P3|Discontinued After Period 1|Participant Withdrew Consent|2
2478802|NCT02217475|8561504|P2|Discontinued After Period 1|Participant Withdrew Consent|1
2478803|NCT02217475|8561505|P1|Discontinued After Period 1|Participant Withdrew Consent|1
2478804|NCT02217475|8561503|P3|Discontinued After Period 1|Adverse Event|0
2478805|NCT02217475|8561504|P2|Discontinued After Period 1|Adverse Event|2
2478806|NCT02217475|8561505|P1|Discontinued After Period 1|Adverse Event|1
2478807|NCT02217475|8561503|P3|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1
2478808|NCT02217475|8561504|P2|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0
2478809|NCT02217475|8561505|P1|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0
2478810|NCT02217475|8561503|P3|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11
2478811|NCT02217475|8561504|P2|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2
2478812|NCT02217475|8561505|P1|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5
2478813|NCT02217475|8561503|P3|Treatment Period 1 (Year 1)|Lost to Follow-up|0
2478814|NCT02217475|8561504|P2|Treatment Period 1 (Year 1)|Lost to Follow-up|0
2478815|NCT02217475|8561505|P1|Treatment Period 1 (Year 1)|Lost to Follow-up|1
2478816|NCT02217475|8561503|P3|Treatment Period 1 (Year 1)|Adverse Event|9
2478817|NCT02217475|8561504|P2|Treatment Period 1 (Year 1)|Adverse Event|5
2478818|NCT02217475|8561505|P1|Treatment Period 1 (Year 1)|Adverse Event|4
2478819|NCT02217475|8561503|P3|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0
2478820|NCT02217475|8561504|P2|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1
2478821|NCT02217475|8561505|P1|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0
2478822|NCT02217436|8561622|P2|Overall Study|Incomplete data|1
2478823|NCT02217436|8561623|P1|Overall Study|Incomplete data|0
2478824|NCT02217436|8561622|P2|Overall Study|Protocol Violation|1
2478825|NCT02217436|8561623|P1|Overall Study|Protocol Violation|1
2478826|NCT02217410|8561634|P3|Overall Study|Physician Decision|0
2478827|NCT02217410|8561635|P2|Overall Study|Physician Decision|3
2478828|NCT02217410|8561636|P1|Overall Study|Physician Decision|1
2478829|NCT02217410|8561634|P3|Overall Study|Lack of Efficacy|0
2478830|NCT02217410|8561635|P2|Overall Study|Lack of Efficacy|1
2478831|NCT02217410|8561636|P1|Overall Study|Lack of Efficacy|0
2478832|NCT02217410|8561634|P3|Overall Study|Lost to Follow-up|1
2478833|NCT02217410|8561635|P2|Overall Study|Lost to Follow-up|0
2478834|NCT02217410|8561636|P1|Overall Study|Lost to Follow-up|0
2478835|NCT02217410|8561634|P3|Overall Study|Withdrawal by Subject|2
2478836|NCT02217410|8561635|P2|Overall Study|Withdrawal by Subject|0
2478837|NCT02217410|8561636|P1|Overall Study|Withdrawal by Subject|0
2478838|NCT02217410|8561634|P3|Overall Study|Graft Loss|2
2478839|NCT02217410|8561635|P2|Overall Study|Graft Loss|0
2478840|NCT02217410|8561636|P1|Overall Study|Graft Loss|0
2478841|NCT02217280|8561659|P1|Overall Study|Post-consent sceen fail|2
2478842|NCT02217280|8561659|P1|Overall Study|Withdrawal by Subject|2
2478843|NCT02216812|8561666|P2|Overall Study|Lost to Follow-up|5
2478844|NCT02216812|8561667|P1|Overall Study|Lost to Follow-up|10
2478845|NCT02216773|8561683|P2|Overall Study|Abandoned|3
2478846|NCT02216773|8561684|P1|Overall Study|Abandoned|4
2478847|NCT02216773|8561683|P2|Overall Study|Insufficient FLRV|0
2478848|NCT02216773|8561684|P1|Overall Study|Insufficient FLRV|4
2478849|NCT02216773|8561683|P2|Overall Study|Disease progression|2
2478850|NCT02216773|8561684|P1|Overall Study|Disease progression|4
2478851|NCT02216591|8561705|P2|Overall Study|Lost to Follow-up|1
2478852|NCT02216591|8561706|P1|Overall Study|Lost to Follow-up|0
2478853|NCT02216526|8561719|P3|Overall Study|Hospitalization|3
2478854|NCT02216526|8561720|P2|Overall Study|Hospitalization|1
2478855|NCT02216526|8561721|P1|Overall Study|Hospitalization|2
2478856|NCT02216526|8561719|P3|Overall Study|Protocol Violation|2
2478857|NCT02216526|8561720|P2|Overall Study|Protocol Violation|0
2478858|NCT02216526|8561721|P1|Overall Study|Protocol Violation|2
2478859|NCT02216526|8561719|P3|Overall Study|Death|3
2478860|NCT02216526|8561720|P2|Overall Study|Death|1
2478861|NCT02216526|8561721|P1|Overall Study|Death|0
2478862|NCT02216526|8561719|P3|Overall Study|Adverse Event|0
2478863|NCT02216526|8561720|P2|Overall Study|Adverse Event|1
2478864|NCT02216526|8561721|P1|Overall Study|Adverse Event|1
2478865|NCT02216357|8561839|P2|Overall Study|Inclusion or exclusion criteria not met|1
2478866|NCT02216357|8561840|P1|Overall Study|Inclusion or exclusion criteria not met|2
2478867|NCT02216214|8561866|P2|Overall Study|Miscellaneous|1
2478868|NCT02216214|8561867|P1|Overall Study|Miscellaneous|1
2478869|NCT02216214|8561866|P2|Overall Study|Study Terminated By Sponsor|1
2478870|NCT02216214|8561867|P1|Overall Study|Study Terminated By Sponsor|0
2478871|NCT02216214|8561866|P2|Overall Study|Withdrawal by Subject|20
2478872|NCT02216214|8561867|P1|Overall Study|Withdrawal by Subject|22
2478873|NCT02216214|8561866|P2|Overall Study|Protocol Violation|2
2478874|NCT02216214|8561867|P1|Overall Study|Protocol Violation|4
2478875|NCT02216214|8561866|P2|Overall Study|Lost to Follow-up|2
2478876|NCT02216214|8561867|P1|Overall Study|Lost to Follow-up|3
2478877|NCT02216214|8561866|P2|Overall Study|Lack of Efficacy|2
2478878|NCT02216214|8561867|P1|Overall Study|Lack of Efficacy|2
2478879|NCT02216214|8561866|P2|Overall Study|Adverse Event|8
2478880|NCT02216214|8561867|P1|Overall Study|Adverse Event|10
2478881|NCT02216214|8561866|P2|Overall Study|Randomized Never Received Study Drug|0
2478882|NCT02216214|8561867|P1|Overall Study|Randomized Never Received Study Drug|1
2478883|NCT02216123|8561938|P2|Overall Study|Withdrawal by Subject|0
2478884|NCT02216123|8561939|P1|Overall Study|Withdrawal by Subject|2
2478885|NCT02216123|8561938|P2|Overall Study|Lost to Follow-up|2
2478886|NCT02216123|8561939|P1|Overall Study|Lost to Follow-up|4
2478887|NCT02215967|8562032|P4|Overall Study|Patient did not get CAR T-Cells|0
2478888|NCT02215967|8562033|P3|Overall Study|Patient did not get CAR T-Cells|1
2478889|NCT02215967|8562034|P2|Overall Study|Patient did not get CAR T-Cells|0
2478890|NCT02215967|8562035|P1|Overall Study|Patient did not get CAR T-Cells|0
2478891|NCT02215967|8562032|P4|Overall Study|Patient became ineligible for treatment|3
2478892|NCT02215967|8562033|P3|Overall Study|Patient became ineligible for treatment|0
2478893|NCT02215967|8562034|P2|Overall Study|Patient became ineligible for treatment|0
2478894|NCT02215967|8562035|P1|Overall Study|Patient became ineligible for treatment|0
2478895|NCT02215954|8562056|P3|Overall Study|Not exposed|3
2478896|NCT02215954|8562057|P2|Overall Study|Not exposed|1
2478897|NCT02215954|8562058|P1|Overall Study|Not exposed|1
2478898|NCT02215954|8562056|P3|Overall Study|Withdrawal by Subject|2
2478899|NCT02215954|8562057|P2|Overall Study|Withdrawal by Subject|0
2478900|NCT02215954|8562058|P1|Overall Study|Withdrawal by Subject|0
2478901|NCT02215954|8562056|P3|Overall Study|Adverse Event|1
2478902|NCT02215954|8562057|P2|Overall Study|Adverse Event|0
2478903|NCT02215954|8562058|P1|Overall Study|Adverse Event|0
2478904|NCT02215616|8562082|P4|Overall Study|Other than specified|1
2478905|NCT02215616|8562083|P3|Overall Study|Other than specified|1
2478906|NCT02215616|8562084|P2|Overall Study|Other than specified|0
2478907|NCT02215616|8562085|P1|Overall Study|Other than specified|1
2478908|NCT02215616|8562082|P4|Overall Study|Lost to Follow-up|1
2478909|NCT02215616|8562083|P3|Overall Study|Lost to Follow-up|0
2478910|NCT02215616|8562084|P2|Overall Study|Lost to Follow-up|1
2478911|NCT02215616|8562085|P1|Overall Study|Lost to Follow-up|1
2478912|NCT02215616|8562082|P4|Overall Study|Protocol Violation|0
2478913|NCT02215616|8562083|P3|Overall Study|Protocol Violation|0
2478914|NCT02215616|8562084|P2|Overall Study|Protocol Violation|2
2478915|NCT02215616|8562085|P1|Overall Study|Protocol Violation|0
2478916|NCT02215616|8562082|P4|Overall Study|Non-compliance|0
2478917|NCT02215616|8562083|P3|Overall Study|Non-compliance|1
2478918|NCT02215616|8562084|P2|Overall Study|Non-compliance|2
2478919|NCT02215616|8562085|P1|Overall Study|Non-compliance|0
2478920|NCT02215616|8562082|P4|Overall Study|Withdrawal by Subject|5
2478921|NCT02215616|8562083|P3|Overall Study|Withdrawal by Subject|2
2478922|NCT02215616|8562084|P2|Overall Study|Withdrawal by Subject|8
2478923|NCT02215616|8562085|P1|Overall Study|Withdrawal by Subject|1
2478924|NCT02215616|8562082|P4|Overall Study|Adverse Event|2
2478925|NCT02215616|8562083|P3|Overall Study|Adverse Event|9
2478926|NCT02215616|8562084|P2|Overall Study|Adverse Event|4
2478927|NCT02215616|8562085|P1|Overall Study|Adverse Event|7
2478928|NCT02215616|8562082|P4|Overall Study|Death|0
2478929|NCT02215616|8562083|P3|Overall Study|Death|0
2478930|NCT02215616|8562084|P2|Overall Study|Death|0
2478931|NCT02215616|8562085|P1|Overall Study|Death|1
2478932|NCT02215616|8562082|P4|Overall Study|Sponsor requested to stop study drug|4
2478933|NCT02215616|8562083|P3|Overall Study|Sponsor requested to stop study drug|1
2478934|NCT02215616|8562084|P2|Overall Study|Sponsor requested to stop study drug|0
2478935|NCT02215616|8562085|P1|Overall Study|Sponsor requested to stop study drug|0
2478936|NCT02215252|8562107|P3|Overall Study|Other|1
2478937|NCT02215252|8562108|P2|Overall Study|Other|1
2478938|NCT02215252|8562109|P1|Overall Study|Other|0
2478939|NCT02215252|8562107|P3|Overall Study|Withdrawal by Subject|0
2478940|NCT02215252|8562108|P2|Overall Study|Withdrawal by Subject|0
2478941|NCT02215252|8562109|P1|Overall Study|Withdrawal by Subject|1
2478942|NCT02215252|8562107|P3|Overall Study|Protocol Violation|0
2478943|NCT02215252|8562108|P2|Overall Study|Protocol Violation|1
2478944|NCT02215252|8562109|P1|Overall Study|Protocol Violation|0
2478945|NCT02215252|8562107|P3|Overall Study|Does not Meet Entrance Criteria|0
2478946|NCT02215252|8562108|P2|Overall Study|Does not Meet Entrance Criteria|1
2478947|NCT02215252|8562109|P1|Overall Study|Does not Meet Entrance Criteria|0
2478948|NCT02215252|8562107|P3|Overall Study|Lost to Follow-up|1
2478949|NCT02215252|8562108|P2|Overall Study|Lost to Follow-up|0
2478950|NCT02215252|8562109|P1|Overall Study|Lost to Follow-up|0
2478951|NCT02215252|8562107|P3|Overall Study|Adverse Event|2
2478952|NCT02215252|8562108|P2|Overall Study|Adverse Event|5
2478953|NCT02215252|8562109|P1|Overall Study|Adverse Event|1
2478954|NCT02214225|8562263|P3|Overall Study|randomized in error, not vaccinated|1
2478955|NCT02214225|8562264|P2|Overall Study|randomized in error, not vaccinated|1
2478956|NCT02214225|8562265|P1|Overall Study|randomized in error, not vaccinated|2
2478957|NCT02214225|8562263|P3|Overall Study|Death|1
2478958|NCT02214225|8562264|P2|Overall Study|Death|0
2478959|NCT02214225|8562265|P1|Overall Study|Death|5
2478960|NCT02214225|8562263|P3|Overall Study|Withdrawal by Subject|2
2478961|NCT02214225|8562264|P2|Overall Study|Withdrawal by Subject|0
2478962|NCT02214225|8562265|P1|Overall Study|Withdrawal by Subject|2
2478963|NCT02214225|8562263|P3|Overall Study|Lost to Follow-up|18
2478964|NCT02214225|8562264|P2|Overall Study|Lost to Follow-up|18
2478965|NCT02214225|8562265|P1|Overall Study|Lost to Follow-up|46
2478966|NCT02214186|8562324|P2|Overall Study|Protocol Violation|1
2478967|NCT02214186|8562325|P1|Overall Study|Protocol Violation|1
2478968|NCT02214186|8562324|P2|Overall Study|Lost to Follow-up|1
2478969|NCT02214186|8562325|P1|Overall Study|Lost to Follow-up|1
2478970|NCT02214121|8562393|P3|Part B|Lost to Follow-up|1
2478971|NCT02214121|8562394|P2|Part B|Lost to Follow-up|0
2478972|NCT02214121|8562395|P1|Part B|Lost to Follow-up|0
2478973|NCT02214121|8562393|P3|Part B|Dev. of study-specific withdrawal crit.|0
2478974|NCT02214121|8562394|P2|Part B|Dev. of study-specific withdrawal crit.|2
2478975|NCT02214121|8562395|P1|Part B|Dev. of study-specific withdrawal crit.|0
2478976|NCT02214121|8562393|P3|Part B|Patient decision|0
2478977|NCT02214121|8562394|P2|Part B|Patient decision|1
2478978|NCT02214121|8562395|P1|Part B|Patient decision|0
2478979|NCT02214121|8562393|P3|Part A|Other|0
2478980|NCT02214121|8562394|P2|Part A|Other|0
2478981|NCT02214121|8562395|P1|Part A|Other|1
2478982|NCT02214121|8562393|P3|Part A|Dev. of study-specific withdrawal crit.|0
2478983|NCT02214121|8562394|P2|Part A|Dev. of study-specific withdrawal crit.|0
2478984|NCT02214121|8562395|P1|Part A|Dev. of study-specific withdrawal crit.|4
2478985|NCT02214121|8562393|P3|Part A|Patient decision|0
2478986|NCT02214121|8562394|P2|Part A|Patient decision|0
2478987|NCT02214121|8562395|P1|Part A|Patient decision|2
2478988|NCT02213666|8562504|P1|Overall Study|Withdrawal by Subject|1
2478989|NCT02213510|8562510|P2|Overall Study|Lost to Follow-up|0
2478990|NCT02213510|8562511|P1|Overall Study|Lost to Follow-up|1
2478991|NCT02213510|8562510|P2|Overall Study|Death|1
2478992|NCT02213510|8562511|P1|Overall Study|Death|0
2478993|NCT02213263|8562539|P2|Overall Study|Adverse Event|3
2478994|NCT02213263|8562540|P1|Overall Study|Adverse Event|1
2478995|NCT02213263|8562539|P2|Overall Study|Protocol Violation|1
2478996|NCT02213263|8562540|P1|Overall Study|Protocol Violation|0
2478997|NCT02213263|8562539|P2|Overall Study|Progressive disease|14
2478998|NCT02213263|8562540|P1|Overall Study|Progressive disease|20
2478999|NCT02213263|8562539|P2|Overall Study|No longer willing to participate|4
2479000|NCT02213263|8562540|P1|Overall Study|No longer willing to participate|3
2479001|NCT02213263|8562539|P2|Overall Study|Lost to Follow-up|1
2479002|NCT02213263|8562540|P1|Overall Study|Lost to Follow-up|0
2479003|NCT02213263|8562539|P2|Overall Study|Insufficient clinical response|3
2479004|NCT02213263|8562540|P1|Overall Study|Insufficient clinical response|4
2479005|NCT02213198|8562608|P2|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7
2479006|NCT02213198|8562609|P1|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23
2479007|NCT02213198|8562608|P2|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10
2479008|NCT02213198|8562609|P1|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17
2479009|NCT02213198|8562608|P2|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25
2479010|NCT02213198|8562609|P1|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68
2479011|NCT02213198|8562608|P2|Follow up 1 3 Mos Post BL End of TCC tx|Death|0
2479012|NCT02213198|8562609|P1|Follow up 1 3 Mos Post BL End of TCC tx|Death|1
2479013|NCT02213198|8562608|P2|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2
2479014|NCT02213198|8562609|P1|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3
2479015|NCT02213198|8562608|P2|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
2479016|NCT02213198|8562609|P1|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
2479017|NCT02213198|8562608|P2|Baseline|incarcerated,violent|1
2479018|NCT02213198|8562609|P1|Baseline|incarcerated,violent|0
2479019|NCT02213198|8562608|P2|Baseline|Lost to Follow-up|21
2479020|NCT02213198|8562609|P1|Baseline|Lost to Follow-up|40
2479021|NCT02213198|8562608|P2|Baseline|transferred out of clinic|9
2479022|NCT02213198|8562609|P1|Baseline|transferred out of clinic|7
2479023|NCT02213198|8562608|P2|Baseline|Withdrawal by Subject|11
2479024|NCT02213198|8562609|P1|Baseline|Withdrawal by Subject|34
2479025|NCT02213198|8562608|P2|Baseline|No show for intake|9
2479026|NCT02213198|8562609|P1|Baseline|No show for intake|7
2479027|NCT02213094|8562619|P2|Overall Study|Adverse Event|0
2479028|NCT02213094|8562620|P1|Overall Study|Adverse Event|1
2479029|NCT02213055|8562628|P2|Overall Study|Did not Return to School|0
2479030|NCT02213055|8562629|P1|Overall Study|Did not Return to School|5
2479031|NCT02213055|8562628|P2|Overall Study|Did not meet Inclusion Criteria|0
2479032|NCT02213055|8562629|P1|Overall Study|Did not meet Inclusion Criteria|6
2479033|NCT02213055|8562628|P2|Overall Study|Had another Treatment during the Study|0
2479034|NCT02213055|8562629|P1|Overall Study|Had another Treatment during the Study|3
2479035|NCT02213055|8562628|P2|Overall Study|Did not have Live Lice|0
2479036|NCT02213055|8562629|P1|Overall Study|Did not have Live Lice|8
2479037|NCT02213055|8562628|P2|Overall Study|Documentation Issue during Study|0
2479038|NCT02213055|8562629|P1|Overall Study|Documentation Issue during Study|10
2479039|NCT02213055|8562628|P2|Overall Study|Documentation Issue at Enrollment|0
2479040|NCT02213055|8562629|P1|Overall Study|Documentation Issue at Enrollment|1
2479041|NCT02213055|8562628|P2|Overall Study|Protocol was not Followed during Study|0
2479042|NCT02213055|8562629|P1|Overall Study|Protocol was not Followed during Study|1
2479043|NCT02213055|8562628|P2|Overall Study|Protocol was not Followed at Enrollment|0
2479044|NCT02213055|8562629|P1|Overall Study|Protocol was not Followed at Enrollment|5
2479045|NCT02212678|8562661|P1|Overall Study|Adverse Event|1
2479046|NCT02212457|8562671|P6|Overall Study|Other|1
2479047|NCT02212457|8562672|P5|Overall Study|Other|0
2479048|NCT02212457|8562673|P4|Overall Study|Other|1
2479049|NCT02212457|8562674|P3|Overall Study|Other|2
2479050|NCT02212457|8562675|P2|Overall Study|Other|1
2479051|NCT02212457|8562676|P1|Overall Study|Other|2
2479052|NCT02212457|8562671|P6|Overall Study|Protocol Violation|3
2479053|NCT02212457|8562672|P5|Overall Study|Protocol Violation|2
2479054|NCT02212457|8562673|P4|Overall Study|Protocol Violation|1
2479055|NCT02212457|8562674|P3|Overall Study|Protocol Violation|0
2479056|NCT02212457|8562675|P2|Overall Study|Protocol Violation|1
2479057|NCT02212457|8562676|P1|Overall Study|Protocol Violation|2
2479058|NCT02212457|8562671|P6|Overall Study|Lost to Follow-up|4
2479059|NCT02212457|8562672|P5|Overall Study|Lost to Follow-up|8
2479060|NCT02212457|8562673|P4|Overall Study|Lost to Follow-up|1
2479061|NCT02212457|8562674|P3|Overall Study|Lost to Follow-up|4
2479062|NCT02212457|8562675|P2|Overall Study|Lost to Follow-up|7
2479063|NCT02212457|8562676|P1|Overall Study|Lost to Follow-up|6
2479064|NCT02212457|8562671|P6|Overall Study|Withdrawal by Subject|4
2479065|NCT02212457|8562672|P5|Overall Study|Withdrawal by Subject|5
2479066|NCT02212457|8562673|P4|Overall Study|Withdrawal by Subject|6
2479067|NCT02212457|8562674|P3|Overall Study|Withdrawal by Subject|8
2479068|NCT02212457|8562675|P2|Overall Study|Withdrawal by Subject|10
2479069|NCT02212457|8562676|P1|Overall Study|Withdrawal by Subject|8
2479070|NCT02212457|8562671|P6|Overall Study|Adverse Event|1
2479071|NCT02212457|8562672|P5|Overall Study|Adverse Event|0
2479072|NCT02212457|8562673|P4|Overall Study|Adverse Event|2
2479073|NCT02212457|8562674|P3|Overall Study|Adverse Event|2
2479074|NCT02212457|8562675|P2|Overall Study|Adverse Event|2
2479075|NCT02212457|8562676|P1|Overall Study|Adverse Event|1
2479076|NCT02212301|8562800|P2|Period 1|Lost to Follow-up|1
2479077|NCT02212301|8562801|P1|Period 1|Lost to Follow-up|0
2479078|NCT02212197|8562812|P3|Overall Study|Need for radiotherapy|0
2479079|NCT02212197|8562813|P2|Overall Study|Need for radiotherapy|0
2479080|NCT02212197|8562814|P1|Overall Study|Need for radiotherapy|1
2479081|NCT02211638|8562867|P1|Overall Study|Protocol Violation|692
2479082|NCT02211638|8562867|P1|Overall Study|Case Report Forms Uncollected|291
2479083|NCT02211313|8562901|P2|Overall Study|No Follow up Questionnaires|1
2479084|NCT02211313|8562902|P1|Overall Study|No Follow up Questionnaires|1
2479085|NCT02211313|8562901|P2|Overall Study|Treatment Failure|2
2479086|NCT02211313|8562902|P1|Overall Study|Treatment Failure|5
2479087|NCT02211261|8562919|P11|Overall Study|Lost to Follow-up|0
2479088|NCT02211261|8562920|P10|Overall Study|Lost to Follow-up|0
2479089|NCT02211261|8562921|P9|Overall Study|Lost to Follow-up|0
2479090|NCT02211261|8562922|P8|Overall Study|Lost to Follow-up|1
2479091|NCT02211261|8562923|P7|Overall Study|Lost to Follow-up|0
2479092|NCT02211261|8562924|P6|Overall Study|Lost to Follow-up|0
2479093|NCT02211261|8562925|P5|Overall Study|Lost to Follow-up|0
2479094|NCT02211261|8562926|P4|Overall Study|Lost to Follow-up|0
2479095|NCT02211261|8562927|P3|Overall Study|Lost to Follow-up|0
2479096|NCT02211261|8562928|P2|Overall Study|Lost to Follow-up|0
2479097|NCT02211261|8562929|P1|Overall Study|Lost to Follow-up|0
2479098|NCT02211261|8562919|P11|Overall Study|Other|0
2479099|NCT02211261|8562920|P10|Overall Study|Other|2
2479100|NCT02211261|8562921|P9|Overall Study|Other|0
2479101|NCT02211261|8562922|P8|Overall Study|Other|0
2479102|NCT02211261|8562923|P7|Overall Study|Other|0
2479103|NCT02211261|8562924|P6|Overall Study|Other|1
2479104|NCT02211261|8562925|P5|Overall Study|Other|0
2479105|NCT02211261|8562926|P4|Overall Study|Other|0
2479106|NCT02211261|8562927|P3|Overall Study|Other|0
2479107|NCT02211261|8562928|P2|Overall Study|Other|0
2479108|NCT02211261|8562929|P1|Overall Study|Other|0
2479109|NCT02211261|8562919|P11|Overall Study|Withdrawal by Subject|0
2479110|NCT02211261|8562920|P10|Overall Study|Withdrawal by Subject|0
2479111|NCT02211261|8562921|P9|Overall Study|Withdrawal by Subject|0
2479112|NCT02211261|8562922|P8|Overall Study|Withdrawal by Subject|0
2479113|NCT02211261|8562923|P7|Overall Study|Withdrawal by Subject|0
2479114|NCT02211261|8562924|P6|Overall Study|Withdrawal by Subject|0
2479115|NCT02211261|8562925|P5|Overall Study|Withdrawal by Subject|2
2479116|NCT02211261|8562926|P4|Overall Study|Withdrawal by Subject|0
2479117|NCT02211261|8562927|P3|Overall Study|Withdrawal by Subject|1
2479118|NCT02211261|8562928|P2|Overall Study|Withdrawal by Subject|0
2479119|NCT02211261|8562929|P1|Overall Study|Withdrawal by Subject|0
2479120|NCT02210689|8563053|P3|Overall Study|Other|8
2479121|NCT02210689|8563054|P2|Overall Study|Other|21
2479122|NCT02210689|8563055|P1|Overall Study|Other|25
2479123|NCT02210689|8563053|P3|Overall Study|Negative Nugent score at baseline|2
2479124|NCT02210689|8563054|P2|Overall Study|Negative Nugent score at baseline|2
2479125|NCT02210689|8563055|P1|Overall Study|Negative Nugent score at baseline|6
2479126|NCT02210689|8563053|P3|Overall Study|Prohibited medication|1
2479127|NCT02210689|8563054|P2|Overall Study|Prohibited medication|8
2479128|NCT02210689|8563055|P1|Overall Study|Prohibited medication|2
2479129|NCT02210689|8563053|P3|Overall Study|Lack of Efficacy|5
2479130|NCT02210689|8563054|P2|Overall Study|Lack of Efficacy|1
2479131|NCT02210689|8563055|P1|Overall Study|Lack of Efficacy|0
2479132|NCT02210689|8563053|P3|Overall Study|Pregnancy|0
2479133|NCT02210689|8563054|P2|Overall Study|Pregnancy|1
2479134|NCT02210689|8563055|P1|Overall Study|Pregnancy|0
2479135|NCT02210689|8563053|P3|Overall Study|Lost to Follow-up|5
2479136|NCT02210689|8563054|P2|Overall Study|Lost to Follow-up|9
2479137|NCT02210689|8563055|P1|Overall Study|Lost to Follow-up|11
2479138|NCT02210689|8563053|P3|Overall Study|Protocol Violation|0
2479139|NCT02210689|8563054|P2|Overall Study|Protocol Violation|0
2479140|NCT02210689|8563055|P1|Overall Study|Protocol Violation|1
2479141|NCT02210689|8563053|P3|Overall Study|Adverse Event|0
2479142|NCT02210689|8563054|P2|Overall Study|Adverse Event|1
2479143|NCT02210689|8563055|P1|Overall Study|Adverse Event|0
2479144|NCT02210689|8563053|P3|Overall Study|Withdrawal by Subject|2
2479145|NCT02210689|8563054|P2|Overall Study|Withdrawal by Subject|4
2479146|NCT02210689|8563055|P1|Overall Study|Withdrawal by Subject|7
2479147|NCT02210208|8563063|P1|Period B (Donor Site)|7 subjects healed at or before Day 14|7
2479148|NCT02210208|8563063|P1|Period A (Graft Site)|Physician decided not to graft at OR|1
2479149|NCT02210208|8563063|P1|Period A (Graft Site)|Withdrawal by Subject|1
2479150|NCT02210091|8563083|P2|Overall Study|Withdrawal by Sponsor|1
2479151|NCT02210091|8563084|P1|Overall Study|Withdrawal by Sponsor|0
2479152|NCT02210091|8563083|P2|Overall Study|Physician Decision|1
2479153|NCT02210091|8563084|P1|Overall Study|Physician Decision|0
2479154|NCT02210000|8563171|P2|Overall Study|Physician Decision|1
2479155|NCT02210000|8563172|P1|Overall Study|Physician Decision|0
2479156|NCT02210000|8563171|P2|Overall Study|Lost to Follow-up|2
2479157|NCT02210000|8563172|P1|Overall Study|Lost to Follow-up|0
2479158|NCT02210000|8563171|P2|Overall Study|Adverse Event|5
2479159|NCT02210000|8563172|P1|Overall Study|Adverse Event|1
2479160|NCT02210000|8563171|P2|Overall Study|Withdrawal by Subject|1
2479161|NCT02210000|8563172|P1|Overall Study|Withdrawal by Subject|7
2479162|NCT02210000|8563171|P2|Overall Study|Study Terminated|12
2479163|NCT02210000|8563172|P1|Overall Study|Study Terminated|11
2479164|NCT02209766|8563198|P5|Overall Study|Withdrawal by Subject|0
2479165|NCT02209766|8563199|P4|Overall Study|Withdrawal by Subject|1
2479166|NCT02209766|8563200|P3|Overall Study|Withdrawal by Subject|0
2479167|NCT02209766|8563201|P2|Overall Study|Withdrawal by Subject|0
2479168|NCT02209766|8563202|P1|Overall Study|Withdrawal by Subject|0
2479169|NCT02209597|8563261|P1|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1
2479170|NCT02209597|8563261|P1|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3
2479171|NCT02209597|8563261|P1|Phase 1 Current Tx (Non-randomized)|Adverse Event|1
2479172|NCT02209597|8563261|P1|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2
2479173|NCT02209506|8563306|P5|Overall Study|Withdrawal by Subject|1
2479174|NCT02209506|8563307|P4|Overall Study|Withdrawal by Subject|0
2479175|NCT02209506|8563308|P3|Overall Study|Withdrawal by Subject|0
2479176|NCT02209506|8563309|P2|Overall Study|Withdrawal by Subject|0
2479177|NCT02209506|8563310|P1|Overall Study|Withdrawal by Subject|0
2479178|NCT02209454|8563385|P2|Second Period|Adverse Event|0
2479179|NCT02209454|8563386|P1|Second Period|Adverse Event|1
2479180|NCT02209181|8563436|P4|Overall Study|Withdrawal by Subject|0
2479181|NCT02209181|8563437|P3|Overall Study|Withdrawal by Subject|0
2479182|NCT02209181|8563438|P2|Overall Study|Withdrawal by Subject|1
2479183|NCT02209181|8563439|P1|Overall Study|Withdrawal by Subject|0
2479184|NCT02209181|8563436|P4|Overall Study|Adverse Event|0
2479185|NCT02209181|8563437|P3|Overall Study|Adverse Event|1
2479186|NCT02209181|8563438|P2|Overall Study|Adverse Event|0
2479187|NCT02209181|8563439|P1|Overall Study|Adverse Event|1
2479188|NCT02208999|8563610|P1|Overall Study|Lost to Follow-up|1
2479189|NCT02208843|8563632|P1|Overall Study|Switched to commercial afatinib|20
2479190|NCT02208843|8563632|P1|Overall Study|Withdrawal by Subject|1
2479191|NCT02208843|8563632|P1|Overall Study|Protocol Violation|1
2479192|NCT02208843|8563632|P1|Overall Study|Adverse Event|12
2479193|NCT02208843|8563632|P1|Overall Study|Progression disease according to RECIST|24
2479194|NCT02208843|8563632|P1|Overall Study|Clinical symptoms of progression|2
2479195|NCT02208089|8563684|P2|Overall Study|Lost to Follow-up|0
2479196|NCT02208089|8563685|P1|Overall Study|Lost to Follow-up|6
2479197|NCT02208089|8563684|P2|Overall Study|Withdrawal by Subject|0
2479198|NCT02208089|8563685|P1|Overall Study|Withdrawal by Subject|1
2479199|NCT02208063|8563701|P2|Overall Study|Lost to Follow-up|0
2479200|NCT02208063|8563702|P1|Overall Study|Lost to Follow-up|1
2479201|NCT02208063|8563701|P2|Overall Study|Withdrawal by Subject|2
2479202|NCT02208063|8563702|P1|Overall Study|Withdrawal by Subject|5
2479203|NCT02208063|8563701|P2|Overall Study|Not Specified in report|4
2479204|NCT02208063|8563702|P1|Overall Study|Not Specified in report|3
2479205|NCT02208063|8563701|P2|Overall Study|Death|5
2479206|NCT02208063|8563702|P1|Overall Study|Death|3
2479207|NCT02207907|8563781|P2|Overall Study|Pregnancy|1
2479208|NCT02207907|8563782|P1|Overall Study|Pregnancy|0
2479209|NCT02207907|8563781|P2|Overall Study|Did not meet study criteria|0
2479210|NCT02207907|8563782|P1|Overall Study|Did not meet study criteria|3
2479211|NCT02207907|8563781|P2|Overall Study|Withdrawal by Subject|6
2479212|NCT02207907|8563782|P1|Overall Study|Withdrawal by Subject|5
2479213|NCT02207907|8563781|P2|Overall Study|Lost to Follow-up|1
2479214|NCT02207907|8563782|P1|Overall Study|Lost to Follow-up|3
2479215|NCT02207829|8563800|P2|Overall Study|Withdrew consent|14
2479216|NCT02207829|8563801|P1|Overall Study|Withdrew consent|18
2479217|NCT02207829|8563800|P2|Overall Study|Protocol deviation|4
2479218|NCT02207829|8563801|P1|Overall Study|Protocol deviation|5
2479219|NCT02207829|8563800|P2|Overall Study|Lost to Follow-up|2
2479220|NCT02207829|8563801|P1|Overall Study|Lost to Follow-up|2
2479221|NCT02207829|8563800|P2|Overall Study|Lack of Efficacy|5
2479222|NCT02207829|8563801|P1|Overall Study|Lack of Efficacy|7
2479223|NCT02207829|8563800|P2|Overall Study|Adverse Event|9
2479224|NCT02207829|8563801|P1|Overall Study|Adverse Event|10
2479225|NCT02207816|8563810|P3|Overall Study|Other|4
2479226|NCT02207816|8563811|P2|Overall Study|Other|2
2479227|NCT02207816|8563812|P1|Overall Study|Other|1
2479228|NCT02207816|8563810|P3|Overall Study|Lost to Follow-up|1
2479229|NCT02207816|8563811|P2|Overall Study|Lost to Follow-up|9
2479230|NCT02207816|8563812|P1|Overall Study|Lost to Follow-up|3
2479231|NCT02207816|8563810|P3|Overall Study|Migrated/Moved From Study Area|51
2479232|NCT02207816|8563811|P2|Overall Study|Migrated/Moved From Study Area|60
2479233|NCT02207816|8563812|P1|Overall Study|Migrated/Moved From Study Area|41
2479234|NCT02207816|8563810|P3|Overall Study|Withdrawal by Subject|7
2479235|NCT02207816|8563811|P2|Overall Study|Withdrawal by Subject|9
2479236|NCT02207816|8563812|P1|Overall Study|Withdrawal by Subject|4
2479237|NCT02207816|8563810|P3|Overall Study|Eligibility Criteria Not Fulfilled|2
2479238|NCT02207816|8563811|P2|Overall Study|Eligibility Criteria Not Fulfilled|1
2479239|NCT02207816|8563812|P1|Overall Study|Eligibility Criteria Not Fulfilled|2
2479240|NCT02207816|8563810|P3|Overall Study|Serious Adverse Event|2
2479241|NCT02207816|8563811|P2|Overall Study|Serious Adverse Event|5
2479242|NCT02207816|8563812|P1|Overall Study|Serious Adverse Event|0
2479243|NCT02207725|8563970|P4|Overall Study|Did Not Receive Treatment|1
2479244|NCT02207725|8563971|P3|Overall Study|Did Not Receive Treatment|1
2479245|NCT02207725|8563972|P2|Overall Study|Did Not Receive Treatment|1
2479246|NCT02207725|8563973|P1|Overall Study|Did Not Receive Treatment|0
2479247|NCT02207634|8564003|P2|Overall Study|Lost to Follow-up|0
2479248|NCT02207634|8564004|P1|Overall Study|Lost to Follow-up|1
2479249|NCT02207634|8564003|P2|Overall Study|Withdrawal by Subject|31
2479250|NCT02207634|8564004|P1|Overall Study|Withdrawal by Subject|21
2479251|NCT02207621|8564019|P3|Overall Study|Other(Site,Sponsor and Subject request)|5
2479252|NCT02207621|8564020|P2|Overall Study|Other(Site,Sponsor and Subject request)|1
2479253|NCT02207621|8564021|P1|Overall Study|Other(Site,Sponsor and Subject request)|2
2479254|NCT02207621|8564019|P3|Overall Study|Death|0
2479255|NCT02207621|8564020|P2|Overall Study|Death|0
2479256|NCT02207621|8564021|P1|Overall Study|Death|2
2479257|NCT02207621|8564019|P3|Overall Study|Protocol Violation|6
2479258|NCT02207621|8564020|P2|Overall Study|Protocol Violation|10
2479259|NCT02207621|8564021|P1|Overall Study|Protocol Violation|4
2479260|NCT02207621|8564019|P3|Overall Study|Physician Decision|2
2479261|NCT02207621|8564020|P2|Overall Study|Physician Decision|2
2479262|NCT02207621|8564021|P1|Overall Study|Physician Decision|1
2479263|NCT02207621|8564019|P3|Overall Study|Disallowed Concurrent Medication|2
2479264|NCT02207621|8564020|P2|Overall Study|Disallowed Concurrent Medication|5
2479265|NCT02207621|8564021|P1|Overall Study|Disallowed Concurrent Medication|2
2479266|NCT02207621|8564019|P3|Overall Study|Lack of Efficacy|4
2479267|NCT02207621|8564020|P2|Overall Study|Lack of Efficacy|2
2479268|NCT02207621|8564021|P1|Overall Study|Lack of Efficacy|10
2479269|NCT02207621|8564019|P3|Overall Study|Lost to Follow-up|3
2479270|NCT02207621|8564020|P2|Overall Study|Lost to Follow-up|0
2479271|NCT02207621|8564021|P1|Overall Study|Lost to Follow-up|1
2479272|NCT02207621|8564019|P3|Overall Study|Non-Compliant|1
2479273|NCT02207621|8564020|P2|Overall Study|Non-Compliant|3
2479274|NCT02207621|8564021|P1|Overall Study|Non-Compliant|3
2479275|NCT02207621|8564019|P3|Overall Study|Withdrawal by Subject|13
2479276|NCT02207621|8564020|P2|Overall Study|Withdrawal by Subject|9
2479277|NCT02207621|8564021|P1|Overall Study|Withdrawal by Subject|9
2479278|NCT02207621|8564019|P3|Overall Study|Adverse Event|132
2479279|NCT02207621|8564020|P2|Overall Study|Adverse Event|15
2479280|NCT02207621|8564021|P1|Overall Study|Adverse Event|71
2479281|NCT02207608|8564034|P2|Overall Study|Adverse Event|0
2479282|NCT02207608|8564035|P1|Overall Study|Adverse Event|1
2479283|NCT02207556|8564061|P2|Overall Study|Death|5
2479284|NCT02207556|8564062|P1|Overall Study|Death|0
2479285|NCT02207556|8564061|P2|Overall Study|Withdrawal by Subject|0
2479286|NCT02207556|8564062|P1|Overall Study|Withdrawal by Subject|1
2479287|NCT02207556|8564061|P2|Overall Study|Physician Decision|0
2479288|NCT02207556|8564062|P1|Overall Study|Physician Decision|1
2479289|NCT02207530|8564067|P1|Overall Study|Adverse Event|8
2479290|NCT02207530|8564067|P1|Overall Study|Patient decision to stop study treatment|5
2479291|NCT02207530|8564067|P1|Overall Study|Worsening condition under investigation|78
2479292|NCT02207491|8564081|P2|Overall Study|Protocol Violation|5
2479293|NCT02207491|8564082|P1|Overall Study|Protocol Violation|3
2479294|NCT02207491|8564081|P2|Overall Study|Physician Decision|0
2479295|NCT02207491|8564082|P1|Overall Study|Physician Decision|2
2479296|NCT02207491|8564081|P2|Overall Study|Lack of Efficacy|0
2479297|NCT02207491|8564082|P1|Overall Study|Lack of Efficacy|3
2479298|NCT02207491|8564081|P2|Overall Study|Lost to Follow-up|1
2479299|NCT02207491|8564082|P1|Overall Study|Lost to Follow-up|0
2479300|NCT02207491|8564081|P2|Overall Study|Non-compliant|1
2479301|NCT02207491|8564082|P1|Overall Study|Non-compliant|0
2479302|NCT02207491|8564081|P2|Overall Study|Withdrawal by Subject|2
2479303|NCT02207491|8564082|P1|Overall Study|Withdrawal by Subject|3
2479304|NCT02207491|8564081|P2|Overall Study|Adverse Event|4
2479305|NCT02207491|8564082|P1|Overall Study|Adverse Event|20
2479306|NCT02207413|8564107|P6|Overall Study|Migrated/moved from study area|0
2479307|NCT02207413|8564108|P5|Overall Study|Migrated/moved from study area|1
2479308|NCT02207413|8564109|P4|Overall Study|Migrated/moved from study area|0
2479309|NCT02207413|8564110|P3|Overall Study|Migrated/moved from study area|0
2479310|NCT02207413|8564111|P2|Overall Study|Migrated/moved from study area|0
2479311|NCT02207413|8564112|P1|Overall Study|Migrated/moved from study area|0
2479312|NCT02207413|8564107|P6|Overall Study|Adverse Event|1
2479313|NCT02207413|8564108|P5|Overall Study|Adverse Event|2
2479314|NCT02207413|8564109|P4|Overall Study|Adverse Event|0
2479315|NCT02207413|8564110|P3|Overall Study|Adverse Event|0
2479316|NCT02207413|8564111|P2|Overall Study|Adverse Event|0
2479317|NCT02207413|8564112|P1|Overall Study|Adverse Event|0
2479318|NCT02207413|8564107|P6|Overall Study|Lost to Follow-up|5
2479319|NCT02207413|8564108|P5|Overall Study|Lost to Follow-up|1
2479320|NCT02207413|8564109|P4|Overall Study|Lost to Follow-up|1
2479321|NCT02207413|8564110|P3|Overall Study|Lost to Follow-up|0
2479322|NCT02207413|8564111|P2|Overall Study|Lost to Follow-up|0
2479323|NCT02207413|8564112|P1|Overall Study|Lost to Follow-up|0
2479324|NCT02207413|8564107|P6|Overall Study|Withdrawal by Subject|7
2479325|NCT02207413|8564108|P5|Overall Study|Withdrawal by Subject|3
2479326|NCT02207413|8564109|P4|Overall Study|Withdrawal by Subject|0
2479327|NCT02207413|8564110|P3|Overall Study|Withdrawal by Subject|0
2479328|NCT02207413|8564111|P2|Overall Study|Withdrawal by Subject|0
2479329|NCT02207413|8564112|P1|Overall Study|Withdrawal by Subject|1
2479330|NCT02207400|8564208|P2|Overall Study|Positive Urine Pregnancy Test|1
2479331|NCT02207400|8564209|P1|Overall Study|Positive Urine Pregnancy Test|0
2479332|NCT02207400|8564208|P2|Overall Study|Withdrawal by Subject|4
2479333|NCT02207400|8564209|P1|Overall Study|Withdrawal by Subject|8
2479334|NCT02207400|8564208|P2|Overall Study|Protocol Violation|1
2479335|NCT02207400|8564209|P1|Overall Study|Protocol Violation|1
2479336|NCT02207400|8564208|P2|Overall Study|Lost to Follow-up|7
2479337|NCT02207400|8564209|P1|Overall Study|Lost to Follow-up|6
2479338|NCT02207400|8564208|P2|Overall Study|Adverse Event|1
2479339|NCT02207400|8564209|P1|Overall Study|Adverse Event|1
2479340|NCT02207374|8564230|P3|Overall Study|Missing follow-up information|1
2479341|NCT02207374|8564231|P2|Overall Study|Missing follow-up information|1
2479342|NCT02207374|8564232|P1|Overall Study|Missing follow-up information|0
2479343|NCT02207374|8564230|P3|Overall Study|Death|1
2479344|NCT02207374|8564231|P2|Overall Study|Death|0
2479345|NCT02207374|8564232|P1|Overall Study|Death|1
2479346|NCT02207374|8564230|P3|Overall Study|Withdrawal by Subject|4
2479347|NCT02207374|8564231|P2|Overall Study|Withdrawal by Subject|9
2479348|NCT02207374|8564232|P1|Overall Study|Withdrawal by Subject|5
2479349|NCT02207244|8564296|P9|Withdrawal, Retreatment Period:Week28-48|Other|0
2479350|NCT02207244|8564297|P8|Withdrawal, Retreatment Period:Week28-48|Other|1
2479351|NCT02207244|8564298|P7|Withdrawal, Retreatment Period:Week28-48|Other|0
2479352|NCT02207244|8564299|P6|Withdrawal, Retreatment Period:Week28-48|Other|0
2479353|NCT02207244|8564300|P5|Withdrawal, Retreatment Period:Week28-48|Other|0
2479354|NCT02207244|8564301|P4|Withdrawal, Retreatment Period:Week28-48|Other|0
2479355|NCT02207244|8564302|P3|Withdrawal, Retreatment Period:Week28-48|Other|0
2479356|NCT02207244|8564303|P2|Withdrawal, Retreatment Period:Week28-48|Other|0
2479357|NCT02207244|8564304|P1|Withdrawal, Retreatment Period:Week28-48|Other|0
2479358|NCT02207244|8564296|P9|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
2479359|NCT02207244|8564297|P8|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
2479360|NCT02207244|8564298|P7|Withdrawal, Retreatment Period:Week28-48|Non-compliance|1
2479361|NCT02207244|8564299|P6|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
2479362|NCT02207244|8564300|P5|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
2479363|NCT02207244|8564301|P4|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
2479364|NCT02207244|8564302|P3|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
2479365|NCT02207244|8564303|P2|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
2479366|NCT02207244|8564304|P1|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
2479367|NCT02207244|8564296|P9|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
2479368|NCT02207244|8564297|P8|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
2479369|NCT02207244|8564298|P7|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|1
2479370|NCT02207244|8564299|P6|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
2479371|NCT02207244|8564300|P5|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
2479372|NCT02207244|8564301|P4|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
2479373|NCT02207244|8564302|P3|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
2479374|NCT02207244|8564303|P2|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
2479375|NCT02207244|8564304|P1|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
2479376|NCT02207244|8564296|P9|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|1
2479377|NCT02207244|8564297|P8|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|2
2479378|NCT02207244|8564298|P7|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|1
2479379|NCT02207244|8564299|P6|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
2479380|NCT02207244|8564300|P5|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
2479381|NCT02207244|8564301|P4|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
2479382|NCT02207244|8564302|P3|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
2479383|NCT02207244|8564303|P2|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
2479384|NCT02207244|8564304|P1|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
2479385|NCT02207244|8564296|P9|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|2
2479386|NCT02207244|8564297|P8|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|5
2479387|NCT02207244|8564298|P7|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|2
2479388|NCT02207244|8564299|P6|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
2479389|NCT02207244|8564300|P5|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
2479390|NCT02207244|8564301|P4|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
2479391|NCT02207244|8564302|P3|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
2479392|NCT02207244|8564303|P2|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
2479393|NCT02207244|8564304|P1|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
2479394|NCT02207244|8564296|P9|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|2
2479395|NCT02207244|8564297|P8|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|2
2479396|NCT02207244|8564298|P7|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
2479397|NCT02207244|8564299|P6|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
2479398|NCT02207244|8564300|P5|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
2479399|NCT02207244|8564301|P4|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
2479400|NCT02207244|8564302|P3|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
2479401|NCT02207244|8564303|P2|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
2479402|NCT02207244|8564304|P1|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
2479403|NCT02207244|8564296|P9|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
2479404|NCT02207244|8564297|P8|Withdrawal, Retreatment Period:Week28-48|Pregnancy|2
2479405|NCT02207244|8564298|P7|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
2479406|NCT02207244|8564299|P6|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
2479407|NCT02207244|8564300|P5|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
2479408|NCT02207244|8564301|P4|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
2479409|NCT02207244|8564302|P3|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
2479410|NCT02207244|8564303|P2|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
2479411|NCT02207244|8564304|P1|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
2479412|NCT02207244|8564296|P9|Withdrawal, Retreatment Period:Week28-48|Adverse Event|3
2479413|NCT02207244|8564297|P8|Withdrawal, Retreatment Period:Week28-48|Adverse Event|1
2479414|NCT02207244|8564298|P7|Withdrawal, Retreatment Period:Week28-48|Adverse Event|3
2479415|NCT02207244|8564299|P6|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
2479416|NCT02207244|8564300|P5|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
2479417|NCT02207244|8564301|P4|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
2479418|NCT02207244|8564302|P3|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
2479419|NCT02207244|8564303|P2|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
2479420|NCT02207244|8564304|P1|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
2479421|NCT02207244|8564296|P9|Placebo Crossover and ACP: Week 16 - 28|Other|0
2479422|NCT02207244|8564297|P8|Placebo Crossover and ACP: Week 16 - 28|Other|0
2479423|NCT02207244|8564298|P7|Placebo Crossover and ACP: Week 16 - 28|Other|0
2479424|NCT02207244|8564299|P6|Placebo Crossover and ACP: Week 16 - 28|Other|0
2479425|NCT02207244|8564300|P5|Placebo Crossover and ACP: Week 16 - 28|Other|0
2479426|NCT02207244|8564301|P4|Placebo Crossover and ACP: Week 16 - 28|Other|1
2479427|NCT02207244|8564302|P3|Placebo Crossover and ACP: Week 16 - 28|Other|0
2479428|NCT02207244|8564303|P2|Placebo Crossover and ACP: Week 16 - 28|Other|0
2479429|NCT02207244|8564304|P1|Placebo Crossover and ACP: Week 16 - 28|Other|0
2479430|NCT02207244|8564296|P9|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
2479431|NCT02207244|8564297|P8|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
2479432|NCT02207244|8564298|P7|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
2479433|NCT02207244|8564299|P6|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|1
2479434|NCT02207244|8564300|P5|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
2479435|NCT02207244|8564301|P4|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|1
2479436|NCT02207244|8564302|P3|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
2479437|NCT02207244|8564303|P2|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
2479438|NCT02207244|8564304|P1|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
2479439|NCT02207244|8564296|P9|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
2479440|NCT02207244|8564297|P8|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
2479441|NCT02207244|8564298|P7|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
2479442|NCT02207244|8564299|P6|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|2
2479443|NCT02207244|8564300|P5|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|3
2479444|NCT02207244|8564301|P4|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|3
2479445|NCT02207244|8564302|P3|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
2479446|NCT02207244|8564303|P2|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
2479447|NCT02207244|8564304|P1|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
2479448|NCT02207244|8564296|P9|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
2479449|NCT02207244|8564297|P8|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
2479450|NCT02207244|8564298|P7|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
2479451|NCT02207244|8564299|P6|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|2
2479452|NCT02207244|8564300|P5|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|2
2479453|NCT02207244|8564301|P4|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|1
2479454|NCT02207244|8564302|P3|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
2479455|NCT02207244|8564303|P2|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
2479456|NCT02207244|8564304|P1|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
2479457|NCT02207244|8564296|P9|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
2479458|NCT02207244|8564297|P8|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
2479459|NCT02207244|8564298|P7|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
2479460|NCT02207244|8564299|P6|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|2
2479461|NCT02207244|8564300|P5|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
2479462|NCT02207244|8564301|P4|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
2479463|NCT02207244|8564302|P3|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
2479464|NCT02207244|8564303|P2|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
2479465|NCT02207244|8564304|P1|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
2479466|NCT02207244|8564296|P9|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
2479467|NCT02207244|8564297|P8|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
2479468|NCT02207244|8564298|P7|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
2479469|NCT02207244|8564299|P6|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|2
2479470|NCT02207244|8564300|P5|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|3
2479471|NCT02207244|8564301|P4|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
2479472|NCT02207244|8564302|P3|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
2479473|NCT02207244|8564303|P2|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
2479474|NCT02207244|8564304|P1|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
2479475|NCT02207244|8564296|P9|Placebo Controlled Period: Week 0 - 16|Other|0
2479476|NCT02207244|8564297|P8|Placebo Controlled Period: Week 0 - 16|Other|0
2479477|NCT02207244|8564298|P7|Placebo Controlled Period: Week 0 - 16|Other|0
2479478|NCT02207244|8564299|P6|Placebo Controlled Period: Week 0 - 16|Other|0
2479479|NCT02207244|8564300|P5|Placebo Controlled Period: Week 0 - 16|Other|0
2479480|NCT02207244|8564301|P4|Placebo Controlled Period: Week 0 - 16|Other|0
2479481|NCT02207244|8564302|P3|Placebo Controlled Period: Week 0 - 16|Other|0
2479482|NCT02207244|8564303|P2|Placebo Controlled Period: Week 0 - 16|Other|1
2479483|NCT02207244|8564304|P1|Placebo Controlled Period: Week 0 - 16|Other|0
2479484|NCT02207244|8564296|P9|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
2479485|NCT02207244|8564297|P8|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
2479486|NCT02207244|8564298|P7|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
2479487|NCT02207244|8564299|P6|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
2479488|NCT02207244|8564300|P5|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
2479489|NCT02207244|8564301|P4|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
2479490|NCT02207244|8564302|P3|Placebo Controlled Period: Week 0 - 16|Non-Compliance|2
2479491|NCT02207244|8564303|P2|Placebo Controlled Period: Week 0 - 16|Non-Compliance|1
2479492|NCT02207244|8564304|P1|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
2479493|NCT02207244|8564296|P9|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
2479494|NCT02207244|8564297|P8|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
2479495|NCT02207244|8564298|P7|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
2479496|NCT02207244|8564299|P6|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
2479497|NCT02207244|8564300|P5|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
2479498|NCT02207244|8564301|P4|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
2479499|NCT02207244|8564302|P3|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
2479500|NCT02207244|8564303|P2|Placebo Controlled Period: Week 0 - 16|Protocol Violation|3
2479501|NCT02207244|8564304|P1|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
2479502|NCT02207244|8564296|P9|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
2479503|NCT02207244|8564297|P8|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
2479504|NCT02207244|8564298|P7|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
2479505|NCT02207244|8564299|P6|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
2479506|NCT02207244|8564300|P5|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
2479507|NCT02207244|8564301|P4|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
2479508|NCT02207244|8564302|P3|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
2479509|NCT02207244|8564303|P2|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|1
2479510|NCT02207244|8564304|P1|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|7
2479511|NCT02207244|8564296|P9|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
2479512|NCT02207244|8564297|P8|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
2479513|NCT02207244|8564298|P7|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
2479514|NCT02207244|8564299|P6|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
2479515|NCT02207244|8564300|P5|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
2479516|NCT02207244|8564301|P4|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
2479517|NCT02207244|8564302|P3|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|2
2479518|NCT02207244|8564303|P2|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|3
2479519|NCT02207244|8564304|P1|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
2479520|NCT02207244|8564296|P9|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
2479521|NCT02207244|8564297|P8|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
2479522|NCT02207244|8564298|P7|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
2479523|NCT02207244|8564299|P6|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
2479524|NCT02207244|8564300|P5|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
2479525|NCT02207244|8564301|P4|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
2479526|NCT02207244|8564302|P3|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
2479527|NCT02207244|8564303|P2|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
2479528|NCT02207244|8564304|P1|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|4
2479529|NCT02207244|8564296|P9|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
2479530|NCT02207244|8564297|P8|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
2479531|NCT02207244|8564298|P7|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
2479532|NCT02207244|8564299|P6|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
2479533|NCT02207244|8564300|P5|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
2479534|NCT02207244|8564301|P4|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
2479535|NCT02207244|8564302|P3|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
2479536|NCT02207244|8564303|P2|Placebo Controlled Period: Week 0 - 16|Adverse Event|9
2479537|NCT02207244|8564304|P1|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
2479538|NCT02207231|8564345|P3|Active Controlled Period: Week 16 - 48|Non-compliance|3
2479539|NCT02207231|8564346|P2|Active Controlled Period: Week 16 - 48|Non-compliance|3
2479540|NCT02207231|8564347|P1|Active Controlled Period: Week 16 - 48|Non-compliance|0
2479541|NCT02207231|8564345|P3|Active Controlled Period: Week 16 - 48|Other|3
2479542|NCT02207231|8564346|P2|Active Controlled Period: Week 16 - 48|Other|2
2479543|NCT02207231|8564347|P1|Active Controlled Period: Week 16 - 48|Other|0
2479544|NCT02207231|8564345|P3|Active Controlled Period: Week 16 - 48|Protocol Violation|0
2479545|NCT02207231|8564346|P2|Active Controlled Period: Week 16 - 48|Protocol Violation|1
2479546|NCT02207231|8564347|P1|Active Controlled Period: Week 16 - 48|Protocol Violation|0
2479547|NCT02207231|8564345|P3|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10
2479548|NCT02207231|8564346|P2|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4
2479549|NCT02207231|8564347|P1|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1
2479550|NCT02207231|8564345|P3|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5
2479551|NCT02207231|8564346|P2|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2
2479552|NCT02207231|8564347|P1|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1
2479553|NCT02207231|8564345|P3|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11
2479554|NCT02207231|8564346|P2|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3
2479555|NCT02207231|8564347|P1|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0
2479556|NCT02207231|8564345|P3|Active Controlled Period: Week 16 - 48|Pregnancy|1
2479557|NCT02207231|8564346|P2|Active Controlled Period: Week 16 - 48|Pregnancy|0
2479558|NCT02207231|8564347|P1|Active Controlled Period: Week 16 - 48|Pregnancy|0
2479559|NCT02207231|8564345|P3|Active Controlled Period: Week 16 - 48|Adverse Event|9
2479560|NCT02207231|8564346|P2|Active Controlled Period: Week 16 - 48|Adverse Event|6
2479561|NCT02207231|8564347|P1|Active Controlled Period: Week 16 - 48|Adverse Event|1
2479562|NCT02207231|8564345|P3|Placebo Controlled Period: Week 0 - 16|Noncompliance|1
2479563|NCT02207231|8564346|P2|Placebo Controlled Period: Week 0 - 16|Noncompliance|2
2479564|NCT02207231|8564347|P1|Placebo Controlled Period: Week 0 - 16|Noncompliance|0
2479565|NCT02207231|8564345|P3|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
2479566|NCT02207231|8564346|P2|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
2479567|NCT02207231|8564347|P1|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
2479568|NCT02207231|8564345|P3|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4
2479569|NCT02207231|8564346|P2|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
2479570|NCT02207231|8564347|P1|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2
2479571|NCT02207231|8564345|P3|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
2479572|NCT02207231|8564346|P2|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
2479573|NCT02207231|8564347|P1|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
2479574|NCT02207231|8564345|P3|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1
2479575|NCT02207231|8564346|P2|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
2479576|NCT02207231|8564347|P1|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
2479577|NCT02207231|8564345|P3|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
2479578|NCT02207231|8564346|P2|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
2479579|NCT02207231|8564347|P1|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
2479580|NCT02207088|8564379|P1|Overall Study|Adverse Event|2
2479581|NCT02206828|8564385|P1|Overall Study|Lost to Follow-up|7
2479582|NCT02206620|8564421|P2|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2
2479583|NCT02206620|8564422|P1|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0
2479584|NCT02206620|8564421|P2|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1
2479585|NCT02206620|8564422|P1|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1
2479586|NCT02206607|8564438|P5|Second Intervention Period|Insufficient Clinical Response|0
2479587|NCT02206607|8564439|P4|Second Intervention Period|Insufficient Clinical Response|1
2479588|NCT02206607|8564440|P3|Second Intervention Period|Insufficient Clinical Response|0
2479589|NCT02206607|8564441|P2|Second Intervention Period|Insufficient Clinical Response|0
2479590|NCT02206607|8564442|P1|Second Intervention Period|Insufficient Clinical Response|0
2479591|NCT02206607|8564438|P5|Open-Label Run-In|Withdrawal by Subject|0
2479592|NCT02206607|8564439|P4|Open-Label Run-In|Withdrawal by Subject|0
2479593|NCT02206607|8564440|P3|Open-Label Run-In|Withdrawal by Subject|0
2479594|NCT02206607|8564441|P2|Open-Label Run-In|Withdrawal by Subject|0
2479595|NCT02206607|8564442|P1|Open-Label Run-In|Withdrawal by Subject|3
2479596|NCT02206152|8564505|P1|Pre-Randomization|Withdrawal by Subject|2
2479597|NCT02205814|8564532|P4|Overall Study|not compliant with study procedures|0
2479598|NCT02205814|8564533|P3|Overall Study|not compliant with study procedures|1
2479599|NCT02205814|8564534|P2|Overall Study|not compliant with study procedures|0
2479600|NCT02205814|8564535|P1|Overall Study|not compliant with study procedures|0
2479601|NCT02205814|8564532|P4|Overall Study|Withdrawal by Subject|1
2479602|NCT02205814|8564533|P3|Overall Study|Withdrawal by Subject|2
2479603|NCT02205814|8564534|P2|Overall Study|Withdrawal by Subject|1
2479604|NCT02205814|8564535|P1|Overall Study|Withdrawal by Subject|0
2479605|NCT02205814|8564532|P4|Overall Study|Protocol Violation|1
2479606|NCT02205814|8564533|P3|Overall Study|Protocol Violation|0
2479607|NCT02205814|8564534|P2|Overall Study|Protocol Violation|0
2479608|NCT02205814|8564535|P1|Overall Study|Protocol Violation|1
2479609|NCT02205814|8564532|P4|Overall Study|Physician Decision|0
2479610|NCT02205814|8564533|P3|Overall Study|Physician Decision|1
2479611|NCT02205814|8564534|P2|Overall Study|Physician Decision|0
2479612|NCT02205814|8564535|P1|Overall Study|Physician Decision|0
2479613|NCT02205814|8564532|P4|Overall Study|Lack of Efficacy|1
2479614|NCT02205814|8564533|P3|Overall Study|Lack of Efficacy|1
2479615|NCT02205814|8564534|P2|Overall Study|Lack of Efficacy|0
2479616|NCT02205814|8564535|P1|Overall Study|Lack of Efficacy|1
2479617|NCT02205814|8564532|P4|Overall Study|Lost to Follow-up|1
2479618|NCT02205814|8564533|P3|Overall Study|Lost to Follow-up|0
2479619|NCT02205814|8564534|P2|Overall Study|Lost to Follow-up|0
2479620|NCT02205814|8564535|P1|Overall Study|Lost to Follow-up|0
2479621|NCT02205476|8564588|P2|Overall Study|Study termination by Sponsor|3
2479622|NCT02205476|8564589|P1|Overall Study|Study termination by Sponsor|7
2479623|NCT02205333|8564628|P9|Overall Study|Withdrawal by Subject|0
2479624|NCT02205333|8564629|P8|Overall Study|Withdrawal by Subject|0
2479625|NCT02205333|8564630|P7|Overall Study|Withdrawal by Subject|2
2479626|NCT02205333|8564631|P6|Overall Study|Withdrawal by Subject|0
2479627|NCT02205333|8564632|P5|Overall Study|Withdrawal by Subject|0
2479628|NCT02205333|8564633|P4|Overall Study|Withdrawal by Subject|1
2479629|NCT02205333|8564634|P3|Overall Study|Withdrawal by Subject|0
2479630|NCT02205333|8564635|P2|Overall Study|Withdrawal by Subject|0
2479631|NCT02205333|8564636|P1|Overall Study|Withdrawal by Subject|1
2479632|NCT02205333|8564628|P9|Overall Study|Death|0
2479633|NCT02205333|8564629|P8|Overall Study|Death|2
2479634|NCT02205333|8564630|P7|Overall Study|Death|3
2479635|NCT02205333|8564631|P6|Overall Study|Death|3
2479636|NCT02205333|8564632|P5|Overall Study|Death|5
2479637|NCT02205333|8564633|P4|Overall Study|Death|6
2479638|NCT02205333|8564634|P3|Overall Study|Death|2
2479639|NCT02205333|8564635|P2|Overall Study|Death|6
2479640|NCT02205333|8564636|P1|Overall Study|Death|5
2479641|NCT02204982|8564822|P2|Overall Study|Termination of Study bySponsor|1
2479642|NCT02204982|8564823|P1|Overall Study|Termination of Study bySponsor|0
2479643|NCT02204982|8564822|P2|Overall Study|Protocol-Specified Disease Progression|4
2479644|NCT02204982|8564823|P1|Overall Study|Protocol-Specified Disease Progression|0
2479645|NCT02204982|8564822|P2|Overall Study|Physician Decision|2
2479646|NCT02204982|8564823|P1|Overall Study|Physician Decision|0
2479647|NCT02204982|8564822|P2|Overall Study|Adverse Event and Investigator decision|0
2479648|NCT02204982|8564823|P1|Overall Study|Adverse Event and Investigator decision|1
2479649|NCT02204982|8564822|P2|Overall Study|Adverse Event|0
2479650|NCT02204982|8564823|P1|Overall Study|Adverse Event|1
2479651|NCT02204982|8564822|P2|Overall Study|Withdrawal by Subject|0
2479652|NCT02204982|8564823|P1|Overall Study|Withdrawal by Subject|1
2479653|NCT02204982|8564822|P2|Overall Study|Patient ineligible-medical monitor|0
2479654|NCT02204982|8564823|P1|Overall Study|Patient ineligible-medical monitor|1
2479655|NCT02204917|8564831|P1|Overall Study|Protocol Violation|1
2479656|NCT02204579|8564868|P1|Overall Study|Screen failures|2
2479657|NCT02204449|8564926|P2|Overall Study|Withdrawal by Subject|1
2479658|NCT02204449|8564927|P1|Overall Study|Withdrawal by Subject|0
2479659|NCT02204449|8564926|P2|Overall Study|Death|1
2479660|NCT02204449|8564927|P1|Overall Study|Death|0
2479661|NCT02204449|8564926|P2|Overall Study|Lost to Follow-up|9
2479662|NCT02204449|8564927|P1|Overall Study|Lost to Follow-up|7
2479663|NCT02204410|8564937|P1|Overall Study|Withdrawal by Subject|3
2479664|NCT02204410|8564937|P1|Overall Study|Protocol Violation|1
2479665|NCT02204410|8564937|P1|Overall Study|Physician Decision|2
2479666|NCT02204410|8564937|P1|Overall Study|Lost to Follow-up|5
2479667|NCT02204371|8564942|P1|Overall Study|Adverse Event|1
2479668|NCT02204319|8564965|P1|Overall Study|Withdrawal by Subject|2
2479669|NCT02204319|8564965|P1|Overall Study|Pregnancy|1
2479670|NCT02204007|8565026|P2|Overall Study|Surgery Canceled|1
2479671|NCT02204007|8565027|P1|Overall Study|Surgery Canceled|1
2479672|NCT02203916|8565038|P3|Overall Study|Reason Not Specified|1
2479673|NCT02203916|8565039|P2|Overall Study|Reason Not Specified|2
2479674|NCT02203916|8565040|P1|Overall Study|Reason Not Specified|0
2479675|NCT02203916|8565038|P3|Overall Study|Lack of Efficacy|0
2479676|NCT02203916|8565039|P2|Overall Study|Lack of Efficacy|0
2479677|NCT02203916|8565040|P1|Overall Study|Lack of Efficacy|3
2479678|NCT02203916|8565038|P3|Overall Study|Voluntary Withdrawal|8
2479679|NCT02203916|8565039|P2|Overall Study|Voluntary Withdrawal|3
2479680|NCT02203916|8565040|P1|Overall Study|Voluntary Withdrawal|3
2479681|NCT02203916|8565038|P3|Overall Study|Lost to Follow-up|0
2479682|NCT02203916|8565039|P2|Overall Study|Lost to Follow-up|1
2479683|NCT02203916|8565040|P1|Overall Study|Lost to Follow-up|0
2479684|NCT02203916|8565038|P3|Overall Study|Major Protocol Deviation|0
2479685|NCT02203916|8565039|P2|Overall Study|Major Protocol Deviation|1
2479686|NCT02203916|8565040|P1|Overall Study|Major Protocol Deviation|1
2479687|NCT02203916|8565038|P3|Overall Study|Pretreatment Event/Adverse Event|2
2479688|NCT02203916|8565039|P2|Overall Study|Pretreatment Event/Adverse Event|3
2479689|NCT02203916|8565040|P1|Overall Study|Pretreatment Event/Adverse Event|1
2479690|NCT02203851|8565060|P1|Overall Study|Other|1
2479691|NCT02203851|8565060|P1|Overall Study|Withdrawal by Subject|6
2479692|NCT02203851|8565060|P1|Overall Study|Lost to Follow-up|4
2479693|NCT02203838|8565098|P4|Overall Study|Other|0
2479694|NCT02203838|8565099|P3|Overall Study|Other|0
2479695|NCT02203838|8565100|P2|Overall Study|Other|0
2479696|NCT02203838|8565101|P1|Overall Study|Other|1
2479697|NCT02203838|8565098|P4|Overall Study|Physician Decision|3
2479698|NCT02203838|8565099|P3|Overall Study|Physician Decision|2
2479699|NCT02203838|8565100|P2|Overall Study|Physician Decision|0
2479700|NCT02203838|8565101|P1|Overall Study|Physician Decision|27
2479701|NCT02203838|8565098|P4|Overall Study|Withdrawal by Subject|11
2479702|NCT02203838|8565099|P3|Overall Study|Withdrawal by Subject|8
2479703|NCT02203838|8565100|P2|Overall Study|Withdrawal by Subject|10
2479704|NCT02203838|8565101|P1|Overall Study|Withdrawal by Subject|83
2479705|NCT02203838|8565098|P4|Overall Study|Protocol Violation|0
2479706|NCT02203838|8565099|P3|Overall Study|Protocol Violation|0
2479707|NCT02203838|8565100|P2|Overall Study|Protocol Violation|3
2479708|NCT02203838|8565101|P1|Overall Study|Protocol Violation|7
2479709|NCT02203838|8565098|P4|Overall Study|Lost to Follow-up|1
2479710|NCT02203838|8565099|P3|Overall Study|Lost to Follow-up|2
2479711|NCT02203838|8565100|P2|Overall Study|Lost to Follow-up|3
2479712|NCT02203838|8565101|P1|Overall Study|Lost to Follow-up|39
2479713|NCT02203838|8565098|P4|Overall Study|Adverse Event|2
2479714|NCT02203838|8565099|P3|Overall Study|Adverse Event|3
2479715|NCT02203838|8565100|P2|Overall Study|Adverse Event|6
2479716|NCT02203838|8565101|P1|Overall Study|Adverse Event|46
2479717|NCT02203838|8565098|P4|Overall Study|Lack of Efficacy|1
2479718|NCT02203838|8565099|P3|Overall Study|Lack of Efficacy|1
2479719|NCT02203838|8565100|P2|Overall Study|Lack of Efficacy|0
2479720|NCT02203838|8565101|P1|Overall Study|Lack of Efficacy|7
2479721|NCT02203721|8565181|P2|Overall Study|Illness|1
2479722|NCT02203721|8565182|P1|Overall Study|Illness|0
2479723|NCT02203721|8565181|P2|Overall Study|Death|2
2479724|NCT02203721|8565182|P1|Overall Study|Death|0
2479725|NCT02203721|8565181|P2|Overall Study|Lost to Follow-up|0
2479726|NCT02203721|8565182|P1|Overall Study|Lost to Follow-up|1
2479727|NCT02203357|8565282|P3|Overall Study|Lost to Follow-up|70
2479728|NCT02203357|8565283|P2|Overall Study|Lost to Follow-up|66
2479729|NCT02203357|8565284|P1|Overall Study|Lost to Follow-up|58
2479730|NCT02203331|8565307|P6|Overall Study|Lost to Follow-up|0
2479731|NCT02203331|8565308|P5|Overall Study|Lost to Follow-up|1
2479732|NCT02203331|8565309|P4|Overall Study|Lost to Follow-up|0
2479733|NCT02203331|8565310|P3|Overall Study|Lost to Follow-up|0
2479734|NCT02203331|8565311|P2|Overall Study|Lost to Follow-up|0
2479735|NCT02203331|8565312|P1|Overall Study|Lost to Follow-up|0
2479736|NCT02203331|8565307|P6|Overall Study|Protocol Violation|0
2479737|NCT02203331|8565308|P5|Overall Study|Protocol Violation|1
2479738|NCT02203331|8565309|P4|Overall Study|Protocol Violation|1
2479739|NCT02203331|8565310|P3|Overall Study|Protocol Violation|0
2479740|NCT02203331|8565311|P2|Overall Study|Protocol Violation|2
2479741|NCT02203331|8565312|P1|Overall Study|Protocol Violation|0
2479742|NCT02203331|8565307|P6|Overall Study|Lack of Efficacy|1
2479743|NCT02203331|8565308|P5|Overall Study|Lack of Efficacy|0
2479744|NCT02203331|8565309|P4|Overall Study|Lack of Efficacy|0
2479745|NCT02203331|8565310|P3|Overall Study|Lack of Efficacy|1
2479746|NCT02203331|8565311|P2|Overall Study|Lack of Efficacy|2
2479747|NCT02203331|8565312|P1|Overall Study|Lack of Efficacy|0
2479748|NCT02203331|8565307|P6|Overall Study|Other Reasons|0
2479749|NCT02203331|8565308|P5|Overall Study|Other Reasons|0
2479750|NCT02203331|8565309|P4|Overall Study|Other Reasons|2
2479751|NCT02203331|8565310|P3|Overall Study|Other Reasons|0
2479752|NCT02203331|8565311|P2|Overall Study|Other Reasons|2
2479753|NCT02203331|8565312|P1|Overall Study|Other Reasons|1
2479754|NCT02203331|8565307|P6|Overall Study|Adverse Event|3
2479755|NCT02203331|8565308|P5|Overall Study|Adverse Event|3
2479756|NCT02203331|8565309|P4|Overall Study|Adverse Event|4
2479757|NCT02203331|8565310|P3|Overall Study|Adverse Event|3
2479758|NCT02203331|8565311|P2|Overall Study|Adverse Event|8
2479759|NCT02203331|8565312|P1|Overall Study|Adverse Event|4
2479760|NCT02203331|8565307|P6|Overall Study|Withdrawal by Subject|3
2479761|NCT02203331|8565308|P5|Overall Study|Withdrawal by Subject|0
2479762|NCT02203331|8565309|P4|Overall Study|Withdrawal by Subject|0
2479763|NCT02203331|8565310|P3|Overall Study|Withdrawal by Subject|1
2479764|NCT02203331|8565311|P2|Overall Study|Withdrawal by Subject|0
2479765|NCT02203331|8565312|P1|Overall Study|Withdrawal by Subject|1
2479766|NCT02203331|8565307|P6|Overall Study|Pregnancy|0
2479767|NCT02203331|8565308|P5|Overall Study|Pregnancy|2
2479768|NCT02203331|8565309|P4|Overall Study|Pregnancy|0
2479769|NCT02203331|8565310|P3|Overall Study|Pregnancy|0
2479770|NCT02203331|8565311|P2|Overall Study|Pregnancy|0
2479771|NCT02203331|8565312|P1|Overall Study|Pregnancy|1
2479772|NCT02203149|8565371|P5|Part 2|Adverse Event|1
2479773|NCT02203149|8565372|P4|Part 2|Adverse Event|1
2479774|NCT02203149|8565373|P3|Part 2|Adverse Event|0
2479775|NCT02203149|8565374|P2|Part 2|Adverse Event|0
2479776|NCT02203149|8565375|P1|Part 2|Adverse Event|0
2479777|NCT02203149|8565371|P5|Part 2|Withdrawal by Subject|0
2479778|NCT02203149|8565372|P4|Part 2|Withdrawal by Subject|1
2479779|NCT02203149|8565373|P3|Part 2|Withdrawal by Subject|0
2479780|NCT02203149|8565374|P2|Part 2|Withdrawal by Subject|0
2479781|NCT02203149|8565375|P1|Part 2|Withdrawal by Subject|0
2479782|NCT02203149|8565371|P5|Part 2|Death|0
2479783|NCT02203149|8565372|P4|Part 2|Death|1
2479784|NCT02203149|8565373|P3|Part 2|Death|1
2479785|NCT02203149|8565374|P2|Part 2|Death|0
2479786|NCT02203149|8565375|P1|Part 2|Death|0
2479787|NCT02203149|8565371|P5|Part 1|Adverse Event|0
2479788|NCT02203149|8565372|P4|Part 1|Adverse Event|0
2479789|NCT02203149|8565373|P3|Part 1|Adverse Event|0
2479790|NCT02203149|8565374|P2|Part 1|Adverse Event|1
2479791|NCT02203149|8565375|P1|Part 1|Adverse Event|0
2479792|NCT02203071|8565410|P2|Overall Study|Lost to Follow-up|1
2479793|NCT02203071|8565411|P1|Overall Study|Lost to Follow-up|3
2479794|NCT02203032|8565427|P4|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2
2479795|NCT02203032|8565428|P3|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3
2479796|NCT02203032|8565429|P2|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1
2479797|NCT02203032|8565430|P1|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0
2479798|NCT02203032|8565427|P4|Blinded Phase (Week 16 to Week 44)|Death|1
2479799|NCT02203032|8565428|P3|Blinded Phase (Week 16 to Week 44)|Death|0
2479800|NCT02203032|8565429|P2|Blinded Phase (Week 16 to Week 44)|Death|0
2479801|NCT02203032|8565430|P1|Blinded Phase (Week 16 to Week 44)|Death|0
2479802|NCT02203032|8565427|P4|Blinded Phase (Week 16 to Week 44)|Other|15
2479803|NCT02203032|8565428|P3|Blinded Phase (Week 16 to Week 44)|Other|1
2479804|NCT02203032|8565429|P2|Blinded Phase (Week 16 to Week 44)|Other|4
2479805|NCT02203032|8565430|P1|Blinded Phase (Week 16 to Week 44)|Other|0
2479806|NCT02203032|8565427|P4|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20
2479807|NCT02203032|8565428|P3|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19
2479808|NCT02203032|8565429|P2|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8
2479809|NCT02203032|8565430|P1|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0
2479810|NCT02203032|8565427|P4|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8
2479811|NCT02203032|8565428|P3|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3
2479812|NCT02203032|8565429|P2|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2
2479813|NCT02203032|8565430|P1|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0
2479814|NCT02203032|8565427|P4|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
2479815|NCT02203032|8565428|P3|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
2479816|NCT02203032|8565429|P2|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
2479817|NCT02203032|8565430|P1|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1
2479818|NCT02203032|8565427|P4|Open Label Run-in (Week 0 to Week 16)|Other|0
2479819|NCT02203032|8565428|P3|Open Label Run-in (Week 0 to Week 16)|Other|0
2479820|NCT02203032|8565429|P2|Open Label Run-in (Week 0 to Week 16)|Other|0
2479821|NCT02203032|8565430|P1|Open Label Run-in (Week 0 to Week 16)|Other|2
2479822|NCT02203032|8565427|P4|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
2479823|NCT02203032|8565428|P3|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
2479824|NCT02203032|8565429|P2|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
2479825|NCT02203032|8565430|P1|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4
2479826|NCT02203032|8565427|P4|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
2479827|NCT02203032|8565428|P3|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
2479828|NCT02203032|8565429|P2|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
2479829|NCT02203032|8565430|P1|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6
2479830|NCT02203032|8565427|P4|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
2479831|NCT02203032|8565428|P3|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
2479832|NCT02203032|8565429|P2|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
2479833|NCT02203032|8565430|P1|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3
2479834|NCT02203032|8565427|P4|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
2479835|NCT02203032|8565428|P3|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
2479836|NCT02203032|8565429|P2|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
2479837|NCT02203032|8565430|P1|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1
2479838|NCT02203032|8565427|P4|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
2479839|NCT02203032|8565428|P3|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
2479840|NCT02203032|8565429|P2|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
2479841|NCT02203032|8565430|P1|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2
2479842|NCT02202980|8565473|P14|Overall Study|Withdrew Consent|0
2479843|NCT02202980|8565474|P13|Overall Study|Withdrew Consent|0
2479844|NCT02202980|8565475|P12|Overall Study|Withdrew Consent|0
2479845|NCT02202980|8565476|P11|Overall Study|Withdrew Consent|0
2479846|NCT02202980|8565477|P10|Overall Study|Withdrew Consent|0
2479847|NCT02202980|8565478|P9|Overall Study|Withdrew Consent|1
2479848|NCT02202980|8565479|P8|Overall Study|Withdrew Consent|0
2479849|NCT02202980|8565480|P7|Overall Study|Withdrew Consent|0
2479850|NCT02202980|8565481|P6|Overall Study|Withdrew Consent|0
2479851|NCT02202980|8565482|P5|Overall Study|Withdrew Consent|0
2479852|NCT02202980|8565483|P4|Overall Study|Withdrew Consent|0
2479853|NCT02202980|8565484|P3|Overall Study|Withdrew Consent|2
2479854|NCT02202980|8565485|P2|Overall Study|Withdrew Consent|1
2479855|NCT02202980|8565486|P1|Overall Study|Withdrew Consent|0
2479856|NCT02202980|8565473|P14|Overall Study|Lost to Follow-up|0
2479857|NCT02202980|8565474|P13|Overall Study|Lost to Follow-up|1
2479858|NCT02202980|8565475|P12|Overall Study|Lost to Follow-up|0
2479859|NCT02202980|8565476|P11|Overall Study|Lost to Follow-up|0
2479860|NCT02202980|8565477|P10|Overall Study|Lost to Follow-up|0
2479861|NCT02202980|8565478|P9|Overall Study|Lost to Follow-up|1
2479862|NCT02202980|8565479|P8|Overall Study|Lost to Follow-up|1
2479863|NCT02202980|8565480|P7|Overall Study|Lost to Follow-up|0
2479864|NCT02202980|8565481|P6|Overall Study|Lost to Follow-up|0
2479865|NCT02202980|8565482|P5|Overall Study|Lost to Follow-up|0
2479866|NCT02202980|8565483|P4|Overall Study|Lost to Follow-up|1
2479867|NCT02202980|8565484|P3|Overall Study|Lost to Follow-up|1
2479868|NCT02202980|8565485|P2|Overall Study|Lost to Follow-up|1
2479869|NCT02202980|8565486|P1|Overall Study|Lost to Follow-up|0
2479870|NCT02202980|8565473|P14|Overall Study|Protocol Violation|0
2479871|NCT02202980|8565474|P13|Overall Study|Protocol Violation|0
2479872|NCT02202980|8565475|P12|Overall Study|Protocol Violation|0
2479873|NCT02202980|8565476|P11|Overall Study|Protocol Violation|0
2479874|NCT02202980|8565477|P10|Overall Study|Protocol Violation|0
2479875|NCT02202980|8565478|P9|Overall Study|Protocol Violation|0
2479876|NCT02202980|8565479|P8|Overall Study|Protocol Violation|0
2479877|NCT02202980|8565480|P7|Overall Study|Protocol Violation|0
2479878|NCT02202980|8565481|P6|Overall Study|Protocol Violation|0
2479879|NCT02202980|8565482|P5|Overall Study|Protocol Violation|3
2479880|NCT02202980|8565483|P4|Overall Study|Protocol Violation|3
2479881|NCT02202980|8565484|P3|Overall Study|Protocol Violation|0
2479882|NCT02202980|8565485|P2|Overall Study|Protocol Violation|0
2479883|NCT02202980|8565486|P1|Overall Study|Protocol Violation|0
2479884|NCT02202980|8565473|P14|Overall Study|Lack of Efficacy|0
2479885|NCT02202980|8565474|P13|Overall Study|Lack of Efficacy|10
2479886|NCT02202980|8565475|P12|Overall Study|Lack of Efficacy|3
2479887|NCT02202980|8565476|P11|Overall Study|Lack of Efficacy|0
2479888|NCT02202980|8565477|P10|Overall Study|Lack of Efficacy|0
2479889|NCT02202980|8565478|P9|Overall Study|Lack of Efficacy|2
2479890|NCT02202980|8565479|P8|Overall Study|Lack of Efficacy|2
2479891|NCT02202980|8565480|P7|Overall Study|Lack of Efficacy|11
2479892|NCT02202980|8565481|P6|Overall Study|Lack of Efficacy|1
2479893|NCT02202980|8565482|P5|Overall Study|Lack of Efficacy|3
2479894|NCT02202980|8565483|P4|Overall Study|Lack of Efficacy|0
2479895|NCT02202980|8565484|P3|Overall Study|Lack of Efficacy|7
2479896|NCT02202980|8565485|P2|Overall Study|Lack of Efficacy|0
2479897|NCT02202980|8565486|P1|Overall Study|Lack of Efficacy|1
2479898|NCT02202850|8565574|P2|Overall Study|Lost to Follow-up|1
2479899|NCT02202850|8565575|P1|Overall Study|Lost to Follow-up|7
2479900|NCT02202850|8565574|P2|Overall Study|Enbrel treatment discontinued|3
2479901|NCT02202850|8565575|P1|Overall Study|Enbrel treatment discontinued|15
2479902|NCT02202850|8565574|P2|Overall Study|Other|2
2479903|NCT02202850|8565575|P1|Overall Study|Other|2
2479904|NCT02202837|8565627|P2|Overall Study|Lost to Follow-up|1
2479905|NCT02202837|8565628|P1|Overall Study|Lost to Follow-up|7
2479906|NCT02202837|8565627|P2|Overall Study|Other|0
2479907|NCT02202837|8565628|P1|Overall Study|Other|10
2479908|NCT02202837|8565627|P2|Overall Study|Enbrel treatment discontinued|4
2479909|NCT02202837|8565628|P1|Overall Study|Enbrel treatment discontinued|36
2479910|NCT02202785|8565679|P3|Overall Study|Reason not Specified|13
2479911|NCT02202785|8565680|P2|Overall Study|Reason not Specified|7
2479912|NCT02202785|8565681|P1|Overall Study|Reason not Specified|10
2479913|NCT02202785|8565679|P3|Overall Study|Lost to Follow-up|0
2479914|NCT02202785|8565680|P2|Overall Study|Lost to Follow-up|1
2479915|NCT02202785|8565681|P1|Overall Study|Lost to Follow-up|0
2479916|NCT02202785|8565679|P3|Overall Study|Withdrawal by Subject|0
2479917|NCT02202785|8565680|P2|Overall Study|Withdrawal by Subject|1
2479918|NCT02202785|8565681|P1|Overall Study|Withdrawal by Subject|0
2479919|NCT02202785|8565679|P3|Overall Study|Study Terminated by Sponsor|4
2479920|NCT02202785|8565680|P2|Overall Study|Study Terminated by Sponsor|6
2479921|NCT02202785|8565681|P1|Overall Study|Study Terminated by Sponsor|1
2479922|NCT02202759|8565718|P3|Overall Study|Reason not Specified|10
2479923|NCT02202759|8565719|P2|Overall Study|Reason not Specified|11
2479924|NCT02202759|8565720|P1|Overall Study|Reason not Specified|4
2479925|NCT02202759|8565718|P3|Overall Study|Withdrawal by Subject|1
2479926|NCT02202759|8565719|P2|Overall Study|Withdrawal by Subject|1
2479927|NCT02202759|8565720|P1|Overall Study|Withdrawal by Subject|2
2479928|NCT02202759|8565718|P3|Overall Study|Study Terminated by Sponsor|3
2479929|NCT02202759|8565719|P2|Overall Study|Study Terminated by Sponsor|3
2479930|NCT02202759|8565720|P1|Overall Study|Study Terminated by Sponsor|3
2479931|NCT02202616|8565754|P1|Overall Study|Unsatisfactory therapeutic effect|1
2479932|NCT02202616|8565754|P1|Overall Study|Abnormal test procedure result|1
2479933|NCT02202616|8565754|P1|Overall Study|Administrative problems|6
2479934|NCT02202616|8565754|P1|Overall Study|Lost to Follow-up|6
2479935|NCT02202616|8565754|P1|Overall Study|Patient withdrew consent|12
2479936|NCT02202616|8565754|P1|Overall Study|Protocol deviation|18
2479937|NCT02202616|8565754|P1|Overall Study|Adverse Event|32
2479938|NCT02202616|8565754|P1|Overall Study|Screen failed|24
2479939|NCT02202538|8565765|P1|Overall Study|Investigator Decision|1
2479940|NCT02202538|8565765|P1|Overall Study|Did not meet all inclusion criteria|2
2479941|NCT02202538|8565765|P1|Overall Study|Withdrawal by Subject|5
2479942|NCT02202499|8565779|P3|Overall Study|Auto accident|0
2479943|NCT02202499|8565780|P2|Overall Study|Auto accident|0
2479944|NCT02202499|8565781|P1|Overall Study|Auto accident|1
2479945|NCT02202499|8565779|P3|Overall Study|Declined before randomization|0
2479946|NCT02202499|8565780|P2|Overall Study|Declined before randomization|0
2479947|NCT02202499|8565781|P1|Overall Study|Declined before randomization|1
2479948|NCT02202499|8565779|P3|Overall Study|Moved from area|1
2479949|NCT02202499|8565780|P2|Overall Study|Moved from area|0
2479950|NCT02202499|8565781|P1|Overall Study|Moved from area|0
2479951|NCT02202499|8565779|P3|Overall Study|Cancer diagnosis|1
2479952|NCT02202499|8565780|P2|Overall Study|Cancer diagnosis|0
2479953|NCT02202499|8565781|P1|Overall Study|Cancer diagnosis|0
2479954|NCT02202434|8565808|P4|Overall Study|Other|1
2479955|NCT02202434|8565809|P3|Overall Study|Other|0
2479956|NCT02202434|8565810|P2|Overall Study|Other|0
2479957|NCT02202434|8565811|P1|Overall Study|Other|1
2479958|NCT02202434|8565808|P4|Overall Study|Visit Missed|5
2479959|NCT02202434|8565809|P3|Overall Study|Visit Missed|0
2479960|NCT02202434|8565810|P2|Overall Study|Visit Missed|12
2479961|NCT02202434|8565811|P1|Overall Study|Visit Missed|21
2479962|NCT02202434|8565808|P4|Overall Study|Completed Study|0
2479963|NCT02202434|8565809|P3|Overall Study|Completed Study|0
2479964|NCT02202434|8565810|P2|Overall Study|Completed Study|0
2479965|NCT02202434|8565811|P1|Overall Study|Completed Study|1
2479966|NCT02202434|8565808|P4|Overall Study|Withdrawal by Subject|4
2479967|NCT02202434|8565809|P3|Overall Study|Withdrawal by Subject|1
2479968|NCT02202434|8565810|P2|Overall Study|Withdrawal by Subject|14
2479969|NCT02202434|8565811|P1|Overall Study|Withdrawal by Subject|13
2479970|NCT02202434|8565808|P4|Overall Study|Physician Decision|0
2479971|NCT02202434|8565809|P3|Overall Study|Physician Decision|0
2479972|NCT02202434|8565810|P2|Overall Study|Physician Decision|3
2479973|NCT02202434|8565811|P1|Overall Study|Physician Decision|2
2479974|NCT02202434|8565808|P4|Overall Study|Lost to Follow-up|0
2479975|NCT02202434|8565809|P3|Overall Study|Lost to Follow-up|1
2479976|NCT02202434|8565810|P2|Overall Study|Lost to Follow-up|1
2479977|NCT02202434|8565811|P1|Overall Study|Lost to Follow-up|1
2479978|NCT02202434|8565808|P4|Overall Study|Death|27
2479979|NCT02202434|8565809|P3|Overall Study|Death|13
2479980|NCT02202434|8565810|P2|Overall Study|Death|39
2479981|NCT02202434|8565811|P1|Overall Study|Death|70
2479982|NCT02202317|8565935|P1|Overall Study|Lost to Follow-up|1
2479983|NCT02202161|8565962|P8|Overall Study|Withdrawal by Subject|0
2479984|NCT02202161|8565963|P7|Overall Study|Withdrawal by Subject|0
2479985|NCT02202161|8565964|P6|Overall Study|Withdrawal by Subject|0
2479986|NCT02202161|8565965|P5|Overall Study|Withdrawal by Subject|1
2479987|NCT02202161|8565966|P4|Overall Study|Withdrawal by Subject|0
2479988|NCT02202161|8565967|P3|Overall Study|Withdrawal by Subject|0
2479989|NCT02202161|8565968|P2|Overall Study|Withdrawal by Subject|0
2479990|NCT02202161|8565969|P1|Overall Study|Withdrawal by Subject|0
2479991|NCT02202161|8565962|P8|Overall Study|Physician Decision|3
2479992|NCT02202161|8565963|P7|Overall Study|Physician Decision|0
2479993|NCT02202161|8565964|P6|Overall Study|Physician Decision|0
2479994|NCT02202161|8565965|P5|Overall Study|Physician Decision|0
2479995|NCT02202161|8565966|P4|Overall Study|Physician Decision|0
2479996|NCT02202161|8565967|P3|Overall Study|Physician Decision|0
2479997|NCT02202161|8565968|P2|Overall Study|Physician Decision|0
2479998|NCT02202161|8565969|P1|Overall Study|Physician Decision|0
2479999|NCT02202161|8565962|P8|Overall Study|Did not meet continuation criteria|3
2480000|NCT02202161|8565963|P7|Overall Study|Did not meet continuation criteria|0
2480001|NCT02202161|8565964|P6|Overall Study|Did not meet continuation criteria|0
2480002|NCT02202161|8565965|P5|Overall Study|Did not meet continuation criteria|0
2480003|NCT02202161|8565966|P4|Overall Study|Did not meet continuation criteria|0
2480004|NCT02202161|8565967|P3|Overall Study|Did not meet continuation criteria|0
2480005|NCT02202161|8565968|P2|Overall Study|Did not meet continuation criteria|0
2480006|NCT02202161|8565969|P1|Overall Study|Did not meet continuation criteria|0
2480007|NCT02202161|8565962|P8|Overall Study|Adverse Event|0
2480008|NCT02202161|8565963|P7|Overall Study|Adverse Event|0
2480009|NCT02202161|8565964|P6|Overall Study|Adverse Event|1
2480010|NCT02202161|8565965|P5|Overall Study|Adverse Event|0
2480011|NCT02202161|8565966|P4|Overall Study|Adverse Event|0
2480012|NCT02202161|8565967|P3|Overall Study|Adverse Event|0
2480013|NCT02202161|8565968|P2|Overall Study|Adverse Event|1
2480014|NCT02202161|8565969|P1|Overall Study|Adverse Event|1
2480015|NCT02202109|8566129|P2|Overall Study|Withdrawal by Subject|0
2480016|NCT02202109|8566130|P1|Overall Study|Withdrawal by Subject|2
2480017|NCT02202109|8566129|P2|Overall Study|Lost to Follow-up|87
2480018|NCT02202109|8566130|P1|Overall Study|Lost to Follow-up|88
2480019|NCT02202031|8566147|P2|Overall Study|Intolerance/Lack of Improvement|0
2480020|NCT02202031|8566148|P1|Overall Study|Intolerance/Lack of Improvement|3
2480021|NCT02202031|8566147|P2|Overall Study|Illness/Medical Reason|2
2480022|NCT02202031|8566148|P1|Overall Study|Illness/Medical Reason|0
2480023|NCT02202031|8566147|P2|Overall Study|Too Busy|3
2480024|NCT02202031|8566148|P1|Overall Study|Too Busy|1
2480025|NCT02202031|8566147|P2|Overall Study|Lost to Follow-up|0
2480026|NCT02202031|8566148|P1|Overall Study|Lost to Follow-up|1
2480027|NCT02201953|8566196|P2|Overall Study|Death|3
2480028|NCT02201953|8566197|P1|Overall Study|Death|0
2480029|NCT02201953|8566196|P2|Overall Study|Adverse Event|5
2480030|NCT02201953|8566197|P1|Overall Study|Adverse Event|0
2480031|NCT02201953|8566196|P2|Overall Study|Withdrew Consent|5
2480032|NCT02201953|8566197|P1|Overall Study|Withdrew Consent|2
2480033|NCT02201953|8566196|P2|Overall Study|Lost to Follow-up|8
2480034|NCT02201953|8566197|P1|Overall Study|Lost to Follow-up|8
2480035|NCT02201953|8566196|P2|Overall Study|Lack of Efficacy|30
2480036|NCT02201953|8566197|P1|Overall Study|Lack of Efficacy|9
2480037|NCT02201953|8566196|P2|Overall Study|Randomized but Never Treated|5
2480038|NCT02201953|8566197|P1|Overall Study|Randomized but Never Treated|1
2480039|NCT02201940|8566215|P2|Overall Study|Adverse Event|1
2480040|NCT02201940|8566216|P1|Overall Study|Adverse Event|0
2480041|NCT02201940|8566215|P2|Overall Study|Death|0
2480042|NCT02201940|8566216|P1|Overall Study|Death|1
2480043|NCT02201940|8566215|P2|Overall Study|Investigator's Discretion|1
2480044|NCT02201940|8566216|P1|Overall Study|Investigator's Discretion|1
2480045|NCT02201940|8566215|P2|Overall Study|Withdrew Consent|1
2480046|NCT02201940|8566216|P1|Overall Study|Withdrew Consent|2
2480047|NCT02201940|8566215|P2|Overall Study|Lost to Follow-up|0
2480048|NCT02201940|8566216|P1|Overall Study|Lost to Follow-up|5
2480049|NCT02201940|8566215|P2|Overall Study|Lack of Efficacy|113
2480050|NCT02201940|8566216|P1|Overall Study|Lack of Efficacy|2
2480051|NCT02201940|8566215|P2|Overall Study|Randomized/Enrolled but Never Treated|0
2480052|NCT02201940|8566216|P1|Overall Study|Randomized/Enrolled but Never Treated|1
2480053|NCT02201901|8566235|P3|Overall Study|Adverse Event|0
2480054|NCT02201901|8566236|P2|Overall Study|Adverse Event|1
2480055|NCT02201901|8566237|P1|Overall Study|Adverse Event|1
2480056|NCT02201901|8566235|P3|Overall Study|Withdrew Consent|2
2480057|NCT02201901|8566236|P2|Overall Study|Withdrew Consent|0
2480058|NCT02201901|8566237|P1|Overall Study|Withdrew Consent|2
2480059|NCT02201901|8566235|P3|Overall Study|Lost to Follow-up|2
2480060|NCT02201901|8566236|P2|Overall Study|Lost to Follow-up|3
2480061|NCT02201901|8566237|P1|Overall Study|Lost to Follow-up|2
2480062|NCT02201901|8566235|P3|Overall Study|Death|3
2480063|NCT02201901|8566236|P2|Overall Study|Death|3
2480064|NCT02201901|8566237|P1|Overall Study|Death|3
2480065|NCT02201901|8566235|P3|Overall Study|Lack of Efficacy|6
2480066|NCT02201901|8566236|P2|Overall Study|Lack of Efficacy|1
2480067|NCT02201901|8566237|P1|Overall Study|Lack of Efficacy|7
2480068|NCT02201901|8566235|P3|Overall Study|Randomized but never treated|0
2480069|NCT02201901|8566236|P2|Overall Study|Randomized but never treated|1
2480070|NCT02201901|8566237|P1|Overall Study|Randomized but never treated|0
2480071|NCT02201784|8566268|P2|Overall Study|Failure to achieve adequate block|0
2480072|NCT02201784|8566269|P1|Overall Study|Failure to achieve adequate block|2
2480073|NCT02201771|8566286|P3|Overall Study|Protocol Violation|10
2480074|NCT02201771|8566287|P2|Overall Study|Protocol Violation|8
2480075|NCT02201771|8566288|P1|Overall Study|Protocol Violation|10
2480076|NCT02201771|8566286|P3|Overall Study|Death|0
2480077|NCT02201771|8566287|P2|Overall Study|Death|2
2480078|NCT02201771|8566288|P1|Overall Study|Death|3
2480079|NCT02201524|8566315|P4|Overall Study|Other|0
2480080|NCT02201524|8566316|P3|Overall Study|Other|0
2480081|NCT02201524|8566317|P2|Overall Study|Other|1
2480082|NCT02201524|8566318|P1|Overall Study|Other|1
2480083|NCT02201524|8566315|P4|Overall Study|Withdrawal by Subject|1
2480084|NCT02201524|8566316|P3|Overall Study|Withdrawal by Subject|1
2480085|NCT02201524|8566317|P2|Overall Study|Withdrawal by Subject|0
2480086|NCT02201524|8566318|P1|Overall Study|Withdrawal by Subject|0
2480087|NCT02201524|8566315|P4|Overall Study|Protocol Violation|1
2480088|NCT02201524|8566316|P3|Overall Study|Protocol Violation|0
2480089|NCT02201524|8566317|P2|Overall Study|Protocol Violation|0
2480090|NCT02201524|8566318|P1|Overall Study|Protocol Violation|0
2480091|NCT02201524|8566315|P4|Overall Study|No longer meets eligibility criteria|2
2480092|NCT02201524|8566316|P3|Overall Study|No longer meets eligibility criteria|0
2480093|NCT02201524|8566317|P2|Overall Study|No longer meets eligibility criteria|0
2480094|NCT02201524|8566318|P1|Overall Study|No longer meets eligibility criteria|0
2480095|NCT02201524|8566315|P4|Overall Study|Lost to Follow-up|0
2480096|NCT02201524|8566316|P3|Overall Study|Lost to Follow-up|2
2480097|NCT02201524|8566317|P2|Overall Study|Lost to Follow-up|0
2480098|NCT02201524|8566318|P1|Overall Study|Lost to Follow-up|0
2480099|NCT02201524|8566315|P4|Overall Study|Insufficient clinical response|0
2480100|NCT02201524|8566316|P3|Overall Study|Insufficient clinical response|0
2480101|NCT02201524|8566317|P2|Overall Study|Insufficient clinical response|0
2480102|NCT02201524|8566318|P1|Overall Study|Insufficient clinical response|1
2480103|NCT02201524|8566315|P4|Overall Study|Adverse Event|0
2480104|NCT02201524|8566316|P3|Overall Study|Adverse Event|1
2480105|NCT02201524|8566317|P2|Overall Study|Adverse Event|2
2480106|NCT02201524|8566318|P1|Overall Study|Adverse Event|0
2480107|NCT02201329|8566443|P1|Overall Study|Withdrawal by Subject|2
2480108|NCT02201329|8566443|P1|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3
2480109|NCT02201290|8566451|P1|Overall Study|Adverse Event|1
2480110|NCT02201290|8566451|P1|Overall Study|Lack of Efficacy|2
2480111|NCT02201290|8566451|P1|Overall Study|Withdrawal by Subject|2
2480112|NCT02201277|8566457|P2|Overall Study|Physician Decision|0
2480113|NCT02201277|8566458|P1|Overall Study|Physician Decision|1
2480114|NCT02201277|8566457|P2|Overall Study|Failed retrieval|0
2480115|NCT02201277|8566458|P1|Overall Study|Failed retrieval|1
2480116|NCT02201277|8566457|P2|Overall Study|Lost to Follow-up|1
2480117|NCT02201277|8566458|P1|Overall Study|Lost to Follow-up|2
2480118|NCT02201277|8566457|P2|Overall Study|Death|4
2480119|NCT02201277|8566458|P1|Overall Study|Death|3
2480120|NCT02200770|8566548|P2|Open-label Period (OLP)|Participants ongoing|162
2480121|NCT02200770|8566549|P1|Open-label Period (OLP)|Participants ongoing|51
2480122|NCT02200770|8566548|P2|Randomized-controlled Period (RCP)|Other|2
2480123|NCT02200770|8566549|P1|Randomized-controlled Period (RCP)|Other|1
2480124|NCT02200770|8566548|P2|Randomized-controlled Period (RCP)|Not treated|1
2480125|NCT02200770|8566549|P1|Randomized-controlled Period (RCP)|Not treated|0
2480126|NCT02200770|8566548|P2|Randomized-controlled Period (RCP)|Withdrawal by Subject|1
2480127|NCT02200770|8566549|P1|Randomized-controlled Period (RCP)|Withdrawal by Subject|1
2480128|NCT02200770|8566548|P2|Randomized-controlled Period (RCP)|Adverse Event|2
2480129|NCT02200770|8566549|P1|Randomized-controlled Period (RCP)|Adverse Event|0
2480130|NCT02200614|8566580|P2|Follow-up Period|personal reason|72
2480131|NCT02200614|8566581|P1|Follow-up Period|personal reason|81
2480132|NCT02200614|8566580|P2|Follow-up Period|Other|28
2480133|NCT02200614|8566581|P1|Follow-up Period|Other|23
2480134|NCT02200614|8566580|P2|Follow-up Period|Lost to Follow-up|12
2480135|NCT02200614|8566581|P1|Follow-up Period|Lost to Follow-up|6
2480136|NCT02200614|8566580|P2|Follow-up Period|Death|51
2480137|NCT02200614|8566581|P1|Follow-up Period|Death|64
2480138|NCT02200614|8566580|P2|Treatment Period to Primary Completion|Study drug never administered|0
2480139|NCT02200614|8566581|P1|Treatment Period to Primary Completion|Study drug never administered|1
2480140|NCT02200614|8566580|P2|Treatment Period to Primary Completion|Personal reason|78
2480141|NCT02200614|8566581|P1|Treatment Period to Primary Completion|Personal reason|68
2480142|NCT02200614|8566580|P2|Treatment Period to Primary Completion|Protocol deviation|7
2480143|NCT02200614|8566581|P1|Treatment Period to Primary Completion|Protocol deviation|13
2480144|NCT02200614|8566580|P2|Treatment Period to Primary Completion|Judgment of the investigator|91
2480145|NCT02200614|8566581|P1|Treatment Period to Primary Completion|Judgment of the investigator|54
2480146|NCT02200614|8566580|P2|Treatment Period to Primary Completion|Confirmed metastasis|129
2480147|NCT02200614|8566581|P1|Treatment Period to Primary Completion|Confirmed metastasis|112
2480148|NCT02200614|8566580|P2|Treatment Period to Primary Completion|Other reason|2
2480149|NCT02200614|8566581|P1|Treatment Period to Primary Completion|Other reason|6
2480150|NCT02200614|8566580|P2|Treatment Period to Primary Completion|Adverse Event|47
2480151|NCT02200614|8566581|P1|Treatment Period to Primary Completion|Adverse Event|86
2480152|NCT02200510|8566613|P2|Overall Study|potential COI - joined study team|0
2480153|NCT02200510|8566614|P1|Overall Study|potential COI - joined study team|1
2480154|NCT02200510|8566613|P2|Overall Study|Lost to Follow-up|1
2480155|NCT02200510|8566614|P1|Overall Study|Lost to Follow-up|7
2480156|NCT02200510|8566613|P2|Overall Study|Protocol Violation|1
2480157|NCT02200510|8566614|P1|Overall Study|Protocol Violation|0
2480158|NCT02200510|8566613|P2|Overall Study|Death|1
2480159|NCT02200510|8566614|P1|Overall Study|Death|1
2480160|NCT02200211|8566639|P4|Overall Study|Withdrawal by Subject|0
2480161|NCT02200211|8566640|P3|Overall Study|Withdrawal by Subject|0
2480162|NCT02200211|8566641|P2|Overall Study|Withdrawal by Subject|0
2480163|NCT02200211|8566642|P1|Overall Study|Withdrawal by Subject|1
2480164|NCT02200211|8566639|P4|Overall Study|Lost to Follow-up|2
2480165|NCT02200211|8566640|P3|Overall Study|Lost to Follow-up|1
2480166|NCT02200211|8566641|P2|Overall Study|Lost to Follow-up|7
2480167|NCT02200211|8566642|P1|Overall Study|Lost to Follow-up|7
2480168|NCT02200042|8566755|P2|Overall Study|Withdrawal by Subject|1
2480169|NCT02200042|8566756|P1|Overall Study|Withdrawal by Subject|0
2480170|NCT02199795|8566785|P2|Overall Study|withdrew due to shoulder pain|0
2480171|NCT02199795|8566786|P1|Overall Study|withdrew due to shoulder pain|1
2480172|NCT02199795|8566785|P2|Overall Study|no longer met inclusion criteria|0
2480173|NCT02199795|8566786|P1|Overall Study|no longer met inclusion criteria|1
2480174|NCT02199509|8566827|P2|Overall Study|Misunderstood titration schedule|0
2480175|NCT02199509|8566828|P1|Overall Study|Misunderstood titration schedule|1
2480176|NCT02199509|8566827|P2|Overall Study|Suicidal Ideation|1
2480177|NCT02199509|8566828|P1|Overall Study|Suicidal Ideation|0
2480178|NCT02199080|8566851|P1|Overall Study|Protocol Violation|12
2480179|NCT02199028|8566876|P2|Week 3|Adverse Event|0
2480180|NCT02199028|8566877|P1|Week 3|Adverse Event|1
2480181|NCT02199028|8566876|P2|Week 1|Adverse Event|0
2480182|NCT02199028|8566877|P1|Week 1|Adverse Event|1
2480183|NCT02198963|8566886|P1|Overall Study|Withdrawal by Subject|6
2480184|NCT02198963|8566886|P1|Overall Study|Adverse Event|1
2480185|NCT02198651|8566910|P5|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
2480186|NCT02198651|8566911|P4|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1
2480187|NCT02198651|8566912|P3|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
2480188|NCT02198651|8566913|P2|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
2480189|NCT02198651|8566914|P1|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
2480190|NCT02198651|8566910|P5|Open-label Rescue Period|Withdrew consent|0
2480191|NCT02198651|8566911|P4|Open-label Rescue Period|Withdrew consent|2
2480192|NCT02198651|8566912|P3|Open-label Rescue Period|Withdrew consent|0
2480193|NCT02198651|8566913|P2|Open-label Rescue Period|Withdrew consent|0
2480194|NCT02198651|8566914|P1|Open-label Rescue Period|Withdrew consent|0
2480195|NCT02198651|8566910|P5|Double-blind Period|Other, not specified|0
2480196|NCT02198651|8566911|P4|Double-blind Period|Other, not specified|0
2480197|NCT02198651|8566912|P3|Double-blind Period|Other, not specified|1
2480198|NCT02198651|8566913|P2|Double-blind Period|Other, not specified|4
2480199|NCT02198651|8566914|P1|Double-blind Period|Other, not specified|0
2480200|NCT02198651|8566910|P5|Double-blind Period|Adverse Event|0
2480201|NCT02198651|8566911|P4|Double-blind Period|Adverse Event|0
2480202|NCT02198651|8566912|P3|Double-blind Period|Adverse Event|0
2480203|NCT02198651|8566913|P2|Double-blind Period|Adverse Event|1
2480204|NCT02198651|8566914|P1|Double-blind Period|Adverse Event|0
2480205|NCT02198651|8566910|P5|Double-blind Period|Withdrew consent|0
2480206|NCT02198651|8566911|P4|Double-blind Period|Withdrew consent|0
2480207|NCT02198651|8566912|P3|Double-blind Period|Withdrew consent|0
2480208|NCT02198651|8566913|P2|Double-blind Period|Withdrew consent|4
2480209|NCT02198651|8566914|P1|Double-blind Period|Withdrew consent|0
2480210|NCT02198651|8566910|P5|Lead-in Period|Other, not specified|0
2480211|NCT02198651|8566911|P4|Lead-in Period|Other, not specified|0
2480212|NCT02198651|8566912|P3|Lead-in Period|Other, not specified|0
2480213|NCT02198651|8566913|P2|Lead-in Period|Other, not specified|0
2480214|NCT02198651|8566914|P1|Lead-in Period|Other, not specified|22
2480215|NCT02198651|8566910|P5|Lead-in Period|Adverse Event|0
2480216|NCT02198651|8566911|P4|Lead-in Period|Adverse Event|0
2480217|NCT02198651|8566912|P3|Lead-in Period|Adverse Event|0
2480218|NCT02198651|8566913|P2|Lead-in Period|Adverse Event|0
2480219|NCT02198651|8566914|P1|Lead-in Period|Adverse Event|2
2480220|NCT02198651|8566910|P5|Lead-in Period|Withdrew consent|0
2480221|NCT02198651|8566911|P4|Lead-in Period|Withdrew consent|0
2480222|NCT02198651|8566912|P3|Lead-in Period|Withdrew consent|0
2480223|NCT02198651|8566913|P2|Lead-in Period|Withdrew consent|0
2480224|NCT02198651|8566914|P1|Lead-in Period|Withdrew consent|13
2480225|NCT02198235|8567015|P3|Overall Study|Lost to Follow-up|2
2480226|NCT02198235|8567016|P2|Overall Study|Lost to Follow-up|2
2480227|NCT02198235|8567017|P1|Overall Study|Lost to Follow-up|3
2480228|NCT02198040|8567037|P3|Overall Study|Withdrawal by Subject|1
2480229|NCT02198040|8567038|P2|Overall Study|Withdrawal by Subject|0
2480230|NCT02198040|8567039|P1|Overall Study|Withdrawal by Subject|0
2480231|NCT02198040|8567037|P3|Overall Study|Work reasons|0
2480232|NCT02198040|8567038|P2|Overall Study|Work reasons|1
2480233|NCT02198040|8567039|P1|Overall Study|Work reasons|0
2480234|NCT02197806|8567069|P4|Overall Study|Adverse Event|1
2480235|NCT02197806|8567070|P3|Overall Study|Adverse Event|0
2480236|NCT02197806|8567071|P2|Overall Study|Adverse Event|1
2480237|NCT02197806|8567072|P1|Overall Study|Adverse Event|0
2480238|NCT02197572|8567087|P1|Overall Study|Reason Not Specified|4
2480239|NCT02197572|8567087|P1|Overall Study|Adverse Event|3
2480240|NCT02197572|8567087|P1|Overall Study|Withdrawal by Subject|9
2480241|NCT02197572|8567087|P1|Overall Study|Progressive Disease|28
2480242|NCT02197520|8567104|P2|Period 2|Withdrawal by Subject|0
2480243|NCT02197520|8567105|P1|Period 2|Withdrawal by Subject|1
2480244|NCT02197520|8567104|P2|Period 2|Adverse Event|2
2480245|NCT02197520|8567105|P1|Period 2|Adverse Event|0
2480246|NCT02197520|8567104|P2|Period 1|Withdrawal by Subject|0
2480247|NCT02197520|8567105|P1|Period 1|Withdrawal by Subject|1
2480248|NCT02197377|8567151|P2|Overall Study|Insertion Failure|3
2480249|NCT02197377|8567152|P1|Overall Study|Insertion Failure|0
2480250|NCT02197247|8567173|P1|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9
2480251|NCT02197247|8567173|P1|Part B: Day 78 to End Part B (AZD9291)|Death|1
2480252|NCT02197247|8567173|P1|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1
2480253|NCT02197247|8567173|P1|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2
2480254|NCT02197247|8567173|P1|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2
2480255|NCT02197247|8567173|P1|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5
2480256|NCT02197247|8567173|P1|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2
2480257|NCT02197247|8567173|P1|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2
2480258|NCT02197234|8567218|P1|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22
2480259|NCT02197234|8567218|P1|Part B: Day 33 to End Part B (AZD9291)|Death|6
2480260|NCT02197234|8567218|P1|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1
2480261|NCT02197234|8567218|P1|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1
2480262|NCT02197234|8567218|P1|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1
2480263|NCT02197234|8567218|P1|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1
2480264|NCT02197234|8567218|P1|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1
2480265|NCT02197130|8567240|P3|Overall Study|Other|3
2480266|NCT02197130|8567241|P2|Overall Study|Other|0
2480267|NCT02197130|8567242|P1|Overall Study|Other|1
2480268|NCT02197130|8567240|P3|Overall Study|Withdrawal by Subject|4
2480269|NCT02197130|8567241|P2|Overall Study|Withdrawal by Subject|3
2480270|NCT02197130|8567242|P1|Overall Study|Withdrawal by Subject|0
2480271|NCT02197130|8567240|P3|Overall Study|Does not meet entrance criteria|1
2480272|NCT02197130|8567241|P2|Overall Study|Does not meet entrance criteria|0
2480273|NCT02197130|8567242|P1|Overall Study|Does not meet entrance criteria|0
2480274|NCT02197130|8567240|P3|Overall Study|Lost to Follow-up|1
2480275|NCT02197130|8567241|P2|Overall Study|Lost to Follow-up|0
2480276|NCT02197130|8567242|P1|Overall Study|Lost to Follow-up|2
2480277|NCT02197130|8567240|P3|Overall Study|Death|0
2480278|NCT02197130|8567241|P2|Overall Study|Death|1
2480279|NCT02197130|8567242|P1|Overall Study|Death|0
2480280|NCT02197130|8567240|P3|Overall Study|Adverse Event|23
2480281|NCT02197130|8567241|P2|Overall Study|Adverse Event|4
2480282|NCT02197130|8567242|P1|Overall Study|Adverse Event|13
2480283|NCT02196714|8567488|P4|Overall Study|Protocol Violation|0
2480284|NCT02196714|8567489|P3|Overall Study|Protocol Violation|1
2480285|NCT02196714|8567490|P2|Overall Study|Protocol Violation|0
2480286|NCT02196714|8567491|P1|Overall Study|Protocol Violation|0
2480287|NCT02196701|8567613|P1|Overall Study|Non-adherence to Protocol|1
2480288|NCT02196701|8567613|P1|Overall Study|Lost to Follow-up|1
2480289|NCT02196701|8567613|P1|Overall Study|Adverse Event|1
2480290|NCT02196675|8567687|P3|Overall Study|Death|1
2480291|NCT02196675|8567688|P2|Overall Study|Death|0
2480292|NCT02196675|8567689|P1|Overall Study|Death|0
2480293|NCT02196675|8567687|P3|Overall Study|Protocol Violation|0
2480294|NCT02196675|8567688|P2|Overall Study|Protocol Violation|1
2480295|NCT02196675|8567689|P1|Overall Study|Protocol Violation|0
2480296|NCT02196675|8567687|P3|Overall Study|Intra-operative surgical exclusion|0
2480297|NCT02196675|8567688|P2|Overall Study|Intra-operative surgical exclusion|1
2480298|NCT02196675|8567689|P1|Overall Study|Intra-operative surgical exclusion|1
2480299|NCT02196675|8567687|P3|Overall Study|Withdrawal by Subject|0
2480300|NCT02196675|8567688|P2|Overall Study|Withdrawal by Subject|0
2480301|NCT02196675|8567689|P1|Overall Study|Withdrawal by Subject|1
2480302|NCT02196506|8567711|P4|Phase A+|Participant withdrawn by investigator|1
2480303|NCT02196506|8567712|P3|Phase A+|Participant withdrawn by investigator|0
2480304|NCT02196506|8567713|P2|Phase A+|Participant withdrawn by investigator|0
2480305|NCT02196506|8567714|P1|Phase A+|Participant withdrawn by investigator|0
2480306|NCT02196506|8567711|P4|Phase A+|Lost to Follow-up|6
2480307|NCT02196506|8567712|P3|Phase A+|Lost to Follow-up|0
2480308|NCT02196506|8567713|P2|Phase A+|Lost to Follow-up|0
2480309|NCT02196506|8567714|P1|Phase A+|Lost to Follow-up|0
2480310|NCT02196506|8567711|P4|Phase A+|Adverse Event|1
2480311|NCT02196506|8567712|P3|Phase A+|Adverse Event|0
2480312|NCT02196506|8567713|P2|Phase A+|Adverse Event|0
2480313|NCT02196506|8567714|P1|Phase A+|Adverse Event|0
2480314|NCT02196506|8567711|P4|Phase A+|Withdrawal by Participant|5
2480315|NCT02196506|8567712|P3|Phase A+|Withdrawal by Participant|0
2480316|NCT02196506|8567713|P2|Phase A+|Withdrawal by Participant|0
2480317|NCT02196506|8567714|P1|Phase A+|Withdrawal by Participant|0
2480318|NCT02196506|8567711|P4|Phase A+|Participant Met Withdrawal Criteria|1
2480319|NCT02196506|8567712|P3|Phase A+|Participant Met Withdrawal Criteria|0
2480320|NCT02196506|8567713|P2|Phase A+|Participant Met Withdrawal Criteria|0
2480321|NCT02196506|8567714|P1|Phase A+|Participant Met Withdrawal Criteria|0
2480322|NCT02196506|8567711|P4|Phase B|Lost to Follow-up|0
2480323|NCT02196506|8567712|P3|Phase B|Lost to Follow-up|1
2480324|NCT02196506|8567713|P2|Phase B|Lost to Follow-up|2
2480325|NCT02196506|8567714|P1|Phase B|Lost to Follow-up|0
2480326|NCT02196506|8567711|P4|Phase B|Adverse Event|0
2480327|NCT02196506|8567712|P3|Phase B|Adverse Event|1
2480328|NCT02196506|8567713|P2|Phase B|Adverse Event|4
2480329|NCT02196506|8567714|P1|Phase B|Adverse Event|0
2480330|NCT02196506|8567711|P4|Phase B|Withdrawal by Participant|0
2480331|NCT02196506|8567712|P3|Phase B|Withdrawal by Participant|1
2480332|NCT02196506|8567713|P2|Phase B|Withdrawal by Participant|8
2480333|NCT02196506|8567714|P1|Phase B|Withdrawal by Participant|0
2480334|NCT02196506|8567711|P4|Phase B|Lack of Efficacy|0
2480335|NCT02196506|8567712|P3|Phase B|Lack of Efficacy|2
2480336|NCT02196506|8567713|P2|Phase B|Lack of Efficacy|1
2480337|NCT02196506|8567714|P1|Phase B|Lack of Efficacy|0
2480338|NCT02196506|8567711|P4|Phase B|Participant Met Withdrawal Criteria|0
2480339|NCT02196506|8567712|P3|Phase B|Participant Met Withdrawal Criteria|1
2480340|NCT02196506|8567713|P2|Phase B|Participant Met Withdrawal Criteria|0
2480341|NCT02196506|8567714|P1|Phase B|Participant Met Withdrawal Criteria|0
2480342|NCT02196506|8567711|P4|Phase A|Participant withdrawn by investigator|0
2480343|NCT02196506|8567712|P3|Phase A|Participant withdrawn by investigator|0
2480344|NCT02196506|8567713|P2|Phase A|Participant withdrawn by investigator|0
2480345|NCT02196506|8567714|P1|Phase A|Participant withdrawn by investigator|10
2480346|NCT02196506|8567711|P4|Phase A|Protocol deviation|0
2480347|NCT02196506|8567712|P3|Phase A|Protocol deviation|0
2480348|NCT02196506|8567713|P2|Phase A|Protocol deviation|0
2480349|NCT02196506|8567714|P1|Phase A|Protocol deviation|12
2480350|NCT02196506|8567711|P4|Phase A|Lost to Follow-up|0
2480351|NCT02196506|8567712|P3|Phase A|Lost to Follow-up|0
2480352|NCT02196506|8567713|P2|Phase A|Lost to Follow-up|0
2480353|NCT02196506|8567714|P1|Phase A|Lost to Follow-up|9
2480354|NCT02196506|8567711|P4|Phase A|Adverse Event|0
2480355|NCT02196506|8567712|P3|Phase A|Adverse Event|0
2480356|NCT02196506|8567713|P2|Phase A|Adverse Event|0
2480357|NCT02196506|8567714|P1|Phase A|Adverse Event|22
2480358|NCT02196506|8567711|P4|Phase A|Withdrawal by Subject|0
2480359|NCT02196506|8567712|P3|Phase A|Withdrawal by Subject|0
2480360|NCT02196506|8567713|P2|Phase A|Withdrawal by Subject|0
2480361|NCT02196506|8567714|P1|Phase A|Withdrawal by Subject|34
2480362|NCT02196506|8567711|P4|Phase A|Participant Met Withdrawal Criteria|0
2480363|NCT02196506|8567712|P3|Phase A|Participant Met Withdrawal Criteria|0
2480364|NCT02196506|8567713|P2|Phase A|Participant Met Withdrawal Criteria|0
2480365|NCT02196506|8567714|P1|Phase A|Participant Met Withdrawal Criteria|34
2480366|NCT02196259|8567729|P3|Overall Study|Partial data analysis|0
2480367|NCT02196259|8567730|P2|Overall Study|Partial data analysis|3
2480368|NCT02196259|8567731|P1|Overall Study|Partial data analysis|0
2480369|NCT02196259|8567729|P3|Overall Study|Researcher choice|1
2480370|NCT02196259|8567730|P2|Overall Study|Researcher choice|0
2480371|NCT02196259|8567731|P1|Overall Study|Researcher choice|0
2480372|NCT02196077|8567759|P1|Overall Study|Protocol Violation|24
2480373|NCT02196077|8567759|P1|Overall Study|Lost to Follow-up|3
2480374|NCT02196077|8567759|P1|Overall Study|Physician Decision|1
2480375|NCT02196077|8567759|P1|Overall Study|Withdrawal by Subject|14
2480376|NCT02196077|8567759|P1|Overall Study|Lack of Efficacy|1
2480377|NCT02196077|8567759|P1|Overall Study|Adverse Event|4
2480378|NCT02195986|8567809|P3|Overall Study|Non-compliance|0
2480379|NCT02195986|8567810|P2|Overall Study|Non-compliance|1
2480380|NCT02195986|8567811|P1|Overall Study|Non-compliance|0
2480381|NCT02195986|8567809|P3|Overall Study|Protocol Violation|1
2480382|NCT02195986|8567810|P2|Overall Study|Protocol Violation|1
2480383|NCT02195986|8567811|P1|Overall Study|Protocol Violation|0
2480384|NCT02195986|8567809|P3|Overall Study|Family Emergency|1
2480385|NCT02195986|8567810|P2|Overall Study|Family Emergency|0
2480386|NCT02195986|8567811|P1|Overall Study|Family Emergency|0
2480387|NCT02195986|8567809|P3|Overall Study|Withdrawal by Subject|0
2480388|NCT02195986|8567810|P2|Overall Study|Withdrawal by Subject|3
2480389|NCT02195986|8567811|P1|Overall Study|Withdrawal by Subject|0
2480390|NCT02195986|8567809|P3|Overall Study|Adverse Event|0
2480391|NCT02195986|8567810|P2|Overall Study|Adverse Event|0
2480392|NCT02195986|8567811|P1|Overall Study|Adverse Event|3
2480393|NCT02195869|8567834|P1|Overall Study|Noncompliance with study drug|2
2480394|NCT02195869|8567834|P1|Overall Study|Study Terminated by Sponsor|7
2480395|NCT02195869|8567834|P1|Overall Study|Physician Decision|4
2480396|NCT02195869|8567834|P1|Overall Study|Withdrawal by Subject|7
2480397|NCT02195869|8567834|P1|Overall Study|Adverse Event|15
2480398|NCT02195869|8567834|P1|Overall Study|Malignancy Progression/relapse|2
2480399|NCT02195869|8567834|P1|Overall Study|cGVHD Progression|5
2480400|NCT02195700|8567856|P2|Overall Study|Lost to Follow-up|1
2480401|NCT02195700|8567857|P1|Overall Study|Lost to Follow-up|1
2480402|NCT02195700|8567856|P2|Overall Study|Withdrawal by Subject|2
2480403|NCT02195700|8567857|P1|Overall Study|Withdrawal by Subject|3
2480404|NCT02195700|8567856|P2|Overall Study|Adverse Event|2
2480405|NCT02195700|8567857|P1|Overall Study|Adverse Event|1
2480406|NCT02195700|8567856|P2|Overall Study|Noncompliance|0
2480407|NCT02195700|8567857|P1|Overall Study|Noncompliance|1
2480408|NCT02195700|8567856|P2|Overall Study|Protocol Violation|2
2480409|NCT02195700|8567857|P1|Overall Study|Protocol Violation|0
2480410|NCT02195687|8567879|P2|Overall Study|Lost to Follow-up|1
2480411|NCT02195687|8567880|P1|Overall Study|Lost to Follow-up|4
2480412|NCT02195687|8567879|P2|Overall Study|Personal Reasons|1
2480413|NCT02195687|8567880|P1|Overall Study|Personal Reasons|1
2480414|NCT02195583|8567905|P1|Overall Study|Other Reason|2
2480415|NCT02195583|8567905|P1|Overall Study|Adverse Event|2
2480416|NCT02195583|8567905|P1|Overall Study|Withdrawal by Subject|4
2480417|NCT02195583|8567905|P1|Overall Study|Lost to Follow-up|1
2480418|NCT02195531|8567940|P3|Overall Study|Withdrawal by Subject|1
2480419|NCT02195531|8567941|P2|Overall Study|Withdrawal by Subject|1
2480420|NCT02195531|8567942|P1|Overall Study|Withdrawal by Subject|1
2480421|NCT02195518|8567967|P1|Overall Study|Lost to Follow-up|1
2480422|NCT02195518|8567967|P1|Overall Study|Withdrawal by Subject|1
2480423|NCT02195518|8567967|P1|Overall Study|Pregnancy|2
2480424|NCT02195518|8567967|P1|Overall Study|Protocol Violation|4
2480425|NCT02195518|8567967|P1|Overall Study|Adverse Event|1
2480426|NCT02195479|8567990|P2|Overall Study|Ongoing|297
2480427|NCT02195479|8567991|P1|Overall Study|Ongoing|291
2480428|NCT02195479|8567990|P2|Overall Study|Other|2
2480429|NCT02195479|8567991|P1|Overall Study|Other|2
2480430|NCT02195479|8567990|P2|Overall Study|Withdrawal by Subject|6
2480431|NCT02195479|8567991|P1|Overall Study|Withdrawal by Subject|11
2480432|NCT02195479|8567990|P2|Overall Study|Physician Decision|0
2480433|NCT02195479|8567991|P1|Overall Study|Physician Decision|1
2480434|NCT02195479|8567990|P2|Overall Study|Death|45
2480435|NCT02195479|8567991|P1|Overall Study|Death|48
2480436|NCT02195479|8567990|P2|Overall Study|Lost to Follow-up|0
2480437|NCT02195479|8567991|P1|Overall Study|Lost to Follow-up|3
2480438|NCT02195427|8568029|P2|Overall Study|Conditional re-treatment at W52|1
2480439|NCT02195427|8568030|P1|Overall Study|Conditional re-treatment at W52|2
2480440|NCT02195427|8568029|P2|Overall Study|Protocol Violation|14
2480441|NCT02195427|8568030|P1|Overall Study|Protocol Violation|7
2480442|NCT02195427|8568029|P2|Overall Study|Lost to Follow-up|1
2480443|NCT02195427|8568030|P1|Overall Study|Lost to Follow-up|0
2480444|NCT02195427|8568029|P2|Overall Study|Withdrawal by Subject|2
2480445|NCT02195427|8568030|P1|Overall Study|Withdrawal by Subject|4
2480446|NCT02195427|8568029|P2|Overall Study|Did not consent to study extension|9
2480447|NCT02195427|8568030|P1|Overall Study|Did not consent to study extension|13
2480448|NCT02195011|8568395|P2|Overall Study|Withdrawal by Subject|0
2480449|NCT02195011|8568396|P1|Overall Study|Withdrawal by Subject|3
2480450|NCT02195011|8568395|P2|Overall Study|Progressive Disease|1
2480451|NCT02195011|8568396|P1|Overall Study|Progressive Disease|18
2480452|NCT02195011|8568395|P2|Overall Study|Adverse Event|0
2480453|NCT02195011|8568396|P1|Overall Study|Adverse Event|4
2480454|NCT02194998|8568412|P4|Post-HCV Treatment Follow-Up|Lost to Follow-up|0
2480455|NCT02194998|8568413|P3|Post-HCV Treatment Follow-Up|Lost to Follow-up|1
2480456|NCT02194998|8568414|P2|Post-HCV Treatment Follow-Up|Lost to Follow-up|0
2480457|NCT02194998|8568415|P1|Post-HCV Treatment Follow-Up|Lost to Follow-up|1
2480458|NCT02194998|8568412|P4|On-HCV Treatment|Did not pick up study medication|0
2480459|NCT02194998|8568413|P3|On-HCV Treatment|Did not pick up study medication|0
2480460|NCT02194998|8568414|P2|On-HCV Treatment|Did not pick up study medication|1
2480461|NCT02194998|8568415|P1|On-HCV Treatment|Did not pick up study medication|0
2480462|NCT02194933|8568479|P2|Overall Study|Lack of Efficacy|2
2480463|NCT02194933|8568480|P1|Overall Study|Lack of Efficacy|1
2480464|NCT02194933|8568479|P2|Overall Study|Withdrawal by Subject|2
2480465|NCT02194933|8568480|P1|Overall Study|Withdrawal by Subject|0
2480466|NCT02194933|8568479|P2|Overall Study|Participant met withdrawal criteria|3
2480467|NCT02194933|8568480|P1|Overall Study|Participant met withdrawal criteria|1
2480468|NCT02194933|8568479|P2|Overall Study|Lost to Follow-up|2
2480469|NCT02194933|8568480|P1|Overall Study|Lost to Follow-up|1
2480470|NCT02194699|8568534|P2|With Potential to Receive 52 Weeks of IP|Other|16
2480471|NCT02194699|8568535|P1|With Potential to Receive 52 Weeks of IP|Other|24
2480472|NCT02194699|8568534|P2|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20
2480473|NCT02194699|8568535|P1|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14
2480474|NCT02194699|8568534|P2|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
2480475|NCT02194699|8568535|P1|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
2480476|NCT02194699|8568534|P2|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8
2480477|NCT02194699|8568535|P1|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5
2480478|NCT02194699|8568534|P2|With Potential to Receive 52 Weeks of IP|Death|3
2480479|NCT02194699|8568535|P1|With Potential to Receive 52 Weeks of IP|Death|1
2480480|NCT02194699|8568534|P2|With Potential to Receive 52 Weeks of IP|Adverse Event|3
2480481|NCT02194699|8568535|P1|With Potential to Receive 52 Weeks of IP|Adverse Event|4
2480482|NCT02194699|8568534|P2|Randomised|Duplicate patient|1
2480483|NCT02194699|8568535|P1|Randomised|Duplicate patient|2
2480484|NCT02194699|8568534|P2|Randomised|Without potential for 52 weeks of IP|5
2480485|NCT02194699|8568535|P1|Randomised|Without potential for 52 weeks of IP|5
2480486|NCT02194699|8568534|P2|Randomised|Did not receive treatment|5
2480487|NCT02194699|8568535|P1|Randomised|Did not receive treatment|1
2480488|NCT02194621|8568643|P3|Overall Study|Withdrawal by Subject|7
2480489|NCT02194621|8568644|P2|Overall Study|Withdrawal by Subject|4
2480490|NCT02194621|8568645|P1|Overall Study|Withdrawal by Subject|4
2480491|NCT02194621|8568643|P3|Overall Study|6 withdrew prior to randomization|2
2480492|NCT02194621|8568644|P2|Overall Study|6 withdrew prior to randomization|2
2480493|NCT02194621|8568645|P1|Overall Study|6 withdrew prior to randomization|2
2480494|NCT02194062|8568678|P3|Overall Study|Lost to Follow-up|5
2480495|NCT02194062|8568679|P2|Overall Study|Lost to Follow-up|2
2480496|NCT02194062|8568680|P1|Overall Study|Lost to Follow-up|2
2480497|NCT02193880|8568691|P1|Overall Study|patients did not collect enough HPC|3
2480498|NCT02193867|8568696|P1|Overall Study|Sponsor Study Termination|2
2480499|NCT02193867|8568696|P1|Overall Study|Death|2
2480500|NCT02193828|8568714|P4|Overall Study|Withdrawal by Subject|1
2480501|NCT02193828|8568715|P3|Overall Study|Withdrawal by Subject|1
2480502|NCT02193828|8568716|P2|Overall Study|Withdrawal by Subject|0
2480503|NCT02193828|8568717|P1|Overall Study|Withdrawal by Subject|0
2480504|NCT02193776|8568794|P4|Overall Study|Adverse event/Specific toxicity|2
2480505|NCT02193776|8568795|P3|Overall Study|Adverse event/Specific toxicity|2
2480506|NCT02193776|8568796|P2|Overall Study|Adverse event/Specific toxicity|5
2480507|NCT02193776|8568797|P1|Overall Study|Adverse event/Specific toxicity|5
2480508|NCT02193776|8568794|P4|Overall Study|Death|0
2480509|NCT02193776|8568795|P3|Overall Study|Death|0
2480510|NCT02193776|8568796|P2|Overall Study|Death|0
2480511|NCT02193776|8568797|P1|Overall Study|Death|1
2480512|NCT02193776|8568794|P4|Overall Study|Investigator/Sponsor decision|0
2480513|NCT02193776|8568795|P3|Overall Study|Investigator/Sponsor decision|0
2480514|NCT02193776|8568796|P2|Overall Study|Investigator/Sponsor decision|1
2480515|NCT02193776|8568797|P1|Overall Study|Investigator/Sponsor decision|1
2480516|NCT02193776|8568794|P4|Overall Study|Failure to comply with protocol|0
2480517|NCT02193776|8568795|P3|Overall Study|Failure to comply with protocol|0
2480518|NCT02193776|8568796|P2|Overall Study|Failure to comply with protocol|1
2480519|NCT02193776|8568797|P1|Overall Study|Failure to comply with protocol|0
2480520|NCT02193776|8568794|P4|Overall Study|Consent withdrawn|0
2480521|NCT02193776|8568795|P3|Overall Study|Consent withdrawn|0
2480522|NCT02193776|8568796|P2|Overall Study|Consent withdrawn|0
2480523|NCT02193776|8568797|P1|Overall Study|Consent withdrawn|1
2480524|NCT02193178|8568824|P1|Overall Study|Dry eyes|1
2480525|NCT02193178|8568824|P1|Overall Study|Lost to Follow-up|1
2480526|NCT02193165|8568874|P3|6 Week Product Use|Lost to Follow-up|0
2480527|NCT02193165|8568875|P2|6 Week Product Use|Lost to Follow-up|1
2480528|NCT02193165|8568876|P1|6 Week Product Use|Lost to Follow-up|0
2480529|NCT02193165|8568874|P3|4 Week Product Use|Lost to Follow-up|1
2480530|NCT02193165|8568875|P2|4 Week Product Use|Lost to Follow-up|1
2480531|NCT02193165|8568876|P1|4 Week Product Use|Lost to Follow-up|1
2480532|NCT02193087|8568903|P4|Overall Study|Did Not Receive Any Vaccination|1
2480533|NCT02193087|8568904|P3|Overall Study|Did Not Receive Any Vaccination|0
2480534|NCT02193087|8568905|P2|Overall Study|Did Not Receive Any Vaccination|3
2480535|NCT02193087|8568906|P1|Overall Study|Did Not Receive Any Vaccination|2
2480536|NCT02193087|8568903|P4|Overall Study|Other Reason Not Specified|9
2480537|NCT02193087|8568904|P3|Overall Study|Other Reason Not Specified|1
2480538|NCT02193087|8568905|P2|Overall Study|Other Reason Not Specified|2
2480539|NCT02193087|8568906|P1|Overall Study|Other Reason Not Specified|7
2480540|NCT02193087|8568903|P4|Overall Study|Withdrawal by Subject|19
2480541|NCT02193087|8568904|P3|Overall Study|Withdrawal by Subject|1
2480542|NCT02193087|8568905|P2|Overall Study|Withdrawal by Subject|3
2480543|NCT02193087|8568906|P1|Overall Study|Withdrawal by Subject|10
2480544|NCT02193087|8568903|P4|Overall Study|Protocol Violation|2
2480545|NCT02193087|8568904|P3|Overall Study|Protocol Violation|1
2480546|NCT02193087|8568905|P2|Overall Study|Protocol Violation|0
2480547|NCT02193087|8568906|P1|Overall Study|Protocol Violation|2
2480548|NCT02193087|8568903|P4|Overall Study|Lost to Follow-up|37
2480549|NCT02193087|8568904|P3|Overall Study|Lost to Follow-up|4
2480550|NCT02193087|8568905|P2|Overall Study|Lost to Follow-up|6
2480551|NCT02193087|8568906|P1|Overall Study|Lost to Follow-up|14
2480552|NCT02193087|8568903|P4|Overall Study|Adverse Event|11
2480553|NCT02193087|8568904|P3|Overall Study|Adverse Event|0
2480554|NCT02193087|8568905|P2|Overall Study|Adverse Event|0
2480555|NCT02193087|8568906|P1|Overall Study|Adverse Event|2
2480556|NCT02193074|8568951|P2|Overall Study|Adverse Event|13
2480557|NCT02193074|8568952|P1|Overall Study|Adverse Event|16
2480558|NCT02193074|8568951|P2|Overall Study|Withdrawal by Subject|2
2480559|NCT02193074|8568952|P1|Overall Study|Withdrawal by Subject|1
2480560|NCT02192905|8568984|P1|Overall Study|Lost to Follow-up|1
2480561|NCT02192606|8569048|P2|Overall Study|3D equipment rep unable to join|1
2480562|NCT02192606|8569049|P1|Overall Study|3D equipment rep unable to join|0
2480563|NCT02192606|8569048|P2|Overall Study|Physician Decision|2
2480564|NCT02192606|8569049|P1|Overall Study|Physician Decision|1
2480565|NCT02192606|8569048|P2|Overall Study|surgery type was changed|1
2480566|NCT02192606|8569049|P1|Overall Study|surgery type was changed|1
2480567|NCT02192190|8569097|P6|Overall Study|Inadequate Pain Relief|0
2480568|NCT02192190|8569098|P5|Overall Study|Inadequate Pain Relief|0
2480569|NCT02192190|8569099|P4|Overall Study|Inadequate Pain Relief|0
2480570|NCT02192190|8569100|P3|Overall Study|Inadequate Pain Relief|1
2480571|NCT02192190|8569101|P2|Overall Study|Inadequate Pain Relief|1
2480572|NCT02192190|8569102|P1|Overall Study|Inadequate Pain Relief|0
2480573|NCT02192190|8569097|P6|Overall Study|Positive Drug Screen|0
2480574|NCT02192190|8569098|P5|Overall Study|Positive Drug Screen|0
2480575|NCT02192190|8569099|P4|Overall Study|Positive Drug Screen|1
2480576|NCT02192190|8569100|P3|Overall Study|Positive Drug Screen|0
2480577|NCT02192190|8569101|P2|Overall Study|Positive Drug Screen|0
2480578|NCT02192190|8569102|P1|Overall Study|Positive Drug Screen|0
2480579|NCT02192190|8569097|P6|Overall Study|Could not Keep Visit Schedule|0
2480580|NCT02192190|8569098|P5|Overall Study|Could not Keep Visit Schedule|0
2480581|NCT02192190|8569099|P4|Overall Study|Could not Keep Visit Schedule|0
2480582|NCT02192190|8569100|P3|Overall Study|Could not Keep Visit Schedule|0
2480583|NCT02192190|8569101|P2|Overall Study|Could not Keep Visit Schedule|0
2480584|NCT02192190|8569102|P1|Overall Study|Could not Keep Visit Schedule|1
2480585|NCT02192190|8569097|P6|Overall Study|Withdrawal by Subject|3
2480586|NCT02192190|8569098|P5|Overall Study|Withdrawal by Subject|5
2480587|NCT02192190|8569099|P4|Overall Study|Withdrawal by Subject|1
2480588|NCT02192190|8569100|P3|Overall Study|Withdrawal by Subject|2
2480589|NCT02192190|8569101|P2|Overall Study|Withdrawal by Subject|1
2480590|NCT02192190|8569102|P1|Overall Study|Withdrawal by Subject|4
2480591|NCT02192190|8569097|P6|Overall Study|Terminated by Sponsor|23
2480592|NCT02192190|8569098|P5|Overall Study|Terminated by Sponsor|21
2480593|NCT02192190|8569099|P4|Overall Study|Terminated by Sponsor|23
2480594|NCT02192190|8569100|P3|Overall Study|Terminated by Sponsor|20
2480595|NCT02192190|8569101|P2|Overall Study|Terminated by Sponsor|23
2480596|NCT02192190|8569102|P1|Overall Study|Terminated by Sponsor|43
2480597|NCT02192190|8569097|P6|Overall Study|Physician Decision|0
2480598|NCT02192190|8569098|P5|Overall Study|Physician Decision|0
2480599|NCT02192190|8569099|P4|Overall Study|Physician Decision|0
2480600|NCT02192190|8569100|P3|Overall Study|Physician Decision|0
2480601|NCT02192190|8569101|P2|Overall Study|Physician Decision|0
2480602|NCT02192190|8569102|P1|Overall Study|Physician Decision|2
2480603|NCT02192190|8569097|P6|Overall Study|Lost to Follow-up|3
2480604|NCT02192190|8569098|P5|Overall Study|Lost to Follow-up|4
2480605|NCT02192190|8569099|P4|Overall Study|Lost to Follow-up|1
2480606|NCT02192190|8569100|P3|Overall Study|Lost to Follow-up|2
2480607|NCT02192190|8569101|P2|Overall Study|Lost to Follow-up|3
2480608|NCT02192190|8569102|P1|Overall Study|Lost to Follow-up|3
2480609|NCT02192190|8569097|P6|Overall Study|Adverse Event|0
2480610|NCT02192190|8569098|P5|Overall Study|Adverse Event|0
2480611|NCT02192190|8569099|P4|Overall Study|Adverse Event|0
2480612|NCT02192190|8569100|P3|Overall Study|Adverse Event|0
2480613|NCT02192190|8569101|P2|Overall Study|Adverse Event|1
2480614|NCT02192190|8569102|P1|Overall Study|Adverse Event|1
2480615|NCT02192164|8569146|P1|Overall Study|Did not meet the exclusion criteria|1
2480616|NCT02192164|8569146|P1|Overall Study|Physician Decision|4
2480617|NCT02192164|8569146|P1|Overall Study|Withdrawal by Subject|1
2480618|NCT02192164|8569146|P1|Overall Study|Other|8
2480619|NCT02192099|8569162|P1|Overall Study|Miscellaneous Reasons|5
2480620|NCT02192099|8569162|P1|Overall Study|Withdrawal by Subject|11
2480621|NCT02192099|8569162|P1|Overall Study|Study Terminated by Sponsor|32
2480622|NCT02192099|8569162|P1|Overall Study|Protocol Violation|8
2480623|NCT02192099|8569162|P1|Overall Study|Pregnancy|1
2480624|NCT02192099|8569162|P1|Overall Study|Physician Decision|1
2480625|NCT02192099|8569162|P1|Overall Study|Lost to Follow-up|2
2480626|NCT02192099|8569162|P1|Overall Study|Adverse Event|1
2480627|NCT02191618|8569191|P1|Overall Study|Missed Visit|4
2480628|NCT02191618|8569191|P1|Overall Study|Withdrawal by Subject|3
2480629|NCT02191605|8569201|P5|Overall Study|Lost to Follow-up|4
2480630|NCT02191605|8569202|P4|Overall Study|Lost to Follow-up|3
2480631|NCT02191605|8569203|P3|Overall Study|Lost to Follow-up|7
2480632|NCT02191605|8569204|P2|Overall Study|Lost to Follow-up|4
2480633|NCT02191605|8569205|P1|Overall Study|Lost to Follow-up|9
2480634|NCT02191579|8569224|P2|Treatment 2|Multiple Reasons Specified|25
2480635|NCT02191579|8569225|P1|Treatment 2|Multiple Reasons Specified|0
2480636|NCT02191579|8569224|P2|Treatment 1|Multiple Reasons Specified|58
2480637|NCT02191579|8569225|P1|Treatment 1|Multiple Reasons Specified|27
2480638|NCT02191397|8569239|P2|Overall Study|Withdrawal by Subject|27
2480639|NCT02191397|8569240|P1|Overall Study|Withdrawal by Subject|22
2480640|NCT02191397|8569239|P2|Overall Study|Physician Decision|3
2480641|NCT02191397|8569240|P1|Overall Study|Physician Decision|8
2480642|NCT02191397|8569239|P2|Overall Study|Lost to Follow-up|11
2480643|NCT02191397|8569240|P1|Overall Study|Lost to Follow-up|10
2480644|NCT02191397|8569239|P2|Overall Study|Met protocol-defined stopping criteria|4
2480645|NCT02191397|8569240|P1|Overall Study|Met protocol-defined stopping criteria|5
2480646|NCT02191397|8569239|P2|Overall Study|Protocol Violation|3
2480647|NCT02191397|8569240|P1|Overall Study|Protocol Violation|0
2480648|NCT02191397|8569239|P2|Overall Study|Lack of Efficacy|5
2480649|NCT02191397|8569240|P1|Overall Study|Lack of Efficacy|10
2480650|NCT02191397|8569239|P2|Overall Study|Adverse Event|17
2480651|NCT02191397|8569240|P1|Overall Study|Adverse Event|28
2480652|NCT02191267|8569301|P3|Overall Study|Withdrawal by Subject|0
2480653|NCT02191267|8569302|P2|Overall Study|Withdrawal by Subject|0
2480654|NCT02191267|8569303|P1|Overall Study|Withdrawal by Subject|1
2480655|NCT02191137|8569314|P1|Follow-up|Adverse Event|1
2480656|NCT02191137|8569314|P1|Follow-up|Ongoing/unknown|2
2480657|NCT02191137|8569314|P1|Follow-up|Lost to Follow-up|2
2480658|NCT02191137|8569314|P1|Treatment|Other|1
2480659|NCT02191137|8569314|P1|Treatment|Adverse Event|2
2480660|NCT02191137|8569314|P1|Treatment|Withdrawal by Subject|3
2480661|NCT02191137|8569314|P1|Treatment|Death|4
2480662|NCT02191046|8569344|P2|Overall Study|low compliance|1
2480663|NCT02191046|8569345|P1|Overall Study|low compliance|5
2480664|NCT02190721|8569376|P3|Overall Study|Patient was out of the city|0
2480665|NCT02190721|8569377|P2|Overall Study|Patient was out of the city|1
2480666|NCT02190721|8569378|P1|Overall Study|Patient was out of the city|0
2480667|NCT02190604|8569501|P19|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2480668|NCT02190604|8569502|P18|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2480669|NCT02190604|8569503|P17|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2480670|NCT02190604|8569504|P16|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2480671|NCT02190604|8569505|P15|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2480672|NCT02190604|8569506|P14|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1
2480673|NCT02190604|8569507|P13|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2480674|NCT02190604|8569508|P12|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2480675|NCT02190604|8569509|P11|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2480676|NCT02190604|8569510|P10|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2480677|NCT02190604|8569511|P9|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2480678|NCT02190604|8569512|P8|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2480679|NCT02190604|8569513|P7|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2480680|NCT02190604|8569514|P6|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2480681|NCT02190604|8569515|P5|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2480682|NCT02190604|8569516|P4|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2480683|NCT02190604|8569517|P3|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2480684|NCT02190604|8569518|P2|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2480685|NCT02190604|8569519|P1|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
2480686|NCT02190604|8569501|P19|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2480687|NCT02190604|8569502|P18|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2480688|NCT02190604|8569503|P17|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2480689|NCT02190604|8569504|P16|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2480690|NCT02190604|8569505|P15|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2
2480691|NCT02190604|8569506|P14|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2480692|NCT02190604|8569507|P13|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2480693|NCT02190604|8569508|P12|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2480694|NCT02190604|8569509|P11|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2480695|NCT02190604|8569510|P10|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2480696|NCT02190604|8569511|P9|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2480697|NCT02190604|8569512|P8|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2480698|NCT02190604|8569513|P7|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2480699|NCT02190604|8569514|P6|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2480700|NCT02190604|8569515|P5|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2480701|NCT02190604|8569516|P4|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2480702|NCT02190604|8569517|P3|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2480703|NCT02190604|8569518|P2|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2480704|NCT02190604|8569519|P1|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
2480705|NCT02190591|8569710|P2|Overall Study|face presentation so she was ineligible|1
2480706|NCT02190591|8569711|P1|Overall Study|face presentation so she was ineligible|0
2480707|NCT02190591|8569710|P2|Overall Study|did not use peanut ball as instructed|2
2480708|NCT02190591|8569711|P1|Overall Study|did not use peanut ball as instructed|0
2480709|NCT02190591|8569710|P2|Overall Study|Protocol Violation|0
2480710|NCT02190591|8569711|P1|Overall Study|Protocol Violation|1
2480711|NCT02190591|8569710|P2|Overall Study|Withdrawal by Subject|8
2480712|NCT02190591|8569711|P1|Overall Study|Withdrawal by Subject|1
2480713|NCT02190435|8569734|P2|Overall Study|3 consented screen fails|0
2480714|NCT02190435|8569735|P1|Overall Study|3 consented screen fails|3
2480715|NCT02190435|8569734|P2|Overall Study|First 12 patients were lead-ins|0
2480716|NCT02190435|8569735|P1|Overall Study|First 12 patients were lead-ins|12
2480717|NCT02190279|8569746|P3|Overall Study|Screening failure|1
2480718|NCT02190279|8569747|P2|Overall Study|Screening failure|0
2480719|NCT02190279|8569748|P1|Overall Study|Screening failure|0
2480720|NCT02190279|8569746|P3|Overall Study|Refused further treatment|1
2480721|NCT02190279|8569747|P2|Overall Study|Refused further treatment|0
2480722|NCT02190279|8569748|P1|Overall Study|Refused further treatment|0
2480723|NCT02190279|8569746|P3|Overall Study|Lost to Follow-up|0
2480724|NCT02190279|8569747|P2|Overall Study|Lost to Follow-up|0
2480725|NCT02190279|8569748|P1|Overall Study|Lost to Follow-up|2
2480726|NCT02190279|8569746|P3|Overall Study|Withdrawal consent|1
2480727|NCT02190279|8569747|P2|Overall Study|Withdrawal consent|0
2480728|NCT02190279|8569748|P1|Overall Study|Withdrawal consent|1
2480729|NCT02189941|8569787|P3|Overall Study|Non-compliance|1
2480730|NCT02189941|8569788|P2|Overall Study|Non-compliance|0
2480731|NCT02189941|8569789|P1|Overall Study|Non-compliance|0
2480732|NCT02189863|8569817|P2|First 2 Weeks|Motion Sickness|2
2480733|NCT02189863|8569818|P1|First 2 Weeks|Motion Sickness|4
2480734|NCT02189837|8569833|P4|Overall Study|Sponsor Decision|1
2480735|NCT02189837|8569834|P3|Overall Study|Sponsor Decision|0
2480736|NCT02189837|8569835|P2|Overall Study|Sponsor Decision|0
2480737|NCT02189837|8569836|P1|Overall Study|Sponsor Decision|0
2480738|NCT02189837|8569833|P4|Overall Study|Withdrawal by Subject|1
2480739|NCT02189837|8569834|P3|Overall Study|Withdrawal by Subject|3
2480740|NCT02189837|8569835|P2|Overall Study|Withdrawal by Subject|1
2480741|NCT02189837|8569836|P1|Overall Study|Withdrawal by Subject|2
2480742|NCT02189759|8569866|P4|Overall Study|Lost to Follow-up|5
2480743|NCT02189759|8569867|P3|Overall Study|Lost to Follow-up|2
2480744|NCT02189759|8569868|P2|Overall Study|Lost to Follow-up|0
2480745|NCT02189759|8569869|P1|Overall Study|Lost to Follow-up|0
2480746|NCT02189473|8569905|P2|Overall Study|Lost to Follow-up|2
2480747|NCT02189473|8569906|P1|Overall Study|Lost to Follow-up|1
2480748|NCT02189473|8569905|P2|Overall Study|Death|23
2480749|NCT02189473|8569906|P1|Overall Study|Death|22
2480750|NCT02189252|8569954|P4|Period 1 (Visit 4b, Week 4)|Adverse Event|0
2480751|NCT02189252|8569955|P3|Period 1 (Visit 4b, Week 4)|Adverse Event|0
2480752|NCT02189252|8569956|P2|Period 1 (Visit 4b, Week 4)|Adverse Event|1
2480753|NCT02189252|8569957|P1|Period 1 (Visit 4b, Week 4)|Adverse Event|0
2480754|NCT02189252|8569954|P4|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
2480755|NCT02189252|8569955|P3|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
2480756|NCT02189252|8569956|P2|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1
2480757|NCT02189252|8569957|P1|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
2480758|NCT02188849|8570016|P2|Overall Study|Lost to Follow-up|8
2480759|NCT02188849|8570017|P1|Overall Study|Lost to Follow-up|3
2480760|NCT02188784|8570031|P2|Overall Study|Physician Decision|3
2480761|NCT02188784|8570032|P1|Overall Study|Physician Decision|2
2480762|NCT02188784|8570031|P2|Overall Study|Withdrawal by Subject|9
2480763|NCT02188784|8570032|P1|Overall Study|Withdrawal by Subject|3
2480764|NCT02188784|8570031|P2|Overall Study|Lost to Follow-up|0
2480765|NCT02188784|8570032|P1|Overall Study|Lost to Follow-up|1
2480766|NCT02188784|8570031|P2|Overall Study|Death|1
2480767|NCT02188784|8570032|P1|Overall Study|Death|3
2480768|NCT02188589|8570048|P1|Overall Study|Withdrawal by Subject|5
2480769|NCT02187861|8570080|P4|Overall Study|Other|1
2480770|NCT02187861|8570081|P3|Overall Study|Other|7
2480771|NCT02187861|8570082|P2|Overall Study|Other|1
2480772|NCT02187861|8570083|P1|Overall Study|Other|0
2480773|NCT02187861|8570080|P4|Overall Study|Withdrawal by Subject|3
2480774|NCT02187861|8570081|P3|Overall Study|Withdrawal by Subject|3
2480775|NCT02187861|8570082|P2|Overall Study|Withdrawal by Subject|0
2480776|NCT02187861|8570083|P1|Overall Study|Withdrawal by Subject|0
2480777|NCT02187861|8570080|P4|Overall Study|Progressive Disease|22
2480778|NCT02187861|8570081|P3|Overall Study|Progressive Disease|19
2480779|NCT02187861|8570082|P2|Overall Study|Progressive Disease|42
2480780|NCT02187861|8570083|P1|Overall Study|Progressive Disease|4
2480781|NCT02187861|8570080|P4|Overall Study|Physician Decision|3
2480782|NCT02187861|8570081|P3|Overall Study|Physician Decision|0
2480783|NCT02187861|8570082|P2|Overall Study|Physician Decision|1
2480784|NCT02187861|8570083|P1|Overall Study|Physician Decision|0
2480785|NCT02187861|8570080|P4|Overall Study|Death|2
2480786|NCT02187861|8570081|P3|Overall Study|Death|1
2480787|NCT02187861|8570082|P2|Overall Study|Death|3
2480788|NCT02187861|8570083|P1|Overall Study|Death|0
2480789|NCT02187861|8570080|P4|Overall Study|Adverse Event|1
2480790|NCT02187861|8570081|P3|Overall Study|Adverse Event|2
2480791|NCT02187861|8570082|P2|Overall Study|Adverse Event|1
2480792|NCT02187861|8570083|P1|Overall Study|Adverse Event|2
2480793|NCT02187809|8570179|P1|Overall Study|The study was terminated|3
2480794|NCT02187783|8570189|P1|Overall Study|Study terminated by sponsor|1
2480795|NCT02187783|8570189|P1|Overall Study|Withdrawal by Subject|9
2480796|NCT02187783|8570189|P1|Overall Study|Physician Decision|2
2480797|NCT02187783|8570189|P1|Overall Study|Protocol Violation|3
2480798|NCT02187783|8570189|P1|Overall Study|Progressive disease|80
2480799|NCT02187783|8570189|P1|Overall Study|Death|3
2480800|NCT02187783|8570189|P1|Overall Study|Adverse Event|8
2480801|NCT02187744|8570200|P2|Treatment|Participant refused continued treatment|1
2480802|NCT02187744|8570201|P1|Treatment|Participant refused continued treatment|1
2480803|NCT02187744|8570200|P2|Treatment|Other|0
2480804|NCT02187744|8570201|P1|Treatment|Other|2
2480805|NCT02187744|8570200|P2|Treatment|Lost to Follow-up|1
2480806|NCT02187744|8570201|P1|Treatment|Lost to Follow-up|0
2480807|NCT02187744|8570200|P2|Treatment|Related adverse event, not serious|2
2480808|NCT02187744|8570201|P1|Treatment|Related adverse event, not serious|0
2480809|NCT02187744|8570200|P2|Treatment|Related adverse event, serious non-fatal|1
2480810|NCT02187744|8570201|P1|Treatment|Related adverse event, serious non-fatal|0
2480811|NCT02187744|8570200|P2|Treatment|Death|0
2480812|NCT02187744|8570201|P1|Treatment|Death|1
2480813|NCT02187744|8570200|P2|Study|Related adverse event, serious non-fatal|1
2480814|NCT02187744|8570201|P1|Study|Related adverse event, serious non-fatal|0
2480815|NCT02187744|8570200|P2|Study|Death|0
2480816|NCT02187744|8570201|P1|Study|Death|1
2480817|NCT02187744|8570200|P2|Study|Related adverse event, not serious|2
2480818|NCT02187744|8570201|P1|Study|Related adverse event, not serious|0
2480819|NCT02187744|8570200|P2|Study|Lost to Follow-up|2
2480820|NCT02187744|8570201|P1|Study|Lost to Follow-up|0
2480821|NCT02187744|8570200|P2|Study|Other|1
2480822|NCT02187744|8570201|P1|Study|Other|2
2480823|NCT02187744|8570200|P2|Study|Participant refused further follow-up|0
2480824|NCT02187744|8570201|P1|Study|Participant refused further follow-up|1
2480825|NCT02187172|8570219|P2|Overall Study|Physician Decision|1
2480826|NCT02187172|8570220|P1|Overall Study|Physician Decision|1
2480827|NCT02187172|8570219|P2|Overall Study|Adverse Event|1
2480828|NCT02187172|8570220|P1|Overall Study|Adverse Event|0
2480829|NCT02187172|8570219|P2|Overall Study|Lack of Efficacy|2
2480830|NCT02187172|8570220|P1|Overall Study|Lack of Efficacy|1
2480831|NCT02187172|8570219|P2|Overall Study|Lost to Follow-up|2
2480832|NCT02187172|8570220|P1|Overall Study|Lost to Follow-up|1
2480833|NCT02187055|8570387|P3|Overall Study|Death|0
2480834|NCT02187055|8570388|P2|Overall Study|Death|0
2480835|NCT02187055|8570389|P1|Overall Study|Death|2
2480836|NCT02187055|8570387|P3|Overall Study|Adverse Event|36
2480837|NCT02187055|8570388|P2|Overall Study|Adverse Event|26
2480838|NCT02187055|8570389|P1|Overall Study|Adverse Event|21
2480839|NCT02187055|8570387|P3|Overall Study|Withdrawal by Subject|11
2480840|NCT02187055|8570388|P2|Overall Study|Withdrawal by Subject|11
2480841|NCT02187055|8570389|P1|Overall Study|Withdrawal by Subject|11
2480842|NCT02187055|8570387|P3|Overall Study|Pregnancy|0
2480843|NCT02187055|8570388|P2|Overall Study|Pregnancy|1
2480844|NCT02187055|8570389|P1|Overall Study|Pregnancy|3
2480845|NCT02187055|8570387|P3|Overall Study|Protocol Violation|4
2480846|NCT02187055|8570388|P2|Overall Study|Protocol Violation|9
2480847|NCT02187055|8570389|P1|Overall Study|Protocol Violation|9
2480848|NCT02187055|8570387|P3|Overall Study|Other|3
2480849|NCT02187055|8570388|P2|Overall Study|Other|6
2480850|NCT02187055|8570389|P1|Overall Study|Other|5
2480851|NCT02187055|8570387|P3|Overall Study|No longer willing to participate|10
2480852|NCT02187055|8570388|P2|Overall Study|No longer willing to participate|8
2480853|NCT02187055|8570389|P1|Overall Study|No longer willing to participate|6
2480854|NCT02187055|8570387|P3|Overall Study|No longer meets eligibility criteria|0
2480855|NCT02187055|8570388|P2|Overall Study|No longer meets eligibility criteria|2
2480856|NCT02187055|8570389|P1|Overall Study|No longer meets eligibility criteria|0
2480857|NCT02187055|8570387|P3|Overall Study|Lost to Follow-up|3
2480858|NCT02187055|8570388|P2|Overall Study|Lost to Follow-up|7
2480859|NCT02187055|8570389|P1|Overall Study|Lost to Follow-up|2
2480860|NCT02187055|8570387|P3|Overall Study|Lack of Efficacy|7
2480861|NCT02187055|8570388|P2|Overall Study|Lack of Efficacy|3
2480862|NCT02187055|8570389|P1|Overall Study|Lack of Efficacy|10
2480863|NCT02187042|8570489|P2|Overall Study|Progressive disease|8
2480864|NCT02187042|8570490|P1|Overall Study|Progressive disease|4
2480865|NCT02187042|8570489|P2|Overall Study|Doctor choice|0
2480866|NCT02187042|8570490|P1|Overall Study|Doctor choice|1
2480867|NCT02187042|8570489|P2|Overall Study|Participant choice|0
2480868|NCT02187042|8570490|P1|Overall Study|Participant choice|1
2480869|NCT02187042|8570489|P2|Overall Study|Toxicity|5
2480870|NCT02187042|8570490|P1|Overall Study|Toxicity|6
2480871|NCT02187042|8570489|P2|Overall Study|Death|1
2480872|NCT02187042|8570490|P1|Overall Study|Death|1
2480873|NCT02187029|8570536|P4|Overall Study|Withdrawal by Subject|0
2480874|NCT02187029|8570537|P3|Overall Study|Withdrawal by Subject|0
2480875|NCT02187029|8570538|P2|Overall Study|Withdrawal by Subject|0
2480876|NCT02187029|8570539|P1|Overall Study|Withdrawal by Subject|1
2480877|NCT02187029|8570536|P4|Overall Study|Study Terminated by Sponsor|3
2480878|NCT02187029|8570537|P3|Overall Study|Study Terminated by Sponsor|10
2480879|NCT02187029|8570538|P2|Overall Study|Study Terminated by Sponsor|0
2480880|NCT02187029|8570539|P1|Overall Study|Study Terminated by Sponsor|0
2480881|NCT02187029|8570536|P4|Overall Study|Adverse Event|0
2480882|NCT02187029|8570537|P3|Overall Study|Adverse Event|1
2480883|NCT02187029|8570538|P2|Overall Study|Adverse Event|1
2480884|NCT02187029|8570539|P1|Overall Study|Adverse Event|0
2480885|NCT02186873|8570661|P2|Overall Study|Withdrawal by Subject|2
2480886|NCT02186873|8570662|P1|Overall Study|Withdrawal by Subject|7
2480887|NCT02186873|8570661|P2|Overall Study|Lost to Follow-up|2
2480888|NCT02186873|8570662|P1|Overall Study|Lost to Follow-up|1
2480889|NCT02186873|8570661|P2|Overall Study|Lack of Efficacy|1
2480890|NCT02186873|8570662|P1|Overall Study|Lack of Efficacy|0
2480891|NCT02186873|8570661|P2|Overall Study|Adverse Event|3
2480892|NCT02186873|8570662|P1|Overall Study|Adverse Event|1
2480893|NCT02186834|8570685|P6|Treatment at RP2D|Died prior to treatment|1
2480894|NCT02186834|8570686|P5|Treatment at RP2D|Died prior to treatment|0
2480895|NCT02186834|8570687|P4|Treatment at RP2D|Died prior to treatment|0
2480896|NCT02186834|8570688|P3|Treatment at RP2D|Died prior to treatment|0
2480897|NCT02186834|8570689|P2|Treatment at RP2D|Died prior to treatment|0
2480898|NCT02186834|8570690|P1|Treatment at RP2D|Died prior to treatment|0
2480899|NCT02186834|8570685|P6|Dose Escalation|Death|0
2480900|NCT02186834|8570686|P5|Dose Escalation|Death|0
2480901|NCT02186834|8570687|P4|Dose Escalation|Death|1
2480902|NCT02186834|8570688|P3|Dose Escalation|Death|0
2480903|NCT02186834|8570689|P2|Dose Escalation|Death|0
2480904|NCT02186834|8570690|P1|Dose Escalation|Death|0
2480905|NCT02186652|8570726|P2|Overall Study|Lost to Follow-up|0
2480906|NCT02186652|8570727|P1|Overall Study|Lost to Follow-up|2
2480907|NCT02186561|8570760|P1|1- Year Post Index Procedure Visit|Missed|1
2480908|NCT02186561|8570760|P1|1- Year Post Index Procedure Visit|Death|1
2480909|NCT02186561|8570760|P1|30-Day Post Index Procedure Visit|Death|1
2480910|NCT02186561|8570760|P1|Enrollment|Investigator Withdrew Consent|1
2480911|NCT02186561|8570760|P1|Enrollment|Withdrawal by Subject|2
2480912|NCT02186561|8570760|P1|Enrollment|Insurance Denial|2
2480913|NCT02186561|8570760|P1|Enrollment|Enrollment Cap Reached|5
2480914|NCT02186561|8570760|P1|Enrollment|Did Not Meet Inclusion Criteria|46
2480915|NCT02186301|8570780|P3|Overall Study|Other|1
2480916|NCT02186301|8570781|P2|Overall Study|Other|0
2480917|NCT02186301|8570782|P1|Overall Study|Other|0
2480918|NCT02186301|8570780|P3|Overall Study|Missing|2
2480919|NCT02186301|8570781|P2|Overall Study|Missing|0
2480920|NCT02186301|8570782|P1|Overall Study|Missing|0
2480921|NCT02186301|8570780|P3|Overall Study|Protocol Deviation|0
2480922|NCT02186301|8570781|P2|Overall Study|Protocol Deviation|2
2480923|NCT02186301|8570782|P1|Overall Study|Protocol Deviation|0
2480924|NCT02186301|8570780|P3|Overall Study|Study Terminated by Sponsor|11
2480925|NCT02186301|8570781|P2|Overall Study|Study Terminated by Sponsor|0
2480926|NCT02186301|8570782|P1|Overall Study|Study Terminated by Sponsor|1
2480927|NCT02186301|8570780|P3|Overall Study|Physician Decision|1
2480928|NCT02186301|8570781|P2|Overall Study|Physician Decision|0
2480929|NCT02186301|8570782|P1|Overall Study|Physician Decision|1
2480930|NCT02186301|8570780|P3|Overall Study|Withdrawal by Subject|3
2480931|NCT02186301|8570781|P2|Overall Study|Withdrawal by Subject|1
2480932|NCT02186301|8570782|P1|Overall Study|Withdrawal by Subject|5
2480933|NCT02186301|8570780|P3|Overall Study|Death|0
2480934|NCT02186301|8570781|P2|Overall Study|Death|0
2480935|NCT02186301|8570782|P1|Overall Study|Death|1
2480936|NCT02186301|8570780|P3|Overall Study|Adverse Event|5
2480937|NCT02186301|8570781|P2|Overall Study|Adverse Event|5
2480938|NCT02186301|8570782|P1|Overall Study|Adverse Event|5
2480939|NCT02186301|8570780|P3|Overall Study|Progressive Disease|27
2480940|NCT02186301|8570781|P2|Overall Study|Progressive Disease|22
2480941|NCT02186301|8570782|P1|Overall Study|Progressive Disease|7
2480942|NCT02186223|8570798|P1|Overall Study|Device in place less than 48 hours|9
2480943|NCT02186223|8570798|P1|Overall Study|Death|3
2480944|NCT02186223|8570798|P1|Overall Study|Unable to obtain femoral access|3
2480945|NCT02186223|8570798|P1|Overall Study|Not eligible for device placement|6
2480946|NCT02186171|8570820|P2|Overall Study|Protocol-specified Criteria|2
2480947|NCT02186171|8570821|P1|Overall Study|Protocol-specified Criteria|0
2480948|NCT02186171|8570820|P2|Overall Study|Death|2
2480949|NCT02186171|8570821|P1|Overall Study|Death|1
2480950|NCT02186171|8570820|P2|Overall Study|Lost to Follow-up|2
2480951|NCT02186171|8570821|P1|Overall Study|Lost to Follow-up|2
2480952|NCT02186171|8570820|P2|Overall Study|Withdrawal by Subject|9
2480953|NCT02186171|8570821|P1|Overall Study|Withdrawal by Subject|1
2480954|NCT02185534|8570858|P6|First Washout Period|Protocol Violation|1
2480955|NCT02185534|8570859|P5|First Washout Period|Protocol Violation|0
2480956|NCT02185534|8570860|P4|First Washout Period|Protocol Violation|0
2480957|NCT02185534|8570861|P3|First Washout Period|Protocol Violation|0
2480958|NCT02185534|8570862|P2|First Washout Period|Protocol Violation|0
2480959|NCT02185534|8570863|P1|First Washout Period|Protocol Violation|0
2480960|NCT02185534|8570858|P6|First Washout Period|Withdrawal by Subject|0
2480961|NCT02185534|8570859|P5|First Washout Period|Withdrawal by Subject|1
2480962|NCT02185534|8570860|P4|First Washout Period|Withdrawal by Subject|0
2480963|NCT02185534|8570861|P3|First Washout Period|Withdrawal by Subject|0
2480964|NCT02185534|8570862|P2|First Washout Period|Withdrawal by Subject|0
2480965|NCT02185534|8570863|P1|First Washout Period|Withdrawal by Subject|1
2480966|NCT02185534|8570858|P6|First Period|Withdrawal by Subject|0
2480967|NCT02185534|8570859|P5|First Period|Withdrawal by Subject|0
2480968|NCT02185534|8570860|P4|First Period|Withdrawal by Subject|1
2480969|NCT02185534|8570861|P3|First Period|Withdrawal by Subject|0
2480970|NCT02185534|8570862|P2|First Period|Withdrawal by Subject|0
2480971|NCT02185534|8570863|P1|First Period|Withdrawal by Subject|0
2480972|NCT02185521|8570878|P1|Overall Study|Protocol Violation|1
2480973|NCT02185521|8570878|P1|Overall Study|Withdrawal by Subject|1
2480974|NCT02185040|8570971|P7|Active Treatment Extension Phase|Lost to Follow-up|2
2480975|NCT02185040|8570972|P6|Active Treatment Extension Phase|Lost to Follow-up|0
2480976|NCT02185040|8570973|P5|Active Treatment Extension Phase|Lost to Follow-up|0
2480977|NCT02185040|8570974|P4|Active Treatment Extension Phase|Lost to Follow-up|0
2480978|NCT02185040|8570975|P3|Active Treatment Extension Phase|Lost to Follow-up|0
2480979|NCT02185040|8570976|P2|Active Treatment Extension Phase|Lost to Follow-up|0
2480980|NCT02185040|8570977|P1|Active Treatment Extension Phase|Lost to Follow-up|0
2480981|NCT02185040|8570971|P7|Active Treatment Extension Phase|Withdrawal by Subject|1
2480982|NCT02185040|8570972|P6|Active Treatment Extension Phase|Withdrawal by Subject|1
2480983|NCT02185040|8570973|P5|Active Treatment Extension Phase|Withdrawal by Subject|0
2480984|NCT02185040|8570974|P4|Active Treatment Extension Phase|Withdrawal by Subject|0
2480985|NCT02185040|8570975|P3|Active Treatment Extension Phase|Withdrawal by Subject|0
2480986|NCT02185040|8570976|P2|Active Treatment Extension Phase|Withdrawal by Subject|0
2480987|NCT02185040|8570977|P1|Active Treatment Extension Phase|Withdrawal by Subject|0
2480988|NCT02185040|8570971|P7|Active Treatment Extension Phase|Adverse Event|4
2480989|NCT02185040|8570972|P6|Active Treatment Extension Phase|Adverse Event|1
2480990|NCT02185040|8570973|P5|Active Treatment Extension Phase|Adverse Event|0
2480991|NCT02185040|8570974|P4|Active Treatment Extension Phase|Adverse Event|0
2480992|NCT02185040|8570975|P3|Active Treatment Extension Phase|Adverse Event|0
2480993|NCT02185040|8570976|P2|Active Treatment Extension Phase|Adverse Event|0
2480994|NCT02185040|8570977|P1|Active Treatment Extension Phase|Adverse Event|0
2480995|NCT02185040|8570971|P7|Active Treatment Extension Phase|Miscellaneous|0
2480996|NCT02185040|8570972|P6|Active Treatment Extension Phase|Miscellaneous|1
2480997|NCT02185040|8570973|P5|Active Treatment Extension Phase|Miscellaneous|0
2480998|NCT02185040|8570974|P4|Active Treatment Extension Phase|Miscellaneous|0
2480999|NCT02185040|8570975|P3|Active Treatment Extension Phase|Miscellaneous|0
2481000|NCT02185040|8570976|P2|Active Treatment Extension Phase|Miscellaneous|0
2481001|NCT02185040|8570977|P1|Active Treatment Extension Phase|Miscellaneous|0
2481002|NCT02185040|8570971|P7|Part 1 Treatment Phase|Lost to Follow-up|0
2481003|NCT02185040|8570972|P6|Part 1 Treatment Phase|Lost to Follow-up|0
2481004|NCT02185040|8570973|P5|Part 1 Treatment Phase|Lost to Follow-up|0
2481005|NCT02185040|8570974|P4|Part 1 Treatment Phase|Lost to Follow-up|0
2481006|NCT02185040|8570975|P3|Part 1 Treatment Phase|Lost to Follow-up|0
2481007|NCT02185040|8570976|P2|Part 1 Treatment Phase|Lost to Follow-up|1
2481008|NCT02185040|8570977|P1|Part 1 Treatment Phase|Lost to Follow-up|0
2481009|NCT02185040|8570971|P7|Part 1 Treatment Phase|Withdrawal by Subject|0
2481010|NCT02185040|8570972|P6|Part 1 Treatment Phase|Withdrawal by Subject|0
2481011|NCT02185040|8570973|P5|Part 1 Treatment Phase|Withdrawal by Subject|0
2481012|NCT02185040|8570974|P4|Part 1 Treatment Phase|Withdrawal by Subject|0
2481013|NCT02185040|8570975|P3|Part 1 Treatment Phase|Withdrawal by Subject|0
2481014|NCT02185040|8570976|P2|Part 1 Treatment Phase|Withdrawal by Subject|1
2481015|NCT02185040|8570977|P1|Part 1 Treatment Phase|Withdrawal by Subject|0
2481016|NCT02185040|8570971|P7|Part 1 Treatment Phase|Adverse Event|0
2481017|NCT02185040|8570972|P6|Part 1 Treatment Phase|Adverse Event|0
2481018|NCT02185040|8570973|P5|Part 1 Treatment Phase|Adverse Event|3
2481019|NCT02185040|8570974|P4|Part 1 Treatment Phase|Adverse Event|2
2481020|NCT02185040|8570975|P3|Part 1 Treatment Phase|Adverse Event|0
2481021|NCT02185040|8570976|P2|Part 1 Treatment Phase|Adverse Event|0
2481022|NCT02185040|8570977|P1|Part 1 Treatment Phase|Adverse Event|1
2481023|NCT02185040|8570971|P7|Part 1 Treatment Phase|Miscellaneous|0
2481024|NCT02185040|8570972|P6|Part 1 Treatment Phase|Miscellaneous|0
2481025|NCT02185040|8570973|P5|Part 1 Treatment Phase|Miscellaneous|0
2481026|NCT02185040|8570974|P4|Part 1 Treatment Phase|Miscellaneous|0
2481027|NCT02185040|8570975|P3|Part 1 Treatment Phase|Miscellaneous|1
2481028|NCT02185040|8570976|P2|Part 1 Treatment Phase|Miscellaneous|0
2481029|NCT02185040|8570977|P1|Part 1 Treatment Phase|Miscellaneous|0
2481030|NCT02185014|8571031|P1|Overall Study|Other|4
2481031|NCT02185014|8571031|P1|Overall Study|Subject Noncompliance|1
2481032|NCT02185014|8571031|P1|Overall Study|Requires Alternative/Prohibited Therapy|5
2481033|NCT02185014|8571031|P1|Overall Study|Lack of Efficacy|14
2481034|NCT02185014|8571031|P1|Overall Study|Lost to Follow-up|4
2481035|NCT02185014|8571031|P1|Overall Study|Withdrew Consent|8
2481036|NCT02185014|8571031|P1|Overall Study|Adverse Event|18
2481037|NCT02184988|8571035|P1|Overall Study|Lost to Follow-up|32
2481038|NCT02184988|8571035|P1|Overall Study|various other reasons|9
2481039|NCT02184988|8571035|P1|Overall Study|work scheduling issues|4
2481040|NCT02184988|8571035|P1|Overall Study|moving away/travelling/unable to complet|6
2481041|NCT02184988|8571035|P1|Overall Study|Adverse Event|2
2481042|NCT02184988|8571035|P1|Overall Study|Pregnancy|2
2481043|NCT02184611|8571093|P2|Overall Study|Protocol defined stopping criteria|1
2481044|NCT02184611|8571094|P1|Overall Study|Protocol defined stopping criteria|0
2481045|NCT02184611|8571093|P2|Overall Study|Protocol Violation|1
2481046|NCT02184611|8571094|P1|Overall Study|Protocol Violation|1
2481047|NCT02184611|8571093|P2|Overall Study|Adverse Event|5
2481048|NCT02184611|8571094|P1|Overall Study|Adverse Event|4
2481049|NCT02184611|8571093|P2|Overall Study|Withdrawal by Subject|6
2481050|NCT02184611|8571094|P1|Overall Study|Withdrawal by Subject|5
2481051|NCT02184611|8571093|P2|Overall Study|Lack of Efficacy|15
2481052|NCT02184611|8571094|P1|Overall Study|Lack of Efficacy|11
2481053|NCT02184572|8571130|P2|Overall Study|Withdrawal by Subject|9
2481054|NCT02184572|8571131|P1|Overall Study|Withdrawal by Subject|14
2481055|NCT02184572|8571130|P2|Overall Study|Traveling Outside The Country|0
2481056|NCT02184572|8571131|P1|Overall Study|Traveling Outside The Country|1
2481057|NCT02184572|8571130|P2|Overall Study|2nd blooddraw & diary card incomplete|0
2481058|NCT02184572|8571131|P1|Overall Study|2nd blooddraw & diary card incomplete|1
2481059|NCT02184572|8571130|P2|Overall Study|Loss Of Kaiser Insurance|0
2481060|NCT02184572|8571131|P1|Overall Study|Loss Of Kaiser Insurance|1
2481061|NCT02184572|8571130|P2|Overall Study|Family Out Of Country Until 9/29/2015|0
2481062|NCT02184572|8571131|P1|Overall Study|Family Out Of Country Until 9/29/2015|1
2481063|NCT02184572|8571130|P2|Overall Study|Lost to Follow-up|21
2481064|NCT02184572|8571131|P1|Overall Study|Lost to Follow-up|29
2481065|NCT02184455|8571192|P1|Overall Study|Lost to Follow-up|1
2481066|NCT02184442|8571203|P2|Overall Study|Withdrawal by Subject|11
2481067|NCT02184442|8571204|P1|Overall Study|Withdrawal by Subject|3
2481068|NCT02184442|8571203|P2|Overall Study|Death|65
2481069|NCT02184442|8571204|P1|Overall Study|Death|61
2481070|NCT02184195|8571224|P2|Overall Study|Other|2
2481071|NCT02184195|8571225|P1|Overall Study|Other|0
2481072|NCT02184195|8571224|P2|Overall Study|Lost to Follow-up|2
2481073|NCT02184195|8571225|P1|Overall Study|Lost to Follow-up|0
2481074|NCT02184195|8571224|P2|Overall Study|Death|29
2481075|NCT02184195|8571225|P1|Overall Study|Death|40
2481076|NCT02184195|8571224|P2|Overall Study|Eligibility criteria not fulfilled|1
2481077|NCT02184195|8571225|P1|Overall Study|Eligibility criteria not fulfilled|0
2481078|NCT02184195|8571224|P2|Overall Study|Patient decision|1
2481079|NCT02184195|8571225|P1|Overall Study|Patient decision|3
2481080|NCT02184143|8571251|P2|Overall Study|Death|0
2481081|NCT02184143|8571252|P1|Overall Study|Death|1
2481082|NCT02184143|8571251|P2|Overall Study|Lost to Follow-up|3
2481083|NCT02184143|8571252|P1|Overall Study|Lost to Follow-up|5
2481084|NCT02184143|8571251|P2|Overall Study|Withdrawal by Subject|4
2481085|NCT02184143|8571252|P1|Overall Study|Withdrawal by Subject|4
2481086|NCT02183675|8571281|P6|Treatment Period 2 (10 Days)|Adverse Event|2
2481087|NCT02183675|8571282|P5|Treatment Period 2 (10 Days)|Adverse Event|0
2481088|NCT02183675|8571283|P4|Treatment Period 2 (10 Days)|Adverse Event|0
2481089|NCT02183675|8571284|P3|Treatment Period 2 (10 Days)|Adverse Event|0
2481090|NCT02183675|8571285|P2|Treatment Period 2 (10 Days)|Adverse Event|0
2481091|NCT02183675|8571286|P1|Treatment Period 2 (10 Days)|Adverse Event|0
2481092|NCT02183519|8571310|P2|Overall Study|Did not respond to cough inducter|3
2481093|NCT02183519|8571311|P1|Overall Study|Did not respond to cough inducter|0
2481094|NCT02183519|8571310|P2|Overall Study|computer error|0
2481095|NCT02183519|8571311|P1|Overall Study|computer error|3
2481096|NCT02182999|8571319|P2|Overall Study|Physician Decision|0
2481097|NCT02182999|8571320|P1|Overall Study|Physician Decision|1
2481098|NCT02182999|8571319|P2|Overall Study|Adverse Event|3
2481099|NCT02182999|8571320|P1|Overall Study|Adverse Event|4
2481100|NCT02182973|8571336|P2|Overall Study|Withdrawal by Subject|0
2481101|NCT02182973|8571337|P1|Overall Study|Withdrawal by Subject|3
2481102|NCT02182895|8571349|P2|Overall Study|Discharged from hospital within 24 hours|4
2481103|NCT02182895|8571350|P1|Overall Study|Discharged from hospital within 24 hours|2
2481104|NCT02182843|8571370|P1|Overall Study|Adverse Event|1
2481105|NCT02182843|8571370|P1|Overall Study|Lost to Follow-up|2
2481106|NCT02182843|8571370|P1|Overall Study|Withdrawal by Subject|7
2481107|NCT02182830|8571377|P2|Overall Study|Lost to Follow-up|3
2481108|NCT02182830|8571378|P1|Overall Study|Lost to Follow-up|3
2481109|NCT02182830|8571377|P2|Overall Study|Consent withdrawn|8
2481110|NCT02182830|8571378|P1|Overall Study|Consent withdrawn|8
2481111|NCT02182830|8571377|P2|Overall Study|Trial stopped, reason missing|3
2481112|NCT02182830|8571378|P1|Overall Study|Trial stopped, reason missing|3
2481113|NCT02182830|8571377|P2|Overall Study|Not Treated|1
2481114|NCT02182830|8571378|P1|Overall Study|Not Treated|1
2481115|NCT02182440|8571419|P4|Overall Study|different, e.g adm other hospital|10
2481116|NCT02182440|8571420|P3|Overall Study|different, e.g adm other hospital|3
2481117|NCT02182440|8571421|P2|Overall Study|different, e.g adm other hospital|3
2481118|NCT02182440|8571422|P1|Overall Study|different, e.g adm other hospital|12
2481119|NCT02182440|8571419|P4|Overall Study|Withdrawal by Subject|4
2481120|NCT02182440|8571420|P3|Overall Study|Withdrawal by Subject|3
2481121|NCT02182440|8571421|P2|Overall Study|Withdrawal by Subject|1
2481122|NCT02182440|8571422|P1|Overall Study|Withdrawal by Subject|1
2481123|NCT02182440|8571419|P4|Overall Study|Physician Decision|0
2481124|NCT02182440|8571420|P3|Overall Study|Physician Decision|0
2481125|NCT02182440|8571421|P2|Overall Study|Physician Decision|0
2481126|NCT02182440|8571422|P1|Overall Study|Physician Decision|1
2481127|NCT02182440|8571419|P4|Overall Study|Protocol Violation|0
2481128|NCT02182440|8571420|P3|Overall Study|Protocol Violation|0
2481129|NCT02182440|8571421|P2|Overall Study|Protocol Violation|1
2481130|NCT02182440|8571422|P1|Overall Study|Protocol Violation|0
2481131|NCT02182440|8571419|P4|Overall Study|Death|16
2481132|NCT02182440|8571420|P3|Overall Study|Death|5
2481133|NCT02182440|8571421|P2|Overall Study|Death|8
2481134|NCT02182440|8571422|P1|Overall Study|Death|31
2481135|NCT02182440|8571419|P4|Overall Study|Adverse Event|0
2481136|NCT02182440|8571420|P3|Overall Study|Adverse Event|0
2481137|NCT02182440|8571421|P2|Overall Study|Adverse Event|1
2481138|NCT02182440|8571422|P1|Overall Study|Adverse Event|0
2481139|NCT02181842|8571461|P1|Overall Study|Case Report Forms Uncollected|2
2481140|NCT02181816|8571478|P1|Overall Study|Protocol Deviation|21
2481141|NCT02181816|8571478|P1|Overall Study|Case Report Forms Uncollected|38
2481142|NCT02181803|8571493|P9|Overall Study|Adverse Event|0
2481143|NCT02181803|8571494|P8|Overall Study|Adverse Event|0
2481144|NCT02181803|8571495|P7|Overall Study|Adverse Event|1
2481145|NCT02181803|8571496|P6|Overall Study|Adverse Event|0
2481146|NCT02181803|8571497|P5|Overall Study|Adverse Event|0
2481147|NCT02181803|8571498|P4|Overall Study|Adverse Event|1
2481148|NCT02181803|8571499|P3|Overall Study|Adverse Event|0
2481149|NCT02181803|8571500|P2|Overall Study|Adverse Event|2
2481150|NCT02181803|8571501|P1|Overall Study|Adverse Event|0
2481151|NCT02181803|8571493|P9|Overall Study|Physician Decision|0
2481152|NCT02181803|8571494|P8|Overall Study|Physician Decision|1
2481153|NCT02181803|8571495|P7|Overall Study|Physician Decision|0
2481154|NCT02181803|8571496|P6|Overall Study|Physician Decision|0
2481155|NCT02181803|8571497|P5|Overall Study|Physician Decision|0
2481156|NCT02181803|8571498|P4|Overall Study|Physician Decision|1
2481157|NCT02181803|8571499|P3|Overall Study|Physician Decision|0
2481158|NCT02181803|8571500|P2|Overall Study|Physician Decision|0
2481159|NCT02181803|8571501|P1|Overall Study|Physician Decision|0
2481160|NCT02181803|8571493|P9|Overall Study|Withdrawal by Subject|0
2481161|NCT02181803|8571494|P8|Overall Study|Withdrawal by Subject|0
2481162|NCT02181803|8571495|P7|Overall Study|Withdrawal by Subject|0
2481163|NCT02181803|8571496|P6|Overall Study|Withdrawal by Subject|0
2481164|NCT02181803|8571497|P5|Overall Study|Withdrawal by Subject|0
2481165|NCT02181803|8571498|P4|Overall Study|Withdrawal by Subject|0
2481166|NCT02181803|8571499|P3|Overall Study|Withdrawal by Subject|0
2481167|NCT02181803|8571500|P2|Overall Study|Withdrawal by Subject|2
2481168|NCT02181803|8571501|P1|Overall Study|Withdrawal by Subject|0
2481169|NCT02181790|8571652|P2|Overall Study|study terminated|0
2481170|NCT02181790|8571653|P1|Overall Study|study terminated|2
2481171|NCT02181738|8571665|P4|Overall Study|Patient Return to Home Country|0
2481172|NCT02181738|8571666|P3|Overall Study|Patient Return to Home Country|0
2481173|NCT02181738|8571667|P2|Overall Study|Patient Return to Home Country|1
2481174|NCT02181738|8571668|P1|Overall Study|Patient Return to Home Country|0
2481175|NCT02181738|8571665|P4|Overall Study|Lost to Follow-up|0
2481176|NCT02181738|8571666|P3|Overall Study|Lost to Follow-up|2
2481177|NCT02181738|8571667|P2|Overall Study|Lost to Follow-up|4
2481178|NCT02181738|8571668|P1|Overall Study|Lost to Follow-up|0
2481179|NCT02181738|8571665|P4|Overall Study|Subject Withdrew Consent|1
2481180|NCT02181738|8571666|P3|Overall Study|Subject Withdrew Consent|2
2481181|NCT02181738|8571667|P2|Overall Study|Subject Withdrew Consent|3
2481182|NCT02181738|8571668|P1|Overall Study|Subject Withdrew Consent|1
2481183|NCT02181738|8571665|P4|Overall Study|Death|1
2481184|NCT02181738|8571666|P3|Overall Study|Death|6
2481185|NCT02181738|8571667|P2|Overall Study|Death|1
2481186|NCT02181738|8571668|P1|Overall Study|Death|1
2481187|NCT02181673|8571709|P3|Week 24-Week 60|Physician Decision|1
2481188|NCT02181673|8571710|P2|Week 24-Week 60|Physician Decision|0
2481189|NCT02181673|8571711|P1|Week 24-Week 60|Physician Decision|0
2481190|NCT02181673|8571709|P3|Week 24-Week 60|Lost to Follow-up|1
2481191|NCT02181673|8571710|P2|Week 24-Week 60|Lost to Follow-up|0
2481192|NCT02181673|8571711|P1|Week 24-Week 60|Lost to Follow-up|0
2481193|NCT02181673|8571709|P3|Week 24-Week 60|Lack of Efficacy|1
2481194|NCT02181673|8571710|P2|Week 24-Week 60|Lack of Efficacy|0
2481195|NCT02181673|8571711|P1|Week 24-Week 60|Lack of Efficacy|0
2481196|NCT02181673|8571709|P3|Week 24-Week 60|Pregnancy|1
2481197|NCT02181673|8571710|P2|Week 24-Week 60|Pregnancy|0
2481198|NCT02181673|8571711|P1|Week 24-Week 60|Pregnancy|0
2481199|NCT02181673|8571709|P3|Week 24-Week 60|Withdrawal by Subject|2
2481200|NCT02181673|8571710|P2|Week 24-Week 60|Withdrawal by Subject|2
2481201|NCT02181673|8571711|P1|Week 24-Week 60|Withdrawal by Subject|0
2481202|NCT02181673|8571709|P3|Week 24-Week 60|Other|1
2481203|NCT02181673|8571710|P2|Week 24-Week 60|Other|2
2481204|NCT02181673|8571711|P1|Week 24-Week 60|Other|0
2481205|NCT02181673|8571709|P3|Week 24-Week 60|Adverse Event|10
2481206|NCT02181673|8571710|P2|Week 24-Week 60|Adverse Event|4
2481207|NCT02181673|8571711|P1|Week 24-Week 60|Adverse Event|0
2481208|NCT02181673|8571709|P3|Up to Week 24|Randomized not Treated|1
2481209|NCT02181673|8571710|P2|Up to Week 24|Randomized not Treated|0
2481210|NCT02181673|8571711|P1|Up to Week 24|Randomized not Treated|0
2481211|NCT02181673|8571709|P3|Up to Week 24|Other|3
2481212|NCT02181673|8571710|P2|Up to Week 24|Other|0
2481213|NCT02181673|8571711|P1|Up to Week 24|Other|2
2481214|NCT02181673|8571709|P3|Up to Week 24|Withdrawal by Subject|1
2481215|NCT02181673|8571710|P2|Up to Week 24|Withdrawal by Subject|0
2481216|NCT02181673|8571711|P1|Up to Week 24|Withdrawal by Subject|10
2481217|NCT02181673|8571709|P3|Up to Week 24|Physician Decision|3
2481218|NCT02181673|8571710|P2|Up to Week 24|Physician Decision|0
2481219|NCT02181673|8571711|P1|Up to Week 24|Physician Decision|0
2481220|NCT02181673|8571709|P3|Up to Week 24|Lost to Follow-up|0
2481221|NCT02181673|8571710|P2|Up to Week 24|Lost to Follow-up|0
2481222|NCT02181673|8571711|P1|Up to Week 24|Lost to Follow-up|1
2481223|NCT02181673|8571709|P3|Up to Week 24|Lack of Efficacy|0
2481224|NCT02181673|8571710|P2|Up to Week 24|Lack of Efficacy|0
2481225|NCT02181673|8571711|P1|Up to Week 24|Lack of Efficacy|1
2481226|NCT02181673|8571709|P3|Up to Week 24|Death|0
2481227|NCT02181673|8571710|P2|Up to Week 24|Death|0
2481228|NCT02181673|8571711|P1|Up to Week 24|Death|1
2481229|NCT02181673|8571709|P3|Up to Week 24|Adverse Event|3
2481230|NCT02181673|8571710|P2|Up to Week 24|Adverse Event|0
2481231|NCT02181673|8571711|P1|Up to Week 24|Adverse Event|2
2481232|NCT02181634|8571738|P1|Overall Study|Patient opted to proceed to surgery|1
2481233|NCT02181634|8571738|P1|Overall Study|Symptomatic progression|1
2481234|NCT02181634|8571738|P1|Overall Study|Max number of dose reduction|1
2481235|NCT02181634|8571738|P1|Overall Study|Ineligible|1
2481236|NCT02181634|8571738|P1|Overall Study|Treatment delayed greater than 4 weeks|3
2481237|NCT02181634|8571738|P1|Overall Study|Death|2
2481238|NCT02181634|8571738|P1|Overall Study|Withdrawal by Subject|5
2481239|NCT02181634|8571738|P1|Overall Study|Physician Decision|8
2481240|NCT02181634|8571738|P1|Overall Study|Adverse Event|17
2481241|NCT02181634|8571738|P1|Overall Study|Lack of Efficacy|33
2481242|NCT02181504|8571787|P3|Overall Study|Adverse Event|1
2481243|NCT02181504|8571788|P2|Overall Study|Adverse Event|1
2481244|NCT02181504|8571789|P1|Overall Study|Adverse Event|1
2481245|NCT02181413|8571828|P2|Overall Study|Lost to Follow-up|1
2481246|NCT02181413|8571829|P1|Overall Study|Lost to Follow-up|0
2481247|NCT02181413|8571828|P2|Overall Study|Ongoing Study Treatment|1
2481248|NCT02181413|8571829|P1|Overall Study|Ongoing Study Treatment|0
2481249|NCT02181413|8571828|P2|Overall Study|Reason Not Specified|20
2481250|NCT02181413|8571829|P1|Overall Study|Reason Not Specified|19
2481251|NCT02181413|8571828|P2|Overall Study|Withdrawal by Subject|8
2481252|NCT02181413|8571829|P1|Overall Study|Withdrawal by Subject|5
2481253|NCT02181413|8571828|P2|Overall Study|Progressive Disease|143
2481254|NCT02181413|8571829|P1|Overall Study|Progressive Disease|121
2481255|NCT02181413|8571828|P2|Overall Study|Adverse Event|24
2481256|NCT02181413|8571829|P1|Overall Study|Adverse Event|7
2481257|NCT02181296|8571874|P2|Overall Study|Lost to Follow-up|6
2481258|NCT02181296|8571875|P1|Overall Study|Lost to Follow-up|7
2481259|NCT02180724|8572017|P2|Overall Study|Ongoing Study|11
2481260|NCT02180724|8572018|P1|Overall Study|Ongoing Study|78
2481261|NCT02180724|8572017|P2|Overall Study|Withdrawal by Subject|2
2481262|NCT02180724|8572018|P1|Overall Study|Withdrawal by Subject|1
2481263|NCT02180724|8572017|P2|Overall Study|Lost to Follow-up|0
2481264|NCT02180724|8572018|P1|Overall Study|Lost to Follow-up|1
2481265|NCT02180724|8572017|P2|Overall Study|Death|1
2481266|NCT02180724|8572018|P1|Overall Study|Death|12
2481267|NCT02180659|8572032|P2|Overall Study|AT REQUEST OF THE SPONSOR|1
2481268|NCT02180659|8572033|P1|Overall Study|AT REQUEST OF THE SPONSOR|0
2481269|NCT02180659|8572032|P2|Overall Study|Withdrawal by Subject|2
2481270|NCT02180659|8572033|P1|Overall Study|Withdrawal by Subject|0
2481271|NCT02180659|8572032|P2|Overall Study|Subject incarcerated during conduct|0
2481272|NCT02180659|8572033|P1|Overall Study|Subject incarcerated during conduct|1
2481273|NCT02180659|8572032|P2|Overall Study|Lost to Follow-up|2
2481274|NCT02180659|8572033|P1|Overall Study|Lost to Follow-up|4
2481275|NCT02180659|8572032|P2|Overall Study|Adverse Event|0
2481276|NCT02180659|8572033|P1|Overall Study|Adverse Event|1
2481277|NCT02180438|8572068|P1|Overall Study|Lost to Follow-up|1
2481278|NCT02180165|8572092|P4|Overall Study|Withdrawal by Subject|1
2481279|NCT02180165|8572093|P3|Overall Study|Withdrawal by Subject|2
2481280|NCT02180165|8572094|P2|Overall Study|Withdrawal by Subject|0
2481281|NCT02180165|8572095|P1|Overall Study|Withdrawal by Subject|3
2481282|NCT02180165|8572092|P4|Overall Study|Physician Decision|0
2481283|NCT02180165|8572093|P3|Overall Study|Physician Decision|5
2481284|NCT02180165|8572094|P2|Overall Study|Physician Decision|0
2481285|NCT02180165|8572095|P1|Overall Study|Physician Decision|1
2481286|NCT02180165|8572092|P4|Overall Study|Lack of Efficacy|2
2481287|NCT02180165|8572093|P3|Overall Study|Lack of Efficacy|3
2481288|NCT02180165|8572094|P2|Overall Study|Lack of Efficacy|1
2481289|NCT02180165|8572095|P1|Overall Study|Lack of Efficacy|0
2481290|NCT02180165|8572092|P4|Overall Study|Adverse Event|3
2481291|NCT02180165|8572093|P3|Overall Study|Adverse Event|18
2481292|NCT02180165|8572094|P2|Overall Study|Adverse Event|0
2481293|NCT02180165|8572095|P1|Overall Study|Adverse Event|7
2481294|NCT02180165|8572092|P4|Overall Study|Not Treated|0
2481295|NCT02180165|8572093|P3|Overall Study|Not Treated|1
2481296|NCT02180165|8572094|P2|Overall Study|Not Treated|0
2481297|NCT02180165|8572095|P1|Overall Study|Not Treated|0
2481298|NCT02180061|8572183|P2|Overall Study|Physician Decision|0
2481299|NCT02180061|8572184|P1|Overall Study|Physician Decision|1
2481300|NCT02180061|8572183|P2|Overall Study|Progressive Disease|5
2481301|NCT02180061|8572184|P1|Overall Study|Progressive Disease|15
2481302|NCT02180061|8572183|P2|Overall Study|Clinical Progression|1
2481303|NCT02180061|8572184|P1|Overall Study|Clinical Progression|5
2481304|NCT02180061|8572183|P2|Overall Study|Adverse Event|2
2481305|NCT02180061|8572184|P1|Overall Study|Adverse Event|4
2481306|NCT02179918|8572203|P5|Overall Study|Subject refused further follow-up|1
2481307|NCT02179918|8572204|P4|Overall Study|Subject refused further follow-up|0
2481308|NCT02179918|8572205|P3|Overall Study|Subject refused further follow-up|0
2481309|NCT02179918|8572206|P2|Overall Study|Subject refused further follow-up|1
2481310|NCT02179918|8572207|P1|Overall Study|Subject refused further follow-up|0
2481311|NCT02179918|8572203|P5|Overall Study|Other|1
2481312|NCT02179918|8572204|P4|Overall Study|Other|0
2481313|NCT02179918|8572205|P3|Overall Study|Other|0
2481314|NCT02179918|8572206|P2|Overall Study|Other|1
2481315|NCT02179918|8572207|P1|Overall Study|Other|0
2481316|NCT02179918|8572203|P5|Overall Study|Progressive Disease|6
2481317|NCT02179918|8572204|P4|Overall Study|Progressive Disease|2
2481318|NCT02179918|8572205|P3|Overall Study|Progressive Disease|1
2481319|NCT02179918|8572206|P2|Overall Study|Progressive Disease|1
2481320|NCT02179918|8572207|P1|Overall Study|Progressive Disease|4
2481321|NCT02179918|8572203|P5|Overall Study|Lost to Follow-up|0
2481322|NCT02179918|8572204|P4|Overall Study|Lost to Follow-up|0
2481323|NCT02179918|8572205|P3|Overall Study|Lost to Follow-up|1
2481324|NCT02179918|8572206|P2|Overall Study|Lost to Follow-up|0
2481325|NCT02179918|8572207|P1|Overall Study|Lost to Follow-up|0
2481326|NCT02179918|8572203|P5|Overall Study|Death|0
2481327|NCT02179918|8572204|P4|Overall Study|Death|1
2481328|NCT02179918|8572205|P3|Overall Study|Death|0
2481329|NCT02179918|8572206|P2|Overall Study|Death|0
2481330|NCT02179918|8572207|P1|Overall Study|Death|0
2481331|NCT02179398|8572411|P2|Overall Study|Lost to Follow-up|1
2481332|NCT02179398|8572412|P1|Overall Study|Lost to Follow-up|0
2481333|NCT02179398|8572411|P2|Overall Study|Lack of obligatory data|3
2481334|NCT02179398|8572412|P1|Overall Study|Lack of obligatory data|3
2481335|NCT02179190|8572430|P1|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1
2481336|NCT02179190|8572430|P1|Follow-Up Post Barrel VRD Implanted|Physician Decision|2
2481337|NCT02179190|8572430|P1|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3
2481338|NCT02179190|8572430|P1|Follow-Up Post Barrel VRD Implanted|Death|3
2481339|NCT02179190|8572430|P1|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7
2481340|NCT02179190|8572430|P1|Enrollment|Exit Prior to Device Attempt|11
2481341|NCT02179177|8572443|P2|Overall Study|Withdrawal by Subject|1
2481342|NCT02179177|8572444|P1|Overall Study|Withdrawal by Subject|1
2481343|NCT02179177|8572443|P2|Overall Study|Lost to Follow-up|1
2481344|NCT02179177|8572444|P1|Overall Study|Lost to Follow-up|1
2481345|NCT02178995|8572484|P9|Open Label|Adverse Event|0
2481346|NCT02178995|8572485|P8|Open Label|Adverse Event|0
2481347|NCT02178995|8572486|P7|Open Label|Adverse Event|0
2481348|NCT02178995|8572487|P6|Open Label|Adverse Event|0
2481349|NCT02178995|8572488|P5|Open Label|Adverse Event|0
2481350|NCT02178995|8572489|P4|Open Label|Adverse Event|0
2481351|NCT02178995|8572490|P3|Open Label|Adverse Event|0
2481352|NCT02178995|8572491|P2|Open Label|Adverse Event|0
2481353|NCT02178995|8572492|P1|Open Label|Adverse Event|2
2481354|NCT02178995|8572484|P9|Double Blind|Lost to Follow-up|0
2481355|NCT02178995|8572485|P8|Double Blind|Lost to Follow-up|1
2481356|NCT02178995|8572486|P7|Double Blind|Lost to Follow-up|0
2481357|NCT02178995|8572487|P6|Double Blind|Lost to Follow-up|0
2481358|NCT02178995|8572488|P5|Double Blind|Lost to Follow-up|0
2481359|NCT02178995|8572489|P4|Double Blind|Lost to Follow-up|0
2481360|NCT02178995|8572490|P3|Double Blind|Lost to Follow-up|0
2481361|NCT02178995|8572491|P2|Double Blind|Lost to Follow-up|1
2481362|NCT02178995|8572492|P1|Double Blind|Lost to Follow-up|0
2481363|NCT02178995|8572484|P9|Double Blind|Adverse Event|1
2481364|NCT02178995|8572485|P8|Double Blind|Adverse Event|1
2481365|NCT02178995|8572486|P7|Double Blind|Adverse Event|0
2481366|NCT02178995|8572487|P6|Double Blind|Adverse Event|1
2481367|NCT02178995|8572488|P5|Double Blind|Adverse Event|0
2481368|NCT02178995|8572489|P4|Double Blind|Adverse Event|0
2481369|NCT02178995|8572490|P3|Double Blind|Adverse Event|0
2481370|NCT02178995|8572491|P2|Double Blind|Adverse Event|0
2481371|NCT02178995|8572492|P1|Double Blind|Adverse Event|0
2481372|NCT02178787|8572600|P2|Overall Study|Physician Decision|0
2481373|NCT02178787|8572601|P1|Overall Study|Physician Decision|1
2481374|NCT02178787|8572600|P2|Overall Study|No TCD window|7
2481375|NCT02178787|8572601|P1|Overall Study|No TCD window|3
2481376|NCT02178787|8572600|P2|Overall Study|Withdrawal by Subject|2
2481377|NCT02178787|8572601|P1|Overall Study|Withdrawal by Subject|0
2481378|NCT02178787|8572600|P2|Overall Study|Lost to Follow-up|0
2481379|NCT02178787|8572601|P1|Overall Study|Lost to Follow-up|1
2481380|NCT02178722|8572614|P5|Overall Study|Participants Ongoing in study|74
2481381|NCT02178722|8572615|P4|Overall Study|Participants Ongoing in study|2
2481382|NCT02178722|8572616|P3|Overall Study|Participants Ongoing in study|4
2481383|NCT02178722|8572617|P2|Overall Study|Participants Ongoing in study|1
2481384|NCT02178722|8572618|P1|Overall Study|Participants Ongoing in study|1
2481385|NCT02178722|8572614|P5|Overall Study|Other Unspecified|1
2481386|NCT02178722|8572615|P4|Overall Study|Other Unspecified|0
2481387|NCT02178722|8572616|P3|Overall Study|Other Unspecified|0
2481388|NCT02178722|8572617|P2|Overall Study|Other Unspecified|0
2481389|NCT02178722|8572618|P1|Overall Study|Other Unspecified|0
2481390|NCT02178722|8572614|P5|Overall Study|Physician Decision|2
2481391|NCT02178722|8572615|P4|Overall Study|Physician Decision|0
2481392|NCT02178722|8572616|P3|Overall Study|Physician Decision|0
2481393|NCT02178722|8572617|P2|Overall Study|Physician Decision|0
2481394|NCT02178722|8572618|P1|Overall Study|Physician Decision|0
2481395|NCT02178722|8572614|P5|Overall Study|Study Terminated by Sponsor|65
2481396|NCT02178722|8572615|P4|Overall Study|Study Terminated by Sponsor|3
2481397|NCT02178722|8572616|P3|Overall Study|Study Terminated by Sponsor|2
2481398|NCT02178722|8572617|P2|Overall Study|Study Terminated by Sponsor|6
2481399|NCT02178722|8572618|P1|Overall Study|Study Terminated by Sponsor|1
2481400|NCT02178722|8572614|P5|Overall Study|Lost to Follow-up|11
2481401|NCT02178722|8572615|P4|Overall Study|Lost to Follow-up|2
2481402|NCT02178722|8572616|P3|Overall Study|Lost to Follow-up|0
2481403|NCT02178722|8572617|P2|Overall Study|Lost to Follow-up|0
2481404|NCT02178722|8572618|P1|Overall Study|Lost to Follow-up|0
2481405|NCT02178722|8572614|P5|Overall Study|Death|199
2481406|NCT02178722|8572615|P4|Overall Study|Death|11
2481407|NCT02178722|8572616|P3|Overall Study|Death|12
2481408|NCT02178722|8572617|P2|Overall Study|Death|13
2481409|NCT02178722|8572618|P1|Overall Study|Death|2
2481410|NCT02178722|8572614|P5|Overall Study|Participant decision|30
2481411|NCT02178722|8572615|P4|Overall Study|Participant decision|2
2481412|NCT02178722|8572616|P3|Overall Study|Participant decision|0
2481413|NCT02178722|8572617|P2|Overall Study|Participant decision|0
2481414|NCT02178722|8572618|P1|Overall Study|Participant decision|0
2481415|NCT02178709|8572630|P1|Overall Study|Disease Progression|5
2481416|NCT02178709|8572630|P1|Overall Study|Physician Decision|2
2481417|NCT02178709|8572630|P1|Overall Study|Withdrawal by Subject|2
2481418|NCT02178709|8572630|P1|Overall Study|Death|2
2481419|NCT02178709|8572630|P1|Overall Study|Adverse Event|5
2481420|NCT02178592|8572657|P2|Overall Study|Physician Decision|0
2481421|NCT02178592|8572658|P1|Overall Study|Physician Decision|1
2481422|NCT02178592|8572657|P2|Overall Study|Lost to Follow-up|3
2481423|NCT02178592|8572658|P1|Overall Study|Lost to Follow-up|11
2481424|NCT02178592|8572657|P2|Overall Study|Withdrawal by Subject|1
2481425|NCT02178592|8572658|P1|Overall Study|Withdrawal by Subject|3
2481426|NCT02178592|8572657|P2|Overall Study|Protocol Violation|2
2481427|NCT02178592|8572658|P1|Overall Study|Protocol Violation|3
2481428|NCT02178592|8572657|P2|Overall Study|Lack of Efficacy|1
2481429|NCT02178592|8572658|P1|Overall Study|Lack of Efficacy|1
2481430|NCT02178592|8572657|P2|Overall Study|Adverse Event|2
2481431|NCT02178592|8572658|P1|Overall Study|Adverse Event|0
2481432|NCT02178553|8572686|P2|Overall Study|Technical problem with injection|3
2481433|NCT02178553|8572687|P1|Overall Study|Technical problem with injection|1
2481434|NCT02178553|8572686|P2|Overall Study|Physician Decision|4
2481435|NCT02178553|8572687|P1|Overall Study|Physician Decision|0
2481436|NCT02178553|8572686|P2|Overall Study|Did not proceed to open thoracotomy|3
2481437|NCT02178553|8572687|P1|Overall Study|Did not proceed to open thoracotomy|7
2481438|NCT02178475|8572706|P1|Overall Study|Protocol-specified Criteria|99
2481439|NCT02178475|8572706|P1|Overall Study|Death|13
2481440|NCT02178475|8572706|P1|Overall Study|Lost to Follow-up|10
2481441|NCT02178475|8572706|P1|Overall Study|Withdrawal by Subject|7
2481442|NCT02178059|8572733|P2|Washout|Physician Decision|0
2481443|NCT02178059|8572734|P1|Washout|Physician Decision|1
2481444|NCT02177942|8572752|P2|Overall Study|Withdrawal by Subject|81
2481445|NCT02177942|8572753|P1|Overall Study|Withdrawal by Subject|71
2481446|NCT02177942|8572752|P2|Overall Study|Protocol Violation|6
2481447|NCT02177942|8572753|P1|Overall Study|Protocol Violation|4
2481448|NCT02177942|8572752|P2|Overall Study|Lost to Follow-up|1
2481449|NCT02177942|8572753|P1|Overall Study|Lost to Follow-up|1
2481450|NCT02177942|8572752|P2|Overall Study|Adverse Event|0
2481451|NCT02177942|8572753|P1|Overall Study|Adverse Event|1
2481452|NCT02177812|8572784|P9|Part 1 (Median of 4 Weeks)|Adverse Event|0
2481453|NCT02177812|8572785|P8|Part 1 (Median of 4 Weeks)|Adverse Event|1
2481454|NCT02177812|8572786|P7|Part 1 (Median of 4 Weeks)|Adverse Event|6
2481455|NCT02177812|8572787|P6|Part 1 (Median of 4 Weeks)|Adverse Event|1
2481456|NCT02177812|8572788|P5|Part 1 (Median of 4 Weeks)|Adverse Event|1
2481457|NCT02177812|8572789|P4|Part 1 (Median of 4 Weeks)|Adverse Event|1
2481458|NCT02177812|8572790|P3|Part 1 (Median of 4 Weeks)|Adverse Event|0
2481459|NCT02177812|8572791|P2|Part 1 (Median of 4 Weeks)|Adverse Event|0
2481460|NCT02177812|8572792|P1|Part 1 (Median of 4 Weeks)|Adverse Event|0
2481461|NCT02177812|8572784|P9|Part 1 (Median of 4 Weeks)|Physician Decision|0
2481462|NCT02177812|8572785|P8|Part 1 (Median of 4 Weeks)|Physician Decision|0
2481463|NCT02177812|8572786|P7|Part 1 (Median of 4 Weeks)|Physician Decision|1
2481464|NCT02177812|8572787|P6|Part 1 (Median of 4 Weeks)|Physician Decision|1
2481465|NCT02177812|8572788|P5|Part 1 (Median of 4 Weeks)|Physician Decision|0
2481466|NCT02177812|8572789|P4|Part 1 (Median of 4 Weeks)|Physician Decision|0
2481467|NCT02177812|8572790|P3|Part 1 (Median of 4 Weeks)|Physician Decision|0
2481468|NCT02177812|8572791|P2|Part 1 (Median of 4 Weeks)|Physician Decision|0
2481469|NCT02177812|8572792|P1|Part 1 (Median of 4 Weeks)|Physician Decision|0
2481470|NCT02177812|8572784|P9|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
2481471|NCT02177812|8572785|P8|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1
2481472|NCT02177812|8572786|P7|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2
2481473|NCT02177812|8572787|P6|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1
2481474|NCT02177812|8572788|P5|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
2481475|NCT02177812|8572789|P4|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
2481476|NCT02177812|8572790|P3|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
2481477|NCT02177812|8572791|P2|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
2481478|NCT02177812|8572792|P1|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
2481479|NCT02177786|8573009|P4|Overall Study|Missing study completion status|0
2481480|NCT02177786|8573010|P3|Overall Study|Missing study completion status|0
2481481|NCT02177786|8573011|P2|Overall Study|Missing study completion status|1
2481482|NCT02177786|8573012|P1|Overall Study|Missing study completion status|0
2481483|NCT02177786|8573009|P4|Overall Study|Progressive Disease|0
2481484|NCT02177786|8573010|P3|Overall Study|Progressive Disease|0
2481485|NCT02177786|8573011|P2|Overall Study|Progressive Disease|1
2481486|NCT02177786|8573012|P1|Overall Study|Progressive Disease|0
2481487|NCT02177786|8573009|P4|Overall Study|Protocol Violation|0
2481488|NCT02177786|8573010|P3|Overall Study|Protocol Violation|2
2481489|NCT02177786|8573011|P2|Overall Study|Protocol Violation|0
2481490|NCT02177786|8573012|P1|Overall Study|Protocol Violation|0
2481491|NCT02177786|8573009|P4|Overall Study|Non-Compliance with Study Drug|1
2481492|NCT02177786|8573010|P3|Overall Study|Non-Compliance with Study Drug|0
2481493|NCT02177786|8573011|P2|Overall Study|Non-Compliance with Study Drug|1
2481494|NCT02177786|8573012|P1|Overall Study|Non-Compliance with Study Drug|0
2481495|NCT02177786|8573009|P4|Overall Study|Lost to Follow-up|2
2481496|NCT02177786|8573010|P3|Overall Study|Lost to Follow-up|2
2481497|NCT02177786|8573011|P2|Overall Study|Lost to Follow-up|0
2481498|NCT02177786|8573012|P1|Overall Study|Lost to Follow-up|0
2481499|NCT02177786|8573009|P4|Overall Study|Death|1
2481500|NCT02177786|8573010|P3|Overall Study|Death|1
2481501|NCT02177786|8573011|P2|Overall Study|Death|1
2481502|NCT02177786|8573012|P1|Overall Study|Death|1
2481503|NCT02177786|8573009|P4|Overall Study|Adverse Event|3
2481504|NCT02177786|8573010|P3|Overall Study|Adverse Event|2
2481505|NCT02177786|8573011|P2|Overall Study|Adverse Event|1
2481506|NCT02177786|8573012|P1|Overall Study|Adverse Event|1
2481507|NCT02177786|8573009|P4|Overall Study|Progression to End Stage Renal Disease|1
2481508|NCT02177786|8573010|P3|Overall Study|Progression to End Stage Renal Disease|2
2481509|NCT02177786|8573011|P2|Overall Study|Progression to End Stage Renal Disease|3
2481510|NCT02177786|8573012|P1|Overall Study|Progression to End Stage Renal Disease|2
2481511|NCT02177786|8573009|P4|Overall Study|Withdrew Consent|5
2481512|NCT02177786|8573010|P3|Overall Study|Withdrew Consent|9
2481513|NCT02177786|8573011|P2|Overall Study|Withdrew Consent|6
2481514|NCT02177786|8573012|P1|Overall Study|Withdrew Consent|2
2481515|NCT02177266|8573035|P2|Overall Study|Withdrawal by Subject|0
2481516|NCT02177266|8573036|P1|Overall Study|Withdrawal by Subject|1
2481517|NCT02177266|8573035|P2|Overall Study|Adverse Event|1
2481518|NCT02177266|8573036|P1|Overall Study|Adverse Event|0
2481519|NCT02177136|8573058|P3|Overall Study|Protocol Violation|1
2481520|NCT02177136|8573059|P2|Overall Study|Protocol Violation|0
2481521|NCT02177136|8573060|P1|Overall Study|Protocol Violation|0
2481522|NCT02177136|8573058|P3|Overall Study|Adverse Event|3
2481523|NCT02177136|8573059|P2|Overall Study|Adverse Event|2
2481524|NCT02177136|8573060|P1|Overall Study|Adverse Event|3
2481525|NCT02177136|8573058|P3|Overall Study|Discontinued due to pruritus|0
2481526|NCT02177136|8573059|P2|Overall Study|Discontinued due to pruritus|3
2481527|NCT02177136|8573060|P1|Overall Study|Discontinued due to pruritus|1
2481528|NCT02177136|8573058|P3|Overall Study|Withdrawal by Subject|0
2481529|NCT02177136|8573059|P2|Overall Study|Withdrawal by Subject|0
2481530|NCT02177136|8573060|P1|Overall Study|Withdrawal by Subject|2
2481531|NCT02177032|8573093|P4|Overall Study|Withdrawal by Subject|0
2481532|NCT02177032|8573094|P3|Overall Study|Withdrawal by Subject|1
2481533|NCT02177032|8573095|P2|Overall Study|Withdrawal by Subject|0
2481534|NCT02177032|8573096|P1|Overall Study|Withdrawal by Subject|1
2481535|NCT02177032|8573093|P4|Overall Study|OTHER|0
2481536|NCT02177032|8573094|P3|Overall Study|OTHER|1
2481537|NCT02177032|8573095|P2|Overall Study|OTHER|0
2481538|NCT02177032|8573096|P1|Overall Study|OTHER|2
2481539|NCT02177032|8573093|P4|Overall Study|Lost to Follow-up|0
2481540|NCT02177032|8573094|P3|Overall Study|Lost to Follow-up|0
2481541|NCT02177032|8573095|P2|Overall Study|Lost to Follow-up|2
2481542|NCT02177032|8573096|P1|Overall Study|Lost to Follow-up|0
2481543|NCT02177032|8573093|P4|Overall Study|ADMINISTRATIVE REASON|0
2481544|NCT02177032|8573094|P3|Overall Study|ADMINISTRATIVE REASON|1
2481545|NCT02177032|8573095|P2|Overall Study|ADMINISTRATIVE REASON|0
2481546|NCT02177032|8573096|P1|Overall Study|ADMINISTRATIVE REASON|2
2481547|NCT02176655|8573134|P1|Overall Study|Subjects did not treat|6
2481548|NCT02176642|8573157|P2|Overall Study|Withdrawal by Subject|1
2481549|NCT02176642|8573158|P1|Overall Study|Withdrawal by Subject|0
2481550|NCT02176525|8573188|P8|Overall Study|not treated|0
2481551|NCT02176525|8573189|P7|Overall Study|not treated|0
2481552|NCT02176525|8573190|P6|Overall Study|not treated|1
2481553|NCT02176525|8573191|P5|Overall Study|not treated|0
2481554|NCT02176525|8573192|P4|Overall Study|not treated|0
2481555|NCT02176525|8573193|P3|Overall Study|not treated|0
2481556|NCT02176525|8573194|P2|Overall Study|not treated|0
2481557|NCT02176525|8573195|P1|Overall Study|not treated|1
2481558|NCT02176525|8573188|P8|Overall Study|Adverse Event|0
2481559|NCT02176525|8573189|P7|Overall Study|Adverse Event|1
2481560|NCT02176525|8573190|P6|Overall Study|Adverse Event|0
2481561|NCT02176525|8573191|P5|Overall Study|Adverse Event|1
2481562|NCT02176525|8573192|P4|Overall Study|Adverse Event|1
2481563|NCT02176525|8573193|P3|Overall Study|Adverse Event|0
2481564|NCT02176525|8573194|P2|Overall Study|Adverse Event|0
2481565|NCT02176525|8573195|P1|Overall Study|Adverse Event|0
2481566|NCT02176421|8573411|P1|Overall Study|Adverse Event|1
2481567|NCT02176421|8573411|P1|Overall Study|Lost to Follow-up|4
2481568|NCT02176356|8573443|P1|Overall Study|Other Miscellaneous Reasons|2
2481569|NCT02176356|8573443|P1|Overall Study|Personal Reasons|3
2481570|NCT02176356|8573443|P1|Overall Study|Lost to Follow-up|4
2481571|NCT02176356|8573443|P1|Overall Study|Screen Failure|14
2481572|NCT02176291|8573473|P2|Overall Study|Withdrawal by Subject|0
2481573|NCT02176291|8573474|P1|Overall Study|Withdrawal by Subject|2
2481574|NCT02176291|8573473|P2|Overall Study|non compliance with protocol|0
2481575|NCT02176291|8573474|P1|Overall Study|non compliance with protocol|2
2481576|NCT02176291|8573473|P2|Overall Study|Death|0
2481577|NCT02176291|8573474|P1|Overall Study|Death|1
2481578|NCT02176226|8573482|P1|Overall Study|Withdrew prior to treatment|6
2481579|NCT02176226|8573482|P1|Overall Study|Lost to Follow-up|3
2481580|NCT02176018|8573508|P2|Overall Study|Withdrawal by Subject|2
2481581|NCT02176018|8573509|P1|Overall Study|Withdrawal by Subject|1
2481582|NCT02176018|8573508|P2|Overall Study|Protocol Violation|1
2481583|NCT02176018|8573509|P1|Overall Study|Protocol Violation|1
2481584|NCT02176018|8573508|P2|Overall Study|Lost to Follow-up|1
2481585|NCT02176018|8573509|P1|Overall Study|Lost to Follow-up|3
2481586|NCT02176018|8573508|P2|Overall Study|Adverse Event|2
2481587|NCT02176018|8573509|P1|Overall Study|Adverse Event|0
2481588|NCT02175966|8573593|P2|Follow-up Period|Lack of Efficacy|6
2481589|NCT02175966|8573594|P1|Follow-up Period|Lack of Efficacy|10
2481590|NCT02175771|8573622|P9|Treatment Period|Other|0
2481591|NCT02175771|8573623|P8|Treatment Period|Other|2
2481592|NCT02175771|8573624|P7|Treatment Period|Other|0
2481593|NCT02175771|8573625|P6|Treatment Period|Other|0
2481594|NCT02175771|8573626|P5|Treatment Period|Other|1
2481595|NCT02175771|8573627|P4|Treatment Period|Other|3
2481596|NCT02175771|8573628|P3|Treatment Period|Other|0
2481597|NCT02175771|8573629|P2|Treatment Period|Other|1
2481598|NCT02175771|8573630|P1|Treatment Period|Other|0
2481599|NCT02175771|8573622|P9|Treatment Period|Lack of Efficacy|0
2481600|NCT02175771|8573623|P8|Treatment Period|Lack of Efficacy|1
2481601|NCT02175771|8573624|P7|Treatment Period|Lack of Efficacy|0
2481602|NCT02175771|8573625|P6|Treatment Period|Lack of Efficacy|1
2481603|NCT02175771|8573626|P5|Treatment Period|Lack of Efficacy|0
2481604|NCT02175771|8573627|P4|Treatment Period|Lack of Efficacy|0
2481605|NCT02175771|8573628|P3|Treatment Period|Lack of Efficacy|0
2481606|NCT02175771|8573629|P2|Treatment Period|Lack of Efficacy|0
2481607|NCT02175771|8573630|P1|Treatment Period|Lack of Efficacy|0
2481608|NCT02175771|8573622|P9|Treatment Period|Lost to Follow-up|2
2481609|NCT02175771|8573623|P8|Treatment Period|Lost to Follow-up|2
2481610|NCT02175771|8573624|P7|Treatment Period|Lost to Follow-up|1
2481611|NCT02175771|8573625|P6|Treatment Period|Lost to Follow-up|2
2481612|NCT02175771|8573626|P5|Treatment Period|Lost to Follow-up|1
2481613|NCT02175771|8573627|P4|Treatment Period|Lost to Follow-up|3
2481614|NCT02175771|8573628|P3|Treatment Period|Lost to Follow-up|1
2481615|NCT02175771|8573629|P2|Treatment Period|Lost to Follow-up|3
2481616|NCT02175771|8573630|P1|Treatment Period|Lost to Follow-up|0
2481617|NCT02175771|8573622|P9|Treatment Period|Disease progression|0
2481618|NCT02175771|8573623|P8|Treatment Period|Disease progression|2
2481619|NCT02175771|8573624|P7|Treatment Period|Disease progression|0
2481620|NCT02175771|8573625|P6|Treatment Period|Disease progression|0
2481621|NCT02175771|8573626|P5|Treatment Period|Disease progression|0
2481622|NCT02175771|8573627|P4|Treatment Period|Disease progression|0
2481623|NCT02175771|8573628|P3|Treatment Period|Disease progression|0
2481624|NCT02175771|8573629|P2|Treatment Period|Disease progression|0
2481625|NCT02175771|8573630|P1|Treatment Period|Disease progression|0
2481626|NCT02175771|8573622|P9|Treatment Period|Protocol Violation|0
2481627|NCT02175771|8573623|P8|Treatment Period|Protocol Violation|1
2481628|NCT02175771|8573624|P7|Treatment Period|Protocol Violation|0
2481629|NCT02175771|8573625|P6|Treatment Period|Protocol Violation|0
2481630|NCT02175771|8573626|P5|Treatment Period|Protocol Violation|0
2481631|NCT02175771|8573627|P4|Treatment Period|Protocol Violation|0
2481632|NCT02175771|8573628|P3|Treatment Period|Protocol Violation|0
2481633|NCT02175771|8573629|P2|Treatment Period|Protocol Violation|0
2481634|NCT02175771|8573630|P1|Treatment Period|Protocol Violation|0
2481635|NCT02175771|8573622|P9|Treatment Period|Noncompliance|1
2481636|NCT02175771|8573623|P8|Treatment Period|Noncompliance|0
2481637|NCT02175771|8573624|P7|Treatment Period|Noncompliance|0
2481638|NCT02175771|8573625|P6|Treatment Period|Noncompliance|0
2481639|NCT02175771|8573626|P5|Treatment Period|Noncompliance|0
2481640|NCT02175771|8573627|P4|Treatment Period|Noncompliance|0
2481641|NCT02175771|8573628|P3|Treatment Period|Noncompliance|2
2481642|NCT02175771|8573629|P2|Treatment Period|Noncompliance|1
2481643|NCT02175771|8573630|P1|Treatment Period|Noncompliance|0
2481644|NCT02175771|8573622|P9|Treatment Period|Withdrawal by Subject|2
2481645|NCT02175771|8573623|P8|Treatment Period|Withdrawal by Subject|9
2481646|NCT02175771|8573624|P7|Treatment Period|Withdrawal by Subject|2
2481647|NCT02175771|8573625|P6|Treatment Period|Withdrawal by Subject|4
2481648|NCT02175771|8573626|P5|Treatment Period|Withdrawal by Subject|2
2481649|NCT02175771|8573627|P4|Treatment Period|Withdrawal by Subject|6
2481650|NCT02175771|8573628|P3|Treatment Period|Withdrawal by Subject|3
2481651|NCT02175771|8573629|P2|Treatment Period|Withdrawal by Subject|9
2481652|NCT02175771|8573630|P1|Treatment Period|Withdrawal by Subject|0
2481653|NCT02175771|8573622|P9|Treatment Period|Adverse Event|1
2481654|NCT02175771|8573623|P8|Treatment Period|Adverse Event|0
2481655|NCT02175771|8573624|P7|Treatment Period|Adverse Event|2
2481656|NCT02175771|8573625|P6|Treatment Period|Adverse Event|3
2481657|NCT02175771|8573626|P5|Treatment Period|Adverse Event|1
2481658|NCT02175771|8573627|P4|Treatment Period|Adverse Event|1
2481659|NCT02175771|8573628|P3|Treatment Period|Adverse Event|1
2481660|NCT02175771|8573629|P2|Treatment Period|Adverse Event|2
2481661|NCT02175771|8573630|P1|Treatment Period|Adverse Event|0
2481662|NCT02175771|8573622|P9|Run-In Period (Pre-assignment)|Other|0
2481663|NCT02175771|8573623|P8|Run-In Period (Pre-assignment)|Other|0
2481664|NCT02175771|8573624|P7|Run-In Period (Pre-assignment)|Other|0
2481665|NCT02175771|8573625|P6|Run-In Period (Pre-assignment)|Other|0
2481666|NCT02175771|8573626|P5|Run-In Period (Pre-assignment)|Other|0
2481667|NCT02175771|8573627|P4|Run-In Period (Pre-assignment)|Other|0
2481668|NCT02175771|8573628|P3|Run-In Period (Pre-assignment)|Other|0
2481669|NCT02175771|8573629|P2|Run-In Period (Pre-assignment)|Other|0
2481670|NCT02175771|8573630|P1|Run-In Period (Pre-assignment)|Other|8
2481671|NCT02175771|8573622|P9|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2481672|NCT02175771|8573623|P8|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2481673|NCT02175771|8573624|P7|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2481674|NCT02175771|8573625|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2481675|NCT02175771|8573626|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2481676|NCT02175771|8573627|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2481677|NCT02175771|8573628|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2481678|NCT02175771|8573629|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2481679|NCT02175771|8573630|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
2481680|NCT02175771|8573622|P9|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2481681|NCT02175771|8573623|P8|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2481682|NCT02175771|8573624|P7|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2481683|NCT02175771|8573625|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2481684|NCT02175771|8573626|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2481685|NCT02175771|8573627|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2481686|NCT02175771|8573628|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2481687|NCT02175771|8573629|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2481688|NCT02175771|8573630|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|7
2481689|NCT02175771|8573622|P9|Run-In Period (Pre-assignment)|Adverse Event|0
2481690|NCT02175771|8573623|P8|Run-In Period (Pre-assignment)|Adverse Event|0
2481691|NCT02175771|8573624|P7|Run-In Period (Pre-assignment)|Adverse Event|0
2481692|NCT02175771|8573625|P6|Run-In Period (Pre-assignment)|Adverse Event|0
2481693|NCT02175771|8573626|P5|Run-In Period (Pre-assignment)|Adverse Event|0
2481694|NCT02175771|8573627|P4|Run-In Period (Pre-assignment)|Adverse Event|0
2481695|NCT02175771|8573628|P3|Run-In Period (Pre-assignment)|Adverse Event|0
2481696|NCT02175771|8573629|P2|Run-In Period (Pre-assignment)|Adverse Event|0
2481697|NCT02175771|8573630|P1|Run-In Period (Pre-assignment)|Adverse Event|9
2481698|NCT02175771|8573622|P9|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2481699|NCT02175771|8573623|P8|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2481700|NCT02175771|8573624|P7|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2481701|NCT02175771|8573625|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2481702|NCT02175771|8573626|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2481703|NCT02175771|8573627|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2481704|NCT02175771|8573628|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2481787|NCT02174848|8574065|P1|Overall Study|Withdrawal by Subject|3
2481705|NCT02175771|8573629|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2481706|NCT02175771|8573630|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|11
2481707|NCT02175771|8573622|P9|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2481708|NCT02175771|8573623|P8|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2481709|NCT02175771|8573624|P7|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2481710|NCT02175771|8573625|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2481711|NCT02175771|8573626|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2481712|NCT02175771|8573627|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2481713|NCT02175771|8573628|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2481714|NCT02175771|8573629|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2481715|NCT02175771|8573630|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|20
2481716|NCT02175771|8573622|P9|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2481717|NCT02175771|8573623|P8|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2481718|NCT02175771|8573624|P7|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2481719|NCT02175771|8573625|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2481720|NCT02175771|8573626|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2481721|NCT02175771|8573627|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2481722|NCT02175771|8573628|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2481723|NCT02175771|8573629|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2481724|NCT02175771|8573630|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|23
2481725|NCT02175758|8573694|P6|Treatment Phase|Adverse Event|0
2481726|NCT02175758|8573695|P5|Treatment Phase|Adverse Event|1
2481727|NCT02175758|8573696|P4|Treatment Phase|Adverse Event|0
2481728|NCT02175758|8573697|P3|Treatment Phase|Adverse Event|0
2481729|NCT02175758|8573698|P2|Treatment Phase|Adverse Event|0
2481730|NCT02175758|8573699|P1|Treatment Phase|Adverse Event|0
2481731|NCT02175758|8573694|P6|Treatment Phase|Lost to Follow-up|0
2481732|NCT02175758|8573695|P5|Treatment Phase|Lost to Follow-up|0
2481733|NCT02175758|8573696|P4|Treatment Phase|Lost to Follow-up|0
2481734|NCT02175758|8573697|P3|Treatment Phase|Lost to Follow-up|0
2481735|NCT02175758|8573698|P2|Treatment Phase|Lost to Follow-up|1
2481736|NCT02175758|8573699|P1|Treatment Phase|Lost to Follow-up|0
2481737|NCT02175745|8573802|P1|Overall Study|Not Eligible|1
2481738|NCT02175368|8573841|P1|Overall Study|Lost to Follow-up|1
2481739|NCT02175277|8573846|P1|Overall Study|Protocol-specified Criteria|1
2481740|NCT02175225|8573852|P2|Overall Study|Study drug not administered|2
2481741|NCT02175225|8573853|P1|Overall Study|Study drug not administered|1
2481742|NCT02175225|8573852|P2|Overall Study|Lost to Follow-up|7
2481743|NCT02175225|8573853|P1|Overall Study|Lost to Follow-up|6
2481744|NCT02175225|8573852|P2|Overall Study|Withdrawal by Subject|2
2481745|NCT02175225|8573853|P1|Overall Study|Withdrawal by Subject|1
2481746|NCT02175199|8573904|P2|Overall Study|Sponsor Decision|0
2481747|NCT02175199|8573905|P1|Overall Study|Sponsor Decision|1
2481748|NCT02175199|8573904|P2|Overall Study|Randomized in Error|0
2481749|NCT02175199|8573905|P1|Overall Study|Randomized in Error|1
2481750|NCT02175199|8573904|P2|Overall Study|Withdrawal by Subject|5
2481751|NCT02175199|8573905|P1|Overall Study|Withdrawal by Subject|1
2481752|NCT02175121|8573919|P5|Overall Study|Time issues|0
2481753|NCT02175121|8573920|P4|Overall Study|Time issues|0
2481754|NCT02175121|8573921|P3|Overall Study|Time issues|1
2481755|NCT02175121|8573922|P2|Overall Study|Time issues|0
2481756|NCT02175121|8573923|P1|Overall Study|Time issues|0
2481757|NCT02175121|8573919|P5|Overall Study|Schedule conflict|0
2481758|NCT02175121|8573920|P4|Overall Study|Schedule conflict|0
2481759|NCT02175121|8573921|P3|Overall Study|Schedule conflict|1
2481760|NCT02175121|8573922|P2|Overall Study|Schedule conflict|0
2481761|NCT02175121|8573923|P1|Overall Study|Schedule conflict|0
2481762|NCT02175121|8573919|P5|Overall Study|Personal emergency|1
2481763|NCT02175121|8573920|P4|Overall Study|Personal emergency|0
2481764|NCT02175121|8573921|P3|Overall Study|Personal emergency|0
2481765|NCT02175121|8573922|P2|Overall Study|Personal emergency|0
2481766|NCT02175121|8573923|P1|Overall Study|Personal emergency|0
2481767|NCT02175121|8573919|P5|Overall Study|Lost to Follow-up|0
2481768|NCT02175121|8573920|P4|Overall Study|Lost to Follow-up|1
2481769|NCT02175121|8573921|P3|Overall Study|Lost to Follow-up|0
2481770|NCT02175121|8573922|P2|Overall Study|Lost to Follow-up|1
2481771|NCT02175121|8573923|P1|Overall Study|Lost to Follow-up|0
2481772|NCT02175121|8573919|P5|Overall Study|Lack of Efficacy|0
2481773|NCT02175121|8573920|P4|Overall Study|Lack of Efficacy|0
2481774|NCT02175121|8573921|P3|Overall Study|Lack of Efficacy|0
2481775|NCT02175121|8573922|P2|Overall Study|Lack of Efficacy|0
2481776|NCT02175121|8573923|P1|Overall Study|Lack of Efficacy|1
2481777|NCT02174861|8574050|P1|Overall Study|Lost to Follow-up|26
2481778|NCT02174861|8574050|P1|Overall Study|Withdrawal by Subject|124
2481779|NCT02174861|8574050|P1|Overall Study|Decision by sponsor|8
2481780|NCT02174848|8574064|P2|Overall Study|Unable to comply with study requirements|0
2481781|NCT02174848|8574065|P1|Overall Study|Unable to comply with study requirements|1
2481782|NCT02174848|8574064|P2|Overall Study|Worsening of disease|1
2481783|NCT02174848|8574065|P1|Overall Study|Worsening of disease|1
2481784|NCT02174848|8574064|P2|Overall Study|Lost to Follow-up|1
2481785|NCT02174848|8574065|P1|Overall Study|Lost to Follow-up|0
2481786|NCT02174848|8574064|P2|Overall Study|Withdrawal by Subject|3
2481788|NCT02174848|8574064|P2|Overall Study|Adverse Event|1
2481789|NCT02174848|8574065|P1|Overall Study|Adverse Event|2
2481790|NCT02174731|8574086|P2|Overall Study|Missing|0
2481791|NCT02174731|8574087|P1|Overall Study|Missing|2
2481792|NCT02174731|8574086|P2|Overall Study|Incorrect enrolment before randomization|1
2481793|NCT02174731|8574087|P1|Overall Study|Incorrect enrolment before randomization|0
2481794|NCT02174731|8574086|P2|Overall Study|Participant decision|64
2481795|NCT02174731|8574087|P1|Overall Study|Participant decision|67
2481796|NCT02174627|8574109|P2|Overall Study|Participant decision|128
2481797|NCT02174627|8574110|P1|Overall Study|Participant decision|84
2481798|NCT02174627|8574109|P2|Overall Study|Incorrect enrolment before randomization|1
2481799|NCT02174627|8574110|P1|Overall Study|Incorrect enrolment before randomization|0
2481800|NCT02174627|8574109|P2|Overall Study|Missing|1
2481801|NCT02174627|8574110|P1|Overall Study|Missing|0
2481802|NCT02174523|8574138|P2|Overall Study|Withdrawal by Subject|0
2481803|NCT02174523|8574139|P1|Overall Study|Withdrawal by Subject|1
2481804|NCT02174276|8574207|P4|OTEP (Weeks 48 to 144)|Withdrew Consent|2
2481805|NCT02174276|8574208|P3|OTEP (Weeks 48 to 144)|Withdrew Consent|1
2481806|NCT02174276|8574209|P2|OTEP (Weeks 48 to 144)|Withdrew Consent|0
2481807|NCT02174276|8574210|P1|OTEP (Weeks 48 to 144)|Withdrew Consent|1
2481808|NCT02174276|8574207|P4|OTEP (Weeks 48 to 144)|Pregnancy|0
2481809|NCT02174276|8574208|P3|OTEP (Weeks 48 to 144)|Pregnancy|1
2481810|NCT02174276|8574209|P2|OTEP (Weeks 48 to 144)|Pregnancy|0
2481811|NCT02174276|8574210|P1|OTEP (Weeks 48 to 144)|Pregnancy|0
2481812|NCT02174276|8574207|P4|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
2481813|NCT02174276|8574208|P3|OTEP (Weeks 48 to 144)|Lost to Follow-up|1
2481814|NCT02174276|8574209|P2|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
2481815|NCT02174276|8574210|P1|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
2481816|NCT02174276|8574207|P4|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0
2481817|NCT02174276|8574208|P3|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2
2481818|NCT02174276|8574209|P2|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1
2481819|NCT02174276|8574210|P1|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0
2481820|NCT02174276|8574207|P4|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
2481821|NCT02174276|8574208|P3|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1
2481822|NCT02174276|8574209|P2|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
2481823|NCT02174276|8574210|P1|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
2481824|NCT02174276|8574207|P4|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
2481825|NCT02174276|8574208|P3|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
2481826|NCT02174276|8574209|P2|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
2481827|NCT02174276|8574210|P1|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1
2481828|NCT02173769|8574317|P1|Overall Study|Protocol Violation|4
2481829|NCT02173704|8574330|P2|Overall Study|Withdrawal by Subject|4
2481830|NCT02173704|8574331|P1|Overall Study|Withdrawal by Subject|9
2481831|NCT02173704|8574330|P2|Overall Study|Protocol Violation|0
2481832|NCT02173704|8574331|P1|Overall Study|Protocol Violation|1
2481833|NCT02173704|8574330|P2|Overall Study|Other|0
2481834|NCT02173704|8574331|P1|Overall Study|Other|1
2481835|NCT02173704|8574330|P2|Overall Study|Lost to Follow-up|0
2481836|NCT02173704|8574331|P1|Overall Study|Lost to Follow-up|1
2481837|NCT02173704|8574330|P2|Overall Study|Adverse Event|0
2481838|NCT02173704|8574331|P1|Overall Study|Adverse Event|1
2481839|NCT02173548|8574357|P2|Overall Study|Withdrawal by Subject|0
2481840|NCT02173548|8574358|P1|Overall Study|Withdrawal by Subject|1
2481841|NCT02173548|8574357|P2|Overall Study|Lost to Follow-up|2
2481842|NCT02173548|8574358|P1|Overall Study|Lost to Follow-up|0
2481843|NCT02173379|8574490|P2|Overall Study|Withdrawn by the physician|1
2481844|NCT02173379|8574491|P1|Overall Study|Withdrawn by the physician|0
2481845|NCT02173379|8574490|P2|Overall Study|Death|1
2481846|NCT02173379|8574491|P1|Overall Study|Death|1
2481847|NCT02173379|8574490|P2|Overall Study|Physician Decision|1
2481848|NCT02173379|8574491|P1|Overall Study|Physician Decision|4
2481849|NCT02173379|8574490|P2|Overall Study|Withdrawal by Subject|4
2481850|NCT02173379|8574491|P1|Overall Study|Withdrawal by Subject|1
2481851|NCT02173379|8574490|P2|Overall Study|Lost to Follow-up|0
2481852|NCT02173379|8574491|P1|Overall Study|Lost to Follow-up|3
2481853|NCT02173158|8574557|P1|Efficacy Phase|Adverse Event|1
2481854|NCT02173054|8574574|P3|Overall Study|Withdrawal by Subject|1
2481855|NCT02173054|8574575|P2|Overall Study|Withdrawal by Subject|0
2481856|NCT02173054|8574576|P1|Overall Study|Withdrawal by Subject|0
2481857|NCT02173054|8574574|P3|Overall Study|lack of compliance|0
2481858|NCT02173054|8574575|P2|Overall Study|lack of compliance|0
2481859|NCT02173054|8574576|P1|Overall Study|lack of compliance|1
2481860|NCT02172664|8574632|P2|Overall Study|Moved out of area|1
2481861|NCT02172664|8574633|P1|Overall Study|Moved out of area|1
2481862|NCT02172664|8574632|P2|Overall Study|Death|1
2481863|NCT02172664|8574633|P1|Overall Study|Death|1
2481864|NCT02172664|8574632|P2|Overall Study|Lost to Follow-up|4
2481865|NCT02172664|8574633|P1|Overall Study|Lost to Follow-up|4
2481866|NCT02172625|8574642|P2|Overall Study|car accident|1
2481867|NCT02172625|8574643|P1|Overall Study|car accident|0
2481868|NCT02172625|8574642|P2|Overall Study|Pregnancy|1
2481869|NCT02172625|8574643|P1|Overall Study|Pregnancy|0
2481870|NCT02172625|8574642|P2|Overall Study|Adverse Event|1
2481871|NCT02172625|8574643|P1|Overall Study|Adverse Event|0
2481872|NCT02172040|8574665|P4|Overall Study|Family emergency abroad|1
2481873|NCT02172040|8574666|P3|Overall Study|Family emergency abroad|0
2481874|NCT02172040|8574667|P2|Overall Study|Family emergency abroad|0
2481875|NCT02172040|8574668|P1|Overall Study|Family emergency abroad|0
2481876|NCT02172040|8574665|P4|Overall Study|Not available for Day 13 & 14 visits|0
2481877|NCT02172040|8574666|P3|Overall Study|Not available for Day 13 & 14 visits|1
2481878|NCT02172040|8574667|P2|Overall Study|Not available for Day 13 & 14 visits|0
2481879|NCT02172040|8574668|P1|Overall Study|Not available for Day 13 & 14 visits|0
2481880|NCT02172040|8574665|P4|Overall Study|Withdrawal by Subject|0
2481881|NCT02172040|8574666|P3|Overall Study|Withdrawal by Subject|1
2481882|NCT02172040|8574667|P2|Overall Study|Withdrawal by Subject|0
2481883|NCT02172040|8574668|P1|Overall Study|Withdrawal by Subject|0
2481884|NCT02172040|8574665|P4|Overall Study|Protocol Violation|0
2481885|NCT02172040|8574666|P3|Overall Study|Protocol Violation|0
2481886|NCT02172040|8574667|P2|Overall Study|Protocol Violation|1
2481887|NCT02172040|8574668|P1|Overall Study|Protocol Violation|0
2481888|NCT02172040|8574665|P4|Overall Study|Adverse Event|0
2481889|NCT02172040|8574666|P3|Overall Study|Adverse Event|0
2481890|NCT02172040|8574667|P2|Overall Study|Adverse Event|2
2481891|NCT02172040|8574668|P1|Overall Study|Adverse Event|0
2481892|NCT02171260|8574831|P4|Overall Study|Evidence of progressive disease|4
2481893|NCT02171260|8574832|P3|Overall Study|Evidence of progressive disease|4
2481894|NCT02171260|8574833|P2|Overall Study|Evidence of progressive disease|6
2481895|NCT02171260|8574834|P1|Overall Study|Evidence of progressive disease|4
2481896|NCT02171260|8574831|P4|Overall Study|Withdrawal by Subject|0
2481897|NCT02171260|8574832|P3|Overall Study|Withdrawal by Subject|0
2481898|NCT02171260|8574833|P2|Overall Study|Withdrawal by Subject|0
2481899|NCT02171260|8574834|P1|Overall Study|Withdrawal by Subject|1
2481900|NCT02171260|8574831|P4|Overall Study|Physician Decision|0
2481901|NCT02171260|8574832|P3|Overall Study|Physician Decision|1
2481902|NCT02171260|8574833|P2|Overall Study|Physician Decision|0
2481903|NCT02171260|8574834|P1|Overall Study|Physician Decision|1
2481904|NCT02171260|8574831|P4|Overall Study|Death|1
2481905|NCT02171260|8574832|P3|Overall Study|Death|0
2481906|NCT02171260|8574833|P2|Overall Study|Death|0
2481907|NCT02171260|8574834|P1|Overall Study|Death|0
2481908|NCT02171130|8574970|P1|Overall Study|Met Exclusion Criteria|1
2481909|NCT02171130|8574970|P1|Overall Study|Lost to Follow-up|1
2481910|NCT02171130|8574970|P1|Overall Study|Physician Decision|1
2481911|NCT02171130|8574970|P1|Overall Study|Withdrawal by Subject|3
2481912|NCT02171130|8574970|P1|Overall Study|Discontinued; Site Termination|5
2481913|NCT02171130|8574970|P1|Overall Study|Discontinued; Clinical Material Issue|16
2481914|NCT02171130|8574970|P1|Overall Study|Death|1
2481915|NCT02170779|8575011|P2|Overall Study|Lost to Follow-up|1
2481916|NCT02170779|8575012|P1|Overall Study|Lost to Follow-up|0
2481917|NCT02170779|8575011|P2|Overall Study|Withdrawal by Subject|0
2481918|NCT02170779|8575012|P1|Overall Study|Withdrawal by Subject|1
2481919|NCT02170727|8575036|P2|Overall Study|Withdrawal by Subject|0
2481920|NCT02170727|8575037|P1|Overall Study|Withdrawal by Subject|2
2481921|NCT02170727|8575036|P2|Overall Study|Lost to Follow-up|0
2481922|NCT02170727|8575037|P1|Overall Study|Lost to Follow-up|1
2481923|NCT02170688|8575068|P5|Overall Study|Physician Decision|0
2481924|NCT02170688|8575069|P4|Overall Study|Physician Decision|0
2481925|NCT02170688|8575070|P3|Overall Study|Physician Decision|1
2481926|NCT02170688|8575071|P2|Overall Study|Physician Decision|0
2481927|NCT02170688|8575072|P1|Overall Study|Physician Decision|0
2481928|NCT02170688|8575068|P5|Overall Study|Full dose not received|0
2481929|NCT02170688|8575069|P4|Overall Study|Full dose not received|0
2481930|NCT02170688|8575070|P3|Overall Study|Full dose not received|0
2481931|NCT02170688|8575071|P2|Overall Study|Full dose not received|1
2481932|NCT02170688|8575072|P1|Overall Study|Full dose not received|0
2481933|NCT02170688|8575068|P5|Overall Study|Exclusion Criteria: Fatty Liver|0
2481934|NCT02170688|8575069|P4|Overall Study|Exclusion Criteria: Fatty Liver|2
2481935|NCT02170688|8575070|P3|Overall Study|Exclusion Criteria: Fatty Liver|3
2481936|NCT02170688|8575071|P2|Overall Study|Exclusion Criteria: Fatty Liver|2
2481937|NCT02170688|8575072|P1|Overall Study|Exclusion Criteria: Fatty Liver|4
2481938|NCT02170389|8575158|P1|Overall Study|Study terminated prior to start of treat|1
2481939|NCT02170298|8575223|P2|Overall Study|unblinded, rerandomized to intervention|0
2481940|NCT02170298|8575224|P1|Overall Study|unblinded, rerandomized to intervention|1
2481941|NCT02170298|8575223|P2|Overall Study|Withdrawal by Subject|1
2481942|NCT02170298|8575224|P1|Overall Study|Withdrawal by Subject|0
2481943|NCT02170207|8575261|P1|Overall Study|Case report forms unavailable|5
2481944|NCT02170077|8575272|P3|Overall Study|Exacerbation of seizures|1
2481945|NCT02170077|8575273|P2|Overall Study|Exacerbation of seizures|2
2481946|NCT02170077|8575274|P1|Overall Study|Exacerbation of seizures|0
2481947|NCT02170077|8575272|P3|Overall Study|Exclusion criteria|5
2481948|NCT02170077|8575273|P2|Overall Study|Exclusion criteria|2
2481949|NCT02170077|8575274|P1|Overall Study|Exclusion criteria|2
2481950|NCT02170077|8575272|P3|Overall Study|Lost to Follow-up|0
2481951|NCT02170077|8575273|P2|Overall Study|Lost to Follow-up|1
2481952|NCT02170077|8575274|P1|Overall Study|Lost to Follow-up|0
2481953|NCT02170077|8575272|P3|Overall Study|Adverse Event|4
2481954|NCT02170077|8575273|P2|Overall Study|Adverse Event|4
2481955|NCT02170077|8575274|P1|Overall Study|Adverse Event|4
2481956|NCT02170077|8575272|P3|Overall Study|Withdrawal by Subject|2
2481957|NCT02170077|8575273|P2|Overall Study|Withdrawal by Subject|4
2481958|NCT02170077|8575274|P1|Overall Study|Withdrawal by Subject|3
2481959|NCT02170064|8575285|P3|Overall Study|Physician Decision|0
2481960|NCT02170064|8575286|P2|Overall Study|Physician Decision|1
2481961|NCT02170064|8575287|P1|Overall Study|Physician Decision|1
2481962|NCT02170064|8575285|P3|Overall Study|Withdrawal by Subject|1
2481963|NCT02170064|8575286|P2|Overall Study|Withdrawal by Subject|1
2481964|NCT02170064|8575287|P1|Overall Study|Withdrawal by Subject|5
2481965|NCT02170025|8575303|P2|Overall Study|Adverse Event|0
2481966|NCT02170025|8575304|P1|Overall Study|Adverse Event|2
2481967|NCT02169674|8575348|P2|Overall Study|Lost to Follow-up|1
2481968|NCT02169674|8575349|P1|Overall Study|Lost to Follow-up|0
2481969|NCT02169674|8575348|P2|Overall Study|Seroprotected|76
2481970|NCT02169674|8575349|P1|Overall Study|Seroprotected|30
2481971|NCT02169674|8575348|P2|Overall Study|Withdrawal by Subject|1
2481972|NCT02169674|8575349|P1|Overall Study|Withdrawal by Subject|2
2481973|NCT02169505|8575363|P1|Overall Study|Withdrawal by Subject|1
2481974|NCT02169414|8575491|P4|Overall Study|Adverse Event|0
2481975|NCT02169414|8575492|P3|Overall Study|Adverse Event|0
2481976|NCT02169414|8575493|P2|Overall Study|Adverse Event|1
2481977|NCT02169414|8575494|P1|Overall Study|Adverse Event|0
2481978|NCT02169414|8575491|P4|Overall Study|Withdrawal by Subject|0
2481979|NCT02169414|8575492|P3|Overall Study|Withdrawal by Subject|0
2481980|NCT02169414|8575493|P2|Overall Study|Withdrawal by Subject|0
2481981|NCT02169414|8575494|P1|Overall Study|Withdrawal by Subject|1
2481982|NCT02169336|8575535|P3|Overall Study|Subject declined to continue dosing|1
2481983|NCT02169336|8575536|P2|Overall Study|Subject declined to continue dosing|0
2481984|NCT02169336|8575537|P1|Overall Study|Subject declined to continue dosing|0
2481985|NCT02169336|8575535|P3|Overall Study|Physician Decision|1
2481986|NCT02169336|8575536|P2|Overall Study|Physician Decision|0
2481987|NCT02169336|8575537|P1|Overall Study|Physician Decision|0
2481988|NCT02169336|8575535|P3|Overall Study|Withdrawal by Subject|0
2481989|NCT02169336|8575536|P2|Overall Study|Withdrawal by Subject|0
2481990|NCT02169336|8575537|P1|Overall Study|Withdrawal by Subject|1
2481991|NCT02169336|8575535|P3|Overall Study|Adverse Event|1
2481992|NCT02169336|8575536|P2|Overall Study|Adverse Event|3
2481993|NCT02169336|8575537|P1|Overall Study|Adverse Event|2
2481994|NCT02169336|8575535|P3|Overall Study|Lack of Efficacy|0
2481995|NCT02169336|8575536|P2|Overall Study|Lack of Efficacy|1
2481996|NCT02169336|8575537|P1|Overall Study|Lack of Efficacy|1
2481997|NCT02169219|8575545|P1|Overall Study|Lack of Efficacy|6
2481998|NCT02168946|8575571|P2|Overall Study|Subject unable to come back for visits|0
2481999|NCT02168946|8575572|P1|Overall Study|Subject unable to come back for visits|1
2482000|NCT02168946|8575571|P2|Overall Study|Lost to Follow-up|0
2482001|NCT02168946|8575572|P1|Overall Study|Lost to Follow-up|3
2482002|NCT02168946|8575571|P2|Overall Study|Adverse Event|5
2482003|NCT02168946|8575572|P1|Overall Study|Adverse Event|8
2482004|NCT02168842|8575618|P2|Overall Study|Physician Decision|2
2482005|NCT02168842|8575619|P1|Overall Study|Physician Decision|1
2482006|NCT02168842|8575618|P2|Overall Study|Death|1
2482007|NCT02168842|8575619|P1|Overall Study|Death|2
2482008|NCT02168842|8575618|P2|Overall Study|Lost to Follow-up|2
2482009|NCT02168842|8575619|P1|Overall Study|Lost to Follow-up|0
2482010|NCT02168842|8575618|P2|Overall Study|Withdrawal by Subject|3
2482011|NCT02168842|8575619|P1|Overall Study|Withdrawal by Subject|5
2482012|NCT02168816|8575677|P2|Overall Study|Lost to Follow-up|2
2482013|NCT02168816|8575678|P1|Overall Study|Lost to Follow-up|2
2482014|NCT02168803|8575689|P3|Overall Study|Sponsor Decision|1
2482015|NCT02168803|8575690|P2|Overall Study|Sponsor Decision|0
2482016|NCT02168803|8575691|P1|Overall Study|Sponsor Decision|0
2482017|NCT02168803|8575689|P3|Overall Study|Death|1
2482018|NCT02168803|8575690|P2|Overall Study|Death|0
2482019|NCT02168803|8575691|P1|Overall Study|Death|0
2482020|NCT02168803|8575689|P3|Overall Study|Adverse Event|1
2482021|NCT02168803|8575690|P2|Overall Study|Adverse Event|1
2482022|NCT02168803|8575691|P1|Overall Study|Adverse Event|0
2482023|NCT02168803|8575689|P3|Overall Study|Physician Decision|0
2482024|NCT02168803|8575690|P2|Overall Study|Physician Decision|1
2482025|NCT02168803|8575691|P1|Overall Study|Physician Decision|0
2482026|NCT02168803|8575689|P3|Overall Study|Withdrawal by Subject|2
2482027|NCT02168803|8575690|P2|Overall Study|Withdrawal by Subject|1
2482028|NCT02168803|8575691|P1|Overall Study|Withdrawal by Subject|1
2482029|NCT02168803|8575689|P3|Overall Study|Lost to Follow-up|1
2482030|NCT02168803|8575690|P2|Overall Study|Lost to Follow-up|0
2482031|NCT02168803|8575691|P1|Overall Study|Lost to Follow-up|1
2482032|NCT02168777|8575721|P3|Overall Study|Other reason|0
2482033|NCT02168777|8575722|P2|Overall Study|Other reason|1
2482034|NCT02168777|8575723|P1|Overall Study|Other reason|0
2482035|NCT02168777|8575721|P3|Overall Study|Clinical disease progression|2
2482036|NCT02168777|8575722|P2|Overall Study|Clinical disease progression|1
2482037|NCT02168777|8575723|P1|Overall Study|Clinical disease progression|0
2482038|NCT02168777|8575721|P3|Overall Study|Radiological disease progression|5
2482039|NCT02168777|8575722|P2|Overall Study|Radiological disease progression|5
2482040|NCT02168777|8575723|P1|Overall Study|Radiological disease progression|0
2482041|NCT02168777|8575721|P3|Overall Study|Disease recurrence|1
2482042|NCT02168777|8575722|P2|Overall Study|Disease recurrence|0
2482043|NCT02168777|8575723|P1|Overall Study|Disease recurrence|0
2482044|NCT02168777|8575721|P3|Overall Study|Adverse Event|1
2482045|NCT02168777|8575722|P2|Overall Study|Adverse Event|0
2482046|NCT02168777|8575723|P1|Overall Study|Adverse Event|1
2482047|NCT02168777|8575721|P3|Overall Study|Withdrawal by Subject|2
2482048|NCT02168777|8575722|P2|Overall Study|Withdrawal by Subject|0
2482049|NCT02168777|8575723|P1|Overall Study|Withdrawal by Subject|1
2482050|NCT02168491|8575819|P1|Overall Study|Withdrawal by Subject|1
2482051|NCT02168478|8575825|P1|Overall Study|Did Not Meet Exclusionary Criteria|1
2482052|NCT02168478|8575825|P1|Overall Study|Did Not Consent to Participation|2
2482053|NCT02168478|8575825|P1|Overall Study|Withdrawal by Subject|1
2482054|NCT02168439|8575831|P2|Overall Study|Protocol Violation|2
2482055|NCT02168439|8575832|P1|Overall Study|Protocol Violation|0
2482056|NCT02168387|8575850|P2|Overall Study|Death|0
2482057|NCT02168387|8575851|P1|Overall Study|Death|1
2482058|NCT02168387|8575850|P2|Overall Study|Planned exubation|3
2482059|NCT02168387|8575851|P1|Overall Study|Planned exubation|6
2482060|NCT02168270|8575883|P1|Overall Study|Lack of Efficacy|4
2482061|NCT02168101|8575910|P3|Overall Study|Death|1
2482062|NCT02168101|8575911|P2|Overall Study|Death|2
2482063|NCT02168101|8575912|P1|Overall Study|Death|2
2482064|NCT02167893|8575931|P1|Overall Study|Case report forms not collected|68
2482065|NCT02167893|8575931|P1|Overall Study|Investigator health reasons|10
2482066|NCT02167893|8575931|P1|Overall Study|Investigator transferred|85
2482067|NCT02167451|8575963|P1|Overall Study|Withdrawal by Subject|1
2482068|NCT02167256|8575980|P2|Overall Study|Study partner unable to participate|0
2482069|NCT02167256|8575981|P1|Overall Study|Study partner unable to participate|1
2482070|NCT02167256|8575980|P2|Overall Study|non-compliance|0
2482071|NCT02167256|8575981|P1|Overall Study|non-compliance|3
2482072|NCT02167256|8575980|P2|Overall Study|Withdrawal by Subject|4
2482073|NCT02167256|8575981|P1|Overall Study|Withdrawal by Subject|4
2482074|NCT02167256|8575980|P2|Overall Study|Adverse Event|6
2482075|NCT02167256|8575981|P1|Overall Study|Adverse Event|13
2482076|NCT02167139|8576014|P4|Transition-extension|Lost to Follow-up|0
2482077|NCT02167139|8576015|P3|Transition-extension|Lost to Follow-up|0
2482078|NCT02167139|8576016|P2|Transition-extension|Lost to Follow-up|0
2482079|NCT02167139|8576017|P1|Transition-extension|Lost to Follow-up|1
2482080|NCT02167139|8576014|P4|Transition-extension|Other|0
2482081|NCT02167139|8576015|P3|Transition-extension|Other|1
2482082|NCT02167139|8576016|P2|Transition-extension|Other|0
2482083|NCT02167139|8576017|P1|Transition-extension|Other|1
2482084|NCT02167139|8576014|P4|Transition-extension|Lack of Efficacy|1
2482085|NCT02167139|8576015|P3|Transition-extension|Lack of Efficacy|1
2482086|NCT02167139|8576016|P2|Transition-extension|Lack of Efficacy|0
2482087|NCT02167139|8576017|P1|Transition-extension|Lack of Efficacy|0
2482088|NCT02167139|8576014|P4|Transition-extension|Withdrawal by Subject|1
2482089|NCT02167139|8576015|P3|Transition-extension|Withdrawal by Subject|4
2482090|NCT02167139|8576016|P2|Transition-extension|Withdrawal by Subject|0
2482091|NCT02167139|8576017|P1|Transition-extension|Withdrawal by Subject|2
2482092|NCT02167139|8576014|P4|Transition-extension|Adverse Event|3
2482093|NCT02167139|8576015|P3|Transition-extension|Adverse Event|2
2482094|NCT02167139|8576016|P2|Transition-extension|Adverse Event|0
2482095|NCT02167139|8576017|P1|Transition-extension|Adverse Event|2
2482096|NCT02167139|8576014|P4|Randomised, Double-blind|Other|0
2482097|NCT02167139|8576015|P3|Randomised, Double-blind|Other|0
2482098|NCT02167139|8576016|P2|Randomised, Double-blind|Other|0
2482099|NCT02167139|8576017|P1|Randomised, Double-blind|Other|3
2482100|NCT02167139|8576014|P4|Randomised, Double-blind|Lack of Efficacy|0
2482101|NCT02167139|8576015|P3|Randomised, Double-blind|Lack of Efficacy|0
2482102|NCT02167139|8576016|P2|Randomised, Double-blind|Lack of Efficacy|2
2482103|NCT02167139|8576017|P1|Randomised, Double-blind|Lack of Efficacy|1
2482104|NCT02167139|8576014|P4|Randomised, Double-blind|Adverse Event|0
2482105|NCT02167139|8576015|P3|Randomised, Double-blind|Adverse Event|0
2482106|NCT02167139|8576016|P2|Randomised, Double-blind|Adverse Event|9
2482107|NCT02167139|8576017|P1|Randomised, Double-blind|Adverse Event|2
2482108|NCT02167139|8576014|P4|Randomised, Double-blind|Withdrawal by Subject|0
2482109|NCT02167139|8576015|P3|Randomised, Double-blind|Withdrawal by Subject|0
2482110|NCT02167139|8576016|P2|Randomised, Double-blind|Withdrawal by Subject|8
2482111|NCT02167139|8576017|P1|Randomised, Double-blind|Withdrawal by Subject|11
2482112|NCT02167035|8576052|P2|Overall Study|Randomized to incorrect Study Medication|1
2482113|NCT02167035|8576053|P1|Overall Study|Randomized to incorrect Study Medication|0
2482114|NCT02167035|8576052|P2|Overall Study|Lost to Follow-up|3
2482115|NCT02167035|8576053|P1|Overall Study|Lost to Follow-up|3
2482116|NCT02167035|8576052|P2|Overall Study|Adverse Event|2
2482117|NCT02167035|8576053|P1|Overall Study|Adverse Event|2
2482118|NCT02166697|8576061|P1|Overall Study|Protocol Violation|347
2482119|NCT02166606|8576070|P1|Overall Study|Enrolled after End of Enrollment|4
2482120|NCT02166606|8576070|P1|Overall Study|Device upgrade|1
2482121|NCT02166606|8576070|P1|Overall Study|Physician Decision|1
2482122|NCT02166606|8576070|P1|Overall Study|Withdrawal by Subject|1
2482123|NCT02166606|8576070|P1|Overall Study|Lost to Follow-up|30
2482124|NCT02166606|8576070|P1|Overall Study|Protocol Violation|7
2482125|NCT02166606|8576070|P1|Overall Study|Death|31
2482126|NCT02166606|8576070|P1|Overall Study|Adverse Event|3
2482127|NCT02166476|8576077|P2|Overall Study|Unable to Come for Visit|3
2482128|NCT02166476|8576078|P1|Overall Study|Unable to Come for Visit|0
2482129|NCT02166476|8576077|P2|Overall Study|Physician Decision|0
2482130|NCT02166476|8576078|P1|Overall Study|Physician Decision|1
2482131|NCT02166476|8576077|P2|Overall Study|Lost to Follow-up|10
2482132|NCT02166476|8576078|P1|Overall Study|Lost to Follow-up|5
2482133|NCT02166476|8576077|P2|Overall Study|Adverse Event|3
2482134|NCT02166476|8576078|P1|Overall Study|Adverse Event|3
2482135|NCT02166476|8576077|P2|Overall Study|Withdrawal by Subject|7
2482136|NCT02166476|8576078|P1|Overall Study|Withdrawal by Subject|5
2482137|NCT02165826|8576142|P3|Down-Titration Period|Reason Not Specified|2
2482138|NCT02165826|8576143|P2|Down-Titration Period|Reason Not Specified|0
2482139|NCT02165826|8576144|P1|Down-Titration Period|Reason Not Specified|1
2482140|NCT02165826|8576142|P3|Down-Titration Period|Voluntary Withdrawal|2
2482141|NCT02165826|8576143|P2|Down-Titration Period|Voluntary Withdrawal|1
2482142|NCT02165826|8576144|P1|Down-Titration Period|Voluntary Withdrawal|2
2482143|NCT02165826|8576142|P3|Down-Titration Period|Pre-treatment Event/Adverse Event|3
2482144|NCT02165826|8576143|P2|Down-Titration Period|Pre-treatment Event/Adverse Event|10
2482145|NCT02165826|8576144|P1|Down-Titration Period|Pre-treatment Event/Adverse Event|4
2482146|NCT02165826|8576142|P3|Main Treatment Period|Did Not Receive Study Drug|0
2482147|NCT02165826|8576143|P2|Main Treatment Period|Did Not Receive Study Drug|2
2482148|NCT02165826|8576144|P1|Main Treatment Period|Did Not Receive Study Drug|0
2482149|NCT02165826|8576142|P3|Main Treatment Period|Reason Not Specified|16
2482150|NCT02165826|8576143|P2|Main Treatment Period|Reason Not Specified|5
2482151|NCT02165826|8576144|P1|Main Treatment Period|Reason Not Specified|8
2482152|NCT02165826|8576142|P3|Main Treatment Period|Lack of Efficacy|0
2482153|NCT02165826|8576143|P2|Main Treatment Period|Lack of Efficacy|0
2482154|NCT02165826|8576144|P1|Main Treatment Period|Lack of Efficacy|2
2482155|NCT02165826|8576142|P3|Main Treatment Period|Voluntary Withdrawal|21
2482156|NCT02165826|8576143|P2|Main Treatment Period|Voluntary Withdrawal|23
2482157|NCT02165826|8576144|P1|Main Treatment Period|Voluntary Withdrawal|23
2482158|NCT02165826|8576142|P3|Main Treatment Period|Lost to Follow-up|1
2482159|NCT02165826|8576143|P2|Main Treatment Period|Lost to Follow-up|2
2482160|NCT02165826|8576144|P1|Main Treatment Period|Lost to Follow-up|4
2482161|NCT02165826|8576142|P3|Main Treatment Period|Major/Significant Protocol Deviation|3
2482162|NCT02165826|8576143|P2|Main Treatment Period|Major/Significant Protocol Deviation|1
2482163|NCT02165826|8576144|P1|Main Treatment Period|Major/Significant Protocol Deviation|0
2482164|NCT02165826|8576142|P3|Main Treatment Period|Pre-treatment Event/Adverse Event|68
2482165|NCT02165826|8576143|P2|Main Treatment Period|Pre-treatment Event/Adverse Event|57
2482166|NCT02165826|8576144|P1|Main Treatment Period|Pre-treatment Event/Adverse Event|44
2482167|NCT02165735|8576212|P2|Overall Study|Protocol Violation|1
2482168|NCT02165735|8576213|P1|Overall Study|Protocol Violation|0
2482169|NCT02165735|8576212|P2|Overall Study|Participant indicated lack of time|3
2482170|NCT02165735|8576213|P1|Overall Study|Participant indicated lack of time|1
2482171|NCT02165735|8576212|P2|Overall Study|Withdrawal by Subject|0
2482172|NCT02165735|8576213|P1|Overall Study|Withdrawal by Subject|3
2482173|NCT02165735|8576212|P2|Overall Study|Lost to Follow-up|10
2482174|NCT02165735|8576213|P1|Overall Study|Lost to Follow-up|12
2482175|NCT02165202|8576278|P2|Injection Phase|Participant unwilling to comply|0
2482176|NCT02165202|8576279|P1|Injection Phase|Participant unwilling to comply|1
2482177|NCT02165202|8576278|P2|Injection Phase|No longer interested|1
2482178|NCT02165202|8576279|P1|Injection Phase|No longer interested|0
2482179|NCT02165202|8576278|P2|Injection Phase|Study Product related Toxicity|0
2482180|NCT02165202|8576279|P1|Injection Phase|Study Product related Toxicity|1
2482181|NCT02165202|8576278|P2|Injection Phase|End of Study|1
2482182|NCT02165202|8576279|P1|Injection Phase|End of Study|2
2482183|NCT02165202|8576278|P2|Injection Phase|QTcF>500 ms or increase of>60 ms|1
2482184|NCT02165202|8576279|P1|Injection Phase|QTcF>500 ms or increase of>60 ms|0
2482185|NCT02165202|8576278|P2|Injection Phase|Unable to attend within Visit Window|0
2482186|NCT02165202|8576279|P1|Injection Phase|Unable to attend within Visit Window|1
2482187|NCT02165202|8576278|P2|Injection Phase|Reactive HIV or HIV Suspected|2
2482188|NCT02165202|8576279|P1|Injection Phase|Reactive HIV or HIV Suspected|0
2482189|NCT02165202|8576278|P2|Injection Phase|Abnormal Lab Value|1
2482190|NCT02165202|8576279|P1|Injection Phase|Abnormal Lab Value|5
2482191|NCT02165202|8576278|P2|Oral Phase|Abnormal EKG|1
2482192|NCT02165202|8576279|P1|Oral Phase|Abnormal EKG|0
2482193|NCT02165202|8576278|P2|Oral Phase|Relocated, no follow-up planned|0
2482194|NCT02165202|8576279|P1|Oral Phase|Relocated, no follow-up planned|1
2482195|NCT02165202|8576278|P2|Oral Phase|CMC advised termination|0
2482196|NCT02165202|8576279|P1|Oral Phase|CMC advised termination|1
2482197|NCT02165202|8576278|P2|Oral Phase|QTcF>500 ms or increase of>60 ms|0
2482198|NCT02165202|8576279|P1|Oral Phase|QTcF>500 ms or increase of>60 ms|1
2482199|NCT02165202|8576278|P2|Oral Phase|Clinical reasons|0
2482200|NCT02165202|8576279|P1|Oral Phase|Clinical reasons|1
2482201|NCT02165202|8576278|P2|Oral Phase|Unable to contact Participant|1
2482202|NCT02165202|8576279|P1|Oral Phase|Unable to contact Participant|1
2482203|NCT02165202|8576278|P2|Oral Phase|Study product Related Toxicity|0
2482204|NCT02165202|8576279|P1|Oral Phase|Study product Related Toxicity|1
2482205|NCT02165202|8576278|P2|Oral Phase|Refused further participation|1
2482206|NCT02165202|8576279|P1|Oral Phase|Refused further participation|5
2482207|NCT02164981|8576316|P3|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
2482208|NCT02164981|8576317|P2|Phase 2 (Day 14 - Day 28)|Protocol Violation|1
2482209|NCT02164981|8576318|P1|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
2482210|NCT02164981|8576316|P3|Phase 2 (Day 14 - Day 28)|Adverse Event|0
2482211|NCT02164981|8576317|P2|Phase 2 (Day 14 - Day 28)|Adverse Event|1
2482212|NCT02164981|8576318|P1|Phase 2 (Day 14 - Day 28)|Adverse Event|2
2482213|NCT02164981|8576316|P3|Phase 1 (Day 0 - Day 14)|Adverse Event|0
2482214|NCT02164981|8576317|P2|Phase 1 (Day 0 - Day 14)|Adverse Event|2
2482215|NCT02164981|8576318|P1|Phase 1 (Day 0 - Day 14)|Adverse Event|0
2482216|NCT02164981|8576316|P3|Started|Adverse Event|0
2482217|NCT02164981|8576317|P2|Started|Adverse Event|2
2482218|NCT02164981|8576318|P1|Started|Adverse Event|1
2482219|NCT02164981|8576316|P3|Started|Protocol Violation|0
2482220|NCT02164981|8576317|P2|Started|Protocol Violation|0
2482221|NCT02164981|8576318|P1|Started|Protocol Violation|2
2482222|NCT02164981|8576316|P3|Started|Withdrawal by Subject|0
2482223|NCT02164981|8576317|P2|Started|Withdrawal by Subject|1
2482224|NCT02164981|8576318|P1|Started|Withdrawal by Subject|2
2482225|NCT02164929|8576391|P4|Overall Study|Failed regional block|0
2482226|NCT02164929|8576392|P3|Overall Study|Failed regional block|1
2482227|NCT02164929|8576393|P2|Overall Study|Failed regional block|0
2482228|NCT02164929|8576394|P1|Overall Study|Failed regional block|0
2482229|NCT02164929|8576391|P4|Overall Study|Converted to open procedure|2
2482230|NCT02164929|8576392|P3|Overall Study|Converted to open procedure|0
2482231|NCT02164929|8576393|P2|Overall Study|Converted to open procedure|0
2482232|NCT02164929|8576394|P1|Overall Study|Converted to open procedure|1
2482233|NCT02164916|8576438|P2|Overall Study|Not eligible|5
2482234|NCT02164916|8576439|P1|Overall Study|Not eligible|2
2482235|NCT02164916|8576438|P2|Overall Study|Reason under review|6
2482236|NCT02164916|8576439|P1|Overall Study|Reason under review|1
2482237|NCT02164916|8576438|P2|Overall Study|Not protocol specified|1
2482238|NCT02164916|8576439|P1|Overall Study|Not protocol specified|5
2482239|NCT02164916|8576438|P2|Overall Study|Progression|26
2482240|NCT02164916|8576439|P1|Overall Study|Progression|37
2482241|NCT02164916|8576438|P2|Overall Study|Refusal unrelated to adverse event|7
2482242|NCT02164916|8576439|P1|Overall Study|Refusal unrelated to adverse event|3
2482243|NCT02164916|8576438|P2|Overall Study|Death|1
2482244|NCT02164916|8576439|P1|Overall Study|Death|1
2482245|NCT02164916|8576438|P2|Overall Study|Adverse Event|8
2482246|NCT02164916|8576439|P1|Overall Study|Adverse Event|3
2482247|NCT02164864|8576459|P3|Overall Study|Other than stated|14
2482248|NCT02164864|8576460|P2|Overall Study|Other than stated|4
2482249|NCT02164864|8576461|P1|Overall Study|Other than stated|3
2482250|NCT02164864|8576459|P3|Overall Study|Consent withdrawn, not due to AE|56
2482251|NCT02164864|8576460|P2|Overall Study|Consent withdrawn, not due to AE|8
2482252|NCT02164864|8576461|P1|Overall Study|Consent withdrawn, not due to AE|21
2482253|NCT02164864|8576459|P3|Overall Study|Lost to Follow-up|2
2482254|NCT02164864|8576460|P2|Overall Study|Lost to Follow-up|3
2482255|NCT02164864|8576461|P1|Overall Study|Lost to Follow-up|4
2482256|NCT02164864|8576459|P3|Overall Study|Protocol Violation|1
2482257|NCT02164864|8576460|P2|Overall Study|Protocol Violation|4
2482258|NCT02164864|8576461|P1|Overall Study|Protocol Violation|2
2482259|NCT02164864|8576459|P3|Overall Study|Other Adverse Event (AE)|49
2482260|NCT02164864|8576460|P2|Overall Study|Other Adverse Event (AE)|32
2482261|NCT02164864|8576461|P1|Overall Study|Other Adverse Event (AE)|52
2482262|NCT02164864|8576459|P3|Overall Study|Other pre-existing disease worsening|9
2482263|NCT02164864|8576460|P2|Overall Study|Other pre-existing disease worsening|4
2482264|NCT02164864|8576461|P1|Overall Study|Other pre-existing disease worsening|6
2482265|NCT02164864|8576459|P3|Overall Study|Trial disease worsening|1
2482266|NCT02164864|8576460|P2|Overall Study|Trial disease worsening|5
2482267|NCT02164864|8576461|P1|Overall Study|Trial disease worsening|7
2482268|NCT02164539|8576536|P7|Treatment Phase C (1 Week)|Physician Decision|1
2482269|NCT02164539|8576537|P6|Treatment Phase C (1 Week)|Physician Decision|0
2482270|NCT02164539|8576538|P5|Treatment Phase C (1 Week)|Physician Decision|0
2482271|NCT02164539|8576539|P4|Treatment Phase C (1 Week)|Physician Decision|0
2482272|NCT02164539|8576540|P3|Treatment Phase C (1 Week)|Physician Decision|0
2482273|NCT02164539|8576541|P2|Treatment Phase C (1 Week)|Physician Decision|0
2482274|NCT02164539|8576542|P1|Treatment Phase C (1 Week)|Physician Decision|0
2482275|NCT02164539|8576536|P7|Treatment Phase C (1 Week)|Adverse Event|1
2482276|NCT02164539|8576537|P6|Treatment Phase C (1 Week)|Adverse Event|0
2482277|NCT02164539|8576538|P5|Treatment Phase C (1 Week)|Adverse Event|0
2482278|NCT02164539|8576539|P4|Treatment Phase C (1 Week)|Adverse Event|0
2482279|NCT02164539|8576540|P3|Treatment Phase C (1 Week)|Adverse Event|0
2482280|NCT02164539|8576541|P2|Treatment Phase C (1 Week)|Adverse Event|0
2482281|NCT02164539|8576542|P1|Treatment Phase C (1 Week)|Adverse Event|0
2482282|NCT02164539|8576536|P7|Treatment Phase C (1 Week)|Withdrawal by Subject|0
2482283|NCT02164539|8576537|P6|Treatment Phase C (1 Week)|Withdrawal by Subject|0
2482284|NCT02164539|8576538|P5|Treatment Phase C (1 Week)|Withdrawal by Subject|0
2482285|NCT02164539|8576539|P4|Treatment Phase C (1 Week)|Withdrawal by Subject|0
2482286|NCT02164539|8576540|P3|Treatment Phase C (1 Week)|Withdrawal by Subject|0
2482287|NCT02164539|8576541|P2|Treatment Phase C (1 Week)|Withdrawal by Subject|0
2482288|NCT02164539|8576542|P1|Treatment Phase C (1 Week)|Withdrawal by Subject|1
2482289|NCT02164539|8576536|P7|Treatment Phase B (1 Week)|Physician Decision|1
2482290|NCT02164539|8576537|P6|Treatment Phase B (1 Week)|Physician Decision|0
2482291|NCT02164539|8576538|P5|Treatment Phase B (1 Week)|Physician Decision|1
2482292|NCT02164539|8576539|P4|Treatment Phase B (1 Week)|Physician Decision|0
2482293|NCT02164539|8576540|P3|Treatment Phase B (1 Week)|Physician Decision|0
2482294|NCT02164539|8576541|P2|Treatment Phase B (1 Week)|Physician Decision|0
2482295|NCT02164539|8576542|P1|Treatment Phase B (1 Week)|Physician Decision|0
2482296|NCT02164539|8576536|P7|Treatment Phase B (1 Week)|Adverse Event|0
2482297|NCT02164539|8576537|P6|Treatment Phase B (1 Week)|Adverse Event|0
2482298|NCT02164539|8576538|P5|Treatment Phase B (1 Week)|Adverse Event|2
2482299|NCT02164539|8576539|P4|Treatment Phase B (1 Week)|Adverse Event|0
2482300|NCT02164539|8576540|P3|Treatment Phase B (1 Week)|Adverse Event|0
2482301|NCT02164539|8576541|P2|Treatment Phase B (1 Week)|Adverse Event|0
2482302|NCT02164539|8576542|P1|Treatment Phase B (1 Week)|Adverse Event|0
2482303|NCT02164539|8576536|P7|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
2482304|NCT02164539|8576537|P6|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
2482305|NCT02164539|8576538|P5|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3
2482306|NCT02164539|8576539|P4|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
2482307|NCT02164539|8576540|P3|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
2482308|NCT02164539|8576541|P2|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
2482309|NCT02164539|8576542|P1|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
2482310|NCT02164513|8576590|P3|Overall Study|Other: Reason not provided by site|0
2482311|NCT02164513|8576591|P2|Overall Study|Other: Reason not provided by site|0
2482312|NCT02164513|8576592|P1|Overall Study|Other: Reason not provided by site|1
2482313|NCT02164513|8576590|P3|Overall Study|Withdrawal by Subject|130
2482314|NCT02164513|8576591|P2|Overall Study|Withdrawal by Subject|261
2482315|NCT02164513|8576592|P1|Overall Study|Withdrawal by Subject|192
2482316|NCT02164513|8576590|P3|Overall Study|Physician Decision|28
2482317|NCT02164513|8576591|P2|Overall Study|Physician Decision|57
2482318|NCT02164513|8576592|P1|Overall Study|Physician Decision|47
2482319|NCT02164513|8576590|P3|Overall Study|Lost to Follow-up|22
2482320|NCT02164513|8576591|P2|Overall Study|Lost to Follow-up|36
2482321|NCT02164513|8576592|P1|Overall Study|Lost to Follow-up|30
2482322|NCT02164513|8576590|P3|Overall Study|Other: Study Closed or terminated|4
2482323|NCT02164513|8576591|P2|Overall Study|Other: Study Closed or terminated|2
2482324|NCT02164513|8576592|P1|Overall Study|Other: Study Closed or terminated|5
2482325|NCT02164513|8576590|P3|Overall Study|Adverse Event|111
2482326|NCT02164513|8576591|P2|Overall Study|Adverse Event|180
2482327|NCT02164513|8576592|P1|Overall Study|Adverse Event|162
2482328|NCT02164383|8576629|P2|Overall Study|Lost to Follow-up|0
2482329|NCT02164383|8576630|P1|Overall Study|Lost to Follow-up|1
2482330|NCT02164318|8576640|P4|Overall Study|Withdrawal by Subject|1
2482331|NCT02164318|8576641|P3|Overall Study|Withdrawal by Subject|0
2482332|NCT02164318|8576642|P2|Overall Study|Withdrawal by Subject|1
2482333|NCT02164318|8576643|P1|Overall Study|Withdrawal by Subject|0
2482334|NCT02163993|8576678|P5|Post-treatment Period|Withdrawal by Subject|2
2482335|NCT02163993|8576679|P4|Post-treatment Period|Withdrawal by Subject|1
2482336|NCT02163993|8576680|P3|Post-treatment Period|Withdrawal by Subject|0
2482337|NCT02163993|8576681|P2|Post-treatment Period|Withdrawal by Subject|4
2482338|NCT02163993|8576682|P1|Post-treatment Period|Withdrawal by Subject|2
2482339|NCT02163993|8576678|P5|Post-treatment Period|Protocol Violation|1
2482340|NCT02163993|8576679|P4|Post-treatment Period|Protocol Violation|0
2482341|NCT02163993|8576680|P3|Post-treatment Period|Protocol Violation|0
2482342|NCT02163993|8576681|P2|Post-treatment Period|Protocol Violation|0
2482343|NCT02163993|8576682|P1|Post-treatment Period|Protocol Violation|0
2482344|NCT02163993|8576678|P5|Post-treatment Period|Lost to Follow-up|0
2482345|NCT02163993|8576679|P4|Post-treatment Period|Lost to Follow-up|1
2482346|NCT02163993|8576680|P3|Post-treatment Period|Lost to Follow-up|3
2482347|NCT02163993|8576681|P2|Post-treatment Period|Lost to Follow-up|2
2482348|NCT02163993|8576682|P1|Post-treatment Period|Lost to Follow-up|2
2482349|NCT02163993|8576678|P5|Post-treatment Period|Adverse Event|0
2482350|NCT02163993|8576679|P4|Post-treatment Period|Adverse Event|0
2482351|NCT02163993|8576680|P3|Post-treatment Period|Adverse Event|1
2482352|NCT02163993|8576681|P2|Post-treatment Period|Adverse Event|0
2482353|NCT02163993|8576682|P1|Post-treatment Period|Adverse Event|0
2482354|NCT02163993|8576678|P5|Treatment Period|Not treated|2
2482355|NCT02163993|8576679|P4|Treatment Period|Not treated|1
2482356|NCT02163993|8576680|P3|Treatment Period|Not treated|0
2482357|NCT02163993|8576681|P2|Treatment Period|Not treated|0
2482358|NCT02163993|8576682|P1|Treatment Period|Not treated|1
2482359|NCT02163993|8576678|P5|Treatment Period|Withdrawal by Subject|1
2482360|NCT02163993|8576679|P4|Treatment Period|Withdrawal by Subject|4
2482361|NCT02163993|8576680|P3|Treatment Period|Withdrawal by Subject|1
2482362|NCT02163993|8576681|P2|Treatment Period|Withdrawal by Subject|4
2482363|NCT02163993|8576682|P1|Treatment Period|Withdrawal by Subject|6
2482364|NCT02163993|8576678|P5|Treatment Period|Protocol Violation|2
2482365|NCT02163993|8576679|P4|Treatment Period|Protocol Violation|1
2482366|NCT02163993|8576680|P3|Treatment Period|Protocol Violation|0
2482367|NCT02163993|8576681|P2|Treatment Period|Protocol Violation|1
2482368|NCT02163993|8576682|P1|Treatment Period|Protocol Violation|2
2482369|NCT02163993|8576678|P5|Treatment Period|Physician Decision|0
2482370|NCT02163993|8576679|P4|Treatment Period|Physician Decision|0
2482371|NCT02163993|8576680|P3|Treatment Period|Physician Decision|0
2482372|NCT02163993|8576681|P2|Treatment Period|Physician Decision|0
2482373|NCT02163993|8576682|P1|Treatment Period|Physician Decision|1
2482374|NCT02163993|8576678|P5|Treatment Period|Lost to Follow-up|1
2482375|NCT02163993|8576679|P4|Treatment Period|Lost to Follow-up|3
2482376|NCT02163993|8576680|P3|Treatment Period|Lost to Follow-up|1
2482377|NCT02163993|8576681|P2|Treatment Period|Lost to Follow-up|3
2482378|NCT02163993|8576682|P1|Treatment Period|Lost to Follow-up|2
2482379|NCT02163993|8576678|P5|Treatment Period|Adverse Event|1
2482380|NCT02163993|8576679|P4|Treatment Period|Adverse Event|0
2482381|NCT02163993|8576680|P3|Treatment Period|Adverse Event|0
2482382|NCT02163993|8576681|P2|Treatment Period|Adverse Event|1
2482383|NCT02163993|8576682|P1|Treatment Period|Adverse Event|0
2482384|NCT02163915|8576785|P5|Overall Study|Physician Decision|0
2482385|NCT02163915|8576786|P4|Overall Study|Physician Decision|1
2482386|NCT02163915|8576787|P3|Overall Study|Physician Decision|0
2482387|NCT02163915|8576788|P2|Overall Study|Physician Decision|0
2482388|NCT02163915|8576789|P1|Overall Study|Physician Decision|0
2482389|NCT02163915|8576785|P5|Overall Study|Study termination|2
2482390|NCT02163915|8576786|P4|Overall Study|Study termination|0
2482391|NCT02163915|8576787|P3|Overall Study|Study termination|0
2482392|NCT02163915|8576788|P2|Overall Study|Study termination|0
2482393|NCT02163915|8576789|P1|Overall Study|Study termination|1
2482394|NCT02163915|8576785|P5|Overall Study|Withdrawal by Subject|2
2482395|NCT02163915|8576786|P4|Overall Study|Withdrawal by Subject|2
2482396|NCT02163915|8576787|P3|Overall Study|Withdrawal by Subject|2
2482397|NCT02163915|8576788|P2|Overall Study|Withdrawal by Subject|0
2482398|NCT02163915|8576789|P1|Overall Study|Withdrawal by Subject|2
2482399|NCT02163902|8576844|P2|Overall Study|Administrative Decision|2
2482400|NCT02163902|8576845|P1|Overall Study|Administrative Decision|2
2482401|NCT02163902|8576844|P2|Overall Study|Lost to Follow-up|7
2482402|NCT02163902|8576845|P1|Overall Study|Lost to Follow-up|6
2482403|NCT02163902|8576844|P2|Overall Study|Subject's Request|4
2482404|NCT02163902|8576845|P1|Overall Study|Subject's Request|3
2482405|NCT02163733|8576871|P3|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19
2482406|NCT02163733|8576872|P2|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
2482407|NCT02163733|8576873|P1|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
2482408|NCT02163733|8576871|P3|Part B: Day 15 to End Part B (AZD9291)|Death|5
2482409|NCT02163733|8576872|P2|Part B: Day 15 to End Part B (AZD9291)|Death|0
2482410|NCT02163733|8576873|P1|Part B: Day 15 to End Part B (AZD9291)|Death|0
2482411|NCT02163538|8576975|P2|Overall Study|Physician Decision|1
2482412|NCT02163538|8576976|P1|Overall Study|Physician Decision|0
2482413|NCT02163538|8576975|P2|Overall Study|Protocol Violation|0
2482414|NCT02163538|8576976|P1|Overall Study|Protocol Violation|1
2482415|NCT02163499|8576992|P1|Extended Dosing Phase: ZS|Various reasons|16
2482416|NCT02163499|8576992|P1|Extended Dosing Phase: ZS|Hyperkalemia|5
2482417|NCT02163499|8576992|P1|Extended Dosing Phase: ZS|Subject Compliance|17
2482418|NCT02163499|8576992|P1|Extended Dosing Phase: ZS|Death|8
2482419|NCT02163499|8576992|P1|Extended Dosing Phase: ZS|Protocol Violation|2
2482420|NCT02163499|8576992|P1|Extended Dosing Phase: ZS|Lost to Follow-up|31
2482421|NCT02163499|8576992|P1|Extended Dosing Phase: ZS|Physician Decision|8
2482422|NCT02163499|8576992|P1|Extended Dosing Phase: ZS|Withdrawal by Subject|81
2482423|NCT02163499|8576992|P1|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7
2482424|NCT02163499|8576992|P1|Extended Dosing Phase: ZS|Sponsor's Decision|5
2482425|NCT02163499|8576992|P1|Extended Dosing Phase: ZS|Hypokalemia|9
2482426|NCT02163499|8576992|P1|Extended Dosing Phase: ZS|Expected Progression of CKD|40
2482427|NCT02163499|8576992|P1|Extended Dosing Phase: ZS|Adverse Event|51
2482428|NCT02163499|8576992|P1|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1
2482429|NCT02163499|8576992|P1|Acute Phase: ZS 10 g TID|Physician Decision|1
2482430|NCT02163499|8576992|P1|Acute Phase: ZS 10 g TID|Protocol Violation|1
2482431|NCT02163499|8576992|P1|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1
2482432|NCT02163499|8576992|P1|Acute Phase: ZS 10 g TID|Participant's Compliance|1
2482433|NCT02163447|8577020|P3|Overall Study|Became HIV infected at time of delivery|0
2482434|NCT02163447|8577021|P2|Overall Study|Became HIV infected at time of delivery|0
2482435|NCT02163447|8577022|P1|Overall Study|Became HIV infected at time of delivery|1
2482436|NCT02163447|8577020|P3|Overall Study|Moved out of study area|2
2482437|NCT02163447|8577021|P2|Overall Study|Moved out of study area|3
2482438|NCT02163447|8577022|P1|Overall Study|Moved out of study area|2
2482439|NCT02163447|8577020|P3|Overall Study|Lost to Follow-up|0
2482440|NCT02163447|8577021|P2|Overall Study|Lost to Follow-up|3
2482441|NCT02163447|8577022|P1|Overall Study|Lost to Follow-up|1
2482442|NCT02163447|8577020|P3|Overall Study|Withdrawal by Subject|1
2482443|NCT02163447|8577021|P2|Overall Study|Withdrawal by Subject|0
2482444|NCT02163447|8577022|P1|Overall Study|Withdrawal by Subject|2
2482445|NCT02163395|8577062|P1|Overall Study|Adverse Event|1
2482446|NCT02163395|8577062|P1|Overall Study|Lost to Follow-up|3
2482447|NCT02163395|8577062|P1|Overall Study|Withdrawal by Subject|1
2482448|NCT02163187|8577071|P2|Overall Study|Progressive disease|0
2482449|NCT02163187|8577072|P1|Overall Study|Progressive disease|1
2482450|NCT02163187|8577071|P2|Overall Study|Device removed|0
2482451|NCT02163187|8577072|P1|Overall Study|Device removed|1
2482452|NCT02162862|8577107|P3|Overall Study|Subject did not feel the med was needed|4
2482453|NCT02162862|8577108|P2|Overall Study|Subject did not feel the med was needed|0
2482454|NCT02162862|8577109|P1|Overall Study|Subject did not feel the med was needed|0
2482455|NCT02162862|8577107|P3|Overall Study|Lost to Follow-up|0
2482456|NCT02162862|8577108|P2|Overall Study|Lost to Follow-up|11
2482457|NCT02162862|8577109|P1|Overall Study|Lost to Follow-up|0
2482458|NCT02162771|8577122|P2|Maintenance Study Period (Part 2)|Stable Disease|1
2482459|NCT02162771|8577123|P1|Maintenance Study Period (Part 2)|Stable Disease|0
2482460|NCT02162771|8577122|P2|Maintenance Study Period (Part 2)|Protocol Violation|1
2482461|NCT02162771|8577123|P1|Maintenance Study Period (Part 2)|Protocol Violation|0
2482462|NCT02162771|8577122|P2|Maintenance Study Period (Part 2)|Withdrawal by Subject|3
2482463|NCT02162771|8577123|P1|Maintenance Study Period (Part 2)|Withdrawal by Subject|0
2482464|NCT02162771|8577122|P2|Maintenance Study Period (Part 2)|Death|1
2482465|NCT02162771|8577123|P1|Maintenance Study Period (Part 2)|Death|2
2482466|NCT02162771|8577122|P2|Maintenance Study Period (Part 2)|Adverse Event|3
2482467|NCT02162771|8577123|P1|Maintenance Study Period (Part 2)|Adverse Event|3
2482468|NCT02162771|8577122|P2|Maintenance Study Period (Part 2)|Progressive Disease|13
2482469|NCT02162771|8577123|P1|Maintenance Study Period (Part 2)|Progressive Disease|11
2482470|NCT02162771|8577122|P2|Core Study Period (Part 2)|Death|0
2482471|NCT02162771|8577123|P1|Core Study Period (Part 2)|Death|1
2482472|NCT02162771|8577122|P2|Core Study Period (Part 2)|Physician Decision|2
2482473|NCT02162771|8577123|P1|Core Study Period (Part 2)|Physician Decision|0
2482474|NCT02162771|8577122|P2|Core Study Period (Part 2)|Withdrawal by Subject|2
2482475|NCT02162771|8577123|P1|Core Study Period (Part 2)|Withdrawal by Subject|1
2482476|NCT02162771|8577122|P2|Core Study Period (Part 2)|Adverse Event|1
2482477|NCT02162771|8577123|P1|Core Study Period (Part 2)|Adverse Event|4
2482478|NCT02162771|8577122|P2|Core Study Period (Part 2)|Progressive Disease|3
2482479|NCT02162771|8577123|P1|Core Study Period (Part 2)|Progressive Disease|2
2482480|NCT02162758|8577137|P2|Overall Study|Study termination|1
2482481|NCT02162758|8577138|P1|Overall Study|Study termination|0
2482482|NCT02161757|8577273|P3|Treatment Through Study Completion|Death|1
2482483|NCT02161757|8577274|P2|Treatment Through Study Completion|Death|1
2482484|NCT02161757|8577275|P1|Treatment Through Study Completion|Death|2
2482485|NCT02161757|8577273|P3|Treatment Through Study Completion|Other|12
2482486|NCT02161757|8577274|P2|Treatment Through Study Completion|Other|19
2482487|NCT02161757|8577275|P1|Treatment Through Study Completion|Other|20
2482488|NCT02161757|8577273|P3|Treatment Through Study Completion|Lost to Follow-up|4
2482489|NCT02161757|8577274|P2|Treatment Through Study Completion|Lost to Follow-up|2
2482490|NCT02161757|8577275|P1|Treatment Through Study Completion|Lost to Follow-up|7
2482491|NCT02161757|8577273|P3|Treatment Through Study Completion|Withdrawal by Subject|20
2482492|NCT02161757|8577274|P2|Treatment Through Study Completion|Withdrawal by Subject|19
2482493|NCT02161757|8577275|P1|Treatment Through Study Completion|Withdrawal by Subject|27
2482494|NCT02161757|8577273|P3|Treatment Through Study Completion|Protocol Violation|2
2482495|NCT02161757|8577274|P2|Treatment Through Study Completion|Protocol Violation|1
2482496|NCT02161757|8577275|P1|Treatment Through Study Completion|Protocol Violation|0
2482497|NCT02161757|8577273|P3|Treatment Through Study Completion|Adverse Event|0
2482498|NCT02161757|8577274|P2|Treatment Through Study Completion|Adverse Event|1
2482499|NCT02161757|8577275|P1|Treatment Through Study Completion|Adverse Event|1
2482500|NCT02161757|8577273|P3|Randomised Through Start Treatment|Did not receive treatment|0
2482501|NCT02161757|8577274|P2|Randomised Through Start Treatment|Did not receive treatment|2
2482502|NCT02161757|8577275|P1|Randomised Through Start Treatment|Did not receive treatment|3
2482503|NCT02161731|8577333|P2|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1
2482504|NCT02161731|8577334|P1|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0
2482505|NCT02161731|8577333|P2|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1
2482506|NCT02161731|8577334|P1|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0
2482507|NCT02161575|8577362|P1|Overall Study|Adverse Event|2
2482508|NCT02161575|8577362|P1|Overall Study|Lack of Efficacy|1
2482509|NCT02161575|8577362|P1|Overall Study|Protocol Violation|8
2482510|NCT02161562|8577382|P2|Overall Study|Participant moved out of province|0
2482511|NCT02161562|8577383|P1|Overall Study|Participant moved out of province|1
2482512|NCT02161562|8577382|P2|Overall Study|Withdrew due to being out of the country|0
2482513|NCT02161562|8577383|P1|Overall Study|Withdrew due to being out of the country|1
2482514|NCT02161562|8577382|P2|Overall Study|Participant moved back to home country|0
2482515|NCT02161562|8577383|P1|Overall Study|Participant moved back to home country|1
2482516|NCT02161562|8577382|P2|Overall Study|Adverse Event|1
2482517|NCT02161562|8577383|P1|Overall Study|Adverse Event|1
2482518|NCT02161562|8577382|P2|Overall Study|Lack of Efficacy|1
2482519|NCT02161562|8577383|P1|Overall Study|Lack of Efficacy|4
2482520|NCT02161562|8577382|P2|Overall Study|Lost to Follow-up|1
2482521|NCT02161562|8577383|P1|Overall Study|Lost to Follow-up|3
2482522|NCT02161562|8577382|P2|Overall Study|Pregnancy|2
2482523|NCT02161562|8577383|P1|Overall Study|Pregnancy|1
2482524|NCT02161562|8577382|P2|Overall Study|Protocol Violation|4
2482525|NCT02161562|8577383|P1|Overall Study|Protocol Violation|9
2482526|NCT02161562|8577382|P2|Overall Study|Withdrawal by Subject|8
2482527|NCT02161562|8577383|P1|Overall Study|Withdrawal by Subject|5
2482528|NCT02161549|8577411|P2|Overall Study|Physician Decision|2
2482529|NCT02161549|8577412|P1|Overall Study|Physician Decision|6
2482530|NCT02161458|8577460|P4|Overall Study|Lost to Follow-up|0
2482531|NCT02161458|8577461|P3|Overall Study|Lost to Follow-up|1
2482532|NCT02161458|8577462|P2|Overall Study|Lost to Follow-up|2
2482533|NCT02161458|8577463|P1|Overall Study|Lost to Follow-up|0
2482534|NCT02161458|8577460|P4|Overall Study|Withdrawal by Subject|0
2482535|NCT02161458|8577461|P3|Overall Study|Withdrawal by Subject|4
2482536|NCT02161458|8577462|P2|Overall Study|Withdrawal by Subject|4
2482537|NCT02161458|8577463|P1|Overall Study|Withdrawal by Subject|0
2482538|NCT02161406|8577475|P2|Overall Study|relocation|1
2482539|NCT02161406|8577476|P1|Overall Study|relocation|0
2482540|NCT02161406|8577475|P2|Overall Study|Lack of Efficacy|1
2482541|NCT02161406|8577476|P1|Overall Study|Lack of Efficacy|1
2482542|NCT02161406|8577475|P2|Overall Study|investigator withdrew subject|1
2482543|NCT02161406|8577476|P1|Overall Study|investigator withdrew subject|3
2482544|NCT02161406|8577475|P2|Overall Study|Withdrawal by Subject|4
2482545|NCT02161406|8577476|P1|Overall Study|Withdrawal by Subject|2
2482546|NCT02161406|8577475|P2|Overall Study|Lost to Follow-up|1
2482547|NCT02161406|8577476|P1|Overall Study|Lost to Follow-up|2
2482548|NCT02161406|8577475|P2|Overall Study|Death|1
2482549|NCT02161406|8577476|P1|Overall Study|Death|2
2482550|NCT02161185|8577550|P1|Treatment Phase|Administrative/Other|7
2482551|NCT02161146|8577560|P5|Overall Study|Other Miscellaneous Reasons|0
2482552|NCT02161146|8577561|P4|Overall Study|Other Miscellaneous Reasons|0
2482553|NCT02161146|8577562|P3|Overall Study|Other Miscellaneous Reasons|0
2482554|NCT02161146|8577563|P2|Overall Study|Other Miscellaneous Reasons|1
2482555|NCT02161146|8577564|P1|Overall Study|Other Miscellaneous Reasons|0
2482556|NCT02161146|8577560|P5|Overall Study|Personal Reasons|1
2482557|NCT02161146|8577561|P4|Overall Study|Personal Reasons|2
2482558|NCT02161146|8577562|P3|Overall Study|Personal Reasons|0
2482559|NCT02161146|8577563|P2|Overall Study|Personal Reasons|1
2482560|NCT02161146|8577564|P1|Overall Study|Personal Reasons|0
2482561|NCT02161146|8577560|P5|Overall Study|Lost to Follow-up|0
2482562|NCT02161146|8577561|P4|Overall Study|Lost to Follow-up|0
2482563|NCT02161146|8577562|P3|Overall Study|Lost to Follow-up|0
2482564|NCT02161146|8577563|P2|Overall Study|Lost to Follow-up|1
2482565|NCT02161146|8577564|P1|Overall Study|Lost to Follow-up|0
2482566|NCT02161146|8577560|P5|Overall Study|Adverse Event|0
2482567|NCT02161146|8577561|P4|Overall Study|Adverse Event|1
2482568|NCT02161146|8577562|P3|Overall Study|Adverse Event|0
2482569|NCT02161146|8577563|P2|Overall Study|Adverse Event|1
2482570|NCT02161146|8577564|P1|Overall Study|Adverse Event|1
2482571|NCT02161016|8577577|P1|Overall Study|withdrawn by IRB|1
2482572|NCT02160977|8577608|P2|Six Months After Surgery|Lost to Follow-up|1
2482573|NCT02160977|8577609|P1|Six Months After Surgery|Lost to Follow-up|2
2482574|NCT02160977|8577608|P2|Three Months After Surgery|Lost to Follow-up|2
2482575|NCT02160977|8577609|P1|Three Months After Surgery|Lost to Follow-up|0
2482576|NCT02160977|8577608|P2|Six Weeks After Surgery|Lost to Follow-up|0
2482577|NCT02160977|8577609|P1|Six Weeks After Surgery|Lost to Follow-up|1
2482578|NCT02160899|8577625|P6|Overall Study|Adverse Event or Serious Adverse Event|0
2482579|NCT02160899|8577626|P5|Overall Study|Adverse Event or Serious Adverse Event|2
2482580|NCT02160899|8577627|P4|Overall Study|Adverse Event or Serious Adverse Event|1
2482581|NCT02160899|8577628|P3|Overall Study|Adverse Event or Serious Adverse Event|0
2482582|NCT02160899|8577629|P2|Overall Study|Adverse Event or Serious Adverse Event|1
2482583|NCT02160899|8577630|P1|Overall Study|Adverse Event or Serious Adverse Event|0
2482584|NCT02160626|8577692|P3|Overall Study|Withdrawal by Subject|0
2482585|NCT02160626|8577693|P2|Overall Study|Withdrawal by Subject|1
2482586|NCT02160626|8577694|P1|Overall Study|Withdrawal by Subject|0
2482587|NCT02160626|8577692|P3|Overall Study|Schedule not conducive to study visits|1
2482588|NCT02160626|8577693|P2|Overall Study|Schedule not conducive to study visits|0
2482589|NCT02160626|8577694|P1|Overall Study|Schedule not conducive to study visits|0
2482590|NCT02160626|8577692|P3|Overall Study|Adverse Event|0
2482591|NCT02160626|8577693|P2|Overall Study|Adverse Event|0
2482592|NCT02160626|8577694|P1|Overall Study|Adverse Event|1
2482593|NCT02160314|8577717|P2|Overall Study|Lost to Follow-up|1
2482594|NCT02160314|8577718|P1|Overall Study|Lost to Follow-up|0
2482595|NCT02160314|8577717|P2|Overall Study|Withdrawal by Subject|2
2482596|NCT02160314|8577718|P1|Overall Study|Withdrawal by Subject|1
2482597|NCT02160314|8577717|P2|Overall Study|Protocol Violation|4
2482598|NCT02160314|8577718|P1|Overall Study|Protocol Violation|0
2482599|NCT02160314|8577717|P2|Overall Study|Adverse Event|6
2482600|NCT02160314|8577718|P1|Overall Study|Adverse Event|0
2482601|NCT02160145|8577726|P3|Randomized Double-blind Period|Physician Decision|5
2482602|NCT02160145|8577727|P2|Randomized Double-blind Period|Physician Decision|7
2482603|NCT02160145|8577728|P1|Randomized Double-blind Period|Physician Decision|0
2482604|NCT02160145|8577726|P3|Randomized Double-blind Period|Lost to Follow-up|3
2482605|NCT02160145|8577727|P2|Randomized Double-blind Period|Lost to Follow-up|1
2482606|NCT02160145|8577728|P1|Randomized Double-blind Period|Lost to Follow-up|0
2482607|NCT02160145|8577726|P3|Randomized Double-blind Period|Subject decision|20
2482608|NCT02160145|8577727|P2|Randomized Double-blind Period|Subject decision|21
2482609|NCT02160145|8577728|P1|Randomized Double-blind Period|Subject decision|0
2482610|NCT02160145|8577726|P3|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
2482611|NCT02160145|8577727|P2|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
2482612|NCT02160145|8577728|P1|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126
2482613|NCT02160145|8577726|P3|Prerandomization Single-blind Period|Placebo run-in failure|0
2482614|NCT02160145|8577727|P2|Prerandomization Single-blind Period|Placebo run-in failure|0
2482615|NCT02160145|8577728|P1|Prerandomization Single-blind Period|Placebo run-in failure|23
2482616|NCT02160041|8577741|P1|Overall Study|study terminated by by sponsor|1
2482617|NCT02160041|8577741|P1|Overall Study|Withdrawal by Subject|8
2482618|NCT02160041|8577741|P1|Overall Study|Physician Decision|3
2482619|NCT02160041|8577741|P1|Overall Study|non-compliance with study|1
2482620|NCT02160041|8577741|P1|Overall Study|Protocol Violation|1
2482621|NCT02160041|8577741|P1|Overall Study|disease progression|57
2482622|NCT02160041|8577741|P1|Overall Study|Death|2
2482623|NCT02160041|8577741|P1|Overall Study|Adverse Event|11
2482624|NCT02160002|8577753|P2|Overall Study|Withdrawal by Subject|1
2482625|NCT02160002|8577754|P1|Overall Study|Withdrawal by Subject|2
2482626|NCT02159950|8577801|P2|Overall Study|Progression|1
2482627|NCT02159950|8577802|P1|Overall Study|Progression|0
2482628|NCT02159950|8577801|P2|Overall Study|Adverse Event|1
2482629|NCT02159950|8577802|P1|Overall Study|Adverse Event|0
2482630|NCT02159807|8577861|P3|Overall Study|elevated blood pressure|1
2482631|NCT02159807|8577862|P2|Overall Study|elevated blood pressure|0
2482632|NCT02159807|8577863|P1|Overall Study|elevated blood pressure|0
2482633|NCT02159807|8577861|P3|Overall Study|No CSF|1
2482634|NCT02159807|8577862|P2|Overall Study|No CSF|1
2482635|NCT02159807|8577863|P1|Overall Study|No CSF|1
2482636|NCT02159807|8577861|P3|Overall Study|Adverse Event|1
2482637|NCT02159807|8577862|P2|Overall Study|Adverse Event|0
2482638|NCT02159807|8577863|P1|Overall Study|Adverse Event|0
2482639|NCT02159729|8577884|P2|Overall Study|Other Unspecified|1
2482640|NCT02159729|8577885|P1|Overall Study|Other Unspecified|3
2482641|NCT02159729|8577884|P2|Overall Study|Non compliance|0
2482642|NCT02159729|8577885|P1|Overall Study|Non compliance|2
2482643|NCT02159729|8577884|P2|Overall Study|Lost to Follow-up|9
2482644|NCT02159729|8577885|P1|Overall Study|Lost to Follow-up|24
2482645|NCT02159729|8577884|P2|Overall Study|Subject's Request|10
2482646|NCT02159729|8577885|P1|Overall Study|Subject's Request|13
2482647|NCT02159729|8577884|P2|Overall Study|Adverse Event|1
2482648|NCT02159729|8577885|P1|Overall Study|Adverse Event|0
2482649|NCT02159521|8577912|P1|Overall Study|Other than specified|1
2482650|NCT02159521|8577912|P1|Overall Study|Death|1
2482651|NCT02159521|8577912|P1|Overall Study|Lost to Follow-up|6
2482652|NCT02159521|8577912|P1|Overall Study|Withdrawal by Subject|7
2482653|NCT02159521|8577912|P1|Overall Study|Enrolled but not treated|3
2482654|NCT02159482|8577933|P1|Overall Study|Physician Decision|3
2482655|NCT02159482|8577933|P1|Overall Study|Withdrawal by Subject|2
2482656|NCT02159469|8577938|P1|Overall Study|Multiple|29
2482657|NCT02159469|8577938|P1|Overall Study|Other|1
2482658|NCT02159469|8577938|P1|Overall Study|Met Stopping Criteria|3
2482659|NCT02159469|8577938|P1|Overall Study|Sponsor's request|2
2482660|NCT02159469|8577938|P1|Overall Study|Lost to Follow-up|1
2482661|NCT02159469|8577938|P1|Overall Study|Withdrawal by Subject|9
2482662|NCT02159469|8577938|P1|Overall Study|Non-compliance|2
2482663|NCT02159469|8577938|P1|Overall Study|Adverse Event|5
2482664|NCT02159469|8577938|P1|Overall Study|Missing Completion status|1
2482665|NCT02159365|8577943|P1|Overall Study|Lost to Follow-up|1
2482666|NCT02159365|8577943|P1|Overall Study|Death|1
2482667|NCT02159365|8577943|P1|Overall Study|Subject withdrew consent|3
2482668|NCT02159365|8577943|P1|Overall Study|Subject request to discontinue treatment|3
2482669|NCT02159365|8577943|P1|Overall Study|Maximum clinical benefit|3
2482670|NCT02159365|8577943|P1|Overall Study|Study drug toxicity|7
2482671|NCT02159365|8577943|P1|Overall Study|Adverse Event unrelated to study drug|9
2482672|NCT02159365|8577943|P1|Overall Study|Administrative reason by Sponsor|9
2482673|NCT02159365|8577943|P1|Overall Study|Other reasons|11
2482674|NCT02159365|8577943|P1|Overall Study|Disease Progression|23
2482675|NCT02159352|8577950|P2|Overall Study|Withdrawal by Subject|1
2482676|NCT02159352|8577951|P1|Overall Study|Withdrawal by Subject|0
2482677|NCT02159352|8577950|P2|Overall Study|Adverse Event|1
2482678|NCT02159352|8577951|P1|Overall Study|Adverse Event|3
2482679|NCT02159183|8578003|P2|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1
2482680|NCT02159183|8578004|P1|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2
2482681|NCT02159183|8578003|P2|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0
2482682|NCT02159183|8578004|P1|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1
2482683|NCT02159183|8578003|P2|Analysis After the 36 Months Follow-up|Death|1
2482684|NCT02159183|8578004|P1|Analysis After the 36 Months Follow-up|Death|0
2482685|NCT02159183|8578003|P2|Analysis After the 36 Months Follow-up|Adverse Event|0
2482686|NCT02159183|8578004|P1|Analysis After the 36 Months Follow-up|Adverse Event|1
2482687|NCT02159183|8578003|P2|Analysis After the 36 Months Follow-up|Protocol Violation|1
2482688|NCT02159183|8578004|P1|Analysis After the 36 Months Follow-up|Protocol Violation|2
2482689|NCT02159053|8578077|P3|Overall Study|Participants/guardian decision|6
2482690|NCT02159053|8578078|P2|Overall Study|Participants/guardian decision|10
2482691|NCT02159053|8578079|P1|Overall Study|Participants/guardian decision|8
2482692|NCT02159053|8578077|P3|Overall Study|Adverse Event|5
2482693|NCT02159053|8578078|P2|Overall Study|Adverse Event|6
2482694|NCT02159053|8578079|P1|Overall Study|Adverse Event|7
2482695|NCT02159053|8578077|P3|Overall Study|Lack of Efficacy|7
2482696|NCT02159053|8578078|P2|Overall Study|Lack of Efficacy|4
2482697|NCT02159053|8578079|P1|Overall Study|Lack of Efficacy|3
2482698|NCT02159053|8578077|P3|Overall Study|Physician Decision|1
2482699|NCT02159053|8578078|P2|Overall Study|Physician Decision|1
2482700|NCT02159053|8578079|P1|Overall Study|Physician Decision|0
2482701|NCT02159053|8578077|P3|Overall Study|Death|1
2482702|NCT02159053|8578078|P2|Overall Study|Death|0
2482703|NCT02159053|8578079|P1|Overall Study|Death|2
2482704|NCT02159040|8578116|P1|Overall Study|Death|1
2482705|NCT02158975|8578129|P1|Overall Study|Did not complete 1 cycle nor > 1dose|1
2482706|NCT02158936|8578139|P2|Overall Study|Lost to Follow-up|1
2482707|NCT02158936|8578140|P1|Overall Study|Lost to Follow-up|0
2482708|NCT02158936|8578139|P2|Overall Study|Physician Decision|13
2482709|NCT02158936|8578140|P1|Overall Study|Physician Decision|15
2482710|NCT02158936|8578139|P2|Overall Study|Withdrawal by Subject|16
2482711|NCT02158936|8578140|P1|Overall Study|Withdrawal by Subject|15
2482712|NCT02158936|8578139|P2|Overall Study|Adverse Event|24
2482713|NCT02158936|8578140|P1|Overall Study|Adverse Event|39
2482714|NCT02158936|8578139|P2|Overall Study|Azacitidine tx discontinued|46
2482715|NCT02158936|8578140|P1|Overall Study|Azacitidine tx discontinued|53
2482716|NCT02158936|8578139|P2|Overall Study|Study closed/ terminated|77
2482717|NCT02158936|8578140|P1|Overall Study|Study closed/ terminated|57
2482718|NCT02158884|8578182|P1|12 Month Assessment|Missed SMFA|17
2482719|NCT02158884|8578182|P1|6 Month Assessment|Missed SMFA|20
2482720|NCT02158884|8578182|P1|Post Intervention (~4 Weeks)|Did not complete performance assessment|10
2482721|NCT02158884|8578182|P1|Intervention: IDEO and PT Program|Did not complete PT intervention|6
2482722|NCT02158884|8578182|P1|Baseline Assessment|Missed SMFA|1
2482723|NCT02158884|8578182|P1|Baseline Assessment|Missed performance assessment|3
2482724|NCT02158806|8578217|P2|Overall Study|Transferred to palliative care|1
2482725|NCT02158806|8578218|P1|Overall Study|Transferred to palliative care|0
2482726|NCT02158806|8578217|P2|Overall Study|Moved out of area|1
2482727|NCT02158806|8578218|P1|Overall Study|Moved out of area|0
2482728|NCT02158806|8578217|P2|Overall Study|Lost to Follow-up|3
2482729|NCT02158806|8578218|P1|Overall Study|Lost to Follow-up|0
2482730|NCT02158806|8578217|P2|Overall Study|Withdrawal by Subject|0
2482731|NCT02158806|8578218|P1|Overall Study|Withdrawal by Subject|2
2482732|NCT02158806|8578217|P2|Overall Study|Death|0
2482733|NCT02158806|8578218|P1|Overall Study|Death|2
2482734|NCT02158728|8578238|P1|Overall Study|no qualified dataset|24
2482735|NCT02158728|8578238|P1|Overall Study|no procedure according to CIP done|3
2482736|NCT02158663|8578244|P2|Overall Study|Withdrawal by Subject|4
2482737|NCT02158663|8578245|P1|Overall Study|Withdrawal by Subject|5
2482738|NCT02158546|8578268|P4|Overall Study|Site Excluded|4
2482739|NCT02158546|8578269|P3|Overall Study|Site Excluded|3
2482740|NCT02158546|8578270|P2|Overall Study|Site Excluded|5
2482741|NCT02158546|8578271|P1|Overall Study|Site Excluded|5
2482742|NCT02158546|8578268|P4|Overall Study|Lost to Follow-up|1
2482743|NCT02158546|8578269|P3|Overall Study|Lost to Follow-up|0
2482744|NCT02158546|8578270|P2|Overall Study|Lost to Follow-up|4
2482745|NCT02158546|8578271|P1|Overall Study|Lost to Follow-up|5
2482746|NCT02158546|8578268|P4|Overall Study|Withdrawal by Subject|0
2482747|NCT02158546|8578269|P3|Overall Study|Withdrawal by Subject|1
2482748|NCT02158546|8578270|P2|Overall Study|Withdrawal by Subject|2
2482749|NCT02158546|8578271|P1|Overall Study|Withdrawal by Subject|6
2482750|NCT02158546|8578268|P4|Overall Study|Adverse Event|0
2482751|NCT02158546|8578269|P3|Overall Study|Adverse Event|0
2482752|NCT02158546|8578270|P2|Overall Study|Adverse Event|2
2482753|NCT02158546|8578271|P1|Overall Study|Adverse Event|2
2482754|NCT02158546|8578268|P4|Overall Study|Lack of Efficacy|0
2482755|NCT02158546|8578269|P3|Overall Study|Lack of Efficacy|0
2482756|NCT02158546|8578270|P2|Overall Study|Lack of Efficacy|1
2482757|NCT02158546|8578271|P1|Overall Study|Lack of Efficacy|1
2482758|NCT02158546|8578268|P4|Overall Study|Failure to meet eligibility criteria|0
2482759|NCT02158546|8578269|P3|Overall Study|Failure to meet eligibility criteria|0
2482760|NCT02158546|8578270|P2|Overall Study|Failure to meet eligibility criteria|1
2482761|NCT02158546|8578271|P1|Overall Study|Failure to meet eligibility criteria|0
2482762|NCT02158546|8578268|P4|Overall Study|Non-compliance|1
2482763|NCT02158546|8578269|P3|Overall Study|Non-compliance|0
2482764|NCT02158546|8578270|P2|Overall Study|Non-compliance|1
2482765|NCT02158546|8578271|P1|Overall Study|Non-compliance|0
2482766|NCT02158546|8578268|P4|Overall Study|Physician Decision|0
2482767|NCT02158546|8578269|P3|Overall Study|Physician Decision|0
2482768|NCT02158546|8578270|P2|Overall Study|Physician Decision|1
2482769|NCT02158546|8578271|P1|Overall Study|Physician Decision|0
2482770|NCT02158533|8578290|P6|Stage 2|Non-adherence with study visits|1
2482771|NCT02158533|8578291|P5|Stage 2|Non-adherence with study visits|0
2482772|NCT02158533|8578292|P4|Stage 2|Non-adherence with study visits|0
2482773|NCT02158533|8578293|P3|Stage 2|Non-adherence with study visits|0
2482774|NCT02158533|8578294|P2|Stage 2|Non-adherence with study visits|0
2482775|NCT02158533|8578295|P1|Stage 2|Non-adherence with study visits|0
2482776|NCT02158533|8578290|P6|Stage 2|Psychiatrist decision to try new tx|0
2482777|NCT02158533|8578291|P5|Stage 2|Psychiatrist decision to try new tx|0
2482778|NCT02158533|8578292|P4|Stage 2|Psychiatrist decision to try new tx|1
2482779|NCT02158533|8578293|P3|Stage 2|Psychiatrist decision to try new tx|0
2482780|NCT02158533|8578294|P2|Stage 2|Psychiatrist decision to try new tx|0
2482781|NCT02158533|8578295|P1|Stage 2|Psychiatrist decision to try new tx|0
2482782|NCT02158533|8578290|P6|Stage 2|Pregnancy|0
2482783|NCT02158533|8578291|P5|Stage 2|Pregnancy|0
2482784|NCT02158533|8578292|P4|Stage 2|Pregnancy|1
2482785|NCT02158533|8578293|P3|Stage 2|Pregnancy|0
2482786|NCT02158533|8578294|P2|Stage 2|Pregnancy|0
2482787|NCT02158533|8578295|P1|Stage 2|Pregnancy|0
2482788|NCT02158533|8578290|P6|Stage 2|Physician Decision|0
2482789|NCT02158533|8578291|P5|Stage 2|Physician Decision|1
2482790|NCT02158533|8578292|P4|Stage 2|Physician Decision|0
2482791|NCT02158533|8578293|P3|Stage 2|Physician Decision|0
2482792|NCT02158533|8578294|P2|Stage 2|Physician Decision|0
2482793|NCT02158533|8578295|P1|Stage 2|Physician Decision|0
2482794|NCT02158533|8578290|P6|Stage 2|Withdrawal by Subject|2
2482795|NCT02158533|8578291|P5|Stage 2|Withdrawal by Subject|1
2482796|NCT02158533|8578292|P4|Stage 2|Withdrawal by Subject|0
2482797|NCT02158533|8578293|P3|Stage 2|Withdrawal by Subject|0
2482798|NCT02158533|8578294|P2|Stage 2|Withdrawal by Subject|0
2482799|NCT02158533|8578295|P1|Stage 2|Withdrawal by Subject|0
2482800|NCT02158533|8578290|P6|Stage 2|Lost to Follow-up|2
2482801|NCT02158533|8578291|P5|Stage 2|Lost to Follow-up|1
2482802|NCT02158533|8578292|P4|Stage 2|Lost to Follow-up|1
2482803|NCT02158533|8578293|P3|Stage 2|Lost to Follow-up|0
2482804|NCT02158533|8578294|P2|Stage 2|Lost to Follow-up|0
2482805|NCT02158533|8578295|P1|Stage 2|Lost to Follow-up|0
2482806|NCT02158533|8578290|P6|Stage 2|Lack of Efficacy|0
2482807|NCT02158533|8578291|P5|Stage 2|Lack of Efficacy|1
2482808|NCT02158533|8578292|P4|Stage 2|Lack of Efficacy|0
2482809|NCT02158533|8578293|P3|Stage 2|Lack of Efficacy|0
2482810|NCT02158533|8578294|P2|Stage 2|Lack of Efficacy|0
2482811|NCT02158533|8578295|P1|Stage 2|Lack of Efficacy|0
2482812|NCT02158533|8578290|P6|Stage 2|Adverse Event|1
2482813|NCT02158533|8578291|P5|Stage 2|Adverse Event|0
2482814|NCT02158533|8578292|P4|Stage 2|Adverse Event|0
2482815|NCT02158533|8578293|P3|Stage 2|Adverse Event|0
2482816|NCT02158533|8578294|P2|Stage 2|Adverse Event|0
2482817|NCT02158533|8578295|P1|Stage 2|Adverse Event|0
2482818|NCT02158533|8578290|P6|Stage 1|Non-compliance with study visits|0
2482819|NCT02158533|8578291|P5|Stage 1|Non-compliance with study visits|0
2482820|NCT02158533|8578292|P4|Stage 1|Non-compliance with study visits|0
2482821|NCT02158533|8578293|P3|Stage 1|Non-compliance with study visits|0
2482822|NCT02158533|8578294|P2|Stage 1|Non-compliance with study visits|0
2482823|NCT02158533|8578295|P1|Stage 1|Non-compliance with study visits|1
2482824|NCT02158533|8578290|P6|Stage 1|Failure to Meet Eligibility Criteria|0
2482825|NCT02158533|8578291|P5|Stage 1|Failure to Meet Eligibility Criteria|0
2482826|NCT02158533|8578292|P4|Stage 1|Failure to Meet Eligibility Criteria|0
2482827|NCT02158533|8578293|P3|Stage 1|Failure to Meet Eligibility Criteria|0
2482828|NCT02158533|8578294|P2|Stage 1|Failure to Meet Eligibility Criteria|1
2482829|NCT02158533|8578295|P1|Stage 1|Failure to Meet Eligibility Criteria|0
2482830|NCT02158533|8578290|P6|Stage 1|Lost to Follow-up|0
2482831|NCT02158533|8578291|P5|Stage 1|Lost to Follow-up|0
2482832|NCT02158533|8578292|P4|Stage 1|Lost to Follow-up|0
2482833|NCT02158533|8578293|P3|Stage 1|Lost to Follow-up|0
2482834|NCT02158533|8578294|P2|Stage 1|Lost to Follow-up|1
2482835|NCT02158533|8578295|P1|Stage 1|Lost to Follow-up|3
2482836|NCT02158533|8578290|P6|Stage 1|Lack of Efficacy|0
2482837|NCT02158533|8578291|P5|Stage 1|Lack of Efficacy|0
2482838|NCT02158533|8578292|P4|Stage 1|Lack of Efficacy|0
2482839|NCT02158533|8578293|P3|Stage 1|Lack of Efficacy|0
2482840|NCT02158533|8578294|P2|Stage 1|Lack of Efficacy|0
2482841|NCT02158533|8578295|P1|Stage 1|Lack of Efficacy|1
2482842|NCT02158533|8578290|P6|Stage 1|Withdrawal by Subject|0
2482843|NCT02158533|8578291|P5|Stage 1|Withdrawal by Subject|0
2482844|NCT02158533|8578292|P4|Stage 1|Withdrawal by Subject|0
2482845|NCT02158533|8578293|P3|Stage 1|Withdrawal by Subject|1
2482846|NCT02158533|8578294|P2|Stage 1|Withdrawal by Subject|2
2482847|NCT02158533|8578295|P1|Stage 1|Withdrawal by Subject|3
2482848|NCT02158533|8578290|P6|Stage 1|Adverse Event|0
2482849|NCT02158533|8578291|P5|Stage 1|Adverse Event|0
2482850|NCT02158533|8578292|P4|Stage 1|Adverse Event|0
2482851|NCT02158533|8578293|P3|Stage 1|Adverse Event|7
2482852|NCT02158533|8578294|P2|Stage 1|Adverse Event|4
2482853|NCT02158533|8578295|P1|Stage 1|Adverse Event|6
2482854|NCT02158442|8578371|P2|Overall Study|Perfusion staff not available|0
2482855|NCT02158442|8578372|P1|Overall Study|Perfusion staff not available|1
2482856|NCT02158442|8578371|P2|Overall Study|Withdrawal by Subject|0
2482857|NCT02158442|8578372|P1|Overall Study|Withdrawal by Subject|1
2482858|NCT02158364|8578378|P1|Overall Study|Protocol Deviation|50
2482859|NCT02158364|8578378|P1|Overall Study|Case report forms uncollected|10
2482860|NCT02158247|8578396|P1|Overall Study|Invisible vocal cords|5
2482861|NCT02158091|8578415|P3|Overall Study|DLT|0
2482862|NCT02158091|8578416|P2|Overall Study|DLT|1
2482863|NCT02158091|8578417|P1|Overall Study|DLT|2
2482864|NCT02158039|8578425|P1|Overall Study|Screen Failure|9
2482865|NCT02158039|8578425|P1|Overall Study|Withdrawal by Subject|1
2482866|NCT02157948|8578432|P2|Overall Study|Decision by Sponsor|1
2482867|NCT02157948|8578433|P1|Overall Study|Decision by Sponsor|0
2482868|NCT02157948|8578432|P2|Overall Study|Protocol Specified Criteria|1
2482869|NCT02157948|8578433|P1|Overall Study|Protocol Specified Criteria|2
2482870|NCT02157948|8578432|P2|Overall Study|Lost to Follow-up|2
2482871|NCT02157948|8578433|P1|Overall Study|Lost to Follow-up|3
2482872|NCT02157948|8578432|P2|Overall Study|Withdrawal by Subject|5
2482873|NCT02157948|8578433|P1|Overall Study|Withdrawal by Subject|4
2482874|NCT02157935|8578445|P2|Overall Study|Adverse Event|5
2482875|NCT02157935|8578446|P1|Overall Study|Adverse Event|3
2482876|NCT02157935|8578445|P2|Overall Study|Death|4
2482877|NCT02157935|8578446|P1|Overall Study|Death|4
2482878|NCT02157935|8578445|P2|Overall Study|Lack of Efficacy|1
2482879|NCT02157935|8578446|P1|Overall Study|Lack of Efficacy|0
2482880|NCT02157935|8578445|P2|Overall Study|Other|12
2482881|NCT02157935|8578446|P1|Overall Study|Other|5
2482882|NCT02157935|8578445|P2|Overall Study|Progressive disease|2
2482883|NCT02157935|8578446|P1|Overall Study|Progressive disease|0
2482884|NCT02157935|8578445|P2|Overall Study|Protocol Violation|0
2482885|NCT02157935|8578446|P1|Overall Study|Protocol Violation|1
2482886|NCT02157935|8578445|P2|Overall Study|Screen failure|2
2482887|NCT02157935|8578446|P1|Overall Study|Screen failure|1
2482888|NCT02157935|8578445|P2|Overall Study|Withdrawal by Subject|39
2482889|NCT02157935|8578446|P1|Overall Study|Withdrawal by Subject|25
2482890|NCT02157883|8578472|P1|Part B: Day 19 to End Part B (AZD9291)|Death|3
2482891|NCT02157883|8578472|P1|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1
2482892|NCT02157883|8578472|P1|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15
2482893|NCT02157883|8578472|P1|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3
2482894|NCT02157883|8578472|P1|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1
2482895|NCT02157779|8578503|P2|Overall Study|Need for alternative treatment|0
2482896|NCT02157779|8578504|P1|Overall Study|Need for alternative treatment|1
2482897|NCT02157779|8578503|P2|Overall Study|Medical Issue|0
2482898|NCT02157779|8578504|P1|Overall Study|Medical Issue|1
2482899|NCT02157779|8578503|P2|Overall Study|Moved|0
2482900|NCT02157779|8578504|P1|Overall Study|Moved|1
2482901|NCT02157779|8578503|P2|Overall Study|No response to outreach after Baseline|1
2482902|NCT02157779|8578504|P1|Overall Study|No response to outreach after Baseline|1
2482903|NCT02157779|8578503|P2|Overall Study|Withdrawal by Subject|1
2482904|NCT02157779|8578504|P1|Overall Study|Withdrawal by Subject|4
2482905|NCT02157779|8578503|P2|Overall Study|Failure to comply - Missed Sessions|5
2482906|NCT02157779|8578504|P1|Overall Study|Failure to comply - Missed Sessions|8
2482907|NCT02157779|8578503|P2|Overall Study|Logistical|4
2482908|NCT02157779|8578504|P1|Overall Study|Logistical|8
2482909|NCT02157623|8578528|P2|Overall Study|Physician Decision|3
2482910|NCT02157623|8578529|P1|Overall Study|Physician Decision|4
2482911|NCT02157519|8578537|P2|Overall Study|Lost to Follow-up|0
2482912|NCT02157519|8578538|P1|Overall Study|Lost to Follow-up|1
2482913|NCT02157519|8578537|P2|Overall Study|Withdrawal by Subject|0
2482914|NCT02157519|8578538|P1|Overall Study|Withdrawal by Subject|7
2482915|NCT02157519|8578537|P2|Overall Study|Death|1
2482916|NCT02157519|8578538|P1|Overall Study|Death|3
2482917|NCT02157506|8578561|P5|Overall Study|Lost to Follow-up|0
2482918|NCT02157506|8578562|P4|Overall Study|Lost to Follow-up|0
2482919|NCT02157506|8578563|P3|Overall Study|Lost to Follow-up|1
2482920|NCT02157506|8578564|P2|Overall Study|Lost to Follow-up|0
2482921|NCT02157506|8578565|P1|Overall Study|Lost to Follow-up|0
2482922|NCT02157506|8578561|P5|Overall Study|Adverse Event|0
2482923|NCT02157506|8578562|P4|Overall Study|Adverse Event|0
2482924|NCT02157506|8578563|P3|Overall Study|Adverse Event|0
2482925|NCT02157506|8578564|P2|Overall Study|Adverse Event|1
2482926|NCT02157506|8578565|P1|Overall Study|Adverse Event|0
2482927|NCT02157376|8578624|P2|Overall Study|Investigator's misjudgement|2
2482928|NCT02157376|8578625|P1|Overall Study|Investigator's misjudgement|1
2482929|NCT02157376|8578624|P2|Overall Study|Not treated|3
2482930|NCT02157376|8578625|P1|Overall Study|Not treated|8
2482931|NCT02157376|8578624|P2|Overall Study|Withdrawal by Subject|8
2482932|NCT02157376|8578625|P1|Overall Study|Withdrawal by Subject|3
2482933|NCT02157376|8578624|P2|Overall Study|Eligibility criteria not fulfilled|1
2482934|NCT02157376|8578625|P1|Overall Study|Eligibility criteria not fulfilled|0
2482935|NCT02157376|8578624|P2|Overall Study|Death|4
2482936|NCT02157376|8578625|P1|Overall Study|Death|10
2482937|NCT02157298|8578635|P2|Overall Study|Withdrawal by Subject|0
2482938|NCT02157298|8578636|P1|Overall Study|Withdrawal by Subject|1
2482939|NCT02157298|8578635|P2|Overall Study|Poor/Non-compliance|0
2482940|NCT02157298|8578636|P1|Overall Study|Poor/Non-compliance|1
2482941|NCT02157298|8578635|P2|Overall Study|Subject no longer meets study criteria|2
2482942|NCT02157298|8578636|P1|Overall Study|Subject no longer meets study criteria|1
2482943|NCT02157298|8578635|P2|Overall Study|Adverse Event|0
2482944|NCT02157298|8578636|P1|Overall Study|Adverse Event|1
2482945|NCT02157116|8578675|P1|Overall Study|Failed Screening|2
2482946|NCT02157116|8578675|P1|Overall Study|Physician Decision|3
2482947|NCT02157116|8578675|P1|Overall Study|Withdrawal by Subject|4
2482948|NCT02156804|8578690|P1|Overall Study|Withdrawal by Subject|1
2482949|NCT02156492|8578701|P3|Period 3|Adverse Event|0
2482950|NCT02156492|8578702|P2|Period 3|Adverse Event|1
2482951|NCT02156492|8578703|P1|Period 3|Adverse Event|0
2482952|NCT02156492|8578701|P3|Period 1|No Reason Given|0
2482953|NCT02156492|8578702|P2|Period 1|No Reason Given|1
2482954|NCT02156492|8578703|P1|Period 1|No Reason Given|0
2482955|NCT02156466|8578729|P5|Overall Study|Quantiferon Positivity|0
2482956|NCT02156466|8578730|P4|Overall Study|Quantiferon Positivity|1
2482957|NCT02156466|8578731|P3|Overall Study|Quantiferon Positivity|0
2482958|NCT02156466|8578732|P2|Overall Study|Quantiferon Positivity|0
2482959|NCT02156466|8578733|P1|Overall Study|Quantiferon Positivity|0
2482960|NCT02156466|8578729|P5|Overall Study|Adverse Event|0
2482961|NCT02156466|8578730|P4|Overall Study|Adverse Event|1
2482962|NCT02156466|8578731|P3|Overall Study|Adverse Event|1
2482963|NCT02156466|8578732|P2|Overall Study|Adverse Event|0
2482964|NCT02156466|8578733|P1|Overall Study|Adverse Event|0
2482965|NCT02156271|8578914|P2|Overall Study|Physician Decision|3
2482966|NCT02156271|8578915|P1|Overall Study|Physician Decision|4
2482967|NCT02156076|8578955|P4|Follow-up Period|Withdrawal by Subject|0
2482968|NCT02156076|8578956|P3|Follow-up Period|Withdrawal by Subject|0
2482969|NCT02156076|8578957|P2|Follow-up Period|Withdrawal by Subject|0
2482970|NCT02156076|8578958|P1|Follow-up Period|Withdrawal by Subject|1
2482971|NCT02156076|8578955|P4|Treatment Period|Adverse Event|1
2482972|NCT02156076|8578956|P3|Treatment Period|Adverse Event|0
2482973|NCT02156076|8578957|P2|Treatment Period|Adverse Event|0
2482974|NCT02156076|8578958|P1|Treatment Period|Adverse Event|0
2482975|NCT02156076|8578955|P4|Treatment Period|Subject request to discontinue treatment|0
2482976|NCT02156076|8578956|P3|Treatment Period|Subject request to discontinue treatment|0
2482977|NCT02156076|8578957|P2|Treatment Period|Subject request to discontinue treatment|1
2482978|NCT02156076|8578958|P1|Treatment Period|Subject request to discontinue treatment|0
2482979|NCT02156076|8578955|P4|Treatment Period|Withdrawal by Subject|0
2482980|NCT02156076|8578956|P3|Treatment Period|Withdrawal by Subject|1
2482981|NCT02156076|8578957|P2|Treatment Period|Withdrawal by Subject|0
2482982|NCT02156076|8578958|P1|Treatment Period|Withdrawal by Subject|0
2482983|NCT02156076|8578955|P4|Treatment Period|Lost to Follow-up|1
2482984|NCT02156076|8578956|P3|Treatment Period|Lost to Follow-up|0
2482985|NCT02156076|8578957|P2|Treatment Period|Lost to Follow-up|0
2482986|NCT02156076|8578958|P1|Treatment Period|Lost to Follow-up|0
2482987|NCT02156076|8578955|P4|Treatment Period|Poor/non-compliance|0
2482988|NCT02156076|8578956|P3|Treatment Period|Poor/non-compliance|0
2482989|NCT02156076|8578957|P2|Treatment Period|Poor/non-compliance|1
2482990|NCT02156076|8578958|P1|Treatment Period|Poor/non-compliance|0
2482991|NCT02156076|8578955|P4|Treatment Period|no longer meets study criteria|0
2482992|NCT02156076|8578956|P3|Treatment Period|no longer meets study criteria|1
2482993|NCT02156076|8578957|P2|Treatment Period|no longer meets study criteria|0
2482994|NCT02156076|8578958|P1|Treatment Period|no longer meets study criteria|0
2482995|NCT02155985|8579015|P3|Overall Study|Lost to Follow-up|0
2482996|NCT02155985|8579016|P2|Overall Study|Lost to Follow-up|0
2482997|NCT02155985|8579017|P1|Overall Study|Lost to Follow-up|1
2482998|NCT02155985|8579015|P3|Overall Study|Withdrawal by Subject|1
2482999|NCT02155985|8579016|P2|Overall Study|Withdrawal by Subject|0
2483000|NCT02155985|8579017|P1|Overall Study|Withdrawal by Subject|0
2483001|NCT02155881|8579084|P2|Overall Study|Inappropriately randomized|2
2483002|NCT02155881|8579085|P1|Overall Study|Inappropriately randomized|2
2483003|NCT02155881|8579084|P2|Overall Study|Withdrawal by Subject|2
2483004|NCT02155881|8579085|P1|Overall Study|Withdrawal by Subject|0
2483005|NCT02155738|8579109|P4|Overall Study|Missing critical information|1
2483006|NCT02155738|8579110|P3|Overall Study|Missing critical information|0
2483007|NCT02155738|8579111|P2|Overall Study|Missing critical information|0
2483008|NCT02155738|8579112|P1|Overall Study|Missing critical information|1
2483009|NCT02155712|8579132|P2|Primary Objective|Withdrawal by Subject|0
2483010|NCT02155712|8579133|P1|Primary Objective|Withdrawal by Subject|21
2483011|NCT02155712|8579132|P2|Primary Objective|Revision/Removal of Tibial Baseplate|0
2483012|NCT02155712|8579133|P1|Primary Objective|Revision/Removal of Tibial Baseplate|1
2483013|NCT02155712|8579132|P2|Primary Objective|No 2-Year Forms but not Terminated|0
2483014|NCT02155712|8579133|P1|Primary Objective|No 2-Year Forms but not Terminated|13
2483015|NCT02155712|8579132|P2|Primary Objective|Lost to Follow-up|0
2483016|NCT02155712|8579133|P1|Primary Objective|Lost to Follow-up|22
2483017|NCT02155712|8579132|P2|Primary Objective|Death|0
2483018|NCT02155712|8579133|P1|Primary Objective|Death|3
2483019|NCT02155660|8579143|P4|Overall Study|Withdrawal by Subject|21
2483020|NCT02155660|8579144|P3|Overall Study|Withdrawal by Subject|24
2483021|NCT02155660|8579145|P2|Overall Study|Withdrawal by Subject|31
2483022|NCT02155660|8579146|P1|Overall Study|Withdrawal by Subject|28
2483023|NCT02155660|8579143|P4|Overall Study|Death|19
2483024|NCT02155660|8579144|P3|Overall Study|Death|17
2483025|NCT02155660|8579145|P2|Overall Study|Death|19
2483026|NCT02155660|8579146|P1|Overall Study|Death|17
2483027|NCT02155660|8579143|P4|Overall Study|Lost to Follow-up|8
2483028|NCT02155660|8579144|P3|Overall Study|Lost to Follow-up|5
2483029|NCT02155660|8579145|P2|Overall Study|Lost to Follow-up|6
2483030|NCT02155660|8579146|P1|Overall Study|Lost to Follow-up|3
2483031|NCT02155660|8579143|P4|Overall Study|Adverse Event|1
2483032|NCT02155660|8579144|P3|Overall Study|Adverse Event|3
2483033|NCT02155660|8579145|P2|Overall Study|Adverse Event|6
2483034|NCT02155660|8579146|P1|Overall Study|Adverse Event|2
2483035|NCT02155660|8579143|P4|Overall Study|Severe non-compliance|1
2483036|NCT02155660|8579144|P3|Overall Study|Severe non-compliance|0
2483037|NCT02155660|8579145|P2|Overall Study|Severe non-compliance|4
2483038|NCT02155660|8579146|P1|Overall Study|Severe non-compliance|0
2483039|NCT02155660|8579143|P4|Overall Study|Study-specific withdrawal criteria|1
2483040|NCT02155660|8579144|P3|Overall Study|Study-specific withdrawal criteria|1
2483041|NCT02155660|8579145|P2|Overall Study|Study-specific withdrawal criteria|1
2483042|NCT02155660|8579146|P1|Overall Study|Study-specific withdrawal criteria|0
2483043|NCT02155660|8579143|P4|Overall Study|Other Reason|10
2483044|NCT02155660|8579144|P3|Overall Study|Other Reason|10
2483045|NCT02155660|8579145|P2|Overall Study|Other Reason|6
2483046|NCT02155660|8579146|P1|Overall Study|Other Reason|8
2483047|NCT02155608|8579229|P2|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1
2483048|NCT02155608|8579230|P1|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1
2483049|NCT02155608|8579229|P2|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1
2483050|NCT02155608|8579230|P1|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0
2483051|NCT02155322|8579327|P1|Overall Study|Withdrawal by Subject|4
2483052|NCT02155322|8579327|P1|Overall Study|Relapse/Recurrence|8
2483053|NCT02155322|8579327|P1|Overall Study|Physician Decision|1
2483054|NCT02155322|8579327|P1|Overall Study|Adverse Event|1
2483055|NCT02155309|8579334|P3|Overall Study|Protocol Violation|1
2483056|NCT02155309|8579335|P2|Overall Study|Protocol Violation|0
2483057|NCT02155309|8579336|P1|Overall Study|Protocol Violation|0
2483058|NCT02155283|8579343|P1|Overall Study|Protocol Violation|3
2483059|NCT02155283|8579343|P1|Overall Study|Withdrawal by Subject|1
2483060|NCT02155283|8579343|P1|Overall Study|Lost to Follow-up|3
2483061|NCT02154581|8579519|P2|Overall Study|Lost to Follow-up|8
2483062|NCT02154581|8579520|P1|Overall Study|Lost to Follow-up|7
2483063|NCT02154425|8579545|P1|Screening Period|Adverse Event|1
2483064|NCT02154347|8579590|P2|Open-label Period|Withdrawal by Subject|1
2483065|NCT02154347|8579591|P1|Open-label Period|Withdrawal by Subject|0
2483066|NCT02154347|8579590|P2|Open-label Period|Protocol Violation|1
2483067|NCT02154347|8579591|P1|Open-label Period|Protocol Violation|0
2483068|NCT02154347|8579590|P2|Open-label Period|Lack of Efficacy|19
2483069|NCT02154347|8579591|P1|Open-label Period|Lack of Efficacy|4
2483070|NCT02154347|8579590|P2|Open-label Period|Adverse Event|4
2483071|NCT02154347|8579591|P1|Open-label Period|Adverse Event|3
2483072|NCT02154347|8579590|P2|Double-blind Period|Withdrawal by Subject|1
2483073|NCT02154347|8579591|P1|Double-blind Period|Withdrawal by Subject|1
2483074|NCT02154347|8579590|P2|Double-blind Period|Physician Decision|1
2483075|NCT02154347|8579591|P1|Double-blind Period|Physician Decision|0
2483076|NCT02154347|8579590|P2|Double-blind Period|Lack of Efficacy|0
2483077|NCT02154347|8579591|P1|Double-blind Period|Lack of Efficacy|1
2483078|NCT02154347|8579590|P2|Double-blind Period|Adverse Event|2
2483079|NCT02154347|8579591|P1|Double-blind Period|Adverse Event|1
2483080|NCT02154139|8579614|P1|Overall Study|Investigator transferred|3
2483081|NCT02154139|8579614|P1|Overall Study|Other|2
2483082|NCT02154139|8579614|P1|Overall Study|Injection not administered|2
2483083|NCT02154087|8579622|P1|Overall Study|Study Termination|1
2483084|NCT02154061|8579628|P2|Overall Study|enrolled but not vaccinated|0
2483085|NCT02154061|8579629|P1|Overall Study|enrolled but not vaccinated|1
2483086|NCT02154061|8579628|P2|Overall Study|Pregnancy|0
2483087|NCT02154061|8579629|P1|Overall Study|Pregnancy|1
2483088|NCT02153918|8579676|P1|Overall Study|Refused further treatment|1
2483089|NCT02153905|8579687|P2|Overall Study|Death|0
2483090|NCT02153905|8579688|P1|Overall Study|Death|1
2483091|NCT02153827|8579706|P2|Overall Study|Lost to Follow-up|9
2483092|NCT02153827|8579707|P1|Overall Study|Lost to Follow-up|3
2483093|NCT02153788|8579723|P2|Overall Study|Physician Decision|1
2483094|NCT02153788|8579724|P1|Overall Study|Physician Decision|2
2483095|NCT02153736|8579744|P2|Overall Study|Withdrawal by Subject|1
2483096|NCT02153736|8579745|P1|Overall Study|Withdrawal by Subject|0
2483097|NCT02153736|8579744|P2|Overall Study|Death|1
2483098|NCT02153736|8579745|P1|Overall Study|Death|0
2483099|NCT02153736|8579744|P2|Overall Study|Medical status change made ineligible|0
2483100|NCT02153736|8579745|P1|Overall Study|Medical status change made ineligible|1
2483101|NCT02153736|8579744|P2|Overall Study|Lost to Follow-up|0
2483102|NCT02153736|8579745|P1|Overall Study|Lost to Follow-up|1
2483103|NCT02153398|8579972|P5|Overall Study|Adverse Event|0
2483104|NCT02153398|8579973|P4|Overall Study|Adverse Event|1
2483105|NCT02153398|8579974|P3|Overall Study|Adverse Event|1
2483106|NCT02153398|8579975|P2|Overall Study|Adverse Event|0
2483107|NCT02153398|8579976|P1|Overall Study|Adverse Event|0
2483108|NCT02153398|8579972|P5|Overall Study|Withdrawal by Subject|0
2483109|NCT02153398|8579973|P4|Overall Study|Withdrawal by Subject|0
2483110|NCT02153398|8579974|P3|Overall Study|Withdrawal by Subject|0
2483111|NCT02153398|8579975|P2|Overall Study|Withdrawal by Subject|0
2483112|NCT02153398|8579976|P1|Overall Study|Withdrawal by Subject|1
2483113|NCT02153359|8580098|P2|Intervention 2 (1 Month)|Lost to Follow-up|2
2483114|NCT02153359|8580099|P1|Intervention 2 (1 Month)|Lost to Follow-up|0
2483115|NCT02153346|8580133|P1|Overall Study|Lost to Follow-up|11
2483116|NCT02153112|8580150|P10|Overall Study|Reason not Specified|1
2483117|NCT02153112|8580151|P9|Overall Study|Reason not Specified|1
2483118|NCT02153112|8580152|P8|Overall Study|Reason not Specified|0
2483119|NCT02153112|8580153|P7|Overall Study|Reason not Specified|0
2483120|NCT02153112|8580154|P6|Overall Study|Reason not Specified|0
2483121|NCT02153112|8580155|P5|Overall Study|Reason not Specified|0
2483122|NCT02153112|8580156|P4|Overall Study|Reason not Specified|0
2483123|NCT02153112|8580157|P3|Overall Study|Reason not Specified|0
2483124|NCT02153112|8580158|P2|Overall Study|Reason not Specified|0
2483125|NCT02153112|8580159|P1|Overall Study|Reason not Specified|0
2483126|NCT02153112|8580150|P10|Overall Study|Withdrawal by Subject|12
2483127|NCT02153112|8580151|P9|Overall Study|Withdrawal by Subject|13
2483128|NCT02153112|8580152|P8|Overall Study|Withdrawal by Subject|2
2483129|NCT02153112|8580153|P7|Overall Study|Withdrawal by Subject|7
2483130|NCT02153112|8580154|P6|Overall Study|Withdrawal by Subject|1
2483131|NCT02153112|8580155|P5|Overall Study|Withdrawal by Subject|1
2483132|NCT02153112|8580156|P4|Overall Study|Withdrawal by Subject|2
2483133|NCT02153112|8580157|P3|Overall Study|Withdrawal by Subject|2
2483134|NCT02153112|8580158|P2|Overall Study|Withdrawal by Subject|1
2483135|NCT02153112|8580159|P1|Overall Study|Withdrawal by Subject|3
2483136|NCT02153112|8580150|P10|Overall Study|Lost to Follow-up|1
2483137|NCT02153112|8580151|P9|Overall Study|Lost to Follow-up|1
2483138|NCT02153112|8580152|P8|Overall Study|Lost to Follow-up|0
2483139|NCT02153112|8580153|P7|Overall Study|Lost to Follow-up|1
2483140|NCT02153112|8580154|P6|Overall Study|Lost to Follow-up|1
2483141|NCT02153112|8580155|P5|Overall Study|Lost to Follow-up|2
2483142|NCT02153112|8580156|P4|Overall Study|Lost to Follow-up|0
2483143|NCT02153112|8580157|P3|Overall Study|Lost to Follow-up|0
2483144|NCT02153112|8580158|P2|Overall Study|Lost to Follow-up|1
2483145|NCT02153112|8580159|P1|Overall Study|Lost to Follow-up|1
2483146|NCT02153112|8580150|P10|Overall Study|Adverse Event|0
2483147|NCT02153112|8580151|P9|Overall Study|Adverse Event|0
2483148|NCT02153112|8580152|P8|Overall Study|Adverse Event|0
2483149|NCT02153112|8580153|P7|Overall Study|Adverse Event|0
2483150|NCT02153112|8580154|P6|Overall Study|Adverse Event|0
2483151|NCT02153112|8580155|P5|Overall Study|Adverse Event|0
2483152|NCT02153112|8580156|P4|Overall Study|Adverse Event|0
2483153|NCT02153112|8580157|P3|Overall Study|Adverse Event|1
2483154|NCT02153112|8580158|P2|Overall Study|Adverse Event|0
2483155|NCT02153112|8580159|P1|Overall Study|Adverse Event|0
2483156|NCT02153086|8580498|P1|Overall Study|Other|2
2483157|NCT02153086|8580498|P1|Overall Study|Not enrolled >=28 days and <=56 days|2
2483158|NCT02153073|8580512|P1|Overall Study|Protocol Deviation|68
2483159|NCT02153073|8580512|P1|Overall Study|Case Report Forms Uncollected|230
2483160|NCT02152631|8580527|P2|Overall Study|On Treatment|3
2483161|NCT02152631|8580528|P1|Overall Study|On Treatment|19
2483162|NCT02152631|8580527|P2|Overall Study|Lost to Follow-up|1
2483163|NCT02152631|8580528|P1|Overall Study|Lost to Follow-up|0
2483164|NCT02152631|8580527|P2|Overall Study|Physician Decision|2
2483165|NCT02152631|8580528|P1|Overall Study|Physician Decision|1
2483166|NCT02152631|8580527|P2|Overall Study|Noncompliance with study drug|0
2483167|NCT02152631|8580528|P1|Overall Study|Noncompliance with study drug|1
2483168|NCT02152631|8580527|P2|Overall Study|Withdrawal by Subject|16
2483169|NCT02152631|8580528|P1|Overall Study|Withdrawal by Subject|13
2483170|NCT02152631|8580527|P2|Overall Study|Adverse Event|4
2483171|NCT02152631|8580528|P1|Overall Study|Adverse Event|32
2483172|NCT02152605|8580547|P2|Overall Study|Withdrew consent|2
2483173|NCT02152605|8580548|P1|Overall Study|Withdrew consent|4
2483174|NCT02152605|8580547|P2|Overall Study|Lost to Follow-up|0
2483175|NCT02152605|8580548|P1|Overall Study|Lost to Follow-up|1
2483176|NCT02152605|8580547|P2|Overall Study|Protocol deviation|4
2483177|NCT02152605|8580548|P1|Overall Study|Protocol deviation|1
2483178|NCT02152605|8580547|P2|Overall Study|Lack of Efficacy|4
2483179|NCT02152605|8580548|P1|Overall Study|Lack of Efficacy|7
2483180|NCT02152605|8580547|P2|Overall Study|Adverse Event|8
2483181|NCT02152605|8580548|P1|Overall Study|Adverse Event|6
2483182|NCT02152566|8580558|P1|Overall Study|Withdrawal by Subject|2
2483183|NCT02152566|8580558|P1|Overall Study|Lost to Follow-up|1
2483184|NCT02152384|8580571|P2|Period 1|Adverse Event|1
2483185|NCT02152384|8580572|P1|Period 1|Adverse Event|1
2483186|NCT02152384|8580571|P2|Period 1|Withdrawal by Subject|1
2483187|NCT02152384|8580572|P1|Period 1|Withdrawal by Subject|0
2483188|NCT02152371|8580592|P2|Overall Study|Reason Not Given|1
2483189|NCT02152371|8580593|P1|Overall Study|Reason Not Given|0
2483190|NCT02152371|8580592|P2|Overall Study|Physician Decision|2
2483191|NCT02152371|8580593|P1|Overall Study|Physician Decision|0
2483192|NCT02152371|8580592|P2|Overall Study|Lack of Efficacy|1
2483193|NCT02152371|8580593|P1|Overall Study|Lack of Efficacy|0
2483194|NCT02152371|8580592|P2|Overall Study|Lost to Follow-up|0
2483195|NCT02152371|8580593|P1|Overall Study|Lost to Follow-up|1
2483196|NCT02152371|8580592|P2|Overall Study|Protocol Violation|3
2483197|NCT02152371|8580593|P1|Overall Study|Protocol Violation|2
2483198|NCT02152371|8580592|P2|Overall Study|Withdrawal by Subject|7
2483199|NCT02152371|8580593|P1|Overall Study|Withdrawal by Subject|3
2483200|NCT02152371|8580592|P2|Overall Study|Adverse Event|2
2483201|NCT02152371|8580593|P1|Overall Study|Adverse Event|6
2483202|NCT02152345|8580631|P2|Overall Study|Withdrawal by Subject|1
2483203|NCT02152345|8580632|P1|Overall Study|Withdrawal by Subject|2
2483204|NCT02152345|8580631|P2|Overall Study|Case Cancellations|4
2483205|NCT02152345|8580632|P1|Overall Study|Case Cancellations|2
2483206|NCT02152137|8580644|P1|Overall Study|Originally assigned to Arm B|3
2483207|NCT02152137|8580644|P1|Overall Study|Withdrawal by Subject|1
2483208|NCT02152007|8580652|P1|Overall Study|Withdrawal by Subject|1
2483209|NCT02151981|8580713|P2|Overall Study|Eligibility criteria not fulfilled|1
2483210|NCT02151981|8580714|P1|Overall Study|Eligibility criteria not fulfilled|0
2483211|NCT02151981|8580713|P2|Overall Study|Ongoing Study at Data Cut-off|95
2483212|NCT02151981|8580714|P1|Overall Study|Ongoing Study at Data Cut-off|224
2483213|NCT02151981|8580713|P2|Overall Study|Withdrawal by Subject|18
2483214|NCT02151981|8580714|P1|Overall Study|Withdrawal by Subject|19
2483215|NCT02151981|8580713|P2|Overall Study|Lost to Follow-up|0
2483216|NCT02151981|8580714|P1|Overall Study|Lost to Follow-up|1
2483217|NCT02151981|8580713|P2|Overall Study|Death|26
2483218|NCT02151981|8580714|P1|Overall Study|Death|35
2483219|NCT02151851|8580751|P2|Overall Study|Adverse Event|28
2483220|NCT02151851|8580752|P1|Overall Study|Adverse Event|6
2483221|NCT02151851|8580751|P2|Overall Study|Subject entered into study in error|1
2483222|NCT02151851|8580752|P1|Overall Study|Subject entered into study in error|0
2483223|NCT02151851|8580751|P2|Overall Study|Low compliance to study visits|1
2483224|NCT02151851|8580752|P1|Overall Study|Low compliance to study visits|0
2483225|NCT02151851|8580751|P2|Overall Study|Medical impairment|0
2483226|NCT02151851|8580752|P1|Overall Study|Medical impairment|1
2483227|NCT02151851|8580751|P2|Overall Study|Withdrawal by Subject|5
2483228|NCT02151851|8580752|P1|Overall Study|Withdrawal by Subject|2
2483229|NCT02151851|8580751|P2|Overall Study|Protocol Violation|1
2483230|NCT02151851|8580752|P1|Overall Study|Protocol Violation|0
2483231|NCT02151851|8580751|P2|Overall Study|Lack of Efficacy|94
2483232|NCT02151851|8580752|P1|Overall Study|Lack of Efficacy|67
2483233|NCT02151786|8580764|P1|Overall Study|Unavailability of Information|8
2483234|NCT02151786|8580764|P1|Overall Study|Randomized, not Treated|1
2483235|NCT02151786|8580764|P1|Overall Study|Outside the Contract Period|1
2483236|NCT02151786|8580764|P1|Overall Study|Unavailability of Case Report Form|26
2483237|NCT02151773|8580775|P1|Overall Study|Protocol Deviation|64
2483238|NCT02151682|8580782|P6|Part 2: Observ. Aft. Tapent. Extension|Various other|2
2483239|NCT02151682|8580783|P5|Part 2: Observ. Aft. Tapent. Extension|Various other|0
2483240|NCT02151682|8580784|P4|Part 2: Observ. Aft. Tapent. Extension|Various other|0
2483241|NCT02151682|8580785|P3|Part 2: Observ. Aft. Tapent. Extension|Various other|0
2483242|NCT02151682|8580786|P2|Part 2: Observ. Aft. Tapent. Extension|Various other|0
2483243|NCT02151682|8580787|P1|Part 2: Observ. Aft. Tapent. Extension|Various other|0
2483244|NCT02151682|8580782|P6|Part 2: Observ. Aft. Tapent. Extension|Missing|3
2483245|NCT02151682|8580783|P5|Part 2: Observ. Aft. Tapent. Extension|Missing|0
2483246|NCT02151682|8580784|P4|Part 2: Observ. Aft. Tapent. Extension|Missing|0
2483247|NCT02151682|8580785|P3|Part 2: Observ. Aft. Tapent. Extension|Missing|0
2483248|NCT02151682|8580786|P2|Part 2: Observ. Aft. Tapent. Extension|Missing|0
2483249|NCT02151682|8580787|P1|Part 2: Observ. Aft. Tapent. Extension|Missing|0
2483250|NCT02151682|8580782|P6|Part 2: Observ. Aft. Tapent. Extension|Death|1
2483251|NCT02151682|8580783|P5|Part 2: Observ. Aft. Tapent. Extension|Death|0
2483252|NCT02151682|8580784|P4|Part 2: Observ. Aft. Tapent. Extension|Death|0
2483253|NCT02151682|8580785|P3|Part 2: Observ. Aft. Tapent. Extension|Death|0
2483254|NCT02151682|8580786|P2|Part 2: Observ. Aft. Tapent. Extension|Death|0
2483255|NCT02151682|8580787|P1|Part 2: Observ. Aft. Tapent. Extension|Death|0
2483256|NCT02151682|8580782|P6|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1
2483257|NCT02151682|8580783|P5|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
2483258|NCT02151682|8580784|P4|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
2483259|NCT02151682|8580785|P3|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
2483260|NCT02151682|8580786|P2|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
2483261|NCT02151682|8580787|P1|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
2483262|NCT02151682|8580782|P6|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
2483263|NCT02151682|8580783|P5|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
2483264|NCT02151682|8580784|P4|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
2483265|NCT02151682|8580785|P3|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1
2483266|NCT02151682|8580786|P2|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
2483267|NCT02151682|8580787|P1|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
2483268|NCT02151682|8580782|P6|Part 2: Tapent. Extension or Observation|Various other|0
2483269|NCT02151682|8580783|P5|Part 2: Tapent. Extension or Observation|Various other|0
2483270|NCT02151682|8580784|P4|Part 2: Tapent. Extension or Observation|Various other|0
2483271|NCT02151682|8580785|P3|Part 2: Tapent. Extension or Observation|Various other|6
2483272|NCT02151682|8580786|P2|Part 2: Tapent. Extension or Observation|Various other|0
2483273|NCT02151682|8580787|P1|Part 2: Tapent. Extension or Observation|Various other|0
2483274|NCT02151682|8580782|P6|Part 2: Tapent. Extension or Observation|Missing|0
2483275|NCT02151682|8580783|P5|Part 2: Tapent. Extension or Observation|Missing|0
2483276|NCT02151682|8580784|P4|Part 2: Tapent. Extension or Observation|Missing|1
2483277|NCT02151682|8580785|P3|Part 2: Tapent. Extension or Observation|Missing|0
2483278|NCT02151682|8580786|P2|Part 2: Tapent. Extension or Observation|Missing|0
2483279|NCT02151682|8580787|P1|Part 2: Tapent. Extension or Observation|Missing|0
2483280|NCT02151682|8580782|P6|Part 2: Tapent. Extension or Observation|No need for opioid|0
2483281|NCT02151682|8580783|P5|Part 2: Tapent. Extension or Observation|No need for opioid|0
2483282|NCT02151682|8580784|P4|Part 2: Tapent. Extension or Observation|No need for opioid|0
2483283|NCT02151682|8580785|P3|Part 2: Tapent. Extension or Observation|No need for opioid|13
2483284|NCT02151682|8580786|P2|Part 2: Tapent. Extension or Observation|No need for opioid|0
2483285|NCT02151682|8580787|P1|Part 2: Tapent. Extension or Observation|No need for opioid|0
2483286|NCT02151682|8580782|P6|Part 2: Tapent. Extension or Observation|Protocol Violation|0
2483287|NCT02151682|8580783|P5|Part 2: Tapent. Extension or Observation|Protocol Violation|0
2483288|NCT02151682|8580784|P4|Part 2: Tapent. Extension or Observation|Protocol Violation|0
2483289|NCT02151682|8580785|P3|Part 2: Tapent. Extension or Observation|Protocol Violation|1
2483290|NCT02151682|8580786|P2|Part 2: Tapent. Extension or Observation|Protocol Violation|0
2483291|NCT02151682|8580787|P1|Part 2: Tapent. Extension or Observation|Protocol Violation|0
2483292|NCT02151682|8580782|P6|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
2483293|NCT02151682|8580783|P5|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
2483294|NCT02151682|8580784|P4|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
2483295|NCT02151682|8580785|P3|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3
2483296|NCT02151682|8580786|P2|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
2483297|NCT02151682|8580787|P1|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
2483298|NCT02151682|8580782|P6|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
2483299|NCT02151682|8580783|P5|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
2483300|NCT02151682|8580784|P4|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1
2483301|NCT02151682|8580785|P3|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1
2483302|NCT02151682|8580786|P2|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
2483303|NCT02151682|8580787|P1|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
2483304|NCT02151682|8580782|P6|Part 2: Tapent. Extension or Observation|Death|0
2483305|NCT02151682|8580783|P5|Part 2: Tapent. Extension or Observation|Death|0
2483306|NCT02151682|8580784|P4|Part 2: Tapent. Extension or Observation|Death|2
2483307|NCT02151682|8580785|P3|Part 2: Tapent. Extension or Observation|Death|0
2483308|NCT02151682|8580786|P2|Part 2: Tapent. Extension or Observation|Death|0
2483309|NCT02151682|8580787|P1|Part 2: Tapent. Extension or Observation|Death|0
2483310|NCT02151682|8580782|P6|Part 2: Tapent. Extension or Observation|Adverse Event|0
2483311|NCT02151682|8580783|P5|Part 2: Tapent. Extension or Observation|Adverse Event|0
2483312|NCT02151682|8580784|P4|Part 2: Tapent. Extension or Observation|Adverse Event|0
2483313|NCT02151682|8580785|P3|Part 2: Tapent. Extension or Observation|Adverse Event|3
2483314|NCT02151682|8580786|P2|Part 2: Tapent. Extension or Observation|Adverse Event|0
2483315|NCT02151682|8580787|P1|Part 2: Tapent. Extension or Observation|Adverse Event|0
2483316|NCT02151682|8580782|P6|Part 1: 14 Days Morphine or Tapentadol|Missing|0
2483317|NCT02151682|8580783|P5|Part 1: 14 Days Morphine or Tapentadol|Missing|0
2483318|NCT02151682|8580784|P4|Part 1: 14 Days Morphine or Tapentadol|Missing|0
2483319|NCT02151682|8580785|P3|Part 1: 14 Days Morphine or Tapentadol|Missing|0
2483320|NCT02151682|8580786|P2|Part 1: 14 Days Morphine or Tapentadol|Missing|0
2483321|NCT02151682|8580787|P1|Part 1: 14 Days Morphine or Tapentadol|Missing|1
2483322|NCT02151682|8580782|P6|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
2483323|NCT02151682|8580783|P5|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
2483324|NCT02151682|8580784|P4|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
2483325|NCT02151682|8580785|P3|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
2483326|NCT02151682|8580786|P2|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1
2483327|NCT02151682|8580787|P1|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1
2483328|NCT02151682|8580782|P6|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
2483329|NCT02151682|8580783|P5|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
2483330|NCT02151682|8580784|P4|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
2483331|NCT02151682|8580785|P3|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
2483332|NCT02151682|8580786|P2|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1
2483333|NCT02151682|8580787|P1|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
2483334|NCT02151682|8580782|P6|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
2483335|NCT02151682|8580783|P5|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
2483336|NCT02151682|8580784|P4|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
2483337|NCT02151682|8580785|P3|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
2483338|NCT02151682|8580786|P2|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1
2483339|NCT02151682|8580787|P1|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
2483340|NCT02151682|8580782|P6|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
2483341|NCT02151682|8580783|P5|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
2483342|NCT02151682|8580784|P4|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
2483343|NCT02151682|8580785|P3|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
2483344|NCT02151682|8580786|P2|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2
2483345|NCT02151682|8580787|P1|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
2483346|NCT02151643|8580837|P5|Overall Study|High Ferritin levels|1
2483347|NCT02151643|8580838|P4|Overall Study|High Ferritin levels|2
2483348|NCT02151643|8580839|P3|Overall Study|High Ferritin levels|2
2483349|NCT02151643|8580840|P2|Overall Study|High Ferritin levels|3
2483350|NCT02151643|8580841|P1|Overall Study|High Ferritin levels|3
2483351|NCT02151643|8580837|P5|Overall Study|Hyperphosphataemia|1
2483352|NCT02151643|8580838|P4|Overall Study|Hyperphosphataemia|0
2483353|NCT02151643|8580839|P3|Overall Study|Hyperphosphataemia|0
2483354|NCT02151643|8580840|P2|Overall Study|Hyperphosphataemia|0
2483355|NCT02151643|8580841|P1|Overall Study|Hyperphosphataemia|1
2483356|NCT02151643|8580837|P5|Overall Study|Withdrawal by Subject|1
2483357|NCT02151643|8580838|P4|Overall Study|Withdrawal by Subject|1
2483358|NCT02151643|8580839|P3|Overall Study|Withdrawal by Subject|1
2483359|NCT02151643|8580840|P2|Overall Study|Withdrawal by Subject|1
2483360|NCT02151643|8580841|P1|Overall Study|Withdrawal by Subject|0
2483361|NCT02151643|8580837|P5|Overall Study|Adverse Event|0
2483362|NCT02151643|8580838|P4|Overall Study|Adverse Event|4
2483363|NCT02151643|8580839|P3|Overall Study|Adverse Event|1
2483364|NCT02151643|8580840|P2|Overall Study|Adverse Event|0
2483365|NCT02151643|8580841|P1|Overall Study|Adverse Event|2
2483366|NCT02151591|8580880|P2|Overall Study|Lost to Follow-up|3
2483367|NCT02151591|8580881|P1|Overall Study|Lost to Follow-up|6
2483368|NCT02151461|8580952|P4|Overall Study|Treatment discontinuation|0
2483369|NCT02151461|8580953|P3|Overall Study|Treatment discontinuation|1
2483370|NCT02151461|8580954|P2|Overall Study|Treatment discontinuation|0
2483371|NCT02151461|8580955|P1|Overall Study|Treatment discontinuation|0
2483372|NCT02151461|8580952|P4|Overall Study|Withdrawal by Subject|1
2483373|NCT02151461|8580953|P3|Overall Study|Withdrawal by Subject|1
2483374|NCT02151461|8580954|P2|Overall Study|Withdrawal by Subject|0
2483375|NCT02151461|8580955|P1|Overall Study|Withdrawal by Subject|1
2483376|NCT02151461|8580952|P4|Overall Study|Lost to Follow-up|1
2483377|NCT02151461|8580953|P3|Overall Study|Lost to Follow-up|1
2483378|NCT02151461|8580954|P2|Overall Study|Lost to Follow-up|0
2483379|NCT02151461|8580955|P1|Overall Study|Lost to Follow-up|0
2483380|NCT02151461|8580952|P4|Overall Study|Adverse Event|2
2483381|NCT02151461|8580953|P3|Overall Study|Adverse Event|0
2483382|NCT02151461|8580954|P2|Overall Study|Adverse Event|1
2483383|NCT02151461|8580955|P1|Overall Study|Adverse Event|5
2483384|NCT02151266|8581087|P3|Overall Study|Not able to exercise|4
2483385|NCT02151266|8581088|P2|Overall Study|Not able to exercise|5
2483386|NCT02151266|8581089|P1|Overall Study|Not able to exercise|4
2483387|NCT02151266|8581087|P3|Overall Study|Did NOT receive intervention|2
2483388|NCT02151266|8581088|P2|Overall Study|Did NOT receive intervention|6
2483389|NCT02151266|8581089|P1|Overall Study|Did NOT receive intervention|3
2483390|NCT02151266|8581087|P3|Overall Study|Lost to Follow-up|1
2483391|NCT02151266|8581088|P2|Overall Study|Lost to Follow-up|4
2483392|NCT02151266|8581089|P1|Overall Study|Lost to Follow-up|1
2483393|NCT02151149|8581132|P2|Follow-Up Period|Death|34
2483394|NCT02151149|8581133|P1|Follow-Up Period|Death|37
2483395|NCT02151149|8581132|P2|Follow-Up Period|Lost to Follow-up|3
2483396|NCT02151149|8581133|P1|Follow-Up Period|Lost to Follow-up|2
2483397|NCT02151149|8581132|P2|Treatment Period|Participants randomized but not treated|2
2483398|NCT02151149|8581133|P1|Treatment Period|Participants randomized but not treated|3
2483399|NCT02151149|8581132|P2|Treatment Period|Miscellaneous|7
2483400|NCT02151149|8581133|P1|Treatment Period|Miscellaneous|8
2483401|NCT02151149|8581132|P2|Treatment Period|Withdrawal by Subject|11
2483402|NCT02151149|8581133|P1|Treatment Period|Withdrawal by Subject|13
2483403|NCT02151149|8581132|P2|Treatment Period|Symptomatic Deterioration|10
2483404|NCT02151149|8581133|P1|Treatment Period|Symptomatic Deterioration|2
2483405|NCT02151149|8581132|P2|Treatment Period|Progressive Disease|24
2483406|NCT02151149|8581133|P1|Treatment Period|Progressive Disease|25
2483407|NCT02151149|8581132|P2|Treatment Period|Adverse Event|14
2483408|NCT02151149|8581133|P1|Treatment Period|Adverse Event|17
2483409|NCT02151149|8581132|P2|Treatment Period|Death|3
2483410|NCT02151149|8581133|P1|Treatment Period|Death|2
2483411|NCT02151110|8581165|P8|Overall Study|Lost to Follow-up|2
2483412|NCT02151110|8581166|P7|Overall Study|Lost to Follow-up|0
2483413|NCT02151110|8581167|P6|Overall Study|Lost to Follow-up|0
2483414|NCT02151110|8581168|P5|Overall Study|Lost to Follow-up|0
2483415|NCT02151110|8581169|P4|Overall Study|Lost to Follow-up|0
2483416|NCT02151110|8581170|P3|Overall Study|Lost to Follow-up|0
2483417|NCT02151110|8581171|P2|Overall Study|Lost to Follow-up|0
2483418|NCT02151110|8581172|P1|Overall Study|Lost to Follow-up|0
2483419|NCT02151110|8581165|P8|Overall Study|Withdrawal by Subject|1
2483420|NCT02151110|8581166|P7|Overall Study|Withdrawal by Subject|0
2483421|NCT02151110|8581167|P6|Overall Study|Withdrawal by Subject|0
2483422|NCT02151110|8581168|P5|Overall Study|Withdrawal by Subject|0
2483423|NCT02151110|8581169|P4|Overall Study|Withdrawal by Subject|0
2483424|NCT02151110|8581170|P3|Overall Study|Withdrawal by Subject|0
2483425|NCT02151110|8581171|P2|Overall Study|Withdrawal by Subject|0
2483426|NCT02151110|8581172|P1|Overall Study|Withdrawal by Subject|0
2483427|NCT02151058|8581265|P3|Overall Study|Lost to Follow-up|2
2483428|NCT02151058|8581266|P2|Overall Study|Lost to Follow-up|0
2483429|NCT02151058|8581267|P1|Overall Study|Lost to Follow-up|1
2483430|NCT02151058|8581265|P3|Overall Study|Withdrawal by Subject|3
2483431|NCT02151058|8581266|P2|Overall Study|Withdrawal by Subject|1
2483432|NCT02151058|8581267|P1|Overall Study|Withdrawal by Subject|1
2483433|NCT02150954|8581301|P2|Overall Study|Protocol Violation|0
2483434|NCT02150954|8581302|P1|Overall Study|Protocol Violation|1
2483435|NCT02150863|8581327|P3|Overall Study|Lost to Follow-up|0
2483436|NCT02150863|8581328|P2|Overall Study|Lost to Follow-up|1
2483437|NCT02150863|8581329|P1|Overall Study|Lost to Follow-up|0
2483438|NCT02150343|8581575|P4|Overall Study|Other|2
2483439|NCT02150343|8581576|P3|Overall Study|Other|0
2483440|NCT02150343|8581577|P2|Overall Study|Other|6
2483441|NCT02150343|8581578|P1|Overall Study|Other|2
2483442|NCT02150343|8581575|P4|Overall Study|Lost to Follow-up|3
2483443|NCT02150343|8581576|P3|Overall Study|Lost to Follow-up|2
2483444|NCT02150343|8581577|P2|Overall Study|Lost to Follow-up|4
2483445|NCT02150343|8581578|P1|Overall Study|Lost to Follow-up|4
2483446|NCT02150343|8581575|P4|Overall Study|Withdrawal by Subject|4
2483447|NCT02150343|8581576|P3|Overall Study|Withdrawal by Subject|9
2483448|NCT02150343|8581577|P2|Overall Study|Withdrawal by Subject|10
2483449|NCT02150343|8581578|P1|Overall Study|Withdrawal by Subject|13
2483450|NCT02150343|8581575|P4|Overall Study|Adverse Event|1
2483451|NCT02150343|8581576|P3|Overall Study|Adverse Event|1
2483452|NCT02150343|8581577|P2|Overall Study|Adverse Event|0
2483453|NCT02150343|8581578|P1|Overall Study|Adverse Event|2
2483454|NCT02150213|8581616|P1|Overall Study|Withdrawal by Subject|1
2483455|NCT02150213|8581616|P1|Overall Study|Lost to Follow-up|1
2483456|NCT02150057|8581635|P2|Overall Study|Lost to Follow-up|4
2483457|NCT02150057|8581636|P1|Overall Study|Lost to Follow-up|6
2483458|NCT02149875|8581651|P3|Overall Study|Physician Decision|2
2483459|NCT02149875|8581652|P2|Overall Study|Physician Decision|2
2483460|NCT02149875|8581653|P1|Overall Study|Physician Decision|1
2483461|NCT02149875|8581651|P3|Overall Study|Withdrawal by Subject|2
2483462|NCT02149875|8581652|P2|Overall Study|Withdrawal by Subject|2
2483463|NCT02149875|8581653|P1|Overall Study|Withdrawal by Subject|3
2483464|NCT02149875|8581651|P3|Overall Study|Lost to Follow-up|5
2483465|NCT02149875|8581652|P2|Overall Study|Lost to Follow-up|4
2483466|NCT02149875|8581653|P1|Overall Study|Lost to Follow-up|3
2483467|NCT02149836|8581664|P1|Overall Study|Withdrawal by Subject|1
2483468|NCT02149420|8581691|P3|Open Label VAY736 10 mg/kg Extension|Administrative problems|0
2483469|NCT02149420|8581692|P2|Open Label VAY736 10 mg/kg Extension|Administrative problems|0
2483470|NCT02149420|8581693|P1|Open Label VAY736 10 mg/kg Extension|Administrative problems|1
2483471|NCT02149420|8581691|P3|Core Study|Administrative problems|2
2483472|NCT02149420|8581692|P2|Core Study|Administrative problems|1
2483473|NCT02149420|8581693|P1|Core Study|Administrative problems|0
2483474|NCT02149264|8581761|P1|Overall Study|Protocol Violation|1
2483475|NCT02149264|8581761|P1|Overall Study|Physician Decision|3
2483476|NCT02149264|8581761|P1|Overall Study|Adverse Event|7
2483477|NCT02149264|8581761|P1|Overall Study|Withdrawal by Subject|9
2483478|NCT02149199|8581777|P3|Overall Study|Adverse Event|9
2483479|NCT02149199|8581778|P2|Overall Study|Adverse Event|15
2483480|NCT02149199|8581779|P1|Overall Study|Adverse Event|6
2483481|NCT02149199|8581777|P3|Overall Study|Death|1
2483482|NCT02149199|8581778|P2|Overall Study|Death|0
2483483|NCT02149199|8581779|P1|Overall Study|Death|0
2483484|NCT02149199|8581777|P3|Overall Study|Lost to Follow-up|11
2483485|NCT02149199|8581778|P2|Overall Study|Lost to Follow-up|12
2483486|NCT02149199|8581779|P1|Overall Study|Lost to Follow-up|3
2483487|NCT02149199|8581777|P3|Overall Study|Protocol Violation|15
2483488|NCT02149199|8581778|P2|Overall Study|Protocol Violation|13
2483489|NCT02149199|8581779|P1|Overall Study|Protocol Violation|16
2483490|NCT02149199|8581777|P3|Overall Study|Withdrawal by Subject|77
2483491|NCT02149199|8581778|P2|Overall Study|Withdrawal by Subject|93
2483492|NCT02149199|8581779|P1|Overall Study|Withdrawal by Subject|75
2483493|NCT02149199|8581777|P3|Overall Study|Eligibility criteria not fulfilled|8
2483494|NCT02149199|8581778|P2|Overall Study|Eligibility criteria not fulfilled|14
2483495|NCT02149199|8581779|P1|Overall Study|Eligibility criteria not fulfilled|9
2483496|NCT02149199|8581777|P3|Overall Study|Other|20
2483497|NCT02149199|8581778|P2|Overall Study|Other|25
2483498|NCT02149199|8581779|P1|Overall Study|Other|20
2483499|NCT02149199|8581777|P3|Overall Study|Study specific withdrawal criteria|6
2483500|NCT02149199|8581778|P2|Overall Study|Study specific withdrawal criteria|21
2483501|NCT02149199|8581779|P1|Overall Study|Study specific withdrawal criteria|4
2483502|NCT02149108|8581858|P2|Overall Study|Lost to Follow-up|0
2483503|NCT02149108|8581859|P1|Overall Study|Lost to Follow-up|1
2483504|NCT02149108|8581858|P2|Overall Study|Refusal to continue trial medication|11
2483505|NCT02149108|8581859|P1|Overall Study|Refusal to continue trial medication|15
2483506|NCT02149108|8581858|P2|Overall Study|Other not defined above|2
2483507|NCT02149108|8581859|P1|Overall Study|Other not defined above|0
2483508|NCT02149108|8581858|P2|Overall Study|Other Adverse Event (AE)|18
2483509|NCT02149108|8581859|P1|Overall Study|Other Adverse Event (AE)|8
2483510|NCT02149108|8581858|P2|Overall Study|Worsening/adverse event cancer disease|32
2483511|NCT02149108|8581859|P1|Overall Study|Worsening/adverse event cancer disease|31
2483512|NCT02149108|8581858|P2|Overall Study|Progressive Disease (PD)|318
2483513|NCT02149108|8581859|P1|Overall Study|Progressive Disease (PD)|324
2483514|NCT02149108|8581858|P2|Overall Study|Not treated|2
2483515|NCT02149108|8581859|P1|Overall Study|Not treated|1
2483516|NCT02148952|8581873|P2|Follow-Up|Withdrawal by Subject|48
2483517|NCT02148952|8581874|P1|Follow-Up|Withdrawal by Subject|46
2483518|NCT02148952|8581873|P2|Follow-Up|Lost to Follow-up|231
2483519|NCT02148952|8581874|P1|Follow-Up|Lost to Follow-up|219
2483520|NCT02148952|8581873|P2|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556
2483521|NCT02148952|8581874|P1|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862
2483522|NCT02148952|8581873|P2|Assessing Eligibility and Consent|Were not eligible for inclusion|1591
2483523|NCT02148952|8581874|P1|Assessing Eligibility and Consent|Were not eligible for inclusion|1241
2483524|NCT02148718|8581957|P1|Overall Study|Discontinued Study Prematurely|5
2483525|NCT02148718|8581957|P1|Overall Study|Protocol Violation|26
2483526|NCT02148445|8582005|P2|Overall Study|Death|3
2483527|NCT02148445|8582006|P1|Overall Study|Death|1
2483528|NCT02148250|8582057|P2|Screening|Withdrawal by Subject|0
2483529|NCT02148250|8582058|P1|Screening|Withdrawal by Subject|5
2483530|NCT02148133|8582072|P1|Overall Study|Protocol-defined stopping criteria|2
2483531|NCT02148133|8582072|P1|Overall Study|Protocol deviation|1
2483532|NCT02148133|8582072|P1|Overall Study|Lack of Efficacy|1
2483533|NCT02148133|8582072|P1|Overall Study|Investigator discretion|1
2483534|NCT02147691|8582148|P2|Overall Study|Lost to Follow-up|1
2483535|NCT02147691|8582149|P1|Overall Study|Lost to Follow-up|0
2483536|NCT02147691|8582148|P2|Overall Study|Adverse Event|0
2483537|NCT02147691|8582149|P1|Overall Study|Adverse Event|2
2483538|NCT02147691|8582148|P2|Overall Study|Withdrawal by Subject|0
2483539|NCT02147691|8582149|P1|Overall Study|Withdrawal by Subject|2
2483540|NCT02147587|8582208|P2|Overall Study|Lack of Efficacy|1
2483541|NCT02147587|8582209|P1|Overall Study|Lack of Efficacy|2
2483542|NCT02147587|8582208|P2|Overall Study|Adverse Event|4
2483543|NCT02147587|8582209|P1|Overall Study|Adverse Event|9
2483544|NCT02147561|8582229|P1|Overall Study|Subjects who didn’t receive BOTOX|1
2483545|NCT02147561|8582229|P1|Overall Study|Lost to Follow-up|3
2483546|NCT02147353|8582250|P2|Overall Study|medication noncompliance|0
2483547|NCT02147353|8582251|P1|Overall Study|medication noncompliance|3
2483548|NCT02147353|8582250|P2|Overall Study|unable to make visits|0
2483549|NCT02147353|8582251|P1|Overall Study|unable to make visits|4
2483550|NCT02147353|8582250|P2|Overall Study|Lost to Follow-up|0
2483551|NCT02147353|8582251|P1|Overall Study|Lost to Follow-up|2
2483552|NCT02147288|8582284|P10|Overall Study|complications from concurrent hernia rep|0
2483553|NCT02147288|8582285|P9|Overall Study|complications from concurrent hernia rep|0
2483554|NCT02147288|8582286|P8|Overall Study|complications from concurrent hernia rep|0
2483555|NCT02147288|8582287|P7|Overall Study|complications from concurrent hernia rep|0
2483556|NCT02147288|8582288|P6|Overall Study|complications from concurrent hernia rep|0
2483557|NCT02147288|8582289|P5|Overall Study|complications from concurrent hernia rep|0
2483558|NCT02147288|8582290|P4|Overall Study|complications from concurrent hernia rep|0
2483559|NCT02147288|8582291|P3|Overall Study|complications from concurrent hernia rep|0
2483560|NCT02147288|8582292|P2|Overall Study|complications from concurrent hernia rep|1
2483561|NCT02147288|8582293|P1|Overall Study|complications from concurrent hernia rep|0
2483562|NCT02147288|8582284|P10|Overall Study|post-operative hematoma|0
2483563|NCT02147288|8582285|P9|Overall Study|post-operative hematoma|0
2483564|NCT02147288|8582286|P8|Overall Study|post-operative hematoma|0
2483565|NCT02147288|8582287|P7|Overall Study|post-operative hematoma|0
2483566|NCT02147288|8582288|P6|Overall Study|post-operative hematoma|0
2483567|NCT02147288|8582289|P5|Overall Study|post-operative hematoma|0
2483568|NCT02147288|8582290|P4|Overall Study|post-operative hematoma|0
2483569|NCT02147288|8582291|P3|Overall Study|post-operative hematoma|0
2483570|NCT02147288|8582292|P2|Overall Study|post-operative hematoma|1
2483571|NCT02147288|8582293|P1|Overall Study|post-operative hematoma|1
2483572|NCT02147197|8582302|P3|Overall Study|Other Miscellaneous Reasons|3
2483573|NCT02147197|8582303|P2|Overall Study|Other Miscellaneous Reasons|0
2483574|NCT02147197|8582304|P1|Overall Study|Other Miscellaneous Reasons|1
2483575|NCT02147197|8582302|P3|Overall Study|Protocol Violation|3
2483576|NCT02147197|8582303|P2|Overall Study|Protocol Violation|0
2483577|NCT02147197|8582304|P1|Overall Study|Protocol Violation|1
2483578|NCT02147197|8582302|P3|Overall Study|Lost to Follow-up|1
2483579|NCT02147197|8582303|P2|Overall Study|Lost to Follow-up|3
2483580|NCT02147197|8582304|P1|Overall Study|Lost to Follow-up|2
2483581|NCT02147197|8582302|P3|Overall Study|Withdrawal of Consent|2
2483582|NCT02147197|8582303|P2|Overall Study|Withdrawal of Consent|3
2483583|NCT02147197|8582304|P1|Overall Study|Withdrawal of Consent|4
2483584|NCT02147197|8582302|P3|Overall Study|Adverse Event|0
2483585|NCT02147197|8582303|P2|Overall Study|Adverse Event|0
2483586|NCT02147197|8582304|P1|Overall Study|Adverse Event|1
2483587|NCT02147184|8582323|P2|Overall Study|Other|0
2483588|NCT02147184|8582324|P1|Overall Study|Other|1
2483589|NCT02147184|8582323|P2|Overall Study|Physician Decision|2
2483590|NCT02147184|8582324|P1|Overall Study|Physician Decision|0
2483591|NCT02147184|8582323|P2|Overall Study|Moved out of state|3
2483592|NCT02147184|8582324|P1|Overall Study|Moved out of state|3
2483593|NCT02147184|8582323|P2|Overall Study|Pregnancy|0
2483594|NCT02147184|8582324|P1|Overall Study|Pregnancy|6
2483595|NCT02147184|8582323|P2|Overall Study|Study Burden|7
2483596|NCT02147184|8582324|P1|Overall Study|Study Burden|11
2483597|NCT02147184|8582323|P2|Overall Study|Lost to Follow-up|15
2483598|NCT02147184|8582324|P1|Overall Study|Lost to Follow-up|28
2483599|NCT02147158|8582348|P6|Off-Treatment Interval 2|Other Miscellaneous Reasons|1
2483600|NCT02147158|8582349|P5|Off-Treatment Interval 2|Other Miscellaneous Reasons|0
2483601|NCT02147158|8582350|P4|Off-Treatment Interval 2|Other Miscellaneous Reasons|4
2483602|NCT02147158|8582351|P3|Off-Treatment Interval 2|Other Miscellaneous Reasons|1
2483603|NCT02147158|8582352|P2|Off-Treatment Interval 2|Other Miscellaneous Reasons|3
2483604|NCT02147158|8582353|P1|Off-Treatment Interval 2|Other Miscellaneous Reasons|0
2483605|NCT02147158|8582348|P6|Off-Treatment Interval 2|Protocol Violation|0
2483606|NCT02147158|8582349|P5|Off-Treatment Interval 2|Protocol Violation|0
2483607|NCT02147158|8582350|P4|Off-Treatment Interval 2|Protocol Violation|1
2483608|NCT02147158|8582351|P3|Off-Treatment Interval 2|Protocol Violation|0
2483609|NCT02147158|8582352|P2|Off-Treatment Interval 2|Protocol Violation|0
2483610|NCT02147158|8582353|P1|Off-Treatment Interval 2|Protocol Violation|0
2483611|NCT02147158|8582348|P6|Off-Treatment Interval 2|Lost to Follow-up|2
2483612|NCT02147158|8582349|P5|Off-Treatment Interval 2|Lost to Follow-up|2
2483613|NCT02147158|8582350|P4|Off-Treatment Interval 2|Lost to Follow-up|2
2483614|NCT02147158|8582351|P3|Off-Treatment Interval 2|Lost to Follow-up|3
2483615|NCT02147158|8582352|P2|Off-Treatment Interval 2|Lost to Follow-up|0
2483616|NCT02147158|8582353|P1|Off-Treatment Interval 2|Lost to Follow-up|0
2483617|NCT02147158|8582348|P6|Off-Treatment Interval 2|Withdrawal of Consent|1
2483618|NCT02147158|8582349|P5|Off-Treatment Interval 2|Withdrawal of Consent|0
2483619|NCT02147158|8582350|P4|Off-Treatment Interval 2|Withdrawal of Consent|4
2483620|NCT02147158|8582351|P3|Off-Treatment Interval 2|Withdrawal of Consent|5
2483621|NCT02147158|8582352|P2|Off-Treatment Interval 2|Withdrawal of Consent|0
2483622|NCT02147158|8582353|P1|Off-Treatment Interval 2|Withdrawal of Consent|4
2483623|NCT02147158|8582348|P6|Off-Treatment Interval 2|Lack of Efficacy|0
2483624|NCT02147158|8582349|P5|Off-Treatment Interval 2|Lack of Efficacy|0
2483625|NCT02147158|8582350|P4|Off-Treatment Interval 2|Lack of Efficacy|0
2483626|NCT02147158|8582351|P3|Off-Treatment Interval 2|Lack of Efficacy|1
2483627|NCT02147158|8582352|P2|Off-Treatment Interval 2|Lack of Efficacy|1
2483628|NCT02147158|8582353|P1|Off-Treatment Interval 2|Lack of Efficacy|0
2483629|NCT02147158|8582348|P6|Treatment Course 2|Lost to Follow-up|1
2483630|NCT02147158|8582349|P5|Treatment Course 2|Lost to Follow-up|0
2483631|NCT02147158|8582350|P4|Treatment Course 2|Lost to Follow-up|1
2483632|NCT02147158|8582351|P3|Treatment Course 2|Lost to Follow-up|1
2483633|NCT02147158|8582352|P2|Treatment Course 2|Lost to Follow-up|0
2483634|NCT02147158|8582353|P1|Treatment Course 2|Lost to Follow-up|1
2483635|NCT02147158|8582348|P6|Treatment Course 2|Withdrawal of Consent|0
2483636|NCT02147158|8582349|P5|Treatment Course 2|Withdrawal of Consent|0
2483637|NCT02147158|8582350|P4|Treatment Course 2|Withdrawal of Consent|3
2483638|NCT02147158|8582351|P3|Treatment Course 2|Withdrawal of Consent|2
2483639|NCT02147158|8582352|P2|Treatment Course 2|Withdrawal of Consent|1
2483640|NCT02147158|8582353|P1|Treatment Course 2|Withdrawal of Consent|0
2483641|NCT02147158|8582348|P6|Treatment Course 2|Adverse Event|1
2483642|NCT02147158|8582349|P5|Treatment Course 2|Adverse Event|0
2483643|NCT02147158|8582350|P4|Treatment Course 2|Adverse Event|1
2483644|NCT02147158|8582351|P3|Treatment Course 2|Adverse Event|2
2483645|NCT02147158|8582352|P2|Treatment Course 2|Adverse Event|4
2483646|NCT02147158|8582353|P1|Treatment Course 2|Adverse Event|0
2483647|NCT02147158|8582348|P6|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
2483648|NCT02147158|8582349|P5|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
2483649|NCT02147158|8582350|P4|Off-Treatment Interval 1|Other Miscellaneous Reasons|2
2483650|NCT02147158|8582351|P3|Off-Treatment Interval 1|Other Miscellaneous Reasons|3
2483651|NCT02147158|8582352|P2|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
2483652|NCT02147158|8582353|P1|Off-Treatment Interval 1|Other Miscellaneous Reasons|2
2483653|NCT02147158|8582348|P6|Off-Treatment Interval 1|Lack of Efficacy|0
2483654|NCT02147158|8582349|P5|Off-Treatment Interval 1|Lack of Efficacy|1
2483655|NCT02147158|8582350|P4|Off-Treatment Interval 1|Lack of Efficacy|0
2483656|NCT02147158|8582351|P3|Off-Treatment Interval 1|Lack of Efficacy|2
2483657|NCT02147158|8582352|P2|Off-Treatment Interval 1|Lack of Efficacy|0
2483658|NCT02147158|8582353|P1|Off-Treatment Interval 1|Lack of Efficacy|0
2483659|NCT02147158|8582348|P6|Off-Treatment Interval 1|Withdrawal of Consent|3
2483660|NCT02147158|8582349|P5|Off-Treatment Interval 1|Withdrawal of Consent|2
2483661|NCT02147158|8582350|P4|Off-Treatment Interval 1|Withdrawal of Consent|10
2483662|NCT02147158|8582351|P3|Off-Treatment Interval 1|Withdrawal of Consent|5
2483663|NCT02147158|8582352|P2|Off-Treatment Interval 1|Withdrawal of Consent|3
2483664|NCT02147158|8582353|P1|Off-Treatment Interval 1|Withdrawal of Consent|4
2483665|NCT02147158|8582348|P6|Off-Treatment Interval 1|Protocol Violation|0
2483666|NCT02147158|8582349|P5|Off-Treatment Interval 1|Protocol Violation|1
2483667|NCT02147158|8582350|P4|Off-Treatment Interval 1|Protocol Violation|0
2483668|NCT02147158|8582351|P3|Off-Treatment Interval 1|Protocol Violation|2
2483669|NCT02147158|8582352|P2|Off-Treatment Interval 1|Protocol Violation|0
2483670|NCT02147158|8582353|P1|Off-Treatment Interval 1|Protocol Violation|1
2483671|NCT02147158|8582348|P6|Off-Treatment Interval 1|Lost to Follow-up|2
2483672|NCT02147158|8582349|P5|Off-Treatment Interval 1|Lost to Follow-up|4
2483673|NCT02147158|8582350|P4|Off-Treatment Interval 1|Lost to Follow-up|2
2483674|NCT02147158|8582351|P3|Off-Treatment Interval 1|Lost to Follow-up|3
2483675|NCT02147158|8582352|P2|Off-Treatment Interval 1|Lost to Follow-up|1
2483676|NCT02147158|8582353|P1|Off-Treatment Interval 1|Lost to Follow-up|2
2483677|NCT02147158|8582348|P6|Off-Treatment Interval 1|Adverse Event|0
2483678|NCT02147158|8582349|P5|Off-Treatment Interval 1|Adverse Event|0
2483679|NCT02147158|8582350|P4|Off-Treatment Interval 1|Adverse Event|1
2483680|NCT02147158|8582351|P3|Off-Treatment Interval 1|Adverse Event|0
2483681|NCT02147158|8582352|P2|Off-Treatment Interval 1|Adverse Event|0
2483682|NCT02147158|8582353|P1|Off-Treatment Interval 1|Adverse Event|1
2483683|NCT02147158|8582348|P6|Treatment Course 1|Withdrawal of Consent|2
2483684|NCT02147158|8582349|P5|Treatment Course 1|Withdrawal of Consent|3
2483685|NCT02147158|8582350|P4|Treatment Course 1|Withdrawal of Consent|5
2483686|NCT02147158|8582351|P3|Treatment Course 1|Withdrawal of Consent|1
2483687|NCT02147158|8582352|P2|Treatment Course 1|Withdrawal of Consent|1
2483688|NCT02147158|8582353|P1|Treatment Course 1|Withdrawal of Consent|1
2483689|NCT02147158|8582348|P6|Treatment Course 1|Protocol Violation|0
2483690|NCT02147158|8582349|P5|Treatment Course 1|Protocol Violation|0
2483691|NCT02147158|8582350|P4|Treatment Course 1|Protocol Violation|1
2483692|NCT02147158|8582351|P3|Treatment Course 1|Protocol Violation|1
2483693|NCT02147158|8582352|P2|Treatment Course 1|Protocol Violation|0
2483694|NCT02147158|8582353|P1|Treatment Course 1|Protocol Violation|0
2483695|NCT02147158|8582348|P6|Treatment Course 1|Lost to Follow-up|4
2483696|NCT02147158|8582349|P5|Treatment Course 1|Lost to Follow-up|2
2483697|NCT02147158|8582350|P4|Treatment Course 1|Lost to Follow-up|3
2483698|NCT02147158|8582351|P3|Treatment Course 1|Lost to Follow-up|3
2483699|NCT02147158|8582352|P2|Treatment Course 1|Lost to Follow-up|4
2483700|NCT02147158|8582353|P1|Treatment Course 1|Lost to Follow-up|2
2483701|NCT02147158|8582348|P6|Treatment Course 1|Adverse Event|2
2483702|NCT02147158|8582349|P5|Treatment Course 1|Adverse Event|1
2483703|NCT02147158|8582350|P4|Treatment Course 1|Adverse Event|4
2483704|NCT02147158|8582351|P3|Treatment Course 1|Adverse Event|3
2483705|NCT02147158|8582352|P2|Treatment Course 1|Adverse Event|4
2483706|NCT02147158|8582353|P1|Treatment Course 1|Adverse Event|1
2483707|NCT02147132|8582382|P4|Overall Study|Lost to Follow-up|0
2483708|NCT02147132|8582383|P3|Overall Study|Lost to Follow-up|0
2483709|NCT02147132|8582384|P2|Overall Study|Lost to Follow-up|0
2483710|NCT02147132|8582385|P1|Overall Study|Lost to Follow-up|1
2483711|NCT02147093|8582405|P2|Period 2|Protocol Violation|0
2483712|NCT02147093|8582406|P1|Period 2|Protocol Violation|2
2483713|NCT02147093|8582405|P2|Period 1|Lost to Follow-up|1
2483714|NCT02147093|8582406|P1|Period 1|Lost to Follow-up|0
2483715|NCT02147067|8582416|P2|Overall Study|Withdrawal by Subject|2
2483716|NCT02147067|8582417|P1|Overall Study|Withdrawal by Subject|2
2483717|NCT02146599|8582443|P1|Overall Study|Failed to meet inclusion criteria|5
2483718|NCT02146365|8582462|P8|Overall Study|Other|0
2483719|NCT02146365|8582463|P7|Overall Study|Other|0
2483720|NCT02146365|8582464|P6|Overall Study|Other|0
2483721|NCT02146365|8582465|P5|Overall Study|Other|0
2483722|NCT02146365|8582466|P4|Overall Study|Other|1
2483723|NCT02146365|8582467|P3|Overall Study|Other|2
2483724|NCT02146365|8582468|P2|Overall Study|Other|0
2483725|NCT02146365|8582469|P1|Overall Study|Other|1
2483726|NCT02146365|8582462|P8|Overall Study|Unable to Comply with Protocol|0
2483727|NCT02146365|8582463|P7|Overall Study|Unable to Comply with Protocol|0
2483728|NCT02146365|8582464|P6|Overall Study|Unable to Comply with Protocol|0
2483729|NCT02146365|8582465|P5|Overall Study|Unable to Comply with Protocol|0
2483730|NCT02146365|8582466|P4|Overall Study|Unable to Comply with Protocol|0
2483731|NCT02146365|8582467|P3|Overall Study|Unable to Comply with Protocol|1
2483732|NCT02146365|8582468|P2|Overall Study|Unable to Comply with Protocol|1
2483733|NCT02146365|8582469|P1|Overall Study|Unable to Comply with Protocol|0
2483734|NCT02146365|8582462|P8|Overall Study|Withdrawal by Subject|0
2483735|NCT02146365|8582463|P7|Overall Study|Withdrawal by Subject|0
2483736|NCT02146365|8582464|P6|Overall Study|Withdrawal by Subject|0
2483737|NCT02146365|8582465|P5|Overall Study|Withdrawal by Subject|1
2483738|NCT02146365|8582466|P4|Overall Study|Withdrawal by Subject|5
2483739|NCT02146365|8582467|P3|Overall Study|Withdrawal by Subject|1
2483740|NCT02146365|8582468|P2|Overall Study|Withdrawal by Subject|2
2483741|NCT02146365|8582469|P1|Overall Study|Withdrawal by Subject|1
2483742|NCT02146365|8582462|P8|Overall Study|Lost to Follow-up|1
2483743|NCT02146365|8582463|P7|Overall Study|Lost to Follow-up|0
2483744|NCT02146365|8582464|P6|Overall Study|Lost to Follow-up|1
2483745|NCT02146365|8582465|P5|Overall Study|Lost to Follow-up|1
2483746|NCT02146365|8582466|P4|Overall Study|Lost to Follow-up|3
2483747|NCT02146365|8582467|P3|Overall Study|Lost to Follow-up|3
2483748|NCT02146365|8582468|P2|Overall Study|Lost to Follow-up|1
2483749|NCT02146365|8582469|P1|Overall Study|Lost to Follow-up|2
2483750|NCT02146352|8582595|P1|Overall Study|Patient entered hospice care|1
2483751|NCT02146352|8582595|P1|Overall Study|Death|1
2483752|NCT02146326|8582613|P4|Overall Study|Unable to complete interview|6
2483753|NCT02146326|8582614|P3|Overall Study|Unable to complete interview|10
2483754|NCT02146326|8582615|P2|Overall Study|Unable to complete interview|0
2483755|NCT02146326|8582616|P1|Overall Study|Unable to complete interview|0
2483756|NCT02146326|8582613|P4|Overall Study|Death|4
2483757|NCT02146326|8582614|P3|Overall Study|Death|4
2483758|NCT02146326|8582615|P2|Overall Study|Death|0
2483759|NCT02146326|8582616|P1|Overall Study|Death|0
2483760|NCT02146326|8582613|P4|Overall Study|Incarcerated|8
2483761|NCT02146326|8582614|P3|Overall Study|Incarcerated|3
2483762|NCT02146326|8582615|P2|Overall Study|Incarcerated|0
2483763|NCT02146326|8582616|P1|Overall Study|Incarcerated|0
2483764|NCT02146326|8582613|P4|Overall Study|Separated from mental health center|0
2483765|NCT02146326|8582614|P3|Overall Study|Separated from mental health center|0
2483766|NCT02146326|8582615|P2|Overall Study|Separated from mental health center|33
2483767|NCT02146326|8582616|P1|Overall Study|Separated from mental health center|23
2483768|NCT02146326|8582613|P4|Overall Study|Withdrawal by Subject|11
2483769|NCT02146326|8582614|P3|Overall Study|Withdrawal by Subject|15
2483770|NCT02146326|8582615|P2|Overall Study|Withdrawal by Subject|1
2483771|NCT02146326|8582616|P1|Overall Study|Withdrawal by Subject|2
2483772|NCT02146326|8582613|P4|Overall Study|Lost to Follow-up|19
2483773|NCT02146326|8582614|P3|Overall Study|Lost to Follow-up|11
2483774|NCT02146326|8582615|P2|Overall Study|Lost to Follow-up|3
2483775|NCT02146326|8582616|P1|Overall Study|Lost to Follow-up|3
2483776|NCT02146274|8582778|P1|Overall Study|Protocol Violation|73
2483777|NCT02146248|8582785|P1|Overall Study|Withdrawal by Subject|2
2483778|NCT02146131|8582795|P2|Overall Study|Physician Decision|56
2483779|NCT02146131|8582796|P1|Overall Study|Physician Decision|61
2483780|NCT02146105|8582802|P1|Overall Study|Withdrawal by Subject|5
2483781|NCT02146105|8582802|P1|Overall Study|Adverse Event|1
2483782|NCT02145468|8582853|P2|Overall Study|Withdrawal by Subject|8
2483783|NCT02145468|8582854|P1|Overall Study|Withdrawal by Subject|5
2483784|NCT02145429|8582912|P2|Overall Study|Withdrawal by Subject|3
2483785|NCT02145429|8582913|P1|Overall Study|Withdrawal by Subject|8
2483786|NCT02145429|8582912|P2|Overall Study|Lost to Follow-up|3
2483787|NCT02145429|8582913|P1|Overall Study|Lost to Follow-up|4
2483788|NCT02145429|8582912|P2|Overall Study|Death|5
2483789|NCT02145429|8582913|P1|Overall Study|Death|4
2483790|NCT02145390|8582944|P1|Overall Study|Withdrawal by Subject|1
2483791|NCT02145182|8582993|P2|Overall Study|Withdrawal by Subject|4
2483792|NCT02145182|8582994|P1|Overall Study|Withdrawal by Subject|5
2483793|NCT02145182|8582993|P2|Overall Study|Pre-transplant Withdrawal|2
2483794|NCT02145182|8582994|P1|Overall Study|Pre-transplant Withdrawal|0
2483795|NCT02145182|8582993|P2|Overall Study|Lost to Follow-up|2
2483796|NCT02145182|8582994|P1|Overall Study|Lost to Follow-up|2
2483797|NCT02145182|8582993|P2|Overall Study|Death|7
2483798|NCT02145182|8582994|P1|Overall Study|Death|7
2483799|NCT02145182|8582993|P2|Overall Study|Adverse Event|1
2483800|NCT02145182|8582994|P1|Overall Study|Adverse Event|4
2483801|NCT02145156|8583027|P3|Overall Study|No match to vaccination records|41
2483802|NCT02145156|8583028|P2|Overall Study|No match to vaccination records|52
2483803|NCT02145156|8583029|P1|Overall Study|No match to vaccination records|60
2483804|NCT02145026|8583079|P1|Overall Study|Physician Decision|4
2483805|NCT02145026|8583079|P1|Overall Study|Withdrawal by Subject|2
2483806|NCT02145026|8583079|P1|Overall Study|Death|4
2483807|NCT02145026|8583079|P1|Overall Study|Adverse Event|2
2483808|NCT02144701|8583110|P2|Overall Study|development of relapse, GVHD or death|3
2483809|NCT02144701|8583111|P1|Overall Study|development of relapse, GVHD or death|9
2483810|NCT02144610|8583138|P2|Overall Study|Other|1
2483811|NCT02144610|8583139|P1|Overall Study|Other|0
2483812|NCT02144610|8583138|P2|Overall Study|Study Discontinuation by Sponsor|14
2483813|NCT02144610|8583139|P1|Overall Study|Study Discontinuation by Sponsor|19
2483814|NCT02144610|8583138|P2|Overall Study|Death|2
2483815|NCT02144610|8583139|P1|Overall Study|Death|2
2483816|NCT02144610|8583138|P2|Overall Study|Withdrawal by Subject|5
2483817|NCT02144610|8583139|P1|Overall Study|Withdrawal by Subject|1
2483818|NCT02144610|8583138|P2|Overall Study|Physician Decision|0
2483819|NCT02144610|8583139|P1|Overall Study|Physician Decision|1
2483820|NCT02144337|8583180|P2|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0
2483821|NCT02144337|8583181|P1|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1
2483822|NCT02144337|8583180|P2|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0
2483823|NCT02144337|8583181|P1|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2
2483824|NCT02144337|8583180|P2|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0
2483825|NCT02144337|8583181|P1|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1
2483826|NCT02144337|8583180|P2|T2 Follow-up (Post-intervention)|Lost to Follow-up|0
2483827|NCT02144337|8583181|P1|T2 Follow-up (Post-intervention)|Lost to Follow-up|2
2483828|NCT02144337|8583180|P2|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
2483829|NCT02144337|8583181|P1|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
2483830|NCT02144285|8583201|P10|Overall Study|Withdrawal by Subject|0
2483831|NCT02144285|8583202|P9|Overall Study|Withdrawal by Subject|0
2483832|NCT02144285|8583203|P8|Overall Study|Withdrawal by Subject|0
2483833|NCT02144285|8583204|P7|Overall Study|Withdrawal by Subject|0
2483834|NCT02144285|8583205|P6|Overall Study|Withdrawal by Subject|0
2483835|NCT02144285|8583206|P5|Overall Study|Withdrawal by Subject|1
2483836|NCT02144285|8583207|P4|Overall Study|Withdrawal by Subject|0
2483837|NCT02144285|8583208|P3|Overall Study|Withdrawal by Subject|0
2483838|NCT02144285|8583209|P2|Overall Study|Withdrawal by Subject|0
2483839|NCT02144285|8583210|P1|Overall Study|Withdrawal by Subject|0
2483840|NCT02144220|8583336|P1|Overall Study|Protocol Violation|1
2483841|NCT02144220|8583336|P1|Overall Study|Withdrawal by Subject|2
2483842|NCT02144220|8583336|P1|Overall Study|Physician Decision|3
2483843|NCT02144220|8583336|P1|Overall Study|Lack of Efficacy|4
2483844|NCT02144220|8583336|P1|Overall Study|technology incompatibility|9
2483845|NCT02144077|8583355|P2|Overall Study|no visits 7 & 8/no visits after visit 4|0
2483846|NCT02144077|8583356|P1|Overall Study|no visits 7 & 8/no visits after visit 4|2
2483847|NCT02144077|8583355|P2|Overall Study|Death|1
2483848|NCT02144077|8583356|P1|Overall Study|Death|0
2483849|NCT02144077|8583355|P2|Overall Study|Protocol Violation|2
2483850|NCT02144077|8583356|P1|Overall Study|Protocol Violation|1
2483851|NCT02144077|8583355|P2|Overall Study|Lost to Follow-up|2
2483852|NCT02144077|8583356|P1|Overall Study|Lost to Follow-up|2
2483853|NCT02144077|8583355|P2|Overall Study|Adverse Event|3
2483854|NCT02144077|8583356|P1|Overall Study|Adverse Event|2
2483855|NCT02144077|8583355|P2|Overall Study|Withdrawal by Subject|3
2483856|NCT02144077|8583356|P1|Overall Study|Withdrawal by Subject|3
2483857|NCT02144012|8583374|P2|Overall Study|Other|0
2483858|NCT02144012|8583375|P1|Overall Study|Other|3
2483859|NCT02144012|8583374|P2|Overall Study|Study Terminated by Sponsor|12
2483860|NCT02144012|8583375|P1|Overall Study|Study Terminated by Sponsor|18
2483861|NCT02144012|8583374|P2|Overall Study|Withdrawal by Subject|3
2483862|NCT02144012|8583375|P1|Overall Study|Withdrawal by Subject|11
2483863|NCT02144012|8583374|P2|Overall Study|Death|0
2483864|NCT02144012|8583375|P1|Overall Study|Death|1
2483865|NCT02144012|8583374|P2|Overall Study|Adverse Event|0
2483866|NCT02144012|8583375|P1|Overall Study|Adverse Event|1
2483867|NCT02143947|8583412|P2|Overall Study|Lost to Follow-up|2
2483868|NCT02143947|8583413|P1|Overall Study|Lost to Follow-up|4
2483869|NCT02143843|8583425|P1|Overall Study|Withdrawal by Subject|2
2483870|NCT02143843|8583425|P1|Overall Study|Lack of Efficacy|2
2483871|NCT02143843|8583425|P1|Overall Study|Adverse Event|8
2483872|NCT02143778|8583430|P1|Overall Study|Device malfunction|1
2483873|NCT02143778|8583430|P1|Overall Study|Withdrawal by Subject|2
2483874|NCT02143713|8583439|P4|Post-treatment Follow-up (12 Months)|Other|7
2483875|NCT02143713|8583440|P3|Post-treatment Follow-up (12 Months)|Other|7
2483876|NCT02143713|8583441|P2|Post-treatment Follow-up (12 Months)|Other|4
2483877|NCT02143713|8583442|P1|Post-treatment Follow-up (12 Months)|Other|3
2483878|NCT02143713|8583439|P4|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
2483879|NCT02143713|8583440|P3|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
2483880|NCT02143713|8583441|P2|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
2483881|NCT02143713|8583442|P1|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
2483882|NCT02143713|8583439|P4|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1
2483883|NCT02143713|8583440|P3|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
2483884|NCT02143713|8583441|P2|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
2483885|NCT02143713|8583442|P1|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2
2483886|NCT02143713|8583439|P4|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
2483887|NCT02143713|8583440|P3|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11
2483888|NCT02143713|8583441|P2|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
2483889|NCT02143713|8583442|P1|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3
2483890|NCT02143713|8583439|P4|Post-treatment Follow-up (12 Months)|Adverse Event|0
2483891|NCT02143713|8583440|P3|Post-treatment Follow-up (12 Months)|Adverse Event|1
2483892|NCT02143713|8583441|P2|Post-treatment Follow-up (12 Months)|Adverse Event|0
2483893|NCT02143713|8583442|P1|Post-treatment Follow-up (12 Months)|Adverse Event|0
2483894|NCT02143713|8583439|P4|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10
2483895|NCT02143713|8583440|P3|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
2483896|NCT02143713|8583441|P2|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7
2483897|NCT02143713|8583442|P1|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
2483898|NCT02143713|8583439|P4|Treatment Period (6 Months)|Lack of Efficacy|1
2483899|NCT02143713|8583440|P3|Treatment Period (6 Months)|Lack of Efficacy|0
2483900|NCT02143713|8583441|P2|Treatment Period (6 Months)|Lack of Efficacy|0
2483901|NCT02143713|8583442|P1|Treatment Period (6 Months)|Lack of Efficacy|1
2483902|NCT02143713|8583439|P4|Treatment Period (6 Months)|Exclusionary Medication|0
2483903|NCT02143713|8583440|P3|Treatment Period (6 Months)|Exclusionary Medication|0
2483904|NCT02143713|8583441|P2|Treatment Period (6 Months)|Exclusionary Medication|0
2483905|NCT02143713|8583442|P1|Treatment Period (6 Months)|Exclusionary Medication|2
2483906|NCT02143713|8583439|P4|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4
2483907|NCT02143713|8583440|P3|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
2483908|NCT02143713|8583441|P2|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
2483909|NCT02143713|8583442|P1|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
2483910|NCT02143713|8583439|P4|Treatment Period (6 Months)|Other|2
2483911|NCT02143713|8583440|P3|Treatment Period (6 Months)|Other|3
2483912|NCT02143713|8583441|P2|Treatment Period (6 Months)|Other|0
2483913|NCT02143713|8583442|P1|Treatment Period (6 Months)|Other|3
2483914|NCT02143713|8583439|P4|Treatment Period (6 Months)|Non-compliance|3
2483915|NCT02143713|8583440|P3|Treatment Period (6 Months)|Non-compliance|0
2483916|NCT02143713|8583441|P2|Treatment Period (6 Months)|Non-compliance|0
2483917|NCT02143713|8583442|P1|Treatment Period (6 Months)|Non-compliance|1
2483918|NCT02143713|8583439|P4|Treatment Period (6 Months)|Pregnancy|0
2483919|NCT02143713|8583440|P3|Treatment Period (6 Months)|Pregnancy|2
2483920|NCT02143713|8583441|P2|Treatment Period (6 Months)|Pregnancy|2
2483921|NCT02143713|8583442|P1|Treatment Period (6 Months)|Pregnancy|0
2483922|NCT02143713|8583439|P4|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
2483923|NCT02143713|8583440|P3|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
2483924|NCT02143713|8583441|P2|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
2483925|NCT02143713|8583442|P1|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
2483926|NCT02143713|8583439|P4|Treatment Period (6 Months)|Lost to Follow-up|3
2483927|NCT02143713|8583440|P3|Treatment Period (6 Months)|Lost to Follow-up|4
2483928|NCT02143713|8583441|P2|Treatment Period (6 Months)|Lost to Follow-up|0
2483929|NCT02143713|8583442|P1|Treatment Period (6 Months)|Lost to Follow-up|3
2483930|NCT02143713|8583439|P4|Treatment Period (6 Months)|Adverse Event|9
2483931|NCT02143713|8583440|P3|Treatment Period (6 Months)|Adverse Event|8
2483932|NCT02143713|8583441|P2|Treatment Period (6 Months)|Adverse Event|8
2483933|NCT02143713|8583442|P1|Treatment Period (6 Months)|Adverse Event|7
2483934|NCT02143713|8583439|P4|Treatment Period (6 Months)|Withdrawal by Subject|4
2483935|NCT02143713|8583440|P3|Treatment Period (6 Months)|Withdrawal by Subject|5
2483936|NCT02143713|8583441|P2|Treatment Period (6 Months)|Withdrawal by Subject|2
2483937|NCT02143713|8583442|P1|Treatment Period (6 Months)|Withdrawal by Subject|1
2483938|NCT02143583|8583523|P3|Overall Study|husband illness|1
2483939|NCT02143583|8583524|P2|Overall Study|husband illness|0
2483940|NCT02143583|8583525|P1|Overall Study|husband illness|0
2483941|NCT02143583|8583523|P3|Overall Study|Withdrawal by Subject|1
2483942|NCT02143583|8583524|P2|Overall Study|Withdrawal by Subject|0
2483943|NCT02143583|8583525|P1|Overall Study|Withdrawal by Subject|1
2483944|NCT02143141|8583548|P2|Overall Study|pain scores at 24 hours not collected|0
2483945|NCT02143141|8583549|P1|Overall Study|pain scores at 24 hours not collected|1
2483946|NCT02143102|8583561|P2|Overall Study|Lost to Follow-up|0
2483947|NCT02143102|8583562|P1|Overall Study|Lost to Follow-up|11
2483948|NCT02143024|8583572|P2|Overall Study|Withdrawal by Subject|0
2483949|NCT02143024|8583573|P1|Overall Study|Withdrawal by Subject|1
2483950|NCT02143024|8583572|P2|Overall Study|Lost to Follow-up|1
2483951|NCT02143024|8583573|P1|Overall Study|Lost to Follow-up|1
2483952|NCT02142894|8583579|P1|Overall Study|Protocol Violation|8
2483953|NCT02142738|8583585|P2|Overall Study|Ongoing in Study|82
2483954|NCT02142738|8583586|P1|Overall Study|Ongoing in Study|107
2483955|NCT02142738|8583585|P2|Overall Study|Withdrawal by Subject|5
2483956|NCT02142738|8583586|P1|Overall Study|Withdrawal by Subject|5
2483957|NCT02142738|8583585|P2|Overall Study|Progressive Disease|1
2483958|NCT02142738|8583586|P1|Overall Study|Progressive Disease|0
2483959|NCT02142738|8583585|P2|Overall Study|Death|55
2483960|NCT02142738|8583586|P1|Overall Study|Death|33
2483961|NCT02142738|8583585|P2|Overall Study|Adverse Event|8
2483962|NCT02142738|8583586|P1|Overall Study|Adverse Event|9
2483963|NCT02142712|8583599|P4|Overall Study|Lost to Follow-up|0
2483964|NCT02142712|8583600|P3|Overall Study|Lost to Follow-up|1
2483965|NCT02142712|8583601|P2|Overall Study|Lost to Follow-up|1
2483966|NCT02142712|8583602|P1|Overall Study|Lost to Follow-up|1
2483967|NCT02142504|8583625|P3|Overall Study|Reason Not Specified|4
2483968|NCT02142504|8583626|P2|Overall Study|Reason Not Specified|5
2483969|NCT02142504|8583627|P1|Overall Study|Reason Not Specified|4
2483970|NCT02142504|8583625|P3|Overall Study|Physician Decision|3
2483971|NCT02142504|8583626|P2|Overall Study|Physician Decision|1
2483972|NCT02142504|8583627|P1|Overall Study|Physician Decision|0
2483973|NCT02142504|8583625|P3|Overall Study|Pregnancy|2
2483974|NCT02142504|8583626|P2|Overall Study|Pregnancy|4
2483975|NCT02142504|8583627|P1|Overall Study|Pregnancy|4
2483976|NCT02142504|8583625|P3|Overall Study|Withdrawal by Subject|11
2483977|NCT02142504|8583626|P2|Overall Study|Withdrawal by Subject|9
2483978|NCT02142504|8583627|P1|Overall Study|Withdrawal by Subject|7
2483979|NCT02142504|8583625|P3|Overall Study|Lost to Follow-up|17
2483980|NCT02142504|8583626|P2|Overall Study|Lost to Follow-up|19
2483981|NCT02142504|8583627|P1|Overall Study|Lost to Follow-up|12
2483982|NCT02142504|8583625|P3|Overall Study|Adverse Event|4
2483983|NCT02142504|8583626|P2|Overall Study|Adverse Event|3
2483984|NCT02142504|8583627|P1|Overall Study|Adverse Event|2
2483985|NCT02142504|8583625|P3|Overall Study|Protocol Violation|2
2483986|NCT02142504|8583626|P2|Overall Study|Protocol Violation|1
2483987|NCT02142504|8583627|P1|Overall Study|Protocol Violation|2
2483988|NCT02142283|8583816|P2|Overall Study|Withdrawal by Subject|3
2483989|NCT02142283|8583817|P1|Overall Study|Withdrawal by Subject|1
2483990|NCT02142283|8583816|P2|Overall Study|Death|18
2483991|NCT02142283|8583817|P1|Overall Study|Death|20
2483992|NCT02141997|8583926|P4|Overall Study|Other|0
2483993|NCT02141997|8583927|P3|Overall Study|Other|0
2483994|NCT02141997|8583928|P2|Overall Study|Other|4
2483995|NCT02141997|8583929|P1|Overall Study|Other|1
2483996|NCT02141997|8583926|P4|Overall Study|Withdrew consent|0
2483997|NCT02141997|8583927|P3|Overall Study|Withdrew consent|3
2483998|NCT02141997|8583928|P2|Overall Study|Withdrew consent|0
2483999|NCT02141997|8583929|P1|Overall Study|Withdrew consent|1
2484000|NCT02141997|8583926|P4|Overall Study|Participant noncompliance|0
2484001|NCT02141997|8583927|P3|Overall Study|Participant noncompliance|0
2484002|NCT02141997|8583928|P2|Overall Study|Participant noncompliance|0
2484003|NCT02141997|8583929|P1|Overall Study|Participant noncompliance|1
2484004|NCT02141997|8583926|P4|Overall Study|Adverse Event|1
2484005|NCT02141997|8583927|P3|Overall Study|Adverse Event|0
2484006|NCT02141997|8583928|P2|Overall Study|Adverse Event|2
2484007|NCT02141997|8583929|P1|Overall Study|Adverse Event|0
2484008|NCT02141984|8583967|P1|Overall Study|Lack of Efficacy|2
2484009|NCT02141854|8583986|P6|Treatment Period|Lost to Follow-up|1
2484010|NCT02141854|8583987|P5|Treatment Period|Lost to Follow-up|0
2484011|NCT02141854|8583988|P4|Treatment Period|Lost to Follow-up|1
2484012|NCT02141854|8583989|P3|Treatment Period|Lost to Follow-up|1
2484013|NCT02141854|8583990|P2|Treatment Period|Lost to Follow-up|1
2484014|NCT02141854|8583991|P1|Treatment Period|Lost to Follow-up|0
2484015|NCT02141854|8583986|P6|Treatment Period|Disease progression|18
2484016|NCT02141854|8583987|P5|Treatment Period|Disease progression|0
2484017|NCT02141854|8583988|P4|Treatment Period|Disease progression|3
2484018|NCT02141854|8583989|P3|Treatment Period|Disease progression|1
2484019|NCT02141854|8583990|P2|Treatment Period|Disease progression|2
2484020|NCT02141854|8583991|P1|Treatment Period|Disease progression|0
2484021|NCT02141854|8583986|P6|Treatment Period|Withdrawal by Subject|7
2484022|NCT02141854|8583987|P5|Treatment Period|Withdrawal by Subject|4
2484023|NCT02141854|8583988|P4|Treatment Period|Withdrawal by Subject|3
2484024|NCT02141854|8583989|P3|Treatment Period|Withdrawal by Subject|3
2484025|NCT02141854|8583990|P2|Treatment Period|Withdrawal by Subject|2
2484026|NCT02141854|8583991|P1|Treatment Period|Withdrawal by Subject|0
2484027|NCT02141854|8583986|P6|Treatment Period|Adverse Event|2
2484028|NCT02141854|8583987|P5|Treatment Period|Adverse Event|2
2484029|NCT02141854|8583988|P4|Treatment Period|Adverse Event|0
2484030|NCT02141854|8583989|P3|Treatment Period|Adverse Event|2
2484031|NCT02141854|8583990|P2|Treatment Period|Adverse Event|2
2484032|NCT02141854|8583991|P1|Treatment Period|Adverse Event|0
2484033|NCT02141854|8583986|P6|Treatment Period|Other|2
2484034|NCT02141854|8583987|P5|Treatment Period|Other|1
2484035|NCT02141854|8583988|P4|Treatment Period|Other|0
2484036|NCT02141854|8583989|P3|Treatment Period|Other|2
2484037|NCT02141854|8583990|P2|Treatment Period|Other|1
2484038|NCT02141854|8583991|P1|Treatment Period|Other|0
2484039|NCT02141854|8583986|P6|Treatment Period|Pregnancy|0
2484040|NCT02141854|8583987|P5|Treatment Period|Pregnancy|0
2484041|NCT02141854|8583988|P4|Treatment Period|Pregnancy|0
2484042|NCT02141854|8583989|P3|Treatment Period|Pregnancy|0
2484043|NCT02141854|8583990|P2|Treatment Period|Pregnancy|1
2484044|NCT02141854|8583991|P1|Treatment Period|Pregnancy|0
2484045|NCT02141854|8583986|P6|Treatment Period|Lack of Efficacy|7
2484046|NCT02141854|8583987|P5|Treatment Period|Lack of Efficacy|1
2484047|NCT02141854|8583988|P4|Treatment Period|Lack of Efficacy|1
2484048|NCT02141854|8583989|P3|Treatment Period|Lack of Efficacy|0
2484049|NCT02141854|8583990|P2|Treatment Period|Lack of Efficacy|0
2484050|NCT02141854|8583991|P1|Treatment Period|Lack of Efficacy|0
2484051|NCT02141854|8583986|P6|Treatment Period|Noncompliance|0
2484052|NCT02141854|8583987|P5|Treatment Period|Noncompliance|0
2484053|NCT02141854|8583988|P4|Treatment Period|Noncompliance|1
2484054|NCT02141854|8583989|P3|Treatment Period|Noncompliance|0
2484055|NCT02141854|8583990|P2|Treatment Period|Noncompliance|0
2484056|NCT02141854|8583991|P1|Treatment Period|Noncompliance|0
2484057|NCT02141854|8583986|P6|Treatment Period|Protocol Violation|1
2484058|NCT02141854|8583987|P5|Treatment Period|Protocol Violation|2
2484059|NCT02141854|8583988|P4|Treatment Period|Protocol Violation|2
2484060|NCT02141854|8583989|P3|Treatment Period|Protocol Violation|0
2484061|NCT02141854|8583990|P2|Treatment Period|Protocol Violation|1
2484062|NCT02141854|8583991|P1|Treatment Period|Protocol Violation|0
2484063|NCT02141854|8583986|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2484064|NCT02141854|8583987|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2484065|NCT02141854|8583988|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2484066|NCT02141854|8583989|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2484067|NCT02141854|8583990|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2484068|NCT02141854|8583991|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
2484069|NCT02141854|8583986|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2484070|NCT02141854|8583987|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2484071|NCT02141854|8583988|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2484072|NCT02141854|8583989|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2484073|NCT02141854|8583990|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2484074|NCT02141854|8583991|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|9
2484075|NCT02141854|8583986|P6|Run-In Period (Pre-assignment)|Adverse Event|0
2484076|NCT02141854|8583987|P5|Run-In Period (Pre-assignment)|Adverse Event|0
2484077|NCT02141854|8583988|P4|Run-In Period (Pre-assignment)|Adverse Event|0
2484078|NCT02141854|8583989|P3|Run-In Period (Pre-assignment)|Adverse Event|0
2484079|NCT02141854|8583990|P2|Run-In Period (Pre-assignment)|Adverse Event|0
2484080|NCT02141854|8583991|P1|Run-In Period (Pre-assignment)|Adverse Event|10
2484081|NCT02141854|8583986|P6|Run-In Period (Pre-assignment)|Other|0
2484082|NCT02141854|8583987|P5|Run-In Period (Pre-assignment)|Other|0
2484083|NCT02141854|8583988|P4|Run-In Period (Pre-assignment)|Other|0
2484084|NCT02141854|8583989|P3|Run-In Period (Pre-assignment)|Other|0
2484085|NCT02141854|8583990|P2|Run-In Period (Pre-assignment)|Other|0
2484086|NCT02141854|8583991|P1|Run-In Period (Pre-assignment)|Other|14
2484087|NCT02141854|8583986|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2484088|NCT02141854|8583987|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2484089|NCT02141854|8583988|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2484090|NCT02141854|8583989|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2484091|NCT02141854|8583990|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2484092|NCT02141854|8583991|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|14
2484093|NCT02141854|8583986|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2484094|NCT02141854|8583987|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2484095|NCT02141854|8583988|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2484096|NCT02141854|8583989|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2484097|NCT02141854|8583990|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2484098|NCT02141854|8583991|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|76
2484099|NCT02141854|8583986|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2484100|NCT02141854|8583987|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2484101|NCT02141854|8583988|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2484102|NCT02141854|8583989|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2484103|NCT02141854|8583990|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2484104|NCT02141854|8583991|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|25
2484105|NCT02141659|8584049|P6|Overall Study|Pretreatment Event/ Adverse Event|1
2484106|NCT02141659|8584050|P5|Overall Study|Pretreatment Event/ Adverse Event|2
2484107|NCT02141659|8584051|P4|Overall Study|Pretreatment Event/ Adverse Event|0
2484108|NCT02141659|8584052|P3|Overall Study|Pretreatment Event/ Adverse Event|0
2484109|NCT02141659|8584053|P2|Overall Study|Pretreatment Event/ Adverse Event|0
2484110|NCT02141659|8584054|P1|Overall Study|Pretreatment Event/ Adverse Event|0
2484111|NCT02141659|8584049|P6|Overall Study|Lack of Efficacy|1
2484112|NCT02141659|8584050|P5|Overall Study|Lack of Efficacy|0
2484113|NCT02141659|8584051|P4|Overall Study|Lack of Efficacy|0
2484114|NCT02141659|8584052|P3|Overall Study|Lack of Efficacy|0
2484115|NCT02141659|8584053|P2|Overall Study|Lack of Efficacy|0
2484116|NCT02141659|8584054|P1|Overall Study|Lack of Efficacy|0
2484117|NCT02141659|8584049|P6|Overall Study|Major Protocol Deviation|0
2484118|NCT02141659|8584050|P5|Overall Study|Major Protocol Deviation|0
2484119|NCT02141659|8584051|P4|Overall Study|Major Protocol Deviation|0
2484120|NCT02141659|8584052|P3|Overall Study|Major Protocol Deviation|0
2484121|NCT02141659|8584053|P2|Overall Study|Major Protocol Deviation|1
2484122|NCT02141659|8584054|P1|Overall Study|Major Protocol Deviation|0
2484123|NCT02141633|8584110|P2|Overall Study|Physician Decision|0
2484124|NCT02141633|8584111|P1|Overall Study|Physician Decision|1
2484125|NCT02141620|8584119|P2|Treatment Condition 1 (7 Days)|Adverse Event|0
2484126|NCT02141620|8584120|P1|Treatment Condition 1 (7 Days)|Adverse Event|1
2484127|NCT02141516|8584212|P3|Overall Study|Other|0
2484128|NCT02141516|8584213|P2|Overall Study|Other|3
2484129|NCT02141516|8584214|P1|Overall Study|Other|0
2484130|NCT02141516|8584212|P3|Overall Study|Lost to Follow-up|0
2484131|NCT02141516|8584213|P2|Overall Study|Lost to Follow-up|1
2484132|NCT02141516|8584214|P1|Overall Study|Lost to Follow-up|0
2484133|NCT02141516|8584212|P3|Overall Study|Adverse Event|0
2484134|NCT02141516|8584213|P2|Overall Study|Adverse Event|1
2484135|NCT02141516|8584214|P1|Overall Study|Adverse Event|0
2484136|NCT02141490|8584265|P3|Overall Study|Screening failures|0
2484137|NCT02141490|8584266|P2|Overall Study|Screening failures|0
2484138|NCT02141490|8584267|P1|Overall Study|Screening failures|4
2484139|NCT02141399|8584312|P1|Overall Study|Failure to meet eligibility criteria|14
2484140|NCT02141399|8584312|P1|Overall Study|Withdrawal by Subject|238
2484141|NCT02141399|8584312|P1|Overall Study|Protocol Violation|38
2484142|NCT02141399|8584312|P1|Overall Study|Pregnancy|3
2484143|NCT02141399|8584312|P1|Overall Study|Physician Decision|17
2484144|NCT02141399|8584312|P1|Overall Study|Other|45
2484145|NCT02141399|8584312|P1|Overall Study|Non-compliance with study drug|18
2484146|NCT02141399|8584312|P1|Overall Study|Lost to Follow-up|151
2484147|NCT02141399|8584312|P1|Overall Study|Lack of Efficacy|62
2484148|NCT02141399|8584312|P1|Overall Study|Adverse Event|158
2484149|NCT02141360|8584318|P3|Overall Study|Study Terminated before Visit|0
2484150|NCT02141360|8584319|P2|Overall Study|Study Terminated before Visit|0
2484151|NCT02141360|8584320|P1|Overall Study|Study Terminated before Visit|1
2484152|NCT02141360|8584318|P3|Overall Study|Withdrawal by Subject|0
2484153|NCT02141360|8584319|P2|Overall Study|Withdrawal by Subject|0
2484154|NCT02141360|8584320|P1|Overall Study|Withdrawal by Subject|6
2484155|NCT02141295|8584331|P3|Overall Study|Withdrawal by Subject|4
2484156|NCT02141295|8584332|P2|Overall Study|Withdrawal by Subject|9
2484157|NCT02141295|8584333|P1|Overall Study|Withdrawal by Subject|0
2484158|NCT02141295|8584331|P3|Overall Study|Reason not specified|10
2484159|NCT02141295|8584332|P2|Overall Study|Reason not specified|9
2484160|NCT02141295|8584333|P1|Overall Study|Reason not specified|0
2484161|NCT02141295|8584331|P3|Overall Study|Progressive disease|50
2484162|NCT02141295|8584332|P2|Overall Study|Progressive disease|32
2484163|NCT02141295|8584333|P1|Overall Study|Progressive disease|3
2484164|NCT02141295|8584331|P3|Overall Study|Non-compliance|0
2484165|NCT02141295|8584332|P2|Overall Study|Non-compliance|1
2484166|NCT02141295|8584333|P1|Overall Study|Non-compliance|0
2484167|NCT02141295|8584331|P3|Overall Study|Study terminated by sponsor|6
2484168|NCT02141295|8584332|P2|Overall Study|Study terminated by sponsor|6
2484169|NCT02141295|8584333|P1|Overall Study|Study terminated by sponsor|0
2484170|NCT02141295|8584331|P3|Overall Study|Physician Decision|14
2484171|NCT02141295|8584332|P2|Overall Study|Physician Decision|19
2484172|NCT02141295|8584333|P1|Overall Study|Physician Decision|2
2484173|NCT02141295|8584331|P3|Overall Study|Adverse Event|11
2484174|NCT02141295|8584332|P2|Overall Study|Adverse Event|18
2484175|NCT02141295|8584333|P1|Overall Study|Adverse Event|1
2484176|NCT02141217|8584369|P2|Overall Study|Surgical Intervention|1
2484177|NCT02141217|8584370|P1|Overall Study|Surgical Intervention|1
2484178|NCT02141217|8584369|P2|Overall Study|Physician Decision|0
2484179|NCT02141217|8584370|P1|Overall Study|Physician Decision|1
2484180|NCT02141217|8584369|P2|Overall Study|Lost to Follow-up|1
2484181|NCT02141217|8584370|P1|Overall Study|Lost to Follow-up|1
2484182|NCT02141217|8584369|P2|Overall Study|Withdrawal by Subject|0
2484183|NCT02141217|8584370|P1|Overall Study|Withdrawal by Subject|6
2484184|NCT02141217|8584369|P2|Overall Study|Protocol Violation|4
2484185|NCT02141217|8584370|P1|Overall Study|Protocol Violation|1
2484186|NCT02141217|8584369|P2|Overall Study|Adverse Event|2
2484187|NCT02141217|8584370|P1|Overall Study|Adverse Event|1
2484188|NCT02140775|8584432|P2|Overall Study|Withdrawal by Subject|7
2484189|NCT02140775|8584433|P1|Overall Study|Withdrawal by Subject|30
2484190|NCT02140762|8584445|P2|Overall Study|Other|1
2484191|NCT02140762|8584446|P1|Overall Study|Other|0
2484192|NCT02140762|8584445|P2|Overall Study|Withdrawal by Subject|4
2484193|NCT02140762|8584446|P1|Overall Study|Withdrawal by Subject|6
2484194|NCT02140762|8584445|P2|Overall Study|Protocol Violation|1
2484195|NCT02140762|8584446|P1|Overall Study|Protocol Violation|1
2484196|NCT02140762|8584445|P2|Overall Study|Lost to Follow-up|5
2484197|NCT02140762|8584446|P1|Overall Study|Lost to Follow-up|9
2484198|NCT02140762|8584445|P2|Overall Study|Adverse Event|1
2484199|NCT02140762|8584446|P1|Overall Study|Adverse Event|1
2484200|NCT02140645|8584512|P6|Overall Study|Not linked|70896
2484201|NCT02140645|8584513|P5|Overall Study|Not linked|3286
2484202|NCT02140645|8584514|P4|Overall Study|Not linked|13833
2484203|NCT02140645|8584515|P3|Overall Study|Not linked|4236
2484204|NCT02140645|8584516|P2|Overall Study|Not linked|61654
2484205|NCT02140645|8584517|P1|Overall Study|Not linked|5489
2484206|NCT02140567|8584615|P1|Overall Study|Problems with recording equipment|6
2484207|NCT02140411|8584620|P1|Overall Study|Adverse Event|1
2484208|NCT02140164|8584640|P1|Overall Study|Cystoid Macular Edema (CME) resolved|2
2484209|NCT02140060|8584661|P6|Overall Study|Lack of Efficacy|0
2484210|NCT02140060|8584662|P5|Overall Study|Lack of Efficacy|0
2484211|NCT02140060|8584663|P4|Overall Study|Lack of Efficacy|1
2484212|NCT02140060|8584664|P3|Overall Study|Lack of Efficacy|0
2484213|NCT02140060|8584665|P2|Overall Study|Lack of Efficacy|0
2484214|NCT02140060|8584666|P1|Overall Study|Lack of Efficacy|0
2484215|NCT02140060|8584661|P6|Overall Study|Adverse Event|1
2484216|NCT02140060|8584662|P5|Overall Study|Adverse Event|1
2484217|NCT02140060|8584663|P4|Overall Study|Adverse Event|1
2484218|NCT02140060|8584664|P3|Overall Study|Adverse Event|0
2484219|NCT02140060|8584665|P2|Overall Study|Adverse Event|0
2484220|NCT02140060|8584666|P1|Overall Study|Adverse Event|0
2484221|NCT02139982|8584691|P10|Overall Study|Lack of Efficacy|0
2484222|NCT02139982|8584692|P9|Overall Study|Lack of Efficacy|0
2484223|NCT02139982|8584693|P8|Overall Study|Lack of Efficacy|0
2484224|NCT02139982|8584694|P7|Overall Study|Lack of Efficacy|0
2484225|NCT02139982|8584695|P6|Overall Study|Lack of Efficacy|0
2484226|NCT02139982|8584696|P5|Overall Study|Lack of Efficacy|0
2484227|NCT02139982|8584697|P4|Overall Study|Lack of Efficacy|1
2484228|NCT02139982|8584698|P3|Overall Study|Lack of Efficacy|0
2484229|NCT02139982|8584699|P2|Overall Study|Lack of Efficacy|1
2484230|NCT02139982|8584700|P1|Overall Study|Lack of Efficacy|0
2484231|NCT02139943|8584745|P3|Overall Study|eGFR Withdrawal Criteria|1
2484232|NCT02139943|8584746|P2|Overall Study|eGFR Withdrawal Criteria|0
2484233|NCT02139943|8584747|P1|Overall Study|eGFR Withdrawal Criteria|0
2484234|NCT02139943|8584745|P3|Overall Study|Participant in Poor Compliance|1
2484235|NCT02139943|8584746|P2|Overall Study|Participant in Poor Compliance|0
2484236|NCT02139943|8584747|P1|Overall Study|Participant in Poor Compliance|1
2484237|NCT02139943|8584745|P3|Overall Study|Participant wishes to discontinue|0
2484238|NCT02139943|8584746|P2|Overall Study|Participant wishes to discontinue|0
2484239|NCT02139943|8584747|P1|Overall Study|Participant wishes to discontinue|2
2484240|NCT02139943|8584745|P3|Overall Study|Other|1
2484241|NCT02139943|8584746|P2|Overall Study|Other|0
2484242|NCT02139943|8584747|P1|Overall Study|Other|0
2484243|NCT02139943|8584745|P3|Overall Study|Withdrawal by Subject|0
2484244|NCT02139943|8584746|P2|Overall Study|Withdrawal by Subject|3
2484245|NCT02139943|8584747|P1|Overall Study|Withdrawal by Subject|4
2484246|NCT02139943|8584745|P3|Overall Study|Lost to Follow-up|2
2484247|NCT02139943|8584746|P2|Overall Study|Lost to Follow-up|2
2484248|NCT02139943|8584747|P1|Overall Study|Lost to Follow-up|3
2484249|NCT02139943|8584745|P3|Overall Study|Adverse Event|2
2484250|NCT02139943|8584746|P2|Overall Study|Adverse Event|1
2484251|NCT02139943|8584747|P1|Overall Study|Adverse Event|0
2484252|NCT02139644|8584772|P6|Treatment Period|Other|1
2484253|NCT02139644|8584773|P5|Treatment Period|Other|0
2484254|NCT02139644|8584774|P4|Treatment Period|Other|1
2484255|NCT02139644|8584775|P3|Treatment Period|Other|1
2484256|NCT02139644|8584776|P2|Treatment Period|Other|3
2484257|NCT02139644|8584777|P1|Treatment Period|Other|0
2484258|NCT02139644|8584772|P6|Treatment Period|Lack of Efficacy|4
2484259|NCT02139644|8584773|P5|Treatment Period|Lack of Efficacy|1
2484260|NCT02139644|8584774|P4|Treatment Period|Lack of Efficacy|0
2484261|NCT02139644|8584775|P3|Treatment Period|Lack of Efficacy|1
2484262|NCT02139644|8584776|P2|Treatment Period|Lack of Efficacy|0
2484263|NCT02139644|8584777|P1|Treatment Period|Lack of Efficacy|0
2484264|NCT02139644|8584772|P6|Treatment Period|Lost to Follow-up|1
2484265|NCT02139644|8584773|P5|Treatment Period|Lost to Follow-up|1
2484266|NCT02139644|8584774|P4|Treatment Period|Lost to Follow-up|1
2484267|NCT02139644|8584775|P3|Treatment Period|Lost to Follow-up|1
2484268|NCT02139644|8584776|P2|Treatment Period|Lost to Follow-up|0
2484269|NCT02139644|8584777|P1|Treatment Period|Lost to Follow-up|0
2484270|NCT02139644|8584772|P6|Treatment Period|Disease progression|2
2484271|NCT02139644|8584773|P5|Treatment Period|Disease progression|1
2484272|NCT02139644|8584774|P4|Treatment Period|Disease progression|1
2484273|NCT02139644|8584775|P3|Treatment Period|Disease progression|0
2484274|NCT02139644|8584776|P2|Treatment Period|Disease progression|0
2484275|NCT02139644|8584777|P1|Treatment Period|Disease progression|0
2484276|NCT02139644|8584772|P6|Treatment Period|Protocol Violation|1
2484277|NCT02139644|8584773|P5|Treatment Period|Protocol Violation|1
2484278|NCT02139644|8584774|P4|Treatment Period|Protocol Violation|1
2484279|NCT02139644|8584775|P3|Treatment Period|Protocol Violation|0
2484280|NCT02139644|8584776|P2|Treatment Period|Protocol Violation|0
2484281|NCT02139644|8584777|P1|Treatment Period|Protocol Violation|0
2484282|NCT02139644|8584772|P6|Treatment Period|Non-compliance|0
2484283|NCT02139644|8584773|P5|Treatment Period|Non-compliance|0
2484284|NCT02139644|8584774|P4|Treatment Period|Non-compliance|1
2484285|NCT02139644|8584775|P3|Treatment Period|Non-compliance|0
2484286|NCT02139644|8584776|P2|Treatment Period|Non-compliance|0
2484287|NCT02139644|8584777|P1|Treatment Period|Non-compliance|0
2484288|NCT02139644|8584772|P6|Treatment Period|Withdrawal by Subject|2
2484289|NCT02139644|8584773|P5|Treatment Period|Withdrawal by Subject|3
2484290|NCT02139644|8584774|P4|Treatment Period|Withdrawal by Subject|2
2484291|NCT02139644|8584775|P3|Treatment Period|Withdrawal by Subject|2
2484292|NCT02139644|8584776|P2|Treatment Period|Withdrawal by Subject|0
2484293|NCT02139644|8584777|P1|Treatment Period|Withdrawal by Subject|0
2484294|NCT02139644|8584772|P6|Treatment Period|Adverse Event|6
2484295|NCT02139644|8584773|P5|Treatment Period|Adverse Event|1
2484296|NCT02139644|8584774|P4|Treatment Period|Adverse Event|2
2484297|NCT02139644|8584775|P3|Treatment Period|Adverse Event|3
2484298|NCT02139644|8584776|P2|Treatment Period|Adverse Event|0
2484299|NCT02139644|8584777|P1|Treatment Period|Adverse Event|0
2484300|NCT02139644|8584772|P6|Run-In Period (Pre-assignment)|Other|0
2484301|NCT02139644|8584773|P5|Run-In Period (Pre-assignment)|Other|0
2484302|NCT02139644|8584774|P4|Run-In Period (Pre-assignment)|Other|0
2484303|NCT02139644|8584775|P3|Run-In Period (Pre-assignment)|Other|0
2484304|NCT02139644|8584776|P2|Run-In Period (Pre-assignment)|Other|0
2484305|NCT02139644|8584777|P1|Run-In Period (Pre-assignment)|Other|6
2484306|NCT02139644|8584772|P6|Run-In Period (Pre-assignment)|Adverse Event|0
2484307|NCT02139644|8584773|P5|Run-In Period (Pre-assignment)|Adverse Event|0
2484308|NCT02139644|8584774|P4|Run-In Period (Pre-assignment)|Adverse Event|0
2484309|NCT02139644|8584775|P3|Run-In Period (Pre-assignment)|Adverse Event|0
2484310|NCT02139644|8584776|P2|Run-In Period (Pre-assignment)|Adverse Event|0
2484311|NCT02139644|8584777|P1|Run-In Period (Pre-assignment)|Adverse Event|3
2484312|NCT02139644|8584772|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2484313|NCT02139644|8584773|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2484314|NCT02139644|8584774|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2484315|NCT02139644|8584775|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2484316|NCT02139644|8584776|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
2484317|NCT02139644|8584777|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|8
2484318|NCT02139644|8584772|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2484319|NCT02139644|8584773|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2484320|NCT02139644|8584774|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2484321|NCT02139644|8584775|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2484322|NCT02139644|8584776|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
2484323|NCT02139644|8584777|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|11
2484324|NCT02139644|8584772|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2484325|NCT02139644|8584773|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2484326|NCT02139644|8584774|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2484327|NCT02139644|8584775|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2484328|NCT02139644|8584776|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
2484329|NCT02139644|8584777|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|12
2484330|NCT02139644|8584772|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2484331|NCT02139644|8584773|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2484332|NCT02139644|8584774|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2484333|NCT02139644|8584775|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2484334|NCT02139644|8584776|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
2484335|NCT02139644|8584777|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|30
2484336|NCT02139644|8584772|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2484337|NCT02139644|8584773|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2484338|NCT02139644|8584774|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2484339|NCT02139644|8584775|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2484340|NCT02139644|8584776|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
2484341|NCT02139644|8584777|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|70
2484342|NCT02139592|8584829|P1|Overall Study|Case Report Forms Uncollected|8
2484343|NCT02139124|8584899|P5|Overall Study|Lost to Follow-up|4
2484344|NCT02139124|8584900|P4|Overall Study|Lost to Follow-up|5
2484345|NCT02139124|8584901|P3|Overall Study|Lost to Follow-up|0
2484346|NCT02139124|8584902|P2|Overall Study|Lost to Follow-up|2
2484347|NCT02139124|8584903|P1|Overall Study|Lost to Follow-up|3
2484348|NCT02139124|8584899|P5|Overall Study|subject moved|0
2484349|NCT02139124|8584900|P4|Overall Study|subject moved|0
2484350|NCT02139124|8584901|P3|Overall Study|subject moved|0
2484351|NCT02139124|8584902|P2|Overall Study|subject moved|0
2484352|NCT02139124|8584903|P1|Overall Study|subject moved|1
2484353|NCT02139124|8584899|P5|Overall Study|incarceration|0
2484354|NCT02139124|8584900|P4|Overall Study|incarceration|0
2484355|NCT02139124|8584901|P3|Overall Study|incarceration|1
2484356|NCT02139124|8584902|P2|Overall Study|incarceration|0
2484357|NCT02139124|8584903|P1|Overall Study|incarceration|0
2484358|NCT02139124|8584899|P5|Overall Study|non-compliant|0
2484359|NCT02139124|8584900|P4|Overall Study|non-compliant|2
2484360|NCT02139124|8584901|P3|Overall Study|non-compliant|0
2484361|NCT02139124|8584902|P2|Overall Study|non-compliant|0
2484362|NCT02139124|8584903|P1|Overall Study|non-compliant|1
2484363|NCT02139124|8584899|P5|Overall Study|Protocol Violation|1
2484364|NCT02139124|8584900|P4|Overall Study|Protocol Violation|1
2484365|NCT02139124|8584901|P3|Overall Study|Protocol Violation|0
2484366|NCT02139124|8584902|P2|Overall Study|Protocol Violation|0
2484367|NCT02139124|8584903|P1|Overall Study|Protocol Violation|0
2484368|NCT02139124|8584899|P5|Overall Study|Withdrawal by Subject|3
2484369|NCT02139124|8584900|P4|Overall Study|Withdrawal by Subject|2
2484370|NCT02139124|8584901|P3|Overall Study|Withdrawal by Subject|2
2484371|NCT02139124|8584902|P2|Overall Study|Withdrawal by Subject|2
2484372|NCT02139124|8584903|P1|Overall Study|Withdrawal by Subject|2
2484373|NCT02139124|8584899|P5|Overall Study|Adverse Event|5
2484374|NCT02139124|8584900|P4|Overall Study|Adverse Event|2
2484375|NCT02139124|8584901|P3|Overall Study|Adverse Event|1
2484376|NCT02139124|8584902|P2|Overall Study|Adverse Event|0
2484377|NCT02139124|8584903|P1|Overall Study|Adverse Event|2
2484378|NCT02139046|8584920|P5|Overall Study|Other Miscellaneous Reasons|12
2484379|NCT02139046|8584921|P4|Overall Study|Other Miscellaneous Reasons|9
2484380|NCT02139046|8584922|P3|Overall Study|Other Miscellaneous Reasons|4
2484381|NCT02139046|8584923|P2|Overall Study|Other Miscellaneous Reasons|9
2484382|NCT02139046|8584924|P1|Overall Study|Other Miscellaneous Reasons|10
2484383|NCT02139046|8584920|P5|Overall Study|Withdrawal due to a Gout Flare|1
2484384|NCT02139046|8584921|P4|Overall Study|Withdrawal due to a Gout Flare|0
2484385|NCT02139046|8584922|P3|Overall Study|Withdrawal due to a Gout Flare|1
2484386|NCT02139046|8584923|P2|Overall Study|Withdrawal due to a Gout Flare|1
2484387|NCT02139046|8584924|P1|Overall Study|Withdrawal due to a Gout Flare|1
2484388|NCT02139046|8584920|P5|Overall Study|Lack of Efficacy|2
2484389|NCT02139046|8584921|P4|Overall Study|Lack of Efficacy|1
2484390|NCT02139046|8584922|P3|Overall Study|Lack of Efficacy|2
2484391|NCT02139046|8584923|P2|Overall Study|Lack of Efficacy|1
2484392|NCT02139046|8584924|P1|Overall Study|Lack of Efficacy|0
2484393|NCT02139046|8584920|P5|Overall Study|Voluntary Withdrawal|16
2484394|NCT02139046|8584921|P4|Overall Study|Voluntary Withdrawal|15
2484395|NCT02139046|8584922|P3|Overall Study|Voluntary Withdrawal|10
2484396|NCT02139046|8584923|P2|Overall Study|Voluntary Withdrawal|8
2484397|NCT02139046|8584924|P1|Overall Study|Voluntary Withdrawal|20
2484398|NCT02139046|8584920|P5|Overall Study|Lost to Follow-up|13
2484399|NCT02139046|8584921|P4|Overall Study|Lost to Follow-up|18
2484400|NCT02139046|8584922|P3|Overall Study|Lost to Follow-up|16
2484401|NCT02139046|8584923|P2|Overall Study|Lost to Follow-up|16
2484402|NCT02139046|8584924|P1|Overall Study|Lost to Follow-up|13
2484403|NCT02139046|8584920|P5|Overall Study|Major Protocol Deviation|6
2484404|NCT02139046|8584921|P4|Overall Study|Major Protocol Deviation|12
2484405|NCT02139046|8584922|P3|Overall Study|Major Protocol Deviation|16
2484406|NCT02139046|8584923|P2|Overall Study|Major Protocol Deviation|10
2484407|NCT02139046|8584924|P1|Overall Study|Major Protocol Deviation|9
2484408|NCT02139046|8584920|P5|Overall Study|Pretreatment Event/Adverse Event|7
2484409|NCT02139046|8584921|P4|Overall Study|Pretreatment Event/Adverse Event|13
2484410|NCT02139046|8584922|P3|Overall Study|Pretreatment Event/Adverse Event|10
2484411|NCT02139046|8584923|P2|Overall Study|Pretreatment Event/Adverse Event|9
2484412|NCT02139046|8584924|P1|Overall Study|Pretreatment Event/Adverse Event|9
2484413|NCT02138916|8584965|P3|Overall Study|Adverse Event|3
2484414|NCT02138916|8584966|P2|Overall Study|Adverse Event|4
2484415|NCT02138916|8584967|P1|Overall Study|Adverse Event|4
2484416|NCT02138916|8584965|P3|Overall Study|Lost to Follow-up|3
2484417|NCT02138916|8584966|P2|Overall Study|Lost to Follow-up|2
2484418|NCT02138916|8584967|P1|Overall Study|Lost to Follow-up|4
2484419|NCT02138916|8584965|P3|Overall Study|Severe non-compliance|1
2484420|NCT02138916|8584966|P2|Overall Study|Severe non-compliance|2
2484421|NCT02138916|8584967|P1|Overall Study|Severe non-compliance|1
2484422|NCT02138916|8584965|P3|Overall Study|incorrect enrolment|0
2484423|NCT02138916|8584966|P2|Overall Study|incorrect enrolment|1
2484424|NCT02138916|8584967|P1|Overall Study|incorrect enrolment|1
2484425|NCT02138916|8584965|P3|Overall Study|Study specific withdrawal criteria|1
2484426|NCT02138916|8584966|P2|Overall Study|Study specific withdrawal criteria|0
2484427|NCT02138916|8584967|P1|Overall Study|Study specific withdrawal criteria|0
2484428|NCT02138916|8584965|P3|Overall Study|Withdrawal by Subject|32
2484429|NCT02138916|8584966|P2|Overall Study|Withdrawal by Subject|31
2484430|NCT02138916|8584967|P1|Overall Study|Withdrawal by Subject|27
2484431|NCT02138916|8584965|P3|Overall Study|Death|12
2484432|NCT02138916|8584966|P2|Overall Study|Death|11
2484433|NCT02138916|8584967|P1|Overall Study|Death|14
2484434|NCT02138916|8584965|P3|Overall Study|eg., meds change, lack of efficacy, etc.|7
2484435|NCT02138916|8584966|P2|Overall Study|eg., meds change, lack of efficacy, etc.|9
2484436|NCT02138916|8584967|P1|Overall Study|eg., meds change, lack of efficacy, etc.|6
2484437|NCT02138890|8585030|P2|Overall Study|Adverse Event|0
2484438|NCT02138890|8585031|P1|Overall Study|Adverse Event|1
2484439|NCT02138838|8585073|P2|Overall Study|Withdrawal by Subject|5
2484440|NCT02138838|8585074|P1|Overall Study|Withdrawal by Subject|1
2484441|NCT02138838|8585073|P2|Overall Study|Study Closure|6
2484442|NCT02138838|8585074|P1|Overall Study|Study Closure|7
2484443|NCT02138825|8585092|P2|Safety Follow-up|withdrawn due to lung transplant|1
2484444|NCT02138825|8585093|P1|Safety Follow-up|withdrawn due to lung transplant|0
2484445|NCT02138825|8585092|P2|Safety Follow-up|treatment unblinded|1
2484446|NCT02138825|8585093|P1|Safety Follow-up|treatment unblinded|0
2484447|NCT02138825|8585092|P2|Safety Follow-up|too unwell to attend the visit|1
2484448|NCT02138825|8585093|P1|Safety Follow-up|too unwell to attend the visit|0
2484449|NCT02138825|8585092|P2|Safety Follow-up|progressive disease|2
2484450|NCT02138825|8585093|P1|Safety Follow-up|progressive disease|0
2484451|NCT02138825|8585092|P2|Safety Follow-up|logistical difficulties|1
2484452|NCT02138825|8585093|P1|Safety Follow-up|logistical difficulties|0
2484453|NCT02138825|8585092|P2|Safety Follow-up|withdrawal by PI|0
2484454|NCT02138825|8585093|P1|Safety Follow-up|withdrawal by PI|1
2484455|NCT02138825|8585092|P2|Safety Follow-up|clinic worsening|0
2484456|NCT02138825|8585093|P1|Safety Follow-up|clinic worsening|1
2484457|NCT02138825|8585092|P2|Safety Follow-up|Withdrawal by Subject|3
2484458|NCT02138825|8585093|P1|Safety Follow-up|Withdrawal by Subject|5
2484459|NCT02138825|8585092|P2|Safety Follow-up|Death|5
2484460|NCT02138825|8585093|P1|Safety Follow-up|Death|11
2484461|NCT02138825|8585092|P2|Safety Follow-up|Adverse Event|3
2484462|NCT02138825|8585093|P1|Safety Follow-up|Adverse Event|4
2484463|NCT02138825|8585092|P2|Long-term Extension|Study termination by sponsor|38
2484464|NCT02138825|8585093|P1|Long-term Extension|Study termination by sponsor|32
2484465|NCT02138825|8585092|P2|Main Study Treatment|Medical decision|0
2484466|NCT02138825|8585093|P1|Main Study Treatment|Medical decision|1
2484467|NCT02138825|8585092|P2|Main Study Treatment|Withdrawal by Subject|1
2484468|NCT02138825|8585093|P1|Main Study Treatment|Withdrawal by Subject|3
2484469|NCT02138825|8585092|P2|Main Study Treatment|Study terminated by sponsor|9
2484470|NCT02138825|8585093|P1|Main Study Treatment|Study terminated by sponsor|10
2484471|NCT02138825|8585092|P2|Main Study Treatment|Sponsor decision|18
2484472|NCT02138825|8585093|P1|Main Study Treatment|Sponsor decision|12
2484473|NCT02138825|8585092|P2|Main Study Treatment|Protocol Violation|2
2484474|NCT02138825|8585093|P1|Main Study Treatment|Protocol Violation|2
2484475|NCT02138825|8585092|P2|Main Study Treatment|Death|2
2484476|NCT02138825|8585093|P1|Main Study Treatment|Death|1
2484477|NCT02138825|8585092|P2|Main Study Treatment|Adverse Event|3
2484478|NCT02138825|8585093|P1|Main Study Treatment|Adverse Event|11
2484479|NCT02138786|8585110|P3|Overall Study|Non-Compliance|1
2484480|NCT02138786|8585111|P2|Overall Study|Non-Compliance|0
2484481|NCT02138786|8585112|P1|Overall Study|Non-Compliance|0
2484482|NCT02138786|8585110|P3|Overall Study|Sponsor Terminated Study|1
2484483|NCT02138786|8585111|P2|Overall Study|Sponsor Terminated Study|1
2484484|NCT02138786|8585112|P1|Overall Study|Sponsor Terminated Study|0
2484485|NCT02138786|8585110|P3|Overall Study|Patient's Wish|0
2484486|NCT02138786|8585111|P2|Overall Study|Patient's Wish|2
2484487|NCT02138786|8585112|P1|Overall Study|Patient's Wish|0
2484488|NCT02138786|8585110|P3|Overall Study|Withdrawal by Subject|0
2484489|NCT02138786|8585111|P2|Overall Study|Withdrawal by Subject|2
2484490|NCT02138786|8585112|P1|Overall Study|Withdrawal by Subject|1
2484491|NCT02138786|8585110|P3|Overall Study|Disease Progression|3
2484492|NCT02138786|8585111|P2|Overall Study|Disease Progression|1
2484493|NCT02138786|8585112|P1|Overall Study|Disease Progression|1
2484494|NCT02138786|8585110|P3|Overall Study|Death|2
2484495|NCT02138786|8585111|P2|Overall Study|Death|7
2484496|NCT02138786|8585112|P1|Overall Study|Death|1
2484497|NCT02138786|8585110|P3|Overall Study|Adverse Event|1
2484498|NCT02138786|8585111|P2|Overall Study|Adverse Event|2
2484499|NCT02138786|8585112|P1|Overall Study|Adverse Event|0
2484500|NCT02138747|8585129|P4|Treatment Period 2|Other - Miscellaneous|0
2484501|NCT02138747|8585130|P3|Treatment Period 2|Other - Miscellaneous|0
2484502|NCT02138747|8585131|P2|Treatment Period 2|Other - Miscellaneous|0
2484503|NCT02138747|8585132|P1|Treatment Period 2|Other - Miscellaneous|3
2484504|NCT02138747|8585129|P4|Treatment Period 2|Withdrawal by Subject|2
2484505|NCT02138747|8585130|P3|Treatment Period 2|Withdrawal by Subject|1
2484506|NCT02138747|8585131|P2|Treatment Period 2|Withdrawal by Subject|4
2484507|NCT02138747|8585132|P1|Treatment Period 2|Withdrawal by Subject|5
2484508|NCT02138747|8585129|P4|Treatment Period 2|Protocol Violation|0
2484509|NCT02138747|8585130|P3|Treatment Period 2|Protocol Violation|0
2484510|NCT02138747|8585131|P2|Treatment Period 2|Protocol Violation|0
2484511|NCT02138747|8585132|P1|Treatment Period 2|Protocol Violation|1
2484512|NCT02138747|8585129|P4|Treatment Period 2|Lost to Follow-up|0
2484513|NCT02138747|8585130|P3|Treatment Period 2|Lost to Follow-up|0
2484514|NCT02138747|8585131|P2|Treatment Period 2|Lost to Follow-up|0
2484515|NCT02138747|8585132|P1|Treatment Period 2|Lost to Follow-up|2
2484516|NCT02138747|8585129|P4|Treatment Period 2|Adverse Event|1
2484517|NCT02138747|8585130|P3|Treatment Period 2|Adverse Event|1
2484518|NCT02138747|8585131|P2|Treatment Period 2|Adverse Event|3
2484519|NCT02138747|8585132|P1|Treatment Period 2|Adverse Event|6
2484520|NCT02138747|8585129|P4|Treatment Period 1|Other - Miscellaneous|0
2484521|NCT02138747|8585130|P3|Treatment Period 1|Other - Miscellaneous|0
2484522|NCT02138747|8585131|P2|Treatment Period 1|Other - Miscellaneous|4
2484523|NCT02138747|8585132|P1|Treatment Period 1|Other - Miscellaneous|2
2484524|NCT02138747|8585129|P4|Treatment Period 1|Withdrawal by Subject|3
2484525|NCT02138747|8585130|P3|Treatment Period 1|Withdrawal by Subject|1
2484526|NCT02138747|8585131|P2|Treatment Period 1|Withdrawal by Subject|4
2484527|NCT02138747|8585132|P1|Treatment Period 1|Withdrawal by Subject|8
2484528|NCT02138747|8585129|P4|Treatment Period 1|Protocol Violation|0
2484529|NCT02138747|8585130|P3|Treatment Period 1|Protocol Violation|0
2484530|NCT02138747|8585131|P2|Treatment Period 1|Protocol Violation|2
2484531|NCT02138747|8585132|P1|Treatment Period 1|Protocol Violation|0
2484532|NCT02138747|8585129|P4|Treatment Period 1|Lost to Follow-up|0
2484533|NCT02138747|8585130|P3|Treatment Period 1|Lost to Follow-up|1
2484534|NCT02138747|8585131|P2|Treatment Period 1|Lost to Follow-up|1
2484535|NCT02138747|8585132|P1|Treatment Period 1|Lost to Follow-up|0
2484536|NCT02138747|8585129|P4|Treatment Period 1|Adverse Event|1
2484537|NCT02138747|8585130|P3|Treatment Period 1|Adverse Event|2
2484538|NCT02138747|8585131|P2|Treatment Period 1|Adverse Event|14
2484539|NCT02138747|8585132|P1|Treatment Period 1|Adverse Event|10
2484540|NCT02138253|8585206|P2|Overall Study|Withdrawal by Subject|0
2484541|NCT02138253|8585207|P1|Overall Study|Withdrawal by Subject|1
2484542|NCT02138253|8585206|P2|Overall Study|Non compliance|0
2484543|NCT02138253|8585207|P1|Overall Study|Non compliance|1
2484544|NCT02138253|8585206|P2|Overall Study|Physician Decision|0
2484545|NCT02138253|8585207|P1|Overall Study|Physician Decision|2
2484546|NCT02138253|8585206|P2|Overall Study|Lost to Follow-up|1
2484547|NCT02138253|8585207|P1|Overall Study|Lost to Follow-up|2
2484548|NCT02138253|8585206|P2|Overall Study|Adverse Event|3
2484549|NCT02138253|8585207|P1|Overall Study|Adverse Event|3
2484550|NCT02138136|8585279|P1|Overall Study|Withdrawn by Sponsor|5
2484551|NCT02138136|8585279|P1|Overall Study|Lost to Follow-up|32
2484552|NCT02138136|8585279|P1|Overall Study|Withdrawal by Subject|36
2484553|NCT02138136|8585279|P1|Overall Study|Adverse Event|18
2484554|NCT02138136|8585279|P1|Overall Study|Pregnancy|2
2484555|NCT02138136|8585279|P1|Overall Study|Lack of Efficacy|35
2484556|NCT02138136|8585279|P1|Overall Study|Physician Decision|7
2484557|NCT02138136|8585279|P1|Overall Study|Protocol Violation|4
2484558|NCT02138110|8585286|P1|Overall Scaffold Implantation|Death|3
2484559|NCT02138110|8585286|P1|Enrolled for Scaffold Implantation|Physician Decision|1
2484560|NCT02137785|8585518|P2|Overall Study|subject moved out of state|0
2484561|NCT02137785|8585519|P1|Overall Study|subject moved out of state|1
2484562|NCT02137785|8585518|P2|Overall Study|Withdrawal by Subject|4
2484563|NCT02137785|8585519|P1|Overall Study|Withdrawal by Subject|1
2484564|NCT02137785|8585518|P2|Overall Study|Lost to Follow-up|0
2484565|NCT02137785|8585519|P1|Overall Study|Lost to Follow-up|1
2484566|NCT02137772|8585627|P2|Overall Study|Not treated|2
2484567|NCT02137772|8585628|P1|Overall Study|Not treated|3
2484568|NCT02137772|8585627|P2|Overall Study|Non-compliance with study drug|0
2484569|NCT02137772|8585628|P1|Overall Study|Non-compliance with study drug|1
2484570|NCT02137772|8585627|P2|Overall Study|Withdrawal by Subject|17
2484571|NCT02137772|8585628|P1|Overall Study|Withdrawal by Subject|28
2484572|NCT02137772|8585627|P2|Overall Study|Physician Decision|5
2484573|NCT02137772|8585628|P1|Overall Study|Physician Decision|15
2484574|NCT02137772|8585627|P2|Overall Study|Lost to Follow-up|4
2484575|NCT02137772|8585628|P1|Overall Study|Lost to Follow-up|8
2484576|NCT02137772|8585627|P2|Overall Study|Death|44
2484577|NCT02137772|8585628|P1|Overall Study|Death|71
2484578|NCT02137772|8585627|P2|Overall Study|Adverse Event|3
2484579|NCT02137772|8585628|P1|Overall Study|Adverse Event|6
2484580|NCT02137226|8585886|P5|Period 2 (Re - Randomization)|Other Reason|1
2484581|NCT02137226|8585887|P4|Period 2 (Re - Randomization)|Other Reason|1
2484582|NCT02137226|8585888|P3|Period 2 (Re - Randomization)|Other Reason|1
2484583|NCT02137226|8585889|P2|Period 2 (Re - Randomization)|Other Reason|0
2484584|NCT02137226|8585890|P1|Period 2 (Re - Randomization)|Other Reason|0
2484585|NCT02137226|8585886|P5|Period 2 (Re - Randomization)|Lack of Efficacy|0
2484586|NCT02137226|8585887|P4|Period 2 (Re - Randomization)|Lack of Efficacy|0
2484587|NCT02137226|8585888|P3|Period 2 (Re - Randomization)|Lack of Efficacy|2
2484588|NCT02137226|8585889|P2|Period 2 (Re - Randomization)|Lack of Efficacy|0
2484589|NCT02137226|8585890|P1|Period 2 (Re - Randomization)|Lack of Efficacy|0
2484590|NCT02137226|8585886|P5|Period 2 (Re - Randomization)|Lost to Follow-up|0
2484591|NCT02137226|8585887|P4|Period 2 (Re - Randomization)|Lost to Follow-up|0
2484592|NCT02137226|8585888|P3|Period 2 (Re - Randomization)|Lost to Follow-up|3
2484593|NCT02137226|8585889|P2|Period 2 (Re - Randomization)|Lost to Follow-up|0
2484594|NCT02137226|8585890|P1|Period 2 (Re - Randomization)|Lost to Follow-up|0
2484595|NCT02137226|8585886|P5|Period 2 (Re - Randomization)|Physician Decision|0
2484596|NCT02137226|8585887|P4|Period 2 (Re - Randomization)|Physician Decision|1
2484597|NCT02137226|8585888|P3|Period 2 (Re - Randomization)|Physician Decision|0
2484598|NCT02137226|8585889|P2|Period 2 (Re - Randomization)|Physician Decision|0
2484599|NCT02137226|8585890|P1|Period 2 (Re - Randomization)|Physician Decision|0
2484600|NCT02137226|8585886|P5|Period 2 (Re - Randomization)|Withdrawal by Subject|4
2484601|NCT02137226|8585887|P4|Period 2 (Re - Randomization)|Withdrawal by Subject|5
2484602|NCT02137226|8585888|P3|Period 2 (Re - Randomization)|Withdrawal by Subject|8
2484603|NCT02137226|8585889|P2|Period 2 (Re - Randomization)|Withdrawal by Subject|0
2484604|NCT02137226|8585890|P1|Period 2 (Re - Randomization)|Withdrawal by Subject|0
2484605|NCT02137226|8585886|P5|Period 2 (Re - Randomization)|Adverse Event|4
2484606|NCT02137226|8585887|P4|Period 2 (Re - Randomization)|Adverse Event|1
2484607|NCT02137226|8585888|P3|Period 2 (Re - Randomization)|Adverse Event|3
2484608|NCT02137226|8585889|P2|Period 2 (Re - Randomization)|Adverse Event|0
2484609|NCT02137226|8585890|P1|Period 2 (Re - Randomization)|Adverse Event|0
2484610|NCT02137226|8585886|P5|Period 1 (Initial Randomization)|Other Reason|0
2484611|NCT02137226|8585887|P4|Period 1 (Initial Randomization)|Other Reason|0
2484612|NCT02137226|8585888|P3|Period 1 (Initial Randomization)|Other Reason|0
2484613|NCT02137226|8585889|P2|Period 1 (Initial Randomization)|Other Reason|3
2484614|NCT02137226|8585890|P1|Period 1 (Initial Randomization)|Other Reason|1
2484615|NCT02137226|8585886|P5|Period 1 (Initial Randomization)|Lack of Efficacy|0
2484616|NCT02137226|8585887|P4|Period 1 (Initial Randomization)|Lack of Efficacy|0
2484617|NCT02137226|8585888|P3|Period 1 (Initial Randomization)|Lack of Efficacy|0
2484618|NCT02137226|8585889|P2|Period 1 (Initial Randomization)|Lack of Efficacy|0
2484619|NCT02137226|8585890|P1|Period 1 (Initial Randomization)|Lack of Efficacy|1
2484620|NCT02137226|8585886|P5|Period 1 (Initial Randomization)|Lost to Follow-up|0
2484621|NCT02137226|8585887|P4|Period 1 (Initial Randomization)|Lost to Follow-up|0
2484622|NCT02137226|8585888|P3|Period 1 (Initial Randomization)|Lost to Follow-up|0
2484623|NCT02137226|8585889|P2|Period 1 (Initial Randomization)|Lost to Follow-up|2
2484624|NCT02137226|8585890|P1|Period 1 (Initial Randomization)|Lost to Follow-up|3
2484625|NCT02137226|8585886|P5|Period 1 (Initial Randomization)|Physician Decision|0
2484626|NCT02137226|8585887|P4|Period 1 (Initial Randomization)|Physician Decision|0
2484627|NCT02137226|8585888|P3|Period 1 (Initial Randomization)|Physician Decision|0
2484628|NCT02137226|8585889|P2|Period 1 (Initial Randomization)|Physician Decision|3
2484629|NCT02137226|8585890|P1|Period 1 (Initial Randomization)|Physician Decision|1
2484630|NCT02137226|8585886|P5|Period 1 (Initial Randomization)|Withdrawal by Subject|0
2484631|NCT02137226|8585887|P4|Period 1 (Initial Randomization)|Withdrawal by Subject|0
2484632|NCT02137226|8585888|P3|Period 1 (Initial Randomization)|Withdrawal by Subject|0
2484633|NCT02137226|8585889|P2|Period 1 (Initial Randomization)|Withdrawal by Subject|5
2484634|NCT02137226|8585890|P1|Period 1 (Initial Randomization)|Withdrawal by Subject|11
2484635|NCT02137226|8585886|P5|Period 1 (Initial Randomization)|Adverse Event|0
2484636|NCT02137226|8585887|P4|Period 1 (Initial Randomization)|Adverse Event|0
2484637|NCT02137226|8585888|P3|Period 1 (Initial Randomization)|Adverse Event|0
2484638|NCT02137226|8585889|P2|Period 1 (Initial Randomization)|Adverse Event|3
2484639|NCT02137226|8585890|P1|Period 1 (Initial Randomization)|Adverse Event|3
2484640|NCT02136914|8585908|P2|Overall Study|Death|1
2484641|NCT02136914|8585909|P1|Overall Study|Death|0
2484642|NCT02136914|8585908|P2|Overall Study|Lack of Efficacy|0
2484643|NCT02136914|8585909|P1|Overall Study|Lack of Efficacy|1
2484644|NCT02136914|8585908|P2|Overall Study|Did Not Receive Study Drug|0
2484645|NCT02136914|8585909|P1|Overall Study|Did Not Receive Study Drug|2
2484646|NCT02136914|8585908|P2|Overall Study|Lost to Follow-up|1
2484647|NCT02136914|8585909|P1|Overall Study|Lost to Follow-up|1
2484648|NCT02136914|8585908|P2|Overall Study|Subject Unwilling to Proceed|2
2484649|NCT02136914|8585909|P1|Overall Study|Subject Unwilling to Proceed|7
2484650|NCT02136914|8585908|P2|Overall Study|Withdrawal by Subject|10
2484651|NCT02136914|8585909|P1|Overall Study|Withdrawal by Subject|3
2484652|NCT02136914|8585908|P2|Overall Study|Sponsor's Decision to Stop the Study|7
2484653|NCT02136914|8585909|P1|Overall Study|Sponsor's Decision to Stop the Study|7
2484654|NCT02136680|8585929|P2|Overall Study|Study ended before interview due|3
2484655|NCT02136680|8585930|P1|Overall Study|Study ended before interview due|6
2484656|NCT02136680|8585929|P2|Overall Study|Unable to schedule|16
2484657|NCT02136680|8585930|P1|Overall Study|Unable to schedule|17
2484658|NCT02136680|8585929|P2|Overall Study|Moved away|4
2484659|NCT02136680|8585930|P1|Overall Study|Moved away|5
2484660|NCT02136680|8585929|P2|Overall Study|No longer receiving care at clinic|5
2484661|NCT02136680|8585930|P1|Overall Study|No longer receiving care at clinic|3
2484662|NCT02136680|8585929|P2|Overall Study|No Longer Interested|1
2484663|NCT02136680|8585930|P1|Overall Study|No Longer Interested|1
2484664|NCT02136134|8586005|P2|Overall Study|Subjects randomized but not treated|8
2484665|NCT02136134|8586006|P1|Overall Study|Subjects randomized but not treated|10
2484666|NCT02136134|8586005|P2|Overall Study|Ongoing|207
2484667|NCT02136134|8586006|P1|Overall Study|Ongoing|185
2484668|NCT02136134|8586005|P2|Overall Study|Other|3
2484669|NCT02136134|8586006|P1|Overall Study|Other|3
2484670|NCT02136134|8586005|P2|Overall Study|Withdrawal by Subject|4
2484671|NCT02136134|8586006|P1|Overall Study|Withdrawal by Subject|14
2484672|NCT02136134|8586005|P2|Overall Study|Death|29
2484673|NCT02136134|8586006|P1|Overall Study|Death|35
2484674|NCT02135848|8586068|P2|Overall Study|Withdrawal by Subject|1
2484675|NCT02135848|8586069|P1|Overall Study|Withdrawal by Subject|1
2484676|NCT02135848|8586068|P2|Overall Study|Adverse Event|0
2484677|NCT02135848|8586069|P1|Overall Study|Adverse Event|2
2484678|NCT02135692|8586127|P1|Overall Study|Withdrawal by Subject|15
2484679|NCT02135692|8586127|P1|Overall Study|Lost to Follow-up|4
2484680|NCT02135692|8586127|P1|Overall Study|Study closed/terminated|153
2484681|NCT02135692|8586127|P1|Overall Study|Product commercially available|159
2484682|NCT02135692|8586127|P1|Overall Study|Subject met Liver Stopping Criteria|1
2484683|NCT02135692|8586127|P1|Overall Study|Protocol Violation|2
2484684|NCT02135692|8586127|P1|Overall Study|Lack of Efficacy|2
2484685|NCT02135692|8586127|P1|Overall Study|Adverse Event|3
2484686|NCT02135614|8586146|P2|Overall Study|Lost to Follow-up|0
2484687|NCT02135614|8586147|P1|Overall Study|Lost to Follow-up|3
2484688|NCT02135614|8586146|P2|Overall Study|Withdrew Consent|2
2484689|NCT02135614|8586147|P1|Overall Study|Withdrew Consent|2
2484690|NCT02135614|8586146|P2|Overall Study|Investigator's Discretion|1
2484691|NCT02135614|8586147|P1|Overall Study|Investigator's Discretion|0
2484692|NCT02135614|8586146|P2|Overall Study|Death|0
2484693|NCT02135614|8586147|P1|Overall Study|Death|1
2484694|NCT02135614|8586146|P2|Overall Study|Adverse Event|1
2484695|NCT02135614|8586147|P1|Overall Study|Adverse Event|0
2484696|NCT02135614|8586146|P2|Overall Study|Randomized but Not Treated|1
2484697|NCT02135614|8586147|P1|Overall Study|Randomized but Not Treated|2
2484698|NCT02135445|8586161|P2|Overall Study|Withdrawal by Subject|0
2484699|NCT02135445|8586162|P1|Overall Study|Withdrawal by Subject|1
2484700|NCT02135445|8586161|P2|Overall Study|Lost to Follow-up|0
2484701|NCT02135445|8586162|P1|Overall Study|Lost to Follow-up|1
2484702|NCT02135107|8586247|P4|Maintenance Therapy Period|Other|8
2484703|NCT02135107|8586248|P3|Maintenance Therapy Period|Other|7
2484704|NCT02135107|8586249|P2|Maintenance Therapy Period|Other|0
2484705|NCT02135107|8586250|P1|Maintenance Therapy Period|Other|0
2484706|NCT02135107|8586247|P4|Maintenance Therapy Period|Pregnancy|1
2484707|NCT02135107|8586248|P3|Maintenance Therapy Period|Pregnancy|0
2484708|NCT02135107|8586249|P2|Maintenance Therapy Period|Pregnancy|0
2484709|NCT02135107|8586250|P1|Maintenance Therapy Period|Pregnancy|0
2484710|NCT02135107|8586247|P4|Maintenance Therapy Period|Withdrawal by Subject|4
2484711|NCT02135107|8586248|P3|Maintenance Therapy Period|Withdrawal by Subject|5
2484712|NCT02135107|8586249|P2|Maintenance Therapy Period|Withdrawal by Subject|0
2484713|NCT02135107|8586250|P1|Maintenance Therapy Period|Withdrawal by Subject|0
2484714|NCT02135107|8586247|P4|Maintenance Therapy Period|Adverse Event|7
2484715|NCT02135107|8586248|P3|Maintenance Therapy Period|Adverse Event|3
2484716|NCT02135107|8586249|P2|Maintenance Therapy Period|Adverse Event|0
2484717|NCT02135107|8586250|P1|Maintenance Therapy Period|Adverse Event|0
2484718|NCT02135107|8586247|P4|Treatment Period|Other|0
2484719|NCT02135107|8586248|P3|Treatment Period|Other|0
2484720|NCT02135107|8586249|P2|Treatment Period|Other|24
2484721|NCT02135107|8586250|P1|Treatment Period|Other|115
2484722|NCT02135107|8586247|P4|Treatment Period|Pregnancy|0
2484723|NCT02135107|8586248|P3|Treatment Period|Pregnancy|0
2484724|NCT02135107|8586249|P2|Treatment Period|Pregnancy|0
2484725|NCT02135107|8586250|P1|Treatment Period|Pregnancy|1
2484726|NCT02135107|8586247|P4|Treatment Period|Adverse Event|0
2484727|NCT02135107|8586248|P3|Treatment Period|Adverse Event|0
2484728|NCT02135107|8586249|P2|Treatment Period|Adverse Event|2
2484729|NCT02135107|8586250|P1|Treatment Period|Adverse Event|5
2484730|NCT02135107|8586247|P4|Treatment Period|Withdrawal by Subject|0
2484731|NCT02135107|8586248|P3|Treatment Period|Withdrawal by Subject|0
2484732|NCT02135107|8586249|P2|Treatment Period|Withdrawal by Subject|0
2484733|NCT02135107|8586250|P1|Treatment Period|Withdrawal by Subject|11
2484734|NCT02135029|8586296|P3|Overall Study|Death|0
2484735|NCT02135029|8586297|P2|Overall Study|Death|1
2484736|NCT02135029|8586298|P1|Overall Study|Death|0
2484737|NCT02135029|8586296|P3|Overall Study|Other|0
2484738|NCT02135029|8586297|P2|Overall Study|Other|1
2484739|NCT02135029|8586298|P1|Overall Study|Other|0
2484740|NCT02135029|8586296|P3|Overall Study|Withdrawal by Subject|1
2484741|NCT02135029|8586297|P2|Overall Study|Withdrawal by Subject|0
2484742|NCT02135029|8586298|P1|Overall Study|Withdrawal by Subject|2
2484743|NCT02135029|8586296|P3|Overall Study|Lost to Follow-up|0
2484744|NCT02135029|8586297|P2|Overall Study|Lost to Follow-up|1
2484745|NCT02135029|8586298|P1|Overall Study|Lost to Follow-up|0
2484746|NCT02135029|8586296|P3|Overall Study|Adverse Event|2
2484747|NCT02135029|8586297|P2|Overall Study|Adverse Event|2
2484748|NCT02135029|8586298|P1|Overall Study|Adverse Event|2
2484749|NCT02134977|8586403|P1|Overall Study|Protocol Deviation|102
2484750|NCT02134925|8586437|P2|Overall Study|Cancel|6
2484751|NCT02134925|8586438|P1|Overall Study|Cancel|1
2484752|NCT02134925|8586437|P2|Overall Study|Withdrawal by Subject|0
2484753|NCT02134925|8586438|P1|Overall Study|Withdrawal by Subject|1
2484754|NCT02134587|8586479|P1|Overall Study|Did not completed all meetings|30
2484755|NCT02134015|8586618|P2|Overall Study|Withdrawal by Subject|7
2484756|NCT02134015|8586619|P1|Overall Study|Withdrawal by Subject|3
2484757|NCT02134015|8586618|P2|Overall Study|Adverse Event|10
2484758|NCT02134015|8586619|P1|Overall Study|Adverse Event|9
2484759|NCT02134015|8586618|P2|Overall Study|Study terminated by sponsor|3
2484760|NCT02134015|8586619|P1|Overall Study|Study terminated by sponsor|2
2484761|NCT02134015|8586618|P2|Overall Study|Progressive disease (per RECIST 1.1)|43
2484762|NCT02134015|8586619|P1|Overall Study|Progressive disease (per RECIST 1.1)|40
2484763|NCT02134015|8586618|P2|Overall Study|Clinical progression|7
2484764|NCT02134015|8586619|P1|Overall Study|Clinical progression|14
2484765|NCT02134015|8586618|P2|Overall Study|Reason not provided|2
2484766|NCT02134015|8586619|P1|Overall Study|Reason not provided|1
2484767|NCT02134015|8586618|P2|Overall Study|Death|1
2484768|NCT02134015|8586619|P1|Overall Study|Death|2
2484769|NCT02134015|8586618|P2|Overall Study|Protocol Violation|1
2484770|NCT02134015|8586619|P1|Overall Study|Protocol Violation|0
2484771|NCT02133742|8586655|P1|Period 2:Dose Expansion Phase (903 Days)|Ongoing at date of cutoff|41
2484772|NCT02133742|8586655|P1|Period 2:Dose Expansion Phase (903 Days)|Death|5
2484773|NCT02133742|8586655|P1|Period 2:Dose Expansion Phase (903 Days)|Other|2
2484774|NCT02133742|8586655|P1|Period 2:Dose Expansion Phase (903 Days)|Lost to Follow-up|4
2484775|NCT02133664|8586674|P2|Overall Study|Adverse Event|6
2484776|NCT02133664|8586675|P1|Overall Study|Adverse Event|3
2484777|NCT02133664|8586674|P2|Overall Study|Lost to Follow-up|1
2484778|NCT02133664|8586675|P1|Overall Study|Lost to Follow-up|2
2484779|NCT02133508|8586691|P1|Overall Study|Lost to Follow-up|2
2484780|NCT02133508|8586691|P1|Overall Study|Death|12
2484781|NCT02133508|8586691|P1|Overall Study|Decision of Investigator or Sponsor|1
2484782|NCT02133352|8586699|P1|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6
2484783|NCT02133131|8586730|P7|Overall Study|Protocol Violation|1
2484784|NCT02133131|8586731|P6|Overall Study|Protocol Violation|0
2484785|NCT02133131|8586732|P5|Overall Study|Protocol Violation|0
2484786|NCT02133131|8586733|P4|Overall Study|Protocol Violation|0
2484787|NCT02133131|8586734|P3|Overall Study|Protocol Violation|0
2484788|NCT02133131|8586735|P2|Overall Study|Protocol Violation|0
2484789|NCT02133131|8586736|P1|Overall Study|Protocol Violation|0
2484790|NCT02133131|8586730|P7|Overall Study|Ongoing in study|11
2484791|NCT02133131|8586731|P6|Overall Study|Ongoing in study|14
2484792|NCT02133131|8586732|P5|Overall Study|Ongoing in study|15
2484793|NCT02133131|8586733|P4|Overall Study|Ongoing in study|0
2484794|NCT02133131|8586734|P3|Overall Study|Ongoing in study|0
2484795|NCT02133131|8586735|P2|Overall Study|Ongoing in study|0
2484796|NCT02133131|8586736|P1|Overall Study|Ongoing in study|0
2484797|NCT02133131|8586730|P7|Overall Study|Status not recorded|0
2484798|NCT02133131|8586731|P6|Overall Study|Status not recorded|0
2484799|NCT02133131|8586732|P5|Overall Study|Status not recorded|0
2484800|NCT02133131|8586733|P4|Overall Study|Status not recorded|4
2484801|NCT02133131|8586734|P3|Overall Study|Status not recorded|1
2484802|NCT02133131|8586735|P2|Overall Study|Status not recorded|5
2484803|NCT02133131|8586736|P1|Overall Study|Status not recorded|4
2484804|NCT02133131|8586730|P7|Overall Study|Lost to Follow-up|0
2484805|NCT02133131|8586731|P6|Overall Study|Lost to Follow-up|0
2484806|NCT02133131|8586732|P5|Overall Study|Lost to Follow-up|0
2484807|NCT02133131|8586733|P4|Overall Study|Lost to Follow-up|1
2484808|NCT02133131|8586734|P3|Overall Study|Lost to Follow-up|0
2484809|NCT02133131|8586735|P2|Overall Study|Lost to Follow-up|0
2484810|NCT02133131|8586736|P1|Overall Study|Lost to Follow-up|1
2484811|NCT02133131|8586730|P7|Overall Study|Adverse Event|0
2484812|NCT02133131|8586731|P6|Overall Study|Adverse Event|0
2484813|NCT02133131|8586732|P5|Overall Study|Adverse Event|0
2484814|NCT02133131|8586733|P4|Overall Study|Adverse Event|1
2484815|NCT02133131|8586734|P3|Overall Study|Adverse Event|0
2484816|NCT02133131|8586735|P2|Overall Study|Adverse Event|0
2484817|NCT02133131|8586736|P1|Overall Study|Adverse Event|0
2484818|NCT02133001|8586790|P2|Follow-Up Phase (Day 26-81)|Other|1
2484819|NCT02133001|8586791|P1|Follow-Up Phase (Day 26-81)|Other|0
2484820|NCT02133001|8586790|P2|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1
2484821|NCT02133001|8586791|P1|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1
2484822|NCT02133001|8586790|P2|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1
2484823|NCT02133001|8586791|P1|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1
2484824|NCT02133001|8586790|P2|Double Blind (Day 1-25)|Withdrawal by Subject|1
2484825|NCT02133001|8586791|P1|Double Blind (Day 1-25)|Withdrawal by Subject|1
2484826|NCT02133001|8586790|P2|Double Blind (Day 1-25)|Other|2
2484827|NCT02133001|8586791|P1|Double Blind (Day 1-25)|Other|2
2484828|NCT02133001|8586790|P2|Double Blind (Day 1-25)|Lost to Follow-up|0
2484829|NCT02133001|8586791|P1|Double Blind (Day 1-25)|Lost to Follow-up|2
2484830|NCT02133001|8586790|P2|Double Blind (Day 1-25)|Lack of Efficacy|1
2484831|NCT02133001|8586791|P1|Double Blind (Day 1-25)|Lack of Efficacy|4
2484832|NCT02133001|8586790|P2|Double Blind (Day 1-25)|Adverse Event|5
2484833|NCT02133001|8586791|P1|Double Blind (Day 1-25)|Adverse Event|1
2484834|NCT02132949|8586839|P2|Adjuvant Treatment Period|Ongoing in Adjuvant Treatment|157
2484835|NCT02132949|8586840|P1|Adjuvant Treatment Period|Ongoing in Adjuvant Treatment|142
2484836|NCT02132949|8586839|P2|Adjuvant Treatment Period|Protocol Deviation|0
2484837|NCT02132949|8586840|P1|Adjuvant Treatment Period|Protocol Deviation|1
2484838|NCT02132949|8586839|P2|Adjuvant Treatment Period|Withdrawal by Subject|1
2484839|NCT02132949|8586840|P1|Adjuvant Treatment Period|Withdrawal by Subject|1
2484840|NCT02132949|8586839|P2|Adjuvant Treatment Period|Physician Decision|0
2484841|NCT02132949|8586840|P1|Adjuvant Treatment Period|Physician Decision|1
2484842|NCT02132949|8586839|P2|Adjuvant Treatment Period|Disease Relapse|1
2484843|NCT02132949|8586840|P1|Adjuvant Treatment Period|Disease Relapse|0
2484844|NCT02132949|8586839|P2|Adjuvant Treatment Period|Disease Progression|1
2484845|NCT02132949|8586840|P1|Adjuvant Treatment Period|Disease Progression|0
2484846|NCT02132949|8586839|P2|Adjuvant Treatment Period|Reason unspecified|1
2484847|NCT02132949|8586840|P1|Adjuvant Treatment Period|Reason unspecified|0
2484848|NCT02132949|8586839|P2|Adjuvant Treatment Period|Adverse Event|6
2484849|NCT02132949|8586840|P1|Adjuvant Treatment Period|Adverse Event|4
2484850|NCT02132949|8586839|P2|Neoadjuvant Treatment Period|Withdrew prior to treatment|3
2484851|NCT02132949|8586840|P1|Neoadjuvant Treatment Period|Withdrew prior to treatment|0
2484852|NCT02132949|8586839|P2|Neoadjuvant Treatment Period|Adverse Event|3
2484853|NCT02132949|8586840|P1|Neoadjuvant Treatment Period|Adverse Event|6
2484854|NCT02132949|8586839|P2|Neoadjuvant Treatment Period|Disease Progression|1
2484855|NCT02132949|8586840|P1|Neoadjuvant Treatment Period|Disease Progression|1
2484856|NCT02132949|8586839|P2|Neoadjuvant Treatment Period|Withdrawal by Subject|0
2484857|NCT02132949|8586840|P1|Neoadjuvant Treatment Period|Withdrawal by Subject|1
2484858|NCT02132949|8586839|P2|Neoadjuvant Treatment Period|Physician Decision|0
2484859|NCT02132949|8586840|P1|Neoadjuvant Treatment Period|Physician Decision|2
2484860|NCT02132949|8586839|P2|Neoadjuvant Treatment Period|Lack of Efficacy|1
2484861|NCT02132949|8586840|P1|Neoadjuvant Treatment Period|Lack of Efficacy|0
2484862|NCT02132949|8586839|P2|Neoadjuvant Treatment Period|Reason unspecified|1
2484863|NCT02132949|8586840|P1|Neoadjuvant Treatment Period|Reason unspecified|3
2484864|NCT02132949|8586839|P2|Neoadjuvant Treatment Period|Early surgery|3
2484865|NCT02132949|8586840|P1|Neoadjuvant Treatment Period|Early surgery|4
2484866|NCT02132767|8586952|P2|Overall Study|Lost to Follow-up|4
2484867|NCT02132767|8586953|P1|Overall Study|Lost to Follow-up|4
2484868|NCT02132767|8586952|P2|Overall Study|Withdrawal by Subject|9
2484869|NCT02132767|8586953|P1|Overall Study|Withdrawal by Subject|10
2484870|NCT02132767|8586952|P2|Overall Study|Death|2
2484871|NCT02132767|8586953|P1|Overall Study|Death|3
2484872|NCT02132637|8586975|P2|Study Period 2 (Crossover)|Physician Decision|0
2484873|NCT02132637|8586976|P1|Study Period 2 (Crossover)|Physician Decision|2
2484874|NCT02132637|8586975|P2|Study Period 2 (Crossover)|Adverse Event|1
2484875|NCT02132637|8586976|P1|Study Period 2 (Crossover)|Adverse Event|0
2484876|NCT02132637|8586975|P2|Study Period 1|Physician Decision|0
2484877|NCT02132637|8586976|P1|Study Period 1|Physician Decision|1
2484878|NCT02132637|8586975|P2|Study Period 1|Withdrawal by Subject|4
2484879|NCT02132637|8586976|P1|Study Period 1|Withdrawal by Subject|0
2484880|NCT02132611|8587000|P1|Overall Study|Death|2
2484881|NCT02132247|8587051|P2|Overall Study|Protocol Violation|0
2484882|NCT02132247|8587052|P1|Overall Study|Protocol Violation|1
2484883|NCT02132195|8587067|P3|Rescue Therapy|Adverse Event|2
2484884|NCT02132195|8587068|P2|Rescue Therapy|Adverse Event|0
2484885|NCT02132195|8587069|P1|Rescue Therapy|Adverse Event|0
2484886|NCT02132195|8587067|P3|Rescue Therapy|Withdrawal by Subject|1
2484887|NCT02132195|8587068|P2|Rescue Therapy|Withdrawal by Subject|0
2484888|NCT02132195|8587069|P1|Rescue Therapy|Withdrawal by Subject|0
2484889|NCT02132195|8587067|P3|Rescue Therapy|Physician Decision|1
2484890|NCT02132195|8587068|P2|Rescue Therapy|Physician Decision|0
2484891|NCT02132195|8587069|P1|Rescue Therapy|Physician Decision|0
2484892|NCT02132195|8587067|P3|Rescue Therapy|Relapsed|7
2484893|NCT02132195|8587068|P2|Rescue Therapy|Relapsed|0
2484894|NCT02132195|8587069|P1|Rescue Therapy|Relapsed|0
2484895|NCT02132195|8587067|P3|Initial Assignment|Relapsed|0
2484896|NCT02132195|8587068|P2|Initial Assignment|Relapsed|0
2484897|NCT02132195|8587069|P1|Initial Assignment|Relapsed|14
2484898|NCT02132117|8587100|P2|Overall Study|Other Miscellaneous Reasons|0
2484899|NCT02132117|8587101|P1|Overall Study|Other Miscellaneous Reasons|2
2484900|NCT02132117|8587100|P2|Overall Study|Personal Reasons|2
2484901|NCT02132117|8587101|P1|Overall Study|Personal Reasons|1
2484902|NCT02132117|8587100|P2|Overall Study|Lost to Follow-up|2
2484903|NCT02132117|8587101|P1|Overall Study|Lost to Follow-up|2
2484904|NCT02132117|8587100|P2|Overall Study|Adverse Event|1
2484905|NCT02132117|8587101|P1|Overall Study|Adverse Event|6
2484906|NCT02131766|8587117|P1|Overall Study|Withdrawal by Subject|4
2484907|NCT02131662|8587133|P5|Overall Study|Not treated|3
2484908|NCT02131662|8587134|P4|Overall Study|Not treated|2
2484909|NCT02131662|8587135|P3|Overall Study|Not treated|2
2484910|NCT02131662|8587136|P2|Overall Study|Not treated|0
2484911|NCT02131662|8587137|P1|Overall Study|Not treated|2
2484912|NCT02131662|8587133|P5|Overall Study|Lost to Follow-up|0
2484913|NCT02131662|8587134|P4|Overall Study|Lost to Follow-up|9
2484914|NCT02131662|8587135|P3|Overall Study|Lost to Follow-up|0
2484915|NCT02131662|8587136|P2|Overall Study|Lost to Follow-up|3
2484916|NCT02131662|8587137|P1|Overall Study|Lost to Follow-up|1
2484917|NCT02131662|8587133|P5|Overall Study|Withdrawal by Subject|6
2484918|NCT02131662|8587134|P4|Overall Study|Withdrawal by Subject|5
2484919|NCT02131662|8587135|P3|Overall Study|Withdrawal by Subject|1
2484920|NCT02131662|8587136|P2|Overall Study|Withdrawal by Subject|5
2484921|NCT02131662|8587137|P1|Overall Study|Withdrawal by Subject|1
2484922|NCT02131662|8587133|P5|Overall Study|Lack of Efficacy|1
2484923|NCT02131662|8587134|P4|Overall Study|Lack of Efficacy|0
2484924|NCT02131662|8587135|P3|Overall Study|Lack of Efficacy|0
2484925|NCT02131662|8587136|P2|Overall Study|Lack of Efficacy|0
2484926|NCT02131662|8587137|P1|Overall Study|Lack of Efficacy|1
2484927|NCT02131662|8587133|P5|Overall Study|Wish for pregnancy|1
2484928|NCT02131662|8587134|P4|Overall Study|Wish for pregnancy|0
2484929|NCT02131662|8587135|P3|Overall Study|Wish for pregnancy|0
2484930|NCT02131662|8587136|P2|Overall Study|Wish for pregnancy|0
2484931|NCT02131662|8587137|P1|Overall Study|Wish for pregnancy|0
2484932|NCT02131662|8587133|P5|Overall Study|Pregnancy|0
2484933|NCT02131662|8587134|P4|Overall Study|Pregnancy|1
2484934|NCT02131662|8587135|P3|Overall Study|Pregnancy|0
2484935|NCT02131662|8587136|P2|Overall Study|Pregnancy|1
2484936|NCT02131662|8587137|P1|Overall Study|Pregnancy|0
2484937|NCT02131662|8587133|P5|Overall Study|Adverse Event|3
2484938|NCT02131662|8587134|P4|Overall Study|Adverse Event|1
2484939|NCT02131662|8587135|P3|Overall Study|Adverse Event|1
2484940|NCT02131662|8587136|P2|Overall Study|Adverse Event|1
2484941|NCT02131662|8587137|P1|Overall Study|Adverse Event|0
2484942|NCT02131662|8587133|P5|Overall Study|Other|4
2484943|NCT02131662|8587134|P4|Overall Study|Other|3
2484944|NCT02131662|8587135|P3|Overall Study|Other|3
2484945|NCT02131662|8587136|P2|Overall Study|Other|4
2484946|NCT02131662|8587137|P1|Overall Study|Other|2
2484947|NCT02131662|8587133|P5|Overall Study|Protocol Violation|0
2484948|NCT02131662|8587134|P4|Overall Study|Protocol Violation|0
2484949|NCT02131662|8587135|P3|Overall Study|Protocol Violation|0
2484950|NCT02131662|8587136|P2|Overall Study|Protocol Violation|0
2484951|NCT02131662|8587137|P1|Overall Study|Protocol Violation|1
2484952|NCT02131636|8587183|P2|Overall Study|Adverse Event|1
2484953|NCT02131636|8587184|P1|Overall Study|Adverse Event|4
2484954|NCT02131636|8587183|P2|Overall Study|Lost to Follow-up|0
2484955|NCT02131636|8587184|P1|Overall Study|Lost to Follow-up|4
2484956|NCT02131636|8587183|P2|Overall Study|Personal Reasons|4
2484957|NCT02131636|8587184|P1|Overall Study|Personal Reasons|4
2484958|NCT02131532|8587200|P1|Overall Study|Other health conditions|2
2484959|NCT02131532|8587200|P1|Overall Study|Physician Decision|1
2484960|NCT02131532|8587200|P1|Overall Study|Withdrawal by Subject|1
2484961|NCT02131324|8587292|P2|Overall Study|Lost to Follow-up|1
2484962|NCT02131324|8587293|P1|Overall Study|Lost to Follow-up|1
2484963|NCT02131324|8587292|P2|Overall Study|Withdrawal by Subject|2
2484964|NCT02131324|8587293|P1|Overall Study|Withdrawal by Subject|1
2484965|NCT02131311|8587299|P1|Overall Study|Lost to Follow-up|1
2484966|NCT02131311|8587299|P1|Overall Study|Protocol Violation|1
2484967|NCT02131311|8587299|P1|Overall Study|Adverse Event|2
2484968|NCT02131272|8587311|P2|Overall Study|Withdrawal Criteria|0
2484969|NCT02131272|8587312|P1|Overall Study|Withdrawal Criteria|1
2484970|NCT02131272|8587311|P2|Overall Study|Withdrawal by Subject|1
2484971|NCT02131272|8587312|P1|Overall Study|Withdrawal by Subject|0
2484972|NCT02131272|8587311|P2|Overall Study|Withdrawal by parent|1
2484973|NCT02131272|8587312|P1|Overall Study|Withdrawal by parent|0
2484974|NCT02131259|8587330|P1|Overall Study|Missing|3
2484975|NCT02131259|8587330|P1|Overall Study|Progressive disease/AE/other|1
2484976|NCT02131259|8587330|P1|Overall Study|AE/other|1
2484977|NCT02131259|8587330|P1|Overall Study|AE/lost to follow-up|1
2484978|NCT02131259|8587330|P1|Overall Study|Progressive disease/other|2
2484979|NCT02131259|8587330|P1|Overall Study|Progressive disease/relocation|1
2484980|NCT02131259|8587330|P1|Overall Study|Progressive disease/Adverse Event (AE)|22
2484981|NCT02131259|8587330|P1|Overall Study|Other|63
2484982|NCT02131259|8587330|P1|Overall Study|Relocation|32
2484983|NCT02131259|8587330|P1|Overall Study|Lost to Follow-up|7
2484984|NCT02131259|8587330|P1|Overall Study|Adverse Event|341
2484985|NCT02131259|8587330|P1|Overall Study|Progressive disease|751
2484986|NCT02131233|8587337|P2|Overall Study|Withdrawal by Subject|11
2484987|NCT02131233|8587338|P1|Overall Study|Withdrawal by Subject|18
2484988|NCT02131233|8587337|P2|Overall Study|Pregnancy|0
2484989|NCT02131233|8587338|P1|Overall Study|Pregnancy|4
2484990|NCT02131233|8587337|P2|Overall Study|Physician Decision|0
2484991|NCT02131233|8587338|P1|Overall Study|Physician Decision|7
2484992|NCT02131233|8587337|P2|Overall Study|Non-Compliance With Study Drug|5
2484993|NCT02131233|8587338|P1|Overall Study|Non-Compliance With Study Drug|8
2484994|NCT02131233|8587337|P2|Overall Study|Lost to Follow-up|13
2484995|NCT02131233|8587338|P1|Overall Study|Lost to Follow-up|14
2484996|NCT02131233|8587337|P2|Overall Study|Lack of Efficacy|3
2484997|NCT02131233|8587338|P1|Overall Study|Lack of Efficacy|6
2484998|NCT02131233|8587337|P2|Overall Study|Death|1
2484999|NCT02131233|8587338|P1|Overall Study|Death|0
2485000|NCT02131233|8587337|P2|Overall Study|Adverse Event|6
2485001|NCT02131233|8587338|P1|Overall Study|Adverse Event|7
2485002|NCT02131233|8587337|P2|Overall Study|Not Treated|3
2485003|NCT02131233|8587338|P1|Overall Study|Not Treated|2
2485004|NCT02131155|8587372|P2|Overall Study|Study early termination|10
2485005|NCT02131155|8587373|P1|Overall Study|Study early termination|20
2485006|NCT02131155|8587372|P2|Overall Study|Refused to continue study medication|0
2485007|NCT02131155|8587373|P1|Overall Study|Refused to continue study medication|1
2485008|NCT02131155|8587372|P2|Overall Study|Primary tumour recurrence|1
2485009|NCT02131155|8587373|P1|Overall Study|Primary tumour recurrence|2
2485010|NCT02131155|8587372|P2|Overall Study|Treatment completed|0
2485011|NCT02131155|8587373|P1|Overall Study|Treatment completed|1
2485012|NCT02131155|8587372|P2|Overall Study|Adverse Event|0
2485013|NCT02131155|8587373|P1|Overall Study|Adverse Event|1
2485014|NCT02131129|8587387|P2|Overall Study|Withdrawal by Subject|0
2485015|NCT02131129|8587388|P1|Overall Study|Withdrawal by Subject|1
2485016|NCT02131064|8587406|P2|Overall Study|Other|2
2485017|NCT02131064|8587407|P1|Overall Study|Other|2
2485018|NCT02131064|8587406|P2|Overall Study|Withdrawal by Subject|18
2485019|NCT02131064|8587407|P1|Overall Study|Withdrawal by Subject|14
2485020|NCT02131064|8587406|P2|Overall Study|Lost to Follow-up|8
2485021|NCT02131064|8587407|P1|Overall Study|Lost to Follow-up|4
2485022|NCT02131064|8587406|P2|Overall Study|Death|6
2485023|NCT02131064|8587407|P1|Overall Study|Death|5
2485024|NCT02130986|8587476|P2|Overall Study|Lost to Follow-up|160
2485025|NCT02130986|8587477|P1|Overall Study|Lost to Follow-up|151
2485026|NCT02130986|8587476|P2|Overall Study|Withdrawal by Subject|4
2485027|NCT02130986|8587477|P1|Overall Study|Withdrawal by Subject|4
2485028|NCT02130765|8587491|P4|Overall Study|Did not receive treatment|0
2485029|NCT02130765|8587492|P3|Overall Study|Did not receive treatment|0
2485030|NCT02130765|8587493|P2|Overall Study|Did not receive treatment|0
2485031|NCT02130765|8587494|P1|Overall Study|Did not receive treatment|4
2485032|NCT02130570|8587740|P2|Overall Study|Part of practice that discontinued study|5
2485033|NCT02130570|8587741|P1|Overall Study|Part of practice that discontinued study|0
2485034|NCT02130570|8587740|P2|Overall Study|Withdrawal by Subject|3
2485035|NCT02130570|8587741|P1|Overall Study|Withdrawal by Subject|6
2485036|NCT02130570|8587740|P2|Overall Study|Death|5
2485037|NCT02130570|8587741|P1|Overall Study|Death|3
2485038|NCT02130557|8587759|P2|Overall Study|Ongoing|255
2485039|NCT02130557|8587760|P1|Overall Study|Ongoing|260
2485040|NCT02130557|8587759|P2|Overall Study|Deceased|6
2485041|NCT02130557|8587760|P1|Overall Study|Deceased|1
2485042|NCT02130557|8587759|P2|Overall Study|Lost to Follow-up|2
2485043|NCT02130557|8587760|P1|Overall Study|Lost to Follow-up|2
2485044|NCT02130557|8587759|P2|Overall Study|Withdrawal by Subject|2
2485045|NCT02130557|8587760|P1|Overall Study|Withdrawal by Subject|5
2485046|NCT02130557|8587759|P2|Overall Study|Randomized, not treated|3
2485047|NCT02130557|8587760|P1|Overall Study|Randomized, not treated|0
2485048|NCT02130284|8587792|P1|Overall Study|Screen Failure|1
2485049|NCT02130284|8587792|P1|Overall Study|Subject was screened as backup for study|3
2485050|NCT02130284|8587792|P1|Overall Study|Subject's sensor failed at Visit 2, Day|1
2485051|NCT02130284|8587792|P1|Overall Study|Subject Withdrew Consent|1
2485052|NCT02130284|8587792|P1|Overall Study|Withdrawal by Subject|3
2485053|NCT02130193|8587818|P3|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
2485054|NCT02130193|8587819|P2|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
2485055|NCT02130193|8587820|P1|Part B: 52-week Double-blind Period|Withdrawal by Subject|0
2485056|NCT02130193|8587818|P3|Part B: 52-week Double-blind Period|Physician Decision|1
2485057|NCT02130193|8587819|P2|Part B: 52-week Double-blind Period|Physician Decision|0
2485058|NCT02130193|8587820|P1|Part B: 52-week Double-blind Period|Physician Decision|0
2485059|NCT02130193|8587818|P3|Part B: 52-week Double-blind Period|Protocol Violation|1
2485060|NCT02130193|8587819|P2|Part B: 52-week Double-blind Period|Protocol Violation|2
2485061|NCT02130193|8587820|P1|Part B: 52-week Double-blind Period|Protocol Violation|0
2485062|NCT02130193|8587818|P3|Part B: 52-week Double-blind Period|Adverse Event|3
2485063|NCT02130193|8587819|P2|Part B: 52-week Double-blind Period|Adverse Event|5
2485064|NCT02130193|8587820|P1|Part B: 52-week Double-blind Period|Adverse Event|0
2485065|NCT02130024|8587901|P2|Overall Study|Subject Withdrew Consent|14
2485066|NCT02130024|8587902|P1|Overall Study|Subject Withdrew Consent|6
2485067|NCT02130024|8587901|P2|Overall Study|Site Administration Problems|0
2485068|NCT02130024|8587902|P1|Overall Study|Site Administration Problems|1
2485069|NCT02130024|8587901|P2|Overall Study|Protocol Deviation|0
2485070|NCT02130024|8587902|P1|Overall Study|Protocol Deviation|4
2485071|NCT02130024|8587901|P2|Overall Study|Physician Decision|3
2485072|NCT02130024|8587902|P1|Overall Study|Physician Decision|1
2485073|NCT02130024|8587901|P2|Overall Study|Lost to Follow-up|1
2485074|NCT02130024|8587902|P1|Overall Study|Lost to Follow-up|1
2485075|NCT02130024|8587901|P2|Overall Study|Death|2
2485076|NCT02130024|8587902|P1|Overall Study|Death|2
2485077|NCT02130024|8587901|P2|Overall Study|Adverse Event|11
2485078|NCT02130024|8587902|P1|Overall Study|Adverse Event|10
2485079|NCT02129777|8587939|P7|Open-Label Period|Study Termination|39
2485080|NCT02129777|8587940|P6|Open-Label Period|Study Termination|10
2485081|NCT02129777|8587941|P5|Open-Label Period|Study Termination|0
2485082|NCT02129777|8587942|P4|Open-Label Period|Study Termination|0
2485083|NCT02129777|8587943|P3|Open-Label Period|Study Termination|0
2485084|NCT02129777|8587944|P2|Open-Label Period|Study Termination|0
2485085|NCT02129777|8587945|P1|Open-Label Period|Study Termination|0
2485086|NCT02129777|8587939|P7|Open-Label Period|Withdrawal by Subject|3
2485087|NCT02129777|8587940|P6|Open-Label Period|Withdrawal by Subject|1
2485088|NCT02129777|8587941|P5|Open-Label Period|Withdrawal by Subject|0
2485089|NCT02129777|8587942|P4|Open-Label Period|Withdrawal by Subject|0
2485090|NCT02129777|8587943|P3|Open-Label Period|Withdrawal by Subject|0
2485091|NCT02129777|8587944|P2|Open-Label Period|Withdrawal by Subject|0
2485092|NCT02129777|8587945|P1|Open-Label Period|Withdrawal by Subject|0
2485093|NCT02129777|8587939|P7|Open-Label Period|Lost to Follow-up|1
2485094|NCT02129777|8587940|P6|Open-Label Period|Lost to Follow-up|1
2485095|NCT02129777|8587941|P5|Open-Label Period|Lost to Follow-up|0
2485096|NCT02129777|8587942|P4|Open-Label Period|Lost to Follow-up|0
2485097|NCT02129777|8587943|P3|Open-Label Period|Lost to Follow-up|0
2485098|NCT02129777|8587944|P2|Open-Label Period|Lost to Follow-up|0
2485099|NCT02129777|8587945|P1|Open-Label Period|Lost to Follow-up|0
2485100|NCT02129777|8587939|P7|Open-Label Period|Lack of Efficacy|5
2485101|NCT02129777|8587940|P6|Open-Label Period|Lack of Efficacy|0
2485102|NCT02129777|8587941|P5|Open-Label Period|Lack of Efficacy|0
2485103|NCT02129777|8587942|P4|Open-Label Period|Lack of Efficacy|0
2485104|NCT02129777|8587943|P3|Open-Label Period|Lack of Efficacy|0
2485105|NCT02129777|8587944|P2|Open-Label Period|Lack of Efficacy|0
2485106|NCT02129777|8587945|P1|Open-Label Period|Lack of Efficacy|0
2485107|NCT02129777|8587939|P7|Double-Blind Period|Other|0
2485108|NCT02129777|8587940|P6|Double-Blind Period|Other|0
2485109|NCT02129777|8587941|P5|Double-Blind Period|Other|0
2485110|NCT02129777|8587942|P4|Double-Blind Period|Other|0
2485111|NCT02129777|8587943|P3|Double-Blind Period|Other|0
2485112|NCT02129777|8587944|P2|Double-Blind Period|Other|2
2485113|NCT02129777|8587945|P1|Double-Blind Period|Other|1
2485114|NCT02129777|8587939|P7|Double-Blind Period|Lack of Efficacy|0
2485115|NCT02129777|8587940|P6|Double-Blind Period|Lack of Efficacy|0
2485116|NCT02129777|8587941|P5|Double-Blind Period|Lack of Efficacy|2
2485117|NCT02129777|8587942|P4|Double-Blind Period|Lack of Efficacy|3
2485118|NCT02129777|8587943|P3|Double-Blind Period|Lack of Efficacy|0
2485119|NCT02129777|8587944|P2|Double-Blind Period|Lack of Efficacy|1
2485120|NCT02129777|8587945|P1|Double-Blind Period|Lack of Efficacy|3
2485121|NCT02129777|8587939|P7|Double-Blind Period|Pregnancy|0
2485122|NCT02129777|8587940|P6|Double-Blind Period|Pregnancy|0
2485123|NCT02129777|8587941|P5|Double-Blind Period|Pregnancy|1
2485124|NCT02129777|8587942|P4|Double-Blind Period|Pregnancy|0
2485125|NCT02129777|8587943|P3|Double-Blind Period|Pregnancy|0
2485126|NCT02129777|8587944|P2|Double-Blind Period|Pregnancy|0
2485127|NCT02129777|8587945|P1|Double-Blind Period|Pregnancy|0
2485128|NCT02129777|8587939|P7|Double-Blind Period|Withdrawal by Subject|0
2485129|NCT02129777|8587940|P6|Double-Blind Period|Withdrawal by Subject|0
2485130|NCT02129777|8587941|P5|Double-Blind Period|Withdrawal by Subject|3
2485131|NCT02129777|8587942|P4|Double-Blind Period|Withdrawal by Subject|2
2485132|NCT02129777|8587943|P3|Double-Blind Period|Withdrawal by Subject|3
2485133|NCT02129777|8587944|P2|Double-Blind Period|Withdrawal by Subject|4
2485134|NCT02129777|8587945|P1|Double-Blind Period|Withdrawal by Subject|2
2485135|NCT02129777|8587939|P7|Double-Blind Period|Lost to Follow-up|0
2485136|NCT02129777|8587940|P6|Double-Blind Period|Lost to Follow-up|0
2485137|NCT02129777|8587941|P5|Double-Blind Period|Lost to Follow-up|0
2485138|NCT02129777|8587942|P4|Double-Blind Period|Lost to Follow-up|2
2485139|NCT02129777|8587943|P3|Double-Blind Period|Lost to Follow-up|1
2485140|NCT02129777|8587944|P2|Double-Blind Period|Lost to Follow-up|1
2485141|NCT02129777|8587945|P1|Double-Blind Period|Lost to Follow-up|1
2485142|NCT02129777|8587939|P7|Double-Blind Period|Adverse Event|0
2485143|NCT02129777|8587940|P6|Double-Blind Period|Adverse Event|0
2485144|NCT02129777|8587941|P5|Double-Blind Period|Adverse Event|1
2485145|NCT02129777|8587942|P4|Double-Blind Period|Adverse Event|0
2485146|NCT02129777|8587943|P3|Double-Blind Period|Adverse Event|0
2485147|NCT02129777|8587944|P2|Double-Blind Period|Adverse Event|0
2485148|NCT02129777|8587945|P1|Double-Blind Period|Adverse Event|0
2485149|NCT02129608|8588112|P3|Overall Study|Withdrawal by Subject|2
2485150|NCT02129608|8588113|P2|Overall Study|Withdrawal by Subject|0
2485151|NCT02129608|8588114|P1|Overall Study|Withdrawal by Subject|0
2485152|NCT02129608|8588112|P3|Overall Study|Lost to Follow-up|1
2485153|NCT02129608|8588113|P2|Overall Study|Lost to Follow-up|1
2485154|NCT02129608|8588114|P1|Overall Study|Lost to Follow-up|0
2485155|NCT02129205|8588171|P10|Overall Study|Other|0
2485156|NCT02129205|8588172|P9|Overall Study|Other|1
2485157|NCT02129205|8588173|P8|Overall Study|Other|2
2485158|NCT02129205|8588174|P7|Overall Study|Other|3
2485159|NCT02129205|8588175|P6|Overall Study|Other|3
2485160|NCT02129205|8588176|P5|Overall Study|Other|2
2485161|NCT02129205|8588177|P4|Overall Study|Other|0
2485162|NCT02129205|8588178|P3|Overall Study|Other|0
2485163|NCT02129205|8588179|P2|Overall Study|Other|0
2485164|NCT02129205|8588180|P1|Overall Study|Other|1
2485165|NCT02129205|8588171|P10|Overall Study|Withdrawal by Subject|0
2485166|NCT02129205|8588172|P9|Overall Study|Withdrawal by Subject|1
2485167|NCT02129205|8588173|P8|Overall Study|Withdrawal by Subject|0
2485168|NCT02129205|8588174|P7|Overall Study|Withdrawal by Subject|1
2485169|NCT02129205|8588175|P6|Overall Study|Withdrawal by Subject|1
2485170|NCT02129205|8588176|P5|Overall Study|Withdrawal by Subject|1
2485171|NCT02129205|8588177|P4|Overall Study|Withdrawal by Subject|0
2485172|NCT02129205|8588178|P3|Overall Study|Withdrawal by Subject|0
2485173|NCT02129205|8588179|P2|Overall Study|Withdrawal by Subject|0
2485174|NCT02129205|8588180|P1|Overall Study|Withdrawal by Subject|0
2485175|NCT02129192|8588333|P2|Period 1 Including Washout Period|Withdrawal by Subject|1
2485176|NCT02129192|8588334|P1|Period 1 Including Washout Period|Withdrawal by Subject|0
2485177|NCT02129062|8588351|P1|Overall Study|Disease Progression|2
2485178|NCT02129062|8588351|P1|Overall Study|Death|1
2485179|NCT02128997|8588358|P2|Overall Study|Lost to Follow-up|11
2485180|NCT02128997|8588359|P1|Overall Study|Lost to Follow-up|6
2485181|NCT02128932|8588374|P3|Overall Study|No reason for withdrawal|7
2485182|NCT02128932|8588375|P2|Overall Study|No reason for withdrawal|11
2485183|NCT02128932|8588376|P1|Overall Study|No reason for withdrawal|12
2485184|NCT02128932|8588374|P3|Overall Study|Lost to Follow-up|1
2485185|NCT02128932|8588375|P2|Overall Study|Lost to Follow-up|1
2485186|NCT02128932|8588376|P1|Overall Study|Lost to Follow-up|2
2485187|NCT02128932|8588374|P3|Overall Study|Death|2
2485188|NCT02128932|8588375|P2|Overall Study|Death|0
2485189|NCT02128932|8588376|P1|Overall Study|Death|2
2485190|NCT02128932|8588374|P3|Overall Study|Withdrawal by Subject|8
2485191|NCT02128932|8588375|P2|Overall Study|Withdrawal by Subject|7
2485192|NCT02128932|8588376|P1|Overall Study|Withdrawal by Subject|11
2485193|NCT02128763|8588433|P2|Overall Study|Lost to Follow-up|16
2485194|NCT02128763|8588434|P1|Overall Study|Lost to Follow-up|19
2485195|NCT02128763|8588433|P2|Overall Study|Death|0
2485196|NCT02128763|8588434|P1|Overall Study|Death|1
2485197|NCT02128724|8588480|P4|Overall Study|Withdrawal by Subject|1
2485198|NCT02128724|8588481|P3|Overall Study|Withdrawal by Subject|0
2485199|NCT02128724|8588482|P2|Overall Study|Withdrawal by Subject|0
2485200|NCT02128724|8588483|P1|Overall Study|Withdrawal by Subject|0
2485201|NCT02128724|8588480|P4|Overall Study|Physician Decision|2
2485202|NCT02128724|8588481|P3|Overall Study|Physician Decision|0
2485203|NCT02128724|8588482|P2|Overall Study|Physician Decision|0
2485204|NCT02128724|8588483|P1|Overall Study|Physician Decision|0
2485205|NCT02128724|8588480|P4|Overall Study|Adverse Event|0
2485206|NCT02128724|8588481|P3|Overall Study|Adverse Event|0
2485207|NCT02128724|8588482|P2|Overall Study|Adverse Event|1
2485208|NCT02128724|8588483|P1|Overall Study|Adverse Event|0
2485209|NCT02128724|8588480|P4|Overall Study|Death|0
2485210|NCT02128724|8588481|P3|Overall Study|Death|0
2485211|NCT02128724|8588482|P2|Overall Study|Death|0
2485212|NCT02128724|8588483|P1|Overall Study|Death|1
2485213|NCT02128542|8588538|P2|Overall Study|Withdrew Consent|0
2485214|NCT02128542|8588539|P1|Overall Study|Withdrew Consent|1
2485215|NCT02128542|8588538|P2|Overall Study|Lost to Follow-up|0
2485216|NCT02128542|8588539|P1|Overall Study|Lost to Follow-up|3
2485217|NCT02128490|8588557|P5|Overall Study|Other Miscellaneous Reasons|1
2485218|NCT02128490|8588558|P4|Overall Study|Other Miscellaneous Reasons|1
2485219|NCT02128490|8588559|P3|Overall Study|Other Miscellaneous Reasons|2
2485220|NCT02128490|8588560|P2|Overall Study|Other Miscellaneous Reasons|0
2485221|NCT02128490|8588561|P1|Overall Study|Other Miscellaneous Reasons|0
2485222|NCT02128490|8588557|P5|Overall Study|Withdraw from Study Drug, Gout Flare|1
2485223|NCT02128490|8588558|P4|Overall Study|Withdraw from Study Drug, Gout Flare|0
2485224|NCT02128490|8588559|P3|Overall Study|Withdraw from Study Drug, Gout Flare|0
2485225|NCT02128490|8588560|P2|Overall Study|Withdraw from Study Drug, Gout Flare|0
2485226|NCT02128490|8588561|P1|Overall Study|Withdraw from Study Drug, Gout Flare|0
2485227|NCT02128490|8588557|P5|Overall Study|Lack of Efficacy|0
2485228|NCT02128490|8588558|P4|Overall Study|Lack of Efficacy|0
2485229|NCT02128490|8588559|P3|Overall Study|Lack of Efficacy|0
2485230|NCT02128490|8588560|P2|Overall Study|Lack of Efficacy|1
2485231|NCT02128490|8588561|P1|Overall Study|Lack of Efficacy|0
2485232|NCT02128490|8588557|P5|Overall Study|Voluntary Withdrawal|2
2485233|NCT02128490|8588558|P4|Overall Study|Voluntary Withdrawal|1
2485234|NCT02128490|8588559|P3|Overall Study|Voluntary Withdrawal|1
2485235|NCT02128490|8588560|P2|Overall Study|Voluntary Withdrawal|3
2485236|NCT02128490|8588561|P1|Overall Study|Voluntary Withdrawal|3
2485237|NCT02128490|8588557|P5|Overall Study|Lost to Follow-up|1
2485238|NCT02128490|8588558|P4|Overall Study|Lost to Follow-up|1
2485239|NCT02128490|8588559|P3|Overall Study|Lost to Follow-up|1
2485240|NCT02128490|8588560|P2|Overall Study|Lost to Follow-up|0
2485241|NCT02128490|8588561|P1|Overall Study|Lost to Follow-up|0
2485242|NCT02128490|8588557|P5|Overall Study|Major Protocol Deviation|2
2485243|NCT02128490|8588558|P4|Overall Study|Major Protocol Deviation|2
2485244|NCT02128490|8588559|P3|Overall Study|Major Protocol Deviation|0
2485245|NCT02128490|8588560|P2|Overall Study|Major Protocol Deviation|2
2485246|NCT02128490|8588561|P1|Overall Study|Major Protocol Deviation|1
2485247|NCT02128490|8588557|P5|Overall Study|Pretreatment Event/Adverse Event|0
2485248|NCT02128490|8588558|P4|Overall Study|Pretreatment Event/Adverse Event|1
2485249|NCT02128490|8588559|P3|Overall Study|Pretreatment Event/Adverse Event|1
2485250|NCT02128490|8588560|P2|Overall Study|Pretreatment Event/Adverse Event|0
2485251|NCT02128490|8588561|P1|Overall Study|Pretreatment Event/Adverse Event|1
2485252|NCT02128269|8588583|P1|Treatment Period|Physician Decision|1
2485253|NCT02128269|8588583|P1|Treatment Period|Adverse Event|1
2485254|NCT02128217|8588589|P2|Overall Study|Lost to Follow-up|1
2485255|NCT02128217|8588590|P1|Overall Study|Lost to Follow-up|0
2485256|NCT02127970|8588638|P2|Overall Study|Subject Withdrew Consent|3
2485257|NCT02127970|8588639|P1|Overall Study|Subject Withdrew Consent|5
2485258|NCT02127970|8588638|P2|Overall Study|Pregnancy|1
2485259|NCT02127970|8588639|P1|Overall Study|Pregnancy|0
2485260|NCT02127970|8588638|P2|Overall Study|Reason not Specified|7
2485261|NCT02127970|8588639|P1|Overall Study|Reason not Specified|4
2485262|NCT02127970|8588638|P2|Overall Study|Lost to Follow-up|14
2485263|NCT02127970|8588639|P1|Overall Study|Lost to Follow-up|14
2485264|NCT02127970|8588638|P2|Overall Study|Death|1
2485265|NCT02127970|8588639|P1|Overall Study|Death|1
2485266|NCT02127970|8588638|P2|Overall Study|Adverse Event|1
2485267|NCT02127970|8588639|P1|Overall Study|Adverse Event|2
2485268|NCT02127931|8588661|P1|Overall Study|Glitch in Game|1
2485269|NCT02127372|8588780|P2|Overall Study|Withdrawal by Subject|0
2485270|NCT02127372|8588781|P1|Overall Study|Withdrawal by Subject|1
2485271|NCT02127307|8588791|P1|Overall Study|Other than specified above|169
2485272|NCT02127307|8588791|P1|Overall Study|Death|101
2485273|NCT02127307|8588791|P1|Overall Study|Lost to Follow-up|2
2485274|NCT02127307|8588791|P1|Overall Study|Protocol Violation|36
2485275|NCT02127281|8588797|P2|Overall Study|Lost to Follow-up|0
2485276|NCT02127281|8588798|P1|Overall Study|Lost to Follow-up|1
2485277|NCT02126969|8588826|P2|Overall Study|Withdrawal by Subject|2
2485278|NCT02126969|8588827|P1|Overall Study|Withdrawal by Subject|1
2485279|NCT02126839|8588837|P2|Overall Study|Other|5
2485280|NCT02126839|8588838|P1|Overall Study|Other|5
2485281|NCT02126839|8588837|P2|Overall Study|Lost to Follow-up|4
2485282|NCT02126839|8588838|P1|Overall Study|Lost to Follow-up|1
2485283|NCT02126839|8588837|P2|Overall Study|Sponsor request|1
2485284|NCT02126839|8588838|P1|Overall Study|Sponsor request|0
2485285|NCT02126839|8588837|P2|Overall Study|Protocol Violation|3
2485286|NCT02126839|8588838|P1|Overall Study|Protocol Violation|2
2485287|NCT02126839|8588837|P2|Overall Study|Withdrawal by parent/guardian|0
2485288|NCT02126839|8588838|P1|Overall Study|Withdrawal by parent/guardian|1
2485289|NCT02126839|8588837|P2|Overall Study|Withdrawal by Subject|0
2485290|NCT02126839|8588838|P1|Overall Study|Withdrawal by Subject|1
2485291|NCT02126839|8588837|P2|Overall Study|Adverse Event|1
2485292|NCT02126839|8588838|P1|Overall Study|Adverse Event|0
2485293|NCT02126826|8588855|P7|Overall Study|Withdrawal by Subject|0
2485294|NCT02126826|8588856|P6|Overall Study|Withdrawal by Subject|0
2485295|NCT02126826|8588857|P5|Overall Study|Withdrawal by Subject|0
2485296|NCT02126826|8588858|P4|Overall Study|Withdrawal by Subject|1
2485297|NCT02126826|8588859|P3|Overall Study|Withdrawal by Subject|0
2485298|NCT02126826|8588860|P2|Overall Study|Withdrawal by Subject|0
2485299|NCT02126826|8588861|P1|Overall Study|Withdrawal by Subject|0
2485300|NCT02126670|8588929|P4|Overall Study|Withdrawal by Subject|1
2485301|NCT02126670|8588930|P3|Overall Study|Withdrawal by Subject|0
2485302|NCT02126670|8588931|P2|Overall Study|Withdrawal by Subject|0
2485303|NCT02126670|8588932|P1|Overall Study|Withdrawal by Subject|1
2485304|NCT02125877|8588984|P2|Overall Study|Adverse Event|4
2485305|NCT02125877|8588985|P1|Overall Study|Adverse Event|6
2485306|NCT02125877|8588984|P2|Overall Study|Protocol deviation|1
2485307|NCT02125877|8588985|P1|Overall Study|Protocol deviation|4
2485308|NCT02125877|8588984|P2|Overall Study|Withdrawal by Subject|1
2485309|NCT02125877|8588985|P1|Overall Study|Withdrawal by Subject|2
2485310|NCT02125877|8588984|P2|Overall Study|Participant/guardian decision|2
2485311|NCT02125877|8588985|P1|Overall Study|Participant/guardian decision|0
2485312|NCT02125877|8588984|P2|Overall Study|Administrative problems|1
2485313|NCT02125877|8588985|P1|Overall Study|Administrative problems|0
2485314|NCT02125877|8588984|P2|Overall Study|Death|1
2485315|NCT02125877|8588985|P1|Overall Study|Death|0
2485316|NCT02125877|8588984|P2|Overall Study|Physician Decision|0
2485317|NCT02125877|8588985|P1|Overall Study|Physician Decision|1
2485318|NCT02125838|8589015|P2|Overall Study|Lost to Follow-up|4
2485319|NCT02125838|8589016|P1|Overall Study|Lost to Follow-up|4
2485320|NCT02125734|8589034|P2|Period 2|Adverse Event|1
2485321|NCT02125734|8589035|P1|Period 2|Adverse Event|0
2485322|NCT02125604|8589045|P1|Overall Study|Adverse Event|20
2485323|NCT02125604|8589045|P1|Overall Study|Consent Withdrawn|4
2485324|NCT02125604|8589045|P1|Overall Study|Lost to Follow-up|2
2485325|NCT02125604|8589045|P1|Overall Study|Investigator Decision|1
2485326|NCT02125604|8589045|P1|Overall Study|Other|4
2485327|NCT02125461|8589061|P2|Overall Study|Death|115
2485328|NCT02125461|8589062|P1|Overall Study|Death|180
2485329|NCT02125461|8589061|P2|Overall Study|Lost to Follow-up|0
2485330|NCT02125461|8589062|P1|Overall Study|Lost to Follow-up|1
2485331|NCT02125461|8589061|P2|Overall Study|Withdrawal by Subject|14
2485332|NCT02125461|8589062|P1|Overall Study|Withdrawal by Subject|22
2485333|NCT02125279|8589117|P1|Overall Study|Lost to Follow-up|4
2485334|NCT02125279|8589117|P1|Overall Study|Protocol Violation|1
2485335|NCT02125279|8589117|P1|Overall Study|Withdrawal by Subject|6
2485336|NCT02125279|8589117|P1|Overall Study|Lack of Efficacy|2
2485337|NCT02124811|8589161|P2|Overall Study|Withdrawal by Subject|0
2485338|NCT02124811|8589162|P1|Overall Study|Withdrawal by Subject|1
2485339|NCT02124811|8589161|P2|Overall Study|Early termination|2
2485340|NCT02124811|8589162|P1|Overall Study|Early termination|2
2485341|NCT02124798|8589178|P1|Overall Study|Lost to Follow-up|1
2485342|NCT02124798|8589178|P1|Overall Study|Adverse Event|3
2485343|NCT02124564|8589190|P1|Treatment Period|Withdrawal by Subject|2
2485344|NCT02124564|8589190|P1|Treatment Period|Lack of Efficacy|3
2485345|NCT02124564|8589190|P1|Treatment Period|Adverse Event|2
2485346|NCT02124265|8589255|P1|Overall Study|Adverse Event|1
2485347|NCT02124161|8589261|P2|Overall Study|Lost to Follow-up|4
2485348|NCT02124161|8589262|P1|Overall Study|Lost to Follow-up|3
2485349|NCT02124161|8589261|P2|Overall Study|No longer meets eligibility criteria|4
2485350|NCT02124161|8589262|P1|Overall Study|No longer meets eligibility criteria|5
2485351|NCT02124161|8589261|P2|Overall Study|Does not meet entrance criteria|3
2485352|NCT02124161|8589262|P1|Overall Study|Does not meet entrance criteria|2
2485353|NCT02124161|8589261|P2|Overall Study|Adverse Event|0
2485354|NCT02124161|8589262|P1|Overall Study|Adverse Event|2
2485355|NCT02124161|8589261|P2|Overall Study|Withdrawal by Subject|2
2485356|NCT02124161|8589262|P1|Overall Study|Withdrawal by Subject|1
2485357|NCT02124161|8589261|P2|Overall Study|Protocol Violation|1
2485358|NCT02124161|8589262|P1|Overall Study|Protocol Violation|2
2485359|NCT02124161|8589261|P2|Overall Study|Death|0
2485360|NCT02124161|8589262|P1|Overall Study|Death|1
2485361|NCT02124161|8589261|P2|Overall Study|Other unspecified|1
2485362|NCT02124161|8589262|P1|Overall Study|Other unspecified|0
2485363|NCT02123966|8589337|P1|Overall Study|Intercurrent Illness|1
2485364|NCT02123576|8589379|P2|Overall Study|Adverse Event|0
2485365|NCT02123576|8589380|P1|Overall Study|Adverse Event|1
2485366|NCT02123511|8589398|P2|Overall Study|Ineligible|1
2485367|NCT02123511|8589399|P1|Overall Study|Ineligible|0
2485368|NCT02123511|8589398|P2|Overall Study|Incomplete data|3
2485369|NCT02123511|8589399|P1|Overall Study|Incomplete data|1
2485370|NCT02123511|8589398|P2|Overall Study|Cancelled treatment|0
2485371|NCT02123511|8589399|P1|Overall Study|Cancelled treatment|1
2485372|NCT02123472|8589423|P2|Period 2 (7 Days)|Withdrawal by Subject|1
2485373|NCT02123472|8589424|P1|Period 2 (7 Days)|Withdrawal by Subject|0
2485374|NCT02123459|8589434|P2|Washout Period (1 Day)|Adverse Event|0
2485375|NCT02123459|8589435|P1|Washout Period (1 Day)|Adverse Event|1
2485376|NCT02123446|8589445|P2|Washout Period (1 Day)|Physician Decision|0
2485377|NCT02123446|8589446|P1|Washout Period (1 Day)|Physician Decision|1
2485378|NCT02123251|8589487|P2|Overall Study|Switched Managed Care Organization (MCO)|4
2485379|NCT02123251|8589488|P1|Overall Study|Switched Managed Care Organization (MCO)|4
2485380|NCT02123251|8589487|P2|Overall Study|Lost Medicaid eligibility|22
2485381|NCT02123251|8589488|P1|Overall Study|Lost Medicaid eligibility|29
2485382|NCT02123251|8589487|P2|Overall Study|Withdrawal by Subject|3
2485383|NCT02123251|8589488|P1|Overall Study|Withdrawal by Subject|0
2485384|NCT02123251|8589487|P2|Overall Study|Death|1
2485385|NCT02123251|8589488|P1|Overall Study|Death|1
2485386|NCT02123134|8589514|P2|Overall Study|Administrative decision|1
2485387|NCT02123134|8589515|P1|Overall Study|Administrative decision|0
2485388|NCT02123134|8589514|P2|Overall Study|Withdrawal of consent|2
2485389|NCT02123134|8589515|P1|Overall Study|Withdrawal of consent|3
2485390|NCT02122887|8589572|P2|Overall Study|Withdrawal by Subject|2
2485391|NCT02122887|8589573|P1|Overall Study|Withdrawal by Subject|20
2485392|NCT02122770|8589613|P6|Part B: Standard of Care|Progressive Disease|8
2485393|NCT02122770|8589614|P5|Part B: Standard of Care|Progressive Disease|10
2485394|NCT02122770|8589615|P4|Part B: Standard of Care|Progressive Disease|0
2485395|NCT02122770|8589616|P3|Part B: Standard of Care|Progressive Disease|0
2485396|NCT02122770|8589617|P2|Part B: Standard of Care|Progressive Disease|0
2485397|NCT02122770|8589618|P1|Part B: Standard of Care|Progressive Disease|0
2485398|NCT02122770|8589613|P6|Part B: Standard of Care|Symptomatic Deterioration|0
2485399|NCT02122770|8589614|P5|Part B: Standard of Care|Symptomatic Deterioration|5
2485400|NCT02122770|8589615|P4|Part B: Standard of Care|Symptomatic Deterioration|0
2485401|NCT02122770|8589616|P3|Part B: Standard of Care|Symptomatic Deterioration|0
2485402|NCT02122770|8589617|P2|Part B: Standard of Care|Symptomatic Deterioration|0
2485403|NCT02122770|8589618|P1|Part B: Standard of Care|Symptomatic Deterioration|0
2485404|NCT02122770|8589613|P6|Part B: Standard of Care|Withdrawal by Subject|2
2485405|NCT02122770|8589614|P5|Part B: Standard of Care|Withdrawal by Subject|4
2485406|NCT02122770|8589615|P4|Part B: Standard of Care|Withdrawal by Subject|0
2485407|NCT02122770|8589616|P3|Part B: Standard of Care|Withdrawal by Subject|0
2485408|NCT02122770|8589617|P2|Part B: Standard of Care|Withdrawal by Subject|0
2485409|NCT02122770|8589618|P1|Part B: Standard of Care|Withdrawal by Subject|0
2485410|NCT02122770|8589613|P6|Part B: Standard of Care|Other|2
2485411|NCT02122770|8589614|P5|Part B: Standard of Care|Other|0
2485412|NCT02122770|8589615|P4|Part B: Standard of Care|Other|0
2485413|NCT02122770|8589616|P3|Part B: Standard of Care|Other|0
2485414|NCT02122770|8589617|P2|Part B: Standard of Care|Other|0
2485415|NCT02122770|8589618|P1|Part B: Standard of Care|Other|0
2485416|NCT02122770|8589613|P6|Part B: Standard of Care|Adverse Event|1
2485417|NCT02122770|8589614|P5|Part B: Standard of Care|Adverse Event|4
2485418|NCT02122770|8589615|P4|Part B: Standard of Care|Adverse Event|0
2485419|NCT02122770|8589616|P3|Part B: Standard of Care|Adverse Event|0
2485420|NCT02122770|8589617|P2|Part B: Standard of Care|Adverse Event|0
2485421|NCT02122770|8589618|P1|Part B: Standard of Care|Adverse Event|0
2485422|NCT02122770|8589613|P6|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
2485423|NCT02122770|8589614|P5|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
2485424|NCT02122770|8589615|P4|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1
2485425|NCT02122770|8589616|P3|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
2485426|NCT02122770|8589617|P2|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5
2485427|NCT02122770|8589618|P1|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1
2485428|NCT02122770|8589613|P6|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
2485429|NCT02122770|8589614|P5|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
2485430|NCT02122770|8589615|P4|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
2485431|NCT02122770|8589616|P3|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
2485432|NCT02122770|8589617|P2|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1
2485433|NCT02122770|8589618|P1|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
2485434|NCT02122770|8589613|P6|Part A: Drug-drug Interaction 2|Other|0
2485435|NCT02122770|8589614|P5|Part A: Drug-drug Interaction 2|Other|0
2485436|NCT02122770|8589615|P4|Part A: Drug-drug Interaction 2|Other|0
2485437|NCT02122770|8589616|P3|Part A: Drug-drug Interaction 2|Other|1
2485438|NCT02122770|8589617|P2|Part A: Drug-drug Interaction 2|Other|0
2485439|NCT02122770|8589618|P1|Part A: Drug-drug Interaction 2|Other|0
2485440|NCT02122770|8589613|P6|Part A: Drug-drug Interaction 2|Adverse Event|0
2485441|NCT02122770|8589614|P5|Part A: Drug-drug Interaction 2|Adverse Event|0
2485442|NCT02122770|8589615|P4|Part A: Drug-drug Interaction 2|Adverse Event|2
2485443|NCT02122770|8589616|P3|Part A: Drug-drug Interaction 2|Adverse Event|1
2485444|NCT02122770|8589617|P2|Part A: Drug-drug Interaction 2|Adverse Event|0
2485445|NCT02122770|8589618|P1|Part A: Drug-drug Interaction 2|Adverse Event|3
2485446|NCT02122146|8589761|P8|Part 1: Dose Escalation|Other|2
2485447|NCT02122146|8589762|P7|Part 1: Dose Escalation|Other|1
2485448|NCT02122146|8589763|P6|Part 1: Dose Escalation|Other|1
2485449|NCT02122146|8589764|P5|Part 1: Dose Escalation|Other|0
2485450|NCT02122146|8589765|P4|Part 1: Dose Escalation|Other|0
2485451|NCT02122146|8589766|P3|Part 1: Dose Escalation|Other|0
2485452|NCT02122146|8589767|P2|Part 1: Dose Escalation|Other|0
2485453|NCT02122146|8589768|P1|Part 1: Dose Escalation|Other|1
2485454|NCT02122146|8589761|P8|Part 1: Dose Escalation|Withdrawal by Subject|0
2485455|NCT02122146|8589762|P7|Part 1: Dose Escalation|Withdrawal by Subject|0
2485456|NCT02122146|8589763|P6|Part 1: Dose Escalation|Withdrawal by Subject|0
2485457|NCT02122146|8589764|P5|Part 1: Dose Escalation|Withdrawal by Subject|0
2485458|NCT02122146|8589765|P4|Part 1: Dose Escalation|Withdrawal by Subject|1
2485459|NCT02122146|8589766|P3|Part 1: Dose Escalation|Withdrawal by Subject|0
2485460|NCT02122146|8589767|P2|Part 1: Dose Escalation|Withdrawal by Subject|0
2485461|NCT02122146|8589768|P1|Part 1: Dose Escalation|Withdrawal by Subject|0
2485462|NCT02122146|8589761|P8|Part 1: Dose Escalation|Lost to Follow-up|0
2485463|NCT02122146|8589762|P7|Part 1: Dose Escalation|Lost to Follow-up|0
2485464|NCT02122146|8589763|P6|Part 1: Dose Escalation|Lost to Follow-up|0
2485465|NCT02122146|8589764|P5|Part 1: Dose Escalation|Lost to Follow-up|1
2485466|NCT02122146|8589765|P4|Part 1: Dose Escalation|Lost to Follow-up|0
2485467|NCT02122146|8589766|P3|Part 1: Dose Escalation|Lost to Follow-up|1
2485468|NCT02122146|8589767|P2|Part 1: Dose Escalation|Lost to Follow-up|0
2485469|NCT02122146|8589768|P1|Part 1: Dose Escalation|Lost to Follow-up|0
2485470|NCT02122146|8589761|P8|Part 1: Dose Escalation|Death|0
2485471|NCT02122146|8589762|P7|Part 1: Dose Escalation|Death|0
2485472|NCT02122146|8589763|P6|Part 1: Dose Escalation|Death|0
2485473|NCT02122146|8589764|P5|Part 1: Dose Escalation|Death|0
2485474|NCT02122146|8589765|P4|Part 1: Dose Escalation|Death|0
2485475|NCT02122146|8589766|P3|Part 1: Dose Escalation|Death|1
2485476|NCT02122146|8589767|P2|Part 1: Dose Escalation|Death|1
2485477|NCT02122146|8589768|P1|Part 1: Dose Escalation|Death|0
2485478|NCT02121847|8590042|P1|Overall Study|Adverse Event|2
2485479|NCT02121847|8590042|P1|Overall Study|Administrative Reasons|1
2485480|NCT02121834|8590068|P7|Overall Study|Lost to Follow-up|0
2485481|NCT02121834|8590069|P6|Overall Study|Lost to Follow-up|0
2485482|NCT02121834|8590070|P5|Overall Study|Lost to Follow-up|0
2485483|NCT02121834|8590071|P4|Overall Study|Lost to Follow-up|0
2485484|NCT02121834|8590072|P3|Overall Study|Lost to Follow-up|1
2485485|NCT02121834|8590073|P2|Overall Study|Lost to Follow-up|0
2485486|NCT02121834|8590074|P1|Overall Study|Lost to Follow-up|0
2485487|NCT02121834|8590068|P7|Overall Study|Withdrawal by Subject|0
2485488|NCT02121834|8590069|P6|Overall Study|Withdrawal by Subject|0
2485489|NCT02121834|8590070|P5|Overall Study|Withdrawal by Subject|0
2485490|NCT02121834|8590071|P4|Overall Study|Withdrawal by Subject|0
2485491|NCT02121834|8590072|P3|Overall Study|Withdrawal by Subject|1
2485492|NCT02121834|8590073|P2|Overall Study|Withdrawal by Subject|1
2485493|NCT02121834|8590074|P1|Overall Study|Withdrawal by Subject|0
2485494|NCT02121834|8590068|P7|Overall Study|Protocol Violation|0
2485495|NCT02121834|8590069|P6|Overall Study|Protocol Violation|0
2485496|NCT02121834|8590070|P5|Overall Study|Protocol Violation|0
2485497|NCT02121834|8590071|P4|Overall Study|Protocol Violation|0
2485498|NCT02121834|8590072|P3|Overall Study|Protocol Violation|0
2485499|NCT02121834|8590073|P2|Overall Study|Protocol Violation|1
2485500|NCT02121834|8590074|P1|Overall Study|Protocol Violation|0
2485501|NCT02121808|8590100|P1|Overall Study|Technical problem|3
2485502|NCT02121795|8590111|P2|Open-Label Phase|Lost to Follow-up|0
2485503|NCT02121795|8590112|P1|Open-Label Phase|Lost to Follow-up|1
2485504|NCT02121795|8590111|P2|Open-Label Phase|Withdrawal by Subject|2
2485505|NCT02121795|8590112|P1|Open-Label Phase|Withdrawal by Subject|3
2485506|NCT02121795|8590111|P2|Open-Label Phase|Physician Decision|8
2485507|NCT02121795|8590112|P1|Open-Label Phase|Physician Decision|8
2485508|NCT02121795|8590111|P2|Double-Blind Phase|Death|1
2485509|NCT02121795|8590112|P1|Double-Blind Phase|Death|1
2485510|NCT02121795|8590111|P2|Double-Blind Phase|Protocol Violation|3
2485511|NCT02121795|8590112|P1|Double-Blind Phase|Protocol Violation|0
2485512|NCT02121795|8590111|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
2485513|NCT02121795|8590112|P1|Double-Blind Phase|Non-Compliance with Study Drug|3
2485514|NCT02121795|8590111|P2|Double-Blind Phase|Adverse Event|0
2485515|NCT02121795|8590112|P1|Double-Blind Phase|Adverse Event|5
2485516|NCT02121795|8590111|P2|Double-Blind Phase|Physician Decision|5
2485517|NCT02121795|8590112|P1|Double-Blind Phase|Physician Decision|2
2485518|NCT02121795|8590111|P2|Double-Blind Phase|Lost to Follow-up|4
2485519|NCT02121795|8590112|P1|Double-Blind Phase|Lost to Follow-up|7
2485520|NCT02121795|8590111|P2|Double-Blind Phase|Withdrawal by Subject|16
2485521|NCT02121795|8590112|P1|Double-Blind Phase|Withdrawal by Subject|19
2485522|NCT02121795|8590111|P2|Double-Blind Phase|Randomized but Never Treated|4
2485523|NCT02121795|8590112|P1|Double-Blind Phase|Randomized but Never Treated|1
2485524|NCT02121756|8590140|P2|Overall Study|Physician Decision|1
2485525|NCT02121756|8590141|P1|Overall Study|Physician Decision|2
2485526|NCT02121756|8590140|P2|Overall Study|Protocol Violation|1
2485527|NCT02121756|8590141|P1|Overall Study|Protocol Violation|1
2485528|NCT02121756|8590140|P2|Overall Study|Adverse Event|0
2485529|NCT02121756|8590141|P1|Overall Study|Adverse Event|3
2485530|NCT02121535|8590178|P2|Period 3 (8 Trial Days)|Withdrawal by Subject|0
2485531|NCT02121535|8590179|P1|Period 3 (8 Trial Days)|Withdrawal by Subject|1
2485532|NCT02121535|8590178|P2|Period 1 (8 Trial Days)|Withdrawal by Subject|1
2485533|NCT02121535|8590179|P1|Period 1 (8 Trial Days)|Withdrawal by Subject|0
2485534|NCT02121522|8590202|P1|Overall Study|Adverse Event|1
2485535|NCT02121509|8590209|P4|Washout Period (35 Days)|elevated AST and ALT levels|0
2485536|NCT02121509|8590210|P3|Washout Period (35 Days)|elevated AST and ALT levels|0
2485537|NCT02121509|8590211|P2|Washout Period (35 Days)|elevated AST and ALT levels|0
2485538|NCT02121509|8590212|P1|Washout Period (35 Days)|elevated AST and ALT levels|1
2485539|NCT02121509|8590209|P4|Washout Period (35 Days)|Withdrawal by Subject|0
2485540|NCT02121509|8590210|P3|Washout Period (35 Days)|Withdrawal by Subject|0
2485541|NCT02121509|8590211|P2|Washout Period (35 Days)|Withdrawal by Subject|3
2485542|NCT02121509|8590212|P1|Washout Period (35 Days)|Withdrawal by Subject|0
2485543|NCT02121509|8590209|P4|Washout Period (35 Days)|Adverse Event|0
2485544|NCT02121509|8590210|P3|Washout Period (35 Days)|Adverse Event|0
2485545|NCT02121509|8590211|P2|Washout Period (35 Days)|Adverse Event|1
2485546|NCT02121509|8590212|P1|Washout Period (35 Days)|Adverse Event|1
2485547|NCT02121210|8590283|P2|Overall Study|Other than specified above|2
2485548|NCT02121210|8590284|P1|Overall Study|Other than specified above|0
2485549|NCT02121210|8590283|P2|Overall Study|Lack of Efficacy|0
2485550|NCT02121210|8590284|P1|Overall Study|Lack of Efficacy|2
2485551|NCT02121210|8590283|P2|Overall Study|Adverse Event|7
2485552|NCT02121210|8590284|P1|Overall Study|Adverse Event|5
2485553|NCT02120950|8590309|P3|Overall Study|Lost to Follow-up|1
2485554|NCT02120950|8590310|P2|Overall Study|Lost to Follow-up|2
2485555|NCT02120950|8590311|P1|Overall Study|Lost to Follow-up|0
2485556|NCT02120950|8590309|P3|Overall Study|Other reasons|1
2485557|NCT02120950|8590310|P2|Overall Study|Other reasons|4
2485558|NCT02120950|8590311|P1|Overall Study|Other reasons|5
2485559|NCT02120950|8590309|P3|Overall Study|Protocol Violation|7
2485560|NCT02120950|8590310|P2|Overall Study|Protocol Violation|1
2485561|NCT02120950|8590311|P1|Overall Study|Protocol Violation|1
2485562|NCT02120950|8590309|P3|Overall Study|Withdrawal by Subject|2
2485563|NCT02120950|8590310|P2|Overall Study|Withdrawal by Subject|3
2485564|NCT02120950|8590311|P1|Overall Study|Withdrawal by Subject|6
2485565|NCT02120950|8590309|P3|Overall Study|Death|1
2485566|NCT02120950|8590310|P2|Overall Study|Death|0
2485567|NCT02120950|8590311|P1|Overall Study|Death|3
2485568|NCT02120950|8590309|P3|Overall Study|Adverse Event|3
2485569|NCT02120950|8590310|P2|Overall Study|Adverse Event|4
2485570|NCT02120950|8590311|P1|Overall Study|Adverse Event|5
2485571|NCT02120898|8590347|P3|Overall Study|Lost to Follow-up|1
2485572|NCT02120898|8590348|P2|Overall Study|Lost to Follow-up|0
2485573|NCT02120898|8590349|P1|Overall Study|Lost to Follow-up|0
2485574|NCT02120898|8590347|P3|Overall Study|Protocol Violation|0
2485575|NCT02120898|8590348|P2|Overall Study|Protocol Violation|2
2485576|NCT02120898|8590349|P1|Overall Study|Protocol Violation|1
2485577|NCT02120898|8590347|P3|Overall Study|Adverse Event|1
2485578|NCT02120898|8590348|P2|Overall Study|Adverse Event|2
2485579|NCT02120898|8590349|P1|Overall Study|Adverse Event|1
2485580|NCT02120898|8590347|P3|Overall Study|Non-compliance with study drug|0
2485581|NCT02120898|8590348|P2|Overall Study|Non-compliance with study drug|0
2485582|NCT02120898|8590349|P1|Overall Study|Non-compliance with study drug|3
2485583|NCT02120898|8590347|P3|Overall Study|Withdrawal by Subject|2
2485584|NCT02120898|8590348|P2|Overall Study|Withdrawal by Subject|2
2485585|NCT02120898|8590349|P1|Overall Study|Withdrawal by Subject|4
2485586|NCT02120833|8590371|P2|Overall Study|Lost to Follow-up|1
2485587|NCT02120833|8590372|P1|Overall Study|Lost to Follow-up|1
2485588|NCT02120833|8590371|P2|Overall Study|Withdrawal by Subject|0
2485589|NCT02120833|8590372|P1|Overall Study|Withdrawal by Subject|2
2485590|NCT02120833|8590371|P2|Overall Study|Adverse Event|0
2485591|NCT02120833|8590372|P1|Overall Study|Adverse Event|1
2485592|NCT02120794|8590526|P1|Overall Study|Due to insurance coverage|1
2485593|NCT02120794|8590526|P1|Overall Study|Physician Decision|4
2485594|NCT02120794|8590526|P1|Overall Study|Adverse Event|10
2485595|NCT02120794|8590526|P1|Overall Study|Withdrawal by Subject|43
2485596|NCT02120664|8590550|P5|Overall Study|Withdrawal by Subject|0
2485597|NCT02120664|8590551|P4|Overall Study|Withdrawal by Subject|1
2485598|NCT02120664|8590552|P3|Overall Study|Withdrawal by Subject|0
2485599|NCT02120664|8590553|P2|Overall Study|Withdrawal by Subject|0
2485600|NCT02120664|8590554|P1|Overall Study|Withdrawal by Subject|0
2485601|NCT02120625|8590572|P1|Overall Study|Physician Decision|2
2485602|NCT02120456|8590588|P9|Part 2 Double-blind Phase|Unable to attend visit due to work|1
2485603|NCT02120456|8590589|P8|Part 2 Double-blind Phase|Unable to attend visit due to work|0
2485604|NCT02120456|8590590|P7|Part 2 Double-blind Phase|Unable to attend visit due to work|0
2485605|NCT02120456|8590591|P6|Part 2 Double-blind Phase|Unable to attend visit due to work|0
2485606|NCT02120456|8590592|P5|Part 2 Double-blind Phase|Unable to attend visit due to work|0
2485607|NCT02120456|8590593|P4|Part 2 Double-blind Phase|Unable to attend visit due to work|0
2485608|NCT02120456|8590594|P3|Part 2 Double-blind Phase|Unable to attend visit due to work|0
2485609|NCT02120456|8590595|P2|Part 2 Double-blind Phase|Unable to attend visit due to work|0
2485610|NCT02120456|8590596|P1|Part 2 Double-blind Phase|Unable to attend visit due to work|0
2485611|NCT02120456|8590588|P9|Part 2 Double-blind Phase|Withdrawal of consent|0
2485612|NCT02120456|8590589|P8|Part 2 Double-blind Phase|Withdrawal of consent|0
2485613|NCT02120456|8590590|P7|Part 2 Double-blind Phase|Withdrawal of consent|1
2485614|NCT02120456|8590591|P6|Part 2 Double-blind Phase|Withdrawal of consent|0
2485615|NCT02120456|8590592|P5|Part 2 Double-blind Phase|Withdrawal of consent|0
2485616|NCT02120456|8590593|P4|Part 2 Double-blind Phase|Withdrawal of consent|0
2485617|NCT02120456|8590594|P3|Part 2 Double-blind Phase|Withdrawal of consent|0
2485618|NCT02120456|8590595|P2|Part 2 Double-blind Phase|Withdrawal of consent|0
2485619|NCT02120456|8590596|P1|Part 2 Double-blind Phase|Withdrawal of consent|0
2485620|NCT02120456|8590588|P9|Part 2 Double-blind Phase|Lost to Follow-up|0
2485621|NCT02120456|8590589|P8|Part 2 Double-blind Phase|Lost to Follow-up|0
2485622|NCT02120456|8590590|P7|Part 2 Double-blind Phase|Lost to Follow-up|1
2485623|NCT02120456|8590591|P6|Part 2 Double-blind Phase|Lost to Follow-up|0
2485624|NCT02120456|8590592|P5|Part 2 Double-blind Phase|Lost to Follow-up|0
2485625|NCT02120456|8590593|P4|Part 2 Double-blind Phase|Lost to Follow-up|0
2485626|NCT02120456|8590594|P3|Part 2 Double-blind Phase|Lost to Follow-up|0
2485627|NCT02120456|8590595|P2|Part 2 Double-blind Phase|Lost to Follow-up|0
2485628|NCT02120456|8590596|P1|Part 2 Double-blind Phase|Lost to Follow-up|0
2485629|NCT02120417|8590630|P2|Overall Study|Other unspecified|4
2485630|NCT02120417|8590631|P1|Overall Study|Other unspecified|5
2485631|NCT02120417|8590630|P2|Overall Study|Physician Decision|3
2485632|NCT02120417|8590631|P1|Overall Study|Physician Decision|2
2485633|NCT02120417|8590630|P2|Overall Study|Noncompliance with study treatment|2
2485634|NCT02120417|8590631|P1|Overall Study|Noncompliance with study treatment|0
2485635|NCT02120417|8590630|P2|Overall Study|Disease progression|45
2485636|NCT02120417|8590631|P1|Overall Study|Disease progression|41
2485637|NCT02120417|8590630|P2|Overall Study|Participant decision|4
2485638|NCT02120417|8590631|P1|Overall Study|Participant decision|4
2485639|NCT02120417|8590630|P2|Overall Study|Adverse Event|9
2485640|NCT02120417|8590631|P1|Overall Study|Adverse Event|3
2485641|NCT02120417|8590630|P2|Overall Study|Death|1
2485642|NCT02120417|8590631|P1|Overall Study|Death|5
2485643|NCT02120300|8590653|P4|Overall Study|Lost to Follow-up|0
2485644|NCT02120300|8590654|P3|Overall Study|Lost to Follow-up|0
2485645|NCT02120300|8590655|P2|Overall Study|Lost to Follow-up|0
2485646|NCT02120300|8590656|P1|Overall Study|Lost to Follow-up|1
2485647|NCT02120300|8590653|P4|Overall Study|Lack of Efficacy|1
2485648|NCT02120300|8590654|P3|Overall Study|Lack of Efficacy|0
2485649|NCT02120300|8590655|P2|Overall Study|Lack of Efficacy|0
2485650|NCT02120300|8590656|P1|Overall Study|Lack of Efficacy|0
2485651|NCT02120300|8590653|P4|Overall Study|Enrolled but Never Treated|0
2485652|NCT02120300|8590654|P3|Overall Study|Enrolled but Never Treated|0
2485653|NCT02120300|8590655|P2|Overall Study|Enrolled but Never Treated|0
2485654|NCT02120300|8590656|P1|Overall Study|Enrolled but Never Treated|2
2485655|NCT02120157|8590727|P2|Overall Study|Graft Failure before Day 100|0
2485656|NCT02120157|8590728|P1|Overall Study|Graft Failure before Day 100|2
2485657|NCT02120157|8590727|P2|Overall Study|Death|2
2485658|NCT02120157|8590728|P1|Overall Study|Death|4
2485659|NCT02120027|8590738|P2|Overall Study|Withdrawal by Subject|25
2485660|NCT02120027|8590739|P1|Overall Study|Withdrawal by Subject|33
2485661|NCT02120027|8590738|P2|Overall Study|Study terminated by Sponsor|47
2485662|NCT02120027|8590739|P1|Overall Study|Study terminated by Sponsor|45
2485663|NCT02120027|8590738|P2|Overall Study|Protocol Violation|21
2485664|NCT02120027|8590739|P1|Overall Study|Protocol Violation|18
2485665|NCT02120027|8590738|P2|Overall Study|Physician Decision|3
2485666|NCT02120027|8590739|P1|Overall Study|Physician Decision|4
2485667|NCT02120027|8590738|P2|Overall Study|Other|0
2485668|NCT02120027|8590739|P1|Overall Study|Other|4
2485669|NCT02120027|8590738|P2|Overall Study|Lost to Follow-up|13
2485670|NCT02120027|8590739|P1|Overall Study|Lost to Follow-up|5
2485671|NCT02120027|8590738|P2|Overall Study|Lack of Efficacy|5
2485672|NCT02120027|8590739|P1|Overall Study|Lack of Efficacy|3
2485673|NCT02120027|8590738|P2|Overall Study|Adverse Event|5
2485674|NCT02120027|8590739|P1|Overall Study|Adverse Event|4
2485675|NCT02119936|8590764|P1|Overall Study|Lost to Follow-up|10
2485676|NCT02119676|8590798|P4|Overall Study|Did not receive study med|5
2485677|NCT02119676|8590799|P3|Overall Study|Did not receive study med|4
2485678|NCT02119676|8590800|P2|Overall Study|Did not receive study med|2
2485679|NCT02119676|8590801|P1|Overall Study|Did not receive study med|2
2485680|NCT02119676|8590798|P4|Overall Study|Other, unspecified|4
2485681|NCT02119676|8590799|P3|Overall Study|Other, unspecified|3
2485682|NCT02119676|8590800|P2|Overall Study|Other, unspecified|1
2485683|NCT02119676|8590801|P1|Overall Study|Other, unspecified|2
2485684|NCT02119676|8590798|P4|Overall Study|Protocol deviation|0
2485685|NCT02119676|8590799|P3|Overall Study|Protocol deviation|1
2485686|NCT02119676|8590800|P2|Overall Study|Protocol deviation|0
2485687|NCT02119676|8590801|P1|Overall Study|Protocol deviation|0
2485688|NCT02119676|8590798|P4|Overall Study|Lost to Follow-up|0
2485689|NCT02119676|8590799|P3|Overall Study|Lost to Follow-up|1
2485690|NCT02119676|8590800|P2|Overall Study|Lost to Follow-up|0
2485691|NCT02119676|8590801|P1|Overall Study|Lost to Follow-up|0
2485692|NCT02119676|8590798|P4|Overall Study|Noncompliance|0
2485693|NCT02119676|8590799|P3|Overall Study|Noncompliance|0
2485694|NCT02119676|8590800|P2|Overall Study|Noncompliance|1
2485695|NCT02119676|8590801|P1|Overall Study|Noncompliance|0
2485696|NCT02119676|8590798|P4|Overall Study|Death|1
2485697|NCT02119676|8590799|P3|Overall Study|Death|2
2485698|NCT02119676|8590800|P2|Overall Study|Death|3
2485699|NCT02119676|8590801|P1|Overall Study|Death|9
2485700|NCT02119676|8590798|P4|Overall Study|Physician Decision|2
2485701|NCT02119676|8590799|P3|Overall Study|Physician Decision|3
2485702|NCT02119676|8590800|P2|Overall Study|Physician Decision|2
2485703|NCT02119676|8590801|P1|Overall Study|Physician Decision|4
2485704|NCT02119676|8590798|P4|Overall Study|Patient decision, inc. consent withdrawn|6
2485705|NCT02119676|8590799|P3|Overall Study|Patient decision, inc. consent withdrawn|5
2485706|NCT02119676|8590800|P2|Overall Study|Patient decision, inc. consent withdrawn|5
2485707|NCT02119676|8590801|P1|Overall Study|Patient decision, inc. consent withdrawn|4
2485708|NCT02119676|8590798|P4|Overall Study|Disease progression|73
2485709|NCT02119676|8590799|P3|Overall Study|Disease progression|68
2485710|NCT02119676|8590800|P2|Overall Study|Disease progression|55
2485711|NCT02119676|8590801|P1|Overall Study|Disease progression|53
2485712|NCT02119676|8590798|P4|Overall Study|Adverse Event|10
2485713|NCT02119676|8590799|P3|Overall Study|Adverse Event|10
2485714|NCT02119676|8590800|P2|Overall Study|Adverse Event|17
2485715|NCT02119676|8590801|P1|Overall Study|Adverse Event|9
2485716|NCT02119663|8590833|P2|Overall Study|Study Terminated by the Sponsor|4
2485717|NCT02119663|8590834|P1|Overall Study|Study Terminated by the Sponsor|3
2485718|NCT02119663|8590833|P2|Overall Study|Subject decision|1
2485719|NCT02119663|8590834|P1|Overall Study|Subject decision|0
2485720|NCT02119663|8590833|P2|Overall Study|Other unspecified|0
2485721|NCT02119663|8590834|P1|Overall Study|Other unspecified|2
2485722|NCT02119663|8590833|P2|Overall Study|Physician Decision|2
2485723|NCT02119663|8590834|P1|Overall Study|Physician Decision|1
2485724|NCT02119663|8590833|P2|Overall Study|Death|2
2485725|NCT02119663|8590834|P1|Overall Study|Death|3
2485726|NCT02119663|8590833|P2|Overall Study|Adverse Event|5
2485727|NCT02119663|8590834|P1|Overall Study|Adverse Event|5
2485728|NCT02119663|8590833|P2|Overall Study|Disease progression|27
2485729|NCT02119663|8590834|P1|Overall Study|Disease progression|26
2485730|NCT02119650|8590852|P2|Overall Study|Multiple reasons for termination|1
2485731|NCT02119650|8590853|P1|Overall Study|Multiple reasons for termination|2
2485732|NCT02119650|8590852|P2|Overall Study|Physician Decision|2
2485733|NCT02119650|8590853|P1|Overall Study|Physician Decision|0
2485734|NCT02119650|8590852|P2|Overall Study|Study terminated by the sponsor|0
2485735|NCT02119650|8590853|P1|Overall Study|Study terminated by the sponsor|1
2485736|NCT02119650|8590852|P2|Overall Study|Noncompliance with study treatment|1
2485737|NCT02119650|8590853|P1|Overall Study|Noncompliance with study treatment|1
2485738|NCT02119650|8590852|P2|Overall Study|Death|1
2485739|NCT02119650|8590853|P1|Overall Study|Death|5
2485740|NCT02119650|8590852|P2|Overall Study|Disease progression|14
2485741|NCT02119650|8590853|P1|Overall Study|Disease progression|11
2485742|NCT02119650|8590852|P2|Overall Study|Subject decision|3
2485743|NCT02119650|8590853|P1|Overall Study|Subject decision|2
2485744|NCT02119650|8590852|P2|Overall Study|Adverse Event|4
2485745|NCT02119650|8590853|P1|Overall Study|Adverse Event|3
2485746|NCT02119325|8590888|P2|Washout Period 1|Adverse Event|1
2485747|NCT02119325|8590889|P1|Washout Period 1|Adverse Event|0
2485748|NCT02119299|8590933|P1|Overall Study|Pregnancy|1
2485749|NCT02119299|8590933|P1|Overall Study|Lack of Efficacy|1
2485750|NCT02119299|8590933|P1|Overall Study|Withdrawal by Subject|7
2485751|NCT02119286|8590947|P3|Overall Study|Withdrawal by Subject|0
2485752|NCT02119286|8590948|P2|Overall Study|Withdrawal by Subject|1
2485753|NCT02119286|8590949|P1|Overall Study|Withdrawal by Subject|4
2485754|NCT02119286|8590947|P3|Overall Study|Lost to Follow-up|1
2485755|NCT02119286|8590948|P2|Overall Study|Lost to Follow-up|0
2485756|NCT02119286|8590949|P1|Overall Study|Lost to Follow-up|2
2485757|NCT02119286|8590947|P3|Overall Study|Lack of Efficacy|4
2485758|NCT02119286|8590948|P2|Overall Study|Lack of Efficacy|3
2485759|NCT02119286|8590949|P1|Overall Study|Lack of Efficacy|11
2485760|NCT02119286|8590947|P3|Overall Study|Adverse Event|2
2485761|NCT02119286|8590948|P2|Overall Study|Adverse Event|7
2485762|NCT02119286|8590949|P1|Overall Study|Adverse Event|9
2485763|NCT02119260|8590967|P7|Overall Study|Withdrew consent|0
2485764|NCT02119260|8590968|P6|Overall Study|Withdrew consent|0
2485765|NCT02119260|8590969|P5|Overall Study|Withdrew consent|0
2485766|NCT02119260|8590970|P4|Overall Study|Withdrew consent|0
2485767|NCT02119260|8590971|P3|Overall Study|Withdrew consent|1
2485768|NCT02119260|8590972|P2|Overall Study|Withdrew consent|1
2485769|NCT02119260|8590973|P1|Overall Study|Withdrew consent|0
2485770|NCT02119260|8590967|P7|Overall Study|Adverse Event|0
2485771|NCT02119260|8590968|P6|Overall Study|Adverse Event|0
2485772|NCT02119260|8590969|P5|Overall Study|Adverse Event|0
2485773|NCT02119260|8590970|P4|Overall Study|Adverse Event|0
2485774|NCT02119260|8590971|P3|Overall Study|Adverse Event|0
2485775|NCT02119260|8590972|P2|Overall Study|Adverse Event|0
2485776|NCT02119260|8590973|P1|Overall Study|Adverse Event|1
2485777|NCT02119156|8591046|P3|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7
2485778|NCT02119156|8591047|P2|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10
2485779|NCT02119156|8591048|P1|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0
2485780|NCT02119156|8591046|P3|Treatment Phase (Up to 52 Weeks)|Physician Decision|0
2485781|NCT02119156|8591047|P2|Treatment Phase (Up to 52 Weeks)|Physician Decision|0
2485782|NCT02119156|8591048|P1|Treatment Phase (Up to 52 Weeks)|Physician Decision|1
2485783|NCT02119156|8591046|P3|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0
2485784|NCT02119156|8591047|P2|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2
2485785|NCT02119156|8591048|P1|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1
2485786|NCT02119156|8591046|P3|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0
2485787|NCT02119156|8591047|P2|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0
2485788|NCT02119156|8591048|P1|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4
2485789|NCT02119156|8591046|P3|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1
2485790|NCT02119156|8591047|P2|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0
2485791|NCT02119156|8591048|P1|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0
2485792|NCT02119104|8591106|P1|Overall Study|Protocol Violation|16
2485793|NCT02119026|8591112|P2|2nd-line Treatment|Adverse Event|1
2485794|NCT02119026|8591113|P1|2nd-line Treatment|Adverse Event|4
2485795|NCT02119026|8591112|P2|2nd-line Treatment|Withdrawal by Subject|1
2485796|NCT02119026|8591113|P1|2nd-line Treatment|Withdrawal by Subject|3
2485797|NCT02119026|8591112|P2|2nd-line Treatment|Lost to Follow-up|0
2485798|NCT02119026|8591113|P1|2nd-line Treatment|Lost to Follow-up|2
2485799|NCT02119026|8591112|P2|1st-line Treatment|Death|1
2485800|NCT02119026|8591113|P1|1st-line Treatment|Death|2
2485801|NCT02119026|8591112|P2|1st-line Treatment|Surgery of metastases|1
2485802|NCT02119026|8591113|P1|1st-line Treatment|Surgery of metastases|2
2485803|NCT02119026|8591112|P2|1st-line Treatment|Patient condition or compliance|4
2485804|NCT02119026|8591113|P1|1st-line Treatment|Patient condition or compliance|6
2485805|NCT02119026|8591112|P2|1st-line Treatment|Withdrawal by Subject|10
2485806|NCT02119026|8591113|P1|1st-line Treatment|Withdrawal by Subject|4
2485807|NCT02119026|8591112|P2|1st-line Treatment|Physician Decision|8
2485808|NCT02119026|8591113|P1|1st-line Treatment|Physician Decision|3
2485809|NCT02119026|8591112|P2|1st-line Treatment|Adverse Event|14
2485810|NCT02119026|8591113|P1|1st-line Treatment|Adverse Event|9
2485811|NCT02118961|8591137|P2|Overall Study|Withdrawal by Subject|0
2485812|NCT02118961|8591138|P1|Overall Study|Withdrawal by Subject|1
2485813|NCT02118896|8591166|P10|Overall Study|Miscellaneous|0
2485814|NCT02118896|8591167|P9|Overall Study|Miscellaneous|0
2485815|NCT02118896|8591168|P8|Overall Study|Miscellaneous|0
2485816|NCT02118896|8591169|P7|Overall Study|Miscellaneous|0
2485817|NCT02118896|8591170|P6|Overall Study|Miscellaneous|4
2485818|NCT02118896|8591171|P5|Overall Study|Miscellaneous|0
2485819|NCT02118896|8591172|P4|Overall Study|Miscellaneous|2
2485820|NCT02118896|8591173|P3|Overall Study|Miscellaneous|0
2485821|NCT02118896|8591174|P2|Overall Study|Miscellaneous|2
2485822|NCT02118896|8591175|P1|Overall Study|Miscellaneous|1
2485823|NCT02118896|8591166|P10|Overall Study|Prohibited medication|0
2485824|NCT02118896|8591167|P9|Overall Study|Prohibited medication|0
2485825|NCT02118896|8591168|P8|Overall Study|Prohibited medication|0
2485826|NCT02118896|8591169|P7|Overall Study|Prohibited medication|0
2485827|NCT02118896|8591170|P6|Overall Study|Prohibited medication|3
2485828|NCT02118896|8591171|P5|Overall Study|Prohibited medication|1
2485829|NCT02118896|8591172|P4|Overall Study|Prohibited medication|0
2485830|NCT02118896|8591173|P3|Overall Study|Prohibited medication|0
2485831|NCT02118896|8591174|P2|Overall Study|Prohibited medication|0
2485832|NCT02118896|8591175|P1|Overall Study|Prohibited medication|0
2485833|NCT02118896|8591166|P10|Overall Study|Immunosuppressive regimen (not MR4)|2
2485834|NCT02118896|8591167|P9|Overall Study|Immunosuppressive regimen (not MR4)|0
2485835|NCT02118896|8591168|P8|Overall Study|Immunosuppressive regimen (not MR4)|0
2485836|NCT02118896|8591169|P7|Overall Study|Immunosuppressive regimen (not MR4)|0
2485837|NCT02118896|8591170|P6|Overall Study|Immunosuppressive regimen (not MR4)|2
2485838|NCT02118896|8591171|P5|Overall Study|Immunosuppressive regimen (not MR4)|4
2485839|NCT02118896|8591172|P4|Overall Study|Immunosuppressive regimen (not MR4)|2
2485840|NCT02118896|8591173|P3|Overall Study|Immunosuppressive regimen (not MR4)|1
2485841|NCT02118896|8591174|P2|Overall Study|Immunosuppressive regimen (not MR4)|5
2485842|NCT02118896|8591175|P1|Overall Study|Immunosuppressive regimen (not MR4)|1
2485843|NCT02118896|8591166|P10|Overall Study|Lost to Follow-up|0
2485844|NCT02118896|8591167|P9|Overall Study|Lost to Follow-up|0
2485845|NCT02118896|8591168|P8|Overall Study|Lost to Follow-up|0
2485846|NCT02118896|8591169|P7|Overall Study|Lost to Follow-up|0
2485847|NCT02118896|8591170|P6|Overall Study|Lost to Follow-up|1
2485848|NCT02118896|8591171|P5|Overall Study|Lost to Follow-up|2
2485849|NCT02118896|8591172|P4|Overall Study|Lost to Follow-up|0
2485850|NCT02118896|8591173|P3|Overall Study|Lost to Follow-up|1
2485851|NCT02118896|8591174|P2|Overall Study|Lost to Follow-up|2
2485852|NCT02118896|8591175|P1|Overall Study|Lost to Follow-up|1
2485853|NCT02118896|8591166|P10|Overall Study|Pregnancy|0
2485854|NCT02118896|8591167|P9|Overall Study|Pregnancy|0
2485855|NCT02118896|8591168|P8|Overall Study|Pregnancy|0
2485856|NCT02118896|8591169|P7|Overall Study|Pregnancy|1
2485857|NCT02118896|8591170|P6|Overall Study|Pregnancy|3
2485858|NCT02118896|8591171|P5|Overall Study|Pregnancy|1
2485859|NCT02118896|8591172|P4|Overall Study|Pregnancy|0
2485860|NCT02118896|8591173|P3|Overall Study|Pregnancy|0
2485861|NCT02118896|8591174|P2|Overall Study|Pregnancy|1
2485862|NCT02118896|8591175|P1|Overall Study|Pregnancy|1
2485863|NCT02118896|8591166|P10|Overall Study|Non-compliance|0
2485864|NCT02118896|8591167|P9|Overall Study|Non-compliance|0
2485865|NCT02118896|8591168|P8|Overall Study|Non-compliance|1
2485866|NCT02118896|8591169|P7|Overall Study|Non-compliance|0
2485867|NCT02118896|8591170|P6|Overall Study|Non-compliance|1
2485868|NCT02118896|8591171|P5|Overall Study|Non-compliance|0
2485869|NCT02118896|8591172|P4|Overall Study|Non-compliance|5
2485870|NCT02118896|8591173|P3|Overall Study|Non-compliance|1
2485871|NCT02118896|8591174|P2|Overall Study|Non-compliance|1
2485872|NCT02118896|8591175|P1|Overall Study|Non-compliance|2
2485873|NCT02118896|8591166|P10|Overall Study|Consent withdrawn|0
2485874|NCT02118896|8591167|P9|Overall Study|Consent withdrawn|0
2485875|NCT02118896|8591168|P8|Overall Study|Consent withdrawn|0
2485876|NCT02118896|8591169|P7|Overall Study|Consent withdrawn|0
2485877|NCT02118896|8591170|P6|Overall Study|Consent withdrawn|4
2485878|NCT02118896|8591171|P5|Overall Study|Consent withdrawn|1
2485879|NCT02118896|8591172|P4|Overall Study|Consent withdrawn|4
2485880|NCT02118896|8591173|P3|Overall Study|Consent withdrawn|3
2485881|NCT02118896|8591174|P2|Overall Study|Consent withdrawn|0
2485882|NCT02118896|8591175|P1|Overall Study|Consent withdrawn|2
2485883|NCT02118896|8591166|P10|Overall Study|Adverse Event|0
2485884|NCT02118896|8591167|P9|Overall Study|Adverse Event|4
2485885|NCT02118896|8591168|P8|Overall Study|Adverse Event|1
2485886|NCT02118896|8591169|P7|Overall Study|Adverse Event|1
2485887|NCT02118896|8591170|P6|Overall Study|Adverse Event|9
2485888|NCT02118896|8591171|P5|Overall Study|Adverse Event|5
2485889|NCT02118896|8591172|P4|Overall Study|Adverse Event|5
2485890|NCT02118896|8591173|P3|Overall Study|Adverse Event|4
2485891|NCT02118896|8591174|P2|Overall Study|Adverse Event|4
2485892|NCT02118896|8591175|P1|Overall Study|Adverse Event|5
2485893|NCT02118896|8591166|P10|Overall Study|Death|0
2485894|NCT02118896|8591167|P9|Overall Study|Death|0
2485895|NCT02118896|8591168|P8|Overall Study|Death|0
2485896|NCT02118896|8591169|P7|Overall Study|Death|0
2485897|NCT02118896|8591170|P6|Overall Study|Death|1
2485898|NCT02118896|8591171|P5|Overall Study|Death|3
2485899|NCT02118896|8591172|P4|Overall Study|Death|6
2485900|NCT02118896|8591173|P3|Overall Study|Death|4
2485901|NCT02118896|8591174|P2|Overall Study|Death|0
2485902|NCT02118896|8591175|P1|Overall Study|Death|4
2485903|NCT02118792|8591265|P2|Overall Study|Randomised but not treated|0
2485904|NCT02118792|8591266|P1|Overall Study|Randomised but not treated|1
2485905|NCT02118792|8591265|P2|Overall Study|Other|6
2485906|NCT02118792|8591266|P1|Overall Study|Other|1
2485907|NCT02118792|8591265|P2|Overall Study|Withdrawal by parent/guardian|20
2485908|NCT02118792|8591266|P1|Overall Study|Withdrawal by parent/guardian|14
2485909|NCT02118792|8591265|P2|Overall Study|Adverse Event|4
2485910|NCT02118792|8591266|P1|Overall Study|Adverse Event|5
2485911|NCT02118792|8591265|P2|Overall Study|Lost to Follow-up|4
2485912|NCT02118792|8591266|P1|Overall Study|Lost to Follow-up|4
2485913|NCT02118792|8591265|P2|Overall Study|Withdrawal by Subject|3
2485914|NCT02118792|8591266|P1|Overall Study|Withdrawal by Subject|6
2485915|NCT02118766|8591308|P2|Overall Study|Other|1
2485916|NCT02118766|8591309|P1|Overall Study|Other|3
2485917|NCT02118766|8591308|P2|Overall Study|Withdrawal by parent/guardian|18
2485918|NCT02118766|8591309|P1|Overall Study|Withdrawal by parent/guardian|12
2485919|NCT02118766|8591308|P2|Overall Study|Lost to Follow-up|4
2485920|NCT02118766|8591309|P1|Overall Study|Lost to Follow-up|5
2485921|NCT02118766|8591308|P2|Overall Study|Withdrawal by Subject|6
2485922|NCT02118766|8591309|P1|Overall Study|Withdrawal by Subject|3
2485923|NCT02118766|8591308|P2|Overall Study|Adverse Event|2
2485924|NCT02118766|8591309|P1|Overall Study|Adverse Event|7
2485925|NCT02118714|8591331|P1|Overall Study|Protocol Violation|1
2485926|NCT02118714|8591331|P1|Overall Study|Lost to Follow-up|2
2485927|NCT02118597|8591356|P1|Overall Study|Investigator's decision|1
2485928|NCT02118597|8591356|P1|Overall Study|Serious Adverse Event|1
2485929|NCT02118597|8591356|P1|Overall Study|Sponsor terminated the study|14
2485930|NCT02118428|8591387|P3|Overall Study|Screen Failure or Became Inelegible|1
2485931|NCT02118428|8591388|P2|Overall Study|Screen Failure or Became Inelegible|0
2485932|NCT02118428|8591389|P1|Overall Study|Screen Failure or Became Inelegible|1
2485933|NCT02118428|8591387|P3|Overall Study|Lost to Follow-up|0
2485934|NCT02118428|8591388|P2|Overall Study|Lost to Follow-up|1
2485935|NCT02118428|8591389|P1|Overall Study|Lost to Follow-up|3
2485936|NCT02118428|8591387|P3|Overall Study|Death|0
2485937|NCT02118428|8591388|P2|Overall Study|Death|5
2485938|NCT02118428|8591389|P1|Overall Study|Death|7
2485939|NCT02118428|8591387|P3|Overall Study|Withdrawal by Subject|0
2485940|NCT02118428|8591388|P2|Overall Study|Withdrawal by Subject|2
2485941|NCT02118428|8591389|P1|Overall Study|Withdrawal by Subject|2
2485942|NCT02118428|8591387|P3|Overall Study|Physician Decision|0
2485943|NCT02118428|8591388|P2|Overall Study|Physician Decision|1
2485944|NCT02118428|8591389|P1|Overall Study|Physician Decision|0
2485945|NCT02117687|8591459|P2|Overall Study|Other Reasons|1
2485946|NCT02117687|8591460|P1|Overall Study|Other Reasons|1
2485947|NCT02117687|8591459|P2|Overall Study|Adverse Event|2
2485948|NCT02117687|8591460|P1|Overall Study|Adverse Event|0
2485949|NCT02117687|8591459|P2|Overall Study|Lost to Follow-up|1
2485950|NCT02117687|8591460|P1|Overall Study|Lost to Follow-up|0
2485951|NCT02117648|8591492|P1|Abemaciclib Safety-Extension Phase|Adverse Event|2
2485952|NCT02117648|8591492|P1|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2
2485953|NCT02117648|8591492|P1|Abemaciclib Safety-Extension Phase|Death|3
2485954|NCT02117648|8591492|P1|Abemaciclib Safety-Extension Phase|Physician Decision|1
2485955|NCT02117648|8591492|P1|Abemaciclib Safety-Extension Phase|Progressive Disease|12
2485956|NCT02117648|8591492|P1|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1
2485957|NCT02117648|8591492|P1|Abemaciclib + Clarithromycin Period 2|Adverse Event|1
2485958|NCT02117648|8591492|P1|Abemaciclib + Clarithromycin Period 2|Death|1
2485959|NCT02117648|8591492|P1|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1
2485960|NCT02117648|8591492|P1|Abemaciclib Alone Period 1|Adverse Event|1
2485961|NCT02117648|8591492|P1|Abemaciclib Alone Period 1|Withdrawal by Subject|1
2485962|NCT02117570|8591505|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
2485963|NCT02117570|8591506|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1
2485964|NCT02117570|8591507|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
2485965|NCT02117570|8591505|P3|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
2485966|NCT02117570|8591506|P2|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
2485967|NCT02117570|8591507|P1|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1
2485968|NCT02117570|8591505|P3|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1
2485969|NCT02117570|8591506|P2|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
2485970|NCT02117570|8591507|P1|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
2485971|NCT02117570|8591505|P3|Stage 2 Participants Aged 65 to 85 Years|Death|1
2485972|NCT02117570|8591506|P2|Stage 2 Participants Aged 65 to 85 Years|Death|0
2485973|NCT02117570|8591507|P1|Stage 2 Participants Aged 65 to 85 Years|Death|0
2485974|NCT02117570|8591505|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2
2485975|NCT02117570|8591506|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
2485976|NCT02117570|8591507|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
2485977|NCT02117570|8591505|P3|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0
2485978|NCT02117570|8591506|P2|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
2485979|NCT02117570|8591507|P1|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
2485980|NCT02117570|8591505|P3|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1
2485981|NCT02117570|8591506|P2|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2
2485982|NCT02117570|8591507|P1|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0
2485983|NCT02117544|8591557|P2|Period 1|Lost to follow-up (prior to treatment)|0
2485984|NCT02117544|8591558|P1|Period 1|Lost to follow-up (prior to treatment)|2
2485985|NCT02117479|8591573|P2|Overall Study|Other unspecified|7
2485986|NCT02117479|8591574|P1|Overall Study|Other unspecified|11
2485987|NCT02117479|8591573|P2|Overall Study|Physician Decision|2
2485988|NCT02117479|8591574|P1|Overall Study|Physician Decision|7
2485989|NCT02117479|8591573|P2|Overall Study|Study terminated by the sponsor|6
2485990|NCT02117479|8591574|P1|Overall Study|Study terminated by the sponsor|4
2485991|NCT02117479|8591573|P2|Overall Study|Noncompliance with study treatment|0
2485992|NCT02117479|8591574|P1|Overall Study|Noncompliance with study treatment|1
2485993|NCT02117479|8591573|P2|Overall Study|Disease progression|108
2485994|NCT02117479|8591574|P1|Overall Study|Disease progression|104
2485995|NCT02117479|8591573|P2|Overall Study|Subject decision|9
2485996|NCT02117479|8591574|P1|Overall Study|Subject decision|8
2485997|NCT02117479|8591573|P2|Overall Study|Adverse Event|16
2485998|NCT02117479|8591574|P1|Overall Study|Adverse Event|8
2485999|NCT02117479|8591573|P2|Overall Study|Death|8
2486000|NCT02117479|8591574|P1|Overall Study|Death|13
2486001|NCT02117427|8591593|P3|Overall Study|Death|0
2486002|NCT02117427|8591594|P2|Overall Study|Death|1
2486003|NCT02117427|8591595|P1|Overall Study|Death|0
2486004|NCT02117427|8591593|P3|Overall Study|No longer meets inclusion criteria|0
2486005|NCT02117427|8591594|P2|Overall Study|No longer meets inclusion criteria|1
2486006|NCT02117427|8591595|P1|Overall Study|No longer meets inclusion criteria|0
2486007|NCT02117427|8591593|P3|Overall Study|Physician Decision|0
2486008|NCT02117427|8591594|P2|Overall Study|Physician Decision|2
2486009|NCT02117427|8591595|P1|Overall Study|Physician Decision|0
2486010|NCT02117427|8591593|P3|Overall Study|Permanent need for exogenous ESA Tx|0
2486011|NCT02117427|8591594|P2|Overall Study|Permanent need for exogenous ESA Tx|1
2486012|NCT02117427|8591595|P1|Overall Study|Permanent need for exogenous ESA Tx|3
2486013|NCT02117427|8591593|P3|Overall Study|Permanent need for exogenous EPO Tx|0
2486014|NCT02117427|8591594|P2|Overall Study|Permanent need for exogenous EPO Tx|0
2486015|NCT02117427|8591595|P1|Overall Study|Permanent need for exogenous EPO Tx|2
2486016|NCT02117414|8591605|P2|Overall Study|Withdrawal by Subject|4
2486017|NCT02117414|8591606|P1|Overall Study|Withdrawal by Subject|10
2486018|NCT02117414|8591605|P2|Overall Study|Death|2
2486019|NCT02117414|8591606|P1|Overall Study|Death|5
2486020|NCT02117349|8591626|P2|Overall Study|Death|0
2486021|NCT02117349|8591627|P1|Overall Study|Death|1
2486022|NCT02117349|8591626|P2|Overall Study|Lost to Follow-up|1
2486023|NCT02117349|8591627|P1|Overall Study|Lost to Follow-up|1
2486024|NCT02117349|8591626|P2|Overall Study|Withdrawal by Subject|0
2486025|NCT02117349|8591627|P1|Overall Study|Withdrawal by Subject|1
2486026|NCT02117050|8591663|P1|Overall Study|Subject Enrolled but not Dosed|1
2486027|NCT02117024|8591677|P2|Overall Study|Physician Decision|2
2486028|NCT02117024|8591678|P1|Overall Study|Physician Decision|0
2486029|NCT02117024|8591677|P2|Overall Study|Patient took treatment break|1
2486030|NCT02117024|8591678|P1|Overall Study|Patient took treatment break|0
2486031|NCT02117024|8591677|P2|Overall Study|Patient returned to primary oncologist|1
2486032|NCT02117024|8591678|P1|Overall Study|Patient returned to primary oncologist|0
2486033|NCT02117024|8591677|P2|Overall Study|Randomized in Error|0
2486034|NCT02117024|8591678|P1|Overall Study|Randomized in Error|1
2486035|NCT02117024|8591677|P2|Overall Study|Adverse Event|2
2486036|NCT02117024|8591678|P1|Overall Study|Adverse Event|1
2486037|NCT02117024|8591677|P2|Overall Study|Protocol Violation|0
2486038|NCT02117024|8591678|P1|Overall Study|Protocol Violation|1
2486039|NCT02117024|8591677|P2|Overall Study|Withdrawal by Subject|1
2486040|NCT02117024|8591678|P1|Overall Study|Withdrawal by Subject|3
2486041|NCT02117024|8591677|P2|Overall Study|Death|0
2486042|NCT02117024|8591678|P1|Overall Study|Death|5
2486043|NCT02117024|8591677|P2|Overall Study|Significant Clinical Progression|4
2486044|NCT02117024|8591678|P1|Overall Study|Significant Clinical Progression|7
2486045|NCT02117024|8591677|P2|Overall Study|Progressive Disease|9
2486046|NCT02117024|8591678|P1|Overall Study|Progressive Disease|26
2486047|NCT02116972|8591705|P3|Overall Study|scheduling conflicts and relocation|6
2486048|NCT02116972|8591706|P2|Overall Study|scheduling conflicts and relocation|3
2486049|NCT02116972|8591707|P1|Overall Study|scheduling conflicts and relocation|3
2486050|NCT02116972|8591705|P3|Overall Study|Lack of Efficacy|5
2486051|NCT02116972|8591706|P2|Overall Study|Lack of Efficacy|6
2486052|NCT02116972|8591707|P1|Overall Study|Lack of Efficacy|6
2486053|NCT02116972|8591705|P3|Overall Study|Lost to Follow-up|1
2486054|NCT02116972|8591706|P2|Overall Study|Lost to Follow-up|3
2486055|NCT02116972|8591707|P1|Overall Study|Lost to Follow-up|4
2486056|NCT02116972|8591705|P3|Overall Study|Protocol Violation|1
2486057|NCT02116972|8591706|P2|Overall Study|Protocol Violation|0
2486058|NCT02116972|8591707|P1|Overall Study|Protocol Violation|1
2486059|NCT02116972|8591705|P3|Overall Study|Withdrawal by Subject|5
2486060|NCT02116972|8591706|P2|Overall Study|Withdrawal by Subject|1
2486061|NCT02116972|8591707|P1|Overall Study|Withdrawal by Subject|1
2486062|NCT02116972|8591705|P3|Overall Study|Adverse Event|1
2486063|NCT02116972|8591706|P2|Overall Study|Adverse Event|4
2486064|NCT02116972|8591707|P1|Overall Study|Adverse Event|4
2486065|NCT02116803|8591739|P2|Overall Study|Death|0
2486066|NCT02116803|8591740|P1|Overall Study|Death|1
2486067|NCT02116803|8591739|P2|Overall Study|Study terminated by sponsor|1
2486068|NCT02116803|8591740|P1|Overall Study|Study terminated by sponsor|2
2486069|NCT02116803|8591739|P2|Overall Study|Progressive disease|0
2486070|NCT02116803|8591740|P1|Overall Study|Progressive disease|4
2486071|NCT02116803|8591739|P2|Overall Study|Physician Decision|0
2486072|NCT02116803|8591740|P1|Overall Study|Physician Decision|1
2486073|NCT02116803|8591739|P2|Overall Study|Adverse Event|1
2486074|NCT02116803|8591740|P1|Overall Study|Adverse Event|2
2486075|NCT02116660|8591748|P2|Overall Study|Organization reason|0
2486076|NCT02116660|8591749|P1|Overall Study|Organization reason|1
2486077|NCT02116660|8591748|P2|Overall Study|Withdrawal by Subject|2
2486078|NCT02116660|8591749|P1|Overall Study|Withdrawal by Subject|0
2486079|NCT02116660|8591748|P2|Overall Study|Adverse Event|1
2486080|NCT02116660|8591749|P1|Overall Study|Adverse Event|1
2486081|NCT02116660|8591748|P2|Overall Study|Deteriorating renal function|1
2486082|NCT02116660|8591749|P1|Overall Study|Deteriorating renal function|0
2486083|NCT02116621|8591793|P2|Twelve Month Follow-up|Enrolled within 12 months of study end|8
2486084|NCT02116621|8591794|P1|Twelve Month Follow-up|Enrolled within 12 months of study end|14
2486085|NCT02116621|8591793|P2|Twelve Month Follow-up|Did not complete follow-up survey|3
2486086|NCT02116621|8591794|P1|Twelve Month Follow-up|Did not complete follow-up survey|1
2486087|NCT02116621|8591793|P2|Twelve Month Follow-up|Lost to Follow-up|1
2486088|NCT02116621|8591794|P1|Twelve Month Follow-up|Lost to Follow-up|0
2486089|NCT02116621|8591793|P2|Twelve Month Follow-up|Withdrawal by Subject|0
2486090|NCT02116621|8591794|P1|Twelve Month Follow-up|Withdrawal by Subject|1
2486091|NCT02116621|8591793|P2|Six Month Follow-up|Did not complete follow-up survey|1
2486092|NCT02116621|8591794|P1|Six Month Follow-up|Did not complete follow-up survey|1
2486093|NCT02116621|8591793|P2|Six Month Follow-up|Lost to Follow-up|1
2486094|NCT02116621|8591794|P1|Six Month Follow-up|Lost to Follow-up|2
2486095|NCT02116621|8591793|P2|Six Month Follow-up|Withdrawal by Subject|1
2486096|NCT02116621|8591794|P1|Six Month Follow-up|Withdrawal by Subject|1
2486097|NCT02116621|8591793|P2|Three Month Follow-up|Did not complete follow-up survey|4
2486098|NCT02116621|8591794|P1|Three Month Follow-up|Did not complete follow-up survey|14
2486099|NCT02116621|8591793|P2|Three Month Follow-up|Lost to Follow-up|1
2486100|NCT02116621|8591794|P1|Three Month Follow-up|Lost to Follow-up|0
2486101|NCT02116621|8591793|P2|Three Month Follow-up|Withdrawal by Subject|1
2486102|NCT02116621|8591794|P1|Three Month Follow-up|Withdrawal by Subject|4
2486103|NCT02116621|8591793|P2|Three Month Follow-up|Death|1
2486104|NCT02116621|8591794|P1|Three Month Follow-up|Death|1
2486105|NCT02116621|8591793|P2|Baseline|Withdrawal by Subject|4
2486106|NCT02116621|8591794|P1|Baseline|Withdrawal by Subject|0
2486107|NCT02116582|8591882|P1|Overall Study|Other: Transitioned to 9785-CL-0123|12
2486108|NCT02116582|8591882|P1|Overall Study|Lost to Follow-up|1
2486109|NCT02116582|8591882|P1|Overall Study|Other: Miscellaneous|11
2486110|NCT02116582|8591882|P1|Overall Study|Withdrawal by Subject|8
2486111|NCT02116582|8591882|P1|Overall Study|Protocol Violation|3
2486112|NCT02116582|8591882|P1|Overall Study|Progressive Disease|148
2486113|NCT02116582|8591882|P1|Overall Study|Death|9
2486114|NCT02116582|8591882|P1|Overall Study|Adverse Event|22
2486115|NCT02116582|8591882|P1|Overall Study|Enrolled but Never Received Study Drug|1
2486116|NCT02116530|8591892|P2|Overall Study|Other Medical Problems|2
2486117|NCT02116530|8591893|P1|Overall Study|Other Medical Problems|2
2486118|NCT02116530|8591892|P2|Overall Study|Lost to Follow-up|0
2486119|NCT02116530|8591893|P1|Overall Study|Lost to Follow-up|1
2486120|NCT02116530|8591892|P2|Overall Study|Physician Decision|0
2486121|NCT02116530|8591893|P1|Overall Study|Physician Decision|1
2486122|NCT02116530|8591892|P2|Overall Study|Adverse Event|0
2486123|NCT02116530|8591893|P1|Overall Study|Adverse Event|4
2486124|NCT02116530|8591892|P2|Overall Study|Withdrawal by Subject|2
2486125|NCT02116530|8591893|P1|Overall Study|Withdrawal by Subject|1
2486126|NCT02116361|8591911|P4|Overall Study|Investigator Decision - Relapse|5
2486127|NCT02116361|8591912|P3|Overall Study|Investigator Decision - Relapse|8
2486128|NCT02116361|8591913|P2|Overall Study|Investigator Decision - Relapse|7
2486129|NCT02116361|8591914|P1|Overall Study|Investigator Decision - Relapse|9
2486130|NCT02116361|8591911|P4|Overall Study|Personal Reasons|9
2486131|NCT02116361|8591912|P3|Overall Study|Personal Reasons|4
2486132|NCT02116361|8591913|P2|Overall Study|Personal Reasons|6
2486133|NCT02116361|8591914|P1|Overall Study|Personal Reasons|6
2486134|NCT02116361|8591911|P4|Overall Study|Lost to Follow-up|5
2486135|NCT02116361|8591912|P3|Overall Study|Lost to Follow-up|7
2486136|NCT02116361|8591913|P2|Overall Study|Lost to Follow-up|5
2486137|NCT02116361|8591914|P1|Overall Study|Lost to Follow-up|4
2486138|NCT02116361|8591911|P4|Overall Study|Lack of Efficacy|3
2486139|NCT02116361|8591912|P3|Overall Study|Lack of Efficacy|4
2486140|NCT02116361|8591913|P2|Overall Study|Lack of Efficacy|7
2486141|NCT02116361|8591914|P1|Overall Study|Lack of Efficacy|5
2486142|NCT02116361|8591911|P4|Overall Study|Other Reasons|3
2486143|NCT02116361|8591912|P3|Overall Study|Other Reasons|3
2486144|NCT02116361|8591913|P2|Overall Study|Other Reasons|3
2486145|NCT02116361|8591914|P1|Overall Study|Other Reasons|3
2486146|NCT02116361|8591911|P4|Overall Study|Adverse Event|3
2486147|NCT02116361|8591912|P3|Overall Study|Adverse Event|0
2486148|NCT02116361|8591913|P2|Overall Study|Adverse Event|0
2486149|NCT02116361|8591914|P1|Overall Study|Adverse Event|1
2486150|NCT02116361|8591911|P4|Overall Study|Physician Decision|0
2486151|NCT02116361|8591912|P3|Overall Study|Physician Decision|0
2486152|NCT02116361|8591913|P2|Overall Study|Physician Decision|3
2486153|NCT02116361|8591914|P1|Overall Study|Physician Decision|2
2486154|NCT02116361|8591911|P4|Overall Study|Protocol Violation|2
2486155|NCT02116361|8591912|P3|Overall Study|Protocol Violation|0
2486156|NCT02116361|8591913|P2|Overall Study|Protocol Violation|0
2486157|NCT02116361|8591914|P1|Overall Study|Protocol Violation|1
2486158|NCT02116361|8591911|P4|Overall Study|Pregnancy|1
2486159|NCT02116361|8591912|P3|Overall Study|Pregnancy|0
2486160|NCT02116361|8591913|P2|Overall Study|Pregnancy|0
2486161|NCT02116361|8591914|P1|Overall Study|Pregnancy|0
2486162|NCT02116309|8591951|P2|Overall Study|Lost to Follow-up|1
2486163|NCT02116309|8591952|P1|Overall Study|Lost to Follow-up|0
2486164|NCT02115815|8591984|P7|Overall Study|Missed appointment, randomized in error|0
2486165|NCT02115815|8591985|P6|Overall Study|Missed appointment, randomized in error|1
2486166|NCT02115815|8591986|P5|Overall Study|Missed appointment, randomized in error|0
2486167|NCT02115815|8591987|P4|Overall Study|Missed appointment, randomized in error|0
2486168|NCT02115815|8591988|P3|Overall Study|Missed appointment, randomized in error|0
2486169|NCT02115815|8591989|P2|Overall Study|Missed appointment, randomized in error|0
2486170|NCT02115815|8591990|P1|Overall Study|Missed appointment, randomized in error|0
2486171|NCT02115815|8591984|P7|Overall Study|Not enough drug to dose participant|0
2486172|NCT02115815|8591985|P6|Overall Study|Not enough drug to dose participant|1
2486173|NCT02115815|8591986|P5|Overall Study|Not enough drug to dose participant|0
2486174|NCT02115815|8591987|P4|Overall Study|Not enough drug to dose participant|0
2486175|NCT02115815|8591988|P3|Overall Study|Not enough drug to dose participant|0
2486176|NCT02115815|8591989|P2|Overall Study|Not enough drug to dose participant|0
2486177|NCT02115815|8591990|P1|Overall Study|Not enough drug to dose participant|0
2486178|NCT02115815|8591984|P7|Overall Study|Withdrawal by Subject|0
2486179|NCT02115815|8591985|P6|Overall Study|Withdrawal by Subject|0
2486180|NCT02115815|8591986|P5|Overall Study|Withdrawal by Subject|0
2486181|NCT02115815|8591987|P4|Overall Study|Withdrawal by Subject|0
2486182|NCT02115815|8591988|P3|Overall Study|Withdrawal by Subject|0
2486183|NCT02115815|8591989|P2|Overall Study|Withdrawal by Subject|0
2486184|NCT02115815|8591990|P1|Overall Study|Withdrawal by Subject|2
2486185|NCT02115607|8592132|P1|Overall Study|Withdrawal by Subject|1
2486186|NCT02115386|8592158|P1|Overall Study|Administrative - trial was terminated|6
2486187|NCT02115386|8592158|P1|Overall Study|Protocol Violation|1
2486188|NCT02115321|8592261|P2|Overall Study|Death|0
2486189|NCT02115321|8592262|P1|Overall Study|Death|1
2486190|NCT02115308|8592284|P2|Overall Study|Safety Screening|2
2486191|NCT02115308|8592285|P1|Overall Study|Safety Screening|2
2486192|NCT02115269|8592301|P1|Overall Study|Didn't take study drug|2
2486193|NCT02115269|8592301|P1|Overall Study|Withdrawal by Subject|2
2486194|NCT02115269|8592301|P1|Overall Study|Moved to another city|7
2486195|NCT02115269|8592301|P1|Overall Study|Did not complete patient diary|3
2486196|NCT02115269|8592301|P1|Overall Study|Lost to Follow-up|43
2486197|NCT02115256|8592321|P2|Overall Study|Withdrawal by Subject|1
2486198|NCT02115256|8592322|P1|Overall Study|Withdrawal by Subject|0
2486199|NCT02115113|8592334|P3|Participants Randomized|Death|0
2486200|NCT02115113|8592335|P2|Participants Randomized|Death|0
2486201|NCT02115113|8592336|P1|Participants Randomized|Death|1
2486202|NCT02115113|8592334|P3|Participants Randomized|Lost to Follow-up|0
2486203|NCT02115113|8592335|P2|Participants Randomized|Lost to Follow-up|0
2486204|NCT02115113|8592336|P1|Participants Randomized|Lost to Follow-up|1
2486205|NCT02115113|8592334|P3|Participants in Run-in Period|Withdrawal by Subject|3
2486206|NCT02115113|8592335|P2|Participants in Run-in Period|Withdrawal by Subject|0
2486207|NCT02115113|8592336|P1|Participants in Run-in Period|Withdrawal by Subject|0
2486208|NCT02115113|8592334|P3|Participants in Run-in Period|Lost to Follow-up|5
2486209|NCT02115113|8592335|P2|Participants in Run-in Period|Lost to Follow-up|0
2486210|NCT02115113|8592336|P1|Participants in Run-in Period|Lost to Follow-up|0
2486211|NCT02115113|8592334|P3|Participants in Run-in Period|Administrative problems|1
2486212|NCT02115113|8592335|P2|Participants in Run-in Period|Administrative problems|0
2486213|NCT02115113|8592336|P1|Participants in Run-in Period|Administrative problems|0
2486214|NCT02115113|8592334|P3|Participants in Run-in Period|Death|1
2486215|NCT02115113|8592335|P2|Participants in Run-in Period|Death|0
2486216|NCT02115113|8592336|P1|Participants in Run-in Period|Death|0
2486217|NCT02114931|8592368|P2|Overall Study|Other|1
2486218|NCT02114931|8592369|P1|Overall Study|Other|2
2486219|NCT02114931|8592368|P2|Overall Study|Physician Decision|2
2486220|NCT02114931|8592369|P1|Overall Study|Physician Decision|1
2486221|NCT02114931|8592368|P2|Overall Study|Lost to Follow-up|3
2486222|NCT02114931|8592369|P1|Overall Study|Lost to Follow-up|3
2486223|NCT02114931|8592368|P2|Overall Study|Adverse Event|6
2486224|NCT02114931|8592369|P1|Overall Study|Adverse Event|4
2486225|NCT02114931|8592368|P2|Overall Study|Withdrawal by Subject|18
2486226|NCT02114931|8592369|P1|Overall Study|Withdrawal by Subject|15
2486227|NCT02114892|8592385|P2|Overall Study|Lost to Follow-up|2
2486228|NCT02114892|8592386|P1|Overall Study|Lost to Follow-up|1
2486229|NCT02114697|8592422|P2|Overall Study|Study terminated|4
2486230|NCT02114697|8592423|P1|Overall Study|Study terminated|5
2486231|NCT02114684|8592431|P2|Overall Study|Patient Incarcerated|0
2486232|NCT02114684|8592432|P1|Overall Study|Patient Incarcerated|1
2486233|NCT02114684|8592431|P2|Overall Study|Rifampicin resistant on culture|1
2486234|NCT02114684|8592432|P1|Overall Study|Rifampicin resistant on culture|0
2486235|NCT02114684|8592431|P2|Overall Study|Relocation|1
2486236|NCT02114684|8592432|P1|Overall Study|Relocation|3
2486237|NCT02114684|8592431|P2|Overall Study|Withdrawal by Subject|2
2486238|NCT02114684|8592432|P1|Overall Study|Withdrawal by Subject|1
2486239|NCT02114684|8592431|P2|Overall Study|Lost to Follow-up|2
2486240|NCT02114684|8592432|P1|Overall Study|Lost to Follow-up|1
2486241|NCT02114684|8592431|P2|Overall Study|Death|4
2486242|NCT02114684|8592432|P1|Overall Study|Death|6
2486243|NCT02114515|8592450|P2|Overall Study|Other|61
2486244|NCT02114515|8592451|P1|Overall Study|Other|65
2486245|NCT02114515|8592450|P2|Overall Study|Withdrawal by Subject|22
2486246|NCT02114515|8592451|P1|Overall Study|Withdrawal by Subject|4
2486247|NCT02114515|8592450|P2|Overall Study|Death|12
2486248|NCT02114515|8592451|P1|Overall Study|Death|12
2486249|NCT02114515|8592450|P2|Overall Study|Lost to Follow-up|55
2486250|NCT02114515|8592451|P1|Overall Study|Lost to Follow-up|52
2486251|NCT02114385|8592497|P2|Overall Study|Lost to Follow-up|6
2486252|NCT02114385|8592498|P1|Overall Study|Lost to Follow-up|0
2486253|NCT02114385|8592497|P2|Overall Study|Withdrawal by Subject|2
2486254|NCT02114385|8592498|P1|Overall Study|Withdrawal by Subject|3
2486255|NCT02114268|8592539|P6|Overall Study|Withdrawn by site due to noncompliance|0
2486256|NCT02114268|8592540|P5|Overall Study|Withdrawn by site due to noncompliance|0
2486257|NCT02114268|8592541|P4|Overall Study|Withdrawn by site due to noncompliance|0
2486258|NCT02114268|8592542|P3|Overall Study|Withdrawn by site due to noncompliance|0
2486259|NCT02114268|8592543|P2|Overall Study|Withdrawn by site due to noncompliance|0
2486260|NCT02114268|8592544|P1|Overall Study|Withdrawn by site due to noncompliance|1
2486261|NCT02114268|8592539|P6|Overall Study|Withdrawal by Subject|1
2486262|NCT02114268|8592540|P5|Overall Study|Withdrawal by Subject|0
2486263|NCT02114268|8592541|P4|Overall Study|Withdrawal by Subject|0
2486264|NCT02114268|8592542|P3|Overall Study|Withdrawal by Subject|0
2486265|NCT02114268|8592543|P2|Overall Study|Withdrawal by Subject|0
2486266|NCT02114268|8592544|P1|Overall Study|Withdrawal by Subject|1
2486267|NCT02114268|8592539|P6|Overall Study|Lost to Follow-up|2
2486268|NCT02114268|8592540|P5|Overall Study|Lost to Follow-up|0
2486269|NCT02114268|8592541|P4|Overall Study|Lost to Follow-up|0
2486270|NCT02114268|8592542|P3|Overall Study|Lost to Follow-up|1
2486271|NCT02114268|8592543|P2|Overall Study|Lost to Follow-up|1
2486272|NCT02114268|8592544|P1|Overall Study|Lost to Follow-up|4
2486273|NCT02114203|8592613|P3|Overall Study|Withdrawal by Subject|0
2486274|NCT02114203|8592614|P2|Overall Study|Withdrawal by Subject|1
2486275|NCT02114203|8592615|P1|Overall Study|Withdrawal by Subject|0
2486276|NCT02114203|8592613|P3|Overall Study|Adverse Event|0
2486277|NCT02114203|8592614|P2|Overall Study|Adverse Event|1
2486278|NCT02114203|8592615|P1|Overall Study|Adverse Event|0
2486279|NCT02114177|8592649|P2|Overall Study|Other|1
2486280|NCT02114177|8592650|P1|Overall Study|Other|2
2486281|NCT02114177|8592649|P2|Overall Study|Withdrawal by Subject|1
2486282|NCT02114177|8592650|P1|Overall Study|Withdrawal by Subject|6
2486283|NCT02114177|8592649|P2|Overall Study|Lost to Follow-up|2
2486284|NCT02114177|8592650|P1|Overall Study|Lost to Follow-up|1
2486285|NCT02114151|8592674|P1|Overall Study|Withdrawal by Subject|5
2486286|NCT02114151|8592674|P1|Overall Study|Lost to Follow-up|1
2486287|NCT02114151|8592674|P1|Overall Study|Death|1
2486288|NCT02113956|8592691|P2|3 Month Post-intervention|Lost to Follow-up|2
2486289|NCT02113956|8592692|P1|3 Month Post-intervention|Lost to Follow-up|4
2486290|NCT02113956|8592691|P2|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3
2486291|NCT02113956|8592692|P1|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4
2486292|NCT02113956|8592691|P2|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1
2486293|NCT02113956|8592692|P1|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5
2486294|NCT02113579|8592726|P2|Overall Study|Lost to Follow-up|2
2486295|NCT02113579|8592727|P1|Overall Study|Lost to Follow-up|6
2486296|NCT02113579|8592726|P2|Overall Study|Withdrawal by Subject|2
2486297|NCT02113579|8592727|P1|Overall Study|Withdrawal by Subject|3
2486298|NCT02113579|8592726|P2|Overall Study|Adverse Event|0
2486299|NCT02113579|8592727|P1|Overall Study|Adverse Event|1
2486300|NCT02113449|8592751|P1|Overall Study|Adverse Event|4
2486301|NCT02113436|8592767|P4|Period 2: 16 Weeks|Withdrawal by Subject|1
2486302|NCT02113436|8592768|P3|Period 2: 16 Weeks|Withdrawal by Subject|1
2486303|NCT02113436|8592769|P2|Period 2: 16 Weeks|Withdrawal by Subject|0
2486304|NCT02113436|8592770|P1|Period 2: 16 Weeks|Withdrawal by Subject|0
2486305|NCT02113436|8592767|P4|Period 2: 16 Weeks|Physician Decision|0
2486306|NCT02113436|8592768|P3|Period 2: 16 Weeks|Physician Decision|2
2486307|NCT02113436|8592769|P2|Period 2: 16 Weeks|Physician Decision|0
2486308|NCT02113436|8592770|P1|Period 2: 16 Weeks|Physician Decision|0
2486309|NCT02113436|8592767|P4|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5
2486310|NCT02113436|8592768|P3|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2
2486311|NCT02113436|8592769|P2|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
2486312|NCT02113436|8592770|P1|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
2486313|NCT02113436|8592767|P4|Period 2: 16 Weeks|Adverse Event|5
2486314|NCT02113436|8592768|P3|Period 2: 16 Weeks|Adverse Event|4
2486315|NCT02113436|8592769|P2|Period 2: 16 Weeks|Adverse Event|0
2486316|NCT02113436|8592770|P1|Period 2: 16 Weeks|Adverse Event|0
2486317|NCT02113436|8592767|P4|Period 1: 8 Weeks|Withdrawal by Subject|0
2486318|NCT02113436|8592768|P3|Period 1: 8 Weeks|Withdrawal by Subject|0
2486319|NCT02113436|8592769|P2|Period 1: 8 Weeks|Withdrawal by Subject|0
2486320|NCT02113436|8592770|P1|Period 1: 8 Weeks|Withdrawal by Subject|1
2486321|NCT02113436|8592767|P4|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
2486322|NCT02113436|8592768|P3|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
2486323|NCT02113436|8592769|P2|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2
2486324|NCT02113436|8592770|P1|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5
2486325|NCT02113436|8592767|P4|Period 1: 8 Weeks|Protocol Violation|0
2486326|NCT02113436|8592768|P3|Period 1: 8 Weeks|Protocol Violation|0
2486327|NCT02113436|8592769|P2|Period 1: 8 Weeks|Protocol Violation|0
2486328|NCT02113436|8592770|P1|Period 1: 8 Weeks|Protocol Violation|1
2486329|NCT02113436|8592767|P4|Period 1: 8 Weeks|Adverse Event|0
2486330|NCT02113436|8592768|P3|Period 1: 8 Weeks|Adverse Event|0
2486331|NCT02113436|8592769|P2|Period 1: 8 Weeks|Adverse Event|0
2486332|NCT02113436|8592770|P1|Period 1: 8 Weeks|Adverse Event|1
2486333|NCT02113189|8592821|P3|Overall Study|Lost to follow up|3
2486334|NCT02113189|8592822|P2|Overall Study|Lost to follow up|1
2486335|NCT02113189|8592823|P1|Overall Study|Lost to follow up|2
2486336|NCT02113124|8592839|P2|Overall Study|Unable to retrieve blood sample|1
2486337|NCT02113124|8592840|P1|Overall Study|Unable to retrieve blood sample|1
2486338|NCT02113007|8592846|P1|Overall Study|Progressive disease|2
2486339|NCT02112994|8592852|P3|Overall Study|Withdrawal by Subject|1
2486340|NCT02112994|8592853|P2|Overall Study|Withdrawal by Subject|0
2486341|NCT02112994|8592854|P1|Overall Study|Withdrawal by Subject|0
2486342|NCT02112994|8592852|P3|Overall Study|Liver Transplant|0
2486343|NCT02112994|8592853|P2|Overall Study|Liver Transplant|1
2486344|NCT02112994|8592854|P1|Overall Study|Liver Transplant|0
2486345|NCT02112994|8592852|P3|Overall Study|Pregnancy|1
2486346|NCT02112994|8592853|P2|Overall Study|Pregnancy|1
2486347|NCT02112994|8592854|P1|Overall Study|Pregnancy|0
2486348|NCT02112994|8592852|P3|Overall Study|Progressive Disease|1
2486349|NCT02112994|8592853|P2|Overall Study|Progressive Disease|0
2486350|NCT02112994|8592854|P1|Overall Study|Progressive Disease|0
2486351|NCT02112877|8592872|P2|Overall Study|Visit Missed|6
2486352|NCT02112877|8592873|P1|Overall Study|Visit Missed|1
2486353|NCT02112877|8592872|P2|Overall Study|Withdrawal by Subject|7
2486354|NCT02112877|8592873|P1|Overall Study|Withdrawal by Subject|1
2486355|NCT02112448|8592952|P2|Overall Study|required heparin so could not use ketoro|0
2486356|NCT02112448|8592953|P1|Overall Study|required heparin so could not use ketoro|1
2486357|NCT02112448|8592952|P2|Overall Study|Physician Decision|6
2486358|NCT02112448|8592953|P1|Overall Study|Physician Decision|4
2486359|NCT02112448|8592952|P2|Overall Study|Protocol Violation|2
2486360|NCT02112448|8592953|P1|Overall Study|Protocol Violation|1
2486361|NCT02112448|8592952|P2|Overall Study|lab values precluding use of ketorolac|2
2486362|NCT02112448|8592953|P1|Overall Study|lab values precluding use of ketorolac|2
2486363|NCT02112045|8592986|P2|Overall Study|Withdrawal by Subject|0
2486364|NCT02112045|8592987|P1|Overall Study|Withdrawal by Subject|1
2486365|NCT02111993|8593007|P2|Overall Study|Physician Decision|4
2486366|NCT02111993|8593008|P1|Overall Study|Physician Decision|5
2486367|NCT02111811|8593049|P2|Follow up Period (Aim 2)|Death|0
2486368|NCT02111811|8593050|P1|Follow up Period (Aim 2)|Death|2
2486369|NCT02111811|8593049|P2|Follow up Period (Aim 2)|Lost to Follow-up|17
2486370|NCT02111811|8593050|P1|Follow up Period (Aim 2)|Lost to Follow-up|26
2486371|NCT02111811|8593049|P2|Treatment Phase|Death|0
2486372|NCT02111811|8593050|P1|Treatment Phase|Death|2
2486373|NCT02111811|8593049|P2|Treatment Phase|Lost to Follow-up|18
2486374|NCT02111811|8593050|P1|Treatment Phase|Lost to Follow-up|22
2486375|NCT02111785|8593063|P4|Overall Study|Death|0
2486376|NCT02111785|8593064|P3|Overall Study|Death|0
2486377|NCT02111785|8593065|P2|Overall Study|Death|1
2486378|NCT02111785|8593066|P1|Overall Study|Death|0
2486379|NCT02111603|8593128|P1|Overall Study|Withdrawal by Subject|1
2486380|NCT02111564|8593139|P2|Overall Study|Withdrawal by Subject|20
2486381|NCT02111564|8593140|P1|Overall Study|Withdrawal by Subject|20
2486382|NCT02111564|8593139|P2|Overall Study|Lost to Follow-up|3
2486383|NCT02111564|8593140|P1|Overall Study|Lost to Follow-up|2
2486384|NCT02111564|8593139|P2|Overall Study|Death|120
2486385|NCT02111564|8593140|P1|Overall Study|Death|109
2486386|NCT02111369|8593179|P1|Overall Study|Withdrawal by Subject|1
2486387|NCT02111369|8593179|P1|Overall Study|Lost to Follow-up|2
2486388|NCT02111213|8593203|P2|Overall Study|Lost to Follow-up|4
2486389|NCT02111213|8593204|P1|Overall Study|Lost to Follow-up|3
2486390|NCT02111213|8593203|P2|Overall Study|Withdrawal by Subject|2
2486391|NCT02111213|8593204|P1|Overall Study|Withdrawal by Subject|3
2486392|NCT02111174|8593248|P2|Secondary Outcomes (2 and 3 Month f/u)|Death|1
2486393|NCT02111174|8593249|P1|Secondary Outcomes (2 and 3 Month f/u)|Death|0
2486394|NCT02111174|8593248|P2|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6
2486395|NCT02111174|8593249|P1|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8
2486396|NCT02111174|8593248|P2|Treatment and Primary Outcome|Withdrawal by Subject|2
2486397|NCT02111174|8593249|P1|Treatment and Primary Outcome|Withdrawal by Subject|2
2486398|NCT02111174|8593248|P2|Treatment and Primary Outcome|Ineligible (not used in analysis)|0
2486399|NCT02111174|8593249|P1|Treatment and Primary Outcome|Ineligible (not used in analysis)|1
2486400|NCT02111096|8593278|P3|Overall Study|Withdrawal by Subject|8
2486401|NCT02111096|8593279|P2|Overall Study|Withdrawal by Subject|2
2486402|NCT02111096|8593280|P1|Overall Study|Withdrawal by Subject|4
2486403|NCT02111096|8593278|P3|Overall Study|Terminated by Sponsor|54
2486404|NCT02111096|8593279|P2|Overall Study|Terminated by Sponsor|35
2486405|NCT02111096|8593280|P1|Overall Study|Terminated by Sponsor|53
2486406|NCT02111096|8593278|P3|Overall Study|Protocol Violation|1
2486407|NCT02111096|8593279|P2|Overall Study|Protocol Violation|0
2486408|NCT02111096|8593280|P1|Overall Study|Protocol Violation|1
2486409|NCT02111096|8593278|P3|Overall Study|Physician Decision|0
2486410|NCT02111096|8593279|P2|Overall Study|Physician Decision|1
2486411|NCT02111096|8593280|P1|Overall Study|Physician Decision|0
2486412|NCT02111096|8593278|P3|Overall Study|Lost to Follow Up|1
2486413|NCT02111096|8593279|P2|Overall Study|Lost to Follow Up|1
2486414|NCT02111096|8593280|P1|Overall Study|Lost to Follow Up|1
2486415|NCT02111096|8593278|P3|Overall Study|Non-Compliance with Study Drug|0
2486416|NCT02111096|8593279|P2|Overall Study|Non-Compliance with Study Drug|1
2486417|NCT02111096|8593280|P1|Overall Study|Non-Compliance with Study Drug|1
2486418|NCT02111096|8593278|P3|Overall Study|Adverse Event|2
2486419|NCT02111096|8593279|P2|Overall Study|Adverse Event|1
2486420|NCT02111096|8593280|P1|Overall Study|Adverse Event|4
2486421|NCT02111083|8593328|P2|Interval Between Dosing (7-8 Days)|Adverse Event|1
2486422|NCT02111083|8593329|P1|Interval Between Dosing (7-8 Days)|Adverse Event|1
2486423|NCT02110901|8593349|P2|Overall Study|received a kidney transplant|0
2486424|NCT02110901|8593350|P1|Overall Study|received a kidney transplant|5
2486425|NCT02110901|8593349|P2|Overall Study|Withdrawal by Subject|3
2486426|NCT02110901|8593350|P1|Overall Study|Withdrawal by Subject|7
2486427|NCT02110901|8593349|P2|Overall Study|Lost to Follow-up|8
2486428|NCT02110901|8593350|P1|Overall Study|Lost to Follow-up|12
2486429|NCT02110901|8593349|P2|Overall Study|Death|3
2486430|NCT02110901|8593350|P1|Overall Study|Death|6
2486431|NCT02110706|8593364|P2|Overall Study|Patients who didn't receive 2nd infusion|1
2486432|NCT02110706|8593365|P1|Overall Study|Patients who didn't receive 2nd infusion|3
2486433|NCT02110706|8593364|P2|Overall Study|Adverse Event|3
2486434|NCT02110706|8593365|P1|Overall Study|Adverse Event|2
2486435|NCT02110693|8593377|P2|Overall Study|Other|0
2486436|NCT02110693|8593378|P1|Overall Study|Other|1
2486437|NCT02110693|8593377|P2|Overall Study|technical difficulties|4
2486438|NCT02110693|8593378|P1|Overall Study|technical difficulties|6
2486439|NCT02110693|8593377|P2|Overall Study|skipped assessment|18
2486440|NCT02110693|8593378|P1|Overall Study|skipped assessment|15
2486441|NCT02110693|8593377|P2|Overall Study|Withdrawal by Subject|7
2486442|NCT02110693|8593378|P1|Overall Study|Withdrawal by Subject|6
2486443|NCT02110238|8593459|P2|14 Week Blinded Extension Phase|Withdrawal by Subject|3
2486444|NCT02110238|8593460|P1|14 Week Blinded Extension Phase|Withdrawal by Subject|4
2486445|NCT02110238|8593459|P2|14 Week Blinded Extension Phase|Protocol Violation|3
2486446|NCT02110238|8593460|P1|14 Week Blinded Extension Phase|Protocol Violation|2
2486447|NCT02110238|8593459|P2|14 Week Blinded Extension Phase|Lost to Follow-up|1
2486448|NCT02110238|8593460|P1|14 Week Blinded Extension Phase|Lost to Follow-up|3
2486449|NCT02110238|8593459|P2|14 Week Blinded Extension Phase|Lack of Efficacy|4
2486450|NCT02110238|8593460|P1|14 Week Blinded Extension Phase|Lack of Efficacy|2
2486451|NCT02110238|8593459|P2|14 Week Blinded Extension Phase|Adverse Event|1
2486452|NCT02110238|8593460|P1|14 Week Blinded Extension Phase|Adverse Event|1
2486453|NCT02110238|8593459|P2|12 Week Pivotal Phase|Withdrawal by Subject|3
2486454|NCT02110238|8593460|P1|12 Week Pivotal Phase|Withdrawal by Subject|3
2486455|NCT02110238|8593459|P2|12 Week Pivotal Phase|Protocol Violation|1
2486456|NCT02110238|8593460|P1|12 Week Pivotal Phase|Protocol Violation|0
2486457|NCT02110238|8593459|P2|12 Week Pivotal Phase|Physician Decision|2
2486458|NCT02110238|8593460|P1|12 Week Pivotal Phase|Physician Decision|0
2486459|NCT02110238|8593459|P2|12 Week Pivotal Phase|Lost to Follow-up|0
2486460|NCT02110238|8593460|P1|12 Week Pivotal Phase|Lost to Follow-up|2
2486461|NCT02110238|8593459|P2|12 Week Pivotal Phase|Lack of Efficacy|3
2486462|NCT02110238|8593460|P1|12 Week Pivotal Phase|Lack of Efficacy|2
2486463|NCT02110238|8593459|P2|12 Week Pivotal Phase|Adverse Event|0
2486464|NCT02110238|8593460|P1|12 Week Pivotal Phase|Adverse Event|3
2486465|NCT02110225|8593469|P3|Overall Study|Lost to Follow-up|0
2486466|NCT02110225|8593470|P2|Overall Study|Lost to Follow-up|1
2486467|NCT02110225|8593471|P1|Overall Study|Lost to Follow-up|0
2486468|NCT02109562|8593581|P3|Overall Study|Physician Decision|5
2486469|NCT02109562|8593582|P2|Overall Study|Physician Decision|4
2486470|NCT02109562|8593583|P1|Overall Study|Physician Decision|3
2486471|NCT02109562|8593581|P3|Overall Study|Withdrawal by Subject|21
2486472|NCT02109562|8593582|P2|Overall Study|Withdrawal by Subject|25
2486473|NCT02109562|8593583|P1|Overall Study|Withdrawal by Subject|20
2486474|NCT02109562|8593581|P3|Overall Study|Protocol Violation|1
2486475|NCT02109562|8593582|P2|Overall Study|Protocol Violation|3
2486476|NCT02109562|8593583|P1|Overall Study|Protocol Violation|0
2486477|NCT02109562|8593581|P3|Overall Study|Lost to Follow-up|1
2486478|NCT02109562|8593582|P2|Overall Study|Lost to Follow-up|0
2486479|NCT02109562|8593583|P1|Overall Study|Lost to Follow-up|1
2486480|NCT02109562|8593581|P3|Overall Study|Adverse Event|3
2486481|NCT02109562|8593582|P2|Overall Study|Adverse Event|2
2486482|NCT02109562|8593583|P1|Overall Study|Adverse Event|0
2486483|NCT02109562|8593581|P3|Overall Study|Insufficient clinical response|4
2486484|NCT02109562|8593582|P2|Overall Study|Insufficient clinical response|0
2486485|NCT02109562|8593583|P1|Overall Study|Insufficient clinical response|2
2486486|NCT02109484|8593610|P8|Overall Study|Moved away from study area|1
2486487|NCT02109484|8593611|P7|Overall Study|Moved away from study area|1
2486488|NCT02109484|8593612|P6|Overall Study|Moved away from study area|0
2486489|NCT02109484|8593613|P5|Overall Study|Moved away from study area|0
2486490|NCT02109484|8593614|P4|Overall Study|Moved away from study area|0
2486491|NCT02109484|8593615|P3|Overall Study|Moved away from study area|0
2486492|NCT02109484|8593616|P2|Overall Study|Moved away from study area|0
2486493|NCT02109484|8593617|P1|Overall Study|Moved away from study area|0
2486494|NCT02109484|8593610|P8|Overall Study|Death|2
2486495|NCT02109484|8593611|P7|Overall Study|Death|0
2486496|NCT02109484|8593612|P6|Overall Study|Death|0
2486497|NCT02109484|8593613|P5|Overall Study|Death|0
2486498|NCT02109484|8593614|P4|Overall Study|Death|0
2486499|NCT02109484|8593615|P3|Overall Study|Death|0
2486500|NCT02109484|8593616|P2|Overall Study|Death|0
2486501|NCT02109484|8593617|P1|Overall Study|Death|0
2486502|NCT02109484|8593610|P8|Overall Study|Physician Decision|0
2486503|NCT02109484|8593611|P7|Overall Study|Physician Decision|0
2486504|NCT02109484|8593612|P6|Overall Study|Physician Decision|0
2486505|NCT02109484|8593613|P5|Overall Study|Physician Decision|2
2486506|NCT02109484|8593614|P4|Overall Study|Physician Decision|0
2486507|NCT02109484|8593615|P3|Overall Study|Physician Decision|0
2486508|NCT02109484|8593616|P2|Overall Study|Physician Decision|0
2486509|NCT02109484|8593617|P1|Overall Study|Physician Decision|0
2486510|NCT02109484|8593610|P8|Overall Study|Withdrawal by Subject|0
2486511|NCT02109484|8593611|P7|Overall Study|Withdrawal by Subject|1
2486512|NCT02109484|8593612|P6|Overall Study|Withdrawal by Subject|1
2486513|NCT02109484|8593613|P5|Overall Study|Withdrawal by Subject|1
2486514|NCT02109484|8593614|P4|Overall Study|Withdrawal by Subject|0
2486515|NCT02109484|8593615|P3|Overall Study|Withdrawal by Subject|0
2486516|NCT02109484|8593616|P2|Overall Study|Withdrawal by Subject|0
2486517|NCT02109484|8593617|P1|Overall Study|Withdrawal by Subject|0
2486518|NCT02109484|8593610|P8|Overall Study|Lost to Follow-up|0
2486519|NCT02109484|8593611|P7|Overall Study|Lost to Follow-up|1
2486520|NCT02109484|8593612|P6|Overall Study|Lost to Follow-up|0
2486521|NCT02109484|8593613|P5|Overall Study|Lost to Follow-up|1
2486522|NCT02109484|8593614|P4|Overall Study|Lost to Follow-up|1
2486523|NCT02109484|8593615|P3|Overall Study|Lost to Follow-up|0
2486524|NCT02109484|8593616|P2|Overall Study|Lost to Follow-up|0
2486525|NCT02109484|8593617|P1|Overall Study|Lost to Follow-up|0
2486526|NCT02109445|8593673|P1|Overall Study|Adverse Event|1
2486527|NCT02109445|8593673|P1|Overall Study|Symptomatic deterioration|2
2486528|NCT02109432|8593706|P1|Overall Study|Withdrawal by Subject|1
2486529|NCT02109172|8593716|P6|Overall Study|Death|0
2486530|NCT02109172|8593717|P5|Overall Study|Death|1
2486531|NCT02109172|8593718|P4|Overall Study|Death|0
2486532|NCT02109172|8593719|P3|Overall Study|Death|0
2486533|NCT02109172|8593720|P2|Overall Study|Death|0
2486534|NCT02109172|8593721|P1|Overall Study|Death|0
2486535|NCT02109172|8593716|P6|Overall Study|Adverse Event|1
2486536|NCT02109172|8593717|P5|Overall Study|Adverse Event|0
2486537|NCT02109172|8593718|P4|Overall Study|Adverse Event|0
2486538|NCT02109172|8593719|P3|Overall Study|Adverse Event|1
2486539|NCT02109172|8593720|P2|Overall Study|Adverse Event|0
2486540|NCT02109172|8593721|P1|Overall Study|Adverse Event|0
2486541|NCT02109172|8593716|P6|Overall Study|Withdrawal by Subject|0
2486542|NCT02109172|8593717|P5|Overall Study|Withdrawal by Subject|0
2486543|NCT02109172|8593718|P4|Overall Study|Withdrawal by Subject|1
2486544|NCT02109172|8593719|P3|Overall Study|Withdrawal by Subject|0
2486545|NCT02109172|8593720|P2|Overall Study|Withdrawal by Subject|0
2486546|NCT02109172|8593721|P1|Overall Study|Withdrawal by Subject|1
2486547|NCT02109133|8593742|P2|Overall Study|Lost to Follow-up|0
2486548|NCT02109133|8593743|P1|Overall Study|Lost to Follow-up|1
2486549|NCT02109107|8593755|P1|Overall Study|Lost to Follow-up|2
2486550|NCT02109042|8593762|P1|Overall Study|Sponsor Decision|15
2486551|NCT02109029|8593771|P6|Part B|Adverse Event|1
2486552|NCT02109029|8593772|P5|Part B|Adverse Event|1
2486553|NCT02109029|8593773|P4|Part B|Adverse Event|0
2486554|NCT02109029|8593774|P3|Part B|Adverse Event|0
2486555|NCT02109029|8593775|P2|Part B|Adverse Event|0
2486556|NCT02109029|8593776|P1|Part B|Adverse Event|0
2486557|NCT02108951|8593805|P1|Overall Study|Study Terminated by Sponsor|14
2486558|NCT02108951|8593805|P1|Overall Study|Patient's/guardian's decision|1
2486559|NCT02108951|8593805|P1|Overall Study|Lost to Follow-up|1
2486560|NCT02108912|8593824|P2|Overall Study|high blood pressure|0
2486561|NCT02108912|8593825|P1|Overall Study|high blood pressure|1
2486562|NCT02108912|8593824|P2|Overall Study|lack of transportation|0
2486563|NCT02108912|8593825|P1|Overall Study|lack of transportation|1
2486564|NCT02108912|8593824|P2|Overall Study|Lost to Follow-up|1
2486565|NCT02108912|8593825|P1|Overall Study|Lost to Follow-up|1
2486566|NCT02108652|8593854|P1|Overall Study|Ongoing at data cutoff 04 July 2016|74
2486567|NCT02108652|8593854|P1|Overall Study|Withdrawal by Subject|8
2486568|NCT02108652|8593854|P1|Overall Study|Lost to Follow-up|2
2486569|NCT02108652|8593854|P1|Overall Study|Death|226
2486570|NCT02107898|8594032|P2|Overall Study|Randomized but not treated|1
2486571|NCT02107898|8594033|P1|Overall Study|Randomized but not treated|0
2486572|NCT02107898|8594032|P2|Overall Study|Consent withdrawn by participant|1
2486573|NCT02107898|8594033|P1|Overall Study|Consent withdrawn by participant|2
2486574|NCT02107898|8594032|P2|Overall Study|Participant moved|2
2486575|NCT02107898|8594033|P1|Overall Study|Participant moved|0
2486576|NCT02107898|8594032|P2|Overall Study|Poor compliance to protocol|1
2486577|NCT02107898|8594033|P1|Overall Study|Poor compliance to protocol|0
2486578|NCT02107898|8594032|P2|Overall Study|Adverse Event|7
2486579|NCT02107898|8594033|P1|Overall Study|Adverse Event|4
2486580|NCT02107859|8594085|P1|Overall Study|Other than specified|3
2486581|NCT02107859|8594085|P1|Overall Study|Study closure|41
2486582|NCT02107859|8594085|P1|Overall Study|Adverse Event|3
2486583|NCT02107859|8594085|P1|Overall Study|Withdrawal by Subject|14
2486584|NCT02107703|8594101|P2|Overall Study|On study treatment/follow up|152
2486585|NCT02107703|8594102|P1|Overall Study|On study treatment/follow up|319
2486586|NCT02107703|8594101|P2|Overall Study|Lost to Follow-up|4
2486587|NCT02107703|8594102|P1|Overall Study|Lost to Follow-up|6
2486588|NCT02107703|8594101|P2|Overall Study|Withdrawal by Subject|19
2486589|NCT02107703|8594102|P1|Overall Study|Withdrawal by Subject|36
2486590|NCT02107482|8594134|P1|Overall Study|Lack of Efficacy|1
2486591|NCT02107482|8594134|P1|Overall Study|Lost to Follow-up|1
2486592|NCT02107482|8594134|P1|Overall Study|inconveinence|2
2486593|NCT02107443|8594142|P2|Overall Study|Withdrawal: Personal Issues|3
2486594|NCT02107443|8594143|P1|Overall Study|Withdrawal: Personal Issues|0
2486595|NCT02107443|8594142|P2|Overall Study|Withdrawal: Disease Progression|2
2486596|NCT02107443|8594143|P1|Overall Study|Withdrawal: Disease Progression|4
2486597|NCT02107443|8594142|P2|Overall Study|Withdrawal: Other Medical|5
2486598|NCT02107443|8594143|P1|Overall Study|Withdrawal: Other Medical|9
2486599|NCT02107443|8594142|P2|Overall Study|Withdrawal: Feeling Overwhelmed|1
2486600|NCT02107443|8594143|P1|Overall Study|Withdrawal: Feeling Overwhelmed|2
2486601|NCT02107443|8594142|P2|Overall Study|Withdrawal: Too Time Consuming|6
2486602|NCT02107443|8594143|P1|Overall Study|Withdrawal: Too Time Consuming|3
2486603|NCT02107443|8594142|P2|Overall Study|Withdrawal: Too Many Forms|1
2486604|NCT02107443|8594143|P1|Overall Study|Withdrawal: Too Many Forms|3
2486605|NCT02107443|8594142|P2|Overall Study|Withdrawal: Changed MD/Facility|3
2486606|NCT02107443|8594143|P1|Overall Study|Withdrawal: Changed MD/Facility|1
2486607|NCT02107443|8594142|P2|Overall Study|Withdrawal: Changed Mind|0
2486608|NCT02107443|8594143|P1|Overall Study|Withdrawal: Changed Mind|2
2486609|NCT02107443|8594142|P2|Overall Study|Withdrawal: Disliked Study Procedures|2
2486610|NCT02107443|8594143|P1|Overall Study|Withdrawal: Disliked Study Procedures|1
2486611|NCT02107443|8594142|P2|Overall Study|Withdrawal: Hospitalization/Hospice|28
2486612|NCT02107443|8594143|P1|Overall Study|Withdrawal: Hospitalization/Hospice|28
2486613|NCT02107443|8594142|P2|Overall Study|Registered but Not Eligible|1
2486614|NCT02107443|8594143|P1|Overall Study|Registered but Not Eligible|0
2486615|NCT02107443|8594142|P2|Overall Study|Study Protocol Violation|1
2486616|NCT02107443|8594143|P1|Overall Study|Study Protocol Violation|3
2486617|NCT02107443|8594142|P2|Overall Study|Death|30
2486618|NCT02107443|8594143|P1|Overall Study|Death|42
2486619|NCT02107313|8594190|P2|Overall Study|One participant did not do the FED cohor|1
2486620|NCT02107313|8594191|P1|Overall Study|One participant did not do the FED cohor|0
2486621|NCT02107274|8594212|P2|Control Phase|Adverse Event|1
2486622|NCT02107274|8594213|P1|Control Phase|Adverse Event|0
2486623|NCT02107274|8594212|P2|Control Phase|Death|0
2486624|NCT02107274|8594213|P1|Control Phase|Death|2
2486625|NCT02107274|8594212|P2|Control Phase|Lost to Follow-up|1
2486626|NCT02107274|8594213|P1|Control Phase|Lost to Follow-up|1
2486627|NCT02107274|8594212|P2|Treatment vs. Placebo|Lost to Follow-up|2
2486628|NCT02107274|8594213|P1|Treatment vs. Placebo|Lost to Follow-up|0
2486629|NCT02107274|8594212|P2|Treatment vs. Placebo|Adverse Event|0
2486630|NCT02107274|8594213|P1|Treatment vs. Placebo|Adverse Event|3
2486631|NCT02107196|8594227|P2|4-week Randomized Withdrawal (RW) Period|Reason Missing|5
2486632|NCT02107196|8594228|P1|4-week Randomized Withdrawal (RW) Period|Reason Missing|18
2486633|NCT02107196|8594227|P2|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0
2486634|NCT02107196|8594228|P1|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2
2486635|NCT02107196|8594227|P2|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
2486636|NCT02107196|8594228|P1|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1
2486637|NCT02107196|8594227|P2|4-week Randomized Withdrawal (RW) Period|Adverse Event|0
2486638|NCT02107196|8594228|P1|4-week Randomized Withdrawal (RW) Period|Adverse Event|2
2486639|NCT02107196|8594227|P2|12-week Treatment Period|Reason Missing|8
2486640|NCT02107196|8594228|P1|12-week Treatment Period|Reason Missing|11
2486641|NCT02107196|8594227|P2|12-week Treatment Period|Protocol Violation|8
2486642|NCT02107196|8594228|P1|12-week Treatment Period|Protocol Violation|7
2486643|NCT02107196|8594227|P2|12-week Treatment Period|Withdrawal by Subject|12
2486644|NCT02107196|8594228|P1|12-week Treatment Period|Withdrawal by Subject|15
2486645|NCT02107196|8594227|P2|12-week Treatment Period|Physician Decision|1
2486646|NCT02107196|8594228|P1|12-week Treatment Period|Physician Decision|0
2486647|NCT02107196|8594227|P2|12-week Treatment Period|Lost to Follow-up|6
2486648|NCT02107196|8594228|P1|12-week Treatment Period|Lost to Follow-up|3
2486649|NCT02107196|8594227|P2|12-week Treatment Period|Lack of Efficacy|1
2486650|NCT02107196|8594228|P1|12-week Treatment Period|Lack of Efficacy|2
2486651|NCT02107196|8594227|P2|12-week Treatment Period|Adverse Event|3
2486652|NCT02107196|8594228|P1|12-week Treatment Period|Adverse Event|6
2486653|NCT02107131|8594243|P2|Overall Study|Protocol Violation|4
2486654|NCT02107131|8594244|P1|Overall Study|Protocol Violation|0
2486655|NCT02107131|8594243|P2|Overall Study|Death|1
2486656|NCT02107131|8594244|P1|Overall Study|Death|0
2486657|NCT02107131|8594243|P2|Overall Study|mental instability|0
2486658|NCT02107131|8594244|P1|Overall Study|mental instability|1
2486659|NCT02107131|8594243|P2|Overall Study|Withdrawal by Subject|0
2486660|NCT02107131|8594244|P1|Overall Study|Withdrawal by Subject|2
2486661|NCT02107131|8594243|P2|Overall Study|Physician Decision|0
2486662|NCT02107131|8594244|P1|Overall Study|Physician Decision|1
2486663|NCT02107131|8594243|P2|Overall Study|Lost to Follow-up|4
2486664|NCT02107131|8594244|P1|Overall Study|Lost to Follow-up|4
2486665|NCT02107092|8594256|P1|Overall Study|Expected progression of CKD|12
2486666|NCT02107092|8594256|P1|Overall Study|Adverse Event|7
2486667|NCT02107092|8594256|P1|Overall Study|Withdrawal by Subject|9
2486668|NCT02107092|8594256|P1|Overall Study|Lost to Follow-up|2
2486669|NCT02107092|8594256|P1|Overall Study|Physician Decision|3
2486670|NCT02107092|8594256|P1|Overall Study|Met ECG withdrawal criteria|3
2486671|NCT02107092|8594256|P1|Overall Study|Hypo-or hyperkalemia|2
2486672|NCT02107092|8594256|P1|Overall Study|Subject compliance|3
2486673|NCT02107092|8594256|P1|Overall Study|Miscellaneous|3
2486674|NCT02107014|8594261|P1|Overall Study|Withdrew before drug: moving interstate|1
2486675|NCT02106975|8594331|P2|Overall Study|Death|39
2486676|NCT02106975|8594332|P1|Overall Study|Death|25
2486677|NCT02106923|8594392|P6|Overall Study|Protocol Violation|1
2486678|NCT02106923|8594393|P5|Overall Study|Protocol Violation|0
2486679|NCT02106923|8594394|P4|Overall Study|Protocol Violation|0
2486680|NCT02106923|8594395|P3|Overall Study|Protocol Violation|0
2486681|NCT02106923|8594396|P2|Overall Study|Protocol Violation|0
2486682|NCT02106923|8594397|P1|Overall Study|Protocol Violation|0
2486683|NCT02106884|8594443|P2|Overall Study|Change of diagnosis/exclusion|1
2486684|NCT02106884|8594444|P1|Overall Study|Change of diagnosis/exclusion|0
2486685|NCT02106832|8594468|P4|Overall Study|Technical problems|0
2486686|NCT02106832|8594469|P3|Overall Study|Technical problems|0
2486687|NCT02106832|8594470|P2|Overall Study|Technical problems|1
2486688|NCT02106832|8594471|P1|Overall Study|Technical problems|0
2486689|NCT02106832|8594468|P4|Overall Study|Withdrawal by Subject|7
2486690|NCT02106832|8594469|P3|Overall Study|Withdrawal by Subject|10
2486691|NCT02106832|8594470|P2|Overall Study|Withdrawal by Subject|17
2486692|NCT02106832|8594471|P1|Overall Study|Withdrawal by Subject|17
2486693|NCT02106832|8594468|P4|Overall Study|Protocol Violation|1
2486694|NCT02106832|8594469|P3|Overall Study|Protocol Violation|0
2486695|NCT02106832|8594470|P2|Overall Study|Protocol Violation|0
2486696|NCT02106832|8594471|P1|Overall Study|Protocol Violation|0
2486697|NCT02106832|8594468|P4|Overall Study|Physician Decision|0
2486698|NCT02106832|8594469|P3|Overall Study|Physician Decision|0
2486699|NCT02106832|8594470|P2|Overall Study|Physician Decision|0
2486700|NCT02106832|8594471|P1|Overall Study|Physician Decision|1
2486701|NCT02106832|8594468|P4|Overall Study|Lost to Follow-up|3
2486702|NCT02106832|8594469|P3|Overall Study|Lost to Follow-up|1
2486703|NCT02106832|8594470|P2|Overall Study|Lost to Follow-up|1
2486704|NCT02106832|8594471|P1|Overall Study|Lost to Follow-up|0
2486705|NCT02106832|8594468|P4|Overall Study|Deterioration of general conditions|0
2486706|NCT02106832|8594469|P3|Overall Study|Deterioration of general conditions|1
2486707|NCT02106832|8594470|P2|Overall Study|Deterioration of general conditions|0
2486708|NCT02106832|8594471|P1|Overall Study|Deterioration of general conditions|0
2486709|NCT02106832|8594468|P4|Overall Study|Death|4
2486710|NCT02106832|8594469|P3|Overall Study|Death|1
2486711|NCT02106832|8594470|P2|Overall Study|Death|4
2486712|NCT02106832|8594471|P1|Overall Study|Death|4
2486713|NCT02106832|8594468|P4|Overall Study|Adverse Event|0
2486714|NCT02106832|8594469|P3|Overall Study|Adverse Event|3
2486715|NCT02106832|8594470|P2|Overall Study|Adverse Event|2
2486716|NCT02106832|8594471|P1|Overall Study|Adverse Event|1
2486717|NCT02106455|8594538|P1|Overall Study|Protocol Deviation|2
2486718|NCT02106455|8594538|P1|Overall Study|Case Report Form Uncollected|6
2486719|NCT02106442|8594552|P1|Overall Study|Protocol Deviation|30
2486720|NCT02106442|8594552|P1|Overall Study|Case Report Forms Uncollected|7
2486721|NCT02106403|8594570|P6|Follow-Up Visit 3|Other Reason|1
2486722|NCT02106403|8594571|P5|Follow-Up Visit 3|Other Reason|0
2486723|NCT02106403|8594572|P4|Follow-Up Visit 3|Other Reason|0
2486724|NCT02106403|8594573|P3|Follow-Up Visit 3|Other Reason|0
2486725|NCT02106403|8594574|P2|Follow-Up Visit 3|Other Reason|0
2486726|NCT02106403|8594575|P1|Follow-Up Visit 3|Other Reason|0
2486727|NCT02106390|8594598|P3|Overall Study|Protocol Violation|0
2486728|NCT02106390|8594599|P2|Overall Study|Protocol Violation|1
2486729|NCT02106390|8594600|P1|Overall Study|Protocol Violation|0
2486730|NCT02106390|8594598|P3|Overall Study|Adverse Event|1
2486731|NCT02106390|8594599|P2|Overall Study|Adverse Event|2
2486732|NCT02106390|8594600|P1|Overall Study|Adverse Event|0
2486733|NCT02106390|8594598|P3|Overall Study|Other: Unspecified|2
2486734|NCT02106390|8594599|P2|Overall Study|Other: Unspecified|4
2486735|NCT02106390|8594600|P1|Overall Study|Other: Unspecified|1
2486736|NCT02106390|8594598|P3|Overall Study|Other: Administrative Reason|12
2486737|NCT02106390|8594599|P2|Overall Study|Other: Administrative Reason|5
2486738|NCT02106390|8594600|P1|Overall Study|Other: Administrative Reason|8
2486739|NCT02106390|8594598|P3|Overall Study|Lost to Follow-up|13
2486740|NCT02106390|8594599|P2|Overall Study|Lost to Follow-up|20
2486741|NCT02106390|8594600|P1|Overall Study|Lost to Follow-up|25
2486742|NCT02106390|8594598|P3|Overall Study|Withdrawal by Subject|15
2486743|NCT02106390|8594599|P2|Overall Study|Withdrawal by Subject|16
2486744|NCT02106390|8594600|P1|Overall Study|Withdrawal by Subject|15
2486745|NCT02106351|8594677|P3|Treatment Cycle 4|Other|0
2486746|NCT02106351|8594678|P2|Treatment Cycle 4|Other|1
2486747|NCT02106351|8594679|P1|Treatment Cycle 4|Other|0
2486748|NCT02106351|8594677|P3|Treatment Cycle 4|Consent withdrawn|2
2486749|NCT02106351|8594678|P2|Treatment Cycle 4|Consent withdrawn|0
2486750|NCT02106351|8594679|P1|Treatment Cycle 4|Consent withdrawn|0
2486751|NCT02106351|8594677|P3|Treatment Cycle 3|Other|3
2486752|NCT02106351|8594678|P2|Treatment Cycle 3|Other|2
2486753|NCT02106351|8594679|P1|Treatment Cycle 3|Other|0
2486754|NCT02106351|8594677|P3|Treatment Cycle 3|Lost to Follow-up|0
2486755|NCT02106351|8594678|P2|Treatment Cycle 3|Lost to Follow-up|1
2486756|NCT02106351|8594679|P1|Treatment Cycle 3|Lost to Follow-up|0
2486757|NCT02106351|8594677|P3|Treatment Cycle 3|Consent withdrawn|2
2486758|NCT02106351|8594678|P2|Treatment Cycle 3|Consent withdrawn|0
2486759|NCT02106351|8594679|P1|Treatment Cycle 3|Consent withdrawn|0
2486760|NCT02106351|8594677|P3|Treatment Cycle 3|Adverse Event|0
2486761|NCT02106351|8594678|P2|Treatment Cycle 3|Adverse Event|1
2486762|NCT02106351|8594679|P1|Treatment Cycle 3|Adverse Event|0
2486763|NCT02106351|8594677|P3|Treatment Cycle 2|Other|2
2486764|NCT02106351|8594678|P2|Treatment Cycle 2|Other|2
2486765|NCT02106351|8594679|P1|Treatment Cycle 2|Other|0
2486766|NCT02106351|8594677|P3|Treatment Cycle 2|Consent withdrawn|1
2486767|NCT02106351|8594678|P2|Treatment Cycle 2|Consent withdrawn|1
2486768|NCT02106351|8594679|P1|Treatment Cycle 2|Consent withdrawn|0
2486769|NCT02106351|8594677|P3|Treatment Cycle 2|Adverse Event|0
2486770|NCT02106351|8594678|P2|Treatment Cycle 2|Adverse Event|2
2486771|NCT02106351|8594679|P1|Treatment Cycle 2|Adverse Event|0
2486772|NCT02106351|8594677|P3|Treatment Cycle 1|Randomised but not treated|1
2486773|NCT02106351|8594678|P2|Treatment Cycle 1|Randomised but not treated|0
2486774|NCT02106351|8594679|P1|Treatment Cycle 1|Randomised but not treated|1
2486775|NCT02106351|8594677|P3|Treatment Cycle 1|Other|1
2486776|NCT02106351|8594678|P2|Treatment Cycle 1|Other|3
2486777|NCT02106351|8594679|P1|Treatment Cycle 1|Other|0
2486778|NCT02106351|8594677|P3|Treatment Cycle 1|Lost to Follow-up|0
2486779|NCT02106351|8594678|P2|Treatment Cycle 1|Lost to Follow-up|0
2486780|NCT02106351|8594679|P1|Treatment Cycle 1|Lost to Follow-up|1
2486781|NCT02106351|8594677|P3|Treatment Cycle 1|Consent withdrawn|2
2486782|NCT02106351|8594678|P2|Treatment Cycle 1|Consent withdrawn|0
2486783|NCT02106351|8594679|P1|Treatment Cycle 1|Consent withdrawn|1
2486784|NCT02106351|8594677|P3|Treatment Cycle 1|Adverse Event|0
2486785|NCT02106351|8594678|P2|Treatment Cycle 1|Adverse Event|0
2486786|NCT02106351|8594679|P1|Treatment Cycle 1|Adverse Event|2
2486787|NCT02106325|8594722|P2|Phase 3|Lost to Follow-up|1
2486788|NCT02106325|8594723|P1|Phase 3|Lost to Follow-up|2
2486789|NCT02106325|8594722|P2|Phase 2|Lost to Follow-up|3
2486790|NCT02106325|8594723|P1|Phase 2|Lost to Follow-up|2
2486791|NCT02106325|8594722|P2|Phase 1|Lost to Follow-up|2
2486792|NCT02106325|8594723|P1|Phase 1|Lost to Follow-up|2
2486793|NCT02106156|8594748|P3|Overall Study|Relocation/Change of Physician|0
2486794|NCT02106156|8594749|P2|Overall Study|Relocation/Change of Physician|1
2486795|NCT02106156|8594750|P1|Overall Study|Relocation/Change of Physician|40
2486796|NCT02106156|8594748|P3|Overall Study|Hospitalization/Surgical Intervention|0
2486797|NCT02106156|8594749|P2|Overall Study|Hospitalization/Surgical Intervention|0
2486798|NCT02106156|8594750|P1|Overall Study|Hospitalization/Surgical Intervention|6
2486799|NCT02106156|8594748|P3|Overall Study|Change of Laboratory Parameter|0
2486800|NCT02106156|8594749|P2|Overall Study|Change of Laboratory Parameter|0
2486801|NCT02106156|8594750|P1|Overall Study|Change of Laboratory Parameter|10
2486802|NCT02106156|8594748|P3|Overall Study|Unplanned Event|0
2486803|NCT02106156|8594749|P2|Overall Study|Unplanned Event|2
2486804|NCT02106156|8594750|P1|Overall Study|Unplanned Event|82
2486805|NCT02106156|8594748|P3|Overall Study|Lost to Follow-up|0
2486806|NCT02106156|8594749|P2|Overall Study|Lost to Follow-up|8
2486807|NCT02106156|8594750|P1|Overall Study|Lost to Follow-up|451
2486808|NCT02106156|8594748|P3|Overall Study|Patients Request|0
2486809|NCT02106156|8594749|P2|Overall Study|Patients Request|9
2486810|NCT02106156|8594750|P1|Overall Study|Patients Request|307
2486811|NCT02106156|8594748|P3|Overall Study|Lack of Compliance|0
2486812|NCT02106156|8594749|P2|Overall Study|Lack of Compliance|7
2486813|NCT02106156|8594750|P1|Overall Study|Lack of Compliance|211
2486814|NCT02106156|8594748|P3|Overall Study|Concomitant Disease|0
2486815|NCT02106156|8594749|P2|Overall Study|Concomitant Disease|2
2486816|NCT02106156|8594750|P1|Overall Study|Concomitant Disease|74
2486817|NCT02106156|8594748|P3|Overall Study|Lack of Virological Response|0
2486818|NCT02106156|8594749|P2|Overall Study|Lack of Virological Response|8
2486819|NCT02106156|8594750|P1|Overall Study|Lack of Virological Response|1044
2486820|NCT02106156|8594748|P3|Overall Study|Lack of Tolerability|0
2486821|NCT02106156|8594749|P2|Overall Study|Lack of Tolerability|3
2486822|NCT02106156|8594750|P1|Overall Study|Lack of Tolerability|305
2486823|NCT02106156|8594748|P3|Overall Study|Patient Died|0
2486824|NCT02106156|8594749|P2|Overall Study|Patient Died|0
2486825|NCT02106156|8594750|P1|Overall Study|Patient Died|19
2486826|NCT02105987|8594774|P6|Continuation Phase|Protocol Violation|0
2486827|NCT02105987|8594775|P5|Continuation Phase|Protocol Violation|1
2486828|NCT02105987|8594776|P4|Continuation Phase|Protocol Violation|0
2486829|NCT02105987|8594777|P3|Continuation Phase|Protocol Violation|0
2486830|NCT02105987|8594778|P2|Continuation Phase|Protocol Violation|0
2486831|NCT02105987|8594779|P1|Continuation Phase|Protocol Violation|0
2486832|NCT02105987|8594774|P6|Late Switch Phase (24 Weeks)|Per sponsor request|0
2486833|NCT02105987|8594775|P5|Late Switch Phase (24 Weeks)|Per sponsor request|0
2486834|NCT02105987|8594776|P4|Late Switch Phase (24 Weeks)|Per sponsor request|0
2486835|NCT02105987|8594777|P3|Late Switch Phase (24 Weeks)|Per sponsor request|1
2486836|NCT02105987|8594778|P2|Late Switch Phase (24 Weeks)|Per sponsor request|0
2486837|NCT02105987|8594779|P1|Late Switch Phase (24 Weeks)|Per sponsor request|0
2486838|NCT02105987|8594774|P6|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
2486839|NCT02105987|8594775|P5|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
2486840|NCT02105987|8594776|P4|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1
2486841|NCT02105987|8594777|P3|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
2486842|NCT02105987|8594778|P2|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
2486843|NCT02105987|8594779|P1|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
2486844|NCT02105987|8594774|P6|Late Switch Phase (24 Weeks)|Physician Decision|0
2486845|NCT02105987|8594775|P5|Late Switch Phase (24 Weeks)|Physician Decision|0
2486846|NCT02105987|8594776|P4|Late Switch Phase (24 Weeks)|Physician Decision|0
2486847|NCT02105987|8594777|P3|Late Switch Phase (24 Weeks)|Physician Decision|5
2486848|NCT02105987|8594778|P2|Late Switch Phase (24 Weeks)|Physician Decision|0
2486849|NCT02105987|8594779|P1|Late Switch Phase (24 Weeks)|Physician Decision|0
2486850|NCT02105987|8594774|P6|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
2486851|NCT02105987|8594775|P5|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
2486852|NCT02105987|8594776|P4|Late Switch Phase (24 Weeks)|Lost to Follow-up|3
2486853|NCT02105987|8594777|P3|Late Switch Phase (24 Weeks)|Lost to Follow-up|8
2486854|NCT02105987|8594778|P2|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
2486855|NCT02105987|8594779|P1|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
2486856|NCT02105987|8594774|P6|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
2486857|NCT02105987|8594775|P5|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
2486858|NCT02105987|8594776|P4|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5
2486859|NCT02105987|8594777|P3|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6
2486860|NCT02105987|8594778|P2|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
2486861|NCT02105987|8594779|P1|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
2486862|NCT02105987|8594774|P6|Late Switch Phase (24 Weeks)|Protocol Violation|0
2486863|NCT02105987|8594775|P5|Late Switch Phase (24 Weeks)|Protocol Violation|0
2486864|NCT02105987|8594776|P4|Late Switch Phase (24 Weeks)|Protocol Violation|1
2486865|NCT02105987|8594777|P3|Late Switch Phase (24 Weeks)|Protocol Violation|15
2486866|NCT02105987|8594778|P2|Late Switch Phase (24 Weeks)|Protocol Violation|0
2486867|NCT02105987|8594779|P1|Late Switch Phase (24 Weeks)|Protocol Violation|0
2486868|NCT02105987|8594774|P6|Late Switch Phase (24 Weeks)|Adverse Event|0
2486869|NCT02105987|8594775|P5|Late Switch Phase (24 Weeks)|Adverse Event|0
2486870|NCT02105987|8594776|P4|Late Switch Phase (24 Weeks)|Adverse Event|4
2486871|NCT02105987|8594777|P3|Late Switch Phase (24 Weeks)|Adverse Event|10
2486872|NCT02105987|8594778|P2|Late Switch Phase (24 Weeks)|Adverse Event|0
2486873|NCT02105987|8594779|P1|Late Switch Phase (24 Weeks)|Adverse Event|0
2486874|NCT02105987|8594774|P6|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
2486875|NCT02105987|8594775|P5|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
2486876|NCT02105987|8594776|P4|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
2486877|NCT02105987|8594777|P3|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
2486878|NCT02105987|8594778|P2|Early Switch Phase (24 Weeks)|Missing Disposition Data|1
2486879|NCT02105987|8594779|P1|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
2486880|NCT02105987|8594774|P6|Early Switch Phase (24 Weeks)|Physician Decision|0
2486881|NCT02105987|8594775|P5|Early Switch Phase (24 Weeks)|Physician Decision|0
2486882|NCT02105987|8594776|P4|Early Switch Phase (24 Weeks)|Physician Decision|0
2486883|NCT02105987|8594777|P3|Early Switch Phase (24 Weeks)|Physician Decision|0
2486884|NCT02105987|8594778|P2|Early Switch Phase (24 Weeks)|Physician Decision|3
2486885|NCT02105987|8594779|P1|Early Switch Phase (24 Weeks)|Physician Decision|4
2486886|NCT02105987|8594774|P6|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
2486887|NCT02105987|8594775|P5|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
2486888|NCT02105987|8594776|P4|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
2486889|NCT02105987|8594777|P3|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
2486890|NCT02105987|8594778|P2|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
2486891|NCT02105987|8594779|P1|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
2486892|NCT02105987|8594774|P6|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
2486893|NCT02105987|8594775|P5|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
2486894|NCT02105987|8594776|P4|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
2486895|NCT02105987|8594777|P3|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
2486896|NCT02105987|8594778|P2|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10
2486897|NCT02105987|8594779|P1|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4
2486898|NCT02105987|8594774|P6|Early Switch Phase (24 Weeks)|Protocol Violation|0
2486899|NCT02105987|8594775|P5|Early Switch Phase (24 Weeks)|Protocol Violation|0
2486900|NCT02105987|8594776|P4|Early Switch Phase (24 Weeks)|Protocol Violation|0
2486901|NCT02105987|8594777|P3|Early Switch Phase (24 Weeks)|Protocol Violation|0
2486902|NCT02105987|8594778|P2|Early Switch Phase (24 Weeks)|Protocol Violation|17
2486903|NCT02105987|8594779|P1|Early Switch Phase (24 Weeks)|Protocol Violation|15
2486904|NCT02105987|8594774|P6|Early Switch Phase (24 Weeks)|Adverse Event|0
2486905|NCT02105987|8594775|P5|Early Switch Phase (24 Weeks)|Adverse Event|0
2486906|NCT02105987|8594776|P4|Early Switch Phase (24 Weeks)|Adverse Event|0
2486907|NCT02105987|8594777|P3|Early Switch Phase (24 Weeks)|Adverse Event|0
2486908|NCT02105987|8594778|P2|Early Switch Phase (24 Weeks)|Adverse Event|0
2486909|NCT02105987|8594779|P1|Early Switch Phase (24 Weeks)|Adverse Event|10
2486910|NCT02105974|8594833|P3|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18
2486911|NCT02105974|8594834|P2|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12
2486912|NCT02105974|8594835|P1|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0
2486913|NCT02105974|8594833|P3|12 Week (Wk) Treatment Period (TP)|Physician Decision|4
2486914|NCT02105974|8594834|P2|12 Week (Wk) Treatment Period (TP)|Physician Decision|7
2486915|NCT02105974|8594835|P1|12 Week (Wk) Treatment Period (TP)|Physician Decision|0
2486916|NCT02105974|8594833|P3|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1
2486917|NCT02105974|8594834|P2|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
2486918|NCT02105974|8594835|P1|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
2486919|NCT02105974|8594833|P3|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2
2486920|NCT02105974|8594834|P2|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1
2486921|NCT02105974|8594835|P1|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0
2486922|NCT02105974|8594833|P3|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6
2486923|NCT02105974|8594834|P2|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2
2486924|NCT02105974|8594835|P1|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0
2486925|NCT02105974|8594833|P3|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9
2486926|NCT02105974|8594834|P2|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6
2486927|NCT02105974|8594835|P1|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0
2486928|NCT02105974|8594833|P3|12 Week (Wk) Treatment Period (TP)|Adverse Event|18
2486929|NCT02105974|8594834|P2|12 Week (Wk) Treatment Period (TP)|Adverse Event|14
2486930|NCT02105974|8594835|P1|12 Week (Wk) Treatment Period (TP)|Adverse Event|0
2486931|NCT02105974|8594833|P3|2 Week Run-in Period|Investigator discretion|0
2486932|NCT02105974|8594834|P2|2 Week Run-in Period|Investigator discretion|0
2486933|NCT02105974|8594835|P1|2 Week Run-in Period|Investigator discretion|8
2486934|NCT02105974|8594833|P3|2 Week Run-in Period|Withdrew consent|0
2486935|NCT02105974|8594834|P2|2 Week Run-in Period|Withdrew consent|0
2486936|NCT02105974|8594835|P1|2 Week Run-in Period|Withdrew consent|23
2486937|NCT02105974|8594833|P3|2 Week Run-in Period|Lost to Follow-up|0
2486938|NCT02105974|8594834|P2|2 Week Run-in Period|Lost to Follow-up|0
2486939|NCT02105974|8594835|P1|2 Week Run-in Period|Lost to Follow-up|2
2486940|NCT02105974|8594833|P3|2 Week Run-in Period|Study closed/terminated|0
2486941|NCT02105974|8594834|P2|2 Week Run-in Period|Study closed/terminated|0
2486942|NCT02105974|8594835|P1|2 Week Run-in Period|Study closed/terminated|1
2486943|NCT02105974|8594833|P3|2 Week Run-in Period|Adverse Event|0
2486944|NCT02105974|8594834|P2|2 Week Run-in Period|Adverse Event|0
2486945|NCT02105974|8594835|P1|2 Week Run-in Period|Adverse Event|6
2486946|NCT02105974|8594833|P3|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
2486947|NCT02105974|8594834|P2|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
2486948|NCT02105974|8594835|P1|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603
2486949|NCT02105974|8594833|P3|2 Week Run-in Period|Withdrew during pre-screen period|0
2486950|NCT02105974|8594834|P2|2 Week Run-in Period|Withdrew during pre-screen period|0
2486951|NCT02105974|8594835|P1|2 Week Run-in Period|Withdrew during pre-screen period|158
2486952|NCT02105961|8594848|P3|Overall Study|Withdrawal by Subject|11
2486953|NCT02105961|8594849|P2|Overall Study|Withdrawal by Subject|7
2486954|NCT02105961|8594850|P1|Overall Study|Withdrawal by Subject|15
2486955|NCT02105961|8594848|P3|Overall Study|Physician Decision|2
2486956|NCT02105961|8594849|P2|Overall Study|Physician Decision|3
2486957|NCT02105961|8594850|P1|Overall Study|Physician Decision|3
2486958|NCT02105961|8594848|P3|Overall Study|Lost to Follow-up|1
2486959|NCT02105961|8594849|P2|Overall Study|Lost to Follow-up|0
2486960|NCT02105961|8594850|P1|Overall Study|Lost to Follow-up|2
2486961|NCT02105961|8594848|P3|Overall Study|Lack of Efficacy|3
2486962|NCT02105961|8594849|P2|Overall Study|Lack of Efficacy|0
2486963|NCT02105961|8594850|P1|Overall Study|Lack of Efficacy|3
2486964|NCT02105961|8594848|P3|Overall Study|Adverse Event|13
2486965|NCT02105961|8594849|P2|Overall Study|Adverse Event|7
2486966|NCT02105961|8594850|P1|Overall Study|Adverse Event|18
2486967|NCT02105948|8594874|P4|Overall Study|Withdrawal by Subject|11
2486968|NCT02105948|8594875|P3|Overall Study|Withdrawal by Subject|10
2486969|NCT02105948|8594876|P2|Overall Study|Withdrawal by Subject|10
2486970|NCT02105948|8594877|P1|Overall Study|Withdrawal by Subject|15
2486971|NCT02105948|8594874|P4|Overall Study|Physician Decision|2
2486972|NCT02105948|8594875|P3|Overall Study|Physician Decision|2
2486973|NCT02105948|8594876|P2|Overall Study|Physician Decision|2
2486974|NCT02105948|8594877|P1|Overall Study|Physician Decision|2
2486975|NCT02105948|8594874|P4|Overall Study|Lost to Follow-up|1
2486976|NCT02105948|8594875|P3|Overall Study|Lost to Follow-up|2
2486977|NCT02105948|8594876|P2|Overall Study|Lost to Follow-up|0
2486978|NCT02105948|8594877|P1|Overall Study|Lost to Follow-up|0
2486979|NCT02105948|8594874|P4|Overall Study|Lack of Efficacy|2
2486980|NCT02105948|8594875|P3|Overall Study|Lack of Efficacy|3
2486981|NCT02105948|8594876|P2|Overall Study|Lack of Efficacy|1
2486982|NCT02105948|8594877|P1|Overall Study|Lack of Efficacy|0
2486983|NCT02105948|8594874|P4|Overall Study|Adverse Event|11
2486984|NCT02105948|8594875|P3|Overall Study|Adverse Event|11
2486985|NCT02105948|8594876|P2|Overall Study|Adverse Event|7
2486986|NCT02105948|8594877|P1|Overall Study|Adverse Event|10
2486987|NCT02105701|8594918|P4|Overall Study|Death|0
2486988|NCT02105701|8594919|P3|Overall Study|Death|0
2486989|NCT02105701|8594920|P2|Overall Study|Death|0
2486990|NCT02105701|8594921|P1|Overall Study|Death|1
2486991|NCT02105701|8594918|P4|Overall Study|Withdrawal by Subject|1
2486992|NCT02105701|8594919|P3|Overall Study|Withdrawal by Subject|0
2486993|NCT02105701|8594920|P2|Overall Study|Withdrawal by Subject|1
2486994|NCT02105701|8594921|P1|Overall Study|Withdrawal by Subject|2
2486995|NCT02105701|8594918|P4|Overall Study|Protocol Violation|0
2486996|NCT02105701|8594919|P3|Overall Study|Protocol Violation|1
2486997|NCT02105701|8594920|P2|Overall Study|Protocol Violation|0
2486998|NCT02105701|8594921|P1|Overall Study|Protocol Violation|0
2486999|NCT02105701|8594918|P4|Overall Study|Lost to Follow-up|1
2487000|NCT02105701|8594919|P3|Overall Study|Lost to Follow-up|2
2487001|NCT02105701|8594920|P2|Overall Study|Lost to Follow-up|0
2487002|NCT02105701|8594921|P1|Overall Study|Lost to Follow-up|1
2487003|NCT02105688|8594945|P2|Part B: Observational Follow-up|Physician Decision|1
2487004|NCT02105688|8594946|P1|Part B: Observational Follow-up|Physician Decision|3
2487005|NCT02105688|8594945|P2|Part B: Observational Follow-up|Withdrawal by Subject|3
2487006|NCT02105688|8594946|P1|Part B: Observational Follow-up|Withdrawal by Subject|9
2487007|NCT02105688|8594945|P2|Part B: Observational Follow-up|Lost to Follow-up|15
2487008|NCT02105688|8594946|P1|Part B: Observational Follow-up|Lost to Follow-up|23
2487009|NCT02105688|8594945|P2|Part B: Observational Follow-up|Death|1
2487010|NCT02105688|8594946|P1|Part B: Observational Follow-up|Death|2
2487011|NCT02105688|8594945|P2|Part A: Double-Blind|Withdrawal by Subject|2
2487012|NCT02105688|8594946|P1|Part A: Double-Blind|Withdrawal by Subject|4
2487013|NCT02105688|8594945|P2|Part A: Double-Blind|Status Unknown|2
2487014|NCT02105688|8594946|P1|Part A: Double-Blind|Status Unknown|0
2487015|NCT02105688|8594945|P2|Part A: Double-Blind|Physician Decision|1
2487016|NCT02105688|8594946|P1|Part A: Double-Blind|Physician Decision|0
2487017|NCT02105688|8594945|P2|Part A: Double-Blind|Lost to Follow-up|11
2487018|NCT02105688|8594946|P1|Part A: Double-Blind|Lost to Follow-up|15
2487019|NCT02105688|8594945|P2|Part A: Double-Blind|Death|1
2487020|NCT02105688|8594946|P1|Part A: Double-Blind|Death|0
2487021|NCT02105688|8594945|P2|Part A: Double-Blind|Adverse Event|0
2487022|NCT02105688|8594946|P1|Part A: Double-Blind|Adverse Event|1
2487023|NCT02105662|8594959|P1|Overall Study|Withdrawal by Subject|1
2487024|NCT02105662|8594959|P1|Overall Study|Lost to Follow-up|5
2487025|NCT02105636|8594968|P2|Overall Study|Not Reported|0
2487026|NCT02105636|8594969|P1|Overall Study|Not Reported|3
2487027|NCT02105636|8594968|P2|Overall Study|Reason Not Specified|2
2487028|NCT02105636|8594969|P1|Overall Study|Reason Not Specified|0
2487029|NCT02105636|8594968|P2|Overall Study|Poor/Non-compliance|1
2487030|NCT02105636|8594969|P1|Overall Study|Poor/Non-compliance|0
2487031|NCT02105636|8594968|P2|Overall Study|Maximum Clinical Benefit|1
2487032|NCT02105636|8594969|P1|Overall Study|Maximum Clinical Benefit|1
2487033|NCT02105636|8594968|P2|Overall Study|Subject Withdrew Consent|1
2487034|NCT02105636|8594969|P1|Overall Study|Subject Withdrew Consent|4
2487035|NCT02105636|8594968|P2|Overall Study|Subject Request to Discontinue Treatment|6
2487036|NCT02105636|8594969|P1|Overall Study|Subject Request to Discontinue Treatment|4
2487037|NCT02105636|8594968|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
2487038|NCT02105636|8594969|P1|Overall Study|Adverse Event Unrelated to Study Drug|12
2487039|NCT02105636|8594968|P2|Overall Study|Study Drug Toxicity|11
2487040|NCT02105636|8594969|P1|Overall Study|Study Drug Toxicity|9
2487041|NCT02105636|8594968|P2|Overall Study|Disease Progression|83
2487042|NCT02105636|8594969|P1|Overall Study|Disease Progression|162
2487043|NCT02105467|8595012|P2|Period 3|Lost to Follow-up|1
2487044|NCT02105467|8595013|P1|Period 3|Lost to Follow-up|0
2487045|NCT02105467|8595012|P2|Period 2|Withdrawal by Subject|2
2487046|NCT02105467|8595013|P1|Period 2|Withdrawal by Subject|0
2487047|NCT02105467|8595012|P2|Period 2|Death|0
2487048|NCT02105467|8595013|P1|Period 2|Death|1
2487049|NCT02105467|8595012|P2|Period 2|Lost to Follow-up|0
2487050|NCT02105467|8595013|P1|Period 2|Lost to Follow-up|1
2487051|NCT02105467|8595012|P2|Period 1|Death|0
2487052|NCT02105467|8595013|P1|Period 1|Death|1
2487053|NCT02105467|8595012|P2|Period 1|Lost to Follow-up|0
2487054|NCT02105467|8595013|P1|Period 1|Lost to Follow-up|1
2487055|NCT02105454|8595025|P1|Overall Study|Withdrawal by Subject|1
2487056|NCT02105285|8595137|P3|Overall Study|Withdrawal by Subject|0
2487057|NCT02105285|8595138|P2|Overall Study|Withdrawal by Subject|0
2487058|NCT02105285|8595139|P1|Overall Study|Withdrawal by Subject|1
2487059|NCT02105285|8595137|P3|Overall Study|Protocol Violation|0
2487060|NCT02105285|8595138|P2|Overall Study|Protocol Violation|1
2487061|NCT02105285|8595139|P1|Overall Study|Protocol Violation|0
2487062|NCT02105285|8595137|P3|Overall Study|Adverse Event|0
2487063|NCT02105285|8595138|P2|Overall Study|Adverse Event|1
2487064|NCT02105285|8595139|P1|Overall Study|Adverse Event|1
2487065|NCT02105272|8595158|P2|Overall Study|Withdrawal by Subject|0
2487066|NCT02105272|8595159|P1|Overall Study|Withdrawal by Subject|2
2487067|NCT02105272|8595158|P2|Overall Study|Protocol Violation|0
2487068|NCT02105272|8595159|P1|Overall Study|Protocol Violation|2
2487069|NCT02105272|8595158|P2|Overall Study|Physician Decision|1
2487070|NCT02105272|8595159|P1|Overall Study|Physician Decision|0
2487071|NCT02105272|8595158|P2|Overall Study|Adverse Event|2
2487072|NCT02105272|8595159|P1|Overall Study|Adverse Event|1
2487073|NCT02105116|8595188|P1|Overall Study|Death|1
2487074|NCT02105116|8595188|P1|Overall Study|not eligible for step 2 of trial|5
2487075|NCT02105012|8595195|P1|Overall Study|Lack of Efficacy|1
2487076|NCT02105012|8595195|P1|Overall Study|Adverse Event|1
2487077|NCT02105012|8595195|P1|Overall Study|Physician Decision|3
2487078|NCT02105012|8595195|P1|Overall Study|Protocol Violation|4
2487079|NCT02105012|8595195|P1|Overall Study|Lost to Follow-up|4
2487080|NCT02105012|8595195|P1|Overall Study|Protocol Specified Criteria|9
2487081|NCT02105012|8595195|P1|Overall Study|Withdrawal by Subject|11
2487082|NCT02104947|8595229|P2|Overall Study|Other than stated above|3
2487083|NCT02104947|8595230|P1|Overall Study|Other than stated above|2
2487084|NCT02104947|8595229|P2|Overall Study|Adverse Event|38
2487085|NCT02104947|8595230|P1|Overall Study|Adverse Event|57
2487086|NCT02104947|8595229|P2|Overall Study|Protocol Violation|8
2487087|NCT02104947|8595230|P1|Overall Study|Protocol Violation|6
2487088|NCT02104947|8595229|P2|Overall Study|Lost to Follow-up|4
2487089|NCT02104947|8595230|P1|Overall Study|Lost to Follow-up|4
2487090|NCT02104947|8595229|P2|Overall Study|Withdrawal by Subject|3
2487091|NCT02104947|8595230|P1|Overall Study|Withdrawal by Subject|10
2487092|NCT02104895|8595248|P2|Overall Study|Withdrawal by Subject|14
2487093|NCT02104895|8595249|P1|Overall Study|Withdrawal by Subject|0
2487094|NCT02104804|8595289|P2|Overall Study|Withdrawal by Subject|12
2487095|NCT02104804|8595290|P1|Overall Study|Withdrawal by Subject|4
2487096|NCT02104804|8595289|P2|Overall Study|Adverse Event|3
2487097|NCT02104804|8595290|P1|Overall Study|Adverse Event|4
2487098|NCT02104804|8595289|P2|Overall Study|Protocol Violation|1
2487099|NCT02104804|8595290|P1|Overall Study|Protocol Violation|0
2487100|NCT02104804|8595289|P2|Overall Study|Other listed|1
2487101|NCT02104804|8595290|P1|Overall Study|Other listed|2
2487102|NCT02104804|8595289|P2|Overall Study|Study specific discontinuation criteria|1
2487103|NCT02104804|8595290|P1|Overall Study|Study specific discontinuation criteria|6
2487104|NCT02104804|8595289|P2|Overall Study|Did not take study medication|1
2487105|NCT02104804|8595290|P1|Overall Study|Did not take study medication|0
2487106|NCT02104765|8595313|P7|Overall Study|Withdrawal by Subject|1
2487107|NCT02104765|8595314|P6|Overall Study|Withdrawal by Subject|0
2487108|NCT02104765|8595315|P5|Overall Study|Withdrawal by Subject|1
2487109|NCT02104765|8595316|P4|Overall Study|Withdrawal by Subject|1
2487110|NCT02104765|8595317|P3|Overall Study|Withdrawal by Subject|0
2487111|NCT02104765|8595318|P2|Overall Study|Withdrawal by Subject|0
2487112|NCT02104765|8595319|P1|Overall Study|Withdrawal by Subject|0
2487113|NCT02104765|8595313|P7|Overall Study|Lost to Follow-up|0
2487114|NCT02104765|8595314|P6|Overall Study|Lost to Follow-up|0
2487115|NCT02104765|8595315|P5|Overall Study|Lost to Follow-up|0
2487116|NCT02104765|8595316|P4|Overall Study|Lost to Follow-up|0
2487117|NCT02104765|8595317|P3|Overall Study|Lost to Follow-up|1
2487118|NCT02104765|8595318|P2|Overall Study|Lost to Follow-up|0
2487119|NCT02104765|8595319|P1|Overall Study|Lost to Follow-up|0
2487120|NCT02104752|8595347|P2|Overall Study|Weight gain; unrelated anxiety|2
2487121|NCT02104752|8595348|P1|Overall Study|Weight gain; unrelated anxiety|0
2487122|NCT02104752|8595347|P2|Overall Study|Withdrawal by Subject|0
2487123|NCT02104752|8595348|P1|Overall Study|Withdrawal by Subject|1
2487124|NCT02104583|8595431|P5|Overall Study|Randomized but Never Treated|0
2487125|NCT02104583|8595432|P4|Overall Study|Randomized but Never Treated|1
2487126|NCT02104583|8595433|P3|Overall Study|Randomized but Never Treated|0
2487127|NCT02104583|8595434|P2|Overall Study|Randomized but Never Treated|0
2487128|NCT02104583|8595435|P1|Overall Study|Randomized but Never Treated|0
2487129|NCT02104583|8595431|P5|Overall Study|Lost to Follow-up|0
2487130|NCT02104583|8595432|P4|Overall Study|Lost to Follow-up|0
2487131|NCT02104583|8595433|P3|Overall Study|Lost to Follow-up|0
2487132|NCT02104583|8595434|P2|Overall Study|Lost to Follow-up|0
2487133|NCT02104583|8595435|P1|Overall Study|Lost to Follow-up|1
2487134|NCT02104583|8595431|P5|Overall Study|Adverse Event|1
2487135|NCT02104583|8595432|P4|Overall Study|Adverse Event|6
2487136|NCT02104583|8595433|P3|Overall Study|Adverse Event|6
2487137|NCT02104583|8595434|P2|Overall Study|Adverse Event|3
2487138|NCT02104583|8595435|P1|Overall Study|Adverse Event|3
2487139|NCT02104583|8595431|P5|Overall Study|Protocol Violation|0
2487140|NCT02104583|8595432|P4|Overall Study|Protocol Violation|0
2487141|NCT02104583|8595433|P3|Overall Study|Protocol Violation|1
2487142|NCT02104583|8595434|P2|Overall Study|Protocol Violation|0
2487143|NCT02104583|8595435|P1|Overall Study|Protocol Violation|0
2487144|NCT02104583|8595431|P5|Overall Study|Investigator's Discretion|0
2487145|NCT02104583|8595432|P4|Overall Study|Investigator's Discretion|0
2487146|NCT02104583|8595433|P3|Overall Study|Investigator's Discretion|0
2487147|NCT02104583|8595434|P2|Overall Study|Investigator's Discretion|0
2487148|NCT02104583|8595435|P1|Overall Study|Investigator's Discretion|1
2487149|NCT02104583|8595431|P5|Overall Study|Withdrew Consent|1
2487150|NCT02104583|8595432|P4|Overall Study|Withdrew Consent|2
2487151|NCT02104583|8595433|P3|Overall Study|Withdrew Consent|0
2487152|NCT02104583|8595434|P2|Overall Study|Withdrew Consent|2
2487153|NCT02104583|8595435|P1|Overall Study|Withdrew Consent|3
2487154|NCT02104583|8595431|P5|Overall Study|Subject required prohibited medication|1
2487155|NCT02104583|8595432|P4|Overall Study|Subject required prohibited medication|0
2487156|NCT02104583|8595433|P3|Overall Study|Subject required prohibited medication|1
2487157|NCT02104583|8595434|P2|Overall Study|Subject required prohibited medication|1
2487158|NCT02104583|8595435|P1|Overall Study|Subject required prohibited medication|0
2487159|NCT02104583|8595431|P5|Overall Study|Subject required cardiac ablation|4
2487160|NCT02104583|8595432|P4|Overall Study|Subject required cardiac ablation|5
2487161|NCT02104583|8595433|P3|Overall Study|Subject required cardiac ablation|4
2487162|NCT02104583|8595434|P2|Overall Study|Subject required cardiac ablation|4
2487163|NCT02104583|8595435|P1|Overall Study|Subject required cardiac ablation|6
2487164|NCT02104583|8595431|P5|Overall Study|Death|5
2487165|NCT02104583|8595432|P4|Overall Study|Death|3
2487166|NCT02104583|8595433|P3|Overall Study|Death|3
2487167|NCT02104583|8595434|P2|Overall Study|Death|1
2487168|NCT02104583|8595435|P1|Overall Study|Death|2
2487169|NCT02104583|8595431|P5|Overall Study|New ICD or CRT-D implanted|0
2487170|NCT02104583|8595432|P4|Overall Study|New ICD or CRT-D implanted|0
2487171|NCT02104583|8595433|P3|Overall Study|New ICD or CRT-D implanted|1
2487172|NCT02104583|8595434|P2|Overall Study|New ICD or CRT-D implanted|0
2487173|NCT02104583|8595435|P1|Overall Study|New ICD or CRT-D implanted|2
2487174|NCT02104505|8595498|P2|Second Intervention (14 Days)|Adverse Event|0
2487175|NCT02104505|8595499|P1|Second Intervention (14 Days)|Adverse Event|2
2487176|NCT02104505|8595498|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
2487177|NCT02104505|8595499|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
2487178|NCT02104505|8595498|P2|First Intervention (14 Days)|exclusionary condition|1
2487179|NCT02104505|8595499|P1|First Intervention (14 Days)|exclusionary condition|0
2487180|NCT02104505|8595498|P2|First Intervention (14 Days)|Lost to Follow-up|1
2487181|NCT02104505|8595499|P1|First Intervention (14 Days)|Lost to Follow-up|0
2487182|NCT02104505|8595498|P2|First Intervention (14 Days)|Withdrawal by Subject|1
2487183|NCT02104505|8595499|P1|First Intervention (14 Days)|Withdrawal by Subject|0
2487184|NCT02104505|8595498|P2|First Intervention (14 Days)|Adverse Event|0
2487185|NCT02104505|8595499|P1|First Intervention (14 Days)|Adverse Event|2
2487186|NCT02104180|8595571|P2|Overall Study|Protocol Violation|0
2487187|NCT02104180|8595572|P1|Overall Study|Protocol Violation|1
2487188|NCT02103439|8595602|P2|Overall Study|Withdrawal by Subject|1
2487189|NCT02103439|8595603|P1|Overall Study|Withdrawal by Subject|3
2487190|NCT02103439|8595602|P2|Overall Study|Adverse Event|2
2487191|NCT02103439|8595603|P1|Overall Study|Adverse Event|0
2487192|NCT02103062|8595762|P2|Overall Study|Death|1
2487193|NCT02103062|8595763|P1|Overall Study|Death|0
2487194|NCT02103062|8595762|P2|Overall Study|Progressive Disease|20
2487195|NCT02103062|8595763|P1|Overall Study|Progressive Disease|17
2487196|NCT02103062|8595762|P2|Overall Study|Adverse Event|2
2487197|NCT02103062|8595763|P1|Overall Study|Adverse Event|1
2487198|NCT02102724|8595856|P2|Overall Study|surgery for brain aneurysm|1
2487199|NCT02102724|8595857|P1|Overall Study|surgery for brain aneurysm|1
2487200|NCT02102724|8595856|P2|Overall Study|Lost to Follow-up|0
2487201|NCT02102724|8595857|P1|Overall Study|Lost to Follow-up|1
2487202|NCT02102490|8595863|P1|Overall Study|Lost to Follow-up|1
2487203|NCT02102490|8595863|P1|Overall Study|Death|6
2487204|NCT02102464|8595877|P3|Randomized Study|Withdrawal by Subject|0
2487205|NCT02102464|8595878|P2|Randomized Study|Withdrawal by Subject|1
2487206|NCT02102464|8595879|P1|Randomized Study|Withdrawal by Subject|0
2487207|NCT02102399|8595898|P2|Overall Study|Withdrawal by Subject|4
2487208|NCT02102399|8595899|P1|Overall Study|Withdrawal by Subject|6
2487209|NCT02102204|8595969|P1|Overall Study|Ongoing|5
2487210|NCT02102204|8595969|P1|Overall Study|Sponsor Decision|5
2487211|NCT02102204|8595969|P1|Overall Study|Lost to Follow-up|65
2487212|NCT02102204|8595969|P1|Overall Study|Death|92
2487213|NCT02102204|8595969|P1|Overall Study|Withdrawal by Subject|137
2487214|NCT02101983|8595989|P2|Overall Study|Physician Decision|0
2487215|NCT02101983|8595990|P1|Overall Study|Physician Decision|1
2487216|NCT02101359|8596086|P2|Overall Study|Protocol Violation|2
2487217|NCT02101359|8596087|P1|Overall Study|Protocol Violation|0
2487218|NCT02101359|8596086|P2|Overall Study|Lost to Follow-up|0
2487219|NCT02101359|8596087|P1|Overall Study|Lost to Follow-up|1
2487220|NCT02101359|8596086|P2|Overall Study|Withdrawal by Subject|4
2487221|NCT02101359|8596087|P1|Overall Study|Withdrawal by Subject|5
2487222|NCT02101359|8596086|P2|Overall Study|Not included|13
2487223|NCT02101359|8596087|P1|Overall Study|Not included|23
2487224|NCT02101294|8596093|P1|Overall Study|Lost to Follow-up|6
2487225|NCT02101294|8596093|P1|Overall Study|Withdrawal by Subject|5
2487226|NCT02101281|8596102|P2|Overall Study|Adverse Event|1
2487227|NCT02101281|8596103|P1|Overall Study|Adverse Event|0
2487228|NCT02101112|8596156|P6|Overall Study|Withdrawal by Subject|0
2487229|NCT02101112|8596157|P5|Overall Study|Withdrawal by Subject|1
2487230|NCT02101112|8596158|P4|Overall Study|Withdrawal by Subject|0
2487231|NCT02101112|8596159|P3|Overall Study|Withdrawal by Subject|0
2487232|NCT02101112|8596160|P2|Overall Study|Withdrawal by Subject|0
2487233|NCT02101112|8596161|P1|Overall Study|Withdrawal by Subject|0
2487234|NCT02101112|8596156|P6|Overall Study|Adverse Event|0
2487235|NCT02101112|8596157|P5|Overall Study|Adverse Event|0
2487236|NCT02101112|8596158|P4|Overall Study|Adverse Event|0
2487237|NCT02101112|8596159|P3|Overall Study|Adverse Event|1
2487238|NCT02101112|8596160|P2|Overall Study|Adverse Event|0
2487239|NCT02101112|8596161|P1|Overall Study|Adverse Event|0
2487240|NCT02101021|8596191|P5|Overall Study|Study Terminated by Sponsor|1
2487241|NCT02101021|8596192|P4|Overall Study|Study Terminated by Sponsor|1
2487242|NCT02101021|8596193|P3|Overall Study|Study Terminated by Sponsor|1
2487243|NCT02101021|8596194|P2|Overall Study|Study Terminated by Sponsor|0
2487244|NCT02101021|8596195|P1|Overall Study|Study Terminated by Sponsor|1
2487245|NCT02101021|8596191|P5|Overall Study|Lost to Follow-up|0
2487246|NCT02101021|8596192|P4|Overall Study|Lost to Follow-up|0
2487247|NCT02101021|8596193|P3|Overall Study|Lost to Follow-up|0
2487248|NCT02101021|8596194|P2|Overall Study|Lost to Follow-up|0
2487249|NCT02101021|8596195|P1|Overall Study|Lost to Follow-up|1
2487250|NCT02101021|8596191|P5|Overall Study|Withdrew Consent from study|0
2487251|NCT02101021|8596192|P4|Overall Study|Withdrew Consent from study|2
2487252|NCT02101021|8596193|P3|Overall Study|Withdrew Consent from study|0
2487253|NCT02101021|8596194|P2|Overall Study|Withdrew Consent from study|1
2487254|NCT02101021|8596195|P1|Overall Study|Withdrew Consent from study|1
2487255|NCT02101021|8596191|P5|Overall Study|Death|3
2487256|NCT02101021|8596192|P4|Overall Study|Death|0
2487257|NCT02101021|8596193|P3|Overall Study|Death|6
2487258|NCT02101021|8596194|P2|Overall Study|Death|3
2487259|NCT02101021|8596195|P1|Overall Study|Death|4
2487260|NCT02100969|8596242|P1|Overall Study|Did not pass screening phase|1
2487261|NCT02100839|8596261|P2|Multiple Ascending Dose|Withdrawal by Subject|0
2487262|NCT02100839|8596262|P1|Multiple Ascending Dose|Withdrawal by Subject|2
2487263|NCT02100839|8596261|P2|Multiple Ascending Dose|Adverse Event|0
2487264|NCT02100839|8596262|P1|Multiple Ascending Dose|Adverse Event|2
2487265|NCT02100813|8596293|P8|Overall Study|Adverse Event|1
2487266|NCT02100813|8596294|P7|Overall Study|Adverse Event|0
2487267|NCT02100813|8596295|P6|Overall Study|Adverse Event|0
2487268|NCT02100813|8596296|P5|Overall Study|Adverse Event|0
2487269|NCT02100813|8596297|P4|Overall Study|Adverse Event|0
2487270|NCT02100813|8596298|P3|Overall Study|Adverse Event|0
2487271|NCT02100813|8596299|P2|Overall Study|Adverse Event|0
2487272|NCT02100813|8596300|P1|Overall Study|Adverse Event|0
2487273|NCT02100670|8596328|P4|Overall Study|Withdrawal by Subject|0
2487274|NCT02100670|8596329|P3|Overall Study|Withdrawal by Subject|0
2487275|NCT02100670|8596330|P2|Overall Study|Withdrawal by Subject|0
2487276|NCT02100670|8596331|P1|Overall Study|Withdrawal by Subject|1
2487277|NCT02100670|8596328|P4|Overall Study|Physician Decision|0
2487278|NCT02100670|8596329|P3|Overall Study|Physician Decision|0
2487279|NCT02100670|8596330|P2|Overall Study|Physician Decision|1
2487280|NCT02100670|8596331|P1|Overall Study|Physician Decision|0
2487281|NCT02100670|8596328|P4|Overall Study|Poor Efficacy|0
2487282|NCT02100670|8596329|P3|Overall Study|Poor Efficacy|0
2487283|NCT02100670|8596330|P2|Overall Study|Poor Efficacy|1
2487284|NCT02100670|8596331|P1|Overall Study|Poor Efficacy|0
2487285|NCT02100670|8596328|P4|Overall Study|No swelling no pain|0
2487286|NCT02100670|8596329|P3|Overall Study|No swelling no pain|0
2487287|NCT02100670|8596330|P2|Overall Study|No swelling no pain|0
2487288|NCT02100670|8596331|P1|Overall Study|No swelling no pain|1
2487289|NCT02100670|8596328|P4|Overall Study|Withdrawal of Consent|0
2487290|NCT02100670|8596329|P3|Overall Study|Withdrawal of Consent|1
2487291|NCT02100670|8596330|P2|Overall Study|Withdrawal of Consent|1
2487292|NCT02100670|8596331|P1|Overall Study|Withdrawal of Consent|0
2487293|NCT02100670|8596328|P4|Overall Study|Protocol Violation|1
2487294|NCT02100670|8596329|P3|Overall Study|Protocol Violation|0
2487295|NCT02100670|8596330|P2|Overall Study|Protocol Violation|1
2487296|NCT02100670|8596331|P1|Overall Study|Protocol Violation|0
2487297|NCT02100670|8596328|P4|Overall Study|Lost to Follow-up|0
2487298|NCT02100670|8596329|P3|Overall Study|Lost to Follow-up|0
2487299|NCT02100670|8596330|P2|Overall Study|Lost to Follow-up|0
2487300|NCT02100670|8596331|P1|Overall Study|Lost to Follow-up|1
2487301|NCT02100670|8596328|P4|Overall Study|Adverse Event|0
2487302|NCT02100670|8596329|P3|Overall Study|Adverse Event|3
2487303|NCT02100670|8596330|P2|Overall Study|Adverse Event|3
2487304|NCT02100670|8596331|P1|Overall Study|Adverse Event|10
2487305|NCT02100644|8596391|P3|LTG Escalation Phase|Withdrawal by Subject|0
2487306|NCT02100644|8596392|P2|LTG Escalation Phase|Withdrawal by Subject|0
2487307|NCT02100644|8596393|P1|LTG Escalation Phase|Withdrawal by Subject|3
2487308|NCT02100644|8596391|P3|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
2487309|NCT02100644|8596392|P2|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
2487310|NCT02100644|8596393|P1|LTG Escalation Phase|Protocol-defined Stopping Criteria|1
2487311|NCT02100644|8596391|P3|LTG Escalation Phase|Adverse Event|0
2487312|NCT02100644|8596392|P2|LTG Escalation Phase|Adverse Event|0
2487313|NCT02100644|8596393|P1|LTG Escalation Phase|Adverse Event|9
2487314|NCT02100514|8596418|P5|Extension Period|Withdrew consent|0
2487315|NCT02100514|8596419|P4|Extension Period|Withdrew consent|0
2487316|NCT02100514|8596420|P3|Extension Period|Withdrew consent|2
2487317|NCT02100514|8596421|P2|Extension Period|Withdrew consent|0
2487318|NCT02100514|8596422|P1|Extension Period|Withdrew consent|0
2487319|NCT02100514|8596418|P5|Treatment Period|Other|0
2487320|NCT02100514|8596419|P4|Treatment Period|Other|0
2487321|NCT02100514|8596420|P3|Treatment Period|Other|0
2487322|NCT02100514|8596421|P2|Treatment Period|Other|11
2487323|NCT02100514|8596422|P1|Treatment Period|Other|9
2487324|NCT02100514|8596418|P5|Treatment Period|Withdrawal by Subject|0
2487325|NCT02100514|8596419|P4|Treatment Period|Withdrawal by Subject|0
2487326|NCT02100514|8596420|P3|Treatment Period|Withdrawal by Subject|0
2487327|NCT02100514|8596421|P2|Treatment Period|Withdrawal by Subject|37
2487328|NCT02100514|8596422|P1|Treatment Period|Withdrawal by Subject|12
2487329|NCT02100514|8596418|P5|Treatment Period|Protocol Violation|0
2487330|NCT02100514|8596419|P4|Treatment Period|Protocol Violation|0
2487331|NCT02100514|8596420|P3|Treatment Period|Protocol Violation|0
2487332|NCT02100514|8596421|P2|Treatment Period|Protocol Violation|1
2487333|NCT02100514|8596422|P1|Treatment Period|Protocol Violation|1
2487334|NCT02100514|8596418|P5|Treatment Period|Did Not Meet Entrance Criteria|0
2487335|NCT02100514|8596419|P4|Treatment Period|Did Not Meet Entrance Criteria|0
2487336|NCT02100514|8596420|P3|Treatment Period|Did Not Meet Entrance Criteria|0
2487337|NCT02100514|8596421|P2|Treatment Period|Did Not Meet Entrance Criteria|1
2487338|NCT02100514|8596422|P1|Treatment Period|Did Not Meet Entrance Criteria|0
2487339|NCT02100514|8596418|P5|Treatment Period|Lost to Follow-up|0
2487340|NCT02100514|8596419|P4|Treatment Period|Lost to Follow-up|0
2487341|NCT02100514|8596420|P3|Treatment Period|Lost to Follow-up|0
2487342|NCT02100514|8596421|P2|Treatment Period|Lost to Follow-up|17
2487343|NCT02100514|8596422|P1|Treatment Period|Lost to Follow-up|5
2487344|NCT02100514|8596418|P5|Treatment Period|Death|0
2487345|NCT02100514|8596419|P4|Treatment Period|Death|0
2487346|NCT02100514|8596420|P3|Treatment Period|Death|0
2487347|NCT02100514|8596421|P2|Treatment Period|Death|2
2487348|NCT02100514|8596422|P1|Treatment Period|Death|2
2487349|NCT02100514|8596418|P5|Treatment Period|Adverse Event|0
2487350|NCT02100514|8596419|P4|Treatment Period|Adverse Event|0
2487351|NCT02100514|8596420|P3|Treatment Period|Adverse Event|0
2487352|NCT02100514|8596421|P2|Treatment Period|Adverse Event|5
2487353|NCT02100514|8596422|P1|Treatment Period|Adverse Event|0
2487354|NCT02100475|8596490|P2|Overall Study|Withdrawal criteria|0
2487355|NCT02100475|8596491|P1|Overall Study|Withdrawal criteria|1
2487356|NCT02100475|8596490|P2|Overall Study|Unclassified|2
2487357|NCT02100475|8596491|P1|Overall Study|Unclassified|1
2487358|NCT02100319|8596522|P1|Overall Study|Protocol Deviation|5
2487359|NCT02100319|8596522|P1|Overall Study|Case Report Forms Uncollected|11
2487360|NCT02100228|8596550|P2|Overall Study|Death|1
2487361|NCT02100228|8596551|P1|Overall Study|Death|1
2487362|NCT02100228|8596550|P2|Overall Study|Adverse Event|12
2487363|NCT02100228|8596551|P1|Overall Study|Adverse Event|16
2487364|NCT02100228|8596550|P2|Overall Study|Withdrawal by Subject|37
2487365|NCT02100228|8596551|P1|Overall Study|Withdrawal by Subject|27
2487366|NCT02100228|8596550|P2|Overall Study|Lost to Follow-up|1
2487367|NCT02100228|8596551|P1|Overall Study|Lost to Follow-up|0
2487368|NCT02100228|8596550|P2|Overall Study|Non-compliance|3
2487369|NCT02100228|8596551|P1|Overall Study|Non-compliance|0
2487370|NCT02100228|8596550|P2|Overall Study|Inclusion/Exclusion criteria not met|16
2487371|NCT02100228|8596551|P1|Overall Study|Inclusion/Exclusion criteria not met|12
2487372|NCT02100228|8596550|P2|Overall Study|Administrative reason|1
2487373|NCT02100228|8596551|P1|Overall Study|Administrative reason|0
2487374|NCT02100228|8596550|P2|Overall Study|Other|19
2487375|NCT02100228|8596551|P1|Overall Study|Other|19
2487376|NCT02100124|8596587|P3|Overall Study|Withdrawal by Subject|0
2487377|NCT02100124|8596588|P2|Overall Study|Withdrawal by Subject|0
2487378|NCT02100124|8596589|P1|Overall Study|Withdrawal by Subject|1
2487379|NCT02100124|8596587|P3|Overall Study|Lost to Follow-up|3
2487380|NCT02100124|8596588|P2|Overall Study|Lost to Follow-up|11
2487381|NCT02100124|8596589|P1|Overall Study|Lost to Follow-up|5
2487382|NCT02099838|8596619|P2|Overall Study|Withdrawal by Subject|1
2487383|NCT02099838|8596620|P1|Overall Study|Withdrawal by Subject|0
2487384|NCT02099838|8596619|P2|Overall Study|Lost to Follow-up|1
2487385|NCT02099838|8596620|P1|Overall Study|Lost to Follow-up|3
2487386|NCT02099838|8596619|P2|Overall Study|Death|0
2487387|NCT02099838|8596620|P1|Overall Study|Death|1
2487388|NCT02099708|8596665|P1|Overall Study|Other|29
2487389|NCT02099708|8596665|P1|Overall Study|Lost to Follow-up|141
2487390|NCT02099708|8596665|P1|Overall Study|Data Not Available|30
2487391|NCT02099682|8596676|P1|Overall Study|Other|29
2487392|NCT02099682|8596676|P1|Overall Study|Lost to Follow-up|31
2487393|NCT02099682|8596676|P1|Overall Study|Data Not Available|51
2487394|NCT02099344|8596702|P2|Overall Study|Physician Decision|0
2487395|NCT02099344|8596703|P1|Overall Study|Physician Decision|1
2487396|NCT02099110|8596740|P5|Overall Study|Physician Decision|1
2487397|NCT02099110|8596741|P4|Overall Study|Physician Decision|2
2487398|NCT02099110|8596742|P3|Overall Study|Physician Decision|1
2487399|NCT02099110|8596743|P2|Overall Study|Physician Decision|0
2487400|NCT02099110|8596744|P1|Overall Study|Physician Decision|3
2487401|NCT02099110|8596740|P5|Overall Study|Non-compliance with study drug|1
2487402|NCT02099110|8596741|P4|Overall Study|Non-compliance with study drug|0
2487403|NCT02099110|8596742|P3|Overall Study|Non-compliance with study drug|0
2487404|NCT02099110|8596743|P2|Overall Study|Non-compliance with study drug|0
2487405|NCT02099110|8596744|P1|Overall Study|Non-compliance with study drug|2
2487406|NCT02099110|8596740|P5|Overall Study|Screen failure|1
2487407|NCT02099110|8596741|P4|Overall Study|Screen failure|0
2487408|NCT02099110|8596742|P3|Overall Study|Screen failure|0
2487409|NCT02099110|8596743|P2|Overall Study|Screen failure|0
2487410|NCT02099110|8596744|P1|Overall Study|Screen failure|0
2487411|NCT02099110|8596740|P5|Overall Study|Death|0
2487412|NCT02099110|8596741|P4|Overall Study|Death|0
2487413|NCT02099110|8596742|P3|Overall Study|Death|0
2487414|NCT02099110|8596743|P2|Overall Study|Death|1
2487415|NCT02099110|8596744|P1|Overall Study|Death|0
2487416|NCT02099110|8596740|P5|Overall Study|Lost to Follow-up|6
2487417|NCT02099110|8596741|P4|Overall Study|Lost to Follow-up|5
2487418|NCT02099110|8596742|P3|Overall Study|Lost to Follow-up|11
2487419|NCT02099110|8596743|P2|Overall Study|Lost to Follow-up|12
2487420|NCT02099110|8596744|P1|Overall Study|Lost to Follow-up|6
2487421|NCT02099110|8596740|P5|Overall Study|Adverse Event|2
2487422|NCT02099110|8596741|P4|Overall Study|Adverse Event|3
2487423|NCT02099110|8596742|P3|Overall Study|Adverse Event|2
2487424|NCT02099110|8596743|P2|Overall Study|Adverse Event|5
2487425|NCT02099110|8596744|P1|Overall Study|Adverse Event|3
2487426|NCT02099110|8596740|P5|Overall Study|Withdrawal by Subject|13
2487427|NCT02099110|8596741|P4|Overall Study|Withdrawal by Subject|9
2487428|NCT02099110|8596742|P3|Overall Study|Withdrawal by Subject|13
2487429|NCT02099110|8596743|P2|Overall Study|Withdrawal by Subject|11
2487430|NCT02099110|8596744|P1|Overall Study|Withdrawal by Subject|7
2487431|NCT02099110|8596740|P5|Overall Study|Participant moved|2
2487432|NCT02099110|8596741|P4|Overall Study|Participant moved|0
2487433|NCT02099110|8596742|P3|Overall Study|Participant moved|1
2487434|NCT02099110|8596743|P2|Overall Study|Participant moved|1
2487435|NCT02099110|8596744|P1|Overall Study|Participant moved|1
2487436|NCT02099110|8596740|P5|Overall Study|Protocol Violation|1
2487437|NCT02099110|8596741|P4|Overall Study|Protocol Violation|3
2487438|NCT02099110|8596742|P3|Overall Study|Protocol Violation|0
2487439|NCT02099110|8596743|P2|Overall Study|Protocol Violation|1
2487440|NCT02099110|8596744|P1|Overall Study|Protocol Violation|2
2487441|NCT02098746|8596845|P1|Overall Study|Data Not Available After Treatment|1
2487442|NCT02098746|8596845|P1|Overall Study|Enrolled 15 Days After the First Dose|1
2487443|NCT02098746|8596845|P1|Overall Study|Other Miscellaneous Reasons|1
2487444|NCT02098746|8596845|P1|Overall Study|Changes of Investigator|2
2487445|NCT02098733|8596853|P1|Overall Study|Lost to Follow-up|5
2487446|NCT02098733|8596853|P1|Overall Study|Data Not Available|5
2487447|NCT02098395|8596867|P4|Overall Study|Unclassified|2
2487448|NCT02098395|8596868|P3|Overall Study|Unclassified|3
2487449|NCT02098395|8596869|P2|Overall Study|Unclassified|0
2487450|NCT02098395|8596870|P1|Overall Study|Unclassified|0
2487451|NCT02098395|8596867|P4|Overall Study|Lost to Follow-up|3
2487452|NCT02098395|8596868|P3|Overall Study|Lost to Follow-up|0
2487453|NCT02098395|8596869|P2|Overall Study|Lost to Follow-up|1
2487454|NCT02098395|8596870|P1|Overall Study|Lost to Follow-up|2
2487455|NCT02098395|8596867|P4|Overall Study|Adverse Event|2
2487456|NCT02098395|8596868|P3|Overall Study|Adverse Event|34
2487457|NCT02098395|8596869|P2|Overall Study|Adverse Event|19
2487458|NCT02098395|8596870|P1|Overall Study|Adverse Event|12
2487459|NCT02098395|8596867|P4|Overall Study|Withdrawal by Subject|13
2487460|NCT02098395|8596868|P3|Overall Study|Withdrawal by Subject|5
2487461|NCT02098395|8596869|P2|Overall Study|Withdrawal by Subject|10
2487462|NCT02098395|8596870|P1|Overall Study|Withdrawal by Subject|10
2487463|NCT02098395|8596867|P4|Overall Study|Protocol Violation|7
2487464|NCT02098395|8596868|P3|Overall Study|Protocol Violation|0
2487465|NCT02098395|8596869|P2|Overall Study|Protocol Violation|2
2487466|NCT02098395|8596870|P1|Overall Study|Protocol Violation|2
2487467|NCT02098369|8596891|P3|Overall Study|Other|1
2487468|NCT02098369|8596892|P2|Overall Study|Other|2
2487469|NCT02098369|8596893|P1|Overall Study|Other|0
2487470|NCT02098369|8596891|P3|Overall Study|Death|1
2487471|NCT02098369|8596892|P2|Overall Study|Death|1
2487472|NCT02098369|8596893|P1|Overall Study|Death|1
2487473|NCT02098369|8596891|P3|Overall Study|Lost to Follow-up|3
2487474|NCT02098369|8596892|P2|Overall Study|Lost to Follow-up|1
2487475|NCT02098369|8596893|P1|Overall Study|Lost to Follow-up|5
2487476|NCT02098369|8596891|P3|Overall Study|Withdrawal by Subject|0
2487477|NCT02098369|8596892|P2|Overall Study|Withdrawal by Subject|5
2487478|NCT02098369|8596893|P1|Overall Study|Withdrawal by Subject|1
2487479|NCT02098109|8596931|P2|Overall Study|Protocol Violation|0
2487480|NCT02098109|8596932|P1|Overall Study|Protocol Violation|3
2487481|NCT02097823|8597010|P2|Overall Study|Withdrawal by Subject|1
2487482|NCT02097823|8597011|P1|Overall Study|Withdrawal by Subject|1
2487483|NCT02097745|8597026|P1|Overall Study|Reason Not Specified|96
2487484|NCT02097745|8597026|P1|Overall Study|Administrative/Other|27
2487485|NCT02097745|8597026|P1|Overall Study|Failure to Return|14
2487486|NCT02097745|8597026|P1|Overall Study|Death|16
2487487|NCT02097745|8597026|P1|Overall Study|Adverse Event|25
2487488|NCT02097719|8597064|P2|Overall Study|Adverse Event|0
2487489|NCT02097719|8597065|P1|Overall Study|Adverse Event|2
2487490|NCT02097719|8597064|P2|Overall Study|Lost to Follow-up|1
2487491|NCT02097719|8597065|P1|Overall Study|Lost to Follow-up|0
2487492|NCT02097719|8597064|P2|Overall Study|Subject Withdrew Consent|0
2487493|NCT02097719|8597065|P1|Overall Study|Subject Withdrew Consent|1
2487494|NCT02097472|8597130|P8|Received Vaccination 2|Adverse Event|0
2487495|NCT02097472|8597131|P7|Received Vaccination 2|Adverse Event|1
2487496|NCT02097472|8597132|P6|Received Vaccination 2|Adverse Event|0
2487497|NCT02097472|8597133|P5|Received Vaccination 2|Adverse Event|0
2487498|NCT02097472|8597134|P4|Received Vaccination 2|Adverse Event|0
2487499|NCT02097472|8597135|P3|Received Vaccination 2|Adverse Event|0
2487500|NCT02097472|8597136|P2|Received Vaccination 2|Adverse Event|0
2487501|NCT02097472|8597137|P1|Received Vaccination 2|Adverse Event|0
2487502|NCT02097290|8597568|P1|Overall Study|Attempt|8
2487503|NCT02097290|8597568|P1|Overall Study|Total Withdrawals|3
2487504|NCT02097290|8597568|P1|Overall Study|Death|6
2487505|NCT02097277|8597583|P5|Overall Study|Adverse Event|0
2487506|NCT02097277|8597584|P4|Overall Study|Adverse Event|2
2487507|NCT02097277|8597585|P3|Overall Study|Adverse Event|1
2487508|NCT02097277|8597586|P2|Overall Study|Adverse Event|0
2487509|NCT02097277|8597587|P1|Overall Study|Adverse Event|0
2487510|NCT02097277|8597583|P5|Overall Study|Withdrawal by Subject|0
2487511|NCT02097277|8597584|P4|Overall Study|Withdrawal by Subject|1
2487512|NCT02097277|8597585|P3|Overall Study|Withdrawal by Subject|0
2487513|NCT02097277|8597586|P2|Overall Study|Withdrawal by Subject|1
2487514|NCT02097277|8597587|P1|Overall Study|Withdrawal by Subject|2
2487515|NCT02097277|8597583|P5|Overall Study|Lost to Follow-up|0
2487516|NCT02097277|8597584|P4|Overall Study|Lost to Follow-up|0
2487517|NCT02097277|8597585|P3|Overall Study|Lost to Follow-up|1
2487518|NCT02097277|8597586|P2|Overall Study|Lost to Follow-up|1
2487519|NCT02097277|8597587|P1|Overall Study|Lost to Follow-up|0
2487520|NCT02097277|8597583|P5|Overall Study|Subject request to discontinue treatment|1
2487521|NCT02097277|8597584|P4|Overall Study|Subject request to discontinue treatment|0
2487522|NCT02097277|8597585|P3|Overall Study|Subject request to discontinue treatment|0
2487523|NCT02097277|8597586|P2|Overall Study|Subject request to discontinue treatment|0
2487524|NCT02097277|8597587|P1|Overall Study|Subject request to discontinue treatment|0
2487525|NCT02097277|8597583|P5|Overall Study|Subject no longer meets study criteria|0
2487526|NCT02097277|8597584|P4|Overall Study|Subject no longer meets study criteria|1
2487527|NCT02097277|8597585|P3|Overall Study|Subject no longer meets study criteria|0
2487528|NCT02097277|8597586|P2|Overall Study|Subject no longer meets study criteria|1
2487529|NCT02097277|8597587|P1|Overall Study|Subject no longer meets study criteria|0
2487530|NCT02097238|8597670|P1|Overall Study|Progressive Disease|17
2487531|NCT02097238|8597670|P1|Overall Study|Physician Decision|1
2487532|NCT02097238|8597670|P1|Overall Study|Death|1
2487533|NCT02097134|8597679|P1|Overall Study|Refusal of Further Protocol Therapy|1
2487534|NCT02097134|8597679|P1|Overall Study|Progressive Disease|3
2487535|NCT02097134|8597679|P1|Overall Study|Non-Protocol Therapy|1
2487536|NCT02097134|8597679|P1|Overall Study|Physician Decision|4
2487537|NCT02097108|8597687|P1|Overall Study|patient was abroad for 6 months|1
2487538|NCT02097108|8597687|P1|Overall Study|Adverse Event|1
2487539|NCT02097056|8597694|P1|Overall Study|Other|2
2487540|NCT02097056|8597694|P1|Overall Study|Adverse Event|37
2487541|NCT02097056|8597694|P1|Overall Study|Lost to Follow-up|2
2487542|NCT02097056|8597694|P1|Overall Study|Withdrawal by Subject|15
2487543|NCT02097056|8597694|P1|Overall Study|Protocol Violation|2
2487544|NCT02097030|8597702|P2|First Intervention (3 Days)|Visual Acuity|1
2487545|NCT02097030|8597703|P1|First Intervention (3 Days)|Visual Acuity|0
2487546|NCT02097030|8597702|P2|First Intervention (3 Days)|Lost to Follow-up|0
2487547|NCT02097030|8597703|P1|First Intervention (3 Days)|Lost to Follow-up|1
2487548|NCT02096952|8597764|P1|Overall Study|Adverse Event|1
2487549|NCT02096900|8597770|P2|Overall Study|Surgery cancelled- medication received|1
2487550|NCT02096900|8597771|P1|Overall Study|Surgery cancelled- medication received|1
2487551|NCT02096900|8597770|P2|Overall Study|Did not receive medication|1
2487552|NCT02096900|8597771|P1|Overall Study|Did not receive medication|3
2487553|NCT02096835|8597823|P3|Overall Study|Lost to Follow-up|1
2487554|NCT02096835|8597824|P2|Overall Study|Lost to Follow-up|0
2487555|NCT02096835|8597825|P1|Overall Study|Lost to Follow-up|1
2487556|NCT02096835|8597823|P3|Overall Study|converted to open procedures|0
2487557|NCT02096835|8597824|P2|Overall Study|converted to open procedures|0
2487558|NCT02096835|8597825|P1|Overall Study|converted to open procedures|1
2487559|NCT02096835|8597823|P3|Overall Study|Withdrawal by Subject|0
2487560|NCT02096835|8597824|P2|Overall Study|Withdrawal by Subject|0
2487561|NCT02096835|8597825|P1|Overall Study|Withdrawal by Subject|1
2487562|NCT02096744|8597842|P2|Treatment Period 3 (7 Days)|Withdrawal by Subject|1
2487563|NCT02096744|8597843|P1|Treatment Period 3 (7 Days)|Withdrawal by Subject|0
2487564|NCT02096744|8597842|P2|Treatment Period 1(7 Days)|Non compliance with the site rule|0
2487565|NCT02096744|8597843|P1|Treatment Period 1(7 Days)|Non compliance with the site rule|1
2487566|NCT02096744|8597842|P2|Treatment Period 1(7 Days)|Accidental early removal of the patch|1
2487567|NCT02096744|8597843|P1|Treatment Period 1(7 Days)|Accidental early removal of the patch|0
2487568|NCT02096705|8597897|P2|Follow-up|Subjects not reporting status|2
2487569|NCT02096705|8597898|P1|Follow-up|Subjects not reporting status|1
2487570|NCT02096705|8597897|P2|Follow-up|Adverse Event|2
2487571|NCT02096705|8597898|P1|Follow-up|Adverse Event|2
2487572|NCT02096705|8597897|P2|Follow-up|Withdrawal by Subject|0
2487573|NCT02096705|8597898|P1|Follow-up|Withdrawal by Subject|1
2487574|NCT02096705|8597897|P2|Treatment|Other|1
2487575|NCT02096705|8597898|P1|Treatment|Other|1
2487576|NCT02096705|8597897|P2|Treatment|Withdrawal by Subject|0
2487577|NCT02096705|8597898|P1|Treatment|Withdrawal by Subject|1
2487578|NCT02096705|8597897|P2|Treatment|Subject request to discontinue treatment|1
2487579|NCT02096705|8597898|P1|Treatment|Subject request to discontinue treatment|1
2487580|NCT02096705|8597897|P2|Treatment|Adverse Event|3
2487581|NCT02096705|8597898|P1|Treatment|Adverse Event|6
2487582|NCT02096588|8597941|P2|Overall Study|Withdrawal by Subject|1
2487583|NCT02096588|8597942|P1|Overall Study|Withdrawal by Subject|0
2487584|NCT02096588|8597941|P2|Overall Study|Lack of Efficacy|0
2487585|NCT02096588|8597942|P1|Overall Study|Lack of Efficacy|2
2487586|NCT02096471|8597968|P1|Overall Study|Non-Compliant|2
2487587|NCT02096471|8597968|P1|Overall Study|Withdrawal by Subject|3
2487588|NCT02096471|8597968|P1|Overall Study|Lack of Efficacy|7
2487589|NCT02096471|8597968|P1|Overall Study|Adverse Event|1
2487590|NCT02096263|8597986|P3|Overall Study|Withdrawal by Subject|8
2487591|NCT02096263|8597987|P2|Overall Study|Withdrawal by Subject|7
2487592|NCT02096263|8597988|P1|Overall Study|Withdrawal by Subject|5
2487593|NCT02096263|8597986|P3|Overall Study|Protocol Violation|8
2487594|NCT02096263|8597987|P2|Overall Study|Protocol Violation|2
2487595|NCT02096263|8597988|P1|Overall Study|Protocol Violation|7
2487596|NCT02096263|8597986|P3|Overall Study|Sponsor study termination|1
2487597|NCT02096263|8597987|P2|Overall Study|Sponsor study termination|0
2487598|NCT02096263|8597988|P1|Overall Study|Sponsor study termination|0
2487599|NCT02096263|8597986|P3|Overall Study|Other|6
2487600|NCT02096263|8597987|P2|Overall Study|Other|9
2487601|NCT02096263|8597988|P1|Overall Study|Other|7
2487602|NCT02096263|8597986|P3|Overall Study|Lost to Follow-up|15
2487603|NCT02096263|8597987|P2|Overall Study|Lost to Follow-up|18
2487604|NCT02096263|8597988|P1|Overall Study|Lost to Follow-up|14
2487605|NCT02096263|8597986|P3|Overall Study|Adverse Event|1
2487606|NCT02096263|8597987|P2|Overall Study|Adverse Event|0
2487607|NCT02096263|8597988|P1|Overall Study|Adverse Event|1
2487608|NCT02096042|8598176|P3|Overall Study|Disease Progression|0
2487609|NCT02096042|8598177|P2|Overall Study|Disease Progression|0
2487610|NCT02096042|8598178|P1|Overall Study|Disease Progression|1
2487611|NCT02096003|8598200|P2|Overall Study|additional surgery|1
2487612|NCT02096003|8598201|P1|Overall Study|additional surgery|2
2487613|NCT02096003|8598200|P2|Overall Study|Protocol Violation|2
2487614|NCT02096003|8598201|P1|Overall Study|Protocol Violation|0
2487615|NCT02095951|8598217|P2|Overall Study|NO POSITIVE BLOOD CULTURE|6
2487616|NCT02095951|8598218|P1|Overall Study|NO POSITIVE BLOOD CULTURE|9
2487617|NCT02095873|8598238|P2|Second Intervention (8 Weeks)|Protocol Violation|0
2487618|NCT02095873|8598239|P1|Second Intervention (8 Weeks)|Protocol Violation|1
2487619|NCT02095873|8598238|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|0
2487620|NCT02095873|8598239|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|1
2487621|NCT02095873|8598238|P2|First Intervention (8 Weeks)|Withdrawal by Subject|0
2487622|NCT02095873|8598239|P1|First Intervention (8 Weeks)|Withdrawal by Subject|1
2487623|NCT02095691|8598251|P1|Overall Study|Physician Decision|1
2487624|NCT02095535|8598283|P1|Recruitment|Protocol Violation|2
2487625|NCT02095223|8598305|P2|Overall Study|Withdrawal by Subject|0
2487626|NCT02095223|8598306|P1|Overall Study|Withdrawal by Subject|1
2487627|NCT02095197|8598316|P2|Overall Study|Lost to Follow-up|3
2487628|NCT02095197|8598317|P1|Overall Study|Lost to Follow-up|0
2487629|NCT02095158|8598329|P1|Overall Study|Other Miscellaneous Reasons|1
2487630|NCT02095158|8598329|P1|Overall Study|Protocol Violation|1
2487631|NCT02095158|8598329|P1|Overall Study|Personal Reasons|35
2487632|NCT02095158|8598329|P1|Overall Study|Lost to Follow-up|20
2487633|NCT02095158|8598329|P1|Overall Study|Pregnancy|1
2487634|NCT02095158|8598329|P1|Overall Study|Lack of Efficacy|3
2487635|NCT02095158|8598329|P1|Overall Study|Adverse Event|14
2487636|NCT02095145|8598336|P2|Overall Study|Withdrawal by Subject|0
2487637|NCT02095145|8598337|P1|Overall Study|Withdrawal by Subject|1
2487638|NCT02095106|8598383|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
2487639|NCT02095106|8598384|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
2487640|NCT02094937|8598400|P4|12 Weeks in Period 2|Randomized incorrectly|0
2487641|NCT02094937|8598401|P3|12 Weeks in Period 2|Randomized incorrectly|0
2487642|NCT02094937|8598402|P2|12 Weeks in Period 2|Randomized incorrectly|1
2487643|NCT02094937|8598403|P1|12 Weeks in Period 2|Randomized incorrectly|0
2487644|NCT02094937|8598400|P4|12 Weeks in Period 2|Withdrawal by Subject|0
2487645|NCT02094937|8598401|P3|12 Weeks in Period 2|Withdrawal by Subject|2
2487646|NCT02094937|8598402|P2|12 Weeks in Period 2|Withdrawal by Subject|2
2487647|NCT02094937|8598403|P1|12 Weeks in Period 2|Withdrawal by Subject|0
2487648|NCT02094937|8598400|P4|12 Weeks in Period 2|Protocol defined stopping criteria|11
2487649|NCT02094937|8598401|P3|12 Weeks in Period 2|Protocol defined stopping criteria|6
2487650|NCT02094937|8598402|P2|12 Weeks in Period 2|Protocol defined stopping criteria|5
2487651|NCT02094937|8598403|P1|12 Weeks in Period 2|Protocol defined stopping criteria|0
2487652|NCT02094937|8598400|P4|12 Weeks in Period 2|Lack of Efficacy|0
2487653|NCT02094937|8598401|P3|12 Weeks in Period 2|Lack of Efficacy|0
2487654|NCT02094937|8598402|P2|12 Weeks in Period 2|Lack of Efficacy|1
2487655|NCT02094937|8598403|P1|12 Weeks in Period 2|Lack of Efficacy|0
2487656|NCT02094937|8598400|P4|12 Weeks in Period 2|Adverse Event|1
2487657|NCT02094937|8598401|P3|12 Weeks in Period 2|Adverse Event|4
2487658|NCT02094937|8598402|P2|12 Weeks in Period 2|Adverse Event|2
2487659|NCT02094937|8598403|P1|12 Weeks in Period 2|Adverse Event|0
2487660|NCT02094937|8598400|P4|8 Weeks in Period 1|Withdrawal by Subject|0
2487661|NCT02094937|8598401|P3|8 Weeks in Period 1|Withdrawal by Subject|0
2487662|NCT02094937|8598402|P2|8 Weeks in Period 1|Withdrawal by Subject|0
2487663|NCT02094937|8598403|P1|8 Weeks in Period 1|Withdrawal by Subject|4
2487664|NCT02094937|8598400|P4|8 Weeks in Period 1|Physician Decision|0
2487665|NCT02094937|8598401|P3|8 Weeks in Period 1|Physician Decision|0
2487666|NCT02094937|8598402|P2|8 Weeks in Period 1|Physician Decision|0
2487667|NCT02094937|8598403|P1|8 Weeks in Period 1|Physician Decision|1
2487668|NCT02094937|8598400|P4|8 Weeks in Period 1|Protocol defined stopping criteria|0
2487669|NCT02094937|8598401|P3|8 Weeks in Period 1|Protocol defined stopping criteria|0
2487670|NCT02094937|8598402|P2|8 Weeks in Period 1|Protocol defined stopping criteria|0
2487671|NCT02094937|8598403|P1|8 Weeks in Period 1|Protocol defined stopping criteria|41
2487672|NCT02094937|8598400|P4|8 Weeks in Period 1|Protocol Violation|0
2487673|NCT02094937|8598401|P3|8 Weeks in Period 1|Protocol Violation|0
2487674|NCT02094937|8598402|P2|8 Weeks in Period 1|Protocol Violation|0
2487675|NCT02094937|8598403|P1|8 Weeks in Period 1|Protocol Violation|2
2487676|NCT02094937|8598400|P4|8 Weeks in Period 1|Lack of Efficacy|0
2487677|NCT02094937|8598401|P3|8 Weeks in Period 1|Lack of Efficacy|0
2487678|NCT02094937|8598402|P2|8 Weeks in Period 1|Lack of Efficacy|0
2487679|NCT02094937|8598403|P1|8 Weeks in Period 1|Lack of Efficacy|3
2487680|NCT02094937|8598400|P4|8 Weeks in Period 1|Adverse Event|0
2487681|NCT02094937|8598401|P3|8 Weeks in Period 1|Adverse Event|0
2487682|NCT02094937|8598402|P2|8 Weeks in Period 1|Adverse Event|0
2487683|NCT02094937|8598403|P1|8 Weeks in Period 1|Adverse Event|9
2487684|NCT02094898|8598433|P1|Overall Study|Lack of Efficacy|1
2487685|NCT02094898|8598433|P1|Overall Study|Adverse Event|2
2487686|NCT02094898|8598433|P1|Overall Study|Clinical Worsening|2
2487687|NCT02094885|8598480|P2|Overall Study|Withdrawn due to age|0
2487688|NCT02094885|8598481|P1|Overall Study|Withdrawn due to age|1
2487689|NCT02094885|8598480|P2|Overall Study|Death|5
2487690|NCT02094885|8598481|P1|Overall Study|Death|1
2487691|NCT02094677|8598504|P2|Overall Study|Screening|1
2487692|NCT02094677|8598505|P1|Overall Study|Screening|3
2487693|NCT02094612|8598584|P2|Overall Study|Never started ADHD medication|23
2487694|NCT02094612|8598585|P1|Overall Study|Never started ADHD medication|32
2487695|NCT02094612|8598584|P2|Overall Study|Lost to Follow-up|47
2487696|NCT02094612|8598585|P1|Overall Study|Lost to Follow-up|47
2487697|NCT02094573|8598605|P2|Overall Study|Ongoing|76
2487698|NCT02094573|8598606|P1|Overall Study|Ongoing|64
2487699|NCT02094573|8598605|P2|Overall Study|Randomized but not treated|0
2487700|NCT02094573|8598606|P1|Overall Study|Randomized but not treated|3
2487701|NCT02094573|8598605|P2|Overall Study|Withdrawal by Subject|4
2487702|NCT02094573|8598606|P1|Overall Study|Withdrawal by Subject|2
2487703|NCT02094573|8598605|P2|Overall Study|Non-compliance with study drug|1
2487704|NCT02094573|8598606|P1|Overall Study|Non-compliance with study drug|0
2487705|NCT02094573|8598605|P2|Overall Study|Death|1
2487706|NCT02094573|8598606|P1|Overall Study|Death|7
2487707|NCT02094573|8598605|P2|Overall Study|Adverse Event|9
2487708|NCT02094573|8598606|P1|Overall Study|Adverse Event|3
2487709|NCT02094573|8598605|P2|Overall Study|Clinical Progressive Disease|3
2487710|NCT02094573|8598606|P1|Overall Study|Clinical Progressive Disease|4
2487711|NCT02094573|8598605|P2|Overall Study|Documented Progressive Disease|16
2487712|NCT02094573|8598606|P1|Overall Study|Documented Progressive Disease|29
2487713|NCT02094300|8598688|P1|Overall Study|Still be eligible for follow-up|3
2487714|NCT02094300|8598688|P1|Overall Study|Lost to Follow-up|10
2487715|NCT02094300|8598688|P1|Overall Study|Death|7
2487716|NCT02094261|8598692|P1|Overall Study|Ongoing Study at Data Cut-off|181
2487717|NCT02094261|8598692|P1|Overall Study|Withdrawal by Subject|4
2487718|NCT02094261|8598692|P1|Overall Study|Lost to Follow-up|1
2487719|NCT02094261|8598692|P1|Overall Study|Death|24
2487720|NCT02093923|8598734|P5|Overall Study|Screen failure after randomization|0
2487721|NCT02093923|8598735|P4|Overall Study|Screen failure after randomization|1
2487722|NCT02093923|8598736|P3|Overall Study|Screen failure after randomization|0
2487723|NCT02093923|8598737|P2|Overall Study|Screen failure after randomization|0
2487724|NCT02093923|8598738|P1|Overall Study|Screen failure after randomization|0
2487725|NCT02093923|8598734|P5|Overall Study|Lost to Follow-up|0
2487726|NCT02093923|8598735|P4|Overall Study|Lost to Follow-up|1
2487727|NCT02093923|8598736|P3|Overall Study|Lost to Follow-up|0
2487728|NCT02093923|8598737|P2|Overall Study|Lost to Follow-up|0
2487729|NCT02093923|8598738|P1|Overall Study|Lost to Follow-up|0
2487730|NCT02093897|8598793|P1|Overall Study|Adverse event, non-fatal|1
2487731|NCT02093897|8598793|P1|Overall Study|Planned age group closure - no's reached|17
2487732|NCT02093897|8598793|P1|Overall Study|Physician Decision|1
2487733|NCT02093689|8598896|P3|Overall Study|Physician Decision|0
2487734|NCT02093689|8598897|P2|Overall Study|Physician Decision|0
2487735|NCT02093689|8598898|P1|Overall Study|Physician Decision|4
2487736|NCT02093663|8598904|P5|Double Blind Maintenance Phase(26 Weeks)|Missing|1
2487737|NCT02093663|8598905|P4|Double Blind Maintenance Phase(26 Weeks)|Missing|0
2487738|NCT02093663|8598906|P3|Double Blind Maintenance Phase(26 Weeks)|Missing|0
2487739|NCT02093663|8598907|P2|Double Blind Maintenance Phase(26 Weeks)|Missing|0
2487740|NCT02093663|8598908|P1|Double Blind Maintenance Phase(26 Weeks)|Missing|0
2487741|NCT02093663|8598904|P5|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1
2487742|NCT02093663|8598905|P4|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1
2487743|NCT02093663|8598906|P3|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
2487744|NCT02093663|8598907|P2|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
2487745|NCT02093663|8598908|P1|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
2487746|NCT02093663|8598904|P5|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7
2487747|NCT02093663|8598905|P4|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6
2487748|NCT02093663|8598906|P3|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
2487749|NCT02093663|8598907|P2|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
2487750|NCT02093663|8598908|P1|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
2487751|NCT02093663|8598904|P5|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2
2487752|NCT02093663|8598905|P4|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3
2487753|NCT02093663|8598906|P3|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
2487754|NCT02093663|8598907|P2|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
2487755|NCT02093663|8598908|P1|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
2487756|NCT02093663|8598904|P5|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
2487757|NCT02093663|8598905|P4|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
2487758|NCT02093663|8598906|P3|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5
2487759|NCT02093663|8598907|P2|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
2487760|NCT02093663|8598908|P1|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
2487761|NCT02093663|8598904|P5|Open Label Acute Phase (8 Weeks)|Adverse Event|0
2487762|NCT02093663|8598905|P4|Open Label Acute Phase (8 Weeks)|Adverse Event|0
2487763|NCT02093663|8598906|P3|Open Label Acute Phase (8 Weeks)|Adverse Event|1
2487764|NCT02093663|8598907|P2|Open Label Acute Phase (8 Weeks)|Adverse Event|0
2487765|NCT02093663|8598908|P1|Open Label Acute Phase (8 Weeks)|Adverse Event|0
2487766|NCT02093663|8598904|P5|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
2487767|NCT02093663|8598905|P4|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
2487768|NCT02093663|8598906|P3|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
2487769|NCT02093663|8598907|P2|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4
2487770|NCT02093663|8598908|P1|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2
2487771|NCT02093663|8598904|P5|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
2487772|NCT02093663|8598905|P4|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
2487773|NCT02093663|8598906|P3|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
2487774|NCT02093663|8598907|P2|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
2487775|NCT02093663|8598908|P1|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5
2487776|NCT02093663|8598904|P5|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
2487777|NCT02093663|8598905|P4|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
2487778|NCT02093663|8598906|P3|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
2487779|NCT02093663|8598907|P2|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
2487780|NCT02093663|8598908|P1|Double Blind Acute Phase (8 Weeks)|Adverse Event|1
2487781|NCT02093520|8598937|P2|Overall Study|Not treated|22
2487782|NCT02093520|8598938|P1|Overall Study|Not treated|6
2487783|NCT02093390|8598950|P2|Overall Study|Withdrawal by Subject|1
2487784|NCT02093390|8598951|P1|Overall Study|Withdrawal by Subject|0
2487785|NCT02093351|8598990|P4|Part B|Death|1
2487786|NCT02093351|8598991|P3|Part B|Death|0
2487787|NCT02093351|8598992|P2|Part B|Death|0
2487788|NCT02093351|8598993|P1|Part B|Death|0
2487789|NCT02093351|8598990|P4|Part B|Adverse Event|2
2487790|NCT02093351|8598991|P3|Part B|Adverse Event|0
2487791|NCT02093351|8598992|P2|Part B|Adverse Event|0
2487792|NCT02093351|8598993|P1|Part B|Adverse Event|0
2487793|NCT02093351|8598990|P4|Part B|Condition under investigation worsened|39
2487794|NCT02093351|8598991|P3|Part B|Condition under investigation worsened|0
2487795|NCT02093351|8598992|P2|Part B|Condition under investigation worsened|0
2487796|NCT02093351|8598993|P1|Part B|Condition under investigation worsened|0
2487797|NCT02093351|8598990|P4|Part B|Lack of therapeutic response|12
2487798|NCT02093351|8598991|P3|Part B|Lack of therapeutic response|0
2487799|NCT02093351|8598992|P2|Part B|Lack of therapeutic response|0
2487800|NCT02093351|8598993|P1|Part B|Lack of therapeutic response|0
2487801|NCT02093351|8598990|P4|Part B|Adverse event + disease progression|1
2487802|NCT02093351|8598991|P3|Part B|Adverse event + disease progression|0
2487803|NCT02093351|8598992|P2|Part B|Adverse event + disease progression|0
2487804|NCT02093351|8598993|P1|Part B|Adverse event + disease progression|0
2487805|NCT02093351|8598990|P4|Part B|Complete response|1
2487806|NCT02093351|8598991|P3|Part B|Complete response|0
2487807|NCT02093351|8598992|P2|Part B|Complete response|0
2487808|NCT02093351|8598993|P1|Part B|Complete response|0
2487809|NCT02093351|8598990|P4|Part B|Disease progression|4
2487810|NCT02093351|8598991|P3|Part B|Disease progression|0
2487811|NCT02093351|8598992|P2|Part B|Disease progression|0
2487812|NCT02093351|8598993|P1|Part B|Disease progression|0
2487813|NCT02093351|8598990|P4|Part B|Patient decision|3
2487814|NCT02093351|8598991|P3|Part B|Patient decision|0
2487815|NCT02093351|8598992|P2|Part B|Patient decision|0
2487816|NCT02093351|8598993|P1|Part B|Patient decision|0
2487817|NCT02093351|8598990|P4|Part A|Death|0
2487818|NCT02093351|8598991|P3|Part A|Death|0
2487819|NCT02093351|8598992|P2|Part A|Death|1
2487820|NCT02093351|8598993|P1|Part A|Death|0
2487821|NCT02093351|8598990|P4|Part A|Condition under investigation worsened|0
2487822|NCT02093351|8598991|P3|Part A|Condition under investigation worsened|2
2487823|NCT02093351|8598992|P2|Part A|Condition under investigation worsened|0
2487824|NCT02093351|8598993|P1|Part A|Condition under investigation worsened|2
2487825|NCT02093351|8598990|P4|Part A|Adverse Event|0
2487826|NCT02093351|8598991|P3|Part A|Adverse Event|1
2487827|NCT02093351|8598992|P2|Part A|Adverse Event|1
2487828|NCT02093351|8598993|P1|Part A|Adverse Event|0
2487829|NCT02093221|8599050|P5|Overall Study|Study termination|7
2487830|NCT02093221|8599051|P4|Overall Study|Study termination|6
2487831|NCT02093221|8599052|P3|Overall Study|Study termination|4
2487832|NCT02093221|8599053|P2|Overall Study|Study termination|5
2487833|NCT02093221|8599054|P1|Overall Study|Study termination|6
2487834|NCT02093221|8599050|P5|Overall Study|Protocol Violation|0
2487835|NCT02093221|8599051|P4|Overall Study|Protocol Violation|0
2487836|NCT02093221|8599052|P3|Overall Study|Protocol Violation|0
2487837|NCT02093221|8599053|P2|Overall Study|Protocol Violation|1
2487838|NCT02093221|8599054|P1|Overall Study|Protocol Violation|0
2487839|NCT02093221|8599050|P5|Overall Study|Death|0
2487840|NCT02093221|8599051|P4|Overall Study|Death|0
2487841|NCT02093221|8599052|P3|Overall Study|Death|0
2487842|NCT02093221|8599053|P2|Overall Study|Death|1
2487843|NCT02093221|8599054|P1|Overall Study|Death|0
2487844|NCT02093221|8599050|P5|Overall Study|Lost to Follow-up|0
2487845|NCT02093221|8599051|P4|Overall Study|Lost to Follow-up|1
2487846|NCT02093221|8599052|P3|Overall Study|Lost to Follow-up|1
2487847|NCT02093221|8599053|P2|Overall Study|Lost to Follow-up|0
2487848|NCT02093221|8599054|P1|Overall Study|Lost to Follow-up|2
2487849|NCT02093221|8599050|P5|Overall Study|Withdrawal by Subject|1
2487850|NCT02093221|8599051|P4|Overall Study|Withdrawal by Subject|1
2487851|NCT02093221|8599052|P3|Overall Study|Withdrawal by Subject|4
2487852|NCT02093221|8599053|P2|Overall Study|Withdrawal by Subject|1
2487853|NCT02093221|8599054|P1|Overall Study|Withdrawal by Subject|1
2487854|NCT02093221|8599050|P5|Overall Study|Adverse Event|0
2487855|NCT02093221|8599051|P4|Overall Study|Adverse Event|0
2487856|NCT02093221|8599052|P3|Overall Study|Adverse Event|0
2487857|NCT02093221|8599053|P2|Overall Study|Adverse Event|0
2487858|NCT02093221|8599054|P1|Overall Study|Adverse Event|1
2487859|NCT02093026|8599091|P1|Overall Study|Other|157
2487860|NCT02093026|8599091|P1|Overall Study|Death|10
2487861|NCT02093026|8599091|P1|Overall Study|Adverse Event|26
2487862|NCT02092961|8599113|P3|Overall Study|Adverse Event|0
2487863|NCT02092961|8599114|P2|Overall Study|Adverse Event|4
2487864|NCT02092961|8599115|P1|Overall Study|Adverse Event|2
2487865|NCT02092961|8599113|P3|Overall Study|Dev. of study specific discont. criteria|0
2487866|NCT02092961|8599114|P2|Overall Study|Dev. of study specific discont. criteria|0
2487867|NCT02092961|8599115|P1|Overall Study|Dev. of study specific discont. criteria|3
2487868|NCT02092961|8599113|P3|Overall Study|Lack of therapeutic response|3
2487869|NCT02092961|8599114|P2|Overall Study|Lack of therapeutic response|1
2487870|NCT02092961|8599115|P1|Overall Study|Lack of therapeutic response|2
2487871|NCT02092961|8599113|P3|Overall Study|Study stopped|12
2487872|NCT02092961|8599114|P2|Overall Study|Study stopped|9
2487873|NCT02092961|8599115|P1|Overall Study|Study stopped|13
2487874|NCT02092961|8599113|P3|Overall Study|Not reported|1
2487875|NCT02092961|8599114|P2|Overall Study|Not reported|0
2487876|NCT02092961|8599115|P1|Overall Study|Not reported|1
2487877|NCT02092909|8599140|P4|Overall Study|Miscellaneous|1
2487878|NCT02092909|8599141|P3|Overall Study|Miscellaneous|2
2487879|NCT02092909|8599142|P2|Overall Study|Miscellaneous|1
2487880|NCT02092909|8599143|P1|Overall Study|Miscellaneous|1
2487881|NCT02092909|8599140|P4|Overall Study|Study terminated by Sponsor|2
2487882|NCT02092909|8599141|P3|Overall Study|Study terminated by Sponsor|0
2487883|NCT02092909|8599142|P2|Overall Study|Study terminated by Sponsor|0
2487884|NCT02092909|8599143|P1|Overall Study|Study terminated by Sponsor|0
2487885|NCT02092909|8599140|P4|Overall Study|Withdrawal by Subject|1
2487886|NCT02092909|8599141|P3|Overall Study|Withdrawal by Subject|2
2487887|NCT02092909|8599142|P2|Overall Study|Withdrawal by Subject|0
2487888|NCT02092909|8599143|P1|Overall Study|Withdrawal by Subject|0
2487889|NCT02092909|8599140|P4|Overall Study|Lack of Efficacy|0
2487890|NCT02092909|8599141|P3|Overall Study|Lack of Efficacy|1
2487891|NCT02092909|8599142|P2|Overall Study|Lack of Efficacy|2
2487892|NCT02092909|8599143|P1|Overall Study|Lack of Efficacy|0
2487893|NCT02092909|8599140|P4|Overall Study|Adverse Event|2
2487894|NCT02092909|8599141|P3|Overall Study|Adverse Event|4
2487895|NCT02092909|8599142|P2|Overall Study|Adverse Event|0
2487896|NCT02092909|8599143|P1|Overall Study|Adverse Event|0
2487897|NCT02092662|8599184|P2|Overall Study|Lost to Follow-up|0
2487898|NCT02092662|8599185|P1|Overall Study|Lost to Follow-up|13
2487899|NCT02092389|8599244|P1|Overall Study|Other|5
2487900|NCT02092389|8599244|P1|Overall Study|Adverse Event|1
2487901|NCT02092350|8599256|P2|Overall Study|Withdrawal by Subject|2
2487902|NCT02092350|8599257|P1|Overall Study|Withdrawal by Subject|2
2487903|NCT02092350|8599256|P2|Overall Study|Screen Failure|0
2487904|NCT02092350|8599257|P1|Overall Study|Screen Failure|1
2487905|NCT02092350|8599256|P2|Overall Study|Physician Decision|1
2487906|NCT02092350|8599257|P1|Overall Study|Physician Decision|1
2487907|NCT02092350|8599256|P2|Overall Study|Protocol Violation|0
2487908|NCT02092350|8599257|P1|Overall Study|Protocol Violation|1
2487909|NCT02092350|8599256|P2|Overall Study|Lost to Follow-up|1
2487910|NCT02092350|8599257|P1|Overall Study|Lost to Follow-up|3
2487911|NCT02092350|8599256|P2|Overall Study|Death|5
2487912|NCT02092350|8599257|P1|Overall Study|Death|2
2487913|NCT02092350|8599256|P2|Overall Study|Adverse Event|3
2487914|NCT02092350|8599257|P1|Overall Study|Adverse Event|0
2487915|NCT02092285|8599285|P1|Maintenance Phase & Follow-up|Lack of Efficacy|23
2487916|NCT02092285|8599285|P1|Maintenance Phase & Follow-up|Withdrawal by Subject|11
2487917|NCT02092285|8599285|P1|Maintenance Phase & Follow-up|Relapse/recurrence|29
2487918|NCT02092285|8599285|P1|Maintenance Phase & Follow-up|Protocol Violation|11
2487919|NCT02092285|8599285|P1|Maintenance Phase & Follow-up|Pregnancy|1
2487920|NCT02092285|8599285|P1|Maintenance Phase & Follow-up|Physician Decision|10
2487921|NCT02092285|8599285|P1|Maintenance Phase & Follow-up|Non-compliance with study drug|2
2487922|NCT02092285|8599285|P1|Maintenance Phase & Follow-up|Lost to Follow-up|1
2487923|NCT02092285|8599285|P1|Maintenance Phase & Follow-up|Adverse Event|22
2487924|NCT02092285|8599285|P1|Induction Phase|Lack of Efficacy|14
2487925|NCT02092285|8599285|P1|Induction Phase|Withdrawal by Subject|2
2487926|NCT02092285|8599285|P1|Induction Phase|Relapse/Recurrence|7
2487927|NCT02092285|8599285|P1|Induction Phase|Pregnancy|1
2487928|NCT02092285|8599285|P1|Induction Phase|Physician Decision|4
2487929|NCT02092285|8599285|P1|Induction Phase|Adverse Event|7
2487930|NCT02092220|8599289|P2|Period 2|Nausea, Anxiety, Inconvenience|1
2487931|NCT02092220|8599290|P1|Period 2|Nausea, Anxiety, Inconvenience|0
2487932|NCT02092220|8599289|P2|Period 2|Severe Hypoglycaemia|0
2487933|NCT02092220|8599290|P1|Period 2|Severe Hypoglycaemia|1
2487934|NCT02092220|8599289|P2|Period 1|Unrelated Illness|2
2487935|NCT02092220|8599290|P1|Period 1|Unrelated Illness|0
2487936|NCT02092116|8599363|P2|Overall Study|Adverse Event|1
2487937|NCT02092116|8599364|P1|Overall Study|Adverse Event|0
2487938|NCT02092116|8599363|P2|Overall Study|Withdrawal by Subject|3
2487939|NCT02092116|8599364|P1|Overall Study|Withdrawal by Subject|0
2487940|NCT02092025|8599373|P1|Overall Study|Protocol Deviation|24
2487941|NCT02092025|8599373|P1|Overall Study|Case Report Forms Uncollected|44
2487942|NCT02091986|8599382|P3|Overall Study|Adverse Event|2
2487943|NCT02091986|8599383|P2|Overall Study|Adverse Event|0
2487944|NCT02091986|8599384|P1|Overall Study|Adverse Event|0
2487945|NCT02091986|8599382|P3|Overall Study|Withdrawal by Subject|3
2487946|NCT02091986|8599383|P2|Overall Study|Withdrawal by Subject|8
2487947|NCT02091986|8599384|P1|Overall Study|Withdrawal by Subject|4
2487948|NCT02091986|8599382|P3|Overall Study|Lost to Follow-up|0
2487949|NCT02091986|8599383|P2|Overall Study|Lost to Follow-up|0
2487950|NCT02091986|8599384|P1|Overall Study|Lost to Follow-up|1
2487951|NCT02091986|8599382|P3|Overall Study|7 rand in error 1 patient decision|3
2487952|NCT02091986|8599383|P2|Overall Study|7 rand in error 1 patient decision|3
2487953|NCT02091986|8599384|P1|Overall Study|7 rand in error 1 patient decision|2
2487954|NCT02091960|8599431|P1|Overall Study|On Study at Data Cut-off|12
2487955|NCT02091960|8599431|P1|Overall Study|Miscellaneous Reasons|31
2487956|NCT02091960|8599431|P1|Overall Study|Withdrawal by Subject|1
2487957|NCT02091960|8599431|P1|Overall Study|Death|7
2487958|NCT02091921|8599442|P1|Overall Study|Adverse Event|3
2487959|NCT02091869|8599451|P2|Overall Study|Withdrawal by Subject|3
2487960|NCT02091869|8599452|P1|Overall Study|Withdrawal by Subject|0
2487961|NCT02091752|8599493|P1|Overall Study|Adverse Event|1
2487962|NCT02091752|8599493|P1|Overall Study|Study terminated by Sponsor|2
2487963|NCT02091739|8599507|P5|EP: 48 Weeks|Withdrawal by Subject|6
2487964|NCT02091739|8599508|P4|EP: 48 Weeks|Withdrawal by Subject|2
2487965|NCT02091739|8599509|P3|EP: 48 Weeks|Withdrawal by Subject|0
2487966|NCT02091739|8599510|P2|EP: 48 Weeks|Withdrawal by Subject|0
2487967|NCT02091739|8599511|P1|EP: 48 Weeks|Withdrawal by Subject|0
2487968|NCT02091739|8599507|P5|EP: 48 Weeks|Adverse Event|6
2487969|NCT02091739|8599508|P4|EP: 48 Weeks|Adverse Event|2
2487970|NCT02091739|8599509|P3|EP: 48 Weeks|Adverse Event|0
2487971|NCT02091739|8599510|P2|EP: 48 Weeks|Adverse Event|0
2487972|NCT02091739|8599511|P1|EP: 48 Weeks|Adverse Event|0
2487973|NCT02091739|8599507|P5|EP: 48 Weeks|Death|2
2487974|NCT02091739|8599508|P4|EP: 48 Weeks|Death|3
2487975|NCT02091739|8599509|P3|EP: 48 Weeks|Death|0
2487976|NCT02091739|8599510|P2|EP: 48 Weeks|Death|0
2487977|NCT02091739|8599511|P1|EP: 48 Weeks|Death|0
2487978|NCT02091739|8599507|P5|EP: 48 Weeks|Other|0
2487979|NCT02091739|8599508|P4|EP: 48 Weeks|Other|1
2487980|NCT02091739|8599509|P3|EP: 48 Weeks|Other|0
2487981|NCT02091739|8599510|P2|EP: 48 Weeks|Other|0
2487982|NCT02091739|8599511|P1|EP: 48 Weeks|Other|0
2487983|NCT02091739|8599507|P5|MP: 16 Weeks|Lost to Follow-up|0
2487984|NCT02091739|8599508|P4|MP: 16 Weeks|Lost to Follow-up|0
2487985|NCT02091739|8599509|P3|MP: 16 Weeks|Lost to Follow-up|1
2487986|NCT02091739|8599510|P2|MP: 16 Weeks|Lost to Follow-up|0
2487987|NCT02091739|8599511|P1|MP: 16 Weeks|Lost to Follow-up|0
2487988|NCT02091739|8599507|P5|MP: 16 Weeks|Withdrawal by Subject|0
2487989|NCT02091739|8599508|P4|MP: 16 Weeks|Withdrawal by Subject|0
2487990|NCT02091739|8599509|P3|MP: 16 Weeks|Withdrawal by Subject|0
2487991|NCT02091739|8599510|P2|MP: 16 Weeks|Withdrawal by Subject|4
2487992|NCT02091739|8599511|P1|MP: 16 Weeks|Withdrawal by Subject|3
2487993|NCT02091739|8599507|P5|MP: 16 Weeks|Adverse Event|0
2487994|NCT02091739|8599508|P4|MP: 16 Weeks|Adverse Event|0
2487995|NCT02091739|8599509|P3|MP: 16 Weeks|Adverse Event|1
2487996|NCT02091739|8599510|P2|MP: 16 Weeks|Adverse Event|1
2487997|NCT02091739|8599511|P1|MP: 16 Weeks|Adverse Event|1
2487998|NCT02091726|8599530|P1|Overall Study|Lost to Follow-up|6
2487999|NCT02091440|8599553|P1|Overall Study|Death|2
2488000|NCT02091414|8599563|P1|Overall Study|Death|2
2488001|NCT02091414|8599563|P1|Overall Study|Withdrawal by Subject|2
2488002|NCT02091375|8599577|P2|Overall Study|Withdrawn by the investigator|0
2488003|NCT02091375|8599578|P1|Overall Study|Withdrawn by the investigator|1
2488004|NCT02091375|8599577|P2|Overall Study|Withdrawal by Subject|1
2488005|NCT02091375|8599578|P1|Overall Study|Withdrawal by Subject|0
2488006|NCT02091375|8599577|P2|Overall Study|Lost to Follow-up|1
2488007|NCT02091375|8599578|P1|Overall Study|Lost to Follow-up|0
2488008|NCT02091375|8599577|P2|Overall Study|Adverse Event|1
2488009|NCT02091375|8599578|P1|Overall Study|Adverse Event|8
2488010|NCT02091362|8599608|P2|Period 2|Withdrawal by Subject|1
2488011|NCT02091362|8599609|P1|Period 2|Withdrawal by Subject|1
2488012|NCT02091362|8599608|P2|Period 2|Lost to Follow-up|1
2488013|NCT02091362|8599609|P1|Period 2|Lost to Follow-up|0
2488014|NCT02091362|8599608|P2|Period 2|Adverse Event|0
2488015|NCT02091362|8599609|P1|Period 2|Adverse Event|1
2488016|NCT02091362|8599608|P2|Wash-out|Withdrawal by Subject|2
2488017|NCT02091362|8599609|P1|Wash-out|Withdrawal by Subject|0
2488018|NCT02091362|8599608|P2|Wash-out|Lost to Follow-up|1
2488019|NCT02091362|8599609|P1|Wash-out|Lost to Follow-up|1
2488020|NCT02091362|8599608|P2|Period 1|Adverse Event|0
2488021|NCT02091362|8599609|P1|Period 1|Adverse Event|2
2488022|NCT02091362|8599608|P2|Period 1|Lost to Follow-up|1
2488023|NCT02091362|8599609|P1|Period 1|Lost to Follow-up|0
2488024|NCT02091362|8599608|P2|Period 1|Withdrawal by Subject|3
2488025|NCT02091362|8599609|P1|Period 1|Withdrawal by Subject|2
2488026|NCT02091362|8599608|P2|Period 1|Protocol Violation|0
2488027|NCT02091362|8599609|P1|Period 1|Protocol Violation|1
2488028|NCT02091284|8599631|P2|Overall Study|unreliable data|0
2488029|NCT02091284|8599632|P1|Overall Study|unreliable data|1
2488030|NCT02091284|8599631|P2|Overall Study|Withdrawal by Subject|1
2488031|NCT02091284|8599632|P1|Overall Study|Withdrawal by Subject|2
2488032|NCT02091206|8599654|P4|Taper Period|Lost to Follow-up|1
2488033|NCT02091206|8599655|P3|Taper Period|Lost to Follow-up|0
2488034|NCT02091206|8599656|P2|Taper Period|Lost to Follow-up|0
2488035|NCT02091206|8599657|P1|Taper Period|Lost to Follow-up|0
2488036|NCT02091206|8599654|P4|Taper Period|Participant refused study drug|1
2488037|NCT02091206|8599655|P3|Taper Period|Participant refused study drug|0
2488038|NCT02091206|8599656|P2|Taper Period|Participant refused study drug|0
2488039|NCT02091206|8599657|P1|Taper Period|Participant refused study drug|1
2488040|NCT02091206|8599654|P4|Treatment Period|Met withdrawal criteria|0
2488041|NCT02091206|8599655|P3|Treatment Period|Met withdrawal criteria|1
2488042|NCT02091206|8599656|P2|Treatment Period|Met withdrawal criteria|0
2488043|NCT02091206|8599657|P1|Treatment Period|Met withdrawal criteria|0
2488044|NCT02091206|8599654|P4|Treatment Period|Adverse Event|0
2488045|NCT02091206|8599655|P3|Treatment Period|Adverse Event|0
2488046|NCT02091206|8599656|P2|Treatment Period|Adverse Event|1
2488047|NCT02091206|8599657|P1|Treatment Period|Adverse Event|0
2488048|NCT02091167|8599676|P2|Overall Study|Lost to Follow-up|2
2488049|NCT02091167|8599677|P1|Overall Study|Lost to Follow-up|0
2488050|NCT02090855|8599690|P1|Overall Study|no evaluable Standard of Truth results|2
2488051|NCT02090764|8599703|P2|Overall Study|Lost to Follow-up|2
2488052|NCT02090764|8599704|P1|Overall Study|Lost to Follow-up|2
2488053|NCT02090764|8599703|P2|Overall Study|Intercurrent illness and other|1
2488054|NCT02090764|8599704|P1|Overall Study|Intercurrent illness and other|1
2488055|NCT02090764|8599703|P2|Overall Study|Withdrawal by Subject|1
2488056|NCT02090764|8599704|P1|Overall Study|Withdrawal by Subject|2
2488057|NCT02090764|8599703|P2|Overall Study|Lack of Efficacy|13
2488058|NCT02090764|8599704|P1|Overall Study|Lack of Efficacy|0
2488059|NCT02090764|8599703|P2|Overall Study|Adverse Event|3
2488060|NCT02090764|8599704|P1|Overall Study|Adverse Event|1
2488061|NCT02090725|8599710|P1|Overall Study|participants moved from area|3
2488062|NCT02090725|8599710|P1|Overall Study|Withdrawal by Subject|1
2488063|NCT02090426|8599716|P2|Overall Study|Lost to Follow-up|6
2488064|NCT02090426|8599717|P1|Overall Study|Lost to Follow-up|12
2488065|NCT02090413|8599748|P3|Overall Study|Lost to Follow-up|0
2488066|NCT02090413|8599749|P2|Overall Study|Lost to Follow-up|1
2488067|NCT02090413|8599750|P1|Overall Study|Lost to Follow-up|1
2488068|NCT02090413|8599748|P3|Overall Study|Other|0
2488069|NCT02090413|8599749|P2|Overall Study|Other|1
2488070|NCT02090413|8599750|P1|Overall Study|Other|2
2488071|NCT02090413|8599748|P3|Overall Study|Investigator Decision|0
2488072|NCT02090413|8599749|P2|Overall Study|Investigator Decision|1
2488073|NCT02090413|8599750|P1|Overall Study|Investigator Decision|1
2488074|NCT02090413|8599748|P3|Overall Study|Withdrawal by Subject|2
2488075|NCT02090413|8599749|P2|Overall Study|Withdrawal by Subject|2
2488076|NCT02090413|8599750|P1|Overall Study|Withdrawal by Subject|2
2488077|NCT02090413|8599748|P3|Overall Study|Flushing event|1
2488078|NCT02090413|8599749|P2|Overall Study|Flushing event|0
2488079|NCT02090413|8599750|P1|Overall Study|Flushing event|2
2488080|NCT02090413|8599748|P3|Overall Study|Adverse Event|20
2488081|NCT02090413|8599749|P2|Overall Study|Adverse Event|15
2488082|NCT02090413|8599750|P1|Overall Study|Adverse Event|11
2488083|NCT02090283|8599827|P3|Overall Study|Protocol Violation|0
2488084|NCT02090283|8599828|P2|Overall Study|Protocol Violation|0
2488085|NCT02090283|8599829|P1|Overall Study|Protocol Violation|2
2488086|NCT02090283|8599827|P3|Overall Study|Adverse Event|0
2488087|NCT02090283|8599828|P2|Overall Study|Adverse Event|1
2488088|NCT02090283|8599829|P1|Overall Study|Adverse Event|1
2488089|NCT02090283|8599827|P3|Overall Study|Lost to Follow-up|3
2488090|NCT02090283|8599828|P2|Overall Study|Lost to Follow-up|2
2488091|NCT02090283|8599829|P1|Overall Study|Lost to Follow-up|2
2488092|NCT02090283|8599827|P3|Overall Study|Sponsor Terminated Study|1
2488093|NCT02090283|8599828|P2|Overall Study|Sponsor Terminated Study|6
2488094|NCT02090283|8599829|P1|Overall Study|Sponsor Terminated Study|6
2488095|NCT02090283|8599827|P3|Overall Study|Withdrawal by Subject|6
2488096|NCT02090283|8599828|P2|Overall Study|Withdrawal by Subject|6
2488097|NCT02090283|8599829|P1|Overall Study|Withdrawal by Subject|6
2488098|NCT02089997|8599863|P1|Overall Study|Protocol Violation|147
2488099|NCT02089997|8599863|P1|Overall Study|Case report forms uncollected|99
2488100|NCT02089737|8599878|P1|Overall Study|Not treated|1
2488101|NCT02089737|8599878|P1|Overall Study|Survey form not completed|5
2488102|NCT02089347|8599903|P2|Overall Study|Protocol Violation|0
2488103|NCT02089347|8599904|P1|Overall Study|Protocol Violation|1
2488104|NCT02088957|8599946|P2|Overall Study|Lack of Efficacy|0
2488105|NCT02088957|8599947|P1|Overall Study|Lack of Efficacy|1
2488106|NCT02088905|8599965|P2|Overall Study|Withdrawal by Subject|1
2488107|NCT02088905|8599966|P1|Overall Study|Withdrawal by Subject|5
2488108|NCT02088177|8600037|P1|Overall Study|Lost to Follow-up|3
2488109|NCT02088073|8600047|P5|Maintanance Phase|Subject compliance|0
2488110|NCT02088073|8600048|P4|Maintanance Phase|Subject compliance|0
2488111|NCT02088073|8600049|P3|Maintanance Phase|Subject compliance|0
2488112|NCT02088073|8600050|P2|Maintanance Phase|Subject compliance|1
2488113|NCT02088073|8600051|P1|Maintanance Phase|Subject compliance|0
2488114|NCT02088073|8600047|P5|Maintanance Phase|Met ECG withdrawal criteria|2
2488115|NCT02088073|8600048|P4|Maintanance Phase|Met ECG withdrawal criteria|0
2488116|NCT02088073|8600049|P3|Maintanance Phase|Met ECG withdrawal criteria|1
2488117|NCT02088073|8600050|P2|Maintanance Phase|Met ECG withdrawal criteria|0
2488118|NCT02088073|8600051|P1|Maintanance Phase|Met ECG withdrawal criteria|0
2488119|NCT02088073|8600047|P5|Maintanance Phase|Miscellaneous|1
2488120|NCT02088073|8600048|P4|Maintanance Phase|Miscellaneous|2
2488121|NCT02088073|8600049|P3|Maintanance Phase|Miscellaneous|1
2488122|NCT02088073|8600050|P2|Maintanance Phase|Miscellaneous|2
2488123|NCT02088073|8600051|P1|Maintanance Phase|Miscellaneous|0
2488124|NCT02088073|8600047|P5|Maintanance Phase|Hypo- or hyperkalemia|1
2488125|NCT02088073|8600048|P4|Maintanance Phase|Hypo- or hyperkalemia|3
2488126|NCT02088073|8600049|P3|Maintanance Phase|Hypo- or hyperkalemia|0
2488127|NCT02088073|8600050|P2|Maintanance Phase|Hypo- or hyperkalemia|3
2488128|NCT02088073|8600051|P1|Maintanance Phase|Hypo- or hyperkalemia|0
2488129|NCT02088073|8600047|P5|Maintanance Phase|Sponsor's decision|1
2488130|NCT02088073|8600048|P4|Maintanance Phase|Sponsor's decision|2
2488131|NCT02088073|8600049|P3|Maintanance Phase|Sponsor's decision|0
2488132|NCT02088073|8600050|P2|Maintanance Phase|Sponsor's decision|2
2488133|NCT02088073|8600051|P1|Maintanance Phase|Sponsor's decision|0
2488134|NCT02088073|8600047|P5|Maintanance Phase|Physician Decision|1
2488135|NCT02088073|8600048|P4|Maintanance Phase|Physician Decision|0
2488136|NCT02088073|8600049|P3|Maintanance Phase|Physician Decision|0
2488137|NCT02088073|8600050|P2|Maintanance Phase|Physician Decision|0
2488138|NCT02088073|8600051|P1|Maintanance Phase|Physician Decision|0
2488139|NCT02088073|8600047|P5|Maintanance Phase|Adverse Event|1
2488140|NCT02088073|8600048|P4|Maintanance Phase|Adverse Event|0
2488141|NCT02088073|8600049|P3|Maintanance Phase|Adverse Event|3
2488142|NCT02088073|8600050|P2|Maintanance Phase|Adverse Event|0
2488143|NCT02088073|8600051|P1|Maintanance Phase|Adverse Event|0
2488144|NCT02088073|8600047|P5|Maintanance Phase|Withdrawal by Subject|0
2488145|NCT02088073|8600048|P4|Maintanance Phase|Withdrawal by Subject|0
2488146|NCT02088073|8600049|P3|Maintanance Phase|Withdrawal by Subject|0
2488147|NCT02088073|8600050|P2|Maintanance Phase|Withdrawal by Subject|2
2488148|NCT02088073|8600051|P1|Maintanance Phase|Withdrawal by Subject|0
2488149|NCT02088073|8600047|P5|Acute Phase|Hyperkalemia|0
2488150|NCT02088073|8600048|P4|Acute Phase|Hyperkalemia|0
2488151|NCT02088073|8600049|P3|Acute Phase|Hyperkalemia|0
2488152|NCT02088073|8600050|P2|Acute Phase|Hyperkalemia|0
2488153|NCT02088073|8600051|P1|Acute Phase|Hyperkalemia|2
2488154|NCT02088073|8600047|P5|Acute Phase|Withdrawal by Subject|0
2488155|NCT02088073|8600048|P4|Acute Phase|Withdrawal by Subject|0
2488156|NCT02088073|8600049|P3|Acute Phase|Withdrawal by Subject|0
2488157|NCT02088073|8600050|P2|Acute Phase|Withdrawal by Subject|0
2488158|NCT02088073|8600051|P1|Acute Phase|Withdrawal by Subject|5
2488159|NCT02087943|8600125|P5|Active Treatment Phase Week 12-24|Other-Unspecified|0
2488160|NCT02087943|8600126|P4|Active Treatment Phase Week 12-24|Other-Unspecified|1
2488161|NCT02087943|8600127|P3|Active Treatment Phase Week 12-24|Other-Unspecified|1
2488162|NCT02087943|8600128|P2|Active Treatment Phase Week 12-24|Other-Unspecified|0
2488163|NCT02087943|8600129|P1|Active Treatment Phase Week 12-24|Other-Unspecified|0
2488164|NCT02087943|8600125|P5|Active Treatment Phase Week 12-24|Lost to Follow-up|1
2488165|NCT02087943|8600126|P4|Active Treatment Phase Week 12-24|Lost to Follow-up|0
2488166|NCT02087943|8600127|P3|Active Treatment Phase Week 12-24|Lost to Follow-up|0
2488167|NCT02087943|8600128|P2|Active Treatment Phase Week 12-24|Lost to Follow-up|0
2488168|NCT02087943|8600129|P1|Active Treatment Phase Week 12-24|Lost to Follow-up|0
2488169|NCT02087943|8600125|P5|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
2488170|NCT02087943|8600126|P4|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
2488171|NCT02087943|8600127|P3|Active Treatment Phase Week 12-24|Withdrawal by Subject|1
2488172|NCT02087943|8600128|P2|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
2488173|NCT02087943|8600129|P1|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
2488174|NCT02087943|8600125|P5|Active Treatment Phase Week 12-24|Lack of Efficacy|0
2488175|NCT02087943|8600126|P4|Active Treatment Phase Week 12-24|Lack of Efficacy|1
2488176|NCT02087943|8600127|P3|Active Treatment Phase Week 12-24|Lack of Efficacy|1
2488177|NCT02087943|8600128|P2|Active Treatment Phase Week 12-24|Lack of Efficacy|3
2488178|NCT02087943|8600129|P1|Active Treatment Phase Week 12-24|Lack of Efficacy|0
2488179|NCT02087943|8600125|P5|Active Treatment Phase Week 12-24|Adverse Event|1
2488180|NCT02087943|8600126|P4|Active Treatment Phase Week 12-24|Adverse Event|0
2488181|NCT02087943|8600127|P3|Active Treatment Phase Week 12-24|Adverse Event|2
2488182|NCT02087943|8600128|P2|Active Treatment Phase Week 12-24|Adverse Event|1
2488183|NCT02087943|8600129|P1|Active Treatment Phase Week 12-24|Adverse Event|0
2488184|NCT02087943|8600125|P5|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
2488185|NCT02087943|8600126|P4|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
2488186|NCT02087943|8600127|P3|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
2488187|NCT02087943|8600128|P2|Placebo-Controlled Phase Week 0-12|Protocol Violation|1
2488188|NCT02087943|8600129|P1|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
2488189|NCT02087943|8600125|P5|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
2488190|NCT02087943|8600126|P4|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
2488191|NCT02087943|8600127|P3|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
2488192|NCT02087943|8600128|P2|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
2488193|NCT02087943|8600129|P1|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
2488194|NCT02087943|8600125|P5|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
2488195|NCT02087943|8600126|P4|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
2488196|NCT02087943|8600127|P3|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
2488197|NCT02087943|8600128|P2|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
2488198|NCT02087943|8600129|P1|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4
2488286|NCT02087150|8600409|P1|Overall Study|Withdrawal by Subject|2
2488199|NCT02087943|8600125|P5|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
2488200|NCT02087943|8600126|P4|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
2488201|NCT02087943|8600127|P3|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4
2488202|NCT02087943|8600128|P2|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7
2488203|NCT02087943|8600129|P1|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8
2488204|NCT02087943|8600125|P5|Placebo-Controlled Phase Week 0-12|Adverse Event|0
2488205|NCT02087943|8600126|P4|Placebo-Controlled Phase Week 0-12|Adverse Event|0
2488206|NCT02087943|8600127|P3|Placebo-Controlled Phase Week 0-12|Adverse Event|6
2488207|NCT02087943|8600128|P2|Placebo-Controlled Phase Week 0-12|Adverse Event|2
2488208|NCT02087943|8600129|P1|Placebo-Controlled Phase Week 0-12|Adverse Event|1
2488209|NCT02087904|8600157|P4|Overall Study|Lost to Follow-up|2
2488210|NCT02087904|8600158|P3|Overall Study|Lost to Follow-up|2
2488211|NCT02087904|8600159|P2|Overall Study|Lost to Follow-up|4
2488212|NCT02087904|8600160|P1|Overall Study|Lost to Follow-up|0
2488213|NCT02087904|8600157|P4|Overall Study|Withdrawal by Subject|4
2488214|NCT02087904|8600158|P3|Overall Study|Withdrawal by Subject|7
2488215|NCT02087904|8600159|P2|Overall Study|Withdrawal by Subject|3
2488216|NCT02087904|8600160|P1|Overall Study|Withdrawal by Subject|8
2488217|NCT02087904|8600157|P4|Overall Study|Other|4
2488218|NCT02087904|8600158|P3|Overall Study|Other|4
2488219|NCT02087904|8600159|P2|Overall Study|Other|2
2488220|NCT02087904|8600160|P1|Overall Study|Other|6
2488221|NCT02087904|8600157|P4|Overall Study|Lack of Efficacy|2
2488222|NCT02087904|8600158|P3|Overall Study|Lack of Efficacy|3
2488223|NCT02087904|8600159|P2|Overall Study|Lack of Efficacy|6
2488224|NCT02087904|8600160|P1|Overall Study|Lack of Efficacy|3
2488225|NCT02087904|8600157|P4|Overall Study|Adverse Event|12
2488226|NCT02087904|8600158|P3|Overall Study|Adverse Event|4
2488227|NCT02087904|8600159|P2|Overall Study|Adverse Event|4
2488228|NCT02087904|8600160|P1|Overall Study|Adverse Event|8
2488229|NCT02087904|8600157|P4|Overall Study|Did Not Receive Study Drug|1
2488230|NCT02087904|8600158|P3|Overall Study|Did Not Receive Study Drug|2
2488231|NCT02087904|8600159|P2|Overall Study|Did Not Receive Study Drug|0
2488232|NCT02087904|8600160|P1|Overall Study|Did Not Receive Study Drug|0
2488233|NCT02087774|8600276|P2|Overall Study|Were absent day of data collection|20
2488234|NCT02087774|8600277|P1|Overall Study|Were absent day of data collection|8
2488235|NCT02087670|8600297|P2|Overall Study|Withdrawal by Subject|2
2488236|NCT02087670|8600298|P1|Overall Study|Withdrawal by Subject|3
2488237|NCT02087423|8600334|P3|Overall Study|Terminated from study at final DCO|25
2488238|NCT02087423|8600335|P2|Overall Study|Terminated from study at final DCO|36
2488239|NCT02087423|8600336|P1|Overall Study|Terminated from study at final DCO|23
2488240|NCT02087423|8600334|P3|Overall Study|Lost to Follow-up|0
2488241|NCT02087423|8600335|P2|Overall Study|Lost to Follow-up|2
2488242|NCT02087423|8600336|P1|Overall Study|Lost to Follow-up|0
2488243|NCT02087423|8600334|P3|Overall Study|Death|40
2488244|NCT02087423|8600335|P2|Overall Study|Death|207
2488245|NCT02087423|8600336|P1|Overall Study|Death|68
2488246|NCT02087423|8600334|P3|Overall Study|Withdrawal by Subject|3
2488247|NCT02087423|8600335|P2|Overall Study|Withdrawal by Subject|20
2488248|NCT02087423|8600336|P1|Overall Study|Withdrawal by Subject|20
2488249|NCT02087241|8600365|P4|Overall Study|Study Terminated by Sponsor|4
2488250|NCT02087241|8600366|P3|Overall Study|Study Terminated by Sponsor|0
2488251|NCT02087241|8600367|P2|Overall Study|Study Terminated by Sponsor|2
2488252|NCT02087241|8600368|P1|Overall Study|Study Terminated by Sponsor|0
2488253|NCT02087241|8600365|P4|Overall Study|Progressive Disease|1
2488254|NCT02087241|8600366|P3|Overall Study|Progressive Disease|0
2488255|NCT02087241|8600367|P2|Overall Study|Progressive Disease|0
2488256|NCT02087241|8600368|P1|Overall Study|Progressive Disease|0
2488257|NCT02087241|8600365|P4|Overall Study|Withdrawal by Subject|1
2488258|NCT02087241|8600366|P3|Overall Study|Withdrawal by Subject|0
2488259|NCT02087241|8600367|P2|Overall Study|Withdrawal by Subject|0
2488260|NCT02087241|8600368|P1|Overall Study|Withdrawal by Subject|1
2488261|NCT02087241|8600365|P4|Overall Study|Death|1
2488262|NCT02087241|8600366|P3|Overall Study|Death|1
2488263|NCT02087241|8600367|P2|Overall Study|Death|1
2488264|NCT02087241|8600368|P1|Overall Study|Death|2
2488265|NCT02087176|8600394|P1|Overall Study|Study Terminated by Sponsor|2
2488266|NCT02087176|8600394|P1|Overall Study|Censored|19
2488267|NCT02087176|8600394|P1|Overall Study|Death|10
2488268|NCT02087176|8600394|P1|Overall Study|Withdrawal by Subject|1
2488269|NCT02087150|8600407|P3|Overall Study|Pt moved out of town|0
2488270|NCT02087150|8600408|P2|Overall Study|Pt moved out of town|1
2488271|NCT02087150|8600409|P1|Overall Study|Pt moved out of town|0
2488272|NCT02087150|8600407|P3|Overall Study|Other|0
2488273|NCT02087150|8600408|P2|Overall Study|Other|0
2488274|NCT02087150|8600409|P1|Overall Study|Other|1
2488275|NCT02087150|8600407|P3|Overall Study|F/U not completed w/in study window|1
2488276|NCT02087150|8600408|P2|Overall Study|F/U not completed w/in study window|0
2488277|NCT02087150|8600409|P1|Overall Study|F/U not completed w/in study window|0
2488278|NCT02087150|8600407|P3|Overall Study|Procedure not done|0
2488279|NCT02087150|8600408|P2|Overall Study|Procedure not done|13
2488280|NCT02087150|8600409|P1|Overall Study|Procedure not done|1
2488281|NCT02087150|8600407|P3|Overall Study|Physician Decision|0
2488282|NCT02087150|8600408|P2|Overall Study|Physician Decision|1
2488283|NCT02087150|8600409|P1|Overall Study|Physician Decision|0
2488284|NCT02087150|8600407|P3|Overall Study|Withdrawal by Subject|3
2488285|NCT02087150|8600408|P2|Overall Study|Withdrawal by Subject|5
2488287|NCT02087150|8600407|P3|Overall Study|Lost to Follow-up|7
2488288|NCT02087150|8600408|P2|Overall Study|Lost to Follow-up|13
2488289|NCT02087150|8600409|P1|Overall Study|Lost to Follow-up|6
2488290|NCT02087150|8600407|P3|Overall Study|Death|0
2488291|NCT02087150|8600408|P2|Overall Study|Death|1
2488292|NCT02087150|8600409|P1|Overall Study|Death|0
2488293|NCT02087085|8600428|P2|Overall Study|Other Miscellaneous Reasons|4
2488294|NCT02087085|8600429|P1|Overall Study|Other Miscellaneous Reasons|3
2488295|NCT02087085|8600428|P2|Overall Study|Study Terminated by Sponsor|80
2488296|NCT02087085|8600429|P1|Overall Study|Study Terminated by Sponsor|87
2488297|NCT02087085|8600428|P2|Overall Study|Protocol Violation|0
2488298|NCT02087085|8600429|P1|Overall Study|Protocol Violation|1
2488299|NCT02087085|8600428|P2|Overall Study|Withdrawal by Subject|11
2488300|NCT02087085|8600429|P1|Overall Study|Withdrawal by Subject|9
2488301|NCT02087085|8600428|P2|Overall Study|Lost to Follow-up|4
2488302|NCT02087085|8600429|P1|Overall Study|Lost to Follow-up|6
2488303|NCT02087085|8600428|P2|Overall Study|Lack of Efficacy|3
2488304|NCT02087085|8600429|P1|Overall Study|Lack of Efficacy|4
2488305|NCT02087085|8600428|P2|Overall Study|Adverse Event|14
2488306|NCT02087085|8600429|P1|Overall Study|Adverse Event|10
2488307|NCT02087059|8600439|P1|Overall Study|Lost to Follow-up|1
2488308|NCT02087059|8600439|P1|Overall Study|Adverse Event|5
2488309|NCT02087059|8600439|P1|Overall Study|Disease Progression|1
2488310|NCT02086591|8600495|P1|Overall Study|protocol terminated|3
2488311|NCT02086591|8600495|P1|Overall Study|Withdrawal by Subject|1
2488312|NCT02086591|8600495|P1|Overall Study|Adverse Event|1
2488313|NCT02086565|8600503|P2|Overall Study|withdrawn by research team|2
2488314|NCT02086565|8600504|P1|Overall Study|withdrawn by research team|2
2488315|NCT02086565|8600503|P2|Overall Study|Death|2
2488316|NCT02086565|8600504|P1|Overall Study|Death|3
2488317|NCT02086565|8600503|P2|Overall Study|Withdrawal by Subject|1
2488318|NCT02086565|8600504|P1|Overall Study|Withdrawal by Subject|2
2488319|NCT02086565|8600503|P2|Overall Study|Lost to Follow-up|7
2488320|NCT02086565|8600504|P1|Overall Study|Lost to Follow-up|9
2488321|NCT02086552|8600518|P1|Overall Study|Withdrawal by Subject|1
2488322|NCT02086162|8600527|P2|Overall Study|Death|0
2488323|NCT02086162|8600528|P1|Overall Study|Death|1
2488324|NCT02086162|8600527|P2|Overall Study|Lost to Follow-up|2
2488325|NCT02086162|8600528|P1|Overall Study|Lost to Follow-up|4
2488326|NCT02086162|8600527|P2|Overall Study|moved|1
2488327|NCT02086162|8600528|P1|Overall Study|moved|1
2488328|NCT02086162|8600527|P2|Overall Study|Withdrawal by Subject|4
2488329|NCT02086162|8600528|P1|Overall Study|Withdrawal by Subject|4
2488330|NCT02086110|8600540|P2|Overall Study|Withdrawal by Subject|1
2488331|NCT02086110|8600541|P1|Overall Study|Withdrawal by Subject|1
2488332|NCT02085785|8600552|P2|Overall Study|Lost to Follow-up|1
2488333|NCT02085785|8600553|P1|Overall Study|Lost to Follow-up|0
2488334|NCT02085785|8600552|P2|Overall Study|Withdrawal by Subject|1
2488335|NCT02085785|8600553|P1|Overall Study|Withdrawal by Subject|2
2488336|NCT02085252|8600702|P2|Overall Study|Reason Unknown|1
2488337|NCT02085252|8600703|P1|Overall Study|Reason Unknown|0
2488338|NCT02085252|8600702|P2|Overall Study|Reason Not Specified|1
2488339|NCT02085252|8600703|P1|Overall Study|Reason Not Specified|0
2488340|NCT02085252|8600702|P2|Overall Study|Discontinuation Due to Patient Decision|1
2488341|NCT02085252|8600703|P1|Overall Study|Discontinuation Due to Patient Decision|0
2488342|NCT02085252|8600702|P2|Overall Study|Adverse Event|1
2488343|NCT02085252|8600703|P1|Overall Study|Adverse Event|0
2488344|NCT02085252|8600702|P2|Overall Study|Withdrawal of Consent|0
2488345|NCT02085252|8600703|P1|Overall Study|Withdrawal of Consent|1
2488346|NCT02085161|8600727|P4|Overall Study|Other Reason|1
2488347|NCT02085161|8600728|P3|Overall Study|Other Reason|1
2488348|NCT02085161|8600729|P2|Overall Study|Other Reason|0
2488349|NCT02085161|8600730|P1|Overall Study|Other Reason|1
2488350|NCT02085161|8600727|P4|Overall Study|Withdrawal by Subject|3
2488351|NCT02085161|8600728|P3|Overall Study|Withdrawal by Subject|0
2488352|NCT02085161|8600729|P2|Overall Study|Withdrawal by Subject|4
2488353|NCT02085161|8600730|P1|Overall Study|Withdrawal by Subject|2
2488354|NCT02085161|8600727|P4|Overall Study|Protocol Violation|1
2488355|NCT02085161|8600728|P3|Overall Study|Protocol Violation|0
2488356|NCT02085161|8600729|P2|Overall Study|Protocol Violation|1
2488357|NCT02085161|8600730|P1|Overall Study|Protocol Violation|0
2488358|NCT02085161|8600727|P4|Overall Study|Adverse Event|5
2488359|NCT02085161|8600728|P3|Overall Study|Adverse Event|4
2488360|NCT02085161|8600729|P2|Overall Study|Adverse Event|5
2488361|NCT02085161|8600730|P1|Overall Study|Adverse Event|8
2488362|NCT02085161|8600727|P4|Overall Study|Not Treated|0
2488363|NCT02085161|8600728|P3|Overall Study|Not Treated|0
2488364|NCT02085161|8600729|P2|Overall Study|Not Treated|0
2488365|NCT02085161|8600730|P1|Overall Study|Not Treated|1
2488366|NCT02085135|8600771|P2|Overall Study|Lack of Efficacy|0
2488367|NCT02085135|8600772|P1|Overall Study|Lack of Efficacy|2
2488368|NCT02085135|8600771|P2|Overall Study|Withdrawal by Subject|0
2488369|NCT02085135|8600772|P1|Overall Study|Withdrawal by Subject|3
2488370|NCT02085135|8600771|P2|Overall Study|Lost to Follow-up|2
2488371|NCT02085135|8600772|P1|Overall Study|Lost to Follow-up|2
2488372|NCT02085135|8600771|P2|Overall Study|Adverse Event|7
2488373|NCT02085135|8600772|P1|Overall Study|Adverse Event|4
2488374|NCT02084238|8600844|P1|Overall Study|Lost to Follow-up|2
2488375|NCT02084134|8600869|P2|Overall Study|Death|1
2488376|NCT02084134|8600870|P1|Overall Study|Death|0
2488377|NCT02084134|8600869|P2|Overall Study|Protocol Violation|2
2488378|NCT02084134|8600870|P1|Overall Study|Protocol Violation|4
2488379|NCT02084082|8600880|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|1
2488380|NCT02084082|8600881|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
2488381|NCT02084082|8600882|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
2488382|NCT02084082|8600883|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|0
2488383|NCT02084082|8600880|P4|Washout Period 1 (35 Days)|Adverse Event|1
2488384|NCT02084082|8600881|P3|Washout Period 1 (35 Days)|Adverse Event|1
2488385|NCT02084082|8600882|P2|Washout Period 1 (35 Days)|Adverse Event|0
2488386|NCT02084082|8600883|P1|Washout Period 1 (35 Days)|Adverse Event|0
2488387|NCT02084056|8600924|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|0
2488388|NCT02084056|8600925|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
2488389|NCT02084056|8600926|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
2488390|NCT02084056|8600927|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|1
2488391|NCT02084056|8600924|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
2488392|NCT02084056|8600925|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
2488393|NCT02084056|8600926|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
2488394|NCT02084056|8600927|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
2488395|NCT02083965|8600959|P2|Treatment Period|Other|0
2488396|NCT02083965|8600960|P1|Treatment Period|Other|1
2488397|NCT02083653|8601055|P3|Overall Study|Reason Missing|4
2488398|NCT02083653|8601056|P2|Overall Study|Reason Missing|0
2488399|NCT02083653|8601057|P1|Overall Study|Reason Missing|0
2488400|NCT02083653|8601055|P3|Overall Study|Other Events|2
2488401|NCT02083653|8601056|P2|Overall Study|Other Events|2
2488402|NCT02083653|8601057|P1|Overall Study|Other Events|0
2488403|NCT02083653|8601055|P3|Overall Study|Withdrawal by Subject|2
2488404|NCT02083653|8601056|P2|Overall Study|Withdrawal by Subject|1
2488405|NCT02083653|8601057|P1|Overall Study|Withdrawal by Subject|2
2488406|NCT02083653|8601055|P3|Overall Study|Progressive Disease|63
2488407|NCT02083653|8601056|P2|Overall Study|Progressive Disease|73
2488408|NCT02083653|8601057|P1|Overall Study|Progressive Disease|65
2488409|NCT02083653|8601055|P3|Overall Study|Death|2
2488410|NCT02083653|8601056|P2|Overall Study|Death|2
2488411|NCT02083653|8601057|P1|Overall Study|Death|2
2488412|NCT02083653|8601055|P3|Overall Study|Lost to Follow-up|0
2488413|NCT02083653|8601056|P2|Overall Study|Lost to Follow-up|0
2488414|NCT02083653|8601057|P1|Overall Study|Lost to Follow-up|1
2488415|NCT02083653|8601055|P3|Overall Study|Adverse Event|4
2488416|NCT02083653|8601056|P2|Overall Study|Adverse Event|5
2488417|NCT02083653|8601057|P1|Overall Study|Adverse Event|12
2488418|NCT02083653|8601055|P3|Overall Study|Randomized but not Treated|7
2488419|NCT02083653|8601056|P2|Overall Study|Randomized but not Treated|2
2488420|NCT02083653|8601057|P1|Overall Study|Randomized but not Treated|0
2488421|NCT02083380|8601125|P3|Overall Study|Other|6
2488422|NCT02083380|8601126|P2|Overall Study|Other|4
2488423|NCT02083380|8601127|P1|Overall Study|Other|8
2488424|NCT02083380|8601125|P3|Overall Study|Lost to Follow-up|3
2488425|NCT02083380|8601126|P2|Overall Study|Lost to Follow-up|3
2488426|NCT02083380|8601127|P1|Overall Study|Lost to Follow-up|5
2488427|NCT02083380|8601125|P3|Overall Study|Adverse Event|1
2488428|NCT02083380|8601126|P2|Overall Study|Adverse Event|0
2488429|NCT02083380|8601127|P1|Overall Study|Adverse Event|0
2488430|NCT02083380|8601125|P3|Overall Study|Physician Decision|3
2488431|NCT02083380|8601126|P2|Overall Study|Physician Decision|6
2488432|NCT02083380|8601127|P1|Overall Study|Physician Decision|1
2488433|NCT02083380|8601125|P3|Overall Study|Withdrawal by Subject|7
2488434|NCT02083380|8601126|P2|Overall Study|Withdrawal by Subject|3
2488435|NCT02083380|8601127|P1|Overall Study|Withdrawal by Subject|9
2488436|NCT02083380|8601125|P3|Overall Study|Lack of Efficacy|64
2488437|NCT02083380|8601126|P2|Overall Study|Lack of Efficacy|79
2488438|NCT02083380|8601127|P1|Overall Study|Lack of Efficacy|68
2488439|NCT02083185|8601232|P3|Overall Study|Did not Receive Study Drug|0
2488440|NCT02083185|8601233|P2|Overall Study|Did not Receive Study Drug|2
2488441|NCT02083185|8601234|P1|Overall Study|Did not Receive Study Drug|0
2488442|NCT02083185|8601232|P3|Overall Study|Study Terminated by Sponsor|0
2488443|NCT02083185|8601233|P2|Overall Study|Study Terminated by Sponsor|1
2488444|NCT02083185|8601234|P1|Overall Study|Study Terminated by Sponsor|0
2488445|NCT02083185|8601232|P3|Overall Study|Reason not Specified|5
2488446|NCT02083185|8601233|P2|Overall Study|Reason not Specified|6
2488447|NCT02083185|8601234|P1|Overall Study|Reason not Specified|9
2488448|NCT02083185|8601232|P3|Overall Study|Death|1
2488449|NCT02083185|8601233|P2|Overall Study|Death|2
2488450|NCT02083185|8601234|P1|Overall Study|Death|2
2488451|NCT02083185|8601232|P3|Overall Study|Withdrawal by Subject|1
2488452|NCT02083185|8601233|P2|Overall Study|Withdrawal by Subject|15
2488453|NCT02083185|8601234|P1|Overall Study|Withdrawal by Subject|9
2488454|NCT02083185|8601232|P3|Overall Study|Lost to Follow-up|0
2488455|NCT02083185|8601233|P2|Overall Study|Lost to Follow-up|3
2488456|NCT02083185|8601234|P1|Overall Study|Lost to Follow-up|0
2488457|NCT02082977|8601339|P10|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
2488458|NCT02082977|8601340|P9|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
2488459|NCT02082977|8601341|P8|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2
2488460|NCT02082977|8601342|P7|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
2488461|NCT02082977|8601343|P6|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
2488462|NCT02082977|8601344|P5|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
2488463|NCT02082977|8601345|P4|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
2488549|NCT02082158|8601785|P6|Overall Study|Failed Fit-testing|7
2488464|NCT02082977|8601346|P3|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
2488465|NCT02082977|8601347|P2|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
2488466|NCT02082977|8601348|P1|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
2488467|NCT02082977|8601339|P10|Part 1 (Up to 3.2 Years)|Physician Decision|0
2488468|NCT02082977|8601340|P9|Part 1 (Up to 3.2 Years)|Physician Decision|2
2488469|NCT02082977|8601341|P8|Part 1 (Up to 3.2 Years)|Physician Decision|1
2488470|NCT02082977|8601342|P7|Part 1 (Up to 3.2 Years)|Physician Decision|4
2488471|NCT02082977|8601343|P6|Part 1 (Up to 3.2 Years)|Physician Decision|1
2488472|NCT02082977|8601344|P5|Part 1 (Up to 3.2 Years)|Physician Decision|1
2488473|NCT02082977|8601345|P4|Part 1 (Up to 3.2 Years)|Physician Decision|0
2488474|NCT02082977|8601346|P3|Part 1 (Up to 3.2 Years)|Physician Decision|0
2488475|NCT02082977|8601347|P2|Part 1 (Up to 3.2 Years)|Physician Decision|0
2488476|NCT02082977|8601348|P1|Part 1 (Up to 3.2 Years)|Physician Decision|0
2488477|NCT02082977|8601339|P10|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
2488478|NCT02082977|8601340|P9|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
2488479|NCT02082977|8601341|P8|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
2488480|NCT02082977|8601342|P7|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
2488481|NCT02082977|8601343|P6|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1
2488482|NCT02082977|8601344|P5|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
2488483|NCT02082977|8601345|P4|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
2488484|NCT02082977|8601346|P3|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
2488485|NCT02082977|8601347|P2|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
2488486|NCT02082977|8601348|P1|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
2488487|NCT02082977|8601339|P10|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
2488488|NCT02082977|8601340|P9|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
2488489|NCT02082977|8601341|P8|Part 1 (Up to 3.2 Years)|Study closed/terminated|2
2488490|NCT02082977|8601342|P7|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
2488491|NCT02082977|8601343|P6|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
2488492|NCT02082977|8601344|P5|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
2488493|NCT02082977|8601345|P4|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
2488494|NCT02082977|8601346|P3|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
2488495|NCT02082977|8601347|P2|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
2488496|NCT02082977|8601348|P1|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
2488497|NCT02082977|8601339|P10|Part 1 (Up to 3.2 Years)|Death|0
2488498|NCT02082977|8601340|P9|Part 1 (Up to 3.2 Years)|Death|1
2488499|NCT02082977|8601341|P8|Part 1 (Up to 3.2 Years)|Death|0
2488500|NCT02082977|8601342|P7|Part 1 (Up to 3.2 Years)|Death|2
2488501|NCT02082977|8601343|P6|Part 1 (Up to 3.2 Years)|Death|1
2488502|NCT02082977|8601344|P5|Part 1 (Up to 3.2 Years)|Death|0
2488503|NCT02082977|8601345|P4|Part 1 (Up to 3.2 Years)|Death|0
2488504|NCT02082977|8601346|P3|Part 1 (Up to 3.2 Years)|Death|0
2488505|NCT02082977|8601347|P2|Part 1 (Up to 3.2 Years)|Death|0
2488506|NCT02082977|8601348|P1|Part 1 (Up to 3.2 Years)|Death|1
2488507|NCT02082912|8601602|P2|Overall Study|Physician Decision|1
2488508|NCT02082912|8601603|P1|Overall Study|Physician Decision|0
2488509|NCT02082522|8601638|P2|Overall Study|Chemotherapy change|3
2488510|NCT02082522|8601639|P1|Overall Study|Chemotherapy change|1
2488511|NCT02082522|8601638|P2|Overall Study|Disease progression|2
2488512|NCT02082522|8601639|P1|Overall Study|Disease progression|2
2488513|NCT02082522|8601638|P2|Overall Study|Physician Decision|1
2488514|NCT02082522|8601639|P1|Overall Study|Physician Decision|3
2488515|NCT02082522|8601638|P2|Overall Study|Lost to Follow-up|0
2488516|NCT02082522|8601639|P1|Overall Study|Lost to Follow-up|1
2488517|NCT02082522|8601638|P2|Overall Study|Death|0
2488518|NCT02082522|8601639|P1|Overall Study|Death|1
2488519|NCT02082522|8601638|P2|Overall Study|Withdrawal by Subject|4
2488520|NCT02082522|8601639|P1|Overall Study|Withdrawal by Subject|2
2488521|NCT02082522|8601638|P2|Overall Study|Sponsor termination|3
2488522|NCT02082522|8601639|P1|Overall Study|Sponsor termination|5
2488523|NCT02082483|8601689|P2|Overall Study|Death|3
2488524|NCT02082483|8601690|P1|Overall Study|Death|2
2488525|NCT02082483|8601689|P2|Overall Study|Physician Decision|1
2488526|NCT02082483|8601690|P1|Overall Study|Physician Decision|1
2488527|NCT02082483|8601689|P2|Overall Study|Withdrawal by Subject|1
2488528|NCT02082483|8601690|P1|Overall Study|Withdrawal by Subject|2
2488529|NCT02082483|8601689|P2|Overall Study|Lost to Follow-up|1
2488530|NCT02082483|8601690|P1|Overall Study|Lost to Follow-up|1
2488531|NCT02082340|8601742|P2|Overall Study|Lost to Follow-up|1
2488532|NCT02082340|8601743|P1|Overall Study|Lost to Follow-up|1
2488533|NCT02082262|8601753|P1|Overall Study|Adverse Event|48
2488534|NCT02082262|8601753|P1|Overall Study|Withdrawal by Subject|3
2488535|NCT02082184|8601759|P2|Overall Study|Subject non-compliance|1
2488536|NCT02082184|8601760|P1|Overall Study|Subject non-compliance|0
2488537|NCT02082184|8601759|P2|Overall Study|Lost to Follow-up|2
2488538|NCT02082184|8601760|P1|Overall Study|Lost to Follow-up|0
2488539|NCT02082184|8601759|P2|Overall Study|Protocol Violation|6
2488540|NCT02082184|8601760|P1|Overall Study|Protocol Violation|0
2488541|NCT02082184|8601759|P2|Overall Study|Withdrawal by Subject|2
2488542|NCT02082184|8601760|P1|Overall Study|Withdrawal by Subject|3
2488543|NCT02082184|8601759|P2|Overall Study|Device associated symptoms|0
2488544|NCT02082184|8601760|P1|Overall Study|Device associated symptoms|5
2488545|NCT02082184|8601759|P2|Overall Study|Medical diagnosis|2
2488546|NCT02082184|8601760|P1|Overall Study|Medical diagnosis|1
2488547|NCT02082184|8601759|P2|Overall Study|Adverse Event|0
2488548|NCT02082184|8601760|P1|Overall Study|Adverse Event|1
2488550|NCT02082158|8601786|P5|Overall Study|Failed Fit-testing|3
2488551|NCT02082158|8601787|P4|Overall Study|Failed Fit-testing|4
2488552|NCT02082158|8601788|P3|Overall Study|Failed Fit-testing|14
2488553|NCT02082158|8601789|P2|Overall Study|Failed Fit-testing|8
2488554|NCT02082158|8601790|P1|Overall Study|Failed Fit-testing|8
2488555|NCT02082158|8601785|P6|Overall Study|Withdrawal by Subject|0
2488556|NCT02082158|8601786|P5|Overall Study|Withdrawal by Subject|1
2488557|NCT02082158|8601787|P4|Overall Study|Withdrawal by Subject|0
2488558|NCT02082158|8601788|P3|Overall Study|Withdrawal by Subject|0
2488559|NCT02082158|8601789|P2|Overall Study|Withdrawal by Subject|0
2488560|NCT02082158|8601790|P1|Overall Study|Withdrawal by Subject|0
2488561|NCT02081859|8601844|P2|Overall Study|Other reasons|0
2488562|NCT02081859|8601845|P1|Overall Study|Other reasons|2
2488563|NCT02081859|8601844|P2|Overall Study|< 4 embryos|23
2488564|NCT02081859|8601845|P1|Overall Study|< 4 embryos|27
2488565|NCT02081859|8601844|P2|Overall Study|Unanticipated freeze all cycle|6
2488566|NCT02081859|8601845|P1|Overall Study|Unanticipated freeze all cycle|2
2488567|NCT02081859|8601844|P2|Overall Study|No sperm|0
2488568|NCT02081859|8601845|P1|Overall Study|No sperm|1
2488569|NCT02081859|8601844|P2|Overall Study|No fertilization|2
2488570|NCT02081859|8601845|P1|Overall Study|No fertilization|2
2488571|NCT02081846|8601855|P2|Overall Study|invalid consent|0
2488572|NCT02081846|8601856|P1|Overall Study|invalid consent|1
2488573|NCT02081846|8601855|P2|Overall Study|Withdrawal by Subject|0
2488574|NCT02081846|8601856|P1|Overall Study|Withdrawal by Subject|1
2488575|NCT02081690|8602025|P1|Overall Study|Withdrawal by Subject|1
2488576|NCT02081690|8602025|P1|Overall Study|Physician Decision|3
2488577|NCT02081690|8602025|P1|Overall Study|Death|3
2488578|NCT02081677|8602036|P4|Overall Study|Unsatisfactory Lens Fitting|0
2488579|NCT02081677|8602037|P3|Overall Study|Unsatisfactory Lens Fitting|0
2488580|NCT02081677|8602038|P2|Overall Study|Unsatisfactory Lens Fitting|1
2488581|NCT02081677|8602039|P1|Overall Study|Unsatisfactory Lens Fitting|0
2488582|NCT02081677|8602036|P4|Overall Study|Not comfortable with lens care system|0
2488583|NCT02081677|8602037|P3|Overall Study|Not comfortable with lens care system|0
2488584|NCT02081677|8602038|P2|Overall Study|Not comfortable with lens care system|0
2488585|NCT02081677|8602039|P1|Overall Study|Not comfortable with lens care system|1
2488586|NCT02081677|8602036|P4|Overall Study|No Longer Meets Eligibility Criteria|0
2488587|NCT02081677|8602037|P3|Overall Study|No Longer Meets Eligibility Criteria|1
2488588|NCT02081677|8602038|P2|Overall Study|No Longer Meets Eligibility Criteria|0
2488589|NCT02081677|8602039|P1|Overall Study|No Longer Meets Eligibility Criteria|0
2488590|NCT02081677|8602036|P4|Overall Study|Adverse Event|0
2488591|NCT02081677|8602037|P3|Overall Study|Adverse Event|1
2488592|NCT02081677|8602038|P2|Overall Study|Adverse Event|0
2488593|NCT02081677|8602039|P1|Overall Study|Adverse Event|0
2488594|NCT02081599|8602131|P2|Period 2：Open-label Period|Withdrawal by Subject|0
2488595|NCT02081599|8602132|P1|Period 2：Open-label Period|Withdrawal by Subject|2
2488596|NCT02081599|8602131|P2|Period 2：Open-label Period|Physician Decision|0
2488597|NCT02081599|8602132|P1|Period 2：Open-label Period|Physician Decision|1
2488598|NCT02081599|8602131|P2|Period 2：Open-label Period|Lack of Efficacy|4
2488599|NCT02081599|8602132|P1|Period 2：Open-label Period|Lack of Efficacy|2
2488600|NCT02081599|8602131|P2|Period 2：Open-label Period|Adverse Event|0
2488601|NCT02081599|8602132|P1|Period 2：Open-label Period|Adverse Event|1
2488602|NCT02081599|8602131|P2|Period 1：Double-blind Period|stopping criteria|0
2488603|NCT02081599|8602132|P1|Period 1：Double-blind Period|stopping criteria|1
2488604|NCT02081599|8602131|P2|Period 1：Double-blind Period|Withdrawal by Subject|0
2488605|NCT02081599|8602132|P1|Period 1：Double-blind Period|Withdrawal by Subject|1
2488606|NCT02081599|8602131|P2|Period 1：Double-blind Period|Protocol Violation|1
2488607|NCT02081599|8602132|P1|Period 1：Double-blind Period|Protocol Violation|0
2488608|NCT02081599|8602131|P2|Period 1：Double-blind Period|Physician Decision|0
2488609|NCT02081599|8602132|P1|Period 1：Double-blind Period|Physician Decision|1
2488610|NCT02081599|8602131|P2|Period 1：Double-blind Period|Lack of Efficacy|1
2488611|NCT02081599|8602132|P1|Period 1：Double-blind Period|Lack of Efficacy|2
2488612|NCT02081599|8602131|P2|Period 1：Double-blind Period|Adverse Event|0
2488613|NCT02081599|8602132|P1|Period 1：Double-blind Period|Adverse Event|3
2488614|NCT02081586|8602150|P4|Overall Study|Head injury not related to study|0
2488615|NCT02081586|8602151|P3|Overall Study|Head injury not related to study|1
2488616|NCT02081586|8602152|P2|Overall Study|Head injury not related to study|0
2488617|NCT02081586|8602153|P1|Overall Study|Head injury not related to study|0
2488618|NCT02081586|8602150|P4|Overall Study|Lost to Follow-up|1
2488619|NCT02081586|8602151|P3|Overall Study|Lost to Follow-up|0
2488620|NCT02081586|8602152|P2|Overall Study|Lost to Follow-up|1
2488621|NCT02081586|8602153|P1|Overall Study|Lost to Follow-up|0
2488622|NCT02081417|8602219|P2|Overall Study|Did not start treatment|21
2488623|NCT02081417|8602220|P1|Overall Study|Did not start treatment|17
2488624|NCT02081417|8602219|P2|Overall Study|Admitted to Residential Treatment|0
2488625|NCT02081417|8602220|P1|Overall Study|Admitted to Residential Treatment|2
2488626|NCT02081417|8602219|P2|Overall Study|Withdrawal by Subject|0
2488627|NCT02081417|8602220|P1|Overall Study|Withdrawal by Subject|4
2488628|NCT02081417|8602219|P2|Overall Study|Death|3
2488629|NCT02081417|8602220|P1|Overall Study|Death|4
2488630|NCT02081417|8602219|P2|Overall Study|Incarcerated|2
2488631|NCT02081417|8602220|P1|Overall Study|Incarcerated|2
2488632|NCT02081417|8602219|P2|Overall Study|Moved Away|2
2488633|NCT02081417|8602220|P1|Overall Study|Moved Away|1
2488634|NCT02081417|8602219|P2|Overall Study|Lost to Follow-up|23
2488635|NCT02081417|8602220|P1|Overall Study|Lost to Follow-up|26
2488636|NCT02081391|8602240|P4|24-hour Treatment and Trial Completion|Further reasons|0
2488637|NCT02081391|8602241|P3|24-hour Treatment and Trial Completion|Further reasons|0
2488638|NCT02081391|8602242|P2|24-hour Treatment and Trial Completion|Further reasons|4
2488639|NCT02081391|8602243|P1|24-hour Treatment and Trial Completion|Further reasons|3
2488640|NCT02081391|8602240|P4|24-hour Treatment and Trial Completion|Technical Problems|0
2488641|NCT02081391|8602241|P3|24-hour Treatment and Trial Completion|Technical Problems|0
2488642|NCT02081391|8602242|P2|24-hour Treatment and Trial Completion|Technical Problems|1
2488643|NCT02081391|8602243|P1|24-hour Treatment and Trial Completion|Technical Problems|1
2488644|NCT02081391|8602240|P4|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0
2488645|NCT02081391|8602241|P3|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1
2488646|NCT02081391|8602242|P2|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5
2488647|NCT02081391|8602243|P1|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11
2488648|NCT02081391|8602240|P4|24-hour Treatment and Trial Completion|Adverse Event|0
2488649|NCT02081391|8602241|P3|24-hour Treatment and Trial Completion|Adverse Event|0
2488650|NCT02081391|8602242|P2|24-hour Treatment and Trial Completion|Adverse Event|0
2488651|NCT02081391|8602243|P1|24-hour Treatment and Trial Completion|Adverse Event|1
2488652|NCT02081391|8602240|P4|24-hour Treatment and Trial Completion|Lack of Efficacy|0
2488653|NCT02081391|8602241|P3|24-hour Treatment and Trial Completion|Lack of Efficacy|0
2488654|NCT02081391|8602242|P2|24-hour Treatment and Trial Completion|Lack of Efficacy|3
2488655|NCT02081391|8602243|P1|24-hour Treatment and Trial Completion|Lack of Efficacy|1
2488656|NCT02081391|8602240|P4|24-hour Treatment and Trial Completion|Physician Decision|0
2488657|NCT02081391|8602241|P3|24-hour Treatment and Trial Completion|Physician Decision|0
2488658|NCT02081391|8602242|P2|24-hour Treatment and Trial Completion|Physician Decision|5
2488659|NCT02081391|8602243|P1|24-hour Treatment and Trial Completion|Physician Decision|10
2488660|NCT02081391|8602240|P4|12-hour Treatment|Further reasons|0
2488661|NCT02081391|8602241|P3|12-hour Treatment|Further reasons|0
2488662|NCT02081391|8602242|P2|12-hour Treatment|Further reasons|1
2488663|NCT02081391|8602243|P1|12-hour Treatment|Further reasons|2
2488664|NCT02081391|8602240|P4|12-hour Treatment|Recovery (opioid no longer needed)|0
2488665|NCT02081391|8602241|P3|12-hour Treatment|Recovery (opioid no longer needed)|1
2488666|NCT02081391|8602242|P2|12-hour Treatment|Recovery (opioid no longer needed)|0
2488667|NCT02081391|8602243|P1|12-hour Treatment|Recovery (opioid no longer needed)|2
2488668|NCT02081391|8602240|P4|12-hour Treatment|Adverse Event|0
2488669|NCT02081391|8602241|P3|12-hour Treatment|Adverse Event|0
2488670|NCT02081391|8602242|P2|12-hour Treatment|Adverse Event|2
2488671|NCT02081391|8602243|P1|12-hour Treatment|Adverse Event|4
2488672|NCT02081391|8602240|P4|12-hour Treatment|Lack of Efficacy|0
2488673|NCT02081391|8602241|P3|12-hour Treatment|Lack of Efficacy|0
2488674|NCT02081391|8602242|P2|12-hour Treatment|Lack of Efficacy|0
2488675|NCT02081391|8602243|P1|12-hour Treatment|Lack of Efficacy|3
2488676|NCT02081391|8602240|P4|12-hour Treatment|Physician Decision|0
2488677|NCT02081391|8602241|P3|12-hour Treatment|Physician Decision|0
2488678|NCT02081391|8602242|P2|12-hour Treatment|Physician Decision|1
2488679|NCT02081391|8602243|P1|12-hour Treatment|Physician Decision|4
2488680|NCT02081391|8602240|P4|12-hour Treatment|Withdrawal by Subject|0
2488681|NCT02081391|8602241|P3|12-hour Treatment|Withdrawal by Subject|0
2488682|NCT02081391|8602242|P2|12-hour Treatment|Withdrawal by Subject|2
2488683|NCT02081391|8602243|P1|12-hour Treatment|Withdrawal by Subject|3
2488684|NCT02081183|8602337|P2|Overall Study|Other|3
2488685|NCT02081183|8602338|P1|Overall Study|Other|3
2488686|NCT02081183|8602337|P2|Overall Study|Protocol Violation|0
2488687|NCT02081183|8602338|P1|Overall Study|Protocol Violation|1
2488688|NCT02081183|8602337|P2|Overall Study|Lost to Follow-up|1
2488689|NCT02081183|8602338|P1|Overall Study|Lost to Follow-up|0
2488690|NCT02081079|8602354|P2|Overall Study|Lost to Follow-up|0
2488691|NCT02081079|8602355|P1|Overall Study|Lost to Follow-up|1
2488692|NCT02081079|8602354|P2|Overall Study|Lack of Efficacy|2
2488693|NCT02081079|8602355|P1|Overall Study|Lack of Efficacy|3
2488694|NCT02081001|8602428|P12|Overall Study|Adverse Event|0
2488695|NCT02081001|8602429|P11|Overall Study|Adverse Event|0
2488696|NCT02081001|8602430|P10|Overall Study|Adverse Event|0
2488697|NCT02081001|8602431|P9|Overall Study|Adverse Event|0
2488698|NCT02081001|8602432|P8|Overall Study|Adverse Event|0
2488699|NCT02081001|8602433|P7|Overall Study|Adverse Event|0
2488700|NCT02081001|8602434|P6|Overall Study|Adverse Event|0
2488701|NCT02081001|8602435|P5|Overall Study|Adverse Event|1
2488702|NCT02081001|8602436|P4|Overall Study|Adverse Event|0
2488703|NCT02081001|8602437|P3|Overall Study|Adverse Event|0
2488704|NCT02081001|8602438|P2|Overall Study|Adverse Event|0
2488705|NCT02081001|8602439|P1|Overall Study|Adverse Event|0
2488706|NCT02080871|8602503|P1|Overall Study|Lost to Follow-up|1
2488707|NCT02080871|8602503|P1|Overall Study|Death|1
2488708|NCT02080832|8602587|P3|Overall Study|Lost to Follow-up|2
2488709|NCT02080832|8602588|P2|Overall Study|Lost to Follow-up|2
2488710|NCT02080832|8602589|P1|Overall Study|Lost to Follow-up|0
2488711|NCT02080832|8602587|P3|Overall Study|Excluded from analysis by MRI|14
2488712|NCT02080832|8602588|P2|Overall Study|Excluded from analysis by MRI|10
2488713|NCT02080832|8602589|P1|Overall Study|Excluded from analysis by MRI|9
2488714|NCT02080481|8602661|P2|Overall Study|Never received a block.|0
2488715|NCT02080481|8602662|P1|Overall Study|Never received a block.|1
2488716|NCT02080260|8602848|P1|Overall Study|Withdrawal by Subject|1
2488717|NCT02080260|8602848|P1|Overall Study|Death|18
2488718|NCT02080091|8602865|P1|Overall Study|Other|1
2488719|NCT02080091|8602865|P1|Overall Study|Withdrawal by Subject|1
2488720|NCT02080091|8602865|P1|Overall Study|Death|1
2488721|NCT02080091|8602865|P1|Overall Study|Study Terminated|22
2488722|NCT02079909|8602893|P3|Overall Study|Relocation etc.|3
2488723|NCT02079909|8602894|P2|Overall Study|Relocation etc.|2
2488724|NCT02079909|8602895|P1|Overall Study|Relocation etc.|2
2488725|NCT02079909|8602893|P3|Overall Study|Physician Decision|1
2488726|NCT02079909|8602894|P2|Overall Study|Physician Decision|1
2488727|NCT02079909|8602895|P1|Overall Study|Physician Decision|0
2488728|NCT02079909|8602893|P3|Overall Study|Protocol Violation|1
2488729|NCT02079909|8602894|P2|Overall Study|Protocol Violation|1
2488730|NCT02079909|8602895|P1|Overall Study|Protocol Violation|0
2488731|NCT02079909|8602893|P3|Overall Study|Lack of Efficacy|1
2488732|NCT02079909|8602894|P2|Overall Study|Lack of Efficacy|0
2488733|NCT02079909|8602895|P1|Overall Study|Lack of Efficacy|0
2488734|NCT02079909|8602893|P3|Overall Study|Death|0
2488735|NCT02079909|8602894|P2|Overall Study|Death|2
2488736|NCT02079909|8602895|P1|Overall Study|Death|2
2488737|NCT02079909|8602893|P3|Overall Study|Lost to Follow-up|1
2488738|NCT02079909|8602894|P2|Overall Study|Lost to Follow-up|3
2488739|NCT02079909|8602895|P1|Overall Study|Lost to Follow-up|2
2488740|NCT02079909|8602893|P3|Overall Study|Withdrawal by Subject|4
2488741|NCT02079909|8602894|P2|Overall Study|Withdrawal by Subject|17
2488742|NCT02079909|8602895|P1|Overall Study|Withdrawal by Subject|9
2488743|NCT02079909|8602893|P3|Overall Study|Adverse Event|7
2488744|NCT02079909|8602894|P2|Overall Study|Adverse Event|23
2488745|NCT02079909|8602895|P1|Overall Study|Adverse Event|23
2488746|NCT02079844|8602912|P3|Treatment Period 2|Voluntary Withdrawal|0
2488747|NCT02079844|8602913|P2|Treatment Period 2|Voluntary Withdrawal|1
2488748|NCT02079844|8602914|P1|Treatment Period 2|Voluntary Withdrawal|0
2488749|NCT02079844|8602912|P3|Treatment Period 1|Voluntary Withdrawal|2
2488750|NCT02079844|8602913|P2|Treatment Period 1|Voluntary Withdrawal|0
2488751|NCT02079844|8602914|P1|Treatment Period 1|Voluntary Withdrawal|0
2488752|NCT02079805|8602972|P2|Overall Study|Voluntary Withdrawal|1
2488753|NCT02079805|8602973|P1|Overall Study|Voluntary Withdrawal|0
2488754|NCT02079805|8602972|P2|Overall Study|Pretreatment Event/Adverse Event|1
2488755|NCT02079805|8602973|P1|Overall Study|Pretreatment Event/Adverse Event|0
2488756|NCT02079649|8602995|P4|Overall Study|Randomization error (prior to treatment)|0
2488757|NCT02079649|8602996|P3|Overall Study|Randomization error (prior to treatment)|1
2488758|NCT02079649|8602997|P2|Overall Study|Randomization error (prior to treatment)|0
2488759|NCT02079649|8602998|P1|Overall Study|Randomization error (prior to treatment)|1
2488760|NCT02079649|8602995|P4|Overall Study|Withdrawal by Subject|1
2488761|NCT02079649|8602996|P3|Overall Study|Withdrawal by Subject|0
2488762|NCT02079649|8602997|P2|Overall Study|Withdrawal by Subject|0
2488763|NCT02079649|8602998|P1|Overall Study|Withdrawal by Subject|0
2488764|NCT02079649|8602995|P4|Overall Study|Lost to Follow-up|1
2488765|NCT02079649|8602996|P3|Overall Study|Lost to Follow-up|0
2488766|NCT02079649|8602997|P2|Overall Study|Lost to Follow-up|0
2488767|NCT02079649|8602998|P1|Overall Study|Lost to Follow-up|0
2488768|NCT02079610|8603015|P2|Overall Study|Withdrawal by Subject|1
2488769|NCT02079610|8603016|P1|Overall Study|Withdrawal by Subject|1
2488770|NCT02079532|8603026|P1|Overall Study|Other|3
2488771|NCT02079532|8603026|P1|Overall Study|Inclusion into ReFIRST|3
2488772|NCT02079532|8603026|P1|Overall Study|Administrative problems|1
2488773|NCT02079532|8603026|P1|Overall Study|Withdrawal by Subject|1
2488774|NCT02079532|8603026|P1|Overall Study|Protocol Violation|3
2488775|NCT02079532|8603026|P1|Overall Study|Lack of Efficacy|9
2488776|NCT02079532|8603026|P1|Overall Study|Additional or changed therapy|2
2488777|NCT02079532|8603026|P1|Overall Study|Adverse Event|7
2488778|NCT02079519|8603048|P1|Overall Study|Adverse Event|1
2488779|NCT02079519|8603048|P1|Overall Study|Disease Progression|9
2488780|NCT02079246|8603061|P2|OLEX-MEM|Other: Moved to nursing home|3
2488781|NCT02079246|8603062|P1|OLEX-MEM|Other: Moved to nursing home|0
2488782|NCT02079246|8603061|P2|OLEX-MEM|Lost to Follow-up|1
2488783|NCT02079246|8603062|P1|OLEX-MEM|Lost to Follow-up|0
2488784|NCT02079246|8603061|P2|OLEX-MEM|Protocol Violation|2
2488785|NCT02079246|8603062|P1|OLEX-MEM|Protocol Violation|0
2488786|NCT02079246|8603061|P2|OLEX-MEM|Withdrawal by Subject|7
2488787|NCT02079246|8603062|P1|OLEX-MEM|Withdrawal by Subject|0
2488788|NCT02079246|8603061|P2|OLEX-MEM|Adverse Event|6
2488789|NCT02079246|8603062|P1|OLEX-MEM|Adverse Event|0
2488790|NCT02079246|8603061|P2|OLEX|Other: Withdrawal of caregiver consent|0
2488791|NCT02079246|8603062|P1|OLEX|Other: Withdrawal of caregiver consent|1
2488792|NCT02079246|8603061|P2|OLEX|Other: Moved to nursing home|0
2488793|NCT02079246|8603062|P1|OLEX|Other: Moved to nursing home|1
2488794|NCT02079246|8603061|P2|OLEX|Other: Worsening of condition|0
2488795|NCT02079246|8603062|P1|OLEX|Other: Worsening of condition|1
2488796|NCT02079246|8603061|P2|OLEX|Other: Coordinator decision|0
2488797|NCT02079246|8603062|P1|OLEX|Other: Coordinator decision|1
2488798|NCT02079246|8603061|P2|OLEX|Other: Caregiver unavailable|0
2488799|NCT02079246|8603062|P1|OLEX|Other: Caregiver unavailable|3
2488800|NCT02079246|8603061|P2|OLEX|Other: Insufficient compliance|0
2488801|NCT02079246|8603062|P1|OLEX|Other: Insufficient compliance|2
2488802|NCT02079246|8603061|P2|OLEX|Other: Disallowed medication|0
2488803|NCT02079246|8603062|P1|OLEX|Other: Disallowed medication|8
2488804|NCT02079246|8603061|P2|OLEX|Results of the lead-in studies|0
2488805|NCT02079246|8603062|P1|OLEX|Results of the lead-in studies|58
2488806|NCT02079246|8603061|P2|OLEX|Lack of Efficacy|0
2488807|NCT02079246|8603062|P1|OLEX|Lack of Efficacy|3
2488808|NCT02079246|8603061|P2|OLEX|Protocol Violation|0
2488809|NCT02079246|8603062|P1|OLEX|Protocol Violation|6
2488810|NCT02079246|8603061|P2|OLEX|Lost to Follow-up|0
2488811|NCT02079246|8603062|P1|OLEX|Lost to Follow-up|6
2488812|NCT02079246|8603061|P2|OLEX|Withdrawal by Subject|0
2488813|NCT02079246|8603062|P1|OLEX|Withdrawal by Subject|60
2488814|NCT02079246|8603061|P2|OLEX|Adverse Event|0
2488815|NCT02079246|8603062|P1|OLEX|Adverse Event|66
2488816|NCT02079246|8603061|P2|OLEX|Death|0
2488817|NCT02079246|8603062|P1|OLEX|Death|11
2488818|NCT02079246|8603061|P2|OLEX|Withdrawal before treatment|0
2488819|NCT02079246|8603062|P1|OLEX|Withdrawal before treatment|1
2488820|NCT02079077|8603081|P2|Overall Study|Became STIs Positive|2
2488821|NCT02079077|8603082|P1|Overall Study|Became STIs Positive|1
2488822|NCT02079077|8603081|P2|Overall Study|Lost to Follow-up|7
2488823|NCT02079077|8603082|P1|Overall Study|Lost to Follow-up|5
2488824|NCT02078960|8603105|P3|Follow-up Period|Lost to Follow-up|0
2488825|NCT02078960|8603106|P2|Follow-up Period|Lost to Follow-up|1
2488826|NCT02078960|8603107|P1|Follow-up Period|Lost to Follow-up|0
2488827|NCT02078960|8603105|P3|Follow-up Period|Death|0
2488828|NCT02078960|8603106|P2|Follow-up Period|Death|0
2488829|NCT02078960|8603107|P1|Follow-up Period|Death|2
2488830|NCT02078960|8603105|P3|Treatment Period|Death|1
2488831|NCT02078960|8603106|P2|Treatment Period|Death|0
2488832|NCT02078960|8603107|P1|Treatment Period|Death|0
2488833|NCT02078960|8603105|P3|Treatment Period|Adverse Event|0
2488834|NCT02078960|8603106|P2|Treatment Period|Adverse Event|0
2488835|NCT02078960|8603107|P1|Treatment Period|Adverse Event|1
2488836|NCT02078960|8603105|P3|Treatment Period|Withdrawal by Subject|1
2488837|NCT02078960|8603106|P2|Treatment Period|Withdrawal by Subject|1
2488838|NCT02078960|8603107|P1|Treatment Period|Withdrawal by Subject|0
2488839|NCT02078960|8603105|P3|Treatment Period|Disease progression - blast phase|0
2488840|NCT02078960|8603106|P2|Treatment Period|Disease progression - blast phase|0
2488841|NCT02078960|8603107|P1|Treatment Period|Disease progression - blast phase|1
2488842|NCT02078960|8603105|P3|Treatment Period|Disease progression - accelerated phase|0
2488843|NCT02078960|8603106|P2|Treatment Period|Disease progression - accelerated phase|1
2488844|NCT02078960|8603107|P1|Treatment Period|Disease progression - accelerated phase|0
2488845|NCT02078960|8603105|P3|Treatment Period|Lack of Efficacy|0
2488846|NCT02078960|8603106|P2|Treatment Period|Lack of Efficacy|1
2488847|NCT02078960|8603107|P1|Treatment Period|Lack of Efficacy|0
2488848|NCT02078960|8603105|P3|Treatment Period|Other|1
2488849|NCT02078960|8603106|P2|Treatment Period|Other|0
2488850|NCT02078960|8603107|P1|Treatment Period|Other|0
2488851|NCT02078817|8603141|P1|Overall Study|Withdrawal by Subject|1
2488852|NCT02078752|8603163|P10|Overall Study|Study terminated by sponsor|5
2488853|NCT02078752|8603164|P9|Overall Study|Study terminated by sponsor|0
2488854|NCT02078752|8603165|P8|Overall Study|Study terminated by sponsor|0
2488855|NCT02078752|8603166|P7|Overall Study|Study terminated by sponsor|0
2488856|NCT02078752|8603167|P6|Overall Study|Study terminated by sponsor|0
2488857|NCT02078752|8603168|P5|Overall Study|Study terminated by sponsor|0
2488858|NCT02078752|8603169|P4|Overall Study|Study terminated by sponsor|0
2488859|NCT02078752|8603170|P3|Overall Study|Study terminated by sponsor|0
2488860|NCT02078752|8603171|P2|Overall Study|Study terminated by sponsor|0
2488861|NCT02078752|8603172|P1|Overall Study|Study terminated by sponsor|0
2488862|NCT02078752|8603163|P10|Overall Study|Other|0
2488863|NCT02078752|8603164|P9|Overall Study|Other|0
2488864|NCT02078752|8603165|P8|Overall Study|Other|1
2488865|NCT02078752|8603166|P7|Overall Study|Other|0
2488866|NCT02078752|8603167|P6|Overall Study|Other|0
2488867|NCT02078752|8603168|P5|Overall Study|Other|1
2488868|NCT02078752|8603169|P4|Overall Study|Other|0
2488869|NCT02078752|8603170|P3|Overall Study|Other|0
2488870|NCT02078752|8603171|P2|Overall Study|Other|3
2488871|NCT02078752|8603172|P1|Overall Study|Other|0
2488872|NCT02078752|8603163|P10|Overall Study|Withdrawal by Subject|1
2488873|NCT02078752|8603164|P9|Overall Study|Withdrawal by Subject|0
2488874|NCT02078752|8603165|P8|Overall Study|Withdrawal by Subject|1
2488875|NCT02078752|8603166|P7|Overall Study|Withdrawal by Subject|2
2488876|NCT02078752|8603167|P6|Overall Study|Withdrawal by Subject|3
2488877|NCT02078752|8603168|P5|Overall Study|Withdrawal by Subject|0
2488878|NCT02078752|8603169|P4|Overall Study|Withdrawal by Subject|1
2488879|NCT02078752|8603170|P3|Overall Study|Withdrawal by Subject|1
2488880|NCT02078752|8603171|P2|Overall Study|Withdrawal by Subject|1
2488881|NCT02078752|8603172|P1|Overall Study|Withdrawal by Subject|1
2488882|NCT02078752|8603163|P10|Overall Study|Lost to Follow-up|0
2488883|NCT02078752|8603164|P9|Overall Study|Lost to Follow-up|0
2488884|NCT02078752|8603165|P8|Overall Study|Lost to Follow-up|0
2488885|NCT02078752|8603166|P7|Overall Study|Lost to Follow-up|0
2488886|NCT02078752|8603167|P6|Overall Study|Lost to Follow-up|0
2488887|NCT02078752|8603168|P5|Overall Study|Lost to Follow-up|0
2488888|NCT02078752|8603169|P4|Overall Study|Lost to Follow-up|1
2488889|NCT02078752|8603170|P3|Overall Study|Lost to Follow-up|0
2488890|NCT02078752|8603171|P2|Overall Study|Lost to Follow-up|0
2488891|NCT02078752|8603172|P1|Overall Study|Lost to Follow-up|1
2488892|NCT02078752|8603163|P10|Overall Study|Death|4
2488893|NCT02078752|8603164|P9|Overall Study|Death|0
2488894|NCT02078752|8603165|P8|Overall Study|Death|1
2488895|NCT02078752|8603166|P7|Overall Study|Death|0
2488896|NCT02078752|8603167|P6|Overall Study|Death|1
2488897|NCT02078752|8603168|P5|Overall Study|Death|0
2488898|NCT02078752|8603169|P4|Overall Study|Death|0
2488899|NCT02078752|8603170|P3|Overall Study|Death|0
2488900|NCT02078752|8603171|P2|Overall Study|Death|3
2488901|NCT02078752|8603172|P1|Overall Study|Death|0
2488902|NCT02078713|8603448|P4|Overall Study|Enrolled twice|0
2488903|NCT02078713|8603449|P3|Overall Study|Enrolled twice|0
2488904|NCT02078713|8603450|P2|Overall Study|Enrolled twice|1
2488905|NCT02078713|8603451|P1|Overall Study|Enrolled twice|0
2488906|NCT02078713|8603448|P4|Overall Study|Pregnant at baseline|0
2488907|NCT02078713|8603449|P3|Overall Study|Pregnant at baseline|0
2488908|NCT02078713|8603450|P2|Overall Study|Pregnant at baseline|5
2488909|NCT02078713|8603451|P1|Overall Study|Pregnant at baseline|3
2488910|NCT02078713|8603448|P4|Overall Study|Lost to Follow-up|0
2488911|NCT02078713|8603449|P3|Overall Study|Lost to Follow-up|0
2488912|NCT02078713|8603450|P2|Overall Study|Lost to Follow-up|55
2488913|NCT02078713|8603451|P1|Overall Study|Lost to Follow-up|49
2488914|NCT02078219|8603536|P5|Overall Study|Adverse Event|0
2488915|NCT02078219|8603537|P4|Overall Study|Adverse Event|1
2488916|NCT02078219|8603538|P3|Overall Study|Adverse Event|3
2488917|NCT02078219|8603539|P2|Overall Study|Adverse Event|1
2488918|NCT02078219|8603540|P1|Overall Study|Adverse Event|1
2488919|NCT02078219|8603536|P5|Overall Study|Death|0
2488920|NCT02078219|8603537|P4|Overall Study|Death|1
2488921|NCT02078219|8603538|P3|Overall Study|Death|0
2488922|NCT02078219|8603539|P2|Overall Study|Death|0
2488923|NCT02078219|8603540|P1|Overall Study|Death|0
2488924|NCT02078219|8603536|P5|Overall Study|Protocol Violation|0
2488925|NCT02078219|8603537|P4|Overall Study|Protocol Violation|1
2488926|NCT02078219|8603538|P3|Overall Study|Protocol Violation|0
2488927|NCT02078219|8603539|P2|Overall Study|Protocol Violation|0
2488928|NCT02078219|8603540|P1|Overall Study|Protocol Violation|0
2488929|NCT02078219|8603536|P5|Overall Study|Withdrawal by Subject|1
2488930|NCT02078219|8603537|P4|Overall Study|Withdrawal by Subject|1
2488931|NCT02078219|8603538|P3|Overall Study|Withdrawal by Subject|0
2488932|NCT02078219|8603539|P2|Overall Study|Withdrawal by Subject|1
2488933|NCT02078219|8603540|P1|Overall Study|Withdrawal by Subject|0
2488934|NCT02078219|8603536|P5|Overall Study|Other|1
2488935|NCT02078219|8603537|P4|Overall Study|Other|0
2488936|NCT02078219|8603538|P3|Overall Study|Other|3
2488937|NCT02078219|8603539|P2|Overall Study|Other|2
2488938|NCT02078219|8603540|P1|Overall Study|Other|2
2488939|NCT02077374|8603590|P2|Overall Study|Protocol Violation|1
2488940|NCT02077374|8603591|P1|Overall Study|Protocol Violation|0
2488941|NCT02077374|8603590|P2|Overall Study|Withdrawal by Subject|1
2488942|NCT02077374|8603591|P1|Overall Study|Withdrawal by Subject|0
2488943|NCT02077140|8603612|P5|Overall Study|Withdrawal by Subject|2
2488944|NCT02077140|8603613|P4|Overall Study|Withdrawal by Subject|2
2488945|NCT02077140|8603614|P3|Overall Study|Withdrawal by Subject|0
2488946|NCT02077140|8603615|P2|Overall Study|Withdrawal by Subject|1
2488947|NCT02077140|8603616|P1|Overall Study|Withdrawal by Subject|0
2488948|NCT02077140|8603612|P5|Overall Study|Lost to Follow-up|3
2488949|NCT02077140|8603613|P4|Overall Study|Lost to Follow-up|2
2488950|NCT02077140|8603614|P3|Overall Study|Lost to Follow-up|2
2488951|NCT02077140|8603615|P2|Overall Study|Lost to Follow-up|1
2488952|NCT02077140|8603616|P1|Overall Study|Lost to Follow-up|4
2488953|NCT02076334|8603894|P4|Overall Study|muscle soreness|1
2488954|NCT02076334|8603895|P3|Overall Study|muscle soreness|0
2488955|NCT02076334|8603896|P2|Overall Study|muscle soreness|0
2488956|NCT02076334|8603897|P1|Overall Study|muscle soreness|0
2488957|NCT02076334|8603894|P4|Overall Study|Lost to Follow-up|0
2488958|NCT02076334|8603895|P3|Overall Study|Lost to Follow-up|1
2488959|NCT02076334|8603896|P2|Overall Study|Lost to Follow-up|1
2488960|NCT02076334|8603897|P1|Overall Study|Lost to Follow-up|0
2488961|NCT02076334|8603894|P4|Overall Study|Protocol Violation|0
2488962|NCT02076334|8603895|P3|Overall Study|Protocol Violation|0
2488963|NCT02076334|8603896|P2|Overall Study|Protocol Violation|0
2488964|NCT02076334|8603897|P1|Overall Study|Protocol Violation|1
2488965|NCT02076178|8603930|P2|Injection Phase|Lost to Follow-up|1
2488966|NCT02076178|8603931|P1|Injection Phase|Lost to Follow-up|0
2488967|NCT02076178|8603930|P2|Injection Phase|Physician Decision|3
2488968|NCT02076178|8603931|P1|Injection Phase|Physician Decision|0
2488969|NCT02076178|8603930|P2|Injection Phase|Withdrawal by Subject|3
2488970|NCT02076178|8603931|P1|Injection Phase|Withdrawal by Subject|0
2488971|NCT02076178|8603930|P2|Injection Phase|Protocol defined stopping criteria|0
2488972|NCT02076178|8603931|P1|Injection Phase|Protocol defined stopping criteria|1
2488973|NCT02076178|8603930|P2|Oral Phase|Physician Decision|1
2488974|NCT02076178|8603931|P1|Oral Phase|Physician Decision|0
2488975|NCT02076178|8603930|P2|Oral Phase|Withdrawal by Subject|4
2488976|NCT02076178|8603931|P1|Oral Phase|Withdrawal by Subject|0
2488977|NCT02076178|8603930|P2|Oral Phase|Adverse Event|7
2488978|NCT02076178|8603931|P1|Oral Phase|Adverse Event|0
2488979|NCT02076165|8603965|P2|Overall Study|Refused follow-up assessment|1
2488980|NCT02076165|8603966|P1|Overall Study|Refused follow-up assessment|1
2488981|NCT02076165|8603965|P2|Overall Study|Lost to Follow-up|5
2488982|NCT02076165|8603966|P1|Overall Study|Lost to Follow-up|7
2488983|NCT02076022|8604036|P2|Overall Study|Withdrawal by Subject|0
2488984|NCT02076022|8604037|P1|Overall Study|Withdrawal by Subject|2
2488985|NCT02076009|8604049|P2|Overall Study|Subjects randomized but not treated|3
2488986|NCT02076009|8604050|P1|Overall Study|Subjects randomized but not treated|2
2488987|NCT02076009|8604049|P2|Overall Study|Ongoing|249
2488988|NCT02076009|8604050|P1|Overall Study|Ongoing|226
2488989|NCT02076009|8604049|P2|Overall Study|Progressive disease|0
2488990|NCT02076009|8604050|P1|Overall Study|Progressive disease|1
2488991|NCT02076009|8604049|P2|Overall Study|Lost to Follow-up|1
2488992|NCT02076009|8604050|P1|Overall Study|Lost to Follow-up|1
2488993|NCT02076009|8604049|P2|Overall Study|Withdrawal by Subject|3
2488994|NCT02076009|8604050|P1|Overall Study|Withdrawal by Subject|9
2488995|NCT02076009|8604049|P2|Overall Study|Death|30
2488996|NCT02076009|8604050|P1|Overall Study|Death|44
2488997|NCT02075840|8604072|P2|Overall Study|Ongoing at CCOD|82
2488998|NCT02075840|8604073|P1|Overall Study|Ongoing at CCOD|99
2488999|NCT02075840|8604072|P2|Overall Study|Physician Decision|3
2489000|NCT02075840|8604073|P1|Overall Study|Physician Decision|1
2489001|NCT02075840|8604072|P2|Overall Study|Lost to Follow-up|2
2489002|NCT02075840|8604073|P1|Overall Study|Lost to Follow-up|3
2489003|NCT02075840|8604072|P2|Overall Study|Death|40
2489004|NCT02075840|8604073|P1|Overall Study|Death|35
2489005|NCT02075840|8604072|P2|Overall Study|Adverse Event|2
2489006|NCT02075840|8604073|P1|Overall Study|Adverse Event|0
2489007|NCT02075840|8604072|P2|Overall Study|Reason not specified|0
2489008|NCT02075840|8604073|P1|Overall Study|Reason not specified|1
2489009|NCT02075840|8604072|P2|Overall Study|Withdrawal by Subject|22
2489010|NCT02075840|8604073|P1|Overall Study|Withdrawal by Subject|13
2489011|NCT02075658|8604129|P2|Overall Study|Physician Decision|2
2489012|NCT02075658|8604130|P1|Overall Study|Physician Decision|2
2489013|NCT02075632|8604140|P2|Overall Study|Withdrawal by Subject|1
2489014|NCT02075632|8604141|P1|Overall Study|Withdrawal by Subject|0
2489015|NCT02075632|8604140|P2|Overall Study|Lost to Follow-up|3
2489016|NCT02075632|8604141|P1|Overall Study|Lost to Follow-up|0
2489017|NCT02075632|8604140|P2|Overall Study|Adverse Event|1
2489018|NCT02075632|8604141|P1|Overall Study|Adverse Event|1
2489019|NCT02075606|8604151|P1|Overall Study|Increasing Symptoms|1
2489020|NCT02075606|8604151|P1|Overall Study|Symptom management|1
2489021|NCT02075606|8604151|P1|Overall Study|Investigator's decision|1
2489022|NCT02075606|8604151|P1|Overall Study|Death|1
2489023|NCT02075606|8604151|P1|Overall Study|Withdrawal by Subject|1
2489024|NCT02075606|8604151|P1|Overall Study|Adverse Event|5
2489025|NCT02075541|8604175|P2|Overall Study|Other- unable to perform study procedure|0
2489026|NCT02075541|8604176|P1|Overall Study|Other- unable to perform study procedure|1
2489027|NCT02075541|8604175|P2|Overall Study|Sponsor study termination|1
2489028|NCT02075541|8604176|P1|Overall Study|Sponsor study termination|0
2489029|NCT02075541|8604175|P2|Overall Study|Withdrawal by Subject|3
2489030|NCT02075541|8604176|P1|Overall Study|Withdrawal by Subject|1
2489031|NCT02075541|8604175|P2|Overall Study|Protocol Violation|0
2489032|NCT02075541|8604176|P1|Overall Study|Protocol Violation|1
2489033|NCT02075541|8604175|P2|Overall Study|Serious Adverse Event|4
2489034|NCT02075541|8604176|P1|Overall Study|Serious Adverse Event|1
2489035|NCT02075515|8604225|P3|Overall Study|Lost to Follow-up|6
2489036|NCT02075515|8604226|P2|Overall Study|Lost to Follow-up|3
2489037|NCT02075515|8604227|P1|Overall Study|Lost to Follow-up|1
2489038|NCT02075515|8604225|P3|Overall Study|Withdrawal by Subject|1
2489039|NCT02075515|8604226|P2|Overall Study|Withdrawal by Subject|0
2489040|NCT02075515|8604227|P1|Overall Study|Withdrawal by Subject|2
2489041|NCT02075515|8604225|P3|Overall Study|Non-Serious Adverse Event|0
2489042|NCT02075515|8604226|P2|Overall Study|Non-Serious Adverse Event|1
2489043|NCT02075515|8604227|P1|Overall Study|Non-Serious Adverse Event|0
2489044|NCT02075515|8604225|P3|Overall Study|Serious Adverse Event|1
2489045|NCT02075515|8604226|P2|Overall Study|Serious Adverse Event|1
2489046|NCT02075515|8604227|P1|Overall Study|Serious Adverse Event|1
2489047|NCT02075476|8604264|P2|Overall Study|Lost to Follow-up|3
2489048|NCT02075476|8604265|P1|Overall Study|Lost to Follow-up|1
2489049|NCT02075476|8604264|P2|Overall Study|Death|2
2489050|NCT02075476|8604265|P1|Overall Study|Death|2
2489051|NCT02075463|8604275|P1|Overall Study|Withdrawal by Subject|1
2489052|NCT02075463|8604275|P1|Overall Study|Par. reached stopping criteria|4
2489053|NCT02075463|8604275|P1|Overall Study|Adverse Event|3
2489054|NCT02075320|8604325|P1|Overall Study|Withdrawal by Subject|2
2489055|NCT02075255|8604335|P3|Overall Study|Death|0
2489056|NCT02075255|8604336|P2|Overall Study|Death|2
2489057|NCT02075255|8604337|P1|Overall Study|Death|0
2489058|NCT02075255|8604335|P3|Overall Study|Adverse Event|1
2489059|NCT02075255|8604336|P2|Overall Study|Adverse Event|0
2489060|NCT02075255|8604337|P1|Overall Study|Adverse Event|0
2489061|NCT02075255|8604335|P3|Overall Study|Lost to Follow-up|1
2489062|NCT02075255|8604336|P2|Overall Study|Lost to Follow-up|0
2489063|NCT02075255|8604337|P1|Overall Study|Lost to Follow-up|0
2489064|NCT02075255|8604335|P3|Overall Study|Withdrawal by Subject|0
2489065|NCT02075255|8604336|P2|Overall Study|Withdrawal by Subject|1
2489066|NCT02075255|8604337|P1|Overall Study|Withdrawal by Subject|4
2489067|NCT02075255|8604335|P3|Overall Study|Study specific withdrawal criteria|1
2489068|NCT02075255|8604336|P2|Overall Study|Study specific withdrawal criteria|1
2489069|NCT02075255|8604337|P1|Overall Study|Study specific withdrawal criteria|0
2489070|NCT02075203|8604447|P3|Overall Study|participant refused to use contraception|0
2489071|NCT02075203|8604448|P2|Overall Study|participant refused to use contraception|0
2489072|NCT02075203|8604449|P1|Overall Study|participant refused to use contraception|1
2489073|NCT02075203|8604447|P3|Overall Study|Adverse Event|0
2489074|NCT02075203|8604448|P2|Overall Study|Adverse Event|0
2489075|NCT02075203|8604449|P1|Overall Study|Adverse Event|1
2489076|NCT02075203|8604447|P3|Overall Study|Withdrawal by Subject|1
2489077|NCT02075203|8604448|P2|Overall Study|Withdrawal by Subject|0
2489078|NCT02075203|8604449|P1|Overall Study|Withdrawal by Subject|1
2489079|NCT02075073|8604490|P3|Overall Study|Withdrawal by Subject|0
2489080|NCT02075073|8604491|P2|Overall Study|Withdrawal by Subject|1
2489081|NCT02075073|8604492|P1|Overall Study|Withdrawal by Subject|0
2489082|NCT02075008|8604514|P1|Overall Study|Study terminated by Sponsor|159
2489083|NCT02075008|8604514|P1|Overall Study|Withdrawal by Subject|6
2489084|NCT02075008|8604514|P1|Overall Study|Adverse Event|5
2489085|NCT02075008|8604514|P1|Overall Study|Death|1
2489086|NCT02075008|8604514|P1|Overall Study|Lack of Efficacy|1
2489087|NCT02075008|8604514|P1|Overall Study|Lost to Follow-up|1
2489088|NCT02075008|8604514|P1|Overall Study|Physician Decision|1
2489089|NCT02075008|8604514|P1|Overall Study|Pregnancy|1
2489090|NCT02075008|8604514|P1|Overall Study|Technical problems|1
2489091|NCT02074982|8604537|P2|Overall Study|Death|2
2489092|NCT02074982|8604538|P1|Overall Study|Death|0
2489093|NCT02074982|8604537|P2|Overall Study|Subject/guardian decision|24
2489094|NCT02074982|8604538|P1|Overall Study|Subject/guardian decision|15
2489095|NCT02074982|8604537|P2|Overall Study|Technical problems|2
2489096|NCT02074982|8604538|P1|Overall Study|Technical problems|0
2489097|NCT02074982|8604537|P2|Overall Study|Protocol deviation|3
2489098|NCT02074982|8604538|P1|Overall Study|Protocol deviation|4
2489099|NCT02074982|8604537|P2|Overall Study|Pregnancy|2
2489100|NCT02074982|8604538|P1|Overall Study|Pregnancy|1
2489101|NCT02074982|8604537|P2|Overall Study|Physician Decision|1
2489102|NCT02074982|8604538|P1|Overall Study|Physician Decision|1
2489103|NCT02074982|8604537|P2|Overall Study|Non-compliance with study treatment|2
2489104|NCT02074982|8604538|P1|Overall Study|Non-compliance with study treatment|0
2489105|NCT02074982|8604537|P2|Overall Study|Lost to Follow-up|10
2489106|NCT02074982|8604538|P1|Overall Study|Lost to Follow-up|9
2489107|NCT02074982|8604537|P2|Overall Study|Lack of Efficacy|1
2489108|NCT02074982|8604538|P1|Overall Study|Lack of Efficacy|6
2489109|NCT02074982|8604537|P2|Overall Study|Adverse Event|7
2489110|NCT02074982|8604538|P1|Overall Study|Adverse Event|15
2489111|NCT02074553|8604585|P8|Washout Period 3|Physician Decision|1
2489112|NCT02074553|8604586|P7|Washout Period 3|Physician Decision|0
2489113|NCT02074553|8604587|P6|Washout Period 3|Physician Decision|0
2489114|NCT02074553|8604588|P5|Washout Period 3|Physician Decision|0
2489115|NCT02074553|8604589|P4|Washout Period 3|Physician Decision|0
2489116|NCT02074553|8604590|P3|Washout Period 3|Physician Decision|0
2489117|NCT02074553|8604591|P2|Washout Period 3|Physician Decision|0
2489118|NCT02074553|8604592|P1|Washout Period 3|Physician Decision|0
2489119|NCT02074553|8604585|P8|Washout Period 2|Lost to Follow-up|0
2489120|NCT02074553|8604586|P7|Washout Period 2|Lost to Follow-up|0
2489121|NCT02074553|8604587|P6|Washout Period 2|Lost to Follow-up|0
2489122|NCT02074553|8604588|P5|Washout Period 2|Lost to Follow-up|0
2489123|NCT02074553|8604589|P4|Washout Period 2|Lost to Follow-up|0
2489124|NCT02074553|8604590|P3|Washout Period 2|Lost to Follow-up|1
2489125|NCT02074553|8604591|P2|Washout Period 2|Lost to Follow-up|0
2489126|NCT02074553|8604592|P1|Washout Period 2|Lost to Follow-up|0
2489127|NCT02074553|8604585|P8|Washout Period 2|Physician Decision|0
2489128|NCT02074553|8604586|P7|Washout Period 2|Physician Decision|0
2489129|NCT02074553|8604587|P6|Washout Period 2|Physician Decision|1
2489130|NCT02074553|8604588|P5|Washout Period 2|Physician Decision|0
2489131|NCT02074553|8604589|P4|Washout Period 2|Physician Decision|0
2489132|NCT02074553|8604590|P3|Washout Period 2|Physician Decision|0
2489133|NCT02074553|8604591|P2|Washout Period 2|Physician Decision|0
2489134|NCT02074553|8604592|P1|Washout Period 2|Physician Decision|0
2489135|NCT02074553|8604585|P8|Washout Period 2|Adverse Event|0
2489136|NCT02074553|8604586|P7|Washout Period 2|Adverse Event|1
2489137|NCT02074553|8604587|P6|Washout Period 2|Adverse Event|0
2489138|NCT02074553|8604588|P5|Washout Period 2|Adverse Event|0
2489139|NCT02074553|8604589|P4|Washout Period 2|Adverse Event|0
2489140|NCT02074553|8604590|P3|Washout Period 2|Adverse Event|0
2489141|NCT02074553|8604591|P2|Washout Period 2|Adverse Event|0
2489142|NCT02074553|8604592|P1|Washout Period 2|Adverse Event|0
2489143|NCT02074553|8604585|P8|Washout Period 1|Other|0
2489144|NCT02074553|8604586|P7|Washout Period 1|Other|0
2489145|NCT02074553|8604587|P6|Washout Period 1|Other|1
2489146|NCT02074553|8604588|P5|Washout Period 1|Other|0
2489147|NCT02074553|8604589|P4|Washout Period 1|Other|0
2489148|NCT02074553|8604590|P3|Washout Period 1|Other|0
2489149|NCT02074553|8604591|P2|Washout Period 1|Other|0
2489150|NCT02074553|8604592|P1|Washout Period 1|Other|0
2489151|NCT02074553|8604585|P8|Washout Period 1|Physician Decision|0
2489152|NCT02074553|8604586|P7|Washout Period 1|Physician Decision|0
2489153|NCT02074553|8604587|P6|Washout Period 1|Physician Decision|0
2489154|NCT02074553|8604588|P5|Washout Period 1|Physician Decision|0
2489155|NCT02074553|8604589|P4|Washout Period 1|Physician Decision|1
2489156|NCT02074553|8604590|P3|Washout Period 1|Physician Decision|0
2489157|NCT02074553|8604591|P2|Washout Period 1|Physician Decision|0
2489158|NCT02074553|8604592|P1|Washout Period 1|Physician Decision|0
2489159|NCT02074553|8604585|P8|Washout Period 1|Adverse Event|0
2489160|NCT02074553|8604586|P7|Washout Period 1|Adverse Event|0
2489161|NCT02074553|8604587|P6|Washout Period 1|Adverse Event|0
2489162|NCT02074553|8604588|P5|Washout Period 1|Adverse Event|0
2489163|NCT02074553|8604589|P4|Washout Period 1|Adverse Event|0
2489164|NCT02074553|8604590|P3|Washout Period 1|Adverse Event|0
2489165|NCT02074553|8604591|P2|Washout Period 1|Adverse Event|0
2489166|NCT02074553|8604592|P1|Washout Period 1|Adverse Event|1
2489167|NCT02074553|8604585|P8|Intervention Period 1|Family Emergency|0
2489168|NCT02074553|8604586|P7|Intervention Period 1|Family Emergency|0
2489169|NCT02074553|8604587|P6|Intervention Period 1|Family Emergency|0
2489170|NCT02074553|8604588|P5|Intervention Period 1|Family Emergency|0
2489171|NCT02074553|8604589|P4|Intervention Period 1|Family Emergency|1
2489172|NCT02074553|8604590|P3|Intervention Period 1|Family Emergency|0
2489173|NCT02074553|8604591|P2|Intervention Period 1|Family Emergency|0
2489174|NCT02074553|8604592|P1|Intervention Period 1|Family Emergency|0
2489175|NCT02074514|8604774|P2|Overall Study|Withdrew Consent|1
2489176|NCT02074514|8604775|P1|Overall Study|Withdrew Consent|0
2489177|NCT02074514|8604774|P2|Overall Study|Lost to Follow-up|1
2489178|NCT02074514|8604775|P1|Overall Study|Lost to Follow-up|0
2489179|NCT02074514|8604774|P2|Overall Study|Lack of Efficacy|2
2489180|NCT02074514|8604775|P1|Overall Study|Lack of Efficacy|3
2489181|NCT02074059|8604916|P6|Overall Study|Death|1
2489182|NCT02074059|8604917|P5|Overall Study|Death|1
2489183|NCT02074059|8604918|P4|Overall Study|Death|0
2489184|NCT02074059|8604919|P3|Overall Study|Death|0
2489185|NCT02074059|8604920|P2|Overall Study|Death|0
2489186|NCT02074059|8604921|P1|Overall Study|Death|0
2489187|NCT02073929|8604965|P2|Overall Study|Withdrawal by Subject|1
2489188|NCT02073929|8604966|P1|Overall Study|Withdrawal by Subject|0
2489189|NCT02073929|8604965|P2|Overall Study|Adverse Event|1
2489190|NCT02073929|8604966|P1|Overall Study|Adverse Event|2
2489191|NCT02073929|8604965|P2|Overall Study|Lost to Follow-up|1
2489192|NCT02073929|8604966|P1|Overall Study|Lost to Follow-up|2
2489193|NCT02073682|8605003|P2|Overall Study|ID: Benefit/Risk Judgment|46
2489194|NCT02073682|8605004|P1|Overall Study|ID: Benefit/Risk Judgment|32
2489195|NCT02073682|8605003|P2|Overall Study|Lost to Follow-up|1
2489196|NCT02073682|8605004|P1|Overall Study|Lost to Follow-up|1
2489197|NCT02073682|8605003|P2|Overall Study|PD: Inconvenience of Dosing|78
2489198|NCT02073682|8605004|P1|Overall Study|PD: Inconvenience of Dosing|21
2489199|NCT02073682|8605003|P2|Overall Study|No reason provided|9
2489200|NCT02073682|8605004|P1|Overall Study|No reason provided|11
2489201|NCT02073682|8605003|P2|Overall Study|Adverse Event|62
2489202|NCT02073682|8605004|P1|Overall Study|Adverse Event|79
2489203|NCT02073682|8605003|P2|Overall Study|Protocol Violation|0
2489204|NCT02073682|8605004|P1|Overall Study|Protocol Violation|1
2489205|NCT02073682|8605003|P2|Overall Study|Cancer Progression|33
2489206|NCT02073682|8605004|P1|Overall Study|Cancer Progression|53
2489207|NCT02073682|8605003|P2|Overall Study|Start of New Chemotherapy Regimen|3
2489208|NCT02073682|8605004|P1|Overall Study|Start of New Chemotherapy Regimen|6
2489209|NCT02073682|8605003|P2|Overall Study|Withdrawal by Subject|8
2489210|NCT02073682|8605004|P1|Overall Study|Withdrawal by Subject|6
2489211|NCT02073682|8605003|P2|Overall Study|Surgery/Medical Procedure|1
2489212|NCT02073682|8605004|P1|Overall Study|Surgery/Medical Procedure|3
2489213|NCT02073682|8605003|P2|Overall Study|Platelet Count <50,000/mL|2
2489214|NCT02073682|8605004|P1|Overall Study|Platelet Count <50,000/mL|1
2489215|NCT02073682|8605003|P2|Overall Study|Prohibited Concomitant Medication Use|1
2489216|NCT02073682|8605004|P1|Overall Study|Prohibited Concomitant Medication Use|0
2489217|NCT02073682|8605003|P2|Overall Study|ID: Palliative Treatment Only|7
2489218|NCT02073682|8605004|P1|Overall Study|ID: Palliative Treatment Only|10
2489219|NCT02073682|8605003|P2|Overall Study|ID: Patient Noncompliance|2
2489220|NCT02073682|8605004|P1|Overall Study|ID: Patient Noncompliance|1
2489221|NCT02073682|8605003|P2|Overall Study|Cancer Cured|15
2489222|NCT02073682|8605004|P1|Overall Study|Cancer Cured|10
2489223|NCT02073682|8605003|P2|Overall Study|Death|100
2489224|NCT02073682|8605004|P1|Overall Study|Death|86
2489225|NCT02073682|8605003|P2|Overall Study|Low Creatinine Clearance|2
2489226|NCT02073682|8605004|P1|Overall Study|Low Creatinine Clearance|1
2489227|NCT02073656|8605022|P1|Primary Study|Withdrew Consent|1
2489228|NCT02073656|8605022|P1|Primary Study|Death|1
2489229|NCT02073656|8605022|P1|Primary Study|Lost to Follow-up|6
2489230|NCT02073643|8605038|P1|Overall Study|Lost to Follow-up|24
2489231|NCT02073565|8605049|P2|Cohort C|Lost to Follow-up|2
2489232|NCT02073565|8605050|P1|Cohort C|Lost to Follow-up|0
2489233|NCT02073565|8605049|P2|Cohort C|Withdrawal by Subject|2
2489234|NCT02073565|8605050|P1|Cohort C|Withdrawal by Subject|0
2489235|NCT02073565|8605049|P2|Cohort B|Withdrawal by Subject|2
2489236|NCT02073565|8605050|P1|Cohort B|Withdrawal by Subject|1
2489237|NCT02073565|8605049|P2|Cohort A|Withdrawal by Subject|0
2489238|NCT02073565|8605050|P1|Cohort A|Withdrawal by Subject|1
2489239|NCT02072980|8605170|P2|Period 2, Second Wear|Adverse Event|1
2489240|NCT02072980|8605171|P1|Period 2, Second Wear|Adverse Event|0
2489241|NCT02072941|8605179|P2|Overall Study|Removed by Study Staff|2
2489242|NCT02072941|8605180|P1|Overall Study|Removed by Study Staff|2
2489243|NCT02072941|8605179|P2|Overall Study|Death|2
2489244|NCT02072941|8605180|P1|Overall Study|Death|3
2489245|NCT02072941|8605179|P2|Overall Study|Lost to Follow-up|4
2489246|NCT02072941|8605180|P1|Overall Study|Lost to Follow-up|4
2489247|NCT02072941|8605179|P2|Overall Study|Withdrawal by Subject|21
2489248|NCT02072941|8605180|P1|Overall Study|Withdrawal by Subject|29
2489249|NCT02072824|8605195|P3|Overall Study|Adverse Event|1
2489250|NCT02072824|8605196|P2|Overall Study|Adverse Event|0
2489251|NCT02072824|8605197|P1|Overall Study|Adverse Event|0
2489252|NCT02072824|8605195|P3|Overall Study|Medication error|0
2489253|NCT02072824|8605196|P2|Overall Study|Medication error|1
2489254|NCT02072824|8605197|P1|Overall Study|Medication error|0
2489255|NCT02072824|8605195|P3|Overall Study|No longer willing to participate|1
2489256|NCT02072824|8605196|P2|Overall Study|No longer willing to participate|0
2489257|NCT02072824|8605197|P1|Overall Study|No longer willing to participate|1
2489258|NCT02072824|8605195|P3|Overall Study|Insufficient clinical response|1
2489259|NCT02072824|8605196|P2|Overall Study|Insufficient clinical response|0
2489260|NCT02072824|8605197|P1|Overall Study|Insufficient clinical response|1
2489261|NCT02072668|8605232|P2|Second Intervention|Lost to Follow-up|0
2489262|NCT02072668|8605233|P1|Second Intervention|Lost to Follow-up|1
2489263|NCT02072434|8605273|P2|Overall Study|Lost to Follow-up|1
2489264|NCT02072434|8605274|P1|Overall Study|Lost to Follow-up|0
2489265|NCT02072434|8605273|P2|Overall Study|Other|29
2489266|NCT02072434|8605274|P1|Overall Study|Other|14
2489267|NCT02072434|8605273|P2|Overall Study|Withdrawal by Subject|29
2489268|NCT02072434|8605274|P1|Overall Study|Withdrawal by Subject|17
2489269|NCT02072434|8605273|P2|Overall Study|Adverse Event|6
2489270|NCT02072434|8605274|P1|Overall Study|Adverse Event|7
2489271|NCT02072434|8605273|P2|Overall Study|Adverse event, serious fatal|6
2489272|NCT02072434|8605274|P1|Overall Study|Adverse event, serious fatal|1
2489273|NCT02072434|8605273|P2|Overall Study|Physician Decision|10
2489274|NCT02072434|8605274|P1|Overall Study|Physician Decision|5
2489275|NCT02072434|8605273|P2|Overall Study|Protocol Violation|9
2489276|NCT02072434|8605274|P1|Overall Study|Protocol Violation|10
2489277|NCT02072226|8605294|P2|Overall Study|Patient Withdrawal of Consent|0
2489278|NCT02072226|8605295|P1|Overall Study|Patient Withdrawal of Consent|1
2489279|NCT02072226|8605294|P2|Overall Study|Death|0
2489280|NCT02072226|8605295|P1|Overall Study|Death|1
2489281|NCT02072226|8605294|P2|Overall Study|Patient Non-compliance|3
2489282|NCT02072226|8605295|P1|Overall Study|Patient Non-compliance|2
2489283|NCT02072226|8605294|P2|Overall Study|Lost to Follow-up|7
2489284|NCT02072226|8605295|P1|Overall Study|Lost to Follow-up|11
2489285|NCT02072174|8605325|P2|Overall Study|Non-compliance with protocol requirement|0
2489286|NCT02072174|8605326|P1|Overall Study|Non-compliance with protocol requirement|2
2489287|NCT02072174|8605325|P2|Overall Study|Physician Decision|1
2489288|NCT02072174|8605326|P1|Overall Study|Physician Decision|0
2489289|NCT02072174|8605325|P2|Overall Study|Protocol Violation|23
2489290|NCT02072174|8605326|P1|Overall Study|Protocol Violation|16
2489291|NCT02072174|8605325|P2|Overall Study|Did Not Meet In-/Exclusion Criteria|15
2489292|NCT02072174|8605326|P1|Overall Study|Did Not Meet In-/Exclusion Criteria|14
2489293|NCT02072096|8605350|P2|Overall Study|Lost to Follow-up|0
2489294|NCT02072096|8605351|P1|Overall Study|Lost to Follow-up|1
2489295|NCT02072096|8605350|P2|Overall Study|Study Terminated by Sponsor|30
2489296|NCT02072096|8605351|P1|Overall Study|Study Terminated by Sponsor|43
2489297|NCT02072096|8605350|P2|Overall Study|Physician Decision|1
2489298|NCT02072096|8605351|P1|Overall Study|Physician Decision|0
2489299|NCT02072096|8605350|P2|Overall Study|Death|0
2489300|NCT02072096|8605351|P1|Overall Study|Death|2
2489301|NCT02072096|8605350|P2|Overall Study|No Reason Provided|2
2489302|NCT02072096|8605351|P1|Overall Study|No Reason Provided|4
2489303|NCT02072096|8605350|P2|Overall Study|Adverse Event|2
2489304|NCT02072096|8605351|P1|Overall Study|Adverse Event|5
2489305|NCT02072096|8605350|P2|Overall Study|Withdrawal by Subject|7
2489306|NCT02072096|8605351|P1|Overall Study|Withdrawal by Subject|5
2489307|NCT02072096|8605350|P2|Overall Study|Protocol Violation|7
2489308|NCT02072096|8605351|P1|Overall Study|Protocol Violation|7
2489309|NCT02072096|8605350|P2|Overall Study|Lack of Efficacy|29
2489310|NCT02072096|8605351|P1|Overall Study|Lack of Efficacy|18
2489311|NCT02071849|8605386|P1|2-year Extended Follow-up|Adverse Event|1
2489312|NCT02071849|8605386|P1|6-month Primary Endpoint|Adverse Event|1
2489313|NCT02071849|8605386|P1|6-month Primary Endpoint|Did not receive device|4
2489314|NCT02071771|8605452|P2|Period 1: First 10 Days|Unavailable lens power|0
2489315|NCT02071771|8605453|P1|Period 1: First 10 Days|Unavailable lens power|1
2489316|NCT02071771|8605452|P2|Period 1: First 10 Days|Unacceptable lens fit|0
2489317|NCT02071771|8605453|P1|Period 1: First 10 Days|Unacceptable lens fit|1
2489318|NCT02071706|8605461|P1|Overall Study|Withdrawal by Subject|2
2489319|NCT02071706|8605461|P1|Overall Study|Adverse Event|1
2489320|NCT02071290|8605477|P2|Overall Study|Physician Decision|1
2489321|NCT02071290|8605478|P1|Overall Study|Physician Decision|0
2489322|NCT02071290|8605477|P2|Overall Study|Protocol Violation|5
2489323|NCT02071290|8605478|P1|Overall Study|Protocol Violation|3
2489324|NCT02071290|8605477|P2|Overall Study|Withdrawal by Subject|1
2489325|NCT02071290|8605478|P1|Overall Study|Withdrawal by Subject|0
2489326|NCT02071290|8605477|P2|Overall Study|Death|0
2489327|NCT02071290|8605478|P1|Overall Study|Death|1
2489328|NCT02071225|8605532|P1|Overall Study|Death|25
2489329|NCT02071225|8605532|P1|Overall Study|Lost to Follow-up|2
2489330|NCT02071225|8605532|P1|Overall Study|Protocol Deviation|1
2489331|NCT02071225|8605532|P1|Overall Study|Withdrawal of Consent|2
2489332|NCT02071082|8605588|P2|Overall Study|Lost to Follow-up|1
2489333|NCT02071082|8605589|P1|Overall Study|Lost to Follow-up|1
2489334|NCT02071082|8605588|P2|Overall Study|Withdrew Consent|4
2489335|NCT02071082|8605589|P1|Overall Study|Withdrew Consent|0
2489336|NCT02071082|8605588|P2|Overall Study|Adverse Event|1
2489337|NCT02071082|8605589|P1|Overall Study|Adverse Event|0
2489338|NCT02071082|8605588|P2|Overall Study|Enrolled and Never Treated|1
2489339|NCT02071082|8605589|P1|Overall Study|Enrolled and Never Treated|1
2489340|NCT02070991|8605619|P2|Overall Study|Withdrawal by Subject|0
2489341|NCT02070991|8605620|P1|Overall Study|Withdrawal by Subject|1
2489342|NCT02070991|8605619|P2|Overall Study|Death|0
2489343|NCT02070991|8605620|P1|Overall Study|Death|2
2489344|NCT02070978|8605643|P3|Overall Study|Terminated by Sponsor|39
2489345|NCT02070978|8605644|P2|Overall Study|Terminated by Sponsor|40
2489346|NCT02070978|8605645|P1|Overall Study|Terminated by Sponsor|33
2489347|NCT02070978|8605643|P3|Overall Study|Un-specified|2
2489348|NCT02070978|8605644|P2|Overall Study|Un-specified|2
2489349|NCT02070978|8605645|P1|Overall Study|Un-specified|3
2489350|NCT02070978|8605643|P3|Overall Study|Death|2
2489351|NCT02070978|8605644|P2|Overall Study|Death|0
2489352|NCT02070978|8605645|P1|Overall Study|Death|0
2489353|NCT02070978|8605643|P3|Overall Study|Lack of Efficacy|0
2489354|NCT02070978|8605644|P2|Overall Study|Lack of Efficacy|1
2489355|NCT02070978|8605645|P1|Overall Study|Lack of Efficacy|0
2489356|NCT02070978|8605643|P3|Overall Study|Protocol Violation|3
2489357|NCT02070978|8605644|P2|Overall Study|Protocol Violation|0
2489358|NCT02070978|8605645|P1|Overall Study|Protocol Violation|1
2489359|NCT02070978|8605643|P3|Overall Study|Withdrawal by Subject|3
2489360|NCT02070978|8605644|P2|Overall Study|Withdrawal by Subject|5
2489361|NCT02070978|8605645|P1|Overall Study|Withdrawal by Subject|3
2489362|NCT02070978|8605643|P3|Overall Study|Lost to Follow-up|4
2489363|NCT02070978|8605644|P2|Overall Study|Lost to Follow-up|3
2489364|NCT02070978|8605645|P1|Overall Study|Lost to Follow-up|1
2489365|NCT02070978|8605643|P3|Overall Study|Adverse Event|0
2489366|NCT02070978|8605644|P2|Overall Study|Adverse Event|2
2489367|NCT02070978|8605645|P1|Overall Study|Adverse Event|6
2489368|NCT02070965|8605707|P3|Overall Study|Subject moved|0
2489369|NCT02070965|8605708|P2|Overall Study|Subject moved|0
2489370|NCT02070965|8605709|P1|Overall Study|Subject moved|1
2489371|NCT02070965|8605707|P3|Overall Study|Withdrawal by Subject|1
2489372|NCT02070965|8605708|P2|Overall Study|Withdrawal by Subject|1
2489373|NCT02070965|8605709|P1|Overall Study|Withdrawal by Subject|1
2489374|NCT02070965|8605707|P3|Overall Study|Lost to Follow-up|0
2489375|NCT02070965|8605708|P2|Overall Study|Lost to Follow-up|1
2489376|NCT02070965|8605709|P1|Overall Study|Lost to Follow-up|0
2489377|NCT02070757|8605719|P2|Overall Study|Discharged from Study Hospital|2
2489378|NCT02070757|8605720|P1|Overall Study|Discharged from Study Hospital|2
2489379|NCT02070757|8605719|P2|Overall Study|Investigator Decision|2
2489380|NCT02070757|8605720|P1|Overall Study|Investigator Decision|0
2489381|NCT02070757|8605719|P2|Overall Study|Withdrawal by Subject|3
2489382|NCT02070757|8605720|P1|Overall Study|Withdrawal by Subject|1
2489383|NCT02070757|8605719|P2|Overall Study|Protocol Violation|4
2489384|NCT02070757|8605720|P1|Overall Study|Protocol Violation|0
2489385|NCT02070757|8605719|P2|Overall Study|Lost to Follow-up|4
2489386|NCT02070757|8605720|P1|Overall Study|Lost to Follow-up|7
2489387|NCT02070757|8605719|P2|Overall Study|Adverse Event|99
2489388|NCT02070757|8605720|P1|Overall Study|Adverse Event|107
2489389|NCT02070744|8605754|P5|OLE Phase (48 Weeks)|Other|1
2489390|NCT02070744|8605755|P4|OLE Phase (48 Weeks)|Other|0
2489391|NCT02070744|8605756|P3|OLE Phase (48 Weeks)|Other|0
2489392|NCT02070744|8605757|P2|OLE Phase (48 Weeks)|Other|0
2489393|NCT02070744|8605758|P1|OLE Phase (48 Weeks)|Other|0
2489394|NCT02070744|8605754|P5|OLE Phase (48 Weeks)|Withdrawal by Subject|2
2489395|NCT02070744|8605755|P4|OLE Phase (48 Weeks)|Withdrawal by Subject|0
2489396|NCT02070744|8605756|P3|OLE Phase (48 Weeks)|Withdrawal by Subject|0
2489397|NCT02070744|8605757|P2|OLE Phase (48 Weeks)|Withdrawal by Subject|0
2489398|NCT02070744|8605758|P1|OLE Phase (48 Weeks)|Withdrawal by Subject|0
2489399|NCT02070744|8605754|P5|PC Phase (12 Weeks)|Randomized, but not treated|0
2489400|NCT02070744|8605755|P4|PC Phase (12 Weeks)|Randomized, but not treated|1
2489401|NCT02070744|8605756|P3|PC Phase (12 Weeks)|Randomized, but not treated|0
2489402|NCT02070744|8605757|P2|PC Phase (12 Weeks)|Randomized, but not treated|0
2489403|NCT02070744|8605758|P1|PC Phase (12 Weeks)|Randomized, but not treated|0
2489404|NCT02070588|8605841|P3|Overall Study|Adverse Event|0
2489405|NCT02070588|8605842|P2|Overall Study|Adverse Event|0
2489406|NCT02070588|8605843|P1|Overall Study|Adverse Event|1
2489407|NCT02070588|8605841|P3|Overall Study|Writhdrawal due to early termination|0
2489408|NCT02070588|8605842|P2|Overall Study|Writhdrawal due to early termination|0
2489409|NCT02070588|8605843|P1|Overall Study|Writhdrawal due to early termination|9
2489410|NCT02070588|8605841|P3|Overall Study|Withdrawal by Subject|0
2489411|NCT02070588|8605842|P2|Overall Study|Withdrawal by Subject|1
2489412|NCT02070588|8605843|P1|Overall Study|Withdrawal by Subject|29
2489413|NCT02070484|8605859|P2|Overall Study|Withdrawal by Subject|0
2489414|NCT02070484|8605860|P1|Overall Study|Withdrawal by Subject|1
2489415|NCT02070380|8605882|P4|Second Injection|Protocol Violation|5
2489416|NCT02070380|8605883|P3|Second Injection|Protocol Violation|1
2489417|NCT02070380|8605884|P2|Second Injection|Protocol Violation|1
2489418|NCT02070380|8605885|P1|Second Injection|Protocol Violation|0
2489419|NCT02070380|8605882|P4|Second Injection|Image sets missing or technically inadeq|0
2489420|NCT02070380|8605883|P3|Second Injection|Image sets missing or technically inadeq|0
2489421|NCT02070380|8605884|P2|Second Injection|Image sets missing or technically inadeq|1
2489422|NCT02070380|8605885|P1|Second Injection|Image sets missing or technically inadeq|0
2489423|NCT02070380|8605882|P4|Washout (no Second Injection/MRI)|Withdrawal by Subject|3
2489424|NCT02070380|8605883|P3|Washout (no Second Injection/MRI)|Withdrawal by Subject|2
2489425|NCT02070380|8605884|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|5
2489426|NCT02070380|8605885|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|0
2489427|NCT02069392|8606017|P2|Overall Study|Withdrawal by Subject|2
2489428|NCT02069392|8606018|P1|Overall Study|Withdrawal by Subject|4
2489429|NCT02069379|8606042|P4|Second Treatment Arm|Lost to Follow-up|0
2489430|NCT02069379|8606043|P3|Second Treatment Arm|Lost to Follow-up|1
2489431|NCT02069379|8606044|P2|Second Treatment Arm|Lost to Follow-up|0
2489432|NCT02069379|8606045|P1|Second Treatment Arm|Lost to Follow-up|0
2489433|NCT02069379|8606042|P4|Washout Period (4 Weeks)|Unrelated event|0
2489434|NCT02069379|8606043|P3|Washout Period (4 Weeks)|Unrelated event|0
2489435|NCT02069379|8606044|P2|Washout Period (4 Weeks)|Unrelated event|1
2489436|NCT02069379|8606045|P1|Washout Period (4 Weeks)|Unrelated event|0
2489437|NCT02069379|8606042|P4|Washout Period (4 Weeks)|Lost to Follow-up|0
2489438|NCT02069379|8606043|P3|Washout Period (4 Weeks)|Lost to Follow-up|0
2489439|NCT02069379|8606044|P2|Washout Period (4 Weeks)|Lost to Follow-up|1
2489440|NCT02069379|8606045|P1|Washout Period (4 Weeks)|Lost to Follow-up|0
2489441|NCT02069379|8606042|P4|First Treatment Arm|Lost to Follow-up|0
2489442|NCT02069379|8606043|P3|First Treatment Arm|Lost to Follow-up|1
2489443|NCT02069379|8606044|P2|First Treatment Arm|Lost to Follow-up|1
2489444|NCT02069379|8606045|P1|First Treatment Arm|Lost to Follow-up|0
2489445|NCT02069379|8606042|P4|Baseline Measurements|Ineligible based on initial assessments|2
2489446|NCT02069379|8606043|P3|Baseline Measurements|Ineligible based on initial assessments|0
2489447|NCT02069379|8606044|P2|Baseline Measurements|Ineligible based on initial assessments|0
2489448|NCT02069379|8606045|P1|Baseline Measurements|Ineligible based on initial assessments|2
2489449|NCT02069379|8606042|P4|Baseline Measurements|Lost to Follow-up|0
2489450|NCT02069379|8606043|P3|Baseline Measurements|Lost to Follow-up|0
2489451|NCT02069379|8606044|P2|Baseline Measurements|Lost to Follow-up|0
2489452|NCT02069379|8606045|P1|Baseline Measurements|Lost to Follow-up|1
2489453|NCT02069093|8606132|P1|Overall Study|Adverse Event|10
2489454|NCT02069093|8606132|P1|Overall Study|Abnormal laboratory values|1
2489455|NCT02069093|8606132|P1|Overall Study|Withdrawal by Subject|2
2489456|NCT02069093|8606132|P1|Overall Study|Administrative problems|1
2489457|NCT02069093|8606132|P1|Overall Study|Death|1
2489458|NCT02069093|8606132|P1|Overall Study|New cancer therapy|1
2489459|NCT02069093|8606132|P1|Overall Study|Disease progression|14
2489460|NCT02068768|8606182|P1|Overall Study|Early Termination by Sponsor|2
2489461|NCT02068768|8606182|P1|Overall Study|Lost to Follow-up|5
2489462|NCT02068599|8606191|P3|Overall Study|Noncompliance|1
2489463|NCT02068599|8606192|P2|Overall Study|Noncompliance|0
2489464|NCT02068599|8606193|P1|Overall Study|Noncompliance|0
2489465|NCT02068599|8606191|P3|Overall Study|Lack of Efficacy|3
2489466|NCT02068599|8606192|P2|Overall Study|Lack of Efficacy|0
2489467|NCT02068599|8606193|P1|Overall Study|Lack of Efficacy|0
2489468|NCT02068599|8606191|P3|Overall Study|Lost to Follow-up|0
2489469|NCT02068599|8606192|P2|Overall Study|Lost to Follow-up|0
2489470|NCT02068599|8606193|P1|Overall Study|Lost to Follow-up|1
2489471|NCT02068599|8606191|P3|Overall Study|Protocol Violation|3
2489472|NCT02068599|8606192|P2|Overall Study|Protocol Violation|2
2489473|NCT02068599|8606193|P1|Overall Study|Protocol Violation|4
2489474|NCT02068599|8606191|P3|Overall Study|Withdrawal by Subject|5
2489475|NCT02068599|8606192|P2|Overall Study|Withdrawal by Subject|7
2489476|NCT02068599|8606193|P1|Overall Study|Withdrawal by Subject|2
2489477|NCT02068599|8606191|P3|Overall Study|Adverse Event|1
2489478|NCT02068599|8606192|P2|Overall Study|Adverse Event|1
2489479|NCT02068599|8606193|P1|Overall Study|Adverse Event|4
2489480|NCT02068547|8606233|P2|Overall Study|Physician Decision|0
2489481|NCT02068547|8606234|P1|Overall Study|Physician Decision|1
2489482|NCT02068547|8606233|P2|Overall Study|Lost to Follow-up|3
2489483|NCT02068547|8606234|P1|Overall Study|Lost to Follow-up|3
2489484|NCT02068508|8606244|P1|Overall Study|Protocol Violation|4
2489485|NCT02068508|8606244|P1|Overall Study|Patient did not visit the study site|1
2489486|NCT02068508|8606244|P1|Overall Study|Case report forms uncollected|27
2489487|NCT02068495|8606254|P1|Overall Study|Protocol Deviation|49
2489488|NCT02068495|8606254|P1|Overall Study|Case Report Forms Uncollected|60
2489489|NCT02068443|8606266|P3|Overall Study|Other Reason Not Specified|0
2489490|NCT02068443|8606267|P2|Overall Study|Other Reason Not Specified|0
2489491|NCT02068443|8606268|P1|Overall Study|Other Reason Not Specified|1
2489492|NCT02068443|8606266|P3|Overall Study|Lack of Efficacy|0
2489493|NCT02068443|8606267|P2|Overall Study|Lack of Efficacy|1
2489494|NCT02068443|8606268|P1|Overall Study|Lack of Efficacy|2
2489495|NCT02068443|8606266|P3|Overall Study|Voluntary Withdrawal|1
2489496|NCT02068443|8606267|P2|Overall Study|Voluntary Withdrawal|0
2489497|NCT02068443|8606268|P1|Overall Study|Voluntary Withdrawal|4
2489498|NCT02068443|8606266|P3|Overall Study|Pretreatment Event/Adverse Event|2
2489499|NCT02068443|8606267|P2|Overall Study|Pretreatment Event/Adverse Event|5
2489500|NCT02068443|8606268|P1|Overall Study|Pretreatment Event/Adverse Event|0
2489501|NCT02068222|8606303|P1|Overall Study|Lost to Follow-up|1
2489502|NCT02067728|8606334|P2|6 Month Measurements|Unable to attend|97
2489503|NCT02067728|8606335|P1|6 Month Measurements|Unable to attend|114
2489504|NCT02067728|8606334|P2|6 Month Follow up Survey|Lost to Follow-up|60
2489505|NCT02067728|8606335|P1|6 Month Follow up Survey|Lost to Follow-up|48
2489506|NCT02067728|8606334|P2|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28
2489507|NCT02067728|8606335|P1|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7
2489508|NCT02067676|8606369|P6|Overall Study|Withdrawal by Subject|0
2489509|NCT02067676|8606370|P5|Overall Study|Withdrawal by Subject|0
2489510|NCT02067676|8606371|P4|Overall Study|Withdrawal by Subject|0
2489511|NCT02067676|8606372|P3|Overall Study|Withdrawal by Subject|0
2489512|NCT02067676|8606373|P2|Overall Study|Withdrawal by Subject|0
2489513|NCT02067676|8606374|P1|Overall Study|Withdrawal by Subject|1
2489514|NCT02067663|8606414|P2|Overall Study|Lost to Follow-up|14
2489515|NCT02067663|8606415|P1|Overall Study|Lost to Follow-up|13
2489516|NCT02067533|8606514|P2|Overall Study|Lost to Follow-up|2
2489517|NCT02067533|8606515|P1|Overall Study|Lost to Follow-up|4
2489518|NCT02067104|8606566|P2|Overall Study|Study termination due to low accrual|5
2489519|NCT02067104|8606567|P1|Overall Study|Study termination due to low accrual|4
2489520|NCT02066922|8606590|P1|Overall Study|Adverse Event|1
2489521|NCT02066467|8606642|P1|Overall Study|Not defined|4
2489522|NCT02066467|8606642|P1|Overall Study|Physician Decision|2
2489523|NCT02066467|8606642|P1|Overall Study|Withdrawal by Subject|16
2489524|NCT02066467|8606642|P1|Overall Study|Adverse Event|20
2489525|NCT02066467|8606642|P1|Overall Study|Lost to Follow-up|51
2489526|NCT02066467|8606642|P1|Overall Study|Death|54
2489527|NCT02066467|8606642|P1|Overall Study|Consent ineligible|1
2489528|NCT02066467|8606642|P1|Overall Study|Attempted to implant withoput success|43
2489529|NCT02066467|8606642|P1|Overall Study|Did not undergo implant procedure|24
2489530|NCT02066415|8606651|P3|Overall Study|Lost to Follow-up|2
2489531|NCT02066415|8606652|P2|Overall Study|Lost to Follow-up|2
2489532|NCT02066415|8606653|P1|Overall Study|Lost to Follow-up|7
2489533|NCT02066415|8606651|P3|Overall Study|Withdrawal by Subject|4
2489534|NCT02066415|8606652|P2|Overall Study|Withdrawal by Subject|1
2489535|NCT02066415|8606653|P1|Overall Study|Withdrawal by Subject|9
2489536|NCT02066415|8606651|P3|Overall Study|Decision by Sponsor|2
2489537|NCT02066415|8606652|P2|Overall Study|Decision by Sponsor|4
2489538|NCT02066415|8606653|P1|Overall Study|Decision by Sponsor|5
2489539|NCT02066402|8606678|P2|Overall Study|Protocol driven decision point|1
2489540|NCT02066402|8606679|P1|Overall Study|Protocol driven decision point|0
2489541|NCT02066402|8606678|P2|Overall Study|Progressive disease-clinical progression|1
2489542|NCT02066402|8606679|P1|Overall Study|Progressive disease-clinical progression|0
2489543|NCT02066402|8606678|P2|Overall Study|Withdrawal by Subject|11
2489544|NCT02066402|8606679|P1|Overall Study|Withdrawal by Subject|14
2489545|NCT02066402|8606678|P2|Overall Study|Lost to Follow-up|8
2489546|NCT02066402|8606679|P1|Overall Study|Lost to Follow-up|11
2489547|NCT02066402|8606678|P2|Overall Study|Adverse Event|2
2489548|NCT02066402|8606679|P1|Overall Study|Adverse Event|1
2489549|NCT02066389|8606711|P6|Overall Study|Randomized in Error|1
2489550|NCT02066389|8606712|P5|Overall Study|Randomized in Error|0
2489551|NCT02066389|8606713|P4|Overall Study|Randomized in Error|0
2489552|NCT02066389|8606714|P3|Overall Study|Randomized in Error|0
2489553|NCT02066389|8606715|P2|Overall Study|Randomized in Error|0
2489554|NCT02066389|8606716|P1|Overall Study|Randomized in Error|0
2489555|NCT02066389|8606711|P6|Overall Study|Lost to Follow-up|1
2489556|NCT02066389|8606712|P5|Overall Study|Lost to Follow-up|1
2489557|NCT02066389|8606713|P4|Overall Study|Lost to Follow-up|1
2489558|NCT02066389|8606714|P3|Overall Study|Lost to Follow-up|0
2489559|NCT02066389|8606715|P2|Overall Study|Lost to Follow-up|0
2489560|NCT02066389|8606716|P1|Overall Study|Lost to Follow-up|0
2489561|NCT02066389|8606711|P6|Overall Study|Withdrawal by Subject|2
2489562|NCT02066389|8606712|P5|Overall Study|Withdrawal by Subject|1
2489563|NCT02066389|8606713|P4|Overall Study|Withdrawal by Subject|1
2489564|NCT02066389|8606714|P3|Overall Study|Withdrawal by Subject|5
2489565|NCT02066389|8606715|P2|Overall Study|Withdrawal by Subject|0
2489566|NCT02066389|8606716|P1|Overall Study|Withdrawal by Subject|4
2489567|NCT02066389|8606711|P6|Overall Study|Adverse Event|1
2489568|NCT02066389|8606712|P5|Overall Study|Adverse Event|5
2489569|NCT02066389|8606713|P4|Overall Study|Adverse Event|1
2489570|NCT02066389|8606714|P3|Overall Study|Adverse Event|1
2489571|NCT02066389|8606715|P2|Overall Study|Adverse Event|1
2489572|NCT02066389|8606716|P1|Overall Study|Adverse Event|1
2489573|NCT02066311|8606766|P1|Overall Study|Withdrawal by Subject|1
2489574|NCT02066311|8606766|P1|Overall Study|Adverse Event|4
2489575|NCT02066298|8606776|P6|Overall Study|Physician Decision|0
2489576|NCT02066298|8606777|P5|Overall Study|Physician Decision|1
2489577|NCT02066298|8606778|P4|Overall Study|Physician Decision|0
2489578|NCT02066298|8606779|P3|Overall Study|Physician Decision|1
2489579|NCT02066298|8606780|P2|Overall Study|Physician Decision|0
2489580|NCT02066298|8606781|P1|Overall Study|Physician Decision|0
2489581|NCT02066298|8606776|P6|Overall Study|Withdrawal by Subject|8
2489582|NCT02066298|8606777|P5|Overall Study|Withdrawal by Subject|5
2489583|NCT02066298|8606778|P4|Overall Study|Withdrawal by Subject|4
2489584|NCT02066298|8606779|P3|Overall Study|Withdrawal by Subject|6
2489585|NCT02066298|8606780|P2|Overall Study|Withdrawal by Subject|6
2489586|NCT02066298|8606781|P1|Overall Study|Withdrawal by Subject|6
2489587|NCT02066298|8606776|P6|Overall Study|Lost to Follow-up|4
2489588|NCT02066298|8606777|P5|Overall Study|Lost to Follow-up|3
2489589|NCT02066298|8606778|P4|Overall Study|Lost to Follow-up|2
2489590|NCT02066298|8606779|P3|Overall Study|Lost to Follow-up|3
2489591|NCT02066298|8606780|P2|Overall Study|Lost to Follow-up|2
2489592|NCT02066298|8606781|P1|Overall Study|Lost to Follow-up|3
2489593|NCT02066233|8606805|P2|EG Scan II (Day 1)|difficulty intubating subject|6
2489594|NCT02066233|8606806|P1|EG Scan II (Day 1)|difficulty intubating subject|6
2489595|NCT02066181|8606816|P2|Overall Study|Withdrawal by Subject|1
2489596|NCT02066181|8606817|P1|Overall Study|Withdrawal by Subject|1
2489597|NCT02066129|8606839|P2|Overall Study|Physician Decision|1
2489598|NCT02066129|8606840|P1|Overall Study|Physician Decision|1
2489599|NCT02066129|8606839|P2|Overall Study|Lack of Efficacy|10
2489600|NCT02066129|8606840|P1|Overall Study|Lack of Efficacy|8
2489601|NCT02066129|8606839|P2|Overall Study|Withdrawal by Subject|10
2489602|NCT02066129|8606840|P1|Overall Study|Withdrawal by Subject|7
2489603|NCT02066129|8606839|P2|Overall Study|Lost to Follow-up|12
2489604|NCT02066129|8606840|P1|Overall Study|Lost to Follow-up|13
2489605|NCT02066051|8606854|P1|Overall Study|Subject developed active GVHD|1
2489606|NCT02065895|8606859|P6|Overall Study|Scheduling conflicts|0
2489607|NCT02065895|8606860|P5|Overall Study|Scheduling conflicts|0
2489608|NCT02065895|8606861|P4|Overall Study|Scheduling conflicts|0
2489609|NCT02065895|8606862|P3|Overall Study|Scheduling conflicts|0
2489610|NCT02065895|8606863|P2|Overall Study|Scheduling conflicts|1
2489611|NCT02065895|8606864|P1|Overall Study|Scheduling conflicts|0
2489612|NCT02065895|8606859|P6|Overall Study|Protocol Violation|0
2489613|NCT02065895|8606860|P5|Overall Study|Protocol Violation|0
2489614|NCT02065895|8606861|P4|Overall Study|Protocol Violation|1
2489615|NCT02065895|8606862|P3|Overall Study|Protocol Violation|0
2489616|NCT02065895|8606863|P2|Overall Study|Protocol Violation|0
2489617|NCT02065895|8606864|P1|Overall Study|Protocol Violation|1
2489618|NCT02065791|8606883|P2|Overall Study|Lost to Follow-up|9
2489619|NCT02065791|8606884|P1|Overall Study|Lost to Follow-up|13
2489620|NCT02065791|8606883|P2|Overall Study|Withdrawal by Subject|5
2489621|NCT02065791|8606884|P1|Overall Study|Withdrawal by Subject|11
2489622|NCT02065791|8606883|P2|Overall Study|Closed Site|1
2489623|NCT02065791|8606884|P1|Overall Study|Closed Site|1
2489624|NCT02065518|8606908|P4|Overall Study|Withdrawal by Subject|2
2489625|NCT02065518|8606909|P3|Overall Study|Withdrawal by Subject|9
2489626|NCT02065518|8606910|P2|Overall Study|Withdrawal by Subject|4
2489627|NCT02065518|8606911|P1|Overall Study|Withdrawal by Subject|3
2489628|NCT02065518|8606908|P4|Overall Study|Lost to Follow-up|3
2489629|NCT02065518|8606909|P3|Overall Study|Lost to Follow-up|0
2489630|NCT02065518|8606910|P2|Overall Study|Lost to Follow-up|4
2489631|NCT02065518|8606911|P1|Overall Study|Lost to Follow-up|3
2489632|NCT02065336|8606977|P10|Extension Phase|Study Terminated by Sponsor|8
2489633|NCT02065336|8606978|P9|Extension Phase|Study Terminated by Sponsor|2
2489634|NCT02065336|8606979|P8|Extension Phase|Study Terminated by Sponsor|0
2489635|NCT02065336|8606980|P7|Extension Phase|Study Terminated by Sponsor|0
2489636|NCT02065336|8606981|P6|Extension Phase|Study Terminated by Sponsor|0
2489637|NCT02065336|8606982|P5|Extension Phase|Study Terminated by Sponsor|0
2489638|NCT02065336|8606983|P4|Extension Phase|Study Terminated by Sponsor|0
2489639|NCT02065336|8606984|P3|Extension Phase|Study Terminated by Sponsor|0
2489640|NCT02065336|8606985|P2|Extension Phase|Study Terminated by Sponsor|0
2489641|NCT02065336|8606986|P1|Extension Phase|Study Terminated by Sponsor|0
2489642|NCT02064920|8607246|P2|Overall Study|Withdrawal by Subject|3
2489643|NCT02064920|8607247|P1|Overall Study|Withdrawal by Subject|1
2489644|NCT02064920|8607246|P2|Overall Study|Technical Problems|1
2489645|NCT02064920|8607247|P1|Overall Study|Technical Problems|0
2489646|NCT02064920|8607246|P2|Overall Study|Physician Decision|1
2489647|NCT02064920|8607247|P1|Overall Study|Physician Decision|0
2489648|NCT02064920|8607246|P2|Overall Study|Adverse Event|4
2489649|NCT02064920|8607247|P1|Overall Study|Adverse Event|0
2489650|NCT02064894|8607277|P3|Overall Study|Withdrawal by Subject|115
2489651|NCT02064894|8607278|P2|Overall Study|Withdrawal by Subject|102
2489652|NCT02064894|8607279|P1|Overall Study|Withdrawal by Subject|43
2489653|NCT02064868|8607292|P2|Overall Study|Technical Problems or Missing|2
2489654|NCT02064868|8607293|P1|Overall Study|Technical Problems or Missing|5
2489655|NCT02064868|8607292|P2|Overall Study|Withdrawal by Subject|3
2489656|NCT02064868|8607293|P1|Overall Study|Withdrawal by Subject|14
2489657|NCT02064868|8607292|P2|Overall Study|Physician Decision|0
2489658|NCT02064868|8607293|P1|Overall Study|Physician Decision|1
2489659|NCT02064868|8607292|P2|Overall Study|Lost to Follow-up|8
2489660|NCT02064868|8607293|P1|Overall Study|Lost to Follow-up|14
2489661|NCT02064816|8607313|P2|Overall Study|Other|3
2489662|NCT02064816|8607314|P1|Overall Study|Other|1
2489663|NCT02064816|8607313|P2|Overall Study|Therapeutic failure|1
2489664|NCT02064816|8607314|P1|Overall Study|Therapeutic failure|0
2489665|NCT02064816|8607313|P2|Overall Study|Lost to Follow-up|1
2489666|NCT02064816|8607314|P1|Overall Study|Lost to Follow-up|2
2489667|NCT02064816|8607313|P2|Overall Study|Withdrawal by Subject|1
2489668|NCT02064816|8607314|P1|Overall Study|Withdrawal by Subject|2
2489669|NCT02064816|8607313|P2|Overall Study|Adverse Event|2
2489670|NCT02064816|8607314|P1|Overall Study|Adverse Event|3
2489671|NCT02064439|8607355|P3|Overall Study|Other|7
2489672|NCT02064439|8607356|P2|Overall Study|Other|2
2489673|NCT02064439|8607357|P1|Overall Study|Other|2
2489674|NCT02064439|8607355|P3|Overall Study|Safety outcome reached|10
2489675|NCT02064439|8607356|P2|Overall Study|Safety outcome reached|20
2489676|NCT02064439|8607357|P1|Overall Study|Safety outcome reached|12
2489677|NCT02064439|8607355|P3|Overall Study|Efficacy outcome reached|57
2489678|NCT02064439|8607356|P2|Overall Study|Efficacy outcome reached|16
2489679|NCT02064439|8607357|P1|Overall Study|Efficacy outcome reached|18
2489680|NCT02064439|8607355|P3|Overall Study|Logistical difficulties|2
2489681|NCT02064439|8607356|P2|Overall Study|Logistical difficulties|5
2489682|NCT02064439|8607357|P1|Overall Study|Logistical difficulties|6
2489683|NCT02064439|8607355|P3|Overall Study|Physician Decision|1
2489684|NCT02064439|8607356|P2|Overall Study|Physician Decision|1
2489685|NCT02064439|8607357|P1|Overall Study|Physician Decision|0
2489686|NCT02064439|8607355|P3|Overall Study|Non-compliance with study medication|23
2489687|NCT02064439|8607356|P2|Overall Study|Non-compliance with study medication|19
2489688|NCT02064439|8607357|P1|Overall Study|Non-compliance with study medication|21
2489689|NCT02064439|8607355|P3|Overall Study|Lost to Follow-up|4
2489690|NCT02064439|8607356|P2|Overall Study|Lost to Follow-up|3
2489691|NCT02064439|8607357|P1|Overall Study|Lost to Follow-up|1
2489692|NCT02064439|8607355|P3|Overall Study|Protocol Violation|3
2489693|NCT02064439|8607356|P2|Overall Study|Protocol Violation|5
2489694|NCT02064439|8607357|P1|Overall Study|Protocol Violation|3
2489695|NCT02064439|8607355|P3|Overall Study|Withdrawal by Subject|26
2489696|NCT02064439|8607356|P2|Overall Study|Withdrawal by Subject|18
2489697|NCT02064439|8607357|P1|Overall Study|Withdrawal by Subject|29
2489698|NCT02064439|8607355|P3|Overall Study|Death|3
2489699|NCT02064439|8607356|P2|Overall Study|Death|2
2489700|NCT02064439|8607357|P1|Overall Study|Death|0
2489701|NCT02064439|8607355|P3|Overall Study|Adverse Event|46
2489702|NCT02064439|8607356|P2|Overall Study|Adverse Event|47
2489703|NCT02064439|8607357|P1|Overall Study|Adverse Event|51
2489704|NCT02064387|8607385|P11|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|8
2489705|NCT02064387|8607386|P10|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2489706|NCT02064387|8607387|P9|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2489707|NCT02064387|8607388|P8|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2489708|NCT02064387|8607389|P7|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2489709|NCT02064387|8607390|P6|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2489710|NCT02064387|8607391|P5|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2489711|NCT02064387|8607392|P4|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2489712|NCT02064387|8607393|P3|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2489713|NCT02064387|8607394|P2|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2489714|NCT02064387|8607395|P1|Part 2 Max 24.2 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2489715|NCT02064387|8607385|P11|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|1
2489716|NCT02064387|8607386|P10|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
2489717|NCT02064387|8607387|P9|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
2489718|NCT02064387|8607388|P8|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
2489719|NCT02064387|8607389|P7|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
2489720|NCT02064387|8607390|P6|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
2489721|NCT02064387|8607391|P5|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
2489722|NCT02064387|8607392|P4|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
2489723|NCT02064387|8607393|P3|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
2489724|NCT02064387|8607394|P2|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
2489725|NCT02064387|8607395|P1|Part 2 Max 24.2 Mnths Follow-up Duration|Withdrawal by Subject|0
2489726|NCT02064387|8607385|P11|Part 2 Max 24.2 Mnths Follow-up Duration|Death|4
2489727|NCT02064387|8607386|P10|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
2489728|NCT02064387|8607387|P9|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
2489729|NCT02064387|8607388|P8|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
2489730|NCT02064387|8607389|P7|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
2489731|NCT02064387|8607390|P6|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
2489732|NCT02064387|8607391|P5|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
2489733|NCT02064387|8607392|P4|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
2489734|NCT02064387|8607393|P3|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
2489735|NCT02064387|8607394|P2|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
2489736|NCT02064387|8607395|P1|Part 2 Max 24.2 Mnths Follow-up Duration|Death|0
2489737|NCT02064387|8607385|P11|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
2489738|NCT02064387|8607386|P10|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
2489739|NCT02064387|8607387|P9|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|1
2489740|NCT02064387|8607388|P8|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
2489741|NCT02064387|8607389|P7|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
2489742|NCT02064387|8607390|P6|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
2489743|NCT02064387|8607391|P5|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
2489744|NCT02064387|8607392|P4|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
2489745|NCT02064387|8607393|P3|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
2489746|NCT02064387|8607394|P2|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
2489747|NCT02064387|8607395|P1|Part 1 Max 21.6 Mnths Follow-up Duration|Withdrawal by Subject|0
2489748|NCT02064387|8607385|P11|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2489749|NCT02064387|8607386|P10|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2489750|NCT02064387|8607387|P9|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2489751|NCT02064387|8607388|P8|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|1
2489752|NCT02064387|8607389|P7|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2489753|NCT02064387|8607390|P6|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2489754|NCT02064387|8607391|P5|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2489755|NCT02064387|8607392|P4|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2489756|NCT02064387|8607393|P3|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2489757|NCT02064387|8607394|P2|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2489758|NCT02064387|8607395|P1|Part 1 Max 21.6 Mnths Follow-up Duration|Ongoing at the time of analysis|0
2489759|NCT02064387|8607385|P11|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
2489760|NCT02064387|8607386|P10|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
2489761|NCT02064387|8607387|P9|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
2489762|NCT02064387|8607388|P8|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|1
2489763|NCT02064387|8607389|P7|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
2489764|NCT02064387|8607390|P6|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
2489765|NCT02064387|8607391|P5|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
2489766|NCT02064387|8607392|P4|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
2489767|NCT02064387|8607393|P3|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
2489768|NCT02064387|8607394|P2|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
2489769|NCT02064387|8607395|P1|Part 1 Max 21.6 Mnths Follow-up Duration|Lost to Follow-up|0
2489770|NCT02064387|8607385|P11|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
2489771|NCT02064387|8607386|P10|Part 1 Max 21.6 Mnths Follow-up Duration|Death|1
2489772|NCT02064387|8607387|P9|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
2489773|NCT02064387|8607388|P8|Part 1 Max 21.6 Mnths Follow-up Duration|Death|1
2489774|NCT02064387|8607389|P7|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
2489775|NCT02064387|8607390|P6|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
2489776|NCT02064387|8607391|P5|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
2489777|NCT02064387|8607392|P4|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
2489778|NCT02064387|8607393|P3|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
2489779|NCT02064387|8607394|P2|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
2489780|NCT02064387|8607395|P1|Part 1 Max 21.6 Mnths Follow-up Duration|Death|0
2489781|NCT02064231|8607710|P4|Second Test Period (Test B or Test D)|Lack of Efficacy|0
2489782|NCT02064231|8607711|P3|Second Test Period (Test B or Test D)|Lack of Efficacy|0
2489783|NCT02064231|8607712|P2|Second Test Period (Test B or Test D)|Lack of Efficacy|1
2489784|NCT02064231|8607713|P1|Second Test Period (Test B or Test D)|Lack of Efficacy|1
2489785|NCT02064231|8607710|P4|First Test Period (Test A or Test C)|Adverse Event|0
2489786|NCT02064231|8607711|P3|First Test Period (Test A or Test C)|Adverse Event|1
2489787|NCT02064231|8607712|P2|First Test Period (Test A or Test C)|Adverse Event|0
2489788|NCT02064231|8607713|P1|First Test Period (Test A or Test C)|Adverse Event|1
2489789|NCT02064231|8607710|P4|First Test Period (Test A or Test C)|Withdrawal by Subject|0
2489790|NCT02064231|8607711|P3|First Test Period (Test A or Test C)|Withdrawal by Subject|0
2489791|NCT02064231|8607712|P2|First Test Period (Test A or Test C)|Withdrawal by Subject|1
2489792|NCT02064231|8607713|P1|First Test Period (Test A or Test C)|Withdrawal by Subject|1
2489793|NCT02064231|8607710|P4|First Test Period (Test A or Test C)|Lack of Efficacy|0
2489794|NCT02064231|8607711|P3|First Test Period (Test A or Test C)|Lack of Efficacy|0
2489795|NCT02064231|8607712|P2|First Test Period (Test A or Test C)|Lack of Efficacy|3
2489796|NCT02064231|8607713|P1|First Test Period (Test A or Test C)|Lack of Efficacy|5
2489797|NCT02064205|8607725|P1|Overall Study|Withdrawal by Subject|1
2489798|NCT02064166|8607743|P2|Overall Study|Adverse Event|0
2489799|NCT02064166|8607744|P1|Overall Study|Adverse Event|1
2489800|NCT02063880|8607774|P2|Overall Study|Ineligible|2
2489801|NCT02063880|8607775|P1|Overall Study|Ineligible|0
2489802|NCT02063880|8607774|P2|Overall Study|Lost to Follow-up|7
2489803|NCT02063880|8607775|P1|Overall Study|Lost to Follow-up|7
2489804|NCT02063880|8607774|P2|Overall Study|Death|18
2489805|NCT02063880|8607775|P1|Overall Study|Death|21
2489806|NCT02063854|8607813|P7|Overall Study|Did Not Receive Study Drug|0
2489807|NCT02063854|8607814|P6|Overall Study|Did Not Receive Study Drug|1
2489808|NCT02063854|8607815|P5|Overall Study|Did Not Receive Study Drug|0
2489809|NCT02063854|8607816|P4|Overall Study|Did Not Receive Study Drug|0
2489810|NCT02063854|8607817|P3|Overall Study|Did Not Receive Study Drug|0
2489811|NCT02063854|8607818|P2|Overall Study|Did Not Receive Study Drug|0
2489812|NCT02063854|8607819|P1|Overall Study|Did Not Receive Study Drug|0
2489813|NCT02063854|8607813|P7|Overall Study|Reason Not Specified|0
2489814|NCT02063854|8607814|P6|Overall Study|Reason Not Specified|0
2489815|NCT02063854|8607815|P5|Overall Study|Reason Not Specified|0
2489816|NCT02063854|8607816|P4|Overall Study|Reason Not Specified|0
2489817|NCT02063854|8607817|P3|Overall Study|Reason Not Specified|0
2489818|NCT02063854|8607818|P2|Overall Study|Reason Not Specified|0
2489819|NCT02063854|8607819|P1|Overall Study|Reason Not Specified|1
2489820|NCT02063854|8607813|P7|Overall Study|Surgical Dental Work Performed/Planned|1
2489821|NCT02063854|8607814|P6|Overall Study|Surgical Dental Work Performed/Planned|6
2489822|NCT02063854|8607815|P5|Overall Study|Surgical Dental Work Performed/Planned|1
2489823|NCT02063854|8607816|P4|Overall Study|Surgical Dental Work Performed/Planned|1
2489824|NCT02063854|8607817|P3|Overall Study|Surgical Dental Work Performed/Planned|6
2489825|NCT02063854|8607818|P2|Overall Study|Surgical Dental Work Performed/Planned|2
2489826|NCT02063854|8607819|P1|Overall Study|Surgical Dental Work Performed/Planned|5
2489827|NCT02063854|8607813|P7|Overall Study|Voluntary Withdrawal|1
2489828|NCT02063854|8607814|P6|Overall Study|Voluntary Withdrawal|6
2489829|NCT02063854|8607815|P5|Overall Study|Voluntary Withdrawal|3
2489830|NCT02063854|8607816|P4|Overall Study|Voluntary Withdrawal|1
2489831|NCT02063854|8607817|P3|Overall Study|Voluntary Withdrawal|8
2489832|NCT02063854|8607818|P2|Overall Study|Voluntary Withdrawal|0
2489833|NCT02063854|8607819|P1|Overall Study|Voluntary Withdrawal|2
2489834|NCT02063854|8607813|P7|Overall Study|Major Protocol Deviation|0
2489835|NCT02063854|8607814|P6|Overall Study|Major Protocol Deviation|0
2489836|NCT02063854|8607815|P5|Overall Study|Major Protocol Deviation|0
2489837|NCT02063854|8607816|P4|Overall Study|Major Protocol Deviation|0
2489838|NCT02063854|8607817|P3|Overall Study|Major Protocol Deviation|3
2489839|NCT02063854|8607818|P2|Overall Study|Major Protocol Deviation|0
2489840|NCT02063854|8607819|P1|Overall Study|Major Protocol Deviation|0
2489841|NCT02063854|8607813|P7|Overall Study|Pretreatment Event/Adverse Event|4
2489842|NCT02063854|8607814|P6|Overall Study|Pretreatment Event/Adverse Event|18
2489843|NCT02063854|8607815|P5|Overall Study|Pretreatment Event/Adverse Event|7
2489844|NCT02063854|8607816|P4|Overall Study|Pretreatment Event/Adverse Event|8
2489845|NCT02063854|8607817|P3|Overall Study|Pretreatment Event/Adverse Event|13
2489846|NCT02063854|8607818|P2|Overall Study|Pretreatment Event/Adverse Event|10
2489847|NCT02063854|8607819|P1|Overall Study|Pretreatment Event/Adverse Event|13
2489848|NCT02063737|8607903|P2|Overall Study|Lost to Follow-up|4
2489849|NCT02063737|8607904|P1|Overall Study|Lost to Follow-up|11
2489850|NCT02063724|8607936|P1|Overall Study|Disease progression|1
2489851|NCT02063698|8607944|P2|Overall Study|did not complete booklet for days 2-8|2
2489852|NCT02063698|8607945|P1|Overall Study|did not complete booklet for days 2-8|1
2489853|NCT02063672|8607969|P2|Overall Study|Withdrawal by Subject|2
2489854|NCT02063672|8607970|P1|Overall Study|Withdrawal by Subject|2
2489855|NCT02063672|8607969|P2|Overall Study|Lost to Follow-up|3
2489856|NCT02063672|8607970|P1|Overall Study|Lost to Follow-up|1
2489857|NCT02063672|8607969|P2|Overall Study|Death|3
2489858|NCT02063672|8607970|P1|Overall Study|Death|5
2489859|NCT02063672|8607969|P2|Overall Study|Ongoing Follow-up|14
2489860|NCT02063672|8607970|P1|Overall Study|Ongoing Follow-up|27
2489861|NCT02063659|8608017|P4|Open-Label Extension Period (OLE)|Reason not Specified|2
2489862|NCT02063659|8608018|P3|Open-Label Extension Period (OLE)|Reason not Specified|0
2489863|NCT02063659|8608019|P2|Open-Label Extension Period (OLE)|Reason not Specified|0
2489864|NCT02063659|8608020|P1|Open-Label Extension Period (OLE)|Reason not Specified|0
2489865|NCT02063659|8608017|P4|Open-Label Extension Period (OLE)|Adverse Event|7
2489866|NCT02063659|8608018|P3|Open-Label Extension Period (OLE)|Adverse Event|0
2489867|NCT02063659|8608019|P2|Open-Label Extension Period (OLE)|Adverse Event|0
2489868|NCT02063659|8608020|P1|Open-Label Extension Period (OLE)|Adverse Event|0
2489869|NCT02063659|8608017|P4|Open-Label Extension Period (OLE)|Lack of Efficacy|1
2489870|NCT02063659|8608018|P3|Open-Label Extension Period (OLE)|Lack of Efficacy|0
2489871|NCT02063659|8608019|P2|Open-Label Extension Period (OLE)|Lack of Efficacy|0
2489872|NCT02063659|8608020|P1|Open-Label Extension Period (OLE)|Lack of Efficacy|0
2489873|NCT02063659|8608017|P4|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
2489874|NCT02063659|8608018|P3|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
2489875|NCT02063659|8608019|P2|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
2489876|NCT02063659|8608020|P1|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
2489877|NCT02063659|8608017|P4|Open-Label Extension Period (OLE)|Physician Decision|1
2489878|NCT02063659|8608018|P3|Open-Label Extension Period (OLE)|Physician Decision|0
2489879|NCT02063659|8608019|P2|Open-Label Extension Period (OLE)|Physician Decision|0
2489880|NCT02063659|8608020|P1|Open-Label Extension Period (OLE)|Physician Decision|0
2489881|NCT02063659|8608017|P4|Double-Blind Treatment Period|Withdrawal of consent|0
2489882|NCT02063659|8608018|P3|Double-Blind Treatment Period|Withdrawal of consent|3
2489883|NCT02063659|8608019|P2|Double-Blind Treatment Period|Withdrawal of consent|1
2489884|NCT02063659|8608020|P1|Double-Blind Treatment Period|Withdrawal of consent|0
2489885|NCT02063659|8608017|P4|Double-Blind Treatment Period|Physician Decision|0
2489886|NCT02063659|8608018|P3|Double-Blind Treatment Period|Physician Decision|0
2489887|NCT02063659|8608019|P2|Double-Blind Treatment Period|Physician Decision|0
2489888|NCT02063659|8608020|P1|Double-Blind Treatment Period|Physician Decision|1
2489889|NCT02063659|8608017|P4|Double-Blind Treatment Period|Adverse Event|0
2489890|NCT02063659|8608018|P3|Double-Blind Treatment Period|Adverse Event|0
2489891|NCT02063659|8608019|P2|Double-Blind Treatment Period|Adverse Event|2
2489892|NCT02063659|8608020|P1|Double-Blind Treatment Period|Adverse Event|1
2489893|NCT02063217|8608103|P3|Overall Study|Withdrawal by Subject|0
2489894|NCT02063217|8608104|P2|Overall Study|Withdrawal by Subject|0
2489895|NCT02063217|8608105|P1|Overall Study|Withdrawal by Subject|1
2489896|NCT02062879|8608181|P2|Overall Study|Withdrawal by Subject|1
2489897|NCT02062879|8608182|P1|Overall Study|Withdrawal by Subject|4
2489898|NCT02062658|8608218|P1|Overall Study|Lack of Efficacy|1
2489899|NCT02062658|8608218|P1|Overall Study|Withdrawal by Subject|1
2489900|NCT02062645|8608222|P1|Overall Study|Lost to Follow-up|5
2489901|NCT02062645|8608222|P1|Overall Study|Protocol Violation|8
2489902|NCT02062645|8608222|P1|Overall Study|Adverse Event|2
2489903|NCT02062632|8608230|P1|Overall Study|No treatment data|1
2489904|NCT02062450|8608271|P1|Overall Study|No follow-up visit|124
2489905|NCT02062437|8608285|P1|Overall Study|Pt. couldn't come due to med. condition|1
2489906|NCT02062437|8608285|P1|Overall Study|Death|2
2489907|NCT02062437|8608285|P1|Overall Study|Patient not available for the 2y visit|18
2489908|NCT02062437|8608285|P1|Overall Study|Pt. didn't want to come for the 2y visit|31
2489909|NCT02062398|8608294|P1|Overall Study|Implant removal|1
2489910|NCT02062385|8608306|P4|Overall Study|Lost to Follow-up|0
2489911|NCT02062385|8608307|P3|Overall Study|Lost to Follow-up|1
2489912|NCT02062385|8608308|P2|Overall Study|Lost to Follow-up|0
2489913|NCT02062385|8608309|P1|Overall Study|Lost to Follow-up|0
2489914|NCT02062385|8608306|P4|Overall Study|Death|1
2489915|NCT02062385|8608307|P3|Overall Study|Death|0
2489916|NCT02062385|8608308|P2|Overall Study|Death|0
2489917|NCT02062385|8608309|P1|Overall Study|Death|0
2489918|NCT02062385|8608306|P4|Overall Study|Withdrawn by parent/guardian|8
2489919|NCT02062385|8608307|P3|Overall Study|Withdrawn by parent/guardian|9
2489920|NCT02062385|8608308|P2|Overall Study|Withdrawn by parent/guardian|41
2489921|NCT02062385|8608309|P1|Overall Study|Withdrawn by parent/guardian|46
2489922|NCT02062385|8608306|P4|Overall Study|Moved|0
2489923|NCT02062385|8608307|P3|Overall Study|Moved|1
2489924|NCT02062385|8608308|P2|Overall Study|Moved|11
2489925|NCT02062385|8608309|P1|Overall Study|Moved|10
2489926|NCT02062385|8608306|P4|Overall Study|Incomplete EPI by database lock|0
2489927|NCT02062385|8608307|P3|Overall Study|Incomplete EPI by database lock|0
2489928|NCT02062385|8608308|P2|Overall Study|Incomplete EPI by database lock|0
2489929|NCT02062385|8608309|P1|Overall Study|Incomplete EPI by database lock|2
2489930|NCT02062385|8608306|P4|Overall Study|Protocol Violation|0
2489931|NCT02062385|8608307|P3|Overall Study|Protocol Violation|0
2489932|NCT02062385|8608308|P2|Overall Study|Protocol Violation|0
2489933|NCT02062385|8608309|P1|Overall Study|Protocol Violation|1
2489934|NCT02062385|8608306|P4|Overall Study|Adverse Event|0
2489935|NCT02062385|8608307|P3|Overall Study|Adverse Event|1
2489936|NCT02062385|8608308|P2|Overall Study|Adverse Event|13
2489937|NCT02062385|8608309|P1|Overall Study|Adverse Event|19
2489938|NCT02062151|8608353|P1|Overall Study|screen failure|1
2489939|NCT02061592|8608513|P2|Period 2|Lost to Follow-up|1
2489940|NCT02061592|8608514|P1|Period 2|Lost to Follow-up|0
2489941|NCT02061592|8608513|P2|Period 1|Protocol Violation|0
2489942|NCT02061592|8608514|P1|Period 1|Protocol Violation|1
2489943|NCT02061592|8608513|P2|Period 1|Withdrawal by Subject|0
2489944|NCT02061592|8608514|P1|Period 1|Withdrawal by Subject|1
2489945|NCT02061540|8608526|P1|Overall Study|Withdrawal by Subject|2
2489946|NCT02061540|8608526|P1|Overall Study|Adverse Event|2
2489947|NCT02061280|8608694|P2|Overall Study|Lost to Follow-up|1
2489948|NCT02061280|8608695|P1|Overall Study|Lost to Follow-up|5
2489949|NCT02061280|8608694|P2|Overall Study|Withdrawal by Subject|2
2489950|NCT02061280|8608695|P1|Overall Study|Withdrawal by Subject|1
2489951|NCT02061280|8608694|P2|Overall Study|moved out of state|1
2489952|NCT02061280|8608695|P1|Overall Study|moved out of state|0
2489953|NCT02061280|8608694|P2|Overall Study|Protocol Violation|8
2489954|NCT02061280|8608695|P1|Overall Study|Protocol Violation|12
2489955|NCT02061202|8608727|P2|Overall Study|Lost to Follow-up|1
2489956|NCT02061202|8608728|P1|Overall Study|Lost to Follow-up|1
2489957|NCT02060383|8608867|P5|Extension Phase|Protocol Violation|1
2489958|NCT02060383|8608868|P4|Extension Phase|Protocol Violation|0
2489959|NCT02060383|8608869|P3|Extension Phase|Protocol Violation|0
2489960|NCT02060383|8608870|P2|Extension Phase|Protocol Violation|0
2489961|NCT02060383|8608871|P1|Extension Phase|Protocol Violation|0
2489962|NCT02060383|8608867|P5|Extension Phase|Death|1
2489963|NCT02060383|8608868|P4|Extension Phase|Death|0
2489964|NCT02060383|8608869|P3|Extension Phase|Death|1
2489965|NCT02060383|8608870|P2|Extension Phase|Death|0
2489966|NCT02060383|8608871|P1|Extension Phase|Death|0
2489967|NCT02060383|8608867|P5|Extension Phase|Administrative problems|0
2489968|NCT02060383|8608868|P4|Extension Phase|Administrative problems|0
2489969|NCT02060383|8608869|P3|Extension Phase|Administrative problems|0
2489970|NCT02060383|8608870|P2|Extension Phase|Administrative problems|0
2489971|NCT02060383|8608871|P1|Extension Phase|Administrative problems|1
2489972|NCT02060383|8608867|P5|Extension Phase|Withdrawal by Subject|2
2489973|NCT02060383|8608868|P4|Extension Phase|Withdrawal by Subject|0
2489974|NCT02060383|8608869|P3|Extension Phase|Withdrawal by Subject|0
2489975|NCT02060383|8608870|P2|Extension Phase|Withdrawal by Subject|1
2489976|NCT02060383|8608871|P1|Extension Phase|Withdrawal by Subject|0
2489977|NCT02060383|8608867|P5|Extension Phase|Adverse Event|1
2489978|NCT02060383|8608868|P4|Extension Phase|Adverse Event|0
2489979|NCT02060383|8608869|P3|Extension Phase|Adverse Event|2
2489980|NCT02060383|8608870|P2|Extension Phase|Adverse Event|1
2489981|NCT02060383|8608871|P1|Extension Phase|Adverse Event|1
2489982|NCT02060383|8608867|P5|Extension Phase|Unsatisfactory therapeutic effect|2
2489983|NCT02060383|8608868|P4|Extension Phase|Unsatisfactory therapeutic effect|2
2489984|NCT02060383|8608869|P3|Extension Phase|Unsatisfactory therapeutic effect|0
2489985|NCT02060383|8608870|P2|Extension Phase|Unsatisfactory therapeutic effect|1
2489986|NCT02060383|8608871|P1|Extension Phase|Unsatisfactory therapeutic effect|1
2489987|NCT02060383|8608867|P5|Core Phase|Withdrawal by Subject|2
2489988|NCT02060383|8608868|P4|Core Phase|Withdrawal by Subject|4
2489989|NCT02060383|8608869|P3|Core Phase|Withdrawal by Subject|0
2489990|NCT02060383|8608870|P2|Core Phase|Withdrawal by Subject|0
2489991|NCT02060383|8608871|P1|Core Phase|Withdrawal by Subject|0
2489992|NCT02060383|8608867|P5|Core Phase|Protocol Violation|0
2489993|NCT02060383|8608868|P4|Core Phase|Protocol Violation|1
2489994|NCT02060383|8608869|P3|Core Phase|Protocol Violation|0
2489995|NCT02060383|8608870|P2|Core Phase|Protocol Violation|0
2489996|NCT02060383|8608871|P1|Core Phase|Protocol Violation|0
2489997|NCT02060383|8608867|P5|Core Phase|Administrative problems|0
2489998|NCT02060383|8608868|P4|Core Phase|Administrative problems|0
2489999|NCT02060383|8608869|P3|Core Phase|Administrative problems|0
2490000|NCT02060383|8608870|P2|Core Phase|Administrative problems|1
2490001|NCT02060383|8608871|P1|Core Phase|Administrative problems|0
2490002|NCT02060383|8608867|P5|Core Phase|Adverse Event|6
2490003|NCT02060383|8608868|P4|Core Phase|Adverse Event|2
2490004|NCT02060383|8608869|P3|Core Phase|Adverse Event|0
2490005|NCT02060383|8608870|P2|Core Phase|Adverse Event|0
2490006|NCT02060383|8608871|P1|Core Phase|Adverse Event|2
2490007|NCT02060383|8608867|P5|Core Phase|Unsatisfactory therapeutic effect|0
2490008|NCT02060383|8608868|P4|Core Phase|Unsatisfactory therapeutic effect|0
2490009|NCT02060383|8608869|P3|Core Phase|Unsatisfactory therapeutic effect|0
2490010|NCT02060383|8608870|P2|Core Phase|Unsatisfactory therapeutic effect|5
2490011|NCT02060383|8608871|P1|Core Phase|Unsatisfactory therapeutic effect|1
2490012|NCT02060370|8608897|P1|Overall Study|Physician Decision|1
2490013|NCT02059980|8608936|P2|Overall Study|Lost to Follow-up|1
2490014|NCT02059980|8608937|P1|Overall Study|Lost to Follow-up|2
2490015|NCT02059434|8608982|P9|Washout Between Periods 7 and 8|Withdrawal by Subject|1
2490016|NCT02059434|8608983|P8|Washout Between Periods 7 and 8|Withdrawal by Subject|0
2490017|NCT02059434|8608984|P7|Washout Between Periods 7 and 8|Withdrawal by Subject|0
2490018|NCT02059434|8608985|P6|Washout Between Periods 7 and 8|Withdrawal by Subject|0
2490019|NCT02059434|8608986|P5|Washout Between Periods 7 and 8|Withdrawal by Subject|0
2490020|NCT02059434|8608987|P4|Washout Between Periods 7 and 8|Withdrawal by Subject|0
2490021|NCT02059434|8608988|P3|Washout Between Periods 7 and 8|Withdrawal by Subject|0
2490022|NCT02059434|8608989|P2|Washout Between Periods 7 and 8|Withdrawal by Subject|0
2490023|NCT02059434|8608990|P1|Washout Between Periods 7 and 8|Withdrawal by Subject|0
2490024|NCT02059434|8608982|P9|Washout Between Periods 7 and 8|Adverse Event|1
2490025|NCT02059434|8608983|P8|Washout Between Periods 7 and 8|Adverse Event|0
2490026|NCT02059434|8608984|P7|Washout Between Periods 7 and 8|Adverse Event|0
2490027|NCT02059434|8608985|P6|Washout Between Periods 7 and 8|Adverse Event|0
2490028|NCT02059434|8608986|P5|Washout Between Periods 7 and 8|Adverse Event|0
2490029|NCT02059434|8608987|P4|Washout Between Periods 7 and 8|Adverse Event|0
2490030|NCT02059434|8608988|P3|Washout Between Periods 7 and 8|Adverse Event|0
2490031|NCT02059434|8608989|P2|Washout Between Periods 7 and 8|Adverse Event|0
2490032|NCT02059434|8608990|P1|Washout Between Periods 7 and 8|Adverse Event|0
2490033|NCT02059434|8608982|P9|Washout Between Periods 6 and 7|Physician Decision|1
2490034|NCT02059434|8608983|P8|Washout Between Periods 6 and 7|Physician Decision|0
2490035|NCT02059434|8608984|P7|Washout Between Periods 6 and 7|Physician Decision|0
2490036|NCT02059434|8608985|P6|Washout Between Periods 6 and 7|Physician Decision|0
2490037|NCT02059434|8608986|P5|Washout Between Periods 6 and 7|Physician Decision|0
2490038|NCT02059434|8608987|P4|Washout Between Periods 6 and 7|Physician Decision|0
2490039|NCT02059434|8608988|P3|Washout Between Periods 6 and 7|Physician Decision|0
2490040|NCT02059434|8608989|P2|Washout Between Periods 6 and 7|Physician Decision|0
2490041|NCT02059434|8608990|P1|Washout Between Periods 6 and 7|Physician Decision|0
2490042|NCT02059434|8608982|P9|Washout Between Periods 4 and 5|Adverse Event|1
2490043|NCT02059434|8608983|P8|Washout Between Periods 4 and 5|Adverse Event|0
2490044|NCT02059434|8608984|P7|Washout Between Periods 4 and 5|Adverse Event|0
2490045|NCT02059434|8608985|P6|Washout Between Periods 4 and 5|Adverse Event|0
2490046|NCT02059434|8608986|P5|Washout Between Periods 4 and 5|Adverse Event|0
2490047|NCT02059434|8608987|P4|Washout Between Periods 4 and 5|Adverse Event|0
2490048|NCT02059434|8608988|P3|Washout Between Periods 4 and 5|Adverse Event|0
2490049|NCT02059434|8608989|P2|Washout Between Periods 4 and 5|Adverse Event|0
2490050|NCT02059434|8608990|P1|Washout Between Periods 4 and 5|Adverse Event|0
2490051|NCT02059434|8608982|P9|Washout Between Periods 1 and 2|Physician Decision|0
2490052|NCT02059434|8608983|P8|Washout Between Periods 1 and 2|Physician Decision|1
2490053|NCT02059434|8608984|P7|Washout Between Periods 1 and 2|Physician Decision|0
2490054|NCT02059434|8608985|P6|Washout Between Periods 1 and 2|Physician Decision|0
2490055|NCT02059434|8608986|P5|Washout Between Periods 1 and 2|Physician Decision|0
2490056|NCT02059434|8608987|P4|Washout Between Periods 1 and 2|Physician Decision|0
2490057|NCT02059434|8608988|P3|Washout Between Periods 1 and 2|Physician Decision|0
2490058|NCT02059434|8608989|P2|Washout Between Periods 1 and 2|Physician Decision|0
2490059|NCT02059434|8608990|P1|Washout Between Periods 1 and 2|Physician Decision|0
2490060|NCT02059408|8609055|P3|Overall Study|Did not get tested|358
2490061|NCT02059408|8609056|P2|Overall Study|Did not get tested|330
2490062|NCT02059408|8609057|P1|Overall Study|Did not get tested|0
2490063|NCT02059395|8609076|P2|Overall Study|Lost to Follow-up|4
2490064|NCT02059395|8609077|P1|Overall Study|Lost to Follow-up|2
2490065|NCT02059291|8609092|P25|Epoch 4|Lack of Efficacy|0
2490066|NCT02059291|8609093|P24|Epoch 4|Lack of Efficacy|1
2490067|NCT02059291|8609094|P23|Epoch 4|Lack of Efficacy|0
2490068|NCT02059291|8609095|P22|Epoch 4|Lack of Efficacy|0
2490069|NCT02059291|8609096|P21|Epoch 4|Lack of Efficacy|0
2490070|NCT02059291|8609097|P20|Epoch 4|Lack of Efficacy|0
2490071|NCT02059291|8609098|P19|Epoch 4|Lack of Efficacy|0
2490072|NCT02059291|8609099|P18|Epoch 4|Lack of Efficacy|0
2490073|NCT02059291|8609100|P17|Epoch 4|Lack of Efficacy|0
2490074|NCT02059291|8609101|P16|Epoch 4|Lack of Efficacy|0
2490075|NCT02059291|8609102|P15|Epoch 4|Lack of Efficacy|0
2490076|NCT02059291|8609103|P14|Epoch 4|Lack of Efficacy|0
2490077|NCT02059291|8609104|P13|Epoch 4|Lack of Efficacy|0
2490078|NCT02059291|8609105|P12|Epoch 4|Lack of Efficacy|0
2490079|NCT02059291|8609106|P11|Epoch 4|Lack of Efficacy|0
2490080|NCT02059291|8609107|P10|Epoch 4|Lack of Efficacy|0
2490081|NCT02059291|8609108|P9|Epoch 4|Lack of Efficacy|0
2490082|NCT02059291|8609109|P8|Epoch 4|Lack of Efficacy|0
2490083|NCT02059291|8609110|P7|Epoch 4|Lack of Efficacy|0
2490084|NCT02059291|8609111|P6|Epoch 4|Lack of Efficacy|0
2490085|NCT02059291|8609112|P5|Epoch 4|Lack of Efficacy|0
2490086|NCT02059291|8609113|P4|Epoch 4|Lack of Efficacy|0
2490087|NCT02059291|8609114|P3|Epoch 4|Lack of Efficacy|0
2490088|NCT02059291|8609115|P2|Epoch 4|Lack of Efficacy|0
2490089|NCT02059291|8609116|P1|Epoch 4|Lack of Efficacy|0
2490090|NCT02059291|8609092|P25|Epoch 4|Withdrawal by Subject|0
2490091|NCT02059291|8609093|P24|Epoch 4|Withdrawal by Subject|0
2490092|NCT02059291|8609094|P23|Epoch 4|Withdrawal by Subject|0
2490093|NCT02059291|8609095|P22|Epoch 4|Withdrawal by Subject|0
2490094|NCT02059291|8609096|P21|Epoch 4|Withdrawal by Subject|1
2490095|NCT02059291|8609097|P20|Epoch 4|Withdrawal by Subject|0
2490096|NCT02059291|8609098|P19|Epoch 4|Withdrawal by Subject|0
2490097|NCT02059291|8609099|P18|Epoch 4|Withdrawal by Subject|0
2490098|NCT02059291|8609100|P17|Epoch 4|Withdrawal by Subject|0
2490099|NCT02059291|8609101|P16|Epoch 4|Withdrawal by Subject|0
2490100|NCT02059291|8609102|P15|Epoch 4|Withdrawal by Subject|0
2490101|NCT02059291|8609103|P14|Epoch 4|Withdrawal by Subject|0
2490102|NCT02059291|8609104|P13|Epoch 4|Withdrawal by Subject|0
2490103|NCT02059291|8609105|P12|Epoch 4|Withdrawal by Subject|0
2490104|NCT02059291|8609106|P11|Epoch 4|Withdrawal by Subject|0
2490105|NCT02059291|8609107|P10|Epoch 4|Withdrawal by Subject|0
2490106|NCT02059291|8609108|P9|Epoch 4|Withdrawal by Subject|0
2490107|NCT02059291|8609109|P8|Epoch 4|Withdrawal by Subject|0
2490108|NCT02059291|8609110|P7|Epoch 4|Withdrawal by Subject|0
2490109|NCT02059291|8609111|P6|Epoch 4|Withdrawal by Subject|0
2490110|NCT02059291|8609112|P5|Epoch 4|Withdrawal by Subject|0
2490111|NCT02059291|8609113|P4|Epoch 4|Withdrawal by Subject|0
2490112|NCT02059291|8609114|P3|Epoch 4|Withdrawal by Subject|0
2490113|NCT02059291|8609115|P2|Epoch 4|Withdrawal by Subject|0
2490114|NCT02059291|8609116|P1|Epoch 4|Withdrawal by Subject|0
2490115|NCT02059291|8609092|P25|Epoch 4|Pregnancy|0
2490116|NCT02059291|8609093|P24|Epoch 4|Pregnancy|0
2490117|NCT02059291|8609094|P23|Epoch 4|Pregnancy|0
2490118|NCT02059291|8609095|P22|Epoch 4|Pregnancy|0
2490119|NCT02059291|8609096|P21|Epoch 4|Pregnancy|0
2490120|NCT02059291|8609097|P20|Epoch 4|Pregnancy|0
2490121|NCT02059291|8609098|P19|Epoch 4|Pregnancy|0
2490122|NCT02059291|8609099|P18|Epoch 4|Pregnancy|0
2490123|NCT02059291|8609100|P17|Epoch 4|Pregnancy|1
2490124|NCT02059291|8609101|P16|Epoch 4|Pregnancy|0
2490125|NCT02059291|8609102|P15|Epoch 4|Pregnancy|0
2490126|NCT02059291|8609103|P14|Epoch 4|Pregnancy|0
2490127|NCT02059291|8609104|P13|Epoch 4|Pregnancy|0
2490128|NCT02059291|8609105|P12|Epoch 4|Pregnancy|0
2490129|NCT02059291|8609106|P11|Epoch 4|Pregnancy|0
2490130|NCT02059291|8609107|P10|Epoch 4|Pregnancy|0
2490131|NCT02059291|8609108|P9|Epoch 4|Pregnancy|0
2490132|NCT02059291|8609109|P8|Epoch 4|Pregnancy|0
2490133|NCT02059291|8609110|P7|Epoch 4|Pregnancy|0
2490134|NCT02059291|8609111|P6|Epoch 4|Pregnancy|0
2490135|NCT02059291|8609112|P5|Epoch 4|Pregnancy|0
2490136|NCT02059291|8609113|P4|Epoch 4|Pregnancy|0
2490137|NCT02059291|8609114|P3|Epoch 4|Pregnancy|0
2490138|NCT02059291|8609115|P2|Epoch 4|Pregnancy|0
2490139|NCT02059291|8609116|P1|Epoch 4|Pregnancy|0
2490140|NCT02059291|8609092|P25|Epoch 4|Adverse Event|0
2490141|NCT02059291|8609093|P24|Epoch 4|Adverse Event|0
2490142|NCT02059291|8609094|P23|Epoch 4|Adverse Event|1
2490143|NCT02059291|8609095|P22|Epoch 4|Adverse Event|0
2490144|NCT02059291|8609096|P21|Epoch 4|Adverse Event|0
2490145|NCT02059291|8609097|P20|Epoch 4|Adverse Event|0
2490146|NCT02059291|8609098|P19|Epoch 4|Adverse Event|0
2490147|NCT02059291|8609099|P18|Epoch 4|Adverse Event|0
2490148|NCT02059291|8609100|P17|Epoch 4|Adverse Event|1
2490149|NCT02059291|8609101|P16|Epoch 4|Adverse Event|0
2490150|NCT02059291|8609102|P15|Epoch 4|Adverse Event|0
2490151|NCT02059291|8609103|P14|Epoch 4|Adverse Event|0
2490152|NCT02059291|8609104|P13|Epoch 4|Adverse Event|0
2490153|NCT02059291|8609105|P12|Epoch 4|Adverse Event|0
2490154|NCT02059291|8609106|P11|Epoch 4|Adverse Event|0
2490155|NCT02059291|8609107|P10|Epoch 4|Adverse Event|0
2490156|NCT02059291|8609108|P9|Epoch 4|Adverse Event|0
2490157|NCT02059291|8609109|P8|Epoch 4|Adverse Event|0
2490158|NCT02059291|8609110|P7|Epoch 4|Adverse Event|0
2490159|NCT02059291|8609111|P6|Epoch 4|Adverse Event|0
2490160|NCT02059291|8609112|P5|Epoch 4|Adverse Event|0
2490161|NCT02059291|8609113|P4|Epoch 4|Adverse Event|0
2490162|NCT02059291|8609114|P3|Epoch 4|Adverse Event|0
2490163|NCT02059291|8609115|P2|Epoch 4|Adverse Event|0
2490164|NCT02059291|8609116|P1|Epoch 4|Adverse Event|0
2490165|NCT02059291|8609092|P25|Epoch 3|Withdrawal by Subject|0
2490166|NCT02059291|8609093|P24|Epoch 3|Withdrawal by Subject|0
2490167|NCT02059291|8609094|P23|Epoch 3|Withdrawal by Subject|0
2490168|NCT02059291|8609095|P22|Epoch 3|Withdrawal by Subject|0
2490169|NCT02059291|8609096|P21|Epoch 3|Withdrawal by Subject|0
2490170|NCT02059291|8609097|P20|Epoch 3|Withdrawal by Subject|0
2490171|NCT02059291|8609098|P19|Epoch 3|Withdrawal by Subject|0
2490172|NCT02059291|8609099|P18|Epoch 3|Withdrawal by Subject|0
2490173|NCT02059291|8609100|P17|Epoch 3|Withdrawal by Subject|0
2490174|NCT02059291|8609101|P16|Epoch 3|Withdrawal by Subject|1
2490175|NCT02059291|8609102|P15|Epoch 3|Withdrawal by Subject|0
2490176|NCT02059291|8609103|P14|Epoch 3|Withdrawal by Subject|0
2490177|NCT02059291|8609104|P13|Epoch 3|Withdrawal by Subject|0
2490178|NCT02059291|8609105|P12|Epoch 3|Withdrawal by Subject|0
2490179|NCT02059291|8609106|P11|Epoch 3|Withdrawal by Subject|0
2490180|NCT02059291|8609107|P10|Epoch 3|Withdrawal by Subject|0
2490181|NCT02059291|8609108|P9|Epoch 3|Withdrawal by Subject|0
2490182|NCT02059291|8609109|P8|Epoch 3|Withdrawal by Subject|0
2490183|NCT02059291|8609110|P7|Epoch 3|Withdrawal by Subject|0
2490184|NCT02059291|8609111|P6|Epoch 3|Withdrawal by Subject|0
2490185|NCT02059291|8609112|P5|Epoch 3|Withdrawal by Subject|0
2490186|NCT02059291|8609113|P4|Epoch 3|Withdrawal by Subject|0
2490187|NCT02059291|8609114|P3|Epoch 3|Withdrawal by Subject|0
2490188|NCT02059291|8609115|P2|Epoch 3|Withdrawal by Subject|0
2490189|NCT02059291|8609116|P1|Epoch 3|Withdrawal by Subject|0
2490190|NCT02059291|8609092|P25|Epoch 3|Lack of Efficacy|0
2490191|NCT02059291|8609093|P24|Epoch 3|Lack of Efficacy|0
2490192|NCT02059291|8609094|P23|Epoch 3|Lack of Efficacy|0
2490193|NCT02059291|8609095|P22|Epoch 3|Lack of Efficacy|0
2490194|NCT02059291|8609096|P21|Epoch 3|Lack of Efficacy|0
2490195|NCT02059291|8609097|P20|Epoch 3|Lack of Efficacy|0
2490196|NCT02059291|8609098|P19|Epoch 3|Lack of Efficacy|0
2490197|NCT02059291|8609099|P18|Epoch 3|Lack of Efficacy|0
2490198|NCT02059291|8609100|P17|Epoch 3|Lack of Efficacy|0
2490199|NCT02059291|8609101|P16|Epoch 3|Lack of Efficacy|3
2490200|NCT02059291|8609102|P15|Epoch 3|Lack of Efficacy|0
2490201|NCT02059291|8609103|P14|Epoch 3|Lack of Efficacy|0
2490202|NCT02059291|8609104|P13|Epoch 3|Lack of Efficacy|0
2490203|NCT02059291|8609105|P12|Epoch 3|Lack of Efficacy|0
2490204|NCT02059291|8609106|P11|Epoch 3|Lack of Efficacy|0
2490205|NCT02059291|8609107|P10|Epoch 3|Lack of Efficacy|0
2490206|NCT02059291|8609108|P9|Epoch 3|Lack of Efficacy|0
2490207|NCT02059291|8609109|P8|Epoch 3|Lack of Efficacy|0
2490208|NCT02059291|8609110|P7|Epoch 3|Lack of Efficacy|0
2490209|NCT02059291|8609111|P6|Epoch 3|Lack of Efficacy|0
2490210|NCT02059291|8609112|P5|Epoch 3|Lack of Efficacy|0
2490211|NCT02059291|8609113|P4|Epoch 3|Lack of Efficacy|0
2490212|NCT02059291|8609114|P3|Epoch 3|Lack of Efficacy|0
2490213|NCT02059291|8609115|P2|Epoch 3|Lack of Efficacy|0
2490214|NCT02059291|8609116|P1|Epoch 3|Lack of Efficacy|0
2490215|NCT02059291|8609092|P25|Epoch 3|Adverse Event|0
2490216|NCT02059291|8609093|P24|Epoch 3|Adverse Event|0
2490217|NCT02059291|8609094|P23|Epoch 3|Adverse Event|0
2490218|NCT02059291|8609095|P22|Epoch 3|Adverse Event|0
2490219|NCT02059291|8609096|P21|Epoch 3|Adverse Event|0
2490220|NCT02059291|8609097|P20|Epoch 3|Adverse Event|0
2490221|NCT02059291|8609098|P19|Epoch 3|Adverse Event|0
2490222|NCT02059291|8609099|P18|Epoch 3|Adverse Event|0
2490223|NCT02059291|8609100|P17|Epoch 3|Adverse Event|0
2490224|NCT02059291|8609101|P16|Epoch 3|Adverse Event|1
2490225|NCT02059291|8609102|P15|Epoch 3|Adverse Event|0
2490226|NCT02059291|8609103|P14|Epoch 3|Adverse Event|0
2490227|NCT02059291|8609104|P13|Epoch 3|Adverse Event|0
2490228|NCT02059291|8609105|P12|Epoch 3|Adverse Event|0
2490229|NCT02059291|8609106|P11|Epoch 3|Adverse Event|0
2490230|NCT02059291|8609107|P10|Epoch 3|Adverse Event|0
2490231|NCT02059291|8609108|P9|Epoch 3|Adverse Event|0
2490232|NCT02059291|8609109|P8|Epoch 3|Adverse Event|0
2490233|NCT02059291|8609110|P7|Epoch 3|Adverse Event|0
2490234|NCT02059291|8609111|P6|Epoch 3|Adverse Event|0
2490235|NCT02059291|8609112|P5|Epoch 3|Adverse Event|0
2490236|NCT02059291|8609113|P4|Epoch 3|Adverse Event|0
2490237|NCT02059291|8609114|P3|Epoch 3|Adverse Event|0
2490238|NCT02059291|8609115|P2|Epoch 3|Adverse Event|0
2490239|NCT02059291|8609116|P1|Epoch 3|Adverse Event|0
2490240|NCT02059291|8609092|P25|Epoch 3|Physician Decision|0
2490241|NCT02059291|8609093|P24|Epoch 3|Physician Decision|0
2490242|NCT02059291|8609094|P23|Epoch 3|Physician Decision|0
2490243|NCT02059291|8609095|P22|Epoch 3|Physician Decision|0
2490244|NCT02059291|8609096|P21|Epoch 3|Physician Decision|0
2490245|NCT02059291|8609097|P20|Epoch 3|Physician Decision|0
2490246|NCT02059291|8609098|P19|Epoch 3|Physician Decision|0
2490247|NCT02059291|8609099|P18|Epoch 3|Physician Decision|0
2490248|NCT02059291|8609100|P17|Epoch 3|Physician Decision|0
2490249|NCT02059291|8609101|P16|Epoch 3|Physician Decision|1
2490250|NCT02059291|8609102|P15|Epoch 3|Physician Decision|0
2490251|NCT02059291|8609103|P14|Epoch 3|Physician Decision|1
2490252|NCT02059291|8609104|P13|Epoch 3|Physician Decision|0
2490253|NCT02059291|8609105|P12|Epoch 3|Physician Decision|0
2490254|NCT02059291|8609106|P11|Epoch 3|Physician Decision|0
2490255|NCT02059291|8609107|P10|Epoch 3|Physician Decision|0
2490256|NCT02059291|8609108|P9|Epoch 3|Physician Decision|0
2490257|NCT02059291|8609109|P8|Epoch 3|Physician Decision|0
2490258|NCT02059291|8609110|P7|Epoch 3|Physician Decision|0
2490259|NCT02059291|8609111|P6|Epoch 3|Physician Decision|0
2490260|NCT02059291|8609112|P5|Epoch 3|Physician Decision|0
2490261|NCT02059291|8609113|P4|Epoch 3|Physician Decision|0
2490262|NCT02059291|8609114|P3|Epoch 3|Physician Decision|0
2490263|NCT02059291|8609115|P2|Epoch 3|Physician Decision|0
2490264|NCT02059291|8609116|P1|Epoch 3|Physician Decision|0
2490265|NCT02059291|8609092|P25|Epoch 2|Withdrawal by Subject|0
2490266|NCT02059291|8609093|P24|Epoch 2|Withdrawal by Subject|0
2490267|NCT02059291|8609094|P23|Epoch 2|Withdrawal by Subject|0
2490268|NCT02059291|8609095|P22|Epoch 2|Withdrawal by Subject|0
2490269|NCT02059291|8609096|P21|Epoch 2|Withdrawal by Subject|0
2490270|NCT02059291|8609097|P20|Epoch 2|Withdrawal by Subject|0
2490271|NCT02059291|8609098|P19|Epoch 2|Withdrawal by Subject|0
2490272|NCT02059291|8609099|P18|Epoch 2|Withdrawal by Subject|0
2490273|NCT02059291|8609100|P17|Epoch 2|Withdrawal by Subject|0
2490274|NCT02059291|8609101|P16|Epoch 2|Withdrawal by Subject|0
2490275|NCT02059291|8609102|P15|Epoch 2|Withdrawal by Subject|0
2490276|NCT02059291|8609103|P14|Epoch 2|Withdrawal by Subject|0
2490277|NCT02059291|8609104|P13|Epoch 2|Withdrawal by Subject|0
2490278|NCT02059291|8609105|P12|Epoch 2|Withdrawal by Subject|0
2490279|NCT02059291|8609106|P11|Epoch 2|Withdrawal by Subject|0
2490280|NCT02059291|8609107|P10|Epoch 2|Withdrawal by Subject|0
2490281|NCT02059291|8609108|P9|Epoch 2|Withdrawal by Subject|1
2490282|NCT02059291|8609109|P8|Epoch 2|Withdrawal by Subject|0
2490283|NCT02059291|8609110|P7|Epoch 2|Withdrawal by Subject|0
2490284|NCT02059291|8609111|P6|Epoch 2|Withdrawal by Subject|1
2490285|NCT02059291|8609112|P5|Epoch 2|Withdrawal by Subject|0
2490286|NCT02059291|8609113|P4|Epoch 2|Withdrawal by Subject|0
2490287|NCT02059291|8609114|P3|Epoch 2|Withdrawal by Subject|0
2490288|NCT02059291|8609115|P2|Epoch 2|Withdrawal by Subject|1
2490289|NCT02059291|8609116|P1|Epoch 2|Withdrawal by Subject|0
2490290|NCT02059291|8609092|P25|Epoch 2|Adverse Event|0
2490291|NCT02059291|8609093|P24|Epoch 2|Adverse Event|0
2490292|NCT02059291|8609094|P23|Epoch 2|Adverse Event|0
2490293|NCT02059291|8609095|P22|Epoch 2|Adverse Event|0
2490294|NCT02059291|8609096|P21|Epoch 2|Adverse Event|0
2490295|NCT02059291|8609097|P20|Epoch 2|Adverse Event|0
2490296|NCT02059291|8609098|P19|Epoch 2|Adverse Event|0
2490297|NCT02059291|8609099|P18|Epoch 2|Adverse Event|0
2490298|NCT02059291|8609100|P17|Epoch 2|Adverse Event|0
2490299|NCT02059291|8609101|P16|Epoch 2|Adverse Event|0
2490300|NCT02059291|8609102|P15|Epoch 2|Adverse Event|0
2490301|NCT02059291|8609103|P14|Epoch 2|Adverse Event|0
2490302|NCT02059291|8609104|P13|Epoch 2|Adverse Event|0
2490303|NCT02059291|8609105|P12|Epoch 2|Adverse Event|0
2490304|NCT02059291|8609106|P11|Epoch 2|Adverse Event|0
2490305|NCT02059291|8609107|P10|Epoch 2|Adverse Event|0
2490306|NCT02059291|8609108|P9|Epoch 2|Adverse Event|1
2490307|NCT02059291|8609109|P8|Epoch 2|Adverse Event|1
2490308|NCT02059291|8609110|P7|Epoch 2|Adverse Event|0
2490309|NCT02059291|8609111|P6|Epoch 2|Adverse Event|0
2490310|NCT02059291|8609112|P5|Epoch 2|Adverse Event|0
2490311|NCT02059291|8609113|P4|Epoch 2|Adverse Event|1
2490312|NCT02059291|8609114|P3|Epoch 2|Adverse Event|1
2490313|NCT02059291|8609115|P2|Epoch 2|Adverse Event|0
2490314|NCT02059291|8609116|P1|Epoch 2|Adverse Event|0
2490315|NCT02059291|8609092|P25|Epoch 2|Lack of Efficacy|0
2490316|NCT02059291|8609093|P24|Epoch 2|Lack of Efficacy|0
2490317|NCT02059291|8609094|P23|Epoch 2|Lack of Efficacy|0
2490318|NCT02059291|8609095|P22|Epoch 2|Lack of Efficacy|0
2490319|NCT02059291|8609096|P21|Epoch 2|Lack of Efficacy|0
2490320|NCT02059291|8609097|P20|Epoch 2|Lack of Efficacy|0
2490321|NCT02059291|8609098|P19|Epoch 2|Lack of Efficacy|0
2490322|NCT02059291|8609099|P18|Epoch 2|Lack of Efficacy|0
2490323|NCT02059291|8609100|P17|Epoch 2|Lack of Efficacy|0
2490324|NCT02059291|8609101|P16|Epoch 2|Lack of Efficacy|0
2490325|NCT02059291|8609102|P15|Epoch 2|Lack of Efficacy|0
2490326|NCT02059291|8609103|P14|Epoch 2|Lack of Efficacy|0
2490327|NCT02059291|8609104|P13|Epoch 2|Lack of Efficacy|0
2490328|NCT02059291|8609105|P12|Epoch 2|Lack of Efficacy|0
2490329|NCT02059291|8609106|P11|Epoch 2|Lack of Efficacy|0
2490330|NCT02059291|8609107|P10|Epoch 2|Lack of Efficacy|0
2490331|NCT02059291|8609108|P9|Epoch 2|Lack of Efficacy|0
2490332|NCT02059291|8609109|P8|Epoch 2|Lack of Efficacy|0
2490333|NCT02059291|8609110|P7|Epoch 2|Lack of Efficacy|0
2490334|NCT02059291|8609111|P6|Epoch 2|Lack of Efficacy|1
2490335|NCT02059291|8609112|P5|Epoch 2|Lack of Efficacy|0
2490336|NCT02059291|8609113|P4|Epoch 2|Lack of Efficacy|1
2490337|NCT02059291|8609114|P3|Epoch 2|Lack of Efficacy|0
2490338|NCT02059291|8609115|P2|Epoch 2|Lack of Efficacy|0
2490339|NCT02059291|8609116|P1|Epoch 2|Lack of Efficacy|0
2490340|NCT02059278|8609170|P2|Overall Study|Ran out of IP and decided to discontinue|0
2490341|NCT02059278|8609171|P1|Overall Study|Ran out of IP and decided to discontinue|1
2490342|NCT02059278|8609170|P2|Overall Study|Withdrawal by Subject|3
2490343|NCT02059278|8609171|P1|Overall Study|Withdrawal by Subject|0
2490344|NCT02059278|8609170|P2|Overall Study|Lost to Follow-up|0
2490345|NCT02059278|8609171|P1|Overall Study|Lost to Follow-up|1
2490346|NCT02059278|8609170|P2|Overall Study|Adverse Event|1
2490347|NCT02059278|8609171|P1|Overall Study|Adverse Event|1
2490348|NCT02059265|8609185|P1|Overall Study|Ineligible|4
2490349|NCT02059187|8609204|P2|Overall Study|Withdrawal by Subject|8
2490350|NCT02059187|8609205|P1|Overall Study|Withdrawal by Subject|12
2490351|NCT02059187|8609204|P2|Overall Study|Protocol Violation|0
2490352|NCT02059187|8609205|P1|Overall Study|Protocol Violation|1
2490353|NCT02059187|8609204|P2|Overall Study|Physician Decision|2
2490354|NCT02059187|8609205|P1|Overall Study|Physician Decision|1
2490355|NCT02059187|8609204|P2|Overall Study|Non-compliance with study drug|0
2490356|NCT02059187|8609205|P1|Overall Study|Non-compliance with study drug|1
2490357|NCT02059187|8609204|P2|Overall Study|Lost to Follow-up|8
2490358|NCT02059187|8609205|P1|Overall Study|Lost to Follow-up|9
2490359|NCT02059187|8609204|P2|Overall Study|Death|1
2490360|NCT02059187|8609205|P1|Overall Study|Death|1
2490361|NCT02059187|8609204|P2|Overall Study|Adverse Event|3
2490362|NCT02059187|8609205|P1|Overall Study|Adverse Event|0
2490363|NCT02059174|8609231|P2|Period 3|Physician Decision|0
2490364|NCT02059174|8609232|P1|Period 3|Physician Decision|1
2490365|NCT02059174|8609231|P2|Period 2|Protocol Violation|0
2490366|NCT02059174|8609232|P1|Period 2|Protocol Violation|1
2490367|NCT02059174|8609231|P2|Period 2|Withdrawal by Subject|2
2490368|NCT02059174|8609232|P1|Period 2|Withdrawal by Subject|0
2490369|NCT02059174|8609231|P2|Period 1|Withdrawal by Subject|2
2490370|NCT02059174|8609232|P1|Period 1|Withdrawal by Subject|0
2490371|NCT02059161|8609256|P2|Overall Study|Non-compliance with study drug|2
2490372|NCT02059161|8609257|P1|Overall Study|Non-compliance with study drug|6
2490373|NCT02059161|8609256|P2|Overall Study|Randomized in error, no study drug|1
2490374|NCT02059161|8609257|P1|Overall Study|Randomized in error, no study drug|0
2490375|NCT02059161|8609256|P2|Overall Study|Withdrawal by Subject|13
2490376|NCT02059161|8609257|P1|Overall Study|Withdrawal by Subject|16
2490377|NCT02059161|8609256|P2|Overall Study|Protocol Violation|1
2490378|NCT02059161|8609257|P1|Overall Study|Protocol Violation|1
2490379|NCT02059161|8609256|P2|Overall Study|Physician Decision|4
2490380|NCT02059161|8609257|P1|Overall Study|Physician Decision|4
2490381|NCT02059161|8609256|P2|Overall Study|Lost to Follow-up|12
2490382|NCT02059161|8609257|P1|Overall Study|Lost to Follow-up|20
2490383|NCT02059161|8609256|P2|Overall Study|Adverse Event|6
2490384|NCT02059161|8609257|P1|Overall Study|Adverse Event|2
2490385|NCT02059161|8609256|P2|Overall Study|Pregnancy|2
2490386|NCT02059161|8609257|P1|Overall Study|Pregnancy|0
2490387|NCT02059148|8609317|P6|Treatment 1|Protocol Violation|1
2490388|NCT02059148|8609318|P5|Treatment 1|Protocol Violation|0
2490389|NCT02059148|8609319|P4|Treatment 1|Protocol Violation|0
2490390|NCT02059148|8609320|P3|Treatment 1|Protocol Violation|0
2490391|NCT02059148|8609321|P2|Treatment 1|Protocol Violation|0
2490392|NCT02059148|8609322|P1|Treatment 1|Protocol Violation|0
2490393|NCT02059135|8609341|P2|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1
2490394|NCT02059135|8609342|P1|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0
2490395|NCT02059135|8609341|P2|Neonatal Follow-up (Safety Population)|delivered at another hospital|1
2490396|NCT02059135|8609342|P1|Neonatal Follow-up (Safety Population)|delivered at another hospital|0
2490397|NCT02059135|8609341|P2|Neonatal Follow-up (Safety Population)|Death|2
2490398|NCT02059135|8609342|P1|Neonatal Follow-up (Safety Population)|Death|3
2490399|NCT02059135|8609341|P2|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0
2490400|NCT02059135|8609342|P1|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1
2490401|NCT02059135|8609341|P2|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1
2490402|NCT02059135|8609342|P1|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0
2490403|NCT02059135|8609341|P2|Maternal Follow-up (ITT Population)|declined to see site staff|1
2490404|NCT02059135|8609342|P1|Maternal Follow-up (ITT Population)|declined to see site staff|0
2490405|NCT02059135|8609341|P2|Maternal Follow-up (ITT Population)|Lost to Follow-up|3
2490406|NCT02059135|8609342|P1|Maternal Follow-up (ITT Population)|Lost to Follow-up|0
2490407|NCT02059135|8609341|P2|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2
2490408|NCT02059135|8609342|P1|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3
2490409|NCT02059005|8609378|P2|Overall Study|Inpatient|1
2490410|NCT02059005|8609379|P1|Overall Study|Inpatient|0
2490411|NCT02059005|8609378|P2|Overall Study|Incarceration|1
2490412|NCT02059005|8609379|P1|Overall Study|Incarceration|0
2490413|NCT02059005|8609378|P2|Overall Study|Lost to Follow-up|19
2490414|NCT02059005|8609379|P1|Overall Study|Lost to Follow-up|19
2490415|NCT02059005|8609378|P2|Overall Study|Death|3
2490416|NCT02059005|8609379|P1|Overall Study|Death|1
2490417|NCT02058992|8609389|P1|Overall Study|CRF Uncollected|20
2490418|NCT02058992|8609389|P1|Overall Study|Protocol Violation|92
2490419|NCT02058992|8609389|P1|Overall Study|Lost to Follow-up|4
2490420|NCT02058966|8609398|P1|First Intervention|Withdrawal by Subject|1
2490421|NCT02058966|8609398|P1|Open-Label Methamphetamine|Adverse Event|1
2490422|NCT02058940|8609425|P1|Overall Study|Discharged from Critical Care Unit|1
2490423|NCT02058849|8609449|P2|Overall Study|Withdrawal by Subject|0
2490424|NCT02058849|8609450|P1|Overall Study|Withdrawal by Subject|4
2490425|NCT02058849|8609449|P2|Overall Study|Lost to Follow-up|0
2490426|NCT02058849|8609450|P1|Overall Study|Lost to Follow-up|1
2490427|NCT02058849|8609449|P2|Overall Study|Death|0
2490428|NCT02058849|8609450|P1|Overall Study|Death|1
2490429|NCT02058849|8609449|P2|Overall Study|Hospitalization|1
2490430|NCT02058849|8609450|P1|Overall Study|Hospitalization|1
2490431|NCT02058836|8609478|P2|Overall Study|Withdrawal by Subject|1
2490432|NCT02058836|8609479|P1|Overall Study|Withdrawal by Subject|1
2490433|NCT02058628|8609509|P2|Overall Study|Non compliance|0
2490434|NCT02058628|8609510|P1|Overall Study|Non compliance|1
2490435|NCT02058628|8609509|P2|Overall Study|A lot of time for study for participant|0
2490436|NCT02058628|8609510|P1|Overall Study|A lot of time for study for participant|1
2490437|NCT02058628|8609509|P2|Overall Study|The visit date was not in timeline|1
2490438|NCT02058628|8609510|P1|Overall Study|The visit date was not in timeline|0
2490439|NCT02058628|8609509|P2|Overall Study|Not in time schedule|1
2490440|NCT02058628|8609510|P1|Overall Study|Not in time schedule|0
2490441|NCT02058628|8609509|P2|Overall Study|Lost to Follow-up|4
2490442|NCT02058628|8609510|P1|Overall Study|Lost to Follow-up|2
2490443|NCT02058628|8609509|P2|Overall Study|Withdrawal by Subject|2
2490444|NCT02058628|8609510|P1|Overall Study|Withdrawal by Subject|2
2490445|NCT02058628|8609509|P2|Overall Study|Adverse Event|0
2490446|NCT02058628|8609510|P1|Overall Study|Adverse Event|1
2490447|NCT02058589|8609542|P2|Overall Study|Withdrawal by Subject|1
2490448|NCT02058589|8609543|P1|Overall Study|Withdrawal by Subject|0
2490449|NCT02058589|8609542|P2|Overall Study|Non-Serious Adverse Event|0
2490450|NCT02058589|8609543|P1|Overall Study|Non-Serious Adverse Event|1
2490451|NCT02058589|8609542|P2|Overall Study|Serious Adverse Event|1
2490452|NCT02058589|8609543|P1|Overall Study|Serious Adverse Event|1
2490453|NCT02058563|8609585|P2|Overall Study|Other (patient incarcerated)|1
2490454|NCT02058563|8609586|P1|Overall Study|Other (patient incarcerated)|0
2490455|NCT02058563|8609585|P2|Overall Study|Consent Withdrawal|1
2490456|NCT02058563|8609586|P1|Overall Study|Consent Withdrawal|1
2490457|NCT02058563|8609585|P2|Overall Study|Other (vaccinated later as new subject)|0
2490458|NCT02058563|8609586|P1|Overall Study|Other (vaccinated later as new subject)|1
2490459|NCT02058563|8609585|P2|Overall Study|Lost to Follow-up|22
2490460|NCT02058563|8609586|P1|Overall Study|Lost to Follow-up|26
2490461|NCT02058537|8609622|P1|Overall Study|Withdrawal by Subject|1
2490462|NCT02058498|8609633|P1|Overall Study|Withdrawal by Subject|4
2490463|NCT02058368|8609641|P2|Overall Study|Withdrawal by Subject|26
2490464|NCT02058368|8609642|P1|Overall Study|Withdrawal by Subject|22
2490465|NCT02058368|8609641|P2|Overall Study|Physician Decision|3
2490466|NCT02058368|8609642|P1|Overall Study|Physician Decision|2
2490467|NCT02058368|8609641|P2|Overall Study|Lost to Follow-up|0
2490468|NCT02058368|8609642|P1|Overall Study|Lost to Follow-up|2
2490469|NCT02058368|8609641|P2|Overall Study|Protocol Violation|4
2490470|NCT02058368|8609642|P1|Overall Study|Protocol Violation|0
2490471|NCT02058368|8609641|P2|Overall Study|Lack of Efficacy|1
2490472|NCT02058368|8609642|P1|Overall Study|Lack of Efficacy|0
2490473|NCT02058368|8609641|P2|Overall Study|Adverse Event|20
2490474|NCT02058368|8609642|P1|Overall Study|Adverse Event|15
2490475|NCT02058290|8609694|P2|Overall Study|Withdrawal by Subject|1
2490476|NCT02058290|8609695|P1|Overall Study|Withdrawal by Subject|0
2490477|NCT02058290|8609694|P2|Overall Study|Didn't meet intraoperative criteria|7
2490478|NCT02058290|8609695|P1|Overall Study|Didn't meet intraoperative criteria|8
2490479|NCT02058290|8609694|P2|Overall Study|Physician Decision|0
2490480|NCT02058290|8609695|P1|Overall Study|Physician Decision|1
2490481|NCT02058290|8609694|P2|Overall Study|Protocol Violation|1
2490482|NCT02058290|8609695|P1|Overall Study|Protocol Violation|2
2490483|NCT02058160|8609722|P2|Overall Study|Other than specified above|6
2490484|NCT02058160|8609723|P1|Overall Study|Other than specified above|12
2490485|NCT02058160|8609722|P2|Overall Study|Lost to Follow-up|0
2490486|NCT02058160|8609723|P1|Overall Study|Lost to Follow-up|1
2490487|NCT02058160|8609722|P2|Overall Study|Adverse Event|3
2490488|NCT02058160|8609723|P1|Overall Study|Adverse Event|12
2490489|NCT02058160|8609722|P2|Overall Study|Poor compliance to protocol|1
2490490|NCT02058160|8609723|P1|Overall Study|Poor compliance to protocol|4
2490491|NCT02058160|8609722|P2|Overall Study|Randomized but not treated|4
2490492|NCT02058160|8609723|P1|Overall Study|Randomized but not treated|2
2490493|NCT02058147|8609760|P3|Overall Study|Other than specified|0
2490494|NCT02058147|8609761|P2|Overall Study|Other than specified|9
2490495|NCT02058147|8609762|P1|Overall Study|Other than specified|8
2490496|NCT02058147|8609760|P3|Overall Study|Poor compliance to protocol|4
2490497|NCT02058147|8609761|P2|Overall Study|Poor compliance to protocol|9
2490498|NCT02058147|8609762|P1|Overall Study|Poor compliance to protocol|8
2490499|NCT02058147|8609760|P3|Overall Study|Lack of Efficacy|3
2490500|NCT02058147|8609761|P2|Overall Study|Lack of Efficacy|0
2490501|NCT02058147|8609762|P1|Overall Study|Lack of Efficacy|1
2490502|NCT02058147|8609760|P3|Overall Study|Adverse Event|21
2490503|NCT02058147|8609761|P2|Overall Study|Adverse Event|9
2490504|NCT02058147|8609762|P1|Overall Study|Adverse Event|12
2490505|NCT02058147|8609760|P3|Overall Study|Randomized but not treated|1
2490506|NCT02058147|8609761|P2|Overall Study|Randomized but not treated|0
2490507|NCT02058147|8609762|P1|Overall Study|Randomized but not treated|0
2490508|NCT02058108|8609813|P2|Overall Study|Protocol Violation|1
2490509|NCT02058108|8609814|P1|Overall Study|Protocol Violation|0
2490510|NCT02058108|8609813|P2|Overall Study|Administrative problems|3
2490511|NCT02058108|8609814|P1|Overall Study|Administrative problems|3
2490512|NCT02058108|8609813|P2|Overall Study|Withdrawal by Subject|0
2490513|NCT02058108|8609814|P1|Overall Study|Withdrawal by Subject|1
2490514|NCT02058108|8609813|P2|Overall Study|No longer requires study drug|1
2490515|NCT02058108|8609814|P1|Overall Study|No longer requires study drug|0
2490516|NCT02058108|8609813|P2|Overall Study|Unsatisfactory therapeutic effect|4
2490517|NCT02058108|8609814|P1|Overall Study|Unsatisfactory therapeutic effect|37
2490518|NCT02058108|8609813|P2|Overall Study|Abnormal Laboratory Values|1
2490519|NCT02058108|8609814|P1|Overall Study|Abnormal Laboratory Values|0
2490520|NCT02058069|8609838|P1|Overall Study|Withdrawal by Subject|6
2490521|NCT02058069|8609838|P1|Overall Study|Exclusion due to implant size|5
2490522|NCT02057874|8609897|P1|Overall Study|participant did not return for scan|1
2490523|NCT02057835|8609915|P10|Overall Study|Withdrawal by Subject|0
2490524|NCT02057835|8609916|P9|Overall Study|Withdrawal by Subject|0
2490525|NCT02057835|8609917|P8|Overall Study|Withdrawal by Subject|0
2490526|NCT02057835|8609918|P7|Overall Study|Withdrawal by Subject|0
2490527|NCT02057835|8609919|P6|Overall Study|Withdrawal by Subject|0
2490528|NCT02057835|8609920|P5|Overall Study|Withdrawal by Subject|0
2490529|NCT02057835|8609921|P4|Overall Study|Withdrawal by Subject|0
2490530|NCT02057835|8609922|P3|Overall Study|Withdrawal by Subject|0
2490531|NCT02057835|8609923|P2|Overall Study|Withdrawal by Subject|2
2490532|NCT02057835|8609924|P1|Overall Study|Withdrawal by Subject|0
2490533|NCT02057757|8610003|P2|Overall Study|Non-compliance|0
2490534|NCT02057757|8610004|P1|Overall Study|Non-compliance|1
2490535|NCT02057757|8610003|P2|Overall Study|Lost to Follow-up|3
2490536|NCT02057757|8610004|P1|Overall Study|Lost to Follow-up|8
2490537|NCT02057757|8610003|P2|Overall Study|Death|0
2490538|NCT02057757|8610004|P1|Overall Study|Death|2
2490539|NCT02057757|8610003|P2|Overall Study|Withdrawal by Subject|5
2490540|NCT02057757|8610004|P1|Overall Study|Withdrawal by Subject|3
2490541|NCT02057692|8610058|P4|Overall Study|Lost to Follow-up|1
2490542|NCT02057692|8610059|P3|Overall Study|Lost to Follow-up|0
2490543|NCT02057692|8610060|P2|Overall Study|Lost to Follow-up|0
2490544|NCT02057692|8610061|P1|Overall Study|Lost to Follow-up|0
2490545|NCT02057692|8610058|P4|Overall Study|Adverse Event|0
2490546|NCT02057692|8610059|P3|Overall Study|Adverse Event|0
2490547|NCT02057692|8610060|P2|Overall Study|Adverse Event|0
2490548|NCT02057692|8610061|P1|Overall Study|Adverse Event|1
2490549|NCT02057575|8610107|P4|Overall Study|Protocol Violation|0
2490550|NCT02057575|8610108|P3|Overall Study|Protocol Violation|0
2490551|NCT02057575|8610109|P2|Overall Study|Protocol Violation|1
2490552|NCT02057575|8610110|P1|Overall Study|Protocol Violation|0
2490553|NCT02057575|8610107|P4|Overall Study|Dissallowed Concurrent Medication|0
2490554|NCT02057575|8610108|P3|Overall Study|Dissallowed Concurrent Medication|0
2490555|NCT02057575|8610109|P2|Overall Study|Dissallowed Concurrent Medication|1
2490556|NCT02057575|8610110|P1|Overall Study|Dissallowed Concurrent Medication|0
2490557|NCT02057575|8610107|P4|Overall Study|Withdrawal by Subject|0
2490558|NCT02057575|8610108|P3|Overall Study|Withdrawal by Subject|0
2490559|NCT02057575|8610109|P2|Overall Study|Withdrawal by Subject|0
2490560|NCT02057575|8610110|P1|Overall Study|Withdrawal by Subject|1
2490561|NCT02057575|8610107|P4|Overall Study|Adverse Event|1
2490562|NCT02057575|8610108|P3|Overall Study|Adverse Event|0
2490563|NCT02057575|8610109|P2|Overall Study|Adverse Event|2
2490564|NCT02057575|8610110|P1|Overall Study|Adverse Event|0
2490565|NCT02057549|8610122|P2|Overall Study|Withdrawal by Subject|0
2490566|NCT02057549|8610123|P1|Overall Study|Withdrawal by Subject|1
2490567|NCT02057549|8610122|P2|Overall Study|Physician Decision|0
2490568|NCT02057549|8610123|P1|Overall Study|Physician Decision|1
2490569|NCT02057549|8610122|P2|Overall Study|Lost to Follow-up|0
2490570|NCT02057549|8610123|P1|Overall Study|Lost to Follow-up|1
2490571|NCT02057458|8610143|P3|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0
2490572|NCT02057458|8610144|P2|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0
2490573|NCT02057458|8610145|P1|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1
2490574|NCT02057458|8610143|P3|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0
2490575|NCT02057458|8610144|P2|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0
2490576|NCT02057458|8610145|P1|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2
2490577|NCT02057458|8610143|P3|Met Inclusion Criteria|Prior history of migraine headaches|0
2490578|NCT02057458|8610144|P2|Met Inclusion Criteria|Prior history of migraine headaches|1
2490579|NCT02057458|8610145|P1|Met Inclusion Criteria|Prior history of migraine headaches|0
2490580|NCT02057406|8610183|P3|Overall Study|Patient transportation issues|1
2490581|NCT02057406|8610184|P2|Overall Study|Patient transportation issues|0
2490582|NCT02057406|8610185|P1|Overall Study|Patient transportation issues|0
2490583|NCT02057406|8610183|P3|Overall Study|Protocol Violation|0
2490584|NCT02057406|8610184|P2|Overall Study|Protocol Violation|1
2490585|NCT02057406|8610185|P1|Overall Study|Protocol Violation|0
2490586|NCT02057406|8610183|P3|Overall Study|Death|0
2490587|NCT02057406|8610184|P2|Overall Study|Death|0
2490588|NCT02057406|8610185|P1|Overall Study|Death|1
2490589|NCT02057406|8610183|P3|Overall Study|Lost to Follow-up|1
2490590|NCT02057406|8610184|P2|Overall Study|Lost to Follow-up|0
2490591|NCT02057406|8610185|P1|Overall Study|Lost to Follow-up|0
2490592|NCT02057406|8610183|P3|Overall Study|Withdrawal by Subject|0
2490593|NCT02057406|8610184|P2|Overall Study|Withdrawal by Subject|2
2490594|NCT02057406|8610185|P1|Overall Study|Withdrawal by Subject|0
2490595|NCT02057406|8610183|P3|Overall Study|Physician Decision|2
2490596|NCT02057406|8610184|P2|Overall Study|Physician Decision|0
2490597|NCT02057406|8610185|P1|Overall Study|Physician Decision|0
2490598|NCT02057393|8610196|P1|Overall Study|Patient did not meet criteria|1
2490599|NCT02057393|8610196|P1|Overall Study|Withdrawal by Subject|1
2490600|NCT02057250|8610217|P5|Extension Phase|Other than specified above|7
2490601|NCT02057250|8610218|P4|Extension Phase|Other than specified above|0
2490602|NCT02057250|8610219|P3|Extension Phase|Other than specified above|0
2490603|NCT02057250|8610220|P2|Extension Phase|Other than specified above|0
2490604|NCT02057250|8610221|P1|Extension Phase|Other than specified above|0
2490605|NCT02057250|8610217|P5|Extension Phase|Entered in this period but not treated|4
2490606|NCT02057250|8610218|P4|Extension Phase|Entered in this period but not treated|0
2490607|NCT02057250|8610219|P3|Extension Phase|Entered in this period but not treated|0
2490608|NCT02057250|8610220|P2|Extension Phase|Entered in this period but not treated|0
2490609|NCT02057250|8610221|P1|Extension Phase|Entered in this period but not treated|0
2490610|NCT02057250|8610217|P5|Extension Phase|Lack of Efficacy|10
2490611|NCT02057250|8610218|P4|Extension Phase|Lack of Efficacy|0
2490612|NCT02057250|8610219|P3|Extension Phase|Lack of Efficacy|0
2490613|NCT02057250|8610220|P2|Extension Phase|Lack of Efficacy|0
2490614|NCT02057250|8610221|P1|Extension Phase|Lack of Efficacy|0
2490615|NCT02057250|8610217|P5|Extension Phase|Adverse Event|15
2490616|NCT02057250|8610218|P4|Extension Phase|Adverse Event|0
2490617|NCT02057250|8610219|P3|Extension Phase|Adverse Event|0
2490618|NCT02057250|8610220|P2|Extension Phase|Adverse Event|0
2490619|NCT02057250|8610221|P1|Extension Phase|Adverse Event|0
2490620|NCT02057250|8610217|P5|AID Assessment Phase|Other than specified above|0
2490621|NCT02057250|8610218|P4|AID Assessment Phase|Other than specified above|1
2490622|NCT02057250|8610219|P3|AID Assessment Phase|Other than specified above|1
2490623|NCT02057250|8610220|P2|AID Assessment Phase|Other than specified above|1
2490624|NCT02057250|8610221|P1|AID Assessment Phase|Other than specified above|1
2490625|NCT02057250|8610217|P5|AID Assessment Phase|Adverse Event|0
2490626|NCT02057250|8610218|P4|AID Assessment Phase|Adverse Event|1
2490627|NCT02057250|8610219|P3|AID Assessment Phase|Adverse Event|6
2490628|NCT02057250|8610220|P2|AID Assessment Phase|Adverse Event|2
2490629|NCT02057250|8610221|P1|AID Assessment Phase|Adverse Event|3
2490630|NCT02057198|8610242|P3|Overall Study|Discharged early; lost to followup|0
2490631|NCT02057198|8610243|P2|Overall Study|Discharged early; lost to followup|1
2490632|NCT02057198|8610244|P1|Overall Study|Discharged early; lost to followup|0
2490633|NCT02057198|8610242|P3|Overall Study|Death|1
2490634|NCT02057198|8610243|P2|Overall Study|Death|0
2490635|NCT02057198|8610244|P1|Overall Study|Death|0
2490636|NCT02057068|8610269|P2|Overall Study|Lost to Follow-up|2
2490637|NCT02057068|8610270|P1|Overall Study|Lost to Follow-up|2
2490638|NCT02057068|8610269|P2|Overall Study|Carepartner (CP) Health|2
2490639|NCT02057068|8610270|P1|Overall Study|Carepartner (CP) Health|4
2490640|NCT02057068|8610269|P2|Overall Study|Caregiver (CG) Health|2
2490641|NCT02057068|8610270|P1|Overall Study|Caregiver (CG) Health|0
2490642|NCT02057068|8610269|P2|Overall Study|Withdrawal by Subject|2
2490643|NCT02057068|8610270|P1|Overall Study|Withdrawal by Subject|2
2490644|NCT02056834|8610299|P1|Overall Study|Lost to Follow-up|7
2490645|NCT02056652|8610320|P2|Overall Study|Lost to Follow-up|3
2490646|NCT02056652|8610321|P1|Overall Study|Lost to Follow-up|0
2490647|NCT02056652|8610320|P2|Overall Study|Withdrawal by Subject|0
2490648|NCT02056652|8610321|P1|Overall Study|Withdrawal by Subject|1
2490649|NCT02056626|8610358|P4|Overall Study|patient did not follow directions|0
2490650|NCT02056626|8610359|P3|Overall Study|patient did not follow directions|0
2490651|NCT02056626|8610360|P2|Overall Study|patient did not follow directions|1
2490652|NCT02056626|8610361|P1|Overall Study|patient did not follow directions|3
2490653|NCT02056392|8610396|P6|Overall Study|Withdrawal by Subject|0
2490654|NCT02056392|8610397|P5|Overall Study|Withdrawal by Subject|1
2490655|NCT02056392|8610398|P4|Overall Study|Withdrawal by Subject|0
2490656|NCT02056392|8610399|P3|Overall Study|Withdrawal by Subject|0
2490657|NCT02056392|8610400|P2|Overall Study|Withdrawal by Subject|0
2490658|NCT02056392|8610401|P1|Overall Study|Withdrawal by Subject|1
2490659|NCT02056392|8610396|P6|Overall Study|Protocol Violation|0
2490660|NCT02056392|8610397|P5|Overall Study|Protocol Violation|0
2490661|NCT02056392|8610398|P4|Overall Study|Protocol Violation|0
2490662|NCT02056392|8610399|P3|Overall Study|Protocol Violation|1
2490663|NCT02056392|8610400|P2|Overall Study|Protocol Violation|0
2490664|NCT02056392|8610401|P1|Overall Study|Protocol Violation|1
2490665|NCT02056392|8610396|P6|Overall Study|Lost to Follow-up|0
2490666|NCT02056392|8610397|P5|Overall Study|Lost to Follow-up|0
2490667|NCT02056392|8610398|P4|Overall Study|Lost to Follow-up|0
2490668|NCT02056392|8610399|P3|Overall Study|Lost to Follow-up|2
2490669|NCT02056392|8610400|P2|Overall Study|Lost to Follow-up|1
2490670|NCT02056392|8610401|P1|Overall Study|Lost to Follow-up|0
2490671|NCT02056340|8610438|P2|Overall Study|Withdrawal by Subject|6
2490672|NCT02056340|8610439|P1|Overall Study|Withdrawal by Subject|2
2490673|NCT02056340|8610438|P2|Overall Study|Lost to Follow-up|5
2490674|NCT02056340|8610439|P1|Overall Study|Lost to Follow-up|5
2490675|NCT02055976|8610469|P9|Overall Study|Lost to Follow-up|0
2490676|NCT02055976|8610470|P8|Overall Study|Lost to Follow-up|0
2490677|NCT02055976|8610471|P7|Overall Study|Lost to Follow-up|0
2490678|NCT02055976|8610472|P6|Overall Study|Lost to Follow-up|0
2490679|NCT02055976|8610473|P5|Overall Study|Lost to Follow-up|0
2490680|NCT02055976|8610474|P4|Overall Study|Lost to Follow-up|1
2490681|NCT02055976|8610475|P3|Overall Study|Lost to Follow-up|0
2490682|NCT02055976|8610476|P2|Overall Study|Lost to Follow-up|0
2490683|NCT02055976|8610477|P1|Overall Study|Lost to Follow-up|0
2490684|NCT02055976|8610469|P9|Overall Study|Does not meet entrance criteria|0
2490685|NCT02055976|8610470|P8|Overall Study|Does not meet entrance criteria|0
2490686|NCT02055976|8610471|P7|Overall Study|Does not meet entrance criteria|1
2490687|NCT02055976|8610472|P6|Overall Study|Does not meet entrance criteria|0
2490688|NCT02055976|8610473|P5|Overall Study|Does not meet entrance criteria|0
2490689|NCT02055976|8610474|P4|Overall Study|Does not meet entrance criteria|0
2490690|NCT02055976|8610475|P3|Overall Study|Does not meet entrance criteria|0
2490691|NCT02055976|8610476|P2|Overall Study|Does not meet entrance criteria|0
2490692|NCT02055976|8610477|P1|Overall Study|Does not meet entrance criteria|0
2490693|NCT02055976|8610469|P9|Overall Study|Adverse Event|0
2490694|NCT02055976|8610470|P8|Overall Study|Adverse Event|0
2490695|NCT02055976|8610471|P7|Overall Study|Adverse Event|1
2490696|NCT02055976|8610472|P6|Overall Study|Adverse Event|1
2490697|NCT02055976|8610473|P5|Overall Study|Adverse Event|0
2490698|NCT02055976|8610474|P4|Overall Study|Adverse Event|0
2490699|NCT02055976|8610475|P3|Overall Study|Adverse Event|0
2490700|NCT02055976|8610476|P2|Overall Study|Adverse Event|0
2490701|NCT02055976|8610477|P1|Overall Study|Adverse Event|0
2490702|NCT02055976|8610469|P9|Overall Study|Other|0
2490703|NCT02055976|8610470|P8|Overall Study|Other|0
2490704|NCT02055976|8610471|P7|Overall Study|Other|0
2490705|NCT02055976|8610472|P6|Overall Study|Other|0
2490706|NCT02055976|8610473|P5|Overall Study|Other|0
2490707|NCT02055976|8610474|P4|Overall Study|Other|0
2490708|NCT02055976|8610475|P3|Overall Study|Other|1
2490709|NCT02055976|8610476|P2|Overall Study|Other|0
2490710|NCT02055976|8610477|P1|Overall Study|Other|0
2490711|NCT02055820|8610906|P10|Phase II: Expansion|Death|0
2490712|NCT02055820|8610907|P9|Phase II: Expansion|Death|0
2490713|NCT02055820|8610908|P8|Phase II: Expansion|Death|0
2490714|NCT02055820|8610909|P7|Phase II: Expansion|Death|0
2490715|NCT02055820|8610910|P6|Phase II: Expansion|Death|0
2490716|NCT02055820|8610911|P5|Phase II: Expansion|Death|15
2490717|NCT02055820|8610912|P4|Phase II: Expansion|Death|0
2490718|NCT02055820|8610913|P3|Phase II: Expansion|Death|0
2490719|NCT02055820|8610914|P2|Phase II: Expansion|Death|0
2490720|NCT02055820|8610915|P1|Phase II: Expansion|Death|0
2490721|NCT02055820|8610906|P10|Phase II: Expansion|Withdrawal by Subject|0
2490722|NCT02055820|8610907|P9|Phase II: Expansion|Withdrawal by Subject|0
2490723|NCT02055820|8610908|P8|Phase II: Expansion|Withdrawal by Subject|0
2490724|NCT02055820|8610909|P7|Phase II: Expansion|Withdrawal by Subject|0
2490725|NCT02055820|8610910|P6|Phase II: Expansion|Withdrawal by Subject|0
2490726|NCT02055820|8610911|P5|Phase II: Expansion|Withdrawal by Subject|10
2490727|NCT02055820|8610912|P4|Phase II: Expansion|Withdrawal by Subject|0
2490728|NCT02055820|8610913|P3|Phase II: Expansion|Withdrawal by Subject|0
2490729|NCT02055820|8610914|P2|Phase II: Expansion|Withdrawal by Subject|0
2490730|NCT02055820|8610915|P1|Phase II: Expansion|Withdrawal by Subject|0
2490731|NCT02055820|8610906|P10|Phase II: Expansion|Lost to Follow-up|0
2490732|NCT02055820|8610907|P9|Phase II: Expansion|Lost to Follow-up|0
2490733|NCT02055820|8610908|P8|Phase II: Expansion|Lost to Follow-up|0
2490734|NCT02055820|8610909|P7|Phase II: Expansion|Lost to Follow-up|0
2490735|NCT02055820|8610910|P6|Phase II: Expansion|Lost to Follow-up|0
2490736|NCT02055820|8610911|P5|Phase II: Expansion|Lost to Follow-up|3
2490737|NCT02055820|8610912|P4|Phase II: Expansion|Lost to Follow-up|0
2490738|NCT02055820|8610913|P3|Phase II: Expansion|Lost to Follow-up|0
2490739|NCT02055820|8610914|P2|Phase II: Expansion|Lost to Follow-up|0
2490740|NCT02055820|8610915|P1|Phase II: Expansion|Lost to Follow-up|0
2490741|NCT02055820|8610906|P10|Phase II: Expansion|Participants still in study|0
2490742|NCT02055820|8610907|P9|Phase II: Expansion|Participants still in study|0
2490743|NCT02055820|8610908|P8|Phase II: Expansion|Participants still in study|0
2490744|NCT02055820|8610909|P7|Phase II: Expansion|Participants still in study|0
2490745|NCT02055820|8610910|P6|Phase II: Expansion|Participants still in study|0
2490746|NCT02055820|8610911|P5|Phase II: Expansion|Participants still in study|177
2490747|NCT02055820|8610912|P4|Phase II: Expansion|Participants still in study|0
2490748|NCT02055820|8610913|P3|Phase II: Expansion|Participants still in study|0
2490749|NCT02055820|8610914|P2|Phase II: Expansion|Participants still in study|0
2490750|NCT02055820|8610915|P1|Phase II: Expansion|Participants still in study|0
2490751|NCT02055820|8610906|P10|Phase II: Expansion|Unspecified Reason|0
2490752|NCT02055820|8610907|P9|Phase II: Expansion|Unspecified Reason|0
2490753|NCT02055820|8610908|P8|Phase II: Expansion|Unspecified Reason|0
2490754|NCT02055820|8610909|P7|Phase II: Expansion|Unspecified Reason|0
2490755|NCT02055820|8610910|P6|Phase II: Expansion|Unspecified Reason|0
2490756|NCT02055820|8610911|P5|Phase II: Expansion|Unspecified Reason|3
2490757|NCT02055820|8610912|P4|Phase II: Expansion|Unspecified Reason|0
2490758|NCT02055820|8610913|P3|Phase II: Expansion|Unspecified Reason|0
2490759|NCT02055820|8610914|P2|Phase II: Expansion|Unspecified Reason|0
2490760|NCT02055820|8610915|P1|Phase II: Expansion|Unspecified Reason|0
2490761|NCT02055820|8610906|P10|Phase I: Dose-Finding|Participants still in study|6
2490762|NCT02055820|8610907|P9|Phase I: Dose-Finding|Participants still in study|6
2490763|NCT02055820|8610908|P8|Phase I: Dose-Finding|Participants still in study|6
2490764|NCT02055820|8610909|P7|Phase I: Dose-Finding|Participants still in study|7
2490765|NCT02055820|8610910|P6|Phase I: Dose-Finding|Participants still in study|6
2490766|NCT02055820|8610911|P5|Phase I: Dose-Finding|Participants still in study|0
2490767|NCT02055820|8610912|P4|Phase I: Dose-Finding|Participants still in study|4
2490768|NCT02055820|8610913|P3|Phase I: Dose-Finding|Participants still in study|7
2490769|NCT02055820|8610914|P2|Phase I: Dose-Finding|Participants still in study|3
2490770|NCT02055820|8610915|P1|Phase I: Dose-Finding|Participants still in study|6
2490771|NCT02055820|8610906|P10|Phase I: Dose-Finding|Death|0
2490772|NCT02055820|8610907|P9|Phase I: Dose-Finding|Death|0
2490773|NCT02055820|8610908|P8|Phase I: Dose-Finding|Death|0
2490774|NCT02055820|8610909|P7|Phase I: Dose-Finding|Death|0
2490775|NCT02055820|8610910|P6|Phase I: Dose-Finding|Death|0
2490776|NCT02055820|8610911|P5|Phase I: Dose-Finding|Death|0
2490777|NCT02055820|8610912|P4|Phase I: Dose-Finding|Death|2
2490778|NCT02055820|8610913|P3|Phase I: Dose-Finding|Death|1
2490779|NCT02055820|8610914|P2|Phase I: Dose-Finding|Death|0
2490780|NCT02055820|8610915|P1|Phase I: Dose-Finding|Death|1
2490781|NCT02055820|8610906|P10|Phase I: Dose-Finding|Withdrawal by Subject|0
2490782|NCT02055820|8610907|P9|Phase I: Dose-Finding|Withdrawal by Subject|0
2490783|NCT02055820|8610908|P8|Phase I: Dose-Finding|Withdrawal by Subject|0
2490784|NCT02055820|8610909|P7|Phase I: Dose-Finding|Withdrawal by Subject|0
2490785|NCT02055820|8610910|P6|Phase I: Dose-Finding|Withdrawal by Subject|1
2490786|NCT02055820|8610911|P5|Phase I: Dose-Finding|Withdrawal by Subject|0
2490787|NCT02055820|8610912|P4|Phase I: Dose-Finding|Withdrawal by Subject|0
2490788|NCT02055820|8610913|P3|Phase I: Dose-Finding|Withdrawal by Subject|0
2490789|NCT02055820|8610914|P2|Phase I: Dose-Finding|Withdrawal by Subject|0
2490790|NCT02055820|8610915|P1|Phase I: Dose-Finding|Withdrawal by Subject|0
2490791|NCT02055365|8611048|P1|Overall Study|Prematurely Withdrawn|1
2490792|NCT02055352|8611061|P2|Overall Study|Reason unknown|5
2490793|NCT02055352|8611062|P1|Overall Study|Reason unknown|1
2490794|NCT02055352|8611061|P2|Overall Study|Withdrawal of informed consent|0
2490795|NCT02055352|8611062|P1|Overall Study|Withdrawal of informed consent|1
2490796|NCT02055352|8611061|P2|Overall Study|AE, study drug would be detrimental|3
2490797|NCT02055352|8611062|P1|Overall Study|AE, study drug would be detrimental|1
2490798|NCT02055352|8611061|P2|Overall Study|Use of prohibited treatment|3
2490799|NCT02055352|8611062|P1|Overall Study|Use of prohibited treatment|0
2490800|NCT02055352|8611061|P2|Overall Study|Patient decision|1
2490801|NCT02055352|8611062|P1|Overall Study|Patient decision|1
2490802|NCT02055352|8611061|P2|Overall Study|Death|2
2490803|NCT02055352|8611062|P1|Overall Study|Death|1
2490804|NCT02055352|8611061|P2|Overall Study|Poor compliance|1
2490805|NCT02055352|8611062|P1|Overall Study|Poor compliance|1
2490806|NCT02055352|8611061|P2|Overall Study|Non-eligible|1
2490807|NCT02055352|8611062|P1|Overall Study|Non-eligible|0
2490808|NCT02055352|8611061|P2|Overall Study|Adverse Event|1
2490809|NCT02055352|8611062|P1|Overall Study|Adverse Event|0
2490810|NCT02055118|8611079|P3|Overall Study|Withdrawal by Subject|0
2490811|NCT02055118|8611080|P2|Overall Study|Withdrawal by Subject|2
2490812|NCT02055118|8611081|P1|Overall Study|Withdrawal by Subject|0
2490813|NCT02054910|8611140|P2|Overall Study|Lost to Follow-up|1
2490814|NCT02054910|8611141|P1|Overall Study|Lost to Follow-up|4
2490815|NCT02054897|8611160|P3|Overall Study|Randomized but not exposed|0
2490816|NCT02054897|8611161|P2|Overall Study|Randomized but not exposed|0
2490817|NCT02054897|8611162|P1|Overall Study|Randomized but not exposed|1
2490818|NCT02054897|8611160|P3|Overall Study|Lost to Follow-up|7
2490819|NCT02054897|8611161|P2|Overall Study|Lost to Follow-up|2
2490820|NCT02054897|8611162|P1|Overall Study|Lost to Follow-up|4
2490821|NCT02054897|8611160|P3|Overall Study|Missing follow-up information|3
2490822|NCT02054897|8611161|P2|Overall Study|Missing follow-up information|5
2490823|NCT02054897|8611162|P1|Overall Study|Missing follow-up information|3
2490824|NCT02054897|8611160|P3|Overall Study|Withdrawal by Subject|2
2490825|NCT02054897|8611161|P2|Overall Study|Withdrawal by Subject|0
2490826|NCT02054897|8611162|P1|Overall Study|Withdrawal by Subject|2
2490827|NCT02054715|8611209|P2|Follow-up 2|Treatment Change or Delay|0
2490828|NCT02054715|8611210|P1|Follow-up 2|Treatment Change or Delay|1
2490829|NCT02054715|8611209|P2|Follow-up 2|No Reason|0
2490830|NCT02054715|8611210|P1|Follow-up 2|No Reason|2
2490831|NCT02054715|8611209|P2|Follow-up 2|Changed Mind|1
2490832|NCT02054715|8611210|P1|Follow-up 2|Changed Mind|0
2490833|NCT02054715|8611209|P2|Follow-up 2|Changed MD/Facility|1
2490834|NCT02054715|8611210|P1|Follow-up 2|Changed MD/Facility|0
2490835|NCT02054715|8611209|P2|Follow-up 2|Hospitalization|2
2490836|NCT02054715|8611210|P1|Follow-up 2|Hospitalization|0
2490837|NCT02054715|8611209|P2|Follow-up 2|Death|3
2490838|NCT02054715|8611210|P1|Follow-up 2|Death|3
2490839|NCT02054715|8611209|P2|Follow-up 2|Ineligible|5
2490840|NCT02054715|8611210|P1|Follow-up 2|Ineligible|4
2490841|NCT02054715|8611209|P2|Follow-up 2|Followup Not Completed|4
2490842|NCT02054715|8611210|P1|Follow-up 2|Followup Not Completed|3
2490843|NCT02054715|8611209|P2|Follow-up 2|Refused|2
2490844|NCT02054715|8611210|P1|Follow-up 2|Refused|3
2490845|NCT02054715|8611209|P2|Follow-up 2|Lost to Followup|1
2490846|NCT02054715|8611210|P1|Follow-up 2|Lost to Followup|3
2490847|NCT02054715|8611209|P2|Baseline/Follow-up 1|Changed Mind|0
2490848|NCT02054715|8611210|P1|Baseline/Follow-up 1|Changed Mind|1
2490849|NCT02054715|8611209|P2|Baseline/Follow-up 1|Hospitalization|0
2490850|NCT02054715|8611210|P1|Baseline/Follow-up 1|Hospitalization|1
2490851|NCT02054715|8611209|P2|Baseline/Follow-up 1|Ineligible|0
2490852|NCT02054715|8611210|P1|Baseline/Follow-up 1|Ineligible|3
2490853|NCT02054715|8611209|P2|Baseline/Follow-up 1|Overwhelmed|0
2490854|NCT02054715|8611210|P1|Baseline/Follow-up 1|Overwhelmed|2
2490855|NCT02054715|8611209|P2|Baseline/Follow-up 1|No Reason|1
2490856|NCT02054715|8611210|P1|Baseline/Follow-up 1|No Reason|0
2490857|NCT02054715|8611209|P2|Baseline/Follow-up 1|Disliked Procedure|1
2490858|NCT02054715|8611210|P1|Baseline/Follow-up 1|Disliked Procedure|0
2490859|NCT02054715|8611209|P2|Baseline/Follow-up 1|Changed MD/Facility|1
2490860|NCT02054715|8611210|P1|Baseline/Follow-up 1|Changed MD/Facility|0
2490861|NCT02054715|8611209|P2|Baseline/Follow-up 1|Medical|1
2490862|NCT02054715|8611210|P1|Baseline/Follow-up 1|Medical|0
2490863|NCT02054715|8611209|P2|Baseline/Follow-up 1|Refused|3
2490864|NCT02054715|8611210|P1|Baseline/Follow-up 1|Refused|1
2490865|NCT02054702|8611224|P2|Overall Study|Withdrawal by Subject|4
2490866|NCT02054702|8611225|P1|Overall Study|Withdrawal by Subject|14
2490867|NCT02054702|8611224|P2|Overall Study|Physician Decision|1
2490868|NCT02054702|8611225|P1|Overall Study|Physician Decision|0
2490869|NCT02054702|8611224|P2|Overall Study|Met Withdrawal Criteria|1
2490870|NCT02054702|8611225|P1|Overall Study|Met Withdrawal Criteria|4
2490871|NCT02054702|8611224|P2|Overall Study|Adverse Event|1
2490872|NCT02054702|8611225|P1|Overall Study|Adverse Event|3
2490873|NCT02054702|8611224|P2|Overall Study|Lost to Follow-up|5
2490874|NCT02054702|8611225|P1|Overall Study|Lost to Follow-up|3
2490875|NCT02054520|8611282|P6|Overall Study|Study terminated by Sponsor|0
2490876|NCT02054520|8611283|P5|Overall Study|Study terminated by Sponsor|0
2490877|NCT02054520|8611284|P4|Overall Study|Study terminated by Sponsor|1
2490878|NCT02054520|8611285|P3|Overall Study|Study terminated by Sponsor|2
2490879|NCT02054520|8611286|P2|Overall Study|Study terminated by Sponsor|0
2490880|NCT02054520|8611287|P1|Overall Study|Study terminated by Sponsor|0
2490881|NCT02054520|8611282|P6|Overall Study|Physician Decision|1
2490882|NCT02054520|8611283|P5|Overall Study|Physician Decision|0
2490883|NCT02054520|8611284|P4|Overall Study|Physician Decision|1
2490884|NCT02054520|8611285|P3|Overall Study|Physician Decision|0
2490885|NCT02054520|8611286|P2|Overall Study|Physician Decision|1
2490886|NCT02054520|8611287|P1|Overall Study|Physician Decision|0
2490887|NCT02054520|8611282|P6|Overall Study|Withdrawal by Subject|0
2490888|NCT02054520|8611283|P5|Overall Study|Withdrawal by Subject|1
2490889|NCT02054520|8611284|P4|Overall Study|Withdrawal by Subject|2
2490890|NCT02054520|8611285|P3|Overall Study|Withdrawal by Subject|0
2490891|NCT02054520|8611286|P2|Overall Study|Withdrawal by Subject|0
2490892|NCT02054520|8611287|P1|Overall Study|Withdrawal by Subject|1
2490893|NCT02054520|8611282|P6|Overall Study|Lack of Efficacy|2
2490894|NCT02054520|8611283|P5|Overall Study|Lack of Efficacy|3
2490895|NCT02054520|8611284|P4|Overall Study|Lack of Efficacy|1
2490896|NCT02054520|8611285|P3|Overall Study|Lack of Efficacy|2
2490897|NCT02054520|8611286|P2|Overall Study|Lack of Efficacy|0
2490898|NCT02054520|8611287|P1|Overall Study|Lack of Efficacy|7
2490899|NCT02054520|8611282|P6|Overall Study|Adverse Event|0
2490900|NCT02054520|8611283|P5|Overall Study|Adverse Event|1
2490901|NCT02054520|8611284|P4|Overall Study|Adverse Event|1
2490902|NCT02054520|8611285|P3|Overall Study|Adverse Event|2
2490903|NCT02054520|8611286|P2|Overall Study|Adverse Event|4
2490904|NCT02054520|8611287|P1|Overall Study|Adverse Event|1
2490905|NCT02054481|8611311|P4|Overall Study|Other reason|0
2490906|NCT02054481|8611312|P3|Overall Study|Other reason|2
2490907|NCT02054481|8611313|P2|Overall Study|Other reason|1
2490908|NCT02054481|8611314|P1|Overall Study|Other reason|2
2490909|NCT02054481|8611311|P4|Overall Study|Lost to Follow-up|0
2490910|NCT02054481|8611312|P3|Overall Study|Lost to Follow-up|0
2490911|NCT02054481|8611313|P2|Overall Study|Lost to Follow-up|0
2490912|NCT02054481|8611314|P1|Overall Study|Lost to Follow-up|1
2490913|NCT02054481|8611311|P4|Overall Study|Adverse Event|1
2490914|NCT02054481|8611312|P3|Overall Study|Adverse Event|0
2490915|NCT02054481|8611313|P2|Overall Study|Adverse Event|1
2490916|NCT02054481|8611314|P1|Overall Study|Adverse Event|1
2490917|NCT02054325|8611375|P2|Overall Study|Lost to Follow-up|5
2490918|NCT02054325|8611376|P1|Overall Study|Lost to Follow-up|8
2490919|NCT02054130|8611403|P4|Overall Study|Missed dose|10
2490920|NCT02054130|8611404|P3|Overall Study|Missed dose|7
2490921|NCT02054130|8611405|P2|Overall Study|Missed dose|6
2490922|NCT02054130|8611406|P1|Overall Study|Missed dose|4
2490923|NCT02054130|8611403|P4|Overall Study|Lost to Follow-up|2
2490924|NCT02054130|8611404|P3|Overall Study|Lost to Follow-up|1
2490925|NCT02054130|8611405|P2|Overall Study|Lost to Follow-up|0
2490926|NCT02054130|8611406|P1|Overall Study|Lost to Follow-up|0
2490927|NCT02054130|8611403|P4|Overall Study|Death|0
2490928|NCT02054130|8611404|P3|Overall Study|Death|0
2490929|NCT02054130|8611405|P2|Overall Study|Death|1
2490930|NCT02054130|8611406|P1|Overall Study|Death|0
2490931|NCT02054130|8611403|P4|Overall Study|Withdrawal by Subject|10
2490932|NCT02054130|8611404|P3|Overall Study|Withdrawal by Subject|7
2490933|NCT02054130|8611405|P2|Overall Study|Withdrawal by Subject|4
2490934|NCT02054130|8611406|P1|Overall Study|Withdrawal by Subject|4
2490935|NCT02053753|8611500|P2|Overall Study|Lost to Follow-up|3
2490936|NCT02053753|8611501|P1|Overall Study|Lost to Follow-up|4
2490937|NCT02053753|8611500|P2|Overall Study|Decision by Sponsor|1
2490938|NCT02053753|8611501|P1|Overall Study|Decision by Sponsor|1
2490939|NCT02053753|8611500|P2|Overall Study|Withdrawal by Subject|4
2490940|NCT02053753|8611501|P1|Overall Study|Withdrawal by Subject|2
2490941|NCT02053610|8611525|P2|Overall Study|Violation of Selection Criteria|0
2490942|NCT02053610|8611526|P1|Overall Study|Violation of Selection Criteria|1
2490943|NCT02053610|8611525|P2|Overall Study|Insufficient Therapeutic Response|1
2490944|NCT02053610|8611526|P1|Overall Study|Insufficient Therapeutic Response|1
2490945|NCT02053610|8611525|P2|Overall Study|Did not Receive Treatment|2
2490946|NCT02053610|8611526|P1|Overall Study|Did not Receive Treatment|4
2490947|NCT02053610|8611525|P2|Overall Study|Refused treatment/Did not cooperate|3
2490948|NCT02053610|8611526|P1|Overall Study|Refused treatment/Did not cooperate|1
2490949|NCT02053610|8611525|P2|Overall Study|Disease Progression|3
2490950|NCT02053610|8611526|P1|Overall Study|Disease Progression|2
2490951|NCT02053610|8611525|P2|Overall Study|Administrative/Other|1
2490952|NCT02053610|8611526|P1|Overall Study|Administrative/Other|1
2490953|NCT02053610|8611525|P2|Overall Study|Death|5
2490954|NCT02053610|8611526|P1|Overall Study|Death|5
2490955|NCT02053610|8611525|P2|Overall Study|Withdrew Consent|9
2490956|NCT02053610|8611526|P1|Overall Study|Withdrew Consent|2
2490957|NCT02053610|8611525|P2|Overall Study|Adverse Event/Intercurrent Illness|43
2490958|NCT02053610|8611526|P1|Overall Study|Adverse Event/Intercurrent Illness|25
2490959|NCT02053493|8611558|P2|Overall Study|Withdrawal by Subject|1
2490960|NCT02053493|8611559|P1|Overall Study|Withdrawal by Subject|1
2490961|NCT02053168|8611608|P1|Overall Study|Lost to Follow-up|1
2490962|NCT02053168|8611608|P1|Overall Study|Physician Decision|1
2490963|NCT02053168|8611608|P1|Overall Study|Withdrawal by Subject|1
2490964|NCT02052596|8611687|P2|Safety Phase|Lost due to Crohn`s disease|1
2490965|NCT02052596|8611688|P1|Safety Phase|Lost due to Crohn`s disease|0
2490966|NCT02052596|8611687|P2|Safety Phase|Enrolled in error|0
2490967|NCT02052596|8611688|P1|Safety Phase|Enrolled in error|1
2490968|NCT02052596|8611687|P2|Safety Phase|Withdrawal by Subject|11
2490969|NCT02052596|8611688|P1|Safety Phase|Withdrawal by Subject|8
2490970|NCT02052596|8611687|P2|Safety Phase|Protocol Violation|2
2490971|NCT02052596|8611688|P1|Safety Phase|Protocol Violation|1
2490972|NCT02052596|8611687|P2|Safety Phase|Lost to Follow-up|18
2490973|NCT02052596|8611688|P1|Safety Phase|Lost to Follow-up|11
2490974|NCT02052596|8611687|P2|Safety Phase|Adverse Event|3
2490975|NCT02052596|8611688|P1|Safety Phase|Adverse Event|6
2490976|NCT02052596|8611687|P2|Active Phase|Lost due to Crohn`s disease|1
2490977|NCT02052596|8611688|P1|Active Phase|Lost due to Crohn`s disease|0
2490978|NCT02052596|8611687|P2|Active Phase|Enrolled in error|0
2490979|NCT02052596|8611688|P1|Active Phase|Enrolled in error|1
2490980|NCT02052596|8611687|P2|Active Phase|Withdrawal by Subject|4
2490981|NCT02052596|8611688|P1|Active Phase|Withdrawal by Subject|3
2490982|NCT02052596|8611687|P2|Active Phase|Protocol Violation|2
2490983|NCT02052596|8611688|P1|Active Phase|Protocol Violation|1
2490984|NCT02052596|8611687|P2|Active Phase|Lost to Follow-up|11
2490985|NCT02052596|8611688|P1|Active Phase|Lost to Follow-up|8
2490986|NCT02052596|8611687|P2|Active Phase|Adverse Event|2
2490987|NCT02052596|8611688|P1|Active Phase|Adverse Event|3
2490988|NCT02052466|8611718|P1|Overall Study|Acromial fracture|1
2490989|NCT02052466|8611718|P1|Overall Study|Withdrawal by Subject|1
2490990|NCT02052440|8611735|P2|Overall Study|Withdrawal by Subject|1
2490991|NCT02052440|8611736|P1|Overall Study|Withdrawal by Subject|0
2490992|NCT02052414|8611748|P1|Overall Study|Withdrawal by Subject|3
2490993|NCT02052414|8611748|P1|Overall Study|Lack of Efficacy|2
2490994|NCT02052414|8611748|P1|Overall Study|Adverse Event|12
2490995|NCT02052011|8611783|P2|Overall Study|Withdrawal by Subject|2
2490996|NCT02052011|8611784|P1|Overall Study|Withdrawal by Subject|1
2490997|NCT02052011|8611783|P2|Overall Study|Lost to Follow-up|0
2490998|NCT02052011|8611784|P1|Overall Study|Lost to Follow-up|3
2490999|NCT02051296|8611939|P2|Overall Study|withdraw prior to treatment|7
2491000|NCT02051296|8611940|P1|Overall Study|withdraw prior to treatment|7
2491001|NCT02051296|8611939|P2|Overall Study|Lost to Follow-up|2
2491002|NCT02051296|8611940|P1|Overall Study|Lost to Follow-up|1
2491003|NCT02050321|8611996|P1|Overall Study|Adverse Event|1
2491004|NCT02050321|8611996|P1|Overall Study|Withdrawal by Subject|1
2491005|NCT02050048|8612012|P2|Overall Study|Ineligible after ERCP|1
2491006|NCT02050048|8612013|P1|Overall Study|Ineligible after ERCP|4
2491007|NCT02050048|8612012|P2|Overall Study|Death|0
2491008|NCT02050048|8612013|P1|Overall Study|Death|1
2491009|NCT02050048|8612012|P2|Overall Study|Lost to Follow-up|1
2491010|NCT02050048|8612013|P1|Overall Study|Lost to Follow-up|0
2491011|NCT02049957|8612028|P9|Overall Study|Physician Decision|0
2491012|NCT02049957|8612029|P8|Overall Study|Physician Decision|0
2491013|NCT02049957|8612030|P7|Overall Study|Physician Decision|0
2491014|NCT02049957|8612031|P6|Overall Study|Physician Decision|1
2491015|NCT02049957|8612032|P5|Overall Study|Physician Decision|0
2491016|NCT02049957|8612033|P4|Overall Study|Physician Decision|0
2491017|NCT02049957|8612034|P3|Overall Study|Physician Decision|0
2491018|NCT02049957|8612035|P2|Overall Study|Physician Decision|0
2491019|NCT02049957|8612036|P1|Overall Study|Physician Decision|0
2491020|NCT02049957|8612028|P9|Overall Study|Withdrawal by Subject|1
2491021|NCT02049957|8612029|P8|Overall Study|Withdrawal by Subject|3
2491022|NCT02049957|8612030|P7|Overall Study|Withdrawal by Subject|0
2491023|NCT02049957|8612031|P6|Overall Study|Withdrawal by Subject|2
2491024|NCT02049957|8612032|P5|Overall Study|Withdrawal by Subject|0
2491025|NCT02049957|8612033|P4|Overall Study|Withdrawal by Subject|1
2491026|NCT02049957|8612034|P3|Overall Study|Withdrawal by Subject|0
2491027|NCT02049957|8612035|P2|Overall Study|Withdrawal by Subject|0
2491028|NCT02049957|8612036|P1|Overall Study|Withdrawal by Subject|0
2491029|NCT02049957|8612028|P9|Overall Study|Study Terminated by Sponsor|0
2491030|NCT02049957|8612029|P8|Overall Study|Study Terminated by Sponsor|0
2491031|NCT02049957|8612030|P7|Overall Study|Study Terminated by Sponsor|1
2491032|NCT02049957|8612031|P6|Overall Study|Study Terminated by Sponsor|0
2491033|NCT02049957|8612032|P5|Overall Study|Study Terminated by Sponsor|0
2491034|NCT02049957|8612033|P4|Overall Study|Study Terminated by Sponsor|0
2491035|NCT02049957|8612034|P3|Overall Study|Study Terminated by Sponsor|0
2491036|NCT02049957|8612035|P2|Overall Study|Study Terminated by Sponsor|1
2491037|NCT02049957|8612036|P1|Overall Study|Study Terminated by Sponsor|0
2491038|NCT02049957|8612028|P9|Overall Study|Adverse Event|1
2491039|NCT02049957|8612029|P8|Overall Study|Adverse Event|6
2491040|NCT02049957|8612030|P7|Overall Study|Adverse Event|0
2491041|NCT02049957|8612031|P6|Overall Study|Adverse Event|5
2491042|NCT02049957|8612032|P5|Overall Study|Adverse Event|0
2491043|NCT02049957|8612033|P4|Overall Study|Adverse Event|0
2491044|NCT02049957|8612034|P3|Overall Study|Adverse Event|1
2491045|NCT02049957|8612035|P2|Overall Study|Adverse Event|1
2491046|NCT02049957|8612036|P1|Overall Study|Adverse Event|1
2491047|NCT02049957|8612028|P9|Overall Study|Progressive Disease|6
2491048|NCT02049957|8612029|P8|Overall Study|Progressive Disease|26
2491049|NCT02049957|8612030|P7|Overall Study|Progressive Disease|7
2491050|NCT02049957|8612031|P6|Overall Study|Progressive Disease|35
2491051|NCT02049957|8612032|P5|Overall Study|Progressive Disease|6
2491052|NCT02049957|8612033|P4|Overall Study|Progressive Disease|2
2491053|NCT02049957|8612034|P3|Overall Study|Progressive Disease|2
2491054|NCT02049957|8612035|P2|Overall Study|Progressive Disease|4
2491055|NCT02049957|8612036|P1|Overall Study|Progressive Disease|5
2491056|NCT02049814|8612128|P2|Overall Study|Voluntary withdrawal|8
2491057|NCT02049814|8612129|P1|Overall Study|Voluntary withdrawal|9
2491058|NCT02049814|8612128|P2|Overall Study|Pretreatment event/Adverse Event (AE)|5
2491059|NCT02049814|8612129|P1|Overall Study|Pretreatment event/Adverse Event (AE)|8
2491060|NCT02049814|8612128|P2|Overall Study|Study Termination|1
2491061|NCT02049814|8612129|P1|Overall Study|Study Termination|0
2491062|NCT02049814|8612128|P2|Overall Study|Serious Protocol Violation|7
2491063|NCT02049814|8612129|P1|Overall Study|Serious Protocol Violation|5
2491064|NCT02049814|8612128|P2|Overall Study|Lost to Follow-up|3
2491065|NCT02049814|8612129|P1|Overall Study|Lost to Follow-up|2
2491066|NCT02049814|8612128|P2|Overall Study|Pregnancy|0
2491067|NCT02049814|8612129|P1|Overall Study|Pregnancy|1
2491068|NCT02049814|8612128|P2|Overall Study|Reason not Specified|3
2491069|NCT02049814|8612129|P1|Overall Study|Reason not Specified|4
2491070|NCT02049450|8612178|P1|Overall Study|Patients/guardian decision|1
2491071|NCT02049450|8612178|P1|Overall Study|Withdrawal by Subject|1
2491072|NCT02049450|8612178|P1|Overall Study|Adverse Event|2
2491073|NCT02048904|8612227|P1|Overall Study|Physician Decision|70
2491074|NCT02048904|8612227|P1|Overall Study|Withdrawal by Subject|7
2491075|NCT02048241|8612272|P2|Overall Study|Withdrawal by Subject|1
2491076|NCT02048241|8612273|P1|Overall Study|Withdrawal by Subject|0
2491077|NCT02048072|8612279|P1|Overall Study|Lost to Follow-up|1
2491078|NCT02048072|8612279|P1|Overall Study|Adverse Event|3
2491079|NCT02047903|8612318|P1|Overall Study|Not Treated|9
2491080|NCT02047903|8612318|P1|Overall Study|Reason not listed|6
2491081|NCT02047903|8612318|P1|Overall Study|Lost to Follow-up|4
2491082|NCT02047903|8612318|P1|Overall Study|Withdrawal by Subject|16
2491083|NCT02047903|8612318|P1|Overall Study|Serious adverse event|10
2491084|NCT02047903|8612318|P1|Overall Study|Adverse Event|14
2491085|NCT02047253|8612369|P1|Overall Study|Lost to Follow-up|8
2491086|NCT02047227|8612379|P2|Overall Study|Other|9
2491087|NCT02047227|8612380|P1|Overall Study|Other|10
2491088|NCT02047227|8612379|P2|Overall Study|All embryos discarded|11
2491089|NCT02047227|8612380|P1|Overall Study|All embryos discarded|12
2491090|NCT02047227|8612379|P2|Overall Study|Intention to freeze all embryos|0
2491091|NCT02047227|8612380|P1|Overall Study|Intention to freeze all embryos|1
2491092|NCT02047227|8612379|P2|Overall Study|No fertilization|51
2491093|NCT02047227|8612380|P1|Overall Study|No fertilization|61
2491094|NCT02047227|8612379|P2|Overall Study|No oocytes retrieved|20
2491095|NCT02047227|8612380|P1|Overall Study|No oocytes retrieved|21
2491096|NCT02047227|8612379|P2|Overall Study|Lack of ovarian response to stimulation|32
2491097|NCT02047227|8612380|P1|Overall Study|Lack of ovarian response to stimulation|35
2491098|NCT02047227|8612379|P2|Overall Study|Spontaneous pregnancy|0
2491099|NCT02047227|8612380|P1|Overall Study|Spontaneous pregnancy|1
2491100|NCT02047227|8612379|P2|Overall Study|Protocol Violation|0
2491101|NCT02047227|8612380|P1|Overall Study|Protocol Violation|1
2491102|NCT02047227|8612379|P2|Overall Study|Lost to Follow-up|3
2491103|NCT02047227|8612380|P1|Overall Study|Lost to Follow-up|0
2491104|NCT02047227|8612379|P2|Overall Study|Adverse Event|4
2491105|NCT02047227|8612380|P1|Overall Study|Adverse Event|2
2491106|NCT02047110|8612400|P4|OLE Treatment Period|Other than specified|0
2491107|NCT02047110|8612401|P3|OLE Treatment Period|Other than specified|1
2491108|NCT02047110|8612402|P2|OLE Treatment Period|Other than specified|0
2491109|NCT02047110|8612403|P1|OLE Treatment Period|Other than specified|0
2491110|NCT02047110|8612400|P4|Escape Treatment Period|Other than specified|1
2491111|NCT02047110|8612401|P3|Escape Treatment Period|Other than specified|0
2491112|NCT02047110|8612402|P2|Escape Treatment Period|Other than specified|2
2491113|NCT02047110|8612403|P1|Escape Treatment Period|Other than specified|1
2491114|NCT02047110|8612400|P4|Escape Treatment Period|Adverse Event|0
2491115|NCT02047110|8612401|P3|Escape Treatment Period|Adverse Event|2
2491116|NCT02047110|8612402|P2|Escape Treatment Period|Adverse Event|2
2491117|NCT02047110|8612403|P1|Escape Treatment Period|Adverse Event|1
2491118|NCT02047110|8612400|P4|Escape Treatment Period|Withdrawal by Subject|1
2491119|NCT02047110|8612401|P3|Escape Treatment Period|Withdrawal by Subject|1
2491120|NCT02047110|8612402|P2|Escape Treatment Period|Withdrawal by Subject|2
2491121|NCT02047110|8612403|P1|Escape Treatment Period|Withdrawal by Subject|1
2491122|NCT02047110|8612400|P4|DB (Week 12 up to Week 24)|Other than specified|0
2491123|NCT02047110|8612401|P3|DB (Week 12 up to Week 24)|Other than specified|1
2491124|NCT02047110|8612402|P2|DB (Week 12 up to Week 24)|Other than specified|1
2491125|NCT02047110|8612403|P1|DB (Week 12 up to Week 24)|Other than specified|0
2491126|NCT02047110|8612400|P4|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
2491127|NCT02047110|8612401|P3|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
2491128|NCT02047110|8612402|P2|DB (Week 12 up to Week 24)|Withdrawal by Subject|1
2491129|NCT02047110|8612403|P1|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
2491130|NCT02047110|8612400|P4|DB Treatment Period up to Week 24|Other than specified|1
2491131|NCT02047110|8612401|P3|DB Treatment Period up to Week 24|Other than specified|3
2491132|NCT02047110|8612402|P2|DB Treatment Period up to Week 24|Other than specified|2
2491133|NCT02047110|8612403|P1|DB Treatment Period up to Week 24|Other than specified|1
2491134|NCT02047110|8612400|P4|DB Treatment Period up to Week 24|Withdrawal by Subject|1
2491135|NCT02047110|8612401|P3|DB Treatment Period up to Week 24|Withdrawal by Subject|0
2491136|NCT02047110|8612402|P2|DB Treatment Period up to Week 24|Withdrawal by Subject|0
2491137|NCT02047110|8612403|P1|DB Treatment Period up to Week 24|Withdrawal by Subject|1
2491138|NCT02047110|8612400|P4|DB Treatment Period up to Week 24|Protocol Violation|0
2491139|NCT02047110|8612401|P3|DB Treatment Period up to Week 24|Protocol Violation|0
2491140|NCT02047110|8612402|P2|DB Treatment Period up to Week 24|Protocol Violation|0
2491141|NCT02047110|8612403|P1|DB Treatment Period up to Week 24|Protocol Violation|1
2491142|NCT02047110|8612400|P4|DB Treatment Period up to Week 24|Lost to Follow-up|0
2491143|NCT02047110|8612401|P3|DB Treatment Period up to Week 24|Lost to Follow-up|0
2491144|NCT02047110|8612402|P2|DB Treatment Period up to Week 24|Lost to Follow-up|0
2491145|NCT02047110|8612403|P1|DB Treatment Period up to Week 24|Lost to Follow-up|1
2491146|NCT02047110|8612400|P4|DB Treatment Period up to Week 24|Adverse Event|0
2491147|NCT02047110|8612401|P3|DB Treatment Period up to Week 24|Adverse Event|0
2491148|NCT02047110|8612402|P2|DB Treatment Period up to Week 24|Adverse Event|0
2491149|NCT02047110|8612403|P1|DB Treatment Period up to Week 24|Adverse Event|1
2491150|NCT02047045|8612446|P2|Treatment Period (8 Weeks )|Withdrawal by Subject|2
2491151|NCT02047045|8612447|P1|Treatment Period (8 Weeks )|Withdrawal by Subject|4
2491152|NCT02047045|8612446|P2|Treatment Period (8 Weeks )|Lost to Follow-up|0
2491153|NCT02047045|8612447|P1|Treatment Period (8 Weeks )|Lost to Follow-up|1
2491154|NCT02047045|8612446|P2|Treatment Period (8 Weeks )|Adverse Event|1
2491155|NCT02047045|8612447|P1|Treatment Period (8 Weeks )|Adverse Event|2
2491156|NCT02047045|8612446|P2|Baseline|Withdrawal by Subject|15
2491157|NCT02047045|8612447|P1|Baseline|Withdrawal by Subject|8
2491158|NCT02046993|8612511|P2|Overall Study|Lost to Follow-up|1
2491159|NCT02046993|8612512|P1|Overall Study|Lost to Follow-up|1
2491160|NCT02046993|8612511|P2|Overall Study|Withdrawal by Subject|10
2491161|NCT02046993|8612512|P1|Overall Study|Withdrawal by Subject|2
2491162|NCT02046616|8612584|P1|8-Week FU Period|Lost to Follow-up|1
2491163|NCT02046616|8612584|P1|24-Week Treatment Period|Other|1
2491164|NCT02046616|8612584|P1|24-Week Treatment Period|Physician Decision|3
2491165|NCT02046616|8612584|P1|24-Week Treatment Period|Insufficient Therapeutic Response|1
2491166|NCT02046616|8612584|P1|24-Week Treatment Period|Any Other Adverse Event|13
2491167|NCT02046616|8612584|P1|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1
2491168|NCT02046603|8612606|P2|Overall Study|Adverse Event|1
2491169|NCT02046603|8612607|P1|Overall Study|Adverse Event|0
2491170|NCT02046603|8612606|P2|Overall Study|Death|1
2491171|NCT02046603|8612607|P1|Overall Study|Death|0
2491172|NCT02046603|8612606|P2|Overall Study|Lost to Follow-up|2
2491173|NCT02046603|8612607|P1|Overall Study|Lost to Follow-up|1
2491174|NCT02046603|8612606|P2|Overall Study|Physician Decision|1
2491175|NCT02046603|8612607|P1|Overall Study|Physician Decision|2
2491176|NCT02046603|8612606|P2|Overall Study|Participant/legal guardian decision|3
2491177|NCT02046603|8612607|P1|Overall Study|Participant/legal guardian decision|1
2491178|NCT02046603|8612606|P2|Overall Study|Protocol Violation|1
2491179|NCT02046603|8612607|P1|Overall Study|Protocol Violation|0
2491180|NCT02046603|8612606|P2|Overall Study|Other|66
2491181|NCT02046603|8612607|P1|Overall Study|Other|11
2491182|NCT02046564|8612686|P2|Overall Study|Subject met withdrawal criteria|5
2491183|NCT02046564|8612687|P1|Overall Study|Subject met withdrawal criteria|2
2491184|NCT02046564|8612686|P2|Overall Study|Withdrawal by Subject|10
2491185|NCT02046564|8612687|P1|Overall Study|Withdrawal by Subject|4
2491186|NCT02046564|8612686|P2|Overall Study|Protocol Violation|1
2491187|NCT02046564|8612687|P1|Overall Study|Protocol Violation|3
2491188|NCT02046564|8612686|P2|Overall Study|Physician Decision|1
2491189|NCT02046564|8612687|P1|Overall Study|Physician Decision|0
2491190|NCT02046564|8612686|P2|Overall Study|Adverse Event|3
2491191|NCT02046564|8612687|P1|Overall Study|Adverse Event|6
2491192|NCT02046369|8612735|P2|Overall Study|non compliance|0
2491193|NCT02046369|8612736|P1|Overall Study|non compliance|1
2491194|NCT02046369|8612735|P2|Overall Study|never received study drug|1
2491195|NCT02046369|8612736|P1|Overall Study|never received study drug|0
2491196|NCT02046369|8612735|P2|Overall Study|Withdrawal by Subject|6
2491197|NCT02046369|8612736|P1|Overall Study|Withdrawal by Subject|3
2491198|NCT02046369|8612735|P2|Overall Study|Protocol Violation|2
2491199|NCT02046369|8612736|P1|Overall Study|Protocol Violation|1
2491200|NCT02046369|8612735|P2|Overall Study|Lost to Follow-up|3
2491201|NCT02046369|8612736|P1|Overall Study|Lost to Follow-up|3
2491202|NCT02046369|8612735|P2|Overall Study|Lack of Efficacy|3
2491203|NCT02046369|8612736|P1|Overall Study|Lack of Efficacy|3
2491204|NCT02046369|8612735|P2|Overall Study|Adverse Event|3
2491205|NCT02046369|8612736|P1|Overall Study|Adverse Event|3
2491206|NCT02046226|8612780|P1|Overall Study|Lost to Follow-up|7
2491207|NCT02046148|8612828|P2|Overall Study|Withdrawal by Subject|2
2491208|NCT02046148|8612829|P1|Overall Study|Withdrawal by Subject|0
2491209|NCT02046148|8612828|P2|Overall Study|Lost to Follow-up|1
2491210|NCT02046148|8612829|P1|Overall Study|Lost to Follow-up|1
2491211|NCT02046122|8612889|P1|Overall Study|Withdrawal by Subject|1
2491212|NCT02046122|8612889|P1|Overall Study|Physician Decision|8
2491213|NCT02046070|8612899|P3|Overall Study|Reason not Specified|6
2491214|NCT02046070|8612900|P2|Overall Study|Reason not Specified|4
2491215|NCT02046070|8612901|P1|Overall Study|Reason not Specified|4
2491216|NCT02046070|8612899|P3|Overall Study|Study Terminated by Sponsor|1
2491217|NCT02046070|8612900|P2|Overall Study|Study Terminated by Sponsor|1
2491218|NCT02046070|8612901|P1|Overall Study|Study Terminated by Sponsor|1
2491219|NCT02046070|8612899|P3|Overall Study|Withdrawal by Subject|6
2491220|NCT02046070|8612900|P2|Overall Study|Withdrawal by Subject|2
2491221|NCT02046070|8612901|P1|Overall Study|Withdrawal by Subject|1
2491222|NCT02046070|8612899|P3|Overall Study|Adverse Event|17
2491223|NCT02046070|8612900|P2|Overall Study|Adverse Event|10
2491224|NCT02046070|8612901|P1|Overall Study|Adverse Event|8
2491225|NCT02046070|8612899|P3|Overall Study|Progressive Disease|40
2491226|NCT02046070|8612900|P2|Overall Study|Progressive Disease|11
2491227|NCT02046070|8612901|P1|Overall Study|Progressive Disease|18
2491228|NCT02045979|8612961|P3|Overall Study|not specified above|0
2491229|NCT02045979|8612962|P2|Overall Study|not specified above|1
2491230|NCT02045979|8612963|P1|Overall Study|not specified above|0
2491231|NCT02045979|8612961|P3|Overall Study|Informed Consent Withdrawn|1
2491232|NCT02045979|8612962|P2|Overall Study|Informed Consent Withdrawn|0
2491233|NCT02045979|8612963|P1|Overall Study|Informed Consent Withdrawn|2
2491234|NCT02045875|8613000|P2|Overall Study|Withdrawal by Subject|3
2491235|NCT02045875|8613001|P1|Overall Study|Withdrawal by Subject|4
2491236|NCT02045875|8613000|P2|Overall Study|Lost to Follow-up|0
2491237|NCT02045875|8613001|P1|Overall Study|Lost to Follow-up|3
2491238|NCT02045862|8613012|P3|Overall Study|Lost to Follow-up|6
2491239|NCT02045862|8613013|P2|Overall Study|Lost to Follow-up|2
2491240|NCT02045862|8613014|P1|Overall Study|Lost to Follow-up|1
2491241|NCT02045862|8613012|P3|Overall Study|Adverse Event|27
2491242|NCT02045862|8613013|P2|Overall Study|Adverse Event|5
2491243|NCT02045862|8613014|P1|Overall Study|Adverse Event|7
2491244|NCT02045862|8613012|P3|Overall Study|Randomized but not Received Study Drug|8
2491245|NCT02045862|8613013|P2|Overall Study|Randomized but not Received Study Drug|2
2491246|NCT02045862|8613014|P1|Overall Study|Randomized but not Received Study Drug|0
2491247|NCT02045862|8613012|P3|Overall Study|Lack of Efficacy|13
2491248|NCT02045862|8613013|P2|Overall Study|Lack of Efficacy|4
2491249|NCT02045862|8613014|P1|Overall Study|Lack of Efficacy|8
2491250|NCT02045862|8613012|P3|Overall Study|Protocol Violation|6
2491251|NCT02045862|8613013|P2|Overall Study|Protocol Violation|0
2491252|NCT02045862|8613014|P1|Overall Study|Protocol Violation|0
2491253|NCT02045862|8613012|P3|Overall Study|Withdrawal by Patient|57
2491254|NCT02045862|8613013|P2|Overall Study|Withdrawal by Patient|27
2491255|NCT02045862|8613014|P1|Overall Study|Withdrawal by Patient|18
2491256|NCT02045862|8613012|P3|Overall Study|Miscellaneous|8
2491257|NCT02045862|8613013|P2|Overall Study|Miscellaneous|0
2491258|NCT02045862|8613014|P1|Overall Study|Miscellaneous|5
2491259|NCT02045862|8613012|P3|Overall Study|Death|1
2491260|NCT02045862|8613013|P2|Overall Study|Death|0
2491261|NCT02045862|8613014|P1|Overall Study|Death|0
2491262|NCT02045836|8613195|P2|Overall Study|Migrated from study area|2
2491263|NCT02045836|8613196|P1|Overall Study|Migrated from study area|0
2491264|NCT02045836|8613195|P2|Overall Study|Lost to Follow-up|7
2491265|NCT02045836|8613196|P1|Overall Study|Lost to Follow-up|4
2491266|NCT02045836|8613195|P2|Overall Study|Withdrawal by Subject|1
2491267|NCT02045836|8613196|P1|Overall Study|Withdrawal by Subject|1
2491268|NCT02045836|8613195|P2|Overall Study|Adverse Event|4
2491269|NCT02045836|8613196|P1|Overall Study|Adverse Event|4
2491270|NCT02045797|8613228|P3|Overall Study|Withdrawal by Subject|0
2491271|NCT02045797|8613229|P2|Overall Study|Withdrawal by Subject|2
2491272|NCT02045797|8613230|P1|Overall Study|Withdrawal by Subject|1
2491273|NCT02045797|8613228|P3|Overall Study|Physician Decision|0
2491274|NCT02045797|8613229|P2|Overall Study|Physician Decision|1
2491275|NCT02045797|8613230|P1|Overall Study|Physician Decision|0
2491276|NCT02045797|8613228|P3|Overall Study|Lost to Follow-up|1
2491277|NCT02045797|8613229|P2|Overall Study|Lost to Follow-up|3
2491278|NCT02045797|8613230|P1|Overall Study|Lost to Follow-up|2
2491279|NCT02045797|8613228|P3|Overall Study|Lack of Efficacy|0
2491280|NCT02045797|8613229|P2|Overall Study|Lack of Efficacy|0
2491281|NCT02045797|8613230|P1|Overall Study|Lack of Efficacy|1
2491282|NCT02045797|8613228|P3|Overall Study|Adverse Event|0
2491283|NCT02045797|8613229|P2|Overall Study|Adverse Event|1
2491284|NCT02045797|8613230|P1|Overall Study|Adverse Event|3
2491285|NCT02045732|8613375|P2|Overall Study|At the discretion of the investigator|1
2491286|NCT02045732|8613376|P1|Overall Study|At the discretion of the investigator|1
2491287|NCT02045433|8613413|P1|Overall Study|Withdrawal by Subject|1
2491288|NCT02045212|8613445|P2|Overall Study|Finished 13 weeks, chose not to extend|0
2491289|NCT02045212|8613446|P1|Overall Study|Finished 13 weeks, chose not to extend|1
2491290|NCT02045212|8613445|P2|Overall Study|Withdrawal by Subject|0
2491291|NCT02045212|8613446|P1|Overall Study|Withdrawal by Subject|1
2491292|NCT02045212|8613445|P2|Overall Study|Adverse Event|1
2491293|NCT02045212|8613446|P1|Overall Study|Adverse Event|0
2491294|NCT02045095|8613511|P7|Overall Study|Adverse Event|0
2491295|NCT02045095|8613512|P6|Overall Study|Adverse Event|2
2491296|NCT02045095|8613513|P5|Overall Study|Adverse Event|0
2491297|NCT02045095|8613514|P4|Overall Study|Adverse Event|0
2491298|NCT02045095|8613515|P3|Overall Study|Adverse Event|1
2491299|NCT02045095|8613516|P2|Overall Study|Adverse Event|1
2491300|NCT02045095|8613517|P1|Overall Study|Adverse Event|0
2491301|NCT02045095|8613511|P7|Overall Study|Withdrawal by Subject|0
2491302|NCT02045095|8613512|P6|Overall Study|Withdrawal by Subject|0
2491303|NCT02045095|8613513|P5|Overall Study|Withdrawal by Subject|3
2491304|NCT02045095|8613514|P4|Overall Study|Withdrawal by Subject|0
2491305|NCT02045095|8613515|P3|Overall Study|Withdrawal by Subject|0
2491306|NCT02045095|8613516|P2|Overall Study|Withdrawal by Subject|0
2491307|NCT02045095|8613517|P1|Overall Study|Withdrawal by Subject|0
2491308|NCT02045095|8613511|P7|Overall Study|Progressive Disease|1
2491309|NCT02045095|8613512|P6|Overall Study|Progressive Disease|4
2491310|NCT02045095|8613513|P5|Overall Study|Progressive Disease|2
2491311|NCT02045095|8613514|P4|Overall Study|Progressive Disease|4
2491312|NCT02045095|8613515|P3|Overall Study|Progressive Disease|2
2491313|NCT02045095|8613516|P2|Overall Study|Progressive Disease|3
2491314|NCT02045095|8613517|P1|Overall Study|Progressive Disease|3
2491315|NCT02045095|8613511|P7|Overall Study|Other|0
2491316|NCT02045095|8613512|P6|Overall Study|Other|2
2491317|NCT02045095|8613513|P5|Overall Study|Other|0
2491318|NCT02045095|8613514|P4|Overall Study|Other|0
2491319|NCT02045095|8613515|P3|Overall Study|Other|1
2491320|NCT02045095|8613516|P2|Overall Study|Other|0
2491321|NCT02045095|8613517|P1|Overall Study|Other|0
2491322|NCT02044874|8613675|P3|Overall Study|Other|8
2491323|NCT02044874|8613676|P2|Overall Study|Other|3
2491324|NCT02044874|8613677|P1|Overall Study|Other|7
2491325|NCT02044874|8613675|P3|Overall Study|Sponsor Decision|1
2491326|NCT02044874|8613676|P2|Overall Study|Sponsor Decision|1
2491327|NCT02044874|8613677|P1|Overall Study|Sponsor Decision|0
2491328|NCT02044874|8613675|P3|Overall Study|Lost to Follow-up|21
2491329|NCT02044874|8613676|P2|Overall Study|Lost to Follow-up|27
2491330|NCT02044874|8613677|P1|Overall Study|Lost to Follow-up|10
2491331|NCT02044874|8613675|P3|Overall Study|Physician Decision|1
2491332|NCT02044874|8613676|P2|Overall Study|Physician Decision|2
2491333|NCT02044874|8613677|P1|Overall Study|Physician Decision|0
2491334|NCT02044874|8613675|P3|Overall Study|Withdrawal by Subject|23
2491335|NCT02044874|8613676|P2|Overall Study|Withdrawal by Subject|16
2491336|NCT02044874|8613677|P1|Overall Study|Withdrawal by Subject|8
2491337|NCT02044874|8613675|P3|Overall Study|Adverse Event|6
2491338|NCT02044874|8613676|P2|Overall Study|Adverse Event|6
2491339|NCT02044874|8613677|P1|Overall Study|Adverse Event|5
2491340|NCT02044848|8613699|P2|Overall Study|Administrative Problems|3
2491341|NCT02044848|8613700|P1|Overall Study|Administrative Problems|2
2491342|NCT02044822|8613706|P1|Overall Study|Lost to Follow-up|1
2491343|NCT02044822|8613706|P1|Overall Study|Initiation of Anti-Neoplastic Therapy|2
2491344|NCT02044822|8613706|P1|Overall Study|Withdrew Consent|3
2491345|NCT02044822|8613706|P1|Overall Study|Investigator's Discretion|10
2491346|NCT02044822|8613706|P1|Overall Study|Study Terminated by Sponsor|77
2491347|NCT02044510|8613748|P2|Overall Study|Adverse Event|2
2491348|NCT02044510|8613749|P1|Overall Study|Adverse Event|1
2491349|NCT02044458|8613757|P2|Overall Study|Protocol Violation|8
2491350|NCT02044458|8613758|P1|Overall Study|Protocol Violation|3
2491351|NCT02044302|8613844|P2|Overall Study|study terminated|0
2491352|NCT02044302|8613845|P1|Overall Study|study terminated|2
2491353|NCT02044159|8613853|P2|Overall Study|Nurse declined to give study drug|0
2491354|NCT02044159|8613854|P1|Overall Study|Nurse declined to give study drug|1
2491355|NCT02044159|8613853|P2|Overall Study|No longer eligible, drug not given|0
2491356|NCT02044159|8613854|P1|Overall Study|No longer eligible, drug not given|1
2491357|NCT02044159|8613853|P2|Overall Study|Consent declined (deferred consent)|4
2491358|NCT02044159|8613854|P1|Overall Study|Consent declined (deferred consent)|2
2491359|NCT02044094|8613867|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1
2491360|NCT02044094|8613867|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1
2491361|NCT02044094|8613867|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2
2491362|NCT02044094|8613867|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5
2491363|NCT02044094|8613867|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4
2491364|NCT02044094|8613867|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3
2491365|NCT02044094|8613867|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3
2491366|NCT02044094|8613867|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3
2491367|NCT02043938|8613924|P1|Overall Study|Investigator decision|1
2491368|NCT02043938|8613924|P1|Overall Study|No show by subject|1
2491369|NCT02043938|8613924|P1|Overall Study|Unable to place EEG sensors on patient|1
2491370|NCT02043938|8613924|P1|Overall Study|Withdrawal by Subject|7
2491371|NCT02043782|8613979|P6|Period 1|Adverse Event|0
2491372|NCT02043782|8613980|P5|Period 1|Adverse Event|0
2491373|NCT02043782|8613981|P4|Period 1|Adverse Event|0
2491374|NCT02043782|8613982|P3|Period 1|Adverse Event|1
2491375|NCT02043782|8613983|P2|Period 1|Adverse Event|0
2491376|NCT02043782|8613984|P1|Period 1|Adverse Event|0
2491377|NCT02043678|8614027|P2|Overall Study|Ongoing with treatment|104
2491378|NCT02043678|8614028|P1|Overall Study|Ongoing with treatment|87
2491379|NCT02043678|8614027|P2|Overall Study|Withdrawal by Subject|13
2491380|NCT02043678|8614028|P1|Overall Study|Withdrawal by Subject|10
2491381|NCT02043678|8614027|P2|Overall Study|Protocol-driven decision point|45
2491382|NCT02043678|8614028|P1|Overall Study|Protocol-driven decision point|53
2491383|NCT02043678|8614027|P2|Overall Study|Radiological PD|67
2491384|NCT02043678|8614028|P1|Overall Study|Radiological PD|78
2491385|NCT02043678|8614027|P2|Overall Study|Clinical PD|112
2491386|NCT02043678|8614028|P1|Overall Study|Clinical PD|88
2491387|NCT02043678|8614027|P2|Overall Study|Other|8
2491388|NCT02043678|8614028|P1|Overall Study|Other|15
2491389|NCT02043678|8614027|P2|Overall Study|Lost to Follow-up|1
2491390|NCT02043678|8614028|P1|Overall Study|Lost to Follow-up|1
2491391|NCT02043678|8614027|P2|Overall Study|AE without clinical PD|31
2491392|NCT02043678|8614028|P1|Overall Study|AE without clinical PD|41
2491393|NCT02043678|8614027|P2|Overall Study|AE with clinical progressive disease(PD)|15
2491394|NCT02043678|8614028|P1|Overall Study|AE with clinical progressive disease(PD)|17
2491395|NCT02043678|8614027|P2|Overall Study|Never treated|9
2491396|NCT02043678|8614028|P1|Overall Study|Never treated|11
2491397|NCT02043509|8614064|P2|Baseline to 2nd Follow-up|Withdrawal by Subject|5
2491398|NCT02043509|8614065|P1|Baseline to 2nd Follow-up|Withdrawal by Subject|7
2491399|NCT02043509|8614064|P2|Baseline to 2nd Follow-up|Lost to Follow-up|67
2491400|NCT02043509|8614065|P1|Baseline to 2nd Follow-up|Lost to Follow-up|67
2491401|NCT02043509|8614064|P2|Baseline to 1st Follow-up|Withdrawal by Subject|0
2491402|NCT02043509|8614065|P1|Baseline to 1st Follow-up|Withdrawal by Subject|4
2491403|NCT02043509|8614064|P2|Baseline to 1st Follow-up|Lost to Follow-up|47
2491404|NCT02043509|8614065|P1|Baseline to 1st Follow-up|Lost to Follow-up|61
2491405|NCT02043366|8614153|P6|Overall Study|Lost to Follow-up|2
2491406|NCT02043366|8614154|P5|Overall Study|Lost to Follow-up|2
2491407|NCT02043366|8614155|P4|Overall Study|Lost to Follow-up|2
2491408|NCT02043366|8614156|P3|Overall Study|Lost to Follow-up|2
2491409|NCT02043366|8614157|P2|Overall Study|Lost to Follow-up|2
2491410|NCT02043366|8614158|P1|Overall Study|Lost to Follow-up|2
2491411|NCT02043301|8614181|P3|Overall Study|Discontinued|0
2491412|NCT02043301|8614182|P2|Overall Study|Discontinued|1
2491413|NCT02043301|8614183|P1|Overall Study|Discontinued|0
2491414|NCT02043132|8614280|P2|Overall Study|screen failures|8
2491415|NCT02043132|8614281|P1|Overall Study|screen failures|4
2491416|NCT02043132|8614280|P2|Overall Study|Lost to Follow-up|1
2491417|NCT02043132|8614281|P1|Overall Study|Lost to Follow-up|1
2491418|NCT02043015|8614301|P1|Overall Study|Incarceration|1
2491419|NCT02043015|8614301|P1|Overall Study|Participant moved away from study city|4
2491420|NCT02043015|8614301|P1|Overall Study|Removed once target enrollment reached|15
2491421|NCT02043015|8614301|P1|Overall Study|Withdrawal by Subject|4
2491422|NCT02043015|8614301|P1|Overall Study|Lost to Follow-up|4
2491423|NCT02042950|8614314|P1|Overall Study|Progressive Disease|4
2491424|NCT02042924|8614320|P1|Overall Study|Early Death|1
2491425|NCT02042443|8614368|P2|Overall Study|Not eligible/not analyzable|6
2491426|NCT02042443|8614369|P1|Overall Study|Not eligible/not analyzable|3
2491427|NCT02042443|8614368|P2|Overall Study|not protocol specified|1
2491428|NCT02042443|8614369|P1|Overall Study|not protocol specified|1
2491429|NCT02042443|8614368|P2|Overall Study|Progression|17
2491430|NCT02042443|8614369|P1|Overall Study|Progression|21
2491431|NCT02042443|8614368|P2|Overall Study|Withdrawal by Subject|1
2491432|NCT02042443|8614369|P1|Overall Study|Withdrawal by Subject|0
2491433|NCT02042443|8614368|P2|Overall Study|Adverse Event|1
2491434|NCT02042443|8614369|P1|Overall Study|Adverse Event|2
2491435|NCT02042404|8614381|P2|Overall Study|Inability to meet time requirements|0
2491436|NCT02042404|8614382|P1|Overall Study|Inability to meet time requirements|1
2491437|NCT02042404|8614381|P2|Overall Study|Unrelated Adverse Event|0
2491438|NCT02042404|8614382|P1|Overall Study|Unrelated Adverse Event|3
2491439|NCT02042404|8614381|P2|Overall Study|Death|0
2491440|NCT02042404|8614382|P1|Overall Study|Death|1
2491441|NCT02042014|8614420|P1|Overall Study|Physician Decision|7
2491442|NCT02042014|8614420|P1|Overall Study|Adverse Event|1
2491443|NCT02041962|8614426|P2|Overall Study|Withdrawal by Subject|11
2491444|NCT02041962|8614427|P1|Overall Study|Withdrawal by Subject|0
2491445|NCT02041962|8614426|P2|Overall Study|Lost to Follow-up|32
2491446|NCT02041962|8614427|P1|Overall Study|Lost to Follow-up|37
2491447|NCT02041962|8614426|P2|Overall Study|Death|1
2491448|NCT02041962|8614427|P1|Overall Study|Death|1
2491449|NCT02041962|8614426|P2|Overall Study|Lost Aetna Coverage|40
2491450|NCT02041962|8614427|P1|Overall Study|Lost Aetna Coverage|43
2491451|NCT02041702|8614437|P2|Overall Study|Cardiac Resynchronization Therapy|0
2491452|NCT02041702|8614438|P1|Overall Study|Cardiac Resynchronization Therapy|1
2491453|NCT02041702|8614437|P2|Overall Study|Patient not confirmed as MRI compatible|0
2491454|NCT02041702|8614438|P1|Overall Study|Patient not confirmed as MRI compatible|1
2491455|NCT02041702|8614437|P2|Overall Study|Withdrawal by Subject|3
2491456|NCT02041702|8614438|P1|Overall Study|Withdrawal by Subject|4
2491457|NCT02041702|8614437|P2|Overall Study|Death|0
2491458|NCT02041702|8614438|P1|Overall Study|Death|4
2491459|NCT02041702|8614437|P2|Overall Study|Lost to Follow-up|6
2491460|NCT02041702|8614438|P1|Overall Study|Lost to Follow-up|1
2491461|NCT02041533|8614453|P2|Overall Study|Randomized, not treated|7
2491462|NCT02041533|8614454|P1|Overall Study|Randomized, not treated|4
2491463|NCT02041533|8614453|P2|Overall Study|Completed max number of chemo cycles|29
2491464|NCT02041533|8614454|P1|Overall Study|Completed max number of chemo cycles|0
2491465|NCT02041533|8614453|P2|Overall Study|Other reasons|1
2491466|NCT02041533|8614454|P1|Overall Study|Other reasons|0
2491467|NCT02041533|8614453|P2|Overall Study|Poor/non-compliance|0
2491468|NCT02041533|8614454|P1|Overall Study|Poor/non-compliance|1
2491469|NCT02041533|8614453|P2|Overall Study|Maximum clinical benefit|18
2491470|NCT02041533|8614454|P1|Overall Study|Maximum clinical benefit|0
2491471|NCT02041533|8614453|P2|Overall Study|Withdrawal by Subject|1
2491472|NCT02041533|8614454|P1|Overall Study|Withdrawal by Subject|2
2491473|NCT02041533|8614453|P2|Overall Study|Subject request to discontinue treatment|9
2491474|NCT02041533|8614454|P1|Overall Study|Subject request to discontinue treatment|5
2491475|NCT02041533|8614453|P2|Overall Study|Adverse Event unrelated to study drug|21
2491476|NCT02041533|8614454|P1|Overall Study|Adverse Event unrelated to study drug|20
2491477|NCT02041533|8614453|P2|Overall Study|Death|0
2491478|NCT02041533|8614454|P1|Overall Study|Death|1
2491479|NCT02041533|8614453|P2|Overall Study|Study drug toxicity|30
2491480|NCT02041533|8614454|P1|Overall Study|Study drug toxicity|27
2491481|NCT02041533|8614453|P2|Overall Study|Disease Progression|142
2491482|NCT02041533|8614454|P1|Overall Study|Disease Progression|168
2491483|NCT02041520|8614476|P2|Overall Study|Hypothiroidism identified during follow-|1
2491484|NCT02041520|8614477|P1|Overall Study|Hypothiroidism identified during follow-|0
2491485|NCT02041520|8614476|P2|Overall Study|Lost to Follow-up|1
2491486|NCT02041520|8614477|P1|Overall Study|Lost to Follow-up|0
2491487|NCT02041520|8614476|P2|Overall Study|Protocol Violation|0
2491488|NCT02041520|8614477|P1|Overall Study|Protocol Violation|1
2491489|NCT02041520|8614476|P2|Overall Study|Withdrawal by Subject|4
2491490|NCT02041520|8614477|P1|Overall Study|Withdrawal by Subject|3
2491491|NCT02041520|8614476|P2|Overall Study|Adverse Event|1
2491492|NCT02041520|8614477|P1|Overall Study|Adverse Event|2
2491493|NCT02041286|8614520|P1|Overall Study|Adverse Event|1
2491494|NCT02041104|8614555|P2|Overall Study|discomfort during OGTT|3
2491495|NCT02041104|8614556|P1|Overall Study|discomfort during OGTT|0
2491496|NCT02041104|8614555|P2|Overall Study|Lost to Follow-up|4
2491497|NCT02041104|8614556|P1|Overall Study|Lost to Follow-up|1
2491498|NCT02041091|8614596|P2|Optional Safety Extension Period|Lost to Follow-up|3
2491499|NCT02041091|8614597|P1|Optional Safety Extension Period|Lost to Follow-up|2
2491500|NCT02041091|8614596|P2|Optional Safety Extension Period|Sponsor Decision|74
2491501|NCT02041091|8614597|P1|Optional Safety Extension Period|Sponsor Decision|70
2491502|NCT02041091|8614596|P2|Optional Safety Extension Period|Physician Decision|1
2491503|NCT02041091|8614597|P1|Optional Safety Extension Period|Physician Decision|2
2491504|NCT02041091|8614596|P2|Optional Safety Extension Period|Protocol Violation|0
2491505|NCT02041091|8614597|P1|Optional Safety Extension Period|Protocol Violation|2
2491506|NCT02041091|8614596|P2|Optional Safety Extension Period|Withdrawal by Subject|2
2491507|NCT02041091|8614597|P1|Optional Safety Extension Period|Withdrawal by Subject|5
2491508|NCT02041091|8614596|P2|Optional Safety Extension Period|Adverse Event|2
2491509|NCT02041091|8614597|P1|Optional Safety Extension Period|Adverse Event|4
2491510|NCT02041091|8614596|P2|Treatment|Lost to Follow-up|0
2491511|NCT02041091|8614597|P1|Treatment|Lost to Follow-up|1
2491512|NCT02041091|8614596|P2|Treatment|Sponsor Decision|16
2491513|NCT02041091|8614597|P1|Treatment|Sponsor Decision|15
2491514|NCT02041091|8614596|P2|Treatment|Physician Decision|0
2491515|NCT02041091|8614597|P1|Treatment|Physician Decision|1
2491516|NCT02041091|8614596|P2|Treatment|Withdrawal by Subject|4
2491517|NCT02041091|8614597|P1|Treatment|Withdrawal by Subject|2
2491518|NCT02041091|8614596|P2|Treatment|Adverse Event|3
2491519|NCT02041091|8614597|P1|Treatment|Adverse Event|3
2491520|NCT02040870|8614619|P1|Overall Study|Death|13
2491521|NCT02040870|8614619|P1|Overall Study|Lost to Follow-up|3
2491522|NCT02040870|8614619|P1|Overall Study|Subject/guardian decision|10
2491523|NCT02040870|8614619|P1|Overall Study|Physician Decision|6
2491524|NCT02040870|8614619|P1|Overall Study|Progressive disease|58
2491525|NCT02040870|8614619|P1|Overall Study|Adverse Event|7
2491526|NCT02040870|8614619|P1|Overall Study|Completed treatment phase|6
2491527|NCT02040844|8614643|P3|Overall Study|Concomitant medication|1
2491528|NCT02040844|8614644|P2|Overall Study|Concomitant medication|3
2491529|NCT02040844|8614645|P1|Overall Study|Concomitant medication|1
2491530|NCT02040844|8614643|P3|Overall Study|Non-specified|5
2491531|NCT02040844|8614644|P2|Overall Study|Non-specified|2
2491532|NCT02040844|8614645|P1|Overall Study|Non-specified|8
2491533|NCT02040844|8614643|P3|Overall Study|Missing|2
2491534|NCT02040844|8614644|P2|Overall Study|Missing|3
2491535|NCT02040844|8614645|P1|Overall Study|Missing|13
2491536|NCT02040844|8614643|P3|Overall Study|Lost to Follow-up|13
2491537|NCT02040844|8614644|P2|Overall Study|Lost to Follow-up|9
2491538|NCT02040844|8614645|P1|Overall Study|Lost to Follow-up|12
2491539|NCT02040844|8614643|P3|Overall Study|Withdrawal by Subject|25
2491540|NCT02040844|8614644|P2|Overall Study|Withdrawal by Subject|22
2491541|NCT02040844|8614645|P1|Overall Study|Withdrawal by Subject|16
2491542|NCT02040844|8614643|P3|Overall Study|Adverse Event|1
2491543|NCT02040844|8614644|P2|Overall Study|Adverse Event|0
2491544|NCT02040844|8614645|P1|Overall Study|Adverse Event|0
2491545|NCT02040805|8614670|P2|Overall Study|Withdrawal by Subject|41
2491546|NCT02040805|8614671|P1|Overall Study|Withdrawal by Subject|28
2491547|NCT02040805|8614670|P2|Overall Study|Lost to Follow-up|9
2491548|NCT02040805|8614671|P1|Overall Study|Lost to Follow-up|14
2491549|NCT02040779|8614707|P3|Overall Study|Lack of Efficacy|0
2491550|NCT02040779|8614708|P2|Overall Study|Lack of Efficacy|2
2491551|NCT02040779|8614709|P1|Overall Study|Lack of Efficacy|4
2491552|NCT02040779|8614707|P3|Overall Study|Lost to Follow-up|1
2491553|NCT02040779|8614708|P2|Overall Study|Lost to Follow-up|2
2491554|NCT02040779|8614709|P1|Overall Study|Lost to Follow-up|1
2491555|NCT02040779|8614707|P3|Overall Study|Protocol Violation|0
2491556|NCT02040779|8614708|P2|Overall Study|Protocol Violation|1
2491557|NCT02040779|8614709|P1|Overall Study|Protocol Violation|2
2491558|NCT02040779|8614707|P3|Overall Study|Non-compliance|0
2491559|NCT02040779|8614708|P2|Overall Study|Non-compliance|1
2491560|NCT02040779|8614709|P1|Overall Study|Non-compliance|0
2491561|NCT02040779|8614707|P3|Overall Study|Withdrawal by Subject|3
2491562|NCT02040779|8614708|P2|Overall Study|Withdrawal by Subject|1
2491563|NCT02040779|8614709|P1|Overall Study|Withdrawal by Subject|4
2491564|NCT02040779|8614707|P3|Overall Study|Adverse Event|0
2491565|NCT02040779|8614708|P2|Overall Study|Adverse Event|0
2491566|NCT02040779|8614709|P1|Overall Study|Adverse Event|1
2491567|NCT02040766|8614749|P5|Overall Study|Lack of Efficacy|5
2491568|NCT02040766|8614750|P4|Overall Study|Lack of Efficacy|6
2491569|NCT02040766|8614751|P3|Overall Study|Lack of Efficacy|4
2491570|NCT02040766|8614752|P2|Overall Study|Lack of Efficacy|3
2491571|NCT02040766|8614753|P1|Overall Study|Lack of Efficacy|6
2491572|NCT02040766|8614749|P5|Overall Study|Not reported|0
2491573|NCT02040766|8614750|P4|Overall Study|Not reported|0
2491574|NCT02040766|8614751|P3|Overall Study|Not reported|0
2491575|NCT02040766|8614752|P2|Overall Study|Not reported|0
2491576|NCT02040766|8614753|P1|Overall Study|Not reported|1
2491577|NCT02040766|8614749|P5|Overall Study|Lost to Follow-up|4
2491578|NCT02040766|8614750|P4|Overall Study|Lost to Follow-up|1
2491579|NCT02040766|8614751|P3|Overall Study|Lost to Follow-up|3
2491580|NCT02040766|8614752|P2|Overall Study|Lost to Follow-up|1
2491581|NCT02040766|8614753|P1|Overall Study|Lost to Follow-up|4
2491582|NCT02040766|8614749|P5|Overall Study|Protocol Violation|0
2491583|NCT02040766|8614750|P4|Overall Study|Protocol Violation|3
2491584|NCT02040766|8614751|P3|Overall Study|Protocol Violation|2
2491585|NCT02040766|8614752|P2|Overall Study|Protocol Violation|1
2491586|NCT02040766|8614753|P1|Overall Study|Protocol Violation|2
2491587|NCT02040766|8614749|P5|Overall Study|Non-compliance|0
2491588|NCT02040766|8614750|P4|Overall Study|Non-compliance|0
2491589|NCT02040766|8614751|P3|Overall Study|Non-compliance|0
2491590|NCT02040766|8614752|P2|Overall Study|Non-compliance|1
2491591|NCT02040766|8614753|P1|Overall Study|Non-compliance|0
2491592|NCT02040766|8614749|P5|Overall Study|Withdrawal by Subject|2
2491593|NCT02040766|8614750|P4|Overall Study|Withdrawal by Subject|3
2491594|NCT02040766|8614751|P3|Overall Study|Withdrawal by Subject|2
2491595|NCT02040766|8614752|P2|Overall Study|Withdrawal by Subject|3
2491596|NCT02040766|8614753|P1|Overall Study|Withdrawal by Subject|4
2491597|NCT02040766|8614749|P5|Overall Study|Adverse Event|2
2491598|NCT02040766|8614750|P4|Overall Study|Adverse Event|0
2491599|NCT02040766|8614751|P3|Overall Study|Adverse Event|1
2491600|NCT02040766|8614752|P2|Overall Study|Adverse Event|1
2491601|NCT02040766|8614753|P1|Overall Study|Adverse Event|1
2491602|NCT02040584|8614806|P2|Overall Study|Immunosuppressant/prohibited med use|10
2491603|NCT02040584|8614807|P1|Overall Study|Immunosuppressant/prohibited med use|7
2491604|NCT02040584|8614806|P2|Overall Study|Transplant rejection/retransplant|1
2491605|NCT02040584|8614807|P1|Overall Study|Transplant rejection/retransplant|0
2491606|NCT02040584|8614806|P2|Overall Study|Death|3
2491607|NCT02040584|8614807|P1|Overall Study|Death|6
2491608|NCT02040584|8614806|P2|Overall Study|Unsatisfactory therapeutic effect|1
2491609|NCT02040584|8614807|P1|Overall Study|Unsatisfactory therapeutic effect|0
2491610|NCT02040584|8614806|P2|Overall Study|Protocol Violation|11
2491611|NCT02040584|8614807|P1|Overall Study|Protocol Violation|9
2491612|NCT02040584|8614806|P2|Overall Study|Adverse Event|6
2491613|NCT02040584|8614807|P1|Overall Study|Adverse Event|13
2491614|NCT02040532|8614840|P1|Overall Study|Withdrawal by Subject|3
2491615|NCT02040532|8614840|P1|Overall Study|Adverse Event|4
2491616|NCT02040532|8614840|P1|Overall Study|Physician Decision|4
2491617|NCT02040532|8614840|P1|Overall Study|Lost to Follow-up|1
2491618|NCT02040428|8614853|P2|Overall Study|Withdrawal by Subject|1
2491619|NCT02040428|8614854|P1|Overall Study|Withdrawal by Subject|1
2491620|NCT02040428|8614853|P2|Overall Study|Death|3
2491621|NCT02040428|8614854|P1|Overall Study|Death|4
2491622|NCT02039908|8614932|P4|Phase 2-School Year|Withdrawal by Subject|5
2491623|NCT02039908|8614933|P3|Phase 2-School Year|Withdrawal by Subject|8
2491624|NCT02039908|8614934|P2|Phase 2-School Year|Withdrawal by Subject|0
2491625|NCT02039908|8614935|P1|Phase 2-School Year|Withdrawal by Subject|0
2491626|NCT02039908|8614932|P4|Phase 2-School Year|Protocol Violation|0
2491627|NCT02039908|8614933|P3|Phase 2-School Year|Protocol Violation|3
2491628|NCT02039908|8614934|P2|Phase 2-School Year|Protocol Violation|0
2491629|NCT02039908|8614935|P1|Phase 2-School Year|Protocol Violation|0
2491630|NCT02039908|8614932|P4|Phase 2-School Year|Lost to Follow-up|3
2491631|NCT02039908|8614933|P3|Phase 2-School Year|Lost to Follow-up|1
2491632|NCT02039908|8614934|P2|Phase 2-School Year|Lost to Follow-up|0
2491633|NCT02039908|8614935|P1|Phase 2-School Year|Lost to Follow-up|0
2491634|NCT02039908|8614932|P4|Phase 1-Summer|Protocol Violation|0
2491635|NCT02039908|8614933|P3|Phase 1-Summer|Protocol Violation|0
2491636|NCT02039908|8614934|P2|Phase 1-Summer|Protocol Violation|0
2491637|NCT02039908|8614935|P1|Phase 1-Summer|Protocol Violation|6
2491638|NCT02039908|8614932|P4|Phase 1-Summer|Withdrawal by Subject|0
2491639|NCT02039908|8614933|P3|Phase 1-Summer|Withdrawal by Subject|0
2491640|NCT02039908|8614934|P2|Phase 1-Summer|Withdrawal by Subject|6
2491641|NCT02039908|8614935|P1|Phase 1-Summer|Withdrawal by Subject|7
2491642|NCT02039856|8614949|P2|Overall Study|Withdrawal by Subject|618
2491643|NCT02039856|8614950|P1|Overall Study|Withdrawal by Subject|1573
2491644|NCT02039856|8614949|P2|Overall Study|Lost to Follow-up|206
2491645|NCT02039856|8614950|P1|Overall Study|Lost to Follow-up|388
2491646|NCT02039856|8614949|P2|Overall Study|Partial survey completion|26
2491647|NCT02039856|8614950|P1|Overall Study|Partial survey completion|61
2491648|NCT02039856|8614949|P2|Overall Study|Death|3
2491649|NCT02039856|8614950|P1|Overall Study|Death|5
2491650|NCT02039778|8614982|P1|Overall Study|Never started the protocol treatment|1
2491651|NCT02039778|8614982|P1|Overall Study|Withdrawal by Subject|1
2491652|NCT02039778|8614982|P1|Overall Study|Death|2
2491653|NCT02039687|8615005|P4|Overall Study|treatment assignment could not be confir|0
2491654|NCT02039687|8615006|P3|Overall Study|treatment assignment could not be confir|2
2491655|NCT02039687|8615007|P2|Overall Study|treatment assignment could not be confir|0
2491656|NCT02039687|8615008|P1|Overall Study|treatment assignment could not be confir|0
2491657|NCT02039687|8615005|P4|Overall Study|Withdrawal by Subject|0
2491658|NCT02039687|8615006|P3|Overall Study|Withdrawal by Subject|0
2491659|NCT02039687|8615007|P2|Overall Study|Withdrawal by Subject|1
2491660|NCT02039687|8615008|P1|Overall Study|Withdrawal by Subject|0
2491661|NCT02039687|8615005|P4|Overall Study|Adverse Event|0
2491662|NCT02039687|8615006|P3|Overall Study|Adverse Event|1
2491663|NCT02039687|8615007|P2|Overall Study|Adverse Event|0
2491664|NCT02039687|8615008|P1|Overall Study|Adverse Event|0
2491665|NCT02039674|8615048|P14|Overall Study|Ongoing in Study|3
2491666|NCT02039674|8615049|P13|Overall Study|Ongoing in Study|33
2491667|NCT02039674|8615050|P12|Overall Study|Ongoing in Study|34
2491668|NCT02039674|8615051|P11|Overall Study|Ongoing in Study|1
2491669|NCT02039674|8615052|P10|Overall Study|Ongoing in Study|6
2491670|NCT02039674|8615053|P9|Overall Study|Ongoing in Study|1
2491671|NCT02039674|8615054|P8|Overall Study|Ongoing in Study|0
2491672|NCT02039674|8615055|P7|Overall Study|Ongoing in Study|2
2491673|NCT02039674|8615056|P6|Overall Study|Ongoing in Study|1
2491674|NCT02039674|8615057|P5|Overall Study|Ongoing in Study|3
2491675|NCT02039674|8615058|P4|Overall Study|Ongoing in Study|2
2491676|NCT02039674|8615059|P3|Overall Study|Ongoing in Study|3
2491677|NCT02039674|8615060|P2|Overall Study|Ongoing in Study|2
2491678|NCT02039674|8615061|P1|Overall Study|Ongoing in Study|5
2491679|NCT02039674|8615048|P14|Overall Study|Withdrawal by Subject|2
2491680|NCT02039674|8615049|P13|Overall Study|Withdrawal by Subject|5
2491681|NCT02039674|8615050|P12|Overall Study|Withdrawal by Subject|3
2491682|NCT02039674|8615051|P11|Overall Study|Withdrawal by Subject|1
2491683|NCT02039674|8615052|P10|Overall Study|Withdrawal by Subject|2
2491684|NCT02039674|8615053|P9|Overall Study|Withdrawal by Subject|0
2491685|NCT02039674|8615054|P8|Overall Study|Withdrawal by Subject|0
2491686|NCT02039674|8615055|P7|Overall Study|Withdrawal by Subject|0
2491687|NCT02039674|8615056|P6|Overall Study|Withdrawal by Subject|0
2491688|NCT02039674|8615057|P5|Overall Study|Withdrawal by Subject|1
2491689|NCT02039674|8615058|P4|Overall Study|Withdrawal by Subject|0
2491690|NCT02039674|8615059|P3|Overall Study|Withdrawal by Subject|1
2491691|NCT02039674|8615060|P2|Overall Study|Withdrawal by Subject|2
2491692|NCT02039674|8615061|P1|Overall Study|Withdrawal by Subject|0
2491693|NCT02039674|8615048|P14|Overall Study|Progressive Disease|16
2491694|NCT02039674|8615049|P13|Overall Study|Progressive Disease|18
2491695|NCT02039674|8615050|P12|Overall Study|Progressive Disease|17
2491696|NCT02039674|8615051|P11|Overall Study|Progressive Disease|0
2491697|NCT02039674|8615052|P10|Overall Study|Progressive Disease|2
2491698|NCT02039674|8615053|P9|Overall Study|Progressive Disease|7
2491699|NCT02039674|8615054|P8|Overall Study|Progressive Disease|3
2491700|NCT02039674|8615055|P7|Overall Study|Progressive Disease|1
2491701|NCT02039674|8615056|P6|Overall Study|Progressive Disease|10
2491702|NCT02039674|8615057|P5|Overall Study|Progressive Disease|8
2491703|NCT02039674|8615058|P4|Overall Study|Progressive Disease|7
2491704|NCT02039674|8615059|P3|Overall Study|Progressive Disease|6
2491705|NCT02039674|8615060|P2|Overall Study|Progressive Disease|7
2491706|NCT02039674|8615061|P1|Overall Study|Progressive Disease|6
2491707|NCT02039674|8615048|P14|Overall Study|Physician Decision|0
2491708|NCT02039674|8615049|P13|Overall Study|Physician Decision|0
2491709|NCT02039674|8615050|P12|Overall Study|Physician Decision|1
2491710|NCT02039674|8615051|P11|Overall Study|Physician Decision|0
2491711|NCT02039674|8615052|P10|Overall Study|Physician Decision|0
2491712|NCT02039674|8615053|P9|Overall Study|Physician Decision|0
2491713|NCT02039674|8615054|P8|Overall Study|Physician Decision|0
2491714|NCT02039674|8615055|P7|Overall Study|Physician Decision|0
2491715|NCT02039674|8615056|P6|Overall Study|Physician Decision|0
2491716|NCT02039674|8615057|P5|Overall Study|Physician Decision|0
2491717|NCT02039674|8615058|P4|Overall Study|Physician Decision|0
2491718|NCT02039674|8615059|P3|Overall Study|Physician Decision|0
2491719|NCT02039674|8615060|P2|Overall Study|Physician Decision|0
2491720|NCT02039674|8615061|P1|Overall Study|Physician Decision|0
2491721|NCT02039674|8615048|P14|Overall Study|Lost to Follow-up|0
2491722|NCT02039674|8615049|P13|Overall Study|Lost to Follow-up|1
2491723|NCT02039674|8615050|P12|Overall Study|Lost to Follow-up|0
2491724|NCT02039674|8615051|P11|Overall Study|Lost to Follow-up|0
2491725|NCT02039674|8615052|P10|Overall Study|Lost to Follow-up|0
2491726|NCT02039674|8615053|P9|Overall Study|Lost to Follow-up|0
2491727|NCT02039674|8615054|P8|Overall Study|Lost to Follow-up|0
2491728|NCT02039674|8615055|P7|Overall Study|Lost to Follow-up|0
2491729|NCT02039674|8615056|P6|Overall Study|Lost to Follow-up|0
2491730|NCT02039674|8615057|P5|Overall Study|Lost to Follow-up|0
2491731|NCT02039674|8615058|P4|Overall Study|Lost to Follow-up|0
2491732|NCT02039674|8615059|P3|Overall Study|Lost to Follow-up|0
2491733|NCT02039674|8615060|P2|Overall Study|Lost to Follow-up|0
2491734|NCT02039674|8615061|P1|Overall Study|Lost to Follow-up|0
2491735|NCT02039674|8615048|P14|Overall Study|Excluded Medication|3
2491736|NCT02039674|8615049|P13|Overall Study|Excluded Medication|4
2491737|NCT02039674|8615050|P12|Overall Study|Excluded Medication|2
2491738|NCT02039674|8615051|P11|Overall Study|Excluded Medication|4
2491739|NCT02039674|8615052|P10|Overall Study|Excluded Medication|2
2491740|NCT02039674|8615053|P9|Overall Study|Excluded Medication|2
2491741|NCT02039674|8615054|P8|Overall Study|Excluded Medication|0
2491742|NCT02039674|8615055|P7|Overall Study|Excluded Medication|0
2491743|NCT02039674|8615056|P6|Overall Study|Excluded Medication|1
2491744|NCT02039674|8615057|P5|Overall Study|Excluded Medication|0
2491745|NCT02039674|8615058|P4|Overall Study|Excluded Medication|1
2491746|NCT02039674|8615059|P3|Overall Study|Excluded Medication|0
2491747|NCT02039674|8615060|P2|Overall Study|Excluded Medication|1
2491748|NCT02039674|8615061|P1|Overall Study|Excluded Medication|1
2491749|NCT02039674|8615048|P14|Overall Study|Death|8
2491750|NCT02039674|8615049|P13|Overall Study|Death|0
2491751|NCT02039674|8615050|P12|Overall Study|Death|1
2491752|NCT02039674|8615051|P11|Overall Study|Death|1
2491753|NCT02039674|8615052|P10|Overall Study|Death|0
2491754|NCT02039674|8615053|P9|Overall Study|Death|0
2491755|NCT02039674|8615054|P8|Overall Study|Death|0
2491756|NCT02039674|8615055|P7|Overall Study|Death|0
2491757|NCT02039674|8615056|P6|Overall Study|Death|0
2491758|NCT02039674|8615057|P5|Overall Study|Death|0
2491759|NCT02039674|8615058|P4|Overall Study|Death|2
2491760|NCT02039674|8615059|P3|Overall Study|Death|1
2491761|NCT02039674|8615060|P2|Overall Study|Death|0
2491762|NCT02039674|8615061|P1|Overall Study|Death|0
2491763|NCT02039674|8615048|P14|Overall Study|Adverse Event|1
2491764|NCT02039674|8615049|P13|Overall Study|Adverse Event|2
2491765|NCT02039674|8615050|P12|Overall Study|Adverse Event|2
2491766|NCT02039674|8615051|P11|Overall Study|Adverse Event|0
2491767|NCT02039674|8615052|P10|Overall Study|Adverse Event|0
2491768|NCT02039674|8615053|P9|Overall Study|Adverse Event|2
2491769|NCT02039674|8615054|P8|Overall Study|Adverse Event|0
2491770|NCT02039674|8615055|P7|Overall Study|Adverse Event|0
2491771|NCT02039674|8615056|P6|Overall Study|Adverse Event|0
2491772|NCT02039674|8615057|P5|Overall Study|Adverse Event|0
2491773|NCT02039674|8615058|P4|Overall Study|Adverse Event|1
2491774|NCT02039674|8615059|P3|Overall Study|Adverse Event|1
2491775|NCT02039674|8615060|P2|Overall Study|Adverse Event|0
2491776|NCT02039674|8615061|P1|Overall Study|Adverse Event|0
2491777|NCT02039505|8615103|P7|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1
2491778|NCT02039505|8615104|P6|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
2491779|NCT02039505|8615105|P5|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
2491780|NCT02039505|8615106|P4|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
2491781|NCT02039505|8615107|P3|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
2491782|NCT02039505|8615108|P2|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
2491783|NCT02039505|8615109|P1|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
2491784|NCT02039505|8615103|P7|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7
2491785|NCT02039505|8615104|P6|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
2491786|NCT02039505|8615105|P5|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
2491787|NCT02039505|8615106|P4|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
2491788|NCT02039505|8615107|P3|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
2491789|NCT02039505|8615108|P2|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
2491790|NCT02039505|8615109|P1|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
2491791|NCT02039505|8615103|P7|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19
2491792|NCT02039505|8615104|P6|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
2491793|NCT02039505|8615105|P5|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
2491794|NCT02039505|8615106|P4|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
2491795|NCT02039505|8615107|P3|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
2491796|NCT02039505|8615108|P2|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
2491797|NCT02039505|8615109|P1|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
2491798|NCT02039505|8615103|P7|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44
2491799|NCT02039505|8615104|P6|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
2491800|NCT02039505|8615105|P5|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
2491801|NCT02039505|8615106|P4|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
2491802|NCT02039505|8615107|P3|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
2491803|NCT02039505|8615108|P2|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
2491804|NCT02039505|8615109|P1|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
2491805|NCT02039505|8615103|P7|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
2491806|NCT02039505|8615104|P6|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
2491807|NCT02039505|8615105|P5|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
2491808|NCT02039505|8615106|P4|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2
2491809|NCT02039505|8615107|P3|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
2491810|NCT02039505|8615108|P2|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
2491811|NCT02039505|8615109|P1|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
2491812|NCT02039505|8615103|P7|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
2491813|NCT02039505|8615104|P6|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1
2491814|NCT02039505|8615105|P5|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2
2491815|NCT02039505|8615106|P4|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3
2491816|NCT02039505|8615107|P3|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
2491817|NCT02039505|8615108|P2|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
2491818|NCT02039505|8615109|P1|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
2491819|NCT02039505|8615103|P7|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
2491820|NCT02039505|8615104|P6|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1
2491821|NCT02039505|8615105|P5|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1
2491822|NCT02039505|8615106|P4|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6
2491823|NCT02039505|8615107|P3|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
2491824|NCT02039505|8615108|P2|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
2491825|NCT02039505|8615109|P1|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
2491826|NCT02039505|8615103|P7|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
2491827|NCT02039505|8615104|P6|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12
2491828|NCT02039505|8615105|P5|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8
2491829|NCT02039505|8615106|P4|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13
2491830|NCT02039505|8615107|P3|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
2491831|NCT02039505|8615108|P2|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
2491988|NCT02038907|8615427|P10|Overall Study|Withdrawal by Subject|0
2491832|NCT02039505|8615109|P1|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
2491833|NCT02039505|8615103|P7|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
2491834|NCT02039505|8615104|P6|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
2491835|NCT02039505|8615105|P5|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
2491836|NCT02039505|8615106|P4|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
2491837|NCT02039505|8615107|P3|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
2491838|NCT02039505|8615108|P2|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
2491839|NCT02039505|8615109|P1|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1
2491840|NCT02039505|8615103|P7|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
2491841|NCT02039505|8615104|P6|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
2491842|NCT02039505|8615105|P5|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
2491843|NCT02039505|8615106|P4|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
2491844|NCT02039505|8615107|P3|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3
2491845|NCT02039505|8615108|P2|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1
2491846|NCT02039505|8615109|P1|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1
2491847|NCT02039505|8615103|P7|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
2491848|NCT02039505|8615104|P6|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
2491849|NCT02039505|8615105|P5|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
2491850|NCT02039505|8615106|P4|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
2491851|NCT02039505|8615107|P3|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7
2491852|NCT02039505|8615108|P2|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8
2491853|NCT02039505|8615109|P1|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2
2491854|NCT02039427|8615185|P4|Overall Study|Steroid Use|0
2491855|NCT02039427|8615186|P3|Overall Study|Steroid Use|0
2491856|NCT02039427|8615187|P2|Overall Study|Steroid Use|0
2491857|NCT02039427|8615188|P1|Overall Study|Steroid Use|1
2491858|NCT02039427|8615185|P4|Overall Study|Loss of follow - up|4
2491859|NCT02039427|8615186|P3|Overall Study|Loss of follow - up|2
2491860|NCT02039427|8615187|P2|Overall Study|Loss of follow - up|0
2491861|NCT02039427|8615188|P1|Overall Study|Loss of follow - up|1
2491862|NCT02039427|8615185|P4|Overall Study|Cancellation of surgery|0
2491863|NCT02039427|8615186|P3|Overall Study|Cancellation of surgery|1
2491864|NCT02039427|8615187|P2|Overall Study|Cancellation of surgery|0
2491865|NCT02039427|8615188|P1|Overall Study|Cancellation of surgery|0
2491866|NCT02039427|8615185|P4|Overall Study|Withdrawal on concent|1
2491867|NCT02039427|8615186|P3|Overall Study|Withdrawal on concent|0
2491868|NCT02039427|8615187|P2|Overall Study|Withdrawal on concent|0
2491869|NCT02039427|8615188|P1|Overall Study|Withdrawal on concent|0
2491870|NCT02039427|8615185|P4|Overall Study|Duration of surgery > 3h|0
2491871|NCT02039427|8615186|P3|Overall Study|Duration of surgery > 3h|0
2491872|NCT02039427|8615187|P2|Overall Study|Duration of surgery > 3h|1
2491873|NCT02039427|8615188|P1|Overall Study|Duration of surgery > 3h|1
2491874|NCT02039414|8615208|P2|Overall Study|Protocol Violation|1
2491875|NCT02039414|8615209|P1|Overall Study|Protocol Violation|3
2491876|NCT02039414|8615208|P2|Overall Study|Lost to Follow-up|0
2491877|NCT02039414|8615209|P1|Overall Study|Lost to Follow-up|2
2491878|NCT02039414|8615208|P2|Overall Study|Delivered|1
2491879|NCT02039414|8615209|P1|Overall Study|Delivered|1
2491880|NCT02039375|8615221|P1|Overall Study|Lost to Follow-up|2
2491881|NCT02039219|8615232|P2|Follow up|Adverse Event|1
2491882|NCT02039219|8615233|P1|Follow up|Adverse Event|0
2491883|NCT02039219|8615232|P2|Treatment|Death|0
2491884|NCT02039219|8615233|P1|Treatment|Death|1
2491885|NCT02039219|8615232|P2|Treatment|Protocol Violation|0
2491886|NCT02039219|8615233|P1|Treatment|Protocol Violation|1
2491887|NCT02039219|8615232|P2|Treatment|Lost to Follow-up|1
2491888|NCT02039219|8615233|P1|Treatment|Lost to Follow-up|0
2491889|NCT02039219|8615232|P2|Treatment|Physician Decision|0
2491890|NCT02039219|8615233|P1|Treatment|Physician Decision|1
2491891|NCT02039219|8615232|P2|Treatment|Adverse Event|1
2491892|NCT02039219|8615233|P1|Treatment|Adverse Event|0
2491893|NCT02039219|8615232|P2|Treatment|Withdrawal by Subject|0
2491894|NCT02039219|8615233|P1|Treatment|Withdrawal by Subject|1
2491895|NCT02038959|8615282|P2|Overall Study|Withdrawal by Subject|8
2491896|NCT02038959|8615283|P1|Overall Study|Withdrawal by Subject|6
2491897|NCT02038946|8615309|P1|Overall Study|Other reasons|1
2491898|NCT02038946|8615309|P1|Overall Study|Lost to Follow-up|2
2491899|NCT02038946|8615309|P1|Overall Study|Withdrawal by Subject|3
2491900|NCT02038946|8615309|P1|Overall Study|Death|5
2491901|NCT02038933|8615320|P1|Follow-up|Disease Progression|2
2491902|NCT02038933|8615320|P1|Follow-up|Withdrawal by Subject|1
2491903|NCT02038933|8615320|P1|Follow-up|Lost to Follow-up|1
2491904|NCT02038933|8615320|P1|Follow-up|Adverse event unrelated to study drug|4
2491905|NCT02038933|8615320|P1|Follow-up|Death|11
2491906|NCT02038933|8615320|P1|Treatment|Withdrawal by Subject|1
2491907|NCT02038933|8615320|P1|Treatment|Disease Progression|101
2491908|NCT02038933|8615320|P1|Treatment|Study Drug Toxicity|4
2491909|NCT02038933|8615320|P1|Treatment|Adverse Event Unrelated to Study Drug|6
2491910|NCT02038933|8615320|P1|Treatment|Lost to Follow-up|1
2491911|NCT02038933|8615320|P1|Treatment|No longer meets study criteria|1
2491912|NCT02038920|8615341|P6|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2
2491913|NCT02038920|8615342|P5|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
2491914|NCT02038920|8615343|P4|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
2491915|NCT02038920|8615344|P3|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
2491916|NCT02038920|8615345|P2|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
2491917|NCT02038920|8615346|P1|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
2491918|NCT02038920|8615341|P6|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23
2491919|NCT02038920|8615342|P5|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
2491920|NCT02038920|8615343|P4|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
2491921|NCT02038920|8615344|P3|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
2491922|NCT02038920|8615345|P2|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
2491923|NCT02038920|8615346|P1|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
2491924|NCT02038920|8615341|P6|Open Label Cohort (Week 10 to 154)|Pregnancy|1
2491925|NCT02038920|8615342|P5|Open Label Cohort (Week 10 to 154)|Pregnancy|0
2491926|NCT02038920|8615343|P4|Open Label Cohort (Week 10 to 154)|Pregnancy|0
2491927|NCT02038920|8615344|P3|Open Label Cohort (Week 10 to 154)|Pregnancy|0
2491928|NCT02038920|8615345|P2|Open Label Cohort (Week 10 to 154)|Pregnancy|0
2491929|NCT02038920|8615346|P1|Open Label Cohort (Week 10 to 154)|Pregnancy|0
2491930|NCT02038920|8615341|P6|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7
2491931|NCT02038920|8615342|P5|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
2491932|NCT02038920|8615343|P4|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
2491933|NCT02038920|8615344|P3|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
2491934|NCT02038920|8615345|P2|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
2491935|NCT02038920|8615346|P1|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
2491936|NCT02038920|8615341|P6|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1
2491937|NCT02038920|8615342|P5|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
2491938|NCT02038920|8615343|P4|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
2491939|NCT02038920|8615344|P3|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
2491940|NCT02038920|8615345|P2|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
2491941|NCT02038920|8615346|P1|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
2491942|NCT02038920|8615341|P6|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43
2491943|NCT02038920|8615342|P5|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
2491944|NCT02038920|8615343|P4|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
2491945|NCT02038920|8615344|P3|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
2491946|NCT02038920|8615345|P2|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
2491947|NCT02038920|8615346|P1|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
2491948|NCT02038920|8615341|P6|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
2491949|NCT02038920|8615342|P5|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10
2491950|NCT02038920|8615343|P4|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4
2491951|NCT02038920|8615344|P3|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2
2491952|NCT02038920|8615345|P2|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
2491953|NCT02038920|8615346|P1|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
2491954|NCT02038920|8615341|P6|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
2491955|NCT02038920|8615342|P5|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
2491956|NCT02038920|8615343|P4|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
2491957|NCT02038920|8615344|P3|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1
2491958|NCT02038920|8615345|P2|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
2491959|NCT02038920|8615346|P1|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
2491960|NCT02038920|8615341|P6|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
2491961|NCT02038920|8615342|P5|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2
2491962|NCT02038920|8615343|P4|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4
2491963|NCT02038920|8615344|P3|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2
2491964|NCT02038920|8615345|P2|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
2491965|NCT02038920|8615346|P1|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
2491966|NCT02038920|8615341|P6|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
2491967|NCT02038920|8615342|P5|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
2491968|NCT02038920|8615343|P4|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
2491969|NCT02038920|8615344|P3|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
2491970|NCT02038920|8615345|P2|Induction Phase (Week 0 to 14)|Lack of Efficacy|1
2491971|NCT02038920|8615346|P1|Induction Phase (Week 0 to 14)|Lack of Efficacy|1
2491972|NCT02038920|8615341|P6|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
2491973|NCT02038920|8615342|P5|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
2491974|NCT02038920|8615343|P4|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
2491975|NCT02038920|8615344|P3|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
2491976|NCT02038920|8615345|P2|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
2491977|NCT02038920|8615346|P1|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2
2491978|NCT02038920|8615341|P6|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
2491979|NCT02038920|8615342|P5|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
2491980|NCT02038920|8615343|P4|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
2491981|NCT02038920|8615344|P3|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
2491982|NCT02038920|8615345|P2|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11
2491983|NCT02038920|8615346|P1|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3
2491984|NCT02038907|8615423|P14|Overall Study|Withdrawal by Subject|0
2491985|NCT02038907|8615424|P13|Overall Study|Withdrawal by Subject|0
2491986|NCT02038907|8615425|P12|Overall Study|Withdrawal by Subject|0
2491987|NCT02038907|8615426|P11|Overall Study|Withdrawal by Subject|1
2491989|NCT02038907|8615428|P9|Overall Study|Withdrawal by Subject|0
2491990|NCT02038907|8615429|P8|Overall Study|Withdrawal by Subject|0
2491991|NCT02038907|8615430|P7|Overall Study|Withdrawal by Subject|0
2491992|NCT02038907|8615431|P6|Overall Study|Withdrawal by Subject|0
2491993|NCT02038907|8615432|P5|Overall Study|Withdrawal by Subject|0
2491994|NCT02038907|8615433|P4|Overall Study|Withdrawal by Subject|0
2491995|NCT02038907|8615434|P3|Overall Study|Withdrawal by Subject|0
2491996|NCT02038907|8615435|P2|Overall Study|Withdrawal by Subject|0
2491997|NCT02038907|8615436|P1|Overall Study|Withdrawal by Subject|0
2491998|NCT02038907|8615423|P14|Overall Study|Protocol Violation|0
2491999|NCT02038907|8615424|P13|Overall Study|Protocol Violation|0
2492000|NCT02038907|8615425|P12|Overall Study|Protocol Violation|0
2492001|NCT02038907|8615426|P11|Overall Study|Protocol Violation|1
2492002|NCT02038907|8615427|P10|Overall Study|Protocol Violation|0
2492003|NCT02038907|8615428|P9|Overall Study|Protocol Violation|0
2492004|NCT02038907|8615429|P8|Overall Study|Protocol Violation|0
2492005|NCT02038907|8615430|P7|Overall Study|Protocol Violation|0
2492006|NCT02038907|8615431|P6|Overall Study|Protocol Violation|0
2492007|NCT02038907|8615432|P5|Overall Study|Protocol Violation|0
2492008|NCT02038907|8615433|P4|Overall Study|Protocol Violation|0
2492009|NCT02038907|8615434|P3|Overall Study|Protocol Violation|0
2492010|NCT02038907|8615435|P2|Overall Study|Protocol Violation|0
2492011|NCT02038907|8615436|P1|Overall Study|Protocol Violation|0
2492012|NCT02038881|8615967|P3|Overall Study|incarcerated|0
2492013|NCT02038881|8615968|P2|Overall Study|incarcerated|0
2492014|NCT02038881|8615969|P1|Overall Study|incarcerated|1
2492015|NCT02038881|8615967|P3|Overall Study|Lost to Follow-up|0
2492016|NCT02038881|8615968|P2|Overall Study|Lost to Follow-up|0
2492017|NCT02038881|8615969|P1|Overall Study|Lost to Follow-up|2
2492018|NCT02038881|8615967|P3|Overall Study|Withdrawal by Subject|1
2492019|NCT02038881|8615968|P2|Overall Study|Withdrawal by Subject|0
2492020|NCT02038881|8615969|P1|Overall Study|Withdrawal by Subject|0
2492021|NCT02038829|8616042|P12|Treatment Period 6|Adverse Event|0
2492022|NCT02038829|8616043|P11|Treatment Period 6|Adverse Event|0
2492023|NCT02038829|8616044|P10|Treatment Period 6|Adverse Event|0
2492024|NCT02038829|8616045|P9|Treatment Period 6|Adverse Event|0
2492025|NCT02038829|8616046|P8|Treatment Period 6|Adverse Event|0
2492026|NCT02038829|8616047|P7|Treatment Period 6|Adverse Event|0
2492027|NCT02038829|8616048|P6|Treatment Period 6|Adverse Event|0
2492028|NCT02038829|8616049|P5|Treatment Period 6|Adverse Event|0
2492029|NCT02038829|8616050|P4|Treatment Period 6|Adverse Event|0
2492030|NCT02038829|8616051|P3|Treatment Period 6|Adverse Event|1
2492031|NCT02038829|8616052|P2|Treatment Period 6|Adverse Event|0
2492032|NCT02038829|8616053|P1|Treatment Period 6|Adverse Event|0
2492033|NCT02038829|8616042|P12|Washout Period 4|Adverse Event|0
2492034|NCT02038829|8616043|P11|Washout Period 4|Adverse Event|0
2492035|NCT02038829|8616044|P10|Washout Period 4|Adverse Event|0
2492036|NCT02038829|8616045|P9|Washout Period 4|Adverse Event|0
2492037|NCT02038829|8616046|P8|Washout Period 4|Adverse Event|0
2492038|NCT02038829|8616047|P7|Washout Period 4|Adverse Event|1
2492039|NCT02038829|8616048|P6|Washout Period 4|Adverse Event|0
2492040|NCT02038829|8616049|P5|Washout Period 4|Adverse Event|0
2492041|NCT02038829|8616050|P4|Washout Period 4|Adverse Event|0
2492042|NCT02038829|8616051|P3|Washout Period 4|Adverse Event|0
2492043|NCT02038829|8616052|P2|Washout Period 4|Adverse Event|0
2492044|NCT02038829|8616053|P1|Washout Period 4|Adverse Event|0
2492045|NCT02038829|8616042|P12|Treatment Period 4|Adverse Event|0
2492046|NCT02038829|8616043|P11|Treatment Period 4|Adverse Event|0
2492047|NCT02038829|8616044|P10|Treatment Period 4|Adverse Event|0
2492048|NCT02038829|8616045|P9|Treatment Period 4|Adverse Event|0
2492049|NCT02038829|8616046|P8|Treatment Period 4|Adverse Event|0
2492050|NCT02038829|8616047|P7|Treatment Period 4|Adverse Event|0
2492051|NCT02038829|8616048|P6|Treatment Period 4|Adverse Event|0
2492052|NCT02038829|8616049|P5|Treatment Period 4|Adverse Event|0
2492053|NCT02038829|8616050|P4|Treatment Period 4|Adverse Event|0
2492054|NCT02038829|8616051|P3|Treatment Period 4|Adverse Event|0
2492055|NCT02038829|8616052|P2|Treatment Period 4|Adverse Event|1
2492056|NCT02038829|8616053|P1|Treatment Period 4|Adverse Event|0
2492057|NCT02038829|8616042|P12|Washout Period 2|Withdrawal by Subject|0
2492058|NCT02038829|8616043|P11|Washout Period 2|Withdrawal by Subject|0
2492059|NCT02038829|8616044|P10|Washout Period 2|Withdrawal by Subject|0
2492060|NCT02038829|8616045|P9|Washout Period 2|Withdrawal by Subject|0
2492061|NCT02038829|8616046|P8|Washout Period 2|Withdrawal by Subject|0
2492062|NCT02038829|8616047|P7|Washout Period 2|Withdrawal by Subject|0
2492063|NCT02038829|8616048|P6|Washout Period 2|Withdrawal by Subject|1
2492064|NCT02038829|8616049|P5|Washout Period 2|Withdrawal by Subject|0
2492065|NCT02038829|8616050|P4|Washout Period 2|Withdrawal by Subject|0
2492066|NCT02038829|8616051|P3|Washout Period 2|Withdrawal by Subject|0
2492067|NCT02038829|8616052|P2|Washout Period 2|Withdrawal by Subject|0
2492068|NCT02038829|8616053|P1|Washout Period 2|Withdrawal by Subject|0
2492069|NCT02038829|8616042|P12|Washout Period 2|Adverse Event|0
2492070|NCT02038829|8616043|P11|Washout Period 2|Adverse Event|0
2492071|NCT02038829|8616044|P10|Washout Period 2|Adverse Event|0
2492072|NCT02038829|8616045|P9|Washout Period 2|Adverse Event|1
2492073|NCT02038829|8616046|P8|Washout Period 2|Adverse Event|0
2492074|NCT02038829|8616047|P7|Washout Period 2|Adverse Event|0
2492075|NCT02038829|8616048|P6|Washout Period 2|Adverse Event|0
2492076|NCT02038829|8616049|P5|Washout Period 2|Adverse Event|0
2492077|NCT02038829|8616050|P4|Washout Period 2|Adverse Event|0
2492078|NCT02038829|8616051|P3|Washout Period 2|Adverse Event|0
2492079|NCT02038829|8616052|P2|Washout Period 2|Adverse Event|0
2492080|NCT02038829|8616053|P1|Washout Period 2|Adverse Event|0
2492081|NCT02038829|8616042|P12|Treatment Period 2|Withdrawal by Subject|0
2492082|NCT02038829|8616043|P11|Treatment Period 2|Withdrawal by Subject|0
2492083|NCT02038829|8616044|P10|Treatment Period 2|Withdrawal by Subject|0
2492084|NCT02038829|8616045|P9|Treatment Period 2|Withdrawal by Subject|0
2492085|NCT02038829|8616046|P8|Treatment Period 2|Withdrawal by Subject|0
2492086|NCT02038829|8616047|P7|Treatment Period 2|Withdrawal by Subject|0
2492087|NCT02038829|8616048|P6|Treatment Period 2|Withdrawal by Subject|0
2492088|NCT02038829|8616049|P5|Treatment Period 2|Withdrawal by Subject|0
2492089|NCT02038829|8616050|P4|Treatment Period 2|Withdrawal by Subject|0
2492090|NCT02038829|8616051|P3|Treatment Period 2|Withdrawal by Subject|0
2492091|NCT02038829|8616052|P2|Treatment Period 2|Withdrawal by Subject|0
2492092|NCT02038829|8616053|P1|Treatment Period 2|Withdrawal by Subject|1
2492093|NCT02038829|8616042|P12|Treatment Period 2|Adverse Event|0
2492094|NCT02038829|8616043|P11|Treatment Period 2|Adverse Event|1
2492095|NCT02038829|8616044|P10|Treatment Period 2|Adverse Event|0
2492096|NCT02038829|8616045|P9|Treatment Period 2|Adverse Event|0
2492097|NCT02038829|8616046|P8|Treatment Period 2|Adverse Event|0
2492098|NCT02038829|8616047|P7|Treatment Period 2|Adverse Event|0
2492099|NCT02038829|8616048|P6|Treatment Period 2|Adverse Event|0
2492100|NCT02038829|8616049|P5|Treatment Period 2|Adverse Event|0
2492101|NCT02038829|8616050|P4|Treatment Period 2|Adverse Event|0
2492102|NCT02038829|8616051|P3|Treatment Period 2|Adverse Event|0
2492103|NCT02038829|8616052|P2|Treatment Period 2|Adverse Event|0
2492104|NCT02038829|8616053|P1|Treatment Period 2|Adverse Event|0
2492105|NCT02038829|8616042|P12|Washout Period 1|Death|0
2492106|NCT02038829|8616043|P11|Washout Period 1|Death|0
2492107|NCT02038829|8616044|P10|Washout Period 1|Death|0
2492108|NCT02038829|8616045|P9|Washout Period 1|Death|0
2492109|NCT02038829|8616046|P8|Washout Period 1|Death|0
2492110|NCT02038829|8616047|P7|Washout Period 1|Death|0
2492111|NCT02038829|8616048|P6|Washout Period 1|Death|0
2492112|NCT02038829|8616049|P5|Washout Period 1|Death|1
2492113|NCT02038829|8616050|P4|Washout Period 1|Death|0
2492114|NCT02038829|8616051|P3|Washout Period 1|Death|0
2492115|NCT02038829|8616052|P2|Washout Period 1|Death|0
2492116|NCT02038829|8616053|P1|Washout Period 1|Death|0
2492117|NCT02038790|8616087|P2|Day 0 - First Treatment|Withdrawal by Subject|1
2492118|NCT02038790|8616088|P1|Day 0 - First Treatment|Withdrawal by Subject|1
2492119|NCT02038764|8616124|P5|Overall Study|Other|0
2492120|NCT02038764|8616125|P4|Overall Study|Other|0
2492121|NCT02038764|8616126|P3|Overall Study|Other|1
2492122|NCT02038764|8616127|P2|Overall Study|Other|0
2492123|NCT02038764|8616128|P1|Overall Study|Other|1
2492124|NCT02038764|8616124|P5|Overall Study|Withdrawal by Subject|1
2492125|NCT02038764|8616125|P4|Overall Study|Withdrawal by Subject|0
2492126|NCT02038764|8616126|P3|Overall Study|Withdrawal by Subject|0
2492127|NCT02038764|8616127|P2|Overall Study|Withdrawal by Subject|0
2492128|NCT02038764|8616128|P1|Overall Study|Withdrawal by Subject|0
2492129|NCT02038764|8616124|P5|Overall Study|Lost to Follow-up|0
2492130|NCT02038764|8616125|P4|Overall Study|Lost to Follow-up|0
2492131|NCT02038764|8616126|P3|Overall Study|Lost to Follow-up|0
2492132|NCT02038764|8616127|P2|Overall Study|Lost to Follow-up|1
2492133|NCT02038764|8616128|P1|Overall Study|Lost to Follow-up|0
2492134|NCT02038764|8616124|P5|Overall Study|Adverse Event|0
2492135|NCT02038764|8616125|P4|Overall Study|Adverse Event|0
2492136|NCT02038764|8616126|P3|Overall Study|Adverse Event|1
2492137|NCT02038764|8616127|P2|Overall Study|Adverse Event|0
2492138|NCT02038764|8616128|P1|Overall Study|Adverse Event|0
2492139|NCT02038647|8616230|P2|Overall Study|Ongoing at Datacut|10
2492140|NCT02038647|8616231|P1|Overall Study|Ongoing at Datacut|9
2492141|NCT02038647|8616230|P2|Overall Study|Not Reported|1
2492142|NCT02038647|8616231|P1|Overall Study|Not Reported|0
2492143|NCT02038647|8616230|P2|Overall Study|Withdrawal by Subject|2
2492144|NCT02038647|8616231|P1|Overall Study|Withdrawal by Subject|5
2492145|NCT02038647|8616230|P2|Overall Study|Symptomatic Deterioration|7
2492146|NCT02038647|8616231|P1|Overall Study|Symptomatic Deterioration|7
2492147|NCT02038647|8616230|P2|Overall Study|Adverse Event|10
2492148|NCT02038647|8616231|P1|Overall Study|Adverse Event|18
2492149|NCT02038647|8616230|P2|Overall Study|Progressive Disease|59
2492150|NCT02038647|8616231|P1|Overall Study|Progressive Disease|50
2492151|NCT02038543|8616294|P4|Overall Study|Withdrawal by Subject|1
2492152|NCT02038543|8616295|P3|Overall Study|Withdrawal by Subject|0
2492153|NCT02038543|8616296|P2|Overall Study|Withdrawal by Subject|0
2492154|NCT02038543|8616297|P1|Overall Study|Withdrawal by Subject|0
2492155|NCT02038543|8616294|P4|Overall Study|Screen Failure|1
2492156|NCT02038543|8616295|P3|Overall Study|Screen Failure|0
2492157|NCT02038543|8616296|P2|Overall Study|Screen Failure|0
2492158|NCT02038543|8616297|P1|Overall Study|Screen Failure|0
2492159|NCT02038075|8616324|P2|Overall Study|Withdrawal by Subject|0
2492160|NCT02038075|8616325|P1|Overall Study|Withdrawal by Subject|3
2492161|NCT02038049|8616333|P2|Overall Study|Lost to Follow-up|0
2492162|NCT02038049|8616334|P1|Overall Study|Lost to Follow-up|1
2492163|NCT02038010|8616363|P4|Follow Up|Other|0
2492164|NCT02038010|8616364|P3|Follow Up|Other|0
2492165|NCT02038010|8616365|P2|Follow Up|Other|0
2492166|NCT02038010|8616366|P1|Follow Up|Other|3
2492167|NCT02038010|8616363|P4|Follow Up|Death|0
2492168|NCT02038010|8616364|P3|Follow Up|Death|0
2492169|NCT02038010|8616365|P2|Follow Up|Death|3
2492170|NCT02038010|8616366|P1|Follow Up|Death|4
2492171|NCT02038010|8616363|P4|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0
2492172|NCT02038010|8616364|P3|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0
2492173|NCT02038010|8616365|P2|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1
2492174|NCT02038010|8616366|P1|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1
2492175|NCT02038010|8616363|P4|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
2492176|NCT02038010|8616364|P3|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
2492177|NCT02038010|8616365|P2|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1
2492178|NCT02038010|8616366|P1|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
2492179|NCT02038010|8616363|P4|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
2492180|NCT02038010|8616364|P3|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
2492181|NCT02038010|8616365|P2|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
2492182|NCT02038010|8616366|P1|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1
2492183|NCT02038010|8616363|P4|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
2492184|NCT02038010|8616364|P3|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
2492185|NCT02038010|8616365|P2|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1
2492186|NCT02038010|8616366|P1|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
2492187|NCT02037984|8616393|P8|Overall Study|Withdrawal by Subject|1
2492188|NCT02037984|8616394|P7|Overall Study|Withdrawal by Subject|0
2492189|NCT02037984|8616395|P6|Overall Study|Withdrawal by Subject|3
2492190|NCT02037984|8616396|P5|Overall Study|Withdrawal by Subject|1
2492191|NCT02037984|8616397|P4|Overall Study|Withdrawal by Subject|1
2492192|NCT02037984|8616398|P3|Overall Study|Withdrawal by Subject|0
2492193|NCT02037984|8616399|P2|Overall Study|Withdrawal by Subject|0
2492194|NCT02037984|8616400|P1|Overall Study|Withdrawal by Subject|0
2492195|NCT02037984|8616393|P8|Overall Study|Withdrawal by Parent/Guardian|2
2492196|NCT02037984|8616394|P7|Overall Study|Withdrawal by Parent/Guardian|4
2492197|NCT02037984|8616395|P6|Overall Study|Withdrawal by Parent/Guardian|1
2492198|NCT02037984|8616396|P5|Overall Study|Withdrawal by Parent/Guardian|5
2492199|NCT02037984|8616397|P4|Overall Study|Withdrawal by Parent/Guardian|2
2492200|NCT02037984|8616398|P3|Overall Study|Withdrawal by Parent/Guardian|3
2492201|NCT02037984|8616399|P2|Overall Study|Withdrawal by Parent/Guardian|0
2492202|NCT02037984|8616400|P1|Overall Study|Withdrawal by Parent/Guardian|0
2492203|NCT02037984|8616393|P8|Overall Study|Technical Problems|2
2492204|NCT02037984|8616394|P7|Overall Study|Technical Problems|4
2492205|NCT02037984|8616395|P6|Overall Study|Technical Problems|3
2492206|NCT02037984|8616396|P5|Overall Study|Technical Problems|2
2492207|NCT02037984|8616397|P4|Overall Study|Technical Problems|3
2492208|NCT02037984|8616398|P3|Overall Study|Technical Problems|3
2492209|NCT02037984|8616399|P2|Overall Study|Technical Problems|0
2492210|NCT02037984|8616400|P1|Overall Study|Technical Problems|0
2492211|NCT02037984|8616393|P8|Overall Study|Protocol Violation|0
2492212|NCT02037984|8616394|P7|Overall Study|Protocol Violation|2
2492213|NCT02037984|8616395|P6|Overall Study|Protocol Violation|1
2492214|NCT02037984|8616396|P5|Overall Study|Protocol Violation|0
2492215|NCT02037984|8616397|P4|Overall Study|Protocol Violation|0
2492216|NCT02037984|8616398|P3|Overall Study|Protocol Violation|0
2492217|NCT02037984|8616399|P2|Overall Study|Protocol Violation|0
2492218|NCT02037984|8616400|P1|Overall Study|Protocol Violation|0
2492219|NCT02037984|8616393|P8|Overall Study|Physician Decision|0
2492220|NCT02037984|8616394|P7|Overall Study|Physician Decision|1
2492221|NCT02037984|8616395|P6|Overall Study|Physician Decision|0
2492222|NCT02037984|8616396|P5|Overall Study|Physician Decision|0
2492223|NCT02037984|8616397|P4|Overall Study|Physician Decision|0
2492224|NCT02037984|8616398|P3|Overall Study|Physician Decision|0
2492225|NCT02037984|8616399|P2|Overall Study|Physician Decision|0
2492226|NCT02037984|8616400|P1|Overall Study|Physician Decision|0
2492227|NCT02037984|8616393|P8|Overall Study|Lost to Follow-up|4
2492228|NCT02037984|8616394|P7|Overall Study|Lost to Follow-up|2
2492229|NCT02037984|8616395|P6|Overall Study|Lost to Follow-up|2
2492230|NCT02037984|8616396|P5|Overall Study|Lost to Follow-up|2
2492231|NCT02037984|8616397|P4|Overall Study|Lost to Follow-up|5
2492232|NCT02037984|8616398|P3|Overall Study|Lost to Follow-up|3
2492233|NCT02037984|8616399|P2|Overall Study|Lost to Follow-up|0
2492234|NCT02037984|8616400|P1|Overall Study|Lost to Follow-up|1
2492235|NCT02037984|8616393|P8|Overall Study|Lack of Efficacy|3
2492236|NCT02037984|8616394|P7|Overall Study|Lack of Efficacy|4
2492237|NCT02037984|8616395|P6|Overall Study|Lack of Efficacy|2
2492238|NCT02037984|8616396|P5|Overall Study|Lack of Efficacy|2
2492239|NCT02037984|8616397|P4|Overall Study|Lack of Efficacy|10
2492240|NCT02037984|8616398|P3|Overall Study|Lack of Efficacy|3
2492241|NCT02037984|8616399|P2|Overall Study|Lack of Efficacy|0
2492242|NCT02037984|8616400|P1|Overall Study|Lack of Efficacy|0
2492243|NCT02037568|8616545|P2|Overall Study|Patient did not receive transplant|1
2492244|NCT02037568|8616546|P1|Overall Study|Patient did not receive transplant|0
2492245|NCT02037568|8616545|P2|Overall Study|Screen Failure|1
2492246|NCT02037568|8616546|P1|Overall Study|Screen Failure|3
2492247|NCT02037568|8616545|P2|Overall Study|Lost to Follow-up|13
2492248|NCT02037568|8616546|P1|Overall Study|Lost to Follow-up|16
2492249|NCT02037568|8616545|P2|Overall Study|Withdrawal by Subject|24
2492250|NCT02037568|8616546|P1|Overall Study|Withdrawal by Subject|17
2492251|NCT02037477|8616581|P4|Treatment Period 1|Pre-treatment Event/Adverse Event|0
2492252|NCT02037477|8616582|P3|Treatment Period 1|Pre-treatment Event/Adverse Event|1
2492253|NCT02037477|8616583|P2|Treatment Period 1|Pre-treatment Event/Adverse Event|0
2492254|NCT02037477|8616584|P1|Treatment Period 1|Pre-treatment Event/Adverse Event|0
2492255|NCT02037165|8616711|P5|Washout Period 4 (6 Days)|Withdrawal by Subject|1
2492256|NCT02037165|8616712|P4|Washout Period 4 (6 Days)|Withdrawal by Subject|0
2492257|NCT02037165|8616713|P3|Washout Period 4 (6 Days)|Withdrawal by Subject|0
2492258|NCT02037165|8616714|P2|Washout Period 4 (6 Days)|Withdrawal by Subject|0
2492259|NCT02037165|8616715|P1|Washout Period 4 (6 Days)|Withdrawal by Subject|0
2492260|NCT02036775|8616775|P6|Treatment Period 2 (6 Days)|Withdrawal by Subject|1
2492261|NCT02036775|8616776|P5|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
2492262|NCT02036775|8616777|P4|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
2492263|NCT02036775|8616778|P3|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
2492264|NCT02036775|8616779|P2|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
2492265|NCT02036775|8616780|P1|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
2492266|NCT02036645|8616830|P12|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2492267|NCT02036645|8616831|P11|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2492268|NCT02036645|8616832|P10|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2492269|NCT02036645|8616833|P9|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2492270|NCT02036645|8616834|P8|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2492271|NCT02036645|8616835|P7|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2492272|NCT02036645|8616836|P6|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2492273|NCT02036645|8616837|P5|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2492274|NCT02036645|8616838|P4|SAD Cohorts : Study Part 1|Withdrawal by Subject|1
2492275|NCT02036645|8616839|P3|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2492276|NCT02036645|8616840|P2|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2492277|NCT02036645|8616841|P1|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
2492278|NCT02036645|8616830|P12|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2492279|NCT02036645|8616831|P11|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2492280|NCT02036645|8616832|P10|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2492281|NCT02036645|8616833|P9|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2492282|NCT02036645|8616834|P8|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2492283|NCT02036645|8616835|P7|SAD Cohorts : Study Part 1|Lost to Follow-up|1
2492284|NCT02036645|8616836|P6|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2492285|NCT02036645|8616837|P5|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2492286|NCT02036645|8616838|P4|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2492287|NCT02036645|8616839|P3|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2492288|NCT02036645|8616840|P2|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2492289|NCT02036645|8616841|P1|SAD Cohorts : Study Part 1|Lost to Follow-up|0
2492290|NCT02036580|8616946|P3|Overall Study|Adverse Event|0
2492291|NCT02036580|8616947|P2|Overall Study|Adverse Event|0
2492292|NCT02036580|8616948|P1|Overall Study|Adverse Event|1
2492293|NCT02036580|8616946|P3|Overall Study|Withdrawal by Subject|0
2492294|NCT02036580|8616947|P2|Overall Study|Withdrawal by Subject|1
2492295|NCT02036580|8616948|P1|Overall Study|Withdrawal by Subject|0
2492296|NCT02036515|8616969|P3|Overall Study|Hyperglycemia|1
2492297|NCT02036515|8616970|P2|Overall Study|Hyperglycemia|0
2492298|NCT02036515|8616971|P1|Overall Study|Hyperglycemia|0
2492299|NCT02036515|8616969|P3|Overall Study|Withdrawal by Subject|9
2492300|NCT02036515|8616970|P2|Overall Study|Withdrawal by Subject|7
2492301|NCT02036515|8616971|P1|Overall Study|Withdrawal by Subject|4
2492302|NCT02036515|8616969|P3|Overall Study|Screen failure|0
2492303|NCT02036515|8616970|P2|Overall Study|Screen failure|2
2492304|NCT02036515|8616971|P1|Overall Study|Screen failure|0
2492305|NCT02036515|8616969|P3|Overall Study|Non-compliance with study drug|2
2492306|NCT02036515|8616970|P2|Overall Study|Non-compliance with study drug|0
2492307|NCT02036515|8616971|P1|Overall Study|Non-compliance with study drug|0
2492308|NCT02036515|8616969|P3|Overall Study|Lost to Follow-up|0
2492309|NCT02036515|8616970|P2|Overall Study|Lost to Follow-up|2
2492310|NCT02036515|8616971|P1|Overall Study|Lost to Follow-up|0
2492311|NCT02036515|8616969|P3|Overall Study|Adverse Event|2
2492312|NCT02036515|8616970|P2|Overall Study|Adverse Event|1
2492313|NCT02036515|8616971|P1|Overall Study|Adverse Event|1
2492314|NCT02036294|8617072|P2|Overall Study|Withdrawal by Subject|3
2492315|NCT02036294|8617073|P1|Overall Study|Withdrawal by Subject|2
2492316|NCT02036294|8617072|P2|Overall Study|Death|8
2492317|NCT02036294|8617073|P1|Overall Study|Death|7
2492318|NCT02035748|8617089|P1|Overall Study|Progressive Disease|1
2492319|NCT02035748|8617089|P1|Overall Study|Withdrawal by Subject|6
2492320|NCT02035748|8617089|P1|Overall Study|Physician Decision|3
2492321|NCT02035748|8617089|P1|Overall Study|Lost to Follow-up|2
2492322|NCT02035748|8617089|P1|Overall Study|Death|3
2492323|NCT02035748|8617089|P1|Overall Study|Adverse Event|5
2492324|NCT02035696|8617103|P4|Overall Study|Withdrawal by Subject|1
2492325|NCT02035696|8617104|P3|Overall Study|Withdrawal by Subject|2
2492326|NCT02035696|8617105|P2|Overall Study|Withdrawal by Subject|0
2492327|NCT02035696|8617106|P1|Overall Study|Withdrawal by Subject|3
2492328|NCT02035696|8617103|P4|Overall Study|Lost to Follow-up|2
2492329|NCT02035696|8617104|P3|Overall Study|Lost to Follow-up|1
2492330|NCT02035696|8617105|P2|Overall Study|Lost to Follow-up|3
2492331|NCT02035696|8617106|P1|Overall Study|Lost to Follow-up|0
2492332|NCT02035553|8617162|P2|Overall Study|Other Reason|4
2492333|NCT02035553|8617163|P1|Overall Study|Other Reason|0
2492334|NCT02035553|8617162|P2|Overall Study|Lost to Follow-up|1
2492335|NCT02035553|8617163|P1|Overall Study|Lost to Follow-up|0
2492336|NCT02035553|8617162|P2|Overall Study|Non-compliance with Study Drug|1
2492337|NCT02035553|8617163|P1|Overall Study|Non-compliance with Study Drug|0
2492338|NCT02035553|8617162|P2|Overall Study|Withdrawal by Subject|7
2492339|NCT02035553|8617163|P1|Overall Study|Withdrawal by Subject|4
2492340|NCT02035553|8617162|P2|Overall Study|Lack of Efficacy|1
2492341|NCT02035553|8617163|P1|Overall Study|Lack of Efficacy|1
2492342|NCT02035553|8617162|P2|Overall Study|Physician Decision|2
2492343|NCT02035553|8617163|P1|Overall Study|Physician Decision|3
2492344|NCT02035553|8617162|P2|Overall Study|Adverse Event|6
2492345|NCT02035553|8617163|P1|Overall Study|Adverse Event|10
2492346|NCT02035553|8617162|P2|Overall Study|Death (See All-Cause Mortality Table)|1
2492347|NCT02035553|8617163|P1|Overall Study|Death (See All-Cause Mortality Table)|0
2492348|NCT02035475|8617169|P1|Overall Study|Equipment Error|1
2492349|NCT02035475|8617169|P1|Overall Study|Physician Decision|1
2492350|NCT02035475|8617169|P1|Overall Study|Withdrawal by Subject|4
2492351|NCT02035332|8617180|P1|Overall Study|Procedure Aborted due to Uterine Width|1
2492352|NCT02035267|8617190|P4|Overall Study|Other unspecified|0
2492353|NCT02035267|8617191|P3|Overall Study|Other unspecified|0
2492354|NCT02035267|8617192|P2|Overall Study|Other unspecified|1
2492355|NCT02035267|8617193|P1|Overall Study|Other unspecified|0
2492356|NCT02035267|8617190|P4|Overall Study|Lost to Follow-up|1
2492357|NCT02035267|8617191|P3|Overall Study|Lost to Follow-up|0
2492358|NCT02035267|8617192|P2|Overall Study|Lost to Follow-up|0
2492359|NCT02035267|8617193|P1|Overall Study|Lost to Follow-up|0
2492360|NCT02035267|8617190|P4|Overall Study|Adverse Event|0
2492361|NCT02035267|8617191|P3|Overall Study|Adverse Event|1
2492362|NCT02035267|8617192|P2|Overall Study|Adverse Event|0
2492363|NCT02035267|8617193|P1|Overall Study|Adverse Event|0
2492364|NCT02035267|8617190|P4|Overall Study|Withdrawal consent-subject convenience|0
2492365|NCT02035267|8617191|P3|Overall Study|Withdrawal consent-subject convenience|1
2492366|NCT02035267|8617192|P2|Overall Study|Withdrawal consent-subject convenience|0
2492367|NCT02035267|8617193|P1|Overall Study|Withdrawal consent-subject convenience|0
2492368|NCT02035202|8617224|P3|Overall Study|Lost to Follow-up|2
2492369|NCT02035202|8617225|P2|Overall Study|Lost to Follow-up|16
2492370|NCT02035202|8617226|P1|Overall Study|Lost to Follow-up|8
2492371|NCT02034916|8617242|P2|Overall Study|Study terminated by sponsor|5
2492372|NCT02034916|8617243|P1|Overall Study|Study terminated by sponsor|4
2492373|NCT02034916|8617242|P2|Overall Study|Lost to Follow-up|1
2492374|NCT02034916|8617243|P1|Overall Study|Lost to Follow-up|4
2492375|NCT02034916|8617242|P2|Overall Study|Withdrawal by Subject|1
2492376|NCT02034916|8617243|P1|Overall Study|Withdrawal by Subject|2
2492377|NCT02034916|8617242|P2|Overall Study|Death|28
2492378|NCT02034916|8617243|P1|Overall Study|Death|39
2492379|NCT02034877|8617280|P2|Overall Study|No Longer Willing to Participate|3
2492380|NCT02034877|8617281|P1|Overall Study|No Longer Willing to Participate|0
2492381|NCT02034877|8617280|P2|Overall Study|Lost to Follow-up|3
2492382|NCT02034877|8617281|P1|Overall Study|Lost to Follow-up|0
2492383|NCT02034799|8617299|P2|Overall Study|Death|1
2492384|NCT02034799|8617300|P1|Overall Study|Death|2
2492385|NCT02034799|8617299|P2|Overall Study|Lost to Follow-up|1
2492386|NCT02034799|8617300|P1|Overall Study|Lost to Follow-up|0
2492387|NCT02034799|8617299|P2|Overall Study|Withdrawal by Subject|2
2492388|NCT02034799|8617300|P1|Overall Study|Withdrawal by Subject|0
2492389|NCT02034708|8617314|P2|Wash-out (From 2 Days up to 14 Days)|other reason|2
2492390|NCT02034708|8617315|P1|Wash-out (From 2 Days up to 14 Days)|other reason|3
2492391|NCT02034708|8617314|P2|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
2492392|NCT02034708|8617315|P1|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
2492393|NCT02034708|8617314|P2|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0
2492394|NCT02034708|8617315|P1|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1
2492395|NCT02034708|8617314|P2|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5
2492396|NCT02034708|8617315|P1|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2
2492397|NCT02034591|8617326|P6|Overall Study|Withdrawal by Subject|0
2492398|NCT02034591|8617327|P5|Overall Study|Withdrawal by Subject|1
2492399|NCT02034591|8617328|P4|Overall Study|Withdrawal by Subject|0
2492400|NCT02034591|8617329|P3|Overall Study|Withdrawal by Subject|0
2492401|NCT02034591|8617330|P2|Overall Study|Withdrawal by Subject|0
2492402|NCT02034591|8617331|P1|Overall Study|Withdrawal by Subject|0
2492403|NCT02034565|8617386|P2|Overall Study|Adverse Event|0
2492404|NCT02034565|8617387|P1|Overall Study|Adverse Event|1
2492405|NCT02034552|8617404|P3|Overall Study|Clinical progression|9
2492406|NCT02034552|8617405|P2|Overall Study|Clinical progression|7
2492407|NCT02034552|8617406|P1|Overall Study|Clinical progression|5
2492408|NCT02034552|8617404|P3|Overall Study|Non-compliance with study drug|1
2492409|NCT02034552|8617405|P2|Overall Study|Non-compliance with study drug|0
2492410|NCT02034552|8617406|P1|Overall Study|Non-compliance with study drug|0
2492411|NCT02034552|8617404|P3|Overall Study|Withdrawal by Subject|1
2492412|NCT02034552|8617405|P2|Overall Study|Withdrawal by Subject|1
2492413|NCT02034552|8617406|P1|Overall Study|Withdrawal by Subject|2
2492414|NCT02034552|8617404|P3|Overall Study|AE associated with disease progression|0
2492415|NCT02034552|8617405|P2|Overall Study|AE associated with disease progression|1
2492416|NCT02034552|8617406|P1|Overall Study|AE associated with disease progression|0
2492417|NCT02034552|8617404|P3|Overall Study|AE not assoc. with disease progression|2
2492418|NCT02034552|8617405|P2|Overall Study|AE not assoc. with disease progression|4
2492419|NCT02034552|8617406|P1|Overall Study|AE not assoc. with disease progression|1
2492420|NCT02034552|8617404|P3|Overall Study|Radiological progression|4
2492421|NCT02034552|8617405|P2|Overall Study|Radiological progression|5
2492422|NCT02034552|8617406|P1|Overall Study|Radiological progression|3
2492423|NCT02034552|8617404|P3|Overall Study|Never treated|0
2492424|NCT02034552|8617405|P2|Overall Study|Never treated|2
2492425|NCT02034552|8617406|P1|Overall Study|Never treated|3
2492426|NCT02034513|8617437|P2|Overall Study|Unclassified|1
2492427|NCT02034513|8617438|P1|Overall Study|Unclassified|0
2492428|NCT02034513|8617437|P2|Overall Study|Withdrawal by Subject|25
2492429|NCT02034513|8617438|P1|Overall Study|Withdrawal by Subject|25
2492430|NCT02034513|8617437|P2|Overall Study|Protocol Violation|10
2492431|NCT02034513|8617438|P1|Overall Study|Protocol Violation|7
2492432|NCT02034513|8617437|P2|Overall Study|Pregnancy|3
2492433|NCT02034513|8617438|P1|Overall Study|Pregnancy|0
2492434|NCT02034513|8617437|P2|Overall Study|Lost to Follow-up|7
2492435|NCT02034513|8617438|P1|Overall Study|Lost to Follow-up|6
2492436|NCT02034513|8617437|P2|Overall Study|Lack of Efficacy|1
2492437|NCT02034513|8617438|P1|Overall Study|Lack of Efficacy|0
2492438|NCT02034513|8617437|P2|Overall Study|Adverse Event|10
2492439|NCT02034513|8617438|P1|Overall Study|Adverse Event|11
2492440|NCT02034474|8617456|P2|Overall Study|Withdrawal by Subject|2
2492441|NCT02034474|8617457|P1|Overall Study|Withdrawal by Subject|1
2492442|NCT02034474|8617456|P2|Overall Study|Adverse Event|2
2492443|NCT02034474|8617457|P1|Overall Study|Adverse Event|3
2492444|NCT02034162|8617473|P3|Double-blind|Withdrawal by Subject|0
2492445|NCT02034162|8617474|P2|Double-blind|Withdrawal by Subject|7
2492446|NCT02034162|8617475|P1|Double-blind|Withdrawal by Subject|5
2492447|NCT02034162|8617473|P3|Double-blind|Protocol Violation|0
2492448|NCT02034162|8617474|P2|Double-blind|Protocol Violation|1
2492449|NCT02034162|8617475|P1|Double-blind|Protocol Violation|0
2492450|NCT02034162|8617473|P3|Double-blind|Physician Decision|0
2492451|NCT02034162|8617474|P2|Double-blind|Physician Decision|0
2492452|NCT02034162|8617475|P1|Double-blind|Physician Decision|1
2492453|NCT02034162|8617473|P3|Double-blind|Lost to Follow-up|0
2492454|NCT02034162|8617474|P2|Double-blind|Lost to Follow-up|0
2492455|NCT02034162|8617475|P1|Double-blind|Lost to Follow-up|3
2492456|NCT02034123|8617521|P18|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2492457|NCT02034123|8617522|P17|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2492458|NCT02034123|8617523|P16|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2492459|NCT02034123|8617524|P15|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2492460|NCT02034123|8617525|P14|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2492461|NCT02034123|8617526|P13|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2492462|NCT02034123|8617527|P12|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2492463|NCT02034123|8617528|P11|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2492464|NCT02034123|8617529|P10|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2492465|NCT02034123|8617530|P9|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2492466|NCT02034123|8617531|P8|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2492467|NCT02034123|8617532|P7|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2492468|NCT02034123|8617533|P6|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2492469|NCT02034123|8617534|P5|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1
2492470|NCT02034123|8617535|P4|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1
2492471|NCT02034123|8617536|P3|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2492472|NCT02034123|8617537|P2|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2492473|NCT02034123|8617538|P1|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
2492474|NCT02034123|8617521|P18|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2492475|NCT02034123|8617522|P17|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2492476|NCT02034123|8617523|P16|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2492477|NCT02034123|8617524|P15|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2492478|NCT02034123|8617525|P14|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2492479|NCT02034123|8617526|P13|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2492480|NCT02034123|8617527|P12|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2492481|NCT02034123|8617528|P11|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2492482|NCT02034123|8617529|P10|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2492483|NCT02034123|8617530|P9|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1
2492484|NCT02034123|8617531|P8|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2492485|NCT02034123|8617532|P7|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2492486|NCT02034123|8617533|P6|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2492487|NCT02034123|8617534|P5|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2492488|NCT02034123|8617535|P4|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2492489|NCT02034123|8617536|P3|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2492490|NCT02034123|8617537|P2|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2492491|NCT02034123|8617538|P1|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
2492492|NCT02034123|8617521|P18|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2492493|NCT02034123|8617522|P17|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2492494|NCT02034123|8617523|P16|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2492495|NCT02034123|8617524|P15|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2492496|NCT02034123|8617525|P14|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2492497|NCT02034123|8617526|P13|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2492498|NCT02034123|8617527|P12|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2492499|NCT02034123|8617528|P11|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2492500|NCT02034123|8617529|P10|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2492501|NCT02034123|8617530|P9|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2492502|NCT02034123|8617531|P8|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2492503|NCT02034123|8617532|P7|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2492504|NCT02034123|8617533|P6|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2492505|NCT02034123|8617534|P5|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2492506|NCT02034123|8617535|P4|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1
2492507|NCT02034123|8617536|P3|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2492508|NCT02034123|8617537|P2|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2492509|NCT02034123|8617538|P1|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
2492510|NCT02034123|8617521|P18|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2492511|NCT02034123|8617522|P17|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2492512|NCT02034123|8617523|P16|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2492513|NCT02034123|8617524|P15|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2492514|NCT02034123|8617525|P14|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2492515|NCT02034123|8617526|P13|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2492516|NCT02034123|8617527|P12|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2492517|NCT02034123|8617528|P11|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2492518|NCT02034123|8617529|P10|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2492519|NCT02034123|8617530|P9|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
2492520|NCT02034123|8617531|P8|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
2492521|NCT02034123|8617532|P7|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2492522|NCT02034123|8617533|P6|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2492523|NCT02034123|8617534|P5|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
2492524|NCT02034123|8617535|P4|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2492525|NCT02034123|8617536|P3|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2492526|NCT02034123|8617537|P2|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2492527|NCT02034123|8617538|P1|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
2492528|NCT02034058|8617857|P1|Overall Study|Death|3
2492529|NCT02034006|8617878|P1|Overall Study|Pregnancy|1
2492530|NCT02034006|8617878|P1|Overall Study|Death|1
2492531|NCT02034006|8617878|P1|Overall Study|Lost to Follow-up|5
2492532|NCT02034006|8617878|P1|Overall Study|Withdrawal by Subject|7
2492533|NCT02033889|8617929|P3|Overall Study|Withdrawal by Subject|13
2492534|NCT02033889|8617930|P2|Overall Study|Withdrawal by Subject|10
2492535|NCT02033889|8617931|P1|Overall Study|Withdrawal by Subject|18
2492536|NCT02033889|8617929|P3|Overall Study|Participant moved|0
2492537|NCT02033889|8617930|P2|Overall Study|Participant moved|1
2492538|NCT02033889|8617931|P1|Overall Study|Participant moved|0
2492539|NCT02033889|8617929|P3|Overall Study|Physician Decision|1
2492540|NCT02033889|8617930|P2|Overall Study|Physician Decision|1
2492541|NCT02033889|8617931|P1|Overall Study|Physician Decision|0
2492542|NCT02033889|8617929|P3|Overall Study|Non-Compliance With Study Drug|0
2492543|NCT02033889|8617930|P2|Overall Study|Non-Compliance With Study Drug|0
2492544|NCT02033889|8617931|P1|Overall Study|Non-Compliance With Study Drug|1
2492545|NCT02033889|8617929|P3|Overall Study|Lost to Follow-up|6
2492546|NCT02033889|8617930|P2|Overall Study|Lost to Follow-up|5
2492547|NCT02033889|8617931|P1|Overall Study|Lost to Follow-up|8
2492548|NCT02033889|8617929|P3|Overall Study|Excluded Medication|0
2492549|NCT02033889|8617930|P2|Overall Study|Excluded Medication|1
2492550|NCT02033889|8617931|P1|Overall Study|Excluded Medication|1
2492551|NCT02033889|8617929|P3|Overall Study|Death|2
2492552|NCT02033889|8617930|P2|Overall Study|Death|1
2492553|NCT02033889|8617931|P1|Overall Study|Death|3
2492554|NCT02033889|8617929|P3|Overall Study|Adverse Event|3
2492555|NCT02033889|8617930|P2|Overall Study|Adverse Event|1
2492556|NCT02033889|8617931|P1|Overall Study|Adverse Event|3
2492557|NCT02033850|8618108|P2|Overall Study|unrelated medical reason|1
2492558|NCT02033850|8618109|P1|Overall Study|unrelated medical reason|1
2492559|NCT02033850|8618108|P2|Overall Study|Death|0
2492560|NCT02033850|8618109|P1|Overall Study|Death|1
2492561|NCT02033369|8618176|P2|Overall Study|Protocol Violation|0
2492562|NCT02033369|8618177|P1|Overall Study|Protocol Violation|2
2492563|NCT02033369|8618176|P2|Overall Study|Lost to Follow-up|0
2492564|NCT02033369|8618177|P1|Overall Study|Lost to Follow-up|1
2492565|NCT02033369|8618176|P2|Overall Study|Withdrawal by Subject|1
2492566|NCT02033369|8618177|P1|Overall Study|Withdrawal by Subject|1
2492567|NCT02033369|8618176|P2|Overall Study|Not a good demographic match|2
2492568|NCT02033369|8618177|P1|Overall Study|Not a good demographic match|0
2492569|NCT02033369|8618176|P2|Overall Study|Physician Decision|2
2492570|NCT02033369|8618177|P1|Overall Study|Physician Decision|1
2492571|NCT02032901|8618271|P2|Follow-Up Period (24 Weeks)|Lost to Follow-up|1
2492572|NCT02032901|8618272|P1|Follow-Up Period (24 Weeks)|Lost to Follow-up|0
2492573|NCT02032901|8618271|P2|Treatment Period (12 Weeks)|Pregnancy|0
2492574|NCT02032901|8618272|P1|Treatment Period (12 Weeks)|Pregnancy|1
2492575|NCT02032888|8618296|P3|Follow-up Period|Other|0
2492576|NCT02032888|8618297|P2|Follow-up Period|Other|0
2492577|NCT02032888|8618298|P1|Follow-up Period|Other|1
2492578|NCT02032888|8618296|P3|Follow-up Period|Death|0
2492579|NCT02032888|8618297|P2|Follow-up Period|Death|1
2492580|NCT02032888|8618298|P1|Follow-up Period|Death|1
2492581|NCT02032888|8618296|P3|Follow-up Period|Lost to Follow-up|0
2492582|NCT02032888|8618297|P2|Follow-up Period|Lost to Follow-up|1
2492583|NCT02032888|8618298|P1|Follow-up Period|Lost to Follow-up|1
2492584|NCT02032888|8618296|P3|Treatment Period|Other|0
2492585|NCT02032888|8618297|P2|Treatment Period|Other|1
2492586|NCT02032888|8618298|P1|Treatment Period|Other|1
2492587|NCT02032888|8618296|P3|Treatment Period|Poor compliance/noncompliance|0
2492588|NCT02032888|8618297|P2|Treatment Period|Poor compliance/noncompliance|1
2492589|NCT02032888|8618298|P1|Treatment Period|Poor compliance/noncompliance|1
2492590|NCT02032875|8618329|P2|Follow-up Period|Virologic Relapse|10
2492591|NCT02032875|8618330|P1|Follow-up Period|Virologic Relapse|3
2492592|NCT02032875|8618329|P2|Follow-up Period|Death|1
2492593|NCT02032875|8618330|P1|Follow-up Period|Death|0
2492594|NCT02032875|8618329|P2|Treatment Period|Liver transplant, Treatment extension|3
2492595|NCT02032875|8618330|P1|Treatment Period|Liver transplant, Treatment extension|0
2492596|NCT02032875|8618329|P2|Treatment Period|Liver transplant, No extension needed|1
2492597|NCT02032875|8618330|P1|Treatment Period|Liver transplant, No extension needed|0
2492598|NCT02032875|8618329|P2|Treatment Period|Adverse Event|0
2492599|NCT02032875|8618330|P1|Treatment Period|Adverse Event|1
2492600|NCT02032706|8618373|P1|Overall Study|Protocol Violation|1
2492601|NCT02032706|8618373|P1|Overall Study|Did not qualify|5
2492602|NCT02032407|8618430|P1|Overall Study|Other Miscellaneous Reasons|2
2492603|NCT02032407|8618430|P1|Overall Study|Pregnancy|1
2492604|NCT02032407|8618430|P1|Overall Study|Lost to Follow-up|2
2492605|NCT02032238|8618443|P2|Overall Study|Lost to Follow-up|0
2492606|NCT02032238|8618444|P1|Overall Study|Lost to Follow-up|2
2492607|NCT02031679|8618485|P2|Overall Study|Lack of Efficacy|1
2492608|NCT02031679|8618486|P1|Overall Study|Lack of Efficacy|0
2492609|NCT02031679|8618485|P2|Overall Study|Protocol Violation|1
2492610|NCT02031679|8618486|P1|Overall Study|Protocol Violation|0
2492611|NCT02031640|8618501|P6|Double-blind Treatment Period|Lost to Follow-up|0
2492612|NCT02031640|8618502|P5|Double-blind Treatment Period|Lost to Follow-up|1
2492613|NCT02031640|8618503|P4|Double-blind Treatment Period|Lost to Follow-up|0
2492614|NCT02031640|8618504|P3|Double-blind Treatment Period|Lost to Follow-up|0
2492615|NCT02031640|8618505|P2|Double-blind Treatment Period|Lost to Follow-up|3
2492616|NCT02031640|8618506|P1|Double-blind Treatment Period|Lost to Follow-up|0
2492617|NCT02031640|8618501|P6|Double-blind Treatment Period|Withdrawal by Subject|1
2492618|NCT02031640|8618502|P5|Double-blind Treatment Period|Withdrawal by Subject|1
2492619|NCT02031640|8618503|P4|Double-blind Treatment Period|Withdrawal by Subject|1
2492620|NCT02031640|8618504|P3|Double-blind Treatment Period|Withdrawal by Subject|3
2492621|NCT02031640|8618505|P2|Double-blind Treatment Period|Withdrawal by Subject|2
2492622|NCT02031640|8618506|P1|Double-blind Treatment Period|Withdrawal by Subject|0
2492623|NCT02031640|8618501|P6|Double-blind Treatment Period|Adverse Event|0
2492624|NCT02031640|8618502|P5|Double-blind Treatment Period|Adverse Event|0
2492625|NCT02031640|8618503|P4|Double-blind Treatment Period|Adverse Event|2
2492626|NCT02031640|8618504|P3|Double-blind Treatment Period|Adverse Event|0
2492627|NCT02031640|8618505|P2|Double-blind Treatment Period|Adverse Event|0
2492628|NCT02031640|8618506|P1|Double-blind Treatment Period|Adverse Event|0
2492629|NCT02031640|8618501|P6|Double-blind Treatment Period|Non-compliance|0
2492630|NCT02031640|8618502|P5|Double-blind Treatment Period|Non-compliance|1
2492631|NCT02031640|8618503|P4|Double-blind Treatment Period|Non-compliance|1
2492632|NCT02031640|8618504|P3|Double-blind Treatment Period|Non-compliance|0
2492633|NCT02031640|8618505|P2|Double-blind Treatment Period|Non-compliance|1
2492634|NCT02031640|8618506|P1|Double-blind Treatment Period|Non-compliance|0
2492635|NCT02031640|8618501|P6|Double-blind Treatment Period|Lack of Efficacy|1
2492636|NCT02031640|8618502|P5|Double-blind Treatment Period|Lack of Efficacy|5
2492637|NCT02031640|8618503|P4|Double-blind Treatment Period|Lack of Efficacy|2
2492638|NCT02031640|8618504|P3|Double-blind Treatment Period|Lack of Efficacy|3
2492639|NCT02031640|8618505|P2|Double-blind Treatment Period|Lack of Efficacy|14
2492640|NCT02031640|8618506|P1|Double-blind Treatment Period|Lack of Efficacy|0
2492641|NCT02031640|8618501|P6|Double-blind Treatment Period|Protocol deviation|1
2492642|NCT02031640|8618502|P5|Double-blind Treatment Period|Protocol deviation|3
2492643|NCT02031640|8618503|P4|Double-blind Treatment Period|Protocol deviation|1
2492644|NCT02031640|8618504|P3|Double-blind Treatment Period|Protocol deviation|0
2492645|NCT02031640|8618505|P2|Double-blind Treatment Period|Protocol deviation|2
2492646|NCT02031640|8618506|P1|Double-blind Treatment Period|Protocol deviation|0
2492647|NCT02031640|8618501|P6|Run-In Period|Various administrative reasons|0
2492648|NCT02031640|8618502|P5|Run-In Period|Various administrative reasons|0
2492649|NCT02031640|8618503|P4|Run-In Period|Various administrative reasons|0
2492650|NCT02031640|8618504|P3|Run-In Period|Various administrative reasons|0
2492651|NCT02031640|8618505|P2|Run-In Period|Various administrative reasons|0
2492652|NCT02031640|8618506|P1|Run-In Period|Various administrative reasons|17
2492653|NCT02031640|8618501|P6|Run-In Period|Randomization criteria not met|0
2492654|NCT02031640|8618502|P5|Run-In Period|Randomization criteria not met|0
2492655|NCT02031640|8618503|P4|Run-In Period|Randomization criteria not met|0
2492656|NCT02031640|8618504|P3|Run-In Period|Randomization criteria not met|0
2492657|NCT02031640|8618505|P2|Run-In Period|Randomization criteria not met|0
2492658|NCT02031640|8618506|P1|Run-In Period|Randomization criteria not met|85
2492659|NCT02031640|8618501|P6|Run-In Period|Exclusion criteria met|0
2492660|NCT02031640|8618502|P5|Run-In Period|Exclusion criteria met|0
2492661|NCT02031640|8618503|P4|Run-In Period|Exclusion criteria met|0
2492662|NCT02031640|8618504|P3|Run-In Period|Exclusion criteria met|0
2492663|NCT02031640|8618505|P2|Run-In Period|Exclusion criteria met|0
2492664|NCT02031640|8618506|P1|Run-In Period|Exclusion criteria met|8
2492665|NCT02031640|8618501|P6|Run-In Period|Inclusion criteria not met|0
2492666|NCT02031640|8618502|P5|Run-In Period|Inclusion criteria not met|0
2492667|NCT02031640|8618503|P4|Run-In Period|Inclusion criteria not met|0
2492668|NCT02031640|8618504|P3|Run-In Period|Inclusion criteria not met|0
2492669|NCT02031640|8618505|P2|Run-In Period|Inclusion criteria not met|0
2492670|NCT02031640|8618506|P1|Run-In Period|Inclusion criteria not met|38
2492671|NCT02031640|8618501|P6|Run-In Period|Withdrawal by Subject|0
2492672|NCT02031640|8618502|P5|Run-In Period|Withdrawal by Subject|0
2492673|NCT02031640|8618503|P4|Run-In Period|Withdrawal by Subject|0
2492674|NCT02031640|8618504|P3|Run-In Period|Withdrawal by Subject|0
2492675|NCT02031640|8618505|P2|Run-In Period|Withdrawal by Subject|0
2492676|NCT02031640|8618506|P1|Run-In Period|Withdrawal by Subject|17
2492677|NCT02031640|8618501|P6|Run-In Period|Adverse Event|0
2492678|NCT02031640|8618502|P5|Run-In Period|Adverse Event|0
2492679|NCT02031640|8618503|P4|Run-In Period|Adverse Event|0
2492680|NCT02031640|8618504|P3|Run-In Period|Adverse Event|0
2492681|NCT02031640|8618505|P2|Run-In Period|Adverse Event|0
2492682|NCT02031640|8618506|P1|Run-In Period|Adverse Event|4
2492683|NCT02031640|8618501|P6|Screening Period|Enrollment closed|0
2492684|NCT02031640|8618502|P5|Screening Period|Enrollment closed|0
2492685|NCT02031640|8618503|P4|Screening Period|Enrollment closed|0
2492686|NCT02031640|8618504|P3|Screening Period|Enrollment closed|0
2492687|NCT02031640|8618505|P2|Screening Period|Enrollment closed|0
2492688|NCT02031640|8618506|P1|Screening Period|Enrollment closed|26
2492689|NCT02031640|8618501|P6|Screening Period|Lost to Follow-up|0
2492690|NCT02031640|8618502|P5|Screening Period|Lost to Follow-up|0
2492691|NCT02031640|8618503|P4|Screening Period|Lost to Follow-up|0
2492692|NCT02031640|8618504|P3|Screening Period|Lost to Follow-up|0
2492693|NCT02031640|8618505|P2|Screening Period|Lost to Follow-up|0
2492694|NCT02031640|8618506|P1|Screening Period|Lost to Follow-up|14
2492695|NCT02031640|8618501|P6|Screening Period|Exclusion criteria met|0
2492696|NCT02031640|8618502|P5|Screening Period|Exclusion criteria met|0
2492697|NCT02031640|8618503|P4|Screening Period|Exclusion criteria met|0
2492698|NCT02031640|8618504|P3|Screening Period|Exclusion criteria met|0
2492699|NCT02031640|8618505|P2|Screening Period|Exclusion criteria met|0
2492700|NCT02031640|8618506|P1|Screening Period|Exclusion criteria met|30
2492701|NCT02031640|8618501|P6|Screening Period|Inclusion criteria not met|0
2492702|NCT02031640|8618502|P5|Screening Period|Inclusion criteria not met|0
2492703|NCT02031640|8618503|P4|Screening Period|Inclusion criteria not met|0
2492704|NCT02031640|8618504|P3|Screening Period|Inclusion criteria not met|0
2492705|NCT02031640|8618505|P2|Screening Period|Inclusion criteria not met|0
2492706|NCT02031640|8618506|P1|Screening Period|Inclusion criteria not met|312
2492707|NCT02031640|8618501|P6|Screening Period|Withdrawal by Subject|0
2492708|NCT02031640|8618502|P5|Screening Period|Withdrawal by Subject|0
2492709|NCT02031640|8618503|P4|Screening Period|Withdrawal by Subject|0
2492710|NCT02031640|8618504|P3|Screening Period|Withdrawal by Subject|0
2492711|NCT02031640|8618505|P2|Screening Period|Withdrawal by Subject|0
2492712|NCT02031640|8618506|P1|Screening Period|Withdrawal by Subject|29
2492713|NCT02031640|8618501|P6|Screening Period|Adverse Event|0
2492714|NCT02031640|8618502|P5|Screening Period|Adverse Event|0
2492715|NCT02031640|8618503|P4|Screening Period|Adverse Event|0
2492716|NCT02031640|8618504|P3|Screening Period|Adverse Event|0
2492717|NCT02031640|8618505|P2|Screening Period|Adverse Event|0
2492718|NCT02031640|8618506|P1|Screening Period|Adverse Event|1
2492719|NCT02031471|8618549|P1|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1
2492720|NCT02031471|8618549|P1|Long Term Extension (LTE) Period|Adverse Event|1
2492721|NCT02031471|8618549|P1|24 Week Treatment Period|Hypersensitivity Reaction|1
2492722|NCT02031471|8618549|P1|24 Week Treatment Period|Insufficient Therapeutic Response|1
2492723|NCT02031471|8618549|P1|24 Week Treatment Period|Protocol Violation|1
2492724|NCT02031471|8618549|P1|24 Week Treatment Period|Participant Decision to Withdraw|2
2492725|NCT02031471|8618549|P1|24 Week Treatment Period|Adverse Event|6
2492726|NCT02031458|8618582|P3|Baseline to May 8, 2015|Lost to Follow-up|2
2492727|NCT02031458|8618583|P2|Baseline to May 8, 2015|Lost to Follow-up|1
2492728|NCT02031458|8618584|P1|Baseline to May 8, 2015|Lost to Follow-up|1
2492729|NCT02031458|8618582|P3|Baseline to May 8, 2015|On Treatment|73
2492730|NCT02031458|8618583|P2|Baseline to May 8, 2015|On Treatment|81
2492731|NCT02031458|8618584|P1|Baseline to May 8, 2015|On Treatment|43
2492732|NCT02031458|8618582|P3|Baseline to May 8, 2015|On Survival Follow-Up|73
2492733|NCT02031458|8618583|P2|Baseline to May 8, 2015|On Survival Follow-Up|83
2492734|NCT02031458|8618584|P1|Baseline to May 8, 2015|On Survival Follow-Up|46
2492735|NCT02031458|8618582|P3|Baseline to May 8, 2015|Withdrawal by Subject|3
2492736|NCT02031458|8618583|P2|Baseline to May 8, 2015|Withdrawal by Subject|9
2492737|NCT02031458|8618584|P1|Baseline to May 8, 2015|Withdrawal by Subject|6
2492738|NCT02031458|8618582|P3|Baseline to May 8, 2015|Unknown Reason|2
2492739|NCT02031458|8618583|P2|Baseline to May 8, 2015|Unknown Reason|1
2492740|NCT02031458|8618584|P1|Baseline to May 8, 2015|Unknown Reason|0
2492741|NCT02031458|8618582|P3|Baseline to May 8, 2015|Physician Decision|0
2492742|NCT02031458|8618583|P2|Baseline to May 8, 2015|Physician Decision|1
2492743|NCT02031458|8618584|P1|Baseline to May 8, 2015|Physician Decision|0
2492744|NCT02031458|8618582|P3|Baseline to May 8, 2015|Protocol Violation|0
2492745|NCT02031458|8618583|P2|Baseline to May 8, 2015|Protocol Violation|4
2492746|NCT02031458|8618584|P1|Baseline to May 8, 2015|Protocol Violation|7
2492747|NCT02031458|8618582|P3|Baseline to May 8, 2015|Death|100
2492748|NCT02031458|8618583|P2|Baseline to May 8, 2015|Death|87
2492749|NCT02031458|8618584|P1|Baseline to May 8, 2015|Death|36
2492750|NCT02031458|8618582|P3|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14
2492751|NCT02031458|8618583|P2|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16
2492752|NCT02031458|8618584|P1|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13
2492753|NCT02031458|8618582|P3|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23
2492754|NCT02031458|8618583|P2|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42
2492755|NCT02031458|8618584|P1|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24
2492756|NCT02031458|8618582|P3|May 8, 2015 to January 11, 2019|Protocol Violation|0
2492757|NCT02031458|8618583|P2|May 8, 2015 to January 11, 2019|Protocol Violation|4
2492758|NCT02031458|8618584|P1|May 8, 2015 to January 11, 2019|Protocol Violation|7
2492759|NCT02031458|8618582|P3|May 8, 2015 to January 11, 2019|Physician Decision|3
2492760|NCT02031458|8618583|P2|May 8, 2015 to January 11, 2019|Physician Decision|3
2492761|NCT02031458|8618584|P1|May 8, 2015 to January 11, 2019|Physician Decision|2
2492762|NCT02031458|8618582|P3|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6
2492763|NCT02031458|8618583|P2|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6
2492764|NCT02031458|8618584|P1|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1
2492765|NCT02031458|8618582|P3|May 8, 2015 to January 11, 2019|Lost to Follow-up|8
2492766|NCT02031458|8618583|P2|May 8, 2015 to January 11, 2019|Lost to Follow-up|5
2492767|NCT02031458|8618584|P1|May 8, 2015 to January 11, 2019|Lost to Follow-up|2
2492768|NCT02031458|8618582|P3|May 8, 2015 to January 11, 2019|Death|198
2492769|NCT02031458|8618583|P2|May 8, 2015 to January 11, 2019|Death|193
2492770|NCT02031458|8618584|P1|May 8, 2015 to January 11, 2019|Death|89
2492771|NCT02031432|8618678|P1|Overall Study|Death|10
2492772|NCT02031432|8618678|P1|Overall Study|Inclusion/Exclusion criteria not met|5
2492773|NCT02031432|8618678|P1|Overall Study|Lost to Follow-up|1
2492774|NCT02031432|8618678|P1|Overall Study|Withdrawal by Subject|5
2492775|NCT02031432|8618678|P1|Overall Study|Adverse Event|8
2492776|NCT02031432|8618678|P1|Overall Study|Withdrawn as forbidden meds required|1
2492777|NCT02031432|8618678|P1|Overall Study|Cancer Progression|2
2492778|NCT02031432|8618678|P1|Overall Study|Lack of Efficacy|5
2492779|NCT02031432|8618678|P1|Overall Study|Protocol Violation|1
2492780|NCT02031302|8618705|P2|Overall Study|Lost to Follow-up|0
2492781|NCT02031302|8618706|P1|Overall Study|Lost to Follow-up|4
2492782|NCT02031302|8618705|P2|Overall Study|Missed Follow Up|0
2492783|NCT02031302|8618706|P1|Overall Study|Missed Follow Up|27
2492784|NCT02031302|8618705|P2|Overall Study|Not treated with study valve system|0
2492785|NCT02031302|8618706|P1|Overall Study|Not treated with study valve system|18
2492786|NCT02031302|8618705|P2|Overall Study|Death|0
2492787|NCT02031302|8618706|P1|Overall Study|Death|115
2492788|NCT02031276|8618727|P3|Period 3 Open-label Risankizumab SC|Other|1
2492789|NCT02031276|8618728|P2|Period 3 Open-label Risankizumab SC|Other|0
2492790|NCT02031276|8618729|P1|Period 3 Open-label Risankizumab SC|Other|0
2492791|NCT02031276|8618727|P3|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
2492792|NCT02031276|8618728|P2|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
2492793|NCT02031276|8618729|P1|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
2492794|NCT02031276|8618727|P3|Period 3 Open-label Risankizumab SC|Protocol Violation|0
2492795|NCT02031276|8618728|P2|Period 3 Open-label Risankizumab SC|Protocol Violation|0
2492796|NCT02031276|8618729|P1|Period 3 Open-label Risankizumab SC|Protocol Violation|2
2492797|NCT02031276|8618727|P3|Period 3 Open-label Risankizumab SC|Adverse Event|0
2492798|NCT02031276|8618728|P2|Period 3 Open-label Risankizumab SC|Adverse Event|2
2492799|NCT02031276|8618729|P1|Period 3 Open-label Risankizumab SC|Adverse Event|0
2492800|NCT02031276|8618727|P3|Period 2 Open-label Risankizumab IV|Other|1
2492801|NCT02031276|8618728|P2|Period 2 Open-label Risankizumab IV|Other|2
2492802|NCT02031276|8618729|P1|Period 2 Open-label Risankizumab IV|Other|0
2492803|NCT02031276|8618727|P3|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
2492804|NCT02031276|8618728|P2|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
2492805|NCT02031276|8618729|P1|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3
2492806|NCT02031276|8618727|P3|Period 2 Open-label Risankizumab IV|Adverse Event|0
2492807|NCT02031276|8618728|P2|Period 2 Open-label Risankizumab IV|Adverse Event|0
2492808|NCT02031276|8618729|P1|Period 2 Open-label Risankizumab IV|Adverse Event|1
2492809|NCT02031276|8618727|P3|Period 1 Double-blind IV|Other|0
2492810|NCT02031276|8618728|P2|Period 1 Double-blind IV|Other|1
2492811|NCT02031276|8618729|P1|Period 1 Double-blind IV|Other|0
2492812|NCT02031276|8618727|P3|Period 1 Double-blind IV|Adverse Event|1
2492813|NCT02031276|8618728|P2|Period 1 Double-blind IV|Adverse Event|5
2492814|NCT02031276|8618729|P1|Period 1 Double-blind IV|Adverse Event|6
2492815|NCT02031237|8618763|P3|Overall Study|Alternate Treatment Given|3
2492816|NCT02031237|8618764|P2|Overall Study|Alternate Treatment Given|0
2492817|NCT02031237|8618765|P1|Overall Study|Alternate Treatment Given|0
2492818|NCT02031237|8618763|P3|Overall Study|Protocol Violation|0
2492819|NCT02031237|8618764|P2|Overall Study|Protocol Violation|6
2492820|NCT02031237|8618765|P1|Overall Study|Protocol Violation|2
2492821|NCT02031237|8618763|P3|Overall Study|Withdrawal by Subject|0
2492822|NCT02031237|8618764|P2|Overall Study|Withdrawal by Subject|2
2492823|NCT02031237|8618765|P1|Overall Study|Withdrawal by Subject|2
2492824|NCT02031237|8618763|P3|Overall Study|Physician Decision|0
2492825|NCT02031237|8618764|P2|Overall Study|Physician Decision|1
2492826|NCT02031237|8618765|P1|Overall Study|Physician Decision|0
2492827|NCT02031237|8618763|P3|Overall Study|Death|0
2492828|NCT02031237|8618764|P2|Overall Study|Death|5
2492829|NCT02031237|8618765|P1|Overall Study|Death|1
2492830|NCT02030847|8618772|P1|Overall Study|Withdrawal by Subject|1
2492831|NCT02030847|8618772|P1|Overall Study|Physician Decision|3
2492832|NCT02030847|8618772|P1|Overall Study|New Cancer Therapy|8
2492833|NCT02030847|8618772|P1|Overall Study|Disease Progression|15
2492834|NCT02030847|8618772|P1|Overall Study|Death|10
2492835|NCT02030821|8618781|P4|Overall Study|Physician Decision|2
2492836|NCT02030821|8618782|P3|Overall Study|Physician Decision|5
2492837|NCT02030821|8618783|P2|Overall Study|Physician Decision|2
2492838|NCT02030821|8618784|P1|Overall Study|Physician Decision|2
2492839|NCT02030600|8618812|P2|Treatment Period 2|Unclassified|0
2492840|NCT02030600|8618813|P1|Treatment Period 2|Unclassified|1
2492841|NCT02030600|8618812|P2|Treatment Period 2|Withdrawal by Subject|9
2492842|NCT02030600|8618813|P1|Treatment Period 2|Withdrawal by Subject|13
2492843|NCT02030600|8618812|P2|Treatment Period 2|Protocol Violation|2
2492844|NCT02030600|8618813|P1|Treatment Period 2|Protocol Violation|1
2492845|NCT02030600|8618812|P2|Treatment Period 2|Lost to Follow-up|2
2492846|NCT02030600|8618813|P1|Treatment Period 2|Lost to Follow-up|4
2492847|NCT02030600|8618812|P2|Treatment Period 2|Lack of Efficacy|1
2492848|NCT02030600|8618813|P1|Treatment Period 2|Lack of Efficacy|2
2492849|NCT02030600|8618812|P2|Treatment Period 2|Adverse Event|4
2492850|NCT02030600|8618813|P1|Treatment Period 2|Adverse Event|4
2492851|NCT02030600|8618812|P2|Treatment Period 1|Unclassified|0
2492852|NCT02030600|8618813|P1|Treatment Period 1|Unclassified|1
2492853|NCT02030600|8618812|P2|Treatment Period 1|Casebook Unsigned|0
2492854|NCT02030600|8618813|P1|Treatment Period 1|Casebook Unsigned|1
2492855|NCT02030600|8618812|P2|Treatment Period 1|Withdrawal by Subject|17
2492856|NCT02030600|8618813|P1|Treatment Period 1|Withdrawal by Subject|13
2492857|NCT02030600|8618812|P2|Treatment Period 1|Protocol Violation|17
2492858|NCT02030600|8618813|P1|Treatment Period 1|Protocol Violation|22
2492859|NCT02030600|8618812|P2|Treatment Period 1|Lost to Follow-up|3
2492860|NCT02030600|8618813|P1|Treatment Period 1|Lost to Follow-up|11
2492861|NCT02030600|8618812|P2|Treatment Period 1|Lack of Efficacy|1
2492862|NCT02030600|8618813|P1|Treatment Period 1|Lack of Efficacy|0
2492863|NCT02030600|8618812|P2|Treatment Period 1|Adverse Event|7
2492864|NCT02030600|8618813|P1|Treatment Period 1|Adverse Event|5
2492865|NCT02030535|8618834|P1|Washout Period 1 (21 Days)|Adverse Event|1
2492866|NCT02030405|8618902|P1|Overall Study|Lost to Follow-up|1
2492867|NCT02030405|8618902|P1|Overall Study|Withdrawal by Subject|1
2492868|NCT02030119|8618913|P4|Overall Study|Ineligible (see Pre-assignment Details)|0
2492869|NCT02030119|8618914|P3|Overall Study|Ineligible (see Pre-assignment Details)|1
2492870|NCT02030119|8618915|P2|Overall Study|Ineligible (see Pre-assignment Details)|1
2492871|NCT02030119|8618916|P1|Overall Study|Ineligible (see Pre-assignment Details)|0
2492872|NCT02030119|8618913|P4|Overall Study|Withdrawal by Subject|3
2492873|NCT02030119|8618914|P3|Overall Study|Withdrawal by Subject|5
2492874|NCT02030119|8618915|P2|Overall Study|Withdrawal by Subject|1
2492875|NCT02030119|8618916|P1|Overall Study|Withdrawal by Subject|3
2492876|NCT02030041|8618954|P3|Overall Study|Withdrawal by Subject|1
2492877|NCT02030041|8618955|P2|Overall Study|Withdrawal by Subject|2
2492878|NCT02030041|8618956|P1|Overall Study|Withdrawal by Subject|2
2492879|NCT02029989|8618969|P2|Overall Study|Protocol Violation|0
2492880|NCT02029989|8618970|P1|Overall Study|Protocol Violation|1
2492881|NCT02029989|8618969|P2|Overall Study|Death|1
2492882|NCT02029989|8618970|P1|Overall Study|Death|0
2492883|NCT02029989|8618969|P2|Overall Study|Lost to Follow-up|7
2492884|NCT02029989|8618970|P1|Overall Study|Lost to Follow-up|9
2492885|NCT02029989|8618969|P2|Overall Study|Physician Decision|0
2492886|NCT02029989|8618970|P1|Overall Study|Physician Decision|2
2492887|NCT02029989|8618969|P2|Overall Study|Change of location|3
2492888|NCT02029989|8618970|P1|Overall Study|Change of location|2
2492889|NCT02029989|8618969|P2|Overall Study|Withdrawal: Fear of needles|0
2492890|NCT02029989|8618970|P1|Overall Study|Withdrawal: Fear of needles|1
2492891|NCT02029989|8618969|P2|Overall Study|Withdrawal by Subject|0
2492892|NCT02029989|8618970|P1|Overall Study|Withdrawal by Subject|1
2492893|NCT02029846|8618993|P2|Overall Study|n=1 each arm|1
2492894|NCT02029846|8618994|P1|Overall Study|n=1 each arm|1
2492895|NCT02029638|8619032|P3|Overall Study|Decision by Study Sponsor or Regulatory|0
2492896|NCT02029638|8619033|P2|Overall Study|Decision by Study Sponsor or Regulatory|0
2492897|NCT02029638|8619034|P1|Overall Study|Decision by Study Sponsor or Regulatory|2
2492898|NCT02029638|8619032|P3|Overall Study|Death|1
2492899|NCT02029638|8619033|P2|Overall Study|Death|0
2492900|NCT02029638|8619034|P1|Overall Study|Death|0
2492901|NCT02029521|8619063|P2|Overall Study|Withdrawal by Subject|1
2492902|NCT02029521|8619064|P1|Overall Study|Withdrawal by Subject|1
2492903|NCT02029521|8619063|P2|Overall Study|Protocol Violation|0
2492904|NCT02029521|8619064|P1|Overall Study|Protocol Violation|1
2492905|NCT02029417|8619162|P1|Overall Study|Adverse Event|1
2492906|NCT02029417|8619162|P1|Overall Study|Death|1
2492907|NCT02029274|8619171|P4|Overall Study|Adverse Event|2
2492908|NCT02029274|8619172|P3|Overall Study|Adverse Event|2
2492909|NCT02029274|8619173|P2|Overall Study|Adverse Event|0
2492910|NCT02029274|8619174|P1|Overall Study|Adverse Event|1
2492911|NCT02029235|8619206|P2|Overall Study|Non-compliance with study meds or diary|1
2492912|NCT02029235|8619207|P1|Overall Study|Non-compliance with study meds or diary|4
2492913|NCT02028871|8619239|P2|Overall Study|Current Illness|0
2492914|NCT02028871|8619240|P1|Overall Study|Current Illness|1
2492915|NCT02028871|8619239|P2|Overall Study|IV placement difficulty|0
2492916|NCT02028871|8619240|P1|Overall Study|IV placement difficulty|1
2492917|NCT02028871|8619239|P2|Overall Study|Withdrawal by Subject|2
2492918|NCT02028871|8619240|P1|Overall Study|Withdrawal by Subject|1
2492919|NCT02028871|8619239|P2|Overall Study|Positive urine drug screen|1
2492920|NCT02028871|8619240|P1|Overall Study|Positive urine drug screen|1
2492921|NCT02028767|8619337|P2|Treatment Period 2|Reason other than those specified above|0
2492922|NCT02028767|8619338|P1|Treatment Period 2|Reason other than those specified above|1
2492923|NCT02028767|8619337|P2|Treatment Period 2|Non compliant with protocol|0
2492924|NCT02028767|8619338|P1|Treatment Period 2|Non compliant with protocol|1
2492925|NCT02028715|8619371|P2|Overall Study|Did not complete satisfaction surveys|2
2492926|NCT02028715|8619372|P1|Overall Study|Did not complete satisfaction surveys|2
2492927|NCT02028715|8619371|P2|Overall Study|Physician Decision|0
2492928|NCT02028715|8619372|P1|Overall Study|Physician Decision|1
2492929|NCT02028715|8619371|P2|Overall Study|Adverse Event|2
2492930|NCT02028715|8619372|P1|Overall Study|Adverse Event|2
2492931|NCT02028169|8619584|P1|Overall Study|Concomitant Medication Usage|1
2492932|NCT02028169|8619584|P1|Overall Study|Cessation of Drug|1
2492933|NCT02028169|8619584|P1|Overall Study|Adverse Event|1
2492934|NCT02028169|8619584|P1|Overall Study|Withdrawal by Subject|2
2492935|NCT02028169|8619584|P1|Overall Study|Lack of Efficacy|2
2492936|NCT02028169|8619584|P1|Overall Study|Lost to Follow-up|21
2492937|NCT02028065|8619610|P3|Treatment Through Study Completion|Adverse Event|5
2492938|NCT02028065|8619611|P2|Treatment Through Study Completion|Adverse Event|3
2492939|NCT02028065|8619612|P1|Treatment Through Study Completion|Adverse Event|3
2492940|NCT02028065|8619610|P3|Treatment Through Study Completion|Withdrawal by Subject|3
2492941|NCT02028065|8619611|P2|Treatment Through Study Completion|Withdrawal by Subject|4
2492942|NCT02028065|8619612|P1|Treatment Through Study Completion|Withdrawal by Subject|5
2492943|NCT02028065|8619610|P3|Treatment Through Study Completion|Protocol Violation|0
2492944|NCT02028065|8619611|P2|Treatment Through Study Completion|Protocol Violation|4
2492945|NCT02028065|8619612|P1|Treatment Through Study Completion|Protocol Violation|1
2492946|NCT02028065|8619610|P3|Treatment Through Study Completion|Physician Decision|0
2492947|NCT02028065|8619611|P2|Treatment Through Study Completion|Physician Decision|0
2492948|NCT02028065|8619612|P1|Treatment Through Study Completion|Physician Decision|1
2492949|NCT02028065|8619610|P3|Treatment Through Study Completion|Lost to Follow-up|6
2492950|NCT02028065|8619611|P2|Treatment Through Study Completion|Lost to Follow-up|4
2492951|NCT02028065|8619612|P1|Treatment Through Study Completion|Lost to Follow-up|2
2492952|NCT02028065|8619610|P3|Randomization Through Start Treatment|Not treated|3
2492953|NCT02028065|8619611|P2|Randomization Through Start Treatment|Not treated|3
2492954|NCT02028065|8619612|P1|Randomization Through Start Treatment|Not treated|1
2492955|NCT02027844|8619639|P3|Overall Study|Incomlete data|0
2492956|NCT02027844|8619640|P2|Overall Study|Incomlete data|0
2492957|NCT02027844|8619641|P1|Overall Study|Incomlete data|2
2492958|NCT02027844|8619639|P3|Overall Study|Protocol Violation|0
2492959|NCT02027844|8619640|P2|Overall Study|Protocol Violation|2
2492960|NCT02027844|8619641|P1|Overall Study|Protocol Violation|0
2492961|NCT02027844|8619639|P3|Overall Study|Lost to Follow-up|1
2492962|NCT02027844|8619640|P2|Overall Study|Lost to Follow-up|2
2492963|NCT02027844|8619641|P1|Overall Study|Lost to Follow-up|0
2492964|NCT02027844|8619639|P3|Overall Study|Withdrawal by Subject|1
2492965|NCT02027844|8619640|P2|Overall Study|Withdrawal by Subject|2
2492966|NCT02027844|8619641|P1|Overall Study|Withdrawal by Subject|3
2492967|NCT02027701|8619658|P1|Overall Study|Withdrawal by Subject|3
2492968|NCT02027701|8619658|P1|Overall Study|Physician Decision|2
2492969|NCT02027701|8619658|P1|Overall Study|Lack of Efficacy|8
2492970|NCT02027701|8619658|P1|Overall Study|Adverse Event|3
2492971|NCT02027623|8619676|P2|Overall Study|Withdrawal by Subject|9
2492972|NCT02027623|8619677|P1|Overall Study|Withdrawal by Subject|6
2492973|NCT02027623|8619676|P2|Overall Study|Lost to Follow-up|3
2492974|NCT02027623|8619677|P1|Overall Study|Lost to Follow-up|3
2492975|NCT02027558|8619769|P2|Overall Study|Refused assessment|0
2492976|NCT02027558|8619770|P1|Overall Study|Refused assessment|3
2492977|NCT02027558|8619769|P2|Overall Study|Lost to Follow-up|1
2492978|NCT02027558|8619770|P1|Overall Study|Lost to Follow-up|4
2492979|NCT02027558|8619769|P2|Overall Study|Withdrawal by Subject|0
2492980|NCT02027558|8619770|P1|Overall Study|Withdrawal by Subject|2
2492981|NCT02027558|8619769|P2|Overall Study|Death|1
2492982|NCT02027558|8619770|P1|Overall Study|Death|0
2492983|NCT02027545|8619788|P2|Overall Study|Failed to attend study visit|0
2492984|NCT02027545|8619789|P1|Overall Study|Failed to attend study visit|2
2492985|NCT02027545|8619788|P2|Overall Study|Failed to sign HIPAA|2
2492986|NCT02027545|8619789|P1|Overall Study|Failed to sign HIPAA|0
2492987|NCT02027428|8619801|P3|Survival Follow-up|Lost to Follow-up|0
2492988|NCT02027428|8619802|P2|Survival Follow-up|Lost to Follow-up|1
2492989|NCT02027428|8619803|P1|Survival Follow-up|Lost to Follow-up|0
2492990|NCT02027428|8619801|P3|Survival Follow-up|Death|30
2492991|NCT02027428|8619802|P2|Survival Follow-up|Death|47
2492992|NCT02027428|8619803|P1|Survival Follow-up|Death|0
2492993|NCT02027428|8619801|P3|Maintenance|Other|3
2492994|NCT02027428|8619802|P2|Maintenance|Other|6
2492995|NCT02027428|8619803|P1|Maintenance|Other|0
2492996|NCT02027428|8619801|P3|Maintenance|Protocol Violation|1
2492997|NCT02027428|8619802|P2|Maintenance|Protocol Violation|0
2492998|NCT02027428|8619803|P1|Maintenance|Protocol Violation|0
2492999|NCT02027428|8619801|P3|Maintenance|Withdrawal by Subject|5
2493000|NCT02027428|8619802|P2|Maintenance|Withdrawal by Subject|6
2493001|NCT02027428|8619803|P1|Maintenance|Withdrawal by Subject|0
2493002|NCT02027428|8619801|P3|Maintenance|Symptomatic deterioration|1
2493003|NCT02027428|8619802|P2|Maintenance|Symptomatic deterioration|4
2493004|NCT02027428|8619803|P1|Maintenance|Symptomatic deterioration|0
2493005|NCT02027428|8619801|P3|Maintenance|Progressive disease|47
2493006|NCT02027428|8619802|P2|Maintenance|Progressive disease|84
2493007|NCT02027428|8619803|P1|Maintenance|Progressive disease|0
2493008|NCT02027428|8619801|P3|Maintenance|Adverse Event|1
2493009|NCT02027428|8619802|P2|Maintenance|Adverse Event|21
2493010|NCT02027428|8619803|P1|Maintenance|Adverse Event|0
2493011|NCT02027428|8619801|P3|Maintenance|Death|2
2493012|NCT02027428|8619802|P2|Maintenance|Death|3
2493013|NCT02027428|8619803|P1|Maintenance|Death|0
2493014|NCT02027428|8619801|P3|Induction|Induction treatment ongoing|0
2493015|NCT02027428|8619802|P2|Induction|Induction treatment ongoing|0
2493016|NCT02027428|8619803|P1|Induction|Induction treatment ongoing|4
2493017|NCT02027428|8619801|P3|Induction|Protocol Violation|0
2493018|NCT02027428|8619802|P2|Induction|Protocol Violation|0
2493019|NCT02027428|8619803|P1|Induction|Protocol Violation|1
2493020|NCT02027428|8619801|P3|Induction|Study terminated by sponsor|0
2493021|NCT02027428|8619802|P2|Induction|Study terminated by sponsor|0
2493022|NCT02027428|8619803|P1|Induction|Study terminated by sponsor|12
2493023|NCT02027428|8619801|P3|Induction|Other|0
2493024|NCT02027428|8619802|P2|Induction|Other|0
2493025|NCT02027428|8619803|P1|Induction|Other|14
2493026|NCT02027428|8619801|P3|Induction|Symptomatic deterioration|0
2493027|NCT02027428|8619802|P2|Induction|Symptomatic deterioration|0
2493028|NCT02027428|8619803|P1|Induction|Symptomatic deterioration|16
2493029|NCT02027428|8619801|P3|Induction|Death|0
2493030|NCT02027428|8619802|P2|Induction|Death|0
2493031|NCT02027428|8619803|P1|Induction|Death|21
2493032|NCT02027428|8619801|P3|Induction|Withdrawal by Subject|0
2493033|NCT02027428|8619802|P2|Induction|Withdrawal by Subject|0
2493034|NCT02027428|8619803|P1|Induction|Withdrawal by Subject|22
2493035|NCT02027428|8619801|P3|Induction|Adverse Event|0
2493036|NCT02027428|8619802|P2|Induction|Adverse Event|0
2493037|NCT02027428|8619803|P1|Induction|Adverse Event|51
2493038|NCT02027428|8619801|P3|Induction|Progressive disease|0
2493039|NCT02027428|8619802|P2|Induction|Progressive disease|0
2493040|NCT02027428|8619803|P1|Induction|Progressive disease|77
2493041|NCT02027428|8619801|P3|Induction|Never treated|0
2493042|NCT02027428|8619802|P2|Induction|Never treated|0
2493043|NCT02027428|8619803|P1|Induction|Never treated|7
2493044|NCT02027402|8619841|P2|Overall Study|Withdrawal by Subject|1
2493045|NCT02027402|8619842|P1|Overall Study|Withdrawal by Subject|4
2493046|NCT02027376|8619854|P3|Overall Study|Death|0
2493047|NCT02027376|8619855|P2|Overall Study|Death|0
2493048|NCT02027376|8619856|P1|Overall Study|Death|1
2493049|NCT02027311|8619882|P2|Overall Study|Protocol Violation|2
2493050|NCT02027311|8619883|P1|Overall Study|Protocol Violation|3
2493051|NCT02027025|8619903|P3|Overall Study|Sponsor's decision|0
2493052|NCT02027025|8619904|P2|Overall Study|Sponsor's decision|1
2493053|NCT02027025|8619905|P1|Overall Study|Sponsor's decision|0
2493054|NCT02027025|8619903|P3|Overall Study|Withdrawal by Subject|0
2493055|NCT02027025|8619904|P2|Overall Study|Withdrawal by Subject|1
2493056|NCT02027025|8619905|P1|Overall Study|Withdrawal by Subject|0
2493057|NCT02027025|8619903|P3|Overall Study|Lost to Follow-up|0
2493058|NCT02027025|8619904|P2|Overall Study|Lost to Follow-up|2
2493059|NCT02027025|8619905|P1|Overall Study|Lost to Follow-up|0
2493060|NCT02027025|8619903|P3|Overall Study|Protocol Violation|0
2493061|NCT02027025|8619904|P2|Overall Study|Protocol Violation|0
2493062|NCT02027025|8619905|P1|Overall Study|Protocol Violation|1
2493063|NCT02027025|8619903|P3|Overall Study|Adverse Event|1
2493064|NCT02027025|8619904|P2|Overall Study|Adverse Event|1
2493065|NCT02027025|8619905|P1|Overall Study|Adverse Event|0
2493066|NCT02026258|8619955|P2|Recieved Allocated Intervention|Lost to Follow-up|1
2493067|NCT02026258|8619956|P1|Recieved Allocated Intervention|Lost to Follow-up|0
2493068|NCT02026258|8619955|P2|Recieved Allocated Intervention|Withdrawal by Subject|1
2493069|NCT02026258|8619956|P1|Recieved Allocated Intervention|Withdrawal by Subject|1
2493070|NCT02026258|8619955|P2|Randomized|Presence of periodontal disease|1
2493071|NCT02026258|8619956|P1|Randomized|Presence of periodontal disease|1
2493072|NCT02026258|8619955|P2|Randomized|Change in treatment plan|0
2493073|NCT02026258|8619956|P1|Randomized|Change in treatment plan|1
2493074|NCT02026258|8619955|P2|Randomized|Did not start treatment|1
2493075|NCT02026258|8619956|P1|Randomized|Did not start treatment|2
2493076|NCT02026141|8619990|P2|Overall Study|Protocol Violation|1
2493077|NCT02026141|8619991|P1|Overall Study|Protocol Violation|0
2493078|NCT02026063|8619999|P2|Overall Study|Reason not Specified|7
2493079|NCT02026063|8620000|P1|Overall Study|Reason not Specified|2
2493080|NCT02026063|8619999|P2|Overall Study|Lost to Follow-up|1
2493081|NCT02026063|8620000|P1|Overall Study|Lost to Follow-up|0
2493082|NCT02026063|8619999|P2|Overall Study|Lack of Efficacy|4
2493083|NCT02026063|8620000|P1|Overall Study|Lack of Efficacy|0
2493084|NCT02026063|8619999|P2|Overall Study|Adverse Event|20
2493085|NCT02026063|8620000|P1|Overall Study|Adverse Event|5
2493086|NCT02026063|8619999|P2|Overall Study|Withdrawal of Consent|6
2493087|NCT02026063|8620000|P1|Overall Study|Withdrawal of Consent|1
2493088|NCT02026063|8619999|P2|Overall Study|Noncompliance with Study Drug|1
2493089|NCT02026063|8620000|P1|Overall Study|Noncompliance with Study Drug|1
2493090|NCT02026063|8619999|P2|Overall Study|Physician Decision|10
2493091|NCT02026063|8620000|P1|Overall Study|Physician Decision|0
2493092|NCT02026011|8620012|P2|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2
2493093|NCT02026011|8620013|P1|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1
2493094|NCT02026011|8620012|P2|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0
2493095|NCT02026011|8620013|P1|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1
2493096|NCT02026011|8620012|P2|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2
2493097|NCT02026011|8620013|P1|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1
2493098|NCT02026011|8620012|P2|Allocation 1 (First Set of Medication)|Side Effects|0
2493099|NCT02026011|8620013|P1|Allocation 1 (First Set of Medication)|Side Effects|6
2493100|NCT02025907|8620039|P2|Overall Study|Potential misconduct,GCPcompliance issue|1
2493101|NCT02025907|8620040|P1|Overall Study|Potential misconduct,GCPcompliance issue|2
2493102|NCT02025907|8620039|P2|Overall Study|Adverse Event|1
2493103|NCT02025907|8620040|P1|Overall Study|Adverse Event|3
2493104|NCT02025907|8620039|P2|Overall Study|Lost to Follow-up|2
2493105|NCT02025907|8620040|P1|Overall Study|Lost to Follow-up|2
2493106|NCT02025907|8620039|P2|Overall Study|Physician Decision|0
2493107|NCT02025907|8620040|P1|Overall Study|Physician Decision|2
2493108|NCT02025907|8620039|P2|Overall Study|Protocol Violation|0
2493109|NCT02025907|8620040|P1|Overall Study|Protocol Violation|2
2493110|NCT02025907|8620039|P2|Overall Study|Withdrawal by Subject|8
2493111|NCT02025907|8620040|P1|Overall Study|Withdrawal by Subject|15
2493112|NCT02025907|8620039|P2|Overall Study|Lack of Efficacy|0
2493113|NCT02025907|8620040|P1|Overall Study|Lack of Efficacy|1
2493114|NCT02025725|8620068|P2|Overall Study|Post-dose QTcB > 270 msec|1
2493115|NCT02025725|8620069|P1|Overall Study|Post-dose QTcB > 270 msec|0
2493116|NCT02025725|8620068|P2|Overall Study|Withdrawal by Subject|2
2493117|NCT02025725|8620069|P1|Overall Study|Withdrawal by Subject|3
2493118|NCT02025725|8620068|P2|Overall Study|Protocol Violation|1
2493119|NCT02025725|8620069|P1|Overall Study|Protocol Violation|1
2493120|NCT02025725|8620068|P2|Overall Study|Lost to Follow-up|0
2493121|NCT02025725|8620069|P1|Overall Study|Lost to Follow-up|2
2493122|NCT02025725|8620068|P2|Overall Study|Adverse Event|0
2493123|NCT02025725|8620069|P1|Overall Study|Adverse Event|5
2493124|NCT02025621|8620106|P2|Overall Study|Surgery initiated before infusion|3
2493125|NCT02025621|8620107|P1|Overall Study|Surgery initiated before infusion|3
2493126|NCT02025621|8620106|P2|Overall Study|No longer eligible|15
2493127|NCT02025621|8620107|P1|Overall Study|No longer eligible|10
2493128|NCT02025621|8620106|P2|Overall Study|Death|1
2493129|NCT02025621|8620107|P1|Overall Study|Death|0
2493130|NCT02025621|8620106|P2|Overall Study|Withdrawal by Subject|0
2493131|NCT02025621|8620107|P1|Overall Study|Withdrawal by Subject|1
2493132|NCT02025530|8620127|P2|Overall Study|No longer met elligibility criteria|1
2493133|NCT02025530|8620128|P1|Overall Study|No longer met elligibility criteria|5
2493134|NCT02025205|8620140|P2|Overall Study|Death|1
2493135|NCT02025205|8620141|P1|Overall Study|Death|0
2493136|NCT02025205|8620140|P2|Overall Study|Protocol Violation|1
2493137|NCT02025205|8620141|P1|Overall Study|Protocol Violation|2
2493138|NCT02025205|8620140|P2|Overall Study|Withdrawal by Subject|1
2493139|NCT02025205|8620141|P1|Overall Study|Withdrawal by Subject|1
2493140|NCT02025179|8620185|P3|Overall Study|Lost to Follow-up|1
2493141|NCT02025179|8620186|P2|Overall Study|Lost to Follow-up|0
2493142|NCT02025179|8620187|P1|Overall Study|Lost to Follow-up|0
2493143|NCT02024971|8620237|P1|Overall Study|Lost to Follow-up|6
2493144|NCT02024971|8620237|P1|Overall Study|Data Not Available|30
2493145|NCT02024932|8620250|P6|Overall Study|Abnormal laboratory value|0
2493146|NCT02024932|8620251|P5|Overall Study|Abnormal laboratory value|0
2493147|NCT02024932|8620252|P4|Overall Study|Abnormal laboratory value|2
2493148|NCT02024932|8620253|P3|Overall Study|Abnormal laboratory value|0
2493149|NCT02024932|8620254|P2|Overall Study|Abnormal laboratory value|0
2493150|NCT02024932|8620255|P1|Overall Study|Abnormal laboratory value|0
2493151|NCT02024932|8620250|P6|Overall Study|Adverse Event|0
2493152|NCT02024932|8620251|P5|Overall Study|Adverse Event|2
2493153|NCT02024932|8620252|P4|Overall Study|Adverse Event|0
2493154|NCT02024932|8620253|P3|Overall Study|Adverse Event|0
2493155|NCT02024932|8620254|P2|Overall Study|Adverse Event|3
2493156|NCT02024932|8620255|P1|Overall Study|Adverse Event|2
2493157|NCT02024867|8620314|P2|Overall Study|Lost to Follow-up|4
2493158|NCT02024867|8620315|P1|Overall Study|Lost to Follow-up|6
2493159|NCT02024867|8620314|P2|Overall Study|Protocol Violation|3
2493160|NCT02024867|8620315|P1|Overall Study|Protocol Violation|3
2493161|NCT02024750|8620333|P2|Overall Study|Withdrawal by Subject|1
2493162|NCT02024750|8620334|P1|Overall Study|Withdrawal by Subject|2
2493163|NCT02024698|8620355|P2|First Intervention (7 Days)|Withdrawal by Subject|1
2493164|NCT02024698|8620356|P1|First Intervention (7 Days)|Withdrawal by Subject|0
2493165|NCT02023879|8620466|P3|Extension Open Label Treatment|Other than specified above|2
2493166|NCT02023879|8620467|P2|Extension Open Label Treatment|Other than specified above|7
2493167|NCT02023879|8620468|P1|Extension Open Label Treatment|Other than specified above|2
2493168|NCT02023879|8620466|P3|Extension Open Label Treatment|Participant moved|0
2493169|NCT02023879|8620467|P2|Extension Open Label Treatment|Participant moved|2
2493170|NCT02023879|8620468|P1|Extension Open Label Treatment|Participant moved|1
2493171|NCT02023879|8620466|P3|Extension Open Label Treatment|Poor compliance to protocol|0
2493172|NCT02023879|8620467|P2|Extension Open Label Treatment|Poor compliance to protocol|1
2493173|NCT02023879|8620468|P1|Extension Open Label Treatment|Poor compliance to protocol|1
2493174|NCT02023879|8620466|P3|Extension Open Label Treatment|Adverse Event|3
2493175|NCT02023879|8620467|P2|Extension Open Label Treatment|Adverse Event|7
2493176|NCT02023879|8620468|P1|Extension Open Label Treatment|Adverse Event|1
2493177|NCT02023879|8620466|P3|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
2493178|NCT02023879|8620467|P2|Period 1: 24-Week Double-blind Treatment|Other than specified above|3
2493179|NCT02023879|8620468|P1|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
2493180|NCT02023879|8620466|P3|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
2493181|NCT02023879|8620467|P2|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
2493182|NCT02023879|8620468|P1|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0
2493183|NCT02023879|8620466|P3|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
2493184|NCT02023879|8620467|P2|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0
2493185|NCT02023879|8620468|P1|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
2493186|NCT02023879|8620466|P3|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
2493187|NCT02023879|8620467|P2|Period 1: 24-Week Double-blind Treatment|Physician Decision|1
2493188|NCT02023879|8620468|P1|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
2493189|NCT02023879|8620466|P3|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1
2493190|NCT02023879|8620467|P2|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2
2493191|NCT02023879|8620468|P1|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0
2493192|NCT02023879|8620466|P3|Period 1: 24-Week Double-blind Treatment|Adverse Event|5
2493193|NCT02023879|8620467|P2|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
2493194|NCT02023879|8620468|P1|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
2493195|NCT02023866|8620557|P1|Overall Study|Withdrawal by Subject|1
2493196|NCT02023866|8620557|P1|Overall Study|Adverse Event|3
2493197|NCT02023866|8620557|P1|Overall Study|Non-compliance|2
2493198|NCT02023697|8620579|P3|Long-term Follow-up Period|Other unspecified|5
2493199|NCT02023697|8620580|P2|Long-term Follow-up Period|Other unspecified|3
2493200|NCT02023697|8620581|P1|Long-term Follow-up Period|Other unspecified|6
2493201|NCT02023697|8620579|P3|Long-term Follow-up Period|Technical problems|1
2493202|NCT02023697|8620580|P2|Long-term Follow-up Period|Technical problems|0
2493203|NCT02023697|8620581|P1|Long-term Follow-up Period|Technical problems|0
2493204|NCT02023697|8620579|P3|Long-term Follow-up Period|Entered the long-term follow-up study|6
2493205|NCT02023697|8620580|P2|Long-term Follow-up Period|Entered the long-term follow-up study|9
2493206|NCT02023697|8620581|P1|Long-term Follow-up Period|Entered the long-term follow-up study|6
2493207|NCT02023697|8620579|P3|Long-term Follow-up Period|Lost to Follow-up|1
2493208|NCT02023697|8620580|P2|Long-term Follow-up Period|Lost to Follow-up|0
2493209|NCT02023697|8620581|P1|Long-term Follow-up Period|Lost to Follow-up|1
2493210|NCT02023697|8620579|P3|Long-term Follow-up Period|Withdrawal by Subject|0
2493211|NCT02023697|8620580|P2|Long-term Follow-up Period|Withdrawal by Subject|3
2493212|NCT02023697|8620581|P1|Long-term Follow-up Period|Withdrawal by Subject|6
2493213|NCT02023697|8620579|P3|Long-term Follow-up Period|Death|4
2493214|NCT02023697|8620580|P2|Long-term Follow-up Period|Death|6
2493215|NCT02023697|8620581|P1|Long-term Follow-up Period|Death|9
2493216|NCT02023697|8620579|P3|Active Follow-up Period|Death|87
2493217|NCT02023697|8620580|P2|Active Follow-up Period|Death|82
2493218|NCT02023697|8620581|P1|Active Follow-up Period|Death|83
2493219|NCT02023697|8620579|P3|Active Follow-up Period|Radiological progression|1
2493220|NCT02023697|8620580|P2|Active Follow-up Period|Radiological progression|0
2493221|NCT02023697|8620581|P1|Active Follow-up Period|Radiological progression|0
2493222|NCT02023697|8620579|P3|Active Follow-up Period|Clinical progression|1
2493223|NCT02023697|8620580|P2|Active Follow-up Period|Clinical progression|2
2493224|NCT02023697|8620581|P1|Active Follow-up Period|Clinical progression|0
2493225|NCT02023697|8620579|P3|Active Follow-up Period|Other unspecified|1
2493226|NCT02023697|8620580|P2|Active Follow-up Period|Other unspecified|0
2493227|NCT02023697|8620581|P1|Active Follow-up Period|Other unspecified|2
2493228|NCT02023697|8620579|P3|Active Follow-up Period|Deterioration of general condition|1
2493229|NCT02023697|8620580|P2|Active Follow-up Period|Deterioration of general condition|1
2493230|NCT02023697|8620581|P1|Active Follow-up Period|Deterioration of general condition|1
2493231|NCT02023697|8620579|P3|Active Follow-up Period|Lost to Follow-up|1
2493232|NCT02023697|8620580|P2|Active Follow-up Period|Lost to Follow-up|1
2493233|NCT02023697|8620581|P1|Active Follow-up Period|Lost to Follow-up|1
2493234|NCT02023697|8620579|P3|Active Follow-up Period|Withdrawal by Subject|7
2493235|NCT02023697|8620580|P2|Active Follow-up Period|Withdrawal by Subject|13
2493236|NCT02023697|8620581|P1|Active Follow-up Period|Withdrawal by Subject|5
2493237|NCT02023697|8620579|P3|Treatment Period|Physician Decision|1
2493238|NCT02023697|8620580|P2|Treatment Period|Physician Decision|0
2493239|NCT02023697|8620581|P1|Treatment Period|Physician Decision|0
2493240|NCT02023697|8620579|P3|Treatment Period|Safety outcome reached|0
2493241|NCT02023697|8620580|P2|Treatment Period|Safety outcome reached|1
2493242|NCT02023697|8620581|P1|Treatment Period|Safety outcome reached|0
2493243|NCT02023697|8620579|P3|Treatment Period|Withdrawal by Subject|13
2493244|NCT02023697|8620580|P2|Treatment Period|Withdrawal by Subject|5
2493245|NCT02023697|8620581|P1|Treatment Period|Withdrawal by Subject|4
2493246|NCT02023697|8620579|P3|Treatment Period|Clinical progression|28
2493247|NCT02023697|8620580|P2|Treatment Period|Clinical progression|8
2493248|NCT02023697|8620581|P1|Treatment Period|Clinical progression|10
2493249|NCT02023697|8620579|P3|Treatment Period|Logistical difficulties|1
2493250|NCT02023697|8620580|P2|Treatment Period|Logistical difficulties|1
2493251|NCT02023697|8620581|P1|Treatment Period|Logistical difficulties|1
2493252|NCT02023697|8620579|P3|Treatment Period|Adverse Event|23
2493253|NCT02023697|8620580|P2|Treatment Period|Adverse Event|25
2493254|NCT02023697|8620581|P1|Treatment Period|Adverse Event|13
2493255|NCT02023697|8620579|P3|Treatment Period|Never Treated|10
2493256|NCT02023697|8620580|P2|Treatment Period|Never Treated|6
2493257|NCT02023697|8620581|P1|Treatment Period|Never Treated|5
2493258|NCT02023697|8620579|P3|Treatment Period|Radiological progression|26
2493259|NCT02023697|8620580|P2|Treatment Period|Radiological progression|17
2493260|NCT02023697|8620581|P1|Treatment Period|Radiological progression|13
2493261|NCT02023268|8620694|P2|Overall Study|Withdrawal by Subject|1
2493262|NCT02023268|8620695|P1|Overall Study|Withdrawal by Subject|0
2493263|NCT02023268|8620694|P2|Overall Study|Adverse Event|2
2493264|NCT02023268|8620695|P1|Overall Study|Adverse Event|0
2493265|NCT02023268|8620694|P2|Overall Study|Lack of Efficacy|1
2493266|NCT02023268|8620695|P1|Overall Study|Lack of Efficacy|0
2493267|NCT02023242|8620703|P2|Overall Study|Death|1
2493268|NCT02023242|8620704|P1|Overall Study|Death|0
2493269|NCT02023242|8620703|P2|Overall Study|Lost to Follow-up|1
2493270|NCT02023242|8620704|P1|Overall Study|Lost to Follow-up|3
2493271|NCT02023151|8620718|P1|Overall Study|Lost to Follow-up|4
2493272|NCT02023112|8620788|P2|Overall Study|Withdrawal by Subject|1
2493273|NCT02023112|8620789|P1|Overall Study|Withdrawal by Subject|2
2493274|NCT02023099|8620810|P3|Overall Study|Non-treatment-emergent Fatal AE|1
2493275|NCT02023099|8620811|P2|Overall Study|Non-treatment-emergent Fatal AE|0
2493276|NCT02023099|8620812|P1|Overall Study|Non-treatment-emergent Fatal AE|0
2493277|NCT02023099|8620810|P3|Overall Study|Withdrawn Consent|1
2493278|NCT02023099|8620811|P2|Overall Study|Withdrawn Consent|0
2493279|NCT02023099|8620812|P1|Overall Study|Withdrawn Consent|3
2493280|NCT02023099|8620810|P3|Overall Study|Non-fatal Adverse Event (AE)|1
2493281|NCT02023099|8620811|P2|Overall Study|Non-fatal Adverse Event (AE)|0
2493282|NCT02023099|8620812|P1|Overall Study|Non-fatal Adverse Event (AE)|0
2493283|NCT02022748|8620835|P3|Overall Study|Withdrawal by Subject|0
2493284|NCT02022748|8620836|P2|Overall Study|Withdrawal by Subject|1
2493285|NCT02022748|8620837|P1|Overall Study|Withdrawal by Subject|0
2493286|NCT02022748|8620835|P3|Overall Study|Adverse Event|0
2493287|NCT02022748|8620836|P2|Overall Study|Adverse Event|1
2493288|NCT02022748|8620837|P1|Overall Study|Adverse Event|1
2493289|NCT02022670|8620863|P3|Overall Study|Adverse Event|1
2493290|NCT02022670|8620864|P2|Overall Study|Adverse Event|0
2493291|NCT02022670|8620865|P1|Overall Study|Adverse Event|1
2493292|NCT02022657|8620879|P6|Overall Study|Physician Decision|1
2493293|NCT02022657|8620880|P5|Overall Study|Physician Decision|0
2493294|NCT02022657|8620881|P4|Overall Study|Physician Decision|0
2493295|NCT02022657|8620882|P3|Overall Study|Physician Decision|0
2493296|NCT02022657|8620883|P2|Overall Study|Physician Decision|0
2493297|NCT02022657|8620884|P1|Overall Study|Physician Decision|0
2493298|NCT02022657|8620879|P6|Overall Study|Withdrawal by Subject|0
2493299|NCT02022657|8620880|P5|Overall Study|Withdrawal by Subject|0
2493300|NCT02022657|8620881|P4|Overall Study|Withdrawal by Subject|0
2493301|NCT02022657|8620882|P3|Overall Study|Withdrawal by Subject|1
2493302|NCT02022657|8620883|P2|Overall Study|Withdrawal by Subject|0
2493303|NCT02022657|8620884|P1|Overall Study|Withdrawal by Subject|2
2493304|NCT02022007|8620925|P3|Overall Study|Noncompliant|1
2493305|NCT02022007|8620926|P2|Overall Study|Noncompliant|0
2493306|NCT02022007|8620927|P1|Overall Study|Noncompliant|0
2493307|NCT02022007|8620925|P3|Overall Study|Withdrawal by Subject|1
2493308|NCT02022007|8620926|P2|Overall Study|Withdrawal by Subject|1
2493309|NCT02022007|8620927|P1|Overall Study|Withdrawal by Subject|1
2493310|NCT02021656|8621010|P1|Overall Study|Withdrew Consent|2
2493311|NCT02021656|8621010|P1|Overall Study|Lost to Follow-up|1
2493312|NCT02021656|8621010|P1|Overall Study|Lack of Efficacy|2
2493313|NCT02021656|8621010|P1|Overall Study|Adverse Event|1
2493314|NCT02021643|8621030|P4|Overall Study|Withdrew Consent|0
2493315|NCT02021643|8621031|P3|Overall Study|Withdrew Consent|0
2493316|NCT02021643|8621032|P2|Overall Study|Withdrew Consent|1
2493317|NCT02021643|8621033|P1|Overall Study|Withdrew Consent|0
2493318|NCT02021643|8621030|P4|Overall Study|Lost to Follow-up|0
2493319|NCT02021643|8621031|P3|Overall Study|Lost to Follow-up|0
2493320|NCT02021643|8621032|P2|Overall Study|Lost to Follow-up|1
2493321|NCT02021643|8621033|P1|Overall Study|Lost to Follow-up|0
2493322|NCT02021643|8621030|P4|Overall Study|Lack of Efficacy|12
2493323|NCT02021643|8621031|P3|Overall Study|Lack of Efficacy|0
2493324|NCT02021643|8621032|P2|Overall Study|Lack of Efficacy|6
2493325|NCT02021643|8621033|P1|Overall Study|Lack of Efficacy|7
2493326|NCT02021643|8621030|P4|Overall Study|Investigator's Discretion|0
2493327|NCT02021643|8621031|P3|Overall Study|Investigator's Discretion|0
2493328|NCT02021643|8621032|P2|Overall Study|Investigator's Discretion|0
2493329|NCT02021643|8621033|P1|Overall Study|Investigator's Discretion|1
2493330|NCT02021643|8621030|P4|Overall Study|Death|0
2493331|NCT02021643|8621031|P3|Overall Study|Death|0
2493332|NCT02021643|8621032|P2|Overall Study|Death|1
2493333|NCT02021643|8621033|P1|Overall Study|Death|0
2493334|NCT02021643|8621030|P4|Overall Study|Adverse Event|0
2493335|NCT02021643|8621031|P3|Overall Study|Adverse Event|0
2493336|NCT02021643|8621032|P2|Overall Study|Adverse Event|1
2493337|NCT02021643|8621033|P1|Overall Study|Adverse Event|0
2493338|NCT02021643|8621030|P4|Overall Study|Enrolled but Never Treated|0
2493339|NCT02021643|8621031|P3|Overall Study|Enrolled but Never Treated|0
2493340|NCT02021643|8621032|P2|Overall Study|Enrolled but Never Treated|0
2493341|NCT02021643|8621033|P1|Overall Study|Enrolled but Never Treated|1
2493342|NCT02021565|8621075|P2|3-month Follow-up|Protocol Violation|2
2493343|NCT02021565|8621076|P1|3-month Follow-up|Protocol Violation|3
2493344|NCT02021565|8621075|P2|3-month Follow-up|Withdrawal by Subject|0
2493345|NCT02021565|8621076|P1|3-month Follow-up|Withdrawal by Subject|4
2493346|NCT02021565|8621075|P2|3-month Follow-up|Death|0
2493347|NCT02021565|8621076|P1|3-month Follow-up|Death|3
2493348|NCT02021565|8621075|P2|Baseline Through Intervention|Lost to Follow-up|2
2493349|NCT02021565|8621076|P1|Baseline Through Intervention|Lost to Follow-up|4
2493350|NCT02021565|8621075|P2|Baseline Through Intervention|Protocol Violation|7
2493351|NCT02021565|8621076|P1|Baseline Through Intervention|Protocol Violation|0
2493352|NCT02021565|8621075|P2|Baseline Through Intervention|Withdrawal by Subject|8
2493353|NCT02021565|8621076|P1|Baseline Through Intervention|Withdrawal by Subject|8
2493354|NCT02021565|8621075|P2|Baseline Through Intervention|Death|1
2493355|NCT02021565|8621076|P1|Baseline Through Intervention|Death|0
2493356|NCT02021331|8621096|P2|Overall Study|Adverse Event|2
2493357|NCT02021331|8621097|P1|Overall Study|Adverse Event|0
2493358|NCT02021292|8621109|P2|Overall Study|Death|1
2493359|NCT02021292|8621110|P1|Overall Study|Death|0
2493360|NCT02021292|8621109|P2|Overall Study|Lost to Follow-up|1
2493361|NCT02021292|8621110|P1|Overall Study|Lost to Follow-up|0
2493362|NCT02021292|8621109|P2|Overall Study|Physician Decision|1
2493363|NCT02021292|8621110|P1|Overall Study|Physician Decision|0
2493364|NCT02020941|8621136|P1|Overall Study|Disease Progression|4
2493365|NCT02020941|8621136|P1|Overall Study|Withdrawal by Subject|1
2493366|NCT02020941|8621136|P1|Overall Study|Physician Decision|2
2493367|NCT02020941|8621136|P1|Overall Study|Adverse Event|1
2493368|NCT02020889|8621147|P2|Overall Study|Withdrawal by Subject|2
2493369|NCT02020889|8621148|P1|Overall Study|Withdrawal by Subject|3
2493370|NCT02020889|8621147|P2|Overall Study|Physician Decision|0
2493371|NCT02020889|8621148|P1|Overall Study|Physician Decision|2
2493372|NCT02020889|8621147|P2|Overall Study|Lost to Follow-up|0
2493373|NCT02020889|8621148|P1|Overall Study|Lost to Follow-up|1
2493374|NCT02020889|8621147|P2|Overall Study|Lack of Efficacy|0
2493375|NCT02020889|8621148|P1|Overall Study|Lack of Efficacy|1
2493376|NCT02020889|8621147|P2|Overall Study|Adverse Event|1
2493377|NCT02020889|8621148|P1|Overall Study|Adverse Event|0
2493378|NCT02020863|8621202|P1|Overall Study|Team chose not to place an a line|1
2493379|NCT02020863|8621202|P1|Overall Study|Discovery of Metastatic disease|4
2493380|NCT02020616|8621232|P7|Overall Study|Lack of Efficacy|0
2493381|NCT02020616|8621233|P6|Overall Study|Lack of Efficacy|0
2493382|NCT02020616|8621234|P5|Overall Study|Lack of Efficacy|1
2493383|NCT02020616|8621235|P4|Overall Study|Lack of Efficacy|0
2493384|NCT02020616|8621236|P3|Overall Study|Lack of Efficacy|0
2493385|NCT02020616|8621237|P2|Overall Study|Lack of Efficacy|0
2493386|NCT02020616|8621238|P1|Overall Study|Lack of Efficacy|0
2493387|NCT02020616|8621232|P7|Overall Study|Randomized in Error|0
2493388|NCT02020616|8621233|P6|Overall Study|Randomized in Error|0
2493389|NCT02020616|8621234|P5|Overall Study|Randomized in Error|0
2493390|NCT02020616|8621235|P4|Overall Study|Randomized in Error|1
2493391|NCT02020616|8621236|P3|Overall Study|Randomized in Error|0
2493392|NCT02020616|8621237|P2|Overall Study|Randomized in Error|0
2493393|NCT02020616|8621238|P1|Overall Study|Randomized in Error|0
2493394|NCT02020616|8621232|P7|Overall Study|Early Termination Criteria Met|0
2493395|NCT02020616|8621233|P6|Overall Study|Early Termination Criteria Met|1
2493396|NCT02020616|8621234|P5|Overall Study|Early Termination Criteria Met|0
2493397|NCT02020616|8621235|P4|Overall Study|Early Termination Criteria Met|0
2493398|NCT02020616|8621236|P3|Overall Study|Early Termination Criteria Met|1
2493399|NCT02020616|8621237|P2|Overall Study|Early Termination Criteria Met|0
2493400|NCT02020616|8621238|P1|Overall Study|Early Termination Criteria Met|0
2493401|NCT02020616|8621232|P7|Overall Study|Lost to Follow-up|0
2493402|NCT02020616|8621233|P6|Overall Study|Lost to Follow-up|1
2493403|NCT02020616|8621234|P5|Overall Study|Lost to Follow-up|1
2493404|NCT02020616|8621235|P4|Overall Study|Lost to Follow-up|1
2493405|NCT02020616|8621236|P3|Overall Study|Lost to Follow-up|0
2493406|NCT02020616|8621237|P2|Overall Study|Lost to Follow-up|1
2493407|NCT02020616|8621238|P1|Overall Study|Lost to Follow-up|0
2493408|NCT02020616|8621232|P7|Overall Study|Withdrawal by Subject|1
2493409|NCT02020616|8621233|P6|Overall Study|Withdrawal by Subject|1
2493410|NCT02020616|8621234|P5|Overall Study|Withdrawal by Subject|0
2493411|NCT02020616|8621235|P4|Overall Study|Withdrawal by Subject|0
2493412|NCT02020616|8621236|P3|Overall Study|Withdrawal by Subject|1
2493413|NCT02020616|8621237|P2|Overall Study|Withdrawal by Subject|0
2493414|NCT02020616|8621238|P1|Overall Study|Withdrawal by Subject|0
2493415|NCT02020616|8621232|P7|Overall Study|Physician Decision|2
2493416|NCT02020616|8621233|P6|Overall Study|Physician Decision|1
2493417|NCT02020616|8621234|P5|Overall Study|Physician Decision|0
2493418|NCT02020616|8621235|P4|Overall Study|Physician Decision|0
2493419|NCT02020616|8621236|P3|Overall Study|Physician Decision|0
2493420|NCT02020616|8621237|P2|Overall Study|Physician Decision|0
2493421|NCT02020616|8621238|P1|Overall Study|Physician Decision|0
2493422|NCT02020616|8621232|P7|Overall Study|Adverse Event|1
2493423|NCT02020616|8621233|P6|Overall Study|Adverse Event|1
2493424|NCT02020616|8621234|P5|Overall Study|Adverse Event|0
2493425|NCT02020616|8621235|P4|Overall Study|Adverse Event|0
2493426|NCT02020616|8621236|P3|Overall Study|Adverse Event|0
2493427|NCT02020616|8621237|P2|Overall Study|Adverse Event|0
2493428|NCT02020616|8621238|P1|Overall Study|Adverse Event|0
2493429|NCT02020577|8621331|P2|Overall Study|Other than stated above|1
2493430|NCT02020577|8621332|P1|Overall Study|Other than stated above|0
2493431|NCT02020577|8621331|P2|Overall Study|Withdrawal by Subject|1
2493432|NCT02020577|8621332|P1|Overall Study|Withdrawal by Subject|0
2493433|NCT02020577|8621331|P2|Overall Study|Other AE or clinical progression|15
2493434|NCT02020577|8621332|P1|Overall Study|Other AE or clinical progression|0
2493435|NCT02020577|8621331|P2|Overall Study|Progressive disease|38
2493436|NCT02020577|8621332|P1|Overall Study|Progressive disease|3
2493437|NCT02020512|8621359|P1|Overall Study|Protocol Violation|4
2493438|NCT02020512|8621359|P1|Overall Study|Lost to Follow-up|3
2493439|NCT02020512|8621359|P1|Overall Study|Adverse Event|1
2493440|NCT02020031|8621438|P2|Overall Study|Physician Decision|1
2493441|NCT02020031|8621439|P1|Overall Study|Physician Decision|1
2493442|NCT02019979|8621460|P1|Overall Study|study terminated|14
2493443|NCT02019927|8621476|P6|Overall Study|Lost to Follow-up|1
2493444|NCT02019927|8621477|P5|Overall Study|Lost to Follow-up|3
2493445|NCT02019927|8621478|P4|Overall Study|Lost to Follow-up|2
2493446|NCT02019927|8621479|P3|Overall Study|Lost to Follow-up|1
2493447|NCT02019927|8621480|P2|Overall Study|Lost to Follow-up|4
2493448|NCT02019927|8621481|P1|Overall Study|Lost to Follow-up|2
2493449|NCT02019719|8621581|P5|Overall Study|Physician Decision|0
2493450|NCT02019719|8621582|P4|Overall Study|Physician Decision|0
2493451|NCT02019719|8621583|P3|Overall Study|Physician Decision|0
2493452|NCT02019719|8621584|P2|Overall Study|Physician Decision|0
2493453|NCT02019719|8621585|P1|Overall Study|Physician Decision|2
2493454|NCT02019719|8621581|P5|Overall Study|Protocol defined stopping criteria|1
2493455|NCT02019719|8621582|P4|Overall Study|Protocol defined stopping criteria|1
2493456|NCT02019719|8621583|P3|Overall Study|Protocol defined stopping criteria|0
2493457|NCT02019719|8621584|P2|Overall Study|Protocol defined stopping criteria|0
2493458|NCT02019719|8621585|P1|Overall Study|Protocol defined stopping criteria|2
2493459|NCT02019719|8621581|P5|Overall Study|Protocol Violation|0
2493460|NCT02019719|8621582|P4|Overall Study|Protocol Violation|0
2493461|NCT02019719|8621583|P3|Overall Study|Protocol Violation|0
2493462|NCT02019719|8621584|P2|Overall Study|Protocol Violation|1
2493463|NCT02019719|8621585|P1|Overall Study|Protocol Violation|1
2493464|NCT02019719|8621581|P5|Overall Study|Adverse Event|1
2493465|NCT02019719|8621582|P4|Overall Study|Adverse Event|1
2493466|NCT02019719|8621583|P3|Overall Study|Adverse Event|0
2493467|NCT02019719|8621584|P2|Overall Study|Adverse Event|0
2493468|NCT02019719|8621585|P1|Overall Study|Adverse Event|1
2493469|NCT02019667|8621682|P2|2nd Intervention (6 Months)|Physician Decision|1
2493470|NCT02019667|8621683|P1|2nd Intervention (6 Months)|Physician Decision|0
2493471|NCT02019667|8621682|P2|2nd Intervention (6 Months)|Adverse Event|1
2493472|NCT02019667|8621683|P1|2nd Intervention (6 Months)|Adverse Event|0
2493473|NCT02019667|8621682|P2|First Intervention (6 Months)|Adverse Event|1
2493474|NCT02019667|8621683|P1|First Intervention (6 Months)|Adverse Event|0
2493475|NCT02019602|8621703|P2|Screening Period|Adverse Event|0
2493476|NCT02019602|8621704|P1|Screening Period|Adverse Event|1
2493477|NCT02019602|8621703|P2|Screening Period|Ineligibility|0
2493478|NCT02019602|8621704|P1|Screening Period|Ineligibility|4
2493479|NCT02019550|8621733|P2|Treatment Period 1 (4 Weeks)|Adverse Event|1
2493480|NCT02019550|8621734|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
2493481|NCT02019472|8621775|P3|Overall Study|Other|6
2493482|NCT02019472|8621776|P2|Overall Study|Other|8
2493483|NCT02019472|8621777|P1|Overall Study|Other|3
2493484|NCT02019472|8621775|P3|Overall Study|Withdrawal by Subject|11
2493485|NCT02019472|8621776|P2|Overall Study|Withdrawal by Subject|10
2493486|NCT02019472|8621777|P1|Overall Study|Withdrawal by Subject|11
2493487|NCT02019472|8621775|P3|Overall Study|Pregnancy|2
2493488|NCT02019472|8621776|P2|Overall Study|Pregnancy|2
2493489|NCT02019472|8621777|P1|Overall Study|Pregnancy|1
2493490|NCT02019472|8621775|P3|Overall Study|Physician Decision|0
2493491|NCT02019472|8621776|P2|Overall Study|Physician Decision|2
2493492|NCT02019472|8621777|P1|Overall Study|Physician Decision|1
2493493|NCT02019472|8621775|P3|Overall Study|Lost to Follow-up|1
2493494|NCT02019472|8621776|P2|Overall Study|Lost to Follow-up|2
2493495|NCT02019472|8621777|P1|Overall Study|Lost to Follow-up|0
2493496|NCT02019472|8621775|P3|Overall Study|Lack of Efficacy|4
2493497|NCT02019472|8621776|P2|Overall Study|Lack of Efficacy|4
2493498|NCT02019472|8621777|P1|Overall Study|Lack of Efficacy|7
2493499|NCT02019472|8621775|P3|Overall Study|Death|1
2493500|NCT02019472|8621776|P2|Overall Study|Death|1
2493501|NCT02019472|8621777|P1|Overall Study|Death|0
2493502|NCT02019472|8621775|P3|Overall Study|Adverse Event|17
2493503|NCT02019472|8621776|P2|Overall Study|Adverse Event|23
2493504|NCT02019472|8621777|P1|Overall Study|Adverse Event|14
2493505|NCT02019420|8621800|P2|Overall Study|Transferred to other care facility|1
2493506|NCT02019420|8621801|P1|Overall Study|Transferred to other care facility|1
2493507|NCT02019420|8621800|P2|Overall Study|Death|99
2493508|NCT02019420|8621801|P1|Overall Study|Death|104
2493509|NCT02019420|8621800|P2|Overall Study|At request of sponsor or investigator|1
2493510|NCT02019420|8621801|P1|Overall Study|At request of sponsor or investigator|0
2493511|NCT02019420|8621800|P2|Overall Study|Withdrawal by Subject|3
2493512|NCT02019420|8621801|P1|Overall Study|Withdrawal by Subject|1
2493513|NCT02019420|8621800|P2|Overall Study|Did not receive study drug|2
2493514|NCT02019420|8621801|P1|Overall Study|Did not receive study drug|2
2493515|NCT02019277|8621829|P1|Overall Study|Adverse Event|1
2493516|NCT02019277|8621829|P1|Overall Study|Did no Cooperate|1
2493517|NCT02019277|8621829|P1|Overall Study|Death|7
2493518|NCT02019277|8621829|P1|Overall Study|Withdrawal by Subject|3
2493519|NCT02019264|8621848|P2|Overall Study|Missing|11
2493520|NCT02019264|8621849|P1|Overall Study|Missing|14
2493521|NCT02019264|8621848|P2|Overall Study|Administrative reason|28
2493522|NCT02019264|8621849|P1|Overall Study|Administrative reason|36
2493523|NCT02019264|8621848|P2|Overall Study|Withdrawal by Subject|117
2493524|NCT02019264|8621849|P1|Overall Study|Withdrawal by Subject|142
2493525|NCT02019264|8621848|P2|Overall Study|Lost to Follow-up|47
2493526|NCT02019264|8621849|P1|Overall Study|Lost to Follow-up|50
2493527|NCT02019264|8621848|P2|Overall Study|Not treated|4
2493528|NCT02019264|8621849|P1|Overall Study|Not treated|6
2493529|NCT02019108|8621885|P2|Overall Study|Lost to Follow-up|7
2493530|NCT02019108|8621886|P1|Overall Study|Lost to Follow-up|5
2493531|NCT02018887|8621928|P11|Part C: Cohort 8 Overall|Physician Decision|1
2493532|NCT02018887|8621929|P10|Part C: Cohort 8 Overall|Physician Decision|0
2493533|NCT02018887|8621930|P9|Part C: Cohort 8 Overall|Physician Decision|2
2493534|NCT02018887|8621931|P8|Part C: Cohort 8 Overall|Physician Decision|0
2493535|NCT02018887|8621932|P7|Part C: Cohort 8 Overall|Physician Decision|0
2493536|NCT02018887|8621933|P6|Part C: Cohort 8 Overall|Physician Decision|0
2493537|NCT02018887|8621934|P5|Part C: Cohort 8 Overall|Physician Decision|0
2493538|NCT02018887|8621935|P4|Part C: Cohort 8 Overall|Physician Decision|0
2493539|NCT02018887|8621936|P3|Part C: Cohort 8 Overall|Physician Decision|0
2493540|NCT02018887|8621937|P2|Part C: Cohort 8 Overall|Physician Decision|0
2493541|NCT02018887|8621938|P1|Part C: Cohort 8 Overall|Physician Decision|0
2493542|NCT02018887|8621928|P11|Part C: Cohort 8 Overall|Adverse Event|0
2493543|NCT02018887|8621929|P10|Part C: Cohort 8 Overall|Adverse Event|3
2493544|NCT02018887|8621930|P9|Part C: Cohort 8 Overall|Adverse Event|1
2493545|NCT02018887|8621931|P8|Part C: Cohort 8 Overall|Adverse Event|0
2493546|NCT02018887|8621932|P7|Part C: Cohort 8 Overall|Adverse Event|0
2493547|NCT02018887|8621933|P6|Part C: Cohort 8 Overall|Adverse Event|0
2493548|NCT02018887|8621934|P5|Part C: Cohort 8 Overall|Adverse Event|0
2493549|NCT02018887|8621935|P4|Part C: Cohort 8 Overall|Adverse Event|0
2493550|NCT02018887|8621936|P3|Part C: Cohort 8 Overall|Adverse Event|0
2493551|NCT02018887|8621937|P2|Part C: Cohort 8 Overall|Adverse Event|0
2493552|NCT02018887|8621938|P1|Part C: Cohort 8 Overall|Adverse Event|0
2493553|NCT02018887|8621928|P11|Part B: Cohorts 3-7 Overall|Adverse Event|0
2493554|NCT02018887|8621929|P10|Part B: Cohorts 3-7 Overall|Adverse Event|0
2493555|NCT02018887|8621930|P9|Part B: Cohorts 3-7 Overall|Adverse Event|0
2493556|NCT02018887|8621931|P8|Part B: Cohorts 3-7 Overall|Adverse Event|4
2493557|NCT02018887|8621932|P7|Part B: Cohorts 3-7 Overall|Adverse Event|1
2493558|NCT02018887|8621933|P6|Part B: Cohorts 3-7 Overall|Adverse Event|0
2493559|NCT02018887|8621934|P5|Part B: Cohorts 3-7 Overall|Adverse Event|1
2493560|NCT02018887|8621935|P4|Part B: Cohorts 3-7 Overall|Adverse Event|0
2493561|NCT02018887|8621936|P3|Part B: Cohorts 3-7 Overall|Adverse Event|0
2493562|NCT02018887|8621937|P2|Part B: Cohorts 3-7 Overall|Adverse Event|0
2493563|NCT02018887|8621938|P1|Part B: Cohorts 3-7 Overall|Adverse Event|0
2493564|NCT02018887|8621928|P11|Part A: Cohorts 1-2: Period 3|Adverse Event|0
2493565|NCT02018887|8621929|P10|Part A: Cohorts 1-2: Period 3|Adverse Event|0
2493566|NCT02018887|8621930|P9|Part A: Cohorts 1-2: Period 3|Adverse Event|0
2493567|NCT02018887|8621931|P8|Part A: Cohorts 1-2: Period 3|Adverse Event|0
2493568|NCT02018887|8621932|P7|Part A: Cohorts 1-2: Period 3|Adverse Event|0
2493569|NCT02018887|8621933|P6|Part A: Cohorts 1-2: Period 3|Adverse Event|0
2493570|NCT02018887|8621934|P5|Part A: Cohorts 1-2: Period 3|Adverse Event|0
2493571|NCT02018887|8621935|P4|Part A: Cohorts 1-2: Period 3|Adverse Event|0
2493572|NCT02018887|8621936|P3|Part A: Cohorts 1-2: Period 3|Adverse Event|0
2493573|NCT02018887|8621937|P2|Part A: Cohorts 1-2: Period 3|Adverse Event|0
2493574|NCT02018887|8621938|P1|Part A: Cohorts 1-2: Period 3|Adverse Event|1
2493575|NCT02018822|8622027|P3|Overall Study|Lost to Follow-up|5
2493576|NCT02018822|8622028|P2|Overall Study|Lost to Follow-up|6
2493577|NCT02018822|8622029|P1|Overall Study|Lost to Follow-up|6
2493578|NCT02018822|8622027|P3|Overall Study|Physician Decision|1
2493579|NCT02018822|8622028|P2|Overall Study|Physician Decision|1
2493580|NCT02018822|8622029|P1|Overall Study|Physician Decision|0
2493581|NCT02018822|8622027|P3|Overall Study|filling replaced by crown|0
2493582|NCT02018822|8622028|P2|Overall Study|filling replaced by crown|1
2493583|NCT02018822|8622029|P1|Overall Study|filling replaced by crown|0
2493584|NCT02018562|8622109|P2|Overall Study|Discharged prior to study completion|0
2493585|NCT02018562|8622110|P1|Overall Study|Discharged prior to study completion|1
2493586|NCT02018562|8622109|P2|Overall Study|Withdrawal by Subject|0
2493587|NCT02018562|8622110|P1|Overall Study|Withdrawal by Subject|2
2493588|NCT02018458|8622128|P1|Overall Study|Death|4
2493589|NCT02018042|8622155|P1|Overall Study|Withdrawal by Subject|1
2493590|NCT02017964|8622161|P1|Overall Study|Patient deemed ineligible|1
2493591|NCT02017899|8622175|P6|Overall Study|Withdrawal by Subject|0
2493592|NCT02017899|8622176|P5|Overall Study|Withdrawal by Subject|1
2493593|NCT02017899|8622177|P4|Overall Study|Withdrawal by Subject|1
2493594|NCT02017899|8622178|P3|Overall Study|Withdrawal by Subject|0
2493595|NCT02017899|8622179|P2|Overall Study|Withdrawal by Subject|0
2493596|NCT02017899|8622180|P1|Overall Study|Withdrawal by Subject|0
2493597|NCT02017860|8622254|P1|Overall Study|Withdrawal by Subject|1
2493598|NCT02017860|8622254|P1|Overall Study|Adverse Event|1
2493599|NCT02017535|8622273|P4|Overall Study|Withdrawal by Subject|0
2493600|NCT02017535|8622274|P3|Overall Study|Withdrawal by Subject|0
2493601|NCT02017535|8622275|P2|Overall Study|Withdrawal by Subject|0
2493602|NCT02017535|8622276|P1|Overall Study|Withdrawal by Subject|1
2493603|NCT02017522|8622298|P1|Overall Study|Withdrawal by Subject|1
2493604|NCT02017223|8622316|P1|Overall Study|Algorithm problems|2
2493605|NCT02017015|8622371|P1|Overall Study|Physician Decision|2
2493606|NCT02017015|8622371|P1|Overall Study|Non-compliance with study drug|2
2493607|NCT02017015|8622371|P1|Overall Study|Progressive Disease|31
2493608|NCT02017015|8622371|P1|Overall Study|Death|4
2493609|NCT02017015|8622371|P1|Overall Study|Withdrawal by Subject|21
2493610|NCT02017015|8622371|P1|Overall Study|Adverse Event|9
2493611|NCT02016898|8622396|P2|Overall Study|Lost to Follow-up|4
2493612|NCT02016898|8622397|P1|Overall Study|Lost to Follow-up|4
2493613|NCT02016898|8622396|P2|Overall Study|Death|1
2493614|NCT02016898|8622397|P1|Overall Study|Death|1
2493615|NCT02016716|8622454|P3|Overall Study|Lost to Follow-up|1
2493616|NCT02016716|8622455|P2|Overall Study|Lost to Follow-up|2
2493617|NCT02016716|8622456|P1|Overall Study|Lost to Follow-up|1
2493618|NCT02016716|8622454|P3|Overall Study|Protocol-specified Criteria|0
2493619|NCT02016716|8622455|P2|Overall Study|Protocol-specified Criteria|1
2493620|NCT02016716|8622456|P1|Overall Study|Protocol-specified Criteria|0
2493621|NCT02016716|8622454|P3|Overall Study|Withdrawal by Subject|5
2493622|NCT02016716|8622455|P2|Overall Study|Withdrawal by Subject|5
2493623|NCT02016716|8622456|P1|Overall Study|Withdrawal by Subject|5
2493624|NCT02016690|8622477|P1|Overall Study|Hospitalized for RSV at study start|3
2493625|NCT02016690|8622477|P1|Overall Study|Did not meet inclusion criteria|13
2493626|NCT02016690|8622477|P1|Overall Study|Excluded from SAS: Ineligible for study|2
2493627|NCT02016690|8622477|P1|Overall Study|Excluded from SAS: Early treatment|2
2493628|NCT02016690|8622477|P1|Overall Study|Excluded from SAS: Duplication|2
2493629|NCT02016690|8622477|P1|Overall Study|Excluded from SAS: Enrollment violation|2
2493630|NCT02016625|8622490|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0
2493631|NCT02016625|8622491|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2
2493632|NCT02016625|8622490|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0
2493633|NCT02016625|8622491|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1
2493634|NCT02016625|8622490|P2|Cyclo or Tac (Single Dose, Day 1)|not treated|1
2493635|NCT02016625|8622491|P1|Cyclo or Tac (Single Dose, Day 1)|not treated|0
2493636|NCT02016482|8622546|P2|Period B|Required Alternative/Prohibited Therapy|2
2493637|NCT02016482|8622547|P1|Period B|Required Alternative/Prohibited Therapy|0
2493638|NCT02016482|8622546|P2|Period B|Other|0
2493639|NCT02016482|8622547|P1|Period B|Other|4
2493640|NCT02016482|8622546|P2|Period B|Lack of Efficacy|4
2493641|NCT02016482|8622547|P1|Period B|Lack of Efficacy|6
2493642|NCT02016482|8622546|P2|Period B|Lost to Follow-up|0
2493643|NCT02016482|8622547|P1|Period B|Lost to Follow-up|2
2493644|NCT02016482|8622546|P2|Period B|Withdrawal by Subject|1
2493645|NCT02016482|8622547|P1|Period B|Withdrawal by Subject|1
2493646|NCT02016482|8622546|P2|Period A|Required Alternative/Prohibited Therapy|1
2493647|NCT02016482|8622547|P1|Period A|Required Alternative/Prohibited Therapy|0
2493648|NCT02016482|8622546|P2|Period A|Protocol Violation|1
2493649|NCT02016482|8622547|P1|Period A|Protocol Violation|0
2493650|NCT02016482|8622546|P2|Period A|Other|0
2493651|NCT02016482|8622547|P1|Period A|Other|3
2493652|NCT02016482|8622546|P2|Period A|Lack of Efficacy|1
2493653|NCT02016482|8622547|P1|Period A|Lack of Efficacy|2
2493654|NCT02016482|8622546|P2|Period A|Lost to Follow-up|3
2493655|NCT02016482|8622547|P1|Period A|Lost to Follow-up|3
2493656|NCT02016482|8622546|P2|Period A|Withdrawal by Subject|4
2493657|NCT02016482|8622547|P1|Period A|Withdrawal by Subject|3
2493658|NCT02016482|8622546|P2|Period A|Adverse Event|5
2493659|NCT02016482|8622547|P1|Period A|Adverse Event|3
2493660|NCT02016300|8622637|P2|Overall Study|Lost to Follow-up|3
2493661|NCT02016300|8622638|P1|Overall Study|Lost to Follow-up|0
2493662|NCT02016183|8622669|P1|Overall Study|Protocol Violation|52
2493663|NCT02016183|8622669|P1|Overall Study|Case Report Forms Uncollected|13
2493664|NCT02016170|8622679|P3|Overall Study|Protocol Violation|0
2493665|NCT02016170|8622680|P2|Overall Study|Protocol Violation|0
2493666|NCT02016170|8622681|P1|Overall Study|Protocol Violation|1
2493667|NCT02016170|8622679|P3|Overall Study|Adverse Event|0
2493668|NCT02016170|8622680|P2|Overall Study|Adverse Event|1
2493669|NCT02016170|8622681|P1|Overall Study|Adverse Event|1
2493670|NCT02016105|8622692|P6|EXTENSION PERIOD|Lost to Follow-up|2
2493671|NCT02016105|8622693|P5|EXTENSION PERIOD|Lost to Follow-up|0
2493672|NCT02016105|8622694|P4|EXTENSION PERIOD|Lost to Follow-up|0
2493673|NCT02016105|8622695|P3|EXTENSION PERIOD|Lost to Follow-up|0
2493674|NCT02016105|8622696|P2|EXTENSION PERIOD|Lost to Follow-up|0
2493675|NCT02016105|8622697|P1|EXTENSION PERIOD|Lost to Follow-up|0
2493676|NCT02016105|8622692|P6|EXTENSION PERIOD|Non-compliance with study indication|0
2493677|NCT02016105|8622693|P5|EXTENSION PERIOD|Non-compliance with study indication|1
2493678|NCT02016105|8622694|P4|EXTENSION PERIOD|Non-compliance with study indication|0
2493679|NCT02016105|8622695|P3|EXTENSION PERIOD|Non-compliance with study indication|0
2493680|NCT02016105|8622696|P2|EXTENSION PERIOD|Non-compliance with study indication|0
2493681|NCT02016105|8622697|P1|EXTENSION PERIOD|Non-compliance with study indication|0
2493682|NCT02016105|8622692|P6|EXTENSION PERIOD|Withdrawal by Subject|2
2493683|NCT02016105|8622693|P5|EXTENSION PERIOD|Withdrawal by Subject|2
2493684|NCT02016105|8622694|P4|EXTENSION PERIOD|Withdrawal by Subject|2
2493685|NCT02016105|8622695|P3|EXTENSION PERIOD|Withdrawal by Subject|2
2493686|NCT02016105|8622696|P2|EXTENSION PERIOD|Withdrawal by Subject|0
2493687|NCT02016105|8622697|P1|EXTENSION PERIOD|Withdrawal by Subject|0
2493688|NCT02016105|8622692|P6|EXTENSION PERIOD|Adverse Event|0
2493689|NCT02016105|8622693|P5|EXTENSION PERIOD|Adverse Event|1
2493690|NCT02016105|8622694|P4|EXTENSION PERIOD|Adverse Event|0
2493691|NCT02016105|8622695|P3|EXTENSION PERIOD|Adverse Event|2
2493692|NCT02016105|8622696|P2|EXTENSION PERIOD|Adverse Event|0
2493693|NCT02016105|8622697|P1|EXTENSION PERIOD|Adverse Event|0
2493694|NCT02016105|8622692|P6|EXTENSION PERIOD|Lack of Efficacy|1
2493695|NCT02016105|8622693|P5|EXTENSION PERIOD|Lack of Efficacy|1
2493696|NCT02016105|8622694|P4|EXTENSION PERIOD|Lack of Efficacy|3
2493697|NCT02016105|8622695|P3|EXTENSION PERIOD|Lack of Efficacy|1
2493698|NCT02016105|8622696|P2|EXTENSION PERIOD|Lack of Efficacy|0
2493699|NCT02016105|8622697|P1|EXTENSION PERIOD|Lack of Efficacy|0
2493700|NCT02016105|8622692|P6|EXTENSION PERIOD|New therapy for study indication|1
2493701|NCT02016105|8622693|P5|EXTENSION PERIOD|New therapy for study indication|1
2493702|NCT02016105|8622694|P4|EXTENSION PERIOD|New therapy for study indication|0
2493703|NCT02016105|8622695|P3|EXTENSION PERIOD|New therapy for study indication|0
2493704|NCT02016105|8622696|P2|EXTENSION PERIOD|New therapy for study indication|0
2493705|NCT02016105|8622697|P1|EXTENSION PERIOD|New therapy for study indication|0
2493706|NCT02016105|8622692|P6|TREATMENT PERIOD 2|Lost to Follow-up|1
2493707|NCT02016105|8622693|P5|TREATMENT PERIOD 2|Lost to Follow-up|0
2493708|NCT02016105|8622694|P4|TREATMENT PERIOD 2|Lost to Follow-up|0
2493709|NCT02016105|8622695|P3|TREATMENT PERIOD 2|Lost to Follow-up|1
2493710|NCT02016105|8622696|P2|TREATMENT PERIOD 2|Lost to Follow-up|0
2493711|NCT02016105|8622697|P1|TREATMENT PERIOD 2|Lost to Follow-up|0
2493712|NCT02016105|8622692|P6|TREATMENT PERIOD 2|Withdrawal by Subject|7
2493713|NCT02016105|8622693|P5|TREATMENT PERIOD 2|Withdrawal by Subject|1
2493714|NCT02016105|8622694|P4|TREATMENT PERIOD 2|Withdrawal by Subject|1
2493715|NCT02016105|8622695|P3|TREATMENT PERIOD 2|Withdrawal by Subject|3
2493716|NCT02016105|8622696|P2|TREATMENT PERIOD 2|Withdrawal by Subject|0
2493717|NCT02016105|8622697|P1|TREATMENT PERIOD 2|Withdrawal by Subject|0
2493718|NCT02016105|8622692|P6|TREATMENT PERIOD 2|Adverse Event|1
2493719|NCT02016105|8622693|P5|TREATMENT PERIOD 2|Adverse Event|0
2493720|NCT02016105|8622694|P4|TREATMENT PERIOD 2|Adverse Event|4
2493721|NCT02016105|8622695|P3|TREATMENT PERIOD 2|Adverse Event|0
2493722|NCT02016105|8622696|P2|TREATMENT PERIOD 2|Adverse Event|0
2493723|NCT02016105|8622697|P1|TREATMENT PERIOD 2|Adverse Event|0
2493724|NCT02016105|8622692|P6|TREATMENT PERIOD 2|Death|1
2493725|NCT02016105|8622693|P5|TREATMENT PERIOD 2|Death|0
2493726|NCT02016105|8622694|P4|TREATMENT PERIOD 2|Death|0
2493727|NCT02016105|8622695|P3|TREATMENT PERIOD 2|Death|0
2493728|NCT02016105|8622696|P2|TREATMENT PERIOD 2|Death|0
2493729|NCT02016105|8622697|P1|TREATMENT PERIOD 2|Death|0
2493730|NCT02016105|8622692|P6|TREATMENT PERIOD 2|Pregnancy|1
2493731|NCT02016105|8622693|P5|TREATMENT PERIOD 2|Pregnancy|0
2493732|NCT02016105|8622694|P4|TREATMENT PERIOD 2|Pregnancy|0
2493733|NCT02016105|8622695|P3|TREATMENT PERIOD 2|Pregnancy|0
2493734|NCT02016105|8622696|P2|TREATMENT PERIOD 2|Pregnancy|0
2493735|NCT02016105|8622697|P1|TREATMENT PERIOD 2|Pregnancy|0
2493736|NCT02016105|8622692|P6|TREATMENT PERIOD 2|Lack of Efficacy|2
2493737|NCT02016105|8622693|P5|TREATMENT PERIOD 2|Lack of Efficacy|3
2493738|NCT02016105|8622694|P4|TREATMENT PERIOD 2|Lack of Efficacy|6
2493739|NCT02016105|8622695|P3|TREATMENT PERIOD 2|Lack of Efficacy|2
2493740|NCT02016105|8622696|P2|TREATMENT PERIOD 2|Lack of Efficacy|0
2493741|NCT02016105|8622697|P1|TREATMENT PERIOD 2|Lack of Efficacy|0
2493742|NCT02016105|8622692|P6|TREATMENT PERIOD 2|Non compliance study medication|1
2493743|NCT02016105|8622693|P5|TREATMENT PERIOD 2|Non compliance study medication|0
2493744|NCT02016105|8622694|P4|TREATMENT PERIOD 2|Non compliance study medication|0
2493745|NCT02016105|8622695|P3|TREATMENT PERIOD 2|Non compliance study medication|0
2493746|NCT02016105|8622696|P2|TREATMENT PERIOD 2|Non compliance study medication|0
2493747|NCT02016105|8622697|P1|TREATMENT PERIOD 2|Non compliance study medication|0
2493748|NCT02016105|8622692|P6|TREATMENT PERIOD 1|Lost to Follow-up|0
2493749|NCT02016105|8622693|P5|TREATMENT PERIOD 1|Lost to Follow-up|0
2493750|NCT02016105|8622694|P4|TREATMENT PERIOD 1|Lost to Follow-up|0
2493751|NCT02016105|8622695|P3|TREATMENT PERIOD 1|Lost to Follow-up|0
2493752|NCT02016105|8622696|P2|TREATMENT PERIOD 1|Lost to Follow-up|4
2493753|NCT02016105|8622697|P1|TREATMENT PERIOD 1|Lost to Follow-up|6
2493754|NCT02016105|8622692|P6|TREATMENT PERIOD 1|Withdrawal by Subject|0
2493755|NCT02016105|8622693|P5|TREATMENT PERIOD 1|Withdrawal by Subject|0
2493756|NCT02016105|8622694|P4|TREATMENT PERIOD 1|Withdrawal by Subject|0
2493757|NCT02016105|8622695|P3|TREATMENT PERIOD 1|Withdrawal by Subject|0
2493758|NCT02016105|8622696|P2|TREATMENT PERIOD 1|Withdrawal by Subject|11
2493759|NCT02016105|8622697|P1|TREATMENT PERIOD 1|Withdrawal by Subject|15
2493760|NCT02016105|8622692|P6|TREATMENT PERIOD 1|Adverse Event|0
2493761|NCT02016105|8622693|P5|TREATMENT PERIOD 1|Adverse Event|0
2493762|NCT02016105|8622694|P4|TREATMENT PERIOD 1|Adverse Event|0
2493763|NCT02016105|8622695|P3|TREATMENT PERIOD 1|Adverse Event|0
2493764|NCT02016105|8622696|P2|TREATMENT PERIOD 1|Adverse Event|5
2493765|NCT02016105|8622697|P1|TREATMENT PERIOD 1|Adverse Event|3
2493766|NCT02016105|8622692|P6|TREATMENT PERIOD 1|Pregnancy|0
2493767|NCT02016105|8622693|P5|TREATMENT PERIOD 1|Pregnancy|0
2493768|NCT02016105|8622694|P4|TREATMENT PERIOD 1|Pregnancy|0
2493769|NCT02016105|8622695|P3|TREATMENT PERIOD 1|Pregnancy|0
2493770|NCT02016105|8622696|P2|TREATMENT PERIOD 1|Pregnancy|1
2493771|NCT02016105|8622697|P1|TREATMENT PERIOD 1|Pregnancy|0
2493772|NCT02016105|8622692|P6|TREATMENT PERIOD 1|Lack of Efficacy|0
2493773|NCT02016105|8622693|P5|TREATMENT PERIOD 1|Lack of Efficacy|0
2493774|NCT02016105|8622694|P4|TREATMENT PERIOD 1|Lack of Efficacy|0
2493775|NCT02016105|8622695|P3|TREATMENT PERIOD 1|Lack of Efficacy|0
2493776|NCT02016105|8622696|P2|TREATMENT PERIOD 1|Lack of Efficacy|2
2493777|NCT02016105|8622697|P1|TREATMENT PERIOD 1|Lack of Efficacy|4
2493778|NCT02016105|8622692|P6|TREATMENT PERIOD 1|Physician Decision|0
2493779|NCT02016105|8622693|P5|TREATMENT PERIOD 1|Physician Decision|0
2493780|NCT02016105|8622694|P4|TREATMENT PERIOD 1|Physician Decision|0
2493781|NCT02016105|8622695|P3|TREATMENT PERIOD 1|Physician Decision|0
2493782|NCT02016105|8622696|P2|TREATMENT PERIOD 1|Physician Decision|2
2493783|NCT02016105|8622697|P1|TREATMENT PERIOD 1|Physician Decision|0
2493784|NCT02016105|8622692|P6|TREATMENT PERIOD 1|Protocol Violation|0
2493785|NCT02016105|8622693|P5|TREATMENT PERIOD 1|Protocol Violation|0
2493786|NCT02016105|8622694|P4|TREATMENT PERIOD 1|Protocol Violation|0
2493787|NCT02016105|8622695|P3|TREATMENT PERIOD 1|Protocol Violation|0
2493788|NCT02016105|8622696|P2|TREATMENT PERIOD 1|Protocol Violation|8
2493789|NCT02016105|8622697|P1|TREATMENT PERIOD 1|Protocol Violation|2
2493790|NCT02015793|8622756|P2|Overall Study|Withdrawal by Subject|1
2493791|NCT02015793|8622757|P1|Overall Study|Withdrawal by Subject|1
2493792|NCT02015793|8622756|P2|Overall Study|Adverse Event|3
2493793|NCT02015793|8622757|P1|Overall Study|Adverse Event|3
2493794|NCT02015754|8622787|P1|Overall Study|Lost to Follow-up|1
2493795|NCT02015754|8622787|P1|Overall Study|Change in treatment modality|5
2493796|NCT02015754|8622787|P1|Overall Study|Disease progression|5
2493797|NCT02015676|8622807|P3|Overall Study|Disease progression|1
2493798|NCT02015676|8622808|P2|Overall Study|Disease progression|1
2493799|NCT02015676|8622809|P1|Overall Study|Disease progression|3
2493800|NCT02015676|8622807|P3|Overall Study|Death|0
2493801|NCT02015676|8622808|P2|Overall Study|Death|1
2493802|NCT02015676|8622809|P1|Overall Study|Death|0
2493803|NCT02015676|8622807|P3|Overall Study|Administrative reasons|1
2493804|NCT02015676|8622808|P2|Overall Study|Administrative reasons|3
2493805|NCT02015676|8622809|P1|Overall Study|Administrative reasons|0
2493806|NCT02015676|8622807|P3|Overall Study|Withdrawal by Subject|1
2493807|NCT02015676|8622808|P2|Overall Study|Withdrawal by Subject|7
2493808|NCT02015676|8622809|P1|Overall Study|Withdrawal by Subject|1
2493809|NCT02015676|8622807|P3|Overall Study|Protocol Violation|0
2493810|NCT02015676|8622808|P2|Overall Study|Protocol Violation|0
2493811|NCT02015676|8622809|P1|Overall Study|Protocol Violation|1
2493812|NCT02015676|8622807|P3|Overall Study|Lack of Efficacy|0
2493813|NCT02015676|8622808|P2|Overall Study|Lack of Efficacy|4
2493814|NCT02015676|8622809|P1|Overall Study|Lack of Efficacy|2
2493815|NCT02015676|8622807|P3|Overall Study|Adverse Event|0
2493816|NCT02015676|8622808|P2|Overall Study|Adverse Event|18
2493817|NCT02015676|8622809|P1|Overall Study|Adverse Event|2
2493818|NCT02015663|8622825|P2|Overall Study|Administrative problems|11
2493819|NCT02015663|8622826|P1|Overall Study|Administrative problems|10
2493820|NCT02015663|8622825|P2|Overall Study|Adverse Event|0
2493821|NCT02015663|8622826|P1|Overall Study|Adverse Event|3
2493822|NCT02015663|8622825|P2|Overall Study|Protocol Violation|1
2493823|NCT02015663|8622826|P1|Overall Study|Protocol Violation|0
2493824|NCT02015663|8622825|P2|Overall Study|Withdrawal by Subject|0
2493825|NCT02015663|8622826|P1|Overall Study|Withdrawal by Subject|1
2493826|NCT02015663|8622825|P2|Overall Study|unsatisfactory therapeutic effect|0
2493827|NCT02015663|8622826|P1|Overall Study|unsatisfactory therapeutic effect|1
2493828|NCT02015637|8622857|P2|Overall Study|Did not take study drug|0
2493829|NCT02015637|8622858|P1|Overall Study|Did not take study drug|2
2493830|NCT02015637|8622857|P2|Overall Study|Adverse Event|0
2493831|NCT02015637|8622858|P1|Overall Study|Adverse Event|3
2493832|NCT02015637|8622857|P2|Overall Study|Lost to Follow-up|5
2493833|NCT02015637|8622858|P1|Overall Study|Lost to Follow-up|3
2493834|NCT02015546|8622869|P3|Overall Study|Screem Failure|3
2493835|NCT02015546|8622870|P2|Overall Study|Screem Failure|1
2493836|NCT02015546|8622871|P1|Overall Study|Screem Failure|2
2493837|NCT02015546|8622869|P3|Overall Study|Withdrawal by Subject|1
2493838|NCT02015546|8622870|P2|Overall Study|Withdrawal by Subject|1
2493839|NCT02015546|8622871|P1|Overall Study|Withdrawal by Subject|1
2493840|NCT02015481|8622903|P1|Overall Study|Death|1
2493841|NCT02015221|8622936|P2|Overall Study|Lost to Follow-up|0
2493842|NCT02015221|8622937|P1|Overall Study|Lost to Follow-up|1
2493843|NCT02015221|8622936|P2|Overall Study|Withdrawal by Subject|6
2493844|NCT02015221|8622937|P1|Overall Study|Withdrawal by Subject|8
2493845|NCT02015195|8622950|P7|Overall Study|Adverse Event|0
2493846|NCT02015195|8622951|P6|Overall Study|Adverse Event|0
2493847|NCT02015195|8622952|P5|Overall Study|Adverse Event|0
2493848|NCT02015195|8622953|P4|Overall Study|Adverse Event|1
2493849|NCT02015195|8622954|P3|Overall Study|Adverse Event|0
2493850|NCT02015195|8622955|P2|Overall Study|Adverse Event|0
2493851|NCT02015195|8622956|P1|Overall Study|Adverse Event|0
2493852|NCT02015104|8622979|P2|Overall Study|Withdrew consent prior to treatment|1
2493853|NCT02015104|8622980|P1|Overall Study|Withdrew consent prior to treatment|0
2493854|NCT02015104|8622979|P2|Overall Study|Withdrew consent after first dose drug|0
2493855|NCT02015104|8622980|P1|Overall Study|Withdrew consent after first dose drug|1
2493856|NCT02015065|8622997|P3|Overall Study|Death on study|1
2493857|NCT02015065|8622998|P2|Overall Study|Death on study|2
2493858|NCT02015065|8622999|P1|Overall Study|Death on study|1
2493859|NCT02015039|8623021|P2|Overall Study|Not eligible|1
2493860|NCT02015039|8623022|P1|Overall Study|Not eligible|0
2493861|NCT02014740|8623042|P2|Overall Study|Withdrawal by Subject|1
2493862|NCT02014740|8623043|P1|Overall Study|Withdrawal by Subject|2
2493863|NCT02014740|8623042|P2|Overall Study|Lost to Follow-up|4
2493864|NCT02014740|8623043|P1|Overall Study|Lost to Follow-up|4
2493865|NCT02014584|8623051|P6|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
2493866|NCT02014584|8623052|P5|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1
2493867|NCT02014584|8623053|P4|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
2493868|NCT02014584|8623054|P3|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
2493869|NCT02014584|8623055|P2|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
2493870|NCT02014584|8623056|P1|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
2493871|NCT02014584|8623051|P6|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
2493872|NCT02014584|8623052|P5|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
2493873|NCT02014584|8623053|P4|Open-Label Period (24 Weeks)|Withdrawal by Subject|1
2493874|NCT02014584|8623054|P3|Open-Label Period (24 Weeks)|Withdrawal by Subject|3
2493875|NCT02014584|8623055|P2|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
2493876|NCT02014584|8623056|P1|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
2493877|NCT02014584|8623051|P6|Open-Label Period (24 Weeks)|Lost to Follow-up|0
2493878|NCT02014584|8623052|P5|Open-Label Period (24 Weeks)|Lost to Follow-up|0
2493879|NCT02014584|8623053|P4|Open-Label Period (24 Weeks)|Lost to Follow-up|0
2493880|NCT02014584|8623054|P3|Open-Label Period (24 Weeks)|Lost to Follow-up|2
2493881|NCT02014584|8623055|P2|Open-Label Period (24 Weeks)|Lost to Follow-up|0
2493882|NCT02014584|8623056|P1|Open-Label Period (24 Weeks)|Lost to Follow-up|0
2493883|NCT02014584|8623051|P6|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
2493884|NCT02014584|8623052|P5|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
2493885|NCT02014584|8623053|P4|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
2493886|NCT02014584|8623054|P3|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
2493887|NCT02014584|8623055|P2|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5
2493888|NCT02014584|8623056|P1|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2
2493889|NCT02014584|8623051|P6|Double-Blind Period (24 Weeks)|Protocol Violation|0
2493890|NCT02014584|8623052|P5|Double-Blind Period (24 Weeks)|Protocol Violation|0
2493891|NCT02014584|8623053|P4|Double-Blind Period (24 Weeks)|Protocol Violation|0
2493892|NCT02014584|8623054|P3|Double-Blind Period (24 Weeks)|Protocol Violation|0
2493893|NCT02014584|8623055|P2|Double-Blind Period (24 Weeks)|Protocol Violation|1
2493894|NCT02014584|8623056|P1|Double-Blind Period (24 Weeks)|Protocol Violation|0
2493895|NCT02014558|8623186|P13|Overall Study|Miscellaneous|1
2493896|NCT02014558|8623187|P12|Overall Study|Miscellaneous|11
2493897|NCT02014558|8623188|P11|Overall Study|Miscellaneous|12
2493898|NCT02014558|8623189|P10|Overall Study|Miscellaneous|3
2493899|NCT02014558|8623190|P9|Overall Study|Miscellaneous|1
2493900|NCT02014558|8623191|P8|Overall Study|Miscellaneous|1
2493901|NCT02014558|8623192|P7|Overall Study|Miscellaneous|0
2493902|NCT02014558|8623193|P6|Overall Study|Miscellaneous|1
2493903|NCT02014558|8623194|P5|Overall Study|Miscellaneous|0
2493904|NCT02014558|8623195|P4|Overall Study|Miscellaneous|1
2493905|NCT02014558|8623196|P3|Overall Study|Miscellaneous|1
2493906|NCT02014558|8623197|P2|Overall Study|Miscellaneous|1
2493907|NCT02014558|8623198|P1|Overall Study|Miscellaneous|2
2493908|NCT02014558|8623186|P13|Overall Study|Withdrawal by Subject|0
2493909|NCT02014558|8623187|P12|Overall Study|Withdrawal by Subject|10
2493910|NCT02014558|8623188|P11|Overall Study|Withdrawal by Subject|6
2493911|NCT02014558|8623189|P10|Overall Study|Withdrawal by Subject|2
2493912|NCT02014558|8623190|P9|Overall Study|Withdrawal by Subject|0
2493913|NCT02014558|8623191|P8|Overall Study|Withdrawal by Subject|0
2493914|NCT02014558|8623192|P7|Overall Study|Withdrawal by Subject|0
2493915|NCT02014558|8623193|P6|Overall Study|Withdrawal by Subject|0
2493916|NCT02014558|8623194|P5|Overall Study|Withdrawal by Subject|1
2493917|NCT02014558|8623195|P4|Overall Study|Withdrawal by Subject|0
2493918|NCT02014558|8623196|P3|Overall Study|Withdrawal by Subject|0
2493919|NCT02014558|8623197|P2|Overall Study|Withdrawal by Subject|0
2493920|NCT02014558|8623198|P1|Overall Study|Withdrawal by Subject|0
2493921|NCT02014558|8623186|P13|Overall Study|Progressive Disease|6
2493922|NCT02014558|8623187|P12|Overall Study|Progressive Disease|31
2493923|NCT02014558|8623188|P11|Overall Study|Progressive Disease|22
2493924|NCT02014558|8623189|P10|Overall Study|Progressive Disease|6
2493925|NCT02014558|8623190|P9|Overall Study|Progressive Disease|5
2493926|NCT02014558|8623191|P8|Overall Study|Progressive Disease|6
2493927|NCT02014558|8623192|P7|Overall Study|Progressive Disease|1
2493928|NCT02014558|8623193|P6|Overall Study|Progressive Disease|2
2493929|NCT02014558|8623194|P5|Overall Study|Progressive Disease|1
2493930|NCT02014558|8623195|P4|Overall Study|Progressive Disease|1
2493931|NCT02014558|8623196|P3|Overall Study|Progressive Disease|1
2493932|NCT02014558|8623197|P2|Overall Study|Progressive Disease|0
2493933|NCT02014558|8623198|P1|Overall Study|Progressive Disease|1
2493934|NCT02014558|8623186|P13|Overall Study|Lost to Follow-up|0
2493935|NCT02014558|8623187|P12|Overall Study|Lost to Follow-up|0
2493936|NCT02014558|8623188|P11|Overall Study|Lost to Follow-up|1
2493937|NCT02014558|8623189|P10|Overall Study|Lost to Follow-up|0
2493938|NCT02014558|8623190|P9|Overall Study|Lost to Follow-up|0
2493939|NCT02014558|8623191|P8|Overall Study|Lost to Follow-up|0
2493940|NCT02014558|8623192|P7|Overall Study|Lost to Follow-up|0
2493941|NCT02014558|8623193|P6|Overall Study|Lost to Follow-up|0
2493942|NCT02014558|8623194|P5|Overall Study|Lost to Follow-up|0
2493943|NCT02014558|8623195|P4|Overall Study|Lost to Follow-up|0
2493944|NCT02014558|8623196|P3|Overall Study|Lost to Follow-up|0
2493945|NCT02014558|8623197|P2|Overall Study|Lost to Follow-up|0
2493946|NCT02014558|8623198|P1|Overall Study|Lost to Follow-up|0
2493947|NCT02014558|8623186|P13|Overall Study|Lack of Efficacy|5
2493948|NCT02014558|8623187|P12|Overall Study|Lack of Efficacy|8
2493949|NCT02014558|8623188|P11|Overall Study|Lack of Efficacy|16
2493950|NCT02014558|8623189|P10|Overall Study|Lack of Efficacy|3
2493951|NCT02014558|8623190|P9|Overall Study|Lack of Efficacy|3
2493952|NCT02014558|8623191|P8|Overall Study|Lack of Efficacy|3
2493953|NCT02014558|8623192|P7|Overall Study|Lack of Efficacy|1
2493954|NCT02014558|8623193|P6|Overall Study|Lack of Efficacy|0
2493955|NCT02014558|8623194|P5|Overall Study|Lack of Efficacy|0
2493956|NCT02014558|8623195|P4|Overall Study|Lack of Efficacy|1
2493957|NCT02014558|8623196|P3|Overall Study|Lack of Efficacy|1
2493958|NCT02014558|8623197|P2|Overall Study|Lack of Efficacy|2
2493959|NCT02014558|8623198|P1|Overall Study|Lack of Efficacy|1
2493960|NCT02014558|8623186|P13|Overall Study|Death|2
2493961|NCT02014558|8623187|P12|Overall Study|Death|19
2493962|NCT02014558|8623188|P11|Overall Study|Death|5
2493963|NCT02014558|8623189|P10|Overall Study|Death|5
2493964|NCT02014558|8623190|P9|Overall Study|Death|2
2493965|NCT02014558|8623191|P8|Overall Study|Death|1
2493966|NCT02014558|8623192|P7|Overall Study|Death|1
2493967|NCT02014558|8623193|P6|Overall Study|Death|0
2493968|NCT02014558|8623194|P5|Overall Study|Death|0
2493969|NCT02014558|8623195|P4|Overall Study|Death|0
2493970|NCT02014558|8623196|P3|Overall Study|Death|0
2493971|NCT02014558|8623197|P2|Overall Study|Death|0
2493972|NCT02014558|8623198|P1|Overall Study|Death|1
2493973|NCT02014558|8623186|P13|Overall Study|Adverse Event|3
2493974|NCT02014558|8623187|P12|Overall Study|Adverse Event|21
2493975|NCT02014558|8623188|P11|Overall Study|Adverse Event|5
2493976|NCT02014558|8623189|P10|Overall Study|Adverse Event|2
2493977|NCT02014558|8623190|P9|Overall Study|Adverse Event|2
2493978|NCT02014558|8623191|P8|Overall Study|Adverse Event|0
2493979|NCT02014558|8623192|P7|Overall Study|Adverse Event|0
2493980|NCT02014558|8623193|P6|Overall Study|Adverse Event|0
2493981|NCT02014558|8623194|P5|Overall Study|Adverse Event|1
2493982|NCT02014558|8623195|P4|Overall Study|Adverse Event|0
2493983|NCT02014558|8623196|P3|Overall Study|Adverse Event|0
2493984|NCT02014558|8623197|P2|Overall Study|Adverse Event|0
2493985|NCT02014558|8623198|P1|Overall Study|Adverse Event|0
2493986|NCT02014558|8623186|P13|Overall Study|Never Received Study Drug|0
2493987|NCT02014558|8623187|P12|Overall Study|Never Received Study Drug|2
2493988|NCT02014558|8623188|P11|Overall Study|Never Received Study Drug|2
2493989|NCT02014558|8623189|P10|Overall Study|Never Received Study Drug|0
2493990|NCT02014558|8623190|P9|Overall Study|Never Received Study Drug|2
2493991|NCT02014558|8623191|P8|Overall Study|Never Received Study Drug|0
2493992|NCT02014558|8623192|P7|Overall Study|Never Received Study Drug|1
2493993|NCT02014558|8623193|P6|Overall Study|Never Received Study Drug|0
2493994|NCT02014558|8623194|P5|Overall Study|Never Received Study Drug|1
2493995|NCT02014558|8623195|P4|Overall Study|Never Received Study Drug|0
2493996|NCT02014558|8623196|P3|Overall Study|Never Received Study Drug|0
2493997|NCT02014558|8623197|P2|Overall Study|Never Received Study Drug|0
2493998|NCT02014558|8623198|P1|Overall Study|Never Received Study Drug|0
2493999|NCT02014480|8623563|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|1
2494000|NCT02014480|8623564|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
2494001|NCT02014480|8623565|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
2494002|NCT02014480|8623566|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
2494003|NCT02014480|8623567|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
2494004|NCT02014480|8623568|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
2494005|NCT02014480|8623563|P6|Treatment Period 3 (14 Days)|Adverse Event|1
2494006|NCT02014480|8623564|P5|Treatment Period 3 (14 Days)|Adverse Event|0
2494007|NCT02014480|8623565|P4|Treatment Period 3 (14 Days)|Adverse Event|0
2494008|NCT02014480|8623566|P3|Treatment Period 3 (14 Days)|Adverse Event|1
2494009|NCT02014480|8623567|P2|Treatment Period 3 (14 Days)|Adverse Event|0
2494010|NCT02014480|8623568|P1|Treatment Period 3 (14 Days)|Adverse Event|0
2494011|NCT02014480|8623563|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
2494012|NCT02014480|8623564|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
2494013|NCT02014480|8623565|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
2494014|NCT02014480|8623566|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
2494015|NCT02014480|8623567|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
2494016|NCT02014480|8623568|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
2494017|NCT02014480|8623563|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
2494018|NCT02014480|8623564|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
2494019|NCT02014480|8623565|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
2494020|NCT02014480|8623566|P3|Treatment Period 2 (14 Days)|Protocol Violation|2
2494021|NCT02014480|8623567|P2|Treatment Period 2 (14 Days)|Protocol Violation|1
2494022|NCT02014480|8623568|P1|Treatment Period 2 (14 Days)|Protocol Violation|1
2494023|NCT02014480|8623563|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
2494024|NCT02014480|8623564|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
2494025|NCT02014480|8623565|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
2494026|NCT02014480|8623566|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
2494027|NCT02014480|8623567|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
2494028|NCT02014480|8623568|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
2494029|NCT02014480|8623563|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2494030|NCT02014480|8623564|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
2494031|NCT02014480|8623565|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|2
2494032|NCT02014480|8623566|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2494033|NCT02014480|8623567|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
2494034|NCT02014480|8623568|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2494035|NCT02014480|8623563|P6|Treatment Period 1 (14 Days)|Lack of Efficacy|0
2494036|NCT02014480|8623564|P5|Treatment Period 1 (14 Days)|Lack of Efficacy|0
2494037|NCT02014480|8623565|P4|Treatment Period 1 (14 Days)|Lack of Efficacy|0
2494038|NCT02014480|8623566|P3|Treatment Period 1 (14 Days)|Lack of Efficacy|1
2494039|NCT02014480|8623567|P2|Treatment Period 1 (14 Days)|Lack of Efficacy|0
2494040|NCT02014480|8623568|P1|Treatment Period 1 (14 Days)|Lack of Efficacy|0
2494041|NCT02014467|8623587|P2|Overall Study|Withdrawal by Subject|4
2494042|NCT02014467|8623588|P1|Overall Study|Withdrawal by Subject|16
2494043|NCT02014467|8623587|P2|Overall Study|Physician Decision|3
2494044|NCT02014467|8623588|P1|Overall Study|Physician Decision|2
2494045|NCT02014467|8623587|P2|Overall Study|Protocol Violation|0
2494046|NCT02014467|8623588|P1|Overall Study|Protocol Violation|3
2494047|NCT02014467|8623587|P2|Overall Study|Adverse Event|0
2494048|NCT02014467|8623588|P1|Overall Study|Adverse Event|4
2494049|NCT02014441|8623648|P1|Overall Study|Withdrawal by Subject|12
2494050|NCT02014402|8623744|P4|Overall Study|Lost to Follow-up|2
2494051|NCT02014402|8623745|P3|Overall Study|Lost to Follow-up|1
2494052|NCT02014402|8623746|P2|Overall Study|Lost to Follow-up|0
2494053|NCT02014402|8623747|P1|Overall Study|Lost to Follow-up|0
2494054|NCT02014402|8623744|P4|Overall Study|Subject did not have transportation|0
2494055|NCT02014402|8623745|P3|Overall Study|Subject did not have transportation|0
2494056|NCT02014402|8623746|P2|Overall Study|Subject did not have transportation|1
2494057|NCT02014402|8623747|P1|Overall Study|Subject did not have transportation|0
2494058|NCT02014402|8623744|P4|Overall Study|Withdrawal by Subject|1
2494059|NCT02014402|8623745|P3|Overall Study|Withdrawal by Subject|2
2494060|NCT02014402|8623746|P2|Overall Study|Withdrawal by Subject|2
2494061|NCT02014402|8623747|P1|Overall Study|Withdrawal by Subject|1
2494062|NCT02014402|8623744|P4|Overall Study|Adverse Event|0
2494063|NCT02014402|8623745|P3|Overall Study|Adverse Event|0
2494064|NCT02014402|8623746|P2|Overall Study|Adverse Event|0
2494065|NCT02014402|8623747|P1|Overall Study|Adverse Event|1
2494066|NCT02014376|8623777|P3|Overall Study|Lost to Follow-up|0
2494067|NCT02014376|8623778|P2|Overall Study|Lost to Follow-up|0
2494068|NCT02014376|8623779|P1|Overall Study|Lost to Follow-up|2
2494069|NCT02014376|8623777|P3|Overall Study|Adverse Event|0
2494070|NCT02014376|8623778|P2|Overall Study|Adverse Event|1
2494071|NCT02014376|8623779|P1|Overall Study|Adverse Event|1
2494072|NCT02014272|8623815|P2|Intervention Period 1|Adverse Event|1
2494073|NCT02014272|8623816|P1|Intervention Period 1|Adverse Event|0
2494074|NCT02014272|8623815|P2|Intervention Period 1|Withdrawal by Subject|0
2494075|NCT02014272|8623816|P1|Intervention Period 1|Withdrawal by Subject|1
2494076|NCT02014116|8623843|P9|Overall Study|Physician Decision|1
2494077|NCT02014116|8623844|P8|Overall Study|Physician Decision|0
2494078|NCT02014116|8623845|P7|Overall Study|Physician Decision|0
2494079|NCT02014116|8623846|P6|Overall Study|Physician Decision|0
2494080|NCT02014116|8623847|P5|Overall Study|Physician Decision|0
2494081|NCT02014116|8623848|P4|Overall Study|Physician Decision|0
2494082|NCT02014116|8623849|P3|Overall Study|Physician Decision|0
2494083|NCT02014116|8623850|P2|Overall Study|Physician Decision|0
2494084|NCT02014116|8623851|P1|Overall Study|Physician Decision|0
2494085|NCT02014116|8623843|P9|Overall Study|Withdrawal Caregiver Decision|0
2494086|NCT02014116|8623844|P8|Overall Study|Withdrawal Caregiver Decision|0
2494087|NCT02014116|8623845|P7|Overall Study|Withdrawal Caregiver Decision|0
2494088|NCT02014116|8623846|P6|Overall Study|Withdrawal Caregiver Decision|1
2494089|NCT02014116|8623847|P5|Overall Study|Withdrawal Caregiver Decision|0
2494090|NCT02014116|8623848|P4|Overall Study|Withdrawal Caregiver Decision|0
2494091|NCT02014116|8623849|P3|Overall Study|Withdrawal Caregiver Decision|0
2494092|NCT02014116|8623850|P2|Overall Study|Withdrawal Caregiver Decision|0
2494093|NCT02014116|8623851|P1|Overall Study|Withdrawal Caregiver Decision|0
2494094|NCT02014116|8623843|P9|Overall Study|Withdrawal by Subject|0
2494095|NCT02014116|8623844|P8|Overall Study|Withdrawal by Subject|0
2494096|NCT02014116|8623845|P7|Overall Study|Withdrawal by Subject|0
2494097|NCT02014116|8623846|P6|Overall Study|Withdrawal by Subject|1
2494098|NCT02014116|8623847|P5|Overall Study|Withdrawal by Subject|0
2494099|NCT02014116|8623848|P4|Overall Study|Withdrawal by Subject|1
2494100|NCT02014116|8623849|P3|Overall Study|Withdrawal by Subject|1
2494101|NCT02014116|8623850|P2|Overall Study|Withdrawal by Subject|0
2494102|NCT02014116|8623851|P1|Overall Study|Withdrawal by Subject|0
2494103|NCT02014116|8623843|P9|Overall Study|Death|1
2494104|NCT02014116|8623844|P8|Overall Study|Death|1
2494105|NCT02014116|8623845|P7|Overall Study|Death|0
2494106|NCT02014116|8623846|P6|Overall Study|Death|0
2494107|NCT02014116|8623847|P5|Overall Study|Death|0
2494108|NCT02014116|8623848|P4|Overall Study|Death|0
2494109|NCT02014116|8623849|P3|Overall Study|Death|0
2494110|NCT02014116|8623850|P2|Overall Study|Death|0
2494111|NCT02014116|8623851|P1|Overall Study|Death|0
2494112|NCT02014116|8623843|P9|Overall Study|Lost to Follow-up|1
2494113|NCT02014116|8623844|P8|Overall Study|Lost to Follow-up|0
2494114|NCT02014116|8623845|P7|Overall Study|Lost to Follow-up|0
2494115|NCT02014116|8623846|P6|Overall Study|Lost to Follow-up|1
2494116|NCT02014116|8623847|P5|Overall Study|Lost to Follow-up|0
2494117|NCT02014116|8623848|P4|Overall Study|Lost to Follow-up|0
2494118|NCT02014116|8623849|P3|Overall Study|Lost to Follow-up|0
2494119|NCT02014116|8623850|P2|Overall Study|Lost to Follow-up|0
2494120|NCT02014116|8623851|P1|Overall Study|Lost to Follow-up|0
2494121|NCT02014116|8623843|P9|Overall Study|Adverse Event|0
2494122|NCT02014116|8623844|P8|Overall Study|Adverse Event|1
2494123|NCT02014116|8623845|P7|Overall Study|Adverse Event|0
2494124|NCT02014116|8623846|P6|Overall Study|Adverse Event|0
2494125|NCT02014116|8623847|P5|Overall Study|Adverse Event|1
2494126|NCT02014116|8623848|P4|Overall Study|Adverse Event|0
2494127|NCT02014116|8623849|P3|Overall Study|Adverse Event|0
2494128|NCT02014116|8623850|P2|Overall Study|Adverse Event|0
2494129|NCT02014116|8623851|P1|Overall Study|Adverse Event|0
2494130|NCT02014116|8623843|P9|Overall Study|Progressive Disease|7
2494131|NCT02014116|8623844|P8|Overall Study|Progressive Disease|3
2494132|NCT02014116|8623845|P7|Overall Study|Progressive Disease|1
2494133|NCT02014116|8623846|P6|Overall Study|Progressive Disease|13
2494134|NCT02014116|8623847|P5|Overall Study|Progressive Disease|1
2494135|NCT02014116|8623848|P4|Overall Study|Progressive Disease|6
2494136|NCT02014116|8623849|P3|Overall Study|Progressive Disease|2
2494137|NCT02014116|8623850|P2|Overall Study|Progressive Disease|4
2494138|NCT02014116|8623851|P1|Overall Study|Progressive Disease|3
2494139|NCT02013830|8623916|P1|Overall Study|Refused treatment|1
2494140|NCT02013830|8623916|P1|Overall Study|Insufficient therapeutic response|25
2494141|NCT02013830|8623916|P1|Overall Study|Death|1
2494142|NCT02013830|8623916|P1|Overall Study|Adverse Event|3
2494143|NCT02013817|8623927|P1|Overall Study|Other|9
2494144|NCT02013817|8623927|P1|Overall Study|Death|2
2494145|NCT02013817|8623927|P1|Overall Study|Withdrawal by Subject|4
2494146|NCT02013817|8623927|P1|Overall Study|Adverse Event|12
2494147|NCT02013791|8623945|P9|Period 1|Other Miscellaneous Reasons|0
2494148|NCT02013791|8623946|P8|Period 1|Other Miscellaneous Reasons|0
2494149|NCT02013791|8623947|P7|Period 1|Other Miscellaneous Reasons|0
2494150|NCT02013791|8623948|P6|Period 1|Other Miscellaneous Reasons|0
2494151|NCT02013791|8623949|P5|Period 1|Other Miscellaneous Reasons|0
2494152|NCT02013791|8623950|P4|Period 1|Other Miscellaneous Reasons|0
2494153|NCT02013791|8623951|P3|Period 1|Other Miscellaneous Reasons|0
2494154|NCT02013791|8623952|P2|Period 1|Other Miscellaneous Reasons|2
2494155|NCT02013791|8623953|P1|Period 1|Other Miscellaneous Reasons|0
2494156|NCT02013791|8623945|P9|Period 1|Lost to Follow-up|0
2494157|NCT02013791|8623946|P8|Period 1|Lost to Follow-up|1
2494158|NCT02013791|8623947|P7|Period 1|Lost to Follow-up|1
2494159|NCT02013791|8623948|P6|Period 1|Lost to Follow-up|0
2494160|NCT02013791|8623949|P5|Period 1|Lost to Follow-up|0
2494161|NCT02013791|8623950|P4|Period 1|Lost to Follow-up|1
2494162|NCT02013791|8623951|P3|Period 1|Lost to Follow-up|0
2494163|NCT02013791|8623952|P2|Period 1|Lost to Follow-up|0
2494164|NCT02013791|8623953|P1|Period 1|Lost to Follow-up|0
2494165|NCT02013778|8623974|P1|Overall Study|Adverse Event|1
2494166|NCT02013778|8623974|P1|Overall Study|Physician Decision|1
2494167|NCT02013778|8623974|P1|Overall Study|Withdrawal by Subject|1
2494168|NCT02013778|8623974|P1|Overall Study|Death|4
2494169|NCT02013765|8623978|P1|Overall Study|Trial was terminated by sponsor|1
2494170|NCT02013687|8623992|P4|Overall Study|Missed visits due to patient travel|0
2494171|NCT02013687|8623993|P3|Overall Study|Missed visits due to patient travel|1
2494172|NCT02013687|8623994|P2|Overall Study|Missed visits due to patient travel|0
2494173|NCT02013687|8623995|P1|Overall Study|Missed visits due to patient travel|0
2494174|NCT02013687|8623992|P4|Overall Study|Withdrawal by Subject|1
2494175|NCT02013687|8623993|P3|Overall Study|Withdrawal by Subject|0
2494176|NCT02013687|8623994|P2|Overall Study|Withdrawal by Subject|0
2494177|NCT02013687|8623995|P1|Overall Study|Withdrawal by Subject|0
2494178|NCT02013687|8623992|P4|Overall Study|Protocol Violation|1
2494179|NCT02013687|8623993|P3|Overall Study|Protocol Violation|0
2494180|NCT02013687|8623994|P2|Overall Study|Protocol Violation|0
2494181|NCT02013687|8623995|P1|Overall Study|Protocol Violation|0
2494182|NCT02013687|8623992|P4|Overall Study|Lost to Follow-up|0
2494183|NCT02013687|8623993|P3|Overall Study|Lost to Follow-up|1
2494184|NCT02013687|8623994|P2|Overall Study|Lost to Follow-up|0
2494185|NCT02013687|8623995|P1|Overall Study|Lost to Follow-up|0
2494186|NCT02013674|8624027|P2|Overall Study|Lost to Follow-up|0
2494187|NCT02013674|8624028|P1|Overall Study|Lost to Follow-up|1
2494188|NCT02013674|8624027|P2|Overall Study|Death|1
2494189|NCT02013674|8624028|P1|Overall Study|Death|0
2494190|NCT02013622|8624078|P1|Overall Study|Lack of Efficacy|1
2494191|NCT02013622|8624078|P1|Overall Study|Protocol Deviation|1
2494192|NCT02013622|8624078|P1|Overall Study|Withdrawal by Subject|6
2494193|NCT02013622|8624078|P1|Overall Study|Met Withdrawal Criteria|3
2494194|NCT02013622|8624078|P1|Overall Study|Adverse Event|3
2494195|NCT02013622|8624078|P1|Overall Study|Lost to Follow-up|10
2494196|NCT02013609|8624098|P1|Overall Study|Met Withdrawal Criteria|3
2494197|NCT02013609|8624098|P1|Overall Study|Adverse Event|3
2494198|NCT02013609|8624098|P1|Overall Study|Lost to Follow-up|3
2494199|NCT02013609|8624098|P1|Overall Study|Withdrawal by Subject|9
2494200|NCT02013544|8624123|P2|Overall Study|Entry criteria not met/non-compliance|3
2494201|NCT02013544|8624124|P1|Overall Study|Entry criteria not met/non-compliance|2
2494202|NCT02013544|8624123|P2|Overall Study|Physician Decision|1
2494203|NCT02013544|8624124|P1|Overall Study|Physician Decision|0
2494204|NCT02013544|8624123|P2|Overall Study|Withdrawal by Subject|8
2494205|NCT02013544|8624124|P1|Overall Study|Withdrawal by Subject|2
2494206|NCT02013544|8624123|P2|Overall Study|Lost to Follow-up|3
2494207|NCT02013544|8624124|P1|Overall Study|Lost to Follow-up|2
2494208|NCT02013544|8624123|P2|Overall Study|Adverse Event|5
2494209|NCT02013544|8624124|P1|Overall Study|Adverse Event|5
2494210|NCT02013531|8624146|P1|Overall Study|Withdrawal by Subject|1
2494211|NCT02013531|8624146|P1|Overall Study|Met Withdrawal Criteria|1
2494212|NCT02013531|8624146|P1|Overall Study|Lost to Follow-up|3
2494213|NCT02013388|8624182|P8|Overall Study|work emergency|0
2494214|NCT02013388|8624183|P7|Overall Study|work emergency|0
2494215|NCT02013388|8624184|P6|Overall Study|work emergency|0
2494216|NCT02013388|8624185|P5|Overall Study|work emergency|1
2494217|NCT02013388|8624186|P4|Overall Study|work emergency|0
2494218|NCT02013388|8624187|P3|Overall Study|work emergency|0
2494219|NCT02013388|8624188|P2|Overall Study|work emergency|0
2494220|NCT02013388|8624189|P1|Overall Study|work emergency|1
2494221|NCT02013375|8624223|P1|Overall Study|Did not engraft|1
2494222|NCT02013375|8624223|P1|Overall Study|Did not engraft|1
2494223|NCT02013206|8624253|P2|Overall Study|Other reasons off treatment|2
2494224|NCT02013206|8624254|P1|Overall Study|Other reasons off treatment|5
2494225|NCT02013206|8624253|P2|Overall Study|Death|2
2494226|NCT02013206|8624254|P1|Overall Study|Death|1
2494227|NCT02013206|8624253|P2|Overall Study|Patient non-compliance|0
2494228|NCT02013206|8624254|P1|Overall Study|Patient non-compliance|1
2494229|NCT02013206|8624253|P2|Overall Study|Patient refusal|0
2494230|NCT02013206|8624254|P1|Overall Study|Patient refusal|2
2494231|NCT02013206|8624253|P2|Overall Study|Adverse Event|0
2494232|NCT02013206|8624254|P1|Overall Study|Adverse Event|1
2494233|NCT02013206|8624253|P2|Overall Study|Symptomatic deterioration|1
2494234|NCT02013206|8624254|P1|Overall Study|Symptomatic deterioration|3
2494235|NCT02013206|8624253|P2|Overall Study|Progressive disease (PD)|17
2494236|NCT02013206|8624254|P1|Overall Study|Progressive disease (PD)|14
2494237|NCT02013167|8624285|P2|Overall Study|Death|160
2494238|NCT02013167|8624286|P1|Overall Study|Death|85
2494239|NCT02013167|8624285|P2|Overall Study|Lost to Follow-up|1
2494240|NCT02013167|8624286|P1|Overall Study|Lost to Follow-up|0
2494241|NCT02013167|8624285|P2|Overall Study|Sponsor Decision|3
2494242|NCT02013167|8624286|P1|Overall Study|Sponsor Decision|1
2494243|NCT02013167|8624285|P2|Overall Study|Withdrawal by Subject|14
2494244|NCT02013167|8624286|P1|Overall Study|Withdrawal by Subject|15
2494245|NCT02012959|8624362|P5|Treatment Phase A|Adverse Event|0
2494246|NCT02012959|8624363|P4|Treatment Phase A|Adverse Event|0
2494247|NCT02012959|8624364|P3|Treatment Phase A|Adverse Event|0
2494248|NCT02012959|8624365|P2|Treatment Phase A|Adverse Event|0
2494249|NCT02012959|8624366|P1|Treatment Phase A|Adverse Event|2
2494250|NCT02012686|8624379|P2|Overall Study|electrocardiography monitoring noise|1
2494251|NCT02012686|8624380|P1|Overall Study|electrocardiography monitoring noise|0
2494252|NCT02012686|8624379|P2|Overall Study|muscle contraction|1
2494253|NCT02012686|8624380|P1|Overall Study|muscle contraction|0
2494254|NCT02012491|8624442|P2|Overall Study|Withdrawal by Subject|0
2494255|NCT02012491|8624443|P1|Overall Study|Withdrawal by Subject|1
2494256|NCT02012491|8624442|P2|Overall Study|Protocol Violation|1
2494257|NCT02012491|8624443|P1|Overall Study|Protocol Violation|0
2494258|NCT02012491|8624442|P2|Overall Study|Lost to Follow-up|0
2494259|NCT02012491|8624443|P1|Overall Study|Lost to Follow-up|1
2494260|NCT02012452|8624461|P2|Overall Study|Withdrawal by Subject|0
2494261|NCT02012452|8624462|P1|Overall Study|Withdrawal by Subject|4
2494262|NCT02012452|8624461|P2|Overall Study|Lost to Follow-up|1
2494263|NCT02012452|8624462|P1|Overall Study|Lost to Follow-up|2
2494264|NCT02012218|8624505|P5|Overall Study|Protocol Deviation|0
2494265|NCT02012218|8624506|P4|Overall Study|Protocol Deviation|0
2494266|NCT02012218|8624507|P3|Overall Study|Protocol Deviation|0
2494267|NCT02012218|8624508|P2|Overall Study|Protocol Deviation|0
2494268|NCT02012218|8624509|P1|Overall Study|Protocol Deviation|1
2494269|NCT02012218|8624505|P5|Overall Study|Protocol Specified|0
2494270|NCT02012218|8624506|P4|Overall Study|Protocol Specified|0
2494271|NCT02012218|8624507|P3|Overall Study|Protocol Specified|0
2494272|NCT02012218|8624508|P2|Overall Study|Protocol Specified|0
2494273|NCT02012218|8624509|P1|Overall Study|Protocol Specified|1
2494274|NCT02012218|8624505|P5|Overall Study|Lost to Follow-up|0
2494275|NCT02012218|8624506|P4|Overall Study|Lost to Follow-up|0
2494276|NCT02012218|8624507|P3|Overall Study|Lost to Follow-up|1
2494277|NCT02012218|8624508|P2|Overall Study|Lost to Follow-up|1
2494278|NCT02012218|8624509|P1|Overall Study|Lost to Follow-up|0
2494279|NCT02012218|8624505|P5|Overall Study|Adverse Event|0
2494280|NCT02012218|8624506|P4|Overall Study|Adverse Event|1
2494281|NCT02012218|8624507|P3|Overall Study|Adverse Event|0
2494282|NCT02012218|8624508|P2|Overall Study|Adverse Event|0
2494283|NCT02012218|8624509|P1|Overall Study|Adverse Event|1
2494284|NCT02012218|8624505|P5|Overall Study|Withdrawal by Subject|1
2494285|NCT02012218|8624506|P4|Overall Study|Withdrawal by Subject|1
2494286|NCT02012218|8624507|P3|Overall Study|Withdrawal by Subject|1
2494287|NCT02012218|8624508|P2|Overall Study|Withdrawal by Subject|0
2494288|NCT02012218|8624509|P1|Overall Study|Withdrawal by Subject|1
2494289|NCT02011945|8624533|P3|Overall Study|Sub-Optimal Response to dasatinib|0
2494290|NCT02011945|8624534|P2|Overall Study|Sub-Optimal Response to dasatinib|0
2494291|NCT02011945|8624535|P1|Overall Study|Sub-Optimal Response to dasatinib|1
2494292|NCT02011945|8624533|P3|Overall Study|Proceeded to stem cell transplant|1
2494293|NCT02011945|8624534|P2|Overall Study|Proceeded to stem cell transplant|0
2494294|NCT02011945|8624535|P1|Overall Study|Proceeded to stem cell transplant|0
2494295|NCT02011945|8624533|P3|Overall Study|No Longer Meets Study Criteria|0
2494296|NCT02011945|8624534|P2|Overall Study|No Longer Meets Study Criteria|0
2494297|NCT02011945|8624535|P1|Overall Study|No Longer Meets Study Criteria|1
2494298|NCT02011945|8624533|P3|Overall Study|Treatment Failure|6
2494299|NCT02011945|8624534|P2|Overall Study|Treatment Failure|7
2494300|NCT02011945|8624535|P1|Overall Study|Treatment Failure|0
2494301|NCT02011945|8624533|P3|Overall Study|Study Drug Toxicity|1
2494302|NCT02011945|8624534|P2|Overall Study|Study Drug Toxicity|0
2494303|NCT02011945|8624535|P1|Overall Study|Study Drug Toxicity|0
2494304|NCT02011945|8624533|P3|Overall Study|Adverse Event unrelated to Drug|1
2494305|NCT02011945|8624534|P2|Overall Study|Adverse Event unrelated to Drug|2
2494306|NCT02011945|8624535|P1|Overall Study|Adverse Event unrelated to Drug|0
2494307|NCT02011945|8624533|P3|Overall Study|Participant requested to Discontinue|1
2494308|NCT02011945|8624534|P2|Overall Study|Participant requested to Discontinue|1
2494309|NCT02011945|8624535|P1|Overall Study|Participant requested to Discontinue|0
2494310|NCT02011893|8624612|P3|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1
2494311|NCT02011893|8624613|P2|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
2494312|NCT02011893|8624614|P1|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
2494313|NCT02011893|8624612|P3|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2
2494314|NCT02011893|8624613|P2|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
2494315|NCT02011893|8624614|P1|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
2494316|NCT02011893|8624612|P3|Period 1 (Randomization to 12 Weeks)|Physician Decision|1
2494317|NCT02011893|8624613|P2|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
2494318|NCT02011893|8624614|P1|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
2494319|NCT02011893|8624612|P3|Enrollment to Randomization|Insurance/Financial Reasons|0
2494320|NCT02011893|8624613|P2|Enrollment to Randomization|Insurance/Financial Reasons|0
2494321|NCT02011893|8624614|P1|Enrollment to Randomization|Insurance/Financial Reasons|2
2494322|NCT02011893|8624612|P3|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
2494323|NCT02011893|8624613|P2|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
2494324|NCT02011893|8624614|P1|Enrollment to Randomization|Temporary Trial Stimulation Failure|9
2494325|NCT02011893|8624612|P3|Enrollment to Randomization|Screening Failure|0
2494326|NCT02011893|8624613|P2|Enrollment to Randomization|Screening Failure|0
2494327|NCT02011893|8624614|P1|Enrollment to Randomization|Screening Failure|29
2494328|NCT02011893|8624612|P3|Enrollment to Randomization|Withdrawal by Subject|0
2494329|NCT02011893|8624613|P2|Enrollment to Randomization|Withdrawal by Subject|0
2494330|NCT02011893|8624614|P1|Enrollment to Randomization|Withdrawal by Subject|21
2494331|NCT02011893|8624612|P3|Enrollment to Randomization|Physician Decision|0
2494332|NCT02011893|8624613|P2|Enrollment to Randomization|Physician Decision|0
2494333|NCT02011893|8624614|P1|Enrollment to Randomization|Physician Decision|10
2494334|NCT02011893|8624612|P3|Enrollment to Randomization|Adverse Event|0
2494335|NCT02011893|8624613|P2|Enrollment to Randomization|Adverse Event|0
2494336|NCT02011893|8624614|P1|Enrollment to Randomization|Adverse Event|2
2494337|NCT02011542|8624625|P1|Overall Study|Physician Decision|1
2494338|NCT02011113|8624756|P1|Overall Study|Study terminated by sponsor|11
2494339|NCT02011113|8624756|P1|Overall Study|Investigator's judgement- DP|3
2494340|NCT02011113|8624756|P1|Overall Study|Insufficient effect of Pomalidomide|1
2494341|NCT02011113|8624756|P1|Overall Study|Death|1
2494342|NCT02011113|8624756|P1|Overall Study|Disease Progression (DP)|16
2494343|NCT02011113|8624756|P1|Overall Study|Adverse Event|4
2494344|NCT02010775|8624788|P5|Overall Study|Personal Reasons|4
2494345|NCT02010775|8624789|P4|Overall Study|Personal Reasons|2
2494346|NCT02010775|8624790|P3|Overall Study|Personal Reasons|1
2494347|NCT02010775|8624791|P2|Overall Study|Personal Reasons|3
2494348|NCT02010775|8624792|P1|Overall Study|Personal Reasons|3
2494349|NCT02010775|8624788|P5|Overall Study|Lost to Follow-up|1
2494350|NCT02010775|8624789|P4|Overall Study|Lost to Follow-up|1
2494351|NCT02010775|8624790|P3|Overall Study|Lost to Follow-up|0
2494352|NCT02010775|8624791|P2|Overall Study|Lost to Follow-up|0
2494353|NCT02010775|8624792|P1|Overall Study|Lost to Follow-up|2
2494354|NCT02010775|8624788|P5|Overall Study|Pregnancy|0
2494355|NCT02010775|8624789|P4|Overall Study|Pregnancy|0
2494356|NCT02010775|8624790|P3|Overall Study|Pregnancy|2
2494357|NCT02010775|8624791|P2|Overall Study|Pregnancy|0
2494358|NCT02010775|8624792|P1|Overall Study|Pregnancy|0
2494359|NCT02010775|8624788|P5|Overall Study|Adverse Event|1
2494360|NCT02010775|8624789|P4|Overall Study|Adverse Event|0
2494361|NCT02010775|8624790|P3|Overall Study|Adverse Event|0
2494362|NCT02010775|8624791|P2|Overall Study|Adverse Event|0
2494363|NCT02010775|8624792|P1|Overall Study|Adverse Event|0
2494364|NCT02010684|8624833|P2|Overall Study|Withdrawal by Subject|5
2494365|NCT02010684|8624834|P1|Overall Study|Withdrawal by Subject|4
2494366|NCT02010684|8624833|P2|Overall Study|Lost to Follow-up|18
2494367|NCT02010684|8624834|P1|Overall Study|Lost to Follow-up|8
2494368|NCT02010632|8624856|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
2494369|NCT02010632|8624857|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
2494370|NCT02010567|8624868|P5|Overall Study|Adverse Event|1
2494371|NCT02010567|8624869|P4|Overall Study|Adverse Event|0
2494372|NCT02010567|8624870|P3|Overall Study|Adverse Event|1
2494373|NCT02010567|8624871|P2|Overall Study|Adverse Event|0
2494374|NCT02010567|8624872|P1|Overall Study|Adverse Event|0
2494375|NCT02010255|8624924|P14|Overall Study|Randomized but Not Treated|1
2494376|NCT02010255|8624925|P13|Overall Study|Randomized but Not Treated|0
2494377|NCT02010255|8624926|P12|Overall Study|Randomized but Not Treated|0
2494378|NCT02010255|8624927|P11|Overall Study|Randomized but Not Treated|0
2494379|NCT02010255|8624928|P10|Overall Study|Randomized but Not Treated|0
2494380|NCT02010255|8624929|P9|Overall Study|Randomized but Not Treated|0
2494381|NCT02010255|8624930|P8|Overall Study|Randomized but Not Treated|0
2494382|NCT02010255|8624931|P7|Overall Study|Randomized but Not Treated|0
2494383|NCT02010255|8624932|P6|Overall Study|Randomized but Not Treated|0
2494384|NCT02010255|8624933|P5|Overall Study|Randomized but Not Treated|0
2494385|NCT02010255|8624934|P4|Overall Study|Randomized but Not Treated|0
2494386|NCT02010255|8624935|P3|Overall Study|Randomized but Not Treated|0
2494387|NCT02010255|8624936|P2|Overall Study|Randomized but Not Treated|0
2494388|NCT02010255|8624937|P1|Overall Study|Randomized but Not Treated|0
2494389|NCT02010255|8624924|P14|Overall Study|Lost to Follow-up|0
2494390|NCT02010255|8624925|P13|Overall Study|Lost to Follow-up|0
2494391|NCT02010255|8624926|P12|Overall Study|Lost to Follow-up|0
2494392|NCT02010255|8624927|P11|Overall Study|Lost to Follow-up|0
2494393|NCT02010255|8624928|P10|Overall Study|Lost to Follow-up|0
2494394|NCT02010255|8624929|P9|Overall Study|Lost to Follow-up|0
2494395|NCT02010255|8624930|P8|Overall Study|Lost to Follow-up|0
2494396|NCT02010255|8624931|P7|Overall Study|Lost to Follow-up|0
2494397|NCT02010255|8624932|P6|Overall Study|Lost to Follow-up|0
2494398|NCT02010255|8624933|P5|Overall Study|Lost to Follow-up|1
2494399|NCT02010255|8624934|P4|Overall Study|Lost to Follow-up|0
2494400|NCT02010255|8624935|P3|Overall Study|Lost to Follow-up|1
2494401|NCT02010255|8624936|P2|Overall Study|Lost to Follow-up|0
2494402|NCT02010255|8624937|P1|Overall Study|Lost to Follow-up|0
2494403|NCT02010255|8624924|P14|Overall Study|Adverse Event|0
2494404|NCT02010255|8624925|P13|Overall Study|Adverse Event|0
2494405|NCT02010255|8624926|P12|Overall Study|Adverse Event|0
2494406|NCT02010255|8624927|P11|Overall Study|Adverse Event|0
2494407|NCT02010255|8624928|P10|Overall Study|Adverse Event|0
2494408|NCT02010255|8624929|P9|Overall Study|Adverse Event|0
2494409|NCT02010255|8624930|P8|Overall Study|Adverse Event|0
2494410|NCT02010255|8624931|P7|Overall Study|Adverse Event|0
2494411|NCT02010255|8624932|P6|Overall Study|Adverse Event|0
2494412|NCT02010255|8624933|P5|Overall Study|Adverse Event|0
2494413|NCT02010255|8624934|P4|Overall Study|Adverse Event|0
2494414|NCT02010255|8624935|P3|Overall Study|Adverse Event|0
2494415|NCT02010255|8624936|P2|Overall Study|Adverse Event|0
2494416|NCT02010255|8624937|P1|Overall Study|Adverse Event|1
2494417|NCT02010255|8624924|P14|Overall Study|Withdrew Consent|0
2494418|NCT02010255|8624925|P13|Overall Study|Withdrew Consent|0
2494419|NCT02010255|8624926|P12|Overall Study|Withdrew Consent|0
2494420|NCT02010255|8624927|P11|Overall Study|Withdrew Consent|0
2494421|NCT02010255|8624928|P10|Overall Study|Withdrew Consent|0
2494422|NCT02010255|8624929|P9|Overall Study|Withdrew Consent|0
2494423|NCT02010255|8624930|P8|Overall Study|Withdrew Consent|0
2494424|NCT02010255|8624931|P7|Overall Study|Withdrew Consent|0
2494425|NCT02010255|8624932|P6|Overall Study|Withdrew Consent|0
2494426|NCT02010255|8624933|P5|Overall Study|Withdrew Consent|0
2494427|NCT02010255|8624934|P4|Overall Study|Withdrew Consent|1
2494428|NCT02010255|8624935|P3|Overall Study|Withdrew Consent|0
2494429|NCT02010255|8624936|P2|Overall Study|Withdrew Consent|0
2494430|NCT02010255|8624937|P1|Overall Study|Withdrew Consent|1
2494431|NCT02010255|8624924|P14|Overall Study|Lack of Efficacy|0
2494432|NCT02010255|8624925|P13|Overall Study|Lack of Efficacy|0
2494433|NCT02010255|8624926|P12|Overall Study|Lack of Efficacy|0
2494434|NCT02010255|8624927|P11|Overall Study|Lack of Efficacy|1
2494435|NCT02010255|8624928|P10|Overall Study|Lack of Efficacy|0
2494436|NCT02010255|8624929|P9|Overall Study|Lack of Efficacy|0
2494437|NCT02010255|8624930|P8|Overall Study|Lack of Efficacy|0
2494438|NCT02010255|8624931|P7|Overall Study|Lack of Efficacy|0
2494439|NCT02010255|8624932|P6|Overall Study|Lack of Efficacy|0
2494440|NCT02010255|8624933|P5|Overall Study|Lack of Efficacy|1
2494441|NCT02010255|8624934|P4|Overall Study|Lack of Efficacy|1
2494442|NCT02010255|8624935|P3|Overall Study|Lack of Efficacy|2
2494443|NCT02010255|8624936|P2|Overall Study|Lack of Efficacy|1
2494444|NCT02010255|8624937|P1|Overall Study|Lack of Efficacy|4
2494445|NCT02010255|8624924|P14|Overall Study|Death|0
2494446|NCT02010255|8624925|P13|Overall Study|Death|0
2494447|NCT02010255|8624926|P12|Overall Study|Death|1
2494448|NCT02010255|8624927|P11|Overall Study|Death|1
2494449|NCT02010255|8624928|P10|Overall Study|Death|0
2494450|NCT02010255|8624929|P9|Overall Study|Death|1
2494451|NCT02010255|8624930|P8|Overall Study|Death|1
2494452|NCT02010255|8624931|P7|Overall Study|Death|1
2494453|NCT02010255|8624932|P6|Overall Study|Death|0
2494454|NCT02010255|8624933|P5|Overall Study|Death|2
2494455|NCT02010255|8624934|P4|Overall Study|Death|4
2494456|NCT02010255|8624935|P3|Overall Study|Death|4
2494457|NCT02010255|8624936|P2|Overall Study|Death|1
2494458|NCT02010255|8624937|P1|Overall Study|Death|0
2494459|NCT02009878|8625385|P3|Overall Study|Participant Met Withdrawal Criteria|0
2494460|NCT02009878|8625386|P2|Overall Study|Participant Met Withdrawal Criteria|1
2494461|NCT02009878|8625387|P1|Overall Study|Participant Met Withdrawal Criteria|0
2494462|NCT02009865|8625421|P2|Overall Study|Withdrawal by Subject|1
2494463|NCT02009865|8625422|P1|Overall Study|Withdrawal by Subject|1
2494464|NCT02009865|8625421|P2|Overall Study|Protocol Violation|2
2494465|NCT02009865|8625422|P1|Overall Study|Protocol Violation|0
2494466|NCT02009865|8625421|P2|Overall Study|Adverse Event|2
2494467|NCT02009865|8625422|P1|Overall Study|Adverse Event|0
2494468|NCT02009722|8625438|P2|Overall Study|Did not receive intervention|1
2494469|NCT02009722|8625439|P1|Overall Study|Did not receive intervention|0
2494470|NCT02009722|8625438|P2|Overall Study|Protocol Violation|2
2494471|NCT02009722|8625439|P1|Overall Study|Protocol Violation|1
2494472|NCT02009696|8625463|P1|Overall Study|Withdrawal by Subject|2
2494473|NCT02009163|8625480|P3|Randomized-withdrawal Period|Other|5
2494474|NCT02009163|8625481|P2|Randomized-withdrawal Period|Other|9
2494475|NCT02009163|8625482|P1|Randomized-withdrawal Period|Other|0
2494476|NCT02009163|8625480|P3|Randomized-withdrawal Period|Pregnancy|2
2494477|NCT02009163|8625481|P2|Randomized-withdrawal Period|Pregnancy|0
2494478|NCT02009163|8625482|P1|Randomized-withdrawal Period|Pregnancy|0
2494479|NCT02009163|8625480|P3|Randomized-withdrawal Period|Protocol Violation|2
2494480|NCT02009163|8625481|P2|Randomized-withdrawal Period|Protocol Violation|1
2494481|NCT02009163|8625482|P1|Randomized-withdrawal Period|Protocol Violation|0
2494482|NCT02009163|8625480|P3|Randomized-withdrawal Period|Relapse Criteria Met|5
2494483|NCT02009163|8625481|P2|Randomized-withdrawal Period|Relapse Criteria Met|40
2494484|NCT02009163|8625482|P1|Randomized-withdrawal Period|Relapse Criteria Met|0
2494485|NCT02009163|8625480|P3|Randomized-withdrawal Period|Adverse Event|6
2494486|NCT02009163|8625481|P2|Randomized-withdrawal Period|Adverse Event|0
2494487|NCT02009163|8625482|P1|Randomized-withdrawal Period|Adverse Event|0
2494488|NCT02009163|8625480|P3|Randomized-withdrawal Period|Lost to Follow-up|6
2494489|NCT02009163|8625481|P2|Randomized-withdrawal Period|Lost to Follow-up|13
2494490|NCT02009163|8625482|P1|Randomized-withdrawal Period|Lost to Follow-up|0
2494491|NCT02009163|8625480|P3|Randomized-withdrawal Period|Withdrawal by Subject|9
2494492|NCT02009163|8625481|P2|Randomized-withdrawal Period|Withdrawal by Subject|25
2494493|NCT02009163|8625482|P1|Randomized-withdrawal Period|Withdrawal by Subject|0
2494494|NCT02009163|8625480|P3|Open-label Period (Non-randomized)|Other|0
2494495|NCT02009163|8625481|P2|Open-label Period (Non-randomized)|Other|0
2494496|NCT02009163|8625482|P1|Open-label Period (Non-randomized)|Other|13
2494497|NCT02009163|8625480|P3|Open-label Period (Non-randomized)|Pregnancy|0
2494498|NCT02009163|8625481|P2|Open-label Period (Non-randomized)|Pregnancy|0
2494499|NCT02009163|8625482|P1|Open-label Period (Non-randomized)|Pregnancy|1
2494500|NCT02009163|8625480|P3|Open-label Period (Non-randomized)|Protocol Violation|0
2494501|NCT02009163|8625481|P2|Open-label Period (Non-randomized)|Protocol Violation|0
2494502|NCT02009163|8625482|P1|Open-label Period (Non-randomized)|Protocol Violation|10
2494503|NCT02009163|8625480|P3|Open-label Period (Non-randomized)|Lost to Follow-up|0
2494504|NCT02009163|8625481|P2|Open-label Period (Non-randomized)|Lost to Follow-up|0
2494505|NCT02009163|8625482|P1|Open-label Period (Non-randomized)|Lost to Follow-up|20
2494506|NCT02009163|8625480|P3|Open-label Period (Non-randomized)|Adverse Event|0
2494507|NCT02009163|8625481|P2|Open-label Period (Non-randomized)|Adverse Event|0
2494508|NCT02009163|8625482|P1|Open-label Period (Non-randomized)|Adverse Event|22
2494509|NCT02009163|8625480|P3|Open-label Period (Non-randomized)|Withdrawal by Subject|0
2494510|NCT02009163|8625481|P2|Open-label Period (Non-randomized)|Withdrawal by Subject|0
2494511|NCT02009163|8625482|P1|Open-label Period (Non-randomized)|Withdrawal by Subject|29
2494512|NCT02009163|8625480|P3|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
2494513|NCT02009163|8625481|P2|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
2494514|NCT02009163|8625482|P1|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48
2494515|NCT02009046|8625517|P2|Overall Study|Lost to Follow-up|206
2494516|NCT02009046|8625518|P1|Overall Study|Lost to Follow-up|256
2494517|NCT02008916|8625578|P3|Week 16 - 156|Physician Decision|0
2494518|NCT02008916|8625579|P2|Week 16 - 156|Physician Decision|1
2494519|NCT02008916|8625580|P1|Week 16 - 156|Physician Decision|0
2494520|NCT02008916|8625578|P3|Week 16 - 156|Pregnancy|0
2494521|NCT02008916|8625579|P2|Week 16 - 156|Pregnancy|1
2494522|NCT02008916|8625580|P1|Week 16 - 156|Pregnancy|0
2494523|NCT02008916|8625578|P3|Week 16 - 156|Lack of Efficacy|2
2494524|NCT02008916|8625579|P2|Week 16 - 156|Lack of Efficacy|5
2494525|NCT02008916|8625580|P1|Week 16 - 156|Lack of Efficacy|3
2494526|NCT02008916|8625578|P3|Week 16 - 156|Lost to Follow-up|0
2494527|NCT02008916|8625579|P2|Week 16 - 156|Lost to Follow-up|0
2494528|NCT02008916|8625580|P1|Week 16 - 156|Lost to Follow-up|5
2494529|NCT02008916|8625578|P3|Week 16 - 156|No longer requires treatment|0
2494530|NCT02008916|8625579|P2|Week 16 - 156|No longer requires treatment|1
2494531|NCT02008916|8625580|P1|Week 16 - 156|No longer requires treatment|0
2494532|NCT02008916|8625578|P3|Week 16 - 156|Withdrawal by Subject|5
2494533|NCT02008916|8625579|P2|Week 16 - 156|Withdrawal by Subject|3
2494534|NCT02008916|8625580|P1|Week 16 - 156|Withdrawal by Subject|7
2494535|NCT02008916|8625578|P3|Week 16 - 156|Adverse Event|3
2494536|NCT02008916|8625579|P2|Week 16 - 156|Adverse Event|2
2494537|NCT02008916|8625580|P1|Week 16 - 156|Adverse Event|4
2494538|NCT02008916|8625578|P3|Primary Assessment (up to Week 16)|Withdrawal by Subject|3
2494539|NCT02008916|8625579|P2|Primary Assessment (up to Week 16)|Withdrawal by Subject|1
2494540|NCT02008916|8625580|P1|Primary Assessment (up to Week 16)|Withdrawal by Subject|0
2494541|NCT02008890|8625616|P5|Extension Period|Adverse Event|2
2494542|NCT02008890|8625617|P4|Extension Period|Adverse Event|0
2494543|NCT02008890|8625618|P3|Extension Period|Adverse Event|0
2494544|NCT02008890|8625619|P2|Extension Period|Adverse Event|3
2494545|NCT02008890|8625620|P1|Extension Period|Adverse Event|1
2494546|NCT02008890|8625616|P5|Extension Period|Lost to Follow-up|0
2494547|NCT02008890|8625617|P4|Extension Period|Lost to Follow-up|0
2494548|NCT02008890|8625618|P3|Extension Period|Lost to Follow-up|0
2494549|NCT02008890|8625619|P2|Extension Period|Lost to Follow-up|0
2494550|NCT02008890|8625620|P1|Extension Period|Lost to Follow-up|1
2494551|NCT02008890|8625616|P5|Extension Period|Withdrawal by Subject|2
2494552|NCT02008890|8625617|P4|Extension Period|Withdrawal by Subject|4
2494553|NCT02008890|8625618|P3|Extension Period|Withdrawal by Subject|0
2494554|NCT02008890|8625619|P2|Extension Period|Withdrawal by Subject|2
2494555|NCT02008890|8625620|P1|Extension Period|Withdrawal by Subject|3
2494556|NCT02008890|8625616|P5|Period 2|Lost to Follow-up|0
2494557|NCT02008890|8625617|P4|Period 2|Lost to Follow-up|0
2494558|NCT02008890|8625618|P3|Period 2|Lost to Follow-up|1
2494559|NCT02008890|8625619|P2|Period 2|Lost to Follow-up|0
2494560|NCT02008890|8625620|P1|Period 2|Lost to Follow-up|0
2494561|NCT02008890|8625616|P5|Period 2|Physician Decision|1
2494562|NCT02008890|8625617|P4|Period 2|Physician Decision|2
2494563|NCT02008890|8625618|P3|Period 2|Physician Decision|0
2494564|NCT02008890|8625619|P2|Period 2|Physician Decision|0
2494565|NCT02008890|8625620|P1|Period 2|Physician Decision|4
2494566|NCT02008890|8625616|P5|Period 2|Withdrawal by Subject|2
2494567|NCT02008890|8625617|P4|Period 2|Withdrawal by Subject|7
2494568|NCT02008890|8625618|P3|Period 2|Withdrawal by Subject|0
2494569|NCT02008890|8625619|P2|Period 2|Withdrawal by Subject|8
2494570|NCT02008890|8625620|P1|Period 2|Withdrawal by Subject|11
2494571|NCT02008890|8625616|P5|Period 2|Adverse Event|5
2494572|NCT02008890|8625617|P4|Period 2|Adverse Event|5
2494573|NCT02008890|8625618|P3|Period 2|Adverse Event|0
2494574|NCT02008890|8625619|P2|Period 2|Adverse Event|7
2494575|NCT02008890|8625620|P1|Period 2|Adverse Event|12
2494576|NCT02008890|8625616|P5|Period 1|Adverse Event|0
2494577|NCT02008890|8625617|P4|Period 1|Adverse Event|0
2494578|NCT02008890|8625618|P3|Period 1|Adverse Event|6
2494579|NCT02008890|8625619|P2|Period 1|Adverse Event|8
2494580|NCT02008890|8625620|P1|Period 1|Adverse Event|6
2494581|NCT02008890|8625616|P5|Period 1|Physician Decision|0
2494582|NCT02008890|8625617|P4|Period 1|Physician Decision|0
2494583|NCT02008890|8625618|P3|Period 1|Physician Decision|1
2494584|NCT02008890|8625619|P2|Period 1|Physician Decision|0
2494585|NCT02008890|8625620|P1|Period 1|Physician Decision|1
2494586|NCT02008890|8625616|P5|Period 1|Pregnancy|0
2494587|NCT02008890|8625617|P4|Period 1|Pregnancy|0
2494588|NCT02008890|8625618|P3|Period 1|Pregnancy|0
2494589|NCT02008890|8625619|P2|Period 1|Pregnancy|0
2494590|NCT02008890|8625620|P1|Period 1|Pregnancy|1
2494591|NCT02008890|8625616|P5|Period 1|Withdrawal by Subject|0
2494592|NCT02008890|8625617|P4|Period 1|Withdrawal by Subject|0
2494593|NCT02008890|8625618|P3|Period 1|Withdrawal by Subject|5
2494594|NCT02008890|8625619|P2|Period 1|Withdrawal by Subject|7
2494595|NCT02008890|8625620|P1|Period 1|Withdrawal by Subject|7
2494596|NCT02008877|8625656|P3|Overall Study|Inevaluable|0
2494597|NCT02008877|8625657|P2|Overall Study|Inevaluable|1
2494598|NCT02008877|8625658|P1|Overall Study|Inevaluable|0
2494599|NCT02008773|8625677|P4|Overall Study|Lost to Follow-up|2
2494600|NCT02008773|8625678|P3|Overall Study|Lost to Follow-up|3
2494601|NCT02008773|8625679|P2|Overall Study|Lost to Follow-up|1
2494602|NCT02008773|8625680|P1|Overall Study|Lost to Follow-up|0
2494603|NCT02008773|8625677|P4|Overall Study|Withdrawal by Subject|6
2494604|NCT02008773|8625678|P3|Overall Study|Withdrawal by Subject|7
2494605|NCT02008773|8625679|P2|Overall Study|Withdrawal by Subject|4
2494606|NCT02008773|8625680|P1|Overall Study|Withdrawal by Subject|8
2494607|NCT02008773|8625677|P4|Overall Study|Medication Non-compliance|2
2494608|NCT02008773|8625678|P3|Overall Study|Medication Non-compliance|3
2494609|NCT02008773|8625679|P2|Overall Study|Medication Non-compliance|1
2494610|NCT02008773|8625680|P1|Overall Study|Medication Non-compliance|2
2494611|NCT02008773|8625677|P4|Overall Study|Adverse Event|2
2494612|NCT02008773|8625678|P3|Overall Study|Adverse Event|1
2494613|NCT02008773|8625679|P2|Overall Study|Adverse Event|3
2494614|NCT02008773|8625680|P1|Overall Study|Adverse Event|3
2494615|NCT02008565|8625746|P4|Overall Study|Protocol Violation|0
2494616|NCT02008565|8625747|P3|Overall Study|Protocol Violation|2
2494617|NCT02008565|8625748|P2|Overall Study|Protocol Violation|1
2494618|NCT02008565|8625749|P1|Overall Study|Protocol Violation|1
2494619|NCT02008526|8625810|P3|Overall Study|Lost to Follow-up|6
2494620|NCT02008526|8625811|P2|Overall Study|Lost to Follow-up|9
2494621|NCT02008526|8625812|P1|Overall Study|Lost to Follow-up|5
2494622|NCT02008526|8625810|P3|Overall Study|Withdrawal by Subject|2
2494623|NCT02008526|8625811|P2|Overall Study|Withdrawal by Subject|3
2494624|NCT02008526|8625812|P1|Overall Study|Withdrawal by Subject|3
2494625|NCT02008526|8625810|P3|Overall Study|Death|1
2494626|NCT02008526|8625811|P2|Overall Study|Death|2
2494627|NCT02008526|8625812|P1|Overall Study|Death|0
2494628|NCT02008370|8625823|P1|Overall Study|Lost to Follow-up|7
2494629|NCT02008318|8625831|P2|Overall Study|Withdrawal by Subject|0
2494630|NCT02008318|8625832|P1|Overall Study|Withdrawal by Subject|3
2494631|NCT02008318|8625831|P2|Overall Study|Protocol Violation|1
2494632|NCT02008318|8625832|P1|Overall Study|Protocol Violation|1
2494633|NCT02008318|8625831|P2|Overall Study|Progressive Disease|0
2494634|NCT02008318|8625832|P1|Overall Study|Progressive Disease|2
2494635|NCT02008318|8625831|P2|Overall Study|Physician Decision|0
2494636|NCT02008318|8625832|P1|Overall Study|Physician Decision|2
2494637|NCT02008318|8625831|P2|Overall Study|Adverse Event|0
2494638|NCT02008318|8625832|P1|Overall Study|Adverse Event|4
2494639|NCT02008227|8625853|P2|Overall Study|Study Terminated By Sponsor|83
2494640|NCT02008227|8625854|P1|Overall Study|Study Terminated By Sponsor|44
2494641|NCT02008227|8625853|P2|Overall Study|Withdrawal by Subject|36
2494642|NCT02008227|8625854|P1|Overall Study|Withdrawal by Subject|67
2494643|NCT02008227|8625853|P2|Overall Study|Death|485
2494644|NCT02008227|8625854|P1|Overall Study|Death|494
2494645|NCT02008227|8625853|P2|Overall Study|Lost to Follow-up|9
2494646|NCT02008227|8625854|P1|Overall Study|Lost to Follow-up|7
2494647|NCT02007954|8625942|P1|Overall Study|Death|1
2494648|NCT02007954|8625942|P1|Overall Study|Disease progression and unrelated AE|1
2494649|NCT02007954|8625942|P1|Overall Study|Switch in treatment modality|2
2494650|NCT02007954|8625942|P1|Overall Study|Received liver transplant|3
2494651|NCT02007720|8625961|P2|Overall Study|patient followd less than 165 days|5
2494652|NCT02007720|8625962|P1|Overall Study|patient followd less than 165 days|11
2494653|NCT02007720|8625961|P2|Overall Study|technical problem|2
2494654|NCT02007720|8625962|P1|Overall Study|technical problem|4
2494655|NCT02007720|8625961|P2|Overall Study|study terminated by sponsor|54
2494656|NCT02007720|8625962|P1|Overall Study|study terminated by sponsor|58
2494657|NCT02007720|8625961|P2|Overall Study|Withdrawal by Subject|11
2494658|NCT02007720|8625962|P1|Overall Study|Withdrawal by Subject|9
2494659|NCT02007577|8625997|P2|Overall Study|Withdrawal by Subject|1
2494660|NCT02007577|8625998|P1|Overall Study|Withdrawal by Subject|0
2494661|NCT02007577|8625997|P2|Overall Study|Adverse Event|0
2494662|NCT02007577|8625998|P1|Overall Study|Adverse Event|1
2494663|NCT02007512|8626010|P4|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
2494664|NCT02007512|8626011|P3|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
2494665|NCT02007512|8626012|P2|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3
2494666|NCT02007512|8626013|P1|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
2494667|NCT02007512|8626010|P4|Open Label Treatment Period|Disease progression|11
2494668|NCT02007512|8626011|P3|Open Label Treatment Period|Disease progression|0
2494669|NCT02007512|8626012|P2|Open Label Treatment Period|Disease progression|17
2494670|NCT02007512|8626013|P1|Open Label Treatment Period|Disease progression|0
2494671|NCT02007512|8626010|P4|Open Label Treatment Period|Other|1
2494672|NCT02007512|8626011|P3|Open Label Treatment Period|Other|0
2494673|NCT02007512|8626012|P2|Open Label Treatment Period|Other|0
2494674|NCT02007512|8626013|P1|Open Label Treatment Period|Other|0
2494675|NCT02007512|8626010|P4|Open Label Treatment Period|Adverse Event|0
2494676|NCT02007512|8626011|P3|Open Label Treatment Period|Adverse Event|0
2494677|NCT02007512|8626012|P2|Open Label Treatment Period|Adverse Event|1
2494678|NCT02007512|8626013|P1|Open Label Treatment Period|Adverse Event|0
2494679|NCT02007512|8626010|P4|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1
2494680|NCT02007512|8626011|P3|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5
2494681|NCT02007512|8626012|P2|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11
2494682|NCT02007512|8626013|P1|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10
2494683|NCT02007512|8626010|P4|Double Blind Treatment Period|Other|2
2494684|NCT02007512|8626011|P3|Double Blind Treatment Period|Other|1
2494685|NCT02007512|8626012|P2|Double Blind Treatment Period|Other|0
2494686|NCT02007512|8626013|P1|Double Blind Treatment Period|Other|0
2494687|NCT02007512|8626010|P4|Double Blind Treatment Period|Protocol Violation|1
2494688|NCT02007512|8626011|P3|Double Blind Treatment Period|Protocol Violation|0
2494689|NCT02007512|8626012|P2|Double Blind Treatment Period|Protocol Violation|0
2494690|NCT02007512|8626013|P1|Double Blind Treatment Period|Protocol Violation|0
2494691|NCT02007512|8626010|P4|Double Blind Treatment Period|Withdrawal by Subject|3
2494692|NCT02007512|8626011|P3|Double Blind Treatment Period|Withdrawal by Subject|3
2494693|NCT02007512|8626012|P2|Double Blind Treatment Period|Withdrawal by Subject|2
2494694|NCT02007512|8626013|P1|Double Blind Treatment Period|Withdrawal by Subject|4
2494695|NCT02007512|8626010|P4|Double Blind Treatment Period|Disease progression|51
2494696|NCT02007512|8626011|P3|Double Blind Treatment Period|Disease progression|45
2494697|NCT02007512|8626012|P2|Double Blind Treatment Period|Disease progression|49
2494698|NCT02007512|8626013|P1|Double Blind Treatment Period|Disease progression|44
2494699|NCT02007512|8626010|P4|Double Blind Treatment Period|Death|0
2494700|NCT02007512|8626011|P3|Double Blind Treatment Period|Death|0
2494701|NCT02007512|8626012|P2|Double Blind Treatment Period|Death|0
2494702|NCT02007512|8626013|P1|Double Blind Treatment Period|Death|1
2494703|NCT02007512|8626010|P4|Double Blind Treatment Period|Adverse Event|2
2494704|NCT02007512|8626011|P3|Double Blind Treatment Period|Adverse Event|6
2494705|NCT02007512|8626012|P2|Double Blind Treatment Period|Adverse Event|2
2494706|NCT02007512|8626013|P1|Double Blind Treatment Period|Adverse Event|4
2494707|NCT02007434|8626091|P8|Overall Study|Non-compliance|0
2494708|NCT02007434|8626092|P7|Overall Study|Non-compliance|0
2494709|NCT02007434|8626093|P6|Overall Study|Non-compliance|0
2494710|NCT02007434|8626094|P5|Overall Study|Non-compliance|0
2494711|NCT02007434|8626095|P4|Overall Study|Non-compliance|0
2494712|NCT02007434|8626096|P3|Overall Study|Non-compliance|1
2494713|NCT02007434|8626097|P2|Overall Study|Non-compliance|0
2494714|NCT02007434|8626098|P1|Overall Study|Non-compliance|1
2494715|NCT02007434|8626091|P8|Overall Study|Lost to Follow-up|0
2494716|NCT02007434|8626092|P7|Overall Study|Lost to Follow-up|0
2494717|NCT02007434|8626093|P6|Overall Study|Lost to Follow-up|0
2494718|NCT02007434|8626094|P5|Overall Study|Lost to Follow-up|0
2494719|NCT02007434|8626095|P4|Overall Study|Lost to Follow-up|0
2494720|NCT02007434|8626096|P3|Overall Study|Lost to Follow-up|0
2494721|NCT02007434|8626097|P2|Overall Study|Lost to Follow-up|1
2494722|NCT02007434|8626098|P1|Overall Study|Lost to Follow-up|0
2494723|NCT02007278|8626229|P2|Overall Study|Mis-randomization|1
2494724|NCT02007278|8626230|P1|Overall Study|Mis-randomization|1
2494725|NCT02007278|8626229|P2|Overall Study|Incorrect medication administration|0
2494726|NCT02007278|8626230|P1|Overall Study|Incorrect medication administration|1
2494727|NCT02007278|8626229|P2|Overall Study|Ingestion of drugs not allowed in study|1
2494728|NCT02007278|8626230|P1|Overall Study|Ingestion of drugs not allowed in study|0
2494729|NCT02007278|8626229|P2|Overall Study|Failure to comply with an eligibility|1
2494730|NCT02007278|8626230|P1|Overall Study|Failure to comply with an eligibility|0
2494731|NCT02007252|8626252|P2|Overall Study|Adverse Event|4
2494732|NCT02007252|8626253|P1|Overall Study|Adverse Event|7
2494733|NCT02007252|8626252|P2|Overall Study|Abnormal laboratory value(s)|0
2494734|NCT02007252|8626253|P1|Overall Study|Abnormal laboratory value(s)|1
2494735|NCT02007252|8626252|P2|Overall Study|Administrative problems|7
2494736|NCT02007252|8626253|P1|Overall Study|Administrative problems|3
2494737|NCT02007109|8626266|P1|Overall Study|Excluded - Age<7yo|9
2494738|NCT02007109|8626266|P1|Overall Study|Diary not returned or excluded|102
2494739|NCT02007096|8626275|P2|Overall Study|no mesh placed|1
2494740|NCT02007096|8626276|P1|Overall Study|no mesh placed|0
2494741|NCT02007096|8626275|P2|Overall Study|converted to open surgery|1
2494742|NCT02007096|8626276|P1|Overall Study|converted to open surgery|1
2494743|NCT02007096|8626275|P2|Overall Study|did not follow postoperative protocol|11
2494744|NCT02007096|8626276|P1|Overall Study|did not follow postoperative protocol|8
2494745|NCT02007096|8626275|P2|Overall Study|did not inject saline|3
2494746|NCT02007096|8626276|P1|Overall Study|did not inject saline|0
2494747|NCT02007096|8626275|P2|Overall Study|medication not available|0
2494748|NCT02007096|8626276|P1|Overall Study|medication not available|2
2494749|NCT02007070|8626288|P1|Overall Study|Progressive Disease|21
2494750|NCT02007070|8626288|P1|Overall Study|Physician Decision|1
2494751|NCT02007070|8626288|P1|Overall Study|Protocol Violation|2
2494752|NCT02007070|8626288|P1|Overall Study|Death|1
2494753|NCT02007070|8626288|P1|Overall Study|Clinical Progression|4
2494754|NCT02007070|8626288|P1|Overall Study|Adverse Event|4
2494755|NCT02006979|8626309|P2|Overall Study|Protocol Violation|1
2494756|NCT02006979|8626310|P1|Overall Study|Protocol Violation|0
2494757|NCT02006979|8626309|P2|Overall Study|Withdrawal by Subject|1
2494758|NCT02006979|8626310|P1|Overall Study|Withdrawal by Subject|1
2494759|NCT02006758|8626356|P1|Overall Study|Other|2
2494760|NCT02006758|8626356|P1|Overall Study|Procedurally excluded|1
2494761|NCT02006758|8626356|P1|Overall Study|Withdrawal by Subject|4
2494762|NCT02006758|8626356|P1|Overall Study|Lost to Follow-up|4
2494763|NCT02006758|8626356|P1|Overall Study|Death|1
2494764|NCT02006758|8626356|P1|Overall Study|Protocol Violation|1
2494765|NCT02006732|8626387|P4|Overall Study|Withdrawal by Subject|1
2494766|NCT02006732|8626388|P3|Overall Study|Withdrawal by Subject|4
2494767|NCT02006732|8626389|P2|Overall Study|Withdrawal by Subject|0
2494768|NCT02006732|8626390|P1|Overall Study|Withdrawal by Subject|3
2494769|NCT02006732|8626387|P4|Overall Study|Lost to Follow-up|0
2494770|NCT02006732|8626388|P3|Overall Study|Lost to Follow-up|0
2494771|NCT02006732|8626389|P2|Overall Study|Lost to Follow-up|1
2494772|NCT02006732|8626390|P1|Overall Study|Lost to Follow-up|0
2494773|NCT02006732|8626387|P4|Overall Study|Protocol Violation|0
2494774|NCT02006732|8626388|P3|Overall Study|Protocol Violation|0
2494775|NCT02006732|8626389|P2|Overall Study|Protocol Violation|1
2494776|NCT02006732|8626390|P1|Overall Study|Protocol Violation|1
2494777|NCT02006732|8626387|P4|Overall Study|Lack of Efficacy|1
2494778|NCT02006732|8626388|P3|Overall Study|Lack of Efficacy|1
2494779|NCT02006732|8626389|P2|Overall Study|Lack of Efficacy|3
2494780|NCT02006732|8626390|P1|Overall Study|Lack of Efficacy|6
2494781|NCT02006732|8626387|P4|Overall Study|Adverse Event|2
2494782|NCT02006732|8626388|P3|Overall Study|Adverse Event|4
2494783|NCT02006732|8626389|P2|Overall Study|Adverse Event|7
2494784|NCT02006732|8626390|P1|Overall Study|Adverse Event|10
2494785|NCT02006719|8626430|P2|Overall Study|Other/Unknown|1
2494786|NCT02006719|8626431|P1|Overall Study|Other/Unknown|0
2494787|NCT02006719|8626430|P2|Overall Study|Adverse Event|1
2494788|NCT02006719|8626431|P1|Overall Study|Adverse Event|1
2494789|NCT02006719|8626430|P2|Overall Study|Protocol Violation|0
2494790|NCT02006719|8626431|P1|Overall Study|Protocol Violation|2
2494791|NCT02006719|8626430|P2|Overall Study|Lost to Follow-up|1
2494792|NCT02006719|8626431|P1|Overall Study|Lost to Follow-up|5
2494793|NCT02006719|8626430|P2|Overall Study|Withdrawal by Subject|2
2494794|NCT02006719|8626431|P1|Overall Study|Withdrawal by Subject|10
2494795|NCT02006706|8626461|P1|Overall Study|Lost to Follow-up|1
2494796|NCT02006693|8626468|P2|Overall Study|Patient Decision|0
2494797|NCT02006693|8626469|P1|Overall Study|Patient Decision|4
2494798|NCT02006693|8626468|P2|Overall Study|Lost to Follow-up|1
2494799|NCT02006693|8626469|P1|Overall Study|Lost to Follow-up|4
2494800|NCT02006693|8626468|P2|Overall Study|Death|2
2494801|NCT02006693|8626469|P1|Overall Study|Death|2
2494802|NCT02006693|8626468|P2|Overall Study|XEN Implant Explantation|1
2494803|NCT02006693|8626469|P1|Overall Study|XEN Implant Explantation|0
2494804|NCT02006693|8626468|P2|Overall Study|Another Glaucoma-related Surgery|1
2494805|NCT02006693|8626469|P1|Overall Study|Another Glaucoma-related Surgery|12
2494806|NCT02006693|8626468|P2|Overall Study|No Reason Specified|8
2494807|NCT02006693|8626469|P1|Overall Study|No Reason Specified|6
2494808|NCT02006667|8626481|P1|Overall Study|Withdrawal by Subject|1
2494809|NCT02006667|8626481|P1|Overall Study|Death|2
2494810|NCT02006667|8626481|P1|Overall Study|Adverse Event|3
2494811|NCT02006654|8626493|P2|Overall Study|moving out of state|1
2494812|NCT02006654|8626494|P1|Overall Study|moving out of state|0
2494813|NCT02006654|8626493|P2|Overall Study|disallowed medication|0
2494814|NCT02006654|8626494|P1|Overall Study|disallowed medication|1
2494815|NCT02006654|8626493|P2|Overall Study|mood disorder|1
2494816|NCT02006654|8626494|P1|Overall Study|mood disorder|0
2494817|NCT02006654|8626493|P2|Overall Study|faecal incontinence|1
2494818|NCT02006654|8626494|P1|Overall Study|faecal incontinence|0
2494819|NCT02006654|8626493|P2|Overall Study|worsening cognitive condition|1
2494820|NCT02006654|8626494|P1|Overall Study|worsening cognitive condition|0
2494821|NCT02006654|8626493|P2|Overall Study|insufficient compliance|0
2494822|NCT02006654|8626494|P1|Overall Study|insufficient compliance|1
2494823|NCT02006654|8626493|P2|Overall Study|patient's will|1
2494824|NCT02006654|8626494|P1|Overall Study|patient's will|2
2494825|NCT02006654|8626493|P2|Overall Study|Lost to Follow-up|0
2494826|NCT02006654|8626494|P1|Overall Study|Lost to Follow-up|1
2494827|NCT02006654|8626493|P2|Overall Study|Protocol Violation|8
2494828|NCT02006654|8626494|P1|Overall Study|Protocol Violation|5
2494829|NCT02006654|8626493|P2|Overall Study|Withdrawal by Subject|12
2494830|NCT02006654|8626494|P1|Overall Study|Withdrawal by Subject|14
2494831|NCT02006654|8626493|P2|Overall Study|Death|0
2494832|NCT02006654|8626494|P1|Overall Study|Death|1
2494833|NCT02006654|8626493|P2|Overall Study|Adverse Event|17
2494834|NCT02006654|8626494|P1|Overall Study|Adverse Event|16
2494835|NCT02006654|8626493|P2|Overall Study|Withdrawal before treatment|2
2494836|NCT02006654|8626494|P1|Overall Study|Withdrawal before treatment|4
2494837|NCT02006641|8626523|P3|Overall Study|Other reason: protocol non-compliance|1
2494838|NCT02006641|8626524|P2|Overall Study|Other reason: protocol non-compliance|0
2494839|NCT02006641|8626525|P1|Overall Study|Other reason: protocol non-compliance|0
2494840|NCT02006641|8626523|P3|Overall Study|Other reason: caregiver impossibility|1
2494841|NCT02006641|8626524|P2|Overall Study|Other reason: caregiver impossibility|0
2494842|NCT02006641|8626525|P1|Overall Study|Other reason: caregiver impossibility|0
2494843|NCT02006641|8626523|P3|Overall Study|Other reason: hospitalisation|0
2494844|NCT02006641|8626524|P2|Overall Study|Other reason: hospitalisation|1
2494845|NCT02006641|8626525|P1|Overall Study|Other reason: hospitalisation|0
2494846|NCT02006641|8626523|P3|Overall Study|Other reason: patient's wife has died|1
2494847|NCT02006641|8626524|P2|Overall Study|Other reason: patient's wife has died|0
2494848|NCT02006641|8626525|P1|Overall Study|Other reason: patient's wife has died|0
2494849|NCT02006641|8626523|P3|Overall Study|Other reason: caregiver in hospital|0
2494850|NCT02006641|8626524|P2|Overall Study|Other reason: caregiver in hospital|1
2494851|NCT02006641|8626525|P1|Overall Study|Other reason: caregiver in hospital|0
2494852|NCT02006641|8626523|P3|Overall Study|Other reason: patient has moved|1
2494853|NCT02006641|8626524|P2|Overall Study|Other reason: patient has moved|0
2494854|NCT02006641|8626525|P1|Overall Study|Other reason: patient has moved|1
2494855|NCT02006641|8626523|P3|Overall Study|Other reason:patient didn't want to come|1
2494856|NCT02006641|8626524|P2|Overall Study|Other reason:patient didn't want to come|0
2494857|NCT02006641|8626525|P1|Overall Study|Other reason:patient didn't want to come|0
2494858|NCT02006641|8626523|P3|Overall Study|Other reason: patient didn't show up|0
2494859|NCT02006641|8626524|P2|Overall Study|Other reason: patient didn't show up|0
2494860|NCT02006641|8626525|P1|Overall Study|Other reason: patient didn't show up|1
2494861|NCT02006641|8626523|P3|Overall Study|Withdrawal by Subject|11
2494862|NCT02006641|8626524|P2|Overall Study|Withdrawal by Subject|12
2494863|NCT02006641|8626525|P1|Overall Study|Withdrawal by Subject|7
2494864|NCT02006641|8626523|P3|Overall Study|Lost to Follow-up|0
2494865|NCT02006641|8626524|P2|Overall Study|Lost to Follow-up|1
2494866|NCT02006641|8626525|P1|Overall Study|Lost to Follow-up|0
2494867|NCT02006641|8626523|P3|Overall Study|Protocol Violation|2
2494868|NCT02006641|8626524|P2|Overall Study|Protocol Violation|2
2494869|NCT02006641|8626525|P1|Overall Study|Protocol Violation|0
2494870|NCT02006641|8626523|P3|Overall Study|Adverse Event|15
2494871|NCT02006641|8626524|P2|Overall Study|Adverse Event|11
2494872|NCT02006641|8626525|P1|Overall Study|Adverse Event|15
2494873|NCT02006641|8626523|P3|Overall Study|Withdrawal before treatment|3
2494874|NCT02006641|8626524|P2|Overall Study|Withdrawal before treatment|5
2494875|NCT02006641|8626525|P1|Overall Study|Withdrawal before treatment|2
2494876|NCT02006628|8626565|P2|Overall Study|Withdrawal by Subject|1
2494877|NCT02006628|8626566|P1|Overall Study|Withdrawal by Subject|2
2494878|NCT02006628|8626565|P2|Overall Study|Adverse Event|1
2494879|NCT02006628|8626566|P1|Overall Study|Adverse Event|1
2494880|NCT02006576|8626591|P3|Overall Study|Screen Failure, too sick, other|13
2494881|NCT02006576|8626592|P2|Overall Study|Screen Failure, too sick, other|1
2494882|NCT02006576|8626593|P1|Overall Study|Screen Failure, too sick, other|13
2494883|NCT02006576|8626591|P3|Overall Study|Lost to Follow-up|1
2494884|NCT02006576|8626592|P2|Overall Study|Lost to Follow-up|0
2494885|NCT02006576|8626593|P1|Overall Study|Lost to Follow-up|1
2494886|NCT02006576|8626591|P3|Overall Study|Death|1
2494887|NCT02006576|8626592|P2|Overall Study|Death|0
2494888|NCT02006576|8626593|P1|Overall Study|Death|0
2494889|NCT02006576|8626591|P3|Overall Study|Withdrawal by Subject|2
2494890|NCT02006576|8626592|P2|Overall Study|Withdrawal by Subject|6
2494891|NCT02006576|8626593|P1|Overall Study|Withdrawal by Subject|4
2494892|NCT02006121|8626676|P2|Open Label Phase|Non-compliance with study drug|0
2494893|NCT02006121|8626677|P1|Open Label Phase|Non-compliance with study drug|3
2494894|NCT02006121|8626676|P2|Open Label Phase|Withdrawal by Subject|0
2494895|NCT02006121|8626677|P1|Open Label Phase|Withdrawal by Subject|3
2494896|NCT02006121|8626676|P2|Open Label Phase|Protocol Violation|0
2494897|NCT02006121|8626677|P1|Open Label Phase|Protocol Violation|2
2494898|NCT02006121|8626676|P2|Open Label Phase|Lack of Efficacy|0
2494899|NCT02006121|8626677|P1|Open Label Phase|Lack of Efficacy|2
2494900|NCT02006121|8626676|P2|Open Label Phase|Adverse Event|0
2494901|NCT02006121|8626677|P1|Open Label Phase|Adverse Event|15
2494902|NCT02006121|8626676|P2|Double Blind Phase|Inconvenience of infusion system|1
2494903|NCT02006121|8626677|P1|Double Blind Phase|Inconvenience of infusion system|0
2494904|NCT02006121|8626676|P2|Double Blind Phase|Minimum infusion rate poorly tolerated|0
2494905|NCT02006121|8626677|P1|Double Blind Phase|Minimum infusion rate poorly tolerated|1
2494906|NCT02006121|8626676|P2|Double Blind Phase|Non-compliance with study drug|3
2494907|NCT02006121|8626677|P1|Double Blind Phase|Non-compliance with study drug|1
2494908|NCT02006121|8626676|P2|Double Blind Phase|Withdrawal by Subject|4
2494909|NCT02006121|8626677|P1|Double Blind Phase|Withdrawal by Subject|3
2494910|NCT02006121|8626676|P2|Double Blind Phase|Lack of Efficacy|16
2494911|NCT02006121|8626677|P1|Double Blind Phase|Lack of Efficacy|1
2494912|NCT02006121|8626676|P2|Double Blind Phase|Adverse Event|0
2494913|NCT02006121|8626677|P1|Double Blind Phase|Adverse Event|6
2494914|NCT02005887|8626710|P2|Overall Study|Protocol Violation|2
2494915|NCT02005887|8626711|P1|Overall Study|Protocol Violation|0
2494916|NCT02005692|8626729|P1|Overall Study|Discharged earlier than anticipated|5
2494917|NCT02005692|8626729|P1|Overall Study|Withdrawal by Subject|1
2494918|NCT02005692|8626729|P1|Overall Study|Protocol Violation|1
2494919|NCT02005627|8626736|P2|Overall Study|Withdrawal by Subject|2
2494920|NCT02005627|8626737|P1|Overall Study|Withdrawal by Subject|1
2494921|NCT02005627|8626736|P2|Overall Study|Lost to Follow-up|2
2494922|NCT02005627|8626737|P1|Overall Study|Lost to Follow-up|1
2494923|NCT02005562|8626766|P2|Overall Study|Physician Decision|1
2494924|NCT02005562|8626767|P1|Overall Study|Physician Decision|0
2494925|NCT02005562|8626766|P2|Overall Study|No transplant|4
2494926|NCT02005562|8626767|P1|Overall Study|No transplant|1
2494927|NCT02005562|8626766|P2|Overall Study|Withdrawal by Subject|2
2494928|NCT02005562|8626767|P1|Overall Study|Withdrawal by Subject|2
2494929|NCT02005562|8626766|P2|Overall Study|Graft loss|6
2494930|NCT02005562|8626767|P1|Overall Study|Graft loss|7
2494931|NCT02005562|8626766|P2|Overall Study|Death|2
2494932|NCT02005562|8626767|P1|Overall Study|Death|2
2494933|NCT02005484|8626809|P1|Overall Study|Sponsor decision|1
2494934|NCT02005484|8626809|P1|Overall Study|Changed to a Different Study|1
2494935|NCT02005484|8626809|P1|Overall Study|Disease progression|1
2494936|NCT02005484|8626809|P1|Overall Study|Death|1
2494937|NCT02005471|8626821|P2|Overall Study|Withdrawal by Subject|7
2494938|NCT02005471|8626822|P1|Overall Study|Withdrawal by Subject|18
2494939|NCT02005471|8626821|P2|Overall Study|Progressive Disease|0
2494940|NCT02005471|8626822|P1|Overall Study|Progressive Disease|3
2494941|NCT02005471|8626821|P2|Overall Study|Physician Decision|1
2494942|NCT02005471|8626822|P1|Overall Study|Physician Decision|2
2494943|NCT02005471|8626821|P2|Overall Study|Lost to Follow-up|0
2494944|NCT02005471|8626822|P1|Overall Study|Lost to Follow-up|1
2494945|NCT02005471|8626821|P2|Overall Study|Death|15
2494946|NCT02005471|8626822|P1|Overall Study|Death|26
2494947|NCT02005471|8626821|P2|Overall Study|Adverse Event|0
2494948|NCT02005471|8626822|P1|Overall Study|Adverse Event|1
2494949|NCT02005471|8626821|P2|Overall Study|Ongoing in Study|171
2494950|NCT02005471|8626822|P1|Overall Study|Ongoing in Study|144
2494951|NCT02005445|8626877|P2|Overall Study|Dual study enrollment|1
2494952|NCT02005445|8626878|P1|Overall Study|Dual study enrollment|0
2494953|NCT02005276|8626901|P4|Overall Study|No longer interested|3
2494954|NCT02005276|8626902|P3|Overall Study|No longer interested|3
2494955|NCT02005276|8626903|P2|Overall Study|No longer interested|2
2494956|NCT02005276|8626904|P1|Overall Study|No longer interested|5
2494957|NCT02005250|8626920|P2|Overall Study|Lost to Follow-up|5
2494958|NCT02005250|8626921|P1|Overall Study|Lost to Follow-up|15
2494959|NCT02005211|8626934|P7|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
2494960|NCT02005211|8626935|P6|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
2494961|NCT02005211|8626936|P5|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1
2494962|NCT02005211|8626937|P4|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
2494963|NCT02005211|8626938|P3|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
2494964|NCT02005211|8626939|P2|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
2494965|NCT02005211|8626940|P1|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
2494966|NCT02005029|8626975|P2|First Intervention (1 Day)|participant withdrawn for noncompliance|0
2494967|NCT02005029|8626976|P1|First Intervention (1 Day)|participant withdrawn for noncompliance|1
2494968|NCT02004886|8627033|P4|Overall Study|Unable to attend future visits|0
2494969|NCT02004886|8627034|P3|Overall Study|Unable to attend future visits|0
2494970|NCT02004886|8627035|P2|Overall Study|Unable to attend future visits|0
2494971|NCT02004886|8627036|P1|Overall Study|Unable to attend future visits|1
2494972|NCT02004886|8627033|P4|Overall Study|Adverse Event|0
2494973|NCT02004886|8627034|P3|Overall Study|Adverse Event|0
2494974|NCT02004886|8627035|P2|Overall Study|Adverse Event|1
2494975|NCT02004886|8627036|P1|Overall Study|Adverse Event|0
2494976|NCT02004873|8627086|P1|Overall Study|Withdrawal by Subject|1
2494977|NCT02004873|8627086|P1|Overall Study|Death|23
2494978|NCT02004873|8627086|P1|Overall Study|Missed 6-month visit|4
2494979|NCT02004873|8627086|P1|Overall Study|Awaiting 6-month visit|390
2494980|NCT02004873|8627086|P1|Overall Study|Implant unsuccessful|6
2494981|NCT02004847|8627095|P2|Overall Study|Protocol Violation|1
2494982|NCT02004847|8627096|P1|Overall Study|Protocol Violation|1
2494983|NCT02004522|8627142|P2|Overall Study|Completed Treatrment Cycles Per Protocol|103
2494984|NCT02004522|8627143|P1|Overall Study|Completed Treatrment Cycles Per Protocol|1
2494985|NCT02004522|8627142|P2|Overall Study|Disease Progression|31
2494986|NCT02004522|8627143|P1|Overall Study|Disease Progression|35
2494987|NCT02004522|8627142|P2|Overall Study|Never Dosed|4
2494988|NCT02004522|8627143|P1|Overall Study|Never Dosed|2
2494989|NCT02004522|8627142|P2|Overall Study|Other is reason listed by PI.|1
2494990|NCT02004522|8627143|P1|Overall Study|Other is reason listed by PI.|4
2494991|NCT02004522|8627142|P2|Overall Study|Protocol Violation|0
2494992|NCT02004522|8627143|P1|Overall Study|Protocol Violation|1
2494993|NCT02004522|8627142|P2|Overall Study|Physician Decision|4
2494994|NCT02004522|8627143|P1|Overall Study|Physician Decision|3
2494995|NCT02004522|8627142|P2|Overall Study|Death|3
2494996|NCT02004522|8627143|P1|Overall Study|Death|12
2494997|NCT02004522|8627142|P2|Overall Study|Withdrawal by Subject|7
2494998|NCT02004522|8627143|P1|Overall Study|Withdrawal by Subject|13
2494999|NCT02004522|8627142|P2|Overall Study|Adverse Event|6
2495000|NCT02004522|8627143|P1|Overall Study|Adverse Event|55
2495001|NCT02004262|8627264|P6|Overall Study|Study Terminated by Sponsor|5
2495002|NCT02004262|8627265|P5|Overall Study|Study Terminated by Sponsor|1
2495003|NCT02004262|8627266|P4|Overall Study|Study Terminated by Sponsor|1
2495004|NCT02004262|8627267|P3|Overall Study|Study Terminated by Sponsor|2
2495005|NCT02004262|8627268|P2|Overall Study|Study Terminated by Sponsor|3
2495006|NCT02004262|8627269|P1|Overall Study|Study Terminated by Sponsor|4
2495007|NCT02004262|8627264|P6|Overall Study|Lost to Follow-up|0
2495008|NCT02004262|8627265|P5|Overall Study|Lost to Follow-up|0
2495009|NCT02004262|8627266|P4|Overall Study|Lost to Follow-up|0
2495010|NCT02004262|8627267|P3|Overall Study|Lost to Follow-up|0
2495011|NCT02004262|8627268|P2|Overall Study|Lost to Follow-up|1
2495012|NCT02004262|8627269|P1|Overall Study|Lost to Follow-up|1
2495013|NCT02004262|8627264|P6|Overall Study|Withdrawal by Subject|3
2495014|NCT02004262|8627265|P5|Overall Study|Withdrawal by Subject|1
2495015|NCT02004262|8627266|P4|Overall Study|Withdrawal by Subject|0
2495016|NCT02004262|8627267|P3|Overall Study|Withdrawal by Subject|4
2495017|NCT02004262|8627268|P2|Overall Study|Withdrawal by Subject|0
2495018|NCT02004262|8627269|P1|Overall Study|Withdrawal by Subject|1
2495019|NCT02004262|8627264|P6|Overall Study|Death|22
2495020|NCT02004262|8627265|P5|Overall Study|Death|29
2495021|NCT02004262|8627266|P4|Overall Study|Death|28
2495022|NCT02004262|8627267|P3|Overall Study|Death|66
2495023|NCT02004262|8627268|P2|Overall Study|Death|64
2495024|NCT02004262|8627269|P1|Overall Study|Death|67
2495025|NCT02004236|8627289|P3|Overall Study|Lack of Efficacy|16
2495026|NCT02004236|8627290|P2|Overall Study|Lack of Efficacy|0
2495027|NCT02004236|8627291|P1|Overall Study|Lack of Efficacy|0
2495028|NCT02004093|8627351|P2|Overall Study|Other|1
2495029|NCT02004093|8627352|P1|Overall Study|Other|3
2495030|NCT02004093|8627351|P2|Overall Study|Withdrawal by Subject|7
2495031|NCT02004093|8627352|P1|Overall Study|Withdrawal by Subject|3
2495032|NCT02004093|8627351|P2|Overall Study|Lost to Follow-up|1
2495033|NCT02004093|8627352|P1|Overall Study|Lost to Follow-up|0
2495034|NCT02004093|8627351|P2|Overall Study|Protocol Violation|1
2495035|NCT02004093|8627352|P1|Overall Study|Protocol Violation|0
2495036|NCT02004093|8627351|P2|Overall Study|Lack of Efficacy|62
2495037|NCT02004093|8627352|P1|Overall Study|Lack of Efficacy|66
2495038|NCT02004093|8627351|P2|Overall Study|Death|1
2495039|NCT02004093|8627352|P1|Overall Study|Death|2
2495040|NCT02003963|8627384|P2|Overall Study|Lost to Follow-up|1
2495041|NCT02003963|8627385|P1|Overall Study|Lost to Follow-up|2
2495042|NCT02003924|8627407|P2|Overall Study|Adverse Event|29
2495043|NCT02003924|8627408|P1|Overall Study|Adverse Event|91
2495044|NCT02003924|8627407|P2|Overall Study|Withdrawal by Subject|34
2495045|NCT02003924|8627408|P1|Overall Study|Withdrawal by Subject|49
2495046|NCT02003924|8627407|P2|Overall Study|Other than specified|19
2495047|NCT02003924|8627408|P1|Overall Study|Other than specified|18
2495048|NCT02003924|8627407|P2|Overall Study|Lost to Follow-up|1
2495049|NCT02003924|8627408|P1|Overall Study|Lost to Follow-up|2
2495050|NCT02003924|8627407|P2|Overall Study|Protocol Violation|2
2495051|NCT02003924|8627408|P1|Overall Study|Protocol Violation|1
2495052|NCT02003924|8627407|P2|Overall Study|Disease progression|207
2495053|NCT02003924|8627408|P1|Overall Study|Disease progression|138
2495054|NCT02003924|8627407|P2|Overall Study|Ongoing in study|176
2495055|NCT02003924|8627408|P1|Overall Study|Ongoing in study|634
2495056|NCT02003898|8627506|P1|Overall Study|Withdrawal by Subject|52
2495057|NCT02003898|8627506|P1|Overall Study|Lost to Follow-up|12
2495058|NCT02003898|8627506|P1|Overall Study|Death|3
2495059|NCT02003638|8627515|P2|Overall Study|Withdrawal by Subject|0
2495060|NCT02003638|8627516|P1|Overall Study|Withdrawal by Subject|1
2495061|NCT02003573|8627525|P3|Overall Study|Other than specified|3
2495062|NCT02003573|8627526|P2|Overall Study|Other than specified|2
2495063|NCT02003573|8627527|P1|Overall Study|Other than specified|1
2495064|NCT02003573|8627525|P3|Overall Study|Refuse to take trial medication|1
2495065|NCT02003573|8627526|P2|Overall Study|Refuse to take trial medication|1
2495066|NCT02003573|8627527|P1|Overall Study|Refuse to take trial medication|0
2495067|NCT02003573|8627525|P3|Overall Study|Other Adverse event|1
2495068|NCT02003573|8627526|P2|Overall Study|Other Adverse event|1
2495069|NCT02003573|8627527|P1|Overall Study|Other Adverse event|0
2495070|NCT02003573|8627525|P3|Overall Study|Progressive disease|1
2495071|NCT02003573|8627526|P2|Overall Study|Progressive disease|0
2495072|NCT02003573|8627527|P1|Overall Study|Progressive disease|2
2495073|NCT02003534|8627537|P1|Overall Study|Lost to Follow-up|47
2495074|NCT02003391|8627558|P2|Overall Study|Adverse Event|0
2495075|NCT02003391|8627559|P1|Overall Study|Adverse Event|1
2495076|NCT02003391|8627558|P2|Overall Study|Protocol Violation|1
2495077|NCT02003391|8627559|P1|Overall Study|Protocol Violation|0
2495078|NCT02003391|8627558|P2|Overall Study|Withdrawal by Subject|1
2495079|NCT02003391|8627559|P1|Overall Study|Withdrawal by Subject|2
2495080|NCT02003365|8627572|P3|Overall Study|Lost to Follow-up|1
2495081|NCT02003365|8627573|P2|Overall Study|Lost to Follow-up|0
2495082|NCT02003365|8627574|P1|Overall Study|Lost to Follow-up|0
2495083|NCT02003183|8627591|P2|Overall Study|Lost to Follow-up|2
2495084|NCT02003183|8627592|P1|Overall Study|Lost to Follow-up|0
2495085|NCT02003014|8627607|P1|Overall Study|Investigator's transfer|4
2495086|NCT02003014|8627607|P1|Overall Study|Patient did not visit the study site|5
2495087|NCT02003014|8627607|P1|Overall Study|Treatment started after contract period|1
2495088|NCT02003014|8627607|P1|Overall Study|Case report forms uncollected|9
2495089|NCT02002975|8627617|P1|Overall Study|Protocol Deviation|437
2495090|NCT02002975|8627617|P1|Overall Study|Case Report Forms Uncollected|135
2495091|NCT02002689|8627716|P1|Overall Study|Adverse Event|3
2495092|NCT02002689|8627716|P1|Overall Study|Disease Progression|7
2495093|NCT02002533|8627735|P2|Overall Study|Lost to Follow-up|1
2495094|NCT02002533|8627736|P1|Overall Study|Lost to Follow-up|0
2495095|NCT02002533|8627735|P2|Overall Study|Adverse Event|3
2495096|NCT02002533|8627736|P1|Overall Study|Adverse Event|0
2495097|NCT02002533|8627735|P2|Overall Study|Protocol Violation|1
2495098|NCT02002533|8627736|P1|Overall Study|Protocol Violation|0
2495099|NCT02002533|8627735|P2|Overall Study|Withdrawal by Subject|13
2495100|NCT02002533|8627736|P1|Overall Study|Withdrawal by Subject|6
2495101|NCT02002221|8627761|P2|Overall Study|Patient withdrew consent|1
2495102|NCT02002221|8627762|P1|Overall Study|Patient withdrew consent|0
2495103|NCT02002221|8627761|P2|Overall Study|Unsatisfactory therapeutic effect|1
2495104|NCT02002221|8627762|P1|Overall Study|Unsatisfactory therapeutic effect|0
2495105|NCT02002221|8627761|P2|Overall Study|Adverse Event|1
2495106|NCT02002221|8627762|P1|Overall Study|Adverse Event|2
2495107|NCT02002091|8627789|P2|Screening|Death|2
2495108|NCT02002091|8627790|P1|Screening|Death|3
2495109|NCT02002091|8627789|P2|Screening|Lost to Follow-up|12
2495110|NCT02002091|8627790|P1|Screening|Lost to Follow-up|10
2495111|NCT02001987|8627825|P1|LTE Period (52 Weeks)|Other|3
2495112|NCT02001987|8627825|P1|LTE Period (52 Weeks)|Lack of Efficacy|1
2495113|NCT02001987|8627825|P1|LTE Period (52 Weeks)|Withdrawal by Subject|1
2495114|NCT02001987|8627825|P1|LTE Period (52 Weeks)|Physician Decision|2
2495115|NCT02001987|8627825|P1|LTE Period (52 Weeks)|Lost to Follow-up|2
2495116|NCT02001987|8627825|P1|Core Study Period (24 Weeks)|Lack of Efficacy|3
2495117|NCT02001987|8627825|P1|Core Study Period (24 Weeks)|Protocol Violation|3
2495118|NCT02001987|8627825|P1|Core Study Period (24 Weeks)|Withdrawal by Subject|4
2495119|NCT02001987|8627825|P1|Core Study Period (24 Weeks)|Physician Decision|1
2495120|NCT02001987|8627825|P1|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2
2495121|NCT02001987|8627825|P1|Core Study Period (24 Weeks)|Death|1
2495122|NCT02001987|8627825|P1|Core Study Period (24 Weeks)|Adverse Event|9
2495123|NCT02001688|8627911|P3|Overall Study|Adverse Event|0
2495124|NCT02001688|8627912|P2|Overall Study|Adverse Event|1
2495125|NCT02001688|8627913|P1|Overall Study|Adverse Event|0
2495126|NCT02001688|8627911|P3|Overall Study|Withdrawal by Subject|1
2495127|NCT02001688|8627912|P2|Overall Study|Withdrawal by Subject|0
2495128|NCT02001688|8627913|P1|Overall Study|Withdrawal by Subject|0
2495129|NCT02001558|8627932|P2|Overall Study|Lost to Follow-up|14
2495130|NCT02001558|8627933|P1|Overall Study|Lost to Follow-up|8
2495131|NCT02001194|8627969|P4|Follow-Up Period (13 Weeks)|No longer interested|0
2495132|NCT02001194|8627970|P3|Follow-Up Period (13 Weeks)|No longer interested|1
2495133|NCT02001194|8627971|P2|Follow-Up Period (13 Weeks)|No longer interested|2
2495134|NCT02001194|8627972|P1|Follow-Up Period (13 Weeks)|No longer interested|3
2495135|NCT02001194|8627969|P4|Intervention Period (13 Weeks)|No longer interested|2
2495136|NCT02001194|8627970|P3|Intervention Period (13 Weeks)|No longer interested|2
2495137|NCT02001194|8627971|P2|Intervention Period (13 Weeks)|No longer interested|0
2495138|NCT02001194|8627972|P1|Intervention Period (13 Weeks)|No longer interested|1
2495139|NCT02001181|8627988|P2|Overall Study|Withdrawal by Subject|1
2495140|NCT02001181|8627989|P1|Overall Study|Withdrawal by Subject|0
2495141|NCT02001181|8627988|P2|Overall Study|Lost to Follow-up|0
2495142|NCT02001181|8627989|P1|Overall Study|Lost to Follow-up|1
2495143|NCT02001181|8627988|P2|Overall Study|Adverse Event|2
2495144|NCT02001181|8627989|P1|Overall Study|Adverse Event|0
2495145|NCT02001051|8628005|P2|Overall Study|Deemed not eligible following enrollment|1
2495146|NCT02001051|8628006|P1|Overall Study|Deemed not eligible following enrollment|0
2495147|NCT02000921|8628058|P3|Overall Study|Physician Decision|0
2495148|NCT02000921|8628059|P2|Overall Study|Physician Decision|2
2495149|NCT02000921|8628060|P1|Overall Study|Physician Decision|0
2495150|NCT02000921|8628058|P3|Overall Study|Lost to Follow-up|5
2495151|NCT02000921|8628059|P2|Overall Study|Lost to Follow-up|4
2495152|NCT02000921|8628060|P1|Overall Study|Lost to Follow-up|2
2495153|NCT02000921|8628058|P3|Overall Study|Withdrawal by Subject|5
2495154|NCT02000921|8628059|P2|Overall Study|Withdrawal by Subject|10
2495155|NCT02000921|8628060|P1|Overall Study|Withdrawal by Subject|3
2495156|NCT02000817|8628090|P4|Overall Study|Lost to Follow-up|0
2495157|NCT02000817|8628091|P3|Overall Study|Lost to Follow-up|1
2495158|NCT02000817|8628092|P2|Overall Study|Lost to Follow-up|0
2495159|NCT02000817|8628093|P1|Overall Study|Lost to Follow-up|0
2495160|NCT02000817|8628090|P4|Overall Study|Adverse Event|0
2495161|NCT02000817|8628091|P3|Overall Study|Adverse Event|0
2495162|NCT02000817|8628092|P2|Overall Study|Adverse Event|1
2495163|NCT02000817|8628093|P1|Overall Study|Adverse Event|0
2495164|NCT02000817|8628090|P4|Overall Study|Withdrawal by Subject|0
2495165|NCT02000817|8628091|P3|Overall Study|Withdrawal by Subject|0
2495166|NCT02000817|8628092|P2|Overall Study|Withdrawal by Subject|0
2495167|NCT02000817|8628093|P1|Overall Study|Withdrawal by Subject|2
2495168|NCT02000752|8628188|P2|Overall Study|Shift Changes|5
2495169|NCT02000752|8628189|P1|Overall Study|Shift Changes|12
2495170|NCT02000752|8628188|P2|Overall Study|Dystocic delivery|8
2495171|NCT02000752|8628189|P1|Overall Study|Dystocic delivery|19
2495172|NCT02000622|8628203|P2|Overall Study|Withdrawal by Subject|7
2495173|NCT02000622|8628204|P1|Overall Study|Withdrawal by Subject|5
2495174|NCT02000622|8628203|P2|Overall Study|Death|46
2495175|NCT02000622|8628204|P1|Overall Study|Death|94
2495176|NCT02000622|8628203|P2|Overall Study|Lost to Follow-up|0
2495177|NCT02000622|8628204|P1|Overall Study|Lost to Follow-up|1
2495178|NCT02000622|8628203|P2|Overall Study|Withdrawn due to site closure|0
2495179|NCT02000622|8628204|P1|Overall Study|Withdrawn due to site closure|1
2495180|NCT02000531|8628226|P2|Overall Study|Discontinued due to data cut-off|8
2495181|NCT02000531|8628227|P1|Overall Study|Discontinued due to data cut-off|3
2495182|NCT02000531|8628226|P2|Overall Study|Lost to Follow-up|0
2495183|NCT02000531|8628227|P1|Overall Study|Lost to Follow-up|1
2495184|NCT02000440|8628235|P1|Overall Study|Other-Protocol-defined Stopping Criteria|1
2495185|NCT02000440|8628235|P1|Overall Study|Adverse Event|3
2495186|NCT02000427|8628255|P1|Overall Study|Death|22
2495187|NCT01999972|8628309|P6|Dose Expansion Part|Death|1
2495188|NCT01999972|8628310|P5|Dose Expansion Part|Death|2
2495189|NCT01999972|8628311|P4|Dose Expansion Part|Death|0
2495190|NCT01999972|8628312|P3|Dose Expansion Part|Death|0
2495191|NCT01999972|8628313|P2|Dose Expansion Part|Death|0
2495192|NCT01999972|8628314|P1|Dose Expansion Part|Death|0
2495193|NCT01999972|8628309|P6|Dose Expansion Part|Ongoing at data cut-off date|2
2495194|NCT01999972|8628310|P5|Dose Expansion Part|Ongoing at data cut-off date|8
2495195|NCT01999972|8628311|P4|Dose Expansion Part|Ongoing at data cut-off date|0
2495196|NCT01999972|8628312|P3|Dose Expansion Part|Ongoing at data cut-off date|0
2495197|NCT01999972|8628313|P2|Dose Expansion Part|Ongoing at data cut-off date|0
2495198|NCT01999972|8628314|P1|Dose Expansion Part|Ongoing at data cut-off date|0
2495199|NCT01999972|8628309|P6|Dose Expansion Part|Disease progression|4
2495200|NCT01999972|8628310|P5|Dose Expansion Part|Disease progression|11
2495201|NCT01999972|8628311|P4|Dose Expansion Part|Disease progression|0
2495202|NCT01999972|8628312|P3|Dose Expansion Part|Disease progression|0
2495203|NCT01999972|8628313|P2|Dose Expansion Part|Disease progression|0
2495204|NCT01999972|8628314|P1|Dose Expansion Part|Disease progression|0
2495205|NCT01999972|8628309|P6|Dose Escalation Part|Enrolled but not treated|0
2495206|NCT01999972|8628310|P5|Dose Escalation Part|Enrolled but not treated|0
2495207|NCT01999972|8628311|P4|Dose Escalation Part|Enrolled but not treated|1
2495208|NCT01999972|8628312|P3|Dose Escalation Part|Enrolled but not treated|1
2495209|NCT01999972|8628313|P2|Dose Escalation Part|Enrolled but not treated|0
2495210|NCT01999972|8628314|P1|Dose Escalation Part|Enrolled but not treated|0
2495211|NCT01999972|8628309|P6|Dose Escalation Part|Death|0
2495212|NCT01999972|8628310|P5|Dose Escalation Part|Death|0
2495213|NCT01999972|8628311|P4|Dose Escalation Part|Death|0
2495214|NCT01999972|8628312|P3|Dose Escalation Part|Death|0
2495215|NCT01999972|8628313|P2|Dose Escalation Part|Death|1
2495216|NCT01999972|8628314|P1|Dose Escalation Part|Death|0
2495217|NCT01999972|8628309|P6|Dose Escalation Part|Ongoing at data cut-off date|0
2495218|NCT01999972|8628310|P5|Dose Escalation Part|Ongoing at data cut-off date|0
2495219|NCT01999972|8628311|P4|Dose Escalation Part|Ongoing at data cut-off date|1
2495220|NCT01999972|8628312|P3|Dose Escalation Part|Ongoing at data cut-off date|1
2495221|NCT01999972|8628313|P2|Dose Escalation Part|Ongoing at data cut-off date|0
2495222|NCT01999972|8628314|P1|Dose Escalation Part|Ongoing at data cut-off date|0
2495223|NCT01999972|8628309|P6|Dose Escalation Part|Disease progression|0
2495224|NCT01999972|8628310|P5|Dose Escalation Part|Disease progression|0
2495225|NCT01999972|8628311|P4|Dose Escalation Part|Disease progression|8
2495226|NCT01999972|8628312|P3|Dose Escalation Part|Disease progression|3
2495227|NCT01999972|8628313|P2|Dose Escalation Part|Disease progression|2
2495228|NCT01999972|8628314|P1|Dose Escalation Part|Disease progression|4
2495229|NCT01999972|8628309|P6|Dose Escalation Part|Participant refused further follow-up|0
2495230|NCT01999972|8628310|P5|Dose Escalation Part|Participant refused further follow-up|0
2495231|NCT01999972|8628311|P4|Dose Escalation Part|Participant refused further follow-up|1
2495232|NCT01999972|8628312|P3|Dose Escalation Part|Participant refused further follow-up|0
2495233|NCT01999972|8628313|P2|Dose Escalation Part|Participant refused further follow-up|0
2495234|NCT01999972|8628314|P1|Dose Escalation Part|Participant refused further follow-up|1
2495235|NCT01999894|8628445|P1|Overall Study|Inclusion/exclusion criteria not met|1
2495236|NCT01999894|8628445|P1|Overall Study|Other Reason|3
2495237|NCT01999894|8628445|P1|Overall Study|Lost to Follow-up|10
2495238|NCT01999894|8628445|P1|Overall Study|Withdrawal by Subject|7
2495239|NCT01999894|8628445|P1|Overall Study|Protocol Violation|1
2495240|NCT01999894|8628445|P1|Overall Study|Lack of Efficacy|5
2495241|NCT01999894|8628445|P1|Overall Study|Adverse Event|9
2495242|NCT01999868|8628453|P3|Blinded Observation Phase (Week 40 – 88)|Worsening psoriasis|0
2495243|NCT01999868|8628454|P2|Blinded Observation Phase (Week 40 – 88)|Worsening psoriasis|4
2495244|NCT01999868|8628455|P1|Blinded Observation Phase (Week 40 – 88)|Worsening psoriasis|12
2495245|NCT01999868|8628453|P3|Blinded Observation Phase (Week 40 – 88)|Terminated early from study in error|0
2495246|NCT01999868|8628454|P2|Blinded Observation Phase (Week 40 – 88)|Terminated early from study in error|2
2495247|NCT01999868|8628455|P1|Blinded Observation Phase (Week 40 – 88)|Terminated early from study in error|0
2495248|NCT01999868|8628453|P3|Blinded Observation Phase (Week 40 – 88)|Met psoriasis relapse criterion|0
2495249|NCT01999868|8628454|P2|Blinded Observation Phase (Week 40 – 88)|Met psoriasis relapse criterion|19
2495250|NCT01999868|8628455|P1|Blinded Observation Phase (Week 40 – 88)|Met psoriasis relapse criterion|10
2495251|NCT01999868|8628453|P3|Blinded Observation Phase (Week 40 – 88)|Withdrawal by Subject|0
2495252|NCT01999868|8628454|P2|Blinded Observation Phase (Week 40 – 88)|Withdrawal by Subject|2
2495253|NCT01999868|8628455|P1|Blinded Observation Phase (Week 40 – 88)|Withdrawal by Subject|1
2495254|NCT01999868|8628453|P3|Blinded Observation Phase (Week 40 – 88)|Lost to Follow-up|0
2495255|NCT01999868|8628454|P2|Blinded Observation Phase (Week 40 – 88)|Lost to Follow-up|1
2495256|NCT01999868|8628455|P1|Blinded Observation Phase (Week 40 – 88)|Lost to Follow-up|0
2495257|NCT01999868|8628453|P3|Blinded Observation Phase (Week 40 – 88)|Adverse Event|0
2495258|NCT01999868|8628454|P2|Blinded Observation Phase (Week 40 – 88)|Adverse Event|1
2495259|NCT01999868|8628455|P1|Blinded Observation Phase (Week 40 – 88)|Adverse Event|0
2495260|NCT01999868|8628453|P3|Blinded Treatment Phase (Week 12 – 40)|Worsening psoriasis|0
2495261|NCT01999868|8628454|P2|Blinded Treatment Phase (Week 12 – 40)|Worsening psoriasis|0
2495262|NCT01999868|8628455|P1|Blinded Treatment Phase (Week 12 – 40)|Worsening psoriasis|4
2495263|NCT01999868|8628453|P3|Blinded Treatment Phase (Week 12 – 40)|Transportation issues|0
2495264|NCT01999868|8628454|P2|Blinded Treatment Phase (Week 12 – 40)|Transportation issues|0
2495265|NCT01999868|8628455|P1|Blinded Treatment Phase (Week 12 – 40)|Transportation issues|1
2495266|NCT01999868|8628453|P3|Blinded Treatment Phase (Week 12 – 40)|Met psoriasis relapse criterion|0
2495267|NCT01999868|8628454|P2|Blinded Treatment Phase (Week 12 – 40)|Met psoriasis relapse criterion|1
2495268|NCT01999868|8628455|P1|Blinded Treatment Phase (Week 12 – 40)|Met psoriasis relapse criterion|8
2495269|NCT01999868|8628453|P3|Blinded Treatment Phase (Week 12 – 40)|Met study drug Discontinuation Criteria|0
2495270|NCT01999868|8628454|P2|Blinded Treatment Phase (Week 12 – 40)|Met study drug Discontinuation Criteria|2
2495271|NCT01999868|8628455|P1|Blinded Treatment Phase (Week 12 – 40)|Met study drug Discontinuation Criteria|1
2495272|NCT01999868|8628453|P3|Blinded Treatment Phase (Week 12 – 40)|Withdrawal by Subject|0
2495273|NCT01999868|8628454|P2|Blinded Treatment Phase (Week 12 – 40)|Withdrawal by Subject|2
2495274|NCT01999868|8628455|P1|Blinded Treatment Phase (Week 12 – 40)|Withdrawal by Subject|0
2495275|NCT01999868|8628453|P3|Blinded Treatment Phase (Week 12 – 40)|Pregnancy|0
2495276|NCT01999868|8628454|P2|Blinded Treatment Phase (Week 12 – 40)|Pregnancy|1
2495277|NCT01999868|8628455|P1|Blinded Treatment Phase (Week 12 – 40)|Pregnancy|0
2495278|NCT01999868|8628453|P3|Blinded Treatment Phase (Week 12 – 40)|Lost to Follow-up|0
2495279|NCT01999868|8628454|P2|Blinded Treatment Phase (Week 12 – 40)|Lost to Follow-up|4
2495280|NCT01999868|8628455|P1|Blinded Treatment Phase (Week 12 – 40)|Lost to Follow-up|3
2495281|NCT01999868|8628453|P3|Blinded Treatment Phase (Week 12 – 40)|Adverse Event|0
2495282|NCT01999868|8628454|P2|Blinded Treatment Phase (Week 12 – 40)|Adverse Event|1
2495283|NCT01999868|8628455|P1|Blinded Treatment Phase (Week 12 – 40)|Adverse Event|1
2495284|NCT01999868|8628453|P3|Lead-in Phase (Week 0 – 12)|Lost to Follow-up|5
2495285|NCT01999868|8628454|P2|Lead-in Phase (Week 0 – 12)|Lost to Follow-up|0
2495286|NCT01999868|8628455|P1|Lead-in Phase (Week 0 – 12)|Lost to Follow-up|0
2495287|NCT01999465|8628506|P2|Overall Study|Protocol Violation|1
2495288|NCT01999465|8628507|P1|Overall Study|Protocol Violation|0
2495289|NCT01999465|8628506|P2|Overall Study|Lost to Follow-up|2
2495290|NCT01999465|8628507|P1|Overall Study|Lost to Follow-up|0
2495291|NCT01999322|8628552|P2|Overall Study|Adverse Event|0
2495292|NCT01999322|8628553|P1|Overall Study|Adverse Event|1
2495293|NCT01999218|8628605|P3|Overall Study|Treated but excluded at 1 trial site|2
2495294|NCT01999218|8628606|P2|Overall Study|Treated but excluded at 1 trial site|5
2495295|NCT01999218|8628607|P1|Overall Study|Treated but excluded at 1 trial site|3
2495296|NCT01999218|8628605|P3|Overall Study|Adverse Event|7
2495297|NCT01999218|8628606|P2|Overall Study|Adverse Event|7
2495298|NCT01999218|8628607|P1|Overall Study|Adverse Event|9
2495299|NCT01999218|8628605|P3|Overall Study|Excluded Medication|2
2495300|NCT01999218|8628606|P2|Overall Study|Excluded Medication|1
2495301|NCT01999218|8628607|P1|Overall Study|Excluded Medication|1
2495302|NCT01999218|8628605|P3|Overall Study|Death|2
2495303|NCT01999218|8628606|P2|Overall Study|Death|1
2495304|NCT01999218|8628607|P1|Overall Study|Death|7
2495305|NCT01999218|8628605|P3|Overall Study|Creatinine/eGFR|1
2495306|NCT01999218|8628606|P2|Overall Study|Creatinine/eGFR|0
2495307|NCT01999218|8628607|P1|Overall Study|Creatinine/eGFR|0
2495308|NCT01999218|8628605|P3|Overall Study|Withdrawal by Subject|34
2495309|NCT01999218|8628606|P2|Overall Study|Withdrawal by Subject|29
2495310|NCT01999218|8628607|P1|Overall Study|Withdrawal by Subject|28
2495311|NCT01999218|8628605|P3|Overall Study|Participant moves|3
2495312|NCT01999218|8628606|P2|Overall Study|Participant moves|5
2495313|NCT01999218|8628607|P1|Overall Study|Participant moves|2
2495314|NCT01999218|8628605|P3|Overall Study|Study Terminated By Sponsor|12
2495315|NCT01999218|8628606|P2|Overall Study|Study Terminated By Sponsor|5
2495316|NCT01999218|8628607|P1|Overall Study|Study Terminated By Sponsor|7
2495317|NCT01999218|8628605|P3|Overall Study|Screen failure|0
2495318|NCT01999218|8628606|P2|Overall Study|Screen failure|1
2495319|NCT01999218|8628607|P1|Overall Study|Screen failure|0
2495320|NCT01999218|8628605|P3|Overall Study|Protocol Violation|4
2495321|NCT01999218|8628606|P2|Overall Study|Protocol Violation|5
2495322|NCT01999218|8628607|P1|Overall Study|Protocol Violation|4
2495323|NCT01999218|8628605|P3|Overall Study|Physician Decision|6
2495324|NCT01999218|8628606|P2|Overall Study|Physician Decision|4
2495325|NCT01999218|8628607|P1|Overall Study|Physician Decision|1
2495326|NCT01999218|8628605|P3|Overall Study|Non-Compliance With Study Drug|1
2495327|NCT01999218|8628606|P2|Overall Study|Non-Compliance With Study Drug|4
2495328|NCT01999218|8628607|P1|Overall Study|Non-Compliance With Study Drug|6
2495329|NCT01999218|8628605|P3|Overall Study|Lost to Follow-up|18
2495330|NCT01999218|8628606|P2|Overall Study|Lost to Follow-up|17
2495331|NCT01999218|8628607|P1|Overall Study|Lost to Follow-up|22
2495332|NCT01999218|8628605|P3|Overall Study|Lack of Efficacy|1
2495333|NCT01999218|8628606|P2|Overall Study|Lack of Efficacy|0
2495334|NCT01999218|8628607|P1|Overall Study|Lack of Efficacy|1
2495335|NCT01999218|8628605|P3|Overall Study|Hyperglycemia|17
2495336|NCT01999218|8628606|P2|Overall Study|Hyperglycemia|17
2495337|NCT01999218|8628607|P1|Overall Study|Hyperglycemia|18
2495338|NCT01999114|8628652|P5|Overall Study|Administrative|2
2495339|NCT01999114|8628653|P4|Overall Study|Administrative|1
2495340|NCT01999114|8628654|P3|Overall Study|Administrative|1
2495341|NCT01999114|8628655|P2|Overall Study|Administrative|0
2495342|NCT01999114|8628656|P1|Overall Study|Administrative|0
2495343|NCT01999114|8628652|P5|Overall Study|Lost to Follow-up|0
2495344|NCT01999114|8628653|P4|Overall Study|Lost to Follow-up|0
2495345|NCT01999114|8628654|P3|Overall Study|Lost to Follow-up|1
2495346|NCT01999114|8628655|P2|Overall Study|Lost to Follow-up|0
2495347|NCT01999114|8628656|P1|Overall Study|Lost to Follow-up|0
2495348|NCT01999114|8628652|P5|Overall Study|Withdrawal by Subject|1
2495349|NCT01999114|8628653|P4|Overall Study|Withdrawal by Subject|0
2495350|NCT01999114|8628654|P3|Overall Study|Withdrawal by Subject|1
2495351|NCT01999114|8628655|P2|Overall Study|Withdrawal by Subject|0
2495352|NCT01999114|8628656|P1|Overall Study|Withdrawal by Subject|0
2495353|NCT01999114|8628652|P5|Overall Study|Adverse Event|1
2495354|NCT01999114|8628653|P4|Overall Study|Adverse Event|2
2495355|NCT01999114|8628654|P3|Overall Study|Adverse Event|2
2495356|NCT01999114|8628655|P2|Overall Study|Adverse Event|7
2495357|NCT01999114|8628656|P1|Overall Study|Adverse Event|8
2495358|NCT01998984|8628724|P4|Overall Study|Other|1
2495359|NCT01998984|8628725|P3|Overall Study|Other|0
2495360|NCT01998984|8628726|P2|Overall Study|Other|0
2495361|NCT01998984|8628727|P1|Overall Study|Other|0
2495362|NCT01998984|8628724|P4|Overall Study|Withdrawal by Subject|0
2495363|NCT01998984|8628725|P3|Overall Study|Withdrawal by Subject|1
2495364|NCT01998984|8628726|P2|Overall Study|Withdrawal by Subject|0
2495365|NCT01998984|8628727|P1|Overall Study|Withdrawal by Subject|0
2495366|NCT01998984|8628724|P4|Overall Study|Lost to Follow-up|1
2495367|NCT01998984|8628725|P3|Overall Study|Lost to Follow-up|0
2495368|NCT01998984|8628726|P2|Overall Study|Lost to Follow-up|1
2495369|NCT01998984|8628727|P1|Overall Study|Lost to Follow-up|0
2495370|NCT01998984|8628724|P4|Overall Study|Adverse Event|1
2495371|NCT01998984|8628725|P3|Overall Study|Adverse Event|0
2495372|NCT01998984|8628726|P2|Overall Study|Adverse Event|0
2495373|NCT01998984|8628727|P1|Overall Study|Adverse Event|0
2495374|NCT01998958|8628752|P32|Open Label Phase (Optional)|Withdrawal by Subject|0
2495375|NCT01998958|8628753|P31|Open Label Phase (Optional)|Withdrawal by Subject|0
2495376|NCT01998958|8628754|P30|Open Label Phase (Optional)|Withdrawal by Subject|0
2495377|NCT01998958|8628755|P29|Open Label Phase (Optional)|Withdrawal by Subject|0
2495378|NCT01998958|8628756|P28|Open Label Phase (Optional)|Withdrawal by Subject|0
2495379|NCT01998958|8628757|P27|Open Label Phase (Optional)|Withdrawal by Subject|0
2495380|NCT01998958|8628758|P26|Open Label Phase (Optional)|Withdrawal by Subject|0
2495381|NCT01998958|8628759|P25|Open Label Phase (Optional)|Withdrawal by Subject|0
2495382|NCT01998958|8628760|P24|Open Label Phase (Optional)|Withdrawal by Subject|2
2495383|NCT01998958|8628761|P23|Open Label Phase (Optional)|Withdrawal by Subject|1
2495384|NCT01998958|8628762|P22|Open Label Phase (Optional)|Withdrawal by Subject|2
2495385|NCT01998958|8628763|P21|Open Label Phase (Optional)|Withdrawal by Subject|0
2495386|NCT01998958|8628764|P20|Open Label Phase (Optional)|Withdrawal by Subject|0
2495387|NCT01998958|8628765|P19|Open Label Phase (Optional)|Withdrawal by Subject|0
2495388|NCT01998958|8628766|P18|Open Label Phase (Optional)|Withdrawal by Subject|0
2495389|NCT01998958|8628767|P17|Open Label Phase (Optional)|Withdrawal by Subject|0
2495390|NCT01998958|8628768|P16|Open Label Phase (Optional)|Withdrawal by Subject|0
2495391|NCT01998958|8628769|P15|Open Label Phase (Optional)|Withdrawal by Subject|0
2495392|NCT01998958|8628770|P14|Open Label Phase (Optional)|Withdrawal by Subject|0
2495393|NCT01998958|8628771|P13|Open Label Phase (Optional)|Withdrawal by Subject|0
2495394|NCT01998958|8628772|P12|Open Label Phase (Optional)|Withdrawal by Subject|0
2495395|NCT01998958|8628773|P11|Open Label Phase (Optional)|Withdrawal by Subject|0
2495396|NCT01998958|8628774|P10|Open Label Phase (Optional)|Withdrawal by Subject|0
2495397|NCT01998958|8628775|P9|Open Label Phase (Optional)|Withdrawal by Subject|0
2495398|NCT01998958|8628776|P8|Open Label Phase (Optional)|Withdrawal by Subject|0
2495399|NCT01998958|8628777|P7|Open Label Phase (Optional)|Withdrawal by Subject|0
2495400|NCT01998958|8628778|P6|Open Label Phase (Optional)|Withdrawal by Subject|0
2495401|NCT01998958|8628779|P5|Open Label Phase (Optional)|Withdrawal by Subject|0
2495402|NCT01998958|8628780|P4|Open Label Phase (Optional)|Withdrawal by Subject|0
2495403|NCT01998958|8628781|P3|Open Label Phase (Optional)|Withdrawal by Subject|0
2495404|NCT01998958|8628782|P2|Open Label Phase (Optional)|Withdrawal by Subject|0
2495405|NCT01998958|8628783|P1|Open Label Phase (Optional)|Withdrawal by Subject|0
2495406|NCT01998958|8628752|P32|Open Label Phase (Optional)|Lack of Efficacy|0
2495407|NCT01998958|8628753|P31|Open Label Phase (Optional)|Lack of Efficacy|0
2495408|NCT01998958|8628754|P30|Open Label Phase (Optional)|Lack of Efficacy|0
2495409|NCT01998958|8628755|P29|Open Label Phase (Optional)|Lack of Efficacy|0
2495410|NCT01998958|8628756|P28|Open Label Phase (Optional)|Lack of Efficacy|0
2495411|NCT01998958|8628757|P27|Open Label Phase (Optional)|Lack of Efficacy|0
2495412|NCT01998958|8628758|P26|Open Label Phase (Optional)|Lack of Efficacy|0
2495413|NCT01998958|8628759|P25|Open Label Phase (Optional)|Lack of Efficacy|0
2495414|NCT01998958|8628760|P24|Open Label Phase (Optional)|Lack of Efficacy|0
2495415|NCT01998958|8628761|P23|Open Label Phase (Optional)|Lack of Efficacy|2
2495416|NCT01998958|8628762|P22|Open Label Phase (Optional)|Lack of Efficacy|1
2495417|NCT01998958|8628763|P21|Open Label Phase (Optional)|Lack of Efficacy|0
2495418|NCT01998958|8628764|P20|Open Label Phase (Optional)|Lack of Efficacy|0
2495419|NCT01998958|8628765|P19|Open Label Phase (Optional)|Lack of Efficacy|0
2495420|NCT01998958|8628766|P18|Open Label Phase (Optional)|Lack of Efficacy|0
2495421|NCT01998958|8628767|P17|Open Label Phase (Optional)|Lack of Efficacy|0
2495422|NCT01998958|8628768|P16|Open Label Phase (Optional)|Lack of Efficacy|0
2495423|NCT01998958|8628769|P15|Open Label Phase (Optional)|Lack of Efficacy|0
2495424|NCT01998958|8628770|P14|Open Label Phase (Optional)|Lack of Efficacy|0
2495425|NCT01998958|8628771|P13|Open Label Phase (Optional)|Lack of Efficacy|0
2495426|NCT01998958|8628772|P12|Open Label Phase (Optional)|Lack of Efficacy|0
2495427|NCT01998958|8628773|P11|Open Label Phase (Optional)|Lack of Efficacy|0
2495428|NCT01998958|8628774|P10|Open Label Phase (Optional)|Lack of Efficacy|0
2495429|NCT01998958|8628775|P9|Open Label Phase (Optional)|Lack of Efficacy|0
2495430|NCT01998958|8628776|P8|Open Label Phase (Optional)|Lack of Efficacy|0
2495431|NCT01998958|8628777|P7|Open Label Phase (Optional)|Lack of Efficacy|0
2495432|NCT01998958|8628778|P6|Open Label Phase (Optional)|Lack of Efficacy|0
2495433|NCT01998958|8628779|P5|Open Label Phase (Optional)|Lack of Efficacy|0
2495434|NCT01998958|8628780|P4|Open Label Phase (Optional)|Lack of Efficacy|0
2495435|NCT01998958|8628781|P3|Open Label Phase (Optional)|Lack of Efficacy|0
2495436|NCT01998958|8628782|P2|Open Label Phase (Optional)|Lack of Efficacy|0
2495437|NCT01998958|8628783|P1|Open Label Phase (Optional)|Lack of Efficacy|0
2495438|NCT01998958|8628752|P32|Open Label Phase (Optional)|Lost to Follow-up|0
2495439|NCT01998958|8628753|P31|Open Label Phase (Optional)|Lost to Follow-up|0
2495440|NCT01998958|8628754|P30|Open Label Phase (Optional)|Lost to Follow-up|0
2495441|NCT01998958|8628755|P29|Open Label Phase (Optional)|Lost to Follow-up|0
2495442|NCT01998958|8628756|P28|Open Label Phase (Optional)|Lost to Follow-up|0
2495443|NCT01998958|8628757|P27|Open Label Phase (Optional)|Lost to Follow-up|0
2495444|NCT01998958|8628758|P26|Open Label Phase (Optional)|Lost to Follow-up|0
2495445|NCT01998958|8628759|P25|Open Label Phase (Optional)|Lost to Follow-up|0
2495446|NCT01998958|8628760|P24|Open Label Phase (Optional)|Lost to Follow-up|0
2495447|NCT01998958|8628761|P23|Open Label Phase (Optional)|Lost to Follow-up|1
2495448|NCT01998958|8628762|P22|Open Label Phase (Optional)|Lost to Follow-up|0
2495449|NCT01998958|8628763|P21|Open Label Phase (Optional)|Lost to Follow-up|0
2495450|NCT01998958|8628764|P20|Open Label Phase (Optional)|Lost to Follow-up|0
2495451|NCT01998958|8628765|P19|Open Label Phase (Optional)|Lost to Follow-up|0
2495452|NCT01998958|8628766|P18|Open Label Phase (Optional)|Lost to Follow-up|0
2495453|NCT01998958|8628767|P17|Open Label Phase (Optional)|Lost to Follow-up|0
2495454|NCT01998958|8628768|P16|Open Label Phase (Optional)|Lost to Follow-up|0
2495455|NCT01998958|8628769|P15|Open Label Phase (Optional)|Lost to Follow-up|0
2495456|NCT01998958|8628770|P14|Open Label Phase (Optional)|Lost to Follow-up|0
2495457|NCT01998958|8628771|P13|Open Label Phase (Optional)|Lost to Follow-up|0
2495458|NCT01998958|8628772|P12|Open Label Phase (Optional)|Lost to Follow-up|0
2495459|NCT01998958|8628773|P11|Open Label Phase (Optional)|Lost to Follow-up|0
2495460|NCT01998958|8628774|P10|Open Label Phase (Optional)|Lost to Follow-up|0
2495461|NCT01998958|8628775|P9|Open Label Phase (Optional)|Lost to Follow-up|0
2495462|NCT01998958|8628776|P8|Open Label Phase (Optional)|Lost to Follow-up|0
2495463|NCT01998958|8628777|P7|Open Label Phase (Optional)|Lost to Follow-up|0
2495464|NCT01998958|8628778|P6|Open Label Phase (Optional)|Lost to Follow-up|0
2495465|NCT01998958|8628779|P5|Open Label Phase (Optional)|Lost to Follow-up|0
2495466|NCT01998958|8628780|P4|Open Label Phase (Optional)|Lost to Follow-up|0
2495467|NCT01998958|8628781|P3|Open Label Phase (Optional)|Lost to Follow-up|0
2495468|NCT01998958|8628782|P2|Open Label Phase (Optional)|Lost to Follow-up|0
2495469|NCT01998958|8628783|P1|Open Label Phase (Optional)|Lost to Follow-up|0
2495470|NCT01998958|8628752|P32|Open Label Phase (Optional)|Other|0
2495471|NCT01998958|8628753|P31|Open Label Phase (Optional)|Other|0
2495472|NCT01998958|8628754|P30|Open Label Phase (Optional)|Other|0
2495473|NCT01998958|8628755|P29|Open Label Phase (Optional)|Other|0
2495474|NCT01998958|8628756|P28|Open Label Phase (Optional)|Other|0
2495475|NCT01998958|8628757|P27|Open Label Phase (Optional)|Other|0
2495476|NCT01998958|8628758|P26|Open Label Phase (Optional)|Other|0
2495477|NCT01998958|8628759|P25|Open Label Phase (Optional)|Other|0
2495478|NCT01998958|8628760|P24|Open Label Phase (Optional)|Other|1
2495479|NCT01998958|8628761|P23|Open Label Phase (Optional)|Other|5
2495480|NCT01998958|8628762|P22|Open Label Phase (Optional)|Other|0
2495481|NCT01998958|8628763|P21|Open Label Phase (Optional)|Other|0
2495482|NCT01998958|8628764|P20|Open Label Phase (Optional)|Other|0
2495483|NCT01998958|8628765|P19|Open Label Phase (Optional)|Other|0
2495484|NCT01998958|8628766|P18|Open Label Phase (Optional)|Other|0
2495485|NCT01998958|8628767|P17|Open Label Phase (Optional)|Other|0
2495486|NCT01998958|8628768|P16|Open Label Phase (Optional)|Other|0
2495487|NCT01998958|8628769|P15|Open Label Phase (Optional)|Other|0
2495488|NCT01998958|8628770|P14|Open Label Phase (Optional)|Other|0
2495489|NCT01998958|8628771|P13|Open Label Phase (Optional)|Other|0
2495490|NCT01998958|8628772|P12|Open Label Phase (Optional)|Other|0
2495491|NCT01998958|8628773|P11|Open Label Phase (Optional)|Other|0
2495492|NCT01998958|8628774|P10|Open Label Phase (Optional)|Other|0
2495493|NCT01998958|8628775|P9|Open Label Phase (Optional)|Other|0
2495494|NCT01998958|8628776|P8|Open Label Phase (Optional)|Other|0
2495495|NCT01998958|8628777|P7|Open Label Phase (Optional)|Other|0
2495496|NCT01998958|8628778|P6|Open Label Phase (Optional)|Other|0
2495497|NCT01998958|8628779|P5|Open Label Phase (Optional)|Other|0
2495498|NCT01998958|8628780|P4|Open Label Phase (Optional)|Other|0
2495499|NCT01998958|8628781|P3|Open Label Phase (Optional)|Other|0
2495500|NCT01998958|8628782|P2|Open Label Phase (Optional)|Other|0
2495501|NCT01998958|8628783|P1|Open Label Phase (Optional)|Other|0
2495502|NCT01998958|8628752|P32|Open Label Phase (Optional)|Adverse Event|0
2495503|NCT01998958|8628753|P31|Open Label Phase (Optional)|Adverse Event|0
2495504|NCT01998958|8628754|P30|Open Label Phase (Optional)|Adverse Event|0
2495505|NCT01998958|8628755|P29|Open Label Phase (Optional)|Adverse Event|0
2495506|NCT01998958|8628756|P28|Open Label Phase (Optional)|Adverse Event|0
2495507|NCT01998958|8628757|P27|Open Label Phase (Optional)|Adverse Event|0
2495508|NCT01998958|8628758|P26|Open Label Phase (Optional)|Adverse Event|0
2495509|NCT01998958|8628759|P25|Open Label Phase (Optional)|Adverse Event|0
2495510|NCT01998958|8628760|P24|Open Label Phase (Optional)|Adverse Event|1
2495511|NCT01998958|8628761|P23|Open Label Phase (Optional)|Adverse Event|0
2495512|NCT01998958|8628762|P22|Open Label Phase (Optional)|Adverse Event|0
2495513|NCT01998958|8628763|P21|Open Label Phase (Optional)|Adverse Event|0
2495514|NCT01998958|8628764|P20|Open Label Phase (Optional)|Adverse Event|0
2495515|NCT01998958|8628765|P19|Open Label Phase (Optional)|Adverse Event|0
2495516|NCT01998958|8628766|P18|Open Label Phase (Optional)|Adverse Event|0
2495517|NCT01998958|8628767|P17|Open Label Phase (Optional)|Adverse Event|0
2495518|NCT01998958|8628768|P16|Open Label Phase (Optional)|Adverse Event|0
2495519|NCT01998958|8628769|P15|Open Label Phase (Optional)|Adverse Event|0
2495520|NCT01998958|8628770|P14|Open Label Phase (Optional)|Adverse Event|0
2495521|NCT01998958|8628771|P13|Open Label Phase (Optional)|Adverse Event|0
2495522|NCT01998958|8628772|P12|Open Label Phase (Optional)|Adverse Event|0
2495523|NCT01998958|8628773|P11|Open Label Phase (Optional)|Adverse Event|0
2495524|NCT01998958|8628774|P10|Open Label Phase (Optional)|Adverse Event|0
2495525|NCT01998958|8628775|P9|Open Label Phase (Optional)|Adverse Event|0
2495526|NCT01998958|8628776|P8|Open Label Phase (Optional)|Adverse Event|0
2495527|NCT01998958|8628777|P7|Open Label Phase (Optional)|Adverse Event|0
2495528|NCT01998958|8628778|P6|Open Label Phase (Optional)|Adverse Event|0
2495529|NCT01998958|8628779|P5|Open Label Phase (Optional)|Adverse Event|0
2495530|NCT01998958|8628780|P4|Open Label Phase (Optional)|Adverse Event|0
2495531|NCT01998958|8628781|P3|Open Label Phase (Optional)|Adverse Event|0
2495532|NCT01998958|8628782|P2|Open Label Phase (Optional)|Adverse Event|0
2495533|NCT01998958|8628783|P1|Open Label Phase (Optional)|Adverse Event|0
2495534|NCT01998958|8628752|P32|Period 2 (Panel A and B)|Withdrawal by Subject|0
2495535|NCT01998958|8628753|P31|Period 2 (Panel A and B)|Withdrawal by Subject|0
2495536|NCT01998958|8628754|P30|Period 2 (Panel A and B)|Withdrawal by Subject|0
2495537|NCT01998958|8628755|P29|Period 2 (Panel A and B)|Withdrawal by Subject|0
2495538|NCT01998958|8628756|P28|Period 2 (Panel A and B)|Withdrawal by Subject|0
2495539|NCT01998958|8628757|P27|Period 2 (Panel A and B)|Withdrawal by Subject|0
2495540|NCT01998958|8628758|P26|Period 2 (Panel A and B)|Withdrawal by Subject|0
2495541|NCT01998958|8628759|P25|Period 2 (Panel A and B)|Withdrawal by Subject|0
2495542|NCT01998958|8628760|P24|Period 2 (Panel A and B)|Withdrawal by Subject|0
2495543|NCT01998958|8628761|P23|Period 2 (Panel A and B)|Withdrawal by Subject|0
2495544|NCT01998958|8628762|P22|Period 2 (Panel A and B)|Withdrawal by Subject|0
2495545|NCT01998958|8628763|P21|Period 2 (Panel A and B)|Withdrawal by Subject|0
2495546|NCT01998958|8628764|P20|Period 2 (Panel A and B)|Withdrawal by Subject|0
2495547|NCT01998958|8628765|P19|Period 2 (Panel A and B)|Withdrawal by Subject|1
2495548|NCT01998958|8628766|P18|Period 2 (Panel A and B)|Withdrawal by Subject|0
2495549|NCT01998958|8628767|P17|Period 2 (Panel A and B)|Withdrawal by Subject|0
2495550|NCT01998958|8628768|P16|Period 2 (Panel A and B)|Withdrawal by Subject|0
2495551|NCT01998958|8628769|P15|Period 2 (Panel A and B)|Withdrawal by Subject|1
2495552|NCT01998958|8628770|P14|Period 2 (Panel A and B)|Withdrawal by Subject|0
2495553|NCT01998958|8628771|P13|Period 2 (Panel A and B)|Withdrawal by Subject|0
2495554|NCT01998958|8628772|P12|Period 2 (Panel A and B)|Withdrawal by Subject|0
2495555|NCT01998958|8628773|P11|Period 2 (Panel A and B)|Withdrawal by Subject|0
2495556|NCT01998958|8628774|P10|Period 2 (Panel A and B)|Withdrawal by Subject|0
2495557|NCT01998958|8628775|P9|Period 2 (Panel A and B)|Withdrawal by Subject|0
2495558|NCT01998958|8628776|P8|Period 2 (Panel A and B)|Withdrawal by Subject|0
2495559|NCT01998958|8628777|P7|Period 2 (Panel A and B)|Withdrawal by Subject|0
2495560|NCT01998958|8628778|P6|Period 2 (Panel A and B)|Withdrawal by Subject|0
2495561|NCT01998958|8628779|P5|Period 2 (Panel A and B)|Withdrawal by Subject|0
2495562|NCT01998958|8628780|P4|Period 2 (Panel A and B)|Withdrawal by Subject|0
2495563|NCT01998958|8628781|P3|Period 2 (Panel A and B)|Withdrawal by Subject|0
2495564|NCT01998958|8628782|P2|Period 2 (Panel A and B)|Withdrawal by Subject|0
2495565|NCT01998958|8628783|P1|Period 2 (Panel A and B)|Withdrawal by Subject|0
2495566|NCT01998958|8628752|P32|Period 2 (Panel A and B)|Adverse Event|0
2495567|NCT01998958|8628753|P31|Period 2 (Panel A and B)|Adverse Event|0
2495568|NCT01998958|8628754|P30|Period 2 (Panel A and B)|Adverse Event|0
2495569|NCT01998958|8628755|P29|Period 2 (Panel A and B)|Adverse Event|0
2495570|NCT01998958|8628756|P28|Period 2 (Panel A and B)|Adverse Event|0
2495571|NCT01998958|8628757|P27|Period 2 (Panel A and B)|Adverse Event|0
2495572|NCT01998958|8628758|P26|Period 2 (Panel A and B)|Adverse Event|0
2495573|NCT01998958|8628759|P25|Period 2 (Panel A and B)|Adverse Event|0
2495574|NCT01998958|8628760|P24|Period 2 (Panel A and B)|Adverse Event|0
2495575|NCT01998958|8628761|P23|Period 2 (Panel A and B)|Adverse Event|0
2495576|NCT01998958|8628762|P22|Period 2 (Panel A and B)|Adverse Event|0
2495577|NCT01998958|8628763|P21|Period 2 (Panel A and B)|Adverse Event|0
2495578|NCT01998958|8628764|P20|Period 2 (Panel A and B)|Adverse Event|0
2495579|NCT01998958|8628765|P19|Period 2 (Panel A and B)|Adverse Event|0
2495580|NCT01998958|8628766|P18|Period 2 (Panel A and B)|Adverse Event|0
2495581|NCT01998958|8628767|P17|Period 2 (Panel A and B)|Adverse Event|0
2495582|NCT01998958|8628768|P16|Period 2 (Panel A and B)|Adverse Event|0
2495583|NCT01998958|8628769|P15|Period 2 (Panel A and B)|Adverse Event|1
2495584|NCT01998958|8628770|P14|Period 2 (Panel A and B)|Adverse Event|0
2495585|NCT01998958|8628771|P13|Period 2 (Panel A and B)|Adverse Event|0
2495586|NCT01998958|8628772|P12|Period 2 (Panel A and B)|Adverse Event|0
2495587|NCT01998958|8628773|P11|Period 2 (Panel A and B)|Adverse Event|1
2495588|NCT01998958|8628774|P10|Period 2 (Panel A and B)|Adverse Event|0
2495589|NCT01998958|8628775|P9|Period 2 (Panel A and B)|Adverse Event|0
2495590|NCT01998958|8628776|P8|Period 2 (Panel A and B)|Adverse Event|0
2495591|NCT01998958|8628777|P7|Period 2 (Panel A and B)|Adverse Event|0
2495592|NCT01998958|8628778|P6|Period 2 (Panel A and B)|Adverse Event|0
2495593|NCT01998958|8628779|P5|Period 2 (Panel A and B)|Adverse Event|0
2495594|NCT01998958|8628780|P4|Period 2 (Panel A and B)|Adverse Event|0
2495595|NCT01998958|8628781|P3|Period 2 (Panel A and B)|Adverse Event|0
2495596|NCT01998958|8628782|P2|Period 2 (Panel A and B)|Adverse Event|0
2495597|NCT01998958|8628783|P1|Period 2 (Panel A and B)|Adverse Event|0
2495598|NCT01998958|8628752|P32|Period 1 (Panel A and B)|Other|0
2495599|NCT01998958|8628753|P31|Period 1 (Panel A and B)|Other|0
2495600|NCT01998958|8628754|P30|Period 1 (Panel A and B)|Other|0
2495601|NCT01998958|8628755|P29|Period 1 (Panel A and B)|Other|0
2495602|NCT01998958|8628756|P28|Period 1 (Panel A and B)|Other|0
2495603|NCT01998958|8628757|P27|Period 1 (Panel A and B)|Other|0
2495604|NCT01998958|8628758|P26|Period 1 (Panel A and B)|Other|0
2495605|NCT01998958|8628759|P25|Period 1 (Panel A and B)|Other|0
2495606|NCT01998958|8628760|P24|Period 1 (Panel A and B)|Other|0
2495607|NCT01998958|8628761|P23|Period 1 (Panel A and B)|Other|0
2495608|NCT01998958|8628762|P22|Period 1 (Panel A and B)|Other|0
2495609|NCT01998958|8628763|P21|Period 1 (Panel A and B)|Other|0
2495610|NCT01998958|8628764|P20|Period 1 (Panel A and B)|Other|0
2495611|NCT01998958|8628765|P19|Period 1 (Panel A and B)|Other|0
2495612|NCT01998958|8628766|P18|Period 1 (Panel A and B)|Other|0
2495613|NCT01998958|8628767|P17|Period 1 (Panel A and B)|Other|0
2495614|NCT01998958|8628768|P16|Period 1 (Panel A and B)|Other|0
2495615|NCT01998958|8628769|P15|Period 1 (Panel A and B)|Other|0
2495616|NCT01998958|8628770|P14|Period 1 (Panel A and B)|Other|0
2495617|NCT01998958|8628771|P13|Period 1 (Panel A and B)|Other|0
2495618|NCT01998958|8628772|P12|Period 1 (Panel A and B)|Other|0
2495619|NCT01998958|8628773|P11|Period 1 (Panel A and B)|Other|0
2495620|NCT01998958|8628774|P10|Period 1 (Panel A and B)|Other|0
2495621|NCT01998958|8628775|P9|Period 1 (Panel A and B)|Other|0
2495622|NCT01998958|8628776|P8|Period 1 (Panel A and B)|Other|0
2495623|NCT01998958|8628777|P7|Period 1 (Panel A and B)|Other|0
2495624|NCT01998958|8628778|P6|Period 1 (Panel A and B)|Other|0
2495625|NCT01998958|8628779|P5|Period 1 (Panel A and B)|Other|0
2495626|NCT01998958|8628780|P4|Period 1 (Panel A and B)|Other|0
2495627|NCT01998958|8628781|P3|Period 1 (Panel A and B)|Other|0
2495628|NCT01998958|8628782|P2|Period 1 (Panel A and B)|Other|0
2495629|NCT01998958|8628783|P1|Period 1 (Panel A and B)|Other|1
2495630|NCT01998958|8628752|P32|Period 1 (Panel A and B)|Adverse Event|0
2495631|NCT01998958|8628753|P31|Period 1 (Panel A and B)|Adverse Event|0
2495632|NCT01998958|8628754|P30|Period 1 (Panel A and B)|Adverse Event|0
2495633|NCT01998958|8628755|P29|Period 1 (Panel A and B)|Adverse Event|0
2495634|NCT01998958|8628756|P28|Period 1 (Panel A and B)|Adverse Event|0
2495635|NCT01998958|8628757|P27|Period 1 (Panel A and B)|Adverse Event|0
2495636|NCT01998958|8628758|P26|Period 1 (Panel A and B)|Adverse Event|0
2495637|NCT01998958|8628759|P25|Period 1 (Panel A and B)|Adverse Event|0
2495638|NCT01998958|8628760|P24|Period 1 (Panel A and B)|Adverse Event|0
2495639|NCT01998958|8628761|P23|Period 1 (Panel A and B)|Adverse Event|0
2495640|NCT01998958|8628762|P22|Period 1 (Panel A and B)|Adverse Event|0
2495641|NCT01998958|8628763|P21|Period 1 (Panel A and B)|Adverse Event|0
2495642|NCT01998958|8628764|P20|Period 1 (Panel A and B)|Adverse Event|0
2495643|NCT01998958|8628765|P19|Period 1 (Panel A and B)|Adverse Event|0
2495644|NCT01998958|8628766|P18|Period 1 (Panel A and B)|Adverse Event|0
2495645|NCT01998958|8628767|P17|Period 1 (Panel A and B)|Adverse Event|0
2495646|NCT01998958|8628768|P16|Period 1 (Panel A and B)|Adverse Event|0
2495647|NCT01998958|8628769|P15|Period 1 (Panel A and B)|Adverse Event|0
2495648|NCT01998958|8628770|P14|Period 1 (Panel A and B)|Adverse Event|0
2495649|NCT01998958|8628771|P13|Period 1 (Panel A and B)|Adverse Event|0
2495650|NCT01998958|8628772|P12|Period 1 (Panel A and B)|Adverse Event|0
2495651|NCT01998958|8628773|P11|Period 1 (Panel A and B)|Adverse Event|0
2495652|NCT01998958|8628774|P10|Period 1 (Panel A and B)|Adverse Event|0
2495653|NCT01998958|8628775|P9|Period 1 (Panel A and B)|Adverse Event|0
2495654|NCT01998958|8628776|P8|Period 1 (Panel A and B)|Adverse Event|0
2495655|NCT01998958|8628777|P7|Period 1 (Panel A and B)|Adverse Event|0
2495656|NCT01998958|8628778|P6|Period 1 (Panel A and B)|Adverse Event|0
2495657|NCT01998958|8628779|P5|Period 1 (Panel A and B)|Adverse Event|0
2495658|NCT01998958|8628780|P4|Period 1 (Panel A and B)|Adverse Event|0
2495659|NCT01998958|8628781|P3|Period 1 (Panel A and B)|Adverse Event|0
2495660|NCT01998958|8628782|P2|Period 1 (Panel A and B)|Adverse Event|1
2495661|NCT01998958|8628783|P1|Period 1 (Panel A and B)|Adverse Event|0
2495662|NCT01998958|8628752|P32|Period 1 (Panel A and B)|Lack of Efficacy|0
2495663|NCT01998958|8628753|P31|Period 1 (Panel A and B)|Lack of Efficacy|0
2495664|NCT01998958|8628754|P30|Period 1 (Panel A and B)|Lack of Efficacy|0
2495665|NCT01998958|8628755|P29|Period 1 (Panel A and B)|Lack of Efficacy|0
2495666|NCT01998958|8628756|P28|Period 1 (Panel A and B)|Lack of Efficacy|0
2495667|NCT01998958|8628757|P27|Period 1 (Panel A and B)|Lack of Efficacy|0
2495668|NCT01998958|8628758|P26|Period 1 (Panel A and B)|Lack of Efficacy|0
2495669|NCT01998958|8628759|P25|Period 1 (Panel A and B)|Lack of Efficacy|0
2495670|NCT01998958|8628760|P24|Period 1 (Panel A and B)|Lack of Efficacy|0
2495671|NCT01998958|8628761|P23|Period 1 (Panel A and B)|Lack of Efficacy|0
2495672|NCT01998958|8628762|P22|Period 1 (Panel A and B)|Lack of Efficacy|0
2495673|NCT01998958|8628763|P21|Period 1 (Panel A and B)|Lack of Efficacy|0
2495674|NCT01998958|8628764|P20|Period 1 (Panel A and B)|Lack of Efficacy|0
2495675|NCT01998958|8628765|P19|Period 1 (Panel A and B)|Lack of Efficacy|0
2495676|NCT01998958|8628766|P18|Period 1 (Panel A and B)|Lack of Efficacy|0
2495677|NCT01998958|8628767|P17|Period 1 (Panel A and B)|Lack of Efficacy|0
2495678|NCT01998958|8628768|P16|Period 1 (Panel A and B)|Lack of Efficacy|0
2495679|NCT01998958|8628769|P15|Period 1 (Panel A and B)|Lack of Efficacy|0
2495680|NCT01998958|8628770|P14|Period 1 (Panel A and B)|Lack of Efficacy|0
2495681|NCT01998958|8628771|P13|Period 1 (Panel A and B)|Lack of Efficacy|0
2495682|NCT01998958|8628772|P12|Period 1 (Panel A and B)|Lack of Efficacy|0
2495683|NCT01998958|8628773|P11|Period 1 (Panel A and B)|Lack of Efficacy|0
2495684|NCT01998958|8628774|P10|Period 1 (Panel A and B)|Lack of Efficacy|0
2495685|NCT01998958|8628775|P9|Period 1 (Panel A and B)|Lack of Efficacy|0
2495686|NCT01998958|8628776|P8|Period 1 (Panel A and B)|Lack of Efficacy|0
2495687|NCT01998958|8628777|P7|Period 1 (Panel A and B)|Lack of Efficacy|0
2495688|NCT01998958|8628778|P6|Period 1 (Panel A and B)|Lack of Efficacy|0
2495689|NCT01998958|8628779|P5|Period 1 (Panel A and B)|Lack of Efficacy|0
2495690|NCT01998958|8628780|P4|Period 1 (Panel A and B)|Lack of Efficacy|0
2495691|NCT01998958|8628781|P3|Period 1 (Panel A and B)|Lack of Efficacy|0
2495692|NCT01998958|8628782|P2|Period 1 (Panel A and B)|Lack of Efficacy|1
2495693|NCT01998958|8628783|P1|Period 1 (Panel A and B)|Lack of Efficacy|0
2495694|NCT01998958|8628752|P32|Period 1 (Panel A and B)|Withdrawal by Subject|0
2495695|NCT01998958|8628753|P31|Period 1 (Panel A and B)|Withdrawal by Subject|0
2495696|NCT01998958|8628754|P30|Period 1 (Panel A and B)|Withdrawal by Subject|0
2495697|NCT01998958|8628755|P29|Period 1 (Panel A and B)|Withdrawal by Subject|0
2495698|NCT01998958|8628756|P28|Period 1 (Panel A and B)|Withdrawal by Subject|0
2495699|NCT01998958|8628757|P27|Period 1 (Panel A and B)|Withdrawal by Subject|0
2495700|NCT01998958|8628758|P26|Period 1 (Panel A and B)|Withdrawal by Subject|0
2495701|NCT01998958|8628759|P25|Period 1 (Panel A and B)|Withdrawal by Subject|0
2495702|NCT01998958|8628760|P24|Period 1 (Panel A and B)|Withdrawal by Subject|0
2495703|NCT01998958|8628761|P23|Period 1 (Panel A and B)|Withdrawal by Subject|0
2495704|NCT01998958|8628762|P22|Period 1 (Panel A and B)|Withdrawal by Subject|0
2495705|NCT01998958|8628763|P21|Period 1 (Panel A and B)|Withdrawal by Subject|0
2495706|NCT01998958|8628764|P20|Period 1 (Panel A and B)|Withdrawal by Subject|0
2495707|NCT01998958|8628765|P19|Period 1 (Panel A and B)|Withdrawal by Subject|0
2495708|NCT01998958|8628766|P18|Period 1 (Panel A and B)|Withdrawal by Subject|0
2495709|NCT01998958|8628767|P17|Period 1 (Panel A and B)|Withdrawal by Subject|0
2495710|NCT01998958|8628768|P16|Period 1 (Panel A and B)|Withdrawal by Subject|0
2495711|NCT01998958|8628769|P15|Period 1 (Panel A and B)|Withdrawal by Subject|0
2495712|NCT01998958|8628770|P14|Period 1 (Panel A and B)|Withdrawal by Subject|0
2495713|NCT01998958|8628771|P13|Period 1 (Panel A and B)|Withdrawal by Subject|0
2495714|NCT01998958|8628772|P12|Period 1 (Panel A and B)|Withdrawal by Subject|0
2495715|NCT01998958|8628773|P11|Period 1 (Panel A and B)|Withdrawal by Subject|0
2495716|NCT01998958|8628774|P10|Period 1 (Panel A and B)|Withdrawal by Subject|0
2495717|NCT01998958|8628775|P9|Period 1 (Panel A and B)|Withdrawal by Subject|0
2495718|NCT01998958|8628776|P8|Period 1 (Panel A and B)|Withdrawal by Subject|0
2495719|NCT01998958|8628777|P7|Period 1 (Panel A and B)|Withdrawal by Subject|0
2495720|NCT01998958|8628778|P6|Period 1 (Panel A and B)|Withdrawal by Subject|0
2495721|NCT01998958|8628779|P5|Period 1 (Panel A and B)|Withdrawal by Subject|0
2495722|NCT01998958|8628780|P4|Period 1 (Panel A and B)|Withdrawal by Subject|0
2495723|NCT01998958|8628781|P3|Period 1 (Panel A and B)|Withdrawal by Subject|0
2495724|NCT01998958|8628782|P2|Period 1 (Panel A and B)|Withdrawal by Subject|1
2495725|NCT01998958|8628783|P1|Period 1 (Panel A and B)|Withdrawal by Subject|0
2495726|NCT01998919|8628922|P2|Overall Study|Other|2
2495727|NCT01998919|8628923|P1|Overall Study|Other|5
2495728|NCT01998919|8628922|P2|Overall Study|Lost to Follow-up|0
2495729|NCT01998919|8628923|P1|Overall Study|Lost to Follow-up|2
2495730|NCT01998919|8628922|P2|Overall Study|Withdrawal by Subject|4
2495731|NCT01998919|8628923|P1|Overall Study|Withdrawal by Subject|2
2495732|NCT01998919|8628922|P2|Overall Study|Disease progression|22
2495733|NCT01998919|8628923|P1|Overall Study|Disease progression|31
2495734|NCT01998919|8628922|P2|Overall Study|Adverse Event|5
2495735|NCT01998919|8628923|P1|Overall Study|Adverse Event|0
2495736|NCT01998919|8628922|P2|Overall Study|Death|2
2495737|NCT01998919|8628923|P1|Overall Study|Death|2
2495738|NCT01998906|8628944|P3|Overall Study|Other|4
2495739|NCT01998906|8628945|P2|Overall Study|Other|8
2495740|NCT01998906|8628946|P1|Overall Study|Other|3
2495741|NCT01998906|8628944|P3|Overall Study|Administrative/Other|3
2495742|NCT01998906|8628945|P2|Overall Study|Administrative/Other|1
2495743|NCT01998906|8628946|P1|Overall Study|Administrative/Other|2
2495744|NCT01998906|8628944|P3|Overall Study|Withdrawal by Subject|3
2495745|NCT01998906|8628945|P2|Overall Study|Withdrawal by Subject|4
2495746|NCT01998906|8628946|P1|Overall Study|Withdrawal by Subject|1
2495747|NCT01998906|8628944|P3|Overall Study|Violation of Selection Criteria|1
2495748|NCT01998906|8628945|P2|Overall Study|Violation of Selection Criteria|0
2495749|NCT01998906|8628946|P1|Overall Study|Violation of Selection Criteria|0
2495750|NCT01998906|8628944|P3|Overall Study|Failure to return|4
2495751|NCT01998906|8628945|P2|Overall Study|Failure to return|2
2495752|NCT01998906|8628946|P1|Overall Study|Failure to return|0
2495753|NCT01998906|8628944|P3|Overall Study|Lack of Efficacy|8
2495754|NCT01998906|8628945|P2|Overall Study|Lack of Efficacy|9
2495755|NCT01998906|8628946|P1|Overall Study|Lack of Efficacy|10
2495756|NCT01998906|8628944|P3|Overall Study|Death|17
2495757|NCT01998906|8628945|P2|Overall Study|Death|30
2495758|NCT01998906|8628946|P1|Overall Study|Death|21
2495759|NCT01998906|8628944|P3|Overall Study|Participants ongoing in follow−up|58
2495760|NCT01998906|8628945|P2|Overall Study|Participants ongoing in follow−up|60
2495761|NCT01998906|8628946|P1|Overall Study|Participants ongoing in follow−up|77
2495762|NCT01998893|8628990|P1|Overall Study|Transformation to high-grade lymphoma|1
2495763|NCT01998893|8628990|P1|Overall Study|Withdrawal by Subject|1
2495764|NCT01998893|8628990|P1|Overall Study|Protocol Violation|2
2495765|NCT01998893|8628990|P1|Overall Study|Physician Decision|2
2495766|NCT01998893|8628990|P1|Overall Study|Lost to Follow-up|8
2495767|NCT01998893|8628990|P1|Overall Study|Death|1
2495768|NCT01998893|8628990|P1|Overall Study|Adverse Event|2
2495769|NCT01998880|8629002|P2|Overall Study|Did Not Receive Treatment|2
2495770|NCT01998880|8629003|P1|Overall Study|Did Not Receive Treatment|3
2495771|NCT01998880|8629002|P2|Overall Study|Violation of Selection Criteria at Entry|1
2495772|NCT01998880|8629003|P1|Overall Study|Violation of Selection Criteria at Entry|0
2495773|NCT01998880|8629002|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
2495774|NCT01998880|8629003|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
2495775|NCT01998880|8629002|P2|Overall Study|Administrative/Other|1
2495776|NCT01998880|8629003|P1|Overall Study|Administrative/Other|1
2495777|NCT01998880|8629002|P2|Overall Study|Insufficient Therapeutic Response|5
2495778|NCT01998880|8629003|P1|Overall Study|Insufficient Therapeutic Response|1
2495779|NCT01998880|8629002|P2|Overall Study|Death|6
2495780|NCT01998880|8629003|P1|Overall Study|Death|3
2495781|NCT01998880|8629002|P2|Overall Study|Withdrew Consent|1
2495782|NCT01998880|8629003|P1|Overall Study|Withdrew Consent|2
2495783|NCT01998880|8629002|P2|Overall Study|Disease Progression|8
2495784|NCT01998880|8629003|P1|Overall Study|Disease Progression|1
2495785|NCT01998880|8629002|P2|Overall Study|Adverse Events or Intercurrent Illness|16
2495786|NCT01998880|8629003|P1|Overall Study|Adverse Events or Intercurrent Illness|16
2495787|NCT01998737|8629035|P2|Overall Study|Corrupted database|0
2495788|NCT01998737|8629036|P1|Overall Study|Corrupted database|23
2495789|NCT01998633|8629048|P1|Overall Study|Death|1
2495790|NCT01998581|8629066|P2|Overall Study|Randomized but withdrew before treatment|0
2495791|NCT01998581|8629067|P1|Overall Study|Randomized but withdrew before treatment|1
2495792|NCT01998581|8629066|P2|Overall Study|Other reasons|2
2495793|NCT01998581|8629067|P1|Overall Study|Other reasons|3
2495794|NCT01998581|8629066|P2|Overall Study|Adverse Event|1
2495795|NCT01998581|8629067|P1|Overall Study|Adverse Event|1
2495796|NCT01998581|8629066|P2|Overall Study|Lost to Follow-up|4
2495797|NCT01998581|8629067|P1|Overall Study|Lost to Follow-up|12
2495798|NCT01998581|8629066|P2|Overall Study|Withdrawal by Subject|1
2495799|NCT01998581|8629067|P1|Overall Study|Withdrawal by Subject|8
2495800|NCT01998581|8629066|P2|Overall Study|Protocol Violation|0
2495801|NCT01998581|8629067|P1|Overall Study|Protocol Violation|1
2495802|NCT01998581|8629066|P2|Overall Study|Refused repeat treatment|4
2495803|NCT01998581|8629067|P1|Overall Study|Refused repeat treatment|20
2495804|NCT01998477|8629080|P2|Overall Study|Withdrawal by Subject|0
2495805|NCT01998477|8629081|P1|Overall Study|Withdrawal by Subject|6
2495806|NCT01998477|8629080|P2|Overall Study|Lost to Follow-up|5
2495807|NCT01998477|8629081|P1|Overall Study|Lost to Follow-up|4
2495808|NCT01998399|8629127|P2|Overall Study|Withdrawal by Subject|1
2495809|NCT01998399|8629128|P1|Overall Study|Withdrawal by Subject|0
2495810|NCT01998399|8629127|P2|Overall Study|Study stopped before dosing completed|3
2495811|NCT01998399|8629128|P1|Overall Study|Study stopped before dosing completed|3
2495812|NCT01998399|8629127|P2|Overall Study|Death|2
2495813|NCT01998399|8629128|P1|Overall Study|Death|4
2495814|NCT01998399|8629127|P2|Overall Study|Lost to Follow-up|3
2495815|NCT01998399|8629128|P1|Overall Study|Lost to Follow-up|1
2495816|NCT01998243|8629183|P2|Overall Study|Withdrawal by Subject|4
2495817|NCT01998243|8629184|P1|Overall Study|Withdrawal by Subject|3
2495818|NCT01998243|8629183|P2|Overall Study|Protocol Violation|2
2495819|NCT01998243|8629184|P1|Overall Study|Protocol Violation|5
2495820|NCT01998243|8629183|P2|Overall Study|Pregnancy|1
2495821|NCT01998243|8629184|P1|Overall Study|Pregnancy|0
2495822|NCT01997892|8629207|P1|Overall Study|Study completion data not recorded|35
2495823|NCT01997892|8629207|P1|Overall Study|Other|3
2495824|NCT01997892|8629207|P1|Overall Study|Renal transplant|8
2495825|NCT01997892|8629207|P1|Overall Study|Death|14
2495826|NCT01997892|8629207|P1|Overall Study|Lost to Follow-up|6
2495827|NCT01997892|8629207|P1|Overall Study|Physician Decision|2
2495828|NCT01997333|8629381|P2|Survival Follow up|Various|2
2495829|NCT01997333|8629382|P1|Survival Follow up|Various|1
2495830|NCT01997333|8629381|P2|Survival Follow up|Lost to Follow-up|6
2495831|NCT01997333|8629382|P1|Survival Follow up|Lost to Follow-up|0
2495832|NCT01997333|8629381|P2|Survival Follow up|Withdrawal by Subject|6
2495833|NCT01997333|8629382|P1|Survival Follow up|Withdrawal by Subject|15
2495834|NCT01997333|8629381|P2|Randomization and Treatment|Did not receive treatment|5
2495835|NCT01997333|8629382|P1|Randomization and Treatment|Did not receive treatment|17
2495836|NCT01997333|8629381|P2|Randomization and Treatment|Withdrawal by Subject|3
2495837|NCT01997333|8629382|P1|Randomization and Treatment|Withdrawal by Subject|6
2495838|NCT01997333|8629381|P2|Randomization and Treatment|Physician Decision|4
2495839|NCT01997333|8629382|P1|Randomization and Treatment|Physician Decision|0
2495840|NCT01997333|8629381|P2|Randomization and Treatment|Adverse Event|32
2495841|NCT01997333|8629382|P1|Randomization and Treatment|Adverse Event|10
2495842|NCT01997333|8629381|P2|Randomization and Treatment|Disease Progression|159
2495843|NCT01997333|8629382|P1|Randomization and Treatment|Disease Progression|70
2495844|NCT01996982|8629417|P1|Overall Study|PI/team left institution|7
2495845|NCT01996904|8629433|P2|Overall Study|Lost to Follow-up|27
2495846|NCT01996904|8629434|P1|Overall Study|Lost to Follow-up|38
2495847|NCT01996748|8629502|P2|Overall Study|Lost to Follow-up|1
2495848|NCT01996748|8629503|P1|Overall Study|Lost to Follow-up|4
2495849|NCT01996748|8629502|P2|Overall Study|Withdrawal by Subject|1
2495850|NCT01996748|8629503|P1|Overall Study|Withdrawal by Subject|0
2495851|NCT01996748|8629502|P2|Overall Study|Adverse Event|4
2495852|NCT01996748|8629503|P1|Overall Study|Adverse Event|1
2495853|NCT01996748|8629502|P2|Overall Study|Physician Decision|0
2495854|NCT01996748|8629503|P1|Overall Study|Physician Decision|2
2495855|NCT01996748|8629502|P2|Overall Study|Personal reason|0
2495856|NCT01996748|8629503|P1|Overall Study|Personal reason|1
2495857|NCT01996709|8629517|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
2495858|NCT01996709|8629518|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
2495859|NCT01996709|8629517|P2|Overall Study|Subject Non-Compliant|0
2495860|NCT01996709|8629518|P1|Overall Study|Subject Non-Compliant|1
2495861|NCT01996709|8629517|P2|Overall Study|Lost to Follow-up|0
2495862|NCT01996709|8629518|P1|Overall Study|Lost to Follow-up|3
2495863|NCT01996709|8629517|P2|Overall Study|Withdrawal by Subject|0
2495864|NCT01996709|8629518|P1|Overall Study|Withdrawal by Subject|1
2495865|NCT01996592|8629565|P1|Overall Study|change in mode of delivery|4
2495866|NCT01996592|8629565|P1|Overall Study|Withdrawal by Subject|5
2495867|NCT01996592|8629565|P1|Overall Study|change in surgical date|4
2495868|NCT01996592|8629565|P1|Overall Study|no response to text/no diary entry|32
2495869|NCT01996332|8629601|P1|Overall Study|Lost to Follow-up|34
2495870|NCT01996332|8629601|P1|Overall Study|Physician Decision|17
2495871|NCT01996332|8629601|P1|Overall Study|Clinical Deterioration|28
2495872|NCT01996332|8629601|P1|Overall Study|Other|20
2495873|NCT01996332|8629601|P1|Overall Study|Withdrawal by Subject|71
2495874|NCT01996332|8629601|P1|Overall Study|Protocol Violation|9
2495875|NCT01996332|8629601|P1|Overall Study|Death|264
2495876|NCT01996332|8629601|P1|Overall Study|Lack of Efficacy|1245
2495877|NCT01996332|8629601|P1|Overall Study|Adverse Event|117
2495878|NCT01996319|8629609|P2|Overall Study|Adverse Event|2
2495879|NCT01996319|8629610|P1|Overall Study|Adverse Event|2
2495880|NCT01996319|8629609|P2|Overall Study|Severe or moderate (COPD) Exacerbation|1
2495881|NCT01996319|8629610|P1|Overall Study|Severe or moderate (COPD) Exacerbation|5
2495882|NCT01996319|8629609|P2|Overall Study|Protocol Violation|0
2495883|NCT01996319|8629610|P1|Overall Study|Protocol Violation|1
2495884|NCT01996254|8629632|P3|Overall Study|Lost to Follow-up|4
2495885|NCT01996254|8629633|P2|Overall Study|Lost to Follow-up|0
2495886|NCT01996254|8629634|P1|Overall Study|Lost to Follow-up|1
2495887|NCT01996254|8629632|P3|Overall Study|Withdrawal by Subject|4
2495888|NCT01996254|8629633|P2|Overall Study|Withdrawal by Subject|3
2495889|NCT01996254|8629634|P1|Overall Study|Withdrawal by Subject|0
2495890|NCT01996254|8629632|P3|Overall Study|Change in Eligibility|0
2495891|NCT01996254|8629633|P2|Overall Study|Change in Eligibility|2
2495892|NCT01996254|8629634|P1|Overall Study|Change in Eligibility|0
2495893|NCT01996241|8629662|P2|Overall Study|Lost to Follow-up|235
2495894|NCT01996241|8629663|P1|Overall Study|Lost to Follow-up|252
2495895|NCT01996033|8629679|P1|Overall Study|Lost to Follow-up|3
2495896|NCT01996033|8629679|P1|Overall Study|Withdrawal by Subject|4
2495897|NCT01996033|8629679|P1|Overall Study|Physician Decision|1
2495898|NCT01996033|8629679|P1|Overall Study|Death|1
2495899|NCT01995838|8629699|P7|Overall Study|Other|2
2495900|NCT01995838|8629700|P6|Overall Study|Other|1
2495901|NCT01995838|8629701|P5|Overall Study|Other|1
2495902|NCT01995838|8629702|P4|Overall Study|Other|2
2495903|NCT01995838|8629703|P3|Overall Study|Other|0
2495904|NCT01995838|8629704|P2|Overall Study|Other|1
2495905|NCT01995838|8629705|P1|Overall Study|Other|3
2495906|NCT01995838|8629699|P7|Overall Study|Withdrawal by Subject|0
2495907|NCT01995838|8629700|P6|Overall Study|Withdrawal by Subject|0
2495908|NCT01995838|8629701|P5|Overall Study|Withdrawal by Subject|1
2495909|NCT01995838|8629702|P4|Overall Study|Withdrawal by Subject|0
2495910|NCT01995838|8629703|P3|Overall Study|Withdrawal by Subject|0
2495911|NCT01995838|8629704|P2|Overall Study|Withdrawal by Subject|0
2495912|NCT01995838|8629705|P1|Overall Study|Withdrawal by Subject|0
2495913|NCT01995838|8629699|P7|Overall Study|Adverse Event|1
2495914|NCT01995838|8629700|P6|Overall Study|Adverse Event|0
2495915|NCT01995838|8629701|P5|Overall Study|Adverse Event|0
2495916|NCT01995838|8629702|P4|Overall Study|Adverse Event|0
2495917|NCT01995838|8629703|P3|Overall Study|Adverse Event|0
2495918|NCT01995838|8629704|P2|Overall Study|Adverse Event|0
2495919|NCT01995838|8629705|P1|Overall Study|Adverse Event|0
2495920|NCT01995838|8629699|P7|Overall Study|Participant choice|1
2495921|NCT01995838|8629700|P6|Overall Study|Participant choice|1
2495922|NCT01995838|8629701|P5|Overall Study|Participant choice|0
2495923|NCT01995838|8629702|P4|Overall Study|Participant choice|0
2495924|NCT01995838|8629703|P3|Overall Study|Participant choice|0
2495925|NCT01995838|8629704|P2|Overall Study|Participant choice|0
2495926|NCT01995838|8629705|P1|Overall Study|Participant choice|2
2495927|NCT01995838|8629699|P7|Overall Study|Lost to Follow-up|1
2495928|NCT01995838|8629700|P6|Overall Study|Lost to Follow-up|0
2495929|NCT01995838|8629701|P5|Overall Study|Lost to Follow-up|0
2495930|NCT01995838|8629702|P4|Overall Study|Lost to Follow-up|0
2495931|NCT01995838|8629703|P3|Overall Study|Lost to Follow-up|0
2495932|NCT01995838|8629704|P2|Overall Study|Lost to Follow-up|1
2495933|NCT01995838|8629705|P1|Overall Study|Lost to Follow-up|0
2495934|NCT01995552|8629804|P1|Overall Study|Death|1
2495935|NCT01995552|8629804|P1|Overall Study|Lack of Efficacy|15
2495936|NCT01995552|8629804|P1|Overall Study|Protocol Violation|1
2495937|NCT01995539|8629810|P1|Overall Study|Subject missed visit 3,4, came in for V5|1
2495938|NCT01995539|8629810|P1|Overall Study|Lost to Follow-up|5
2495939|NCT01995539|8629810|P1|Overall Study|Withdrawal by Subject|11
2495940|NCT01995539|8629810|P1|Overall Study|Withdrawal by Investigator|15
2495941|NCT01995539|8629810|P1|Overall Study|Screening Failure|1
2495942|NCT01995526|8629815|P1|Overall Study|Physician Decision|1
2495943|NCT01995513|8629823|P3|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|18
2495944|NCT01995513|8629824|P2|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|27
2495945|NCT01995513|8629825|P1|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
2495946|NCT01995513|8629823|P3|Double Blind Treatment Period|Disease Progression|93
2495947|NCT01995513|8629824|P2|Double Blind Treatment Period|Disease Progression|82
2495948|NCT01995513|8629825|P1|Double Blind Treatment Period|Disease Progression|0
2495949|NCT01995513|8629823|P3|Double Blind Treatment Period|Death|1
2495950|NCT01995513|8629824|P2|Double Blind Treatment Period|Death|0
2495951|NCT01995513|8629825|P1|Double Blind Treatment Period|Death|0
2495952|NCT01995513|8629823|P3|Double Blind Treatment Period|Withdrawal by Subject|6
2495953|NCT01995513|8629824|P2|Double Blind Treatment Period|Withdrawal by Subject|4
2495954|NCT01995513|8629825|P1|Double Blind Treatment Period|Withdrawal by Subject|0
2495955|NCT01995513|8629823|P3|Double Blind Treatment Period|Other|2
2495956|NCT01995513|8629824|P2|Double Blind Treatment Period|Other|1
2495957|NCT01995513|8629825|P1|Double Blind Treatment Period|Other|0
2495958|NCT01995513|8629823|P3|Double Blind Treatment Period|Adverse Event|5
2495959|NCT01995513|8629824|P2|Double Blind Treatment Period|Adverse Event|12
2495960|NCT01995513|8629825|P1|Double Blind Treatment Period|Adverse Event|0
2495961|NCT01995513|8629823|P3|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
2495962|NCT01995513|8629824|P2|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
2495963|NCT01995513|8629825|P1|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|84
2495964|NCT01995513|8629823|P3|Open Label Treatment Period|Death|0
2495965|NCT01995513|8629824|P2|Open Label Treatment Period|Death|0
2495966|NCT01995513|8629825|P1|Open Label Treatment Period|Death|8
2495967|NCT01995513|8629823|P3|Open Label Treatment Period|Adverse Event|0
2495968|NCT01995513|8629824|P2|Open Label Treatment Period|Adverse Event|0
2495969|NCT01995513|8629825|P1|Open Label Treatment Period|Adverse Event|35
2495970|NCT01995513|8629823|P3|Open Label Treatment Period|No PSA response at week 13|0
2495971|NCT01995513|8629824|P2|Open Label Treatment Period|No PSA response at week 13|0
2495972|NCT01995513|8629825|P1|Open Label Treatment Period|No PSA response at week 13|43
2495973|NCT01995513|8629823|P3|Open Label Treatment Period|Disease Progression|0
2495974|NCT01995513|8629824|P2|Open Label Treatment Period|Disease Progression|0
2495975|NCT01995513|8629825|P1|Open Label Treatment Period|Disease Progression|64
2495976|NCT01995513|8629823|P3|Open Label Treatment Period|Protocol Violation|0
2495977|NCT01995513|8629824|P2|Open Label Treatment Period|Protocol Violation|0
2495978|NCT01995513|8629825|P1|Open Label Treatment Period|Protocol Violation|1
2495979|NCT01995513|8629823|P3|Open Label Treatment Period|Withdrawal by Subject|0
2495980|NCT01995513|8629824|P2|Open Label Treatment Period|Withdrawal by Subject|0
2495981|NCT01995513|8629825|P1|Open Label Treatment Period|Withdrawal by Subject|14
2495982|NCT01995513|8629823|P3|Open Label Treatment Period|Other|0
2495983|NCT01995513|8629824|P2|Open Label Treatment Period|Other|0
2495984|NCT01995513|8629825|P1|Open Label Treatment Period|Other|9
2495985|NCT01995461|8629868|P1|Overall Study|Withdrawal by Subject|2
2495986|NCT01995461|8629868|P1|Overall Study|Lost to Follow-up|2
2495987|NCT01995461|8629868|P1|Overall Study|Death|1
2495988|NCT01995357|8629874|P6|Period 5|Adverse Event|0
2495989|NCT01995357|8629875|P5|Period 5|Adverse Event|0
2495990|NCT01995357|8629876|P4|Period 5|Adverse Event|0
2495991|NCT01995357|8629877|P3|Period 5|Adverse Event|1
2495992|NCT01995357|8629878|P2|Period 5|Adverse Event|0
2495993|NCT01995357|8629879|P1|Period 5|Adverse Event|1
2495994|NCT01995357|8629874|P6|Period 5|Lack of Efficacy|0
2495995|NCT01995357|8629875|P5|Period 5|Lack of Efficacy|0
2495996|NCT01995357|8629876|P4|Period 5|Lack of Efficacy|0
2495997|NCT01995357|8629877|P3|Period 5|Lack of Efficacy|0
2495998|NCT01995357|8629878|P2|Period 5|Lack of Efficacy|0
2495999|NCT01995357|8629879|P1|Period 5|Lack of Efficacy|1
2496000|NCT01995266|8629895|P1|Overall Study|Adverse Event|2
2496001|NCT01995266|8629895|P1|Overall Study|Lack of Efficacy|6
2496002|NCT01995266|8629895|P1|Overall Study|Death|1
2496003|NCT01995201|8629910|P7|From Week 24 Until Week 48|Protocol Violation|0
2496004|NCT01995201|8629911|P6|From Week 24 Until Week 48|Protocol Violation|0
2496005|NCT01995201|8629912|P5|From Week 24 Until Week 48|Protocol Violation|2
2496006|NCT01995201|8629913|P4|From Week 24 Until Week 48|Protocol Violation|0
2496007|NCT01995201|8629914|P3|From Week 24 Until Week 48|Protocol Violation|1
2496008|NCT01995201|8629915|P2|From Week 24 Until Week 48|Protocol Violation|0
2496009|NCT01995201|8629916|P1|From Week 24 Until Week 48|Protocol Violation|0
2496010|NCT01995201|8629910|P7|From Week 24 Until Week 48|Physician Decision|0
2496011|NCT01995201|8629911|P6|From Week 24 Until Week 48|Physician Decision|0
2496012|NCT01995201|8629912|P5|From Week 24 Until Week 48|Physician Decision|1
2496013|NCT01995201|8629913|P4|From Week 24 Until Week 48|Physician Decision|0
2496014|NCT01995201|8629914|P3|From Week 24 Until Week 48|Physician Decision|0
2496015|NCT01995201|8629915|P2|From Week 24 Until Week 48|Physician Decision|0
2496016|NCT01995201|8629916|P1|From Week 24 Until Week 48|Physician Decision|0
2496017|NCT01995201|8629910|P7|From Week 24 Until Week 48|Withdrawal by Subject|0
2496018|NCT01995201|8629911|P6|From Week 24 Until Week 48|Withdrawal by Subject|0
2496019|NCT01995201|8629912|P5|From Week 24 Until Week 48|Withdrawal by Subject|1
2496020|NCT01995201|8629913|P4|From Week 24 Until Week 48|Withdrawal by Subject|0
2496021|NCT01995201|8629914|P3|From Week 24 Until Week 48|Withdrawal by Subject|1
2496022|NCT01995201|8629915|P2|From Week 24 Until Week 48|Withdrawal by Subject|0
2496023|NCT01995201|8629916|P1|From Week 24 Until Week 48|Withdrawal by Subject|0
2496024|NCT01995201|8629910|P7|From Week 24 Until Week 48|Lost to Follow-up|0
2496025|NCT01995201|8629911|P6|From Week 24 Until Week 48|Lost to Follow-up|1
2496026|NCT01995201|8629912|P5|From Week 24 Until Week 48|Lost to Follow-up|1
2496027|NCT01995201|8629913|P4|From Week 24 Until Week 48|Lost to Follow-up|0
2496028|NCT01995201|8629914|P3|From Week 24 Until Week 48|Lost to Follow-up|0
2496029|NCT01995201|8629915|P2|From Week 24 Until Week 48|Lost to Follow-up|0
2496030|NCT01995201|8629916|P1|From Week 24 Until Week 48|Lost to Follow-up|0
2496031|NCT01995201|8629910|P7|From Week 24 Until Week 48|Lack of Efficacy|1
2496032|NCT01995201|8629911|P6|From Week 24 Until Week 48|Lack of Efficacy|2
2496033|NCT01995201|8629912|P5|From Week 24 Until Week 48|Lack of Efficacy|0
2496034|NCT01995201|8629913|P4|From Week 24 Until Week 48|Lack of Efficacy|0
2496035|NCT01995201|8629914|P3|From Week 24 Until Week 48|Lack of Efficacy|1
2496036|NCT01995201|8629915|P2|From Week 24 Until Week 48|Lack of Efficacy|0
2496037|NCT01995201|8629916|P1|From Week 24 Until Week 48|Lack of Efficacy|0
2496038|NCT01995201|8629910|P7|From Week 24 Until Week 48|Death|0
2496039|NCT01995201|8629911|P6|From Week 24 Until Week 48|Death|2
2496040|NCT01995201|8629912|P5|From Week 24 Until Week 48|Death|0
2496041|NCT01995201|8629913|P4|From Week 24 Until Week 48|Death|0
2496042|NCT01995201|8629914|P3|From Week 24 Until Week 48|Death|0
2496043|NCT01995201|8629915|P2|From Week 24 Until Week 48|Death|0
2496044|NCT01995201|8629916|P1|From Week 24 Until Week 48|Death|0
2496045|NCT01995201|8629910|P7|From Week 24 Until Week 48|Adverse Event|1
2496046|NCT01995201|8629911|P6|From Week 24 Until Week 48|Adverse Event|3
2496047|NCT01995201|8629912|P5|From Week 24 Until Week 48|Adverse Event|1
2496048|NCT01995201|8629913|P4|From Week 24 Until Week 48|Adverse Event|1
2496049|NCT01995201|8629914|P3|From Week 24 Until Week 48|Adverse Event|2
2496050|NCT01995201|8629915|P2|From Week 24 Until Week 48|Adverse Event|0
2496051|NCT01995201|8629916|P1|From Week 24 Until Week 48|Adverse Event|0
2496052|NCT01995201|8629910|P7|From Baseline Until Week 24|Protocol Violation|0
2496053|NCT01995201|8629911|P6|From Baseline Until Week 24|Protocol Violation|0
2496054|NCT01995201|8629912|P5|From Baseline Until Week 24|Protocol Violation|0
2496055|NCT01995201|8629913|P4|From Baseline Until Week 24|Protocol Violation|0
2496056|NCT01995201|8629914|P3|From Baseline Until Week 24|Protocol Violation|0
2496057|NCT01995201|8629915|P2|From Baseline Until Week 24|Protocol Violation|9
2496058|NCT01995201|8629916|P1|From Baseline Until Week 24|Protocol Violation|0
2496059|NCT01995201|8629910|P7|From Baseline Until Week 24|Physician Decision|0
2496060|NCT01995201|8629911|P6|From Baseline Until Week 24|Physician Decision|0
2496061|NCT01995201|8629912|P5|From Baseline Until Week 24|Physician Decision|0
2496062|NCT01995201|8629913|P4|From Baseline Until Week 24|Physician Decision|0
2496063|NCT01995201|8629914|P3|From Baseline Until Week 24|Physician Decision|0
2496064|NCT01995201|8629915|P2|From Baseline Until Week 24|Physician Decision|2
2496065|NCT01995201|8629916|P1|From Baseline Until Week 24|Physician Decision|0
2496066|NCT01995201|8629910|P7|From Baseline Until Week 24|Withdrawal by Subject|0
2496067|NCT01995201|8629911|P6|From Baseline Until Week 24|Withdrawal by Subject|0
2496068|NCT01995201|8629912|P5|From Baseline Until Week 24|Withdrawal by Subject|0
2496069|NCT01995201|8629913|P4|From Baseline Until Week 24|Withdrawal by Subject|0
2496070|NCT01995201|8629914|P3|From Baseline Until Week 24|Withdrawal by Subject|0
2496071|NCT01995201|8629915|P2|From Baseline Until Week 24|Withdrawal by Subject|8
2496072|NCT01995201|8629916|P1|From Baseline Until Week 24|Withdrawal by Subject|2
2496073|NCT01995201|8629910|P7|From Baseline Until Week 24|Lost to Follow-up|0
2496074|NCT01995201|8629911|P6|From Baseline Until Week 24|Lost to Follow-up|0
2496075|NCT01995201|8629912|P5|From Baseline Until Week 24|Lost to Follow-up|0
2496076|NCT01995201|8629913|P4|From Baseline Until Week 24|Lost to Follow-up|0
2496077|NCT01995201|8629914|P3|From Baseline Until Week 24|Lost to Follow-up|0
2496078|NCT01995201|8629915|P2|From Baseline Until Week 24|Lost to Follow-up|3
2496079|NCT01995201|8629916|P1|From Baseline Until Week 24|Lost to Follow-up|2
2496080|NCT01995201|8629910|P7|From Baseline Until Week 24|Lack of Efficacy|0
2496081|NCT01995201|8629911|P6|From Baseline Until Week 24|Lack of Efficacy|0
2496082|NCT01995201|8629912|P5|From Baseline Until Week 24|Lack of Efficacy|0
2496083|NCT01995201|8629913|P4|From Baseline Until Week 24|Lack of Efficacy|0
2496084|NCT01995201|8629914|P3|From Baseline Until Week 24|Lack of Efficacy|0
2496085|NCT01995201|8629915|P2|From Baseline Until Week 24|Lack of Efficacy|5
2496086|NCT01995201|8629916|P1|From Baseline Until Week 24|Lack of Efficacy|2
2496087|NCT01995201|8629910|P7|From Baseline Until Week 24|Death|0
2496088|NCT01995201|8629911|P6|From Baseline Until Week 24|Death|0
2496089|NCT01995201|8629912|P5|From Baseline Until Week 24|Death|0
2496090|NCT01995201|8629913|P4|From Baseline Until Week 24|Death|0
2496091|NCT01995201|8629914|P3|From Baseline Until Week 24|Death|0
2496092|NCT01995201|8629915|P2|From Baseline Until Week 24|Death|1
2496093|NCT01995201|8629916|P1|From Baseline Until Week 24|Death|0
2496094|NCT01995201|8629910|P7|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
2496095|NCT01995201|8629911|P6|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
2496096|NCT01995201|8629912|P5|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
2496097|NCT01995201|8629913|P4|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
2496098|NCT01995201|8629914|P3|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
2496099|NCT01995201|8629915|P2|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3
2496100|NCT01995201|8629916|P1|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
2496101|NCT01995201|8629910|P7|From Baseline Until Week 24|Adverse Event|0
2496102|NCT01995201|8629911|P6|From Baseline Until Week 24|Adverse Event|0
2496103|NCT01995201|8629912|P5|From Baseline Until Week 24|Adverse Event|0
2496104|NCT01995201|8629913|P4|From Baseline Until Week 24|Adverse Event|0
2496105|NCT01995201|8629914|P3|From Baseline Until Week 24|Adverse Event|0
2496106|NCT01995201|8629915|P2|From Baseline Until Week 24|Adverse Event|15
2496107|NCT01995201|8629916|P1|From Baseline Until Week 24|Adverse Event|4
2496108|NCT01995175|8630025|P1|Overall Study|Migrated / moved from the study area|49
2496109|NCT01995175|8630025|P1|Overall Study|Other|67
2496110|NCT01995175|8630025|P1|Overall Study|Lost to Follow-up|102
2496111|NCT01995175|8630025|P1|Overall Study|Withdrawal by Subject|35
2496112|NCT01995136|8630035|P1|Overall Study|Change in residence|1
2496113|NCT01995071|8630064|P12|Overall Study|Incarcerated|0
2496114|NCT01995071|8630065|P11|Overall Study|Incarcerated|0
2496115|NCT01995071|8630066|P10|Overall Study|Incarcerated|0
2496116|NCT01995071|8630067|P9|Overall Study|Incarcerated|0
2496117|NCT01995071|8630068|P8|Overall Study|Incarcerated|1
2496118|NCT01995071|8630069|P7|Overall Study|Incarcerated|0
2496119|NCT01995071|8630070|P6|Overall Study|Incarcerated|0
2496120|NCT01995071|8630071|P5|Overall Study|Incarcerated|0
2496121|NCT01995071|8630072|P4|Overall Study|Incarcerated|0
2496122|NCT01995071|8630073|P3|Overall Study|Incarcerated|0
2496123|NCT01995071|8630074|P2|Overall Study|Incarcerated|0
2496124|NCT01995071|8630075|P1|Overall Study|Incarcerated|0
2496125|NCT01995071|8630064|P12|Overall Study|Lost to Follow-up|0
2496126|NCT01995071|8630065|P11|Overall Study|Lost to Follow-up|0
2496127|NCT01995071|8630066|P10|Overall Study|Lost to Follow-up|0
2496128|NCT01995071|8630067|P9|Overall Study|Lost to Follow-up|1
2496129|NCT01995071|8630068|P8|Overall Study|Lost to Follow-up|1
2496130|NCT01995071|8630069|P7|Overall Study|Lost to Follow-up|0
2496131|NCT01995071|8630070|P6|Overall Study|Lost to Follow-up|0
2496132|NCT01995071|8630071|P5|Overall Study|Lost to Follow-up|0
2496133|NCT01995071|8630072|P4|Overall Study|Lost to Follow-up|0
2496134|NCT01995071|8630073|P3|Overall Study|Lost to Follow-up|0
2496135|NCT01995071|8630074|P2|Overall Study|Lost to Follow-up|0
2496136|NCT01995071|8630075|P1|Overall Study|Lost to Follow-up|1
2496137|NCT01995071|8630064|P12|Overall Study|Moved|0
2496138|NCT01995071|8630065|P11|Overall Study|Moved|1
2496139|NCT01995071|8630066|P10|Overall Study|Moved|0
2496140|NCT01995071|8630067|P9|Overall Study|Moved|0
2496141|NCT01995071|8630068|P8|Overall Study|Moved|0
2496142|NCT01995071|8630069|P7|Overall Study|Moved|0
2496143|NCT01995071|8630070|P6|Overall Study|Moved|0
2496144|NCT01995071|8630071|P5|Overall Study|Moved|1
2496145|NCT01995071|8630072|P4|Overall Study|Moved|0
2496146|NCT01995071|8630073|P3|Overall Study|Moved|1
2496147|NCT01995071|8630074|P2|Overall Study|Moved|0
2496148|NCT01995071|8630075|P1|Overall Study|Moved|0
2496149|NCT01995071|8630064|P12|Overall Study|Adverse Event|0
2496150|NCT01995071|8630065|P11|Overall Study|Adverse Event|0
2496151|NCT01995071|8630066|P10|Overall Study|Adverse Event|0
2496152|NCT01995071|8630067|P9|Overall Study|Adverse Event|0
2496153|NCT01995071|8630068|P8|Overall Study|Adverse Event|0
2496154|NCT01995071|8630069|P7|Overall Study|Adverse Event|1
2496155|NCT01995071|8630070|P6|Overall Study|Adverse Event|0
2496156|NCT01995071|8630071|P5|Overall Study|Adverse Event|0
2496157|NCT01995071|8630072|P4|Overall Study|Adverse Event|0
2496158|NCT01995071|8630073|P3|Overall Study|Adverse Event|0
2496159|NCT01995071|8630074|P2|Overall Study|Adverse Event|0
2496160|NCT01995071|8630075|P1|Overall Study|Adverse Event|0
2496161|NCT01994954|8630212|P2|Overall Study|6 Month Follow-up Not Complete|4
2496162|NCT01994954|8630213|P1|Overall Study|6 Month Follow-up Not Complete|5
2496163|NCT01994954|8630212|P2|Overall Study|Lost to Follow-up|10
2496164|NCT01994954|8630213|P1|Overall Study|Lost to Follow-up|8
2496165|NCT01994954|8630212|P2|Overall Study|Physician Decision|2
2496166|NCT01994954|8630213|P1|Overall Study|Physician Decision|2
2496167|NCT01994954|8630212|P2|Overall Study|Withdrawal by Subject|14
2496168|NCT01994954|8630213|P1|Overall Study|Withdrawal by Subject|9
2496169|NCT01994954|8630212|P2|Overall Study|Death|0
2496170|NCT01994954|8630213|P1|Overall Study|Death|1
2496171|NCT01994902|8630231|P2|Test Period 2|Other|3
2496172|NCT01994902|8630232|P1|Test Period 2|Other|0
2496173|NCT01994902|8630231|P2|Test Period 2|Lack of Efficacy|1
2496174|NCT01994902|8630232|P1|Test Period 2|Lack of Efficacy|0
2496175|NCT01994902|8630231|P2|Test Period 2|Withdrawal by Subject|2
2496176|NCT01994902|8630232|P1|Test Period 2|Withdrawal by Subject|0
2496177|NCT01994902|8630231|P2|Test Period 1|bag too small|0
2496178|NCT01994902|8630232|P1|Test Period 1|bag too small|1
2496179|NCT01994902|8630231|P2|Test Period 1|Lack of Efficacy|1
2496180|NCT01994902|8630232|P1|Test Period 1|Lack of Efficacy|0
2496181|NCT01994902|8630231|P2|Test Period 1|Adverse Event|1
2496182|NCT01994902|8630232|P1|Test Period 1|Adverse Event|2
2496183|NCT01994902|8630231|P2|Test Period 1|device deficiency with adverse event|1
2496184|NCT01994902|8630232|P1|Test Period 1|device deficiency with adverse event|0
2496185|NCT01994902|8630231|P2|Test Period 1|Withdrawal by Subject|0
2496186|NCT01994902|8630232|P1|Test Period 1|Withdrawal by Subject|3
2496187|NCT01994889|8630241|P3|Overall Study|Death|38
2496188|NCT01994889|8630242|P2|Overall Study|Death|25
2496189|NCT01994889|8630243|P1|Overall Study|Death|14
2496190|NCT01994889|8630241|P3|Overall Study|Protocol Violation|1
2496191|NCT01994889|8630242|P2|Overall Study|Protocol Violation|1
2496192|NCT01994889|8630243|P1|Overall Study|Protocol Violation|0
2496193|NCT01994889|8630241|P3|Overall Study|Lost to Follow-up|0
2496194|NCT01994889|8630242|P2|Overall Study|Lost to Follow-up|1
2496195|NCT01994889|8630243|P1|Overall Study|Lost to Follow-up|0
2496196|NCT01994889|8630241|P3|Overall Study|No longer willing to participate|37
2496197|NCT01994889|8630242|P2|Overall Study|No longer willing to participate|17
2496198|NCT01994889|8630243|P1|Overall Study|No longer willing to participate|8
2496199|NCT01994889|8630241|P3|Overall Study|Organ Transplantation|5
2496200|NCT01994889|8630242|P2|Overall Study|Organ Transplantation|5
2496201|NCT01994889|8630243|P1|Overall Study|Organ Transplantation|1
2496202|NCT01994889|8630241|P3|Overall Study|Cardiac Device Implantation|0
2496203|NCT01994889|8630242|P2|Overall Study|Cardiac Device Implantation|2
2496204|NCT01994889|8630243|P1|Overall Study|Cardiac Device Implantation|0
2496205|NCT01994889|8630241|P3|Overall Study|Adverse Event|11
2496206|NCT01994889|8630242|P2|Overall Study|Adverse Event|12
2496207|NCT01994889|8630243|P1|Overall Study|Adverse Event|5
2496208|NCT01994876|8630262|P2|Test Period 2|Protocol Violation|1
2496209|NCT01994876|8630263|P1|Test Period 2|Protocol Violation|0
2496210|NCT01994876|8630262|P2|Test Period 2|Adverse Event|0
2496211|NCT01994876|8630263|P1|Test Period 2|Adverse Event|1
2496212|NCT01994876|8630262|P2|Test Period 1|Adverse Event|1
2496213|NCT01994876|8630263|P1|Test Period 1|Adverse Event|0
2496214|NCT01994876|8630262|P2|Test Period 1|Withdrawal by Subject|1
2496215|NCT01994876|8630263|P1|Test Period 1|Withdrawal by Subject|0
2496216|NCT01994863|8630271|P2|Period 2|Withdrawal by Subject|1
2496217|NCT01994863|8630272|P1|Period 2|Withdrawal by Subject|1
2496218|NCT01994863|8630271|P2|Period 2|Lack of Efficacy|2
2496219|NCT01994863|8630272|P1|Period 2|Lack of Efficacy|0
2496220|NCT01994863|8630271|P2|Period 2|Adverse Event|1
2496221|NCT01994863|8630272|P1|Period 2|Adverse Event|0
2496222|NCT01994863|8630271|P2|Period 1|Lack of Efficacy|0
2496223|NCT01994863|8630272|P1|Period 1|Lack of Efficacy|1
2496224|NCT01994863|8630271|P2|Period 1|Trial stopped by sponsor|3
2496225|NCT01994863|8630272|P1|Period 1|Trial stopped by sponsor|1
2496226|NCT01994863|8630271|P2|Period 1|Withdrawal by Subject|0
2496227|NCT01994863|8630272|P1|Period 1|Withdrawal by Subject|1
2496228|NCT01994863|8630271|P2|Period 1|Adverse Event|0
2496229|NCT01994863|8630272|P1|Period 1|Adverse Event|4
2496230|NCT01994850|8630278|P1|Overall Study|Withdrawal by Subject|1
2496231|NCT01994850|8630278|P1|Overall Study|Physician Decision|1
2496232|NCT01994837|8630283|P1|Overall Study|Removed from study due to no response|1
2496233|NCT01994837|8630283|P1|Overall Study|Proceeded to transplant|1
2496234|NCT01994837|8630283|P1|Overall Study|Chose palliative care|1
2496235|NCT01994837|8630283|P1|Overall Study|Adverse event not related to progression|1
2496236|NCT01994837|8630283|P1|Overall Study|Fatal progressive disease|2
2496237|NCT01994837|8630283|P1|Overall Study|Adv event related to progressive disease|3
2496238|NCT01994837|8630283|P1|Overall Study|Progressive disease per protocol|23
2496239|NCT01994720|8630340|P2|Overall Study|Withdrawal by Subject|56
2496240|NCT01994720|8630341|P1|Overall Study|Withdrawal by Subject|46
2496241|NCT01994629|8630383|P2|Overall Study|Lost to Follow-up|3
2496242|NCT01994629|8630384|P1|Overall Study|Lost to Follow-up|0
2496243|NCT01994629|8630383|P2|Overall Study|Withdrawal by Subject|0
2496244|NCT01994629|8630384|P1|Overall Study|Withdrawal by Subject|1
2496245|NCT01994590|8630408|P1|Overall Study|Trial Terminated|1
2496246|NCT01994590|8630408|P1|Overall Study|Adverse Event|1
2496247|NCT01994395|8630423|P2|Overall Study|Withdrawal by Subject|2
2496248|NCT01994395|8630424|P1|Overall Study|Withdrawal by Subject|1
2496249|NCT01994291|8630449|P3|Overall Study|Other|0
2496250|NCT01994291|8630450|P2|Overall Study|Other|2
2496251|NCT01994291|8630451|P1|Overall Study|Other|1
2496252|NCT01994291|8630449|P3|Overall Study|Withdrawal by Subject|5
2496253|NCT01994291|8630450|P2|Overall Study|Withdrawal by Subject|3
2496254|NCT01994291|8630451|P1|Overall Study|Withdrawal by Subject|6
2496255|NCT01994291|8630449|P3|Overall Study|Protocol Violation|0
2496256|NCT01994291|8630450|P2|Overall Study|Protocol Violation|0
2496257|NCT01994291|8630451|P1|Overall Study|Protocol Violation|1
2496258|NCT01994291|8630449|P3|Overall Study|Medication error without associated AE|1
2496259|NCT01994291|8630450|P2|Overall Study|Medication error without associated AE|0
2496260|NCT01994291|8630451|P1|Overall Study|Medication error without associated AE|1
2496261|NCT01994291|8630449|P3|Overall Study|Does not meet entrance criteria|0
2496262|NCT01994291|8630450|P2|Overall Study|Does not meet entrance criteria|0
2496263|NCT01994291|8630451|P1|Overall Study|Does not meet entrance criteria|1
2496264|NCT01994291|8630449|P3|Overall Study|Lost to Follow-up|0
2496265|NCT01994291|8630450|P2|Overall Study|Lost to Follow-up|1
2496266|NCT01994291|8630451|P1|Overall Study|Lost to Follow-up|1
2496267|NCT01994291|8630449|P3|Overall Study|Adverse Event|3
2496268|NCT01994291|8630450|P2|Overall Study|Adverse Event|1
2496269|NCT01994291|8630451|P1|Overall Study|Adverse Event|4
2496270|NCT01994226|8630507|P2|Overall Study|Early Cessation of treatment|11
2496271|NCT01994226|8630508|P1|Overall Study|Early Cessation of treatment|6
2496272|NCT01994226|8630507|P2|Overall Study|Protocol Violation|10
2496273|NCT01994226|8630508|P1|Overall Study|Protocol Violation|13
2496274|NCT01993940|8630534|P2|Overall Study|Other - Miscellaneous|1
2496275|NCT01993940|8630535|P1|Overall Study|Other - Miscellaneous|1
2496276|NCT01993940|8630534|P2|Overall Study|Death|0
2496277|NCT01993940|8630535|P1|Overall Study|Death|1
2496278|NCT01993940|8630534|P2|Overall Study|Protocol Violation|8
2496279|NCT01993940|8630535|P1|Overall Study|Protocol Violation|5
2496280|NCT01993940|8630534|P2|Overall Study|Lost to Follow-up|5
2496281|NCT01993940|8630535|P1|Overall Study|Lost to Follow-up|2
2496282|NCT01993940|8630534|P2|Overall Study|Withdrawal by Subject|19
2496283|NCT01993940|8630535|P1|Overall Study|Withdrawal by Subject|15
2496284|NCT01993940|8630534|P2|Overall Study|Adverse Event|11
2496285|NCT01993940|8630535|P1|Overall Study|Adverse Event|16
2496286|NCT01993927|8630549|P1|Overall Study|Protocol Violation|11
2496287|NCT01993927|8630549|P1|Overall Study|Case Report Forms Uncollected|18
2496288|NCT01993888|8630557|P2|Overall Study|Withdrawal by Subject|1
2496289|NCT01993888|8630558|P1|Overall Study|Withdrawal by Subject|0
2496290|NCT01993888|8630557|P2|Overall Study|Lost to Follow-up|1
2496291|NCT01993888|8630558|P1|Overall Study|Lost to Follow-up|1
2496292|NCT01993888|8630557|P2|Overall Study|Death|1
2496293|NCT01993888|8630558|P1|Overall Study|Death|1
2496294|NCT01993823|8630606|P2|Overall Study|Lost to Follow-up|4
2496295|NCT01993823|8630607|P1|Overall Study|Lost to Follow-up|1
2496296|NCT01993823|8630606|P2|Overall Study|Protocol Violation|1
2496297|NCT01993823|8630607|P1|Overall Study|Protocol Violation|0
2496298|NCT01993823|8630606|P2|Overall Study|Requested by the patient|11
2496299|NCT01993823|8630607|P1|Overall Study|Requested by the patient|6
2496300|NCT01993667|8630617|P2|Overall Study|Lost to Follow-up|2
2496301|NCT01993667|8630618|P1|Overall Study|Lost to Follow-up|2
2496302|NCT01993667|8630617|P2|Overall Study|Insufficient altitude reached|1
2496303|NCT01993667|8630618|P1|Overall Study|Insufficient altitude reached|3
2496304|NCT01993667|8630617|P2|Overall Study|Insufficient data to analyze|16
2496305|NCT01993667|8630618|P1|Overall Study|Insufficient data to analyze|16
2496306|NCT01993030|8630665|P2|Overall Study|Adverse Event|4
2496307|NCT01993030|8630666|P1|Overall Study|Adverse Event|0
2496308|NCT01993017|8630683|P3|Overall Study|Ineligible after randomization|5
2496309|NCT01993017|8630684|P2|Overall Study|Ineligible after randomization|5
2496310|NCT01993017|8630685|P1|Overall Study|Ineligible after randomization|4
2496311|NCT01993017|8630683|P3|Overall Study|Other reasons|7
2496312|NCT01993017|8630684|P2|Overall Study|Other reasons|11
2496313|NCT01993017|8630685|P1|Overall Study|Other reasons|17
2496314|NCT01993017|8630683|P3|Overall Study|Dropped out|11
2496315|NCT01993017|8630684|P2|Overall Study|Dropped out|6
2496316|NCT01993017|8630685|P1|Overall Study|Dropped out|19
2496317|NCT01993017|8630683|P3|Overall Study|Could not be contacted|38
2496318|NCT01993017|8630684|P2|Overall Study|Could not be contacted|42
2496319|NCT01993017|8630685|P1|Overall Study|Could not be contacted|43
2496320|NCT01993017|8630683|P3|Overall Study|Death|18
2496321|NCT01993017|8630684|P2|Overall Study|Death|26
2496322|NCT01993017|8630685|P1|Overall Study|Death|23
2496323|NCT01992757|8630726|P1|Overall Study|2 patients excluded due to FFP given.|2
2496324|NCT01992653|8630739|P8|Overall Study|Disease Progression|0
2496325|NCT01992653|8630740|P7|Overall Study|Disease Progression|4
2496326|NCT01992653|8630741|P6|Overall Study|Disease Progression|0
2496327|NCT01992653|8630742|P5|Overall Study|Disease Progression|0
2496328|NCT01992653|8630743|P4|Overall Study|Disease Progression|0
2496329|NCT01992653|8630744|P3|Overall Study|Disease Progression|0
2496330|NCT01992653|8630745|P2|Overall Study|Disease Progression|0
2496331|NCT01992653|8630746|P1|Overall Study|Disease Progression|0
2496332|NCT01992653|8630739|P8|Overall Study|Study Completed|1
2496333|NCT01992653|8630740|P7|Overall Study|Study Completed|0
2496334|NCT01992653|8630741|P6|Overall Study|Study Completed|0
2496335|NCT01992653|8630742|P5|Overall Study|Study Completed|0
2496336|NCT01992653|8630743|P4|Overall Study|Study Completed|0
2496337|NCT01992653|8630744|P3|Overall Study|Study Completed|0
2496338|NCT01992653|8630745|P2|Overall Study|Study Completed|0
2496339|NCT01992653|8630746|P1|Overall Study|Study Completed|0
2496340|NCT01992653|8630739|P8|Overall Study|Lost to Follow-up|1
2496341|NCT01992653|8630740|P7|Overall Study|Lost to Follow-up|0
2496342|NCT01992653|8630741|P6|Overall Study|Lost to Follow-up|0
2496343|NCT01992653|8630742|P5|Overall Study|Lost to Follow-up|0
2496344|NCT01992653|8630743|P4|Overall Study|Lost to Follow-up|0
2496345|NCT01992653|8630744|P3|Overall Study|Lost to Follow-up|0
2496346|NCT01992653|8630745|P2|Overall Study|Lost to Follow-up|0
2496347|NCT01992653|8630746|P1|Overall Study|Lost to Follow-up|0
2496348|NCT01992653|8630739|P8|Overall Study|Death|2
2496349|NCT01992653|8630740|P7|Overall Study|Death|4
2496350|NCT01992653|8630741|P6|Overall Study|Death|0
2496351|NCT01992653|8630742|P5|Overall Study|Death|1
2496352|NCT01992653|8630743|P4|Overall Study|Death|0
2496353|NCT01992653|8630744|P3|Overall Study|Death|1
2496354|NCT01992653|8630745|P2|Overall Study|Death|0
2496355|NCT01992653|8630746|P1|Overall Study|Death|0
2496356|NCT01992549|8630972|P1|Overall Study|Product Switch to Extend Half Life|1
2496357|NCT01992549|8630972|P1|Overall Study|Serious Adverse Event|1
2496358|NCT01992549|8630972|P1|Overall Study|Lost to Follow-up|2
2496359|NCT01992536|8630992|P10|Overall Study|Withdrawal by Subject|0
2496360|NCT01992536|8630993|P9|Overall Study|Withdrawal by Subject|0
2496361|NCT01992536|8630994|P8|Overall Study|Withdrawal by Subject|0
2496362|NCT01992536|8630995|P7|Overall Study|Withdrawal by Subject|0
2496363|NCT01992536|8630996|P6|Overall Study|Withdrawal by Subject|0
2496364|NCT01992536|8630997|P5|Overall Study|Withdrawal by Subject|0
2496365|NCT01992536|8630998|P4|Overall Study|Withdrawal by Subject|2
2496366|NCT01992536|8630999|P3|Overall Study|Withdrawal by Subject|0
2496367|NCT01992536|8631000|P2|Overall Study|Withdrawal by Subject|1
2496368|NCT01992536|8631001|P1|Overall Study|Withdrawal by Subject|0
2496369|NCT01992536|8630992|P10|Overall Study|Lost to Follow-up|1
2496370|NCT01992536|8630993|P9|Overall Study|Lost to Follow-up|1
2496371|NCT01992536|8630994|P8|Overall Study|Lost to Follow-up|0
2496372|NCT01992536|8630995|P7|Overall Study|Lost to Follow-up|0
2496373|NCT01992536|8630996|P6|Overall Study|Lost to Follow-up|1
2496374|NCT01992536|8630997|P5|Overall Study|Lost to Follow-up|0
2496375|NCT01992536|8630998|P4|Overall Study|Lost to Follow-up|0
2496376|NCT01992536|8630999|P3|Overall Study|Lost to Follow-up|1
2496377|NCT01992536|8631000|P2|Overall Study|Lost to Follow-up|2
2496378|NCT01992536|8631001|P1|Overall Study|Lost to Follow-up|4
2496379|NCT01992536|8630992|P10|Overall Study|Administrative Reason|0
2496380|NCT01992536|8630993|P9|Overall Study|Administrative Reason|0
2496381|NCT01992536|8630994|P8|Overall Study|Administrative Reason|0
2496382|NCT01992536|8630995|P7|Overall Study|Administrative Reason|7
2496383|NCT01992536|8630996|P6|Overall Study|Administrative Reason|0
2496384|NCT01992536|8630997|P5|Overall Study|Administrative Reason|0
2496385|NCT01992536|8630998|P4|Overall Study|Administrative Reason|0
2496386|NCT01992536|8630999|P3|Overall Study|Administrative Reason|0
2496387|NCT01992536|8631000|P2|Overall Study|Administrative Reason|0
2496388|NCT01992536|8631001|P1|Overall Study|Administrative Reason|0
2496389|NCT01992159|8631258|P4|Overall Study|Death|0
2496390|NCT01992159|8631259|P3|Overall Study|Death|1
2496391|NCT01992159|8631260|P2|Overall Study|Death|0
2496392|NCT01992159|8631261|P1|Overall Study|Death|0
2496393|NCT01992159|8631258|P4|Overall Study|Adverse Event|1
2496394|NCT01992159|8631259|P3|Overall Study|Adverse Event|0
2496395|NCT01992159|8631260|P2|Overall Study|Adverse Event|1
2496396|NCT01992159|8631261|P1|Overall Study|Adverse Event|0
2496397|NCT01992159|8631258|P4|Overall Study|Withdrawal by Subject|3
2496398|NCT01992159|8631259|P3|Overall Study|Withdrawal by Subject|0
2496399|NCT01992159|8631260|P2|Overall Study|Withdrawal by Subject|7
2496400|NCT01992159|8631261|P1|Overall Study|Withdrawal by Subject|4
2496401|NCT01992107|8631314|P3|Overall Study|Withdrawal by Subject|8
2496402|NCT01992107|8631315|P2|Overall Study|Withdrawal by Subject|7
2496403|NCT01992107|8631316|P1|Overall Study|Withdrawal by Subject|13
2496404|NCT01992107|8631314|P3|Overall Study|noncompliance and were unavailable|2
2496405|NCT01992107|8631315|P2|Overall Study|noncompliance and were unavailable|3
2496406|NCT01992107|8631316|P1|Overall Study|noncompliance and were unavailable|7
2496407|NCT01992107|8631314|P3|Overall Study|Lost to Follow-up|26
2496408|NCT01992107|8631315|P2|Overall Study|Lost to Follow-up|22
2496409|NCT01992107|8631316|P1|Overall Study|Lost to Follow-up|46
2496410|NCT01992107|8631314|P3|Overall Study|Adverse Event|0
2496411|NCT01992107|8631315|P2|Overall Study|Adverse Event|1
2496412|NCT01992107|8631316|P1|Overall Study|Adverse Event|0
2496413|NCT01992107|8631314|P3|Overall Study|Administrative reasons|0
2496414|NCT01992107|8631315|P2|Overall Study|Administrative reasons|0
2496415|NCT01992107|8631316|P1|Overall Study|Administrative reasons|2
2496416|NCT01992094|8631372|P3|Overall Study|Withdrawal by Subject|4
2496417|NCT01992094|8631373|P2|Overall Study|Withdrawal by Subject|3
2496418|NCT01992094|8631374|P1|Overall Study|Withdrawal by Subject|7
2496419|NCT01992094|8631372|P3|Overall Study|Protocol Violation|1
2496420|NCT01992094|8631373|P2|Overall Study|Protocol Violation|0
2496421|NCT01992094|8631374|P1|Overall Study|Protocol Violation|1
2496422|NCT01992094|8631372|P3|Overall Study|OTHER|0
2496423|NCT01992094|8631373|P2|Overall Study|OTHER|0
2496424|NCT01992094|8631374|P1|Overall Study|OTHER|4
2496425|NCT01992094|8631372|P3|Overall Study|Lost to Follow-up|13
2496426|NCT01992094|8631373|P2|Overall Study|Lost to Follow-up|9
2496427|NCT01992094|8631374|P1|Overall Study|Lost to Follow-up|26
2496428|NCT01992094|8631372|P3|Overall Study|Death|2
2496429|NCT01992094|8631373|P2|Overall Study|Death|5
2496430|NCT01992094|8631374|P1|Overall Study|Death|5
2496431|NCT01992094|8631372|P3|Overall Study|Adverse Event|0
2496432|NCT01992094|8631373|P2|Overall Study|Adverse Event|0
2496433|NCT01992094|8631374|P1|Overall Study|Adverse Event|1
2496434|NCT01992094|8631372|P3|Overall Study|ADMINISTRATIVE REASON|1
2496435|NCT01992094|8631373|P2|Overall Study|ADMINISTRATIVE REASON|7
2496436|NCT01992094|8631374|P1|Overall Study|ADMINISTRATIVE REASON|6
2496437|NCT01991977|8631482|P1|Overall Study|Withdrew after start of treatment|5
2496438|NCT01991977|8631482|P1|Overall Study|Withdrew prior to receiving treatment|7
2496439|NCT01991795|8631534|P2|Overall Study|Site prematurely closed by sponsor|25
2496440|NCT01991795|8631535|P1|Overall Study|Site prematurely closed by sponsor|26
2496441|NCT01991795|8631534|P2|Overall Study|Withdrawal by Subject|94
2496442|NCT01991795|8631535|P1|Overall Study|Withdrawal by Subject|117
2496443|NCT01991795|8631534|P2|Overall Study|Lost to Follow-up|4
2496444|NCT01991795|8631535|P1|Overall Study|Lost to Follow-up|6
2496445|NCT01991743|8631561|P4|Overall Study|external cephalic version not performed|0
2496446|NCT01991743|8631562|P3|Overall Study|external cephalic version not performed|1
2496447|NCT01991743|8631563|P2|Overall Study|external cephalic version not performed|0
2496448|NCT01991743|8631564|P1|Overall Study|external cephalic version not performed|0
2496449|NCT01991483|8631609|P4|Dose Level 1000 mg|Protocol Violation|1
2496450|NCT01991483|8631610|P3|Dose Level 1000 mg|Protocol Violation|0
2496451|NCT01991483|8631611|P2|Dose Level 1000 mg|Protocol Violation|0
2496452|NCT01991483|8631612|P1|Dose Level 1000 mg|Protocol Violation|0
2496453|NCT01991483|8631609|P4|Dose Level 600 mg|Physician Decision|0
2496454|NCT01991483|8631610|P3|Dose Level 600 mg|Physician Decision|1
2496455|NCT01991483|8631611|P2|Dose Level 600 mg|Physician Decision|0
2496456|NCT01991483|8631612|P1|Dose Level 600 mg|Physician Decision|0
2496457|NCT01991483|8631609|P4|Dose Level 600 mg|Withdrawal by Subject|0
2496458|NCT01991483|8631610|P3|Dose Level 600 mg|Withdrawal by Subject|1
2496459|NCT01991483|8631611|P2|Dose Level 600 mg|Withdrawal by Subject|0
2496460|NCT01991483|8631612|P1|Dose Level 600 mg|Withdrawal by Subject|0
2496461|NCT01991470|8631678|P1|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1
2496462|NCT01991470|8631678|P1|Enlite 3 Period|Physician Decision|8
2496463|NCT01991470|8631678|P1|Enlite 3 Period|Physician Decision|2
2496464|NCT01991470|8631678|P1|Enlite 3 Period|Lost to Follow-up|1
2496465|NCT01991470|8631678|P1|Enlite 1 Period|Inclusion/Exclusion not met|1
2496466|NCT01991470|8631678|P1|Enlite 1 Period|Adverse Event|1
2496467|NCT01991470|8631678|P1|Enlite 1 Period|Withdrawal by Subject|18
2496468|NCT01991314|8631692|P2|Overall Study|Lost to Follow-up|10
2496469|NCT01991314|8631693|P1|Overall Study|Lost to Follow-up|6
2496470|NCT01991314|8631692|P2|Overall Study|Adverse Event|1
2496471|NCT01991314|8631693|P1|Overall Study|Adverse Event|5
2496472|NCT01990859|8631715|P1|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17
2496473|NCT01990859|8631715|P1|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5
2496474|NCT01990768|8631850|P3|6-Month Follow-up|Patient at psychiatric hospital|0
2496475|NCT01990768|8631851|P2|6-Month Follow-up|Patient at psychiatric hospital|0
2496476|NCT01990768|8631852|P1|6-Month Follow-up|Patient at psychiatric hospital|1
2496477|NCT01990768|8631850|P3|6-Month Follow-up|Prisoner at time of follow-up|0
2496478|NCT01990768|8631851|P2|6-Month Follow-up|Prisoner at time of follow-up|2
2496479|NCT01990768|8631852|P1|6-Month Follow-up|Prisoner at time of follow-up|0
2496480|NCT01990768|8631850|P3|6-Month Follow-up|Prisoner at time of enrollment|1
2496481|NCT01990768|8631851|P2|6-Month Follow-up|Prisoner at time of enrollment|0
2496482|NCT01990768|8631852|P1|6-Month Follow-up|Prisoner at time of enrollment|0
2496483|NCT01990768|8631850|P3|6-Month Follow-up|Homeless|6
2496484|NCT01990768|8631851|P2|6-Month Follow-up|Homeless|3
2496485|NCT01990768|8631852|P1|6-Month Follow-up|Homeless|4
2496486|NCT01990768|8631850|P3|6-Month Follow-up|No contact information|5
2496487|NCT01990768|8631851|P2|6-Month Follow-up|No contact information|6
2496488|NCT01990768|8631852|P1|6-Month Follow-up|No contact information|5
2496489|NCT01990768|8631850|P3|6-Month Follow-up|Calls unreturned or refused contact|20
2496490|NCT01990768|8631851|P2|6-Month Follow-up|Calls unreturned or refused contact|15
2496491|NCT01990768|8631852|P1|6-Month Follow-up|Calls unreturned or refused contact|4
2496492|NCT01990768|8631850|P3|6-Month Follow-up|Withdrawal by Subject|26
2496493|NCT01990768|8631851|P2|6-Month Follow-up|Withdrawal by Subject|25
2496494|NCT01990768|8631852|P1|6-Month Follow-up|Withdrawal by Subject|25
2496495|NCT01990768|8631850|P3|In-Hospital Study Drug Infusion|Unknown if completed|1
2496496|NCT01990768|8631851|P2|In-Hospital Study Drug Infusion|Unknown if completed|0
2496497|NCT01990768|8631852|P1|In-Hospital Study Drug Infusion|Unknown if completed|0
2496498|NCT01990768|8631850|P3|In-Hospital Study Drug Infusion|Other procoagulant administered|2
2496499|NCT01990768|8631851|P2|In-Hospital Study Drug Infusion|Other procoagulant administered|1
2496500|NCT01990768|8631852|P1|In-Hospital Study Drug Infusion|Other procoagulant administered|0
2496501|NCT01990768|8631850|P3|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0
2496502|NCT01990768|8631851|P2|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1
2496503|NCT01990768|8631852|P1|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1
2496504|NCT01990768|8631850|P3|In-Hospital Study Drug Infusion|Found not to be injured|1
2496505|NCT01990768|8631851|P2|In-Hospital Study Drug Infusion|Found not to be injured|1
2496506|NCT01990768|8631852|P1|In-Hospital Study Drug Infusion|Found not to be injured|1
2496507|NCT01990768|8631850|P3|In-Hospital Study Drug Infusion|Taken into police custody|3
2496508|NCT01990768|8631851|P2|In-Hospital Study Drug Infusion|Taken into police custody|0
2496509|NCT01990768|8631852|P1|In-Hospital Study Drug Infusion|Taken into police custody|4
2496510|NCT01990768|8631850|P3|In-Hospital Study Drug Infusion|Other safety concern|3
2496511|NCT01990768|8631851|P2|In-Hospital Study Drug Infusion|Other safety concern|2
2496512|NCT01990768|8631852|P1|In-Hospital Study Drug Infusion|Other safety concern|4
2496513|NCT01990768|8631850|P3|In-Hospital Study Drug Infusion|Required CPR|1
2496514|NCT01990768|8631851|P2|In-Hospital Study Drug Infusion|Required CPR|7
2496515|NCT01990768|8631852|P1|In-Hospital Study Drug Infusion|Required CPR|3
2496516|NCT01990768|8631850|P3|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4
2496517|NCT01990768|8631851|P2|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5
2496518|NCT01990768|8631852|P1|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5
2496519|NCT01990768|8631850|P3|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17
2496520|NCT01990768|8631851|P2|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9
2496521|NCT01990768|8631852|P1|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8
2496522|NCT01990768|8631850|P3|In-Hospital Study Drug Infusion|Emergency unblinding|7
2496523|NCT01990768|8631851|P2|In-Hospital Study Drug Infusion|Emergency unblinding|4
2496524|NCT01990768|8631852|P1|In-Hospital Study Drug Infusion|Emergency unblinding|11
2496525|NCT01990768|8631850|P3|In-Hospital Study Drug Infusion|Death or comfort care|6
2496526|NCT01990768|8631851|P2|In-Hospital Study Drug Infusion|Death or comfort care|11
2496527|NCT01990768|8631852|P1|In-Hospital Study Drug Infusion|Death or comfort care|12
2496528|NCT01990768|8631850|P3|In-Hospital Study Drug Infusion|Withdrawal by Subject|12
2496529|NCT01990768|8631851|P2|In-Hospital Study Drug Infusion|Withdrawal by Subject|7
2496530|NCT01990768|8631852|P1|In-Hospital Study Drug Infusion|Withdrawal by Subject|13
2496531|NCT01990768|8631850|P3|In-Hospital Study Drug Infusion|Protocol non-compliance|10
2496532|NCT01990768|8631851|P2|In-Hospital Study Drug Infusion|Protocol non-compliance|17
2496533|NCT01990768|8631852|P1|In-Hospital Study Drug Infusion|Protocol non-compliance|14
2496534|NCT01990768|8631850|P3|In-Hospital Study Drug Infusion|Discharged|13
2496535|NCT01990768|8631851|P2|In-Hospital Study Drug Infusion|Discharged|18
2496536|NCT01990768|8631852|P1|In-Hospital Study Drug Infusion|Discharged|19
2496537|NCT01990768|8631850|P3|Prehospital Study Drug Infusion|Unknown if completed|2
2496538|NCT01990768|8631851|P2|Prehospital Study Drug Infusion|Unknown if completed|4
2496539|NCT01990768|8631852|P1|Prehospital Study Drug Infusion|Unknown if completed|1
2496540|NCT01990768|8631850|P3|Prehospital Study Drug Infusion|Emergency unblinding|1
2496541|NCT01990768|8631851|P2|Prehospital Study Drug Infusion|Emergency unblinding|0
2496542|NCT01990768|8631852|P1|Prehospital Study Drug Infusion|Emergency unblinding|0
2496543|NCT01990768|8631850|P3|Prehospital Study Drug Infusion|Withdrawal by Subject|0
2496544|NCT01990768|8631851|P2|Prehospital Study Drug Infusion|Withdrawal by Subject|0
2496545|NCT01990768|8631852|P1|Prehospital Study Drug Infusion|Withdrawal by Subject|1
2496546|NCT01990768|8631850|P3|Prehospital Study Drug Infusion|Discharged|0
2496547|NCT01990768|8631851|P2|Prehospital Study Drug Infusion|Discharged|1
2496548|NCT01990768|8631852|P1|Prehospital Study Drug Infusion|Discharged|2
2496549|NCT01990768|8631850|P3|Prehospital Study Drug Infusion|Death|1
2496550|NCT01990768|8631851|P2|Prehospital Study Drug Infusion|Death|1
2496551|NCT01990768|8631852|P1|Prehospital Study Drug Infusion|Death|3
2496552|NCT01990768|8631850|P3|Prehospital Study Drug Infusion|Other safety concern|1
2496553|NCT01990768|8631851|P2|Prehospital Study Drug Infusion|Other safety concern|1
2496554|NCT01990768|8631852|P1|Prehospital Study Drug Infusion|Other safety concern|2
2496555|NCT01990768|8631850|P3|Prehospital Study Drug Infusion|Required CPR|0
2496556|NCT01990768|8631851|P2|Prehospital Study Drug Infusion|Required CPR|6
2496557|NCT01990768|8631852|P1|Prehospital Study Drug Infusion|Required CPR|2
2496558|NCT01990768|8631850|P3|Prehospital Study Drug Infusion|Seizure or concern for seizure|4
2496559|NCT01990768|8631851|P2|Prehospital Study Drug Infusion|Seizure or concern for seizure|3
2496560|NCT01990768|8631852|P1|Prehospital Study Drug Infusion|Seizure or concern for seizure|4
2496561|NCT01990768|8631850|P3|Prehospital Study Drug Infusion|Protocol non-compliance|10
2496562|NCT01990768|8631851|P2|Prehospital Study Drug Infusion|Protocol non-compliance|11
2496563|NCT01990768|8631852|P1|Prehospital Study Drug Infusion|Protocol non-compliance|4
2496564|NCT01990768|8631850|P3|Intervention Started|Discovered to be pregnant|0
2496565|NCT01990768|8631851|P2|Intervention Started|Discovered to be pregnant|1
2496566|NCT01990768|8631852|P1|Intervention Started|Discovered to be pregnant|0
2496567|NCT01990768|8631850|P3|Intervention Started|Seizure or hx of seizure|2
2496568|NCT01990768|8631851|P2|Intervention Started|Seizure or hx of seizure|0
2496569|NCT01990768|8631852|P1|Intervention Started|Seizure or hx of seizure|0
2496570|NCT01990768|8631850|P3|Intervention Started|Required CPR|0
2496571|NCT01990768|8631851|P2|Intervention Started|Required CPR|1
2496572|NCT01990768|8631852|P1|Intervention Started|Required CPR|1
2496573|NCT01990768|8631850|P3|Intervention Started|IV lost|2
2496574|NCT01990768|8631851|P2|Intervention Started|IV lost|2
2496575|NCT01990768|8631852|P1|Intervention Started|IV lost|2
2496576|NCT01990768|8631850|P3|Intervention Started|Patient care priority|3
2496577|NCT01990768|8631851|P2|Intervention Started|Patient care priority|2
2496578|NCT01990768|8631852|P1|Intervention Started|Patient care priority|1
2496579|NCT01990768|8631850|P3|Intervention Started|Not enough time for EMS to enroll|0
2496580|NCT01990768|8631851|P2|Intervention Started|Not enough time for EMS to enroll|3
2496581|NCT01990768|8631852|P1|Intervention Started|Not enough time for EMS to enroll|4
2496582|NCT01990768|8631850|P3|Intervention Started|Patient became ineligible due to vitals|2
2496583|NCT01990768|8631851|P2|Intervention Started|Patient became ineligible due to vitals|5
2496584|NCT01990768|8631852|P1|Intervention Started|Patient became ineligible due to vitals|5
2496585|NCT01990768|8631850|P3|Intervention Started|Study drug issue or kit malfunction|7
2496586|NCT01990768|8631851|P2|Intervention Started|Study drug issue or kit malfunction|6
2496587|NCT01990768|8631852|P1|Intervention Started|Study drug issue or kit malfunction|9
2496588|NCT01990768|8631850|P3|Intervention Started|Found to be ineligible|11
2496589|NCT01990768|8631851|P2|Intervention Started|Found to be ineligible|13
2496590|NCT01990768|8631852|P1|Intervention Started|Found to be ineligible|14
2496591|NCT01990742|8631917|P2|Overall Study|Facility closed|270
2496592|NCT01990742|8631918|P1|Overall Study|Facility closed|0
2496593|NCT01990742|8631917|P2|Overall Study|Withdrawal by facility|1083
2496594|NCT01990742|8631918|P1|Overall Study|Withdrawal by facility|407
2496595|NCT01990664|8631954|P2|Overall Study|Unsatisfactory Visual Response|1
2496596|NCT01990664|8631955|P1|Overall Study|Unsatisfactory Visual Response|0
2496597|NCT01990664|8631954|P2|Overall Study|Lens Handling Difficulties|0
2496598|NCT01990664|8631955|P1|Overall Study|Lens Handling Difficulties|1
2496599|NCT01990664|8631954|P2|Overall Study|Lens Discomfort|1
2496600|NCT01990664|8631955|P1|Overall Study|Lens Discomfort|1
2496601|NCT01990664|8631954|P2|Overall Study|Protocol Violation|0
2496602|NCT01990664|8631955|P1|Overall Study|Protocol Violation|1
2496603|NCT01990664|8631954|P2|Overall Study|Withdrawal by Subject|3
2496604|NCT01990664|8631955|P1|Overall Study|Withdrawal by Subject|2
2496605|NCT01990664|8631954|P2|Overall Study|Lost to Follow-up|6
2496606|NCT01990664|8631955|P1|Overall Study|Lost to Follow-up|2
2496607|NCT01990612|8631963|P2|Overall Study|Withdrawal by Subject|2
2496608|NCT01990612|8631964|P1|Overall Study|Withdrawal by Subject|5
2496609|NCT01990612|8631963|P2|Overall Study|Lost to Follow-up|1
2496610|NCT01990612|8631964|P1|Overall Study|Lost to Follow-up|2
2496611|NCT01990573|8632045|P3|Overall Study|Physician Decision|1
2496612|NCT01990573|8632046|P2|Overall Study|Physician Decision|0
2496613|NCT01990573|8632047|P1|Overall Study|Physician Decision|0
2496614|NCT01990560|8632060|P1|Overall Study|Withdrawal by Subject|1
2496615|NCT01990534|8632074|P1|Overall Study|Overall Survival Follow-up|25
2496616|NCT01990534|8632074|P1|Overall Study|Progression Free Survival Follow-up|11
2496617|NCT01990534|8632074|P1|Overall Study|Reason Not Specified|2
2496618|NCT01990534|8632074|P1|Overall Study|Withdrawal by Subject|3
2496619|NCT01990534|8632074|P1|Overall Study|Symptomatic Deterioration|1
2496620|NCT01990534|8632074|P1|Overall Study|Withdrawal of Informed Consent|2
2496621|NCT01990534|8632074|P1|Overall Study|Protocol Violation|1
2496622|NCT01990534|8632074|P1|Overall Study|Progressive disease|3
2496623|NCT01990534|8632074|P1|Overall Study|Death|12
2496624|NCT01990339|8632090|P1|Overall Study|Lost to Follow-up|861
2496625|NCT01990339|8632090|P1|Overall Study|Voluntary Withdrawal|1402
2496626|NCT01990339|8632090|P1|Overall Study|Data Not Available|49
2496627|NCT01990313|8632095|P1|Overall Study|Lost to Follow-up|1
2496628|NCT01990300|8632100|P1|Overall Study|Protocol Deviation|53
2496629|NCT01990300|8632100|P1|Overall Study|Case Report Forms Uncollected|89
2496630|NCT01990261|8632106|P1|Overall Study|Lost to Follow-up|2
2496631|NCT01990261|8632106|P1|Overall Study|Dossier not Approved|1
2496632|NCT01990261|8632106|P1|Overall Study|PD Before Treatment Start|1
2496633|NCT01990261|8632106|P1|Overall Study|Disease Progression (PD)|8
2496634|NCT01990261|8632106|P1|Overall Study|Death From other Causes|1
2496635|NCT01990261|8632106|P1|Overall Study|Death due to Disease Progression (PD)|10
2496636|NCT01990261|8632106|P1|Overall Study|Death Before Treatment Start|2
2496637|NCT01989754|8632163|P2|Overall Study|Closed Site|1
2496638|NCT01989754|8632164|P1|Overall Study|Closed Site|1
2496639|NCT01989754|8632163|P2|Overall Study|Lost to Follow-up|20
2496640|NCT01989754|8632164|P1|Overall Study|Lost to Follow-up|28
2496641|NCT01989754|8632163|P2|Overall Study|Withdrawal by Subject|14
2496642|NCT01989754|8632164|P1|Overall Study|Withdrawal by Subject|10
2496643|NCT01989689|8632176|P2|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1
2496644|NCT01989689|8632177|P1|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0
2496645|NCT01989689|8632176|P2|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2
2496646|NCT01989689|8632177|P1|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0
2496647|NCT01989676|8632189|P2|Overall Study|Discontinued|68
2496648|NCT01989676|8632190|P1|Overall Study|Discontinued|59
2496649|NCT01989676|8632189|P2|Overall Study|Ongoing at data cutoff|279
2496650|NCT01989676|8632190|P1|Overall Study|Ongoing at data cutoff|279
2496651|NCT01989572|8632216|P6|Overall Study|alternative therapy|3
2496652|NCT01989572|8632217|P5|Overall Study|alternative therapy|1
2496653|NCT01989572|8632218|P4|Overall Study|alternative therapy|0
2496654|NCT01989572|8632219|P3|Overall Study|alternative therapy|0
2496655|NCT01989572|8632220|P2|Overall Study|alternative therapy|0
2496656|NCT01989572|8632221|P1|Overall Study|alternative therapy|3
2496657|NCT01989572|8632216|P6|Overall Study|not start protocol therapy|18
2496658|NCT01989572|8632217|P5|Overall Study|not start protocol therapy|4
2496659|NCT01989572|8632218|P4|Overall Study|not start protocol therapy|3
2496660|NCT01989572|8632219|P3|Overall Study|not start protocol therapy|2
2496661|NCT01989572|8632220|P2|Overall Study|not start protocol therapy|1
2496662|NCT01989572|8632221|P1|Overall Study|not start protocol therapy|5
2496663|NCT01989572|8632216|P6|Overall Study|unknown/not specify|5
2496664|NCT01989572|8632217|P5|Overall Study|unknown/not specify|3
2496665|NCT01989572|8632218|P4|Overall Study|unknown/not specify|3
2496666|NCT01989572|8632219|P3|Overall Study|unknown/not specify|1
2496667|NCT01989572|8632220|P2|Overall Study|unknown/not specify|4
2496668|NCT01989572|8632221|P1|Overall Study|unknown/not specify|3
2496669|NCT01989572|8632216|P6|Overall Study|maximum dose reached|0
2496670|NCT01989572|8632217|P5|Overall Study|maximum dose reached|1
2496671|NCT01989572|8632218|P4|Overall Study|maximum dose reached|0
2496672|NCT01989572|8632219|P3|Overall Study|maximum dose reached|0
2496673|NCT01989572|8632220|P2|Overall Study|maximum dose reached|1
2496674|NCT01989572|8632221|P1|Overall Study|maximum dose reached|0
2496675|NCT01989572|8632216|P6|Overall Study|error|1
2496676|NCT01989572|8632217|P5|Overall Study|error|1
2496677|NCT01989572|8632218|P4|Overall Study|error|1
2496678|NCT01989572|8632219|P3|Overall Study|error|1
2496679|NCT01989572|8632220|P2|Overall Study|error|1
2496680|NCT01989572|8632221|P1|Overall Study|error|2
2496681|NCT01989572|8632216|P6|Overall Study|complicating disease|0
2496682|NCT01989572|8632217|P5|Overall Study|complicating disease|1
2496683|NCT01989572|8632218|P4|Overall Study|complicating disease|0
2496684|NCT01989572|8632219|P3|Overall Study|complicating disease|2
2496685|NCT01989572|8632220|P2|Overall Study|complicating disease|1
2496686|NCT01989572|8632221|P1|Overall Study|complicating disease|1
2496687|NCT01989572|8632216|P6|Overall Study|Withdrawal by Subject|4
2496688|NCT01989572|8632217|P5|Overall Study|Withdrawal by Subject|12
2496689|NCT01989572|8632218|P4|Overall Study|Withdrawal by Subject|1
2496690|NCT01989572|8632219|P3|Overall Study|Withdrawal by Subject|5
2496691|NCT01989572|8632220|P2|Overall Study|Withdrawal by Subject|1
2496692|NCT01989572|8632221|P1|Overall Study|Withdrawal by Subject|4
2496693|NCT01989572|8632216|P6|Overall Study|Death|0
2496694|NCT01989572|8632217|P5|Overall Study|Death|1
2496695|NCT01989572|8632218|P4|Overall Study|Death|0
2496696|NCT01989572|8632219|P3|Overall Study|Death|0
2496697|NCT01989572|8632220|P2|Overall Study|Death|0
2496698|NCT01989572|8632221|P1|Overall Study|Death|0
2496699|NCT01989572|8632216|P6|Overall Study|Adverse Event|0
2496700|NCT01989572|8632217|P5|Overall Study|Adverse Event|3
2496701|NCT01989572|8632218|P4|Overall Study|Adverse Event|0
2496702|NCT01989572|8632219|P3|Overall Study|Adverse Event|3
2496703|NCT01989572|8632220|P2|Overall Study|Adverse Event|1
2496704|NCT01989572|8632221|P1|Overall Study|Adverse Event|2
2496705|NCT01989572|8632216|P6|Overall Study|Lack of Efficacy|79
2496706|NCT01989572|8632217|P5|Overall Study|Lack of Efficacy|71
2496707|NCT01989572|8632218|P4|Overall Study|Lack of Efficacy|43
2496708|NCT01989572|8632219|P3|Overall Study|Lack of Efficacy|48
2496709|NCT01989572|8632220|P2|Overall Study|Lack of Efficacy|48
2496710|NCT01989572|8632221|P1|Overall Study|Lack of Efficacy|35
2496711|NCT01989468|8632252|P5|Overall Study|Death|0
2496712|NCT01989468|8632253|P4|Overall Study|Death|0
2496713|NCT01989468|8632254|P3|Overall Study|Death|1
2496714|NCT01989468|8632255|P2|Overall Study|Death|0
2496715|NCT01989468|8632256|P1|Overall Study|Death|3
2496716|NCT01989468|8632252|P5|Overall Study|Subject Guardian Decision|1
2496717|NCT01989468|8632253|P4|Overall Study|Subject Guardian Decision|4
2496718|NCT01989468|8632254|P3|Overall Study|Subject Guardian Decision|4
2496719|NCT01989468|8632255|P2|Overall Study|Subject Guardian Decision|6
2496720|NCT01989468|8632256|P1|Overall Study|Subject Guardian Decision|11
2496721|NCT01989468|8632252|P5|Overall Study|Technical Problems|0
2496722|NCT01989468|8632253|P4|Overall Study|Technical Problems|1
2496723|NCT01989468|8632254|P3|Overall Study|Technical Problems|3
2496724|NCT01989468|8632255|P2|Overall Study|Technical Problems|1
2496725|NCT01989468|8632256|P1|Overall Study|Technical Problems|3
2496726|NCT01989468|8632252|P5|Overall Study|Pregnancy|0
2496727|NCT01989468|8632253|P4|Overall Study|Pregnancy|0
2496728|NCT01989468|8632254|P3|Overall Study|Pregnancy|0
2496729|NCT01989468|8632255|P2|Overall Study|Pregnancy|1
2496730|NCT01989468|8632256|P1|Overall Study|Pregnancy|0
2496731|NCT01989468|8632252|P5|Overall Study|Physician Decision|0
2496732|NCT01989468|8632253|P4|Overall Study|Physician Decision|1
2496733|NCT01989468|8632254|P3|Overall Study|Physician Decision|0
2496734|NCT01989468|8632255|P2|Overall Study|Physician Decision|1
2496735|NCT01989468|8632256|P1|Overall Study|Physician Decision|4
2496736|NCT01989468|8632252|P5|Overall Study|Lost to Follow-up|1
2496737|NCT01989468|8632253|P4|Overall Study|Lost to Follow-up|1
2496738|NCT01989468|8632254|P3|Overall Study|Lost to Follow-up|0
2496739|NCT01989468|8632255|P2|Overall Study|Lost to Follow-up|2
2496740|NCT01989468|8632256|P1|Overall Study|Lost to Follow-up|5
2496741|NCT01989468|8632252|P5|Overall Study|Lack of Efficacy|2
2496742|NCT01989468|8632253|P4|Overall Study|Lack of Efficacy|4
2496743|NCT01989468|8632254|P3|Overall Study|Lack of Efficacy|7
2496744|NCT01989468|8632255|P2|Overall Study|Lack of Efficacy|11
2496745|NCT01989468|8632256|P1|Overall Study|Lack of Efficacy|11
2496746|NCT01989468|8632252|P5|Overall Study|Adverse Event|4
2496747|NCT01989468|8632253|P4|Overall Study|Adverse Event|5
2496748|NCT01989468|8632254|P3|Overall Study|Adverse Event|4
2496749|NCT01989468|8632255|P2|Overall Study|Adverse Event|15
2496750|NCT01989468|8632256|P1|Overall Study|Adverse Event|10
2496751|NCT01989455|8632298|P5|Overall Study|Technical problems with infusion|1
2496752|NCT01989455|8632299|P4|Overall Study|Technical problems with infusion|0
2496753|NCT01989455|8632300|P3|Overall Study|Technical problems with infusion|1
2496754|NCT01989455|8632301|P2|Overall Study|Technical problems with infusion|0
2496755|NCT01989455|8632302|P1|Overall Study|Technical problems with infusion|0
2496756|NCT01989455|8632298|P5|Overall Study|Withdrawal by Subject|0
2496757|NCT01989455|8632299|P4|Overall Study|Withdrawal by Subject|0
2496758|NCT01989455|8632300|P3|Overall Study|Withdrawal by Subject|0
2496759|NCT01989455|8632301|P2|Overall Study|Withdrawal by Subject|1
2496760|NCT01989455|8632302|P1|Overall Study|Withdrawal by Subject|0
2496761|NCT01989455|8632298|P5|Overall Study|Adverse Event|0
2496762|NCT01989455|8632299|P4|Overall Study|Adverse Event|0
2496763|NCT01989455|8632300|P3|Overall Study|Adverse Event|0
2496764|NCT01989455|8632301|P2|Overall Study|Adverse Event|1
2496765|NCT01989455|8632302|P1|Overall Study|Adverse Event|0
2496766|NCT01989208|8632338|P2|200 mg (7 Days)|Protocol Violation|1
2496767|NCT01989208|8632339|P1|200 mg (7 Days)|Protocol Violation|0
2496768|NCT01989169|8632367|P2|Period 2|Adverse Event|1
2496769|NCT01989169|8632368|P1|Period 2|Adverse Event|0
2496770|NCT01989156|8632381|P3|End of Study (Population at Day 90)|Employment Conflict|0
2496771|NCT01989156|8632382|P2|End of Study (Population at Day 90)|Employment Conflict|1
2496772|NCT01989156|8632383|P1|End of Study (Population at Day 90)|Employment Conflict|0
2496773|NCT01989156|8632381|P3|End of Study (Population at Day 90)|Moved out of state|0
2496774|NCT01989156|8632382|P2|End of Study (Population at Day 90)|Moved out of state|0
2496775|NCT01989156|8632383|P1|End of Study (Population at Day 90)|Moved out of state|1
2496776|NCT01989156|8632381|P3|End of Study (Population at Day 90)|Physician Decision|1
2496777|NCT01989156|8632382|P2|End of Study (Population at Day 90)|Physician Decision|0
2496778|NCT01989156|8632383|P1|End of Study (Population at Day 90)|Physician Decision|1
2496779|NCT01989156|8632381|P3|End of Study (Population at Day 90)|Lost to Follow-up|0
2496780|NCT01989156|8632382|P2|End of Study (Population at Day 90)|Lost to Follow-up|2
2496781|NCT01989156|8632383|P1|End of Study (Population at Day 90)|Lost to Follow-up|3
2496782|NCT01989156|8632381|P3|End of Study (Population at Day 90)|Withdrawal by Subject|2
2496783|NCT01989156|8632382|P2|End of Study (Population at Day 90)|Withdrawal by Subject|2
2496784|NCT01989156|8632383|P1|End of Study (Population at Day 90)|Withdrawal by Subject|2
2496785|NCT01989156|8632381|P3|Confinement Period (Population at Day 5)|Adverse Event|1
2496786|NCT01989156|8632382|P2|Confinement Period (Population at Day 5)|Adverse Event|0
2496787|NCT01989156|8632383|P1|Confinement Period (Population at Day 5)|Adverse Event|0
2496788|NCT01989156|8632381|P3|Confinement Period (Population at Day 5)|Patient Anxiety|1
2496789|NCT01989156|8632382|P2|Confinement Period (Population at Day 5)|Patient Anxiety|0
2496790|NCT01989156|8632383|P1|Confinement Period (Population at Day 5)|Patient Anxiety|0
2496791|NCT01989156|8632381|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|3
2496792|NCT01989156|8632382|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
2496793|NCT01989156|8632383|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|0
2496794|NCT01988779|8632443|P2|Overall Study|Protocol Violation|0
2496795|NCT01988779|8632444|P1|Overall Study|Protocol Violation|1
2496796|NCT01988779|8632443|P2|Overall Study|Withdrawal by Subject|2
2496797|NCT01988779|8632444|P1|Overall Study|Withdrawal by Subject|2
2496798|NCT01988662|8632460|P2|Overall Study|Adverse Event|1
2496799|NCT01988662|8632461|P1|Overall Study|Adverse Event|3
2496800|NCT01988662|8632460|P2|Overall Study|Subject/guardian decision|1
2496801|NCT01988662|8632461|P1|Overall Study|Subject/guardian decision|1
2496802|NCT01988493|8632483|P5|Overall Study|Ongoing|0
2496803|NCT01988493|8632484|P4|Overall Study|Ongoing|2
2496804|NCT01988493|8632485|P3|Overall Study|Ongoing|0
2496805|NCT01988493|8632486|P2|Overall Study|Ongoing|0
2496806|NCT01988493|8632487|P1|Overall Study|Ongoing|0
2496807|NCT01988493|8632483|P5|Overall Study|Randomized but not treated|1
2496808|NCT01988493|8632484|P4|Overall Study|Randomized but not treated|0
2496809|NCT01988493|8632485|P3|Overall Study|Randomized but not treated|0
2496810|NCT01988493|8632486|P2|Overall Study|Randomized but not treated|0
2496811|NCT01988493|8632487|P1|Overall Study|Randomized but not treated|0
2496812|NCT01988402|8632566|P2|Overall Study|Withdrawal by Subject|0
2496813|NCT01988402|8632567|P1|Overall Study|Withdrawal by Subject|1
2496814|NCT01988402|8632566|P2|Overall Study|Adverse Event|2
2496815|NCT01988402|8632567|P1|Overall Study|Adverse Event|1
2496816|NCT01988103|8632621|P5|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2
2496817|NCT01988103|8632622|P4|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0
2496818|NCT01988103|8632623|P3|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2
2496819|NCT01988103|8632624|P2|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1
2496820|NCT01988103|8632625|P1|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0
2496821|NCT01988103|8632621|P5|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1
2496822|NCT01988103|8632622|P4|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0
2496823|NCT01988103|8632623|P3|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4
2496824|NCT01988103|8632624|P2|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5
2496825|NCT01988103|8632625|P1|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0
2496826|NCT01988103|8632621|P5|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
2496827|NCT01988103|8632622|P4|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
2496828|NCT01988103|8632623|P3|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2
2496829|NCT01988103|8632624|P2|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1
2496830|NCT01988103|8632625|P1|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
2496831|NCT01988103|8632621|P5|Active Treatment Phase (Weeks 16-68)|Adverse Event|2
2496832|NCT01988103|8632622|P4|Active Treatment Phase (Weeks 16-68)|Adverse Event|3
2496833|NCT01988103|8632623|P3|Active Treatment Phase (Weeks 16-68)|Adverse Event|3
2496834|NCT01988103|8632624|P2|Active Treatment Phase (Weeks 16-68)|Adverse Event|6
2496835|NCT01988103|8632625|P1|Active Treatment Phase (Weeks 16-68)|Adverse Event|0
2496836|NCT01988103|8632621|P5|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0
2496837|NCT01988103|8632622|P4|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0
2496838|NCT01988103|8632623|P3|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1
2496839|NCT01988103|8632624|P2|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4
2496840|NCT01988103|8632625|P1|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8
2496841|NCT01988103|8632621|P5|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0
2496842|NCT01988103|8632622|P4|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0
2496843|NCT01988103|8632623|P3|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2
2496844|NCT01988103|8632624|P2|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2
2496845|NCT01988103|8632625|P1|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1
2496846|NCT01988103|8632621|P5|Placebo-Controlled Phase Week 0-16|Adverse Event|0
2496847|NCT01988103|8632622|P4|Placebo-Controlled Phase Week 0-16|Adverse Event|0
2496848|NCT01988103|8632623|P3|Placebo-Controlled Phase Week 0-16|Adverse Event|6
2496849|NCT01988103|8632624|P2|Placebo-Controlled Phase Week 0-16|Adverse Event|10
2496850|NCT01988103|8632625|P1|Placebo-Controlled Phase Week 0-16|Adverse Event|3
2496851|NCT01988090|8632672|P2|Complete Study After Start|Protocol Violation|1
2496852|NCT01988090|8632673|P1|Complete Study After Start|Protocol Violation|1
2496853|NCT01988090|8632672|P2|Complete Study After Start|Withdrawal by Subject|0
2496854|NCT01988090|8632673|P1|Complete Study After Start|Withdrawal by Subject|2
2496855|NCT01988090|8632672|P2|Start Treament After Randomization|Protocol Violation|1
2496856|NCT01988090|8632673|P1|Start Treament After Randomization|Protocol Violation|0
2496857|NCT01988090|8632672|P2|Start Treament After Randomization|Withdrawal by Subject|3
2496858|NCT01988090|8632673|P1|Start Treament After Randomization|Withdrawal by Subject|2
2496859|NCT01988012|8632683|P1|Overall Study|Protocol Violation|1
2496860|NCT01988012|8632683|P1|Overall Study|Physician Decision|1
2496861|NCT01988012|8632683|P1|Overall Study|Lost to Follow-up|1
2496862|NCT01988012|8632683|P1|Overall Study|Patient Withdrawal of Consent|4
2496863|NCT01988012|8632683|P1|Overall Study|Insufficient Therapeutic Response|3
2496864|NCT01988012|8632683|P1|Overall Study|Adverse Event|5
2496865|NCT01987986|8632709|P4|Overall Study|Adverse Event|0
2496866|NCT01987986|8632710|P3|Overall Study|Adverse Event|2
2496867|NCT01987986|8632711|P2|Overall Study|Adverse Event|0
2496868|NCT01987986|8632712|P1|Overall Study|Adverse Event|1
2496869|NCT01987986|8632709|P4|Overall Study|Lost to Follow-up|0
2496870|NCT01987986|8632710|P3|Overall Study|Lost to Follow-up|0
2496871|NCT01987986|8632711|P2|Overall Study|Lost to Follow-up|0
2496872|NCT01987986|8632712|P1|Overall Study|Lost to Follow-up|1
2496873|NCT01987960|8632752|P4|Period 3|Administrative or other reason|43
2496874|NCT01987960|8632753|P3|Period 3|Administrative or other reason|0
2496875|NCT01987960|8632754|P2|Period 3|Administrative or other reason|0
2496876|NCT01987960|8632755|P1|Period 3|Administrative or other reason|0
2496877|NCT01987960|8632752|P4|Period 3|Lost to Follow-up|5
2496878|NCT01987960|8632753|P3|Period 3|Lost to Follow-up|0
2496879|NCT01987960|8632754|P2|Period 3|Lost to Follow-up|0
2496880|NCT01987960|8632755|P1|Period 3|Lost to Follow-up|0
2496881|NCT01987960|8632752|P4|Period 3|Withdrawal by Subject|9
2496882|NCT01987960|8632753|P3|Period 3|Withdrawal by Subject|0
2496883|NCT01987960|8632754|P2|Period 3|Withdrawal by Subject|0
2496884|NCT01987960|8632755|P1|Period 3|Withdrawal by Subject|0
2496885|NCT01987960|8632752|P4|Period 3|Protocol Violation|6
2496886|NCT01987960|8632753|P3|Period 3|Protocol Violation|0
2496887|NCT01987960|8632754|P2|Period 3|Protocol Violation|0
2496888|NCT01987960|8632755|P1|Period 3|Protocol Violation|0
2496889|NCT01987960|8632752|P4|Period 3|Non-compliance with IMP|1
2496890|NCT01987960|8632753|P3|Period 3|Non-compliance with IMP|0
2496891|NCT01987960|8632754|P2|Period 3|Non-compliance with IMP|0
2496892|NCT01987960|8632755|P1|Period 3|Non-compliance with IMP|0
2496893|NCT01987960|8632752|P4|Period 3|Adverse Event|7
2496894|NCT01987960|8632753|P3|Period 3|Adverse Event|0
2496895|NCT01987960|8632754|P2|Period 3|Adverse Event|0
2496896|NCT01987960|8632755|P1|Period 3|Adverse Event|0
2496897|NCT01987960|8632752|P4|Period 2|Administrative or other reason|0
2496898|NCT01987960|8632753|P3|Period 2|Administrative or other reason|7
2496899|NCT01987960|8632754|P2|Period 2|Administrative or other reason|5
2496900|NCT01987960|8632755|P1|Period 2|Administrative or other reason|0
2496901|NCT01987960|8632752|P4|Period 2|Withdrawal by Subject|0
2496902|NCT01987960|8632753|P3|Period 2|Withdrawal by Subject|1
2496903|NCT01987960|8632754|P2|Period 2|Withdrawal by Subject|0
2496904|NCT01987960|8632755|P1|Period 2|Withdrawal by Subject|0
2496905|NCT01987960|8632752|P4|Period 2|Adverse Event|0
2496906|NCT01987960|8632753|P3|Period 2|Adverse Event|1
2496907|NCT01987960|8632754|P2|Period 2|Adverse Event|0
2496908|NCT01987960|8632755|P1|Period 2|Adverse Event|0
2496909|NCT01987960|8632752|P4|Period 1|Withdrawal of consent before treatment|0
2496910|NCT01987960|8632753|P3|Period 1|Withdrawal of consent before treatment|0
2496911|NCT01987960|8632754|P2|Period 1|Withdrawal of consent before treatment|0
2496912|NCT01987960|8632755|P1|Period 1|Withdrawal of consent before treatment|4
2496913|NCT01987960|8632752|P4|Period 1|administrative or other reason|0
2496914|NCT01987960|8632753|P3|Period 1|administrative or other reason|0
2496915|NCT01987960|8632754|P2|Period 1|administrative or other reason|0
2496916|NCT01987960|8632755|P1|Period 1|administrative or other reason|75
2496917|NCT01987960|8632752|P4|Period 1|Lost to Follow-up|0
2496918|NCT01987960|8632753|P3|Period 1|Lost to Follow-up|0
2496919|NCT01987960|8632754|P2|Period 1|Lost to Follow-up|0
2496920|NCT01987960|8632755|P1|Period 1|Lost to Follow-up|40
2496921|NCT01987960|8632752|P4|Period 1|Withdrawal by Subject|0
2496922|NCT01987960|8632753|P3|Period 1|Withdrawal by Subject|0
2496923|NCT01987960|8632754|P2|Period 1|Withdrawal by Subject|0
2496924|NCT01987960|8632755|P1|Period 1|Withdrawal by Subject|21
2496925|NCT01987960|8632752|P4|Period 1|Protocol Violation|0
2496926|NCT01987960|8632753|P3|Period 1|Protocol Violation|0
2496927|NCT01987960|8632754|P2|Period 1|Protocol Violation|0
2496928|NCT01987960|8632755|P1|Period 1|Protocol Violation|12
2496929|NCT01987960|8632752|P4|Period 1|Non-compliance with IMP|0
2496930|NCT01987960|8632753|P3|Period 1|Non-compliance with IMP|0
2496931|NCT01987960|8632754|P2|Period 1|Non-compliance with IMP|0
2496932|NCT01987960|8632755|P1|Period 1|Non-compliance with IMP|6
2496933|NCT01987960|8632752|P4|Period 1|Lack of Efficacy|0
2496934|NCT01987960|8632753|P3|Period 1|Lack of Efficacy|0
2496935|NCT01987960|8632754|P2|Period 1|Lack of Efficacy|0
2496936|NCT01987960|8632755|P1|Period 1|Lack of Efficacy|4
2496937|NCT01987960|8632752|P4|Period 1|Adverse Event|0
2496938|NCT01987960|8632753|P3|Period 1|Adverse Event|0
2496939|NCT01987960|8632754|P2|Period 1|Adverse Event|0
2496940|NCT01987960|8632755|P1|Period 1|Adverse Event|24
2496941|NCT01987908|8632767|P3|Post-Treatment Observation Period|Other: Bad Veins|0
2496942|NCT01987908|8632768|P2|Post-Treatment Observation Period|Other: Bad Veins|1
2496943|NCT01987908|8632769|P1|Post-Treatment Observation Period|Other: Bad Veins|0
2496944|NCT01987908|8632767|P3|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
2496945|NCT01987908|8632768|P2|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2
2496946|NCT01987908|8632769|P1|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
2496947|NCT01987908|8632767|P3|Treatment Period|Adverse Event|1
2496948|NCT01987908|8632768|P2|Treatment Period|Adverse Event|1
2496949|NCT01987908|8632769|P1|Treatment Period|Adverse Event|0
2496950|NCT01987908|8632767|P3|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
2496951|NCT01987908|8632768|P2|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
2496952|NCT01987908|8632769|P1|Placebo Lead-in Period|Other: Study Termination by Sponsor|4
2496953|NCT01987908|8632767|P3|Placebo Lead-in Period|Withdrawal by Subject|0
2496954|NCT01987908|8632768|P2|Placebo Lead-in Period|Withdrawal by Subject|0
2496955|NCT01987908|8632769|P1|Placebo Lead-in Period|Withdrawal by Subject|1
2496956|NCT01987908|8632767|P3|Placebo Lead-in Period|Physician Decision|0
2496957|NCT01987908|8632768|P2|Placebo Lead-in Period|Physician Decision|0
2496958|NCT01987908|8632769|P1|Placebo Lead-in Period|Physician Decision|2
2496959|NCT01987908|8632767|P3|Placebo Lead-in Period|Adverse Event|0
2496960|NCT01987908|8632768|P2|Placebo Lead-in Period|Adverse Event|0
2496961|NCT01987908|8632769|P1|Placebo Lead-in Period|Adverse Event|2
2496962|NCT01987895|8632852|P2|Overall Study|randomized before giving IC|1
2496963|NCT01987895|8632853|P1|Overall Study|randomized before giving IC|0
2496964|NCT01987895|8632852|P2|Overall Study|Lost to Follow-up|5
2496965|NCT01987895|8632853|P1|Overall Study|Lost to Follow-up|3
2496966|NCT01987895|8632852|P2|Overall Study|Death|7
2496967|NCT01987895|8632853|P1|Overall Study|Death|7
2496968|NCT01987895|8632852|P2|Overall Study|Physician Decision|10
2496969|NCT01987895|8632853|P1|Overall Study|Physician Decision|8
2496970|NCT01987895|8632852|P2|Overall Study|Withdrawal by Subject|7
2496971|NCT01987895|8632853|P1|Overall Study|Withdrawal by Subject|12
2496972|NCT01987765|8632877|P1|Overall Study|Lost to Follow-up|37
2496973|NCT01987765|8632877|P1|Overall Study|Protocol Violation|65
2496974|NCT01987609|8632887|P1|Overall Study|Adverse Event|1
2496975|NCT01987557|8632932|P3|Overall Study|Adverse Event|0
2496976|NCT01987557|8632933|P2|Overall Study|Adverse Event|2
2496977|NCT01987557|8632934|P1|Overall Study|Adverse Event|0
2496978|NCT01987557|8632932|P3|Overall Study|Withdrawal by Subject|2
2496979|NCT01987557|8632933|P2|Overall Study|Withdrawal by Subject|1
2496980|NCT01987557|8632934|P1|Overall Study|Withdrawal by Subject|2
2496981|NCT01987557|8632932|P3|Overall Study|Protocol Violation|1
2496982|NCT01987557|8632933|P2|Overall Study|Protocol Violation|0
2496983|NCT01987557|8632934|P1|Overall Study|Protocol Violation|1
2496984|NCT01987505|8632944|P1|Overall Study|Death|4
2496985|NCT01987505|8632944|P1|Overall Study|Investigator Decision|2
2496986|NCT01987505|8632944|P1|Overall Study|Lost to Follow-up|15
2496987|NCT01987505|8632944|P1|Overall Study|Other Reason|2
2496988|NCT01987505|8632944|P1|Overall Study|Withdrawal by Subject|2
2496989|NCT01987505|8632944|P1|Overall Study|Other|9
2496990|NCT01987479|8632974|P1|Overall Study|Adverse Event|7
2496991|NCT01987479|8632974|P1|Overall Study|Lost to Follow-up|1
2496992|NCT01987479|8632974|P1|Overall Study|Other|5
2496993|NCT01987479|8632974|P1|Overall Study|Participant/legal guardian decision|1
2496994|NCT01987479|8632974|P1|Overall Study|Physician Decision|2
2496995|NCT01987479|8632974|P1|Overall Study|Protocol Violation|1
2496996|NCT01987453|8633002|P3|Overall Study|Lack of Efficacy|0
2496997|NCT01987453|8633003|P2|Overall Study|Lack of Efficacy|12
2496998|NCT01987453|8633004|P1|Overall Study|Lack of Efficacy|1
2496999|NCT01987453|8633002|P3|Overall Study|Death|1
2497000|NCT01987453|8633003|P2|Overall Study|Death|0
2497001|NCT01987453|8633004|P1|Overall Study|Death|0
2497002|NCT01987427|8633030|P3|Overall Study|Other|0
2497003|NCT01987427|8633031|P2|Overall Study|Other|1
2497004|NCT01987427|8633032|P1|Overall Study|Other|1
2497005|NCT01987427|8633030|P3|Overall Study|Lack of Efficacy|0
2497006|NCT01987427|8633031|P2|Overall Study|Lack of Efficacy|0
2497007|NCT01987427|8633032|P1|Overall Study|Lack of Efficacy|1
2497008|NCT01987427|8633030|P3|Overall Study|Withdrawal by Subject|3
2497009|NCT01987427|8633031|P2|Overall Study|Withdrawal by Subject|1
2497010|NCT01987427|8633032|P1|Overall Study|Withdrawal by Subject|2
2497011|NCT01987427|8633030|P3|Overall Study|Lost to Follow-up|9
2497012|NCT01987427|8633031|P2|Overall Study|Lost to Follow-up|6
2497013|NCT01987427|8633032|P1|Overall Study|Lost to Follow-up|6
2497014|NCT01987427|8633030|P3|Overall Study|Adverse Event|8
2497015|NCT01987427|8633031|P2|Overall Study|Adverse Event|2
2497016|NCT01987427|8633032|P1|Overall Study|Adverse Event|4
2497017|NCT01987232|8633169|P5|Overall Study|Ongoing in Study|0
2497018|NCT01987232|8633170|P4|Overall Study|Ongoing in Study|1
2497019|NCT01987232|8633171|P3|Overall Study|Ongoing in Study|0
2497020|NCT01987232|8633172|P2|Overall Study|Ongoing in Study|0
2497021|NCT01987232|8633173|P1|Overall Study|Ongoing in Study|0
2497022|NCT01987102|8633262|P2|2 Courses of HDMTX With MOD Rescue|Adverse Event|1
2497023|NCT01987102|8633263|P1|2 Courses of HDMTX With MOD Rescue|Adverse Event|0
2497024|NCT01987102|8633262|P2|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1
2497025|NCT01987102|8633263|P1|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0
2497026|NCT01987102|8633262|P2|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1
2497027|NCT01987102|8633263|P1|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0
2497028|NCT01987102|8633262|P2|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0
2497029|NCT01987102|8633263|P1|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1
2497030|NCT01987102|8633262|P2|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2
2497031|NCT01987102|8633263|P1|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1
2497032|NCT01987102|8633262|P2|2 Courses of HDMTX With SOC Rescue|Adverse Event|2
2497033|NCT01987102|8633263|P1|2 Courses of HDMTX With SOC Rescue|Adverse Event|2
2497034|NCT01986985|8633295|P1|Overall Study|Scan not completed due to malfunction|3
2497035|NCT01986985|8633295|P1|Overall Study|Withdrawal by Subject|4
2497036|NCT01986920|8633332|P4|Placebo|Withdrawal by Subject|1
2497037|NCT01986920|8633333|P3|Placebo|Withdrawal by Subject|0
2497038|NCT01986920|8633334|P2|Placebo|Withdrawal by Subject|0
2497039|NCT01986920|8633335|P1|Placebo|Withdrawal by Subject|0
2497040|NCT01986920|8633332|P4|A-101 40%|Withdrawal by Subject|0
2497041|NCT01986920|8633333|P3|A-101 40%|Withdrawal by Subject|1
2497042|NCT01986920|8633334|P2|A-101 40%|Withdrawal by Subject|0
2497043|NCT01986920|8633335|P1|A-101 40%|Withdrawal by Subject|0
2497044|NCT01986920|8633332|P4|A-101 32.5%|Withdrawal by Subject|0
2497045|NCT01986920|8633333|P3|A-101 32.5%|Withdrawal by Subject|0
2497046|NCT01986920|8633334|P2|A-101 32.5%|Withdrawal by Subject|1
2497047|NCT01986920|8633335|P1|A-101 32.5%|Withdrawal by Subject|0
2497048|NCT01986920|8633332|P4|A- 101 25%|Withdrawal by Subject|0
2497049|NCT01986920|8633333|P3|A- 101 25%|Withdrawal by Subject|0
2497050|NCT01986920|8633334|P2|A- 101 25%|Withdrawal by Subject|0
2497051|NCT01986920|8633335|P1|A- 101 25%|Withdrawal by Subject|1
2497052|NCT01986907|8633349|P1|Overall Study|Death|9
2497053|NCT01986907|8633349|P1|Overall Study|Lost to Follow-up|38
2497054|NCT01986907|8633349|P1|Overall Study|Withdrawal by Subject|76
2497055|NCT01986907|8633349|P1|Overall Study|Protocol Violation|4
2497056|NCT01986907|8633349|P1|Overall Study|Unsatisfactory therapeutic effect|24
2497057|NCT01986907|8633349|P1|Overall Study|Adverse Event|11
2497058|NCT01986855|8633362|P3|Overall Study|Withdrawal by Subject|5
2497059|NCT01986855|8633363|P2|Overall Study|Withdrawal by Subject|8
2497060|NCT01986855|8633364|P1|Overall Study|Withdrawal by Subject|7
2497061|NCT01986855|8633362|P3|Overall Study|Participant Moved|2
2497062|NCT01986855|8633363|P2|Overall Study|Participant Moved|0
2497063|NCT01986855|8633364|P1|Overall Study|Participant Moved|0
2497064|NCT01986855|8633362|P3|Overall Study|Screen Failure|0
2497065|NCT01986855|8633363|P2|Overall Study|Screen Failure|1
2497066|NCT01986855|8633364|P1|Overall Study|Screen Failure|0
2497067|NCT01986855|8633362|P3|Overall Study|Lost to Follow-up|0
2497068|NCT01986855|8633363|P2|Overall Study|Lost to Follow-up|1
2497069|NCT01986855|8633364|P1|Overall Study|Lost to Follow-up|2
2497070|NCT01986855|8633362|P3|Overall Study|Death|4
2497071|NCT01986855|8633363|P2|Overall Study|Death|4
2497072|NCT01986855|8633364|P1|Overall Study|Death|3
2497073|NCT01986855|8633362|P3|Overall Study|Adverse Event|0
2497074|NCT01986855|8633363|P2|Overall Study|Adverse Event|0
2497075|NCT01986855|8633364|P1|Overall Study|Adverse Event|1
2497076|NCT01986829|8633393|P1|Overall Study|Death|1
2497077|NCT01986751|8633441|P2|Overall Study|improperly consented|2
2497078|NCT01986751|8633442|P1|Overall Study|improperly consented|10
2497079|NCT01986647|8633475|P4|Overall Study|Health|4
2497080|NCT01986647|8633476|P3|Overall Study|Health|6
2497081|NCT01986647|8633477|P2|Overall Study|Health|3
2497082|NCT01986647|8633478|P1|Overall Study|Health|5
2497083|NCT01986647|8633475|P4|Overall Study|Withdrawal by Subject|3
2497084|NCT01986647|8633476|P3|Overall Study|Withdrawal by Subject|2
2497085|NCT01986647|8633477|P2|Overall Study|Withdrawal by Subject|3
2497086|NCT01986647|8633478|P1|Overall Study|Withdrawal by Subject|1
2497087|NCT01986647|8633475|P4|Overall Study|Lost to Follow-up|4
2497088|NCT01986647|8633476|P3|Overall Study|Lost to Follow-up|4
2497089|NCT01986647|8633477|P2|Overall Study|Lost to Follow-up|1
2497090|NCT01986647|8633478|P1|Overall Study|Lost to Follow-up|4
2497091|NCT01986231|8633573|P1|Overall Study|Adverse Event|1
2497092|NCT01986140|8633580|P2|Overall Study|progression disease|1
2497093|NCT01986140|8633581|P1|Overall Study|progression disease|0
2497094|NCT01986140|8633580|P2|Overall Study|Adverse Event|1
2497095|NCT01986140|8633581|P1|Overall Study|Adverse Event|0
2497096|NCT01986140|8633580|P2|Overall Study|found not eligible|0
2497097|NCT01986140|8633581|P1|Overall Study|found not eligible|3
2497098|NCT01986140|8633580|P2|Overall Study|alternative treatment|1
2497099|NCT01986140|8633581|P1|Overall Study|alternative treatment|1
2497100|NCT01986140|8633580|P2|Overall Study|Withdrawal by Subject|25
2497101|NCT01986140|8633581|P1|Overall Study|Withdrawal by Subject|31
2497102|NCT01986114|8633587|P1|Overall Study|Other reason|7
2497103|NCT01986114|8633587|P1|Overall Study|Lost to Follow-up|5
2497104|NCT01986114|8633587|P1|Overall Study|Protocol Violation|1
2497105|NCT01986114|8633587|P1|Overall Study|Noncompliance|3
2497106|NCT01986114|8633587|P1|Overall Study|Withdrawal by Subject|58
2497107|NCT01986114|8633587|P1|Overall Study|Lack of Efficacy|23
2497108|NCT01986114|8633587|P1|Overall Study|Adverse Event|59
2497109|NCT01986062|8633626|P2|Overall Study|Lost to Follow-up|1
2497110|NCT01986062|8633627|P1|Overall Study|Lost to Follow-up|1
2497111|NCT01985334|8633731|P8|Overall Study|Lost to Follow-up|3
2497112|NCT01985334|8633732|P7|Overall Study|Lost to Follow-up|0
2497113|NCT01985334|8633733|P6|Overall Study|Lost to Follow-up|4
2497114|NCT01985334|8633734|P5|Overall Study|Lost to Follow-up|1
2497115|NCT01985334|8633735|P4|Overall Study|Lost to Follow-up|3
2497116|NCT01985334|8633736|P3|Overall Study|Lost to Follow-up|0
2497117|NCT01985334|8633737|P2|Overall Study|Lost to Follow-up|2
2497118|NCT01985334|8633738|P1|Overall Study|Lost to Follow-up|0
2497119|NCT01985334|8633731|P8|Overall Study|Investigator decision|4
2497120|NCT01985334|8633732|P7|Overall Study|Investigator decision|0
2497121|NCT01985334|8633733|P6|Overall Study|Investigator decision|1
2497122|NCT01985334|8633734|P5|Overall Study|Investigator decision|1
2497123|NCT01985334|8633735|P4|Overall Study|Investigator decision|7
2497124|NCT01985334|8633736|P3|Overall Study|Investigator decision|0
2497125|NCT01985334|8633737|P2|Overall Study|Investigator decision|3
2497126|NCT01985334|8633738|P1|Overall Study|Investigator decision|0
2497127|NCT01985334|8633731|P8|Overall Study|Use of prohibited treatment|0
2497128|NCT01985334|8633732|P7|Overall Study|Use of prohibited treatment|2
2497129|NCT01985334|8633733|P6|Overall Study|Use of prohibited treatment|6
2497130|NCT01985334|8633734|P5|Overall Study|Use of prohibited treatment|1
2497131|NCT01985334|8633735|P4|Overall Study|Use of prohibited treatment|2
2497132|NCT01985334|8633736|P3|Overall Study|Use of prohibited treatment|1
2497133|NCT01985334|8633737|P2|Overall Study|Use of prohibited treatment|4
2497134|NCT01985334|8633738|P1|Overall Study|Use of prohibited treatment|1
2497135|NCT01985334|8633731|P8|Overall Study|Medication non-compliance|3
2497136|NCT01985334|8633732|P7|Overall Study|Medication non-compliance|1
2497137|NCT01985334|8633733|P6|Overall Study|Medication non-compliance|3
2497138|NCT01985334|8633734|P5|Overall Study|Medication non-compliance|2
2497139|NCT01985334|8633735|P4|Overall Study|Medication non-compliance|6
2497140|NCT01985334|8633736|P3|Overall Study|Medication non-compliance|1
2497141|NCT01985334|8633737|P2|Overall Study|Medication non-compliance|4
2497142|NCT01985334|8633738|P1|Overall Study|Medication non-compliance|0
2497143|NCT01985334|8633731|P8|Overall Study|Other|2
2497144|NCT01985334|8633732|P7|Overall Study|Other|2
2497145|NCT01985334|8633733|P6|Overall Study|Other|6
2497146|NCT01985334|8633734|P5|Overall Study|Other|1
2497147|NCT01985334|8633735|P4|Overall Study|Other|10
2497148|NCT01985334|8633736|P3|Overall Study|Other|3
2497149|NCT01985334|8633737|P2|Overall Study|Other|2
2497150|NCT01985334|8633738|P1|Overall Study|Other|4
2497151|NCT01985334|8633731|P8|Overall Study|Adverse Event|15
2497152|NCT01985334|8633732|P7|Overall Study|Adverse Event|3
2497153|NCT01985334|8633733|P6|Overall Study|Adverse Event|18
2497154|NCT01985334|8633734|P5|Overall Study|Adverse Event|3
2497155|NCT01985334|8633735|P4|Overall Study|Adverse Event|26
2497156|NCT01985334|8633736|P3|Overall Study|Adverse Event|2
2497157|NCT01985334|8633737|P2|Overall Study|Adverse Event|8
2497158|NCT01985334|8633738|P1|Overall Study|Adverse Event|0
2497159|NCT01985334|8633731|P8|Overall Study|Subject withdrawal of consent|20
2497160|NCT01985334|8633732|P7|Overall Study|Subject withdrawal of consent|0
2497161|NCT01985334|8633733|P6|Overall Study|Subject withdrawal of consent|19
2497162|NCT01985334|8633734|P5|Overall Study|Subject withdrawal of consent|4
2497163|NCT01985334|8633735|P4|Overall Study|Subject withdrawal of consent|28
2497164|NCT01985334|8633736|P3|Overall Study|Subject withdrawal of consent|2
2497165|NCT01985334|8633737|P2|Overall Study|Subject withdrawal of consent|6
2497166|NCT01985334|8633738|P1|Overall Study|Subject withdrawal of consent|3
2497167|NCT01985334|8633731|P8|Overall Study|Moderate / severe COPD exacerbation|19
2497168|NCT01985334|8633732|P7|Overall Study|Moderate / severe COPD exacerbation|8
2497169|NCT01985334|8633733|P6|Overall Study|Moderate / severe COPD exacerbation|40
2497170|NCT01985334|8633734|P5|Overall Study|Moderate / severe COPD exacerbation|6
2497171|NCT01985334|8633735|P4|Overall Study|Moderate / severe COPD exacerbation|40
2497172|NCT01985334|8633736|P3|Overall Study|Moderate / severe COPD exacerbation|12
2497173|NCT01985334|8633737|P2|Overall Study|Moderate / severe COPD exacerbation|14
2497174|NCT01985334|8633738|P1|Overall Study|Moderate / severe COPD exacerbation|5
2497175|NCT01985334|8633731|P8|Overall Study|Protocol deviation|42
2497176|NCT01985334|8633732|P7|Overall Study|Protocol deviation|15
2497177|NCT01985334|8633733|P6|Overall Study|Protocol deviation|47
2497178|NCT01985334|8633734|P5|Overall Study|Protocol deviation|17
2497179|NCT01985334|8633735|P4|Overall Study|Protocol deviation|84
2497180|NCT01985334|8633736|P3|Overall Study|Protocol deviation|25
2497181|NCT01985334|8633737|P2|Overall Study|Protocol deviation|31
2497182|NCT01985334|8633738|P1|Overall Study|Protocol deviation|6
2497183|NCT01985334|8633731|P8|Overall Study|Other|7
2497184|NCT01985334|8633732|P7|Overall Study|Other|4
2497185|NCT01985334|8633733|P6|Overall Study|Other|8
2497186|NCT01985334|8633734|P5|Overall Study|Other|4
2497187|NCT01985334|8633735|P4|Overall Study|Other|17
2497188|NCT01985334|8633736|P3|Overall Study|Other|7
2497189|NCT01985334|8633737|P2|Overall Study|Other|9
2497190|NCT01985334|8633738|P1|Overall Study|Other|2
2497191|NCT01985334|8633731|P8|Overall Study|Worsening of disease|1
2497192|NCT01985334|8633732|P7|Overall Study|Worsening of disease|0
2497193|NCT01985334|8633733|P6|Overall Study|Worsening of disease|3
2497194|NCT01985334|8633734|P5|Overall Study|Worsening of disease|0
2497195|NCT01985334|8633735|P4|Overall Study|Worsening of disease|1
2497196|NCT01985334|8633736|P3|Overall Study|Worsening of disease|0
2497197|NCT01985334|8633737|P2|Overall Study|Worsening of disease|0
2497198|NCT01985334|8633738|P1|Overall Study|Worsening of disease|0
2497199|NCT01985334|8633731|P8|Overall Study|Death|2
2497200|NCT01985334|8633732|P7|Overall Study|Death|1
2497201|NCT01985334|8633733|P6|Overall Study|Death|0
2497202|NCT01985334|8633734|P5|Overall Study|Death|0
2497203|NCT01985334|8633735|P4|Overall Study|Death|3
2497204|NCT01985334|8633736|P3|Overall Study|Death|0
2497205|NCT01985334|8633737|P2|Overall Study|Death|0
2497206|NCT01985334|8633738|P1|Overall Study|Death|1
2497207|NCT01985334|8633731|P8|Overall Study|Administrative problems|3
2497208|NCT01985334|8633732|P7|Overall Study|Administrative problems|1
2497209|NCT01985334|8633733|P6|Overall Study|Administrative problems|1
2497210|NCT01985334|8633734|P5|Overall Study|Administrative problems|0
2497211|NCT01985334|8633735|P4|Overall Study|Administrative problems|2
2497212|NCT01985334|8633736|P3|Overall Study|Administrative problems|0
2497213|NCT01985334|8633737|P2|Overall Study|Administrative problems|1
2497214|NCT01985334|8633738|P1|Overall Study|Administrative problems|1
2497215|NCT01985321|8633806|P2|Overall Study|Subject treated wrong type of sore|0
2497216|NCT01985321|8633807|P1|Overall Study|Subject treated wrong type of sore|1
2497217|NCT01985321|8633806|P2|Overall Study|Lost to Follow-up|2
2497218|NCT01985321|8633807|P1|Overall Study|Lost to Follow-up|5
2497219|NCT01985321|8633806|P2|Overall Study|Withdrawal by Subject|0
2497220|NCT01985321|8633807|P1|Overall Study|Withdrawal by Subject|1
2497221|NCT01985321|8633806|P2|Overall Study|Protocol Violation|3
2497222|NCT01985321|8633807|P1|Overall Study|Protocol Violation|4
2497223|NCT01985126|8633817|P2|Overall Study|Withdrawal by Subject|7
2497224|NCT01985126|8633818|P1|Overall Study|Withdrawal by Subject|2
2497225|NCT01985126|8633817|P2|Overall Study|Study Terminated By Sponsor|22
2497226|NCT01985126|8633818|P1|Overall Study|Study Terminated By Sponsor|1
2497227|NCT01985126|8633817|P2|Overall Study|Lost to Follow-up|8
2497228|NCT01985126|8633818|P1|Overall Study|Lost to Follow-up|0
2497229|NCT01985126|8633817|P2|Overall Study|Death|69
2497230|NCT01985126|8633818|P1|Overall Study|Death|15
2497231|NCT01984892|8633836|P1|Overall Study|Progressive disease|7
2497232|NCT01984697|8633847|P5|Overall Study|Pregnancy|1
2497233|NCT01984697|8633848|P4|Overall Study|Pregnancy|0
2497234|NCT01984697|8633849|P3|Overall Study|Pregnancy|1
2497235|NCT01984697|8633850|P2|Overall Study|Pregnancy|0
2497236|NCT01984697|8633851|P1|Overall Study|Pregnancy|2
2497237|NCT01984697|8633847|P5|Overall Study|Death|0
2497238|NCT01984697|8633848|P4|Overall Study|Death|1
2497239|NCT01984697|8633849|P3|Overall Study|Death|0
2497240|NCT01984697|8633850|P2|Overall Study|Death|0
2497241|NCT01984697|8633851|P1|Overall Study|Death|0
2497242|NCT01984697|8633847|P5|Overall Study|Missed last follow-up visit|0
2497243|NCT01984697|8633848|P4|Overall Study|Missed last follow-up visit|0
2497244|NCT01984697|8633849|P3|Overall Study|Missed last follow-up visit|0
2497245|NCT01984697|8633850|P2|Overall Study|Missed last follow-up visit|0
2497246|NCT01984697|8633851|P1|Overall Study|Missed last follow-up visit|1
2497247|NCT01984697|8633847|P5|Overall Study|Withdrawal by Subject|13
2497248|NCT01984697|8633848|P4|Overall Study|Withdrawal by Subject|11
2497249|NCT01984697|8633849|P3|Overall Study|Withdrawal by Subject|13
2497250|NCT01984697|8633850|P2|Overall Study|Withdrawal by Subject|21
2497251|NCT01984697|8633851|P1|Overall Study|Withdrawal by Subject|15
2497252|NCT01984697|8633847|P5|Overall Study|Protocol Violation|0
2497253|NCT01984697|8633848|P4|Overall Study|Protocol Violation|2
2497254|NCT01984697|8633849|P3|Overall Study|Protocol Violation|3
2497255|NCT01984697|8633850|P2|Overall Study|Protocol Violation|5
2497256|NCT01984697|8633851|P1|Overall Study|Protocol Violation|8
2497257|NCT01984697|8633847|P5|Overall Study|Physician Decision|0
2497258|NCT01984697|8633848|P4|Overall Study|Physician Decision|1
2497259|NCT01984697|8633849|P3|Overall Study|Physician Decision|0
2497260|NCT01984697|8633850|P2|Overall Study|Physician Decision|0
2497261|NCT01984697|8633851|P1|Overall Study|Physician Decision|3
2497262|NCT01984697|8633847|P5|Overall Study|Lost to Follow-up|21
2497263|NCT01984697|8633848|P4|Overall Study|Lost to Follow-up|6
2497264|NCT01984697|8633849|P3|Overall Study|Lost to Follow-up|10
2497265|NCT01984697|8633850|P2|Overall Study|Lost to Follow-up|5
2497266|NCT01984697|8633851|P1|Overall Study|Lost to Follow-up|14
2497267|NCT01984697|8633847|P5|Overall Study|Adverse Event|0
2497268|NCT01984697|8633848|P4|Overall Study|Adverse Event|0
2497269|NCT01984697|8633849|P3|Overall Study|Adverse Event|2
2497270|NCT01984697|8633850|P2|Overall Study|Adverse Event|0
2497271|NCT01984697|8633851|P1|Overall Study|Adverse Event|0
2497272|NCT01984684|8633970|P2|Overall Study|Subject had inadequate IV access|1
2497273|NCT01984684|8633971|P1|Overall Study|Subject had inadequate IV access|0
2497274|NCT01984684|8633970|P2|Overall Study|Study drug not available at site|1
2497275|NCT01984684|8633971|P1|Overall Study|Study drug not available at site|1
2497276|NCT01984684|8633970|P2|Overall Study|Subject incarcerated|0
2497277|NCT01984684|8633971|P1|Overall Study|Subject incarcerated|1
2497278|NCT01984684|8633970|P2|Overall Study|Noncompliance with study drug|1
2497279|NCT01984684|8633971|P1|Overall Study|Noncompliance with study drug|2
2497280|NCT01984684|8633970|P2|Overall Study|Death|1
2497281|NCT01984684|8633971|P1|Overall Study|Death|0
2497282|NCT01984684|8633970|P2|Overall Study|Protocol Violation|2
2497283|NCT01984684|8633971|P1|Overall Study|Protocol Violation|4
2497284|NCT01984684|8633970|P2|Overall Study|Physician Decision|2
2497285|NCT01984684|8633971|P1|Overall Study|Physician Decision|4
2497286|NCT01984684|8633970|P2|Overall Study|Lack of Efficacy|6
2497287|NCT01984684|8633971|P1|Overall Study|Lack of Efficacy|3
2497288|NCT01984684|8633970|P2|Overall Study|Withdrawal by Subject|9
2497289|NCT01984684|8633971|P1|Overall Study|Withdrawal by Subject|9
2497290|NCT01984684|8633970|P2|Overall Study|Adverse Event|12
2497291|NCT01984684|8633971|P1|Overall Study|Adverse Event|8
2497292|NCT01984684|8633970|P2|Overall Study|Lost to Follow-up|24
2497293|NCT01984684|8633971|P1|Overall Study|Lost to Follow-up|25
2497294|NCT01984424|8633989|P2|Overall Study|Lost to Follow-up|1
2497295|NCT01984424|8633990|P1|Overall Study|Lost to Follow-up|0
2497296|NCT01984424|8633989|P2|Overall Study|Sponsor Decision|1
2497297|NCT01984424|8633990|P1|Overall Study|Sponsor Decision|0
2497298|NCT01984424|8633989|P2|Overall Study|Withdrawal by Subject|5
2497299|NCT01984424|8633990|P1|Overall Study|Withdrawal by Subject|3
2497300|NCT01984294|8634060|P3|Overall Study|Adverse Event|0
2497301|NCT01984294|8634061|P2|Overall Study|Adverse Event|1
2497302|NCT01984294|8634062|P1|Overall Study|Adverse Event|0
2497303|NCT01984294|8634060|P3|Overall Study|Lack of Efficacy|6
2497304|NCT01984294|8634061|P2|Overall Study|Lack of Efficacy|2
2497305|NCT01984294|8634062|P1|Overall Study|Lack of Efficacy|4
2497306|NCT01984294|8634060|P3|Overall Study|Randomized but Never Treated|1
2497307|NCT01984294|8634061|P2|Overall Study|Randomized but Never Treated|0
2497308|NCT01984294|8634062|P1|Overall Study|Randomized but Never Treated|0
2497309|NCT01984242|8634085|P3|Overall Study|Disease Progression|1
2497310|NCT01984242|8634086|P2|Overall Study|Disease Progression|0
2497311|NCT01984242|8634087|P1|Overall Study|Disease Progression|0
2497312|NCT01984242|8634085|P3|Overall Study|Study terminated by Sponsor|34
2497313|NCT01984242|8634086|P2|Overall Study|Study terminated by Sponsor|50
2497314|NCT01984242|8634087|P1|Overall Study|Study terminated by Sponsor|38
2497315|NCT01984242|8634085|P3|Overall Study|Non-Compliance|0
2497316|NCT01984242|8634086|P2|Overall Study|Non-Compliance|0
2497317|NCT01984242|8634087|P1|Overall Study|Non-Compliance|1
2497318|NCT01984242|8634085|P3|Overall Study|Sponsor Decision|0
2497319|NCT01984242|8634086|P2|Overall Study|Sponsor Decision|0
2497320|NCT01984242|8634087|P1|Overall Study|Sponsor Decision|1
2497321|NCT01984242|8634085|P3|Overall Study|Lost to Follow-up|3
2497322|NCT01984242|8634086|P2|Overall Study|Lost to Follow-up|0
2497323|NCT01984242|8634087|P1|Overall Study|Lost to Follow-up|4
2497324|NCT01984242|8634085|P3|Overall Study|Physician Decision|1
2497325|NCT01984242|8634086|P2|Overall Study|Physician Decision|0
2497326|NCT01984242|8634087|P1|Overall Study|Physician Decision|0
2497327|NCT01984242|8634085|P3|Overall Study|Withdrawal by Subject|10
2497328|NCT01984242|8634086|P2|Overall Study|Withdrawal by Subject|3
2497329|NCT01984242|8634087|P1|Overall Study|Withdrawal by Subject|5
2497330|NCT01984242|8634085|P3|Overall Study|Death|52
2497331|NCT01984242|8634086|P2|Overall Study|Death|50
2497332|NCT01984242|8634087|P1|Overall Study|Death|52
2497333|NCT01984229|8634237|P2|Safety Follow-up Period|Lost to Follow-up|0
2497334|NCT01984229|8634238|P1|Safety Follow-up Period|Lost to Follow-up|1
2497335|NCT01984229|8634237|P2|Safety Follow-up Period|Adverse Event|1
2497336|NCT01984229|8634238|P1|Safety Follow-up Period|Adverse Event|1
2497337|NCT01983969|8634291|P3|Overall Study|Disease Progression|0
2497338|NCT01983969|8634292|P2|Overall Study|Disease Progression|1
2497339|NCT01983969|8634293|P1|Overall Study|Disease Progression|0
2497340|NCT01983930|8634307|P2|Overall Study|Adverse Event|1
2497341|NCT01983930|8634308|P1|Overall Study|Adverse Event|0
2497342|NCT01983930|8634307|P2|Overall Study|Withdrawal by Subject|8
2497343|NCT01983930|8634308|P1|Overall Study|Withdrawal by Subject|9
2497344|NCT01983683|8634382|P2|Overall Study|Sponsor Decision|1
2497345|NCT01983683|8634383|P1|Overall Study|Sponsor Decision|1
2497346|NCT01983683|8634382|P2|Overall Study|Lost to Follow-up|8
2497347|NCT01983683|8634383|P1|Overall Study|Lost to Follow-up|4
2497348|NCT01983683|8634382|P2|Overall Study|Physician Decision|9
2497349|NCT01983683|8634383|P1|Overall Study|Physician Decision|8
2497350|NCT01983683|8634382|P2|Overall Study|Death|15
2497351|NCT01983683|8634383|P1|Overall Study|Death|11
2497352|NCT01983683|8634382|P2|Overall Study|Withdrawal by Subject|18
2497353|NCT01983683|8634383|P1|Overall Study|Withdrawal by Subject|14
2497354|NCT01983293|8634470|P2|Overall Study|Missing NYHA/Patient Global Assessment|1
2497355|NCT01983293|8634471|P1|Overall Study|Missing NYHA/Patient Global Assessment|1
2497356|NCT01983293|8634470|P2|Overall Study|Missing 12-month visit|3
2497357|NCT01983293|8634471|P1|Overall Study|Missing 12-month visit|3
2497358|NCT01983293|8634470|P2|Overall Study|Withdrawal by Subject|15
2497359|NCT01983293|8634471|P1|Overall Study|Withdrawal by Subject|29
2497360|NCT01983254|8634479|P2|Overall Study|too ill|8
2497361|NCT01983254|8634480|P1|Overall Study|too ill|11
2497362|NCT01983254|8634479|P2|Overall Study|Lost to Follow-up|16
2497363|NCT01983254|8634480|P1|Overall Study|Lost to Follow-up|17
2497364|NCT01983254|8634479|P2|Overall Study|Death|6
2497365|NCT01983254|8634480|P1|Overall Study|Death|6
2497366|NCT01983111|8634492|P2|Overall Study|Protocol Violation|1
2497367|NCT01983111|8634493|P1|Overall Study|Protocol Violation|0
2497368|NCT01983111|8634492|P2|Overall Study|Adverse Event|0
2497369|NCT01983111|8634493|P1|Overall Study|Adverse Event|4
2497370|NCT01983111|8634492|P2|Overall Study|Withdrawal by Subject|6
2497371|NCT01983111|8634493|P1|Overall Study|Withdrawal by Subject|8
2497372|NCT01982812|8634528|P2|Overall Study|Adverse Event|5
2497373|NCT01982812|8634529|P1|Overall Study|Adverse Event|0
2497374|NCT01982812|8634528|P2|Overall Study|Death|5
2497375|NCT01982812|8634529|P1|Overall Study|Death|1
2497376|NCT01982773|8634543|P2|Overall Study|Lost to Follow-up|1
2497377|NCT01982773|8634544|P1|Overall Study|Lost to Follow-up|7
2497378|NCT01982773|8634543|P2|Overall Study|Withdrawal by Subject|3
2497379|NCT01982773|8634544|P1|Overall Study|Withdrawal by Subject|1
2497380|NCT01982682|8634565|P1|Overall Study|Physician Decision|1
2497381|NCT01982435|8634585|P2|Overall Study|Adverse Event|0
2497382|NCT01982435|8634586|P1|Overall Study|Adverse Event|1
2497383|NCT01982331|8634625|P2|Completed Study (Day 112)|Withdrawal by Subject|0
2497384|NCT01982331|8634626|P1|Completed Study (Day 112)|Withdrawal by Subject|2
2497385|NCT01982331|8634625|P2|Received Vaccination 2|Withdrawal by Subject|1
2497386|NCT01982331|8634626|P1|Received Vaccination 2|Withdrawal by Subject|0
2497387|NCT01982331|8634625|P2|Received Vaccination 2|Adverse Event|2
2497388|NCT01982331|8634626|P1|Received Vaccination 2|Adverse Event|1
2497389|NCT01982292|8634662|P2|Overall Study|Technical Problems|0
2497390|NCT01982292|8634663|P1|Overall Study|Technical Problems|2
2497391|NCT01982292|8634662|P2|Overall Study|Patient/Guardian Decision|1
2497392|NCT01982292|8634663|P1|Overall Study|Patient/Guardian Decision|3
2497393|NCT01982292|8634662|P2|Overall Study|Protocol Deviation|0
2497394|NCT01982292|8634663|P1|Overall Study|Protocol Deviation|1
2497395|NCT01982292|8634662|P2|Overall Study|Non-Compliance With Study Treatment|0
2497396|NCT01982292|8634663|P1|Overall Study|Non-Compliance With Study Treatment|1
2497397|NCT01982292|8634662|P2|Overall Study|Lost to Follow-up|0
2497398|NCT01982292|8634663|P1|Overall Study|Lost to Follow-up|2
2497399|NCT01982292|8634662|P2|Overall Study|Death|0
2497400|NCT01982292|8634663|P1|Overall Study|Death|1
2497401|NCT01982292|8634662|P2|Overall Study|Adverse Event|0
2497402|NCT01982292|8634663|P1|Overall Study|Adverse Event|2
2497403|NCT01982253|8634684|P3|Overall Study|Study terminated by sponsor|4
2497404|NCT01982253|8634685|P2|Overall Study|Study terminated by sponsor|4
2497405|NCT01982253|8634686|P1|Overall Study|Study terminated by sponsor|1
2497406|NCT01982253|8634684|P3|Overall Study|Withdrawal by Subject|0
2497407|NCT01982253|8634685|P2|Overall Study|Withdrawal by Subject|0
2497408|NCT01982253|8634686|P1|Overall Study|Withdrawal by Subject|1
2497409|NCT01981954|8634740|P1|Fixed-Dose Assessment Period|Lack of Efficacy|1
2497410|NCT01981954|8634740|P1|Titration Period|Protocol Deviation|1
2497411|NCT01981616|8634813|P2|Overall Study|Protocol Violation|0
2497412|NCT01981616|8634814|P1|Overall Study|Protocol Violation|1
2497413|NCT01981616|8634813|P2|Overall Study|Adverse Event|1
2497414|NCT01981616|8634814|P1|Overall Study|Adverse Event|0
2497415|NCT01981551|8634844|P1|Overall Study|Adverse Event|1
2497416|NCT01981551|8634844|P1|Overall Study|Refused further treatment|8
2497417|NCT01981473|8634854|P3|Overall Study|Received treatment for >24 months|6
2497418|NCT01981473|8634855|P2|Overall Study|Received treatment for >24 months|0
2497419|NCT01981473|8634856|P1|Overall Study|Received treatment for >24 months|2
2497420|NCT01981473|8634854|P3|Overall Study|Received treatment for < 6 months|1
2497421|NCT01981473|8634855|P2|Overall Study|Received treatment for < 6 months|0
2497422|NCT01981473|8634856|P1|Overall Study|Received treatment for < 6 months|0
2497423|NCT01981473|8634854|P3|Overall Study|Incorrect diagnosis of RA|1
2497424|NCT01981473|8634855|P2|Overall Study|Incorrect diagnosis of RA|0
2497425|NCT01981473|8634856|P1|Overall Study|Incorrect diagnosis of RA|0
2497426|NCT01981356|8634897|P2|Overall Study|Protocol Violation|0
2497427|NCT01981356|8634898|P1|Overall Study|Protocol Violation|2
2497428|NCT01981356|8634897|P2|Overall Study|Withdrawal by Subject|1
2497429|NCT01981356|8634898|P1|Overall Study|Withdrawal by Subject|1
2497430|NCT01981356|8634897|P2|Overall Study|Lost to Follow-up|1
2497431|NCT01981356|8634898|P1|Overall Study|Lost to Follow-up|4
2497432|NCT01981122|8634925|P2|Overall Study|Death|15
2497433|NCT01981122|8634926|P1|Overall Study|Death|14
2497434|NCT01981122|8634925|P2|Overall Study|Investigator Or Dendreon Discretion|1
2497435|NCT01981122|8634926|P1|Overall Study|Investigator Or Dendreon Discretion|0
2497436|NCT01981122|8634925|P2|Overall Study|Lost to Follow-up|1
2497437|NCT01981122|8634926|P1|Overall Study|Lost to Follow-up|0
2497438|NCT01981122|8634925|P2|Overall Study|Protocol Violation|1
2497439|NCT01981122|8634926|P1|Overall Study|Protocol Violation|0
2497440|NCT01981122|8634925|P2|Overall Study|Withdrawal by Subject|2
2497441|NCT01981122|8634926|P1|Overall Study|Withdrawal by Subject|0
2497442|NCT01981109|8634932|P1|Overall Study|No data available|2
2497443|NCT01981109|8634932|P1|Overall Study|Study Termination|100
2497444|NCT01981109|8634932|P1|Overall Study|No Discontinuation Documentation|37
2497445|NCT01981109|8634932|P1|Overall Study|Lost to Follow-up|9
2497446|NCT01981109|8634932|P1|Overall Study|Withdrawal by Subject|40
2497447|NCT01981109|8634932|P1|Overall Study|Death|36
2497448|NCT01981096|8634939|P2|Overall Study|Lost to Follow-up|0
2497449|NCT01981096|8634940|P1|Overall Study|Lost to Follow-up|2
2497450|NCT01981096|8634939|P2|Overall Study|Withdrawal by Subject|1
2497451|NCT01981096|8634940|P1|Overall Study|Withdrawal by Subject|0
2497452|NCT01981096|8634939|P2|Overall Study|Parent illness|0
2497453|NCT01981096|8634940|P1|Overall Study|Parent illness|1
2497454|NCT01980992|8634961|P2|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1
2497455|NCT01980992|8634962|P1|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0
2497456|NCT01980992|8634961|P2|52 Weeks Open Label Active Wheat OIT|Non-compliance|0
2497457|NCT01980992|8634962|P1|52 Weeks Open Label Active Wheat OIT|Non-compliance|1
2497458|NCT01980992|8634961|P2|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0
2497459|NCT01980992|8634962|P1|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2
2497460|NCT01980992|8634961|P2|52 Weeks Blinded Study Treatment|Non-compliance|0
2497461|NCT01980992|8634962|P1|52 Weeks Blinded Study Treatment|Non-compliance|1
2497462|NCT01980992|8634961|P2|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
2497463|NCT01980992|8634962|P1|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
2497464|NCT01980992|8634961|P2|52 Weeks Blinded Study Treatment|Dosing Symptoms|3
2497465|NCT01980992|8634962|P1|52 Weeks Blinded Study Treatment|Dosing Symptoms|0
2497466|NCT01980940|8634987|P8|Overall Study|Protocol Violation|0
2497467|NCT01980940|8634988|P7|Overall Study|Protocol Violation|0
2497468|NCT01980940|8634989|P6|Overall Study|Protocol Violation|2
2497469|NCT01980940|8634990|P5|Overall Study|Protocol Violation|0
2497470|NCT01980940|8634991|P4|Overall Study|Protocol Violation|0
2497471|NCT01980940|8634992|P3|Overall Study|Protocol Violation|0
2497472|NCT01980940|8634993|P2|Overall Study|Protocol Violation|0
2497473|NCT01980940|8634994|P1|Overall Study|Protocol Violation|0
2497474|NCT01980888|8635053|P2|Overall Study|Non-Compliance with Study Drug|2
2497475|NCT01980888|8635054|P1|Overall Study|Non-Compliance with Study Drug|3
2497476|NCT01980888|8635053|P2|Overall Study|Investigator's Discretion|3
2497477|NCT01980888|8635054|P1|Overall Study|Investigator's Discretion|8
2497478|NCT01980888|8635053|P2|Overall Study|Withdrew Consent|6
2497479|NCT01980888|8635054|P1|Overall Study|Withdrew Consent|17
2497480|NCT01980888|8635053|P2|Overall Study|Study Terminated by Sponsor|122
2497481|NCT01980888|8635054|P1|Overall Study|Study Terminated by Sponsor|116
2497482|NCT01980875|8635073|P3|Overall Study|Lost to Follow-up|1
2497483|NCT01980875|8635074|P2|Overall Study|Lost to Follow-up|0
2497484|NCT01980875|8635075|P1|Overall Study|Lost to Follow-up|0
2497485|NCT01980875|8635073|P3|Overall Study|Study Terminated by Sponsor|22
2497486|NCT01980875|8635074|P2|Overall Study|Study Terminated by Sponsor|24
2497487|NCT01980875|8635075|P1|Overall Study|Study Terminated by Sponsor|7
2497488|NCT01980875|8635073|P3|Overall Study|Withdrew Consent|1
2497489|NCT01980875|8635074|P2|Overall Study|Withdrew Consent|1
2497490|NCT01980875|8635075|P1|Overall Study|Withdrew Consent|1
2497491|NCT01980706|8635110|P3|Overall Study|miscellaneous|3
2497492|NCT01980706|8635111|P2|Overall Study|miscellaneous|5
2497493|NCT01980706|8635112|P1|Overall Study|miscellaneous|4
2497494|NCT01980706|8635110|P3|Overall Study|Lost to Follow-up|3
2497495|NCT01980706|8635111|P2|Overall Study|Lost to Follow-up|4
2497496|NCT01980706|8635112|P1|Overall Study|Lost to Follow-up|3
2497497|NCT01980706|8635110|P3|Overall Study|Adverse Event|5
2497498|NCT01980706|8635111|P2|Overall Study|Adverse Event|2
2497499|NCT01980706|8635112|P1|Overall Study|Adverse Event|1
2497500|NCT01980706|8635110|P3|Overall Study|Withdrawal by Subject|2
2497501|NCT01980706|8635111|P2|Overall Study|Withdrawal by Subject|6
2497502|NCT01980706|8635112|P1|Overall Study|Withdrawal by Subject|9
2497503|NCT01980628|8635152|P1|Overall Study|PD, Subj non-Compliant,Study Terminated|42
2497504|NCT01980628|8635152|P1|Overall Study|Withdrawal by Subject|4
2497505|NCT01980628|8635152|P1|Overall Study|Physician Decision|5
2497506|NCT01980628|8635152|P1|Overall Study|Adverse Event|12
2497507|NCT01980095|8635211|P2|Overall Study|Randomized by mistake|0
2497508|NCT01980095|8635212|P1|Overall Study|Randomized by mistake|1
2497509|NCT01980095|8635211|P2|Overall Study|Study drug discontinued|0
2497510|NCT01980095|8635212|P1|Overall Study|Study drug discontinued|1
2497511|NCT01980095|8635211|P2|Overall Study|Safety issue|1
2497512|NCT01980095|8635212|P1|Overall Study|Safety issue|0
2497513|NCT01980095|8635211|P2|Overall Study|Poor compliance|0
2497514|NCT01980095|8635212|P1|Overall Study|Poor compliance|5
2497515|NCT01980095|8635211|P2|Overall Study|Withdrawal by Subject|3
2497516|NCT01980095|8635212|P1|Overall Study|Withdrawal by Subject|2
2497517|NCT01980095|8635211|P2|Overall Study|Lost to Follow-up|7
2497518|NCT01980095|8635212|P1|Overall Study|Lost to Follow-up|6
2497519|NCT01980056|8635223|P3|Overall Study|Death|0
2497520|NCT01980056|8635224|P2|Overall Study|Death|1
2497521|NCT01980056|8635225|P1|Overall Study|Death|1
2497522|NCT01979952|8635239|P2|Overall Study|Other than specified above|0
2497523|NCT01979952|8635240|P1|Overall Study|Other than specified above|1
2497524|NCT01979952|8635239|P2|Overall Study|Withdrawal by Subject|1
2497525|NCT01979952|8635240|P1|Overall Study|Withdrawal by Subject|2
2497526|NCT01979952|8635239|P2|Overall Study|Protocol Violation|0
2497527|NCT01979952|8635240|P1|Overall Study|Protocol Violation|1
2497528|NCT01979952|8635239|P2|Overall Study|Adverse Event|5
2497529|NCT01979952|8635240|P1|Overall Study|Adverse Event|4
2497530|NCT01979835|8635268|P1|Follow-up|Lost to Follow-up|32
2497531|NCT01979835|8635268|P1|Primary Outcome SA Measurment|failed insertion|18
2497532|NCT01979614|8635275|P2|Overall Study|Adverse Event|1
2497533|NCT01979614|8635276|P1|Overall Study|Adverse Event|1
2497534|NCT01979523|8635298|P2|Overall Study|Withdrawal by Subject|0
2497535|NCT01979523|8635299|P1|Overall Study|Withdrawal by Subject|1
2497536|NCT01979185|8635359|P2|Period 2|Other|1
2497537|NCT01979185|8635360|P1|Period 2|Other|0
2497538|NCT01979016|8635408|P2|Overall Study|Adverse Event|1
2497539|NCT01979016|8635409|P1|Overall Study|Adverse Event|0
2497540|NCT01979016|8635408|P2|Overall Study|Withdrawal by Subject|0
2497541|NCT01979016|8635409|P1|Overall Study|Withdrawal by Subject|2
2497542|NCT01978938|8635443|P2|Overall Study|Previously scheduled procedure|1
2497543|NCT01978938|8635444|P1|Overall Study|Previously scheduled procedure|0
2497544|NCT01978938|8635443|P2|Overall Study|Did not meet inclusion criteria|1
2497545|NCT01978938|8635444|P1|Overall Study|Did not meet inclusion criteria|0
2497546|NCT01978938|8635443|P2|Overall Study|Participant noncompliance|1
2497547|NCT01978938|8635444|P1|Overall Study|Participant noncompliance|1
2497548|NCT01978938|8635443|P2|Overall Study|Adverse Event, non-fatal|1
2497549|NCT01978938|8635444|P1|Overall Study|Adverse Event, non-fatal|2
2497550|NCT01978938|8635443|P2|Overall Study|Withdrawal by Subject|4
2497551|NCT01978938|8635444|P1|Overall Study|Withdrawal by Subject|8
2497552|NCT01978938|8635443|P2|Overall Study|Lost to Follow-up|6
2497553|NCT01978938|8635444|P1|Overall Study|Lost to Follow-up|12
2497554|NCT01978912|8635458|P4|Overall Study|Intradiscal Steroid Injection|0
2497555|NCT01978912|8635459|P3|Overall Study|Intradiscal Steroid Injection|0
2497556|NCT01978912|8635460|P2|Overall Study|Intradiscal Steroid Injection|1
2497557|NCT01978912|8635461|P1|Overall Study|Intradiscal Steroid Injection|0
2497558|NCT01978912|8635458|P4|Overall Study|Lumbar Surgery|0
2497559|NCT01978912|8635459|P3|Overall Study|Lumbar Surgery|1
2497560|NCT01978912|8635460|P2|Overall Study|Lumbar Surgery|0
2497561|NCT01978912|8635461|P1|Overall Study|Lumbar Surgery|1
2497562|NCT01978912|8635458|P4|Overall Study|Withdrawal by Subject|2
2497563|NCT01978912|8635459|P3|Overall Study|Withdrawal by Subject|2
2497564|NCT01978912|8635460|P2|Overall Study|Withdrawal by Subject|0
2497565|NCT01978912|8635461|P1|Overall Study|Withdrawal by Subject|1
2497566|NCT01978912|8635458|P4|Overall Study|Lost to Follow-up|1
2497567|NCT01978912|8635459|P3|Overall Study|Lost to Follow-up|0
2497568|NCT01978912|8635460|P2|Overall Study|Lost to Follow-up|1
2497569|NCT01978912|8635461|P1|Overall Study|Lost to Follow-up|1
2497570|NCT01978912|8635458|P4|Overall Study|Adverse Event|0
2497571|NCT01978912|8635459|P3|Overall Study|Adverse Event|0
2497572|NCT01978912|8635460|P2|Overall Study|Adverse Event|1
2497573|NCT01978912|8635461|P1|Overall Study|Adverse Event|0
2497574|NCT01978262|8635632|P1|Overall Study|Lost to Follow-up|2
2497575|NCT01978262|8635632|P1|Overall Study|Withdrawal by Subject|9
2497576|NCT01978236|8635637|P1|Overall Study|Discontinued due to study close|2
2497577|NCT01978184|8635658|P2|Overall Study|Withdrew- toxicities or physical decline|8
2497578|NCT01978184|8635659|P1|Overall Study|Withdrew- toxicities or physical decline|4
2497579|NCT01978184|8635658|P2|Overall Study|Death|0
2497580|NCT01978184|8635659|P1|Overall Study|Death|1
2497581|NCT01978184|8635658|P2|Overall Study|Noncompliance|2
2497582|NCT01978184|8635659|P1|Overall Study|Noncompliance|1
2497583|NCT01978184|8635658|P2|Overall Study|Physician Decision|3
2497584|NCT01978184|8635659|P1|Overall Study|Physician Decision|0
2497585|NCT01978184|8635658|P2|Overall Study|Other than PDA|2
2497586|NCT01978184|8635659|P1|Overall Study|Other than PDA|2
2497587|NCT01978184|8635658|P2|Overall Study|Progressive disease|5
2497588|NCT01978184|8635659|P1|Overall Study|Progressive disease|5
2497589|NCT01978145|8635685|P2|Treatment Period 2|Par. reached defined stopping criteria|5
2497590|NCT01978145|8635686|P1|Treatment Period 2|Par. reached defined stopping criteria|8
2497591|NCT01978145|8635685|P2|Treatment Period 2|Withdrawal by Subject|4
2497592|NCT01978145|8635686|P1|Treatment Period 2|Withdrawal by Subject|7
2497593|NCT01978145|8635685|P2|Treatment Period 2|Lost to Follow-up|1
2497594|NCT01978145|8635686|P1|Treatment Period 2|Lost to Follow-up|1
2497595|NCT01978145|8635685|P2|Treatment Period 2|Protocol Violation|1
2497596|NCT01978145|8635686|P1|Treatment Period 2|Protocol Violation|0
2497597|NCT01978145|8635685|P2|Treatment Period 2|Adverse Event|3
2497598|NCT01978145|8635686|P1|Treatment Period 2|Adverse Event|3
2497599|NCT01978145|8635685|P2|Washout Period 1|Par. reached defined stopping criteria|1
2497600|NCT01978145|8635686|P1|Washout Period 1|Par. reached defined stopping criteria|0
2497601|NCT01978145|8635685|P2|Washout Period 1|Withdrawal by Subject|1
2497602|NCT01978145|8635686|P1|Washout Period 1|Withdrawal by Subject|1
2497603|NCT01978145|8635685|P2|Washout Period 1|Adverse Event|1
2497604|NCT01978145|8635686|P1|Washout Period 1|Adverse Event|0
2497605|NCT01978145|8635685|P2|Treatment Period 1|Par. reached defined stopping criteria|3
2497606|NCT01978145|8635686|P1|Treatment Period 1|Par. reached defined stopping criteria|2
2497607|NCT01978145|8635685|P2|Treatment Period 1|Withdrawal by Subject|4
2497608|NCT01978145|8635686|P1|Treatment Period 1|Withdrawal by Subject|5
2497609|NCT01978145|8635685|P2|Treatment Period 1|Physician Decision|0
2497610|NCT01978145|8635686|P1|Treatment Period 1|Physician Decision|1
2497611|NCT01978145|8635685|P2|Treatment Period 1|Adverse Event|9
2497612|NCT01978145|8635686|P1|Treatment Period 1|Adverse Event|1
2497613|NCT01978119|8635702|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
2497614|NCT01978119|8635703|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
2497615|NCT01978119|8635702|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
2497616|NCT01978119|8635703|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
2497617|NCT01978119|8635702|P2|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0
2497618|NCT01978119|8635703|P1|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1
2497619|NCT01978093|8635729|P2|Overall Study|N/A for vaccine administration|1
2497620|NCT01978093|8635730|P1|Overall Study|N/A for vaccine administration|0
2497621|NCT01978093|8635729|P2|Overall Study|Child was in care of grandmother|1
2497622|NCT01978093|8635730|P1|Overall Study|Child was in care of grandmother|0
2497623|NCT01978093|8635729|P2|Overall Study|Mother lost custody of child|1
2497624|NCT01978093|8635730|P1|Overall Study|Mother lost custody of child|0
2497625|NCT01978093|8635729|P2|Overall Study|Lost kaiser health plan unable to contac|0
2497626|NCT01978093|8635730|P1|Overall Study|Lost kaiser health plan unable to contac|1
2497627|NCT01978093|8635729|P2|Overall Study|Loss of kaiser coverage|10
2497628|NCT01978093|8635730|P1|Overall Study|Loss of kaiser coverage|4
2497629|NCT01978093|8635729|P2|Overall Study|Migrated/moved from study area|13
2497630|NCT01978093|8635730|P1|Overall Study|Migrated/moved from study area|11
2497631|NCT01978093|8635729|P2|Overall Study|Lost to Follow-up|15
2497632|NCT01978093|8635730|P1|Overall Study|Lost to Follow-up|11
2497633|NCT01978093|8635729|P2|Overall Study|Withdrawal by Subject|25
2497634|NCT01978093|8635730|P1|Overall Study|Withdrawal by Subject|29
2497635|NCT01978093|8635729|P2|Overall Study|Protocol Violation|2
2497636|NCT01978093|8635730|P1|Overall Study|Protocol Violation|8
2497637|NCT01978093|8635729|P2|Overall Study|Adverse Event|5
2497638|NCT01978093|8635730|P1|Overall Study|Adverse Event|0
2497639|NCT01978093|8635729|P2|Overall Study|Death|0
2497640|NCT01978093|8635730|P1|Overall Study|Death|1
2497641|NCT01977937|8635774|P2|Overall Study|Physician Decision|1
2497642|NCT01977937|8635775|P1|Overall Study|Physician Decision|0
2497643|NCT01977937|8635774|P2|Overall Study|Adverse Event|0
2497644|NCT01977937|8635775|P1|Overall Study|Adverse Event|1
2497645|NCT01977937|8635774|P2|Overall Study|Withdrawal by Subject|1
2497646|NCT01977937|8635775|P1|Overall Study|Withdrawal by Subject|2
2497647|NCT01977846|8635785|P2|Total Study - Prospective|Protocol Violation|1
2497648|NCT01977846|8635786|P1|Total Study - Prospective|Protocol Violation|0
2497649|NCT01977846|8635785|P2|Total Study - Prospective|No show|1
2497650|NCT01977846|8635786|P1|Total Study - Prospective|No show|0
2497651|NCT01977846|8635785|P2|Total Study - Prospective|Not available at time of visit|5
2497652|NCT01977846|8635786|P1|Total Study - Prospective|Not available at time of visit|0
2497653|NCT01977846|8635785|P2|Total Study - Prospective|Withdrawal by Subject|13
2497654|NCT01977846|8635786|P1|Total Study - Prospective|Withdrawal by Subject|0
2497655|NCT01977846|8635785|P2|Total Study - Prospective|Lost to Follow-up|8
2497656|NCT01977846|8635786|P1|Total Study - Prospective|Lost to Follow-up|0
2497657|NCT01977846|8635785|P2|Total Study - Prospective|Death|1
2497658|NCT01977846|8635786|P1|Total Study - Prospective|Death|0
2497659|NCT01977820|8635804|P2|Overall Study|Sponsor terminated the study|1
2497660|NCT01977820|8635805|P1|Overall Study|Sponsor terminated the study|1
2497661|NCT01977794|8635813|P2|Overall Study|Other|1
2497662|NCT01977794|8635814|P1|Overall Study|Other|0
2497663|NCT01977794|8635813|P2|Overall Study|Withdrew consent|1
2497664|NCT01977794|8635814|P1|Overall Study|Withdrew consent|2
2497665|NCT01977794|8635813|P2|Overall Study|Death|1
2497666|NCT01977794|8635814|P1|Overall Study|Death|1
2497667|NCT01977794|8635813|P2|Overall Study|Protocol Violation|0
2497668|NCT01977794|8635814|P1|Overall Study|Protocol Violation|1
2497669|NCT01977794|8635813|P2|Overall Study|Lost to Follow-up|1
2497670|NCT01977794|8635814|P1|Overall Study|Lost to Follow-up|2
2497671|NCT01977794|8635813|P2|Overall Study|Adverse Event|2
2497672|NCT01977794|8635814|P1|Overall Study|Adverse Event|2
2497673|NCT01977729|8635849|P1|Overall Study|Study terminated|1
2497674|NCT01977690|8635861|P2|Overall Study|Withdrawal by Subject|4
2497675|NCT01977690|8635862|P1|Overall Study|Withdrawal by Subject|0
2497676|NCT01977677|8635871|P3|Overall Study|Unrelated Adverse Event|1
2497677|NCT01977677|8635872|P2|Overall Study|Unrelated Adverse Event|0
2497678|NCT01977677|8635873|P1|Overall Study|Unrelated Adverse Event|0
2497679|NCT01977625|8635884|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
2497680|NCT01977625|8635885|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
2497681|NCT01977625|8635884|P2|First Intervention (4 Weeks)|Withdrawal by Subject|0
2497682|NCT01977625|8635885|P1|First Intervention (4 Weeks)|Withdrawal by Subject|3
2497683|NCT01977612|8635895|P2|Overall Study|Lost to Follow-up|1
2497684|NCT01977612|8635896|P1|Overall Study|Lost to Follow-up|1
2497685|NCT01977573|8635918|P4|Overall Study|Withdrawal by Subject|1
2497686|NCT01977573|8635919|P3|Overall Study|Withdrawal by Subject|1
2497687|NCT01977573|8635920|P2|Overall Study|Withdrawal by Subject|1
2497688|NCT01977573|8635921|P1|Overall Study|Withdrawal by Subject|6
2497689|NCT01977573|8635918|P4|Overall Study|Reached Defined Stopping Criteria|0
2497690|NCT01977573|8635919|P3|Overall Study|Reached Defined Stopping Criteria|1
2497691|NCT01977573|8635920|P2|Overall Study|Reached Defined Stopping Criteria|1
2497692|NCT01977573|8635921|P1|Overall Study|Reached Defined Stopping Criteria|2
2497693|NCT01977573|8635918|P4|Overall Study|Protocol Violation|0
2497694|NCT01977573|8635919|P3|Overall Study|Protocol Violation|0
2497695|NCT01977573|8635920|P2|Overall Study|Protocol Violation|1
2497696|NCT01977573|8635921|P1|Overall Study|Protocol Violation|3
2497697|NCT01977573|8635918|P4|Overall Study|Physician Decision|0
2497698|NCT01977573|8635919|P3|Overall Study|Physician Decision|0
2497699|NCT01977573|8635920|P2|Overall Study|Physician Decision|0
2497700|NCT01977573|8635921|P1|Overall Study|Physician Decision|1
2497701|NCT01977573|8635918|P4|Overall Study|Lost to Follow-up|1
2497702|NCT01977573|8635919|P3|Overall Study|Lost to Follow-up|0
2497703|NCT01977573|8635920|P2|Overall Study|Lost to Follow-up|0
2497704|NCT01977573|8635921|P1|Overall Study|Lost to Follow-up|1
2497705|NCT01977573|8635918|P4|Overall Study|Adverse Event|1
2497706|NCT01977573|8635919|P3|Overall Study|Adverse Event|2
2497707|NCT01977573|8635920|P2|Overall Study|Adverse Event|0
2497708|NCT01977573|8635921|P1|Overall Study|Adverse Event|7
2497709|NCT01977482|8636035|P6|Overall Study|Withdrawal by Subject|5
2497710|NCT01977482|8636036|P5|Overall Study|Withdrawal by Subject|1
2497711|NCT01977482|8636037|P4|Overall Study|Withdrawal by Subject|3
2497712|NCT01977482|8636038|P3|Overall Study|Withdrawal by Subject|1
2497713|NCT01977482|8636039|P2|Overall Study|Withdrawal by Subject|4
2497714|NCT01977482|8636040|P1|Overall Study|Withdrawal by Subject|2
2497715|NCT01977482|8636035|P6|Overall Study|Other-Protocol-defined Stopping Criteria|0
2497716|NCT01977482|8636036|P5|Overall Study|Other-Protocol-defined Stopping Criteria|0
2497717|NCT01977482|8636037|P4|Overall Study|Other-Protocol-defined Stopping Criteria|1
2497718|NCT01977482|8636038|P3|Overall Study|Other-Protocol-defined Stopping Criteria|2
2497719|NCT01977482|8636039|P2|Overall Study|Other-Protocol-defined Stopping Criteria|3
2497720|NCT01977482|8636040|P1|Overall Study|Other-Protocol-defined Stopping Criteria|0
2497721|NCT01977482|8636035|P6|Overall Study|Protocol Violation|0
2497722|NCT01977482|8636036|P5|Overall Study|Protocol Violation|0
2497723|NCT01977482|8636037|P4|Overall Study|Protocol Violation|0
2497724|NCT01977482|8636038|P3|Overall Study|Protocol Violation|1
2497725|NCT01977482|8636039|P2|Overall Study|Protocol Violation|0
2497726|NCT01977482|8636040|P1|Overall Study|Protocol Violation|0
2497727|NCT01977482|8636035|P6|Overall Study|Physician Decision|0
2497728|NCT01977482|8636036|P5|Overall Study|Physician Decision|0
2497729|NCT01977482|8636037|P4|Overall Study|Physician Decision|0
2497730|NCT01977482|8636038|P3|Overall Study|Physician Decision|0
2497731|NCT01977482|8636039|P2|Overall Study|Physician Decision|1
2497732|NCT01977482|8636040|P1|Overall Study|Physician Decision|0
2497733|NCT01977482|8636035|P6|Overall Study|Lost to Follow-up|0
2497734|NCT01977482|8636036|P5|Overall Study|Lost to Follow-up|0
2497735|NCT01977482|8636037|P4|Overall Study|Lost to Follow-up|0
2497736|NCT01977482|8636038|P3|Overall Study|Lost to Follow-up|0
2497737|NCT01977482|8636039|P2|Overall Study|Lost to Follow-up|0
2497738|NCT01977482|8636040|P1|Overall Study|Lost to Follow-up|1
2497739|NCT01977482|8636035|P6|Overall Study|Adverse Event|0
2497740|NCT01977482|8636036|P5|Overall Study|Adverse Event|2
2497741|NCT01977482|8636037|P4|Overall Study|Adverse Event|0
2497742|NCT01977482|8636038|P3|Overall Study|Adverse Event|1
2497743|NCT01977482|8636039|P2|Overall Study|Adverse Event|1
2497744|NCT01977482|8636040|P1|Overall Study|Adverse Event|0
2497745|NCT01977456|8636155|P1|Overall Study|Death|5
2497746|NCT01977352|8636164|P2|Overall Study|Lost to Follow-up|2
2497747|NCT01977352|8636165|P1|Overall Study|Lost to Follow-up|1
2497748|NCT01977222|8636183|P1|Overall Study|Withdrawal by Subject|1
2497749|NCT01977092|8636196|P2|Overall Study|In prison|11
2497750|NCT01977092|8636197|P1|Overall Study|In prison|3
2497751|NCT01977092|8636196|P2|Overall Study|Withdrawal by Subject|1
2497752|NCT01977092|8636197|P1|Overall Study|Withdrawal by Subject|2
2497753|NCT01977092|8636196|P2|Overall Study|Lost to Follow-up|14
2497754|NCT01977092|8636197|P1|Overall Study|Lost to Follow-up|23
2497755|NCT01977092|8636196|P2|Overall Study|Death|4
2497756|NCT01977092|8636197|P1|Overall Study|Death|3
2497757|NCT01977040|8636207|P1|Overall Study|Vasa previa not confirmed|2
2497758|NCT01976845|8636261|P3|Overall Study|Physician Decision|3
2497759|NCT01976845|8636262|P2|Overall Study|Physician Decision|8
2497760|NCT01976845|8636263|P1|Overall Study|Physician Decision|8
2497761|NCT01976806|8636288|P2|Overall Study|Withdrawal by Subject|1
2497762|NCT01976806|8636289|P1|Overall Study|Withdrawal by Subject|1
2497763|NCT01976806|8636288|P2|Overall Study|Adverse Event|1
2497764|NCT01976806|8636289|P1|Overall Study|Adverse Event|1
2497765|NCT01976806|8636288|P2|Overall Study|Lost to Follow-up|4
2497766|NCT01976806|8636289|P1|Overall Study|Lost to Follow-up|1
2497767|NCT01976741|8636327|P10|Overall Study|Adverse Event|4
2497768|NCT01976741|8636328|P9|Overall Study|Adverse Event|1
2497769|NCT01976741|8636329|P8|Overall Study|Adverse Event|8
2497770|NCT01976741|8636330|P7|Overall Study|Adverse Event|3
2497771|NCT01976741|8636331|P6|Overall Study|Adverse Event|0
2497772|NCT01976741|8636332|P5|Overall Study|Adverse Event|0
2497773|NCT01976741|8636333|P4|Overall Study|Adverse Event|0
2497774|NCT01976741|8636334|P3|Overall Study|Adverse Event|2
2497775|NCT01976741|8636335|P2|Overall Study|Adverse Event|0
2497776|NCT01976741|8636336|P1|Overall Study|Adverse Event|0
2497777|NCT01976741|8636327|P10|Overall Study|Withdrawal by Subject|0
2497778|NCT01976741|8636328|P9|Overall Study|Withdrawal by Subject|0
2497779|NCT01976741|8636329|P8|Overall Study|Withdrawal by Subject|4
2497780|NCT01976741|8636330|P7|Overall Study|Withdrawal by Subject|1
2497781|NCT01976741|8636331|P6|Overall Study|Withdrawal by Subject|0
2497782|NCT01976741|8636332|P5|Overall Study|Withdrawal by Subject|0
2497783|NCT01976741|8636333|P4|Overall Study|Withdrawal by Subject|1
2497784|NCT01976741|8636334|P3|Overall Study|Withdrawal by Subject|1
2497785|NCT01976741|8636335|P2|Overall Study|Withdrawal by Subject|0
2497786|NCT01976741|8636336|P1|Overall Study|Withdrawal by Subject|1
2497787|NCT01976663|8636574|P1|Overall Study|Lost to Follow-up|3
2497788|NCT01976663|8636574|P1|Overall Study|Adverse Event|2
2497789|NCT01976663|8636574|P1|Overall Study|Screen Failure|3
2497790|NCT01976663|8636574|P1|Overall Study|Withdrawal by Subject|4
2497791|NCT01976663|8636574|P1|Overall Study|Personal Reasons|6
2497792|NCT01976663|8636574|P1|Overall Study|Completed 18 mos but no repeat treatment|24
2497793|NCT01976624|8636593|P1|Overall Study|Participants age less than 19 years|12
2497794|NCT01976624|8636593|P1|Overall Study|Participants contraindicated|2
2497795|NCT01976507|8636621|P1|Overall Study|ablation not done, drug not given|1
2497796|NCT01976507|8636621|P1|Overall Study|Adverse Event|6
2497797|NCT01976338|8636654|P2|Overall Study|Adverse Event|1
2497798|NCT01976338|8636655|P1|Overall Study|Adverse Event|5
2497799|NCT01976338|8636654|P2|Overall Study|Withdrawal by Subject|2
2497800|NCT01976338|8636655|P1|Overall Study|Withdrawal by Subject|5
2497801|NCT01976338|8636654|P2|Overall Study|Lost to Follow-up|0
2497802|NCT01976338|8636655|P1|Overall Study|Lost to Follow-up|3
2497803|NCT01976338|8636654|P2|Overall Study|Physician Decision|1
2497804|NCT01976338|8636655|P1|Overall Study|Physician Decision|0
2497805|NCT01976312|8636682|P2|Overall Study|Protocol Violation|0
2497806|NCT01976312|8636683|P1|Overall Study|Protocol Violation|2
2497807|NCT01976312|8636682|P2|Overall Study|Adverse Event|6
2497808|NCT01976312|8636683|P1|Overall Study|Adverse Event|6
2497809|NCT01976312|8636682|P2|Overall Study|Withdrawal by Subject|2
2497810|NCT01976312|8636683|P1|Overall Study|Withdrawal by Subject|7
2497811|NCT01976312|8636682|P2|Overall Study|Lost to Follow-up|0
2497812|NCT01976312|8636683|P1|Overall Study|Lost to Follow-up|2
2497813|NCT01976312|8636682|P2|Overall Study|Pregnancy|1
2497814|NCT01976312|8636683|P1|Overall Study|Pregnancy|0
2497815|NCT01976299|8636704|P2|Overall Study|See clarification above in comments|2
2497816|NCT01976299|8636705|P1|Overall Study|See clarification above in comments|9
2497817|NCT01976299|8636704|P2|Overall Study|Lost to Follow-up|1
2497818|NCT01976299|8636705|P1|Overall Study|Lost to Follow-up|7
2497819|NCT01976299|8636704|P2|Overall Study|Death|2
2497820|NCT01976299|8636705|P1|Overall Study|Death|4
2497821|NCT01976299|8636704|P2|Overall Study|Withdrawal by Subject|1
2497822|NCT01976299|8636705|P1|Overall Study|Withdrawal by Subject|3
2497823|NCT01976104|8636732|P4|Overall Study|Other|0
2497824|NCT01976104|8636733|P3|Overall Study|Other|0
2497825|NCT01976104|8636734|P2|Overall Study|Other|1
2497826|NCT01976104|8636735|P1|Overall Study|Other|0
2497827|NCT01976104|8636732|P4|Overall Study|Withdrawal by Subject|1
2497828|NCT01976104|8636733|P3|Overall Study|Withdrawal by Subject|0
2497829|NCT01976104|8636734|P2|Overall Study|Withdrawal by Subject|0
2497830|NCT01976104|8636735|P1|Overall Study|Withdrawal by Subject|3
2497831|NCT01976104|8636732|P4|Overall Study|Subject Choice|1
2497832|NCT01976104|8636733|P3|Overall Study|Subject Choice|0
2497833|NCT01976104|8636734|P2|Overall Study|Subject Choice|1
2497834|NCT01976104|8636735|P1|Overall Study|Subject Choice|0
2497835|NCT01976104|8636732|P4|Overall Study|Lost to Follow-up|1
2497836|NCT01976104|8636733|P3|Overall Study|Lost to Follow-up|1
2497837|NCT01976104|8636734|P2|Overall Study|Lost to Follow-up|0
2497838|NCT01976104|8636735|P1|Overall Study|Lost to Follow-up|3
2497839|NCT01976104|8636732|P4|Overall Study|Adverse Event|0
2497840|NCT01976104|8636733|P3|Overall Study|Adverse Event|1
2497841|NCT01976104|8636734|P2|Overall Study|Adverse Event|0
2497842|NCT01976104|8636735|P1|Overall Study|Adverse Event|0
2497843|NCT01975948|8636769|P4|Overall Study|Withdrawal by Subject|6
2497844|NCT01975948|8636770|P3|Overall Study|Withdrawal by Subject|7
2497845|NCT01975948|8636771|P2|Overall Study|Withdrawal by Subject|21
2497846|NCT01975948|8636772|P1|Overall Study|Withdrawal by Subject|17
2497847|NCT01975701|8636839|P1|Overall Study|Physician Decision|1
2497848|NCT01975701|8636839|P1|Overall Study|Death|23
2497849|NCT01975701|8636839|P1|Overall Study|Lost to Follow-up|1
2497850|NCT01975675|8636850|P4|Overall Study|Death|0
2497851|NCT01975675|8636851|P3|Overall Study|Death|0
2497852|NCT01975675|8636852|P2|Overall Study|Death|1
2497853|NCT01975675|8636853|P1|Overall Study|Death|0
2497854|NCT01975389|8636886|P2|Overall Study|Randomized, not treated|5
2497855|NCT01975389|8636887|P1|Overall Study|Randomized, not treated|4
2497856|NCT01975389|8636886|P2|Overall Study|Other|9
2497857|NCT01975389|8636887|P1|Overall Study|Other|6
2497858|NCT01975389|8636886|P2|Overall Study|Withdrawal by Subject|76
2497859|NCT01975389|8636887|P1|Overall Study|Withdrawal by Subject|90
2497860|NCT01975389|8636886|P2|Overall Study|Lost to Follow-up|86
2497861|NCT01975389|8636887|P1|Overall Study|Lost to Follow-up|81
2497862|NCT01975389|8636886|P2|Overall Study|Death|54
2497863|NCT01975389|8636887|P1|Overall Study|Death|61
2497864|NCT01975389|8636886|P2|Overall Study|Adverse Event|6
2497865|NCT01975389|8636887|P1|Overall Study|Adverse Event|10
2497866|NCT01975376|8636947|P2|Overall Study|Randomized, Not Treated|8
2497867|NCT01975376|8636948|P1|Overall Study|Randomized, Not Treated|16
2497868|NCT01975376|8636947|P2|Overall Study|Other|4
2497869|NCT01975376|8636948|P1|Overall Study|Other|2
2497870|NCT01975376|8636947|P2|Overall Study|Withdrew consent|62
2497871|NCT01975376|8636948|P1|Overall Study|Withdrew consent|68
2497872|NCT01975376|8636947|P2|Overall Study|Lost to Follow-up|66
2497873|NCT01975376|8636948|P1|Overall Study|Lost to Follow-up|70
2497874|NCT01975376|8636947|P2|Overall Study|Death|72
2497875|NCT01975376|8636948|P1|Overall Study|Death|65
2497876|NCT01975376|8636947|P2|Overall Study|Adverse Event|5
2497877|NCT01975376|8636948|P1|Overall Study|Adverse Event|5
2497878|NCT01975285|8637008|P2|Overall Study|Failed Block and follow up|2
2497879|NCT01975285|8637009|P1|Overall Study|Failed Block and follow up|2
2497880|NCT01975246|8637025|P2|Overall Study|Other than stated|1
2497881|NCT01975246|8637026|P1|Overall Study|Other than stated|0
2497882|NCT01975246|8637025|P2|Overall Study|Protocol Violation|0
2497883|NCT01975246|8637026|P1|Overall Study|Protocol Violation|1
2497884|NCT01975246|8637025|P2|Overall Study|Lack of Efficacy|0
2497885|NCT01975246|8637026|P1|Overall Study|Lack of Efficacy|1
2497886|NCT01975246|8637025|P2|Overall Study|Adverse Event|1
2497887|NCT01975246|8637026|P1|Overall Study|Adverse Event|2
2497888|NCT01975220|8637039|P6|Test Period 1|Not treated|0
2497889|NCT01975220|8637040|P5|Test Period 1|Not treated|0
2497890|NCT01975220|8637041|P4|Test Period 1|Not treated|0
2497891|NCT01975220|8637042|P3|Test Period 1|Not treated|0
2497892|NCT01975220|8637043|P2|Test Period 1|Not treated|1
2497893|NCT01975220|8637044|P1|Test Period 1|Not treated|0
2497894|NCT01974895|8637100|P2|Overall Study|Other (Reason unknown)|8
2497895|NCT01974895|8637101|P1|Overall Study|Other (Reason unknown)|9
2497896|NCT01974895|8637100|P2|Overall Study|Other (Missed Visit)|0
2497897|NCT01974895|8637101|P1|Overall Study|Other (Missed Visit)|1
2497898|NCT01974895|8637100|P2|Overall Study|Withdrawal by Subject|1
2497899|NCT01974895|8637101|P1|Overall Study|Withdrawal by Subject|0
2497900|NCT01974895|8637100|P2|Overall Study|Lost to Follow-up|6
2497901|NCT01974895|8637101|P1|Overall Study|Lost to Follow-up|4
2497902|NCT01974895|8637100|P2|Overall Study|Protocol Violation|0
2497903|NCT01974895|8637101|P1|Overall Study|Protocol Violation|1
2497904|NCT01974817|8637131|P1|Overall Study|Protocol Violation|2
2497905|NCT01974817|8637131|P1|Overall Study|Lost to Follow-up|2
2497906|NCT01974817|8637131|P1|Overall Study|Death|4
2497907|NCT01974752|8637137|P2|Overall Study|Other Eligibility Criteria|1
2497908|NCT01974752|8637138|P1|Overall Study|Other Eligibility Criteria|0
2497909|NCT01974752|8637137|P2|Overall Study|Withdrawal by Subject|3
2497910|NCT01974752|8637138|P1|Overall Study|Withdrawal by Subject|2
2497911|NCT01974752|8637137|P2|Overall Study|Lost to Follow-up|0
2497912|NCT01974752|8637138|P1|Overall Study|Lost to Follow-up|2
2497913|NCT01974752|8637137|P2|Overall Study|Death|11
2497914|NCT01974752|8637138|P1|Overall Study|Death|33
2497915|NCT01974323|8637566|P2|Overall Study|Adverse Event|2
2497916|NCT01974323|8637567|P1|Overall Study|Adverse Event|2
2497917|NCT01974323|8637566|P2|Overall Study|Lack of Efficacy|1
2497918|NCT01974323|8637567|P1|Overall Study|Lack of Efficacy|1
2497919|NCT01974323|8637566|P2|Overall Study|Pregnancy|1
2497920|NCT01974323|8637567|P1|Overall Study|Pregnancy|2
2497921|NCT01974323|8637566|P2|Overall Study|Lost to Follow-up|40
2497922|NCT01974323|8637567|P1|Overall Study|Lost to Follow-up|45
2497923|NCT01974323|8637566|P2|Overall Study|Personal Reasons|19
2497924|NCT01974323|8637567|P1|Overall Study|Personal Reasons|15
2497925|NCT01974323|8637566|P2|Overall Study|Protocol Violation|2
2497926|NCT01974323|8637567|P1|Overall Study|Protocol Violation|2
2497927|NCT01974323|8637566|P2|Overall Study|Other Reasons|28
2497928|NCT01974323|8637567|P1|Overall Study|Other Reasons|25
2497929|NCT01974141|8637607|P2|Overall Study|Adverse Event|5
2497930|NCT01974141|8637608|P1|Overall Study|Adverse Event|4
2497931|NCT01974141|8637607|P2|Overall Study|Lack of Efficacy|1
2497932|NCT01974141|8637608|P1|Overall Study|Lack of Efficacy|0
2497933|NCT01974141|8637607|P2|Overall Study|Pregnancy|3
2497934|NCT01974141|8637608|P1|Overall Study|Pregnancy|3
2497935|NCT01974141|8637607|P2|Overall Study|Lost to Follow-up|29
2497936|NCT01974141|8637608|P1|Overall Study|Lost to Follow-up|38
2497937|NCT01974141|8637607|P2|Overall Study|Personal Reasons|20
2497938|NCT01974141|8637608|P1|Overall Study|Personal Reasons|21
2497939|NCT01974141|8637607|P2|Overall Study|Protocol Violation|6
2497940|NCT01974141|8637608|P1|Overall Study|Protocol Violation|2
2497941|NCT01974141|8637607|P2|Overall Study|Other Reasons|18
2497942|NCT01974141|8637608|P1|Overall Study|Other Reasons|28
2497943|NCT01973998|8637652|P2|Overall Study|Death|2
2497944|NCT01973998|8637653|P1|Overall Study|Death|2
2497945|NCT01973595|8637715|P4|Washout|Withdrawal by Subject|0
2497946|NCT01973595|8637716|P3|Washout|Withdrawal by Subject|1
2497947|NCT01973595|8637717|P2|Washout|Withdrawal by Subject|0
2497948|NCT01973595|8637718|P1|Washout|Withdrawal by Subject|1
2497949|NCT01973569|8637735|P3|Overall Study|Did not receive study drug|3
2497950|NCT01973569|8637736|P2|Overall Study|Did not receive study drug|3
2497951|NCT01973569|8637737|P1|Overall Study|Did not receive study drug|6
2497952|NCT01973569|8637735|P3|Overall Study|Other|0
2497953|NCT01973569|8637736|P2|Overall Study|Other|1
2497954|NCT01973569|8637737|P1|Overall Study|Other|1
2497955|NCT01973569|8637735|P3|Overall Study|Disease progression|0
2497956|NCT01973569|8637736|P2|Overall Study|Disease progression|3
2497957|NCT01973569|8637737|P1|Overall Study|Disease progression|0
2497958|NCT01973569|8637735|P3|Overall Study|Prohibited concomitant d|0
2497959|NCT01973569|8637736|P2|Overall Study|Prohibited concomitant d|5
2497960|NCT01973569|8637737|P1|Overall Study|Prohibited concomitant d|1
2497961|NCT01973569|8637735|P3|Overall Study|Invasive dental treatment|6
2497962|NCT01973569|8637736|P2|Overall Study|Invasive dental treatment|5
2497963|NCT01973569|8637737|P1|Overall Study|Invasive dental treatment|3
2497964|NCT01973569|8637735|P3|Overall Study|Withdrawal by Subject|2
2497965|NCT01973569|8637736|P2|Overall Study|Withdrawal by Subject|5
2497966|NCT01973569|8637737|P1|Overall Study|Withdrawal by Subject|7
2497967|NCT01973569|8637735|P3|Overall Study|Protocol Violation|3
2497968|NCT01973569|8637736|P2|Overall Study|Protocol Violation|1
2497969|NCT01973569|8637737|P1|Overall Study|Protocol Violation|2
2497970|NCT01973569|8637735|P3|Overall Study|Adverse Event|4
2497971|NCT01973569|8637736|P2|Overall Study|Adverse Event|2
2497972|NCT01973569|8637737|P1|Overall Study|Adverse Event|9
2497973|NCT01973491|8637763|P1|Treatment Period (16 Weeks)|Adverse Event|1
2497974|NCT01973491|8637763|P1|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1
2497975|NCT01973491|8637763|P1|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17
2497976|NCT01973439|8637779|P1|Overall Study|PK curve incomplete|2
2497977|NCT01973439|8637779|P1|Overall Study|Vomiting after commencing once daily|1
2497978|NCT01973439|8637779|P1|Overall Study|Lost samples from one PK Day|2
2497979|NCT01973387|8637801|P2|Overall Study|Randomized, not treated|2
2497980|NCT01973387|8637802|P1|Overall Study|Randomized, not treated|2
2497981|NCT01973387|8637801|P2|Overall Study|Death|3
2497982|NCT01973387|8637802|P1|Overall Study|Death|4
2497983|NCT01973387|8637801|P2|Overall Study|Progressive disease or relapse|5
2497984|NCT01973387|8637802|P1|Overall Study|Progressive disease or relapse|16
2497985|NCT01973387|8637801|P2|Overall Study|Study terminated by sponsor|0
2497986|NCT01973387|8637802|P1|Overall Study|Study terminated by sponsor|63
2497987|NCT01973387|8637801|P2|Overall Study|Withdrawal by Subject|4
2497988|NCT01973387|8637802|P1|Overall Study|Withdrawal by Subject|7
2497989|NCT01973387|8637801|P2|Overall Study|Adverse Event|4
2497990|NCT01973387|8637802|P1|Overall Study|Adverse Event|14
2497991|NCT01973231|8637884|P2|Overall Study|Withdrawal by Subject|9
2497992|NCT01973231|8637885|P1|Overall Study|Withdrawal by Subject|7
2497993|NCT01973231|8637884|P2|Overall Study|unclassified|1
2497994|NCT01973231|8637885|P1|Overall Study|unclassified|2
2497995|NCT01973231|8637884|P2|Overall Study|Lost to Follow-up|1
2497996|NCT01973231|8637885|P1|Overall Study|Lost to Follow-up|1
2497997|NCT01973231|8637884|P2|Overall Study|Protocol Violation|1
2497998|NCT01973231|8637885|P1|Overall Study|Protocol Violation|1
2497999|NCT01973218|8637905|P2|Overall Study|Withdrawal by Subject|0
2498000|NCT01973218|8637906|P1|Overall Study|Withdrawal by Subject|1
2498001|NCT01973218|8637905|P2|Overall Study|Adverse Event|0
2498002|NCT01973218|8637906|P1|Overall Study|Adverse Event|1
2498003|NCT01972841|8637999|P6|Overall Study|Did not have end of treatment page|0
2498004|NCT01972841|8638000|P5|Overall Study|Did not have end of treatment page|1
2498005|NCT01972841|8638001|P4|Overall Study|Did not have end of treatment page|0
2498006|NCT01972841|8638002|P3|Overall Study|Did not have end of treatment page|0
2498007|NCT01972841|8638003|P2|Overall Study|Did not have end of treatment page|0
2498008|NCT01972841|8638004|P1|Overall Study|Did not have end of treatment page|0
2498009|NCT01972841|8637999|P6|Overall Study|Miscellaneous|4
2498010|NCT01972841|8638000|P5|Overall Study|Miscellaneous|0
2498011|NCT01972841|8638001|P4|Overall Study|Miscellaneous|1
2498012|NCT01972841|8638002|P3|Overall Study|Miscellaneous|4
2498013|NCT01972841|8638003|P2|Overall Study|Miscellaneous|0
2498014|NCT01972841|8638004|P1|Overall Study|Miscellaneous|0
2498015|NCT01972841|8637999|P6|Overall Study|Withdrawal by participants|34
2498016|NCT01972841|8638000|P5|Overall Study|Withdrawal by participants|33
2498017|NCT01972841|8638001|P4|Overall Study|Withdrawal by participants|16
2498018|NCT01972841|8638002|P3|Overall Study|Withdrawal by participants|23
2498019|NCT01972841|8638003|P2|Overall Study|Withdrawal by participants|27
2498020|NCT01972841|8638004|P1|Overall Study|Withdrawal by participants|21
2498021|NCT01972841|8637999|P6|Overall Study|Protocol Violation|4
2498022|NCT01972841|8638000|P5|Overall Study|Protocol Violation|9
2498023|NCT01972841|8638001|P4|Overall Study|Protocol Violation|5
2498024|NCT01972841|8638002|P3|Overall Study|Protocol Violation|3
2498025|NCT01972841|8638003|P2|Overall Study|Protocol Violation|2
2498026|NCT01972841|8638004|P1|Overall Study|Protocol Violation|2
2498027|NCT01972841|8637999|P6|Overall Study|Lost to Follow-up|3
2498028|NCT01972841|8638000|P5|Overall Study|Lost to Follow-up|9
2498029|NCT01972841|8638001|P4|Overall Study|Lost to Follow-up|2
2498030|NCT01972841|8638002|P3|Overall Study|Lost to Follow-up|4
2498031|NCT01972841|8638003|P2|Overall Study|Lost to Follow-up|2
2498032|NCT01972841|8638004|P1|Overall Study|Lost to Follow-up|4
2498033|NCT01972841|8637999|P6|Overall Study|Lack of Efficacy|1
2498034|NCT01972841|8638000|P5|Overall Study|Lack of Efficacy|4
2498035|NCT01972841|8638001|P4|Overall Study|Lack of Efficacy|2
2498036|NCT01972841|8638002|P3|Overall Study|Lack of Efficacy|0
2498037|NCT01972841|8638003|P2|Overall Study|Lack of Efficacy|0
2498038|NCT01972841|8638004|P1|Overall Study|Lack of Efficacy|1
2498039|NCT01972841|8637999|P6|Overall Study|Adverse Event|26
2498040|NCT01972841|8638000|P5|Overall Study|Adverse Event|21
2498041|NCT01972841|8638001|P4|Overall Study|Adverse Event|9
2498042|NCT01972841|8638002|P3|Overall Study|Adverse Event|12
2498043|NCT01972841|8638003|P2|Overall Study|Adverse Event|8
2498044|NCT01972841|8638004|P1|Overall Study|Adverse Event|13
2498045|NCT01972841|8637999|P6|Overall Study|Randomized but Never Received Treatment|13
2498046|NCT01972841|8638000|P5|Overall Study|Randomized but Never Received Treatment|6
2498047|NCT01972841|8638001|P4|Overall Study|Randomized but Never Received Treatment|2
2498048|NCT01972841|8638002|P3|Overall Study|Randomized but Never Received Treatment|4
2498049|NCT01972841|8638003|P2|Overall Study|Randomized but Never Received Treatment|5
2498050|NCT01972841|8638004|P1|Overall Study|Randomized but Never Received Treatment|2
2498051|NCT01972789|8638434|P2|Overall Study|Physician Decision|2
2498052|NCT01972789|8638435|P1|Overall Study|Physician Decision|3
2498053|NCT01972789|8638434|P2|Overall Study|Protocol deviation|0
2498054|NCT01972789|8638435|P1|Overall Study|Protocol deviation|1
2498055|NCT01972789|8638434|P2|Overall Study|Death|5
2498056|NCT01972789|8638435|P1|Overall Study|Death|7
2498057|NCT01972789|8638434|P2|Overall Study|Lost to Follow-up|7
2498058|NCT01972789|8638435|P1|Overall Study|Lost to Follow-up|4
2498059|NCT01972789|8638434|P2|Overall Study|Subject withdrew consent|12
2498060|NCT01972789|8638435|P1|Overall Study|Subject withdrew consent|14
2498061|NCT01972789|8638434|P2|Overall Study|Adverse Event|4
2498062|NCT01972789|8638435|P1|Overall Study|Adverse Event|11
2498063|NCT01972776|8638469|P6|Part 2|Administrative problems|7
2498064|NCT01972776|8638470|P5|Part 2|Administrative problems|10
2498065|NCT01972776|8638471|P4|Part 2|Administrative problems|0
2498066|NCT01972776|8638472|P3|Part 2|Administrative problems|0
2498067|NCT01972776|8638473|P2|Part 2|Administrative problems|0
2498068|NCT01972776|8638474|P1|Part 2|Administrative problems|0
2498069|NCT01972776|8638469|P6|Part 2|Adverse Event|0
2498070|NCT01972776|8638470|P5|Part 2|Adverse Event|3
2498071|NCT01972776|8638471|P4|Part 2|Adverse Event|0
2498072|NCT01972776|8638472|P3|Part 2|Adverse Event|0
2498073|NCT01972776|8638473|P2|Part 2|Adverse Event|0
2498074|NCT01972776|8638474|P1|Part 2|Adverse Event|0
2498075|NCT01972776|8638469|P6|Part 1|Adverse Event|0
2498076|NCT01972776|8638470|P5|Part 1|Adverse Event|0
2498077|NCT01972776|8638471|P4|Part 1|Adverse Event|1
2498078|NCT01972776|8638472|P3|Part 1|Adverse Event|1
2498079|NCT01972776|8638473|P2|Part 1|Adverse Event|0
2498080|NCT01972776|8638474|P1|Part 1|Adverse Event|0
2498081|NCT01972776|8638469|P6|Part 1|Withdrawal by Subject|0
2498082|NCT01972776|8638470|P5|Part 1|Withdrawal by Subject|0
2498083|NCT01972776|8638471|P4|Part 1|Withdrawal by Subject|0
2498084|NCT01972776|8638472|P3|Part 1|Withdrawal by Subject|1
2498085|NCT01972776|8638473|P2|Part 1|Withdrawal by Subject|0
2498086|NCT01972776|8638474|P1|Part 1|Withdrawal by Subject|0
2498087|NCT01972724|8638545|P3|Open-Label|Significant Protocol Deviation|2
2498088|NCT01972724|8638546|P2|Open-Label|Significant Protocol Deviation|0
2498089|NCT01972724|8638547|P1|Open-Label|Significant Protocol Deviation|0
2498090|NCT01972724|8638545|P3|Open-Label|Withdrew Consent|3
2498091|NCT01972724|8638546|P2|Open-Label|Withdrew Consent|0
2498092|NCT01972724|8638547|P1|Open-Label|Withdrew Consent|0
2498093|NCT01972724|8638545|P3|Double-Blind|Significant Protocol Deviation|0
2498094|NCT01972724|8638546|P2|Double-Blind|Significant Protocol Deviation|8
2498095|NCT01972724|8638547|P1|Double-Blind|Significant Protocol Deviation|5
2498096|NCT01972724|8638545|P3|Double-Blind|Withdrawal of Consent|0
2498097|NCT01972724|8638546|P2|Double-Blind|Withdrawal of Consent|1
2498098|NCT01972724|8638547|P1|Double-Blind|Withdrawal of Consent|2
2498099|NCT01972724|8638545|P3|Double-Blind|Adverse Event|0
2498100|NCT01972724|8638546|P2|Double-Blind|Adverse Event|0
2498101|NCT01972724|8638547|P1|Double-Blind|Adverse Event|1
2498102|NCT01972724|8638545|P3|Double-Blind|Rescue Criteria Met|0
2498103|NCT01972724|8638546|P2|Double-Blind|Rescue Criteria Met|0
2498104|NCT01972724|8638547|P1|Double-Blind|Rescue Criteria Met|1
2498105|NCT01972659|8638560|P2|Overall Study|problems realted to acceleromyograph|1
2498106|NCT01972659|8638561|P1|Overall Study|problems realted to acceleromyograph|2
2498107|NCT01972659|8638560|P2|Overall Study|Protocol Violation|2
2498108|NCT01972659|8638561|P1|Overall Study|Protocol Violation|2
2498109|NCT01972568|8638570|P3|Overall Study|Adverse Event|5
2498110|NCT01972568|8638571|P2|Overall Study|Adverse Event|6
2498111|NCT01972568|8638572|P1|Overall Study|Adverse Event|5
2498112|NCT01972568|8638570|P3|Overall Study|Lost to Follow-up|0
2498113|NCT01972568|8638571|P2|Overall Study|Lost to Follow-up|0
2498114|NCT01972568|8638572|P1|Overall Study|Lost to Follow-up|1
2498115|NCT01972568|8638570|P3|Overall Study|Withdrawal by Subject|7
2498116|NCT01972568|8638571|P2|Overall Study|Withdrawal by Subject|3
2498117|NCT01972568|8638572|P1|Overall Study|Withdrawal by Subject|6
2498118|NCT01972568|8638570|P3|Overall Study|Protocol Violation|2
2498119|NCT01972568|8638571|P2|Overall Study|Protocol Violation|2
2498120|NCT01972568|8638572|P1|Overall Study|Protocol Violation|1
2498121|NCT01972568|8638570|P3|Overall Study|Lack of Efficacy|2
2498122|NCT01972568|8638571|P2|Overall Study|Lack of Efficacy|1
2498123|NCT01972568|8638572|P1|Overall Study|Lack of Efficacy|0
2498124|NCT01972568|8638570|P3|Overall Study|Other events|0
2498125|NCT01972568|8638571|P2|Overall Study|Other events|0
2498126|NCT01972568|8638572|P1|Overall Study|Other events|3
2498127|NCT01972529|8638611|P4|Overall Study|Not treated|1
2498128|NCT01972529|8638612|P3|Overall Study|Not treated|2
2498129|NCT01972529|8638613|P2|Overall Study|Not treated|1
2498130|NCT01972529|8638614|P1|Overall Study|Not treated|0
2498131|NCT01972529|8638611|P4|Overall Study|Other|2
2498132|NCT01972529|8638612|P3|Overall Study|Other|0
2498133|NCT01972529|8638613|P2|Overall Study|Other|0
2498134|NCT01972529|8638614|P1|Overall Study|Other|0
2498135|NCT01972529|8638611|P4|Overall Study|Withdrawl of Consent|1
2498136|NCT01972529|8638612|P3|Overall Study|Withdrawl of Consent|0
2498137|NCT01972529|8638613|P2|Overall Study|Withdrawl of Consent|2
2498138|NCT01972529|8638614|P1|Overall Study|Withdrawl of Consent|1
2498139|NCT01972529|8638611|P4|Overall Study|Participant Choice|0
2498140|NCT01972529|8638612|P3|Overall Study|Participant Choice|0
2498141|NCT01972529|8638613|P2|Overall Study|Participant Choice|1
2498142|NCT01972529|8638614|P1|Overall Study|Participant Choice|0
2498143|NCT01972529|8638611|P4|Overall Study|Lost to Follow-up|0
2498144|NCT01972529|8638612|P3|Overall Study|Lost to Follow-up|0
2498145|NCT01972529|8638613|P2|Overall Study|Lost to Follow-up|0
2498146|NCT01972529|8638614|P1|Overall Study|Lost to Follow-up|1
2498147|NCT01972529|8638611|P4|Overall Study|Adverse Event|0
2498148|NCT01972529|8638612|P3|Overall Study|Adverse Event|0
2498149|NCT01972529|8638613|P2|Overall Study|Adverse Event|1
2498150|NCT01972529|8638614|P1|Overall Study|Adverse Event|0
2498151|NCT01972464|8638659|P2|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
2498152|NCT01972464|8638660|P1|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
2498153|NCT01972464|8638659|P2|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1
2498154|NCT01972464|8638660|P1|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0
2498155|NCT01972464|8638659|P2|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0
2498156|NCT01972464|8638660|P1|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1
2498157|NCT01972464|8638659|P2|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3
2498158|NCT01972464|8638660|P1|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2
2498159|NCT01972438|8638676|P2|Post Month 12 Study Period|Early Study Closure|4
2498160|NCT01972438|8638677|P1|Post Month 12 Study Period|Early Study Closure|3
2498161|NCT01972438|8638676|P2|Months 6-12 Study Period|Early Study Closure|2
2498162|NCT01972438|8638677|P1|Months 6-12 Study Period|Early Study Closure|2
2498163|NCT01972438|8638676|P2|Months 6-12 Study Period|Death|0
2498164|NCT01972438|8638677|P1|Months 6-12 Study Period|Death|1
2498165|NCT01972438|8638676|P2|Months 3-6 Crossover Period|Early Study Closure|1
2498166|NCT01972438|8638677|P1|Months 3-6 Crossover Period|Early Study Closure|0
2498167|NCT01972438|8638676|P2|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2
2498168|NCT01972438|8638677|P1|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1
2498169|NCT01972438|8638676|P2|Baseline-Month 3 Crossover Period|Unable to donate blood|1
2498170|NCT01972438|8638677|P1|Baseline-Month 3 Crossover Period|Unable to donate blood|0
2498171|NCT01972438|8638676|P2|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0
2498172|NCT01972438|8638677|P1|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1
2498173|NCT01972438|8638676|P2|Baseline-Month 3 Crossover Period|Death|0
2498174|NCT01972438|8638677|P1|Baseline-Month 3 Crossover Period|Death|1
2498175|NCT01972308|8638731|P2|Overall Study|Death|1
2498176|NCT01972308|8638732|P1|Overall Study|Death|4
2498177|NCT01972308|8638731|P2|Overall Study|Lost to Follow-up|6
2498178|NCT01972308|8638732|P1|Overall Study|Lost to Follow-up|4
2498179|NCT01972308|8638731|P2|Overall Study|Withdrawal by Subject|1
2498180|NCT01972308|8638732|P1|Overall Study|Withdrawal by Subject|0
2498181|NCT01972217|8638758|P4|Part B Double-blind, Randomised Period|Withdrawal by Subject|1
2498182|NCT01972217|8638759|P3|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
2498183|NCT01972217|8638760|P2|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
2498184|NCT01972217|8638761|P1|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
2498185|NCT01972217|8638758|P4|Part B Double-blind, Randomised Period|Lost to Follow-up|1
2498186|NCT01972217|8638759|P3|Part B Double-blind, Randomised Period|Lost to Follow-up|2
2498187|NCT01972217|8638760|P2|Part B Double-blind, Randomised Period|Lost to Follow-up|0
2498188|NCT01972217|8638761|P1|Part B Double-blind, Randomised Period|Lost to Follow-up|0
2498189|NCT01972217|8638758|P4|Part B Double-blind, Randomised Period|Screen failure|1
2498190|NCT01972217|8638759|P3|Part B Double-blind, Randomised Period|Screen failure|0
2498191|NCT01972217|8638760|P2|Part B Double-blind, Randomised Period|Screen failure|0
2498192|NCT01972217|8638761|P1|Part B Double-blind, Randomised Period|Screen failure|0
2498193|NCT01972217|8638758|P4|Part B Double-blind, Randomised Period|Reason not recorded|0
2498194|NCT01972217|8638759|P3|Part B Double-blind, Randomised Period|Reason not recorded|1
2498195|NCT01972217|8638760|P2|Part B Double-blind, Randomised Period|Reason not recorded|0
2498196|NCT01972217|8638761|P1|Part B Double-blind, Randomised Period|Reason not recorded|0
2498197|NCT01972217|8638758|P4|Part B Double-blind, Randomised Period|Death|44
2498198|NCT01972217|8638759|P3|Part B Double-blind, Randomised Period|Death|43
2498199|NCT01972217|8638760|P2|Part B Double-blind, Randomised Period|Death|0
2498200|NCT01972217|8638761|P1|Part B Double-blind, Randomised Period|Death|0
2498201|NCT01972217|8638758|P4|Part A: Open-label Safety Run-in Period|Death|0
2498202|NCT01972217|8638759|P3|Part A: Open-label Safety Run-in Period|Death|0
2498203|NCT01972217|8638760|P2|Part A: Open-label Safety Run-in Period|Death|1
2498204|NCT01972217|8638761|P1|Part A: Open-label Safety Run-in Period|Death|0
2498205|NCT01972217|8638758|P4|Part A: Open-label Safety Run-in Period|Adverse Event|0
2498206|NCT01972217|8638759|P3|Part A: Open-label Safety Run-in Period|Adverse Event|0
2498207|NCT01972217|8638760|P2|Part A: Open-label Safety Run-in Period|Adverse Event|1
2498208|NCT01972217|8638761|P1|Part A: Open-label Safety Run-in Period|Adverse Event|0
2498209|NCT01972217|8638758|P4|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
2498210|NCT01972217|8638759|P3|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
2498211|NCT01972217|8638760|P2|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9
2498212|NCT01972217|8638761|P1|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1
2498213|NCT01972217|8638758|P4|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
2498214|NCT01972217|8638759|P3|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
2498215|NCT01972217|8638760|P2|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1
2498216|NCT01972217|8638761|P1|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
2498217|NCT01972152|8638822|P6|Second Treatment Visit|Protocol Violation|0
2498218|NCT01972152|8638823|P5|Second Treatment Visit|Protocol Violation|0
2498219|NCT01972152|8638824|P4|Second Treatment Visit|Protocol Violation|0
2498220|NCT01972152|8638825|P3|Second Treatment Visit|Protocol Violation|0
2498221|NCT01972152|8638826|P2|Second Treatment Visit|Protocol Violation|1
2498222|NCT01972152|8638827|P1|Second Treatment Visit|Protocol Violation|0
2498223|NCT01972152|8638822|P6|First Treatment Visit|Lost to Follow-up|0
2498224|NCT01972152|8638823|P5|First Treatment Visit|Lost to Follow-up|0
2498225|NCT01972152|8638824|P4|First Treatment Visit|Lost to Follow-up|0
2498226|NCT01972152|8638825|P3|First Treatment Visit|Lost to Follow-up|0
2498227|NCT01972152|8638826|P2|First Treatment Visit|Lost to Follow-up|1
2498228|NCT01972152|8638827|P1|First Treatment Visit|Lost to Follow-up|0
2498229|NCT01972074|8638865|P3|Overall Study|Scanner Unavailable|1
2498230|NCT01972074|8638866|P2|Overall Study|Scanner Unavailable|0
2498231|NCT01972074|8638867|P1|Overall Study|Scanner Unavailable|0
2498232|NCT01972074|8638865|P3|Overall Study|Withdrawal by Subject|1
2498233|NCT01972074|8638866|P2|Overall Study|Withdrawal by Subject|1
2498234|NCT01972074|8638867|P1|Overall Study|Withdrawal by Subject|1
2498235|NCT01972074|8638865|P3|Overall Study|Lost to Follow-up|1
2498236|NCT01972074|8638866|P2|Overall Study|Lost to Follow-up|1
2498237|NCT01972074|8638867|P1|Overall Study|Lost to Follow-up|0
2498238|NCT01972074|8638865|P3|Overall Study|Lack of Efficacy|0
2498239|NCT01972074|8638866|P2|Overall Study|Lack of Efficacy|1
2498240|NCT01972074|8638867|P1|Overall Study|Lack of Efficacy|1
2498241|NCT01972074|8638865|P3|Overall Study|Adverse Event|0
2498242|NCT01972074|8638866|P2|Overall Study|Adverse Event|1
2498243|NCT01972074|8638867|P1|Overall Study|Adverse Event|4
2498244|NCT01971723|8638893|P2|Overall Study|Protocol Violation|2
2498245|NCT01971723|8638894|P1|Overall Study|Protocol Violation|1
2498246|NCT01971723|8638893|P2|Overall Study|Withdrawal by Subject|1
2498247|NCT01971723|8638894|P1|Overall Study|Withdrawal by Subject|1
2498248|NCT01971645|8638927|P3|Overall Study|Protocol Violation|1
2498249|NCT01971645|8638928|P2|Overall Study|Protocol Violation|0
2498250|NCT01971645|8638929|P1|Overall Study|Protocol Violation|0
2498251|NCT01971645|8638927|P3|Overall Study|Lost to Follow-up|1
2498252|NCT01971645|8638928|P2|Overall Study|Lost to Follow-up|0
2498253|NCT01971645|8638929|P1|Overall Study|Lost to Follow-up|1
2498254|NCT01971645|8638927|P3|Overall Study|Adverse Event|0
2498255|NCT01971645|8638928|P2|Overall Study|Adverse Event|0
2498256|NCT01971645|8638929|P1|Overall Study|Adverse Event|1
2498257|NCT01971567|8638963|P2|Overall Study|Lost to Follow-up|0
2498258|NCT01971567|8638964|P1|Overall Study|Lost to Follow-up|1
2498259|NCT01971567|8638963|P2|Overall Study|Withdrawal by Subject|2
2498260|NCT01971567|8638964|P1|Overall Study|Withdrawal by Subject|3
2498261|NCT01971554|8638990|P4|Overall Study|Lost to Follow-up|0
2498262|NCT01971554|8638991|P3|Overall Study|Lost to Follow-up|0
2498263|NCT01971554|8638992|P2|Overall Study|Lost to Follow-up|0
2498264|NCT01971554|8638993|P1|Overall Study|Lost to Follow-up|1
2498265|NCT01971476|8639030|P3|Cohort 2: 12 to <18 Years|Adverse Event|0
2498266|NCT01971476|8639031|P2|Cohort 2: 12 to <18 Years|Adverse Event|1
2498267|NCT01971476|8639032|P1|Cohort 2: 12 to <18 Years|Adverse Event|0
2498268|NCT01971476|8639030|P3|Cohort 2: 12 to <18 Years|Other not defined|0
2498269|NCT01971476|8639031|P2|Cohort 2: 12 to <18 Years|Other not defined|3
2498270|NCT01971476|8639032|P1|Cohort 2: 12 to <18 Years|Other not defined|6
2498271|NCT01971476|8639030|P3|Cohort 1: 2 to <12 Years|Other not defined|6
2498272|NCT01971476|8639031|P2|Cohort 1: 2 to <12 Years|Other not defined|3
2498273|NCT01971476|8639032|P1|Cohort 1: 2 to <12 Years|Other not defined|3
2498274|NCT01971346|8639126|P1|Overall Study|Physician Decision|1
2498275|NCT01971346|8639126|P1|Overall Study|Withdrawal by Subject|2
2498276|NCT01971346|8639126|P1|Overall Study|Lost to Follow-up|2
2498277|NCT01971346|8639126|P1|Overall Study|Protocol Violation|3
2498278|NCT01971203|8639159|P2|Overall Study|Adverse Event|0
2498279|NCT01971203|8639160|P1|Overall Study|Adverse Event|1
2498280|NCT01971203|8639159|P2|Overall Study|Withdrawal by Subject|6
2498281|NCT01971203|8639160|P1|Overall Study|Withdrawal by Subject|5
2498282|NCT01971203|8639159|P2|Overall Study|Protocol Violation|2
2498283|NCT01971203|8639160|P1|Overall Study|Protocol Violation|3
2498284|NCT01970995|8639187|P3|End of Study (Population at Day 90)|Withdrawal by Subject|1
2498285|NCT01970995|8639188|P2|End of Study (Population at Day 90)|Withdrawal by Subject|0
2498286|NCT01970995|8639189|P1|End of Study (Population at Day 90)|Withdrawal by Subject|1
2498287|NCT01970995|8639187|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
2498288|NCT01970995|8639188|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
2498289|NCT01970995|8639189|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
2498290|NCT01970982|8639212|P3|Overall Study|Withdrawal by Subject|2
2498291|NCT01970982|8639213|P2|Overall Study|Withdrawal by Subject|0
2498292|NCT01970982|8639214|P1|Overall Study|Withdrawal by Subject|0
2498293|NCT01970878|8639249|P4|Overall Study|No Completion Status|0
2498294|NCT01970878|8639250|P3|Overall Study|No Completion Status|0
2498295|NCT01970878|8639251|P2|Overall Study|No Completion Status|1
2498296|NCT01970878|8639252|P1|Overall Study|No Completion Status|0
2498297|NCT01970878|8639249|P4|Overall Study|Physician Decision|0
2498298|NCT01970878|8639250|P3|Overall Study|Physician Decision|1
2498299|NCT01970878|8639251|P2|Overall Study|Physician Decision|1
2498300|NCT01970878|8639252|P1|Overall Study|Physician Decision|0
2498301|NCT01970878|8639249|P4|Overall Study|Protocol Specified Criteria|6
2498302|NCT01970878|8639250|P3|Overall Study|Protocol Specified Criteria|3
2498303|NCT01970878|8639251|P2|Overall Study|Protocol Specified Criteria|4
2498304|NCT01970878|8639252|P1|Overall Study|Protocol Specified Criteria|10
2498305|NCT01970878|8639249|P4|Overall Study|Adverse Event|3
2498306|NCT01970878|8639250|P3|Overall Study|Adverse Event|4
2498307|NCT01970878|8639251|P2|Overall Study|Adverse Event|7
2498308|NCT01970878|8639252|P1|Overall Study|Adverse Event|12
2498309|NCT01970878|8639249|P4|Overall Study|Lack of Efficacy|0
2498310|NCT01970878|8639250|P3|Overall Study|Lack of Efficacy|2
2498311|NCT01970878|8639251|P2|Overall Study|Lack of Efficacy|1
2498312|NCT01970878|8639252|P1|Overall Study|Lack of Efficacy|2
2498313|NCT01970878|8639249|P4|Overall Study|Administrative Reasons|4
2498314|NCT01970878|8639250|P3|Overall Study|Administrative Reasons|0
2498315|NCT01970878|8639251|P2|Overall Study|Administrative Reasons|0
2498316|NCT01970878|8639252|P1|Overall Study|Administrative Reasons|1
2498317|NCT01970878|8639249|P4|Overall Study|Lost to Follow-up|4
2498318|NCT01970878|8639250|P3|Overall Study|Lost to Follow-up|2
2498319|NCT01970878|8639251|P2|Overall Study|Lost to Follow-up|3
2498320|NCT01970878|8639252|P1|Overall Study|Lost to Follow-up|1
2498321|NCT01970878|8639249|P4|Overall Study|Withdrawal by Subject|7
2498322|NCT01970878|8639250|P3|Overall Study|Withdrawal by Subject|14
2498323|NCT01970878|8639251|P2|Overall Study|Withdrawal by Subject|10
2498324|NCT01970878|8639252|P1|Overall Study|Withdrawal by Subject|11
2498325|NCT01970865|8639295|P17|Overall Study|Study ongoing|2
2498326|NCT01970865|8639296|P16|Overall Study|Study ongoing|29
2498327|NCT01970865|8639297|P15|Overall Study|Study ongoing|29
2498328|NCT01970865|8639298|P14|Overall Study|Study ongoing|41
2498329|NCT01970865|8639299|P13|Overall Study|Study ongoing|43
2498330|NCT01970865|8639300|P12|Overall Study|Study ongoing|22
2498331|NCT01970865|8639301|P11|Overall Study|Study ongoing|29
2498332|NCT01970865|8639302|P10|Overall Study|Study ongoing|3
2498333|NCT01970865|8639303|P9|Overall Study|Study ongoing|1
2498334|NCT01970865|8639304|P8|Overall Study|Study ongoing|0
2498335|NCT01970865|8639305|P7|Overall Study|Study ongoing|2
2498336|NCT01970865|8639306|P6|Overall Study|Study ongoing|0
2498337|NCT01970865|8639307|P5|Overall Study|Study ongoing|8
2498338|NCT01970865|8639308|P4|Overall Study|Study ongoing|6
2498339|NCT01970865|8639309|P3|Overall Study|Study ongoing|0
2498340|NCT01970865|8639310|P2|Overall Study|Study ongoing|2
2498341|NCT01970865|8639311|P1|Overall Study|Study ongoing|0
2498342|NCT01970865|8639295|P17|Overall Study|Other|0
2498343|NCT01970865|8639296|P16|Overall Study|Other|1
2498344|NCT01970865|8639297|P15|Overall Study|Other|0
2498345|NCT01970865|8639298|P14|Overall Study|Other|1
2498346|NCT01970865|8639299|P13|Overall Study|Other|0
2498347|NCT01970865|8639300|P12|Overall Study|Other|0
2498348|NCT01970865|8639301|P11|Overall Study|Other|0
2498349|NCT01970865|8639302|P10|Overall Study|Other|0
2498350|NCT01970865|8639303|P9|Overall Study|Other|0
2498351|NCT01970865|8639304|P8|Overall Study|Other|0
2498352|NCT01970865|8639305|P7|Overall Study|Other|0
2498353|NCT01970865|8639306|P6|Overall Study|Other|0
2498354|NCT01970865|8639307|P5|Overall Study|Other|0
2498355|NCT01970865|8639308|P4|Overall Study|Other|1
2498356|NCT01970865|8639309|P3|Overall Study|Other|0
2498357|NCT01970865|8639310|P2|Overall Study|Other|0
2498358|NCT01970865|8639311|P1|Overall Study|Other|0
2498359|NCT01970865|8639295|P17|Overall Study|Withdrawal by Subject|0
2498360|NCT01970865|8639296|P16|Overall Study|Withdrawal by Subject|7
2498361|NCT01970865|8639297|P15|Overall Study|Withdrawal by Subject|2
2498362|NCT01970865|8639298|P14|Overall Study|Withdrawal by Subject|5
2498363|NCT01970865|8639299|P13|Overall Study|Withdrawal by Subject|2
2498364|NCT01970865|8639300|P12|Overall Study|Withdrawal by Subject|1
2498365|NCT01970865|8639301|P11|Overall Study|Withdrawal by Subject|0
2498366|NCT01970865|8639302|P10|Overall Study|Withdrawal by Subject|0
2498367|NCT01970865|8639303|P9|Overall Study|Withdrawal by Subject|0
2498368|NCT01970865|8639304|P8|Overall Study|Withdrawal by Subject|0
2498369|NCT01970865|8639305|P7|Overall Study|Withdrawal by Subject|0
2498370|NCT01970865|8639306|P6|Overall Study|Withdrawal by Subject|0
2498371|NCT01970865|8639307|P5|Overall Study|Withdrawal by Subject|2
2498372|NCT01970865|8639308|P4|Overall Study|Withdrawal by Subject|1
2498373|NCT01970865|8639309|P3|Overall Study|Withdrawal by Subject|0
2498374|NCT01970865|8639310|P2|Overall Study|Withdrawal by Subject|0
2498375|NCT01970865|8639311|P1|Overall Study|Withdrawal by Subject|0
2498376|NCT01970865|8639295|P17|Overall Study|Lost to Follow-up|0
2498377|NCT01970865|8639296|P16|Overall Study|Lost to Follow-up|0
2498378|NCT01970865|8639297|P15|Overall Study|Lost to Follow-up|0
2498379|NCT01970865|8639298|P14|Overall Study|Lost to Follow-up|0
2498380|NCT01970865|8639299|P13|Overall Study|Lost to Follow-up|1
2498381|NCT01970865|8639300|P12|Overall Study|Lost to Follow-up|0
2498382|NCT01970865|8639301|P11|Overall Study|Lost to Follow-up|0
2498383|NCT01970865|8639302|P10|Overall Study|Lost to Follow-up|0
2498384|NCT01970865|8639303|P9|Overall Study|Lost to Follow-up|0
2498385|NCT01970865|8639304|P8|Overall Study|Lost to Follow-up|0
2498386|NCT01970865|8639305|P7|Overall Study|Lost to Follow-up|0
2498387|NCT01970865|8639306|P6|Overall Study|Lost to Follow-up|0
2498388|NCT01970865|8639307|P5|Overall Study|Lost to Follow-up|1
2498389|NCT01970865|8639308|P4|Overall Study|Lost to Follow-up|1
2498390|NCT01970865|8639309|P3|Overall Study|Lost to Follow-up|0
2498391|NCT01970865|8639310|P2|Overall Study|Lost to Follow-up|0
2498392|NCT01970865|8639311|P1|Overall Study|Lost to Follow-up|0
2498393|NCT01970865|8639295|P17|Overall Study|Death|1
2498394|NCT01970865|8639296|P16|Overall Study|Death|10
2498395|NCT01970865|8639297|P15|Overall Study|Death|15
2498396|NCT01970865|8639298|P14|Overall Study|Death|19
2498397|NCT01970865|8639299|P13|Overall Study|Death|14
2498398|NCT01970865|8639300|P12|Overall Study|Death|4
2498399|NCT01970865|8639301|P11|Overall Study|Death|1
2498400|NCT01970865|8639302|P10|Overall Study|Death|1
2498401|NCT01970865|8639303|P9|Overall Study|Death|2
2498402|NCT01970865|8639304|P8|Overall Study|Death|3
2498403|NCT01970865|8639305|P7|Overall Study|Death|1
2498404|NCT01970865|8639306|P6|Overall Study|Death|3
2498405|NCT01970865|8639307|P5|Overall Study|Death|6
2498406|NCT01970865|8639308|P4|Overall Study|Death|4
2498407|NCT01970865|8639309|P3|Overall Study|Death|3
2498408|NCT01970865|8639310|P2|Overall Study|Death|1
2498409|NCT01970865|8639311|P1|Overall Study|Death|3
2498410|NCT01970592|8639743|P1|Overall Study|Adverse Event|1
2498411|NCT01970592|8639743|P1|Overall Study|Physician Decision|1
2498412|NCT01970592|8639743|P1|Overall Study|Withdrawal by Subject|4
2498413|NCT01970540|8639751|P3|Overall Study|Clinical deterioration|0
2498414|NCT01970540|8639752|P2|Overall Study|Clinical deterioration|0
2498415|NCT01970540|8639753|P1|Overall Study|Clinical deterioration|1
2498416|NCT01970540|8639751|P3|Overall Study|Withdrawal by Subject|1
2498417|NCT01970540|8639752|P2|Overall Study|Withdrawal by Subject|0
2498418|NCT01970540|8639753|P1|Overall Study|Withdrawal by Subject|4
2498419|NCT01970540|8639751|P3|Overall Study|Treatment-related AE|2
2498420|NCT01970540|8639752|P2|Overall Study|Treatment-related AE|0
2498421|NCT01970540|8639753|P1|Overall Study|Treatment-related AE|4
2498422|NCT01970540|8639751|P3|Overall Study|Adverse Event|1
2498423|NCT01970540|8639752|P2|Overall Study|Adverse Event|2
2498424|NCT01970540|8639753|P1|Overall Study|Adverse Event|0
2498425|NCT01970540|8639751|P3|Overall Study|End of study|2
2498426|NCT01970540|8639752|P2|Overall Study|End of study|0
2498427|NCT01970540|8639753|P1|Overall Study|End of study|2
2498428|NCT01970540|8639751|P3|Overall Study|Clinical progression|1
2498429|NCT01970540|8639752|P2|Overall Study|Clinical progression|1
2498430|NCT01970540|8639753|P1|Overall Study|Clinical progression|0
2498431|NCT01970540|8639751|P3|Overall Study|Physician Decision|0
2498432|NCT01970540|8639752|P2|Overall Study|Physician Decision|2
2498433|NCT01970540|8639753|P1|Overall Study|Physician Decision|7
2498434|NCT01970540|8639751|P3|Overall Study|Treatment delay over protocol|1
2498435|NCT01970540|8639752|P2|Overall Study|Treatment delay over protocol|0
2498436|NCT01970540|8639753|P1|Overall Study|Treatment delay over protocol|0
2498437|NCT01970540|8639751|P3|Overall Study|Progressive disease|10
2498438|NCT01970540|8639752|P2|Overall Study|Progressive disease|23
2498439|NCT01970540|8639753|P1|Overall Study|Progressive disease|55
2498440|NCT01970540|8639751|P3|Overall Study|Non-treatment-related AE|1
2498441|NCT01970540|8639752|P2|Overall Study|Non-treatment-related AE|0
2498442|NCT01970540|8639753|P1|Overall Study|Non-treatment-related AE|0
2498443|NCT01970527|8639784|P2|Follow-up Clinic Visit|Lost to Follow-up|1
2498444|NCT01970527|8639785|P1|Follow-up Clinic Visit|Lost to Follow-up|0
2498445|NCT01970527|8639784|P2|Follow-up Clinic Visit|Withdrawal by Subject|1
2498446|NCT01970527|8639785|P1|Follow-up Clinic Visit|Withdrawal by Subject|0
2498447|NCT01970527|8639784|P2|Follow-up Clinic Visit|Disease progression|1
2498448|NCT01970527|8639785|P1|Follow-up Clinic Visit|Disease progression|1
2498449|NCT01970527|8639784|P2|Treatment|Death|1
2498450|NCT01970527|8639785|P1|Treatment|Death|0
2498451|NCT01970527|8639784|P2|Treatment|Participant did not tolerate Ipilimumab|1
2498452|NCT01970527|8639785|P1|Treatment|Participant did not tolerate Ipilimumab|0
2498453|NCT01970527|8639784|P2|Treatment|Disease progression|1
2498454|NCT01970527|8639785|P1|Treatment|Disease progression|0
2498455|NCT01970527|8639784|P2|Pre-treatment/Baseline|Screen fail- participant had brain mets|0
2498456|NCT01970527|8639785|P1|Pre-treatment/Baseline|Screen fail- participant had brain mets|1
2498457|NCT01970488|8639798|P5|Part 2: Post Week 16|Lost to Follow-up|2
2498458|NCT01970488|8639799|P4|Part 2: Post Week 16|Lost to Follow-up|1
2498459|NCT01970488|8639800|P3|Part 2: Post Week 16|Lost to Follow-up|1
2498460|NCT01970488|8639801|P2|Part 2: Post Week 16|Lost to Follow-up|0
2498461|NCT01970488|8639802|P1|Part 2: Post Week 16|Lost to Follow-up|0
2498462|NCT01970488|8639798|P5|Part 2: Post Week 16|Withdrawal by Subject|3
2498463|NCT01970488|8639799|P4|Part 2: Post Week 16|Withdrawal by Subject|3
2498464|NCT01970488|8639800|P3|Part 2: Post Week 16|Withdrawal by Subject|8
2498465|NCT01970488|8639801|P2|Part 2: Post Week 16|Withdrawal by Subject|0
2498466|NCT01970488|8639802|P1|Part 2: Post Week 16|Withdrawal by Subject|0
2498467|NCT01970488|8639798|P5|Part 2: Post Week 16|Adverse Event|1
2498468|NCT01970488|8639799|P4|Part 2: Post Week 16|Adverse Event|1
2498469|NCT01970488|8639800|P3|Part 2: Post Week 16|Adverse Event|5
2498470|NCT01970488|8639801|P2|Part 2: Post Week 16|Adverse Event|0
2498471|NCT01970488|8639802|P1|Part 2: Post Week 16|Adverse Event|0
2498472|NCT01970488|8639798|P5|Part 2: Post Week 16|Lack of Efficacy|1
2498473|NCT01970488|8639799|P4|Part 2: Post Week 16|Lack of Efficacy|3
2498474|NCT01970488|8639800|P3|Part 2: Post Week 16|Lack of Efficacy|2
2498475|NCT01970488|8639801|P2|Part 2: Post Week 16|Lack of Efficacy|0
2498476|NCT01970488|8639802|P1|Part 2: Post Week 16|Lack of Efficacy|0
2498477|NCT01970488|8639798|P5|Part 2: Post Week 16|Non-compliance|0
2498478|NCT01970488|8639799|P4|Part 2: Post Week 16|Non-compliance|0
2498479|NCT01970488|8639800|P3|Part 2: Post Week 16|Non-compliance|1
2498480|NCT01970488|8639801|P2|Part 2: Post Week 16|Non-compliance|0
2498481|NCT01970488|8639802|P1|Part 2: Post Week 16|Non-compliance|0
2498482|NCT01970488|8639798|P5|Part 2: Post Week 16|Physician Decision|1
2498483|NCT01970488|8639799|P4|Part 2: Post Week 16|Physician Decision|0
2498484|NCT01970488|8639800|P3|Part 2: Post Week 16|Physician Decision|0
2498485|NCT01970488|8639801|P2|Part 2: Post Week 16|Physician Decision|0
2498486|NCT01970488|8639802|P1|Part 2: Post Week 16|Physician Decision|0
2498487|NCT01970488|8639798|P5|Part 1: Through Week 16|Lost to Follow-up|0
2498488|NCT01970488|8639799|P4|Part 1: Through Week 16|Lost to Follow-up|0
2498489|NCT01970488|8639800|P3|Part 1: Through Week 16|Lost to Follow-up|0
2498490|NCT01970488|8639801|P2|Part 1: Through Week 16|Lost to Follow-up|2
2498491|NCT01970488|8639802|P1|Part 1: Through Week 16|Lost to Follow-up|0
2498492|NCT01970488|8639798|P5|Part 1: Through Week 16|Withdrawal by Subject|0
2498493|NCT01970488|8639799|P4|Part 1: Through Week 16|Withdrawal by Subject|0
2498494|NCT01970488|8639800|P3|Part 1: Through Week 16|Withdrawal by Subject|0
2498495|NCT01970488|8639801|P2|Part 1: Through Week 16|Withdrawal by Subject|2
2498496|NCT01970488|8639802|P1|Part 1: Through Week 16|Withdrawal by Subject|3
2498497|NCT01970488|8639798|P5|Part 1: Through Week 16|Adverse Event|0
2498498|NCT01970488|8639799|P4|Part 1: Through Week 16|Adverse Event|0
2498499|NCT01970488|8639800|P3|Part 1: Through Week 16|Adverse Event|0
2498500|NCT01970488|8639801|P2|Part 1: Through Week 16|Adverse Event|5
2498501|NCT01970488|8639802|P1|Part 1: Through Week 16|Adverse Event|6
2498502|NCT01970488|8639798|P5|Part 1: Through Week 16|Protocol Violation|0
2498503|NCT01970488|8639799|P4|Part 1: Through Week 16|Protocol Violation|0
2498504|NCT01970488|8639800|P3|Part 1: Through Week 16|Protocol Violation|0
2498505|NCT01970488|8639801|P2|Part 1: Through Week 16|Protocol Violation|2
2498506|NCT01970488|8639802|P1|Part 1: Through Week 16|Protocol Violation|1
2498507|NCT01970488|8639798|P5|Part 1: Through Week 16|Protocol-specified Criteria|0
2498508|NCT01970488|8639799|P4|Part 1: Through Week 16|Protocol-specified Criteria|0
2498509|NCT01970488|8639800|P3|Part 1: Through Week 16|Protocol-specified Criteria|0
2498510|NCT01970488|8639801|P2|Part 1: Through Week 16|Protocol-specified Criteria|2
2498511|NCT01970488|8639802|P1|Part 1: Through Week 16|Protocol-specified Criteria|1
2498512|NCT01970475|8639869|P2|Overall Study|Protocol Violation|0
2498513|NCT01970475|8639870|P1|Overall Study|Protocol Violation|1
2498514|NCT01970475|8639869|P2|Overall Study|Lost to Follow-up|2
2498515|NCT01970475|8639870|P1|Overall Study|Lost to Follow-up|2
2498516|NCT01970475|8639869|P2|Overall Study|Adverse Event|3
2498517|NCT01970475|8639870|P1|Overall Study|Adverse Event|7
2498518|NCT01970475|8639869|P2|Overall Study|Withdrawal by Subject|6
2498519|NCT01970475|8639870|P1|Overall Study|Withdrawal by Subject|11
2498520|NCT01970462|8639890|P2|Overall Study|Lost to Follow-up|2
2498521|NCT01970462|8639891|P1|Overall Study|Lost to Follow-up|0
2498522|NCT01970397|8639905|P2|Overall Study|Protocol Violation|1
2498523|NCT01970397|8639906|P1|Overall Study|Protocol Violation|1
2498524|NCT01970397|8639905|P2|Overall Study|Personal Reasons|2
2498525|NCT01970397|8639906|P1|Overall Study|Personal Reasons|1
2498526|NCT01970397|8639905|P2|Overall Study|Lost to Follow-up|1
2498527|NCT01970397|8639906|P1|Overall Study|Lost to Follow-up|0
2498528|NCT01970397|8639905|P2|Overall Study|Adverse Event|1
2498529|NCT01970397|8639906|P1|Overall Study|Adverse Event|0
2498530|NCT01970371|8639919|P3|Overall Study|Lost to Follow-up|1
2498531|NCT01970371|8639920|P2|Overall Study|Lost to Follow-up|0
2498532|NCT01970371|8639921|P1|Overall Study|Lost to Follow-up|0
2498533|NCT01970371|8639919|P3|Overall Study|Death|12
2498534|NCT01970371|8639920|P2|Overall Study|Death|13
2498535|NCT01970371|8639921|P1|Overall Study|Death|8
2498536|NCT01970241|8639946|P2|Overall Study|Steroid d/c;discharge<48 hrs.|8
2498537|NCT01970241|8639947|P1|Overall Study|Steroid d/c;discharge<48 hrs.|15
2498538|NCT01970241|8639946|P2|Overall Study|Withdrawal by Subject|0
2498539|NCT01970241|8639947|P1|Overall Study|Withdrawal by Subject|2
2498540|NCT01969851|8639994|P3|Overall Study|Sponsor decision|1
2498541|NCT01969851|8639995|P2|Overall Study|Sponsor decision|0
2498542|NCT01969851|8639996|P1|Overall Study|Sponsor decision|0
2498543|NCT01969851|8639994|P3|Overall Study|No effective dose in Titration period|1
2498544|NCT01969851|8639995|P2|Overall Study|No effective dose in Titration period|0
2498545|NCT01969851|8639996|P1|Overall Study|No effective dose in Titration period|0
2498546|NCT01969851|8639994|P3|Overall Study|Withdrawal by Subject|1
2498547|NCT01969851|8639995|P2|Overall Study|Withdrawal by Subject|0
2498548|NCT01969851|8639996|P1|Overall Study|Withdrawal by Subject|1
2498549|NCT01969851|8639994|P3|Overall Study|Lack of Efficacy|1
2498550|NCT01969851|8639995|P2|Overall Study|Lack of Efficacy|3
2498551|NCT01969851|8639996|P1|Overall Study|Lack of Efficacy|0
2498552|NCT01969851|8639994|P3|Overall Study|Adverse Event|3
2498553|NCT01969851|8639995|P2|Overall Study|Adverse Event|0
2498554|NCT01969851|8639996|P1|Overall Study|Adverse Event|0
2498555|NCT01969799|8640018|P2|Overall Study|Physician Decision|0
2498556|NCT01969799|8640019|P1|Overall Study|Physician Decision|1
2498557|NCT01969799|8640018|P2|Overall Study|Lost to Follow-up|2
2498558|NCT01969799|8640019|P1|Overall Study|Lost to Follow-up|0
2498559|NCT01969799|8640018|P2|Overall Study|Death|11
2498560|NCT01969799|8640019|P1|Overall Study|Death|16
2498561|NCT01969799|8640018|P2|Overall Study|Adverse Event|1
2498562|NCT01969799|8640019|P1|Overall Study|Adverse Event|0
2498563|NCT01969721|8640056|P4|Overall Study|Discontinued during washout periods.|2
2498564|NCT01969721|8640057|P3|Overall Study|Discontinued during washout periods.|1
2498565|NCT01969721|8640058|P2|Overall Study|Discontinued during washout periods.|1
2498566|NCT01969721|8640059|P1|Overall Study|Discontinued during washout periods.|0
2498567|NCT01969721|8640056|P4|Overall Study|Other not defined above|0
2498568|NCT01969721|8640057|P3|Overall Study|Other not defined above|0
2498569|NCT01969721|8640058|P2|Overall Study|Other not defined above|2
2498570|NCT01969721|8640059|P1|Overall Study|Other not defined above|0
2498571|NCT01969721|8640056|P4|Overall Study|Non compliant with protocol|2
2498572|NCT01969721|8640057|P3|Overall Study|Non compliant with protocol|0
2498573|NCT01969721|8640058|P2|Overall Study|Non compliant with protocol|1
2498574|NCT01969721|8640059|P1|Overall Study|Non compliant with protocol|1
2498575|NCT01969721|8640056|P4|Overall Study|Lack of Efficacy|0
2498576|NCT01969721|8640057|P3|Overall Study|Lack of Efficacy|1
2498577|NCT01969721|8640058|P2|Overall Study|Lack of Efficacy|0
2498578|NCT01969721|8640059|P1|Overall Study|Lack of Efficacy|0
2498579|NCT01969721|8640056|P4|Overall Study|Adverse Event|2
2498580|NCT01969721|8640057|P3|Overall Study|Adverse Event|3
2498581|NCT01969721|8640058|P2|Overall Study|Adverse Event|8
2498582|NCT01969721|8640059|P1|Overall Study|Adverse Event|3
2498583|NCT01969565|8640104|P1|Overall Study|Withdrawal by Subject|1
2498584|NCT01969500|8640118|P2|Overall Study|extended hospitalization|1
2498585|NCT01969500|8640119|P1|Overall Study|extended hospitalization|1
2498586|NCT01969500|8640118|P2|Overall Study|Death|1
2498587|NCT01969500|8640119|P1|Overall Study|Death|0
2498588|NCT01969084|8640240|P2|Overall Study|Adverse Event|1
2498589|NCT01969084|8640241|P1|Overall Study|Adverse Event|0
2498590|NCT01969058|8640257|P2|Overall Study|Adverse Event|0
2498591|NCT01969058|8640258|P1|Overall Study|Adverse Event|1
2498592|NCT01969058|8640257|P2|Overall Study|Withdrawal by Subject|0
2498593|NCT01969058|8640258|P1|Overall Study|Withdrawal by Subject|2
2498594|NCT01968980|8640302|P2|Overall Study|Other unspecified|2
2498595|NCT01968980|8640303|P1|Overall Study|Other unspecified|1
2498596|NCT01968980|8640302|P2|Overall Study|Withdrawal by Subject|5
2498597|NCT01968980|8640303|P1|Overall Study|Withdrawal by Subject|13
2498598|NCT01968980|8640302|P2|Overall Study|Does not meet entry criteria|3
2498599|NCT01968980|8640303|P1|Overall Study|Does not meet entry criteria|1
2498600|NCT01968980|8640302|P2|Overall Study|Adverse Event|3
2498601|NCT01968980|8640303|P1|Overall Study|Adverse Event|1
2498602|NCT01968980|8640302|P2|Overall Study|Death|1
2498603|NCT01968980|8640303|P1|Overall Study|Death|0
2498604|NCT01968967|8640365|P5|Extension Period|Withdrew Consent|5
2498605|NCT01968967|8640366|P4|Extension Period|Withdrew Consent|0
2498606|NCT01968967|8640367|P3|Extension Period|Withdrew Consent|2
2498607|NCT01968967|8640368|P2|Extension Period|Withdrew Consent|0
2498608|NCT01968967|8640369|P1|Extension Period|Withdrew Consent|0
2498609|NCT01968967|8640365|P5|Treatment Period|Randomized Not Treated|0
2498610|NCT01968967|8640366|P4|Treatment Period|Randomized Not Treated|0
2498611|NCT01968967|8640367|P3|Treatment Period|Randomized Not Treated|0
2498612|NCT01968967|8640368|P2|Treatment Period|Randomized Not Treated|5
2498613|NCT01968967|8640369|P1|Treatment Period|Randomized Not Treated|6
2498614|NCT01968967|8640365|P5|Treatment Period|Death|0
2498615|NCT01968967|8640366|P4|Treatment Period|Death|0
2498616|NCT01968967|8640367|P3|Treatment Period|Death|0
2498617|NCT01968967|8640368|P2|Treatment Period|Death|2
2498618|NCT01968967|8640369|P1|Treatment Period|Death|9
2498619|NCT01968967|8640365|P5|Treatment Period|Adverse Event|0
2498620|NCT01968967|8640366|P4|Treatment Period|Adverse Event|0
2498621|NCT01968967|8640367|P3|Treatment Period|Adverse Event|0
2498622|NCT01968967|8640368|P2|Treatment Period|Adverse Event|8
2498623|NCT01968967|8640369|P1|Treatment Period|Adverse Event|9
2498624|NCT01968967|8640365|P5|Treatment Period|Protocol Violation|0
2498625|NCT01968967|8640366|P4|Treatment Period|Protocol Violation|0
2498626|NCT01968967|8640367|P3|Treatment Period|Protocol Violation|0
2498627|NCT01968967|8640368|P2|Treatment Period|Protocol Violation|2
2498628|NCT01968967|8640369|P1|Treatment Period|Protocol Violation|1
2498629|NCT01968967|8640365|P5|Treatment Period|Lost to Follow-up|0
2498630|NCT01968967|8640366|P4|Treatment Period|Lost to Follow-up|0
2498631|NCT01968967|8640367|P3|Treatment Period|Lost to Follow-up|0
2498632|NCT01968967|8640368|P2|Treatment Period|Lost to Follow-up|31
2498633|NCT01968967|8640369|P1|Treatment Period|Lost to Follow-up|26
2498634|NCT01968967|8640365|P5|Treatment Period|Did Not Meet Entrance Criteria|0
2498635|NCT01968967|8640366|P4|Treatment Period|Did Not Meet Entrance Criteria|0
2498636|NCT01968967|8640367|P3|Treatment Period|Did Not Meet Entrance Criteria|0
2498637|NCT01968967|8640368|P2|Treatment Period|Did Not Meet Entrance Criteria|3
2498638|NCT01968967|8640369|P1|Treatment Period|Did Not Meet Entrance Criteria|2
2498639|NCT01968967|8640365|P5|Treatment Period|Withdrawal by Subject|0
2498640|NCT01968967|8640366|P4|Treatment Period|Withdrawal by Subject|0
2498641|NCT01968967|8640367|P3|Treatment Period|Withdrawal by Subject|0
2498642|NCT01968967|8640368|P2|Treatment Period|Withdrawal by Subject|61
2498643|NCT01968967|8640369|P1|Treatment Period|Withdrawal by Subject|71
2498644|NCT01968967|8640365|P5|Treatment Period|Other|0
2498645|NCT01968967|8640366|P4|Treatment Period|Other|0
2498646|NCT01968967|8640367|P3|Treatment Period|Other|0
2498647|NCT01968967|8640368|P2|Treatment Period|Other|22
2498648|NCT01968967|8640369|P1|Treatment Period|Other|22
2498649|NCT01968954|8640438|P2|Overall Study|Did not met inclusion criteria|2
2498650|NCT01968954|8640439|P1|Overall Study|Did not met inclusion criteria|0
2498651|NCT01968954|8640438|P2|Overall Study|Protocol Violation|1
2498652|NCT01968954|8640439|P1|Overall Study|Protocol Violation|0
2498653|NCT01968954|8640438|P2|Overall Study|Other|8
2498654|NCT01968954|8640439|P1|Overall Study|Other|7
2498655|NCT01968954|8640438|P2|Overall Study|Withdrawal by Subject|23
2498656|NCT01968954|8640439|P1|Overall Study|Withdrawal by Subject|20
2498657|NCT01968954|8640438|P2|Overall Study|Lost to Follow-up|4
2498658|NCT01968954|8640439|P1|Overall Study|Lost to Follow-up|6
2498659|NCT01968954|8640438|P2|Overall Study|Death|2
2498660|NCT01968954|8640439|P1|Overall Study|Death|1
2498661|NCT01968954|8640438|P2|Overall Study|Adverse Event|3
2498662|NCT01968954|8640439|P1|Overall Study|Adverse Event|6
2498663|NCT01968811|8640503|P1|Overall Study|post op.ref. of subject to other hospita|1
2498664|NCT01968811|8640503|P1|Overall Study|Protocol Violation|4
2498665|NCT01968694|8640510|P2|Washout (1 Month)|Lost to Follow-up|1
2498666|NCT01968694|8640511|P1|Washout (1 Month)|Lost to Follow-up|0
2498667|NCT01968551|8640528|P3|Extension Phase|Lost to Follow-up|1
2498668|NCT01968551|8640529|P2|Extension Phase|Lost to Follow-up|0
2498669|NCT01968551|8640530|P1|Extension Phase|Lost to Follow-up|1
2498670|NCT01968551|8640528|P3|Extension Phase|Withdrew Consent|1
2498671|NCT01968551|8640529|P2|Extension Phase|Withdrew Consent|0
2498672|NCT01968551|8640530|P1|Extension Phase|Withdrew Consent|0
2498673|NCT01968551|8640528|P3|Extension Phase|Death|0
2498674|NCT01968551|8640529|P2|Extension Phase|Death|1
2498675|NCT01968551|8640530|P1|Extension Phase|Death|0
2498676|NCT01968551|8640528|P3|Extension Phase|Adverse Event|2
2498677|NCT01968551|8640529|P2|Extension Phase|Adverse Event|0
2498678|NCT01968551|8640530|P1|Extension Phase|Adverse Event|0
2498679|NCT01968551|8640528|P3|Open Label Phase (48 Weeks)|Lost to Follow-up|2
2498680|NCT01968551|8640529|P2|Open Label Phase (48 Weeks)|Lost to Follow-up|0
2498681|NCT01968551|8640530|P1|Open Label Phase (48 Weeks)|Lost to Follow-up|0
2498682|NCT01968551|8640528|P3|Open Label Phase (48 Weeks)|Withdrew Consent|3
2498683|NCT01968551|8640529|P2|Open Label Phase (48 Weeks)|Withdrew Consent|1
2498684|NCT01968551|8640530|P1|Open Label Phase (48 Weeks)|Withdrew Consent|1
2498685|NCT01968551|8640528|P3|Open Label Phase (48 Weeks)|Investigator’s Discretion|0
2498686|NCT01968551|8640529|P2|Open Label Phase (48 Weeks)|Investigator’s Discretion|1
2498687|NCT01968551|8640530|P1|Open Label Phase (48 Weeks)|Investigator’s Discretion|0
2498688|NCT01968551|8640528|P3|Open Label Phase (48 Weeks)|Randomized but Never Treated|0
2498689|NCT01968551|8640529|P2|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
2498690|NCT01968551|8640530|P1|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
2498691|NCT01968434|8640567|P2|Overall Study|Lost to Follow-up|6
2498692|NCT01968434|8640568|P1|Overall Study|Lost to Follow-up|3
2498693|NCT01968226|8640636|P1|Overall Study|[F-18] RDG-K5 was not available|2
2498694|NCT01968213|8640642|P2|Overall Study|Ongoing|9
2498695|NCT01968213|8640643|P1|Overall Study|Ongoing|90
2498696|NCT01968070|8640685|P18|Period 2|Withdrawal by Subject|0
2498697|NCT01968070|8640686|P17|Period 2|Withdrawal by Subject|0
2498698|NCT01968070|8640687|P16|Period 2|Withdrawal by Subject|0
2498699|NCT01968070|8640688|P15|Period 2|Withdrawal by Subject|0
2498700|NCT01968070|8640689|P14|Period 2|Withdrawal by Subject|0
2498701|NCT01968070|8640690|P13|Period 2|Withdrawal by Subject|0
2498702|NCT01968070|8640691|P12|Period 2|Withdrawal by Subject|0
2498703|NCT01968070|8640692|P11|Period 2|Withdrawal by Subject|0
2498704|NCT01968070|8640693|P10|Period 2|Withdrawal by Subject|0
2498705|NCT01968070|8640694|P9|Period 2|Withdrawal by Subject|0
2498706|NCT01968070|8640695|P8|Period 2|Withdrawal by Subject|0
2498707|NCT01968070|8640696|P7|Period 2|Withdrawal by Subject|0
2498708|NCT01968070|8640697|P6|Period 2|Withdrawal by Subject|0
2498709|NCT01968070|8640698|P5|Period 2|Withdrawal by Subject|1
2498710|NCT01968070|8640699|P4|Period 2|Withdrawal by Subject|0
2498711|NCT01968070|8640700|P3|Period 2|Withdrawal by Subject|0
2498712|NCT01968070|8640701|P2|Period 2|Withdrawal by Subject|0
2498713|NCT01968070|8640702|P1|Period 2|Withdrawal by Subject|0
2498714|NCT01968070|8640685|P18|Period 1|Physician Decision|0
2498715|NCT01968070|8640686|P17|Period 1|Physician Decision|0
2498716|NCT01968070|8640687|P16|Period 1|Physician Decision|0
2498717|NCT01968070|8640688|P15|Period 1|Physician Decision|0
2498718|NCT01968070|8640689|P14|Period 1|Physician Decision|0
2498719|NCT01968070|8640690|P13|Period 1|Physician Decision|0
2498720|NCT01968070|8640691|P12|Period 1|Physician Decision|1
2498721|NCT01968070|8640692|P11|Period 1|Physician Decision|0
2498722|NCT01968070|8640693|P10|Period 1|Physician Decision|0
2498723|NCT01968070|8640694|P9|Period 1|Physician Decision|0
2498724|NCT01968070|8640695|P8|Period 1|Physician Decision|0
2498725|NCT01968070|8640696|P7|Period 1|Physician Decision|0
2498726|NCT01968070|8640697|P6|Period 1|Physician Decision|0
2498727|NCT01968070|8640698|P5|Period 1|Physician Decision|0
2498728|NCT01968070|8640699|P4|Period 1|Physician Decision|0
2498729|NCT01968070|8640700|P3|Period 1|Physician Decision|0
2498730|NCT01968070|8640701|P2|Period 1|Physician Decision|0
2498731|NCT01968070|8640702|P1|Period 1|Physician Decision|0
2498732|NCT01968070|8640685|P18|Period 1|Adverse Event|0
2498733|NCT01968070|8640686|P17|Period 1|Adverse Event|0
2498734|NCT01968070|8640687|P16|Period 1|Adverse Event|0
2498735|NCT01968070|8640688|P15|Period 1|Adverse Event|0
2498736|NCT01968070|8640689|P14|Period 1|Adverse Event|0
2498737|NCT01968070|8640690|P13|Period 1|Adverse Event|0
2498738|NCT01968070|8640691|P12|Period 1|Adverse Event|0
2498739|NCT01968070|8640692|P11|Period 1|Adverse Event|0
2498740|NCT01968070|8640693|P10|Period 1|Adverse Event|0
2498741|NCT01968070|8640694|P9|Period 1|Adverse Event|0
2498742|NCT01968070|8640695|P8|Period 1|Adverse Event|0
2498743|NCT01968070|8640696|P7|Period 1|Adverse Event|1
2498744|NCT01968070|8640697|P6|Period 1|Adverse Event|0
2498745|NCT01968070|8640698|P5|Period 1|Adverse Event|0
2498746|NCT01968070|8640699|P4|Period 1|Adverse Event|0
2498747|NCT01968070|8640700|P3|Period 1|Adverse Event|0
2498748|NCT01968070|8640701|P2|Period 1|Adverse Event|0
2498749|NCT01968070|8640702|P1|Period 1|Adverse Event|0
2498750|NCT01968070|8640685|P18|Period 1|Lost to Follow-up|0
2498751|NCT01968070|8640686|P17|Period 1|Lost to Follow-up|0
2498752|NCT01968070|8640687|P16|Period 1|Lost to Follow-up|0
2498753|NCT01968070|8640688|P15|Period 1|Lost to Follow-up|0
2498754|NCT01968070|8640689|P14|Period 1|Lost to Follow-up|0
2498755|NCT01968070|8640690|P13|Period 1|Lost to Follow-up|0
2498756|NCT01968070|8640691|P12|Period 1|Lost to Follow-up|0
2498757|NCT01968070|8640692|P11|Period 1|Lost to Follow-up|0
2498758|NCT01968070|8640693|P10|Period 1|Lost to Follow-up|0
2498759|NCT01968070|8640694|P9|Period 1|Lost to Follow-up|0
2498760|NCT01968070|8640695|P8|Period 1|Lost to Follow-up|0
2498761|NCT01968070|8640696|P7|Period 1|Lost to Follow-up|0
2498762|NCT01968070|8640697|P6|Period 1|Lost to Follow-up|0
2498763|NCT01968070|8640698|P5|Period 1|Lost to Follow-up|0
2498764|NCT01968070|8640699|P4|Period 1|Lost to Follow-up|1
2498765|NCT01968070|8640700|P3|Period 1|Lost to Follow-up|0
2498766|NCT01968070|8640701|P2|Period 1|Lost to Follow-up|0
2498767|NCT01968070|8640702|P1|Period 1|Lost to Follow-up|0
2498768|NCT01968070|8640685|P18|Period 1|Protocol Violation|0
2498769|NCT01968070|8640686|P17|Period 1|Protocol Violation|0
2498770|NCT01968070|8640687|P16|Period 1|Protocol Violation|0
2498771|NCT01968070|8640688|P15|Period 1|Protocol Violation|0
2498772|NCT01968070|8640689|P14|Period 1|Protocol Violation|0
2498773|NCT01968070|8640690|P13|Period 1|Protocol Violation|0
2498774|NCT01968070|8640691|P12|Period 1|Protocol Violation|0
2498775|NCT01968070|8640692|P11|Period 1|Protocol Violation|0
2498776|NCT01968070|8640693|P10|Period 1|Protocol Violation|0
2498777|NCT01968070|8640694|P9|Period 1|Protocol Violation|0
2498778|NCT01968070|8640695|P8|Period 1|Protocol Violation|0
2498779|NCT01968070|8640696|P7|Period 1|Protocol Violation|0
2498780|NCT01968070|8640697|P6|Period 1|Protocol Violation|0
2498781|NCT01968070|8640698|P5|Period 1|Protocol Violation|1
2498782|NCT01968070|8640699|P4|Period 1|Protocol Violation|1
2498783|NCT01968070|8640700|P3|Period 1|Protocol Violation|0
2498784|NCT01968070|8640701|P2|Period 1|Protocol Violation|0
2498785|NCT01968070|8640702|P1|Period 1|Protocol Violation|0
2498786|NCT01968070|8640685|P18|Period 1|Withdrawal by Subject|0
2498787|NCT01968070|8640686|P17|Period 1|Withdrawal by Subject|0
2498788|NCT01968070|8640687|P16|Period 1|Withdrawal by Subject|1
2498789|NCT01968070|8640688|P15|Period 1|Withdrawal by Subject|0
2498790|NCT01968070|8640689|P14|Period 1|Withdrawal by Subject|0
2498791|NCT01968070|8640690|P13|Period 1|Withdrawal by Subject|0
2498792|NCT01968070|8640691|P12|Period 1|Withdrawal by Subject|0
2498793|NCT01968070|8640692|P11|Period 1|Withdrawal by Subject|0
2498794|NCT01968070|8640693|P10|Period 1|Withdrawal by Subject|0
2498795|NCT01968070|8640694|P9|Period 1|Withdrawal by Subject|0
2498796|NCT01968070|8640695|P8|Period 1|Withdrawal by Subject|0
2498797|NCT01968070|8640696|P7|Period 1|Withdrawal by Subject|1
2498798|NCT01968070|8640697|P6|Period 1|Withdrawal by Subject|0
2498799|NCT01968070|8640698|P5|Period 1|Withdrawal by Subject|0
2498800|NCT01968070|8640699|P4|Period 1|Withdrawal by Subject|0
2498801|NCT01968070|8640700|P3|Period 1|Withdrawal by Subject|0
2498802|NCT01968070|8640701|P2|Period 1|Withdrawal by Subject|1
2498803|NCT01968070|8640702|P1|Period 1|Withdrawal by Subject|0
2498804|NCT01967940|8640773|P4|Part 2|Unknown Reason|1
2498805|NCT01967940|8640774|P3|Part 2|Unknown Reason|0
2498806|NCT01967940|8640775|P2|Part 2|Unknown Reason|0
2498807|NCT01967940|8640776|P1|Part 2|Unknown Reason|0
2498808|NCT01967940|8640773|P4|Part 2|Adverse Event|1
2498809|NCT01967940|8640774|P3|Part 2|Adverse Event|0
2498810|NCT01967940|8640775|P2|Part 2|Adverse Event|0
2498811|NCT01967940|8640776|P1|Part 2|Adverse Event|0
2498812|NCT01967940|8640773|P4|Part 2|Enrolled in Part 2 and Never Treated|1
2498813|NCT01967940|8640774|P3|Part 2|Enrolled in Part 2 and Never Treated|0
2498814|NCT01967940|8640775|P2|Part 2|Enrolled in Part 2 and Never Treated|0
2498815|NCT01967940|8640776|P1|Part 2|Enrolled in Part 2 and Never Treated|0
2498816|NCT01967888|8640804|P2|Overall Study|Subject Unable To Comply With Final Day|1
2498817|NCT01967888|8640805|P1|Overall Study|Subject Unable To Comply With Final Day|0
2498818|NCT01967888|8640804|P2|Overall Study|Patient didn't proceed to pancreatectomy|1
2498819|NCT01967888|8640805|P1|Overall Study|Patient didn't proceed to pancreatectomy|0
2498820|NCT01967888|8640804|P2|Overall Study|Subject excluded after randomization|0
2498821|NCT01967888|8640805|P1|Overall Study|Subject excluded after randomization|1
2498822|NCT01967888|8640804|P2|Overall Study|Research visit not done, data recorded|0
2498823|NCT01967888|8640805|P1|Overall Study|Research visit not done, data recorded|1
2498824|NCT01967888|8640804|P2|Overall Study|Did Not Have Transplant|0
2498825|NCT01967888|8640805|P1|Overall Study|Did Not Have Transplant|1
2498826|NCT01967888|8640804|P2|Overall Study|Withdrawal by Subject|1
2498827|NCT01967888|8640805|P1|Overall Study|Withdrawal by Subject|1
2498828|NCT01967888|8640804|P2|Overall Study|Lost to Follow-up|4
2498829|NCT01967888|8640805|P1|Overall Study|Lost to Follow-up|6
2498830|NCT01967732|8640889|P4|First Intervention (Day 1)|Poor venous access|0
2498831|NCT01967732|8640890|P3|First Intervention (Day 1)|Poor venous access|0
2498832|NCT01967732|8640891|P2|First Intervention (Day 1)|Poor venous access|1
2498833|NCT01967732|8640892|P1|First Intervention (Day 1)|Poor venous access|0
2498834|NCT01967732|8640889|P4|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
2498835|NCT01967732|8640890|P3|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
2498836|NCT01967732|8640891|P2|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1
2498837|NCT01967732|8640892|P1|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
2498838|NCT01967719|8640906|P4|Second Intervention (Day 3)|Withdrawal by Subject|0
2498839|NCT01967719|8640907|P3|Second Intervention (Day 3)|Withdrawal by Subject|0
2498840|NCT01967719|8640908|P2|Second Intervention (Day 3)|Withdrawal by Subject|1
2498841|NCT01967719|8640909|P1|Second Intervention (Day 3)|Withdrawal by Subject|0
2498842|NCT01967719|8640906|P4|First Intervention (Day 1)|Withdrawal by Subject|1
2498843|NCT01967719|8640907|P3|First Intervention (Day 1)|Withdrawal by Subject|0
2498844|NCT01967719|8640908|P2|First Intervention (Day 1)|Withdrawal by Subject|1
2498845|NCT01967719|8640909|P1|First Intervention (Day 1)|Withdrawal by Subject|0
2498846|NCT01967706|8640924|P4|First Intervention (Day 1)|Withdrawal by Subject|0
2498847|NCT01967706|8640925|P3|First Intervention (Day 1)|Withdrawal by Subject|0
2498848|NCT01967706|8640926|P2|First Intervention (Day 1)|Withdrawal by Subject|0
2498849|NCT01967706|8640927|P1|First Intervention (Day 1)|Withdrawal by Subject|1
2498850|NCT01967628|8640948|P2|Overall Study|Low protein concentration in sample|25
2498851|NCT01967628|8640949|P1|Overall Study|Low protein concentration in sample|20
2498852|NCT01967628|8640948|P2|Overall Study|Lost to Follow-up|0
2498853|NCT01967628|8640949|P1|Overall Study|Lost to Follow-up|1
2498854|NCT01967628|8640948|P2|Overall Study|Unable to complete bronchoscopy|6
2498855|NCT01967628|8640949|P1|Overall Study|Unable to complete bronchoscopy|4
2498856|NCT01967628|8640948|P2|Overall Study|Withdrawal by Subject|0
2498857|NCT01967628|8640949|P1|Overall Study|Withdrawal by Subject|2
2498858|NCT01967550|8640957|P2|Overall Study|Non Compliance|1
2498859|NCT01967550|8640958|P1|Overall Study|Non Compliance|0
2498860|NCT01967550|8640957|P2|Overall Study|Protocol Violation|1
2498861|NCT01967550|8640958|P1|Overall Study|Protocol Violation|2
2498862|NCT01967550|8640957|P2|Overall Study|Adverse Event|0
2498863|NCT01967550|8640958|P1|Overall Study|Adverse Event|2
2498864|NCT01967550|8640957|P2|Overall Study|Withdrawal by Subject|0
2498865|NCT01967550|8640958|P1|Overall Study|Withdrawal by Subject|1
2498866|NCT01967537|8640964|P1|Overall Study|Lost to Follow-up|6
2498867|NCT01967537|8640964|P1|Overall Study|Refuse treatment|2
2498868|NCT01967537|8640964|P1|Overall Study|Withdrawal by Subject|52
2498869|NCT01967277|8641018|P2|Overall Study|Unrelated illness|1
2498870|NCT01967277|8641019|P1|Overall Study|Unrelated illness|0
2498871|NCT01967277|8641018|P2|Overall Study|Lost to Follow-up|2
2498872|NCT01967277|8641019|P1|Overall Study|Lost to Follow-up|1
2498873|NCT01967225|8641031|P2|Overall Study|Protocol Violation|0
2498874|NCT01967225|8641032|P1|Overall Study|Protocol Violation|2
2498875|NCT01967225|8641031|P2|Overall Study|Logistical difficulties|0
2498876|NCT01967225|8641032|P1|Overall Study|Logistical difficulties|1
2498877|NCT01967225|8641031|P2|Overall Study|Protocol driven decision point|0
2498878|NCT01967225|8641032|P1|Overall Study|Protocol driven decision point|1
2498879|NCT01967225|8641031|P2|Overall Study|Switching to other therapy|0
2498880|NCT01967225|8641032|P1|Overall Study|Switching to other therapy|2
2498881|NCT01967225|8641031|P2|Overall Study|Lack of Efficacy|1
2498882|NCT01967225|8641032|P1|Overall Study|Lack of Efficacy|1
2498883|NCT01967225|8641031|P2|Overall Study|Withdrawal by Subject|1
2498884|NCT01967225|8641032|P1|Overall Study|Withdrawal by Subject|2
2498885|NCT01967225|8641031|P2|Overall Study|Adverse Event|1
2498886|NCT01967225|8641032|P1|Overall Study|Adverse Event|3
2498887|NCT01967173|8641064|P8|Overall Study|Withdrawal by Subject|12
2498888|NCT01967173|8641065|P7|Overall Study|Withdrawal by Subject|10
2498889|NCT01967173|8641066|P6|Overall Study|Withdrawal by Subject|9
2498890|NCT01967173|8641067|P5|Overall Study|Withdrawal by Subject|8
2498891|NCT01967173|8641068|P4|Overall Study|Withdrawal by Subject|7
2498892|NCT01967173|8641069|P3|Overall Study|Withdrawal by Subject|10
2498893|NCT01967173|8641070|P2|Overall Study|Withdrawal by Subject|14
2498894|NCT01967173|8641071|P1|Overall Study|Withdrawal by Subject|15
2498895|NCT01967173|8641064|P8|Overall Study|Adverse Event|1
2498896|NCT01967173|8641065|P7|Overall Study|Adverse Event|0
2498897|NCT01967173|8641066|P6|Overall Study|Adverse Event|0
2498898|NCT01967173|8641067|P5|Overall Study|Adverse Event|0
2498899|NCT01967173|8641068|P4|Overall Study|Adverse Event|0
2498900|NCT01967173|8641069|P3|Overall Study|Adverse Event|0
2498901|NCT01967173|8641070|P2|Overall Study|Adverse Event|0
2498902|NCT01967173|8641071|P1|Overall Study|Adverse Event|0
2498903|NCT01967173|8641064|P8|Overall Study|Pregnancy|1
2498904|NCT01967173|8641065|P7|Overall Study|Pregnancy|1
2498905|NCT01967173|8641066|P6|Overall Study|Pregnancy|0
2498906|NCT01967173|8641067|P5|Overall Study|Pregnancy|0
2498907|NCT01967173|8641068|P4|Overall Study|Pregnancy|0
2498908|NCT01967173|8641069|P3|Overall Study|Pregnancy|0
2498909|NCT01967173|8641070|P2|Overall Study|Pregnancy|0
2498910|NCT01967173|8641071|P1|Overall Study|Pregnancy|0
2498911|NCT01967173|8641064|P8|Overall Study|Lack of Efficacy|2
2498912|NCT01967173|8641065|P7|Overall Study|Lack of Efficacy|0
2498913|NCT01967173|8641066|P6|Overall Study|Lack of Efficacy|1
2498914|NCT01967173|8641067|P5|Overall Study|Lack of Efficacy|0
2498915|NCT01967173|8641068|P4|Overall Study|Lack of Efficacy|2
2498916|NCT01967173|8641069|P3|Overall Study|Lack of Efficacy|2
2498917|NCT01967173|8641070|P2|Overall Study|Lack of Efficacy|0
2498918|NCT01967173|8641071|P1|Overall Study|Lack of Efficacy|2
2498919|NCT01967173|8641064|P8|Overall Study|Physician Decision|0
2498920|NCT01967173|8641065|P7|Overall Study|Physician Decision|1
2498921|NCT01967173|8641066|P6|Overall Study|Physician Decision|1
2498922|NCT01967173|8641067|P5|Overall Study|Physician Decision|1
2498923|NCT01967173|8641068|P4|Overall Study|Physician Decision|1
2498924|NCT01967173|8641069|P3|Overall Study|Physician Decision|2
2498925|NCT01967173|8641070|P2|Overall Study|Physician Decision|0
2498926|NCT01967173|8641071|P1|Overall Study|Physician Decision|2
2498927|NCT01967173|8641064|P8|Overall Study|Lost to Follow-up|8
2498928|NCT01967173|8641065|P7|Overall Study|Lost to Follow-up|6
2498929|NCT01967173|8641066|P6|Overall Study|Lost to Follow-up|12
2498930|NCT01967173|8641067|P5|Overall Study|Lost to Follow-up|8
2498931|NCT01967173|8641068|P4|Overall Study|Lost to Follow-up|4
2498932|NCT01967173|8641069|P3|Overall Study|Lost to Follow-up|2
2498933|NCT01967173|8641070|P2|Overall Study|Lost to Follow-up|3
2498934|NCT01967173|8641071|P1|Overall Study|Lost to Follow-up|5
2498935|NCT01967147|8641085|P2|Overall Study|Other|5
2498936|NCT01967147|8641086|P1|Overall Study|Other|4
2498937|NCT01967147|8641085|P2|Overall Study|Non-compliance with Study Drug|3
2498938|NCT01967147|8641086|P1|Overall Study|Non-compliance with Study Drug|0
2498939|NCT01967147|8641085|P2|Overall Study|Withdrawal by Subject|4
2498940|NCT01967147|8641086|P1|Overall Study|Withdrawal by Subject|2
2498941|NCT01967147|8641085|P2|Overall Study|Lost to Follow-up|2
2498942|NCT01967147|8641086|P1|Overall Study|Lost to Follow-up|1
2498943|NCT01967147|8641085|P2|Overall Study|Lack of Efficacy|4
2498944|NCT01967147|8641086|P1|Overall Study|Lack of Efficacy|1
2498945|NCT01967147|8641085|P2|Overall Study|Adverse Event|2
2498946|NCT01967147|8641086|P1|Overall Study|Adverse Event|5
2498947|NCT01967134|8641104|P3|Overall Study|Lost to Follow-up|0
2498948|NCT01967134|8641105|P2|Overall Study|Lost to Follow-up|1
2498949|NCT01967134|8641106|P1|Overall Study|Lost to Follow-up|0
2498950|NCT01967069|8641141|P2|Overall Study|Lack of Efficacy|1
2498951|NCT01967069|8641142|P1|Overall Study|Lack of Efficacy|0
2498952|NCT01967069|8641141|P2|Overall Study|Withdrawal by Subject|3
2498953|NCT01967069|8641142|P1|Overall Study|Withdrawal by Subject|1
2498954|NCT01967069|8641141|P2|Overall Study|Lost to Follow-up|2
2498955|NCT01967069|8641142|P1|Overall Study|Lost to Follow-up|5
2498956|NCT01967069|8641141|P2|Overall Study|Adverse Event|2
2498957|NCT01967069|8641142|P1|Overall Study|Adverse Event|2
2498958|NCT01966445|8641345|P7|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2
2498959|NCT01966445|8641346|P6|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
2498960|NCT01966445|8641347|P5|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
2498961|NCT01966445|8641348|P4|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
2498962|NCT01966445|8641349|P3|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
2498963|NCT01966445|8641350|P2|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
2498964|NCT01966445|8641351|P1|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
2498965|NCT01966445|8641345|P7|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3
2498966|NCT01966445|8641346|P6|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
2498967|NCT01966445|8641347|P5|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
2498968|NCT01966445|8641348|P4|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
2498969|NCT01966445|8641349|P3|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
2498970|NCT01966445|8641350|P2|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
2498971|NCT01966445|8641351|P1|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
2498972|NCT01966445|8641345|P7|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
2498973|NCT01966445|8641346|P6|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
2498974|NCT01966445|8641347|P5|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2
2498975|NCT01966445|8641348|P4|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
2498976|NCT01966445|8641349|P3|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1
2498977|NCT01966445|8641350|P2|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1
2498978|NCT01966445|8641351|P1|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
2498979|NCT01966445|8641345|P7|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
2498980|NCT01966445|8641346|P6|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
2498981|NCT01966445|8641347|P5|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
2498982|NCT01966445|8641348|P4|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
2498983|NCT01966445|8641349|P3|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
2498984|NCT01966445|8641350|P2|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
2498985|NCT01966445|8641351|P1|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
2498986|NCT01966445|8641345|P7|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
2498987|NCT01966445|8641346|P6|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1
2498988|NCT01966445|8641347|P5|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
2498989|NCT01966445|8641348|P4|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2
2498990|NCT01966445|8641349|P3|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
2498991|NCT01966445|8641350|P2|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
2498992|NCT01966445|8641351|P1|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
2498993|NCT01966432|8641461|P3|Overall Study|SBIRT program ended|20
2498994|NCT01966432|8641462|P2|Overall Study|SBIRT program ended|8
2498995|NCT01966432|8641463|P1|Overall Study|SBIRT program ended|1
2498996|NCT01966432|8641461|P3|Overall Study|Subject Incarcerated|1
2498997|NCT01966432|8641462|P2|Overall Study|Subject Incarcerated|0
2498998|NCT01966432|8641463|P1|Overall Study|Subject Incarcerated|0
2498999|NCT01966432|8641461|P3|Overall Study|Withdrawal by Subject|0
2499000|NCT01966432|8641462|P2|Overall Study|Withdrawal by Subject|3
2499001|NCT01966432|8641463|P1|Overall Study|Withdrawal by Subject|1
2499002|NCT01966432|8641461|P3|Overall Study|Lost to Follow-up|5
2499003|NCT01966432|8641462|P2|Overall Study|Lost to Follow-up|2
2499004|NCT01966432|8641463|P1|Overall Study|Lost to Follow-up|3
2499005|NCT01966120|8641533|P2|Overall Study|Lost to Follow-up|1
2499006|NCT01966120|8641534|P1|Overall Study|Lost to Follow-up|1
2499007|NCT01966120|8641533|P2|Overall Study|Withdrawal by Subject|5
2499008|NCT01966120|8641534|P1|Overall Study|Withdrawal by Subject|0
2499009|NCT01966107|8641558|P2|Overall Study|withdrew from the study|303
2499010|NCT01966107|8641559|P1|Overall Study|withdrew from the study|272
2499011|NCT01966107|8641558|P2|Overall Study|due to study closure|186
2499012|NCT01966107|8641559|P1|Overall Study|due to study closure|164
2499013|NCT01966107|8641558|P2|Overall Study|discontinued treatment|372
2499014|NCT01966107|8641559|P1|Overall Study|discontinued treatment|345
2499015|NCT01966107|8641558|P2|Overall Study|excluded from FAS|20
2499016|NCT01966107|8641559|P1|Overall Study|excluded from FAS|21
2499017|NCT01966068|8641573|P1|Overall Study|Lost to Follow-up|81
2499018|NCT01966068|8641573|P1|Overall Study|Withdrawal by Subject|57
2499019|NCT01966042|8641578|P1|Overall Study|Death|2
2499020|NCT01966003|8641587|P2|Overall Study|Other|1
2499021|NCT01966003|8641588|P1|Overall Study|Other|1
2499022|NCT01966003|8641587|P2|Overall Study|Plan to Receive Commercial Bevacizumab|67
2499023|NCT01966003|8641588|P1|Overall Study|Plan to Receive Commercial Bevacizumab|44
2499024|NCT01966003|8641587|P2|Overall Study|Plan to Receive Other Anticancer Therapy|127
2499025|NCT01966003|8641588|P1|Overall Study|Plan to Receive Other Anticancer Therapy|131
2499026|NCT01966003|8641587|P2|Overall Study|Withdrawal by Subject|19
2499027|NCT01966003|8641588|P1|Overall Study|Withdrawal by Subject|29
2499028|NCT01966003|8641587|P2|Overall Study|Physician Decision|13
2499029|NCT01966003|8641588|P1|Overall Study|Physician Decision|12
2499030|NCT01966003|8641587|P2|Overall Study|Lost to Follow-up|3
2499031|NCT01966003|8641588|P1|Overall Study|Lost to Follow-up|4
2499032|NCT01966003|8641587|P2|Overall Study|Protocol Violation|4
2499033|NCT01966003|8641588|P1|Overall Study|Protocol Violation|6
2499034|NCT01966003|8641587|P2|Overall Study|Death|36
2499035|NCT01966003|8641588|P1|Overall Study|Death|43
2499036|NCT01965938|8641606|P2|Overall Study|Withdrawal by Subject|0
2499037|NCT01965938|8641607|P1|Overall Study|Withdrawal by Subject|1
2499038|NCT01965834|8641638|P1|Overall Study|Lack of Efficacy|4
2499039|NCT01965652|8641679|P2|Overall Study|Pregnancy|1
2499040|NCT01965652|8641680|P1|Overall Study|Pregnancy|0
2499041|NCT01965652|8641679|P2|Overall Study|Other - Miscellaneous|21
2499042|NCT01965652|8641680|P1|Overall Study|Other - Miscellaneous|18
2499043|NCT01965652|8641679|P2|Overall Study|Death|4
2499044|NCT01965652|8641680|P1|Overall Study|Death|3
2499045|NCT01965652|8641679|P2|Overall Study|Protocol Violation|38
2499046|NCT01965652|8641680|P1|Overall Study|Protocol Violation|34
2499047|NCT01965652|8641679|P2|Overall Study|Lost to Follow-up|40
2499048|NCT01965652|8641680|P1|Overall Study|Lost to Follow-up|53
2499049|NCT01965652|8641679|P2|Overall Study|Withdrawal by Subject|69
2499050|NCT01965652|8641680|P1|Overall Study|Withdrawal by Subject|62
2499051|NCT01965652|8641679|P2|Overall Study|Adverse Event|37
2499052|NCT01965652|8641680|P1|Overall Study|Adverse Event|40
2499053|NCT01965600|8641710|P4|Second Intervention|Study terminated by Sponsor|2
2499054|NCT01965600|8641711|P3|Second Intervention|Study terminated by Sponsor|2
2499055|NCT01965600|8641712|P2|Second Intervention|Study terminated by Sponsor|0
2499056|NCT01965600|8641713|P1|Second Intervention|Study terminated by Sponsor|0
2499057|NCT01965600|8641710|P4|Washout Period of Approximately 15 Days|Adverse Event|1
2499058|NCT01965600|8641711|P3|Washout Period of Approximately 15 Days|Adverse Event|0
2499059|NCT01965600|8641712|P2|Washout Period of Approximately 15 Days|Adverse Event|0
2499060|NCT01965600|8641713|P1|Washout Period of Approximately 15 Days|Adverse Event|0
2499061|NCT01965600|8641710|P4|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
2499062|NCT01965600|8641711|P3|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
2499063|NCT01965600|8641712|P2|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
2499064|NCT01965600|8641713|P1|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1
2499065|NCT01965600|8641710|P4|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
2499151|NCT01964430|8642299|P2|Overall Study|Adverse Event|37
2499066|NCT01965600|8641711|P3|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
2499067|NCT01965600|8641712|P2|Washout Period of Approximately 15 Days|Withdrawal by Subject|1
2499068|NCT01965600|8641713|P1|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
2499069|NCT01965600|8641710|P4|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
2499070|NCT01965600|8641711|P3|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2
2499071|NCT01965600|8641712|P2|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3
2499072|NCT01965600|8641713|P1|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
2499073|NCT01965535|8641770|P2|Overall Study|Lack of Efficacy|1
2499074|NCT01965535|8641771|P1|Overall Study|Lack of Efficacy|2
2499075|NCT01965431|8641785|P6|Overall Study|Other than stated above|6
2499076|NCT01965431|8641786|P5|Overall Study|Other than stated above|6
2499077|NCT01965431|8641787|P4|Overall Study|Other than stated above|6
2499078|NCT01965431|8641788|P3|Overall Study|Other than stated above|6
2499079|NCT01965431|8641789|P2|Overall Study|Other than stated above|5
2499080|NCT01965431|8641790|P1|Overall Study|Other than stated above|6
2499081|NCT01965431|8641785|P6|Overall Study|Adverse Event|0
2499082|NCT01965431|8641786|P5|Overall Study|Adverse Event|0
2499083|NCT01965431|8641787|P4|Overall Study|Adverse Event|0
2499084|NCT01965431|8641788|P3|Overall Study|Adverse Event|0
2499085|NCT01965431|8641789|P2|Overall Study|Adverse Event|1
2499086|NCT01965431|8641790|P1|Overall Study|Adverse Event|0
2499087|NCT01965327|8641814|P1|Overall Study|Physician Decision|2
2499088|NCT01965262|8642028|P2|Second Intervention (7 Days)|Poor visual acuity|0
2499089|NCT01965262|8642029|P1|Second Intervention (7 Days)|Poor visual acuity|1
2499090|NCT01965262|8642028|P2|Second Intervention (7 Days)|Poor lens fit|9
2499091|NCT01965262|8642029|P1|Second Intervention (7 Days)|Poor lens fit|0
2499092|NCT01965262|8642028|P2|Second Intervention (7 Days)|Discontinued|1
2499093|NCT01965262|8642029|P1|Second Intervention (7 Days)|Discontinued|0
2499094|NCT01965158|8642093|P2|Overall Study|Other - Miscellaneous|0
2499095|NCT01965158|8642094|P1|Overall Study|Other - Miscellaneous|3
2499096|NCT01965158|8642093|P2|Overall Study|Protocol Violation|1
2499097|NCT01965158|8642094|P1|Overall Study|Protocol Violation|1
2499098|NCT01965158|8642093|P2|Overall Study|Lost to Follow-up|5
2499099|NCT01965158|8642094|P1|Overall Study|Lost to Follow-up|7
2499100|NCT01965158|8642093|P2|Overall Study|Withdrawal by Subject|24
2499101|NCT01965158|8642094|P1|Overall Study|Withdrawal by Subject|16
2499102|NCT01965158|8642093|P2|Overall Study|Adverse Event|5
2499103|NCT01965158|8642094|P1|Overall Study|Adverse Event|14
2499104|NCT01964976|8642135|P1|Overall Study|Protocol Violation|31
2499105|NCT01964963|8642147|P1|Overall Study|Data Reliability was not Assured|5
2499106|NCT01964963|8642147|P1|Overall Study|Protocol Deviation|50
2499107|NCT01964963|8642147|P1|Overall Study|Case Report Forms Uncollected|888
2499108|NCT01964950|8642155|P1|Overall Study|Protocol Violation|25
2499109|NCT01964924|8642167|P2|Trametinib Monotherapy|Progression|0
2499110|NCT01964924|8642168|P1|Trametinib Monotherapy|Progression|19
2499111|NCT01964898|8642192|P2|Overall Study|Withdrawal by Subject|0
2499112|NCT01964898|8642193|P1|Overall Study|Withdrawal by Subject|1
2499113|NCT01964898|8642192|P2|Overall Study|Lost to Follow-up|5
2499114|NCT01964898|8642193|P1|Overall Study|Lost to Follow-up|3
2499115|NCT01964898|8642192|P2|Overall Study|did not receive the allocated interventi|1
2499116|NCT01964898|8642193|P1|Overall Study|did not receive the allocated interventi|2
2499117|NCT01964898|8642192|P2|Overall Study|ineligible post-randomization|1
2499118|NCT01964898|8642193|P1|Overall Study|ineligible post-randomization|1
2499119|NCT01964755|8642213|P1|Overall Study|Death|2
2499120|NCT01964716|8642228|P2|Overall Study|Death|0
2499121|NCT01964716|8642229|P1|Overall Study|Death|1
2499122|NCT01964716|8642228|P2|Overall Study|No longer met eligibility criteria|1
2499123|NCT01964716|8642229|P1|Overall Study|No longer met eligibility criteria|1
2499124|NCT01964716|8642228|P2|Overall Study|Lost to Follow-up|2
2499125|NCT01964716|8642229|P1|Overall Study|Lost to Follow-up|1
2499126|NCT01964716|8642228|P2|Overall Study|Withdrawal by Subject|3
2499127|NCT01964716|8642229|P1|Overall Study|Withdrawal by Subject|2
2499128|NCT01964547|8642267|P2|Overall Study|Withdrawal by Investigator|1
2499129|NCT01964547|8642268|P1|Overall Study|Withdrawal by Investigator|0
2499130|NCT01964547|8642267|P2|Overall Study|Lost to Follow-up|1
2499131|NCT01964547|8642268|P1|Overall Study|Lost to Follow-up|0
2499132|NCT01964547|8642267|P2|Overall Study|Withdrawal by Subject|7
2499133|NCT01964547|8642268|P1|Overall Study|Withdrawal by Subject|4
2499134|NCT01964547|8642267|P2|Overall Study|Adverse Event|2
2499135|NCT01964547|8642268|P1|Overall Study|Adverse Event|8
2499136|NCT01964521|8642292|P1|Overall Study|Lost to Follow-up|4
2499137|NCT01964430|8642299|P2|Overall Study|Randomized but not Treated|11
2499138|NCT01964430|8642300|P1|Overall Study|Randomized but not Treated|3
2499139|NCT01964430|8642299|P2|Overall Study|Miscellaneous|3
2499140|NCT01964430|8642300|P1|Overall Study|Miscellaneous|1
2499141|NCT01964430|8642299|P2|Overall Study|Disease Relapse|38
2499142|NCT01964430|8642300|P1|Overall Study|Disease Relapse|28
2499143|NCT01964430|8642299|P2|Overall Study|Physician Decision|4
2499144|NCT01964430|8642300|P1|Overall Study|Physician Decision|5
2499145|NCT01964430|8642299|P2|Overall Study|Protocol Deviation|1
2499146|NCT01964430|8642300|P1|Overall Study|Protocol Deviation|0
2499147|NCT01964430|8642299|P2|Overall Study|Death|3
2499148|NCT01964430|8642300|P1|Overall Study|Death|1
2499149|NCT01964430|8642299|P2|Overall Study|Withdrawal by Subject|27
2499150|NCT01964430|8642300|P1|Overall Study|Withdrawal by Subject|36
2499152|NCT01964430|8642300|P1|Overall Study|Adverse Event|71
2499153|NCT01964378|8642312|P2|Overall Study|Other|2
2499154|NCT01964378|8642313|P1|Overall Study|Other|1
2499155|NCT01964378|8642312|P2|Overall Study|Inclusion/exclusion criteria not met|3
2499156|NCT01964378|8642313|P1|Overall Study|Inclusion/exclusion criteria not met|1
2499157|NCT01964378|8642312|P2|Overall Study|Withdrawal by Subject|5
2499158|NCT01964378|8642313|P1|Overall Study|Withdrawal by Subject|7
2499159|NCT01964378|8642312|P2|Overall Study|Lost to Follow-up|1
2499160|NCT01964378|8642313|P1|Overall Study|Lost to Follow-up|0
2499161|NCT01964378|8642312|P2|Overall Study|Protocol Violation|1
2499162|NCT01964378|8642313|P1|Overall Study|Protocol Violation|0
2499163|NCT01964378|8642312|P2|Overall Study|Lack of Efficacy|1
2499164|NCT01964378|8642313|P1|Overall Study|Lack of Efficacy|0
2499165|NCT01964378|8642312|P2|Overall Study|Adverse Event|5
2499166|NCT01964378|8642313|P1|Overall Study|Adverse Event|12
2499167|NCT01964378|8642312|P2|Overall Study|Death|2
2499168|NCT01964378|8642313|P1|Overall Study|Death|3
2499169|NCT01964378|8642312|P2|Overall Study|Disc. due to AE before first dosing|0
2499170|NCT01964378|8642313|P1|Overall Study|Disc. due to AE before first dosing|1
2499171|NCT01964378|8642312|P2|Overall Study|Disc. due to death before first dosing|1
2499172|NCT01964378|8642313|P1|Overall Study|Disc. due to death before first dosing|0
2499173|NCT01964352|8642349|P4|Overall Study|Other than stated above|2
2499174|NCT01964352|8642350|P3|Overall Study|Other than stated above|1
2499175|NCT01964352|8642351|P2|Overall Study|Other than stated above|2
2499176|NCT01964352|8642352|P1|Overall Study|Other than stated above|0
2499177|NCT01964352|8642349|P4|Overall Study|Withdrawal by Subject|0
2499178|NCT01964352|8642350|P3|Overall Study|Withdrawal by Subject|1
2499179|NCT01964352|8642351|P2|Overall Study|Withdrawal by Subject|2
2499180|NCT01964352|8642352|P1|Overall Study|Withdrawal by Subject|4
2499181|NCT01964352|8642349|P4|Overall Study|Lost to Follow-up|1
2499182|NCT01964352|8642350|P3|Overall Study|Lost to Follow-up|0
2499183|NCT01964352|8642351|P2|Overall Study|Lost to Follow-up|0
2499184|NCT01964352|8642352|P1|Overall Study|Lost to Follow-up|1
2499185|NCT01964352|8642349|P4|Overall Study|Protocol Violation|2
2499186|NCT01964352|8642350|P3|Overall Study|Protocol Violation|0
2499187|NCT01964352|8642351|P2|Overall Study|Protocol Violation|4
2499188|NCT01964352|8642352|P1|Overall Study|Protocol Violation|2
2499189|NCT01964352|8642349|P4|Overall Study|Lack of Efficacy|0
2499190|NCT01964352|8642350|P3|Overall Study|Lack of Efficacy|0
2499191|NCT01964352|8642351|P2|Overall Study|Lack of Efficacy|0
2499192|NCT01964352|8642352|P1|Overall Study|Lack of Efficacy|6
2499193|NCT01964352|8642349|P4|Overall Study|Adverse Event|3
2499194|NCT01964352|8642350|P3|Overall Study|Adverse Event|4
2499195|NCT01964352|8642351|P2|Overall Study|Adverse Event|3
2499196|NCT01964352|8642352|P1|Overall Study|Adverse Event|13
2499197|NCT01964326|8642382|P1|Overall Study|Did not meet eligibility criteria|1
2499198|NCT01964326|8642382|P1|Overall Study|Other|9
2499199|NCT01964326|8642382|P1|Overall Study|Investigator Discretion|1
2499200|NCT01964326|8642382|P1|Overall Study|Physician Decision|55
2499201|NCT01964326|8642382|P1|Overall Study|No Longer Meets Eligibility Criteria|1
2499202|NCT01964326|8642382|P1|Overall Study|Pregnancy|1
2499203|NCT01964326|8642382|P1|Overall Study|Withdrawal by Subject|87
2499204|NCT01964326|8642382|P1|Overall Study|Lost to Follow-up|88
2499205|NCT01964326|8642382|P1|Overall Study|Protocol Violation|4
2499206|NCT01964326|8642382|P1|Overall Study|Death|2
2499207|NCT01964326|8642382|P1|Overall Study|Adverse Event|48
2499208|NCT01964300|8642391|P2|Overall Study|Weight criteria not met|1
2499209|NCT01964300|8642392|P1|Overall Study|Weight criteria not met|0
2499210|NCT01964300|8642391|P2|Overall Study|Enlargement of cyst requiring drainage|0
2499211|NCT01964300|8642392|P1|Overall Study|Enlargement of cyst requiring drainage|1
2499212|NCT01964300|8642391|P2|Overall Study|To receive alternative therapy|2
2499213|NCT01964300|8642392|P1|Overall Study|To receive alternative therapy|1
2499214|NCT01964300|8642391|P2|Overall Study|Withdrawal by Subject|1
2499215|NCT01964300|8642392|P1|Overall Study|Withdrawal by Subject|0
2499216|NCT01964300|8642391|P2|Overall Study|Lack of Efficacy|5
2499217|NCT01964300|8642392|P1|Overall Study|Lack of Efficacy|3
2499218|NCT01964300|8642391|P2|Overall Study|Adverse Event|1
2499219|NCT01964300|8642392|P1|Overall Study|Adverse Event|1
2499220|NCT01964300|8642391|P2|Overall Study|Ineligible after enrollment|1
2499221|NCT01964300|8642392|P1|Overall Study|Ineligible after enrollment|0
2499222|NCT01964222|8642406|P2|Overall Study|Screening Failure|0
2499223|NCT01964222|8642407|P1|Overall Study|Screening Failure|2
2499224|NCT01964222|8642406|P2|Overall Study|Withdrawal by Subject|6
2499225|NCT01964222|8642407|P1|Overall Study|Withdrawal by Subject|6
2499226|NCT01964222|8642406|P2|Overall Study|Lost to Follow-up|5
2499227|NCT01964222|8642407|P1|Overall Study|Lost to Follow-up|7
2499228|NCT01964105|8642424|P3|Overall Study|Lost to Follow-up|0
2499229|NCT01964105|8642425|P2|Overall Study|Lost to Follow-up|13
2499230|NCT01964105|8642426|P1|Overall Study|Lost to Follow-up|2
2499231|NCT01963767|8642453|P2|Overall Study|Adverse Event|0
2499232|NCT01963767|8642454|P1|Overall Study|Adverse Event|2
2499233|NCT01963767|8642453|P2|Overall Study|Withdrawal by Subject|2
2499234|NCT01963767|8642454|P1|Overall Study|Withdrawal by Subject|4
2499235|NCT01963676|8642464|P2|Overall Study|Withdrawal by Subject|0
2499236|NCT01963676|8642465|P1|Overall Study|Withdrawal by Subject|1
2499237|NCT01963611|8642478|P5|Overall Study|Other|45
2499238|NCT01963611|8642479|P4|Overall Study|Other|45
2499239|NCT01963611|8642480|P3|Overall Study|Other|48
2499240|NCT01963611|8642481|P2|Overall Study|Other|46
2499241|NCT01963611|8642482|P1|Overall Study|Other|47
2499242|NCT01963611|8642478|P5|Overall Study|Withdrawal by Subject|3
2499243|NCT01963611|8642479|P4|Overall Study|Withdrawal by Subject|1
2499244|NCT01963611|8642480|P3|Overall Study|Withdrawal by Subject|1
2499245|NCT01963611|8642481|P2|Overall Study|Withdrawal by Subject|2
2499246|NCT01963611|8642482|P1|Overall Study|Withdrawal by Subject|3
2499247|NCT01963611|8642478|P5|Overall Study|Lack of Efficacy|0
2499248|NCT01963611|8642479|P4|Overall Study|Lack of Efficacy|1
2499249|NCT01963611|8642480|P3|Overall Study|Lack of Efficacy|0
2499250|NCT01963611|8642481|P2|Overall Study|Lack of Efficacy|0
2499251|NCT01963611|8642482|P1|Overall Study|Lack of Efficacy|0
2499252|NCT01963611|8642478|P5|Overall Study|Protocol Violation|0
2499253|NCT01963611|8642479|P4|Overall Study|Protocol Violation|1
2499254|NCT01963611|8642480|P3|Overall Study|Protocol Violation|0
2499255|NCT01963611|8642481|P2|Overall Study|Protocol Violation|0
2499256|NCT01963611|8642482|P1|Overall Study|Protocol Violation|0
2499257|NCT01963611|8642478|P5|Overall Study|Adverse Event|3
2499258|NCT01963611|8642479|P4|Overall Study|Adverse Event|4
2499259|NCT01963611|8642480|P3|Overall Study|Adverse Event|3
2499260|NCT01963611|8642481|P2|Overall Study|Adverse Event|1
2499261|NCT01963611|8642482|P1|Overall Study|Adverse Event|1
2499262|NCT01963403|8642547|P2|Overall Study|Implant removal|1
2499263|NCT01963403|8642548|P1|Overall Study|Implant removal|0
2499264|NCT01963403|8642547|P2|Overall Study|Lost to Follow-up|3
2499265|NCT01963403|8642548|P1|Overall Study|Lost to Follow-up|2
2499266|NCT01963260|8642570|P10|Overall Study|Withdrawal by Subject|0
2499267|NCT01963260|8642571|P9|Overall Study|Withdrawal by Subject|0
2499268|NCT01963260|8642572|P8|Overall Study|Withdrawal by Subject|0
2499269|NCT01963260|8642573|P7|Overall Study|Withdrawal by Subject|0
2499270|NCT01963260|8642574|P6|Overall Study|Withdrawal by Subject|0
2499271|NCT01963260|8642575|P5|Overall Study|Withdrawal by Subject|2
2499272|NCT01963260|8642576|P4|Overall Study|Withdrawal by Subject|1
2499273|NCT01963260|8642577|P3|Overall Study|Withdrawal by Subject|0
2499274|NCT01963260|8642578|P2|Overall Study|Withdrawal by Subject|0
2499275|NCT01963260|8642579|P1|Overall Study|Withdrawal by Subject|2
2499276|NCT01963117|8642693|P1|Overall Study|Death|1
2499277|NCT01962974|8642732|P1|Overall Study|Study termination|7
2499278|NCT01962922|8642759|P2|Extendion Portion (up to Month 6)|Physician Decision|0
2499279|NCT01962922|8642760|P1|Extendion Portion (up to Month 6)|Physician Decision|1
2499280|NCT01962922|8642759|P2|Extendion Portion (up to Month 6)|no longer wished to participate in study|3
2499281|NCT01962922|8642760|P1|Extendion Portion (up to Month 6)|no longer wished to participate in study|4
2499282|NCT01962922|8642759|P2|PK Portion Day 7|non-compliance|0
2499283|NCT01962922|8642760|P1|PK Portion Day 7|non-compliance|1
2499284|NCT01962922|8642759|P2|PK Portion Day 7|Withdrawal by Subject|0
2499285|NCT01962922|8642760|P1|PK Portion Day 7|Withdrawal by Subject|3
2499286|NCT01962896|8642782|P1|Overall Study|Lack of Efficacy|4
2499287|NCT01962493|8642904|P2|Overall Study|Withdrawal by Subject|2
2499288|NCT01962493|8642905|P1|Overall Study|Withdrawal by Subject|4
2499289|NCT01962493|8642904|P2|Overall Study|Protocol Violation|1
2499290|NCT01962493|8642905|P1|Overall Study|Protocol Violation|0
2499291|NCT01962493|8642904|P2|Overall Study|Adverse Event|2
2499292|NCT01962493|8642905|P1|Overall Study|Adverse Event|1
2499293|NCT01962441|8642928|P3|Retreatment Substudy|Lost to Follow-up|0
2499294|NCT01962441|8642929|P2|Retreatment Substudy|Lost to Follow-up|0
2499295|NCT01962441|8642930|P1|Retreatment Substudy|Lost to Follow-up|1
2499296|NCT01962441|8642928|P3|Retreatment Substudy|Lack of Efficacy|0
2499297|NCT01962441|8642929|P2|Retreatment Substudy|Lack of Efficacy|0
2499298|NCT01962441|8642930|P1|Retreatment Substudy|Lack of Efficacy|1
2499299|NCT01962441|8642928|P3|Randomized Period|Protocol Violation|0
2499300|NCT01962441|8642929|P2|Randomized Period|Protocol Violation|1
2499301|NCT01962441|8642930|P1|Randomized Period|Protocol Violation|0
2499302|NCT01962441|8642928|P3|Randomized Period|Death|2
2499303|NCT01962441|8642929|P2|Randomized Period|Death|0
2499304|NCT01962441|8642930|P1|Randomized Period|Death|0
2499305|NCT01962441|8642928|P3|Randomized Period|Adverse Event|0
2499306|NCT01962441|8642929|P2|Randomized Period|Adverse Event|1
2499307|NCT01962441|8642930|P1|Randomized Period|Adverse Event|1
2499308|NCT01962441|8642928|P3|Randomized Period|Withdrew Consent|2
2499309|NCT01962441|8642929|P2|Randomized Period|Withdrew Consent|3
2499310|NCT01962441|8642930|P1|Randomized Period|Withdrew Consent|3
2499311|NCT01962441|8642928|P3|Randomized Period|Lost to Follow-up|4
2499312|NCT01962441|8642929|P2|Randomized Period|Lost to Follow-up|4
2499313|NCT01962441|8642930|P1|Randomized Period|Lost to Follow-up|2
2499314|NCT01962441|8642928|P3|Randomized Period|Randomized but Never Treated|3
2499315|NCT01962441|8642929|P2|Randomized Period|Randomized but Never Treated|2
2499316|NCT01962441|8642930|P1|Randomized Period|Randomized but Never Treated|4
2499317|NCT01962298|8642974|P5|Overall Study|Physician Decision|1
2499318|NCT01962298|8642975|P4|Overall Study|Physician Decision|0
2499319|NCT01962298|8642976|P3|Overall Study|Physician Decision|0
2499320|NCT01962298|8642977|P2|Overall Study|Physician Decision|1
2499321|NCT01962298|8642978|P1|Overall Study|Physician Decision|0
2499322|NCT01962298|8642974|P5|Overall Study|Incorrect data recorded|0
2499323|NCT01962298|8642975|P4|Overall Study|Incorrect data recorded|0
2499324|NCT01962298|8642976|P3|Overall Study|Incorrect data recorded|0
2499325|NCT01962298|8642977|P2|Overall Study|Incorrect data recorded|1
2499326|NCT01962298|8642978|P1|Overall Study|Incorrect data recorded|0
2499327|NCT01962298|8642974|P5|Overall Study|Insufficient data|1
2499328|NCT01962298|8642975|P4|Overall Study|Insufficient data|0
2499329|NCT01962298|8642976|P3|Overall Study|Insufficient data|1
2499330|NCT01962298|8642977|P2|Overall Study|Insufficient data|2
2499331|NCT01962298|8642978|P1|Overall Study|Insufficient data|0
2499332|NCT01962298|8642974|P5|Overall Study|Data quality insufficient|4
2499333|NCT01962298|8642975|P4|Overall Study|Data quality insufficient|1
2499334|NCT01962298|8642976|P3|Overall Study|Data quality insufficient|3
2499335|NCT01962298|8642977|P2|Overall Study|Data quality insufficient|0
2499336|NCT01962298|8642978|P1|Overall Study|Data quality insufficient|2
2499337|NCT01962298|8642974|P5|Overall Study|Protocol Violation|0
2499338|NCT01962298|8642975|P4|Overall Study|Protocol Violation|1
2499339|NCT01962298|8642976|P3|Overall Study|Protocol Violation|1
2499340|NCT01962298|8642977|P2|Overall Study|Protocol Violation|0
2499341|NCT01962298|8642978|P1|Overall Study|Protocol Violation|1
2499342|NCT01962207|8642999|P4|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5
2499343|NCT01962207|8643000|P3|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13
2499344|NCT01962207|8643001|P2|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7
2499345|NCT01962207|8643002|P1|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21
2499346|NCT01962207|8642999|P4|Persistence Phase (5 Years)|Adverse Event|0
2499347|NCT01962207|8643000|P3|Persistence Phase (5 Years)|Adverse Event|1
2499348|NCT01962207|8643001|P2|Persistence Phase (5 Years)|Adverse Event|0
2499349|NCT01962207|8643002|P1|Persistence Phase (5 Years)|Adverse Event|0
2499350|NCT01962207|8642999|P4|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1
2499351|NCT01962207|8643000|P3|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3
2499352|NCT01962207|8643001|P2|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0
2499353|NCT01962207|8643002|P1|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0
2499354|NCT01962207|8642999|P4|Persistence Phase (5 Years)|Withdrawal by Subject|4
2499355|NCT01962207|8643000|P3|Persistence Phase (5 Years)|Withdrawal by Subject|18
2499356|NCT01962207|8643001|P2|Persistence Phase (5 Years)|Withdrawal by Subject|5
2499357|NCT01962207|8643002|P1|Persistence Phase (5 Years)|Withdrawal by Subject|4
2499358|NCT01962207|8642999|P4|Persistence Phase (5 Years)|Migrated/moved from study area|0
2499359|NCT01962207|8643000|P3|Persistence Phase (5 Years)|Migrated/moved from study area|4
2499360|NCT01962207|8643001|P2|Persistence Phase (5 Years)|Migrated/moved from study area|0
2499361|NCT01962207|8643002|P1|Persistence Phase (5 Years)|Migrated/moved from study area|2
2499362|NCT01962207|8642999|P4|Persistence Phase (5 Years)|Lost to Follow-up|2
2499363|NCT01962207|8643000|P3|Persistence Phase (5 Years)|Lost to Follow-up|5
2499364|NCT01962207|8643001|P2|Persistence Phase (5 Years)|Lost to Follow-up|1
2499365|NCT01962207|8643002|P1|Persistence Phase (5 Years)|Lost to Follow-up|2
2499366|NCT01962103|8643113|P9|Phase 2|Symptomatic Deterioration|0
2499367|NCT01962103|8643114|P8|Phase 2|Symptomatic Deterioration|2
2499368|NCT01962103|8643115|P7|Phase 2|Symptomatic Deterioration|2
2499369|NCT01962103|8643116|P6|Phase 2|Symptomatic Deterioration|0
2499370|NCT01962103|8643117|P5|Phase 2|Symptomatic Deterioration|0
2499371|NCT01962103|8643118|P4|Phase 2|Symptomatic Deterioration|0
2499372|NCT01962103|8643119|P3|Phase 2|Symptomatic Deterioration|0
2499373|NCT01962103|8643120|P2|Phase 2|Symptomatic Deterioration|0
2499374|NCT01962103|8643121|P1|Phase 2|Symptomatic Deterioration|0
2499375|NCT01962103|8643113|P9|Phase 2|Progressive Disease|11
2499376|NCT01962103|8643114|P8|Phase 2|Progressive Disease|12
2499377|NCT01962103|8643115|P7|Phase 2|Progressive Disease|11
2499378|NCT01962103|8643116|P6|Phase 2|Progressive Disease|0
2499379|NCT01962103|8643117|P5|Phase 2|Progressive Disease|0
2499380|NCT01962103|8643118|P4|Phase 2|Progressive Disease|0
2499381|NCT01962103|8643119|P3|Phase 2|Progressive Disease|0
2499382|NCT01962103|8643120|P2|Phase 2|Progressive Disease|0
2499383|NCT01962103|8643121|P1|Phase 2|Progressive Disease|0
2499384|NCT01962103|8643113|P9|Phase 2|Adverse Event|3
2499385|NCT01962103|8643114|P8|Phase 2|Adverse Event|0
2499386|NCT01962103|8643115|P7|Phase 2|Adverse Event|1
2499387|NCT01962103|8643116|P6|Phase 2|Adverse Event|0
2499388|NCT01962103|8643117|P5|Phase 2|Adverse Event|0
2499389|NCT01962103|8643118|P4|Phase 2|Adverse Event|0
2499390|NCT01962103|8643119|P3|Phase 2|Adverse Event|0
2499391|NCT01962103|8643120|P2|Phase 2|Adverse Event|0
2499392|NCT01962103|8643121|P1|Phase 2|Adverse Event|0
2499393|NCT01962103|8643113|P9|Phase 1|Miscellaneous|0
2499394|NCT01962103|8643114|P8|Phase 1|Miscellaneous|0
2499395|NCT01962103|8643115|P7|Phase 1|Miscellaneous|0
2499396|NCT01962103|8643116|P6|Phase 1|Miscellaneous|0
2499397|NCT01962103|8643117|P5|Phase 1|Miscellaneous|0
2499398|NCT01962103|8643118|P4|Phase 1|Miscellaneous|0
2499399|NCT01962103|8643119|P3|Phase 1|Miscellaneous|0
2499400|NCT01962103|8643120|P2|Phase 1|Miscellaneous|0
2499401|NCT01962103|8643121|P1|Phase 1|Miscellaneous|1
2499402|NCT01962103|8643113|P9|Phase 1|Symptomatic Deterioration|0
2499403|NCT01962103|8643114|P8|Phase 1|Symptomatic Deterioration|0
2499404|NCT01962103|8643115|P7|Phase 1|Symptomatic Deterioration|0
2499405|NCT01962103|8643116|P6|Phase 1|Symptomatic Deterioration|1
2499406|NCT01962103|8643117|P5|Phase 1|Symptomatic Deterioration|1
2499407|NCT01962103|8643118|P4|Phase 1|Symptomatic Deterioration|2
2499408|NCT01962103|8643119|P3|Phase 1|Symptomatic Deterioration|2
2499409|NCT01962103|8643120|P2|Phase 1|Symptomatic Deterioration|2
2499410|NCT01962103|8643121|P1|Phase 1|Symptomatic Deterioration|3
2499411|NCT01962103|8643113|P9|Phase 1|Physician Decision|0
2499412|NCT01962103|8643114|P8|Phase 1|Physician Decision|0
2499413|NCT01962103|8643115|P7|Phase 1|Physician Decision|0
2499414|NCT01962103|8643116|P6|Phase 1|Physician Decision|0
2499415|NCT01962103|8643117|P5|Phase 1|Physician Decision|0
2499416|NCT01962103|8643118|P4|Phase 1|Physician Decision|1
2499417|NCT01962103|8643119|P3|Phase 1|Physician Decision|0
2499418|NCT01962103|8643120|P2|Phase 1|Physician Decision|0
2499419|NCT01962103|8643121|P1|Phase 1|Physician Decision|0
2499420|NCT01962103|8643113|P9|Phase 1|Withdrawal by Parent/Guardian|0
2499421|NCT01962103|8643114|P8|Phase 1|Withdrawal by Parent/Guardian|0
2499422|NCT01962103|8643115|P7|Phase 1|Withdrawal by Parent/Guardian|0
2499423|NCT01962103|8643116|P6|Phase 1|Withdrawal by Parent/Guardian|0
2499424|NCT01962103|8643117|P5|Phase 1|Withdrawal by Parent/Guardian|0
2499425|NCT01962103|8643118|P4|Phase 1|Withdrawal by Parent/Guardian|1
2499426|NCT01962103|8643119|P3|Phase 1|Withdrawal by Parent/Guardian|2
2499427|NCT01962103|8643120|P2|Phase 1|Withdrawal by Parent/Guardian|0
2499428|NCT01962103|8643121|P1|Phase 1|Withdrawal by Parent/Guardian|0
2499429|NCT01962103|8643113|P9|Phase 1|Withdrawal by Subject|0
2499430|NCT01962103|8643114|P8|Phase 1|Withdrawal by Subject|0
2499431|NCT01962103|8643115|P7|Phase 1|Withdrawal by Subject|0
2499432|NCT01962103|8643116|P6|Phase 1|Withdrawal by Subject|0
2499433|NCT01962103|8643117|P5|Phase 1|Withdrawal by Subject|0
2499434|NCT01962103|8643118|P4|Phase 1|Withdrawal by Subject|2
2499435|NCT01962103|8643119|P3|Phase 1|Withdrawal by Subject|0
2499436|NCT01962103|8643120|P2|Phase 1|Withdrawal by Subject|0
2499437|NCT01962103|8643121|P1|Phase 1|Withdrawal by Subject|0
2499438|NCT01962103|8643113|P9|Phase 1|Progressive Disease|0
2499439|NCT01962103|8643114|P8|Phase 1|Progressive Disease|0
2499440|NCT01962103|8643115|P7|Phase 1|Progressive Disease|0
2499441|NCT01962103|8643116|P6|Phase 1|Progressive Disease|4
2499442|NCT01962103|8643117|P5|Phase 1|Progressive Disease|5
2499443|NCT01962103|8643118|P4|Phase 1|Progressive Disease|4
2499444|NCT01962103|8643119|P3|Phase 1|Progressive Disease|8
2499445|NCT01962103|8643120|P2|Phase 1|Progressive Disease|6
2499446|NCT01962103|8643121|P1|Phase 1|Progressive Disease|8
2499447|NCT01962103|8643113|P9|Phase 1|Adverse Event|0
2499448|NCT01962103|8643114|P8|Phase 1|Adverse Event|0
2499449|NCT01962103|8643115|P7|Phase 1|Adverse Event|0
2499450|NCT01962103|8643116|P6|Phase 1|Adverse Event|2
2499451|NCT01962103|8643117|P5|Phase 1|Adverse Event|2
2499452|NCT01962103|8643118|P4|Phase 1|Adverse Event|1
2499453|NCT01962103|8643119|P3|Phase 1|Adverse Event|2
2499454|NCT01962103|8643120|P2|Phase 1|Adverse Event|0
2499455|NCT01962103|8643121|P1|Phase 1|Adverse Event|4
2499456|NCT01961609|8643233|P4|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2
2499457|NCT01961609|8643234|P3|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0
2499458|NCT01961609|8643235|P2|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0
2499459|NCT01961609|8643236|P1|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1
2499460|NCT01961609|8643233|P4|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1
2499461|NCT01961609|8643234|P3|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3
2499462|NCT01961609|8643235|P2|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0
2499463|NCT01961609|8643236|P1|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3
2499464|NCT01961609|8643233|P4|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
2499465|NCT01961609|8643234|P3|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
2499466|NCT01961609|8643235|P2|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1
2499467|NCT01961609|8643236|P1|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
2499468|NCT01961609|8643233|P4|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
2499469|NCT01961609|8643234|P3|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
2499470|NCT01961609|8643235|P2|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
2499471|NCT01961609|8643236|P1|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1
2499472|NCT01961609|8643233|P4|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
2499473|NCT01961609|8643234|P3|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1
2499474|NCT01961609|8643235|P2|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
2499475|NCT01961609|8643236|P1|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
2499476|NCT01961609|8643233|P4|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4
2499477|NCT01961609|8643234|P3|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0
2499478|NCT01961609|8643235|P2|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5
2499479|NCT01961609|8643236|P1|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7
2499480|NCT01961609|8643233|P4|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
2499481|NCT01961609|8643234|P3|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1
2499482|NCT01961609|8643235|P2|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
2499483|NCT01961609|8643236|P1|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
2499484|NCT01961609|8643233|P4|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0
2499485|NCT01961609|8643234|P3|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3
2499486|NCT01961609|8643235|P2|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6
2499487|NCT01961609|8643236|P1|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6
2499488|NCT01961609|8643233|P4|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0
2499489|NCT01961609|8643234|P3|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10
2499490|NCT01961609|8643235|P2|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4
2499491|NCT01961609|8643236|P1|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13
2499492|NCT01961609|8643233|P4|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0
2499493|NCT01961609|8643234|P3|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1
2499494|NCT01961609|8643235|P2|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1
2499495|NCT01961609|8643236|P1|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0
2499496|NCT01961609|8643233|P4|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0
2499497|NCT01961609|8643234|P3|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1
2499498|NCT01961609|8643235|P2|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0
2499499|NCT01961609|8643236|P1|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3
2499500|NCT01961609|8643233|P4|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0
2499501|NCT01961609|8643234|P3|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3
2499502|NCT01961609|8643235|P2|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0
2499503|NCT01961609|8643236|P1|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1
2499504|NCT01961609|8643233|P4|Initiation|Randomized but not treated|0
2499505|NCT01961609|8643234|P3|Initiation|Randomized but not treated|0
2499506|NCT01961609|8643235|P2|Initiation|Randomized but not treated|1
2499507|NCT01961609|8643236|P1|Initiation|Randomized but not treated|1
2499508|NCT01961609|8643233|P4|Initiation|Adverse Event|0
2499509|NCT01961609|8643234|P3|Initiation|Adverse Event|0
2499510|NCT01961609|8643235|P2|Initiation|Adverse Event|5
2499511|NCT01961609|8643236|P1|Initiation|Adverse Event|3
2499512|NCT01961609|8643233|P4|Initiation|Abnormal lab values|0
2499513|NCT01961609|8643234|P3|Initiation|Abnormal lab values|0
2499514|NCT01961609|8643235|P2|Initiation|Abnormal lab values|1
2499515|NCT01961609|8643236|P1|Initiation|Abnormal lab values|0
2499516|NCT01961609|8643233|P4|Initiation|Lack of Efficacy|0
2499517|NCT01961609|8643234|P3|Initiation|Lack of Efficacy|0
2499518|NCT01961609|8643235|P2|Initiation|Lack of Efficacy|1
2499519|NCT01961609|8643236|P1|Initiation|Lack of Efficacy|2
2499520|NCT01961609|8643233|P4|Initiation|Withdrawal by Subject|0
2499521|NCT01961609|8643234|P3|Initiation|Withdrawal by Subject|0
2499522|NCT01961609|8643235|P2|Initiation|Withdrawal by Subject|2
2499523|NCT01961609|8643236|P1|Initiation|Withdrawal by Subject|1
2499524|NCT01961609|8643233|P4|Initiation|Administrative problems|0
2499525|NCT01961609|8643234|P3|Initiation|Administrative problems|0
2499526|NCT01961609|8643235|P2|Initiation|Administrative problems|0
2499527|NCT01961609|8643236|P1|Initiation|Administrative problems|1
2499528|NCT01961609|8643233|P4|Initiation|Death|0
2499529|NCT01961609|8643234|P3|Initiation|Death|0
2499530|NCT01961609|8643235|P2|Initiation|Death|1
2499531|NCT01961609|8643236|P1|Initiation|Death|0
2499532|NCT01961609|8643233|P4|Initiation|Protocol deviation|0
2499533|NCT01961609|8643234|P3|Initiation|Protocol deviation|0
2499534|NCT01961609|8643235|P2|Initiation|Protocol deviation|0
2499535|NCT01961609|8643236|P1|Initiation|Protocol deviation|1
2499536|NCT01961609|8643233|P4|Initiation|Missing|0
2499537|NCT01961609|8643234|P3|Initiation|Missing|0
2499538|NCT01961609|8643235|P2|Initiation|Missing|2
2499539|NCT01961609|8643236|P1|Initiation|Missing|3
2499540|NCT01961544|8643288|P1|Overall Study|Aggravation of Steral Pain|1
2499541|NCT01961544|8643288|P1|Overall Study|Poor Tolerance|1
2499542|NCT01961544|8643288|P1|Overall Study|Physician Decision|2
2499543|NCT01961544|8643288|P1|Overall Study|Adverse Event|1
2499544|NCT01961544|8643288|P1|Overall Study|Withdrawal by Subject|7
2499545|NCT01961544|8643288|P1|Overall Study|Protocol Violation|1
2499546|NCT01961349|8643302|P3|Overall Study|registration error, personal reason etc|1
2499547|NCT01961349|8643303|P2|Overall Study|registration error, personal reason etc|2
2499548|NCT01961349|8643304|P1|Overall Study|registration error, personal reason etc|2
2499549|NCT01961349|8643302|P3|Overall Study|Adverse Event|1
2499550|NCT01961349|8643303|P2|Overall Study|Adverse Event|0
2499551|NCT01961349|8643304|P1|Overall Study|Adverse Event|0
2499552|NCT01961349|8643302|P3|Overall Study|Withdrawal by Subject|0
2499553|NCT01961349|8643303|P2|Overall Study|Withdrawal by Subject|4
2499554|NCT01961349|8643304|P1|Overall Study|Withdrawal by Subject|1
2499555|NCT01961323|8643315|P1|Overall Study|screen failure|34
2499556|NCT01961323|8643315|P1|Overall Study|Lost to Follow-up|8
2499557|NCT01961323|8643315|P1|Overall Study|Withdrawal by Subject|7
2499558|NCT01961297|8643323|P2|Overall Study|unconfirmed diagnosis of SD|1
2499559|NCT01961297|8643324|P1|Overall Study|unconfirmed diagnosis of SD|2
2499560|NCT01961115|8643388|P3|Overall Study|Adverse Event|1
2499561|NCT01961115|8643389|P2|Overall Study|Adverse Event|0
2499562|NCT01961115|8643390|P1|Overall Study|Adverse Event|1
2499563|NCT01961115|8643388|P3|Overall Study|Disease Progression|3
2499564|NCT01961115|8643389|P2|Overall Study|Disease Progression|0
2499565|NCT01961115|8643390|P1|Overall Study|Disease Progression|1
2499566|NCT01960907|8643433|P2|Overall Study|Withdrawal by Subject|42
2499567|NCT01960907|8643434|P1|Overall Study|Withdrawal by Subject|32
2499568|NCT01960907|8643433|P2|Overall Study|Death|3
2499569|NCT01960907|8643434|P1|Overall Study|Death|4
2499570|NCT01960855|8643449|P5|Overall Study|Lost to Follow-up|2
2499571|NCT01960855|8643450|P4|Overall Study|Lost to Follow-up|0
2499572|NCT01960855|8643451|P3|Overall Study|Lost to Follow-up|0
2499573|NCT01960855|8643452|P2|Overall Study|Lost to Follow-up|1
2499574|NCT01960855|8643453|P1|Overall Study|Lost to Follow-up|2
2499575|NCT01960855|8643449|P5|Overall Study|Consent withdrawn by subject|1
2499576|NCT01960855|8643450|P4|Overall Study|Consent withdrawn by subject|1
2499577|NCT01960855|8643451|P3|Overall Study|Consent withdrawn by subject|2
2499578|NCT01960855|8643452|P2|Overall Study|Consent withdrawn by subject|1
2499579|NCT01960855|8643453|P1|Overall Study|Consent withdrawn by subject|3
2499580|NCT01960855|8643449|P5|Overall Study|Other|0
2499581|NCT01960855|8643450|P4|Overall Study|Other|1
2499582|NCT01960855|8643451|P3|Overall Study|Other|1
2499583|NCT01960855|8643452|P2|Overall Study|Other|1
2499584|NCT01960855|8643453|P1|Overall Study|Other|2
2499585|NCT01960855|8643449|P5|Overall Study|Lack of Efficacy|0
2499586|NCT01960855|8643450|P4|Overall Study|Lack of Efficacy|0
2499587|NCT01960855|8643451|P3|Overall Study|Lack of Efficacy|0
2499588|NCT01960855|8643452|P2|Overall Study|Lack of Efficacy|1
2499589|NCT01960855|8643453|P1|Overall Study|Lack of Efficacy|1
2499590|NCT01960855|8643449|P5|Overall Study|Adverse Event|2
2499591|NCT01960855|8643450|P4|Overall Study|Adverse Event|2
2499592|NCT01960855|8643451|P3|Overall Study|Adverse Event|6
2499593|NCT01960855|8643452|P2|Overall Study|Adverse Event|0
2499594|NCT01960855|8643453|P1|Overall Study|Adverse Event|2
2499595|NCT01960855|8643449|P5|Overall Study|Subject noncompliant|0
2499596|NCT01960855|8643450|P4|Overall Study|Subject noncompliant|0
2499597|NCT01960855|8643451|P3|Overall Study|Subject noncompliant|0
2499598|NCT01960855|8643452|P2|Overall Study|Subject noncompliant|0
2499599|NCT01960855|8643453|P1|Overall Study|Subject noncompliant|1
2499600|NCT01960842|8643485|P1|Overall Study|Withdrawal by Subject|2
2499601|NCT01960842|8643485|P1|Overall Study|Adverse Event|1
2499602|NCT01960816|8643508|P1|Overall Study|Lost to Follow-up|1
2499603|NCT01960790|8643514|P1|Overall Study|Unevaluable for safety|1
2499604|NCT01960790|8643514|P1|Overall Study|Transferred to another hospital|4
2499605|NCT01960790|8643514|P1|Overall Study|Treat with Humira outside survey period|3
2499606|NCT01960790|8643514|P1|Overall Study|Survey forms could not be recovered|3
2499607|NCT01960725|8643526|P2|Overall Study|unable to obtain blood sample|2
2499608|NCT01960725|8643527|P1|Overall Study|unable to obtain blood sample|1
2499609|NCT01960725|8643526|P2|Overall Study|Withdrawal by Subject|0
2499610|NCT01960725|8643527|P1|Overall Study|Withdrawal by Subject|1
2499611|NCT01960725|8643526|P2|Overall Study|Lost to Follow-up|3
2499612|NCT01960725|8643527|P1|Overall Study|Lost to Follow-up|4
2499613|NCT01960413|8643584|P2|Overall Study|Lost to Follow-up|0
2499614|NCT01960413|8643585|P1|Overall Study|Lost to Follow-up|2
2499615|NCT01960413|8643584|P2|Overall Study|Physician Decision|0
2499616|NCT01960413|8643585|P1|Overall Study|Physician Decision|1
2499617|NCT01960413|8643584|P2|Overall Study|Withdrawal by Subject|1
2499618|NCT01960413|8643585|P1|Overall Study|Withdrawal by Subject|1
2499619|NCT01960348|8643615|P2|Overall Study|Protocol Violation|0
2499620|NCT01960348|8643616|P1|Overall Study|Protocol Violation|1
2499621|NCT01960348|8643615|P2|Overall Study|Physician Decision|1
2499622|NCT01960348|8643616|P1|Overall Study|Physician Decision|0
2499623|NCT01960348|8643615|P2|Overall Study|Withdrawal by Subject|11
2499624|NCT01960348|8643616|P1|Overall Study|Withdrawal by Subject|1
2499625|NCT01960348|8643615|P2|Overall Study|Adverse event, serious non-fatal|3
2499626|NCT01960348|8643616|P1|Overall Study|Adverse event, serious non-fatal|0
2499627|NCT01960348|8643615|P2|Overall Study|Adverse event, serious fatal|5
2499628|NCT01960348|8643616|P1|Overall Study|Adverse event, serious fatal|6
2499629|NCT01960348|8643615|P2|Overall Study|Adverse event, not serious|2
2499630|NCT01960348|8643616|P1|Overall Study|Adverse event, not serious|2
2499631|NCT01960296|8643636|P2|Overall Study|Received different procedure|3
2499632|NCT01960296|8643637|P1|Overall Study|Received different procedure|1
2499633|NCT01960296|8643636|P2|Overall Study|Postponed surgery|0
2499634|NCT01960296|8643637|P1|Overall Study|Postponed surgery|1
2499635|NCT01960140|8643657|P1|Period 2 (Days 3-18)|Adverse Event|2
2499636|NCT01960114|8643668|P2|Overall Study|Could not swallow study medication|1
2499637|NCT01960114|8643669|P1|Overall Study|Could not swallow study medication|0
2499638|NCT01960114|8643668|P2|Overall Study|Adverse Event|0
2499639|NCT01960114|8643669|P1|Overall Study|Adverse Event|1
2499640|NCT01959932|8643776|P3|Overall Study|Withdrawal by Subject|0
2499641|NCT01959932|8643777|P2|Overall Study|Withdrawal by Subject|0
2499642|NCT01959932|8643778|P1|Overall Study|Withdrawal by Subject|1
2499643|NCT01959919|8643796|P1|Overall Study|Did not meet the eligibility criteria|2
2499644|NCT01959880|8643810|P4|Overall Study|Study completed early-FDA approved|152
2499645|NCT01959880|8643811|P3|Overall Study|Study completed early-FDA approved|179
2499646|NCT01959880|8643812|P2|Overall Study|Study completed early-FDA approved|311
2499647|NCT01959880|8643813|P1|Overall Study|Study completed early-FDA approved|1003
2499648|NCT01959880|8643810|P4|Overall Study|Explantation w/o study device reimplant.|12
2499649|NCT01959880|8643811|P3|Overall Study|Explantation w/o study device reimplant.|5
2499650|NCT01959880|8643812|P2|Overall Study|Explantation w/o study device reimplant.|17
2499651|NCT01959880|8643813|P1|Overall Study|Explantation w/o study device reimplant.|22
2499652|NCT01959880|8643810|P4|Overall Study|Lost to Follow-up|8
2499653|NCT01959880|8643811|P3|Overall Study|Lost to Follow-up|15
2499654|NCT01959880|8643812|P2|Overall Study|Lost to Follow-up|18
2499655|NCT01959880|8643813|P1|Overall Study|Lost to Follow-up|95
2499656|NCT01959880|8643810|P4|Overall Study|Death|2
2499657|NCT01959880|8643811|P3|Overall Study|Death|1
2499658|NCT01959880|8643812|P2|Overall Study|Death|10
2499659|NCT01959880|8643813|P1|Overall Study|Death|1
2499660|NCT01959880|8643810|P4|Overall Study|Withdrawal by Subject|7
2499661|NCT01959880|8643811|P3|Overall Study|Withdrawal by Subject|8
2499662|NCT01959880|8643812|P2|Overall Study|Withdrawal by Subject|13
2499663|NCT01959880|8643813|P1|Overall Study|Withdrawal by Subject|11
2499664|NCT01959841|8643838|P3|Overall Study|Platelet count below on day1 or 4|11
2499665|NCT01959841|8643839|P2|Overall Study|Platelet count below on day1 or 4|15
2499666|NCT01959841|8643840|P1|Overall Study|Platelet count below on day1 or 4|11
2499667|NCT01959841|8643838|P3|Overall Study|Clinical laboratory value|6
2499668|NCT01959841|8643839|P2|Overall Study|Clinical laboratory value|6
2499669|NCT01959841|8643840|P1|Overall Study|Clinical laboratory value|2
2499670|NCT01959841|8643838|P3|Overall Study|Withdrawal by Subject|5
2499671|NCT01959841|8643839|P2|Overall Study|Withdrawal by Subject|7
2499672|NCT01959841|8643840|P1|Overall Study|Withdrawal by Subject|7
2499673|NCT01959841|8643838|P3|Overall Study|Protocol Violation|16
2499674|NCT01959841|8643839|P2|Overall Study|Protocol Violation|23
2499675|NCT01959841|8643840|P1|Overall Study|Protocol Violation|16
2499676|NCT01959841|8643838|P3|Overall Study|Physician Decision|3
2499677|NCT01959841|8643839|P2|Overall Study|Physician Decision|2
2499678|NCT01959841|8643840|P1|Overall Study|Physician Decision|0
2499679|NCT01959841|8643838|P3|Overall Study|Lost to Follow-up|0
2499680|NCT01959841|8643839|P2|Overall Study|Lost to Follow-up|1
2499681|NCT01959841|8643840|P1|Overall Study|Lost to Follow-up|1
2499682|NCT01959841|8643838|P3|Overall Study|Lack of Efficacy|0
2499683|NCT01959841|8643839|P2|Overall Study|Lack of Efficacy|0
2499684|NCT01959841|8643840|P1|Overall Study|Lack of Efficacy|5
2499685|NCT01959841|8643838|P3|Overall Study|Adverse Event|2
2499686|NCT01959841|8643839|P2|Overall Study|Adverse Event|3
2499687|NCT01959841|8643840|P1|Overall Study|Adverse Event|1
2499688|NCT01959672|8643868|P1|Overall Study|Death|1
2499689|NCT01959607|8643879|P4|First Intervention (Day 1)|Withdrawal by Subject|0
2499690|NCT01959607|8643880|P3|First Intervention (Day 1)|Withdrawal by Subject|0
2499691|NCT01959607|8643881|P2|First Intervention (Day 1)|Withdrawal by Subject|1
2499692|NCT01959607|8643882|P1|First Intervention (Day 1)|Withdrawal by Subject|1
2499693|NCT01959581|8643895|P1|Overall Study|Lost to Follow-up|5
2499694|NCT01959529|8643901|P2|Overall Study|Lack of glycaemic control|1
2499695|NCT01959529|8643902|P1|Overall Study|Lack of glycaemic control|1
2499696|NCT01959529|8643901|P2|Overall Study|Hypoglycaemia|1
2499697|NCT01959529|8643902|P1|Overall Study|Hypoglycaemia|1
2499698|NCT01959529|8643901|P2|Overall Study|Other|68
2499699|NCT01959529|8643902|P1|Overall Study|Other|70
2499700|NCT01959529|8643901|P2|Overall Study|Lost to Follow-up|1
2499701|NCT01959529|8643902|P1|Overall Study|Lost to Follow-up|4
2499702|NCT01959529|8643901|P2|Overall Study|Adverse event (not hypoglycaemia)|1
2499703|NCT01959529|8643902|P1|Overall Study|Adverse event (not hypoglycaemia)|0
2499704|NCT01959516|8643914|P2|Epoch 2|Moderate or severe COPD exacerbation|1
2499705|NCT01959516|8643915|P1|Epoch 2|Moderate or severe COPD exacerbation|0
2499706|NCT01959516|8643914|P2|Epoch 2|Subject withdrew consent|0
2499707|NCT01959516|8643915|P1|Epoch 2|Subject withdrew consent|1
2499708|NCT01959516|8643914|P2|Epoch 2|unsatisfactory therapeutic effect|0
2499709|NCT01959516|8643915|P1|Epoch 2|unsatisfactory therapeutic effect|1
2499710|NCT01959516|8643914|P2|Epoch 1|Protocol deviation|1
2499711|NCT01959516|8643915|P1|Epoch 1|Protocol deviation|0
2499712|NCT01959516|8643914|P2|Epoch 1|Moderate or severe COPD exacerbation|1
2499713|NCT01959516|8643915|P1|Epoch 1|Moderate or severe COPD exacerbation|0
2499714|NCT01959516|8643914|P2|Epoch 1|Use of prohibited treatment|0
2499715|NCT01959516|8643915|P1|Epoch 1|Use of prohibited treatment|1
2499716|NCT01959516|8643914|P2|Epoch 1|Administrative problems|0
2499717|NCT01959516|8643915|P1|Epoch 1|Administrative problems|1
2499718|NCT01959516|8643914|P2|Epoch 1|Subject withdrew consent|2
2499719|NCT01959516|8643915|P1|Epoch 1|Subject withdrew consent|3
2499720|NCT01959516|8643914|P2|Epoch 1|unsatisfactory therapeutic effect|0
2499721|NCT01959516|8643915|P1|Epoch 1|unsatisfactory therapeutic effect|1
2499722|NCT01959516|8643914|P2|Epoch 1|Adverse Event|1
2499723|NCT01959516|8643915|P1|Epoch 1|Adverse Event|4
2499724|NCT01959503|8643925|P2|Overall Study|Randomized but not treated|1
2499725|NCT01959503|8643926|P1|Overall Study|Randomized but not treated|1
2499726|NCT01959503|8643925|P2|Overall Study|Death|1
2499727|NCT01959503|8643926|P1|Overall Study|Death|2
2499728|NCT01959412|8643977|P6|Overall Study|Adverse Event|0
2499729|NCT01959412|8643978|P5|Overall Study|Adverse Event|0
2499730|NCT01959412|8643979|P4|Overall Study|Adverse Event|1
2499731|NCT01959412|8643980|P3|Overall Study|Adverse Event|0
2499732|NCT01959412|8643981|P2|Overall Study|Adverse Event|0
2499733|NCT01959412|8643982|P1|Overall Study|Adverse Event|0
2499734|NCT01959412|8643977|P6|Overall Study|Protocol deviation|0
2499735|NCT01959412|8643978|P5|Overall Study|Protocol deviation|3
2499736|NCT01959412|8643979|P4|Overall Study|Protocol deviation|1
2499737|NCT01959412|8643980|P3|Overall Study|Protocol deviation|0
2499738|NCT01959412|8643981|P2|Overall Study|Protocol deviation|1
2499739|NCT01959412|8643982|P1|Overall Study|Protocol deviation|1
2499740|NCT01959334|8644022|P2|Third Dose|Adverse Event|1
2499741|NCT01959334|8644023|P1|Third Dose|Adverse Event|0
2499742|NCT01959334|8644022|P2|Second Dose|Adverse Event|0
2499743|NCT01959334|8644023|P1|Second Dose|Adverse Event|1
2499744|NCT01959243|8644035|P2|Overall Study|Lost to Follow-up|1
2499745|NCT01959243|8644036|P1|Overall Study|Lost to Follow-up|3
2499746|NCT01959243|8644035|P2|Overall Study|Administrative reasons|1
2499747|NCT01959243|8644036|P1|Overall Study|Administrative reasons|2
2499748|NCT01959243|8644035|P2|Overall Study|Adverse Event|2
2499749|NCT01959243|8644036|P1|Overall Study|Adverse Event|5
2499750|NCT01959243|8644035|P2|Overall Study|Investigator Decision|0
2499751|NCT01959243|8644036|P1|Overall Study|Investigator Decision|3
2499752|NCT01959230|8644048|P2|Overall Study|Withdrawal by Subject|0
2499753|NCT01959230|8644049|P1|Overall Study|Withdrawal by Subject|2
2499754|NCT01959230|8644048|P2|Overall Study|Administrative reasons|0
2499755|NCT01959230|8644049|P1|Overall Study|Administrative reasons|2
2499756|NCT01959230|8644048|P2|Overall Study|Failure to follow study procedures|1
2499757|NCT01959230|8644049|P1|Overall Study|Failure to follow study procedures|0
2499758|NCT01959165|8644063|P4|Overall Study|Welfare recipient|0
2499759|NCT01959165|8644064|P3|Overall Study|Welfare recipient|0
2499760|NCT01959165|8644065|P2|Overall Study|Welfare recipient|1
2499761|NCT01959165|8644066|P1|Overall Study|Welfare recipient|0
2499762|NCT01959165|8644063|P4|Overall Study|overdose|1
2499763|NCT01959165|8644064|P3|Overall Study|overdose|0
2499764|NCT01959165|8644065|P2|Overall Study|overdose|0
2499765|NCT01959165|8644066|P1|Overall Study|overdose|0
2499766|NCT01959165|8644063|P4|Overall Study|Lack of Efficacy|0
2499767|NCT01959165|8644064|P3|Overall Study|Lack of Efficacy|0
2499768|NCT01959165|8644065|P2|Overall Study|Lack of Efficacy|0
2499769|NCT01959165|8644066|P1|Overall Study|Lack of Efficacy|1
2499770|NCT01959165|8644063|P4|Overall Study|Adverse Event|1
2499771|NCT01959165|8644064|P3|Overall Study|Adverse Event|0
2499772|NCT01959165|8644065|P2|Overall Study|Adverse Event|0
2499773|NCT01959165|8644066|P1|Overall Study|Adverse Event|0
2499774|NCT01959139|8644092|P4|Phase II|On treatment|0
2499775|NCT01959139|8644093|P3|Phase II|On treatment|4
2499776|NCT01959139|8644094|P2|Phase II|On treatment|0
2499777|NCT01959139|8644095|P1|Phase II|On treatment|0
2499778|NCT01959139|8644092|P4|Phase II|Other/Unknown|5
2499779|NCT01959139|8644093|P3|Phase II|Other/Unknown|8
2499780|NCT01959139|8644094|P2|Phase II|Other/Unknown|0
2499781|NCT01959139|8644095|P1|Phase II|Other/Unknown|0
2499782|NCT01959139|8644092|P4|Phase II|Death|1
2499783|NCT01959139|8644093|P3|Phase II|Death|3
2499784|NCT01959139|8644094|P2|Phase II|Death|0
2499785|NCT01959139|8644095|P1|Phase II|Death|0
2499786|NCT01959139|8644092|P4|Phase II|Patient Refusal|4
2499787|NCT01959139|8644093|P3|Phase II|Patient Refusal|5
2499788|NCT01959139|8644094|P2|Phase II|Patient Refusal|0
2499789|NCT01959139|8644095|P1|Phase II|Patient Refusal|0
2499790|NCT01959139|8644092|P4|Phase II|Adverse Event|11
2499791|NCT01959139|8644093|P3|Phase II|Adverse Event|10
2499792|NCT01959139|8644094|P2|Phase II|Adverse Event|0
2499793|NCT01959139|8644095|P1|Phase II|Adverse Event|0
2499794|NCT01959139|8644092|P4|Phase II|Disease progression|34
2499795|NCT01959139|8644093|P3|Phase II|Disease progression|26
2499796|NCT01959139|8644094|P2|Phase II|Disease progression|0
2499797|NCT01959139|8644095|P1|Phase II|Disease progression|0
2499798|NCT01959035|8644122|P1|Overall Study|Other (no primary reason given)|1
2499799|NCT01959035|8644122|P1|Overall Study|Lost to Follow-up|1
2499800|NCT01959035|8644122|P1|Overall Study|Withdrawal by Subject|4
2499801|NCT01959035|8644122|P1|Overall Study|Adverse Event|5
2499802|NCT01958918|8644150|P2|Overall Study|administrative problems|2
2499803|NCT01958918|8644151|P1|Overall Study|administrative problems|0
2499804|NCT01958918|8644150|P2|Overall Study|Adverse Event|12
2499805|NCT01958918|8644151|P1|Overall Study|Adverse Event|12
2499806|NCT01958918|8644150|P2|Overall Study|Lack of Efficacy|10
2499807|NCT01958918|8644151|P1|Overall Study|Lack of Efficacy|13
2499808|NCT01958918|8644150|P2|Overall Study|Withdrawal by Subject|8
2499809|NCT01958918|8644151|P1|Overall Study|Withdrawal by Subject|13
2499810|NCT01958918|8644150|P2|Overall Study|Lost to Follow-up|7
2499811|NCT01958918|8644151|P1|Overall Study|Lost to Follow-up|4
2499812|NCT01958918|8644150|P2|Overall Study|Death|3
2499813|NCT01958918|8644151|P1|Overall Study|Death|1
2499814|NCT01958827|8644165|P1|Overall Study|Concomitant Prohibited Medicine for AE|1
2499815|NCT01958827|8644165|P1|Overall Study|Lack of Efficacy|6
2499816|NCT01958827|8644165|P1|Overall Study|Adverse Event|3
2499817|NCT01958671|8644196|P3|Overall Study|Withdrawal by Subject|13
2499818|NCT01958671|8644197|P2|Overall Study|Withdrawal by Subject|10
2499819|NCT01958671|8644198|P1|Overall Study|Withdrawal by Subject|8
2499820|NCT01958671|8644196|P3|Overall Study|Participant moved|1
2499821|NCT01958671|8644197|P2|Overall Study|Participant moved|0
2499822|NCT01958671|8644198|P1|Overall Study|Participant moved|0
2499823|NCT01958671|8644196|P3|Overall Study|Study site terminated by sponsor|1
2499824|NCT01958671|8644197|P2|Overall Study|Study site terminated by sponsor|0
2499825|NCT01958671|8644198|P1|Overall Study|Study site terminated by sponsor|1
2499826|NCT01958671|8644196|P3|Overall Study|Protocol Violation|0
2499827|NCT01958671|8644197|P2|Overall Study|Protocol Violation|1
2499828|NCT01958671|8644198|P1|Overall Study|Protocol Violation|0
2499829|NCT01958671|8644196|P3|Overall Study|Pregnancy|1
2499830|NCT01958671|8644197|P2|Overall Study|Pregnancy|0
2499831|NCT01958671|8644198|P1|Overall Study|Pregnancy|0
2499832|NCT01958671|8644196|P3|Overall Study|Non-compliance with study drug|1
2499833|NCT01958671|8644197|P2|Overall Study|Non-compliance with study drug|1
2499834|NCT01958671|8644198|P1|Overall Study|Non-compliance with study drug|1
2499835|NCT01958671|8644196|P3|Overall Study|Lost to Follow-up|7
2499836|NCT01958671|8644197|P2|Overall Study|Lost to Follow-up|11
2499837|NCT01958671|8644198|P1|Overall Study|Lost to Follow-up|7
2499838|NCT01958671|8644196|P3|Overall Study|Hyperglycemia|2
2499839|NCT01958671|8644197|P2|Overall Study|Hyperglycemia|0
2499840|NCT01958671|8644198|P1|Overall Study|Hyperglycemia|0
2499841|NCT01958671|8644196|P3|Overall Study|Excluded medication|1
2499842|NCT01958671|8644197|P2|Overall Study|Excluded medication|0
2499843|NCT01958671|8644198|P1|Overall Study|Excluded medication|0
2499844|NCT01958671|8644196|P3|Overall Study|Death|0
2499845|NCT01958671|8644197|P2|Overall Study|Death|0
2499846|NCT01958671|8644198|P1|Overall Study|Death|1
2499847|NCT01958671|8644196|P3|Overall Study|Adverse Event|5
2499848|NCT01958671|8644197|P2|Overall Study|Adverse Event|1
2499849|NCT01958671|8644198|P1|Overall Study|Adverse Event|1
2499850|NCT01958619|8644272|P4|Overall Study|Protocol Violation|0
2499851|NCT01958619|8644273|P3|Overall Study|Protocol Violation|1
2499852|NCT01958619|8644274|P2|Overall Study|Protocol Violation|0
2499853|NCT01958619|8644275|P1|Overall Study|Protocol Violation|2
2499854|NCT01958489|8644336|P2|Period 2|Adverse Event|1
2499855|NCT01958489|8644337|P1|Period 2|Adverse Event|0
2499856|NCT01958476|8644353|P2|Overall Study|Parent requested exclusion from analysis|0
2499857|NCT01958476|8644354|P1|Overall Study|Parent requested exclusion from analysis|1
2499858|NCT01958437|8644384|P4|Overall Study|Incidental MRI findings|1
2499859|NCT01958437|8644385|P3|Overall Study|Incidental MRI findings|1
2499860|NCT01958437|8644386|P2|Overall Study|Incidental MRI findings|0
2499861|NCT01958437|8644387|P1|Overall Study|Incidental MRI findings|0
2499862|NCT01958294|8644451|P1|Overall Study|Clinical Circumstances|2
2499863|NCT01958281|8644460|P3|Overall Study|Withdrew Consent|0
2499864|NCT01958281|8644461|P2|Overall Study|Withdrew Consent|0
2499865|NCT01958281|8644462|P1|Overall Study|Withdrew Consent|1
2499866|NCT01958281|8644460|P3|Overall Study|Adverse Event|0
2499867|NCT01958281|8644461|P2|Overall Study|Adverse Event|2
2499868|NCT01958281|8644462|P1|Overall Study|Adverse Event|0
2499869|NCT01958281|8644460|P3|Overall Study|Lack of Efficacy|0
2499870|NCT01958281|8644461|P2|Overall Study|Lack of Efficacy|2
2499871|NCT01958281|8644462|P1|Overall Study|Lack of Efficacy|5
2499872|NCT01958164|8644538|P2|Overall Study|Lost to Follow-up|3
2499873|NCT01958164|8644539|P1|Overall Study|Lost to Follow-up|2
2499874|NCT01958164|8644538|P2|Overall Study|Adverse Event|2
2499875|NCT01958164|8644539|P1|Overall Study|Adverse Event|0
2499876|NCT01958125|8644554|P2|Overall Study|No headache attacks|2
2499877|NCT01958125|8644555|P1|Overall Study|No headache attacks|0
2499878|NCT01958125|8644554|P2|Overall Study|Missing diary data|6
2499879|NCT01958125|8644555|P1|Overall Study|Missing diary data|2
2499880|NCT01958060|8644583|P6|Overall Study|Not treated|0
2499881|NCT01958060|8644584|P5|Overall Study|Not treated|1
2499882|NCT01958060|8644585|P4|Overall Study|Not treated|0
2499883|NCT01958060|8644586|P3|Overall Study|Not treated|0
2499884|NCT01958060|8644587|P2|Overall Study|Not treated|0
2499885|NCT01958060|8644588|P1|Overall Study|Not treated|2
2499886|NCT01958021|8644613|P2|Overall Study|Death|0
2499887|NCT01958021|8644614|P1|Overall Study|Death|2
2499888|NCT01958021|8644613|P2|Overall Study|Protocol Violation|1
2499889|NCT01958021|8644614|P1|Overall Study|Protocol Violation|3
2499890|NCT01958021|8644613|P2|Overall Study|Physician Decision|13
2499891|NCT01958021|8644614|P1|Overall Study|Physician Decision|10
2499892|NCT01958021|8644613|P2|Overall Study|Subject/guardian decision|13
2499893|NCT01958021|8644614|P1|Overall Study|Subject/guardian decision|12
2499894|NCT01958021|8644613|P2|Overall Study|Adverse Event|7
2499895|NCT01958021|8644614|P1|Overall Study|Adverse Event|25
2499896|NCT01958021|8644613|P2|Overall Study|Progressive disease|146
2499897|NCT01958021|8644614|P1|Overall Study|Progressive disease|87
2499898|NCT01958008|8644626|P4|Overall Study|Other adverse event|0
2499899|NCT01958008|8644627|P3|Overall Study|Other adverse event|0
2499900|NCT01958008|8644628|P2|Overall Study|Other adverse event|0
2499901|NCT01958008|8644629|P1|Overall Study|Other adverse event|1
2499902|NCT01958008|8644626|P4|Overall Study|Worsening of disease under study|0
2499903|NCT01958008|8644627|P3|Overall Study|Worsening of disease under study|1
2499904|NCT01958008|8644628|P2|Overall Study|Worsening of disease under study|0
2499905|NCT01958008|8644629|P1|Overall Study|Worsening of disease under study|0
2499906|NCT01957865|8644672|P3|Overall Study|Lost to Follow-up|2
2499907|NCT01957865|8644673|P2|Overall Study|Lost to Follow-up|2
2499908|NCT01957865|8644674|P1|Overall Study|Lost to Follow-up|0
2499909|NCT01957865|8644672|P3|Overall Study|Found HIV negative|1
2499910|NCT01957865|8644673|P2|Overall Study|Found HIV negative|0
2499911|NCT01957865|8644674|P1|Overall Study|Found HIV negative|0
2499912|NCT01957787|8644685|P1|Overall Study|Local therapy, not cryoablation|6
2499913|NCT01957787|8644685|P1|Overall Study|Index Tumor was Primary Lung Cancer|2
2499914|NCT01957787|8644685|P1|Overall Study|Index Tumor(s) Resected|2
2499915|NCT01957787|8644685|P1|Overall Study|Entered Hospice or Similar Program|2
2499916|NCT01957787|8644685|P1|Overall Study|Withdrawal by Subject|3
2499917|NCT01957787|8644685|P1|Overall Study|Lost to Follow-up|3
2499918|NCT01957787|8644685|P1|Overall Study|Death|18
2499919|NCT01957709|8644704|P1|Overall Study|Patient refused to complete post-tx bx|1
2499920|NCT01957644|8644729|P5|Overall Study|Protocol Violation|0
2499921|NCT01957644|8644730|P4|Overall Study|Protocol Violation|0
2499922|NCT01957644|8644731|P3|Overall Study|Protocol Violation|0
2499923|NCT01957644|8644732|P2|Overall Study|Protocol Violation|1
2499924|NCT01957644|8644733|P1|Overall Study|Protocol Violation|0
2499925|NCT01957644|8644729|P5|Overall Study|Withdrawal by Subject|0
2499926|NCT01957644|8644730|P4|Overall Study|Withdrawal by Subject|0
2499927|NCT01957644|8644731|P3|Overall Study|Withdrawal by Subject|0
2499928|NCT01957644|8644732|P2|Overall Study|Withdrawal by Subject|0
2499929|NCT01957644|8644733|P1|Overall Study|Withdrawal by Subject|1
2499930|NCT01957644|8644729|P5|Overall Study|Other reason|0
2499931|NCT01957644|8644730|P4|Overall Study|Other reason|1
2499932|NCT01957644|8644731|P3|Overall Study|Other reason|1
2499933|NCT01957644|8644732|P2|Overall Study|Other reason|2
2499934|NCT01957644|8644733|P1|Overall Study|Other reason|1
2499935|NCT01957644|8644729|P5|Overall Study|Progressive disease / relapse|0
2499936|NCT01957644|8644730|P4|Overall Study|Progressive disease / relapse|1
2499937|NCT01957644|8644731|P3|Overall Study|Progressive disease / relapse|0
2499938|NCT01957644|8644732|P2|Overall Study|Progressive disease / relapse|1
2499939|NCT01957644|8644733|P1|Overall Study|Progressive disease / relapse|0
2499940|NCT01957644|8644729|P5|Overall Study|Adverse Event|1
2499941|NCT01957644|8644730|P4|Overall Study|Adverse Event|0
2499942|NCT01957644|8644731|P3|Overall Study|Adverse Event|0
2499943|NCT01957644|8644732|P2|Overall Study|Adverse Event|2
2499944|NCT01957644|8644733|P1|Overall Study|Adverse Event|4
2499945|NCT01957579|8644757|P4|Overall Study|Death|0
2499946|NCT01957579|8644758|P3|Overall Study|Death|2
2499947|NCT01957579|8644759|P2|Overall Study|Death|0
2499948|NCT01957579|8644760|P1|Overall Study|Death|0
2499949|NCT01957579|8644757|P4|Overall Study|Withdrawal of concent|0
2499950|NCT01957579|8644758|P3|Overall Study|Withdrawal of concent|0
2499951|NCT01957579|8644759|P2|Overall Study|Withdrawal of concent|1
2499952|NCT01957579|8644760|P1|Overall Study|Withdrawal of concent|0
2499953|NCT01957553|8644827|P2|Test Period 2 (21 +- 1 Days)|Other|0
2499954|NCT01957553|8644828|P1|Test Period 2 (21 +- 1 Days)|Other|1
2499955|NCT01957553|8644827|P2|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1
2499956|NCT01957553|8644828|P1|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0
2499957|NCT01957553|8644827|P2|Test Period 2 (21 +- 1 Days)|completed early by mistake|1
2499958|NCT01957553|8644828|P1|Test Period 2 (21 +- 1 Days)|completed early by mistake|0
2499959|NCT01957553|8644827|P2|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2
2499960|NCT01957553|8644828|P1|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1
2499961|NCT01957553|8644827|P2|Test Period 2 (21 +- 1 Days)|Adverse Event|3
2499962|NCT01957553|8644828|P1|Test Period 2 (21 +- 1 Days)|Adverse Event|1
2499963|NCT01957553|8644827|P2|Test Period 1 (21 +- 1 Days)|screen failure|0
2499964|NCT01957553|8644828|P1|Test Period 1 (21 +- 1 Days)|screen failure|1
2499965|NCT01957553|8644827|P2|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0
2499966|NCT01957553|8644828|P1|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2
2499967|NCT01957553|8644827|P2|Test Period 1 (21 +- 1 Days)|Adverse Event|0
2499968|NCT01957553|8644828|P1|Test Period 1 (21 +- 1 Days)|Adverse Event|2
2499969|NCT01957553|8644827|P2|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3
2499970|NCT01957553|8644828|P1|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2
2499971|NCT01957488|8644834|P6|Test Period 3|Lack of Efficacy|0
2499972|NCT01957488|8644835|P5|Test Period 3|Lack of Efficacy|0
2499973|NCT01957488|8644836|P4|Test Period 3|Lack of Efficacy|0
2499974|NCT01957488|8644837|P3|Test Period 3|Lack of Efficacy|0
2499975|NCT01957488|8644838|P2|Test Period 3|Lack of Efficacy|1
2499976|NCT01957488|8644839|P1|Test Period 3|Lack of Efficacy|0
2499977|NCT01957488|8644834|P6|Test Period 3|Withdrawal by Subject|0
2499978|NCT01957488|8644835|P5|Test Period 3|Withdrawal by Subject|0
2499979|NCT01957488|8644836|P4|Test Period 3|Withdrawal by Subject|0
2499980|NCT01957488|8644837|P3|Test Period 3|Withdrawal by Subject|0
2499981|NCT01957488|8644838|P2|Test Period 3|Withdrawal by Subject|0
2499982|NCT01957488|8644839|P1|Test Period 3|Withdrawal by Subject|1
2499983|NCT01957488|8644834|P6|Test Period 2|Discontinue due to personal problems|1
2499984|NCT01957488|8644835|P5|Test Period 2|Discontinue due to personal problems|0
2499985|NCT01957488|8644836|P4|Test Period 2|Discontinue due to personal problems|0
2499986|NCT01957488|8644837|P3|Test Period 2|Discontinue due to personal problems|0
2499987|NCT01957488|8644838|P2|Test Period 2|Discontinue due to personal problems|0
2499988|NCT01957488|8644839|P1|Test Period 2|Discontinue due to personal problems|0
2499989|NCT01957488|8644834|P6|Test Period 2|Adverse Event|0
2499990|NCT01957488|8644835|P5|Test Period 2|Adverse Event|2
2499991|NCT01957488|8644836|P4|Test Period 2|Adverse Event|0
2499992|NCT01957488|8644837|P3|Test Period 2|Adverse Event|0
2499993|NCT01957488|8644838|P2|Test Period 2|Adverse Event|0
2499994|NCT01957488|8644839|P1|Test Period 2|Adverse Event|0
2499995|NCT01957488|8644834|P6|Test Period 2|Withdrawal by Subject|0
2499996|NCT01957488|8644835|P5|Test Period 2|Withdrawal by Subject|0
2499997|NCT01957488|8644836|P4|Test Period 2|Withdrawal by Subject|0
2499998|NCT01957488|8644837|P3|Test Period 2|Withdrawal by Subject|0
2499999|NCT01957488|8644838|P2|Test Period 2|Withdrawal by Subject|1
2500000|NCT01957488|8644839|P1|Test Period 2|Withdrawal by Subject|0
2500001|NCT01957488|8644834|P6|Test Period 2|Other|0
2500002|NCT01957488|8644835|P5|Test Period 2|Other|0
2500003|NCT01957488|8644836|P4|Test Period 2|Other|0
2500004|NCT01957488|8644837|P3|Test Period 2|Other|0
2500005|NCT01957488|8644838|P2|Test Period 2|Other|0
2500006|NCT01957488|8644839|P1|Test Period 2|Other|1
2500007|NCT01957488|8644834|P6|Test Period 2|Protocol Violation|0
2500008|NCT01957488|8644835|P5|Test Period 2|Protocol Violation|0
2500009|NCT01957488|8644836|P4|Test Period 2|Protocol Violation|1
2500010|NCT01957488|8644837|P3|Test Period 2|Protocol Violation|1
2500011|NCT01957488|8644838|P2|Test Period 2|Protocol Violation|0
2500012|NCT01957488|8644839|P1|Test Period 2|Protocol Violation|2
2500013|NCT01957488|8644834|P6|Test Period 1|screen failure|1
2500014|NCT01957488|8644835|P5|Test Period 1|screen failure|0
2500015|NCT01957488|8644836|P4|Test Period 1|screen failure|0
2500016|NCT01957488|8644837|P3|Test Period 1|screen failure|0
2500017|NCT01957488|8644838|P2|Test Period 1|screen failure|0
2500018|NCT01957488|8644839|P1|Test Period 1|screen failure|0
2500019|NCT01957488|8644834|P6|Test Period 1|subject did not want to wait for cut bag|0
2500020|NCT01957488|8644835|P5|Test Period 1|subject did not want to wait for cut bag|1
2500021|NCT01957488|8644836|P4|Test Period 1|subject did not want to wait for cut bag|0
2500022|NCT01957488|8644837|P3|Test Period 1|subject did not want to wait for cut bag|0
2500023|NCT01957488|8644838|P2|Test Period 1|subject did not want to wait for cut bag|0
2500024|NCT01957488|8644839|P1|Test Period 1|subject did not want to wait for cut bag|0
2500025|NCT01957488|8644834|P6|Test Period 1|Withdrawal by Subject|2
2500026|NCT01957488|8644835|P5|Test Period 1|Withdrawal by Subject|1
2500027|NCT01957488|8644836|P4|Test Period 1|Withdrawal by Subject|1
2500028|NCT01957488|8644837|P3|Test Period 1|Withdrawal by Subject|0
2500029|NCT01957488|8644838|P2|Test Period 1|Withdrawal by Subject|0
2500030|NCT01957488|8644839|P1|Test Period 1|Withdrawal by Subject|0
2500031|NCT01957488|8644834|P6|Test Period 1|Adverse Event|0
2500032|NCT01957488|8644835|P5|Test Period 1|Adverse Event|1
2500033|NCT01957488|8644836|P4|Test Period 1|Adverse Event|0
2500034|NCT01957488|8644837|P3|Test Period 1|Adverse Event|1
2500035|NCT01957488|8644838|P2|Test Period 1|Adverse Event|1
2500036|NCT01957488|8644839|P1|Test Period 1|Adverse Event|0
2500037|NCT01957488|8644834|P6|Test Period 1|Protocol Violation|3
2500038|NCT01957488|8644835|P5|Test Period 1|Protocol Violation|0
2500039|NCT01957488|8644836|P4|Test Period 1|Protocol Violation|1
2500040|NCT01957488|8644837|P3|Test Period 1|Protocol Violation|2
2500041|NCT01957488|8644838|P2|Test Period 1|Protocol Violation|2
2500042|NCT01957488|8644839|P1|Test Period 1|Protocol Violation|1
2500043|NCT01957488|8644834|P6|Test Period 1|Lost to Follow-up|0
2500044|NCT01957488|8644835|P5|Test Period 1|Lost to Follow-up|0
2500045|NCT01957488|8644836|P4|Test Period 1|Lost to Follow-up|1
2500046|NCT01957488|8644837|P3|Test Period 1|Lost to Follow-up|1
2500047|NCT01957488|8644838|P2|Test Period 1|Lost to Follow-up|0
2500048|NCT01957488|8644839|P1|Test Period 1|Lost to Follow-up|2
2500049|NCT01957475|8644847|P2|Test Period 2|Adverse Event|0
2500050|NCT01957475|8644848|P1|Test Period 2|Adverse Event|1
2500051|NCT01957475|8644847|P2|Test Period 1|Lack of Efficacy|1
2500052|NCT01957475|8644848|P1|Test Period 1|Lack of Efficacy|0
2500053|NCT01957475|8644847|P2|Test Period 1|Other|0
2500054|NCT01957475|8644848|P1|Test Period 1|Other|1
2500055|NCT01957475|8644847|P2|Test Period 1|Withdrawal by Subject|0
2500056|NCT01957475|8644848|P1|Test Period 1|Withdrawal by Subject|1
2500057|NCT01957462|8644854|P2|Test Period 1|Adverse Event|0
2500058|NCT01957462|8644855|P1|Test Period 1|Adverse Event|1
2500059|NCT01957462|8644854|P2|Test Period 1|Withdrawal by Subject|0
2500060|NCT01957462|8644855|P1|Test Period 1|Withdrawal by Subject|1
2500061|NCT01957397|8644866|P2|Test Period 3|the adhesive did not work|0
2500062|NCT01957397|8644867|P1|Test Period 3|the adhesive did not work|1
2500063|NCT01957397|8644866|P2|Test Period 3|Adverse Event|2
2500064|NCT01957397|8644867|P1|Test Period 3|Adverse Event|1
2500065|NCT01957397|8644866|P2|Test Period 2|Adverse Event|1
2500066|NCT01957397|8644867|P1|Test Period 2|Adverse Event|0
2500067|NCT01957397|8644866|P2|Test Period 1|Withdrawal by Subject|0
2500068|NCT01957397|8644867|P1|Test Period 1|Withdrawal by Subject|1
2500069|NCT01957397|8644866|P2|Test Period 1|sudden leakage/small bag|1
2500070|NCT01957397|8644867|P1|Test Period 1|sudden leakage/small bag|1
2500071|NCT01957215|8644892|P2|Overall Study|Withdrawal by Subject|5
2500072|NCT01957215|8644893|P1|Overall Study|Withdrawal by Subject|7
2500073|NCT01957215|8644892|P2|Overall Study|Protocol Violation|2
2500074|NCT01957215|8644893|P1|Overall Study|Protocol Violation|1
2500075|NCT01957215|8644892|P2|Overall Study|Lost to Follow-up|3
2500076|NCT01957215|8644893|P1|Overall Study|Lost to Follow-up|3
2500077|NCT01957215|8644892|P2|Overall Study|Adverse Event|2
2500078|NCT01957215|8644893|P1|Overall Study|Adverse Event|2
2500079|NCT01957202|8644921|P18|Treatment Period 3 (8 Days)|Adverse Event|0
2500080|NCT01957202|8644922|P17|Treatment Period 3 (8 Days)|Adverse Event|1
2500081|NCT01957202|8644923|P16|Treatment Period 3 (8 Days)|Adverse Event|0
2500082|NCT01957202|8644924|P15|Treatment Period 3 (8 Days)|Adverse Event|0
2500083|NCT01957202|8644925|P14|Treatment Period 3 (8 Days)|Adverse Event|0
2500084|NCT01957202|8644926|P13|Treatment Period 3 (8 Days)|Adverse Event|0
2500085|NCT01957202|8644927|P12|Treatment Period 3 (8 Days)|Adverse Event|0
2500086|NCT01957202|8644928|P11|Treatment Period 3 (8 Days)|Adverse Event|0
2500087|NCT01957202|8644929|P10|Treatment Period 3 (8 Days)|Adverse Event|0
2500088|NCT01957202|8644930|P9|Treatment Period 3 (8 Days)|Adverse Event|0
2500089|NCT01957202|8644931|P8|Treatment Period 3 (8 Days)|Adverse Event|0
2500090|NCT01957202|8644932|P7|Treatment Period 3 (8 Days)|Adverse Event|0
2500091|NCT01957202|8644933|P6|Treatment Period 3 (8 Days)|Adverse Event|0
2500092|NCT01957202|8644934|P5|Treatment Period 3 (8 Days)|Adverse Event|0
2500093|NCT01957202|8644935|P4|Treatment Period 3 (8 Days)|Adverse Event|0
2500094|NCT01957202|8644936|P3|Treatment Period 3 (8 Days)|Adverse Event|0
2500095|NCT01957202|8644937|P2|Treatment Period 3 (8 Days)|Adverse Event|0
2500096|NCT01957202|8644938|P1|Treatment Period 3 (8 Days)|Adverse Event|0
2500097|NCT01957202|8644921|P18|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2500098|NCT01957202|8644922|P17|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
2500099|NCT01957202|8644923|P16|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2500100|NCT01957202|8644924|P15|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2500101|NCT01957202|8644925|P14|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2500102|NCT01957202|8644926|P13|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2500103|NCT01957202|8644927|P12|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2500104|NCT01957202|8644928|P11|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2500105|NCT01957202|8644929|P10|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2500106|NCT01957202|8644930|P9|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2500107|NCT01957202|8644931|P8|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2500108|NCT01957202|8644932|P7|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2500109|NCT01957202|8644933|P6|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2500110|NCT01957202|8644934|P5|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2500111|NCT01957202|8644935|P4|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2500112|NCT01957202|8644936|P3|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2500113|NCT01957202|8644937|P2|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
2500114|NCT01957202|8644938|P1|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
2500115|NCT01957163|8644963|P3|Overall Study|Withdrawal by Subject|4
2500116|NCT01957163|8644964|P2|Overall Study|Withdrawal by Subject|2
2500117|NCT01957163|8644965|P1|Overall Study|Withdrawal by Subject|4
2500118|NCT01957163|8644963|P3|Overall Study|Lost to Follow-up|0
2500119|NCT01957163|8644964|P2|Overall Study|Lost to Follow-up|1
2500120|NCT01957163|8644965|P1|Overall Study|Lost to Follow-up|0
2500121|NCT01957163|8644963|P3|Overall Study|Met Protocol-Defined Stopping Criteria|1
2500122|NCT01957163|8644964|P2|Overall Study|Met Protocol-Defined Stopping Criteria|0
2500123|NCT01957163|8644965|P1|Overall Study|Met Protocol-Defined Stopping Criteria|0
2500124|NCT01957163|8644963|P3|Overall Study|Protocol Violation|0
2500125|NCT01957163|8644964|P2|Overall Study|Protocol Violation|2
2500126|NCT01957163|8644965|P1|Overall Study|Protocol Violation|1
2500127|NCT01957163|8644963|P3|Overall Study|Lack of Efficacy|9
2500128|NCT01957163|8644964|P2|Overall Study|Lack of Efficacy|4
2500129|NCT01957163|8644965|P1|Overall Study|Lack of Efficacy|5
2500130|NCT01957163|8644963|P3|Overall Study|Adverse Event|4
2500131|NCT01957163|8644964|P2|Overall Study|Adverse Event|2
2500132|NCT01957163|8644965|P1|Overall Study|Adverse Event|5
2500133|NCT01957150|8644978|P2|Overall Study|Lack of Efficacy|11
2500134|NCT01957150|8644979|P1|Overall Study|Lack of Efficacy|11
2500135|NCT01957150|8644978|P2|Overall Study|Protocol Violation|0
2500136|NCT01957150|8644979|P1|Overall Study|Protocol Violation|1
2500137|NCT01957150|8644978|P2|Overall Study|Lost to Follow-up|4
2500138|NCT01957150|8644979|P1|Overall Study|Lost to Follow-up|4
2500139|NCT01957150|8644978|P2|Overall Study|Physician Decision|6
2500140|NCT01957150|8644979|P1|Overall Study|Physician Decision|3
2500141|NCT01957150|8644978|P2|Overall Study|Withdrawal by Subject|17
2500142|NCT01957150|8644979|P1|Overall Study|Withdrawal by Subject|13
2500143|NCT01957150|8644978|P2|Overall Study|Adverse Event|20
2500144|NCT01957150|8644979|P1|Overall Study|Adverse Event|23
2500145|NCT01957137|8644995|P1|Randomized Portion|Withdrawal by Subject|1
2500146|NCT01957137|8644995|P1|Randomized Portion|Adverse Event|1
2500147|NCT01957111|8645025|P2|Overall Study|Withdrawal by Subject|1
2500148|NCT01957111|8645026|P1|Overall Study|Withdrawal by Subject|1
2500149|NCT01956773|8645045|P2|Overall Study|Lost to Follow-up|1
2500150|NCT01956773|8645046|P1|Overall Study|Lost to Follow-up|628
2500151|NCT01956240|8645067|P2|Overall Study|Adverse Event|4
2500152|NCT01956240|8645068|P1|Overall Study|Adverse Event|17
2500153|NCT01956240|8645067|P2|Overall Study|Lost to Follow-up|20
2500154|NCT01956240|8645068|P1|Overall Study|Lost to Follow-up|6
2500155|NCT01956123|8645078|P4|COS Cycle 3|Withdrawal by Subject|1
2500156|NCT01956123|8645079|P3|COS Cycle 3|Withdrawal by Subject|0
2500157|NCT01956123|8645080|P2|COS Cycle 3|Withdrawal by Subject|0
2500158|NCT01956123|8645081|P1|COS Cycle 3|Withdrawal by Subject|0
2500159|NCT01956123|8645078|P4|COS Cycle 3|Personal Reasons|0
2500160|NCT01956123|8645079|P3|COS Cycle 3|Personal Reasons|1
2500161|NCT01956123|8645080|P2|COS Cycle 3|Personal Reasons|0
2500162|NCT01956123|8645081|P1|COS Cycle 3|Personal Reasons|0
2500163|NCT01956123|8645078|P4|COS Cycle 3|Adverse Event|0
2500164|NCT01956123|8645079|P3|COS Cycle 3|Adverse Event|3
2500165|NCT01956123|8645080|P2|COS Cycle 3|Adverse Event|0
2500166|NCT01956123|8645081|P1|COS Cycle 3|Adverse Event|0
2500167|NCT01956123|8645078|P4|COS Cycle 3|Protocol Violation|1
2500168|NCT01956123|8645079|P3|COS Cycle 3|Protocol Violation|2
2500169|NCT01956123|8645080|P2|COS Cycle 3|Protocol Violation|0
2500170|NCT01956123|8645081|P1|COS Cycle 3|Protocol Violation|0
2500171|NCT01956123|8645078|P4|COS Cycle 2|Withdrawal by Subject|0
2500172|NCT01956123|8645079|P3|COS Cycle 2|Withdrawal by Subject|0
2500173|NCT01956123|8645080|P2|COS Cycle 2|Withdrawal by Subject|0
2500174|NCT01956123|8645081|P1|COS Cycle 2|Withdrawal by Subject|1
2500175|NCT01956123|8645078|P4|COS Cycle 2|Personal Reasons|0
2500176|NCT01956123|8645079|P3|COS Cycle 2|Personal Reasons|0
2500177|NCT01956123|8645080|P2|COS Cycle 2|Personal Reasons|0
2500178|NCT01956123|8645081|P1|COS Cycle 2|Personal Reasons|2
2500179|NCT01956123|8645078|P4|COS Cycle 2|Adverse Event|0
2500180|NCT01956123|8645079|P3|COS Cycle 2|Adverse Event|0
2500181|NCT01956123|8645080|P2|COS Cycle 2|Adverse Event|4
2500182|NCT01956123|8645081|P1|COS Cycle 2|Adverse Event|3
2500183|NCT01956123|8645078|P4|COS Cycle 2|Protocol Violation|0
2500184|NCT01956123|8645079|P3|COS Cycle 2|Protocol Violation|0
2500185|NCT01956123|8645080|P2|COS Cycle 2|Protocol Violation|3
2500186|NCT01956123|8645081|P1|COS Cycle 2|Protocol Violation|8
2500187|NCT01956110|8645133|P2|Overall Study|Personal reasons|1
2500188|NCT01956110|8645134|P1|Overall Study|Personal reasons|1
2500189|NCT01956110|8645133|P2|Overall Study|Adverse Event|10
2500190|NCT01956110|8645134|P1|Overall Study|Adverse Event|9
2500191|NCT01956110|8645133|P2|Overall Study|Protocol Violation|11
2500192|NCT01956110|8645134|P1|Overall Study|Protocol Violation|25
2500193|NCT01955733|8645269|P3|Period 2|Other not defined above|2
2500194|NCT01955733|8645270|P2|Period 2|Other not defined above|2
2500195|NCT01955733|8645271|P1|Period 2|Other not defined above|0
2500196|NCT01955733|8645269|P3|Period 2|Lost to Follow-up|0
2500197|NCT01955733|8645270|P2|Period 2|Lost to Follow-up|0
2500198|NCT01955733|8645271|P1|Period 2|Lost to Follow-up|2
2500199|NCT01955733|8645269|P3|Period 2|Study terminated by sponsor|16
2500200|NCT01955733|8645270|P2|Period 2|Study terminated by sponsor|14
2500201|NCT01955733|8645271|P1|Period 2|Study terminated by sponsor|8
2500202|NCT01955733|8645269|P3|Period 2|Withdrawal by Subject|2
2500203|NCT01955733|8645270|P2|Period 2|Withdrawal by Subject|3
2500204|NCT01955733|8645271|P1|Period 2|Withdrawal by Subject|1
2500205|NCT01955733|8645269|P3|Period 2|Physician Decision|1
2500206|NCT01955733|8645270|P2|Period 2|Physician Decision|0
2500207|NCT01955733|8645271|P1|Period 2|Physician Decision|0
2500208|NCT01955733|8645269|P3|Period 2|Adverse Event|0
2500209|NCT01955733|8645270|P2|Period 2|Adverse Event|0
2500210|NCT01955733|8645271|P1|Period 2|Adverse Event|1
2500211|NCT01955733|8645269|P3|Period 1|Lost to Follow-up|0
2500212|NCT01955733|8645270|P2|Period 1|Lost to Follow-up|0
2500213|NCT01955733|8645271|P1|Period 1|Lost to Follow-up|1
2500214|NCT01955707|8645364|P2|Overall Study|Other|2
2500215|NCT01955707|8645365|P1|Overall Study|Other|4
2500216|NCT01955707|8645364|P2|Overall Study|Death|14
2500217|NCT01955707|8645365|P1|Overall Study|Death|13
2500218|NCT01955707|8645364|P2|Overall Study|Withdrawal by Subject|3
2500219|NCT01955707|8645365|P1|Overall Study|Withdrawal by Subject|0
2500220|NCT01955707|8645364|P2|Overall Study|Lost to Follow-up|1
2500221|NCT01955707|8645365|P1|Overall Study|Lost to Follow-up|2
2500222|NCT01955707|8645364|P2|Overall Study|Adverse Event|2
2500223|NCT01955707|8645365|P1|Overall Study|Adverse Event|1
2500224|NCT01955161|8645633|P3|Overall Study|Other reason: patient's will|1
2500225|NCT01955161|8645634|P2|Overall Study|Other reason: patient's will|0
2500226|NCT01955161|8645635|P1|Overall Study|Other reason: patient's will|0
2500227|NCT01955161|8645633|P3|Overall Study|Other reason: primary biliary cirrhosis|0
2500228|NCT01955161|8645634|P2|Overall Study|Other reason: primary biliary cirrhosis|0
2500229|NCT01955161|8645635|P1|Overall Study|Other reason: primary biliary cirrhosis|1
2500230|NCT01955161|8645633|P3|Overall Study|Other reason: insufficient compliance|1
2500231|NCT01955161|8645634|P2|Overall Study|Other reason: insufficient compliance|0
2500232|NCT01955161|8645635|P1|Overall Study|Other reason: insufficient compliance|0
2500233|NCT01955161|8645633|P3|Overall Study|Other reason: moved to nursing home|0
2500234|NCT01955161|8645634|P2|Overall Study|Other reason: moved to nursing home|1
2500235|NCT01955161|8645635|P1|Overall Study|Other reason: moved to nursing home|0
2500236|NCT01955161|8645633|P3|Overall Study|Other reason: caregiver unavailable|0
2500237|NCT01955161|8645634|P2|Overall Study|Other reason: caregiver unavailable|0
2500238|NCT01955161|8645635|P1|Overall Study|Other reason: caregiver unavailable|1
2500239|NCT01955161|8645633|P3|Overall Study|Other reason: disallowed medication|1
2500240|NCT01955161|8645634|P2|Overall Study|Other reason: disallowed medication|0
2500241|NCT01955161|8645635|P1|Overall Study|Other reason: disallowed medication|1
2500242|NCT01955161|8645633|P3|Overall Study|Other reason: physician decision|1
2500243|NCT01955161|8645634|P2|Overall Study|Other reason: physician decision|1
2500244|NCT01955161|8645635|P1|Overall Study|Other reason: physician decision|0
2500245|NCT01955161|8645633|P3|Overall Study|Protocol Violation|0
2500246|NCT01955161|8645634|P2|Overall Study|Protocol Violation|0
2500247|NCT01955161|8645635|P1|Overall Study|Protocol Violation|2
2500248|NCT01955161|8645633|P3|Overall Study|Withdrawal by Subject|12
2500249|NCT01955161|8645634|P2|Overall Study|Withdrawal by Subject|8
2500250|NCT01955161|8645635|P1|Overall Study|Withdrawal by Subject|9
2500251|NCT01955161|8645633|P3|Overall Study|Death|3
2500252|NCT01955161|8645634|P2|Overall Study|Death|1
2500253|NCT01955161|8645635|P1|Overall Study|Death|1
2500254|NCT01955161|8645633|P3|Overall Study|Adverse Event|15
2500255|NCT01955161|8645634|P2|Overall Study|Adverse Event|14
2500256|NCT01955161|8645635|P1|Overall Study|Adverse Event|10
2500257|NCT01955161|8645633|P3|Overall Study|Withdrawal before treatment|1
2500258|NCT01955161|8645634|P2|Overall Study|Withdrawal before treatment|0
2500259|NCT01955161|8645635|P1|Overall Study|Withdrawal before treatment|2
2500260|NCT01955122|8645675|P2|Overall Study|Physician Decision|5
2500261|NCT01955122|8645676|P1|Overall Study|Physician Decision|5
2500262|NCT01955083|8645696|P2|Overall Study|Lost to Follow-up|1
2500263|NCT01955083|8645697|P1|Overall Study|Lost to Follow-up|1
2500264|NCT01955044|8645730|P3|Overall Study|Death|0
2500265|NCT01955044|8645731|P2|Overall Study|Death|1
2500266|NCT01955044|8645732|P1|Overall Study|Death|1
2500267|NCT01955005|8645745|P2|Overall Study|Withdrawal by Subject|5
2500268|NCT01955005|8645746|P1|Overall Study|Withdrawal by Subject|3
2500269|NCT01954927|8645758|P2|Overall Study|Withdrawal by Subject|1
2500270|NCT01954927|8645759|P1|Overall Study|Withdrawal by Subject|3
2500271|NCT01954771|8645780|P3|Overall Study|Missing HbA1c and CGMS of end-point|3
2500272|NCT01954771|8645781|P2|Overall Study|Missing HbA1c and CGMS of end-point|1
2500273|NCT01954771|8645782|P1|Overall Study|Missing HbA1c and CGMS of end-point|5
2500274|NCT01954771|8645780|P3|Overall Study|Missing CGMS of end-point|0
2500275|NCT01954771|8645781|P2|Overall Study|Missing CGMS of end-point|1
2500276|NCT01954771|8645782|P1|Overall Study|Missing CGMS of end-point|1
2500277|NCT01954771|8645780|P3|Overall Study|Missing HbA1c of end-point|0
2500278|NCT01954771|8645781|P2|Overall Study|Missing HbA1c of end-point|1
2500279|NCT01954771|8645782|P1|Overall Study|Missing HbA1c of end-point|1
2500280|NCT01954745|8645799|P1|Overall Study|Death|1
2500281|NCT01954745|8645799|P1|Overall Study|Adverse Event|2
2500282|NCT01954745|8645799|P1|Overall Study|Clinical Progression|5
2500283|NCT01954745|8645799|P1|Overall Study|Radiological Progression|11
2500284|NCT01954394|8645830|P2|Overall Study|Other than specified above|21
2500285|NCT01954394|8645831|P1|Overall Study|Other than specified above|10
2500286|NCT01954394|8645830|P2|Overall Study|Related to Study Drug administration|2
2500287|NCT01954394|8645831|P1|Overall Study|Related to Study Drug administration|2
2500288|NCT01954394|8645830|P2|Overall Study|Participant Moved|4
2500289|NCT01954394|8645831|P1|Overall Study|Participant Moved|0
2500290|NCT01954394|8645830|P2|Overall Study|Poor compliance to protocol|7
2500291|NCT01954394|8645831|P1|Overall Study|Poor compliance to protocol|7
2500292|NCT01954394|8645830|P2|Overall Study|Adverse Event|23
2500293|NCT01954394|8645831|P1|Overall Study|Adverse Event|10
2500294|NCT01954394|8645830|P2|Overall Study|Enrolled but not treated|0
2500295|NCT01954394|8645831|P1|Overall Study|Enrolled but not treated|1
2500296|NCT01954251|8645933|P2|Overall Study|Withdrawal by Subject|6
2500297|NCT01954251|8645934|P1|Overall Study|Withdrawal by Subject|2
2500298|NCT01954251|8645933|P2|Overall Study|Lost to Follow-up|6
2500299|NCT01954251|8645934|P1|Overall Study|Lost to Follow-up|6
2500300|NCT01954251|8645933|P2|Overall Study|Adverse Event|7
2500301|NCT01954251|8645934|P1|Overall Study|Adverse Event|5
2500302|NCT01954121|8646031|P2|Overall Study|Subject did not follow instructions|2
2500303|NCT01954121|8646032|P1|Overall Study|Subject did not follow instructions|0
2500304|NCT01954121|8646031|P2|Overall Study|Non-compliant patient|1
2500305|NCT01954121|8646032|P1|Overall Study|Non-compliant patient|1
2500306|NCT01954121|8646031|P2|Overall Study|Non-compliant with study procedures|0
2500307|NCT01954121|8646032|P1|Overall Study|Non-compliant with study procedures|1
2500308|NCT01954121|8646031|P2|Overall Study|SAE, non-fatal|4
2500309|NCT01954121|8646032|P1|Overall Study|SAE, non-fatal|1
2500310|NCT01954121|8646031|P2|Overall Study|AE, non-serious non-fatal|22
2500311|NCT01954121|8646032|P1|Overall Study|AE, non-serious non-fatal|5
2500312|NCT01954121|8646031|P2|Overall Study|AE, serious fatal|0
2500313|NCT01954121|8646032|P1|Overall Study|AE, serious fatal|1
2500314|NCT01954121|8646031|P2|Overall Study|Pregnancy|1
2500315|NCT01954121|8646032|P1|Overall Study|Pregnancy|1
2500316|NCT01954121|8646031|P2|Overall Study|Withdrawal by Subject|12
2500317|NCT01954121|8646032|P1|Overall Study|Withdrawal by Subject|18
2500318|NCT01954121|8646031|P2|Overall Study|Lost to Follow-up|6
2500319|NCT01954121|8646032|P1|Overall Study|Lost to Follow-up|5
2500320|NCT01954121|8646031|P2|Overall Study|Protocol Violation|2
2500321|NCT01954121|8646032|P1|Overall Study|Protocol Violation|0
2500322|NCT01954121|8646031|P2|Overall Study|Lack of Efficacy|41
2500323|NCT01954121|8646032|P1|Overall Study|Lack of Efficacy|94
2500324|NCT01954082|8646048|P2|Overall Study|Randomized not Treated|2
2500325|NCT01954082|8646049|P1|Overall Study|Randomized not Treated|4
2500326|NCT01954082|8646048|P2|Overall Study|Infant Moved|1
2500327|NCT01954082|8646049|P1|Overall Study|Infant Moved|0
2500328|NCT01954082|8646048|P2|Overall Study|Comfort Care|1
2500329|NCT01954082|8646049|P1|Overall Study|Comfort Care|0
2500330|NCT01954082|8646048|P2|Overall Study|Miscalculation of Final Dose Day|3
2500331|NCT01954082|8646049|P1|Overall Study|Miscalculation of Final Dose Day|0
2500332|NCT01954082|8646048|P2|Overall Study|Redirection of Care|2
2500333|NCT01954082|8646049|P1|Overall Study|Redirection of Care|0
2500334|NCT01954082|8646048|P2|Overall Study|Discontinued Early Prior to Transfer|2
2500335|NCT01954082|8646049|P1|Overall Study|Discontinued Early Prior to Transfer|3
2500336|NCT01954082|8646048|P2|Overall Study|Withdrawal by Subject|1
2500337|NCT01954082|8646049|P1|Overall Study|Withdrawal by Subject|0
2500338|NCT01954082|8646048|P2|Overall Study|Parent Decision|0
2500339|NCT01954082|8646049|P1|Overall Study|Parent Decision|1
2500340|NCT01954082|8646048|P2|Overall Study|Physician Decision|0
2500341|NCT01954082|8646049|P1|Overall Study|Physician Decision|2
2500342|NCT01954082|8646048|P2|Overall Study|Non-compliance|4
2500343|NCT01954082|8646049|P1|Overall Study|Non-compliance|6
2500344|NCT01954082|8646048|P2|Overall Study|Intolerance|1
2500345|NCT01954082|8646049|P1|Overall Study|Intolerance|0
2500346|NCT01954082|8646048|P2|Overall Study|Adverse Event|4
2500347|NCT01954082|8646049|P1|Overall Study|Adverse Event|10
2500348|NCT01954082|8646048|P2|Overall Study|Study Suspension|36
2500349|NCT01954082|8646049|P1|Overall Study|Study Suspension|42
2500350|NCT01954056|8646069|P2|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0
2500351|NCT01954056|8646070|P1|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1
2500352|NCT01954017|8646115|P3|Overall Study|All other reasons|7
2500353|NCT01954017|8646116|P2|Overall Study|All other reasons|2
2500354|NCT01954017|8646117|P1|Overall Study|All other reasons|2
2500355|NCT01954017|8646115|P3|Overall Study|Enteral intake stopped >7 days|1
2500356|NCT01954017|8646116|P2|Overall Study|Enteral intake stopped >7 days|1
2500357|NCT01954017|8646117|P1|Overall Study|Enteral intake stopped >7 days|0
2500358|NCT01954017|8646115|P3|Overall Study|Necrotizing enterocolitis|1
2500359|NCT01954017|8646116|P2|Overall Study|Necrotizing enterocolitis|0
2500360|NCT01954017|8646117|P1|Overall Study|Necrotizing enterocolitis|1
2500361|NCT01954017|8646115|P3|Overall Study|Protocol Violation|2
2500362|NCT01954017|8646116|P2|Overall Study|Protocol Violation|3
2500363|NCT01954017|8646117|P1|Overall Study|Protocol Violation|0
2500364|NCT01954017|8646115|P3|Overall Study|Withdrawal by Subject|0
2500365|NCT01954017|8646116|P2|Overall Study|Withdrawal by Subject|1
2500366|NCT01954017|8646117|P1|Overall Study|Withdrawal by Subject|0
2500367|NCT01954017|8646115|P3|Overall Study|Death|1
2500368|NCT01954017|8646116|P2|Overall Study|Death|1
2500369|NCT01954017|8646117|P1|Overall Study|Death|2
2500370|NCT01954017|8646115|P3|Overall Study|Adverse Event|1
2500371|NCT01954017|8646116|P2|Overall Study|Adverse Event|0
2500372|NCT01954017|8646117|P1|Overall Study|Adverse Event|0
2500373|NCT01953913|8646343|P1|Overall Study|Not Treated|1
2500374|NCT01953913|8646343|P1|Overall Study|Other than listed|108
2500375|NCT01953913|8646343|P1|Overall Study|Withdrawal by Subject|32
2500376|NCT01953913|8646343|P1|Overall Study|Lost to Follow-up|4
2500377|NCT01953913|8646343|P1|Overall Study|Protocol Violation|6
2500378|NCT01953913|8646343|P1|Overall Study|Adverse Event|20
2500379|NCT01953913|8646343|P1|Overall Study|Worsening of underlying cancer|22
2500380|NCT01953913|8646343|P1|Overall Study|Disease Progression|349
2500381|NCT01953601|8646398|P3|Part 2 (Extension Study)|Withdrawal by Subject|2
2500382|NCT01953601|8646399|P2|Part 2 (Extension Study)|Withdrawal by Subject|4
2500383|NCT01953601|8646400|P1|Part 2 (Extension Study)|Withdrawal by Subject|5
2500384|NCT01953601|8646398|P3|Part 2 (Extension Study)|Subject moved|1
2500385|NCT01953601|8646399|P2|Part 2 (Extension Study)|Subject moved|0
2500386|NCT01953601|8646400|P1|Part 2 (Extension Study)|Subject moved|0
2500387|NCT01953601|8646398|P3|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0
2500388|NCT01953601|8646399|P2|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3
2500389|NCT01953601|8646400|P1|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1
2500390|NCT01953601|8646398|P3|Part 2 (Extension Study)|Study terminated by sponsor|187
2500391|NCT01953601|8646399|P2|Part 2 (Extension Study)|Study terminated by sponsor|178
2500392|NCT01953601|8646400|P1|Part 2 (Extension Study)|Study terminated by sponsor|185
2500393|NCT01953601|8646398|P3|Part 2 (Extension Study)|Site discontinued study participation|1
2500394|NCT01953601|8646399|P2|Part 2 (Extension Study)|Site discontinued study participation|1
2500395|NCT01953601|8646400|P1|Part 2 (Extension Study)|Site discontinued study participation|0
2500396|NCT01953601|8646398|P3|Part 2 (Extension Study)|Physician Decision|2
2500397|NCT01953601|8646399|P2|Part 2 (Extension Study)|Physician Decision|0
2500398|NCT01953601|8646400|P1|Part 2 (Extension Study)|Physician Decision|2
2500399|NCT01953601|8646398|P3|Part 2 (Extension Study)|Lost to Follow-up|1
2500400|NCT01953601|8646399|P2|Part 2 (Extension Study)|Lost to Follow-up|1
2500401|NCT01953601|8646400|P1|Part 2 (Extension Study)|Lost to Follow-up|2
2500402|NCT01953601|8646398|P3|Part 2 (Extension Study)|Lack of Efficacy|0
2500403|NCT01953601|8646399|P2|Part 2 (Extension Study)|Lack of Efficacy|0
2500404|NCT01953601|8646400|P1|Part 2 (Extension Study)|Lack of Efficacy|2
2500405|NCT01953601|8646398|P3|Part 2 (Extension Study)|Death|0
2500406|NCT01953601|8646399|P2|Part 2 (Extension Study)|Death|3
2500407|NCT01953601|8646400|P1|Part 2 (Extension Study)|Death|0
2500408|NCT01953601|8646398|P3|Part 2 (Extension Study)|Adverse Event|10
2500409|NCT01953601|8646399|P2|Part 2 (Extension Study)|Adverse Event|1
2500410|NCT01953601|8646400|P1|Part 2 (Extension Study)|Adverse Event|1
2500411|NCT01953601|8646398|P3|Part 1 (Base Study)|Withdrawal by Subject|22
2500412|NCT01953601|8646399|P2|Part 1 (Base Study)|Withdrawal by Subject|23
2500413|NCT01953601|8646400|P1|Part 1 (Base Study)|Withdrawal by Subject|32
2500414|NCT01953601|8646398|P3|Part 1 (Base Study)|Subject moved|1
2500415|NCT01953601|8646399|P2|Part 1 (Base Study)|Subject moved|2
2500416|NCT01953601|8646400|P1|Part 1 (Base Study)|Subject moved|2
2500417|NCT01953601|8646398|P3|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10
2500418|NCT01953601|8646399|P2|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8
2500419|NCT01953601|8646400|P1|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7
2500420|NCT01953601|8646398|P3|Part 1 (Base Study)|Study terminated by sponsor|179
2500421|NCT01953601|8646399|P2|Part 1 (Base Study)|Study terminated by sponsor|169
2500422|NCT01953601|8646400|P1|Part 1 (Base Study)|Study terminated by sponsor|174
2500423|NCT01953601|8646398|P3|Part 1 (Base Study)|Site discontinued study participation|0
2500424|NCT01953601|8646399|P2|Part 1 (Base Study)|Site discontinued study participation|0
2500425|NCT01953601|8646400|P1|Part 1 (Base Study)|Site discontinued study participation|2
2500426|NCT01953601|8646398|P3|Part 1 (Base Study)|Screen failure|1
2500427|NCT01953601|8646399|P2|Part 1 (Base Study)|Screen failure|0
2500428|NCT01953601|8646400|P1|Part 1 (Base Study)|Screen failure|1
2500429|NCT01953601|8646398|P3|Part 1 (Base Study)|Physician Decision|4
2500430|NCT01953601|8646399|P2|Part 1 (Base Study)|Physician Decision|7
2500431|NCT01953601|8646400|P1|Part 1 (Base Study)|Physician Decision|3
2500432|NCT01953601|8646398|P3|Part 1 (Base Study)|Non-compliance with study drug|1
2500433|NCT01953601|8646399|P2|Part 1 (Base Study)|Non-compliance with study drug|3
2500434|NCT01953601|8646400|P1|Part 1 (Base Study)|Non-compliance with study drug|0
2500435|NCT01953601|8646398|P3|Part 1 (Base Study)|Lost to Follow-up|6
2500436|NCT01953601|8646399|P2|Part 1 (Base Study)|Lost to Follow-up|3
2500437|NCT01953601|8646400|P1|Part 1 (Base Study)|Lost to Follow-up|1
2500438|NCT01953601|8646398|P3|Part 1 (Base Study)|Lack of Efficacy|4
2500439|NCT01953601|8646399|P2|Part 1 (Base Study)|Lack of Efficacy|1
2500440|NCT01953601|8646400|P1|Part 1 (Base Study)|Lack of Efficacy|3
2500441|NCT01953601|8646398|P3|Part 1 (Base Study)|Death|3
2500442|NCT01953601|8646399|P2|Part 1 (Base Study)|Death|0
2500443|NCT01953601|8646400|P1|Part 1 (Base Study)|Death|2
2500444|NCT01953601|8646398|P3|Part 1 (Base Study)|Adverse Event|15
2500445|NCT01953601|8646399|P2|Part 1 (Base Study)|Adverse Event|37
2500446|NCT01953601|8646400|P1|Part 1 (Base Study)|Adverse Event|24
2500447|NCT01953354|8646471|P2|Overall Study|Disease Exacerbation|0
2500448|NCT01953354|8646472|P1|Overall Study|Disease Exacerbation|1
2500449|NCT01953354|8646471|P2|Overall Study|Decision of Sponsor|1
2500450|NCT01953354|8646472|P1|Overall Study|Decision of Sponsor|0
2500451|NCT01953354|8646471|P2|Overall Study|Withdrawal by Subject|1
2500452|NCT01953354|8646472|P1|Overall Study|Withdrawal by Subject|0
2500453|NCT01953328|8646500|P8|Overall Study|Lost to Follow-up|0
2500454|NCT01953328|8646501|P7|Overall Study|Lost to Follow-up|0
2500455|NCT01953328|8646502|P6|Overall Study|Lost to Follow-up|0
2500456|NCT01953328|8646503|P5|Overall Study|Lost to Follow-up|1
2500457|NCT01953328|8646504|P4|Overall Study|Lost to Follow-up|0
2500458|NCT01953328|8646505|P3|Overall Study|Lost to Follow-up|0
2500459|NCT01953328|8646506|P2|Overall Study|Lost to Follow-up|0
2500460|NCT01953328|8646507|P1|Overall Study|Lost to Follow-up|0
2500461|NCT01953328|8646500|P8|Overall Study|Withdrawal by Subject|0
2500462|NCT01953328|8646501|P7|Overall Study|Withdrawal by Subject|0
2500463|NCT01953328|8646502|P6|Overall Study|Withdrawal by Subject|0
2500464|NCT01953328|8646503|P5|Overall Study|Withdrawal by Subject|1
2500465|NCT01953328|8646504|P4|Overall Study|Withdrawal by Subject|0
2500466|NCT01953328|8646505|P3|Overall Study|Withdrawal by Subject|0
2500467|NCT01953328|8646506|P2|Overall Study|Withdrawal by Subject|0
2500468|NCT01953328|8646507|P1|Overall Study|Withdrawal by Subject|0
2500469|NCT01953224|8646720|P2|Overall Study|Withdrawal by Subject|2
2500470|NCT01953224|8646721|P1|Overall Study|Withdrawal by Subject|1
2500471|NCT01953224|8646720|P2|Overall Study|Lost to Follow-up|1
2500472|NCT01953224|8646721|P1|Overall Study|Lost to Follow-up|1
2500473|NCT01953003|8646770|P2|Overall Study|Withdrawal by Subject|4
2500474|NCT01953003|8646771|P1|Overall Study|Withdrawal by Subject|14
2500475|NCT01953003|8646770|P2|Overall Study|Protocol Violation|1
2500476|NCT01953003|8646771|P1|Overall Study|Protocol Violation|0
2500477|NCT01953003|8646770|P2|Overall Study|Non-related adverse events|2
2500478|NCT01953003|8646771|P1|Overall Study|Non-related adverse events|0
2500479|NCT01953003|8646770|P2|Overall Study|Related Adverse events|2
2500480|NCT01953003|8646771|P1|Overall Study|Related Adverse events|7
2500481|NCT01953003|8646770|P2|Overall Study|Progressive disease|45
2500482|NCT01953003|8646771|P1|Overall Study|Progressive disease|35
2500483|NCT01953003|8646770|P2|Overall Study|Not treated|1
2500484|NCT01953003|8646771|P1|Overall Study|Not treated|0
2500485|NCT01952834|8646777|P1|Overall Study|Adverse Event|1
2500486|NCT01952691|8646784|P1|Overall Study|Lost to Follow-up|2
2500487|NCT01952665|8646811|P2|Overall Study|Protocol Violation|1
2500488|NCT01952665|8646812|P1|Overall Study|Protocol Violation|0
2500489|NCT01952665|8646811|P2|Overall Study|Adverse Event|1
2500490|NCT01952665|8646812|P1|Overall Study|Adverse Event|2
2500491|NCT01952665|8646811|P2|Overall Study|Lost to Follow-up|2
2500492|NCT01952665|8646812|P1|Overall Study|Lost to Follow-up|1
2500493|NCT01952665|8646811|P2|Overall Study|Physician Decision|2
2500494|NCT01952665|8646812|P1|Overall Study|Physician Decision|3
2500495|NCT01952574|8646967|P4|Overall Study|Lost to Follow-up|0
2500496|NCT01952574|8646968|P3|Overall Study|Lost to Follow-up|1
2500497|NCT01952574|8646969|P2|Overall Study|Lost to Follow-up|0
2500498|NCT01952574|8646970|P1|Overall Study|Lost to Follow-up|2
2500499|NCT01952574|8646967|P4|Overall Study|Sponsor Decision|2
2500500|NCT01952574|8646968|P3|Overall Study|Sponsor Decision|5
2500501|NCT01952574|8646969|P2|Overall Study|Sponsor Decision|0
2500502|NCT01952574|8646970|P1|Overall Study|Sponsor Decision|6
2500503|NCT01952574|8646967|P4|Overall Study|Withdrawal by Subject|4
2500504|NCT01952574|8646968|P3|Overall Study|Withdrawal by Subject|3
2500505|NCT01952574|8646969|P2|Overall Study|Withdrawal by Subject|3
2500506|NCT01952574|8646970|P1|Overall Study|Withdrawal by Subject|9
2500507|NCT01952366|8647069|P1|Overall Study|Withdrawal by Subject|9
2500508|NCT01952366|8647069|P1|Overall Study|Death|22
2500509|NCT01952145|8647084|P2|Overall Study|Unclassified|1
2500510|NCT01952145|8647085|P1|Overall Study|Unclassified|1
2500511|NCT01952145|8647084|P2|Overall Study|Withdrawal Criteria|11
2500512|NCT01952145|8647085|P1|Overall Study|Withdrawal Criteria|16
2500513|NCT01952145|8647084|P2|Overall Study|Adverse Event|0
2500514|NCT01952145|8647085|P1|Overall Study|Adverse Event|9
2500515|NCT01952145|8647084|P2|Overall Study|Death|1
2500516|NCT01952145|8647085|P1|Overall Study|Death|0
2500517|NCT01952145|8647084|P2|Overall Study|Protocol Violation|1
2500518|NCT01952145|8647085|P1|Overall Study|Protocol Violation|2
2500519|NCT01952080|8647099|P4|Overall Study|Protocol Non-compliance|0
2500520|NCT01952080|8647100|P3|Overall Study|Protocol Non-compliance|0
2500521|NCT01952080|8647101|P2|Overall Study|Protocol Non-compliance|1
2500522|NCT01952080|8647102|P1|Overall Study|Protocol Non-compliance|0
2500523|NCT01952080|8647099|P4|Overall Study|Withdrawal by Subject|1
2500524|NCT01952080|8647100|P3|Overall Study|Withdrawal by Subject|0
2500525|NCT01952080|8647101|P2|Overall Study|Withdrawal by Subject|0
2500526|NCT01952080|8647102|P1|Overall Study|Withdrawal by Subject|0
2500527|NCT01952054|8647148|P1|Overall Study|Physician Decision|1
2500528|NCT01952041|8647156|P2|Overall Study|Death|0
2500529|NCT01952041|8647157|P1|Overall Study|Death|1
2500530|NCT01952041|8647156|P2|Overall Study|Withdrawal by Subject|5
2500531|NCT01952041|8647157|P1|Overall Study|Withdrawal by Subject|7
2500532|NCT01952041|8647156|P2|Overall Study|Lost to Follow-up|16
2500533|NCT01952041|8647157|P1|Overall Study|Lost to Follow-up|9
2500534|NCT01952015|8647171|P1|Treatment Period 3|Physician Decision|9
2500535|NCT01952015|8647171|P1|Maintenance|Adverse Event|2
2500536|NCT01952015|8647171|P1|Induction|Protocol Violation|1
2500537|NCT01951703|8647238|P2|Second Intervention|Unsatisfactory Lens fitting|1
2500538|NCT01951703|8647239|P1|Second Intervention|Unsatisfactory Lens fitting|0
2500539|NCT01951703|8647238|P2|Second Intervention|Protocol Violation|1
2500540|NCT01951703|8647239|P1|Second Intervention|Protocol Violation|0
2500541|NCT01951703|8647238|P2|First Intervention|Physician Decision|0
2500542|NCT01951703|8647239|P1|First Intervention|Physician Decision|1
2500543|NCT01951703|8647238|P2|First Intervention|Subject was not compliant|1
2500544|NCT01951703|8647239|P1|First Intervention|Subject was not compliant|1
2500545|NCT01951703|8647238|P2|First Intervention|Withdrawal by Subject|0
2500546|NCT01951703|8647239|P1|First Intervention|Withdrawal by Subject|1
2500547|NCT01951586|8647264|P2|Overall Study|Sponsor Decision|10
2500548|NCT01951586|8647265|P1|Overall Study|Sponsor Decision|9
2500549|NCT01951586|8647264|P2|Overall Study|Lost to Follow-up|1
2500550|NCT01951586|8647265|P1|Overall Study|Lost to Follow-up|0
2500551|NCT01951586|8647264|P2|Overall Study|Withdrawal by Subject|17
2500552|NCT01951586|8647265|P1|Overall Study|Withdrawal by Subject|8
2500553|NCT01951586|8647264|P2|Overall Study|Death|120
2500554|NCT01951586|8647265|P1|Overall Study|Death|61
2500555|NCT01951573|8647289|P2|Washout Period|Adverse Event|1
2500556|NCT01951573|8647290|P1|Washout Period|Adverse Event|0
2500557|NCT01951417|8647300|P1|Overall Study|Lost to Follow-up|6
2500558|NCT01951417|8647300|P1|Overall Study|Protocol Violation|2
2500559|NCT01951417|8647300|P1|Overall Study|Withdrawal by Subject|1
2500560|NCT01951170|8647366|P1|Overall Study|Investigator decision|1
2500561|NCT01951157|8647392|P3|Overall Study|Treatment-related death|0
2500562|NCT01951157|8647393|P2|Overall Study|Treatment-related death|2
2500563|NCT01951157|8647394|P1|Overall Study|Treatment-related death|0
2500564|NCT01951157|8647392|P3|Overall Study|Consent withdrawn by subject|3
2500565|NCT01951157|8647393|P2|Overall Study|Consent withdrawn by subject|1
2500566|NCT01951157|8647394|P1|Overall Study|Consent withdrawn by subject|0
2500567|NCT01951157|8647392|P3|Overall Study|Treatment-related AE|4
2500568|NCT01951157|8647393|P2|Overall Study|Treatment-related AE|0
2500569|NCT01951157|8647394|P1|Overall Study|Treatment-related AE|2
2500570|NCT01951157|8647392|P3|Overall Study|No treated|0
2500571|NCT01951157|8647393|P2|Overall Study|No treated|1
2500572|NCT01951157|8647394|P1|Overall Study|No treated|0
2500573|NCT01951157|8647392|P3|Overall Study|Non-treatmentrelated death|2
2500574|NCT01951157|8647393|P2|Overall Study|Non-treatmentrelated death|2
2500575|NCT01951157|8647394|P1|Overall Study|Non-treatmentrelated death|2
2500576|NCT01951157|8647392|P3|Overall Study|Physician Decision|2
2500577|NCT01951157|8647393|P2|Overall Study|Physician Decision|3
2500578|NCT01951157|8647394|P1|Overall Study|Physician Decision|5
2500579|NCT01951157|8647392|P3|Overall Study|Study Termination|1
2500580|NCT01951157|8647393|P2|Overall Study|Study Termination|0
2500581|NCT01951157|8647394|P1|Overall Study|Study Termination|0
2500582|NCT01951157|8647392|P3|Overall Study|Treatment-unrelated AE|3
2500583|NCT01951157|8647393|P2|Overall Study|Treatment-unrelated AE|0
2500584|NCT01951157|8647394|P1|Overall Study|Treatment-unrelated AE|1
2500585|NCT01951157|8647392|P3|Overall Study|Progressive Disease|10
2500586|NCT01951157|8647393|P2|Overall Study|Progressive Disease|13
2500587|NCT01951157|8647394|P1|Overall Study|Progressive Disease|12
2500588|NCT01951105|8647426|P3|Overall Study|Withdrawal by Subject|1
2500589|NCT01951105|8647427|P2|Overall Study|Withdrawal by Subject|3
2500590|NCT01951105|8647428|P1|Overall Study|Withdrawal by Subject|0
2500591|NCT01951105|8647426|P3|Overall Study|Protocol Violation|1
2500592|NCT01951105|8647427|P2|Overall Study|Protocol Violation|1
2500593|NCT01951105|8647428|P1|Overall Study|Protocol Violation|1
2500594|NCT01951105|8647426|P3|Overall Study|Lost to Follow-up|0
2500595|NCT01951105|8647427|P2|Overall Study|Lost to Follow-up|1
2500596|NCT01951105|8647428|P1|Overall Study|Lost to Follow-up|0
2500597|NCT01951105|8647426|P3|Overall Study|Adverse Event|0
2500598|NCT01951105|8647427|P2|Overall Study|Adverse Event|5
2500599|NCT01951105|8647428|P1|Overall Study|Adverse Event|0
2500600|NCT01951092|8647442|P1|Overall Study|Transfer of Care|1
2500601|NCT01951092|8647442|P1|Overall Study|Incarceration|1
2500602|NCT01951092|8647442|P1|Overall Study|Lost to Follow-up|10
2500603|NCT01950819|8647455|P2|Overall Study|Lost to Follow-up|17
2500604|NCT01950819|8647456|P1|Overall Study|Lost to Follow-up|9
2500605|NCT01950819|8647455|P2|Overall Study|Pregnancy|2
2500606|NCT01950819|8647456|P1|Overall Study|Pregnancy|0
2500607|NCT01950819|8647455|P2|Overall Study|technical problems|0
2500608|NCT01950819|8647456|P1|Overall Study|technical problems|2
2500609|NCT01950819|8647455|P2|Overall Study|Subject / Gardian decision|51
2500610|NCT01950819|8647456|P1|Overall Study|Subject / Gardian decision|54
2500611|NCT01950819|8647455|P2|Overall Study|Death|34
2500612|NCT01950819|8647456|P1|Overall Study|Death|29
2500613|NCT01950819|8647455|P2|Overall Study|Graft Loss|30
2500614|NCT01950819|8647456|P1|Overall Study|Graft Loss|35
2500615|NCT01950741|8647509|P1|Overall Study|Withdrawal by Subject|1
2500616|NCT01950741|8647509|P1|Overall Study|Death|1
2500617|NCT01950741|8647509|P1|Overall Study|Lost to Follow-up|1
2500618|NCT01950364|8647524|P2|Overall Study|Protocol Violation|1
2500619|NCT01950364|8647525|P1|Overall Study|Protocol Violation|0
2500620|NCT01950364|8647524|P2|Overall Study|Withdrawal by Subject|1
2500621|NCT01950364|8647525|P1|Overall Study|Withdrawal by Subject|0
2500622|NCT01950364|8647524|P2|Overall Study|Disease Progression|2
2500623|NCT01950364|8647525|P1|Overall Study|Disease Progression|5
2500624|NCT01950364|8647524|P2|Overall Study|Stem Cell Transplant|6
2500625|NCT01950364|8647525|P1|Overall Study|Stem Cell Transplant|2
2500626|NCT01950364|8647524|P2|Overall Study|Adverse Event|0
2500627|NCT01950364|8647525|P1|Overall Study|Adverse Event|3
2500628|NCT01950273|8647647|P2|Overall Study|Other not defined above|0
2500629|NCT01950273|8647648|P1|Overall Study|Other not defined above|1
2500630|NCT01950273|8647647|P2|Overall Study|Withdrawal by Subject|0
2500631|NCT01950273|8647648|P1|Overall Study|Withdrawal by Subject|2
2500632|NCT01950273|8647647|P2|Overall Study|Protocol Violation|0
2500633|NCT01950273|8647648|P1|Overall Study|Protocol Violation|1
2500634|NCT01950013|8647695|P3|Overall Study|Withdrawal by Subject|0
2500635|NCT01950013|8647696|P2|Overall Study|Withdrawal by Subject|2
2500636|NCT01950013|8647697|P1|Overall Study|Withdrawal by Subject|0
2500637|NCT01949870|8647708|P1|Overall Study|Eligibility requirements not fulfilled|2
2500638|NCT01949870|8647708|P1|Overall Study|Study termination|1
2500639|NCT01949870|8647708|P1|Overall Study|Adverse Event|1
2500640|NCT01949870|8647708|P1|Overall Study|Lack of Efficacy|2
2500641|NCT01949532|8647877|P2|Overall Study|On-study at the Data Cut-off Date|3
2500642|NCT01949532|8647878|P1|Overall Study|On-study at the Data Cut-off Date|3
2500643|NCT01949480|8647948|P2|Overall Study|Physician Decision|8
2500644|NCT01949480|8647949|P1|Overall Study|Physician Decision|5
2500645|NCT01949155|8647984|P2|Overall Study|Protocol Violation|0
2500646|NCT01949155|8647985|P1|Overall Study|Protocol Violation|1
2500647|NCT01949155|8647984|P2|Overall Study|Lost to Follow-up|0
2500648|NCT01949155|8647985|P1|Overall Study|Lost to Follow-up|1
2500649|NCT01949142|8647997|P2|Overall Study|Parent changed their mind|0
2500650|NCT01949142|8647998|P1|Overall Study|Parent changed their mind|1
2500651|NCT01949142|8647997|P2|Overall Study|Lost to Follow-up|1
2500652|NCT01949142|8647998|P1|Overall Study|Lost to Follow-up|1
2500653|NCT01949142|8647997|P2|Overall Study|Withdrawal of consent|0
2500654|NCT01949142|8647998|P1|Overall Study|Withdrawal of consent|1
2500655|NCT01949116|8648010|P2|Overall Study|Withdrawal by Subject|3
2500656|NCT01949116|8648011|P1|Overall Study|Withdrawal by Subject|5
2500657|NCT01949116|8648010|P2|Overall Study|Lost to Follow-up|3
2500658|NCT01949116|8648011|P1|Overall Study|Lost to Follow-up|1
2500659|NCT01949116|8648010|P2|Overall Study|Death|0
2500660|NCT01949116|8648011|P1|Overall Study|Death|2
2500661|NCT01949090|8648048|P5|Overall Study|Lost to Follow-up|1
2500662|NCT01949090|8648049|P4|Overall Study|Lost to Follow-up|1
2500663|NCT01949090|8648050|P3|Overall Study|Lost to Follow-up|0
2500664|NCT01949090|8648051|P2|Overall Study|Lost to Follow-up|1
2500665|NCT01949090|8648052|P1|Overall Study|Lost to Follow-up|2
2500666|NCT01949090|8648048|P5|Overall Study|Protocol non-compliance|1
2500667|NCT01949090|8648049|P4|Overall Study|Protocol non-compliance|0
2500668|NCT01949090|8648050|P3|Overall Study|Protocol non-compliance|0
2500669|NCT01949090|8648051|P2|Overall Study|Protocol non-compliance|0
2500670|NCT01949090|8648052|P1|Overall Study|Protocol non-compliance|0
2500671|NCT01949090|8648048|P5|Overall Study|Withdrawal by Subject|1
2500672|NCT01949090|8648049|P4|Overall Study|Withdrawal by Subject|0
2500673|NCT01949090|8648050|P3|Overall Study|Withdrawal by Subject|0
2500674|NCT01949090|8648051|P2|Overall Study|Withdrawal by Subject|0
2500675|NCT01949090|8648052|P1|Overall Study|Withdrawal by Subject|2
2500676|NCT01949090|8648048|P5|Overall Study|Serious Adverse Event|1
2500677|NCT01949090|8648049|P4|Overall Study|Serious Adverse Event|0
2500678|NCT01949090|8648050|P3|Overall Study|Serious Adverse Event|2
2500679|NCT01949090|8648051|P2|Overall Study|Serious Adverse Event|1
2500680|NCT01949090|8648052|P1|Overall Study|Serious Adverse Event|0
2500681|NCT01949051|8648229|P6|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
2500682|NCT01949051|8648230|P5|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
2500683|NCT01949051|8648231|P4|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
2500684|NCT01949051|8648232|P3|Treatment Period 2 (7 Days)|Withdrawal by Subject|1
2500685|NCT01949051|8648233|P2|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
2500686|NCT01949051|8648234|P1|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
2500687|NCT01949051|8648229|P6|Treatment Period 2 (7 Days)|Lost to Follow-up|0
2500688|NCT01949051|8648230|P5|Treatment Period 2 (7 Days)|Lost to Follow-up|0
2500689|NCT01949051|8648231|P4|Treatment Period 2 (7 Days)|Lost to Follow-up|0
2500690|NCT01949051|8648232|P3|Treatment Period 2 (7 Days)|Lost to Follow-up|0
2500691|NCT01949051|8648233|P2|Treatment Period 2 (7 Days)|Lost to Follow-up|1
2500692|NCT01949051|8648234|P1|Treatment Period 2 (7 Days)|Lost to Follow-up|0
2500693|NCT01949051|8648229|P6|Treatment Period 2 (7 Days)|Protocol Violation|1
2500694|NCT01949051|8648230|P5|Treatment Period 2 (7 Days)|Protocol Violation|0
2500695|NCT01949051|8648231|P4|Treatment Period 2 (7 Days)|Protocol Violation|0
2500696|NCT01949051|8648232|P3|Treatment Period 2 (7 Days)|Protocol Violation|0
2500697|NCT01949051|8648233|P2|Treatment Period 2 (7 Days)|Protocol Violation|0
2500698|NCT01949051|8648234|P1|Treatment Period 2 (7 Days)|Protocol Violation|0
2500699|NCT01949051|8648229|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2500700|NCT01949051|8648230|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2500701|NCT01949051|8648231|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2500702|NCT01949051|8648232|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2500703|NCT01949051|8648233|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2500704|NCT01949051|8648234|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|1
2500705|NCT01949051|8648229|P6|Treatment Period 1 (7 Days)|Protocol Violation|0
2500706|NCT01949051|8648230|P5|Treatment Period 1 (7 Days)|Protocol Violation|0
2500707|NCT01949051|8648231|P4|Treatment Period 1 (7 Days)|Protocol Violation|1
2500708|NCT01949051|8648232|P3|Treatment Period 1 (7 Days)|Protocol Violation|0
2500709|NCT01949051|8648233|P2|Treatment Period 1 (7 Days)|Protocol Violation|0
2500710|NCT01949051|8648234|P1|Treatment Period 1 (7 Days)|Protocol Violation|1
2500711|NCT01948908|8648429|P3|Overall Study|Protocol Violation|2
2500712|NCT01948908|8648430|P2|Overall Study|Protocol Violation|0
2500713|NCT01948908|8648431|P1|Overall Study|Protocol Violation|1
2500714|NCT01948830|8648447|P2|Overall Study|Death|4
2500715|NCT01948830|8648448|P1|Overall Study|Death|3
2500716|NCT01948830|8648447|P2|Overall Study|Adverse Event|2
2500717|NCT01948830|8648448|P1|Overall Study|Adverse Event|9
2500718|NCT01948830|8648447|P2|Overall Study|Withdrawal by Subject|17
2500719|NCT01948830|8648448|P1|Overall Study|Withdrawal by Subject|14
2500720|NCT01948830|8648447|P2|Overall Study|Lost to Follow-up|4
2500721|NCT01948830|8648448|P1|Overall Study|Lost to Follow-up|5
2500722|NCT01948830|8648447|P2|Overall Study|Protocol deviation|2
2500723|NCT01948830|8648448|P1|Overall Study|Protocol deviation|1
2500724|NCT01948830|8648447|P2|Overall Study|Physician Decision|3
2500725|NCT01948830|8648448|P1|Overall Study|Physician Decision|1
2500726|NCT01948791|8648480|P1|Overall Study|Screening failure|35
2500727|NCT01948791|8648480|P1|Overall Study|Others|7
2500728|NCT01948791|8648480|P1|Overall Study|Management issues|1
2500729|NCT01948791|8648480|P1|Overall Study|Lost to Follow-up|6
2500730|NCT01948791|8648480|P1|Overall Study|Withdrawal by Subject|5
2500731|NCT01948791|8648480|P1|Overall Study|Protocol Violation|2
2500732|NCT01948791|8648480|P1|Overall Study|Lack of Efficacy|3
2500733|NCT01948791|8648480|P1|Overall Study|Adverse Event|12
2500734|NCT01948258|8648540|P1|Overall Study|Removed from statistical analysis|2
2500735|NCT01948258|8648540|P1|Overall Study|Health Care Professional|43
2500736|NCT01948258|8648540|P1|Overall Study|Withdrawal by Subject|6
2500737|NCT01948258|8648540|P1|Overall Study|Withdrawal by SPD|8
2500738|NCT01948258|8648540|P1|Overall Study|Lost to Follow-up|27
2500739|NCT01948258|8648540|P1|Overall Study|Did not complete by cut-off date|35
2500740|NCT01948258|8648540|P1|Overall Study|Pregnancy|41
2500741|NCT01948193|8648546|P1|Overall Study|Lost to Follow-up|7
2500742|NCT01948193|8648546|P1|Overall Study|Serious event|2
2500743|NCT01948076|8648568|P2|Overall Study|Withdrawal by Subject|1
2500744|NCT01948076|8648569|P1|Overall Study|Withdrawal by Subject|0
2500745|NCT01948063|8648579|P2|Overall Study|Blood samples were accidentally thawed|0
2500746|NCT01948063|8648580|P1|Overall Study|Blood samples were accidentally thawed|1
2500747|NCT01948063|8648579|P2|Overall Study|Discovered an enrollment in other study|1
2500748|NCT01948063|8648580|P1|Overall Study|Discovered an enrollment in other study|0
2500749|NCT01948063|8648579|P2|Overall Study|Boston MCI halted research protocol|1
2500750|NCT01948063|8648580|P1|Overall Study|Boston MCI halted research protocol|0
2500751|NCT01948050|8648588|P2|Overall Study|Withdrawal by Subject|1
2500752|NCT01948050|8648589|P1|Overall Study|Withdrawal by Subject|0
2500753|NCT01947894|8648657|P3|Overall Study|Switched to other growth hormone brand|23
2500754|NCT01947894|8648658|P2|Overall Study|Switched to other growth hormone brand|8
2500755|NCT01947894|8648659|P1|Overall Study|Switched to other growth hormone brand|53
2500756|NCT01947894|8648657|P3|Overall Study|Adverse Event|0
2500757|NCT01947894|8648658|P2|Overall Study|Adverse Event|1
2500758|NCT01947894|8648659|P1|Overall Study|Adverse Event|5
2500759|NCT01947894|8648657|P3|Overall Study|Physician Decision|0
2500760|NCT01947894|8648658|P2|Overall Study|Physician Decision|0
2500761|NCT01947894|8648659|P1|Overall Study|Physician Decision|2
2500762|NCT01947894|8648657|P3|Overall Study|Death|0
2500763|NCT01947894|8648658|P2|Overall Study|Death|1
2500764|NCT01947894|8648659|P1|Overall Study|Death|12
2500765|NCT01947894|8648657|P3|Overall Study|Withdrawal by Subject|1
2500766|NCT01947894|8648658|P2|Overall Study|Withdrawal by Subject|4
2500767|NCT01947894|8648659|P1|Overall Study|Withdrawal by Subject|12
2500768|NCT01947894|8648657|P3|Overall Study|Other|3
2500769|NCT01947894|8648658|P2|Overall Study|Other|4
2500770|NCT01947894|8648659|P1|Overall Study|Other|3
2500771|NCT01947855|8648724|P3|Overall Study|Withdrawal by Subject|0
2500772|NCT01947855|8648725|P2|Overall Study|Withdrawal by Subject|0
2500773|NCT01947855|8648726|P1|Overall Study|Withdrawal by Subject|1
2500774|NCT01947582|8648761|P1|Overall Study|Withdrawal by Subject|1
2500775|NCT01947517|8648770|P2|Overall Study|Withdrawal by Subject|1
2500776|NCT01947517|8648771|P1|Overall Study|Withdrawal by Subject|1
2500777|NCT01947491|8648789|P4|Overall Study|Adverse Event|2
2500778|NCT01947491|8648790|P3|Overall Study|Adverse Event|0
2500779|NCT01947491|8648791|P2|Overall Study|Adverse Event|1
2500780|NCT01947491|8648792|P1|Overall Study|Adverse Event|0
2500781|NCT01947491|8648789|P4|Overall Study|Worsening of condition|0
2500782|NCT01947491|8648790|P3|Overall Study|Worsening of condition|0
2500783|NCT01947491|8648791|P2|Overall Study|Worsening of condition|1
2500784|NCT01947491|8648792|P1|Overall Study|Worsening of condition|0
2500785|NCT01947491|8648789|P4|Overall Study|Withdrawal by Subject|0
2500786|NCT01947491|8648790|P3|Overall Study|Withdrawal by Subject|1
2500787|NCT01947491|8648791|P2|Overall Study|Withdrawal by Subject|1
2500788|NCT01947491|8648792|P1|Overall Study|Withdrawal by Subject|1
2500789|NCT01947491|8648789|P4|Overall Study|Protocol Violation|0
2500790|NCT01947491|8648790|P3|Overall Study|Protocol Violation|0
2500791|NCT01947491|8648791|P2|Overall Study|Protocol Violation|0
2500792|NCT01947491|8648792|P1|Overall Study|Protocol Violation|1
2500793|NCT01947491|8648789|P4|Overall Study|Lack of Efficacy|1
2500794|NCT01947491|8648790|P3|Overall Study|Lack of Efficacy|0
2500795|NCT01947491|8648791|P2|Overall Study|Lack of Efficacy|0
2500796|NCT01947491|8648792|P1|Overall Study|Lack of Efficacy|1
2500797|NCT01947491|8648789|P4|Overall Study|Lost to Follow-up|2
2500798|NCT01947491|8648790|P3|Overall Study|Lost to Follow-up|1
2500799|NCT01947491|8648791|P2|Overall Study|Lost to Follow-up|3
2500800|NCT01947491|8648792|P1|Overall Study|Lost to Follow-up|5
2500801|NCT01947283|8648822|P7|Overall Study|No patients were enrolled in study|1
2500802|NCT01947283|8648823|P6|Overall Study|No patients were enrolled in study|3
2500803|NCT01947283|8648824|P5|Overall Study|No patients were enrolled in study|0
2500804|NCT01947283|8648825|P4|Overall Study|No patients were enrolled in study|0
2500805|NCT01947283|8648826|P3|Overall Study|No patients were enrolled in study|0
2500806|NCT01947283|8648827|P2|Overall Study|No patients were enrolled in study|0
2500807|NCT01947283|8648828|P1|Overall Study|No patients were enrolled in study|0
2500808|NCT01947283|8648822|P7|Overall Study|Missing Follow-up Assessment|0
2500809|NCT01947283|8648823|P6|Overall Study|Missing Follow-up Assessment|2
2500810|NCT01947283|8648824|P5|Overall Study|Missing Follow-up Assessment|0
2500811|NCT01947283|8648825|P4|Overall Study|Missing Follow-up Assessment|0
2500812|NCT01947283|8648826|P3|Overall Study|Missing Follow-up Assessment|3
2500813|NCT01947283|8648827|P2|Overall Study|Missing Follow-up Assessment|2
2500814|NCT01947283|8648828|P1|Overall Study|Missing Follow-up Assessment|2
2500815|NCT01947283|8648822|P7|Overall Study|Non-coding Clinical Recording language|0
2500816|NCT01947283|8648823|P6|Overall Study|Non-coding Clinical Recording language|0
2500817|NCT01947283|8648824|P5|Overall Study|Non-coding Clinical Recording language|0
2500818|NCT01947283|8648825|P4|Overall Study|Non-coding Clinical Recording language|1
2500819|NCT01947283|8648826|P3|Overall Study|Non-coding Clinical Recording language|0
2500820|NCT01947283|8648827|P2|Overall Study|Non-coding Clinical Recording language|0
2500821|NCT01947283|8648828|P1|Overall Study|Non-coding Clinical Recording language|0
2500822|NCT01947283|8648822|P7|Overall Study|No Clinical Recording|0
2500823|NCT01947283|8648823|P6|Overall Study|No Clinical Recording|0
2500824|NCT01947283|8648824|P5|Overall Study|No Clinical Recording|0
2500825|NCT01947283|8648825|P4|Overall Study|No Clinical Recording|10
2500826|NCT01947283|8648826|P3|Overall Study|No Clinical Recording|8
2500827|NCT01947283|8648827|P2|Overall Study|No Clinical Recording|6
2500828|NCT01947283|8648828|P1|Overall Study|No Clinical Recording|12
2500829|NCT01947283|8648822|P7|Overall Study|Withdrawal by Subject|2
2500830|NCT01947283|8648823|P6|Overall Study|Withdrawal by Subject|0
2500831|NCT01947283|8648824|P5|Overall Study|Withdrawal by Subject|0
2500832|NCT01947283|8648825|P4|Overall Study|Withdrawal by Subject|1
2500833|NCT01947283|8648826|P3|Overall Study|Withdrawal by Subject|4
2500834|NCT01947283|8648827|P2|Overall Study|Withdrawal by Subject|8
2500835|NCT01947283|8648828|P1|Overall Study|Withdrawal by Subject|10
2500836|NCT01947283|8648822|P7|Overall Study|Lost to Follow-up|5
2500837|NCT01947283|8648823|P6|Overall Study|Lost to Follow-up|2
2500838|NCT01947283|8648824|P5|Overall Study|Lost to Follow-up|0
2500839|NCT01947283|8648825|P4|Overall Study|Lost to Follow-up|5
2500840|NCT01947283|8648826|P3|Overall Study|Lost to Follow-up|5
2500841|NCT01947283|8648827|P2|Overall Study|Lost to Follow-up|6
2500842|NCT01947283|8648828|P1|Overall Study|Lost to Follow-up|4
2500843|NCT01947283|8648822|P7|Overall Study|Death|0
2500844|NCT01947283|8648823|P6|Overall Study|Death|0
2500845|NCT01947283|8648824|P5|Overall Study|Death|0
2500846|NCT01947283|8648825|P4|Overall Study|Death|0
2500847|NCT01947283|8648826|P3|Overall Study|Death|1
2500848|NCT01947283|8648827|P2|Overall Study|Death|1
2500849|NCT01947283|8648828|P1|Overall Study|Death|1
2500850|NCT01947127|8648900|P2|Overall Study|Data loss|4
2500851|NCT01947127|8648901|P1|Overall Study|Data loss|4
2500852|NCT01947127|8648900|P2|Overall Study|Withdrawal by Subject|1
2500853|NCT01947127|8648901|P1|Overall Study|Withdrawal by Subject|1
2500854|NCT01947127|8648900|P2|Overall Study|Protocol Violation|38
2500855|NCT01947127|8648901|P1|Overall Study|Protocol Violation|18
2500856|NCT01946529|8648925|P3|Completion of All Therapy|Some pts. still receiving study therapy|6
2500857|NCT01946529|8648926|P2|Completion of All Therapy|Some pts. still receiving study therapy|16
2500858|NCT01946529|8648927|P1|Completion of All Therapy|Some pts. still receiving study therapy|1
2500859|NCT01946529|8648925|P3|End of Window Therapy (2 Courses)|Physician Decision|0
2500860|NCT01946529|8648926|P2|End of Window Therapy (2 Courses)|Physician Decision|1
2500861|NCT01946529|8648927|P1|End of Window Therapy (2 Courses)|Physician Decision|0
2500862|NCT01946438|8648938|P4|Overall Study|Withdrawal by Subject|0
2500863|NCT01946438|8648939|P3|Overall Study|Withdrawal by Subject|0
2500864|NCT01946438|8648940|P2|Overall Study|Withdrawal by Subject|0
2500865|NCT01946438|8648941|P1|Overall Study|Withdrawal by Subject|1
2500866|NCT01946438|8648938|P4|Overall Study|Protocol Violation|0
2500867|NCT01946438|8648939|P3|Overall Study|Protocol Violation|1
2500868|NCT01946438|8648940|P2|Overall Study|Protocol Violation|0
2500869|NCT01946438|8648941|P1|Overall Study|Protocol Violation|0
2500870|NCT01946438|8648938|P4|Overall Study|Serious Adverse event|0
2500871|NCT01946438|8648939|P3|Overall Study|Serious Adverse event|0
2500872|NCT01946438|8648940|P2|Overall Study|Serious Adverse event|0
2500873|NCT01946438|8648941|P1|Overall Study|Serious Adverse event|1
2500874|NCT01946438|8648938|P4|Overall Study|Adverse Event|1
2500875|NCT01946438|8648939|P3|Overall Study|Adverse Event|0
2500876|NCT01946438|8648940|P2|Overall Study|Adverse Event|0
2500877|NCT01946438|8648941|P1|Overall Study|Adverse Event|0
2500878|NCT01946425|8648969|P2|Overall Study|Withdrawal by Subject|0
2500879|NCT01946425|8648970|P1|Overall Study|Withdrawal by Subject|1
2500880|NCT01946425|8648969|P2|Overall Study|Protocol Violation|0
2500881|NCT01946425|8648970|P1|Overall Study|Protocol Violation|1
2500882|NCT01946412|8648984|P1|Overall Study|Difficulty in swallowing|1
2500883|NCT01946412|8648984|P1|Overall Study|Continued with commercial Kalydeco|2
2500884|NCT01946412|8648984|P1|Overall Study|Non-Compliance|1
2500885|NCT01946412|8648984|P1|Overall Study|Adverse Event|1
2500886|NCT01946282|8649009|P3|Year 3|Did not return FIT kit|30
2500887|NCT01946282|8649010|P2|Year 3|Did not return FIT kit|43
2500888|NCT01946282|8649011|P1|Year 3|Did not return FIT kit|288
2500889|NCT01946282|8649009|P3|Year 2|Did not return FIT kit|115
2500890|NCT01946282|8649010|P2|Year 2|Did not return FIT kit|131
2500891|NCT01946282|8649011|P1|Year 2|Did not return FIT kit|803
2500892|NCT01946282|8649009|P3|Year 1|Did not return FIT kit|654
2500893|NCT01946282|8649010|P2|Year 1|Did not return FIT kit|608
2500894|NCT01946282|8649011|P1|Year 1|Did not return FIT kit|4186
2500895|NCT01946204|8649044|P2|Overall Study|Other|3
2500896|NCT01946204|8649045|P1|Overall Study|Other|7
2500897|NCT01946204|8649044|P2|Overall Study|Ongoing|687
2500898|NCT01946204|8649045|P1|Overall Study|Ongoing|316
2500899|NCT01946204|8649044|P2|Overall Study|Lost to Follow-up|7
2500900|NCT01946204|8649045|P1|Overall Study|Lost to Follow-up|3
2500901|NCT01946204|8649044|P2|Overall Study|Withdrawal by Subject|50
2500902|NCT01946204|8649045|P1|Overall Study|Withdrawal by Subject|37
2500903|NCT01946204|8649044|P2|Overall Study|Death|59
2500904|NCT01946204|8649045|P1|Overall Study|Death|38
2500905|NCT01946178|8649061|P1|Overall Study|Lost to Follow-up|1
2500906|NCT01946178|8649061|P1|Overall Study|Pregnancy|1
2500907|NCT01946165|8649071|P2|Overall Study|Withdrawal by Subject|2
2500908|NCT01946165|8649072|P1|Overall Study|Withdrawal by Subject|0
2500909|NCT01946165|8649071|P2|Overall Study|Physician Decision|0
2500910|NCT01946165|8649072|P1|Overall Study|Physician Decision|2
2500911|NCT01945996|8649099|P2|Overall Study|Lost to Follow-up|5
2500912|NCT01945996|8649100|P1|Overall Study|Lost to Follow-up|3
2500913|NCT01945944|8649176|P2|Overall Study|Withdrawal by Subject|1
2500914|NCT01945944|8649177|P1|Overall Study|Withdrawal by Subject|0
2500915|NCT01945944|8649176|P2|Overall Study|Physician Decision|0
2500916|NCT01945944|8649177|P1|Overall Study|Physician Decision|1
2500917|NCT01945944|8649176|P2|Overall Study|Adverse Event|2
2500918|NCT01945944|8649177|P1|Overall Study|Adverse Event|0
2500919|NCT01945866|8649201|P2|Overall Study|Eyes did not complete or were dropped|0
2500920|NCT01945866|8649202|P1|Overall Study|Eyes did not complete or were dropped|2
2500921|NCT01945775|8649223|P2|Overall Study|Lost to Follow-up|6
2500922|NCT01945775|8649224|P1|Overall Study|Lost to Follow-up|7
2500923|NCT01945775|8649223|P2|Overall Study|Withdrawal by Subject|20
2500924|NCT01945775|8649224|P1|Overall Study|Withdrawal by Subject|7
2500925|NCT01945775|8649223|P2|Overall Study|Death|53
2500926|NCT01945775|8649224|P1|Overall Study|Death|107
2500927|NCT01945775|8649223|P2|Overall Study|On going|65
2500928|NCT01945775|8649224|P1|Overall Study|On going|166
2500929|NCT01945710|8649260|P7|Overall Study|Withdrawal by Subject|0
2500930|NCT01945710|8649261|P6|Overall Study|Withdrawal by Subject|0
2500931|NCT01945710|8649262|P5|Overall Study|Withdrawal by Subject|1
2500932|NCT01945710|8649263|P4|Overall Study|Withdrawal by Subject|0
2500933|NCT01945710|8649264|P3|Overall Study|Withdrawal by Subject|1
2500934|NCT01945710|8649265|P2|Overall Study|Withdrawal by Subject|1
2500935|NCT01945710|8649266|P1|Overall Study|Withdrawal by Subject|0
2500936|NCT01945710|8649260|P7|Overall Study|Other|4
2500937|NCT01945710|8649261|P6|Overall Study|Other|0
2500938|NCT01945710|8649262|P5|Overall Study|Other|1
2500939|NCT01945710|8649263|P4|Overall Study|Other|1
2500940|NCT01945710|8649264|P3|Overall Study|Other|3
2500941|NCT01945710|8649265|P2|Overall Study|Other|0
2500942|NCT01945710|8649266|P1|Overall Study|Other|2
2500943|NCT01945710|8649260|P7|Overall Study|Adverse Event|0
2500944|NCT01945710|8649261|P6|Overall Study|Adverse Event|0
2500945|NCT01945710|8649262|P5|Overall Study|Adverse Event|0
2500946|NCT01945710|8649263|P4|Overall Study|Adverse Event|0
2500947|NCT01945710|8649264|P3|Overall Study|Adverse Event|0
2500948|NCT01945710|8649265|P2|Overall Study|Adverse Event|1
2500949|NCT01945710|8649266|P1|Overall Study|Adverse Event|0
2500950|NCT01945710|8649260|P7|Overall Study|Progressive Disease|19
2500951|NCT01945710|8649261|P6|Overall Study|Progressive Disease|3
2500952|NCT01945710|8649262|P5|Overall Study|Progressive Disease|7
2500953|NCT01945710|8649263|P4|Overall Study|Progressive Disease|2
2500954|NCT01945710|8649264|P3|Overall Study|Progressive Disease|3
2500955|NCT01945710|8649265|P2|Overall Study|Progressive Disease|4
2500956|NCT01945710|8649266|P1|Overall Study|Progressive Disease|5
2500957|NCT01945593|8649385|P4|Overall Study|Other: Screen Failure|0
2500958|NCT01945593|8649386|P3|Overall Study|Other: Screen Failure|0
2500959|NCT01945593|8649387|P2|Overall Study|Other: Screen Failure|2
2500960|NCT01945593|8649388|P1|Overall Study|Other: Screen Failure|0
2500961|NCT01945593|8649385|P4|Overall Study|Other: Surgical Procedure|6
2500962|NCT01945593|8649386|P3|Overall Study|Other: Surgical Procedure|0
2500963|NCT01945593|8649387|P2|Overall Study|Other: Surgical Procedure|2
2500964|NCT01945593|8649388|P1|Overall Study|Other: Surgical Procedure|0
2500965|NCT01945593|8649385|P4|Overall Study|Other: Terminated|1
2500966|NCT01945593|8649386|P3|Overall Study|Other: Terminated|0
2500967|NCT01945593|8649387|P2|Overall Study|Other: Terminated|0
2500968|NCT01945593|8649388|P1|Overall Study|Other: Terminated|0
2500969|NCT01945593|8649385|P4|Overall Study|Death|0
2500970|NCT01945593|8649386|P3|Overall Study|Death|1
2500971|NCT01945593|8649387|P2|Overall Study|Death|0
2500972|NCT01945593|8649388|P1|Overall Study|Death|0
2500973|NCT01945593|8649385|P4|Overall Study|Protocol Violation|3
2500974|NCT01945593|8649386|P3|Overall Study|Protocol Violation|1
2500975|NCT01945593|8649387|P2|Overall Study|Protocol Violation|2
2500976|NCT01945593|8649388|P1|Overall Study|Protocol Violation|0
2500977|NCT01945593|8649385|P4|Overall Study|Withdrawal by Subject|4
2500978|NCT01945593|8649386|P3|Overall Study|Withdrawal by Subject|0
2500979|NCT01945593|8649387|P2|Overall Study|Withdrawal by Subject|2
2500980|NCT01945593|8649388|P1|Overall Study|Withdrawal by Subject|0
2500981|NCT01945593|8649385|P4|Overall Study|Physician Decision|1
2500982|NCT01945593|8649386|P3|Overall Study|Physician Decision|1
2500983|NCT01945593|8649387|P2|Overall Study|Physician Decision|0
2500984|NCT01945593|8649388|P1|Overall Study|Physician Decision|0
2500985|NCT01945593|8649385|P4|Overall Study|Adverse Event|5
2500986|NCT01945593|8649386|P3|Overall Study|Adverse Event|0
2500987|NCT01945593|8649387|P2|Overall Study|Adverse Event|0
2500988|NCT01945593|8649388|P1|Overall Study|Adverse Event|0
2500989|NCT01945489|8649470|P2|Cycle 2|Lost to Follow-up|1
2500990|NCT01945489|8649471|P1|Cycle 2|Lost to Follow-up|0
2500991|NCT01945489|8649470|P2|Cycle 2|Adverse Event|0
2500992|NCT01945489|8649471|P1|Cycle 2|Adverse Event|1
2500993|NCT01945489|8649470|P2|Cycle 1|Other Miscellaneous Reasons|1
2500994|NCT01945489|8649471|P1|Cycle 1|Other Miscellaneous Reasons|3
2500995|NCT01945489|8649470|P2|Cycle 1|Protocol Violation|1
2500996|NCT01945489|8649471|P1|Cycle 1|Protocol Violation|0
2500997|NCT01945489|8649470|P2|Cycle 1|Personal Reasons|2
2500998|NCT01945489|8649471|P1|Cycle 1|Personal Reasons|4
2500999|NCT01945489|8649470|P2|Cycle 1|Lost to Follow-up|0
2501000|NCT01945489|8649471|P1|Cycle 1|Lost to Follow-up|4
2501001|NCT01945489|8649470|P2|Cycle 1|Adverse Event|0
2501002|NCT01945489|8649471|P1|Cycle 1|Adverse Event|2
2501003|NCT01945281|8649525|P2|Overall Study|Technical Problems|0
2501004|NCT01945281|8649526|P1|Overall Study|Technical Problems|1
2501005|NCT01945281|8649525|P2|Overall Study|Physician Decision|1
2501006|NCT01945281|8649526|P1|Overall Study|Physician Decision|1
2501007|NCT01945281|8649525|P2|Overall Study|Death|3
2501008|NCT01945281|8649526|P1|Overall Study|Death|3
2501009|NCT01945281|8649525|P2|Overall Study|Adverse Event|0
2501010|NCT01945281|8649526|P1|Overall Study|Adverse Event|1
2501011|NCT01945242|8649538|P2|Overall Study|Physician Decision|3
2501012|NCT01945242|8649539|P1|Overall Study|Physician Decision|3
2501013|NCT01945216|8649554|P1|Overall Study|CRF not assured by investigators|5
2501014|NCT01945216|8649554|P1|Overall Study|Protocol Violation|42
2501015|NCT01945216|8649554|P1|Overall Study|Case report forms (CRF) uncollected|52
2501016|NCT01945086|8649612|P3|Overall Study|Adverse Event|1
2501017|NCT01945086|8649613|P2|Overall Study|Adverse Event|0
2501018|NCT01945086|8649614|P1|Overall Study|Adverse Event|0
2501019|NCT01945086|8649612|P3|Overall Study|Withdrawal by Subject|1
2501020|NCT01945086|8649613|P2|Overall Study|Withdrawal by Subject|0
2501021|NCT01945086|8649614|P1|Overall Study|Withdrawal by Subject|1
2501022|NCT01945034|8649658|P3|Overall Study|Protocol Violation|1
2501023|NCT01945034|8649659|P2|Overall Study|Protocol Violation|0
2501024|NCT01945034|8649660|P1|Overall Study|Protocol Violation|1
2501025|NCT01945034|8649658|P3|Overall Study|Lost to Follow-up|2
2501026|NCT01945034|8649659|P2|Overall Study|Lost to Follow-up|0
2501027|NCT01945034|8649660|P1|Overall Study|Lost to Follow-up|0
2501028|NCT01945034|8649658|P3|Overall Study|Other|3
2501029|NCT01945034|8649659|P2|Overall Study|Other|1
2501030|NCT01945034|8649660|P1|Overall Study|Other|0
2501031|NCT01945034|8649658|P3|Overall Study|Withdrawal by Subject|1
2501032|NCT01945034|8649659|P2|Overall Study|Withdrawal by Subject|3
2501033|NCT01945034|8649660|P1|Overall Study|Withdrawal by Subject|0
2501034|NCT01945034|8649658|P3|Overall Study|Medication Error|0
2501035|NCT01945034|8649659|P2|Overall Study|Medication Error|1
2501036|NCT01945034|8649660|P1|Overall Study|Medication Error|0
2501037|NCT01945021|8649710|P1|Overall Study|Non-RECIST disease progression|1
2501038|NCT01945021|8649710|P1|Overall Study|Withdrawal of consent|3
2501039|NCT01945021|8649710|P1|Overall Study|Withdrawal by Subject|2
2501040|NCT01945021|8649710|P1|Overall Study|Global deterioration of health-related s|1
2501041|NCT01945021|8649710|P1|Overall Study|Disease progression by RECIST v1.1|30
2501042|NCT01945021|8649710|P1|Overall Study|Pregnancy|1
2501043|NCT01945021|8649710|P1|Overall Study|Death|1
2501044|NCT01945021|8649710|P1|Overall Study|Adverse Event|8
2501045|NCT01944969|8649724|P1|Overall Study|Administrative or other reasons|23
2501046|NCT01944969|8649724|P1|Overall Study|Non-compliance with IMP|1
2501047|NCT01944969|8649724|P1|Overall Study|Lack of Efficacy|1
2501048|NCT01944969|8649724|P1|Overall Study|Adverse Event|1
2501049|NCT01944839|8649748|P2|Overall Study|Subject non-compliance|3
2501050|NCT01944839|8649749|P1|Overall Study|Subject non-compliance|0
2501051|NCT01944839|8649748|P2|Overall Study|Lost to Follow-up|0
2501052|NCT01944839|8649749|P1|Overall Study|Lost to Follow-up|1
2501053|NCT01944839|8649748|P2|Overall Study|Withdrawal by Subject|17
2501054|NCT01944839|8649749|P1|Overall Study|Withdrawal by Subject|9
2501055|NCT01944839|8649748|P2|Overall Study|Adverse Event|5
2501056|NCT01944839|8649749|P1|Overall Study|Adverse Event|10
2501057|NCT01944839|8649748|P2|Overall Study|Protocol Violation|1
2501058|NCT01944839|8649749|P1|Overall Study|Protocol Violation|0
2501059|NCT01944839|8649748|P2|Overall Study|Physician Decision|2
2501060|NCT01944839|8649749|P1|Overall Study|Physician Decision|2
2501061|NCT01944774|8649758|P3|Overall Study|Lost to Follow-up|0
2501062|NCT01944774|8649759|P2|Overall Study|Lost to Follow-up|1
2501063|NCT01944774|8649760|P1|Overall Study|Lost to Follow-up|0
2501064|NCT01944774|8649758|P3|Overall Study|Lack of Efficacy|2
2501065|NCT01944774|8649759|P2|Overall Study|Lack of Efficacy|2
2501066|NCT01944774|8649760|P1|Overall Study|Lack of Efficacy|1
2501067|NCT01944774|8649758|P3|Overall Study|Adverse Event|3
2501068|NCT01944774|8649759|P2|Overall Study|Adverse Event|2
2501069|NCT01944774|8649760|P1|Overall Study|Adverse Event|3
2501070|NCT01944774|8649758|P3|Overall Study|Withdrawal by Subject|3
2501071|NCT01944774|8649759|P2|Overall Study|Withdrawal by Subject|3
2501072|NCT01944774|8649760|P1|Overall Study|Withdrawal by Subject|2
2501073|NCT01944722|8649803|P1|Overall Study|>ASCUS Cytology|1122
2501074|NCT01944722|8649803|P1|Overall Study|Unsatisfactory Cytology Result|63
2501075|NCT01944722|8649803|P1|Overall Study|NILM Subjects <30 years old|8106
2501076|NCT01944722|8649803|P1|Overall Study|Withdrawal by Subject|8
2501077|NCT01944722|8649803|P1|Overall Study|Specimens Mislabeled|2
2501078|NCT01944722|8649803|P1|Overall Study|Missing Specimens|3
2501079|NCT01944722|8649803|P1|Overall Study|Insufficient Volume for Test|1
2501080|NCT01944722|8649803|P1|Overall Study|Improper Storage/Transport|5
2501081|NCT01944722|8649803|P1|Overall Study|Specimen Shipping Issues|34
2501082|NCT01944722|8649803|P1|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171
2501083|NCT01944670|8649837|P1|Overall Study|Lost to Follow-up|2
2501084|NCT01944631|8649859|P2|Overall Study|Withdrawal by Subject|1
2501085|NCT01944631|8649860|P1|Overall Study|Withdrawal by Subject|0
2501086|NCT01944631|8649859|P2|Overall Study|Lost to Follow-up|1
2501087|NCT01944631|8649860|P1|Overall Study|Lost to Follow-up|3
2501088|NCT01944631|8649859|P2|Overall Study|Adverse Event|0
2501089|NCT01944631|8649860|P1|Overall Study|Adverse Event|1
2501090|NCT01944462|8649876|P1|PPPP Educational Program|Lost to Follow-up|60
2501091|NCT01944098|8649917|P2|Overall Study|Physician Decision|0
2501092|NCT01944098|8649918|P1|Overall Study|Physician Decision|1
2501093|NCT01944059|8649930|P1|Overall Study|Adverse Event|2
2501094|NCT01944059|8649930|P1|Overall Study|Withdrawal by Subject|1
2501095|NCT01944059|8649930|P1|Overall Study|Physician Decision|3
2501096|NCT01944059|8649930|P1|Overall Study|Lost to Follow-up|1
2501097|NCT01943825|8649971|P4|Overall Study|Other than specified above|1
2501098|NCT01943825|8649972|P3|Overall Study|Other than specified above|0
2501099|NCT01943825|8649973|P2|Overall Study|Other than specified above|1
2501100|NCT01943825|8649974|P1|Overall Study|Other than specified above|0
2501101|NCT01943825|8649971|P4|Overall Study|Withdrawal by Subject|2
2501102|NCT01943825|8649972|P3|Overall Study|Withdrawal by Subject|3
2501103|NCT01943825|8649973|P2|Overall Study|Withdrawal by Subject|0
2501104|NCT01943825|8649974|P1|Overall Study|Withdrawal by Subject|1
2501105|NCT01943825|8649971|P4|Overall Study|Lost to Follow-up|8
2501106|NCT01943825|8649972|P3|Overall Study|Lost to Follow-up|12
2501107|NCT01943825|8649973|P2|Overall Study|Lost to Follow-up|3
2501108|NCT01943825|8649974|P1|Overall Study|Lost to Follow-up|9
2501109|NCT01943799|8650016|P4|Overall Study|Withdrawal by Subject|0
2501110|NCT01943799|8650017|P3|Overall Study|Withdrawal by Subject|1
2501111|NCT01943799|8650018|P2|Overall Study|Withdrawal by Subject|2
2501112|NCT01943799|8650019|P1|Overall Study|Withdrawal by Subject|4
2501113|NCT01943799|8650016|P4|Overall Study|Protocol Violation|0
2501114|NCT01943799|8650017|P3|Overall Study|Protocol Violation|0
2501115|NCT01943799|8650018|P2|Overall Study|Protocol Violation|0
2501116|NCT01943799|8650019|P1|Overall Study|Protocol Violation|1
2501117|NCT01943799|8650016|P4|Overall Study|Lost to Follow-up|0
2501118|NCT01943799|8650017|P3|Overall Study|Lost to Follow-up|1
2501119|NCT01943799|8650018|P2|Overall Study|Lost to Follow-up|1
2501120|NCT01943799|8650019|P1|Overall Study|Lost to Follow-up|0
2501121|NCT01943591|8650059|P2|Overall Study|Death|7
2501122|NCT01943591|8650060|P1|Overall Study|Death|2
2501123|NCT01943591|8650059|P2|Overall Study|Lost to Follow-up|4
2501124|NCT01943591|8650060|P1|Overall Study|Lost to Follow-up|3
2501125|NCT01943552|8650118|P2|Overall Study|Other Reasons|17
2501126|NCT01943552|8650119|P1|Overall Study|Other Reasons|16
2501127|NCT01943552|8650118|P2|Overall Study|Withdrawal by Subject|6
2501128|NCT01943552|8650119|P1|Overall Study|Withdrawal by Subject|6
2501129|NCT01943552|8650118|P2|Overall Study|Adverse Event|2
2501130|NCT01943552|8650119|P1|Overall Study|Adverse Event|3
2501131|NCT01943539|8650135|P2|Overall Study|Non-compliance with at-home intervention|0
2501132|NCT01943539|8650136|P1|Overall Study|Non-compliance with at-home intervention|4
2501133|NCT01943435|8650172|P3|6 Month Follow up|Lost to Follow-up|15
2501134|NCT01943435|8650173|P2|6 Month Follow up|Lost to Follow-up|7
2501135|NCT01943435|8650174|P1|6 Month Follow up|Lost to Follow-up|12
2501136|NCT01943435|8650172|P3|2 Month Follow up|Lost to Follow-up|0
2501137|NCT01943435|8650173|P2|2 Month Follow up|Lost to Follow-up|3
2501138|NCT01943435|8650174|P1|2 Month Follow up|Lost to Follow-up|2
2501139|NCT01943435|8650172|P3|Intervention Period|Withdrawal by Subject|4
2501140|NCT01943435|8650173|P2|Intervention Period|Withdrawal by Subject|3
2501141|NCT01943435|8650174|P1|Intervention Period|Withdrawal by Subject|3
2501142|NCT01943435|8650172|P3|Baseline Eligibility and Randomization|Withdrawal by Subject|3
2501143|NCT01943435|8650173|P2|Baseline Eligibility and Randomization|Withdrawal by Subject|12
2501144|NCT01943435|8650174|P1|Baseline Eligibility and Randomization|Withdrawal by Subject|4
2501145|NCT01943292|8650197|P3|Overall Study|Withdrawal by Subject|0
2501146|NCT01943292|8650198|P2|Overall Study|Withdrawal by Subject|0
2501147|NCT01943292|8650199|P1|Overall Study|Withdrawal by Subject|1
2501148|NCT01942785|8650235|P1|Overall Study|Protocol Violation|1
2501149|NCT01942785|8650235|P1|Overall Study|Withdrawal by Subject|1
2501150|NCT01942785|8650235|P1|Overall Study|Adverse Event|2
2501151|NCT01942733|8650264|P1|Overall Study|Administrative|1
2501152|NCT01942733|8650264|P1|Overall Study|Non-compliance with IMP|1
2501153|NCT01942733|8650264|P1|Overall Study|Lost to Follow-up|1
2501154|NCT01942590|8651382|P2|Overall Study|Adverse Event|0
2501155|NCT01942590|8651383|P1|Overall Study|Adverse Event|1
2501156|NCT01942590|8651382|P2|Overall Study|Withdrawal by Subject|1
2501157|NCT01942590|8651383|P1|Overall Study|Withdrawal by Subject|0
2501158|NCT01942486|8651413|P1|Overall Study|Lost to Follow-up|27
2501159|NCT01942161|8651420|P3|Overall Study|Withdrawal by Subject|1
2501160|NCT01942161|8651421|P2|Overall Study|Withdrawal by Subject|3
2501161|NCT01942161|8651422|P1|Overall Study|Withdrawal by Subject|3
2501162|NCT01942161|8651420|P3|Overall Study|Protocol Violation|0
2501163|NCT01942161|8651421|P2|Overall Study|Protocol Violation|0
2501164|NCT01942161|8651422|P1|Overall Study|Protocol Violation|1
2501165|NCT01942161|8651420|P3|Overall Study|Physician Decision|0
2501166|NCT01942161|8651421|P2|Overall Study|Physician Decision|1
2501167|NCT01942161|8651422|P1|Overall Study|Physician Decision|3
2501168|NCT01942161|8651420|P3|Overall Study|Adverse Event|5
2501169|NCT01942161|8651421|P2|Overall Study|Adverse Event|2
2501170|NCT01942161|8651422|P1|Overall Study|Adverse Event|1
2501171|NCT01942148|8651442|P1|Overall Study|Use of the prohibition medicine|1
2501172|NCT01942148|8651442|P1|Overall Study|Withdrawal by Subject|8
2501173|NCT01942148|8651442|P1|Overall Study|Protocol Violation|1
2501174|NCT01942148|8651442|P1|Overall Study|Physician Decision|11
2501175|NCT01942148|8651442|P1|Overall Study|Lack of Efficacy|2
2501176|NCT01942148|8651442|P1|Overall Study|Adverse Event|4
2501177|NCT01942135|8651450|P2|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75
2501178|NCT01942135|8651451|P1|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238
2501179|NCT01942135|8651450|P2|Overall Study|Withdrawal by Subject|2
2501180|NCT01942135|8651451|P1|Overall Study|Withdrawal by Subject|4
2501181|NCT01942135|8651450|P2|Overall Study|Participant Refused toContinue Treatment|1
2501182|NCT01942135|8651451|P1|Overall Study|Participant Refused toContinue Treatment|1
2501183|NCT01942135|8651450|P2|Overall Study|ObjectiveProgression+Progressive Disease|87
2501184|NCT01942135|8651451|P1|Overall Study|ObjectiveProgression+Progressive Disease|85
2501185|NCT01942135|8651450|P2|Overall Study|Death|1
2501186|NCT01942135|8651451|P1|Overall Study|Death|0
2501187|NCT01942135|8651450|P2|Overall Study|Randomized Not Treated|2
2501188|NCT01942135|8651451|P1|Overall Study|Randomized Not Treated|2
2501189|NCT01942135|8651450|P2|Overall Study|Global deterioration of health status|3
2501190|NCT01942135|8651451|P1|Overall Study|Global deterioration of health status|8
2501191|NCT01942135|8651450|P2|Overall Study|Adverse Event|3
2501192|NCT01942135|8651451|P1|Overall Study|Adverse Event|9
2501193|NCT01941940|8651488|P1|Overall Study|Other|1
2501194|NCT01941940|8651488|P1|Overall Study|Other|1
2501195|NCT01941940|8651488|P1|Overall Study|Death|1
2501196|NCT01941940|8651488|P1|Overall Study|Withdrawal by Subject|15
2501197|NCT01941940|8651488|P1|Overall Study|Physician Decision|2
2501198|NCT01941940|8651488|P1|Overall Study|Lost to Follow-up|2
2501199|NCT01941940|8651488|P1|Overall Study|Adverse Event|11
2501200|NCT01941537|8651596|P2|Overall Study|Withdrawal by Subject|1
2501201|NCT01941537|8651597|P1|Overall Study|Withdrawal by Subject|0
2501202|NCT01941537|8651596|P2|Overall Study|Adverse Event|0
2501203|NCT01941537|8651597|P1|Overall Study|Adverse Event|1
2501204|NCT01941537|8651596|P2|Overall Study|Pregnancy|0
2501205|NCT01941537|8651597|P1|Overall Study|Pregnancy|1
2501206|NCT01941537|8651596|P2|Overall Study|Lost to Follow-up|0
2501207|NCT01941537|8651597|P1|Overall Study|Lost to Follow-up|1
2501208|NCT01941537|8651596|P2|Overall Study|Lack of Efficacy|2
2501209|NCT01941537|8651597|P1|Overall Study|Lack of Efficacy|1
2501210|NCT01941498|8651609|P1|Overall Study|Relocated out of state|1
2501211|NCT01941186|8651727|P2|Follow-up|Lost to Follow-up|0
2501212|NCT01941186|8651728|P1|Follow-up|Lost to Follow-up|1
2501213|NCT01941095|8651754|P1|Overall Study|Lost to Follow-up|10
2501214|NCT01941095|8651754|P1|Overall Study|Withdrawal by Subject|17
2501215|NCT01941095|8651754|P1|Overall Study|Physician Decision|3
2501216|NCT01941095|8651754|P1|Overall Study|Adverse Event|11
2501217|NCT01941095|8651754|P1|Overall Study|Anaphylaxis or serious hypersensitivity|2
2501218|NCT01941095|8651754|P1|Overall Study|Insufficient therapeutic response|13
2501219|NCT01941030|8651779|P2|Overall Study|Withdrawal by Subject|6
2501220|NCT01941030|8651780|P1|Overall Study|Withdrawal by Subject|4
2501221|NCT01941030|8651779|P2|Overall Study|Lost to Follow-up|5
2501222|NCT01941030|8651780|P1|Overall Study|Lost to Follow-up|6
2501223|NCT01941030|8651779|P2|Overall Study|Death|2
2501224|NCT01941030|8651780|P1|Overall Study|Death|3
2501225|NCT01940939|8651802|P2|Overall Study|Withdrawal by Subject|8
2501226|NCT01940939|8651803|P1|Overall Study|Withdrawal by Subject|2
2501227|NCT01940900|8651815|P2|Overall Study|other|0
2501228|NCT01940900|8651816|P1|Overall Study|other|1
2501229|NCT01940900|8651815|P2|Overall Study|subject non-compliance|1
2501230|NCT01940900|8651816|P1|Overall Study|subject non-compliance|1
2501231|NCT01940900|8651815|P2|Overall Study|Sponsor Decision|0
2501232|NCT01940900|8651816|P1|Overall Study|Sponsor Decision|1
2501233|NCT01940900|8651815|P2|Overall Study|Lost to Follow-up|0
2501234|NCT01940900|8651816|P1|Overall Study|Lost to Follow-up|1
2501235|NCT01940900|8651815|P2|Overall Study|Withdrawal by Subject|15
2501236|NCT01940900|8651816|P1|Overall Study|Withdrawal by Subject|11
2501237|NCT01940900|8651815|P2|Overall Study|Adverse Event|15
2501238|NCT01940900|8651816|P1|Overall Study|Adverse Event|10
2501239|NCT01940900|8651815|P2|Overall Study|Physician Decision|0
2501240|NCT01940900|8651816|P1|Overall Study|Physician Decision|4
2501241|NCT01940705|8651826|P4|Overall Study|Withdrawal by team - hearing aid change|0
2501242|NCT01940705|8651827|P3|Overall Study|Withdrawal by team - hearing aid change|0
2501243|NCT01940705|8651828|P2|Overall Study|Withdrawal by team - hearing aid change|0
2501244|NCT01940705|8651829|P1|Overall Study|Withdrawal by team - hearing aid change|1
2501245|NCT01940705|8651826|P4|Overall Study|Intervention not given|0
2501246|NCT01940705|8651827|P3|Overall Study|Intervention not given|3
2501247|NCT01940705|8651828|P2|Overall Study|Intervention not given|3
2501248|NCT01940705|8651829|P1|Overall Study|Intervention not given|0
2501249|NCT01940705|8651826|P4|Overall Study|Withdrawal by Subject|2
2501250|NCT01940705|8651827|P3|Overall Study|Withdrawal by Subject|3
2501251|NCT01940705|8651828|P2|Overall Study|Withdrawal by Subject|2
2501252|NCT01940705|8651829|P1|Overall Study|Withdrawal by Subject|2
2501253|NCT01940705|8651826|P4|Overall Study|Lost to Follow-up|2
2501254|NCT01940705|8651827|P3|Overall Study|Lost to Follow-up|2
2501255|NCT01940705|8651828|P2|Overall Study|Lost to Follow-up|3
2501256|NCT01940705|8651829|P1|Overall Study|Lost to Follow-up|1
2501257|NCT01940497|8651893|P2|Overall Study|Administrative/Other|1
2501258|NCT01940497|8651894|P1|Overall Study|Administrative/Other|1
2501259|NCT01940497|8651893|P2|Overall Study|Withdrew Consent|2
2501260|NCT01940497|8651894|P1|Overall Study|Withdrew Consent|6
2501261|NCT01940497|8651893|P2|Overall Study|Refused Treatment|3
2501262|NCT01940497|8651894|P1|Overall Study|Refused Treatment|1
2501263|NCT01940497|8651893|P2|Overall Study|Violation of Entry Criteria|1
2501264|NCT01940497|8651894|P1|Overall Study|Violation of Entry Criteria|1
2501265|NCT01940497|8651893|P2|Overall Study|Recurrence of Disease Postsurgery|3
2501266|NCT01940497|8651894|P1|Overall Study|Recurrence of Disease Postsurgery|1
2501267|NCT01940497|8651893|P2|Overall Study|Adverse Event/Intercurrent Illness|8
2501268|NCT01940497|8651894|P1|Overall Study|Adverse Event/Intercurrent Illness|11
2501269|NCT01940484|8651935|P1|Overall Study|Adverse Event|1
2501270|NCT01940484|8651935|P1|Overall Study|Death|2
2501271|NCT01940484|8651935|P1|Overall Study|Underwent transplantation|4
2501272|NCT01940484|8651935|P1|Overall Study|Withdrawal by Subject|3
2501273|NCT01940471|8651955|P2|Open-Label Extension|Still in Open-Label Extension Phase|8
2501274|NCT01940471|8651956|P1|Open-Label Extension|Still in Open-Label Extension Phase|14
2501275|NCT01940471|8651955|P2|Double-Blind Phase|Still in Double-Blind Phase|270
2501276|NCT01940471|8651956|P1|Double-Blind Phase|Still in Double-Blind Phase|539
2501277|NCT01940471|8651955|P2|Double-Blind Phase|Protocol Violation|1
2501278|NCT01940471|8651956|P1|Double-Blind Phase|Protocol Violation|0
2501279|NCT01940471|8651955|P2|Double-Blind Phase|Lack of Efficacy|0
2501280|NCT01940471|8651956|P1|Double-Blind Phase|Lack of Efficacy|1
2501281|NCT01940471|8651955|P2|Double-Blind Phase|Death|0
2501282|NCT01940471|8651956|P1|Double-Blind Phase|Death|1
2501283|NCT01940471|8651955|P2|Double-Blind Phase|Protocol-Specified Criteria|0
2501284|NCT01940471|8651956|P1|Double-Blind Phase|Protocol-Specified Criteria|1
2501285|NCT01940471|8651955|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
2501286|NCT01940471|8651956|P1|Double-Blind Phase|Non-Compliance with Study Drug|1
2501287|NCT01940471|8651955|P2|Double-Blind Phase|Investigator's Discretion|0
2501288|NCT01940471|8651956|P1|Double-Blind Phase|Investigator's Discretion|5
2501289|NCT01940471|8651955|P2|Double-Blind Phase|Pregnancy|1
2501290|NCT01940471|8651956|P1|Double-Blind Phase|Pregnancy|2
2501291|NCT01940471|8651955|P2|Double-Blind Phase|Lost to Follow-up|2
2501292|NCT01940471|8651956|P1|Double-Blind Phase|Lost to Follow-up|3
2501293|NCT01940471|8651955|P2|Double-Blind Phase|Adverse Event|2
2501294|NCT01940471|8651956|P1|Double-Blind Phase|Adverse Event|1
2501295|NCT01940471|8651955|P2|Double-Blind Phase|Withdrew Consent|7
2501296|NCT01940471|8651956|P1|Double-Blind Phase|Withdrew Consent|13
2501297|NCT01940471|8651955|P2|Double-Blind Phase|Randomized but Never Treated|1
2501298|NCT01940471|8651956|P1|Double-Blind Phase|Randomized but Never Treated|1
2501299|NCT01940354|8651974|P2|Overall Study|Withdrawal by Subject|2
2501300|NCT01940354|8651975|P1|Overall Study|Withdrawal by Subject|4
2501301|NCT01940341|8651987|P2|Open-label Extension Phase|Still on Study|1
2501302|NCT01940341|8651988|P1|Open-label Extension Phase|Still on Study|4
2501303|NCT01940341|8651987|P2|Double-Blind Phase|Still on Double-Blind Treatment|132
2501304|NCT01940341|8651988|P1|Double-Blind Phase|Still on Double-Blind Treatment|269
2501305|NCT01940341|8651987|P2|Double-Blind Phase|Protocol Specified Criteria|0
2501306|NCT01940341|8651988|P1|Double-Blind Phase|Protocol Specified Criteria|1
2501307|NCT01940341|8651987|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
2501308|NCT01940341|8651988|P1|Double-Blind Phase|Non-Compliance with Study Drug|0
2501309|NCT01940341|8651987|P2|Double-Blind Phase|Investigator's Discretion|0
2501310|NCT01940341|8651988|P1|Double-Blind Phase|Investigator's Discretion|1
2501311|NCT01940341|8651987|P2|Double-Blind Phase|Pregnancy|1
2501312|NCT01940341|8651988|P1|Double-Blind Phase|Pregnancy|0
2501313|NCT01940341|8651987|P2|Double-Blind Phase|Lost to Follow-up|1
2501314|NCT01940341|8651988|P1|Double-Blind Phase|Lost to Follow-up|4
2501315|NCT01940341|8651987|P2|Double-Blind Phase|Withdrew Consent|2
2501316|NCT01940341|8651988|P1|Double-Blind Phase|Withdrew Consent|3
2501317|NCT01940341|8651987|P2|Double-Blind Phase|Adverse Event|2
2501318|NCT01940341|8651988|P1|Double-Blind Phase|Adverse Event|3
2501319|NCT01940341|8651987|P2|Double-Blind Phase|Randomized but Never Treated|1
2501320|NCT01940341|8651988|P1|Double-Blind Phase|Randomized but Never Treated|0
2501321|NCT01940120|8652019|P1|Overall Study|Withdrawal by Subject|8
2501322|NCT01940120|8652019|P1|Overall Study|Death|40
2501323|NCT01939977|8652175|P2|Overall Study|Did not receive study medication|1
2501324|NCT01939977|8652176|P1|Overall Study|Did not receive study medication|0
2501325|NCT01939977|8652175|P2|Overall Study|Did not meet inclusion criteria|0
2501326|NCT01939977|8652176|P1|Overall Study|Did not meet inclusion criteria|1
2501327|NCT01939977|8652175|P2|Overall Study|Withdrawal by Subject|2
2501328|NCT01939977|8652176|P1|Overall Study|Withdrawal by Subject|0
2501329|NCT01939977|8652175|P2|Overall Study|Physician Decision|1
2501330|NCT01939977|8652176|P1|Overall Study|Physician Decision|1
2501331|NCT01939977|8652175|P2|Overall Study|Lack of Efficacy|0
2501332|NCT01939977|8652176|P1|Overall Study|Lack of Efficacy|3
2501333|NCT01939977|8652175|P2|Overall Study|Adverse Event|3
2501334|NCT01939977|8652176|P1|Overall Study|Adverse Event|4
2501335|NCT01939899|8652223|P5|Phase 2|Disease Progression|1
2501336|NCT01939899|8652224|P4|Phase 2|Disease Progression|9
2501337|NCT01939899|8652225|P3|Phase 2|Disease Progression|0
2501338|NCT01939899|8652226|P2|Phase 2|Disease Progression|0
2501339|NCT01939899|8652227|P1|Phase 2|Disease Progression|0
2501340|NCT01939899|8652223|P5|Phase 2|Withdrawal by Subject|0
2501341|NCT01939899|8652224|P4|Phase 2|Withdrawal by Subject|2
2501342|NCT01939899|8652225|P3|Phase 2|Withdrawal by Subject|0
2501343|NCT01939899|8652226|P2|Phase 2|Withdrawal by Subject|0
2501344|NCT01939899|8652227|P1|Phase 2|Withdrawal by Subject|0
2501345|NCT01939899|8652223|P5|Lead-in Dose Finding Phase|Other|0
2501346|NCT01939899|8652224|P4|Lead-in Dose Finding Phase|Other|0
2501347|NCT01939899|8652225|P3|Lead-in Dose Finding Phase|Other|1
2501348|NCT01939899|8652226|P2|Lead-in Dose Finding Phase|Other|0
2501349|NCT01939899|8652227|P1|Lead-in Dose Finding Phase|Other|0
2501350|NCT01939899|8652223|P5|Lead-in Dose Finding Phase|Disease Progression|0
2501351|NCT01939899|8652224|P4|Lead-in Dose Finding Phase|Disease Progression|0
2501352|NCT01939899|8652225|P3|Lead-in Dose Finding Phase|Disease Progression|3
2501353|NCT01939899|8652226|P2|Lead-in Dose Finding Phase|Disease Progression|4
2501354|NCT01939899|8652227|P1|Lead-in Dose Finding Phase|Disease Progression|2
2501355|NCT01939899|8652223|P5|Lead-in Dose Finding Phase|Death|0
2501356|NCT01939899|8652224|P4|Lead-in Dose Finding Phase|Death|0
2501357|NCT01939899|8652225|P3|Lead-in Dose Finding Phase|Death|1
2501358|NCT01939899|8652226|P2|Lead-in Dose Finding Phase|Death|3
2501359|NCT01939899|8652227|P1|Lead-in Dose Finding Phase|Death|0
2501360|NCT01939548|8652274|P3|Overall Study|Did not complete follow-up|0
2501361|NCT01939548|8652275|P2|Overall Study|Did not complete follow-up|1
2501362|NCT01939548|8652276|P1|Overall Study|Did not complete follow-up|0
2501363|NCT01939548|8652274|P3|Overall Study|Participant withdrew consent|0
2501364|NCT01939548|8652275|P2|Overall Study|Participant withdrew consent|2
2501365|NCT01939548|8652276|P1|Overall Study|Participant withdrew consent|0
2501366|NCT01939548|8652274|P3|Overall Study|Participant unwilling to continue|0
2501367|NCT01939548|8652275|P2|Overall Study|Participant unwilling to continue|1
2501368|NCT01939548|8652276|P1|Overall Study|Participant unwilling to continue|0
2501369|NCT01939548|8652274|P3|Overall Study|Participant dropped|1
2501370|NCT01939548|8652275|P2|Overall Study|Participant dropped|0
2501371|NCT01939548|8652276|P1|Overall Study|Participant dropped|0
2501372|NCT01939548|8652274|P3|Overall Study|Death|1
2501373|NCT01939548|8652275|P2|Overall Study|Death|0
2501374|NCT01939548|8652276|P1|Overall Study|Death|0
2501375|NCT01939548|8652274|P3|Overall Study|Adverse Event|7
2501376|NCT01939548|8652275|P2|Overall Study|Adverse Event|9
2501377|NCT01939548|8652276|P1|Overall Study|Adverse Event|2
2501378|NCT01939548|8652274|P3|Overall Study|Lost to Follow-up|3
2501379|NCT01939548|8652275|P2|Overall Study|Lost to Follow-up|5
2501380|NCT01939548|8652276|P1|Overall Study|Lost to Follow-up|5
2501381|NCT01939548|8652274|P3|Overall Study|Protocol Violation|5
2501382|NCT01939548|8652275|P2|Overall Study|Protocol Violation|6
2501383|NCT01939548|8652276|P1|Overall Study|Protocol Violation|7
2501384|NCT01939548|8652274|P3|Overall Study|Withdrawal by Subject|1
2501385|NCT01939548|8652275|P2|Overall Study|Withdrawal by Subject|4
2501386|NCT01939548|8652276|P1|Overall Study|Withdrawal by Subject|4
2501387|NCT01939548|8652274|P3|Overall Study|Did Not Meet Entrance Criteria|0
2501388|NCT01939548|8652275|P2|Overall Study|Did Not Meet Entrance Criteria|0
2501389|NCT01939548|8652276|P1|Overall Study|Did Not Meet Entrance Criteria|1
2501390|NCT01939548|8652274|P3|Overall Study|Insufficient Clinical Response|0
2501391|NCT01939548|8652275|P2|Overall Study|Insufficient Clinical Response|0
2501392|NCT01939548|8652276|P1|Overall Study|Insufficient Clinical Response|1
2501393|NCT01939548|8652274|P3|Overall Study|Study Terminated by Sponsor|12
2501394|NCT01939548|8652275|P2|Overall Study|Study Terminated by Sponsor|19
2501395|NCT01939548|8652276|P1|Overall Study|Study Terminated by Sponsor|17
2501396|NCT01939548|8652274|P3|Overall Study|Non compliance|0
2501397|NCT01939548|8652275|P2|Overall Study|Non compliance|2
2501398|NCT01939548|8652276|P1|Overall Study|Non compliance|0
2501399|NCT01939496|8652350|P3|Overall Study|Other|1
2501400|NCT01939496|8652351|P2|Overall Study|Other|0
2501401|NCT01939496|8652352|P1|Overall Study|Other|2
2501402|NCT01939496|8652350|P3|Overall Study|Blood Pressure Withdrawal Criteria|0
2501403|NCT01939496|8652351|P2|Overall Study|Blood Pressure Withdrawal Criteria|1
2501404|NCT01939496|8652352|P1|Overall Study|Blood Pressure Withdrawal Criteria|0
2501405|NCT01939496|8652350|P3|Overall Study|Withdrawal by Subject|1
2501406|NCT01939496|8652351|P2|Overall Study|Withdrawal by Subject|1
2501407|NCT01939496|8652352|P1|Overall Study|Withdrawal by Subject|0
2501408|NCT01939496|8652350|P3|Overall Study|Protocol Violation|0
2501409|NCT01939496|8652351|P2|Overall Study|Protocol Violation|0
2501410|NCT01939496|8652352|P1|Overall Study|Protocol Violation|3
2501411|NCT01939496|8652350|P3|Overall Study|Physician Decision|0
2501412|NCT01939496|8652351|P2|Overall Study|Physician Decision|0
2501413|NCT01939496|8652352|P1|Overall Study|Physician Decision|1
2501414|NCT01939496|8652350|P3|Overall Study|Lost to Follow-up|0
2501415|NCT01939496|8652351|P2|Overall Study|Lost to Follow-up|1
2501416|NCT01939496|8652352|P1|Overall Study|Lost to Follow-up|1
2501417|NCT01939496|8652350|P3|Overall Study|Adverse Event|0
2501418|NCT01939496|8652351|P2|Overall Study|Adverse Event|0
2501419|NCT01939496|8652352|P1|Overall Study|Adverse Event|2
2501420|NCT01939366|8652422|P5|Overall Study|GCP non-compliance at site|3
2501421|NCT01939366|8652423|P4|Overall Study|GCP non-compliance at site|3
2501422|NCT01939366|8652424|P3|Overall Study|GCP non-compliance at site|2
2501423|NCT01939366|8652425|P2|Overall Study|GCP non-compliance at site|3
2501424|NCT01939366|8652426|P1|Overall Study|GCP non-compliance at site|2
2501425|NCT01939366|8652422|P5|Overall Study|Sponsor decision|2
2501426|NCT01939366|8652423|P4|Overall Study|Sponsor decision|0
2501427|NCT01939366|8652424|P3|Overall Study|Sponsor decision|0
2501428|NCT01939366|8652425|P2|Overall Study|Sponsor decision|0
2501429|NCT01939366|8652426|P1|Overall Study|Sponsor decision|0
2501430|NCT01939366|8652422|P5|Overall Study|Protocol Violation|0
2501431|NCT01939366|8652423|P4|Overall Study|Protocol Violation|1
2501432|NCT01939366|8652424|P3|Overall Study|Protocol Violation|0
2501433|NCT01939366|8652425|P2|Overall Study|Protocol Violation|0
2501434|NCT01939366|8652426|P1|Overall Study|Protocol Violation|0
2501435|NCT01939366|8652422|P5|Overall Study|Other|1
2501436|NCT01939366|8652423|P4|Overall Study|Other|2
2501437|NCT01939366|8652424|P3|Overall Study|Other|2
2501438|NCT01939366|8652425|P2|Overall Study|Other|0
2501439|NCT01939366|8652426|P1|Overall Study|Other|0
2501440|NCT01939366|8652422|P5|Overall Study|Inclusion criteria not met|1
2501441|NCT01939366|8652423|P4|Overall Study|Inclusion criteria not met|0
2501442|NCT01939366|8652424|P3|Overall Study|Inclusion criteria not met|1
2501443|NCT01939366|8652425|P2|Overall Study|Inclusion criteria not met|1
2501444|NCT01939366|8652426|P1|Overall Study|Inclusion criteria not met|0
2501445|NCT01939366|8652422|P5|Overall Study|Withdrawal by Subject|3
2501446|NCT01939366|8652423|P4|Overall Study|Withdrawal by Subject|2
2501447|NCT01939366|8652424|P3|Overall Study|Withdrawal by Subject|2
2501448|NCT01939366|8652425|P2|Overall Study|Withdrawal by Subject|0
2501449|NCT01939366|8652426|P1|Overall Study|Withdrawal by Subject|1
2501450|NCT01939366|8652422|P5|Overall Study|Lost to Follow-up|0
2501451|NCT01939366|8652423|P4|Overall Study|Lost to Follow-up|0
2501452|NCT01939366|8652424|P3|Overall Study|Lost to Follow-up|0
2501453|NCT01939366|8652425|P2|Overall Study|Lost to Follow-up|1
2501454|NCT01939366|8652426|P1|Overall Study|Lost to Follow-up|1
2501455|NCT01939366|8652422|P5|Overall Study|Lack of Efficacy|3
2501456|NCT01939366|8652423|P4|Overall Study|Lack of Efficacy|1
2501457|NCT01939366|8652424|P3|Overall Study|Lack of Efficacy|1
2501458|NCT01939366|8652425|P2|Overall Study|Lack of Efficacy|1
2501459|NCT01939366|8652426|P1|Overall Study|Lack of Efficacy|2
2501460|NCT01939366|8652422|P5|Overall Study|Adverse Event|5
2501461|NCT01939366|8652423|P4|Overall Study|Adverse Event|8
2501462|NCT01939366|8652424|P3|Overall Study|Adverse Event|30
2501463|NCT01939366|8652425|P2|Overall Study|Adverse Event|17
2501464|NCT01939366|8652426|P1|Overall Study|Adverse Event|8
2501465|NCT01939314|8652440|P2|Overall Study|Lost to Follow-up|6
2501466|NCT01939314|8652441|P1|Overall Study|Lost to Follow-up|5
2501467|NCT01939314|8652440|P2|Overall Study|Pregnancy|1
2501468|NCT01939314|8652441|P1|Overall Study|Pregnancy|0
2501469|NCT01939314|8652440|P2|Overall Study|Protocol Violation|0
2501470|NCT01939314|8652441|P1|Overall Study|Protocol Violation|1
2501471|NCT01939314|8652440|P2|Overall Study|Withdrawal by Subject|1
2501472|NCT01939314|8652441|P1|Overall Study|Withdrawal by Subject|3
2501473|NCT01939223|8652475|P2|Overall Study|Withdrawal by Subject|0
2501474|NCT01939223|8652476|P1|Overall Study|Withdrawal by Subject|6
2501475|NCT01939223|8652475|P2|Overall Study|Study stopped by Sponsor|7
2501476|NCT01939223|8652476|P1|Overall Study|Study stopped by Sponsor|5
2501477|NCT01939223|8652475|P2|Overall Study|Disease recurrence (radiological)|3
2501478|NCT01939223|8652476|P1|Overall Study|Disease recurrence (radiological)|1
2501479|NCT01939223|8652475|P2|Overall Study|AE not assoc. with disease recurrence|1
2501480|NCT01939223|8652476|P1|Overall Study|AE not assoc. with disease recurrence|1
2501481|NCT01939197|8652491|P7|Overall Study|Lost to Follow-up|2
2501482|NCT01939197|8652492|P6|Overall Study|Lost to Follow-up|1
2501483|NCT01939197|8652493|P5|Overall Study|Lost to Follow-up|3
2501484|NCT01939197|8652494|P4|Overall Study|Lost to Follow-up|1
2501485|NCT01939197|8652495|P3|Overall Study|Lost to Follow-up|0
2501486|NCT01939197|8652496|P2|Overall Study|Lost to Follow-up|1
2501487|NCT01939197|8652497|P1|Overall Study|Lost to Follow-up|0
2501488|NCT01939197|8652491|P7|Overall Study|Withdrawal by Subject|0
2501489|NCT01939197|8652492|P6|Overall Study|Withdrawal by Subject|0
2501490|NCT01939197|8652493|P5|Overall Study|Withdrawal by Subject|1
2501491|NCT01939197|8652494|P4|Overall Study|Withdrawal by Subject|0
2501492|NCT01939197|8652495|P3|Overall Study|Withdrawal by Subject|0
2501493|NCT01939197|8652496|P2|Overall Study|Withdrawal by Subject|0
2501494|NCT01939197|8652497|P1|Overall Study|Withdrawal by Subject|1
2501495|NCT01939002|8652568|P2|Overall Study|Other|2
2501496|NCT01939002|8652569|P1|Overall Study|Other|1
2501497|NCT01939002|8652568|P2|Overall Study|Withdrawal by Subject|3
2501498|NCT01939002|8652569|P1|Overall Study|Withdrawal by Subject|5
2501499|NCT01939002|8652568|P2|Overall Study|Adverse Event|13
2501500|NCT01939002|8652569|P1|Overall Study|Adverse Event|13
2501501|NCT01938846|8652645|P3|Overall Study|Other than listed|4
2501502|NCT01938846|8652646|P2|Overall Study|Other than listed|1
2501503|NCT01938846|8652647|P1|Overall Study|Other than listed|5
2501504|NCT01938846|8652645|P3|Overall Study|Withdrawal by Subject|1
2501505|NCT01938846|8652646|P2|Overall Study|Withdrawal by Subject|2
2501506|NCT01938846|8652647|P1|Overall Study|Withdrawal by Subject|2
2501507|NCT01938846|8652645|P3|Overall Study|Adverse Event|3
2501508|NCT01938846|8652646|P2|Overall Study|Adverse Event|4
2501509|NCT01938846|8652647|P1|Overall Study|Adverse Event|8
2501510|NCT01938846|8652645|P3|Overall Study|Progressive disease|16
2501511|NCT01938846|8652646|P2|Overall Study|Progressive disease|18
2501512|NCT01938846|8652647|P1|Overall Study|Progressive disease|26
2501513|NCT01938625|8652862|P2|Overall Study|Adverse Event|1
2501514|NCT01938625|8652863|P1|Overall Study|Adverse Event|0
2501515|NCT01938625|8652862|P2|Overall Study|Withdrawal by Subject|1
2501516|NCT01938625|8652863|P1|Overall Study|Withdrawal by Subject|0
2501517|NCT01938573|8652883|P2|Overall Study|Operation at other hospital|0
2501518|NCT01938573|8652884|P1|Overall Study|Operation at other hospital|1
2501519|NCT01938573|8652883|P2|Overall Study|Lack of Efficacy|0
2501520|NCT01938573|8652884|P1|Overall Study|Lack of Efficacy|1
2501521|NCT01938430|8652904|P14|Overall Study|Withdrew Consent|0
2501522|NCT01938430|8652905|P13|Overall Study|Withdrew Consent|0
2501523|NCT01938430|8652906|P12|Overall Study|Withdrew Consent|0
2501524|NCT01938430|8652907|P11|Overall Study|Withdrew Consent|0
2501525|NCT01938430|8652908|P10|Overall Study|Withdrew Consent|0
2501526|NCT01938430|8652909|P9|Overall Study|Withdrew Consent|1
2501527|NCT01938430|8652910|P8|Overall Study|Withdrew Consent|0
2501528|NCT01938430|8652911|P7|Overall Study|Withdrew Consent|0
2501529|NCT01938430|8652912|P6|Overall Study|Withdrew Consent|0
2501530|NCT01938430|8652913|P5|Overall Study|Withdrew Consent|0
2501531|NCT01938430|8652914|P4|Overall Study|Withdrew Consent|0
2501532|NCT01938430|8652915|P3|Overall Study|Withdrew Consent|0
2501533|NCT01938430|8652916|P2|Overall Study|Withdrew Consent|0
2501534|NCT01938430|8652917|P1|Overall Study|Withdrew Consent|0
2501535|NCT01938430|8652904|P14|Overall Study|Lost to Follow-up|0
2501536|NCT01938430|8652905|P13|Overall Study|Lost to Follow-up|0
2501537|NCT01938430|8652906|P12|Overall Study|Lost to Follow-up|0
2501538|NCT01938430|8652907|P11|Overall Study|Lost to Follow-up|0
2501539|NCT01938430|8652908|P10|Overall Study|Lost to Follow-up|0
2501540|NCT01938430|8652909|P9|Overall Study|Lost to Follow-up|0
2501541|NCT01938430|8652910|P8|Overall Study|Lost to Follow-up|0
2501542|NCT01938430|8652911|P7|Overall Study|Lost to Follow-up|0
2501543|NCT01938430|8652912|P6|Overall Study|Lost to Follow-up|1
2501544|NCT01938430|8652913|P5|Overall Study|Lost to Follow-up|0
2501545|NCT01938430|8652914|P4|Overall Study|Lost to Follow-up|0
2501546|NCT01938430|8652915|P3|Overall Study|Lost to Follow-up|1
2501547|NCT01938430|8652916|P2|Overall Study|Lost to Follow-up|0
2501548|NCT01938430|8652917|P1|Overall Study|Lost to Follow-up|0
2501549|NCT01938430|8652904|P14|Overall Study|Lack of Efficacy|0
2501550|NCT01938430|8652905|P13|Overall Study|Lack of Efficacy|0
2501551|NCT01938430|8652906|P12|Overall Study|Lack of Efficacy|1
2501552|NCT01938430|8652907|P11|Overall Study|Lack of Efficacy|2
2501553|NCT01938430|8652908|P10|Overall Study|Lack of Efficacy|0
2501554|NCT01938430|8652909|P9|Overall Study|Lack of Efficacy|1
2501555|NCT01938430|8652910|P8|Overall Study|Lack of Efficacy|0
2501556|NCT01938430|8652911|P7|Overall Study|Lack of Efficacy|0
2501557|NCT01938430|8652912|P6|Overall Study|Lack of Efficacy|0
2501558|NCT01938430|8652913|P5|Overall Study|Lack of Efficacy|0
2501559|NCT01938430|8652914|P4|Overall Study|Lack of Efficacy|1
2501560|NCT01938430|8652915|P3|Overall Study|Lack of Efficacy|1
2501561|NCT01938430|8652916|P2|Overall Study|Lack of Efficacy|1
2501562|NCT01938430|8652917|P1|Overall Study|Lack of Efficacy|3
2501563|NCT01938430|8652904|P14|Overall Study|Investigator's Discretion|0
2501564|NCT01938430|8652905|P13|Overall Study|Investigator's Discretion|0
2501565|NCT01938430|8652906|P12|Overall Study|Investigator's Discretion|0
2501566|NCT01938430|8652907|P11|Overall Study|Investigator's Discretion|0
2501567|NCT01938430|8652908|P10|Overall Study|Investigator's Discretion|0
2501568|NCT01938430|8652909|P9|Overall Study|Investigator's Discretion|0
2501569|NCT01938430|8652910|P8|Overall Study|Investigator's Discretion|0
2501570|NCT01938430|8652911|P7|Overall Study|Investigator's Discretion|0
2501571|NCT01938430|8652912|P6|Overall Study|Investigator's Discretion|0
2501572|NCT01938430|8652913|P5|Overall Study|Investigator's Discretion|0
2501573|NCT01938430|8652914|P4|Overall Study|Investigator's Discretion|0
2501574|NCT01938430|8652915|P3|Overall Study|Investigator's Discretion|1
2501575|NCT01938430|8652916|P2|Overall Study|Investigator's Discretion|0
2501576|NCT01938430|8652917|P1|Overall Study|Investigator's Discretion|0
2501577|NCT01938430|8652904|P14|Overall Study|Death|0
2501578|NCT01938430|8652905|P13|Overall Study|Death|0
2501579|NCT01938430|8652906|P12|Overall Study|Death|0
2501580|NCT01938430|8652907|P11|Overall Study|Death|0
2501581|NCT01938430|8652908|P10|Overall Study|Death|3
2501582|NCT01938430|8652909|P9|Overall Study|Death|2
2501583|NCT01938430|8652910|P8|Overall Study|Death|1
2501584|NCT01938430|8652911|P7|Overall Study|Death|1
2501585|NCT01938430|8652912|P6|Overall Study|Death|0
2501586|NCT01938430|8652913|P5|Overall Study|Death|0
2501587|NCT01938430|8652914|P4|Overall Study|Death|1
2501588|NCT01938430|8652915|P3|Overall Study|Death|2
2501589|NCT01938430|8652916|P2|Overall Study|Death|2
2501590|NCT01938430|8652917|P1|Overall Study|Death|1
2501591|NCT01938430|8652904|P14|Overall Study|Adverse Event|0
2501592|NCT01938430|8652905|P13|Overall Study|Adverse Event|0
2501593|NCT01938430|8652906|P12|Overall Study|Adverse Event|0
2501594|NCT01938430|8652907|P11|Overall Study|Adverse Event|0
2501595|NCT01938430|8652908|P10|Overall Study|Adverse Event|0
2501596|NCT01938430|8652909|P9|Overall Study|Adverse Event|0
2501597|NCT01938430|8652910|P8|Overall Study|Adverse Event|0
2501598|NCT01938430|8652911|P7|Overall Study|Adverse Event|1
2501599|NCT01938430|8652912|P6|Overall Study|Adverse Event|0
2501600|NCT01938430|8652913|P5|Overall Study|Adverse Event|0
2501601|NCT01938430|8652914|P4|Overall Study|Adverse Event|0
2501602|NCT01938430|8652915|P3|Overall Study|Adverse Event|0
2501603|NCT01938430|8652916|P2|Overall Study|Adverse Event|0
2501604|NCT01938430|8652917|P1|Overall Study|Adverse Event|0
2501605|NCT01938430|8652904|P14|Overall Study|Randomized but Not Treated|1
2501606|NCT01938430|8652905|P13|Overall Study|Randomized but Not Treated|0
2501607|NCT01938430|8652906|P12|Overall Study|Randomized but Not Treated|0
2501608|NCT01938430|8652907|P11|Overall Study|Randomized but Not Treated|1
2501609|NCT01938430|8652908|P10|Overall Study|Randomized but Not Treated|0
2501610|NCT01938430|8652909|P9|Overall Study|Randomized but Not Treated|0
2501611|NCT01938430|8652910|P8|Overall Study|Randomized but Not Treated|0
2501612|NCT01938430|8652911|P7|Overall Study|Randomized but Not Treated|0
2501613|NCT01938430|8652912|P6|Overall Study|Randomized but Not Treated|0
2501614|NCT01938430|8652913|P5|Overall Study|Randomized but Not Treated|0
2501615|NCT01938430|8652914|P4|Overall Study|Randomized but Not Treated|0
2501616|NCT01938430|8652915|P3|Overall Study|Randomized but Not Treated|0
2501617|NCT01938430|8652916|P2|Overall Study|Randomized but Not Treated|0
2501618|NCT01938430|8652917|P1|Overall Study|Randomized but Not Treated|0
2501619|NCT01938391|8653242|P1|12 Month Follow up|Withdrawal by Subject|1
2501620|NCT01938391|8653242|P1|12 Month Follow up|Physician Decision|1
2501621|NCT01938391|8653242|P1|6 Month Follow up|Withdrawal by Subject|1
2501622|NCT01938001|8653376|P2|Overall Study|Death|26
2501623|NCT01938001|8653377|P1|Overall Study|Death|16
2501624|NCT01938001|8653376|P2|Overall Study|Lost to Follow-up|3
2501625|NCT01938001|8653377|P1|Overall Study|Lost to Follow-up|1
2501626|NCT01938001|8653376|P2|Overall Study|Participant Moved|1
2501627|NCT01938001|8653377|P1|Overall Study|Participant Moved|0
2501628|NCT01938001|8653376|P2|Overall Study|Non-compliant|0
2501629|NCT01938001|8653377|P1|Overall Study|Non-compliant|1
2501630|NCT01938001|8653376|P2|Overall Study|Withdrawal by Subject|17
2501631|NCT01938001|8653377|P1|Overall Study|Withdrawal by Subject|25
2501632|NCT01937871|8653456|P3|Overall Study|Entry Criteria Not Met|1
2501633|NCT01937871|8653457|P2|Overall Study|Entry Criteria Not Met|2
2501634|NCT01937871|8653458|P1|Overall Study|Entry Criteria Not Met|1
2501635|NCT01937871|8653456|P3|Overall Study|Physician Decision|0
2501636|NCT01937871|8653457|P2|Overall Study|Physician Decision|1
2501637|NCT01937871|8653458|P1|Overall Study|Physician Decision|0
2501638|NCT01937871|8653456|P3|Overall Study|Withdrawal by Subject|4
2501639|NCT01937871|8653457|P2|Overall Study|Withdrawal by Subject|6
2501640|NCT01937871|8653458|P1|Overall Study|Withdrawal by Subject|9
2501641|NCT01937871|8653456|P3|Overall Study|Lost to Follow-up|4
2501642|NCT01937871|8653457|P2|Overall Study|Lost to Follow-up|2
2501643|NCT01937871|8653458|P1|Overall Study|Lost to Follow-up|8
2501644|NCT01937871|8653456|P3|Overall Study|Adverse Event|2
2501645|NCT01937871|8653457|P2|Overall Study|Adverse Event|6
2501646|NCT01937871|8653458|P1|Overall Study|Adverse Event|6
2501647|NCT01937715|8653534|P5|Overall Study|Other|0
2501648|NCT01937715|8653535|P4|Overall Study|Other|3
2501649|NCT01937715|8653536|P3|Overall Study|Other|0
2501650|NCT01937715|8653537|P2|Overall Study|Other|0
2501651|NCT01937715|8653538|P1|Overall Study|Other|0
2501652|NCT01937715|8653534|P5|Overall Study|Withdrawal by Subject|2
2501653|NCT01937715|8653535|P4|Overall Study|Withdrawal by Subject|0
2501654|NCT01937715|8653536|P3|Overall Study|Withdrawal by Subject|0
2501655|NCT01937715|8653537|P2|Overall Study|Withdrawal by Subject|1
2501656|NCT01937715|8653538|P1|Overall Study|Withdrawal by Subject|0
2501657|NCT01937715|8653534|P5|Overall Study|Death|0
2501658|NCT01937715|8653535|P4|Overall Study|Death|1
2501659|NCT01937715|8653536|P3|Overall Study|Death|0
2501660|NCT01937715|8653537|P2|Overall Study|Death|0
2501661|NCT01937715|8653538|P1|Overall Study|Death|0
2501662|NCT01937390|8653733|P1|Overall Study|Fail to return|21
2501663|NCT01937390|8653733|P1|Overall Study|Withdrawal by Subject|5
2501664|NCT01937390|8653733|P1|Overall Study|Lost to Follow-up|7
2501665|NCT01937390|8653733|P1|Overall Study|Death|2
2501666|NCT01937364|8653743|P2|Overall Study|Adverse Event|1
2501667|NCT01937364|8653744|P1|Overall Study|Adverse Event|2
2501668|NCT01937351|8653756|P2|Overall Study|Not treated w device, per protocol fail|0
2501669|NCT01937351|8653757|P1|Overall Study|Not treated w device, per protocol fail|4
2501670|NCT01937351|8653756|P2|Overall Study|Death|0
2501671|NCT01937351|8653757|P1|Overall Study|Death|1
2501672|NCT01937351|8653756|P2|Overall Study|Withdrawal by Subject|2
2501673|NCT01937351|8653757|P1|Overall Study|Withdrawal by Subject|4
2501674|NCT01937312|8653765|P2|Overall Study|Withdrawal of subject prior to treatment|1
2501675|NCT01937312|8653766|P1|Overall Study|Withdrawal of subject prior to treatment|1
2501676|NCT01937312|8653765|P2|Overall Study|Lack of Efficacy|1
2501677|NCT01937312|8653766|P1|Overall Study|Lack of Efficacy|0
2501678|NCT01937312|8653765|P2|Overall Study|Adverse Event|1
2501679|NCT01937312|8653766|P1|Overall Study|Adverse Event|10
2501680|NCT01937299|8653781|P2|Overall Study|Withdrawal by Subject|0
2501681|NCT01937299|8653782|P1|Overall Study|Withdrawal by Subject|1
2501682|NCT01937299|8653781|P2|Overall Study|Lack of Efficacy|4
2501683|NCT01937299|8653782|P1|Overall Study|Lack of Efficacy|0
2501684|NCT01937299|8653781|P2|Overall Study|Adverse Event|0
2501685|NCT01937299|8653782|P1|Overall Study|Adverse Event|13
2501686|NCT01937130|8653817|P4|Overall Study|Patient lost to FU due to death|0
2501687|NCT01937130|8653818|P3|Overall Study|Patient lost to FU due to death|0
2501688|NCT01937130|8653819|P2|Overall Study|Patient lost to FU due to death|0
2501689|NCT01937130|8653820|P1|Overall Study|Patient lost to FU due to death|2
2501690|NCT01937130|8653817|P4|Overall Study|Patients unable to swallow|0
2501691|NCT01937130|8653818|P3|Overall Study|Patients unable to swallow|0
2501692|NCT01937130|8653819|P2|Overall Study|Patients unable to swallow|1
2501693|NCT01937130|8653820|P1|Overall Study|Patients unable to swallow|0
2501694|NCT01937130|8653817|P4|Overall Study|Physician Decision|0
2501695|NCT01937130|8653818|P3|Overall Study|Physician Decision|0
2501696|NCT01937130|8653819|P2|Overall Study|Physician Decision|1
2501697|NCT01937130|8653820|P1|Overall Study|Physician Decision|0
2501698|NCT01937130|8653817|P4|Overall Study|Lost to Follow-up|0
2501699|NCT01937130|8653818|P3|Overall Study|Lost to Follow-up|2
2501700|NCT01937130|8653819|P2|Overall Study|Lost to Follow-up|0
2501701|NCT01937130|8653820|P1|Overall Study|Lost to Follow-up|2
2501702|NCT01937130|8653817|P4|Overall Study|Death|0
2501703|NCT01937130|8653818|P3|Overall Study|Death|1
2501704|NCT01937130|8653819|P2|Overall Study|Death|1
2501705|NCT01937130|8653820|P1|Overall Study|Death|1
2501706|NCT01937130|8653817|P4|Overall Study|Adverse Event|1
2501707|NCT01937130|8653818|P3|Overall Study|Adverse Event|0
2501708|NCT01937130|8653819|P2|Overall Study|Adverse Event|1
2501709|NCT01937130|8653820|P1|Overall Study|Adverse Event|0
2501710|NCT01937130|8653817|P4|Overall Study|Withdrawal by Subject|1
2501711|NCT01937130|8653818|P3|Overall Study|Withdrawal by Subject|0
2501712|NCT01937130|8653819|P2|Overall Study|Withdrawal by Subject|0
2501713|NCT01937130|8653820|P1|Overall Study|Withdrawal by Subject|0
2501714|NCT01937117|8653847|P1|Overall Study|Adverse Event|2
2501715|NCT01937117|8653847|P1|Overall Study|Physician Decision|4
2501716|NCT01937117|8653847|P1|Overall Study|Disease Progression|7
2501717|NCT01936974|8653862|P2|Overall Study|Physician Decision|5
2501718|NCT01936974|8653863|P1|Overall Study|Physician Decision|2
2501719|NCT01936870|8653893|P1|Overall Study|No Drug Administration|1
2501720|NCT01936870|8653893|P1|Overall Study|Protocol Violation|12
2501721|NCT01936870|8653893|P1|Overall Study|No Visit After Treatment|176
2501722|NCT01936649|8653930|P1|Overall Study|Other than specified above|5
2501723|NCT01936649|8653930|P1|Overall Study|Protocol Violation|2
2501724|NCT01936649|8653930|P1|Overall Study|Physician Decision|2
2501725|NCT01936649|8653930|P1|Overall Study|Withdrawal by Subject|4
2501726|NCT01936623|8653937|P2|Overall Study|Lost to Follow-up|5
2501727|NCT01936623|8653938|P1|Overall Study|Lost to Follow-up|0
2501728|NCT01936181|8654046|P4|Transition-extension|Withdrawal by Subject|1
2501729|NCT01936181|8654047|P3|Transition-extension|Withdrawal by Subject|2
2501730|NCT01936181|8654048|P2|Transition-extension|Withdrawal by Subject|0
2501731|NCT01936181|8654049|P1|Transition-extension|Withdrawal by Subject|7
2501732|NCT01936181|8654046|P4|Transition-extension|Physician Decision|1
2501733|NCT01936181|8654047|P3|Transition-extension|Physician Decision|0
2501734|NCT01936181|8654048|P2|Transition-extension|Physician Decision|0
2501735|NCT01936181|8654049|P1|Transition-extension|Physician Decision|2
2501736|NCT01936181|8654046|P4|Transition-extension|Lost to Follow-up|2
2501737|NCT01936181|8654047|P3|Transition-extension|Lost to Follow-up|1
2501738|NCT01936181|8654048|P2|Transition-extension|Lost to Follow-up|0
2501739|NCT01936181|8654049|P1|Transition-extension|Lost to Follow-up|3
2501740|NCT01936181|8654046|P4|Transition-extension|Adverse Event|1
2501741|NCT01936181|8654047|P3|Transition-extension|Adverse Event|3
2501742|NCT01936181|8654048|P2|Transition-extension|Adverse Event|0
2501743|NCT01936181|8654049|P1|Transition-extension|Adverse Event|3
2501744|NCT01936181|8654046|P4|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
2501745|NCT01936181|8654047|P3|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
2501746|NCT01936181|8654048|P2|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
2501747|NCT01936181|8654049|P1|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
2501748|NCT01936181|8654046|P4|Randomised, Double-blind|Withdrawal by Subject|0
2501749|NCT01936181|8654047|P3|Randomised, Double-blind|Withdrawal by Subject|0
2501750|NCT01936181|8654048|P2|Randomised, Double-blind|Withdrawal by Subject|26
2501751|NCT01936181|8654049|P1|Randomised, Double-blind|Withdrawal by Subject|23
2501752|NCT01936181|8654046|P4|Randomised, Double-blind|Physician Decision|0
2501753|NCT01936181|8654047|P3|Randomised, Double-blind|Physician Decision|0
2501754|NCT01936181|8654048|P2|Randomised, Double-blind|Physician Decision|4
2501755|NCT01936181|8654049|P1|Randomised, Double-blind|Physician Decision|4
2501756|NCT01936181|8654046|P4|Randomised, Double-blind|Pregnancy|0
2501757|NCT01936181|8654047|P3|Randomised, Double-blind|Pregnancy|0
2501758|NCT01936181|8654048|P2|Randomised, Double-blind|Pregnancy|1
2501759|NCT01936181|8654049|P1|Randomised, Double-blind|Pregnancy|0
2501760|NCT01936181|8654046|P4|Randomised, Double-blind|Lost to Follow-up|0
2501761|NCT01936181|8654047|P3|Randomised, Double-blind|Lost to Follow-up|0
2501762|NCT01936181|8654048|P2|Randomised, Double-blind|Lost to Follow-up|1
2501763|NCT01936181|8654049|P1|Randomised, Double-blind|Lost to Follow-up|0
2501764|NCT01936181|8654046|P4|Randomised, Double-blind|Lack of Efficacy|0
2501765|NCT01936181|8654047|P3|Randomised, Double-blind|Lack of Efficacy|0
2501766|NCT01936181|8654048|P2|Randomised, Double-blind|Lack of Efficacy|6
2501767|NCT01936181|8654049|P1|Randomised, Double-blind|Lack of Efficacy|5
2501768|NCT01936181|8654046|P4|Randomised, Double-blind|Protocol Violation|0
2501769|NCT01936181|8654047|P3|Randomised, Double-blind|Protocol Violation|0
2501770|NCT01936181|8654048|P2|Randomised, Double-blind|Protocol Violation|5
2501771|NCT01936181|8654049|P1|Randomised, Double-blind|Protocol Violation|1
2501772|NCT01936181|8654046|P4|Randomised, Double-blind|Adverse Event|0
2501773|NCT01936181|8654047|P3|Randomised, Double-blind|Adverse Event|0
2501774|NCT01936181|8654048|P2|Randomised, Double-blind|Adverse Event|21
2501775|NCT01936181|8654049|P1|Randomised, Double-blind|Adverse Event|27
2501776|NCT01935947|8654063|P3|Overall Study|Death|0
2501777|NCT01935947|8654064|P2|Overall Study|Death|0
2501778|NCT01935947|8654065|P1|Overall Study|Death|1
2501779|NCT01935947|8654063|P3|Overall Study|Diease Progression|2
2501780|NCT01935947|8654064|P2|Overall Study|Diease Progression|2
2501781|NCT01935947|8654065|P1|Overall Study|Diease Progression|2
2501782|NCT01935947|8654063|P3|Overall Study|Adverse Event|0
2501783|NCT01935947|8654064|P2|Overall Study|Adverse Event|2
2501784|NCT01935947|8654065|P1|Overall Study|Adverse Event|0
2501785|NCT01934894|8654124|P2|Overall Study|Progressive Disease|2
2501786|NCT01934894|8654125|P1|Overall Study|Progressive Disease|3
2501787|NCT01934894|8654124|P2|Overall Study|Withdrawal by Subject|1
2501788|NCT01934894|8654125|P1|Overall Study|Withdrawal by Subject|0
2501789|NCT01934894|8654124|P2|Overall Study|Death|0
2501790|NCT01934894|8654125|P1|Overall Study|Death|2
2501791|NCT01934894|8654124|P2|Overall Study|Adverse Event|2
2501792|NCT01934894|8654125|P1|Overall Study|Adverse Event|1
2501793|NCT01934790|8654140|P1|Active Follow up|Other reason|1
2501794|NCT01934790|8654140|P1|Active Follow up|Progressive disease|1
2501795|NCT01934790|8654140|P1|Active Follow up|Physician Decision|2
2501796|NCT01934790|8654140|P1|Active Follow up|Death|20
2501797|NCT01934790|8654140|P1|Treatment|Study drug never administered|1
2501798|NCT01934790|8654140|P1|Treatment|Withdrawal by Subject|2
2501799|NCT01934790|8654140|P1|Treatment|Radiological progression|4
2501800|NCT01934790|8654140|P1|Treatment|Clinical progression|6
2501801|NCT01934790|8654140|P1|Treatment|Adverse Event|3
2501802|NCT01934504|8654207|P4|Overall Study|Study Terminated by Sponsor|5
2501803|NCT01934504|8654208|P3|Overall Study|Study Terminated by Sponsor|5
2501804|NCT01934504|8654209|P2|Overall Study|Study Terminated by Sponsor|0
2501805|NCT01934504|8654210|P1|Overall Study|Study Terminated by Sponsor|1
2501806|NCT01934504|8654207|P4|Overall Study|Protocol Deviation|2
2501807|NCT01934504|8654208|P3|Overall Study|Protocol Deviation|0
2501808|NCT01934504|8654209|P2|Overall Study|Protocol Deviation|0
2501809|NCT01934504|8654210|P1|Overall Study|Protocol Deviation|0
2501810|NCT01934218|8654243|P2|Open-Label Phase|Failure to Exam Primary Evaluation|1
2501811|NCT01934218|8654244|P1|Open-Label Phase|Failure to Exam Primary Evaluation|0
2501812|NCT01934218|8654243|P2|Open-Label Phase|Noncompliance with Study Protocol|2
2501813|NCT01934218|8654244|P1|Open-Label Phase|Noncompliance with Study Protocol|4
2501814|NCT01934218|8654243|P2|Open-Label Phase|Withdrawal by Subject|11
2501815|NCT01934218|8654244|P1|Open-Label Phase|Withdrawal by Subject|13
2501816|NCT01934218|8654243|P2|Open-Label Phase|Protocol Violation|0
2501817|NCT01934218|8654244|P1|Open-Label Phase|Protocol Violation|1
2501818|NCT01934218|8654243|P2|Open-Label Phase|Physician Decision|0
2501819|NCT01934218|8654244|P1|Open-Label Phase|Physician Decision|1
2501820|NCT01934218|8654243|P2|Open-Label Phase|Lost to Follow-up|2
2501821|NCT01934218|8654244|P1|Open-Label Phase|Lost to Follow-up|4
2501822|NCT01934218|8654243|P2|Open-Label Phase|Lack of Efficacy|4
2501823|NCT01934218|8654244|P1|Open-Label Phase|Lack of Efficacy|1
2501824|NCT01934218|8654243|P2|Open-Label Phase|Adverse Event|4
2501825|NCT01934218|8654244|P1|Open-Label Phase|Adverse Event|2
2501826|NCT01934218|8654243|P2|Double-blind Phase|Protocol Violation of Study Eligibility|2
2501827|NCT01934218|8654244|P1|Double-blind Phase|Protocol Violation of Study Eligibility|1
2501828|NCT01934218|8654243|P2|Double-blind Phase|Noncompliance with Study Protocol|8
2501829|NCT01934218|8654244|P1|Double-blind Phase|Noncompliance with Study Protocol|5
2501830|NCT01934218|8654243|P2|Double-blind Phase|Withdrawal by Subject|13
2501831|NCT01934218|8654244|P1|Double-blind Phase|Withdrawal by Subject|16
2501832|NCT01934218|8654243|P2|Double-blind Phase|Protocol Violation|0
2501833|NCT01934218|8654244|P1|Double-blind Phase|Protocol Violation|4
2501834|NCT01934218|8654243|P2|Double-blind Phase|Physician Decision|2
2501835|NCT01934218|8654244|P1|Double-blind Phase|Physician Decision|1
2501836|NCT01934218|8654243|P2|Double-blind Phase|Lost to Follow-up|14
2501837|NCT01934218|8654244|P1|Double-blind Phase|Lost to Follow-up|7
2501838|NCT01934218|8654243|P2|Double-blind Phase|Lack of Efficacy|7
2501839|NCT01934218|8654244|P1|Double-blind Phase|Lack of Efficacy|6
2501840|NCT01934218|8654243|P2|Double-blind Phase|Adverse Event|8
2501841|NCT01934218|8654244|P1|Double-blind Phase|Adverse Event|8
2501842|NCT01934192|8654255|P4|Overall Study|Physician Decision|0
2501843|NCT01934192|8654256|P3|Overall Study|Physician Decision|0
2501844|NCT01934192|8654257|P2|Overall Study|Physician Decision|2
2501845|NCT01934192|8654258|P1|Overall Study|Physician Decision|3
2501846|NCT01934192|8654255|P4|Overall Study|Other: reached stopping criteria|0
2501847|NCT01934192|8654256|P3|Overall Study|Other: reached stopping criteria|1
2501848|NCT01934192|8654257|P2|Overall Study|Other: reached stopping criteria|5
2501849|NCT01934192|8654258|P1|Overall Study|Other: reached stopping criteria|6
2501850|NCT01934192|8654255|P4|Overall Study|Protocol Violation|1
2501851|NCT01934192|8654256|P3|Overall Study|Protocol Violation|0
2501852|NCT01934192|8654257|P2|Overall Study|Protocol Violation|0
2501853|NCT01934192|8654258|P1|Overall Study|Protocol Violation|0
2501854|NCT01934140|8654394|P2|Booster Phase (6 Months)|Migrated/moved from study area|2
2501855|NCT01934140|8654395|P1|Booster Phase (6 Months)|Migrated/moved from study area|2
2501856|NCT01934140|8654394|P2|Booster Phase (6 Months)|Missed at least 1 booster visit|1
2501857|NCT01934140|8654395|P1|Booster Phase (6 Months)|Missed at least 1 booster visit|2
2501858|NCT01934140|8654394|P2|Booster Phase (6 Months)|Lost to Follow-up|0
2501859|NCT01934140|8654395|P1|Booster Phase (6 Months)|Lost to Follow-up|1
2501860|NCT01934140|8654394|P2|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7
2501861|NCT01934140|8654395|P1|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21
2501862|NCT01934140|8654394|P2|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0
2501863|NCT01934140|8654395|P1|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2
2501864|NCT01934140|8654394|P2|Persistence Phase (Year 6-10)|Migrated/moved from study area|10
2501865|NCT01934140|8654395|P1|Persistence Phase (Year 6-10)|Migrated/moved from study area|31
2501866|NCT01934140|8654394|P2|Persistence Phase (Year 6-10)|Lost to Follow-up|2
2501867|NCT01934140|8654395|P1|Persistence Phase (Year 6-10)|Lost to Follow-up|5
2501868|NCT01934140|8654394|P2|Persistence Phase (Year 6-10)|Other|6
2501869|NCT01934140|8654395|P1|Persistence Phase (Year 6-10)|Other|24
2501870|NCT01934010|8654446|P3|Overall Study|Lost to Follow-up|0
2501871|NCT01934010|8654447|P2|Overall Study|Lost to Follow-up|4
2501872|NCT01934010|8654448|P1|Overall Study|Lost to Follow-up|7
2501873|NCT01934010|8654446|P3|Overall Study|Withdrawal by Subject|2
2501874|NCT01934010|8654447|P2|Overall Study|Withdrawal by Subject|6
2501875|NCT01934010|8654448|P1|Overall Study|Withdrawal by Subject|15
2501876|NCT01934010|8654446|P3|Overall Study|Adverse Event|0
2501877|NCT01934010|8654447|P2|Overall Study|Adverse Event|1
2501878|NCT01934010|8654448|P1|Overall Study|Adverse Event|1
2501879|NCT01933932|8654490|P2|Overall Study|Eligibility criteria not fulfilled|1
2501880|NCT01933932|8654491|P1|Overall Study|Eligibility criteria not fulfilled|0
2501881|NCT01933932|8654490|P2|Overall Study|Withdrawal by Subject|14
2501882|NCT01933932|8654491|P1|Overall Study|Withdrawal by Subject|11
2501883|NCT01933932|8654490|P2|Overall Study|Death|163
2501884|NCT01933932|8654491|P1|Overall Study|Death|173
2501885|NCT01933919|8654509|P2|Open-label Long-term Phase|Other|2
2501886|NCT01933919|8654510|P1|Open-label Long-term Phase|Other|1
2501887|NCT01933919|8654509|P2|Open-label Long-term Phase|Lost to Follow-up|0
2501888|NCT01933919|8654510|P1|Open-label Long-term Phase|Lost to Follow-up|1
2501889|NCT01933919|8654509|P2|Open-label Long-term Phase|Withdrawal by Subject|4
2501890|NCT01933919|8654510|P1|Open-label Long-term Phase|Withdrawal by Subject|3
2501891|NCT01933919|8654509|P2|Open-label Long-term Phase|Adverse Event|0
2501892|NCT01933919|8654510|P1|Open-label Long-term Phase|Adverse Event|2
2501893|NCT01933919|8654509|P2|Double-blind Placebo-controlled Phase|Lack of Efficacy|2
2501894|NCT01933919|8654510|P1|Double-blind Placebo-controlled Phase|Lack of Efficacy|0
2501895|NCT01933919|8654509|P2|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1
2501896|NCT01933919|8654510|P1|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0
2501897|NCT01933919|8654509|P2|Double-blind Placebo-controlled Phase|Adverse Event|1
2501898|NCT01933919|8654510|P1|Double-blind Placebo-controlled Phase|Adverse Event|0
2501899|NCT01933880|8654546|P2|Overall Study|Protocol Violation|0
2501900|NCT01933880|8654547|P1|Overall Study|Protocol Violation|1
2501901|NCT01933880|8654546|P2|Overall Study|Other|0
2501902|NCT01933880|8654547|P1|Overall Study|Other|4
2501903|NCT01933880|8654546|P2|Overall Study|Followup exceeded 4 days to visit window|0
2501904|NCT01933880|8654547|P1|Overall Study|Followup exceeded 4 days to visit window|19
2501905|NCT01933880|8654546|P2|Overall Study|Concomitant medication Interference|1
2501906|NCT01933880|8654547|P1|Overall Study|Concomitant medication Interference|0
2501907|NCT01933880|8654546|P2|Overall Study|Lack of Efficacy|0
2501908|NCT01933880|8654547|P1|Overall Study|Lack of Efficacy|1
2501909|NCT01933880|8654546|P2|Overall Study|Withdrawal by Subject|0
2501910|NCT01933880|8654547|P1|Overall Study|Withdrawal by Subject|5
2501911|NCT01933789|8654621|P9|Overall Study|Became Ineligible|0
2501912|NCT01933789|8654622|P8|Overall Study|Became Ineligible|6
2501913|NCT01933789|8654623|P7|Overall Study|Became Ineligible|13
2501914|NCT01933789|8654624|P6|Overall Study|Became Ineligible|10
2501915|NCT01933789|8654625|P5|Overall Study|Became Ineligible|13
2501916|NCT01933789|8654626|P4|Overall Study|Became Ineligible|0
2501917|NCT01933789|8654627|P3|Overall Study|Became Ineligible|0
2501918|NCT01933789|8654628|P2|Overall Study|Became Ineligible|0
2501919|NCT01933789|8654629|P1|Overall Study|Became Ineligible|4
2501920|NCT01933789|8654621|P9|Overall Study|Withdrawal by Subject|0
2501921|NCT01933789|8654622|P8|Overall Study|Withdrawal by Subject|4
2501922|NCT01933789|8654623|P7|Overall Study|Withdrawal by Subject|1
2501923|NCT01933789|8654624|P6|Overall Study|Withdrawal by Subject|16
2501924|NCT01933789|8654625|P5|Overall Study|Withdrawal by Subject|17
2501925|NCT01933789|8654626|P4|Overall Study|Withdrawal by Subject|0
2501926|NCT01933789|8654627|P3|Overall Study|Withdrawal by Subject|0
2501927|NCT01933789|8654628|P2|Overall Study|Withdrawal by Subject|1
2501928|NCT01933789|8654629|P1|Overall Study|Withdrawal by Subject|2
2501929|NCT01933789|8654621|P9|Overall Study|Lost to Follow-up|0
2501930|NCT01933789|8654622|P8|Overall Study|Lost to Follow-up|4
2501931|NCT01933789|8654623|P7|Overall Study|Lost to Follow-up|1
2501932|NCT01933789|8654624|P6|Overall Study|Lost to Follow-up|9
2501933|NCT01933789|8654625|P5|Overall Study|Lost to Follow-up|8
2501934|NCT01933789|8654626|P4|Overall Study|Lost to Follow-up|1
2501935|NCT01933789|8654627|P3|Overall Study|Lost to Follow-up|0
2501936|NCT01933789|8654628|P2|Overall Study|Lost to Follow-up|0
2501937|NCT01933789|8654629|P1|Overall Study|Lost to Follow-up|0
2501938|NCT01933789|8654621|P9|Overall Study|Death|0
2501939|NCT01933789|8654622|P8|Overall Study|Death|0
2501940|NCT01933789|8654623|P7|Overall Study|Death|0
2501941|NCT01933789|8654624|P6|Overall Study|Death|32
2501942|NCT01933789|8654625|P5|Overall Study|Death|21
2501943|NCT01933789|8654626|P4|Overall Study|Death|0
2501944|NCT01933789|8654627|P3|Overall Study|Death|0
2501945|NCT01933789|8654628|P2|Overall Study|Death|0
2501946|NCT01933789|8654629|P1|Overall Study|Death|0
2501947|NCT01933672|8654939|P7|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
2501948|NCT01933672|8654940|P6|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
2501949|NCT01933672|8654941|P5|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
2501950|NCT01933672|8654942|P4|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
2501951|NCT01933672|8654943|P3|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
2501952|NCT01933672|8654944|P2|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1
2501953|NCT01933672|8654945|P1|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
2501954|NCT01933672|8654939|P7|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
2501955|NCT01933672|8654940|P6|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
2501956|NCT01933672|8654941|P5|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
2501957|NCT01933672|8654942|P4|Third Intervention Period (12-16 Days)|Lost to Follow-up|1
2501958|NCT01933672|8654943|P3|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
2501959|NCT01933672|8654944|P2|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
2501960|NCT01933672|8654945|P1|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
2501961|NCT01933672|8654939|P7|Second Intervention Period (12-16 Days)|Other|0
2501962|NCT01933672|8654940|P6|Second Intervention Period (12-16 Days)|Other|0
2501963|NCT01933672|8654941|P5|Second Intervention Period (12-16 Days)|Other|0
2501964|NCT01933672|8654942|P4|Second Intervention Period (12-16 Days)|Other|0
2501965|NCT01933672|8654943|P3|Second Intervention Period (12-16 Days)|Other|1
2501966|NCT01933672|8654944|P2|Second Intervention Period (12-16 Days)|Other|1
2501967|NCT01933672|8654945|P1|Second Intervention Period (12-16 Days)|Other|0
2501968|NCT01933672|8654939|P7|First Intervention Period (12-16 Days)|Other|0
2501969|NCT01933672|8654940|P6|First Intervention Period (12-16 Days)|Other|1
2501970|NCT01933672|8654941|P5|First Intervention Period (12-16 Days)|Other|0
2501971|NCT01933672|8654942|P4|First Intervention Period (12-16 Days)|Other|0
2501972|NCT01933672|8654943|P3|First Intervention Period (12-16 Days)|Other|1
2501973|NCT01933672|8654944|P2|First Intervention Period (12-16 Days)|Other|0
2501974|NCT01933672|8654945|P1|First Intervention Period (12-16 Days)|Other|0
2501975|NCT01933672|8654939|P7|First Intervention Period (12-16 Days)|Lost to Follow-up|0
2501976|NCT01933672|8654940|P6|First Intervention Period (12-16 Days)|Lost to Follow-up|0
2501977|NCT01933672|8654941|P5|First Intervention Period (12-16 Days)|Lost to Follow-up|1
2501978|NCT01933672|8654942|P4|First Intervention Period (12-16 Days)|Lost to Follow-up|0
2501979|NCT01933672|8654943|P3|First Intervention Period (12-16 Days)|Lost to Follow-up|0
2501980|NCT01933672|8654944|P2|First Intervention Period (12-16 Days)|Lost to Follow-up|0
2501981|NCT01933672|8654945|P1|First Intervention Period (12-16 Days)|Lost to Follow-up|0
2501982|NCT01933672|8654939|P7|Metformin Run-in Period|Other|0
2501983|NCT01933672|8654940|P6|Metformin Run-in Period|Other|0
2501984|NCT01933672|8654941|P5|Metformin Run-in Period|Other|0
2501985|NCT01933672|8654942|P4|Metformin Run-in Period|Other|0
2501986|NCT01933672|8654943|P3|Metformin Run-in Period|Other|0
2501987|NCT01933672|8654944|P2|Metformin Run-in Period|Other|0
2501988|NCT01933672|8654945|P1|Metformin Run-in Period|Other|5
2501989|NCT01933672|8654939|P7|Metformin Run-in Period|No longer meets eligibility criteria|0
2501990|NCT01933672|8654940|P6|Metformin Run-in Period|No longer meets eligibility criteria|0
2501991|NCT01933672|8654941|P5|Metformin Run-in Period|No longer meets eligibility criteria|0
2501992|NCT01933672|8654942|P4|Metformin Run-in Period|No longer meets eligibility criteria|0
2501993|NCT01933672|8654943|P3|Metformin Run-in Period|No longer meets eligibility criteria|0
2501994|NCT01933672|8654944|P2|Metformin Run-in Period|No longer meets eligibility criteria|0
2501995|NCT01933672|8654945|P1|Metformin Run-in Period|No longer meets eligibility criteria|4
2501996|NCT01933672|8654939|P7|Metformin Run-in Period|Adverse Event|0
2501997|NCT01933672|8654940|P6|Metformin Run-in Period|Adverse Event|0
2501998|NCT01933672|8654941|P5|Metformin Run-in Period|Adverse Event|0
2501999|NCT01933672|8654942|P4|Metformin Run-in Period|Adverse Event|0
2502000|NCT01933672|8654943|P3|Metformin Run-in Period|Adverse Event|0
2502001|NCT01933672|8654944|P2|Metformin Run-in Period|Adverse Event|0
2502002|NCT01933672|8654945|P1|Metformin Run-in Period|Adverse Event|1
2502003|NCT01933594|8654997|P6|Overall Study|Ineligible for subsequent study step|0
2502004|NCT01933594|8654998|P5|Overall Study|Ineligible for subsequent study step|1
2502005|NCT01933594|8654999|P4|Overall Study|Ineligible for subsequent study step|0
2502006|NCT01933594|8655000|P3|Overall Study|Ineligible for subsequent study step|0
2502007|NCT01933594|8655001|P2|Overall Study|Ineligible for subsequent study step|0
2502008|NCT01933594|8655002|P1|Overall Study|Ineligible for subsequent study step|0
2502009|NCT01933594|8654997|P6|Overall Study|Lost to Follow-up|0
2502010|NCT01933594|8654998|P5|Overall Study|Lost to Follow-up|1
2502011|NCT01933594|8654999|P4|Overall Study|Lost to Follow-up|0
2502012|NCT01933594|8655000|P3|Overall Study|Lost to Follow-up|0
2502013|NCT01933594|8655001|P2|Overall Study|Lost to Follow-up|0
2502014|NCT01933594|8655002|P1|Overall Study|Lost to Follow-up|1
2502015|NCT01933334|8655136|P2|Overall Study|Withdrawal by Subject|1
2502016|NCT01933334|8655137|P1|Overall Study|Withdrawal by Subject|0
2502017|NCT01933334|8655136|P2|Overall Study|Adverse Event|1
2502018|NCT01933334|8655137|P1|Overall Study|Adverse Event|5
2502019|NCT01933113|8655164|P1|Overall Study|Fractured nonfunctioning lead.|1
2502020|NCT01933048|8655170|P2|Overall Study|unknown reasons|1
2502021|NCT01933048|8655171|P1|Overall Study|unknown reasons|1
2502022|NCT01933048|8655170|P2|Overall Study|Physician Decision|0
2502023|NCT01933048|8655171|P1|Overall Study|Physician Decision|1
2502024|NCT01933048|8655170|P2|Overall Study|Protocol Violation|8
2502025|NCT01933048|8655171|P1|Overall Study|Protocol Violation|7
2502026|NCT01933048|8655170|P2|Overall Study|personal reasons|1
2502027|NCT01933048|8655171|P1|Overall Study|personal reasons|1
2502028|NCT01933048|8655170|P2|Overall Study|Lost to Follow-up|18
2502029|NCT01933048|8655171|P1|Overall Study|Lost to Follow-up|15
2502030|NCT01932970|8655184|P1|Overall Study|Protocol Specified Criteria|10
2502031|NCT01932970|8655184|P1|Overall Study|Lost to Follow-up|2
2502032|NCT01932970|8655184|P1|Overall Study|Death|1
2502033|NCT01932970|8655184|P1|Overall Study|Withdrawal by Subject|5
2502034|NCT01932788|8655194|P2|Overall Study|Withdrawal by Subject|5
2502035|NCT01932788|8655195|P1|Overall Study|Withdrawal by Subject|0
2502036|NCT01932788|8655194|P2|Overall Study|Lack of Efficacy|0
2502037|NCT01932788|8655195|P1|Overall Study|Lack of Efficacy|2
2502038|NCT01932788|8655194|P2|Overall Study|Lost to Follow-up|46
2502039|NCT01932788|8655195|P1|Overall Study|Lost to Follow-up|18
2502040|NCT01932788|8655194|P2|Overall Study|Protocol Violation|0
2502041|NCT01932788|8655195|P1|Overall Study|Protocol Violation|18
2502042|NCT01932762|8655205|P4|Overall Study|Physician Decision|0
2502043|NCT01932762|8655206|P3|Overall Study|Physician Decision|0
2502044|NCT01932762|8655207|P2|Overall Study|Physician Decision|0
2502045|NCT01932762|8655208|P1|Overall Study|Physician Decision|1
2502046|NCT01932762|8655205|P4|Overall Study|Lost to Follow-up|1
2502047|NCT01932762|8655206|P3|Overall Study|Lost to Follow-up|0
2502048|NCT01932762|8655207|P2|Overall Study|Lost to Follow-up|0
2502049|NCT01932762|8655208|P1|Overall Study|Lost to Follow-up|4
2502050|NCT01932762|8655205|P4|Overall Study|Withdrawal by Subject|0
2502051|NCT01932762|8655206|P3|Overall Study|Withdrawal by Subject|0
2502052|NCT01932762|8655207|P2|Overall Study|Withdrawal by Subject|2
2502053|NCT01932762|8655208|P1|Overall Study|Withdrawal by Subject|1
2502054|NCT01932697|8655244|P2|Overall Study|Ineligible|0
2502055|NCT01932697|8655245|P1|Overall Study|Ineligible|1
2502056|NCT01932697|8655244|P2|Overall Study|Received a different amount of tx|0
2502057|NCT01932697|8655245|P1|Overall Study|Received a different amount of tx|1
2502058|NCT01932437|8655312|P6|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1
2502059|NCT01932437|8655313|P5|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
2502060|NCT01932437|8655314|P4|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
2502061|NCT01932437|8655315|P3|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
2502062|NCT01932437|8655316|P2|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
2502063|NCT01932437|8655317|P1|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
2502064|NCT01932294|8655367|P1|Overall Study|Transferred to other hospitals|12
2502065|NCT01932294|8655367|P1|Overall Study|Heart Transplantation|16
2502066|NCT01932294|8655367|P1|Overall Study|VAD Implantation|20
2502067|NCT01932294|8655367|P1|Overall Study|Lost to Follow-up|8
2502068|NCT01932294|8655367|P1|Overall Study|Death|43
2502069|NCT01931956|8655444|P4|Overall Study|Not due|0
2502070|NCT01931956|8655445|P3|Overall Study|Not due|21
2502071|NCT01931956|8655446|P2|Overall Study|Not due|0
2502072|NCT01931956|8655447|P1|Overall Study|Not due|0
2502073|NCT01931956|8655444|P4|Overall Study|Expected|0
2502074|NCT01931956|8655445|P3|Overall Study|Expected|6
2502075|NCT01931956|8655446|P2|Overall Study|Expected|0
2502076|NCT01931956|8655447|P1|Overall Study|Expected|2
2502077|NCT01931956|8655444|P4|Overall Study|Lost to Follow-up|7
2502078|NCT01931956|8655445|P3|Overall Study|Lost to Follow-up|11
2502079|NCT01931956|8655446|P2|Overall Study|Lost to Follow-up|0
2502080|NCT01931956|8655447|P1|Overall Study|Lost to Follow-up|2
2502081|NCT01931956|8655444|P4|Overall Study|Withdrawal by Subject|30
2502082|NCT01931956|8655445|P3|Overall Study|Withdrawal by Subject|70
2502083|NCT01931956|8655446|P2|Overall Study|Withdrawal by Subject|0
2502084|NCT01931956|8655447|P1|Overall Study|Withdrawal by Subject|5
2502085|NCT01931956|8655444|P4|Overall Study|Death|96
2502086|NCT01931956|8655445|P3|Overall Study|Death|379
2502087|NCT01931956|8655446|P2|Overall Study|Death|7
2502088|NCT01931956|8655447|P1|Overall Study|Death|42
2502089|NCT01931865|8655814|P1|Overall Study|Withdrawal by Subject|2
2502090|NCT01931865|8655814|P1|Overall Study|Lost to Follow-up|2
2502091|NCT01931839|8655827|P7|Overall Study|Other|0
2502092|NCT01931839|8655828|P6|Overall Study|Other|0
2502093|NCT01931839|8655829|P5|Overall Study|Other|0
2502094|NCT01931839|8655830|P4|Overall Study|Other|0
2502095|NCT01931839|8655831|P3|Overall Study|Other|6
2502096|NCT01931839|8655832|P2|Overall Study|Other|2
2502097|NCT01931839|8655833|P1|Overall Study|Other|4
2502098|NCT01931839|8655827|P7|Overall Study|Lost to Follow-up|0
2502099|NCT01931839|8655828|P6|Overall Study|Lost to Follow-up|0
2502100|NCT01931839|8655829|P5|Overall Study|Lost to Follow-up|0
2502101|NCT01931839|8655830|P4|Overall Study|Lost to Follow-up|5
2502102|NCT01931839|8655831|P3|Overall Study|Lost to Follow-up|4
2502103|NCT01931839|8655832|P2|Overall Study|Lost to Follow-up|2
2502104|NCT01931839|8655833|P1|Overall Study|Lost to Follow-up|1
2502105|NCT01931839|8655827|P7|Overall Study|Other non-compliance|0
2502106|NCT01931839|8655828|P6|Overall Study|Other non-compliance|3
2502107|NCT01931839|8655829|P5|Overall Study|Other non-compliance|0
2502108|NCT01931839|8655830|P4|Overall Study|Other non-compliance|3
2502109|NCT01931839|8655831|P3|Overall Study|Other non-compliance|12
2502110|NCT01931839|8655832|P2|Overall Study|Other non-compliance|9
2502111|NCT01931839|8655833|P1|Overall Study|Other non-compliance|15
2502112|NCT01931839|8655827|P7|Overall Study|Withdrawal of consent (not due to AE)|2
2502113|NCT01931839|8655828|P6|Overall Study|Withdrawal of consent (not due to AE)|2
2502114|NCT01931839|8655829|P5|Overall Study|Withdrawal of consent (not due to AE)|0
2502115|NCT01931839|8655830|P4|Overall Study|Withdrawal of consent (not due to AE)|3
2502116|NCT01931839|8655831|P3|Overall Study|Withdrawal of consent (not due to AE)|13
2502117|NCT01931839|8655832|P2|Overall Study|Withdrawal of consent (not due to AE)|8
2502118|NCT01931839|8655833|P1|Overall Study|Withdrawal of consent (not due to AE)|11
2502119|NCT01931839|8655827|P7|Overall Study|Adverse Event|1
2502120|NCT01931839|8655828|P6|Overall Study|Adverse Event|0
2502121|NCT01931839|8655829|P5|Overall Study|Adverse Event|0
2502122|NCT01931839|8655830|P4|Overall Study|Adverse Event|3
2502123|NCT01931839|8655831|P3|Overall Study|Adverse Event|1
2502124|NCT01931839|8655832|P2|Overall Study|Adverse Event|4
2502125|NCT01931839|8655833|P1|Overall Study|Adverse Event|9
2502126|NCT01931839|8655827|P7|Overall Study|Withdrawal of consent|0
2502127|NCT01931839|8655828|P6|Overall Study|Withdrawal of consent|0
2502128|NCT01931839|8655829|P5|Overall Study|Withdrawal of consent|1
2502129|NCT01931839|8655830|P4|Overall Study|Withdrawal of consent|0
2502130|NCT01931839|8655831|P3|Overall Study|Withdrawal of consent|0
2502131|NCT01931839|8655832|P2|Overall Study|Withdrawal of consent|0
2502132|NCT01931839|8655833|P1|Overall Study|Withdrawal of consent|0
2502133|NCT01931839|8655827|P7|Overall Study|Physician Decision|1
2502134|NCT01931839|8655828|P6|Overall Study|Physician Decision|0
2502135|NCT01931839|8655829|P5|Overall Study|Physician Decision|0
2502136|NCT01931839|8655830|P4|Overall Study|Physician Decision|0
2502137|NCT01931839|8655831|P3|Overall Study|Physician Decision|1
2502138|NCT01931839|8655832|P2|Overall Study|Physician Decision|0
2502139|NCT01931839|8655833|P1|Overall Study|Physician Decision|1
2502140|NCT01931839|8655827|P7|Overall Study|Death|0
2502141|NCT01931839|8655828|P6|Overall Study|Death|0
2502142|NCT01931839|8655829|P5|Overall Study|Death|0
2502143|NCT01931839|8655830|P4|Overall Study|Death|0
2502144|NCT01931839|8655831|P3|Overall Study|Death|2
2502145|NCT01931839|8655832|P2|Overall Study|Death|1
2502146|NCT01931839|8655833|P1|Overall Study|Death|0
2502147|NCT01931735|8655905|P4|Observational Non-Randomized Phase|Withdrawal by Subject|1
2502148|NCT01931735|8655906|P3|Observational Non-Randomized Phase|Withdrawal by Subject|0
2502149|NCT01931735|8655907|P2|Observational Non-Randomized Phase|Withdrawal by Subject|0
2502150|NCT01931735|8655908|P1|Observational Non-Randomized Phase|Withdrawal by Subject|0
2502151|NCT01931735|8655905|P4|Observational Non-Randomized Phase|Adverse Event|1
2502152|NCT01931735|8655906|P3|Observational Non-Randomized Phase|Adverse Event|0
2502153|NCT01931735|8655907|P2|Observational Non-Randomized Phase|Adverse Event|0
2502154|NCT01931735|8655908|P1|Observational Non-Randomized Phase|Adverse Event|0
2502155|NCT01931735|8655905|P4|Randomized Phase|Lost to Follow-up|0
2502156|NCT01931735|8655906|P3|Randomized Phase|Lost to Follow-up|5
2502157|NCT01931735|8655907|P2|Randomized Phase|Lost to Follow-up|2
2502158|NCT01931735|8655908|P1|Randomized Phase|Lost to Follow-up|2
2502159|NCT01931670|8655955|P3|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2
2502160|NCT01931670|8655956|P2|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
2502161|NCT01931670|8655957|P1|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
2502162|NCT01931670|8655955|P3|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13
2502163|NCT01931670|8655956|P2|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3
2502164|NCT01931670|8655957|P1|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6
2502165|NCT01931670|8655955|P3|Post-Treatment Follow-Up (PTFU) Period|Other|3
2502166|NCT01931670|8655956|P2|Post-Treatment Follow-Up (PTFU) Period|Other|3
2502167|NCT01931670|8655957|P1|Post-Treatment Follow-Up (PTFU) Period|Other|6
2502168|NCT01931670|8655955|P3|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2
2502169|NCT01931670|8655956|P2|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
2502170|NCT01931670|8655957|P1|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
2502171|NCT01931670|8655955|P3|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1
2502172|NCT01931670|8655956|P2|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2
2502173|NCT01931670|8655957|P1|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0
2502174|NCT01931670|8655955|P3|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
2502175|NCT01931670|8655956|P2|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
2502176|NCT01931670|8655957|P1|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3
2502177|NCT01931670|8655955|P3|Treatment Period|Lost to Follow-up|7
2502178|NCT01931670|8655956|P2|Treatment Period|Lost to Follow-up|5
2502179|NCT01931670|8655957|P1|Treatment Period|Lost to Follow-up|19
2502180|NCT01931670|8655955|P3|Treatment Period|Consent Withdrawn by Subject|7
2502181|NCT01931670|8655956|P2|Treatment Period|Consent Withdrawn by Subject|12
2502182|NCT01931670|8655957|P1|Treatment Period|Consent Withdrawn by Subject|17
2502183|NCT01931670|8655955|P3|Treatment Period|Other|2
2502184|NCT01931670|8655956|P2|Treatment Period|Other|7
2502185|NCT01931670|8655957|P1|Treatment Period|Other|8
2502186|NCT01931670|8655955|P3|Treatment Period|Pregnancy|0
2502187|NCT01931670|8655956|P2|Treatment Period|Pregnancy|2
2502188|NCT01931670|8655957|P1|Treatment Period|Pregnancy|7
2502189|NCT01931670|8655955|P3|Treatment Period|Lack of Efficacy|2
2502190|NCT01931670|8655956|P2|Treatment Period|Lack of Efficacy|2
2502191|NCT01931670|8655957|P1|Treatment Period|Lack of Efficacy|11
2502192|NCT01931670|8655955|P3|Treatment Period|Adverse Event|21
2502193|NCT01931670|8655956|P2|Treatment Period|Adverse Event|8
2502194|NCT01931670|8655957|P1|Treatment Period|Adverse Event|19
2502195|NCT01931670|8655955|P3|Treatment Period|Subject Noncompliant|5
2502196|NCT01931670|8655956|P2|Treatment Period|Subject Noncompliant|9
2502197|NCT01931670|8655957|P1|Treatment Period|Subject Noncompliant|4
2502198|NCT01931670|8655955|P3|Treatment Period|Surgery/Invasive Intervention|0
2502199|NCT01931670|8655956|P2|Treatment Period|Surgery/Invasive Intervention|2
2502200|NCT01931670|8655957|P1|Treatment Period|Surgery/Invasive Intervention|4
2502201|NCT01931670|8655955|P3|Treatment Period|Exclusionary Medication Received|1
2502202|NCT01931670|8655956|P2|Treatment Period|Exclusionary Medication Received|1
2502203|NCT01931670|8655957|P1|Treatment Period|Exclusionary Medication Received|1
2502204|NCT01931566|8656058|P3|Overall Study|Missing|1
2502205|NCT01931566|8656059|P2|Overall Study|Missing|0
2502206|NCT01931566|8656060|P1|Overall Study|Missing|0
2502207|NCT01931566|8656058|P3|Overall Study|Reason Not Specified|53
2502208|NCT01931566|8656059|P2|Overall Study|Reason Not Specified|47
2502209|NCT01931566|8656060|P1|Overall Study|Reason Not Specified|11
2502210|NCT01931566|8656058|P3|Overall Study|Study Termination|1037
2502211|NCT01931566|8656059|P2|Overall Study|Study Termination|968
2502212|NCT01931566|8656060|P1|Overall Study|Study Termination|289
2502213|NCT01931566|8656058|P3|Overall Study|Voluntary Withdrawal|225
2502214|NCT01931566|8656059|P2|Overall Study|Voluntary Withdrawal|245
2502215|NCT01931566|8656060|P1|Overall Study|Voluntary Withdrawal|78
2502216|NCT01931566|8656058|P3|Overall Study|Lost to Follow-up|23
2502217|NCT01931566|8656059|P2|Overall Study|Lost to Follow-up|26
2502218|NCT01931566|8656060|P1|Overall Study|Lost to Follow-up|3
2502219|NCT01931566|8656058|P3|Overall Study|Major Protocol Deviation|21
2502220|NCT01931566|8656059|P2|Overall Study|Major Protocol Deviation|14
2502221|NCT01931566|8656060|P1|Overall Study|Major Protocol Deviation|5
2502222|NCT01931566|8656058|P3|Overall Study|Adverse Event|132
2502223|NCT01931566|8656059|P2|Overall Study|Adverse Event|167
2502224|NCT01931566|8656060|P1|Overall Study|Adverse Event|37
2502225|NCT01931566|8656058|P3|Overall Study|Randomized But Not Treated|14
2502226|NCT01931566|8656059|P2|Overall Study|Randomized But Not Treated|9
2502227|NCT01931566|8656060|P1|Overall Study|Randomized But Not Treated|6
2502228|NCT01931475|8656098|P2|Period 2: Extension Treatment Phase|Lack of Efficacy|1
2502229|NCT01931475|8656099|P1|Period 2: Extension Treatment Phase|Lack of Efficacy|1
2502230|NCT01931475|8656098|P2|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0
2502231|NCT01931475|8656099|P1|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1
2502232|NCT01931475|8656098|P2|Period 2: Extension Treatment Phase|Physician Decision|1
2502233|NCT01931475|8656099|P1|Period 2: Extension Treatment Phase|Physician Decision|1
2502234|NCT01931475|8656098|P2|Period 2: Extension Treatment Phase|Withdrawal by Subject|9
2502235|NCT01931475|8656099|P1|Period 2: Extension Treatment Phase|Withdrawal by Subject|0
2502236|NCT01931475|8656098|P2|Period 2: Extension Treatment Phase|Protocol Violation|0
2502237|NCT01931475|8656099|P1|Period 2: Extension Treatment Phase|Protocol Violation|1
2502238|NCT01931475|8656098|P2|Period 2: Extension Treatment Phase|Adverse Event|8
2502239|NCT01931475|8656099|P1|Period 2: Extension Treatment Phase|Adverse Event|0
2502240|NCT01931475|8656098|P2|Period 1: Double-Blind Treatment Phase|Physician Decision|1
2502241|NCT01931475|8656099|P1|Period 1: Double-Blind Treatment Phase|Physician Decision|0
2502242|NCT01931475|8656098|P2|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3
2502243|NCT01931475|8656099|P1|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2
2502244|NCT01931475|8656098|P2|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12
2502245|NCT01931475|8656099|P1|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16
2502246|NCT01931475|8656098|P2|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0
2502247|NCT01931475|8656099|P1|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1
2502248|NCT01931475|8656098|P2|Period 1: Double-Blind Treatment Phase|Adverse Event|10
2502249|NCT01931475|8656099|P1|Period 1: Double-Blind Treatment Phase|Adverse Event|20
2502250|NCT01931462|8656126|P1|Overall Study|Withdrawal by Subject|1
2502251|NCT01931397|8656137|P1|Overall Study|moved out of state|1
2502252|NCT01931397|8656137|P1|Overall Study|Withdrawal by Subject|8
2502253|NCT01931397|8656137|P1|Overall Study|Physician Decision|2
2502254|NCT01931202|8656149|P3|Overall Study|Lost to Follow-up|2
2502255|NCT01931202|8656150|P2|Overall Study|Lost to Follow-up|5
2502256|NCT01931202|8656151|P1|Overall Study|Lost to Follow-up|0
2502257|NCT01931202|8656149|P3|Overall Study|Withdrawal by Subject|2
2502258|NCT01931202|8656150|P2|Overall Study|Withdrawal by Subject|0
2502259|NCT01931202|8656151|P1|Overall Study|Withdrawal by Subject|0
2502260|NCT01931150|8656197|P2|Overall Study|Withdrawal by Subject|2
2502261|NCT01931150|8656198|P1|Overall Study|Withdrawal by Subject|1
2502262|NCT01931059|8656206|P2|Day3|Lost to Follow-up|0
2502263|NCT01931059|8656207|P1|Day3|Lost to Follow-up|1
2502264|NCT01931059|8656206|P2|Day 1|Pregnancy|1
2502265|NCT01931059|8656207|P1|Day 1|Pregnancy|0
2502266|NCT01930890|8656223|P4|Overall Study|Adverse Event|0
2502267|NCT01930890|8656224|P3|Overall Study|Adverse Event|0
2502268|NCT01930890|8656225|P2|Overall Study|Adverse Event|1
2502269|NCT01930890|8656226|P1|Overall Study|Adverse Event|0
2502270|NCT01930890|8656223|P4|Overall Study|Consent Withdrawn|1
2502271|NCT01930890|8656224|P3|Overall Study|Consent Withdrawn|0
2502272|NCT01930890|8656225|P2|Overall Study|Consent Withdrawn|3
2502273|NCT01930890|8656226|P1|Overall Study|Consent Withdrawn|0
2502274|NCT01930890|8656223|P4|Overall Study|Investigator Decision|0
2502275|NCT01930890|8656224|P3|Overall Study|Investigator Decision|0
2502276|NCT01930890|8656225|P2|Overall Study|Investigator Decision|1
2502277|NCT01930890|8656226|P1|Overall Study|Investigator Decision|0
2502278|NCT01930890|8656223|P4|Overall Study|Death|1
2502279|NCT01930890|8656224|P3|Overall Study|Death|0
2502280|NCT01930890|8656225|P2|Overall Study|Death|0
2502281|NCT01930890|8656226|P1|Overall Study|Death|0
2502282|NCT01930890|8656223|P4|Overall Study|Study Termination|25
2502283|NCT01930890|8656224|P3|Overall Study|Study Termination|13
2502284|NCT01930890|8656225|P2|Overall Study|Study Termination|28
2502285|NCT01930890|8656226|P1|Overall Study|Study Termination|14
2502286|NCT01930799|8656240|P1|Overall Study|Lost to Follow-up|5
2502287|NCT01930799|8656240|P1|Overall Study|Withdrawal by Subject|3
2502288|NCT01930214|8656379|P3|Overall Study|Physician Decision|0
2502289|NCT01930214|8656380|P2|Overall Study|Physician Decision|0
2502290|NCT01930214|8656381|P1|Overall Study|Physician Decision|2
2502291|NCT01930214|8656379|P3|Overall Study|Voluntary withdrawal of infomed consent|2
2502292|NCT01930214|8656380|P2|Overall Study|Voluntary withdrawal of infomed consent|4
2502293|NCT01930214|8656381|P1|Overall Study|Voluntary withdrawal of infomed consent|2
2502294|NCT01930214|8656379|P3|Overall Study|Lost to Follow-up|12
2502295|NCT01930214|8656380|P2|Overall Study|Lost to Follow-up|13
2502296|NCT01930214|8656381|P1|Overall Study|Lost to Follow-up|12
2502297|NCT01930214|8656379|P3|Overall Study|Death|11
2502298|NCT01930214|8656380|P2|Overall Study|Death|4
2502299|NCT01930214|8656381|P1|Overall Study|Death|4
2502300|NCT01930188|8656401|P3|Overall Study|Withdrawal by Subject|8
2502301|NCT01930188|8656402|P2|Overall Study|Withdrawal by Subject|11
2502302|NCT01930188|8656403|P1|Overall Study|Withdrawal by Subject|9
2502303|NCT01930188|8656401|P3|Overall Study|Death|3
2502304|NCT01930188|8656402|P2|Overall Study|Death|1
2502305|NCT01930188|8656403|P1|Overall Study|Death|2
2502306|NCT01930188|8656401|P3|Overall Study|Lost to Follow-up|2
2502307|NCT01930188|8656402|P2|Overall Study|Lost to Follow-up|2
2502308|NCT01930188|8656403|P1|Overall Study|Lost to Follow-up|5
2502309|NCT01930188|8656401|P3|Overall Study|Missing follow-up information|3
2502310|NCT01930188|8656402|P2|Overall Study|Missing follow-up information|2
2502311|NCT01930188|8656403|P1|Overall Study|Missing follow-up information|2
2502312|NCT01930188|8656401|P3|Overall Study|unclassified|3
2502313|NCT01930188|8656402|P2|Overall Study|unclassified|5
2502314|NCT01930188|8656403|P1|Overall Study|unclassified|4
2502315|NCT01930162|8656427|P1|Overall Study|Death|1
2502316|NCT01930162|8656427|P1|Overall Study|Abnormal test procedure result(s)|4
2502317|NCT01930045|8656463|P6|Pause (up to 37 Days)|Protocol Violation|1
2502318|NCT01930045|8656464|P5|Pause (up to 37 Days)|Protocol Violation|0
2502319|NCT01930045|8656465|P4|Pause (up to 37 Days)|Protocol Violation|0
2502320|NCT01930045|8656466|P3|Pause (up to 37 Days)|Protocol Violation|0
2502321|NCT01930045|8656467|P2|Pause (up to 37 Days)|Protocol Violation|0
2502322|NCT01930045|8656468|P1|Pause (up to 37 Days)|Protocol Violation|0
2502323|NCT01930045|8656463|P6|Pause (up to 37 Days)|Withdrawal by Subject|1
2502324|NCT01930045|8656464|P5|Pause (up to 37 Days)|Withdrawal by Subject|0
2502325|NCT01930045|8656465|P4|Pause (up to 37 Days)|Withdrawal by Subject|0
2502326|NCT01930045|8656466|P3|Pause (up to 37 Days)|Withdrawal by Subject|0
2502327|NCT01930045|8656467|P2|Pause (up to 37 Days)|Withdrawal by Subject|0
2502328|NCT01930045|8656468|P1|Pause (up to 37 Days)|Withdrawal by Subject|0
2502329|NCT01929993|8656495|P2|Overall Study|Absent CIN, invasion present or artifact|22
2502330|NCT01929993|8656496|P1|Overall Study|Absent CIN, invasion present or artifact|26
2502331|NCT01929993|8656495|P2|Overall Study|Protocol Violation|6
2502332|NCT01929993|8656496|P1|Overall Study|Protocol Violation|4
2502333|NCT01929980|8656502|P1|Overall Study|Physician Decision|1
2502334|NCT01929876|8656510|P1|Period 2|Non-Compliance|1
2502335|NCT01929863|8656523|P2|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1
2502336|NCT01929863|8656524|P1|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0
2502337|NCT01929863|8656523|P2|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1
2502338|NCT01929863|8656524|P1|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0
2502339|NCT01929863|8656523|P2|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0
2502340|NCT01929863|8656524|P1|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1
2502341|NCT01929707|8656579|P8|Intervention Period 2|Withdrawal by Subject|0
2502342|NCT01929707|8656580|P7|Intervention Period 2|Withdrawal by Subject|0
2502343|NCT01929707|8656581|P6|Intervention Period 2|Withdrawal by Subject|2
2502344|NCT01929707|8656582|P5|Intervention Period 2|Withdrawal by Subject|0
2502345|NCT01929707|8656583|P4|Intervention Period 2|Withdrawal by Subject|0
2502346|NCT01929707|8656584|P3|Intervention Period 2|Withdrawal by Subject|0
2502347|NCT01929707|8656585|P2|Intervention Period 2|Withdrawal by Subject|0
2502348|NCT01929707|8656586|P1|Intervention Period 2|Withdrawal by Subject|0
2502349|NCT01929707|8656579|P8|Intervention Period 1|Withdrawal by Subject|0
2502350|NCT01929707|8656580|P7|Intervention Period 1|Withdrawal by Subject|0
2502351|NCT01929707|8656581|P6|Intervention Period 1|Withdrawal by Subject|0
2502352|NCT01929707|8656582|P5|Intervention Period 1|Withdrawal by Subject|0
2502353|NCT01929707|8656583|P4|Intervention Period 1|Withdrawal by Subject|2
2502354|NCT01929707|8656584|P3|Intervention Period 1|Withdrawal by Subject|0
2502355|NCT01929707|8656585|P2|Intervention Period 1|Withdrawal by Subject|0
2502356|NCT01929707|8656586|P1|Intervention Period 1|Withdrawal by Subject|0
2502357|NCT01929707|8656579|P8|Intervention Period 1|Lost to Follow-up|0
2502358|NCT01929707|8656580|P7|Intervention Period 1|Lost to Follow-up|0
2502359|NCT01929707|8656581|P6|Intervention Period 1|Lost to Follow-up|0
2502360|NCT01929707|8656582|P5|Intervention Period 1|Lost to Follow-up|0
2502361|NCT01929707|8656583|P4|Intervention Period 1|Lost to Follow-up|1
2502362|NCT01929707|8656584|P3|Intervention Period 1|Lost to Follow-up|0
2502363|NCT01929707|8656585|P2|Intervention Period 1|Lost to Follow-up|0
2502364|NCT01929707|8656586|P1|Intervention Period 1|Lost to Follow-up|0
2502365|NCT01929681|8656618|P2|Overall Study|Physician Decision|1
2502366|NCT01929681|8656619|P1|Overall Study|Physician Decision|1
2502367|NCT01929681|8656618|P2|Overall Study|Withdrawal by Subject|0
2502368|NCT01929681|8656619|P1|Overall Study|Withdrawal by Subject|1
2502369|NCT01929408|8656662|P1|Overall Study|received HCT as initial treatment|8
2502370|NCT01929395|8656670|P3|Overall Study|Screen Fail|1
2502371|NCT01929395|8656671|P2|Overall Study|Screen Fail|0
2502372|NCT01929395|8656672|P1|Overall Study|Screen Fail|0
2502373|NCT01929395|8656670|P3|Overall Study|Withdrawal by Subject|0
2502374|NCT01929395|8656671|P2|Overall Study|Withdrawal by Subject|1
2502375|NCT01929395|8656672|P1|Overall Study|Withdrawal by Subject|0
2502376|NCT01929395|8656670|P3|Overall Study|Did not complete - non-related toxicity|0
2502377|NCT01929395|8656671|P2|Overall Study|Did not complete - non-related toxicity|0
2502378|NCT01929395|8656672|P1|Overall Study|Did not complete - non-related toxicity|1
2502379|NCT01929317|8656684|P2|Long-term Phase|Study Closed/Terminated|3
2502380|NCT01929317|8656685|P1|Long-term Phase|Study Closed/Terminated|5
2502381|NCT01929317|8656684|P2|Long-term Phase|Protocol-defined Stopping Criteria|0
2502382|NCT01929317|8656685|P1|Long-term Phase|Protocol-defined Stopping Criteria|1
2502383|NCT01929317|8656684|P2|Long-term Phase|Protocol Violation|0
2502384|NCT01929317|8656685|P1|Long-term Phase|Protocol Violation|1
2502385|NCT01929317|8656684|P2|Long-term Phase|Withdrawal by Subject|0
2502386|NCT01929317|8656685|P1|Long-term Phase|Withdrawal by Subject|4
2502387|NCT01929317|8656684|P2|Long-term Phase|Physician Decision|0
2502388|NCT01929317|8656685|P1|Long-term Phase|Physician Decision|3
2502389|NCT01929317|8656684|P2|Long-term Phase|Adverse Event|1
2502390|NCT01929317|8656685|P1|Long-term Phase|Adverse Event|5
2502391|NCT01929317|8656684|P2|Dose Increase Effect Verification Phase|Withdrawal by Subject|0
2502392|NCT01929317|8656685|P1|Dose Increase Effect Verification Phase|Withdrawal by Subject|3
2502393|NCT01929317|8656684|P2|Dose Increase Effect Verification Phase|Physician Decision|0
2502394|NCT01929317|8656685|P1|Dose Increase Effect Verification Phase|Physician Decision|1
2502395|NCT01929317|8656684|P2|Dose Increase Effect Verification Phase|Adverse Event|1
2502396|NCT01929317|8656685|P1|Dose Increase Effect Verification Phase|Adverse Event|5
2502397|NCT01929226|8656760|P2|Overall Study|Withdrawal by Subject|1
2502398|NCT01929226|8656761|P1|Overall Study|Withdrawal by Subject|1
2502399|NCT01929226|8656760|P2|Overall Study|Lost to Follow-up|0
2502400|NCT01929226|8656761|P1|Overall Study|Lost to Follow-up|4
2502401|NCT01929135|8656787|P2|Overall Study|Lost to Follow-up|1
2502402|NCT01929135|8656788|P1|Overall Study|Lost to Follow-up|1
2502403|NCT01929109|8656807|P5|Period 1 (All Groups)|Deviation from protocol|0
2502404|NCT01929109|8656808|P4|Period 1 (All Groups)|Deviation from protocol|0
2502405|NCT01929109|8656809|P3|Period 1 (All Groups)|Deviation from protocol|1
2502406|NCT01929109|8656810|P2|Period 1 (All Groups)|Deviation from protocol|0
2502407|NCT01929109|8656811|P1|Period 1 (All Groups)|Deviation from protocol|0
2502408|NCT01929083|8656830|P2|Intervention 2|Adverse Event|1
2502409|NCT01929083|8656831|P1|Intervention 2|Adverse Event|0
2502410|NCT01929083|8656830|P2|Intervention 1|Nonadherent to study medications|0
2502411|NCT01929083|8656831|P1|Intervention 1|Nonadherent to study medications|1
2502412|NCT01929083|8656830|P2|Intervention 1|Lost to Follow-up|0
2502413|NCT01929083|8656831|P1|Intervention 1|Lost to Follow-up|2
2502414|NCT01929044|8656868|P2|Overall Study|Not Treated|3
2502415|NCT01929044|8656869|P1|Overall Study|Not Treated|1
2502416|NCT01929044|8656868|P2|Overall Study|Protocol Violation|14
2502417|NCT01929044|8656869|P1|Overall Study|Protocol Violation|9
2502418|NCT01929044|8656868|P2|Overall Study|Adverse Event|0
2502419|NCT01929044|8656869|P1|Overall Study|Adverse Event|1
2502420|NCT01929031|8656891|P6|Overall Study|Reason other than specified above|0
2502421|NCT01929031|8656892|P5|Overall Study|Reason other than specified above|1
2502422|NCT01929031|8656893|P4|Overall Study|Reason other than specified above|0
2502423|NCT01929031|8656894|P3|Overall Study|Reason other than specified above|0
2502424|NCT01929031|8656895|P2|Overall Study|Reason other than specified above|1
2502425|NCT01929031|8656896|P1|Overall Study|Reason other than specified above|0
2502426|NCT01929031|8656891|P6|Overall Study|Protocol Violation|1
2502427|NCT01929031|8656892|P5|Overall Study|Protocol Violation|0
2502428|NCT01929031|8656893|P4|Overall Study|Protocol Violation|0
2502429|NCT01929031|8656894|P3|Overall Study|Protocol Violation|0
2502430|NCT01929031|8656895|P2|Overall Study|Protocol Violation|0
2502431|NCT01929031|8656896|P1|Overall Study|Protocol Violation|1
2502432|NCT01929031|8656891|P6|Overall Study|Adverse Event|0
2502433|NCT01929031|8656892|P5|Overall Study|Adverse Event|0
2502434|NCT01929031|8656893|P4|Overall Study|Adverse Event|0
2502435|NCT01929031|8656894|P3|Overall Study|Adverse Event|1
2502436|NCT01929031|8656895|P2|Overall Study|Adverse Event|1
2502437|NCT01929031|8656896|P1|Overall Study|Adverse Event|3
2502438|NCT01929018|8656920|P2|Overall Study|Hospitalization|1
2502439|NCT01929018|8656921|P1|Overall Study|Hospitalization|0
2502440|NCT01929018|8656920|P2|Overall Study|Lost to Follow-up|0
2502441|NCT01929018|8656921|P1|Overall Study|Lost to Follow-up|1
2502442|NCT01928940|8656945|P2|Overall Study|Adverse Event|1
2502443|NCT01928940|8656946|P1|Overall Study|Adverse Event|0
2502444|NCT01928927|8656989|P2|Overall Study|Withdrawal by Subject|1
2502445|NCT01928927|8656990|P1|Overall Study|Withdrawal by Subject|1
2502446|NCT01928927|8656989|P2|Overall Study|Lost to Follow-up|0
2502447|NCT01928927|8656990|P1|Overall Study|Lost to Follow-up|1
2502448|NCT01928862|8657117|P5|Overall Study|Lost to Follow-up|1
2502449|NCT01928862|8657118|P4|Overall Study|Lost to Follow-up|0
2502450|NCT01928862|8657119|P3|Overall Study|Lost to Follow-up|0
2502451|NCT01928862|8657120|P2|Overall Study|Lost to Follow-up|0
2502452|NCT01928862|8657121|P1|Overall Study|Lost to Follow-up|1
2502453|NCT01928771|8657195|P3|Overall Study|Severe Non-Compliance to Protocol|2
2502454|NCT01928771|8657196|P2|Overall Study|Severe Non-Compliance to Protocol|2
2502455|NCT01928771|8657197|P1|Overall Study|Severe Non-Compliance to Protocol|4
2502456|NCT01928771|8657195|P3|Overall Study|Other Reasons|14
2502457|NCT01928771|8657196|P2|Overall Study|Other Reasons|9
2502458|NCT01928771|8657197|P1|Overall Study|Other Reasons|9
2502459|NCT01928771|8657195|P3|Overall Study|Study-Specific Withdrawal Criteria|1
2502460|NCT01928771|8657196|P2|Overall Study|Study-Specific Withdrawal Criteria|1
2502461|NCT01928771|8657197|P1|Overall Study|Study-Specific Withdrawal Criteria|0
2502462|NCT01928771|8657195|P3|Overall Study|Withdrawal by Subject|17
2502463|NCT01928771|8657196|P2|Overall Study|Withdrawal by Subject|15
2502464|NCT01928771|8657197|P1|Overall Study|Withdrawal by Subject|20
2502465|NCT01928771|8657195|P3|Overall Study|Lost to Follow-up|3
2502466|NCT01928771|8657196|P2|Overall Study|Lost to Follow-up|6
2502467|NCT01928771|8657197|P1|Overall Study|Lost to Follow-up|5
2502468|NCT01928771|8657195|P3|Overall Study|Death|2
2502469|NCT01928771|8657196|P2|Overall Study|Death|2
2502470|NCT01928771|8657197|P1|Overall Study|Death|2
2502471|NCT01928771|8657195|P3|Overall Study|Adverse Event|1
2502472|NCT01928771|8657196|P2|Overall Study|Adverse Event|5
2502473|NCT01928771|8657197|P1|Overall Study|Adverse Event|6
2502474|NCT01928758|8657276|P2|Overall Study|Protocol Violation|4
2502475|NCT01928758|8657277|P1|Overall Study|Protocol Violation|3
2502476|NCT01928758|8657276|P2|Overall Study|Adverse Event|5
2502477|NCT01928758|8657277|P1|Overall Study|Adverse Event|3
2502478|NCT01928758|8657276|P2|Overall Study|Withdrawal by Subject|2
2502479|NCT01928758|8657277|P1|Overall Study|Withdrawal by Subject|5
2502480|NCT01928758|8657276|P2|Overall Study|Lost to Follow-up|9
2502481|NCT01928758|8657277|P1|Overall Study|Lost to Follow-up|14
2502482|NCT01928719|8657295|P2|Overall Study|Adverse Event|0
2502483|NCT01928719|8657296|P1|Overall Study|Adverse Event|1
2502484|NCT01928719|8657295|P2|Overall Study|Protocol Violation|1
2502485|NCT01928719|8657296|P1|Overall Study|Protocol Violation|3
2502486|NCT01928719|8657295|P2|Overall Study|Withdrawal by Subject|7
2502487|NCT01928719|8657296|P1|Overall Study|Withdrawal by Subject|22
2502488|NCT01928719|8657295|P2|Overall Study|Lost to Follow-up|11
2502489|NCT01928719|8657296|P1|Overall Study|Lost to Follow-up|26
2502490|NCT01928615|8657348|P1|Overall Study|Study Terminated by Sponsor|2
2502491|NCT01928485|8657365|P2|Overall Study|Physician Decision|1
2502492|NCT01928485|8657366|P1|Overall Study|Physician Decision|0
2502493|NCT01928472|8657396|P4|Overall Study|Unclassified|0
2502494|NCT01928472|8657397|P3|Overall Study|Unclassified|1
2502495|NCT01928472|8657398|P2|Overall Study|Unclassified|0
2502496|NCT01928472|8657399|P1|Overall Study|Unclassified|0
2502497|NCT01928472|8657396|P4|Overall Study|Administrative Reason|0
2502498|NCT01928472|8657397|P3|Overall Study|Administrative Reason|0
2502499|NCT01928472|8657398|P2|Overall Study|Administrative Reason|1
2502500|NCT01928472|8657399|P1|Overall Study|Administrative Reason|2
2502501|NCT01928472|8657396|P4|Overall Study|Lost to Follow-up|0
2502502|NCT01928472|8657397|P3|Overall Study|Lost to Follow-up|4
2502503|NCT01928472|8657398|P2|Overall Study|Lost to Follow-up|3
2502504|NCT01928472|8657399|P1|Overall Study|Lost to Follow-up|2
2502505|NCT01928472|8657396|P4|Overall Study|Withdrawal by Subject|2
2502506|NCT01928472|8657397|P3|Overall Study|Withdrawal by Subject|1
2502507|NCT01928472|8657398|P2|Overall Study|Withdrawal by Subject|4
2502508|NCT01928472|8657399|P1|Overall Study|Withdrawal by Subject|4
2502509|NCT01928472|8657396|P4|Overall Study|Death|0
2502510|NCT01928472|8657397|P3|Overall Study|Death|1
2502511|NCT01928472|8657398|P2|Overall Study|Death|0
2502512|NCT01928472|8657399|P1|Overall Study|Death|0
2502513|NCT01928433|8657469|P3|Overall Study|Other reasons|4
2502514|NCT01928433|8657470|P2|Overall Study|Other reasons|3
2502515|NCT01928433|8657471|P1|Overall Study|Other reasons|3
2502516|NCT01928433|8657469|P3|Overall Study|Lost to Follow-up|3
2502517|NCT01928433|8657470|P2|Overall Study|Lost to Follow-up|2
2502518|NCT01928433|8657471|P1|Overall Study|Lost to Follow-up|0
2502519|NCT01928433|8657469|P3|Overall Study|Negative screening urine culture|10
2502520|NCT01928433|8657470|P2|Overall Study|Negative screening urine culture|6
2502521|NCT01928433|8657471|P1|Overall Study|Negative screening urine culture|7
2502522|NCT01928433|8657469|P3|Overall Study|Withdrawal by Subject|0
2502523|NCT01928433|8657470|P2|Overall Study|Withdrawal by Subject|4
2502524|NCT01928433|8657471|P1|Overall Study|Withdrawal by Subject|0
2502525|NCT01928433|8657469|P3|Overall Study|Lack of Efficacy|4
2502526|NCT01928433|8657470|P2|Overall Study|Lack of Efficacy|4
2502527|NCT01928433|8657471|P1|Overall Study|Lack of Efficacy|5
2502528|NCT01928433|8657469|P3|Overall Study|Protocol Violation|2
2502529|NCT01928433|8657470|P2|Overall Study|Protocol Violation|0
2502530|NCT01928433|8657471|P1|Overall Study|Protocol Violation|0
2502531|NCT01928433|8657469|P3|Overall Study|Adverse Event|5
2502532|NCT01928433|8657470|P2|Overall Study|Adverse Event|2
2502533|NCT01928433|8657471|P1|Overall Study|Adverse Event|5
2502534|NCT01928394|8657517|P23|Follow-up Period|Lost to Follow-up|1
2502535|NCT01928394|8657518|P22|Follow-up Period|Lost to Follow-up|0
2502536|NCT01928394|8657519|P21|Follow-up Period|Lost to Follow-up|0
2502537|NCT01928394|8657520|P20|Follow-up Period|Lost to Follow-up|0
2502538|NCT01928394|8657521|P19|Follow-up Period|Lost to Follow-up|0
2502539|NCT01928394|8657522|P18|Follow-up Period|Lost to Follow-up|0
2502540|NCT01928394|8657523|P17|Follow-up Period|Lost to Follow-up|1
2502541|NCT01928394|8657524|P16|Follow-up Period|Lost to Follow-up|0
2502542|NCT01928394|8657525|P15|Follow-up Period|Lost to Follow-up|1
2502543|NCT01928394|8657526|P14|Follow-up Period|Lost to Follow-up|0
2502544|NCT01928394|8657527|P13|Follow-up Period|Lost to Follow-up|1
2502545|NCT01928394|8657528|P12|Follow-up Period|Lost to Follow-up|1
2502546|NCT01928394|8657529|P11|Follow-up Period|Lost to Follow-up|0
2502547|NCT01928394|8657530|P10|Follow-up Period|Lost to Follow-up|0
2502548|NCT01928394|8657531|P9|Follow-up Period|Lost to Follow-up|0
2502549|NCT01928394|8657532|P8|Follow-up Period|Lost to Follow-up|0
2502550|NCT01928394|8657533|P7|Follow-up Period|Lost to Follow-up|0
2502551|NCT01928394|8657534|P6|Follow-up Period|Lost to Follow-up|0
2502552|NCT01928394|8657535|P5|Follow-up Period|Lost to Follow-up|0
2502553|NCT01928394|8657536|P4|Follow-up Period|Lost to Follow-up|0
2502554|NCT01928394|8657537|P3|Follow-up Period|Lost to Follow-up|0
2502555|NCT01928394|8657538|P2|Follow-up Period|Lost to Follow-up|0
2502556|NCT01928394|8657539|P1|Follow-up Period|Lost to Follow-up|0
2502557|NCT01928394|8657517|P23|Follow-up Period|other reason|1
2502558|NCT01928394|8657518|P22|Follow-up Period|other reason|0
2502559|NCT01928394|8657519|P21|Follow-up Period|other reason|0
2502560|NCT01928394|8657520|P20|Follow-up Period|other reason|1
2502561|NCT01928394|8657521|P19|Follow-up Period|other reason|1
2502562|NCT01928394|8657522|P18|Follow-up Period|other reason|0
2502563|NCT01928394|8657523|P17|Follow-up Period|other reason|2
2502564|NCT01928394|8657524|P16|Follow-up Period|other reason|0
2502565|NCT01928394|8657525|P15|Follow-up Period|other reason|4
2502566|NCT01928394|8657526|P14|Follow-up Period|other reason|1
2502567|NCT01928394|8657527|P13|Follow-up Period|other reason|0
2502568|NCT01928394|8657528|P12|Follow-up Period|other reason|1
2502569|NCT01928394|8657529|P11|Follow-up Period|other reason|2
2502570|NCT01928394|8657530|P10|Follow-up Period|other reason|0
2502571|NCT01928394|8657531|P9|Follow-up Period|other reason|0
2502572|NCT01928394|8657532|P8|Follow-up Period|other reason|3
2502573|NCT01928394|8657533|P7|Follow-up Period|other reason|1
2502574|NCT01928394|8657534|P6|Follow-up Period|other reason|0
2502575|NCT01928394|8657535|P5|Follow-up Period|other reason|0
2502576|NCT01928394|8657536|P4|Follow-up Period|other reason|0
2502577|NCT01928394|8657537|P3|Follow-up Period|other reason|0
2502578|NCT01928394|8657538|P2|Follow-up Period|other reason|0
2502579|NCT01928394|8657539|P1|Follow-up Period|other reason|0
2502580|NCT01928394|8657517|P23|Follow-up Period|Death|2
2502581|NCT01928394|8657518|P22|Follow-up Period|Death|3
2502582|NCT01928394|8657519|P21|Follow-up Period|Death|5
2502583|NCT01928394|8657520|P20|Follow-up Period|Death|13
2502584|NCT01928394|8657521|P19|Follow-up Period|Death|13
2502585|NCT01928394|8657522|P18|Follow-up Period|Death|5
2502586|NCT01928394|8657523|P17|Follow-up Period|Death|6
2502587|NCT01928394|8657524|P16|Follow-up Period|Death|0
2502588|NCT01928394|8657525|P15|Follow-up Period|Death|18
2502589|NCT01928394|8657526|P14|Follow-up Period|Death|25
2502590|NCT01928394|8657527|P13|Follow-up Period|Death|11
2502591|NCT01928394|8657528|P12|Follow-up Period|Death|12
2502592|NCT01928394|8657529|P11|Follow-up Period|Death|4
2502593|NCT01928394|8657530|P10|Follow-up Period|Death|2
2502594|NCT01928394|8657531|P9|Follow-up Period|Death|1
2502595|NCT01928394|8657532|P8|Follow-up Period|Death|2
2502596|NCT01928394|8657533|P7|Follow-up Period|Death|6
2502597|NCT01928394|8657534|P6|Follow-up Period|Death|6
2502598|NCT01928394|8657535|P5|Follow-up Period|Death|0
2502599|NCT01928394|8657536|P4|Follow-up Period|Death|6
2502600|NCT01928394|8657537|P3|Follow-up Period|Death|2
2502601|NCT01928394|8657538|P2|Follow-up Period|Death|0
2502602|NCT01928394|8657539|P1|Follow-up Period|Death|0
2502603|NCT01928394|8657517|P23|Follow-up Period|Participant withdrew consent|2
2502604|NCT01928394|8657518|P22|Follow-up Period|Participant withdrew consent|6
2502605|NCT01928394|8657519|P21|Follow-up Period|Participant withdrew consent|4
2502606|NCT01928394|8657520|P20|Follow-up Period|Participant withdrew consent|7
2502607|NCT01928394|8657521|P19|Follow-up Period|Participant withdrew consent|2
2502608|NCT01928394|8657522|P18|Follow-up Period|Participant withdrew consent|3
2502609|NCT01928394|8657523|P17|Follow-up Period|Participant withdrew consent|5
2502610|NCT01928394|8657524|P16|Follow-up Period|Participant withdrew consent|0
2502611|NCT01928394|8657525|P15|Follow-up Period|Participant withdrew consent|7
2502612|NCT01928394|8657526|P14|Follow-up Period|Participant withdrew consent|12
2502613|NCT01928394|8657527|P13|Follow-up Period|Participant withdrew consent|2
2502614|NCT01928394|8657528|P12|Follow-up Period|Participant withdrew consent|8
2502615|NCT01928394|8657529|P11|Follow-up Period|Participant withdrew consent|5
2502616|NCT01928394|8657530|P10|Follow-up Period|Participant withdrew consent|0
2502617|NCT01928394|8657531|P9|Follow-up Period|Participant withdrew consent|0
2502618|NCT01928394|8657532|P8|Follow-up Period|Participant withdrew consent|1
2502619|NCT01928394|8657533|P7|Follow-up Period|Participant withdrew consent|5
2502620|NCT01928394|8657534|P6|Follow-up Period|Participant withdrew consent|2
2502621|NCT01928394|8657535|P5|Follow-up Period|Participant withdrew consent|0
2502622|NCT01928394|8657536|P4|Follow-up Period|Participant withdrew consent|4
2502623|NCT01928394|8657537|P3|Follow-up Period|Participant withdrew consent|1
2502624|NCT01928394|8657538|P2|Follow-up Period|Participant withdrew consent|0
2502625|NCT01928394|8657539|P1|Follow-up Period|Participant withdrew consent|3
2502626|NCT01928394|8657517|P23|Treatment Period|Death|0
2502627|NCT01928394|8657518|P22|Treatment Period|Death|0
2502628|NCT01928394|8657519|P21|Treatment Period|Death|0
2502629|NCT01928394|8657520|P20|Treatment Period|Death|0
2502630|NCT01928394|8657521|P19|Treatment Period|Death|0
2502631|NCT01928394|8657522|P18|Treatment Period|Death|0
2502632|NCT01928394|8657523|P17|Treatment Period|Death|0
2502633|NCT01928394|8657524|P16|Treatment Period|Death|0
2502634|NCT01928394|8657525|P15|Treatment Period|Death|2
2502635|NCT01928394|8657526|P14|Treatment Period|Death|1
2502636|NCT01928394|8657527|P13|Treatment Period|Death|0
2502637|NCT01928394|8657528|P12|Treatment Period|Death|0
2502638|NCT01928394|8657529|P11|Treatment Period|Death|0
2502639|NCT01928394|8657530|P10|Treatment Period|Death|0
2502640|NCT01928394|8657531|P9|Treatment Period|Death|0
2502641|NCT01928394|8657532|P8|Treatment Period|Death|0
2502642|NCT01928394|8657533|P7|Treatment Period|Death|0
2502643|NCT01928394|8657534|P6|Treatment Period|Death|0
2502644|NCT01928394|8657535|P5|Treatment Period|Death|0
2502645|NCT01928394|8657536|P4|Treatment Period|Death|0
2502646|NCT01928394|8657537|P3|Treatment Period|Death|0
2502647|NCT01928394|8657538|P2|Treatment Period|Death|0
2502648|NCT01928394|8657539|P1|Treatment Period|Death|0
2502649|NCT01928394|8657517|P23|Treatment Period|Lost to Follow-up|1
2502650|NCT01928394|8657518|P22|Treatment Period|Lost to Follow-up|0
2502651|NCT01928394|8657519|P21|Treatment Period|Lost to Follow-up|0
2502652|NCT01928394|8657520|P20|Treatment Period|Lost to Follow-up|0
2502653|NCT01928394|8657521|P19|Treatment Period|Lost to Follow-up|0
2502654|NCT01928394|8657522|P18|Treatment Period|Lost to Follow-up|0
2502655|NCT01928394|8657523|P17|Treatment Period|Lost to Follow-up|0
2502656|NCT01928394|8657524|P16|Treatment Period|Lost to Follow-up|0
2502657|NCT01928394|8657525|P15|Treatment Period|Lost to Follow-up|0
2502658|NCT01928394|8657526|P14|Treatment Period|Lost to Follow-up|0
2502659|NCT01928394|8657527|P13|Treatment Period|Lost to Follow-up|0
2502660|NCT01928394|8657528|P12|Treatment Period|Lost to Follow-up|0
2502661|NCT01928394|8657529|P11|Treatment Period|Lost to Follow-up|0
2502662|NCT01928394|8657530|P10|Treatment Period|Lost to Follow-up|0
2502663|NCT01928394|8657531|P9|Treatment Period|Lost to Follow-up|0
2502664|NCT01928394|8657532|P8|Treatment Period|Lost to Follow-up|0
2502665|NCT01928394|8657533|P7|Treatment Period|Lost to Follow-up|0
2502666|NCT01928394|8657534|P6|Treatment Period|Lost to Follow-up|0
2502667|NCT01928394|8657535|P5|Treatment Period|Lost to Follow-up|0
2502668|NCT01928394|8657536|P4|Treatment Period|Lost to Follow-up|0
2502669|NCT01928394|8657537|P3|Treatment Period|Lost to Follow-up|0
2502670|NCT01928394|8657538|P2|Treatment Period|Lost to Follow-up|0
2502671|NCT01928394|8657539|P1|Treatment Period|Lost to Follow-up|0
2502672|NCT01928394|8657517|P23|Treatment Period|Maximum clinical benefit|0
2502673|NCT01928394|8657518|P22|Treatment Period|Maximum clinical benefit|0
2502674|NCT01928394|8657519|P21|Treatment Period|Maximum clinical benefit|2
2502675|NCT01928394|8657520|P20|Treatment Period|Maximum clinical benefit|0
2502676|NCT01928394|8657521|P19|Treatment Period|Maximum clinical benefit|1
2502677|NCT01928394|8657522|P18|Treatment Period|Maximum clinical benefit|1
2502678|NCT01928394|8657523|P17|Treatment Period|Maximum clinical benefit|0
2502679|NCT01928394|8657524|P16|Treatment Period|Maximum clinical benefit|0
2502680|NCT01928394|8657525|P15|Treatment Period|Maximum clinical benefit|1
2502681|NCT01928394|8657526|P14|Treatment Period|Maximum clinical benefit|0
2502682|NCT01928394|8657527|P13|Treatment Period|Maximum clinical benefit|0
2502683|NCT01928394|8657528|P12|Treatment Period|Maximum clinical benefit|1
2502684|NCT01928394|8657529|P11|Treatment Period|Maximum clinical benefit|1
2502685|NCT01928394|8657530|P10|Treatment Period|Maximum clinical benefit|0
2502686|NCT01928394|8657531|P9|Treatment Period|Maximum clinical benefit|0
2502687|NCT01928394|8657532|P8|Treatment Period|Maximum clinical benefit|0
2502688|NCT01928394|8657533|P7|Treatment Period|Maximum clinical benefit|0
2502689|NCT01928394|8657534|P6|Treatment Period|Maximum clinical benefit|0
2502690|NCT01928394|8657535|P5|Treatment Period|Maximum clinical benefit|0
2502691|NCT01928394|8657536|P4|Treatment Period|Maximum clinical benefit|0
2502692|NCT01928394|8657537|P3|Treatment Period|Maximum clinical benefit|0
2502693|NCT01928394|8657538|P2|Treatment Period|Maximum clinical benefit|0
2502694|NCT01928394|8657539|P1|Treatment Period|Maximum clinical benefit|0
2502695|NCT01928394|8657517|P23|Treatment Period|other reason|0
2502696|NCT01928394|8657518|P22|Treatment Period|other reason|0
2502697|NCT01928394|8657519|P21|Treatment Period|other reason|0
2502698|NCT01928394|8657520|P20|Treatment Period|other reason|2
2502699|NCT01928394|8657521|P19|Treatment Period|other reason|2
2502700|NCT01928394|8657522|P18|Treatment Period|other reason|0
2502701|NCT01928394|8657523|P17|Treatment Period|other reason|0
2502702|NCT01928394|8657524|P16|Treatment Period|other reason|0
2502703|NCT01928394|8657525|P15|Treatment Period|other reason|1
2502704|NCT01928394|8657526|P14|Treatment Period|other reason|0
2502705|NCT01928394|8657527|P13|Treatment Period|other reason|1
2502706|NCT01928394|8657528|P12|Treatment Period|other reason|1
2502707|NCT01928394|8657529|P11|Treatment Period|other reason|1
2502708|NCT01928394|8657530|P10|Treatment Period|other reason|0
2502709|NCT01928394|8657531|P9|Treatment Period|other reason|0
2502710|NCT01928394|8657532|P8|Treatment Period|other reason|0
2502711|NCT01928394|8657533|P7|Treatment Period|other reason|0
2502712|NCT01928394|8657534|P6|Treatment Period|other reason|0
2502713|NCT01928394|8657535|P5|Treatment Period|other reason|0
2502714|NCT01928394|8657536|P4|Treatment Period|other reason|0
2502715|NCT01928394|8657537|P3|Treatment Period|other reason|0
2502716|NCT01928394|8657538|P2|Treatment Period|other reason|0
2502717|NCT01928394|8657539|P1|Treatment Period|other reason|0
2502718|NCT01928394|8657517|P23|Treatment Period|Poor/non-compliance|0
2502719|NCT01928394|8657518|P22|Treatment Period|Poor/non-compliance|0
2502720|NCT01928394|8657519|P21|Treatment Period|Poor/non-compliance|0
2502721|NCT01928394|8657520|P20|Treatment Period|Poor/non-compliance|1
2502722|NCT01928394|8657521|P19|Treatment Period|Poor/non-compliance|0
2502723|NCT01928394|8657522|P18|Treatment Period|Poor/non-compliance|1
2502724|NCT01928394|8657523|P17|Treatment Period|Poor/non-compliance|0
2502725|NCT01928394|8657524|P16|Treatment Period|Poor/non-compliance|0
2502726|NCT01928394|8657525|P15|Treatment Period|Poor/non-compliance|1
2502727|NCT01928394|8657526|P14|Treatment Period|Poor/non-compliance|0
2502728|NCT01928394|8657527|P13|Treatment Period|Poor/non-compliance|1
2502729|NCT01928394|8657528|P12|Treatment Period|Poor/non-compliance|0
2502730|NCT01928394|8657529|P11|Treatment Period|Poor/non-compliance|0
2502731|NCT01928394|8657530|P10|Treatment Period|Poor/non-compliance|0
2502732|NCT01928394|8657531|P9|Treatment Period|Poor/non-compliance|0
2502733|NCT01928394|8657532|P8|Treatment Period|Poor/non-compliance|0
2502734|NCT01928394|8657533|P7|Treatment Period|Poor/non-compliance|0
2502735|NCT01928394|8657534|P6|Treatment Period|Poor/non-compliance|0
2502736|NCT01928394|8657535|P5|Treatment Period|Poor/non-compliance|0
2502737|NCT01928394|8657536|P4|Treatment Period|Poor/non-compliance|1
2502738|NCT01928394|8657537|P3|Treatment Period|Poor/non-compliance|0
2502739|NCT01928394|8657538|P2|Treatment Period|Poor/non-compliance|0
2502740|NCT01928394|8657539|P1|Treatment Period|Poor/non-compliance|0
2502741|NCT01928394|8657517|P23|Treatment Period|Participant withdrew consent|0
2502742|NCT01928394|8657518|P22|Treatment Period|Participant withdrew consent|2
2502743|NCT01928394|8657519|P21|Treatment Period|Participant withdrew consent|0
2502744|NCT01928394|8657520|P20|Treatment Period|Participant withdrew consent|1
2502745|NCT01928394|8657521|P19|Treatment Period|Participant withdrew consent|1
2502746|NCT01928394|8657522|P18|Treatment Period|Participant withdrew consent|1
2502747|NCT01928394|8657523|P17|Treatment Period|Participant withdrew consent|2
2502748|NCT01928394|8657524|P16|Treatment Period|Participant withdrew consent|0
2502749|NCT01928394|8657525|P15|Treatment Period|Participant withdrew consent|2
2502750|NCT01928394|8657526|P14|Treatment Period|Participant withdrew consent|0
2502751|NCT01928394|8657527|P13|Treatment Period|Participant withdrew consent|1
2502752|NCT01928394|8657528|P12|Treatment Period|Participant withdrew consent|1
2502753|NCT01928394|8657529|P11|Treatment Period|Participant withdrew consent|1
2502754|NCT01928394|8657530|P10|Treatment Period|Participant withdrew consent|0
2502755|NCT01928394|8657531|P9|Treatment Period|Participant withdrew consent|0
2502756|NCT01928394|8657532|P8|Treatment Period|Participant withdrew consent|1
2502757|NCT01928394|8657533|P7|Treatment Period|Participant withdrew consent|0
2502758|NCT01928394|8657534|P6|Treatment Period|Participant withdrew consent|1
2502759|NCT01928394|8657535|P5|Treatment Period|Participant withdrew consent|0
2502760|NCT01928394|8657536|P4|Treatment Period|Participant withdrew consent|1
2502761|NCT01928394|8657537|P3|Treatment Period|Participant withdrew consent|1
2502762|NCT01928394|8657538|P2|Treatment Period|Participant withdrew consent|0
2502763|NCT01928394|8657539|P1|Treatment Period|Participant withdrew consent|0
2502764|NCT01928394|8657517|P23|Treatment Period|Participant request to stop therapy|3
2502765|NCT01928394|8657518|P22|Treatment Period|Participant request to stop therapy|1
2502766|NCT01928394|8657519|P21|Treatment Period|Participant request to stop therapy|3
2502767|NCT01928394|8657520|P20|Treatment Period|Participant request to stop therapy|1
2502768|NCT01928394|8657521|P19|Treatment Period|Participant request to stop therapy|1
2502769|NCT01928394|8657522|P18|Treatment Period|Participant request to stop therapy|3
2502770|NCT01928394|8657523|P17|Treatment Period|Participant request to stop therapy|1
2502771|NCT01928394|8657524|P16|Treatment Period|Participant request to stop therapy|0
2502772|NCT01928394|8657525|P15|Treatment Period|Participant request to stop therapy|4
2502773|NCT01928394|8657526|P14|Treatment Period|Participant request to stop therapy|2
2502774|NCT01928394|8657527|P13|Treatment Period|Participant request to stop therapy|1
2502775|NCT01928394|8657528|P12|Treatment Period|Participant request to stop therapy|2
2502776|NCT01928394|8657529|P11|Treatment Period|Participant request to stop therapy|3
2502777|NCT01928394|8657530|P10|Treatment Period|Participant request to stop therapy|0
2502778|NCT01928394|8657531|P9|Treatment Period|Participant request to stop therapy|0
2502779|NCT01928394|8657532|P8|Treatment Period|Participant request to stop therapy|0
2502780|NCT01928394|8657533|P7|Treatment Period|Participant request to stop therapy|3
2502781|NCT01928394|8657534|P6|Treatment Period|Participant request to stop therapy|3
2502782|NCT01928394|8657535|P5|Treatment Period|Participant request to stop therapy|0
2502783|NCT01928394|8657536|P4|Treatment Period|Participant request to stop therapy|0
2502784|NCT01928394|8657537|P3|Treatment Period|Participant request to stop therapy|0
2502785|NCT01928394|8657538|P2|Treatment Period|Participant request to stop therapy|0
2502786|NCT01928394|8657539|P1|Treatment Period|Participant request to stop therapy|0
2502787|NCT01928394|8657517|P23|Treatment Period|AE unrelated to study drug|0
2502788|NCT01928394|8657518|P22|Treatment Period|AE unrelated to study drug|1
2502789|NCT01928394|8657519|P21|Treatment Period|AE unrelated to study drug|1
2502790|NCT01928394|8657520|P20|Treatment Period|AE unrelated to study drug|5
2502791|NCT01928394|8657521|P19|Treatment Period|AE unrelated to study drug|3
2502792|NCT01928394|8657522|P18|Treatment Period|AE unrelated to study drug|6
2502793|NCT01928394|8657523|P17|Treatment Period|AE unrelated to study drug|1
2502794|NCT01928394|8657524|P16|Treatment Period|AE unrelated to study drug|1
2502795|NCT01928394|8657525|P15|Treatment Period|AE unrelated to study drug|6
2502796|NCT01928394|8657526|P14|Treatment Period|AE unrelated to study drug|13
2502797|NCT01928394|8657527|P13|Treatment Period|AE unrelated to study drug|6
2502798|NCT01928394|8657528|P12|Treatment Period|AE unrelated to study drug|12
2502799|NCT01928394|8657529|P11|Treatment Period|AE unrelated to study drug|0
2502800|NCT01928394|8657530|P10|Treatment Period|AE unrelated to study drug|2
2502801|NCT01928394|8657531|P9|Treatment Period|AE unrelated to study drug|0
2502802|NCT01928394|8657532|P8|Treatment Period|AE unrelated to study drug|0
2502803|NCT01928394|8657533|P7|Treatment Period|AE unrelated to study drug|1
2502804|NCT01928394|8657534|P6|Treatment Period|AE unrelated to study drug|5
2502805|NCT01928394|8657535|P5|Treatment Period|AE unrelated to study drug|0
2502806|NCT01928394|8657536|P4|Treatment Period|AE unrelated to study drug|3
2502807|NCT01928394|8657537|P3|Treatment Period|AE unrelated to study drug|2
2502808|NCT01928394|8657538|P2|Treatment Period|AE unrelated to study drug|0
2502809|NCT01928394|8657539|P1|Treatment Period|AE unrelated to study drug|0
2502810|NCT01928394|8657517|P23|Treatment Period|Study drug toxicity|4
2502811|NCT01928394|8657518|P22|Treatment Period|Study drug toxicity|7
2502812|NCT01928394|8657519|P21|Treatment Period|Study drug toxicity|4
2502813|NCT01928394|8657520|P20|Treatment Period|Study drug toxicity|15
2502814|NCT01928394|8657521|P19|Treatment Period|Study drug toxicity|12
2502815|NCT01928394|8657522|P18|Treatment Period|Study drug toxicity|3
2502816|NCT01928394|8657523|P17|Treatment Period|Study drug toxicity|3
2502817|NCT01928394|8657524|P16|Treatment Period|Study drug toxicity|0
2502818|NCT01928394|8657525|P15|Treatment Period|Study drug toxicity|12
2502819|NCT01928394|8657526|P14|Treatment Period|Study drug toxicity|5
2502820|NCT01928394|8657527|P13|Treatment Period|Study drug toxicity|7
2502821|NCT01928394|8657528|P12|Treatment Period|Study drug toxicity|3
2502822|NCT01928394|8657529|P11|Treatment Period|Study drug toxicity|2
2502823|NCT01928394|8657530|P10|Treatment Period|Study drug toxicity|5
2502824|NCT01928394|8657531|P9|Treatment Period|Study drug toxicity|0
2502825|NCT01928394|8657532|P8|Treatment Period|Study drug toxicity|1
2502826|NCT01928394|8657533|P7|Treatment Period|Study drug toxicity|7
2502827|NCT01928394|8657534|P6|Treatment Period|Study drug toxicity|9
2502828|NCT01928394|8657535|P5|Treatment Period|Study drug toxicity|0
2502829|NCT01928394|8657536|P4|Treatment Period|Study drug toxicity|3
2502830|NCT01928394|8657537|P3|Treatment Period|Study drug toxicity|3
2502831|NCT01928394|8657538|P2|Treatment Period|Study drug toxicity|1
2502832|NCT01928394|8657539|P1|Treatment Period|Study drug toxicity|1
2502833|NCT01928394|8657517|P23|Treatment Period|Disease progression|31
2502834|NCT01928394|8657518|P22|Treatment Period|Disease progression|31
2502835|NCT01928394|8657519|P21|Treatment Period|Disease progression|30
2502836|NCT01928394|8657520|P20|Treatment Period|Disease progression|71
2502837|NCT01928394|8657521|P19|Treatment Period|Disease progression|50
2502838|NCT01928394|8657522|P18|Treatment Period|Disease progression|56
2502839|NCT01928394|8657523|P17|Treatment Period|Disease progression|43
2502840|NCT01928394|8657524|P16|Treatment Period|Disease progression|1
2502841|NCT01928394|8657525|P15|Treatment Period|Disease progression|59
2502842|NCT01928394|8657526|P14|Treatment Period|Disease progression|118
2502843|NCT01928394|8657527|P13|Treatment Period|Disease progression|38
2502844|NCT01928394|8657528|P12|Treatment Period|Disease progression|73
2502845|NCT01928394|8657529|P11|Treatment Period|Disease progression|22
2502846|NCT01928394|8657530|P10|Treatment Period|Disease progression|11
2502847|NCT01928394|8657531|P9|Treatment Period|Disease progression|3
2502848|NCT01928394|8657532|P8|Treatment Period|Disease progression|16
2502849|NCT01928394|8657533|P7|Treatment Period|Disease progression|38
2502850|NCT01928394|8657534|P6|Treatment Period|Disease progression|25
2502851|NCT01928394|8657535|P5|Treatment Period|Disease progression|3
2502852|NCT01928394|8657536|P4|Treatment Period|Disease progression|48
2502853|NCT01928394|8657537|P3|Treatment Period|Disease progression|12
2502854|NCT01928394|8657538|P2|Treatment Period|Disease progression|2
2502855|NCT01928394|8657539|P1|Treatment Period|Disease progression|17
2502856|NCT01928381|8657587|P7|Part 2 - Post Third Intervention|Protocol Violation|0
2502857|NCT01928381|8657588|P6|Part 2 - Post Third Intervention|Protocol Violation|0
2502858|NCT01928381|8657589|P5|Part 2 - Post Third Intervention|Protocol Violation|0
2502859|NCT01928381|8657590|P4|Part 2 - Post Third Intervention|Protocol Violation|0
2502860|NCT01928381|8657591|P3|Part 2 - Post Third Intervention|Protocol Violation|1
2502861|NCT01928381|8657592|P2|Part 2 - Post Third Intervention|Protocol Violation|0
2502862|NCT01928381|8657593|P1|Part 2 - Post Third Intervention|Protocol Violation|0
2502863|NCT01928381|8657587|P7|Part 2 - Second Intervention|Lost to Follow-up|0
2502864|NCT01928381|8657588|P6|Part 2 - Second Intervention|Lost to Follow-up|0
2502865|NCT01928381|8657589|P5|Part 2 - Second Intervention|Lost to Follow-up|0
2502866|NCT01928381|8657590|P4|Part 2 - Second Intervention|Lost to Follow-up|1
2502867|NCT01928381|8657591|P3|Part 2 - Second Intervention|Lost to Follow-up|0
2502868|NCT01928381|8657592|P2|Part 2 - Second Intervention|Lost to Follow-up|1
2502869|NCT01928381|8657593|P1|Part 2 - Second Intervention|Lost to Follow-up|0
2502870|NCT01928381|8657587|P7|Washout First Intervention|Protocol Violation|0
2502871|NCT01928381|8657588|P6|Washout First Intervention|Protocol Violation|0
2502872|NCT01928381|8657589|P5|Washout First Intervention|Protocol Violation|1
2502873|NCT01928381|8657590|P4|Washout First Intervention|Protocol Violation|0
2502874|NCT01928381|8657591|P3|Washout First Intervention|Protocol Violation|0
2502875|NCT01928381|8657592|P2|Washout First Intervention|Protocol Violation|0
2502876|NCT01928381|8657593|P1|Washout First Intervention|Protocol Violation|0
2502877|NCT01928381|8657587|P7|Part 2 - First Intervention|Lost to Follow-up|0
2502878|NCT01928381|8657588|P6|Part 2 - First Intervention|Lost to Follow-up|0
2502879|NCT01928381|8657589|P5|Part 2 - First Intervention|Lost to Follow-up|0
2502880|NCT01928381|8657590|P4|Part 2 - First Intervention|Lost to Follow-up|1
2502881|NCT01928381|8657591|P3|Part 2 - First Intervention|Lost to Follow-up|0
2502882|NCT01928381|8657592|P2|Part 2 - First Intervention|Lost to Follow-up|0
2502883|NCT01928381|8657593|P1|Part 2 - First Intervention|Lost to Follow-up|0
2502884|NCT01928381|8657587|P7|Part 2 - First Intervention|Eligibility criterion not met|1
2502885|NCT01928381|8657588|P6|Part 2 - First Intervention|Eligibility criterion not met|1
2502886|NCT01928381|8657589|P5|Part 2 - First Intervention|Eligibility criterion not met|0
2502887|NCT01928381|8657590|P4|Part 2 - First Intervention|Eligibility criterion not met|0
2502888|NCT01928381|8657591|P3|Part 2 - First Intervention|Eligibility criterion not met|0
2502889|NCT01928381|8657592|P2|Part 2 - First Intervention|Eligibility criterion not met|0
2502890|NCT01928381|8657593|P1|Part 2 - First Intervention|Eligibility criterion not met|0
2502891|NCT01928381|8657587|P7|Part 2 - First Intervention|Study specific withdrawal criteria|0
2502892|NCT01928381|8657588|P6|Part 2 - First Intervention|Study specific withdrawal criteria|0
2502893|NCT01928381|8657589|P5|Part 2 - First Intervention|Study specific withdrawal criteria|0
2502894|NCT01928381|8657590|P4|Part 2 - First Intervention|Study specific withdrawal criteria|0
2502895|NCT01928381|8657591|P3|Part 2 - First Intervention|Study specific withdrawal criteria|1
2502896|NCT01928381|8657592|P2|Part 2 - First Intervention|Study specific withdrawal criteria|0
2502897|NCT01928381|8657593|P1|Part 2 - First Intervention|Study specific withdrawal criteria|0
2502898|NCT01928381|8657587|P7|Part 2 - First Intervention|Withdrawal by Subject|0
2502899|NCT01928381|8657588|P6|Part 2 - First Intervention|Withdrawal by Subject|0
2502900|NCT01928381|8657589|P5|Part 2 - First Intervention|Withdrawal by Subject|0
2502901|NCT01928381|8657590|P4|Part 2 - First Intervention|Withdrawal by Subject|0
2502902|NCT01928381|8657591|P3|Part 2 - First Intervention|Withdrawal by Subject|1
2502903|NCT01928381|8657592|P2|Part 2 - First Intervention|Withdrawal by Subject|0
2502904|NCT01928381|8657593|P1|Part 2 - First Intervention|Withdrawal by Subject|0
2502905|NCT01928381|8657587|P7|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
2502906|NCT01928381|8657588|P6|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
2502907|NCT01928381|8657589|P5|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
2502908|NCT01928381|8657590|P4|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
2502909|NCT01928381|8657591|P3|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
2502910|NCT01928381|8657592|P2|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
2502911|NCT01928381|8657593|P1|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10
2502912|NCT01928381|8657587|P7|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
2502913|NCT01928381|8657588|P6|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
2502914|NCT01928381|8657589|P5|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
2502915|NCT01928381|8657590|P4|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
2502916|NCT01928381|8657591|P3|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
2502917|NCT01928381|8657592|P2|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
2502918|NCT01928381|8657593|P1|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1
2502919|NCT01928381|8657587|P7|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
2502920|NCT01928381|8657588|P6|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
2502921|NCT01928381|8657589|P5|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
2502922|NCT01928381|8657590|P4|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
2502923|NCT01928381|8657591|P3|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
2502924|NCT01928381|8657592|P2|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
2502925|NCT01928381|8657593|P1|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2
2502926|NCT01928381|8657587|P7|Placebo run-in & Part 2 Eligibility|Adverse Event|0
2502927|NCT01928381|8657588|P6|Placebo run-in & Part 2 Eligibility|Adverse Event|0
2502928|NCT01928381|8657589|P5|Placebo run-in & Part 2 Eligibility|Adverse Event|0
2502929|NCT01928381|8657590|P4|Placebo run-in & Part 2 Eligibility|Adverse Event|0
2502930|NCT01928381|8657591|P3|Placebo run-in & Part 2 Eligibility|Adverse Event|0
2502931|NCT01928381|8657592|P2|Placebo run-in & Part 2 Eligibility|Adverse Event|0
2502932|NCT01928381|8657593|P1|Placebo run-in & Part 2 Eligibility|Adverse Event|1
2502933|NCT01928381|8657587|P7|Part 1 - Pain Training|Protocol Violation|0
2502934|NCT01928381|8657588|P6|Part 1 - Pain Training|Protocol Violation|0
2502935|NCT01928381|8657589|P5|Part 1 - Pain Training|Protocol Violation|0
2502936|NCT01928381|8657590|P4|Part 1 - Pain Training|Protocol Violation|0
2502937|NCT01928381|8657591|P3|Part 1 - Pain Training|Protocol Violation|0
2502938|NCT01928381|8657592|P2|Part 1 - Pain Training|Protocol Violation|0
2502939|NCT01928381|8657593|P1|Part 1 - Pain Training|Protocol Violation|1
2502940|NCT01928381|8657587|P7|Part 1 - Pain Training|Lost to Follow-up|0
2502941|NCT01928381|8657588|P6|Part 1 - Pain Training|Lost to Follow-up|0
2502942|NCT01928381|8657589|P5|Part 1 - Pain Training|Lost to Follow-up|0
2502943|NCT01928381|8657590|P4|Part 1 - Pain Training|Lost to Follow-up|0
2502944|NCT01928381|8657591|P3|Part 1 - Pain Training|Lost to Follow-up|0
2502945|NCT01928381|8657592|P2|Part 1 - Pain Training|Lost to Follow-up|0
2502946|NCT01928381|8657593|P1|Part 1 - Pain Training|Lost to Follow-up|4
2502947|NCT01928381|8657587|P7|Part 1 - Pain Training|Withdrawal by Subject|0
2502948|NCT01928381|8657588|P6|Part 1 - Pain Training|Withdrawal by Subject|0
2502949|NCT01928381|8657589|P5|Part 1 - Pain Training|Withdrawal by Subject|0
2502950|NCT01928381|8657590|P4|Part 1 - Pain Training|Withdrawal by Subject|0
2502951|NCT01928381|8657591|P3|Part 1 - Pain Training|Withdrawal by Subject|0
2502952|NCT01928381|8657592|P2|Part 1 - Pain Training|Withdrawal by Subject|0
2502953|NCT01928381|8657593|P1|Part 1 - Pain Training|Withdrawal by Subject|1
2502954|NCT01928381|8657587|P7|Part 1 - Pain Training|Pain training criteria not met|0
2502955|NCT01928381|8657588|P6|Part 1 - Pain Training|Pain training criteria not met|0
2502956|NCT01928381|8657589|P5|Part 1 - Pain Training|Pain training criteria not met|0
2502957|NCT01928381|8657590|P4|Part 1 - Pain Training|Pain training criteria not met|0
2502958|NCT01928381|8657591|P3|Part 1 - Pain Training|Pain training criteria not met|0
2502959|NCT01928381|8657592|P2|Part 1 - Pain Training|Pain training criteria not met|0
2502960|NCT01928381|8657593|P1|Part 1 - Pain Training|Pain training criteria not met|29
2502961|NCT01928381|8657587|P7|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
2502962|NCT01928381|8657588|P6|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
2502963|NCT01928381|8657589|P5|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
2502964|NCT01928381|8657590|P4|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
2502965|NCT01928381|8657591|P3|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
2502966|NCT01928381|8657592|P2|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
2502967|NCT01928381|8657593|P1|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60
2502968|NCT01928329|8657608|P2|Overall Study|Physician Decision|1
2502969|NCT01928329|8657609|P1|Overall Study|Physician Decision|1
2502970|NCT01928329|8657608|P2|Overall Study|Withdrawal by Subject|5
2502971|NCT01928329|8657609|P1|Overall Study|Withdrawal by Subject|1
2502972|NCT01928329|8657608|P2|Overall Study|Stopping Rule: Lost Greater than 5kg|1
2502973|NCT01928329|8657609|P1|Overall Study|Stopping Rule: Lost Greater than 5kg|4
2502974|NCT01928329|8657608|P2|Overall Study|Adverse Event|3
2502975|NCT01928329|8657609|P1|Overall Study|Adverse Event|5
2502976|NCT01928329|8657608|P2|Overall Study|Removed from Study Prior to Receiving Dr|1
2502977|NCT01928329|8657609|P1|Overall Study|Removed from Study Prior to Receiving Dr|0
2502978|NCT01928329|8657608|P2|Overall Study|Withdrew Consent Prior to Receiving Drug|3
2502979|NCT01928329|8657609|P1|Overall Study|Withdrew Consent Prior to Receiving Drug|1
2502980|NCT01928082|8657648|P1|Overall Study|Study terminated.|1
2502981|NCT01927861|8657682|P2|Extension Phase (104 Weeks)|Unclassified|1
2502982|NCT01927861|8657683|P1|Extension Phase (104 Weeks)|Unclassified|0
2502983|NCT01927861|8657682|P2|Extension Phase (104 Weeks)|Adverse Event|2
2502984|NCT01927861|8657683|P1|Extension Phase (104 Weeks)|Adverse Event|0
2502985|NCT01927757|8657821|P1|Overall Study|Ethical Reasons|4
2502986|NCT01927757|8657821|P1|Overall Study|Other|1
2502987|NCT01927757|8657821|P1|Overall Study|Decision by Sponsor|2
2502988|NCT01927757|8657821|P1|Overall Study|Lost to Follow-up|2
2502989|NCT01927757|8657821|P1|Overall Study|Withdrawal by Subject|14
2502990|NCT01927627|8657843|P1|Overall Study|Financial Concerns|1
2502991|NCT01927627|8657843|P1|Overall Study|Lack of Efficacy|1
2502992|NCT01927627|8657843|P1|Overall Study|Adverse Event|3
2502993|NCT01927562|8657856|P1|Overall Study|Physician Decision|5
2502994|NCT01927562|8657856|P1|Overall Study|Withdrawal by Subject|3
2502995|NCT01927562|8657856|P1|Overall Study|Lost to Follow-up|30
2502996|NCT01927419|8657862|P2|Overall Study|Not reported|0
2502997|NCT01927419|8657863|P1|Overall Study|Not reported|1
2502998|NCT01927419|8657862|P2|Overall Study|Other|1
2502999|NCT01927419|8657863|P1|Overall Study|Other|2
2503000|NCT01927419|8657862|P2|Overall Study|Withdrawal by Subject|1
2503001|NCT01927419|8657863|P1|Overall Study|Withdrawal by Subject|3
2503002|NCT01927419|8657862|P2|Overall Study|Adverse event unrelated to study drug|1
2503003|NCT01927419|8657863|P1|Overall Study|Adverse event unrelated to study drug|6
2503004|NCT01927419|8657862|P2|Overall Study|Death|1
2503005|NCT01927419|8657863|P1|Overall Study|Death|0
2503006|NCT01927419|8657862|P2|Overall Study|Study drug toxicity|7
2503007|NCT01927419|8657863|P1|Overall Study|Study drug toxicity|43
2503008|NCT01927419|8657862|P2|Overall Study|Disease progression|17
2503009|NCT01927419|8657863|P1|Overall Study|Disease progression|15
2503010|NCT01927055|8657897|P3|Double-Blind|Extended Vacation|0
2503011|NCT01927055|8657898|P2|Double-Blind|Extended Vacation|1
2503012|NCT01927055|8657899|P1|Double-Blind|Extended Vacation|0
2503013|NCT01927055|8657897|P3|Double-Blind|Supine Hypertension|1
2503014|NCT01927055|8657898|P2|Double-Blind|Supine Hypertension|0
2503015|NCT01927055|8657899|P1|Double-Blind|Supine Hypertension|0
2503016|NCT01927055|8657897|P3|Double-Blind|Study Stopped|7
2503017|NCT01927055|8657898|P2|Double-Blind|Study Stopped|7
2503018|NCT01927055|8657899|P1|Double-Blind|Study Stopped|0
2503019|NCT01927055|8657897|P3|Double-Blind|Withdrawal by Subject|3
2503020|NCT01927055|8657898|P2|Double-Blind|Withdrawal by Subject|2
2503021|NCT01927055|8657899|P1|Double-Blind|Withdrawal by Subject|0
2503022|NCT01927055|8657897|P3|Double-Blind|Protocol Violation|1
2503023|NCT01927055|8657898|P2|Double-Blind|Protocol Violation|0
2503024|NCT01927055|8657899|P1|Double-Blind|Protocol Violation|0
2503025|NCT01927055|8657897|P3|Double-Blind|Adverse Event|1
2503026|NCT01927055|8657898|P2|Double-Blind|Adverse Event|1
2503027|NCT01927055|8657899|P1|Double-Blind|Adverse Event|0
2503028|NCT01927055|8657897|P3|Open-label|Difficulty attending study visits|0
2503029|NCT01927055|8657898|P2|Open-label|Difficulty attending study visits|0
2503030|NCT01927055|8657899|P1|Open-label|Difficulty attending study visits|1
2503031|NCT01927055|8657897|P3|Open-label|Supine Hypertension|0
2503032|NCT01927055|8657898|P2|Open-label|Supine Hypertension|0
2503033|NCT01927055|8657899|P1|Open-label|Supine Hypertension|4
2503034|NCT01927055|8657897|P3|Open-label|Study Stopped|0
2503035|NCT01927055|8657898|P2|Open-label|Study Stopped|0
2503036|NCT01927055|8657899|P1|Open-label|Study Stopped|4
2503037|NCT01927055|8657897|P3|Open-label|Withdrawal by Subject|0
2503038|NCT01927055|8657898|P2|Open-label|Withdrawal by Subject|0
2503039|NCT01927055|8657899|P1|Open-label|Withdrawal by Subject|1
2503040|NCT01927055|8657897|P3|Open-label|Adverse Event|0
2503041|NCT01927055|8657898|P2|Open-label|Adverse Event|0
2503042|NCT01927055|8657899|P1|Open-label|Adverse Event|6
2503043|NCT01926886|8657917|P2|Overall Study|Did not cooperate|0
2503044|NCT01926886|8657918|P1|Overall Study|Did not cooperate|1
2503045|NCT01926886|8657917|P2|Overall Study|Death|0
2503046|NCT01926886|8657918|P1|Overall Study|Death|1
2503047|NCT01926886|8657917|P2|Overall Study|Progression of disease|0
2503048|NCT01926886|8657918|P1|Overall Study|Progression of disease|2
2503049|NCT01926886|8657917|P2|Overall Study|Recurrence of disease|0
2503050|NCT01926886|8657918|P1|Overall Study|Recurrence of disease|1
2503051|NCT01926886|8657917|P2|Overall Study|Failure to return|0
2503052|NCT01926886|8657918|P1|Overall Study|Failure to return|3
2503053|NCT01926886|8657917|P2|Overall Study|Withdrawal by Subject|0
2503054|NCT01926886|8657918|P1|Overall Study|Withdrawal by Subject|15
2503055|NCT01926886|8657917|P2|Overall Study|Disease progression/recurrence|0
2503056|NCT01926886|8657918|P1|Overall Study|Disease progression/recurrence|4
2503057|NCT01926886|8657917|P2|Overall Study|Adverse event/intercurrent illness|0
2503058|NCT01926886|8657918|P1|Overall Study|Adverse event/intercurrent illness|4
2503059|NCT01926886|8657917|P2|Overall Study|Administrative/other|0
2503060|NCT01926886|8657918|P1|Overall Study|Administrative/other|1
2503061|NCT01926782|8657937|P6|Overall Study|Related to study drug administration|2
2503062|NCT01926782|8657938|P5|Overall Study|Related to study drug administration|0
2503063|NCT01926782|8657939|P4|Overall Study|Related to study drug administration|0
2503064|NCT01926782|8657940|P3|Overall Study|Related to study drug administration|0
2503065|NCT01926782|8657941|P2|Overall Study|Related to study drug administration|0
2503066|NCT01926782|8657942|P1|Overall Study|Related to study drug administration|0
2503067|NCT01926782|8657937|P6|Overall Study|Withdrawal by Subject|5
2503068|NCT01926782|8657938|P5|Overall Study|Withdrawal by Subject|0
2503069|NCT01926782|8657939|P4|Overall Study|Withdrawal by Subject|1
2503070|NCT01926782|8657940|P3|Overall Study|Withdrawal by Subject|8
2503071|NCT01926782|8657941|P2|Overall Study|Withdrawal by Subject|1
2503072|NCT01926782|8657942|P1|Overall Study|Withdrawal by Subject|6
2503073|NCT01926782|8657937|P6|Overall Study|Randomized and not treated|0
2503074|NCT01926782|8657938|P5|Overall Study|Randomized and not treated|0
2503075|NCT01926782|8657939|P4|Overall Study|Randomized and not treated|1
2503076|NCT01926782|8657940|P3|Overall Study|Randomized and not treated|0
2503077|NCT01926782|8657941|P2|Overall Study|Randomized and not treated|0
2503078|NCT01926782|8657942|P1|Overall Study|Randomized and not treated|0
2503079|NCT01926782|8657937|P6|Overall Study|Poor compliance to protocol|6
2503080|NCT01926782|8657938|P5|Overall Study|Poor compliance to protocol|1
2503081|NCT01926782|8657939|P4|Overall Study|Poor compliance to protocol|0
2503082|NCT01926782|8657940|P3|Overall Study|Poor compliance to protocol|8
2503083|NCT01926782|8657941|P2|Overall Study|Poor compliance to protocol|3
2503084|NCT01926782|8657942|P1|Overall Study|Poor compliance to protocol|5
2503085|NCT01926782|8657937|P6|Overall Study|Adverse Event|14
2503086|NCT01926782|8657938|P5|Overall Study|Adverse Event|3
2503087|NCT01926782|8657939|P4|Overall Study|Adverse Event|4
2503088|NCT01926782|8657940|P3|Overall Study|Adverse Event|17
2503089|NCT01926782|8657941|P2|Overall Study|Adverse Event|4
2503090|NCT01926782|8657942|P1|Overall Study|Adverse Event|13
2503091|NCT01926782|8657937|P6|Overall Study|Other than specified|11
2503092|NCT01926782|8657938|P5|Overall Study|Other than specified|4
2503093|NCT01926782|8657939|P4|Overall Study|Other than specified|12
2503094|NCT01926782|8657940|P3|Overall Study|Other than specified|5
2503095|NCT01926782|8657941|P2|Overall Study|Other than specified|3
2503096|NCT01926782|8657942|P1|Overall Study|Other than specified|2
2503097|NCT01926782|8657937|P6|Overall Study|Physician Decision|0
2503098|NCT01926782|8657938|P5|Overall Study|Physician Decision|0
2503099|NCT01926782|8657939|P4|Overall Study|Physician Decision|1
2503100|NCT01926782|8657940|P3|Overall Study|Physician Decision|1
2503101|NCT01926782|8657941|P2|Overall Study|Physician Decision|2
2503102|NCT01926782|8657942|P1|Overall Study|Physician Decision|0
2503103|NCT01926782|8657937|P6|Overall Study|Participant moved|3
2503104|NCT01926782|8657938|P5|Overall Study|Participant moved|0
2503105|NCT01926782|8657939|P4|Overall Study|Participant moved|1
2503106|NCT01926782|8657940|P3|Overall Study|Participant moved|1
2503107|NCT01926782|8657941|P2|Overall Study|Participant moved|0
2503108|NCT01926782|8657942|P1|Overall Study|Participant moved|2
2503109|NCT01926626|8658091|P1|Overall Study|Lost to Follow-up|7
2503110|NCT01926626|8658091|P1|Overall Study|Withdrawal by Subject|15
2503111|NCT01926509|8658105|P4|Overall Study|vital sign met discontinuation criteria|0
2503112|NCT01926509|8658106|P3|Overall Study|vital sign met discontinuation criteria|0
2503113|NCT01926509|8658107|P2|Overall Study|vital sign met discontinuation criteria|0
2503114|NCT01926509|8658108|P1|Overall Study|vital sign met discontinuation criteria|1
2503115|NCT01926444|8658129|P4|Overall Study|Colonoscopy not performed|2
2503116|NCT01926444|8658130|P3|Overall Study|Colonoscopy not performed|4
2503117|NCT01926444|8658131|P2|Overall Study|Colonoscopy not performed|0
2503118|NCT01926444|8658132|P1|Overall Study|Colonoscopy not performed|0
2503119|NCT01926119|8658174|P1|Overall Study|Withdrawal by Subject|1
2503120|NCT01926028|8658187|P3|Overall Study|Non compliance or other reasons|0
2503121|NCT01926028|8658188|P2|Overall Study|Non compliance or other reasons|2
2503122|NCT01926028|8658189|P1|Overall Study|Non compliance or other reasons|4
2503123|NCT01926028|8658187|P3|Overall Study|Withdrawal by Subject|2
2503124|NCT01926028|8658188|P2|Overall Study|Withdrawal by Subject|9
2503125|NCT01926028|8658189|P1|Overall Study|Withdrawal by Subject|9
2503126|NCT01926028|8658187|P3|Overall Study|Physician Decision|0
2503127|NCT01926028|8658188|P2|Overall Study|Physician Decision|5
2503128|NCT01926028|8658189|P1|Overall Study|Physician Decision|1
2503129|NCT01926028|8658187|P3|Overall Study|Lost to Follow-up|0
2503130|NCT01926028|8658188|P2|Overall Study|Lost to Follow-up|6
2503131|NCT01926028|8658189|P1|Overall Study|Lost to Follow-up|7
2503132|NCT01926015|8658225|P2|Overall Study|Randomized not treated|0
2503133|NCT01926015|8658226|P1|Overall Study|Randomized not treated|2
2503134|NCT01926015|8658225|P2|Overall Study|Withdrawal by parent/guardian|1
2503135|NCT01926015|8658226|P1|Overall Study|Withdrawal by parent/guardian|0
2503136|NCT01925989|8658258|P3|Period 1|Withdrawal by Subject|0
2503137|NCT01925989|8658259|P2|Period 1|Withdrawal by Subject|1
2503138|NCT01925989|8658260|P1|Period 1|Withdrawal by Subject|0
2503139|NCT01925989|8658258|P3|Period 1|Sponsor Decision|0
2503140|NCT01925989|8658259|P2|Period 1|Sponsor Decision|1
2503141|NCT01925989|8658260|P1|Period 1|Sponsor Decision|1
2503142|NCT01925950|8658280|P2|Part 2|Withdrawal by Subject|0
2503143|NCT01925950|8658281|P1|Part 2|Withdrawal by Subject|1
2503144|NCT01925768|8658300|P2|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1
2503145|NCT01925768|8658301|P1|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5
2503146|NCT01925768|8658300|P2|ActiveTreatment/Extension (Weeks 24-104)|Death|1
2503147|NCT01925768|8658301|P1|ActiveTreatment/Extension (Weeks 24-104)|Death|0
2503148|NCT01925768|8658300|P2|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1
2503149|NCT01925768|8658301|P1|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2
2503150|NCT01925768|8658300|P2|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9
2503151|NCT01925768|8658301|P1|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7
2503152|NCT01925768|8658300|P2|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6
2503153|NCT01925768|8658301|P1|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6
2503154|NCT01925768|8658300|P2|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1
2503155|NCT01925768|8658301|P1|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0
2503156|NCT01925768|8658300|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
2503157|NCT01925768|8658301|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
2503158|NCT01925768|8658300|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
2503159|NCT01925768|8658301|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
2503160|NCT01925768|8658300|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
2503161|NCT01925768|8658301|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
2503162|NCT01925768|8658300|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2
2503163|NCT01925768|8658301|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
2503164|NCT01925768|8658300|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2503165|NCT01925768|8658301|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
2503166|NCT01925703|8658349|P1|Overall Study|Discharge prior to full iron repletion|1
2503167|NCT01925703|8658349|P1|Overall Study|Lost to Follow-up|2
2503168|NCT01925703|8658349|P1|Overall Study|Physician Decision|1
2503169|NCT01925612|8658367|P5|Overall Study|Adverse Event|2
2503170|NCT01925612|8658368|P4|Overall Study|Adverse Event|1
2503171|NCT01925612|8658369|P3|Overall Study|Adverse Event|0
2503172|NCT01925612|8658370|P2|Overall Study|Adverse Event|3
2503173|NCT01925612|8658371|P1|Overall Study|Adverse Event|3
2503174|NCT01925612|8658367|P5|Overall Study|Progressive Disease|0
2503175|NCT01925612|8658368|P4|Overall Study|Progressive Disease|0
2503176|NCT01925612|8658369|P3|Overall Study|Progressive Disease|1
2503177|NCT01925612|8658370|P2|Overall Study|Progressive Disease|1
2503178|NCT01925612|8658371|P1|Overall Study|Progressive Disease|1
2503179|NCT01925417|8658421|P1|Overall Study|Death|1
2503180|NCT01925417|8658421|P1|Overall Study|Withdrawal by Subject|2
2503181|NCT01925339|8658452|P2|Overall Study|Adverse Event|0
2503182|NCT01925339|8658453|P1|Overall Study|Adverse Event|2
2503183|NCT01925274|8658464|P3|Overall Study|Protocol amendment|6
2503184|NCT01925274|8658465|P2|Overall Study|Protocol amendment|3
2503185|NCT01925274|8658466|P1|Overall Study|Protocol amendment|1
2503186|NCT01925274|8658464|P3|Overall Study|Study terminated by sponsor|0
2503187|NCT01925274|8658465|P2|Overall Study|Study terminated by sponsor|0
2503188|NCT01925274|8658466|P1|Overall Study|Study terminated by sponsor|4
2503189|NCT01925274|8658464|P3|Overall Study|Withdrawal by Subject|0
2503190|NCT01925274|8658465|P2|Overall Study|Withdrawal by Subject|2
2503191|NCT01925274|8658466|P1|Overall Study|Withdrawal by Subject|1
2503192|NCT01925274|8658464|P3|Overall Study|Lost to Follow-up|0
2503193|NCT01925274|8658465|P2|Overall Study|Lost to Follow-up|1
2503194|NCT01925274|8658466|P1|Overall Study|Lost to Follow-up|0
2503195|NCT01925274|8658464|P3|Overall Study|Death|0
2503196|NCT01925274|8658465|P2|Overall Study|Death|0
2503197|NCT01925274|8658466|P1|Overall Study|Death|1
2503198|NCT01925209|8658547|P4|Follow-up|Withdrawal by Subject|2
2503199|NCT01925209|8658548|P3|Follow-up|Withdrawal by Subject|0
2503200|NCT01925209|8658549|P2|Follow-up|Withdrawal by Subject|2
2503201|NCT01925209|8658550|P1|Follow-up|Withdrawal by Subject|0
2503202|NCT01925209|8658547|P4|Follow-up|Non-compliance with study treatment|1
2503203|NCT01925209|8658548|P3|Follow-up|Non-compliance with study treatment|0
2503204|NCT01925209|8658549|P2|Follow-up|Non-compliance with study treatment|0
2503205|NCT01925209|8658550|P1|Follow-up|Non-compliance with study treatment|0
2503206|NCT01925209|8658547|P4|Follow-up|Physician Decision|0
2503207|NCT01925209|8658548|P3|Follow-up|Physician Decision|1
2503208|NCT01925209|8658549|P2|Follow-up|Physician Decision|0
2503209|NCT01925209|8658550|P1|Follow-up|Physician Decision|0
2503210|NCT01925209|8658547|P4|Follow-up|Adverse Event|1
2503211|NCT01925209|8658548|P3|Follow-up|Adverse Event|0
2503212|NCT01925209|8658549|P2|Follow-up|Adverse Event|4
2503213|NCT01925209|8658550|P1|Follow-up|Adverse Event|1
2503214|NCT01925209|8658547|P4|Maintenance Treatment Epoch|Adverse Event|0
2503215|NCT01925209|8658548|P3|Maintenance Treatment Epoch|Adverse Event|1
2503216|NCT01925209|8658549|P2|Maintenance Treatment Epoch|Adverse Event|0
2503217|NCT01925209|8658550|P1|Maintenance Treatment Epoch|Adverse Event|0
2503218|NCT01925209|8658547|P4|Maintenance Treatment Epoch|Withdrawal by Subject|2
2503219|NCT01925209|8658548|P3|Maintenance Treatment Epoch|Withdrawal by Subject|1
2503220|NCT01925209|8658549|P2|Maintenance Treatment Epoch|Withdrawal by Subject|1
2503221|NCT01925209|8658550|P1|Maintenance Treatment Epoch|Withdrawal by Subject|0
2503222|NCT01925209|8658547|P4|Treatment Epoch|Adverse Event|1
2503223|NCT01925209|8658548|P3|Treatment Epoch|Adverse Event|3
2503224|NCT01925209|8658549|P2|Treatment Epoch|Adverse Event|5
2503225|NCT01925209|8658550|P1|Treatment Epoch|Adverse Event|3
2503226|NCT01925209|8658547|P4|Treatment Epoch|Withdrawal by Subject|2
2503227|NCT01925209|8658548|P3|Treatment Epoch|Withdrawal by Subject|3
2503228|NCT01925209|8658549|P2|Treatment Epoch|Withdrawal by Subject|3
2503229|NCT01925209|8658550|P1|Treatment Epoch|Withdrawal by Subject|4
2503230|NCT01925209|8658547|P4|Treatment Epoch|Protocol deviation|1
2503231|NCT01925209|8658548|P3|Treatment Epoch|Protocol deviation|1
2503232|NCT01925209|8658549|P2|Treatment Epoch|Protocol deviation|0
2503233|NCT01925209|8658550|P1|Treatment Epoch|Protocol deviation|0
2503234|NCT01925209|8658547|P4|Treatment Epoch|Death|0
2503235|NCT01925209|8658548|P3|Treatment Epoch|Death|0
2503236|NCT01925209|8658549|P2|Treatment Epoch|Death|0
2503237|NCT01925209|8658550|P1|Treatment Epoch|Death|1
2503238|NCT01925209|8658547|P4|Treatment Epoch|Non-compliance with study treatment|1
2503239|NCT01925209|8658548|P3|Treatment Epoch|Non-compliance with study treatment|0
2503240|NCT01925209|8658549|P2|Treatment Epoch|Non-compliance with study treatment|0
2503241|NCT01925209|8658550|P1|Treatment Epoch|Non-compliance with study treatment|0
2503242|NCT01925209|8658547|P4|Treatment Epoch|Physician Decision|0
2503243|NCT01925209|8658548|P3|Treatment Epoch|Physician Decision|0
2503244|NCT01925209|8658549|P2|Treatment Epoch|Physician Decision|0
2503245|NCT01925209|8658550|P1|Treatment Epoch|Physician Decision|1
2503246|NCT01925183|8658582|P2|Overall Study|Adverse Event|0
2503247|NCT01925183|8658583|P1|Overall Study|Adverse Event|1
2503248|NCT01925170|8658591|P1|Overall Study|Unverified cancer status|53
2503249|NCT01925014|8658622|P2|Overall Study|Withdrawal by Subject|13
2503250|NCT01925014|8658623|P1|Overall Study|Withdrawal by Subject|5
2503251|NCT01925014|8658622|P2|Overall Study|Inappropriate enrollment|6
2503252|NCT01925014|8658623|P1|Overall Study|Inappropriate enrollment|4
2503253|NCT01924845|8658698|P1|Overall Study|Protocol Violation|1
2503254|NCT01924845|8658698|P1|Overall Study|Withdrawal by Subject|2
2503255|NCT01924845|8658698|P1|Overall Study|Adverse Event|3
2503256|NCT01924806|8658708|P2|Overall Study|Physician Decision|1
2503257|NCT01924806|8658709|P1|Overall Study|Physician Decision|2
2503258|NCT01924767|8658726|P5|Overall Study|Adverse Event|0
2503259|NCT01924767|8658727|P4|Overall Study|Adverse Event|0
2503260|NCT01924767|8658728|P3|Overall Study|Adverse Event|1
2503261|NCT01924767|8658729|P2|Overall Study|Adverse Event|0
2503262|NCT01924767|8658730|P1|Overall Study|Adverse Event|1
2503263|NCT01924689|8658836|P6|Overall Study|Other|0
2503264|NCT01924689|8658837|P5|Overall Study|Other|1
2503265|NCT01924689|8658838|P4|Overall Study|Other|0
2503266|NCT01924689|8658839|P3|Overall Study|Other|0
2503267|NCT01924689|8658840|P2|Overall Study|Other|0
2503268|NCT01924689|8658841|P1|Overall Study|Other|0
2503269|NCT01924689|8658836|P6|Overall Study|Withdrawal of consent|0
2503270|NCT01924689|8658837|P5|Overall Study|Withdrawal of consent|0
2503271|NCT01924689|8658838|P4|Overall Study|Withdrawal of consent|1
2503272|NCT01924689|8658839|P3|Overall Study|Withdrawal of consent|1
2503273|NCT01924689|8658840|P2|Overall Study|Withdrawal of consent|0
2503274|NCT01924689|8658841|P1|Overall Study|Withdrawal of consent|0
2503275|NCT01924689|8658836|P6|Overall Study|New therapy or study|0
2503276|NCT01924689|8658837|P5|Overall Study|New therapy or study|2
2503277|NCT01924689|8658838|P4|Overall Study|New therapy or study|4
2503278|NCT01924689|8658839|P3|Overall Study|New therapy or study|1
2503279|NCT01924689|8658840|P2|Overall Study|New therapy or study|2
2503280|NCT01924689|8658841|P1|Overall Study|New therapy or study|3
2503281|NCT01924689|8658836|P6|Overall Study|Disease progression|2
2503282|NCT01924689|8658837|P5|Overall Study|Disease progression|3
2503283|NCT01924689|8658838|P4|Overall Study|Disease progression|0
2503284|NCT01924689|8658839|P3|Overall Study|Disease progression|2
2503285|NCT01924689|8658840|P2|Overall Study|Disease progression|0
2503286|NCT01924689|8658841|P1|Overall Study|Disease progression|0
2503287|NCT01924689|8658836|P6|Overall Study|Death|0
2503288|NCT01924689|8658837|P5|Overall Study|Death|0
2503289|NCT01924689|8658838|P4|Overall Study|Death|1
2503290|NCT01924689|8658839|P3|Overall Study|Death|0
2503291|NCT01924689|8658840|P2|Overall Study|Death|1
2503292|NCT01924689|8658841|P1|Overall Study|Death|0
2503293|NCT01924533|8658915|P2|Overall Study|Other Eligibility criteria|1
2503294|NCT01924533|8658916|P1|Overall Study|Other Eligibility criteria|1
2503295|NCT01924533|8658915|P2|Overall Study|Withdrawal by Subject|3
2503296|NCT01924533|8658916|P1|Overall Study|Withdrawal by Subject|7
2503297|NCT01924533|8658915|P2|Overall Study|Lost to Follow-up|1
2503298|NCT01924533|8658916|P1|Overall Study|Lost to Follow-up|0
2503299|NCT01924533|8658915|P2|Overall Study|Death|200
2503300|NCT01924533|8658916|P1|Overall Study|Death|181
2503301|NCT01924429|8658957|P2|Washout Period (2 Weeks)|Withdrawal by Subject|2
2503302|NCT01924429|8658958|P1|Washout Period (2 Weeks)|Withdrawal by Subject|3
2503303|NCT01924364|8659001|P1|Overall Study|Physician Decision|3
2503304|NCT01924299|8659018|P2|Period 2|Adverse Event|1
2503305|NCT01924299|8659019|P1|Period 2|Adverse Event|0
2503306|NCT01924299|8659018|P2|Period 2|Withdrawal by Subject|0
2503307|NCT01924299|8659019|P1|Period 2|Withdrawal by Subject|1
2503308|NCT01924182|8659041|P2|Overall Study|Withdrawal by Subject|0
2503309|NCT01924182|8659042|P1|Overall Study|Withdrawal by Subject|1
2503310|NCT01923896|8659083|P2|Overall Study|Adverse Event|0
2503311|NCT01923896|8659084|P1|Overall Study|Adverse Event|1
2503312|NCT01923740|8659107|P2|Overall Study|Withdrawal by Subject|0
2503313|NCT01923740|8659108|P1|Overall Study|Withdrawal by Subject|2
2503314|NCT01923740|8659107|P2|Overall Study|Lost to Follow-up|9
2503315|NCT01923740|8659108|P1|Overall Study|Lost to Follow-up|4
2503316|NCT01923467|8659533|P1|Overall Study|Subject non-interest|479
2503317|NCT01923467|8659533|P1|Overall Study|Lost to Follow-up|62
2503318|NCT01923428|8659541|P4|Overall Study|Lack of Efficacy|1
2503319|NCT01923428|8659542|P3|Overall Study|Lack of Efficacy|1
2503320|NCT01923428|8659543|P2|Overall Study|Lack of Efficacy|0
2503321|NCT01923428|8659544|P1|Overall Study|Lack of Efficacy|0
2503322|NCT01923428|8659541|P4|Overall Study|Non Compliance to treatment|1
2503323|NCT01923428|8659542|P3|Overall Study|Non Compliance to treatment|0
2503324|NCT01923428|8659543|P2|Overall Study|Non Compliance to treatment|2
2503325|NCT01923428|8659544|P1|Overall Study|Non Compliance to treatment|1
2503326|NCT01923428|8659541|P4|Overall Study|Protocol Violation|1
2503327|NCT01923428|8659542|P3|Overall Study|Protocol Violation|2
2503328|NCT01923428|8659543|P2|Overall Study|Protocol Violation|0
2503329|NCT01923428|8659544|P1|Overall Study|Protocol Violation|3
2503330|NCT01923428|8659541|P4|Overall Study|Lost to Follow-up|0
2503331|NCT01923428|8659542|P3|Overall Study|Lost to Follow-up|5
2503332|NCT01923428|8659543|P2|Overall Study|Lost to Follow-up|1
2503333|NCT01923428|8659544|P1|Overall Study|Lost to Follow-up|2
2503334|NCT01923428|8659541|P4|Overall Study|Withdrawal by Subject|4
2503335|NCT01923428|8659542|P3|Overall Study|Withdrawal by Subject|0
2503336|NCT01923428|8659543|P2|Overall Study|Withdrawal by Subject|3
2503337|NCT01923428|8659544|P1|Overall Study|Withdrawal by Subject|5
2503338|NCT01923428|8659541|P4|Overall Study|Adverse Event|3
2503339|NCT01923428|8659542|P3|Overall Study|Adverse Event|3
2503340|NCT01923428|8659543|P2|Overall Study|Adverse Event|6
2503341|NCT01923428|8659544|P1|Overall Study|Adverse Event|8
2503342|NCT01923389|8659556|P2|Overall Study|Protocol Violation|0
2503343|NCT01923389|8659557|P1|Overall Study|Protocol Violation|1
2503344|NCT01923363|8659579|P1|Overall Study|Protocol Violation|1
2503345|NCT01923311|8659588|P2|Overall Study|Study Terminated by Sponsor|0
2503346|NCT01923311|8659589|P1|Overall Study|Study Terminated by Sponsor|12
2503347|NCT01923311|8659588|P2|Overall Study|Withdrew Consent|0
2503348|NCT01923311|8659589|P1|Overall Study|Withdrew Consent|1
2503349|NCT01923311|8659588|P2|Overall Study|Non-Compliance with Study Drug|1
2503350|NCT01923311|8659589|P1|Overall Study|Non-Compliance with Study Drug|2
2503351|NCT01923311|8659588|P2|Overall Study|Investigator's Discretion|0
2503352|NCT01923311|8659589|P1|Overall Study|Investigator's Discretion|1
2503353|NCT01923311|8659588|P2|Overall Study|Pregnancy|0
2503354|NCT01923311|8659589|P1|Overall Study|Pregnancy|1
2503355|NCT01923181|8659641|P9|Overall Study|Lost to Follow-up|1
2503356|NCT01923181|8659642|P8|Overall Study|Lost to Follow-up|3
2503357|NCT01923181|8659643|P7|Overall Study|Lost to Follow-up|3
2503358|NCT01923181|8659644|P6|Overall Study|Lost to Follow-up|1
2503359|NCT01923181|8659645|P5|Overall Study|Lost to Follow-up|2
2503360|NCT01923181|8659646|P4|Overall Study|Lost to Follow-up|1
2503361|NCT01923181|8659647|P3|Overall Study|Lost to Follow-up|2
2503362|NCT01923181|8659648|P2|Overall Study|Lost to Follow-up|3
2503363|NCT01923181|8659649|P1|Overall Study|Lost to Follow-up|0
2503364|NCT01923181|8659641|P9|Overall Study|Other|0
2503365|NCT01923181|8659642|P8|Overall Study|Other|0
2503366|NCT01923181|8659643|P7|Overall Study|Other|0
2503367|NCT01923181|8659644|P6|Overall Study|Other|0
2503368|NCT01923181|8659645|P5|Overall Study|Other|0
2503369|NCT01923181|8659646|P4|Overall Study|Other|1
2503370|NCT01923181|8659647|P3|Overall Study|Other|0
2503371|NCT01923181|8659648|P2|Overall Study|Other|0
2503372|NCT01923181|8659649|P1|Overall Study|Other|1
2503373|NCT01923181|8659641|P9|Overall Study|Withdrawal by Subject|1
2503374|NCT01923181|8659642|P8|Overall Study|Withdrawal by Subject|3
2503375|NCT01923181|8659643|P7|Overall Study|Withdrawal by Subject|4
2503376|NCT01923181|8659644|P6|Overall Study|Withdrawal by Subject|2
2503377|NCT01923181|8659645|P5|Overall Study|Withdrawal by Subject|4
2503378|NCT01923181|8659646|P4|Overall Study|Withdrawal by Subject|1
2503379|NCT01923181|8659647|P3|Overall Study|Withdrawal by Subject|0
2503380|NCT01923181|8659648|P2|Overall Study|Withdrawal by Subject|1
2503381|NCT01923181|8659649|P1|Overall Study|Withdrawal by Subject|0
2503382|NCT01923181|8659641|P9|Overall Study|Protocol Violation|1
2503383|NCT01923181|8659642|P8|Overall Study|Protocol Violation|2
2503384|NCT01923181|8659643|P7|Overall Study|Protocol Violation|1
2503385|NCT01923181|8659644|P6|Overall Study|Protocol Violation|1
2503386|NCT01923181|8659645|P5|Overall Study|Protocol Violation|2
2503387|NCT01923181|8659646|P4|Overall Study|Protocol Violation|2
2503388|NCT01923181|8659647|P3|Overall Study|Protocol Violation|0
2503389|NCT01923181|8659648|P2|Overall Study|Protocol Violation|2
2503390|NCT01923181|8659649|P1|Overall Study|Protocol Violation|2
2503391|NCT01923168|8659727|P3|Overall Study|Death|1
2503392|NCT01923168|8659728|P2|Overall Study|Death|0
2503393|NCT01923168|8659729|P1|Overall Study|Death|0
2503394|NCT01923168|8659727|P3|Overall Study|Progressive disease|7
2503395|NCT01923168|8659728|P2|Overall Study|Progressive disease|3
2503396|NCT01923168|8659729|P1|Overall Study|Progressive disease|4
2503397|NCT01923168|8659727|P3|Overall Study|Physician Decision|5
2503398|NCT01923168|8659728|P2|Overall Study|Physician Decision|9
2503399|NCT01923168|8659729|P1|Overall Study|Physician Decision|6
2503400|NCT01923168|8659727|P3|Overall Study|Adverse Event|0
2503401|NCT01923168|8659728|P2|Overall Study|Adverse Event|12
2503402|NCT01923168|8659729|P1|Overall Study|Adverse Event|12
2503403|NCT01923168|8659727|P3|Overall Study|Subject/guardian decision|4
2503404|NCT01923168|8659728|P2|Overall Study|Subject/guardian decision|14
2503405|NCT01923168|8659729|P1|Overall Study|Subject/guardian decision|14
2503406|NCT01923168|8659727|P3|Overall Study|Protocol Violation|0
2503407|NCT01923168|8659728|P2|Overall Study|Protocol Violation|1
2503408|NCT01923168|8659729|P1|Overall Study|Protocol Violation|1
2503409|NCT01922934|8659812|P2|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284
2503410|NCT01922934|8659813|P1|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21
2503411|NCT01922934|8659812|P2|Visit 0 - Patient Contacted & Consented|No response or could not reach|0
2503412|NCT01922934|8659813|P1|Visit 0 - Patient Contacted & Consented|No response or could not reach|66
2503413|NCT01922934|8659812|P2|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0
2503414|NCT01922934|8659813|P1|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169
2503415|NCT01922934|8659812|P2|Eligible Patients|Did not meet inclusion criteria|81
2503416|NCT01922934|8659813|P1|Eligible Patients|Did not meet inclusion criteria|36
2503417|NCT01922934|8659812|P2|Eligible Patients|Physician Decision|0
2503418|NCT01922934|8659813|P1|Eligible Patients|Physician Decision|17
2503419|NCT01922934|8659812|P2|Eligible Patients|Death|7
2503420|NCT01922934|8659813|P1|Eligible Patients|Death|0
2503421|NCT01922739|8659825|P1|Open-label Treatment Period|Sponsor request - investigator leaving|1
2503422|NCT01922739|8659825|P1|Open-label Treatment Period|Physician Decision|1
2503423|NCT01922739|8659825|P1|Open-label Treatment Period|Lost to Follow-up|2
2503424|NCT01922739|8659825|P1|Open-label Treatment Period|Noncompliance to study procedures|1
2503425|NCT01922739|8659825|P1|Open-label Treatment Period|Pregnancy|1
2503426|NCT01922739|8659825|P1|Open-label Treatment Period|Protocol Violation|5
2503427|NCT01922739|8659825|P1|Open-label Treatment Period|Noncompliance to study medication|3
2503428|NCT01922739|8659825|P1|Open-label Treatment Period|Withdrawal by Subject|14
2503429|NCT01922739|8659825|P1|Open-label Treatment Period|Adverse Event|6
2503430|NCT01922739|8659825|P1|Titration/Adjustment Period|Lack of Efficacy|3
2503431|NCT01922739|8659825|P1|Titration/Adjustment Period|Lost to Follow-up|1
2503432|NCT01922739|8659825|P1|Titration/Adjustment Period|Withdrawal by Subject|5
2503433|NCT01922739|8659825|P1|Titration/Adjustment Period|Adverse Event|3
2503434|NCT01922349|8659854|P4|Multiple Rising Dose (MRD) Period|Adverse Event|1
2503435|NCT01922349|8659855|P3|Multiple Rising Dose (MRD) Period|Adverse Event|0
2503436|NCT01922349|8659856|P2|Multiple Rising Dose (MRD) Period|Adverse Event|0
2503437|NCT01922349|8659857|P1|Multiple Rising Dose (MRD) Period|Adverse Event|0
2503438|NCT01922271|8659986|P2|WASHOUT Period|Withdrawal by Subject|0
2503439|NCT01922271|8659987|P1|WASHOUT Period|Withdrawal by Subject|1
2503440|NCT01922102|8660029|P3|Overall Study|Administrative problems|0
2503441|NCT01922102|8660030|P2|Overall Study|Administrative problems|2
2503442|NCT01922102|8660031|P1|Overall Study|Administrative problems|0
2503443|NCT01922102|8660029|P3|Overall Study|Lost to Follow-up|0
2503444|NCT01922102|8660030|P2|Overall Study|Lost to Follow-up|0
2503445|NCT01922102|8660031|P1|Overall Study|Lost to Follow-up|1
2503446|NCT01922102|8660029|P3|Overall Study|Adverse Event|0
2503447|NCT01922102|8660030|P2|Overall Study|Adverse Event|2
2503448|NCT01922102|8660031|P1|Overall Study|Adverse Event|1
2503449|NCT01922102|8660029|P3|Overall Study|Physician Decision|1
2503450|NCT01922102|8660030|P2|Overall Study|Physician Decision|2
2503451|NCT01922102|8660031|P1|Overall Study|Physician Decision|0
2503452|NCT01922102|8660029|P3|Overall Study|Withdrawal by Subject|7
2503453|NCT01922102|8660030|P2|Overall Study|Withdrawal by Subject|3
2503454|NCT01922102|8660031|P1|Overall Study|Withdrawal by Subject|7
2503455|NCT01922089|8660067|P2|Overall Study|Lost to Follow-up|1
2503456|NCT01922089|8660068|P1|Overall Study|Lost to Follow-up|0
2503457|NCT01922089|8660067|P2|Overall Study|Death|1
2503458|NCT01922089|8660068|P1|Overall Study|Death|2
2503459|NCT01922089|8660067|P2|Overall Study|Physician Decision|3
2503460|NCT01922089|8660068|P1|Overall Study|Physician Decision|2
2503461|NCT01922089|8660067|P2|Overall Study|administrative problems|1
2503462|NCT01922089|8660068|P1|Overall Study|administrative problems|4
2503463|NCT01922089|8660067|P2|Overall Study|Withdrawal by Subject|4
2503464|NCT01922089|8660068|P1|Overall Study|Withdrawal by Subject|3
2503465|NCT01922089|8660067|P2|Overall Study|Protocol Deviation|7
2503466|NCT01922089|8660068|P1|Overall Study|Protocol Deviation|10
2503467|NCT01922089|8660067|P2|Overall Study|Adverse Event|13
2503468|NCT01922089|8660068|P1|Overall Study|Adverse Event|18
2503469|NCT01922037|8660145|P2|Overall Study|Other unspecified|66
2503470|NCT01922037|8660146|P1|Overall Study|Other unspecified|2
2503471|NCT01922037|8660145|P2|Overall Study|Investigator/Sponsor decision|4
2503472|NCT01922037|8660146|P1|Overall Study|Investigator/Sponsor decision|1
2503473|NCT01922037|8660145|P2|Overall Study|Participant non-compliance|46
2503474|NCT01922037|8660146|P1|Overall Study|Participant non-compliance|4
2503475|NCT01922037|8660145|P2|Overall Study|Pregnancy|2
2503476|NCT01922037|8660146|P1|Overall Study|Pregnancy|0
2503477|NCT01922037|8660145|P2|Overall Study|Death|5
2503478|NCT01922037|8660146|P1|Overall Study|Death|0
2503479|NCT01922037|8660145|P2|Overall Study|Adverse Event|7
2503480|NCT01922037|8660146|P1|Overall Study|Adverse Event|1
2503481|NCT01922037|8660145|P2|Overall Study|Withdrawal by Subject|44
2503482|NCT01922037|8660146|P1|Overall Study|Withdrawal by Subject|2
2503483|NCT01922011|8660249|P2|Overall Study|Randomized in error|0
2503484|NCT01922011|8660250|P1|Overall Study|Randomized in error|1
2503485|NCT01922011|8660249|P2|Overall Study|Lack of willing home health agency|0
2503486|NCT01922011|8660250|P1|Overall Study|Lack of willing home health agency|1
2503487|NCT01922011|8660249|P2|Overall Study|Not Treated|0
2503488|NCT01922011|8660250|P1|Overall Study|Not Treated|1
2503489|NCT01922011|8660249|P2|Overall Study|Missed Test-of-Cure Visit|2
2503490|NCT01922011|8660250|P1|Overall Study|Missed Test-of-Cure Visit|0
2503491|NCT01922011|8660249|P2|Overall Study|Lost to Follow-up|1
2503492|NCT01922011|8660250|P1|Overall Study|Lost to Follow-up|0
2503493|NCT01922011|8660249|P2|Overall Study|Parent/Guardian Decision|0
2503494|NCT01922011|8660250|P1|Overall Study|Parent/Guardian Decision|3
2503495|NCT01922011|8660249|P2|Overall Study|Physician Decision|1
2503496|NCT01922011|8660250|P1|Overall Study|Physician Decision|0
2503497|NCT01922011|8660249|P2|Overall Study|Protocol Violation|1
2503498|NCT01922011|8660250|P1|Overall Study|Protocol Violation|0
2503499|NCT01921829|8660317|P2|Overall Study|Withdrawal by Subject|1
2503500|NCT01921829|8660318|P1|Overall Study|Withdrawal by Subject|0
2503501|NCT01921517|8660389|P2|Overall Study|Subject missed final imaging|4
2503502|NCT01921517|8660390|P1|Overall Study|Subject missed final imaging|1
2503503|NCT01921517|8660389|P2|Overall Study|Withdrawal by Subject|3
2503504|NCT01921517|8660390|P1|Overall Study|Withdrawal by Subject|7
2503505|NCT01921517|8660389|P2|Overall Study|Physician Decision|2
2503506|NCT01921517|8660390|P1|Overall Study|Physician Decision|0
2503507|NCT01921517|8660389|P2|Overall Study|Newly diagnosed health concern|0
2503508|NCT01921517|8660390|P1|Overall Study|Newly diagnosed health concern|2
2503509|NCT01921517|8660389|P2|Overall Study|Lost to Follow-up|0
2503510|NCT01921517|8660390|P1|Overall Study|Lost to Follow-up|5
2503511|NCT01921387|8660401|P1|Overall Study|Adverse Event|1
2503512|NCT01921348|8660410|P2|Overall Study|Lost to Follow-up|2
2503513|NCT01921348|8660411|P1|Overall Study|Lost to Follow-up|0
2503514|NCT01921348|8660410|P2|Overall Study|Withdrawal by Subject|0
2503515|NCT01921348|8660411|P1|Overall Study|Withdrawal by Subject|1
2503516|NCT01921270|8660440|P1|Overall Study|Withdrawal by Subject|1
2503517|NCT01921257|8660456|P1|Overall Study|Withdrawal by Subject|1
2503518|NCT01921257|8660456|P1|Overall Study|Protocol Violation|1
2503519|NCT01921257|8660456|P1|Overall Study|Adverse Event|1
2503520|NCT01921205|8660463|P2|Overall Study|Non Compliance Of Child|1
2503521|NCT01921205|8660464|P1|Overall Study|Non Compliance Of Child|0
2503522|NCT01921205|8660463|P2|Overall Study|Non Compliance Of The Parent|1
2503523|NCT01921205|8660464|P1|Overall Study|Non Compliance Of The Parent|0
2503524|NCT01921205|8660463|P2|Overall Study|The Excessive Use Of Rescue Medication|1
2503525|NCT01921205|8660464|P1|Overall Study|The Excessive Use Of Rescue Medication|0
2503526|NCT01921205|8660463|P2|Overall Study|Use Of Prohibited Medication|1
2503527|NCT01921205|8660464|P1|Overall Study|Use Of Prohibited Medication|0
2503528|NCT01921205|8660463|P2|Overall Study|Withdrawal by Subject|5
2503529|NCT01921205|8660464|P1|Overall Study|Withdrawal by Subject|6
2503530|NCT01921205|8660463|P2|Overall Study|Lost to Follow-up|1
2503531|NCT01921205|8660464|P1|Overall Study|Lost to Follow-up|1
2503532|NCT01921205|8660463|P2|Overall Study|Protocol Violation|3
2503533|NCT01921205|8660464|P1|Overall Study|Protocol Violation|1
2503534|NCT01921205|8660463|P2|Overall Study|Lack of Efficacy|0
2503535|NCT01921205|8660464|P1|Overall Study|Lack of Efficacy|1
2503536|NCT01921205|8660463|P2|Overall Study|Adverse Event|7
2503537|NCT01921205|8660464|P1|Overall Study|Adverse Event|12
2503538|NCT01921179|8660494|P2|Long Term Follow-up After GOALS Training|Lost to Follow-up|0
2503539|NCT01921179|8660495|P1|Long Term Follow-up After GOALS Training|Lost to Follow-up|2
2503540|NCT01921179|8660494|P2|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3
2503541|NCT01921179|8660495|P1|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3
2503542|NCT01921101|8660532|P2|Overall Study|Death|6
2503543|NCT01921101|8660533|P1|Overall Study|Death|16
2503544|NCT01920958|8660541|P1|Overall Study|Did Not Fulfill Inclusion Criteria|5
2503545|NCT01920893|8660559|P2|Overall Study|Lack of Efficacy|0
2503546|NCT01920893|8660560|P1|Overall Study|Lack of Efficacy|2
2503547|NCT01920893|8660559|P2|Overall Study|Adverse Event|2
2503548|NCT01920893|8660560|P1|Overall Study|Adverse Event|5
2503549|NCT01920854|8660593|P7|Overall Study|Withdrawal by Subject|1
2503550|NCT01920854|8660594|P6|Overall Study|Withdrawal by Subject|0
2503551|NCT01920854|8660595|P5|Overall Study|Withdrawal by Subject|1
2503552|NCT01920854|8660596|P4|Overall Study|Withdrawal by Subject|0
2503553|NCT01920854|8660597|P3|Overall Study|Withdrawal by Subject|0
2503554|NCT01920854|8660598|P2|Overall Study|Withdrawal by Subject|0
2503555|NCT01920854|8660599|P1|Overall Study|Withdrawal by Subject|1
2503556|NCT01920594|8660759|P2|Overall Study|Investigator discretion|1
2503557|NCT01920594|8660760|P1|Overall Study|Investigator discretion|0
2503558|NCT01920594|8660759|P2|Overall Study|Recovery|0
2503559|NCT01920594|8660760|P1|Overall Study|Recovery|2
2503560|NCT01920594|8660759|P2|Overall Study|Lost to Follow-up|0
2503561|NCT01920594|8660760|P1|Overall Study|Lost to Follow-up|1
2503562|NCT01920594|8660759|P2|Overall Study|Adverse Event|2
2503563|NCT01920594|8660760|P1|Overall Study|Adverse Event|4
2503564|NCT01920568|8660810|P2|Overall Study|Death due to disease progression|12
2503565|NCT01920568|8660811|P1|Overall Study|Death due to disease progression|25
2503566|NCT01920568|8660810|P2|Overall Study|Withdrawal by Subject|55
2503567|NCT01920568|8660811|P1|Overall Study|Withdrawal by Subject|79
2503568|NCT01920568|8660810|P2|Overall Study|Physician Decision|4
2503569|NCT01920568|8660811|P1|Overall Study|Physician Decision|13
2503570|NCT01920568|8660810|P2|Overall Study|Lost to Follow-up|2
2503571|NCT01920568|8660811|P1|Overall Study|Lost to Follow-up|2
2503572|NCT01920568|8660810|P2|Overall Study|Protocol Violation|3
2503573|NCT01920568|8660811|P1|Overall Study|Protocol Violation|5
2503574|NCT01920568|8660810|P2|Overall Study|Adverse Event|8
2503575|NCT01920568|8660811|P1|Overall Study|Adverse Event|27
2503576|NCT01920555|8660837|P5|Overall Study|Lost to Follow-up|0
2503577|NCT01920555|8660838|P4|Overall Study|Lost to Follow-up|1
2503578|NCT01920555|8660839|P3|Overall Study|Lost to Follow-up|0
2503579|NCT01920555|8660840|P2|Overall Study|Lost to Follow-up|1
2503580|NCT01920555|8660841|P1|Overall Study|Lost to Follow-up|0
2503581|NCT01920555|8660837|P5|Overall Study|Travel Difficulties|1
2503582|NCT01920555|8660838|P4|Overall Study|Travel Difficulties|0
2503583|NCT01920555|8660839|P3|Overall Study|Travel Difficulties|0
2503584|NCT01920555|8660840|P2|Overall Study|Travel Difficulties|1
2503585|NCT01920555|8660841|P1|Overall Study|Travel Difficulties|1
2503586|NCT01920555|8660837|P5|Overall Study|Lack of Efficacy|0
2503587|NCT01920555|8660838|P4|Overall Study|Lack of Efficacy|0
2503588|NCT01920555|8660839|P3|Overall Study|Lack of Efficacy|0
2503589|NCT01920555|8660840|P2|Overall Study|Lack of Efficacy|0
2503590|NCT01920555|8660841|P1|Overall Study|Lack of Efficacy|2
2503591|NCT01920555|8660837|P5|Overall Study|Physician Decision|0
2503592|NCT01920555|8660838|P4|Overall Study|Physician Decision|2
2503593|NCT01920555|8660839|P3|Overall Study|Physician Decision|1
2503594|NCT01920555|8660840|P2|Overall Study|Physician Decision|2
2503595|NCT01920555|8660841|P1|Overall Study|Physician Decision|1
2503596|NCT01920477|8660900|P2|Overall Study|Withdrawal by Subject|1
2503597|NCT01920477|8660901|P1|Overall Study|Withdrawal by Subject|0
2503598|NCT01920477|8660900|P2|Overall Study|Study closed/terminated|15
2503599|NCT01920477|8660901|P1|Overall Study|Study closed/terminated|14
2503600|NCT01920477|8660900|P2|Overall Study|Lack of Efficacy|0
2503601|NCT01920477|8660901|P1|Overall Study|Lack of Efficacy|1
2503602|NCT01920477|8660900|P2|Overall Study|Adverse Event|1
2503603|NCT01920477|8660901|P1|Overall Study|Adverse Event|0
2503604|NCT01920178|8660950|P2|Overall Study|Lost to Follow-up|1
2503605|NCT01920178|8660951|P1|Overall Study|Lost to Follow-up|2
2503606|NCT01919970|8660969|P2|Overall Study|Withdrawal by Subject|0
2503607|NCT01919970|8660970|P1|Overall Study|Withdrawal by Subject|3
2503608|NCT01919814|8660978|P2|Overall Study|Withdrawal by Subject|0
2503609|NCT01919814|8660979|P1|Overall Study|Withdrawal by Subject|1
2503610|NCT01919814|8660978|P2|Overall Study|Protocol Violation|0
2503611|NCT01919814|8660979|P1|Overall Study|Protocol Violation|1
2503612|NCT01919814|8660978|P2|Overall Study|Adverse Event|0
2503613|NCT01919814|8660979|P1|Overall Study|Adverse Event|1
2503614|NCT01919801|8660991|P2|Overall Study|Other|1
2503615|NCT01919801|8660992|P1|Overall Study|Other|0
2503616|NCT01919801|8660991|P2|Overall Study|Lost to Follow-up|1
2503617|NCT01919801|8660992|P1|Overall Study|Lost to Follow-up|0
2503618|NCT01919801|8660991|P2|Overall Study|Physician Decision|1
2503619|NCT01919801|8660992|P1|Overall Study|Physician Decision|0
2503620|NCT01919801|8660991|P2|Overall Study|Withdrawal by Subject|0
2503621|NCT01919801|8660992|P1|Overall Study|Withdrawal by Subject|1
2503622|NCT01919723|8661017|P2|Overall Study|Blood Samples Hemolyzed|2
2503623|NCT01919723|8661018|P1|Overall Study|Blood Samples Hemolyzed|2
2503624|NCT01919411|8661091|P2|Overall Study|Protocol Violation|1
2503625|NCT01919411|8661092|P1|Overall Study|Protocol Violation|2
2503626|NCT01919411|8661091|P2|Overall Study|Physician Decision|0
2503627|NCT01919411|8661092|P1|Overall Study|Physician Decision|1
2503628|NCT01919411|8661091|P2|Overall Study|Lost to Follow-up|4
2503629|NCT01919411|8661092|P1|Overall Study|Lost to Follow-up|2
2503630|NCT01919398|8661111|P3|Overall Study|Progressive Disease|4
2503631|NCT01919398|8661112|P2|Overall Study|Progressive Disease|0
2503632|NCT01919398|8661113|P1|Overall Study|Progressive Disease|0
2503633|NCT01919307|8661133|P1|Overall Study|Withdrawal by Subject|9
2503634|NCT01919229|8661143|P3|Overall Study|Subject/guardian decision|1
2503635|NCT01919229|8661144|P2|Overall Study|Subject/guardian decision|0
2503636|NCT01919229|8661145|P1|Overall Study|Subject/guardian decision|0
2503637|NCT01918774|8661208|P1|Overall Study|Lost to Follow-up|1
2503638|NCT01918774|8661208|P1|Overall Study|Lost prior to first CBTw session|4
2503639|NCT01918371|8661232|P2|Overall Study|Missing Data|1
2503640|NCT01918371|8661233|P1|Overall Study|Missing Data|1
2503641|NCT01918332|8661311|P4|Overall Study|lipid result by central lab did not meet|0
2503642|NCT01918332|8661312|P3|Overall Study|lipid result by central lab did not meet|1
2503643|NCT01918332|8661313|P2|Overall Study|lipid result by central lab did not meet|0
2503644|NCT01918332|8661314|P1|Overall Study|lipid result by central lab did not meet|0
2503645|NCT01918332|8661311|P4|Overall Study|Protocol Violation|3
2503646|NCT01918332|8661312|P3|Overall Study|Protocol Violation|6
2503647|NCT01918332|8661313|P2|Overall Study|Protocol Violation|2
2503648|NCT01918332|8661314|P1|Overall Study|Protocol Violation|6
2503649|NCT01918332|8661311|P4|Overall Study|Withdrawal by Subject|3
2503650|NCT01918332|8661312|P3|Overall Study|Withdrawal by Subject|2
2503651|NCT01918332|8661313|P2|Overall Study|Withdrawal by Subject|3
2503652|NCT01918332|8661314|P1|Overall Study|Withdrawal by Subject|2
2503653|NCT01918332|8661311|P4|Overall Study|Adverse Event|1
2503654|NCT01918332|8661312|P3|Overall Study|Adverse Event|0
2503655|NCT01918332|8661313|P2|Overall Study|Adverse Event|0
2503656|NCT01918332|8661314|P1|Overall Study|Adverse Event|0
2503657|NCT01918306|8661326|P4|Overall Study|progress disease, crossover|0
2503658|NCT01918306|8661327|P3|Overall Study|progress disease, crossover|1
2503659|NCT01918306|8661328|P2|Overall Study|progress disease, crossover|0
2503660|NCT01918306|8661329|P1|Overall Study|progress disease, crossover|0
2503661|NCT01918306|8661326|P4|Overall Study|Lack of Efficacy|0
2503662|NCT01918306|8661327|P3|Overall Study|Lack of Efficacy|0
2503663|NCT01918306|8661328|P2|Overall Study|Lack of Efficacy|0
2503664|NCT01918306|8661329|P1|Overall Study|Lack of Efficacy|1
2503665|NCT01918306|8661326|P4|Overall Study|neutropenia|0
2503666|NCT01918306|8661327|P3|Overall Study|neutropenia|0
2503667|NCT01918306|8661328|P2|Overall Study|neutropenia|0
2503668|NCT01918306|8661329|P1|Overall Study|neutropenia|1
2503669|NCT01918306|8661326|P4|Overall Study|Withdrawal by Subject|2
2503670|NCT01918306|8661327|P3|Overall Study|Withdrawal by Subject|0
2503671|NCT01918306|8661328|P2|Overall Study|Withdrawal by Subject|0
2503672|NCT01918306|8661329|P1|Overall Study|Withdrawal by Subject|0
2503673|NCT01918306|8661326|P4|Overall Study|progresive disease|1
2503674|NCT01918306|8661327|P3|Overall Study|progresive disease|1
2503675|NCT01918306|8661328|P2|Overall Study|progresive disease|0
2503676|NCT01918306|8661329|P1|Overall Study|progresive disease|4
2503677|NCT01918085|8661360|P2|Test Period 1: Strata Strip|Adverse Event|1
2503678|NCT01918085|8661361|P1|Test Period 1: Strata Strip|Adverse Event|0
2503679|NCT01918033|8661385|P3|Overall Study|Withdrawal by Subject|0
2503680|NCT01918033|8661386|P2|Overall Study|Withdrawal by Subject|1
2503681|NCT01918033|8661387|P1|Overall Study|Withdrawal by Subject|2
2503682|NCT01918033|8661385|P3|Overall Study|Protocol Violation|1
2503683|NCT01918033|8661386|P2|Overall Study|Protocol Violation|0
2503684|NCT01918033|8661387|P1|Overall Study|Protocol Violation|2
2503685|NCT01918033|8661385|P3|Overall Study|Lost to Follow-up|0
2503686|NCT01918033|8661386|P2|Overall Study|Lost to Follow-up|1
2503687|NCT01918033|8661387|P1|Overall Study|Lost to Follow-up|0
2503688|NCT01918033|8661385|P3|Overall Study|Adverse Event|2
2503689|NCT01918033|8661386|P2|Overall Study|Adverse Event|0
2503690|NCT01918033|8661387|P1|Overall Study|Adverse Event|1
2503691|NCT01917747|8661458|P2|Overall Study|Lost to Follow-up|9
2503692|NCT01917747|8661459|P1|Overall Study|Lost to Follow-up|18
2503693|NCT01917747|8661458|P2|Overall Study|Withdrawal by Subject|2
2503694|NCT01917747|8661459|P1|Overall Study|Withdrawal by Subject|1
2503695|NCT01917656|8661473|P2|Overall Study|Lost to Follow-up|4
2503696|NCT01917656|8661474|P1|Overall Study|Lost to Follow-up|3
2503697|NCT01917656|8661473|P2|Overall Study|Withdrawal by Subject|3
2503698|NCT01917656|8661474|P1|Overall Study|Withdrawal by Subject|4
2503699|NCT01917656|8661473|P2|Overall Study|Unclassified|3
2503700|NCT01917656|8661474|P1|Overall Study|Unclassified|0
2503701|NCT01917656|8661473|P2|Overall Study|Withdrawal criteria|14
2503702|NCT01917656|8661474|P1|Overall Study|Withdrawal criteria|8
2503703|NCT01917656|8661473|P2|Overall Study|Adverse Event|0
2503704|NCT01917656|8661474|P1|Overall Study|Adverse Event|11
2503705|NCT01917526|8661500|P2|Overall Study|Protocol Violation|1
2503706|NCT01917526|8661501|P1|Overall Study|Protocol Violation|1
2503707|NCT01917344|8661518|P1|Overall Study|Withdrawal by Subject|1
2503708|NCT01917318|8661524|P2|First Treatment|Withdrawal by Subject|1
2503709|NCT01917318|8661525|P1|First Treatment|Withdrawal by Subject|0
2503710|NCT01917006|8661578|P8|Open-label Period|Lost to Follow-up|1
2503711|NCT01917006|8661579|P7|Open-label Period|Lost to Follow-up|0
2503712|NCT01917006|8661580|P6|Open-label Period|Lost to Follow-up|0
2503713|NCT01917006|8661581|P5|Open-label Period|Lost to Follow-up|0
2503714|NCT01917006|8661582|P4|Open-label Period|Lost to Follow-up|0
2503715|NCT01917006|8661583|P3|Open-label Period|Lost to Follow-up|0
2503716|NCT01917006|8661584|P2|Open-label Period|Lost to Follow-up|0
2503717|NCT01917006|8661585|P1|Open-label Period|Lost to Follow-up|0
2503718|NCT01917006|8661578|P8|Open-label Period|Adverse Event|1
2503719|NCT01917006|8661579|P7|Open-label Period|Adverse Event|0
2503720|NCT01917006|8661580|P6|Open-label Period|Adverse Event|0
2503721|NCT01917006|8661581|P5|Open-label Period|Adverse Event|0
2503722|NCT01917006|8661582|P4|Open-label Period|Adverse Event|0
2503723|NCT01917006|8661583|P3|Open-label Period|Adverse Event|0
2503724|NCT01917006|8661584|P2|Open-label Period|Adverse Event|0
2503725|NCT01917006|8661585|P1|Open-label Period|Adverse Event|0
2503726|NCT01917006|8661578|P8|Randomized-treatment Period|Other Miscellaneous Reasons|0
2503727|NCT01917006|8661579|P7|Randomized-treatment Period|Other Miscellaneous Reasons|1
2503728|NCT01917006|8661580|P6|Randomized-treatment Period|Other Miscellaneous Reasons|0
2503729|NCT01917006|8661581|P5|Randomized-treatment Period|Other Miscellaneous Reasons|0
2503730|NCT01917006|8661582|P4|Randomized-treatment Period|Other Miscellaneous Reasons|0
2503731|NCT01917006|8661583|P3|Randomized-treatment Period|Other Miscellaneous Reasons|0
2503732|NCT01917006|8661584|P2|Randomized-treatment Period|Other Miscellaneous Reasons|0
2503733|NCT01917006|8661585|P1|Randomized-treatment Period|Other Miscellaneous Reasons|0
2503734|NCT01917006|8661578|P8|Randomized-treatment Period|Protocol Violation|0
2503735|NCT01917006|8661579|P7|Randomized-treatment Period|Protocol Violation|0
2503736|NCT01917006|8661580|P6|Randomized-treatment Period|Protocol Violation|0
2503737|NCT01917006|8661581|P5|Randomized-treatment Period|Protocol Violation|0
2503738|NCT01917006|8661582|P4|Randomized-treatment Period|Protocol Violation|0
2503739|NCT01917006|8661583|P3|Randomized-treatment Period|Protocol Violation|0
2503740|NCT01917006|8661584|P2|Randomized-treatment Period|Protocol Violation|0
2503741|NCT01917006|8661585|P1|Randomized-treatment Period|Protocol Violation|1
2503742|NCT01917006|8661578|P8|Randomized-treatment Period|Personal Reasons|0
2503743|NCT01917006|8661579|P7|Randomized-treatment Period|Personal Reasons|0
2503744|NCT01917006|8661580|P6|Randomized-treatment Period|Personal Reasons|1
2503745|NCT01917006|8661581|P5|Randomized-treatment Period|Personal Reasons|0
2503746|NCT01917006|8661582|P4|Randomized-treatment Period|Personal Reasons|0
2503747|NCT01917006|8661583|P3|Randomized-treatment Period|Personal Reasons|0
2503748|NCT01917006|8661584|P2|Randomized-treatment Period|Personal Reasons|0
2503749|NCT01917006|8661585|P1|Randomized-treatment Period|Personal Reasons|0
2503750|NCT01917006|8661578|P8|Randomized-treatment Period|Lost to Follow-up|0
2503751|NCT01917006|8661579|P7|Randomized-treatment Period|Lost to Follow-up|0
2503752|NCT01917006|8661580|P6|Randomized-treatment Period|Lost to Follow-up|0
2503753|NCT01917006|8661581|P5|Randomized-treatment Period|Lost to Follow-up|0
2503754|NCT01917006|8661582|P4|Randomized-treatment Period|Lost to Follow-up|1
2503755|NCT01917006|8661583|P3|Randomized-treatment Period|Lost to Follow-up|0
2503756|NCT01917006|8661584|P2|Randomized-treatment Period|Lost to Follow-up|0
2503757|NCT01917006|8661585|P1|Randomized-treatment Period|Lost to Follow-up|1
2503758|NCT01916980|8661618|P2|Overall Study|Withdrawal by Subject|0
2503759|NCT01916980|8661619|P1|Overall Study|Withdrawal by Subject|1
2503760|NCT01916980|8661618|P2|Overall Study|Lack of Efficacy|2
2503761|NCT01916980|8661619|P1|Overall Study|Lack of Efficacy|2
2503762|NCT01916980|8661618|P2|Overall Study|Adverse Event|2
2503763|NCT01916980|8661619|P1|Overall Study|Adverse Event|4
2503764|NCT01916967|8661638|P3|Overall Study|Protocol Violation|0
2503765|NCT01916967|8661639|P2|Overall Study|Protocol Violation|1
2503766|NCT01916967|8661640|P1|Overall Study|Protocol Violation|0
2503767|NCT01916967|8661638|P3|Overall Study|Physician Decision|1
2503768|NCT01916967|8661639|P2|Overall Study|Physician Decision|0
2503769|NCT01916967|8661640|P1|Overall Study|Physician Decision|0
2503770|NCT01916967|8661638|P3|Overall Study|Lack of Efficacy|6
2503771|NCT01916967|8661639|P2|Overall Study|Lack of Efficacy|0
2503772|NCT01916967|8661640|P1|Overall Study|Lack of Efficacy|0
2503773|NCT01916967|8661638|P3|Overall Study|Adverse Event|2
2503774|NCT01916967|8661639|P2|Overall Study|Adverse Event|0
2503775|NCT01916967|8661640|P1|Overall Study|Adverse Event|0
2503776|NCT01916824|8661696|P2|Overall Study|Withdrawal by Subject|3
2503777|NCT01916824|8661697|P1|Overall Study|Withdrawal by Subject|2
2503778|NCT01916824|8661696|P2|Overall Study|Physician Decision|0
2503779|NCT01916824|8661697|P1|Overall Study|Physician Decision|2
2503780|NCT01916824|8661696|P2|Overall Study|Lost to Follow-up|6
2503781|NCT01916824|8661697|P1|Overall Study|Lost to Follow-up|3
2503782|NCT01916304|8661779|P1|Overall Study|Screening failure|17
2503783|NCT01916226|8661791|P4|Overall Study|Physician Decision|1
2503784|NCT01916226|8661792|P3|Overall Study|Physician Decision|0
2503785|NCT01916226|8661793|P2|Overall Study|Physician Decision|0
2503786|NCT01916226|8661794|P1|Overall Study|Physician Decision|0
2503787|NCT01916226|8661791|P4|Overall Study|Protocol Violation|1
2503788|NCT01916226|8661792|P3|Overall Study|Protocol Violation|0
2503789|NCT01916226|8661793|P2|Overall Study|Protocol Violation|1
2503790|NCT01916226|8661794|P1|Overall Study|Protocol Violation|0
2503791|NCT01916226|8661791|P4|Overall Study|Lack of Efficacy|1
2503792|NCT01916226|8661792|P3|Overall Study|Lack of Efficacy|2
2503793|NCT01916226|8661793|P2|Overall Study|Lack of Efficacy|0
2503794|NCT01916226|8661794|P1|Overall Study|Lack of Efficacy|0
2503795|NCT01916226|8661791|P4|Overall Study|Adverse Event|1
2503796|NCT01916226|8661792|P3|Overall Study|Adverse Event|1
2503797|NCT01916226|8661793|P2|Overall Study|Adverse Event|0
2503798|NCT01916226|8661794|P1|Overall Study|Adverse Event|1
2503799|NCT01916109|8661828|P1|Overall Study|Withdrawal by Subject|1
2503800|NCT01915940|8661834|P3|Treatment Period|Other Miscellaneous Reasons|0
2503801|NCT01915940|8661835|P2|Treatment Period|Other Miscellaneous Reasons|1
2503802|NCT01915940|8661836|P1|Treatment Period|Other Miscellaneous Reasons|0
2503803|NCT01915940|8661834|P3|Treatment Period|Adverse Event|1
2503804|NCT01915940|8661835|P2|Treatment Period|Adverse Event|9
2503805|NCT01915940|8661836|P1|Treatment Period|Adverse Event|0
2503806|NCT01915940|8661834|P3|Treatment Period|Decision of Participant|3
2503807|NCT01915940|8661835|P2|Treatment Period|Decision of Participant|1
2503808|NCT01915940|8661836|P1|Treatment Period|Decision of Participant|0
2503809|NCT01915940|8661834|P3|Pre-randomization Washout Period|Not Qualified for Randomization|0
2503810|NCT01915940|8661835|P2|Pre-randomization Washout Period|Not Qualified for Randomization|0
2503811|NCT01915940|8661836|P1|Pre-randomization Washout Period|Not Qualified for Randomization|39
2503812|NCT01915914|8661852|P4|Follow-up Phase|Physician Decision|1
2503813|NCT01915914|8661853|P3|Follow-up Phase|Physician Decision|0
2503814|NCT01915914|8661854|P2|Follow-up Phase|Physician Decision|0
2503815|NCT01915914|8661855|P1|Follow-up Phase|Physician Decision|0
2503816|NCT01915914|8661852|P4|Follow-up Phase|Withdrawal by Subject|1
2503817|NCT01915914|8661853|P3|Follow-up Phase|Withdrawal by Subject|0
2503818|NCT01915914|8661854|P2|Follow-up Phase|Withdrawal by Subject|0
2503819|NCT01915914|8661855|P1|Follow-up Phase|Withdrawal by Subject|0
2503820|NCT01915914|8661852|P4|Maintenance Phase|Missing|0
2503821|NCT01915914|8661853|P3|Maintenance Phase|Missing|0
2503822|NCT01915914|8661854|P2|Maintenance Phase|Missing|1
2503823|NCT01915914|8661855|P1|Maintenance Phase|Missing|0
2503824|NCT01915914|8661852|P4|Maintenance Phase|Lost to Follow-up|0
2503825|NCT01915914|8661853|P3|Maintenance Phase|Lost to Follow-up|1
2503826|NCT01915914|8661854|P2|Maintenance Phase|Lost to Follow-up|4
2503827|NCT01915914|8661855|P1|Maintenance Phase|Lost to Follow-up|0
2503828|NCT01915914|8661852|P4|Maintenance Phase|Withdrawal by Subject|0
2503829|NCT01915914|8661853|P3|Maintenance Phase|Withdrawal by Subject|1
2503830|NCT01915914|8661854|P2|Maintenance Phase|Withdrawal by Subject|1
2503831|NCT01915914|8661855|P1|Maintenance Phase|Withdrawal by Subject|0
2503832|NCT01915914|8661852|P4|Acute Phase|Missing|0
2503833|NCT01915914|8661853|P3|Acute Phase|Missing|0
2503834|NCT01915914|8661854|P2|Acute Phase|Missing|0
2503835|NCT01915914|8661855|P1|Acute Phase|Missing|1
2503836|NCT01915914|8661852|P4|Acute Phase|"Not Achieved treatment success"|0
2503837|NCT01915914|8661853|P3|Acute Phase|"Not Achieved treatment success"|0
2503838|NCT01915914|8661854|P2|Acute Phase|"Not Achieved treatment success"|0
2503839|NCT01915914|8661855|P1|Acute Phase|"Not Achieved treatment success"|1
2503840|NCT01915914|8661852|P4|Acute Phase|Accepted Other Topic Therapies|0
2503841|NCT01915914|8661853|P3|Acute Phase|Accepted Other Topic Therapies|0
2503842|NCT01915914|8661854|P2|Acute Phase|Accepted Other Topic Therapies|0
2503843|NCT01915914|8661855|P1|Acute Phase|Accepted Other Topic Therapies|1
2503844|NCT01915914|8661852|P4|Acute Phase|Physician Decision|0
2503845|NCT01915914|8661853|P3|Acute Phase|Physician Decision|0
2503846|NCT01915914|8661854|P2|Acute Phase|Physician Decision|0
2503847|NCT01915914|8661855|P1|Acute Phase|Physician Decision|1
2503848|NCT01915914|8661852|P4|Acute Phase|Lost to Follow-up|0
2503849|NCT01915914|8661853|P3|Acute Phase|Lost to Follow-up|0
2503850|NCT01915914|8661854|P2|Acute Phase|Lost to Follow-up|0
2503851|NCT01915914|8661855|P1|Acute Phase|Lost to Follow-up|4
2503852|NCT01915914|8661852|P4|Acute Phase|Withdrawal by Subject|0
2503853|NCT01915914|8661853|P3|Acute Phase|Withdrawal by Subject|0
2503854|NCT01915914|8661854|P2|Acute Phase|Withdrawal by Subject|0
2503855|NCT01915914|8661855|P1|Acute Phase|Withdrawal by Subject|4
2503856|NCT01915849|8661887|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
2503857|NCT01915849|8661888|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
2503858|NCT01915849|8661889|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
2503859|NCT01915849|8661890|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
2503860|NCT01915849|8661887|P4|Treatment Period 1 (4 Days)|Protocol Violation|0
2503861|NCT01915849|8661888|P3|Treatment Period 1 (4 Days)|Protocol Violation|0
2503862|NCT01915849|8661889|P2|Treatment Period 1 (4 Days)|Protocol Violation|0
2503863|NCT01915849|8661890|P1|Treatment Period 1 (4 Days)|Protocol Violation|1
2503864|NCT01915771|8661913|P1|Day 15|Withdrawal by Subject|1
2503865|NCT01915771|8661913|P1|Day 1|Withdrawal by Subject|1
2503866|NCT01915732|8661937|P2|Overall Study|Poor Conscious Effect|1
2503867|NCT01915732|8661938|P1|Overall Study|Poor Conscious Effect|0
2503868|NCT01915732|8661937|P2|Overall Study|Improper Facial Procedure|1
2503869|NCT01915732|8661938|P1|Overall Study|Improper Facial Procedure|0
2503870|NCT01915732|8661937|P2|Overall Study|Job Transfer|1
2503871|NCT01915732|8661938|P1|Overall Study|Job Transfer|0
2503872|NCT01915732|8661937|P2|Overall Study|Par. Refused to Hospital Visits|1
2503873|NCT01915732|8661938|P1|Overall Study|Par. Refused to Hospital Visits|0
2503874|NCT01915732|8661937|P2|Overall Study|Par. not Willing to Continue Treatment|1
2503875|NCT01915732|8661938|P1|Overall Study|Par. not Willing to Continue Treatment|0
2503876|NCT01915732|8661937|P2|Overall Study|Got Well|1
2503877|NCT01915732|8661938|P1|Overall Study|Got Well|0
2503878|NCT01915732|8661937|P2|Overall Study|Par. Unable to Come to the Hospital|1
2503879|NCT01915732|8661938|P1|Overall Study|Par. Unable to Come to the Hospital|0
2503880|NCT01915732|8661937|P2|Overall Study|Poor Perceived Efficacy|0
2503881|NCT01915732|8661938|P1|Overall Study|Poor Perceived Efficacy|1
2503882|NCT01915732|8661937|P2|Overall Study|Pregnancy|0
2503883|NCT01915732|8661938|P1|Overall Study|Pregnancy|1
2503884|NCT01915732|8661937|P2|Overall Study|Recovered|0
2503885|NCT01915732|8661938|P1|Overall Study|Recovered|1
2503886|NCT01915732|8661937|P2|Overall Study|Drug Release Error|0
2503887|NCT01915732|8661938|P1|Overall Study|Drug Release Error|1
2503888|NCT01915732|8661937|P2|Overall Study|Par. Conscious Ineffective Vol Exit|0
2503889|NCT01915732|8661938|P1|Overall Study|Par. Conscious Ineffective Vol Exit|1
2503890|NCT01915732|8661937|P2|Overall Study|Par. Improved, Voluntary (Vol) exit|0
2503891|NCT01915732|8661938|P1|Overall Study|Par. Improved, Voluntary (Vol) exit|1
2503892|NCT01915732|8661937|P2|Overall Study|Lost to Follow-up|26
2503893|NCT01915732|8661938|P1|Overall Study|Lost to Follow-up|22
2503894|NCT01915732|8661937|P2|Overall Study|Lack of Efficacy|11
2503895|NCT01915732|8661938|P1|Overall Study|Lack of Efficacy|6
2503896|NCT01915732|8661937|P2|Overall Study|Protocol Violation|5
2503897|NCT01915732|8661938|P1|Overall Study|Protocol Violation|5
2503898|NCT01915732|8661937|P2|Overall Study|Adverse Event|4
2503899|NCT01915732|8661938|P1|Overall Study|Adverse Event|12
2503900|NCT01915732|8661937|P2|Overall Study|Failure to Meet Randomization Criteria|0
2503901|NCT01915732|8661938|P1|Overall Study|Failure to Meet Randomization Criteria|1
2503902|NCT01915732|8661937|P2|Overall Study|Withdrawal by Subject|18
2503903|NCT01915732|8661938|P1|Overall Study|Withdrawal by Subject|18
2503904|NCT01914926|8662017|P2|Overall Study|uncooperative, agitated and removed|1
2503905|NCT01914926|8662018|P1|Overall Study|uncooperative, agitated and removed|0
2503906|NCT01914926|8662017|P2|Overall Study|Adverse Event|0
2503907|NCT01914926|8662018|P1|Overall Study|Adverse Event|1
2503908|NCT01914757|8662027|P3|Overall Study|Other reasons|4
2503909|NCT01914757|8662028|P2|Overall Study|Other reasons|9
2503910|NCT01914757|8662029|P1|Overall Study|Other reasons|5
2503911|NCT01914757|8662027|P3|Overall Study|Eligibility criteria not fulfilled|2
2503912|NCT01914757|8662028|P2|Overall Study|Eligibility criteria not fulfilled|0
2503913|NCT01914757|8662029|P1|Overall Study|Eligibility criteria not fulfilled|2
2503914|NCT01914757|8662027|P3|Overall Study|Study specific withdrawal criteria|0
2503915|NCT01914757|8662028|P2|Overall Study|Study specific withdrawal criteria|1
2503916|NCT01914757|8662029|P1|Overall Study|Study specific withdrawal criteria|0
2503917|NCT01914757|8662027|P3|Overall Study|Adverse Event|4
2503918|NCT01914757|8662028|P2|Overall Study|Adverse Event|3
2503919|NCT01914757|8662029|P1|Overall Study|Adverse Event|4
2503920|NCT01914757|8662027|P3|Overall Study|Death|1
2503921|NCT01914757|8662028|P2|Overall Study|Death|2
2503922|NCT01914757|8662029|P1|Overall Study|Death|2
2503923|NCT01914757|8662027|P3|Overall Study|Withdrawal by Subject|19
2503924|NCT01914757|8662028|P2|Overall Study|Withdrawal by Subject|27
2503925|NCT01914757|8662029|P1|Overall Study|Withdrawal by Subject|15
2503926|NCT01914757|8662027|P3|Overall Study|Lost to Follow-up|6
2503927|NCT01914757|8662028|P2|Overall Study|Lost to Follow-up|8
2503928|NCT01914757|8662029|P1|Overall Study|Lost to Follow-up|5
2503929|NCT01914757|8662027|P3|Overall Study|Severe non-compliance to protocol|2
2503930|NCT01914757|8662028|P2|Overall Study|Severe non-compliance to protocol|1
2503931|NCT01914757|8662029|P1|Overall Study|Severe non-compliance to protocol|3
2503932|NCT01914679|8662103|P1|Overall Study|Sponsor terminated study|4
2503933|NCT01914679|8662103|P1|Overall Study|Lack of Efficacy|1
2503934|NCT01914666|8662110|P3|Treatment Period|Physician Decision|2
2503935|NCT01914666|8662111|P2|Treatment Period|Physician Decision|0
2503936|NCT01914666|8662112|P1|Treatment Period|Physician Decision|0
2503937|NCT01914666|8662110|P3|Treatment Period|Withdrawal by Subject|2
2503938|NCT01914666|8662111|P2|Treatment Period|Withdrawal by Subject|2
2503939|NCT01914666|8662112|P1|Treatment Period|Withdrawal by Subject|3
2503940|NCT01914666|8662110|P3|Treatment Period|Adverse Event|2
2503941|NCT01914666|8662111|P2|Treatment Period|Adverse Event|4
2503942|NCT01914666|8662112|P1|Treatment Period|Adverse Event|10
2503943|NCT01914666|8662110|P3|Treatment Period|Lack of Efficacy|2
2503944|NCT01914666|8662111|P2|Treatment Period|Lack of Efficacy|0
2503945|NCT01914666|8662112|P1|Treatment Period|Lack of Efficacy|0
2503946|NCT01914393|8662155|P3|Overall Study|subject never dosed|1
2503947|NCT01914393|8662156|P2|Overall Study|subject never dosed|0
2503948|NCT01914393|8662157|P1|Overall Study|subject never dosed|0
2503949|NCT01914393|8662155|P3|Overall Study|Lost to Follow-up|19
2503950|NCT01914393|8662156|P2|Overall Study|Lost to Follow-up|6
2503951|NCT01914393|8662157|P1|Overall Study|Lost to Follow-up|12
2503952|NCT01914393|8662155|P3|Overall Study|Withdrawal by Subject|47
2503953|NCT01914393|8662156|P2|Overall Study|Withdrawal by Subject|20
2503954|NCT01914393|8662157|P1|Overall Study|Withdrawal by Subject|38
2503955|NCT01914393|8662155|P3|Overall Study|Adverse Event|31
2503956|NCT01914393|8662156|P2|Overall Study|Adverse Event|18
2503957|NCT01914393|8662157|P1|Overall Study|Adverse Event|29
2503958|NCT01914393|8662155|P3|Overall Study|no reason given|16
2503959|NCT01914393|8662156|P2|Overall Study|no reason given|8
2503960|NCT01914393|8662157|P1|Overall Study|no reason given|14
2503961|NCT01914393|8662155|P3|Overall Study|Lack of Efficacy|5
2503962|NCT01914393|8662156|P2|Overall Study|Lack of Efficacy|16
2503963|NCT01914393|8662157|P1|Overall Study|Lack of Efficacy|11
2503964|NCT01914393|8662155|P3|Overall Study|Protocol Violation|19
2503965|NCT01914393|8662156|P2|Overall Study|Protocol Violation|3
2503966|NCT01914393|8662157|P1|Overall Study|Protocol Violation|11
2503967|NCT01913483|8662284|P2|Overall Study|Death|17
2503968|NCT01913483|8662285|P1|Overall Study|Death|14
2503969|NCT01913483|8662284|P2|Overall Study|Lost to Follow-up|3
2503970|NCT01913483|8662285|P1|Overall Study|Lost to Follow-up|6
2503971|NCT01913483|8662284|P2|Overall Study|Withdrawal by Subject|2
2503972|NCT01913483|8662285|P1|Overall Study|Withdrawal by Subject|1
2503973|NCT01913470|8662297|P2|Overall Study|Withdrawal by Subject|1
2503974|NCT01913470|8662298|P1|Overall Study|Withdrawal by Subject|0
2503975|NCT01913470|8662297|P2|Overall Study|Physician Decision|1
2503976|NCT01913470|8662298|P1|Overall Study|Physician Decision|0
2503977|NCT01913470|8662297|P2|Overall Study|Lost to Follow-up|1
2503978|NCT01913470|8662298|P1|Overall Study|Lost to Follow-up|0
2503979|NCT01913405|8662316|P1|Overall Study|Adverse Event|1
2503980|NCT01913405|8662316|P1|Overall Study|Withdrawal by Subject|1
2503981|NCT01913353|8662372|P2|Overall Study|multiple reasons|7
2503982|NCT01913353|8662373|P1|Overall Study|multiple reasons|10
2503983|NCT01913353|8662372|P2|Overall Study|Withdrawal by Subject|6
2503984|NCT01913353|8662373|P1|Overall Study|Withdrawal by Subject|20
2503985|NCT01913353|8662372|P2|Overall Study|Physician Decision|2
2503986|NCT01913353|8662373|P1|Overall Study|Physician Decision|0
2503987|NCT01913353|8662372|P2|Overall Study|Adverse Event|0
2503988|NCT01913353|8662373|P1|Overall Study|Adverse Event|2
2503989|NCT01913327|8662443|P2|Overall Study|Withdrawal by Subject|1
2503990|NCT01913327|8662444|P1|Overall Study|Withdrawal by Subject|0
2503991|NCT01913041|8662469|P1|Overall Study|Physician Decision|1
2503992|NCT01913041|8662469|P1|Overall Study|Withdrawal by Subject|3
2503993|NCT01913041|8662469|P1|Overall Study|Protocol Violation|35
2503994|NCT01912963|8662476|P3|Overall Study|Sought treatment locally|0
2503995|NCT01912963|8662477|P2|Overall Study|Sought treatment locally|1
2503996|NCT01912963|8662478|P1|Overall Study|Sought treatment locally|0
2503997|NCT01912963|8662476|P3|Overall Study|Withdrawal by Subject|0
2503998|NCT01912963|8662477|P2|Overall Study|Withdrawal by Subject|1
2503999|NCT01912963|8662478|P1|Overall Study|Withdrawal by Subject|0
2504000|NCT01912963|8662476|P3|Overall Study|Adverse Event|1
2504001|NCT01912963|8662477|P2|Overall Study|Adverse Event|1
2504002|NCT01912963|8662478|P1|Overall Study|Adverse Event|0
2504003|NCT01912963|8662476|P3|Overall Study|Disease Progression (not RECIST1.1)|1
2504004|NCT01912963|8662477|P2|Overall Study|Disease Progression (not RECIST1.1)|7
2504005|NCT01912963|8662478|P1|Overall Study|Disease Progression (not RECIST1.1)|0
2504006|NCT01912963|8662476|P3|Overall Study|Disease Progression (RECIST1.1)|5
2504007|NCT01912963|8662477|P2|Overall Study|Disease Progression (RECIST1.1)|9
2504008|NCT01912963|8662478|P1|Overall Study|Disease Progression (RECIST1.1)|6
2504009|NCT01912872|8662501|P4|Overall Study|Missing|1
2504010|NCT01912872|8662502|P3|Overall Study|Missing|0
2504011|NCT01912872|8662503|P2|Overall Study|Missing|0
2504012|NCT01912872|8662504|P1|Overall Study|Missing|0
2504013|NCT01912872|8662501|P4|Overall Study|Withdrawal of study medication|2
2504014|NCT01912872|8662502|P3|Overall Study|Withdrawal of study medication|0
2504015|NCT01912872|8662503|P2|Overall Study|Withdrawal of study medication|0
2504016|NCT01912872|8662504|P1|Overall Study|Withdrawal of study medication|0
2504017|NCT01912872|8662501|P4|Overall Study|Unsatisfactory therapeutic effect|2
2504018|NCT01912872|8662502|P3|Overall Study|Unsatisfactory therapeutic effect|0
2504019|NCT01912872|8662503|P2|Overall Study|Unsatisfactory therapeutic effect|0
2504020|NCT01912872|8662504|P1|Overall Study|Unsatisfactory therapeutic effect|0
2504021|NCT01912872|8662501|P4|Overall Study|Protocol Violation|0
2504022|NCT01912872|8662502|P3|Overall Study|Protocol Violation|1
2504023|NCT01912872|8662503|P2|Overall Study|Protocol Violation|0
2504024|NCT01912872|8662504|P1|Overall Study|Protocol Violation|0
2504025|NCT01912872|8662501|P4|Overall Study|Non-compliance with lab inc/exclusion|1
2504026|NCT01912872|8662502|P3|Overall Study|Non-compliance with lab inc/exclusion|0
2504027|NCT01912872|8662503|P2|Overall Study|Non-compliance with lab inc/exclusion|0
2504028|NCT01912872|8662504|P1|Overall Study|Non-compliance with lab inc/exclusion|0
2504029|NCT01912872|8662501|P4|Overall Study|Informed consent withdrawn|1
2504030|NCT01912872|8662502|P3|Overall Study|Informed consent withdrawn|1
2504031|NCT01912872|8662503|P2|Overall Study|Informed consent withdrawn|0
2504032|NCT01912872|8662504|P1|Overall Study|Informed consent withdrawn|0
2504033|NCT01912872|8662501|P4|Overall Study|Other unspecified|0
2504034|NCT01912872|8662502|P3|Overall Study|Other unspecified|3
2504035|NCT01912872|8662503|P2|Overall Study|Other unspecified|1
2504036|NCT01912872|8662504|P1|Overall Study|Other unspecified|3
2504037|NCT01912872|8662501|P4|Overall Study|Lost to Follow-up|5
2504038|NCT01912872|8662502|P3|Overall Study|Lost to Follow-up|5
2504039|NCT01912872|8662503|P2|Overall Study|Lost to Follow-up|3
2504040|NCT01912872|8662504|P1|Overall Study|Lost to Follow-up|2
2504041|NCT01912781|8662548|P2|Overall Study|Withdrawal by Subject|0
2504042|NCT01912781|8662549|P1|Overall Study|Withdrawal by Subject|2
2504043|NCT01912768|8662580|P2|Overall Study|Randomized in error|0
2504044|NCT01912768|8662581|P1|Overall Study|Randomized in error|1
2504045|NCT01912768|8662580|P2|Overall Study|Withdrawal by Subject|3
2504046|NCT01912768|8662581|P1|Overall Study|Withdrawal by Subject|5
2504047|NCT01912768|8662580|P2|Overall Study|Lost to Follow-up|1
2504048|NCT01912768|8662581|P1|Overall Study|Lost to Follow-up|2
2504049|NCT01912768|8662580|P2|Overall Study|Adverse Event|0
2504050|NCT01912768|8662581|P1|Overall Study|Adverse Event|2
2504051|NCT01912729|8662612|P2|Overall Study|Withdrawal by Subject|1
2504052|NCT01912729|8662613|P1|Overall Study|Withdrawal by Subject|0
2504053|NCT01912599|8662636|P2|Overall Study|Withdrawal by Subject|1
2504054|NCT01912599|8662637|P1|Overall Study|Withdrawal by Subject|0
2504055|NCT01912404|8662662|P2|Overall Study|Due to personal reasons|0
2504056|NCT01912404|8662663|P1|Overall Study|Due to personal reasons|1
2504057|NCT01912339|8662676|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46
2504058|NCT01912339|8662677|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0
2504059|NCT01912339|8662678|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120
2504060|NCT01912339|8662676|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1
2504061|NCT01912339|8662677|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
2504062|NCT01912339|8662678|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
2504063|NCT01912339|8662676|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1
2504064|NCT01912339|8662677|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
2504065|NCT01912339|8662678|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
2504066|NCT01912339|8662676|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1
2504067|NCT01912339|8662677|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
2504068|NCT01912339|8662678|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
2504069|NCT01912339|8662676|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1
2504070|NCT01912339|8662677|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
2504071|NCT01912339|8662678|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
2504072|NCT01912339|8662676|P3|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
2504073|NCT01912339|8662677|P2|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
2504074|NCT01912339|8662678|P1|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1
2504075|NCT01912339|8662676|P3|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
2504076|NCT01912339|8662677|P2|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
2504077|NCT01912339|8662678|P1|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1
2504078|NCT01912339|8662676|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3
2504079|NCT01912339|8662677|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0
2504080|NCT01912339|8662678|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1
2504081|NCT01912339|8662676|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
2504082|NCT01912339|8662677|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
2504083|NCT01912339|8662678|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5
2504084|NCT01912339|8662676|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
2504085|NCT01912339|8662677|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
2504086|NCT01912339|8662678|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5
2504087|NCT01912339|8662676|P3|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
2504088|NCT01912339|8662677|P2|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
2504089|NCT01912339|8662678|P1|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1
2504090|NCT01912339|8662676|P3|Blinded (0 to 3 Months)|Open Prostatectomy|0
2504091|NCT01912339|8662677|P2|Blinded (0 to 3 Months)|Open Prostatectomy|0
2504092|NCT01912339|8662678|P1|Blinded (0 to 3 Months)|Open Prostatectomy|1
2504093|NCT01912339|8662676|P3|Blinded (0 to 3 Months)|Declined to participate|0
2504094|NCT01912339|8662677|P2|Blinded (0 to 3 Months)|Declined to participate|0
2504095|NCT01912339|8662678|P1|Blinded (0 to 3 Months)|Declined to participate|1
2504096|NCT01912222|8662695|P3|Part B: Treatment Period|Withdrawal by Subject|2
2504097|NCT01912222|8662696|P2|Part B: Treatment Period|Withdrawal by Subject|1
2504098|NCT01912222|8662697|P1|Part B: Treatment Period|Withdrawal by Subject|2
2504099|NCT01912222|8662695|P3|Part B: Treatment Period|Adverse Event|3
2504100|NCT01912222|8662696|P2|Part B: Treatment Period|Adverse Event|2
2504101|NCT01912222|8662697|P1|Part B: Treatment Period|Adverse Event|1
2504102|NCT01912222|8662695|P3|Part B: Treatment Period|Progressive disease|15
2504103|NCT01912222|8662696|P2|Part B: Treatment Period|Progressive disease|12
2504104|NCT01912222|8662697|P1|Part B: Treatment Period|Progressive disease|10
2504105|NCT01912222|8662695|P3|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
2504106|NCT01912222|8662696|P2|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
2504107|NCT01912222|8662697|P1|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1
2504108|NCT01911845|8662720|P1|Overall Study|Other (not specified)|3
2504109|NCT01911845|8662720|P1|Overall Study|Lost to Follow-up|1
2504110|NCT01911845|8662720|P1|Overall Study|Adverse Event|2
2504111|NCT01911819|8662737|P3|Overall Study|Withdrawal by Subject|0
2504112|NCT01911819|8662738|P2|Overall Study|Withdrawal by Subject|1
2504113|NCT01911819|8662739|P1|Overall Study|Withdrawal by Subject|1
2504114|NCT01911819|8662737|P3|Overall Study|Adverse Event|0
2504115|NCT01911819|8662738|P2|Overall Study|Adverse Event|1
2504116|NCT01911819|8662739|P1|Overall Study|Adverse Event|0
2504117|NCT01911793|8662752|P2|Overall Study|Physician Decision|5
2504118|NCT01911793|8662753|P1|Overall Study|Physician Decision|1
2504119|NCT01911780|8662777|P2|Extension Period (52 Weeks)|Personal reason|1
2504120|NCT01911780|8662778|P1|Extension Period (52 Weeks)|Personal reason|1
2504121|NCT01911780|8662777|P2|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2
2504122|NCT01911780|8662778|P1|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0
2504123|NCT01911780|8662777|P2|Extension Period (52 Weeks)|Adverse Event|0
2504124|NCT01911780|8662778|P1|Extension Period (52 Weeks)|Adverse Event|3
2504125|NCT01911780|8662777|P2|Double-blind Period (8 Weeks)|Personal reason|0
2504126|NCT01911780|8662778|P1|Double-blind Period (8 Weeks)|Personal reason|1
2504127|NCT01911780|8662777|P2|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
2504128|NCT01911780|8662778|P1|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
2504129|NCT01911780|8662777|P2|Double-blind Period (8 Weeks)|Adverse Event|2
2504130|NCT01911780|8662778|P1|Double-blind Period (8 Weeks)|Adverse Event|1
2504131|NCT01911546|8662812|P1|Overall Study|Everolimus was discontinued|5
2504132|NCT01911546|8662812|P1|Overall Study|Lost to Follow-up|1
2504133|NCT01911442|8662822|P3|Overall Study|Mother's Work Schedule|0
2504134|NCT01911442|8662823|P2|Overall Study|Mother's Work Schedule|1
2504135|NCT01911442|8662824|P1|Overall Study|Mother's Work Schedule|0
2504136|NCT01911442|8662822|P3|Overall Study|Withdrawal by Subject|6
2504137|NCT01911442|8662823|P2|Overall Study|Withdrawal by Subject|0
2504138|NCT01911442|8662824|P1|Overall Study|Withdrawal by Subject|1
2504139|NCT01911442|8662822|P3|Overall Study|Lost to Follow-up|1
2504140|NCT01911442|8662823|P2|Overall Study|Lost to Follow-up|0
2504141|NCT01911442|8662824|P1|Overall Study|Lost to Follow-up|2
2504142|NCT01911442|8662822|P3|Overall Study|Lack of Efficacy|1
2504143|NCT01911442|8662823|P2|Overall Study|Lack of Efficacy|1
2504144|NCT01911442|8662824|P1|Overall Study|Lack of Efficacy|1
2504145|NCT01911442|8662822|P3|Overall Study|Adverse Event|4
2504146|NCT01911442|8662823|P2|Overall Study|Adverse Event|2
2504147|NCT01911442|8662824|P1|Overall Study|Adverse Event|2
2504148|NCT01911429|8662853|P3|Overall Study|subject left study|0
2504149|NCT01911429|8662854|P2|Overall Study|subject left study|0
2504150|NCT01911429|8662855|P1|Overall Study|subject left study|1
2504151|NCT01911429|8662853|P3|Overall Study|Accidental randomization|1
2504152|NCT01911429|8662854|P2|Overall Study|Accidental randomization|0
2504153|NCT01911429|8662855|P1|Overall Study|Accidental randomization|0
2504154|NCT01911429|8662853|P3|Overall Study|Withdrawal by Subject|4
2504155|NCT01911429|8662854|P2|Overall Study|Withdrawal by Subject|5
2504156|NCT01911429|8662855|P1|Overall Study|Withdrawal by Subject|5
2504157|NCT01911429|8662853|P3|Overall Study|Protocol Violation|1
2504158|NCT01911429|8662854|P2|Overall Study|Protocol Violation|0
2504159|NCT01911429|8662855|P1|Overall Study|Protocol Violation|0
2504160|NCT01911429|8662853|P3|Overall Study|Lost to Follow-up|1
2504161|NCT01911429|8662854|P2|Overall Study|Lost to Follow-up|0
2504162|NCT01911429|8662855|P1|Overall Study|Lost to Follow-up|0
2504163|NCT01911429|8662853|P3|Overall Study|Lack of Efficacy|4
2504164|NCT01911429|8662854|P2|Overall Study|Lack of Efficacy|2
2504165|NCT01911429|8662855|P1|Overall Study|Lack of Efficacy|1
2504166|NCT01911429|8662853|P3|Overall Study|Adverse Event|9
2504167|NCT01911429|8662854|P2|Overall Study|Adverse Event|3
2504168|NCT01911429|8662855|P1|Overall Study|Adverse Event|5
2504169|NCT01911273|8662947|P2|Overall Study|Withdrawal by Subject|2
2504170|NCT01911273|8662948|P1|Overall Study|Withdrawal by Subject|0
2504171|NCT01911273|8662947|P2|Overall Study|Progression of Disease|0
2504172|NCT01911273|8662948|P1|Overall Study|Progression of Disease|1
2504173|NCT01911260|8662982|P4|Follow-up Period|transference or evasion of school|12
2504174|NCT01911260|8662983|P3|Follow-up Period|transference or evasion of school|15
2504175|NCT01911260|8662984|P2|Follow-up Period|transference or evasion of school|20
2504176|NCT01911260|8662985|P1|Follow-up Period|transference or evasion of school|13
2504177|NCT01911260|8662982|P4|Supplementation Period|less than 12 weeks supplementation|2
2504178|NCT01911260|8662983|P3|Supplementation Period|less than 12 weeks supplementation|1
2504179|NCT01911260|8662984|P2|Supplementation Period|less than 12 weeks supplementation|3
2504180|NCT01911260|8662985|P1|Supplementation Period|less than 12 weeks supplementation|0
2504181|NCT01911260|8662982|P4|Supplementation Period|refused to receive supplement|0
2504182|NCT01911260|8662983|P3|Supplementation Period|refused to receive supplement|1
2504183|NCT01911260|8662984|P2|Supplementation Period|refused to receive supplement|0
2504184|NCT01911260|8662985|P1|Supplementation Period|refused to receive supplement|1
2504185|NCT01911260|8662982|P4|Supplementation Period|Adverse Event|0
2504186|NCT01911260|8662983|P3|Supplementation Period|Adverse Event|1
2504187|NCT01911260|8662984|P2|Supplementation Period|Adverse Event|0
2504188|NCT01911260|8662985|P1|Supplementation Period|Adverse Event|2
2504189|NCT01911260|8662982|P4|Supplementation Period|transference or evasion of school|6
2504190|NCT01911260|8662983|P3|Supplementation Period|transference or evasion of school|7
2504191|NCT01911260|8662984|P2|Supplementation Period|transference or evasion of school|9
2504192|NCT01911260|8662985|P1|Supplementation Period|transference or evasion of school|7
2504193|NCT01910519|8663071|P2|Overall Study|Adverse Event|0
2504194|NCT01910519|8663072|P1|Overall Study|Adverse Event|2
2504195|NCT01910519|8663071|P2|Overall Study|Withdrawal by Subject|0
2504196|NCT01910519|8663072|P1|Overall Study|Withdrawal by Subject|2
2504197|NCT01910441|8663098|P2|Overall Study|Physician Decision|1
2504198|NCT01910441|8663099|P1|Overall Study|Physician Decision|0
2504199|NCT01910441|8663098|P2|Overall Study|Adverse Event|0
2504200|NCT01910441|8663099|P1|Overall Study|Adverse Event|1
2504201|NCT01910441|8663098|P2|Overall Study|Non-compliance|1
2504202|NCT01910441|8663099|P1|Overall Study|Non-compliance|0
2504203|NCT01910441|8663098|P2|Overall Study|Withdrawal by Subject|1
2504204|NCT01910441|8663099|P1|Overall Study|Withdrawal by Subject|0
2504205|NCT01910441|8663098|P2|Overall Study|Lost to Follow-up|5
2504206|NCT01910441|8663099|P1|Overall Study|Lost to Follow-up|6
2504207|NCT01910441|8663098|P2|Overall Study|Sponsor decision|2
2504208|NCT01910441|8663099|P1|Overall Study|Sponsor decision|0
2504209|NCT01910402|8663107|P2|Continuation Phase|Withdrawal by Subject|0
2504210|NCT01910402|8663108|P1|Continuation Phase|Withdrawal by Subject|2
2504211|NCT01910402|8663107|P2|Continuation Phase|Protocol Violation|0
2504212|NCT01910402|8663108|P1|Continuation Phase|Protocol Violation|3
2504213|NCT01910402|8663107|P2|Continuation Phase|Adverse Event|0
2504214|NCT01910402|8663108|P1|Continuation Phase|Adverse Event|1
2504215|NCT01910402|8663107|P2|Continuation Phase|Ongoing|0
2504216|NCT01910402|8663108|P1|Continuation Phase|Ongoing|84
2504217|NCT01910402|8663107|P2|Randomized Phase|Withdrawal by Subject|7
2504218|NCT01910402|8663108|P1|Randomized Phase|Withdrawal by Subject|5
2504219|NCT01910402|8663107|P2|Randomized Phase|Protocol Violation|13
2504220|NCT01910402|8663108|P1|Randomized Phase|Protocol Violation|10
2504221|NCT01910402|8663107|P2|Randomized Phase|Lost to Follow-up|13
2504222|NCT01910402|8663108|P1|Randomized Phase|Lost to Follow-up|11
2504223|NCT01910402|8663107|P2|Randomized Phase|Lack of Efficacy|4
2504224|NCT01910402|8663108|P1|Randomized Phase|Lack of Efficacy|5
2504225|NCT01910402|8663107|P2|Randomized Phase|Physician Decision|0
2504226|NCT01910402|8663108|P1|Randomized Phase|Physician Decision|1
2504227|NCT01910402|8663107|P2|Randomized Phase|Adverse Event|18
2504228|NCT01910402|8663108|P1|Randomized Phase|Adverse Event|10
2504229|NCT01910389|8663178|P2|Overall Study|Study Closed|8
2504230|NCT01910389|8663179|P1|Overall Study|Study Closed|13
2504231|NCT01910389|8663178|P2|Overall Study|Withdrawal by Subject|0
2504232|NCT01910389|8663179|P1|Overall Study|Withdrawal by Subject|2
2504233|NCT01910298|8663222|P2|Overall Study|Other Miscellaneous Reasons|2
2504234|NCT01910298|8663223|P1|Overall Study|Other Miscellaneous Reasons|0
2504235|NCT01910298|8663222|P2|Overall Study|Study Terminated by Sponsor|17
2504236|NCT01910298|8663223|P1|Overall Study|Study Terminated by Sponsor|1
2504237|NCT01910298|8663222|P2|Overall Study|Lost to Follow-up|1
2504238|NCT01910298|8663223|P1|Overall Study|Lost to Follow-up|1
2504239|NCT01910298|8663222|P2|Overall Study|Protocol Deviation|5
2504240|NCT01910298|8663223|P1|Overall Study|Protocol Deviation|0
2504241|NCT01910298|8663222|P2|Overall Study|Withdrawal by Subject|7
2504242|NCT01910298|8663223|P1|Overall Study|Withdrawal by Subject|2
2504243|NCT01910298|8663222|P2|Overall Study|Adverse Event|0
2504244|NCT01910298|8663223|P1|Overall Study|Adverse Event|1
2504245|NCT01910181|8663241|P1|Overall Study|Study Terminated by Sponsor|6
2504246|NCT01910181|8663241|P1|Overall Study|Lost to Follow-up|3
2504247|NCT01910181|8663241|P1|Overall Study|Death|37
2504248|NCT01910129|8663268|P3|Randomized Phase 3|Withdrawal by Subject|0
2504249|NCT01910129|8663269|P2|Randomized Phase 3|Withdrawal by Subject|1
2504250|NCT01910129|8663270|P1|Randomized Phase 3|Withdrawal by Subject|0
2504251|NCT01910129|8663268|P3|Randomized Phase 2|Withdrawal by Subject|0
2504252|NCT01910129|8663269|P2|Randomized Phase 2|Withdrawal by Subject|1
2504253|NCT01910129|8663270|P1|Randomized Phase 2|Withdrawal by Subject|2
2504254|NCT01910116|8663294|P2|Overall Study|incomplete data|1
2504255|NCT01910116|8663295|P1|Overall Study|incomplete data|0
2504256|NCT01910116|8663294|P2|Overall Study|uncertain allocation|3
2504257|NCT01910116|8663295|P1|Overall Study|uncertain allocation|1
2504258|NCT01910116|8663294|P2|Overall Study|Withdrawal by Subject|3
2504259|NCT01910116|8663295|P1|Overall Study|Withdrawal by Subject|8
2504260|NCT01910116|8663294|P2|Overall Study|Protocol Violation|2
2504261|NCT01910116|8663295|P1|Overall Study|Protocol Violation|1
2504262|NCT01910116|8663294|P2|Overall Study|Lost to Follow-up|0
2504263|NCT01910116|8663295|P1|Overall Study|Lost to Follow-up|1
2504264|NCT01910116|8663294|P2|Overall Study|Lack of Efficacy|4
2504265|NCT01910116|8663295|P1|Overall Study|Lack of Efficacy|3
2504266|NCT01910116|8663294|P2|Overall Study|Adverse Event|3
2504267|NCT01910116|8663295|P1|Overall Study|Adverse Event|0
2504268|NCT01909973|8663382|P2|Overall Study|Lost to Follow-up|0
2504269|NCT01909973|8663383|P1|Overall Study|Lost to Follow-up|1
2504270|NCT01909804|8663403|P12|Overall Study|Protocol Violation|1
2504271|NCT01909804|8663404|P11|Overall Study|Protocol Violation|0
2504272|NCT01909804|8663405|P10|Overall Study|Protocol Violation|0
2504273|NCT01909804|8663406|P9|Overall Study|Protocol Violation|0
2504274|NCT01909804|8663407|P8|Overall Study|Protocol Violation|0
2504275|NCT01909804|8663408|P7|Overall Study|Protocol Violation|0
2504276|NCT01909804|8663409|P6|Overall Study|Protocol Violation|0
2504277|NCT01909804|8663410|P5|Overall Study|Protocol Violation|0
2504278|NCT01909804|8663411|P4|Overall Study|Protocol Violation|0
2504279|NCT01909804|8663412|P3|Overall Study|Protocol Violation|0
2504280|NCT01909804|8663413|P2|Overall Study|Protocol Violation|0
2504281|NCT01909804|8663414|P1|Overall Study|Protocol Violation|0
2504282|NCT01909804|8663403|P12|Overall Study|Withdrew Consent|0
2504283|NCT01909804|8663404|P11|Overall Study|Withdrew Consent|0
2504284|NCT01909804|8663405|P10|Overall Study|Withdrew Consent|0
2504285|NCT01909804|8663406|P9|Overall Study|Withdrew Consent|0
2504286|NCT01909804|8663407|P8|Overall Study|Withdrew Consent|0
2504287|NCT01909804|8663408|P7|Overall Study|Withdrew Consent|0
2504288|NCT01909804|8663409|P6|Overall Study|Withdrew Consent|1
2504289|NCT01909804|8663410|P5|Overall Study|Withdrew Consent|1
2504290|NCT01909804|8663411|P4|Overall Study|Withdrew Consent|0
2504291|NCT01909804|8663412|P3|Overall Study|Withdrew Consent|0
2504292|NCT01909804|8663413|P2|Overall Study|Withdrew Consent|0
2504293|NCT01909804|8663414|P1|Overall Study|Withdrew Consent|0
2504294|NCT01909804|8663403|P12|Overall Study|Lack of Efficacy|1
2504295|NCT01909804|8663404|P11|Overall Study|Lack of Efficacy|0
2504296|NCT01909804|8663405|P10|Overall Study|Lack of Efficacy|1
2504297|NCT01909804|8663406|P9|Overall Study|Lack of Efficacy|0
2504298|NCT01909804|8663407|P8|Overall Study|Lack of Efficacy|1
2504299|NCT01909804|8663408|P7|Overall Study|Lack of Efficacy|1
2504300|NCT01909804|8663409|P6|Overall Study|Lack of Efficacy|3
2504301|NCT01909804|8663410|P5|Overall Study|Lack of Efficacy|7
2504302|NCT01909804|8663411|P4|Overall Study|Lack of Efficacy|0
2504303|NCT01909804|8663412|P3|Overall Study|Lack of Efficacy|0
2504304|NCT01909804|8663413|P2|Overall Study|Lack of Efficacy|1
2504305|NCT01909804|8663414|P1|Overall Study|Lack of Efficacy|4
2504306|NCT01909804|8663403|P12|Overall Study|Death|0
2504307|NCT01909804|8663404|P11|Overall Study|Death|1
2504308|NCT01909804|8663405|P10|Overall Study|Death|0
2504309|NCT01909804|8663406|P9|Overall Study|Death|0
2504310|NCT01909804|8663407|P8|Overall Study|Death|0
2504311|NCT01909804|8663408|P7|Overall Study|Death|0
2504312|NCT01909804|8663409|P6|Overall Study|Death|0
2504313|NCT01909804|8663410|P5|Overall Study|Death|0
2504314|NCT01909804|8663411|P4|Overall Study|Death|0
2504315|NCT01909804|8663412|P3|Overall Study|Death|0
2504316|NCT01909804|8663413|P2|Overall Study|Death|0
2504317|NCT01909804|8663414|P1|Overall Study|Death|0
2504318|NCT01909804|8663403|P12|Overall Study|Randomized but Never Treated|1
2504319|NCT01909804|8663404|P11|Overall Study|Randomized but Never Treated|0
2504320|NCT01909804|8663405|P10|Overall Study|Randomized but Never Treated|0
2504321|NCT01909804|8663406|P9|Overall Study|Randomized but Never Treated|0
2504322|NCT01909804|8663407|P8|Overall Study|Randomized but Never Treated|0
2504323|NCT01909804|8663408|P7|Overall Study|Randomized but Never Treated|1
2504324|NCT01909804|8663409|P6|Overall Study|Randomized but Never Treated|0
2504325|NCT01909804|8663410|P5|Overall Study|Randomized but Never Treated|0
2504326|NCT01909804|8663411|P4|Overall Study|Randomized but Never Treated|0
2504327|NCT01909804|8663412|P3|Overall Study|Randomized but Never Treated|0
2504328|NCT01909804|8663413|P2|Overall Study|Randomized but Never Treated|0
2504329|NCT01909804|8663414|P1|Overall Study|Randomized but Never Treated|0
2504330|NCT01909791|8663463|P3|Overall Study|Missed Visit|1
2504331|NCT01909791|8663464|P2|Overall Study|Missed Visit|0
2504332|NCT01909791|8663465|P1|Overall Study|Missed Visit|2
2504333|NCT01909791|8663463|P3|Overall Study|Lost to Follow-up|10
2504334|NCT01909791|8663464|P2|Overall Study|Lost to Follow-up|11
2504335|NCT01909791|8663465|P1|Overall Study|Lost to Follow-up|5
2504336|NCT01909791|8663463|P3|Overall Study|Withdrawal by Subject|13
2504337|NCT01909791|8663464|P2|Overall Study|Withdrawal by Subject|9
2504338|NCT01909791|8663465|P1|Overall Study|Withdrawal by Subject|5
2504339|NCT01909791|8663463|P3|Overall Study|Death|4
2504340|NCT01909791|8663464|P2|Overall Study|Death|8
2504341|NCT01909791|8663465|P1|Overall Study|Death|9
2504342|NCT01909778|8663523|P1|Overall Study|failed screening|1
2504343|NCT01909674|8663602|P2|Overall Study|Withdrawal by Subject|2
2504344|NCT01909674|8663603|P1|Overall Study|Withdrawal by Subject|5
2504345|NCT01909466|8663622|P2|Overall Study|Lack of Efficacy|0
2504346|NCT01909466|8663623|P1|Overall Study|Lack of Efficacy|1
2504347|NCT01909466|8663622|P2|Overall Study|Withdrawal by Subject|9
2504348|NCT01909466|8663623|P1|Overall Study|Withdrawal by Subject|11
2504349|NCT01909466|8663622|P2|Overall Study|Physician Decision|0
2504350|NCT01909466|8663623|P1|Overall Study|Physician Decision|2
2504351|NCT01909466|8663622|P2|Overall Study|Met Withdrawal Criteria|3
2504352|NCT01909466|8663623|P1|Overall Study|Met Withdrawal Criteria|0
2504353|NCT01909466|8663622|P2|Overall Study|Adverse Event|4
2504354|NCT01909466|8663623|P1|Overall Study|Adverse Event|3
2504355|NCT01909466|8663622|P2|Overall Study|Lost to Follow-up|7
2504356|NCT01909466|8663623|P1|Overall Study|Lost to Follow-up|5
2504357|NCT01909336|8663646|P3|Overall Study|Physician Decision|1
2504358|NCT01909336|8663647|P2|Overall Study|Physician Decision|1
2504359|NCT01909336|8663648|P1|Overall Study|Physician Decision|0
2504360|NCT01909336|8663646|P3|Overall Study|Lost to Follow-up|2
2504361|NCT01909336|8663647|P2|Overall Study|Lost to Follow-up|2
2504362|NCT01909336|8663648|P1|Overall Study|Lost to Follow-up|4
2504363|NCT01908907|8663746|P2|Overall Study|Protocol Violation|0
2504364|NCT01908907|8663747|P1|Overall Study|Protocol Violation|1
2504365|NCT01908907|8663746|P2|Overall Study|Physician Decision|0
2504366|NCT01908907|8663747|P1|Overall Study|Physician Decision|1
2504367|NCT01908829|8663791|P3|Overall Study|Withdrawal by Subject|22
2504368|NCT01908829|8663792|P2|Overall Study|Withdrawal by Subject|29
2504369|NCT01908829|8663793|P1|Overall Study|Withdrawal by Subject|26
2504370|NCT01908829|8663791|P3|Overall Study|Lack of Efficacy|2
2504371|NCT01908829|8663792|P2|Overall Study|Lack of Efficacy|3
2504372|NCT01908829|8663793|P1|Overall Study|Lack of Efficacy|1
2504373|NCT01908829|8663791|P3|Overall Study|Protocol Violation|0
2504374|NCT01908829|8663792|P2|Overall Study|Protocol Violation|2
2504375|NCT01908829|8663793|P1|Overall Study|Protocol Violation|2
2504376|NCT01908829|8663791|P3|Overall Study|Miscellaneous|0
2504377|NCT01908829|8663792|P2|Overall Study|Miscellaneous|2
2504378|NCT01908829|8663793|P1|Overall Study|Miscellaneous|0
2504379|NCT01908829|8663791|P3|Overall Study|Discontinued (no EoT page)|0
2504380|NCT01908829|8663792|P2|Overall Study|Discontinued (no EoT page)|0
2504381|NCT01908829|8663793|P1|Overall Study|Discontinued (no EoT page)|2
2504382|NCT01908829|8663791|P3|Overall Study|Randomized no double-blind drug received|1
2504383|NCT01908829|8663792|P2|Overall Study|Randomized no double-blind drug received|0
2504384|NCT01908829|8663793|P1|Overall Study|Randomized no double-blind drug received|1
2504385|NCT01908829|8663791|P3|Overall Study|Lost to Follow-up|1
2504386|NCT01908829|8663792|P2|Overall Study|Lost to Follow-up|2
2504387|NCT01908829|8663793|P1|Overall Study|Lost to Follow-up|4
2504388|NCT01908829|8663791|P3|Overall Study|Adverse Event|13
2504389|NCT01908829|8663792|P2|Overall Study|Adverse Event|11
2504390|NCT01908829|8663793|P1|Overall Study|Adverse Event|13
2504391|NCT01908816|8663910|P4|Overall Study|Early termination|28
2504392|NCT01908816|8663911|P3|Overall Study|Early termination|43
2504393|NCT01908816|8663912|P2|Overall Study|Early termination|60
2504394|NCT01908816|8663913|P1|Overall Study|Early termination|87
2504395|NCT01908816|8663910|P4|Overall Study|Unsatisfactory therapeutic effect|0
2504396|NCT01908816|8663911|P3|Overall Study|Unsatisfactory therapeutic effect|1
2504397|NCT01908816|8663912|P2|Overall Study|Unsatisfactory therapeutic effect|13
2504398|NCT01908816|8663913|P1|Overall Study|Unsatisfactory therapeutic effect|1
2504399|NCT01908816|8663910|P4|Overall Study|Death|1
2504400|NCT01908816|8663911|P3|Overall Study|Death|7
2504401|NCT01908816|8663912|P2|Overall Study|Death|0
2504402|NCT01908816|8663913|P1|Overall Study|Death|1
2504403|NCT01908816|8663910|P4|Overall Study|Lost to Follow-up|2
2504404|NCT01908816|8663911|P3|Overall Study|Lost to Follow-up|4
2504405|NCT01908816|8663912|P2|Overall Study|Lost to Follow-up|5
2504406|NCT01908816|8663913|P1|Overall Study|Lost to Follow-up|3
2504407|NCT01908816|8663910|P4|Overall Study|Withdrawal by Subject|2
2504408|NCT01908816|8663911|P3|Overall Study|Withdrawal by Subject|2
2504409|NCT01908816|8663912|P2|Overall Study|Withdrawal by Subject|4
2504410|NCT01908816|8663913|P1|Overall Study|Withdrawal by Subject|0
2504411|NCT01908816|8663910|P4|Overall Study|Protocol deviation|1
2504412|NCT01908816|8663911|P3|Overall Study|Protocol deviation|1
2504413|NCT01908816|8663912|P2|Overall Study|Protocol deviation|2
2504414|NCT01908816|8663913|P1|Overall Study|Protocol deviation|1
2504415|NCT01908816|8663910|P4|Overall Study|Subject's no longer requires study drug|1
2504416|NCT01908816|8663911|P3|Overall Study|Subject's no longer requires study drug|0
2504417|NCT01908816|8663912|P2|Overall Study|Subject's no longer requires study drug|0
2504418|NCT01908816|8663913|P1|Overall Study|Subject's no longer requires study drug|0
2504419|NCT01908803|8663938|P2|Overall Study|Adverse Event (pre-treatment)|0
2504420|NCT01908803|8663939|P1|Overall Study|Adverse Event (pre-treatment)|1
2504421|NCT01908803|8663938|P2|Overall Study|Randomization Error|0
2504422|NCT01908803|8663939|P1|Overall Study|Randomization Error|1
2504423|NCT01908803|8663938|P2|Overall Study|Withdrawal by Subject|0
2504424|NCT01908803|8663939|P1|Overall Study|Withdrawal by Subject|1
2504425|NCT01908803|8663938|P2|Overall Study|Physician Decision|1
2504426|NCT01908803|8663939|P1|Overall Study|Physician Decision|0
2504427|NCT01908803|8663938|P2|Overall Study|Adverse Event|0
2504428|NCT01908803|8663939|P1|Overall Study|Adverse Event|1
2504429|NCT01908699|8663952|P2|Overall Study|Progressive Disease|29
2504430|NCT01908699|8663953|P1|Overall Study|Progressive Disease|30
2504431|NCT01908699|8663952|P2|Overall Study|Death|12
2504432|NCT01908699|8663953|P1|Overall Study|Death|9
2504433|NCT01908699|8663952|P2|Overall Study|Randomized in Error|0
2504434|NCT01908699|8663953|P1|Overall Study|Randomized in Error|1
2504435|NCT01908699|8663952|P2|Overall Study|Pregnancy|1
2504436|NCT01908699|8663953|P1|Overall Study|Pregnancy|0
2504437|NCT01908699|8663952|P2|Overall Study|Withdrawal by Subject|10
2504438|NCT01908699|8663953|P1|Overall Study|Withdrawal by Subject|15
2504439|NCT01908699|8663952|P2|Overall Study|Physician Decision|8
2504440|NCT01908699|8663953|P1|Overall Study|Physician Decision|8
2504441|NCT01908699|8663952|P2|Overall Study|Lost to Follow-up|4
2504442|NCT01908699|8663953|P1|Overall Study|Lost to Follow-up|2
2504443|NCT01908699|8663952|P2|Overall Study|Lack of Efficacy|2
2504444|NCT01908699|8663953|P1|Overall Study|Lack of Efficacy|2
2504445|NCT01908699|8663952|P2|Overall Study|Adverse Event|12
2504446|NCT01908699|8663953|P1|Overall Study|Adverse Event|8
2504447|NCT01908582|8663969|P1|Period 2|Withdrawal by Subject|1
2504448|NCT01908582|8663969|P1|Period 2|Physician Decision|1
2504449|NCT01908426|8664013|P2|Overall Study|No Study Treatment Given|0
2504450|NCT01908426|8664014|P1|Overall Study|No Study Treatment Given|3
2504451|NCT01908426|8664013|P2|Overall Study|Protocol Violation|0
2504452|NCT01908426|8664014|P1|Overall Study|Protocol Violation|1
2504453|NCT01908426|8664013|P2|Overall Study|Progressive Disease|152
2504454|NCT01908426|8664014|P1|Overall Study|Progressive Disease|206
2504455|NCT01908426|8664013|P2|Overall Study|Withdrawal by Subject|6
2504456|NCT01908426|8664014|P1|Overall Study|Withdrawal by Subject|11
2504457|NCT01908426|8664013|P2|Overall Study|Physician Decision|3
2504458|NCT01908426|8664014|P1|Overall Study|Physician Decision|3
2504459|NCT01908426|8664013|P2|Overall Study|Lost to Follow-up|1
2504460|NCT01908426|8664014|P1|Overall Study|Lost to Follow-up|0
2504461|NCT01908426|8664013|P2|Overall Study|Lack of Efficacy|0
2504462|NCT01908426|8664014|P1|Overall Study|Lack of Efficacy|3
2504463|NCT01908426|8664013|P2|Overall Study|Clinical Deterioration|38
2504464|NCT01908426|8664014|P1|Overall Study|Clinical Deterioration|72
2504465|NCT01908426|8664013|P2|Overall Study|Adverse Event|11
2504466|NCT01908426|8664014|P1|Overall Study|Adverse Event|98
2504467|NCT01908140|8664026|P2|Overall Study|Adverse Event|23
2504468|NCT01908140|8664027|P1|Overall Study|Adverse Event|22
2504469|NCT01908140|8664026|P2|Overall Study|Protocol Violation|9
2504470|NCT01908140|8664027|P1|Overall Study|Protocol Violation|8
2504471|NCT01908140|8664026|P2|Overall Study|Lost to Follow-up|6
2504472|NCT01908140|8664027|P1|Overall Study|Lost to Follow-up|1
2504473|NCT01908140|8664026|P2|Overall Study|Withdrawal by Subject|24
2504474|NCT01908140|8664027|P1|Overall Study|Withdrawal by Subject|23
2504475|NCT01908140|8664026|P2|Overall Study|Lack of Efficacy|5
2504476|NCT01908140|8664027|P1|Overall Study|Lack of Efficacy|7
2504477|NCT01908140|8664026|P2|Overall Study|Other or Progressive Disease|12
2504478|NCT01908140|8664027|P1|Overall Study|Other or Progressive Disease|5
2504479|NCT01907906|8664076|P2|Overall Study|Physician Decision|1
2504480|NCT01907906|8664077|P1|Overall Study|Physician Decision|3
2504481|NCT01907906|8664076|P2|Overall Study|Withdrawal by Subject|0
2504482|NCT01907906|8664077|P1|Overall Study|Withdrawal by Subject|1
2504483|NCT01907854|8664157|P2|Overall Study|Unclassified|3
2504484|NCT01907854|8664158|P1|Overall Study|Unclassified|4
2504485|NCT01907854|8664157|P2|Overall Study|Lost to Follow-up|2
2504486|NCT01907854|8664158|P1|Overall Study|Lost to Follow-up|2
2504487|NCT01907854|8664157|P2|Overall Study|Withdrawal by Subject|7
2504488|NCT01907854|8664158|P1|Overall Study|Withdrawal by Subject|9
2504489|NCT01907854|8664157|P2|Overall Study|Protocol Violation|1
2504490|NCT01907854|8664158|P1|Overall Study|Protocol Violation|1
2504491|NCT01907815|8664178|P2|Overall Study|Withdrawal by Subject|0
2504492|NCT01907815|8664179|P1|Overall Study|Withdrawal by Subject|1
2504493|NCT01907737|8664193|P1|Overall Study|Withdrawal by Subject|1
2504494|NCT01907516|8664205|P2|First Intervention (3 Weeks)|Developed DKA during study|0
2504495|NCT01907516|8664206|P1|First Intervention (3 Weeks)|Developed DKA during study|1
2504496|NCT01907516|8664205|P2|First Intervention (3 Weeks)|Delivered before second arm|4
2504497|NCT01907516|8664206|P1|First Intervention (3 Weeks)|Delivered before second arm|3
2504498|NCT01907516|8664205|P2|First Intervention (3 Weeks)|Lost to Follow-up|3
2504499|NCT01907516|8664206|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
2504500|NCT01907516|8664205|P2|First Intervention (3 Weeks)|Withdrawal by Subject|9
2504501|NCT01907516|8664206|P1|First Intervention (3 Weeks)|Withdrawal by Subject|5
2504502|NCT01907217|8664250|P2|Overall Study|Withdrawal by Subject|2
2504503|NCT01907217|8664251|P1|Overall Study|Withdrawal by Subject|0
2504504|NCT01907100|8664363|P4|Overall Study|Worsening/AE underlying cancer disease|8
2504505|NCT01907100|8664364|P3|Overall Study|Worsening/AE underlying cancer disease|8
2504506|NCT01907100|8664365|P2|Overall Study|Worsening/AE underlying cancer disease|0
2504507|NCT01907100|8664366|P1|Overall Study|Worsening/AE underlying cancer disease|0
2504508|NCT01907100|8664363|P4|Overall Study|Adverse event (AE)|23
2504509|NCT01907100|8664364|P3|Overall Study|Adverse event (AE)|22
2504510|NCT01907100|8664365|P2|Overall Study|Adverse event (AE)|3
2504511|NCT01907100|8664366|P1|Overall Study|Adverse event (AE)|6
2504512|NCT01907100|8664363|P4|Overall Study|Other than reasons specified|6
2504513|NCT01907100|8664364|P3|Overall Study|Other than reasons specified|10
2504514|NCT01907100|8664365|P2|Overall Study|Other than reasons specified|0
2504515|NCT01907100|8664366|P1|Overall Study|Other than reasons specified|1
2504516|NCT01907100|8664363|P4|Overall Study|Not treated|2
2504517|NCT01907100|8664364|P3|Overall Study|Not treated|1
2504518|NCT01907100|8664365|P2|Overall Study|Not treated|0
2504519|NCT01907100|8664366|P1|Overall Study|Not treated|2
2504520|NCT01907100|8664363|P4|Overall Study|Lost to Follow-up|1
2504521|NCT01907100|8664364|P3|Overall Study|Lost to Follow-up|0
2504522|NCT01907100|8664365|P2|Overall Study|Lost to Follow-up|0
2504523|NCT01907100|8664366|P1|Overall Study|Lost to Follow-up|0
2504524|NCT01907100|8664363|P4|Overall Study|Protocol Violation|1
2504525|NCT01907100|8664364|P3|Overall Study|Protocol Violation|1
2504526|NCT01907100|8664365|P2|Overall Study|Protocol Violation|0
2504527|NCT01907100|8664366|P1|Overall Study|Protocol Violation|0
2504528|NCT01907100|8664363|P4|Overall Study|Withdrawal by Subject|13
2504529|NCT01907100|8664364|P3|Overall Study|Withdrawal by Subject|10
2504530|NCT01907100|8664365|P2|Overall Study|Withdrawal by Subject|5
2504531|NCT01907100|8664366|P1|Overall Study|Withdrawal by Subject|2
2504532|NCT01907100|8664363|P4|Overall Study|PD based on modified RECIST criteria|92
2504533|NCT01907100|8664364|P3|Overall Study|PD based on modified RECIST criteria|95
2504534|NCT01907100|8664365|P2|Overall Study|PD based on modified RECIST criteria|32
2504535|NCT01907100|8664366|P1|Overall Study|PD based on modified RECIST criteria|31
2504536|NCT01907087|8664380|P1|Overall Study|Withdrawal by Subject|1
2504537|NCT01906476|8664443|P2|Overall Study|Lost to Follow-up|16
2504538|NCT01906476|8664444|P1|Overall Study|Lost to Follow-up|17
2504539|NCT01906372|8664452|P1|Overall Study|Withdrawal by Subject|2
2504540|NCT01906346|8664457|P1|Overall Study|AEs|1
2504541|NCT01906008|8664465|P2|Overall Study|Adverse Event|3
2504542|NCT01906008|8664466|P1|Overall Study|Adverse Event|0
2504543|NCT01906008|8664465|P2|Overall Study|Lack of compliance of study med|3
2504544|NCT01906008|8664466|P1|Overall Study|Lack of compliance of study med|5
2504545|NCT01906008|8664465|P2|Overall Study|Physician Decision|3
2504546|NCT01906008|8664466|P1|Overall Study|Physician Decision|3
2504547|NCT01906008|8664465|P2|Overall Study|Hospice|0
2504548|NCT01906008|8664466|P1|Overall Study|Hospice|1
2504549|NCT01906008|8664465|P2|Overall Study|Oxaliplatin stops|8
2504550|NCT01906008|8664466|P1|Overall Study|Oxaliplatin stops|10
2504551|NCT01906008|8664465|P2|Overall Study|Did not start study med|4
2504552|NCT01906008|8664466|P1|Overall Study|Did not start study med|3
2504553|NCT01906008|8664465|P2|Overall Study|Withdrawal by Subject|5
2504554|NCT01906008|8664466|P1|Overall Study|Withdrawal by Subject|1
2504555|NCT01906008|8664465|P2|Overall Study|Protocol Violation|1
2504556|NCT01906008|8664466|P1|Overall Study|Protocol Violation|0
2504557|NCT01906008|8664465|P2|Overall Study|Oxaliplatin toxicity|0
2504558|NCT01906008|8664466|P1|Overall Study|Oxaliplatin toxicity|2
2504559|NCT01906008|8664465|P2|Overall Study|Lost to Follow-up|0
2504560|NCT01906008|8664466|P1|Overall Study|Lost to Follow-up|2
2504561|NCT01905943|8664499|P1|Overall Study|Other|12
2504562|NCT01905943|8664499|P1|Overall Study|Adverse Event|3
2504563|NCT01905943|8664499|P1|Overall Study|Death|186
2504564|NCT01905943|8664499|P1|Overall Study|Investigator discretion|7
2504565|NCT01905943|8664499|P1|Overall Study|Lost to Follow-up|16
2504566|NCT01905943|8664499|P1|Overall Study|Withdrawal of consent|90
2504567|NCT01905683|8664616|P1|Overall Study|Lost to Follow-up|4
2504568|NCT01905683|8664616|P1|Overall Study|Adverse Event|4
2504569|NCT01905683|8664616|P1|Overall Study|Withdrawal by Subject|20
2504570|NCT01905683|8664616|P1|Overall Study|Lack of Efficacy|8
2504571|NCT01905683|8664616|P1|Overall Study|Physician Decision|1
2504572|NCT01905683|8664616|P1|Overall Study|Re-injection criteria not met; others|13
2504573|NCT01905683|8664616|P1|Overall Study|Protocol Violation|1
2504574|NCT01905657|8664632|P3|Overall Study|Excluded from Efficacy Analysis|0
2504575|NCT01905657|8664633|P2|Overall Study|Excluded from Efficacy Analysis|0
2504576|NCT01905657|8664634|P1|Overall Study|Excluded from Efficacy Analysis|1
2504577|NCT01905657|8664632|P3|Overall Study|Continuing in Study|11
2504578|NCT01905657|8664633|P2|Overall Study|Continuing in Study|74
2504579|NCT01905657|8664634|P1|Overall Study|Continuing in Study|74
2504580|NCT01905657|8664632|P3|Overall Study|Withdrawal by Subject|45
2504581|NCT01905657|8664633|P2|Overall Study|Withdrawal by Subject|10
2504582|NCT01905657|8664634|P1|Overall Study|Withdrawal by Subject|5
2504583|NCT01905657|8664632|P3|Overall Study|Protocol Violation|1
2504584|NCT01905657|8664633|P2|Overall Study|Protocol Violation|1
2504585|NCT01905657|8664634|P1|Overall Study|Protocol Violation|2
2504586|NCT01905657|8664632|P3|Overall Study|Progressive Disease|89
2504587|NCT01905657|8664633|P2|Overall Study|Progressive Disease|126
2504588|NCT01905657|8664634|P1|Overall Study|Progressive Disease|124
2504589|NCT01905657|8664632|P3|Overall Study|Physician Decision|113
2504590|NCT01905657|8664633|P2|Overall Study|Physician Decision|74
2504591|NCT01905657|8664634|P1|Overall Study|Physician Decision|82
2504592|NCT01905657|8664632|P3|Overall Study|Other|1
2504593|NCT01905657|8664633|P2|Overall Study|Other|7
2504594|NCT01905657|8664634|P1|Overall Study|Other|3
2504595|NCT01905657|8664632|P3|Overall Study|Death|21
2504596|NCT01905657|8664633|P2|Overall Study|Death|21
2504597|NCT01905657|8664634|P1|Overall Study|Death|21
2504598|NCT01905657|8664632|P3|Overall Study|Adverse Event|47
2504599|NCT01905657|8664633|P2|Overall Study|Adverse Event|32
2504600|NCT01905657|8664634|P1|Overall Study|Adverse Event|33
2504601|NCT01905657|8664632|P3|Overall Study|Not Treated|0
2504602|NCT01905657|8664633|P2|Overall Study|Not Treated|1
2504603|NCT01905657|8664634|P1|Overall Study|Not Treated|0
2504604|NCT01905553|8664659|P2|Period 2|Adverse Event|0
2504605|NCT01905553|8664660|P1|Period 2|Adverse Event|1
2504606|NCT01905540|8664674|P4|Period 3|Other|1
2504607|NCT01905540|8664675|P3|Period 3|Other|1
2504608|NCT01905540|8664676|P2|Period 3|Other|0
2504609|NCT01905540|8664677|P1|Period 3|Other|1
2504610|NCT01905267|8664712|P2|Overall Study|Physician Decision|2
2504611|NCT01905267|8664713|P1|Overall Study|Physician Decision|2
2504612|NCT01904773|8664734|P9|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
2504613|NCT01904773|8664735|P8|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
2504614|NCT01904773|8664736|P7|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
2504615|NCT01904773|8664737|P6|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
2504616|NCT01904773|8664738|P5|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
2504617|NCT01904773|8664739|P4|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
2504618|NCT01904773|8664740|P3|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
2504619|NCT01904773|8664741|P2|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1
2504620|NCT01904773|8664742|P1|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
2504621|NCT01904773|8664734|P9|Fifth Intervention|Adverse Event|0
2504622|NCT01904773|8664735|P8|Fifth Intervention|Adverse Event|1
2504623|NCT01904773|8664736|P7|Fifth Intervention|Adverse Event|0
2504624|NCT01904773|8664737|P6|Fifth Intervention|Adverse Event|0
2504625|NCT01904773|8664738|P5|Fifth Intervention|Adverse Event|0
2504626|NCT01904773|8664739|P4|Fifth Intervention|Adverse Event|0
2504627|NCT01904773|8664740|P3|Fifth Intervention|Adverse Event|0
2504628|NCT01904773|8664741|P2|Fifth Intervention|Adverse Event|0
2504629|NCT01904773|8664742|P1|Fifth Intervention|Adverse Event|0
2504630|NCT01904773|8664734|P9|Placebo Washout First Intervention|Condition worsened|0
2504631|NCT01904773|8664735|P8|Placebo Washout First Intervention|Condition worsened|0
2504632|NCT01904773|8664736|P7|Placebo Washout First Intervention|Condition worsened|0
2504633|NCT01904773|8664737|P6|Placebo Washout First Intervention|Condition worsened|0
2504634|NCT01904773|8664738|P5|Placebo Washout First Intervention|Condition worsened|0
2504635|NCT01904773|8664739|P4|Placebo Washout First Intervention|Condition worsened|0
2504636|NCT01904773|8664740|P3|Placebo Washout First Intervention|Condition worsened|0
2504637|NCT01904773|8664741|P2|Placebo Washout First Intervention|Condition worsened|1
2504638|NCT01904773|8664742|P1|Placebo Washout First Intervention|Condition worsened|0
2504639|NCT01904773|8664734|P9|First Intervention|Adverse Event|0
2504640|NCT01904773|8664735|P8|First Intervention|Adverse Event|0
2504641|NCT01904773|8664736|P7|First Intervention|Adverse Event|1
2504642|NCT01904773|8664737|P6|First Intervention|Adverse Event|0
2504643|NCT01904773|8664738|P5|First Intervention|Adverse Event|0
2504644|NCT01904773|8664739|P4|First Intervention|Adverse Event|0
2504645|NCT01904773|8664740|P3|First Intervention|Adverse Event|0
2504646|NCT01904773|8664741|P2|First Intervention|Adverse Event|0
2504647|NCT01904773|8664742|P1|First Intervention|Adverse Event|0
2504648|NCT01904773|8664734|P9|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
2504649|NCT01904773|8664735|P8|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
2504650|NCT01904773|8664736|P7|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
2504651|NCT01904773|8664737|P6|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
2504652|NCT01904773|8664738|P5|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
2504653|NCT01904773|8664739|P4|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
2504654|NCT01904773|8664740|P3|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
2504655|NCT01904773|8664741|P2|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
2504656|NCT01904773|8664742|P1|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1
2504657|NCT01904773|8664734|P9|Screen|Withdrawal by Subject|0
2504658|NCT01904773|8664735|P8|Screen|Withdrawal by Subject|0
2504659|NCT01904773|8664736|P7|Screen|Withdrawal by Subject|0
2504660|NCT01904773|8664737|P6|Screen|Withdrawal by Subject|0
2504661|NCT01904773|8664738|P5|Screen|Withdrawal by Subject|0
2504662|NCT01904773|8664739|P4|Screen|Withdrawal by Subject|0
2504663|NCT01904773|8664740|P3|Screen|Withdrawal by Subject|0
2504664|NCT01904773|8664741|P2|Screen|Withdrawal by Subject|0
2504665|NCT01904773|8664742|P1|Screen|Withdrawal by Subject|1
2504666|NCT01904773|8664734|P9|Screen|Screen failure|0
2504667|NCT01904773|8664735|P8|Screen|Screen failure|0
2504668|NCT01904773|8664736|P7|Screen|Screen failure|0
2504669|NCT01904773|8664737|P6|Screen|Screen failure|0
2504670|NCT01904773|8664738|P5|Screen|Screen failure|0
2504671|NCT01904773|8664739|P4|Screen|Screen failure|0
2504672|NCT01904773|8664740|P3|Screen|Screen failure|0
2504673|NCT01904773|8664741|P2|Screen|Screen failure|0
2504674|NCT01904773|8664742|P1|Screen|Screen failure|3
2504675|NCT01904760|8664759|P2|Overall Study|Protocol Violation|0
2504676|NCT01904760|8664760|P1|Overall Study|Protocol Violation|1
2504677|NCT01904721|8664775|P7|Overall Study|Adverse Event|0
2504678|NCT01904721|8664776|P6|Overall Study|Adverse Event|1
2504679|NCT01904721|8664777|P5|Overall Study|Adverse Event|3
2504680|NCT01904721|8664778|P4|Overall Study|Adverse Event|0
2504681|NCT01904721|8664779|P3|Overall Study|Adverse Event|0
2504682|NCT01904721|8664780|P2|Overall Study|Adverse Event|0
2504683|NCT01904721|8664781|P1|Overall Study|Adverse Event|0
2504684|NCT01904721|8664775|P7|Overall Study|Lack of Efficacy|1
2504685|NCT01904721|8664776|P6|Overall Study|Lack of Efficacy|0
2504686|NCT01904721|8664777|P5|Overall Study|Lack of Efficacy|0
2504687|NCT01904721|8664778|P4|Overall Study|Lack of Efficacy|0
2504688|NCT01904721|8664779|P3|Overall Study|Lack of Efficacy|0
2504689|NCT01904721|8664780|P2|Overall Study|Lack of Efficacy|0
2504690|NCT01904721|8664781|P1|Overall Study|Lack of Efficacy|0
2504691|NCT01904721|8664775|P7|Overall Study|Lost to Follow-up|1
2504692|NCT01904721|8664776|P6|Overall Study|Lost to Follow-up|3
2504693|NCT01904721|8664777|P5|Overall Study|Lost to Follow-up|1
2504694|NCT01904721|8664778|P4|Overall Study|Lost to Follow-up|0
2504695|NCT01904721|8664779|P3|Overall Study|Lost to Follow-up|0
2504696|NCT01904721|8664780|P2|Overall Study|Lost to Follow-up|0
2504697|NCT01904721|8664781|P1|Overall Study|Lost to Follow-up|0
2504698|NCT01904721|8664775|P7|Overall Study|Personal Reasons|3
2504699|NCT01904721|8664776|P6|Overall Study|Personal Reasons|3
2504700|NCT01904721|8664777|P5|Overall Study|Personal Reasons|2
2504701|NCT01904721|8664778|P4|Overall Study|Personal Reasons|0
2504702|NCT01904721|8664779|P3|Overall Study|Personal Reasons|0
2504703|NCT01904721|8664780|P2|Overall Study|Personal Reasons|0
2504704|NCT01904721|8664781|P1|Overall Study|Personal Reasons|0
2504705|NCT01904721|8664775|P7|Overall Study|Other Reasons|2
2504706|NCT01904721|8664776|P6|Overall Study|Other Reasons|2
2504707|NCT01904721|8664777|P5|Overall Study|Other Reasons|2
2504708|NCT01904721|8664778|P4|Overall Study|Other Reasons|1
2504709|NCT01904721|8664779|P3|Overall Study|Other Reasons|1
2504710|NCT01904721|8664780|P2|Overall Study|Other Reasons|0
2504711|NCT01904721|8664781|P1|Overall Study|Other Reasons|0
2504712|NCT01904604|8664811|P3|Overall Study|Lost to Follow-up|1
2504713|NCT01904604|8664812|P2|Overall Study|Lost to Follow-up|0
2504714|NCT01904604|8664813|P1|Overall Study|Lost to Follow-up|0
2504715|NCT01904604|8664811|P3|Overall Study|Participant Relocated|1
2504716|NCT01904604|8664812|P2|Overall Study|Participant Relocated|1
2504717|NCT01904604|8664813|P1|Overall Study|Participant Relocated|1
2504718|NCT01904604|8664811|P3|Overall Study|Withdrawal by Subject|0
2504719|NCT01904604|8664812|P2|Overall Study|Withdrawal by Subject|2
2504720|NCT01904604|8664813|P1|Overall Study|Withdrawal by Subject|1
2504721|NCT01904604|8664811|P3|Overall Study|Passed Week 52 OFC|0
2504722|NCT01904604|8664812|P2|Overall Study|Passed Week 52 OFC|0
2504723|NCT01904604|8664813|P1|Overall Study|Passed Week 52 OFC|1
2504724|NCT01904604|8664811|P3|Overall Study|Unrelated illness|0
2504725|NCT01904604|8664812|P2|Overall Study|Unrelated illness|1
2504726|NCT01904604|8664813|P1|Overall Study|Unrelated illness|0
2504727|NCT01904604|8664811|P3|Overall Study|Increased syncope|0
2504728|NCT01904604|8664812|P2|Overall Study|Increased syncope|1
2504729|NCT01904604|8664813|P1|Overall Study|Increased syncope|0
2504730|NCT01904604|8664811|P3|Overall Study|Patch site reactions|0
2504731|NCT01904604|8664812|P2|Overall Study|Patch site reactions|1
2504732|NCT01904604|8664813|P1|Overall Study|Patch site reactions|1
2504733|NCT01904604|8664811|P3|Overall Study|Anxiety about OFC/Refused OFC|0
2504734|NCT01904604|8664812|P2|Overall Study|Anxiety about OFC/Refused OFC|0
2504735|NCT01904604|8664813|P1|Overall Study|Anxiety about OFC/Refused OFC|2
2504736|NCT01904604|8664811|P3|Overall Study|Non-compliance|0
2504737|NCT01904604|8664812|P2|Overall Study|Non-compliance|0
2504738|NCT01904604|8664813|P1|Overall Study|Non-compliance|1
2504739|NCT01904604|8664811|P3|Overall Study|Withdrew before receiving dosing|0
2504740|NCT01904604|8664812|P2|Overall Study|Withdrew before receiving dosing|1
2504741|NCT01904604|8664813|P1|Overall Study|Withdrew before receiving dosing|0
2504742|NCT01904383|8664878|P1|Overall Study|No patient visit after entry|54
2504743|NCT01904383|8664878|P1|Overall Study|Adverse Event|271
2504744|NCT01904383|8664878|P1|Overall Study|Improvement|141
2504745|NCT01904383|8664878|P1|Overall Study|Lack of Efficacy|370
2504746|NCT01904383|8664878|P1|Overall Study|Lost to Follow-up|674
2504747|NCT01904383|8664878|P1|Overall Study|Reason not listed|147
2504748|NCT01904383|8664878|P1|Overall Study|CRF not collected|117
2504749|NCT01904279|8664885|P2|Overall Study|Withdrawal by Subject|0
2504750|NCT01904279|8664886|P1|Overall Study|Withdrawal by Subject|1
2504751|NCT01904279|8664885|P2|Overall Study|Lack of Efficacy|3
2504752|NCT01904279|8664886|P1|Overall Study|Lack of Efficacy|2
2504753|NCT01904149|8664912|P6|Overall Study|non compliance with study drug|0
2504754|NCT01904149|8664913|P5|Overall Study|non compliance with study drug|0
2504755|NCT01904149|8664914|P4|Overall Study|non compliance with study drug|0
2504756|NCT01904149|8664915|P3|Overall Study|non compliance with study drug|0
2504757|NCT01904149|8664916|P2|Overall Study|non compliance with study drug|0
2504758|NCT01904149|8664917|P1|Overall Study|non compliance with study drug|1
2504759|NCT01904149|8664912|P6|Overall Study|Protocol Violation|0
2504760|NCT01904149|8664913|P5|Overall Study|Protocol Violation|0
2504761|NCT01904149|8664914|P4|Overall Study|Protocol Violation|0
2504762|NCT01904149|8664915|P3|Overall Study|Protocol Violation|0
2504763|NCT01904149|8664916|P2|Overall Study|Protocol Violation|1
2504764|NCT01904149|8664917|P1|Overall Study|Protocol Violation|0
2504765|NCT01904149|8664912|P6|Overall Study|Withdrawal by Subject|0
2504766|NCT01904149|8664913|P5|Overall Study|Withdrawal by Subject|1
2504767|NCT01904149|8664914|P4|Overall Study|Withdrawal by Subject|0
2504768|NCT01904149|8664915|P3|Overall Study|Withdrawal by Subject|1
2504769|NCT01904149|8664916|P2|Overall Study|Withdrawal by Subject|3
2504770|NCT01904149|8664917|P1|Overall Study|Withdrawal by Subject|1
2504771|NCT01904149|8664912|P6|Overall Study|Lack of Efficacy|1
2504772|NCT01904149|8664913|P5|Overall Study|Lack of Efficacy|3
2504773|NCT01904149|8664914|P4|Overall Study|Lack of Efficacy|3
2504774|NCT01904149|8664915|P3|Overall Study|Lack of Efficacy|1
2504775|NCT01904149|8664916|P2|Overall Study|Lack of Efficacy|3
2504776|NCT01904149|8664917|P1|Overall Study|Lack of Efficacy|0
2504777|NCT01904149|8664912|P6|Overall Study|Adverse Event|2
2504778|NCT01904149|8664913|P5|Overall Study|Adverse Event|1
2504779|NCT01904149|8664914|P4|Overall Study|Adverse Event|1
2504780|NCT01904149|8664915|P3|Overall Study|Adverse Event|0
2504781|NCT01904149|8664916|P2|Overall Study|Adverse Event|4
2504782|NCT01904149|8664917|P1|Overall Study|Adverse Event|3
2504783|NCT01904058|8664968|P4|Overall Study|Pregnancy|1
2504784|NCT01904058|8664969|P3|Overall Study|Pregnancy|0
2504785|NCT01904058|8664970|P2|Overall Study|Pregnancy|0
2504786|NCT01904058|8664971|P1|Overall Study|Pregnancy|0
2504787|NCT01904058|8664968|P4|Overall Study|Withdrawal by Subject|0
2504788|NCT01904058|8664969|P3|Overall Study|Withdrawal by Subject|1
2504789|NCT01904058|8664970|P2|Overall Study|Withdrawal by Subject|0
2504790|NCT01904058|8664971|P1|Overall Study|Withdrawal by Subject|1
2504791|NCT01904058|8664968|P4|Overall Study|Adverse Event|0
2504792|NCT01904058|8664969|P3|Overall Study|Adverse Event|0
2504793|NCT01904058|8664970|P2|Overall Study|Adverse Event|0
2504794|NCT01904058|8664971|P1|Overall Study|Adverse Event|2
2504795|NCT01903993|8665011|P2|Overall Study|Terminated by Sponsor After 31 Aug 2018|2
2504796|NCT01903993|8665012|P1|Overall Study|Terminated by Sponsor After 31 Aug 2018|0
2504797|NCT01903993|8665011|P2|Overall Study|Study Terminated by Sponsor|14
2504798|NCT01903993|8665012|P1|Overall Study|Study Terminated by Sponsor|8
2504799|NCT01903993|8665011|P2|Overall Study|Lost to Follow-up|3
2504800|NCT01903993|8665012|P1|Overall Study|Lost to Follow-up|2
2504801|NCT01903993|8665011|P2|Overall Study|Withdrawal by Subject|4
2504802|NCT01903993|8665012|P1|Overall Study|Withdrawal by Subject|15
2504803|NCT01903993|8665011|P2|Overall Study|Death|121
2504804|NCT01903993|8665012|P1|Overall Study|Death|118
2504805|NCT01903876|8665029|P2|Six-Month Follow-up Period|Lost to Follow-up|145
2504806|NCT01903876|8665030|P1|Six-Month Follow-up Period|Lost to Follow-up|91
2504807|NCT01903876|8665029|P2|Baseline to Post-Intervention Period|Lost to Follow-up|108
2504808|NCT01903876|8665030|P1|Baseline to Post-Intervention Period|Lost to Follow-up|184
2504809|NCT01903863|8665040|P2|Overall Study|Physician Decision|0
2504810|NCT01903863|8665041|P1|Overall Study|Physician Decision|2
2504811|NCT01903811|8665063|P2|Overall Study|Withdrawal by Subject|1
2504812|NCT01903811|8665064|P1|Overall Study|Withdrawal by Subject|0
2504813|NCT01903811|8665063|P2|Overall Study|Baseline lab missing/incomplete/untimely|11
2504814|NCT01903811|8665064|P1|Overall Study|Baseline lab missing/incomplete/untimely|6
2504815|NCT01903811|8665063|P2|Overall Study|Incomplete/discontinued prior therapy|1
2504816|NCT01903811|8665064|P1|Overall Study|Incomplete/discontinued prior therapy|1
2504817|NCT01903811|8665063|P2|Overall Study|No measurable disease|1
2504818|NCT01903811|8665064|P1|Overall Study|No measurable disease|1
2504900|NCT01903031|8665312|P1|Overall Study|Lost to Follow-up|0
2504819|NCT01903720|8665098|P1|Overall Study|Treatment with alternative drug|1
2504820|NCT01903720|8665098|P1|Overall Study|Lost to Follow-up|2
2504821|NCT01903720|8665098|P1|Overall Study|Rescinding of informed consent|2
2504822|NCT01903720|8665098|P1|Overall Study|Adverse Event|1
2504823|NCT01903720|8665098|P1|Overall Study|Inclusion / exclusion criteria not met|6
2504824|NCT01903460|8665136|P4|Overall Study|Adverse Event|1
2504825|NCT01903460|8665137|P3|Overall Study|Adverse Event|0
2504826|NCT01903460|8665138|P2|Overall Study|Adverse Event|0
2504827|NCT01903460|8665139|P1|Overall Study|Adverse Event|0
2504828|NCT01903434|8665156|P2|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2
2504829|NCT01903434|8665157|P1|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0
2504830|NCT01903434|8665156|P2|Washout Period 1 (at Least 14 Days)|Adverse Event|0
2504831|NCT01903434|8665157|P1|Washout Period 1 (at Least 14 Days)|Adverse Event|1
2504832|NCT01903356|8665165|P1|Overall Study|Violated the dosage and administration|3
2504833|NCT01903356|8665165|P1|Overall Study|Violated inclusion/exclusion criteria|5
2504834|NCT01903356|8665165|P1|Overall Study|Lost to Follow-up|7
2504835|NCT01903252|8665192|P6|Maintenance, Open-Label|Other|2
2504836|NCT01903252|8665193|P5|Maintenance, Open-Label|Other|6
2504837|NCT01903252|8665194|P4|Maintenance, Open-Label|Other|2
2504838|NCT01903252|8665195|P3|Maintenance, Open-Label|Other|0
2504839|NCT01903252|8665196|P2|Maintenance, Open-Label|Other|0
2504840|NCT01903252|8665197|P1|Maintenance, Open-Label|Other|0
2504841|NCT01903252|8665192|P6|Maintenance, Open-Label|Withdrawal by Subject|2
2504842|NCT01903252|8665193|P5|Maintenance, Open-Label|Withdrawal by Subject|6
2504843|NCT01903252|8665194|P4|Maintenance, Open-Label|Withdrawal by Subject|1
2504844|NCT01903252|8665195|P3|Maintenance, Open-Label|Withdrawal by Subject|0
2504845|NCT01903252|8665196|P2|Maintenance, Open-Label|Withdrawal by Subject|0
2504846|NCT01903252|8665197|P1|Maintenance, Open-Label|Withdrawal by Subject|0
2504847|NCT01903252|8665192|P6|Maintenance, Open-Label|Adverse Event|14
2504848|NCT01903252|8665193|P5|Maintenance, Open-Label|Adverse Event|9
2504849|NCT01903252|8665194|P4|Maintenance, Open-Label|Adverse Event|3
2504850|NCT01903252|8665195|P3|Maintenance, Open-Label|Adverse Event|0
2504851|NCT01903252|8665196|P2|Maintenance, Open-Label|Adverse Event|0
2504852|NCT01903252|8665197|P1|Maintenance, Open-Label|Adverse Event|0
2504853|NCT01903252|8665192|P6|Extended Induction, Open-Label|Physician Decision|0
2504854|NCT01903252|8665193|P5|Extended Induction, Open-Label|Physician Decision|0
2504855|NCT01903252|8665194|P4|Extended Induction, Open-Label|Physician Decision|0
2504856|NCT01903252|8665195|P3|Extended Induction, Open-Label|Physician Decision|1
2504857|NCT01903252|8665196|P2|Extended Induction, Open-Label|Physician Decision|0
2504858|NCT01903252|8665197|P1|Extended Induction, Open-Label|Physician Decision|0
2504859|NCT01903252|8665192|P6|Extended Induction, Open-Label|Withdrawal by Subject|0
2504860|NCT01903252|8665193|P5|Extended Induction, Open-Label|Withdrawal by Subject|0
2504861|NCT01903252|8665194|P4|Extended Induction, Open-Label|Withdrawal by Subject|0
2504862|NCT01903252|8665195|P3|Extended Induction, Open-Label|Withdrawal by Subject|5
2504863|NCT01903252|8665196|P2|Extended Induction, Open-Label|Withdrawal by Subject|0
2504864|NCT01903252|8665197|P1|Extended Induction, Open-Label|Withdrawal by Subject|0
2504865|NCT01903252|8665192|P6|Extended Induction, Open-Label|Adverse Event|0
2504866|NCT01903252|8665193|P5|Extended Induction, Open-Label|Adverse Event|0
2504867|NCT01903252|8665194|P4|Extended Induction, Open-Label|Adverse Event|0
2504868|NCT01903252|8665195|P3|Extended Induction, Open-Label|Adverse Event|17
2504869|NCT01903252|8665196|P2|Extended Induction, Open-Label|Adverse Event|0
2504870|NCT01903252|8665197|P1|Extended Induction, Open-Label|Adverse Event|0
2504871|NCT01903252|8665192|P6|Double-Blind Induction|non-compliance,|0
2504872|NCT01903252|8665193|P5|Double-Blind Induction|non-compliance,|0
2504873|NCT01903252|8665194|P4|Double-Blind Induction|non-compliance,|0
2504874|NCT01903252|8665195|P3|Double-Blind Induction|non-compliance,|0
2504875|NCT01903252|8665196|P2|Double-Blind Induction|non-compliance,|7
2504876|NCT01903252|8665197|P1|Double-Blind Induction|non-compliance,|7
2504877|NCT01903252|8665192|P6|Double-Blind Induction|Physician Decision|0
2504878|NCT01903252|8665193|P5|Double-Blind Induction|Physician Decision|0
2504879|NCT01903252|8665194|P4|Double-Blind Induction|Physician Decision|0
2504880|NCT01903252|8665195|P3|Double-Blind Induction|Physician Decision|0
2504881|NCT01903252|8665196|P2|Double-Blind Induction|Physician Decision|3
2504882|NCT01903252|8665197|P1|Double-Blind Induction|Physician Decision|2
2504883|NCT01903252|8665192|P6|Double-Blind Induction|Withdrawal by Subject|0
2504884|NCT01903252|8665193|P5|Double-Blind Induction|Withdrawal by Subject|0
2504885|NCT01903252|8665194|P4|Double-Blind Induction|Withdrawal by Subject|0
2504886|NCT01903252|8665195|P3|Double-Blind Induction|Withdrawal by Subject|0
2504887|NCT01903252|8665196|P2|Double-Blind Induction|Withdrawal by Subject|13
2504888|NCT01903252|8665197|P1|Double-Blind Induction|Withdrawal by Subject|10
2504889|NCT01903252|8665192|P6|Double-Blind Induction|Adverse Event|0
2504890|NCT01903252|8665193|P5|Double-Blind Induction|Adverse Event|0
2504891|NCT01903252|8665194|P4|Double-Blind Induction|Adverse Event|0
2504892|NCT01903252|8665195|P3|Double-Blind Induction|Adverse Event|0
2504893|NCT01903252|8665196|P2|Double-Blind Induction|Adverse Event|18
2504894|NCT01903252|8665197|P1|Double-Blind Induction|Adverse Event|20
2504895|NCT01903031|8665310|P3|Overall Study|NuvaRing removed prior to Day 21 visit|1
2504896|NCT01903031|8665311|P2|Overall Study|NuvaRing removed prior to Day 21 visit|0
2504897|NCT01903031|8665312|P1|Overall Study|NuvaRing removed prior to Day 21 visit|0
2504898|NCT01903031|8665310|P3|Overall Study|Lost to Follow-up|1
2504899|NCT01903031|8665311|P2|Overall Study|Lost to Follow-up|0
2504901|NCT01903031|8665310|P3|Overall Study|Protocol Violation|2
2504902|NCT01903031|8665311|P2|Overall Study|Protocol Violation|0
2504903|NCT01903031|8665312|P1|Overall Study|Protocol Violation|0
2504904|NCT01903031|8665310|P3|Overall Study|Withdrawal by Subject|1
2504905|NCT01903031|8665311|P2|Overall Study|Withdrawal by Subject|1
2504906|NCT01903031|8665312|P1|Overall Study|Withdrawal by Subject|0
2504907|NCT01903031|8665310|P3|Overall Study|Adverse Event|0
2504908|NCT01903031|8665311|P2|Overall Study|Adverse Event|1
2504909|NCT01903031|8665312|P1|Overall Study|Adverse Event|0
2504910|NCT01903031|8665310|P3|Overall Study|Missed Day 21 Primary Endpoint Visit|0
2504911|NCT01903031|8665311|P2|Overall Study|Missed Day 21 Primary Endpoint Visit|0
2504912|NCT01903031|8665312|P1|Overall Study|Missed Day 21 Primary Endpoint Visit|1
2504913|NCT01903031|8665310|P3|Overall Study|Not Able to Attend Clinic|0
2504914|NCT01903031|8665311|P2|Overall Study|Not Able to Attend Clinic|1
2504915|NCT01903031|8665312|P1|Overall Study|Not Able to Attend Clinic|1
2504916|NCT01902888|8665381|P1|Overall Study|Study Terminated|3
2504917|NCT01902628|8665395|P1|Overall Study|Lost to Follow-up|35
2504918|NCT01902628|8665395|P1|Overall Study|Adverse Event|41
2504919|NCT01902628|8665395|P1|Overall Study|Withdrawal of participant's consent|7
2504920|NCT01902303|8665423|P2|Overall Study|Did not develop a cold sore|19
2504921|NCT01902303|8665424|P1|Overall Study|Did not develop a cold sore|21
2504922|NCT01902303|8665423|P2|Overall Study|subject lost investigational product|1
2504923|NCT01902303|8665424|P1|Overall Study|subject lost investigational product|0
2504924|NCT01902303|8665423|P2|Overall Study|Protocol Violation|2
2504925|NCT01902303|8665424|P1|Overall Study|Protocol Violation|2
2504926|NCT01902303|8665423|P2|Overall Study|Lost to Follow-up|1
2504927|NCT01902303|8665424|P1|Overall Study|Lost to Follow-up|0
2504928|NCT01902303|8665423|P2|Overall Study|Adverse Event|1
2504929|NCT01902303|8665424|P1|Overall Study|Adverse Event|0
2504930|NCT01902134|8665438|P6|Overall Study|Other|0
2504931|NCT01902134|8665439|P5|Overall Study|Other|1
2504932|NCT01902134|8665440|P4|Overall Study|Other|0
2504933|NCT01902134|8665441|P3|Overall Study|Other|2
2504934|NCT01902134|8665442|P2|Overall Study|Other|1
2504935|NCT01902134|8665443|P1|Overall Study|Other|0
2504936|NCT01902134|8665438|P6|Overall Study|no compliance|0
2504937|NCT01902134|8665439|P5|Overall Study|no compliance|0
2504938|NCT01902134|8665440|P4|Overall Study|no compliance|0
2504939|NCT01902134|8665441|P3|Overall Study|no compliance|0
2504940|NCT01902134|8665442|P2|Overall Study|no compliance|0
2504941|NCT01902134|8665443|P1|Overall Study|no compliance|1
2504942|NCT01902134|8665438|P6|Overall Study|Withdrawal by Subject|4
2504943|NCT01902134|8665439|P5|Overall Study|Withdrawal by Subject|5
2504944|NCT01902134|8665440|P4|Overall Study|Withdrawal by Subject|1
2504945|NCT01902134|8665441|P3|Overall Study|Withdrawal by Subject|9
2504946|NCT01902134|8665442|P2|Overall Study|Withdrawal by Subject|8
2504947|NCT01902134|8665443|P1|Overall Study|Withdrawal by Subject|4
2504948|NCT01902134|8665438|P6|Overall Study|Protocol Violation|1
2504949|NCT01902134|8665439|P5|Overall Study|Protocol Violation|0
2504950|NCT01902134|8665440|P4|Overall Study|Protocol Violation|0
2504951|NCT01902134|8665441|P3|Overall Study|Protocol Violation|0
2504952|NCT01902134|8665442|P2|Overall Study|Protocol Violation|0
2504953|NCT01902134|8665443|P1|Overall Study|Protocol Violation|0
2504954|NCT01902134|8665438|P6|Overall Study|Physician Decision|0
2504955|NCT01902134|8665439|P5|Overall Study|Physician Decision|0
2504956|NCT01902134|8665440|P4|Overall Study|Physician Decision|0
2504957|NCT01902134|8665441|P3|Overall Study|Physician Decision|0
2504958|NCT01902134|8665442|P2|Overall Study|Physician Decision|1
2504959|NCT01902134|8665443|P1|Overall Study|Physician Decision|0
2504960|NCT01902134|8665438|P6|Overall Study|Lack of Efficacy|1
2504961|NCT01902134|8665439|P5|Overall Study|Lack of Efficacy|0
2504962|NCT01902134|8665440|P4|Overall Study|Lack of Efficacy|0
2504963|NCT01902134|8665441|P3|Overall Study|Lack of Efficacy|2
2504964|NCT01902134|8665442|P2|Overall Study|Lack of Efficacy|0
2504965|NCT01902134|8665443|P1|Overall Study|Lack of Efficacy|0
2504966|NCT01902134|8665438|P6|Overall Study|Adverse Event|3
2504967|NCT01902134|8665439|P5|Overall Study|Adverse Event|1
2504968|NCT01902134|8665440|P4|Overall Study|Adverse Event|1
2504969|NCT01902134|8665441|P3|Overall Study|Adverse Event|2
2504970|NCT01902134|8665442|P2|Overall Study|Adverse Event|1
2504971|NCT01902134|8665443|P1|Overall Study|Adverse Event|3
2504972|NCT01901874|8665480|P1|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6
2504973|NCT01901874|8665480|P1|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2
2504974|NCT01901874|8665480|P1|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5
2504975|NCT01901874|8665480|P1|1-Year (365-Day) MAE Evaluation|Death|7
2504976|NCT01901874|8665480|P1|30-Day MAE Evaluation|Insufficient Follow-up|1
2504977|NCT01901874|8665480|P1|Screening Committee Retrospective Review|Protocol Violation|47
2504978|NCT01901848|8665495|P2|Removed From Analyses|CPT practice cases to establish fidelity|0
2504979|NCT01901848|8665496|P1|Removed From Analyses|CPT practice cases to establish fidelity|10
2504980|NCT01901848|8665495|P2|Randomized and Treated|Lost to Follow-up|6
2504981|NCT01901848|8665496|P1|Randomized and Treated|Lost to Follow-up|3
2504982|NCT01901653|8665538|P13|Overall Study|Alive at Study Termination by Sponsor|1
2504983|NCT01901653|8665539|P12|Overall Study|Alive at Study Termination by Sponsor|1
2504984|NCT01901653|8665540|P11|Overall Study|Alive at Study Termination by Sponsor|0
2504985|NCT01901653|8665541|P10|Overall Study|Alive at Study Termination by Sponsor|2
2504986|NCT01901653|8665542|P9|Overall Study|Alive at Study Termination by Sponsor|0
2504987|NCT01901653|8665543|P8|Overall Study|Alive at Study Termination by Sponsor|0
2504988|NCT01901653|8665544|P7|Overall Study|Alive at Study Termination by Sponsor|0
2504989|NCT01901653|8665545|P6|Overall Study|Alive at Study Termination by Sponsor|0
2504990|NCT01901653|8665546|P5|Overall Study|Alive at Study Termination by Sponsor|0
2504991|NCT01901653|8665547|P4|Overall Study|Alive at Study Termination by Sponsor|0
2504992|NCT01901653|8665548|P3|Overall Study|Alive at Study Termination by Sponsor|1
2504993|NCT01901653|8665549|P2|Overall Study|Alive at Study Termination by Sponsor|0
2504994|NCT01901653|8665550|P1|Overall Study|Alive at Study Termination by Sponsor|0
2504995|NCT01901653|8665538|P13|Overall Study|Withdrawal by Subject|0
2504996|NCT01901653|8665539|P12|Overall Study|Withdrawal by Subject|0
2504997|NCT01901653|8665540|P11|Overall Study|Withdrawal by Subject|0
2504998|NCT01901653|8665541|P10|Overall Study|Withdrawal by Subject|0
2504999|NCT01901653|8665542|P9|Overall Study|Withdrawal by Subject|0
2505000|NCT01901653|8665543|P8|Overall Study|Withdrawal by Subject|0
2505001|NCT01901653|8665544|P7|Overall Study|Withdrawal by Subject|1
2505002|NCT01901653|8665545|P6|Overall Study|Withdrawal by Subject|0
2505003|NCT01901653|8665546|P5|Overall Study|Withdrawal by Subject|0
2505004|NCT01901653|8665547|P4|Overall Study|Withdrawal by Subject|0
2505005|NCT01901653|8665548|P3|Overall Study|Withdrawal by Subject|0
2505006|NCT01901653|8665549|P2|Overall Study|Withdrawal by Subject|0
2505007|NCT01901653|8665550|P1|Overall Study|Withdrawal by Subject|0
2505008|NCT01901653|8665538|P13|Overall Study|Lost to Follow-up|0
2505009|NCT01901653|8665539|P12|Overall Study|Lost to Follow-up|0
2505010|NCT01901653|8665540|P11|Overall Study|Lost to Follow-up|0
2505011|NCT01901653|8665541|P10|Overall Study|Lost to Follow-up|0
2505012|NCT01901653|8665542|P9|Overall Study|Lost to Follow-up|0
2505013|NCT01901653|8665543|P8|Overall Study|Lost to Follow-up|1
2505014|NCT01901653|8665544|P7|Overall Study|Lost to Follow-up|0
2505015|NCT01901653|8665545|P6|Overall Study|Lost to Follow-up|1
2505016|NCT01901653|8665546|P5|Overall Study|Lost to Follow-up|0
2505017|NCT01901653|8665547|P4|Overall Study|Lost to Follow-up|0
2505018|NCT01901653|8665548|P3|Overall Study|Lost to Follow-up|2
2505019|NCT01901653|8665549|P2|Overall Study|Lost to Follow-up|0
2505020|NCT01901653|8665550|P1|Overall Study|Lost to Follow-up|1
2505021|NCT01901653|8665538|P13|Overall Study|Death|4
2505022|NCT01901653|8665539|P12|Overall Study|Death|15
2505023|NCT01901653|8665540|P11|Overall Study|Death|2
2505024|NCT01901653|8665541|P10|Overall Study|Death|16
2505025|NCT01901653|8665542|P9|Overall Study|Death|1
2505026|NCT01901653|8665543|P8|Overall Study|Death|9
2505027|NCT01901653|8665544|P7|Overall Study|Death|6
2505028|NCT01901653|8665545|P6|Overall Study|Death|2
2505029|NCT01901653|8665546|P5|Overall Study|Death|2
2505030|NCT01901653|8665547|P4|Overall Study|Death|3
2505031|NCT01901653|8665548|P3|Overall Study|Death|8
2505032|NCT01901653|8665549|P2|Overall Study|Death|1
2505033|NCT01901653|8665550|P1|Overall Study|Death|2
2505034|NCT01901614|8665594|P2|Overall Study|Screen Fail|0
2505035|NCT01901614|8665595|P1|Overall Study|Screen Fail|1
2505036|NCT01901614|8665594|P2|Overall Study|Lost to Follow-up|0
2505037|NCT01901614|8665595|P1|Overall Study|Lost to Follow-up|1
2505038|NCT01901614|8665594|P2|Overall Study|Adverse Event|1
2505039|NCT01901614|8665595|P1|Overall Study|Adverse Event|0
2505040|NCT01901432|8665630|P5|Overall Study|Patient decision to stop study drug|1
2505041|NCT01901432|8665631|P4|Overall Study|Patient decision to stop study drug|0
2505042|NCT01901432|8665632|P3|Overall Study|Patient decision to stop study drug|0
2505043|NCT01901432|8665633|P2|Overall Study|Patient decision to stop study drug|0
2505044|NCT01901432|8665634|P1|Overall Study|Patient decision to stop study drug|0
2505045|NCT01901432|8665630|P5|Overall Study|Physician Decision|2
2505046|NCT01901432|8665631|P4|Overall Study|Physician Decision|0
2505047|NCT01901432|8665632|P3|Overall Study|Physician Decision|0
2505048|NCT01901432|8665633|P2|Overall Study|Physician Decision|0
2505049|NCT01901432|8665634|P1|Overall Study|Physician Decision|0
2505050|NCT01901432|8665630|P5|Overall Study|Withdrawal by Subject|5
2505051|NCT01901432|8665631|P4|Overall Study|Withdrawal by Subject|0
2505052|NCT01901432|8665632|P3|Overall Study|Withdrawal by Subject|1
2505053|NCT01901432|8665633|P2|Overall Study|Withdrawal by Subject|0
2505054|NCT01901432|8665634|P1|Overall Study|Withdrawal by Subject|0
2505055|NCT01901432|8665630|P5|Overall Study|Adverse Event|1
2505056|NCT01901432|8665631|P4|Overall Study|Adverse Event|0
2505057|NCT01901432|8665632|P3|Overall Study|Adverse Event|1
2505058|NCT01901432|8665633|P2|Overall Study|Adverse Event|1
2505059|NCT01901432|8665634|P1|Overall Study|Adverse Event|0
2505060|NCT01901393|8665686|P2|Overall Study|Adverse Event|0
2505061|NCT01901393|8665687|P1|Overall Study|Adverse Event|1
2505062|NCT01901341|8665705|P2|Overall Study|Withdrawal by Subject|1
2505063|NCT01901341|8665706|P1|Overall Study|Withdrawal by Subject|1
2505064|NCT01901341|8665705|P2|Overall Study|Study Terminated by Sponsor|15
2505065|NCT01901341|8665706|P1|Overall Study|Study Terminated by Sponsor|13
2505066|NCT01901341|8665705|P2|Overall Study|Protocol Violation|0
2505067|NCT01901341|8665706|P1|Overall Study|Protocol Violation|2
2505068|NCT01901341|8665705|P2|Overall Study|Lost to Follow-up|1
2505069|NCT01901341|8665706|P1|Overall Study|Lost to Follow-up|0
2505070|NCT01901341|8665705|P2|Overall Study|Lack of Efficacy|2
2505071|NCT01901341|8665706|P1|Overall Study|Lack of Efficacy|0
2505072|NCT01901341|8665705|P2|Overall Study|Adverse Event|2
2505073|NCT01901341|8665706|P1|Overall Study|Adverse Event|4
2505074|NCT01901328|8665720|P2|Overall Study|Lack of Efficacy|1
2505075|NCT01901328|8665721|P1|Overall Study|Lack of Efficacy|0
2505076|NCT01901328|8665720|P2|Overall Study|Withdrawal by Subject|2
2505077|NCT01901328|8665721|P1|Overall Study|Withdrawal by Subject|1
2505078|NCT01901328|8665720|P2|Overall Study|Study Terminated by Sponsor|16
2505079|NCT01901328|8665721|P1|Overall Study|Study Terminated by Sponsor|19
2505080|NCT01901328|8665720|P2|Overall Study|Protocol Violation|1
2505081|NCT01901328|8665721|P1|Overall Study|Protocol Violation|1
2505082|NCT01901328|8665720|P2|Overall Study|Physician Decision|1
2505083|NCT01901328|8665721|P1|Overall Study|Physician Decision|0
2505084|NCT01901328|8665720|P2|Overall Study|Lost to Follow-up|0
2505085|NCT01901328|8665721|P1|Overall Study|Lost to Follow-up|1
2505086|NCT01901302|8665735|P2|Overall Study|Withdrawal by Subject|0
2505087|NCT01901302|8665736|P1|Overall Study|Withdrawal by Subject|2
2505088|NCT01901302|8665735|P2|Overall Study|Study Terminated by Sponsor|20
2505089|NCT01901302|8665736|P1|Overall Study|Study Terminated by Sponsor|23
2505090|NCT01901302|8665735|P2|Overall Study|Lack of Efficacy|2
2505091|NCT01901302|8665736|P1|Overall Study|Lack of Efficacy|0
2505092|NCT01901302|8665735|P2|Overall Study|Adverse Event|1
2505093|NCT01901302|8665736|P1|Overall Study|Adverse Event|2
2505094|NCT01901224|8665761|P1|Overall Study|study was not funded and terminated|2
2505095|NCT01901185|8665796|P1|Overall Study|Withdrawal by Subject|2
2505096|NCT01901146|8665805|P5|Adjuvant Phase|Withdrawal by Subject|4
2505097|NCT01901146|8665806|P4|Adjuvant Phase|Withdrawal by Subject|1
2505098|NCT01901146|8665807|P3|Adjuvant Phase|Withdrawal by Subject|4
2505099|NCT01901146|8665808|P2|Adjuvant Phase|Withdrawal by Subject|0
2505100|NCT01901146|8665809|P1|Adjuvant Phase|Withdrawal by Subject|0
2505101|NCT01901146|8665805|P5|Adjuvant Phase|Physician Decision|4
2505102|NCT01901146|8665806|P4|Adjuvant Phase|Physician Decision|2
2505103|NCT01901146|8665807|P3|Adjuvant Phase|Physician Decision|9
2505104|NCT01901146|8665808|P2|Adjuvant Phase|Physician Decision|0
2505105|NCT01901146|8665809|P1|Adjuvant Phase|Physician Decision|0
2505106|NCT01901146|8665805|P5|Adjuvant Phase|Disease Progression or Recurrence|3
2505107|NCT01901146|8665806|P4|Adjuvant Phase|Disease Progression or Recurrence|4
2505108|NCT01901146|8665807|P3|Adjuvant Phase|Disease Progression or Recurrence|12
2505109|NCT01901146|8665808|P2|Adjuvant Phase|Disease Progression or Recurrence|0
2505110|NCT01901146|8665809|P1|Adjuvant Phase|Disease Progression or Recurrence|0
2505111|NCT01901146|8665805|P5|Adjuvant Phase|Death|3
2505112|NCT01901146|8665806|P4|Adjuvant Phase|Death|0
2505113|NCT01901146|8665807|P3|Adjuvant Phase|Death|0
2505114|NCT01901146|8665808|P2|Adjuvant Phase|Death|0
2505115|NCT01901146|8665809|P1|Adjuvant Phase|Death|0
2505116|NCT01901146|8665805|P5|Adjuvant Phase|Other|0
2505117|NCT01901146|8665806|P4|Adjuvant Phase|Other|0
2505118|NCT01901146|8665807|P3|Adjuvant Phase|Other|1
2505119|NCT01901146|8665808|P2|Adjuvant Phase|Other|0
2505120|NCT01901146|8665809|P1|Adjuvant Phase|Other|0
2505121|NCT01901146|8665805|P5|Neoadjuvant Phase|Requirement for Alternative Therapy|0
2505122|NCT01901146|8665806|P4|Neoadjuvant Phase|Requirement for Alternative Therapy|0
2505123|NCT01901146|8665807|P3|Neoadjuvant Phase|Requirement for Alternative Therapy|0
2505124|NCT01901146|8665808|P2|Neoadjuvant Phase|Requirement for Alternative Therapy|1
2505125|NCT01901146|8665809|P1|Neoadjuvant Phase|Requirement for Alternative Therapy|0
2505126|NCT01901146|8665805|P5|Neoadjuvant Phase|Withdrawal by Subject|0
2505127|NCT01901146|8665806|P4|Neoadjuvant Phase|Withdrawal by Subject|0
2505128|NCT01901146|8665807|P3|Neoadjuvant Phase|Withdrawal by Subject|0
2505129|NCT01901146|8665808|P2|Neoadjuvant Phase|Withdrawal by Subject|5
2505130|NCT01901146|8665809|P1|Neoadjuvant Phase|Withdrawal by Subject|2
2505131|NCT01901146|8665805|P5|Neoadjuvant Phase|Physician Decision|0
2505132|NCT01901146|8665806|P4|Neoadjuvant Phase|Physician Decision|0
2505133|NCT01901146|8665807|P3|Neoadjuvant Phase|Physician Decision|0
2505134|NCT01901146|8665808|P2|Neoadjuvant Phase|Physician Decision|2
2505135|NCT01901146|8665809|P1|Neoadjuvant Phase|Physician Decision|1
2505136|NCT01901146|8665805|P5|Neoadjuvant Phase|Lost to Follow-up|0
2505137|NCT01901146|8665806|P4|Neoadjuvant Phase|Lost to Follow-up|0
2505138|NCT01901146|8665807|P3|Neoadjuvant Phase|Lost to Follow-up|0
2505139|NCT01901146|8665808|P2|Neoadjuvant Phase|Lost to Follow-up|1
2505140|NCT01901146|8665809|P1|Neoadjuvant Phase|Lost to Follow-up|0
2505141|NCT01901146|8665805|P5|Neoadjuvant Phase|Disease Progression or Recurrence|0
2505142|NCT01901146|8665806|P4|Neoadjuvant Phase|Disease Progression or Recurrence|0
2505143|NCT01901146|8665807|P3|Neoadjuvant Phase|Disease Progression or Recurrence|0
2505144|NCT01901146|8665808|P2|Neoadjuvant Phase|Disease Progression or Recurrence|3
2505145|NCT01901146|8665809|P1|Neoadjuvant Phase|Disease Progression or Recurrence|2
2505146|NCT01901146|8665805|P5|Neoadjuvant Phase|Death|0
2505147|NCT01901146|8665806|P4|Neoadjuvant Phase|Death|0
2505148|NCT01901146|8665807|P3|Neoadjuvant Phase|Death|0
2505149|NCT01901146|8665808|P2|Neoadjuvant Phase|Death|2
2505150|NCT01901146|8665809|P1|Neoadjuvant Phase|Death|1
2505151|NCT01900899|8665824|P2|Overall Study|Migrated from study area|0
2505152|NCT01900899|8665825|P1|Overall Study|Migrated from study area|2
2505153|NCT01900899|8665824|P2|Overall Study|Withdrawal by Subject|1
2505154|NCT01900899|8665825|P1|Overall Study|Withdrawal by Subject|7
2505155|NCT01900730|8665851|P2|Overall Study|Screen Failure|0
2505156|NCT01900730|8665852|P1|Overall Study|Screen Failure|1
2505157|NCT01900730|8665851|P2|Overall Study|Withdrawal by Subject|0
2505158|NCT01900730|8665852|P1|Overall Study|Withdrawal by Subject|1
2505159|NCT01900665|8665860|P2|Open Label Period|Withdrawal by Subject|28
2505160|NCT01900665|8665861|P1|Open Label Period|Withdrawal by Subject|20
2505161|NCT01900665|8665860|P2|Open Label Period|Sponsor Decision|765
2505162|NCT01900665|8665861|P1|Open Label Period|Sponsor Decision|802
2505163|NCT01900665|8665860|P2|Open Label Period|Protocol Violation|1
2505164|NCT01900665|8665861|P1|Open Label Period|Protocol Violation|0
2505165|NCT01900665|8665860|P2|Open Label Period|Physician Decision|4
2505166|NCT01900665|8665861|P1|Open Label Period|Physician Decision|4
2505167|NCT01900665|8665860|P2|Open Label Period|Parent/Caregiver Decision|34
2505168|NCT01900665|8665861|P1|Open Label Period|Parent/Caregiver Decision|33
2505169|NCT01900665|8665860|P2|Open Label Period|Lost to Follow-up|1
2505170|NCT01900665|8665861|P1|Open Label Period|Lost to Follow-up|1
2505171|NCT01900665|8665860|P2|Open Label Period|Death|6
2505172|NCT01900665|8665861|P1|Open Label Period|Death|5
2505173|NCT01900665|8665860|P2|Open Label Period|Adverse Event|20
2505174|NCT01900665|8665861|P1|Open Label Period|Adverse Event|16
2505175|NCT01900665|8665860|P2|Placebo Controlled Period|Entry Criteria Not Met|9
2505176|NCT01900665|8665861|P1|Placebo Controlled Period|Entry Criteria Not Met|5
2505177|NCT01900665|8665860|P2|Placebo Controlled Period|Caregiver Decision|41
2505178|NCT01900665|8665861|P1|Placebo Controlled Period|Caregiver Decision|33
2505179|NCT01900665|8665860|P2|Placebo Controlled Period|Lost to Follow-up|0
2505180|NCT01900665|8665861|P1|Placebo Controlled Period|Lost to Follow-up|3
2505181|NCT01900665|8665860|P2|Placebo Controlled Period|Physician Decision|7
2505182|NCT01900665|8665861|P1|Placebo Controlled Period|Physician Decision|11
2505183|NCT01900665|8665860|P2|Placebo Controlled Period|Withdrawal by Subject|45
2505184|NCT01900665|8665861|P1|Placebo Controlled Period|Withdrawal by Subject|33
2505185|NCT01900665|8665860|P2|Placebo Controlled Period|Protocol Violation|7
2505186|NCT01900665|8665861|P1|Placebo Controlled Period|Protocol Violation|1
2505187|NCT01900665|8665860|P2|Placebo Controlled Period|Adverse Event|39
2505188|NCT01900665|8665861|P1|Placebo Controlled Period|Adverse Event|48
2505189|NCT01900665|8665860|P2|Placebo Controlled Period|Death|16
2505190|NCT01900665|8665861|P1|Placebo Controlled Period|Death|9
2505191|NCT01900652|8665904|P2|Overall Study|Physician Decision|1
2505192|NCT01900652|8665905|P1|Overall Study|Physician Decision|1
2505193|NCT01900652|8665904|P2|Overall Study|Adverse Event|1
2505194|NCT01900652|8665905|P1|Overall Study|Adverse Event|2
2505195|NCT01900652|8665904|P2|Overall Study|Death|0
2505196|NCT01900652|8665905|P1|Overall Study|Death|3
2505197|NCT01900652|8665904|P2|Overall Study|Consent withdrawn by subject|1
2505198|NCT01900652|8665905|P1|Overall Study|Consent withdrawn by subject|1
2505199|NCT01900652|8665904|P2|Overall Study|Progressive Disease|0
2505200|NCT01900652|8665905|P1|Overall Study|Progressive Disease|1
2505201|NCT01900626|8665941|P2|Overall Study|study was closed due to low enrollment|1
2505202|NCT01900626|8665942|P1|Overall Study|study was closed due to low enrollment|1
2505203|NCT01900444|8666021|P1|Overall Study|Lost to Follow-up|1
2505204|NCT01900444|8666021|P1|Overall Study|Protocol Violation|2
2505205|NCT01900431|8666034|P3|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3
2505206|NCT01900431|8666035|P2|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
2505207|NCT01900431|8666036|P1|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
2505208|NCT01900431|8666034|P3|Open-Label Treatment Period (Part C)|Lack of Efficacy|3
2505209|NCT01900431|8666035|P2|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
2505210|NCT01900431|8666036|P1|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
2505211|NCT01900431|8666034|P3|Open-Label Treatment Period (Part C)|Adverse Event|2
2505212|NCT01900431|8666035|P2|Open-Label Treatment Period (Part C)|Adverse Event|0
2505213|NCT01900431|8666036|P1|Open-Label Treatment Period (Part C)|Adverse Event|0
2505214|NCT01900431|8666034|P3|Extended Treatment Period (Part B)|Other than specified above|0
2505215|NCT01900431|8666035|P2|Extended Treatment Period (Part B)|Other than specified above|1
2505216|NCT01900431|8666036|P1|Extended Treatment Period (Part B)|Other than specified above|0
2505217|NCT01900431|8666034|P3|Extended Treatment Period (Part B)|Lack of Efficacy|0
2505218|NCT01900431|8666035|P2|Extended Treatment Period (Part B)|Lack of Efficacy|7
2505219|NCT01900431|8666036|P1|Extended Treatment Period (Part B)|Lack of Efficacy|1
2505220|NCT01900431|8666034|P3|Extended Treatment Period (Part B)|Adverse Event|0
2505221|NCT01900431|8666035|P2|Extended Treatment Period (Part B)|Adverse Event|2
2505222|NCT01900431|8666036|P1|Extended Treatment Period (Part B)|Adverse Event|0
2505223|NCT01900431|8666034|P3|Principal Treatment Period (Part A)|Other than specified above|0
2505224|NCT01900431|8666035|P2|Principal Treatment Period (Part A)|Other than specified above|1
2505225|NCT01900431|8666036|P1|Principal Treatment Period (Part A)|Other than specified above|0
2505226|NCT01900431|8666034|P3|Principal Treatment Period (Part A)|Lack of Efficacy|0
2505227|NCT01900431|8666035|P2|Principal Treatment Period (Part A)|Lack of Efficacy|6
2505228|NCT01900431|8666036|P1|Principal Treatment Period (Part A)|Lack of Efficacy|6
2505229|NCT01900431|8666034|P3|Principal Treatment Period (Part A)|Adverse Event|0
2505230|NCT01900431|8666035|P2|Principal Treatment Period (Part A)|Adverse Event|3
2505231|NCT01900431|8666036|P1|Principal Treatment Period (Part A)|Adverse Event|1
2505232|NCT01900314|8666078|P2|Overall Study|Withdrawal by Subject|3
2505233|NCT01900314|8666079|P1|Overall Study|Withdrawal by Subject|3
2505234|NCT01900314|8666078|P2|Overall Study|Protocol Violation|1
2505235|NCT01900314|8666079|P1|Overall Study|Protocol Violation|0
2505236|NCT01900314|8666078|P2|Overall Study|Lost to Follow-up|0
2505237|NCT01900314|8666079|P1|Overall Study|Lost to Follow-up|1
2505238|NCT01900054|8666109|P1|Overall Study|Withdrawal by Subject|1
2505239|NCT01900054|8666109|P1|Overall Study|Physician Decision|1
2505240|NCT01899768|8666118|P1|Part B|Withdrawal by Subject|1
2505241|NCT01899768|8666118|P1|Part B|Adverse Event|1
2505242|NCT01899768|8666118|P1|Part A|Withdrawal by Subject|1
2505243|NCT01899768|8666118|P1|Part A|Adverse Event|2
2505244|NCT01899742|8666192|P2|Overall Study|Withdrawal by Subject|5
2505245|NCT01899742|8666193|P1|Overall Study|Withdrawal by Subject|9
2505246|NCT01899742|8666192|P2|Overall Study|Protocol Violation|2
2505247|NCT01899742|8666193|P1|Overall Study|Protocol Violation|2
2505248|NCT01899742|8666192|P2|Overall Study|Lack of Efficacy|5
2505249|NCT01899742|8666193|P1|Overall Study|Lack of Efficacy|1
2505250|NCT01899742|8666192|P2|Overall Study|Adverse Event|4
2505251|NCT01899742|8666193|P1|Overall Study|Adverse Event|5
2505252|NCT01899729|8666206|P5|Overall Study|Lack of Efficacy|1
2505253|NCT01899729|8666207|P4|Overall Study|Lack of Efficacy|0
2505254|NCT01899729|8666208|P3|Overall Study|Lack of Efficacy|2
2505255|NCT01899729|8666209|P2|Overall Study|Lack of Efficacy|0
2505256|NCT01899729|8666210|P1|Overall Study|Lack of Efficacy|0
2505257|NCT01899729|8666206|P5|Overall Study|Withdrawal by Subject|0
2505258|NCT01899729|8666207|P4|Overall Study|Withdrawal by Subject|0
2505259|NCT01899729|8666208|P3|Overall Study|Withdrawal by Subject|0
2505260|NCT01899729|8666209|P2|Overall Study|Withdrawal by Subject|2
2505261|NCT01899729|8666210|P1|Overall Study|Withdrawal by Subject|1
2505262|NCT01899729|8666206|P5|Overall Study|Adverse Event|1
2505263|NCT01899729|8666207|P4|Overall Study|Adverse Event|0
2505264|NCT01899729|8666208|P3|Overall Study|Adverse Event|0
2505265|NCT01899729|8666209|P2|Overall Study|Adverse Event|0
2505266|NCT01899729|8666210|P1|Overall Study|Adverse Event|1
2505267|NCT01899144|8666257|P1|Treatment Period 5|Other|1
2505268|NCT01899144|8666257|P1|Treatment Period 3|Other|2
2505269|NCT01899144|8666257|P1|Treatment Period 2|Other|1
2505270|NCT01899053|8666293|P14|Overall Study|Symptomatic Deterioration|0
2505271|NCT01899053|8666294|P13|Overall Study|Symptomatic Deterioration|2
2505272|NCT01899053|8666295|P12|Overall Study|Symptomatic Deterioration|1
2505273|NCT01899053|8666296|P11|Overall Study|Symptomatic Deterioration|0
2505274|NCT01899053|8666297|P10|Overall Study|Symptomatic Deterioration|0
2505275|NCT01899053|8666298|P9|Overall Study|Symptomatic Deterioration|0
2505276|NCT01899053|8666299|P8|Overall Study|Symptomatic Deterioration|1
2505277|NCT01899053|8666300|P7|Overall Study|Symptomatic Deterioration|0
2505278|NCT01899053|8666301|P6|Overall Study|Symptomatic Deterioration|1
2505279|NCT01899053|8666302|P5|Overall Study|Symptomatic Deterioration|0
2505280|NCT01899053|8666303|P4|Overall Study|Symptomatic Deterioration|0
2505281|NCT01899053|8666304|P3|Overall Study|Symptomatic Deterioration|0
2505282|NCT01899053|8666305|P2|Overall Study|Symptomatic Deterioration|0
2505283|NCT01899053|8666306|P1|Overall Study|Symptomatic Deterioration|0
2505284|NCT01899053|8666293|P14|Overall Study|Unsatisfactory Therapeutic Response|0
2505285|NCT01899053|8666294|P13|Overall Study|Unsatisfactory Therapeutic Response|0
2505286|NCT01899053|8666295|P12|Overall Study|Unsatisfactory Therapeutic Response|0
2505287|NCT01899053|8666296|P11|Overall Study|Unsatisfactory Therapeutic Response|1
2505288|NCT01899053|8666297|P10|Overall Study|Unsatisfactory Therapeutic Response|0
2505289|NCT01899053|8666298|P9|Overall Study|Unsatisfactory Therapeutic Response|0
2505290|NCT01899053|8666299|P8|Overall Study|Unsatisfactory Therapeutic Response|0
2505291|NCT01899053|8666300|P7|Overall Study|Unsatisfactory Therapeutic Response|0
2505292|NCT01899053|8666301|P6|Overall Study|Unsatisfactory Therapeutic Response|0
2505293|NCT01899053|8666302|P5|Overall Study|Unsatisfactory Therapeutic Response|0
2505294|NCT01899053|8666303|P4|Overall Study|Unsatisfactory Therapeutic Response|0
2505295|NCT01899053|8666304|P3|Overall Study|Unsatisfactory Therapeutic Response|0
2505296|NCT01899053|8666305|P2|Overall Study|Unsatisfactory Therapeutic Response|1
2505297|NCT01899053|8666306|P1|Overall Study|Unsatisfactory Therapeutic Response|1
2505298|NCT01899053|8666293|P14|Overall Study|Protocol Violation|0
2505299|NCT01899053|8666294|P13|Overall Study|Protocol Violation|0
2505300|NCT01899053|8666295|P12|Overall Study|Protocol Violation|0
2505301|NCT01899053|8666296|P11|Overall Study|Protocol Violation|0
2505302|NCT01899053|8666297|P10|Overall Study|Protocol Violation|0
2505303|NCT01899053|8666298|P9|Overall Study|Protocol Violation|0
2505304|NCT01899053|8666299|P8|Overall Study|Protocol Violation|0
2505305|NCT01899053|8666300|P7|Overall Study|Protocol Violation|0
2505306|NCT01899053|8666301|P6|Overall Study|Protocol Violation|0
2505307|NCT01899053|8666302|P5|Overall Study|Protocol Violation|0
2505308|NCT01899053|8666303|P4|Overall Study|Protocol Violation|0
2505309|NCT01899053|8666304|P3|Overall Study|Protocol Violation|1
2505310|NCT01899053|8666305|P2|Overall Study|Protocol Violation|0
2505311|NCT01899053|8666306|P1|Overall Study|Protocol Violation|0
2505312|NCT01899053|8666293|P14|Overall Study|Withdrawal by Subject|1
2505313|NCT01899053|8666294|P13|Overall Study|Withdrawal by Subject|1
2505314|NCT01899053|8666295|P12|Overall Study|Withdrawal by Subject|0
2505315|NCT01899053|8666296|P11|Overall Study|Withdrawal by Subject|0
2505316|NCT01899053|8666297|P10|Overall Study|Withdrawal by Subject|0
2505317|NCT01899053|8666298|P9|Overall Study|Withdrawal by Subject|0
2505318|NCT01899053|8666299|P8|Overall Study|Withdrawal by Subject|1
2505319|NCT01899053|8666300|P7|Overall Study|Withdrawal by Subject|0
2505320|NCT01899053|8666301|P6|Overall Study|Withdrawal by Subject|0
2505321|NCT01899053|8666302|P5|Overall Study|Withdrawal by Subject|2
2505322|NCT01899053|8666303|P4|Overall Study|Withdrawal by Subject|0
2505323|NCT01899053|8666304|P3|Overall Study|Withdrawal by Subject|2
2505324|NCT01899053|8666305|P2|Overall Study|Withdrawal by Subject|1
2505325|NCT01899053|8666306|P1|Overall Study|Withdrawal by Subject|1
2505326|NCT01899053|8666293|P14|Overall Study|Reason Not Specified|0
2505327|NCT01899053|8666294|P13|Overall Study|Reason Not Specified|1
2505328|NCT01899053|8666295|P12|Overall Study|Reason Not Specified|0
2505329|NCT01899053|8666296|P11|Overall Study|Reason Not Specified|0
2505330|NCT01899053|8666297|P10|Overall Study|Reason Not Specified|0
2505331|NCT01899053|8666298|P9|Overall Study|Reason Not Specified|0
2505332|NCT01899053|8666299|P8|Overall Study|Reason Not Specified|0
2505333|NCT01899053|8666300|P7|Overall Study|Reason Not Specified|1
2505334|NCT01899053|8666301|P6|Overall Study|Reason Not Specified|0
2505335|NCT01899053|8666302|P5|Overall Study|Reason Not Specified|0
2505336|NCT01899053|8666303|P4|Overall Study|Reason Not Specified|0
2505337|NCT01899053|8666304|P3|Overall Study|Reason Not Specified|0
2505338|NCT01899053|8666305|P2|Overall Study|Reason Not Specified|0
2505339|NCT01899053|8666306|P1|Overall Study|Reason Not Specified|0
2505340|NCT01899053|8666293|P14|Overall Study|Adverse Event|2
2505341|NCT01899053|8666294|P13|Overall Study|Adverse Event|2
2505342|NCT01899053|8666295|P12|Overall Study|Adverse Event|1
2505343|NCT01899053|8666296|P11|Overall Study|Adverse Event|3
2505344|NCT01899053|8666297|P10|Overall Study|Adverse Event|0
2505345|NCT01899053|8666298|P9|Overall Study|Adverse Event|2
2505346|NCT01899053|8666299|P8|Overall Study|Adverse Event|0
2505347|NCT01899053|8666300|P7|Overall Study|Adverse Event|1
2505348|NCT01899053|8666301|P6|Overall Study|Adverse Event|1
2505349|NCT01899053|8666302|P5|Overall Study|Adverse Event|1
2505350|NCT01899053|8666303|P4|Overall Study|Adverse Event|3
2505351|NCT01899053|8666304|P3|Overall Study|Adverse Event|1
2505352|NCT01899053|8666305|P2|Overall Study|Adverse Event|1
2505353|NCT01899053|8666306|P1|Overall Study|Adverse Event|1
2505354|NCT01899053|8666293|P14|Overall Study|Progressive Disease|17
2505355|NCT01899053|8666294|P13|Overall Study|Progressive Disease|8
2505356|NCT01899053|8666295|P12|Overall Study|Progressive Disease|5
2505357|NCT01899053|8666296|P11|Overall Study|Progressive Disease|12
2505358|NCT01899053|8666297|P10|Overall Study|Progressive Disease|3
2505359|NCT01899053|8666298|P9|Overall Study|Progressive Disease|4
2505360|NCT01899053|8666299|P8|Overall Study|Progressive Disease|1
2505361|NCT01899053|8666300|P7|Overall Study|Progressive Disease|1
2505362|NCT01899053|8666301|P6|Overall Study|Progressive Disease|1
2505363|NCT01899053|8666302|P5|Overall Study|Progressive Disease|3
2505364|NCT01899053|8666303|P4|Overall Study|Progressive Disease|0
2505365|NCT01899053|8666304|P3|Overall Study|Progressive Disease|3
2505366|NCT01899053|8666305|P2|Overall Study|Progressive Disease|0
2505367|NCT01899053|8666306|P1|Overall Study|Progressive Disease|4
2505368|NCT01898884|8666563|P9|Multiple Dose Period|Randomized Not Treated|1
2505369|NCT01898884|8666564|P8|Multiple Dose Period|Randomized Not Treated|0
2505370|NCT01898884|8666565|P7|Multiple Dose Period|Randomized Not Treated|0
2505371|NCT01898884|8666566|P6|Multiple Dose Period|Randomized Not Treated|0
2505372|NCT01898884|8666567|P5|Multiple Dose Period|Randomized Not Treated|0
2505373|NCT01898884|8666568|P4|Multiple Dose Period|Randomized Not Treated|0
2505374|NCT01898884|8666569|P3|Multiple Dose Period|Randomized Not Treated|0
2505375|NCT01898884|8666570|P2|Multiple Dose Period|Randomized Not Treated|0
2505376|NCT01898884|8666571|P1|Multiple Dose Period|Randomized Not Treated|0
2505377|NCT01898884|8666563|P9|Multiple Dose Period|Adverse Event|0
2505378|NCT01898884|8666564|P8|Multiple Dose Period|Adverse Event|0
2505379|NCT01898884|8666565|P7|Multiple Dose Period|Adverse Event|1
2505380|NCT01898884|8666566|P6|Multiple Dose Period|Adverse Event|0
2505381|NCT01898884|8666567|P5|Multiple Dose Period|Adverse Event|0
2505382|NCT01898884|8666568|P4|Multiple Dose Period|Adverse Event|0
2505383|NCT01898884|8666569|P3|Multiple Dose Period|Adverse Event|0
2505384|NCT01898884|8666570|P2|Multiple Dose Period|Adverse Event|0
2505385|NCT01898884|8666571|P1|Multiple Dose Period|Adverse Event|0
2505386|NCT01898806|8666721|P1|Overall Study|Physician Decision|1
2505387|NCT01898806|8666721|P1|Overall Study|Withdrawal by Subject|2
2505388|NCT01898598|8666751|P2|Overall Study|Other|1
2505389|NCT01898598|8666752|P1|Overall Study|Other|0
2505390|NCT01898598|8666751|P2|Overall Study|Lost to Follow-up|1
2505391|NCT01898598|8666752|P1|Overall Study|Lost to Follow-up|0
2505392|NCT01898598|8666751|P2|Overall Study|Withdrawal by Subject|0
2505393|NCT01898598|8666752|P1|Overall Study|Withdrawal by Subject|3
2505394|NCT01898598|8666751|P2|Overall Study|Adverse Event|0
2505395|NCT01898598|8666752|P1|Overall Study|Adverse Event|1
2505396|NCT01898442|8666771|P3|Overall Study|Patient vomited pills|1
2505397|NCT01898442|8666772|P2|Overall Study|Patient vomited pills|0
2505398|NCT01898442|8666773|P1|Overall Study|Patient vomited pills|0
2505399|NCT01898442|8666771|P3|Overall Study|Hemolysis/technical problems|2
2505400|NCT01898442|8666772|P2|Overall Study|Hemolysis/technical problems|2
2505401|NCT01898442|8666773|P1|Overall Study|Hemolysis/technical problems|1
2505402|NCT01898299|8666810|P2|Post Treatment (One Month)|Lost to Follow-up|4
2505403|NCT01898299|8666811|P1|Post Treatment (One Month)|Lost to Follow-up|3
2505404|NCT01898286|8666817|P1|Overall Study|Lost to Follow-up|1
2505405|NCT01898286|8666817|P1|Overall Study|Protocol Violation|1
2505406|NCT01898286|8666817|P1|Overall Study|Withdrawal by Subject|1
2505407|NCT01898208|8666827|P3|Overall Study|Lost to Follow-up|1
2505408|NCT01898208|8666828|P2|Overall Study|Lost to Follow-up|1
2505409|NCT01898208|8666829|P1|Overall Study|Lost to Follow-up|3
2505410|NCT01898208|8666827|P3|Overall Study|System/Technical Error|3
2505411|NCT01898208|8666828|P2|Overall Study|System/Technical Error|2
2505412|NCT01898208|8666829|P1|Overall Study|System/Technical Error|1
2505413|NCT01898208|8666827|P3|Overall Study|Non-Blood Specimens in Bottles|4
2505414|NCT01898208|8666828|P2|Overall Study|Non-Blood Specimens in Bottles|5
2505415|NCT01898208|8666829|P1|Overall Study|Non-Blood Specimens in Bottles|3
2505416|NCT01898208|8666827|P3|Overall Study|Negative Gram Stain|6
2505417|NCT01898208|8666828|P2|Overall Study|Negative Gram Stain|9
2505418|NCT01898208|8666829|P1|Overall Study|Negative Gram Stain|6
2505419|NCT01898208|8666827|P3|Overall Study|Death/comfort care within 24 hours|8
2505420|NCT01898208|8666828|P2|Overall Study|Death/comfort care within 24 hours|9
2505421|NCT01898208|8666829|P1|Overall Study|Death/comfort care within 24 hours|10
2505422|NCT01898208|8666827|P3|Overall Study|Positive blood culture|15
2505423|NCT01898208|8666828|P2|Overall Study|Positive blood culture|23
2505424|NCT01898208|8666829|P1|Overall Study|Positive blood culture|17
2505425|NCT01898195|8666876|P3|Smoking Abstinence|Did not have good measurements|36
2505426|NCT01898195|8666877|P2|Smoking Abstinence|Did not have good measurements|38
2505427|NCT01898195|8666878|P1|Smoking Abstinence|Did not have good measurements|35
2505428|NCT01898130|8666889|P1|Follow up Until PD or Death|Lost to Follow-up|1
2505429|NCT01898130|8666889|P1|Treatment|Progressive Disease|4
2505430|NCT01898130|8666889|P1|Treatment|Withdrawal by Subject|2
2505431|NCT01898091|8666904|P2|Overall Study|Withdrawal by Subject|5
2505432|NCT01898091|8666905|P1|Overall Study|Withdrawal by Subject|1
2505433|NCT01898091|8666904|P2|Overall Study|Lost to Follow-up|1
2505434|NCT01898091|8666905|P1|Overall Study|Lost to Follow-up|1
2505435|NCT01898078|8666913|P2|Overall Study|Reason not Specified|1
2505436|NCT01898078|8666914|P1|Overall Study|Reason not Specified|0
2505437|NCT01898078|8666913|P2|Overall Study|Symptomatic Deterioration|0
2505438|NCT01898078|8666914|P1|Overall Study|Symptomatic Deterioration|2
2505439|NCT01898078|8666913|P2|Overall Study|Withdrawal by Subject|1
2505440|NCT01898078|8666914|P1|Overall Study|Withdrawal by Subject|1
2505441|NCT01898078|8666913|P2|Overall Study|Adverse Event|1
2505442|NCT01898078|8666914|P1|Overall Study|Adverse Event|2
2505443|NCT01898078|8666913|P2|Overall Study|Progressive Disease|5
2505444|NCT01898078|8666914|P1|Overall Study|Progressive Disease|1
2505445|NCT01897896|8666951|P2|Overall Study|Other than specified|1
2505446|NCT01897896|8666952|P1|Overall Study|Other than specified|2
2505447|NCT01897896|8666951|P2|Overall Study|Caregiver can no longer participate|2
2505448|NCT01897896|8666952|P1|Overall Study|Caregiver can no longer participate|0
2505449|NCT01897896|8666951|P2|Overall Study|Withdrawal per Investigator’s judgement|1
2505450|NCT01897896|8666952|P1|Overall Study|Withdrawal per Investigator’s judgement|1
2505451|NCT01897896|8666951|P2|Overall Study|Protocol Violation|1
2505452|NCT01897896|8666952|P1|Overall Study|Protocol Violation|1
2505453|NCT01897896|8666951|P2|Overall Study|Require drug that interfere with study|4
2505454|NCT01897896|8666952|P1|Overall Study|Require drug that interfere with study|1
2505455|NCT01897896|8666951|P2|Overall Study|Withdrawal by Subject|1
2505456|NCT01897896|8666952|P1|Overall Study|Withdrawal by Subject|7
2505457|NCT01897896|8666951|P2|Overall Study|Non-compliance with study drug dosing|1
2505458|NCT01897896|8666952|P1|Overall Study|Non-compliance with study drug dosing|1
2505459|NCT01897896|8666951|P2|Overall Study|Lost to Follow-up|0
2505460|NCT01897896|8666952|P1|Overall Study|Lost to Follow-up|1
2505461|NCT01897896|8666951|P2|Overall Study|Adverse Event|1
2505462|NCT01897896|8666952|P1|Overall Study|Adverse Event|11
2505463|NCT01897896|8666951|P2|Overall Study|Death|0
2505464|NCT01897896|8666952|P1|Overall Study|Death|1
2505465|NCT01897727|8667084|P2|Overall Study|Exclusion: central sleep apnea|1
2505466|NCT01897727|8667085|P1|Overall Study|Exclusion: central sleep apnea|0
2505467|NCT01897532|8667093|P2|Discontinuation From Trial|Patient lost to follow-up for MACE|36
2505468|NCT01897532|8667094|P1|Discontinuation From Trial|Patient lost to follow-up for MACE|55
2505469|NCT01897532|8667093|P2|Discontinuation From Trial|Not Treated|5
2505470|NCT01897532|8667094|P1|Discontinuation From Trial|Not Treated|7
2505471|NCT01897532|8667093|P2|Discontinuation From Treatment|Adverse event/ CV outcome event|362
2505472|NCT01897532|8667094|P1|Discontinuation From Treatment|Adverse event/ CV outcome event|402
2505473|NCT01897532|8667093|P2|Discontinuation From Treatment|Non compliance|15
2505474|NCT01897532|8667094|P1|Discontinuation From Treatment|Non compliance|24
2505475|NCT01897532|8667093|P2|Discontinuation From Treatment|Withdrawal by Subject|281
2505476|NCT01897532|8667094|P1|Discontinuation From Treatment|Withdrawal by Subject|333
2505477|NCT01897532|8667093|P2|Discontinuation From Treatment|Other reason than specified|176
2505478|NCT01897532|8667094|P1|Discontinuation From Treatment|Other reason than specified|196
2505479|NCT01897532|8667093|P2|Discontinuation From Treatment|Not Treated|5
2505480|NCT01897532|8667094|P1|Discontinuation From Treatment|Not Treated|7
2505481|NCT01897493|8667102|P1|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1
2505482|NCT01897233|8667138|P1|Part B (24 Weeks)|Physician Decision|1
2505483|NCT01897233|8667138|P1|Part B (24 Weeks)|Withdrawal by Subject|2
2505484|NCT01897233|8667138|P1|Part B (24 Weeks)|Adverse Event|1
2505485|NCT01896986|8667190|P2|Overall Study|samples lost|23
2505486|NCT01896986|8667191|P1|Overall Study|samples lost|14
2505487|NCT01896934|8667197|P1|Overall Study|Withdrawal by Subject|1
2505488|NCT01896934|8667197|P1|Overall Study|Adverse Event|1
2505489|NCT01896895|8667210|P4|Double-blind MP|Lost to Follow-up|0
2505490|NCT01896895|8667211|P3|Double-blind MP|Lost to Follow-up|1
2505491|NCT01896895|8667212|P2|Double-blind MP|Lost to Follow-up|0
2505492|NCT01896895|8667213|P1|Double-blind MP|Lost to Follow-up|1
2505493|NCT01896895|8667210|P4|Double-blind MP|Withdrawal by Subject|0
2505494|NCT01896895|8667211|P3|Double-blind MP|Withdrawal by Subject|1
2505495|NCT01896895|8667212|P2|Double-blind MP|Withdrawal by Subject|2
2505496|NCT01896895|8667213|P1|Double-blind MP|Withdrawal by Subject|0
2505497|NCT01896895|8667210|P4|Double-blind MP|Physician Decision|0
2505498|NCT01896895|8667211|P3|Double-blind MP|Physician Decision|1
2505499|NCT01896895|8667212|P2|Double-blind MP|Physician Decision|0
2505500|NCT01896895|8667213|P1|Double-blind MP|Physician Decision|0
2505501|NCT01896726|8667228|P1|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1
2505502|NCT01896726|8667228|P1|Treatment Period 2 (Days 23-31)|Adverse Event|1
2505503|NCT01896700|8667243|P2|Overall Study|Withdrawal by Subject|1
2505504|NCT01896700|8667244|P1|Overall Study|Withdrawal by Subject|0
2505505|NCT01896700|8667243|P2|Overall Study|Adverse Event|5
2505506|NCT01896700|8667244|P1|Overall Study|Adverse Event|4
2505507|NCT01896557|8667275|P2|Clopidogrel + GI Protector|Reading error|3
2505508|NCT01896557|8667276|P1|Clopidogrel + GI Protector|Reading error|1
2505509|NCT01896557|8667275|P2|Clopidogrel + GI Protector|low adherence|1
2505510|NCT01896557|8667276|P1|Clopidogrel + GI Protector|low adherence|1
2505511|NCT01896557|8667275|P2|Clopidogrel Alone|Adverse Event|0
2505512|NCT01896557|8667276|P1|Clopidogrel Alone|Adverse Event|1
2505513|NCT01896297|8667313|P1|Overall Study|Died in post treatment phase|1
2505514|NCT01896232|8667320|P2|Overall Study|Lost to Follow-up|12
2505515|NCT01896232|8667321|P1|Overall Study|Lost to Follow-up|9
2505516|NCT01896232|8667320|P2|Overall Study|Sponsor Decision|0
2505517|NCT01896232|8667321|P1|Overall Study|Sponsor Decision|2
2505518|NCT01896232|8667320|P2|Overall Study|Withdrawal by Subject|31
2505519|NCT01896232|8667321|P1|Overall Study|Withdrawal by Subject|32
2505520|NCT01896232|8667320|P2|Overall Study|Death|10
2505521|NCT01896232|8667321|P1|Overall Study|Death|6
2505522|NCT01896193|8667349|P2|Overall Study|Withdrew Consent|0
2505523|NCT01896193|8667350|P1|Overall Study|Withdrew Consent|1
2505524|NCT01896193|8667349|P2|Overall Study|Protocol Violation|1
2505525|NCT01896193|8667350|P1|Overall Study|Protocol Violation|0
2505526|NCT01896193|8667349|P2|Overall Study|Lack of Efficacy|11
2505527|NCT01896193|8667350|P1|Overall Study|Lack of Efficacy|20
2505528|NCT01896128|8667376|P2|Overall Study|Withdrawal by Subject|3
2505529|NCT01896128|8667377|P1|Overall Study|Withdrawal by Subject|3
2505530|NCT01896050|8667419|P2|Overall Study|Death|0
2505531|NCT01896050|8667420|P1|Overall Study|Death|1
2505532|NCT01896050|8667419|P2|Overall Study|Adverse Event|2
2505533|NCT01896050|8667420|P1|Overall Study|Adverse Event|37
2505534|NCT01895608|8667487|P4|Overall Study|Withdrawal by Subject|0
2505535|NCT01895608|8667488|P3|Overall Study|Withdrawal by Subject|2
2505536|NCT01895608|8667489|P2|Overall Study|Withdrawal by Subject|0
2505537|NCT01895608|8667490|P1|Overall Study|Withdrawal by Subject|0
2505538|NCT01895608|8667487|P4|Overall Study|change in health status|0
2505539|NCT01895608|8667488|P3|Overall Study|change in health status|1
2505540|NCT01895608|8667489|P2|Overall Study|change in health status|1
2505541|NCT01895608|8667490|P1|Overall Study|change in health status|0
2505542|NCT01895543|8667520|P1|Overall Study|Other (Not fulfilling above criteria)|24
2505543|NCT01895543|8667520|P1|Overall Study|Physician Decision|2
2505544|NCT01895543|8667520|P1|Overall Study|Protocol Violation|1
2505545|NCT01895543|8667520|P1|Overall Study|Subject's substantial non-compliance|6
2505546|NCT01895543|8667520|P1|Overall Study|Adverse Event|28
2505547|NCT01895543|8667520|P1|Overall Study|Lost to Follow-up|25
2505548|NCT01895543|8667520|P1|Overall Study|Withdrawal by Subject|43
2505549|NCT01895452|8667536|P2|Overall Study|Noncompliance with study drug|1
2505550|NCT01895452|8667537|P1|Overall Study|Noncompliance with study drug|0
2505551|NCT01895452|8667536|P2|Overall Study|Underlying disease|3
2505552|NCT01895452|8667537|P1|Overall Study|Underlying disease|0
2505553|NCT01895452|8667536|P2|Overall Study|Withdrawal by Subject|14
2505554|NCT01895452|8667537|P1|Overall Study|Withdrawal by Subject|2
2505555|NCT01895452|8667536|P2|Overall Study|Pregnancy|1
2505556|NCT01895452|8667537|P1|Overall Study|Pregnancy|0
2505557|NCT01895452|8667536|P2|Overall Study|Lost to Follow-up|5
2505558|NCT01895452|8667537|P1|Overall Study|Lost to Follow-up|1
2505559|NCT01895452|8667536|P2|Overall Study|Adverse Event|4
2505560|NCT01895452|8667537|P1|Overall Study|Adverse Event|1
2505561|NCT01895361|8667550|P3|Overall Study|Reasons different from categories above|4
2505562|NCT01895361|8667551|P2|Overall Study|Reasons different from categories above|3
2505563|NCT01895361|8667552|P1|Overall Study|Reasons different from categories above|7
2505564|NCT01895361|8667550|P3|Overall Study|Lack of Efficacy|0
2505565|NCT01895361|8667551|P2|Overall Study|Lack of Efficacy|1
2505566|NCT01895361|8667552|P1|Overall Study|Lack of Efficacy|0
2505567|NCT01895361|8667550|P3|Overall Study|Withdrawal by Subject|6
2505568|NCT01895361|8667551|P2|Overall Study|Withdrawal by Subject|6
2505569|NCT01895361|8667552|P1|Overall Study|Withdrawal by Subject|7
2505570|NCT01895361|8667550|P3|Overall Study|Physician Decision|2
2505571|NCT01895361|8667551|P2|Overall Study|Physician Decision|2
2505572|NCT01895361|8667552|P1|Overall Study|Physician Decision|2
2505573|NCT01895361|8667550|P3|Overall Study|Non-compliance with study|1
2505574|NCT01895361|8667551|P2|Overall Study|Non-compliance with study|3
2505575|NCT01895361|8667552|P1|Overall Study|Non-compliance with study|1
2505576|NCT01895361|8667550|P3|Overall Study|Lost to Follow-up|6
2505577|NCT01895361|8667551|P2|Overall Study|Lost to Follow-up|4
2505578|NCT01895361|8667552|P1|Overall Study|Lost to Follow-up|4
2505579|NCT01895361|8667550|P3|Overall Study|Death|2
2505580|NCT01895361|8667551|P2|Overall Study|Death|1
2505581|NCT01895361|8667552|P1|Overall Study|Death|2
2505582|NCT01895361|8667550|P3|Overall Study|Adverse Event|3
2505583|NCT01895361|8667551|P2|Overall Study|Adverse Event|1
2505584|NCT01895361|8667552|P1|Overall Study|Adverse Event|1
2505585|NCT01895335|8667581|P1|Overall Study|Other than Specified Above|44
2505586|NCT01895335|8667581|P1|Overall Study|Included But Not treated|1
2505587|NCT01895335|8667581|P1|Overall Study|Poor Compliance to Protocol|11
2505588|NCT01895335|8667581|P1|Overall Study|Lack of Efficacy|53
2505589|NCT01895335|8667581|P1|Overall Study|Adverse Event|106
2505590|NCT01895322|8667598|P1|Overall Study|Protocol Violation|10
2505591|NCT01895322|8667598|P1|Overall Study|Withdrawal by Subject|2
2505592|NCT01895322|8667598|P1|Overall Study|Adverse Event|1
2505593|NCT01895309|8667607|P2|Overall Study|Withdrawal by Subject|18
2505594|NCT01895309|8667608|P1|Overall Study|Withdrawal by Subject|9
2505595|NCT01895309|8667607|P2|Overall Study|Physician Decision|10
2505596|NCT01895309|8667608|P1|Overall Study|Physician Decision|15
2505597|NCT01895309|8667607|P2|Overall Study|Lost to Follow-up|3
2505598|NCT01895309|8667608|P1|Overall Study|Lost to Follow-up|1
2505599|NCT01895309|8667607|P2|Overall Study|Lack of Efficacy|3
2505600|NCT01895309|8667608|P1|Overall Study|Lack of Efficacy|1
2505601|NCT01895309|8667607|P2|Overall Study|Protocol Violation|0
2505602|NCT01895309|8667608|P1|Overall Study|Protocol Violation|1
2505603|NCT01895309|8667607|P2|Overall Study|Adverse Event|17
2505604|NCT01895309|8667608|P1|Overall Study|Adverse Event|13
2505605|NCT01895270|8667622|P2|Isradipine Taper (W7-8)|Withdrawal by Subject|1
2505606|NCT01895270|8667623|P1|Isradipine Taper (W7-8)|Withdrawal by Subject|0
2505607|NCT01895270|8667622|P2|Isradipine Taper (W7-8)|Lost to Follow-up|1
2505608|NCT01895270|8667623|P1|Isradipine Taper (W7-8)|Lost to Follow-up|0
2505609|NCT01895270|8667622|P2|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5
2505610|NCT01895270|8667623|P1|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3
2505611|NCT01895270|8667622|P2|Study Medications Induction (W1-4)|Blood pressure issues|1
2505612|NCT01895270|8667623|P1|Study Medications Induction (W1-4)|Blood pressure issues|0
2505613|NCT01895270|8667622|P2|Study Medications Induction (W1-4)|noncompliance- missed medications|1
2505614|NCT01895270|8667623|P1|Study Medications Induction (W1-4)|noncompliance- missed medications|3
2505615|NCT01895270|8667622|P2|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2
2505616|NCT01895270|8667623|P1|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3
2505617|NCT01895270|8667622|P2|Study Medications Induction (W1-4)|Withdrawal by Subject|2
2505618|NCT01895270|8667623|P1|Study Medications Induction (W1-4)|Withdrawal by Subject|0
2505619|NCT01895101|8667642|P3|Overall Study|coagulation disorder|0
2505620|NCT01895101|8667643|P2|Overall Study|coagulation disorder|1
2505621|NCT01895101|8667644|P1|Overall Study|coagulation disorder|0
2505622|NCT01895101|8667642|P3|Overall Study|Death|0
2505623|NCT01895101|8667643|P2|Overall Study|Death|1
2505624|NCT01895101|8667644|P1|Overall Study|Death|0
2505625|NCT01895101|8667642|P3|Overall Study|another study, enrolled in other study|0
2505626|NCT01895101|8667643|P2|Overall Study|another study, enrolled in other study|1
2505627|NCT01895101|8667644|P1|Overall Study|another study, enrolled in other study|0
2505628|NCT01895101|8667642|P3|Overall Study|Withdrawal by Subject|2
2505629|NCT01895101|8667643|P2|Overall Study|Withdrawal by Subject|1
2505630|NCT01895101|8667644|P1|Overall Study|Withdrawal by Subject|0
2505631|NCT01895101|8667642|P3|Overall Study|OPCAB procedure|3
2505632|NCT01895101|8667643|P2|Overall Study|OPCAB procedure|1
2505633|NCT01895101|8667644|P1|Overall Study|OPCAB procedure|1
2505634|NCT01894984|8667679|P2|Overall Study|Other|175
2505635|NCT01894984|8667680|P1|Overall Study|Other|314
2505636|NCT01894919|8667709|P13|Overall Study|Lost to Follow-up|0
2505637|NCT01894919|8667710|P12|Overall Study|Lost to Follow-up|0
2505638|NCT01894919|8667711|P11|Overall Study|Lost to Follow-up|0
2505639|NCT01894919|8667712|P10|Overall Study|Lost to Follow-up|0
2505640|NCT01894919|8667713|P9|Overall Study|Lost to Follow-up|0
2505641|NCT01894919|8667714|P8|Overall Study|Lost to Follow-up|0
2505642|NCT01894919|8667715|P7|Overall Study|Lost to Follow-up|0
2505643|NCT01894919|8667716|P6|Overall Study|Lost to Follow-up|0
2505644|NCT01894919|8667717|P5|Overall Study|Lost to Follow-up|2
2505645|NCT01894919|8667718|P4|Overall Study|Lost to Follow-up|0
2505646|NCT01894919|8667719|P3|Overall Study|Lost to Follow-up|0
2505647|NCT01894919|8667720|P2|Overall Study|Lost to Follow-up|0
2505648|NCT01894919|8667721|P1|Overall Study|Lost to Follow-up|0
2505649|NCT01894919|8667709|P13|Overall Study|Other-Unspecified|0
2505650|NCT01894919|8667710|P12|Overall Study|Other-Unspecified|0
2505651|NCT01894919|8667711|P11|Overall Study|Other-Unspecified|0
2505652|NCT01894919|8667712|P10|Overall Study|Other-Unspecified|0
2505653|NCT01894919|8667713|P9|Overall Study|Other-Unspecified|0
2505654|NCT01894919|8667714|P8|Overall Study|Other-Unspecified|0
2505655|NCT01894919|8667715|P7|Overall Study|Other-Unspecified|0
2505656|NCT01894919|8667716|P6|Overall Study|Other-Unspecified|0
2505657|NCT01894919|8667717|P5|Overall Study|Other-Unspecified|0
2505658|NCT01894919|8667718|P4|Overall Study|Other-Unspecified|0
2505659|NCT01894919|8667719|P3|Overall Study|Other-Unspecified|0
2505660|NCT01894919|8667720|P2|Overall Study|Other-Unspecified|0
2505661|NCT01894919|8667721|P1|Overall Study|Other-Unspecified|1
2505662|NCT01894919|8667709|P13|Overall Study|Adverse Event|0
2505663|NCT01894919|8667710|P12|Overall Study|Adverse Event|0
2505664|NCT01894919|8667711|P11|Overall Study|Adverse Event|1
2505665|NCT01894919|8667712|P10|Overall Study|Adverse Event|0
2505666|NCT01894919|8667713|P9|Overall Study|Adverse Event|0
2505667|NCT01894919|8667714|P8|Overall Study|Adverse Event|0
2505668|NCT01894919|8667715|P7|Overall Study|Adverse Event|0
2505669|NCT01894919|8667716|P6|Overall Study|Adverse Event|0
2505670|NCT01894919|8667717|P5|Overall Study|Adverse Event|0
2505671|NCT01894919|8667718|P4|Overall Study|Adverse Event|0
2505672|NCT01894919|8667719|P3|Overall Study|Adverse Event|0
2505673|NCT01894919|8667720|P2|Overall Study|Adverse Event|0
2505674|NCT01894919|8667721|P1|Overall Study|Adverse Event|0
2505675|NCT01894919|8667709|P13|Overall Study|Withdrawal by Subject|0
2505676|NCT01894919|8667710|P12|Overall Study|Withdrawal by Subject|0
2505677|NCT01894919|8667711|P11|Overall Study|Withdrawal by Subject|1
2505678|NCT01894919|8667712|P10|Overall Study|Withdrawal by Subject|1
2505679|NCT01894919|8667713|P9|Overall Study|Withdrawal by Subject|0
2505680|NCT01894919|8667714|P8|Overall Study|Withdrawal by Subject|0
2505681|NCT01894919|8667715|P7|Overall Study|Withdrawal by Subject|0
2505682|NCT01894919|8667716|P6|Overall Study|Withdrawal by Subject|0
2505683|NCT01894919|8667717|P5|Overall Study|Withdrawal by Subject|1
2505684|NCT01894919|8667718|P4|Overall Study|Withdrawal by Subject|0
2505685|NCT01894919|8667719|P3|Overall Study|Withdrawal by Subject|0
2505686|NCT01894919|8667720|P2|Overall Study|Withdrawal by Subject|0
2505687|NCT01894919|8667721|P1|Overall Study|Withdrawal by Subject|1
2505688|NCT01894841|8667876|P2|Overall Study|Lost to Follow-up|3
2505689|NCT01894841|8667877|P1|Overall Study|Lost to Follow-up|7
2505690|NCT01894841|8667876|P2|Overall Study|Withdrawn by investigator|2
2505691|NCT01894841|8667877|P1|Overall Study|Withdrawn by investigator|2
2505692|NCT01894841|8667876|P2|Overall Study|Withdrawal by Subject|4
2505693|NCT01894841|8667877|P1|Overall Study|Withdrawal by Subject|9
2505694|NCT01894776|8667893|P1|Overall Study|Withdrawal by Subject|1
2505695|NCT01894620|8667907|P2|Overall Study|Withdrawal by Subject|1
2505696|NCT01894620|8667908|P1|Overall Study|Withdrawal by Subject|0
2505697|NCT01894607|8667916|P1|Overall Study|Ineligible|1
2505698|NCT01894581|8667923|P2|Overall Study|Screen Failure|4
2505699|NCT01894581|8667924|P1|Overall Study|Screen Failure|3
2505700|NCT01894581|8667923|P2|Overall Study|Withdrawal by Subject|3
2505701|NCT01894581|8667924|P1|Overall Study|Withdrawal by Subject|2
2505702|NCT01894568|8667932|P2|Overall Study|Lost to Follow-up|1
2505703|NCT01894568|8667933|P1|Overall Study|Lost to Follow-up|0
2505704|NCT01894568|8667932|P2|Overall Study|Physician Decision|0
2505705|NCT01894568|8667933|P1|Overall Study|Physician Decision|1
2505706|NCT01894568|8667932|P2|Overall Study|Withdrawal by Subject|5
2505707|NCT01894568|8667933|P1|Overall Study|Withdrawal by Subject|5
2505708|NCT01894568|8667932|P2|Overall Study|Protocol required discontinuation|1
2505709|NCT01894568|8667933|P1|Overall Study|Protocol required discontinuation|2
2505710|NCT01894568|8667932|P2|Overall Study|Adverse Event|3
2505711|NCT01894568|8667933|P1|Overall Study|Adverse Event|2
2505712|NCT01894477|8667984|P2|Overall Study|protocol changed due SC changed to cord|1
2505713|NCT01894477|8667985|P1|Overall Study|protocol changed due SC changed to cord|0
2505714|NCT01894477|8667984|P2|Overall Study|Protocol Violation|1
2505715|NCT01894477|8667985|P1|Overall Study|Protocol Violation|0
2505716|NCT01894256|8667996|P3|Part B|Lack of Efficacy|13
2505717|NCT01894256|8667997|P2|Part B|Lack of Efficacy|12
2505718|NCT01894256|8667998|P1|Part B|Lack of Efficacy|15
2505719|NCT01894256|8667996|P3|Part B|Withdrawal by Subject|0
2505720|NCT01894256|8667997|P2|Part B|Withdrawal by Subject|1
2505721|NCT01894256|8667998|P1|Part B|Withdrawal by Subject|0
2505722|NCT01894256|8667996|P3|Part B|Death|1
2505723|NCT01894256|8667997|P2|Part B|Death|1
2505724|NCT01894256|8667998|P1|Part B|Death|0
2505725|NCT01894256|8667996|P3|Part A|Adverse Event|0
2505726|NCT01894256|8667997|P2|Part A|Adverse Event|1
2505727|NCT01894256|8667998|P1|Part A|Adverse Event|0
2505728|NCT01894243|8668045|P3|Overall Study|Other|0
2505729|NCT01894243|8668046|P2|Overall Study|Other|0
2505730|NCT01894243|8668047|P1|Overall Study|Other|1
2505731|NCT01894243|8668045|P3|Overall Study|Subject decision|0
2505732|NCT01894243|8668046|P2|Overall Study|Subject decision|0
2505733|NCT01894243|8668047|P1|Overall Study|Subject decision|1
2505734|NCT01894243|8668045|P3|Overall Study|Condition under investigation worsened|2
2505735|NCT01894243|8668046|P2|Overall Study|Condition under investigation worsened|6
2505736|NCT01894243|8668047|P1|Overall Study|Condition under investigation worsened|8
2505737|NCT01894243|8668045|P3|Overall Study|Lack of Efficacy|1
2505738|NCT01894243|8668046|P2|Overall Study|Lack of Efficacy|3
2505739|NCT01894243|8668047|P1|Overall Study|Lack of Efficacy|3
2505740|NCT01894243|8668045|P3|Overall Study|Death|3
2505741|NCT01894243|8668046|P2|Overall Study|Death|0
2505742|NCT01894243|8668047|P1|Overall Study|Death|0
2505743|NCT01894243|8668045|P3|Overall Study|Adverse Event|2
2505744|NCT01894243|8668046|P2|Overall Study|Adverse Event|1
2505745|NCT01894243|8668047|P1|Overall Study|Adverse Event|0
2505746|NCT01894230|8668086|P2|Overall Study|Death|0
2505747|NCT01894230|8668087|P1|Overall Study|Death|1
2505748|NCT01894230|8668086|P2|Overall Study|Non-adherent|1
2505749|NCT01894230|8668087|P1|Overall Study|Non-adherent|0
2505750|NCT01894230|8668086|P2|Overall Study|Withdrawal by Subject|4
2505751|NCT01894230|8668087|P1|Overall Study|Withdrawal by Subject|4
2505752|NCT01894230|8668086|P2|Overall Study|Lost to Follow-up|2
2505753|NCT01894230|8668087|P1|Overall Study|Lost to Follow-up|2
2505754|NCT01894152|8668122|P1|Overall Study|No DMR or due to stent thrombosis|143
2505755|NCT01894100|8668171|P2|Overall Study|Withdrawal by Subject|0
2505756|NCT01894100|8668172|P1|Overall Study|Withdrawal by Subject|3
2505757|NCT01894100|8668171|P2|Overall Study|Lost to Follow-up|1
2505758|NCT01894100|8668172|P1|Overall Study|Lost to Follow-up|0
2505759|NCT01894022|8668197|P2|Overall Study|Study Closed/terminated|10
2505760|NCT01894022|8668198|P1|Overall Study|Study Closed/terminated|7
2505761|NCT01894022|8668197|P2|Overall Study|Adverse Event, non-fatal|0
2505762|NCT01894022|8668198|P1|Overall Study|Adverse Event, non-fatal|1
2505763|NCT01894022|8668197|P2|Overall Study|Death|0
2505764|NCT01894022|8668198|P1|Overall Study|Death|1
2505765|NCT01893905|8668267|P2|Overall Study|Other reason|3
2505766|NCT01893905|8668268|P1|Overall Study|Other reason|1
2505767|NCT01893905|8668267|P2|Overall Study|Lack of adherence to treatment|0
2505768|NCT01893905|8668268|P1|Overall Study|Lack of adherence to treatment|2
2505769|NCT01893905|8668267|P2|Overall Study|Protocol Violation|1
2505770|NCT01893905|8668268|P1|Overall Study|Protocol Violation|6
2505771|NCT01893905|8668267|P2|Overall Study|Lost to Follow-up|0
2505772|NCT01893905|8668268|P1|Overall Study|Lost to Follow-up|1
2505773|NCT01893905|8668267|P2|Overall Study|Lack of Efficacy|7
2505774|NCT01893905|8668268|P1|Overall Study|Lack of Efficacy|5
2505775|NCT01893905|8668267|P2|Overall Study|Adverse Event|3
2505776|NCT01893905|8668268|P1|Overall Study|Adverse Event|9
2505777|NCT01893905|8668267|P2|Overall Study|Withdrawal by Subject|0
2505778|NCT01893905|8668268|P1|Overall Study|Withdrawal by Subject|1
2505779|NCT01893411|8668307|P3|Overall Study|Lost to Follow-up|1
2505780|NCT01893411|8668308|P2|Overall Study|Lost to Follow-up|0
2505781|NCT01893411|8668309|P1|Overall Study|Lost to Follow-up|2
2505782|NCT01893411|8668307|P3|Overall Study|Withdrawal by Subject|3
2505783|NCT01893411|8668308|P2|Overall Study|Withdrawal by Subject|4
2505784|NCT01893411|8668309|P1|Overall Study|Withdrawal by Subject|7
2505785|NCT01893411|8668307|P3|Overall Study|Adverse Event|0
2505786|NCT01893411|8668308|P2|Overall Study|Adverse Event|0
2505787|NCT01893411|8668309|P1|Overall Study|Adverse Event|1
2505788|NCT01893411|8668307|P3|Overall Study|Other|3
2505789|NCT01893411|8668308|P2|Overall Study|Other|1
2505790|NCT01893411|8668309|P1|Overall Study|Other|3
2505791|NCT01893411|8668307|P3|Overall Study|Lack of Efficacy|0
2505792|NCT01893411|8668308|P2|Overall Study|Lack of Efficacy|1
2505793|NCT01893411|8668309|P1|Overall Study|Lack of Efficacy|2
2505794|NCT01893411|8668307|P3|Overall Study|Physician Decision|2
2505795|NCT01893411|8668308|P2|Overall Study|Physician Decision|1
2505796|NCT01893411|8668309|P1|Overall Study|Physician Decision|1
2505797|NCT01893411|8668307|P3|Overall Study|Protocol Violation|0
2505798|NCT01893411|8668308|P2|Overall Study|Protocol Violation|0
2505799|NCT01893411|8668309|P1|Overall Study|Protocol Violation|1
2505800|NCT01893346|8668406|P4|Overall Study|Withdrawal by Subject|0
2505801|NCT01893346|8668407|P3|Overall Study|Withdrawal by Subject|0
2505802|NCT01893346|8668408|P2|Overall Study|Withdrawal by Subject|0
2505803|NCT01893346|8668409|P1|Overall Study|Withdrawal by Subject|2
2505804|NCT01893346|8668406|P4|Overall Study|Protocol Violation|0
2505805|NCT01893346|8668407|P3|Overall Study|Protocol Violation|0
2505806|NCT01893346|8668408|P2|Overall Study|Protocol Violation|0
2505807|NCT01893346|8668409|P1|Overall Study|Protocol Violation|1
2505808|NCT01893346|8668406|P4|Overall Study|Lost to Follow-up|0
2505809|NCT01893346|8668407|P3|Overall Study|Lost to Follow-up|0
2505810|NCT01893346|8668408|P2|Overall Study|Lost to Follow-up|1
2505811|NCT01893346|8668409|P1|Overall Study|Lost to Follow-up|0
2505812|NCT01893281|8668423|P1|Overall Study|Withdrawal by Subject|1
2505813|NCT01893281|8668423|P1|Overall Study|Protocol Violation|1
2505814|NCT01893281|8668423|P1|Overall Study|Adverse Event|1
2505815|NCT01893203|8668430|P1|Overall Study|Withdrawal by Subject|1
2505816|NCT01892722|8668454|P2|Overall Study|Withdrawal by Subject|5
2505817|NCT01892722|8668455|P1|Overall Study|Withdrawal by Subject|3
2505818|NCT01892722|8668454|P2|Overall Study|Lack of Efficacy|7
2505819|NCT01892722|8668455|P1|Overall Study|Lack of Efficacy|0
2505820|NCT01892722|8668454|P2|Overall Study|Adverse Event|2
2505821|NCT01892722|8668455|P1|Overall Study|Adverse Event|3
2505822|NCT01892722|8668454|P2|Overall Study|Physician Decision|2
2505823|NCT01892722|8668455|P1|Overall Study|Physician Decision|1
2505824|NCT01892722|8668454|P2|Overall Study|Patient/guardian decision|2
2505825|NCT01892722|8668455|P1|Overall Study|Patient/guardian decision|0
2505826|NCT01892722|8668454|P2|Overall Study|Administrative problems|1
2505827|NCT01892722|8668455|P1|Overall Study|Administrative problems|0
2505828|NCT01892722|8668454|P2|Overall Study|Protocol deviation|1
2505829|NCT01892722|8668455|P1|Overall Study|Protocol deviation|0
2505830|NCT01892657|8668471|P1|Overall Study|Protocol Violation|12
2505831|NCT01892657|8668471|P1|Overall Study|Withdrawal by Subject|6
2505832|NCT01892540|8668490|P3|Overall Study|Did not fit in scanner|1
2505833|NCT01892540|8668491|P2|Overall Study|Did not fit in scanner|0
2505834|NCT01892540|8668492|P1|Overall Study|Did not fit in scanner|0
2505835|NCT01892540|8668490|P3|Overall Study|Did not complete PET/MRI|2
2505836|NCT01892540|8668491|P2|Overall Study|Did not complete PET/MRI|0
2505837|NCT01892540|8668492|P1|Overall Study|Did not complete PET/MRI|0
2505838|NCT01892436|8668513|P4|Overall Study|Adverse Event|3
2505839|NCT01892436|8668514|P3|Overall Study|Adverse Event|2
2505840|NCT01892436|8668515|P2|Overall Study|Adverse Event|6
2505841|NCT01892436|8668516|P1|Overall Study|Adverse Event|7
2505842|NCT01892436|8668513|P4|Overall Study|non-compliance with treatment|0
2505843|NCT01892436|8668514|P3|Overall Study|non-compliance with treatment|0
2505844|NCT01892436|8668515|P2|Overall Study|non-compliance with treatment|0
2505845|NCT01892436|8668516|P1|Overall Study|non-compliance with treatment|1
2505846|NCT01892436|8668513|P4|Overall Study|Lost to Follow-up|3
2505847|NCT01892436|8668514|P3|Overall Study|Lost to Follow-up|1
2505848|NCT01892436|8668515|P2|Overall Study|Lost to Follow-up|1
2505849|NCT01892436|8668516|P1|Overall Study|Lost to Follow-up|1
2505850|NCT01892436|8668513|P4|Overall Study|Lack of Efficacy|2
2505851|NCT01892436|8668514|P3|Overall Study|Lack of Efficacy|2
2505852|NCT01892436|8668515|P2|Overall Study|Lack of Efficacy|2
2505853|NCT01892436|8668516|P1|Overall Study|Lack of Efficacy|1
2505854|NCT01892436|8668513|P4|Overall Study|Technical problems|1
2505855|NCT01892436|8668514|P3|Overall Study|Technical problems|1
2505856|NCT01892436|8668515|P2|Overall Study|Technical problems|1
2505857|NCT01892436|8668516|P1|Overall Study|Technical problems|2
2505858|NCT01892436|8668513|P4|Overall Study|Pregnancy|0
2505859|NCT01892436|8668514|P3|Overall Study|Pregnancy|1
2505860|NCT01892436|8668515|P2|Overall Study|Pregnancy|2
2505861|NCT01892436|8668516|P1|Overall Study|Pregnancy|0
2505862|NCT01892436|8668513|P4|Overall Study|Physician Decision|1
2505863|NCT01892436|8668514|P3|Overall Study|Physician Decision|0
2505864|NCT01892436|8668515|P2|Overall Study|Physician Decision|1
2505865|NCT01892436|8668516|P1|Overall Study|Physician Decision|2
2505866|NCT01892436|8668513|P4|Overall Study|Death|0
2505867|NCT01892436|8668514|P3|Overall Study|Death|0
2505868|NCT01892436|8668515|P2|Overall Study|Death|1
2505869|NCT01892436|8668516|P1|Overall Study|Death|1
2505870|NCT01892436|8668513|P4|Overall Study|Withdrawal by Subject|4
2505871|NCT01892436|8668514|P3|Overall Study|Withdrawal by Subject|4
2505872|NCT01892436|8668515|P2|Overall Study|Withdrawal by Subject|15
2505873|NCT01892436|8668516|P1|Overall Study|Withdrawal by Subject|8
2505874|NCT01892345|8668556|P2|Overall Study|Withdrawal by Subject|1
2505875|NCT01892345|8668557|P1|Overall Study|Withdrawal by Subject|12
2505876|NCT01892345|8668556|P2|Overall Study|Lost to Follow-up|0
2505877|NCT01892345|8668557|P1|Overall Study|Lost to Follow-up|3
2505878|NCT01892345|8668556|P2|Overall Study|Death|0
2505879|NCT01892345|8668557|P1|Overall Study|Death|1
2505880|NCT01892345|8668556|P2|Overall Study|Adverse Event|2
2505881|NCT01892345|8668557|P1|Overall Study|Adverse Event|0
2505882|NCT01892293|8668598|P1|Overall Study|Apheresed but not treated|4
2505883|NCT01892189|8668642|P9|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
2505884|NCT01892189|8668643|P8|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
2505885|NCT01892189|8668644|P7|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
2505886|NCT01892189|8668645|P6|Washout Period 1 (7 Days)|Noncompliance, Irritability|1
2505887|NCT01892189|8668646|P5|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
2505888|NCT01892189|8668647|P4|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
2505889|NCT01892189|8668648|P3|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
2505890|NCT01892189|8668649|P2|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
2505891|NCT01892189|8668650|P1|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
2505892|NCT01892189|8668642|P9|Washout Period 1 (7 Days)|Withdrawal by Subject|1
2505893|NCT01892189|8668643|P8|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2505894|NCT01892189|8668644|P7|Washout Period 1 (7 Days)|Withdrawal by Subject|1
2505895|NCT01892189|8668645|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2505896|NCT01892189|8668646|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2505897|NCT01892189|8668647|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|1
2505898|NCT01892189|8668648|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|2
2505899|NCT01892189|8668649|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2505900|NCT01892189|8668650|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2505901|NCT01892189|8668642|P9|Washout Period 1 (7 Days)|Adverse Event|1
2505902|NCT01892189|8668643|P8|Washout Period 1 (7 Days)|Adverse Event|0
2505903|NCT01892189|8668644|P7|Washout Period 1 (7 Days)|Adverse Event|0
2505904|NCT01892189|8668645|P6|Washout Period 1 (7 Days)|Adverse Event|0
2505905|NCT01892189|8668646|P5|Washout Period 1 (7 Days)|Adverse Event|0
2505906|NCT01892189|8668647|P4|Washout Period 1 (7 Days)|Adverse Event|0
2505907|NCT01892189|8668648|P3|Washout Period 1 (7 Days)|Adverse Event|0
2505908|NCT01892189|8668649|P2|Washout Period 1 (7 Days)|Adverse Event|0
2505909|NCT01892189|8668650|P1|Washout Period 1 (7 Days)|Adverse Event|0
2505910|NCT01892163|8668692|P2|Overall Study|Lost to Follow-up|0
2505911|NCT01892163|8668693|P1|Overall Study|Lost to Follow-up|1
2505912|NCT01892163|8668692|P2|Overall Study|Death|1
2505913|NCT01892163|8668693|P1|Overall Study|Death|1
2505914|NCT01892020|8668705|P2|Period 2|Protocol Violation|0
2505915|NCT01892020|8668706|P1|Period 2|Protocol Violation|1
2505916|NCT01892020|8668705|P2|Period 1|Unclassified|1
2505917|NCT01892020|8668706|P1|Period 1|Unclassified|0
2505918|NCT01892020|8668705|P2|Period 1|Protocol Violation|4
2505919|NCT01892020|8668706|P1|Period 1|Protocol Violation|2
2505920|NCT01892020|8668705|P2|Period 1|Adverse Event|1
2505921|NCT01892020|8668706|P1|Period 1|Adverse Event|1
2505922|NCT01891890|8668735|P3|Overall Study|Study ended before endpoint reached|6
2505923|NCT01891890|8668736|P2|Overall Study|Study ended before endpoint reached|3
2505924|NCT01891890|8668737|P1|Overall Study|Study ended before endpoint reached|7
2505925|NCT01891890|8668735|P3|Overall Study|Lost to Follow-up|1
2505926|NCT01891890|8668736|P2|Overall Study|Lost to Follow-up|0
2505927|NCT01891890|8668737|P1|Overall Study|Lost to Follow-up|0
2505928|NCT01891864|8668780|P6|Extension Period|Lost to Follow-up|0
2505929|NCT01891864|8668781|P5|Extension Period|Lost to Follow-up|0
2505930|NCT01891864|8668782|P4|Extension Period|Lost to Follow-up|0
2505931|NCT01891864|8668783|P3|Extension Period|Lost to Follow-up|2
2505932|NCT01891864|8668784|P2|Extension Period|Lost to Follow-up|0
2505933|NCT01891864|8668785|P1|Extension Period|Lost to Follow-up|0
2505934|NCT01891864|8668780|P6|Extension Period|Withdrawal by Subject|0
2505935|NCT01891864|8668781|P5|Extension Period|Withdrawal by Subject|4
2505936|NCT01891864|8668782|P4|Extension Period|Withdrawal by Subject|2
2505937|NCT01891864|8668783|P3|Extension Period|Withdrawal by Subject|1
2505938|NCT01891864|8668784|P2|Extension Period|Withdrawal by Subject|0
2505939|NCT01891864|8668785|P1|Extension Period|Withdrawal by Subject|0
2505940|NCT01891864|8668780|P6|Extension Period|Adverse Event|0
2505941|NCT01891864|8668781|P5|Extension Period|Adverse Event|2
2505942|NCT01891864|8668782|P4|Extension Period|Adverse Event|2
2505943|NCT01891864|8668783|P3|Extension Period|Adverse Event|4
2505944|NCT01891864|8668784|P2|Extension Period|Adverse Event|0
2505945|NCT01891864|8668785|P1|Extension Period|Adverse Event|0
2505946|NCT01891864|8668780|P6|Extension Period|Pregnancy|0
2505947|NCT01891864|8668781|P5|Extension Period|Pregnancy|0
2505948|NCT01891864|8668782|P4|Extension Period|Pregnancy|0
2505949|NCT01891864|8668783|P3|Extension Period|Pregnancy|1
2505950|NCT01891864|8668784|P2|Extension Period|Pregnancy|0
2505951|NCT01891864|8668785|P1|Extension Period|Pregnancy|0
2505952|NCT01891864|8668780|P6|Extension Period|Lack of Efficacy|0
2505953|NCT01891864|8668781|P5|Extension Period|Lack of Efficacy|1
2505954|NCT01891864|8668782|P4|Extension Period|Lack of Efficacy|1
2505955|NCT01891864|8668783|P3|Extension Period|Lack of Efficacy|0
2505956|NCT01891864|8668784|P2|Extension Period|Lack of Efficacy|0
2505957|NCT01891864|8668785|P1|Extension Period|Lack of Efficacy|0
2505958|NCT01891864|8668780|P6|Treatment Period 2|Withdrawal by Subject|1
2505959|NCT01891864|8668781|P5|Treatment Period 2|Withdrawal by Subject|1
2505960|NCT01891864|8668782|P4|Treatment Period 2|Withdrawal by Subject|4
2505961|NCT01891864|8668783|P3|Treatment Period 2|Withdrawal by Subject|3
2505962|NCT01891864|8668784|P2|Treatment Period 2|Withdrawal by Subject|0
2505963|NCT01891864|8668785|P1|Treatment Period 2|Withdrawal by Subject|0
2505964|NCT01891864|8668780|P6|Treatment Period 2|Termination of Site|0
2505965|NCT01891864|8668781|P5|Treatment Period 2|Termination of Site|2
2505966|NCT01891864|8668782|P4|Treatment Period 2|Termination of Site|0
2505967|NCT01891864|8668783|P3|Treatment Period 2|Termination of Site|0
2505968|NCT01891864|8668784|P2|Treatment Period 2|Termination of Site|0
2505969|NCT01891864|8668785|P1|Treatment Period 2|Termination of Site|0
2505970|NCT01891864|8668780|P6|Treatment Period 2|Adverse Event|4
2505971|NCT01891864|8668781|P5|Treatment Period 2|Adverse Event|0
2505972|NCT01891864|8668782|P4|Treatment Period 2|Adverse Event|2
2505973|NCT01891864|8668783|P3|Treatment Period 2|Adverse Event|1
2505974|NCT01891864|8668784|P2|Treatment Period 2|Adverse Event|0
2505975|NCT01891864|8668785|P1|Treatment Period 2|Adverse Event|0
2505976|NCT01891864|8668780|P6|Treatment Period 2|Lack of Efficacy|0
2505977|NCT01891864|8668781|P5|Treatment Period 2|Lack of Efficacy|1
2505978|NCT01891864|8668782|P4|Treatment Period 2|Lack of Efficacy|0
2505979|NCT01891864|8668783|P3|Treatment Period 2|Lack of Efficacy|1
2505980|NCT01891864|8668784|P2|Treatment Period 2|Lack of Efficacy|0
2505981|NCT01891864|8668785|P1|Treatment Period 2|Lack of Efficacy|0
2505982|NCT01891864|8668780|P6|Treatment Period 2|Site Termination|0
2505983|NCT01891864|8668781|P5|Treatment Period 2|Site Termination|0
2505984|NCT01891864|8668782|P4|Treatment Period 2|Site Termination|2
2505985|NCT01891864|8668783|P3|Treatment Period 2|Site Termination|1
2505986|NCT01891864|8668784|P2|Treatment Period 2|Site Termination|0
2505987|NCT01891864|8668785|P1|Treatment Period 2|Site Termination|0
2505988|NCT01891864|8668780|P6|Treatment Period 2|Physician Decision|0
2505989|NCT01891864|8668781|P5|Treatment Period 2|Physician Decision|0
2505990|NCT01891864|8668782|P4|Treatment Period 2|Physician Decision|0
2505991|NCT01891864|8668783|P3|Treatment Period 2|Physician Decision|1
2505992|NCT01891864|8668784|P2|Treatment Period 2|Physician Decision|0
2505993|NCT01891864|8668785|P1|Treatment Period 2|Physician Decision|0
2505994|NCT01891864|8668780|P6|Treatment Period 2|Protocol Violation|0
2505995|NCT01891864|8668781|P5|Treatment Period 2|Protocol Violation|0
2505996|NCT01891864|8668782|P4|Treatment Period 2|Protocol Violation|1
2505997|NCT01891864|8668783|P3|Treatment Period 2|Protocol Violation|0
2505998|NCT01891864|8668784|P2|Treatment Period 2|Protocol Violation|0
2505999|NCT01891864|8668785|P1|Treatment Period 2|Protocol Violation|0
2506000|NCT01891864|8668780|P6|Treatment Period 1|Lost to Follow-up|0
2506001|NCT01891864|8668781|P5|Treatment Period 1|Lost to Follow-up|0
2506002|NCT01891864|8668782|P4|Treatment Period 1|Lost to Follow-up|0
2506003|NCT01891864|8668783|P3|Treatment Period 1|Lost to Follow-up|0
2506004|NCT01891864|8668784|P2|Treatment Period 1|Lost to Follow-up|0
2506005|NCT01891864|8668785|P1|Treatment Period 1|Lost to Follow-up|1
2506006|NCT01891864|8668780|P6|Treatment Period 1|Withdrawal by Subject|0
2506007|NCT01891864|8668781|P5|Treatment Period 1|Withdrawal by Subject|0
2506008|NCT01891864|8668782|P4|Treatment Period 1|Withdrawal by Subject|0
2506009|NCT01891864|8668783|P3|Treatment Period 1|Withdrawal by Subject|0
2506010|NCT01891864|8668784|P2|Treatment Period 1|Withdrawal by Subject|5
2506011|NCT01891864|8668785|P1|Treatment Period 1|Withdrawal by Subject|2
2506012|NCT01891864|8668780|P6|Treatment Period 1|Adverse Event / Injection Site Reaction|0
2506013|NCT01891864|8668781|P5|Treatment Period 1|Adverse Event / Injection Site Reaction|0
2506014|NCT01891864|8668782|P4|Treatment Period 1|Adverse Event / Injection Site Reaction|0
2506015|NCT01891864|8668783|P3|Treatment Period 1|Adverse Event / Injection Site Reaction|0
2506016|NCT01891864|8668784|P2|Treatment Period 1|Adverse Event / Injection Site Reaction|4
2506017|NCT01891864|8668785|P1|Treatment Period 1|Adverse Event / Injection Site Reaction|4
2506018|NCT01891864|8668780|P6|Treatment Period 1|Adverse Event, Serious, Fatal|0
2506019|NCT01891864|8668781|P5|Treatment Period 1|Adverse Event, Serious, Fatal|0
2506020|NCT01891864|8668782|P4|Treatment Period 1|Adverse Event, Serious, Fatal|0
2506021|NCT01891864|8668783|P3|Treatment Period 1|Adverse Event, Serious, Fatal|0
2506022|NCT01891864|8668784|P2|Treatment Period 1|Adverse Event, Serious, Fatal|1
2506023|NCT01891864|8668785|P1|Treatment Period 1|Adverse Event, Serious, Fatal|0
2506024|NCT01891864|8668780|P6|Treatment Period 1|Physician Decision|0
2506025|NCT01891864|8668781|P5|Treatment Period 1|Physician Decision|0
2506026|NCT01891864|8668782|P4|Treatment Period 1|Physician Decision|0
2506027|NCT01891864|8668783|P3|Treatment Period 1|Physician Decision|0
2506028|NCT01891864|8668784|P2|Treatment Period 1|Physician Decision|1
2506029|NCT01891864|8668785|P1|Treatment Period 1|Physician Decision|0
2506030|NCT01891864|8668780|P6|Treatment Period 1|Protocol Violation / IMP non-compliance|0
2506031|NCT01891864|8668781|P5|Treatment Period 1|Protocol Violation / IMP non-compliance|0
2506032|NCT01891864|8668782|P4|Treatment Period 1|Protocol Violation / IMP non-compliance|0
2506033|NCT01891864|8668783|P3|Treatment Period 1|Protocol Violation / IMP non-compliance|0
2506034|NCT01891864|8668784|P2|Treatment Period 1|Protocol Violation / IMP non-compliance|1
2506035|NCT01891864|8668785|P1|Treatment Period 1|Protocol Violation / IMP non-compliance|1
2506036|NCT01891721|8668821|P3|Overall Study|Lost to Follow-up|1
2506037|NCT01891721|8668822|P2|Overall Study|Lost to Follow-up|5
2506038|NCT01891721|8668823|P1|Overall Study|Lost to Follow-up|10
2506039|NCT01891669|8668847|P10|Overall Study|Other|0
2506040|NCT01891669|8668848|P9|Overall Study|Other|0
2506041|NCT01891669|8668849|P8|Overall Study|Other|1
2506042|NCT01891669|8668850|P7|Overall Study|Other|0
2506043|NCT01891669|8668851|P6|Overall Study|Other|0
2506044|NCT01891669|8668852|P5|Overall Study|Other|0
2506045|NCT01891669|8668853|P4|Overall Study|Other|0
2506046|NCT01891669|8668854|P3|Overall Study|Other|0
2506047|NCT01891669|8668855|P2|Overall Study|Other|0
2506048|NCT01891669|8668856|P1|Overall Study|Other|1
2506049|NCT01891669|8668847|P10|Overall Study|Withdrawal by Subject|1
2506050|NCT01891669|8668848|P9|Overall Study|Withdrawal by Subject|1
2506051|NCT01891669|8668849|P8|Overall Study|Withdrawal by Subject|2
2506052|NCT01891669|8668850|P7|Overall Study|Withdrawal by Subject|1
2506053|NCT01891669|8668851|P6|Overall Study|Withdrawal by Subject|0
2506054|NCT01891669|8668852|P5|Overall Study|Withdrawal by Subject|0
2506055|NCT01891669|8668853|P4|Overall Study|Withdrawal by Subject|0
2506056|NCT01891669|8668854|P3|Overall Study|Withdrawal by Subject|0
2506057|NCT01891669|8668855|P2|Overall Study|Withdrawal by Subject|1
2506058|NCT01891669|8668856|P1|Overall Study|Withdrawal by Subject|1
2506059|NCT01891669|8668847|P10|Overall Study|Death|1
2506060|NCT01891669|8668848|P9|Overall Study|Death|0
2506061|NCT01891669|8668849|P8|Overall Study|Death|1
2506062|NCT01891669|8668850|P7|Overall Study|Death|0
2506063|NCT01891669|8668851|P6|Overall Study|Death|0
2506064|NCT01891669|8668852|P5|Overall Study|Death|0
2506065|NCT01891669|8668853|P4|Overall Study|Death|0
2506066|NCT01891669|8668854|P3|Overall Study|Death|0
2506067|NCT01891669|8668855|P2|Overall Study|Death|0
2506068|NCT01891669|8668856|P1|Overall Study|Death|0
2506069|NCT01891357|8669007|P1|Overall Study|Protocol Violation|3
2506070|NCT01890967|8669054|P6|Overall Study|Withdrawal by Subject|1
2506071|NCT01890967|8669055|P5|Overall Study|Withdrawal by Subject|3
2506072|NCT01890967|8669056|P4|Overall Study|Withdrawal by Subject|3
2506073|NCT01890967|8669057|P3|Overall Study|Withdrawal by Subject|2
2506074|NCT01890967|8669058|P2|Overall Study|Withdrawal by Subject|4
2506075|NCT01890967|8669059|P1|Overall Study|Withdrawal by Subject|3
2506076|NCT01890967|8669054|P6|Overall Study|Sponsor Decision|3
2506077|NCT01890967|8669055|P5|Overall Study|Sponsor Decision|2
2506078|NCT01890967|8669056|P4|Overall Study|Sponsor Decision|3
2506079|NCT01890967|8669057|P3|Overall Study|Sponsor Decision|1
2506080|NCT01890967|8669058|P2|Overall Study|Sponsor Decision|0
2506081|NCT01890967|8669059|P1|Overall Study|Sponsor Decision|2
2506082|NCT01890967|8669054|P6|Overall Study|Protocol Violation|1
2506083|NCT01890967|8669055|P5|Overall Study|Protocol Violation|4
2506084|NCT01890967|8669056|P4|Overall Study|Protocol Violation|2
2506085|NCT01890967|8669057|P3|Overall Study|Protocol Violation|3
2506086|NCT01890967|8669058|P2|Overall Study|Protocol Violation|3
2506087|NCT01890967|8669059|P1|Overall Study|Protocol Violation|0
2506088|NCT01890967|8669054|P6|Overall Study|Lost to Follow-up|1
2506089|NCT01890967|8669055|P5|Overall Study|Lost to Follow-up|0
2506090|NCT01890967|8669056|P4|Overall Study|Lost to Follow-up|1
2506091|NCT01890967|8669057|P3|Overall Study|Lost to Follow-up|1
2506092|NCT01890967|8669058|P2|Overall Study|Lost to Follow-up|1
2506093|NCT01890967|8669059|P1|Overall Study|Lost to Follow-up|1
2506094|NCT01890967|8669054|P6|Overall Study|Death|0
2506095|NCT01890967|8669055|P5|Overall Study|Death|0
2506096|NCT01890967|8669056|P4|Overall Study|Death|0
2506097|NCT01890967|8669057|P3|Overall Study|Death|0
2506098|NCT01890967|8669058|P2|Overall Study|Death|0
2506099|NCT01890967|8669059|P1|Overall Study|Death|1
2506100|NCT01890967|8669054|P6|Overall Study|Adverse Event|7
2506101|NCT01890967|8669055|P5|Overall Study|Adverse Event|1
2506102|NCT01890967|8669056|P4|Overall Study|Adverse Event|2
2506103|NCT01890967|8669057|P3|Overall Study|Adverse Event|3
2506104|NCT01890967|8669058|P2|Overall Study|Adverse Event|3
2506105|NCT01890967|8669059|P1|Overall Study|Adverse Event|3
2506106|NCT01890915|8669137|P2|Overall Study|Equipment Malfunction|1
2506107|NCT01890915|8669138|P1|Overall Study|Equipment Malfunction|0
2506108|NCT01890915|8669137|P2|Overall Study|Protocol Violation|0
2506109|NCT01890915|8669138|P1|Overall Study|Protocol Violation|2
2506110|NCT01890915|8669137|P2|Overall Study|Adverse Event|0
2506111|NCT01890915|8669138|P1|Overall Study|Adverse Event|1
2506112|NCT01890785|8669154|P6|Third Intervention|Withdrawal by Subject|0
2506113|NCT01890785|8669155|P5|Third Intervention|Withdrawal by Subject|0
2506114|NCT01890785|8669156|P4|Third Intervention|Withdrawal by Subject|0
2506115|NCT01890785|8669157|P3|Third Intervention|Withdrawal by Subject|0
2506116|NCT01890785|8669158|P2|Third Intervention|Withdrawal by Subject|1
2506117|NCT01890785|8669159|P1|Third Intervention|Withdrawal by Subject|0
2506118|NCT01890759|8669178|P2|Overall Study|Withdrawal by Subject|8
2506119|NCT01890759|8669179|P1|Overall Study|Withdrawal by Subject|2
2506120|NCT01890759|8669178|P2|Overall Study|Lost to Follow-up|2
2506121|NCT01890759|8669179|P1|Overall Study|Lost to Follow-up|0
2506122|NCT01890759|8669178|P2|Overall Study|Protocol Violation|2
2506123|NCT01890759|8669179|P1|Overall Study|Protocol Violation|0
2506124|NCT01890746|8669213|P2|Overall Study|Withdrawal by Subject|8
2506125|NCT01890746|8669214|P1|Overall Study|Withdrawal by Subject|5
2506126|NCT01890746|8669213|P2|Overall Study|Physician Decision|2
2506127|NCT01890746|8669214|P1|Overall Study|Physician Decision|3
2506128|NCT01890746|8669213|P2|Overall Study|Lost to Follow-up|1
2506129|NCT01890746|8669214|P1|Overall Study|Lost to Follow-up|4
2506130|NCT01890746|8669213|P2|Overall Study|Adverse Event|0
2506131|NCT01890746|8669214|P1|Overall Study|Adverse Event|1
2506132|NCT01890746|8669213|P2|Overall Study|Death|30
2506133|NCT01890746|8669214|P1|Overall Study|Death|39
2506134|NCT01890707|8669300|P2|Overall Study|Lost to Follow-up|1
2506135|NCT01890707|8669301|P1|Overall Study|Lost to Follow-up|1
2506136|NCT01890512|8669380|P1|Overall Study|Protocol Violation|1
2506137|NCT01890512|8669380|P1|Overall Study|Withdrawal by Subject|1
2506138|NCT01890512|8669380|P1|Overall Study|Physician Decision|1
2506139|NCT01890473|8669386|P2|Overall Study|Poor/non-compliance|0
2506140|NCT01890473|8669387|P1|Overall Study|Poor/non-compliance|1
2506141|NCT01890473|8669386|P2|Overall Study|Lost to Follow-up|0
2506142|NCT01890473|8669387|P1|Overall Study|Lost to Follow-up|1
2506143|NCT01890434|8669413|P1|Overall Study|Withdrawal by PI for ICA not performed|2
2506144|NCT01890434|8669413|P1|Overall Study|Unable to contact|1
2506145|NCT01890434|8669413|P1|Overall Study|Moved out of position|1
2506146|NCT01890434|8669413|P1|Overall Study|Uncontactable by phone|1
2506147|NCT01890434|8669413|P1|Overall Study|Participant didn't complete MRI|1
2506148|NCT01890434|8669413|P1|Overall Study|GSPECT at rest was not done|1
2506149|NCT01890434|8669413|P1|Overall Study|Decline to return for GSPECT|1
2506150|NCT01890434|8669413|P1|Overall Study|Could not get whole set of images|1
2506151|NCT01890434|8669413|P1|Overall Study|CRC didn't contact participant for FU|1
2506152|NCT01890434|8669413|P1|Overall Study|Assessment discrepancy|1
2506153|NCT01890434|8669413|P1|Overall Study|PCI at external hospital|1
2506154|NCT01890434|8669413|P1|Overall Study|Adverse Event|8
2506155|NCT01890421|8669443|P1|Overall Study|Other reason|10
2506156|NCT01890421|8669443|P1|Overall Study|Adverse Event|1
2506157|NCT01890148|8669497|P1|Overall Study|Adverse Event|1
2506158|NCT01890122|8669517|P4|Overall Study|Randomized but not Treated|0
2506159|NCT01890122|8669518|P3|Overall Study|Randomized but not Treated|0
2506160|NCT01890122|8669519|P2|Overall Study|Randomized but not Treated|1
2506161|NCT01890122|8669520|P1|Overall Study|Randomized but not Treated|1
2506162|NCT01890122|8669517|P4|Overall Study|Reason not Specified|2
2506163|NCT01890122|8669518|P3|Overall Study|Reason not Specified|1
2506164|NCT01890122|8669519|P2|Overall Study|Reason not Specified|1
2506165|NCT01890122|8669520|P1|Overall Study|Reason not Specified|0
2506166|NCT01890122|8669517|P4|Overall Study|Lack of Efficacy|41
2506167|NCT01890122|8669518|P3|Overall Study|Lack of Efficacy|7
2506168|NCT01890122|8669519|P2|Overall Study|Lack of Efficacy|24
2506169|NCT01890122|8669520|P1|Overall Study|Lack of Efficacy|14
2506170|NCT01890122|8669517|P4|Overall Study|Voluntary Withdrawal|11
2506171|NCT01890122|8669518|P3|Overall Study|Voluntary Withdrawal|2
2506172|NCT01890122|8669519|P2|Overall Study|Voluntary Withdrawal|8
2506173|NCT01890122|8669520|P1|Overall Study|Voluntary Withdrawal|8
2506174|NCT01890122|8669517|P4|Overall Study|Lost to Follow-up|2
2506175|NCT01890122|8669518|P3|Overall Study|Lost to Follow-up|2
2506176|NCT01890122|8669519|P2|Overall Study|Lost to Follow-up|1
2506177|NCT01890122|8669520|P1|Overall Study|Lost to Follow-up|0
2506178|NCT01890122|8669517|P4|Overall Study|Major Protocol Deviation|1
2506179|NCT01890122|8669518|P3|Overall Study|Major Protocol Deviation|0
2506180|NCT01890122|8669519|P2|Overall Study|Major Protocol Deviation|1
2506181|NCT01890122|8669520|P1|Overall Study|Major Protocol Deviation|3
2506182|NCT01890122|8669517|P4|Overall Study|Adverse Event|2
2506183|NCT01890122|8669518|P3|Overall Study|Adverse Event|1
2506184|NCT01890122|8669519|P2|Overall Study|Adverse Event|1
2506185|NCT01890122|8669520|P1|Overall Study|Adverse Event|1
2506186|NCT01890109|8669584|P2|Overall Study|Lost to Follow-up|2
2506187|NCT01890109|8669585|P1|Overall Study|Lost to Follow-up|1
2506188|NCT01890109|8669584|P2|Overall Study|Withdrawal by Subject|3
2506189|NCT01890109|8669585|P1|Overall Study|Withdrawal by Subject|0
2506190|NCT01889602|8669690|P3|Third Intervention|Withdrawal by Subject|0
2506191|NCT01889602|8669691|P2|Third Intervention|Withdrawal by Subject|2
2506192|NCT01889602|8669692|P1|Third Intervention|Withdrawal by Subject|2
2506193|NCT01889602|8669690|P3|Third Intervention|Protocol Violation|0
2506194|NCT01889602|8669691|P2|Third Intervention|Protocol Violation|0
2506195|NCT01889602|8669692|P1|Third Intervention|Protocol Violation|1
2506196|NCT01889602|8669690|P3|Second Intervention|Withdrawal by Subject|1
2506197|NCT01889602|8669691|P2|Second Intervention|Withdrawal by Subject|0
2506198|NCT01889602|8669692|P1|Second Intervention|Withdrawal by Subject|0
2506199|NCT01889602|8669690|P3|Second Intervention|Study ending|0
2506200|NCT01889602|8669691|P2|Second Intervention|Study ending|0
2506201|NCT01889602|8669692|P1|Second Intervention|Study ending|1
2506202|NCT01889602|8669690|P3|Second Intervention|Adverse Event|1
2506203|NCT01889602|8669691|P2|Second Intervention|Adverse Event|0
2506204|NCT01889602|8669692|P1|Second Intervention|Adverse Event|0
2506205|NCT01889602|8669690|P3|First Intervention|Study ending|0
2506206|NCT01889602|8669691|P2|First Intervention|Study ending|1
2506207|NCT01889602|8669692|P1|First Intervention|Study ending|0
2506208|NCT01889602|8669690|P3|First Intervention|Protocol Violation|1
2506209|NCT01889602|8669691|P2|First Intervention|Protocol Violation|1
2506210|NCT01889602|8669692|P1|First Intervention|Protocol Violation|0
2506211|NCT01889602|8669690|P3|First Intervention|Adverse Event|1
2506212|NCT01889602|8669691|P2|First Intervention|Adverse Event|1
2506213|NCT01889602|8669692|P1|First Intervention|Adverse Event|1
2506214|NCT01889251|8669740|P2|Overall Study|Adverse Event|0
2506215|NCT01889251|8669741|P1|Overall Study|Adverse Event|1
2506216|NCT01889238|8669747|P1|Overall Study|Treatment ongoing|9
2506217|NCT01888965|8669764|P1|Overall Study|Lack of Efficacy|4
2506218|NCT01888965|8669764|P1|Overall Study|Adverse Event|5
2506219|NCT01888900|8669776|P2|Overall Study|failed treatment|2
2506220|NCT01888900|8669777|P1|Overall Study|failed treatment|0
2506221|NCT01888640|8669800|P3|Overall Study|Researcher Termination of Participant|1
2506222|NCT01888640|8669801|P2|Overall Study|Researcher Termination of Participant|1
2506223|NCT01888640|8669802|P1|Overall Study|Researcher Termination of Participant|0
2506224|NCT01888640|8669800|P3|Overall Study|Excluded for prior TENS|0
2506225|NCT01888640|8669801|P2|Overall Study|Excluded for prior TENS|1
2506226|NCT01888640|8669802|P1|Overall Study|Excluded for prior TENS|0
2506227|NCT01888640|8669800|P3|Overall Study|Given wrong unit (placebo)|0
2506228|NCT01888640|8669801|P2|Overall Study|Given wrong unit (placebo)|0
2506229|NCT01888640|8669802|P1|Overall Study|Given wrong unit (placebo)|1
2506230|NCT01888640|8669800|P3|Overall Study|Minimum dose not met|0
2506231|NCT01888640|8669801|P2|Overall Study|Minimum dose not met|16
2506232|NCT01888640|8669802|P1|Overall Study|Minimum dose not met|10
2506233|NCT01888640|8669800|P3|Overall Study|Withdrawal by Subject|4
2506234|NCT01888640|8669801|P2|Overall Study|Withdrawal by Subject|11
2506235|NCT01888640|8669802|P1|Overall Study|Withdrawal by Subject|15
2506236|NCT01888640|8669800|P3|Overall Study|Lost to Follow-up|0
2506237|NCT01888640|8669801|P2|Overall Study|Lost to Follow-up|2
2506238|NCT01888640|8669802|P1|Overall Study|Lost to Follow-up|1
2506239|NCT01888432|8669858|P2|36-month Analysis (Extension)|Death|0
2506240|NCT01888432|8669859|P1|36-month Analysis (Extension)|Death|1
2506241|NCT01888432|8669858|P2|24-month Analysis (FAS)|Death|4
2506242|NCT01888432|8669859|P1|24-month Analysis (FAS)|Death|8
2506243|NCT01888432|8669858|P2|24-month Analysis (FAS)|Withdrawal by Subject|6
2506244|NCT01888432|8669859|P1|24-month Analysis (FAS)|Withdrawal by Subject|7
2506245|NCT01888432|8669858|P2|24-month Analysis (FAS)|Physician Decision|4
2506246|NCT01888432|8669859|P1|24-month Analysis (FAS)|Physician Decision|2
2506247|NCT01888432|8669858|P2|24-month Analysis (FAS)|Lost to Follow-up|2
2506248|NCT01888432|8669859|P1|24-month Analysis (FAS)|Lost to Follow-up|0
2506249|NCT01888432|8669858|P2|24-month Analysis (FAS)|Graft loss|1
2506250|NCT01888432|8669859|P1|24-month Analysis (FAS)|Graft loss|0
2506251|NCT01888432|8669858|P2|12-month Analysis (FAS)|Death|3
2506252|NCT01888432|8669859|P1|12-month Analysis (FAS)|Death|4
2506253|NCT01888432|8669858|P2|12-month Analysis (FAS)|Withdrawal by Subject|3
2506254|NCT01888432|8669859|P1|12-month Analysis (FAS)|Withdrawal by Subject|6
2506255|NCT01888432|8669858|P2|12-month Analysis (FAS)|Physician Decision|1
2506256|NCT01888432|8669859|P1|12-month Analysis (FAS)|Physician Decision|1
2506257|NCT01888432|8669858|P2|12-month Analysis (FAS)|Lost to Follow-up|2
2506258|NCT01888432|8669859|P1|12-month Analysis (FAS)|Lost to Follow-up|0
2506259|NCT01888367|8669900|P3|Overall Study|30-Day Visit Too Early (< 28 Days)|0
2506260|NCT01888367|8669901|P2|Overall Study|30-Day Visit Too Early (< 28 Days)|0
2506261|NCT01888367|8669902|P1|Overall Study|30-Day Visit Too Early (< 28 Days)|1
2506262|NCT01888367|8669900|P3|Overall Study|Protocol Violation|1
2506263|NCT01888367|8669901|P2|Overall Study|Protocol Violation|0
2506264|NCT01888367|8669902|P1|Overall Study|Protocol Violation|0
2506265|NCT01888367|8669900|P3|Overall Study|Lost to Follow-up|0
2506266|NCT01888367|8669901|P2|Overall Study|Lost to Follow-up|1
2506267|NCT01888367|8669902|P1|Overall Study|Lost to Follow-up|1
2506268|NCT01888367|8669900|P3|Overall Study|Withdrawal by Subject|1
2506269|NCT01888367|8669901|P2|Overall Study|Withdrawal by Subject|0
2506270|NCT01888367|8669902|P1|Overall Study|Withdrawal by Subject|1
2506271|NCT01888367|8669900|P3|Overall Study|Death|1
2506272|NCT01888367|8669901|P2|Overall Study|Death|0
2506273|NCT01888367|8669902|P1|Overall Study|Death|2
2506274|NCT01888367|8669900|P3|Overall Study|Physician Decision|2
2506275|NCT01888367|8669901|P2|Overall Study|Physician Decision|4
2506276|NCT01888367|8669902|P1|Overall Study|Physician Decision|3
2506277|NCT01888003|8669922|P3|Overall Study|Study Terminated|40
2506278|NCT01888003|8669923|P2|Overall Study|Study Terminated|6
2506279|NCT01888003|8669924|P1|Overall Study|Study Terminated|5
2506280|NCT01887912|8669964|P2|Overall Study|Other|58
2506281|NCT01887912|8669965|P1|Overall Study|Other|122
2506282|NCT01887912|8669964|P2|Overall Study|Withdrawal by Subject|349
2506283|NCT01887912|8669965|P1|Overall Study|Withdrawal by Subject|606
2506284|NCT01887912|8669964|P2|Overall Study|Lost to Follow-up|74
2506285|NCT01887912|8669965|P1|Overall Study|Lost to Follow-up|163
2506286|NCT01887912|8669964|P2|Overall Study|Protocol Violation|37
2506287|NCT01887912|8669965|P1|Overall Study|Protocol Violation|67
2506288|NCT01887912|8669964|P2|Overall Study|Other Adverse Event|15
2506289|NCT01887912|8669965|P1|Overall Study|Other Adverse Event|34
2506290|NCT01887912|8669964|P2|Overall Study|Serious adverse event|198
2506291|NCT01887912|8669965|P1|Overall Study|Serious adverse event|400
2506292|NCT01887717|8669993|P2|Overall Study|Administrative reasons|2
2506293|NCT01887717|8669994|P1|Overall Study|Administrative reasons|5
2506294|NCT01887717|8669993|P2|Overall Study|Physician Decision|2
2506295|NCT01887717|8669994|P1|Overall Study|Physician Decision|0
2506296|NCT01887717|8669993|P2|Overall Study|Withdrawal by Subject|7
2506297|NCT01887717|8669994|P1|Overall Study|Withdrawal by Subject|1
2506298|NCT01887678|8670016|P2|Overall Study|Specified|2
2506299|NCT01887678|8670017|P1|Overall Study|Specified|1
2506300|NCT01887678|8670016|P2|Overall Study|Non-compliance|3
2506301|NCT01887678|8670017|P1|Overall Study|Non-compliance|0
2506302|NCT01887678|8670016|P2|Overall Study|Lack of Efficacy|2
2506303|NCT01887678|8670017|P1|Overall Study|Lack of Efficacy|1
2506304|NCT01887678|8670016|P2|Overall Study|Deterioration of clinical condition|4
2506305|NCT01887678|8670017|P1|Overall Study|Deterioration of clinical condition|0
2506306|NCT01887678|8670016|P2|Overall Study|Lost to Follow-up|2
2506307|NCT01887678|8670017|P1|Overall Study|Lost to Follow-up|4
2506308|NCT01887678|8670016|P2|Overall Study|Withdrawal of consent|4
2506309|NCT01887678|8670017|P1|Overall Study|Withdrawal of consent|3
2506310|NCT01887678|8670016|P2|Overall Study|Exceeded rescue medication dosage|5
2506311|NCT01887678|8670017|P1|Overall Study|Exceeded rescue medication dosage|4
2506312|NCT01887678|8670016|P2|Overall Study|Adverse Event|6
2506313|NCT01887678|8670017|P1|Overall Study|Adverse Event|4
2506314|NCT01887418|8670090|P3|Overall Study|Travelling difficulties|1
2506315|NCT01887418|8670091|P2|Overall Study|Travelling difficulties|0
2506316|NCT01887418|8670092|P1|Overall Study|Travelling difficulties|0
2506317|NCT01887353|8670111|P2|Overall Study|Study stopped early|3
2506318|NCT01887353|8670112|P1|Overall Study|Study stopped early|4
2506319|NCT01887288|8670140|P1|Overall Study|The study was terminated and the PI has|16
2506320|NCT01887210|8670147|P2|Overall Study|Lost to Follow-up|1
2506321|NCT01887210|8670148|P1|Overall Study|Lost to Follow-up|0
2506322|NCT01887210|8670147|P2|Overall Study|Withdrawal by Subject|3
2506323|NCT01887210|8670148|P1|Overall Study|Withdrawal by Subject|1
2506324|NCT01886872|8670195|P3|Overall Study|Ineligible|12
2506325|NCT01886872|8670196|P2|Overall Study|Ineligible|4
2506326|NCT01886872|8670197|P1|Overall Study|Ineligible|7
2506327|NCT01886833|8670230|P1|Overall Study|IgA not available from both periods|204
2506328|NCT01886781|8670262|P2|Overall Study|Worsening of symptoms|1
2506329|NCT01886781|8670263|P1|Overall Study|Worsening of symptoms|1
2506330|NCT01886781|8670262|P2|Overall Study|Withdrawal by Subject|1
2506331|NCT01886781|8670263|P1|Overall Study|Withdrawal by Subject|2
2506332|NCT01886781|8670262|P2|Overall Study|Lost to Follow-up|0
2506333|NCT01886781|8670263|P1|Overall Study|Lost to Follow-up|5
2506334|NCT01886781|8670262|P2|Overall Study|Adverse Event|0
2506335|NCT01886781|8670263|P1|Overall Study|Adverse Event|1
2506336|NCT01886781|8670262|P2|Overall Study|Protocol Violation|0
2506337|NCT01886781|8670263|P1|Overall Study|Protocol Violation|5
2506338|NCT01886716|8670273|P4|Week 3|Lost to Follow-up|1
2506339|NCT01886716|8670274|P3|Week 3|Lost to Follow-up|0
2506340|NCT01886716|8670275|P2|Week 3|Lost to Follow-up|1
2506341|NCT01886716|8670276|P1|Week 3|Lost to Follow-up|1
2506342|NCT01886716|8670273|P4|Week 2|Lost to Follow-up|3
2506343|NCT01886716|8670274|P3|Week 2|Lost to Follow-up|1
2506344|NCT01886716|8670275|P2|Week 2|Lost to Follow-up|2
2506345|NCT01886716|8670276|P1|Week 2|Lost to Follow-up|3
2506346|NCT01886716|8670273|P4|Week 1|Lost to Follow-up|2
2506347|NCT01886716|8670274|P3|Week 1|Lost to Follow-up|2
2506348|NCT01886716|8670275|P2|Week 1|Lost to Follow-up|0
2506349|NCT01886716|8670276|P1|Week 1|Lost to Follow-up|0
2506350|NCT01886690|8670292|P2|Overall Study|Personal Reasons|1
2506351|NCT01886690|8670293|P1|Overall Study|Personal Reasons|0
2506352|NCT01886690|8670292|P2|Overall Study|Protocol Violation|1
2506353|NCT01886690|8670293|P1|Overall Study|Protocol Violation|0
2506354|NCT01886313|8670309|P2|Overall Study|Adverse Event|1
2506355|NCT01886313|8670310|P1|Overall Study|Adverse Event|1
2506356|NCT01886300|8670316|P1|Overall Study|Trial terminated by sponsor|16
2506357|NCT01886287|8670327|P1|Overall Study|Clinical progression due to disease|1
2506358|NCT01886287|8670327|P1|Overall Study|Radiographic disease progression|1
2506359|NCT01886105|8670343|P1|Overall Study|Lack of Efficacy|3
2506360|NCT01885936|8670350|P2|Overall Study|Withdrawal by Subject|0
2506361|NCT01885936|8670351|P1|Overall Study|Withdrawal by Subject|1
2506362|NCT01885559|8670385|P2|Overall Study|Protocol Violation|1
2506363|NCT01885559|8670386|P1|Overall Study|Protocol Violation|0
2506364|NCT01885559|8670385|P2|Overall Study|Less than full participation|19
2506365|NCT01885559|8670386|P1|Overall Study|Less than full participation|9
2506366|NCT01885559|8670385|P2|Overall Study|Lost to Follow-up|16
2506367|NCT01885559|8670386|P1|Overall Study|Lost to Follow-up|15
2506368|NCT01885208|8670408|P2|Overall Study|Unclassified|38
2506369|NCT01885208|8670409|P1|Overall Study|Unclassified|32
2506370|NCT01885182|8670427|P2|Overall Study|Lack of Efficacy|1
2506371|NCT01885182|8670428|P1|Overall Study|Lack of Efficacy|8
2506372|NCT01885182|8670427|P2|Overall Study|Lost to Follow-up|2
2506373|NCT01885182|8670428|P1|Overall Study|Lost to Follow-up|2
2506374|NCT01885182|8670427|P2|Overall Study|Withdrawal by Subject|6
2506375|NCT01885182|8670428|P1|Overall Study|Withdrawal by Subject|13
2506376|NCT01885182|8670427|P2|Overall Study|Adverse Event|13
2506377|NCT01885182|8670428|P1|Overall Study|Adverse Event|11
2506378|NCT01885104|8670475|P2|Overall Study|Physician Decision|0
2506379|NCT01885104|8670476|P1|Overall Study|Physician Decision|1
2506380|NCT01885104|8670475|P2|Overall Study|Lost to Follow-up|1
2506381|NCT01885104|8670476|P1|Overall Study|Lost to Follow-up|0
2506382|NCT01885104|8670475|P2|Overall Study|Withdrawal of Consent|0
2506383|NCT01885104|8670476|P1|Overall Study|Withdrawal of Consent|1
2506384|NCT01885000|8670486|P2|Overall Study|Protocol Violation|1
2506385|NCT01885000|8670487|P1|Overall Study|Protocol Violation|0
2506386|NCT01885000|8670486|P2|Overall Study|Withdrawal by Subject|1
2506387|NCT01885000|8670487|P1|Overall Study|Withdrawal by Subject|1
2506388|NCT01885000|8670486|P2|Overall Study|Adverse Event|0
2506389|NCT01885000|8670487|P1|Overall Study|Adverse Event|1
2506390|NCT01884688|8670508|P1|Overall Study|Screen Failure|2
2506391|NCT01884675|8670514|P2|Overall Study|Study closed/terminated|2
2506392|NCT01884675|8670515|P1|Overall Study|Study closed/terminated|3
2506393|NCT01884597|8670558|P3|Overall Study|Death|0
2506394|NCT01884597|8670559|P2|Overall Study|Death|1
2506395|NCT01884597|8670560|P1|Overall Study|Death|0
2506396|NCT01884597|8670558|P3|Overall Study|Lack of Efficacy|0
2506397|NCT01884597|8670559|P2|Overall Study|Lack of Efficacy|0
2506398|NCT01884597|8670560|P1|Overall Study|Lack of Efficacy|1
2506399|NCT01884597|8670558|P3|Overall Study|Adverse Event|1
2506400|NCT01884597|8670559|P2|Overall Study|Adverse Event|0
2506401|NCT01884597|8670560|P1|Overall Study|Adverse Event|0
2506402|NCT01884571|8670589|P1|Overall Study|Disease progression|3
2506403|NCT01884571|8670589|P1|Overall Study|Withdrawal by Subject|2
2506404|NCT01884571|8670589|P1|Overall Study|Death|2
2506405|NCT01884571|8670589|P1|Overall Study|Adverse Event|1
2506406|NCT01884545|8670604|P4|Overall Study|Non-adherence|0
2506407|NCT01884545|8670605|P3|Overall Study|Non-adherence|0
2506408|NCT01884545|8670606|P2|Overall Study|Non-adherence|2
2506409|NCT01884545|8670607|P1|Overall Study|Non-adherence|0
2506410|NCT01884545|8670604|P4|Overall Study|Patient withdrawn|5
2506411|NCT01884545|8670605|P3|Overall Study|Patient withdrawn|5
2506412|NCT01884545|8670606|P2|Overall Study|Patient withdrawn|12
2506413|NCT01884545|8670607|P1|Overall Study|Patient withdrawn|7
2506414|NCT01884545|8670604|P4|Overall Study|Lost to Follow-up|4
2506415|NCT01884545|8670605|P3|Overall Study|Lost to Follow-up|9
2506416|NCT01884545|8670606|P2|Overall Study|Lost to Follow-up|4
2506417|NCT01884545|8670607|P1|Overall Study|Lost to Follow-up|6
2506418|NCT01884350|8670760|P3|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0
2506419|NCT01884350|8670761|P2|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0
2506420|NCT01884350|8670762|P1|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2
2506421|NCT01884350|8670760|P3|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0
2506422|NCT01884350|8670761|P2|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0
2506423|NCT01884350|8670762|P1|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1
2506424|NCT01884350|8670760|P3|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0
2506425|NCT01884350|8670761|P2|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1
2506426|NCT01884350|8670762|P1|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4
2506427|NCT01884350|8670760|P3|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0
2506428|NCT01884350|8670761|P2|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0
2506429|NCT01884350|8670762|P1|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3
2506430|NCT01884350|8670760|P3|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0
2506431|NCT01884350|8670761|P2|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0
2506432|NCT01884350|8670762|P1|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4
2506433|NCT01884350|8670760|P3|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2
2506434|NCT01884350|8670761|P2|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0
2506435|NCT01884350|8670762|P1|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3
2506436|NCT01884350|8670760|P3|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0
2506437|NCT01884350|8670761|P2|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3
2506438|NCT01884350|8670762|P1|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17
2506439|NCT01884350|8670760|P3|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3
2506440|NCT01884350|8670761|P2|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6
2506441|NCT01884350|8670762|P1|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17
2506442|NCT01884350|8670760|P3|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1
2506443|NCT01884350|8670761|P2|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0
2506444|NCT01884350|8670762|P1|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1
2506445|NCT01884350|8670760|P3|Primary Efficacy Analysis Set (48 Weeks)|Death|3
2506446|NCT01884350|8670761|P2|Primary Efficacy Analysis Set (48 Weeks)|Death|3
2506447|NCT01884350|8670762|P1|Primary Efficacy Analysis Set (48 Weeks)|Death|7
2506448|NCT01884350|8670760|P3|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2
2506449|NCT01884350|8670761|P2|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0
2506450|NCT01884350|8670762|P1|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21
2506451|NCT01884350|8670760|P3|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0
2506452|NCT01884350|8670761|P2|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3
2506453|NCT01884350|8670762|P1|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3
2506454|NCT01884350|8670760|P3|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0
2506455|NCT01884350|8670761|P2|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1
2506456|NCT01884350|8670762|P1|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1
2506457|NCT01884350|8670760|P3|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0
2506458|NCT01884350|8670761|P2|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1
2506459|NCT01884350|8670762|P1|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1
2506460|NCT01884350|8670760|P3|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0
2506461|NCT01884350|8670761|P2|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0
2506462|NCT01884350|8670762|P1|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2
2506463|NCT01884350|8670760|P3|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0
2506464|NCT01884350|8670761|P2|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5
2506465|NCT01884350|8670762|P1|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2
2506466|NCT01884350|8670760|P3|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0
2506467|NCT01884350|8670761|P2|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2
2506468|NCT01884350|8670762|P1|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0
2506469|NCT01884350|8670760|P3|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0
2506470|NCT01884350|8670761|P2|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11
2506471|NCT01884350|8670762|P1|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15
2506472|NCT01884350|8670760|P3|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0
2506473|NCT01884350|8670761|P2|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6
2506474|NCT01884350|8670762|P1|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7
2506475|NCT01884350|8670760|P3|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0
2506476|NCT01884350|8670761|P2|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1
2506477|NCT01884350|8670762|P1|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0
2506478|NCT01884350|8670760|P3|Primary Efficacy Analysis Set (24 Weeks)|Death|0
2506479|NCT01884350|8670761|P2|Primary Efficacy Analysis Set (24 Weeks)|Death|4
2506480|NCT01884350|8670762|P1|Primary Efficacy Analysis Set (24 Weeks)|Death|6
2506481|NCT01884350|8670760|P3|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0
2506482|NCT01884350|8670761|P2|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20
2506483|NCT01884350|8670762|P1|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17
2506484|NCT01884337|8670785|P2|Follow-up Period|Lost to Follow-up|1
2506485|NCT01884337|8670786|P1|Follow-up Period|Lost to Follow-up|1
2506486|NCT01884337|8670785|P2|Treatment|Subj. request to discont. treatment|0
2506487|NCT01884337|8670786|P1|Treatment|Subj. request to discont. treatment|2
2506488|NCT01884337|8670785|P2|Treatment|Adverse Event|2
2506489|NCT01884337|8670786|P1|Treatment|Adverse Event|2
2506490|NCT01884311|8670794|P1|Overall Study|Precautionary measure|1
2506491|NCT01884311|8670794|P1|Overall Study|withdrew consent due to AEs|1
2506492|NCT01884311|8670794|P1|Overall Study|Withdrawal by Subject|3
2506493|NCT01884077|8670804|P2|Overall Study|study closed|4
2506494|NCT01884077|8670805|P1|Overall Study|study closed|6
2506495|NCT01884077|8670804|P2|Overall Study|Lost to Follow-up|4
2506496|NCT01884077|8670805|P1|Overall Study|Lost to Follow-up|0
2506497|NCT01884077|8670804|P2|Overall Study|canceled surgery|0
2506498|NCT01884077|8670805|P1|Overall Study|canceled surgery|2
2506499|NCT01884077|8670804|P2|Overall Study|screen fail|2
2506500|NCT01884077|8670805|P1|Overall Study|screen fail|0
2506501|NCT01884025|8670826|P2|Overall Study|Lost to Follow-up|4
2506502|NCT01884025|8670827|P1|Overall Study|Lost to Follow-up|3
2506503|NCT01883895|8670887|P1|Overall Study|Lost to Follow-up|2
2506504|NCT01883635|8670901|P2|Overall Study|Withdrawal by Subject|0
2506505|NCT01883635|8670902|P1|Overall Study|Withdrawal by Subject|4
2506506|NCT01883492|8670916|P2|Overall Study|bone anatomy did not meet study criteria|1
2506507|NCT01883492|8670917|P1|Overall Study|bone anatomy did not meet study criteria|1
2506508|NCT01883492|8670916|P2|Overall Study|inappropriate implant used|1
2506509|NCT01883492|8670917|P1|Overall Study|inappropriate implant used|1
2506510|NCT01883492|8670916|P2|Overall Study|Withdrawal by Subject|0
2506511|NCT01883492|8670917|P1|Overall Study|Withdrawal by Subject|1
2506512|NCT01883492|8670916|P2|Overall Study|Poor X-ray quality|4
2506513|NCT01883492|8670917|P1|Overall Study|Poor X-ray quality|7
2506514|NCT01883492|8670916|P2|Overall Study|Surgery on contra-lateral hip|1
2506515|NCT01883492|8670917|P1|Overall Study|Surgery on contra-lateral hip|0
2506516|NCT01883492|8670916|P2|Overall Study|Lost to Follow-up|4
2506517|NCT01883492|8670917|P1|Overall Study|Lost to Follow-up|3
2506518|NCT01883453|8670949|P2|Overall Study|No episode of common cold|23
2506519|NCT01883453|8670950|P1|Overall Study|No episode of common cold|25
2506520|NCT01882985|8670985|P1|Overall Study|Withdrawal by Subject|1
2506521|NCT01882985|8670985|P1|Overall Study|Lost to Follow-up|1
2506522|NCT01882907|8670994|P2|Overall Study|Withdrawal by Subject|6
2506523|NCT01882907|8670995|P1|Overall Study|Withdrawal by Subject|0
2506524|NCT01882907|8670994|P2|Overall Study|Protocol Violation|14
2506525|NCT01882907|8670995|P1|Overall Study|Protocol Violation|10
2506526|NCT01882907|8670994|P2|Overall Study|Lost to Follow-up|4
2506527|NCT01882907|8670995|P1|Overall Study|Lost to Follow-up|1
2506528|NCT01882907|8670994|P2|Overall Study|Lack of Efficacy|3
2506529|NCT01882907|8670995|P1|Overall Study|Lack of Efficacy|0
2506530|NCT01882907|8670994|P2|Overall Study|Adverse Event|1
2506531|NCT01882907|8670995|P1|Overall Study|Adverse Event|3
2506532|NCT01882829|8671041|P1|Overall Study|Withdrawal by Subject|1
2506533|NCT01882829|8671041|P1|Overall Study|Protocol Violation|1
2506534|NCT01882829|8671041|P1|Overall Study|Adverse Event|4
2506535|NCT01882803|8671055|P1|Overall Study|Withdrawal by Subject|4
2506536|NCT01882803|8671055|P1|Overall Study|Protocol Violation|1
2506537|NCT01882803|8671055|P1|Overall Study|Physician Decision|7
2506538|NCT01882803|8671055|P1|Overall Study|Death|7
2506539|NCT01882803|8671055|P1|Overall Study|Adverse Event|22
2506540|NCT01882803|8671055|P1|Overall Study|Disease Progression|53
2506541|NCT01882647|8671082|P2|Overall Study|Withdrawal by Subject|4
2506542|NCT01882647|8671083|P1|Overall Study|Withdrawal by Subject|0
2506543|NCT01882647|8671082|P2|Overall Study|Lost to Follow-up|2
2506544|NCT01882647|8671083|P1|Overall Study|Lost to Follow-up|2
2506545|NCT01882465|8671123|P7|Period 2|Protocol Violation|0
2506546|NCT01882465|8671124|P6|Period 2|Protocol Violation|0
2506547|NCT01882465|8671125|P5|Period 2|Protocol Violation|1
2506548|NCT01882465|8671126|P4|Period 2|Protocol Violation|0
2506549|NCT01882465|8671127|P3|Period 2|Protocol Violation|0
2506550|NCT01882465|8671128|P2|Period 2|Protocol Violation|0
2506551|NCT01882465|8671129|P1|Period 2|Protocol Violation|0
2506552|NCT01882465|8671123|P7|Period 1|Withdrawal by Subject|1
2506553|NCT01882465|8671124|P6|Period 1|Withdrawal by Subject|0
2506554|NCT01882465|8671125|P5|Period 1|Withdrawal by Subject|0
2506555|NCT01882465|8671126|P4|Period 1|Withdrawal by Subject|0
2506556|NCT01882465|8671127|P3|Period 1|Withdrawal by Subject|0
2506557|NCT01882465|8671128|P2|Period 1|Withdrawal by Subject|0
2506558|NCT01882465|8671129|P1|Period 1|Withdrawal by Subject|0
2506559|NCT01882465|8671123|P7|Period 1|Lens Discomfort|0
2506560|NCT01882465|8671124|P6|Period 1|Lens Discomfort|0
2506561|NCT01882465|8671125|P5|Period 1|Lens Discomfort|0
2506562|NCT01882465|8671126|P4|Period 1|Lens Discomfort|1
2506563|NCT01882465|8671127|P3|Period 1|Lens Discomfort|0
2506564|NCT01882465|8671128|P2|Period 1|Lens Discomfort|0
2506565|NCT01882465|8671129|P1|Period 1|Lens Discomfort|0
2506566|NCT01882439|8671141|P4|Overall Study|Adverse event unrelated to study drug|1
2506567|NCT01882439|8671142|P3|Overall Study|Adverse event unrelated to study drug|1
2506568|NCT01882439|8671143|P2|Overall Study|Adverse event unrelated to study drug|2
2506569|NCT01882439|8671144|P1|Overall Study|Adverse event unrelated to study drug|2
2506570|NCT01882439|8671141|P4|Overall Study|Insufficient clinical response|2
2506571|NCT01882439|8671142|P3|Overall Study|Insufficient clinical response|4
2506572|NCT01882439|8671143|P2|Overall Study|Insufficient clinical response|4
2506573|NCT01882439|8671144|P1|Overall Study|Insufficient clinical response|1
2506574|NCT01882439|8671141|P4|Overall Study|Medication error with no associated AE|0
2506575|NCT01882439|8671142|P3|Overall Study|Medication error with no associated AE|2
2506576|NCT01882439|8671143|P2|Overall Study|Medication error with no associated AE|0
2506577|NCT01882439|8671144|P1|Overall Study|Medication error with no associated AE|0
2506578|NCT01882439|8671141|P4|Overall Study|No longer willing to participate|3
2506579|NCT01882439|8671142|P3|Overall Study|No longer willing to participate|2
2506580|NCT01882439|8671143|P2|Overall Study|No longer willing to participate|4
2506581|NCT01882439|8671144|P1|Overall Study|No longer willing to participate|1
2506582|NCT01882439|8671141|P4|Overall Study|Protocol Violation|1
2506583|NCT01882439|8671142|P3|Overall Study|Protocol Violation|0
2506584|NCT01882439|8671143|P2|Overall Study|Protocol Violation|2
2506585|NCT01882439|8671144|P1|Overall Study|Protocol Violation|2
2506586|NCT01882439|8671141|P4|Overall Study|Pregnancy|0
2506587|NCT01882439|8671142|P3|Overall Study|Pregnancy|0
2506588|NCT01882439|8671143|P2|Overall Study|Pregnancy|1
2506589|NCT01882439|8671144|P1|Overall Study|Pregnancy|0
2506590|NCT01882439|8671141|P4|Overall Study|Adverse event related to study drug|2
2506591|NCT01882439|8671142|P3|Overall Study|Adverse event related to study drug|1
2506592|NCT01882439|8671143|P2|Overall Study|Adverse event related to study drug|8
2506593|NCT01882439|8671144|P1|Overall Study|Adverse event related to study drug|3
2506594|NCT01882257|8671341|P3|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4
2506595|NCT01882257|8671342|P2|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11
2506596|NCT01882257|8671343|P1|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0
2506597|NCT01882257|8671341|P3|Study Origination to Beginning Therapy|Withdrawal by Subject|1
2506598|NCT01882257|8671342|P2|Study Origination to Beginning Therapy|Withdrawal by Subject|2
2506599|NCT01882257|8671343|P1|Study Origination to Beginning Therapy|Withdrawal by Subject|0
2506600|NCT01882088|8671350|P1|Overall Study|inadequate pH-impedance tracings|2
2506601|NCT01882088|8671350|P1|Overall Study|Protocol Violation|1
2506602|NCT01882088|8671350|P1|Overall Study|no possibility to place the catheter|1
2506603|NCT01882088|8671350|P1|Overall Study|Intolerance of esophageal manometry|1
2506604|NCT01881776|8671432|P3|Overall Study|Protocol Violation|1
2506605|NCT01881776|8671433|P2|Overall Study|Protocol Violation|2
2506606|NCT01881776|8671434|P1|Overall Study|Protocol Violation|0
2506607|NCT01881776|8671432|P3|Overall Study|Lost to Follow-up|1
2506608|NCT01881776|8671433|P2|Overall Study|Lost to Follow-up|2
2506609|NCT01881776|8671434|P1|Overall Study|Lost to Follow-up|1
2506610|NCT01881750|8671462|P2|Overall Study|Lost to Follow-up|1
2506611|NCT01881750|8671463|P1|Overall Study|Lost to Follow-up|0
2506612|NCT01881750|8671462|P2|Overall Study|Changes in concomitant therapies|3
2506613|NCT01881750|8671463|P1|Overall Study|Changes in concomitant therapies|2
2506614|NCT01881737|8671481|P1|Overall Study|Worsening of baseline behavior|1
2506615|NCT01881737|8671481|P1|Overall Study|Withdrawal by Subject|1
2506616|NCT01881737|8671481|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
2506617|NCT01881620|8671490|P1|Overall Study|Protocol Violation|4
2506618|NCT01881230|8671502|P3|Overall Study|Untreated: Withdrawal Before Study Start|0
2506619|NCT01881230|8671503|P2|Overall Study|Untreated: Withdrawal Before Study Start|0
2506620|NCT01881230|8671504|P1|Overall Study|Untreated: Withdrawal Before Study Start|1
2506621|NCT01881230|8671502|P3|Overall Study|Untreated: Death|1
2506622|NCT01881230|8671503|P2|Overall Study|Untreated: Death|0
2506623|NCT01881230|8671504|P1|Overall Study|Untreated: Death|0
2506624|NCT01881230|8671502|P3|Overall Study|Untreated: Other|1
2506625|NCT01881230|8671503|P2|Overall Study|Untreated: Other|0
2506626|NCT01881230|8671504|P1|Overall Study|Untreated: Other|0
2506627|NCT01881230|8671502|P3|Overall Study|Miscellaneous|0
2506628|NCT01881230|8671503|P2|Overall Study|Miscellaneous|3
2506629|NCT01881230|8671504|P1|Overall Study|Miscellaneous|3
2506630|NCT01881230|8671502|P3|Overall Study|Protocol Violation|0
2506631|NCT01881230|8671503|P2|Overall Study|Protocol Violation|1
2506632|NCT01881230|8671504|P1|Overall Study|Protocol Violation|1
2506633|NCT01881230|8671502|P3|Overall Study|Given Commercially Available Drug|2
2506634|NCT01881230|8671503|P2|Overall Study|Given Commercially Available Drug|0
2506635|NCT01881230|8671504|P1|Overall Study|Given Commercially Available Drug|0
2506636|NCT01881230|8671502|P3|Overall Study|Non-Compliance with Study Drug|0
2506637|NCT01881230|8671503|P2|Overall Study|Non-Compliance with Study Drug|2
2506638|NCT01881230|8671504|P1|Overall Study|Non-Compliance with Study Drug|1
2506639|NCT01881230|8671502|P3|Overall Study|Physician Decision|6
2506640|NCT01881230|8671503|P2|Overall Study|Physician Decision|3
2506641|NCT01881230|8671504|P1|Overall Study|Physician Decision|4
2506642|NCT01881230|8671502|P3|Overall Study|Withdrawal by Subject|6
2506643|NCT01881230|8671503|P2|Overall Study|Withdrawal by Subject|4
2506644|NCT01881230|8671504|P1|Overall Study|Withdrawal by Subject|6
2506645|NCT01881230|8671502|P3|Overall Study|Symptomatic Deterioration|1
2506646|NCT01881230|8671503|P2|Overall Study|Symptomatic Deterioration|3
2506647|NCT01881230|8671504|P1|Overall Study|Symptomatic Deterioration|3
2506648|NCT01881230|8671502|P3|Overall Study|Progressive Disease|36
2506649|NCT01881230|8671503|P2|Overall Study|Progressive Disease|35
2506650|NCT01881230|8671504|P1|Overall Study|Progressive Disease|31
2506651|NCT01881230|8671502|P3|Overall Study|Adverse Event|12
2506652|NCT01881230|8671503|P2|Overall Study|Adverse Event|13
2506653|NCT01881230|8671504|P1|Overall Study|Adverse Event|9
2506654|NCT01881230|8671502|P3|Overall Study|Death|1
2506655|NCT01881230|8671503|P2|Overall Study|Death|0
2506656|NCT01881230|8671504|P1|Overall Study|Death|2
2506657|NCT01881126|8671532|P2|Overall Study|Adverse Event|1
2506658|NCT01881126|8671533|P1|Overall Study|Adverse Event|0
2506659|NCT01881126|8671532|P2|Overall Study|Non-compliance|1
2506660|NCT01881126|8671533|P1|Overall Study|Non-compliance|1
2506661|NCT01881009|8671614|P2|Summer Camp Session (6 Days)|Unable to wear device|1
2506662|NCT01881009|8671615|P1|Summer Camp Session (6 Days)|Unable to wear device|0
2506663|NCT01880736|8671637|P4|Overall Study|Withdrawal Criteria|5
2506664|NCT01880736|8671638|P3|Overall Study|Withdrawal Criteria|1
2506665|NCT01880736|8671639|P2|Overall Study|Withdrawal Criteria|2
2506666|NCT01880736|8671640|P1|Overall Study|Withdrawal Criteria|1
2506667|NCT01880736|8671637|P4|Overall Study|Adverse Event|1
2506668|NCT01880736|8671638|P3|Overall Study|Adverse Event|0
2506669|NCT01880736|8671639|P2|Overall Study|Adverse Event|0
2506670|NCT01880736|8671640|P1|Overall Study|Adverse Event|0
2506671|NCT01880593|8671724|P2|Overall Study|Withdrawal by Subject|1
2506672|NCT01880593|8671725|P1|Overall Study|Withdrawal by Subject|6
2506673|NCT01880593|8671724|P2|Overall Study|Lack of Efficacy|5
2506674|NCT01880593|8671725|P1|Overall Study|Lack of Efficacy|1
2506675|NCT01880593|8671724|P2|Overall Study|Adverse Event|0
2506676|NCT01880593|8671725|P1|Overall Study|Adverse Event|1
2506677|NCT01880528|8671745|P2|Overall Study|Other|1
2506678|NCT01880528|8671746|P1|Overall Study|Other|1
2506679|NCT01880515|8671762|P2|Overall Study|Disease Progression|7
2506680|NCT01880515|8671763|P1|Overall Study|Disease Progression|5
2506681|NCT01880515|8671762|P2|Overall Study|Lost to Follow-up|2
2506682|NCT01880515|8671763|P1|Overall Study|Lost to Follow-up|3
2506683|NCT01880437|8671774|P3|Overall Study|Study terminated by Sponsor|2
2506684|NCT01880437|8671775|P2|Overall Study|Study terminated by Sponsor|0
2506685|NCT01880437|8671776|P1|Overall Study|Study terminated by Sponsor|3
2506686|NCT01880437|8671774|P3|Overall Study|Death|17
2506687|NCT01880437|8671775|P2|Overall Study|Death|4
2506688|NCT01880437|8671776|P1|Overall Study|Death|12
2506689|NCT01880424|8671802|P2|Overall Study|Other|0
2506690|NCT01880424|8671803|P1|Overall Study|Other|1
2506691|NCT01880424|8671802|P2|Overall Study|Withdrawal by Subject|30
2506692|NCT01880424|8671803|P1|Overall Study|Withdrawal by Subject|10
2506693|NCT01880424|8671802|P2|Overall Study|Protocol Violation|13
2506694|NCT01880424|8671803|P1|Overall Study|Protocol Violation|11
2506695|NCT01880424|8671802|P2|Overall Study|Lost to Follow-up|2
2506696|NCT01880424|8671803|P1|Overall Study|Lost to Follow-up|3
2506697|NCT01880424|8671802|P2|Overall Study|Lack of Efficacy|4
2506698|NCT01880424|8671803|P1|Overall Study|Lack of Efficacy|1
2506699|NCT01880424|8671802|P2|Overall Study|Adverse Event|6
2506700|NCT01880424|8671803|P1|Overall Study|Adverse Event|7
2506701|NCT01880086|8671859|P2|Overall Study|Lost to Follow-up|1
2506702|NCT01880086|8671860|P1|Overall Study|Lost to Follow-up|1
2506703|NCT01879852|8671908|P2|Overall Study|Withdrawal by Subject|0
2506704|NCT01879852|8671909|P1|Overall Study|Withdrawal by Subject|2
2506705|NCT01879722|8671964|P10|Overall Study|Voluntary Withdrawal|0
2506706|NCT01879722|8671965|P9|Overall Study|Voluntary Withdrawal|1
2506707|NCT01879722|8671966|P8|Overall Study|Voluntary Withdrawal|0
2506708|NCT01879722|8671967|P7|Overall Study|Voluntary Withdrawal|0
2506709|NCT01879722|8671968|P6|Overall Study|Voluntary Withdrawal|0
2506710|NCT01879722|8671969|P5|Overall Study|Voluntary Withdrawal|0
2506711|NCT01879722|8671970|P4|Overall Study|Voluntary Withdrawal|0
2506712|NCT01879722|8671971|P3|Overall Study|Voluntary Withdrawal|0
2506713|NCT01879722|8671972|P2|Overall Study|Voluntary Withdrawal|0
2506714|NCT01879722|8671973|P1|Overall Study|Voluntary Withdrawal|0
2506715|NCT01879722|8671964|P10|Overall Study|Pretreatment Event/Adverse Event|0
2506716|NCT01879722|8671965|P9|Overall Study|Pretreatment Event/Adverse Event|1
2506717|NCT01879722|8671966|P8|Overall Study|Pretreatment Event/Adverse Event|1
2506718|NCT01879722|8671967|P7|Overall Study|Pretreatment Event/Adverse Event|0
2506719|NCT01879722|8671968|P6|Overall Study|Pretreatment Event/Adverse Event|0
2506720|NCT01879722|8671969|P5|Overall Study|Pretreatment Event/Adverse Event|1
2506721|NCT01879722|8671970|P4|Overall Study|Pretreatment Event/Adverse Event|1
2506722|NCT01879722|8671971|P3|Overall Study|Pretreatment Event/Adverse Event|0
2506723|NCT01879722|8671972|P2|Overall Study|Pretreatment Event/Adverse Event|1
2506724|NCT01879722|8671973|P1|Overall Study|Pretreatment Event/Adverse Event|0
2506725|NCT01879683|8672121|P1|Overall Study|Did not Complete 4-week Follow-up Visit|1
2506726|NCT01879618|8672128|P1|Overall Study|Adverse Event|5
2506727|NCT01879618|8672128|P1|Overall Study|Protocol Violation|6
2506728|NCT01879618|8672128|P1|Overall Study|Surgery;changed schedule; not available|8
2506729|NCT01879618|8672128|P1|Overall Study|Withdrawal by Subject|1
2506730|NCT01879618|8672128|P1|Overall Study|Does not meet entrance criteria|1
2506731|NCT01879579|8672135|P2|Overall Study|Discontinued insulin - possible allergy|1
2506732|NCT01879579|8672136|P1|Overall Study|Discontinued insulin - possible allergy|0
2506733|NCT01879579|8672135|P2|Overall Study|Phenotypic type 1 diabetes|1
2506734|NCT01879579|8672136|P1|Overall Study|Phenotypic type 1 diabetes|0
2506735|NCT01879579|8672135|P2|Overall Study|Did not initiate insulin treatment|0
2506736|NCT01879579|8672136|P1|Overall Study|Did not initiate insulin treatment|1
2506737|NCT01879579|8672135|P2|Overall Study|Did not enroll in texting platform|0
2506738|NCT01879579|8672136|P1|Overall Study|Did not enroll in texting platform|1
2506739|NCT01879579|8672135|P2|Overall Study|Phone incompatible with texting platform|0
2506740|NCT01879579|8672136|P1|Overall Study|Phone incompatible with texting platform|3
2506741|NCT01879553|8672166|P2|Overall Study|Withdrawal by Subject|0
2506742|NCT01879553|8672167|P1|Overall Study|Withdrawal by Subject|1
2506743|NCT01879410|8672201|P2|Overall Study|Randomised in Error|2
2506744|NCT01879410|8672202|P1|Overall Study|Randomised in Error|1
2506745|NCT01879410|8672201|P2|Overall Study|Withdrawal by Subject|8
2506746|NCT01879410|8672202|P1|Overall Study|Withdrawal by Subject|7
2506747|NCT01879410|8672201|P2|Overall Study|Lost to Follow-up|1
2506748|NCT01879410|8672202|P1|Overall Study|Lost to Follow-up|2
2506749|NCT01879410|8672201|P2|Overall Study|Protocol Violation|7
2506750|NCT01879410|8672202|P1|Overall Study|Protocol Violation|1
2506751|NCT01879410|8672201|P2|Overall Study|Lack of Efficacy|6
2506752|NCT01879410|8672202|P1|Overall Study|Lack of Efficacy|4
2506753|NCT01879410|8672201|P2|Overall Study|Adverse Event|14
2506754|NCT01879410|8672202|P1|Overall Study|Adverse Event|9
2506755|NCT01879319|8672269|P2|Overall Study|Lost to Follow-up|5
2506756|NCT01879319|8672270|P1|Overall Study|Lost to Follow-up|1
2506757|NCT01879319|8672269|P2|Overall Study|Withdrawal by Subject|0
2506758|NCT01879319|8672270|P1|Overall Study|Withdrawal by Subject|1
2506759|NCT01879072|8672287|P1|Overall Study|Not Transplanted|30
2506760|NCT01879072|8672287|P1|Overall Study|Withdrawal by Subject|121
2506761|NCT01878292|8672432|P3|Double-blind Down-Taper Period|Withdrawal by Subject|4
2506762|NCT01878292|8672433|P2|Double-blind Down-Taper Period|Withdrawal by Subject|8
2506763|NCT01878292|8672434|P1|Double-blind Down-Taper Period|Withdrawal by Subject|5
2506764|NCT01878292|8672432|P3|Double-blind Treatment Period|Adverse Event|8
2506765|NCT01878292|8672433|P2|Double-blind Treatment Period|Adverse Event|9
2506766|NCT01878292|8672434|P1|Double-blind Treatment Period|Adverse Event|4
2506767|NCT01878292|8672432|P3|Double-blind Treatment Period|Lack of Efficacy|0
2506768|NCT01878292|8672433|P2|Double-blind Treatment Period|Lack of Efficacy|3
2506769|NCT01878292|8672434|P1|Double-blind Treatment Period|Lack of Efficacy|5
2506770|NCT01878292|8672432|P3|Double-blind Treatment Period|Protocol Violation|2
2506771|NCT01878292|8672433|P2|Double-blind Treatment Period|Protocol Violation|4
2506772|NCT01878292|8672434|P1|Double-blind Treatment Period|Protocol Violation|3
2506773|NCT01878292|8672432|P3|Double-blind Treatment Period|Withdrawal by Subject|8
2506774|NCT01878292|8672433|P2|Double-blind Treatment Period|Withdrawal by Subject|7
2506775|NCT01878292|8672434|P1|Double-blind Treatment Period|Withdrawal by Subject|9
2506776|NCT01878292|8672432|P3|Double-blind Treatment Period|Lost to Follow-up|1
2506777|NCT01878292|8672433|P2|Double-blind Treatment Period|Lost to Follow-up|3
2506778|NCT01878292|8672434|P1|Double-blind Treatment Period|Lost to Follow-up|6
2506779|NCT01878292|8672432|P3|Double-blind Treatment Period|Other Reasons|0
2506780|NCT01878292|8672433|P2|Double-blind Treatment Period|Other Reasons|0
2506781|NCT01878292|8672434|P1|Double-blind Treatment Period|Other Reasons|2
2506782|NCT01878292|8672432|P3|Randomized|Adverse Event|0
2506783|NCT01878292|8672433|P2|Randomized|Adverse Event|0
2506784|NCT01878292|8672434|P1|Randomized|Adverse Event|1
2506785|NCT01878292|8672432|P3|Randomized|Lost to Follow-up|0
2506786|NCT01878292|8672433|P2|Randomized|Lost to Follow-up|0
2506787|NCT01878292|8672434|P1|Randomized|Lost to Follow-up|1
2506788|NCT01878292|8672432|P3|Randomized|Protocol Violation|0
2506789|NCT01878292|8672433|P2|Randomized|Protocol Violation|0
2506790|NCT01878292|8672434|P1|Randomized|Protocol Violation|1
2506791|NCT01878253|8672445|P1|Overall Study|Completed Study w/o Follow-up Data|2
2506792|NCT01878253|8672445|P1|Overall Study|Lost to Follow-up|2
2506793|NCT01878253|8672445|P1|Overall Study|Withdrawal by Subject|1
2506794|NCT01878253|8672445|P1|Overall Study|SIdus System Removal|3
2506795|NCT01878253|8672445|P1|Overall Study|Death|1
2506796|NCT01878214|8672456|P2|Overall Study|Lost to Follow-up|36
2506797|NCT01878214|8672457|P1|Overall Study|Lost to Follow-up|35
2506798|NCT01878214|8672456|P2|Overall Study|Death|1
2506799|NCT01878214|8672457|P1|Overall Study|Death|0
2506800|NCT01878214|8672456|P2|Overall Study|Withdrawal by Subject|7
2506801|NCT01878214|8672457|P1|Overall Study|Withdrawal by Subject|18
2506802|NCT01878175|8672471|P1|Overall Study|Developed contraindicated health problem|2
2506803|NCT01878149|8672490|P2|Overall Study|Did Not Meet Eligibility Criteria|2
2506804|NCT01878149|8672491|P1|Overall Study|Did Not Meet Eligibility Criteria|2
2506805|NCT01878097|8672499|P2|Implementation Year 4|Surveys not fully completed|3007
2506806|NCT01878097|8672500|P1|Implementation Year 4|Surveys not fully completed|3604
2506807|NCT01878097|8672499|P2|Implementation Year 3|Surveys not fully completed|2980
2506808|NCT01878097|8672500|P1|Implementation Year 3|Surveys not fully completed|3494
2506809|NCT01878097|8672499|P2|Implementation Year 2|Surveys not fully completed|2841
2506810|NCT01878097|8672500|P1|Implementation Year 2|Surveys not fully completed|3281
2506811|NCT01878097|8672499|P2|Implementation Year 1|Surveys not fully completed|2549
2506812|NCT01878097|8672500|P1|Implementation Year 1|Surveys not fully completed|3202
2506813|NCT01878097|8672499|P2|Baseline|Surveys not fully completed|1800
2506814|NCT01878097|8672500|P1|Baseline|Surveys not fully completed|2497
2506815|NCT01878084|8672508|P1|Overall Study|Physician Decision|2
2506816|NCT01877915|8672542|P2|Overall Study|Other|4
2506817|NCT01877915|8672543|P1|Overall Study|Other|2
2506818|NCT01877915|8672542|P2|Overall Study|Withdrawal by Subject|55
2506819|NCT01877915|8672543|P1|Overall Study|Withdrawal by Subject|42
2506820|NCT01877915|8672542|P2|Overall Study|Lost to Follow-up|9
2506821|NCT01877915|8672543|P1|Overall Study|Lost to Follow-up|10
2506822|NCT01877720|8672565|P2|Overall Study|Adverse Event|0
2506823|NCT01877720|8672566|P1|Overall Study|Adverse Event|1
2506824|NCT01877668|8672595|P5|Overall Study|Adverse event unrelated to study drug|1
2506825|NCT01877668|8672596|P4|Overall Study|Adverse event unrelated to study drug|0
2506826|NCT01877668|8672597|P3|Overall Study|Adverse event unrelated to study drug|2
2506827|NCT01877668|8672598|P2|Overall Study|Adverse event unrelated to study drug|1
2506828|NCT01877668|8672599|P1|Overall Study|Adverse event unrelated to study drug|4
2506829|NCT01877668|8672595|P5|Overall Study|Adverse event related to study drug|1
2506830|NCT01877668|8672596|P4|Overall Study|Adverse event related to study drug|2
2506831|NCT01877668|8672597|P3|Overall Study|Adverse event related to study drug|2
2506832|NCT01877668|8672598|P2|Overall Study|Adverse event related to study drug|2
2506833|NCT01877668|8672599|P1|Overall Study|Adverse event related to study drug|2
2506834|NCT01877668|8672595|P5|Overall Study|Protocol Violation|3
2506835|NCT01877668|8672596|P4|Overall Study|Protocol Violation|0
2506836|NCT01877668|8672597|P3|Overall Study|Protocol Violation|0
2506837|NCT01877668|8672598|P2|Overall Study|Protocol Violation|1
2506838|NCT01877668|8672599|P1|Overall Study|Protocol Violation|1
2506839|NCT01877668|8672595|P5|Overall Study|Other|3
2506840|NCT01877668|8672596|P4|Overall Study|Other|1
2506841|NCT01877668|8672597|P3|Overall Study|Other|1
2506842|NCT01877668|8672598|P2|Overall Study|Other|1
2506843|NCT01877668|8672599|P1|Overall Study|Other|1
2506844|NCT01877668|8672595|P5|Overall Study|Withdrawal by Subject|2
2506845|NCT01877668|8672596|P4|Overall Study|Withdrawal by Subject|2
2506846|NCT01877668|8672597|P3|Overall Study|Withdrawal by Subject|3
2506847|NCT01877668|8672598|P2|Overall Study|Withdrawal by Subject|0
2506848|NCT01877668|8672599|P1|Overall Study|Withdrawal by Subject|2
2506849|NCT01877668|8672595|P5|Overall Study|Lost to Follow-up|0
2506850|NCT01877668|8672596|P4|Overall Study|Lost to Follow-up|0
2506851|NCT01877668|8672597|P3|Overall Study|Lost to Follow-up|1
2506852|NCT01877668|8672598|P2|Overall Study|Lost to Follow-up|2
2506853|NCT01877668|8672599|P1|Overall Study|Lost to Follow-up|0
2506854|NCT01877668|8672595|P5|Overall Study|Insufficient clinical response|0
2506855|NCT01877668|8672596|P4|Overall Study|Insufficient clinical response|2
2506856|NCT01877668|8672597|P3|Overall Study|Insufficient clinical response|2
2506857|NCT01877668|8672598|P2|Overall Study|Insufficient clinical response|1
2506858|NCT01877668|8672599|P1|Overall Study|Insufficient clinical response|0
2506859|NCT01877668|8672595|P5|Overall Study|No longer met study criteria|0
2506860|NCT01877668|8672596|P4|Overall Study|No longer met study criteria|0
2506861|NCT01877668|8672597|P3|Overall Study|No longer met study criteria|1
2506862|NCT01877668|8672598|P2|Overall Study|No longer met study criteria|0
2506863|NCT01877668|8672599|P1|Overall Study|No longer met study criteria|1
2506864|NCT01877668|8672595|P5|Overall Study|Death|0
2506865|NCT01877668|8672596|P4|Overall Study|Death|1
2506866|NCT01877668|8672597|P3|Overall Study|Death|0
2506867|NCT01877668|8672598|P2|Overall Study|Death|0
2506868|NCT01877668|8672599|P1|Overall Study|Death|0
2506869|NCT01877655|8672830|P2|Overall Study|Randomized but Never Received Drug|5
2506870|NCT01877655|8672831|P1|Overall Study|Randomized but Never Received Drug|8
2506871|NCT01877655|8672830|P2|Overall Study|Miscellaneous|4
2506872|NCT01877655|8672831|P1|Overall Study|Miscellaneous|4
2506873|NCT01877655|8672830|P2|Overall Study|Physician Decision|10
2506874|NCT01877655|8672831|P1|Overall Study|Physician Decision|11
2506875|NCT01877655|8672830|P2|Overall Study|Withdrawal by Subject|26
2506876|NCT01877655|8672831|P1|Overall Study|Withdrawal by Subject|18
2506877|NCT01877655|8672830|P2|Overall Study|Death|52
2506878|NCT01877655|8672831|P1|Overall Study|Death|57
2506879|NCT01877551|8672887|P2|Overall Study|Physician Decision|1
2506880|NCT01877551|8672888|P1|Overall Study|Physician Decision|0
2506881|NCT01877421|8672937|P18|Phase 2|Protocol Violation|0
2506882|NCT01877421|8672938|P17|Phase 2|Protocol Violation|0
2506883|NCT01877421|8672939|P16|Phase 2|Protocol Violation|0
2506884|NCT01877421|8672940|P15|Phase 2|Protocol Violation|0
2506885|NCT01877421|8672941|P14|Phase 2|Protocol Violation|0
2506886|NCT01877421|8672942|P13|Phase 2|Protocol Violation|0
2506887|NCT01877421|8672943|P12|Phase 2|Protocol Violation|0
2506888|NCT01877421|8672944|P11|Phase 2|Protocol Violation|1
2506889|NCT01877421|8672945|P10|Phase 2|Protocol Violation|0
2506890|NCT01877421|8672946|P9|Phase 2|Protocol Violation|0
2506891|NCT01877421|8672947|P8|Phase 2|Protocol Violation|0
2506892|NCT01877421|8672948|P7|Phase 2|Protocol Violation|0
2506893|NCT01877421|8672949|P6|Phase 2|Protocol Violation|0
2506894|NCT01877421|8672950|P5|Phase 2|Protocol Violation|0
2506895|NCT01877421|8672951|P4|Phase 2|Protocol Violation|0
2506896|NCT01877421|8672952|P3|Phase 2|Protocol Violation|0
2506897|NCT01877421|8672953|P2|Phase 2|Protocol Violation|0
2506898|NCT01877421|8672954|P1|Phase 2|Protocol Violation|0
2506899|NCT01877421|8672937|P18|Phase 2|Withdrawal by Subject|0
2506900|NCT01877421|8672938|P17|Phase 2|Withdrawal by Subject|0
2506901|NCT01877421|8672939|P16|Phase 2|Withdrawal by Subject|1
2506902|NCT01877421|8672940|P15|Phase 2|Withdrawal by Subject|0
2506903|NCT01877421|8672941|P14|Phase 2|Withdrawal by Subject|0
2506904|NCT01877421|8672942|P13|Phase 2|Withdrawal by Subject|1
2506905|NCT01877421|8672943|P12|Phase 2|Withdrawal by Subject|0
2506906|NCT01877421|8672944|P11|Phase 2|Withdrawal by Subject|1
2506907|NCT01877421|8672945|P10|Phase 2|Withdrawal by Subject|0
2506908|NCT01877421|8672946|P9|Phase 2|Withdrawal by Subject|1
2506909|NCT01877421|8672947|P8|Phase 2|Withdrawal by Subject|0
2506910|NCT01877421|8672948|P7|Phase 2|Withdrawal by Subject|0
2506911|NCT01877421|8672949|P6|Phase 2|Withdrawal by Subject|0
2506912|NCT01877421|8672950|P5|Phase 2|Withdrawal by Subject|0
2506913|NCT01877421|8672951|P4|Phase 2|Withdrawal by Subject|0
2506914|NCT01877421|8672952|P3|Phase 2|Withdrawal by Subject|0
2506915|NCT01877421|8672953|P2|Phase 2|Withdrawal by Subject|0
2506916|NCT01877421|8672954|P1|Phase 2|Withdrawal by Subject|0
2506917|NCT01877421|8672937|P18|Phase 2|Lost to Follow-up|0
2506918|NCT01877421|8672938|P17|Phase 2|Lost to Follow-up|0
2506919|NCT01877421|8672939|P16|Phase 2|Lost to Follow-up|0
2506920|NCT01877421|8672940|P15|Phase 2|Lost to Follow-up|0
2506921|NCT01877421|8672941|P14|Phase 2|Lost to Follow-up|0
2506922|NCT01877421|8672942|P13|Phase 2|Lost to Follow-up|0
2506923|NCT01877421|8672943|P12|Phase 2|Lost to Follow-up|0
2506924|NCT01877421|8672944|P11|Phase 2|Lost to Follow-up|0
2506925|NCT01877421|8672945|P10|Phase 2|Lost to Follow-up|0
2506926|NCT01877421|8672946|P9|Phase 2|Lost to Follow-up|0
2506927|NCT01877421|8672947|P8|Phase 2|Lost to Follow-up|0
2506928|NCT01877421|8672948|P7|Phase 2|Lost to Follow-up|1
2506929|NCT01877421|8672949|P6|Phase 2|Lost to Follow-up|0
2506930|NCT01877421|8672950|P5|Phase 2|Lost to Follow-up|0
2506931|NCT01877421|8672951|P4|Phase 2|Lost to Follow-up|0
2506932|NCT01877421|8672952|P3|Phase 2|Lost to Follow-up|0
2506933|NCT01877421|8672953|P2|Phase 2|Lost to Follow-up|0
2506934|NCT01877421|8672954|P1|Phase 2|Lost to Follow-up|0
2506935|NCT01877408|8673064|P2|Overall Study|Lost to Follow-up|2
2506936|NCT01877408|8673065|P1|Overall Study|Lost to Follow-up|0
2506937|NCT01877278|8673098|P2|Overall Study|Lost to Follow-up|3
2506938|NCT01877278|8673099|P1|Overall Study|Lost to Follow-up|3
2506939|NCT01877265|8673107|P6|Treatment Period 3|Lost to Follow-up|0
2506940|NCT01877265|8673108|P5|Treatment Period 3|Lost to Follow-up|0
2506941|NCT01877265|8673109|P4|Treatment Period 3|Lost to Follow-up|0
2506942|NCT01877265|8673110|P3|Treatment Period 3|Lost to Follow-up|0
2506943|NCT01877265|8673111|P2|Treatment Period 3|Lost to Follow-up|0
2506944|NCT01877265|8673112|P1|Treatment Period 3|Lost to Follow-up|1
2506945|NCT01877265|8673107|P6|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1
2506946|NCT01877265|8673108|P5|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
2506947|NCT01877265|8673109|P4|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
2506948|NCT01877265|8673110|P3|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
2506949|NCT01877265|8673111|P2|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
2506950|NCT01877265|8673112|P1|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
2506951|NCT01877265|8673107|P6|Treatment Period 1|Sponsor Decision|0
2506952|NCT01877265|8673108|P5|Treatment Period 1|Sponsor Decision|0
2506953|NCT01877265|8673109|P4|Treatment Period 1|Sponsor Decision|0
2506954|NCT01877265|8673110|P3|Treatment Period 1|Sponsor Decision|1
2506955|NCT01877265|8673111|P2|Treatment Period 1|Sponsor Decision|0
2506956|NCT01877265|8673112|P1|Treatment Period 1|Sponsor Decision|0
2506957|NCT01877239|8673129|P1|Overall Study|Data not available|35
2506958|NCT01877239|8673129|P1|Overall Study|Lack of Efficacy|4
2506959|NCT01877239|8673129|P1|Overall Study|Other|2
2506960|NCT01877239|8673129|P1|Overall Study|Withdrawal by Subject|4
2506961|NCT01877239|8673129|P1|Overall Study|Disease Remission|1
2506962|NCT01877239|8673129|P1|Overall Study|Adverse Event|4
2506963|NCT01877187|8673135|P1|Overall Study|Liver transplant|2
2506964|NCT01877187|8673135|P1|Overall Study|Declining clinical status|11
2506965|NCT01877187|8673135|P1|Overall Study|Lost to Follow-up|3
2506966|NCT01877187|8673135|P1|Overall Study|Withdrawal by Subject|4
2506967|NCT01877187|8673135|P1|Overall Study|Death|2
2506968|NCT01877083|8673187|P1|Extension Phase|Adverse Event|2
2506969|NCT01877083|8673187|P1|Extension Phase|Disease Progression|3
2506970|NCT01877083|8673187|P1|Treatment Phase|Lost to Follow-up|1
2506971|NCT01877083|8673187|P1|Treatment Phase|Withdrawal by Subject|2
2506972|NCT01877083|8673187|P1|Treatment Phase|Adverse Event|6
2506973|NCT01877083|8673187|P1|Treatment Phase|Clinical Progression|1
2506974|NCT01877083|8673187|P1|Treatment Phase|Disease Progression|10
2506975|NCT01876979|8673211|P2|Overall Study|Physician Decision|3
2506976|NCT01876979|8673212|P1|Overall Study|Physician Decision|2
2506977|NCT01876823|8673218|P1|Overall Study|Patients moved|2
2506978|NCT01876823|8673218|P1|Overall Study|Physician Decision|2
2506979|NCT01876823|8673218|P1|Overall Study|Withdrawal by Subject|5
2506980|NCT01876810|8673231|P2|Overall Study|Physician Decision|1
2506981|NCT01876810|8673232|P1|Overall Study|Physician Decision|0
2506982|NCT01876784|8673244|P2|Overall Study|Ongoing|40
2506983|NCT01876784|8673245|P1|Overall Study|Ongoing|41
2506984|NCT01876784|8673244|P2|Overall Study|Other than specified above|6
2506985|NCT01876784|8673245|P1|Overall Study|Other than specified above|5
2506986|NCT01876784|8673244|P2|Overall Study|Randomized but not treated|1
2506987|NCT01876784|8673245|P1|Overall Study|Randomized but not treated|2
2506988|NCT01876784|8673244|P2|Overall Study|Death|0
2506989|NCT01876784|8673245|P1|Overall Study|Death|1
2506990|NCT01876784|8673244|P2|Overall Study|Lost to Follow-up|1
2506991|NCT01876784|8673245|P1|Overall Study|Lost to Follow-up|0
2506992|NCT01876784|8673244|P2|Overall Study|Disease progression|67
2506993|NCT01876784|8673245|P1|Overall Study|Disease progression|37
2506994|NCT01876784|8673244|P2|Overall Study|Protocol Violation|0
2506995|NCT01876784|8673245|P1|Overall Study|Protocol Violation|1
2506996|NCT01876784|8673244|P2|Overall Study|Adverse Event|2
2506997|NCT01876784|8673245|P1|Overall Study|Adverse Event|15
2506998|NCT01876784|8673244|P2|Overall Study|Withdrawal by Subject|2
2506999|NCT01876784|8673245|P1|Overall Study|Withdrawal by Subject|17
2507000|NCT01876732|8673251|P1|Overall Study|MMA was not over 800mg/dL|75
2507001|NCT01876706|8673256|P1|Overall Study|Death|3
2507002|NCT01876706|8673256|P1|Overall Study|Withdrawals|6
2507003|NCT01876706|8673256|P1|Overall Study|Lost to Follow-up|7
2507004|NCT01876706|8673256|P1|Overall Study|BPH Intervention|9
2507005|NCT01876511|8673276|P3|Overall Study|Physician Decision|1
2507006|NCT01876511|8673277|P2|Overall Study|Physician Decision|0
2507007|NCT01876511|8673278|P1|Overall Study|Physician Decision|1
2507008|NCT01876511|8673276|P3|Overall Study|Patient Decision|6
2507009|NCT01876511|8673277|P2|Overall Study|Patient Decision|0
2507010|NCT01876511|8673278|P1|Overall Study|Patient Decision|3
2507011|NCT01876511|8673276|P3|Overall Study|Drug-related Toxicity|6
2507012|NCT01876511|8673277|P2|Overall Study|Drug-related Toxicity|1
2507013|NCT01876511|8673278|P1|Overall Study|Drug-related Toxicity|5
2507014|NCT01876511|8673276|P3|Overall Study|Death (unrelated)|2
2507015|NCT01876511|8673277|P2|Overall Study|Death (unrelated)|0
2507016|NCT01876511|8673278|P1|Overall Study|Death (unrelated)|3
2507017|NCT01876511|8673276|P3|Overall Study|Disease Progression-clinical/radiologic|16
2507018|NCT01876511|8673277|P2|Overall Study|Disease Progression-clinical/radiologic|24
2507019|NCT01876511|8673278|P1|Overall Study|Disease Progression-clinical/radiologic|11
2507020|NCT01876446|8673326|P2|Overall Study|Physician Decision|3
2507021|NCT01876446|8673327|P1|Overall Study|Physician Decision|1
2507022|NCT01876446|8673326|P2|Overall Study|Withdrawal by Subject|2
2507023|NCT01876446|8673327|P1|Overall Study|Withdrawal by Subject|1
2507024|NCT01876446|8673326|P2|Overall Study|Death|1
2507025|NCT01876446|8673327|P1|Overall Study|Death|0
2507026|NCT01876420|8673343|P1|Overall Study|Missed 30 day visit|1
2507027|NCT01876381|8673355|P1|Overall Study|Withdrawal by Subject|1
2507028|NCT01876381|8673355|P1|Overall Study|Physician Decision|1
2507029|NCT01876381|8673355|P1|Overall Study|Lack of Efficacy|5
2507030|NCT01876368|8673362|P2|Overall Study|Subject/guardian decision|1
2507031|NCT01876368|8673363|P1|Overall Study|Subject/guardian decision|3
2507032|NCT01876368|8673362|P2|Overall Study|Protocol deviation|3
2507033|NCT01876368|8673363|P1|Overall Study|Protocol deviation|3
2507034|NCT01876368|8673362|P2|Overall Study|Physician Decision|2
2507035|NCT01876368|8673363|P1|Overall Study|Physician Decision|0
2507036|NCT01876368|8673362|P2|Overall Study|Non-compliance with study treatment|1
2507037|NCT01876368|8673363|P1|Overall Study|Non-compliance with study treatment|0
2507038|NCT01876368|8673362|P2|Overall Study|Lost to Follow-up|1
2507039|NCT01876368|8673363|P1|Overall Study|Lost to Follow-up|0
2507040|NCT01876368|8673362|P2|Overall Study|Lack of Efficacy|0
2507041|NCT01876368|8673363|P1|Overall Study|Lack of Efficacy|1
2507042|NCT01876368|8673362|P2|Overall Study|Adverse Event|5
2507043|NCT01876368|8673363|P1|Overall Study|Adverse Event|2
2507044|NCT01876251|8673408|P3|Overall Study|Objective progression or relapse|8
2507045|NCT01876251|8673409|P2|Overall Study|Objective progression or relapse|3
2507046|NCT01876251|8673410|P1|Overall Study|Objective progression or relapse|10
2507047|NCT01876251|8673408|P3|Overall Study|Study terminated|0
2507048|NCT01876251|8673409|P2|Overall Study|Study terminated|0
2507049|NCT01876251|8673410|P1|Overall Study|Study terminated|1
2507138|NCT01874145|8673876|P1|Core Period|Non-compliance|1
2507050|NCT01876251|8673408|P3|Overall Study|Participant refused further follow-up|1
2507051|NCT01876251|8673409|P2|Overall Study|Participant refused further follow-up|0
2507052|NCT01876251|8673410|P1|Overall Study|Participant refused further follow-up|0
2507053|NCT01876251|8673408|P3|Overall Study|Participant started new treatment|1
2507054|NCT01876251|8673409|P2|Overall Study|Participant started new treatment|0
2507055|NCT01876251|8673410|P1|Overall Study|Participant started new treatment|1
2507056|NCT01876251|8673408|P3|Overall Study|Death|1
2507057|NCT01876251|8673409|P2|Overall Study|Death|0
2507058|NCT01876251|8673410|P1|Overall Study|Death|2
2507059|NCT01876251|8673408|P3|Overall Study|Clinical progression|0
2507060|NCT01876251|8673409|P2|Overall Study|Clinical progression|0
2507061|NCT01876251|8673410|P1|Overall Study|Clinical progression|1
2507062|NCT01876043|8673514|P1|Overall Study|Withdrawal by Subject|1
2507063|NCT01876043|8673514|P1|Overall Study|Death|1
2507064|NCT01875991|8673526|P2|Overall Study|Sponsor Decision|0
2507065|NCT01875991|8673527|P1|Overall Study|Sponsor Decision|1
2507066|NCT01875991|8673526|P2|Overall Study|Withdrawal by Subject|6
2507067|NCT01875991|8673527|P1|Overall Study|Withdrawal by Subject|6
2507068|NCT01875874|8673563|P1|Overall Study|Death|3
2507069|NCT01875848|8673583|P2|Overall Study|Withdrawal by Subject|0
2507070|NCT01875848|8673584|P1|Overall Study|Withdrawal by Subject|2
2507071|NCT01875731|8673601|P2|Overall Study|Fail to obtain lab sample|0
2507072|NCT01875731|8673602|P1|Overall Study|Fail to obtain lab sample|1
2507073|NCT01875471|8673621|P2|Overall Study|Unsatisfactory Lens Fitting|0
2507074|NCT01875471|8673622|P1|Overall Study|Unsatisfactory Lens Fitting|1
2507075|NCT01875471|8673621|P2|Overall Study|Adverse Event|1
2507076|NCT01875471|8673622|P1|Overall Study|Adverse Event|0
2507077|NCT01875445|8673630|P2|Overall Study|Withdrawal by Subject|0
2507078|NCT01875445|8673631|P1|Overall Study|Withdrawal by Subject|2
2507079|NCT01875445|8673630|P2|Overall Study|Lost to Follow-up|0
2507080|NCT01875445|8673631|P1|Overall Study|Lost to Follow-up|5
2507081|NCT01875237|8673641|P2|Overall Study|DLI cells could not be produced|0
2507082|NCT01875237|8673642|P1|Overall Study|DLI cells could not be produced|1
2507083|NCT01875237|8673641|P2|Overall Study|GVDH before DLI|0
2507084|NCT01875237|8673642|P1|Overall Study|GVDH before DLI|1
2507085|NCT01875185|8673668|P2|Overall Study|study was terminated|48
2507086|NCT01875185|8673669|P1|Overall Study|study was terminated|52
2507087|NCT01874665|8673754|P2|Overall Study|Other|0
2507088|NCT01874665|8673755|P1|Overall Study|Other|2
2507089|NCT01874665|8673754|P2|Overall Study|Documented Progressive Disease|7
2507090|NCT01874665|8673755|P1|Overall Study|Documented Progressive Disease|11
2507091|NCT01874665|8673754|P2|Overall Study|Study Terminated by Sponsor|2
2507092|NCT01874665|8673755|P1|Overall Study|Study Terminated by Sponsor|0
2507093|NCT01874665|8673754|P2|Overall Study|Clinical Progressive Disease|3
2507094|NCT01874665|8673755|P1|Overall Study|Clinical Progressive Disease|4
2507095|NCT01874665|8673754|P2|Overall Study|Physician Decision|0
2507096|NCT01874665|8673755|P1|Overall Study|Physician Decision|3
2507097|NCT01874665|8673754|P2|Overall Study|Withdrawal by Subject|1
2507098|NCT01874665|8673755|P1|Overall Study|Withdrawal by Subject|4
2507099|NCT01874665|8673754|P2|Overall Study|Adverse Event|2
2507100|NCT01874665|8673755|P1|Overall Study|Adverse Event|6
2507101|NCT01874535|8673783|P2|Overall Study|incomplete symptom resolution|35
2507102|NCT01874535|8673784|P1|Overall Study|incomplete symptom resolution|45
2507103|NCT01874535|8673783|P2|Overall Study|Lost to Follow-up|9
2507104|NCT01874535|8673784|P1|Overall Study|Lost to Follow-up|10
2507105|NCT01874353|8673792|P2|Overall Study|Withdrawal by Subject|9
2507106|NCT01874353|8673793|P1|Overall Study|Withdrawal by Subject|7
2507107|NCT01874353|8673792|P2|Overall Study|Death|27
2507108|NCT01874353|8673793|P1|Overall Study|Death|45
2507109|NCT01874353|8673792|P2|Overall Study|Lost to Follow-up|1
2507110|NCT01874353|8673793|P1|Overall Study|Lost to Follow-up|1
2507111|NCT01874353|8673792|P2|Overall Study|Other|0
2507112|NCT01874353|8673793|P1|Overall Study|Other|2
2507113|NCT01874340|8673820|P4|Overall Study|Withdrawal by Subject|1
2507114|NCT01874340|8673821|P3|Overall Study|Withdrawal by Subject|0
2507115|NCT01874340|8673822|P2|Overall Study|Withdrawal by Subject|0
2507116|NCT01874340|8673823|P1|Overall Study|Withdrawal by Subject|0
2507117|NCT01874340|8673820|P4|Overall Study|Study terminated by Sponsor|4
2507118|NCT01874340|8673821|P3|Overall Study|Study terminated by Sponsor|8
2507119|NCT01874340|8673822|P2|Overall Study|Study terminated by Sponsor|8
2507120|NCT01874340|8673823|P1|Overall Study|Study terminated by Sponsor|6
2507121|NCT01874275|8673851|P2|Overall Study|Lost to Follow-up|0
2507122|NCT01874275|8673852|P1|Overall Study|Lost to Follow-up|1
2507123|NCT01874145|8673875|P2|Extension Period|Lost to Follow-up|1
2507124|NCT01874145|8673876|P1|Extension Period|Lost to Follow-up|1
2507125|NCT01874145|8673875|P2|Extension Period|Withdrawal by Subject|1
2507126|NCT01874145|8673876|P1|Extension Period|Withdrawal by Subject|2
2507127|NCT01874145|8673875|P2|Extension Period|Adverse Event|2
2507128|NCT01874145|8673876|P1|Extension Period|Adverse Event|3
2507129|NCT01874145|8673875|P2|Core Period|Withdrawal by Subject|4
2507130|NCT01874145|8673876|P1|Core Period|Withdrawal by Subject|0
2507131|NCT01874145|8673875|P2|Core Period|Adverse Event|1
2507132|NCT01874145|8673876|P1|Core Period|Adverse Event|0
2507133|NCT01874145|8673875|P2|Core Period|Physician Decision|1
2507134|NCT01874145|8673876|P1|Core Period|Physician Decision|1
2507135|NCT01874145|8673875|P2|Core Period|Protocol Violation|1
2507136|NCT01874145|8673876|P1|Core Period|Protocol Violation|1
2507137|NCT01874145|8673875|P2|Core Period|Non-compliance|0
2507139|NCT01874054|8673935|P1|Overall Study|Death|5
2507140|NCT01874054|8673935|P1|Overall Study|Lost to Follow-up|5
2507141|NCT01874054|8673935|P1|Overall Study|Study Termination by Sponsor|42
2507142|NCT01874054|8673935|P1|Overall Study|Withdrawal by Subject|3
2507143|NCT01873950|8673957|P5|Period 5|Withdrawal by Subject|0
2507144|NCT01873950|8673958|P4|Period 5|Withdrawal by Subject|1
2507145|NCT01873950|8673959|P3|Period 5|Withdrawal by Subject|0
2507146|NCT01873950|8673960|P2|Period 5|Withdrawal by Subject|0
2507147|NCT01873950|8673961|P1|Period 5|Withdrawal by Subject|0
2507148|NCT01873859|8673998|P2|Overall Study|Withdrawal by Subject|4
2507149|NCT01873859|8673999|P1|Overall Study|Withdrawal by Subject|0
2507150|NCT01873729|8674015|P1|Overall Study|Withdrawal by Subject|1
2507151|NCT01873586|8674020|P1|Overall Study|Lost to Follow-up|3
2507152|NCT01873495|8674033|P1|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1
2507153|NCT01873495|8674033|P1|Overall Study|Removed for Transplantation|1
2507154|NCT01873495|8674033|P1|Overall Study|Adverse Event|1
2507155|NCT01873495|8674033|P1|Overall Study|Physician Decision|3
2507156|NCT01873495|8674033|P1|Overall Study|Withdrawal by Subject|1
2507157|NCT01873417|8674041|P1|Overall Study|Physician Decision|3
2507158|NCT01873417|8674041|P1|Overall Study|Withdrawal by Subject|2
2507159|NCT01873417|8674041|P1|Overall Study|Lost to Follow-up|2
2507160|NCT01873417|8674041|P1|Overall Study|Adverse Event|24
2507161|NCT01873417|8674041|P1|Overall Study|Did Not Receive Any Study Drug|4
2507162|NCT01872910|8674069|P6|Overall Study|Lost to Follow-up|0
2507163|NCT01872910|8674070|P5|Overall Study|Lost to Follow-up|0
2507164|NCT01872910|8674071|P4|Overall Study|Lost to Follow-up|0
2507165|NCT01872910|8674072|P3|Overall Study|Lost to Follow-up|2
2507166|NCT01872910|8674073|P2|Overall Study|Lost to Follow-up|0
2507167|NCT01872910|8674074|P1|Overall Study|Lost to Follow-up|2
2507168|NCT01872715|8674119|P1|Overall Study|Withdrawal by Subject|2
2507169|NCT01872715|8674119|P1|Overall Study|Protocol Violation|1
2507170|NCT01872715|8674119|P1|Overall Study|Adverse Event|1
2507171|NCT01872689|8674138|P4|Open-Label Period (Only For Monotherapy)|Adverse Event|0
2507172|NCT01872689|8674139|P3|Open-Label Period (Only For Monotherapy)|Adverse Event|0
2507173|NCT01872689|8674140|P2|Open-Label Period (Only For Monotherapy)|Adverse Event|1
2507174|NCT01872689|8674141|P1|Open-Label Period (Only For Monotherapy)|Adverse Event|2
2507175|NCT01872689|8674138|P4|Open-Label Period (Only For Monotherapy)|Death|0
2507176|NCT01872689|8674139|P3|Open-Label Period (Only For Monotherapy)|Death|0
2507177|NCT01872689|8674140|P2|Open-Label Period (Only For Monotherapy)|Death|3
2507178|NCT01872689|8674141|P1|Open-Label Period (Only For Monotherapy)|Death|5
2507179|NCT01872689|8674138|P4|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
2507180|NCT01872689|8674139|P3|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
2507181|NCT01872689|8674140|P2|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3
2507182|NCT01872689|8674141|P1|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1
2507183|NCT01872689|8674138|P4|Open-Label Period (Only For Monotherapy)|Physician Decision|0
2507184|NCT01872689|8674139|P3|Open-Label Period (Only For Monotherapy)|Physician Decision|0
2507185|NCT01872689|8674140|P2|Open-Label Period (Only For Monotherapy)|Physician Decision|1
2507186|NCT01872689|8674141|P1|Open-Label Period (Only For Monotherapy)|Physician Decision|0
2507187|NCT01872689|8674138|P4|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
2507188|NCT01872689|8674139|P3|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
2507189|NCT01872689|8674140|P2|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12
2507190|NCT01872689|8674141|P1|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11
2507191|NCT01872689|8674138|P4|Open-Label Period (Only For Monotherapy)|Other|0
2507192|NCT01872689|8674139|P3|Open-Label Period (Only For Monotherapy)|Other|0
2507193|NCT01872689|8674140|P2|Open-Label Period (Only For Monotherapy)|Other|3
2507194|NCT01872689|8674141|P1|Open-Label Period (Only For Monotherapy)|Other|2
2507195|NCT01872689|8674138|P4|Double-Blind/Placebo-Controlled Period|Adverse Event|7
2507196|NCT01872689|8674139|P3|Double-Blind/Placebo-Controlled Period|Adverse Event|10
2507197|NCT01872689|8674140|P2|Double-Blind/Placebo-Controlled Period|Adverse Event|3
2507198|NCT01872689|8674141|P1|Double-Blind/Placebo-Controlled Period|Adverse Event|6
2507199|NCT01872689|8674138|P4|Double-Blind/Placebo-Controlled Period|Death|9
2507200|NCT01872689|8674139|P3|Double-Blind/Placebo-Controlled Period|Death|14
2507201|NCT01872689|8674140|P2|Double-Blind/Placebo-Controlled Period|Death|4
2507202|NCT01872689|8674141|P1|Double-Blind/Placebo-Controlled Period|Death|3
2507203|NCT01872689|8674138|P4|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
2507204|NCT01872689|8674139|P3|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
2507205|NCT01872689|8674140|P2|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
2507206|NCT01872689|8674141|P1|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
2507207|NCT01872689|8674138|P4|Double-Blind/Placebo-Controlled Period|Physician Decision|1
2507208|NCT01872689|8674139|P3|Double-Blind/Placebo-Controlled Period|Physician Decision|3
2507209|NCT01872689|8674140|P2|Double-Blind/Placebo-Controlled Period|Physician Decision|3
2507210|NCT01872689|8674141|P1|Double-Blind/Placebo-Controlled Period|Physician Decision|0
2507211|NCT01872689|8674138|P4|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
2507212|NCT01872689|8674139|P3|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
2507213|NCT01872689|8674140|P2|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
2507214|NCT01872689|8674141|P1|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
2507215|NCT01872689|8674138|P4|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16
2507216|NCT01872689|8674139|P3|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14
2507217|NCT01872689|8674140|P2|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8
2507218|NCT01872689|8674141|P1|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9
2507219|NCT01872689|8674138|P4|Double-Blind/Placebo-Controlled Period|Other|3
2507220|NCT01872689|8674139|P3|Double-Blind/Placebo-Controlled Period|Other|6
2507221|NCT01872689|8674140|P2|Double-Blind/Placebo-Controlled Period|Other|1
2507222|NCT01872689|8674141|P1|Double-Blind/Placebo-Controlled Period|Other|1
2507223|NCT01872689|8674138|P4|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
2507224|NCT01872689|8674139|P3|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
2507225|NCT01872689|8674140|P2|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1
2507226|NCT01872689|8674141|P1|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
2507227|NCT01872611|8674217|P2|Overall Study|Reason not provided|6
2507228|NCT01872611|8674218|P1|Overall Study|Reason not provided|6
2507229|NCT01872611|8674217|P2|Overall Study|Withdrawal by Subject|1
2507230|NCT01872611|8674218|P1|Overall Study|Withdrawal by Subject|6
2507231|NCT01872611|8674217|P2|Overall Study|Physician Decision|0
2507232|NCT01872611|8674218|P1|Overall Study|Physician Decision|1
2507233|NCT01872611|8674217|P2|Overall Study|Lost to Follow-up|1
2507234|NCT01872611|8674218|P1|Overall Study|Lost to Follow-up|8
2507235|NCT01872611|8674217|P2|Overall Study|Death, prior to treatment|1
2507236|NCT01872611|8674218|P1|Overall Study|Death, prior to treatment|0
2507237|NCT01872611|8674217|P2|Overall Study|Death|1
2507238|NCT01872611|8674218|P1|Overall Study|Death|0
2507239|NCT01872611|8674217|P2|Overall Study|Adverse Event, prior to treatment|1
2507240|NCT01872611|8674218|P1|Overall Study|Adverse Event, prior to treatment|0
2507241|NCT01872611|8674217|P2|Overall Study|Adverse Event|1
2507242|NCT01872611|8674218|P1|Overall Study|Adverse Event|3
2507243|NCT01872078|8674255|P4|Overall Study|Patient met exclusion criterion 16.|1
2507244|NCT01872078|8674256|P3|Overall Study|Patient met exclusion criterion 16.|0
2507245|NCT01872078|8674257|P2|Overall Study|Patient met exclusion criterion 16.|0
2507246|NCT01872078|8674258|P1|Overall Study|Patient met exclusion criterion 16.|0
2507247|NCT01872078|8674255|P4|Overall Study|Withdrawal by Subject|0
2507248|NCT01872078|8674256|P3|Overall Study|Withdrawal by Subject|1
2507249|NCT01872078|8674257|P2|Overall Study|Withdrawal by Subject|0
2507250|NCT01872078|8674258|P1|Overall Study|Withdrawal by Subject|0
2507251|NCT01872078|8674255|P4|Overall Study|Protocol Violation|0
2507252|NCT01872078|8674256|P3|Overall Study|Protocol Violation|1
2507253|NCT01872078|8674257|P2|Overall Study|Protocol Violation|0
2507254|NCT01872078|8674258|P1|Overall Study|Protocol Violation|0
2507255|NCT01872078|8674255|P4|Overall Study|Dose administration non-compliance|1
2507256|NCT01872078|8674256|P3|Overall Study|Dose administration non-compliance|0
2507257|NCT01872078|8674257|P2|Overall Study|Dose administration non-compliance|0
2507258|NCT01872078|8674258|P1|Overall Study|Dose administration non-compliance|0
2507259|NCT01872078|8674255|P4|Overall Study|Adverse Event|0
2507260|NCT01872078|8674256|P3|Overall Study|Adverse Event|1
2507261|NCT01872078|8674257|P2|Overall Study|Adverse Event|0
2507262|NCT01872078|8674258|P1|Overall Study|Adverse Event|0
2507263|NCT01871870|8674268|P1|Overall Study|hyperglycemia|2
2507264|NCT01871870|8674268|P1|Overall Study|Hardware issues|7
2507265|NCT01871805|8674279|P6|Phase II|Lost to Follow-up|13
2507266|NCT01871805|8674280|P5|Phase II|Lost to Follow-up|0
2507267|NCT01871805|8674281|P4|Phase II|Lost to Follow-up|0
2507268|NCT01871805|8674282|P3|Phase II|Lost to Follow-up|0
2507269|NCT01871805|8674283|P2|Phase II|Lost to Follow-up|0
2507270|NCT01871805|8674284|P1|Phase II|Lost to Follow-up|0
2507271|NCT01871805|8674279|P6|Phase II|Alive in Survival Follow-up|29
2507272|NCT01871805|8674280|P5|Phase II|Alive in Survival Follow-up|0
2507273|NCT01871805|8674281|P4|Phase II|Alive in Survival Follow-up|0
2507274|NCT01871805|8674282|P3|Phase II|Alive in Survival Follow-up|0
2507275|NCT01871805|8674283|P2|Phase II|Alive in Survival Follow-up|0
2507276|NCT01871805|8674284|P1|Phase II|Alive in Survival Follow-up|0
2507277|NCT01871805|8674279|P6|Phase II|Death|45
2507278|NCT01871805|8674280|P5|Phase II|Death|0
2507279|NCT01871805|8674281|P4|Phase II|Death|0
2507280|NCT01871805|8674282|P3|Phase II|Death|0
2507281|NCT01871805|8674283|P2|Phase II|Death|0
2507282|NCT01871805|8674284|P1|Phase II|Death|0
2507283|NCT01871805|8674279|P6|Phase I|Lost to Follow-up|0
2507284|NCT01871805|8674280|P5|Phase I|Lost to Follow-up|0
2507285|NCT01871805|8674281|P4|Phase I|Lost to Follow-up|0
2507286|NCT01871805|8674282|P3|Phase I|Lost to Follow-up|3
2507287|NCT01871805|8674283|P2|Phase I|Lost to Follow-up|1
2507288|NCT01871805|8674284|P1|Phase I|Lost to Follow-up|0
2507289|NCT01871805|8674279|P6|Phase I|Alive in Survival Follow-up|0
2507290|NCT01871805|8674280|P5|Phase I|Alive in Survival Follow-up|4
2507291|NCT01871805|8674281|P4|Phase I|Alive in Survival Follow-up|5
2507292|NCT01871805|8674282|P3|Phase I|Alive in Survival Follow-up|4
2507293|NCT01871805|8674283|P2|Phase I|Alive in Survival Follow-up|2
2507294|NCT01871805|8674284|P1|Phase I|Alive in Survival Follow-up|0
2507295|NCT01871805|8674279|P6|Phase I|Death|0
2507296|NCT01871805|8674280|P5|Phase I|Death|9
2507297|NCT01871805|8674281|P4|Phase I|Death|2
2507298|NCT01871805|8674282|P3|Phase I|Death|6
2507299|NCT01871805|8674283|P2|Phase I|Death|4
2507300|NCT01871805|8674284|P1|Phase I|Death|7
2507301|NCT01871558|8674356|P2|Overall Study|Withdrawal by Subject|0
2507302|NCT01871558|8674357|P1|Overall Study|Withdrawal by Subject|2
2507303|NCT01871558|8674356|P2|Overall Study|antidiabetic drug prematurely stopped|1
2507304|NCT01871558|8674357|P1|Overall Study|antidiabetic drug prematurely stopped|1
2507305|NCT01871558|8674356|P2|Overall Study|Other reason|1
2507306|NCT01871558|8674357|P1|Overall Study|Other reason|0
2507307|NCT01871532|8674377|P2|Overall Study|Withdrawal by Subject|2
2507308|NCT01871532|8674378|P1|Overall Study|Withdrawal by Subject|1
2507309|NCT01871519|8674412|P1|Overall Study|Withdrawal by Subject|49
2507310|NCT01871519|8674412|P1|Overall Study|Lost to Follow-up|15
2507311|NCT01871519|8674412|P1|Overall Study|Death|26
2507312|NCT01871402|8674469|P2|Overall Study|Non-compliance|1
2507313|NCT01871402|8674470|P1|Overall Study|Non-compliance|0
2507314|NCT01871402|8674469|P2|Overall Study|Withdrawal by Subject|2
2507315|NCT01871402|8674470|P1|Overall Study|Withdrawal by Subject|0
2507316|NCT01871402|8674469|P2|Overall Study|Lost to Follow-up|0
2507317|NCT01871402|8674470|P1|Overall Study|Lost to Follow-up|1
2507318|NCT01871285|8674488|P4|First Intervention (1 Day)|Lost to Follow-up|0
2507319|NCT01871285|8674489|P3|First Intervention (1 Day)|Lost to Follow-up|1
2507320|NCT01871285|8674490|P2|First Intervention (1 Day)|Lost to Follow-up|1
2507321|NCT01871285|8674491|P1|First Intervention (1 Day)|Lost to Follow-up|0
2507322|NCT01871285|8674488|P4|First Intervention (1 Day)|Adverse Event|0
2507323|NCT01871285|8674489|P3|First Intervention (1 Day)|Adverse Event|0
2507324|NCT01871285|8674490|P2|First Intervention (1 Day)|Adverse Event|0
2507325|NCT01871285|8674491|P1|First Intervention (1 Day)|Adverse Event|1
2507326|NCT01871142|8674517|P1|Overall Study|Adverse Event|1
2507327|NCT01871090|8674533|P2|Overall Study|Subject Non-Compliance|1
2507328|NCT01871090|8674534|P1|Overall Study|Subject Non-Compliance|0
2507329|NCT01871090|8674533|P2|Overall Study|Interrogation not completed correctly|0
2507330|NCT01871090|8674534|P1|Overall Study|Interrogation not completed correctly|1
2507331|NCT01871090|8674533|P2|Overall Study|Interrogation not done in Emergency Room|22
2507332|NCT01871090|8674534|P1|Overall Study|Interrogation not done in Emergency Room|1
2507333|NCT01870999|8674554|P3|Overall Study|Protocol Violation|1
2507334|NCT01870999|8674555|P2|Overall Study|Protocol Violation|0
2507335|NCT01870999|8674556|P1|Overall Study|Protocol Violation|0
2507336|NCT01870999|8674554|P3|Overall Study|Withdrawal by Subject|5
2507337|NCT01870999|8674555|P2|Overall Study|Withdrawal by Subject|2
2507338|NCT01870999|8674556|P1|Overall Study|Withdrawal by Subject|0
2507339|NCT01870999|8674554|P3|Overall Study|Subject withdrawn by Investigator|0
2507340|NCT01870999|8674555|P2|Overall Study|Subject withdrawn by Investigator|0
2507341|NCT01870999|8674556|P1|Overall Study|Subject withdrawn by Investigator|1
2507342|NCT01870999|8674554|P3|Overall Study|Subject met withdrawal criteria|0
2507343|NCT01870999|8674555|P2|Overall Study|Subject met withdrawal criteria|2
2507344|NCT01870999|8674556|P1|Overall Study|Subject met withdrawal criteria|3
2507345|NCT01870999|8674554|P3|Overall Study|Adverse Event|1
2507346|NCT01870999|8674555|P2|Overall Study|Adverse Event|4
2507347|NCT01870999|8674556|P1|Overall Study|Adverse Event|0
2507348|NCT01870973|8674614|P2|Overall Study|Lost to Follow-up|3
2507349|NCT01870973|8674615|P1|Overall Study|Lost to Follow-up|10
2507350|NCT01870921|8674621|P1|Overall Study|Other|1
2507351|NCT01870921|8674621|P1|Overall Study|Subject Lost to Follow up|2
2507352|NCT01870921|8674621|P1|Overall Study|Severe non-compliance to protocol|7
2507353|NCT01870921|8674621|P1|Overall Study|Subject decision|80
2507354|NCT01870843|8674640|P1|Overall Study|Withdrawal by Subject|18
2507355|NCT01870843|8674640|P1|Overall Study|Death|1
2507356|NCT01870843|8674640|P1|Overall Study|Lost to Follow-up|24
2507357|NCT01870843|8674640|P1|Overall Study|Adverse Event|10
2507358|NCT01870778|8674655|P2|Overall Study|Lost to Follow-up|2
2507359|NCT01870778|8674656|P1|Overall Study|Lost to Follow-up|0
2507360|NCT01870778|8674655|P2|Overall Study|Withdrawal by Subject|7
2507361|NCT01870778|8674656|P1|Overall Study|Withdrawal by Subject|8
2507362|NCT01870739|8674682|P2|Add-on Period (40 Weeks)|Patient withdrew consent|0
2507363|NCT01870739|8674683|P1|Add-on Period (40 Weeks)|Patient withdrew consent|1
2507364|NCT01870739|8674682|P2|Add-on Period (40 Weeks)|Protocol deviation|1
2507365|NCT01870739|8674683|P1|Add-on Period (40 Weeks)|Protocol deviation|1
2507366|NCT01870739|8674682|P2|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0
2507367|NCT01870739|8674683|P1|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1
2507368|NCT01870739|8674682|P2|Add-on Period (40 Weeks)|Adverse Event|1
2507369|NCT01870739|8674683|P1|Add-on Period (40 Weeks)|Adverse Event|0
2507370|NCT01870739|8674682|P2|Single Drug Treatment (12 Weeks)|Administrative problems|2
2507371|NCT01870739|8674683|P1|Single Drug Treatment (12 Weeks)|Administrative problems|3
2507372|NCT01870739|8674682|P2|Single Drug Treatment (12 Weeks)|Adverse Event|1
2507373|NCT01870739|8674683|P1|Single Drug Treatment (12 Weeks)|Adverse Event|0
2507374|NCT01870739|8674682|P2|Single Drug Treatment (12 Weeks)|Protocol deviation|1
2507375|NCT01870739|8674683|P1|Single Drug Treatment (12 Weeks)|Protocol deviation|0
2507376|NCT01870726|8674722|P7|Overall Study|Progressive disease|10
2507377|NCT01870726|8674723|P6|Overall Study|Progressive disease|4
2507378|NCT01870726|8674724|P5|Overall Study|Progressive disease|6
2507379|NCT01870726|8674725|P4|Overall Study|Progressive disease|5
2507380|NCT01870726|8674726|P3|Overall Study|Progressive disease|4
2507381|NCT01870726|8674727|P2|Overall Study|Progressive disease|5
2507382|NCT01870726|8674728|P1|Overall Study|Progressive disease|5
2507383|NCT01870726|8674722|P7|Overall Study|Adverse Event|0
2507384|NCT01870726|8674723|P6|Overall Study|Adverse Event|1
2507385|NCT01870726|8674724|P5|Overall Study|Adverse Event|1
2507386|NCT01870726|8674725|P4|Overall Study|Adverse Event|0
2507387|NCT01870726|8674726|P3|Overall Study|Adverse Event|0
2507388|NCT01870726|8674727|P2|Overall Study|Adverse Event|0
2507389|NCT01870726|8674728|P1|Overall Study|Adverse Event|0
2507390|NCT01870726|8674722|P7|Overall Study|Withdrawal by Subject|0
2507391|NCT01870726|8674723|P6|Overall Study|Withdrawal by Subject|0
2507392|NCT01870726|8674724|P5|Overall Study|Withdrawal by Subject|0
2507393|NCT01870726|8674725|P4|Overall Study|Withdrawal by Subject|0
2507394|NCT01870726|8674726|P3|Overall Study|Withdrawal by Subject|0
2507395|NCT01870726|8674727|P2|Overall Study|Withdrawal by Subject|1
2507396|NCT01870726|8674728|P1|Overall Study|Withdrawal by Subject|0
2507397|NCT01870726|8674722|P7|Overall Study|Withdrawal of informed consent|0
2507398|NCT01870726|8674723|P6|Overall Study|Withdrawal of informed consent|0
2507399|NCT01870726|8674724|P5|Overall Study|Withdrawal of informed consent|0
2507400|NCT01870726|8674725|P4|Overall Study|Withdrawal of informed consent|1
2507401|NCT01870726|8674726|P3|Overall Study|Withdrawal of informed consent|0
2507402|NCT01870726|8674727|P2|Overall Study|Withdrawal of informed consent|0
2507403|NCT01870726|8674728|P1|Overall Study|Withdrawal of informed consent|0
2507404|NCT01870583|8674823|P3|Overall Study|Lost to Follow-up|5
2507405|NCT01870583|8674824|P2|Overall Study|Lost to Follow-up|13
2507406|NCT01870583|8674825|P1|Overall Study|Lost to Follow-up|11
2507407|NCT01870583|8674823|P3|Overall Study|Protocol Violation|3
2507408|NCT01870583|8674824|P2|Overall Study|Protocol Violation|5
2507409|NCT01870583|8674825|P1|Overall Study|Protocol Violation|0
2507410|NCT01870297|8674851|P7|Overall Study|Sponsor Decision|1
2507411|NCT01870297|8674852|P6|Overall Study|Sponsor Decision|0
2507412|NCT01870297|8674853|P5|Overall Study|Sponsor Decision|0
2507413|NCT01870297|8674854|P4|Overall Study|Sponsor Decision|0
2507414|NCT01870297|8674855|P3|Overall Study|Sponsor Decision|0
2507415|NCT01870297|8674856|P2|Overall Study|Sponsor Decision|6
2507416|NCT01870297|8674857|P1|Overall Study|Sponsor Decision|0
2507417|NCT01870297|8674851|P7|Overall Study|Withdrawal by Subject|1
2507418|NCT01870297|8674852|P6|Overall Study|Withdrawal by Subject|1
2507419|NCT01870297|8674853|P5|Overall Study|Withdrawal by Subject|1
2507420|NCT01870297|8674854|P4|Overall Study|Withdrawal by Subject|0
2507421|NCT01870297|8674855|P3|Overall Study|Withdrawal by Subject|0
2507422|NCT01870297|8674856|P2|Overall Study|Withdrawal by Subject|0
2507423|NCT01870297|8674857|P1|Overall Study|Withdrawal by Subject|0
2507424|NCT01870297|8674851|P7|Overall Study|Lost to Follow-up|0
2507425|NCT01870297|8674852|P6|Overall Study|Lost to Follow-up|0
2507426|NCT01870297|8674853|P5|Overall Study|Lost to Follow-up|0
2507427|NCT01870297|8674854|P4|Overall Study|Lost to Follow-up|0
2507428|NCT01870297|8674855|P3|Overall Study|Lost to Follow-up|1
2507429|NCT01870297|8674856|P2|Overall Study|Lost to Follow-up|1
2507430|NCT01870297|8674857|P1|Overall Study|Lost to Follow-up|0
2507431|NCT01870297|8674851|P7|Overall Study|Adverse Event|0
2507432|NCT01870297|8674852|P6|Overall Study|Adverse Event|0
2507433|NCT01870297|8674853|P5|Overall Study|Adverse Event|2
2507434|NCT01870297|8674854|P4|Overall Study|Adverse Event|0
2507435|NCT01870297|8674855|P3|Overall Study|Adverse Event|0
2507436|NCT01870297|8674856|P2|Overall Study|Adverse Event|0
2507437|NCT01870297|8674857|P1|Overall Study|Adverse Event|0
2507438|NCT01870076|8674901|P4|Overall Study|Withdrawal by Subject|0
2507439|NCT01870076|8674902|P3|Overall Study|Withdrawal by Subject|1
2507440|NCT01870076|8674903|P2|Overall Study|Withdrawal by Subject|0
2507441|NCT01870076|8674904|P1|Overall Study|Withdrawal by Subject|1
2507442|NCT01869959|8674922|P5|Treatment Period|Withdrawal by Subject|0
2507443|NCT01869959|8674923|P4|Treatment Period|Withdrawal by Subject|0
2507444|NCT01869959|8674924|P3|Treatment Period|Withdrawal by Subject|0
2507445|NCT01869959|8674925|P2|Treatment Period|Withdrawal by Subject|1
2507446|NCT01869959|8674926|P1|Treatment Period|Withdrawal by Subject|0
2507447|NCT01869959|8674922|P5|Treatment Period|Sponsor decision|0
2507448|NCT01869959|8674923|P4|Treatment Period|Sponsor decision|1
2507449|NCT01869959|8674924|P3|Treatment Period|Sponsor decision|0
2507450|NCT01869959|8674925|P2|Treatment Period|Sponsor decision|1
2507451|NCT01869959|8674926|P1|Treatment Period|Sponsor decision|0
2507452|NCT01869959|8674922|P5|Treatment Period|Adverse Event|0
2507453|NCT01869959|8674923|P4|Treatment Period|Adverse Event|1
2507454|NCT01869959|8674924|P3|Treatment Period|Adverse Event|3
2507455|NCT01869959|8674925|P2|Treatment Period|Adverse Event|0
2507456|NCT01869959|8674926|P1|Treatment Period|Adverse Event|1
2507457|NCT01869959|8674922|P5|Randomization Period|Physician Decision|1
2507458|NCT01869959|8674923|P4|Randomization Period|Physician Decision|0
2507459|NCT01869959|8674924|P3|Randomization Period|Physician Decision|0
2507460|NCT01869959|8674925|P2|Randomization Period|Physician Decision|0
2507461|NCT01869959|8674926|P1|Randomization Period|Physician Decision|0
2507462|NCT01869777|8674994|P1|Overall Study|Excluded from the analysis, ineligible|1
2507463|NCT01869764|8675007|P2|Overall Study|Withdrawal by Subject|2
2507464|NCT01869764|8675008|P1|Overall Study|Withdrawal by Subject|0
2507465|NCT01869699|8675026|P2|Overall Study|Withdrawal by Subject|0
2507466|NCT01869699|8675027|P1|Overall Study|Withdrawal by Subject|1
2507467|NCT01869348|8675103|P2|Overall Study|Withdrawal by Subject|1
2507468|NCT01869348|8675104|P1|Overall Study|Withdrawal by Subject|1
2507469|NCT01869192|8675112|P2|Postoperative Chemotherapy|Physician Decision|2
2507470|NCT01869192|8675113|P1|Postoperative Chemotherapy|Physician Decision|0
2507471|NCT01869192|8675112|P2|Preoperative Chemotherapy to Surgery|patient choice|1
2507472|NCT01869192|8675113|P1|Preoperative Chemotherapy to Surgery|patient choice|2
2507473|NCT01868997|8675148|P2|Overall Study|Other|1
2507474|NCT01868997|8675149|P1|Overall Study|Other|3
2507475|NCT01868997|8675148|P2|Overall Study|Lack of Efficacy|0
2507476|NCT01868997|8675149|P1|Overall Study|Lack of Efficacy|2
2507477|NCT01868997|8675148|P2|Overall Study|Adverse Event|5
2507478|NCT01868997|8675149|P1|Overall Study|Adverse Event|2
2507479|NCT01868893|8675165|P1|Overall Study|Neutropenia|1
2507480|NCT01868893|8675165|P1|Overall Study|Commercial availability of study drug|17
2507481|NCT01868893|8675165|P1|Overall Study|Adverse Event|2
2507482|NCT01868646|8675194|P2|Overall Study|Do not meet inclusion criteria|5
2507483|NCT01868646|8675195|P1|Overall Study|Do not meet inclusion criteria|3
2507484|NCT01868594|8675240|P2|Overall Study|Do not meet inclusion criteria|3
2507485|NCT01868594|8675241|P1|Overall Study|Do not meet inclusion criteria|4
2507486|NCT01868542|8675261|P2|Overall Study|Unclassified|1
2507487|NCT01868542|8675262|P1|Overall Study|Unclassified|0
2507488|NCT01868542|8675261|P2|Overall Study|Protocol Violation|1
2507489|NCT01868542|8675262|P1|Overall Study|Protocol Violation|0
2507490|NCT01868503|8675280|P1|Overall Study|Protocol Violation|1
2507491|NCT01868503|8675280|P1|Overall Study|Withdrawal by Subject|1
2507492|NCT01868477|8675290|P2|Overall Study|Withdrawal by Subject|0
2507493|NCT01868477|8675291|P1|Overall Study|Withdrawal by Subject|1
2507494|NCT01868477|8675290|P2|Overall Study|Disease progression|1
2507495|NCT01868477|8675291|P1|Overall Study|Disease progression|1
2507496|NCT01868477|8675290|P2|Overall Study|Adverse Event|4
2507497|NCT01868477|8675291|P1|Overall Study|Adverse Event|2
2507498|NCT01868243|8675395|P2|Overall Study|Death|1
2507499|NCT01868243|8675396|P1|Overall Study|Death|0
2507500|NCT01868165|8675404|P1|Overall Study|Death|4
2507501|NCT01868165|8675404|P1|Overall Study|Lost to Follow-up|3
2507502|NCT01868165|8675404|P1|Overall Study|Physician Decision|2
2507503|NCT01868165|8675404|P1|Overall Study|Withdrawal by Subject|36
2507504|NCT01868074|8675420|P2|Overall Study|Withdrawal by Subject|2
2507505|NCT01868074|8675421|P1|Overall Study|Withdrawal by Subject|4
2507506|NCT01868074|8675420|P2|Overall Study|Lost to Follow-up|2
2507507|NCT01868074|8675421|P1|Overall Study|Lost to Follow-up|3
2507508|NCT01868035|8675431|P1|Overall Study|Non-compliance|1
2507509|NCT01868035|8675431|P1|Overall Study|Progressive Disease|2
2507510|NCT01868035|8675431|P1|Overall Study|Withdrawal by Subject|1
2507511|NCT01868035|8675431|P1|Overall Study|Lost to Follow-up|3
2507512|NCT01868022|8675456|P9|Overall Study|Ongoing|0
2507513|NCT01868022|8675457|P8|Overall Study|Ongoing|3
2507514|NCT01868022|8675458|P7|Overall Study|Ongoing|0
2507515|NCT01868022|8675459|P6|Overall Study|Ongoing|0
2507516|NCT01868022|8675460|P5|Overall Study|Ongoing|0
2507517|NCT01868022|8675461|P4|Overall Study|Ongoing|0
2507518|NCT01868022|8675462|P3|Overall Study|Ongoing|0
2507519|NCT01868022|8675463|P2|Overall Study|Ongoing|0
2507520|NCT01868022|8675464|P1|Overall Study|Ongoing|0
2507521|NCT01868022|8675456|P9|Overall Study|Study closed/terminated|0
2507522|NCT01868022|8675457|P8|Overall Study|Study closed/terminated|1
2507523|NCT01868022|8675458|P7|Overall Study|Study closed/terminated|0
2507524|NCT01868022|8675459|P6|Overall Study|Study closed/terminated|0
2507525|NCT01868022|8675460|P5|Overall Study|Study closed/terminated|0
2507526|NCT01868022|8675461|P4|Overall Study|Study closed/terminated|0
2507527|NCT01868022|8675462|P3|Overall Study|Study closed/terminated|0
2507528|NCT01868022|8675463|P2|Overall Study|Study closed/terminated|0
2507529|NCT01868022|8675464|P1|Overall Study|Study closed/terminated|0
2507530|NCT01868022|8675456|P9|Overall Study|Physician Decision|0
2507531|NCT01868022|8675457|P8|Overall Study|Physician Decision|2
2507532|NCT01868022|8675458|P7|Overall Study|Physician Decision|0
2507533|NCT01868022|8675459|P6|Overall Study|Physician Decision|1
2507534|NCT01868022|8675460|P5|Overall Study|Physician Decision|0
2507535|NCT01868022|8675461|P4|Overall Study|Physician Decision|0
2507536|NCT01868022|8675462|P3|Overall Study|Physician Decision|0
2507537|NCT01868022|8675463|P2|Overall Study|Physician Decision|0
2507538|NCT01868022|8675464|P1|Overall Study|Physician Decision|0
2507539|NCT01868022|8675456|P9|Overall Study|Adverse Event|2
2507540|NCT01868022|8675457|P8|Overall Study|Adverse Event|2
2507541|NCT01868022|8675458|P7|Overall Study|Adverse Event|0
2507542|NCT01868022|8675459|P6|Overall Study|Adverse Event|0
2507543|NCT01868022|8675460|P5|Overall Study|Adverse Event|2
2507544|NCT01868022|8675461|P4|Overall Study|Adverse Event|0
2507545|NCT01868022|8675462|P3|Overall Study|Adverse Event|0
2507546|NCT01868022|8675463|P2|Overall Study|Adverse Event|0
2507547|NCT01868022|8675464|P1|Overall Study|Adverse Event|0
2507548|NCT01868022|8675456|P9|Overall Study|Withdrawal by Subject|0
2507549|NCT01868022|8675457|P8|Overall Study|Withdrawal by Subject|1
2507550|NCT01868022|8675458|P7|Overall Study|Withdrawal by Subject|0
2507551|NCT01868022|8675459|P6|Overall Study|Withdrawal by Subject|0
2507552|NCT01868022|8675460|P5|Overall Study|Withdrawal by Subject|0
2507553|NCT01868022|8675461|P4|Overall Study|Withdrawal by Subject|1
2507554|NCT01868022|8675462|P3|Overall Study|Withdrawal by Subject|1
2507555|NCT01868022|8675463|P2|Overall Study|Withdrawal by Subject|0
2507556|NCT01868022|8675464|P1|Overall Study|Withdrawal by Subject|0
2507557|NCT01868009|8675670|P2|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0
2507558|NCT01868009|8675671|P1|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1
2507559|NCT01868009|8675670|P2|Period 2 (5-9 Days)|Adverse Event|0
2507560|NCT01868009|8675671|P1|Period 2 (5-9 Days)|Adverse Event|1
2507561|NCT01868009|8675670|P2|Period 1 (5-9 Days)|Adverse Event|2
2507562|NCT01868009|8675671|P1|Period 1 (5-9 Days)|Adverse Event|0
2507563|NCT01867710|8675685|P4|Overall Study|Study medication no longer effective|0
2507564|NCT01867710|8675686|P3|Overall Study|Study medication no longer effective|0
2507565|NCT01867710|8675687|P2|Overall Study|Study medication no longer effective|1
2507566|NCT01867710|8675688|P1|Overall Study|Study medication no longer effective|0
2507567|NCT01867710|8675685|P4|Overall Study|PSA-progression|0
2507568|NCT01867710|8675686|P3|Overall Study|PSA-progression|0
2507569|NCT01867710|8675687|P2|Overall Study|PSA-progression|1
2507570|NCT01867710|8675688|P1|Overall Study|PSA-progression|0
2507571|NCT01867710|8675685|P4|Overall Study|Protocol Violation|1
2507572|NCT01867710|8675686|P3|Overall Study|Protocol Violation|0
2507573|NCT01867710|8675687|P2|Overall Study|Protocol Violation|0
2507574|NCT01867710|8675688|P1|Overall Study|Protocol Violation|0
2507575|NCT01867710|8675685|P4|Overall Study|Progressive disease|0
2507576|NCT01867710|8675686|P3|Overall Study|Progressive disease|0
2507577|NCT01867710|8675687|P2|Overall Study|Progressive disease|0
2507578|NCT01867710|8675688|P1|Overall Study|Progressive disease|1
2507579|NCT01867710|8675685|P4|Overall Study|Patient to follow subsequent treatment|0
2507580|NCT01867710|8675686|P3|Overall Study|Patient to follow subsequent treatment|0
2507581|NCT01867710|8675687|P2|Overall Study|Patient to follow subsequent treatment|1
2507582|NCT01867710|8675688|P1|Overall Study|Patient to follow subsequent treatment|0
2507583|NCT01867710|8675685|P4|Overall Study|Patient decision|1
2507584|NCT01867710|8675686|P3|Overall Study|Patient decision|0
2507585|NCT01867710|8675687|P2|Overall Study|Patient decision|0
2507586|NCT01867710|8675688|P1|Overall Study|Patient decision|0
2507587|NCT01867710|8675685|P4|Overall Study|Disease progression|0
2507588|NCT01867710|8675686|P3|Overall Study|Disease progression|0
2507589|NCT01867710|8675687|P2|Overall Study|Disease progression|0
2507590|NCT01867710|8675688|P1|Overall Study|Disease progression|1
2507591|NCT01867710|8675685|P4|Overall Study|Clinical progression|0
2507592|NCT01867710|8675686|P3|Overall Study|Clinical progression|1
2507593|NCT01867710|8675687|P2|Overall Study|Clinical progression|0
2507594|NCT01867710|8675688|P1|Overall Study|Clinical progression|0
2507595|NCT01867710|8675685|P4|Overall Study|Biochemical progression|0
2507596|NCT01867710|8675686|P3|Overall Study|Biochemical progression|0
2507597|NCT01867710|8675687|P2|Overall Study|Biochemical progression|1
2507598|NCT01867710|8675688|P1|Overall Study|Biochemical progression|0
2507599|NCT01867710|8675685|P4|Overall Study|Study Terminated by Sponsor|16
2507600|NCT01867710|8675686|P3|Overall Study|Study Terminated by Sponsor|8
2507601|NCT01867710|8675687|P2|Overall Study|Study Terminated by Sponsor|13
2507602|NCT01867710|8675688|P1|Overall Study|Study Terminated by Sponsor|9
2507603|NCT01867710|8675685|P4|Overall Study|Withdrawal of consent|2
2507604|NCT01867710|8675686|P3|Overall Study|Withdrawal of consent|1
2507605|NCT01867710|8675687|P2|Overall Study|Withdrawal of consent|5
2507606|NCT01867710|8675688|P1|Overall Study|Withdrawal of consent|2
2507607|NCT01867710|8675685|P4|Overall Study|Lost to Follow-up|2
2507608|NCT01867710|8675686|P3|Overall Study|Lost to Follow-up|3
2507609|NCT01867710|8675687|P2|Overall Study|Lost to Follow-up|4
2507610|NCT01867710|8675688|P1|Overall Study|Lost to Follow-up|3
2507611|NCT01867710|8675685|P4|Overall Study|Death|20
2507612|NCT01867710|8675686|P3|Overall Study|Death|27
2507613|NCT01867710|8675687|P2|Overall Study|Death|15
2507614|NCT01867710|8675688|P1|Overall Study|Death|25
2507615|NCT01867671|8675756|P2|Overall Study|Withdrawal by Subject|21
2507616|NCT01867671|8675757|P1|Overall Study|Withdrawal by Subject|21
2507617|NCT01867671|8675756|P2|Overall Study|Non-compliance with Study Drug|2
2507618|NCT01867671|8675757|P1|Overall Study|Non-compliance with Study Drug|1
2507619|NCT01867671|8675756|P2|Overall Study|Lost to Follow-up|1
2507620|NCT01867671|8675757|P1|Overall Study|Lost to Follow-up|0
2507621|NCT01867671|8675756|P2|Overall Study|Inability to reach 3 mg peanut/placebo|0
2507622|NCT01867671|8675757|P1|Overall Study|Inability to reach 3 mg peanut/placebo|2
2507623|NCT01867671|8675756|P2|Overall Study|Anaphylaxis|1
2507624|NCT01867671|8675757|P1|Overall Study|Anaphylaxis|0
2507625|NCT01867671|8675756|P2|Overall Study|Adverse Event|3
2507626|NCT01867671|8675757|P1|Overall Study|Adverse Event|5
2507627|NCT01867658|8675770|P1|Overall Study|Subject could not be contacted|1
2507628|NCT01867658|8675770|P1|Overall Study|Death|2
2507629|NCT01867658|8675770|P1|Overall Study|Withdrawal by Subject|6
2507630|NCT01867606|8675794|P2|Overall Study|Protocol Violation|1
2507631|NCT01867606|8675795|P1|Overall Study|Protocol Violation|0
2507632|NCT01867606|8675794|P2|Overall Study|Withdrawal by Subject|14
2507633|NCT01867606|8675795|P1|Overall Study|Withdrawal by Subject|10
2507634|NCT01867580|8675813|P2|Overall Study|Wound recurrence|1
2507635|NCT01867580|8675814|P1|Overall Study|Wound recurrence|0
2507636|NCT01867580|8675813|P2|Overall Study|Continuation of therapy|1
2507637|NCT01867580|8675814|P1|Overall Study|Continuation of therapy|0
2507638|NCT01867580|8675813|P2|Overall Study|Osteomyelitis|1
2507639|NCT01867580|8675814|P1|Overall Study|Osteomyelitis|0
2507640|NCT01867580|8675813|P2|Overall Study|Interruption to therapy|0
2507641|NCT01867580|8675814|P1|Overall Study|Interruption to therapy|3
2507642|NCT01867580|8675813|P2|Overall Study|Missed follow-up assessment|1
2507643|NCT01867580|8675814|P1|Overall Study|Missed follow-up assessment|2
2507644|NCT01867580|8675813|P2|Overall Study|Sponsor terminated study|0
2507645|NCT01867580|8675814|P1|Overall Study|Sponsor terminated study|1
2507646|NCT01867580|8675813|P2|Overall Study|Lost to Follow-up|5
2507647|NCT01867580|8675814|P1|Overall Study|Lost to Follow-up|3
2507648|NCT01867580|8675813|P2|Overall Study|Physician Decision|12
2507649|NCT01867580|8675814|P1|Overall Study|Physician Decision|17
2507650|NCT01867580|8675813|P2|Overall Study|Withdrawal by Subject|3
2507651|NCT01867580|8675814|P1|Overall Study|Withdrawal by Subject|2
2507652|NCT01867424|8675839|P2|Overall Study|Patient noncompliance|1
2507653|NCT01867424|8675840|P1|Overall Study|Patient noncompliance|2
2507654|NCT01867307|8675854|P2|Overall Study|Other Adverse Event|3
2507655|NCT01867307|8675855|P1|Overall Study|Other Adverse Event|1
2507656|NCT01867307|8675854|P2|Overall Study|Protocol Violation|0
2507657|NCT01867307|8675855|P1|Overall Study|Protocol Violation|2
2507658|NCT01867294|8675865|P4|Overall Study|Withdrawal by Subject|0
2507659|NCT01867294|8675866|P3|Overall Study|Withdrawal by Subject|0
2507660|NCT01867294|8675867|P2|Overall Study|Withdrawal by Subject|1
2507661|NCT01867294|8675868|P1|Overall Study|Withdrawal by Subject|1
2507662|NCT01867216|8675915|P7|Overall Study|Unable to Place Catheter for Blood Draws|0
2507663|NCT01867216|8675916|P6|Overall Study|Unable to Place Catheter for Blood Draws|0
2507664|NCT01867216|8675917|P5|Overall Study|Unable to Place Catheter for Blood Draws|0
2507665|NCT01867216|8675918|P4|Overall Study|Unable to Place Catheter for Blood Draws|0
2507666|NCT01867216|8675919|P3|Overall Study|Unable to Place Catheter for Blood Draws|0
2507667|NCT01867216|8675920|P2|Overall Study|Unable to Place Catheter for Blood Draws|0
2507668|NCT01867216|8675921|P1|Overall Study|Unable to Place Catheter for Blood Draws|1
2507669|NCT01867216|8675915|P7|Overall Study|Physician Decision|0
2507670|NCT01867216|8675916|P6|Overall Study|Physician Decision|0
2507671|NCT01867216|8675917|P5|Overall Study|Physician Decision|0
2507672|NCT01867216|8675918|P4|Overall Study|Physician Decision|0
2507673|NCT01867216|8675919|P3|Overall Study|Physician Decision|0
2507674|NCT01867216|8675920|P2|Overall Study|Physician Decision|0
2507675|NCT01867216|8675921|P1|Overall Study|Physician Decision|1
2507676|NCT01867216|8675915|P7|Overall Study|Withdrawal by Subject|1
2507677|NCT01867216|8675916|P6|Overall Study|Withdrawal by Subject|0
2507678|NCT01867216|8675917|P5|Overall Study|Withdrawal by Subject|1
2507679|NCT01867216|8675918|P4|Overall Study|Withdrawal by Subject|0
2507680|NCT01867216|8675919|P3|Overall Study|Withdrawal by Subject|0
2507681|NCT01867216|8675920|P2|Overall Study|Withdrawal by Subject|0
2507682|NCT01867216|8675921|P1|Overall Study|Withdrawal by Subject|2
2507683|NCT01867086|8675993|P1|Overall Study|Disease Progression|1
2507684|NCT01867047|8676002|P2|Overall Study|surgery not indicated in protocol|2
2507685|NCT01867047|8676003|P1|Overall Study|surgery not indicated in protocol|1
2507686|NCT01867047|8676002|P2|Overall Study|Physician Decision|0
2507687|NCT01867047|8676003|P1|Overall Study|Physician Decision|2
2507688|NCT01867047|8676002|P2|Overall Study|Withdrawal by Subject|0
2507689|NCT01867047|8676003|P1|Overall Study|Withdrawal by Subject|2
2507690|NCT01867047|8676002|P2|Overall Study|Lost to Follow-up|3
2507691|NCT01867047|8676003|P1|Overall Study|Lost to Follow-up|3
2507692|NCT01867021|8676023|P2|Overall Study|Withdrawal by Subject|6
2507693|NCT01867021|8676024|P1|Overall Study|Withdrawal by Subject|1
2507694|NCT01867021|8676023|P2|Overall Study|Lost to Follow-up|2
2507695|NCT01867021|8676024|P1|Overall Study|Lost to Follow-up|0
2507696|NCT01867021|8676023|P2|Overall Study|Death|0
2507697|NCT01867021|8676024|P1|Overall Study|Death|1
2507698|NCT01867021|8676023|P2|Overall Study|Not Eligible|1
2507699|NCT01867021|8676024|P1|Overall Study|Not Eligible|0
2507700|NCT01867021|8676023|P2|Overall Study|Adverse Event|1
2507701|NCT01867021|8676024|P1|Overall Study|Adverse Event|0
2507702|NCT01866826|8676053|P2|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1
2507703|NCT01866826|8676054|P1|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0
2507704|NCT01866826|8676053|P2|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2
2507705|NCT01866826|8676054|P1|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0
2507706|NCT01866826|8676053|P2|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0
2507707|NCT01866826|8676054|P1|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1
2507708|NCT01866709|8676070|P2|Overall Study|Adverse Event|0
2507709|NCT01866709|8676071|P1|Overall Study|Adverse Event|1
2507710|NCT01866423|8676112|P1|Overall Study|Sponsor Decision|1
2507711|NCT01866423|8676112|P1|Overall Study|Lack of Efficacy|3
2507712|NCT01866319|8676140|P3|Overall Study|Remain on study|176
2507713|NCT01866319|8676141|P2|Overall Study|Remain on study|190
2507714|NCT01866319|8676142|P1|Overall Study|Remain on study|131
2507715|NCT01866319|8676140|P3|Overall Study|Withdrawal by Subject|6
2507716|NCT01866319|8676141|P2|Overall Study|Withdrawal by Subject|9
2507717|NCT01866319|8676142|P1|Overall Study|Withdrawal by Subject|31
2507718|NCT01866319|8676140|P3|Overall Study|Physician Decision|0
2507719|NCT01866319|8676141|P2|Overall Study|Physician Decision|0
2507720|NCT01866319|8676142|P1|Overall Study|Physician Decision|1
2507721|NCT01866319|8676140|P3|Overall Study|Lost to Follow-up|6
2507722|NCT01866319|8676141|P2|Overall Study|Lost to Follow-up|0
2507723|NCT01866319|8676142|P1|Overall Study|Lost to Follow-up|3
2507724|NCT01866319|8676140|P3|Overall Study|Death|77
2507725|NCT01866319|8676141|P2|Overall Study|Death|74
2507726|NCT01866319|8676142|P1|Overall Study|Death|97
2507727|NCT01866319|8676140|P3|Overall Study|Clinical progression|0
2507728|NCT01866319|8676141|P2|Overall Study|Clinical progression|0
2507729|NCT01866319|8676142|P1|Overall Study|Clinical progression|1
2507730|NCT01866319|8676140|P3|Overall Study|Adverse Event|12
2507731|NCT01866319|8676141|P2|Overall Study|Adverse Event|6
2507732|NCT01866319|8676142|P1|Overall Study|Adverse Event|13
2507733|NCT01866293|8676241|P1|Overall Study|Adverse Event|2
2507734|NCT01866098|8676286|P3|Overall Study|Death|0
2507735|NCT01866098|8676287|P2|Overall Study|Death|1
2507736|NCT01866098|8676288|P1|Overall Study|Death|0
2507737|NCT01866098|8676286|P3|Overall Study|Pregnancy|0
2507738|NCT01866098|8676287|P2|Overall Study|Pregnancy|0
2507739|NCT01866098|8676288|P1|Overall Study|Pregnancy|2
2507740|NCT01866098|8676286|P3|Overall Study|Non-compliance|1
2507741|NCT01866098|8676287|P2|Overall Study|Non-compliance|0
2507742|NCT01866098|8676288|P1|Overall Study|Non-compliance|1
2507743|NCT01866098|8676286|P3|Overall Study|Unrelated Hospitalization|1
2507744|NCT01866098|8676287|P2|Overall Study|Unrelated Hospitalization|0
2507745|NCT01866098|8676288|P1|Overall Study|Unrelated Hospitalization|2
2507746|NCT01866098|8676286|P3|Overall Study|Withdrawal by Subject|0
2507747|NCT01866098|8676287|P2|Overall Study|Withdrawal by Subject|2
2507748|NCT01866098|8676288|P1|Overall Study|Withdrawal by Subject|1
2507749|NCT01866098|8676286|P3|Overall Study|Protocol Violation|0
2507750|NCT01866098|8676287|P2|Overall Study|Protocol Violation|0
2507751|NCT01866098|8676288|P1|Overall Study|Protocol Violation|1
2507752|NCT01866098|8676286|P3|Overall Study|Adverse Event|4
2507753|NCT01866098|8676287|P2|Overall Study|Adverse Event|5
2507754|NCT01866098|8676288|P1|Overall Study|Adverse Event|1
2507755|NCT01866098|8676286|P3|Overall Study|Physician Decision|2
2507756|NCT01866098|8676287|P2|Overall Study|Physician Decision|1
2507757|NCT01866098|8676288|P1|Overall Study|Physician Decision|0
2507758|NCT01866098|8676286|P3|Overall Study|Lost to Follow-up|13
2507759|NCT01866098|8676287|P2|Overall Study|Lost to Follow-up|18
2507760|NCT01866098|8676288|P1|Overall Study|Lost to Follow-up|11
2507761|NCT01865812|8676317|P1|Overall Study|Adverse Event|2
2507762|NCT01865747|8676325|P2|Primary Intent to Treat (PITT)|Other|1
2507763|NCT01865747|8676326|P1|Primary Intent to Treat (PITT)|Other|0
2507764|NCT01865747|8676325|P2|Primary Intent to Treat (PITT)|Progressive Disease|92
2507765|NCT01865747|8676326|P1|Primary Intent to Treat (PITT)|Progressive Disease|82
2507766|NCT01865747|8676325|P2|Primary Intent to Treat (PITT)|Withdrawal by Subject|7
2507767|NCT01865747|8676326|P1|Primary Intent to Treat (PITT)|Withdrawal by Subject|3
2507768|NCT01865747|8676325|P2|Primary Intent to Treat (PITT)|Physician Decision|2
2507769|NCT01865747|8676326|P1|Primary Intent to Treat (PITT)|Physician Decision|4
2507770|NCT01865747|8676325|P2|Primary Intent to Treat (PITT)|Protocol Violation|1
2507771|NCT01865747|8676326|P1|Primary Intent to Treat (PITT)|Protocol Violation|1
2507772|NCT01865747|8676325|P2|Primary Intent to Treat (PITT)|Lack of Efficacy|0
2507773|NCT01865747|8676326|P1|Primary Intent to Treat (PITT)|Lack of Efficacy|2
2507774|NCT01865747|8676325|P2|Primary Intent to Treat (PITT)|Clinical Deterioration|29
2507775|NCT01865747|8676326|P1|Primary Intent to Treat (PITT)|Clinical Deterioration|18
2507776|NCT01865747|8676325|P2|Primary Intent to Treat (PITT)|Adverse Event|20
2507777|NCT01865747|8676326|P1|Primary Intent to Treat (PITT)|Adverse Event|21
2507778|NCT01865747|8676325|P2|Overall Study (ITT)|Reason Not Provided|1
2507779|NCT01865747|8676326|P1|Overall Study (ITT)|Reason Not Provided|0
2507780|NCT01865747|8676325|P2|Overall Study (ITT)|Progressive Disease|158
2507781|NCT01865747|8676326|P1|Overall Study (ITT)|Progressive Disease|122
2507782|NCT01865747|8676325|P2|Overall Study (ITT)|Sponsor Decision|1
2507783|NCT01865747|8676326|P1|Overall Study (ITT)|Sponsor Decision|0
2507784|NCT01865747|8676325|P2|Overall Study (ITT)|Withdrawal by Subject|11
2507785|NCT01865747|8676326|P1|Overall Study (ITT)|Withdrawal by Subject|6
2507786|NCT01865747|8676325|P2|Overall Study (ITT)|Physician Decision|2
2507787|NCT01865747|8676326|P1|Overall Study (ITT)|Physician Decision|5
2507788|NCT01865747|8676325|P2|Overall Study (ITT)|Protocol Violation|1
2507789|NCT01865747|8676326|P1|Overall Study (ITT)|Protocol Violation|1
2507790|NCT01865747|8676325|P2|Overall Study (ITT)|Lack of Efficacy|0
2507791|NCT01865747|8676326|P1|Overall Study (ITT)|Lack of Efficacy|3
2507792|NCT01865747|8676325|P2|Overall Study (ITT)|Clinical Deterioration|50
2507793|NCT01865747|8676326|P1|Overall Study (ITT)|Clinical Deterioration|29
2507794|NCT01865747|8676325|P2|Overall Study (ITT)|Adverse Event|31
2507795|NCT01865747|8676326|P1|Overall Study (ITT)|Adverse Event|32
2507796|NCT01865552|8676347|P6|Period 1|Other|0
2507797|NCT01865552|8676348|P5|Period 1|Other|1
2507798|NCT01865552|8676349|P4|Period 1|Other|0
2507799|NCT01865552|8676350|P3|Period 1|Other|0
2507800|NCT01865552|8676351|P2|Period 1|Other|0
2507801|NCT01865552|8676352|P1|Period 1|Other|0
2507802|NCT01865552|8676347|P6|Period 1|Pathological lab|0
2507803|NCT01865552|8676348|P5|Period 1|Pathological lab|1
2507804|NCT01865552|8676349|P4|Period 1|Pathological lab|0
2507805|NCT01865552|8676350|P3|Period 1|Pathological lab|0
2507806|NCT01865552|8676351|P2|Period 1|Pathological lab|0
2507807|NCT01865552|8676352|P1|Period 1|Pathological lab|0
2507808|NCT01865552|8676347|P6|Period 1|Adverse Event|1
2507809|NCT01865552|8676348|P5|Period 1|Adverse Event|1
2507810|NCT01865552|8676349|P4|Period 1|Adverse Event|1
2507811|NCT01865552|8676350|P3|Period 1|Adverse Event|0
2507812|NCT01865552|8676351|P2|Period 1|Adverse Event|0
2507813|NCT01865552|8676352|P1|Period 1|Adverse Event|1
2507814|NCT01865487|8676390|P10|Overall Study|Withdrawal by Subject|0
2507815|NCT01865487|8676391|P9|Overall Study|Withdrawal by Subject|0
2507816|NCT01865487|8676392|P8|Overall Study|Withdrawal by Subject|0
2507817|NCT01865487|8676393|P7|Overall Study|Withdrawal by Subject|0
2507818|NCT01865487|8676394|P6|Overall Study|Withdrawal by Subject|0
2507819|NCT01865487|8676395|P5|Overall Study|Withdrawal by Subject|1
2507820|NCT01865487|8676396|P4|Overall Study|Withdrawal by Subject|0
2507821|NCT01865487|8676397|P3|Overall Study|Withdrawal by Subject|0
2507822|NCT01865487|8676398|P2|Overall Study|Withdrawal by Subject|0
2507823|NCT01865487|8676399|P1|Overall Study|Withdrawal by Subject|0
2507824|NCT01865487|8676390|P10|Overall Study|Lost to Follow-up|0
2507825|NCT01865487|8676391|P9|Overall Study|Lost to Follow-up|0
2507826|NCT01865487|8676392|P8|Overall Study|Lost to Follow-up|0
2507827|NCT01865487|8676393|P7|Overall Study|Lost to Follow-up|1
2507828|NCT01865487|8676394|P6|Overall Study|Lost to Follow-up|0
2507829|NCT01865487|8676395|P5|Overall Study|Lost to Follow-up|0
2507830|NCT01865487|8676396|P4|Overall Study|Lost to Follow-up|1
2507831|NCT01865487|8676397|P3|Overall Study|Lost to Follow-up|0
2507832|NCT01865487|8676398|P2|Overall Study|Lost to Follow-up|0
2507833|NCT01865487|8676399|P1|Overall Study|Lost to Follow-up|0
2507834|NCT01865448|8676438|P2|Overall Study|dropout unrelated to study|1
2507835|NCT01865448|8676439|P1|Overall Study|dropout unrelated to study|1
2507836|NCT01865448|8676438|P2|Overall Study|Pregnancy|1
2507837|NCT01865448|8676439|P1|Overall Study|Pregnancy|0
2507838|NCT01865448|8676438|P2|Overall Study|Adverse Event|1
2507839|NCT01865448|8676439|P1|Overall Study|Adverse Event|1
2507840|NCT01865084|8676550|P3|Open Label Extension (OLE) Period|Withdrawal by Subject|2
2507841|NCT01865084|8676551|P2|Open Label Extension (OLE) Period|Withdrawal by Subject|2
2507842|NCT01865084|8676552|P1|Open Label Extension (OLE) Period|Withdrawal by Subject|0
2507843|NCT01865084|8676550|P3|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2
2507844|NCT01865084|8676551|P2|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8
2507845|NCT01865084|8676552|P1|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0
2507846|NCT01865084|8676550|P3|Open Label Extension (OLE) Period|Lost to Follow-up|0
2507847|NCT01865084|8676551|P2|Open Label Extension (OLE) Period|Lost to Follow-up|1
2507848|NCT01865084|8676552|P1|Open Label Extension (OLE) Period|Lost to Follow-up|0
2507849|NCT01865084|8676550|P3|Open Label Extension (OLE) Period|Lack of Efficacy|2
2507850|NCT01865084|8676551|P2|Open Label Extension (OLE) Period|Lack of Efficacy|0
2507851|NCT01865084|8676552|P1|Open Label Extension (OLE) Period|Lack of Efficacy|0
2507852|NCT01865084|8676550|P3|Open Label Extension (OLE) Period|Adverse Event|1
2507853|NCT01865084|8676551|P2|Open Label Extension (OLE) Period|Adverse Event|0
2507854|NCT01865084|8676552|P1|Open Label Extension (OLE) Period|Adverse Event|0
2507855|NCT01865084|8676550|P3|Double Blind Period (DB)|Withdrawal by Subject|0
2507856|NCT01865084|8676551|P2|Double Blind Period (DB)|Withdrawal by Subject|0
2507857|NCT01865084|8676552|P1|Double Blind Period (DB)|Withdrawal by Subject|1
2507858|NCT01865084|8676550|P3|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4
2507859|NCT01865084|8676551|P2|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
2507860|NCT01865084|8676552|P1|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
2507861|NCT01865084|8676550|P3|Double Blind Period (DB)|Protocol Violation|1
2507862|NCT01865084|8676551|P2|Double Blind Period (DB)|Protocol Violation|0
2507863|NCT01865084|8676552|P1|Double Blind Period (DB)|Protocol Violation|0
2507864|NCT01865084|8676550|P3|Double Blind Period (DB)|Adverse Event|1
2507865|NCT01865084|8676551|P2|Double Blind Period (DB)|Adverse Event|2
2507866|NCT01865084|8676552|P1|Double Blind Period (DB)|Adverse Event|2
2507867|NCT01864525|8676584|P2|Overall Study|Adverse Event|0
2507868|NCT01864525|8676585|P1|Overall Study|Adverse Event|1
2507869|NCT01864200|8676608|P2|Overall Study|Protocol Violation|0
2507870|NCT01864200|8676609|P1|Overall Study|Protocol Violation|1
2507871|NCT01864200|8676608|P2|Overall Study|Lost to Follow-up|3
2507872|NCT01864200|8676609|P1|Overall Study|Lost to Follow-up|1
2507873|NCT01864174|8676617|P2|Off Treatment Follow-Up|Subject Withdrew Consent|0
2507874|NCT01864174|8676618|P1|Off Treatment Follow-Up|Subject Withdrew Consent|1
2507875|NCT01864174|8676617|P2|Off Treatment Follow-Up|Other|0
2507876|NCT01864174|8676618|P1|Off Treatment Follow-Up|Other|2
2507877|NCT01864174|8676617|P2|Double Blind - Compliant Randomized|Other|10
2507878|NCT01864174|8676618|P1|Double Blind - Compliant Randomized|Other|6
2507879|NCT01864174|8676617|P2|Double Blind - Compliant Randomized|Poor/Non-compliance|0
2507880|NCT01864174|8676618|P1|Double Blind - Compliant Randomized|Poor/Non-compliance|1
2507881|NCT01864174|8676617|P2|Double Blind - Compliant Randomized|Lost to Follow-up|10
2507882|NCT01864174|8676618|P1|Double Blind - Compliant Randomized|Lost to Follow-up|3
2507883|NCT01864174|8676617|P2|Double Blind - Compliant Randomized|Death|0
2507884|NCT01864174|8676618|P1|Double Blind - Compliant Randomized|Death|1
2507885|NCT01864174|8676617|P2|Double Blind - Compliant Randomized|Subject Withdrew Consent|5
2507886|NCT01864174|8676618|P1|Double Blind - Compliant Randomized|Subject Withdrew Consent|4
2507887|NCT01864174|8676617|P2|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0
2507888|NCT01864174|8676618|P1|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2
2507889|NCT01864174|8676617|P2|Double Blind - Compliant Randomized|Adverse Event|1
2507890|NCT01864174|8676618|P1|Double Blind - Compliant Randomized|Adverse Event|6
2507891|NCT01864174|8676617|P2|Double Blind Treatment - All Treated|Removed due to site non-compliance|14
2507892|NCT01864174|8676618|P1|Double Blind Treatment - All Treated|Removed due to site non-compliance|15
2507893|NCT01864148|8676637|P5|Overall Study|Not Dosed|0
2507894|NCT01864148|8676638|P4|Overall Study|Not Dosed|1
2507895|NCT01864148|8676639|P3|Overall Study|Not Dosed|0
2507896|NCT01864148|8676640|P2|Overall Study|Not Dosed|0
2507897|NCT01864148|8676641|P1|Overall Study|Not Dosed|0
2507898|NCT01864148|8676637|P5|Overall Study|Adverse Event|7
2507899|NCT01864148|8676638|P4|Overall Study|Adverse Event|7
2507900|NCT01864148|8676639|P3|Overall Study|Adverse Event|4
2507901|NCT01864148|8676640|P2|Overall Study|Adverse Event|2
2507902|NCT01864148|8676641|P1|Overall Study|Adverse Event|4
2507903|NCT01864148|8676637|P5|Overall Study|Lost to Follow-up|1
2507904|NCT01864148|8676638|P4|Overall Study|Lost to Follow-up|2
2507905|NCT01864148|8676639|P3|Overall Study|Lost to Follow-up|0
2507906|NCT01864148|8676640|P2|Overall Study|Lost to Follow-up|0
2507907|NCT01864148|8676641|P1|Overall Study|Lost to Follow-up|0
2507908|NCT01864148|8676637|P5|Overall Study|Withdrawal by Subject|8
2507909|NCT01864148|8676638|P4|Overall Study|Withdrawal by Subject|8
2507910|NCT01864148|8676639|P3|Overall Study|Withdrawal by Subject|6
2507911|NCT01864148|8676640|P2|Overall Study|Withdrawal by Subject|2
2507912|NCT01864148|8676641|P1|Overall Study|Withdrawal by Subject|9
2507913|NCT01864148|8676637|P5|Overall Study|Investigator Decision|6
2507914|NCT01864148|8676638|P4|Overall Study|Investigator Decision|4
2507915|NCT01864148|8676639|P3|Overall Study|Investigator Decision|0
2507916|NCT01864148|8676640|P2|Overall Study|Investigator Decision|0
2507917|NCT01864148|8676641|P1|Overall Study|Investigator Decision|5
2507918|NCT01864148|8676637|P5|Overall Study|Death|0
2507919|NCT01864148|8676638|P4|Overall Study|Death|1
2507920|NCT01864148|8676639|P3|Overall Study|Death|0
2507921|NCT01864148|8676640|P2|Overall Study|Death|0
2507922|NCT01864148|8676641|P1|Overall Study|Death|0
2507923|NCT01864148|8676637|P5|Overall Study|Other|1
2507924|NCT01864148|8676638|P4|Overall Study|Other|3
2507925|NCT01864148|8676639|P3|Overall Study|Other|1
2507926|NCT01864148|8676640|P2|Overall Study|Other|1
2507927|NCT01864148|8676641|P1|Overall Study|Other|2
2507928|NCT01864005|8676670|P2|Overall Study|Need GP IIb/IIIa|3
2507929|NCT01864005|8676671|P1|Overall Study|Need GP IIb/IIIa|1
2507930|NCT01864005|8676670|P2|Overall Study|Disease need|1
2507931|NCT01864005|8676671|P1|Overall Study|Disease need|1
2507932|NCT01864005|8676670|P2|Overall Study|Incorrect enrolment|0
2507933|NCT01864005|8676671|P1|Overall Study|Incorrect enrolment|1
2507934|NCT01864005|8676670|P2|Overall Study|Withdrawal by Subject|1
2507935|NCT01864005|8676671|P1|Overall Study|Withdrawal by Subject|0
2507936|NCT01864005|8676670|P2|Overall Study|Protocol Violation|1
2507937|NCT01864005|8676671|P1|Overall Study|Protocol Violation|0
2507938|NCT01863953|8676688|P3|Overall Study|Adverse Event|1
2507939|NCT01863953|8676689|P2|Overall Study|Adverse Event|0
2507940|NCT01863953|8676690|P1|Overall Study|Adverse Event|0
2507941|NCT01863771|8676704|P4|Maintenance Phase|Withdrawal by Subject|3
2507942|NCT01863771|8676705|P3|Maintenance Phase|Withdrawal by Subject|2
2507943|NCT01863771|8676706|P2|Maintenance Phase|Withdrawal by Subject|1
2507944|NCT01863771|8676707|P1|Maintenance Phase|Withdrawal by Subject|0
2507945|NCT01863771|8676704|P4|Maintenance Phase|Pregnancy|0
2507946|NCT01863771|8676705|P3|Maintenance Phase|Pregnancy|0
2507947|NCT01863771|8676706|P2|Maintenance Phase|Pregnancy|1
2507948|NCT01863771|8676707|P1|Maintenance Phase|Pregnancy|0
2507949|NCT01863771|8676704|P4|Maintenance Phase|Physician Decision|1
2507950|NCT01863771|8676705|P3|Maintenance Phase|Physician Decision|2
2507951|NCT01863771|8676706|P2|Maintenance Phase|Physician Decision|0
2507952|NCT01863771|8676707|P1|Maintenance Phase|Physician Decision|0
2507953|NCT01863771|8676704|P4|Maintenance Phase|Lack of Efficacy|38
2507954|NCT01863771|8676705|P3|Maintenance Phase|Lack of Efficacy|7
2507955|NCT01863771|8676706|P2|Maintenance Phase|Lack of Efficacy|3
2507956|NCT01863771|8676707|P1|Maintenance Phase|Lack of Efficacy|0
2507957|NCT01863771|8676704|P4|Maintenance Phase|Adverse Event|1
2507958|NCT01863771|8676705|P3|Maintenance Phase|Adverse Event|1
2507959|NCT01863771|8676706|P2|Maintenance Phase|Adverse Event|0
2507960|NCT01863771|8676707|P1|Maintenance Phase|Adverse Event|0
2507961|NCT01863771|8676704|P4|Induction Phase|Withdrawal by Subject|0
2507962|NCT01863771|8676705|P3|Induction Phase|Withdrawal by Subject|0
2507963|NCT01863771|8676706|P2|Induction Phase|Withdrawal by Subject|0
2507964|NCT01863771|8676707|P1|Induction Phase|Withdrawal by Subject|2
2507965|NCT01863771|8676704|P4|Induction Phase|Lack of Efficacy|0
2507966|NCT01863771|8676705|P3|Induction Phase|Lack of Efficacy|0
2507967|NCT01863771|8676706|P2|Induction Phase|Lack of Efficacy|0
2507968|NCT01863771|8676707|P1|Induction Phase|Lack of Efficacy|10
2507969|NCT01863771|8676704|P4|Induction Phase|Adverse Event|0
2507970|NCT01863771|8676705|P3|Induction Phase|Adverse Event|0
2507971|NCT01863771|8676706|P2|Induction Phase|Adverse Event|0
2507972|NCT01863771|8676707|P1|Induction Phase|Adverse Event|9
2507973|NCT01863758|8676719|P1|Prophylactic Treatment-Phase II|Lost to Follow-up|1
2507974|NCT01863758|8676719|P1|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1
2507975|NCT01863732|8676731|P4|Overall Study|Death|1
2507976|NCT01863732|8676732|P3|Overall Study|Death|0
2507977|NCT01863732|8676733|P2|Overall Study|Death|0
2507978|NCT01863732|8676734|P1|Overall Study|Death|1
2507979|NCT01863732|8676731|P4|Overall Study|Subject/guardian decision|1
2507980|NCT01863732|8676732|P3|Overall Study|Subject/guardian decision|3
2507981|NCT01863732|8676733|P2|Overall Study|Subject/guardian decision|9
2507982|NCT01863732|8676734|P1|Overall Study|Subject/guardian decision|6
2507983|NCT01863732|8676731|P4|Overall Study|Technical problems|0
2507984|NCT01863732|8676732|P3|Overall Study|Technical problems|1
2507985|NCT01863732|8676733|P2|Overall Study|Technical problems|1
2507986|NCT01863732|8676734|P1|Overall Study|Technical problems|0
2507987|NCT01863732|8676731|P4|Overall Study|Pregnancy|1
2507988|NCT01863732|8676732|P3|Overall Study|Pregnancy|0
2507989|NCT01863732|8676733|P2|Overall Study|Pregnancy|0
2507990|NCT01863732|8676734|P1|Overall Study|Pregnancy|0
2507991|NCT01863732|8676731|P4|Overall Study|Physician Decision|0
2507992|NCT01863732|8676732|P3|Overall Study|Physician Decision|1
2507993|NCT01863732|8676733|P2|Overall Study|Physician Decision|0
2507994|NCT01863732|8676734|P1|Overall Study|Physician Decision|1
2507995|NCT01863732|8676731|P4|Overall Study|Lost to Follow-up|1
2507996|NCT01863732|8676732|P3|Overall Study|Lost to Follow-up|1
2507997|NCT01863732|8676733|P2|Overall Study|Lost to Follow-up|2
2507998|NCT01863732|8676734|P1|Overall Study|Lost to Follow-up|2
2507999|NCT01863732|8676731|P4|Overall Study|Lack of Efficacy|1
2508000|NCT01863732|8676732|P3|Overall Study|Lack of Efficacy|2
2508001|NCT01863732|8676733|P2|Overall Study|Lack of Efficacy|0
2508002|NCT01863732|8676734|P1|Overall Study|Lack of Efficacy|1
2508003|NCT01863732|8676731|P4|Overall Study|Adverse Event|3
2508004|NCT01863732|8676732|P3|Overall Study|Adverse Event|3
2508005|NCT01863732|8676733|P2|Overall Study|Adverse Event|0
2508006|NCT01863732|8676734|P1|Overall Study|Adverse Event|2
2508007|NCT01863680|8676747|P1|Overall Study|Other|6
2508008|NCT01863680|8676747|P1|Overall Study|Did not undergo IVF/ET|14
2508009|NCT01863680|8676747|P1|Overall Study|Withdrawal by Subject|1
2508010|NCT01863680|8676747|P1|Overall Study|Spontaneous pregnancy|2
2508011|NCT01863680|8676747|P1|Overall Study|Risk of OHSS|17
2508012|NCT01863680|8676747|P1|Overall Study|Adverse Event|17
2508013|NCT01863667|8676755|P2|Overall Study|Withdrawal by Subject|2
2508014|NCT01863667|8676756|P1|Overall Study|Withdrawal by Subject|2
2508015|NCT01863667|8676755|P2|Overall Study|Study terminated by Sponsor|30
2508016|NCT01863667|8676756|P1|Overall Study|Study terminated by Sponsor|30
2508017|NCT01863667|8676755|P2|Overall Study|Adverse Event|0
2508018|NCT01863667|8676756|P1|Overall Study|Adverse Event|1
2508019|NCT01863433|8676780|P1|Overall Study|Protocol Violation|1
2508020|NCT01863368|8676790|P2|Phase II, Day 35 to Day 90|Lost to Follow-up|0
2508021|NCT01863368|8676791|P1|Phase II, Day 35 to Day 90|Lost to Follow-up|1
2508022|NCT01863368|8676790|P2|Phase II, Day 35 to Day 90|Adverse Event|0
2508023|NCT01863368|8676791|P1|Phase II, Day 35 to Day 90|Adverse Event|1
2508024|NCT01863368|8676790|P2|Phase I, Day 0 to Day 35|Withdrawal by Subject|2
2508025|NCT01863368|8676791|P1|Phase I, Day 0 to Day 35|Withdrawal by Subject|0
2508026|NCT01863368|8676790|P2|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1
2508027|NCT01863368|8676791|P1|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0
2508028|NCT01863368|8676790|P2|Phase I, Day 0 to Day 35|Lost to Follow-up|0
2508029|NCT01863368|8676791|P1|Phase I, Day 0 to Day 35|Lost to Follow-up|1
2508030|NCT01863368|8676790|P2|Phase I, Day 0 to Day 35|Adverse Event|4
2508031|NCT01863368|8676791|P1|Phase I, Day 0 to Day 35|Adverse Event|2
2508032|NCT01862991|8676845|P3|Overall Study|Protocol Violation|0
2508033|NCT01862991|8676846|P2|Overall Study|Protocol Violation|0
2508034|NCT01862991|8676847|P1|Overall Study|Protocol Violation|1
2508035|NCT01862991|8676845|P3|Overall Study|Lost to Follow-up|1
2508036|NCT01862991|8676846|P2|Overall Study|Lost to Follow-up|1
2508037|NCT01862991|8676847|P1|Overall Study|Lost to Follow-up|2
2508038|NCT01862874|8676860|P2|Overall Study|Death|1
2508039|NCT01862874|8676861|P1|Overall Study|Death|0
2508040|NCT01862874|8676860|P2|Overall Study|Withdrawal by Subject|40
2508041|NCT01862874|8676861|P1|Overall Study|Withdrawal by Subject|46
2508042|NCT01862874|8676860|P2|Overall Study|Withdrawn by parent/guardian|1
2508043|NCT01862874|8676861|P1|Overall Study|Withdrawn by parent/guardian|1
2508044|NCT01862874|8676860|P2|Overall Study|Physician Decision|3
2508045|NCT01862874|8676861|P1|Overall Study|Physician Decision|5
2508046|NCT01862874|8676860|P2|Overall Study|Lost to Follow-up|29
2508047|NCT01862874|8676861|P1|Overall Study|Lost to Follow-up|26
2508048|NCT01862874|8676860|P2|Overall Study|Adverse Event|3
2508049|NCT01862874|8676861|P1|Overall Study|Adverse Event|0
2508050|NCT01862874|8676860|P2|Overall Study|Randomized not treated|0
2508051|NCT01862874|8676861|P1|Overall Study|Randomized not treated|1
2508052|NCT01862796|8676880|P3|Overall Study|Prohibited medications|1
2508053|NCT01862796|8676881|P2|Overall Study|Prohibited medications|0
2508054|NCT01862796|8676882|P1|Overall Study|Prohibited medications|0
2508055|NCT01862484|8676895|P2|Overall Study|Withdrawal by Subject|3
2508056|NCT01862484|8676896|P1|Overall Study|Withdrawal by Subject|0
2508057|NCT01862484|8676895|P2|Overall Study|Protocol Violation|2
2508058|NCT01862484|8676896|P1|Overall Study|Protocol Violation|0
2508059|NCT01862484|8676895|P2|Overall Study|Lost to Follow-up|2
2508060|NCT01862484|8676896|P1|Overall Study|Lost to Follow-up|1
2508061|NCT01862484|8676895|P2|Overall Study|Lack of Efficacy|1
2508062|NCT01862484|8676896|P1|Overall Study|Lack of Efficacy|1
2508063|NCT01862250|8676915|P1|Overall Study|Adverse Event|4
2508064|NCT01862029|8676936|P1|Overall Study|Physician Decision|1
2508065|NCT01861522|8677039|P2|Overall Study|Withdrawal by Subject|0
2508066|NCT01861522|8677040|P1|Overall Study|Withdrawal by Subject|2
2508067|NCT01861522|8677039|P2|Overall Study|Adverse Event|0
2508068|NCT01861522|8677040|P1|Overall Study|Adverse Event|1
2508069|NCT01860989|8677064|P1|Overall Study|Unsatisfactory therapeutic|5
2508070|NCT01860976|8677070|P2|Long Term Extension|Ongoing treatment at time of analysis|100
2508071|NCT01860976|8677071|P1|Long Term Extension|Ongoing treatment at time of analysis|106
2508072|NCT01860976|8677070|P2|Long Term Extension|Withdrawal by Subject|0
2508073|NCT01860976|8677071|P1|Long Term Extension|Withdrawal by Subject|1
2508074|NCT01860976|8677070|P2|Long Term Extension|Subject request to discontinue treatment|0
2508075|NCT01860976|8677071|P1|Long Term Extension|Subject request to discontinue treatment|2
2508076|NCT01860976|8677070|P2|Long Term Extension|Lack of Efficacy|7
2508077|NCT01860976|8677071|P1|Long Term Extension|Lack of Efficacy|3
2508078|NCT01860976|8677070|P2|Long Term Extension|Adverse Event|0
2508079|NCT01860976|8677071|P1|Long Term Extension|Adverse Event|1
2508080|NCT01860976|8677070|P2|Open-Label|Ongoing OL treatment at time of analysis|45
2508081|NCT01860976|8677071|P1|Open-Label|Ongoing OL treatment at time of analysis|46
2508082|NCT01860976|8677070|P2|Open-Label|Other Reasons|1
2508083|NCT01860976|8677071|P1|Open-Label|Other Reasons|1
2508084|NCT01860976|8677070|P2|Open-Label|Withdrawal by Subject|1
2508085|NCT01860976|8677071|P1|Open-Label|Withdrawal by Subject|4
2508086|NCT01860976|8677070|P2|Open-Label|Subject request discontinue treatment|3
2508087|NCT01860976|8677071|P1|Open-Label|Subject request discontinue treatment|4
2508088|NCT01860976|8677070|P2|Open-Label|Lost to Follow-up|2
2508089|NCT01860976|8677071|P1|Open-Label|Lost to Follow-up|1
2508090|NCT01860976|8677070|P2|Open-Label|Lack of Efficacy|8
2508091|NCT01860976|8677071|P1|Open-Label|Lack of Efficacy|16
2508092|NCT01860976|8677070|P2|Open-Label|Adverse Event|4
2508093|NCT01860976|8677071|P1|Open-Label|Adverse Event|2
2508094|NCT01860976|8677070|P2|Blinded Treatment|Early Escape: Transitioned to OL period|89
2508095|NCT01860976|8677071|P1|Blinded Treatment|Early Escape: Transitioned to OL period|76
2508096|NCT01860976|8677070|P2|Blinded Treatment|Entered Open-Label in error|1
2508097|NCT01860976|8677071|P1|Blinded Treatment|Entered Open-Label in error|0
2508098|NCT01860976|8677070|P2|Blinded Treatment|Subject no longer met criteria|0
2508099|NCT01860976|8677071|P1|Blinded Treatment|Subject no longer met criteria|1
2508100|NCT01860976|8677070|P2|Blinded Treatment|Withdrawal by Subject|5
2508101|NCT01860976|8677071|P1|Blinded Treatment|Withdrawal by Subject|3
2508102|NCT01860976|8677070|P2|Blinded Treatment|Subject request to discontinue treatment|3
2508103|NCT01860976|8677071|P1|Blinded Treatment|Subject request to discontinue treatment|2
2508104|NCT01860976|8677070|P2|Blinded Treatment|Lack of Efficacy|12
2508105|NCT01860976|8677071|P1|Blinded Treatment|Lack of Efficacy|5
2508106|NCT01860976|8677070|P2|Blinded Treatment|Adverse Event|3
2508107|NCT01860976|8677071|P1|Blinded Treatment|Adverse Event|1
2508108|NCT01860846|8677125|P1|Overall Study|Lost to Follow-up|33
2508109|NCT01860703|8677145|P4|Overall Study|Personal reason|0
2508110|NCT01860703|8677146|P3|Overall Study|Personal reason|1
2508111|NCT01860703|8677147|P2|Overall Study|Personal reason|0
2508112|NCT01860703|8677148|P1|Overall Study|Personal reason|1
2508113|NCT01860703|8677145|P4|Overall Study|Withdrawal by Subject|0
2508114|NCT01860703|8677146|P3|Overall Study|Withdrawal by Subject|0
2508115|NCT01860703|8677147|P2|Overall Study|Withdrawal by Subject|1
2508116|NCT01860703|8677148|P1|Overall Study|Withdrawal by Subject|0
2508117|NCT01860703|8677145|P4|Overall Study|Adverse Event|2
2508118|NCT01860703|8677146|P3|Overall Study|Adverse Event|0
2508119|NCT01860703|8677147|P2|Overall Study|Adverse Event|4
2508120|NCT01860703|8677148|P1|Overall Study|Adverse Event|1
2508121|NCT01860677|8677180|P2|Second Intervention (1 Day)|Lost to Follow-up|0
2508122|NCT01860677|8677181|P1|Second Intervention (1 Day)|Lost to Follow-up|7
2508123|NCT01860534|8677238|P2|ROP #2|discharged prior to ROP #2|0
2508124|NCT01860534|8677239|P1|ROP #2|discharged prior to ROP #2|1
2508125|NCT01860534|8677238|P2|ROP #1|Needed treatment for ROP|1
2508126|NCT01860534|8677239|P1|ROP #1|Needed treatment for ROP|0
2508127|NCT01860079|8677300|P2|Overall Study|Physician Decision|22
2508128|NCT01860079|8677301|P1|Overall Study|Physician Decision|14
2508129|NCT01860040|8677309|P2|Overall Study|Withdrawal by Subject|0
2508130|NCT01860040|8677310|P1|Overall Study|Withdrawal by Subject|1
2508131|NCT01859988|8677321|P6|Overall Study|Other than specified above|3
2508132|NCT01859988|8677322|P5|Overall Study|Other than specified above|5
2508133|NCT01859988|8677323|P4|Overall Study|Other than specified above|3
2508134|NCT01859988|8677324|P3|Overall Study|Other than specified above|11
2508135|NCT01859988|8677325|P2|Overall Study|Other than specified above|2
2508136|NCT01859988|8677326|P1|Overall Study|Other than specified above|0
2508137|NCT01859988|8677321|P6|Overall Study|Protocol Violation|0
2508138|NCT01859988|8677322|P5|Overall Study|Protocol Violation|0
2508139|NCT01859988|8677323|P4|Overall Study|Protocol Violation|0
2508140|NCT01859988|8677324|P3|Overall Study|Protocol Violation|1
2508141|NCT01859988|8677325|P2|Overall Study|Protocol Violation|0
2508142|NCT01859988|8677326|P1|Overall Study|Protocol Violation|0
2508143|NCT01859988|8677321|P6|Overall Study|Lost to Follow-up|2
2508144|NCT01859988|8677322|P5|Overall Study|Lost to Follow-up|3
2508145|NCT01859988|8677323|P4|Overall Study|Lost to Follow-up|0
2508146|NCT01859988|8677324|P3|Overall Study|Lost to Follow-up|3
2508147|NCT01859988|8677325|P2|Overall Study|Lost to Follow-up|2
2508148|NCT01859988|8677326|P1|Overall Study|Lost to Follow-up|1
2508149|NCT01859988|8677321|P6|Overall Study|Adverse Event|2
2508150|NCT01859988|8677322|P5|Overall Study|Adverse Event|2
2508151|NCT01859988|8677323|P4|Overall Study|Adverse Event|1
2508152|NCT01859988|8677324|P3|Overall Study|Adverse Event|3
2508153|NCT01859988|8677325|P2|Overall Study|Adverse Event|1
2508154|NCT01859988|8677326|P1|Overall Study|Adverse Event|2
2508155|NCT01859988|8677321|P6|Overall Study|Physician Decision|1
2508156|NCT01859988|8677322|P5|Overall Study|Physician Decision|4
2508157|NCT01859988|8677323|P4|Overall Study|Physician Decision|3
2508158|NCT01859988|8677324|P3|Overall Study|Physician Decision|1
2508159|NCT01859988|8677325|P2|Overall Study|Physician Decision|3
2508160|NCT01859988|8677326|P1|Overall Study|Physician Decision|1
2508161|NCT01859988|8677321|P6|Overall Study|Lack of Efficacy|9
2508162|NCT01859988|8677322|P5|Overall Study|Lack of Efficacy|7
2508163|NCT01859988|8677323|P4|Overall Study|Lack of Efficacy|0
2508164|NCT01859988|8677324|P3|Overall Study|Lack of Efficacy|5
2508165|NCT01859988|8677325|P2|Overall Study|Lack of Efficacy|1
2508166|NCT01859988|8677326|P1|Overall Study|Lack of Efficacy|1
2508167|NCT01859988|8677321|P6|Overall Study|Withdrawal by Subject|2
2508168|NCT01859988|8677322|P5|Overall Study|Withdrawal by Subject|2
2508169|NCT01859988|8677323|P4|Overall Study|Withdrawal by Subject|3
2508170|NCT01859988|8677324|P3|Overall Study|Withdrawal by Subject|4
2508171|NCT01859988|8677325|P2|Overall Study|Withdrawal by Subject|3
2508172|NCT01859988|8677326|P1|Overall Study|Withdrawal by Subject|6
2508173|NCT01859949|8677420|P2|Overall Study|Adverse Event|1
2508174|NCT01859949|8677421|P1|Overall Study|Adverse Event|0
2508175|NCT01859949|8677420|P2|Overall Study|Protocol Violation|1
2508176|NCT01859949|8677421|P1|Overall Study|Protocol Violation|1
2508177|NCT01859949|8677420|P2|Overall Study|Withdrawal by Subject|10
2508178|NCT01859949|8677421|P1|Overall Study|Withdrawal by Subject|11
2508179|NCT01859949|8677420|P2|Overall Study|Physician Decision|4
2508180|NCT01859949|8677421|P1|Overall Study|Physician Decision|2
2508181|NCT01859949|8677420|P2|Overall Study|Family Matters|1
2508182|NCT01859949|8677421|P1|Overall Study|Family Matters|0
2508183|NCT01859793|8677439|P2|Washout Period (4 Weeks)|Lost to Follow-up|1
2508184|NCT01859793|8677440|P1|Washout Period (4 Weeks)|Lost to Follow-up|1
2508185|NCT01859793|8677439|P2|First Intervention (8 Weeks)|Withdrawal by Subject|1
2508186|NCT01859793|8677440|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
2508187|NCT01859793|8677439|P2|First Intervention (8 Weeks)|Adverse Event|0
2508188|NCT01859793|8677440|P1|First Intervention (8 Weeks)|Adverse Event|1
2508189|NCT01859793|8677439|P2|First Intervention (8 Weeks)|Protocol Violation|0
2508190|NCT01859793|8677440|P1|First Intervention (8 Weeks)|Protocol Violation|2
2508191|NCT01859741|8677458|P8|Overall Study|Other|0
2508192|NCT01859741|8677459|P7|Overall Study|Other|2
2508193|NCT01859741|8677460|P6|Overall Study|Other|0
2508194|NCT01859741|8677461|P5|Overall Study|Other|0
2508195|NCT01859741|8677462|P4|Overall Study|Other|0
2508196|NCT01859741|8677463|P3|Overall Study|Other|0
2508197|NCT01859741|8677464|P2|Overall Study|Other|0
2508198|NCT01859741|8677465|P1|Overall Study|Other|0
2508199|NCT01859741|8677458|P8|Overall Study|Study Terminated by Sponsor|14
2508200|NCT01859741|8677459|P7|Overall Study|Study Terminated by Sponsor|16
2508201|NCT01859741|8677460|P6|Overall Study|Study Terminated by Sponsor|0
2508202|NCT01859741|8677461|P5|Overall Study|Study Terminated by Sponsor|1
2508203|NCT01859741|8677462|P4|Overall Study|Study Terminated by Sponsor|0
2508204|NCT01859741|8677463|P3|Overall Study|Study Terminated by Sponsor|0
2508205|NCT01859741|8677464|P2|Overall Study|Study Terminated by Sponsor|0
2508206|NCT01859741|8677465|P1|Overall Study|Study Terminated by Sponsor|0
2508207|NCT01859741|8677458|P8|Overall Study|Withdrawal by Subject|1
2508208|NCT01859741|8677459|P7|Overall Study|Withdrawal by Subject|1
2508209|NCT01859741|8677460|P6|Overall Study|Withdrawal by Subject|1
2508210|NCT01859741|8677461|P5|Overall Study|Withdrawal by Subject|0
2508211|NCT01859741|8677462|P4|Overall Study|Withdrawal by Subject|0
2508212|NCT01859741|8677463|P3|Overall Study|Withdrawal by Subject|2
2508213|NCT01859741|8677464|P2|Overall Study|Withdrawal by Subject|1
2508214|NCT01859741|8677465|P1|Overall Study|Withdrawal by Subject|0
2508215|NCT01859741|8677458|P8|Overall Study|Lost to Follow-up|4
2508216|NCT01859741|8677459|P7|Overall Study|Lost to Follow-up|0
2508217|NCT01859741|8677460|P6|Overall Study|Lost to Follow-up|1
2508218|NCT01859741|8677461|P5|Overall Study|Lost to Follow-up|0
2508219|NCT01859741|8677462|P4|Overall Study|Lost to Follow-up|0
2508220|NCT01859741|8677463|P3|Overall Study|Lost to Follow-up|0
2508221|NCT01859741|8677464|P2|Overall Study|Lost to Follow-up|0
2508222|NCT01859741|8677465|P1|Overall Study|Lost to Follow-up|0
2508223|NCT01859741|8677458|P8|Overall Study|Death|51
2508224|NCT01859741|8677459|P7|Overall Study|Death|51
2508225|NCT01859741|8677460|P6|Overall Study|Death|4
2508226|NCT01859741|8677461|P5|Overall Study|Death|5
2508227|NCT01859741|8677462|P4|Overall Study|Death|3
2508228|NCT01859741|8677463|P3|Overall Study|Death|4
2508229|NCT01859741|8677464|P2|Overall Study|Death|2
2508230|NCT01859741|8677465|P1|Overall Study|Death|3
2508231|NCT01859715|8677494|P3|Overall Study|No 2nd VAS|23
2508232|NCT01859715|8677495|P2|Overall Study|No 2nd VAS|8
2508233|NCT01859715|8677496|P1|Overall Study|No 2nd VAS|16
2508234|NCT01859702|8677507|P1|Overall Study|Adverse Event|2
2508235|NCT01859702|8677507|P1|Overall Study|Protocol deviation|3
2508236|NCT01859598|8677521|P1|Visit 2 at 3 Months|Lost to Follow-up|1742
2508237|NCT01859507|8677529|P1|Overall Study|left the country|4
2508238|NCT01859494|8677534|P1|Overall Study|Adverse Event|1
2508239|NCT01859390|8677545|P2|Overall Study|Shipment Error|1
2508240|NCT01859390|8677546|P1|Overall Study|Shipment Error|0
2508241|NCT01859390|8677545|P2|Overall Study|Tube Cracked|2
2508242|NCT01859390|8677546|P1|Overall Study|Tube Cracked|0
2508243|NCT01859390|8677545|P2|Overall Study|Sample Missing Collection Date|1
2508244|NCT01859390|8677546|P1|Overall Study|Sample Missing Collection Date|0
2508245|NCT01859390|8677545|P2|Overall Study|Insufficient Sputum Collected|3
2508246|NCT01859390|8677546|P1|Overall Study|Insufficient Sputum Collected|1
2508247|NCT01859143|8677680|P2|Overall Study|Lost to Follow-up|0
2508248|NCT01859143|8677681|P1|Overall Study|Lost to Follow-up|2
2508249|NCT01858766|8677737|P19|Overall Study|Withdrew Consent|0
2508250|NCT01858766|8677738|P18|Overall Study|Withdrew Consent|0
2508251|NCT01858766|8677739|P17|Overall Study|Withdrew Consent|0
2508252|NCT01858766|8677740|P16|Overall Study|Withdrew Consent|0
2508253|NCT01858766|8677741|P15|Overall Study|Withdrew Consent|0
2508254|NCT01858766|8677742|P14|Overall Study|Withdrew Consent|0
2508255|NCT01858766|8677743|P13|Overall Study|Withdrew Consent|0
2508256|NCT01858766|8677744|P12|Overall Study|Withdrew Consent|1
2508257|NCT01858766|8677745|P11|Overall Study|Withdrew Consent|0
2508258|NCT01858766|8677746|P10|Overall Study|Withdrew Consent|0
2508259|NCT01858766|8677747|P9|Overall Study|Withdrew Consent|0
2508260|NCT01858766|8677748|P8|Overall Study|Withdrew Consent|0
2508261|NCT01858766|8677749|P7|Overall Study|Withdrew Consent|0
2508262|NCT01858766|8677750|P6|Overall Study|Withdrew Consent|0
2508263|NCT01858766|8677751|P5|Overall Study|Withdrew Consent|0
2508264|NCT01858766|8677752|P4|Overall Study|Withdrew Consent|0
2508265|NCT01858766|8677753|P3|Overall Study|Withdrew Consent|0
2508266|NCT01858766|8677754|P2|Overall Study|Withdrew Consent|0
2508267|NCT01858766|8677755|P1|Overall Study|Withdrew Consent|0
2508268|NCT01858766|8677737|P19|Overall Study|Lost to Follow-up|1
2508269|NCT01858766|8677738|P18|Overall Study|Lost to Follow-up|0
2508270|NCT01858766|8677739|P17|Overall Study|Lost to Follow-up|1
2508271|NCT01858766|8677740|P16|Overall Study|Lost to Follow-up|1
2508272|NCT01858766|8677741|P15|Overall Study|Lost to Follow-up|3
2508273|NCT01858766|8677742|P14|Overall Study|Lost to Follow-up|0
2508274|NCT01858766|8677743|P13|Overall Study|Lost to Follow-up|0
2508275|NCT01858766|8677744|P12|Overall Study|Lost to Follow-up|1
2508276|NCT01858766|8677745|P11|Overall Study|Lost to Follow-up|0
2508277|NCT01858766|8677746|P10|Overall Study|Lost to Follow-up|0
2508278|NCT01858766|8677747|P9|Overall Study|Lost to Follow-up|0
2508279|NCT01858766|8677748|P8|Overall Study|Lost to Follow-up|2
2508280|NCT01858766|8677749|P7|Overall Study|Lost to Follow-up|0
2508281|NCT01858766|8677750|P6|Overall Study|Lost to Follow-up|1
2508282|NCT01858766|8677751|P5|Overall Study|Lost to Follow-up|0
2508283|NCT01858766|8677752|P4|Overall Study|Lost to Follow-up|0
2508284|NCT01858766|8677753|P3|Overall Study|Lost to Follow-up|0
2508285|NCT01858766|8677754|P2|Overall Study|Lost to Follow-up|0
2508286|NCT01858766|8677755|P1|Overall Study|Lost to Follow-up|0
2508287|NCT01858766|8677737|P19|Overall Study|Lack of Efficacy|3
2508288|NCT01858766|8677738|P18|Overall Study|Lack of Efficacy|3
2508289|NCT01858766|8677739|P17|Overall Study|Lack of Efficacy|2
2508290|NCT01858766|8677740|P16|Overall Study|Lack of Efficacy|5
2508291|NCT01858766|8677741|P15|Overall Study|Lack of Efficacy|5
2508292|NCT01858766|8677742|P14|Overall Study|Lack of Efficacy|3
2508293|NCT01858766|8677743|P13|Overall Study|Lack of Efficacy|5
2508294|NCT01858766|8677744|P12|Overall Study|Lack of Efficacy|3
2508295|NCT01858766|8677745|P11|Overall Study|Lack of Efficacy|0
2508296|NCT01858766|8677746|P10|Overall Study|Lack of Efficacy|0
2508297|NCT01858766|8677747|P9|Overall Study|Lack of Efficacy|0
2508298|NCT01858766|8677748|P8|Overall Study|Lack of Efficacy|0
2508299|NCT01858766|8677749|P7|Overall Study|Lack of Efficacy|0
2508300|NCT01858766|8677750|P6|Overall Study|Lack of Efficacy|2
2508301|NCT01858766|8677751|P5|Overall Study|Lack of Efficacy|1
2508302|NCT01858766|8677752|P4|Overall Study|Lack of Efficacy|0
2508303|NCT01858766|8677753|P3|Overall Study|Lack of Efficacy|0
2508304|NCT01858766|8677754|P2|Overall Study|Lack of Efficacy|0
2508305|NCT01858766|8677755|P1|Overall Study|Lack of Efficacy|1
2508306|NCT01858766|8677737|P19|Overall Study|Death|0
2508307|NCT01858766|8677738|P18|Overall Study|Death|0
2508308|NCT01858766|8677739|P17|Overall Study|Death|0
2508309|NCT01858766|8677740|P16|Overall Study|Death|0
2508310|NCT01858766|8677741|P15|Overall Study|Death|0
2508311|NCT01858766|8677742|P14|Overall Study|Death|0
2508312|NCT01858766|8677743|P13|Overall Study|Death|0
2508313|NCT01858766|8677744|P12|Overall Study|Death|0
2508314|NCT01858766|8677745|P11|Overall Study|Death|0
2508315|NCT01858766|8677746|P10|Overall Study|Death|0
2508316|NCT01858766|8677747|P9|Overall Study|Death|0
2508317|NCT01858766|8677748|P8|Overall Study|Death|0
2508318|NCT01858766|8677749|P7|Overall Study|Death|0
2508319|NCT01858766|8677750|P6|Overall Study|Death|0
2508320|NCT01858766|8677751|P5|Overall Study|Death|0
2508321|NCT01858766|8677752|P4|Overall Study|Death|0
2508322|NCT01858766|8677753|P3|Overall Study|Death|1
2508323|NCT01858766|8677754|P2|Overall Study|Death|0
2508324|NCT01858766|8677755|P1|Overall Study|Death|0
2508325|NCT01858766|8677737|P19|Overall Study|Randomized but Never Treated|0
2508326|NCT01858766|8677738|P18|Overall Study|Randomized but Never Treated|1
2508327|NCT01858766|8677739|P17|Overall Study|Randomized but Never Treated|0
2508328|NCT01858766|8677740|P16|Overall Study|Randomized but Never Treated|0
2508329|NCT01858766|8677741|P15|Overall Study|Randomized but Never Treated|0
2508330|NCT01858766|8677742|P14|Overall Study|Randomized but Never Treated|0
2508331|NCT01858766|8677743|P13|Overall Study|Randomized but Never Treated|0
2508332|NCT01858766|8677744|P12|Overall Study|Randomized but Never Treated|0
2508333|NCT01858766|8677745|P11|Overall Study|Randomized but Never Treated|0
2508334|NCT01858766|8677746|P10|Overall Study|Randomized but Never Treated|0
2508335|NCT01858766|8677747|P9|Overall Study|Randomized but Never Treated|0
2508336|NCT01858766|8677748|P8|Overall Study|Randomized but Never Treated|0
2508337|NCT01858766|8677749|P7|Overall Study|Randomized but Never Treated|0
2508338|NCT01858766|8677750|P6|Overall Study|Randomized but Never Treated|1
2508339|NCT01858766|8677751|P5|Overall Study|Randomized but Never Treated|0
2508340|NCT01858766|8677752|P4|Overall Study|Randomized but Never Treated|0
2508341|NCT01858766|8677753|P3|Overall Study|Randomized but Never Treated|0
2508342|NCT01858766|8677754|P2|Overall Study|Randomized but Never Treated|0
2508343|NCT01858766|8677755|P1|Overall Study|Randomized but Never Treated|0
2508344|NCT01858701|8677826|P2|Period 2, Second 30 Days of Wear|Comfort|1
2508345|NCT01858701|8677827|P1|Period 2, Second 30 Days of Wear|Comfort|0
2508346|NCT01858701|8677826|P2|Washout Period, 1-13 Days|Withdrawal by Subject|2
2508347|NCT01858701|8677827|P1|Washout Period, 1-13 Days|Withdrawal by Subject|1
2508348|NCT01858701|8677826|P2|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0
2508349|NCT01858701|8677827|P1|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1
2508350|NCT01858701|8677826|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
2508351|NCT01858701|8677827|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
2508352|NCT01858636|8677833|P1|Overall Study|Withdrawal by Subject|1
2508353|NCT01858636|8677833|P1|Overall Study|Lost to Follow-up|1
2508354|NCT01858636|8677833|P1|Overall Study|Death|1
2508355|NCT01858636|8677833|P1|Overall Study|Physician Decision|1
2508356|NCT01858636|8677833|P1|Overall Study|No Device Deployment Attempted|24
2508357|NCT01858532|8677851|P4|Overall Study|Other, not specified|11
2508358|NCT01858532|8677852|P3|Overall Study|Other, not specified|13
2508359|NCT01858532|8677853|P2|Overall Study|Other, not specified|15
2508360|NCT01858532|8677854|P1|Overall Study|Other, not specified|29
2508361|NCT01858532|8677851|P4|Overall Study|Investigator request|6
2508362|NCT01858532|8677852|P3|Overall Study|Investigator request|2
2508363|NCT01858532|8677853|P2|Overall Study|Investigator request|4
2508364|NCT01858532|8677854|P1|Overall Study|Investigator request|3
2508365|NCT01858532|8677851|P4|Overall Study|Deterioration of medical status|7
2508366|NCT01858532|8677852|P3|Overall Study|Deterioration of medical status|3
2508367|NCT01858532|8677853|P2|Overall Study|Deterioration of medical status|4
2508368|NCT01858532|8677854|P1|Overall Study|Deterioration of medical status|3
2508369|NCT01858532|8677851|P4|Overall Study|Lost to Follow-up|14
2508370|NCT01858532|8677852|P3|Overall Study|Lost to Follow-up|11
2508371|NCT01858532|8677853|P2|Overall Study|Lost to Follow-up|26
2508372|NCT01858532|8677854|P1|Overall Study|Lost to Follow-up|17
2508373|NCT01858532|8677851|P4|Overall Study|Withdrew consent|27
2508374|NCT01858532|8677852|P3|Overall Study|Withdrew consent|46
2508375|NCT01858532|8677853|P2|Overall Study|Withdrew consent|93
2508376|NCT01858532|8677854|P1|Overall Study|Withdrew consent|71
2508377|NCT01858532|8677851|P4|Overall Study|Adverse Event|28
2508378|NCT01858532|8677852|P3|Overall Study|Adverse Event|23
2508379|NCT01858532|8677853|P2|Overall Study|Adverse Event|50
2508380|NCT01858532|8677854|P1|Overall Study|Adverse Event|58
2508381|NCT01858389|8677908|P2|Overall Study|Did not receive treatment|3
2508382|NCT01858389|8677909|P1|Overall Study|Did not receive treatment|0
2508383|NCT01858389|8677908|P2|Overall Study|Adverse Event|1
2508384|NCT01858389|8677909|P1|Overall Study|Adverse Event|3
2508385|NCT01858389|8677908|P2|Overall Study|Other|4
2508386|NCT01858389|8677909|P1|Overall Study|Other|2
2508387|NCT01858389|8677908|P2|Overall Study|Progressive disease|11
2508388|NCT01858389|8677909|P1|Overall Study|Progressive disease|10
2508389|NCT01858389|8677908|P2|Overall Study|Withdrawal by Subject|1
2508390|NCT01858389|8677909|P1|Overall Study|Withdrawal by Subject|0
2508391|NCT01858389|8677908|P2|Overall Study|Study terminated by sponsor|2
2508392|NCT01858389|8677909|P1|Overall Study|Study terminated by sponsor|0
2508393|NCT01858389|8677908|P2|Overall Study|Death|3
2508394|NCT01858389|8677909|P1|Overall Study|Death|1
2508395|NCT01858376|8677924|P1|Overall Study|Dropped d/t lab work not fitting criter|4
2508396|NCT01858194|8677933|P2|Overall Study|Lost to Follow-up|1
2508397|NCT01858194|8677934|P1|Overall Study|Lost to Follow-up|0
2508398|NCT01858194|8677933|P2|Overall Study|Total Artificial Heart Implant|1
2508399|NCT01858194|8677934|P1|Overall Study|Total Artificial Heart Implant|0
2508400|NCT01857973|8677987|P1|Overall Study|Physician Decision|1
2508401|NCT01857973|8677987|P1|Overall Study|drop out after 3 failed attempts|1
2508402|NCT01857973|8677987|P1|Overall Study|Subject did not meet required BG range|3
2508403|NCT01857869|8678017|P10|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
2508404|NCT01857869|8678018|P9|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
2508405|NCT01857869|8678019|P8|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
2508406|NCT01857869|8678020|P7|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
2508407|NCT01857869|8678021|P6|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
2508408|NCT01857869|8678022|P5|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
2508409|NCT01857869|8678023|P4|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1
2508410|NCT01857869|8678024|P3|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
2508411|NCT01857869|8678025|P2|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
2508412|NCT01857869|8678026|P1|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
2508413|NCT01857869|8678017|P10|Booster/Rechallenge Phase|Withdrawal by Subject|0
2508414|NCT01857869|8678018|P9|Booster/Rechallenge Phase|Withdrawal by Subject|0
2508415|NCT01857869|8678019|P8|Booster/Rechallenge Phase|Withdrawal by Subject|0
2508416|NCT01857869|8678020|P7|Booster/Rechallenge Phase|Withdrawal by Subject|0
2508417|NCT01857869|8678021|P6|Booster/Rechallenge Phase|Withdrawal by Subject|0
2508418|NCT01857869|8678022|P5|Booster/Rechallenge Phase|Withdrawal by Subject|0
2508419|NCT01857869|8678023|P4|Booster/Rechallenge Phase|Withdrawal by Subject|1
2508420|NCT01857869|8678024|P3|Booster/Rechallenge Phase|Withdrawal by Subject|0
2508421|NCT01857869|8678025|P2|Booster/Rechallenge Phase|Withdrawal by Subject|0
2508422|NCT01857869|8678026|P1|Booster/Rechallenge Phase|Withdrawal by Subject|0
2508423|NCT01857869|8678017|P10|Primary/Challenge Phase|Other|0
2508424|NCT01857869|8678018|P9|Primary/Challenge Phase|Other|0
2508425|NCT01857869|8678019|P8|Primary/Challenge Phase|Other|0
2508426|NCT01857869|8678020|P7|Primary/Challenge Phase|Other|0
2508427|NCT01857869|8678021|P6|Primary/Challenge Phase|Other|0
2508428|NCT01857869|8678022|P5|Primary/Challenge Phase|Other|0
2508429|NCT01857869|8678023|P4|Primary/Challenge Phase|Other|0
2508430|NCT01857869|8678024|P3|Primary/Challenge Phase|Other|0
2508431|NCT01857869|8678025|P2|Primary/Challenge Phase|Other|1
2508432|NCT01857869|8678026|P1|Primary/Challenge Phase|Other|1
2508433|NCT01857869|8678017|P10|Primary/Challenge Phase|Protocol Violation|0
2508434|NCT01857869|8678018|P9|Primary/Challenge Phase|Protocol Violation|0
2508435|NCT01857869|8678019|P8|Primary/Challenge Phase|Protocol Violation|0
2508436|NCT01857869|8678020|P7|Primary/Challenge Phase|Protocol Violation|0
2508437|NCT01857869|8678021|P6|Primary/Challenge Phase|Protocol Violation|0
2508438|NCT01857869|8678022|P5|Primary/Challenge Phase|Protocol Violation|0
2508439|NCT01857869|8678023|P4|Primary/Challenge Phase|Protocol Violation|0
2508440|NCT01857869|8678024|P3|Primary/Challenge Phase|Protocol Violation|0
2508441|NCT01857869|8678025|P2|Primary/Challenge Phase|Protocol Violation|0
2508442|NCT01857869|8678026|P1|Primary/Challenge Phase|Protocol Violation|1
2508443|NCT01857869|8678017|P10|Primary/Challenge Phase|Pregnancy|0
2508444|NCT01857869|8678018|P9|Primary/Challenge Phase|Pregnancy|0
2508445|NCT01857869|8678019|P8|Primary/Challenge Phase|Pregnancy|0
2508446|NCT01857869|8678020|P7|Primary/Challenge Phase|Pregnancy|0
2508447|NCT01857869|8678021|P6|Primary/Challenge Phase|Pregnancy|0
2508448|NCT01857869|8678022|P5|Primary/Challenge Phase|Pregnancy|0
2508449|NCT01857869|8678023|P4|Primary/Challenge Phase|Pregnancy|0
2508450|NCT01857869|8678024|P3|Primary/Challenge Phase|Pregnancy|0
2508451|NCT01857869|8678025|P2|Primary/Challenge Phase|Pregnancy|0
2508452|NCT01857869|8678026|P1|Primary/Challenge Phase|Pregnancy|1
2508453|NCT01857869|8678017|P10|Primary/Challenge Phase|Lost to Follow-up|0
2508454|NCT01857869|8678018|P9|Primary/Challenge Phase|Lost to Follow-up|0
2508455|NCT01857869|8678019|P8|Primary/Challenge Phase|Lost to Follow-up|0
2508456|NCT01857869|8678020|P7|Primary/Challenge Phase|Lost to Follow-up|0
2508457|NCT01857869|8678021|P6|Primary/Challenge Phase|Lost to Follow-up|0
2508458|NCT01857869|8678022|P5|Primary/Challenge Phase|Lost to Follow-up|0
2508459|NCT01857869|8678023|P4|Primary/Challenge Phase|Lost to Follow-up|0
2508460|NCT01857869|8678024|P3|Primary/Challenge Phase|Lost to Follow-up|0
2508461|NCT01857869|8678025|P2|Primary/Challenge Phase|Lost to Follow-up|0
2508462|NCT01857869|8678026|P1|Primary/Challenge Phase|Lost to Follow-up|2
2508463|NCT01857622|8678116|P3|Overall Study|Withdrawal by Subject|0
2508464|NCT01857622|8678117|P2|Overall Study|Withdrawal by Subject|0
2508465|NCT01857622|8678118|P1|Overall Study|Withdrawal by Subject|1
2508466|NCT01857622|8678116|P3|Overall Study|Protocol Violation|0
2508467|NCT01857622|8678117|P2|Overall Study|Protocol Violation|1
2508468|NCT01857622|8678118|P1|Overall Study|Protocol Violation|4
2508469|NCT01857622|8678116|P3|Overall Study|Physician Decision|0
2508470|NCT01857622|8678117|P2|Overall Study|Physician Decision|0
2508471|NCT01857622|8678118|P1|Overall Study|Physician Decision|1
2508472|NCT01857622|8678116|P3|Overall Study|Adverse Event|2
2508473|NCT01857622|8678117|P2|Overall Study|Adverse Event|0
2508474|NCT01857622|8678118|P1|Overall Study|Adverse Event|5
2508475|NCT01857583|8678130|P4|Overall Study|Withdrawal by Subject|2
2508476|NCT01857583|8678131|P3|Overall Study|Withdrawal by Subject|1
2508477|NCT01857583|8678132|P2|Overall Study|Withdrawal by Subject|0
2508478|NCT01857583|8678133|P1|Overall Study|Withdrawal by Subject|1
2508479|NCT01857583|8678130|P4|Overall Study|Physician Decision|1
2508480|NCT01857583|8678131|P3|Overall Study|Physician Decision|0
2508481|NCT01857583|8678132|P2|Overall Study|Physician Decision|0
2508482|NCT01857583|8678133|P1|Overall Study|Physician Decision|0
2508483|NCT01857583|8678130|P4|Overall Study|Death|0
2508484|NCT01857583|8678131|P3|Overall Study|Death|1
2508485|NCT01857583|8678132|P2|Overall Study|Death|1
2508486|NCT01857583|8678133|P1|Overall Study|Death|0
2508487|NCT01857583|8678130|P4|Overall Study|Adverse Event|1
2508488|NCT01857583|8678131|P3|Overall Study|Adverse Event|1
2508489|NCT01857583|8678132|P2|Overall Study|Adverse Event|0
2508490|NCT01857583|8678133|P1|Overall Study|Adverse Event|0
2508491|NCT01857531|8678143|P1|Overall Study|Withdrawal by Subject|4
2508492|NCT01857323|8678161|P1|Overall Study|Did not complete 180 doses|48
2508493|NCT01857323|8678161|P1|Overall Study|Other|4
2508494|NCT01857323|8678161|P1|Overall Study|Lost to Follow-up|1
2508495|NCT01857323|8678161|P1|Overall Study|Protocol Violation|6
2508496|NCT01857323|8678161|P1|Overall Study|Non-compliance|1
2508497|NCT01857323|8678161|P1|Overall Study|Withdrawal by Subject|3
2508498|NCT01857323|8678161|P1|Overall Study|Adverse Event|1
2508499|NCT01857206|8678236|P2|Overall Study|Withdrawal by Subject|0
2508500|NCT01857206|8678237|P1|Overall Study|Withdrawal by Subject|1
2508501|NCT01857206|8678236|P2|Overall Study|Unclassified|3
2508502|NCT01857206|8678237|P1|Overall Study|Unclassified|3
2508503|NCT01857206|8678236|P2|Overall Study|Lost to Follow-up|6
2508504|NCT01857206|8678237|P1|Overall Study|Lost to Follow-up|9
2508505|NCT01857206|8678236|P2|Overall Study|ADMINISTRATIVE REASON|1
2508506|NCT01857206|8678237|P1|Overall Study|ADMINISTRATIVE REASON|0
2508507|NCT01857102|8678255|P2|Period 2|Unsatisfactory Lens Fit|0
2508508|NCT01857102|8678256|P1|Period 2|Unsatisfactory Lens Fit|1
2508509|NCT01857102|8678255|P2|Period 2|Lens Discomfort|0
2508510|NCT01857102|8678256|P1|Period 2|Lens Discomfort|1
2508511|NCT01857102|8678255|P2|Period 1|Physician Decision|0
2508512|NCT01857102|8678256|P1|Period 1|Physician Decision|1
2508513|NCT01857102|8678255|P2|Period 1|Unsatisfactory Visual Response|0
2508514|NCT01857102|8678256|P1|Period 1|Unsatisfactory Visual Response|1
2508515|NCT01857102|8678255|P2|Period 1|Unsatisfactory Lens Fit|0
2508516|NCT01857102|8678256|P1|Period 1|Unsatisfactory Lens Fit|1
2508517|NCT01857102|8678255|P2|Period 1|Lost to Follow-up|3
2508518|NCT01857102|8678256|P1|Period 1|Lost to Follow-up|0
2508607|NCT01856309|8678792|P1|Overall Study|Lack of Efficacy|14
2508519|NCT01857102|8678255|P2|Period 1|No longer meets Eligibility Criteria|2
2508520|NCT01857102|8678256|P1|Period 1|No longer meets Eligibility Criteria|0
2508521|NCT01857063|8678266|P2|Period 2 (7 Days)|Withdrawal by Subject|0
2508522|NCT01857063|8678267|P1|Period 2 (7 Days)|Withdrawal by Subject|1
2508523|NCT01857063|8678266|P2|Period 2 (7 Days)|Physician Decision|1
2508524|NCT01857063|8678267|P1|Period 2 (7 Days)|Physician Decision|1
2508525|NCT01857063|8678266|P2|Period 2 (7 Days)|Adverse Event|1
2508526|NCT01857063|8678267|P1|Period 2 (7 Days)|Adverse Event|2
2508527|NCT01857063|8678266|P2|Period 1 (7 Days)|Withdrawal by Subject|3
2508528|NCT01857063|8678267|P1|Period 1 (7 Days)|Withdrawal by Subject|1
2508529|NCT01857063|8678266|P2|Period 1 (7 Days)|Physician Decision|0
2508530|NCT01857063|8678267|P1|Period 1 (7 Days)|Physician Decision|1
2508531|NCT01857063|8678266|P2|Period 1 (7 Days)|Adverse Event|1
2508532|NCT01857063|8678267|P1|Period 1 (7 Days)|Adverse Event|0
2508533|NCT01856907|8678301|P3|Overall Study|Withdrawal by Subject|0
2508534|NCT01856907|8678302|P2|Overall Study|Withdrawal by Subject|1
2508535|NCT01856907|8678303|P1|Overall Study|Withdrawal by Subject|0
2508536|NCT01856907|8678301|P3|Overall Study|Pregnancy|0
2508537|NCT01856907|8678302|P2|Overall Study|Pregnancy|1
2508538|NCT01856907|8678303|P1|Overall Study|Pregnancy|0
2508539|NCT01856907|8678301|P3|Overall Study|Pregnancy|0
2508540|NCT01856907|8678302|P2|Overall Study|Pregnancy|1
2508541|NCT01856907|8678303|P1|Overall Study|Pregnancy|0
2508542|NCT01856790|8678341|P1|Closed Loop Control + Liraglutide|Withdrawal by Subject|2
2508543|NCT01856790|8678341|P1|Closed Loop Control|Withdrawal by Subject|2
2508544|NCT01856686|8678395|P2|Overall Study|Lost to Follow-up|11
2508545|NCT01856686|8678396|P1|Overall Study|Lost to Follow-up|5
2508546|NCT01856673|8678439|P3|Overall Study|Protocol Violation|1
2508547|NCT01856673|8678440|P2|Overall Study|Protocol Violation|0
2508548|NCT01856673|8678441|P1|Overall Study|Protocol Violation|1
2508549|NCT01856673|8678439|P3|Overall Study|Death|0
2508550|NCT01856673|8678440|P2|Overall Study|Death|1
2508551|NCT01856673|8678441|P1|Overall Study|Death|2
2508552|NCT01856673|8678439|P3|Overall Study|Paperwork errors|0
2508553|NCT01856673|8678440|P2|Overall Study|Paperwork errors|0
2508554|NCT01856673|8678441|P1|Overall Study|Paperwork errors|4
2508555|NCT01856673|8678439|P3|Overall Study|Psychologist decision|0
2508556|NCT01856673|8678440|P2|Overall Study|Psychologist decision|0
2508557|NCT01856673|8678441|P1|Overall Study|Psychologist decision|3
2508558|NCT01856673|8678439|P3|Overall Study|Unknown reasons|0
2508559|NCT01856673|8678440|P2|Overall Study|Unknown reasons|0
2508560|NCT01856673|8678441|P1|Overall Study|Unknown reasons|20
2508561|NCT01856673|8678439|P3|Overall Study|Lost to Follow-up|0
2508562|NCT01856673|8678440|P2|Overall Study|Lost to Follow-up|34
2508563|NCT01856673|8678441|P1|Overall Study|Lost to Follow-up|22
2508564|NCT01856673|8678439|P3|Overall Study|Withdrawal by Subject|33
2508565|NCT01856673|8678440|P2|Overall Study|Withdrawal by Subject|50
2508566|NCT01856673|8678441|P1|Overall Study|Withdrawal by Subject|46
2508567|NCT01856595|8678461|P9|Overall Study|Withdrawal by Subject|0
2508568|NCT01856595|8678462|P8|Overall Study|Withdrawal by Subject|0
2508569|NCT01856595|8678463|P7|Overall Study|Withdrawal by Subject|1
2508570|NCT01856595|8678464|P6|Overall Study|Withdrawal by Subject|0
2508571|NCT01856595|8678465|P5|Overall Study|Withdrawal by Subject|0
2508572|NCT01856595|8678466|P4|Overall Study|Withdrawal by Subject|0
2508573|NCT01856595|8678467|P3|Overall Study|Withdrawal by Subject|0
2508574|NCT01856595|8678468|P2|Overall Study|Withdrawal by Subject|1
2508575|NCT01856595|8678469|P1|Overall Study|Withdrawal by Subject|0
2508576|NCT01856582|8678702|P1|Overall Study|Died prior to Boost infusion|1
2508577|NCT01856569|8678706|P1|Overall Study|Did not met inclusion criteria|8
2508578|NCT01856569|8678706|P1|Overall Study|Lost to Follow-up|3
2508579|NCT01856569|8678706|P1|Overall Study|Changed Site/Structure|1
2508580|NCT01856569|8678706|P1|Overall Study|Other|1
2508581|NCT01856543|8678717|P2|Overall Study|Withdrawn before start|3
2508582|NCT01856543|8678718|P1|Overall Study|Withdrawn before start|7
2508583|NCT01856543|8678717|P2|Overall Study|Treatment discontinued|3
2508584|NCT01856543|8678718|P1|Overall Study|Treatment discontinued|6
2508585|NCT01856322|8678776|P3|Overall Study|off study due to lack of accrual|3
2508586|NCT01856322|8678777|P2|Overall Study|off study due to lack of accrual|0
2508587|NCT01856322|8678778|P1|Overall Study|off study due to lack of accrual|0
2508588|NCT01856309|8678789|P4|Overall Study|Noncompliance With Study Drug|1
2508589|NCT01856309|8678790|P3|Overall Study|Noncompliance With Study Drug|4
2508590|NCT01856309|8678791|P2|Overall Study|Noncompliance With Study Drug|1
2508591|NCT01856309|8678792|P1|Overall Study|Noncompliance With Study Drug|0
2508592|NCT01856309|8678789|P4|Overall Study|Physician Decision|8
2508593|NCT01856309|8678790|P3|Overall Study|Physician Decision|6
2508594|NCT01856309|8678791|P2|Overall Study|Physician Decision|1
2508595|NCT01856309|8678792|P1|Overall Study|Physician Decision|6
2508596|NCT01856309|8678789|P4|Overall Study|Pregnancy|1
2508597|NCT01856309|8678790|P3|Overall Study|Pregnancy|0
2508598|NCT01856309|8678791|P2|Overall Study|Pregnancy|0
2508599|NCT01856309|8678792|P1|Overall Study|Pregnancy|0
2508600|NCT01856309|8678789|P4|Overall Study|Adverse Event|65
2508601|NCT01856309|8678790|P3|Overall Study|Adverse Event|55
2508602|NCT01856309|8678791|P2|Overall Study|Adverse Event|31
2508603|NCT01856309|8678792|P1|Overall Study|Adverse Event|31
2508604|NCT01856309|8678789|P4|Overall Study|Lack of Efficacy|25
2508605|NCT01856309|8678790|P3|Overall Study|Lack of Efficacy|40
2508606|NCT01856309|8678791|P2|Overall Study|Lack of Efficacy|9
2508608|NCT01856309|8678789|P4|Overall Study|Other|469
2508609|NCT01856309|8678790|P3|Overall Study|Other|447
2508610|NCT01856309|8678791|P2|Overall Study|Other|225
2508611|NCT01856309|8678792|P1|Overall Study|Other|227
2508612|NCT01856309|8678789|P4|Overall Study|Withdrawal by Subject|26
2508613|NCT01856309|8678790|P3|Overall Study|Withdrawal by Subject|28
2508614|NCT01856309|8678791|P2|Overall Study|Withdrawal by Subject|13
2508615|NCT01856309|8678792|P1|Overall Study|Withdrawal by Subject|11
2508616|NCT01856309|8678789|P4|Overall Study|Lost to Follow-up|8
2508617|NCT01856309|8678790|P3|Overall Study|Lost to Follow-up|4
2508618|NCT01856309|8678791|P2|Overall Study|Lost to Follow-up|2
2508619|NCT01856309|8678792|P1|Overall Study|Lost to Follow-up|6
2508620|NCT01856309|8678789|P4|Overall Study|Death|6
2508621|NCT01856309|8678790|P3|Overall Study|Death|11
2508622|NCT01856309|8678791|P2|Overall Study|Death|6
2508623|NCT01856309|8678792|P1|Overall Study|Death|4
2508624|NCT01856257|8678916|P4|Overall Study|Donor complication|1
2508625|NCT01856257|8678917|P3|Overall Study|Donor complication|0
2508626|NCT01856257|8678918|P2|Overall Study|Donor complication|0
2508627|NCT01856257|8678919|P1|Overall Study|Donor complication|0
2508628|NCT01856257|8678916|P4|Overall Study|Withdrawal by Subject|0
2508629|NCT01856257|8678917|P3|Overall Study|Withdrawal by Subject|0
2508630|NCT01856257|8678918|P2|Overall Study|Withdrawal by Subject|1
2508631|NCT01856257|8678919|P1|Overall Study|Withdrawal by Subject|1
2508632|NCT01856257|8678916|P4|Overall Study|Physician Decision|1
2508633|NCT01856257|8678917|P3|Overall Study|Physician Decision|0
2508634|NCT01856257|8678918|P2|Overall Study|Physician Decision|0
2508635|NCT01856257|8678919|P1|Overall Study|Physician Decision|0
2508636|NCT01856257|8678916|P4|Overall Study|Death|0
2508637|NCT01856257|8678917|P3|Overall Study|Death|0
2508638|NCT01856257|8678918|P2|Overall Study|Death|0
2508639|NCT01856257|8678919|P1|Overall Study|Death|2
2508640|NCT01855958|8679087|P2|Overall Study|Withdrawal by Subject|0
2508641|NCT01855958|8679088|P1|Overall Study|Withdrawal by Subject|1
2508642|NCT01855945|8679118|P12|Overall Study|Withdrawal by Subject|1
2508643|NCT01855945|8679119|P11|Overall Study|Withdrawal by Subject|4
2508644|NCT01855945|8679120|P10|Overall Study|Withdrawal by Subject|2
2508645|NCT01855945|8679121|P9|Overall Study|Withdrawal by Subject|0
2508646|NCT01855945|8679122|P8|Overall Study|Withdrawal by Subject|0
2508647|NCT01855945|8679123|P7|Overall Study|Withdrawal by Subject|1
2508648|NCT01855945|8679124|P6|Overall Study|Withdrawal by Subject|0
2508649|NCT01855945|8679125|P5|Overall Study|Withdrawal by Subject|1
2508650|NCT01855945|8679126|P4|Overall Study|Withdrawal by Subject|1
2508651|NCT01855945|8679127|P3|Overall Study|Withdrawal by Subject|4
2508652|NCT01855945|8679128|P2|Overall Study|Withdrawal by Subject|0
2508653|NCT01855945|8679129|P1|Overall Study|Withdrawal by Subject|4
2508654|NCT01855945|8679118|P12|Overall Study|Other - Unclassified|0
2508655|NCT01855945|8679119|P11|Overall Study|Other - Unclassified|1
2508656|NCT01855945|8679120|P10|Overall Study|Other - Unclassified|0
2508657|NCT01855945|8679121|P9|Overall Study|Other - Unclassified|0
2508658|NCT01855945|8679122|P8|Overall Study|Other - Unclassified|1
2508659|NCT01855945|8679123|P7|Overall Study|Other - Unclassified|2
2508660|NCT01855945|8679124|P6|Overall Study|Other - Unclassified|0
2508661|NCT01855945|8679125|P5|Overall Study|Other - Unclassified|0
2508662|NCT01855945|8679126|P4|Overall Study|Other - Unclassified|0
2508663|NCT01855945|8679127|P3|Overall Study|Other - Unclassified|1
2508664|NCT01855945|8679128|P2|Overall Study|Other - Unclassified|1
2508665|NCT01855945|8679129|P1|Overall Study|Other - Unclassified|1
2508666|NCT01855945|8679118|P12|Overall Study|Lost to Follow-up|2
2508667|NCT01855945|8679119|P11|Overall Study|Lost to Follow-up|0
2508668|NCT01855945|8679120|P10|Overall Study|Lost to Follow-up|0
2508669|NCT01855945|8679121|P9|Overall Study|Lost to Follow-up|2
2508670|NCT01855945|8679122|P8|Overall Study|Lost to Follow-up|7
2508671|NCT01855945|8679123|P7|Overall Study|Lost to Follow-up|4
2508672|NCT01855945|8679124|P6|Overall Study|Lost to Follow-up|3
2508673|NCT01855945|8679125|P5|Overall Study|Lost to Follow-up|0
2508674|NCT01855945|8679126|P4|Overall Study|Lost to Follow-up|3
2508675|NCT01855945|8679127|P3|Overall Study|Lost to Follow-up|7
2508676|NCT01855945|8679128|P2|Overall Study|Lost to Follow-up|10
2508677|NCT01855945|8679129|P1|Overall Study|Lost to Follow-up|11
2508678|NCT01855945|8679118|P12|Overall Study|Death|0
2508679|NCT01855945|8679119|P11|Overall Study|Death|0
2508680|NCT01855945|8679120|P10|Overall Study|Death|0
2508681|NCT01855945|8679121|P9|Overall Study|Death|0
2508682|NCT01855945|8679122|P8|Overall Study|Death|0
2508683|NCT01855945|8679123|P7|Overall Study|Death|2
2508684|NCT01855945|8679124|P6|Overall Study|Death|0
2508685|NCT01855945|8679125|P5|Overall Study|Death|0
2508686|NCT01855945|8679126|P4|Overall Study|Death|0
2508687|NCT01855945|8679127|P3|Overall Study|Death|0
2508688|NCT01855945|8679128|P2|Overall Study|Death|0
2508689|NCT01855945|8679129|P1|Overall Study|Death|0
2508690|NCT01855945|8679118|P12|Overall Study|Adverse Event|0
2508691|NCT01855945|8679119|P11|Overall Study|Adverse Event|0
2508692|NCT01855945|8679120|P10|Overall Study|Adverse Event|0
2508693|NCT01855945|8679121|P9|Overall Study|Adverse Event|0
2508694|NCT01855945|8679122|P8|Overall Study|Adverse Event|0
2508695|NCT01855945|8679123|P7|Overall Study|Adverse Event|1
2508696|NCT01855945|8679124|P6|Overall Study|Adverse Event|0
2508697|NCT01855945|8679125|P5|Overall Study|Adverse Event|0
2508698|NCT01855945|8679126|P4|Overall Study|Adverse Event|0
2508699|NCT01855945|8679127|P3|Overall Study|Adverse Event|0
2508700|NCT01855945|8679128|P2|Overall Study|Adverse Event|0
2508701|NCT01855945|8679129|P1|Overall Study|Adverse Event|0
2508702|NCT01855919|8679265|P2|Overall Study|Protocol Violation|4
2508703|NCT01855919|8679266|P1|Overall Study|Protocol Violation|1
2508704|NCT01855919|8679265|P2|Overall Study|Entry Criteria Not Met|1
2508705|NCT01855919|8679266|P1|Overall Study|Entry Criteria Not Met|1
2508706|NCT01855919|8679265|P2|Overall Study|Withdrawal by Subject|10
2508707|NCT01855919|8679266|P1|Overall Study|Withdrawal by Subject|4
2508708|NCT01855919|8679265|P2|Overall Study|Lack of Efficacy|3
2508709|NCT01855919|8679266|P1|Overall Study|Lack of Efficacy|1
2508710|NCT01855919|8679265|P2|Overall Study|Adverse Event|8
2508711|NCT01855919|8679266|P1|Overall Study|Adverse Event|16
2508712|NCT01855828|8679298|P1|Overall Study|Withdrawal by Subject|1
2508713|NCT01855828|8679298|P1|Overall Study|Adverse Event|1
2508714|NCT01855789|8679308|P4|2) Week 24 up to End of Study|Other|1
2508715|NCT01855789|8679309|P3|2) Week 24 up to End of Study|Other|0
2508716|NCT01855789|8679310|P2|2) Week 24 up to End of Study|Other|0
2508717|NCT01855789|8679311|P1|2) Week 24 up to End of Study|Other|0
2508718|NCT01855789|8679308|P4|2) Week 24 up to End of Study|Sponsor Decision|1
2508719|NCT01855789|8679309|P3|2) Week 24 up to End of Study|Sponsor Decision|0
2508720|NCT01855789|8679310|P2|2) Week 24 up to End of Study|Sponsor Decision|0
2508721|NCT01855789|8679311|P1|2) Week 24 up to End of Study|Sponsor Decision|0
2508722|NCT01855789|8679308|P4|2) Week 24 up to End of Study|Participant Non-compliance|1
2508723|NCT01855789|8679309|P3|2) Week 24 up to End of Study|Participant Non-compliance|0
2508724|NCT01855789|8679310|P2|2) Week 24 up to End of Study|Participant Non-compliance|1
2508725|NCT01855789|8679311|P1|2) Week 24 up to End of Study|Participant Non-compliance|0
2508726|NCT01855789|8679308|P4|2) Week 24 up to End of Study|Physician Decision|4
2508727|NCT01855789|8679309|P3|2) Week 24 up to End of Study|Physician Decision|2
2508728|NCT01855789|8679310|P2|2) Week 24 up to End of Study|Physician Decision|0
2508729|NCT01855789|8679311|P1|2) Week 24 up to End of Study|Physician Decision|0
2508730|NCT01855789|8679308|P4|2) Week 24 up to End of Study|Withdrawal by Subject|8
2508731|NCT01855789|8679309|P3|2) Week 24 up to End of Study|Withdrawal by Subject|5
2508732|NCT01855789|8679310|P2|2) Week 24 up to End of Study|Withdrawal by Subject|7
2508733|NCT01855789|8679311|P1|2) Week 24 up to End of Study|Withdrawal by Subject|0
2508734|NCT01855789|8679308|P4|2) Week 24 up to End of Study|Protocol Violation|1
2508735|NCT01855789|8679309|P3|2) Week 24 up to End of Study|Protocol Violation|0
2508736|NCT01855789|8679310|P2|2) Week 24 up to End of Study|Protocol Violation|0
2508737|NCT01855789|8679311|P1|2) Week 24 up to End of Study|Protocol Violation|0
2508738|NCT01855789|8679308|P4|2) Week 24 up to End of Study|Lost to Follow-up|4
2508739|NCT01855789|8679309|P3|2) Week 24 up to End of Study|Lost to Follow-up|1
2508740|NCT01855789|8679310|P2|2) Week 24 up to End of Study|Lost to Follow-up|1
2508741|NCT01855789|8679311|P1|2) Week 24 up to End of Study|Lost to Follow-up|0
2508742|NCT01855789|8679308|P4|2) Week 24 up to End of Study|Lack of Efficacy|16
2508743|NCT01855789|8679309|P3|2) Week 24 up to End of Study|Lack of Efficacy|5
2508744|NCT01855789|8679310|P2|2) Week 24 up to End of Study|Lack of Efficacy|2
2508745|NCT01855789|8679311|P1|2) Week 24 up to End of Study|Lack of Efficacy|0
2508746|NCT01855789|8679308|P4|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1
2508747|NCT01855789|8679309|P3|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
2508748|NCT01855789|8679310|P2|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
2508749|NCT01855789|8679311|P1|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
2508750|NCT01855789|8679308|P4|2) Week 24 up to End of Study|Adverse Event|21
2508751|NCT01855789|8679309|P3|2) Week 24 up to End of Study|Adverse Event|5
2508752|NCT01855789|8679310|P2|2) Week 24 up to End of Study|Adverse Event|4
2508753|NCT01855789|8679311|P1|2) Week 24 up to End of Study|Adverse Event|0
2508754|NCT01855789|8679308|P4|1) Baseline up to Week 24|Other|0
2508755|NCT01855789|8679309|P3|1) Baseline up to Week 24|Other|0
2508756|NCT01855789|8679310|P2|1) Baseline up to Week 24|Other|0
2508757|NCT01855789|8679311|P1|1) Baseline up to Week 24|Other|4
2508758|NCT01855789|8679308|P4|1) Baseline up to Week 24|Sponsor Decision|0
2508759|NCT01855789|8679309|P3|1) Baseline up to Week 24|Sponsor Decision|0
2508760|NCT01855789|8679310|P2|1) Baseline up to Week 24|Sponsor Decision|0
2508761|NCT01855789|8679311|P1|1) Baseline up to Week 24|Sponsor Decision|3
2508762|NCT01855789|8679308|P4|1) Baseline up to Week 24|Participant Non-compliance|0
2508763|NCT01855789|8679309|P3|1) Baseline up to Week 24|Participant Non-compliance|0
2508764|NCT01855789|8679310|P2|1) Baseline up to Week 24|Participant Non-compliance|0
2508765|NCT01855789|8679311|P1|1) Baseline up to Week 24|Participant Non-compliance|3
2508766|NCT01855789|8679308|P4|1) Baseline up to Week 24|Pregnancy|0
2508767|NCT01855789|8679309|P3|1) Baseline up to Week 24|Pregnancy|0
2508768|NCT01855789|8679310|P2|1) Baseline up to Week 24|Pregnancy|0
2508769|NCT01855789|8679311|P1|1) Baseline up to Week 24|Pregnancy|1
2508770|NCT01855789|8679308|P4|1) Baseline up to Week 24|Physician Decision|0
2508771|NCT01855789|8679309|P3|1) Baseline up to Week 24|Physician Decision|0
2508772|NCT01855789|8679310|P2|1) Baseline up to Week 24|Physician Decision|0
2508773|NCT01855789|8679311|P1|1) Baseline up to Week 24|Physician Decision|4
2508774|NCT01855789|8679308|P4|1) Baseline up to Week 24|Withdrawal by Subject|0
2508775|NCT01855789|8679309|P3|1) Baseline up to Week 24|Withdrawal by Subject|0
2508776|NCT01855789|8679310|P2|1) Baseline up to Week 24|Withdrawal by Subject|0
2508777|NCT01855789|8679311|P1|1) Baseline up to Week 24|Withdrawal by Subject|31
2508778|NCT01855789|8679308|P4|1) Baseline up to Week 24|Protocol Violation|0
2508779|NCT01855789|8679309|P3|1) Baseline up to Week 24|Protocol Violation|0
2508780|NCT01855789|8679310|P2|1) Baseline up to Week 24|Protocol Violation|0
2508781|NCT01855789|8679311|P1|1) Baseline up to Week 24|Protocol Violation|4
2508782|NCT01855789|8679308|P4|1) Baseline up to Week 24|Lost to Follow-up|0
2508783|NCT01855789|8679309|P3|1) Baseline up to Week 24|Lost to Follow-up|0
2508784|NCT01855789|8679310|P2|1) Baseline up to Week 24|Lost to Follow-up|0
2508785|NCT01855789|8679311|P1|1) Baseline up to Week 24|Lost to Follow-up|11
2508786|NCT01855789|8679308|P4|1) Baseline up to Week 24|Lack of Efficacy|0
2508787|NCT01855789|8679309|P3|1) Baseline up to Week 24|Lack of Efficacy|0
2508788|NCT01855789|8679310|P2|1) Baseline up to Week 24|Lack of Efficacy|0
2508789|NCT01855789|8679311|P1|1) Baseline up to Week 24|Lack of Efficacy|16
2508790|NCT01855789|8679308|P4|1) Baseline up to Week 24|Death|0
2508791|NCT01855789|8679309|P3|1) Baseline up to Week 24|Death|0
2508792|NCT01855789|8679310|P2|1) Baseline up to Week 24|Death|0
2508793|NCT01855789|8679311|P1|1) Baseline up to Week 24|Death|2
2508794|NCT01855789|8679308|P4|1) Baseline up to Week 24|Adverse Event|0
2508795|NCT01855789|8679309|P3|1) Baseline up to Week 24|Adverse Event|0
2508796|NCT01855789|8679310|P2|1) Baseline up to Week 24|Adverse Event|0
2508797|NCT01855789|8679311|P1|1) Baseline up to Week 24|Adverse Event|37
2508798|NCT01855750|8679335|P2|Overall Study|Sponsor ends the study|290
2508799|NCT01855750|8679336|P1|Overall Study|Sponsor ends the study|297
2508800|NCT01855750|8679335|P2|Overall Study|Withdrawal by Subject|28
2508801|NCT01855750|8679336|P1|Overall Study|Withdrawal by Subject|35
2508802|NCT01855750|8679335|P2|Overall Study|Lost to Follow-up|23
2508803|NCT01855750|8679336|P1|Overall Study|Lost to Follow-up|9
2508804|NCT01855750|8679335|P2|Overall Study|Death|78
2508805|NCT01855750|8679336|P1|Overall Study|Death|78
2508806|NCT01855425|8679352|P1|Overall Study|Physician Decision|20
2508807|NCT01855399|8679358|P2|12 Month|Lost to Follow-up|11
2508808|NCT01855399|8679359|P1|12 Month|Lost to Follow-up|7
2508809|NCT01855399|8679358|P2|6 Month|Withdrawal by Subject|6
2508810|NCT01855399|8679359|P1|6 Month|Withdrawal by Subject|8
2508811|NCT01855399|8679358|P2|6 Month|Lost to Follow-up|9
2508812|NCT01855399|8679359|P1|6 Month|Lost to Follow-up|12
2508813|NCT01855243|8679368|P3|Overall Study|develpoed diabetic ketoacidosis|0
2508814|NCT01855243|8679369|P2|Overall Study|develpoed diabetic ketoacidosis|0
2508815|NCT01855243|8679370|P1|Overall Study|develpoed diabetic ketoacidosis|1
2508816|NCT01855126|8679392|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|2
2508817|NCT01855126|8679393|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|2
2508818|NCT01855126|8679392|P2|First Intervention (8 Weeks)|Withdrawal by Subject|6
2508819|NCT01855126|8679393|P1|First Intervention (8 Weeks)|Withdrawal by Subject|4
2508820|NCT01855074|8679405|P1|Overall Study|Started but not treated|1
2508821|NCT01855074|8679405|P1|Overall Study|Withdrawal by Subject|8
2508822|NCT01855074|8679405|P1|Overall Study|Lost to Follow-up|4
2508823|NCT01855074|8679405|P1|Overall Study|Adverse Event|1
2508824|NCT01854944|8679417|P3|Overall Study|Withdrawal by Subject|1
2508825|NCT01854944|8679418|P2|Overall Study|Withdrawal by Subject|0
2508826|NCT01854944|8679419|P1|Overall Study|Withdrawal by Subject|0
2508827|NCT01854918|8679471|P2|All-IP Period (Years 2 and 3)|Death|16
2508828|NCT01854918|8679472|P1|All-IP Period (Years 2 and 3)|Death|5
2508829|NCT01854918|8679471|P2|All-IP Period (Years 2 and 3)|Lost to Follow-up|51
2508830|NCT01854918|8679472|P1|All-IP Period (Years 2 and 3)|Lost to Follow-up|27
2508831|NCT01854918|8679471|P2|All-IP Period (Years 2 and 3)|Decision by Sponsor|11
2508832|NCT01854918|8679472|P1|All-IP Period (Years 2 and 3)|Decision by Sponsor|8
2508833|NCT01854918|8679471|P2|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117
2508834|NCT01854918|8679472|P1|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78
2508835|NCT01854918|8679471|P2|SOC-controlled Period (Year 1)|Death|5
2508836|NCT01854918|8679472|P1|SOC-controlled Period (Year 1)|Death|5
2508837|NCT01854918|8679471|P2|SOC-controlled Period (Year 1)|Lost to Follow-up|8
2508838|NCT01854918|8679472|P1|SOC-controlled Period (Year 1)|Lost to Follow-up|3
2508839|NCT01854918|8679471|P2|SOC-controlled Period (Year 1)|Decision by Sponsor|1
2508840|NCT01854918|8679472|P1|SOC-controlled Period (Year 1)|Decision by Sponsor|2
2508841|NCT01854918|8679471|P2|SOC-controlled Period (Year 1)|Withdrawal by Subject|49
2508842|NCT01854918|8679472|P1|SOC-controlled Period (Year 1)|Withdrawal by Subject|20
2508843|NCT01854827|8679491|P1|Overall Study|Death|1
2508844|NCT01854710|8679503|P6|Overall Study|CRI procedural error|2
2508845|NCT01854710|8679504|P5|Overall Study|CRI procedural error|2
2508846|NCT01854710|8679505|P4|Overall Study|CRI procedural error|2
2508847|NCT01854710|8679506|P3|Overall Study|CRI procedural error|2
2508848|NCT01854710|8679507|P2|Overall Study|CRI procedural error|2
2508849|NCT01854710|8679508|P1|Overall Study|CRI procedural error|2
2508850|NCT01854710|8679503|P6|Overall Study|Withdrawal by Subject|0
2508851|NCT01854710|8679504|P5|Overall Study|Withdrawal by Subject|0
2508852|NCT01854710|8679505|P4|Overall Study|Withdrawal by Subject|0
2508853|NCT01854710|8679506|P3|Overall Study|Withdrawal by Subject|0
2508854|NCT01854710|8679507|P2|Overall Study|Withdrawal by Subject|1
2508855|NCT01854710|8679508|P1|Overall Study|Withdrawal by Subject|2
2508856|NCT01854697|8679529|P5|Overall Study|Other|0
2508857|NCT01854697|8679530|P4|Overall Study|Other|0
2508858|NCT01854697|8679531|P3|Overall Study|Other|1
2508859|NCT01854697|8679532|P2|Overall Study|Other|1
2508860|NCT01854697|8679533|P1|Overall Study|Other|0
2508861|NCT01854697|8679529|P5|Overall Study|Withdrew Consent|0
2508862|NCT01854697|8679530|P4|Overall Study|Withdrew Consent|1
2508863|NCT01854697|8679531|P3|Overall Study|Withdrew Consent|0
2508864|NCT01854697|8679532|P2|Overall Study|Withdrew Consent|1
2508865|NCT01854697|8679533|P1|Overall Study|Withdrew Consent|0
2508866|NCT01854697|8679529|P5|Overall Study|To enter another AbbVie study|1
2508867|NCT01854697|8679530|P4|Overall Study|To enter another AbbVie study|0
2508868|NCT01854697|8679531|P3|Overall Study|To enter another AbbVie study|0
2508869|NCT01854697|8679532|P2|Overall Study|To enter another AbbVie study|0
2508870|NCT01854697|8679533|P1|Overall Study|To enter another AbbVie study|1
2508871|NCT01854697|8679529|P5|Overall Study|Lost to Follow-up|0
2508872|NCT01854697|8679530|P4|Overall Study|Lost to Follow-up|2
2508873|NCT01854697|8679531|P3|Overall Study|Lost to Follow-up|1
2508874|NCT01854697|8679532|P2|Overall Study|Lost to Follow-up|1
2508875|NCT01854697|8679533|P1|Overall Study|Lost to Follow-up|4
2508876|NCT01854697|8679529|P5|Overall Study|Adverse Event|1
2508877|NCT01854697|8679530|P4|Overall Study|Adverse Event|0
2508878|NCT01854697|8679531|P3|Overall Study|Adverse Event|0
2508879|NCT01854697|8679532|P2|Overall Study|Adverse Event|0
2508880|NCT01854697|8679533|P1|Overall Study|Adverse Event|1
2508881|NCT01854658|8679577|P4|Overall Study|Administrative reasons|2
2508882|NCT01854658|8679578|P3|Overall Study|Administrative reasons|2
2508883|NCT01854658|8679579|P2|Overall Study|Administrative reasons|1
2508884|NCT01854658|8679580|P1|Overall Study|Administrative reasons|5
2508885|NCT01854658|8679577|P4|Overall Study|Adverse Event|19
2508886|NCT01854658|8679578|P3|Overall Study|Adverse Event|23
2508887|NCT01854658|8679579|P2|Overall Study|Adverse Event|14
2508888|NCT01854658|8679580|P1|Overall Study|Adverse Event|21
2508889|NCT01854658|8679577|P4|Overall Study|Lack of Efficacy|7
2508890|NCT01854658|8679578|P3|Overall Study|Lack of Efficacy|4
2508891|NCT01854658|8679579|P2|Overall Study|Lack of Efficacy|8
2508892|NCT01854658|8679580|P1|Overall Study|Lack of Efficacy|3
2508893|NCT01854658|8679577|P4|Overall Study|Protocol-specified criteria|7
2508894|NCT01854658|8679578|P3|Overall Study|Protocol-specified criteria|10
2508895|NCT01854658|8679579|P2|Overall Study|Protocol-specified criteria|15
2508896|NCT01854658|8679580|P1|Overall Study|Protocol-specified criteria|15
2508897|NCT01854658|8679577|P4|Overall Study|Withdrawal by Subject|15
2508898|NCT01854658|8679578|P3|Overall Study|Withdrawal by Subject|29
2508899|NCT01854658|8679579|P2|Overall Study|Withdrawal by Subject|21
2508900|NCT01854658|8679580|P1|Overall Study|Withdrawal by Subject|28
2508901|NCT01854658|8679577|P4|Overall Study|Lost to Follow-up|4
2508902|NCT01854658|8679578|P3|Overall Study|Lost to Follow-up|8
2508903|NCT01854658|8679579|P2|Overall Study|Lost to Follow-up|9
2508904|NCT01854658|8679580|P1|Overall Study|Lost to Follow-up|8
2508905|NCT01854658|8679577|P4|Overall Study|Physician Decision|4
2508906|NCT01854658|8679578|P3|Overall Study|Physician Decision|2
2508907|NCT01854658|8679579|P2|Overall Study|Physician Decision|5
2508908|NCT01854658|8679580|P1|Overall Study|Physician Decision|7
2508909|NCT01854658|8679577|P4|Overall Study|Protocol Violation|1
2508910|NCT01854658|8679578|P3|Overall Study|Protocol Violation|2
2508911|NCT01854658|8679579|P2|Overall Study|Protocol Violation|2
2508912|NCT01854658|8679580|P1|Overall Study|Protocol Violation|6
2508913|NCT01854645|8679615|P5|Overall Study|Adverse Event|11
2508914|NCT01854645|8679616|P4|Overall Study|Adverse Event|20
2508915|NCT01854645|8679617|P3|Overall Study|Adverse Event|19
2508916|NCT01854645|8679618|P2|Overall Study|Adverse Event|31
2508917|NCT01854645|8679619|P1|Overall Study|Adverse Event|33
2508918|NCT01854645|8679615|P5|Overall Study|Lack of Efficacy|9
2508919|NCT01854645|8679616|P4|Overall Study|Lack of Efficacy|3
2508920|NCT01854645|8679617|P3|Overall Study|Lack of Efficacy|9
2508921|NCT01854645|8679618|P2|Overall Study|Lack of Efficacy|12
2508922|NCT01854645|8679619|P1|Overall Study|Lack of Efficacy|7
2508923|NCT01854645|8679615|P5|Overall Study|Withdrawal by Subject|24
2508924|NCT01854645|8679616|P4|Overall Study|Withdrawal by Subject|21
2508925|NCT01854645|8679617|P3|Overall Study|Withdrawal by Subject|30
2508926|NCT01854645|8679618|P2|Overall Study|Withdrawal by Subject|41
2508927|NCT01854645|8679619|P1|Overall Study|Withdrawal by Subject|31
2508928|NCT01854645|8679615|P5|Overall Study|Physician Decision|7
2508929|NCT01854645|8679616|P4|Overall Study|Physician Decision|3
2508930|NCT01854645|8679617|P3|Overall Study|Physician Decision|3
2508931|NCT01854645|8679618|P2|Overall Study|Physician Decision|5
2508932|NCT01854645|8679619|P1|Overall Study|Physician Decision|1
2508933|NCT01854645|8679615|P5|Overall Study|Lost to Follow-up|0
2508934|NCT01854645|8679616|P4|Overall Study|Lost to Follow-up|5
2508935|NCT01854645|8679617|P3|Overall Study|Lost to Follow-up|8
2508936|NCT01854645|8679618|P2|Overall Study|Lost to Follow-up|7
2508937|NCT01854645|8679619|P1|Overall Study|Lost to Follow-up|10
2508938|NCT01854645|8679615|P5|Overall Study|Protocol Violation|1
2508939|NCT01854645|8679616|P4|Overall Study|Protocol Violation|4
2508940|NCT01854645|8679617|P3|Overall Study|Protocol Violation|5
2508941|NCT01854645|8679618|P2|Overall Study|Protocol Violation|0
2508942|NCT01854645|8679619|P1|Overall Study|Protocol Violation|3
2508943|NCT01854645|8679615|P5|Overall Study|Administrative Reasons / Missing|1
2508944|NCT01854645|8679616|P4|Overall Study|Administrative Reasons / Missing|1
2508945|NCT01854645|8679617|P3|Overall Study|Administrative Reasons / Missing|0
2508946|NCT01854645|8679618|P2|Overall Study|Administrative Reasons / Missing|0
2508947|NCT01854645|8679619|P1|Overall Study|Administrative Reasons / Missing|0
2508948|NCT01854645|8679615|P5|Overall Study|Protocol-Specified Criteria|7
2508949|NCT01854645|8679616|P4|Overall Study|Protocol-Specified Criteria|5
2508950|NCT01854645|8679617|P3|Overall Study|Protocol-Specified Criteria|8
2508951|NCT01854645|8679618|P2|Overall Study|Protocol-Specified Criteria|10
2508952|NCT01854645|8679619|P1|Overall Study|Protocol-Specified Criteria|13
2508953|NCT01854528|8679700|P2|Overall Study|Virologic Failure|9
2508954|NCT01854528|8679701|P1|Overall Study|Virologic Failure|0
2508955|NCT01854528|8679700|P2|Overall Study|Withdrawal by Subject|2
2508956|NCT01854528|8679701|P1|Overall Study|Withdrawal by Subject|0
2508957|NCT01854528|8679700|P2|Overall Study|Adverse Event|4
2508958|NCT01854528|8679701|P1|Overall Study|Adverse Event|0
2508959|NCT01854047|8679772|P5|Overall Study|Other than specified above|8
2508960|NCT01854047|8679773|P4|Overall Study|Other than specified above|5
2508961|NCT01854047|8679774|P3|Overall Study|Other than specified above|3
2508962|NCT01854047|8679775|P2|Overall Study|Other than specified above|3
2508963|NCT01854047|8679776|P1|Overall Study|Other than specified above|3
2508964|NCT01854047|8679772|P5|Overall Study|Randomized but not treated|4
2508965|NCT01854047|8679773|P4|Overall Study|Randomized but not treated|0
2508966|NCT01854047|8679774|P3|Overall Study|Randomized but not treated|2
2508967|NCT01854047|8679775|P2|Overall Study|Randomized but not treated|1
2508968|NCT01854047|8679776|P1|Overall Study|Randomized but not treated|0
2508969|NCT01854047|8679772|P5|Overall Study|Adverse Event|7
2508970|NCT01854047|8679773|P4|Overall Study|Adverse Event|10
2508971|NCT01854047|8679774|P3|Overall Study|Adverse Event|6
2508972|NCT01854047|8679775|P2|Overall Study|Adverse Event|4
2508973|NCT01854047|8679776|P1|Overall Study|Adverse Event|5
2508974|NCT01854047|8679772|P5|Overall Study|Poor compliance to protocol|0
2508975|NCT01854047|8679773|P4|Overall Study|Poor compliance to protocol|0
2508976|NCT01854047|8679774|P3|Overall Study|Poor compliance to protocol|2
2508977|NCT01854047|8679775|P2|Overall Study|Poor compliance to protocol|0
2508978|NCT01854047|8679776|P1|Overall Study|Poor compliance to protocol|3
2508979|NCT01854047|8679772|P5|Overall Study|Lack of Efficacy|0
2508980|NCT01854047|8679773|P4|Overall Study|Lack of Efficacy|0
2508981|NCT01854047|8679774|P3|Overall Study|Lack of Efficacy|0
2508982|NCT01854047|8679775|P2|Overall Study|Lack of Efficacy|0
2508983|NCT01854047|8679776|P1|Overall Study|Lack of Efficacy|1
2508984|NCT01853982|8679907|P2|Overall Study|Lost to Follow-up|1
2508985|NCT01853982|8679908|P1|Overall Study|Lost to Follow-up|0
2508986|NCT01853982|8679907|P2|Overall Study|Death|0
2508987|NCT01853982|8679908|P1|Overall Study|Death|1
2508988|NCT01853982|8679907|P2|Overall Study|Withdrawal by Subject|0
2508989|NCT01853982|8679908|P1|Overall Study|Withdrawal by Subject|1
2508990|NCT01853878|8679925|P2|Overall Study|Other|43
2508991|NCT01853878|8679926|P1|Overall Study|Other|55
2508992|NCT01853878|8679925|P2|Overall Study|Migrated/moved from the study area|0
2508993|NCT01853878|8679926|P1|Overall Study|Migrated/moved from the study area|1
2508994|NCT01853878|8679925|P2|Overall Study|Withdrawal by Subject|1
2508995|NCT01853878|8679926|P1|Overall Study|Withdrawal by Subject|3
2508996|NCT01853878|8679925|P2|Overall Study|Adverse Event|0
2508997|NCT01853878|8679926|P1|Overall Study|Adverse Event|2
2508998|NCT01853878|8679925|P2|Overall Study|Recurrence|0
2508999|NCT01853878|8679926|P1|Overall Study|Recurrence|2
2509000|NCT01853839|8679950|P1|Overall Study|Lost to follow-up or no valid BP measure|336
2509001|NCT01853839|8679950|P1|Overall Study|End of treatment visit too early|33
2509002|NCT01853839|8679950|P1|Overall Study|Not meet ITT population definition|58
2509003|NCT01853839|8679950|P1|Overall Study|Violated inclusion criteria|2
2509004|NCT01853696|8679983|P2|Overall Study|Lost to Follow-up|4
2509005|NCT01853696|8679984|P1|Overall Study|Lost to Follow-up|5
2509006|NCT01853696|8679983|P2|Overall Study|Withdrawal by Subject|1
2509007|NCT01853696|8679984|P1|Overall Study|Withdrawal by Subject|1
2509008|NCT01853644|8679992|P1|Follow up for 3 Years or Until Death|Still in the follow up period|3
2509009|NCT01853644|8679992|P1|Continued Treatment After First Response|Progressive Diseaes|10
2509010|NCT01853644|8679992|P1|Continued Treatment After First Response|Adverse Event|2
2509011|NCT01853644|8679992|P1|Reached First Response/Complete 2 Cycles|Progressive Disease|2
2509012|NCT01853644|8679992|P1|Reached First Response/Complete 2 Cycles|Other|1
2509013|NCT01853644|8679992|P1|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1
2509014|NCT01853644|8679992|P1|Reached First Response/Complete 2 Cycles|Adverse Event|2
2509015|NCT01853644|8679992|P1|Registration and Treatment Start|Did not start treatment|1
2509016|NCT01853618|8680006|P5|Overall Study|Refused further treatment|1
2509017|NCT01853618|8680007|P4|Overall Study|Refused further treatment|0
2509018|NCT01853618|8680008|P3|Overall Study|Refused further treatment|0
2509019|NCT01853618|8680009|P2|Overall Study|Refused further treatment|0
2509020|NCT01853618|8680010|P1|Overall Study|Refused further treatment|0
2509021|NCT01853618|8680006|P5|Overall Study|Physician Decision|0
2509022|NCT01853618|8680007|P4|Overall Study|Physician Decision|0
2509023|NCT01853618|8680008|P3|Overall Study|Physician Decision|1
2509024|NCT01853618|8680009|P2|Overall Study|Physician Decision|1
2509025|NCT01853618|8680010|P1|Overall Study|Physician Decision|0
2509026|NCT01853618|8680006|P5|Overall Study|Progressive disease|2
2509027|NCT01853618|8680007|P4|Overall Study|Progressive disease|1
2509028|NCT01853618|8680008|P3|Overall Study|Progressive disease|1
2509029|NCT01853618|8680009|P2|Overall Study|Progressive disease|1
2509030|NCT01853618|8680010|P1|Overall Study|Progressive disease|1
2509031|NCT01853618|8680006|P5|Overall Study|Bile duct stent blockage/progressive dis|0
2509032|NCT01853618|8680007|P4|Overall Study|Bile duct stent blockage/progressive dis|0
2509033|NCT01853618|8680008|P3|Overall Study|Bile duct stent blockage/progressive dis|0
2509034|NCT01853618|8680009|P2|Overall Study|Bile duct stent blockage/progressive dis|0
2509035|NCT01853618|8680010|P1|Overall Study|Bile duct stent blockage/progressive dis|1
2509036|NCT01853475|8680076|P3|Overall Study|Withdrawal by Subject|0
2509037|NCT01853475|8680077|P2|Overall Study|Withdrawal by Subject|1
2509038|NCT01853475|8680078|P1|Overall Study|Withdrawal by Subject|0
2509039|NCT01853462|8680097|P2|Overall Study|Withdrawal by Subject|1
2509040|NCT01853462|8680098|P1|Overall Study|Withdrawal by Subject|1
2509041|NCT01853397|8680168|P4|Overall Study|Subject Noncompliance|1
2509042|NCT01853397|8680169|P3|Overall Study|Subject Noncompliance|0
2509043|NCT01853397|8680170|P2|Overall Study|Subject Noncompliance|0
2509044|NCT01853397|8680171|P1|Overall Study|Subject Noncompliance|0
2509045|NCT01853397|8680168|P4|Overall Study|Withdrawal by Subject|1
2509046|NCT01853397|8680169|P3|Overall Study|Withdrawal by Subject|0
2509047|NCT01853397|8680170|P2|Overall Study|Withdrawal by Subject|0
2509048|NCT01853397|8680171|P1|Overall Study|Withdrawal by Subject|0
2509049|NCT01853384|8680199|P2|Completed Follow up Visit 2|Lost to Follow-up|1
2509050|NCT01853384|8680200|P1|Completed Follow up Visit 2|Lost to Follow-up|0
2509051|NCT01853384|8680199|P2|Completed Follow up Visit 2|Death|0
2509052|NCT01853384|8680200|P1|Completed Follow up Visit 2|Death|1
2509053|NCT01853384|8680199|P2|Completed Follow up Visit 2|Withdrawal by Subject|2
2509054|NCT01853384|8680200|P1|Completed Follow up Visit 2|Withdrawal by Subject|1
2509055|NCT01853384|8680199|P2|Completed Follow up Visit 2|Adverse Event|0
2509056|NCT01853384|8680200|P1|Completed Follow up Visit 2|Adverse Event|1
2509057|NCT01853384|8680199|P2|Completed Follow up Visit 1|Withdrawal by Subject|0
2509058|NCT01853384|8680200|P1|Completed Follow up Visit 1|Withdrawal by Subject|1
2509059|NCT01853384|8680199|P2|Completed Follow up Visit 1|Early Termination|9
2509060|NCT01853384|8680200|P1|Completed Follow up Visit 1|Early Termination|13
2509061|NCT01853384|8680199|P2|Randomized|Other|3
2509062|NCT01853384|8680200|P1|Randomized|Other|3
2509063|NCT01853384|8680199|P2|Randomized|Sponsor Decision|34
2509064|NCT01853384|8680200|P1|Randomized|Sponsor Decision|47
2509065|NCT01853384|8680199|P2|Randomized|Withdrawal by Subject|3
2509066|NCT01853384|8680200|P1|Randomized|Withdrawal by Subject|5
2509067|NCT01853384|8680199|P2|Randomized|Lost to Follow-up|1
2509068|NCT01853384|8680200|P1|Randomized|Lost to Follow-up|1
2509069|NCT01853384|8680199|P2|Randomized|Death|2
2509070|NCT01853384|8680200|P1|Randomized|Death|1
2509071|NCT01853384|8680199|P2|Randomized|Adverse Event|3
2509072|NCT01853384|8680200|P1|Randomized|Adverse Event|5
2509073|NCT01853280|8680240|P2|Overall Study|Ineligible|1
2509074|NCT01853280|8680241|P1|Overall Study|Ineligible|0
2509075|NCT01853280|8680240|P2|Overall Study|Withdrawal by Subject|1
2509076|NCT01853280|8680241|P1|Overall Study|Withdrawal by Subject|0
2509077|NCT01853280|8680240|P2|Overall Study|Physician Decision|1
2509078|NCT01853280|8680241|P1|Overall Study|Physician Decision|0
2509079|NCT01853280|8680240|P2|Overall Study|Lost to Follow-up|1
2509080|NCT01853280|8680241|P1|Overall Study|Lost to Follow-up|0
2509081|NCT01853280|8680240|P2|Overall Study|Lack of Efficacy|2
2509082|NCT01853280|8680241|P1|Overall Study|Lack of Efficacy|2
2509083|NCT01853254|8680247|P1|Overall Study|Administrative/Other|16
2509084|NCT01853254|8680247|P1|Overall Study|Withdrawal of Consent|16
2509085|NCT01853254|8680247|P1|Overall Study|Other Protocol Violation|1
2509086|NCT01853254|8680247|P1|Overall Study|Refusal of Treatment|1
2509087|NCT01853254|8680247|P1|Overall Study|Insufficient Therapeutic Response|22
2509088|NCT01853254|8680247|P1|Overall Study|Failure to Return|43
2509089|NCT01853254|8680247|P1|Overall Study|Death|1
2509090|NCT01853254|8680247|P1|Overall Study|Adverse Event/Intercurrent Illness|3
2509091|NCT01853254|8680247|P1|Overall Study|Abnormal Laboratory Test|1
2509092|NCT01853228|8680251|P2|Phase 2|Lack of Efficacy|4
2509093|NCT01853228|8680252|P1|Phase 2|Lack of Efficacy|0
2509094|NCT01853228|8680251|P2|Phase 2|Proceed To Transplant|3
2509095|NCT01853228|8680252|P1|Phase 2|Proceed To Transplant|0
2509096|NCT01853228|8680251|P2|Phase 2|Physician Decision|1
2509097|NCT01853228|8680252|P1|Phase 2|Physician Decision|0
2509098|NCT01853228|8680251|P2|Phase 1|Other|0
2509099|NCT01853228|8680252|P1|Phase 1|Other|1
2509100|NCT01853228|8680251|P2|Phase 1|Lack of Efficacy|0
2509101|NCT01853228|8680252|P1|Phase 1|Lack of Efficacy|8
2509102|NCT01853176|8680282|P2|Overall Study|Study terminated|0
2509103|NCT01853176|8680283|P1|Overall Study|Study terminated|4
2509104|NCT01853072|8680302|P2|Overall Study|Reason not specified|6
2509105|NCT01853072|8680303|P1|Overall Study|Reason not specified|9
2509106|NCT01853072|8680302|P2|Overall Study|Withdrawal by Subject|2
2509107|NCT01853072|8680303|P1|Overall Study|Withdrawal by Subject|1
2509108|NCT01853072|8680302|P2|Overall Study|Physician Decision|1
2509109|NCT01853072|8680303|P1|Overall Study|Physician Decision|1
2509110|NCT01853072|8680302|P2|Overall Study|Non-compliance with study drug|1
2509111|NCT01853072|8680303|P1|Overall Study|Non-compliance with study drug|0
2509112|NCT01853072|8680302|P2|Overall Study|Lost to Follow-up|3
2509113|NCT01853072|8680303|P1|Overall Study|Lost to Follow-up|0
2509114|NCT01853072|8680302|P2|Overall Study|Death|4
2509115|NCT01853072|8680303|P1|Overall Study|Death|1
2509116|NCT01853072|8680302|P2|Overall Study|Adverse Event|3
2509117|NCT01853072|8680303|P1|Overall Study|Adverse Event|0
2509118|NCT01853072|8680302|P2|Overall Study|Adverse event prior to treatment|1
2509119|NCT01853072|8680303|P1|Overall Study|Adverse event prior to treatment|0
2509120|NCT01853046|8680323|P2|Overall Study|Disease progression|3
2509121|NCT01853046|8680324|P1|Overall Study|Disease progression|13
2509122|NCT01853046|8680323|P2|Overall Study|Adverse Event|2
2509123|NCT01853046|8680324|P1|Overall Study|Adverse Event|4
2509124|NCT01853046|8680323|P2|Overall Study|Withdrawal by Subject|1
2509125|NCT01853046|8680324|P1|Overall Study|Withdrawal by Subject|1
2509126|NCT01852825|8680392|P3|Overall Study|Withdrawal by Subject|0
2509127|NCT01852825|8680393|P2|Overall Study|Withdrawal by Subject|0
2509128|NCT01852825|8680394|P1|Overall Study|Withdrawal by Subject|2
2509129|NCT01852812|8680420|P3|Overall Study|Non-compliance With Study Drug|0
2509130|NCT01852812|8680421|P2|Overall Study|Non-compliance With Study Drug|1
2509131|NCT01852812|8680422|P1|Overall Study|Non-compliance With Study Drug|0
2509132|NCT01852812|8680420|P3|Overall Study|Adverse Event|1
2509133|NCT01852812|8680421|P2|Overall Study|Adverse Event|0
2509134|NCT01852812|8680422|P1|Overall Study|Adverse Event|0
2509135|NCT01852591|8680460|P1|Overall Study|Not Evaluable at Time of Analysis|1
2509136|NCT01852591|8680460|P1|Overall Study|Withdrawal by Subject|2
2509137|NCT01852292|8680501|P2|Overall Study|Progressive disease|52
2509138|NCT01852292|8680502|P1|Overall Study|Progressive disease|42
2509139|NCT01852292|8680501|P2|Overall Study|Study terminated by Sponsor|1
2509140|NCT01852292|8680502|P1|Overall Study|Study terminated by Sponsor|0
2509141|NCT01852292|8680501|P2|Overall Study|Non-compliance with study treatment|0
2509142|NCT01852292|8680502|P1|Overall Study|Non-compliance with study treatment|1
2509143|NCT01852292|8680501|P2|Overall Study|Protocol Violation|0
2509144|NCT01852292|8680502|P1|Overall Study|Protocol Violation|2
2509145|NCT01852292|8680501|P2|Overall Study|Physician Decision|2
2509146|NCT01852292|8680502|P1|Overall Study|Physician Decision|6
2509147|NCT01852292|8680501|P2|Overall Study|Adverse Event|11
2509148|NCT01852292|8680502|P1|Overall Study|Adverse Event|8
2509149|NCT01852292|8680501|P2|Overall Study|Patient/guardian decision|4
2509150|NCT01852292|8680502|P1|Overall Study|Patient/guardian decision|8
2509151|NCT01852292|8680501|P2|Overall Study|Death|8
2509152|NCT01852292|8680502|P1|Overall Study|Death|9
2509153|NCT01852292|8680501|P2|Overall Study|Untreated - did not receive study drug|1
2509154|NCT01852292|8680502|P1|Overall Study|Untreated - did not receive study drug|3
2509155|NCT01852214|8680526|P2|Washout Period|Withdrawal by Subject|1
2509156|NCT01852214|8680527|P1|Washout Period|Withdrawal by Subject|0
2509157|NCT01852214|8680526|P2|Period 1|Withdrawal by Subject|1
2509158|NCT01852214|8680527|P1|Period 1|Withdrawal by Subject|0
2509159|NCT01852214|8680526|P2|Period 1|Adverse Event|2
2509160|NCT01852214|8680527|P1|Period 1|Adverse Event|1
2509161|NCT01852162|8680579|P2|Overall Study|Withdrawal by Subject|1
2509162|NCT01852162|8680580|P1|Overall Study|Withdrawal by Subject|3
2509163|NCT01852162|8680579|P2|Overall Study|Adverse Event|0
2509164|NCT01852162|8680580|P1|Overall Study|Adverse Event|1
2509165|NCT01852110|8680596|P6|Overall Study|Withdrawal by Subject|0
2509166|NCT01852110|8680597|P5|Overall Study|Withdrawal by Subject|0
2509167|NCT01852110|8680598|P4|Overall Study|Withdrawal by Subject|0
2509168|NCT01852110|8680599|P3|Overall Study|Withdrawal by Subject|0
2509169|NCT01852110|8680600|P2|Overall Study|Withdrawal by Subject|4
2509170|NCT01852110|8680601|P1|Overall Study|Withdrawal by Subject|4
2509171|NCT01852110|8680596|P6|Overall Study|Study Terminated by Sponsor|0
2509172|NCT01852110|8680597|P5|Overall Study|Study Terminated by Sponsor|0
2509173|NCT01852110|8680598|P4|Overall Study|Study Terminated by Sponsor|0
2509174|NCT01852110|8680599|P3|Overall Study|Study Terminated by Sponsor|0
2509175|NCT01852110|8680600|P2|Overall Study|Study Terminated by Sponsor|32
2509176|NCT01852110|8680601|P1|Overall Study|Study Terminated by Sponsor|30
2509177|NCT01852110|8680596|P6|Overall Study|Protocol Violation|0
2509178|NCT01852110|8680597|P5|Overall Study|Protocol Violation|0
2509179|NCT01852110|8680598|P4|Overall Study|Protocol Violation|0
2509180|NCT01852110|8680599|P3|Overall Study|Protocol Violation|0
2509181|NCT01852110|8680600|P2|Overall Study|Protocol Violation|1
2509182|NCT01852110|8680601|P1|Overall Study|Protocol Violation|0
2509183|NCT01852110|8680596|P6|Overall Study|Physician Decision|0
2509184|NCT01852110|8680597|P5|Overall Study|Physician Decision|0
2509185|NCT01852110|8680598|P4|Overall Study|Physician Decision|0
2509186|NCT01852110|8680599|P3|Overall Study|Physician Decision|0
2509187|NCT01852110|8680600|P2|Overall Study|Physician Decision|0
2509188|NCT01852110|8680601|P1|Overall Study|Physician Decision|1
2509189|NCT01852110|8680596|P6|Overall Study|Non-compliance with Study Drug|0
2509190|NCT01852110|8680597|P5|Overall Study|Non-compliance with Study Drug|0
2509191|NCT01852110|8680598|P4|Overall Study|Non-compliance with Study Drug|0
2509192|NCT01852110|8680599|P3|Overall Study|Non-compliance with Study Drug|0
2509193|NCT01852110|8680600|P2|Overall Study|Non-compliance with Study Drug|1
2509194|NCT01852110|8680601|P1|Overall Study|Non-compliance with Study Drug|2
2509195|NCT01852110|8680596|P6|Overall Study|Lost to Follow-up|0
2509196|NCT01852110|8680597|P5|Overall Study|Lost to Follow-up|0
2509197|NCT01852110|8680598|P4|Overall Study|Lost to Follow-up|0
2509198|NCT01852110|8680599|P3|Overall Study|Lost to Follow-up|0
2509199|NCT01852110|8680600|P2|Overall Study|Lost to Follow-up|3
2509200|NCT01852110|8680601|P1|Overall Study|Lost to Follow-up|1
2509201|NCT01852110|8680596|P6|Overall Study|Adverse Event|0
2509202|NCT01852110|8680597|P5|Overall Study|Adverse Event|0
2509203|NCT01852110|8680598|P4|Overall Study|Adverse Event|0
2509204|NCT01852110|8680599|P3|Overall Study|Adverse Event|0
2509205|NCT01852110|8680600|P2|Overall Study|Adverse Event|5
2509206|NCT01852110|8680601|P1|Overall Study|Adverse Event|12
2509207|NCT01852045|8680632|P3|Overall Study|Other Miscellaneous Reasons|2
2509208|NCT01852045|8680633|P2|Overall Study|Other Miscellaneous Reasons|3
2509209|NCT01852045|8680634|P1|Overall Study|Other Miscellaneous Reasons|1
2509210|NCT01852045|8680632|P3|Overall Study|Withdrawal by Subject|1
2509211|NCT01852045|8680633|P2|Overall Study|Withdrawal by Subject|0
2509212|NCT01852045|8680634|P1|Overall Study|Withdrawal by Subject|1
2509213|NCT01852045|8680632|P3|Overall Study|Lost to Follow-up|1
2509214|NCT01852045|8680633|P2|Overall Study|Lost to Follow-up|1
2509215|NCT01852045|8680634|P1|Overall Study|Lost to Follow-up|0
2509216|NCT01852045|8680632|P3|Overall Study|Lack of Efficacy|0
2509217|NCT01852045|8680633|P2|Overall Study|Lack of Efficacy|0
2509218|NCT01852045|8680634|P1|Overall Study|Lack of Efficacy|3
2509219|NCT01852045|8680632|P3|Overall Study|Adverse Event|0
2509220|NCT01852045|8680633|P2|Overall Study|Adverse Event|0
2509221|NCT01852045|8680634|P1|Overall Study|Adverse Event|1
2509222|NCT01851863|8680718|P4|Overall Study|Lost to Follow-up|3
2509223|NCT01851863|8680719|P3|Overall Study|Lost to Follow-up|2
2509224|NCT01851863|8680720|P2|Overall Study|Lost to Follow-up|4
2509225|NCT01851863|8680721|P1|Overall Study|Lost to Follow-up|3
2509226|NCT01851863|8680718|P4|Overall Study|Did not receive study medication|0
2509227|NCT01851863|8680719|P3|Overall Study|Did not receive study medication|3
2509228|NCT01851863|8680720|P2|Overall Study|Did not receive study medication|5
2509229|NCT01851863|8680721|P1|Overall Study|Did not receive study medication|2
2509230|NCT01851720|8680750|P2|Overall Study|Lost to Follow-up|1
2509231|NCT01851720|8680751|P1|Overall Study|Lost to Follow-up|0
2509232|NCT01851590|8680781|P3|Overall Study|Lack of Efficacy|0
2509233|NCT01851590|8680782|P2|Overall Study|Lack of Efficacy|1
2509234|NCT01851590|8680783|P1|Overall Study|Lack of Efficacy|0
2509235|NCT01851590|8680781|P3|Overall Study|Adverse Event|2
2509236|NCT01851590|8680782|P2|Overall Study|Adverse Event|0
2509237|NCT01851590|8680783|P1|Overall Study|Adverse Event|0
2509238|NCT01851590|8680781|P3|Overall Study|Withdrawal by Subject|1
2509239|NCT01851590|8680782|P2|Overall Study|Withdrawal by Subject|0
2509240|NCT01851590|8680783|P1|Overall Study|Withdrawal by Subject|0
2509241|NCT01851330|8680806|P3|Overall Study|Investigator’s Discretion|1
2509242|NCT01851330|8680807|P2|Overall Study|Investigator’s Discretion|0
2509243|NCT01851330|8680808|P1|Overall Study|Investigator’s Discretion|0
2509244|NCT01851330|8680806|P3|Overall Study|Withdrew Consent|0
2509245|NCT01851330|8680807|P2|Overall Study|Withdrew Consent|1
2509246|NCT01851330|8680808|P1|Overall Study|Withdrew Consent|2
2509247|NCT01851330|8680806|P3|Overall Study|Lost to Follow-up|9
2509248|NCT01851330|8680807|P2|Overall Study|Lost to Follow-up|6
2509249|NCT01851330|8680808|P1|Overall Study|Lost to Follow-up|1
2509250|NCT01851330|8680806|P3|Overall Study|Lack of Efficacy|2
2509251|NCT01851330|8680807|P2|Overall Study|Lack of Efficacy|9
2509252|NCT01851330|8680808|P1|Overall Study|Lack of Efficacy|10
2509253|NCT01850641|8680861|P1|Overall Study|Increase in serum ferritin|1
2509254|NCT01850641|8680861|P1|Overall Study|Decrease in serum calcium|2
2509255|NCT01850641|8680861|P1|Overall Study|Decrease in serum phosphorus|1
2509256|NCT01850641|8680861|P1|Overall Study|Physician Decision|1
2509257|NCT01850615|8680875|P2|Overall Study|Unclassified|1
2509258|NCT01850615|8680876|P1|Overall Study|Unclassified|0
2509259|NCT01850615|8680875|P2|Overall Study|Lost to Follow-up|1
2509260|NCT01850615|8680876|P1|Overall Study|Lost to Follow-up|0
2509261|NCT01850615|8680875|P2|Overall Study|Withdrawal by Subject|1
2509262|NCT01850615|8680876|P1|Overall Study|Withdrawal by Subject|3
2509263|NCT01850615|8680875|P2|Overall Study|Adverse Event|1
2509264|NCT01850615|8680876|P1|Overall Study|Adverse Event|2
2509265|NCT01850615|8680875|P2|Overall Study|Protocol Violation|1
2509266|NCT01850615|8680876|P1|Overall Study|Protocol Violation|4
2509267|NCT01850602|8680894|P2|Overall Study|Increase in serum ferritin|0
2509268|NCT01850602|8680895|P1|Overall Study|Increase in serum ferritin|1
2509269|NCT01850602|8680894|P2|Overall Study|Decrease in serum calcium|3
2509270|NCT01850602|8680895|P1|Overall Study|Decrease in serum calcium|2
2509271|NCT01850602|8680894|P2|Overall Study|Withdrawal by Subject|4
2509272|NCT01850602|8680895|P1|Overall Study|Withdrawal by Subject|2
2509273|NCT01850602|8680894|P2|Overall Study|Physician Decision|1
2509274|NCT01850602|8680895|P1|Overall Study|Physician Decision|2
2509275|NCT01850602|8680894|P2|Overall Study|Adverse Event|10
2509276|NCT01850602|8680895|P1|Overall Study|Adverse Event|7
2509277|NCT01850589|8680909|P2|Overall Study|Withdrawal by Subject|0
2509278|NCT01850589|8680910|P1|Overall Study|Withdrawal by Subject|8
2509279|NCT01850446|8680950|P2|Overall Study|Protocol Violation|2
2509280|NCT01850446|8680951|P1|Overall Study|Protocol Violation|0
2509281|NCT01850446|8680950|P2|Overall Study|Withdrawal by Subject|0
2509282|NCT01850446|8680951|P1|Overall Study|Withdrawal by Subject|4
2509283|NCT01850446|8680950|P2|Overall Study|Lack of Efficacy|0
2509284|NCT01850446|8680951|P1|Overall Study|Lack of Efficacy|1
2509285|NCT01850030|8681010|P2|Overall Study|pregnancy not confirmed at visit 4|249
2509286|NCT01850030|8681011|P1|Overall Study|pregnancy not confirmed at visit 4|248
2509287|NCT01850030|8681010|P2|Overall Study|Protocol Violation|28
2509288|NCT01850030|8681011|P1|Overall Study|Protocol Violation|24
2509289|NCT01850030|8681010|P2|Overall Study|Withdrawal by Subject|4
2509290|NCT01850030|8681011|P1|Overall Study|Withdrawal by Subject|3
2509291|NCT01850030|8681010|P2|Overall Study|Lost to Follow-up|5
2509292|NCT01850030|8681011|P1|Overall Study|Lost to Follow-up|5
2509293|NCT01850030|8681010|P2|Overall Study|Lack of Efficacy|1
2509294|NCT01850030|8681011|P1|Overall Study|Lack of Efficacy|3
2509295|NCT01850030|8681010|P2|Overall Study|Adverse Event|82
2509296|NCT01850030|8681011|P1|Overall Study|Adverse Event|64
2509297|NCT01850004|8681023|P1|Overall Study|AE Unrelated to Study Drug|1
2509298|NCT01850004|8681023|P1|Overall Study|Subject Request to Discontinue Treatment|1
2509299|NCT01850004|8681023|P1|Overall Study|Subject Withdrew Consent|4
2509300|NCT01850004|8681023|P1|Overall Study|Poor/Non-compliance|1
2509301|NCT01850004|8681023|P1|Overall Study|Subject Moved|1
2509302|NCT01849848|8681030|P1|Overall Study|Progression of the primary disease|3
2509303|NCT01849848|8681030|P1|Overall Study|Physician Decision|1
2509304|NCT01849588|8681128|P1|Overall Study|Lack of Efficacy|3
2509305|NCT01849562|8681138|P3|Overall Study|Non-compliance with Study Drug|0
2509306|NCT01849562|8681139|P2|Overall Study|Non-compliance with Study Drug|0
2509307|NCT01849562|8681140|P1|Overall Study|Non-compliance with Study Drug|1
2509308|NCT01849562|8681138|P3|Overall Study|Lost to Follow-up|0
2509309|NCT01849562|8681139|P2|Overall Study|Lost to Follow-up|0
2509310|NCT01849562|8681140|P1|Overall Study|Lost to Follow-up|1
2509311|NCT01849497|8681153|P2|Overall Study|Lost to Follow-up|1
2509312|NCT01849497|8681154|P1|Overall Study|Lost to Follow-up|0
2509313|NCT01849497|8681153|P2|Overall Study|Sponsor Decision|1
2509314|NCT01849497|8681154|P1|Overall Study|Sponsor Decision|0
2509315|NCT01849497|8681153|P2|Overall Study|Withdrawal by Subject|2
2509316|NCT01849497|8681154|P1|Overall Study|Withdrawal by Subject|1
2509317|NCT01849458|8681162|P1|Overall Study|Lost to Follow-up|4
2509318|NCT01849289|8681201|P2|Overall Study|Unclassified|18
2509319|NCT01849289|8681202|P1|Overall Study|Unclassified|25
2509320|NCT01849289|8681201|P2|Overall Study|Withdrawal criteria|0
2509321|NCT01849289|8681202|P1|Overall Study|Withdrawal criteria|1
2509322|NCT01849289|8681201|P2|Overall Study|Protocol Violation|3
2509323|NCT01849289|8681202|P1|Overall Study|Protocol Violation|3
2509324|NCT01849289|8681201|P2|Overall Study|Adverse Event|3
2509325|NCT01849289|8681202|P1|Overall Study|Adverse Event|3
2509326|NCT01849276|8681218|P1|Followed for Survival for 5 Years|Early termination of the study|1
2509327|NCT01849276|8681218|P1|Followed for Survival for 5 Years|Death|1
2509328|NCT01849055|8681300|P6|Overall Study|Withdrawal by Subject|0
2509329|NCT01849055|8681301|P5|Overall Study|Withdrawal by Subject|0
2509330|NCT01849055|8681302|P4|Overall Study|Withdrawal by Subject|0
2509331|NCT01849055|8681303|P3|Overall Study|Withdrawal by Subject|1
2509332|NCT01849055|8681304|P2|Overall Study|Withdrawal by Subject|0
2509333|NCT01849055|8681305|P1|Overall Study|Withdrawal by Subject|0
2509334|NCT01848990|8681340|P3|Overall Study|Other|2
2509335|NCT01848990|8681341|P2|Overall Study|Other|4
2509336|NCT01848990|8681342|P1|Overall Study|Other|1
2509337|NCT01848990|8681340|P3|Overall Study|Death|1
2509338|NCT01848990|8681341|P2|Overall Study|Death|0
2509339|NCT01848990|8681342|P1|Overall Study|Death|1
2509340|NCT01848990|8681340|P3|Overall Study|Non Compliance|0
2509341|NCT01848990|8681341|P2|Overall Study|Non Compliance|0
2509342|NCT01848990|8681342|P1|Overall Study|Non Compliance|1
2509343|NCT01848990|8681340|P3|Overall Study|Physician Decision|0
2509344|NCT01848990|8681341|P2|Overall Study|Physician Decision|1
2509345|NCT01848990|8681342|P1|Overall Study|Physician Decision|1
2509346|NCT01848990|8681340|P3|Overall Study|Withdrawal by Subject|11
2509347|NCT01848990|8681341|P2|Overall Study|Withdrawal by Subject|10
2509348|NCT01848990|8681342|P1|Overall Study|Withdrawal by Subject|29
2509349|NCT01848990|8681340|P3|Overall Study|Protocol Violation|0
2509350|NCT01848990|8681341|P2|Overall Study|Protocol Violation|1
2509351|NCT01848990|8681342|P1|Overall Study|Protocol Violation|1
2509352|NCT01848990|8681340|P3|Overall Study|Lost to Follow-up|2
2509353|NCT01848990|8681341|P2|Overall Study|Lost to Follow-up|2
2509354|NCT01848990|8681342|P1|Overall Study|Lost to Follow-up|6
2509355|NCT01848990|8681340|P3|Overall Study|Adverse Event|0
2509356|NCT01848990|8681341|P2|Overall Study|Adverse Event|2
2509357|NCT01848990|8681342|P1|Overall Study|Adverse Event|6
2509358|NCT01848938|8681412|P2|Overall Study|Lost to Follow-up|1
2509359|NCT01848938|8681413|P1|Overall Study|Lost to Follow-up|1
2509360|NCT01848834|8681462|P5|Overall Study|Not Treated|0
2509361|NCT01848834|8681463|P4|Overall Study|Not Treated|0
2509362|NCT01848834|8681464|P3|Overall Study|Not Treated|0
2509363|NCT01848834|8681465|P2|Overall Study|Not Treated|1
2509364|NCT01848834|8681466|P1|Overall Study|Not Treated|0
2509365|NCT01848834|8681462|P5|Overall Study|Withdrawal by Subject|7
2509366|NCT01848834|8681463|P4|Overall Study|Withdrawal by Subject|0
2509367|NCT01848834|8681464|P3|Overall Study|Withdrawal by Subject|3
2509368|NCT01848834|8681465|P2|Overall Study|Withdrawal by Subject|2
2509369|NCT01848834|8681466|P1|Overall Study|Withdrawal by Subject|0
2509370|NCT01848834|8681462|P5|Overall Study|Protocol Violation|2
2509371|NCT01848834|8681463|P4|Overall Study|Protocol Violation|0
2509372|NCT01848834|8681464|P3|Overall Study|Protocol Violation|1
2509373|NCT01848834|8681465|P2|Overall Study|Protocol Violation|0
2509374|NCT01848834|8681466|P1|Overall Study|Protocol Violation|0
2509375|NCT01848834|8681462|P5|Overall Study|Progressive Disease|78
2509376|NCT01848834|8681463|P4|Overall Study|Progressive Disease|36
2509377|NCT01848834|8681464|P3|Overall Study|Progressive Disease|21
2509378|NCT01848834|8681465|P2|Overall Study|Progressive Disease|41
2509379|NCT01848834|8681466|P1|Overall Study|Progressive Disease|27
2509380|NCT01848834|8681462|P5|Overall Study|Death|3
2509381|NCT01848834|8681463|P4|Overall Study|Death|0
2509382|NCT01848834|8681464|P3|Overall Study|Death|0
2509383|NCT01848834|8681465|P2|Overall Study|Death|1
2509384|NCT01848834|8681466|P1|Overall Study|Death|0
2509385|NCT01848834|8681462|P5|Overall Study|Complete Response|0
2509386|NCT01848834|8681463|P4|Overall Study|Complete Response|0
2509387|NCT01848834|8681464|P3|Overall Study|Complete Response|0
2509388|NCT01848834|8681465|P2|Overall Study|Complete Response|1
2509389|NCT01848834|8681466|P1|Overall Study|Complete Response|0
2509390|NCT01848834|8681462|P5|Overall Study|Adverse Event|15
2509391|NCT01848834|8681463|P4|Overall Study|Adverse Event|1
2509392|NCT01848834|8681464|P3|Overall Study|Adverse Event|6
2509393|NCT01848834|8681465|P2|Overall Study|Adverse Event|8
2509394|NCT01848834|8681466|P1|Overall Study|Adverse Event|3
2509395|NCT01848834|8681462|P5|Overall Study|Physician Decision|1
2509396|NCT01848834|8681463|P4|Overall Study|Physician Decision|0
2509397|NCT01848834|8681464|P3|Overall Study|Physician Decision|0
2509398|NCT01848834|8681465|P2|Overall Study|Physician Decision|0
2509399|NCT01848834|8681466|P1|Overall Study|Physician Decision|0
2509400|NCT01848834|8681462|P5|Overall Study|Ongoing in Study|26
2509401|NCT01848834|8681463|P4|Overall Study|Ongoing in Study|0
2509402|NCT01848834|8681464|P3|Overall Study|Ongoing in Study|1
2509403|NCT01848834|8681465|P2|Overall Study|Ongoing in Study|6
2509404|NCT01848834|8681466|P1|Overall Study|Ongoing in Study|0
2509405|NCT01848756|8681514|P1|Overall Study|Enrolled in Error|1
2509406|NCT01848756|8681514|P1|Overall Study|Withdrawal by Subject|1
2509407|NCT01848756|8681514|P1|Overall Study|Adverse Event|1
2509408|NCT01848483|8681526|P2|Overall Study|Incarceration|2
2509409|NCT01848483|8681527|P1|Overall Study|Incarceration|2
2509410|NCT01848483|8681526|P2|Overall Study|Withdrawal by Subject|0
2509411|NCT01848483|8681527|P1|Overall Study|Withdrawal by Subject|1
2509412|NCT01848483|8681526|P2|Overall Study|Lost to Follow-up|8
2509413|NCT01848483|8681527|P1|Overall Study|Lost to Follow-up|6
2509414|NCT01848483|8681526|P2|Overall Study|Death|1
2509415|NCT01848483|8681527|P1|Overall Study|Death|2
2509416|NCT01848457|8681545|P4|Overall Study|Death|0
2509417|NCT01848457|8681546|P3|Overall Study|Death|0
2509418|NCT01848457|8681547|P2|Overall Study|Death|0
2509419|NCT01848457|8681548|P1|Overall Study|Death|1
2509420|NCT01848353|8681580|P4|Phase 3|Withdrawal by Subject|0
2509421|NCT01848353|8681581|P3|Phase 3|Withdrawal by Subject|0
2509422|NCT01848353|8681582|P2|Phase 3|Withdrawal by Subject|1
2509423|NCT01848353|8681583|P1|Phase 3|Withdrawal by Subject|1
2509424|NCT01848353|8681580|P4|Phase 2|Withdrawal by Subject|0
2509425|NCT01848353|8681581|P3|Phase 2|Withdrawal by Subject|0
2509426|NCT01848353|8681582|P2|Phase 2|Withdrawal by Subject|2
2509427|NCT01848353|8681583|P1|Phase 2|Withdrawal by Subject|3
2509428|NCT01848353|8681580|P4|Phase 1|Withdrawal by Subject|0
2509429|NCT01848353|8681581|P3|Phase 1|Withdrawal by Subject|0
2509430|NCT01848353|8681582|P2|Phase 1|Withdrawal by Subject|1
2509431|NCT01848353|8681583|P1|Phase 1|Withdrawal by Subject|3
2509432|NCT01848288|8681639|P1|Overall Study|Withdrawal by Subject|1
2509433|NCT01848288|8681639|P1|Overall Study|Protocol Violation|1
2509434|NCT01848288|8681639|P1|Overall Study|Death|1
2509435|NCT01848210|8681650|P2|Overall Study|Administrative|0
2509436|NCT01848210|8681651|P1|Overall Study|Administrative|1
2509437|NCT01848210|8681650|P2|Overall Study|Chronic Venous Insufficiency Course|2
2509438|NCT01848210|8681651|P1|Overall Study|Chronic Venous Insufficiency Course|1
2509439|NCT01848210|8681650|P2|Overall Study|Hepatic Function Alteration|0
2509440|NCT01848210|8681651|P1|Overall Study|Hepatic Function Alteration|4
2509441|NCT01848210|8681650|P2|Overall Study|Hypesensitivity|0
2509442|NCT01848210|8681651|P1|Overall Study|Hypesensitivity|1
2509443|NCT01848210|8681650|P2|Overall Study|Discontinuation Criterion|7
2509444|NCT01848210|8681651|P1|Overall Study|Discontinuation Criterion|5
2509445|NCT01848210|8681650|P2|Overall Study|Adverse Event|9
2509446|NCT01848210|8681651|P1|Overall Study|Adverse Event|7
2509447|NCT01848210|8681650|P2|Overall Study|Impedition Condition|9
2509448|NCT01848210|8681651|P1|Overall Study|Impedition Condition|5
2509449|NCT01848210|8681650|P2|Overall Study|Use of Forbidden Drugs|10
2509450|NCT01848210|8681651|P1|Overall Study|Use of Forbidden Drugs|9
2509451|NCT01848210|8681650|P2|Overall Study|Protocol Violation|5
2509452|NCT01848210|8681651|P1|Overall Study|Protocol Violation|3
2509453|NCT01848210|8681650|P2|Overall Study|Lost to Follow-up|12
2509454|NCT01848210|8681651|P1|Overall Study|Lost to Follow-up|24
2509455|NCT01848210|8681650|P2|Overall Study|Informed Consent Form Withdrawal|24
2509456|NCT01848210|8681651|P1|Overall Study|Informed Consent Form Withdrawal|28
2509457|NCT01848145|8681673|P1|Subsequent Infusions: Weeks 3-8|Death|1
2509458|NCT01848145|8681673|P1|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3
2509459|NCT01848145|8681673|P1|Subsequent Infusions: Weeks 3-8|Disease Progression|6
2509460|NCT01848145|8681673|P1|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1
2509461|NCT01848145|8681673|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1
2509462|NCT01848145|8681673|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1
2509463|NCT01848145|8681673|P1|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1
2509464|NCT01847885|8681713|P3|Randomization|Screen Failure|0
2509465|NCT01847885|8681714|P2|Randomization|Screen Failure|3
2509466|NCT01847885|8681715|P1|Randomization|Screen Failure|0
2509467|NCT01847885|8681713|P3|Randomization|Withdrawal by Subject|2
2509468|NCT01847885|8681714|P2|Randomization|Withdrawal by Subject|0
2509469|NCT01847885|8681715|P1|Randomization|Withdrawal by Subject|0
2509470|NCT01847885|8681713|P3|Randomization|Protocol Violation|0
2509471|NCT01847885|8681714|P2|Randomization|Protocol Violation|1
2509472|NCT01847885|8681715|P1|Randomization|Protocol Violation|0
2509473|NCT01847885|8681713|P3|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
2509474|NCT01847885|8681714|P2|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
2509475|NCT01847885|8681715|P1|Initial Enrollment (Consented)|Pending prior to enrollment stop|6
2509476|NCT01847885|8681713|P3|Initial Enrollment (Consented)|Screen failure|0
2509477|NCT01847885|8681714|P2|Initial Enrollment (Consented)|Screen failure|0
2509478|NCT01847885|8681715|P1|Initial Enrollment (Consented)|Screen failure|39
2509479|NCT01847885|8681713|P3|Initial Enrollment (Consented)|Withdrawal by Subject|0
2509480|NCT01847885|8681714|P2|Initial Enrollment (Consented)|Withdrawal by Subject|0
2509481|NCT01847885|8681715|P1|Initial Enrollment (Consented)|Withdrawal by Subject|2
2509482|NCT01847885|8681713|P3|Initial Enrollment (Consented)|Protocol Violation|0
2509483|NCT01847885|8681714|P2|Initial Enrollment (Consented)|Protocol Violation|0
2509484|NCT01847885|8681715|P1|Initial Enrollment (Consented)|Protocol Violation|1
2509485|NCT01847443|8681879|P4|Washout Period Before Study Period 4|Positive alcohol test|0
2509486|NCT01847443|8681880|P3|Washout Period Before Study Period 4|Positive alcohol test|0
2509487|NCT01847443|8681881|P2|Washout Period Before Study Period 4|Positive alcohol test|0
2509488|NCT01847443|8681882|P1|Washout Period Before Study Period 4|Positive alcohol test|1
2509489|NCT01847443|8681879|P4|Washout Period Before Study Period 4|Withdrawal by Subject|0
2509490|NCT01847443|8681880|P3|Washout Period Before Study Period 4|Withdrawal by Subject|0
2509491|NCT01847443|8681881|P2|Washout Period Before Study Period 4|Withdrawal by Subject|0
2509492|NCT01847443|8681882|P1|Washout Period Before Study Period 4|Withdrawal by Subject|1
2509493|NCT01847443|8681879|P4|Washout Period Before Study Period 3|Other reason|0
2509494|NCT01847443|8681880|P3|Washout Period Before Study Period 3|Other reason|0
2509495|NCT01847443|8681881|P2|Washout Period Before Study Period 3|Other reason|0
2509496|NCT01847443|8681882|P1|Washout Period Before Study Period 3|Other reason|1
2509497|NCT01847443|8681879|P4|Washout Period Before Study Period 2|Other reason|0
2509498|NCT01847443|8681880|P3|Washout Period Before Study Period 2|Other reason|0
2509499|NCT01847443|8681881|P2|Washout Period Before Study Period 2|Other reason|0
2509500|NCT01847443|8681882|P1|Washout Period Before Study Period 2|Other reason|1
2509501|NCT01847443|8681879|P4|Washout Period Before Study Period 2|Adverse Event|0
2509502|NCT01847443|8681880|P3|Washout Period Before Study Period 2|Adverse Event|0
2509503|NCT01847443|8681881|P2|Washout Period Before Study Period 2|Adverse Event|1
2509504|NCT01847443|8681882|P1|Washout Period Before Study Period 2|Adverse Event|1
2509505|NCT01847443|8681879|P4|Study Period 1|Withdrawal by Subject|0
2509506|NCT01847443|8681880|P3|Study Period 1|Withdrawal by Subject|0
2509507|NCT01847443|8681881|P2|Study Period 1|Withdrawal by Subject|1
2509508|NCT01847443|8681882|P1|Study Period 1|Withdrawal by Subject|0
2509509|NCT01847313|8681925|P2|Overall Study|Withdrawal by Subject|1
2509510|NCT01847313|8681926|P1|Overall Study|Withdrawal by Subject|0
2509511|NCT01847313|8681925|P2|Overall Study|Death|1
2509512|NCT01847313|8681926|P1|Overall Study|Death|0
2509513|NCT01847274|8681942|P4|Overall Study|Non Compliance|0
2509514|NCT01847274|8681943|P3|Overall Study|Non Compliance|2
2509515|NCT01847274|8681944|P2|Overall Study|Non Compliance|0
2509516|NCT01847274|8681945|P1|Overall Study|Non Compliance|0
2509517|NCT01847274|8681942|P4|Overall Study|Other Reasons|3
2509518|NCT01847274|8681943|P3|Overall Study|Other Reasons|11
2509519|NCT01847274|8681944|P2|Overall Study|Other Reasons|1
2509520|NCT01847274|8681945|P1|Overall Study|Other Reasons|3
2509521|NCT01847274|8681942|P4|Overall Study|Treatment Associated Risk|0
2509522|NCT01847274|8681943|P3|Overall Study|Treatment Associated Risk|2
2509523|NCT01847274|8681944|P2|Overall Study|Treatment Associated Risk|2
2509524|NCT01847274|8681945|P1|Overall Study|Treatment Associated Risk|0
2509525|NCT01847274|8681942|P4|Overall Study|Disease Progression|98
2509526|NCT01847274|8681943|P3|Overall Study|Disease Progression|129
2509527|NCT01847274|8681944|P2|Overall Study|Disease Progression|49
2509528|NCT01847274|8681945|P1|Overall Study|Disease Progression|63
2509529|NCT01847274|8681942|P4|Overall Study|Withdrawal by Subject|1
2509530|NCT01847274|8681943|P3|Overall Study|Withdrawal by Subject|11
2509531|NCT01847274|8681944|P2|Overall Study|Withdrawal by Subject|8
2509532|NCT01847274|8681945|P1|Overall Study|Withdrawal by Subject|8
2509533|NCT01847274|8681942|P4|Overall Study|Adverse Event|2
2509534|NCT01847274|8681943|P3|Overall Study|Adverse Event|33
2509535|NCT01847274|8681944|P2|Overall Study|Adverse Event|1
2509536|NCT01847274|8681945|P1|Overall Study|Adverse Event|17
2509537|NCT01847209|8681999|P1|Overall Study|No lung nodule found on intraop CT scan|1
2509538|NCT01847209|8681999|P1|Overall Study|Withdrawal by Subject|1
2509539|NCT01846741|8682066|P1|Baseline Visit|Subject did not meet entry criteria|2
2509540|NCT01846624|8682222|P1|Overall Study|Died during induction, no midostaurin|1
2509541|NCT01846611|8682232|P2|Overall Study|Other|18
2509542|NCT01846611|8682233|P1|Overall Study|Other|19
2509543|NCT01846611|8682232|P2|Overall Study|Withdrawal by Subject|19
2509544|NCT01846611|8682233|P1|Overall Study|Withdrawal by Subject|15
2509545|NCT01846611|8682232|P2|Overall Study|Lost to Follow-up|6
2509546|NCT01846611|8682233|P1|Overall Study|Lost to Follow-up|4
2509547|NCT01846507|8682243|P1|Overall Study|Missing data|2
2509548|NCT01846507|8682243|P1|Overall Study|Protocol Violation|1
2509549|NCT01846507|8682243|P1|Overall Study|Lost to Follow-up|4
2509550|NCT01846442|8682341|P4|Overall Study|Left the city/Lost medication|1
2509551|NCT01846442|8682342|P3|Overall Study|Left the city/Lost medication|1
2509552|NCT01846442|8682343|P2|Overall Study|Left the city/Lost medication|0
2509553|NCT01846442|8682344|P1|Overall Study|Left the city/Lost medication|1
2509554|NCT01846442|8682341|P4|Overall Study|Withdrawal by Subject|1
2509555|NCT01846442|8682342|P3|Overall Study|Withdrawal by Subject|0
2509556|NCT01846442|8682343|P2|Overall Study|Withdrawal by Subject|2
2509557|NCT01846442|8682344|P1|Overall Study|Withdrawal by Subject|3
2509558|NCT01846442|8682341|P4|Overall Study|Lost to Follow-up|0
2509559|NCT01846442|8682342|P3|Overall Study|Lost to Follow-up|1
2509560|NCT01846442|8682343|P2|Overall Study|Lost to Follow-up|0
2509561|NCT01846442|8682344|P1|Overall Study|Lost to Follow-up|0
2509562|NCT01846442|8682341|P4|Overall Study|Adverse Event|1
2509563|NCT01846442|8682342|P3|Overall Study|Adverse Event|2
2509564|NCT01846442|8682343|P2|Overall Study|Adverse Event|4
2509565|NCT01846442|8682344|P1|Overall Study|Adverse Event|2
2509566|NCT01846416|8682385|P3|Survival Follow-up|Other|1
2509567|NCT01846416|8682386|P2|Survival Follow-up|Other|1
2509568|NCT01846416|8682387|P1|Survival Follow-up|Other|3
2509569|NCT01846416|8682385|P3|Survival Follow-up|Study Terminated by Sponsor|0
2509570|NCT01846416|8682386|P2|Survival Follow-up|Study Terminated by Sponsor|8
2509571|NCT01846416|8682387|P1|Survival Follow-up|Study Terminated by Sponsor|2
2509572|NCT01846416|8682385|P3|Survival Follow-up|Withdrawal by Subject|0
2509573|NCT01846416|8682386|P2|Survival Follow-up|Withdrawal by Subject|7
2509574|NCT01846416|8682387|P1|Survival Follow-up|Withdrawal by Subject|2
2509575|NCT01846416|8682385|P3|Survival Follow-up|Lost to Follow-up|2
2509576|NCT01846416|8682386|P2|Survival Follow-up|Lost to Follow-up|2
2509577|NCT01846416|8682387|P1|Survival Follow-up|Lost to Follow-up|0
2509578|NCT01846416|8682385|P3|Survival Follow-up|Death|9
2509579|NCT01846416|8682386|P2|Survival Follow-up|Death|62
2509580|NCT01846416|8682387|P1|Survival Follow-up|Death|21
2509581|NCT01846416|8682385|P3|Treatment Phase|Progressive Disease|9
2509582|NCT01846416|8682386|P2|Treatment Phase|Progressive Disease|63
2509583|NCT01846416|8682387|P1|Treatment Phase|Progressive Disease|21
2509584|NCT01846416|8682385|P3|Treatment Phase|Study Terminated by Sponsor|0
2509585|NCT01846416|8682386|P2|Treatment Phase|Study Terminated by Sponsor|4
2509586|NCT01846416|8682387|P1|Treatment Phase|Study Terminated by Sponsor|1
2509587|NCT01846416|8682385|P3|Treatment Phase|Non-compliance|0
2509588|NCT01846416|8682386|P2|Treatment Phase|Non-compliance|2
2509589|NCT01846416|8682387|P1|Treatment Phase|Non-compliance|0
2509590|NCT01846416|8682385|P3|Treatment Phase|Adverse Event|0
2509591|NCT01846416|8682386|P2|Treatment Phase|Adverse Event|4
2509592|NCT01846416|8682387|P1|Treatment Phase|Adverse Event|3
2509593|NCT01846416|8682385|P3|Treatment Phase|Physician Decision|0
2509594|NCT01846416|8682386|P2|Treatment Phase|Physician Decision|2
2509595|NCT01846416|8682387|P1|Treatment Phase|Physician Decision|1
2509596|NCT01846416|8682385|P3|Treatment Phase|Other|1
2509597|NCT01846416|8682386|P2|Treatment Phase|Other|5
2509598|NCT01846416|8682387|P1|Treatment Phase|Other|1
2509599|NCT01846416|8682385|P3|Treatment Phase|Withdrawal by Subject|2
2509600|NCT01846416|8682386|P2|Treatment Phase|Withdrawal by Subject|4
2509601|NCT01846416|8682387|P1|Treatment Phase|Withdrawal by Subject|2
2509602|NCT01846416|8682385|P3|Treatment Phase|Death|1
2509603|NCT01846416|8682386|P2|Treatment Phase|Death|9
2509604|NCT01846416|8682387|P1|Treatment Phase|Death|2
2509605|NCT01846299|8682432|P2|Overall Study|Adverse Event|0
2509606|NCT01846299|8682433|P1|Overall Study|Adverse Event|2
2509607|NCT01846299|8682432|P2|Overall Study|Withdrawal by Subject|6
2509608|NCT01846299|8682433|P1|Overall Study|Withdrawal by Subject|1
2509609|NCT01846299|8682432|P2|Overall Study|Lost to Follow-up|0
2509610|NCT01846299|8682433|P1|Overall Study|Lost to Follow-up|3
2509611|NCT01846299|8682432|P2|Overall Study|Death|2
2509612|NCT01846299|8682433|P1|Overall Study|Death|1
2509613|NCT01846299|8682432|P2|Overall Study|Protocol deviation|0
2509614|NCT01846299|8682433|P1|Overall Study|Protocol deviation|1
2509615|NCT01846299|8682432|P2|Overall Study|Physician Decision|2
2509616|NCT01846299|8682433|P1|Overall Study|Physician Decision|4
2509617|NCT01846273|8682472|P3|Overall Study|Physician Decision|0
2509618|NCT01846273|8682473|P2|Overall Study|Physician Decision|2
2509619|NCT01846273|8682474|P1|Overall Study|Physician Decision|1
2509620|NCT01846273|8682472|P3|Overall Study|Protocol Deviation|0
2509621|NCT01846273|8682473|P2|Overall Study|Protocol Deviation|3
2509622|NCT01846273|8682474|P1|Overall Study|Protocol Deviation|2
2509623|NCT01846273|8682472|P3|Overall Study|Disease Progression|0
2509624|NCT01846273|8682473|P2|Overall Study|Disease Progression|4
2509625|NCT01846273|8682474|P1|Overall Study|Disease Progression|0
2509626|NCT01846273|8682472|P3|Overall Study|Death|0
2509627|NCT01846273|8682473|P2|Overall Study|Death|1
2509628|NCT01846273|8682474|P1|Overall Study|Death|2
2509629|NCT01846273|8682472|P3|Overall Study|Administrative problems|0
2509630|NCT01846273|8682473|P2|Overall Study|Administrative problems|0
2509631|NCT01846273|8682474|P1|Overall Study|Administrative problems|1
2509632|NCT01846273|8682472|P3|Overall Study|Lost to Follow-up|0
2509633|NCT01846273|8682473|P2|Overall Study|Lost to Follow-up|1
2509634|NCT01846273|8682474|P1|Overall Study|Lost to Follow-up|2
2509635|NCT01846273|8682472|P3|Overall Study|Subject withdrew consent|0
2509636|NCT01846273|8682473|P2|Overall Study|Subject withdrew consent|8
2509637|NCT01846273|8682474|P1|Overall Study|Subject withdrew consent|5
2509638|NCT01846273|8682472|P3|Overall Study|Adverse Event|0
2509639|NCT01846273|8682473|P2|Overall Study|Adverse Event|7
2509640|NCT01846273|8682474|P1|Overall Study|Adverse Event|9
2509641|NCT01846221|8682530|P2|Overall Study|Age Exclusion|0
2509642|NCT01846221|8682531|P1|Overall Study|Age Exclusion|1
2509643|NCT01846221|8682530|P2|Overall Study|Catheter Failure|0
2509644|NCT01846221|8682531|P1|Overall Study|Catheter Failure|2
2509645|NCT01846208|8682548|P3|Overall Study|Refused SU OFC|1
2509646|NCT01846208|8682549|P2|Overall Study|Refused SU OFC|0
2509647|NCT01846208|8682550|P1|Overall Study|Refused SU OFC|0
2509648|NCT01846208|8682548|P3|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
2509649|NCT01846208|8682549|P2|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
2509650|NCT01846208|8682550|P1|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1
2509651|NCT01846208|8682548|P3|Overall Study|Non-compliance|0
2509652|NCT01846208|8682549|P2|Overall Study|Non-compliance|1
2509653|NCT01846208|8682550|P1|Overall Study|Non-compliance|1
2509654|NCT01846208|8682548|P3|Overall Study|Withdrawal by Subject|0
2509655|NCT01846208|8682549|P2|Overall Study|Withdrawal by Subject|0
2509656|NCT01846208|8682550|P1|Overall Study|Withdrawal by Subject|5
2509657|NCT01846208|8682548|P3|Overall Study|Dosing Symptoms|6
2509658|NCT01846208|8682549|P2|Overall Study|Dosing Symptoms|2
2509659|NCT01846208|8682550|P1|Overall Study|Dosing Symptoms|1
2509660|NCT01846208|8682548|P3|Overall Study|Withdrew prior to treatment|1
2509661|NCT01846208|8682549|P2|Overall Study|Withdrew prior to treatment|1
2509662|NCT01846208|8682550|P1|Overall Study|Withdrew prior to treatment|1
2509663|NCT01846104|8682570|P1|Overall Study|Withdrawal by Subject|1
2509664|NCT01846039|8682576|P1|Overall Study|Subject Withdrew Consent|1
2509665|NCT01846039|8682576|P1|Overall Study|Protocol Violation|1
2509666|NCT01845974|8682588|P2|Overall Study|screen failure|0
2509667|NCT01845974|8682589|P1|Overall Study|screen failure|1
2509668|NCT01845831|8682597|P5|Inpatient Phase|Withdrawal by Subject|0
2509669|NCT01845831|8682598|P4|Inpatient Phase|Withdrawal by Subject|0
2509670|NCT01845831|8682599|P3|Inpatient Phase|Withdrawal by Subject|0
2509671|NCT01845831|8682600|P2|Inpatient Phase|Withdrawal by Subject|1
2509672|NCT01845831|8682601|P1|Inpatient Phase|Withdrawal by Subject|1
2509673|NCT01845818|8682630|P2|Overall Study|No Follow-Up Data Available|1
2509674|NCT01845818|8682631|P1|Overall Study|No Follow-Up Data Available|4
2509675|NCT01845818|8682630|P2|Overall Study|Did Not Receive Any Dose of Adalimumab|0
2509676|NCT01845818|8682631|P1|Overall Study|Did Not Receive Any Dose of Adalimumab|5
2509677|NCT01845818|8682630|P2|Overall Study|Other|8
2509678|NCT01845818|8682631|P1|Overall Study|Other|25
2509679|NCT01845818|8682630|P2|Overall Study|Serious Adverse Event|1
2509680|NCT01845818|8682631|P1|Overall Study|Serious Adverse Event|1
2509681|NCT01845818|8682630|P2|Overall Study|Administrative Reasons|1
2509682|NCT01845818|8682631|P1|Overall Study|Administrative Reasons|3
2509683|NCT01845818|8682630|P2|Overall Study|Lost to Follow-up|5
2509684|NCT01845818|8682631|P1|Overall Study|Lost to Follow-up|7
2509685|NCT01845818|8682630|P2|Overall Study|Withdrawal by Subject|1
2509686|NCT01845818|8682631|P1|Overall Study|Withdrawal by Subject|0
2509687|NCT01845077|8682715|P6|Washout Period|Protocol Violation|0
2509688|NCT01845077|8682716|P5|Washout Period|Protocol Violation|1
2509689|NCT01845077|8682717|P4|Washout Period|Protocol Violation|1
2509690|NCT01845077|8682718|P3|Washout Period|Protocol Violation|0
2509691|NCT01845077|8682719|P2|Washout Period|Protocol Violation|0
2509692|NCT01845077|8682720|P1|Washout Period|Protocol Violation|0
2509693|NCT01845077|8682715|P6|Washout Period|elevated lab values (not clinic. sign.)|0
2509694|NCT01845077|8682716|P5|Washout Period|elevated lab values (not clinic. sign.)|0
2509695|NCT01845077|8682717|P4|Washout Period|elevated lab values (not clinic. sign.)|0
2509696|NCT01845077|8682718|P3|Washout Period|elevated lab values (not clinic. sign.)|1
2509697|NCT01845077|8682719|P2|Washout Period|elevated lab values (not clinic. sign.)|0
2509698|NCT01845077|8682720|P1|Washout Period|elevated lab values (not clinic. sign.)|0
2509699|NCT01845077|8682715|P6|Washout Period|Adverse Event|0
2509700|NCT01845077|8682716|P5|Washout Period|Adverse Event|0
2509701|NCT01845077|8682717|P4|Washout Period|Adverse Event|0
2509702|NCT01845077|8682718|P3|Washout Period|Adverse Event|0
2509703|NCT01845077|8682719|P2|Washout Period|Adverse Event|0
2509704|NCT01845077|8682720|P1|Washout Period|Adverse Event|1
2509705|NCT01845077|8682715|P6|Washout Period|Lost to Follow-up|1
2509706|NCT01845077|8682716|P5|Washout Period|Lost to Follow-up|0
2509707|NCT01845077|8682717|P4|Washout Period|Lost to Follow-up|1
2509708|NCT01845077|8682718|P3|Washout Period|Lost to Follow-up|0
2509709|NCT01845077|8682719|P2|Washout Period|Lost to Follow-up|1
2509710|NCT01845077|8682720|P1|Washout Period|Lost to Follow-up|0
2509711|NCT01845025|8682766|P2|Overall Study|Missing|1
2509712|NCT01845025|8682767|P1|Overall Study|Missing|1
2509713|NCT01845025|8682766|P2|Overall Study|Protocol deviation|6
2509714|NCT01845025|8682767|P1|Overall Study|Protocol deviation|3
2509715|NCT01845025|8682766|P2|Overall Study|Death|0
2509716|NCT01845025|8682767|P1|Overall Study|Death|2
2509717|NCT01845025|8682766|P2|Overall Study|Administrative problems|8
2509718|NCT01845025|8682767|P1|Overall Study|Administrative problems|8
2509719|NCT01845025|8682766|P2|Overall Study|Lost to Follow-up|13
2509720|NCT01845025|8682767|P1|Overall Study|Lost to Follow-up|13
2509721|NCT01845025|8682766|P2|Overall Study|Withdrawal by Subject|44
2509722|NCT01845025|8682767|P1|Overall Study|Withdrawal by Subject|48
2509723|NCT01845025|8682766|P2|Overall Study|Unsatisfactory therapeutic effect|2
2509724|NCT01845025|8682767|P1|Overall Study|Unsatisfactory therapeutic effect|4
2509725|NCT01845025|8682766|P2|Overall Study|Adverse Event|3
2509726|NCT01845025|8682767|P1|Overall Study|Adverse Event|6
2509727|NCT01844986|8682791|P2|Overall Study|Death|26
2509728|NCT01844986|8682792|P1|Overall Study|Death|55
2509729|NCT01844986|8682791|P2|Overall Study|Withdrawal by Subject|14
2509730|NCT01844986|8682792|P1|Overall Study|Withdrawal by Subject|21
2509731|NCT01844986|8682791|P2|Overall Study|Severe non-compliance to protocol|0
2509732|NCT01844986|8682792|P1|Overall Study|Severe non-compliance to protocol|1
2509733|NCT01844895|8682814|P1|Day 29 - Day113 - Autoinjector|planned surgery|1
2509734|NCT01844895|8682814|P1|Day 29 - Day113 - Autoinjector|Difficulty using device|3
2509735|NCT01844895|8682814|P1|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1
2509736|NCT01844895|8682814|P1|Day 29 - Day113 - Autoinjector|Adverse Event|1
2509737|NCT01844895|8682814|P1|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1
2509738|NCT01844895|8682814|P1|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1
2509739|NCT01844895|8682814|P1|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1
2509740|NCT01844856|8682832|P2|Overall Study|Randomized but was a Screen Failure|1
2509741|NCT01844856|8682833|P1|Overall Study|Randomized but was a Screen Failure|0
2509742|NCT01844856|8682832|P2|Overall Study|Inadvertently Not Scheduled|0
2509743|NCT01844856|8682833|P1|Overall Study|Inadvertently Not Scheduled|1
2509744|NCT01844856|8682832|P2|Overall Study|Enterococcus Resistant|1
2509745|NCT01844856|8682833|P1|Overall Study|Enterococcus Resistant|0
2509746|NCT01844856|8682832|P2|Overall Study|Noncompliance|3
2509747|NCT01844856|8682833|P1|Overall Study|Noncompliance|2
2509748|NCT01844856|8682832|P2|Overall Study|Withdrawal by Subject|2
2509749|NCT01844856|8682833|P1|Overall Study|Withdrawal by Subject|3
2509750|NCT01844856|8682832|P2|Overall Study|Adverse Event|6
2509751|NCT01844856|8682833|P1|Overall Study|Adverse Event|3
2509752|NCT01844856|8682832|P2|Overall Study|Lost to Follow-up|3
2509753|NCT01844856|8682833|P1|Overall Study|Lost to Follow-up|15
2509754|NCT01844830|8682845|P2|Overall Study|Withdrawal by Subject|0
2509755|NCT01844830|8682846|P1|Overall Study|Withdrawal by Subject|1
2509756|NCT01844817|8682876|P2|Treatment|Other|3
2509757|NCT01844817|8682877|P1|Treatment|Other|0
2509758|NCT01844817|8682876|P2|Treatment|Lost to Follow-up|1
2509759|NCT01844817|8682877|P1|Treatment|Lost to Follow-up|0
2509760|NCT01844817|8682876|P2|Treatment|Death|8
2509761|NCT01844817|8682877|P1|Treatment|Death|10
2509762|NCT01844817|8682876|P2|Treatment|Withdrawal by Subject|6
2509763|NCT01844817|8682877|P1|Treatment|Withdrawal by Subject|10
2509764|NCT01844817|8682876|P2|Treatment|Adverse Event|9
2509765|NCT01844817|8682877|P1|Treatment|Adverse Event|17
2509766|NCT01844817|8682876|P2|Treatment|Progressive Disease|36
2509767|NCT01844817|8682877|P1|Treatment|Progressive Disease|27
2509768|NCT01844817|8682876|P2|Enrolled and Randomized|Withdrawal by Subject|3
2509769|NCT01844817|8682877|P1|Enrolled and Randomized|Withdrawal by Subject|2
2509770|NCT01844778|8682890|P3|Overall Study|Adverse Event|2
2509771|NCT01844778|8682891|P2|Overall Study|Adverse Event|2
2509772|NCT01844778|8682892|P1|Overall Study|Adverse Event|0
2509773|NCT01844778|8682890|P3|Overall Study|Withdrawal by Subject|0
2509774|NCT01844778|8682891|P2|Overall Study|Withdrawal by Subject|0
2509775|NCT01844778|8682892|P1|Overall Study|Withdrawal by Subject|2
2509776|NCT01844778|8682890|P3|Overall Study|Protocol deviation|2
2509777|NCT01844778|8682891|P2|Overall Study|Protocol deviation|1
2509778|NCT01844778|8682892|P1|Overall Study|Protocol deviation|0
2509779|NCT01844765|8682918|P2|Overall Study|Untreated|0
2509780|NCT01844765|8682919|P1|Overall Study|Untreated|1
2509781|NCT01844765|8682918|P2|Overall Study|Protocol Violation|0
2509782|NCT01844765|8682919|P1|Overall Study|Protocol Violation|1
2509783|NCT01844765|8682918|P2|Overall Study|Disease progression|0
2509784|NCT01844765|8682919|P1|Overall Study|Disease progression|1
2509785|NCT01844765|8682918|P2|Overall Study|Administrative problems|1
2509786|NCT01844765|8682919|P1|Overall Study|Administrative problems|1
2509787|NCT01844765|8682918|P2|Overall Study|Withdrawal by Subject|1
2509788|NCT01844765|8682919|P1|Overall Study|Withdrawal by Subject|0
2509789|NCT01844765|8682918|P2|Overall Study|Adverse Event|4
2509790|NCT01844765|8682919|P1|Overall Study|Adverse Event|5
2509791|NCT01844700|8682939|P2|Overall Study|stopped taking meds|1
2509792|NCT01844700|8682940|P1|Overall Study|stopped taking meds|0
2509793|NCT01844700|8682939|P2|Overall Study|Withdrawal by Subject|0
2509794|NCT01844700|8682940|P1|Overall Study|Withdrawal by Subject|1
2509795|NCT01844700|8682939|P2|Overall Study|refused medication switch|0
2509796|NCT01844700|8682940|P1|Overall Study|refused medication switch|1
2509797|NCT01844700|8682939|P2|Overall Study|Lack of Efficacy|0
2509798|NCT01844700|8682940|P1|Overall Study|Lack of Efficacy|1
2509799|NCT01844687|8682952|P1|Visit 4|Withdrawal by Subject|2
2509800|NCT01844687|8682952|P1|Visit 4|Lost to Follow-up|1
2509801|NCT01844687|8682952|P1|Visit 4|Pregnancy|1
2509802|NCT01844687|8682952|P1|Visit 3|child care problems|1
2509803|NCT01844687|8682952|P1|Visit 3|Withdrawal by Subject|3
2509804|NCT01844687|8682952|P1|Visit 3|Lost to Follow-up|1
2509805|NCT01844687|8682952|P1|Visit 2|Protocol Violation|1
2509806|NCT01844687|8682952|P1|Visit 2|Withdrawal by Subject|1
2509807|NCT01844687|8682952|P1|Visit 1|Lost to Follow-up|5
2509808|NCT01844687|8682952|P1|Visit 1|Protocol Violation|3
2509809|NCT01844583|8683013|P2|Overall Study|Didn’t complete dosing;PK/ECG assessment|10
2509810|NCT01844583|8683014|P1|Overall Study|Didn’t complete dosing;PK/ECG assessment|8
2509811|NCT01844531|8683046|P4|Overall Study|Withdrawal by Subject|0
2509812|NCT01844531|8683047|P3|Overall Study|Withdrawal by Subject|0
2509813|NCT01844531|8683048|P2|Overall Study|Withdrawal by Subject|1
2509814|NCT01844531|8683049|P1|Overall Study|Withdrawal by Subject|0
2509815|NCT01844518|8683079|P1|Long-Term Extension|Still in On-Going Study|149
2509816|NCT01844518|8683079|P1|Long-Term Extension|No Longer Met Study Criteria|1
2509817|NCT01844518|8683079|P1|Long-Term Extension|Adverse Event|1
2509818|NCT01844518|8683079|P1|Long-Term Extension|Lack of Efficacy|6
2509819|NCT01844518|8683079|P1|Short-Term (ST) Period|Poor/Non-Compliance|1
2509820|NCT01844518|8683079|P1|Short-Term (ST) Period|Withdrawal of Consent|2
2509821|NCT01844518|8683079|P1|Short-Term (ST) Period|Lack of Efficacy|3
2509822|NCT01844518|8683079|P1|Short-Term (ST) Period|Adverse Event|3
2509823|NCT01844505|8683096|P3|Overall Study|Not Reported|1
2509824|NCT01844505|8683097|P2|Overall Study|Not Reported|0
2509825|NCT01844505|8683098|P1|Overall Study|Not Reported|0
2509826|NCT01844505|8683096|P3|Overall Study|Other Reasons|2
2509827|NCT01844505|8683097|P2|Overall Study|Other Reasons|2
2509828|NCT01844505|8683098|P1|Overall Study|Other Reasons|4
2509829|NCT01844505|8683096|P3|Overall Study|Subject no longer meets criteria|0
2509830|NCT01844505|8683097|P2|Overall Study|Subject no longer meets criteria|1
2509831|NCT01844505|8683098|P1|Overall Study|Subject no longer meets criteria|0
2509832|NCT01844505|8683096|P3|Overall Study|Poor/non-compliance|1
2509833|NCT01844505|8683097|P2|Overall Study|Poor/non-compliance|1
2509834|NCT01844505|8683098|P1|Overall Study|Poor/non-compliance|1
2509835|NCT01844505|8683096|P3|Overall Study|Maximum clinical benefit|2
2509836|NCT01844505|8683097|P2|Overall Study|Maximum clinical benefit|11
2509837|NCT01844505|8683098|P1|Overall Study|Maximum clinical benefit|8
2509838|NCT01844505|8683096|P3|Overall Study|Lost to Follow-up|0
2509839|NCT01844505|8683097|P2|Overall Study|Lost to Follow-up|0
2509840|NCT01844505|8683098|P1|Overall Study|Lost to Follow-up|1
2509841|NCT01844505|8683096|P3|Overall Study|Withdrawal by Subject|0
2509842|NCT01844505|8683097|P2|Overall Study|Withdrawal by Subject|3
2509843|NCT01844505|8683098|P1|Overall Study|Withdrawal by Subject|0
2509844|NCT01844505|8683096|P3|Overall Study|Subject request discontinue treatment|8
2509845|NCT01844505|8683097|P2|Overall Study|Subject request discontinue treatment|14
2509846|NCT01844505|8683098|P1|Overall Study|Subject request discontinue treatment|17
2509847|NCT01844505|8683096|P3|Overall Study|Adverse event unrelated to study drug|6
2509848|NCT01844505|8683097|P2|Overall Study|Adverse event unrelated to study drug|15
2509849|NCT01844505|8683098|P1|Overall Study|Adverse event unrelated to study drug|7
2509850|NCT01844505|8683096|P3|Overall Study|Death|1
2509851|NCT01844505|8683097|P2|Overall Study|Death|3
2509852|NCT01844505|8683098|P1|Overall Study|Death|1
2509853|NCT01844505|8683096|P3|Overall Study|Study drug toxicity|50
2509854|NCT01844505|8683097|P2|Overall Study|Study drug toxicity|131
2509855|NCT01844505|8683098|P1|Overall Study|Study drug toxicity|40
2509856|NCT01844505|8683096|P3|Overall Study|Disease progression|224
2509857|NCT01844505|8683097|P2|Overall Study|Disease progression|88
2509858|NCT01844505|8683098|P1|Overall Study|Disease progression|170
2509859|NCT01844375|8683192|P2|Overall Study|Protocol Violation|1
2509860|NCT01844375|8683193|P1|Overall Study|Protocol Violation|1
2509861|NCT01844284|8683205|P2|Overall Study|Lost to Follow-up|7
2509862|NCT01844284|8683206|P1|Overall Study|Lost to Follow-up|12
2509863|NCT01844115|8683425|P2|Overall Study|Pregnancy|1
2509864|NCT01844115|8683426|P1|Overall Study|Pregnancy|0
2509865|NCT01844115|8683425|P2|Overall Study|Lost to Follow-up|10
2509866|NCT01844115|8683426|P1|Overall Study|Lost to Follow-up|11
2509867|NCT01844115|8683425|P2|Overall Study|Withdrawal by Subject|11
2509868|NCT01844115|8683426|P1|Overall Study|Withdrawal by Subject|11
2509869|NCT01844115|8683425|P2|Overall Study|Protocol Violation|10
2509870|NCT01844115|8683426|P1|Overall Study|Protocol Violation|12
2509871|NCT01844115|8683425|P2|Overall Study|Lack of Efficacy|4
2509872|NCT01844115|8683426|P1|Overall Study|Lack of Efficacy|1
2509873|NCT01844115|8683425|P2|Overall Study|Adverse Event|22
2509874|NCT01844115|8683426|P1|Overall Study|Adverse Event|4
2509875|NCT01843972|8683444|P10|Overall Study|Withdrawal by Subject|0
2509876|NCT01843972|8683445|P9|Overall Study|Withdrawal by Subject|0
2509877|NCT01843972|8683446|P8|Overall Study|Withdrawal by Subject|0
2509878|NCT01843972|8683447|P7|Overall Study|Withdrawal by Subject|0
2509879|NCT01843972|8683448|P6|Overall Study|Withdrawal by Subject|0
2509880|NCT01843972|8683449|P5|Overall Study|Withdrawal by Subject|1
2509881|NCT01843972|8683450|P4|Overall Study|Withdrawal by Subject|0
2509882|NCT01843972|8683451|P3|Overall Study|Withdrawal by Subject|0
2509883|NCT01843972|8683452|P2|Overall Study|Withdrawal by Subject|0
2509884|NCT01843972|8683453|P1|Overall Study|Withdrawal by Subject|0
2509885|NCT01843933|8683523|P2|Overall Study|Data lost|4
2509886|NCT01843933|8683524|P1|Overall Study|Data lost|6
2509887|NCT01843842|8683543|P2|Overall Study|Do not meet inclusion criteria|1
2509888|NCT01843842|8683544|P1|Overall Study|Do not meet inclusion criteria|1
2509889|NCT01843803|8683566|P2|Overall Study|not a Veteran, did not see provider|3
2509890|NCT01843803|8683567|P1|Overall Study|not a Veteran, did not see provider|1
2509891|NCT01843777|8683581|P2|Overall Study|Withdrawal by Subject|0
2509892|NCT01843777|8683582|P1|Overall Study|Withdrawal by Subject|1
2509893|NCT01843673|8683607|P1|Overall Study|Withdrawal by Subject|4
2509894|NCT01843673|8683607|P1|Overall Study|Lack of Efficacy|2
2509895|NCT01843660|8683619|P1|Overall Study|Other|30
2509896|NCT01843374|8683660|P2|Overall Study|Withdrawing due to Other reason|46
2509897|NCT01843374|8683661|P1|Overall Study|Withdrawing due to Other reason|20
2509898|NCT01843374|8683660|P2|Overall Study|Withdrawal by Subject|20
2509899|NCT01843374|8683661|P1|Overall Study|Withdrawal by Subject|14
2509900|NCT01843374|8683660|P2|Overall Study|Death|313
2509901|NCT01843374|8683661|P1|Overall Study|Death|155
2509902|NCT01843348|8683688|P3|Overall Study|Various reasons|6
2509903|NCT01843348|8683689|P2|Overall Study|Various reasons|9
2509904|NCT01843348|8683690|P1|Overall Study|Various reasons|4
2509905|NCT01843348|8683688|P3|Overall Study|Graft loss/retransplantation|11
2509906|NCT01843348|8683689|P2|Overall Study|Graft loss/retransplantation|8
2509907|NCT01843348|8683690|P1|Overall Study|Graft loss/retransplantation|5
2509908|NCT01843348|8683688|P3|Overall Study|Death|4
2509909|NCT01843348|8683689|P2|Overall Study|Death|3
2509910|NCT01843348|8683690|P1|Overall Study|Death|5
2509911|NCT01843348|8683688|P3|Overall Study|Lost to Follow-up|2
2509912|NCT01843348|8683689|P2|Overall Study|Lost to Follow-up|4
2509913|NCT01843348|8683690|P1|Overall Study|Lost to Follow-up|5
2509914|NCT01843348|8683688|P3|Overall Study|Withdrawal by Subject|18
2509915|NCT01843348|8683689|P2|Overall Study|Withdrawal by Subject|16
2509916|NCT01843348|8683690|P1|Overall Study|Withdrawal by Subject|4
2509917|NCT01843205|8683730|P2|First Treatment (11 Days)|Withdrawal by Subject|0
2509918|NCT01843205|8683731|P1|First Treatment (11 Days)|Withdrawal by Subject|1
2509919|NCT01843192|8683792|P3|Overall Study|Intra-operative exclusions per protocol|2
2509920|NCT01843192|8683793|P2|Overall Study|Intra-operative exclusions per protocol|6
2509921|NCT01843192|8683794|P1|Overall Study|Intra-operative exclusions per protocol|2
2509922|NCT01843062|8683825|P2|Overall Study|Lost to Follow-up|4
2509923|NCT01843062|8683826|P1|Overall Study|Lost to Follow-up|2
2509924|NCT01843062|8683825|P2|Overall Study|Death|2
2509925|NCT01843062|8683826|P1|Overall Study|Death|1
2509926|NCT01843062|8683825|P2|Overall Study|Withdrawal by Subject|3
2509927|NCT01843062|8683826|P1|Overall Study|Withdrawal by Subject|12
2509928|NCT01843062|8683825|P2|Overall Study|Incorrect randomisation|0
2509929|NCT01843062|8683826|P1|Overall Study|Incorrect randomisation|1
2509930|NCT01843062|8683825|P2|Overall Study|Adverse Event|0
2509931|NCT01843062|8683826|P1|Overall Study|Adverse Event|2
2509932|NCT01843062|8683825|P2|Overall Study|Pregnancy|0
2509933|NCT01843062|8683826|P1|Overall Study|Pregnancy|1
2509934|NCT01843062|8683825|P2|Overall Study|New treatment following progression|0
2509935|NCT01843062|8683826|P1|Overall Study|New treatment following progression|2
2509936|NCT01843062|8683825|P2|Overall Study|Protocol Violation|0
2509937|NCT01843062|8683826|P1|Overall Study|Protocol Violation|1
2509938|NCT01842958|8683840|P2|Overall Study|Lost to Follow-up|1
2509939|NCT01842958|8683841|P1|Overall Study|Lost to Follow-up|1
2509940|NCT01842633|8683916|P3|Overall Study|Technical issues|0
2509941|NCT01842633|8683917|P2|Overall Study|Technical issues|0
2509942|NCT01842633|8683918|P1|Overall Study|Technical issues|1
2509943|NCT01842633|8683916|P3|Overall Study|Withdrawal by Subject|0
2509944|NCT01842633|8683917|P2|Overall Study|Withdrawal by Subject|1
2509945|NCT01842633|8683918|P1|Overall Study|Withdrawal by Subject|0
2509946|NCT01842633|8683916|P3|Overall Study|Adverse Event|0
2509947|NCT01842633|8683917|P2|Overall Study|Adverse Event|1
2509948|NCT01842633|8683918|P1|Overall Study|Adverse Event|1
2509949|NCT01842633|8683916|P3|Overall Study|Screen Failure|0
2509950|NCT01842633|8683917|P2|Overall Study|Screen Failure|0
2509951|NCT01842633|8683918|P1|Overall Study|Screen Failure|1
2509952|NCT01842620|8683965|P2|Period 1|Withdrawal by Subject|0
2509953|NCT01842620|8683966|P1|Period 1|Withdrawal by Subject|1
2509954|NCT01842607|8683982|P1|Overall Study|Withdrawal by Subject|14
2509955|NCT01842607|8683982|P1|Overall Study|Physician Decision|9
2509956|NCT01842607|8683982|P1|Overall Study|Lost to Follow-up|3
2509957|NCT01842607|8683982|P1|Overall Study|Protocol defined stopping criteria|2
2509958|NCT01842607|8683982|P1|Overall Study|Protocol Violation|8
2509959|NCT01842607|8683982|P1|Overall Study|Lack of Efficacy|19
2509960|NCT01842607|8683982|P1|Overall Study|Adverse Event|11
2509961|NCT01842581|8684008|P2|Overall Study|Other than specified|1
2509962|NCT01842581|8684009|P1|Overall Study|Other than specified|3
2509963|NCT01842581|8684008|P2|Overall Study|Withdrawal by Subject|7
2509964|NCT01842581|8684009|P1|Overall Study|Withdrawal by Subject|5
2509965|NCT01842581|8684008|P2|Overall Study|Lost to Follow-up|5
2509966|NCT01842581|8684009|P1|Overall Study|Lost to Follow-up|2
2509967|NCT01842581|8684008|P2|Overall Study|Liver transplant|0
2509968|NCT01842581|8684009|P1|Overall Study|Liver transplant|2
2509969|NCT01842581|8684008|P2|Overall Study|HE breakthrough|13
2509970|NCT01842581|8684009|P1|Overall Study|HE breakthrough|26
2509971|NCT01842581|8684008|P2|Overall Study|Adverse Event|4
2509972|NCT01842581|8684009|P1|Overall Study|Adverse Event|6
2509973|NCT01842438|8684033|P2|T2: 6month Follow-up|Death|1
2509974|NCT01842438|8684034|P1|T2: 6month Follow-up|Death|0
2509975|NCT01842438|8684033|P2|T2: 6month Follow-up|Withdrawal by Subject|3
2509976|NCT01842438|8684034|P1|T2: 6month Follow-up|Withdrawal by Subject|4
2509977|NCT01842438|8684033|P2|T1: Immediately After the Intervention|Withdrawal by Subject|8
2509978|NCT01842438|8684034|P1|T1: Immediately After the Intervention|Withdrawal by Subject|6
2509979|NCT01842334|8684048|P2|Overall Study|Moved away mid-study|1
2509980|NCT01842334|8684049|P1|Overall Study|Moved away mid-study|0
2509981|NCT01842334|8684048|P2|Overall Study|Withdrawal by Subject|3
2509982|NCT01842334|8684049|P1|Overall Study|Withdrawal by Subject|3
2509983|NCT01841970|8684055|P1|Overall Study|Lost to Follow-up|8
2509984|NCT01841970|8684055|P1|Overall Study|Physician Decision|2
2509985|NCT01841970|8684055|P1|Overall Study|Withdrawal by Subject|1
2509986|NCT01841762|8684079|P1|Post-Treatment Safety Follow-Up Period|Other, administrative error|1
2509987|NCT01841762|8684079|P1|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6
2509988|NCT01841762|8684079|P1|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7
2509989|NCT01841762|8684079|P1|Post-Treatment Safety Follow-Up Period|Death|1
2509990|NCT01841762|8684079|P1|Treatment Period|Other, including non-compliance|5
2509991|NCT01841762|8684079|P1|Treatment Period|Physician Decision|2
2509992|NCT01841762|8684079|P1|Treatment Period|Lost to Follow-up|1
2509993|NCT01841762|8684079|P1|Treatment Period|Withdrawal by Subject|7
2509994|NCT01841762|8684079|P1|Treatment Period|Death|1
2509995|NCT01841762|8684079|P1|Treatment Period|Adverse Event|16
2509996|NCT01841762|8684079|P1|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51
2509997|NCT01841697|8684089|P2|Overall Study|Withdrawal by Subject|16
2509998|NCT01841697|8684090|P1|Overall Study|Withdrawal by Subject|16
2509999|NCT01841697|8684089|P2|Overall Study|Lost to Follow-up|1
2510000|NCT01841697|8684090|P1|Overall Study|Lost to Follow-up|4
2510001|NCT01841697|8684089|P2|Overall Study|Death|1
2510002|NCT01841697|8684090|P1|Overall Study|Death|0
2510003|NCT01841593|8684130|P2|Second Intervention (Days 8 to 14)|Adverse Event|0
2510004|NCT01841593|8684131|P1|Second Intervention (Days 8 to 14)|Adverse Event|1
2510005|NCT01841593|8684130|P2|First Intervention (Days 1 to 7)|Protocol Violation|1
2510006|NCT01841593|8684131|P1|First Intervention (Days 1 to 7)|Protocol Violation|0
2510007|NCT01841567|8684147|P1|Overall Study|Adverse Event|3
2510008|NCT01841554|8684152|P1|Overall Study|Study exit due to secondary intervention|6
2510009|NCT01841554|8684152|P1|Overall Study|Discontinued Follow Up|5
2510010|NCT01841554|8684152|P1|Overall Study|No Implantation|1
2510011|NCT01841554|8684152|P1|Overall Study|Death|7
2510012|NCT01841073|8684201|P2|Overall Study|Lost to Follow-up|2
2510013|NCT01841073|8684202|P1|Overall Study|Lost to Follow-up|0
2510014|NCT01841073|8684201|P2|Overall Study|Physician Decision|0
2510015|NCT01841073|8684202|P1|Overall Study|Physician Decision|1
2510016|NCT01841073|8684201|P2|Overall Study|Adverse Event|1
2510017|NCT01841073|8684202|P1|Overall Study|Adverse Event|1
2510018|NCT01840943|8684224|P2|Overall Study|Lost to Follow-up|4
2510019|NCT01840943|8684225|P1|Overall Study|Lost to Follow-up|4
2510020|NCT01840943|8684224|P2|Overall Study|Physician Decision|2
2510021|NCT01840943|8684225|P1|Overall Study|Physician Decision|4
2510022|NCT01840943|8684224|P2|Overall Study|Withdrawal by Subject|6
2510023|NCT01840943|8684225|P1|Overall Study|Withdrawal by Subject|5
2510024|NCT01840605|8684274|P2|Overall Study|Physician Decision|1
2510025|NCT01840605|8684275|P1|Overall Study|Physician Decision|2
2510026|NCT01840605|8684274|P2|Overall Study|Adverse Event|1
2510027|NCT01840605|8684275|P1|Overall Study|Adverse Event|0
2510028|NCT01840410|8684289|P2|Overall Study|Adverse Event|1
2510029|NCT01840410|8684290|P1|Overall Study|Adverse Event|1
2510030|NCT01840410|8684289|P2|Overall Study|Withdrawal by Subject|1
2510031|NCT01840410|8684290|P1|Overall Study|Withdrawal by Subject|2
2510032|NCT01840410|8684289|P2|Overall Study|Lost to Follow-up|0
2510033|NCT01840410|8684290|P1|Overall Study|Lost to Follow-up|1
2510034|NCT01840410|8684289|P2|Overall Study|Protocol deviation|0
2510035|NCT01840410|8684290|P1|Overall Study|Protocol deviation|1
2510036|NCT01840410|8684289|P2|Overall Study|Pregnancy|0
2510037|NCT01840410|8684290|P1|Overall Study|Pregnancy|1
2510038|NCT01840410|8684289|P2|Overall Study|Physician Decision|2
2510039|NCT01840410|8684290|P1|Overall Study|Physician Decision|1
2510040|NCT01840228|8684339|P2|Overall Study|Lost to Follow-up|1
2510041|NCT01840228|8684340|P1|Overall Study|Lost to Follow-up|1
2510042|NCT01840163|8684368|P2|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35
2510043|NCT01840163|8684369|P1|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43
2510044|NCT01840163|8684368|P2|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40
2510045|NCT01840163|8684369|P1|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48
2510046|NCT01840163|8684368|P2|First Follow up -Primary Outcome|Lost to Follow-up|16
2510047|NCT01840163|8684369|P1|First Follow up -Primary Outcome|Lost to Follow-up|19
2510048|NCT01839916|8684414|P1|Overall Study|Graft Failure|1
2510049|NCT01839916|8684414|P1|Overall Study|GVHD|2
2510050|NCT01839916|8684414|P1|Overall Study|Relapse|12
2510051|NCT01839916|8684414|P1|Overall Study|Physician Decision|17
2510052|NCT01839916|8684414|P1|Overall Study|Death|9
2510053|NCT01839656|8684465|P2|Overall Study|Adverse Event|0
2510054|NCT01839656|8684466|P1|Overall Study|Adverse Event|1
2510055|NCT01839656|8684465|P2|Overall Study|Early study closure|11
2510056|NCT01839656|8684466|P1|Overall Study|Early study closure|0
2510057|NCT01839656|8684465|P2|Overall Study|Adverse event, serious fatal|4
2510058|NCT01839656|8684466|P1|Overall Study|Adverse event, serious fatal|1
2510059|NCT01839656|8684465|P2|Overall Study|Withdrawal by Subject|1
2510060|NCT01839656|8684466|P1|Overall Study|Withdrawal by Subject|1
2510061|NCT01839279|8684554|P3|Overall Study|Classified as 'Other'|0
2510062|NCT01839279|8684555|P2|Overall Study|Classified as 'Other'|0
2510063|NCT01839279|8684556|P1|Overall Study|Classified as 'Other'|5
2510064|NCT01839279|8684554|P3|Overall Study|Withdrawal by Subject|1
2510065|NCT01839279|8684555|P2|Overall Study|Withdrawal by Subject|1
2510066|NCT01839279|8684556|P1|Overall Study|Withdrawal by Subject|4
2510067|NCT01839279|8684554|P3|Overall Study|Adverse Event|1
2510068|NCT01839279|8684555|P2|Overall Study|Adverse Event|1
2510069|NCT01839279|8684556|P1|Overall Study|Adverse Event|4
2510070|NCT01839188|8684575|P1|Overall Study|Withdrawal by Subject|1
2510071|NCT01838941|8684647|P1|Overall Study|Withdrawal by Subject|1
2510072|NCT01838941|8684647|P1|Overall Study|Adverse Event|1
2510073|NCT01838876|8684652|P1|Overall Study|Did not meet eligibility criteria|78
2510074|NCT01838876|8684652|P1|Overall Study|Reason not Specified|7
2510075|NCT01838876|8684652|P1|Overall Study|Study or Site Terminated by Sponsor|1
2510076|NCT01838876|8684652|P1|Overall Study|Lost to Follow-up|21
2510077|NCT01838876|8684652|P1|Overall Study|Withdrawal of Consent|33
2510078|NCT01838876|8684652|P1|Overall Study|Protocol Violation|34
2510079|NCT01838876|8684652|P1|Overall Study|Insufficient Therapeutic Response|10
2510080|NCT01838876|8684652|P1|Overall Study|Adverse Event|49
2510081|NCT01838694|8684761|P2|Overall Study|Adverse Event|1
2510082|NCT01838694|8684762|P1|Overall Study|Adverse Event|0
2510083|NCT01838681|8684771|P4|Period B/A+|Administrative or other reasons|28
2510084|NCT01838681|8684772|P3|Period B/A+|Administrative or other reasons|10
2510085|NCT01838681|8684773|P2|Period B/A+|Administrative or other reasons|6
2510086|NCT01838681|8684774|P1|Period B/A+|Administrative or other reasons|0
2510087|NCT01838681|8684771|P4|Period B/A+|Withdrawal before treatment|0
2510088|NCT01838681|8684772|P3|Period B/A+|Withdrawal before treatment|0
2510089|NCT01838681|8684773|P2|Period B/A+|Withdrawal before treatment|1
2510090|NCT01838681|8684774|P1|Period B/A+|Withdrawal before treatment|0
2510091|NCT01838681|8684771|P4|Period B/A+|Lost to Follow-up|11
2510092|NCT01838681|8684772|P3|Period B/A+|Lost to Follow-up|5
2510093|NCT01838681|8684773|P2|Period B/A+|Lost to Follow-up|2
2510094|NCT01838681|8684774|P1|Period B/A+|Lost to Follow-up|0
2510095|NCT01838681|8684771|P4|Period B/A+|Non-compliance with IMP|3
2510096|NCT01838681|8684772|P3|Period B/A+|Non-compliance with IMP|3
2510097|NCT01838681|8684773|P2|Period B/A+|Non-compliance with IMP|2
2510098|NCT01838681|8684774|P1|Period B/A+|Non-compliance with IMP|0
2510099|NCT01838681|8684771|P4|Period B/A+|Protocol Violation|6
2510100|NCT01838681|8684772|P3|Period B/A+|Protocol Violation|4
2510101|NCT01838681|8684773|P2|Period B/A+|Protocol Violation|1
2510102|NCT01838681|8684774|P1|Period B/A+|Protocol Violation|0
2510103|NCT01838681|8684771|P4|Period B/A+|Withdrawal by Subject|47
2510104|NCT01838681|8684772|P3|Period B/A+|Withdrawal by Subject|35
2510105|NCT01838681|8684773|P2|Period B/A+|Withdrawal by Subject|28
2510106|NCT01838681|8684774|P1|Period B/A+|Withdrawal by Subject|0
2510107|NCT01838681|8684771|P4|Period B/A+|Lack of Efficacy|6
2510108|NCT01838681|8684772|P3|Period B/A+|Lack of Efficacy|11
2510109|NCT01838681|8684773|P2|Period B/A+|Lack of Efficacy|9
2510110|NCT01838681|8684774|P1|Period B/A+|Lack of Efficacy|0
2510111|NCT01838681|8684771|P4|Period B/A+|Adverse Event|16
2510112|NCT01838681|8684772|P3|Period B/A+|Adverse Event|27
2510113|NCT01838681|8684773|P2|Period B/A+|Adverse Event|13
2510114|NCT01838681|8684774|P1|Period B/A+|Adverse Event|0
2510115|NCT01838681|8684771|P4|Period A|Administrative or other reasons|0
2510116|NCT01838681|8684772|P3|Period A|Administrative or other reasons|0
2510117|NCT01838681|8684773|P2|Period A|Administrative or other reasons|0
2510118|NCT01838681|8684774|P1|Period A|Administrative or other reasons|17
2510119|NCT01838681|8684771|P4|Period A|Withdrawal before treatment|0
2510120|NCT01838681|8684772|P3|Period A|Withdrawal before treatment|0
2510121|NCT01838681|8684773|P2|Period A|Withdrawal before treatment|0
2510122|NCT01838681|8684774|P1|Period A|Withdrawal before treatment|4
2510123|NCT01838681|8684771|P4|Period A|Lost to Follow-up|0
2510124|NCT01838681|8684772|P3|Period A|Lost to Follow-up|0
2510125|NCT01838681|8684773|P2|Period A|Lost to Follow-up|0
2510126|NCT01838681|8684774|P1|Period A|Lost to Follow-up|4
2510127|NCT01838681|8684771|P4|Period A|Non-compliance with IMP|0
2510128|NCT01838681|8684772|P3|Period A|Non-compliance with IMP|0
2510129|NCT01838681|8684773|P2|Period A|Non-compliance with IMP|0
2510130|NCT01838681|8684774|P1|Period A|Non-compliance with IMP|6
2510131|NCT01838681|8684771|P4|Period A|Protocol Violation|0
2510132|NCT01838681|8684772|P3|Period A|Protocol Violation|0
2510133|NCT01838681|8684773|P2|Period A|Protocol Violation|0
2510134|NCT01838681|8684774|P1|Period A|Protocol Violation|16
2510135|NCT01838681|8684771|P4|Period A|Withdrawal by Subject|0
2510136|NCT01838681|8684772|P3|Period A|Withdrawal by Subject|0
2510137|NCT01838681|8684773|P2|Period A|Withdrawal by Subject|0
2510138|NCT01838681|8684774|P1|Period A|Withdrawal by Subject|70
2510139|NCT01838681|8684771|P4|Period A|Early response|0
2510140|NCT01838681|8684772|P3|Period A|Early response|0
2510141|NCT01838681|8684773|P2|Period A|Early response|0
2510142|NCT01838681|8684774|P1|Period A|Early response|148
2510143|NCT01838681|8684771|P4|Period A|Lack of Efficacy|0
2510144|NCT01838681|8684772|P3|Period A|Lack of Efficacy|0
2510145|NCT01838681|8684773|P2|Period A|Lack of Efficacy|0
2510146|NCT01838681|8684774|P1|Period A|Lack of Efficacy|21
2510147|NCT01838681|8684771|P4|Period A|Adverse Event|0
2510148|NCT01838681|8684772|P3|Period A|Adverse Event|0
2510149|NCT01838681|8684773|P2|Period A|Adverse Event|0
2510150|NCT01838681|8684774|P1|Period A|Adverse Event|39
2510151|NCT01838642|8684882|P1|Overall Study|Died on study|1
2510152|NCT01838616|8684895|P2|Pick-up Arm|Technical problems|0
2510153|NCT01838616|8684896|P1|Pick-up Arm|Technical problems|1
2510154|NCT01838616|8684895|P2|Pick-up Arm|Withdrawal by Subject|0
2510155|NCT01838616|8684896|P1|Pick-up Arm|Withdrawal by Subject|1
2510156|NCT01838616|8684895|P2|Pick-up Arm|Adverse Event|0
2510157|NCT01838616|8684896|P1|Pick-up Arm|Adverse Event|9
2510158|NCT01838616|8684895|P2|Pick-up Arm|Lack of Efficacy|0
2510159|NCT01838616|8684896|P1|Pick-up Arm|Lack of Efficacy|4
2510160|NCT01838616|8684895|P2|Continuation Period|Technical problems|1
2510161|NCT01838616|8684896|P1|Continuation Period|Technical problems|0
2510162|NCT01838616|8684895|P2|Continuation Period|Withdrawal by Subject|4
2510163|NCT01838616|8684896|P1|Continuation Period|Withdrawal by Subject|0
2510164|NCT01838616|8684895|P2|Continuation Period|Lost to Follow-up|0
2510165|NCT01838616|8684896|P1|Continuation Period|Lost to Follow-up|1
2510166|NCT01838616|8684895|P2|Continuation Period|Protocol Violation|0
2510167|NCT01838616|8684896|P1|Continuation Period|Protocol Violation|2
2510168|NCT01838616|8684895|P2|Continuation Period|Adverse Event|4
2510169|NCT01838616|8684896|P1|Continuation Period|Adverse Event|8
2510170|NCT01838616|8684895|P2|Continuation Period|Lack of Efficacy|5
2510171|NCT01838616|8684896|P1|Continuation Period|Lack of Efficacy|3
2510172|NCT01838616|8684895|P2|Titration Period|Protocol Violation|1
2510173|NCT01838616|8684896|P1|Titration Period|Protocol Violation|0
2510174|NCT01838616|8684895|P2|Titration Period|Other|0
2510175|NCT01838616|8684896|P1|Titration Period|Other|1
2510176|NCT01838616|8684895|P2|Titration Period|Technical problems|0
2510177|NCT01838616|8684896|P1|Titration Period|Technical problems|1
2510178|NCT01838616|8684895|P2|Titration Period|Withdrawal by Subject|5
2510179|NCT01838616|8684896|P1|Titration Period|Withdrawal by Subject|5
2510180|NCT01838616|8684895|P2|Titration Period|Lack of Efficacy|12
2510181|NCT01838616|8684896|P1|Titration Period|Lack of Efficacy|5
2510182|NCT01838616|8684895|P2|Titration Period|Adverse Event|48
2510183|NCT01838616|8684896|P1|Titration Period|Adverse Event|18
2510184|NCT01838590|8684967|P2|Overall Study|Lost to Follow-up|1
2510185|NCT01838590|8684968|P1|Overall Study|Lost to Follow-up|0
2510186|NCT01838590|8684967|P2|Overall Study|Lack of Efficacy|4
2510187|NCT01838590|8684968|P1|Overall Study|Lack of Efficacy|12
2510188|NCT01838499|8684992|P2|Overall Study|Withdrawal by Subject|9
2510189|NCT01838499|8684993|P1|Overall Study|Withdrawal by Subject|19
2510190|NCT01838499|8684992|P2|Overall Study|Adverse Event|1
2510191|NCT01838499|8684993|P1|Overall Study|Adverse Event|2
2510192|NCT01838499|8684992|P2|Overall Study|Lack of Efficacy|2
2510193|NCT01838499|8684993|P1|Overall Study|Lack of Efficacy|1
2510194|NCT01838499|8684992|P2|Overall Study|Lost to Follow-up|4
2510195|NCT01838499|8684993|P1|Overall Study|Lost to Follow-up|2
2510196|NCT01838499|8684992|P2|Overall Study|Protocol Violation|1
2510197|NCT01838499|8684993|P1|Overall Study|Protocol Violation|0
2510198|NCT01838447|8685005|P2|Overall Study|Withdrawal by Subject|1
2510199|NCT01838447|8685006|P1|Overall Study|Withdrawal by Subject|1
2510200|NCT01838447|8685005|P2|Overall Study|Change in surgical plan|2
2510201|NCT01838447|8685006|P1|Overall Study|Change in surgical plan|1
2510202|NCT01838213|8685041|P2|Overall Study|Ineligible|191
2510203|NCT01838213|8685042|P1|Overall Study|Ineligible|166
2510204|NCT01838200|8685050|P2|Overall Study|Progressive disease|0
2510205|NCT01838200|8685051|P1|Overall Study|Progressive disease|3
2510206|NCT01838200|8685050|P2|Overall Study|Adverse Event|2
2510207|NCT01838200|8685051|P1|Overall Study|Adverse Event|0
2510208|NCT01838044|8685063|P2|Overall Study|Lost to Follow-up|2
2510209|NCT01838044|8685064|P1|Overall Study|Lost to Follow-up|0
2510210|NCT01838044|8685063|P2|Overall Study|Medication error without associated AE|1
2510211|NCT01838044|8685064|P1|Overall Study|Medication error without associated AE|0
2510212|NCT01838044|8685063|P2|Overall Study|Insufficient clinical response|2
2510213|NCT01838044|8685064|P1|Overall Study|Insufficient clinical response|1
2510214|NCT01838044|8685063|P2|Overall Study|Withdrawal by Subject|2
2510215|NCT01838044|8685064|P1|Overall Study|Withdrawal by Subject|0
2510216|NCT01838044|8685063|P2|Overall Study|Protocol Violation|3
2510217|NCT01838044|8685064|P1|Overall Study|Protocol Violation|3
2510218|NCT01838044|8685063|P2|Overall Study|Adverse Event|6
2510219|NCT01838044|8685064|P1|Overall Study|Adverse Event|4
2510220|NCT01837966|8685097|P2|Overall Study|Withdrawal by Subject|1
2510221|NCT01837966|8685098|P1|Overall Study|Withdrawal by Subject|2
2510222|NCT01837823|8685104|P1|Overall Study|Lost to Follow-up|6
2510223|NCT01837797|8685135|P5|Period 3|Other|2
2510224|NCT01837797|8685136|P4|Period 3|Other|0
2510225|NCT01837797|8685137|P3|Period 3|Other|0
2510226|NCT01837797|8685138|P2|Period 3|Other|0
2510227|NCT01837797|8685139|P1|Period 3|Other|0
2510228|NCT01837797|8685135|P5|Period 3|Administrative reasons|20
2510229|NCT01837797|8685136|P4|Period 3|Administrative reasons|0
2510230|NCT01837797|8685137|P3|Period 3|Administrative reasons|0
2510231|NCT01837797|8685138|P2|Period 3|Administrative reasons|0
2510232|NCT01837797|8685139|P1|Period 3|Administrative reasons|0
2510233|NCT01837797|8685135|P5|Period 3|Adverse Event|1
2510234|NCT01837797|8685136|P4|Period 3|Adverse Event|0
2510235|NCT01837797|8685137|P3|Period 3|Adverse Event|0
2510236|NCT01837797|8685138|P2|Period 3|Adverse Event|0
2510237|NCT01837797|8685139|P1|Period 3|Adverse Event|0
2510238|NCT01837797|8685135|P5|Period 2|Adverse Event|0
2510239|NCT01837797|8685136|P4|Period 2|Adverse Event|1
2510240|NCT01837797|8685137|P3|Period 2|Adverse Event|0
2510241|NCT01837797|8685138|P2|Period 2|Adverse Event|0
2510242|NCT01837797|8685139|P1|Period 2|Adverse Event|0
2510243|NCT01837797|8685135|P5|Period 2|Administrative or other reasons|0
2510244|NCT01837797|8685136|P4|Period 2|Administrative or other reasons|4
2510245|NCT01837797|8685137|P3|Period 2|Administrative or other reasons|2
2510246|NCT01837797|8685138|P2|Period 2|Administrative or other reasons|5
2510247|NCT01837797|8685139|P1|Period 2|Administrative or other reasons|0
2510248|NCT01837797|8685135|P5|Period 1|Other|0
2510249|NCT01837797|8685136|P4|Period 1|Other|0
2510250|NCT01837797|8685137|P3|Period 1|Other|0
2510251|NCT01837797|8685138|P2|Period 1|Other|0
2510252|NCT01837797|8685139|P1|Period 1|Other|10
2510253|NCT01837797|8685135|P5|Period 1|Withdrawal of consent before treatment|0
2510254|NCT01837797|8685136|P4|Period 1|Withdrawal of consent before treatment|0
2510255|NCT01837797|8685137|P3|Period 1|Withdrawal of consent before treatment|0
2510256|NCT01837797|8685138|P2|Period 1|Withdrawal of consent before treatment|0
2510257|NCT01837797|8685139|P1|Period 1|Withdrawal of consent before treatment|1
2510258|NCT01837797|8685135|P5|Period 1|Administrative reasons|0
2510259|NCT01837797|8685136|P4|Period 1|Administrative reasons|0
2510260|NCT01837797|8685137|P3|Period 1|Administrative reasons|0
2510261|NCT01837797|8685138|P2|Period 1|Administrative reasons|0
2510262|NCT01837797|8685139|P1|Period 1|Administrative reasons|76
2510263|NCT01837797|8685135|P5|Period 1|Withdrawal by Subject|0
2510264|NCT01837797|8685136|P4|Period 1|Withdrawal by Subject|0
2510265|NCT01837797|8685137|P3|Period 1|Withdrawal by Subject|0
2510266|NCT01837797|8685138|P2|Period 1|Withdrawal by Subject|0
2510267|NCT01837797|8685139|P1|Period 1|Withdrawal by Subject|6
2510268|NCT01837797|8685135|P5|Period 1|Adverse Event|0
2510269|NCT01837797|8685136|P4|Period 1|Adverse Event|0
2510270|NCT01837797|8685137|P3|Period 1|Adverse Event|0
2510271|NCT01837797|8685138|P2|Period 1|Adverse Event|0
2510272|NCT01837797|8685139|P1|Period 1|Adverse Event|9
2510273|NCT01837719|8685174|P1|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1
2510274|NCT01837719|8685174|P1|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1
2510275|NCT01837680|8685243|P2|Overall Study|switched to oral hypoglycemic or diet|4
2510276|NCT01837680|8685244|P1|Overall Study|switched to oral hypoglycemic or diet|2
2510277|NCT01837680|8685243|P2|Overall Study|allergic reaction|0
2510278|NCT01837680|8685244|P1|Overall Study|allergic reaction|6
2510279|NCT01837680|8685243|P2|Overall Study|lack of insurance|2
2510280|NCT01837680|8685244|P1|Overall Study|lack of insurance|0
2510281|NCT01837680|8685243|P2|Overall Study|Lost to Follow-up|2
2510282|NCT01837680|8685244|P1|Overall Study|Lost to Follow-up|2
2510283|NCT01836549|8685363|P7|Overall Study|Patient inevaluable to start therapy|1
2510284|NCT01836549|8685364|P6|Overall Study|Patient inevaluable to start therapy|0
2510285|NCT01836549|8685365|P5|Overall Study|Patient inevaluable to start therapy|0
2510286|NCT01836549|8685366|P4|Overall Study|Patient inevaluable to start therapy|0
2510287|NCT01836549|8685367|P3|Overall Study|Patient inevaluable to start therapy|0
2510288|NCT01836549|8685368|P2|Overall Study|Patient inevaluable to start therapy|0
2510289|NCT01836549|8685369|P1|Overall Study|Patient inevaluable to start therapy|0
2510290|NCT01836549|8685363|P7|Overall Study|Patient declared ineligible|0
2510291|NCT01836549|8685364|P6|Overall Study|Patient declared ineligible|0
2510292|NCT01836549|8685365|P5|Overall Study|Patient declared ineligible|0
2510293|NCT01836549|8685366|P4|Overall Study|Patient declared ineligible|1
2510294|NCT01836549|8685367|P3|Overall Study|Patient declared ineligible|0
2510295|NCT01836549|8685368|P2|Overall Study|Patient declared ineligible|0
2510296|NCT01836549|8685369|P1|Overall Study|Patient declared ineligible|0
2510297|NCT01836549|8685363|P7|Overall Study|Did not receive study drug|0
2510298|NCT01836549|8685364|P6|Overall Study|Did not receive study drug|0
2510299|NCT01836549|8685365|P5|Overall Study|Did not receive study drug|0
2510300|NCT01836549|8685366|P4|Overall Study|Did not receive study drug|0
2510301|NCT01836549|8685367|P3|Overall Study|Did not receive study drug|1
2510302|NCT01836549|8685368|P2|Overall Study|Did not receive study drug|0
2510303|NCT01836549|8685369|P1|Overall Study|Did not receive study drug|0
2510304|NCT01836523|8685393|P4|Overall Study|Unclassified|29
2510305|NCT01836523|8685394|P3|Overall Study|Unclassified|19
2510306|NCT01836523|8685395|P2|Overall Study|Unclassified|28
2510307|NCT01836523|8685396|P1|Overall Study|Unclassified|17
2510308|NCT01836523|8685393|P4|Overall Study|Met Withdrawal Criteria|27
2510309|NCT01836523|8685394|P3|Overall Study|Met Withdrawal Criteria|21
2510310|NCT01836523|8685395|P2|Overall Study|Met Withdrawal Criteria|13
2510311|NCT01836523|8685396|P1|Overall Study|Met Withdrawal Criteria|13
2510312|NCT01836523|8685393|P4|Overall Study|Protocol Violation|4
2510313|NCT01836523|8685394|P3|Overall Study|Protocol Violation|2
2510314|NCT01836523|8685395|P2|Overall Study|Protocol Violation|3
2510315|NCT01836523|8685396|P1|Overall Study|Protocol Violation|6
2510316|NCT01836523|8685393|P4|Overall Study|Adverse Event|14
2510317|NCT01836523|8685394|P3|Overall Study|Adverse Event|49
2510318|NCT01836523|8685395|P2|Overall Study|Adverse Event|41
2510319|NCT01836523|8685396|P1|Overall Study|Adverse Event|15
2510320|NCT01836471|8685423|P5|Overall Study|Non compliance with tx|0
2510321|NCT01836471|8685424|P4|Overall Study|Non compliance with tx|0
2510322|NCT01836471|8685425|P3|Overall Study|Non compliance with tx|0
2510323|NCT01836471|8685426|P2|Overall Study|Non compliance with tx|1
2510324|NCT01836471|8685427|P1|Overall Study|Non compliance with tx|1
2510325|NCT01836471|8685423|P5|Overall Study|Adverse Event|2
2510326|NCT01836471|8685424|P4|Overall Study|Adverse Event|1
2510327|NCT01836471|8685425|P3|Overall Study|Adverse Event|1
2510328|NCT01836471|8685426|P2|Overall Study|Adverse Event|3
2510329|NCT01836471|8685427|P1|Overall Study|Adverse Event|6
2510330|NCT01836471|8685423|P5|Overall Study|Lost to Follow-up|1
2510331|NCT01836471|8685424|P4|Overall Study|Lost to Follow-up|1
2510332|NCT01836471|8685425|P3|Overall Study|Lost to Follow-up|0
2510333|NCT01836471|8685426|P2|Overall Study|Lost to Follow-up|0
2510334|NCT01836471|8685427|P1|Overall Study|Lost to Follow-up|0
2510335|NCT01836471|8685423|P5|Overall Study|Physician Decision|0
2510336|NCT01836471|8685424|P4|Overall Study|Physician Decision|0
2510337|NCT01836471|8685425|P3|Overall Study|Physician Decision|0
2510338|NCT01836471|8685426|P2|Overall Study|Physician Decision|1
2510339|NCT01836471|8685427|P1|Overall Study|Physician Decision|0
2510340|NCT01836471|8685423|P5|Overall Study|Withdrawal by Subject|2
2510341|NCT01836471|8685424|P4|Overall Study|Withdrawal by Subject|0
2510342|NCT01836471|8685425|P3|Overall Study|Withdrawal by Subject|1
2510343|NCT01836471|8685426|P2|Overall Study|Withdrawal by Subject|4
2510344|NCT01836471|8685427|P1|Overall Study|Withdrawal by Subject|3
2510345|NCT01836471|8685423|P5|Overall Study|Pregnancy|0
2510346|NCT01836471|8685424|P4|Overall Study|Pregnancy|0
2510347|NCT01836471|8685425|P3|Overall Study|Pregnancy|0
2510348|NCT01836471|8685426|P2|Overall Study|Pregnancy|0
2510349|NCT01836471|8685427|P1|Overall Study|Pregnancy|1
2510350|NCT01836458|8685456|P4|Overall Study|Unsatisfactory therapeutic effect|6
2510351|NCT01836458|8685457|P3|Overall Study|Unsatisfactory therapeutic effect|5
2510352|NCT01836458|8685458|P2|Overall Study|Unsatisfactory therapeutic effect|2
2510353|NCT01836458|8685459|P1|Overall Study|Unsatisfactory therapeutic effect|3
2510354|NCT01836276|8685544|P2|Overall Study|Lost to Follow-up|51
2510355|NCT01836276|8685545|P1|Overall Study|Lost to Follow-up|28
2510356|NCT01836198|8685553|P3|Part A, Period 2|Protocol Violation|0
2510357|NCT01836198|8685554|P2|Part A, Period 2|Protocol Violation|1
2510358|NCT01836198|8685555|P1|Part A, Period 2|Protocol Violation|0
2510359|NCT01835899|8685657|P3|Overall Study|Other than stated above|0
2510360|NCT01835899|8685658|P2|Overall Study|Other than stated above|1
2510361|NCT01835899|8685659|P1|Overall Study|Other than stated above|0
2510362|NCT01835899|8685657|P3|Overall Study|Adverse Event|1
2510363|NCT01835899|8685658|P2|Overall Study|Adverse Event|0
2510364|NCT01835899|8685659|P1|Overall Study|Adverse Event|0
2510365|NCT01835587|8685705|P4|Overall Study|Miscellaneous|0
2510366|NCT01835587|8685706|P3|Overall Study|Miscellaneous|0
2510367|NCT01835587|8685707|P2|Overall Study|Miscellaneous|1
2510368|NCT01835587|8685708|P1|Overall Study|Miscellaneous|0
2510369|NCT01835587|8685705|P4|Overall Study|Death|1
2510370|NCT01835587|8685706|P3|Overall Study|Death|0
2510371|NCT01835587|8685707|P2|Overall Study|Death|0
2510372|NCT01835587|8685708|P1|Overall Study|Death|0
2510373|NCT01835587|8685705|P4|Overall Study|Adverse Event|2
2510374|NCT01835587|8685706|P3|Overall Study|Adverse Event|2
2510375|NCT01835587|8685707|P2|Overall Study|Adverse Event|0
2510376|NCT01835587|8685708|P1|Overall Study|Adverse Event|0
2510377|NCT01835587|8685705|P4|Overall Study|Withdrawal by Subject|3
2510378|NCT01835587|8685706|P3|Overall Study|Withdrawal by Subject|0
2510379|NCT01835587|8685707|P2|Overall Study|Withdrawal by Subject|0
2510380|NCT01835587|8685708|P1|Overall Study|Withdrawal by Subject|2
2510381|NCT01835587|8685705|P4|Overall Study|Disease Recurrence or Relapse|3
2510382|NCT01835587|8685706|P3|Overall Study|Disease Recurrence or Relapse|0
2510383|NCT01835587|8685707|P2|Overall Study|Disease Recurrence or Relapse|3
2510384|NCT01835587|8685708|P1|Overall Study|Disease Recurrence or Relapse|0
2510385|NCT01835548|8685769|P3|Double-Blind Treatment Period|Withdrawal by Subject|0
2510386|NCT01835548|8685770|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
2510387|NCT01835548|8685771|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
2510388|NCT01835548|8685769|P3|Double-Blind Treatment Period|Adverse Event|0
2510389|NCT01835548|8685770|P2|Double-Blind Treatment Period|Adverse Event|1
2510390|NCT01835548|8685771|P1|Double-Blind Treatment Period|Adverse Event|0
2510391|NCT01835548|8685769|P3|Dose Optimization Period|Withdrawal by Subject|1
2510392|NCT01835548|8685770|P2|Dose Optimization Period|Withdrawal by Subject|0
2510393|NCT01835548|8685771|P1|Dose Optimization Period|Withdrawal by Subject|0
2510394|NCT01835548|8685769|P3|Dose Optimization Period|Adverse Event|1
2510395|NCT01835548|8685770|P2|Dose Optimization Period|Adverse Event|0
2510396|NCT01835548|8685771|P1|Dose Optimization Period|Adverse Event|0
2510397|NCT01835470|8685800|P1|Long Term Treatment Period|Lack of Efficacy|3
2510398|NCT01835470|8685800|P1|Long Term Treatment Period|Subject Request to Discontinue|1
2510399|NCT01835431|8685812|P2|Overall Study|Protocol Violation|0
2510400|NCT01835431|8685813|P1|Overall Study|Protocol Violation|1
2510401|NCT01835431|8685812|P2|Overall Study|Withdrawal by Subject|10
2510402|NCT01835431|8685813|P1|Overall Study|Withdrawal by Subject|6
2510403|NCT01835431|8685812|P2|Overall Study|other|2
2510404|NCT01835431|8685813|P1|Overall Study|other|0
2510405|NCT01835431|8685812|P2|Overall Study|Adverse Event|0
2510406|NCT01835431|8685813|P1|Overall Study|Adverse Event|1
2510407|NCT01835158|8685853|P2|Overall Study|Withdrawal by Subject|6
2510408|NCT01835158|8685854|P1|Overall Study|Withdrawal by Subject|1
2510409|NCT01835145|8685866|P2|Overall Study|Ineligible prior to treatment|0
2510410|NCT01835145|8685867|P1|Overall Study|Ineligible prior to treatment|1
2510411|NCT01835132|8685882|P1|Initial Phase|Insufficient Therapeutic Response|2
2510412|NCT01835015|8685927|P5|Overall Study|Adverse Event|0
2510413|NCT01835015|8685928|P4|Overall Study|Adverse Event|0
2510414|NCT01835015|8685929|P3|Overall Study|Adverse Event|1
2510415|NCT01835015|8685930|P2|Overall Study|Adverse Event|0
2510416|NCT01835015|8685931|P1|Overall Study|Adverse Event|0
2510417|NCT01834729|8686008|P4|Overall Study|Adverse Event|2
2510418|NCT01834729|8686009|P3|Overall Study|Adverse Event|0
2510419|NCT01834729|8686010|P2|Overall Study|Adverse Event|0
2510420|NCT01834729|8686011|P1|Overall Study|Adverse Event|0
2510421|NCT01834729|8686008|P4|Overall Study|Withdrawal by Subject|0
2510422|NCT01834729|8686009|P3|Overall Study|Withdrawal by Subject|0
2510423|NCT01834729|8686010|P2|Overall Study|Withdrawal by Subject|1
2510424|NCT01834729|8686011|P1|Overall Study|Withdrawal by Subject|1
2510425|NCT01834729|8686008|P4|Overall Study|Did not return bowel diaries|0
2510426|NCT01834729|8686009|P3|Overall Study|Did not return bowel diaries|3
2510427|NCT01834729|8686010|P2|Overall Study|Did not return bowel diaries|0
2510428|NCT01834729|8686011|P1|Overall Study|Did not return bowel diaries|0
2510429|NCT01834586|8686044|P1|Overall Study|Adverse Event|1
2510430|NCT01834274|8686084|P2|Overall Study|Other|1
2510431|NCT01834274|8686085|P1|Overall Study|Other|2
2510432|NCT01834274|8686084|P2|Overall Study|Lost to Follow-up|1
2510433|NCT01834274|8686085|P1|Overall Study|Lost to Follow-up|3
2510434|NCT01834274|8686084|P2|Overall Study|Withdrawal by Subject|1
2510435|NCT01834274|8686085|P1|Overall Study|Withdrawal by Subject|1
2510436|NCT01834274|8686084|P2|Overall Study|Study Termination|38
2510437|NCT01834274|8686085|P1|Overall Study|Study Termination|41
2510438|NCT01834222|8686108|P1|Overall Study|Not meet inclusion/exclusion criteria|1
2510439|NCT01833897|8686203|P1|Overall Study|Lack of Efficacy|1
2510440|NCT01833832|8686215|P1|Overall Study|Pt could not be cytoreduced for HIPEC|1
2510441|NCT01833533|8686370|P2|Overall Study|Other|7
2510442|NCT01833533|8686371|P1|Overall Study|Other|2
2510443|NCT01833533|8686370|P2|Overall Study|To Enter an Extension Study|4
2510444|NCT01833533|8686371|P1|Overall Study|To Enter an Extension Study|0
2510445|NCT01833533|8686370|P2|Overall Study|Lost to Follow-up|9
2510446|NCT01833533|8686371|P1|Overall Study|Lost to Follow-up|4
2510447|NCT01833533|8686370|P2|Overall Study|Adverse Event|1
2510448|NCT01833533|8686371|P1|Overall Study|Adverse Event|0
2510449|NCT01833494|8686385|P1|Overall Study|Increase in serum ferritin|1
2510450|NCT01833494|8686385|P1|Overall Study|Decrease in serum calcium|4
2510451|NCT01833494|8686385|P1|Overall Study|Decrease in serum phosphorus|4
2510452|NCT01833494|8686385|P1|Overall Study|Withdrawal by Subject|6
2510453|NCT01833494|8686385|P1|Overall Study|Physician Decision|6
2510454|NCT01833494|8686385|P1|Overall Study|Adverse Event|24
2510455|NCT01833455|8686413|P2|Overall Study|Withdrawal by Subject|0
2510456|NCT01833455|8686414|P1|Overall Study|Withdrawal by Subject|1
2510457|NCT01833169|8686443|P1|Overall Study|Physician Decision|2
2510458|NCT01833169|8686443|P1|Overall Study|Death|3
2510459|NCT01833169|8686443|P1|Overall Study|Withdrawal by Subject|9
2510460|NCT01833169|8686443|P1|Overall Study|Adverse Event|33
2510461|NCT01833169|8686443|P1|Overall Study|Disease Progression|99
2510462|NCT01833065|8686512|P5|Overall Study|Others|4
2510463|NCT01833065|8686513|P4|Overall Study|Others|1
2510464|NCT01833065|8686514|P3|Overall Study|Others|1
2510465|NCT01833065|8686515|P2|Overall Study|Others|1
2510466|NCT01833065|8686516|P1|Overall Study|Others|2
2510467|NCT01833065|8686512|P5|Overall Study|Trial terminated by sponsor|13
2510468|NCT01833065|8686513|P4|Overall Study|Trial terminated by sponsor|3
2510469|NCT01833065|8686514|P3|Overall Study|Trial terminated by sponsor|7
2510470|NCT01833065|8686515|P2|Overall Study|Trial terminated by sponsor|8
2510471|NCT01833065|8686516|P1|Overall Study|Trial terminated by sponsor|8
2510472|NCT01833065|8686512|P5|Overall Study|Subject's substantial non-compliance|0
2510473|NCT01833065|8686513|P4|Overall Study|Subject's substantial non-compliance|0
2510474|NCT01833065|8686514|P3|Overall Study|Subject's substantial non-compliance|0
2510475|NCT01833065|8686515|P2|Overall Study|Subject's substantial non-compliance|1
2510476|NCT01833065|8686516|P1|Overall Study|Subject's substantial non-compliance|0
2510477|NCT01833065|8686512|P5|Overall Study|Withdrawal by Subject|11
2510478|NCT01833065|8686513|P4|Overall Study|Withdrawal by Subject|3
2510479|NCT01833065|8686514|P3|Overall Study|Withdrawal by Subject|4
2510480|NCT01833065|8686515|P2|Overall Study|Withdrawal by Subject|2
2510481|NCT01833065|8686516|P1|Overall Study|Withdrawal by Subject|6
2510482|NCT01833065|8686512|P5|Overall Study|Lost to Follow-up|3
2510483|NCT01833065|8686513|P4|Overall Study|Lost to Follow-up|0
2510484|NCT01833065|8686514|P3|Overall Study|Lost to Follow-up|0
2510485|NCT01833065|8686515|P2|Overall Study|Lost to Follow-up|0
2510486|NCT01833065|8686516|P1|Overall Study|Lost to Follow-up|1
2510487|NCT01833065|8686512|P5|Overall Study|Protocol Violation|2
2510488|NCT01833065|8686513|P4|Overall Study|Protocol Violation|0
2510489|NCT01833065|8686514|P3|Overall Study|Protocol Violation|0
2510490|NCT01833065|8686515|P2|Overall Study|Protocol Violation|0
2510491|NCT01833065|8686516|P1|Overall Study|Protocol Violation|1
2510492|NCT01833065|8686512|P5|Overall Study|Adverse Event|3
2510493|NCT01833065|8686513|P4|Overall Study|Adverse Event|2
2510494|NCT01833065|8686514|P3|Overall Study|Adverse Event|0
2510495|NCT01833065|8686515|P2|Overall Study|Adverse Event|1
2510496|NCT01833065|8686516|P1|Overall Study|Adverse Event|6
2510497|NCT01832818|8686585|P1|Overall Study|Lost to Follow-up|6
2510498|NCT01832766|8686594|P2|Washout|Lost to Follow-up|1
2510499|NCT01832766|8686595|P1|Washout|Lost to Follow-up|0
2510500|NCT01832493|8686689|P1|Overall Study|Unable to place LV lead|2
2510501|NCT01832493|8686689|P1|Overall Study|Protocol Violation|4
2510502|NCT01832493|8686689|P1|Overall Study|Physician Decision|2
2510503|NCT01832480|8686698|P2|Overall Study|post randomization ineligible|10
2510504|NCT01832480|8686699|P1|Overall Study|post randomization ineligible|8
2510505|NCT01832480|8686698|P2|Overall Study|Withdrawal by Subject|2
2510506|NCT01832480|8686699|P1|Overall Study|Withdrawal by Subject|0
2510507|NCT01832480|8686698|P2|Overall Study|Lost to Follow-up|30
2510508|NCT01832480|8686699|P1|Overall Study|Lost to Follow-up|33
2510509|NCT01832155|8686720|P2|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0
2510510|NCT01832155|8686721|P1|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1
2510511|NCT01832155|8686720|P2|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0
2510512|NCT01832155|8686721|P1|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1
2510513|NCT01831856|8686824|P2|Overall Study|Unsuccessful Electrical Cardioversion|18
2510514|NCT01831856|8686825|P1|Overall Study|Unsuccessful Electrical Cardioversion|16
2510515|NCT01831856|8686824|P2|Overall Study|Lack of Efficacy|11
2510516|NCT01831856|8686825|P1|Overall Study|Lack of Efficacy|13
2510517|NCT01831856|8686824|P2|Overall Study|Adverse Event|8
2510518|NCT01831856|8686825|P1|Overall Study|Adverse Event|5
2510519|NCT01831817|8686835|P4|Overall Study|Withdrawl of Consent|0
2510520|NCT01831817|8686836|P3|Overall Study|Withdrawl of Consent|0
2510521|NCT01831817|8686837|P2|Overall Study|Withdrawl of Consent|0
2510522|NCT01831817|8686838|P1|Overall Study|Withdrawl of Consent|3
2510523|NCT01831817|8686835|P4|Overall Study|Lost to Follow-up|0
2510524|NCT01831817|8686836|P3|Overall Study|Lost to Follow-up|0
2510525|NCT01831817|8686837|P2|Overall Study|Lost to Follow-up|0
2510526|NCT01831817|8686838|P1|Overall Study|Lost to Follow-up|1
2510527|NCT01831804|8686885|P9|Overall Study|Withdrew Consent|0
2510528|NCT01831804|8686886|P8|Overall Study|Withdrew Consent|2
2510529|NCT01831804|8686887|P7|Overall Study|Withdrew Consent|0
2510530|NCT01831804|8686888|P6|Overall Study|Withdrew Consent|0
2510531|NCT01831804|8686889|P5|Overall Study|Withdrew Consent|0
2510532|NCT01831804|8686890|P4|Overall Study|Withdrew Consent|0
2510533|NCT01831804|8686891|P3|Overall Study|Withdrew Consent|0
2510534|NCT01831804|8686892|P2|Overall Study|Withdrew Consent|1
2510535|NCT01831804|8686893|P1|Overall Study|Withdrew Consent|0
2510536|NCT01831804|8686885|P9|Overall Study|Investigator discretion|0
2510537|NCT01831804|8686886|P8|Overall Study|Investigator discretion|1
2510538|NCT01831804|8686887|P7|Overall Study|Investigator discretion|0
2510539|NCT01831804|8686888|P6|Overall Study|Investigator discretion|0
2510540|NCT01831804|8686889|P5|Overall Study|Investigator discretion|1
2510541|NCT01831804|8686890|P4|Overall Study|Investigator discretion|0
2510542|NCT01831804|8686891|P3|Overall Study|Investigator discretion|0
2510543|NCT01831804|8686892|P2|Overall Study|Investigator discretion|0
2510544|NCT01831804|8686893|P1|Overall Study|Investigator discretion|0
2510545|NCT01831804|8686885|P9|Overall Study|Lost to Follow-up|1
2510546|NCT01831804|8686886|P8|Overall Study|Lost to Follow-up|0
2510547|NCT01831804|8686887|P7|Overall Study|Lost to Follow-up|0
2510548|NCT01831804|8686888|P6|Overall Study|Lost to Follow-up|0
2510549|NCT01831804|8686889|P5|Overall Study|Lost to Follow-up|0
2510550|NCT01831804|8686890|P4|Overall Study|Lost to Follow-up|0
2510551|NCT01831804|8686891|P3|Overall Study|Lost to Follow-up|1
2510552|NCT01831804|8686892|P2|Overall Study|Lost to Follow-up|0
2510553|NCT01831804|8686893|P1|Overall Study|Lost to Follow-up|0
2510554|NCT01831804|8686885|P9|Overall Study|Protocol defined stopping criteria|0
2510555|NCT01831804|8686886|P8|Overall Study|Protocol defined stopping criteria|0
2510556|NCT01831804|8686887|P7|Overall Study|Protocol defined stopping criteria|0
2510557|NCT01831804|8686888|P6|Overall Study|Protocol defined stopping criteria|0
2510558|NCT01831804|8686889|P5|Overall Study|Protocol defined stopping criteria|1
2510559|NCT01831804|8686890|P4|Overall Study|Protocol defined stopping criteria|0
2510560|NCT01831804|8686891|P3|Overall Study|Protocol defined stopping criteria|3
2510561|NCT01831804|8686892|P2|Overall Study|Protocol defined stopping criteria|1
2510562|NCT01831804|8686893|P1|Overall Study|Protocol defined stopping criteria|1
2510563|NCT01831804|8686885|P9|Overall Study|Protocol Violation|0
2510564|NCT01831804|8686886|P8|Overall Study|Protocol Violation|0
2510565|NCT01831804|8686887|P7|Overall Study|Protocol Violation|0
2510566|NCT01831804|8686888|P6|Overall Study|Protocol Violation|0
2510567|NCT01831804|8686889|P5|Overall Study|Protocol Violation|0
2510568|NCT01831804|8686890|P4|Overall Study|Protocol Violation|0
2510569|NCT01831804|8686891|P3|Overall Study|Protocol Violation|2
2510570|NCT01831804|8686892|P2|Overall Study|Protocol Violation|0
2510571|NCT01831804|8686893|P1|Overall Study|Protocol Violation|0
2510572|NCT01831804|8686885|P9|Overall Study|Adverse Event|1
2510573|NCT01831804|8686886|P8|Overall Study|Adverse Event|0
2510574|NCT01831804|8686887|P7|Overall Study|Adverse Event|1
2510575|NCT01831804|8686888|P6|Overall Study|Adverse Event|0
2510576|NCT01831804|8686889|P5|Overall Study|Adverse Event|0
2510577|NCT01831804|8686890|P4|Overall Study|Adverse Event|0
2510578|NCT01831804|8686891|P3|Overall Study|Adverse Event|0
2510579|NCT01831804|8686892|P2|Overall Study|Adverse Event|0
2510580|NCT01831804|8686893|P1|Overall Study|Adverse Event|0
2510581|NCT01831791|8686988|P1|Overall Study|Withdrawal by Subject|10
2510582|NCT01831765|8687017|P3|Overall Study|Lost to Follow-up|3
2510583|NCT01831765|8687018|P2|Overall Study|Lost to Follow-up|3
2510584|NCT01831765|8687019|P1|Overall Study|Lost to Follow-up|2
2510585|NCT01831765|8687017|P3|Overall Study|Withdrawal criteria|16
2510586|NCT01831765|8687018|P2|Overall Study|Withdrawal criteria|10
2510587|NCT01831765|8687019|P1|Overall Study|Withdrawal criteria|12
2510588|NCT01831765|8687017|P3|Overall Study|Withdrawal by Subject|17
2510589|NCT01831765|8687018|P2|Overall Study|Withdrawal by Subject|7
2510590|NCT01831765|8687019|P1|Overall Study|Withdrawal by Subject|22
2510591|NCT01831765|8687017|P3|Overall Study|Adverse Event|3
2510592|NCT01831765|8687018|P2|Overall Study|Adverse Event|3
2510593|NCT01831765|8687019|P1|Overall Study|Adverse Event|5
2510594|NCT01831765|8687017|P3|Overall Study|Other, site closed|0
2510595|NCT01831765|8687018|P2|Overall Study|Other, site closed|1
2510596|NCT01831765|8687019|P1|Overall Study|Other, site closed|1
2510597|NCT01831765|8687017|P3|Overall Study|Death|1
2510598|NCT01831765|8687018|P2|Overall Study|Death|1
2510599|NCT01831765|8687019|P1|Overall Study|Death|0
2510600|NCT01831765|8687017|P3|Overall Study|Pregnancy|2
2510601|NCT01831765|8687018|P2|Overall Study|Pregnancy|1
2510602|NCT01831765|8687019|P1|Overall Study|Pregnancy|1
2510603|NCT01831765|8687017|P3|Overall Study|Other, sponsor withdrew subject|0
2510604|NCT01831765|8687018|P2|Overall Study|Other, sponsor withdrew subject|1
2510605|NCT01831765|8687019|P1|Overall Study|Other, sponsor withdrew subject|0
2510606|NCT01831765|8687017|P3|Overall Study|Lack of Efficacy|0
2510607|NCT01831765|8687018|P2|Overall Study|Lack of Efficacy|0
2510608|NCT01831765|8687019|P1|Overall Study|Lack of Efficacy|1
2510609|NCT01831726|8687045|P1|Overall Study|Subject/guardian decision|7
2510610|NCT01831726|8687045|P1|Overall Study|Physician Decision|1
2510611|NCT01831726|8687045|P1|Overall Study|Disease Progression|49
2510612|NCT01831726|8687045|P1|Overall Study|Death|7
2510613|NCT01831726|8687045|P1|Overall Study|Adverse Event|16
2510614|NCT01831544|8687052|P1|Overall Study|Still on original MVAD device|2
2510615|NCT01831544|8687052|P1|Overall Study|Death|1
2510616|NCT01831466|8687081|P12|Overall Study|Adverse Event|2
2510617|NCT01831466|8687082|P11|Overall Study|Adverse Event|0
2510618|NCT01831466|8687083|P10|Overall Study|Adverse Event|1
2510619|NCT01831466|8687084|P9|Overall Study|Adverse Event|1
2510620|NCT01831466|8687085|P8|Overall Study|Adverse Event|1
2510621|NCT01831466|8687086|P7|Overall Study|Adverse Event|0
2510622|NCT01831466|8687087|P6|Overall Study|Adverse Event|7
2510623|NCT01831466|8687088|P5|Overall Study|Adverse Event|3
2510624|NCT01831466|8687089|P4|Overall Study|Adverse Event|6
2510625|NCT01831466|8687090|P3|Overall Study|Adverse Event|4
2510626|NCT01831466|8687091|P2|Overall Study|Adverse Event|0
2510627|NCT01831466|8687092|P1|Overall Study|Adverse Event|0
2510628|NCT01831466|8687081|P12|Overall Study|Lack of Efficacy|0
2510629|NCT01831466|8687082|P11|Overall Study|Lack of Efficacy|2
2510630|NCT01831466|8687083|P10|Overall Study|Lack of Efficacy|2
2510631|NCT01831466|8687084|P9|Overall Study|Lack of Efficacy|2
2510632|NCT01831466|8687085|P8|Overall Study|Lack of Efficacy|1
2510633|NCT01831466|8687086|P7|Overall Study|Lack of Efficacy|1
2510634|NCT01831466|8687087|P6|Overall Study|Lack of Efficacy|8
2510635|NCT01831466|8687088|P5|Overall Study|Lack of Efficacy|9
2510636|NCT01831466|8687089|P4|Overall Study|Lack of Efficacy|6
2510637|NCT01831466|8687090|P3|Overall Study|Lack of Efficacy|7
2510638|NCT01831466|8687091|P2|Overall Study|Lack of Efficacy|8
2510639|NCT01831466|8687092|P1|Overall Study|Lack of Efficacy|5
2510640|NCT01831466|8687081|P12|Overall Study|Lost to Follow-up|1
2510641|NCT01831466|8687082|P11|Overall Study|Lost to Follow-up|0
2510642|NCT01831466|8687083|P10|Overall Study|Lost to Follow-up|1
2510643|NCT01831466|8687084|P9|Overall Study|Lost to Follow-up|0
2510644|NCT01831466|8687085|P8|Overall Study|Lost to Follow-up|0
2510645|NCT01831466|8687086|P7|Overall Study|Lost to Follow-up|0
2510646|NCT01831466|8687087|P6|Overall Study|Lost to Follow-up|3
2510647|NCT01831466|8687088|P5|Overall Study|Lost to Follow-up|0
2510648|NCT01831466|8687089|P4|Overall Study|Lost to Follow-up|2
2510649|NCT01831466|8687090|P3|Overall Study|Lost to Follow-up|4
2510650|NCT01831466|8687091|P2|Overall Study|Lost to Follow-up|1
2510651|NCT01831466|8687092|P1|Overall Study|Lost to Follow-up|0
2510652|NCT01831466|8687081|P12|Overall Study|Withdrawal by Subject|1
2510653|NCT01831466|8687082|P11|Overall Study|Withdrawal by Subject|0
2510654|NCT01831466|8687083|P10|Overall Study|Withdrawal by Subject|1
2510655|NCT01831466|8687084|P9|Overall Study|Withdrawal by Subject|0
2510656|NCT01831466|8687085|P8|Overall Study|Withdrawal by Subject|0
2510657|NCT01831466|8687086|P7|Overall Study|Withdrawal by Subject|0
2510658|NCT01831466|8687087|P6|Overall Study|Withdrawal by Subject|5
2510659|NCT01831466|8687088|P5|Overall Study|Withdrawal by Subject|3
2510660|NCT01831466|8687089|P4|Overall Study|Withdrawal by Subject|3
2510661|NCT01831466|8687090|P3|Overall Study|Withdrawal by Subject|3
2510662|NCT01831466|8687091|P2|Overall Study|Withdrawal by Subject|3
2510663|NCT01831466|8687092|P1|Overall Study|Withdrawal by Subject|6
2510664|NCT01831466|8687081|P12|Overall Study|Death|0
2510665|NCT01831466|8687082|P11|Overall Study|Death|0
2510666|NCT01831466|8687083|P10|Overall Study|Death|0
2510667|NCT01831466|8687084|P9|Overall Study|Death|0
2510668|NCT01831466|8687085|P8|Overall Study|Death|0
2510669|NCT01831466|8687086|P7|Overall Study|Death|0
2510670|NCT01831466|8687087|P6|Overall Study|Death|0
2510671|NCT01831466|8687088|P5|Overall Study|Death|0
2510672|NCT01831466|8687089|P4|Overall Study|Death|0
2510673|NCT01831466|8687090|P3|Overall Study|Death|0
2510674|NCT01831466|8687091|P2|Overall Study|Death|1
2510675|NCT01831466|8687092|P1|Overall Study|Death|0
2510676|NCT01831466|8687081|P12|Overall Study|Non-compliance with study treatment|0
2510677|NCT01831466|8687082|P11|Overall Study|Non-compliance with study treatment|0
2510678|NCT01831466|8687083|P10|Overall Study|Non-compliance with study treatment|0
2510679|NCT01831466|8687084|P9|Overall Study|Non-compliance with study treatment|0
2510680|NCT01831466|8687085|P8|Overall Study|Non-compliance with study treatment|0
2510681|NCT01831466|8687086|P7|Overall Study|Non-compliance with study treatment|0
2510682|NCT01831466|8687087|P6|Overall Study|Non-compliance with study treatment|1
2510683|NCT01831466|8687088|P5|Overall Study|Non-compliance with study treatment|0
2510684|NCT01831466|8687089|P4|Overall Study|Non-compliance with study treatment|0
2510685|NCT01831466|8687090|P3|Overall Study|Non-compliance with study treatment|1
2510686|NCT01831466|8687091|P2|Overall Study|Non-compliance with study treatment|1
2510687|NCT01831466|8687092|P1|Overall Study|Non-compliance with study treatment|2
2510688|NCT01831466|8687081|P12|Overall Study|Other|0
2510689|NCT01831466|8687082|P11|Overall Study|Other|0
2510690|NCT01831466|8687083|P10|Overall Study|Other|0
2510691|NCT01831466|8687084|P9|Overall Study|Other|0
2510692|NCT01831466|8687085|P8|Overall Study|Other|0
2510693|NCT01831466|8687086|P7|Overall Study|Other|0
2510694|NCT01831466|8687087|P6|Overall Study|Other|1
2510695|NCT01831466|8687088|P5|Overall Study|Other|2
2510696|NCT01831466|8687089|P4|Overall Study|Other|2
2510697|NCT01831466|8687090|P3|Overall Study|Other|2
2510698|NCT01831466|8687091|P2|Overall Study|Other|3
2510699|NCT01831466|8687092|P1|Overall Study|Other|2
2510700|NCT01831466|8687081|P12|Overall Study|Protocol Violation|0
2510701|NCT01831466|8687082|P11|Overall Study|Protocol Violation|0
2510702|NCT01831466|8687083|P10|Overall Study|Protocol Violation|0
2510703|NCT01831466|8687084|P9|Overall Study|Protocol Violation|0
2510704|NCT01831466|8687085|P8|Overall Study|Protocol Violation|0
2510705|NCT01831466|8687086|P7|Overall Study|Protocol Violation|0
2510706|NCT01831466|8687087|P6|Overall Study|Protocol Violation|1
2510707|NCT01831466|8687088|P5|Overall Study|Protocol Violation|0
2510708|NCT01831466|8687089|P4|Overall Study|Protocol Violation|0
2510709|NCT01831466|8687090|P3|Overall Study|Protocol Violation|2
2510710|NCT01831466|8687091|P2|Overall Study|Protocol Violation|1
2510711|NCT01831466|8687092|P1|Overall Study|Protocol Violation|1
2510712|NCT01831258|8687214|P2|Overall Study|Lost to Follow-up|2
2510713|NCT01831258|8687215|P1|Overall Study|Lost to Follow-up|3
2510714|NCT01831258|8687214|P2|Overall Study|Withdrawal by Subject|1
2510715|NCT01831258|8687215|P1|Overall Study|Withdrawal by Subject|2
2510716|NCT01831089|8687305|P6|Cohort B: Arm B|Global end of study|1
2510717|NCT01831089|8687306|P5|Cohort B: Arm B|Global end of study|0
2510718|NCT01831089|8687307|P4|Cohort B: Arm B|Global end of study|0
2510719|NCT01831089|8687308|P3|Cohort B: Arm B|Global end of study|0
2510720|NCT01831089|8687309|P2|Cohort B: Arm B|Global end of study|0
2510721|NCT01831089|8687310|P1|Cohort B: Arm B|Global end of study|0
2510722|NCT01831089|8687305|P6|Cohort B: Arm B|Adverse Event|1
2510723|NCT01831089|8687306|P5|Cohort B: Arm B|Adverse Event|0
2510724|NCT01831089|8687307|P4|Cohort B: Arm B|Adverse Event|0
2510725|NCT01831089|8687308|P3|Cohort B: Arm B|Adverse Event|0
2510726|NCT01831089|8687309|P2|Cohort B: Arm B|Adverse Event|0
2510727|NCT01831089|8687310|P1|Cohort B: Arm B|Adverse Event|0
2510728|NCT01831089|8687305|P6|Cohort B: Arm B|Never treated|2
2510729|NCT01831089|8687306|P5|Cohort B: Arm B|Never treated|0
2510730|NCT01831089|8687307|P4|Cohort B: Arm B|Never treated|0
2510731|NCT01831089|8687308|P3|Cohort B: Arm B|Never treated|0
2510732|NCT01831089|8687309|P2|Cohort B: Arm B|Never treated|0
2510733|NCT01831089|8687310|P1|Cohort B: Arm B|Never treated|0
2510734|NCT01831089|8687305|P6|Cohort B: Arm B|Physician Decision|2
2510735|NCT01831089|8687306|P5|Cohort B: Arm B|Physician Decision|0
2510736|NCT01831089|8687307|P4|Cohort B: Arm B|Physician Decision|0
2510737|NCT01831089|8687308|P3|Cohort B: Arm B|Physician Decision|0
2510738|NCT01831089|8687309|P2|Cohort B: Arm B|Physician Decision|0
2510739|NCT01831089|8687310|P1|Cohort B: Arm B|Physician Decision|0
2510740|NCT01831089|8687305|P6|Cohort B: Arm B|Progressive disease|8
2510741|NCT01831089|8687306|P5|Cohort B: Arm B|Progressive disease|0
2510742|NCT01831089|8687307|P4|Cohort B: Arm B|Progressive disease|0
2510743|NCT01831089|8687308|P3|Cohort B: Arm B|Progressive disease|0
2510744|NCT01831089|8687309|P2|Cohort B: Arm B|Progressive disease|0
2510745|NCT01831089|8687310|P1|Cohort B: Arm B|Progressive disease|0
2510746|NCT01831089|8687305|P6|Cohort V: Dose Level 5|Lost to Follow-up|0
2510747|NCT01831089|8687306|P5|Cohort V: Dose Level 5|Lost to Follow-up|1
2510748|NCT01831089|8687307|P4|Cohort V: Dose Level 5|Lost to Follow-up|0
2510749|NCT01831089|8687308|P3|Cohort V: Dose Level 5|Lost to Follow-up|0
2510750|NCT01831089|8687309|P2|Cohort V: Dose Level 5|Lost to Follow-up|0
2510751|NCT01831089|8687310|P1|Cohort V: Dose Level 5|Lost to Follow-up|0
2510752|NCT01831089|8687305|P6|Cohort V: Dose Level 5|Global end of study|0
2510753|NCT01831089|8687306|P5|Cohort V: Dose Level 5|Global end of study|2
2510754|NCT01831089|8687307|P4|Cohort V: Dose Level 5|Global end of study|0
2510755|NCT01831089|8687308|P3|Cohort V: Dose Level 5|Global end of study|0
2510756|NCT01831089|8687309|P2|Cohort V: Dose Level 5|Global end of study|0
2510757|NCT01831089|8687310|P1|Cohort V: Dose Level 5|Global end of study|0
2510758|NCT01831089|8687305|P6|Cohort V: Dose Level 5|Death|0
2510759|NCT01831089|8687306|P5|Cohort V: Dose Level 5|Death|1
2510760|NCT01831089|8687307|P4|Cohort V: Dose Level 5|Death|0
2510761|NCT01831089|8687308|P3|Cohort V: Dose Level 5|Death|0
2510762|NCT01831089|8687309|P2|Cohort V: Dose Level 5|Death|0
2510763|NCT01831089|8687310|P1|Cohort V: Dose Level 5|Death|0
2510764|NCT01831089|8687305|P6|Cohort V: Dose Level 5|Withdrawal by Subject|0
2510765|NCT01831089|8687306|P5|Cohort V: Dose Level 5|Withdrawal by Subject|3
2510766|NCT01831089|8687307|P4|Cohort V: Dose Level 5|Withdrawal by Subject|0
2510767|NCT01831089|8687308|P3|Cohort V: Dose Level 5|Withdrawal by Subject|0
2510768|NCT01831089|8687309|P2|Cohort V: Dose Level 5|Withdrawal by Subject|0
2510769|NCT01831089|8687310|P1|Cohort V: Dose Level 5|Withdrawal by Subject|0
2510770|NCT01831089|8687305|P6|Cohort V: Dose Level 5|Progressive disease|0
2510771|NCT01831089|8687306|P5|Cohort V: Dose Level 5|Progressive disease|30
2510772|NCT01831089|8687307|P4|Cohort V: Dose Level 5|Progressive disease|0
2510773|NCT01831089|8687308|P3|Cohort V: Dose Level 5|Progressive disease|0
2510774|NCT01831089|8687309|P2|Cohort V: Dose Level 5|Progressive disease|0
2510775|NCT01831089|8687310|P1|Cohort V: Dose Level 5|Progressive disease|0
2510776|NCT01831089|8687305|P6|Cohort IV: Dose Level 4|Progressive disease|0
2510777|NCT01831089|8687306|P5|Cohort IV: Dose Level 4|Progressive disease|0
2510778|NCT01831089|8687307|P4|Cohort IV: Dose Level 4|Progressive disease|6
2510779|NCT01831089|8687308|P3|Cohort IV: Dose Level 4|Progressive disease|0
2510780|NCT01831089|8687309|P2|Cohort IV: Dose Level 4|Progressive disease|0
2510781|NCT01831089|8687310|P1|Cohort IV: Dose Level 4|Progressive disease|0
2510782|NCT01831089|8687305|P6|Cohort III: Dose Level 3|Global end of study|0
2510783|NCT01831089|8687306|P5|Cohort III: Dose Level 3|Global end of study|0
2510784|NCT01831089|8687307|P4|Cohort III: Dose Level 3|Global end of study|0
2510785|NCT01831089|8687308|P3|Cohort III: Dose Level 3|Global end of study|1
2510786|NCT01831089|8687309|P2|Cohort III: Dose Level 3|Global end of study|0
2510787|NCT01831089|8687310|P1|Cohort III: Dose Level 3|Global end of study|0
2510788|NCT01831089|8687305|P6|Cohort III: Dose Level 3|Adverse Event|0
2510789|NCT01831089|8687306|P5|Cohort III: Dose Level 3|Adverse Event|0
2510790|NCT01831089|8687307|P4|Cohort III: Dose Level 3|Adverse Event|0
2510791|NCT01831089|8687308|P3|Cohort III: Dose Level 3|Adverse Event|1
2510792|NCT01831089|8687309|P2|Cohort III: Dose Level 3|Adverse Event|0
2510793|NCT01831089|8687310|P1|Cohort III: Dose Level 3|Adverse Event|0
2510794|NCT01831089|8687305|P6|Cohort III: Dose Level 3|Withdrawal by Subject|0
2510795|NCT01831089|8687306|P5|Cohort III: Dose Level 3|Withdrawal by Subject|0
2510796|NCT01831089|8687307|P4|Cohort III: Dose Level 3|Withdrawal by Subject|0
2510797|NCT01831089|8687308|P3|Cohort III: Dose Level 3|Withdrawal by Subject|1
2510798|NCT01831089|8687309|P2|Cohort III: Dose Level 3|Withdrawal by Subject|0
2510799|NCT01831089|8687310|P1|Cohort III: Dose Level 3|Withdrawal by Subject|0
2510800|NCT01831089|8687305|P6|Cohort III: Dose Level 3|Progressive disease|0
2510801|NCT01831089|8687306|P5|Cohort III: Dose Level 3|Progressive disease|0
2510802|NCT01831089|8687307|P4|Cohort III: Dose Level 3|Progressive disease|0
2510803|NCT01831089|8687308|P3|Cohort III: Dose Level 3|Progressive disease|3
2510804|NCT01831089|8687309|P2|Cohort III: Dose Level 3|Progressive disease|0
2510805|NCT01831089|8687310|P1|Cohort III: Dose Level 3|Progressive disease|0
2510806|NCT01831089|8687305|P6|Cohort II: Dose Level 2|Clinical progressive disease|0
2510807|NCT01831089|8687306|P5|Cohort II: Dose Level 2|Clinical progressive disease|0
2510808|NCT01831089|8687307|P4|Cohort II: Dose Level 2|Clinical progressive disease|0
2510809|NCT01831089|8687308|P3|Cohort II: Dose Level 2|Clinical progressive disease|0
2510810|NCT01831089|8687309|P2|Cohort II: Dose Level 2|Clinical progressive disease|1
2510811|NCT01831089|8687310|P1|Cohort II: Dose Level 2|Clinical progressive disease|0
2510812|NCT01831089|8687305|P6|Cohort II: Dose Level 2|Progressive disease|0
2510813|NCT01831089|8687306|P5|Cohort II: Dose Level 2|Progressive disease|0
2510814|NCT01831089|8687307|P4|Cohort II: Dose Level 2|Progressive disease|0
2510815|NCT01831089|8687308|P3|Cohort II: Dose Level 2|Progressive disease|0
2510816|NCT01831089|8687309|P2|Cohort II: Dose Level 2|Progressive disease|2
2510817|NCT01831089|8687310|P1|Cohort II: Dose Level 2|Progressive disease|0
2510818|NCT01831089|8687305|P6|Cohort I: Dose Level 1|Progressive disease|0
2510819|NCT01831089|8687306|P5|Cohort I: Dose Level 1|Progressive disease|0
2510820|NCT01831089|8687307|P4|Cohort I: Dose Level 1|Progressive disease|0
2510821|NCT01831089|8687308|P3|Cohort I: Dose Level 1|Progressive disease|0
2510822|NCT01831089|8687309|P2|Cohort I: Dose Level 1|Progressive disease|0
2510823|NCT01831089|8687310|P1|Cohort I: Dose Level 1|Progressive disease|3
2510824|NCT01830972|8687361|P2|Part IV|Non-Compliance|0
2510825|NCT01830972|8687362|P1|Part IV|Non-Compliance|1
2510826|NCT01830972|8687361|P2|Part IV|Withdrawal by Subject|1
2510827|NCT01830972|8687362|P1|Part IV|Withdrawal by Subject|2
2510828|NCT01830972|8687361|P2|Part III|Noncompliance|0
2510829|NCT01830972|8687362|P1|Part III|Noncompliance|1
2510830|NCT01830972|8687361|P2|Part III|Withdrawal by Subject|0
2510831|NCT01830972|8687362|P1|Part III|Withdrawal by Subject|1
2510832|NCT01830972|8687361|P2|Part II|Withdrawal by Subject|2
2510833|NCT01830972|8687362|P1|Part II|Withdrawal by Subject|2
2510834|NCT01830920|8687406|P5|Overall Study|Other|3
2510835|NCT01830920|8687407|P4|Overall Study|Other|5
2510836|NCT01830920|8687408|P3|Overall Study|Other|1
2510837|NCT01830920|8687409|P2|Overall Study|Other|1
2510838|NCT01830920|8687410|P1|Overall Study|Other|15
2510839|NCT01830920|8687406|P5|Overall Study|Death|4
2510840|NCT01830920|8687407|P4|Overall Study|Death|4
2510841|NCT01830920|8687408|P3|Overall Study|Death|5
2510842|NCT01830920|8687409|P2|Overall Study|Death|3
2510843|NCT01830920|8687410|P1|Overall Study|Death|3
2510844|NCT01830920|8687406|P5|Overall Study|Withdrawal by Subject|1
2510845|NCT01830920|8687407|P4|Overall Study|Withdrawal by Subject|7
2510846|NCT01830920|8687408|P3|Overall Study|Withdrawal by Subject|1
2510847|NCT01830920|8687409|P2|Overall Study|Withdrawal by Subject|2
2510848|NCT01830920|8687410|P1|Overall Study|Withdrawal by Subject|2
2510849|NCT01830920|8687406|P5|Overall Study|Adverse Event|0
2510850|NCT01830920|8687407|P4|Overall Study|Adverse Event|0
2510851|NCT01830920|8687408|P3|Overall Study|Adverse Event|1
2510852|NCT01830920|8687409|P2|Overall Study|Adverse Event|0
2510853|NCT01830920|8687410|P1|Overall Study|Adverse Event|1
2510854|NCT01830881|8687449|P2|Overall Study|Changed decision to have an abortion|1
2510855|NCT01830881|8687450|P1|Overall Study|Changed decision to have an abortion|0
2510856|NCT01830855|8687498|P4|Overall Study|Lost to Follow-up|33
2510857|NCT01830855|8687499|P3|Overall Study|Lost to Follow-up|23
2510858|NCT01830855|8687500|P2|Overall Study|Lost to Follow-up|20
2510859|NCT01830855|8687501|P1|Overall Study|Lost to Follow-up|47
2510860|NCT01830855|8687498|P4|Overall Study|No longer willing to participate|17
2510861|NCT01830855|8687499|P3|Overall Study|No longer willing to participate|12
2510862|NCT01830855|8687500|P2|Overall Study|No longer willing to participate|13
2510863|NCT01830855|8687501|P1|Overall Study|No longer willing to participate|32
2510864|NCT01830855|8687498|P4|Overall Study|Withdrawal by Subject|12
2510865|NCT01830855|8687499|P3|Overall Study|Withdrawal by Subject|10
2510866|NCT01830855|8687500|P2|Overall Study|Withdrawal by Subject|14
2510867|NCT01830855|8687501|P1|Overall Study|Withdrawal by Subject|33
2510868|NCT01830855|8687498|P4|Overall Study|Protocol deviation|6
2510869|NCT01830855|8687499|P3|Overall Study|Protocol deviation|6
2510870|NCT01830855|8687500|P2|Overall Study|Protocol deviation|5
2510871|NCT01830855|8687501|P1|Overall Study|Protocol deviation|10
2510872|NCT01830855|8687498|P4|Overall Study|Adverse Event|3
2510873|NCT01830855|8687499|P3|Overall Study|Adverse Event|6
2510874|NCT01830855|8687500|P2|Overall Study|Adverse Event|5
2510875|NCT01830855|8687501|P1|Overall Study|Adverse Event|11
2510876|NCT01830855|8687498|P4|Overall Study|No longer meets eligibility criteria|5
2510877|NCT01830855|8687499|P3|Overall Study|No longer meets eligibility criteria|3
2510878|NCT01830855|8687500|P2|Overall Study|No longer meets eligibility criteria|2
2510879|NCT01830855|8687501|P1|Overall Study|No longer meets eligibility criteria|11
2510880|NCT01830855|8687498|P4|Overall Study|Pregnancy|1
2510881|NCT01830855|8687499|P3|Overall Study|Pregnancy|2
2510882|NCT01830855|8687500|P2|Overall Study|Pregnancy|1
2510883|NCT01830855|8687501|P1|Overall Study|Pregnancy|3
2510884|NCT01830855|8687498|P4|Overall Study|Medication error without associated AE|1
2510885|NCT01830855|8687499|P3|Overall Study|Medication error without associated AE|0
2510886|NCT01830855|8687500|P2|Overall Study|Medication error without associated AE|0
2510887|NCT01830855|8687501|P1|Overall Study|Medication error without associated AE|1
2510888|NCT01830855|8687498|P4|Overall Study|Other|4
2510889|NCT01830855|8687499|P3|Overall Study|Other|4
2510890|NCT01830855|8687500|P2|Overall Study|Other|1
2510891|NCT01830855|8687501|P1|Overall Study|Other|7
2510892|NCT01830816|8687617|P3|Overall Study|Reason not Specified|0
2510893|NCT01830816|8687618|P2|Overall Study|Reason not Specified|0
2510894|NCT01830816|8687619|P1|Overall Study|Reason not Specified|2
2510895|NCT01830816|8687617|P3|Overall Study|Symptomatic Deterioration|0
2510896|NCT01830816|8687618|P2|Overall Study|Symptomatic Deterioration|0
2510897|NCT01830816|8687619|P1|Overall Study|Symptomatic Deterioration|1
2510898|NCT01830816|8687617|P3|Overall Study|Lost to Follow-up|0
2510899|NCT01830816|8687618|P2|Overall Study|Lost to Follow-up|1
2510900|NCT01830816|8687619|P1|Overall Study|Lost to Follow-up|0
2510901|NCT01830816|8687617|P3|Overall Study|Withdrawal by Subject|0
2510902|NCT01830816|8687618|P2|Overall Study|Withdrawal by Subject|1
2510903|NCT01830816|8687619|P1|Overall Study|Withdrawal by Subject|1
2510904|NCT01830816|8687617|P3|Overall Study|Study Terminated by Sponsor|0
2510905|NCT01830816|8687618|P2|Overall Study|Study Terminated by Sponsor|1
2510906|NCT01830816|8687619|P1|Overall Study|Study Terminated by Sponsor|1
2510907|NCT01830816|8687617|P3|Overall Study|Adverse Event|0
2510908|NCT01830816|8687618|P2|Overall Study|Adverse Event|4
2510909|NCT01830816|8687619|P1|Overall Study|Adverse Event|3
2510910|NCT01830816|8687617|P3|Overall Study|Progressive Disease|7
2510911|NCT01830816|8687618|P2|Overall Study|Progressive Disease|7
2510912|NCT01830816|8687619|P1|Overall Study|Progressive Disease|12
2510913|NCT01830595|8687683|P2|Washout|Withdrawal by Subject|2
2510914|NCT01830595|8687684|P1|Washout|Withdrawal by Subject|2
2510915|NCT01830595|8687683|P2|First Period|Withdrawal by Subject|3
2510916|NCT01830595|8687684|P1|First Period|Withdrawal by Subject|1
2510917|NCT01830543|8687701|P3|Overall Study|Other|37
2510918|NCT01830543|8687702|P2|Overall Study|Other|17
2510919|NCT01830543|8687703|P1|Overall Study|Other|12
2510920|NCT01830543|8687701|P3|Overall Study|Withdrawal by consent|3
2510921|NCT01830543|8687702|P2|Overall Study|Withdrawal by consent|3
2510922|NCT01830543|8687703|P1|Overall Study|Withdrawal by consent|3
2510923|NCT01830543|8687701|P3|Overall Study|Physician Decision|12
2510924|NCT01830543|8687702|P2|Overall Study|Physician Decision|5
2510925|NCT01830543|8687703|P1|Overall Study|Physician Decision|11
2510926|NCT01830543|8687701|P3|Overall Study|Protocol Violation|7
2510927|NCT01830543|8687702|P2|Overall Study|Protocol Violation|7
2510928|NCT01830543|8687703|P1|Overall Study|Protocol Violation|3
2510929|NCT01830543|8687701|P3|Overall Study|Death|22
2510930|NCT01830543|8687702|P2|Overall Study|Death|22
2510931|NCT01830543|8687703|P1|Overall Study|Death|20
2510932|NCT01830543|8687701|P3|Overall Study|Adverse Event|76
2510933|NCT01830543|8687702|P2|Overall Study|Adverse Event|77
2510934|NCT01830543|8687703|P1|Overall Study|Adverse Event|91
2510935|NCT01830543|8687701|P3|Overall Study|Subject Decision|57
2510936|NCT01830543|8687702|P2|Overall Study|Subject Decision|21
2510937|NCT01830543|8687703|P1|Overall Study|Subject Decision|19
2510938|NCT01830127|8687835|P2|Overall Study|Other reason not defined above|2
2510939|NCT01830127|8687836|P1|Overall Study|Other reason not defined above|0
2510940|NCT01830127|8687835|P2|Overall Study|Withdrawal by Subject|1
2510941|NCT01830127|8687836|P1|Overall Study|Withdrawal by Subject|1
2510942|NCT01830127|8687835|P2|Overall Study|Lack of Efficacy|0
2510943|NCT01830127|8687836|P1|Overall Study|Lack of Efficacy|3
2510944|NCT01830127|8687835|P2|Overall Study|Adverse Event|6
2510945|NCT01830127|8687836|P1|Overall Study|Adverse Event|1
2510946|NCT01829711|8687869|P1|Overall Study|Due to lack of response|1
2510947|NCT01829711|8687869|P1|Overall Study|Due to progression of disease|13
2510948|NCT01829711|8687869|P1|Overall Study|Adverse Event|3
2510949|NCT01829711|8687869|P1|Overall Study|Started new therapies|17
2510950|NCT01829711|8687869|P1|Overall Study|Death|4
2510951|NCT01829711|8687869|P1|Overall Study|Withdrawal by Subject|3
2510952|NCT01829711|8687869|P1|Overall Study|Lost to Follow-up|2
2510953|NCT01829477|8687926|P2|Overall Study|Withdrawal by Subject|0
2510954|NCT01829477|8687927|P1|Overall Study|Withdrawal by Subject|1
2510955|NCT01829477|8687926|P2|Overall Study|Study Terminated by Sponsor|15
2510956|NCT01829477|8687927|P1|Overall Study|Study Terminated by Sponsor|15
2510957|NCT01829464|8687940|P3|Overall Study|Lack of Efficacy|0
2510958|NCT01829464|8687941|P2|Overall Study|Lack of Efficacy|1
2510959|NCT01829464|8687942|P1|Overall Study|Lack of Efficacy|0
2510960|NCT01829464|8687940|P3|Overall Study|Study terminated by sponsor|25
2510961|NCT01829464|8687941|P2|Overall Study|Study terminated by sponsor|28
2510962|NCT01829464|8687942|P1|Overall Study|Study terminated by sponsor|25
2510963|NCT01829464|8687940|P3|Overall Study|Withdrawal by Subject|0
2510964|NCT01829464|8687941|P2|Overall Study|Withdrawal by Subject|0
2510965|NCT01829464|8687942|P1|Overall Study|Withdrawal by Subject|2
2510966|NCT01829464|8687940|P3|Overall Study|Lost to Follow-up|1
2510967|NCT01829464|8687941|P2|Overall Study|Lost to Follow-up|0
2510968|NCT01829464|8687942|P1|Overall Study|Lost to Follow-up|0
2510969|NCT01829464|8687940|P3|Overall Study|Adverse Event|0
2510970|NCT01829464|8687941|P2|Overall Study|Adverse Event|0
2510971|NCT01829464|8687942|P1|Overall Study|Adverse Event|1
2510972|NCT01829425|8687958|P2|Overall Study|Lost to Follow-up|1
2510973|NCT01829425|8687959|P1|Overall Study|Lost to Follow-up|2
2510974|NCT01829425|8687958|P2|Overall Study|Withdrawal by Subject|3
2510975|NCT01829425|8687959|P1|Overall Study|Withdrawal by Subject|4
2510976|NCT01829360|8688002|P4|Overall Study|Protocol Violation|0
2510977|NCT01829360|8688003|P3|Overall Study|Protocol Violation|1
2510978|NCT01829360|8688004|P2|Overall Study|Protocol Violation|0
2510979|NCT01829360|8688005|P1|Overall Study|Protocol Violation|0
2510980|NCT01829347|8688025|P2|VTI-210E|Study terminated prematurely|5
2510981|NCT01829347|8688026|P1|VTI-210E|Study terminated prematurely|1
2510982|NCT01829347|8688025|P2|VTI-210E|Death|1
2510983|NCT01829347|8688026|P1|VTI-210E|Death|2
2510984|NCT01829347|8688025|P2|VTI-210|Withdrawal by Subject|0
2510985|NCT01829347|8688026|P1|VTI-210|Withdrawal by Subject|1
2510986|NCT01829347|8688025|P2|VTI-210|Death|3
2510987|NCT01829347|8688026|P1|VTI-210|Death|5
2510988|NCT01829295|8688036|P4|6-12 Months|Withdrawal by Subject|0
2510989|NCT01829295|8688037|P3|6-12 Months|Withdrawal by Subject|0
2510990|NCT01829295|8688038|P2|6-12 Months|Withdrawal by Subject|2
2510991|NCT01829295|8688039|P1|6-12 Months|Withdrawal by Subject|2
2510992|NCT01829295|8688036|P4|6-12 Months|Lost to Follow-up|0
2510993|NCT01829295|8688037|P3|6-12 Months|Lost to Follow-up|0
2510994|NCT01829295|8688038|P2|6-12 Months|Lost to Follow-up|0
2510995|NCT01829295|8688039|P1|6-12 Months|Lost to Follow-up|2
2510996|NCT01829295|8688036|P4|6-12 Months|Adverse Event|2
2510997|NCT01829295|8688037|P3|6-12 Months|Adverse Event|3
2510998|NCT01829295|8688038|P2|6-12 Months|Adverse Event|0
2510999|NCT01829295|8688039|P1|6-12 Months|Adverse Event|0
2511000|NCT01829295|8688036|P4|6-12 Months|Did not want to switch antimetabolites|11
2511001|NCT01829295|8688037|P3|6-12 Months|Did not want to switch antimetabolites|9
2511002|NCT01829295|8688038|P2|6-12 Months|Did not want to switch antimetabolites|0
2511003|NCT01829295|8688039|P1|6-12 Months|Did not want to switch antimetabolites|0
2511004|NCT01829243|8688049|P2|First Intervention|Screen Failure|2
2511005|NCT01829243|8688050|P1|First Intervention|Screen Failure|4
2511006|NCT01829230|8688064|P2|Overall Study|Lost to Follow-up|1
2511007|NCT01829230|8688065|P1|Overall Study|Lost to Follow-up|1
2511008|NCT01829230|8688064|P2|Overall Study|Withdrawal by Subject|1
2511009|NCT01829230|8688065|P1|Overall Study|Withdrawal by Subject|0
2511010|NCT01829230|8688064|P2|Overall Study|Protocol Violation|2
2511011|NCT01829230|8688065|P1|Overall Study|Protocol Violation|0
2511012|NCT01829191|8688079|P2|Overall Study|Subject was fit for ortho - k|1
2511013|NCT01829191|8688080|P1|Overall Study|Subject was fit for ortho - k|0
2511014|NCT01829191|8688079|P2|Overall Study|Lost to Follow-up|1
2511015|NCT01829191|8688080|P1|Overall Study|Lost to Follow-up|0
2511016|NCT01829191|8688079|P2|Overall Study|Withdrawal by Subject|3
2511017|NCT01829191|8688080|P1|Overall Study|Withdrawal by Subject|2
2511018|NCT01829191|8688079|P2|Overall Study|Protocol Violation|1
2511019|NCT01829191|8688080|P1|Overall Study|Protocol Violation|4
2511020|NCT01829191|8688079|P2|Overall Study|Lens handling difficulty|4
2511021|NCT01829191|8688080|P1|Overall Study|Lens handling difficulty|1
2511022|NCT01829191|8688079|P2|Overall Study|Lens discomfort|3
2511023|NCT01829191|8688080|P1|Overall Study|Lens discomfort|0
2511024|NCT01829191|8688079|P2|Overall Study|Relocation|1
2511025|NCT01829191|8688080|P1|Overall Study|Relocation|0
2511026|NCT01829165|8688089|P2|Overall Study|Did not complete intervention|0
2511027|NCT01829165|8688090|P1|Overall Study|Did not complete intervention|2
2511028|NCT01829113|8688098|P2|Overall Study|Physician Decision|1
2511029|NCT01829113|8688099|P1|Overall Study|Physician Decision|1
2511030|NCT01829113|8688098|P2|Overall Study|No Study Treatment Received|2
2511031|NCT01829113|8688099|P1|Overall Study|No Study Treatment Received|3
2511032|NCT01829113|8688098|P2|Overall Study|Sponsor Decision|1
2511033|NCT01829113|8688099|P1|Overall Study|Sponsor Decision|1
2511034|NCT01829113|8688098|P2|Overall Study|Death|6
2511035|NCT01829113|8688099|P1|Overall Study|Death|4
2511036|NCT01829113|8688098|P2|Overall Study|Withdrawal by Subject|10
2511037|NCT01829113|8688099|P1|Overall Study|Withdrawal by Subject|17
2511038|NCT01829113|8688098|P2|Overall Study|Adverse Event|10
2511039|NCT01829113|8688099|P1|Overall Study|Adverse Event|14
2511040|NCT01829113|8688098|P2|Overall Study|Disease Progression|48
2511041|NCT01829113|8688099|P1|Overall Study|Disease Progression|37
2511042|NCT01829048|8688116|P5|Overall Study|Withdrawal by Subject|0
2511043|NCT01829048|8688117|P4|Overall Study|Withdrawal by Subject|2
2511044|NCT01829048|8688118|P3|Overall Study|Withdrawal by Subject|0
2511045|NCT01829048|8688119|P2|Overall Study|Withdrawal by Subject|0
2511046|NCT01829048|8688120|P1|Overall Study|Withdrawal by Subject|0
2511047|NCT01828567|8688233|P2|Overall Study|Excluded - did not meet criteria|1
2511048|NCT01828567|8688234|P1|Overall Study|Excluded - did not meet criteria|4
2511049|NCT01828567|8688233|P2|Overall Study|Lost to Follow-up|9
2511050|NCT01828567|8688234|P1|Overall Study|Lost to Follow-up|27
2511051|NCT01828281|8688289|P2|Overall Study|Withdrawal by Subject|0
2511052|NCT01828281|8688290|P1|Overall Study|Withdrawal by Subject|1
2511053|NCT01828112|8688323|P2|Overall Study|Subject/guardian decision|8
2511054|NCT01828112|8688324|P1|Overall Study|Subject/guardian decision|6
2511055|NCT01828112|8688323|P2|Overall Study|Progressive disease|82
2511056|NCT01828112|8688324|P1|Overall Study|Progressive disease|56
2511057|NCT01828112|8688323|P2|Overall Study|Physician Decision|5
2511058|NCT01828112|8688324|P1|Overall Study|Physician Decision|5
2511059|NCT01828112|8688323|P2|Overall Study|Death|5
2511060|NCT01828112|8688324|P1|Overall Study|Death|9
2511061|NCT01828112|8688323|P2|Overall Study|Adverse Event|8
2511062|NCT01828112|8688324|P1|Overall Study|Adverse Event|6
2511063|NCT01828099|8688332|P2|Overall Study|Subject/guardian decision|23
2511064|NCT01828099|8688333|P1|Overall Study|Subject/guardian decision|7
2511065|NCT01828099|8688332|P2|Overall Study|Protocol Violation|0
2511066|NCT01828099|8688333|P1|Overall Study|Protocol Violation|1
2511067|NCT01828099|8688332|P2|Overall Study|Progressive disease|94
2511068|NCT01828099|8688333|P1|Overall Study|Progressive disease|51
2511069|NCT01828099|8688332|P2|Overall Study|Physician Decision|11
2511070|NCT01828099|8688333|P1|Overall Study|Physician Decision|7
2511071|NCT01828099|8688332|P2|Overall Study|Non-compliance with study treatment|0
2511072|NCT01828099|8688333|P1|Overall Study|Non-compliance with study treatment|2
2511073|NCT01828099|8688332|P2|Overall Study|Lost to Follow-up|0
2511074|NCT01828099|8688333|P1|Overall Study|Lost to Follow-up|2
2511075|NCT01828099|8688332|P2|Overall Study|Death|11
2511076|NCT01828099|8688333|P1|Overall Study|Death|9
2511077|NCT01828099|8688332|P2|Overall Study|Adverse Event|18
2511078|NCT01828099|8688333|P1|Overall Study|Adverse Event|15
2511079|NCT01828073|8688341|P2|Overall Study|Lost to Follow-up|2
2511080|NCT01828073|8688342|P1|Overall Study|Lost to Follow-up|1
2511081|NCT01827839|8688362|P1|Overall Study|Consent Withdrawal|2
2511082|NCT01827839|8688362|P1|Overall Study|Adverse Event|1
2511083|NCT01827670|8688407|P2|Overall Study|Lost to Follow-up|1
2511084|NCT01827670|8688408|P1|Overall Study|Lost to Follow-up|0
2511085|NCT01827670|8688407|P2|Overall Study|Withdrawal of Consent|2
2511086|NCT01827670|8688408|P1|Overall Study|Withdrawal of Consent|3
2511087|NCT01827592|8688427|P3|Overall Study|Others|3
2511088|NCT01827592|8688428|P2|Overall Study|Others|1
2511089|NCT01827592|8688429|P1|Overall Study|Others|0
2511090|NCT01827592|8688427|P3|Overall Study|Trial terminated by Sponsor|51
2511091|NCT01827592|8688428|P2|Overall Study|Trial terminated by Sponsor|53
2511092|NCT01827592|8688429|P1|Overall Study|Trial terminated by Sponsor|47
2511093|NCT01827592|8688427|P3|Overall Study|Patient's substantial non-compliance|6
2511094|NCT01827592|8688428|P2|Overall Study|Patient's substantial non-compliance|1
2511095|NCT01827592|8688429|P1|Overall Study|Patient's substantial non-compliance|1
2511096|NCT01827592|8688427|P3|Overall Study|Withdrawal by Subject|11
2511097|NCT01827592|8688428|P2|Overall Study|Withdrawal by Subject|11
2511098|NCT01827592|8688429|P1|Overall Study|Withdrawal by Subject|12
2511099|NCT01827592|8688427|P3|Overall Study|Lost to Follow-up|2
2511100|NCT01827592|8688428|P2|Overall Study|Lost to Follow-up|2
2511101|NCT01827592|8688429|P1|Overall Study|Lost to Follow-up|1
2511102|NCT01827592|8688427|P3|Overall Study|Protocol Violation|0
2511103|NCT01827592|8688428|P2|Overall Study|Protocol Violation|1
2511104|NCT01827592|8688429|P1|Overall Study|Protocol Violation|2
2511105|NCT01827592|8688427|P3|Overall Study|Physician Decision|1
2511106|NCT01827592|8688428|P2|Overall Study|Physician Decision|2
2511107|NCT01827592|8688429|P1|Overall Study|Physician Decision|0
2511108|NCT01827592|8688427|P3|Overall Study|Adverse Event|2
2511109|NCT01827592|8688428|P2|Overall Study|Adverse Event|9
2511110|NCT01827592|8688429|P1|Overall Study|Adverse Event|11
2511111|NCT01827371|8688494|P4|Overall Study|Temporary study halt to vaccinations|13
2511112|NCT01827371|8688495|P3|Overall Study|Temporary study halt to vaccinations|5
2511113|NCT01827371|8688496|P2|Overall Study|Temporary study halt to vaccinations|2
2511114|NCT01827371|8688497|P1|Overall Study|Temporary study halt to vaccinations|11
2511115|NCT01827371|8688494|P4|Overall Study|Physician Decision|1
2511116|NCT01827371|8688495|P3|Overall Study|Physician Decision|0
2511117|NCT01827371|8688496|P2|Overall Study|Physician Decision|1
2511118|NCT01827371|8688497|P1|Overall Study|Physician Decision|0
2511119|NCT01827371|8688494|P4|Overall Study|Withdrawal by Subject|3
2511120|NCT01827371|8688495|P3|Overall Study|Withdrawal by Subject|2
2511121|NCT01827371|8688496|P2|Overall Study|Withdrawal by Subject|2
2511122|NCT01827371|8688497|P1|Overall Study|Withdrawal by Subject|1
2511123|NCT01827371|8688494|P4|Overall Study|Protocol Violation|0
2511124|NCT01827371|8688495|P3|Overall Study|Protocol Violation|0
2511125|NCT01827371|8688496|P2|Overall Study|Protocol Violation|0
2511126|NCT01827371|8688497|P1|Overall Study|Protocol Violation|1
2511127|NCT01827371|8688494|P4|Overall Study|Lost to Follow-up|4
2511128|NCT01827371|8688495|P3|Overall Study|Lost to Follow-up|0
2511129|NCT01827371|8688496|P2|Overall Study|Lost to Follow-up|2
2511130|NCT01827371|8688497|P1|Overall Study|Lost to Follow-up|0
2511131|NCT01827371|8688494|P4|Overall Study|Adverse Event|2
2511132|NCT01827371|8688495|P3|Overall Study|Adverse Event|4
2511133|NCT01827371|8688496|P2|Overall Study|Adverse Event|0
2511134|NCT01827371|8688497|P1|Overall Study|Adverse Event|0
2511135|NCT01827332|8688556|P2|Overall Study|Lost to Follow-up|1
2511136|NCT01827332|8688557|P1|Overall Study|Lost to Follow-up|2
2511137|NCT01827319|8688565|P1|Overall Study|Lost to Follow-up|3
2511138|NCT01827267|8688588|P2|Overall Study|Still on study|2
2511139|NCT01827267|8688589|P1|Overall Study|Still on study|0
2511140|NCT01827267|8688588|P2|Overall Study|Sponsor Discontinued Study|8
2511141|NCT01827267|8688589|P1|Overall Study|Sponsor Discontinued Study|2
2511142|NCT01827267|8688588|P2|Overall Study|Disease Progression|1
2511143|NCT01827267|8688589|P1|Overall Study|Disease Progression|1
2511144|NCT01827267|8688588|P2|Overall Study|Physician Decision|0
2511145|NCT01827267|8688589|P1|Overall Study|Physician Decision|1
2511146|NCT01827267|8688588|P2|Overall Study|Did not receive study drug|1
2511147|NCT01827267|8688589|P1|Overall Study|Did not receive study drug|1
2511148|NCT01827254|8688604|P1|Overall Study|Intolerance to treatment|4
2511149|NCT01827254|8688604|P1|Overall Study|Disease progression|36
2511150|NCT01827254|8688604|P1|Overall Study|Did not complete re-challenge|1
2511151|NCT01827254|8688604|P1|Overall Study|Discontinued prior initiation: sunitinib|1
2511152|NCT01827254|8688604|P1|Overall Study|Invalidated centre|3
2511153|NCT01827254|8688604|P1|Overall Study|Case report form not completed|4
2511154|NCT01827254|8688604|P1|Overall Study|Death|10
2511155|NCT01827163|8688614|P1|Overall Study|Adverse Event|9
2511156|NCT01827163|8688614|P1|Overall Study|Hypersensitivity reaction to Paclitaxel|2
2511157|NCT01827046|8688621|P2|Overall Study|Withdrawal by Subject|4
2511158|NCT01827046|8688622|P1|Overall Study|Withdrawal by Subject|0
2511159|NCT01827046|8688621|P2|Overall Study|Lost to Follow-up|5
2511160|NCT01827046|8688622|P1|Overall Study|Lost to Follow-up|1
2511161|NCT01826981|8688677|P15|Overall Study|Enrolled/Randomized but Not Treated|0
2511162|NCT01826981|8688678|P14|Overall Study|Enrolled/Randomized but Not Treated|0
2511163|NCT01826981|8688679|P13|Overall Study|Enrolled/Randomized but Not Treated|0
2511164|NCT01826981|8688680|P12|Overall Study|Enrolled/Randomized but Not Treated|0
2511165|NCT01826981|8688681|P11|Overall Study|Enrolled/Randomized but Not Treated|0
2511166|NCT01826981|8688682|P10|Overall Study|Enrolled/Randomized but Not Treated|0
2511167|NCT01826981|8688683|P9|Overall Study|Enrolled/Randomized but Not Treated|0
2511168|NCT01826981|8688684|P8|Overall Study|Enrolled/Randomized but Not Treated|1
2511169|NCT01826981|8688685|P7|Overall Study|Enrolled/Randomized but Not Treated|0
2511170|NCT01826981|8688686|P6|Overall Study|Enrolled/Randomized but Not Treated|0
2511171|NCT01826981|8688687|P5|Overall Study|Enrolled/Randomized but Not Treated|0
2511172|NCT01826981|8688688|P4|Overall Study|Enrolled/Randomized but Not Treated|0
2511173|NCT01826981|8688689|P3|Overall Study|Enrolled/Randomized but Not Treated|0
2511174|NCT01826981|8688690|P2|Overall Study|Enrolled/Randomized but Not Treated|0
2511175|NCT01826981|8688691|P1|Overall Study|Enrolled/Randomized but Not Treated|0
2511176|NCT01826981|8688677|P15|Overall Study|Upper G-I Haemorrhage|0
2511177|NCT01826981|8688678|P14|Overall Study|Upper G-I Haemorrhage|1
2511178|NCT01826981|8688679|P13|Overall Study|Upper G-I Haemorrhage|0
2511179|NCT01826981|8688680|P12|Overall Study|Upper G-I Haemorrhage|0
2511180|NCT01826981|8688681|P11|Overall Study|Upper G-I Haemorrhage|0
2511181|NCT01826981|8688682|P10|Overall Study|Upper G-I Haemorrhage|0
2511182|NCT01826981|8688683|P9|Overall Study|Upper G-I Haemorrhage|0
2511183|NCT01826981|8688684|P8|Overall Study|Upper G-I Haemorrhage|0
2511184|NCT01826981|8688685|P7|Overall Study|Upper G-I Haemorrhage|0
2511185|NCT01826981|8688686|P6|Overall Study|Upper G-I Haemorrhage|0
2511186|NCT01826981|8688687|P5|Overall Study|Upper G-I Haemorrhage|0
2511187|NCT01826981|8688688|P4|Overall Study|Upper G-I Haemorrhage|0
2511188|NCT01826981|8688689|P3|Overall Study|Upper G-I Haemorrhage|0
2511189|NCT01826981|8688690|P2|Overall Study|Upper G-I Haemorrhage|0
2511190|NCT01826981|8688691|P1|Overall Study|Upper G-I Haemorrhage|0
2511191|NCT01826981|8688677|P15|Overall Study|Adverse Event|0
2511192|NCT01826981|8688678|P14|Overall Study|Adverse Event|0
2511193|NCT01826981|8688679|P13|Overall Study|Adverse Event|0
2511194|NCT01826981|8688680|P12|Overall Study|Adverse Event|0
2511195|NCT01826981|8688681|P11|Overall Study|Adverse Event|0
2511196|NCT01826981|8688682|P10|Overall Study|Adverse Event|0
2511197|NCT01826981|8688683|P9|Overall Study|Adverse Event|0
2511198|NCT01826981|8688684|P8|Overall Study|Adverse Event|0
2511199|NCT01826981|8688685|P7|Overall Study|Adverse Event|0
2511200|NCT01826981|8688686|P6|Overall Study|Adverse Event|0
2511201|NCT01826981|8688687|P5|Overall Study|Adverse Event|1
2511202|NCT01826981|8688688|P4|Overall Study|Adverse Event|0
2511203|NCT01826981|8688689|P3|Overall Study|Adverse Event|0
2511204|NCT01826981|8688690|P2|Overall Study|Adverse Event|0
2511205|NCT01826981|8688691|P1|Overall Study|Adverse Event|0
2511206|NCT01826981|8688677|P15|Overall Study|Withdrew Consent|0
2511207|NCT01826981|8688678|P14|Overall Study|Withdrew Consent|1
2511208|NCT01826981|8688679|P13|Overall Study|Withdrew Consent|0
2511209|NCT01826981|8688680|P12|Overall Study|Withdrew Consent|1
2511210|NCT01826981|8688681|P11|Overall Study|Withdrew Consent|0
2511211|NCT01826981|8688682|P10|Overall Study|Withdrew Consent|0
2511212|NCT01826981|8688683|P9|Overall Study|Withdrew Consent|0
2511213|NCT01826981|8688684|P8|Overall Study|Withdrew Consent|1
2511214|NCT01826981|8688685|P7|Overall Study|Withdrew Consent|1
2511215|NCT01826981|8688686|P6|Overall Study|Withdrew Consent|0
2511216|NCT01826981|8688687|P5|Overall Study|Withdrew Consent|0
2511217|NCT01826981|8688688|P4|Overall Study|Withdrew Consent|0
2511218|NCT01826981|8688689|P3|Overall Study|Withdrew Consent|0
2511219|NCT01826981|8688690|P2|Overall Study|Withdrew Consent|0
2511220|NCT01826981|8688691|P1|Overall Study|Withdrew Consent|0
2511221|NCT01826981|8688677|P15|Overall Study|Lost to Follow-up|0
2511222|NCT01826981|8688678|P14|Overall Study|Lost to Follow-up|0
2511223|NCT01826981|8688679|P13|Overall Study|Lost to Follow-up|1
2511224|NCT01826981|8688680|P12|Overall Study|Lost to Follow-up|1
2511225|NCT01826981|8688681|P11|Overall Study|Lost to Follow-up|1
2511226|NCT01826981|8688682|P10|Overall Study|Lost to Follow-up|1
2511227|NCT01826981|8688683|P9|Overall Study|Lost to Follow-up|0
2511228|NCT01826981|8688684|P8|Overall Study|Lost to Follow-up|1
2511229|NCT01826981|8688685|P7|Overall Study|Lost to Follow-up|0
2511230|NCT01826981|8688686|P6|Overall Study|Lost to Follow-up|1
2511231|NCT01826981|8688687|P5|Overall Study|Lost to Follow-up|1
2511232|NCT01826981|8688688|P4|Overall Study|Lost to Follow-up|0
2511233|NCT01826981|8688689|P3|Overall Study|Lost to Follow-up|0
2511234|NCT01826981|8688690|P2|Overall Study|Lost to Follow-up|0
2511235|NCT01826981|8688691|P1|Overall Study|Lost to Follow-up|0
2511236|NCT01826981|8688677|P15|Overall Study|Lack of Efficacy|0
2511237|NCT01826981|8688678|P14|Overall Study|Lack of Efficacy|3
2511238|NCT01826981|8688679|P13|Overall Study|Lack of Efficacy|0
2511239|NCT01826981|8688680|P12|Overall Study|Lack of Efficacy|0
2511240|NCT01826981|8688681|P11|Overall Study|Lack of Efficacy|1
2511241|NCT01826981|8688682|P10|Overall Study|Lack of Efficacy|0
2511242|NCT01826981|8688683|P9|Overall Study|Lack of Efficacy|7
2511243|NCT01826981|8688684|P8|Overall Study|Lack of Efficacy|8
2511244|NCT01826981|8688685|P7|Overall Study|Lack of Efficacy|0
2511245|NCT01826981|8688686|P6|Overall Study|Lack of Efficacy|0
2511246|NCT01826981|8688687|P5|Overall Study|Lack of Efficacy|5
2511247|NCT01826981|8688688|P4|Overall Study|Lack of Efficacy|0
2511248|NCT01826981|8688689|P3|Overall Study|Lack of Efficacy|0
2511249|NCT01826981|8688690|P2|Overall Study|Lack of Efficacy|1
2511250|NCT01826981|8688691|P1|Overall Study|Lack of Efficacy|0
2511251|NCT01826604|8688877|P2|Overall Study|Lost to Follow-up|9
2511252|NCT01826604|8688878|P1|Overall Study|Lost to Follow-up|8
2511253|NCT01826422|8688922|P2|Overall Study|Withdrawal by Subject|3
2511254|NCT01826422|8688923|P1|Overall Study|Withdrawal by Subject|1
2511255|NCT01826370|8688967|P1|Overall Study|Other reason not defined above|2
2511256|NCT01826370|8688967|P1|Overall Study|Lost to Follow-up|12
2511257|NCT01826370|8688967|P1|Overall Study|Protocol Violation|6
2511258|NCT01826214|8688979|P2|Overall Study|Subject/guardian decision|3
2511259|NCT01826214|8688980|P1|Overall Study|Subject/guardian decision|2
2511260|NCT01826214|8688979|P2|Overall Study|Study terminated by Sponsor|1
2511261|NCT01826214|8688980|P1|Overall Study|Study terminated by Sponsor|0
2511262|NCT01826214|8688979|P2|Overall Study|Progressive disease|21
2511263|NCT01826214|8688980|P1|Overall Study|Progressive disease|22
2511264|NCT01826214|8688979|P2|Overall Study|Physician Decision|2
2511265|NCT01826214|8688980|P1|Overall Study|Physician Decision|0
2511266|NCT01826214|8688979|P2|Overall Study|Lost to Follow-up|0
2511267|NCT01826214|8688980|P1|Overall Study|Lost to Follow-up|1
2511268|NCT01826214|8688979|P2|Overall Study|Death|1
2511269|NCT01826214|8688980|P1|Overall Study|Death|3
2511270|NCT01826214|8688979|P2|Overall Study|Adverse Event|6
2511271|NCT01826214|8688980|P1|Overall Study|Adverse Event|7
2511272|NCT01826201|8688998|P1|Overall Study|Non compliance with protocol|4
2511273|NCT01825941|8689006|P2|Overall Study|Lost to Follow-up|1
2511274|NCT01825941|8689007|P1|Overall Study|Lost to Follow-up|4
2511275|NCT01825876|8689026|P2|Period 2|Withdrawal by Subject|1
2511276|NCT01825876|8689027|P1|Period 2|Withdrawal by Subject|0
2511277|NCT01825837|8689048|P4|PART II|reason unspecified|0
2511278|NCT01825837|8689049|P3|PART II|reason unspecified|2
2511279|NCT01825837|8689050|P2|PART II|reason unspecified|2
2511280|NCT01825837|8689051|P1|PART II|reason unspecified|2
2511281|NCT01825837|8689048|P4|PART II|Treatment failure|0
2511282|NCT01825837|8689049|P3|PART II|Treatment failure|5
2511283|NCT01825837|8689050|P2|PART II|Treatment failure|4
2511284|NCT01825837|8689051|P1|PART II|Treatment failure|6
2511285|NCT01825837|8689048|P4|PART II|Adverse Event|0
2511286|NCT01825837|8689049|P3|PART II|Adverse Event|1
2511287|NCT01825837|8689050|P2|PART II|Adverse Event|3
2511288|NCT01825837|8689051|P1|PART II|Adverse Event|3
2511289|NCT01825837|8689048|P4|PART II|Patient non-compliance|0
2511290|NCT01825837|8689049|P3|PART II|Patient non-compliance|4
2511291|NCT01825837|8689050|P2|PART II|Patient non-compliance|2
2511292|NCT01825837|8689051|P1|PART II|Patient non-compliance|5
2511293|NCT01825837|8689048|P4|PART II|Withdrawal by Subject|0
2511294|NCT01825837|8689049|P3|PART II|Withdrawal by Subject|7
2511295|NCT01825837|8689050|P2|PART II|Withdrawal by Subject|3
2511296|NCT01825837|8689051|P1|PART II|Withdrawal by Subject|3
2511297|NCT01825837|8689048|P4|PART I|reason unspecified|3
2511298|NCT01825837|8689049|P3|PART I|reason unspecified|0
2511299|NCT01825837|8689050|P2|PART I|reason unspecified|0
2511300|NCT01825837|8689051|P1|PART I|reason unspecified|0
2511301|NCT01825837|8689048|P4|PART I|Treatment failure|7
2511302|NCT01825837|8689049|P3|PART I|Treatment failure|0
2511303|NCT01825837|8689050|P2|PART I|Treatment failure|0
2511304|NCT01825837|8689051|P1|PART I|Treatment failure|0
2511305|NCT01825837|8689048|P4|PART I|Patient non-compliance|1
2511306|NCT01825837|8689049|P3|PART I|Patient non-compliance|0
2511307|NCT01825837|8689050|P2|PART I|Patient non-compliance|0
2511308|NCT01825837|8689051|P1|PART I|Patient non-compliance|0
2511309|NCT01825837|8689048|P4|PART I|Withdrawal by Subject|6
2511310|NCT01825837|8689049|P3|PART I|Withdrawal by Subject|0
2511311|NCT01825837|8689050|P2|PART I|Withdrawal by Subject|0
2511312|NCT01825837|8689051|P1|PART I|Withdrawal by Subject|0
2511313|NCT01825798|8689061|P2|Overall Study|Lost to Follow-up|0
2511314|NCT01825798|8689062|P1|Overall Study|Lost to Follow-up|1
2511315|NCT01825798|8689061|P2|Overall Study|Adverse Event|5
2511316|NCT01825798|8689062|P1|Overall Study|Adverse Event|1
2511317|NCT01825785|8689097|P7|Overall Study|Withdrawal by Subject|0
2511318|NCT01825785|8689098|P6|Overall Study|Withdrawal by Subject|1
2511319|NCT01825785|8689099|P5|Overall Study|Withdrawal by Subject|1
2511320|NCT01825785|8689100|P4|Overall Study|Withdrawal by Subject|0
2511321|NCT01825785|8689101|P3|Overall Study|Withdrawal by Subject|0
2511322|NCT01825785|8689102|P2|Overall Study|Withdrawal by Subject|0
2511323|NCT01825785|8689103|P1|Overall Study|Withdrawal by Subject|0
2511324|NCT01825785|8689097|P7|Overall Study|Adverse Event|0
2511325|NCT01825785|8689098|P6|Overall Study|Adverse Event|0
2511326|NCT01825785|8689099|P5|Overall Study|Adverse Event|1
2511327|NCT01825785|8689100|P4|Overall Study|Adverse Event|0
2511328|NCT01825785|8689101|P3|Overall Study|Adverse Event|0
2511329|NCT01825785|8689102|P2|Overall Study|Adverse Event|0
2511330|NCT01825785|8689103|P1|Overall Study|Adverse Event|0
2511331|NCT01825577|8689256|P1|Overall Study|Lack of Efficacy|3
2511332|NCT01825577|8689256|P1|Overall Study|Withdrawn by family members|2
2511333|NCT01825577|8689256|P1|Overall Study|Withdrawal by Subject|1
2511334|NCT01825577|8689256|P1|Overall Study|Physician Decision|2
2511335|NCT01825200|8689280|P2|Overall Study|Withdrawal by Subject|1
2511336|NCT01825200|8689281|P1|Overall Study|Withdrawal by Subject|0
2511337|NCT01825200|8689280|P2|Overall Study|Lost to Follow-up|6
2511338|NCT01825200|8689281|P1|Overall Study|Lost to Follow-up|5
2511339|NCT01824979|8689304|P2|Overall Study|Protocol Violation|13
2511340|NCT01824979|8689305|P1|Overall Study|Protocol Violation|6
2511341|NCT01824979|8689304|P2|Overall Study|Physician Decision|0
2511342|NCT01824979|8689305|P1|Overall Study|Physician Decision|2
2511343|NCT01824979|8689304|P2|Overall Study|Withdrawal by Subject|0
2511344|NCT01824979|8689305|P1|Overall Study|Withdrawal by Subject|5
2511345|NCT01824823|8689322|P2|Overall Study|Off-treatment reason not submitted|0
2511346|NCT01824823|8689323|P1|Overall Study|Off-treatment reason not submitted|1
2511347|NCT01824823|8689322|P2|Overall Study|Lack of Efficacy|1
2511348|NCT01824823|8689323|P1|Overall Study|Lack of Efficacy|1
2511349|NCT01824693|8689332|P3|Overall Study|No Transplant Planned|10
2511350|NCT01824693|8689333|P2|Overall Study|No Transplant Planned|0
2511351|NCT01824693|8689334|P1|Overall Study|No Transplant Planned|0
2511352|NCT01824693|8689332|P3|Overall Study|Ineligible|3
2511353|NCT01824693|8689333|P2|Overall Study|Ineligible|0
2511354|NCT01824693|8689334|P1|Overall Study|Ineligible|0
2511355|NCT01824693|8689332|P3|Overall Study|Progressive Disease|0
2511356|NCT01824693|8689333|P2|Overall Study|Progressive Disease|5
2511357|NCT01824693|8689334|P1|Overall Study|Progressive Disease|0
2511358|NCT01824693|8689332|P3|Overall Study|Withdrawal by Subject|1
2511359|NCT01824693|8689333|P2|Overall Study|Withdrawal by Subject|0
2511360|NCT01824693|8689334|P1|Overall Study|Withdrawal by Subject|0
2511361|NCT01824693|8689332|P3|Overall Study|Physician Decision|1
2511362|NCT01824693|8689333|P2|Overall Study|Physician Decision|1
2511363|NCT01824693|8689334|P1|Overall Study|Physician Decision|1
2511364|NCT01824693|8689332|P3|Overall Study|Death|0
2511365|NCT01824693|8689333|P2|Overall Study|Death|1
2511366|NCT01824693|8689334|P1|Overall Study|Death|0
2511367|NCT01824602|8689351|P4|Overall Study|Treatment failure|1
2511368|NCT01824602|8689352|P3|Overall Study|Treatment failure|0
2511369|NCT01824602|8689353|P2|Overall Study|Treatment failure|0
2511370|NCT01824602|8689354|P1|Overall Study|Treatment failure|0
2511371|NCT01824602|8689351|P4|Overall Study|Adverse Event|2
2511372|NCT01824602|8689352|P3|Overall Study|Adverse Event|2
2511373|NCT01824602|8689353|P2|Overall Study|Adverse Event|0
2511374|NCT01824602|8689354|P1|Overall Study|Adverse Event|1
2511375|NCT01824602|8689351|P4|Overall Study|Patient non-compliance|0
2511376|NCT01824602|8689352|P3|Overall Study|Patient non-compliance|1
2511377|NCT01824602|8689353|P2|Overall Study|Patient non-compliance|0
2511378|NCT01824602|8689354|P1|Overall Study|Patient non-compliance|0
2511379|NCT01824602|8689351|P4|Overall Study|Withdrawal by Subject|2
2511380|NCT01824602|8689352|P3|Overall Study|Withdrawal by Subject|1
2511381|NCT01824602|8689353|P2|Overall Study|Withdrawal by Subject|0
2511382|NCT01824602|8689354|P1|Overall Study|Withdrawal by Subject|0
2511383|NCT01824576|8689393|P1|Overall Study|Device deficiency|2
2511384|NCT01824498|8689411|P6|Washout (8 Weeks)|Withdrawal by Subject|0
2511385|NCT01824498|8689412|P5|Washout (8 Weeks)|Withdrawal by Subject|1
2511386|NCT01824498|8689413|P4|Washout (8 Weeks)|Withdrawal by Subject|1
2511387|NCT01824498|8689414|P3|Washout (8 Weeks)|Withdrawal by Subject|2
2511388|NCT01824498|8689415|P2|Washout (8 Weeks)|Withdrawal by Subject|0
2511389|NCT01824498|8689416|P1|Washout (8 Weeks)|Withdrawal by Subject|2
2511390|NCT01824394|8689450|P3|Overall Study|Excluded Subjects(No catheter inserted)|21
2511391|NCT01824394|8689451|P2|Overall Study|Excluded Subjects(No catheter inserted)|20
2511392|NCT01824394|8689452|P1|Overall Study|Excluded Subjects(No catheter inserted)|23
2511393|NCT01824394|8689450|P3|Overall Study|Discontinued Subjects|2
2511394|NCT01824394|8689451|P2|Overall Study|Discontinued Subjects|1
2511395|NCT01824394|8689452|P1|Overall Study|Discontinued Subjects|1
2511396|NCT01824394|8689450|P3|Overall Study|Death|4
2511397|NCT01824394|8689451|P2|Overall Study|Death|2
2511398|NCT01824394|8689452|P1|Overall Study|Death|3
2511399|NCT01824394|8689450|P3|Overall Study|Lost to Follow-up|3
2511400|NCT01824394|8689451|P2|Overall Study|Lost to Follow-up|9
2511401|NCT01824394|8689452|P1|Overall Study|Lost to Follow-up|0
2511402|NCT01824394|8689450|P3|Overall Study|Withdrawn due to Study Termination|41
2511403|NCT01824394|8689451|P2|Overall Study|Withdrawn due to Study Termination|83
2511404|NCT01824394|8689452|P1|Overall Study|Withdrawn due to Study Termination|91
2511405|NCT01824394|8689450|P3|Overall Study|Early Termination|3
2511406|NCT01824394|8689451|P2|Overall Study|Early Termination|1
2511407|NCT01824394|8689452|P1|Overall Study|Early Termination|1
2511408|NCT01824355|8689462|P1|Overall Study|unevaluable reference method results per|1
2511409|NCT01824355|8689462|P1|Overall Study|Adverse Event|2
2511410|NCT01824342|8689473|P2|Overall Study|Death|0
2511411|NCT01824342|8689474|P1|Overall Study|Death|2
2511412|NCT01824342|8689473|P2|Overall Study|Physician Decision|0
2511413|NCT01824342|8689474|P1|Overall Study|Physician Decision|5
2511414|NCT01824342|8689473|P2|Overall Study|Disease Progression|1
2511415|NCT01824342|8689474|P1|Overall Study|Disease Progression|1
2511416|NCT01824342|8689473|P2|Overall Study|Adverse Event|1
2511417|NCT01824342|8689474|P1|Overall Study|Adverse Event|1
2511418|NCT01824342|8689473|P2|Overall Study|Withdrawal by Subject|3
2511419|NCT01824342|8689474|P1|Overall Study|Withdrawal by Subject|0
2511420|NCT01824303|8689488|P2|Randomized Study|Other Miscellaneous Reasons|0
2511421|NCT01824303|8689489|P1|Randomized Study|Other Miscellaneous Reasons|1
2511422|NCT01824303|8689488|P2|Randomized Study|Withdrawal by Subject|1
2511423|NCT01824303|8689489|P1|Randomized Study|Withdrawal by Subject|1
2511424|NCT01824290|8689515|P2|Overall Study|Investigator Reported Clinical Worsening|1
2511425|NCT01824290|8689516|P1|Overall Study|Investigator Reported Clinical Worsening|1
2511426|NCT01824290|8689515|P2|Overall Study|Parent/Caregiver Decision|1
2511427|NCT01824290|8689516|P1|Overall Study|Parent/Caregiver Decision|1
2511428|NCT01824290|8689515|P2|Overall Study|Entry Criteria Not Met|0
2511429|NCT01824290|8689516|P1|Overall Study|Entry Criteria Not Met|1
2511430|NCT01823991|8689534|P2|Overall Study|Withdrawal by Subject|5
2511431|NCT01823991|8689535|P1|Overall Study|Withdrawal by Subject|8
2511432|NCT01823679|8689576|P1|Overall Study|Death|1
2511433|NCT01823536|8689629|P6|Overall Study|Subject moved out of the state|0
2511434|NCT01823536|8689630|P5|Overall Study|Subject moved out of the state|1
2511435|NCT01823536|8689631|P4|Overall Study|Subject moved out of the state|0
2511436|NCT01823536|8689632|P3|Overall Study|Subject moved out of the state|0
2511437|NCT01823536|8689633|P2|Overall Study|Subject moved out of the state|0
2511438|NCT01823536|8689634|P1|Overall Study|Subject moved out of the state|0
2511439|NCT01823536|8689629|P6|Overall Study|Met exclusion criterion No 6|0
2511440|NCT01823536|8689630|P5|Overall Study|Met exclusion criterion No 6|0
2511441|NCT01823536|8689631|P4|Overall Study|Met exclusion criterion No 6|1
2511442|NCT01823536|8689632|P3|Overall Study|Met exclusion criterion No 6|0
2511443|NCT01823536|8689633|P2|Overall Study|Met exclusion criterion No 6|0
2511444|NCT01823536|8689634|P1|Overall Study|Met exclusion criterion No 6|0
2511445|NCT01823536|8689629|P6|Overall Study|Visit 1 delayed, unable to reschedule|0
2511446|NCT01823536|8689630|P5|Overall Study|Visit 1 delayed, unable to reschedule|0
2511447|NCT01823536|8689631|P4|Overall Study|Visit 1 delayed, unable to reschedule|0
2511448|NCT01823536|8689632|P3|Overall Study|Visit 1 delayed, unable to reschedule|1
2511449|NCT01823536|8689633|P2|Overall Study|Visit 1 delayed, unable to reschedule|0
2511450|NCT01823536|8689634|P1|Overall Study|Visit 1 delayed, unable to reschedule|0
2511451|NCT01823536|8689629|P6|Overall Study|Withdrawal by Subject|0
2511452|NCT01823536|8689630|P5|Overall Study|Withdrawal by Subject|0
2511453|NCT01823536|8689631|P4|Overall Study|Withdrawal by Subject|0
2511454|NCT01823536|8689632|P3|Overall Study|Withdrawal by Subject|0
2511455|NCT01823536|8689633|P2|Overall Study|Withdrawal by Subject|1
2511456|NCT01823536|8689634|P1|Overall Study|Withdrawal by Subject|1
2511457|NCT01823536|8689629|P6|Overall Study|Protocol Violation|0
2511458|NCT01823536|8689630|P5|Overall Study|Protocol Violation|0
2511459|NCT01823536|8689631|P4|Overall Study|Protocol Violation|0
2511460|NCT01823536|8689632|P3|Overall Study|Protocol Violation|0
2511461|NCT01823536|8689633|P2|Overall Study|Protocol Violation|1
2511462|NCT01823536|8689634|P1|Overall Study|Protocol Violation|0
2511463|NCT01823536|8689629|P6|Overall Study|Lost to Follow-up|0
2511464|NCT01823536|8689630|P5|Overall Study|Lost to Follow-up|1
2511465|NCT01823536|8689631|P4|Overall Study|Lost to Follow-up|1
2511466|NCT01823536|8689632|P3|Overall Study|Lost to Follow-up|0
2511467|NCT01823536|8689633|P2|Overall Study|Lost to Follow-up|0
2511468|NCT01823536|8689634|P1|Overall Study|Lost to Follow-up|1
2511469|NCT01823341|8689685|P1|Overall Study|Adverse Event|1
2511470|NCT01823341|8689685|P1|Overall Study|Withdrawal by Subject|7
2511471|NCT01823341|8689685|P1|Overall Study|Failed run-in|7
2511472|NCT01823328|8689730|P2|Overall Study|Withdrawal by Subject|6
2511473|NCT01823328|8689731|P1|Overall Study|Withdrawal by Subject|8
2511474|NCT01823289|8689751|P1|Overall Study|Creatinine clearance<30milliliter/minute|1
2511475|NCT01823289|8689751|P1|Overall Study|Drug affected efficacy and safety|1
2511476|NCT01823289|8689751|P1|Overall Study|Transaminase increased more than 3 times|1
2511477|NCT01823289|8689751|P1|Overall Study|Administered contraindicated medicine|1
2511478|NCT01823289|8689751|P1|Overall Study|Physician Decision|9
2511479|NCT01823289|8689751|P1|Overall Study|Lack of Efficacy|1
2511480|NCT01823289|8689751|P1|Overall Study|Adverse Event|5
2511481|NCT01823289|8689751|P1|Overall Study|Lost to Follow-up|5
2511482|NCT01823224|8689759|P2|Overall Study|Withdrawal by Subject|1
2511483|NCT01823224|8689760|P1|Overall Study|Withdrawal by Subject|0
2511484|NCT01823224|8689759|P2|Overall Study|missed med dose|1
2511485|NCT01823224|8689760|P1|Overall Study|missed med dose|0
2511486|NCT01823224|8689759|P2|Overall Study|pharmacy error|1
2511487|NCT01823224|8689760|P1|Overall Study|pharmacy error|0
2511488|NCT01823224|8689759|P2|Overall Study|didn't qualify|2
2511489|NCT01823224|8689760|P1|Overall Study|didn't qualify|1
2511490|NCT01823224|8689759|P2|Overall Study|Lost to Follow-up|6
2511491|NCT01823224|8689760|P1|Overall Study|Lost to Follow-up|5
2511492|NCT01823146|8689770|P2|Overall Study|Lost to Follow-up|1
2511493|NCT01823146|8689771|P1|Overall Study|Lost to Follow-up|2
2511494|NCT01823146|8689770|P2|Overall Study|Withdrawal by Subject|1
2511495|NCT01823146|8689771|P1|Overall Study|Withdrawal by Subject|0
2511496|NCT01823107|8689781|P1|Overall Study|Withdrawal by Subject|1
2511497|NCT01822925|8689791|P4|Overall Study|Taking prohibited medication|1
2511498|NCT01822925|8689792|P3|Overall Study|Taking prohibited medication|0
2511499|NCT01822925|8689793|P2|Overall Study|Taking prohibited medication|0
2511500|NCT01822925|8689794|P1|Overall Study|Taking prohibited medication|2
2511501|NCT01822925|8689791|P4|Overall Study|Withdrawal by Subject|2
2511502|NCT01822925|8689792|P3|Overall Study|Withdrawal by Subject|2
2511503|NCT01822925|8689793|P2|Overall Study|Withdrawal by Subject|0
2511504|NCT01822925|8689794|P1|Overall Study|Withdrawal by Subject|2
2511505|NCT01822925|8689791|P4|Overall Study|Protocol Violation|1
2511506|NCT01822925|8689792|P3|Overall Study|Protocol Violation|0
2511507|NCT01822925|8689793|P2|Overall Study|Protocol Violation|0
2511508|NCT01822925|8689794|P1|Overall Study|Protocol Violation|1
2511509|NCT01822925|8689791|P4|Overall Study|Lost to Follow-up|0
2511510|NCT01822925|8689792|P3|Overall Study|Lost to Follow-up|0
2511511|NCT01822925|8689793|P2|Overall Study|Lost to Follow-up|1
2511512|NCT01822925|8689794|P1|Overall Study|Lost to Follow-up|0
2511513|NCT01822925|8689791|P4|Overall Study|Adverse Event|1
2511514|NCT01822925|8689792|P3|Overall Study|Adverse Event|1
2511515|NCT01822925|8689793|P2|Overall Study|Adverse Event|1
2511516|NCT01822925|8689794|P1|Overall Study|Adverse Event|1
2511517|NCT01822899|8689846|P2|Overall Study|Withdrawal by Subject|7
2511518|NCT01822899|8689847|P1|Overall Study|Withdrawal by Subject|5
2511519|NCT01822899|8689846|P2|Overall Study|Lost to Follow-up|0
2511520|NCT01822899|8689847|P1|Overall Study|Lost to Follow-up|1
2511521|NCT01822899|8689846|P2|Overall Study|Protocol Violation|3
2511522|NCT01822899|8689847|P1|Overall Study|Protocol Violation|6
2511523|NCT01822899|8689846|P2|Overall Study|Lack of Efficacy|3
2511524|NCT01822899|8689847|P1|Overall Study|Lack of Efficacy|6
2511525|NCT01822899|8689846|P2|Overall Study|Adverse Event|5
2511526|NCT01822899|8689847|P1|Overall Study|Adverse Event|6
2511527|NCT01822821|8689865|P2|Overall Study|Other reasons|0
2511528|NCT01822821|8689866|P1|Overall Study|Other reasons|1
2511529|NCT01822821|8689865|P2|Overall Study|Eligible surgery cancelled|1
2511530|NCT01822821|8689866|P1|Overall Study|Eligible surgery cancelled|1
2511531|NCT01822756|8689895|P5|Overall Study|disease progression & patient preference|0
2511532|NCT01822756|8689896|P4|Overall Study|disease progression & patient preference|0
2511533|NCT01822756|8689897|P3|Overall Study|disease progression & patient preference|1
2511534|NCT01822756|8689898|P2|Overall Study|disease progression & patient preference|0
2511535|NCT01822756|8689899|P1|Overall Study|disease progression & patient preference|2
2511536|NCT01822756|8689895|P5|Overall Study|Physician Decision|0
2511537|NCT01822756|8689896|P4|Overall Study|Physician Decision|0
2511538|NCT01822756|8689897|P3|Overall Study|Physician Decision|0
2511539|NCT01822756|8689898|P2|Overall Study|Physician Decision|1
2511540|NCT01822756|8689899|P1|Overall Study|Physician Decision|0
2511541|NCT01822756|8689895|P5|Overall Study|Lost to Follow-up|1
2511542|NCT01822756|8689896|P4|Overall Study|Lost to Follow-up|0
2511543|NCT01822756|8689897|P3|Overall Study|Lost to Follow-up|1
2511544|NCT01822756|8689898|P2|Overall Study|Lost to Follow-up|0
2511545|NCT01822756|8689899|P1|Overall Study|Lost to Follow-up|1
2511546|NCT01822756|8689895|P5|Overall Study|Death|0
2511547|NCT01822756|8689896|P4|Overall Study|Death|0
2511548|NCT01822756|8689897|P3|Overall Study|Death|1
2511549|NCT01822756|8689898|P2|Overall Study|Death|2
2511550|NCT01822756|8689899|P1|Overall Study|Death|2
2511551|NCT01822756|8689895|P5|Overall Study|Disease progression|6
2511552|NCT01822756|8689896|P4|Overall Study|Disease progression|2
2511553|NCT01822756|8689897|P3|Overall Study|Disease progression|7
2511554|NCT01822756|8689898|P2|Overall Study|Disease progression|1
2511555|NCT01822756|8689899|P1|Overall Study|Disease progression|11
2511556|NCT01822756|8689895|P5|Overall Study|Adverse Event|0
2511557|NCT01822756|8689896|P4|Overall Study|Adverse Event|2
2511558|NCT01822756|8689897|P3|Overall Study|Adverse Event|0
2511559|NCT01822756|8689898|P2|Overall Study|Adverse Event|0
2511560|NCT01822756|8689899|P1|Overall Study|Adverse Event|0
2511561|NCT01822691|8689941|P1|Overall Study|Withdrawal by Subject|2
2511562|NCT01822678|8689952|P3|Overall Study|Lost to Follow-up|1
2511563|NCT01822678|8689953|P2|Overall Study|Lost to Follow-up|2
2511564|NCT01822678|8689954|P1|Overall Study|Lost to Follow-up|0
2511565|NCT01822678|8689952|P3|Overall Study|Lack of Efficacy|5
2511566|NCT01822678|8689953|P2|Overall Study|Lack of Efficacy|6
2511567|NCT01822678|8689954|P1|Overall Study|Lack of Efficacy|3
2511568|NCT01822678|8689952|P3|Overall Study|Adverse Event|1
2511569|NCT01822678|8689953|P2|Overall Study|Adverse Event|3
2511570|NCT01822678|8689954|P1|Overall Study|Adverse Event|4
2511571|NCT01822678|8689952|P3|Overall Study|Withdrawal by Subject|4
2511572|NCT01822678|8689953|P2|Overall Study|Withdrawal by Subject|4
2511573|NCT01822678|8689954|P1|Overall Study|Withdrawal by Subject|5
2511574|NCT01822665|8689962|P1|Overall Study|Other Reason|5
2511575|NCT01822665|8689962|P1|Overall Study|Adverse Event|3
2511576|NCT01822587|8689989|P3|Overall Study|Physician Decision|6
2511577|NCT01822587|8689990|P2|Overall Study|Physician Decision|6
2511578|NCT01822587|8689991|P1|Overall Study|Physician Decision|9
2511579|NCT01822587|8689989|P3|Overall Study|Lost to Follow-up|12
2511580|NCT01822587|8689990|P2|Overall Study|Lost to Follow-up|9
2511581|NCT01822587|8689991|P1|Overall Study|Lost to Follow-up|7
2511582|NCT01822561|8690030|P1|Overall Study|Withdrawal by Subject|2
2511583|NCT01822535|8690051|P2|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0
2511584|NCT01822535|8690052|P1|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1
2511585|NCT01822535|8690051|P2|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2
2511586|NCT01822535|8690052|P1|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4
2511587|NCT01822535|8690051|P2|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0
2511588|NCT01822535|8690052|P1|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2
2511589|NCT01822496|8690068|P4|Overall Study|Withdrawal by Subject|3
2511590|NCT01822496|8690069|P3|Overall Study|Withdrawal by Subject|0
2511591|NCT01822496|8690070|P2|Overall Study|Withdrawal by Subject|0
2511592|NCT01822496|8690071|P1|Overall Study|Withdrawal by Subject|0
2511593|NCT01822496|8690068|P4|Overall Study|Protocol Violation|1
2511594|NCT01822496|8690069|P3|Overall Study|Protocol Violation|0
2511595|NCT01822496|8690070|P2|Overall Study|Protocol Violation|2
2511596|NCT01822496|8690071|P1|Overall Study|Protocol Violation|2
2511597|NCT01822366|8690124|P4|Overall Study|Partial Intervention Completion|15
2511598|NCT01822366|8690125|P3|Overall Study|Partial Intervention Completion|0
2511599|NCT01822366|8690126|P2|Overall Study|Partial Intervention Completion|15
2511600|NCT01822366|8690127|P1|Overall Study|Partial Intervention Completion|0
2511601|NCT01822366|8690124|P4|Overall Study|Withdrawal by Subject|6
2511602|NCT01822366|8690125|P3|Overall Study|Withdrawal by Subject|0
2511603|NCT01822366|8690126|P2|Overall Study|Withdrawal by Subject|6
2511604|NCT01822366|8690127|P1|Overall Study|Withdrawal by Subject|0
2511605|NCT01822366|8690124|P4|Overall Study|Lost to Follow-up|1
2511606|NCT01822366|8690125|P3|Overall Study|Lost to Follow-up|5
2511607|NCT01822366|8690126|P2|Overall Study|Lost to Follow-up|1
2511608|NCT01822366|8690127|P1|Overall Study|Lost to Follow-up|5
2511609|NCT01822353|8690158|P3|Overall Study|Withdrawal by Subject|0
2511610|NCT01822353|8690159|P2|Overall Study|Withdrawal by Subject|1
2511611|NCT01822353|8690160|P1|Overall Study|Withdrawal by Subject|3
2511612|NCT01822353|8690158|P3|Overall Study|Pregnancy|0
2511613|NCT01822353|8690159|P2|Overall Study|Pregnancy|1
2511614|NCT01822353|8690160|P1|Overall Study|Pregnancy|0
2511615|NCT01822353|8690158|P3|Overall Study|Adverse Event|1
2511616|NCT01822353|8690159|P2|Overall Study|Adverse Event|3
2511617|NCT01822353|8690160|P1|Overall Study|Adverse Event|1
2511618|NCT01822223|8690180|P2|Overall Study|Death|1
2511619|NCT01822223|8690181|P1|Overall Study|Death|0
2511620|NCT01822132|8690205|P2|Overall Study|Lost to Follow-up|2
2511621|NCT01822132|8690206|P1|Overall Study|Lost to Follow-up|4
2511622|NCT01821963|8690243|P1|Overall Study|Adverse Event|1
2511623|NCT01821937|8690249|P2|Overall Study|Adverse Event|3
2511624|NCT01821937|8690250|P1|Overall Study|Adverse Event|0
2511625|NCT01821807|8690274|P2|Overall Study|Lost to Follow-up|1
2511626|NCT01821807|8690275|P1|Overall Study|Lost to Follow-up|3
2511627|NCT01821729|8690283|P1|Overall Study|Withdrawal by Subject|1
2511628|NCT01821625|8690288|P1|Overall Study|Medical contraindication|1
2511629|NCT01821625|8690288|P1|Overall Study|Adverse Event|1
2511630|NCT01821625|8690288|P1|Overall Study|Lack of Efficacy|2
2511631|NCT01821625|8690288|P1|Overall Study|Withdrawal by Subject|2
2511632|NCT01821560|8690294|P2|Overall Study|Protocol Violation|1
2511633|NCT01821560|8690295|P1|Overall Study|Protocol Violation|0
2511634|NCT01821560|8690294|P2|Overall Study|Withdrawal by Subject|1
2511635|NCT01821560|8690295|P1|Overall Study|Withdrawal by Subject|1
2511636|NCT01821560|8690294|P2|Overall Study|Lost to Follow-up|5
2511637|NCT01821560|8690295|P1|Overall Study|Lost to Follow-up|5
2511638|NCT01821118|8690416|P2|Overall Study|Death|1
2511639|NCT01821118|8690417|P1|Overall Study|Death|0
2511640|NCT01820637|8690464|P1|Overall Study|Withdrawal by Subject|1
2511641|NCT01820637|8690464|P1|Overall Study|Death|2
2511642|NCT01820585|8690473|P4|Overall Study|Pregnancy|0
2511643|NCT01820585|8690474|P3|Overall Study|Pregnancy|0
2511644|NCT01820585|8690475|P2|Overall Study|Pregnancy|1
2511645|NCT01820585|8690476|P1|Overall Study|Pregnancy|0
2511646|NCT01820585|8690473|P4|Overall Study|at sponsor request|0
2511647|NCT01820585|8690474|P3|Overall Study|at sponsor request|1
2511648|NCT01820585|8690475|P2|Overall Study|at sponsor request|0
2511649|NCT01820585|8690476|P1|Overall Study|at sponsor request|0
2511650|NCT01820585|8690473|P4|Overall Study|Subject non-compliance|2
2511651|NCT01820585|8690474|P3|Overall Study|Subject non-compliance|1
2511652|NCT01820585|8690475|P2|Overall Study|Subject non-compliance|0
2511653|NCT01820585|8690476|P1|Overall Study|Subject non-compliance|0
2511654|NCT01820585|8690473|P4|Overall Study|Protocol Violation|1
2511655|NCT01820585|8690474|P3|Overall Study|Protocol Violation|1
2511656|NCT01820585|8690475|P2|Overall Study|Protocol Violation|1
2511657|NCT01820585|8690476|P1|Overall Study|Protocol Violation|3
2511658|NCT01820585|8690473|P4|Overall Study|Lost to Follow-up|3
2511659|NCT01820585|8690474|P3|Overall Study|Lost to Follow-up|0
2511660|NCT01820585|8690475|P2|Overall Study|Lost to Follow-up|3
2511661|NCT01820585|8690476|P1|Overall Study|Lost to Follow-up|3
2511662|NCT01820585|8690473|P4|Overall Study|Withdrawal by Subject|8
2511663|NCT01820585|8690474|P3|Overall Study|Withdrawal by Subject|3
2511664|NCT01820585|8690475|P2|Overall Study|Withdrawal by Subject|7
2511665|NCT01820585|8690476|P1|Overall Study|Withdrawal by Subject|3
2511666|NCT01820585|8690473|P4|Overall Study|Lack of Efficacy|1
2511667|NCT01820585|8690474|P3|Overall Study|Lack of Efficacy|5
2511668|NCT01820585|8690475|P2|Overall Study|Lack of Efficacy|7
2511669|NCT01820585|8690476|P1|Overall Study|Lack of Efficacy|9
2511670|NCT01820585|8690473|P4|Overall Study|Adverse Event|34
2511671|NCT01820585|8690474|P3|Overall Study|Adverse Event|23
2511672|NCT01820585|8690475|P2|Overall Study|Adverse Event|13
2511673|NCT01820585|8690476|P1|Overall Study|Adverse Event|9
2511674|NCT01820559|8690489|P3|Overall Study|Lack of Efficacy|3
2511675|NCT01820559|8690490|P2|Overall Study|Lack of Efficacy|2
2511676|NCT01820559|8690491|P1|Overall Study|Lack of Efficacy|3
2511677|NCT01820559|8690489|P3|Overall Study|At sponsor request|1
2511678|NCT01820559|8690490|P2|Overall Study|At sponsor request|0
2511679|NCT01820559|8690491|P1|Overall Study|At sponsor request|0
2511680|NCT01820559|8690489|P3|Overall Study|Lost to Follow-up|2
2511681|NCT01820559|8690490|P2|Overall Study|Lost to Follow-up|2
2511682|NCT01820559|8690491|P1|Overall Study|Lost to Follow-up|3
2511683|NCT01820559|8690489|P3|Overall Study|Subject's non-compliance|2
2511684|NCT01820559|8690490|P2|Overall Study|Subject's non-compliance|0
2511685|NCT01820559|8690491|P1|Overall Study|Subject's non-compliance|1
2511686|NCT01820559|8690489|P3|Overall Study|Protocol Violation|3
2511687|NCT01820559|8690490|P2|Overall Study|Protocol Violation|1
2511688|NCT01820559|8690491|P1|Overall Study|Protocol Violation|2
2511689|NCT01820559|8690489|P3|Overall Study|Withdrawal by Subject|5
2511690|NCT01820559|8690490|P2|Overall Study|Withdrawal by Subject|2
2511691|NCT01820559|8690491|P1|Overall Study|Withdrawal by Subject|1
2511692|NCT01820559|8690489|P3|Overall Study|Adverse Event|13
2511693|NCT01820559|8690490|P2|Overall Study|Adverse Event|6
2511694|NCT01820559|8690491|P1|Overall Study|Adverse Event|4
2511695|NCT01820364|8690512|P2|Part II: LGX818 + MEK162|Study Termination|1
2511696|NCT01820364|8690513|P1|Part II: LGX818 + MEK162|Study Termination|0
2511697|NCT01820364|8690512|P2|Part I: LGX818|Disease Progression|0
2511698|NCT01820364|8690513|P1|Part I: LGX818|Disease Progression|4
2511699|NCT01820364|8690512|P2|Part I: LGX818|Adverse Event|0
2511700|NCT01820364|8690513|P1|Part I: LGX818|Adverse Event|6
2511701|NCT01820364|8690512|P2|Part I: LGX818|Administrative Problems|0
2511702|NCT01820364|8690513|P1|Part I: LGX818|Administrative Problems|3
2511703|NCT01820364|8690512|P2|Part I: LGX818|Death|0
2511704|NCT01820364|8690513|P1|Part I: LGX818|Death|1
2511705|NCT01819727|8690657|P2|Overall Study|Quit due to lack of health benifits|1
2511706|NCT01819727|8690658|P1|Overall Study|Quit due to lack of health benifits|0
2511707|NCT01819727|8690657|P2|Overall Study|Unable to demostrate ability self-inject|1
2511708|NCT01819727|8690658|P1|Overall Study|Unable to demostrate ability self-inject|0
2511709|NCT01819727|8690657|P2|Overall Study|Withdrawal by Subject|11
2511710|NCT01819727|8690658|P1|Overall Study|Withdrawal by Subject|6
2511711|NCT01819727|8690657|P2|Overall Study|Study Terminated by Sponsor|1
2511712|NCT01819727|8690658|P1|Overall Study|Study Terminated by Sponsor|0
2511713|NCT01819727|8690657|P2|Overall Study|Protocol Violation|2
2511714|NCT01819727|8690658|P1|Overall Study|Protocol Violation|0
2511715|NCT01819727|8690657|P2|Overall Study|Pregnancy|0
2511716|NCT01819727|8690658|P1|Overall Study|Pregnancy|1
2511717|NCT01819727|8690657|P2|Overall Study|Physician Decision|2
2511718|NCT01819727|8690658|P1|Overall Study|Physician Decision|3
2511719|NCT01819727|8690657|P2|Overall Study|Lost to Follow-up|1
2511720|NCT01819727|8690658|P1|Overall Study|Lost to Follow-up|1
2511721|NCT01819727|8690657|P2|Overall Study|Death|0
2511722|NCT01819727|8690658|P1|Overall Study|Death|1
2511723|NCT01819727|8690657|P2|Overall Study|Adverse Event|9
2511724|NCT01819727|8690658|P1|Overall Study|Adverse Event|8
2511725|NCT01819506|8690680|P2|Overall Study|Withdrawal by Subject|3
2511726|NCT01819506|8690681|P1|Overall Study|Withdrawal by Subject|3
2511727|NCT01819506|8690680|P2|Overall Study|Physician Decision|2
2511728|NCT01819506|8690681|P1|Overall Study|Physician Decision|5
2511729|NCT01819272|8690733|P6|Overall Study|Loss of Glucose Control|0
2511730|NCT01819272|8690734|P5|Overall Study|Loss of Glucose Control|2
2511731|NCT01819272|8690735|P4|Overall Study|Loss of Glucose Control|1
2511732|NCT01819272|8690736|P3|Overall Study|Loss of Glucose Control|0
2511733|NCT01819272|8690737|P2|Overall Study|Loss of Glucose Control|1
2511734|NCT01819272|8690738|P1|Overall Study|Loss of Glucose Control|2
2511735|NCT01819272|8690733|P6|Overall Study|Withdrawal of Consent|1
2511736|NCT01819272|8690734|P5|Overall Study|Withdrawal of Consent|0
2511737|NCT01819272|8690735|P4|Overall Study|Withdrawal of Consent|1
2511738|NCT01819272|8690736|P3|Overall Study|Withdrawal of Consent|2
2511739|NCT01819272|8690737|P2|Overall Study|Withdrawal of Consent|1
2511740|NCT01819272|8690738|P1|Overall Study|Withdrawal of Consent|0
2511741|NCT01819272|8690733|P6|Overall Study|Physician Decision|0
2511742|NCT01819272|8690734|P5|Overall Study|Physician Decision|0
2511743|NCT01819272|8690735|P4|Overall Study|Physician Decision|0
2511744|NCT01819272|8690736|P3|Overall Study|Physician Decision|0
2511745|NCT01819272|8690737|P2|Overall Study|Physician Decision|1
2511746|NCT01819272|8690738|P1|Overall Study|Physician Decision|0
2511747|NCT01819272|8690733|P6|Overall Study|Protocol Violation|3
2511748|NCT01819272|8690734|P5|Overall Study|Protocol Violation|2
2511749|NCT01819272|8690735|P4|Overall Study|Protocol Violation|1
2511750|NCT01819272|8690736|P3|Overall Study|Protocol Violation|0
2511751|NCT01819272|8690737|P2|Overall Study|Protocol Violation|0
2511752|NCT01819272|8690738|P1|Overall Study|Protocol Violation|0
2511753|NCT01819272|8690733|P6|Overall Study|Lost to Follow-up|3
2511754|NCT01819272|8690734|P5|Overall Study|Lost to Follow-up|0
2511755|NCT01819272|8690735|P4|Overall Study|Lost to Follow-up|0
2511756|NCT01819272|8690736|P3|Overall Study|Lost to Follow-up|1
2511757|NCT01819272|8690737|P2|Overall Study|Lost to Follow-up|0
2511758|NCT01819272|8690738|P1|Overall Study|Lost to Follow-up|3
2511759|NCT01819272|8690733|P6|Overall Study|Adverse Event|0
2511760|NCT01819272|8690734|P5|Overall Study|Adverse Event|0
2511761|NCT01819272|8690735|P4|Overall Study|Adverse Event|2
2511762|NCT01819272|8690736|P3|Overall Study|Adverse Event|0
2511763|NCT01819272|8690737|P2|Overall Study|Adverse Event|0
2511764|NCT01819272|8690738|P1|Overall Study|Adverse Event|1
2511765|NCT01819194|8690776|P1|Overall Study|Loss of study articles|2
2511766|NCT01819129|8690783|P2|Overall Study|Withdrawal Criteria|15
2511767|NCT01819129|8690784|P1|Overall Study|Withdrawal Criteria|20
2511768|NCT01819129|8690783|P2|Overall Study|Death|1
2511769|NCT01819129|8690784|P1|Overall Study|Death|1
2511770|NCT01819129|8690783|P2|Overall Study|Adverse Event|4
2511771|NCT01819129|8690784|P1|Overall Study|Adverse Event|1
2511772|NCT01819129|8690783|P2|Overall Study|Lack of Efficacy|1
2511773|NCT01819129|8690784|P1|Overall Study|Lack of Efficacy|0
2511774|NCT01819129|8690783|P2|Overall Study|Lost to Follow-up|2
2511775|NCT01819129|8690784|P1|Overall Study|Lost to Follow-up|5
2511776|NCT01819129|8690783|P2|Overall Study|Withdrawal by Subject|15
2511777|NCT01819129|8690784|P1|Overall Study|Withdrawal by Subject|15
2511778|NCT01819129|8690783|P2|Overall Study|Other, Subject moved out of the country|1
2511779|NCT01819129|8690784|P1|Overall Study|Other, Subject moved out of the country|0
2511780|NCT01819129|8690783|P2|Overall Study|Other, weight gain, hypoglycaemic events|0
2511781|NCT01819129|8690784|P1|Overall Study|Other, weight gain, hypoglycaemic events|1
2511782|NCT01819129|8690783|P2|Overall Study|Other, Subject wanted HbA1c to be > 7%|0
2511783|NCT01819129|8690784|P1|Overall Study|Other, Subject wanted HbA1c to be > 7%|1
2511784|NCT01818765|8690796|P1|Overall Study|Death|2
2511785|NCT01818752|8690809|P2|Overall Study|Randomized but not Dosed|4
2511786|NCT01818752|8690810|P1|Overall Study|Randomized but not Dosed|7
2511787|NCT01818752|8690809|P2|Overall Study|Continuing Treatment|4
2511788|NCT01818752|8690810|P1|Overall Study|Continuing Treatment|1
2511789|NCT01818752|8690809|P2|Overall Study|Other|8
2511790|NCT01818752|8690810|P1|Overall Study|Other|7
2511791|NCT01818752|8690809|P2|Overall Study|Disease Progression|48
2511792|NCT01818752|8690810|P1|Overall Study|Disease Progression|54
2511793|NCT01818752|8690809|P2|Overall Study|Physician Decision|8
2511794|NCT01818752|8690810|P1|Overall Study|Physician Decision|9
2511795|NCT01818752|8690809|P2|Overall Study|Withdrawal by Subject|14
2511796|NCT01818752|8690810|P1|Overall Study|Withdrawal by Subject|15
2511797|NCT01818752|8690809|P2|Overall Study|Non-compliance|20
2511798|NCT01818752|8690810|P1|Overall Study|Non-compliance|16
2511799|NCT01818752|8690809|P2|Overall Study|Death|18
2511800|NCT01818752|8690810|P1|Overall Study|Death|14
2511801|NCT01818752|8690809|P2|Overall Study|Adverse Event|74
2511802|NCT01818752|8690810|P1|Overall Study|Adverse Event|64
2511803|NCT01818726|8690830|P2|Overall Study|Decision to perform 2nd course of trtmnt|0
2511804|NCT01818726|8690831|P1|Overall Study|Decision to perform 2nd course of trtmnt|1
2511805|NCT01818726|8690830|P2|Overall Study|Withdrawal by Subject|1
2511806|NCT01818726|8690831|P1|Overall Study|Withdrawal by Subject|0
2511807|NCT01818726|8690830|P2|Overall Study|Administrative reasons|1
2511808|NCT01818726|8690831|P1|Overall Study|Administrative reasons|5
2511809|NCT01818700|8690841|P1|Overall Study|Other|1
2511810|NCT01818700|8690841|P1|Overall Study|Protocol Violation|2
2511811|NCT01818700|8690841|P1|Overall Study|Withdrawal by Subject|27
2511812|NCT01818700|8690841|P1|Overall Study|Lost to Follow-up|5
2511813|NCT01818700|8690841|P1|Overall Study|Lack of Efficacy|2
2511814|NCT01818700|8690841|P1|Overall Study|Adverse Event|67
2511815|NCT01818596|8690852|P2|Overall Study|Lost to Follow-up|0
2511816|NCT01818596|8690853|P1|Overall Study|Lost to Follow-up|7
2511817|NCT01818596|8690852|P2|Overall Study|Withdrew Consent|0
2511818|NCT01818596|8690853|P1|Overall Study|Withdrew Consent|5
2511819|NCT01818596|8690852|P2|Overall Study|Protocol Violation|0
2511820|NCT01818596|8690853|P1|Overall Study|Protocol Violation|1
2511821|NCT01818596|8690852|P2|Overall Study|Investigator's Discretion|0
2511822|NCT01818596|8690853|P1|Overall Study|Investigator's Discretion|4
2511823|NCT01818596|8690852|P2|Overall Study|Death|0
2511824|NCT01818596|8690853|P1|Overall Study|Death|3
2511825|NCT01818596|8690852|P2|Overall Study|Adverse Event|0
2511826|NCT01818596|8690853|P1|Overall Study|Adverse Event|7
2511827|NCT01818596|8690852|P2|Overall Study|Enrolled but Not Treated|0
2511828|NCT01818596|8690853|P1|Overall Study|Enrolled but Not Treated|4
2511829|NCT01818531|8690892|P2|Overall Study|Withdrawn for failure to place block|1
2511830|NCT01818531|8690893|P1|Overall Study|Withdrawn for failure to place block|0
2511831|NCT01818531|8690892|P2|Overall Study|Withdrawn for long-acting opioid patch|1
2511832|NCT01818531|8690893|P1|Overall Study|Withdrawn for long-acting opioid patch|0
2511833|NCT01818531|8690892|P2|Overall Study|Withdrawn for case delay after block|0
2511834|NCT01818531|8690893|P1|Overall Study|Withdrawn for case delay after block|1
2511835|NCT01818336|8690966|P2|Overall Study|Lost to Follow-up|1
2511836|NCT01818336|8690967|P1|Overall Study|Lost to Follow-up|0
2511837|NCT01818336|8690966|P2|Overall Study|Declined retest visit|11
2511838|NCT01818336|8690967|P1|Overall Study|Declined retest visit|0
2511839|NCT01818297|8690975|P2|Open Label Phase (3-12 Months)|Early study closure|10
2511840|NCT01818297|8690976|P1|Open Label Phase (3-12 Months)|Early study closure|17
2511841|NCT01818297|8690975|P2|Open Label Phase (3-12 Months)|Physician Decision|0
2511842|NCT01818297|8690976|P1|Open Label Phase (3-12 Months)|Physician Decision|1
2511843|NCT01818297|8690975|P2|Blinded Phase (Randomization - 3 Months)|Adverse Event|1
2511844|NCT01818297|8690976|P1|Blinded Phase (Randomization - 3 Months)|Adverse Event|0
2511845|NCT01818284|8690994|P2|Overall Study|Death|2
2511846|NCT01818284|8690995|P1|Overall Study|Death|0
2511847|NCT01818284|8690994|P2|Overall Study|Not eligible due to White Blood Counts|4
2511848|NCT01818284|8690995|P1|Overall Study|Not eligible due to White Blood Counts|4
2511849|NCT01818141|8691028|P2|Overall Study|Lost to Follow-up|2
2511850|NCT01818141|8691029|P1|Overall Study|Lost to Follow-up|0
2511851|NCT01818141|8691028|P2|Overall Study|No baseline C.diff colonies|1
2511852|NCT01818141|8691029|P1|Overall Study|No baseline C.diff colonies|1
2511853|NCT01818141|8691028|P2|Overall Study|Withdrawal by Subject|0
2511854|NCT01818141|8691029|P1|Overall Study|Withdrawal by Subject|2
2511855|NCT01817959|8691052|P2|Overall Study|Patient didn't proceed to 1st Islet Inf|1
2511856|NCT01817959|8691053|P1|Overall Study|Patient didn't proceed to 1st Islet Inf|1
2511857|NCT01817959|8691052|P2|Overall Study|Adverse Event|0
2511858|NCT01817959|8691053|P1|Overall Study|Adverse Event|1
2511859|NCT01817959|8691052|P2|Overall Study|forbidden medication|1
2511860|NCT01817959|8691053|P1|Overall Study|forbidden medication|1
2511861|NCT01817959|8691052|P2|Overall Study|Graft loss|1
2511862|NCT01817959|8691053|P1|Overall Study|Graft loss|1
2511863|NCT01817790|8691145|P2|Overall Study|Other: Could not attend appointment|1
2511864|NCT01817790|8691146|P1|Overall Study|Other: Could not attend appointment|1
2511865|NCT01817790|8691145|P2|Overall Study|Withdrawal by Subject|3
2511866|NCT01817790|8691146|P1|Overall Study|Withdrawal by Subject|1
2511867|NCT01817790|8691145|P2|Overall Study|Protocol Violation|1
2511868|NCT01817790|8691146|P1|Overall Study|Protocol Violation|2
2511869|NCT01817790|8691145|P2|Overall Study|Lost to Follow-up|1
2511870|NCT01817790|8691146|P1|Overall Study|Lost to Follow-up|0
2511871|NCT01817790|8691145|P2|Overall Study|Adverse Event|2
2511872|NCT01817790|8691146|P1|Overall Study|Adverse Event|0
2511873|NCT01817777|8691190|P3|Interventional Phase (20 Weeks)|Early Study Termination|3
2511874|NCT01817777|8691191|P2|Interventional Phase (20 Weeks)|Early Study Termination|1
2511875|NCT01817777|8691192|P1|Interventional Phase (20 Weeks)|Early Study Termination|0
2511876|NCT01817777|8691190|P3|Interventional Phase (20 Weeks)|Lost to Follow-up|2
2511877|NCT01817777|8691191|P2|Interventional Phase (20 Weeks)|Lost to Follow-up|1
2511878|NCT01817777|8691192|P1|Interventional Phase (20 Weeks)|Lost to Follow-up|0
2511879|NCT01817777|8691190|P3|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
2511880|NCT01817777|8691191|P2|Interventional Phase (20 Weeks)|Withdrawal by Subject|3
2511881|NCT01817777|8691192|P1|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
2511882|NCT01817777|8691190|P3|Observational Phase (8 Weeks)|Early Study Termination|0
2511883|NCT01817777|8691191|P2|Observational Phase (8 Weeks)|Early Study Termination|0
2511884|NCT01817777|8691192|P1|Observational Phase (8 Weeks)|Early Study Termination|2
2511885|NCT01817777|8691190|P3|Observational Phase (8 Weeks)|Lost to Follow-up|0
2511886|NCT01817777|8691191|P2|Observational Phase (8 Weeks)|Lost to Follow-up|0
2511887|NCT01817777|8691192|P1|Observational Phase (8 Weeks)|Lost to Follow-up|3
2511888|NCT01817764|8691216|P2|Overall Study|Withdrawal by Subject|12
2511889|NCT01817764|8691217|P1|Overall Study|Withdrawal by Subject|10
2511890|NCT01817764|8691216|P2|Overall Study|Lost to Follow-up|4
2511891|NCT01817764|8691217|P1|Overall Study|Lost to Follow-up|1
2511892|NCT01817764|8691216|P2|Overall Study|Protocol Violation|5
2511893|NCT01817764|8691217|P1|Overall Study|Protocol Violation|7
2511894|NCT01817764|8691216|P2|Overall Study|Lack of Efficacy|7
2511895|NCT01817764|8691217|P1|Overall Study|Lack of Efficacy|9
2511896|NCT01817764|8691216|P2|Overall Study|Adverse Event|10
2511897|NCT01817764|8691217|P1|Overall Study|Adverse Event|7
2511898|NCT01817725|8691225|P1|Overall Study|Withdrawal by Subject|1
2511899|NCT01817582|8691246|P3|Overall Study|Randomized but exclusion criteria met|0
2511900|NCT01817582|8691247|P2|Overall Study|Randomized but exclusion criteria met|0
2511901|NCT01817582|8691248|P1|Overall Study|Randomized but exclusion criteria met|1
2511902|NCT01817582|8691246|P3|Overall Study|Participant revealed masked treatment|0
2511903|NCT01817582|8691247|P2|Overall Study|Participant revealed masked treatment|0
2511904|NCT01817582|8691248|P1|Overall Study|Participant revealed masked treatment|1
2511905|NCT01817582|8691246|P3|Overall Study|Withdrawal by Subject|0
2511906|NCT01817582|8691247|P2|Overall Study|Withdrawal by Subject|1
2511907|NCT01817582|8691248|P1|Overall Study|Withdrawal by Subject|0
2511908|NCT01817075|8691373|P2|Overall Study|Ineligible|2
2511909|NCT01817075|8691374|P1|Overall Study|Ineligible|0
2511910|NCT01817075|8691373|P2|Overall Study|Received Sorafenib after enrollment|1
2511911|NCT01817075|8691374|P1|Overall Study|Received Sorafenib after enrollment|0
2511912|NCT01817075|8691373|P2|Overall Study|Withdrawal by Subject|15
2511913|NCT01817075|8691374|P1|Overall Study|Withdrawal by Subject|31
2511914|NCT01817075|8691373|P2|Overall Study|Physician Decision|12
2511915|NCT01817075|8691374|P1|Overall Study|Physician Decision|9
2511916|NCT01817075|8691373|P2|Overall Study|Adverse Event|5
2511917|NCT01817075|8691374|P1|Overall Study|Adverse Event|7
2511918|NCT01816906|8691388|P2|12 Months|Lost to Follow-up|1
2511919|NCT01816906|8691389|P1|12 Months|Lost to Follow-up|2
2511920|NCT01816906|8691388|P2|12 Months|Death|2
2511921|NCT01816906|8691389|P1|12 Months|Death|0
2511922|NCT01816906|8691388|P2|12 Months|Adverse Event|2
2511923|NCT01816906|8691389|P1|12 Months|Adverse Event|2
2511924|NCT01816906|8691388|P2|Six Months|Lost to Follow-up|16
2511925|NCT01816906|8691389|P1|Six Months|Lost to Follow-up|14
2511926|NCT01816906|8691388|P2|Six Months|Did Not Show Up for Baseline Measurement|6
2511927|NCT01816906|8691389|P1|Six Months|Did Not Show Up for Baseline Measurement|7
2511928|NCT01816893|8691407|P2|Washout Period|Withdrawal by Subject|0
2511929|NCT01816893|8691408|P1|Washout Period|Withdrawal by Subject|2
2511930|NCT01816763|8691444|P3|Overall Study|The main reason for an incomplete survey|11
2512019|NCT01815840|8691669|P1|Overall Study|Refused Treatment|5
2511931|NCT01816763|8691445|P2|Overall Study|The main reason for an incomplete survey|15
2511932|NCT01816763|8691446|P1|Overall Study|The main reason for an incomplete survey|4
2511933|NCT01816685|8691462|P2|Overall Study|Surgery Cancelled|2
2511934|NCT01816685|8691463|P1|Overall Study|Surgery Cancelled|3
2511935|NCT01816685|8691462|P2|Overall Study|Lost to Follow-up|9
2511936|NCT01816685|8691463|P1|Overall Study|Lost to Follow-up|7
2511937|NCT01816594|8691473|P2|Overall Study|Physician Decision|0
2511938|NCT01816594|8691474|P1|Overall Study|Physician Decision|1
2511939|NCT01816594|8691473|P2|Overall Study|Withdrawal by Subject|0
2511940|NCT01816594|8691474|P1|Overall Study|Withdrawal by Subject|1
2511941|NCT01816594|8691473|P2|Overall Study|Adverse Event|0
2511942|NCT01816594|8691474|P1|Overall Study|Adverse Event|9
2511943|NCT01816594|8691473|P2|Overall Study|Local Progress|2
2511944|NCT01816594|8691474|P1|Overall Study|Local Progress|0
2511945|NCT01816477|8691512|P2|Overall Study|Unable to tolerate catheter placement|0
2511946|NCT01816477|8691513|P1|Overall Study|Unable to tolerate catheter placement|3
2511947|NCT01816477|8691512|P2|Overall Study|Withdrawal by Subject|1
2511948|NCT01816477|8691513|P1|Overall Study|Withdrawal by Subject|13
2511949|NCT01816295|8691567|P2|OLE Phase|Lack of Efficacy|7
2511950|NCT01816295|8691568|P1|OLE Phase|Lack of Efficacy|3
2511951|NCT01816295|8691567|P2|OLE Phase|Withdrawal by Subject|10
2511952|NCT01816295|8691568|P1|OLE Phase|Withdrawal by Subject|10
2511953|NCT01816295|8691567|P2|OLE Phase|Sponsor Decision|9
2511954|NCT01816295|8691568|P1|OLE Phase|Sponsor Decision|7
2511955|NCT01816295|8691567|P2|OLE Phase|Protocol Violation|4
2511956|NCT01816295|8691568|P1|OLE Phase|Protocol Violation|4
2511957|NCT01816295|8691567|P2|OLE Phase|Physician Decision|1
2511958|NCT01816295|8691568|P1|OLE Phase|Physician Decision|3
2511959|NCT01816295|8691567|P2|OLE Phase|Lost to Follow-up|5
2511960|NCT01816295|8691568|P1|OLE Phase|Lost to Follow-up|5
2511961|NCT01816295|8691567|P2|OLE Phase|Entry Criteria Not Met|5
2511962|NCT01816295|8691568|P1|OLE Phase|Entry Criteria Not Met|3
2511963|NCT01816295|8691567|P2|OLE Phase|Death|0
2511964|NCT01816295|8691568|P1|OLE Phase|Death|1
2511965|NCT01816295|8691567|P2|OLE Phase|Adverse Event|15
2511966|NCT01816295|8691568|P1|OLE Phase|Adverse Event|17
2511967|NCT01816295|8691567|P2|Double Blind Phase|Withdrawal by Subject|20
2511968|NCT01816295|8691568|P1|Double Blind Phase|Withdrawal by Subject|22
2511969|NCT01816295|8691567|P2|Double Blind Phase|Sponsor Decision|8
2511970|NCT01816295|8691568|P1|Double Blind Phase|Sponsor Decision|8
2511971|NCT01816295|8691567|P2|Double Blind Phase|Protocol Violation|11
2511972|NCT01816295|8691568|P1|Double Blind Phase|Protocol Violation|17
2511973|NCT01816295|8691567|P2|Double Blind Phase|Physician Decision|2
2511974|NCT01816295|8691568|P1|Double Blind Phase|Physician Decision|2
2511975|NCT01816295|8691567|P2|Double Blind Phase|Lost to Follow-up|5
2511976|NCT01816295|8691568|P1|Double Blind Phase|Lost to Follow-up|3
2511977|NCT01816295|8691567|P2|Double Blind Phase|Entry Criteria Not Met|2
2511978|NCT01816295|8691568|P1|Double Blind Phase|Entry Criteria Not Met|0
2511979|NCT01816295|8691567|P2|Double Blind Phase|Adverse Event|8
2511980|NCT01816295|8691568|P1|Double Blind Phase|Adverse Event|11
2511981|NCT01816243|8691583|P1|Overall Study|Amputation|3
2511982|NCT01816243|8691583|P1|Overall Study|Not eligible for the study|1
2511983|NCT01816243|8691583|P1|Overall Study|Lack of Efficacy|1
2511984|NCT01816243|8691583|P1|Overall Study|Lost to Follow-up|1
2511985|NCT01816243|8691583|P1|Overall Study|Adverse Event|6
2511986|NCT01816074|8691594|P4|Phase 2|Withdrawal by Subject|0
2511987|NCT01816074|8691595|P3|Phase 2|Withdrawal by Subject|0
2511988|NCT01816074|8691596|P2|Phase 2|Withdrawal by Subject|0
2511989|NCT01816074|8691597|P1|Phase 2|Withdrawal by Subject|1
2511990|NCT01816074|8691594|P4|Phase 2|Physician Decision|1
2511991|NCT01816074|8691595|P3|Phase 2|Physician Decision|0
2511992|NCT01816074|8691596|P2|Phase 2|Physician Decision|0
2511993|NCT01816074|8691597|P1|Phase 2|Physician Decision|0
2511994|NCT01816074|8691594|P4|Phase 2|Unsatisfied with Randomization assignmen|0
2511995|NCT01816074|8691595|P3|Phase 2|Unsatisfied with Randomization assignmen|0
2511996|NCT01816074|8691596|P2|Phase 2|Unsatisfied with Randomization assignmen|0
2511997|NCT01816074|8691597|P1|Phase 2|Unsatisfied with Randomization assignmen|1
2511998|NCT01816074|8691594|P4|Phase 2|Time commitment Issues|0
2511999|NCT01816074|8691595|P3|Phase 2|Time commitment Issues|0
2512000|NCT01816074|8691596|P2|Phase 2|Time commitment Issues|2
2512001|NCT01816074|8691597|P1|Phase 2|Time commitment Issues|0
2512002|NCT01816074|8691594|P4|Phase 1|Time commitment issues|0
2512003|NCT01816074|8691595|P3|Phase 1|Time commitment issues|1
2512004|NCT01816074|8691596|P2|Phase 1|Time commitment issues|0
2512005|NCT01816074|8691597|P1|Phase 1|Time commitment issues|0
2512006|NCT01816061|8691627|P2|Overall Study|Lost to Follow-up|24
2512007|NCT01816061|8691628|P1|Overall Study|Lost to Follow-up|13
2512008|NCT01816048|8691636|P1|Overall Study|Disease Progression|3
2512009|NCT01816048|8691636|P1|Overall Study|Withdrawal by Subject|1
2512010|NCT01816048|8691636|P1|Overall Study|Death|1
2512011|NCT01816048|8691636|P1|Overall Study|Adverse Event|1
2512012|NCT01815918|8691651|P2|Overall Study|Lack of Efficacy|15
2512013|NCT01815918|8691652|P1|Overall Study|Lack of Efficacy|15
2512014|NCT01815918|8691651|P2|Overall Study|Patient samples not analyzable|4
2512015|NCT01815918|8691652|P1|Overall Study|Patient samples not analyzable|3
2512016|NCT01815840|8691668|P2|Overall Study|Sponsor Termination Treatment|0
2512017|NCT01815840|8691669|P1|Overall Study|Sponsor Termination Treatment|1
2512018|NCT01815840|8691668|P2|Overall Study|Refused Treatment|1
2512020|NCT01815840|8691668|P2|Overall Study|Lost to Follow-up|6
2512021|NCT01815840|8691669|P1|Overall Study|Lost to Follow-up|3
2512022|NCT01815840|8691668|P2|Overall Study|Investigators Decision|3
2512023|NCT01815840|8691669|P1|Overall Study|Investigators Decision|2
2512024|NCT01815840|8691668|P2|Overall Study|Disease progression|2
2512025|NCT01815840|8691669|P1|Overall Study|Disease progression|3
2512026|NCT01815840|8691668|P2|Overall Study|Death|2
2512027|NCT01815840|8691669|P1|Overall Study|Death|2
2512028|NCT01815840|8691668|P2|Overall Study|Adverse Event|16
2512029|NCT01815840|8691669|P1|Overall Study|Adverse Event|10
2512030|NCT01815840|8691668|P2|Overall Study|Administrative/Other|3
2512031|NCT01815840|8691669|P1|Overall Study|Administrative/Other|1
2512032|NCT01815840|8691668|P2|Overall Study|Withdrew Consent|30
2512033|NCT01815840|8691669|P1|Overall Study|Withdrew Consent|31
2512034|NCT01815840|8691668|P2|Overall Study|Missing|0
2512035|NCT01815840|8691669|P1|Overall Study|Missing|1
2512036|NCT01815736|8691699|P2|Overall Study|Still on Study|449
2512037|NCT01815736|8691700|P1|Overall Study|Still on Study|929
2512038|NCT01815736|8691699|P2|Overall Study|Lost to Follow-up|7
2512039|NCT01815736|8691700|P1|Overall Study|Lost to Follow-up|6
2512040|NCT01815736|8691699|P2|Overall Study|Withdrew Consent|15
2512041|NCT01815736|8691700|P1|Overall Study|Withdrew Consent|7
2512042|NCT01815736|8691699|P2|Overall Study|Investigator's Discretion|0
2512043|NCT01815736|8691700|P1|Overall Study|Investigator's Discretion|4
2512044|NCT01815736|8691699|P2|Overall Study|Death|0
2512045|NCT01815736|8691700|P1|Overall Study|Death|4
2512046|NCT01815736|8691699|P2|Overall Study|Adverse Event|4
2512047|NCT01815736|8691700|P1|Overall Study|Adverse Event|7
2512048|NCT01815736|8691699|P2|Overall Study|Randomized but Not Treated|3
2512049|NCT01815736|8691700|P1|Overall Study|Randomized but Not Treated|4
2512050|NCT01815424|8691769|P5|Week 16 to 52|Withdrawal by Subject|0
2512051|NCT01815424|8691770|P4|Week 16 to 52|Withdrawal by Subject|0
2512052|NCT01815424|8691771|P3|Week 16 to 52|Withdrawal by Subject|0
2512053|NCT01815424|8691772|P2|Week 16 to 52|Withdrawal by Subject|2
2512054|NCT01815424|8691773|P1|Week 16 to 52|Withdrawal by Subject|1
2512055|NCT01815424|8691769|P5|Week 16 to 52|Lost to Follow-up|1
2512056|NCT01815424|8691770|P4|Week 16 to 52|Lost to Follow-up|2
2512057|NCT01815424|8691771|P3|Week 16 to 52|Lost to Follow-up|0
2512058|NCT01815424|8691772|P2|Week 16 to 52|Lost to Follow-up|2
2512059|NCT01815424|8691773|P1|Week 16 to 52|Lost to Follow-up|0
2512060|NCT01815424|8691769|P5|Week 16 to 52|Insufficient Clinical Response|1
2512061|NCT01815424|8691770|P4|Week 16 to 52|Insufficient Clinical Response|1
2512062|NCT01815424|8691771|P3|Week 16 to 52|Insufficient Clinical Response|0
2512063|NCT01815424|8691772|P2|Week 16 to 52|Insufficient Clinical Response|0
2512064|NCT01815424|8691773|P1|Week 16 to 52|Insufficient Clinical Response|1
2512065|NCT01815424|8691769|P5|Week 16 to 52|Adverse Event|1
2512066|NCT01815424|8691770|P4|Week 16 to 52|Adverse Event|0
2512067|NCT01815424|8691771|P3|Week 16 to 52|Adverse Event|0
2512068|NCT01815424|8691772|P2|Week 16 to 52|Adverse Event|0
2512069|NCT01815424|8691773|P1|Week 16 to 52|Adverse Event|0
2512070|NCT01815424|8691769|P5|Week 16 to 52|Other|0
2512071|NCT01815424|8691770|P4|Week 16 to 52|Other|0
2512072|NCT01815424|8691771|P3|Week 16 to 52|Other|0
2512073|NCT01815424|8691772|P2|Week 16 to 52|Other|1
2512074|NCT01815424|8691773|P1|Week 16 to 52|Other|0
2512075|NCT01815424|8691769|P5|Week 0 to 16|Insufficient Clinical Response|0
2512076|NCT01815424|8691770|P4|Week 0 to 16|Insufficient Clinical Response|0
2512077|NCT01815424|8691771|P3|Week 0 to 16|Insufficient Clinical Response|4
2512078|NCT01815424|8691772|P2|Week 0 to 16|Insufficient Clinical Response|0
2512079|NCT01815424|8691773|P1|Week 0 to 16|Insufficient Clinical Response|2
2512080|NCT01815424|8691769|P5|Week 0 to 16|Protocol Violation|0
2512081|NCT01815424|8691770|P4|Week 0 to 16|Protocol Violation|0
2512082|NCT01815424|8691771|P3|Week 0 to 16|Protocol Violation|0
2512083|NCT01815424|8691772|P2|Week 0 to 16|Protocol Violation|0
2512084|NCT01815424|8691773|P1|Week 0 to 16|Protocol Violation|1
2512085|NCT01815424|8691769|P5|Week 0 to 16|Other|0
2512086|NCT01815424|8691770|P4|Week 0 to 16|Other|0
2512087|NCT01815424|8691771|P3|Week 0 to 16|Other|3
2512088|NCT01815424|8691772|P2|Week 0 to 16|Other|0
2512089|NCT01815424|8691773|P1|Week 0 to 16|Other|1
2512090|NCT01815424|8691769|P5|Week 0 to 16|Withdrawal by Subject|0
2512091|NCT01815424|8691770|P4|Week 0 to 16|Withdrawal by Subject|0
2512092|NCT01815424|8691771|P3|Week 0 to 16|Withdrawal by Subject|1
2512093|NCT01815424|8691772|P2|Week 0 to 16|Withdrawal by Subject|0
2512094|NCT01815424|8691773|P1|Week 0 to 16|Withdrawal by Subject|0
2512095|NCT01815424|8691769|P5|Week 0 to 16|Lost to Follow-up|0
2512096|NCT01815424|8691770|P4|Week 0 to 16|Lost to Follow-up|0
2512097|NCT01815424|8691771|P3|Week 0 to 16|Lost to Follow-up|0
2512098|NCT01815424|8691772|P2|Week 0 to 16|Lost to Follow-up|1
2512099|NCT01815424|8691773|P1|Week 0 to 16|Lost to Follow-up|0
2512100|NCT01815424|8691769|P5|Week 0 to 16|Does Not Meet Entrance Criteria|0
2512101|NCT01815424|8691770|P4|Week 0 to 16|Does Not Meet Entrance Criteria|0
2512102|NCT01815424|8691771|P3|Week 0 to 16|Does Not Meet Entrance Criteria|0
2512103|NCT01815424|8691772|P2|Week 0 to 16|Does Not Meet Entrance Criteria|0
2512104|NCT01815424|8691773|P1|Week 0 to 16|Does Not Meet Entrance Criteria|2
2512105|NCT01815424|8691769|P5|Week 0 to 16|Adverse Event|0
2512106|NCT01815424|8691770|P4|Week 0 to 16|Adverse Event|0
2512107|NCT01815424|8691771|P3|Week 0 to 16|Adverse Event|3
2512108|NCT01815424|8691772|P2|Week 0 to 16|Adverse Event|3
2512109|NCT01815424|8691773|P1|Week 0 to 16|Adverse Event|1
2512110|NCT01815138|8691985|P2|Overall Study|Physician Decision|5
2512111|NCT01815138|8691986|P1|Overall Study|Physician Decision|8
2512112|NCT01815138|8691985|P2|Overall Study|Withdrawal by Subject|1
2512113|NCT01815138|8691986|P1|Overall Study|Withdrawal by Subject|0
2512114|NCT01815099|8691998|P1|Overall Study|unable to attend study visits|1
2512115|NCT01815099|8691998|P1|Overall Study|Lack of Efficacy|1
2512116|NCT01814878|8692012|P2|Overall Study|Other|0
2512117|NCT01814878|8692013|P1|Overall Study|Other|2
2512118|NCT01814878|8692012|P2|Overall Study|Screening failure (drop-out)|3
2512119|NCT01814878|8692013|P1|Overall Study|Screening failure (drop-out)|0
2512120|NCT01814878|8692012|P2|Overall Study|Physician Decision|1
2512121|NCT01814878|8692013|P1|Overall Study|Physician Decision|3
2512122|NCT01814878|8692012|P2|Overall Study|Protocol Violation|5
2512123|NCT01814878|8692013|P1|Overall Study|Protocol Violation|5
2512124|NCT01814878|8692012|P2|Overall Study|Withdrawal by Subject|16
2512125|NCT01814878|8692013|P1|Overall Study|Withdrawal by Subject|20
2512126|NCT01814878|8692012|P2|Overall Study|Adverse Event|5
2512127|NCT01814878|8692013|P1|Overall Study|Adverse Event|16
2512128|NCT01814826|8692036|P3|Overall Study|Death|3
2512129|NCT01814826|8692037|P2|Overall Study|Death|24
2512130|NCT01814826|8692038|P1|Overall Study|Death|29
2512131|NCT01814826|8692036|P3|Overall Study|Other|0
2512132|NCT01814826|8692037|P2|Overall Study|Other|5
2512133|NCT01814826|8692038|P1|Overall Study|Other|3
2512134|NCT01814800|8692130|P1|Overall Study|Subject relocation|1
2512135|NCT01814800|8692130|P1|Overall Study|Sponsor decision|1
2512136|NCT01814800|8692130|P1|Overall Study|Pregnancy|1
2512137|NCT01814800|8692130|P1|Overall Study|Adverse Event|2
2512138|NCT01814761|8692190|P2|Overall Study|Lost to Follow-up|5
2512139|NCT01814761|8692191|P1|Overall Study|Lost to Follow-up|1
2512140|NCT01814761|8692190|P2|Overall Study|Ocular Adverse Event|15
2512141|NCT01814761|8692191|P1|Overall Study|Ocular Adverse Event|6
2512142|NCT01814761|8692190|P2|Overall Study|Other Reasons|10
2512143|NCT01814761|8692191|P1|Overall Study|Other Reasons|1
2512144|NCT01814748|8692205|P2|Overall Study|Withdrawal by Subject|4
2512145|NCT01814748|8692206|P1|Overall Study|Withdrawal by Subject|6
2512146|NCT01814748|8692205|P2|Overall Study|Study site terminated by sponsor|1
2512147|NCT01814748|8692206|P1|Overall Study|Study site terminated by sponsor|1
2512148|NCT01814748|8692205|P2|Overall Study|Lost to Follow-up|2
2512149|NCT01814748|8692206|P1|Overall Study|Lost to Follow-up|1
2512150|NCT01814696|8692250|P2|Overall Study|Randomized to wrong group|0
2512151|NCT01814696|8692251|P1|Overall Study|Randomized to wrong group|1
2512152|NCT01814696|8692250|P2|Overall Study|Withdrawal by Subject|0
2512153|NCT01814696|8692251|P1|Overall Study|Withdrawal by Subject|1
2512154|NCT01814670|8692269|P1|Overall Study|Protocol Violation|12
2512155|NCT01814553|8692279|P2|Overall Study|Other than stated|8
2512156|NCT01814553|8692280|P1|Overall Study|Other than stated|7
2512157|NCT01814553|8692279|P2|Overall Study|Withdrawal by Subject|1
2512158|NCT01814553|8692280|P1|Overall Study|Withdrawal by Subject|1
2512159|NCT01814553|8692279|P2|Overall Study|Other Adverse Event|5
2512160|NCT01814553|8692280|P1|Overall Study|Other Adverse Event|4
2512161|NCT01814553|8692279|P2|Overall Study|PD per clinical progression|8
2512162|NCT01814553|8692280|P1|Overall Study|PD per clinical progression|6
2512163|NCT01814397|8692294|P1|Overall Study|Withdrawal by Subject|7
2512164|NCT01814397|8692294|P1|Overall Study|Adverse Event|7
2512165|NCT01814371|8692303|P2|Overall Study|Lost to Follow-up|27
2512166|NCT01814371|8692304|P1|Overall Study|Lost to Follow-up|30
2512167|NCT01814332|8692339|P2|Overall Study|Lost to Follow-up|1
2512168|NCT01814332|8692340|P1|Overall Study|Lost to Follow-up|5
2512169|NCT01814332|8692339|P2|Overall Study|Protocol Violation|4
2512170|NCT01814332|8692340|P1|Overall Study|Protocol Violation|0
2512171|NCT01814332|8692339|P2|Overall Study|Withdrawal by Subject|8
2512172|NCT01814332|8692340|P1|Overall Study|Withdrawal by Subject|3
2512173|NCT01814332|8692339|P2|Overall Study|Adverse Event|3
2512174|NCT01814332|8692340|P1|Overall Study|Adverse Event|8
2512175|NCT01814137|8692362|P2|Overall Study|Unclassified|1
2512176|NCT01814137|8692363|P1|Overall Study|Unclassified|2
2512177|NCT01814137|8692362|P2|Overall Study|Physician Decision|1
2512178|NCT01814137|8692363|P1|Overall Study|Physician Decision|1
2512179|NCT01814137|8692362|P2|Overall Study|Withdrawal by Subject|2
2512180|NCT01814137|8692363|P1|Overall Study|Withdrawal by Subject|2
2512181|NCT01814137|8692362|P2|Overall Study|Adverse Event|1
2512182|NCT01814137|8692363|P1|Overall Study|Adverse Event|0
2512183|NCT01814046|8692379|P3|Drug Administration|Death due to complications of RSV|0
2512184|NCT01814046|8692380|P2|Drug Administration|Death due to complications of RSV|0
2512185|NCT01814046|8692381|P1|Drug Administration|Death due to complications of RSV|1
2512186|NCT01813890|8692395|P3|Overall Study|Lack of Efficacy|2
2512187|NCT01813890|8692396|P2|Overall Study|Lack of Efficacy|1
2512188|NCT01813890|8692397|P1|Overall Study|Lack of Efficacy|9
2512189|NCT01813890|8692395|P3|Overall Study|Adverse Event|4
2512190|NCT01813890|8692396|P2|Overall Study|Adverse Event|3
2512191|NCT01813890|8692397|P1|Overall Study|Adverse Event|0
2512192|NCT01813721|8692434|P1|Overall Study|Withdrawal by Subject|1
2512193|NCT01813721|8692434|P1|Overall Study|Ineligibility determined|63
2512194|NCT01813474|8692489|P3|Overall Study|Death|1
2512195|NCT01813474|8692490|P2|Overall Study|Death|0
2512196|NCT01813474|8692491|P1|Overall Study|Death|0
2512197|NCT01813474|8692489|P3|Overall Study|Lack of Efficacy|9
2512198|NCT01813474|8692490|P2|Overall Study|Lack of Efficacy|6
2512199|NCT01813474|8692491|P1|Overall Study|Lack of Efficacy|2
2512200|NCT01813474|8692489|P3|Overall Study|Adverse Event|0
2512201|NCT01813474|8692490|P2|Overall Study|Adverse Event|1
2512202|NCT01813474|8692491|P1|Overall Study|Adverse Event|1
2512203|NCT01813474|8692489|P3|Overall Study|Withdrawal by Subject|1
2512204|NCT01813474|8692490|P2|Overall Study|Withdrawal by Subject|0
2512205|NCT01813474|8692491|P1|Overall Study|Withdrawal by Subject|0
2512206|NCT01813435|8692515|P2|Overall Study|Lost to Follow-up|237
2512207|NCT01813435|8692516|P1|Overall Study|Lost to Follow-up|268
2512208|NCT01813435|8692515|P2|Overall Study|did not finish experimental regimen|770
2512209|NCT01813435|8692516|P1|Overall Study|did not finish experimental regimen|1902
2512210|NCT01813422|8692540|P2|Overall Study|Lost to Follow-up|4
2512211|NCT01813422|8692541|P1|Overall Study|Lost to Follow-up|2
2512212|NCT01813422|8692540|P2|Overall Study|Sponsor Decision|1
2512213|NCT01813422|8692541|P1|Overall Study|Sponsor Decision|2
2512214|NCT01813422|8692540|P2|Overall Study|Death|3
2512215|NCT01813422|8692541|P1|Overall Study|Death|2
2512216|NCT01813422|8692540|P2|Overall Study|Withdrawal by Subject|8
2512217|NCT01813422|8692541|P1|Overall Study|Withdrawal by Subject|14
2512218|NCT01813071|8692586|P9|Overall Study|Met inc/exc criteria|1
2512219|NCT01813071|8692587|P8|Overall Study|Met inc/exc criteria|1
2512220|NCT01813071|8692588|P7|Overall Study|Met inc/exc criteria|0
2512221|NCT01813071|8692589|P6|Overall Study|Met inc/exc criteria|1
2512222|NCT01813071|8692590|P5|Overall Study|Met inc/exc criteria|0
2512223|NCT01813071|8692591|P4|Overall Study|Met inc/exc criteria|0
2512224|NCT01813071|8692592|P3|Overall Study|Met inc/exc criteria|0
2512225|NCT01813071|8692593|P2|Overall Study|Met inc/exc criteria|0
2512226|NCT01813071|8692594|P1|Overall Study|Met inc/exc criteria|0
2512227|NCT01813071|8692586|P9|Overall Study|Physician Decision|0
2512228|NCT01813071|8692587|P8|Overall Study|Physician Decision|0
2512229|NCT01813071|8692588|P7|Overall Study|Physician Decision|1
2512230|NCT01813071|8692589|P6|Overall Study|Physician Decision|0
2512231|NCT01813071|8692590|P5|Overall Study|Physician Decision|0
2512232|NCT01813071|8692591|P4|Overall Study|Physician Decision|0
2512233|NCT01813071|8692592|P3|Overall Study|Physician Decision|0
2512234|NCT01813071|8692593|P2|Overall Study|Physician Decision|0
2512235|NCT01813071|8692594|P1|Overall Study|Physician Decision|0
2512236|NCT01813071|8692586|P9|Overall Study|Adverse Event|0
2512237|NCT01813071|8692587|P8|Overall Study|Adverse Event|0
2512238|NCT01813071|8692588|P7|Overall Study|Adverse Event|0
2512239|NCT01813071|8692589|P6|Overall Study|Adverse Event|1
2512240|NCT01813071|8692590|P5|Overall Study|Adverse Event|0
2512241|NCT01813071|8692591|P4|Overall Study|Adverse Event|0
2512242|NCT01813071|8692592|P3|Overall Study|Adverse Event|0
2512243|NCT01813071|8692593|P2|Overall Study|Adverse Event|0
2512244|NCT01813071|8692594|P1|Overall Study|Adverse Event|0
2512245|NCT01813071|8692586|P9|Overall Study|Withdrawal by Subject|0
2512246|NCT01813071|8692587|P8|Overall Study|Withdrawal by Subject|0
2512247|NCT01813071|8692588|P7|Overall Study|Withdrawal by Subject|0
2512248|NCT01813071|8692589|P6|Overall Study|Withdrawal by Subject|1
2512249|NCT01813071|8692590|P5|Overall Study|Withdrawal by Subject|0
2512250|NCT01813071|8692591|P4|Overall Study|Withdrawal by Subject|0
2512251|NCT01813071|8692592|P3|Overall Study|Withdrawal by Subject|0
2512252|NCT01813071|8692593|P2|Overall Study|Withdrawal by Subject|0
2512253|NCT01813071|8692594|P1|Overall Study|Withdrawal by Subject|0
2512254|NCT01813071|8692586|P9|Overall Study|Protocol Violation|2
2512255|NCT01813071|8692587|P8|Overall Study|Protocol Violation|4
2512256|NCT01813071|8692588|P7|Overall Study|Protocol Violation|2
2512257|NCT01813071|8692589|P6|Overall Study|Protocol Violation|4
2512258|NCT01813071|8692590|P5|Overall Study|Protocol Violation|1
2512259|NCT01813071|8692591|P4|Overall Study|Protocol Violation|0
2512260|NCT01813071|8692592|P3|Overall Study|Protocol Violation|0
2512261|NCT01813071|8692593|P2|Overall Study|Protocol Violation|0
2512262|NCT01813071|8692594|P1|Overall Study|Protocol Violation|0
2512263|NCT01813058|8693061|P2|Overall Study|Withdrawal by Subject|4
2512264|NCT01813058|8693062|P1|Overall Study|Withdrawal by Subject|5
2512265|NCT01813019|8693070|P2|Overall Study|Protocol Deviation|1
2512266|NCT01813019|8693071|P1|Overall Study|Protocol Deviation|2
2512267|NCT01813019|8693070|P2|Overall Study|administrative problems|0
2512268|NCT01813019|8693071|P1|Overall Study|administrative problems|2
2512269|NCT01813019|8693070|P2|Overall Study|Withdrawal by Subject|2
2512270|NCT01813019|8693071|P1|Overall Study|Withdrawal by Subject|3
2512271|NCT01813019|8693070|P2|Overall Study|Adverse Event|3
2512272|NCT01813019|8693071|P1|Overall Study|Adverse Event|0
2512273|NCT01812837|8693082|P3|Overall Study|Protocol Violation|0
2512274|NCT01812837|8693083|P2|Overall Study|Protocol Violation|0
2512275|NCT01812837|8693084|P1|Overall Study|Protocol Violation|1
2512276|NCT01812837|8693082|P3|Overall Study|Lost to Follow-up|0
2512277|NCT01812837|8693083|P2|Overall Study|Lost to Follow-up|1
2512278|NCT01812837|8693084|P1|Overall Study|Lost to Follow-up|1
2512279|NCT01812707|8693096|P4|Overall Study|Consent withdrawn by participant|0
2512280|NCT01812707|8693097|P3|Overall Study|Consent withdrawn by participant|0
2512281|NCT01812707|8693098|P2|Overall Study|Consent withdrawn by participant|0
2512282|NCT01812707|8693099|P1|Overall Study|Consent withdrawn by participant|1
2512283|NCT01812707|8693096|P4|Overall Study|Poor compliance to protocol|0
2512284|NCT01812707|8693097|P3|Overall Study|Poor compliance to protocol|0
2512285|NCT01812707|8693098|P2|Overall Study|Poor compliance to protocol|0
2512286|NCT01812707|8693099|P1|Overall Study|Poor compliance to protocol|1
2512287|NCT01812707|8693096|P4|Overall Study|Adverse Event|2
2512288|NCT01812707|8693097|P3|Overall Study|Adverse Event|0
2512289|NCT01812707|8693098|P2|Overall Study|Adverse Event|0
2512290|NCT01812707|8693099|P1|Overall Study|Adverse Event|0
2512291|NCT01812655|8693147|P3|Overall Study|Protocol Violation|0
2512292|NCT01812655|8693148|P2|Overall Study|Protocol Violation|1
2512293|NCT01812655|8693149|P1|Overall Study|Protocol Violation|1
2512294|NCT01812057|8693174|P2|Overall Study|Physician Decision|0
2512295|NCT01812057|8693175|P1|Overall Study|Physician Decision|1
2512296|NCT01812057|8693174|P2|Overall Study|Protocol Violation|0
2512297|NCT01812057|8693175|P1|Overall Study|Protocol Violation|1
2512298|NCT01811953|8693278|P6|Overall Study|Protocol Violation|0
2512299|NCT01811953|8693279|P5|Overall Study|Protocol Violation|1
2512300|NCT01811953|8693280|P4|Overall Study|Protocol Violation|0
2512301|NCT01811953|8693281|P3|Overall Study|Protocol Violation|0
2512302|NCT01811953|8693282|P2|Overall Study|Protocol Violation|0
2512303|NCT01811953|8693283|P1|Overall Study|Protocol Violation|0
2512304|NCT01811953|8693278|P6|Overall Study|Adverse Event|1
2512305|NCT01811953|8693279|P5|Overall Study|Adverse Event|0
2512306|NCT01811953|8693280|P4|Overall Study|Adverse Event|1
2512307|NCT01811953|8693281|P3|Overall Study|Adverse Event|0
2512308|NCT01811953|8693282|P2|Overall Study|Adverse Event|0
2512309|NCT01811953|8693283|P1|Overall Study|Adverse Event|0
2512310|NCT01811732|8693340|P2|Overall Study|Correct study drug not available on site|0
2512311|NCT01811732|8693341|P1|Overall Study|Correct study drug not available on site|1
2512312|NCT01811732|8693340|P2|Overall Study|Admitted to another facility|0
2512313|NCT01811732|8693341|P1|Overall Study|Admitted to another facility|1
2512314|NCT01811732|8693340|P2|Overall Study|Subject incarcerated|2
2512315|NCT01811732|8693341|P1|Overall Study|Subject incarcerated|1
2512316|NCT01811732|8693340|P2|Overall Study|Protocol Violation|1
2512317|NCT01811732|8693341|P1|Overall Study|Protocol Violation|0
2512318|NCT01811732|8693340|P2|Overall Study|Insufficient venous access|1
2512319|NCT01811732|8693341|P1|Overall Study|Insufficient venous access|0
2512320|NCT01811732|8693340|P2|Overall Study|Death|1
2512321|NCT01811732|8693341|P1|Overall Study|Death|1
2512322|NCT01811732|8693340|P2|Overall Study|Physician Decision|0
2512323|NCT01811732|8693341|P1|Overall Study|Physician Decision|2
2512324|NCT01811732|8693340|P2|Overall Study|Non-compliance with study drug/procedure|3
2512325|NCT01811732|8693341|P1|Overall Study|Non-compliance with study drug/procedure|3
2512326|NCT01811732|8693340|P2|Overall Study|Lack of Efficacy|1
2512327|NCT01811732|8693341|P1|Overall Study|Lack of Efficacy|3
2512328|NCT01811732|8693340|P2|Overall Study|Adverse Event|9
2512329|NCT01811732|8693341|P1|Overall Study|Adverse Event|3
2512330|NCT01811732|8693340|P2|Overall Study|Withdrawal by Subject|10
2512331|NCT01811732|8693341|P1|Overall Study|Withdrawal by Subject|16
2512332|NCT01811732|8693340|P2|Overall Study|Lost to Follow-up|30
2512333|NCT01811732|8693341|P1|Overall Study|Lost to Follow-up|24
2512334|NCT01811706|8693351|P2|First Intervention ( 4 Weeks)|Adverse Event|0
2512335|NCT01811706|8693352|P1|First Intervention ( 4 Weeks)|Adverse Event|1
2512336|NCT01811563|8693380|P2|Overall Study|Incorrect Randomization procedure|1
2512337|NCT01811563|8693381|P1|Overall Study|Incorrect Randomization procedure|0
2512338|NCT01811563|8693380|P2|Overall Study|Lost to Follow-up|2
2512339|NCT01811563|8693381|P1|Overall Study|Lost to Follow-up|5
2512340|NCT01811485|8693410|P3|Overall Study|Protocol Deviation|0
2512341|NCT01811485|8693411|P2|Overall Study|Protocol Deviation|1
2512342|NCT01811485|8693412|P1|Overall Study|Protocol Deviation|0
2512343|NCT01811485|8693410|P3|Overall Study|Administrative problems|0
2512344|NCT01811485|8693411|P2|Overall Study|Administrative problems|0
2512345|NCT01811485|8693412|P1|Overall Study|Administrative problems|1
2512346|NCT01811485|8693410|P3|Overall Study|Unsatisfactory therapeutic effect|3
2512347|NCT01811485|8693411|P2|Overall Study|Unsatisfactory therapeutic effect|0
2512348|NCT01811485|8693412|P1|Overall Study|Unsatisfactory therapeutic effect|0
2512349|NCT01811485|8693410|P3|Overall Study|Adverse Event|2
2512350|NCT01811485|8693411|P2|Overall Study|Adverse Event|3
2512351|NCT01811485|8693412|P1|Overall Study|Adverse Event|1
2512352|NCT01811472|8693432|P3|Overall Study|Subject/guardian decision|0
2512353|NCT01811472|8693433|P2|Overall Study|Subject/guardian decision|0
2512354|NCT01811472|8693434|P1|Overall Study|Subject/guardian decision|1
2512355|NCT01811472|8693432|P3|Overall Study|Lost to Follow-up|1
2512356|NCT01811472|8693433|P2|Overall Study|Lost to Follow-up|0
2512357|NCT01811472|8693434|P1|Overall Study|Lost to Follow-up|0
2512358|NCT01811472|8693432|P3|Overall Study|Adverse Event|4
2512359|NCT01811472|8693433|P2|Overall Study|Adverse Event|0
2512360|NCT01811472|8693434|P1|Overall Study|Adverse Event|1
2512361|NCT01811238|8693521|P1|Overall Study|subject refused study medication|6
2512362|NCT01811238|8693521|P1|Overall Study|Lack of Efficacy|4
2512363|NCT01811238|8693521|P1|Overall Study|Protocol Violation|4
2512364|NCT01811238|8693521|P1|Overall Study|Adverse Event|25
2512365|NCT01811238|8693521|P1|Overall Study|Withdrawal by Subject|42
2512366|NCT01811186|8693545|P2|Overall Study|Lost to Follow-up|2
2512367|NCT01811186|8693546|P1|Overall Study|Lost to Follow-up|4
2512368|NCT01811186|8693545|P2|Overall Study|Lack of Efficacy|6
2512369|NCT01811186|8693546|P1|Overall Study|Lack of Efficacy|3
2512370|NCT01811186|8693545|P2|Overall Study|Withdrawal by Subject|10
2512371|NCT01811186|8693546|P1|Overall Study|Withdrawal by Subject|5
2512372|NCT01811186|8693545|P2|Overall Study|Protocol Violation|6
2512373|NCT01811186|8693546|P1|Overall Study|Protocol Violation|5
2512374|NCT01811186|8693545|P2|Overall Study|Adverse Event|38
2512375|NCT01811186|8693546|P1|Overall Study|Adverse Event|54
2512376|NCT01810939|8693600|P3|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
2512377|NCT01810939|8693601|P2|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1
2512378|NCT01810939|8693602|P1|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
2512379|NCT01810939|8693600|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1
2512380|NCT01810939|8693601|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2
2512381|NCT01810939|8693602|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0
2512382|NCT01810939|8693600|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14
2512383|NCT01810939|8693601|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2
2512384|NCT01810939|8693602|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0
2512385|NCT01810939|8693600|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2
2512386|NCT01810939|8693601|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1
2512387|NCT01810939|8693602|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0
2512388|NCT01810939|8693600|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
2512389|NCT01810939|8693601|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
2512390|NCT01810939|8693602|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0
2512391|NCT01810939|8693600|P3|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1
2512392|NCT01810939|8693601|P2|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
2512393|NCT01810939|8693602|P1|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
2512394|NCT01810939|8693600|P3|Part B Placebo-Controlled Withdrawal|Death|1
2512395|NCT01810939|8693601|P2|Part B Placebo-Controlled Withdrawal|Death|0
2512396|NCT01810939|8693602|P1|Part B Placebo-Controlled Withdrawal|Death|0
2512397|NCT01810939|8693600|P3|Part B Placebo-Controlled Withdrawal|Adverse Event|1
2512398|NCT01810939|8693601|P2|Part B Placebo-Controlled Withdrawal|Adverse Event|1
2512399|NCT01810939|8693602|P1|Part B Placebo-Controlled Withdrawal|Adverse Event|0
2512400|NCT01810939|8693600|P3|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
2512401|NCT01810939|8693601|P2|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1
2512402|NCT01810939|8693602|P1|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
2512403|NCT01810939|8693600|P3|Part B Placebo-Controlled Withdrawal|Physician Decision|1
2512404|NCT01810939|8693601|P2|Part B Placebo-Controlled Withdrawal|Physician Decision|1
2512405|NCT01810939|8693602|P1|Part B Placebo-Controlled Withdrawal|Physician Decision|0
2512406|NCT01810939|8693600|P3|Part A Treatment Period|Protocol-specified (Low K+)|0
2512407|NCT01810939|8693601|P2|Part A Treatment Period|Protocol-specified (Low K+)|0
2512408|NCT01810939|8693602|P1|Part A Treatment Period|Protocol-specified (Low K+)|1
2512409|NCT01810939|8693600|P3|Part A Treatment Period|Protocol-specified (High K+)|0
2512410|NCT01810939|8693601|P2|Part A Treatment Period|Protocol-specified (High K+)|0
2512411|NCT01810939|8693602|P1|Part A Treatment Period|Protocol-specified (High K+)|3
2512412|NCT01810939|8693600|P3|Part A Treatment Period|Protocol-specified (eGFR)|0
2512413|NCT01810939|8693601|P2|Part A Treatment Period|Protocol-specified (eGFR)|0
2512414|NCT01810939|8693602|P1|Part A Treatment Period|Protocol-specified (eGFR)|2
2512415|NCT01810939|8693600|P3|Part A Treatment Period|Withdrawal by Subject|0
2512416|NCT01810939|8693601|P2|Part A Treatment Period|Withdrawal by Subject|0
2512417|NCT01810939|8693602|P1|Part A Treatment Period|Withdrawal by Subject|5
2512418|NCT01810939|8693600|P3|Part A Treatment Period|Adverse Event|0
2512419|NCT01810939|8693601|P2|Part A Treatment Period|Adverse Event|0
2512420|NCT01810939|8693602|P1|Part A Treatment Period|Adverse Event|10
2512421|NCT01810939|8693600|P3|Part A Treatment Period|Protocol Violation|0
2512422|NCT01810939|8693601|P2|Part A Treatment Period|Protocol Violation|0
2512423|NCT01810939|8693602|P1|Part A Treatment Period|Protocol Violation|2
2512424|NCT01810939|8693600|P3|Part A Treatment Period|Non-compliance with Study Drug|0
2512425|NCT01810939|8693601|P2|Part A Treatment Period|Non-compliance with Study Drug|0
2512426|NCT01810939|8693602|P1|Part A Treatment Period|Non-compliance with Study Drug|1
2512427|NCT01810783|8693615|P1|Overall Study|Enrolled, not treated|1
2512428|NCT01810783|8693615|P1|Overall Study|Adminstrative or other reason(s)|23
2512429|NCT01810783|8693615|P1|Overall Study|Non-compliance with IMP|4
2512430|NCT01810783|8693615|P1|Overall Study|Protocol Violation|5
2512431|NCT01810783|8693615|P1|Overall Study|Lost to Follow-up|10
2512432|NCT01810783|8693615|P1|Overall Study|Lack of Efficacy|12
2512433|NCT01810783|8693615|P1|Overall Study|Withdrawal by Subject|22
2512434|NCT01810783|8693615|P1|Overall Study|Adverse Event|32
2512435|NCT01810432|8693640|P2|Period 2|Lost to Follow-up|1
2512436|NCT01810432|8693641|P1|Period 2|Lost to Follow-up|1
2512437|NCT01810432|8693640|P2|Period 2|Physician Decision|0
2512438|NCT01810432|8693641|P1|Period 2|Physician Decision|1
2512439|NCT01810432|8693640|P2|Period 2|Withdrawal by Subject|1
2512440|NCT01810432|8693641|P1|Period 2|Withdrawal by Subject|2
2512441|NCT01810432|8693640|P2|Washout|Adverse Event|0
2512442|NCT01810432|8693641|P1|Washout|Adverse Event|1
2512443|NCT01810432|8693640|P2|Washout|Protocol Violation|1
2512444|NCT01810432|8693641|P1|Washout|Protocol Violation|0
2512445|NCT01810380|8693654|P3|Overall Study|Administrative or other reasons|9
2512446|NCT01810380|8693655|P2|Overall Study|Administrative or other reasons|13
2512447|NCT01810380|8693656|P1|Overall Study|Administrative or other reasons|11
2512448|NCT01810380|8693654|P3|Overall Study|Withdrawal by Subject|6
2512449|NCT01810380|8693655|P2|Overall Study|Withdrawal by Subject|0
2512450|NCT01810380|8693656|P1|Overall Study|Withdrawal by Subject|6
2512451|NCT01810380|8693654|P3|Overall Study|Protocol Violation|1
2512452|NCT01810380|8693655|P2|Overall Study|Protocol Violation|0
2512453|NCT01810380|8693656|P1|Overall Study|Protocol Violation|1
2512454|NCT01810380|8693654|P3|Overall Study|Lack of Efficacy|11
2512455|NCT01810380|8693655|P2|Overall Study|Lack of Efficacy|10
2512456|NCT01810380|8693656|P1|Overall Study|Lack of Efficacy|24
2512457|NCT01810380|8693654|P3|Overall Study|Adverse Event|4
2512458|NCT01810380|8693655|P2|Overall Study|Adverse Event|14
2512459|NCT01810380|8693656|P1|Overall Study|Adverse Event|11
2512460|NCT01810380|8693654|P3|Overall Study|Randomised not treated|1
2512461|NCT01810380|8693655|P2|Overall Study|Randomised not treated|1
2512462|NCT01810380|8693656|P1|Overall Study|Randomised not treated|2
2512463|NCT01810302|8693717|P2|Overall Study|Physician Decision|1
2512464|NCT01810302|8693718|P1|Overall Study|Physician Decision|0
2512465|NCT01810302|8693717|P2|Overall Study|Death|0
2512466|NCT01810302|8693718|P1|Overall Study|Death|1
2512467|NCT01810263|8693745|P2|Overall Study|Lost to Follow-up|7
2512468|NCT01810263|8693746|P1|Overall Study|Lost to Follow-up|8
2512469|NCT01810042|8693752|P1|Overall Study|Lost to Follow-up|10
2512470|NCT01810016|8693762|P3|Overall Study|Death|1
2512471|NCT01810016|8693763|P2|Overall Study|Death|0
2512472|NCT01810016|8693764|P1|Overall Study|Death|0
2512473|NCT01810016|8693762|P3|Overall Study|Progressive disease|0
2512474|NCT01810016|8693763|P2|Overall Study|Progressive disease|1
2512475|NCT01810016|8693764|P1|Overall Study|Progressive disease|1
2512476|NCT01809327|8693834|P5|Overall Study|Other|9
2512477|NCT01809327|8693835|P4|Overall Study|Other|4
2512478|NCT01809327|8693836|P3|Overall Study|Other|7
2512479|NCT01809327|8693837|P2|Overall Study|Other|15
2512480|NCT01809327|8693838|P1|Overall Study|Other|14
2512481|NCT01809327|8693834|P5|Overall Study|Pregnancy|0
2512482|NCT01809327|8693835|P4|Overall Study|Pregnancy|0
2512483|NCT01809327|8693836|P3|Overall Study|Pregnancy|0
2512484|NCT01809327|8693837|P2|Overall Study|Pregnancy|0
2512485|NCT01809327|8693838|P1|Overall Study|Pregnancy|1
2512486|NCT01809327|8693834|P5|Overall Study|Physician Decision|0
2512487|NCT01809327|8693835|P4|Overall Study|Physician Decision|0
2512488|NCT01809327|8693836|P3|Overall Study|Physician Decision|0
2512489|NCT01809327|8693837|P2|Overall Study|Physician Decision|1
2512490|NCT01809327|8693838|P1|Overall Study|Physician Decision|1
2512491|NCT01809327|8693834|P5|Overall Study|Protocol Violation|0
2512492|NCT01809327|8693835|P4|Overall Study|Protocol Violation|0
2512493|NCT01809327|8693836|P3|Overall Study|Protocol Violation|0
2512494|NCT01809327|8693837|P2|Overall Study|Protocol Violation|1
2512495|NCT01809327|8693838|P1|Overall Study|Protocol Violation|0
2512496|NCT01809327|8693834|P5|Overall Study|Death|0
2512497|NCT01809327|8693835|P4|Overall Study|Death|0
2512498|NCT01809327|8693836|P3|Overall Study|Death|0
2512499|NCT01809327|8693837|P2|Overall Study|Death|0
2512500|NCT01809327|8693838|P1|Overall Study|Death|1
2512501|NCT01809327|8693834|P5|Overall Study|Adverse Event|8
2512502|NCT01809327|8693835|P4|Overall Study|Adverse Event|4
2512503|NCT01809327|8693836|P3|Overall Study|Adverse Event|7
2512504|NCT01809327|8693837|P2|Overall Study|Adverse Event|3
2512505|NCT01809327|8693838|P1|Overall Study|Adverse Event|4
2512506|NCT01809327|8693834|P5|Overall Study|Withdrawal by Subject|5
2512507|NCT01809327|8693835|P4|Overall Study|Withdrawal by Subject|2
2512508|NCT01809327|8693836|P3|Overall Study|Withdrawal by Subject|4
2512509|NCT01809327|8693837|P2|Overall Study|Withdrawal by Subject|4
2512510|NCT01809327|8693838|P1|Overall Study|Withdrawal by Subject|6
2512511|NCT01809327|8693834|P5|Overall Study|Lost to Follow-up|3
2512512|NCT01809327|8693835|P4|Overall Study|Lost to Follow-up|2
2512513|NCT01809327|8693836|P3|Overall Study|Lost to Follow-up|4
2512514|NCT01809327|8693837|P2|Overall Study|Lost to Follow-up|2
2512515|NCT01809327|8693838|P1|Overall Study|Lost to Follow-up|5
2512516|NCT01809314|8693880|P1|Overall Study|Lost to Follow-up|724
2512517|NCT01809314|8693880|P1|Overall Study|Insufficient Therapeutic Response|14
2512518|NCT01809314|8693880|P1|Overall Study|Adverse Event|6
2512519|NCT01809314|8693880|P1|Overall Study|Withdrawal Prior to Treatment|1
2512520|NCT01809262|8693886|P10|Period 3 (Third Dose + Washout)|Adverse Event|0
2512521|NCT01809262|8693887|P9|Period 3 (Third Dose + Washout)|Adverse Event|0
2512522|NCT01809262|8693888|P8|Period 3 (Third Dose + Washout)|Adverse Event|0
2512523|NCT01809262|8693889|P7|Period 3 (Third Dose + Washout)|Adverse Event|0
2512524|NCT01809262|8693890|P6|Period 3 (Third Dose + Washout)|Adverse Event|0
2512525|NCT01809262|8693891|P5|Period 3 (Third Dose + Washout)|Adverse Event|0
2512526|NCT01809262|8693892|P4|Period 3 (Third Dose + Washout)|Adverse Event|0
2512527|NCT01809262|8693893|P3|Period 3 (Third Dose + Washout)|Adverse Event|0
2512528|NCT01809262|8693894|P2|Period 3 (Third Dose + Washout)|Adverse Event|1
2512529|NCT01809262|8693895|P1|Period 3 (Third Dose + Washout)|Adverse Event|0
2512530|NCT01809262|8693886|P10|Period 1 (First Dose + Washout)|Adverse Event|0
2512531|NCT01809262|8693887|P9|Period 1 (First Dose + Washout)|Adverse Event|0
2512532|NCT01809262|8693888|P8|Period 1 (First Dose + Washout)|Adverse Event|0
2512533|NCT01809262|8693889|P7|Period 1 (First Dose + Washout)|Adverse Event|0
2512534|NCT01809262|8693890|P6|Period 1 (First Dose + Washout)|Adverse Event|0
2512535|NCT01809262|8693891|P5|Period 1 (First Dose + Washout)|Adverse Event|1
2512536|NCT01809262|8693892|P4|Period 1 (First Dose + Washout)|Adverse Event|0
2512537|NCT01809262|8693893|P3|Period 1 (First Dose + Washout)|Adverse Event|0
2512538|NCT01809262|8693894|P2|Period 1 (First Dose + Washout)|Adverse Event|0
2512539|NCT01809262|8693895|P1|Period 1 (First Dose + Washout)|Adverse Event|0
2512540|NCT01809210|8693969|P7|Overall Study|Death|1
2512541|NCT01809210|8693970|P6|Overall Study|Death|3
2512542|NCT01809210|8693971|P5|Overall Study|Death|1
2512543|NCT01809210|8693972|P4|Overall Study|Death|0
2512544|NCT01809210|8693973|P3|Overall Study|Death|2
2512545|NCT01809210|8693974|P2|Overall Study|Death|1
2512546|NCT01809210|8693975|P1|Overall Study|Death|1
2512547|NCT01809210|8693969|P7|Overall Study|Withdrawal by Subject|4
2512548|NCT01809210|8693970|P6|Overall Study|Withdrawal by Subject|0
2512549|NCT01809210|8693971|P5|Overall Study|Withdrawal by Subject|1
2512550|NCT01809210|8693972|P4|Overall Study|Withdrawal by Subject|1
2512551|NCT01809210|8693973|P3|Overall Study|Withdrawal by Subject|1
2512552|NCT01809210|8693974|P2|Overall Study|Withdrawal by Subject|0
2512553|NCT01809210|8693975|P1|Overall Study|Withdrawal by Subject|0
2512554|NCT01809197|8694049|P2|Overall Study|Product not available|1
2512555|NCT01809197|8694050|P1|Overall Study|Product not available|0
2512556|NCT01809197|8694049|P2|Overall Study|Withdrawal by Subject|1
2512557|NCT01809197|8694050|P1|Overall Study|Withdrawal by Subject|1
2512558|NCT01809197|8694049|P2|Overall Study|Decision Unrelated to an Adverse Event|0
2512559|NCT01809197|8694050|P1|Overall Study|Decision Unrelated to an Adverse Event|1
2512560|NCT01809197|8694049|P2|Overall Study|Non-Compliance|1
2512561|NCT01809197|8694050|P1|Overall Study|Non-Compliance|1
2512562|NCT01809197|8694049|P2|Overall Study|Failed slit lamp exam|0
2512563|NCT01809197|8694050|P1|Overall Study|Failed slit lamp exam|1
2512564|NCT01809197|8694049|P2|Overall Study|Adverse Event|3
2512565|NCT01809197|8694050|P1|Overall Study|Adverse Event|2
2512566|NCT01809197|8694049|P2|Overall Study|Lost to Follow-up|2
2512567|NCT01809197|8694050|P1|Overall Study|Lost to Follow-up|4
2512568|NCT01808690|8694131|P2|Overall Study|Withdrawal by Subject|2
2512569|NCT01808690|8694132|P1|Overall Study|Withdrawal by Subject|1
2512570|NCT01808651|8694151|P3|Study Period 1|Participant Decision|3
2512571|NCT01808651|8694152|P2|Study Period 1|Participant Decision|7
2512572|NCT01808651|8694153|P1|Study Period 1|Participant Decision|9
2512573|NCT01808651|8694151|P3|Study Period 1|Adverse Event|1
2512574|NCT01808651|8694152|P2|Study Period 1|Adverse Event|4
2512575|NCT01808651|8694153|P1|Study Period 1|Adverse Event|10
2512576|NCT01808651|8694151|P3|Study Period 1|Lack of Efficacy|0
2512577|NCT01808651|8694152|P2|Study Period 1|Lack of Efficacy|1
2512578|NCT01808651|8694153|P1|Study Period 1|Lack of Efficacy|2
2512579|NCT01808651|8694151|P3|Study Period 1|Physician Decision|0
2512580|NCT01808651|8694152|P2|Study Period 1|Physician Decision|2
2512581|NCT01808651|8694153|P1|Study Period 1|Physician Decision|3
2512582|NCT01808651|8694151|P3|Study Period 1|Protocol Violation|1
2512583|NCT01808651|8694152|P2|Study Period 1|Protocol Violation|0
2512584|NCT01808651|8694153|P1|Study Period 1|Protocol Violation|1
2512585|NCT01808651|8694151|P3|Study Period 1|Lost to Follow-up|0
2512586|NCT01808651|8694152|P2|Study Period 1|Lost to Follow-up|3
2512587|NCT01808651|8694153|P1|Study Period 1|Lost to Follow-up|1
2512588|NCT01808612|8694188|P3|Discontinuation Period|Lost to Follow-up|0
2512589|NCT01808612|8694189|P2|Discontinuation Period|Lost to Follow-up|1
2512590|NCT01808612|8694190|P1|Discontinuation Period|Lost to Follow-up|0
2512591|NCT01808612|8694188|P3|Discontinuation Period|Physician Decision|0
2512592|NCT01808612|8694189|P2|Discontinuation Period|Physician Decision|0
2512593|NCT01808612|8694190|P1|Discontinuation Period|Physician Decision|1
2512594|NCT01808612|8694188|P3|Discontinuation Period|Adverse Event|0
2512595|NCT01808612|8694189|P2|Discontinuation Period|Adverse Event|0
2512596|NCT01808612|8694190|P1|Discontinuation Period|Adverse Event|1
2512597|NCT01808612|8694188|P3|Treatment Period|Lack of Efficacy|2
2512598|NCT01808612|8694189|P2|Treatment Period|Lack of Efficacy|1
2512599|NCT01808612|8694190|P1|Treatment Period|Lack of Efficacy|1
2512600|NCT01808612|8694188|P3|Treatment Period|Sponsor Decision|0
2512601|NCT01808612|8694189|P2|Treatment Period|Sponsor Decision|0
2512602|NCT01808612|8694190|P1|Treatment Period|Sponsor Decision|1
2512603|NCT01808612|8694188|P3|Treatment Period|Physician Decision|4
2512604|NCT01808612|8694189|P2|Treatment Period|Physician Decision|0
2512605|NCT01808612|8694190|P1|Treatment Period|Physician Decision|1
2512606|NCT01808612|8694188|P3|Treatment Period|Withdrawal by Subject|4
2512607|NCT01808612|8694189|P2|Treatment Period|Withdrawal by Subject|0
2512608|NCT01808612|8694190|P1|Treatment Period|Withdrawal by Subject|1
2512609|NCT01808612|8694188|P3|Treatment Period|Protocol Violation|0
2512610|NCT01808612|8694189|P2|Treatment Period|Protocol Violation|0
2512611|NCT01808612|8694190|P1|Treatment Period|Protocol Violation|1
2512612|NCT01808612|8694188|P3|Treatment Period|Lost to Follow-up|1
2512613|NCT01808612|8694189|P2|Treatment Period|Lost to Follow-up|2
2512614|NCT01808612|8694190|P1|Treatment Period|Lost to Follow-up|2
2512615|NCT01808612|8694188|P3|Treatment Period|Adverse Event|3
2512616|NCT01808612|8694189|P2|Treatment Period|Adverse Event|4
2512617|NCT01808612|8694190|P1|Treatment Period|Adverse Event|8
2512618|NCT01808573|8694221|P2|Overall Study|Randomized in Error|0
2512619|NCT01808573|8694222|P1|Overall Study|Randomized in Error|1
2512620|NCT01808573|8694221|P2|Overall Study|Discontinuation of study by sponsor|64
2512621|NCT01808573|8694222|P1|Overall Study|Discontinuation of study by sponsor|79
2512622|NCT01808573|8694221|P2|Overall Study|Lost to Follow-up|0
2512623|NCT01808573|8694222|P1|Overall Study|Lost to Follow-up|3
2512624|NCT01808573|8694221|P2|Overall Study|Withdrawal by Subject|10
2512625|NCT01808573|8694222|P1|Overall Study|Withdrawal by Subject|12
2512626|NCT01808573|8694221|P2|Overall Study|Death|240
2512627|NCT01808573|8694222|P1|Overall Study|Death|212
2512628|NCT01808534|8694277|P1|Overall Study|Physician Decision|1
2512629|NCT01808534|8694277|P1|Overall Study|Disease progression|3
2512630|NCT01808508|8694288|P3|Overall Study|Lost to Follow-up|0
2512631|NCT01808508|8694289|P2|Overall Study|Lost to Follow-up|0
2512632|NCT01808508|8694290|P1|Overall Study|Lost to Follow-up|1
2512633|NCT01808339|8694307|P6|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
2512634|NCT01808339|8694308|P5|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
2512635|NCT01808339|8694309|P4|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
2512636|NCT01808339|8694310|P3|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1
2512637|NCT01808339|8694311|P2|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
2512638|NCT01808339|8694312|P1|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
2512639|NCT01808339|8694307|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2512640|NCT01808339|8694308|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2512641|NCT01808339|8694309|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
2512642|NCT01808339|8694310|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2512643|NCT01808339|8694311|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
2512644|NCT01808339|8694312|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2512645|NCT01808339|8694307|P6|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
2512646|NCT01808339|8694308|P5|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2
2512647|NCT01808339|8694309|P4|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
2512648|NCT01808339|8694310|P3|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
2512649|NCT01808339|8694311|P2|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
2512650|NCT01808339|8694312|P1|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
2512651|NCT01808313|8694356|P1|Overall Study|Physician Decision|1
2512652|NCT01808313|8694356|P1|Overall Study|Lost to Follow-up|1
2512653|NCT01808313|8694356|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
2512654|NCT01808313|8694356|P1|Overall Study|Protocol Violation|2
2512655|NCT01808313|8694356|P1|Overall Study|Adverse Event|5
2512656|NCT01808261|8694386|P2|Overall Study|Lost to Follow-up|1
2512657|NCT01808261|8694387|P1|Overall Study|Lost to Follow-up|3
2512658|NCT01808261|8694386|P2|Overall Study|Consent withdrawn by subject|7
2512659|NCT01808261|8694387|P1|Overall Study|Consent withdrawn by subject|6
2512660|NCT01808261|8694386|P2|Overall Study|Adverse event, non-fatal|0
2512661|NCT01808261|8694387|P1|Overall Study|Adverse event, non-fatal|2
2512662|NCT01808261|8694386|P2|Overall Study|Study Closed/Terminated|23
2512663|NCT01808261|8694387|P1|Overall Study|Study Closed/Terminated|25
2512664|NCT01808261|8694386|P2|Overall Study|Physician Decision|2
2512665|NCT01808261|8694387|P1|Overall Study|Physician Decision|0
2512666|NCT01808248|8694443|P1|Overall Study|Lost to Follow-up|1
2512667|NCT01808248|8694443|P1|Overall Study|Withdrawal by Subject|1
2512668|NCT01808248|8694443|P1|Overall Study|Lack of Efficacy|3
2512669|NCT01808222|8694455|P1|Overall Study|mpMR scan was not performed|1
2512670|NCT01808209|8694462|P2|Overall Study|Lost to Follow-up|1
2512671|NCT01808209|8694463|P1|Overall Study|Lost to Follow-up|0
2512672|NCT01808144|8694507|P2|Overall Study|Adverse Event|15
2512673|NCT01808144|8694508|P1|Overall Study|Adverse Event|11
2512674|NCT01808144|8694507|P2|Overall Study|Gout flare|1
2512675|NCT01808144|8694508|P1|Overall Study|Gout flare|0
2512676|NCT01808144|8694507|P2|Overall Study|Protocol Violation|6
2512677|NCT01808144|8694508|P1|Overall Study|Protocol Violation|6
2512678|NCT01808144|8694507|P2|Overall Study|Lost to Follow-up|3
2512679|NCT01808144|8694508|P1|Overall Study|Lost to Follow-up|6
2512680|NCT01808144|8694507|P2|Overall Study|Withdrawal by Subject|23
2512681|NCT01808144|8694508|P1|Overall Study|Withdrawal by Subject|16
2512682|NCT01808144|8694507|P2|Overall Study|Death|0
2512683|NCT01808144|8694508|P1|Overall Study|Death|1
2512684|NCT01808118|8694516|P3|Period 2|Switched to other therapy|0
2512685|NCT01808118|8694517|P2|Period 2|Switched to other therapy|1
2512686|NCT01808118|8694518|P1|Period 2|Switched to other therapy|0
2512687|NCT01808118|8694516|P3|Period 2|Investigator no longer conducting trials|0
2512688|NCT01808118|8694517|P2|Period 2|Investigator no longer conducting trials|1
2512689|NCT01808118|8694518|P1|Period 2|Investigator no longer conducting trials|0
2512690|NCT01808118|8694516|P3|Period 2|Lost to Follow-up|2
2512691|NCT01808118|8694517|P2|Period 2|Lost to Follow-up|0
2512692|NCT01808118|8694518|P1|Period 2|Lost to Follow-up|0
2512693|NCT01808118|8694516|P3|Period 2|Withdrew consent|6
2512694|NCT01808118|8694517|P2|Period 2|Withdrew consent|7
2512695|NCT01808118|8694518|P1|Period 2|Withdrew consent|0
2512696|NCT01808118|8694516|P3|Period 2|Adverse Event|0
2512697|NCT01808118|8694517|P2|Period 2|Adverse Event|4
2512698|NCT01808118|8694518|P1|Period 2|Adverse Event|0
2512699|NCT01808118|8694516|P3|Period 1|Lack of Efficacy|0
2512700|NCT01808118|8694517|P2|Period 1|Lack of Efficacy|0
2512701|NCT01808118|8694518|P1|Period 1|Lack of Efficacy|1
2512702|NCT01808118|8694516|P3|Period 1|Non-compliance per sponsor|0
2512703|NCT01808118|8694517|P2|Period 1|Non-compliance per sponsor|0
2512704|NCT01808118|8694518|P1|Period 1|Non-compliance per sponsor|1
2512705|NCT01808118|8694516|P3|Period 1|Investigator decision: site closure|0
2512706|NCT01808118|8694517|P2|Period 1|Investigator decision: site closure|0
2512707|NCT01808118|8694518|P1|Period 1|Investigator decision: site closure|2
2512708|NCT01808118|8694516|P3|Period 1|Non-conformance with inclusion criteria|0
2512709|NCT01808118|8694517|P2|Period 1|Non-conformance with inclusion criteria|0
2512710|NCT01808118|8694518|P1|Period 1|Non-conformance with inclusion criteria|3
2512711|NCT01808118|8694516|P3|Period 1|Did not meet inclusion criteria|0
2512712|NCT01808118|8694517|P2|Period 1|Did not meet inclusion criteria|0
2512713|NCT01808118|8694518|P1|Period 1|Did not meet inclusion criteria|3
2512714|NCT01808118|8694516|P3|Period 1|Enrolled in error|0
2512715|NCT01808118|8694517|P2|Period 1|Enrolled in error|0
2512716|NCT01808118|8694518|P1|Period 1|Enrolled in error|7
2512717|NCT01808118|8694516|P3|Period 1|Did not meet criteria for remission|0
2512718|NCT01808118|8694517|P2|Period 1|Did not meet criteria for remission|0
2512719|NCT01808118|8694518|P1|Period 1|Did not meet criteria for remission|303
2512720|NCT01808118|8694516|P3|Period 1|Lost to Follow-up|0
2512721|NCT01808118|8694517|P2|Period 1|Lost to Follow-up|0
2512722|NCT01808118|8694518|P1|Period 1|Lost to Follow-up|9
2512723|NCT01808118|8694516|P3|Period 1|Withdrew consent|0
2512724|NCT01808118|8694517|P2|Period 1|Withdrew consent|0
2512725|NCT01808118|8694518|P1|Period 1|Withdrew consent|24
2512726|NCT01808118|8694516|P3|Period 1|Adverse Event|0
2512727|NCT01808118|8694517|P2|Period 1|Adverse Event|0
2512728|NCT01808118|8694518|P1|Period 1|Adverse Event|15
2512729|NCT01808092|8694581|P2|Overall Study|Other Eligibility criteria|5
2512730|NCT01808092|8694582|P1|Overall Study|Other Eligibility criteria|3
2512731|NCT01808092|8694581|P2|Overall Study|Withdrawal by Subject|4
2512732|NCT01808092|8694582|P1|Overall Study|Withdrawal by Subject|9
2512733|NCT01808092|8694581|P2|Overall Study|Lost to Follow-up|7
2512734|NCT01808092|8694582|P1|Overall Study|Lost to Follow-up|3
2512735|NCT01808092|8694581|P2|Overall Study|Death|29
2512736|NCT01808092|8694582|P1|Overall Study|Death|39
2512737|NCT01808066|8694684|P1|Overall Study|Withdrawal by Subject|15
2512738|NCT01807949|8694695|P3|Overall Study|Randomized But Not Treated|2
2512739|NCT01807949|8694696|P2|Overall Study|Randomized But Not Treated|2
2512740|NCT01807949|8694697|P1|Overall Study|Randomized But Not Treated|0
2512741|NCT01807949|8694695|P3|Overall Study|Undefined|2
2512742|NCT01807949|8694696|P2|Overall Study|Undefined|1
2512743|NCT01807949|8694697|P1|Overall Study|Undefined|0
2512744|NCT01807949|8694695|P3|Overall Study|Non-Compliance|1
2512745|NCT01807949|8694696|P2|Overall Study|Non-Compliance|0
2512746|NCT01807949|8694697|P1|Overall Study|Non-Compliance|0
2512747|NCT01807949|8694695|P3|Overall Study|Withdrawal by Subject|2
2512748|NCT01807949|8694696|P2|Overall Study|Withdrawal by Subject|2
2512749|NCT01807949|8694697|P1|Overall Study|Withdrawal by Subject|1
2512750|NCT01807949|8694695|P3|Overall Study|Adverse Event|2
2512751|NCT01807949|8694696|P2|Overall Study|Adverse Event|2
2512752|NCT01807949|8694697|P1|Overall Study|Adverse Event|1
2512753|NCT01807923|8694749|P3|Overall Study|Randomized But Not Treated|5
2512754|NCT01807923|8694750|P2|Overall Study|Randomized But Not Treated|2
2512755|NCT01807923|8694751|P1|Overall Study|Randomized But Not Treated|3
2512756|NCT01807923|8694749|P3|Overall Study|Not Eligible (Genotype)|1
2512757|NCT01807923|8694750|P2|Overall Study|Not Eligible (Genotype)|0
2512758|NCT01807923|8694751|P1|Overall Study|Not Eligible (Genotype)|0
2512759|NCT01807923|8694749|P3|Overall Study|Physician Decision|1
2512760|NCT01807923|8694750|P2|Overall Study|Physician Decision|0
2512761|NCT01807923|8694751|P1|Overall Study|Physician Decision|0
2512762|NCT01807923|8694749|P3|Overall Study|Withdrawal of Consent (not due to AE)|2
2512763|NCT01807923|8694750|P2|Overall Study|Withdrawal of Consent (not due to AE)|3
2512764|NCT01807923|8694751|P1|Overall Study|Withdrawal of Consent (not due to AE)|0
2512765|NCT01807923|8694749|P3|Overall Study|Adverse Event|2
2512766|NCT01807923|8694750|P2|Overall Study|Adverse Event|1
2512767|NCT01807923|8694751|P1|Overall Study|Adverse Event|2
2512768|NCT01807650|8694813|P1|Overall Study|Other|2
2512769|NCT01807650|8694813|P1|Overall Study|Adverse Event|5
2512770|NCT01807650|8694813|P1|Overall Study|Lack of Full Wound Closure at Day 28|13
2512771|NCT01807598|8694899|P1|Overall Study|Other Physician Decision|1
2512772|NCT01807598|8694899|P1|Overall Study|Adverse Event|1
2512773|NCT01807598|8694899|P1|Overall Study|Withdrawal by Subject|4
2512774|NCT01807520|8694931|P7|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1
2512775|NCT01807520|8694932|P6|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2
2512776|NCT01807520|8694933|P5|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
2512777|NCT01807520|8694934|P4|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
2512778|NCT01807520|8694935|P3|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
2512779|NCT01807520|8694936|P2|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
2512780|NCT01807520|8694937|P1|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
2512781|NCT01807520|8694931|P7|Follow-up Period (132-140 Weeks)|Study terminated|0
2512782|NCT01807520|8694932|P6|Follow-up Period (132-140 Weeks)|Study terminated|1
2512783|NCT01807520|8694933|P5|Follow-up Period (132-140 Weeks)|Study terminated|0
2512784|NCT01807520|8694934|P4|Follow-up Period (132-140 Weeks)|Study terminated|0
2512785|NCT01807520|8694935|P3|Follow-up Period (132-140 Weeks)|Study terminated|0
2512786|NCT01807520|8694936|P2|Follow-up Period (132-140 Weeks)|Study terminated|0
2512787|NCT01807520|8694937|P1|Follow-up Period (132-140 Weeks)|Study terminated|0
2512788|NCT01807520|8694931|P7|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
2512789|NCT01807520|8694932|P6|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1
2512790|NCT01807520|8694933|P5|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
2512791|NCT01807520|8694934|P4|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
2512792|NCT01807520|8694935|P3|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
2512793|NCT01807520|8694936|P2|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
2512794|NCT01807520|8694937|P1|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
2512795|NCT01807520|8694931|P7|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
2512796|NCT01807520|8694932|P6|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
2512797|NCT01807520|8694933|P5|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
2513102|NCT01804842|8695628|P1|Overall Study|Personal Reason|0
2512798|NCT01807520|8694934|P4|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
2512799|NCT01807520|8694935|P3|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
2512800|NCT01807520|8694936|P2|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6
2512801|NCT01807520|8694937|P1|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5
2512802|NCT01807520|8694931|P7|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
2512803|NCT01807520|8694932|P6|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
2512804|NCT01807520|8694933|P5|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
2512805|NCT01807520|8694934|P4|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
2512806|NCT01807520|8694935|P3|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
2512807|NCT01807520|8694936|P2|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
2512808|NCT01807520|8694937|P1|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
2512809|NCT01807520|8694931|P7|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
2512810|NCT01807520|8694932|P6|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
2512811|NCT01807520|8694933|P5|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1
2512812|NCT01807520|8694934|P4|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
2512813|NCT01807520|8694935|P3|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
2512814|NCT01807520|8694936|P2|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3
2512815|NCT01807520|8694937|P1|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5
2512816|NCT01807520|8694931|P7|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
2512817|NCT01807520|8694932|P6|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
2512818|NCT01807520|8694933|P5|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
2512819|NCT01807520|8694934|P4|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1
2512820|NCT01807520|8694935|P3|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
2512821|NCT01807520|8694936|P2|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
2512822|NCT01807520|8694937|P1|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4
2512823|NCT01807520|8694931|P7|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
2512824|NCT01807520|8694932|P6|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
2512825|NCT01807520|8694933|P5|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
2512826|NCT01807520|8694934|P4|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
2512827|NCT01807520|8694935|P3|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
2512828|NCT01807520|8694936|P2|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2
2512829|NCT01807520|8694937|P1|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
2512830|NCT01807520|8694931|P7|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
2512831|NCT01807520|8694932|P6|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
2512832|NCT01807520|8694933|P5|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
2512833|NCT01807520|8694934|P4|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
2512834|NCT01807520|8694935|P3|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
2512835|NCT01807520|8694936|P2|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
2512836|NCT01807520|8694937|P1|Treatment Period 2 (16-132 Weeks)|Pregnancy|1
2512837|NCT01807520|8694931|P7|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
2512838|NCT01807520|8694932|P6|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
2512839|NCT01807520|8694933|P5|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
2512840|NCT01807520|8694934|P4|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1
2512841|NCT01807520|8694935|P3|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
2512842|NCT01807520|8694936|P2|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
2512843|NCT01807520|8694937|P1|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
2512844|NCT01807520|8694931|P7|Treatment Period 2 (16-132 Weeks)|Study terminated|0
2512845|NCT01807520|8694932|P6|Treatment Period 2 (16-132 Weeks)|Study terminated|0
2512846|NCT01807520|8694933|P5|Treatment Period 2 (16-132 Weeks)|Study terminated|2
2512847|NCT01807520|8694934|P4|Treatment Period 2 (16-132 Weeks)|Study terminated|0
2512848|NCT01807520|8694935|P3|Treatment Period 2 (16-132 Weeks)|Study terminated|0
2512849|NCT01807520|8694936|P2|Treatment Period 2 (16-132 Weeks)|Study terminated|4
2512850|NCT01807520|8694937|P1|Treatment Period 2 (16-132 Weeks)|Study terminated|7
2512851|NCT01807520|8694931|P7|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
2512852|NCT01807520|8694932|P6|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
2512853|NCT01807520|8694933|P5|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
2512854|NCT01807520|8694934|P4|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
2512855|NCT01807520|8694935|P3|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
2512856|NCT01807520|8694936|P2|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
2512857|NCT01807520|8694937|P1|Treatment Period 1 (0-16 Weeks)|Adverse Event|2
2512858|NCT01807520|8694931|P7|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
2512859|NCT01807520|8694932|P6|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
2512860|NCT01807520|8694933|P5|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
2512861|NCT01807520|8694934|P4|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
2512862|NCT01807520|8694935|P3|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2
2512863|NCT01807520|8694936|P2|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
2512864|NCT01807520|8694937|P1|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
2512865|NCT01807520|8694931|P7|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
2512866|NCT01807520|8694932|P6|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
2512867|NCT01807520|8694933|P5|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
2512868|NCT01807520|8694934|P4|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
2512869|NCT01807520|8694935|P3|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
2512870|NCT01807520|8694936|P2|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
2512871|NCT01807520|8694937|P1|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1
2512872|NCT01807520|8694931|P7|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
2512873|NCT01807520|8694932|P6|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
2512874|NCT01807520|8694933|P5|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
2512875|NCT01807520|8694934|P4|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
2512876|NCT01807520|8694935|P3|Treatment Period 1 (0-16 Weeks)|Physician Decision|1
2512877|NCT01807520|8694936|P2|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
2512878|NCT01807520|8694937|P1|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
2512879|NCT01807520|8694931|P7|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
2512880|NCT01807520|8694932|P6|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
2512881|NCT01807520|8694933|P5|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
2512882|NCT01807520|8694934|P4|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
2512883|NCT01807520|8694935|P3|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
2512884|NCT01807520|8694936|P2|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
2512885|NCT01807520|8694937|P1|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
2512886|NCT01807520|8694931|P7|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
2512887|NCT01807520|8694932|P6|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
2512888|NCT01807520|8694933|P5|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
2512889|NCT01807520|8694934|P4|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
2512890|NCT01807520|8694935|P3|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3
2512891|NCT01807520|8694936|P2|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1
2512892|NCT01807520|8694937|P1|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
2512893|NCT01807299|8694968|P4|Overall Study|Protocol Violation|2
2512894|NCT01807299|8694969|P3|Overall Study|Protocol Violation|0
2512895|NCT01807299|8694970|P2|Overall Study|Protocol Violation|1
2512896|NCT01807299|8694971|P1|Overall Study|Protocol Violation|3
2512897|NCT01807234|8694987|P6|Overall Study|Lack of Efficacy|1
2512898|NCT01807234|8694988|P5|Overall Study|Lack of Efficacy|1
2512899|NCT01807234|8694989|P4|Overall Study|Lack of Efficacy|0
2512900|NCT01807234|8694990|P3|Overall Study|Lack of Efficacy|0
2512901|NCT01807234|8694991|P2|Overall Study|Lack of Efficacy|0
2512902|NCT01807234|8694992|P1|Overall Study|Lack of Efficacy|0
2512903|NCT01807234|8694987|P6|Overall Study|Withdrawal by Subject|1
2512904|NCT01807234|8694988|P5|Overall Study|Withdrawal by Subject|2
2512905|NCT01807234|8694989|P4|Overall Study|Withdrawal by Subject|1
2512906|NCT01807234|8694990|P3|Overall Study|Withdrawal by Subject|1
2512907|NCT01807234|8694991|P2|Overall Study|Withdrawal by Subject|1
2512908|NCT01807234|8694992|P1|Overall Study|Withdrawal by Subject|3
2512909|NCT01807234|8694987|P6|Overall Study|Lost to Follow-up|2
2512910|NCT01807234|8694988|P5|Overall Study|Lost to Follow-up|1
2512911|NCT01807234|8694989|P4|Overall Study|Lost to Follow-up|1
2512912|NCT01807234|8694990|P3|Overall Study|Lost to Follow-up|1
2512913|NCT01807234|8694991|P2|Overall Study|Lost to Follow-up|5
2512914|NCT01807234|8694992|P1|Overall Study|Lost to Follow-up|2
2512915|NCT01807156|8695027|P1|Overall Study|Physician Decision|1
2512916|NCT01806961|8695099|P1|Overall Study|sponsor decision|16
2512917|NCT01806896|8695105|P2|Overall Study|Other|0
2512918|NCT01806896|8695106|P1|Overall Study|Other|1
2512919|NCT01806896|8695105|P2|Overall Study|Adverse Event|0
2512920|NCT01806896|8695106|P1|Overall Study|Adverse Event|2
2512921|NCT01806779|8695173|P3|Overall Study|Withdrawal by Subject|22
2512922|NCT01806779|8695174|P2|Overall Study|Withdrawal by Subject|23
2512923|NCT01806779|8695175|P1|Overall Study|Withdrawal by Subject|20
2512924|NCT01806779|8695173|P3|Overall Study|Lost to Follow-up|0
2512925|NCT01806779|8695174|P2|Overall Study|Lost to Follow-up|20
2512926|NCT01806779|8695175|P1|Overall Study|Lost to Follow-up|19
2512927|NCT01806779|8695173|P3|Overall Study|Lack of Efficacy|0
2512928|NCT01806779|8695174|P2|Overall Study|Lack of Efficacy|1
2512929|NCT01806779|8695175|P1|Overall Study|Lack of Efficacy|1
2512930|NCT01806779|8695173|P3|Overall Study|Physician Decision|1
2512931|NCT01806779|8695174|P2|Overall Study|Physician Decision|0
2512932|NCT01806779|8695175|P1|Overall Study|Physician Decision|2
2512933|NCT01806740|8695188|P1|Overall Study|Patient’s refusal of treatment|1
2512934|NCT01806740|8695188|P1|Overall Study|Physician Decision|1
2512935|NCT01806740|8695188|P1|Overall Study|Withdrawal by Subject|4
2512936|NCT01806714|8695199|P2|Overall Study|No functioning phone number|170
2512937|NCT01806714|8695200|P1|Overall Study|No functioning phone number|200
2512938|NCT01806662|8695235|P2|Second Intervention (Weeks 16-32)|Lost to Follow-up|1
2512939|NCT01806662|8695236|P1|Second Intervention (Weeks 16-32)|Lost to Follow-up|0
2512940|NCT01806662|8695235|P2|Second Intervention (Weeks 16-32)|Lack of Efficacy|3
2512941|NCT01806662|8695236|P1|Second Intervention (Weeks 16-32)|Lack of Efficacy|2
2512942|NCT01806662|8695235|P2|First Intervention (Weeks 0-16)|Adverse Event|1
2512943|NCT01806662|8695236|P1|First Intervention (Weeks 0-16)|Adverse Event|0
2512944|NCT01806662|8695235|P2|First Intervention (Weeks 0-16)|Withdrawal by Subject|0
2512945|NCT01806662|8695236|P1|First Intervention (Weeks 0-16)|Withdrawal by Subject|4
2512946|NCT01806623|8695242|P1|Overall Study|Did not meet the inclusion criteria|56
2512947|NCT01806623|8695242|P1|Overall Study|Adverse Event|1
2512948|NCT01806623|8695242|P1|Overall Study|Withdrawal by Subject|1
2512949|NCT01806597|8695262|P6|Follow-up Period (Week 132 to Week 140)|Physician Decision|1
2512950|NCT01806597|8695263|P5|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
2512951|NCT01806597|8695264|P4|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
2512952|NCT01806597|8695265|P3|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
2512953|NCT01806597|8695266|P2|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
2512954|NCT01806597|8695267|P1|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
2512955|NCT01806597|8695262|P6|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2
2512956|NCT01806597|8695263|P5|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
2512957|NCT01806597|8695264|P4|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
2512958|NCT01806597|8695265|P3|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
2512959|NCT01806597|8695266|P2|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
2512960|NCT01806597|8695267|P1|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
2512961|NCT01806597|8695262|P6|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2
2512962|NCT01806597|8695263|P5|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
2512963|NCT01806597|8695264|P4|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
2512964|NCT01806597|8695265|P3|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
2512965|NCT01806597|8695266|P2|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
2512966|NCT01806597|8695267|P1|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
2512967|NCT01806597|8695262|P6|Follow-up Period (Week 132 to Week 140)|Adverse Event|2
2512968|NCT01806597|8695263|P5|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
2512969|NCT01806597|8695264|P4|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
2512970|NCT01806597|8695265|P3|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
2512971|NCT01806597|8695266|P2|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
2512972|NCT01806597|8695267|P1|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
2512973|NCT01806597|8695262|P6|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5
2512974|NCT01806597|8695263|P5|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
2512975|NCT01806597|8695264|P4|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
2512976|NCT01806597|8695265|P3|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
2512977|NCT01806597|8695266|P2|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
2512978|NCT01806597|8695267|P1|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
2512979|NCT01806597|8695262|P6|Treatment Period 2 (Week 16 to Week 132)|Death|0
2512980|NCT01806597|8695263|P5|Treatment Period 2 (Week 16 to Week 132)|Death|0
2512981|NCT01806597|8695264|P4|Treatment Period 2 (Week 16 to Week 132)|Death|0
2512982|NCT01806597|8695265|P3|Treatment Period 2 (Week 16 to Week 132)|Death|0
2512983|NCT01806597|8695266|P2|Treatment Period 2 (Week 16 to Week 132)|Death|0
2512984|NCT01806597|8695267|P1|Treatment Period 2 (Week 16 to Week 132)|Death|1
2512985|NCT01806597|8695262|P6|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
2512986|NCT01806597|8695263|P5|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
2512987|NCT01806597|8695264|P4|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
2512988|NCT01806597|8695265|P3|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
2512989|NCT01806597|8695266|P2|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
2512990|NCT01806597|8695267|P1|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
2512991|NCT01806597|8695262|P6|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
2512992|NCT01806597|8695263|P5|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
2512993|NCT01806597|8695264|P4|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
2512994|NCT01806597|8695265|P3|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6
2512995|NCT01806597|8695266|P2|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
2512996|NCT01806597|8695267|P1|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10
2512997|NCT01806597|8695262|P6|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
2512998|NCT01806597|8695263|P5|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
2512999|NCT01806597|8695264|P4|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
2513000|NCT01806597|8695265|P3|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
2513001|NCT01806597|8695266|P2|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
2513002|NCT01806597|8695267|P1|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
2513003|NCT01806597|8695262|P6|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
2513004|NCT01806597|8695263|P5|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
2513005|NCT01806597|8695264|P4|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
2513006|NCT01806597|8695265|P3|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
2513007|NCT01806597|8695266|P2|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
2513008|NCT01806597|8695267|P1|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2
2513009|NCT01806597|8695262|P6|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
2513010|NCT01806597|8695263|P5|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
2513011|NCT01806597|8695264|P4|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
2513012|NCT01806597|8695265|P3|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
2513013|NCT01806597|8695266|P2|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
2513014|NCT01806597|8695267|P1|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
2513015|NCT01806597|8695262|P6|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
2513016|NCT01806597|8695263|P5|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
2513017|NCT01806597|8695264|P4|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
2513018|NCT01806597|8695265|P3|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
2513019|NCT01806597|8695266|P2|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
2513020|NCT01806597|8695267|P1|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2
2513021|NCT01806597|8695262|P6|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
2513022|NCT01806597|8695263|P5|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
2513023|NCT01806597|8695264|P4|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1
2513024|NCT01806597|8695265|P3|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3
2513025|NCT01806597|8695266|P2|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5
2513026|NCT01806597|8695267|P1|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12
2513027|NCT01806597|8695262|P6|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0
2513028|NCT01806597|8695263|P5|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1
2513029|NCT01806597|8695264|P4|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3
2513030|NCT01806597|8695265|P3|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4
2513031|NCT01806597|8695266|P2|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6
2513032|NCT01806597|8695267|P1|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9
2513033|NCT01806597|8695262|P6|Period 1 (Baseline to Week 16)|Physician Decision|0
2513034|NCT01806597|8695263|P5|Period 1 (Baseline to Week 16)|Physician Decision|0
2513035|NCT01806597|8695264|P4|Period 1 (Baseline to Week 16)|Physician Decision|0
2513036|NCT01806597|8695265|P3|Period 1 (Baseline to Week 16)|Physician Decision|0
2513037|NCT01806597|8695266|P2|Period 1 (Baseline to Week 16)|Physician Decision|1
2513038|NCT01806597|8695267|P1|Period 1 (Baseline to Week 16)|Physician Decision|0
2513039|NCT01806597|8695262|P6|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
2513040|NCT01806597|8695263|P5|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
2513041|NCT01806597|8695264|P4|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
2513042|NCT01806597|8695265|P3|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
2513043|NCT01806597|8695266|P2|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
2513044|NCT01806597|8695267|P1|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3
2513045|NCT01806597|8695262|P6|Period 1 (Baseline to Week 16)|Protocol Violation|0
2513046|NCT01806597|8695263|P5|Period 1 (Baseline to Week 16)|Protocol Violation|0
2513047|NCT01806597|8695264|P4|Period 1 (Baseline to Week 16)|Protocol Violation|0
2513048|NCT01806597|8695265|P3|Period 1 (Baseline to Week 16)|Protocol Violation|0
2513049|NCT01806597|8695266|P2|Period 1 (Baseline to Week 16)|Protocol Violation|1
2513050|NCT01806597|8695267|P1|Period 1 (Baseline to Week 16)|Protocol Violation|0
2513051|NCT01806597|8695262|P6|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
2513052|NCT01806597|8695263|P5|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
2513053|NCT01806597|8695264|P4|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
2513054|NCT01806597|8695265|P3|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
2513055|NCT01806597|8695266|P2|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
2513056|NCT01806597|8695267|P1|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
2513057|NCT01806597|8695262|P6|Period 1 (Baseline to Week 16)|Adverse Event|0
2513058|NCT01806597|8695263|P5|Period 1 (Baseline to Week 16)|Adverse Event|2
2513059|NCT01806597|8695264|P4|Period 1 (Baseline to Week 16)|Adverse Event|0
2513060|NCT01806597|8695265|P3|Period 1 (Baseline to Week 16)|Adverse Event|0
2513061|NCT01806597|8695266|P2|Period 1 (Baseline to Week 16)|Adverse Event|1
2513062|NCT01806597|8695267|P1|Period 1 (Baseline to Week 16)|Adverse Event|1
2513063|NCT01806584|8695303|P2|Overall Study|Other unspecified|0
2513064|NCT01806584|8695304|P1|Overall Study|Other unspecified|1
2513065|NCT01806584|8695303|P2|Overall Study|Withdrawal by Subject|1
2513066|NCT01806584|8695304|P1|Overall Study|Withdrawal by Subject|1
2513067|NCT01806584|8695303|P2|Overall Study|Study terminated by sponsor|14
2513068|NCT01806584|8695304|P1|Overall Study|Study terminated by sponsor|9
2513069|NCT01806584|8695303|P2|Overall Study|Lost to Follow-up|2
2513070|NCT01806584|8695304|P1|Overall Study|Lost to Follow-up|0
2513071|NCT01806584|8695303|P2|Overall Study|Death|0
2513072|NCT01806584|8695304|P1|Overall Study|Death|1
2513073|NCT01806584|8695303|P2|Overall Study|Adverse Event|1
2513074|NCT01806584|8695304|P1|Overall Study|Adverse Event|2
2513075|NCT01806545|8695326|P2|Overall Study|Withdrawal by Subject|2
2513076|NCT01806545|8695327|P1|Overall Study|Withdrawal by Subject|3
2513077|NCT01806545|8695326|P2|Overall Study|Lost to Follow-up|0
2513078|NCT01806545|8695327|P1|Overall Study|Lost to Follow-up|1
2513079|NCT01806545|8695326|P2|Overall Study|Adverse Event|3
2513080|NCT01806545|8695327|P1|Overall Study|Adverse Event|2
2513081|NCT01806506|8695351|P2|Overall Study|Lost to Follow-up|1
2513082|NCT01806506|8695352|P1|Overall Study|Lost to Follow-up|2
2513083|NCT01806389|8695358|P1|Overall Study|Withdrawal by Subject|4
2513084|NCT01806298|8695372|P1|Overall Study|Other|5
2513085|NCT01806298|8695372|P1|Overall Study|Withdrawal by Subject|1
2513086|NCT01806298|8695372|P1|Overall Study|Protocol Non-compliance|1
2513087|NCT01806298|8695372|P1|Overall Study|Adverse Event|3
2513088|NCT01806051|8695393|P1|Overall Study|Withdrawal by Subject|6
2513089|NCT01805180|8695510|P3|Lead-in Donor Phase|screen failure|0
2513090|NCT01805180|8695511|P2|Lead-in Donor Phase|screen failure|0
2513091|NCT01805180|8695512|P1|Lead-in Donor Phase|screen failure|1
2513092|NCT01804946|8695587|P2|Overall Study|Do not meet inclusion criteria|2
2513093|NCT01804946|8695588|P1|Overall Study|Do not meet inclusion criteria|1
2513094|NCT01804946|8695587|P2|Overall Study|Insufficient data available|1
2513095|NCT01804946|8695588|P1|Overall Study|Insufficient data available|0
2513096|NCT01804946|8695587|P2|Overall Study|Adverse Event|1
2513097|NCT01804946|8695588|P1|Overall Study|Adverse Event|0
2513098|NCT01804946|8695587|P2|Overall Study|Protocol Violation|0
2513099|NCT01804946|8695588|P1|Overall Study|Protocol Violation|1
2513100|NCT01804842|8695626|P3|Overall Study|Personal Reason|1
2513101|NCT01804842|8695627|P2|Overall Study|Personal Reason|0
2513103|NCT01804842|8695626|P3|Overall Study|Non-Compliance|0
2513104|NCT01804842|8695627|P2|Overall Study|Non-Compliance|1
2513105|NCT01804842|8695628|P1|Overall Study|Non-Compliance|1
2513106|NCT01804842|8695626|P3|Overall Study|Lost to Follow-up|0
2513107|NCT01804842|8695627|P2|Overall Study|Lost to Follow-up|0
2513108|NCT01804842|8695628|P1|Overall Study|Lost to Follow-up|1
2513109|NCT01804842|8695626|P3|Overall Study|Adverse Event|0
2513110|NCT01804842|8695627|P2|Overall Study|Adverse Event|1
2513111|NCT01804842|8695628|P1|Overall Study|Adverse Event|1
2513112|NCT01804816|8695645|P1|Acupuncture (Second 5 Weeks)|Physician Decision|1
2513113|NCT01804816|8695645|P1|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3
2513114|NCT01804673|8695657|P1|Overall Study|Other|4
2513115|NCT01804673|8695657|P1|Overall Study|Use of Prohibited Medication|1
2513116|NCT01804673|8695657|P1|Overall Study|No Further Therapy Required|84
2513117|NCT01804673|8695657|P1|Overall Study|Change to Oral Therapy|37
2513118|NCT01804673|8695657|P1|Overall Study|Lack of Efficacy|9
2513119|NCT01804673|8695657|P1|Overall Study|Withdrawal by Subject|1
2513120|NCT01804673|8695657|P1|Overall Study|Adverse Event|4
2513121|NCT01804582|8695675|P2|Overall Study|Physician Decision|0
2513122|NCT01804582|8695676|P1|Overall Study|Physician Decision|2
2513123|NCT01804582|8695675|P2|Overall Study|Lost to Follow-up|56
2513124|NCT01804582|8695676|P1|Overall Study|Lost to Follow-up|47
2513125|NCT01804140|8695696|P1|Overall Study|No sampling or biopsy procedures done|114
2513126|NCT01804049|8695730|P2|Overall Study|Enrollment in dual studies|1
2513127|NCT01804049|8695731|P1|Overall Study|Enrollment in dual studies|0
2513128|NCT01804049|8695730|P2|Overall Study|other MD recommended|1
2513129|NCT01804049|8695731|P1|Overall Study|other MD recommended|1
2513130|NCT01804049|8695730|P2|Overall Study|Moved out of area|7
2513131|NCT01804049|8695731|P1|Overall Study|Moved out of area|0
2513132|NCT01804049|8695730|P2|Overall Study|Other health concerns|7
2513133|NCT01804049|8695731|P1|Overall Study|Other health concerns|2
2513134|NCT01804049|8695730|P2|Overall Study|Decreased interest/personal|5
2513135|NCT01804049|8695731|P1|Overall Study|Decreased interest/personal|4
2513136|NCT01804049|8695730|P2|Overall Study|Lost to Follow-up|1
2513137|NCT01804049|8695731|P1|Overall Study|Lost to Follow-up|2
2513138|NCT01804049|8695730|P2|Overall Study|Adverse Event|10
2513139|NCT01804049|8695731|P1|Overall Study|Adverse Event|2
2513140|NCT01803880|8695779|P3|Overall Study|Incomplete data entry by sites|0
2513141|NCT01803880|8695780|P2|Overall Study|Incomplete data entry by sites|0
2513142|NCT01803880|8695781|P1|Overall Study|Incomplete data entry by sites|2
2513143|NCT01803880|8695779|P3|Overall Study|Early study termination|5
2513144|NCT01803880|8695780|P2|Overall Study|Early study termination|6
2513145|NCT01803880|8695781|P1|Overall Study|Early study termination|0
2513146|NCT01803880|8695779|P3|Overall Study|Protocol Violation|0
2513147|NCT01803880|8695780|P2|Overall Study|Protocol Violation|0
2513148|NCT01803880|8695781|P1|Overall Study|Protocol Violation|1
2513149|NCT01803880|8695779|P3|Overall Study|Lost to Follow-up|3
2513150|NCT01803880|8695780|P2|Overall Study|Lost to Follow-up|2
2513151|NCT01803880|8695781|P1|Overall Study|Lost to Follow-up|1
2513152|NCT01803880|8695779|P3|Overall Study|Unable to return for follow-up visits|2
2513153|NCT01803880|8695780|P2|Overall Study|Unable to return for follow-up visits|1
2513154|NCT01803880|8695781|P1|Overall Study|Unable to return for follow-up visits|0
2513155|NCT01803880|8695779|P3|Overall Study|Physician Decision|1
2513156|NCT01803880|8695780|P2|Overall Study|Physician Decision|0
2513157|NCT01803880|8695781|P1|Overall Study|Physician Decision|0
2513158|NCT01803880|8695779|P3|Overall Study|Withdrawal by Subject|4
2513159|NCT01803880|8695780|P2|Overall Study|Withdrawal by Subject|1
2513160|NCT01803880|8695781|P1|Overall Study|Withdrawal by Subject|1
2513161|NCT01803880|8695779|P3|Overall Study|Adverse Event|0
2513162|NCT01803880|8695780|P2|Overall Study|Adverse Event|0
2513163|NCT01803880|8695781|P1|Overall Study|Adverse Event|1
2513164|NCT01803737|8695817|P2|Overall Study|Lost to Follow-up|2
2513165|NCT01803737|8695818|P1|Overall Study|Lost to Follow-up|0
2513166|NCT01803737|8695817|P2|Overall Study|Medical Reason|1
2513167|NCT01803737|8695818|P1|Overall Study|Medical Reason|0
2513168|NCT01803737|8695817|P2|Overall Study|Lack of Time|0
2513169|NCT01803737|8695818|P1|Overall Study|Lack of Time|1
2513170|NCT01803711|8695842|P2|Overall Study|Adverse Event|1
2513171|NCT01803711|8695843|P1|Overall Study|Adverse Event|1
2513172|NCT01803646|8695861|P2|Overall Study|Lost to Follow-up|1
2513173|NCT01803646|8695862|P1|Overall Study|Lost to Follow-up|5
2513174|NCT01803646|8695861|P2|Overall Study|Randomization error|2
2513175|NCT01803646|8695862|P1|Overall Study|Randomization error|1
2513176|NCT01803646|8695861|P2|Overall Study|Withdrawal by Subject|6
2513177|NCT01803646|8695862|P1|Overall Study|Withdrawal by Subject|9
2513178|NCT01803646|8695861|P2|Overall Study|Adverse Event|1
2513179|NCT01803646|8695862|P1|Overall Study|Adverse Event|1
2513180|NCT01803646|8695861|P2|Overall Study|Protocol Violation|0
2513181|NCT01803646|8695862|P1|Overall Study|Protocol Violation|1
2513182|NCT01803607|8695874|P2|Overall Study|Withdrawal by Subject|5
2513183|NCT01803607|8695875|P1|Overall Study|Withdrawal by Subject|6
2513184|NCT01803607|8695874|P2|Overall Study|Study terminated by sponsor|56
2513185|NCT01803607|8695875|P1|Overall Study|Study terminated by sponsor|54
2513186|NCT01803607|8695874|P2|Overall Study|Protocol Violation|2
2513187|NCT01803607|8695875|P1|Overall Study|Protocol Violation|3
2513188|NCT01803607|8695874|P2|Overall Study|Lack of Efficacy|1
2513189|NCT01803607|8695875|P1|Overall Study|Lack of Efficacy|0
2513190|NCT01803607|8695874|P2|Overall Study|Adverse Event|3
2513191|NCT01803607|8695875|P1|Overall Study|Adverse Event|5
2513192|NCT01803464|8695899|P4|Overall Study|Withdrawal by Subject|0
2513193|NCT01803464|8695900|P3|Overall Study|Withdrawal by Subject|0
2513194|NCT01803464|8695901|P2|Overall Study|Withdrawal by Subject|0
2513195|NCT01803464|8695902|P1|Overall Study|Withdrawal by Subject|1
2513196|NCT01803464|8695899|P4|Overall Study|Incomplete data|0
2513197|NCT01803464|8695900|P3|Overall Study|Incomplete data|4
2513198|NCT01803464|8695901|P2|Overall Study|Incomplete data|0
2513199|NCT01803464|8695902|P1|Overall Study|Incomplete data|0
2513200|NCT01803269|8695923|P3|Overall Study|Withdrawal by Subject|0
2513201|NCT01803269|8695924|P2|Overall Study|Withdrawal by Subject|0
2513202|NCT01803269|8695925|P1|Overall Study|Withdrawal by Subject|3
2513203|NCT01802879|8696239|P1|Overall Study|Disease progression|6
2513204|NCT01802879|8696239|P1|Overall Study|Administrative problems|2
2513205|NCT01802775|8696246|P2|Overall Study|Lost to Follow-up|2
2513206|NCT01802775|8696247|P1|Overall Study|Lost to Follow-up|1
2513207|NCT01802775|8696246|P2|Overall Study|Withdrawal by Subject|5
2513208|NCT01802775|8696247|P1|Overall Study|Withdrawal by Subject|3
2513209|NCT01802775|8696246|P2|Overall Study|Adverse Event|1
2513210|NCT01802775|8696247|P1|Overall Study|Adverse Event|1
2513211|NCT01802775|8696246|P2|Overall Study|Physician Decision|0
2513212|NCT01802775|8696247|P1|Overall Study|Physician Decision|1
2513213|NCT01802775|8696246|P2|Overall Study|Reason not provided|1
2513214|NCT01802775|8696247|P1|Overall Study|Reason not provided|0
2513215|NCT01802775|8696246|P2|Overall Study|Death|3
2513216|NCT01802775|8696247|P1|Overall Study|Death|0
2513217|NCT01802632|8696282|P6|Overall Study|Other (not specified)|1
2513218|NCT01802632|8696283|P5|Overall Study|Other (not specified)|0
2513219|NCT01802632|8696284|P4|Overall Study|Other (not specified)|1
2513220|NCT01802632|8696285|P3|Overall Study|Other (not specified)|7
2513221|NCT01802632|8696286|P2|Overall Study|Other (not specified)|0
2513222|NCT01802632|8696287|P1|Overall Study|Other (not specified)|0
2513223|NCT01802632|8696282|P6|Overall Study|Ongoing Study at Data Cut-off|22
2513224|NCT01802632|8696283|P5|Overall Study|Ongoing Study at Data Cut-off|6
2513225|NCT01802632|8696284|P4|Overall Study|Ongoing Study at Data Cut-off|50
2513226|NCT01802632|8696285|P3|Overall Study|Ongoing Study at Data Cut-off|115
2513227|NCT01802632|8696286|P2|Overall Study|Ongoing Study at Data Cut-off|16
2513228|NCT01802632|8696287|P1|Overall Study|Ongoing Study at Data Cut-off|168
2513229|NCT01802632|8696282|P6|Overall Study|Objective Disease Progression|4
2513230|NCT01802632|8696283|P5|Overall Study|Objective Disease Progression|4
2513231|NCT01802632|8696284|P4|Overall Study|Objective Disease Progression|6
2513232|NCT01802632|8696285|P3|Overall Study|Objective Disease Progression|104
2513233|NCT01802632|8696286|P2|Overall Study|Objective Disease Progression|12
2513234|NCT01802632|8696287|P1|Overall Study|Objective Disease Progression|1
2513235|NCT01802632|8696282|P6|Overall Study|Withdrawal by Subject|1
2513236|NCT01802632|8696283|P5|Overall Study|Withdrawal by Subject|0
2513237|NCT01802632|8696284|P4|Overall Study|Withdrawal by Subject|3
2513238|NCT01802632|8696285|P3|Overall Study|Withdrawal by Subject|7
2513239|NCT01802632|8696286|P2|Overall Study|Withdrawal by Subject|2
2513240|NCT01802632|8696287|P1|Overall Study|Withdrawal by Subject|4
2513241|NCT01802632|8696282|P6|Overall Study|Death|0
2513242|NCT01802632|8696283|P5|Overall Study|Death|2
2513243|NCT01802632|8696284|P4|Overall Study|Death|0
2513244|NCT01802632|8696285|P3|Overall Study|Death|38
2513245|NCT01802632|8696286|P2|Overall Study|Death|1
2513246|NCT01802632|8696287|P1|Overall Study|Death|28
2513247|NCT01802580|8696303|P2|Overall Study|Lack of Efficacy|2
2513248|NCT01802580|8696304|P1|Overall Study|Lack of Efficacy|0
2513249|NCT01802580|8696303|P2|Overall Study|Other|3
2513250|NCT01802580|8696304|P1|Overall Study|Other|1
2513251|NCT01802580|8696303|P2|Overall Study|Withdrawal by Subject|6
2513252|NCT01802580|8696304|P1|Overall Study|Withdrawal by Subject|5
2513253|NCT01802580|8696303|P2|Overall Study|Protocol Violation|0
2513254|NCT01802580|8696304|P1|Overall Study|Protocol Violation|2
2513255|NCT01802580|8696303|P2|Overall Study|Physician Decision|0
2513256|NCT01802580|8696304|P1|Overall Study|Physician Decision|1
2513257|NCT01802515|8696335|P3|Overall Study|Withdrawal by Subject|0
2513258|NCT01802515|8696336|P2|Overall Study|Withdrawal by Subject|0
2513259|NCT01802515|8696337|P1|Overall Study|Withdrawal by Subject|3
2513260|NCT01802437|8696350|P2|Overall Study|Withdrawal by Subject|4
2513261|NCT01802437|8696351|P1|Overall Study|Withdrawal by Subject|3
2513262|NCT01802437|8696350|P2|Overall Study|Lost to Follow-up|0
2513263|NCT01802437|8696351|P1|Overall Study|Lost to Follow-up|1
2513264|NCT01802385|8696363|P2|Overall Study|Death|120
2513265|NCT01802385|8696364|P1|Overall Study|Death|106
2513266|NCT01802333|8696387|P3|Overall Study|Did not start treatment|5
2513267|NCT01802333|8696388|P2|Overall Study|Did not start treatment|2
2513268|NCT01802333|8696389|P1|Overall Study|Did not start treatment|0
2513269|NCT01802333|8696387|P3|Overall Study|Other - not protocol specified|24
2513270|NCT01802333|8696388|P2|Overall Study|Other - not protocol specified|22
2513271|NCT01802333|8696389|P1|Overall Study|Other - not protocol specified|32
2513272|NCT01802333|8696387|P3|Overall Study|Death|13
2513273|NCT01802333|8696388|P2|Overall Study|Death|14
2513274|NCT01802333|8696389|P1|Overall Study|Death|7
2513275|NCT01802333|8696387|P3|Overall Study|Progression/relapse|0
2513276|NCT01802333|8696388|P2|Overall Study|Progression/relapse|3
2513277|NCT01802333|8696389|P1|Overall Study|Progression/relapse|1
2513278|NCT01802333|8696387|P3|Overall Study|Withdrawal by Subject|5
2513279|NCT01802333|8696388|P2|Overall Study|Withdrawal by Subject|6
2513280|NCT01802333|8696389|P1|Overall Study|Withdrawal by Subject|6
2513281|NCT01802333|8696387|P3|Overall Study|Adverse Event|8
2513282|NCT01802333|8696388|P2|Overall Study|Adverse Event|8
2513283|NCT01802333|8696389|P1|Overall Study|Adverse Event|1
2513284|NCT01802333|8696387|P3|Overall Study|Ineligible|8
2513285|NCT01802333|8696388|P2|Overall Study|Ineligible|6
2513286|NCT01802333|8696389|P1|Overall Study|Ineligible|2
2513287|NCT01802320|8696416|P1|Overall Study|Withdrawal by Subject|1
2513288|NCT01802320|8696416|P1|Overall Study|Death|1
2513289|NCT01802216|8696426|P2|12 Month Visit|Participant did not show to visit|4
2513290|NCT01802216|8696427|P1|12 Month Visit|Participant did not show to visit|3
2513291|NCT01802216|8696426|P2|8 Month Visit|Participant did not show to visit|5
2513292|NCT01802216|8696427|P1|8 Month Visit|Participant did not show to visit|3
2513293|NCT01802216|8696426|P2|4 Month Visit|Participant did not show to visit|4
2513294|NCT01802216|8696427|P1|4 Month Visit|Participant did not show to visit|3
2513295|NCT01802073|8696506|P2|Overall Study|Physician Decision|7
2513296|NCT01802073|8696507|P1|Overall Study|Physician Decision|0
2513297|NCT01802073|8696506|P2|Overall Study|Withdrawal by Subject|1
2513298|NCT01802073|8696507|P1|Overall Study|Withdrawal by Subject|1
2513299|NCT01802073|8696506|P2|Overall Study|Non-compliant|2
2513300|NCT01802073|8696507|P1|Overall Study|Non-compliant|4
2513301|NCT01802073|8696506|P2|Overall Study|Lost to Follow-up|1
2513302|NCT01802073|8696507|P1|Overall Study|Lost to Follow-up|0
2513303|NCT01801982|8696523|P1|Overall Study|Lost to Follow-up|1
2513304|NCT01801917|8696537|P4|Period 1 - Randomized|Adverse Event|0
2513305|NCT01801917|8696538|P3|Period 1 - Randomized|Adverse Event|1
2513306|NCT01801917|8696539|P2|Period 1 - Randomized|Adverse Event|0
2513307|NCT01801917|8696540|P1|Period 1 - Randomized|Adverse Event|1
2513308|NCT01801735|8696560|P1|Overall Study|Other, including site closure|19
2513309|NCT01801735|8696560|P1|Overall Study|Death|1
2513310|NCT01801735|8696560|P1|Overall Study|Physician Decision|3
2513311|NCT01801735|8696560|P1|Overall Study|Non-compliance with Trial Drug|13
2513312|NCT01801735|8696560|P1|Overall Study|Lost to Follow-up|15
2513313|NCT01801735|8696560|P1|Overall Study|Protocol Violation|25
2513314|NCT01801735|8696560|P1|Overall Study|Withdrawal by Subject|27
2513315|NCT01801735|8696560|P1|Overall Study|Lack of Efficacy|28
2513316|NCT01801735|8696560|P1|Overall Study|Adverse Event|79
2513317|NCT01801475|8696567|P5|Overall Study|Withdrawal by Subject|1
2513318|NCT01801475|8696568|P4|Overall Study|Withdrawal by Subject|0
2513319|NCT01801475|8696569|P3|Overall Study|Withdrawal by Subject|0
2513320|NCT01801475|8696570|P2|Overall Study|Withdrawal by Subject|0
2513321|NCT01801475|8696571|P1|Overall Study|Withdrawal by Subject|0
2513322|NCT01801436|8696596|P1|Overall Study|Progressive disease|4
2513323|NCT01801436|8696596|P1|Overall Study|Adverse Event|2
2513324|NCT01801436|8696596|P1|Overall Study|Withdrawal by Subject|3
2513325|NCT01801358|8696634|P6|Overall Study|Withdrawal by Subject|2
2513326|NCT01801358|8696635|P5|Overall Study|Withdrawal by Subject|0
2513327|NCT01801358|8696636|P4|Overall Study|Withdrawal by Subject|1
2513328|NCT01801358|8696637|P3|Overall Study|Withdrawal by Subject|0
2513329|NCT01801358|8696638|P2|Overall Study|Withdrawal by Subject|0
2513330|NCT01801358|8696639|P1|Overall Study|Withdrawal by Subject|0
2513331|NCT01801358|8696634|P6|Overall Study|Progressive Disease|5
2513332|NCT01801358|8696635|P5|Overall Study|Progressive Disease|6
2513333|NCT01801358|8696636|P4|Overall Study|Progressive Disease|5
2513334|NCT01801358|8696637|P3|Overall Study|Progressive Disease|4
2513335|NCT01801358|8696638|P2|Overall Study|Progressive Disease|4
2513336|NCT01801358|8696639|P1|Overall Study|Progressive Disease|6
2513337|NCT01801358|8696634|P6|Overall Study|Physician Decision|0
2513338|NCT01801358|8696635|P5|Overall Study|Physician Decision|0
2513339|NCT01801358|8696636|P4|Overall Study|Physician Decision|0
2513340|NCT01801358|8696637|P3|Overall Study|Physician Decision|1
2513341|NCT01801358|8696638|P2|Overall Study|Physician Decision|0
2513342|NCT01801358|8696639|P1|Overall Study|Physician Decision|0
2513343|NCT01801358|8696634|P6|Overall Study|Adverse Event|1
2513344|NCT01801358|8696635|P5|Overall Study|Adverse Event|0
2513345|NCT01801358|8696636|P4|Overall Study|Adverse Event|0
2513346|NCT01801358|8696637|P3|Overall Study|Adverse Event|1
2513347|NCT01801358|8696638|P2|Overall Study|Adverse Event|2
2513348|NCT01801358|8696639|P1|Overall Study|Adverse Event|0
2513349|NCT01801280|8696761|P4|Period 4|Protocol Violation|0
2513350|NCT01801280|8696762|P3|Period 4|Protocol Violation|1
2513351|NCT01801280|8696763|P2|Period 4|Protocol Violation|0
2513352|NCT01801280|8696764|P1|Period 4|Protocol Violation|0
2513353|NCT01801280|8696761|P4|Period 2|Withdrawal by Subject|0
2513354|NCT01801280|8696762|P3|Period 2|Withdrawal by Subject|0
2513355|NCT01801280|8696763|P2|Period 2|Withdrawal by Subject|0
2513356|NCT01801280|8696764|P1|Period 2|Withdrawal by Subject|1
2513357|NCT01801280|8696761|P4|Period 1|Withdrawal by Subject|0
2513358|NCT01801280|8696762|P3|Period 1|Withdrawal by Subject|0
2513359|NCT01801280|8696763|P2|Period 1|Withdrawal by Subject|1
2513360|NCT01801280|8696764|P1|Period 1|Withdrawal by Subject|0
2513361|NCT01801111|8696779|P1|Overall Study|Progressive Disease|81
2513362|NCT01801111|8696779|P1|Overall Study|Study Terminated by Sponsor|27
2513363|NCT01801111|8696779|P1|Overall Study|Withdrawal by Subject|4
2513364|NCT01801111|8696779|P1|Overall Study|Other|1
2513365|NCT01801111|8696779|P1|Overall Study|Physician Decision|5
2513366|NCT01801111|8696779|P1|Overall Study|Death|8
2513367|NCT01801111|8696779|P1|Overall Study|Adverse Event|12
2513368|NCT01800968|8696820|P2|Overall Study|Physician Decision|0
2513369|NCT01800968|8696821|P1|Overall Study|Physician Decision|1
2513370|NCT01800968|8696820|P2|Overall Study|Withdrawal by Subject|9
2513371|NCT01800968|8696821|P1|Overall Study|Withdrawal by Subject|7
2513372|NCT01800968|8696820|P2|Overall Study|Lost to Follow-up|7
2513373|NCT01800968|8696821|P1|Overall Study|Lost to Follow-up|5
2513374|NCT01800968|8696820|P2|Overall Study|Death|16
2513375|NCT01800968|8696821|P1|Overall Study|Death|23
2513376|NCT01800916|8696863|P9|Test Period 1 (1 Week)|Adverse Event|0
2513377|NCT01800916|8696864|P8|Test Period 1 (1 Week)|Adverse Event|0
2513378|NCT01800916|8696865|P7|Test Period 1 (1 Week)|Adverse Event|0
2513379|NCT01800916|8696866|P6|Test Period 1 (1 Week)|Adverse Event|0
2513380|NCT01800916|8696867|P5|Test Period 1 (1 Week)|Adverse Event|1
2513381|NCT01800916|8696868|P4|Test Period 1 (1 Week)|Adverse Event|0
2513382|NCT01800916|8696869|P3|Test Period 1 (1 Week)|Adverse Event|0
2513383|NCT01800916|8696870|P2|Test Period 1 (1 Week)|Adverse Event|0
2513384|NCT01800916|8696871|P1|Test Period 1 (1 Week)|Adverse Event|0
2513385|NCT01800916|8696863|P9|Test Period 1 (1 Week)|Convex product user|0
2513386|NCT01800916|8696864|P8|Test Period 1 (1 Week)|Convex product user|0
2513387|NCT01800916|8696865|P7|Test Period 1 (1 Week)|Convex product user|0
2513388|NCT01800916|8696866|P6|Test Period 1 (1 Week)|Convex product user|0
2513389|NCT01800916|8696867|P5|Test Period 1 (1 Week)|Convex product user|0
2513390|NCT01800916|8696868|P4|Test Period 1 (1 Week)|Convex product user|1
2513391|NCT01800916|8696869|P3|Test Period 1 (1 Week)|Convex product user|0
2513392|NCT01800916|8696870|P2|Test Period 1 (1 Week)|Convex product user|0
2513393|NCT01800916|8696871|P1|Test Period 1 (1 Week)|Convex product user|0
2513394|NCT01800903|8696881|P6|Second Test Period|unable to catheterise|0
2513395|NCT01800903|8696882|P5|Second Test Period|unable to catheterise|0
2513396|NCT01800903|8696883|P4|Second Test Period|unable to catheterise|0
2513397|NCT01800903|8696884|P3|Second Test Period|unable to catheterise|0
2513398|NCT01800903|8696885|P2|Second Test Period|unable to catheterise|0
2513399|NCT01800903|8696886|P1|Second Test Period|unable to catheterise|1
2513400|NCT01800201|8696975|P2|Overall Study|PI withdrawal, cognitive concerns|1
2513401|NCT01800201|8696976|P1|Overall Study|PI withdrawal, cognitive concerns|0
2513402|NCT01800201|8696975|P2|Overall Study|did not want to use device|1
2513403|NCT01800201|8696976|P1|Overall Study|did not want to use device|0
2513404|NCT01800201|8696975|P2|Overall Study|patient privacy concerns|1
2513405|NCT01800201|8696976|P1|Overall Study|patient privacy concerns|1
2513406|NCT01800201|8696975|P2|Overall Study|Withdrawal by Subject|0
2513407|NCT01800201|8696976|P1|Overall Study|Withdrawal by Subject|2
2513408|NCT01799993|8697019|P2|Overall Study|Subject didn't return for follow-up|1
2513409|NCT01799993|8697020|P1|Overall Study|Subject didn't return for follow-up|0
2513410|NCT01799993|8697019|P2|Overall Study|Other|0
2513411|NCT01799993|8697020|P1|Overall Study|Other|1
2513412|NCT01799993|8697019|P2|Overall Study|Withdrawal by parent/guardian|1
2513413|NCT01799993|8697020|P1|Overall Study|Withdrawal by parent/guardian|0
2513414|NCT01799993|8697019|P2|Overall Study|Non-compliance with medical device|0
2513415|NCT01799993|8697020|P1|Overall Study|Non-compliance with medical device|1
2513416|NCT01799993|8697019|P2|Overall Study|Protocol deviation|0
2513417|NCT01799993|8697020|P1|Overall Study|Protocol deviation|1
2513418|NCT01799993|8697019|P2|Overall Study|Logistical difficulties|0
2513419|NCT01799993|8697020|P1|Overall Study|Logistical difficulties|1
2513420|NCT01799993|8697019|P2|Overall Study|Recovery|1
2513421|NCT01799993|8697020|P1|Overall Study|Recovery|0
2513422|NCT01799993|8697019|P2|Overall Study|Lack of Efficacy|0
2513423|NCT01799993|8697020|P1|Overall Study|Lack of Efficacy|1
2513424|NCT01799993|8697019|P2|Overall Study|Adverse Event|0
2513425|NCT01799993|8697020|P1|Overall Study|Adverse Event|1
2513426|NCT01799993|8697019|P2|Overall Study|Screen failure|1
2513427|NCT01799993|8697020|P1|Overall Study|Screen failure|0
2513428|NCT01799993|8697019|P2|Overall Study|Deterioration of general conditions|0
2513429|NCT01799993|8697020|P1|Overall Study|Deterioration of general conditions|2
2513430|NCT01799993|8697019|P2|Overall Study|Protocol Violation|1
2513431|NCT01799993|8697020|P1|Overall Study|Protocol Violation|1
2513432|NCT01799993|8697019|P2|Overall Study|Protocol driven decision point|3
2513433|NCT01799993|8697020|P1|Overall Study|Protocol driven decision point|0
2513434|NCT01799993|8697019|P2|Overall Study|Withdrawal by parent/guardian/LAR|3
2513435|NCT01799993|8697020|P1|Overall Study|Withdrawal by parent/guardian/LAR|5
2513436|NCT01799993|8697019|P2|Overall Study|Lost to Follow-up|8
2513437|NCT01799993|8697020|P1|Overall Study|Lost to Follow-up|5
2513438|NCT01799993|8697019|P2|Overall Study|Withdrawal by Subject|24
2513439|NCT01799993|8697020|P1|Overall Study|Withdrawal by Subject|23
2513440|NCT01799993|8697019|P2|Overall Study|Death|45
2513441|NCT01799993|8697020|P1|Overall Study|Death|61
2513442|NCT01799993|8697019|P2|Overall Study|"Didn't complete CRF page End of FU"|40
2513443|NCT01799993|8697020|P1|Overall Study|"Didn't complete CRF page End of FU"|30
2513444|NCT01799941|8697052|P1|Overall Study|Other|15
2513445|NCT01799941|8697052|P1|Overall Study|Lost to Follow-up|17
2513446|NCT01799941|8697052|P1|Overall Study|Lack of Efficacy|3
2513447|NCT01799941|8697052|P1|Overall Study|Investigator Decision|4
2513448|NCT01799941|8697052|P1|Overall Study|Death|2
2513449|NCT01799941|8697052|P1|Overall Study|Withdrawal by Subject|21
2513450|NCT01799941|8697052|P1|Overall Study|Adverse Event|34
2513451|NCT01799720|8697109|P3|Overall Study|Pregnancy|1
2513452|NCT01799720|8697110|P2|Overall Study|Pregnancy|0
2513453|NCT01799720|8697111|P1|Overall Study|Pregnancy|0
2513454|NCT01799720|8697109|P3|Overall Study|Protocol Violation|0
2513455|NCT01799720|8697110|P2|Overall Study|Protocol Violation|1
2513456|NCT01799720|8697111|P1|Overall Study|Protocol Violation|0
2513457|NCT01799720|8697109|P3|Overall Study|Withdrawal by Subject|0
2513458|NCT01799720|8697110|P2|Overall Study|Withdrawal by Subject|0
2513459|NCT01799720|8697111|P1|Overall Study|Withdrawal by Subject|3
2513460|NCT01799590|8697149|P3|Overall Study|Other|1
2513461|NCT01799590|8697150|P2|Overall Study|Other|0
2513462|NCT01799590|8697151|P1|Overall Study|Other|3
2513463|NCT01799590|8697149|P3|Overall Study|Use of prohibited concomitant drugs|0
2513464|NCT01799590|8697150|P2|Overall Study|Use of prohibited concomitant drugs|0
2513465|NCT01799590|8697151|P1|Overall Study|Use of prohibited concomitant drugs|1
2513466|NCT01799590|8697149|P3|Overall Study|Using drugs with restricted days of use|2
2513467|NCT01799590|8697150|P2|Overall Study|Using drugs with restricted days of use|3
2513468|NCT01799590|8697151|P1|Overall Study|Using drugs with restricted days of use|0
2513469|NCT01799590|8697149|P3|Overall Study|Aggravation of complications|1
2513470|NCT01799590|8697150|P2|Overall Study|Aggravation of complications|1
2513471|NCT01799590|8697151|P1|Overall Study|Aggravation of complications|0
2513472|NCT01799590|8697149|P3|Overall Study|Participants convenience|2
2513473|NCT01799590|8697150|P2|Overall Study|Participants convenience|4
2513474|NCT01799590|8697151|P1|Overall Study|Participants convenience|4
2513475|NCT01799590|8697149|P3|Overall Study|Lack of Efficacy|3
2513476|NCT01799590|8697150|P2|Overall Study|Lack of Efficacy|1
2513477|NCT01799590|8697151|P1|Overall Study|Lack of Efficacy|3
2513478|NCT01799590|8697149|P3|Overall Study|Pregnancy|0
2513479|NCT01799590|8697150|P2|Overall Study|Pregnancy|0
2513480|NCT01799590|8697151|P1|Overall Study|Pregnancy|2
2513481|NCT01799590|8697149|P3|Overall Study|Adverse Event|5
2513482|NCT01799590|8697150|P2|Overall Study|Adverse Event|7
2513483|NCT01799590|8697151|P1|Overall Study|Adverse Event|13
2513484|NCT01799239|8697194|P2|Period 2 (7 Days)|Protocol Violation|0
2513485|NCT01799239|8697195|P1|Period 2 (7 Days)|Protocol Violation|1
2513486|NCT01799239|8697194|P2|Period 2 (7 Days)|Withdrawal by Subject|1
2513487|NCT01799239|8697195|P1|Period 2 (7 Days)|Withdrawal by Subject|1
2513488|NCT01799239|8697194|P2|Period 1 (7 Days)|Protocol Violation|1
2513489|NCT01799239|8697195|P1|Period 1 (7 Days)|Protocol Violation|0
2513490|NCT01799239|8697194|P2|Period 1 (7 Days)|Withdrawal by Subject|0
2513491|NCT01799239|8697195|P1|Period 1 (7 Days)|Withdrawal by Subject|2
2513492|NCT01799239|8697194|P2|Period 1 (7 Days)|Lack of Efficacy|0
2513493|NCT01799239|8697195|P1|Period 1 (7 Days)|Lack of Efficacy|1
2513494|NCT01799226|8697203|P2|Overall Study|Disqualified at Day 14|0
2513495|NCT01799226|8697204|P1|Overall Study|Disqualified at Day 14|1
2513496|NCT01799226|8697203|P2|Overall Study|Withdrawal by Subject|0
2513497|NCT01799226|8697204|P1|Overall Study|Withdrawal by Subject|1
2513498|NCT01798992|8697235|P4|Overall Study|Insufficient biopsy tissue|0
2513499|NCT01798992|8697236|P3|Overall Study|Insufficient biopsy tissue|1
2513500|NCT01798992|8697237|P2|Overall Study|Insufficient biopsy tissue|0
2513501|NCT01798992|8697238|P1|Overall Study|Insufficient biopsy tissue|0
2513502|NCT01798992|8697235|P4|Overall Study|Lost to Follow-up|0
2513503|NCT01798992|8697236|P3|Overall Study|Lost to Follow-up|1
2513504|NCT01798992|8697237|P2|Overall Study|Lost to Follow-up|1
2513505|NCT01798992|8697238|P1|Overall Study|Lost to Follow-up|0
2513506|NCT01798992|8697235|P4|Overall Study|Administrative withdrawal|1
2513507|NCT01798992|8697236|P3|Overall Study|Administrative withdrawal|0
2513508|NCT01798992|8697237|P2|Overall Study|Administrative withdrawal|1
2513509|NCT01798992|8697238|P1|Overall Study|Administrative withdrawal|0
2513510|NCT01798927|8697258|P1|Overall Study|Withdrawal by Subject|1
2513511|NCT01798849|8697267|P3|Overall Study|Physician Decision|1
2513512|NCT01798849|8697268|P2|Overall Study|Physician Decision|0
2513513|NCT01798849|8697269|P1|Overall Study|Physician Decision|0
2513514|NCT01798706|8697459|P2|Overall Study|Other than specified above|9
2513515|NCT01798706|8697460|P1|Overall Study|Other than specified above|5
2513516|NCT01798706|8697459|P2|Overall Study|Poor compliance to protocol|0
2513517|NCT01798706|8697460|P1|Overall Study|Poor compliance to protocol|1
2513518|NCT01798706|8697459|P2|Overall Study|Lack of Efficacy|2
2513519|NCT01798706|8697460|P1|Overall Study|Lack of Efficacy|0
2513520|NCT01798706|8697459|P2|Overall Study|Adverse Event|10
2513521|NCT01798706|8697460|P1|Overall Study|Adverse Event|15
2513522|NCT01798485|8697522|P2|Overall Study|Clinical Progression|24
2513523|NCT01798485|8697523|P1|Overall Study|Clinical Progression|35
2513524|NCT01798485|8697522|P2|Overall Study|Sponsor Decision|54
2513525|NCT01798485|8697523|P1|Overall Study|Sponsor Decision|61
2513526|NCT01798485|8697522|P2|Overall Study|Death|22
2513527|NCT01798485|8697523|P1|Overall Study|Death|25
2513528|NCT01798485|8697522|P2|Overall Study|Objective Disease Progression|106
2513529|NCT01798485|8697523|P1|Overall Study|Objective Disease Progression|152
2513530|NCT01798485|8697522|P2|Overall Study|Physician Decision|10
2513531|NCT01798485|8697523|P1|Overall Study|Physician Decision|14
2513532|NCT01798485|8697522|P2|Overall Study|Lost to Follow-up|3
2513533|NCT01798485|8697523|P1|Overall Study|Lost to Follow-up|0
2513534|NCT01798485|8697522|P2|Overall Study|Withdrawal by Subject|31
2513535|NCT01798485|8697523|P1|Overall Study|Withdrawal by Subject|27
2513536|NCT01798485|8697522|P2|Overall Study|Adverse Event|40
2513537|NCT01798485|8697523|P1|Overall Study|Adverse Event|32
2513538|NCT01798134|8697660|P1|Overall Study|Liver transplant/surgery|4
2513539|NCT01798134|8697660|P1|Overall Study|Physician Decision|3
2513540|NCT01798134|8697660|P1|Overall Study|Adverse Event|3
2513541|NCT01798134|8697660|P1|Overall Study|Death|2
2513542|NCT01798134|8697660|P1|Overall Study|Withdrawal by Subject|3
2513543|NCT01798134|8697660|P1|Overall Study|Lost to Follow-up|1
2513544|NCT01798056|8697669|P2|Overall Study|Other|2
2513545|NCT01798056|8697670|P1|Overall Study|Other|0
2513546|NCT01798056|8697669|P2|Overall Study|Lost to Follow-up|1
2513547|NCT01798056|8697670|P1|Overall Study|Lost to Follow-up|1
2513548|NCT01798056|8697669|P2|Overall Study|Migrated/moved from study area|1
2513549|NCT01798056|8697670|P1|Overall Study|Migrated/moved from study area|1
2513550|NCT01798056|8697669|P2|Overall Study|Withdrawal by Subject|9
2513551|NCT01798056|8697670|P1|Overall Study|Withdrawal by Subject|12
2513552|NCT01798056|8697669|P2|Overall Study|Serious Adverse Event|12
2513553|NCT01798056|8697670|P1|Overall Study|Serious Adverse Event|13
2513554|NCT01798004|8697704|P1|Overall Study|Enrollment another COG therapeutic trial|32
2513555|NCT01798004|8697704|P1|Overall Study|Initiation of other non-protocol therapy|5
2513556|NCT01798004|8697704|P1|Overall Study|Patient/parent refusal|7
2513557|NCT01798004|8697704|P1|Overall Study|Ineligible|4
2513558|NCT01798004|8697704|P1|Overall Study|Withdrawal by Subject|4
2513559|NCT01798004|8697704|P1|Overall Study|Physician Decision|25
2513560|NCT01798004|8697704|P1|Overall Study|Lack of Efficacy|8
2513561|NCT01798004|8697704|P1|Overall Study|Death|2
2513562|NCT01797965|8697712|P4|Overall Study|Reason Not Specified|15
2513563|NCT01797965|8697713|P3|Overall Study|Reason Not Specified|0
2513564|NCT01797965|8697714|P2|Overall Study|Reason Not Specified|295
2513565|NCT01797965|8697715|P1|Overall Study|Reason Not Specified|280
2513566|NCT01797965|8697712|P4|Overall Study|Disease progression, defined by protocol|0
2513567|NCT01797965|8697713|P3|Overall Study|Disease progression, defined by protocol|0
2513568|NCT01797965|8697714|P2|Overall Study|Disease progression, defined by protocol|1
2513569|NCT01797965|8697715|P1|Overall Study|Disease progression, defined by protocol|3
2513570|NCT01797965|8697712|P4|Overall Study|Death|0
2513571|NCT01797965|8697713|P3|Overall Study|Death|0
2513572|NCT01797965|8697714|P2|Overall Study|Death|4
2513573|NCT01797965|8697715|P1|Overall Study|Death|2
2513574|NCT01797965|8697712|P4|Overall Study|Investigator decision|0
2513575|NCT01797965|8697713|P3|Overall Study|Investigator decision|0
2513576|NCT01797965|8697714|P2|Overall Study|Investigator decision|15
2513577|NCT01797965|8697715|P1|Overall Study|Investigator decision|21
2513578|NCT01797965|8697712|P4|Overall Study|Consent withdrawn|35
2513579|NCT01797965|8697713|P3|Overall Study|Consent withdrawn|3
2513580|NCT01797965|8697714|P2|Overall Study|Consent withdrawn|117
2513581|NCT01797965|8697715|P1|Overall Study|Consent withdrawn|130
2513582|NCT01797965|8697712|P4|Overall Study|Lost to Follow-up|2
2513583|NCT01797965|8697713|P3|Overall Study|Lost to Follow-up|1
2513584|NCT01797965|8697714|P2|Overall Study|Lost to Follow-up|8
2513585|NCT01797965|8697715|P1|Overall Study|Lost to Follow-up|9
2513586|NCT01797965|8697712|P4|Overall Study|Adverse Event|21
2513587|NCT01797965|8697713|P3|Overall Study|Adverse Event|4
2513588|NCT01797965|8697714|P2|Overall Study|Adverse Event|129
2513589|NCT01797965|8697715|P1|Overall Study|Adverse Event|104
2513590|NCT01797835|8697849|P2|Overall Study|Lost to Follow-up|27
2513591|NCT01797835|8697850|P1|Overall Study|Lost to Follow-up|31
2513592|NCT01797783|8697866|P2|Overall Study|Withdrawal by Subject|0
2513593|NCT01797783|8697867|P1|Overall Study|Withdrawal by Subject|1
2513594|NCT01797783|8697866|P2|Overall Study|Adverse Event|1
2513595|NCT01797783|8697867|P1|Overall Study|Adverse Event|1
2513596|NCT01797731|8697891|P2|Overall Study|Didn't have proper radiographs required|3
2513597|NCT01797731|8697892|P1|Overall Study|Didn't have proper radiographs required|3
2513598|NCT01797705|8697900|P1|Overall Study|Withdrawal by Subject|1
2513599|NCT01797705|8697900|P1|Overall Study|Equipment anomalies during sleep studies|4
2513600|NCT01797536|8697965|P4|Overall Study|Adverse Event|0
2513601|NCT01797536|8697966|P3|Overall Study|Adverse Event|0
2513602|NCT01797536|8697967|P2|Overall Study|Adverse Event|1
2513603|NCT01797536|8697968|P1|Overall Study|Adverse Event|0
2513604|NCT01797445|8698040|P2|Open-Label Extension Phase|Investigator's Discretion|0
2513605|NCT01797445|8698041|P1|Open-Label Extension Phase|Investigator's Discretion|1
2513606|NCT01797445|8698040|P2|Double-Blind Phase|Lost to Follow-up|26
2513607|NCT01797445|8698041|P1|Double-Blind Phase|Lost to Follow-up|34
2513608|NCT01797445|8698040|P2|Double-Blind Phase|Withdrew Consent|35
2513609|NCT01797445|8698041|P1|Double-Blind Phase|Withdrew Consent|20
2513610|NCT01797445|8698040|P2|Double-Blind Phase|Protocol Violation|1
2513611|NCT01797445|8698041|P1|Double-Blind Phase|Protocol Violation|0
2513612|NCT01797445|8698040|P2|Double-Blind Phase|Noncompliance with Study Drug|1
2513613|NCT01797445|8698041|P1|Double-Blind Phase|Noncompliance with Study Drug|5
2513614|NCT01797445|8698040|P2|Double-Blind Phase|Investigator's Discretion|17
2513615|NCT01797445|8698041|P1|Double-Blind Phase|Investigator's Discretion|15
2513616|NCT01797445|8698040|P2|Double-Blind Phase|Lack of Efficacy|2
2513617|NCT01797445|8698041|P1|Double-Blind Phase|Lack of Efficacy|1
2513618|NCT01797445|8698040|P2|Double-Blind Phase|Pregnancy|1
2513619|NCT01797445|8698041|P1|Double-Blind Phase|Pregnancy|0
2513620|NCT01797445|8698040|P2|Double-Blind Phase|Death|4
2513621|NCT01797445|8698041|P1|Double-Blind Phase|Death|5
2513622|NCT01797445|8698040|P2|Double-Blind Phase|Adverse Event|0
2513623|NCT01797445|8698041|P1|Double-Blind Phase|Adverse Event|3
2513624|NCT01797445|8698040|P2|Double-Blind Phase|Randomized but Not Treated|2
2513625|NCT01797445|8698041|P1|Double-Blind Phase|Randomized but Not Treated|4
2513626|NCT01797263|8698101|P2|Overall Study|Lost to Follow-up|15
2513627|NCT01797263|8698102|P1|Overall Study|Lost to Follow-up|15
2513628|NCT01797263|8698101|P2|Overall Study|Death|0
2513629|NCT01797263|8698102|P1|Overall Study|Death|1
2513630|NCT01797263|8698101|P2|Overall Study|Withdrawal by Subject|25
2513631|NCT01797263|8698102|P1|Overall Study|Withdrawal by Subject|21
2513632|NCT01797185|8698137|P3|Overall Study|Protocol Violation|0
2513633|NCT01797185|8698138|P2|Overall Study|Protocol Violation|1
2513634|NCT01797185|8698139|P1|Overall Study|Protocol Violation|1
2513635|NCT01797185|8698137|P3|Overall Study|Physician Decision|0
2513636|NCT01797185|8698138|P2|Overall Study|Physician Decision|3
2513637|NCT01797185|8698139|P1|Overall Study|Physician Decision|1
2513638|NCT01797185|8698137|P3|Overall Study|Withdrawn per sponsor|0
2513639|NCT01797185|8698138|P2|Overall Study|Withdrawn per sponsor|0
2513640|NCT01797185|8698139|P1|Overall Study|Withdrawn per sponsor|5
2513641|NCT01797185|8698137|P3|Overall Study|Lost to Follow-up|1
2513642|NCT01797185|8698138|P2|Overall Study|Lost to Follow-up|6
2513643|NCT01797185|8698139|P1|Overall Study|Lost to Follow-up|2
2513644|NCT01797185|8698137|P3|Overall Study|Site terminated|0
2513645|NCT01797185|8698138|P2|Overall Study|Site terminated|4
2513646|NCT01797185|8698139|P1|Overall Study|Site terminated|8
2513647|NCT01797185|8698137|P3|Overall Study|Withdrawal by Subject|5
2513648|NCT01797185|8698138|P2|Overall Study|Withdrawal by Subject|9
2513649|NCT01797185|8698139|P1|Overall Study|Withdrawal by Subject|6
2513650|NCT01797185|8698137|P3|Overall Study|Adverse Event|6
2513651|NCT01797185|8698138|P2|Overall Study|Adverse Event|15
2513652|NCT01797185|8698139|P1|Overall Study|Adverse Event|5
2513653|NCT01797120|8698149|P2|Overall Study|never start protocol therapy|0
2513654|NCT01797120|8698150|P1|Overall Study|never start protocol therapy|2
2513655|NCT01797120|8698149|P2|Overall Study|still on treatment|4
2513656|NCT01797120|8698150|P1|Overall Study|still on treatment|2
2513657|NCT01797120|8698149|P2|Overall Study|Physician Decision|0
2513658|NCT01797120|8698150|P1|Overall Study|Physician Decision|3
2513659|NCT01797120|8698149|P2|Overall Study|Non-compliance|0
2513660|NCT01797120|8698150|P1|Overall Study|Non-compliance|1
2513661|NCT01797120|8698149|P2|Overall Study|Symptomatic progression|1
2513662|NCT01797120|8698150|P1|Overall Study|Symptomatic progression|2
2513663|NCT01797120|8698149|P2|Overall Study|Withdrawal by Subject|6
2513664|NCT01797120|8698150|P1|Overall Study|Withdrawal by Subject|6
2513665|NCT01797120|8698149|P2|Overall Study|Adverse Event|5
2513666|NCT01797120|8698150|P1|Overall Study|Adverse Event|13
2513667|NCT01797120|8698149|P2|Overall Study|Disesae progression|49
2513668|NCT01797120|8698150|P1|Overall Study|Disesae progression|37
2513669|NCT01797094|8698164|P2|Overall Study|Other Miscellaneous Reasons|0
2513670|NCT01797094|8698165|P1|Overall Study|Other Miscellaneous Reasons|1
2513671|NCT01797094|8698164|P2|Overall Study|Protocol Violation|1
2513672|NCT01797094|8698165|P1|Overall Study|Protocol Violation|0
2513673|NCT01797094|8698164|P2|Overall Study|Personal Reasons|0
2513674|NCT01797094|8698165|P1|Overall Study|Personal Reasons|4
2513675|NCT01797094|8698164|P2|Overall Study|Adverse Event|1
2513676|NCT01797094|8698165|P1|Overall Study|Adverse Event|1
2513677|NCT01797081|8698187|P4|Overall Study|Protocol Violation|1
2513678|NCT01797081|8698188|P3|Overall Study|Protocol Violation|0
2513679|NCT01797081|8698189|P2|Overall Study|Protocol Violation|0
2513680|NCT01797081|8698190|P1|Overall Study|Protocol Violation|0
2513681|NCT01797081|8698187|P4|Overall Study|Personal Reasons|8
2513682|NCT01797081|8698188|P3|Overall Study|Personal Reasons|4
2513683|NCT01797081|8698189|P2|Overall Study|Personal Reasons|4
2513684|NCT01797081|8698190|P1|Overall Study|Personal Reasons|12
2513685|NCT01797081|8698187|P4|Overall Study|Pregnancy|0
2513686|NCT01797081|8698188|P3|Overall Study|Pregnancy|0
2513687|NCT01797081|8698189|P2|Overall Study|Pregnancy|0
2513688|NCT01797081|8698190|P1|Overall Study|Pregnancy|1
2513689|NCT01797081|8698187|P4|Overall Study|Adverse Event|0
2513690|NCT01797081|8698188|P3|Overall Study|Adverse Event|1
2513691|NCT01797081|8698189|P2|Overall Study|Adverse Event|0
2513692|NCT01797081|8698190|P1|Overall Study|Adverse Event|1
2513693|NCT01796964|8698231|P2|Overall Study|Withdrawal by Subject|1
2513694|NCT01796964|8698232|P1|Overall Study|Withdrawal by Subject|1
2513695|NCT01796964|8698231|P2|Overall Study|Protocol Violation|1
2513696|NCT01796964|8698232|P1|Overall Study|Protocol Violation|0
2513697|NCT01796964|8698231|P2|Overall Study|Death|0
2513698|NCT01796964|8698232|P1|Overall Study|Death|1
2513699|NCT01796964|8698231|P2|Overall Study|Adverse Event|1
2513700|NCT01796964|8698232|P1|Overall Study|Adverse Event|1
2513701|NCT01796860|8698273|P1|Overall Study|Withdrawal by Subject|3
2513702|NCT01796548|8698279|P1|Overall Study|Other|2
2513703|NCT01796548|8698279|P1|Overall Study|Lost to Follow-up|1
2513704|NCT01796392|8698293|P2|Overall Study|Lost to Follow-up|0
2513705|NCT01796392|8698294|P1|Overall Study|Lost to Follow-up|1
2513706|NCT01796392|8698293|P2|Overall Study|Excluded for medical reasons|2
2513707|NCT01796392|8698294|P1|Overall Study|Excluded for medical reasons|1
2513708|NCT01796392|8698293|P2|Overall Study|Death|1
2513709|NCT01796392|8698294|P1|Overall Study|Death|5
2513710|NCT01796392|8698293|P2|Overall Study|Withdrawal by Subject|0
2513711|NCT01796392|8698294|P1|Overall Study|Withdrawal by Subject|2
2513712|NCT01796301|8698308|P2|Overall Study|Decision by Sponsor|1
2513713|NCT01796301|8698309|P1|Overall Study|Decision by Sponsor|0
2513714|NCT01796301|8698308|P2|Overall Study|Death|1
2513715|NCT01796301|8698309|P1|Overall Study|Death|0
2513716|NCT01796301|8698308|P2|Overall Study|Lost to Follow-up|3
2513717|NCT01796301|8698309|P1|Overall Study|Lost to Follow-up|3
2513718|NCT01796301|8698308|P2|Overall Study|Withdrawal by Subject|15
2513719|NCT01796301|8698309|P1|Overall Study|Withdrawal by Subject|15
2513720|NCT01795937|8698395|P3|Overall Study|Physician Decision|0
2513721|NCT01795937|8698396|P2|Overall Study|Physician Decision|1
2513722|NCT01795937|8698397|P1|Overall Study|Physician Decision|0
2513723|NCT01795937|8698395|P3|Overall Study|Withdrawal by Subject|0
2513724|NCT01795937|8698396|P2|Overall Study|Withdrawal by Subject|0
2513725|NCT01795937|8698397|P1|Overall Study|Withdrawal by Subject|1
2513726|NCT01795898|8698426|P1|Overall Study|Physician Decision|1
2513727|NCT01795898|8698426|P1|Overall Study|Withdrew consent & had adverse events|3
2513728|NCT01795898|8698426|P1|Overall Study|Death|1
2513729|NCT01795898|8698426|P1|Overall Study|No pain|1
2513730|NCT01795898|8698426|P1|Overall Study|Diagnosed with metastasis|1
2513731|NCT01795898|8698426|P1|Overall Study|Withdrawal of consent|6
2513732|NCT01795898|8698426|P1|Overall Study|Lost to Follow-up|20
2513733|NCT01795898|8698426|P1|Overall Study|Adverse Event|27
2513734|NCT01795547|8698485|P2|Overall Study|Not stated|1
2513735|NCT01795547|8698486|P1|Overall Study|Not stated|0
2513736|NCT01795547|8698485|P2|Overall Study|Others|1
2513737|NCT01795547|8698486|P1|Overall Study|Others|4
2513738|NCT01795547|8698485|P2|Overall Study|Non-compliance with IMP|1
2513739|NCT01795547|8698486|P1|Overall Study|Non-compliance with IMP|1
2513740|NCT01795547|8698485|P2|Overall Study|Not Treated|10
2513741|NCT01795547|8698486|P1|Overall Study|Not Treated|4
2513742|NCT01795547|8698485|P2|Overall Study|Withdrawal of consent|12
2513743|NCT01795547|8698486|P1|Overall Study|Withdrawal of consent|7
2513744|NCT01795547|8698485|P2|Overall Study|Lost to Follow-up|5
2513745|NCT01795547|8698486|P1|Overall Study|Lost to Follow-up|2
2513746|NCT01795547|8698485|P2|Overall Study|Protocol Violation|4
2513747|NCT01795547|8698486|P1|Overall Study|Protocol Violation|6
2513748|NCT01795547|8698485|P2|Overall Study|Lack of Efficacy|3
2513749|NCT01795547|8698486|P1|Overall Study|Lack of Efficacy|8
2513750|NCT01795547|8698485|P2|Overall Study|Adverse Event|27
2513751|NCT01795547|8698486|P1|Overall Study|Adverse Event|16
2513752|NCT01795495|8698518|P3|Overall Study|Physician Decision|1
2513753|NCT01795495|8698519|P2|Overall Study|Physician Decision|0
2513754|NCT01795495|8698520|P1|Overall Study|Physician Decision|0
2513755|NCT01795495|8698518|P3|Overall Study|Protocol Violation|1
2513756|NCT01795495|8698519|P2|Overall Study|Protocol Violation|0
2513757|NCT01795495|8698520|P1|Overall Study|Protocol Violation|1
2513758|NCT01794949|8698540|P2|Overall Study|Lost to Follow-up|0
2513759|NCT01794949|8698541|P1|Overall Study|Lost to Follow-up|1
2513760|NCT01794845|8698552|P1|Overall Study|Withdrawal by Subject|1
2513761|NCT01794780|8698580|P8|Overall Study|Other|1
2513762|NCT01794780|8698581|P7|Overall Study|Other|4
2513763|NCT01794780|8698582|P6|Overall Study|Other|24
2513764|NCT01794780|8698583|P5|Overall Study|Other|1
2513765|NCT01794780|8698584|P4|Overall Study|Other|20
2513766|NCT01794780|8698585|P3|Overall Study|Other|25
2513767|NCT01794780|8698586|P2|Overall Study|Other|12
2513768|NCT01794780|8698587|P1|Overall Study|Other|0
2513769|NCT01794780|8698580|P8|Overall Study|Withdrew informed consent|3
2513770|NCT01794780|8698581|P7|Overall Study|Withdrew informed consent|4
2513771|NCT01794780|8698582|P6|Overall Study|Withdrew informed consent|48
2513772|NCT01794780|8698583|P5|Overall Study|Withdrew informed consent|0
2513773|NCT01794780|8698584|P4|Overall Study|Withdrew informed consent|9
2513774|NCT01794780|8698585|P3|Overall Study|Withdrew informed consent|36
2513775|NCT01794780|8698586|P2|Overall Study|Withdrew informed consent|17
2513776|NCT01794780|8698587|P1|Overall Study|Withdrew informed consent|7
2513777|NCT01794780|8698580|P8|Overall Study|Lost to Follow-up|5
2513778|NCT01794780|8698581|P7|Overall Study|Lost to Follow-up|30
2513779|NCT01794780|8698582|P6|Overall Study|Lost to Follow-up|99
2513780|NCT01794780|8698583|P5|Overall Study|Lost to Follow-up|2
2513781|NCT01794780|8698584|P4|Overall Study|Lost to Follow-up|53
2513782|NCT01794780|8698585|P3|Overall Study|Lost to Follow-up|165
2513783|NCT01794780|8698586|P2|Overall Study|Lost to Follow-up|64
2513784|NCT01794780|8698587|P1|Overall Study|Lost to Follow-up|10
2513785|NCT01794780|8698580|P8|Overall Study|Death|0
2513786|NCT01794780|8698581|P7|Overall Study|Death|4
2513787|NCT01794780|8698582|P6|Overall Study|Death|9
2513788|NCT01794780|8698583|P5|Overall Study|Death|0
2513789|NCT01794780|8698584|P4|Overall Study|Death|1
2513790|NCT01794780|8698585|P3|Overall Study|Death|14
2513791|NCT01794780|8698586|P2|Overall Study|Death|2
2513792|NCT01794780|8698587|P1|Overall Study|Death|0
2513793|NCT01794780|8698580|P8|Overall Study|Adverse Event|0
2513794|NCT01794780|8698581|P7|Overall Study|Adverse Event|0
2513795|NCT01794780|8698582|P6|Overall Study|Adverse Event|0
2513796|NCT01794780|8698583|P5|Overall Study|Adverse Event|0
2513797|NCT01794780|8698584|P4|Overall Study|Adverse Event|0
2513798|NCT01794780|8698585|P3|Overall Study|Adverse Event|2
2513799|NCT01794780|8698586|P2|Overall Study|Adverse Event|1
2513800|NCT01794780|8698587|P1|Overall Study|Adverse Event|0
2513801|NCT01794689|8698663|P4|Intervention 1 (2 Nights)|Adverse Event|0
2513802|NCT01794689|8698664|P3|Intervention 1 (2 Nights)|Adverse Event|0
2513803|NCT01794689|8698665|P2|Intervention 1 (2 Nights)|Adverse Event|1
2513804|NCT01794689|8698666|P1|Intervention 1 (2 Nights)|Adverse Event|0
2513805|NCT01794689|8698663|P4|Intervention 1 (2 Nights)|Physician Decision|0
2513806|NCT01794689|8698664|P3|Intervention 1 (2 Nights)|Physician Decision|0
2513807|NCT01794689|8698665|P2|Intervention 1 (2 Nights)|Physician Decision|1
2513808|NCT01794689|8698666|P1|Intervention 1 (2 Nights)|Physician Decision|1
2513809|NCT01794689|8698663|P4|Intervention 1 (2 Nights)|Protocol Violation|0
2513810|NCT01794689|8698664|P3|Intervention 1 (2 Nights)|Protocol Violation|1
2513811|NCT01794689|8698665|P2|Intervention 1 (2 Nights)|Protocol Violation|0
2513812|NCT01794689|8698666|P1|Intervention 1 (2 Nights)|Protocol Violation|1
2513813|NCT01794689|8698663|P4|Intervention 1 (2 Nights)|Withdrawal by Subject|4
2513814|NCT01794689|8698664|P3|Intervention 1 (2 Nights)|Withdrawal by Subject|2
2513815|NCT01794689|8698665|P2|Intervention 1 (2 Nights)|Withdrawal by Subject|0
2513816|NCT01794689|8698666|P1|Intervention 1 (2 Nights)|Withdrawal by Subject|3
2513817|NCT01794000|8698735|P2|Open-Label Extension Phase (OLE)|Sponsor Decision|0
2513818|NCT01794000|8698736|P1|Open-Label Extension Phase (OLE)|Sponsor Decision|3
2513819|NCT01794000|8698735|P2|Double-Blind Phase (DBP)|Withdrawal by Subject|11
2513820|NCT01794000|8698736|P1|Double-Blind Phase (DBP)|Withdrawal by Subject|6
2513821|NCT01794000|8698735|P2|Double-Blind Phase (DBP)|Sponsor Decision|149
2513822|NCT01794000|8698736|P1|Double-Blind Phase (DBP)|Sponsor Decision|148
2513823|NCT01794000|8698735|P2|Double-Blind Phase (DBP)|Physician Decision|0
2513824|NCT01794000|8698736|P1|Double-Blind Phase (DBP)|Physician Decision|2
2513825|NCT01794000|8698735|P2|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2
2513826|NCT01794000|8698736|P1|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5
2513827|NCT01794000|8698735|P2|Double-Blind Phase (DBP)|Entry Criteria Not Met|0
2513828|NCT01794000|8698736|P1|Double-Blind Phase (DBP)|Entry Criteria Not Met|2
2513829|NCT01794000|8698735|P2|Double-Blind Phase (DBP)|Death|2
2513830|NCT01794000|8698736|P1|Double-Blind Phase (DBP)|Death|1
2513831|NCT01794000|8698735|P2|Double-Blind Phase (DBP)|Adverse Event|2
2513832|NCT01794000|8698736|P1|Double-Blind Phase (DBP)|Adverse Event|5
2513833|NCT01793935|8698769|P2|Overall Study|Lost to Follow-up|1
2513834|NCT01793935|8698770|P1|Overall Study|Lost to Follow-up|0
2513835|NCT01793935|8698769|P2|Overall Study|Patient did not take study medication|1
2513836|NCT01793935|8698770|P1|Overall Study|Patient did not take study medication|1
2513837|NCT01793935|8698769|P2|Overall Study|Adverse Event|0
2513838|NCT01793935|8698770|P1|Overall Study|Adverse Event|2
2513839|NCT01793935|8698769|P2|Overall Study|Protocol Violation|1
2513840|NCT01793935|8698770|P1|Overall Study|Protocol Violation|2
2513841|NCT01793935|8698769|P2|Overall Study|Pregnancy|0
2513842|NCT01793935|8698770|P1|Overall Study|Pregnancy|1
2513843|NCT01793883|8698816|P3|Overall Study|Respiratory distress during spirometry|1
2513844|NCT01793883|8698817|P2|Overall Study|Respiratory distress during spirometry|0
2513845|NCT01793883|8698818|P1|Overall Study|Respiratory distress during spirometry|0
2513846|NCT01793883|8698816|P3|Overall Study|Dosing error|0
2513847|NCT01793883|8698817|P2|Overall Study|Dosing error|1
2513848|NCT01793883|8698818|P1|Overall Study|Dosing error|0
2513849|NCT01793883|8698816|P3|Overall Study|Met exclusion criteria|0
2513850|NCT01793883|8698817|P2|Overall Study|Met exclusion criteria|0
2513851|NCT01793883|8698818|P1|Overall Study|Met exclusion criteria|1
2513852|NCT01793883|8698816|P3|Overall Study|Unable to complete measurements|0
2513853|NCT01793883|8698817|P2|Overall Study|Unable to complete measurements|0
2513854|NCT01793883|8698818|P1|Overall Study|Unable to complete measurements|1
2513855|NCT01793883|8698816|P3|Overall Study|Unable to complete spriometry|0
2513856|NCT01793883|8698817|P2|Overall Study|Unable to complete spriometry|0
2513857|NCT01793883|8698818|P1|Overall Study|Unable to complete spriometry|1
2513858|NCT01793883|8698816|P3|Overall Study|Randomized in error|0
2513859|NCT01793883|8698817|P2|Overall Study|Randomized in error|0
2513860|NCT01793883|8698818|P1|Overall Study|Randomized in error|1
2513861|NCT01793883|8698816|P3|Overall Study|Lost to Follow-up|3
2513862|NCT01793883|8698817|P2|Overall Study|Lost to Follow-up|1
2513863|NCT01793883|8698818|P1|Overall Study|Lost to Follow-up|5
2513864|NCT01793883|8698816|P3|Overall Study|Subject noncompliance|1
2513865|NCT01793883|8698817|P2|Overall Study|Subject noncompliance|1
2513866|NCT01793883|8698818|P1|Overall Study|Subject noncompliance|0
2513867|NCT01793883|8698816|P3|Overall Study|Withdrawal by Subject|3
2513868|NCT01793883|8698817|P2|Overall Study|Withdrawal by Subject|7
2513869|NCT01793883|8698818|P1|Overall Study|Withdrawal by Subject|3
2513870|NCT01793792|8698826|P1|Overall Study|Device Not Implanted|1
2513871|NCT01793792|8698826|P1|Overall Study|Withdrawal by Subject|1
2513872|NCT01793792|8698826|P1|Overall Study|Lost to Follow-up|5
2513873|NCT01793792|8698826|P1|Overall Study|Death|5
2513874|NCT01793688|8698831|P1|Overall Study|Protocol Violation|2
2513875|NCT01793142|8698858|P1|Overall Study|Randomized not treated|7
2513876|NCT01792830|8698888|P11|Overall Study|Adverse Event|0
2513877|NCT01792830|8698889|P10|Overall Study|Adverse Event|0
2513878|NCT01792830|8698890|P9|Overall Study|Adverse Event|1
2513879|NCT01792830|8698891|P8|Overall Study|Adverse Event|0
2513880|NCT01792830|8698892|P7|Overall Study|Adverse Event|0
2513881|NCT01792830|8698893|P6|Overall Study|Adverse Event|0
2513882|NCT01792830|8698894|P5|Overall Study|Adverse Event|0
2513883|NCT01792830|8698895|P4|Overall Study|Adverse Event|0
2513884|NCT01792830|8698896|P3|Overall Study|Adverse Event|0
2513885|NCT01792830|8698897|P2|Overall Study|Adverse Event|0
2513886|NCT01792830|8698898|P1|Overall Study|Adverse Event|0
2513887|NCT01792830|8698888|P11|Overall Study|Death|1
2513888|NCT01792830|8698889|P10|Overall Study|Death|0
2513889|NCT01792830|8698890|P9|Overall Study|Death|1
2513890|NCT01792830|8698891|P8|Overall Study|Death|0
2513891|NCT01792830|8698892|P7|Overall Study|Death|1
2513892|NCT01792830|8698893|P6|Overall Study|Death|0
2513893|NCT01792830|8698894|P5|Overall Study|Death|0
2513894|NCT01792830|8698895|P4|Overall Study|Death|1
2513895|NCT01792830|8698896|P3|Overall Study|Death|0
2513896|NCT01792830|8698897|P2|Overall Study|Death|0
2513897|NCT01792830|8698898|P1|Overall Study|Death|3
2513898|NCT01792830|8698888|P11|Overall Study|Withdrawal by Subject|2
2513899|NCT01792830|8698889|P10|Overall Study|Withdrawal by Subject|0
2513900|NCT01792830|8698890|P9|Overall Study|Withdrawal by Subject|7
2513901|NCT01792830|8698891|P8|Overall Study|Withdrawal by Subject|1
2513902|NCT01792830|8698892|P7|Overall Study|Withdrawal by Subject|1
2513903|NCT01792830|8698893|P6|Overall Study|Withdrawal by Subject|1
2513904|NCT01792830|8698894|P5|Overall Study|Withdrawal by Subject|1
2513905|NCT01792830|8698895|P4|Overall Study|Withdrawal by Subject|2
2513906|NCT01792830|8698896|P3|Overall Study|Withdrawal by Subject|0
2513907|NCT01792830|8698897|P2|Overall Study|Withdrawal by Subject|0
2513908|NCT01792830|8698898|P1|Overall Study|Withdrawal by Subject|22
2513909|NCT01792635|8698985|P3|Part B|Study terminated|3
2513910|NCT01792635|8698986|P2|Part B|Study terminated|4
2513911|NCT01792635|8698987|P1|Part B|Study terminated|0
2513912|NCT01792635|8698985|P3|Part B|Adverse Event|1
2513913|NCT01792635|8698986|P2|Part B|Adverse Event|0
2513914|NCT01792635|8698987|P1|Part B|Adverse Event|0
2513915|NCT01792518|8699015|P2|Overall Study|Other Reason|1
2513916|NCT01792518|8699016|P1|Overall Study|Other Reason|0
2513917|NCT01792518|8699015|P2|Overall Study|Withdrawal by Subject|0
2513918|NCT01792518|8699016|P1|Overall Study|Withdrawal by Subject|2
2513919|NCT01792518|8699015|P2|Overall Study|Lost to Follow-up|1
2513920|NCT01792518|8699016|P1|Overall Study|Lost to Follow-up|3
2513921|NCT01792518|8699015|P2|Overall Study|Protocol Violation|1
2513922|NCT01792518|8699016|P1|Overall Study|Protocol Violation|0
2513923|NCT01792518|8699015|P2|Overall Study|Adverse Event|4
2513924|NCT01792518|8699016|P1|Overall Study|Adverse Event|3
2513925|NCT01792284|8699026|P3|Randomization Period 2|Withdrawal by Subject|0
2513926|NCT01792284|8699027|P2|Randomization Period 2|Withdrawal by Subject|2
2513927|NCT01792284|8699028|P1|Randomization Period 2|Withdrawal by Subject|0
2513928|NCT01792284|8699026|P3|Randomization Period 2|Protocol Violation|0
2513929|NCT01792284|8699027|P2|Randomization Period 2|Protocol Violation|1
2513930|NCT01792284|8699028|P1|Randomization Period 2|Protocol Violation|0
2513931|NCT01792284|8699026|P3|Randomization Period 1|Lost to Follow-up|1
2513932|NCT01792284|8699027|P2|Randomization Period 1|Lost to Follow-up|0
2513933|NCT01792284|8699028|P1|Randomization Period 1|Lost to Follow-up|0
2513934|NCT01792284|8699026|P3|Randomization Period 1|Adverse Event|2
2513935|NCT01792284|8699027|P2|Randomization Period 1|Adverse Event|0
2513936|NCT01792284|8699028|P1|Randomization Period 1|Adverse Event|0
2513937|NCT01792284|8699026|P3|Randomization Period 1|Physician Decision|1
2513938|NCT01792284|8699027|P2|Randomization Period 1|Physician Decision|1
2513939|NCT01792284|8699028|P1|Randomization Period 1|Physician Decision|0
2513940|NCT01792284|8699026|P3|Randomization Period 1|Withdrawal by Subject|1
2513941|NCT01792284|8699027|P2|Randomization Period 1|Withdrawal by Subject|1
2513942|NCT01792284|8699028|P1|Randomization Period 1|Withdrawal by Subject|0
2513943|NCT01792284|8699026|P3|Lead-in Period|Protocol Required Discontinuation|0
2513944|NCT01792284|8699027|P2|Lead-in Period|Protocol Required Discontinuation|0
2513945|NCT01792284|8699028|P1|Lead-in Period|Protocol Required Discontinuation|1
2513946|NCT01792284|8699026|P3|Lead-in Period|Physician Decision|0
2513947|NCT01792284|8699027|P2|Lead-in Period|Physician Decision|0
2513948|NCT01792284|8699028|P1|Lead-in Period|Physician Decision|1
2513949|NCT01792284|8699026|P3|Lead-in Period|Withdrawal by Subject|0
2513950|NCT01792284|8699027|P2|Lead-in Period|Withdrawal by Subject|0
2513951|NCT01792284|8699028|P1|Lead-in Period|Withdrawal by Subject|10
2513952|NCT01792284|8699026|P3|Lead-in Period|Protocol Violation|0
2513953|NCT01792284|8699027|P2|Lead-in Period|Protocol Violation|0
2513954|NCT01792284|8699028|P1|Lead-in Period|Protocol Violation|1
2513955|NCT01792284|8699026|P3|Lead-in Period|Lost to Follow-up|0
2513956|NCT01792284|8699027|P2|Lead-in Period|Lost to Follow-up|0
2513957|NCT01792284|8699028|P1|Lead-in Period|Lost to Follow-up|2
2513958|NCT01792284|8699026|P3|Lead-in Period|Adverse Event|0
2513959|NCT01792284|8699027|P2|Lead-in Period|Adverse Event|0
2513960|NCT01792284|8699028|P1|Lead-in Period|Adverse Event|15
2513961|NCT01791894|8699087|P1|Overall Study|Adverse Event|1
2513962|NCT01791803|8699098|P4|Overall Study|Death|2
2513963|NCT01791803|8699099|P3|Overall Study|Death|2
2513964|NCT01791803|8699100|P2|Overall Study|Death|0
2513965|NCT01791803|8699101|P1|Overall Study|Death|0
2513966|NCT01791803|8699098|P4|Overall Study|Physician Decision|1
2513967|NCT01791803|8699099|P3|Overall Study|Physician Decision|0
2513968|NCT01791803|8699100|P2|Overall Study|Physician Decision|2
2513969|NCT01791803|8699101|P1|Overall Study|Physician Decision|0
2513970|NCT01791803|8699098|P4|Overall Study|Withdrawal by Subject|2
2513971|NCT01791803|8699099|P3|Overall Study|Withdrawal by Subject|0
2513972|NCT01791803|8699100|P2|Overall Study|Withdrawal by Subject|0
2513973|NCT01791803|8699101|P1|Overall Study|Withdrawal by Subject|0
2513974|NCT01791725|8699119|P3|Overall Study|Withdrawal by Subject|0
2513975|NCT01791725|8699120|P2|Overall Study|Withdrawal by Subject|1
2513976|NCT01791725|8699121|P1|Overall Study|Withdrawal by Subject|0
2513977|NCT01791517|8699144|P12|Phase II|Pre-Existing Ocular Issue|1
2513978|NCT01791517|8699145|P11|Phase II|Pre-Existing Ocular Issue|0
2513979|NCT01791517|8699146|P10|Phase II|Pre-Existing Ocular Issue|0
2513980|NCT01791517|8699147|P9|Phase II|Pre-Existing Ocular Issue|0
2513981|NCT01791517|8699148|P8|Phase II|Pre-Existing Ocular Issue|0
2513982|NCT01791517|8699149|P7|Phase II|Pre-Existing Ocular Issue|0
2513983|NCT01791517|8699150|P6|Phase II|Pre-Existing Ocular Issue|0
2513984|NCT01791517|8699151|P5|Phase II|Pre-Existing Ocular Issue|0
2513985|NCT01791517|8699152|P4|Phase II|Pre-Existing Ocular Issue|0
2513986|NCT01791517|8699153|P3|Phase II|Pre-Existing Ocular Issue|0
2513987|NCT01791517|8699154|P2|Phase II|Pre-Existing Ocular Issue|0
2513988|NCT01791517|8699155|P1|Phase II|Pre-Existing Ocular Issue|0
2513989|NCT01791517|8699144|P12|Phase II|Unsatisfactory Lens Fitting|0
2513990|NCT01791517|8699145|P11|Phase II|Unsatisfactory Lens Fitting|0
2513991|NCT01791517|8699146|P10|Phase II|Unsatisfactory Lens Fitting|1
2513992|NCT01791517|8699147|P9|Phase II|Unsatisfactory Lens Fitting|0
2513993|NCT01791517|8699148|P8|Phase II|Unsatisfactory Lens Fitting|0
2513994|NCT01791517|8699149|P7|Phase II|Unsatisfactory Lens Fitting|0
2513995|NCT01791517|8699150|P6|Phase II|Unsatisfactory Lens Fitting|0
2513996|NCT01791517|8699151|P5|Phase II|Unsatisfactory Lens Fitting|0
2513997|NCT01791517|8699152|P4|Phase II|Unsatisfactory Lens Fitting|0
2513998|NCT01791517|8699153|P3|Phase II|Unsatisfactory Lens Fitting|0
2513999|NCT01791517|8699154|P2|Phase II|Unsatisfactory Lens Fitting|0
2514000|NCT01791517|8699155|P1|Phase II|Unsatisfactory Lens Fitting|0
2514001|NCT01791517|8699144|P12|Phase II|Lens Handling Difficulties|0
2514002|NCT01791517|8699145|P11|Phase II|Lens Handling Difficulties|0
2514003|NCT01791517|8699146|P10|Phase II|Lens Handling Difficulties|0
2514004|NCT01791517|8699147|P9|Phase II|Lens Handling Difficulties|1
2514005|NCT01791517|8699148|P8|Phase II|Lens Handling Difficulties|0
2514006|NCT01791517|8699149|P7|Phase II|Lens Handling Difficulties|0
2514007|NCT01791517|8699150|P6|Phase II|Lens Handling Difficulties|0
2514008|NCT01791517|8699151|P5|Phase II|Lens Handling Difficulties|0
2514009|NCT01791517|8699152|P4|Phase II|Lens Handling Difficulties|0
2514010|NCT01791517|8699153|P3|Phase II|Lens Handling Difficulties|0
2514011|NCT01791517|8699154|P2|Phase II|Lens Handling Difficulties|0
2514012|NCT01791517|8699155|P1|Phase II|Lens Handling Difficulties|0
2514013|NCT01791517|8699144|P12|Phase II|Adverse Event|0
2514014|NCT01791517|8699145|P11|Phase II|Adverse Event|0
2514015|NCT01791517|8699146|P10|Phase II|Adverse Event|1
2514016|NCT01791517|8699147|P9|Phase II|Adverse Event|0
2514017|NCT01791517|8699148|P8|Phase II|Adverse Event|1
2514018|NCT01791517|8699149|P7|Phase II|Adverse Event|2
2514019|NCT01791517|8699150|P6|Phase II|Adverse Event|0
2514020|NCT01791517|8699151|P5|Phase II|Adverse Event|0
2514021|NCT01791517|8699152|P4|Phase II|Adverse Event|0
2514022|NCT01791517|8699153|P3|Phase II|Adverse Event|0
2514023|NCT01791517|8699154|P2|Phase II|Adverse Event|0
2514024|NCT01791517|8699155|P1|Phase II|Adverse Event|0
2514025|NCT01791517|8699144|P12|Phase II|Lack of Efficacy|0
2514026|NCT01791517|8699145|P11|Phase II|Lack of Efficacy|0
2514027|NCT01791517|8699146|P10|Phase II|Lack of Efficacy|0
2514028|NCT01791517|8699147|P9|Phase II|Lack of Efficacy|0
2514029|NCT01791517|8699148|P8|Phase II|Lack of Efficacy|0
2514030|NCT01791517|8699149|P7|Phase II|Lack of Efficacy|0
2514031|NCT01791517|8699150|P6|Phase II|Lack of Efficacy|0
2514032|NCT01791517|8699151|P5|Phase II|Lack of Efficacy|1
2514033|NCT01791517|8699152|P4|Phase II|Lack of Efficacy|0
2514034|NCT01791517|8699153|P3|Phase II|Lack of Efficacy|0
2514035|NCT01791517|8699154|P2|Phase II|Lack of Efficacy|0
2514036|NCT01791517|8699155|P1|Phase II|Lack of Efficacy|0
2514037|NCT01791517|8699144|P12|Phase II|Withdrawal by Subject|0
2514038|NCT01791517|8699145|P11|Phase II|Withdrawal by Subject|1
2514039|NCT01791517|8699146|P10|Phase II|Withdrawal by Subject|0
2514040|NCT01791517|8699147|P9|Phase II|Withdrawal by Subject|0
2514041|NCT01791517|8699148|P8|Phase II|Withdrawal by Subject|1
2514042|NCT01791517|8699149|P7|Phase II|Withdrawal by Subject|0
2514043|NCT01791517|8699150|P6|Phase II|Withdrawal by Subject|2
2514044|NCT01791517|8699151|P5|Phase II|Withdrawal by Subject|0
2514045|NCT01791517|8699152|P4|Phase II|Withdrawal by Subject|0
2514046|NCT01791517|8699153|P3|Phase II|Withdrawal by Subject|0
2514047|NCT01791517|8699154|P2|Phase II|Withdrawal by Subject|0
2514048|NCT01791517|8699155|P1|Phase II|Withdrawal by Subject|1
2514049|NCT01791517|8699144|P12|Phase II|Lost to Follow-up|0
2514050|NCT01791517|8699145|P11|Phase II|Lost to Follow-up|0
2514051|NCT01791517|8699146|P10|Phase II|Lost to Follow-up|1
2514052|NCT01791517|8699147|P9|Phase II|Lost to Follow-up|1
2514053|NCT01791517|8699148|P8|Phase II|Lost to Follow-up|1
2514054|NCT01791517|8699149|P7|Phase II|Lost to Follow-up|0
2514055|NCT01791517|8699150|P6|Phase II|Lost to Follow-up|2
2514056|NCT01791517|8699151|P5|Phase II|Lost to Follow-up|1
2514057|NCT01791517|8699152|P4|Phase II|Lost to Follow-up|0
2514058|NCT01791517|8699153|P3|Phase II|Lost to Follow-up|1
2514059|NCT01791517|8699154|P2|Phase II|Lost to Follow-up|0
2514060|NCT01791517|8699155|P1|Phase II|Lost to Follow-up|1
2514061|NCT01791517|8699144|P12|Phase I: Period 3|Adverse Event|0
2514062|NCT01791517|8699145|P11|Phase I: Period 3|Adverse Event|0
2514063|NCT01791517|8699146|P10|Phase I: Period 3|Adverse Event|0
2514064|NCT01791517|8699147|P9|Phase I: Period 3|Adverse Event|0
2514065|NCT01791517|8699148|P8|Phase I: Period 3|Adverse Event|0
2514066|NCT01791517|8699149|P7|Phase I: Period 3|Adverse Event|0
2514067|NCT01791517|8699150|P6|Phase I: Period 3|Adverse Event|0
2514068|NCT01791517|8699151|P5|Phase I: Period 3|Adverse Event|0
2514069|NCT01791517|8699152|P4|Phase I: Period 3|Adverse Event|1
2514070|NCT01791517|8699153|P3|Phase I: Period 3|Adverse Event|0
2514071|NCT01791517|8699154|P2|Phase I: Period 3|Adverse Event|0
2514072|NCT01791517|8699155|P1|Phase I: Period 3|Adverse Event|0
2514073|NCT01791517|8699144|P12|Phase I: Period 3|Lost to Follow-up|0
2514074|NCT01791517|8699145|P11|Phase I: Period 3|Lost to Follow-up|0
2514075|NCT01791517|8699146|P10|Phase I: Period 3|Lost to Follow-up|0
2514076|NCT01791517|8699147|P9|Phase I: Period 3|Lost to Follow-up|0
2514077|NCT01791517|8699148|P8|Phase I: Period 3|Lost to Follow-up|0
2514078|NCT01791517|8699149|P7|Phase I: Period 3|Lost to Follow-up|0
2514079|NCT01791517|8699150|P6|Phase I: Period 3|Lost to Follow-up|0
2514080|NCT01791517|8699151|P5|Phase I: Period 3|Lost to Follow-up|1
2514081|NCT01791517|8699152|P4|Phase I: Period 3|Lost to Follow-up|0
2514082|NCT01791517|8699153|P3|Phase I: Period 3|Lost to Follow-up|0
2514083|NCT01791517|8699154|P2|Phase I: Period 3|Lost to Follow-up|1
2514084|NCT01791517|8699155|P1|Phase I: Period 3|Lost to Follow-up|0
2514085|NCT01791517|8699144|P12|Phase I: Period 3|Lens Discomfort|1
2514086|NCT01791517|8699145|P11|Phase I: Period 3|Lens Discomfort|0
2514087|NCT01791517|8699146|P10|Phase I: Period 3|Lens Discomfort|0
2514088|NCT01791517|8699147|P9|Phase I: Period 3|Lens Discomfort|0
2514089|NCT01791517|8699148|P8|Phase I: Period 3|Lens Discomfort|0
2514090|NCT01791517|8699149|P7|Phase I: Period 3|Lens Discomfort|0
2514091|NCT01791517|8699150|P6|Phase I: Period 3|Lens Discomfort|0
2514092|NCT01791517|8699151|P5|Phase I: Period 3|Lens Discomfort|0
2514093|NCT01791517|8699152|P4|Phase I: Period 3|Lens Discomfort|0
2514094|NCT01791517|8699153|P3|Phase I: Period 3|Lens Discomfort|0
2514095|NCT01791517|8699154|P2|Phase I: Period 3|Lens Discomfort|0
2514096|NCT01791517|8699155|P1|Phase I: Period 3|Lens Discomfort|0
2514097|NCT01791517|8699144|P12|Phase I: Period 2|Lost to Follow-up|0
2514098|NCT01791517|8699145|P11|Phase I: Period 2|Lost to Follow-up|0
2514099|NCT01791517|8699146|P10|Phase I: Period 2|Lost to Follow-up|0
2514100|NCT01791517|8699147|P9|Phase I: Period 2|Lost to Follow-up|0
2514101|NCT01791517|8699148|P8|Phase I: Period 2|Lost to Follow-up|0
2514102|NCT01791517|8699149|P7|Phase I: Period 2|Lost to Follow-up|0
2514103|NCT01791517|8699150|P6|Phase I: Period 2|Lost to Follow-up|0
2514104|NCT01791517|8699151|P5|Phase I: Period 2|Lost to Follow-up|0
2514105|NCT01791517|8699152|P4|Phase I: Period 2|Lost to Follow-up|0
2514106|NCT01791517|8699153|P3|Phase I: Period 2|Lost to Follow-up|2
2514107|NCT01791517|8699154|P2|Phase I: Period 2|Lost to Follow-up|3
2514108|NCT01791517|8699155|P1|Phase I: Period 2|Lost to Follow-up|0
2514109|NCT01791517|8699144|P12|Phase I: Period 2|Lens Discomfort|0
2514110|NCT01791517|8699145|P11|Phase I: Period 2|Lens Discomfort|0
2514111|NCT01791517|8699146|P10|Phase I: Period 2|Lens Discomfort|0
2514112|NCT01791517|8699147|P9|Phase I: Period 2|Lens Discomfort|0
2514113|NCT01791517|8699148|P8|Phase I: Period 2|Lens Discomfort|0
2514114|NCT01791517|8699149|P7|Phase I: Period 2|Lens Discomfort|0
2514115|NCT01791517|8699150|P6|Phase I: Period 2|Lens Discomfort|1
2514116|NCT01791517|8699151|P5|Phase I: Period 2|Lens Discomfort|0
2514117|NCT01791517|8699152|P4|Phase I: Period 2|Lens Discomfort|0
2514118|NCT01791517|8699153|P3|Phase I: Period 2|Lens Discomfort|0
2514119|NCT01791517|8699154|P2|Phase I: Period 2|Lens Discomfort|0
2514120|NCT01791517|8699155|P1|Phase I: Period 2|Lens Discomfort|0
2514121|NCT01791517|8699144|P12|Phase I: Period 2|Unsatisfactory Visual Response|0
2514122|NCT01791517|8699145|P11|Phase I: Period 2|Unsatisfactory Visual Response|1
2514123|NCT01791517|8699146|P10|Phase I: Period 2|Unsatisfactory Visual Response|0
2514124|NCT01791517|8699147|P9|Phase I: Period 2|Unsatisfactory Visual Response|0
2514125|NCT01791517|8699148|P8|Phase I: Period 2|Unsatisfactory Visual Response|0
2514126|NCT01791517|8699149|P7|Phase I: Period 2|Unsatisfactory Visual Response|0
2514127|NCT01791517|8699150|P6|Phase I: Period 2|Unsatisfactory Visual Response|0
2514128|NCT01791517|8699151|P5|Phase I: Period 2|Unsatisfactory Visual Response|0
2514129|NCT01791517|8699152|P4|Phase I: Period 2|Unsatisfactory Visual Response|0
2514130|NCT01791517|8699153|P3|Phase I: Period 2|Unsatisfactory Visual Response|0
2514131|NCT01791517|8699154|P2|Phase I: Period 2|Unsatisfactory Visual Response|0
2514132|NCT01791517|8699155|P1|Phase I: Period 2|Unsatisfactory Visual Response|0
2514133|NCT01791517|8699144|P12|Phase I: Period 2|Withdrawal by Subject|0
2514134|NCT01791517|8699145|P11|Phase I: Period 2|Withdrawal by Subject|1
2514135|NCT01791517|8699146|P10|Phase I: Period 2|Withdrawal by Subject|1
2514136|NCT01791517|8699147|P9|Phase I: Period 2|Withdrawal by Subject|0
2514137|NCT01791517|8699148|P8|Phase I: Period 2|Withdrawal by Subject|0
2514138|NCT01791517|8699149|P7|Phase I: Period 2|Withdrawal by Subject|0
2514139|NCT01791517|8699150|P6|Phase I: Period 2|Withdrawal by Subject|0
2514140|NCT01791517|8699151|P5|Phase I: Period 2|Withdrawal by Subject|0
2514141|NCT01791517|8699152|P4|Phase I: Period 2|Withdrawal by Subject|0
2514142|NCT01791517|8699153|P3|Phase I: Period 2|Withdrawal by Subject|0
2514143|NCT01791517|8699154|P2|Phase I: Period 2|Withdrawal by Subject|0
2514144|NCT01791517|8699155|P1|Phase I: Period 2|Withdrawal by Subject|0
2514145|NCT01791517|8699144|P12|Phase I: Period 2|Protocol Violation|0
2514146|NCT01791517|8699145|P11|Phase I: Period 2|Protocol Violation|0
2514147|NCT01791517|8699146|P10|Phase I: Period 2|Protocol Violation|0
2514148|NCT01791517|8699147|P9|Phase I: Period 2|Protocol Violation|0
2514149|NCT01791517|8699148|P8|Phase I: Period 2|Protocol Violation|0
2514150|NCT01791517|8699149|P7|Phase I: Period 2|Protocol Violation|0
2514151|NCT01791517|8699150|P6|Phase I: Period 2|Protocol Violation|0
2514152|NCT01791517|8699151|P5|Phase I: Period 2|Protocol Violation|0
2514153|NCT01791517|8699152|P4|Phase I: Period 2|Protocol Violation|1
2514154|NCT01791517|8699153|P3|Phase I: Period 2|Protocol Violation|0
2514155|NCT01791517|8699154|P2|Phase I: Period 2|Protocol Violation|0
2514156|NCT01791517|8699155|P1|Phase I: Period 2|Protocol Violation|0
2514157|NCT01791517|8699144|P12|Phase I: Period 2|Unsatisfactory Lens Fit|0
2514158|NCT01791517|8699145|P11|Phase I: Period 2|Unsatisfactory Lens Fit|0
2514159|NCT01791517|8699146|P10|Phase I: Period 2|Unsatisfactory Lens Fit|0
2514160|NCT01791517|8699147|P9|Phase I: Period 2|Unsatisfactory Lens Fit|0
2514161|NCT01791517|8699148|P8|Phase I: Period 2|Unsatisfactory Lens Fit|0
2514162|NCT01791517|8699149|P7|Phase I: Period 2|Unsatisfactory Lens Fit|0
2514163|NCT01791517|8699150|P6|Phase I: Period 2|Unsatisfactory Lens Fit|0
2514164|NCT01791517|8699151|P5|Phase I: Period 2|Unsatisfactory Lens Fit|0
2514165|NCT01791517|8699152|P4|Phase I: Period 2|Unsatisfactory Lens Fit|0
2514166|NCT01791517|8699153|P3|Phase I: Period 2|Unsatisfactory Lens Fit|0
2514167|NCT01791517|8699154|P2|Phase I: Period 2|Unsatisfactory Lens Fit|0
2514168|NCT01791517|8699155|P1|Phase I: Period 2|Unsatisfactory Lens Fit|1
2514169|NCT01791517|8699144|P12|Phase I: Period 1|Lens Handling DIfficulties|1
2514170|NCT01791517|8699145|P11|Phase I: Period 1|Lens Handling DIfficulties|0
2514171|NCT01791517|8699146|P10|Phase I: Period 1|Lens Handling DIfficulties|0
2514172|NCT01791517|8699147|P9|Phase I: Period 1|Lens Handling DIfficulties|0
2514173|NCT01791517|8699148|P8|Phase I: Period 1|Lens Handling DIfficulties|0
2514174|NCT01791517|8699149|P7|Phase I: Period 1|Lens Handling DIfficulties|0
2514175|NCT01791517|8699150|P6|Phase I: Period 1|Lens Handling DIfficulties|0
2514176|NCT01791517|8699151|P5|Phase I: Period 1|Lens Handling DIfficulties|0
2514177|NCT01791517|8699152|P4|Phase I: Period 1|Lens Handling DIfficulties|0
2514178|NCT01791517|8699153|P3|Phase I: Period 1|Lens Handling DIfficulties|0
2514179|NCT01791517|8699154|P2|Phase I: Period 1|Lens Handling DIfficulties|0
2514180|NCT01791517|8699155|P1|Phase I: Period 1|Lens Handling DIfficulties|0
2514181|NCT01791517|8699144|P12|Phase I: Period 1|Lost to Follow-up|0
2514182|NCT01791517|8699145|P11|Phase I: Period 1|Lost to Follow-up|0
2514183|NCT01791517|8699146|P10|Phase I: Period 1|Lost to Follow-up|1
2514184|NCT01791517|8699147|P9|Phase I: Period 1|Lost to Follow-up|1
2514185|NCT01791517|8699148|P8|Phase I: Period 1|Lost to Follow-up|0
2514186|NCT01791517|8699149|P7|Phase I: Period 1|Lost to Follow-up|1
2514187|NCT01791517|8699150|P6|Phase I: Period 1|Lost to Follow-up|0
2514188|NCT01791517|8699151|P5|Phase I: Period 1|Lost to Follow-up|0
2514189|NCT01791517|8699152|P4|Phase I: Period 1|Lost to Follow-up|1
2514190|NCT01791517|8699153|P3|Phase I: Period 1|Lost to Follow-up|0
2514191|NCT01791517|8699154|P2|Phase I: Period 1|Lost to Follow-up|0
2514192|NCT01791517|8699155|P1|Phase I: Period 1|Lost to Follow-up|0
2514193|NCT01791517|8699144|P12|Phase I: Period 1|Protocol Violation|0
2514194|NCT01791517|8699145|P11|Phase I: Period 1|Protocol Violation|0
2514195|NCT01791517|8699146|P10|Phase I: Period 1|Protocol Violation|0
2514196|NCT01791517|8699147|P9|Phase I: Period 1|Protocol Violation|0
2514197|NCT01791517|8699148|P8|Phase I: Period 1|Protocol Violation|0
2514198|NCT01791517|8699149|P7|Phase I: Period 1|Protocol Violation|0
2514199|NCT01791517|8699150|P6|Phase I: Period 1|Protocol Violation|0
2514200|NCT01791517|8699151|P5|Phase I: Period 1|Protocol Violation|0
2514201|NCT01791517|8699152|P4|Phase I: Period 1|Protocol Violation|0
2514202|NCT01791517|8699153|P3|Phase I: Period 1|Protocol Violation|0
2514203|NCT01791517|8699154|P2|Phase I: Period 1|Protocol Violation|1
2514204|NCT01791517|8699155|P1|Phase I: Period 1|Protocol Violation|0
2514205|NCT01791517|8699144|P12|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2514206|NCT01791517|8699145|P11|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2514207|NCT01791517|8699146|P10|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2514208|NCT01791517|8699147|P9|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2514209|NCT01791517|8699148|P8|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2514210|NCT01791517|8699149|P7|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2514211|NCT01791517|8699150|P6|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2514212|NCT01791517|8699151|P5|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2514213|NCT01791517|8699152|P4|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2514214|NCT01791517|8699153|P3|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2514215|NCT01791517|8699154|P2|Phase I: Period 1|Unsatisfactory Lens Fitting|0
2514216|NCT01791517|8699155|P1|Phase I: Period 1|Unsatisfactory Lens Fitting|1
2514217|NCT01791517|8699144|P12|Phase I: Period 1|Adverse Event|0
2514218|NCT01791517|8699145|P11|Phase I: Period 1|Adverse Event|0
2514219|NCT01791517|8699146|P10|Phase I: Period 1|Adverse Event|0
2514220|NCT01791517|8699147|P9|Phase I: Period 1|Adverse Event|0
2514221|NCT01791517|8699148|P8|Phase I: Period 1|Adverse Event|0
2514222|NCT01791517|8699149|P7|Phase I: Period 1|Adverse Event|0
2514223|NCT01791517|8699150|P6|Phase I: Period 1|Adverse Event|0
2514224|NCT01791517|8699151|P5|Phase I: Period 1|Adverse Event|0
2514225|NCT01791517|8699152|P4|Phase I: Period 1|Adverse Event|1
2514226|NCT01791517|8699153|P3|Phase I: Period 1|Adverse Event|1
2514227|NCT01791517|8699154|P2|Phase I: Period 1|Adverse Event|0
2514228|NCT01791517|8699155|P1|Phase I: Period 1|Adverse Event|0
2514229|NCT01791517|8699144|P12|Phase I: Period 1|Withdrawal by Subject|0
2514230|NCT01791517|8699145|P11|Phase I: Period 1|Withdrawal by Subject|0
2514231|NCT01791517|8699146|P10|Phase I: Period 1|Withdrawal by Subject|0
2514232|NCT01791517|8699147|P9|Phase I: Period 1|Withdrawal by Subject|0
2514233|NCT01791517|8699148|P8|Phase I: Period 1|Withdrawal by Subject|0
2514234|NCT01791517|8699149|P7|Phase I: Period 1|Withdrawal by Subject|0
2514235|NCT01791517|8699150|P6|Phase I: Period 1|Withdrawal by Subject|1
2514236|NCT01791517|8699151|P5|Phase I: Period 1|Withdrawal by Subject|1
2514237|NCT01791517|8699152|P4|Phase I: Period 1|Withdrawal by Subject|0
2514238|NCT01791517|8699153|P3|Phase I: Period 1|Withdrawal by Subject|1
2514239|NCT01791517|8699154|P2|Phase I: Period 1|Withdrawal by Subject|1
2514240|NCT01791517|8699155|P1|Phase I: Period 1|Withdrawal by Subject|0
2514241|NCT01791413|8699219|P2|Overall Study|Lost to Follow-up|1
2514242|NCT01791413|8699220|P1|Overall Study|Lost to Follow-up|5
2514243|NCT01791244|8699229|P2|Overall Study|Laboratory Abnormality|1
2514244|NCT01791244|8699230|P1|Overall Study|Laboratory Abnormality|0
2514245|NCT01791244|8699229|P2|Overall Study|Insufficient clinical response|10
2514246|NCT01791244|8699230|P1|Overall Study|Insufficient clinical response|10
2514247|NCT01791244|8699229|P2|Overall Study|Adverse Event|7
2514248|NCT01791244|8699230|P1|Overall Study|Adverse Event|5
2514249|NCT01791205|8699266|P2|Phase II|Physician’s decision|0
2514250|NCT01791205|8699267|P1|Phase II|Physician’s decision|1
2514251|NCT01791205|8699266|P2|Phase II|Remission of disease|0
2514252|NCT01791205|8699267|P1|Phase II|Remission of disease|1
2514253|NCT01791205|8699266|P2|Phase II|Lost to Follow-up|0
2514254|NCT01791205|8699267|P1|Phase II|Lost to Follow-up|1
2514255|NCT01791205|8699266|P2|Phase II|Safety|0
2514256|NCT01791205|8699267|P1|Phase II|Safety|1
2514257|NCT01791205|8699266|P2|Phase II|Adverse Event|0
2514258|NCT01791205|8699267|P1|Phase II|Adverse Event|2
2514259|NCT01791205|8699266|P2|Phase II|Lack of Efficacy|0
2514260|NCT01791205|8699267|P1|Phase II|Lack of Efficacy|6
2514261|NCT01791153|8699351|P8|Part 2: Open-label Period|Physician Decision|0
2514262|NCT01791153|8699352|P7|Part 2: Open-label Period|Physician Decision|0
2514263|NCT01791153|8699353|P6|Part 2: Open-label Period|Physician Decision|1
2514264|NCT01791153|8699354|P5|Part 2: Open-label Period|Physician Decision|1
2514265|NCT01791153|8699355|P4|Part 2: Open-label Period|Physician Decision|0
2514266|NCT01791153|8699356|P3|Part 2: Open-label Period|Physician Decision|0
2514267|NCT01791153|8699357|P2|Part 2: Open-label Period|Physician Decision|0
2514268|NCT01791153|8699358|P1|Part 2: Open-label Period|Physician Decision|0
2514269|NCT01791153|8699351|P8|Part 2: Open-label Period|Withdrawal by Subject|2
2514270|NCT01791153|8699352|P7|Part 2: Open-label Period|Withdrawal by Subject|3
2514271|NCT01791153|8699353|P6|Part 2: Open-label Period|Withdrawal by Subject|1
2514272|NCT01791153|8699354|P5|Part 2: Open-label Period|Withdrawal by Subject|1
2514273|NCT01791153|8699355|P4|Part 2: Open-label Period|Withdrawal by Subject|0
2514274|NCT01791153|8699356|P3|Part 2: Open-label Period|Withdrawal by Subject|0
2514275|NCT01791153|8699357|P2|Part 2: Open-label Period|Withdrawal by Subject|0
2514276|NCT01791153|8699358|P1|Part 2: Open-label Period|Withdrawal by Subject|0
2514277|NCT01791153|8699351|P8|Part 2: Open-label Period|Lack of Efficacy|1
2514278|NCT01791153|8699352|P7|Part 2: Open-label Period|Lack of Efficacy|0
2514279|NCT01791153|8699353|P6|Part 2: Open-label Period|Lack of Efficacy|0
2514280|NCT01791153|8699354|P5|Part 2: Open-label Period|Lack of Efficacy|0
2514281|NCT01791153|8699355|P4|Part 2: Open-label Period|Lack of Efficacy|0
2514282|NCT01791153|8699356|P3|Part 2: Open-label Period|Lack of Efficacy|0
2514283|NCT01791153|8699357|P2|Part 2: Open-label Period|Lack of Efficacy|0
2514284|NCT01791153|8699358|P1|Part 2: Open-label Period|Lack of Efficacy|0
2514285|NCT01791153|8699351|P8|Part 2: Open-label Period|Lost to Follow-up|0
2514286|NCT01791153|8699352|P7|Part 2: Open-label Period|Lost to Follow-up|1
2514287|NCT01791153|8699353|P6|Part 2: Open-label Period|Lost to Follow-up|0
2514288|NCT01791153|8699354|P5|Part 2: Open-label Period|Lost to Follow-up|0
2514289|NCT01791153|8699355|P4|Part 2: Open-label Period|Lost to Follow-up|0
2514290|NCT01791153|8699356|P3|Part 2: Open-label Period|Lost to Follow-up|0
2514291|NCT01791153|8699357|P2|Part 2: Open-label Period|Lost to Follow-up|0
2514292|NCT01791153|8699358|P1|Part 2: Open-label Period|Lost to Follow-up|0
2514293|NCT01791153|8699351|P8|Part 2: Open-label Period|Death|1
2514294|NCT01791153|8699352|P7|Part 2: Open-label Period|Death|1
2514295|NCT01791153|8699353|P6|Part 2: Open-label Period|Death|1
2514296|NCT01791153|8699354|P5|Part 2: Open-label Period|Death|0
2514297|NCT01791153|8699355|P4|Part 2: Open-label Period|Death|0
2514298|NCT01791153|8699356|P3|Part 2: Open-label Period|Death|0
2514299|NCT01791153|8699357|P2|Part 2: Open-label Period|Death|0
2514300|NCT01791153|8699358|P1|Part 2: Open-label Period|Death|0
2514301|NCT01791153|8699351|P8|Part 2: Open-label Period|Adverse Event|2
2514302|NCT01791153|8699352|P7|Part 2: Open-label Period|Adverse Event|1
2514303|NCT01791153|8699353|P6|Part 2: Open-label Period|Adverse Event|1
2514304|NCT01791153|8699354|P5|Part 2: Open-label Period|Adverse Event|0
2514305|NCT01791153|8699355|P4|Part 2: Open-label Period|Adverse Event|0
2514306|NCT01791153|8699356|P3|Part 2: Open-label Period|Adverse Event|0
2514307|NCT01791153|8699357|P2|Part 2: Open-label Period|Adverse Event|0
2514308|NCT01791153|8699358|P1|Part 2: Open-label Period|Adverse Event|0
2514309|NCT01791153|8699351|P8|Part 1: Blinded Period|Withdrawal by Subject|0
2514310|NCT01791153|8699352|P7|Part 1: Blinded Period|Withdrawal by Subject|0
2514311|NCT01791153|8699353|P6|Part 1: Blinded Period|Withdrawal by Subject|0
2514312|NCT01791153|8699354|P5|Part 1: Blinded Period|Withdrawal by Subject|0
2514313|NCT01791153|8699355|P4|Part 1: Blinded Period|Withdrawal by Subject|1
2514314|NCT01791153|8699356|P3|Part 1: Blinded Period|Withdrawal by Subject|2
2514315|NCT01791153|8699357|P2|Part 1: Blinded Period|Withdrawal by Subject|2
2514316|NCT01791153|8699358|P1|Part 1: Blinded Period|Withdrawal by Subject|6
2514317|NCT01791153|8699351|P8|Part 1: Blinded Period|Protocol Violation|0
2514318|NCT01791153|8699352|P7|Part 1: Blinded Period|Protocol Violation|0
2514319|NCT01791153|8699353|P6|Part 1: Blinded Period|Protocol Violation|0
2514320|NCT01791153|8699354|P5|Part 1: Blinded Period|Protocol Violation|0
2514321|NCT01791153|8699355|P4|Part 1: Blinded Period|Protocol Violation|1
2514322|NCT01791153|8699356|P3|Part 1: Blinded Period|Protocol Violation|0
2514323|NCT01791153|8699357|P2|Part 1: Blinded Period|Protocol Violation|0
2514324|NCT01791153|8699358|P1|Part 1: Blinded Period|Protocol Violation|0
2514325|NCT01791153|8699351|P8|Part 1: Blinded Period|Physician Decision|0
2514326|NCT01791153|8699352|P7|Part 1: Blinded Period|Physician Decision|0
2514327|NCT01791153|8699353|P6|Part 1: Blinded Period|Physician Decision|0
2514328|NCT01791153|8699354|P5|Part 1: Blinded Period|Physician Decision|0
2514329|NCT01791153|8699355|P4|Part 1: Blinded Period|Physician Decision|1
2514330|NCT01791153|8699356|P3|Part 1: Blinded Period|Physician Decision|0
2514331|NCT01791153|8699357|P2|Part 1: Blinded Period|Physician Decision|0
2514332|NCT01791153|8699358|P1|Part 1: Blinded Period|Physician Decision|0
2514333|NCT01791153|8699351|P8|Part 1: Blinded Period|Non-Compliance|0
2514334|NCT01791153|8699352|P7|Part 1: Blinded Period|Non-Compliance|0
2514335|NCT01791153|8699353|P6|Part 1: Blinded Period|Non-Compliance|0
2514336|NCT01791153|8699354|P5|Part 1: Blinded Period|Non-Compliance|0
2514337|NCT01791153|8699355|P4|Part 1: Blinded Period|Non-Compliance|0
2514338|NCT01791153|8699356|P3|Part 1: Blinded Period|Non-Compliance|0
2514339|NCT01791153|8699357|P2|Part 1: Blinded Period|Non-Compliance|0
2514340|NCT01791153|8699358|P1|Part 1: Blinded Period|Non-Compliance|1
2514341|NCT01791153|8699351|P8|Part 1: Blinded Period|Lack of Efficacy|0
2514342|NCT01791153|8699352|P7|Part 1: Blinded Period|Lack of Efficacy|0
2514343|NCT01791153|8699353|P6|Part 1: Blinded Period|Lack of Efficacy|0
2514344|NCT01791153|8699354|P5|Part 1: Blinded Period|Lack of Efficacy|0
2514345|NCT01791153|8699355|P4|Part 1: Blinded Period|Lack of Efficacy|2
2514346|NCT01791153|8699356|P3|Part 1: Blinded Period|Lack of Efficacy|2
2514347|NCT01791153|8699357|P2|Part 1: Blinded Period|Lack of Efficacy|3
2514348|NCT01791153|8699358|P1|Part 1: Blinded Period|Lack of Efficacy|1
2514349|NCT01791153|8699351|P8|Part 1: Blinded Period|Adverse Event|0
2514350|NCT01791153|8699352|P7|Part 1: Blinded Period|Adverse Event|0
2514351|NCT01791153|8699353|P6|Part 1: Blinded Period|Adverse Event|0
2514352|NCT01791153|8699354|P5|Part 1: Blinded Period|Adverse Event|0
2514353|NCT01791153|8699355|P4|Part 1: Blinded Period|Adverse Event|0
2514354|NCT01791153|8699356|P3|Part 1: Blinded Period|Adverse Event|2
2514355|NCT01791153|8699357|P2|Part 1: Blinded Period|Adverse Event|3
2514356|NCT01791153|8699358|P1|Part 1: Blinded Period|Adverse Event|7
2514357|NCT01791127|8699418|P1|Overall Study|Study terminated for EP Passion|749
2514358|NCT01791127|8699418|P1|Overall Study|Completion of 30 day safety registry|1
2514359|NCT01791127|8699418|P1|Overall Study|All Siello leads are explanted|31
2514360|NCT01791127|8699418|P1|Overall Study|Lost to Follow-up|42
2514361|NCT01791127|8699418|P1|Overall Study|Patient has withdrawn from study|293
2514362|NCT01791127|8699418|P1|Overall Study|Death|356
2514363|NCT01790932|8699442|P1|Overall Study|Withdrawal by Subject|1
2514364|NCT01790932|8699442|P1|Overall Study|Physician Decision|1
2514365|NCT01790932|8699442|P1|Overall Study|Adverse Event|7
2514366|NCT01790932|8699442|P1|Overall Study|Disease Progression|41
2514367|NCT01790828|8699448|P1|Overall Study|Other|34
2514368|NCT01790633|8699506|P2|Overall Study|RT failure and no follow-up ELISA|3
2514369|NCT01790633|8699507|P1|Overall Study|RT failure and no follow-up ELISA|0
2514370|NCT01790633|8699506|P2|Overall Study|Did not have serology performed|0
2514371|NCT01790633|8699507|P1|Overall Study|Did not have serology performed|47
2514372|NCT01790633|8699506|P2|Overall Study|Protocol Violation|2
2514373|NCT01790633|8699507|P1|Overall Study|Protocol Violation|1
2514374|NCT01790594|8699520|P3|Overall Study|Terminated prior to week 76|0
2514375|NCT01790594|8699521|P2|Overall Study|Terminated prior to week 76|2
2514376|NCT01790594|8699522|P1|Overall Study|Terminated prior to week 76|0
2514377|NCT01790594|8699520|P3|Overall Study|Transplant was not done|3
2514378|NCT01790594|8699521|P2|Overall Study|Transplant was not done|0
2514379|NCT01790594|8699522|P1|Overall Study|Transplant was not done|0
2514380|NCT01790594|8699520|P3|Overall Study|Withdrawal by Subject|0
2514381|NCT01790594|8699521|P2|Overall Study|Withdrawal by Subject|0
2514382|NCT01790594|8699522|P1|Overall Study|Withdrawal by Subject|2
2514383|NCT01790594|8699520|P3|Overall Study|Physician Decision|0
2514384|NCT01790594|8699521|P2|Overall Study|Physician Decision|1
2514385|NCT01790594|8699522|P1|Overall Study|Physician Decision|2
2514386|NCT01790594|8699520|P3|Overall Study|Death|0
2514387|NCT01790594|8699521|P2|Overall Study|Death|0
2514388|NCT01790594|8699522|P1|Overall Study|Death|1
2514389|NCT01790568|8699599|P2|Overall Study|Progression prior to transplant|1
2514390|NCT01790568|8699600|P1|Overall Study|Progression prior to transplant|0
2514391|NCT01790516|8699608|P2|Overall Study|Physician Decision|0
2514392|NCT01790516|8699609|P1|Overall Study|Physician Decision|1
2514393|NCT01790503|8699626|P11|Overall Study|Other|0
2514394|NCT01790503|8699627|P10|Overall Study|Other|2
2514395|NCT01790503|8699628|P9|Overall Study|Other|1
2514396|NCT01790503|8699629|P8|Overall Study|Other|0
2514397|NCT01790503|8699630|P7|Overall Study|Other|0
2514398|NCT01790503|8699631|P6|Overall Study|Other|0
2514399|NCT01790503|8699632|P5|Overall Study|Other|1
2514400|NCT01790503|8699633|P4|Overall Study|Other|0
2514401|NCT01790503|8699634|P3|Overall Study|Other|0
2514402|NCT01790503|8699635|P2|Overall Study|Other|0
2514403|NCT01790503|8699636|P1|Overall Study|Other|0
2514404|NCT01790503|8699626|P11|Overall Study|Non Compliance|0
2514405|NCT01790503|8699627|P10|Overall Study|Non Compliance|0
2514406|NCT01790503|8699628|P9|Overall Study|Non Compliance|0
2514407|NCT01790503|8699629|P8|Overall Study|Non Compliance|0
2514408|NCT01790503|8699630|P7|Overall Study|Non Compliance|0
2514409|NCT01790503|8699631|P6|Overall Study|Non Compliance|0
2514410|NCT01790503|8699632|P5|Overall Study|Non Compliance|1
2514411|NCT01790503|8699633|P4|Overall Study|Non Compliance|0
2514412|NCT01790503|8699634|P3|Overall Study|Non Compliance|0
2514413|NCT01790503|8699635|P2|Overall Study|Non Compliance|0
2514414|NCT01790503|8699636|P1|Overall Study|Non Compliance|0
2514415|NCT01790503|8699626|P11|Overall Study|Death|0
2514416|NCT01790503|8699627|P10|Overall Study|Death|1
2514417|NCT01790503|8699628|P9|Overall Study|Death|0
2514418|NCT01790503|8699629|P8|Overall Study|Death|0
2514419|NCT01790503|8699630|P7|Overall Study|Death|0
2514420|NCT01790503|8699631|P6|Overall Study|Death|0
2514421|NCT01790503|8699632|P5|Overall Study|Death|0
2514422|NCT01790503|8699633|P4|Overall Study|Death|0
2514423|NCT01790503|8699634|P3|Overall Study|Death|0
2514424|NCT01790503|8699635|P2|Overall Study|Death|0
2514425|NCT01790503|8699636|P1|Overall Study|Death|0
2514426|NCT01790503|8699626|P11|Overall Study|Physician Decision|1
2514427|NCT01790503|8699627|P10|Overall Study|Physician Decision|1
2514428|NCT01790503|8699628|P9|Overall Study|Physician Decision|0
2514429|NCT01790503|8699629|P8|Overall Study|Physician Decision|0
2514430|NCT01790503|8699630|P7|Overall Study|Physician Decision|0
2514431|NCT01790503|8699631|P6|Overall Study|Physician Decision|0
2514432|NCT01790503|8699632|P5|Overall Study|Physician Decision|0
2514433|NCT01790503|8699633|P4|Overall Study|Physician Decision|0
2514434|NCT01790503|8699634|P3|Overall Study|Physician Decision|0
2514435|NCT01790503|8699635|P2|Overall Study|Physician Decision|0
2514436|NCT01790503|8699636|P1|Overall Study|Physician Decision|0
2514437|NCT01790503|8699626|P11|Overall Study|Protocol Violation|0
2514438|NCT01790503|8699627|P10|Overall Study|Protocol Violation|1
2514439|NCT01790503|8699628|P9|Overall Study|Protocol Violation|0
2514440|NCT01790503|8699629|P8|Overall Study|Protocol Violation|0
2514441|NCT01790503|8699630|P7|Overall Study|Protocol Violation|0
2514442|NCT01790503|8699631|P6|Overall Study|Protocol Violation|0
2514443|NCT01790503|8699632|P5|Overall Study|Protocol Violation|0
2514444|NCT01790503|8699633|P4|Overall Study|Protocol Violation|0
2514445|NCT01790503|8699634|P3|Overall Study|Protocol Violation|0
2514446|NCT01790503|8699635|P2|Overall Study|Protocol Violation|0
2514447|NCT01790503|8699636|P1|Overall Study|Protocol Violation|0
2514448|NCT01790503|8699626|P11|Overall Study|Disease progression|7
2514449|NCT01790503|8699627|P10|Overall Study|Disease progression|17
2514450|NCT01790503|8699628|P9|Overall Study|Disease progression|0
2514451|NCT01790503|8699629|P8|Overall Study|Disease progression|1
2514452|NCT01790503|8699630|P7|Overall Study|Disease progression|0
2514453|NCT01790503|8699631|P6|Overall Study|Disease progression|1
2514454|NCT01790503|8699632|P5|Overall Study|Disease progression|2
2514455|NCT01790503|8699633|P4|Overall Study|Disease progression|1
2514456|NCT01790503|8699634|P3|Overall Study|Disease progression|0
2514457|NCT01790503|8699635|P2|Overall Study|Disease progression|1
2514458|NCT01790503|8699636|P1|Overall Study|Disease progression|2
2514459|NCT01790503|8699626|P11|Overall Study|Withdrawal by Subject|1
2514460|NCT01790503|8699627|P10|Overall Study|Withdrawal by Subject|0
2514461|NCT01790503|8699628|P9|Overall Study|Withdrawal by Subject|0
2514462|NCT01790503|8699629|P8|Overall Study|Withdrawal by Subject|0
2514463|NCT01790503|8699630|P7|Overall Study|Withdrawal by Subject|1
2514464|NCT01790503|8699631|P6|Overall Study|Withdrawal by Subject|2
2514465|NCT01790503|8699632|P5|Overall Study|Withdrawal by Subject|1
2514466|NCT01790503|8699633|P4|Overall Study|Withdrawal by Subject|1
2514467|NCT01790503|8699634|P3|Overall Study|Withdrawal by Subject|1
2514468|NCT01790503|8699635|P2|Overall Study|Withdrawal by Subject|0
2514469|NCT01790503|8699636|P1|Overall Study|Withdrawal by Subject|0
2514470|NCT01790503|8699626|P11|Overall Study|Adverse Event|7
2514471|NCT01790503|8699627|P10|Overall Study|Adverse Event|4
2514472|NCT01790503|8699628|P9|Overall Study|Adverse Event|2
2514473|NCT01790503|8699629|P8|Overall Study|Adverse Event|0
2514474|NCT01790503|8699630|P7|Overall Study|Adverse Event|0
2514475|NCT01790503|8699631|P6|Overall Study|Adverse Event|2
2514476|NCT01790503|8699632|P5|Overall Study|Adverse Event|0
2514477|NCT01790503|8699633|P4|Overall Study|Adverse Event|0
2514478|NCT01790503|8699634|P3|Overall Study|Adverse Event|0
2514479|NCT01790503|8699635|P2|Overall Study|Adverse Event|0
2514480|NCT01790503|8699636|P1|Overall Study|Adverse Event|1
2514481|NCT01790438|8699706|P2|Overall Study|Protocol Required Discontinuation|1
2514482|NCT01790438|8699707|P1|Overall Study|Protocol Required Discontinuation|7
2514483|NCT01790438|8699706|P2|Overall Study|Sponsor Decision|3
2514484|NCT01790438|8699707|P1|Overall Study|Sponsor Decision|0
2514485|NCT01790438|8699706|P2|Overall Study|Physician Decision|1
2514486|NCT01790438|8699707|P1|Overall Study|Physician Decision|3
2514487|NCT01790438|8699706|P2|Overall Study|Withdrawal by Subject|2
2514488|NCT01790438|8699707|P1|Overall Study|Withdrawal by Subject|13
2514489|NCT01790438|8699706|P2|Overall Study|Lost to Follow-up|2
2514490|NCT01790438|8699707|P1|Overall Study|Lost to Follow-up|5
2514491|NCT01790438|8699706|P2|Overall Study|Death|0
2514492|NCT01790438|8699707|P1|Overall Study|Death|4
2514493|NCT01790438|8699706|P2|Overall Study|Adverse Event|2
2514494|NCT01790438|8699707|P1|Overall Study|Adverse Event|3
2514495|NCT01790295|8699757|P1|Overall Study|Study closure|4
2514496|NCT01790295|8699757|P1|Overall Study|Lack of Efficacy|2
2514497|NCT01790295|8699757|P1|Overall Study|Death|4
2514498|NCT01790295|8699757|P1|Overall Study|Adverse Event|1
2514499|NCT01790126|8699800|P3|Overall Study|Radiographic Progression|0
2514500|NCT01790126|8699801|P2|Overall Study|Radiographic Progression|1
2514501|NCT01790126|8699802|P1|Overall Study|Radiographic Progression|3
2514502|NCT01790126|8699800|P3|Overall Study|Death|0
2514503|NCT01790126|8699801|P2|Overall Study|Death|0
2514504|NCT01790126|8699802|P1|Overall Study|Death|2
2514505|NCT01790126|8699800|P3|Overall Study|Adverse Event|0
2514506|NCT01790126|8699801|P2|Overall Study|Adverse Event|2
2514507|NCT01790126|8699802|P1|Overall Study|Adverse Event|0
2514508|NCT01790126|8699800|P3|Overall Study|Lost to Follow-up|1
2514509|NCT01790126|8699801|P2|Overall Study|Lost to Follow-up|0
2514510|NCT01790126|8699802|P1|Overall Study|Lost to Follow-up|1
2514511|NCT01790126|8699800|P3|Overall Study|Withdrawal by Subject|2
2514512|NCT01790126|8699801|P2|Overall Study|Withdrawal by Subject|1
2514513|NCT01790126|8699802|P1|Overall Study|Withdrawal by Subject|3
2514514|NCT01790126|8699800|P3|Overall Study|Withdrawal by Physician|2
2514515|NCT01790126|8699801|P2|Overall Study|Withdrawal by Physician|1
2514516|NCT01790126|8699802|P1|Overall Study|Withdrawal by Physician|1
2514517|NCT01790126|8699800|P3|Overall Study|Initiation of Non-Protocol Therapy|2
2514518|NCT01790126|8699801|P2|Overall Study|Initiation of Non-Protocol Therapy|4
2514519|NCT01790126|8699802|P1|Overall Study|Initiation of Non-Protocol Therapy|3
2514520|NCT01790126|8699800|P3|Overall Study|Other|8
2514521|NCT01790126|8699801|P2|Overall Study|Other|4
2514522|NCT01790126|8699802|P1|Overall Study|Other|5
2514523|NCT01790126|8699800|P3|Overall Study|PSA Progression|16
2514524|NCT01790126|8699801|P2|Overall Study|PSA Progression|16
2514525|NCT01790126|8699802|P1|Overall Study|PSA Progression|12
2514526|NCT01790048|8699859|P2|Overall Study|Measurement error|0
2514527|NCT01790048|8699860|P1|Overall Study|Measurement error|1
2514528|NCT01790048|8699859|P2|Overall Study|SAM at Enrollment|0
2514529|NCT01790048|8699860|P1|Overall Study|SAM at Enrollment|2
2514530|NCT01790048|8699859|P2|Overall Study|Other|2
2514531|NCT01790048|8699860|P1|Overall Study|Other|0
2514532|NCT01790048|8699859|P2|Overall Study|data entry error|1
2514533|NCT01790048|8699860|P1|Overall Study|data entry error|0
2514534|NCT01790048|8699859|P2|Overall Study|Incorrect Age|14
2514535|NCT01790048|8699860|P1|Overall Study|Incorrect Age|9
2514536|NCT01789970|8699878|P3|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
2514537|NCT01789970|8699879|P2|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1
2514538|NCT01789970|8699880|P1|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
2514539|NCT01789970|8699878|P3|Double-blind Treatment Period (12 Weeks)|Other|3
2514540|NCT01789970|8699879|P2|Double-blind Treatment Period (12 Weeks)|Other|1
2514541|NCT01789970|8699880|P1|Double-blind Treatment Period (12 Weeks)|Other|0
2514542|NCT01789970|8699878|P3|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
2514543|NCT01789970|8699879|P2|Double-blind Treatment Period (12 Weeks)|Pregnancy|1
2514544|NCT01789970|8699880|P1|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
2514545|NCT01789970|8699878|P3|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2
2514546|NCT01789970|8699879|P2|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1
2514547|NCT01789970|8699880|P1|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0
2514548|NCT01789970|8699878|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1
2514549|NCT01789970|8699879|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2
2514550|NCT01789970|8699880|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0
2514551|NCT01789970|8699878|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
2514552|NCT01789970|8699879|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
2514553|NCT01789970|8699880|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
2514554|NCT01789970|8699878|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7
2514555|NCT01789970|8699879|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
2514556|NCT01789970|8699880|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
2514557|NCT01789970|8699878|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9
2514558|NCT01789970|8699879|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7
2514559|NCT01789970|8699880|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
2514560|NCT01789970|8699878|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
2514561|NCT01789970|8699879|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
2514562|NCT01789970|8699880|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
2514563|NCT01789970|8699878|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|15
2514564|NCT01789970|8699879|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|9
2514565|NCT01789970|8699880|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
2514566|NCT01789970|8699878|P3|Open-label Titration Period|Dropped out prior to dosing|0
2514567|NCT01789970|8699879|P2|Open-label Titration Period|Dropped out prior to dosing|0
2514568|NCT01789970|8699880|P1|Open-label Titration Period|Dropped out prior to dosing|2
2514569|NCT01789970|8699878|P3|Open-label Titration Period|Other|0
2514570|NCT01789970|8699879|P2|Open-label Titration Period|Other|0
2514571|NCT01789970|8699880|P1|Open-label Titration Period|Other|76
2514572|NCT01789970|8699878|P3|Open-label Titration Period|Pregnancy|0
2514573|NCT01789970|8699879|P2|Open-label Titration Period|Pregnancy|0
2514574|NCT01789970|8699880|P1|Open-label Titration Period|Pregnancy|2
2514575|NCT01789970|8699878|P3|Open-label Titration Period|Noncompliance with study procedures|0
2514576|NCT01789970|8699879|P2|Open-label Titration Period|Noncompliance with study procedures|0
2514577|NCT01789970|8699880|P1|Open-label Titration Period|Noncompliance with study procedures|8
2514578|NCT01789970|8699878|P3|Open-label Titration Period|Noncompliance with study rescue meds|0
2514579|NCT01789970|8699879|P2|Open-label Titration Period|Noncompliance with study rescue meds|0
2514580|NCT01789970|8699880|P1|Open-label Titration Period|Noncompliance with study rescue meds|2
2514581|NCT01789970|8699878|P3|Open-label Titration Period|Noncompliance to study drug admin|0
2514582|NCT01789970|8699879|P2|Open-label Titration Period|Noncompliance to study drug admin|0
2514583|NCT01789970|8699880|P1|Open-label Titration Period|Noncompliance to study drug admin|11
2514584|NCT01789970|8699878|P3|Open-label Titration Period|Lost to Follow-up|0
2514585|NCT01789970|8699879|P2|Open-label Titration Period|Lost to Follow-up|0
2514586|NCT01789970|8699880|P1|Open-label Titration Period|Lost to Follow-up|5
2514587|NCT01789970|8699878|P3|Open-label Titration Period|Protocol Violation|0
2514588|NCT01789970|8699879|P2|Open-label Titration Period|Protocol Violation|0
2514589|NCT01789970|8699880|P1|Open-label Titration Period|Protocol Violation|18
2514590|NCT01789970|8699878|P3|Open-label Titration Period|Withdrawal by Subject|0
2514591|NCT01789970|8699879|P2|Open-label Titration Period|Withdrawal by Subject|0
2514592|NCT01789970|8699880|P1|Open-label Titration Period|Withdrawal by Subject|31
2514593|NCT01789970|8699878|P3|Open-label Titration Period|Lack of Efficacy|0
2514594|NCT01789970|8699879|P2|Open-label Titration Period|Lack of Efficacy|0
2514595|NCT01789970|8699880|P1|Open-label Titration Period|Lack of Efficacy|31
2514596|NCT01789970|8699878|P3|Open-label Titration Period|Adverse Event|0
2514597|NCT01789970|8699879|P2|Open-label Titration Period|Adverse Event|0
2514598|NCT01789970|8699880|P1|Open-label Titration Period|Adverse Event|68
2514599|NCT01789606|8699938|P2|Overall Study|Ineligible or not Willing to Continue|348
2514600|NCT01789606|8699939|P1|Overall Study|Ineligible or not Willing to Continue|0
2514601|NCT01789606|8699938|P2|Overall Study|Lost to Follow-up|14
2514602|NCT01789606|8699939|P1|Overall Study|Lost to Follow-up|0
2514603|NCT01789606|8699938|P2|Overall Study|Adverse Event|3
2514604|NCT01789606|8699939|P1|Overall Study|Adverse Event|0
2514605|NCT01789606|8699938|P2|Overall Study|Protocol Violation|55
2514606|NCT01789606|8699939|P1|Overall Study|Protocol Violation|0
2514607|NCT01789606|8699938|P2|Overall Study|No Study Medication Taken|1
2514608|NCT01789606|8699939|P1|Overall Study|No Study Medication Taken|0
2514609|NCT01789606|8699938|P2|Overall Study|Administrative Reasons|6
2514610|NCT01789606|8699939|P1|Overall Study|Administrative Reasons|17
2514611|NCT01789606|8699938|P2|Overall Study|Ineligible|2
2514612|NCT01789606|8699939|P1|Overall Study|Ineligible|6
2514613|NCT01789606|8699938|P2|Overall Study|Withdrawal by Subject|1
2514614|NCT01789606|8699939|P1|Overall Study|Withdrawal by Subject|0
2514615|NCT01789606|8699938|P2|Overall Study|Participant not Purchased the Product|20
2514616|NCT01789606|8699939|P1|Overall Study|Participant not Purchased the Product|0
2514617|NCT01789567|8699957|P1|Overall Study|Death|6
2514618|NCT01789476|8699966|P2|Overall Study|Unable to get IV access|0
2514619|NCT01789476|8699967|P1|Overall Study|Unable to get IV access|1
2514620|NCT01789476|8699966|P2|Overall Study|Adverse Event|0
2514621|NCT01789476|8699967|P1|Overall Study|Adverse Event|1
2514622|NCT01789476|8699966|P2|Overall Study|Lack of Efficacy|2
2514623|NCT01789476|8699967|P1|Overall Study|Lack of Efficacy|6
2514624|NCT01789203|8699989|P2|Overall Study|patient non-adherent|0
2514625|NCT01789203|8699990|P1|Overall Study|patient non-adherent|2
2514626|NCT01789203|8699989|P2|Overall Study|Other|1
2514627|NCT01789203|8699990|P1|Overall Study|Other|1
2514628|NCT01789203|8699989|P2|Overall Study|Protocol Violation|1
2514629|NCT01789203|8699990|P1|Overall Study|Protocol Violation|2
2514630|NCT01789203|8699989|P2|Overall Study|Death|0
2514631|NCT01789203|8699990|P1|Overall Study|Death|1
2514632|NCT01789203|8699989|P2|Overall Study|Withdrawal by Subject|0
2514633|NCT01789203|8699990|P1|Overall Study|Withdrawal by Subject|1
2514634|NCT01789203|8699989|P2|Overall Study|Adverse Event|2
2514635|NCT01789203|8699990|P1|Overall Study|Adverse Event|2
2514636|NCT01789047|8700031|P2|Overall Study|Withdrawal by Subject|2
2514637|NCT01789047|8700032|P1|Overall Study|Withdrawal by Subject|1
2514638|NCT01789047|8700031|P2|Overall Study|Adverse Event|2
2514639|NCT01789047|8700032|P1|Overall Study|Adverse Event|3
2514640|NCT01788943|8700040|P2|Overall Study|Withdrawal by Subject|0
2514641|NCT01788943|8700041|P1|Overall Study|Withdrawal by Subject|1
2514642|NCT01788566|8700070|P1|Overall Study|Clinical Progressive Disease|3
2514643|NCT01788566|8700070|P1|Overall Study|Adverse Event|1
2514644|NCT01788566|8700070|P1|Overall Study|Death|4
2514645|NCT01788423|8700108|P3|Overall Study|See Comments in Completed (above)|5
2514646|NCT01788423|8700109|P2|Overall Study|See Comments in Completed (above)|4
2514647|NCT01788423|8700110|P1|Overall Study|See Comments in Completed (above)|0
2514648|NCT01788358|8700121|P1|Overall Study|Adverse Event|51
2514649|NCT01788358|8700121|P1|Overall Study|Lack of Efficacy|1
2514650|NCT01788358|8700121|P1|Overall Study|Withdrawal by Subject|26
2514651|NCT01788358|8700121|P1|Overall Study|Protocol Violation|3
2514652|NCT01788358|8700121|P1|Overall Study|Lost to Follow-up|5
2514653|NCT01788358|8700121|P1|Overall Study|Logistical difficulties|1
2514654|NCT01788358|8700121|P1|Overall Study|Other|11
2514655|NCT01788228|8700135|P2|Overall Study|Migrated/moved from study area|0
2514656|NCT01788228|8700136|P1|Overall Study|Migrated/moved from study area|1
2514657|NCT01788215|8700155|P2|Overall Study|Lost to Follow-up|0
2514658|NCT01788215|8700156|P1|Overall Study|Lost to Follow-up|2
2514659|NCT01788215|8700155|P2|Overall Study|Withdrawal by Subject|1
2514660|NCT01788215|8700156|P1|Overall Study|Withdrawal by Subject|0
2514661|NCT01788163|8700185|P9|Overall Study|Withdrawal by Subject|1
2514662|NCT01788163|8700186|P8|Overall Study|Withdrawal by Subject|0
2514663|NCT01788163|8700187|P7|Overall Study|Withdrawal by Subject|0
2514664|NCT01788163|8700188|P6|Overall Study|Withdrawal by Subject|0
2514665|NCT01788163|8700189|P5|Overall Study|Withdrawal by Subject|0
2514666|NCT01788163|8700190|P4|Overall Study|Withdrawal by Subject|0
2514667|NCT01788163|8700191|P3|Overall Study|Withdrawal by Subject|0
2514668|NCT01788163|8700192|P2|Overall Study|Withdrawal by Subject|0
2514669|NCT01788163|8700193|P1|Overall Study|Withdrawal by Subject|2
2514670|NCT01788163|8700185|P9|Overall Study|Other|15
2514671|NCT01788163|8700186|P8|Overall Study|Other|48
2514672|NCT01788163|8700187|P7|Overall Study|Other|1
2514673|NCT01788163|8700188|P6|Overall Study|Other|7
2514674|NCT01788163|8700189|P5|Overall Study|Other|0
2514675|NCT01788163|8700190|P4|Overall Study|Other|0
2514676|NCT01788163|8700191|P3|Overall Study|Other|0
2514677|NCT01788163|8700192|P2|Overall Study|Other|0
2514678|NCT01788163|8700193|P1|Overall Study|Other|53
2514679|NCT01788046|8700356|P2|Overall Study|Protocol Specified Criteria|1
2514680|NCT01788046|8700357|P1|Overall Study|Protocol Specified Criteria|25
2514681|NCT01788046|8700356|P2|Overall Study|Death|5
2514682|NCT01788046|8700357|P1|Overall Study|Death|7
2514683|NCT01788046|8700356|P2|Overall Study|Lost to Follow-up|19
2514684|NCT01788046|8700357|P1|Overall Study|Lost to Follow-up|12
2514685|NCT01788046|8700356|P2|Overall Study|Withdrawal by Subject|12
2514686|NCT01788046|8700357|P1|Overall Study|Withdrawal by Subject|12
2514687|NCT01787838|8700380|P1|Overall Study|refused|1413
2514688|NCT01787825|8700384|P2|Overall Study|Data Not Analyzable|1
2514689|NCT01787825|8700385|P1|Overall Study|Data Not Analyzable|5
2514690|NCT01787825|8700384|P2|Overall Study|Subject Did Not Ingest Capsules|0
2514691|NCT01787825|8700385|P1|Overall Study|Subject Did Not Ingest Capsules|1
2514692|NCT01787760|8700403|P3|Overall Study|Near vision blur|0
2514693|NCT01787760|8700404|P2|Overall Study|Near vision blur|0
2514694|NCT01787760|8700405|P1|Overall Study|Near vision blur|1
2514695|NCT01787760|8700403|P3|Overall Study|Unsatisfactory visual response|0
2514696|NCT01787760|8700404|P2|Overall Study|Unsatisfactory visual response|1
2514697|NCT01787760|8700405|P1|Overall Study|Unsatisfactory visual response|1
2514698|NCT01787760|8700403|P3|Overall Study|Unsatisfactory physiological response|0
2514699|NCT01787760|8700404|P2|Overall Study|Unsatisfactory physiological response|4
2514700|NCT01787760|8700405|P1|Overall Study|Unsatisfactory physiological response|2
2514701|NCT01787760|8700403|P3|Overall Study|Unsatisfactory lens fitting performance|0
2514702|NCT01787760|8700404|P2|Overall Study|Unsatisfactory lens fitting performance|6
2514703|NCT01787760|8700405|P1|Overall Study|Unsatisfactory lens fitting performance|3
2514704|NCT01787760|8700403|P3|Overall Study|Stroke|0
2514705|NCT01787760|8700404|P2|Overall Study|Stroke|0
2514706|NCT01787760|8700405|P1|Overall Study|Stroke|1
2514707|NCT01787760|8700403|P3|Overall Study|Lost to Follow-up|1
2514708|NCT01787760|8700404|P2|Overall Study|Lost to Follow-up|0
2514709|NCT01787760|8700405|P1|Overall Study|Lost to Follow-up|1
2514710|NCT01787760|8700403|P3|Overall Study|Withdrawal by Subject|2
2514711|NCT01787760|8700404|P2|Overall Study|Withdrawal by Subject|1
2514712|NCT01787760|8700405|P1|Overall Study|Withdrawal by Subject|5
2514713|NCT01787760|8700403|P3|Overall Study|Protocol Violation|1
2514714|NCT01787760|8700404|P2|Overall Study|Protocol Violation|0
2514715|NCT01787760|8700405|P1|Overall Study|Protocol Violation|6
2514716|NCT01787760|8700403|P3|Overall Study|Lens handling difficulty|0
2514717|NCT01787760|8700404|P2|Overall Study|Lens handling difficulty|2
2514718|NCT01787760|8700405|P1|Overall Study|Lens handling difficulty|1
2514719|NCT01787760|8700403|P3|Overall Study|Lens discomfort|0
2514720|NCT01787760|8700404|P2|Overall Study|Lens discomfort|0
2514721|NCT01787760|8700405|P1|Overall Study|Lens discomfort|3
2514722|NCT01787760|8700403|P3|Overall Study|Relocation|0
2514723|NCT01787760|8700404|P2|Overall Study|Relocation|1
2514724|NCT01787760|8700405|P1|Overall Study|Relocation|1
2514725|NCT01787760|8700403|P3|Overall Study|Dryness|0
2514726|NCT01787760|8700404|P2|Overall Study|Dryness|1
2514727|NCT01787760|8700405|P1|Overall Study|Dryness|0
2514728|NCT01787760|8700403|P3|Overall Study|Decompensated on left exotropia|1
2514729|NCT01787760|8700404|P2|Overall Study|Decompensated on left exotropia|0
2514730|NCT01787760|8700405|P1|Overall Study|Decompensated on left exotropia|0
2514731|NCT01787760|8700403|P3|Overall Study|Anisometropia > -1.00D in spherical equi|0
2514732|NCT01787760|8700404|P2|Overall Study|Anisometropia > -1.00D in spherical equi|0
2514733|NCT01787760|8700405|P1|Overall Study|Anisometropia > -1.00D in spherical equi|1
2514734|NCT01787591|8700430|P4|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1
2514735|NCT01787591|8700431|P3|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
2514736|NCT01787591|8700432|P2|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
2514737|NCT01787591|8700433|P1|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
2514738|NCT01787552|8700463|P4|Overall Study|Progressive Disease|1
2514739|NCT01787552|8700464|P3|Overall Study|Progressive Disease|1
2514740|NCT01787552|8700465|P2|Overall Study|Progressive Disease|2
2514741|NCT01787552|8700466|P1|Overall Study|Progressive Disease|2
2514742|NCT01787552|8700463|P4|Overall Study|Study terminated by Sponsor|3
2514743|NCT01787552|8700464|P3|Overall Study|Study terminated by Sponsor|1
2514744|NCT01787552|8700465|P2|Overall Study|Study terminated by Sponsor|0
2514745|NCT01787552|8700466|P1|Overall Study|Study terminated by Sponsor|0
2514746|NCT01787552|8700463|P4|Overall Study|Adverse Event|16
2514747|NCT01787552|8700464|P3|Overall Study|Adverse Event|2
2514748|NCT01787552|8700465|P2|Overall Study|Adverse Event|5
2514749|NCT01787552|8700466|P1|Overall Study|Adverse Event|2
2514750|NCT01787552|8700463|P4|Overall Study|Death|1
2514751|NCT01787552|8700464|P3|Overall Study|Death|0
2514752|NCT01787552|8700465|P2|Overall Study|Death|0
2514753|NCT01787552|8700466|P1|Overall Study|Death|0
2514754|NCT01787552|8700463|P4|Overall Study|Physician Decision|2
2514755|NCT01787552|8700464|P3|Overall Study|Physician Decision|1
2514756|NCT01787552|8700465|P2|Overall Study|Physician Decision|2
2514757|NCT01787552|8700466|P1|Overall Study|Physician Decision|2
2514758|NCT01787552|8700463|P4|Overall Study|Withdrawal by Subject|4
2514759|NCT01787552|8700464|P3|Overall Study|Withdrawal by Subject|0
2514760|NCT01787552|8700465|P2|Overall Study|Withdrawal by Subject|0
2514761|NCT01787552|8700466|P1|Overall Study|Withdrawal by Subject|2
2514762|NCT01787461|8700536|P2|Overall Study|Protocol Violation|0
2514763|NCT01787461|8700537|P1|Overall Study|Protocol Violation|3
2514764|NCT01787461|8700536|P2|Overall Study|Withdrawal by Subject|4
2514765|NCT01787461|8700537|P1|Overall Study|Withdrawal by Subject|3
2514766|NCT01787461|8700536|P2|Overall Study|No longer met eligibility criteria|0
2514767|NCT01787461|8700537|P1|Overall Study|No longer met eligibility criteria|1
2514768|NCT01787461|8700536|P2|Overall Study|Lost to Follow-up|2
2514769|NCT01787461|8700537|P1|Overall Study|Lost to Follow-up|3
2514770|NCT01787461|8700536|P2|Overall Study|Adverse Event|3
2514771|NCT01787461|8700537|P1|Overall Study|Adverse Event|4
2514772|NCT01787331|8700586|P1|Overall Study|Withdrawal by Subject|1
2514773|NCT01787331|8700586|P1|Overall Study|Physician Decision|1
2514774|NCT01787292|8700598|P2|Home Based Exercise Program|Withdrawal by Subject|1
2514775|NCT01787292|8700599|P1|Home Based Exercise Program|Withdrawal by Subject|3
2514776|NCT01787292|8700598|P2|Crossover Exercise Interventions|Withdrawal by Subject|2
2514777|NCT01787292|8700599|P1|Crossover Exercise Interventions|Withdrawal by Subject|2
2514778|NCT01787279|8700616|P1|Overall Study|Lack of Efficacy|1
2514779|NCT01787279|8700616|P1|Overall Study|Lost to Follow-up|2
2514780|NCT01787188|8700642|P3|Overall Study|Other, including patient moved|0
2514781|NCT01787188|8700643|P2|Overall Study|Other, including patient moved|3
2514782|NCT01787188|8700644|P1|Overall Study|Other, including patient moved|0
2514783|NCT01787188|8700642|P3|Overall Study|Lost to Follow-up|2
2514784|NCT01787188|8700643|P2|Overall Study|Lost to Follow-up|2
2514785|NCT01787188|8700644|P1|Overall Study|Lost to Follow-up|1
2514786|NCT01787188|8700642|P3|Overall Study|Protocol Violation|3
2514787|NCT01787188|8700643|P2|Overall Study|Protocol Violation|2
2514788|NCT01787188|8700644|P1|Overall Study|Protocol Violation|3
2514789|NCT01787188|8700642|P3|Overall Study|Withdrawal by Subject|2
2514790|NCT01787188|8700643|P2|Overall Study|Withdrawal by Subject|3
2514791|NCT01787188|8700644|P1|Overall Study|Withdrawal by Subject|4
2514792|NCT01787188|8700642|P3|Overall Study|Non-compliance with Study Drug|0
2514793|NCT01787188|8700643|P2|Overall Study|Non-compliance with Study Drug|1
2514794|NCT01787188|8700644|P1|Overall Study|Non-compliance with Study Drug|0
2514795|NCT01787188|8700642|P3|Overall Study|Lack of Efficacy|5
2514796|NCT01787188|8700643|P2|Overall Study|Lack of Efficacy|3
2514797|NCT01787188|8700644|P1|Overall Study|Lack of Efficacy|7
2514798|NCT01787188|8700642|P3|Overall Study|Adverse Event|6
2514799|NCT01787188|8700643|P2|Overall Study|Adverse Event|4
2514800|NCT01787188|8700644|P1|Overall Study|Adverse Event|2
2514801|NCT01787032|8700716|P6|Overall Study|Protocol Violation|1
2514802|NCT01787032|8700717|P5|Overall Study|Protocol Violation|1
2514803|NCT01787032|8700718|P4|Overall Study|Protocol Violation|0
2514804|NCT01787032|8700719|P3|Overall Study|Protocol Violation|0
2514805|NCT01787032|8700720|P2|Overall Study|Protocol Violation|0
2514806|NCT01787032|8700721|P1|Overall Study|Protocol Violation|0
2514807|NCT01786993|8700774|P2|Overall Study|Hospice Admission|0
2514808|NCT01786993|8700775|P1|Overall Study|Hospice Admission|1
2514809|NCT01786993|8700774|P2|Overall Study|System Explant|0
2514810|NCT01786993|8700775|P1|Overall Study|System Explant|1
2514811|NCT01786993|8700774|P2|Overall Study|Subject Non-Compliance|0
2514812|NCT01786993|8700775|P1|Overall Study|Subject Non-Compliance|1
2514813|NCT01786993|8700774|P2|Overall Study|Lost to Follow-up|1
2514814|NCT01786993|8700775|P1|Overall Study|Lost to Follow-up|0
2514815|NCT01786993|8700774|P2|Overall Study|Withdrawal by Subject|2
2514816|NCT01786993|8700775|P1|Overall Study|Withdrawal by Subject|3
2514817|NCT01786993|8700774|P2|Overall Study|Death|7
2514818|NCT01786993|8700775|P1|Overall Study|Death|6
2514819|NCT01786707|8700834|P2|Overall Study|Lost to Follow-up|1
2514820|NCT01786707|8700835|P1|Overall Study|Lost to Follow-up|1
2514821|NCT01786668|8700847|P4|Overall Study|Lost to Follow-up|0
2514822|NCT01786668|8700848|P3|Overall Study|Lost to Follow-up|1
2514823|NCT01786668|8700849|P2|Overall Study|Lost to Follow-up|0
2514824|NCT01786668|8700850|P1|Overall Study|Lost to Follow-up|1
2514825|NCT01786668|8700847|P4|Overall Study|Pregnancy|1
2514826|NCT01786668|8700848|P3|Overall Study|Pregnancy|0
2514827|NCT01786668|8700849|P2|Overall Study|Pregnancy|0
2514828|NCT01786668|8700850|P1|Overall Study|Pregnancy|0
2514829|NCT01786668|8700847|P4|Overall Study|Withdrawal by Subject|1
2514830|NCT01786668|8700848|P3|Overall Study|Withdrawal by Subject|3
2514831|NCT01786668|8700849|P2|Overall Study|Withdrawal by Subject|0
2514832|NCT01786668|8700850|P1|Overall Study|Withdrawal by Subject|0
2514833|NCT01786668|8700847|P4|Overall Study|Adverse Event|2
2514834|NCT01786668|8700848|P3|Overall Study|Adverse Event|1
2514835|NCT01786668|8700849|P2|Overall Study|Adverse Event|1
2514836|NCT01786668|8700850|P1|Overall Study|Adverse Event|0
2514837|NCT01786629|8700950|P2|Overall Study|Adverse Event|1
2514838|NCT01786629|8700951|P1|Overall Study|Adverse Event|0
2514839|NCT01786629|8700950|P2|Overall Study|Lack of Efficacy|4
2514840|NCT01786629|8700951|P1|Overall Study|Lack of Efficacy|0
2514841|NCT01786603|8700959|P2|Overall Study|Lost to Follow-up|2
2514842|NCT01786603|8700960|P1|Overall Study|Lost to Follow-up|1
2514843|NCT01786603|8700959|P2|Overall Study|Physician decision to withdraw|7
2514844|NCT01786603|8700960|P1|Overall Study|Physician decision to withdraw|6
2514845|NCT01786603|8700959|P2|Overall Study|Adverse Event|2
2514846|NCT01786603|8700960|P1|Overall Study|Adverse Event|6
2514847|NCT01786603|8700959|P2|Overall Study|Death|1
2514848|NCT01786603|8700960|P1|Overall Study|Death|5
2514849|NCT01786551|8700978|P1|Overall Study|Participant withdrew consent|2
2514850|NCT01786330|8700999|P2|Overall Study|Protocol Violation|0
2514851|NCT01786330|8701000|P1|Overall Study|Protocol Violation|1
2514852|NCT01786330|8700999|P2|Overall Study|Excluded intraoperatively|1
2514853|NCT01786330|8701000|P1|Overall Study|Excluded intraoperatively|0
2514854|NCT01786330|8700999|P2|Overall Study|Lost to Follow-up|1
2514855|NCT01786330|8701000|P1|Overall Study|Lost to Follow-up|0
2514856|NCT01786330|8700999|P2|Overall Study|Withdrawal by Subject|1
2514857|NCT01786330|8701000|P1|Overall Study|Withdrawal by Subject|0
2514858|NCT01786174|8701052|P2|Overall Study|Discontinued Study Drug|0
2514859|NCT01786174|8701053|P1|Overall Study|Discontinued Study Drug|2
2514860|NCT01786148|8701082|P2|Overall Study|Incarceration|1
2514861|NCT01786148|8701083|P1|Overall Study|Incarceration|1
2514862|NCT01786148|8701082|P2|Overall Study|Withdrawal by Subject|7
2514863|NCT01786148|8701083|P1|Overall Study|Withdrawal by Subject|0
2514864|NCT01786148|8701082|P2|Overall Study|Death|1
2514865|NCT01786148|8701083|P1|Overall Study|Death|0
2514866|NCT01786148|8701082|P2|Overall Study|Lost to Follow-up|13
2514867|NCT01786148|8701083|P1|Overall Study|Lost to Follow-up|21
2514868|NCT01786109|8701098|P3|Overall Study|adverse effects colon preparation|1
2514869|NCT01786109|8701099|P2|Overall Study|adverse effects colon preparation|0
2514870|NCT01786109|8701100|P1|Overall Study|adverse effects colon preparation|0
2514871|NCT01786109|8701098|P3|Overall Study|unrelated illness|1
2514872|NCT01786109|8701099|P2|Overall Study|unrelated illness|0
2514873|NCT01786109|8701100|P1|Overall Study|unrelated illness|0
2514874|NCT01786109|8701098|P3|Overall Study|fail manometry barostat tube placement|0
2514875|NCT01786109|8701099|P2|Overall Study|fail manometry barostat tube placement|0
2514876|NCT01786109|8701100|P1|Overall Study|fail manometry barostat tube placement|1
2514877|NCT01785875|8701129|P3|Overall Study|Missing|3
2514878|NCT01785875|8701130|P2|Overall Study|Missing|1
2514879|NCT01785875|8701131|P1|Overall Study|Missing|0
2514880|NCT01785875|8701129|P3|Overall Study|Protocol Specified Criteria|55
2514881|NCT01785875|8701130|P2|Overall Study|Protocol Specified Criteria|214
2514882|NCT01785875|8701131|P1|Overall Study|Protocol Specified Criteria|207
2514883|NCT01785875|8701129|P3|Overall Study|Sponsor Decision|0
2514884|NCT01785875|8701130|P2|Overall Study|Sponsor Decision|2
2514885|NCT01785875|8701131|P1|Overall Study|Sponsor Decision|0
2514886|NCT01785875|8701129|P3|Overall Study|Death|7
2514887|NCT01785875|8701130|P2|Overall Study|Death|16
2514888|NCT01785875|8701131|P1|Overall Study|Death|27
2514889|NCT01785875|8701129|P3|Overall Study|Lost to Follow-up|6
2514890|NCT01785875|8701130|P2|Overall Study|Lost to Follow-up|22
2514891|NCT01785875|8701131|P1|Overall Study|Lost to Follow-up|19
2514892|NCT01785875|8701129|P3|Overall Study|Withdrawal by Subject|36
2514893|NCT01785875|8701130|P2|Overall Study|Withdrawal by Subject|34
2514894|NCT01785875|8701131|P1|Overall Study|Withdrawal by Subject|41
2514895|NCT01785849|8701200|P2|Overall Study|Lost to Follow-up|11
2514896|NCT01785849|8701201|P1|Overall Study|Lost to Follow-up|10
2514897|NCT01785849|8701200|P2|Overall Study|Sponsor Decision|1
2514898|NCT01785849|8701201|P1|Overall Study|Sponsor Decision|0
2514899|NCT01785849|8701200|P2|Overall Study|Withdrawal by Subject|12
2514900|NCT01785849|8701201|P1|Overall Study|Withdrawal by Subject|15
2514901|NCT01785849|8701200|P2|Overall Study|Protocol Specified Criteria|1
2514902|NCT01785849|8701201|P1|Overall Study|Protocol Specified Criteria|29
2514903|NCT01785849|8701200|P2|Overall Study|Death|9
2514904|NCT01785849|8701201|P1|Overall Study|Death|7
2514905|NCT01785628|8701234|P2|Overall Study|Lost to Follow-up|3
2514906|NCT01785628|8701235|P1|Overall Study|Lost to Follow-up|2
2514907|NCT01785615|8701258|P4|Dietary Phase|Lost to Follow-up|24
2514908|NCT01785615|8701259|P3|Dietary Phase|Lost to Follow-up|0
2514909|NCT01785615|8701260|P2|Dietary Phase|Lost to Follow-up|0
2514910|NCT01785615|8701261|P1|Dietary Phase|Lost to Follow-up|0
2514911|NCT01785602|8701333|P2|Overall Study|Administrative problems|3
2514912|NCT01785602|8701334|P1|Overall Study|Administrative problems|7
2514913|NCT01785602|8701333|P2|Overall Study|Adverse Event|5
2514914|NCT01785602|8701334|P1|Overall Study|Adverse Event|3
2514915|NCT01785602|8701333|P2|Overall Study|Lost to Follow-up|1
2514916|NCT01785602|8701334|P1|Overall Study|Lost to Follow-up|1
2514917|NCT01785602|8701333|P2|Overall Study|Withdrawal by Subject|0
2514918|NCT01785602|8701334|P1|Overall Study|Withdrawal by Subject|2
2514919|NCT01785524|8701344|P2|Overall Study|Withdrawal by Subject|2
2514920|NCT01785524|8701345|P1|Overall Study|Withdrawal by Subject|2
2514921|NCT01785472|8701364|P3|Overall Study|Technical problems|1
2514922|NCT01785472|8701365|P2|Overall Study|Technical problems|0
2514923|NCT01785472|8701366|P1|Overall Study|Technical problems|0
2514924|NCT01785472|8701364|P3|Overall Study|Subject/guardian decision|11
2514925|NCT01785472|8701365|P2|Overall Study|Subject/guardian decision|10
2514926|NCT01785472|8701366|P1|Overall Study|Subject/guardian decision|15
2514927|NCT01785472|8701364|P3|Overall Study|Protocol deviation|2
2514928|NCT01785472|8701365|P2|Overall Study|Protocol deviation|2
2514929|NCT01785472|8701366|P1|Overall Study|Protocol deviation|0
2514930|NCT01785472|8701364|P3|Overall Study|Physician Decision|1
2514931|NCT01785472|8701365|P2|Overall Study|Physician Decision|1
2514932|NCT01785472|8701366|P1|Overall Study|Physician Decision|1
2514933|NCT01785472|8701364|P3|Overall Study|Lost to Follow-up|0
2514934|NCT01785472|8701365|P2|Overall Study|Lost to Follow-up|2
2514935|NCT01785472|8701366|P1|Overall Study|Lost to Follow-up|1
2514936|NCT01785472|8701364|P3|Overall Study|Lack of Efficacy|1
2514937|NCT01785472|8701365|P2|Overall Study|Lack of Efficacy|0
2514938|NCT01785472|8701366|P1|Overall Study|Lack of Efficacy|2
2514939|NCT01785472|8701364|P3|Overall Study|Adverse Event|6
2514940|NCT01785472|8701365|P2|Overall Study|Adverse Event|4
2514941|NCT01785472|8701366|P1|Overall Study|Adverse Event|5
2514942|NCT01785160|8701452|P1|Washout Period of at Least 7 Days|Consent withdrawn|1
2514943|NCT01785160|8701452|P1|Treatment Period 1: Raltegravir|Not treated|1
2514944|NCT01784965|8701508|P2|Overall Study|Adverse Event|8
2514945|NCT01784965|8701509|P1|Overall Study|Adverse Event|0
2514946|NCT01784965|8701508|P2|Overall Study|Withdrawal by Subject|3
2514947|NCT01784965|8701509|P1|Overall Study|Withdrawal by Subject|6
2514948|NCT01784211|8701632|P6|Part A (Days 1-15)|Withdrawal by Subject|0
2514949|NCT01784211|8701633|P5|Part A (Days 1-15)|Withdrawal by Subject|0
2514950|NCT01784211|8701634|P4|Part A (Days 1-15)|Withdrawal by Subject|0
2514951|NCT01784211|8701635|P3|Part A (Days 1-15)|Withdrawal by Subject|0
2514952|NCT01784211|8701636|P2|Part A (Days 1-15)|Withdrawal by Subject|1
2514953|NCT01784211|8701637|P1|Part A (Days 1-15)|Withdrawal by Subject|2
2514954|NCT01784211|8701632|P6|Part A (Days 1-15)|Adverse Event|0
2514955|NCT01784211|8701633|P5|Part A (Days 1-15)|Adverse Event|0
2514956|NCT01784211|8701634|P4|Part A (Days 1-15)|Adverse Event|0
2514957|NCT01784211|8701635|P3|Part A (Days 1-15)|Adverse Event|0
2514958|NCT01784211|8701636|P2|Part A (Days 1-15)|Adverse Event|1
2514959|NCT01784211|8701637|P1|Part A (Days 1-15)|Adverse Event|1
2514960|NCT01784029|8701662|P3|Overall Study|Lost to Follow-up|22
2514961|NCT01784029|8701663|P2|Overall Study|Lost to Follow-up|20
2514962|NCT01784029|8701664|P1|Overall Study|Lost to Follow-up|19
2514963|NCT01783938|8701674|P2|Overall Study|Other|0
2514964|NCT01783938|8701675|P1|Overall Study|Other|1
2514965|NCT01783938|8701674|P2|Overall Study|Withdrew Consent|0
2514966|NCT01783938|8701675|P1|Overall Study|Withdrew Consent|3
2514967|NCT01783938|8701674|P2|Overall Study|Request to Discontinue Study Treatment|2
2514968|NCT01783938|8701675|P1|Overall Study|Request to Discontinue Study Treatment|1
2514969|NCT01783938|8701674|P2|Overall Study|Adverse Event Unrelated to Study Drug|2
2514970|NCT01783938|8701675|P1|Overall Study|Adverse Event Unrelated to Study Drug|2
2514971|NCT01783938|8701674|P2|Overall Study|Study Drug Toxicity|10
2514972|NCT01783938|8701675|P1|Overall Study|Study Drug Toxicity|22
2514973|NCT01783938|8701674|P2|Overall Study|Disease Progression|39
2514974|NCT01783938|8701675|P1|Overall Study|Disease Progression|18
2514975|NCT01783886|8701703|P3|Overall Study|Adverse Event|4
2514976|NCT01783886|8701704|P2|Overall Study|Adverse Event|5
2514977|NCT01783886|8701705|P1|Overall Study|Adverse Event|4
2514978|NCT01783886|8701703|P3|Overall Study|Withdrawal of consent by participant|4
2514979|NCT01783886|8701704|P2|Overall Study|Withdrawal of consent by participant|3
2514980|NCT01783886|8701705|P1|Overall Study|Withdrawal of consent by participant|1
2514981|NCT01783886|8701703|P3|Overall Study|Protocol deviation|2
2514982|NCT01783886|8701704|P2|Overall Study|Protocol deviation|0
2514983|NCT01783886|8701705|P1|Overall Study|Protocol deviation|0
2514984|NCT01783886|8701703|P3|Overall Study|Lost to Follow-up|0
2514985|NCT01783886|8701704|P2|Overall Study|Lost to Follow-up|3
2514986|NCT01783886|8701705|P1|Overall Study|Lost to Follow-up|0
2514987|NCT01783821|8701768|P2|Overall Study|Screen Failure|1
2514988|NCT01783821|8701769|P1|Overall Study|Screen Failure|1
2514989|NCT01783743|8701787|P2|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236
2514990|NCT01783743|8701788|P1|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305
2514991|NCT01783743|8701787|P2|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684
2514992|NCT01783743|8701788|P1|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591
2514993|NCT01783743|8701787|P2|Screening of Subjects by CTA During MDA|Absent at MDA|4439
2514994|NCT01783743|8701788|P1|Screening of Subjects by CTA During MDA|Absent at MDA|3427
2514995|NCT01783730|8701802|P1|Overall Study|Failed to meet inclusion criteria|6
2514996|NCT01783678|8701827|P6|Overall Study|Withdrew Consent|0
2514997|NCT01783678|8701828|P5|Overall Study|Withdrew Consent|0
2514998|NCT01783678|8701829|P4|Overall Study|Withdrew Consent|2
2514999|NCT01783678|8701830|P3|Overall Study|Withdrew Consent|0
2515000|NCT01783678|8701831|P2|Overall Study|Withdrew Consent|1
2515001|NCT01783678|8701832|P1|Overall Study|Withdrew Consent|1
2515002|NCT01783678|8701827|P6|Overall Study|Lost to Follow-up|0
2515003|NCT01783678|8701828|P5|Overall Study|Lost to Follow-up|1
2515004|NCT01783678|8701829|P4|Overall Study|Lost to Follow-up|2
2515005|NCT01783678|8701830|P3|Overall Study|Lost to Follow-up|0
2515006|NCT01783678|8701831|P2|Overall Study|Lost to Follow-up|4
2515007|NCT01783678|8701832|P1|Overall Study|Lost to Follow-up|0
2515008|NCT01783678|8701827|P6|Overall Study|Lack of Efficacy|5
2515009|NCT01783678|8701828|P5|Overall Study|Lack of Efficacy|6
2515010|NCT01783678|8701829|P4|Overall Study|Lack of Efficacy|3
2515011|NCT01783678|8701830|P3|Overall Study|Lack of Efficacy|1
2515012|NCT01783678|8701831|P2|Overall Study|Lack of Efficacy|13
2515013|NCT01783678|8701832|P1|Overall Study|Lack of Efficacy|1
2515014|NCT01783678|8701827|P6|Overall Study|Randomized but Not Treated|0
2515015|NCT01783678|8701828|P5|Overall Study|Randomized but Not Treated|0
2515016|NCT01783678|8701829|P4|Overall Study|Randomized but Not Treated|1
2515017|NCT01783678|8701830|P3|Overall Study|Randomized but Not Treated|0
2515018|NCT01783678|8701831|P2|Overall Study|Randomized but Not Treated|0
2515019|NCT01783678|8701832|P1|Overall Study|Randomized but Not Treated|0
2515020|NCT01783548|8701936|P2|Overall Study|Lack of Efficacy|1
2515021|NCT01783548|8701937|P1|Overall Study|Lack of Efficacy|1
2515022|NCT01783548|8701936|P2|Overall Study|Lost to Follow-up|3
2515023|NCT01783548|8701937|P1|Overall Study|Lost to Follow-up|8
2515024|NCT01783548|8701936|P2|Overall Study|Protocol Violation|2
2515025|NCT01783548|8701937|P1|Overall Study|Protocol Violation|2
2515026|NCT01783548|8701936|P2|Overall Study|Non-compliance|0
2515027|NCT01783548|8701937|P1|Overall Study|Non-compliance|4
2515028|NCT01783548|8701936|P2|Overall Study|Withdrawal by Subject|8
2515029|NCT01783548|8701937|P1|Overall Study|Withdrawal by Subject|11
2515030|NCT01783548|8701936|P2|Overall Study|Adverse Event|4
2515031|NCT01783548|8701937|P1|Overall Study|Adverse Event|8
2515032|NCT01783496|8701970|P6|Overall Study|Withdrawal by Subject|0
2515033|NCT01783496|8701971|P5|Overall Study|Withdrawal by Subject|0
2515034|NCT01783496|8701972|P4|Overall Study|Withdrawal by Subject|0
2515035|NCT01783496|8701973|P3|Overall Study|Withdrawal by Subject|0
2515036|NCT01783496|8701974|P2|Overall Study|Withdrawal by Subject|0
2515037|NCT01783496|8701975|P1|Overall Study|Withdrawal by Subject|1
2515038|NCT01783496|8701970|P6|Overall Study|Lost to Follow-up|1
2515039|NCT01783496|8701971|P5|Overall Study|Lost to Follow-up|0
2515040|NCT01783496|8701972|P4|Overall Study|Lost to Follow-up|2
2515041|NCT01783496|8701973|P3|Overall Study|Lost to Follow-up|0
2515042|NCT01783496|8701974|P2|Overall Study|Lost to Follow-up|0
2515043|NCT01783496|8701975|P1|Overall Study|Lost to Follow-up|0
2515044|NCT01783483|8702003|P2|Overall Study|Physician Decision|1
2515045|NCT01783483|8702004|P1|Overall Study|Physician Decision|1
2515046|NCT01783483|8702003|P2|Overall Study|Withdrawal by Subject|1
2515047|NCT01783483|8702004|P1|Overall Study|Withdrawal by Subject|2
2515048|NCT01783483|8702003|P2|Overall Study|Lost to Follow-up|10
2515049|NCT01783483|8702004|P1|Overall Study|Lost to Follow-up|14
2515050|NCT01783483|8702003|P2|Overall Study|Death|3
2515051|NCT01783483|8702004|P1|Overall Study|Death|3
2515052|NCT01783418|8702042|P2|Overall Study|Withdrawal by Subject|0
2515053|NCT01783418|8702043|P1|Overall Study|Withdrawal by Subject|1
2515054|NCT01783015|8702096|P3|Open Label Treatment|Study Terminated by Sponsor|6
2515055|NCT01783015|8702097|P2|Open Label Treatment|Study Terminated by Sponsor|0
2515056|NCT01783015|8702098|P1|Open Label Treatment|Study Terminated by Sponsor|0
2515057|NCT01783015|8702096|P3|Blinded Treatment|Study Terminated by Sponsor|0
2515058|NCT01783015|8702097|P2|Blinded Treatment|Study Terminated by Sponsor|0
2515059|NCT01783015|8702098|P1|Blinded Treatment|Study Terminated by Sponsor|2
2515060|NCT01783015|8702096|P3|Blinded Treatment|Withdrawal by Subject|0
2515061|NCT01783015|8702097|P2|Blinded Treatment|Withdrawal by Subject|1
2515062|NCT01783015|8702098|P1|Blinded Treatment|Withdrawal by Subject|0
2515063|NCT01783015|8702096|P3|Blinded Treatment|Protocol Violation|0
2515064|NCT01783015|8702097|P2|Blinded Treatment|Protocol Violation|1
2515065|NCT01783015|8702098|P1|Blinded Treatment|Protocol Violation|0
2515066|NCT01783015|8702096|P3|Blinded Treatment|Adverse Event|0
2515067|NCT01783015|8702097|P2|Blinded Treatment|Adverse Event|1
2515068|NCT01783015|8702098|P1|Blinded Treatment|Adverse Event|0
2515069|NCT01782885|8702211|P2|Overall Study|Lost to Follow-up|6
2515070|NCT01782885|8702212|P1|Overall Study|Lost to Follow-up|4
2515071|NCT01782872|8702238|P4|Overall Study|Withdrawal by Subject|0
2515072|NCT01782872|8702239|P3|Overall Study|Withdrawal by Subject|0
2515073|NCT01782872|8702240|P2|Overall Study|Withdrawal by Subject|1
2515074|NCT01782872|8702241|P1|Overall Study|Withdrawal by Subject|0
2515075|NCT01782872|8702238|P4|Overall Study|Protocol Violation|1
2515076|NCT01782872|8702239|P3|Overall Study|Protocol Violation|0
2515077|NCT01782872|8702240|P2|Overall Study|Protocol Violation|0
2515078|NCT01782872|8702241|P1|Overall Study|Protocol Violation|0
2515079|NCT01782859|8702265|P2|Overall Study|Withdrawal by Subject|1
2515080|NCT01782859|8702266|P1|Overall Study|Withdrawal by Subject|0
2515081|NCT01782859|8702265|P2|Overall Study|Protocol Violation|6
2515082|NCT01782859|8702266|P1|Overall Study|Protocol Violation|6
2515083|NCT01782742|8702288|P2|Double-blind Treatment Phase|Adverse Event|0
2515084|NCT01782742|8702289|P1|Double-blind Treatment Phase|Adverse Event|1
2515085|NCT01782690|8702322|P1|Overall Study|Study completion unknown|7
2515086|NCT01782690|8702322|P1|Overall Study|Death|133
2515087|NCT01782690|8702322|P1|Overall Study|Tumor progression|74
2515088|NCT01782690|8702322|P1|Overall Study|Patient's wish|21
2515089|NCT01782690|8702322|P1|Overall Study|Physician Decision|13
2515090|NCT01782690|8702322|P1|Overall Study|Absent rash|9
2515091|NCT01782690|8702322|P1|Overall Study|Withdrawal of informed consent|2
2515092|NCT01782690|8702322|P1|Overall Study|Lost to Follow-up|31
2515093|NCT01782690|8702322|P1|Overall Study|Toxicity of erlotinib|1
2515094|NCT01782690|8702322|P1|Overall Study|Toxicity of gemcitabine|1
2515095|NCT01782690|8702322|P1|Overall Study|Not reported|7
2515096|NCT01782664|8702344|P6|Overall Study|Withdrawal by Subject|0
2515097|NCT01782664|8702345|P5|Overall Study|Withdrawal by Subject|0
2515098|NCT01782664|8702346|P4|Overall Study|Withdrawal by Subject|0
2515099|NCT01782664|8702347|P3|Overall Study|Withdrawal by Subject|0
2515100|NCT01782664|8702348|P2|Overall Study|Withdrawal by Subject|2
2515101|NCT01782664|8702349|P1|Overall Study|Withdrawal by Subject|2
2515102|NCT01782664|8702344|P6|Overall Study|Protocol Violation|0
2515103|NCT01782664|8702345|P5|Overall Study|Protocol Violation|0
2515104|NCT01782664|8702346|P4|Overall Study|Protocol Violation|1
2515105|NCT01782664|8702347|P3|Overall Study|Protocol Violation|0
2515106|NCT01782664|8702348|P2|Overall Study|Protocol Violation|1
2515107|NCT01782664|8702349|P1|Overall Study|Protocol Violation|0
2515108|NCT01782664|8702344|P6|Overall Study|Lack of Efficacy|0
2515109|NCT01782664|8702345|P5|Overall Study|Lack of Efficacy|0
2515110|NCT01782664|8702346|P4|Overall Study|Lack of Efficacy|2
2515111|NCT01782664|8702347|P3|Overall Study|Lack of Efficacy|2
2515112|NCT01782664|8702348|P2|Overall Study|Lack of Efficacy|0
2515113|NCT01782664|8702349|P1|Overall Study|Lack of Efficacy|2
2515114|NCT01782664|8702344|P6|Overall Study|Adverse Event|0
2515115|NCT01782664|8702345|P5|Overall Study|Adverse Event|0
2515116|NCT01782664|8702346|P4|Overall Study|Adverse Event|2
2515117|NCT01782664|8702347|P3|Overall Study|Adverse Event|2
2515118|NCT01782664|8702348|P2|Overall Study|Adverse Event|2
2515119|NCT01782664|8702349|P1|Overall Study|Adverse Event|2
2515120|NCT01782495|8702506|P11|Overall Study|Withdrew Consent|0
2515121|NCT01782495|8702507|P10|Overall Study|Withdrew Consent|0
2515122|NCT01782495|8702508|P9|Overall Study|Withdrew Consent|0
2515123|NCT01782495|8702509|P8|Overall Study|Withdrew Consent|1
2515124|NCT01782495|8702510|P7|Overall Study|Withdrew Consent|0
2515125|NCT01782495|8702511|P6|Overall Study|Withdrew Consent|0
2515126|NCT01782495|8702512|P5|Overall Study|Withdrew Consent|0
2515127|NCT01782495|8702513|P4|Overall Study|Withdrew Consent|0
2515128|NCT01782495|8702514|P3|Overall Study|Withdrew Consent|0
2515129|NCT01782495|8702515|P2|Overall Study|Withdrew Consent|1
2515130|NCT01782495|8702516|P1|Overall Study|Withdrew Consent|0
2515131|NCT01782495|8702506|P11|Overall Study|Adverse Event|0
2515132|NCT01782495|8702507|P10|Overall Study|Adverse Event|0
2515133|NCT01782495|8702508|P9|Overall Study|Adverse Event|0
2515134|NCT01782495|8702509|P8|Overall Study|Adverse Event|2
2515135|NCT01782495|8702510|P7|Overall Study|Adverse Event|0
2515136|NCT01782495|8702511|P6|Overall Study|Adverse Event|0
2515137|NCT01782495|8702512|P5|Overall Study|Adverse Event|0
2515138|NCT01782495|8702513|P4|Overall Study|Adverse Event|0
2515139|NCT01782495|8702514|P3|Overall Study|Adverse Event|0
2515140|NCT01782495|8702515|P2|Overall Study|Adverse Event|0
2515141|NCT01782495|8702516|P1|Overall Study|Adverse Event|0
2515142|NCT01782482|8702575|P2|Overall Study|Habitually wearing toric lens OS|1
2515143|NCT01782482|8702576|P1|Overall Study|Habitually wearing toric lens OS|0
2515144|NCT01782482|8702575|P2|Overall Study|Randomized in Error|2
2515145|NCT01782482|8702576|P1|Overall Study|Randomized in Error|2
2515146|NCT01782482|8702575|P2|Overall Study|Withdrawal by Subject|3
2515147|NCT01782482|8702576|P1|Overall Study|Withdrawal by Subject|2
2515148|NCT01782482|8702575|P2|Overall Study|Protocol Violation|0
2515149|NCT01782482|8702576|P1|Overall Study|Protocol Violation|1
2515150|NCT01782482|8702575|P2|Overall Study|Physician Decision|0
2515151|NCT01782482|8702576|P1|Overall Study|Physician Decision|1
2515152|NCT01782482|8702575|P2|Overall Study|Lost to Follow-up|3
2515153|NCT01782482|8702576|P1|Overall Study|Lost to Follow-up|2
2515154|NCT01782482|8702575|P2|Overall Study|Adverse Event|1
2515155|NCT01782482|8702576|P1|Overall Study|Adverse Event|2
2515156|NCT01782469|8702584|P1|Overall Study|Lost to Follow-up|1
2515157|NCT01782378|8702594|P2|Second Series|Did not choose to complete S2 Optional|0
2515158|NCT01782378|8702595|P1|Second Series|Did not choose to complete S2 Optional|18
2515159|NCT01782378|8702594|P2|Second Series|Lost to Follow-up|7
2515160|NCT01782378|8702595|P1|Second Series|Lost to Follow-up|8
2515161|NCT01782378|8702594|P2|Second Series|Partial Crossover Design- no Sham 2nd|25
2515162|NCT01782378|8702595|P1|Second Series|Partial Crossover Design- no Sham 2nd|0
2515163|NCT01782378|8702594|P2|First Series|Lost to Follow-up|8
2515164|NCT01782378|8702595|P1|First Series|Lost to Follow-up|7
2515165|NCT01782326|8702661|P2|Double-blind Treatment|Technical problems|5
2515166|NCT01782326|8702662|P1|Double-blind Treatment|Technical problems|0
2515167|NCT01782326|8702661|P2|Double-blind Treatment|Protocol deviation|7
2515168|NCT01782326|8702662|P1|Double-blind Treatment|Protocol deviation|8
2515169|NCT01782326|8702661|P2|Double-blind Treatment|Physician Decision|16
2515170|NCT01782326|8702662|P1|Double-blind Treatment|Physician Decision|13
2515171|NCT01782326|8702661|P2|Double-blind Treatment|Lack of Efficacy|22
2515172|NCT01782326|8702662|P1|Double-blind Treatment|Lack of Efficacy|17
2515173|NCT01782326|8702661|P2|Double-blind Treatment|Subject/guardian decision|125
2515174|NCT01782326|8702662|P1|Double-blind Treatment|Subject/guardian decision|111
2515175|NCT01782326|8702661|P2|Double-blind Treatment|Adverse Event|145
2515176|NCT01782326|8702662|P1|Double-blind Treatment|Adverse Event|129
2515177|NCT01782326|8702661|P2|Planned Treatment Epoch|Technical problems|4
2515178|NCT01782326|8702662|P1|Planned Treatment Epoch|Technical problems|0
2515179|NCT01782326|8702661|P2|Planned Treatment Epoch|Lost to Follow-up|4
2515180|NCT01782326|8702662|P1|Planned Treatment Epoch|Lost to Follow-up|4
2515181|NCT01782326|8702661|P2|Planned Treatment Epoch|Protocol deviation|3
2515182|NCT01782326|8702662|P1|Planned Treatment Epoch|Protocol deviation|2
2515183|NCT01782326|8702661|P2|Planned Treatment Epoch|Physician Decision|16
2515184|NCT01782326|8702662|P1|Planned Treatment Epoch|Physician Decision|18
2515185|NCT01782326|8702661|P2|Planned Treatment Epoch|Death|30
2515186|NCT01782326|8702662|P1|Planned Treatment Epoch|Death|29
2515187|NCT01782326|8702661|P2|Planned Treatment Epoch|Subject/guardian decision|151
2515188|NCT01782326|8702662|P1|Planned Treatment Epoch|Subject/guardian decision|149
2515189|NCT01782313|8702722|P1|Survival Follow up|Lost to Follow-up|1
2515190|NCT01782313|8702722|P1|Continued Treatment After 16 Weeks|Withdrawal by Subject|1
2515191|NCT01782313|8702722|P1|Continued Treatment After 16 Weeks|Progressive Disease|6
2515192|NCT01782313|8702722|P1|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1
2515193|NCT01782313|8702722|P1|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5
2515194|NCT01782313|8702722|P1|Treated Cycle 3|Progressive Disease|21
2515195|NCT01782313|8702722|P1|Reached First Response/Completed 2 Cycle|Progressive Disease|3
2515196|NCT01782313|8702722|P1|Reached First Response/Completed 2 Cycle|Adverse Event|3
2515197|NCT01782222|8702736|P3|Overall Study|Moved to other state|0
2515198|NCT01782222|8702737|P2|Overall Study|Moved to other state|1
2515199|NCT01782222|8702738|P1|Overall Study|Moved to other state|0
2515200|NCT01782222|8702736|P3|Overall Study|Withdrawal by Subject|1
2515201|NCT01782222|8702737|P2|Overall Study|Withdrawal by Subject|4
2515202|NCT01782222|8702738|P1|Overall Study|Withdrawal by Subject|1
2515203|NCT01782222|8702736|P3|Overall Study|Protocol Violation|0
2515204|NCT01782222|8702737|P2|Overall Study|Protocol Violation|0
2515205|NCT01782222|8702738|P1|Overall Study|Protocol Violation|1
2515206|NCT01782222|8702736|P3|Overall Study|Lack of Efficacy|0
2515207|NCT01782222|8702737|P2|Overall Study|Lack of Efficacy|1
2515208|NCT01782222|8702738|P1|Overall Study|Lack of Efficacy|2
2515209|NCT01782222|8702736|P3|Overall Study|Adverse Event|3
2515210|NCT01782222|8702737|P2|Overall Study|Adverse Event|5
2515211|NCT01782222|8702738|P1|Overall Study|Adverse Event|4
2515212|NCT01781975|8702772|P2|Overall Study|Withdrawal by Subject|1
2515213|NCT01781975|8702773|P1|Overall Study|Withdrawal by Subject|1
2515214|NCT01781975|8702772|P2|Overall Study|Death|0
2515215|NCT01781975|8702773|P1|Overall Study|Death|1
2515216|NCT01781962|8702789|P1|Overall Study|Other Miscellaneous Reasons|5
2515217|NCT01781832|8702795|P1|Overall Study|Withdrawal by Subject|1
2515218|NCT01781637|8702815|P2|Overall Study|Withdrawal by Subject|0
2515219|NCT01781637|8702816|P1|Overall Study|Withdrawal by Subject|1
2515220|NCT01781637|8702815|P2|Overall Study|Lack of Efficacy|6
2515221|NCT01781637|8702816|P1|Overall Study|Lack of Efficacy|2
2515222|NCT01781637|8702815|P2|Overall Study|Adverse Event|0
2515223|NCT01781637|8702816|P1|Overall Study|Adverse Event|1
2515224|NCT01781429|8702898|P16|Overall Study|Enrolled, but not treated|0
2515225|NCT01781429|8702899|P15|Overall Study|Enrolled, but not treated|0
2515226|NCT01781429|8702900|P14|Overall Study|Enrolled, but not treated|0
2515227|NCT01781429|8702901|P13|Overall Study|Enrolled, but not treated|0
2515228|NCT01781429|8702902|P12|Overall Study|Enrolled, but not treated|0
2515229|NCT01781429|8702903|P11|Overall Study|Enrolled, but not treated|1
2515230|NCT01781429|8702904|P10|Overall Study|Enrolled, but not treated|0
2515231|NCT01781429|8702905|P9|Overall Study|Enrolled, but not treated|0
2515232|NCT01781429|8702906|P8|Overall Study|Enrolled, but not treated|0
2515233|NCT01781429|8702907|P7|Overall Study|Enrolled, but not treated|0
2515234|NCT01781429|8702908|P6|Overall Study|Enrolled, but not treated|0
2515235|NCT01781429|8702909|P5|Overall Study|Enrolled, but not treated|0
2515236|NCT01781429|8702910|P4|Overall Study|Enrolled, but not treated|0
2515237|NCT01781429|8702911|P3|Overall Study|Enrolled, but not treated|0
2515238|NCT01781429|8702912|P2|Overall Study|Enrolled, but not treated|0
2515239|NCT01781429|8702913|P1|Overall Study|Enrolled, but not treated|0
2515240|NCT01781429|8702898|P16|Overall Study|Other - as entered by PI in eCRF|0
2515241|NCT01781429|8702899|P15|Overall Study|Other - as entered by PI in eCRF|1
2515242|NCT01781429|8702900|P14|Overall Study|Other - as entered by PI in eCRF|1
2515243|NCT01781429|8702901|P13|Overall Study|Other - as entered by PI in eCRF|1
2515244|NCT01781429|8702902|P12|Overall Study|Other - as entered by PI in eCRF|2
2515245|NCT01781429|8702903|P11|Overall Study|Other - as entered by PI in eCRF|1
2515246|NCT01781429|8702904|P10|Overall Study|Other - as entered by PI in eCRF|1
2515247|NCT01781429|8702905|P9|Overall Study|Other - as entered by PI in eCRF|0
2515248|NCT01781429|8702906|P8|Overall Study|Other - as entered by PI in eCRF|0
2515249|NCT01781429|8702907|P7|Overall Study|Other - as entered by PI in eCRF|0
2515250|NCT01781429|8702908|P6|Overall Study|Other - as entered by PI in eCRF|0
2515251|NCT01781429|8702909|P5|Overall Study|Other - as entered by PI in eCRF|0
2515252|NCT01781429|8702910|P4|Overall Study|Other - as entered by PI in eCRF|0
2515253|NCT01781429|8702911|P3|Overall Study|Other - as entered by PI in eCRF|0
2515254|NCT01781429|8702912|P2|Overall Study|Other - as entered by PI in eCRF|1
2515255|NCT01781429|8702913|P1|Overall Study|Other - as entered by PI in eCRF|0
2515256|NCT01781429|8702898|P16|Overall Study|Patient Condition Changed|0
2515257|NCT01781429|8702899|P15|Overall Study|Patient Condition Changed|0
2515258|NCT01781429|8702900|P14|Overall Study|Patient Condition Changed|1
2515259|NCT01781429|8702901|P13|Overall Study|Patient Condition Changed|0
2515260|NCT01781429|8702902|P12|Overall Study|Patient Condition Changed|1
2515261|NCT01781429|8702903|P11|Overall Study|Patient Condition Changed|0
2515262|NCT01781429|8702904|P10|Overall Study|Patient Condition Changed|4
2515263|NCT01781429|8702905|P9|Overall Study|Patient Condition Changed|0
2515264|NCT01781429|8702906|P8|Overall Study|Patient Condition Changed|0
2515265|NCT01781429|8702907|P7|Overall Study|Patient Condition Changed|0
2515266|NCT01781429|8702908|P6|Overall Study|Patient Condition Changed|0
2515267|NCT01781429|8702909|P5|Overall Study|Patient Condition Changed|0
2515268|NCT01781429|8702910|P4|Overall Study|Patient Condition Changed|0
2515269|NCT01781429|8702911|P3|Overall Study|Patient Condition Changed|0
2515270|NCT01781429|8702912|P2|Overall Study|Patient Condition Changed|0
2515271|NCT01781429|8702913|P1|Overall Study|Patient Condition Changed|0
2515272|NCT01781429|8702898|P16|Overall Study|Unacceptable Toxicity|0
2515273|NCT01781429|8702899|P15|Overall Study|Unacceptable Toxicity|0
2515274|NCT01781429|8702900|P14|Overall Study|Unacceptable Toxicity|0
2515275|NCT01781429|8702901|P13|Overall Study|Unacceptable Toxicity|0
2515276|NCT01781429|8702902|P12|Overall Study|Unacceptable Toxicity|2
2515277|NCT01781429|8702903|P11|Overall Study|Unacceptable Toxicity|0
2515278|NCT01781429|8702904|P10|Overall Study|Unacceptable Toxicity|0
2515279|NCT01781429|8702905|P9|Overall Study|Unacceptable Toxicity|0
2515280|NCT01781429|8702906|P8|Overall Study|Unacceptable Toxicity|0
2515281|NCT01781429|8702907|P7|Overall Study|Unacceptable Toxicity|0
2515282|NCT01781429|8702908|P6|Overall Study|Unacceptable Toxicity|0
2515283|NCT01781429|8702909|P5|Overall Study|Unacceptable Toxicity|0
2515284|NCT01781429|8702910|P4|Overall Study|Unacceptable Toxicity|0
2515285|NCT01781429|8702911|P3|Overall Study|Unacceptable Toxicity|0
2515286|NCT01781429|8702912|P2|Overall Study|Unacceptable Toxicity|0
2515287|NCT01781429|8702913|P1|Overall Study|Unacceptable Toxicity|0
2515288|NCT01781429|8702898|P16|Overall Study|Disease Progression|0
2515289|NCT01781429|8702899|P15|Overall Study|Disease Progression|11
2515290|NCT01781429|8702900|P14|Overall Study|Disease Progression|4
2515291|NCT01781429|8702901|P13|Overall Study|Disease Progression|15
2515292|NCT01781429|8702902|P12|Overall Study|Disease Progression|15
2515293|NCT01781429|8702903|P11|Overall Study|Disease Progression|15
2515294|NCT01781429|8702904|P10|Overall Study|Disease Progression|15
2515295|NCT01781429|8702905|P9|Overall Study|Disease Progression|6
2515296|NCT01781429|8702906|P8|Overall Study|Disease Progression|4
2515297|NCT01781429|8702907|P7|Overall Study|Disease Progression|7
2515298|NCT01781429|8702908|P6|Overall Study|Disease Progression|4
2515299|NCT01781429|8702909|P5|Overall Study|Disease Progression|1
2515300|NCT01781429|8702910|P4|Overall Study|Disease Progression|1
2515301|NCT01781429|8702911|P3|Overall Study|Disease Progression|1
2515302|NCT01781429|8702912|P2|Overall Study|Disease Progression|0
2515303|NCT01781429|8702913|P1|Overall Study|Disease Progression|1
2515304|NCT01781429|8702898|P16|Overall Study|Withdrawal by Subject|0
2515305|NCT01781429|8702899|P15|Overall Study|Withdrawal by Subject|3
2515306|NCT01781429|8702900|P14|Overall Study|Withdrawal by Subject|2
2515307|NCT01781429|8702901|P13|Overall Study|Withdrawal by Subject|5
2515308|NCT01781429|8702902|P12|Overall Study|Withdrawal by Subject|1
2515309|NCT01781429|8702903|P11|Overall Study|Withdrawal by Subject|1
2515310|NCT01781429|8702904|P10|Overall Study|Withdrawal by Subject|3
2515311|NCT01781429|8702905|P9|Overall Study|Withdrawal by Subject|1
2515312|NCT01781429|8702906|P8|Overall Study|Withdrawal by Subject|0
2515313|NCT01781429|8702907|P7|Overall Study|Withdrawal by Subject|0
2515314|NCT01781429|8702908|P6|Overall Study|Withdrawal by Subject|0
2515315|NCT01781429|8702909|P5|Overall Study|Withdrawal by Subject|0
2515316|NCT01781429|8702910|P4|Overall Study|Withdrawal by Subject|0
2515317|NCT01781429|8702911|P3|Overall Study|Withdrawal by Subject|0
2515318|NCT01781429|8702912|P2|Overall Study|Withdrawal by Subject|0
2515319|NCT01781429|8702913|P1|Overall Study|Withdrawal by Subject|0
2515320|NCT01781429|8702898|P16|Overall Study|Death|0
2515321|NCT01781429|8702899|P15|Overall Study|Death|1
2515322|NCT01781429|8702900|P14|Overall Study|Death|0
2515323|NCT01781429|8702901|P13|Overall Study|Death|1
2515324|NCT01781429|8702902|P12|Overall Study|Death|0
2515325|NCT01781429|8702903|P11|Overall Study|Death|0
2515326|NCT01781429|8702904|P10|Overall Study|Death|1
2515327|NCT01781429|8702905|P9|Overall Study|Death|0
2515328|NCT01781429|8702906|P8|Overall Study|Death|0
2515329|NCT01781429|8702907|P7|Overall Study|Death|0
2515330|NCT01781429|8702908|P6|Overall Study|Death|0
2515331|NCT01781429|8702909|P5|Overall Study|Death|0
2515332|NCT01781429|8702910|P4|Overall Study|Death|0
2515333|NCT01781429|8702911|P3|Overall Study|Death|0
2515334|NCT01781429|8702912|P2|Overall Study|Death|0
2515335|NCT01781429|8702913|P1|Overall Study|Death|0
2515336|NCT01781299|8702990|P2|Overall Study|Withdrawal by Subject|1
2515337|NCT01781299|8702991|P1|Overall Study|Withdrawal by Subject|0
2515338|NCT01781286|8702999|P6|Overall Study|Noncompliance|0
2515339|NCT01781286|8703000|P5|Overall Study|Noncompliance|0
2515340|NCT01781286|8703001|P4|Overall Study|Noncompliance|1
2515341|NCT01781286|8703002|P3|Overall Study|Noncompliance|0
2515342|NCT01781286|8703003|P2|Overall Study|Noncompliance|0
2515343|NCT01781286|8703004|P1|Overall Study|Noncompliance|0
2515344|NCT01781286|8702999|P6|Overall Study|Time Constraints|0
2515345|NCT01781286|8703000|P5|Overall Study|Time Constraints|0
2515346|NCT01781286|8703001|P4|Overall Study|Time Constraints|0
2515347|NCT01781286|8703002|P3|Overall Study|Time Constraints|2
2515348|NCT01781286|8703003|P2|Overall Study|Time Constraints|0
2515349|NCT01781286|8703004|P1|Overall Study|Time Constraints|2
2515350|NCT01781286|8702999|P6|Overall Study|Lost to Follow-up|1
2515351|NCT01781286|8703000|P5|Overall Study|Lost to Follow-up|0
2515352|NCT01781286|8703001|P4|Overall Study|Lost to Follow-up|0
2515353|NCT01781286|8703002|P3|Overall Study|Lost to Follow-up|0
2515354|NCT01781286|8703003|P2|Overall Study|Lost to Follow-up|0
2515355|NCT01781286|8703004|P1|Overall Study|Lost to Follow-up|0
2515356|NCT01781234|8703029|P2|Overall Study|Withdrawal by Subject|3
2515357|NCT01781234|8703030|P1|Overall Study|Withdrawal by Subject|4
2515358|NCT01781234|8703029|P2|Overall Study|Protocol Violation|0
2515359|NCT01781234|8703030|P1|Overall Study|Protocol Violation|3
2515360|NCT01781234|8703029|P2|Overall Study|Adverse Event|0
2515361|NCT01781234|8703030|P1|Overall Study|Adverse Event|2
2515362|NCT01781026|8703068|P1|Overall Study|Lack of Efficacy|2
2515363|NCT01780987|8703074|P2|Overall Study|Not Receiving any Study Medication|1
2515364|NCT01780987|8703075|P1|Overall Study|Not Receiving any Study Medication|0
2515365|NCT01780987|8703074|P2|Overall Study|Changing Residence|0
2515366|NCT01780987|8703075|P1|Overall Study|Changing Residence|1
2515367|NCT01780987|8703074|P2|Overall Study|Request of Changing Hospital|1
2515368|NCT01780987|8703075|P1|Overall Study|Request of Changing Hospital|0
2515369|NCT01780987|8703074|P2|Overall Study|Withdrawal by Subject|0
2515370|NCT01780987|8703075|P1|Overall Study|Withdrawal by Subject|2
2515371|NCT01780987|8703074|P2|Overall Study|Adverse Event|4
2515372|NCT01780987|8703075|P1|Overall Study|Adverse Event|0
2515373|NCT01780974|8703093|P2|Overall Study|Adverse Event|3
2515374|NCT01780974|8703094|P1|Overall Study|Adverse Event|1
2515375|NCT01780974|8703093|P2|Overall Study|Death|0
2515376|NCT01780974|8703094|P1|Overall Study|Death|1
2515377|NCT01780935|8703104|P2|Overall Study|Patient withdrew consent|9
2515378|NCT01780935|8703105|P1|Overall Study|Patient withdrew consent|8
2515379|NCT01780935|8703104|P2|Overall Study|Protocol deviation|1
2515380|NCT01780935|8703105|P1|Overall Study|Protocol deviation|0
2515381|NCT01780935|8703104|P2|Overall Study|Physician Decision|1
2515382|NCT01780935|8703105|P1|Overall Study|Physician Decision|1
2515383|NCT01780935|8703104|P2|Overall Study|Lost to Follow-up|6
2515384|NCT01780935|8703105|P1|Overall Study|Lost to Follow-up|2
2515385|NCT01780935|8703104|P2|Overall Study|Death|6
2515386|NCT01780935|8703105|P1|Overall Study|Death|1
2515387|NCT01780935|8703104|P2|Overall Study|Adverse Event|4
2515388|NCT01780935|8703105|P1|Overall Study|Adverse Event|2
2515389|NCT01780935|8703104|P2|Overall Study|Admin problems due to early termination|309
2515390|NCT01780935|8703105|P1|Overall Study|Admin problems due to early termination|321
2515391|NCT01780662|8703209|P3|Overall Study|Ineligible|1
2515392|NCT01780662|8703210|P2|Overall Study|Ineligible|0
2515393|NCT01780662|8703211|P1|Overall Study|Ineligible|0
2515394|NCT01780662|8703209|P3|Overall Study|Protocol Violation|0
2515395|NCT01780662|8703210|P2|Overall Study|Protocol Violation|1
2515396|NCT01780662|8703211|P1|Overall Study|Protocol Violation|0
2515397|NCT01780662|8703209|P3|Overall Study|Physician Decision|7
2515398|NCT01780662|8703210|P2|Overall Study|Physician Decision|5
2515399|NCT01780662|8703211|P1|Overall Study|Physician Decision|0
2515400|NCT01780662|8703209|P3|Overall Study|Adverse Event|2
2515401|NCT01780662|8703210|P2|Overall Study|Adverse Event|0
2515402|NCT01780662|8703211|P1|Overall Study|Adverse Event|1
2515403|NCT01780584|8703228|P3|Overall Study|Protocol Violation|1
2515404|NCT01780584|8703229|P2|Overall Study|Protocol Violation|0
2515405|NCT01780584|8703230|P1|Overall Study|Protocol Violation|0
2515406|NCT01780584|8703228|P3|Overall Study|Adverse Event|0
2515407|NCT01780584|8703229|P2|Overall Study|Adverse Event|1
2515408|NCT01780584|8703230|P1|Overall Study|Adverse Event|0
2515409|NCT01780584|8703228|P3|Overall Study|Death|1
2515410|NCT01780584|8703229|P2|Overall Study|Death|0
2515411|NCT01780584|8703230|P1|Overall Study|Death|1
2515412|NCT01780545|8703252|P2|Overall Study|Lost to Follow-up|1
2515413|NCT01780545|8703253|P1|Overall Study|Lost to Follow-up|1
2515414|NCT01780545|8703252|P2|Overall Study|Withdrawal by Subject|1
2515415|NCT01780545|8703253|P1|Overall Study|Withdrawal by Subject|3
2515416|NCT01780506|8703271|P2|Open-Label Extension Phase|Enrolled but not Treated|1
2515417|NCT01780506|8703272|P1|Open-Label Extension Phase|Enrolled but not Treated|0
2515418|NCT01780506|8703271|P2|Double-Blind Phase|Lost to Follow-up|26
2515419|NCT01780506|8703272|P1|Double-Blind Phase|Lost to Follow-up|23
2515420|NCT01780506|8703271|P2|Double-Blind Phase|Withdrew Consent|24
2515421|NCT01780506|8703272|P1|Double-Blind Phase|Withdrew Consent|23
2515422|NCT01780506|8703271|P2|Double-Blind Phase|Protocol Violation|3
2515423|NCT01780506|8703272|P1|Double-Blind Phase|Protocol Violation|4
2515424|NCT01780506|8703271|P2|Double-Blind Phase|Non-Compliance with Study Drug|3
2515425|NCT01780506|8703272|P1|Double-Blind Phase|Non-Compliance with Study Drug|4
2515426|NCT01780506|8703271|P2|Double-Blind Phase|Investigator's Discretion|2
2515427|NCT01780506|8703272|P1|Double-Blind Phase|Investigator's Discretion|5
2515428|NCT01780506|8703271|P2|Double-Blind Phase|Lack of Efficacy|1
2515429|NCT01780506|8703272|P1|Double-Blind Phase|Lack of Efficacy|1
2515430|NCT01780506|8703271|P2|Double-Blind Phase|Pregnancy|1
2515431|NCT01780506|8703272|P1|Double-Blind Phase|Pregnancy|2
2515432|NCT01780506|8703271|P2|Double-Blind Phase|Death|2
2515433|NCT01780506|8703272|P1|Double-Blind Phase|Death|1
2515434|NCT01780506|8703271|P2|Double-Blind Phase|Adverse Event|14
2515435|NCT01780506|8703272|P1|Double-Blind Phase|Adverse Event|4
2515436|NCT01780506|8703271|P2|Double-Blind Phase|Randomized but not Treated|2
2515437|NCT01780506|8703272|P1|Double-Blind Phase|Randomized but not Treated|3
2515438|NCT01780389|8703326|P1|Overall Study|Adverse Event|1
2515439|NCT01779869|8703364|P1|Overall Study|Physician Decision|2
2515440|NCT01779700|8703370|P2|Overall Study|Withdrawal by Subject|2
2515441|NCT01779700|8703371|P1|Overall Study|Withdrawal by Subject|0
2515442|NCT01779700|8703370|P2|Overall Study|Adverse Event|3
2515443|NCT01779700|8703371|P1|Overall Study|Adverse Event|4
2515444|NCT01779648|8703411|P2|Overall Study|Protocol Violation|0
2515445|NCT01779648|8703412|P1|Overall Study|Protocol Violation|1
2515446|NCT01779440|8703442|P2|Overall Study|Withdrawal by Subject|5
2515447|NCT01779440|8703443|P1|Overall Study|Withdrawal by Subject|3
2515448|NCT01778985|8703508|P2|Overall Study|Protocol Violation|1
2515449|NCT01778985|8703509|P1|Overall Study|Protocol Violation|4
2515450|NCT01778985|8703508|P2|Overall Study|Physician Decision|2
2515451|NCT01778985|8703509|P1|Overall Study|Physician Decision|2
2515452|NCT01778985|8703508|P2|Overall Study|Lost to Follow-up|0
2515453|NCT01778985|8703509|P1|Overall Study|Lost to Follow-up|1
2515454|NCT01778855|8703555|P2|Overall Study|Death|1
2515455|NCT01778855|8703556|P1|Overall Study|Death|0
2515456|NCT01778751|8703564|P2|Overall Study|Transfered care|0
2515457|NCT01778751|8703565|P1|Overall Study|Transfered care|1
2515458|NCT01778751|8703564|P2|Overall Study|Withdrawal by Subject|2
2515459|NCT01778751|8703565|P1|Overall Study|Withdrawal by Subject|0
2515460|NCT01778751|8703564|P2|Overall Study|Lost to Follow-up|0
2515461|NCT01778751|8703565|P1|Overall Study|Lost to Follow-up|1
2515462|NCT01778556|8703618|P2|Long-term Follow-up|noncompliance with metreleptin|0
2515463|NCT01778556|8703619|P1|Long-term Follow-up|noncompliance with metreleptin|1
2515464|NCT01778556|8703618|P2|Intervention 2 (14 Days)|Protocol Violation|0
2515465|NCT01778556|8703619|P1|Intervention 2 (14 Days)|Protocol Violation|1
2515466|NCT01778556|8703618|P2|Intervention 1 (5 Days)|Withdrawal by Subject|1
2515467|NCT01778556|8703619|P1|Intervention 1 (5 Days)|Withdrawal by Subject|0
2515468|NCT01778556|8703618|P2|Intervention 1 (5 Days)|Protocol Violation|1
2515469|NCT01778556|8703619|P1|Intervention 1 (5 Days)|Protocol Violation|0
2515470|NCT01778530|8703632|P1|Overall Study|Adverse event/side effect|1
2515471|NCT01778530|8703632|P1|Overall Study|Progression on study|1
2515472|NCT01778127|8703663|P3|Overall Study|Withdrawal by Subject|4
2515473|NCT01778127|8703664|P2|Overall Study|Withdrawal by Subject|1
2515474|NCT01778127|8703665|P1|Overall Study|Withdrawal by Subject|3
2515475|NCT01778127|8703663|P3|Overall Study|Lost to Follow-up|2
2515476|NCT01778127|8703664|P2|Overall Study|Lost to Follow-up|1
2515477|NCT01778127|8703665|P1|Overall Study|Lost to Follow-up|5
2515478|NCT01778062|8703708|P2|Overall Study|major protocol deviation|3
2515479|NCT01778062|8703709|P1|Overall Study|major protocol deviation|4
2515480|NCT01778062|8703708|P2|Overall Study|Consent Withdrawal|5
2515481|NCT01778062|8703709|P1|Overall Study|Consent Withdrawal|1
2515482|NCT01778062|8703708|P2|Overall Study|Adverse Event|3
2515483|NCT01778062|8703709|P1|Overall Study|Adverse Event|1
2515484|NCT01778049|8703723|P6|Double Blind Treatment Period|Other reason not defined above|1
2515485|NCT01778049|8703724|P5|Double Blind Treatment Period|Other reason not defined above|2
2515486|NCT01778049|8703725|P4|Double Blind Treatment Period|Other reason not defined above|2
2515487|NCT01778049|8703726|P3|Double Blind Treatment Period|Other reason not defined above|4
2515488|NCT01778049|8703727|P2|Double Blind Treatment Period|Other reason not defined above|0
2515489|NCT01778049|8703728|P1|Double Blind Treatment Period|Other reason not defined above|0
2515490|NCT01778049|8703723|P6|Double Blind Treatment Period|Not treated|0
2515491|NCT01778049|8703724|P5|Double Blind Treatment Period|Not treated|2
2515492|NCT01778049|8703725|P4|Double Blind Treatment Period|Not treated|2
2515493|NCT01778049|8703726|P3|Double Blind Treatment Period|Not treated|0
2515494|NCT01778049|8703727|P2|Double Blind Treatment Period|Not treated|0
2515495|NCT01778049|8703728|P1|Double Blind Treatment Period|Not treated|0
2515496|NCT01778049|8703723|P6|Double Blind Treatment Period|Withdrawal by Subject|1
2515497|NCT01778049|8703724|P5|Double Blind Treatment Period|Withdrawal by Subject|0
2515498|NCT01778049|8703725|P4|Double Blind Treatment Period|Withdrawal by Subject|2
2515499|NCT01778049|8703726|P3|Double Blind Treatment Period|Withdrawal by Subject|1
2515500|NCT01778049|8703727|P2|Double Blind Treatment Period|Withdrawal by Subject|0
2515501|NCT01778049|8703728|P1|Double Blind Treatment Period|Withdrawal by Subject|0
2515502|NCT01778049|8703723|P6|Double Blind Treatment Period|Lost to Follow-up|2
2515503|NCT01778049|8703724|P5|Double Blind Treatment Period|Lost to Follow-up|5
2515504|NCT01778049|8703725|P4|Double Blind Treatment Period|Lost to Follow-up|1
2515505|NCT01778049|8703726|P3|Double Blind Treatment Period|Lost to Follow-up|4
2515506|NCT01778049|8703727|P2|Double Blind Treatment Period|Lost to Follow-up|0
2515507|NCT01778049|8703728|P1|Double Blind Treatment Period|Lost to Follow-up|0
2515508|NCT01778049|8703723|P6|Double Blind Treatment Period|Protocol Violation|0
2515509|NCT01778049|8703724|P5|Double Blind Treatment Period|Protocol Violation|0
2515510|NCT01778049|8703725|P4|Double Blind Treatment Period|Protocol Violation|0
2515511|NCT01778049|8703726|P3|Double Blind Treatment Period|Protocol Violation|2
2515512|NCT01778049|8703727|P2|Double Blind Treatment Period|Protocol Violation|0
2515513|NCT01778049|8703728|P1|Double Blind Treatment Period|Protocol Violation|0
2515514|NCT01778049|8703723|P6|Double Blind Treatment Period|Lack of Efficacy|1
2515515|NCT01778049|8703724|P5|Double Blind Treatment Period|Lack of Efficacy|0
2515516|NCT01778049|8703725|P4|Double Blind Treatment Period|Lack of Efficacy|0
2515517|NCT01778049|8703726|P3|Double Blind Treatment Period|Lack of Efficacy|0
2515518|NCT01778049|8703727|P2|Double Blind Treatment Period|Lack of Efficacy|0
2515519|NCT01778049|8703728|P1|Double Blind Treatment Period|Lack of Efficacy|0
2515520|NCT01778049|8703723|P6|Double Blind Treatment Period|Adverse Event|2
2515521|NCT01778049|8703724|P5|Double Blind Treatment Period|Adverse Event|3
2515522|NCT01778049|8703725|P4|Double Blind Treatment Period|Adverse Event|5
2515523|NCT01778049|8703726|P3|Double Blind Treatment Period|Adverse Event|4
2515524|NCT01778049|8703727|P2|Double Blind Treatment Period|Adverse Event|0
2515525|NCT01778049|8703728|P1|Double Blind Treatment Period|Adverse Event|0
2515526|NCT01778049|8703723|P6|Open Label Treatment Period|Other reason not defined above|0
2515527|NCT01778049|8703724|P5|Open Label Treatment Period|Other reason not defined above|0
2515528|NCT01778049|8703725|P4|Open Label Treatment Period|Other reason not defined above|0
2515529|NCT01778049|8703726|P3|Open Label Treatment Period|Other reason not defined above|0
2515530|NCT01778049|8703727|P2|Open Label Treatment Period|Other reason not defined above|94
2515531|NCT01778049|8703728|P1|Open Label Treatment Period|Other reason not defined above|77
2515532|NCT01778049|8703723|P6|Open Label Treatment Period|Not treated|0
2515533|NCT01778049|8703724|P5|Open Label Treatment Period|Not treated|0
2515534|NCT01778049|8703725|P4|Open Label Treatment Period|Not treated|0
2515535|NCT01778049|8703726|P3|Open Label Treatment Period|Not treated|0
2515536|NCT01778049|8703727|P2|Open Label Treatment Period|Not treated|1
2515537|NCT01778049|8703728|P1|Open Label Treatment Period|Not treated|2
2515538|NCT01778049|8703723|P6|Open Label Treatment Period|Withdrawal by Subject|0
2515539|NCT01778049|8703724|P5|Open Label Treatment Period|Withdrawal by Subject|0
2515540|NCT01778049|8703725|P4|Open Label Treatment Period|Withdrawal by Subject|0
2515541|NCT01778049|8703726|P3|Open Label Treatment Period|Withdrawal by Subject|0
2515542|NCT01778049|8703727|P2|Open Label Treatment Period|Withdrawal by Subject|10
2515543|NCT01778049|8703728|P1|Open Label Treatment Period|Withdrawal by Subject|4
2515544|NCT01778049|8703723|P6|Open Label Treatment Period|Lost to Follow-up|0
2515545|NCT01778049|8703724|P5|Open Label Treatment Period|Lost to Follow-up|0
2515546|NCT01778049|8703725|P4|Open Label Treatment Period|Lost to Follow-up|0
2515547|NCT01778049|8703726|P3|Open Label Treatment Period|Lost to Follow-up|0
2515548|NCT01778049|8703727|P2|Open Label Treatment Period|Lost to Follow-up|3
2515549|NCT01778049|8703728|P1|Open Label Treatment Period|Lost to Follow-up|4
2515550|NCT01778049|8703723|P6|Open Label Treatment Period|Protocol Violation|0
2515551|NCT01778049|8703724|P5|Open Label Treatment Period|Protocol Violation|0
2515552|NCT01778049|8703725|P4|Open Label Treatment Period|Protocol Violation|0
2515553|NCT01778049|8703726|P3|Open Label Treatment Period|Protocol Violation|0
2515554|NCT01778049|8703727|P2|Open Label Treatment Period|Protocol Violation|5
2515555|NCT01778049|8703728|P1|Open Label Treatment Period|Protocol Violation|5
2515556|NCT01778049|8703723|P6|Open Label Treatment Period|Lack of Efficacy|0
2515557|NCT01778049|8703724|P5|Open Label Treatment Period|Lack of Efficacy|0
2515558|NCT01778049|8703725|P4|Open Label Treatment Period|Lack of Efficacy|0
2515559|NCT01778049|8703726|P3|Open Label Treatment Period|Lack of Efficacy|0
2515560|NCT01778049|8703727|P2|Open Label Treatment Period|Lack of Efficacy|1
2515561|NCT01778049|8703728|P1|Open Label Treatment Period|Lack of Efficacy|1
2515562|NCT01778049|8703723|P6|Open Label Treatment Period|Adverse Event|0
2515563|NCT01778049|8703724|P5|Open Label Treatment Period|Adverse Event|0
2515564|NCT01778049|8703725|P4|Open Label Treatment Period|Adverse Event|0
2515565|NCT01778049|8703726|P3|Open Label Treatment Period|Adverse Event|0
2515566|NCT01778049|8703727|P2|Open Label Treatment Period|Adverse Event|15
2515567|NCT01778049|8703728|P1|Open Label Treatment Period|Adverse Event|5
2515568|NCT01778023|8703746|P2|Overall Study|Withdrawal by Subject|3
2515569|NCT01778023|8703747|P1|Overall Study|Withdrawal by Subject|0
2515570|NCT01778010|8703764|P1|Overall Study|rash while on placebo|1
2515571|NCT01778010|8703764|P1|Overall Study|Arrested|1
2515572|NCT01778010|8703764|P1|Overall Study|abnormal ECG before meds|1
2515573|NCT01778010|8703764|P1|Overall Study|Withdrawal by Subject|2
2515574|NCT01777997|8703805|P1|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1
2515575|NCT01777997|8703805|P1|Weeks 48 to 72/96 on ART|Death|1
2515576|NCT01777997|8703805|P1|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1
2515577|NCT01777997|8703805|P1|12 Week lead-in of no ART|Severe debilitation|2
2515578|NCT01777932|8703827|P1|Overall Study|Patient refused further treatment|10
2515579|NCT01777932|8703827|P1|Overall Study|Reimbursement limit|9
2515580|NCT01777932|8703827|P1|Overall Study|Investigator decision|10
2515581|NCT01777932|8703827|P1|Overall Study|Lost to Follow-up|3
2515582|NCT01777932|8703827|P1|Overall Study|Adverse Event|34
2515583|NCT01777932|8703827|P1|Overall Study|Death|3
2515584|NCT01777932|8703827|P1|Overall Study|Disease progression|136
2515585|NCT01777854|8703841|P2|Overall Study|Physician Decision|3
2515586|NCT01777854|8703842|P1|Overall Study|Physician Decision|3
2515587|NCT01777776|8703850|P4|Overall Study|Withdrawal by Subject|1
2515588|NCT01777776|8703851|P3|Overall Study|Withdrawal by Subject|0
2515589|NCT01777776|8703852|P2|Overall Study|Withdrawal by Subject|0
2515590|NCT01777776|8703853|P1|Overall Study|Withdrawal by Subject|0
2515591|NCT01777776|8703850|P4|Overall Study|Disease Progression|3
2515592|NCT01777776|8703851|P3|Overall Study|Disease Progression|6
2515593|NCT01777776|8703852|P2|Overall Study|Disease Progression|8
2515594|NCT01777776|8703853|P1|Overall Study|Disease Progression|4
2515595|NCT01777776|8703850|P4|Overall Study|Adverse Event|0
2515596|NCT01777776|8703851|P3|Overall Study|Adverse Event|0
2515597|NCT01777776|8703852|P2|Overall Study|Adverse Event|4
2515598|NCT01777776|8703853|P1|Overall Study|Adverse Event|2
2515599|NCT01777763|8703912|P2|Overall Study|Treatment Failure|6
2515600|NCT01777763|8703913|P1|Overall Study|Treatment Failure|1
2515601|NCT01777763|8703912|P2|Overall Study|Withdrawal by Subject|2
2515602|NCT01777763|8703913|P1|Overall Study|Withdrawal by Subject|0
2515603|NCT01777763|8703912|P2|Overall Study|Protocol Violation|7
2515604|NCT01777763|8703913|P1|Overall Study|Protocol Violation|1
2515605|NCT01777763|8703912|P2|Overall Study|Adverse Event|32
2515606|NCT01777763|8703913|P1|Overall Study|Adverse Event|2
2515607|NCT01777620|8703937|P2|Overall Study|Subject Withdrawal|0
2515608|NCT01777620|8703938|P1|Overall Study|Subject Withdrawal|1
2515609|NCT01777581|8703964|P2|Overall Study|Lack of Efficacy|1
2515610|NCT01777581|8703965|P1|Overall Study|Lack of Efficacy|0
2515611|NCT01777581|8703964|P2|Overall Study|Adverse Event|0
2515612|NCT01777581|8703965|P1|Overall Study|Adverse Event|2
2515613|NCT01777581|8703964|P2|Overall Study|Lost to Follow-up|1
2515614|NCT01777581|8703965|P1|Overall Study|Lost to Follow-up|1
2515615|NCT01777542|8703994|P2|Second Intervention (20 Weeks)|Adverse Event|1
2515616|NCT01777542|8703995|P1|Second Intervention (20 Weeks)|Adverse Event|0
2515617|NCT01777490|8704038|P4|Overall Study|Dyad withdrew with data use prohibition|1
2515618|NCT01777490|8704039|P3|Overall Study|Dyad withdrew with data use prohibition|1
2515619|NCT01777490|8704040|P2|Overall Study|Dyad withdrew with data use prohibition|0
2515620|NCT01777490|8704041|P1|Overall Study|Dyad withdrew with data use prohibition|0
2515621|NCT01777334|8704086|P2|Overall Study|Withdrawal by Subject|11
2515622|NCT01777334|8704087|P1|Overall Study|Withdrawal by Subject|14
2515623|NCT01777334|8704086|P2|Overall Study|Lost to Follow-up|2
2515624|NCT01777334|8704087|P1|Overall Study|Lost to Follow-up|3
2515625|NCT01777334|8704086|P2|Overall Study|Protocol Violation|7
2515626|NCT01777334|8704087|P1|Overall Study|Protocol Violation|3
2515627|NCT01777334|8704086|P2|Overall Study|Lack of Efficacy|29
2515628|NCT01777334|8704087|P1|Overall Study|Lack of Efficacy|15
2515629|NCT01777334|8704086|P2|Overall Study|Adverse Event|14
2515630|NCT01777334|8704087|P1|Overall Study|Adverse Event|18
2515631|NCT01777321|8704097|P2|Overall Study|Withdrawal by Subject|1
2515632|NCT01777321|8704098|P1|Overall Study|Withdrawal by Subject|0
2515633|NCT01777308|8704136|P2|Overall Study|Blood draw refusal at Visit 3|0
2515634|NCT01777308|8704137|P1|Overall Study|Blood draw refusal at Visit 3|1
2515635|NCT01777308|8704136|P2|Overall Study|Lost to Follow-up|2
2515636|NCT01777308|8704137|P1|Overall Study|Lost to Follow-up|7
2515637|NCT01777308|8704136|P2|Overall Study|Migrated/moved from study area|0
2515638|NCT01777308|8704137|P1|Overall Study|Migrated/moved from study area|1
2515639|NCT01777308|8704136|P2|Overall Study|Withdrawal by Subject|1
2515640|NCT01777308|8704137|P1|Overall Study|Withdrawal by Subject|5
2515641|NCT01777295|8704169|P2|Overall Study|Investigator call for AEs check|0
2515642|NCT01777295|8704170|P1|Overall Study|Investigator call for AEs check|1
2515643|NCT01777295|8704169|P2|Overall Study|Personal problem|0
2515644|NCT01777295|8704170|P1|Overall Study|Personal problem|1
2515645|NCT01777295|8704169|P2|Overall Study|Pregnancy|1
2515646|NCT01777295|8704170|P1|Overall Study|Pregnancy|0
2515647|NCT01777295|8704169|P2|Overall Study|Withdrawal by Subject|2
2515648|NCT01777295|8704170|P1|Overall Study|Withdrawal by Subject|2
2515649|NCT01777282|8704377|P5|Overall Study|Moved, transfer abroad, did not enter FU|0
2515650|NCT01777282|8704378|P4|Overall Study|Moved, transfer abroad, did not enter FU|0
2515651|NCT01777282|8704379|P3|Overall Study|Moved, transfer abroad, did not enter FU|1
2515652|NCT01777282|8704380|P2|Overall Study|Moved, transfer abroad, did not enter FU|0
2515653|NCT01777282|8704381|P1|Overall Study|Moved, transfer abroad, did not enter FU|1
2515654|NCT01777282|8704377|P5|Overall Study|Protocol Violation|2
2515655|NCT01777282|8704378|P4|Overall Study|Protocol Violation|0
2515656|NCT01777282|8704379|P3|Overall Study|Protocol Violation|1
2515657|NCT01777282|8704380|P2|Overall Study|Protocol Violation|0
2515658|NCT01777282|8704381|P1|Overall Study|Protocol Violation|2
2515659|NCT01777282|8704377|P5|Overall Study|Withdrawal by Subject|2
2515660|NCT01777282|8704378|P4|Overall Study|Withdrawal by Subject|1
2515661|NCT01777282|8704379|P3|Overall Study|Withdrawal by Subject|0
2515662|NCT01777282|8704380|P2|Overall Study|Withdrawal by Subject|0
2515663|NCT01777282|8704381|P1|Overall Study|Withdrawal by Subject|4
2515664|NCT01777282|8704377|P5|Overall Study|Adverse Event|3
2515665|NCT01777282|8704378|P4|Overall Study|Adverse Event|1
2515666|NCT01777282|8704379|P3|Overall Study|Adverse Event|2
2515667|NCT01777282|8704380|P2|Overall Study|Adverse Event|4
2515668|NCT01777282|8704381|P1|Overall Study|Adverse Event|4
2515669|NCT01777282|8704377|P5|Overall Study|New Antidiabetic Medication|0
2515670|NCT01777282|8704378|P4|Overall Study|New Antidiabetic Medication|0
2515671|NCT01777282|8704379|P3|Overall Study|New Antidiabetic Medication|1
2515672|NCT01777282|8704380|P2|Overall Study|New Antidiabetic Medication|0
2515673|NCT01777282|8704381|P1|Overall Study|New Antidiabetic Medication|0
2515674|NCT01777282|8704377|P5|Overall Study|Persistent Hyperglycemia|0
2515675|NCT01777282|8704378|P4|Overall Study|Persistent Hyperglycemia|0
2515676|NCT01777282|8704379|P3|Overall Study|Persistent Hyperglycemia|1
2515677|NCT01777282|8704380|P2|Overall Study|Persistent Hyperglycemia|0
2515678|NCT01777282|8704381|P1|Overall Study|Persistent Hyperglycemia|0
2515679|NCT01777269|8704425|P2|Overall Study|Withdrawal by Subject|9
2515680|NCT01777269|8704426|P1|Overall Study|Withdrawal by Subject|9
2515681|NCT01777269|8704425|P2|Overall Study|Physician Decision|2
2515682|NCT01777269|8704426|P1|Overall Study|Physician Decision|5
2515683|NCT01777269|8704425|P2|Overall Study|Lost to Follow-up|0
2515684|NCT01777269|8704426|P1|Overall Study|Lost to Follow-up|4
2515685|NCT01777269|8704425|P2|Overall Study|Participants reached stopping criteria|1
2515686|NCT01777269|8704426|P1|Overall Study|Participants reached stopping criteria|1
2515687|NCT01777269|8704425|P2|Overall Study|Protocol Violation|4
2515688|NCT01777269|8704426|P1|Overall Study|Protocol Violation|4
2515689|NCT01777269|8704425|P2|Overall Study|Lack of Efficacy|10
2515690|NCT01777269|8704426|P1|Overall Study|Lack of Efficacy|8
2515691|NCT01777269|8704425|P2|Overall Study|Adverse Event|33
2515692|NCT01777269|8704426|P1|Overall Study|Adverse Event|24
2515693|NCT01777191|8704463|P2|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3
2515694|NCT01777191|8704464|P1|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1
2515695|NCT01777191|8704463|P2|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2
2515696|NCT01777191|8704464|P1|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1
2515697|NCT01777191|8704463|P2|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
2515698|NCT01777191|8704464|P1|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
2515699|NCT01777191|8704463|P2|Safety Extension Per (Week 12-Week 48)|Death|1
2515700|NCT01777191|8704464|P1|Safety Extension Per (Week 12-Week 48)|Death|0
2515701|NCT01777191|8704463|P2|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
2515702|NCT01777191|8704464|P1|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
2515703|NCT01777191|8704463|P2|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0
2515784|NCT01775787|8704876|P1|First 7-10 Days|concerns with using IV|1
2515704|NCT01777191|8704464|P1|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1
2515705|NCT01777191|8704463|P2|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
2515706|NCT01777191|8704464|P1|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
2515707|NCT01777191|8704463|P2|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3
2515708|NCT01777191|8704464|P1|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0
2515709|NCT01777191|8704463|P2|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2
2515710|NCT01777191|8704464|P1|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1
2515711|NCT01777191|8704463|P2|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
2515712|NCT01777191|8704464|P1|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
2515713|NCT01777191|8704463|P2|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1
2515714|NCT01777191|8704464|P1|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2
2515715|NCT01777152|8704494|P2|Overall Study|Change of diagnosis|0
2515716|NCT01777152|8704495|P1|Overall Study|Change of diagnosis|1
2515717|NCT01777152|8704494|P2|Overall Study|Not eligible, no study drug received|0
2515718|NCT01777152|8704495|P1|Overall Study|Not eligible, no study drug received|1
2515719|NCT01777152|8704494|P2|Overall Study|Death|73
2515720|NCT01777152|8704495|P1|Overall Study|Death|51
2515721|NCT01777152|8704494|P2|Overall Study|Lost to Follow-up|4
2515722|NCT01777152|8704495|P1|Overall Study|Lost to Follow-up|0
2515723|NCT01777152|8704494|P2|Overall Study|Withdrawal by Subject|10
2515724|NCT01777152|8704495|P1|Overall Study|Withdrawal by Subject|16
2515725|NCT01777152|8704494|P2|Overall Study|In Follow Up|139
2515726|NCT01777152|8704495|P1|Overall Study|In Follow Up|157
2515727|NCT01777139|8704511|P2|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3
2515728|NCT01777139|8704512|P1|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0
2515729|NCT01777139|8704511|P2|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1
2515730|NCT01777139|8704512|P1|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0
2515731|NCT01777139|8704511|P2|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0
2515732|NCT01777139|8704512|P1|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4
2515733|NCT01777139|8704511|P2|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0
2515734|NCT01777139|8704512|P1|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2
2515735|NCT01777139|8704511|P2|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0
2515736|NCT01777139|8704512|P1|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3
2515737|NCT01777139|8704511|P2|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0
2515738|NCT01777139|8704512|P1|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8
2515739|NCT01777139|8704511|P2|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0
2515740|NCT01777139|8704512|P1|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6
2515741|NCT01777139|8704511|P2|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0
2515742|NCT01777139|8704512|P1|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7
2515743|NCT01776554|8704626|P2|Overall Study|Unclassified|1
2515744|NCT01776554|8704627|P1|Overall Study|Unclassified|4
2515745|NCT01776554|8704626|P2|Overall Study|Protocol Violation|0
2515746|NCT01776554|8704627|P1|Overall Study|Protocol Violation|1
2515747|NCT01776554|8704626|P2|Overall Study|Administrative Reason|5
2515748|NCT01776554|8704627|P1|Overall Study|Administrative Reason|2
2515749|NCT01776554|8704626|P2|Overall Study|Lost to Follow-up|9
2515750|NCT01776554|8704627|P1|Overall Study|Lost to Follow-up|6
2515751|NCT01776554|8704626|P2|Overall Study|Withdrawal by Subject|8
2515752|NCT01776554|8704627|P1|Overall Study|Withdrawal by Subject|3
2515753|NCT01776554|8704626|P2|Overall Study|Adverse Event|0
2515754|NCT01776554|8704627|P1|Overall Study|Adverse Event|1
2515755|NCT01776541|8704670|P2|Overall Study|Withdrawal by Subject|20
2515756|NCT01776541|8704671|P1|Overall Study|Withdrawal by Subject|12
2515757|NCT01776541|8704670|P2|Overall Study|Protocol Violation|1
2515758|NCT01776541|8704671|P1|Overall Study|Protocol Violation|2
2515759|NCT01776541|8704670|P2|Overall Study|Unclassified|4
2515760|NCT01776541|8704671|P1|Overall Study|Unclassified|5
2515761|NCT01776541|8704670|P2|Overall Study|Lost to Follow-up|48
2515762|NCT01776541|8704671|P1|Overall Study|Lost to Follow-up|27
2515763|NCT01776541|8704670|P2|Overall Study|Death|0
2515764|NCT01776541|8704671|P1|Overall Study|Death|4
2515765|NCT01776541|8704670|P2|Overall Study|Administrative Reason|2
2515766|NCT01776541|8704671|P1|Overall Study|Administrative Reason|6
2515767|NCT01776424|8704693|P3|Overall Study|Withdrawal by Subject|15
2515768|NCT01776424|8704694|P2|Overall Study|Withdrawal by Subject|11
2515769|NCT01776424|8704695|P1|Overall Study|Withdrawal by Subject|10
2515770|NCT01776424|8704693|P3|Overall Study|Lost to Follow-up|9
2515771|NCT01776424|8704694|P2|Overall Study|Lost to Follow-up|8
2515772|NCT01776424|8704695|P1|Overall Study|Lost to Follow-up|10
2515773|NCT01776008|8704726|P1|Overall Study|ineligible|2
2515774|NCT01775995|8704740|P2|Overall Study|Lost to Follow-up|1
2515775|NCT01775995|8704741|P1|Overall Study|Lost to Follow-up|1
2515776|NCT01775930|8704801|P1|Overall Study|Futility stopping boundary met|1
2515777|NCT01775904|8704809|P1|LY2886721 ODT (Water, Fasting)|Adverse Event|1
2515778|NCT01775904|8704809|P1|LY2886721 Capsule (Water, Fasting)|Adverse Event|1
2515779|NCT01775787|8704875|P2|Second 7-10 Days|concerns with using IV|1
2515780|NCT01775787|8704876|P1|Second 7-10 Days|concerns with using IV|0
2515781|NCT01775787|8704875|P2|Second 7-10 Days|time commitment|1
2515782|NCT01775787|8704876|P1|Second 7-10 Days|time commitment|0
2515783|NCT01775787|8704875|P2|First 7-10 Days|concerns with using IV|2
2515785|NCT01775787|8704875|P2|First 7-10 Days|time commitment|2
2515786|NCT01775787|8704876|P1|First 7-10 Days|time commitment|0
2515787|NCT01775787|8704875|P2|First 7-10 Days|family emergency|1
2515788|NCT01775787|8704876|P1|First 7-10 Days|family emergency|0
2515789|NCT01775787|8704875|P2|First 7-10 Days|Adverse Event|1
2515790|NCT01775787|8704876|P1|First 7-10 Days|Adverse Event|0
2515791|NCT01775670|8704932|P2|Overall Study|Lost to Follow-up|1
2515792|NCT01775670|8704933|P1|Overall Study|Lost to Follow-up|1
2515793|NCT01775553|8704959|P1|Overall Study|Disease Progression|12
2515794|NCT01775553|8704959|P1|Overall Study|Adverse Event|1
2515795|NCT01775501|8704967|P1|Overall Study|Discontinued prior to treatment|1
2515796|NCT01775189|8704976|P7|Treatment Phase: Washout Period 3|Protocol Violation|1
2515797|NCT01775189|8704977|P6|Treatment Phase: Washout Period 3|Protocol Violation|0
2515798|NCT01775189|8704978|P5|Treatment Phase: Washout Period 3|Protocol Violation|0
2515799|NCT01775189|8704979|P4|Treatment Phase: Washout Period 3|Protocol Violation|1
2515800|NCT01775189|8704980|P3|Treatment Phase: Washout Period 3|Protocol Violation|0
2515801|NCT01775189|8704981|P2|Treatment Phase: Washout Period 3|Protocol Violation|0
2515802|NCT01775189|8704982|P1|Treatment Phase: Washout Period 3|Protocol Violation|0
2515803|NCT01775189|8704976|P7|Treatment Phase: Washout Period 2|Protocol Violation|0
2515804|NCT01775189|8704977|P6|Treatment Phase: Washout Period 2|Protocol Violation|0
2515805|NCT01775189|8704978|P5|Treatment Phase: Washout Period 2|Protocol Violation|0
2515806|NCT01775189|8704979|P4|Treatment Phase: Washout Period 2|Protocol Violation|1
2515807|NCT01775189|8704980|P3|Treatment Phase: Washout Period 2|Protocol Violation|0
2515808|NCT01775189|8704981|P2|Treatment Phase: Washout Period 2|Protocol Violation|0
2515809|NCT01775189|8704982|P1|Treatment Phase: Washout Period 2|Protocol Violation|0
2515810|NCT01775189|8704976|P7|Treatment Phase: Washout Period 1|Protocol Violation|0
2515811|NCT01775189|8704977|P6|Treatment Phase: Washout Period 1|Protocol Violation|1
2515812|NCT01775189|8704978|P5|Treatment Phase: Washout Period 1|Protocol Violation|0
2515813|NCT01775189|8704979|P4|Treatment Phase: Washout Period 1|Protocol Violation|0
2515814|NCT01775189|8704980|P3|Treatment Phase: Washout Period 1|Protocol Violation|0
2515815|NCT01775189|8704981|P2|Treatment Phase: Washout Period 1|Protocol Violation|0
2515816|NCT01775189|8704982|P1|Treatment Phase: Washout Period 1|Protocol Violation|0
2515817|NCT01775189|8704976|P7|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
2515818|NCT01775189|8704977|P6|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
2515819|NCT01775189|8704978|P5|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
2515820|NCT01775189|8704979|P4|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
2515821|NCT01775189|8704980|P3|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7
2515822|NCT01775189|8704981|P2|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2
2515823|NCT01775189|8704982|P1|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
2515824|NCT01775189|8704976|P7|Drug Discrimination Phase: Day 2|Protocol Violation|0
2515825|NCT01775189|8704977|P6|Drug Discrimination Phase: Day 2|Protocol Violation|0
2515826|NCT01775189|8704978|P5|Drug Discrimination Phase: Day 2|Protocol Violation|0
2515827|NCT01775189|8704979|P4|Drug Discrimination Phase: Day 2|Protocol Violation|0
2515828|NCT01775189|8704980|P3|Drug Discrimination Phase: Day 2|Protocol Violation|0
2515829|NCT01775189|8704981|P2|Drug Discrimination Phase: Day 2|Protocol Violation|1
2515830|NCT01775189|8704982|P1|Drug Discrimination Phase: Day 2|Protocol Violation|0
2515831|NCT01775189|8704976|P7|Drug Discrimination Phase: Day 1|Adverse Event|0
2515832|NCT01775189|8704977|P6|Drug Discrimination Phase: Day 1|Adverse Event|0
2515833|NCT01775189|8704978|P5|Drug Discrimination Phase: Day 1|Adverse Event|0
2515834|NCT01775189|8704979|P4|Drug Discrimination Phase: Day 1|Adverse Event|0
2515835|NCT01775189|8704980|P3|Drug Discrimination Phase: Day 1|Adverse Event|0
2515836|NCT01775189|8704981|P2|Drug Discrimination Phase: Day 1|Adverse Event|3
2515837|NCT01775189|8704982|P1|Drug Discrimination Phase: Day 1|Adverse Event|0
2515838|NCT01775137|8705201|P1|Overall Study|Withdrawal by participants|5
2515839|NCT01775137|8705201|P1|Overall Study|Adverse Event|1
2515840|NCT01775137|8705201|P1|Overall Study|Unsatisfactory therapeutic effect|2
2515841|NCT01775137|8705201|P1|Overall Study|Protocol deviation|2
2515842|NCT01775137|8705201|P1|Overall Study|Death|1
2515843|NCT01775124|8705228|P2|Extension Period|Withdrawal by Subject|12
2515844|NCT01775124|8705229|P1|Extension Period|Withdrawal by Subject|9
2515845|NCT01775124|8705228|P2|Extension Period|Lost to Follow-up|1
2515846|NCT01775124|8705229|P1|Extension Period|Lost to Follow-up|0
2515847|NCT01775124|8705228|P2|Extension Period|Administrative problems|1
2515848|NCT01775124|8705229|P1|Extension Period|Administrative problems|0
2515849|NCT01775124|8705228|P2|Extension Period|Physician Decision|2
2515850|NCT01775124|8705229|P1|Extension Period|Physician Decision|0
2515851|NCT01775124|8705228|P2|Extension Period|Adverse Event|2
2515852|NCT01775124|8705229|P1|Extension Period|Adverse Event|3
2515853|NCT01775124|8705228|P2|Core Period|Adverse Event|5
2515854|NCT01775124|8705229|P1|Core Period|Adverse Event|5
2515855|NCT01775124|8705228|P2|Core Period|Withdrawal by Subject|2
2515856|NCT01775124|8705229|P1|Core Period|Withdrawal by Subject|4
2515857|NCT01775124|8705228|P2|Core Period|Administrative problems|0
2515858|NCT01775124|8705229|P1|Core Period|Administrative problems|1
2515859|NCT01775124|8705228|P2|Core Period|Death|1
2515860|NCT01775124|8705229|P1|Core Period|Death|0
2515861|NCT01775124|8705228|P2|Core Period|Physician Decision|1
2515862|NCT01775124|8705229|P1|Core Period|Physician Decision|1
2515863|NCT01775124|8705228|P2|Core Period|Disease Progression|1
2515864|NCT01775124|8705229|P1|Core Period|Disease Progression|0
2515865|NCT01774981|8705264|P8|Overall Study|Death|0
2515866|NCT01774981|8705265|P7|Overall Study|Death|0
2515867|NCT01774981|8705266|P6|Overall Study|Death|0
2515868|NCT01774981|8705267|P5|Overall Study|Death|1
2515869|NCT01774981|8705268|P4|Overall Study|Death|0
2515870|NCT01774981|8705269|P3|Overall Study|Death|0
2515871|NCT01774981|8705270|P2|Overall Study|Death|0
2515872|NCT01774981|8705271|P1|Overall Study|Death|0
2515873|NCT01774981|8705264|P8|Overall Study|Withdrawal by Subject|1
2515874|NCT01774981|8705265|P7|Overall Study|Withdrawal by Subject|0
2515875|NCT01774981|8705266|P6|Overall Study|Withdrawal by Subject|0
2515876|NCT01774981|8705267|P5|Overall Study|Withdrawal by Subject|0
2515877|NCT01774981|8705268|P4|Overall Study|Withdrawal by Subject|0
2515878|NCT01774981|8705269|P3|Overall Study|Withdrawal by Subject|0
2515879|NCT01774981|8705270|P2|Overall Study|Withdrawal by Subject|0
2515880|NCT01774981|8705271|P1|Overall Study|Withdrawal by Subject|0
2515881|NCT01774981|8705264|P8|Overall Study|Adverse Event|0
2515882|NCT01774981|8705265|P7|Overall Study|Adverse Event|0
2515883|NCT01774981|8705266|P6|Overall Study|Adverse Event|1
2515884|NCT01774981|8705267|P5|Overall Study|Adverse Event|0
2515885|NCT01774981|8705268|P4|Overall Study|Adverse Event|0
2515886|NCT01774981|8705269|P3|Overall Study|Adverse Event|0
2515887|NCT01774981|8705270|P2|Overall Study|Adverse Event|0
2515888|NCT01774981|8705271|P1|Overall Study|Adverse Event|0
2515889|NCT01774968|8705303|P2|Overall Study|Withdrawal by Subject|11
2515890|NCT01774968|8705304|P1|Overall Study|Withdrawal by Subject|6
2515891|NCT01774968|8705303|P2|Overall Study|Sponsor Decision|2
2515892|NCT01774968|8705304|P1|Overall Study|Sponsor Decision|0
2515893|NCT01774968|8705303|P2|Overall Study|Protocol Violation|13
2515894|NCT01774968|8705304|P1|Overall Study|Protocol Violation|14
2515895|NCT01774968|8705303|P2|Overall Study|Physician Decision|1
2515896|NCT01774968|8705304|P1|Overall Study|Physician Decision|5
2515897|NCT01774968|8705303|P2|Overall Study|Lost to Follow-up|3
2515898|NCT01774968|8705304|P1|Overall Study|Lost to Follow-up|1
2515899|NCT01774968|8705303|P2|Overall Study|Death|1
2515900|NCT01774968|8705304|P1|Overall Study|Death|0
2515901|NCT01774968|8705303|P2|Overall Study|Adverse Event|4
2515902|NCT01774968|8705304|P1|Overall Study|Adverse Event|4
2515903|NCT01774929|8705338|P1|Overall Study|Adverse Event|3
2515904|NCT01774903|8705344|P1|Overall Study|Ineligible to continue the trial|1
2515905|NCT01774903|8705344|P1|Overall Study|Lack of Efficacy|1
2515906|NCT01774903|8705344|P1|Overall Study|Withdrawal by Subject|2
2515907|NCT01774903|8705344|P1|Overall Study|Adverse Event|7
2515908|NCT01774799|8705364|P4|Overall Study|Lost to Follow-up|0
2515909|NCT01774799|8705365|P3|Overall Study|Lost to Follow-up|0
2515910|NCT01774799|8705366|P2|Overall Study|Lost to Follow-up|1
2515911|NCT01774799|8705367|P1|Overall Study|Lost to Follow-up|1
2515912|NCT01774786|8705383|P2|Overall Study|Ineligible for Study|3
2515913|NCT01774786|8705384|P1|Overall Study|Ineligible for Study|1
2515914|NCT01774786|8705383|P2|Overall Study|Physician Decision|0
2515915|NCT01774786|8705384|P1|Overall Study|Physician Decision|1
2515916|NCT01774786|8705383|P2|Overall Study|Withdrawal by Subject|12
2515917|NCT01774786|8705384|P1|Overall Study|Withdrawal by Subject|15
2515918|NCT01774786|8705383|P2|Overall Study|Lost to Follow-up|4
2515919|NCT01774786|8705384|P1|Overall Study|Lost to Follow-up|3
2515920|NCT01774786|8705383|P2|Overall Study|Death|262
2515921|NCT01774786|8705384|P1|Overall Study|Death|242
2515922|NCT01774786|8705383|P2|Overall Study|In Follow-up|62
2515923|NCT01774786|8705384|P1|Overall Study|In Follow-up|65
2515924|NCT01774786|8705383|P2|Overall Study|Between Treatment and Follow-up|2
2515925|NCT01774786|8705384|P1|Overall Study|Between Treatment and Follow-up|6
2515926|NCT01774786|8705383|P2|Overall Study|On Treatment|47
2515927|NCT01774786|8705384|P1|Overall Study|On Treatment|55
2515928|NCT01774721|8705418|P2|Overall Study|Ongoing in study|120
2515929|NCT01774721|8705419|P1|Overall Study|Ongoing in study|136
2515930|NCT01774721|8705418|P2|Overall Study|Did not meet eligibility criteria|3
2515931|NCT01774721|8705419|P1|Overall Study|Did not meet eligibility criteria|0
2515932|NCT01774721|8705418|P2|Overall Study|Lost to Follow-up|1
2515933|NCT01774721|8705419|P1|Overall Study|Lost to Follow-up|1
2515934|NCT01774721|8705418|P2|Overall Study|Withdrawal by Subject|10
2515935|NCT01774721|8705419|P1|Overall Study|Withdrawal by Subject|14
2515936|NCT01774721|8705418|P2|Overall Study|Death|91
2515937|NCT01774721|8705419|P1|Overall Study|Death|76
2515938|NCT01774591|8705484|P2|Overall Study|Adverse Event|2
2515939|NCT01774591|8705485|P1|Overall Study|Adverse Event|0
2515940|NCT01774591|8705484|P2|Overall Study|Withdrawal by Subject|1
2515941|NCT01774591|8705485|P1|Overall Study|Withdrawal by Subject|0
2515942|NCT01774591|8705484|P2|Overall Study|Physician Decision|1
2515943|NCT01774591|8705485|P1|Overall Study|Physician Decision|1
2515944|NCT01774370|8705495|P1|Overall Study|Follow-up failure|34
2515945|NCT01774370|8705495|P1|Overall Study|Violated inclusion/exclusion criteria|53
2515946|NCT01774370|8705495|P1|Overall Study|Subjects of contraindications|34
2515947|NCT01774370|8705495|P1|Overall Study|Administered prior to the contract date|4
2515948|NCT01774370|8705495|P1|Overall Study|Never taken the PRADAXA during the study|4
2515949|NCT01774344|8705503|P2|Overall Study|Non-compliance with study drug|2
2515950|NCT01774344|8705504|P1|Overall Study|Non-compliance with study drug|0
2515951|NCT01774344|8705503|P2|Overall Study|Physician Decision|1
2515952|NCT01774344|8705504|P1|Overall Study|Physician Decision|0
2515953|NCT01774344|8705503|P2|Overall Study|Adverse event (AE)|1
2515954|NCT01774344|8705504|P1|Overall Study|Adverse event (AE)|0
2515955|NCT01774344|8705503|P2|Overall Study|AE not related to disease progression|47
2515956|NCT01774344|8705504|P1|Overall Study|AE not related to disease progression|12
2515957|NCT01774344|8705503|P2|Overall Study|Ongoing with treatment|65
2515958|NCT01774344|8705504|P1|Overall Study|Ongoing with treatment|10
2515959|NCT01774344|8705503|P2|Overall Study|Other|0
2515960|NCT01774344|8705504|P1|Overall Study|Other|1
2515961|NCT01774344|8705503|P2|Overall Study|Study drug never administered|5
2515962|NCT01774344|8705504|P1|Overall Study|Study drug never administered|1
2515963|NCT01774344|8705503|P2|Overall Study|Withdrawal by Subject|26
2515964|NCT01774344|8705504|P1|Overall Study|Withdrawal by Subject|5
2515965|NCT01774344|8705503|P2|Overall Study|Protocol Violation|1
2515966|NCT01774344|8705504|P1|Overall Study|Protocol Violation|3
2515967|NCT01774305|8705520|P2|Overall Study|Physician Decision|0
2515968|NCT01774305|8705521|P1|Overall Study|Physician Decision|1
2515969|NCT01774253|8705529|P1|Overall Study|Death|1
2515970|NCT01774253|8705529|P1|Overall Study|Withdrawal by Subject|2
2515971|NCT01774253|8705529|P1|Overall Study|Physician Decision|2
2515972|NCT01774253|8705529|P1|Overall Study|Lack of Efficacy|4
2515973|NCT01774110|8705548|P1|Overall Study|Lost to Follow-up|7
2515974|NCT01774097|8705556|P2|Overall Study|Adverse Event|1
2515975|NCT01774097|8705557|P1|Overall Study|Adverse Event|1
2515976|NCT01774097|8705556|P2|Overall Study|Withdrawal by Subject|1
2515977|NCT01774097|8705557|P1|Overall Study|Withdrawal by Subject|1
2515978|NCT01774084|8705587|P2|Overall Study|Personal reasons|0
2515979|NCT01774084|8705588|P1|Overall Study|Personal reasons|1
2515980|NCT01773993|8705613|P1|Overall Study|No Visit After Treatment|35
2515981|NCT01773967|8705632|P2|Overall Study|Lost to Follow-up|13
2515982|NCT01773967|8705633|P1|Overall Study|Lost to Follow-up|15
2515983|NCT01773889|8705648|P1|Overall Study|lack of funding|2
2515984|NCT01773473|8705654|P2|Overall Study|Lost to Follow-up|0
2515985|NCT01773473|8705655|P1|Overall Study|Lost to Follow-up|2
2515986|NCT01773473|8705654|P2|Overall Study|Withdrawal by Subject|3
2515987|NCT01773473|8705655|P1|Overall Study|Withdrawal by Subject|5
2515988|NCT01773473|8705654|P2|Overall Study|Non-Compliance with study drug|4
2515989|NCT01773473|8705655|P1|Overall Study|Non-Compliance with study drug|1
2515990|NCT01773473|8705654|P2|Overall Study|Lack of Efficacy|1
2515991|NCT01773473|8705655|P1|Overall Study|Lack of Efficacy|0
2515992|NCT01773473|8705654|P2|Overall Study|Sponsor Decision|0
2515993|NCT01773473|8705655|P1|Overall Study|Sponsor Decision|2
2515994|NCT01773473|8705654|P2|Overall Study|Physician Decision|5
2515995|NCT01773473|8705655|P1|Overall Study|Physician Decision|3
2515996|NCT01773473|8705654|P2|Overall Study|Protocol Violation|4
2515997|NCT01773473|8705655|P1|Overall Study|Protocol Violation|0
2515998|NCT01773473|8705654|P2|Overall Study|Adverse Event|2
2515999|NCT01773473|8705655|P1|Overall Study|Adverse Event|3
2516000|NCT01773421|8705677|P7|Extension Phase|Adverse Event|0
2516001|NCT01773421|8705678|P6|Extension Phase|Adverse Event|0
2516002|NCT01773421|8705679|P5|Extension Phase|Adverse Event|2
2516003|NCT01773421|8705680|P4|Extension Phase|Adverse Event|0
2516004|NCT01773421|8705681|P3|Extension Phase|Adverse Event|0
2516005|NCT01773421|8705682|P2|Extension Phase|Adverse Event|0
2516006|NCT01773421|8705683|P1|Extension Phase|Adverse Event|0
2516007|NCT01773421|8705677|P7|Extension Phase|Other|0
2516008|NCT01773421|8705678|P6|Extension Phase|Other|2
2516009|NCT01773421|8705679|P5|Extension Phase|Other|1
2516010|NCT01773421|8705680|P4|Extension Phase|Other|0
2516011|NCT01773421|8705681|P3|Extension Phase|Other|0
2516012|NCT01773421|8705682|P2|Extension Phase|Other|0
2516013|NCT01773421|8705683|P1|Extension Phase|Other|0
2516014|NCT01773421|8705677|P7|Treatment Phase|Withdrawal by Subject|0
2516015|NCT01773421|8705678|P6|Treatment Phase|Withdrawal by Subject|0
2516016|NCT01773421|8705679|P5|Treatment Phase|Withdrawal by Subject|0
2516017|NCT01773421|8705680|P4|Treatment Phase|Withdrawal by Subject|1
2516018|NCT01773421|8705681|P3|Treatment Phase|Withdrawal by Subject|1
2516019|NCT01773421|8705682|P2|Treatment Phase|Withdrawal by Subject|0
2516020|NCT01773421|8705683|P1|Treatment Phase|Withdrawal by Subject|0
2516021|NCT01773421|8705677|P7|Treatment Phase|Adverse Event|0
2516022|NCT01773421|8705678|P6|Treatment Phase|Adverse Event|0
2516023|NCT01773421|8705679|P5|Treatment Phase|Adverse Event|0
2516024|NCT01773421|8705680|P4|Treatment Phase|Adverse Event|1
2516025|NCT01773421|8705681|P3|Treatment Phase|Adverse Event|3
2516026|NCT01773421|8705682|P2|Treatment Phase|Adverse Event|0
2516027|NCT01773421|8705683|P1|Treatment Phase|Adverse Event|0
2516028|NCT01773421|8705677|P7|Treatment Phase|Other|0
2516029|NCT01773421|8705678|P6|Treatment Phase|Other|0
2516030|NCT01773421|8705679|P5|Treatment Phase|Other|0
2516031|NCT01773421|8705680|P4|Treatment Phase|Other|0
2516032|NCT01773421|8705681|P3|Treatment Phase|Other|2
2516033|NCT01773421|8705682|P2|Treatment Phase|Other|0
2516034|NCT01773421|8705683|P1|Treatment Phase|Other|0
2516035|NCT01773291|8705714|P3|Overall Study|Withdrawal by Subject|1
2516036|NCT01773291|8705715|P2|Overall Study|Withdrawal by Subject|0
2516037|NCT01773291|8705716|P1|Overall Study|Withdrawal by Subject|0
2516038|NCT01773291|8705714|P3|Overall Study|Protocol Violation|0
2516039|NCT01773291|8705715|P2|Overall Study|Protocol Violation|0
2516040|NCT01773291|8705716|P1|Overall Study|Protocol Violation|1
2516041|NCT01773226|8705727|P1|Overall Study|Withdrawal by Subject|1
2516042|NCT01773122|8705746|P4|Overall Study|Due to amended age eligibility criteria|1
2516121|NCT01772316|8706043|P1|Overall Study|Serious adverse event|1
2516043|NCT01773122|8705747|P3|Overall Study|Due to amended age eligibility criteria|0
2516044|NCT01773122|8705748|P2|Overall Study|Due to amended age eligibility criteria|1
2516045|NCT01773122|8705749|P1|Overall Study|Due to amended age eligibility criteria|3
2516046|NCT01773109|8705763|P1|Overall Study|Death|1
2516047|NCT01773109|8705763|P1|Overall Study|Symptomatic Progression|2
2516048|NCT01773070|8705767|P1|Overall Study|Death (unrelated to study procedures)|3
2516049|NCT01773070|8705767|P1|Overall Study|Other|15
2516050|NCT01773070|8705767|P1|Overall Study|Lost to Follow-up|39
2516051|NCT01773070|8705767|P1|Overall Study|Withdrawal by Subject|24
2516052|NCT01772823|8705777|P2|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0
2516053|NCT01772823|8705778|P1|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1
2516054|NCT01772823|8705777|P2|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
2516055|NCT01772823|8705778|P1|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
2516056|NCT01772823|8705777|P2|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2
2516057|NCT01772823|8705778|P1|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1
2516058|NCT01772823|8705777|P2|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5
2516059|NCT01772823|8705778|P1|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6
2516060|NCT01772823|8705777|P2|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
2516061|NCT01772823|8705778|P1|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
2516062|NCT01772823|8705777|P2|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0
2516063|NCT01772823|8705778|P1|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1
2516064|NCT01772823|8705777|P2|Treatment Phase (Week 0- Week 48)|Incarcerated|0
2516065|NCT01772823|8705778|P1|Treatment Phase (Week 0- Week 48)|Incarcerated|1
2516066|NCT01772823|8705777|P2|Treatment Phase (Week 0- Week 48)|Moved out of area|3
2516067|NCT01772823|8705778|P1|Treatment Phase (Week 0- Week 48)|Moved out of area|4
2516068|NCT01772823|8705777|P2|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1
2516069|NCT01772823|8705778|P1|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6
2516070|NCT01772823|8705777|P2|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13
2516071|NCT01772823|8705778|P1|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15
2516072|NCT01772823|8705777|P2|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0
2516073|NCT01772823|8705778|P1|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1
2516074|NCT01772823|8705777|P2|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0
2516075|NCT01772823|8705778|P1|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6
2516076|NCT01772823|8705777|P2|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1
2516077|NCT01772823|8705778|P1|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2
2516078|NCT01772823|8705777|P2|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0
2516079|NCT01772823|8705778|P1|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1
2516080|NCT01772823|8705777|P2|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
2516081|NCT01772823|8705778|P1|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
2516082|NCT01772823|8705777|P2|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0
2516083|NCT01772823|8705778|P1|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1
2516084|NCT01772719|8705891|P1|Overall Study|Lost to Follow-up|1
2516085|NCT01772719|8705891|P1|Overall Study|Protocol Violation|1
2516086|NCT01772719|8705891|P1|Overall Study|Adverse Event|2
2516087|NCT01772719|8705891|P1|Overall Study|Withdrawal by Subject|3
2516088|NCT01772576|8705911|P1|Overall Study|Withdrawal by Subject|6
2516089|NCT01772576|8705911|P1|Overall Study|Adverse Event|6
2516090|NCT01772576|8705911|P1|Overall Study|Study device not used|3
2516091|NCT01772576|8705911|P1|Overall Study|Lost to Follow-up|3
2516092|NCT01772576|8705911|P1|Overall Study|Protocol Violation|1
2516093|NCT01772576|8705911|P1|Overall Study|Death|15
2516094|NCT01772550|8705923|P3|Overall Study|Adverse Event|1
2516095|NCT01772550|8705924|P2|Overall Study|Adverse Event|0
2516096|NCT01772550|8705925|P1|Overall Study|Adverse Event|0
2516097|NCT01772550|8705923|P3|Overall Study|Unable to insert IV in antecubital vein|5
2516098|NCT01772550|8705924|P2|Overall Study|Unable to insert IV in antecubital vein|1
2516099|NCT01772550|8705925|P1|Overall Study|Unable to insert IV in antecubital vein|1
2516100|NCT01772537|8705966|P3|Overall Study|unsuccessful lumbar drain placement|0
2516101|NCT01772537|8705967|P2|Overall Study|unsuccessful lumbar drain placement|0
2516102|NCT01772537|8705968|P1|Overall Study|unsuccessful lumbar drain placement|1
2516103|NCT01772472|8705984|P2|Overall Study|Ongoing|635
2516104|NCT01772472|8705985|P1|Overall Study|Ongoing|597
2516105|NCT01772472|8705984|P2|Overall Study|Withdrawal by Subject|50
2516106|NCT01772472|8705985|P1|Overall Study|Withdrawal by Subject|72
2516107|NCT01772472|8705984|P2|Overall Study|Lost to Follow-up|8
2516108|NCT01772472|8705985|P1|Overall Study|Lost to Follow-up|12
2516109|NCT01772472|8705984|P2|Overall Study|Other|5
2516110|NCT01772472|8705985|P1|Overall Study|Other|5
2516111|NCT01772472|8705984|P2|Overall Study|Physician Decision|3
2516112|NCT01772472|8705985|P1|Overall Study|Physician Decision|1
2516113|NCT01772472|8705984|P2|Overall Study|Death|42
2516114|NCT01772472|8705985|P1|Overall Study|Death|56
2516115|NCT01772368|8705997|P1|Overall Study|Other|1
2516116|NCT01772368|8705997|P1|Overall Study|Protocol Violation|2
2516117|NCT01772368|8705997|P1|Overall Study|Withdrawal by Subject|3
2516118|NCT01772368|8705997|P1|Overall Study|Adverse Event|1
2516119|NCT01772316|8706043|P1|Overall Study|Withdrawn by sponsor decision|5
2516120|NCT01772316|8706043|P1|Overall Study|Inform consent withdrawn|1
2516122|NCT01772147|8706064|P3|Overall Study|Lack of Efficacy|6
2516123|NCT01772147|8706065|P2|Overall Study|Lack of Efficacy|6
2516124|NCT01772147|8706066|P1|Overall Study|Lack of Efficacy|8
2516125|NCT01772147|8706064|P3|Overall Study|Protocol Deviation|1
2516126|NCT01772147|8706065|P2|Overall Study|Protocol Deviation|1
2516127|NCT01772147|8706066|P1|Overall Study|Protocol Deviation|2
2516128|NCT01772147|8706064|P3|Overall Study|Lost to Follow-up|1
2516129|NCT01772147|8706065|P2|Overall Study|Lost to Follow-up|0
2516130|NCT01772147|8706066|P1|Overall Study|Lost to Follow-up|1
2516131|NCT01772147|8706064|P3|Overall Study|Withdrew Consent|4
2516132|NCT01772147|8706065|P2|Overall Study|Withdrew Consent|8
2516133|NCT01772147|8706066|P1|Overall Study|Withdrew Consent|7
2516134|NCT01772147|8706064|P3|Overall Study|Adverse Event|6
2516135|NCT01772147|8706065|P2|Overall Study|Adverse Event|10
2516136|NCT01772147|8706066|P1|Overall Study|Adverse Event|13
2516137|NCT01772134|8706086|P3|Overall Study|Randomized Study Medication Not Received|1
2516138|NCT01772134|8706087|P2|Overall Study|Randomized Study Medication Not Received|0
2516139|NCT01772134|8706088|P1|Overall Study|Randomized Study Medication Not Received|2
2516140|NCT01772134|8706086|P3|Overall Study|Protocol-defined Stopping Criteria|0
2516141|NCT01772134|8706087|P2|Overall Study|Protocol-defined Stopping Criteria|0
2516142|NCT01772134|8706088|P1|Overall Study|Protocol-defined Stopping Criteria|1
2516143|NCT01772134|8706086|P3|Overall Study|Lack of Efficacy|3
2516144|NCT01772134|8706087|P2|Overall Study|Lack of Efficacy|5
2516145|NCT01772134|8706088|P1|Overall Study|Lack of Efficacy|11
2516146|NCT01772134|8706086|P3|Overall Study|Protocol Deviation|3
2516147|NCT01772134|8706087|P2|Overall Study|Protocol Deviation|3
2516148|NCT01772134|8706088|P1|Overall Study|Protocol Deviation|4
2516149|NCT01772134|8706086|P3|Overall Study|Lost to Follow-up|0
2516150|NCT01772134|8706087|P2|Overall Study|Lost to Follow-up|0
2516151|NCT01772134|8706088|P1|Overall Study|Lost to Follow-up|2
2516152|NCT01772134|8706086|P3|Overall Study|Withdrew Consent|5
2516153|NCT01772134|8706087|P2|Overall Study|Withdrew Consent|1
2516154|NCT01772134|8706088|P1|Overall Study|Withdrew Consent|3
2516155|NCT01772134|8706086|P3|Overall Study|Adverse Event|10
2516156|NCT01772134|8706087|P2|Overall Study|Adverse Event|5
2516157|NCT01772134|8706088|P1|Overall Study|Adverse Event|6
2516158|NCT01771913|8706131|P2|Overall Study|Withdrawal by Subject|0
2516159|NCT01771913|8706132|P1|Overall Study|Withdrawal by Subject|1
2516160|NCT01771809|8706144|P2|Overall Study|Other (other)|5
2516161|NCT01771809|8706145|P1|Overall Study|Other (other)|9
2516162|NCT01771809|8706144|P2|Overall Study|Death|0
2516163|NCT01771809|8706145|P1|Overall Study|Death|1
2516164|NCT01771809|8706144|P2|Overall Study|Other (Insufficient clinical response)|20
2516165|NCT01771809|8706145|P1|Overall Study|Other (Insufficient clinical response)|22
2516166|NCT01771809|8706144|P2|Overall Study|Lost to Follow-up|3
2516167|NCT01771809|8706145|P1|Overall Study|Lost to Follow-up|1
2516168|NCT01771809|8706144|P2|Overall Study|Withdrawal by Subject|42
2516169|NCT01771809|8706145|P1|Overall Study|Withdrawal by Subject|34
2516170|NCT01771809|8706144|P2|Overall Study|Protocol Violation|1
2516171|NCT01771809|8706145|P1|Overall Study|Protocol Violation|0
2516172|NCT01771809|8706144|P2|Overall Study|Adverse Event|12
2516173|NCT01771809|8706145|P1|Overall Study|Adverse Event|4
2516174|NCT01771250|8706164|P2|Period 1|Met exclusion criteria|0
2516175|NCT01771250|8706165|P1|Period 1|Met exclusion criteria|1
2516176|NCT01770860|8706181|P1|Overall Study|Administrative decision made by the PI|1
2516177|NCT01770860|8706181|P1|Overall Study|Lost to Follow-up|1
2516178|NCT01770860|8706181|P1|Overall Study|Withdrawal by Subject|4
2516179|NCT01770743|8706229|P5|Overall Study|Moving Out of State|0
2516180|NCT01770743|8706230|P4|Overall Study|Moving Out of State|0
2516181|NCT01770743|8706231|P3|Overall Study|Moving Out of State|0
2516182|NCT01770743|8706232|P2|Overall Study|Moving Out of State|1
2516183|NCT01770743|8706233|P1|Overall Study|Moving Out of State|0
2516184|NCT01770743|8706229|P5|Overall Study|Sponsor Terminated Subject|0
2516185|NCT01770743|8706230|P4|Overall Study|Sponsor Terminated Subject|1
2516186|NCT01770743|8706231|P3|Overall Study|Sponsor Terminated Subject|0
2516187|NCT01770743|8706232|P2|Overall Study|Sponsor Terminated Subject|0
2516188|NCT01770743|8706233|P1|Overall Study|Sponsor Terminated Subject|1
2516189|NCT01770743|8706229|P5|Overall Study|Lost to Follow-up|1
2516190|NCT01770743|8706230|P4|Overall Study|Lost to Follow-up|0
2516191|NCT01770743|8706231|P3|Overall Study|Lost to Follow-up|0
2516192|NCT01770743|8706232|P2|Overall Study|Lost to Follow-up|2
2516193|NCT01770743|8706233|P1|Overall Study|Lost to Follow-up|0
2516194|NCT01770743|8706229|P5|Overall Study|Withdrawal by Subject|1
2516195|NCT01770743|8706230|P4|Overall Study|Withdrawal by Subject|1
2516196|NCT01770743|8706231|P3|Overall Study|Withdrawal by Subject|1
2516197|NCT01770743|8706232|P2|Overall Study|Withdrawal by Subject|0
2516198|NCT01770743|8706233|P1|Overall Study|Withdrawal by Subject|0
2516199|NCT01770743|8706229|P5|Overall Study|Adverse Event|0
2516200|NCT01770743|8706230|P4|Overall Study|Adverse Event|0
2516201|NCT01770743|8706231|P3|Overall Study|Adverse Event|0
2516202|NCT01770743|8706232|P2|Overall Study|Adverse Event|0
2516203|NCT01770743|8706233|P1|Overall Study|Adverse Event|1
2516204|NCT01770509|8706335|P2|Overall Study|Lost to Follow-up|2
2516205|NCT01770509|8706336|P1|Overall Study|Lost to Follow-up|1
2516206|NCT01770509|8706335|P2|Overall Study|Injury|1
2516207|NCT01770509|8706336|P1|Overall Study|Injury|0
2516208|NCT01770392|8706372|P1|Washout Period of at Least 14 Days|Adverse Event|1
2516209|NCT01770379|8706387|P3|Overall Study|Adverse Event|2
2516210|NCT01770379|8706388|P2|Overall Study|Adverse Event|3
2516211|NCT01770379|8706389|P1|Overall Study|Adverse Event|1
2516212|NCT01770379|8706387|P3|Overall Study|Lack of Efficacy|6
2516213|NCT01770379|8706388|P2|Overall Study|Lack of Efficacy|6
2516214|NCT01770379|8706389|P1|Overall Study|Lack of Efficacy|8
2516215|NCT01770379|8706387|P3|Overall Study|Lost to Follow-up|2
2516216|NCT01770379|8706388|P2|Overall Study|Lost to Follow-up|0
2516217|NCT01770379|8706389|P1|Overall Study|Lost to Follow-up|0
2516218|NCT01770379|8706387|P3|Overall Study|Physician Decision|2
2516219|NCT01770379|8706388|P2|Overall Study|Physician Decision|1
2516220|NCT01770379|8706389|P1|Overall Study|Physician Decision|0
2516221|NCT01770379|8706387|P3|Overall Study|Protocol Violation|1
2516222|NCT01770379|8706388|P2|Overall Study|Protocol Violation|1
2516223|NCT01770379|8706389|P1|Overall Study|Protocol Violation|0
2516224|NCT01770379|8706387|P3|Overall Study|study terminated by sponsor|22
2516225|NCT01770379|8706388|P2|Overall Study|study terminated by sponsor|23
2516226|NCT01770379|8706389|P1|Overall Study|study terminated by sponsor|22
2516227|NCT01770379|8706387|P3|Overall Study|Withdrawal by Subject|7
2516228|NCT01770379|8706388|P2|Overall Study|Withdrawal by Subject|10
2516229|NCT01770379|8706389|P1|Overall Study|Withdrawal by Subject|7
2516230|NCT01770379|8706387|P3|Overall Study|Technical issues|0
2516231|NCT01770379|8706388|P2|Overall Study|Technical issues|0
2516232|NCT01770379|8706389|P1|Overall Study|Technical issues|1
2516233|NCT01770353|8706417|P2|Overall Study|Toxicity related diarrhoea + progression|1
2516234|NCT01770353|8706418|P1|Overall Study|Toxicity related diarrhoea + progression|0
2516235|NCT01770353|8706417|P2|Overall Study|Clinical deterioration|6
2516236|NCT01770353|8706418|P1|Overall Study|Clinical deterioration|3
2516237|NCT01770353|8706417|P2|Overall Study|Physician Decision|3
2516238|NCT01770353|8706418|P1|Overall Study|Physician Decision|0
2516239|NCT01770353|8706417|P2|Overall Study|Protocol Violation|0
2516240|NCT01770353|8706418|P1|Overall Study|Protocol Violation|1
2516241|NCT01770353|8706417|P2|Overall Study|Adverse Event|1
2516242|NCT01770353|8706418|P1|Overall Study|Adverse Event|0
2516243|NCT01770353|8706417|P2|Overall Study|Progressive disease|1
2516244|NCT01770353|8706418|P1|Overall Study|Progressive disease|2
2516245|NCT01770145|8706477|P1|Treatment|Withdrawal by Subject|1
2516246|NCT01770145|8706477|P1|Treatment|Adverse Event|3
2516247|NCT01770145|8706477|P1|Baseline|Unable to define optimal dose|4
2516248|NCT01770145|8706477|P1|Baseline|Lost to Follow-up|1
2516249|NCT01770145|8706477|P1|Baseline|Withdrawal by Subject|1
2516250|NCT01770145|8706477|P1|Baseline|Adverse Event|20
2516251|NCT01769508|8706533|P1|Overall Study|Lost to Follow-up|1
2516252|NCT01769508|8706533|P1|Overall Study|Adverse Event|1
2516253|NCT01769508|8706533|P1|Overall Study|Withdrawal by Subject|1
2516254|NCT01769508|8706533|P1|Overall Study|Death|3
2516255|NCT01769469|8706542|P1|Overall Study|Subject Confirmed HIV Positive|3
2516256|NCT01769469|8706542|P1|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7
2516257|NCT01769469|8706542|P1|Overall Study|Lost to Follow-up|17
2516258|NCT01769469|8706542|P1|Overall Study|Moved Out Of Area|3
2516259|NCT01769469|8706542|P1|Overall Study|Consent Withdrawn|5
2516260|NCT01769456|8706702|P1|Overall Study|Parental request to youth to withdraw|1
2516261|NCT01769456|8706702|P1|Overall Study|No wk 0 visit w/in 30 days of screening|5
2516262|NCT01769456|8706702|P1|Overall Study|Moved out of the area|3
2516263|NCT01769456|8706702|P1|Overall Study|Did not receive PCC intervention|6
2516264|NCT01769456|8706702|P1|Overall Study|Withdrawal by Subject|3
2516265|NCT01769456|8706702|P1|Overall Study|Lost to Follow-up|19
2516266|NCT01769443|8706723|P2|Overall Study|Study closure|0
2516267|NCT01769443|8706724|P1|Overall Study|Study closure|1
2516268|NCT01769404|8706766|P2|Treatment Period 2|Sponsor decision|0
2516269|NCT01769404|8706767|P1|Treatment Period 2|Sponsor decision|7
2516270|NCT01769404|8706766|P2|Treatment Period 1|Sponsor decision|0
2516271|NCT01769404|8706767|P1|Treatment Period 1|Sponsor decision|1
2516272|NCT01769404|8706766|P2|Treatment Period 1|Withdrawal by Subject|0
2516273|NCT01769404|8706767|P1|Treatment Period 1|Withdrawal by Subject|3
2516274|NCT01769404|8706766|P2|Treatment Period 1|Did not meet eligibility criteria|0
2516275|NCT01769404|8706767|P1|Treatment Period 1|Did not meet eligibility criteria|1
2516276|NCT01769391|8706789|P2|Overall Study|Investigator Decision|0
2516277|NCT01769391|8706790|P1|Overall Study|Investigator Decision|2
2516278|NCT01769391|8706789|P2|Overall Study|Withdrawal by Subject|3
2516279|NCT01769391|8706790|P1|Overall Study|Withdrawal by Subject|4
2516280|NCT01769391|8706789|P2|Overall Study|Progressive Disease|2
2516281|NCT01769391|8706790|P1|Overall Study|Progressive Disease|1
2516282|NCT01769391|8706789|P2|Overall Study|Adverse Event|3
2516283|NCT01769391|8706790|P1|Overall Study|Adverse Event|0
2516284|NCT01769391|8706789|P2|Overall Study|Death|1
2516285|NCT01769391|8706790|P1|Overall Study|Death|10
2516286|NCT01769378|8706809|P2|Overall Study|Lost to Follow-up|0
2516287|NCT01769378|8706810|P1|Overall Study|Lost to Follow-up|2
2516288|NCT01769378|8706809|P2|Overall Study|Sponsor Decision|0
2516289|NCT01769378|8706810|P1|Overall Study|Sponsor Decision|1
2516290|NCT01769378|8706809|P2|Overall Study|Withdrawal by Subject|3
2516291|NCT01769378|8706810|P1|Overall Study|Withdrawal by Subject|10
2516292|NCT01769378|8706809|P2|Overall Study|Protocol Violation|1
2516293|NCT01769378|8706810|P1|Overall Study|Protocol Violation|1
2516294|NCT01769378|8706809|P2|Overall Study|Entry criteria not met|0
2516295|NCT01769378|8706810|P1|Overall Study|Entry criteria not met|1
2516296|NCT01769378|8706809|P2|Overall Study|Adverse Event|0
2516297|NCT01769378|8706810|P1|Overall Study|Adverse Event|10
2516298|NCT01769339|8706890|P1|Overall Study|Adverse Event|1
2516299|NCT01769339|8706890|P1|Overall Study|Lost to Follow-up|42
2516300|NCT01769326|8706901|P4|Overall Study|Got sick and could not complete study|0
2516301|NCT01769326|8706902|P3|Overall Study|Got sick and could not complete study|1
2516302|NCT01769326|8706903|P2|Overall Study|Got sick and could not complete study|0
2516303|NCT01769326|8706904|P1|Overall Study|Got sick and could not complete study|0
2516304|NCT01769326|8706901|P4|Overall Study|got a job|0
2516305|NCT01769326|8706902|P3|Overall Study|got a job|0
2516306|NCT01769326|8706903|P2|Overall Study|got a job|1
2516307|NCT01769326|8706904|P1|Overall Study|got a job|0
2516308|NCT01769326|8706901|P4|Overall Study|unrelated injry|0
2516309|NCT01769326|8706902|P3|Overall Study|unrelated injry|0
2516310|NCT01769326|8706903|P2|Overall Study|unrelated injry|1
2516311|NCT01769326|8706904|P1|Overall Study|unrelated injry|1
2516312|NCT01769326|8706901|P4|Overall Study|Lost to Follow-up|0
2516313|NCT01769326|8706902|P3|Overall Study|Lost to Follow-up|0
2516314|NCT01769326|8706903|P2|Overall Study|Lost to Follow-up|2
2516315|NCT01769326|8706904|P1|Overall Study|Lost to Follow-up|1
2516316|NCT01769196|8707049|P2|Overall Study|Withdrew consent|40
2516317|NCT01769196|8707050|P1|Overall Study|Withdrew consent|36
2516318|NCT01769196|8707049|P2|Overall Study|Participant never dosed with study drug|0
2516319|NCT01769196|8707050|P1|Overall Study|Participant never dosed with study drug|1
2516320|NCT01769196|8707049|P2|Overall Study|Study terminated by sponsor|161
2516321|NCT01769196|8707050|P1|Overall Study|Study terminated by sponsor|160
2516322|NCT01769196|8707049|P2|Overall Study|Protocol Violation|3
2516323|NCT01769196|8707050|P1|Overall Study|Protocol Violation|0
2516324|NCT01769196|8707049|P2|Overall Study|Protocol defined criteria for withdrawal|11
2516325|NCT01769196|8707050|P1|Overall Study|Protocol defined criteria for withdrawal|9
2516326|NCT01769196|8707049|P2|Overall Study|Progressive disease|6
2516327|NCT01769196|8707050|P1|Overall Study|Progressive disease|11
2516328|NCT01769196|8707049|P2|Overall Study|Lack of Efficacy|2
2516329|NCT01769196|8707050|P1|Overall Study|Lack of Efficacy|3
2516330|NCT01769196|8707049|P2|Overall Study|Investigator Discretion|3
2516331|NCT01769196|8707050|P1|Overall Study|Investigator Discretion|7
2516332|NCT01769196|8707049|P2|Overall Study|Death|26
2516333|NCT01769196|8707050|P1|Overall Study|Death|21
2516334|NCT01769196|8707049|P2|Overall Study|Adverse Event|20
2516335|NCT01769196|8707050|P1|Overall Study|Adverse Event|24
2516336|NCT01769105|8707080|P2|Cross-over|Lost to Follow-up|0
2516337|NCT01769105|8707081|P1|Cross-over|Lost to Follow-up|5
2516338|NCT01769105|8707080|P2|First Intervention|Protocol Violation|2
2516339|NCT01769105|8707081|P1|First Intervention|Protocol Violation|2
2516340|NCT01768858|8707100|P1|Overall Study|Withdrawal by Subject|1
2516341|NCT01768858|8707100|P1|Overall Study|Exanthema|1
2516342|NCT01768858|8707100|P1|Overall Study|Aggravation of NY Heart Assoc 3 status|1
2516343|NCT01768858|8707100|P1|Overall Study|Participant moved to Germany|1
2516344|NCT01768858|8707100|P1|Overall Study|Serious Adverse Event|1
2516345|NCT01768858|8707100|P1|Overall Study|Lack of Efficacy|8
2516346|NCT01768858|8707100|P1|Overall Study|Lost to Follow-up|9
2516347|NCT01768676|8707151|P2|Overall Study|Withdrawal by Subject|10
2516348|NCT01768676|8707152|P1|Overall Study|Withdrawal by Subject|3
2516349|NCT01768676|8707151|P2|Overall Study|Physician Decision|1
2516350|NCT01768676|8707152|P1|Overall Study|Physician Decision|4
2516351|NCT01768676|8707151|P2|Overall Study|Protocol Violation|1
2516352|NCT01768676|8707152|P1|Overall Study|Protocol Violation|1
2516353|NCT01768676|8707151|P2|Overall Study|Lost to Follow-up|16
2516354|NCT01768676|8707152|P1|Overall Study|Lost to Follow-up|13
2516355|NCT01768676|8707151|P2|Overall Study|Adverse Event|3
2516356|NCT01768676|8707152|P1|Overall Study|Adverse Event|3
2516357|NCT01768637|8707168|P2|Overall Study|Difficult blood draw|0
2516358|NCT01768637|8707169|P1|Overall Study|Difficult blood draw|1
2516359|NCT01768637|8707168|P2|Overall Study|Lost to Follow-up|7
2516360|NCT01768637|8707169|P1|Overall Study|Lost to Follow-up|2
2516361|NCT01768572|8707182|P3|Overall Study|Other, Not due to an adverse event|1
2516362|NCT01768572|8707183|P2|Overall Study|Other, Not due to an adverse event|1
2516363|NCT01768572|8707184|P1|Overall Study|Other, Not due to an adverse event|1
2516364|NCT01768572|8707182|P3|Overall Study|Lack of Efficacy|1
2516365|NCT01768572|8707183|P2|Overall Study|Lack of Efficacy|3
2516366|NCT01768572|8707184|P1|Overall Study|Lack of Efficacy|1
2516367|NCT01768572|8707182|P3|Overall Study|Adverse Event|4
2516368|NCT01768572|8707183|P2|Overall Study|Adverse Event|8
2516369|NCT01768572|8707184|P1|Overall Study|Adverse Event|7
2516370|NCT01768559|8707195|P3|Overall Study|Other than specified|5
2516371|NCT01768559|8707196|P2|Overall Study|Other than specified|8
2516372|NCT01768559|8707197|P1|Overall Study|Other than specified|9
2516373|NCT01768559|8707195|P3|Overall Study|Poor compliance to protocol|2
2516374|NCT01768559|8707196|P2|Overall Study|Poor compliance to protocol|3
2516375|NCT01768559|8707197|P1|Overall Study|Poor compliance to protocol|0
2516376|NCT01768559|8707195|P3|Overall Study|Lack of Efficacy|0
2516377|NCT01768559|8707196|P2|Overall Study|Lack of Efficacy|4
2516378|NCT01768559|8707197|P1|Overall Study|Lack of Efficacy|6
2516379|NCT01768559|8707195|P3|Overall Study|Adverse Event|5
2516380|NCT01768559|8707196|P2|Overall Study|Adverse Event|2
2516381|NCT01768559|8707197|P1|Overall Study|Adverse Event|15
2516382|NCT01768559|8707195|P3|Overall Study|Randomized but not treated|1
2516383|NCT01768559|8707196|P2|Overall Study|Randomized but not treated|0
2516384|NCT01768559|8707197|P1|Overall Study|Randomized but not treated|0
2516385|NCT01768286|8707278|P4|Overall Study|Withdrew Consent|0
2516386|NCT01768286|8707279|P3|Overall Study|Withdrew Consent|1
2516387|NCT01768286|8707280|P2|Overall Study|Withdrew Consent|0
2516388|NCT01768286|8707281|P1|Overall Study|Withdrew Consent|0
2516389|NCT01768286|8707278|P4|Overall Study|Lack of Efficacy|1
2516390|NCT01768286|8707279|P3|Overall Study|Lack of Efficacy|0
2516391|NCT01768286|8707280|P2|Overall Study|Lack of Efficacy|4
2516392|NCT01768286|8707281|P1|Overall Study|Lack of Efficacy|7
2516393|NCT01768286|8707278|P4|Overall Study|Randomized But Not Treated|0
2516394|NCT01768286|8707279|P3|Overall Study|Randomized But Not Treated|1
2516395|NCT01768286|8707280|P2|Overall Study|Randomized But Not Treated|0
2516396|NCT01768286|8707281|P1|Overall Study|Randomized But Not Treated|0
2516397|NCT01768117|8707343|P1|Overall Study|Protocol Violation|3
2516398|NCT01768117|8707343|P1|Overall Study|Withdrawal by Subject|2
2516399|NCT01768117|8707343|P1|Overall Study|Lost to Follow-up|1
2516400|NCT01767987|8707407|P2|Overall Study|Physician Decision|1
2516401|NCT01767987|8707408|P1|Overall Study|Physician Decision|4
2516402|NCT01767597|8707482|P2|Overall Study|Withdrawal by Subject|0
2516403|NCT01767597|8707483|P1|Overall Study|Withdrawal by Subject|1
2516404|NCT01767597|8707482|P2|Overall Study|Incomplete intervention|1
2516405|NCT01767597|8707483|P1|Overall Study|Incomplete intervention|3
2516406|NCT01767519|8707492|P3|Overall Study|Adverse Event|1
2516407|NCT01767519|8707493|P2|Overall Study|Adverse Event|5
2516408|NCT01767519|8707494|P1|Overall Study|Adverse Event|5
2516409|NCT01767519|8707492|P3|Overall Study|Lack of Efficacy|0
2516410|NCT01767519|8707493|P2|Overall Study|Lack of Efficacy|0
2516411|NCT01767519|8707494|P1|Overall Study|Lack of Efficacy|1
2516412|NCT01767519|8707492|P3|Overall Study|Lost to Follow-up|2
2516413|NCT01767519|8707493|P2|Overall Study|Lost to Follow-up|1
2516414|NCT01767519|8707494|P1|Overall Study|Lost to Follow-up|3
2516415|NCT01767519|8707492|P3|Overall Study|Personal Reasons|0
2516416|NCT01767519|8707493|P2|Overall Study|Personal Reasons|0
2516417|NCT01767519|8707494|P1|Overall Study|Personal Reasons|1
2516418|NCT01767519|8707492|P3|Overall Study|Protocol Violation|0
2516419|NCT01767519|8707493|P2|Overall Study|Protocol Violation|3
2516420|NCT01767519|8707494|P1|Overall Study|Protocol Violation|0
2516421|NCT01767519|8707492|P3|Overall Study|Other Reasons|2
2516422|NCT01767519|8707493|P2|Overall Study|Other Reasons|4
2516423|NCT01767519|8707494|P1|Overall Study|Other Reasons|4
2516424|NCT01767467|8707535|P2|End of Study Phase (up to Month 13)|Subject Unavailable|2
2516425|NCT01767467|8707536|P1|End of Study Phase (up to Month 13)|Subject Unavailable|0
2516426|NCT01767467|8707535|P2|End of Study Phase (up to Month 13)|Physician Decision|0
2516427|NCT01767467|8707536|P1|End of Study Phase (up to Month 13)|Physician Decision|1
2516428|NCT01767467|8707535|P2|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1
2516429|NCT01767467|8707536|P1|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0
2516430|NCT01767467|8707535|P2|End of Study Phase (up to Month 13)|Lost to Follow-up|4
2516431|NCT01767467|8707536|P1|End of Study Phase (up to Month 13)|Lost to Follow-up|6
2516432|NCT01767467|8707535|P2|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3
2516433|NCT01767467|8707536|P1|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0
2516434|NCT01767467|8707535|P2|End of Study Phase (up to Month 13)|Withdrawal by Subject|14
2516435|NCT01767467|8707536|P1|End of Study Phase (up to Month 13)|Withdrawal by Subject|9
2516436|NCT01767467|8707535|P2|End of Study Phase (up to Month 13)|Protocol Violation|0
2516437|NCT01767467|8707536|P1|End of Study Phase (up to Month 13)|Protocol Violation|2
2516438|NCT01767467|8707535|P2|End of Study Phase (up to Month 13)|Adverse Event|39
2516439|NCT01767467|8707536|P1|End of Study Phase (up to Month 13)|Adverse Event|29
2516440|NCT01767467|8707535|P2|Vaccination Phase (up to Month 2)|Subject unavailable|1
2516441|NCT01767467|8707536|P1|Vaccination Phase (up to Month 2)|Subject unavailable|0
2516442|NCT01767467|8707535|P2|Vaccination Phase (up to Month 2)|Physician Decision|0
2516443|NCT01767467|8707536|P1|Vaccination Phase (up to Month 2)|Physician Decision|1
2516444|NCT01767467|8707535|P2|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1
2516445|NCT01767467|8707536|P1|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0
2516446|NCT01767467|8707535|P2|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10
2516447|NCT01767467|8707536|P1|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7
2516448|NCT01767467|8707535|P2|Vaccination Phase (up to Month 2)|Protocol Violation|0
2516449|NCT01767467|8707536|P1|Vaccination Phase (up to Month 2)|Protocol Violation|1
2516450|NCT01767467|8707535|P2|Vaccination Phase (up to Month 2)|Adverse Event|8
2516451|NCT01767467|8707536|P1|Vaccination Phase (up to Month 2)|Adverse Event|8
2516452|NCT01767376|8707592|P3|Overall Study|Withdrawal by Subject|0
2516453|NCT01767376|8707593|P2|Overall Study|Withdrawal by Subject|1
2516454|NCT01767376|8707594|P1|Overall Study|Withdrawal by Subject|1
2516455|NCT01767376|8707592|P3|Overall Study|Lost to Follow-up|0
2516456|NCT01767376|8707593|P2|Overall Study|Lost to Follow-up|2
2516457|NCT01767376|8707594|P1|Overall Study|Lost to Follow-up|3
2516458|NCT01767194|8707660|P2|Overall Study|Criteria not met on time for next cycle|1
2516459|NCT01767194|8707661|P1|Overall Study|Criteria not met on time for next cycle|0
2516460|NCT01767194|8707660|P2|Overall Study|Refusal by patient/parent|4
2516461|NCT01767194|8707661|P1|Overall Study|Refusal by patient/parent|2
2516462|NCT01767194|8707660|P2|Overall Study|Ineligible|1
2516463|NCT01767194|8707661|P1|Overall Study|Ineligible|1
2516464|NCT01767194|8707660|P2|Overall Study|Withdrawal by Subject|1
2516465|NCT01767194|8707661|P1|Overall Study|Withdrawal by Subject|0
2516466|NCT01767194|8707660|P2|Overall Study|Physician Decision|23
2516467|NCT01767194|8707661|P1|Overall Study|Physician Decision|2
2516468|NCT01767194|8707660|P2|Overall Study|Lack of Efficacy|11
2516469|NCT01767194|8707661|P1|Overall Study|Lack of Efficacy|12
2516470|NCT01767194|8707660|P2|Overall Study|Death|1
2516471|NCT01767194|8707661|P1|Overall Study|Death|0
2516472|NCT01767194|8707660|P2|Overall Study|Adverse Event|1
2516473|NCT01767194|8707661|P1|Overall Study|Adverse Event|1
2516474|NCT01767116|8707685|P2|Overall Study|Lost to Follow-up|2
2516475|NCT01767116|8707686|P1|Overall Study|Lost to Follow-up|2
2516476|NCT01766921|8707744|P2|Overall Study|Withdrawal by Subject|5
2516477|NCT01766921|8707745|P1|Overall Study|Withdrawal by Subject|14
2516478|NCT01766921|8707744|P2|Overall Study|Protocol Violation|1
2516479|NCT01766921|8707745|P1|Overall Study|Protocol Violation|1
2516480|NCT01766921|8707744|P2|Overall Study|Unclassified|2
2516481|NCT01766921|8707745|P1|Overall Study|Unclassified|2
2516482|NCT01766921|8707744|P2|Overall Study|Lost to Follow-up|3
2516483|NCT01766921|8707745|P1|Overall Study|Lost to Follow-up|1
2516484|NCT01766921|8707744|P2|Overall Study|Death|1
2516485|NCT01766921|8707745|P1|Overall Study|Death|1
2516486|NCT01766921|8707744|P2|Overall Study|Administrative Reason|5
2516487|NCT01766921|8707745|P1|Overall Study|Administrative Reason|5
2516488|NCT01766817|8707767|P3|Overall Study|Other|0
2516489|NCT01766817|8707768|P2|Overall Study|Other|0
2516490|NCT01766817|8707769|P1|Overall Study|Other|1
2516491|NCT01766817|8707767|P3|Overall Study|Physician Decision|4
2516492|NCT01766817|8707768|P2|Overall Study|Physician Decision|3
2516493|NCT01766817|8707769|P1|Overall Study|Physician Decision|3
2516494|NCT01766817|8707767|P3|Overall Study|Subject non-compliance|2
2516495|NCT01766817|8707768|P2|Overall Study|Subject non-compliance|1
2516496|NCT01766817|8707769|P1|Overall Study|Subject non-compliance|0
2516497|NCT01766817|8707767|P3|Overall Study|Withdrawal by Subject|3
2516498|NCT01766817|8707768|P2|Overall Study|Withdrawal by Subject|0
2516499|NCT01766817|8707769|P1|Overall Study|Withdrawal by Subject|2
2516500|NCT01766817|8707767|P3|Overall Study|Unable to take study drug|0
2516501|NCT01766817|8707768|P2|Overall Study|Unable to take study drug|1
2516502|NCT01766817|8707769|P1|Overall Study|Unable to take study drug|0
2516503|NCT01766817|8707767|P3|Overall Study|Death|0
2516504|NCT01766817|8707768|P2|Overall Study|Death|1
2516505|NCT01766817|8707769|P1|Overall Study|Death|1
2516506|NCT01766817|8707767|P3|Overall Study|Drug-unrelated adverse event|3
2516507|NCT01766817|8707768|P2|Overall Study|Drug-unrelated adverse event|3
2516508|NCT01766817|8707769|P1|Overall Study|Drug-unrelated adverse event|3
2516509|NCT01766817|8707767|P3|Overall Study|Drug-related adverse event|1
2516510|NCT01766817|8707768|P2|Overall Study|Drug-related adverse event|2
2516511|NCT01766817|8707769|P1|Overall Study|Drug-related adverse event|1
2516512|NCT01766778|8707820|P2|Overall Study|Withdrawal by Subject|0
2516513|NCT01766778|8707821|P1|Overall Study|Withdrawal by Subject|1
2516514|NCT01766778|8707820|P2|Overall Study|Adverse Event|4
2516515|NCT01766778|8707821|P1|Overall Study|Adverse Event|4
2516516|NCT01766401|8707875|P2|Overall Study|Pregnancy|1
2516517|NCT01766401|8707876|P1|Overall Study|Pregnancy|1
2516518|NCT01766401|8707875|P2|Overall Study|Lost to Follow-up|11
2516519|NCT01766401|8707876|P1|Overall Study|Lost to Follow-up|10
2516520|NCT01766401|8707875|P2|Overall Study|Withdrawal by Subject|12
2516521|NCT01766401|8707876|P1|Overall Study|Withdrawal by Subject|15
2516522|NCT01766401|8707875|P2|Overall Study|Protocol Violation|8
2516523|NCT01766401|8707876|P1|Overall Study|Protocol Violation|3
2516524|NCT01766401|8707875|P2|Overall Study|Lack of Efficacy|2
2516525|NCT01766401|8707876|P1|Overall Study|Lack of Efficacy|1
2516526|NCT01766401|8707875|P2|Overall Study|Adverse Event|22
2516527|NCT01766401|8707876|P1|Overall Study|Adverse Event|7
2516528|NCT01766336|8707886|P2|Overall Study|Withdrawal by Subject|15
2516529|NCT01766336|8707887|P1|Overall Study|Withdrawal by Subject|18
2516530|NCT01766336|8707886|P2|Overall Study|Sponsor Decision|43
2516531|NCT01766336|8707887|P1|Overall Study|Sponsor Decision|52
2516532|NCT01766336|8707886|P2|Overall Study|Protocol Violation|1
2516533|NCT01766336|8707887|P1|Overall Study|Protocol Violation|0
2516534|NCT01766336|8707886|P2|Overall Study|Physician Decision|2
2516535|NCT01766336|8707887|P1|Overall Study|Physician Decision|4
2516536|NCT01766336|8707886|P2|Overall Study|Lost to Follow-up|3
2516537|NCT01766336|8707887|P1|Overall Study|Lost to Follow-up|1
2516538|NCT01766336|8707886|P2|Overall Study|Death|3
2516539|NCT01766336|8707887|P1|Overall Study|Death|4
2516540|NCT01766336|8707886|P2|Overall Study|Adverse Event|8
2516541|NCT01766336|8707887|P1|Overall Study|Adverse Event|11
2516542|NCT01766310|8707895|P2|Overall Study|Lost to Follow-up|3
2516543|NCT01766310|8707896|P1|Overall Study|Lost to Follow-up|1
2516544|NCT01766206|8707926|P1|Overall Study|Withdrawal and inappropriate enrollment|1
2516545|NCT01766206|8707926|P1|Overall Study|Inappropriate enrollment|18
2516546|NCT01766206|8707926|P1|Overall Study|Lost to Follow-up|10
2516547|NCT01766206|8707926|P1|Overall Study|Withdrawal by Subject|22
2516548|NCT01766050|8707953|P1|Overall Study|Withdrawal by Subject|2
2516549|NCT01766050|8707953|P1|Overall Study|Lost to Follow-up|1
2516550|NCT01766050|8707953|P1|Overall Study|Adverse Event|1
2516551|NCT01766037|8708088|P2|Overall Study|nausea / discomfort|0
2516552|NCT01766037|8708089|P1|Overall Study|nausea / discomfort|3
2516553|NCT01766037|8708088|P2|Overall Study|medical - unrelated|2
2516554|NCT01766037|8708089|P1|Overall Study|medical - unrelated|1
2516555|NCT01766037|8708088|P2|Overall Study|Moved from area|0
2516556|NCT01766037|8708089|P1|Overall Study|Moved from area|5
2516557|NCT01766037|8708088|P2|Overall Study|Withdrawal by Subject|16
2516558|NCT01766037|8708089|P1|Overall Study|Withdrawal by Subject|18
2516559|NCT01766037|8708088|P2|Overall Study|Physician Decision|1
2516560|NCT01766037|8708089|P1|Overall Study|Physician Decision|0
2516561|NCT01766037|8708088|P2|Overall Study|Lost to Follow-up|10
2516562|NCT01766037|8708089|P1|Overall Study|Lost to Follow-up|0
2516563|NCT01766037|8708088|P2|Overall Study|Lack of Efficacy|0
2516564|NCT01766037|8708089|P1|Overall Study|Lack of Efficacy|1
2516565|NCT01766037|8708088|P2|Overall Study|Adverse Event|0
2516566|NCT01766037|8708089|P1|Overall Study|Adverse Event|1
2516567|NCT01765764|8708158|P3|Treatment Period|Other Miscellaneous Reasons|2
2516568|NCT01765764|8708159|P2|Treatment Period|Other Miscellaneous Reasons|2
2516569|NCT01765764|8708160|P1|Treatment Period|Other Miscellaneous Reasons|1
2516570|NCT01765764|8708158|P3|Treatment Period|Personal Reasons|1
2516571|NCT01765764|8708159|P2|Treatment Period|Personal Reasons|2
2516572|NCT01765764|8708160|P1|Treatment Period|Personal Reasons|1
2516573|NCT01765764|8708158|P3|Treatment Period|Lost to Follow-up|2
2516574|NCT01765764|8708159|P2|Treatment Period|Lost to Follow-up|3
2516575|NCT01765764|8708160|P1|Treatment Period|Lost to Follow-up|0
2516576|NCT01765764|8708158|P3|Treatment Period|Adverse Event|1
2516577|NCT01765764|8708159|P2|Treatment Period|Adverse Event|2
2516578|NCT01765764|8708160|P1|Treatment Period|Adverse Event|1
2516579|NCT01765751|8708180|P3|Overall Study|Lost to Follow-up|1
2516580|NCT01765751|8708181|P2|Overall Study|Lost to Follow-up|2
2516581|NCT01765751|8708182|P1|Overall Study|Lost to Follow-up|0
2516582|NCT01765673|8708214|P1|Overall Study|No transportation for 2nd/3rd visits|1
2516583|NCT01765582|8708247|P3|Overall Study|Withdrawal of Consent|10
2516584|NCT01765582|8708248|P2|Overall Study|Withdrawal of Consent|6
2516585|NCT01765582|8708249|P1|Overall Study|Withdrawal of Consent|11
2516586|NCT01765582|8708247|P3|Overall Study|Sponsor Decision|42
2516587|NCT01765582|8708248|P2|Overall Study|Sponsor Decision|42
2516588|NCT01765582|8708249|P1|Overall Study|Sponsor Decision|46
2516589|NCT01765582|8708247|P3|Overall Study|Death|33
2516590|NCT01765582|8708248|P2|Overall Study|Death|36
2516591|NCT01765582|8708249|P1|Overall Study|Death|31
2516592|NCT01765582|8708247|P3|Overall Study|Lost to Follow-up|1
2516593|NCT01765582|8708248|P2|Overall Study|Lost to Follow-up|2
2516594|NCT01765582|8708249|P1|Overall Study|Lost to Follow-up|2
2516595|NCT01765582|8708247|P3|Overall Study|Other|9
2516596|NCT01765582|8708248|P2|Overall Study|Other|6
2516597|NCT01765582|8708249|P1|Overall Study|Other|3
2516598|NCT01765569|8708282|P1|Period C|Death|1
2516599|NCT01765569|8708282|P1|Period B|Withdrawal by Subject|1
2516600|NCT01765543|8708303|P1|Overall Study|Withdrawal by Subject|2
2516601|NCT01765543|8708303|P1|Overall Study|Death|1
2516602|NCT01765426|8708355|P4|Overall Study|Lost to Follow-up|0
2516603|NCT01765426|8708356|P3|Overall Study|Lost to Follow-up|0
2516604|NCT01765426|8708357|P2|Overall Study|Lost to Follow-up|1
2516605|NCT01765426|8708358|P1|Overall Study|Lost to Follow-up|0
2516606|NCT01765270|8708414|P2|Overall Study|Withdrawal by Subject|1
2516607|NCT01765270|8708415|P1|Overall Study|Withdrawal by Subject|0
2516608|NCT01765270|8708414|P2|Overall Study|Physician Decision|0
2516609|NCT01765270|8708415|P1|Overall Study|Physician Decision|1
2516610|NCT01765192|8708437|P2|End of Treatment Period 2 to Final Visit|Adverse Event|1
2516611|NCT01765192|8708438|P1|End of Treatment Period 2 to Final Visit|Adverse Event|0
2516612|NCT01765192|8708437|P2|Treatment Period 2|Reason not specified|2
2516613|NCT01765192|8708438|P1|Treatment Period 2|Reason not specified|0
2516614|NCT01765192|8708437|P2|Washout Period|Reason not specified|0
2516615|NCT01765192|8708438|P1|Washout Period|Reason not specified|1
2516616|NCT01765192|8708437|P2|Washout Period|Voluntary Withdrawal|1
2516617|NCT01765192|8708438|P1|Washout Period|Voluntary Withdrawal|1
2516618|NCT01765192|8708437|P2|Treatment Period 1|Adverse Event|1
2516619|NCT01765192|8708438|P1|Treatment Period 1|Adverse Event|0
2516620|NCT01765179|8708456|P1|Overall Study|Ca elevated 10.6|1
2516621|NCT01765179|8708456|P1|Overall Study|work conflict|1
2516622|NCT01765179|8708456|P1|Overall Study|lack of venous access|1
2516623|NCT01765179|8708456|P1|Overall Study|Out of country unable to finish study|1
2516624|NCT01765179|8708456|P1|Overall Study|prohibited med|1
2516625|NCT01765179|8708456|P1|Overall Study|Hematocrit >54%|3
2516626|NCT01765179|8708456|P1|Overall Study|Withdrawal by Subject|8
2516627|NCT01765179|8708456|P1|Overall Study|Protocol Violation|1
2516628|NCT01765179|8708456|P1|Overall Study|Non-compliance with study drug|2
2516629|NCT01765179|8708456|P1|Overall Study|Lost to Follow-up|5
2516630|NCT01765179|8708456|P1|Overall Study|Adverse Event|3
2516631|NCT01765153|8708463|P2|Rest Phase 2|Lost to Follow-up|1
2516632|NCT01765153|8708464|P1|Rest Phase 2|Lost to Follow-up|2
2516633|NCT01765153|8708463|P2|Training Phase 2|Withdrawal by Subject|1
2516634|NCT01765153|8708464|P1|Training Phase 2|Withdrawal by Subject|0
2516635|NCT01765153|8708463|P2|Rest Phase 1|Withdrawal by Subject|1
2516636|NCT01765153|8708464|P1|Rest Phase 1|Withdrawal by Subject|0
2516637|NCT01765153|8708463|P2|Training Phase 1|Poor participation in intervention|1
2516638|NCT01765153|8708464|P1|Training Phase 1|Poor participation in intervention|0
2516639|NCT01765153|8708463|P2|Training Phase 1|Format of intervention differed|0
2516640|NCT01765153|8708464|P1|Training Phase 1|Format of intervention differed|1
2516641|NCT01764997|8708571|P5|Study Drug Treatment Period|Other than specified above|10
2516642|NCT01764997|8708572|P4|Study Drug Treatment Period|Other than specified above|0
2516643|NCT01764997|8708573|P3|Study Drug Treatment Period|Other than specified above|0
2516644|NCT01764997|8708574|P2|Study Drug Treatment Period|Other than specified above|0
2516645|NCT01764997|8708575|P1|Study Drug Treatment Period|Other than specified above|0
2516646|NCT01764997|8708571|P5|Study Drug Treatment Period|Lack of Efficacy|2
2516647|NCT01764997|8708572|P4|Study Drug Treatment Period|Lack of Efficacy|0
2516648|NCT01764997|8708573|P3|Study Drug Treatment Period|Lack of Efficacy|0
2516649|NCT01764997|8708574|P2|Study Drug Treatment Period|Lack of Efficacy|0
2516650|NCT01764997|8708575|P1|Study Drug Treatment Period|Lack of Efficacy|0
2516651|NCT01764997|8708571|P5|Study Drug Treatment Period|Adverse Event|24
2516652|NCT01764997|8708572|P4|Study Drug Treatment Period|Adverse Event|0
2516653|NCT01764997|8708573|P3|Study Drug Treatment Period|Adverse Event|0
2516654|NCT01764997|8708574|P2|Study Drug Treatment Period|Adverse Event|1
2516655|NCT01764997|8708575|P1|Study Drug Treatment Period|Adverse Event|0
2516656|NCT01764997|8708571|P5|Run-in Period|Other than specified above|0
2516657|NCT01764997|8708572|P4|Run-in Period|Other than specified above|0
2516658|NCT01764997|8708573|P3|Run-in Period|Other than specified above|0
2516659|NCT01764997|8708574|P2|Run-in Period|Other than specified above|0
2516660|NCT01764997|8708575|P1|Run-in Period|Other than specified above|17
2516661|NCT01764997|8708571|P5|Run-in Period|Poor compliance to protocol|0
2516662|NCT01764997|8708572|P4|Run-in Period|Poor compliance to protocol|0
2516663|NCT01764997|8708573|P3|Run-in Period|Poor compliance to protocol|0
2516664|NCT01764997|8708574|P2|Run-in Period|Poor compliance to protocol|0
2516665|NCT01764997|8708575|P1|Run-in Period|Poor compliance to protocol|1
2516666|NCT01764997|8708571|P5|Run-in Period|Lack of Efficacy|0
2516667|NCT01764997|8708572|P4|Run-in Period|Lack of Efficacy|0
2516668|NCT01764997|8708573|P3|Run-in Period|Lack of Efficacy|0
2516669|NCT01764997|8708574|P2|Run-in Period|Lack of Efficacy|0
2516670|NCT01764997|8708575|P1|Run-in Period|Lack of Efficacy|5
2516671|NCT01764997|8708571|P5|Run-in Period|Adverse Event|0
2516672|NCT01764997|8708572|P4|Run-in Period|Adverse Event|0
2516673|NCT01764997|8708573|P3|Run-in Period|Adverse Event|0
2516674|NCT01764997|8708574|P2|Run-in Period|Adverse Event|0
2516675|NCT01764997|8708575|P1|Run-in Period|Adverse Event|15
2516676|NCT01764945|8708602|P8|Overall Study|Adverse Event|0
2516677|NCT01764945|8708603|P7|Overall Study|Adverse Event|1
2516678|NCT01764945|8708604|P6|Overall Study|Adverse Event|0
2516679|NCT01764945|8708605|P5|Overall Study|Adverse Event|0
2516680|NCT01764945|8708606|P4|Overall Study|Adverse Event|0
2516681|NCT01764945|8708607|P3|Overall Study|Adverse Event|0
2516682|NCT01764945|8708608|P2|Overall Study|Adverse Event|1
2516683|NCT01764945|8708609|P1|Overall Study|Adverse Event|0
2516684|NCT01764841|8708655|P4|Overall Study|Lost to Follow-up|0
2516685|NCT01764841|8708656|P3|Overall Study|Lost to Follow-up|1
2516686|NCT01764841|8708657|P2|Overall Study|Lost to Follow-up|0
2516687|NCT01764841|8708658|P1|Overall Study|Lost to Follow-up|3
2516688|NCT01764841|8708655|P4|Overall Study|Withdrawal by Subject|15
2516689|NCT01764841|8708656|P3|Overall Study|Withdrawal by Subject|11
2516690|NCT01764841|8708657|P2|Overall Study|Withdrawal by Subject|24
2516691|NCT01764841|8708658|P1|Overall Study|Withdrawal by Subject|16
2516692|NCT01764841|8708655|P4|Overall Study|Protocol Violation|0
2516693|NCT01764841|8708656|P3|Overall Study|Protocol Violation|0
2516694|NCT01764841|8708657|P2|Overall Study|Protocol Violation|1
2516695|NCT01764841|8708658|P1|Overall Study|Protocol Violation|0
2516696|NCT01764841|8708655|P4|Overall Study|No Follow Up|0
2516697|NCT01764841|8708656|P3|Overall Study|No Follow Up|1
2516698|NCT01764841|8708657|P2|Overall Study|No Follow Up|0
2516699|NCT01764841|8708658|P1|Overall Study|No Follow Up|1
2516700|NCT01764841|8708655|P4|Overall Study|Death|4
2516701|NCT01764841|8708656|P3|Overall Study|Death|1
2516702|NCT01764841|8708657|P2|Overall Study|Death|0
2516703|NCT01764841|8708658|P1|Overall Study|Death|3
2516704|NCT01764841|8708655|P4|Overall Study|Logistical Difficulties|0
2516705|NCT01764841|8708656|P3|Overall Study|Logistical Difficulties|0
2516706|NCT01764841|8708657|P2|Overall Study|Logistical Difficulties|1
2516707|NCT01764841|8708658|P1|Overall Study|Logistical Difficulties|0
2516708|NCT01764659|8708699|P1|Overall Study|Physician Decision|1
2516709|NCT01764659|8708699|P1|Overall Study|Death|1
2516710|NCT01764633|8708713|P2|Overall Study|Lost to Follow-up|5
2516711|NCT01764633|8708714|P1|Overall Study|Lost to Follow-up|13
2516712|NCT01764633|8708713|P2|Overall Study|Withdrawal by Subject|88
2516713|NCT01764633|8708714|P1|Overall Study|Withdrawal by Subject|105
2516714|NCT01764464|8708743|P2|Second Intervention (Cross-over)|Adverse Event|0
2516715|NCT01764464|8708744|P1|Second Intervention (Cross-over)|Adverse Event|2
2516716|NCT01764464|8708743|P2|First Intervention|did not receive study drug|1
2516717|NCT01764464|8708744|P1|First Intervention|did not receive study drug|0
2516718|NCT01764464|8708743|P2|First Intervention|Adverse Event|2
2516719|NCT01764464|8708744|P1|First Intervention|Adverse Event|0
2516720|NCT01764464|8708743|P2|First Intervention|Lost to Follow-up|0
2516721|NCT01764464|8708744|P1|First Intervention|Lost to Follow-up|1
2516722|NCT01764464|8708743|P2|First Intervention|Withdrawal by Subject|0
2516723|NCT01764464|8708744|P1|First Intervention|Withdrawal by Subject|1
2516724|NCT01764386|8708762|P2|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
2516725|NCT01764386|8708763|P1|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
2516726|NCT01764386|8708762|P2|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
2516727|NCT01764386|8708763|P1|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
2516728|NCT01764386|8708762|P2|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26
2516729|NCT01764386|8708763|P1|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0
2516730|NCT01764386|8708762|P2|Uncontrolled Treatment Period (UTP)|Adverse Event|13
2516731|NCT01764386|8708763|P1|Uncontrolled Treatment Period (UTP)|Adverse Event|2
2516732|NCT01764386|8708762|P2|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2
2516733|NCT01764386|8708763|P1|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6
2516734|NCT01764386|8708762|P2|Controlled Treatment Period (CTP)|Lost to Follow-up|5
2516735|NCT01764386|8708763|P1|Controlled Treatment Period (CTP)|Lost to Follow-up|9
2516736|NCT01764386|8708762|P2|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0
2516737|NCT01764386|8708763|P1|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32
2516738|NCT01764386|8708762|P2|Controlled Treatment Period (CTP)|Adverse Event|0
2516739|NCT01764386|8708763|P1|Controlled Treatment Period (CTP)|Adverse Event|35
2516740|NCT01764256|8708808|P4|Completed Study|Lost to Follow-up|1
2516741|NCT01764256|8708809|P3|Completed Study|Lost to Follow-up|0
2516742|NCT01764256|8708810|P2|Completed Study|Lost to Follow-up|0
2516743|NCT01764256|8708811|P1|Completed Study|Lost to Follow-up|0
2516744|NCT01764256|8708808|P4|Received All Vaccinations|Lost to Follow-up|0
2516745|NCT01764256|8708809|P3|Received All Vaccinations|Lost to Follow-up|0
2516746|NCT01764256|8708810|P2|Received All Vaccinations|Lost to Follow-up|0
2516747|NCT01764256|8708811|P1|Received All Vaccinations|Lost to Follow-up|1
2516748|NCT01764256|8708808|P4|Received All Vaccinations|Did not meet inclusion criteria|0
2516749|NCT01764256|8708809|P3|Received All Vaccinations|Did not meet inclusion criteria|1
2516750|NCT01764256|8708810|P2|Received All Vaccinations|Did not meet inclusion criteria|0
2516751|NCT01764256|8708811|P1|Received All Vaccinations|Did not meet inclusion criteria|0
2516752|NCT01764256|8708808|P4|Received All Vaccinations|Adverse Event|0
2516753|NCT01764256|8708809|P3|Received All Vaccinations|Adverse Event|0
2516754|NCT01764256|8708810|P2|Received All Vaccinations|Adverse Event|1
2516755|NCT01764256|8708811|P1|Received All Vaccinations|Adverse Event|1
2516756|NCT01764022|8708854|P2|Overall Study|Protocol Violation|0
2516757|NCT01764022|8708855|P1|Overall Study|Protocol Violation|1
2516758|NCT01764022|8708854|P2|Overall Study|Lost to Follow-up|0
2516759|NCT01764022|8708855|P1|Overall Study|Lost to Follow-up|2
2516760|NCT01764022|8708854|P2|Overall Study|Physician Decision|2
2516761|NCT01764022|8708855|P1|Overall Study|Physician Decision|0
2516762|NCT01764022|8708854|P2|Overall Study|Lack of Efficacy|1
2516763|NCT01764022|8708855|P1|Overall Study|Lack of Efficacy|0
2516764|NCT01764022|8708854|P2|Overall Study|Withdrawal by Subject|6
2516765|NCT01764022|8708855|P1|Overall Study|Withdrawal by Subject|2
2516766|NCT01764022|8708854|P2|Overall Study|Death|5
2516767|NCT01764022|8708855|P1|Overall Study|Death|3
2516768|NCT01763996|8708887|P2|Treatment Period 2|Adverse Event|1
2516769|NCT01763996|8708888|P1|Treatment Period 2|Adverse Event|0
2516770|NCT01763918|8708929|P4|Overall Study|Sponsor Decision|0
2516771|NCT01763918|8708930|P3|Overall Study|Sponsor Decision|9
2516772|NCT01763918|8708931|P2|Overall Study|Sponsor Decision|0
2516773|NCT01763918|8708932|P1|Overall Study|Sponsor Decision|4
2516774|NCT01763918|8708929|P4|Overall Study|Withdrawal by Subject|2
2516775|NCT01763918|8708930|P3|Overall Study|Withdrawal by Subject|1
2516776|NCT01763918|8708931|P2|Overall Study|Withdrawal by Subject|1
2516777|NCT01763918|8708932|P1|Overall Study|Withdrawal by Subject|2
2516778|NCT01763905|8709030|P4|Overall Study|Lost to Follow-up|0
2516779|NCT01763905|8709031|P3|Overall Study|Lost to Follow-up|1
2516780|NCT01763905|8709032|P2|Overall Study|Lost to Follow-up|0
2516781|NCT01763905|8709033|P1|Overall Study|Lost to Follow-up|0
2516782|NCT01763905|8709030|P4|Overall Study|Decision by sponsor|0
2516783|NCT01763905|8709031|P3|Overall Study|Decision by sponsor|8
2516784|NCT01763905|8709032|P2|Overall Study|Decision by sponsor|0
2516785|NCT01763905|8709033|P1|Overall Study|Decision by sponsor|5
2516786|NCT01763905|8709030|P4|Overall Study|Withdrawal by Subject|1
2516787|NCT01763905|8709031|P3|Overall Study|Withdrawal by Subject|0
2516788|NCT01763905|8709032|P2|Overall Study|Withdrawal by Subject|1
2516789|NCT01763905|8709033|P1|Overall Study|Withdrawal by Subject|1
2516790|NCT01763866|8709151|P24|Overall Study|Death|0
2516791|NCT01763866|8709152|P23|Overall Study|Death|0
2516792|NCT01763866|8709153|P22|Overall Study|Death|0
2516793|NCT01763866|8709154|P21|Overall Study|Death|0
2516794|NCT01763866|8709155|P20|Overall Study|Death|0
2516795|NCT01763866|8709156|P19|Overall Study|Death|0
2516796|NCT01763866|8709157|P18|Overall Study|Death|0
2516797|NCT01763866|8709158|P17|Overall Study|Death|1
2516798|NCT01763866|8709159|P16|Overall Study|Death|0
2516799|NCT01763866|8709160|P15|Overall Study|Death|0
2516800|NCT01763866|8709161|P14|Overall Study|Death|0
2516801|NCT01763866|8709162|P13|Overall Study|Death|0
2516802|NCT01763866|8709163|P12|Overall Study|Death|0
2516803|NCT01763866|8709164|P11|Overall Study|Death|0
2516804|NCT01763866|8709165|P10|Overall Study|Death|0
2516805|NCT01763866|8709166|P9|Overall Study|Death|0
2516806|NCT01763866|8709167|P8|Overall Study|Death|0
2516807|NCT01763866|8709168|P7|Overall Study|Death|0
2516808|NCT01763866|8709169|P6|Overall Study|Death|0
2516809|NCT01763866|8709170|P5|Overall Study|Death|0
2516810|NCT01763866|8709171|P4|Overall Study|Death|0
2516811|NCT01763866|8709172|P3|Overall Study|Death|0
2516812|NCT01763866|8709173|P2|Overall Study|Death|0
2516813|NCT01763866|8709174|P1|Overall Study|Death|0
2516814|NCT01763866|8709151|P24|Overall Study|Lost to Follow-up|1
2516815|NCT01763866|8709152|P23|Overall Study|Lost to Follow-up|0
2516816|NCT01763866|8709153|P22|Overall Study|Lost to Follow-up|0
2516817|NCT01763866|8709154|P21|Overall Study|Lost to Follow-up|0
2516818|NCT01763866|8709155|P20|Overall Study|Lost to Follow-up|1
2516819|NCT01763866|8709156|P19|Overall Study|Lost to Follow-up|1
2516820|NCT01763866|8709157|P18|Overall Study|Lost to Follow-up|0
2516821|NCT01763866|8709158|P17|Overall Study|Lost to Follow-up|0
2516822|NCT01763866|8709159|P16|Overall Study|Lost to Follow-up|0
2516823|NCT01763866|8709160|P15|Overall Study|Lost to Follow-up|1
2516824|NCT01763866|8709161|P14|Overall Study|Lost to Follow-up|0
2516825|NCT01763866|8709162|P13|Overall Study|Lost to Follow-up|1
2516826|NCT01763866|8709163|P12|Overall Study|Lost to Follow-up|0
2516827|NCT01763866|8709164|P11|Overall Study|Lost to Follow-up|0
2516828|NCT01763866|8709165|P10|Overall Study|Lost to Follow-up|0
2516829|NCT01763866|8709166|P9|Overall Study|Lost to Follow-up|0
2516830|NCT01763866|8709167|P8|Overall Study|Lost to Follow-up|0
2516831|NCT01763866|8709168|P7|Overall Study|Lost to Follow-up|1
2516832|NCT01763866|8709169|P6|Overall Study|Lost to Follow-up|0
2516833|NCT01763866|8709170|P5|Overall Study|Lost to Follow-up|0
2516834|NCT01763866|8709171|P4|Overall Study|Lost to Follow-up|0
2516835|NCT01763866|8709172|P3|Overall Study|Lost to Follow-up|0
2516836|NCT01763866|8709173|P2|Overall Study|Lost to Follow-up|0
2516837|NCT01763866|8709174|P1|Overall Study|Lost to Follow-up|0
2516838|NCT01763866|8709151|P24|Overall Study|Decision by sponsor|0
2516839|NCT01763866|8709152|P23|Overall Study|Decision by sponsor|1
2516840|NCT01763866|8709153|P22|Overall Study|Decision by sponsor|0
2516841|NCT01763866|8709154|P21|Overall Study|Decision by sponsor|2
2516842|NCT01763866|8709155|P20|Overall Study|Decision by sponsor|0
2516843|NCT01763866|8709156|P19|Overall Study|Decision by sponsor|4
2516844|NCT01763866|8709157|P18|Overall Study|Decision by sponsor|0
2516845|NCT01763866|8709158|P17|Overall Study|Decision by sponsor|0
2516846|NCT01763866|8709159|P16|Overall Study|Decision by sponsor|0
2516847|NCT01763866|8709160|P15|Overall Study|Decision by sponsor|5
2516848|NCT01763866|8709161|P14|Overall Study|Decision by sponsor|0
2516849|NCT01763866|8709162|P13|Overall Study|Decision by sponsor|1
2516850|NCT01763866|8709163|P12|Overall Study|Decision by sponsor|0
2516851|NCT01763866|8709164|P11|Overall Study|Decision by sponsor|6
2516852|NCT01763866|8709165|P10|Overall Study|Decision by sponsor|0
2516853|NCT01763866|8709166|P9|Overall Study|Decision by sponsor|2
2516854|NCT01763866|8709167|P8|Overall Study|Decision by sponsor|0
2516855|NCT01763866|8709168|P7|Overall Study|Decision by sponsor|2
2516856|NCT01763866|8709169|P6|Overall Study|Decision by sponsor|0
2516857|NCT01763866|8709170|P5|Overall Study|Decision by sponsor|2
2516858|NCT01763866|8709171|P4|Overall Study|Decision by sponsor|0
2516859|NCT01763866|8709172|P3|Overall Study|Decision by sponsor|1
2516860|NCT01763866|8709173|P2|Overall Study|Decision by sponsor|0
2516861|NCT01763866|8709174|P1|Overall Study|Decision by sponsor|0
2516862|NCT01763866|8709151|P24|Overall Study|Withdrawal by Subject|1
2516863|NCT01763866|8709152|P23|Overall Study|Withdrawal by Subject|2
2516864|NCT01763866|8709153|P22|Overall Study|Withdrawal by Subject|1
2516865|NCT01763866|8709154|P21|Overall Study|Withdrawal by Subject|2
2516866|NCT01763866|8709155|P20|Overall Study|Withdrawal by Subject|1
2516867|NCT01763866|8709156|P19|Overall Study|Withdrawal by Subject|1
2516868|NCT01763866|8709157|P18|Overall Study|Withdrawal by Subject|1
2516869|NCT01763866|8709158|P17|Overall Study|Withdrawal by Subject|0
2516870|NCT01763866|8709159|P16|Overall Study|Withdrawal by Subject|3
2516871|NCT01763866|8709160|P15|Overall Study|Withdrawal by Subject|6
2516872|NCT01763866|8709161|P14|Overall Study|Withdrawal by Subject|0
2516873|NCT01763866|8709162|P13|Overall Study|Withdrawal by Subject|2
2516874|NCT01763866|8709163|P12|Overall Study|Withdrawal by Subject|2
2516875|NCT01763866|8709164|P11|Overall Study|Withdrawal by Subject|2
2516876|NCT01763866|8709165|P10|Overall Study|Withdrawal by Subject|1
2516877|NCT01763866|8709166|P9|Overall Study|Withdrawal by Subject|1
2516878|NCT01763866|8709167|P8|Overall Study|Withdrawal by Subject|0
2516879|NCT01763866|8709168|P7|Overall Study|Withdrawal by Subject|4
2516880|NCT01763866|8709169|P6|Overall Study|Withdrawal by Subject|3
2516881|NCT01763866|8709170|P5|Overall Study|Withdrawal by Subject|0
2516882|NCT01763866|8709171|P4|Overall Study|Withdrawal by Subject|0
2516883|NCT01763866|8709172|P3|Overall Study|Withdrawal by Subject|4
2516884|NCT01763866|8709173|P2|Overall Study|Withdrawal by Subject|1
2516885|NCT01763866|8709174|P1|Overall Study|Withdrawal by Subject|2
2516886|NCT01763827|8709734|P6|Overall Study|Lost to Follow-up|1
2516887|NCT01763827|8709735|P5|Overall Study|Lost to Follow-up|2
2516888|NCT01763827|8709736|P4|Overall Study|Lost to Follow-up|1
2516889|NCT01763827|8709737|P3|Overall Study|Lost to Follow-up|1
2516890|NCT01763827|8709738|P2|Overall Study|Lost to Follow-up|1
2516891|NCT01763827|8709739|P1|Overall Study|Lost to Follow-up|0
2516892|NCT01763827|8709734|P6|Overall Study|Decision by sponsor|1
2516893|NCT01763827|8709735|P5|Overall Study|Decision by sponsor|2
2516894|NCT01763827|8709736|P4|Overall Study|Decision by sponsor|0
2516895|NCT01763827|8709737|P3|Overall Study|Decision by sponsor|3
2516896|NCT01763827|8709738|P2|Overall Study|Decision by sponsor|0
2516897|NCT01763827|8709739|P1|Overall Study|Decision by sponsor|2
2516898|NCT01763827|8709734|P6|Overall Study|Withdrawal by Subject|0
2516899|NCT01763827|8709735|P5|Overall Study|Withdrawal by Subject|2
2516900|NCT01763827|8709736|P4|Overall Study|Withdrawal by Subject|0
2516901|NCT01763827|8709737|P3|Overall Study|Withdrawal by Subject|0
2516902|NCT01763827|8709738|P2|Overall Study|Withdrawal by Subject|0
2516903|NCT01763827|8709739|P1|Overall Study|Withdrawal by Subject|1
2516904|NCT01763788|8709883|P4|Overall Study|Lost to Follow-up|0
2516905|NCT01763788|8709884|P3|Overall Study|Lost to Follow-up|1
2516906|NCT01763788|8709885|P2|Overall Study|Lost to Follow-up|0
2516907|NCT01763788|8709886|P1|Overall Study|Lost to Follow-up|0
2516908|NCT01763203|8710095|P2|Overall Study|Physician Decision|1
2516909|NCT01763203|8710096|P1|Overall Study|Physician Decision|2
2516910|NCT01763203|8710095|P2|Overall Study|Moved out of study region|10
2516911|NCT01763203|8710096|P1|Overall Study|Moved out of study region|7
2516912|NCT01763203|8710095|P2|Overall Study|Withdrawal by Subject|12
2516913|NCT01763203|8710096|P1|Overall Study|Withdrawal by Subject|8
2516914|NCT01763203|8710095|P2|Overall Study|Lost to Follow-up|12
2516915|NCT01763203|8710096|P1|Overall Study|Lost to Follow-up|12
2516916|NCT01763203|8710095|P2|Overall Study|Death|7
2516917|NCT01763203|8710096|P1|Overall Study|Death|4
2516918|NCT01763047|8710142|P2|Period 2|Unsatisfactory lens Fitting|1
2516919|NCT01763047|8710143|P1|Period 2|Unsatisfactory lens Fitting|0
2516920|NCT01763047|8710142|P2|Period 2|Protocol Violation|2
2516921|NCT01763047|8710143|P1|Period 2|Protocol Violation|0
2516922|NCT01763047|8710142|P2|Period 2|Unsatisfactory Visual Response|1
2516923|NCT01763047|8710143|P1|Period 2|Unsatisfactory Visual Response|1
2516924|NCT01763047|8710142|P2|Period 2|Study Site office Closed|1
2516925|NCT01763047|8710143|P1|Period 2|Study Site office Closed|1
2516926|NCT01763047|8710142|P2|Period 2|No longer meets Eligibility Criteria|0
2516927|NCT01763047|8710143|P1|Period 2|No longer meets Eligibility Criteria|1
2516928|NCT01763047|8710142|P2|Period 2|Lens Discomfort|0
2516929|NCT01763047|8710143|P1|Period 2|Lens Discomfort|1
2516930|NCT01763047|8710142|P2|Period 1|Study Site office Closed|1
2516931|NCT01763047|8710143|P1|Period 1|Study Site office Closed|0
2516932|NCT01763047|8710142|P2|Period 1|Lens Power Not Available|1
2516933|NCT01763047|8710143|P1|Period 1|Lens Power Not Available|0
2516934|NCT01763047|8710142|P2|Period 1|Unsatisfactory Visual Response|3
2516935|NCT01763047|8710143|P1|Period 1|Unsatisfactory Visual Response|0
2516936|NCT01763047|8710142|P2|Period 1|Adverse Event|1
2516937|NCT01763047|8710143|P1|Period 1|Adverse Event|0
2516938|NCT01763047|8710142|P2|Period 1|No Longer Meets Eligibility criteria|0
2516939|NCT01763047|8710143|P1|Period 1|No Longer Meets Eligibility criteria|1
2516940|NCT01763047|8710142|P2|Period 1|Protocol Violation|4
2516941|NCT01763047|8710143|P1|Period 1|Protocol Violation|4
2516942|NCT01763047|8710142|P2|Period 1|Test Article Not Available|1
2516943|NCT01763047|8710143|P1|Period 1|Test Article Not Available|4
2516944|NCT01762943|8710182|P2|Overall Study|Withdrawal by Subject|1
2516945|NCT01762943|8710183|P1|Overall Study|Withdrawal by Subject|2
2516946|NCT01762943|8710182|P2|Overall Study|Protocol Violation|0
2516947|NCT01762943|8710183|P1|Overall Study|Protocol Violation|1
2516948|NCT01762943|8710182|P2|Overall Study|Physician Decision|1
2516949|NCT01762943|8710183|P1|Overall Study|Physician Decision|1
2516950|NCT01762800|8710200|P2|Overall Study|Withdrawal by Subject|4
2516951|NCT01762800|8710201|P1|Overall Study|Withdrawal by Subject|7
2516952|NCT01762800|8710200|P2|Overall Study|Physician Decision|1
2516953|NCT01762800|8710201|P1|Overall Study|Physician Decision|1
2516954|NCT01762800|8710200|P2|Overall Study|Study Closed/Terminated|1
2516955|NCT01762800|8710201|P1|Overall Study|Study Closed/Terminated|0
2516956|NCT01762800|8710200|P2|Overall Study|Lack of Efficacy|2
2516957|NCT01762800|8710201|P1|Overall Study|Lack of Efficacy|3
2516958|NCT01762800|8710200|P2|Overall Study|Adverse Event|13
2516959|NCT01762800|8710201|P1|Overall Study|Adverse Event|8
2516960|NCT01762761|8710275|P2|Overall Study|Withdrawal by Subject|8
2516961|NCT01762761|8710276|P1|Overall Study|Withdrawal by Subject|7
2516962|NCT01762761|8710275|P2|Overall Study|Physician Decision|6
2516963|NCT01762761|8710276|P1|Overall Study|Physician Decision|4
2516964|NCT01762761|8710275|P2|Overall Study|Lost to Follow-up|6
2516965|NCT01762761|8710276|P1|Overall Study|Lost to Follow-up|3
2516966|NCT01762761|8710275|P2|Overall Study|Study closed/terminated|2
2516967|NCT01762761|8710276|P1|Overall Study|Study closed/terminated|0
2516968|NCT01762761|8710275|P2|Overall Study|Protocol Violation|1
2516969|NCT01762761|8710276|P1|Overall Study|Protocol Violation|1
2516970|NCT01762761|8710275|P2|Overall Study|Lack of Efficacy|25
2516971|NCT01762761|8710276|P1|Overall Study|Lack of Efficacy|9
2516972|NCT01762761|8710275|P2|Overall Study|Adverse Event|17
2516973|NCT01762761|8710276|P1|Overall Study|Adverse Event|15
2516974|NCT01762345|8710375|P1|Overall Study|Protocol Violation|2
2516975|NCT01762345|8710375|P1|Overall Study|Adverse Event|5
2516976|NCT01761565|8710423|P1|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1
2516977|NCT01761266|8710447|P2|Overall Study|Ongoing as of data-cut off|107
2516978|NCT01761266|8710448|P1|Overall Study|Ongoing as of data-cut off|109
2516979|NCT01761266|8710447|P2|Overall Study|Withdrawal by Subject|8
2516980|NCT01761266|8710448|P1|Overall Study|Withdrawal by Subject|13
2516981|NCT01761266|8710447|P2|Overall Study|Lost to Follow-up|11
2516982|NCT01761266|8710448|P1|Overall Study|Lost to Follow-up|5
2516983|NCT01761266|8710447|P2|Overall Study|Death|350
2516984|NCT01761266|8710448|P1|Overall Study|Death|351
2516985|NCT01761162|8710505|P1|Overall Study|Withdrawal by Subject|3
2516986|NCT01760954|8710594|P4|Post-treatment Follow-up (12 Months)|Other|6
2516987|NCT01760954|8710595|P3|Post-treatment Follow-up (12 Months)|Other|9
2516988|NCT01760954|8710596|P2|Post-treatment Follow-up (12 Months)|Other|8
2516989|NCT01760954|8710597|P1|Post-treatment Follow-up (12 Months)|Other|13
2516990|NCT01760954|8710594|P4|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
2516991|NCT01760954|8710595|P3|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1
2516992|NCT01760954|8710596|P2|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
2516993|NCT01760954|8710597|P1|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
2516994|NCT01760954|8710594|P4|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
2516995|NCT01760954|8710595|P3|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
2516996|NCT01760954|8710596|P2|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4
2516997|NCT01760954|8710597|P1|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1
2516998|NCT01760954|8710594|P4|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
2516999|NCT01760954|8710595|P3|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
2517000|NCT01760954|8710596|P2|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10
2517001|NCT01760954|8710597|P1|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6
2517002|NCT01760954|8710594|P4|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0
2517003|NCT01760954|8710595|P3|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2
2517004|NCT01760954|8710596|P2|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7
2517005|NCT01760954|8710597|P1|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4
2517006|NCT01760954|8710594|P4|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9
2517007|NCT01760954|8710595|P3|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
2517008|NCT01760954|8710596|P2|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
2517009|NCT01760954|8710597|P1|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
2517010|NCT01760954|8710594|P4|Treatment Period (6 Months)|Exclusionary Medication|0
2517011|NCT01760954|8710595|P3|Treatment Period (6 Months)|Exclusionary Medication|0
2517012|NCT01760954|8710596|P2|Treatment Period (6 Months)|Exclusionary Medication|0
2517013|NCT01760954|8710597|P1|Treatment Period (6 Months)|Exclusionary Medication|1
2517014|NCT01760954|8710594|P4|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
2517015|NCT01760954|8710595|P3|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
2517016|NCT01760954|8710596|P2|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6
2517017|NCT01760954|8710597|P1|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1
2517018|NCT01760954|8710594|P4|Treatment Period (6 Months)|Other|1
2517019|NCT01760954|8710595|P3|Treatment Period (6 Months)|Other|3
2517020|NCT01760954|8710596|P2|Treatment Period (6 Months)|Other|3
2517021|NCT01760954|8710597|P1|Treatment Period (6 Months)|Other|0
2517022|NCT01760954|8710594|P4|Treatment Period (6 Months)|Non-compliance|3
2517023|NCT01760954|8710595|P3|Treatment Period (6 Months)|Non-compliance|0
2517024|NCT01760954|8710596|P2|Treatment Period (6 Months)|Non-compliance|4
2517025|NCT01760954|8710597|P1|Treatment Period (6 Months)|Non-compliance|1
2517026|NCT01760954|8710594|P4|Treatment Period (6 Months)|Pregnancy|2
2517027|NCT01760954|8710595|P3|Treatment Period (6 Months)|Pregnancy|3
2517028|NCT01760954|8710596|P2|Treatment Period (6 Months)|Pregnancy|0
2517029|NCT01760954|8710597|P1|Treatment Period (6 Months)|Pregnancy|5
2517030|NCT01760954|8710594|P4|Treatment Period (6 Months)|Surgery or invasive intervention for end|2
2517031|NCT01760954|8710595|P3|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
2517032|NCT01760954|8710596|P2|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
2517033|NCT01760954|8710597|P1|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
2517034|NCT01760954|8710594|P4|Treatment Period (6 Months)|Lost to Follow-up|3
2517035|NCT01760954|8710595|P3|Treatment Period (6 Months)|Lost to Follow-up|4
2517036|NCT01760954|8710596|P2|Treatment Period (6 Months)|Lost to Follow-up|1
2517037|NCT01760954|8710597|P1|Treatment Period (6 Months)|Lost to Follow-up|9
2517038|NCT01760954|8710594|P4|Treatment Period (6 Months)|Adverse Event|10
2517039|NCT01760954|8710595|P3|Treatment Period (6 Months)|Adverse Event|4
2517040|NCT01760954|8710596|P2|Treatment Period (6 Months)|Adverse Event|3
2517041|NCT01760954|8710597|P1|Treatment Period (6 Months)|Adverse Event|5
2517042|NCT01760954|8710594|P4|Treatment Period (6 Months)|Withdrawal by Subject|5
2517043|NCT01760954|8710595|P3|Treatment Period (6 Months)|Withdrawal by Subject|4
2517044|NCT01760954|8710596|P2|Treatment Period (6 Months)|Withdrawal by Subject|8
2517045|NCT01760954|8710597|P1|Treatment Period (6 Months)|Withdrawal by Subject|8
2517046|NCT01760876|8710734|P1|Overall Study|Very poor baseline OCT quality|2
2517047|NCT01760876|8710734|P1|Overall Study|Major depression|1
2517048|NCT01760876|8710734|P1|Overall Study|Impaired renal function|1
2517049|NCT01760876|8710734|P1|Overall Study|Carcinoma of prostate|1
2517050|NCT01760876|8710734|P1|Overall Study|Non-cardiac death (head injury)|1
2517051|NCT01760733|8710749|P1|Transplanted|Graft loss|7
2517052|NCT01760733|8710749|P1|Transplanted|Death|26
2517053|NCT01760733|8710749|P1|Transplanted|Not reached 10 years post transplant|184
2517054|NCT01760733|8710749|P1|Waiting List|Not received a transplant yet|13
2517055|NCT01760733|8710749|P1|Waiting List|Removed from waiting list|41
2517056|NCT01760733|8710749|P1|Waiting List|Death|18
2517057|NCT01759862|8711045|P2|Overall Study|Adverse Event|1
2517058|NCT01759862|8711046|P1|Overall Study|Adverse Event|0
2517059|NCT01759862|8711045|P2|Overall Study|Physician Decision|1
2517060|NCT01759862|8711046|P1|Overall Study|Physician Decision|3
2517061|NCT01759511|8711064|P1|Overall Study|Withdrawal by Subject|3
2517062|NCT01759511|8711064|P1|Overall Study|Study Terminated by Sponsor|13
2517063|NCT01759511|8711064|P1|Overall Study|Protocol-Specified Criteria for Withdraw|4
2517064|NCT01759511|8711064|P1|Overall Study|Progressive Disease|5
2517065|NCT01759511|8711064|P1|Overall Study|Physician Decision|1
2517066|NCT01759511|8711064|P1|Overall Study|Lack of Efficacy|2
2517067|NCT01759511|8711064|P1|Overall Study|Death|2
2517068|NCT01759511|8711064|P1|Overall Study|Adverse Event|4
2517069|NCT01759446|8711077|P5|Overall Study|Withdrawal by Subject|0
2517070|NCT01759446|8711078|P4|Overall Study|Withdrawal by Subject|1
2517071|NCT01759446|8711079|P3|Overall Study|Withdrawal by Subject|0
2517072|NCT01759446|8711080|P2|Overall Study|Withdrawal by Subject|1
2517073|NCT01759446|8711081|P1|Overall Study|Withdrawal by Subject|0
2517074|NCT01759446|8711077|P5|Overall Study|Protocol Violation|0
2517075|NCT01759446|8711078|P4|Overall Study|Protocol Violation|0
2517076|NCT01759446|8711079|P3|Overall Study|Protocol Violation|1
2517077|NCT01759446|8711080|P2|Overall Study|Protocol Violation|0
2517078|NCT01759446|8711081|P1|Overall Study|Protocol Violation|1
2517079|NCT01759420|8711093|P1|Overall Study|Inaccurate EKG machine readings|1
2517080|NCT01759420|8711093|P1|Overall Study|Screen failure|5
2517081|NCT01759407|8711100|P2|Overall Study|Protocol Violation|2
2517082|NCT01759407|8711101|P1|Overall Study|Protocol Violation|0
2517083|NCT01759381|8711113|P2|Overall Study|Death|0
2517084|NCT01759381|8711114|P1|Overall Study|Death|1
2517085|NCT01759368|8711122|P2|Overall Study|Lost to Follow-up|0
2517086|NCT01759368|8711123|P1|Overall Study|Lost to Follow-up|1
2517087|NCT01759290|8711141|P1|Overall Study|Unknown reason|4
2517088|NCT01759290|8711141|P1|Overall Study|Lost to Follow-up|53
2517089|NCT01759290|8711141|P1|Overall Study|Death|17
2517090|NCT01759290|8711141|P1|Overall Study|Physician Decision|2
2517091|NCT01759290|8711141|P1|Overall Study|Subjects withdrawn consent|5
2517092|NCT01759264|8711210|P1|Overall Study|Discontinued Humira Due to Business Trip|1
2517093|NCT01759264|8711210|P1|Overall Study|Withdrawal by Subject|3
2517094|NCT01759264|8711210|P1|Overall Study|Lost to Follow-up|2
2517095|NCT01759264|8711210|P1|Overall Study|Other|2
2517096|NCT01759264|8711210|P1|Overall Study|Adverse Event|1
2517097|NCT01759264|8711210|P1|Overall Study|Serious Adverse Events (SAEs)|1
2517098|NCT01758900|8711238|P2|Overall Study|difficulty for further intubation|8
2517099|NCT01758900|8711239|P1|Overall Study|difficulty for further intubation|7
2517100|NCT01758731|8711257|P1|Overall Study|Physician Decision|1
2517101|NCT01758523|8711276|P2|Overall Study|Withdrawal by Subject|7
2517102|NCT01758523|8711277|P1|Overall Study|Withdrawal by Subject|12
2517103|NCT01758523|8711276|P2|Overall Study|Lost to Follow-up|4
2517104|NCT01758523|8711277|P1|Overall Study|Lost to Follow-up|3
2517105|NCT01758523|8711276|P2|Overall Study|Lack of Efficacy|2
2517106|NCT01758523|8711277|P1|Overall Study|Lack of Efficacy|4
2517107|NCT01758523|8711276|P2|Overall Study|Adverse Event|1
2517108|NCT01758523|8711277|P1|Overall Study|Adverse Event|2
2517109|NCT01758289|8711380|P1|Overall Study|Adverse Event|9
2517110|NCT01758289|8711380|P1|Overall Study|Premature Study Termination|44
2517111|NCT01757847|8711406|P2|Overall Study|Withdrawal by Subject|4
2517112|NCT01757847|8711407|P1|Overall Study|Withdrawal by Subject|3
2517113|NCT01757821|8711415|P1|Overall Study|Adverse Event|1
2517114|NCT01757704|8711430|P2|Overall Study|Protocol Violation|3
2517115|NCT01757704|8711431|P1|Overall Study|Protocol Violation|1
2517116|NCT01757691|8711449|P2|Overall Study|Administrative problems|0
2517117|NCT01757691|8711450|P1|Overall Study|Administrative problems|2
2517118|NCT01757665|8711477|P2|Overall Study|Not Implanted with Device|1
2517119|NCT01757665|8711478|P1|Overall Study|Not Implanted with Device|5
2517120|NCT01757665|8711477|P2|Overall Study|Lost to Follow-up|1
2517121|NCT01757665|8711478|P1|Overall Study|Lost to Follow-up|1
2517122|NCT01757665|8711477|P2|Overall Study|Withdrawal by Subject|0
2517123|NCT01757665|8711478|P1|Overall Study|Withdrawal by Subject|10
2517124|NCT01757665|8711477|P2|Overall Study|Explant|2
2517125|NCT01757665|8711478|P1|Overall Study|Explant|1
2517126|NCT01757665|8711477|P2|Overall Study|Death|8
2517127|NCT01757665|8711478|P1|Overall Study|Death|25
2517128|NCT01757665|8711477|P2|Overall Study|Still on Study - Missed Visit|1
2517129|NCT01757665|8711478|P1|Overall Study|Still on Study - Missed Visit|14
2517130|NCT01757665|8711477|P2|Overall Study|Still on Study - Visit Pending|40
2517131|NCT01757665|8711478|P1|Overall Study|Still on Study - Visit Pending|398
2517132|NCT01757665|8711477|P2|Overall Study|Still on Study - Visit Completed|30
2517133|NCT01757665|8711478|P1|Overall Study|Still on Study - Visit Completed|240
2517134|NCT01757405|8711650|P2|Overall Study|Withdrawal by Subject|1
2517135|NCT01757405|8711651|P1|Overall Study|Withdrawal by Subject|0
2517136|NCT01757405|8711650|P2|Overall Study|Lost to Follow-up|1
2517137|NCT01757405|8711651|P1|Overall Study|Lost to Follow-up|1
2517138|NCT01757275|8711686|P2|Overall Study|Not treated|4
2517139|NCT01757275|8711687|P1|Overall Study|Not treated|3
2517140|NCT01757275|8711686|P2|Overall Study|Withdrawal by Subject|4
2517141|NCT01757275|8711687|P1|Overall Study|Withdrawal by Subject|2
2517142|NCT01757275|8711686|P2|Overall Study|Adverse Event|3
2517143|NCT01757275|8711687|P1|Overall Study|Adverse Event|3
2517144|NCT01757275|8711686|P2|Overall Study|Lost to Follow-up|2
2517145|NCT01757275|8711687|P1|Overall Study|Lost to Follow-up|1
2517146|NCT01757197|8711709|P1|Overall Study|Death|2
2517147|NCT01757184|8711718|P4|Open-label Period|Discontinued by Sponsor|2
2517148|NCT01757184|8711719|P3|Open-label Period|Discontinued by Sponsor|1
2517149|NCT01757184|8711720|P2|Open-label Period|Discontinued by Sponsor|0
2517150|NCT01757184|8711721|P1|Open-label Period|Discontinued by Sponsor|0
2517151|NCT01757184|8711718|P4|Open-label Period|Withdrawal by Subject|1
2517152|NCT01757184|8711719|P3|Open-label Period|Withdrawal by Subject|1
2517153|NCT01757184|8711720|P2|Open-label Period|Withdrawal by Subject|0
2517154|NCT01757184|8711721|P1|Open-label Period|Withdrawal by Subject|0
2517155|NCT01757184|8711718|P4|Open-label Period|Lost to Follow-up|0
2517156|NCT01757184|8711719|P3|Open-label Period|Lost to Follow-up|2
2517157|NCT01757184|8711720|P2|Open-label Period|Lost to Follow-up|0
2517158|NCT01757184|8711721|P1|Open-label Period|Lost to Follow-up|0
2517159|NCT01757184|8711718|P4|Double-blind Period|Adverse Event|0
2517160|NCT01757184|8711719|P3|Double-blind Period|Adverse Event|0
2517161|NCT01757184|8711720|P2|Double-blind Period|Adverse Event|0
2517162|NCT01757184|8711721|P1|Double-blind Period|Adverse Event|1
2517163|NCT01757171|8711765|P2|Overall Study|ECOG decline|0
2517164|NCT01757171|8711766|P1|Overall Study|ECOG decline|1
2517165|NCT01757171|8711765|P2|Overall Study|Hospitalization|0
2517166|NCT01757171|8711766|P1|Overall Study|Hospitalization|1
2517167|NCT01757171|8711765|P2|Overall Study|Disease Progression|0
2517168|NCT01757171|8711766|P1|Overall Study|Disease Progression|1
2517169|NCT01757171|8711765|P2|Overall Study|Adverse Event|1
2517170|NCT01757171|8711766|P1|Overall Study|Adverse Event|5
2517171|NCT01756846|8711802|P2|Overall Study|Withdrawal by Subject|2
2517172|NCT01756846|8711803|P1|Overall Study|Withdrawal by Subject|1
2517173|NCT01756846|8711802|P2|Overall Study|Lost to Follow-up|10
2517174|NCT01756846|8711803|P1|Overall Study|Lost to Follow-up|5
2517175|NCT01756456|8711848|P6|Follow Up Period Phase I/II|Other causes|5
2517176|NCT01756456|8711849|P5|Follow Up Period Phase I/II|Other causes|3
2517177|NCT01756456|8711850|P4|Follow Up Period Phase I/II|Other causes|1
2517178|NCT01756456|8711851|P3|Follow Up Period Phase I/II|Other causes|0
2517179|NCT01756456|8711852|P2|Follow Up Period Phase I/II|Other causes|0
2517180|NCT01756456|8711853|P1|Follow Up Period Phase I/II|Other causes|0
2517181|NCT01756456|8711848|P6|Follow Up Period Phase I/II|Lost to Follow-up|1
2517182|NCT01756456|8711849|P5|Follow Up Period Phase I/II|Lost to Follow-up|0
2517183|NCT01756456|8711850|P4|Follow Up Period Phase I/II|Lost to Follow-up|2
2517184|NCT01756456|8711851|P3|Follow Up Period Phase I/II|Lost to Follow-up|1
2517185|NCT01756456|8711852|P2|Follow Up Period Phase I/II|Lost to Follow-up|0
2517186|NCT01756456|8711853|P1|Follow Up Period Phase I/II|Lost to Follow-up|0
2517187|NCT01756456|8711848|P6|Follow Up Period Phase I/II|Adverse Event|1
2517188|NCT01756456|8711849|P5|Follow Up Period Phase I/II|Adverse Event|0
2517189|NCT01756456|8711850|P4|Follow Up Period Phase I/II|Adverse Event|5
2517190|NCT01756456|8711851|P3|Follow Up Period Phase I/II|Adverse Event|0
2517191|NCT01756456|8711852|P2|Follow Up Period Phase I/II|Adverse Event|0
2517192|NCT01756456|8711853|P1|Follow Up Period Phase I/II|Adverse Event|1
2517193|NCT01756456|8711848|P6|Follow Up Period Phase I/II|Lack of Efficacy|1
2517194|NCT01756456|8711849|P5|Follow Up Period Phase I/II|Lack of Efficacy|0
2517195|NCT01756456|8711850|P4|Follow Up Period Phase I/II|Lack of Efficacy|0
2517196|NCT01756456|8711851|P3|Follow Up Period Phase I/II|Lack of Efficacy|0
2517197|NCT01756456|8711852|P2|Follow Up Period Phase I/II|Lack of Efficacy|0
2517198|NCT01756456|8711853|P1|Follow Up Period Phase I/II|Lack of Efficacy|0
2517199|NCT01756456|8711848|P6|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
2517200|NCT01756456|8711849|P5|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
2517201|NCT01756456|8711850|P4|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
2517202|NCT01756456|8711851|P3|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
2517203|NCT01756456|8711852|P2|Follow Up Period Phase I/II|parent withdrew the consent to continue|1
2517204|NCT01756456|8711853|P1|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
2517205|NCT01756456|8711848|P6|Follow Up Period Phase I/II|still in study after week 20|25
2517206|NCT01756456|8711849|P5|Follow Up Period Phase I/II|still in study after week 20|23
2517207|NCT01756456|8711850|P4|Follow Up Period Phase I/II|still in study after week 20|25
2517208|NCT01756456|8711851|P3|Follow Up Period Phase I/II|still in study after week 20|0
2517209|NCT01756456|8711852|P2|Follow Up Period Phase I/II|still in study after week 20|0
2517210|NCT01756456|8711853|P1|Follow Up Period Phase I/II|still in study after week 20|0
2517211|NCT01756456|8711848|P6|Treatment Period: Phase I/II|Other causes|2
2517212|NCT01756456|8711849|P5|Treatment Period: Phase I/II|Other causes|2
2517213|NCT01756456|8711850|P4|Treatment Period: Phase I/II|Other causes|1
2517214|NCT01756456|8711851|P3|Treatment Period: Phase I/II|Other causes|0
2517215|NCT01756456|8711852|P2|Treatment Period: Phase I/II|Other causes|0
2517216|NCT01756456|8711853|P1|Treatment Period: Phase I/II|Other causes|0
2517217|NCT01756456|8711848|P6|Treatment Period: Phase I/II|Adverse Event|1
2517218|NCT01756456|8711849|P5|Treatment Period: Phase I/II|Adverse Event|9
2517219|NCT01756456|8711850|P4|Treatment Period: Phase I/II|Adverse Event|3
2517220|NCT01756456|8711851|P3|Treatment Period: Phase I/II|Adverse Event|2
2517221|NCT01756456|8711852|P2|Treatment Period: Phase I/II|Adverse Event|0
2517222|NCT01756456|8711853|P1|Treatment Period: Phase I/II|Adverse Event|1
2517223|NCT01756456|8711848|P6|Treatment Period: Phase I/II|Withdrawal by Subject|0
2517224|NCT01756456|8711849|P5|Treatment Period: Phase I/II|Withdrawal by Subject|0
2517225|NCT01756456|8711850|P4|Treatment Period: Phase I/II|Withdrawal by Subject|0
2517226|NCT01756456|8711851|P3|Treatment Period: Phase I/II|Withdrawal by Subject|0
2517227|NCT01756456|8711852|P2|Treatment Period: Phase I/II|Withdrawal by Subject|1
2517228|NCT01756456|8711853|P1|Treatment Period: Phase I/II|Withdrawal by Subject|0
2517229|NCT01756456|8711848|P6|Treatment Period: Phase I/II|Lack of Efficacy|0
2517230|NCT01756456|8711849|P5|Treatment Period: Phase I/II|Lack of Efficacy|1
2517231|NCT01756456|8711850|P4|Treatment Period: Phase I/II|Lack of Efficacy|2
2517232|NCT01756456|8711851|P3|Treatment Period: Phase I/II|Lack of Efficacy|0
2517233|NCT01756456|8711852|P2|Treatment Period: Phase I/II|Lack of Efficacy|0
2517234|NCT01756456|8711853|P1|Treatment Period: Phase I/II|Lack of Efficacy|0
2517235|NCT01756456|8711848|P6|Treatment Period: Phase I/II|decision unrelated to adverse event|1
2517236|NCT01756456|8711849|P5|Treatment Period: Phase I/II|decision unrelated to adverse event|1
2517237|NCT01756456|8711850|P4|Treatment Period: Phase I/II|decision unrelated to adverse event|1
2517238|NCT01756456|8711851|P3|Treatment Period: Phase I/II|decision unrelated to adverse event|0
2517239|NCT01756456|8711852|P2|Treatment Period: Phase I/II|decision unrelated to adverse event|0
2517240|NCT01756456|8711853|P1|Treatment Period: Phase I/II|decision unrelated to adverse event|0
2517241|NCT01756352|8711955|P1|Overall Study|moved away and lost to followup|1
2517242|NCT01756300|8711960|P1|Overall Study|Withdrawal by Subject|1
2517243|NCT01756300|8711960|P1|Overall Study|Death|1
2517244|NCT01756274|8711982|P1|Overall Study|Laboratory error|1
2517245|NCT01756274|8711982|P1|Overall Study|Protocol Violation|2
2517246|NCT01756235|8711989|P1|Overall Study|Adalimumab Treatment was not Documented|2
2517247|NCT01756157|8712027|P2|First Intervention Period|Lost to Follow-up|2
2517248|NCT01756157|8712028|P1|First Intervention Period|Lost to Follow-up|0
2517249|NCT01756157|8712027|P2|First Intervention Period|Withdrawal by Subject|0
2517250|NCT01756157|8712028|P1|First Intervention Period|Withdrawal by Subject|1
2517251|NCT01756079|8712042|P1|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4
2517252|NCT01756079|8712042|P1|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20
2517253|NCT01756079|8712042|P1|Treatment / Follow-up: Week 4 to Week 72|No information available|2
2517254|NCT01756079|8712042|P1|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5
2517255|NCT01756079|8712042|P1|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4
2517256|NCT01756053|8712048|P2|Period 2 (10 Days)|Protocol Violation|2
2517257|NCT01756053|8712049|P1|Period 2 (10 Days)|Protocol Violation|0
2517258|NCT01756053|8712048|P2|Period 1 (10 Days)|Protocol Violation|1
2517259|NCT01756053|8712049|P1|Period 1 (10 Days)|Protocol Violation|1
2517260|NCT01755702|8712106|P1|Washout Period II|Other Reason|5
2517261|NCT01755702|8712106|P1|Wash Out Period I|Other Reason|3
2517262|NCT01755689|8712153|P5|Overall Study|Pregnancy|2
2517263|NCT01755689|8712154|P4|Overall Study|Pregnancy|4
2517264|NCT01755689|8712155|P3|Overall Study|Pregnancy|2
2517265|NCT01755689|8712156|P2|Overall Study|Pregnancy|1
2517266|NCT01755689|8712157|P1|Overall Study|Pregnancy|1
2517267|NCT01755689|8712153|P5|Overall Study|Lost to Follow-up|2
2517268|NCT01755689|8712154|P4|Overall Study|Lost to Follow-up|0
2517269|NCT01755689|8712155|P3|Overall Study|Lost to Follow-up|1
2517270|NCT01755689|8712156|P2|Overall Study|Lost to Follow-up|0
2517271|NCT01755689|8712157|P1|Overall Study|Lost to Follow-up|1
2517272|NCT01755689|8712153|P5|Overall Study|Migrated/moved from study area|1
2517273|NCT01755689|8712154|P4|Overall Study|Migrated/moved from study area|1
2517274|NCT01755689|8712155|P3|Overall Study|Migrated/moved from study area|1
2517275|NCT01755689|8712156|P2|Overall Study|Migrated/moved from study area|1
2517276|NCT01755689|8712157|P1|Overall Study|Migrated/moved from study area|0
2517277|NCT01755689|8712153|P5|Overall Study|Withdrawal by Subject|1
2517278|NCT01755689|8712154|P4|Overall Study|Withdrawal by Subject|1
2517279|NCT01755689|8712155|P3|Overall Study|Withdrawal by Subject|2
2517280|NCT01755689|8712156|P2|Overall Study|Withdrawal by Subject|3
2517281|NCT01755689|8712157|P1|Overall Study|Withdrawal by Subject|1
2517282|NCT01755637|8712232|P2|Period 1|Adverse Event|1
2517283|NCT01755637|8712233|P1|Period 1|Adverse Event|0
2517284|NCT01755598|8712253|P2|Overall Study|Adverse Event|28
2517285|NCT01755598|8712254|P1|Overall Study|Adverse Event|19
2517286|NCT01755598|8712253|P2|Overall Study|Protocol Violation|7
2517287|NCT01755598|8712254|P1|Overall Study|Protocol Violation|7
2517288|NCT01755598|8712253|P2|Overall Study|Withdrawal by Subject|31
2517289|NCT01755598|8712254|P1|Overall Study|Withdrawal by Subject|22
2517290|NCT01755598|8712253|P2|Overall Study|Migrated/moved from study area|65
2517291|NCT01755598|8712254|P1|Overall Study|Migrated/moved from study area|76
2517292|NCT01755598|8712253|P2|Overall Study|Lost to Follow-up|43
2517293|NCT01755598|8712254|P1|Overall Study|Lost to Follow-up|32
2517294|NCT01755598|8712253|P2|Overall Study|Other|109
2517295|NCT01755598|8712254|P1|Overall Study|Other|109
2517296|NCT01755546|8712288|P1|Long Term Treatment|other and ongoing|41
2517297|NCT01755546|8712288|P1|Long Term Treatment|Lost to Follow-up|17
2517298|NCT01755546|8712288|P1|Long Term Treatment|Withdrawal by Subject|35
2517299|NCT01755546|8712288|P1|Long Term Treatment|Protocol Violation|10
2517300|NCT01755546|8712288|P1|Long Term Treatment|Lack of Efficacy|6
2517301|NCT01755546|8712288|P1|Long Term Treatment|Adverse Event|12
2517302|NCT01755546|8712288|P1|Titration Phase|Withdrawal by Subject|8
2517303|NCT01755546|8712288|P1|Titration Phase|Other and Continuing|22
2517304|NCT01755546|8712288|P1|Titration Phase|Lost to Follow-up|2
2517305|NCT01755546|8712288|P1|Titration Phase|Protocol Violation|9
2517306|NCT01755546|8712288|P1|Titration Phase|Lack of Efficacy|18
2517307|NCT01755546|8712288|P1|Titration Phase|Adverse Event|11
2517308|NCT01755546|8712288|P1|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5
2517309|NCT01755546|8712288|P1|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1
2517310|NCT01755546|8712288|P1|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3
2517311|NCT01755546|8712288|P1|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1
2517312|NCT01755416|8712305|P2|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2
2517313|NCT01755416|8712306|P1|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1
2517314|NCT01755234|8712314|P2|Overall Study|unblinded|0
2517315|NCT01755234|8712315|P1|Overall Study|unblinded|1
2517316|NCT01755234|8712314|P2|Overall Study|Withdrawal by Subject|1
2517317|NCT01755234|8712315|P1|Overall Study|Withdrawal by Subject|0
2517318|NCT01755234|8712314|P2|Overall Study|case cancelled|0
2517319|NCT01755234|8712315|P1|Overall Study|case cancelled|1
2517320|NCT01755234|8712314|P2|Overall Study|Change in surgical case|1
2517321|NCT01755234|8712315|P1|Overall Study|Change in surgical case|2
2517322|NCT01755234|8712314|P2|Overall Study|Lost to Follow-up|6
2517323|NCT01755234|8712315|P1|Overall Study|Lost to Follow-up|11
2517324|NCT01755156|8712346|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|31
2517325|NCT01755156|8712347|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|27
2517326|NCT01755156|8712346|P2|Phase B (Weeks 24-104)|Lost to Follow-up|5
2517327|NCT01755156|8712347|P1|Phase B (Weeks 24-104)|Lost to Follow-up|12
2517328|NCT01755156|8712346|P2|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
2517329|NCT01755156|8712347|P1|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
2517330|NCT01755156|8712346|P2|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2
2517331|NCT01755156|8712347|P1|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0
2517332|NCT01755156|8712346|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|13
2517333|NCT01755156|8712347|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|6
2517334|NCT01755156|8712346|P2|Phase A (Weeks 0-24)|Protocol Violation|1
2517335|NCT01755156|8712347|P1|Phase A (Weeks 0-24)|Protocol Violation|1
2517336|NCT01755156|8712346|P2|Phase A (Weeks 0-24)|Physician Decision|1
2517337|NCT01755156|8712347|P1|Phase A (Weeks 0-24)|Physician Decision|0
2517338|NCT01755156|8712346|P2|Phase A (Weeks 0-24)|Non-compliance with study drug|0
2517339|NCT01755156|8712347|P1|Phase A (Weeks 0-24)|Non-compliance with study drug|1
2517340|NCT01755156|8712346|P2|Phase A (Weeks 0-24)|Lost to Follow-up|3
2517341|NCT01755156|8712347|P1|Phase A (Weeks 0-24)|Lost to Follow-up|5
2517342|NCT01755156|8712346|P2|Phase A (Weeks 0-24)|Lack of Efficacy|0
2517343|NCT01755156|8712347|P1|Phase A (Weeks 0-24)|Lack of Efficacy|1
2517344|NCT01755156|8712346|P2|Phase A (Weeks 0-24)|Adverse Event|3
2517345|NCT01755156|8712347|P1|Phase A (Weeks 0-24)|Adverse Event|2
2517346|NCT01755091|8712411|P3|Overall Study|Physician Decision|2
2517347|NCT01755091|8712412|P2|Overall Study|Physician Decision|1
2517348|NCT01755091|8712413|P1|Overall Study|Physician Decision|1
2517349|NCT01755091|8712411|P3|Overall Study|Lost to Follow-up|1
2517350|NCT01755091|8712412|P2|Overall Study|Lost to Follow-up|0
2517351|NCT01755091|8712413|P1|Overall Study|Lost to Follow-up|1
2517352|NCT01755091|8712411|P3|Overall Study|Adverse Event|1
2517353|NCT01755091|8712412|P2|Overall Study|Adverse Event|1
2517354|NCT01755091|8712413|P1|Overall Study|Adverse Event|1
2517355|NCT01755091|8712411|P3|Overall Study|Withdrawal by Subject|3
2517356|NCT01755091|8712412|P2|Overall Study|Withdrawal by Subject|1
2517357|NCT01755091|8712413|P1|Overall Study|Withdrawal by Subject|6
2517358|NCT01755026|8712438|P2|Overall Study|Withdrawal by Subject|1
2517359|NCT01755026|8712439|P1|Overall Study|Withdrawal by Subject|1
2517360|NCT01755026|8712438|P2|Overall Study|Adverse Event|0
2517361|NCT01755026|8712439|P1|Overall Study|Adverse Event|1
2517362|NCT01754922|8712462|P2|Overall Study|Adverse Event|1
2517363|NCT01754922|8712463|P1|Overall Study|Adverse Event|0
2517364|NCT01754766|8712489|P3|Overall Study|Personal reasons|0
2517365|NCT01754766|8712490|P2|Overall Study|Personal reasons|1
2517366|NCT01754766|8712491|P1|Overall Study|Personal reasons|1
2517367|NCT01754727|8712505|P1|Overall Study|Adalimumab Treatment was not Documented|2
2517368|NCT01754493|8712637|P1|Overall Study|Scheduling conflict|1
2517369|NCT01754493|8712637|P1|Overall Study|Moved out of town|1
2517370|NCT01754493|8712637|P1|Overall Study|Withdrawal by Subject|1
2517371|NCT01754493|8712637|P1|Overall Study|Lost to Follow-up|3
2517372|NCT01754493|8712637|P1|Overall Study|Adverse Event|1
2517373|NCT01754467|8712662|P1|Overall Study|Lost to Follow-up|1
2517374|NCT01754402|8712672|P3|Overall Study|Lack of Efficacy|1
2517375|NCT01754402|8712673|P2|Overall Study|Lack of Efficacy|0
2517376|NCT01754402|8712674|P1|Overall Study|Lack of Efficacy|0
2517377|NCT01754402|8712672|P3|Overall Study|Withdrawal by Subject|1
2517378|NCT01754402|8712673|P2|Overall Study|Withdrawal by Subject|0
2517379|NCT01754402|8712674|P1|Overall Study|Withdrawal by Subject|0
2517380|NCT01754402|8712672|P3|Overall Study|Adverse Event|1
2517381|NCT01754402|8712673|P2|Overall Study|Adverse Event|2
2517382|NCT01754402|8712674|P1|Overall Study|Adverse Event|2
2517383|NCT01754402|8712672|P3|Overall Study|Death|1
2517384|NCT01754402|8712673|P2|Overall Study|Death|0
2517385|NCT01754402|8712674|P1|Overall Study|Death|0
2517386|NCT01754376|8712708|P1|Overall Study|Lack of Efficacy|2
2517387|NCT01754376|8712708|P1|Overall Study|Adverse Event|1
2517388|NCT01754259|8712719|P2|Overall Study|Lost to Follow-up|1
2517389|NCT01754259|8712720|P1|Overall Study|Lost to Follow-up|0
2517390|NCT01754259|8712719|P2|Overall Study|Adverse Event|1
2517391|NCT01754259|8712720|P1|Overall Study|Adverse Event|3
2517392|NCT01754259|8712719|P2|Overall Study|Withdrawal by Subject|4
2517393|NCT01754259|8712720|P1|Overall Study|Withdrawal by Subject|2
2517394|NCT01754194|8712730|P2|Overall Study|Other|8
2517395|NCT01754194|8712731|P1|Overall Study|Other|9
2517396|NCT01754194|8712730|P2|Overall Study|Withdrawal by Subject|5
2517397|NCT01754194|8712731|P1|Overall Study|Withdrawal by Subject|4
2517398|NCT01754194|8712730|P2|Overall Study|Lost to Follow-up|14
2517399|NCT01754194|8712731|P1|Overall Study|Lost to Follow-up|39
2517400|NCT01754129|8712751|P1|Overall Study|Inclusion/exclusion criteria violation|3
2517401|NCT01754129|8712751|P1|Overall Study|Withdrew consent|1
2517402|NCT01754129|8712751|P1|Overall Study|Lost to Follow-up|7
2517403|NCT01754129|8712751|P1|Overall Study|Duodopa discontinuation|9
2517404|NCT01754129|8712751|P1|Overall Study|Death|13
2517405|NCT01753999|8712774|P2|Period 2 -Cross to Alternate Arm|Physician Decision|1
2517406|NCT01753999|8712775|P1|Period 2 -Cross to Alternate Arm|Physician Decision|1
2517407|NCT01753999|8712774|P2|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5
2517408|NCT01753999|8712775|P1|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3
2517409|NCT01753999|8712774|P2|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17
2517410|NCT01753999|8712775|P1|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13
2517411|NCT01753999|8712774|P2|Period 1 - Initial Assignment|Lost to Follow-up|27
2517412|NCT01753999|8712775|P1|Period 1 - Initial Assignment|Lost to Follow-up|18
2517413|NCT01753999|8712774|P2|Period 1 - Initial Assignment|Withdrawal by Subject|20
2517414|NCT01753999|8712775|P1|Period 1 - Initial Assignment|Withdrawal by Subject|19
2517415|NCT01753999|8712774|P2|Period 1 - Initial Assignment|Physician Decision|3
2517416|NCT01753999|8712775|P1|Period 1 - Initial Assignment|Physician Decision|2
2517417|NCT01753856|8712789|P2|Overall Study|Sponsor Decision|0
2517418|NCT01753856|8712790|P1|Overall Study|Sponsor Decision|2
2517419|NCT01753856|8712789|P2|Overall Study|Withdrawal by Subject|2
2517420|NCT01753856|8712790|P1|Overall Study|Withdrawal by Subject|0
2517421|NCT01753856|8712789|P2|Overall Study|Adverse Event|0
2517422|NCT01753856|8712790|P1|Overall Study|Adverse Event|1
2517423|NCT01753570|8712862|P3|Overall Study|Withdrawal by Subject|0
2517424|NCT01753570|8712863|P2|Overall Study|Withdrawal by Subject|4
2517425|NCT01753570|8712864|P1|Overall Study|Withdrawal by Subject|1
2517426|NCT01753570|8712862|P3|Overall Study|Physician Decision|0
2517427|NCT01753570|8712863|P2|Overall Study|Physician Decision|1
2517428|NCT01753570|8712864|P1|Overall Study|Physician Decision|0
2517429|NCT01753570|8712862|P3|Overall Study|Adverse Event|1
2517430|NCT01753570|8712863|P2|Overall Study|Adverse Event|0
2517431|NCT01753570|8712864|P1|Overall Study|Adverse Event|1
2517432|NCT01753518|8712907|P2|Postpartum Follow-up|Lost to Follow-up|15
2517433|NCT01753518|8712908|P1|Postpartum Follow-up|Lost to Follow-up|22
2517434|NCT01753518|8712907|P2|Intention-to-Treat Analysis|Body Mass Index>50|1
2517435|NCT01753518|8712908|P1|Intention-to-Treat Analysis|Body Mass Index>50|0
2517436|NCT01753518|8712907|P2|Intention-to-Treat Analysis|Multifetal gestation|3
2517437|NCT01753518|8712908|P1|Intention-to-Treat Analysis|Multifetal gestation|2
2517438|NCT01753518|8712907|P2|Intention-to-Treat Analysis|Missing consent form|3
2517439|NCT01753518|8712908|P1|Intention-to-Treat Analysis|Missing consent form|5
2517440|NCT01753401|8712932|P4|Open Label Period (44 Weeks)|Reason not provided|2
2517441|NCT01753401|8712933|P3|Open Label Period (44 Weeks)|Reason not provided|0
2517442|NCT01753401|8712934|P2|Open Label Period (44 Weeks)|Reason not provided|0
2517443|NCT01753401|8712935|P1|Open Label Period (44 Weeks)|Reason not provided|0
2517444|NCT01753401|8712932|P4|Open Label Period (44 Weeks)|Lack of Efficacy|1
2517445|NCT01753401|8712933|P3|Open Label Period (44 Weeks)|Lack of Efficacy|1
2517446|NCT01753401|8712934|P2|Open Label Period (44 Weeks)|Lack of Efficacy|0
2517447|NCT01753401|8712935|P1|Open Label Period (44 Weeks)|Lack of Efficacy|0
2517448|NCT01753401|8712932|P4|Open Label Period (44 Weeks)|Withdrawal by Subject|2
2517449|NCT01753401|8712933|P3|Open Label Period (44 Weeks)|Withdrawal by Subject|0
2517450|NCT01753401|8712934|P2|Open Label Period (44 Weeks)|Withdrawal by Subject|0
2517451|NCT01753401|8712935|P1|Open Label Period (44 Weeks)|Withdrawal by Subject|0
2517452|NCT01753401|8712932|P4|Open Label Period (44 Weeks)|Adverse Event|4
2517453|NCT01753401|8712933|P3|Open Label Period (44 Weeks)|Adverse Event|3
2517454|NCT01753401|8712934|P2|Open Label Period (44 Weeks)|Adverse Event|0
2517455|NCT01753401|8712935|P1|Open Label Period (44 Weeks)|Adverse Event|0
2517456|NCT01753401|8712932|P4|Double-blind Period (8 Weeks)|Protocol Violation|0
2517457|NCT01753401|8712933|P3|Double-blind Period (8 Weeks)|Protocol Violation|0
2517458|NCT01753401|8712934|P2|Double-blind Period (8 Weeks)|Protocol Violation|1
2517459|NCT01753401|8712935|P1|Double-blind Period (8 Weeks)|Protocol Violation|0
2517460|NCT01753401|8712932|P4|Double-blind Period (8 Weeks)|Withdrawal by Subject|0
2517461|NCT01753401|8712933|P3|Double-blind Period (8 Weeks)|Withdrawal by Subject|0
2517462|NCT01753401|8712934|P2|Double-blind Period (8 Weeks)|Withdrawal by Subject|1
2517463|NCT01753401|8712935|P1|Double-blind Period (8 Weeks)|Withdrawal by Subject|1
2517464|NCT01753401|8712932|P4|Double-blind Period (8 Weeks)|Adverse Event|0
2517465|NCT01753401|8712933|P3|Double-blind Period (8 Weeks)|Adverse Event|0
2517466|NCT01753401|8712934|P2|Double-blind Period (8 Weeks)|Adverse Event|2
2517467|NCT01753401|8712935|P1|Double-blind Period (8 Weeks)|Adverse Event|0
2517468|NCT01753336|8712994|P1|Overall Study|Withdrawal by Subject|1
2517469|NCT01753336|8712994|P1|Overall Study|Sponsor's decision|2
2517470|NCT01753336|8712994|P1|Overall Study|Physician Decision|2
2517471|NCT01753336|8712994|P1|Overall Study|Lost to Follow-up|3
2517472|NCT01753336|8712994|P1|Overall Study|Patient decision|12
2517473|NCT01753323|8713006|P3|Overall Study|Adverse Event|1
2517474|NCT01753323|8713007|P2|Overall Study|Adverse Event|0
2517475|NCT01753323|8713008|P1|Overall Study|Adverse Event|0
2517476|NCT01753323|8713006|P3|Overall Study|Protocol deviation|0
2517477|NCT01753323|8713007|P2|Overall Study|Protocol deviation|0
2517478|NCT01753323|8713008|P1|Overall Study|Protocol deviation|1
2517479|NCT01753323|8713006|P3|Overall Study|Lack of Efficacy|8
2517480|NCT01753323|8713007|P2|Overall Study|Lack of Efficacy|0
2517481|NCT01753323|8713008|P1|Overall Study|Lack of Efficacy|0
2517482|NCT01753310|8713046|P2|Overall Study|Withdrawal by Subject|0
2517483|NCT01753310|8713047|P1|Overall Study|Withdrawal by Subject|1
2517484|NCT01753310|8713046|P2|Overall Study|Sponsor decision|0
2517485|NCT01753310|8713047|P1|Overall Study|Sponsor decision|1
2517486|NCT01753310|8713046|P2|Overall Study|Subject decision|2
2517487|NCT01753310|8713047|P1|Overall Study|Subject decision|2
2517488|NCT01753310|8713046|P2|Overall Study|Lost to Follow-up|0
2517489|NCT01753310|8713047|P1|Overall Study|Lost to Follow-up|2
2517490|NCT01753310|8713046|P2|Overall Study|Adverse Event|0
2517491|NCT01753310|8713047|P1|Overall Study|Adverse Event|1
2517492|NCT01753310|8713046|P2|Overall Study|Entered into open label extension study|22
2517493|NCT01753310|8713047|P1|Overall Study|Entered into open label extension study|25
2517494|NCT01753193|8713067|P1|Overall Study|Other|16
2517495|NCT01753193|8713067|P1|Overall Study|Death|1
2517496|NCT01753193|8713067|P1|Overall Study|Lost to Follow-up|6
2517497|NCT01753193|8713067|P1|Overall Study|Withdrawal by Subject|23
2517498|NCT01753115|8713082|P3|Overall Study|Used excluded drug|0
2517499|NCT01753115|8713083|P2|Overall Study|Used excluded drug|1
2517500|NCT01753115|8713084|P1|Overall Study|Used excluded drug|0
2517501|NCT01753115|8713082|P3|Overall Study|Subject non-compliant|0
2517502|NCT01753115|8713083|P2|Overall Study|Subject non-compliant|3
2517503|NCT01753115|8713084|P1|Overall Study|Subject non-compliant|3
2517504|NCT01753115|8713082|P3|Overall Study|Withdrawal by Subject|6
2517505|NCT01753115|8713083|P2|Overall Study|Withdrawal by Subject|5
2517506|NCT01753115|8713084|P1|Overall Study|Withdrawal by Subject|6
2517507|NCT01753115|8713082|P3|Overall Study|Lost to Follow-up|8
2517508|NCT01753115|8713083|P2|Overall Study|Lost to Follow-up|6
2517509|NCT01753115|8713084|P1|Overall Study|Lost to Follow-up|3
2517510|NCT01753076|8713094|P2|Overall Study|Other-Reached Protocol-defined Stopping|0
2517511|NCT01753076|8713095|P1|Overall Study|Other-Reached Protocol-defined Stopping|1
2517512|NCT01753076|8713094|P2|Overall Study|Withdrawal by Subject|24
2517513|NCT01753076|8713095|P1|Overall Study|Withdrawal by Subject|14
2517514|NCT01753076|8713094|P2|Overall Study|Physician Decision|2
2517515|NCT01753076|8713095|P1|Overall Study|Physician Decision|4
2517516|NCT01753076|8713094|P2|Overall Study|Lost to Follow-up|1
2517517|NCT01753076|8713095|P1|Overall Study|Lost to Follow-up|2
2517518|NCT01753076|8713094|P2|Overall Study|Lack of Efficacy|1
2517519|NCT01753076|8713095|P1|Overall Study|Lack of Efficacy|3
2517520|NCT01753076|8713094|P2|Overall Study|Adverse Event|18
2517521|NCT01753076|8713095|P1|Overall Study|Adverse Event|17
2517522|NCT01752985|8713122|P3|Treatment Period|Lost to Follow-up|1
2517523|NCT01752985|8713123|P2|Treatment Period|Lost to Follow-up|0
2517524|NCT01752985|8713124|P1|Treatment Period|Lost to Follow-up|0
2517525|NCT01752985|8713122|P3|Treatment Period|Withdrawal by Subject|0
2517526|NCT01752985|8713123|P2|Treatment Period|Withdrawal by Subject|1
2517527|NCT01752985|8713124|P1|Treatment Period|Withdrawal by Subject|1
2517528|NCT01752985|8713122|P3|Treatment Period|Adverse Event|2
2517529|NCT01752985|8713123|P2|Treatment Period|Adverse Event|1
2517530|NCT01752985|8713124|P1|Treatment Period|Adverse Event|2
2517531|NCT01752985|8713122|P3|Treatment Period|Subject no longer meets study criteria|1
2517532|NCT01752985|8713123|P2|Treatment Period|Subject no longer meets study criteria|1
2517533|NCT01752985|8713124|P1|Treatment Period|Subject no longer meets study criteria|0
2517534|NCT01752985|8713122|P3|Treatment Period|Subject request to discontinue treatment|1
2517535|NCT01752985|8713123|P2|Treatment Period|Subject request to discontinue treatment|0
2517536|NCT01752985|8713124|P1|Treatment Period|Subject request to discontinue treatment|1
2517537|NCT01752933|8713152|P2|Overall Study and Follow-up|Lost to Follow-up|2
2517538|NCT01752933|8713153|P1|Overall Study and Follow-up|Lost to Follow-up|0
2517539|NCT01752933|8713152|P2|Overall Study and Follow-up|Withdrawal by Subject|3
2517540|NCT01752933|8713153|P1|Overall Study and Follow-up|Withdrawal by Subject|0
2517541|NCT01752933|8713152|P2|Overall Study and Follow-up|Sponsor terminated study/Database lock|7
2517542|NCT01752933|8713153|P1|Overall Study and Follow-up|Sponsor terminated study/Database lock|0
2517543|NCT01752933|8713152|P2|Overall Study and Follow-up|Death|34
2517544|NCT01752933|8713153|P1|Overall Study and Follow-up|Death|4
2517545|NCT01752933|8713152|P2|Treatment|Patient unable to travel to appointments|1
2517546|NCT01752933|8713153|P1|Treatment|Patient unable to travel to appointments|0
2517547|NCT01752933|8713152|P2|Treatment|Patient noncompliant|1
2517548|NCT01752933|8713153|P1|Treatment|Patient noncompliant|0
2517549|NCT01752933|8713152|P2|Treatment|Hepatocellular carcinoma not confirmed|1
2517550|NCT01752933|8713153|P1|Treatment|Hepatocellular carcinoma not confirmed|0
2517551|NCT01752933|8713152|P2|Treatment|Death|2
2517552|NCT01752933|8713153|P1|Treatment|Death|0
2517553|NCT01752933|8713152|P2|Treatment|Physician Decision|3
2517554|NCT01752933|8713153|P1|Treatment|Physician Decision|0
2517555|NCT01752933|8713152|P2|Treatment|Adverse Event|4
2517556|NCT01752933|8713153|P1|Treatment|Adverse Event|1
2517557|NCT01752933|8713152|P2|Treatment|Withdrawal by Subject|5
2517558|NCT01752933|8713153|P1|Treatment|Withdrawal by Subject|0
2517559|NCT01752933|8713152|P2|Treatment|Disease Progression|29
2517560|NCT01752933|8713153|P1|Treatment|Disease Progression|3
2517561|NCT01752907|8713171|P2|Overall Study|Decision by Sponsor|9
2517562|NCT01752907|8713172|P1|Overall Study|Decision by Sponsor|6
2517563|NCT01752907|8713171|P2|Overall Study|Lost to Follow-up|1
2517564|NCT01752907|8713172|P1|Overall Study|Lost to Follow-up|2
2517565|NCT01752907|8713171|P2|Overall Study|Withdrawal by Subject|10
2517566|NCT01752907|8713172|P1|Overall Study|Withdrawal by Subject|4
2517567|NCT01752855|8713192|P2|Overall Study|Lack of Efficacy|2
2517568|NCT01752855|8713193|P1|Overall Study|Lack of Efficacy|0
2517569|NCT01752855|8713192|P2|Overall Study|Withdrew Consent|2
2517570|NCT01752855|8713193|P1|Overall Study|Withdrew Consent|0
2517571|NCT01752855|8713192|P2|Overall Study|Adverse Event|0
2517572|NCT01752855|8713193|P1|Overall Study|Adverse Event|1
2517573|NCT01752842|8713209|P2|Overall Study|Withdrawal by Subject|2
2517574|NCT01752842|8713210|P1|Overall Study|Withdrawal by Subject|0
2517575|NCT01752842|8713209|P2|Overall Study|Adverse Event|0
2517576|NCT01752842|8713210|P1|Overall Study|Adverse Event|3
2517577|NCT01752023|8713257|P2|Overall Study|Physician Decision|1
2517578|NCT01752023|8713258|P1|Overall Study|Physician Decision|2
2517579|NCT01751906|8713294|P2|Overall Study|Other|0
2517580|NCT01751906|8713295|P1|Overall Study|Other|1
2517581|NCT01751906|8713294|P2|Overall Study|Death|22
2517582|NCT01751906|8713295|P1|Overall Study|Death|38
2517583|NCT01751906|8713294|P2|Overall Study|Physician Decision|1
2517584|NCT01751906|8713295|P1|Overall Study|Physician Decision|3
2517585|NCT01751906|8713294|P2|Overall Study|Withdrawal by Subject|6
2517586|NCT01751906|8713295|P1|Overall Study|Withdrawal by Subject|14
2517587|NCT01751906|8713294|P2|Overall Study|Lost to Follow-up|18
2517588|NCT01751906|8713295|P1|Overall Study|Lost to Follow-up|28
2517589|NCT01751867|8713499|P2|Overall Study|Randomized but not treated.|1
2517590|NCT01751867|8713500|P1|Overall Study|Randomized but not treated.|2
2517591|NCT01751867|8713499|P2|Overall Study|Other|37
2517592|NCT01751867|8713500|P1|Overall Study|Other|11
2517593|NCT01751867|8713499|P2|Overall Study|Death|5
2517594|NCT01751867|8713500|P1|Overall Study|Death|0
2517595|NCT01751867|8713499|P2|Overall Study|Protocol Violation|2
2517596|NCT01751867|8713500|P1|Overall Study|Protocol Violation|0
2517597|NCT01751867|8713499|P2|Overall Study|Physician Decision|7
2517598|NCT01751867|8713500|P1|Overall Study|Physician Decision|4
2517599|NCT01751867|8713499|P2|Overall Study|Withdrawal by Subject|1
2517600|NCT01751867|8713500|P1|Overall Study|Withdrawal by Subject|3
2517601|NCT01751867|8713499|P2|Overall Study|Poor Compliance|5
2517602|NCT01751867|8713500|P1|Overall Study|Poor Compliance|0
2517603|NCT01751867|8713499|P2|Overall Study|Adverse Event|15
2517604|NCT01751867|8713500|P1|Overall Study|Adverse Event|8
2517605|NCT01751867|8713499|P2|Overall Study|Diease Progression|18
2517606|NCT01751867|8713500|P1|Overall Study|Diease Progression|4
2517607|NCT01751867|8713499|P2|Overall Study|Completed treatment,dropped in follow-up|8
2517608|NCT01751867|8713500|P1|Overall Study|Completed treatment,dropped in follow-up|4
2517609|NCT01751802|8713520|P2|Overall Study|Adverse Event|2
2517610|NCT01751802|8713521|P1|Overall Study|Adverse Event|4
2517611|NCT01751724|8713535|P2|Overall Study|withdrawn by parent|2
2517612|NCT01751724|8713536|P1|Overall Study|withdrawn by parent|0
2517613|NCT01751724|8713535|P2|Overall Study|extubated bef.start assigned treatment|0
2517614|NCT01751724|8713536|P1|Overall Study|extubated bef.start assigned treatment|1
2517615|NCT01751646|8713564|P2|Overall Study|Childcare issues|1
2517616|NCT01751646|8713565|P1|Overall Study|Childcare issues|1
2517617|NCT01751646|8713564|P2|Overall Study|Fails to comply with study requirements|1
2517618|NCT01751646|8713565|P1|Overall Study|Fails to comply with study requirements|0
2517619|NCT01751646|8713564|P2|Overall Study|Off study due to multiple obligations|1
2517620|NCT01751646|8713565|P1|Overall Study|Off study due to multiple obligations|0
2517621|NCT01751646|8713564|P2|Overall Study|Inability to attend required visits|1
2517622|NCT01751646|8713565|P1|Overall Study|Inability to attend required visits|0
2517623|NCT01751646|8713564|P2|Overall Study|Moved out of the area|5
2517624|NCT01751646|8713565|P1|Overall Study|Moved out of the area|1
2517625|NCT01751646|8713564|P2|Overall Study|Inadvertent enrollment|1
2517626|NCT01751646|8713565|P1|Overall Study|Inadvertent enrollment|1
2517627|NCT01751646|8713564|P2|Overall Study|Missed 4 or more consecutive DOT visits|3
2517628|NCT01751646|8713565|P1|Overall Study|Missed 4 or more consecutive DOT visits|2
2517629|NCT01751646|8713564|P2|Overall Study|Starting hormone therapy|0
2517630|NCT01751646|8713565|P1|Overall Study|Starting hormone therapy|1
2517631|NCT01751646|8713564|P2|Overall Study|Withdrawal by Subject|4
2517632|NCT01751646|8713565|P1|Overall Study|Withdrawal by Subject|0
2517633|NCT01751646|8713564|P2|Overall Study|Lost to Follow-up|1
2517634|NCT01751646|8713565|P1|Overall Study|Lost to Follow-up|5
2517635|NCT01751412|8713713|P1|Overall Study|Disease Progression Before Treatment|1
2517636|NCT01751178|8713823|P3|Overall Study|Other Reason (unknown)|2
2517637|NCT01751178|8713824|P2|Overall Study|Other Reason (unknown)|0
2517638|NCT01751178|8713825|P1|Overall Study|Other Reason (unknown)|1
2517639|NCT01751178|8713823|P3|Overall Study|Adverse Event|0
2517640|NCT01751178|8713824|P2|Overall Study|Adverse Event|0
2517641|NCT01751178|8713825|P1|Overall Study|Adverse Event|2
2517642|NCT01751165|8713845|P3|Overall Study|Lost to Follow-up|1
2517643|NCT01751165|8713846|P2|Overall Study|Lost to Follow-up|1
2517644|NCT01751165|8713847|P1|Overall Study|Lost to Follow-up|1
2517645|NCT01751165|8713845|P3|Overall Study|Serious adverse event|0
2517646|NCT01751165|8713846|P2|Overall Study|Serious adverse event|2
2517647|NCT01751165|8713847|P1|Overall Study|Serious adverse event|0
2517648|NCT01751165|8713845|P3|Overall Study|Withdrawal by Subject|1
2517649|NCT01751165|8713846|P2|Overall Study|Withdrawal by Subject|0
2517650|NCT01751165|8713847|P1|Overall Study|Withdrawal by Subject|0
2517651|NCT01751165|8713845|P3|Overall Study|Adverse event, serious fatal|1
2517652|NCT01751165|8713846|P2|Overall Study|Adverse event, serious fatal|0
2517653|NCT01751165|8713847|P1|Overall Study|Adverse event, serious fatal|1
2517654|NCT01751139|8713887|P1|Overall Study|Death|31
2517655|NCT01751139|8713887|P1|Overall Study|Adverse Event|1
2517656|NCT01751139|8713887|P1|Overall Study|Withdrawal by Subject|251
2517657|NCT01751139|8713887|P1|Overall Study|Lost to Follow-up|240
2517658|NCT01751139|8713887|P1|Overall Study|Sponsor study termination|1609
2517659|NCT01751139|8713887|P1|Overall Study|Other|135
2517660|NCT01751113|8713905|P6|Treatment Period 3 (4 Weeks)|Adverse Event|1
2517661|NCT01751113|8713906|P5|Treatment Period 3 (4 Weeks)|Adverse Event|0
2517662|NCT01751113|8713907|P4|Treatment Period 3 (4 Weeks)|Adverse Event|0
2517663|NCT01751113|8713908|P3|Treatment Period 3 (4 Weeks)|Adverse Event|0
2517664|NCT01751113|8713909|P2|Treatment Period 3 (4 Weeks)|Adverse Event|0
2517665|NCT01751113|8713910|P1|Treatment Period 3 (4 Weeks)|Adverse Event|0
2517666|NCT01751113|8713905|P6|Treatment Period 1 (4 Weeks)|Adverse Event|0
2517667|NCT01751113|8713906|P5|Treatment Period 1 (4 Weeks)|Adverse Event|1
2517668|NCT01751113|8713907|P4|Treatment Period 1 (4 Weeks)|Adverse Event|1
2517669|NCT01751113|8713908|P3|Treatment Period 1 (4 Weeks)|Adverse Event|0
2517670|NCT01751113|8713909|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
2517671|NCT01751113|8713910|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
2517672|NCT01751087|8713951|P3|Overall Study|Physician Decision|1
2517673|NCT01751087|8713952|P2|Overall Study|Physician Decision|0
2517674|NCT01751087|8713953|P1|Overall Study|Physician Decision|0
2517675|NCT01751087|8713951|P3|Overall Study|Withdrawal by Subject|0
2517676|NCT01751087|8713952|P2|Overall Study|Withdrawal by Subject|0
2517677|NCT01751087|8713953|P1|Overall Study|Withdrawal by Subject|1
2517678|NCT01751061|8713987|P2|Overall Study|Physician Decision|0
2517679|NCT01751061|8713988|P1|Overall Study|Physician Decision|2
2517680|NCT01751061|8713987|P2|Overall Study|Withdrawal by Subject|1
2517681|NCT01751061|8713988|P1|Overall Study|Withdrawal by Subject|4
2517682|NCT01751061|8713987|P2|Overall Study|patient regained decisional capacity|8
2517683|NCT01751061|8713988|P1|Overall Study|patient regained decisional capacity|4
2517684|NCT01751061|8713987|P2|Overall Study|Lost to Follow-up|25
2517685|NCT01751061|8713988|P1|Overall Study|Lost to Follow-up|40
2517686|NCT01751061|8713987|P2|Overall Study|patient death|0
2517687|NCT01751061|8713988|P1|Overall Study|patient death|5
2517688|NCT01751061|8713987|P2|Overall Study|Death|0
2517689|NCT01751061|8713988|P1|Overall Study|Death|1
2517690|NCT01750840|8714062|P1|Overall Study|Lost to Follow-up|4
2517691|NCT01750697|8714067|P1|Overall Study|Withdrawal by Subject|1
2517692|NCT01750697|8714067|P1|Overall Study|Physician Decision|1
2517693|NCT01750697|8714067|P1|Overall Study|Transferred to Adult Services|5
2517694|NCT01750697|8714067|P1|Overall Study|Physician and Family Decision|1
2517695|NCT01750697|8714067|P1|Overall Study|Transferred Back to Local Hospital|1
2517696|NCT01750684|8714079|P2|Overall Study|Protocol Violation|0
2517697|NCT01750684|8714080|P1|Overall Study|Protocol Violation|1
2517698|NCT01750684|8714079|P2|Overall Study|Withdrawn by Sponsor|1
2517699|NCT01750684|8714080|P1|Overall Study|Withdrawn by Sponsor|0
2517700|NCT01750684|8714079|P2|Overall Study|Non-compliance with Study Drug|1
2517701|NCT01750684|8714080|P1|Overall Study|Non-compliance with Study Drug|0
2517702|NCT01750684|8714079|P2|Overall Study|Death|0
2517703|NCT01750684|8714080|P1|Overall Study|Death|1
2517704|NCT01750346|8714117|P3|Overall Study|Adverse Event|0
2517705|NCT01750346|8714118|P2|Overall Study|Adverse Event|0
2517706|NCT01750346|8714119|P1|Overall Study|Adverse Event|1
2517707|NCT01750294|8714145|P1|Overall Study|Safety Endpoint|1
2517708|NCT01750294|8714145|P1|Overall Study|Withdrawal by Subject|1
2517709|NCT01750281|8714152|P3|Overall Study|Did not receive treatment|0
2517710|NCT01750281|8714153|P2|Overall Study|Did not receive treatment|1
2517711|NCT01750281|8714154|P1|Overall Study|Did not receive treatment|0
2517712|NCT01750281|8714152|P3|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9
2517713|NCT01750281|8714153|P2|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7
2517714|NCT01750281|8714154|P1|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6
2517715|NCT01750281|8714152|P3|Overall Study|Discontinued Selumetinib/Placebo|75
2517716|NCT01750281|8714153|P2|Overall Study|Discontinued Selumetinib/Placebo|77
2517717|NCT01750281|8714154|P1|Overall Study|Discontinued Selumetinib/Placebo|37
2517718|NCT01750242|8714184|P1|Overall Study|Unreadable Images|3
2517719|NCT01750229|8714189|P1|Long-term Follow-up Phase|Withdrawal by Subject|1
2517720|NCT01750229|8714189|P1|Long-term Follow-up Phase|Adverse Event|2
2517721|NCT01750229|8714189|P1|Randomized Crossover Phase|Withdrawal by Subject|1
2517722|NCT01750229|8714189|P1|Randomized Crossover Phase|Adverse Event|1
2517723|NCT01749982|8714216|P4|Overall Study|Withdrawal by Subject|1
2517724|NCT01749982|8714217|P3|Overall Study|Withdrawal by Subject|0
2517725|NCT01749982|8714218|P2|Overall Study|Withdrawal by Subject|0
2517726|NCT01749982|8714219|P1|Overall Study|Withdrawal by Subject|0
2517727|NCT01749982|8714216|P4|Overall Study|Lost to Follow-up|1
2517728|NCT01749982|8714217|P3|Overall Study|Lost to Follow-up|0
2517729|NCT01749982|8714218|P2|Overall Study|Lost to Follow-up|0
2517730|NCT01749982|8714219|P1|Overall Study|Lost to Follow-up|0
2517731|NCT01749982|8714216|P4|Overall Study|Physician Decision|1
2517732|NCT01749982|8714217|P3|Overall Study|Physician Decision|0
2517733|NCT01749982|8714218|P2|Overall Study|Physician Decision|0
2517734|NCT01749982|8714219|P1|Overall Study|Physician Decision|0
2517735|NCT01749826|8714283|P2|Overall Study|Study Terminated|0
2517736|NCT01749826|8714284|P1|Overall Study|Study Terminated|20
2517737|NCT01749800|8714299|P3|Overall Study|Withdrawal by Subject|0
2517738|NCT01749800|8714300|P2|Overall Study|Withdrawal by Subject|1
2517739|NCT01749800|8714301|P1|Overall Study|Withdrawal by Subject|0
2517740|NCT01749800|8714299|P3|Overall Study|not meeting inclusion criteria|0
2517741|NCT01749800|8714300|P2|Overall Study|not meeting inclusion criteria|0
2517742|NCT01749800|8714301|P1|Overall Study|not meeting inclusion criteria|3
2517743|NCT01749735|8714311|P2|Overall Study|Withdrawal by Subject|0
2517744|NCT01749735|8714312|P1|Overall Study|Withdrawal by Subject|1
2517745|NCT01749033|8714363|P3|Overall Study|Lost to Follow-up|1
2517746|NCT01749033|8714364|P2|Overall Study|Lost to Follow-up|2
2517747|NCT01749033|8714365|P1|Overall Study|Lost to Follow-up|0
2517748|NCT01749033|8714363|P3|Overall Study|Did not receive allocated intervention|0
2517749|NCT01749033|8714364|P2|Overall Study|Did not receive allocated intervention|3
2517750|NCT01749033|8714365|P1|Overall Study|Did not receive allocated intervention|3
2517751|NCT01748890|8714435|P1|Overall Study|Insufficient recruitment for analysis|4
2517752|NCT01748760|8714490|P2|Overall Study|Lost to Follow-up|1
2517753|NCT01748760|8714491|P1|Overall Study|Lost to Follow-up|5
2517754|NCT01748760|8714490|P2|Overall Study|Withdrawal by Subject|1
2517755|NCT01748760|8714491|P1|Overall Study|Withdrawal by Subject|1
2517756|NCT01748552|8714537|P12|Intervention Period 2 and Washout|Contingency dose not tested|0
2517757|NCT01748552|8714538|P11|Intervention Period 2 and Washout|Contingency dose not tested|0
2517758|NCT01748552|8714539|P10|Intervention Period 2 and Washout|Contingency dose not tested|0
2517759|NCT01748552|8714540|P9|Intervention Period 2 and Washout|Contingency dose not tested|3
2517760|NCT01748552|8714541|P8|Intervention Period 2 and Washout|Contingency dose not tested|3
2517761|NCT01748552|8714542|P7|Intervention Period 2 and Washout|Contingency dose not tested|3
2517762|NCT01748552|8714543|P6|Intervention Period 2 and Washout|Contingency dose not tested|0
2517763|NCT01748552|8714544|P5|Intervention Period 2 and Washout|Contingency dose not tested|0
2517764|NCT01748552|8714545|P4|Intervention Period 2 and Washout|Contingency dose not tested|0
2517765|NCT01748552|8714546|P3|Intervention Period 2 and Washout|Contingency dose not tested|0
2517766|NCT01748552|8714547|P2|Intervention Period 2 and Washout|Contingency dose not tested|0
2517767|NCT01748552|8714548|P1|Intervention Period 2 and Washout|Contingency dose not tested|0
2517768|NCT01748552|8714537|P12|Intervention Period 2 and Washout|Physician Decision|0
2517769|NCT01748552|8714538|P11|Intervention Period 2 and Washout|Physician Decision|0
2517770|NCT01748552|8714539|P10|Intervention Period 2 and Washout|Physician Decision|0
2517771|NCT01748552|8714540|P9|Intervention Period 2 and Washout|Physician Decision|0
2517772|NCT01748552|8714541|P8|Intervention Period 2 and Washout|Physician Decision|0
2517773|NCT01748552|8714542|P7|Intervention Period 2 and Washout|Physician Decision|0
2517774|NCT01748552|8714543|P6|Intervention Period 2 and Washout|Physician Decision|0
2517775|NCT01748552|8714544|P5|Intervention Period 2 and Washout|Physician Decision|0
2517776|NCT01748552|8714545|P4|Intervention Period 2 and Washout|Physician Decision|0
2517777|NCT01748552|8714546|P3|Intervention Period 2 and Washout|Physician Decision|1
2517778|NCT01748552|8714547|P2|Intervention Period 2 and Washout|Physician Decision|0
2517779|NCT01748552|8714548|P1|Intervention Period 2 and Washout|Physician Decision|0
2517780|NCT01748292|8714618|P2|Overall Study|Withdrawal by Subject|2
2517781|NCT01748292|8714619|P1|Overall Study|Withdrawal by Subject|0
2517782|NCT01748292|8714618|P2|Overall Study|Death|3
2517783|NCT01748292|8714619|P1|Overall Study|Death|0
2517784|NCT01748292|8714618|P2|Overall Study|Lost to Follow-up|3
2517785|NCT01748292|8714619|P1|Overall Study|Lost to Follow-up|0
2517786|NCT01748292|8714618|P2|Overall Study|Adverse Event|4
2517787|NCT01748292|8714619|P1|Overall Study|Adverse Event|2
2517788|NCT01748162|8714653|P2|Overall Study|reasons not available|2
2517789|NCT01748162|8714654|P1|Overall Study|reasons not available|3
2517790|NCT01748162|8714653|P2|Overall Study|participant consented but did not begin|1
2517791|NCT01748162|8714654|P1|Overall Study|participant consented but did not begin|0
2517792|NCT01748162|8714653|P2|Overall Study|no additional croup episodes to evaluate|2
2517793|NCT01748162|8714654|P1|Overall Study|no additional croup episodes to evaluate|2
2517794|NCT01748071|8714665|P3|Overall Study|Adverse Event|0
2517795|NCT01748071|8714666|P2|Overall Study|Adverse Event|2
2517796|NCT01748071|8714667|P1|Overall Study|Adverse Event|2
2517797|NCT01747915|8714930|P3|Overall Study|Pregnancy|1
2517798|NCT01747915|8714931|P2|Overall Study|Pregnancy|0
2517799|NCT01747915|8714932|P1|Overall Study|Pregnancy|0
2517800|NCT01747915|8714930|P3|Overall Study|Protocol Violation|0
2517801|NCT01747915|8714931|P2|Overall Study|Protocol Violation|0
2517802|NCT01747915|8714932|P1|Overall Study|Protocol Violation|1
2517803|NCT01747915|8714930|P3|Overall Study|Withdrawal by Subject|1
2517804|NCT01747915|8714931|P2|Overall Study|Withdrawal by Subject|4
2517805|NCT01747915|8714932|P1|Overall Study|Withdrawal by Subject|4
2517806|NCT01747915|8714930|P3|Overall Study|Lost to Follow-up|0
2517807|NCT01747915|8714931|P2|Overall Study|Lost to Follow-up|0
2517808|NCT01747915|8714932|P1|Overall Study|Lost to Follow-up|1
2517809|NCT01747915|8714930|P3|Overall Study|Lack of Efficacy|0
2517810|NCT01747915|8714931|P2|Overall Study|Lack of Efficacy|1
2517811|NCT01747915|8714932|P1|Overall Study|Lack of Efficacy|0
2517812|NCT01747915|8714930|P3|Overall Study|Death|1
2517813|NCT01747915|8714931|P2|Overall Study|Death|0
2517814|NCT01747915|8714932|P1|Overall Study|Death|0
2517815|NCT01747915|8714930|P3|Overall Study|Adverse Event|2
2517816|NCT01747915|8714931|P2|Overall Study|Adverse Event|5
2517817|NCT01747915|8714932|P1|Overall Study|Adverse Event|8
2517818|NCT01747915|8714930|P3|Overall Study|Other|1
2517819|NCT01747915|8714931|P2|Overall Study|Other|1
2517820|NCT01747915|8714932|P1|Overall Study|Other|1
2517821|NCT01747876|8714946|P3|Overall Study|Trtment duration compl. as per protocol|1
2517822|NCT01747876|8714947|P2|Overall Study|Trtment duration compl. as per protocol|1
2517823|NCT01747876|8714948|P1|Overall Study|Trtment duration compl. as per protocol|0
2517824|NCT01747876|8714946|P3|Overall Study|Disease progression|8
2517825|NCT01747876|8714947|P2|Overall Study|Disease progression|13
2517826|NCT01747876|8714948|P1|Overall Study|Disease progression|4
2517827|NCT01747876|8714946|P3|Overall Study|Withdrawal by Subject|1
2517828|NCT01747876|8714947|P2|Overall Study|Withdrawal by Subject|1
2517829|NCT01747876|8714948|P1|Overall Study|Withdrawal by Subject|0
2517830|NCT01747876|8714946|P3|Overall Study|Adverse Event|2
2517831|NCT01747876|8714947|P2|Overall Study|Adverse Event|0
2517832|NCT01747876|8714948|P1|Overall Study|Adverse Event|1
2517833|NCT01747837|8715001|P2|Overall Study|Death|4
2517834|NCT01747837|8715002|P1|Overall Study|Death|4
2517835|NCT01747837|8715001|P2|Overall Study|Lost to Follow-up|2
2517836|NCT01747837|8715002|P1|Overall Study|Lost to Follow-up|5
2517837|NCT01747811|8715032|P2|Overall Study|Lack of Efficacy|4
2517838|NCT01747811|8715033|P1|Overall Study|Lack of Efficacy|2
2517839|NCT01747772|8715049|P1|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9
2517840|NCT01747655|8715057|P2|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0
2517841|NCT01747655|8715058|P1|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1
2517842|NCT01747655|8715057|P2|PEG-J Period (Duodopa Treatment)|Patient Decision|0
2517843|NCT01747655|8715058|P1|PEG-J Period (Duodopa Treatment)|Patient Decision|8
2517844|NCT01747655|8715057|P2|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0
2517845|NCT01747655|8715058|P1|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5
2517846|NCT01747629|8715088|P2|Overall Study|Other|1
2517847|NCT01747629|8715089|P1|Overall Study|Other|2
2517848|NCT01747629|8715088|P2|Overall Study|Not treated|0
2517849|NCT01747629|8715089|P1|Overall Study|Not treated|1
2517850|NCT01747629|8715088|P2|Overall Study|Inclusion criteria not met|0
2517851|NCT01747629|8715089|P1|Overall Study|Inclusion criteria not met|1
2517852|NCT01747629|8715088|P2|Overall Study|Noncompliance|1
2517853|NCT01747629|8715089|P1|Overall Study|Noncompliance|1
2517854|NCT01747629|8715088|P2|Overall Study|Withdrawal by Subject|2
2517855|NCT01747629|8715089|P1|Overall Study|Withdrawal by Subject|2
2517856|NCT01747629|8715088|P2|Overall Study|Adverse Event|2
2517857|NCT01747629|8715089|P1|Overall Study|Adverse Event|1
2517858|NCT01747551|8715123|P2|Overall Study|Other|0
2517859|NCT01747551|8715124|P1|Overall Study|Other|2
2517860|NCT01747551|8715123|P2|Overall Study|Physician Decision|1
2517861|NCT01747551|8715124|P1|Overall Study|Physician Decision|2
2517862|NCT01747551|8715123|P2|Overall Study|Withdrawal by Subject|1
2517863|NCT01747551|8715124|P1|Overall Study|Withdrawal by Subject|3
2517864|NCT01747551|8715123|P2|Overall Study|Prolonged Treatment Delay|0
2517865|NCT01747551|8715124|P1|Overall Study|Prolonged Treatment Delay|2
2517866|NCT01747551|8715123|P2|Overall Study|Adverse Event|1
2517867|NCT01747551|8715124|P1|Overall Study|Adverse Event|7
2517868|NCT01747551|8715123|P2|Overall Study|Death|1
2517869|NCT01747551|8715124|P1|Overall Study|Death|3
2517870|NCT01747551|8715123|P2|Overall Study|Progressive Disease|17
2517871|NCT01747551|8715124|P1|Overall Study|Progressive Disease|24
2517872|NCT01747499|8715141|P5|Overall Study|Determined not to be eligible|1
2517873|NCT01747499|8715142|P4|Overall Study|Determined not to be eligible|0
2517874|NCT01747499|8715143|P3|Overall Study|Determined not to be eligible|0
2517875|NCT01747499|8715144|P2|Overall Study|Determined not to be eligible|0
2517876|NCT01747499|8715145|P1|Overall Study|Determined not to be eligible|0
2517877|NCT01747499|8715141|P5|Overall Study|Developed AML and death|1
2517878|NCT01747499|8715142|P4|Overall Study|Developed AML and death|0
2517879|NCT01747499|8715143|P3|Overall Study|Developed AML and death|0
2517880|NCT01747499|8715144|P2|Overall Study|Developed AML and death|0
2517881|NCT01747499|8715145|P1|Overall Study|Developed AML and death|0
2517882|NCT01747499|8715141|P5|Overall Study|Withdrawal by Subject|6
2517883|NCT01747499|8715142|P4|Overall Study|Withdrawal by Subject|0
2517884|NCT01747499|8715143|P3|Overall Study|Withdrawal by Subject|0
2517885|NCT01747499|8715144|P2|Overall Study|Withdrawal by Subject|0
2517886|NCT01747499|8715145|P1|Overall Study|Withdrawal by Subject|0
2517887|NCT01747499|8715141|P5|Overall Study|Death|1
2517888|NCT01747499|8715142|P4|Overall Study|Death|1
2517889|NCT01747499|8715143|P3|Overall Study|Death|0
2517890|NCT01747499|8715144|P2|Overall Study|Death|0
2517891|NCT01747499|8715145|P1|Overall Study|Death|0
2517892|NCT01747499|8715141|P5|Overall Study|Physician Decision|2
2517893|NCT01747499|8715142|P4|Overall Study|Physician Decision|0
2517894|NCT01747499|8715143|P3|Overall Study|Physician Decision|0
2517895|NCT01747499|8715144|P2|Overall Study|Physician Decision|1
2517896|NCT01747499|8715145|P1|Overall Study|Physician Decision|0
2517897|NCT01747499|8715141|P5|Overall Study|Steroid refractory aGvHD|4
2517898|NCT01747499|8715142|P4|Overall Study|Steroid refractory aGvHD|1
2517899|NCT01747499|8715143|P3|Overall Study|Steroid refractory aGvHD|0
2517900|NCT01747499|8715144|P2|Overall Study|Steroid refractory aGvHD|0
2517901|NCT01747499|8715145|P1|Overall Study|Steroid refractory aGvHD|1
2517902|NCT01747486|8715181|P2|Stage 2|Disease Progression|0
2517903|NCT01747486|8715182|P1|Stage 2|Disease Progression|3
2517904|NCT01747486|8715181|P2|Stage 2|New Cancer Therapy|0
2517905|NCT01747486|8715182|P1|Stage 2|New Cancer Therapy|3
2517906|NCT01747486|8715181|P2|Stage 2|Withdrawal by Subject|0
2517907|NCT01747486|8715182|P1|Stage 2|Withdrawal by Subject|1
2517908|NCT01747486|8715181|P2|Stage 2|Physician Decision|0
2517909|NCT01747486|8715182|P1|Stage 2|Physician Decision|2
2517910|NCT01747486|8715181|P2|Stage 1|Death|1
2517911|NCT01747486|8715182|P1|Stage 1|Death|1
2517912|NCT01747486|8715181|P2|Stage 1|Disease progression|9
2517913|NCT01747486|8715182|P1|Stage 1|Disease progression|4
2517914|NCT01747486|8715181|P2|Stage 1|Withdrawal by Subject|3
2517915|NCT01747486|8715182|P1|Stage 1|Withdrawal by Subject|4
2517916|NCT01747486|8715181|P2|Stage 1|Physician Decision|0
2517917|NCT01747486|8715182|P1|Stage 1|Physician Decision|3
2517918|NCT01746901|8715232|P9|Treatment Phase: Fourth Intervention|Protocol Violation|1
2517919|NCT01746901|8715233|P8|Treatment Phase: Fourth Intervention|Protocol Violation|0
2517920|NCT01746901|8715234|P7|Treatment Phase: Fourth Intervention|Protocol Violation|1
2517921|NCT01746901|8715235|P6|Treatment Phase: Fourth Intervention|Protocol Violation|0
2517922|NCT01746901|8715236|P5|Treatment Phase: Fourth Intervention|Protocol Violation|0
2517923|NCT01746901|8715237|P4|Treatment Phase: Fourth Intervention|Protocol Violation|0
2517924|NCT01746901|8715238|P3|Treatment Phase: Fourth Intervention|Protocol Violation|0
2517925|NCT01746901|8715239|P2|Treatment Phase: Fourth Intervention|Protocol Violation|0
2517926|NCT01746901|8715240|P1|Treatment Phase: Fourth Intervention|Protocol Violation|0
2517927|NCT01746901|8715232|P9|Treatment Phase: Fourth Intervention|Adverse Event|1
2517928|NCT01746901|8715233|P8|Treatment Phase: Fourth Intervention|Adverse Event|0
2517929|NCT01746901|8715234|P7|Treatment Phase: Fourth Intervention|Adverse Event|0
2517930|NCT01746901|8715235|P6|Treatment Phase: Fourth Intervention|Adverse Event|1
2517931|NCT01746901|8715236|P5|Treatment Phase: Fourth Intervention|Adverse Event|0
2517932|NCT01746901|8715237|P4|Treatment Phase: Fourth Intervention|Adverse Event|0
2517933|NCT01746901|8715238|P3|Treatment Phase: Fourth Intervention|Adverse Event|0
2517934|NCT01746901|8715239|P2|Treatment Phase: Fourth Intervention|Adverse Event|0
2517935|NCT01746901|8715240|P1|Treatment Phase: Fourth Intervention|Adverse Event|0
2517936|NCT01746901|8715232|P9|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
2517937|NCT01746901|8715233|P8|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
2517938|NCT01746901|8715234|P7|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
2517939|NCT01746901|8715235|P6|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
2517940|NCT01746901|8715236|P5|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
2517941|NCT01746901|8715237|P4|Treatment Phase: Fourth Intervention|Lost to Follow-up|1
2517942|NCT01746901|8715238|P3|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
2517943|NCT01746901|8715239|P2|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
2517944|NCT01746901|8715240|P1|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
2517945|NCT01746901|8715232|P9|Treatment Phase: Third Intervention|Protocol Violation|0
2517946|NCT01746901|8715233|P8|Treatment Phase: Third Intervention|Protocol Violation|0
2517947|NCT01746901|8715234|P7|Treatment Phase: Third Intervention|Protocol Violation|1
2517948|NCT01746901|8715235|P6|Treatment Phase: Third Intervention|Protocol Violation|1
2517949|NCT01746901|8715236|P5|Treatment Phase: Third Intervention|Protocol Violation|0
2517950|NCT01746901|8715237|P4|Treatment Phase: Third Intervention|Protocol Violation|0
2517951|NCT01746901|8715238|P3|Treatment Phase: Third Intervention|Protocol Violation|0
2517952|NCT01746901|8715239|P2|Treatment Phase: Third Intervention|Protocol Violation|0
2517953|NCT01746901|8715240|P1|Treatment Phase: Third Intervention|Protocol Violation|0
2517954|NCT01746901|8715232|P9|Treatment Phase: Second Intervention|Withdrawal by Subject|0
2517955|NCT01746901|8715233|P8|Treatment Phase: Second Intervention|Withdrawal by Subject|1
2517956|NCT01746901|8715234|P7|Treatment Phase: Second Intervention|Withdrawal by Subject|0
2517957|NCT01746901|8715235|P6|Treatment Phase: Second Intervention|Withdrawal by Subject|0
2517958|NCT01746901|8715236|P5|Treatment Phase: Second Intervention|Withdrawal by Subject|0
2517959|NCT01746901|8715237|P4|Treatment Phase: Second Intervention|Withdrawal by Subject|0
2517960|NCT01746901|8715238|P3|Treatment Phase: Second Intervention|Withdrawal by Subject|0
2517961|NCT01746901|8715239|P2|Treatment Phase: Second Intervention|Withdrawal by Subject|0
2517962|NCT01746901|8715240|P1|Treatment Phase: Second Intervention|Withdrawal by Subject|0
2517963|NCT01746901|8715232|P9|Treatment Phase: First Intervention|Protocol Violation|0
2517964|NCT01746901|8715233|P8|Treatment Phase: First Intervention|Protocol Violation|0
2517965|NCT01746901|8715234|P7|Treatment Phase: First Intervention|Protocol Violation|1
2517966|NCT01746901|8715235|P6|Treatment Phase: First Intervention|Protocol Violation|0
2517967|NCT01746901|8715236|P5|Treatment Phase: First Intervention|Protocol Violation|0
2517968|NCT01746901|8715237|P4|Treatment Phase: First Intervention|Protocol Violation|0
2517969|NCT01746901|8715238|P3|Treatment Phase: First Intervention|Protocol Violation|0
2517970|NCT01746901|8715239|P2|Treatment Phase: First Intervention|Protocol Violation|0
2517971|NCT01746901|8715240|P1|Treatment Phase: First Intervention|Protocol Violation|0
2517972|NCT01746901|8715232|P9|Drug Discrimination Phase: Day 2|Protocol Violation|0
2517973|NCT01746901|8715233|P8|Drug Discrimination Phase: Day 2|Protocol Violation|0
2517974|NCT01746901|8715234|P7|Drug Discrimination Phase: Day 2|Protocol Violation|0
2517975|NCT01746901|8715235|P6|Drug Discrimination Phase: Day 2|Protocol Violation|0
2517976|NCT01746901|8715236|P5|Drug Discrimination Phase: Day 2|Protocol Violation|0
2517977|NCT01746901|8715237|P4|Drug Discrimination Phase: Day 2|Protocol Violation|0
2517978|NCT01746901|8715238|P3|Drug Discrimination Phase: Day 2|Protocol Violation|3
2517979|NCT01746901|8715239|P2|Drug Discrimination Phase: Day 2|Protocol Violation|3
2517980|NCT01746901|8715240|P1|Drug Discrimination Phase: Day 2|Protocol Violation|0
2517981|NCT01746901|8715232|P9|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
2517982|NCT01746901|8715233|P8|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
2517983|NCT01746901|8715234|P7|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
2518064|NCT01746225|8715744|P1|Overall Study|Withdrawal by Subject|5
2517984|NCT01746901|8715235|P6|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
2517985|NCT01746901|8715236|P5|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
2517986|NCT01746901|8715237|P4|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
2517987|NCT01746901|8715238|P3|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10
2517988|NCT01746901|8715239|P2|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9
2517989|NCT01746901|8715240|P1|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
2517990|NCT01746901|8715232|P9|Drug Discrimination Phase: Day 2|Adverse Event|0
2517991|NCT01746901|8715233|P8|Drug Discrimination Phase: Day 2|Adverse Event|0
2517992|NCT01746901|8715234|P7|Drug Discrimination Phase: Day 2|Adverse Event|0
2517993|NCT01746901|8715235|P6|Drug Discrimination Phase: Day 2|Adverse Event|0
2517994|NCT01746901|8715236|P5|Drug Discrimination Phase: Day 2|Adverse Event|0
2517995|NCT01746901|8715237|P4|Drug Discrimination Phase: Day 2|Adverse Event|0
2517996|NCT01746901|8715238|P3|Drug Discrimination Phase: Day 2|Adverse Event|1
2517997|NCT01746901|8715239|P2|Drug Discrimination Phase: Day 2|Adverse Event|2
2517998|NCT01746901|8715240|P1|Drug Discrimination Phase: Day 2|Adverse Event|0
2517999|NCT01746901|8715232|P9|Drug Discrimination Phase: Day 1|Adverse Event|0
2518000|NCT01746901|8715233|P8|Drug Discrimination Phase: Day 1|Adverse Event|0
2518001|NCT01746901|8715234|P7|Drug Discrimination Phase: Day 1|Adverse Event|0
2518002|NCT01746901|8715235|P6|Drug Discrimination Phase: Day 1|Adverse Event|0
2518003|NCT01746901|8715236|P5|Drug Discrimination Phase: Day 1|Adverse Event|0
2518004|NCT01746901|8715237|P4|Drug Discrimination Phase: Day 1|Adverse Event|0
2518005|NCT01746901|8715238|P3|Drug Discrimination Phase: Day 1|Adverse Event|0
2518006|NCT01746901|8715239|P2|Drug Discrimination Phase: Day 1|Adverse Event|3
2518007|NCT01746901|8715240|P1|Drug Discrimination Phase: Day 1|Adverse Event|0
2518008|NCT01746901|8715232|P9|Naloxone Challenge Phase|Did not meet entrance criteria|0
2518009|NCT01746901|8715233|P8|Naloxone Challenge Phase|Did not meet entrance criteria|0
2518010|NCT01746901|8715234|P7|Naloxone Challenge Phase|Did not meet entrance criteria|0
2518011|NCT01746901|8715235|P6|Naloxone Challenge Phase|Did not meet entrance criteria|0
2518012|NCT01746901|8715236|P5|Naloxone Challenge Phase|Did not meet entrance criteria|0
2518013|NCT01746901|8715237|P4|Naloxone Challenge Phase|Did not meet entrance criteria|0
2518014|NCT01746901|8715238|P3|Naloxone Challenge Phase|Did not meet entrance criteria|0
2518015|NCT01746901|8715239|P2|Naloxone Challenge Phase|Did not meet entrance criteria|0
2518016|NCT01746901|8715240|P1|Naloxone Challenge Phase|Did not meet entrance criteria|1
2518017|NCT01746901|8715232|P9|Naloxone Challenge Phase|Adverse Event|0
2518018|NCT01746901|8715233|P8|Naloxone Challenge Phase|Adverse Event|0
2518019|NCT01746901|8715234|P7|Naloxone Challenge Phase|Adverse Event|0
2518020|NCT01746901|8715235|P6|Naloxone Challenge Phase|Adverse Event|0
2518021|NCT01746901|8715236|P5|Naloxone Challenge Phase|Adverse Event|0
2518022|NCT01746901|8715237|P4|Naloxone Challenge Phase|Adverse Event|0
2518023|NCT01746901|8715238|P3|Naloxone Challenge Phase|Adverse Event|0
2518024|NCT01746901|8715239|P2|Naloxone Challenge Phase|Adverse Event|0
2518025|NCT01746901|8715240|P1|Naloxone Challenge Phase|Adverse Event|2
2518026|NCT01746862|8715563|P2|Overall Study|Entered puberty during the study|0
2518027|NCT01746862|8715564|P1|Overall Study|Entered puberty during the study|1
2518028|NCT01746862|8715563|P2|Overall Study|Consent withdrawal by parent’s guardian|2
2518029|NCT01746862|8715564|P1|Overall Study|Consent withdrawal by parent’s guardian|5
2518030|NCT01746862|8715563|P2|Overall Study|Protocol Violation|0
2518031|NCT01746862|8715564|P1|Overall Study|Protocol Violation|1
2518032|NCT01746862|8715563|P2|Overall Study|Withdrawal by Subject|1
2518033|NCT01746862|8715564|P1|Overall Study|Withdrawal by Subject|1
2518034|NCT01746732|8715628|P3|Period 2|Lost to Follow-up|1
2518035|NCT01746732|8715629|P2|Period 2|Lost to Follow-up|0
2518036|NCT01746732|8715630|P1|Period 2|Lost to Follow-up|0
2518037|NCT01746732|8715628|P3|Period 2|Adverse Event|1
2518038|NCT01746732|8715629|P2|Period 2|Adverse Event|0
2518039|NCT01746732|8715630|P1|Period 2|Adverse Event|0
2518040|NCT01746732|8715628|P3|Period 2|Withdrawal by Subject|2
2518041|NCT01746732|8715629|P2|Period 2|Withdrawal by Subject|0
2518042|NCT01746732|8715630|P1|Period 2|Withdrawal by Subject|0
2518043|NCT01746732|8715628|P3|Period 1|Physician Decision|0
2518044|NCT01746732|8715629|P2|Period 1|Physician Decision|1
2518045|NCT01746732|8715630|P1|Period 1|Physician Decision|0
2518046|NCT01746732|8715628|P3|Lead-In Period|Withdrawal by Subject|0
2518047|NCT01746732|8715629|P2|Lead-In Period|Withdrawal by Subject|0
2518048|NCT01746732|8715630|P1|Lead-In Period|Withdrawal by Subject|1
2518049|NCT01746368|8715711|P2|Overall Study|Withdrawal by Subject|1
2518050|NCT01746368|8715712|P1|Overall Study|Withdrawal by Subject|0
2518051|NCT01746368|8715711|P2|Overall Study|Lost to Follow-up|0
2518052|NCT01746368|8715712|P1|Overall Study|Lost to Follow-up|2
2518053|NCT01746225|8715742|P3|Overall Study|Continuing Treatment|3
2518054|NCT01746225|8715743|P2|Overall Study|Continuing Treatment|8
2518055|NCT01746225|8715744|P1|Overall Study|Continuing Treatment|5
2518056|NCT01746225|8715742|P3|Overall Study|Adverse Event|17
2518057|NCT01746225|8715743|P2|Overall Study|Adverse Event|12
2518058|NCT01746225|8715744|P1|Overall Study|Adverse Event|15
2518059|NCT01746225|8715742|P3|Overall Study|Physician Decision|3
2518060|NCT01746225|8715743|P2|Overall Study|Physician Decision|11
2518061|NCT01746225|8715744|P1|Overall Study|Physician Decision|14
2518062|NCT01746225|8715742|P3|Overall Study|Withdrawal by Subject|19
2518063|NCT01746225|8715743|P2|Overall Study|Withdrawal by Subject|15
2518065|NCT01746225|8715742|P3|Overall Study|Death|1
2518066|NCT01746225|8715743|P2|Overall Study|Death|0
2518067|NCT01746225|8715744|P1|Overall Study|Death|1
2518068|NCT01746173|8715767|P1|Overall Study|Disease Progression|2
2518069|NCT01746108|8715775|P3|Overall Study|Lost to Follow-up|0
2518070|NCT01746108|8715776|P2|Overall Study|Lost to Follow-up|1
2518071|NCT01746108|8715777|P1|Overall Study|Lost to Follow-up|0
2518072|NCT01746108|8715775|P3|Overall Study|Withdrawal by Subject|0
2518073|NCT01746108|8715776|P2|Overall Study|Withdrawal by Subject|1
2518074|NCT01746108|8715777|P1|Overall Study|Withdrawal by Subject|0
2518075|NCT01746108|8715775|P3|Overall Study|Adverse event, non-fatal|0
2518076|NCT01746108|8715776|P2|Overall Study|Adverse event, non-fatal|1
2518077|NCT01746108|8715777|P1|Overall Study|Adverse event, non-fatal|0
2518078|NCT01746108|8715775|P3|Overall Study|Migrated /moved from study area|0
2518079|NCT01746108|8715776|P2|Overall Study|Migrated /moved from study area|1
2518080|NCT01746108|8715777|P1|Overall Study|Migrated /moved from study area|0
2518081|NCT01746017|8715894|P11|Period 3|Withdrawal by Subject|0
2518082|NCT01746017|8715895|P10|Period 3|Withdrawal by Subject|0
2518083|NCT01746017|8715896|P9|Period 3|Withdrawal by Subject|0
2518084|NCT01746017|8715897|P8|Period 3|Withdrawal by Subject|0
2518085|NCT01746017|8715898|P7|Period 3|Withdrawal by Subject|0
2518086|NCT01746017|8715899|P6|Period 3|Withdrawal by Subject|1
2518087|NCT01746017|8715900|P5|Period 3|Withdrawal by Subject|0
2518088|NCT01746017|8715901|P4|Period 3|Withdrawal by Subject|0
2518089|NCT01746017|8715902|P3|Period 3|Withdrawal by Subject|0
2518090|NCT01746017|8715903|P2|Period 3|Withdrawal by Subject|0
2518091|NCT01746017|8715904|P1|Period 3|Withdrawal by Subject|0
2518092|NCT01746017|8715894|P11|Period 1|Withdrawal by Subject|0
2518093|NCT01746017|8715895|P10|Period 1|Withdrawal by Subject|0
2518094|NCT01746017|8715896|P9|Period 1|Withdrawal by Subject|0
2518095|NCT01746017|8715897|P8|Period 1|Withdrawal by Subject|0
2518096|NCT01746017|8715898|P7|Period 1|Withdrawal by Subject|1
2518097|NCT01746017|8715899|P6|Period 1|Withdrawal by Subject|0
2518098|NCT01746017|8715900|P5|Period 1|Withdrawal by Subject|0
2518099|NCT01746017|8715901|P4|Period 1|Withdrawal by Subject|0
2518100|NCT01746017|8715902|P3|Period 1|Withdrawal by Subject|0
2518101|NCT01746017|8715903|P2|Period 1|Withdrawal by Subject|0
2518102|NCT01746017|8715904|P1|Period 1|Withdrawal by Subject|0
2518103|NCT01745848|8716025|P1|Overall Study|Adverse Event|6
2518104|NCT01745393|8716032|P2|12-month Follow-up|Lost to Follow-up|5
2518105|NCT01745393|8716033|P1|12-month Follow-up|Lost to Follow-up|6
2518106|NCT01745393|8716032|P2|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0
2518107|NCT01745393|8716033|P1|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1
2518108|NCT01745393|8716032|P2|Treatment to End-of-treatment Assessment|Lost to Follow-up|8
2518109|NCT01745393|8716033|P1|Treatment to End-of-treatment Assessment|Lost to Follow-up|20
2518110|NCT01745380|8716045|P2|Overall Study|Lack of Efficacy|1
2518111|NCT01745380|8716046|P1|Overall Study|Lack of Efficacy|0
2518112|NCT01745380|8716045|P2|Overall Study|Lost to Follow-up|0
2518113|NCT01745380|8716046|P1|Overall Study|Lost to Follow-up|1
2518114|NCT01745146|8716084|P2|Overall Study|Lost to Follow-up|0
2518115|NCT01745146|8716085|P1|Overall Study|Lost to Follow-up|2
2518116|NCT01745146|8716084|P2|Overall Study|Withdrawal by Subject|3
2518117|NCT01745146|8716085|P1|Overall Study|Withdrawal by Subject|1
2518118|NCT01745120|8716107|P2|Overall Study|Investigator decision|0
2518119|NCT01745120|8716108|P1|Overall Study|Investigator decision|1
2518120|NCT01745094|8716166|P4|Overall Study|Untenable Due to Recurrent Cystitis|0
2518121|NCT01745094|8716167|P3|Overall Study|Untenable Due to Recurrent Cystitis|0
2518122|NCT01745094|8716168|P2|Overall Study|Untenable Due to Recurrent Cystitis|0
2518123|NCT01745094|8716169|P1|Overall Study|Untenable Due to Recurrent Cystitis|1
2518124|NCT01745094|8716166|P4|Overall Study|Show no Stable Solifenacin Intake|0
2518125|NCT01745094|8716167|P3|Overall Study|Show no Stable Solifenacin Intake|1
2518126|NCT01745094|8716168|P2|Overall Study|Show no Stable Solifenacin Intake|0
2518127|NCT01745094|8716169|P1|Overall Study|Show no Stable Solifenacin Intake|0
2518128|NCT01745094|8716166|P4|Overall Study|Need Further Examinations Due to Biopsy|0
2518129|NCT01745094|8716167|P3|Overall Study|Need Further Examinations Due to Biopsy|1
2518130|NCT01745094|8716168|P2|Overall Study|Need Further Examinations Due to Biopsy|0
2518131|NCT01745094|8716169|P1|Overall Study|Need Further Examinations Due to Biopsy|0
2518132|NCT01745094|8716166|P4|Overall Study|Protocol Violation|1
2518133|NCT01745094|8716167|P3|Overall Study|Protocol Violation|3
2518134|NCT01745094|8716168|P2|Overall Study|Protocol Violation|0
2518135|NCT01745094|8716169|P1|Overall Study|Protocol Violation|1
2518136|NCT01745094|8716166|P4|Overall Study|Withdrawal by Subject|2
2518137|NCT01745094|8716167|P3|Overall Study|Withdrawal by Subject|1
2518138|NCT01745094|8716168|P2|Overall Study|Withdrawal by Subject|0
2518139|NCT01745094|8716169|P1|Overall Study|Withdrawal by Subject|2
2518140|NCT01745094|8716166|P4|Overall Study|Adverse Event|0
2518141|NCT01745094|8716167|P3|Overall Study|Adverse Event|3
2518142|NCT01745094|8716168|P2|Overall Study|Adverse Event|0
2518143|NCT01745094|8716169|P1|Overall Study|Adverse Event|0
2518144|NCT01745094|8716166|P4|Overall Study|Not Meeting the Eligibility Criteria|0
2518145|NCT01745094|8716167|P3|Overall Study|Not Meeting the Eligibility Criteria|3
2518146|NCT01745094|8716168|P2|Overall Study|Not Meeting the Eligibility Criteria|0
2518147|NCT01745094|8716169|P1|Overall Study|Not Meeting the Eligibility Criteria|1
2518148|NCT01744977|8716270|P2|Overall Study|No longer meets inclusion|0
2518149|NCT01744977|8716271|P1|Overall Study|No longer meets inclusion|6
2518150|NCT01744977|8716270|P2|Overall Study|Lost to Follow-up|0
2518151|NCT01744977|8716271|P1|Overall Study|Lost to Follow-up|2
2518152|NCT01744977|8716270|P2|Overall Study|Death|3
2518153|NCT01744977|8716271|P1|Overall Study|Death|2
2518154|NCT01744977|8716270|P2|Overall Study|Withdrawal by Subject|2
2518155|NCT01744977|8716271|P1|Overall Study|Withdrawal by Subject|1
2518156|NCT01744782|8716342|P1|Overall Study|Death|1
2518157|NCT01744691|8716503|P1|Overall Study|Physician Decision|4
2518158|NCT01744691|8716503|P1|Overall Study|Withdrawal of consent for treatment|3
2518159|NCT01744691|8716503|P1|Overall Study|Unacceptable toxicity, AE or death|18
2518160|NCT01744691|8716503|P1|Overall Study|Progressive Disease|18
2518161|NCT01744665|8716508|P1|Re-initiation Phase|Withdrawal by Subject|1
2518162|NCT01744665|8716508|P1|Re-initiation Phase|No longer required treatment|1
2518163|NCT01744665|8716508|P1|Re-initiation Phase|Adverse Event|1
2518164|NCT01744665|8716508|P1|Re-initiation Phase|Administrative problems|10
2518165|NCT01744665|8716508|P1|Consolidation Phase|Administrative problems|9
2518166|NCT01744665|8716508|P1|Consolidation Phase|Withdrawal by Subject|4
2518167|NCT01744665|8716508|P1|Consolidation Phase|Unsatisfactory therapeutic effect|4
2518168|NCT01744665|8716508|P1|Consolidation Phase|Adverse Event|2
2518169|NCT01744665|8716508|P1|Monitoring Phase|Did not achieve MR4.5|1
2518170|NCT01744665|8716508|P1|Monitoring Phase|Withdrawal by Subject|5
2518171|NCT01744665|8716508|P1|Monitoring Phase|Unsatisfactory therapeutic effect|7
2518172|NCT01744665|8716508|P1|Monitoring Phase|Abnormal laboratory value(s)|1
2518173|NCT01744665|8716508|P1|Monitoring Phase|Adverse Event|4
2518174|NCT01744496|8716578|P2|Maintenance Period|Subject left town|0
2518175|NCT01744496|8716579|P1|Maintenance Period|Subject left town|1
2518176|NCT01744496|8716578|P2|Maintenance Period|Withdrawal by Subject|1
2518177|NCT01744496|8716579|P1|Maintenance Period|Withdrawal by Subject|1
2518178|NCT01744496|8716578|P2|Maintenance Period|Protocol Violation|0
2518179|NCT01744496|8716579|P1|Maintenance Period|Protocol Violation|1
2518180|NCT01744496|8716578|P2|Maintenance Period|Adverse Event|3
2518181|NCT01744496|8716579|P1|Maintenance Period|Adverse Event|1
2518182|NCT01744496|8716578|P2|Titration Period|Personal reasons|1
2518183|NCT01744496|8716579|P1|Titration Period|Personal reasons|0
2518184|NCT01744496|8716578|P2|Titration Period|Adverse Event|1
2518185|NCT01744496|8716579|P1|Titration Period|Adverse Event|2
2518186|NCT01744483|8716600|P3|Overall Study|Routed to OSH|1
2518187|NCT01744483|8716601|P2|Overall Study|Routed to OSH|0
2518188|NCT01744483|8716602|P1|Overall Study|Routed to OSH|2
2518189|NCT01744483|8716600|P3|Overall Study|No ICU Admit|2
2518190|NCT01744483|8716601|P2|Overall Study|No ICU Admit|1
2518191|NCT01744483|8716602|P1|Overall Study|No ICU Admit|5
2518192|NCT01744483|8716600|P3|Overall Study|Withdrawal by Subject|2
2518193|NCT01744483|8716601|P2|Overall Study|Withdrawal by Subject|6
2518194|NCT01744483|8716602|P1|Overall Study|Withdrawal by Subject|4
2518195|NCT01744483|8716600|P3|Overall Study|Protocol Violation|1
2518196|NCT01744483|8716601|P2|Overall Study|Protocol Violation|2
2518197|NCT01744483|8716602|P1|Overall Study|Protocol Violation|1
2518198|NCT01744483|8716600|P3|Overall Study|Lost to Follow-up|11
2518199|NCT01744483|8716601|P2|Overall Study|Lost to Follow-up|9
2518200|NCT01744483|8716602|P1|Overall Study|Lost to Follow-up|8
2518201|NCT01744483|8716600|P3|Overall Study|Death|11
2518202|NCT01744483|8716601|P2|Overall Study|Death|4
2518203|NCT01744483|8716602|P1|Overall Study|Death|9
2518204|NCT01744392|8716610|P1|Overall Study|Physician Decision|1
2518205|NCT01744197|8716650|P2|Overall Study|No patch received|2
2518206|NCT01744197|8716651|P1|Overall Study|No patch received|2
2518207|NCT01744197|8716650|P2|Overall Study|Received 1 patch|1
2518208|NCT01744197|8716651|P1|Overall Study|Received 1 patch|2
2518209|NCT01743560|8716702|P1|Overall Study|>1 dose of study drug|3
2518210|NCT01743560|8716702|P1|Overall Study|Protocol Violation|1
2518211|NCT01743560|8716702|P1|Overall Study|Withdrawal by Subject|2
2518212|NCT01743560|8716702|P1|Overall Study|Death|3
2518213|NCT01743560|8716702|P1|Overall Study|Adverse Event|8
2518214|NCT01743560|8716702|P1|Overall Study|Disease progression|26
2518215|NCT01743469|8716786|P4|Follow-up Period - Post-Treatment|Lost to Follow-up|0
2518216|NCT01743469|8716787|P3|Follow-up Period - Post-Treatment|Lost to Follow-up|0
2518217|NCT01743469|8716788|P2|Follow-up Period - Post-Treatment|Lost to Follow-up|1
2518218|NCT01743469|8716789|P1|Follow-up Period - Post-Treatment|Lost to Follow-up|1
2518219|NCT01743469|8716786|P4|Follow-up Period - Post-Treatment|Death|16
2518220|NCT01743469|8716787|P3|Follow-up Period - Post-Treatment|Death|22
2518221|NCT01743469|8716788|P2|Follow-up Period - Post-Treatment|Death|47
2518222|NCT01743469|8716789|P1|Follow-up Period - Post-Treatment|Death|43
2518223|NCT01743469|8716786|P4|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
2518224|NCT01743469|8716787|P3|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
2518225|NCT01743469|8716788|P2|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
2518226|NCT01743469|8716789|P1|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
2518227|NCT01743469|8716786|P4|Active Treatment Phase|Missing|0
2518228|NCT01743469|8716787|P3|Active Treatment Phase|Missing|0
2518229|NCT01743469|8716788|P2|Active Treatment Phase|Missing|0
2518230|NCT01743469|8716789|P1|Active Treatment Phase|Missing|1
2518231|NCT01743469|8716786|P4|Active Treatment Phase|Withdrawal by Subject|0
2518232|NCT01743469|8716787|P3|Active Treatment Phase|Withdrawal by Subject|0
2518233|NCT01743469|8716788|P2|Active Treatment Phase|Withdrawal by Subject|3
2518234|NCT01743469|8716789|P1|Active Treatment Phase|Withdrawal by Subject|2
2518235|NCT01743469|8716786|P4|Active Treatment Phase|Disease Progression|20
2518236|NCT01743469|8716787|P3|Active Treatment Phase|Disease Progression|30
2518237|NCT01743469|8716788|P2|Active Treatment Phase|Disease Progression|47
2518238|NCT01743469|8716789|P1|Active Treatment Phase|Disease Progression|40
2518239|NCT01743469|8716786|P4|Active Treatment Phase|Adverse Event|1
2518240|NCT01743469|8716787|P3|Active Treatment Phase|Adverse Event|8
2518241|NCT01743469|8716788|P2|Active Treatment Phase|Adverse Event|5
2518242|NCT01743469|8716789|P1|Active Treatment Phase|Adverse Event|10
2518243|NCT01743092|8716829|P2|Overall Study|Lost to Follow-up|15
2518244|NCT01743092|8716830|P1|Overall Study|Lost to Follow-up|14
2518245|NCT01743027|8716842|P4|Overall Study|Withdrawal by Subject|1
2518246|NCT01743027|8716843|P3|Overall Study|Withdrawal by Subject|3
2518247|NCT01743027|8716844|P2|Overall Study|Withdrawal by Subject|0
2518248|NCT01743027|8716845|P1|Overall Study|Withdrawal by Subject|1
2518249|NCT01743027|8716842|P4|Overall Study|Protocol Violation|0
2518250|NCT01743027|8716843|P3|Overall Study|Protocol Violation|1
2518251|NCT01743027|8716844|P2|Overall Study|Protocol Violation|1
2518252|NCT01743027|8716845|P1|Overall Study|Protocol Violation|1
2518253|NCT01743027|8716842|P4|Overall Study|Progressive Disease|0
2518254|NCT01743027|8716843|P3|Overall Study|Progressive Disease|3
2518255|NCT01743027|8716844|P2|Overall Study|Progressive Disease|4
2518256|NCT01743027|8716845|P1|Overall Study|Progressive Disease|1
2518257|NCT01743027|8716842|P4|Overall Study|Lost to Follow-up|0
2518258|NCT01743027|8716843|P3|Overall Study|Lost to Follow-up|2
2518259|NCT01743027|8716844|P2|Overall Study|Lost to Follow-up|0
2518260|NCT01743027|8716845|P1|Overall Study|Lost to Follow-up|0
2518261|NCT01743027|8716842|P4|Overall Study|Adverse Event|0
2518262|NCT01743027|8716843|P3|Overall Study|Adverse Event|0
2518263|NCT01743027|8716844|P2|Overall Study|Adverse Event|0
2518264|NCT01743027|8716845|P1|Overall Study|Adverse Event|2
2518265|NCT01743001|8716885|P2|Overall Study|Death|0
2518266|NCT01743001|8716886|P1|Overall Study|Death|1
2518267|NCT01743001|8716885|P2|Overall Study|Pregnancy|0
2518268|NCT01743001|8716886|P1|Overall Study|Pregnancy|1
2518269|NCT01743001|8716885|P2|Overall Study|Physician Decision|0
2518270|NCT01743001|8716886|P1|Overall Study|Physician Decision|1
2518271|NCT01742897|8716929|P1|Overall Study|Other|1
2518272|NCT01742897|8716929|P1|Overall Study|Withdrawal by Subject|1
2518273|NCT01742897|8716929|P1|Overall Study|Adverse Event|3
2518274|NCT01742091|8717010|P6|Overall Study|Lost to Follow-up|1
2518275|NCT01742091|8717011|P5|Overall Study|Lost to Follow-up|0
2518276|NCT01742091|8717012|P4|Overall Study|Lost to Follow-up|0
2518277|NCT01742091|8717013|P3|Overall Study|Lost to Follow-up|0
2518278|NCT01742091|8717014|P2|Overall Study|Lost to Follow-up|0
2518279|NCT01742091|8717015|P1|Overall Study|Lost to Follow-up|0
2518280|NCT01742091|8717010|P6|Overall Study|Withdrawal by Subject|0
2518281|NCT01742091|8717011|P5|Overall Study|Withdrawal by Subject|0
2518282|NCT01742091|8717012|P4|Overall Study|Withdrawal by Subject|1
2518283|NCT01742091|8717013|P3|Overall Study|Withdrawal by Subject|0
2518284|NCT01742091|8717014|P2|Overall Study|Withdrawal by Subject|0
2518285|NCT01742091|8717015|P1|Overall Study|Withdrawal by Subject|0
2518286|NCT01742091|8717010|P6|Overall Study|Physician Decision|1
2518287|NCT01742091|8717011|P5|Overall Study|Physician Decision|0
2518288|NCT01742091|8717012|P4|Overall Study|Physician Decision|0
2518289|NCT01742091|8717013|P3|Overall Study|Physician Decision|0
2518290|NCT01742091|8717014|P2|Overall Study|Physician Decision|0
2518291|NCT01742091|8717015|P1|Overall Study|Physician Decision|0
2518292|NCT01742091|8717010|P6|Overall Study|Adverse Event|0
2518293|NCT01742091|8717011|P5|Overall Study|Adverse Event|1
2518294|NCT01742091|8717012|P4|Overall Study|Adverse Event|0
2518295|NCT01742091|8717013|P3|Overall Study|Adverse Event|0
2518296|NCT01742091|8717014|P2|Overall Study|Adverse Event|0
2518297|NCT01742091|8717015|P1|Overall Study|Adverse Event|0
2518298|NCT01742078|8717061|P9|Overall Study|Withdrawal by Subject|0
2518299|NCT01742078|8717062|P8|Overall Study|Withdrawal by Subject|0
2518300|NCT01742078|8717063|P7|Overall Study|Withdrawal by Subject|0
2518301|NCT01742078|8717064|P6|Overall Study|Withdrawal by Subject|0
2518302|NCT01742078|8717065|P5|Overall Study|Withdrawal by Subject|0
2518303|NCT01742078|8717066|P4|Overall Study|Withdrawal by Subject|1
2518304|NCT01742078|8717067|P3|Overall Study|Withdrawal by Subject|0
2518305|NCT01742078|8717068|P2|Overall Study|Withdrawal by Subject|0
2518306|NCT01742078|8717069|P1|Overall Study|Withdrawal by Subject|0
2518307|NCT01741792|8717138|P3|Overall Study|Death|12
2518308|NCT01741792|8717139|P2|Overall Study|Death|1
2518309|NCT01741792|8717140|P1|Overall Study|Death|6
2518310|NCT01741701|8717207|P2|Overall Study|Withdrawal by Subject|1
2518311|NCT01741701|8717208|P1|Overall Study|Withdrawal by Subject|0
2518312|NCT01741701|8717207|P2|Overall Study|Adverse Event|1
2518313|NCT01741701|8717208|P1|Overall Study|Adverse Event|5
2518314|NCT01741688|8717224|P1|Overall Study|Withdrawal by Subject|1
2518315|NCT01741688|8717224|P1|Overall Study|Lack of insurance coverage|2
2518316|NCT01741545|8717243|P2|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
2518317|NCT01741545|8717244|P1|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
2518318|NCT01741545|8717243|P2|Follow-up Period (24 Weeks)|Other than specified|1
2518319|NCT01741545|8717244|P1|Follow-up Period (24 Weeks)|Other than specified|0
2518320|NCT01741545|8717243|P2|Treatment Period|Adverse event, non-fatal|3
2518321|NCT01741545|8717244|P1|Treatment Period|Adverse event, non-fatal|1
2518322|NCT01741545|8717243|P2|Treatment Period|Lack of Efficacy|1
2518323|NCT01741545|8717244|P1|Treatment Period|Lack of Efficacy|0
2519697|NCT01729754|8722271|P7|Part 3|Death|0
2518324|NCT01741532|8717268|P2|Overall Study|Medical event|0
2518325|NCT01741532|8717269|P1|Overall Study|Medical event|1
2518326|NCT01741532|8717268|P2|Overall Study|Sponsor decision|0
2518327|NCT01741532|8717269|P1|Overall Study|Sponsor decision|1
2518328|NCT01741532|8717268|P2|Overall Study|Worsening of the disease|1
2518329|NCT01741532|8717269|P1|Overall Study|Worsening of the disease|3
2518330|NCT01741532|8717268|P2|Overall Study|Protocol Violation|1
2518331|NCT01741532|8717269|P1|Overall Study|Protocol Violation|0
2518332|NCT01741532|8717268|P2|Overall Study|Withdrawal by Subject|1
2518333|NCT01741532|8717269|P1|Overall Study|Withdrawal by Subject|1
2518334|NCT01741532|8717268|P2|Overall Study|Adverse Event|0
2518335|NCT01741532|8717269|P1|Overall Study|Adverse Event|4
2518336|NCT01741259|8717483|P2|Overall Study|Withdrawal by Subject|2
2518337|NCT01741259|8717484|P1|Overall Study|Withdrawal by Subject|0
2518338|NCT01741259|8717483|P2|Overall Study|Protocol Violation|4
2518339|NCT01741259|8717484|P1|Overall Study|Protocol Violation|6
2518340|NCT01741012|8717538|P1|Overall Study|Withdrawal by Subject|2
2518341|NCT01741012|8717538|P1|Overall Study|Lost to Follow-up|1
2518342|NCT01740440|8717610|P1|Overall Study|Lost to Follow-up|3
2518343|NCT01740427|8717618|P2|Overall Study|Study terminated by Sponsor|0
2518344|NCT01740427|8717619|P1|Overall Study|Study terminated by Sponsor|1
2518345|NCT01740427|8717618|P2|Overall Study|Lost to Follow-up|0
2518346|NCT01740427|8717619|P1|Overall Study|Lost to Follow-up|1
2518347|NCT01740427|8717618|P2|Overall Study|Protocol Violation|3
2518348|NCT01740427|8717619|P1|Overall Study|Protocol Violation|5
2518349|NCT01740427|8717618|P2|Overall Study|Death|2
2518350|NCT01740427|8717619|P1|Overall Study|Death|6
2518351|NCT01740427|8717618|P2|Overall Study|Unspecified reasons|4
2518352|NCT01740427|8717619|P1|Overall Study|Unspecified reasons|6
2518353|NCT01740427|8717618|P2|Overall Study|Subject refused continued treatment|9
2518354|NCT01740427|8717619|P1|Overall Study|Subject refused continued treatment|12
2518355|NCT01740427|8717618|P2|Overall Study|Global deterioration of health status|9
2518356|NCT01740427|8717619|P1|Overall Study|Global deterioration of health status|16
2518357|NCT01740427|8717618|P2|Overall Study|Adverse Event|9
2518358|NCT01740427|8717619|P1|Overall Study|Adverse Event|20
2518359|NCT01740427|8717618|P2|Overall Study|Objective progression or relapse|125
2518360|NCT01740427|8717619|P1|Overall Study|Objective progression or relapse|172
2518361|NCT01740427|8717618|P2|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|61
2518362|NCT01740427|8717619|P1|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|205
2518363|NCT01740401|8717671|P1|Overall Study|Did not reach primary endpoint|2
2518364|NCT01740401|8717671|P1|Overall Study|Adverse Event|2
2518365|NCT01740401|8717671|P1|Overall Study|Progression of disease|6
2518366|NCT01740388|8717680|P2|Overall Study|Subjects missing data, completed|36
2518367|NCT01740388|8717681|P1|Overall Study|Subjects missing data, completed|41
2518368|NCT01740388|8717680|P2|Overall Study|Physician Decision|6
2518369|NCT01740388|8717681|P1|Overall Study|Physician Decision|2
2518370|NCT01740388|8717680|P2|Overall Study|Lost to Follow-up|0
2518371|NCT01740388|8717681|P1|Overall Study|Lost to Follow-up|2
2518372|NCT01740388|8717680|P2|Overall Study|Withdrawal by Subject|2
2518373|NCT01740388|8717681|P1|Overall Study|Withdrawal by Subject|1
2518374|NCT01740323|8717732|P2|Overall Study|Randomized but did not take study drug|0
2518375|NCT01740323|8717733|P1|Overall Study|Randomized but did not take study drug|1
2518376|NCT01740323|8717732|P2|Overall Study|Adverse Event|0
2518377|NCT01740323|8717733|P1|Overall Study|Adverse Event|1
2518378|NCT01740297|8717754|P3|Overall Study|Sponsor Decision|0
2518379|NCT01740297|8717755|P2|Overall Study|Sponsor Decision|1
2518380|NCT01740297|8717756|P1|Overall Study|Sponsor Decision|0
2518381|NCT01740297|8717754|P3|Overall Study|Death|19
2518382|NCT01740297|8717755|P2|Overall Study|Death|23
2518383|NCT01740297|8717756|P1|Overall Study|Death|8
2518384|NCT01740297|8717754|P3|Overall Study|Withdrawal by Subject|11
2518385|NCT01740297|8717755|P2|Overall Study|Withdrawal by Subject|9
2518386|NCT01740297|8717756|P1|Overall Study|Withdrawal by Subject|1
2518387|NCT01740297|8717754|P3|Overall Study|Continuing Study|68
2518388|NCT01740297|8717755|P2|Overall Study|Continuing Study|67
2518389|NCT01740297|8717756|P1|Overall Study|Continuing Study|10
2518390|NCT01740154|8717805|P1|Overall Study|Adverse Event|1
2518391|NCT01740128|8717813|P2|Overall Study|Insufficient protocol compliance|2
2518392|NCT01740128|8717814|P1|Overall Study|Insufficient protocol compliance|2
2518393|NCT01740128|8717813|P2|Overall Study|Withdrawal by Subject|0
2518394|NCT01740128|8717814|P1|Overall Study|Withdrawal by Subject|1
2518395|NCT01740128|8717813|P2|Overall Study|Lost to Follow-up|2
2518396|NCT01740128|8717814|P1|Overall Study|Lost to Follow-up|2
2518397|NCT01740128|8717813|P2|Overall Study|Protocol Violation|2
2518398|NCT01740128|8717814|P1|Overall Study|Protocol Violation|1
2518399|NCT01740128|8717813|P2|Overall Study|Pregnancy|1
2518400|NCT01740128|8717814|P1|Overall Study|Pregnancy|0
2518401|NCT01740089|8717843|P3|After 12 Weeks|Withdrawal by Subject|1
2518402|NCT01740089|8717844|P2|After 12 Weeks|Withdrawal by Subject|1
2518403|NCT01740089|8717845|P1|After 12 Weeks|Withdrawal by Subject|1
2518404|NCT01740089|8717843|P3|After 12 Weeks|Protocol Violation|1
2518405|NCT01740089|8717844|P2|After 12 Weeks|Protocol Violation|1
2518406|NCT01740089|8717845|P1|After 12 Weeks|Protocol Violation|1
2518407|NCT01740089|8717843|P3|After 12 Weeks|Adverse Event|5
2518408|NCT01740089|8717844|P2|After 12 Weeks|Adverse Event|0
2518409|NCT01740089|8717845|P1|After 12 Weeks|Adverse Event|2
2518410|NCT01740089|8717843|P3|After 12 Weeks|Lack of Efficacy|4
2519698|NCT01729754|8722272|P6|Part 3|Death|2
2518411|NCT01740089|8717844|P2|After 12 Weeks|Lack of Efficacy|1
2518412|NCT01740089|8717845|P1|After 12 Weeks|Lack of Efficacy|3
2518413|NCT01740089|8717843|P3|First 12 Weeks of Treatment|Withdrawal by Subject|0
2518414|NCT01740089|8717844|P2|First 12 Weeks of Treatment|Withdrawal by Subject|1
2518415|NCT01740089|8717845|P1|First 12 Weeks of Treatment|Withdrawal by Subject|0
2518416|NCT01740089|8717843|P3|First 12 Weeks of Treatment|Adverse Event|2
2518417|NCT01740089|8717844|P2|First 12 Weeks of Treatment|Adverse Event|1
2518418|NCT01740089|8717845|P1|First 12 Weeks of Treatment|Adverse Event|0
2518419|NCT01739803|8717863|P2|Overall Study|Lost to Follow-up|6
2518420|NCT01739803|8717864|P1|Overall Study|Lost to Follow-up|9
2518421|NCT01739790|8717876|P2|Overall Study|Early Trial Termination|4
2518422|NCT01739790|8717877|P1|Overall Study|Early Trial Termination|2
2518423|NCT01739595|8717886|P3|Overall Study|Drug discrepancy|0
2518424|NCT01739595|8717887|P2|Overall Study|Drug discrepancy|0
2518425|NCT01739595|8717888|P1|Overall Study|Drug discrepancy|1
2518426|NCT01739595|8717886|P3|Overall Study|Lab assessment|0
2518427|NCT01739595|8717887|P2|Overall Study|Lab assessment|0
2518428|NCT01739595|8717888|P1|Overall Study|Lab assessment|1
2518429|NCT01739595|8717886|P3|Overall Study|Protocol Violation|0
2518430|NCT01739595|8717887|P2|Overall Study|Protocol Violation|0
2518431|NCT01739595|8717888|P1|Overall Study|Protocol Violation|1
2518432|NCT01739595|8717886|P3|Overall Study|Eligibility issue|0
2518433|NCT01739595|8717887|P2|Overall Study|Eligibility issue|0
2518434|NCT01739595|8717888|P1|Overall Study|Eligibility issue|3
2518435|NCT01739595|8717886|P3|Overall Study|Withdrawal by Subject|2
2518436|NCT01739595|8717887|P2|Overall Study|Withdrawal by Subject|1
2518437|NCT01739595|8717888|P1|Overall Study|Withdrawal by Subject|2
2518438|NCT01739595|8717886|P3|Overall Study|Lost to Follow-up|0
2518439|NCT01739595|8717887|P2|Overall Study|Lost to Follow-up|0
2518440|NCT01739595|8717888|P1|Overall Study|Lost to Follow-up|2
2518441|NCT01739595|8717886|P3|Overall Study|Adverse Event|0
2518442|NCT01739595|8717887|P2|Overall Study|Adverse Event|0
2518443|NCT01739595|8717888|P1|Overall Study|Adverse Event|3
2518444|NCT01739400|8717898|P2|Overall Study|Withdrawal by Subject|7
2518445|NCT01739400|8717899|P1|Overall Study|Withdrawal by Subject|7
2518446|NCT01739400|8717898|P2|Overall Study|Death|2
2518447|NCT01739400|8717899|P1|Overall Study|Death|5
2518448|NCT01739400|8717898|P2|Overall Study|Lost to Follow-up|0
2518449|NCT01739400|8717899|P1|Overall Study|Lost to Follow-up|2
2518450|NCT01739400|8717898|P2|Overall Study|Physician Decision|0
2518451|NCT01739400|8717899|P1|Overall Study|Physician Decision|3
2518452|NCT01739348|8717927|P4|Part II (Extension Study)|Withdrawal by Subject|7
2518453|NCT01739348|8717928|P3|Part II (Extension Study)|Withdrawal by Subject|4
2518454|NCT01739348|8717929|P2|Part II (Extension Study)|Withdrawal by Subject|2
2518455|NCT01739348|8717930|P1|Part II (Extension Study)|Withdrawal by Subject|5
2518456|NCT01739348|8717927|P4|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16
2518457|NCT01739348|8717928|P3|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8
2518458|NCT01739348|8717929|P2|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12
2518459|NCT01739348|8717930|P1|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18
2518460|NCT01739348|8717927|P4|Part II (Extension Study)|Participant Moved|3
2518461|NCT01739348|8717928|P3|Part II (Extension Study)|Participant Moved|0
2518462|NCT01739348|8717929|P2|Part II (Extension Study)|Participant Moved|3
2518463|NCT01739348|8717930|P1|Part II (Extension Study)|Participant Moved|3
2518464|NCT01739348|8717927|P4|Part II (Extension Study)|Study Terminated by Sponsor|323
2518465|NCT01739348|8717928|P3|Part II (Extension Study)|Study Terminated by Sponsor|34
2518466|NCT01739348|8717929|P2|Part II (Extension Study)|Study Terminated by Sponsor|315
2518467|NCT01739348|8717930|P1|Part II (Extension Study)|Study Terminated by Sponsor|329
2518468|NCT01739348|8717927|P4|Part II (Extension Study)|Physician Decision|12
2518469|NCT01739348|8717928|P3|Part II (Extension Study)|Physician Decision|6
2518470|NCT01739348|8717929|P2|Part II (Extension Study)|Physician Decision|11
2518471|NCT01739348|8717930|P1|Part II (Extension Study)|Physician Decision|7
2518472|NCT01739348|8717927|P4|Part II (Extension Study)|Non-Compliance with Study Drug|1
2518473|NCT01739348|8717928|P3|Part II (Extension Study)|Non-Compliance with Study Drug|0
2518474|NCT01739348|8717929|P2|Part II (Extension Study)|Non-Compliance with Study Drug|0
2518475|NCT01739348|8717930|P1|Part II (Extension Study)|Non-Compliance with Study Drug|0
2518476|NCT01739348|8717927|P4|Part II (Extension Study)|Lost to Follow-up|1
2518477|NCT01739348|8717928|P3|Part II (Extension Study)|Lost to Follow-up|0
2518478|NCT01739348|8717929|P2|Part II (Extension Study)|Lost to Follow-up|4
2518479|NCT01739348|8717930|P1|Part II (Extension Study)|Lost to Follow-up|3
2518480|NCT01739348|8717927|P4|Part II (Extension Study)|Lack of Efficacy|1
2518481|NCT01739348|8717928|P3|Part II (Extension Study)|Lack of Efficacy|0
2518482|NCT01739348|8717929|P2|Part II (Extension Study)|Lack of Efficacy|5
2518483|NCT01739348|8717930|P1|Part II (Extension Study)|Lack of Efficacy|1
2518484|NCT01739348|8717927|P4|Part II (Extension Study)|Death|6
2518485|NCT01739348|8717928|P3|Part II (Extension Study)|Death|2
2518486|NCT01739348|8717929|P2|Part II (Extension Study)|Death|3
2518487|NCT01739348|8717930|P1|Part II (Extension Study)|Death|3
2518488|NCT01739348|8717927|P4|Part II (Extension Study)|Adverse Event|26
2518489|NCT01739348|8717928|P3|Part II (Extension Study)|Adverse Event|7
2518490|NCT01739348|8717929|P2|Part II (Extension Study)|Adverse Event|11
2518491|NCT01739348|8717930|P1|Part II (Extension Study)|Adverse Event|10
2518492|NCT01739348|8717927|P4|Part I (Base Study)|Withdrawal by Subject|20
2518493|NCT01739348|8717928|P3|Part I (Base Study)|Withdrawal by Subject|7
2518494|NCT01739348|8717929|P2|Part I (Base Study)|Withdrawal by Subject|21
2518495|NCT01739348|8717930|P1|Part I (Base Study)|Withdrawal by Subject|23
2518496|NCT01739348|8717927|P4|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18
2518497|NCT01739348|8717928|P3|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2
2518498|NCT01739348|8717929|P2|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25
2518499|NCT01739348|8717930|P1|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27
2518500|NCT01739348|8717927|P4|Part I (Base Study)|Participant Moved|7
2518501|NCT01739348|8717928|P3|Part I (Base Study)|Participant Moved|1
2518502|NCT01739348|8717929|P2|Part I (Base Study)|Participant Moved|3
2518503|NCT01739348|8717930|P1|Part I (Base Study)|Participant Moved|4
2518504|NCT01739348|8717927|P4|Part I (Base Study)|Study Terminated by Sponsor|86
2518505|NCT01739348|8717928|P3|Part I (Base Study)|Study Terminated by Sponsor|0
2518506|NCT01739348|8717929|P2|Part I (Base Study)|Study Terminated by Sponsor|73
2518507|NCT01739348|8717930|P1|Part I (Base Study)|Study Terminated by Sponsor|72
2518508|NCT01739348|8717927|P4|Part I (Base Study)|Site Discontinued Study Participation|0
2518509|NCT01739348|8717928|P3|Part I (Base Study)|Site Discontinued Study Participation|0
2518510|NCT01739348|8717929|P2|Part I (Base Study)|Site Discontinued Study Participation|3
2518511|NCT01739348|8717930|P1|Part I (Base Study)|Site Discontinued Study Participation|1
2518512|NCT01739348|8717927|P4|Part I (Base Study)|Screen Failure|0
2518513|NCT01739348|8717928|P3|Part I (Base Study)|Screen Failure|0
2518514|NCT01739348|8717929|P2|Part I (Base Study)|Screen Failure|0
2518515|NCT01739348|8717930|P1|Part I (Base Study)|Screen Failure|2
2518516|NCT01739348|8717927|P4|Part I (Base Study)|Protocol Violation|2
2518517|NCT01739348|8717928|P3|Part I (Base Study)|Protocol Violation|1
2518518|NCT01739348|8717929|P2|Part I (Base Study)|Protocol Violation|0
2518519|NCT01739348|8717930|P1|Part I (Base Study)|Protocol Violation|2
2518520|NCT01739348|8717927|P4|Part I (Base Study)|Physician Decision|4
2518521|NCT01739348|8717928|P3|Part I (Base Study)|Physician Decision|1
2518522|NCT01739348|8717929|P2|Part I (Base Study)|Physician Decision|7
2518523|NCT01739348|8717930|P1|Part I (Base Study)|Physician Decision|10
2518524|NCT01739348|8717927|P4|Part I (Base Study)|Non-Compliance with Study Drug|0
2518525|NCT01739348|8717928|P3|Part I (Base Study)|Non-Compliance with Study Drug|0
2518526|NCT01739348|8717929|P2|Part I (Base Study)|Non-Compliance with Study Drug|2
2518527|NCT01739348|8717930|P1|Part I (Base Study)|Non-Compliance with Study Drug|3
2518528|NCT01739348|8717927|P4|Part I (Base Study)|Lost to Follow-up|4
2518529|NCT01739348|8717928|P3|Part I (Base Study)|Lost to Follow-up|4
2518530|NCT01739348|8717929|P2|Part I (Base Study)|Lost to Follow-up|2
2518531|NCT01739348|8717930|P1|Part I (Base Study)|Lost to Follow-up|4
2518532|NCT01739348|8717927|P4|Part I (Base Study)|Lack of Efficacy|7
2518533|NCT01739348|8717928|P3|Part I (Base Study)|Lack of Efficacy|0
2518534|NCT01739348|8717929|P2|Part I (Base Study)|Lack of Efficacy|8
2518535|NCT01739348|8717930|P1|Part I (Base Study)|Lack of Efficacy|3
2518536|NCT01739348|8717927|P4|Part I (Base Study)|Death|8
2518537|NCT01739348|8717928|P3|Part I (Base Study)|Death|2
2518538|NCT01739348|8717929|P2|Part I (Base Study)|Death|7
2518539|NCT01739348|8717930|P1|Part I (Base Study)|Death|10
2518540|NCT01739348|8717927|P4|Part I (Base Study)|Adverse Event|33
2518541|NCT01739348|8717928|P3|Part I (Base Study)|Adverse Event|8
2518542|NCT01739348|8717929|P2|Part I (Base Study)|Adverse Event|52
2518543|NCT01739348|8717930|P1|Part I (Base Study)|Adverse Event|41
2518544|NCT01739335|8718002|P2|Overall Study|Ineligible patient randomized|1
2518545|NCT01739335|8718003|P1|Overall Study|Ineligible patient randomized|0
2518546|NCT01739335|8718002|P2|Overall Study|Lost to Follow-up|4
2518547|NCT01739335|8718003|P1|Overall Study|Lost to Follow-up|7
2518548|NCT01739309|8718035|P1|Overall Study|On study treatment|3
2518549|NCT01738984|8718230|P2|Overall Study|Lost to Follow-up|39
2518550|NCT01738984|8718231|P1|Overall Study|Lost to Follow-up|59
2518551|NCT01738984|8718230|P2|Overall Study|Withdrawal by Subject|0
2518552|NCT01738984|8718231|P1|Overall Study|Withdrawal by Subject|1
2518553|NCT01738984|8718230|P2|Overall Study|Pregnancy|0
2518554|NCT01738984|8718231|P1|Overall Study|Pregnancy|4
2518555|NCT01738971|8718244|P3|Overall Study|Lost to Follow-up|17
2518556|NCT01738971|8718245|P2|Overall Study|Lost to Follow-up|30
2518557|NCT01738971|8718246|P1|Overall Study|Lost to Follow-up|19
2518558|NCT01738919|8718262|P2|Overall Study|Not treated in accordance to guidelines|1
2518559|NCT01738919|8718263|P1|Overall Study|Not treated in accordance to guidelines|0
2518560|NCT01738919|8718262|P2|Overall Study|Withdrawal by Subject|1
2518561|NCT01738919|8718263|P1|Overall Study|Withdrawal by Subject|0
2518562|NCT01738919|8718262|P2|Overall Study|Immigrated|1
2518563|NCT01738919|8718263|P1|Overall Study|Immigrated|0
2518564|NCT01738919|8718262|P2|Overall Study|Lost to Follow-up|0
2518565|NCT01738919|8718263|P1|Overall Study|Lost to Follow-up|1
2518566|NCT01738646|8718413|P1|Overall Study|Still Receiving Treatment|2
2518567|NCT01738594|8718424|P8|Follow up for 1 Year|Other|0
2518568|NCT01738594|8718425|P7|Follow up for 1 Year|Other|0
2518569|NCT01738594|8718426|P6|Follow up for 1 Year|Other|2
2518570|NCT01738594|8718427|P5|Follow up for 1 Year|Other|0
2518571|NCT01738594|8718428|P4|Follow up for 1 Year|Other|0
2518572|NCT01738594|8718429|P3|Follow up for 1 Year|Other|0
2518573|NCT01738594|8718430|P2|Follow up for 1 Year|Other|0
2518574|NCT01738594|8718431|P1|Follow up for 1 Year|Other|0
2518575|NCT01738594|8718424|P8|Follow up for 1 Year|Death|0
2518576|NCT01738594|8718425|P7|Follow up for 1 Year|Death|0
2518577|NCT01738594|8718426|P6|Follow up for 1 Year|Death|1
2518578|NCT01738594|8718427|P5|Follow up for 1 Year|Death|0
2518579|NCT01738594|8718428|P4|Follow up for 1 Year|Death|0
2518580|NCT01738594|8718429|P3|Follow up for 1 Year|Death|0
2518581|NCT01738594|8718430|P2|Follow up for 1 Year|Death|0
2518582|NCT01738594|8718431|P1|Follow up for 1 Year|Death|0
2518583|NCT01738594|8718424|P8|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
2518584|NCT01738594|8718425|P7|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
2518585|NCT01738594|8718426|P6|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
2518586|NCT01738594|8718427|P5|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1
2518587|NCT01738594|8718428|P4|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
2518588|NCT01738594|8718429|P3|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
2518589|NCT01738594|8718430|P2|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
2518590|NCT01738594|8718431|P1|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
2518591|NCT01738594|8718424|P8|Went on to Continue Treatment Cycle 5|Progressive Disease|0
2518592|NCT01738594|8718425|P7|Went on to Continue Treatment Cycle 5|Progressive Disease|0
2518593|NCT01738594|8718426|P6|Went on to Continue Treatment Cycle 5|Progressive Disease|1
2518594|NCT01738594|8718427|P5|Went on to Continue Treatment Cycle 5|Progressive Disease|0
2518595|NCT01738594|8718428|P4|Went on to Continue Treatment Cycle 5|Progressive Disease|0
2518596|NCT01738594|8718429|P3|Went on to Continue Treatment Cycle 5|Progressive Disease|0
2518597|NCT01738594|8718430|P2|Went on to Continue Treatment Cycle 5|Progressive Disease|0
2518598|NCT01738594|8718431|P1|Went on to Continue Treatment Cycle 5|Progressive Disease|0
2518599|NCT01738594|8718424|P8|Completed 4 Cycles of Treatment|No response/patient benefit|0
2518600|NCT01738594|8718425|P7|Completed 4 Cycles of Treatment|No response/patient benefit|0
2518601|NCT01738594|8718426|P6|Completed 4 Cycles of Treatment|No response/patient benefit|1
2518602|NCT01738594|8718427|P5|Completed 4 Cycles of Treatment|No response/patient benefit|0
2518603|NCT01738594|8718428|P4|Completed 4 Cycles of Treatment|No response/patient benefit|0
2518604|NCT01738594|8718429|P3|Completed 4 Cycles of Treatment|No response/patient benefit|0
2518605|NCT01738594|8718430|P2|Completed 4 Cycles of Treatment|No response/patient benefit|0
2518606|NCT01738594|8718431|P1|Completed 4 Cycles of Treatment|No response/patient benefit|0
2518607|NCT01738594|8718424|P8|Completed 4 Cycles of Treatment|Progressive disease|0
2518608|NCT01738594|8718425|P7|Completed 4 Cycles of Treatment|Progressive disease|0
2518609|NCT01738594|8718426|P6|Completed 4 Cycles of Treatment|Progressive disease|0
2518610|NCT01738594|8718427|P5|Completed 4 Cycles of Treatment|Progressive disease|0
2518611|NCT01738594|8718428|P4|Completed 4 Cycles of Treatment|Progressive disease|0
2518612|NCT01738594|8718429|P3|Completed 4 Cycles of Treatment|Progressive disease|0
2518613|NCT01738594|8718430|P2|Completed 4 Cycles of Treatment|Progressive disease|2
2518614|NCT01738594|8718431|P1|Completed 4 Cycles of Treatment|Progressive disease|0
2518615|NCT01738594|8718424|P8|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
2518616|NCT01738594|8718425|P7|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
2518617|NCT01738594|8718426|P6|Completed 2 Cycles/Reached 1st Response|Physician Decision|1
2518618|NCT01738594|8718427|P5|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
2518619|NCT01738594|8718428|P4|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
2518620|NCT01738594|8718429|P3|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
2518621|NCT01738594|8718430|P2|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
2518622|NCT01738594|8718431|P1|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
2518623|NCT01738594|8718424|P8|Registration and Treatment Start|Adverse Event|0
2518624|NCT01738594|8718425|P7|Registration and Treatment Start|Adverse Event|0
2518625|NCT01738594|8718426|P6|Registration and Treatment Start|Adverse Event|0
2518626|NCT01738594|8718427|P5|Registration and Treatment Start|Adverse Event|0
2518627|NCT01738594|8718428|P4|Registration and Treatment Start|Adverse Event|0
2518628|NCT01738594|8718429|P3|Registration and Treatment Start|Adverse Event|0
2518629|NCT01738594|8718430|P2|Registration and Treatment Start|Adverse Event|1
2518630|NCT01738594|8718431|P1|Registration and Treatment Start|Adverse Event|0
2518631|NCT01738581|8718449|P2|Overall Study|Lost to Follow-up|0
2518632|NCT01738581|8718450|P1|Overall Study|Lost to Follow-up|1
2518633|NCT01738503|8718474|P7|PET Imaging Sub-study|Scheduling issues with imaging facility|1
2518634|NCT01738503|8718475|P6|PET Imaging Sub-study|Scheduling issues with imaging facility|1
2518635|NCT01738503|8718476|P5|PET Imaging Sub-study|Scheduling issues with imaging facility|0
2518636|NCT01738503|8718477|P4|PET Imaging Sub-study|Scheduling issues with imaging facility|0
2518637|NCT01738503|8718478|P3|PET Imaging Sub-study|Scheduling issues with imaging facility|0
2518638|NCT01738503|8718479|P2|PET Imaging Sub-study|Scheduling issues with imaging facility|0
2518639|NCT01738503|8718480|P1|PET Imaging Sub-study|Scheduling issues with imaging facility|0
2518640|NCT01738503|8718474|P7|PET Imaging Sub-study|Adverse Event|0
2518641|NCT01738503|8718475|P6|PET Imaging Sub-study|Adverse Event|1
2518642|NCT01738503|8718476|P5|PET Imaging Sub-study|Adverse Event|0
2518643|NCT01738503|8718477|P4|PET Imaging Sub-study|Adverse Event|0
2518644|NCT01738503|8718478|P3|PET Imaging Sub-study|Adverse Event|0
2518645|NCT01738503|8718479|P2|PET Imaging Sub-study|Adverse Event|0
2518646|NCT01738503|8718480|P1|PET Imaging Sub-study|Adverse Event|0
2518647|NCT01738503|8718474|P7|Treatment Period|Other|0
2518648|NCT01738503|8718475|P6|Treatment Period|Other|0
2518649|NCT01738503|8718476|P5|Treatment Period|Other|0
2518650|NCT01738503|8718477|P4|Treatment Period|Other|0
2518651|NCT01738503|8718478|P3|Treatment Period|Other|1
2518652|NCT01738503|8718479|P2|Treatment Period|Other|0
2518653|NCT01738503|8718480|P1|Treatment Period|Other|0
2518654|NCT01738503|8718474|P7|Treatment Period|Protocol Violation|0
2518655|NCT01738503|8718475|P6|Treatment Period|Protocol Violation|2
2518656|NCT01738503|8718476|P5|Treatment Period|Protocol Violation|4
2518657|NCT01738503|8718477|P4|Treatment Period|Protocol Violation|0
2518658|NCT01738503|8718478|P3|Treatment Period|Protocol Violation|1
2518659|NCT01738503|8718479|P2|Treatment Period|Protocol Violation|3
2518660|NCT01738503|8718480|P1|Treatment Period|Protocol Violation|0
2518661|NCT01738503|8718474|P7|Treatment Period|Withdrawal by Subject|1
2518662|NCT01738503|8718475|P6|Treatment Period|Withdrawal by Subject|1
2518663|NCT01738503|8718476|P5|Treatment Period|Withdrawal by Subject|1
2518664|NCT01738503|8718477|P4|Treatment Period|Withdrawal by Subject|1
2518665|NCT01738503|8718478|P3|Treatment Period|Withdrawal by Subject|0
2518666|NCT01738503|8718479|P2|Treatment Period|Withdrawal by Subject|1
2518667|NCT01738503|8718480|P1|Treatment Period|Withdrawal by Subject|0
2518668|NCT01738503|8718474|P7|Treatment Period|Lost to Follow-up|5
2518669|NCT01738503|8718475|P6|Treatment Period|Lost to Follow-up|1
2518670|NCT01738503|8718476|P5|Treatment Period|Lost to Follow-up|1
2518671|NCT01738503|8718477|P4|Treatment Period|Lost to Follow-up|4
2518672|NCT01738503|8718478|P3|Treatment Period|Lost to Follow-up|3
2518673|NCT01738503|8718479|P2|Treatment Period|Lost to Follow-up|0
2518674|NCT01738503|8718480|P1|Treatment Period|Lost to Follow-up|0
2518675|NCT01738503|8718474|P7|Treatment Period|Adverse Event|2
2518676|NCT01738503|8718475|P6|Treatment Period|Adverse Event|2
2518677|NCT01738503|8718476|P5|Treatment Period|Adverse Event|2
2518678|NCT01738503|8718477|P4|Treatment Period|Adverse Event|1
2518679|NCT01738503|8718478|P3|Treatment Period|Adverse Event|0
2518680|NCT01738503|8718479|P2|Treatment Period|Adverse Event|1
2518681|NCT01738503|8718480|P1|Treatment Period|Adverse Event|0
2518682|NCT01738503|8718474|P7|Induction/Stabilization (Days -14 to -1)|Other|0
2518683|NCT01738503|8718475|P6|Induction/Stabilization (Days -14 to -1)|Other|0
2518684|NCT01738503|8718476|P5|Induction/Stabilization (Days -14 to -1)|Other|0
2518685|NCT01738503|8718477|P4|Induction/Stabilization (Days -14 to -1)|Other|0
2518686|NCT01738503|8718478|P3|Induction/Stabilization (Days -14 to -1)|Other|0
2518687|NCT01738503|8718479|P2|Induction/Stabilization (Days -14 to -1)|Other|0
2518688|NCT01738503|8718480|P1|Induction/Stabilization (Days -14 to -1)|Other|35
2518689|NCT01738477|8718678|P2|Overall Study|Lost to Follow-up|4
2518690|NCT01738477|8718679|P1|Overall Study|Lost to Follow-up|1
2518691|NCT01738438|8718707|P1|Overall Study|Adverse Event|3
2518692|NCT01738438|8718707|P1|Overall Study|Disease Progression|32
2518693|NCT01738191|8718724|P2|Overall Study|Withdrawal by Subject|1
2518694|NCT01738191|8718725|P1|Overall Study|Withdrawal by Subject|4
2518695|NCT01737996|8718748|P3|Overall Study|Withdrawal by Subject|1
2518696|NCT01737996|8718749|P2|Overall Study|Withdrawal by Subject|0
2518697|NCT01737996|8718750|P1|Overall Study|Withdrawal by Subject|0
2518698|NCT01737996|8718748|P3|Overall Study|Adverse Event|1
2518699|NCT01737996|8718749|P2|Overall Study|Adverse Event|1
2518700|NCT01737996|8718750|P1|Overall Study|Adverse Event|0
2518701|NCT01737931|8718812|P3|Overall Study|Physician Decision|0
2518702|NCT01737931|8718813|P2|Overall Study|Physician Decision|1
2518703|NCT01737931|8718814|P1|Overall Study|Physician Decision|0
2518704|NCT01737931|8718812|P3|Overall Study|Withdrawal by Subject|1
2518705|NCT01737931|8718813|P2|Overall Study|Withdrawal by Subject|1
2518706|NCT01737931|8718814|P1|Overall Study|Withdrawal by Subject|0
2518707|NCT01737879|8718829|P1|Overall Study|Sponsor decision|40
2518708|NCT01737879|8718829|P1|Overall Study|Death|1
2518709|NCT01737840|8718838|P2|Overall Study|Diagnosed with an other pathology|2
2518710|NCT01737840|8718839|P1|Overall Study|Diagnosed with an other pathology|2
2518711|NCT01737762|8718849|P2|Overall Study|Trial termination|9
2518712|NCT01737762|8718850|P1|Overall Study|Trial termination|11
2518713|NCT01737762|8718849|P2|Overall Study|Moved from area|1
2518714|NCT01737762|8718850|P1|Overall Study|Moved from area|2
2518715|NCT01737762|8718849|P2|Overall Study|Physician Decision|1
2518716|NCT01737762|8718850|P1|Overall Study|Physician Decision|1
2518717|NCT01737762|8718849|P2|Overall Study|Progressive disease|2
2518718|NCT01737762|8718850|P1|Overall Study|Progressive disease|1
2518719|NCT01737762|8718849|P2|Overall Study|Withdrawal by Subject|2
2518720|NCT01737762|8718850|P1|Overall Study|Withdrawal by Subject|2
2518721|NCT01737762|8718849|P2|Overall Study|Lost to Follow-up|0
2518722|NCT01737762|8718850|P1|Overall Study|Lost to Follow-up|1
2518723|NCT01737762|8718849|P2|Overall Study|Adverse Event|2
2518724|NCT01737762|8718850|P1|Overall Study|Adverse Event|2
2518725|NCT01737710|8718863|P5|Overall Study|Vaccinated in Error/Ineligible|0
2518726|NCT01737710|8718864|P4|Overall Study|Vaccinated in Error/Ineligible|0
2518727|NCT01737710|8718865|P3|Overall Study|Vaccinated in Error/Ineligible|0
2518728|NCT01737710|8718866|P2|Overall Study|Vaccinated in Error/Ineligible|1
2518729|NCT01737710|8718867|P1|Overall Study|Vaccinated in Error/Ineligible|1
2518730|NCT01737710|8718863|P5|Overall Study|Withdrawal by Subject|0
2518731|NCT01737710|8718864|P4|Overall Study|Withdrawal by Subject|0
2518732|NCT01737710|8718865|P3|Overall Study|Withdrawal by Subject|1
2518733|NCT01737710|8718866|P2|Overall Study|Withdrawal by Subject|1
2518734|NCT01737710|8718867|P1|Overall Study|Withdrawal by Subject|1
2518735|NCT01737710|8718863|P5|Overall Study|Lost to Follow-up|0
2518736|NCT01737710|8718864|P4|Overall Study|Lost to Follow-up|0
2518737|NCT01737710|8718865|P3|Overall Study|Lost to Follow-up|2
2518738|NCT01737710|8718866|P2|Overall Study|Lost to Follow-up|2
2519699|NCT01729754|8722273|P5|Part 3|Death|0
2518739|NCT01737710|8718867|P1|Overall Study|Lost to Follow-up|0
2518740|NCT01737697|8718909|P15|Subacute Phase|Death|0
2518741|NCT01737697|8718910|P14|Subacute Phase|Death|0
2518742|NCT01737697|8718911|P13|Subacute Phase|Death|0
2518743|NCT01737697|8718912|P12|Subacute Phase|Death|0
2518744|NCT01737697|8718913|P11|Subacute Phase|Death|1
2518745|NCT01737697|8718914|P10|Subacute Phase|Death|0
2518746|NCT01737697|8718915|P9|Subacute Phase|Death|0
2518747|NCT01737697|8718916|P8|Subacute Phase|Death|0
2518748|NCT01737697|8718917|P7|Subacute Phase|Death|0
2518749|NCT01737697|8718918|P6|Subacute Phase|Death|0
2518750|NCT01737697|8718919|P5|Subacute Phase|Death|0
2518751|NCT01737697|8718920|P4|Subacute Phase|Death|0
2518752|NCT01737697|8718921|P3|Subacute Phase|Death|0
2518753|NCT01737697|8718922|P2|Subacute Phase|Death|0
2518754|NCT01737697|8718923|P1|Subacute Phase|Death|0
2518755|NCT01737697|8718909|P15|Subacute Phase|Physician Decision|0
2518756|NCT01737697|8718910|P14|Subacute Phase|Physician Decision|0
2518757|NCT01737697|8718911|P13|Subacute Phase|Physician Decision|0
2518758|NCT01737697|8718912|P12|Subacute Phase|Physician Decision|0
2518759|NCT01737697|8718913|P11|Subacute Phase|Physician Decision|0
2518760|NCT01737697|8718914|P10|Subacute Phase|Physician Decision|0
2518761|NCT01737697|8718915|P9|Subacute Phase|Physician Decision|1
2518762|NCT01737697|8718916|P8|Subacute Phase|Physician Decision|0
2518763|NCT01737697|8718917|P7|Subacute Phase|Physician Decision|0
2518764|NCT01737697|8718918|P6|Subacute Phase|Physician Decision|0
2518765|NCT01737697|8718919|P5|Subacute Phase|Physician Decision|0
2518766|NCT01737697|8718920|P4|Subacute Phase|Physician Decision|0
2518767|NCT01737697|8718921|P3|Subacute Phase|Physician Decision|0
2518768|NCT01737697|8718922|P2|Subacute Phase|Physician Decision|0
2518769|NCT01737697|8718923|P1|Subacute Phase|Physician Decision|0
2518770|NCT01737697|8718909|P15|Subacute Phase|Protocol Violation|0
2518771|NCT01737697|8718910|P14|Subacute Phase|Protocol Violation|0
2518772|NCT01737697|8718911|P13|Subacute Phase|Protocol Violation|0
2518773|NCT01737697|8718912|P12|Subacute Phase|Protocol Violation|0
2518774|NCT01737697|8718913|P11|Subacute Phase|Protocol Violation|1
2518775|NCT01737697|8718914|P10|Subacute Phase|Protocol Violation|0
2518776|NCT01737697|8718915|P9|Subacute Phase|Protocol Violation|0
2518777|NCT01737697|8718916|P8|Subacute Phase|Protocol Violation|0
2518778|NCT01737697|8718917|P7|Subacute Phase|Protocol Violation|0
2518779|NCT01737697|8718918|P6|Subacute Phase|Protocol Violation|1
2518780|NCT01737697|8718919|P5|Subacute Phase|Protocol Violation|0
2518781|NCT01737697|8718920|P4|Subacute Phase|Protocol Violation|0
2518782|NCT01737697|8718921|P3|Subacute Phase|Protocol Violation|0
2518783|NCT01737697|8718922|P2|Subacute Phase|Protocol Violation|0
2518784|NCT01737697|8718923|P1|Subacute Phase|Protocol Violation|0
2518785|NCT01737697|8718909|P15|Subacute Phase|Hypo-or hyperkalemia|0
2518786|NCT01737697|8718910|P14|Subacute Phase|Hypo-or hyperkalemia|1
2518787|NCT01737697|8718911|P13|Subacute Phase|Hypo-or hyperkalemia|0
2518788|NCT01737697|8718912|P12|Subacute Phase|Hypo-or hyperkalemia|1
2518789|NCT01737697|8718913|P11|Subacute Phase|Hypo-or hyperkalemia|0
2518790|NCT01737697|8718914|P10|Subacute Phase|Hypo-or hyperkalemia|0
2518791|NCT01737697|8718915|P9|Subacute Phase|Hypo-or hyperkalemia|0
2518792|NCT01737697|8718916|P8|Subacute Phase|Hypo-or hyperkalemia|0
2518793|NCT01737697|8718917|P7|Subacute Phase|Hypo-or hyperkalemia|0
2518794|NCT01737697|8718918|P6|Subacute Phase|Hypo-or hyperkalemia|0
2518795|NCT01737697|8718919|P5|Subacute Phase|Hypo-or hyperkalemia|0
2518796|NCT01737697|8718920|P4|Subacute Phase|Hypo-or hyperkalemia|0
2518797|NCT01737697|8718921|P3|Subacute Phase|Hypo-or hyperkalemia|0
2518798|NCT01737697|8718922|P2|Subacute Phase|Hypo-or hyperkalemia|0
2518799|NCT01737697|8718923|P1|Subacute Phase|Hypo-or hyperkalemia|0
2518800|NCT01737697|8718909|P15|Subacute Phase|Lost to Follow-up|1
2518801|NCT01737697|8718910|P14|Subacute Phase|Lost to Follow-up|0
2518802|NCT01737697|8718911|P13|Subacute Phase|Lost to Follow-up|0
2518803|NCT01737697|8718912|P12|Subacute Phase|Lost to Follow-up|0
2518804|NCT01737697|8718913|P11|Subacute Phase|Lost to Follow-up|0
2518805|NCT01737697|8718914|P10|Subacute Phase|Lost to Follow-up|0
2518806|NCT01737697|8718915|P9|Subacute Phase|Lost to Follow-up|0
2518807|NCT01737697|8718916|P8|Subacute Phase|Lost to Follow-up|0
2518808|NCT01737697|8718917|P7|Subacute Phase|Lost to Follow-up|0
2518809|NCT01737697|8718918|P6|Subacute Phase|Lost to Follow-up|0
2518810|NCT01737697|8718919|P5|Subacute Phase|Lost to Follow-up|0
2518811|NCT01737697|8718920|P4|Subacute Phase|Lost to Follow-up|0
2518812|NCT01737697|8718921|P3|Subacute Phase|Lost to Follow-up|0
2518813|NCT01737697|8718922|P2|Subacute Phase|Lost to Follow-up|0
2518814|NCT01737697|8718923|P1|Subacute Phase|Lost to Follow-up|0
2518815|NCT01737697|8718909|P15|Subacute Phase|Withdrawal by Subject|0
2518816|NCT01737697|8718910|P14|Subacute Phase|Withdrawal by Subject|1
2518817|NCT01737697|8718911|P13|Subacute Phase|Withdrawal by Subject|1
2518818|NCT01737697|8718912|P12|Subacute Phase|Withdrawal by Subject|1
2518819|NCT01737697|8718913|P11|Subacute Phase|Withdrawal by Subject|0
2518820|NCT01737697|8718914|P10|Subacute Phase|Withdrawal by Subject|1
2518821|NCT01737697|8718915|P9|Subacute Phase|Withdrawal by Subject|0
2518822|NCT01737697|8718916|P8|Subacute Phase|Withdrawal by Subject|2
2518823|NCT01737697|8718917|P7|Subacute Phase|Withdrawal by Subject|0
2518824|NCT01737697|8718918|P6|Subacute Phase|Withdrawal by Subject|1
2518825|NCT01737697|8718919|P5|Subacute Phase|Withdrawal by Subject|0
2518826|NCT01737697|8718920|P4|Subacute Phase|Withdrawal by Subject|0
2518827|NCT01737697|8718921|P3|Subacute Phase|Withdrawal by Subject|0
2518828|NCT01737697|8718922|P2|Subacute Phase|Withdrawal by Subject|0
2518829|NCT01737697|8718923|P1|Subacute Phase|Withdrawal by Subject|0
2518830|NCT01737697|8718909|P15|Subacute Phase|Adverse Event|0
2518831|NCT01737697|8718910|P14|Subacute Phase|Adverse Event|0
2518832|NCT01737697|8718911|P13|Subacute Phase|Adverse Event|1
2518833|NCT01737697|8718912|P12|Subacute Phase|Adverse Event|1
2518834|NCT01737697|8718913|P11|Subacute Phase|Adverse Event|4
2518835|NCT01737697|8718914|P10|Subacute Phase|Adverse Event|1
2518836|NCT01737697|8718915|P9|Subacute Phase|Adverse Event|1
2518837|NCT01737697|8718916|P8|Subacute Phase|Adverse Event|1
2518838|NCT01737697|8718917|P7|Subacute Phase|Adverse Event|1
2518839|NCT01737697|8718918|P6|Subacute Phase|Adverse Event|1
2518840|NCT01737697|8718919|P5|Subacute Phase|Adverse Event|0
2518841|NCT01737697|8718920|P4|Subacute Phase|Adverse Event|0
2518842|NCT01737697|8718921|P3|Subacute Phase|Adverse Event|0
2518843|NCT01737697|8718922|P2|Subacute Phase|Adverse Event|0
2518844|NCT01737697|8718923|P1|Subacute Phase|Adverse Event|0
2518845|NCT01737697|8718909|P15|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2518846|NCT01737697|8718910|P14|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2518847|NCT01737697|8718911|P13|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2518848|NCT01737697|8718912|P12|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2518849|NCT01737697|8718913|P11|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2518850|NCT01737697|8718914|P10|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2518851|NCT01737697|8718915|P9|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2518852|NCT01737697|8718916|P8|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2518853|NCT01737697|8718917|P7|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2518854|NCT01737697|8718918|P6|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2518855|NCT01737697|8718919|P5|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
2518856|NCT01737697|8718920|P4|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4
2518857|NCT01737697|8718921|P3|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
2518858|NCT01737697|8718922|P2|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
2518859|NCT01737697|8718923|P1|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
2518860|NCT01737697|8718909|P15|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2518861|NCT01737697|8718910|P14|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2518862|NCT01737697|8718911|P13|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2518863|NCT01737697|8718912|P12|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2518864|NCT01737697|8718913|P11|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2518865|NCT01737697|8718914|P10|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2518866|NCT01737697|8718915|P9|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2518867|NCT01737697|8718916|P8|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2518868|NCT01737697|8718917|P7|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2518869|NCT01737697|8718918|P6|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2518870|NCT01737697|8718919|P5|Acute Phase-Initial 48 Hours|Lost to Follow-up|1
2518871|NCT01737697|8718920|P4|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2518872|NCT01737697|8718921|P3|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2518873|NCT01737697|8718922|P2|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2518874|NCT01737697|8718923|P1|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
2518875|NCT01737697|8718909|P15|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2518876|NCT01737697|8718910|P14|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2518877|NCT01737697|8718911|P13|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2518878|NCT01737697|8718912|P12|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2518879|NCT01737697|8718913|P11|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2518880|NCT01737697|8718914|P10|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2518881|NCT01737697|8718915|P9|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2518882|NCT01737697|8718916|P8|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2518883|NCT01737697|8718917|P7|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2518884|NCT01737697|8718918|P6|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2518885|NCT01737697|8718919|P5|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2518886|NCT01737697|8718920|P4|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2518887|NCT01737697|8718921|P3|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2518888|NCT01737697|8718922|P2|Acute Phase-Initial 48 Hours|Sponsor's decision|1
2518889|NCT01737697|8718923|P1|Acute Phase-Initial 48 Hours|Sponsor's decision|0
2518890|NCT01737697|8718909|P15|Acute Phase-Initial 48 Hours|Family emergency|0
2518891|NCT01737697|8718910|P14|Acute Phase-Initial 48 Hours|Family emergency|0
2518892|NCT01737697|8718911|P13|Acute Phase-Initial 48 Hours|Family emergency|0
2518893|NCT01737697|8718912|P12|Acute Phase-Initial 48 Hours|Family emergency|0
2518894|NCT01737697|8718913|P11|Acute Phase-Initial 48 Hours|Family emergency|0
2518895|NCT01737697|8718914|P10|Acute Phase-Initial 48 Hours|Family emergency|0
2518896|NCT01737697|8718915|P9|Acute Phase-Initial 48 Hours|Family emergency|0
2518897|NCT01737697|8718916|P8|Acute Phase-Initial 48 Hours|Family emergency|0
2518898|NCT01737697|8718917|P7|Acute Phase-Initial 48 Hours|Family emergency|0
2518899|NCT01737697|8718918|P6|Acute Phase-Initial 48 Hours|Family emergency|0
2518900|NCT01737697|8718919|P5|Acute Phase-Initial 48 Hours|Family emergency|0
2518901|NCT01737697|8718920|P4|Acute Phase-Initial 48 Hours|Family emergency|1
2518902|NCT01737697|8718921|P3|Acute Phase-Initial 48 Hours|Family emergency|0
2518903|NCT01737697|8718922|P2|Acute Phase-Initial 48 Hours|Family emergency|0
2518904|NCT01737697|8718923|P1|Acute Phase-Initial 48 Hours|Family emergency|0
2518905|NCT01737697|8718909|P15|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2518906|NCT01737697|8718910|P14|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2519700|NCT01729754|8722274|P4|Part 3|Death|0
2518907|NCT01737697|8718911|P13|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2518908|NCT01737697|8718912|P12|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2518909|NCT01737697|8718913|P11|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2518910|NCT01737697|8718914|P10|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2518911|NCT01737697|8718915|P9|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2518912|NCT01737697|8718916|P8|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2518913|NCT01737697|8718917|P7|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2518914|NCT01737697|8718918|P6|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2518915|NCT01737697|8718919|P5|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2518916|NCT01737697|8718920|P4|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
2518917|NCT01737697|8718921|P3|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3
2518918|NCT01737697|8718922|P2|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
2518919|NCT01737697|8718923|P1|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
2518920|NCT01737697|8718909|P15|Acute Phase-Initial 48 Hours|Adverse Event|0
2518921|NCT01737697|8718910|P14|Acute Phase-Initial 48 Hours|Adverse Event|0
2518922|NCT01737697|8718911|P13|Acute Phase-Initial 48 Hours|Adverse Event|0
2518923|NCT01737697|8718912|P12|Acute Phase-Initial 48 Hours|Adverse Event|0
2518924|NCT01737697|8718913|P11|Acute Phase-Initial 48 Hours|Adverse Event|0
2518925|NCT01737697|8718914|P10|Acute Phase-Initial 48 Hours|Adverse Event|0
2518926|NCT01737697|8718915|P9|Acute Phase-Initial 48 Hours|Adverse Event|0
2518927|NCT01737697|8718916|P8|Acute Phase-Initial 48 Hours|Adverse Event|0
2518928|NCT01737697|8718917|P7|Acute Phase-Initial 48 Hours|Adverse Event|0
2518929|NCT01737697|8718918|P6|Acute Phase-Initial 48 Hours|Adverse Event|0
2518930|NCT01737697|8718919|P5|Acute Phase-Initial 48 Hours|Adverse Event|1
2518931|NCT01737697|8718920|P4|Acute Phase-Initial 48 Hours|Adverse Event|1
2518932|NCT01737697|8718921|P3|Acute Phase-Initial 48 Hours|Adverse Event|0
2518933|NCT01737697|8718922|P2|Acute Phase-Initial 48 Hours|Adverse Event|1
2518934|NCT01737697|8718923|P1|Acute Phase-Initial 48 Hours|Adverse Event|0
2518935|NCT01737398|8719066|P2|Overall Study|Sponsor's decision|0
2518936|NCT01737398|8719067|P1|Overall Study|Sponsor's decision|2
2518937|NCT01737398|8719066|P2|Overall Study|Disease progression|3
2518938|NCT01737398|8719067|P1|Overall Study|Disease progression|2
2518939|NCT01737398|8719066|P2|Overall Study|Liver transplant|0
2518940|NCT01737398|8719067|P1|Overall Study|Liver transplant|1
2518941|NCT01737398|8719066|P2|Overall Study|Ineligibility|0
2518942|NCT01737398|8719067|P1|Overall Study|Ineligibility|1
2518943|NCT01737398|8719066|P2|Overall Study|Voluntary withdrawal|3
2518944|NCT01737398|8719067|P1|Overall Study|Voluntary withdrawal|2
2518945|NCT01737398|8719066|P2|Overall Study|Stopping rule met|1
2518946|NCT01737398|8719067|P1|Overall Study|Stopping rule met|2
2518947|NCT01737398|8719066|P2|Overall Study|Adverse event or SAE|1
2518948|NCT01737398|8719067|P1|Overall Study|Adverse event or SAE|16
2518949|NCT01737268|8719120|P1|Overall Study|In consideration of the patient’s safety|1
2518950|NCT01737268|8719120|P1|Overall Study|Worsening of Target Disease|2
2518951|NCT01737268|8719120|P1|Overall Study|Adverse Event|6
2518952|NCT01737021|8719134|P2|Overall Study|Lost to Follow-up|3
2518953|NCT01737021|8719135|P1|Overall Study|Lost to Follow-up|5
2518954|NCT01736917|8719181|P1|Overall Study|Protocol Violation|10
2518955|NCT01736917|8719181|P1|Overall Study|Adverse Event|1
2518956|NCT01736696|8719210|P7|Overall Study|Withdrawal by Subject|0
2518957|NCT01736696|8719211|P6|Overall Study|Withdrawal by Subject|0
2518958|NCT01736696|8719212|P5|Overall Study|Withdrawal by Subject|0
2518959|NCT01736696|8719213|P4|Overall Study|Withdrawal by Subject|0
2518960|NCT01736696|8719214|P3|Overall Study|Withdrawal by Subject|1
2518961|NCT01736696|8719215|P2|Overall Study|Withdrawal by Subject|0
2518962|NCT01736696|8719216|P1|Overall Study|Withdrawal by Subject|0
2518963|NCT01736683|8719538|P5|Overall Study|Other|1
2518964|NCT01736683|8719539|P4|Overall Study|Other|9
2518965|NCT01736683|8719540|P3|Overall Study|Other|1
2518966|NCT01736683|8719541|P2|Overall Study|Other|0
2518967|NCT01736683|8719542|P1|Overall Study|Other|0
2518968|NCT01736683|8719538|P5|Overall Study|Progressive Disease|0
2518969|NCT01736683|8719539|P4|Overall Study|Progressive Disease|1
2518970|NCT01736683|8719540|P3|Overall Study|Progressive Disease|0
2518971|NCT01736683|8719541|P2|Overall Study|Progressive Disease|0
2518972|NCT01736683|8719542|P1|Overall Study|Progressive Disease|0
2518973|NCT01736683|8719538|P5|Overall Study|Lack of Therapeutic Effect|1
2518974|NCT01736683|8719539|P4|Overall Study|Lack of Therapeutic Effect|20
2518975|NCT01736683|8719540|P3|Overall Study|Lack of Therapeutic Effect|13
2518976|NCT01736683|8719541|P2|Overall Study|Lack of Therapeutic Effect|4
2518977|NCT01736683|8719542|P1|Overall Study|Lack of Therapeutic Effect|7
2518978|NCT01736683|8719538|P5|Overall Study|Withdrawal by Subject|1
2518979|NCT01736683|8719539|P4|Overall Study|Withdrawal by Subject|1
2518980|NCT01736683|8719540|P3|Overall Study|Withdrawal by Subject|3
2518981|NCT01736683|8719541|P2|Overall Study|Withdrawal by Subject|0
2518982|NCT01736683|8719542|P1|Overall Study|Withdrawal by Subject|0
2518983|NCT01736683|8719538|P5|Overall Study|Adverse Event|2
2518984|NCT01736683|8719539|P4|Overall Study|Adverse Event|3
2518985|NCT01736683|8719540|P3|Overall Study|Adverse Event|2
2518986|NCT01736683|8719541|P2|Overall Study|Adverse Event|2
2518987|NCT01736683|8719542|P1|Overall Study|Adverse Event|0
2518988|NCT01736683|8719538|P5|Overall Study|Disease Relapse|0
2518989|NCT01736683|8719539|P4|Overall Study|Disease Relapse|1
2518990|NCT01736683|8719540|P3|Overall Study|Disease Relapse|2
2518991|NCT01736683|8719541|P2|Overall Study|Disease Relapse|0
2518992|NCT01736683|8719542|P1|Overall Study|Disease Relapse|0
2518993|NCT01736657|8719604|P1|Overall Study|insufficient vascular access|1
2518994|NCT01736579|8719613|P2|Overall Study|Termination of Study by Sponsor|2
2518995|NCT01736579|8719614|P1|Overall Study|Termination of Study by Sponsor|2
2518996|NCT01736566|8719653|P5|Long Term Follow-up|Still collecting data|1
2518997|NCT01736566|8719654|P4|Long Term Follow-up|Still collecting data|0
2518998|NCT01736566|8719655|P3|Long Term Follow-up|Still collecting data|49
2518999|NCT01736566|8719656|P2|Long Term Follow-up|Still collecting data|0
2519000|NCT01736566|8719657|P1|Long Term Follow-up|Still collecting data|42
2519001|NCT01736553|8719742|P2|Overall Study|Lost to Follow-up|2
2519002|NCT01736553|8719743|P1|Overall Study|Lost to Follow-up|2
2519003|NCT01736553|8719742|P2|Overall Study|Withdrawal by Subject|2
2519004|NCT01736553|8719743|P1|Overall Study|Withdrawal by Subject|5
2519005|NCT01736553|8719742|P2|Overall Study|Death|0
2519006|NCT01736553|8719743|P1|Overall Study|Death|12
2519007|NCT01736540|8719794|P1|Overall Study|Unable to make MRI appointment|3
2519008|NCT01736540|8719794|P1|Overall Study|No show for MRI appointment|1
2519009|NCT01736540|8719794|P1|Overall Study|Unable to tolerate MRI; claustrophobic|1
2519010|NCT01736540|8719794|P1|Overall Study|Protocol Violation|1
2519011|NCT01736540|8719794|P1|Overall Study|Withdrawal by Subject|5
2519012|NCT01736540|8719794|P1|Overall Study|Abnormal test procedure|1
2519013|NCT01736540|8719794|P1|Overall Study|Death|1
2519014|NCT01736540|8719794|P1|Overall Study|Did not complete scan within 45 days|2
2519015|NCT01736475|8719860|P2|Overall Study|Other - Surgical procedure|0
2519016|NCT01736475|8719861|P1|Overall Study|Other - Surgical procedure|1
2519017|NCT01736475|8719860|P2|Overall Study|Other - Screen failure|0
2519018|NCT01736475|8719861|P1|Overall Study|Other - Screen failure|1
2519019|NCT01736475|8719860|P2|Overall Study|Protocol Violation|0
2519020|NCT01736475|8719861|P1|Overall Study|Protocol Violation|4
2519021|NCT01736475|8719860|P2|Overall Study|Withdrawal by Subject|0
2519022|NCT01736475|8719861|P1|Overall Study|Withdrawal by Subject|2
2519023|NCT01736475|8719860|P2|Overall Study|Adverse Event|0
2519024|NCT01736475|8719861|P1|Overall Study|Adverse Event|4
2519025|NCT01736397|8719916|P2|Overall Study|Not stated|4
2519026|NCT01736397|8719917|P1|Overall Study|Not stated|1
2519027|NCT01736397|8719916|P2|Overall Study|Adverse Event|3
2519028|NCT01736397|8719917|P1|Overall Study|Adverse Event|6
2519029|NCT01736397|8719916|P2|Overall Study|Lost to Follow-up|1
2519030|NCT01736397|8719917|P1|Overall Study|Lost to Follow-up|0
2519031|NCT01736397|8719916|P2|Overall Study|Withdrawal by Subject|5
2519032|NCT01736397|8719917|P1|Overall Study|Withdrawal by Subject|6
2519033|NCT01736397|8719916|P2|Overall Study|Lack of Efficacy|11
2519034|NCT01736397|8719917|P1|Overall Study|Lack of Efficacy|1
2519035|NCT01736254|8719946|P1|Period 3 (Days 13 to 23)|Adverse Event|1
2519036|NCT01736254|8719946|P1|Period 2 (Days 2 to 12)|Adverse Event|3
2519037|NCT01736215|8720011|P1|Overall Study|Insufficient data to perform analysis|8
2519038|NCT01736215|8720011|P1|Overall Study|Progressive disease stop chemotherapy|1
2519039|NCT01736215|8720011|P1|Overall Study|Adverse Event|4
2519040|NCT01736215|8720011|P1|Overall Study|Early termination of erythropoietin use|1
2519041|NCT01736189|8720023|P1|Overall Study|Criteria and protocol violations|1
2519042|NCT01736189|8720023|P1|Overall Study|Protocol Violation|4
2519043|NCT01736189|8720023|P1|Overall Study|Violation of registration criteria|41
2519044|NCT01736176|8720032|P1|Overall Study|Unable to Complete PEG Placement|1
2519045|NCT01736176|8720032|P1|Overall Study|Lack of Efficacy|3
2519046|NCT01736176|8720032|P1|Overall Study|Withdrawal by Subject|4
2519047|NCT01736176|8720032|P1|Overall Study|Adverse Event|3
2519048|NCT01735994|8720103|P2|Overall Study|Lost to Follow-up|62
2519049|NCT01735994|8720104|P1|Overall Study|Lost to Follow-up|50
2519050|NCT01735994|8720103|P2|Overall Study|Kicked off team|0
2519051|NCT01735994|8720104|P1|Overall Study|Kicked off team|5
2519052|NCT01735994|8720103|P2|Overall Study|Injury|0
2519053|NCT01735994|8720104|P1|Overall Study|Injury|2
2519054|NCT01735994|8720103|P2|Overall Study|Withdrawal by Subject|4
2519055|NCT01735994|8720104|P1|Overall Study|Withdrawal by Subject|6
2519056|NCT01735916|8720119|P3|Overall Study|Withdrawal by Subject|0
2519057|NCT01735916|8720120|P2|Overall Study|Withdrawal by Subject|0
2519058|NCT01735916|8720121|P1|Overall Study|Withdrawal by Subject|3
2519059|NCT01735916|8720119|P3|Overall Study|Early termination of study by sponsor|7
2519060|NCT01735916|8720120|P2|Overall Study|Early termination of study by sponsor|19
2519061|NCT01735916|8720121|P1|Overall Study|Early termination of study by sponsor|4
2519062|NCT01735916|8720119|P3|Overall Study|Subject not eligible to be randomized|0
2519063|NCT01735916|8720120|P2|Overall Study|Subject not eligible to be randomized|0
2519064|NCT01735916|8720121|P1|Overall Study|Subject not eligible to be randomized|11
2519065|NCT01735630|8720159|P2|Overall Study|Withdrawal by Subject|9
2519066|NCT01735630|8720160|P1|Overall Study|Withdrawal by Subject|7
2519067|NCT01735630|8720159|P2|Overall Study|Sponsor Decision|1
2519068|NCT01735630|8720160|P1|Overall Study|Sponsor Decision|2
2519069|NCT01735630|8720159|P2|Overall Study|Physician Decision|1
2519070|NCT01735630|8720160|P1|Overall Study|Physician Decision|0
2519071|NCT01735630|8720159|P2|Overall Study|Lost to Follow-up|0
2519072|NCT01735630|8720160|P1|Overall Study|Lost to Follow-up|1
2519073|NCT01735630|8720159|P2|Overall Study|Adverse Event|7
2519074|NCT01735630|8720160|P1|Overall Study|Adverse Event|8
2519075|NCT01735396|8720187|P1|Overall Study|not evaluable|1
2519076|NCT01735201|8720216|P8|Overall Study|Other Miscellaneous Reasons|1
2519077|NCT01735201|8720217|P7|Overall Study|Other Miscellaneous Reasons|1
2519078|NCT01735201|8720218|P6|Overall Study|Other Miscellaneous Reasons|2
2519079|NCT01735201|8720219|P5|Overall Study|Other Miscellaneous Reasons|0
2519080|NCT01735201|8720220|P4|Overall Study|Other Miscellaneous Reasons|1
2519081|NCT01735201|8720221|P3|Overall Study|Other Miscellaneous Reasons|0
2519082|NCT01735201|8720222|P2|Overall Study|Other Miscellaneous Reasons|0
2519083|NCT01735201|8720223|P1|Overall Study|Other Miscellaneous Reasons|0
2519084|NCT01735201|8720216|P8|Overall Study|Protocol Violation|0
2519085|NCT01735201|8720217|P7|Overall Study|Protocol Violation|0
2519086|NCT01735201|8720218|P6|Overall Study|Protocol Violation|0
2519087|NCT01735201|8720219|P5|Overall Study|Protocol Violation|0
2519088|NCT01735201|8720220|P4|Overall Study|Protocol Violation|0
2519089|NCT01735201|8720221|P3|Overall Study|Protocol Violation|0
2519090|NCT01735201|8720222|P2|Overall Study|Protocol Violation|0
2519091|NCT01735201|8720223|P1|Overall Study|Protocol Violation|1
2519092|NCT01735201|8720216|P8|Overall Study|Personal Reasons|0
2519093|NCT01735201|8720217|P7|Overall Study|Personal Reasons|0
2519094|NCT01735201|8720218|P6|Overall Study|Personal Reasons|0
2519095|NCT01735201|8720219|P5|Overall Study|Personal Reasons|0
2519096|NCT01735201|8720220|P4|Overall Study|Personal Reasons|0
2519097|NCT01735201|8720221|P3|Overall Study|Personal Reasons|0
2519098|NCT01735201|8720222|P2|Overall Study|Personal Reasons|0
2519099|NCT01735201|8720223|P1|Overall Study|Personal Reasons|1
2519100|NCT01735201|8720216|P8|Overall Study|Adverse Event|1
2519101|NCT01735201|8720217|P7|Overall Study|Adverse Event|2
2519102|NCT01735201|8720218|P6|Overall Study|Adverse Event|3
2519103|NCT01735201|8720219|P5|Overall Study|Adverse Event|1
2519104|NCT01735201|8720220|P4|Overall Study|Adverse Event|1
2519105|NCT01735201|8720221|P3|Overall Study|Adverse Event|0
2519106|NCT01735201|8720222|P2|Overall Study|Adverse Event|1
2519107|NCT01735201|8720223|P1|Overall Study|Adverse Event|1
2519108|NCT01735175|8720259|P2|Overall Study|Other (mostly EOS/EOT visit missing)|7
2519109|NCT01735175|8720260|P1|Overall Study|Other (mostly EOS/EOT visit missing)|13
2519110|NCT01735175|8720259|P2|Overall Study|Death|2
2519111|NCT01735175|8720260|P1|Overall Study|Death|3
2519112|NCT01735175|8720259|P2|Overall Study|Lost to Follow-up|2
2519113|NCT01735175|8720260|P1|Overall Study|Lost to Follow-up|4
2519114|NCT01735175|8720259|P2|Overall Study|Withdrawal by Subject|2
2519115|NCT01735175|8720260|P1|Overall Study|Withdrawal by Subject|9
2519116|NCT01734993|8720280|P1|Overall Study|Lack of Efficacy|1
2519117|NCT01734993|8720280|P1|Overall Study|Adverse Event|1
2519118|NCT01734902|8720308|P2|Overall Study|Other than listed|2
2519119|NCT01734902|8720309|P1|Overall Study|Other than listed|0
2519120|NCT01734785|8720330|P4|Double−Blind Period|Not treated|0
2519121|NCT01734785|8720331|P3|Double−Blind Period|Not treated|0
2519122|NCT01734785|8720332|P2|Double−Blind Period|Not treated|0
2519123|NCT01734785|8720333|P1|Double−Blind Period|Not treated|1
2519124|NCT01734785|8720330|P4|Double−Blind Period|Withdrawal by Subject|0
2519125|NCT01734785|8720331|P3|Double−Blind Period|Withdrawal by Subject|0
2519126|NCT01734785|8720332|P2|Double−Blind Period|Withdrawal by Subject|0
2519127|NCT01734785|8720333|P1|Double−Blind Period|Withdrawal by Subject|2
2519128|NCT01734785|8720330|P4|Double−Blind Period|Lost to Follow-up|0
2519129|NCT01734785|8720331|P3|Double−Blind Period|Lost to Follow-up|2
2519130|NCT01734785|8720332|P2|Double−Blind Period|Lost to Follow-up|4
2519131|NCT01734785|8720333|P1|Double−Blind Period|Lost to Follow-up|2
2519132|NCT01734785|8720330|P4|Double−Blind Period|Protocol Violation|0
2519133|NCT01734785|8720331|P3|Double−Blind Period|Protocol Violation|1
2519134|NCT01734785|8720332|P2|Double−Blind Period|Protocol Violation|1
2519135|NCT01734785|8720333|P1|Double−Blind Period|Protocol Violation|0
2519136|NCT01734785|8720330|P4|Double−Blind Period|Lack of Efficacy|0
2519137|NCT01734785|8720331|P3|Double−Blind Period|Lack of Efficacy|0
2519138|NCT01734785|8720332|P2|Double−Blind Period|Lack of Efficacy|1
2519139|NCT01734785|8720333|P1|Double−Blind Period|Lack of Efficacy|0
2519140|NCT01734785|8720330|P4|Double−Blind Period|Adverse Event|0
2519141|NCT01734785|8720331|P3|Double−Blind Period|Adverse Event|2
2519142|NCT01734785|8720332|P2|Double−Blind Period|Adverse Event|3
2519143|NCT01734785|8720333|P1|Double−Blind Period|Adverse Event|0
2519144|NCT01734785|8720330|P4|Open−Label Period|Other Reasons|224
2519145|NCT01734785|8720331|P3|Open−Label Period|Other Reasons|0
2519146|NCT01734785|8720332|P2|Open−Label Period|Other Reasons|0
2519147|NCT01734785|8720333|P1|Open−Label Period|Other Reasons|0
2519148|NCT01734785|8720330|P4|Open−Label Period|Withdrawal by Subject|12
2519149|NCT01734785|8720331|P3|Open−Label Period|Withdrawal by Subject|0
2519150|NCT01734785|8720332|P2|Open−Label Period|Withdrawal by Subject|0
2519151|NCT01734785|8720333|P1|Open−Label Period|Withdrawal by Subject|0
2519152|NCT01734785|8720330|P4|Open−Label Period|Lost to Follow-up|14
2519153|NCT01734785|8720331|P3|Open−Label Period|Lost to Follow-up|0
2519154|NCT01734785|8720332|P2|Open−Label Period|Lost to Follow-up|0
2519155|NCT01734785|8720333|P1|Open−Label Period|Lost to Follow-up|0
2519156|NCT01734785|8720330|P4|Open−Label Period|Protocol Violation|13
2519157|NCT01734785|8720331|P3|Open−Label Period|Protocol Violation|0
2519158|NCT01734785|8720332|P2|Open−Label Period|Protocol Violation|0
2519159|NCT01734785|8720333|P1|Open−Label Period|Protocol Violation|0
2519160|NCT01734785|8720330|P4|Open−Label Period|Lack of Efficacy|1
2519161|NCT01734785|8720331|P3|Open−Label Period|Lack of Efficacy|0
2519162|NCT01734785|8720332|P2|Open−Label Period|Lack of Efficacy|0
2519163|NCT01734785|8720333|P1|Open−Label Period|Lack of Efficacy|0
2519164|NCT01734785|8720330|P4|Open−Label Period|Adverse Event|9
2519165|NCT01734785|8720331|P3|Open−Label Period|Adverse Event|0
2519166|NCT01734785|8720332|P2|Open−Label Period|Adverse Event|0
2519167|NCT01734785|8720333|P1|Open−Label Period|Adverse Event|0
2519168|NCT01734772|8720350|P2|Overall Study|Withdrawal by Subject|1
2519169|NCT01734772|8720351|P1|Overall Study|Withdrawal by Subject|0
2519170|NCT01734772|8720350|P2|Overall Study|Adverse Event|2
2519171|NCT01734772|8720351|P1|Overall Study|Adverse Event|1
2519172|NCT01734434|8720406|P4|Overall Study|17 Yr Old Subject Signed Consent form|0
2519173|NCT01734434|8720407|P3|Overall Study|17 Yr Old Subject Signed Consent form|1
2519174|NCT01734434|8720408|P2|Overall Study|17 Yr Old Subject Signed Consent form|0
2519175|NCT01734434|8720409|P1|Overall Study|17 Yr Old Subject Signed Consent form|0
2519176|NCT01734434|8720406|P4|Overall Study|Wrong Version of Consent Form Signed|0
2519177|NCT01734434|8720407|P3|Overall Study|Wrong Version of Consent Form Signed|1
2519178|NCT01734434|8720408|P2|Overall Study|Wrong Version of Consent Form Signed|0
2519179|NCT01734434|8720409|P1|Overall Study|Wrong Version of Consent Form Signed|0
2519180|NCT01734434|8720406|P4|Overall Study|Treatment Defaulter|0
2519181|NCT01734434|8720407|P3|Overall Study|Treatment Defaulter|1
2519182|NCT01734434|8720408|P2|Overall Study|Treatment Defaulter|0
2519183|NCT01734434|8720409|P1|Overall Study|Treatment Defaulter|0
2519184|NCT01734434|8720406|P4|Overall Study|Subject Not Reachable|0
2519185|NCT01734434|8720407|P3|Overall Study|Subject Not Reachable|1
2519186|NCT01734434|8720408|P2|Overall Study|Subject Not Reachable|0
2519187|NCT01734434|8720409|P1|Overall Study|Subject Not Reachable|0
2519188|NCT01734434|8720406|P4|Overall Study|Signed Adult Version of Consent Form|0
2519189|NCT01734434|8720407|P3|Overall Study|Signed Adult Version of Consent Form|1
2519190|NCT01734434|8720408|P2|Overall Study|Signed Adult Version of Consent Form|0
2519191|NCT01734434|8720409|P1|Overall Study|Signed Adult Version of Consent Form|0
2519192|NCT01734434|8720406|P4|Overall Study|Withdrawal by Subject|1
2519193|NCT01734434|8720407|P3|Overall Study|Withdrawal by Subject|8
2519194|NCT01734434|8720408|P2|Overall Study|Withdrawal by Subject|0
2519195|NCT01734434|8720409|P1|Overall Study|Withdrawal by Subject|4
2519196|NCT01734434|8720406|P4|Overall Study|No Live Birth|6
2519197|NCT01734434|8720407|P3|Overall Study|No Live Birth|32
2519198|NCT01734434|8720408|P2|Overall Study|No Live Birth|2
2519199|NCT01734434|8720409|P1|Overall Study|No Live Birth|1
2519200|NCT01734434|8720406|P4|Overall Study|Lost to Follow-up|11
2519201|NCT01734434|8720407|P3|Overall Study|Lost to Follow-up|67
2519202|NCT01734434|8720408|P2|Overall Study|Lost to Follow-up|9
2519203|NCT01734434|8720409|P1|Overall Study|Lost to Follow-up|2
2519204|NCT01734434|8720406|P4|Overall Study|Death Infant|5
2519205|NCT01734434|8720407|P3|Overall Study|Death Infant|17
2519206|NCT01734434|8720408|P2|Overall Study|Death Infant|1
2519207|NCT01734434|8720409|P1|Overall Study|Death Infant|3
2519208|NCT01734395|8720431|P1|Overall Study|Missing the reasons for not completed|3
2519209|NCT01734395|8720431|P1|Overall Study|Withdrawal by Subject|10
2519210|NCT01734395|8720431|P1|Overall Study|Adverse Event|40
2519211|NCT01734395|8720431|P1|Overall Study|Lack of Efficacy|5
2519212|NCT01734395|8720431|P1|Overall Study|Lost to Follow-up|287
2519213|NCT01734395|8720431|P1|Overall Study|Other|65
2519214|NCT01734382|8720440|P3|Part 2|Withdrawal by Subject|1
2519215|NCT01734382|8720441|P2|Part 2|Withdrawal by Subject|0
2519216|NCT01734382|8720442|P1|Part 2|Withdrawal by Subject|0
2519217|NCT01734382|8720440|P3|Part 2|Protocol Violation|0
2519218|NCT01734382|8720441|P2|Part 2|Protocol Violation|1
2519219|NCT01734382|8720442|P1|Part 2|Protocol Violation|0
2519220|NCT01734382|8720440|P3|Part 2|Physician Decision|3
2519221|NCT01734382|8720441|P2|Part 2|Physician Decision|0
2519222|NCT01734382|8720442|P1|Part 2|Physician Decision|0
2519223|NCT01734382|8720440|P3|Part 2|Other|1
2519224|NCT01734382|8720441|P2|Part 2|Other|0
2519225|NCT01734382|8720442|P1|Part 2|Other|0
2519226|NCT01734382|8720440|P3|Part 2|Lack of Efficacy|1
2519227|NCT01734382|8720441|P2|Part 2|Lack of Efficacy|1
2519228|NCT01734382|8720442|P1|Part 2|Lack of Efficacy|0
2519229|NCT01734382|8720440|P3|Part 2|Adverse Event|1
2519230|NCT01734382|8720441|P2|Part 2|Adverse Event|0
2519231|NCT01734382|8720442|P1|Part 2|Adverse Event|0
2519232|NCT01734382|8720440|P3|Part 1|Adverse Event|0
2519233|NCT01734382|8720441|P2|Part 1|Adverse Event|0
2519234|NCT01734382|8720442|P1|Part 1|Adverse Event|2
2519235|NCT01733758|8720555|P4|Overall Study|Inv Decision, HbA1c not controlled|1
2519236|NCT01733758|8720556|P3|Overall Study|Inv Decision, HbA1c not controlled|0
2519237|NCT01733758|8720557|P2|Overall Study|Inv Decision, HbA1c not controlled|1
2519238|NCT01733758|8720558|P1|Overall Study|Inv Decision, HbA1c not controlled|1
2519239|NCT01733758|8720555|P4|Overall Study|Intro of New Anti-Diabetic Medication|1
2519240|NCT01733758|8720556|P3|Overall Study|Intro of New Anti-Diabetic Medication|0
2519241|NCT01733758|8720557|P2|Overall Study|Intro of New Anti-Diabetic Medication|0
2519242|NCT01733758|8720558|P1|Overall Study|Intro of New Anti-Diabetic Medication|4
2519243|NCT01733758|8720555|P4|Overall Study|Non-compliance|0
2519244|NCT01733758|8720556|P3|Overall Study|Non-compliance|0
2519245|NCT01733758|8720557|P2|Overall Study|Non-compliance|0
2519246|NCT01733758|8720558|P1|Overall Study|Non-compliance|1
2519247|NCT01733758|8720555|P4|Overall Study|Protocol Violation|2
2519248|NCT01733758|8720556|P3|Overall Study|Protocol Violation|2
2519249|NCT01733758|8720557|P2|Overall Study|Protocol Violation|1
2519250|NCT01733758|8720558|P1|Overall Study|Protocol Violation|0
2519251|NCT01733758|8720555|P4|Overall Study|Persistent Hyperglycemia|0
2519252|NCT01733758|8720556|P3|Overall Study|Persistent Hyperglycemia|0
2519253|NCT01733758|8720557|P2|Overall Study|Persistent Hyperglycemia|2
2519254|NCT01733758|8720558|P1|Overall Study|Persistent Hyperglycemia|3
2519255|NCT01733758|8720555|P4|Overall Study|Withdrawal by Subject|3
2519256|NCT01733758|8720556|P3|Overall Study|Withdrawal by Subject|5
2519257|NCT01733758|8720557|P2|Overall Study|Withdrawal by Subject|1
2519258|NCT01733758|8720558|P1|Overall Study|Withdrawal by Subject|1
2519259|NCT01733758|8720555|P4|Overall Study|Adverse Event|1
2519260|NCT01733758|8720556|P3|Overall Study|Adverse Event|8
2519261|NCT01733758|8720557|P2|Overall Study|Adverse Event|7
2519262|NCT01733758|8720558|P1|Overall Study|Adverse Event|5
2519263|NCT01733732|8720624|P2|Overall Study|Did not attend all study visits|0
2519264|NCT01733732|8720625|P1|Overall Study|Did not attend all study visits|1
2519265|NCT01733732|8720624|P2|Overall Study|Adverse Event|0
2519266|NCT01733732|8720625|P1|Overall Study|Adverse Event|1
2519267|NCT01733680|8720661|P2|Overall Study|Withdrawal by Subject|1
2519268|NCT01733680|8720662|P1|Overall Study|Withdrawal by Subject|0
2519269|NCT01733329|8720721|P2|Overall Study|Uterine artery injury|0
2519270|NCT01733329|8720722|P1|Overall Study|Uterine artery injury|1
2519271|NCT01733329|8720721|P2|Overall Study|Protocol Violation|1
2519272|NCT01733329|8720722|P1|Overall Study|Protocol Violation|1
2519273|NCT01733316|8720734|P1|Long Term Extension Phase|Sponsor Decision|2
2519274|NCT01733316|8720734|P1|Long Term Extension Phase|Consent Withdrawn by Subject|2
2519275|NCT01733316|8720734|P1|Long Term Extension Phase|Adverse Event|1
2519276|NCT01733316|8720734|P1|RP103 Phase|Non-compliance|1
2519277|NCT01733121|8720777|P2|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
2519278|NCT01733121|8720778|P1|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
2519279|NCT01733121|8720777|P2|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3
2519280|NCT01733121|8720778|P1|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
2519281|NCT01733121|8720777|P2|Double-Blind Period (Week 0 to 6)|Non-compliance|2
2519282|NCT01733121|8720778|P1|Double-Blind Period (Week 0 to 6)|Non-compliance|3
2519283|NCT01733121|8720777|P2|Double-Blind Period (Week 0 to 6)|Adverse Event|0
2519284|NCT01733121|8720778|P1|Double-Blind Period (Week 0 to 6)|Adverse Event|2
2519285|NCT01732926|8720820|P2|Overall Study|Blind Broken by Subject or Study Site|1
2519286|NCT01732926|8720821|P1|Overall Study|Blind Broken by Subject or Study Site|1
2519287|NCT01732926|8720820|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|6
2519288|NCT01732926|8720821|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|7
2519289|NCT01732926|8720820|P2|Overall Study|Other Reason|4
2519290|NCT01732926|8720821|P1|Overall Study|Other Reason|21
2519291|NCT01732926|8720820|P2|Overall Study|Physician Decision|11
2519292|NCT01732926|8720821|P1|Overall Study|Physician Decision|24
2519293|NCT01732926|8720820|P2|Overall Study|Withdrawal by Subject|8
2519294|NCT01732926|8720821|P1|Overall Study|Withdrawal by Subject|46
2519295|NCT01732926|8720820|P2|Overall Study|Study Terminated by Sponsor|80
2519296|NCT01732926|8720821|P1|Overall Study|Study Terminated by Sponsor|168
2519297|NCT01732913|8720837|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|2
2519298|NCT01732913|8720838|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|3
2519299|NCT01732913|8720837|P2|Overall Study|Other|1
2519300|NCT01732913|8720838|P1|Overall Study|Other|7
2519301|NCT01732913|8720837|P2|Overall Study|Physician Decision|7
2519302|NCT01732913|8720838|P1|Overall Study|Physician Decision|14
2519303|NCT01732913|8720837|P2|Overall Study|Withdrawal by Subject|4
2519304|NCT01732913|8720838|P1|Overall Study|Withdrawal by Subject|27
2519305|NCT01732913|8720837|P2|Overall Study|Study Terminated by Sponsor|55
2519306|NCT01732913|8720838|P1|Overall Study|Study Terminated by Sponsor|105
2519307|NCT01732835|8720852|P1|2-year Extended Follow-up|Death|1
2519308|NCT01732835|8720852|P1|2-year Extended Follow-up|Adverse Event|3
2519309|NCT01732835|8720852|P1|2-year Extended Follow-up|Withdrawal by Subject|1
2519310|NCT01732835|8720852|P1|6-month Primary Endpoint|Adverse Event|3
2519311|NCT01732835|8720852|P1|6-month Primary Endpoint|Withdrawal by Subject|2
2519312|NCT01732835|8720852|P1|6-month Primary Endpoint|Did not receive device|19
2519313|NCT01732822|8720885|P2|Overall Study|Withdrawal by Subject|113
2519314|NCT01732822|8720886|P1|Overall Study|Withdrawal by Subject|123
2519315|NCT01732796|8720959|P3|Overall Study|Other reason not defined above|2
2519316|NCT01732796|8720960|P2|Overall Study|Other reason not defined above|0
2519317|NCT01732796|8720961|P1|Overall Study|Other reason not defined above|1
2519318|NCT01732796|8720959|P3|Overall Study|Withdrawal by Subject|2
2519319|NCT01732796|8720960|P2|Overall Study|Withdrawal by Subject|8
2519320|NCT01732796|8720961|P1|Overall Study|Withdrawal by Subject|6
2519321|NCT01732796|8720959|P3|Overall Study|Lost to Follow-up|0
2519322|NCT01732796|8720960|P2|Overall Study|Lost to Follow-up|0
2519323|NCT01732796|8720961|P1|Overall Study|Lost to Follow-up|2
2519324|NCT01732796|8720959|P3|Overall Study|Lack of Efficacy|5
2519325|NCT01732796|8720960|P2|Overall Study|Lack of Efficacy|18
2519326|NCT01732796|8720961|P1|Overall Study|Lack of Efficacy|21
2519327|NCT01732796|8720959|P3|Overall Study|Adverse Event|4
2519328|NCT01732796|8720960|P2|Overall Study|Adverse Event|16
2519329|NCT01732796|8720961|P1|Overall Study|Adverse Event|16
2519330|NCT01732783|8720980|P3|Overall Study|Withdrawal by Subject|0
2519331|NCT01732783|8720981|P2|Overall Study|Withdrawal by Subject|0
2519332|NCT01732783|8720982|P1|Overall Study|Withdrawal by Subject|1
2519333|NCT01732783|8720980|P3|Overall Study|Administrative Decision|1
2519334|NCT01732783|8720981|P2|Overall Study|Administrative Decision|2
2519335|NCT01732783|8720982|P1|Overall Study|Administrative Decision|8
2519336|NCT01732783|8720980|P3|Overall Study|Lost to Follow-up|1
2519337|NCT01732783|8720981|P2|Overall Study|Lost to Follow-up|1
2519701|NCT01729754|8722275|P3|Part 3|Death|0
2519338|NCT01732783|8720982|P1|Overall Study|Lost to Follow-up|7
2519339|NCT01732783|8720980|P3|Overall Study|Death|1
2519340|NCT01732783|8720981|P2|Overall Study|Death|4
2519341|NCT01732783|8720982|P1|Overall Study|Death|13
2519342|NCT01732783|8720980|P3|Overall Study|Discontinued Panitumumab Treatment|7
2519343|NCT01732783|8720981|P2|Overall Study|Discontinued Panitumumab Treatment|25
2519344|NCT01732783|8720982|P1|Overall Study|Discontinued Panitumumab Treatment|106
2519345|NCT01732770|8721046|P2|Overall Study|Death|0
2519346|NCT01732770|8721047|P1|Overall Study|Death|1
2519347|NCT01732770|8721046|P2|Overall Study|Decision by Sponsor|2
2519348|NCT01732770|8721047|P1|Overall Study|Decision by Sponsor|2
2519349|NCT01732770|8721046|P2|Overall Study|Withdrawal by Subject|3
2519350|NCT01732770|8721047|P1|Overall Study|Withdrawal by Subject|5
2519351|NCT01732770|8721046|P2|Overall Study|Lost to Follow-up|3
2519352|NCT01732770|8721047|P1|Overall Study|Lost to Follow-up|2
2519353|NCT01732757|8721062|P3|Overall Study|Lost to Follow-up|0
2519354|NCT01732757|8721063|P2|Overall Study|Lost to Follow-up|0
2519355|NCT01732757|8721064|P1|Overall Study|Lost to Follow-up|1
2519356|NCT01732692|8721141|P2|Overall Study|Adverse Event|1
2519357|NCT01732692|8721142|P1|Overall Study|Adverse Event|0
2519358|NCT01732640|8721156|P2|Overall Study|Death|1
2519359|NCT01732640|8721157|P1|Overall Study|Death|0
2519360|NCT01732640|8721156|P2|Overall Study|Adverse Event|1
2519361|NCT01732640|8721157|P1|Overall Study|Adverse Event|0
2519362|NCT01732588|8721175|P3|First Intervention (7 Days)|Adverse Event|0
2519363|NCT01732588|8721176|P2|First Intervention (7 Days)|Adverse Event|1
2519364|NCT01732588|8721177|P1|First Intervention (7 Days)|Adverse Event|0
2519365|NCT01732549|8721193|P2|Overall Study|Other|14
2519366|NCT01732549|8721194|P1|Overall Study|Other|8
2519367|NCT01732549|8721193|P2|Overall Study|Disease progression|50
2519368|NCT01732549|8721194|P1|Overall Study|Disease progression|37
2519369|NCT01732549|8721193|P2|Overall Study|Consent withdrawn|6
2519370|NCT01732549|8721194|P1|Overall Study|Consent withdrawn|13
2519371|NCT01732549|8721193|P2|Overall Study|Adverse Event|3
2519372|NCT01732549|8721194|P1|Overall Study|Adverse Event|13
2519373|NCT01732536|8721216|P2|Overall Study|Withdrawal by Subject|1
2519374|NCT01732536|8721217|P1|Overall Study|Withdrawal by Subject|1
2519375|NCT01732510|8721240|P7|Overall Study|Study Terminated By Sponsor|6
2519376|NCT01732510|8721241|P6|Overall Study|Study Terminated By Sponsor|12
2519377|NCT01732510|8721242|P5|Overall Study|Study Terminated By Sponsor|0
2519378|NCT01732510|8721243|P4|Overall Study|Study Terminated By Sponsor|1
2519379|NCT01732510|8721244|P3|Overall Study|Study Terminated By Sponsor|0
2519380|NCT01732510|8721245|P2|Overall Study|Study Terminated By Sponsor|0
2519381|NCT01732510|8721246|P1|Overall Study|Study Terminated By Sponsor|0
2519382|NCT01732510|8721240|P7|Overall Study|Pregnancy|0
2519383|NCT01732510|8721241|P6|Overall Study|Pregnancy|0
2519384|NCT01732510|8721242|P5|Overall Study|Pregnancy|0
2519385|NCT01732510|8721243|P4|Overall Study|Pregnancy|1
2519386|NCT01732510|8721244|P3|Overall Study|Pregnancy|0
2519387|NCT01732510|8721245|P2|Overall Study|Pregnancy|0
2519388|NCT01732510|8721246|P1|Overall Study|Pregnancy|0
2519389|NCT01732510|8721240|P7|Overall Study|Physician Decision|0
2519390|NCT01732510|8721241|P6|Overall Study|Physician Decision|0
2519391|NCT01732510|8721242|P5|Overall Study|Physician Decision|0
2519392|NCT01732510|8721243|P4|Overall Study|Physician Decision|0
2519393|NCT01732510|8721244|P3|Overall Study|Physician Decision|0
2519394|NCT01732510|8721245|P2|Overall Study|Physician Decision|1
2519395|NCT01732510|8721246|P1|Overall Study|Physician Decision|0
2519396|NCT01732510|8721240|P7|Overall Study|Lost to Follow-up|0
2519397|NCT01732510|8721241|P6|Overall Study|Lost to Follow-up|1
2519398|NCT01732510|8721242|P5|Overall Study|Lost to Follow-up|0
2519399|NCT01732510|8721243|P4|Overall Study|Lost to Follow-up|1
2519400|NCT01732510|8721244|P3|Overall Study|Lost to Follow-up|1
2519401|NCT01732510|8721245|P2|Overall Study|Lost to Follow-up|0
2519402|NCT01732510|8721246|P1|Overall Study|Lost to Follow-up|0
2519403|NCT01732510|8721240|P7|Overall Study|Withdrawal by Subject|1
2519404|NCT01732510|8721241|P6|Overall Study|Withdrawal by Subject|0
2519405|NCT01732510|8721242|P5|Overall Study|Withdrawal by Subject|5
2519406|NCT01732510|8721243|P4|Overall Study|Withdrawal by Subject|1
2519407|NCT01732510|8721244|P3|Overall Study|Withdrawal by Subject|2
2519408|NCT01732510|8721245|P2|Overall Study|Withdrawal by Subject|3
2519409|NCT01732510|8721246|P1|Overall Study|Withdrawal by Subject|1
2519410|NCT01732510|8721240|P7|Overall Study|Protocol Violation|0
2519411|NCT01732510|8721241|P6|Overall Study|Protocol Violation|0
2519412|NCT01732510|8721242|P5|Overall Study|Protocol Violation|0
2519413|NCT01732510|8721243|P4|Overall Study|Protocol Violation|1
2519414|NCT01732510|8721244|P3|Overall Study|Protocol Violation|0
2519415|NCT01732510|8721245|P2|Overall Study|Protocol Violation|0
2519416|NCT01732510|8721246|P1|Overall Study|Protocol Violation|0
2519417|NCT01732510|8721240|P7|Overall Study|Adverse Event|1
2519418|NCT01732510|8721241|P6|Overall Study|Adverse Event|0
2519419|NCT01732510|8721242|P5|Overall Study|Adverse Event|0
2519420|NCT01732510|8721243|P4|Overall Study|Adverse Event|0
2519421|NCT01732510|8721244|P3|Overall Study|Adverse Event|1
2519422|NCT01732510|8721245|P2|Overall Study|Adverse Event|1
2519423|NCT01732510|8721246|P1|Overall Study|Adverse Event|0
2519424|NCT01732484|8721325|P1|Overall Study|chronical illness|5
2519425|NCT01732484|8721325|P1|Overall Study|Lost to Follow-up|14
2519426|NCT01732484|8721325|P1|Overall Study|Death|7
2519427|NCT01732471|8721333|P1|Overall Study|Withdrawal by Subject|1
2519702|NCT01729754|8722276|P2|Part 3|Death|0
2519428|NCT01732458|8721344|P4|Overall Study|Screen Failure|0
2519429|NCT01732458|8721345|P3|Overall Study|Screen Failure|0
2519430|NCT01732458|8721346|P2|Overall Study|Screen Failure|1
2519431|NCT01732458|8721347|P1|Overall Study|Screen Failure|0
2519432|NCT01732458|8721344|P4|Overall Study|Protocol Violation|2
2519433|NCT01732458|8721345|P3|Overall Study|Protocol Violation|0
2519434|NCT01732458|8721346|P2|Overall Study|Protocol Violation|0
2519435|NCT01732458|8721347|P1|Overall Study|Protocol Violation|2
2519436|NCT01732458|8721344|P4|Overall Study|Physician Decision|0
2519437|NCT01732458|8721345|P3|Overall Study|Physician Decision|2
2519438|NCT01732458|8721346|P2|Overall Study|Physician Decision|2
2519439|NCT01732458|8721347|P1|Overall Study|Physician Decision|1
2519440|NCT01732458|8721344|P4|Overall Study|Non-Compliance With Study Drug|0
2519441|NCT01732458|8721345|P3|Overall Study|Non-Compliance With Study Drug|1
2519442|NCT01732458|8721346|P2|Overall Study|Non-Compliance With Study Drug|0
2519443|NCT01732458|8721347|P1|Overall Study|Non-Compliance With Study Drug|0
2519444|NCT01732458|8721344|P4|Overall Study|Lost to Follow-up|0
2519445|NCT01732458|8721345|P3|Overall Study|Lost to Follow-up|0
2519446|NCT01732458|8721346|P2|Overall Study|Lost to Follow-up|2
2519447|NCT01732458|8721347|P1|Overall Study|Lost to Follow-up|0
2519448|NCT01732107|8721509|P1|Overall Study|Withdrawal by Subject|2
2519449|NCT01732107|8721509|P1|Overall Study|Physician Decision|1
2519450|NCT01732107|8721509|P1|Overall Study|Disease Progression|8
2519451|NCT01732107|8721509|P1|Overall Study|Adverse Event|2
2519452|NCT01731990|8721526|P2|Overall Study|Death|0
2519453|NCT01731990|8721527|P1|Overall Study|Death|1
2519454|NCT01731990|8721526|P2|Overall Study|Protocol deviation|2
2519455|NCT01731990|8721527|P1|Overall Study|Protocol deviation|1
2519456|NCT01731990|8721526|P2|Overall Study|Withdrawal by Subject|1
2519457|NCT01731990|8721527|P1|Overall Study|Withdrawal by Subject|1
2519458|NCT01731990|8721526|P2|Overall Study|Adverse Event|5
2519459|NCT01731990|8721527|P1|Overall Study|Adverse Event|1
2519460|NCT01731938|8721543|P2|Primary Part II|Missed Week 6 visit|3
2519461|NCT01731938|8721544|P1|Primary Part II|Missed Week 6 visit|2
2519462|NCT01731938|8721543|P2|Primary Part II|Death|1
2519463|NCT01731938|8721544|P1|Primary Part II|Death|2
2519464|NCT01731938|8721543|P2|Primary Part II|Lost to Follow-up|5
2519465|NCT01731938|8721544|P1|Primary Part II|Lost to Follow-up|4
2519466|NCT01731938|8721543|P2|Primary Part II|Withdrawal by Subject|4
2519467|NCT01731938|8721544|P1|Primary Part II|Withdrawal by Subject|5
2519468|NCT01731938|8721543|P2|Preliminary Part I|Missed Week 6 visit|3
2519469|NCT01731938|8721544|P1|Preliminary Part I|Missed Week 6 visit|0
2519470|NCT01731938|8721543|P2|Preliminary Part I|Lost to Follow-up|3
2519471|NCT01731938|8721544|P1|Preliminary Part I|Lost to Follow-up|0
2519472|NCT01731938|8721543|P2|Preliminary Part I|Physician Decision|0
2519473|NCT01731938|8721544|P1|Preliminary Part I|Physician Decision|1
2519474|NCT01731938|8721543|P2|Preliminary Part I|Withdrawal by Subject|2
2519475|NCT01731938|8721544|P1|Preliminary Part I|Withdrawal by Subject|2
2519476|NCT01731912|8721556|P1|Overall Study|noncompliance|2
2519477|NCT01731886|8721563|P2|Overall Study|Non-compliant|0
2519478|NCT01731886|8721564|P1|Overall Study|Non-compliant|1
2519479|NCT01731886|8721563|P2|Overall Study|Never started treatment|1
2519480|NCT01731886|8721564|P1|Overall Study|Never started treatment|0
2519481|NCT01731886|8721563|P2|Overall Study|Death|0
2519482|NCT01731886|8721564|P1|Overall Study|Death|1
2519483|NCT01731678|8721578|P1|Overall Study|RMT too high, making TMS difficult|3
2519484|NCT01731678|8721578|P1|Overall Study|Did not meet inclusion criteria|1
2519485|NCT01731678|8721578|P1|Overall Study|Withdrawal by Subject|3
2519486|NCT01731600|8721584|P2|Overall Study|Other reasons|0
2519487|NCT01731600|8721585|P1|Overall Study|Other reasons|3
2519488|NCT01731600|8721584|P2|Overall Study|Withdrawal criteria|0
2519489|NCT01731600|8721585|P1|Overall Study|Withdrawal criteria|1
2519490|NCT01731600|8721584|P2|Overall Study|Adverse Event|0
2519491|NCT01731600|8721585|P1|Overall Study|Adverse Event|2
2519492|NCT01731470|8721639|P1|Overall Study|Did not meet study criteria|1
2519493|NCT01731470|8721639|P1|Overall Study|Withdrawal by Subject|1
2519494|NCT01731171|8721646|P2|Overall Study|Terminated for Safety Reasons|1
2519495|NCT01731171|8721647|P1|Overall Study|Terminated for Safety Reasons|0
2519496|NCT01731171|8721646|P2|Overall Study|Terminated for Lack of Adherence|1
2519497|NCT01731171|8721647|P1|Overall Study|Terminated for Lack of Adherence|0
2519498|NCT01731171|8721646|P2|Overall Study|Moved out of Area|2
2519499|NCT01731171|8721647|P1|Overall Study|Moved out of Area|0
2519500|NCT01731171|8721646|P2|Overall Study|Lost to Follow-up|2
2519501|NCT01731171|8721647|P1|Overall Study|Lost to Follow-up|3
2519502|NCT01731171|8721646|P2|Overall Study|Withdrawal by Subject|1
2519503|NCT01731171|8721647|P1|Overall Study|Withdrawal by Subject|4
2519504|NCT01731002|8721681|P3|Overall Study|Inappropriate use of study medications|1
2519505|NCT01731002|8721682|P2|Overall Study|Inappropriate use of study medications|0
2519506|NCT01731002|8721683|P1|Overall Study|Inappropriate use of study medications|0
2519507|NCT01731002|8721681|P3|Overall Study|Elevated IOP|0
2519508|NCT01731002|8721682|P2|Overall Study|Elevated IOP|0
2519509|NCT01731002|8721683|P1|Overall Study|Elevated IOP|1
2519510|NCT01731002|8721681|P3|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
2519511|NCT01731002|8721682|P2|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
2519512|NCT01731002|8721683|P1|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2
2519513|NCT01731002|8721681|P3|Overall Study|Test Agent Discontinuation|0
2519514|NCT01731002|8721682|P2|Overall Study|Test Agent Discontinuation|1
2519515|NCT01731002|8721683|P1|Overall Study|Test Agent Discontinuation|0
2519516|NCT01731002|8721681|P3|Overall Study|Lost to Follow-up|0
2519517|NCT01731002|8721682|P2|Overall Study|Lost to Follow-up|0
2519518|NCT01731002|8721683|P1|Overall Study|Lost to Follow-up|1
2519519|NCT01731002|8721681|P3|Overall Study|Non-Compliant|0
2519520|NCT01731002|8721682|P2|Overall Study|Non-Compliant|1
2519521|NCT01731002|8721683|P1|Overall Study|Non-Compliant|0
2519522|NCT01731002|8721681|P3|Overall Study|Adverse Event|2
2519523|NCT01731002|8721682|P2|Overall Study|Adverse Event|2
2519524|NCT01731002|8721683|P1|Overall Study|Adverse Event|0
2519525|NCT01730950|8721696|P2|Overall Study|Protocol Violation|6
2519526|NCT01730950|8721697|P1|Overall Study|Protocol Violation|6
2519527|NCT01730729|8721743|P1|Overall Study|Progressive Disease|12
2519528|NCT01730729|8721743|P1|Overall Study|Death|1
2519529|NCT01730729|8721743|P1|Overall Study|Adverse Event|1
2519530|NCT01730586|8721757|P1|Overall Study|Hospice|1
2519531|NCT01730586|8721757|P1|Overall Study|Adverse Event|2
2519532|NCT01730586|8721757|P1|Overall Study|Inadequate Trial|8
2519533|NCT01730586|8721757|P1|Overall Study|Progressive Disease|2
2519534|NCT01730534|8721766|P2|Overall Study|Lost to Follow-up|18
2519535|NCT01730534|8721767|P1|Overall Study|Lost to Follow-up|12
2519536|NCT01730534|8721766|P2|Overall Study|Withdrawal by Subject|127
2519537|NCT01730534|8721767|P1|Overall Study|Withdrawal by Subject|97
2519538|NCT01730378|8721781|P2|Overall Study|Lost to Follow-up|0
2519539|NCT01730378|8721782|P1|Overall Study|Lost to Follow-up|1
2519540|NCT01730339|8721813|P2|Overall Study|Un-specified|0
2519541|NCT01730339|8721814|P1|Overall Study|Un-specified|1
2519542|NCT01730339|8721813|P2|Overall Study|Lost to Follow-up|1
2519543|NCT01730339|8721814|P1|Overall Study|Lost to Follow-up|1
2519544|NCT01730339|8721813|P2|Overall Study|Withdrawal by Subject|2
2519545|NCT01730339|8721814|P1|Overall Study|Withdrawal by Subject|3
2519546|NCT01730053|8721854|P6|Overall Study|Other than specified|9
2519547|NCT01730053|8721855|P5|Overall Study|Other than specified|7
2519548|NCT01730053|8721856|P4|Overall Study|Other than specified|4
2519549|NCT01730053|8721857|P3|Overall Study|Other than specified|5
2519550|NCT01730053|8721858|P2|Overall Study|Other than specified|6
2519551|NCT01730053|8721859|P1|Overall Study|Other than specified|2
2519552|NCT01730053|8721854|P6|Overall Study|Poor compliance to protocol|2
2519553|NCT01730053|8721855|P5|Overall Study|Poor compliance to protocol|0
2519554|NCT01730053|8721856|P4|Overall Study|Poor compliance to protocol|0
2519555|NCT01730053|8721857|P3|Overall Study|Poor compliance to protocol|2
2519556|NCT01730053|8721858|P2|Overall Study|Poor compliance to protocol|2
2519557|NCT01730053|8721859|P1|Overall Study|Poor compliance to protocol|1
2519558|NCT01730053|8721854|P6|Overall Study|Adverse Event|2
2519559|NCT01730053|8721855|P5|Overall Study|Adverse Event|2
2519560|NCT01730053|8721856|P4|Overall Study|Adverse Event|3
2519561|NCT01730053|8721857|P3|Overall Study|Adverse Event|3
2519562|NCT01730053|8721858|P2|Overall Study|Adverse Event|6
2519563|NCT01730053|8721859|P1|Overall Study|Adverse Event|2
2519564|NCT01730053|8721854|P6|Overall Study|Physician Decision|0
2519565|NCT01730053|8721855|P5|Overall Study|Physician Decision|0
2519566|NCT01730053|8721856|P4|Overall Study|Physician Decision|1
2519567|NCT01730053|8721857|P3|Overall Study|Physician Decision|0
2519568|NCT01730053|8721858|P2|Overall Study|Physician Decision|0
2519569|NCT01730053|8721859|P1|Overall Study|Physician Decision|0
2519570|NCT01730053|8721854|P6|Overall Study|Participant moved|0
2519571|NCT01730053|8721855|P5|Overall Study|Participant moved|0
2519572|NCT01730053|8721856|P4|Overall Study|Participant moved|0
2519573|NCT01730053|8721857|P3|Overall Study|Participant moved|1
2519574|NCT01730053|8721858|P2|Overall Study|Participant moved|0
2519575|NCT01730053|8721859|P1|Overall Study|Participant moved|0
2519576|NCT01730040|8722018|P7|Overall Study|Poor compliance to protocol|1
2519577|NCT01730040|8722019|P6|Overall Study|Poor compliance to protocol|0
2519578|NCT01730040|8722020|P5|Overall Study|Poor compliance to protocol|0
2519579|NCT01730040|8722021|P4|Overall Study|Poor compliance to protocol|0
2519580|NCT01730040|8722022|P3|Overall Study|Poor compliance to protocol|0
2519581|NCT01730040|8722023|P2|Overall Study|Poor compliance to protocol|4
2519582|NCT01730040|8722024|P1|Overall Study|Poor compliance to protocol|2
2519583|NCT01730040|8722018|P7|Overall Study|Adverse Event|2
2519584|NCT01730040|8722019|P6|Overall Study|Adverse Event|1
2519585|NCT01730040|8722020|P5|Overall Study|Adverse Event|1
2519586|NCT01730040|8722021|P4|Overall Study|Adverse Event|3
2519587|NCT01730040|8722022|P3|Overall Study|Adverse Event|5
2519588|NCT01730040|8722023|P2|Overall Study|Adverse Event|3
2519589|NCT01730040|8722024|P1|Overall Study|Adverse Event|4
2519590|NCT01730040|8722018|P7|Overall Study|Other than specified|4
2519591|NCT01730040|8722019|P6|Overall Study|Other than specified|4
2519592|NCT01730040|8722020|P5|Overall Study|Other than specified|5
2519593|NCT01730040|8722021|P4|Overall Study|Other than specified|5
2519594|NCT01730040|8722022|P3|Overall Study|Other than specified|5
2519595|NCT01730040|8722023|P2|Overall Study|Other than specified|8
2519596|NCT01730040|8722024|P1|Overall Study|Other than specified|7
2519597|NCT01730040|8722018|P7|Overall Study|Physician Decision|1
2519598|NCT01730040|8722019|P6|Overall Study|Physician Decision|1
2519599|NCT01730040|8722020|P5|Overall Study|Physician Decision|0
2519600|NCT01730040|8722021|P4|Overall Study|Physician Decision|0
2519601|NCT01730040|8722022|P3|Overall Study|Physician Decision|0
2519602|NCT01730040|8722023|P2|Overall Study|Physician Decision|0
2519603|NCT01730040|8722024|P1|Overall Study|Physician Decision|0
2519703|NCT01729754|8722277|P1|Part 3|Death|0
2519604|NCT01730040|8722018|P7|Overall Study|Subject moved|1
2519605|NCT01730040|8722019|P6|Overall Study|Subject moved|0
2519606|NCT01730040|8722020|P5|Overall Study|Subject moved|0
2519607|NCT01730040|8722021|P4|Overall Study|Subject moved|0
2519608|NCT01730040|8722022|P3|Overall Study|Subject moved|1
2519609|NCT01730040|8722023|P2|Overall Study|Subject moved|0
2519610|NCT01730040|8722024|P1|Overall Study|Subject moved|0
2519611|NCT01730040|8722018|P7|Overall Study|Randomized but not treated|0
2519612|NCT01730040|8722019|P6|Overall Study|Randomized but not treated|1
2519613|NCT01730040|8722020|P5|Overall Study|Randomized but not treated|0
2519614|NCT01730040|8722021|P4|Overall Study|Randomized but not treated|0
2519615|NCT01730040|8722022|P3|Overall Study|Randomized but not treated|0
2519616|NCT01730040|8722023|P2|Overall Study|Randomized but not treated|0
2519617|NCT01730040|8722024|P1|Overall Study|Randomized but not treated|0
2519618|NCT01729871|8722213|P2|Overall Study|Other|9
2519619|NCT01729871|8722214|P1|Overall Study|Other|4
2519620|NCT01729871|8722213|P2|Overall Study|Withdrawal by Subject|3
2519621|NCT01729871|8722214|P1|Overall Study|Withdrawal by Subject|0
2519622|NCT01729871|8722213|P2|Overall Study|Protocol Violation|0
2519623|NCT01729871|8722214|P1|Overall Study|Protocol Violation|1
2519624|NCT01729871|8722213|P2|Overall Study|Physician Decision|2
2519625|NCT01729871|8722214|P1|Overall Study|Physician Decision|0
2519626|NCT01729871|8722213|P2|Overall Study|Lack of Efficacy|1
2519627|NCT01729871|8722214|P1|Overall Study|Lack of Efficacy|0
2519628|NCT01729871|8722213|P2|Overall Study|Death|1
2519629|NCT01729871|8722214|P1|Overall Study|Death|0
2519630|NCT01729871|8722213|P2|Overall Study|Adverse Event|7
2519631|NCT01729871|8722214|P1|Overall Study|Adverse Event|7
2519632|NCT01729819|8722248|P2|Overall Study|Withdrawal by Subject|2
2519633|NCT01729819|8722249|P1|Overall Study|Withdrawal by Subject|0
2519634|NCT01729819|8722248|P2|Overall Study|Protocol Violation|1
2519635|NCT01729819|8722249|P1|Overall Study|Protocol Violation|0
2519636|NCT01729819|8722248|P2|Overall Study|Other reason|0
2519637|NCT01729819|8722249|P1|Overall Study|Other reason|1
2519638|NCT01729819|8722248|P2|Overall Study|Lost to Follow-up|0
2519639|NCT01729819|8722249|P1|Overall Study|Lost to Follow-up|2
2519640|NCT01729819|8722248|P2|Overall Study|Lack of Efficacy|0
2519641|NCT01729819|8722249|P1|Overall Study|Lack of Efficacy|1
2519642|NCT01729819|8722248|P2|Overall Study|Adverse Event|4
2519643|NCT01729819|8722249|P1|Overall Study|Adverse Event|2
2519644|NCT01729754|8722268|P10|Part 3|Other Protocol Specified Criteria|0
2519645|NCT01729754|8722269|P9|Part 3|Other Protocol Specified Criteria|0
2519646|NCT01729754|8722270|P8|Part 3|Other Protocol Specified Criteria|1
2519647|NCT01729754|8722271|P7|Part 3|Other Protocol Specified Criteria|0
2519648|NCT01729754|8722272|P6|Part 3|Other Protocol Specified Criteria|2
2519649|NCT01729754|8722273|P5|Part 3|Other Protocol Specified Criteria|0
2519650|NCT01729754|8722274|P4|Part 3|Other Protocol Specified Criteria|0
2519651|NCT01729754|8722275|P3|Part 3|Other Protocol Specified Criteria|0
2519652|NCT01729754|8722276|P2|Part 3|Other Protocol Specified Criteria|0
2519653|NCT01729754|8722277|P1|Part 3|Other Protocol Specified Criteria|0
2519654|NCT01729754|8722268|P10|Part 3|Withdrawal by Subject|0
2519655|NCT01729754|8722269|P9|Part 3|Withdrawal by Subject|0
2519656|NCT01729754|8722270|P8|Part 3|Withdrawal by Subject|2
2519657|NCT01729754|8722271|P7|Part 3|Withdrawal by Subject|0
2519658|NCT01729754|8722272|P6|Part 3|Withdrawal by Subject|1
2519659|NCT01729754|8722273|P5|Part 3|Withdrawal by Subject|2
2519660|NCT01729754|8722274|P4|Part 3|Withdrawal by Subject|0
2519661|NCT01729754|8722275|P3|Part 3|Withdrawal by Subject|1
2519662|NCT01729754|8722276|P2|Part 3|Withdrawal by Subject|4
2519663|NCT01729754|8722277|P1|Part 3|Withdrawal by Subject|0
2519664|NCT01729754|8722268|P10|Part 3|Physician Decision|0
2519665|NCT01729754|8722269|P9|Part 3|Physician Decision|0
2519666|NCT01729754|8722270|P8|Part 3|Physician Decision|0
2519667|NCT01729754|8722271|P7|Part 3|Physician Decision|0
2519668|NCT01729754|8722272|P6|Part 3|Physician Decision|0
2519669|NCT01729754|8722273|P5|Part 3|Physician Decision|0
2519670|NCT01729754|8722274|P4|Part 3|Physician Decision|0
2519671|NCT01729754|8722275|P3|Part 3|Physician Decision|1
2519672|NCT01729754|8722276|P2|Part 3|Physician Decision|0
2519673|NCT01729754|8722277|P1|Part 3|Physician Decision|0
2519674|NCT01729754|8722268|P10|Part 3|Lost to Follow-up|0
2519675|NCT01729754|8722269|P9|Part 3|Lost to Follow-up|1
2519676|NCT01729754|8722270|P8|Part 3|Lost to Follow-up|0
2519677|NCT01729754|8722271|P7|Part 3|Lost to Follow-up|0
2519678|NCT01729754|8722272|P6|Part 3|Lost to Follow-up|3
2519679|NCT01729754|8722273|P5|Part 3|Lost to Follow-up|0
2519680|NCT01729754|8722274|P4|Part 3|Lost to Follow-up|0
2519681|NCT01729754|8722275|P3|Part 3|Lost to Follow-up|2
2519682|NCT01729754|8722276|P2|Part 3|Lost to Follow-up|1
2519683|NCT01729754|8722277|P1|Part 3|Lost to Follow-up|0
2519684|NCT01729754|8722268|P10|Part 3|Lack of Efficacy|4
2519685|NCT01729754|8722269|P9|Part 3|Lack of Efficacy|0
2519686|NCT01729754|8722270|P8|Part 3|Lack of Efficacy|0
2519687|NCT01729754|8722271|P7|Part 3|Lack of Efficacy|0
2519688|NCT01729754|8722272|P6|Part 3|Lack of Efficacy|0
2519689|NCT01729754|8722273|P5|Part 3|Lack of Efficacy|2
2519690|NCT01729754|8722274|P4|Part 3|Lack of Efficacy|0
2519691|NCT01729754|8722275|P3|Part 3|Lack of Efficacy|0
2519692|NCT01729754|8722276|P2|Part 3|Lack of Efficacy|0
2519693|NCT01729754|8722277|P1|Part 3|Lack of Efficacy|0
2519694|NCT01729754|8722268|P10|Part 3|Death|0
2519695|NCT01729754|8722269|P9|Part 3|Death|0
2519696|NCT01729754|8722270|P8|Part 3|Death|0
2519704|NCT01729754|8722268|P10|Part 3|Adverse Event|3
2519705|NCT01729754|8722269|P9|Part 3|Adverse Event|0
2519706|NCT01729754|8722270|P8|Part 3|Adverse Event|0
2519707|NCT01729754|8722271|P7|Part 3|Adverse Event|0
2519708|NCT01729754|8722272|P6|Part 3|Adverse Event|5
2519709|NCT01729754|8722273|P5|Part 3|Adverse Event|0
2519710|NCT01729754|8722274|P4|Part 3|Adverse Event|0
2519711|NCT01729754|8722275|P3|Part 3|Adverse Event|1
2519712|NCT01729754|8722276|P2|Part 3|Adverse Event|0
2519713|NCT01729754|8722277|P1|Part 3|Adverse Event|0
2519714|NCT01729754|8722268|P10|Part 2|Other Protocol Specified Criteria|0
2519715|NCT01729754|8722269|P9|Part 2|Other Protocol Specified Criteria|0
2519716|NCT01729754|8722270|P8|Part 2|Other Protocol Specified Criteria|1
2519717|NCT01729754|8722271|P7|Part 2|Other Protocol Specified Criteria|0
2519718|NCT01729754|8722272|P6|Part 2|Other Protocol Specified Criteria|0
2519719|NCT01729754|8722273|P5|Part 2|Other Protocol Specified Criteria|0
2519720|NCT01729754|8722274|P4|Part 2|Other Protocol Specified Criteria|0
2519721|NCT01729754|8722275|P3|Part 2|Other Protocol Specified Criteria|0
2519722|NCT01729754|8722276|P2|Part 2|Other Protocol Specified Criteria|0
2519723|NCT01729754|8722277|P1|Part 2|Other Protocol Specified Criteria|1
2519724|NCT01729754|8722268|P10|Part 2|Withdrawal by Subject|4
2519725|NCT01729754|8722269|P9|Part 2|Withdrawal by Subject|1
2519726|NCT01729754|8722270|P8|Part 2|Withdrawal by Subject|1
2519727|NCT01729754|8722271|P7|Part 2|Withdrawal by Subject|0
2519728|NCT01729754|8722272|P6|Part 2|Withdrawal by Subject|0
2519729|NCT01729754|8722273|P5|Part 2|Withdrawal by Subject|0
2519730|NCT01729754|8722274|P4|Part 2|Withdrawal by Subject|2
2519731|NCT01729754|8722275|P3|Part 2|Withdrawal by Subject|0
2519732|NCT01729754|8722276|P2|Part 2|Withdrawal by Subject|0
2519733|NCT01729754|8722277|P1|Part 2|Withdrawal by Subject|3
2519734|NCT01729754|8722268|P10|Part 2|Pregnancy|1
2519735|NCT01729754|8722269|P9|Part 2|Pregnancy|0
2519736|NCT01729754|8722270|P8|Part 2|Pregnancy|0
2519737|NCT01729754|8722271|P7|Part 2|Pregnancy|0
2519738|NCT01729754|8722272|P6|Part 2|Pregnancy|0
2519739|NCT01729754|8722273|P5|Part 2|Pregnancy|0
2519740|NCT01729754|8722274|P4|Part 2|Pregnancy|1
2519741|NCT01729754|8722275|P3|Part 2|Pregnancy|0
2519742|NCT01729754|8722276|P2|Part 2|Pregnancy|0
2519743|NCT01729754|8722277|P1|Part 2|Pregnancy|0
2519744|NCT01729754|8722268|P10|Part 2|Non-Compliance with Study Drug|1
2519745|NCT01729754|8722269|P9|Part 2|Non-Compliance with Study Drug|0
2519746|NCT01729754|8722270|P8|Part 2|Non-Compliance with Study Drug|0
2519747|NCT01729754|8722271|P7|Part 2|Non-Compliance with Study Drug|0
2519748|NCT01729754|8722272|P6|Part 2|Non-Compliance with Study Drug|0
2519749|NCT01729754|8722273|P5|Part 2|Non-Compliance with Study Drug|0
2519750|NCT01729754|8722274|P4|Part 2|Non-Compliance with Study Drug|0
2519751|NCT01729754|8722275|P3|Part 2|Non-Compliance with Study Drug|0
2519752|NCT01729754|8722276|P2|Part 2|Non-Compliance with Study Drug|0
2519753|NCT01729754|8722277|P1|Part 2|Non-Compliance with Study Drug|0
2519754|NCT01729754|8722268|P10|Part 2|Lost to Follow-up|2
2519755|NCT01729754|8722269|P9|Part 2|Lost to Follow-up|0
2519756|NCT01729754|8722270|P8|Part 2|Lost to Follow-up|1
2519757|NCT01729754|8722271|P7|Part 2|Lost to Follow-up|0
2519758|NCT01729754|8722272|P6|Part 2|Lost to Follow-up|0
2519759|NCT01729754|8722273|P5|Part 2|Lost to Follow-up|0
2519760|NCT01729754|8722274|P4|Part 2|Lost to Follow-up|2
2519761|NCT01729754|8722275|P3|Part 2|Lost to Follow-up|0
2519762|NCT01729754|8722276|P2|Part 2|Lost to Follow-up|0
2519763|NCT01729754|8722277|P1|Part 2|Lost to Follow-up|0
2519764|NCT01729754|8722268|P10|Part 2|Lack of Efficacy|2
2519765|NCT01729754|8722269|P9|Part 2|Lack of Efficacy|2
2519766|NCT01729754|8722270|P8|Part 2|Lack of Efficacy|0
2519767|NCT01729754|8722271|P7|Part 2|Lack of Efficacy|0
2519768|NCT01729754|8722272|P6|Part 2|Lack of Efficacy|0
2519769|NCT01729754|8722273|P5|Part 2|Lack of Efficacy|0
2519770|NCT01729754|8722274|P4|Part 2|Lack of Efficacy|0
2519771|NCT01729754|8722275|P3|Part 2|Lack of Efficacy|0
2519772|NCT01729754|8722276|P2|Part 2|Lack of Efficacy|0
2519773|NCT01729754|8722277|P1|Part 2|Lack of Efficacy|0
2519774|NCT01729754|8722268|P10|Part 2|Adverse Event|2
2519775|NCT01729754|8722269|P9|Part 2|Adverse Event|1
2519776|NCT01729754|8722270|P8|Part 2|Adverse Event|0
2519777|NCT01729754|8722271|P7|Part 2|Adverse Event|0
2519778|NCT01729754|8722272|P6|Part 2|Adverse Event|0
2519779|NCT01729754|8722273|P5|Part 2|Adverse Event|0
2519780|NCT01729754|8722274|P4|Part 2|Adverse Event|0
2519781|NCT01729754|8722275|P3|Part 2|Adverse Event|0
2519782|NCT01729754|8722276|P2|Part 2|Adverse Event|0
2519783|NCT01729754|8722277|P1|Part 2|Adverse Event|2
2519784|NCT01729754|8722268|P10|Part 1|Other Protocol Specified Criteria|4
2519785|NCT01729754|8722269|P9|Part 1|Other Protocol Specified Criteria|0
2519786|NCT01729754|8722270|P8|Part 1|Other Protocol Specified Criteria|0
2519787|NCT01729754|8722271|P7|Part 1|Other Protocol Specified Criteria|1
2519788|NCT01729754|8722272|P6|Part 1|Other Protocol Specified Criteria|0
2519789|NCT01729754|8722273|P5|Part 1|Other Protocol Specified Criteria|0
2519790|NCT01729754|8722274|P4|Part 1|Other Protocol Specified Criteria|0
2519791|NCT01729754|8722275|P3|Part 1|Other Protocol Specified Criteria|0
2519792|NCT01729754|8722276|P2|Part 1|Other Protocol Specified Criteria|0
2519793|NCT01729754|8722277|P1|Part 1|Other Protocol Specified Criteria|2
2519794|NCT01729754|8722268|P10|Part 1|Withdrawal by Subject|6
2519795|NCT01729754|8722269|P9|Part 1|Withdrawal by Subject|0
2519796|NCT01729754|8722270|P8|Part 1|Withdrawal by Subject|0
2519797|NCT01729754|8722271|P7|Part 1|Withdrawal by Subject|5
2519798|NCT01729754|8722272|P6|Part 1|Withdrawal by Subject|0
2519799|NCT01729754|8722273|P5|Part 1|Withdrawal by Subject|0
2519800|NCT01729754|8722274|P4|Part 1|Withdrawal by Subject|7
2519801|NCT01729754|8722275|P3|Part 1|Withdrawal by Subject|0
2519802|NCT01729754|8722276|P2|Part 1|Withdrawal by Subject|0
2519803|NCT01729754|8722277|P1|Part 1|Withdrawal by Subject|5
2519804|NCT01729754|8722268|P10|Part 1|Protocol Violation|0
2519805|NCT01729754|8722269|P9|Part 1|Protocol Violation|0
2519806|NCT01729754|8722270|P8|Part 1|Protocol Violation|0
2519807|NCT01729754|8722271|P7|Part 1|Protocol Violation|1
2519808|NCT01729754|8722272|P6|Part 1|Protocol Violation|0
2519809|NCT01729754|8722273|P5|Part 1|Protocol Violation|0
2519810|NCT01729754|8722274|P4|Part 1|Protocol Violation|1
2519811|NCT01729754|8722275|P3|Part 1|Protocol Violation|0
2519812|NCT01729754|8722276|P2|Part 1|Protocol Violation|0
2519813|NCT01729754|8722277|P1|Part 1|Protocol Violation|2
2519814|NCT01729754|8722268|P10|Part 1|Progressive Disease|1
2519815|NCT01729754|8722269|P9|Part 1|Progressive Disease|0
2519816|NCT01729754|8722270|P8|Part 1|Progressive Disease|0
2519817|NCT01729754|8722271|P7|Part 1|Progressive Disease|0
2519818|NCT01729754|8722272|P6|Part 1|Progressive Disease|0
2519819|NCT01729754|8722273|P5|Part 1|Progressive Disease|0
2519820|NCT01729754|8722274|P4|Part 1|Progressive Disease|0
2519821|NCT01729754|8722275|P3|Part 1|Progressive Disease|0
2519822|NCT01729754|8722276|P2|Part 1|Progressive Disease|0
2519823|NCT01729754|8722277|P1|Part 1|Progressive Disease|0
2519824|NCT01729754|8722268|P10|Part 1|Pregnancy|1
2519825|NCT01729754|8722269|P9|Part 1|Pregnancy|0
2519826|NCT01729754|8722270|P8|Part 1|Pregnancy|0
2519827|NCT01729754|8722271|P7|Part 1|Pregnancy|0
2519828|NCT01729754|8722272|P6|Part 1|Pregnancy|0
2519829|NCT01729754|8722273|P5|Part 1|Pregnancy|0
2519830|NCT01729754|8722274|P4|Part 1|Pregnancy|1
2519831|NCT01729754|8722275|P3|Part 1|Pregnancy|0
2519832|NCT01729754|8722276|P2|Part 1|Pregnancy|0
2519833|NCT01729754|8722277|P1|Part 1|Pregnancy|0
2519834|NCT01729754|8722268|P10|Part 1|Physician Decision|4
2519835|NCT01729754|8722269|P9|Part 1|Physician Decision|0
2519836|NCT01729754|8722270|P8|Part 1|Physician Decision|0
2519837|NCT01729754|8722271|P7|Part 1|Physician Decision|0
2519838|NCT01729754|8722272|P6|Part 1|Physician Decision|0
2519839|NCT01729754|8722273|P5|Part 1|Physician Decision|0
2519840|NCT01729754|8722274|P4|Part 1|Physician Decision|0
2519841|NCT01729754|8722275|P3|Part 1|Physician Decision|0
2519842|NCT01729754|8722276|P2|Part 1|Physician Decision|0
2519843|NCT01729754|8722277|P1|Part 1|Physician Decision|0
2519844|NCT01729754|8722268|P10|Part 1|Non-compliance with Study Drug|0
2519845|NCT01729754|8722269|P9|Part 1|Non-compliance with Study Drug|0
2519846|NCT01729754|8722270|P8|Part 1|Non-compliance with Study Drug|0
2519847|NCT01729754|8722271|P7|Part 1|Non-compliance with Study Drug|0
2519848|NCT01729754|8722272|P6|Part 1|Non-compliance with Study Drug|0
2519849|NCT01729754|8722273|P5|Part 1|Non-compliance with Study Drug|0
2519850|NCT01729754|8722274|P4|Part 1|Non-compliance with Study Drug|0
2519851|NCT01729754|8722275|P3|Part 1|Non-compliance with Study Drug|0
2519852|NCT01729754|8722276|P2|Part 1|Non-compliance with Study Drug|0
2519853|NCT01729754|8722277|P1|Part 1|Non-compliance with Study Drug|1
2519854|NCT01729754|8722268|P10|Part 1|Lost to Follow-up|3
2519855|NCT01729754|8722269|P9|Part 1|Lost to Follow-up|0
2519856|NCT01729754|8722270|P8|Part 1|Lost to Follow-up|0
2519857|NCT01729754|8722271|P7|Part 1|Lost to Follow-up|3
2519858|NCT01729754|8722272|P6|Part 1|Lost to Follow-up|0
2519859|NCT01729754|8722273|P5|Part 1|Lost to Follow-up|0
2519860|NCT01729754|8722274|P4|Part 1|Lost to Follow-up|2
2519861|NCT01729754|8722275|P3|Part 1|Lost to Follow-up|0
2519862|NCT01729754|8722276|P2|Part 1|Lost to Follow-up|0
2519863|NCT01729754|8722277|P1|Part 1|Lost to Follow-up|1
2519864|NCT01729754|8722268|P10|Part 1|Lack of Efficacy|0
2519865|NCT01729754|8722269|P9|Part 1|Lack of Efficacy|0
2519866|NCT01729754|8722270|P8|Part 1|Lack of Efficacy|0
2519867|NCT01729754|8722271|P7|Part 1|Lack of Efficacy|2
2519868|NCT01729754|8722272|P6|Part 1|Lack of Efficacy|0
2519869|NCT01729754|8722273|P5|Part 1|Lack of Efficacy|0
2519870|NCT01729754|8722274|P4|Part 1|Lack of Efficacy|0
2519871|NCT01729754|8722275|P3|Part 1|Lack of Efficacy|0
2519872|NCT01729754|8722276|P2|Part 1|Lack of Efficacy|0
2519873|NCT01729754|8722277|P1|Part 1|Lack of Efficacy|1
2519874|NCT01729754|8722268|P10|Part 1|Adverse Event|5
2519875|NCT01729754|8722269|P9|Part 1|Adverse Event|0
2519876|NCT01729754|8722270|P8|Part 1|Adverse Event|0
2519877|NCT01729754|8722271|P7|Part 1|Adverse Event|2
2519878|NCT01729754|8722272|P6|Part 1|Adverse Event|0
2519879|NCT01729754|8722273|P5|Part 1|Adverse Event|0
2519880|NCT01729754|8722274|P4|Part 1|Adverse Event|1
2519881|NCT01729754|8722275|P3|Part 1|Adverse Event|0
2519882|NCT01729754|8722276|P2|Part 1|Adverse Event|0
2519883|NCT01729754|8722277|P1|Part 1|Adverse Event|2
2519884|NCT01729728|8722484|P3|Overall Study|Protocol Violation|1
2519885|NCT01729728|8722485|P2|Overall Study|Protocol Violation|0
2519886|NCT01729728|8722486|P1|Overall Study|Protocol Violation|1
2519887|NCT01729728|8722484|P3|Overall Study|Adverse Event|0
2519888|NCT01729728|8722485|P2|Overall Study|Adverse Event|6
2519889|NCT01729728|8722486|P1|Overall Study|Adverse Event|0
2519890|NCT01729559|8722636|P2|Overall Study|Protocol Violation|28
2519891|NCT01729559|8722637|P1|Overall Study|Protocol Violation|31
2519892|NCT01729208|8722680|P2|36 Months Follow-up|Withdrawal by Subject|4
2519893|NCT01729208|8722681|P1|36 Months Follow-up|Withdrawal by Subject|2
2519894|NCT01729208|8722680|P2|36 Months Follow-up|Physician Decision|0
2519895|NCT01729208|8722681|P1|36 Months Follow-up|Physician Decision|1
2519896|NCT01729208|8722680|P2|24 Months Follow-up|Lost to Follow-up|0
2519897|NCT01729208|8722681|P1|24 Months Follow-up|Lost to Follow-up|3
2519898|NCT01729208|8722680|P2|12 Months Follow-up|Lost to Follow-up|3
2519899|NCT01729208|8722681|P1|12 Months Follow-up|Lost to Follow-up|3
2519900|NCT01729208|8722680|P2|12 Months Follow-up|Withdrawal by Subject|7
2519901|NCT01729208|8722681|P1|12 Months Follow-up|Withdrawal by Subject|4
2519902|NCT01729208|8722680|P2|Baseline|Physician Decision|4
2519903|NCT01729208|8722681|P1|Baseline|Physician Decision|5
2519904|NCT01729156|8722714|P3|Overall Study|Withdrawal by Subject|0
2519905|NCT01729156|8722715|P2|Overall Study|Withdrawal by Subject|0
2519906|NCT01729156|8722716|P1|Overall Study|Withdrawal by Subject|1
2519907|NCT01729039|8722744|P2|Overall Study|Withdrawal by Subject|7
2519908|NCT01729039|8722745|P1|Overall Study|Withdrawal by Subject|8
2519909|NCT01729039|8722744|P2|Overall Study|disqualified|5
2519910|NCT01729039|8722745|P1|Overall Study|disqualified|2
2519911|NCT01729026|8722761|P2|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2
2519912|NCT01729026|8722762|P1|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1
2519913|NCT01729026|8722761|P2|Randomization to 3-month Follow-up|Lost to Follow-up|2
2519914|NCT01729026|8722762|P1|Randomization to 3-month Follow-up|Lost to Follow-up|2
2519915|NCT01728792|8722790|P5|Overall Study|Lost to Follow-up|0
2519916|NCT01728792|8722791|P4|Overall Study|Lost to Follow-up|2
2519917|NCT01728792|8722792|P3|Overall Study|Lost to Follow-up|4
2519918|NCT01728792|8722793|P2|Overall Study|Lost to Follow-up|1
2519919|NCT01728792|8722794|P1|Overall Study|Lost to Follow-up|2
2519920|NCT01728792|8722790|P5|Overall Study|Withdrawal of Consent|0
2519921|NCT01728792|8722791|P4|Overall Study|Withdrawal of Consent|1
2519922|NCT01728792|8722792|P3|Overall Study|Withdrawal of Consent|0
2519923|NCT01728792|8722793|P2|Overall Study|Withdrawal of Consent|1
2519924|NCT01728792|8722794|P1|Overall Study|Withdrawal of Consent|1
2519925|NCT01728584|8722845|P4|Overall Study|Other reason (not specified)|1
2519926|NCT01728584|8722846|P3|Overall Study|Other reason (not specified)|0
2519927|NCT01728584|8722847|P2|Overall Study|Other reason (not specified)|0
2519928|NCT01728584|8722848|P1|Overall Study|Other reason (not specified)|1
2519929|NCT01728584|8722845|P4|Overall Study|Screen failure|0
2519930|NCT01728584|8722846|P3|Overall Study|Screen failure|0
2519931|NCT01728584|8722847|P2|Overall Study|Screen failure|0
2519932|NCT01728584|8722848|P1|Overall Study|Screen failure|1
2519933|NCT01728584|8722845|P4|Overall Study|Withdrawal by Subject|0
2519934|NCT01728584|8722846|P3|Overall Study|Withdrawal by Subject|0
2519935|NCT01728584|8722847|P2|Overall Study|Withdrawal by Subject|0
2519936|NCT01728584|8722848|P1|Overall Study|Withdrawal by Subject|1
2519937|NCT01728584|8722845|P4|Overall Study|Physician Decision|0
2519938|NCT01728584|8722846|P3|Overall Study|Physician Decision|1
2519939|NCT01728584|8722847|P2|Overall Study|Physician Decision|0
2519940|NCT01728584|8722848|P1|Overall Study|Physician Decision|4
2519941|NCT01728584|8722845|P4|Overall Study|Adverse Event|0
2519942|NCT01728584|8722846|P3|Overall Study|Adverse Event|0
2519943|NCT01728584|8722847|P2|Overall Study|Adverse Event|0
2519944|NCT01728584|8722848|P1|Overall Study|Adverse Event|1
2519945|NCT01728454|8722903|P3|Stage 3|Withdrew due to Adverse Events/Toxicity|0
2519946|NCT01728454|8722904|P2|Stage 3|Withdrew due to Adverse Events/Toxicity|0
2519947|NCT01728454|8722905|P1|Stage 3|Withdrew due to Adverse Events/Toxicity|1
2519948|NCT01728454|8722903|P3|Stage 3|Lost to Follow-up|1
2519949|NCT01728454|8722904|P2|Stage 3|Lost to Follow-up|3
2519950|NCT01728454|8722905|P1|Stage 3|Lost to Follow-up|0
2519951|NCT01728454|8722903|P3|Stage 3|Non-compliance with Protocol|1
2519952|NCT01728454|8722904|P2|Stage 3|Non-compliance with Protocol|0
2519953|NCT01728454|8722905|P1|Stage 3|Non-compliance with Protocol|0
2519954|NCT01728454|8722903|P3|Stage 3|Withdrew Consent|1
2519955|NCT01728454|8722904|P2|Stage 3|Withdrew Consent|0
2519956|NCT01728454|8722905|P1|Stage 3|Withdrew Consent|1
2519957|NCT01728454|8722903|P3|Stage 3|Pregnancy|0
2519958|NCT01728454|8722904|P2|Stage 3|Pregnancy|0
2519959|NCT01728454|8722905|P1|Stage 3|Pregnancy|1
2519960|NCT01728454|8722903|P3|Stage 3|Subject Required Other Treatment|0
2519961|NCT01728454|8722904|P2|Stage 3|Subject Required Other Treatment|1
2519962|NCT01728454|8722905|P1|Stage 3|Subject Required Other Treatment|0
2519963|NCT01728454|8722903|P3|Stage 3|Reason Missing|1
2519964|NCT01728454|8722904|P2|Stage 3|Reason Missing|0
2519965|NCT01728454|8722905|P1|Stage 3|Reason Missing|0
2519966|NCT01728454|8722903|P3|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3
2519967|NCT01728454|8722904|P2|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3
2519968|NCT01728454|8722905|P1|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2
2519969|NCT01728454|8722903|P3|Stage 1 and 2|Lost to Follow-up|0
2519970|NCT01728454|8722904|P2|Stage 1 and 2|Lost to Follow-up|1
2519971|NCT01728454|8722905|P1|Stage 1 and 2|Lost to Follow-up|1
2519972|NCT01728454|8722903|P3|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0
2519973|NCT01728454|8722904|P2|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0
2519974|NCT01728454|8722905|P1|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1
2519975|NCT01728454|8722903|P3|Stage 1 and 2|Non-compliance with Protocol|1
2519976|NCT01728454|8722904|P2|Stage 1 and 2|Non-compliance with Protocol|0
2519977|NCT01728454|8722905|P1|Stage 1 and 2|Non-compliance with Protocol|0
2519978|NCT01728454|8722903|P3|Stage 1 and 2|Pregnancy|0
2519979|NCT01728454|8722904|P2|Stage 1 and 2|Pregnancy|0
2519980|NCT01728454|8722905|P1|Stage 1 and 2|Pregnancy|1
2519981|NCT01728376|8722955|P6|Overall Study|Subject/Parent/Legal Guardian Decision|1
2519982|NCT01728376|8722956|P5|Overall Study|Subject/Parent/Legal Guardian Decision|0
2519983|NCT01728376|8722957|P4|Overall Study|Subject/Parent/Legal Guardian Decision|1
2519984|NCT01728376|8722958|P3|Overall Study|Subject/Parent/Legal Guardian Decision|0
2519985|NCT01728376|8722959|P2|Overall Study|Subject/Parent/Legal Guardian Decision|0
2519986|NCT01728376|8722960|P1|Overall Study|Subject/Parent/Legal Guardian Decision|0
2519987|NCT01728376|8722955|P6|Overall Study|Did not receive treatment|0
2519988|NCT01728376|8722956|P5|Overall Study|Did not receive treatment|0
2519989|NCT01728376|8722957|P4|Overall Study|Did not receive treatment|0
2519990|NCT01728376|8722958|P3|Overall Study|Did not receive treatment|0
2519991|NCT01728376|8722959|P2|Overall Study|Did not receive treatment|1
2519992|NCT01728376|8722960|P1|Overall Study|Did not receive treatment|0
2519993|NCT01728376|8722955|P6|Overall Study|No relevant bacteria|1
2519994|NCT01728376|8722956|P5|Overall Study|No relevant bacteria|1
2519995|NCT01728376|8722957|P4|Overall Study|No relevant bacteria|0
2519996|NCT01728376|8722958|P3|Overall Study|No relevant bacteria|0
2519997|NCT01728376|8722959|P2|Overall Study|No relevant bacteria|0
2519998|NCT01728376|8722960|P1|Overall Study|No relevant bacteria|2
2519999|NCT01728376|8722955|P6|Overall Study|Persistent Positive Blood Cultures|0
2520000|NCT01728376|8722956|P5|Overall Study|Persistent Positive Blood Cultures|0
2520001|NCT01728376|8722957|P4|Overall Study|Persistent Positive Blood Cultures|0
2520002|NCT01728376|8722958|P3|Overall Study|Persistent Positive Blood Cultures|1
2520003|NCT01728376|8722959|P2|Overall Study|Persistent Positive Blood Cultures|0
2520004|NCT01728376|8722960|P1|Overall Study|Persistent Positive Blood Cultures|1
2520005|NCT01728376|8722955|P6|Overall Study|Adverse Event|0
2520006|NCT01728376|8722956|P5|Overall Study|Adverse Event|1
2520007|NCT01728376|8722957|P4|Overall Study|Adverse Event|1
2520008|NCT01728376|8722958|P3|Overall Study|Adverse Event|1
2520009|NCT01728376|8722959|P2|Overall Study|Adverse Event|1
2520010|NCT01728376|8722960|P1|Overall Study|Adverse Event|1
2520011|NCT01728324|8723033|P3|Termination of RBV|Protocol Violation (Placebo Period)|0
2520012|NCT01728324|8723034|P2|Termination of RBV|Protocol Violation (Placebo Period)|1
2520013|NCT01728324|8723035|P1|Termination of RBV|Protocol Violation (Placebo Period)|0
2520014|NCT01728324|8723033|P3|Termination of RBV|Adverse Event (Placebo Period)|0
2520015|NCT01728324|8723034|P2|Termination of RBV|Adverse Event (Placebo Period)|1
2520016|NCT01728324|8723035|P1|Termination of RBV|Adverse Event (Placebo Period)|0
2520017|NCT01728324|8723033|P3|Termination of RBV|Other than stated|1
2520018|NCT01728324|8723034|P2|Termination of RBV|Other than stated|3
2520019|NCT01728324|8723035|P1|Termination of RBV|Other than stated|1
2520020|NCT01728324|8723033|P3|Termination of RBV|Withdrawal by Subject|2
2520021|NCT01728324|8723034|P2|Termination of RBV|Withdrawal by Subject|5
2520022|NCT01728324|8723035|P1|Termination of RBV|Withdrawal by Subject|9
2520023|NCT01728324|8723033|P3|Termination of RBV|Lack of Efficacy|7
2520024|NCT01728324|8723034|P2|Termination of RBV|Lack of Efficacy|11
2520025|NCT01728324|8723035|P1|Termination of RBV|Lack of Efficacy|14
2520026|NCT01728324|8723033|P3|Termination of RBV|Adverse Event|5
2520027|NCT01728324|8723034|P2|Termination of RBV|Adverse Event|16
2520028|NCT01728324|8723035|P1|Termination of RBV|Adverse Event|15
2520029|NCT01728324|8723033|P3|Termination of FDV|Protocol Violation (Placebo Period)|0
2520030|NCT01728324|8723034|P2|Termination of FDV|Protocol Violation (Placebo Period)|1
2520031|NCT01728324|8723035|P1|Termination of FDV|Protocol Violation (Placebo Period)|0
2520032|NCT01728324|8723033|P3|Termination of FDV|Adverse Event (Placebo Period)|0
2520033|NCT01728324|8723034|P2|Termination of FDV|Adverse Event (Placebo Period)|1
2520034|NCT01728324|8723035|P1|Termination of FDV|Adverse Event (Placebo Period)|0
2520035|NCT01728324|8723033|P3|Termination of FDV|Other than stated|0
2520036|NCT01728324|8723034|P2|Termination of FDV|Other than stated|3
2520037|NCT01728324|8723035|P1|Termination of FDV|Other than stated|1
2520038|NCT01728324|8723033|P3|Termination of FDV|Withdrawal by Subject|2
2520039|NCT01728324|8723034|P2|Termination of FDV|Withdrawal by Subject|6
2520040|NCT01728324|8723035|P1|Termination of FDV|Withdrawal by Subject|9
2520041|NCT01728324|8723033|P3|Termination of FDV|Lack of Efficacy|8
2520042|NCT01728324|8723034|P2|Termination of FDV|Lack of Efficacy|12
2520043|NCT01728324|8723035|P1|Termination of FDV|Lack of Efficacy|14
2520044|NCT01728324|8723033|P3|Termination of FDV|Adverse Event|4
2520045|NCT01728324|8723034|P2|Termination of FDV|Adverse Event|13
2520046|NCT01728324|8723035|P1|Termination of FDV|Adverse Event|14
2520047|NCT01728324|8723033|P3|Termination of DBV|Protocol Violation (Placebo Period)|0
2520048|NCT01728324|8723034|P2|Termination of DBV|Protocol Violation (Placebo Period)|1
2520049|NCT01728324|8723035|P1|Termination of DBV|Protocol Violation (Placebo Period)|0
2520050|NCT01728324|8723033|P3|Termination of DBV|Adverse Event (Placebo Period)|0
2520051|NCT01728324|8723034|P2|Termination of DBV|Adverse Event (Placebo Period)|1
2520052|NCT01728324|8723035|P1|Termination of DBV|Adverse Event (Placebo Period)|0
2520053|NCT01728324|8723033|P3|Termination of DBV|Other than stated|0
2520054|NCT01728324|8723034|P2|Termination of DBV|Other than stated|3
2520055|NCT01728324|8723035|P1|Termination of DBV|Other than stated|1
2520056|NCT01728324|8723033|P3|Termination of DBV|Withdrawal by Subject|2
2520057|NCT01728324|8723034|P2|Termination of DBV|Withdrawal by Subject|6
2520058|NCT01728324|8723035|P1|Termination of DBV|Withdrawal by Subject|9
2520059|NCT01728324|8723033|P3|Termination of DBV|Lack of Efficacy|8
2520060|NCT01728324|8723034|P2|Termination of DBV|Lack of Efficacy|12
2520061|NCT01728324|8723035|P1|Termination of DBV|Lack of Efficacy|14
2520062|NCT01728324|8723033|P3|Termination of DBV|Adverse Event|4
2520063|NCT01728324|8723034|P2|Termination of DBV|Adverse Event|13
2520064|NCT01728324|8723035|P1|Termination of DBV|Adverse Event|14
2520065|NCT01728246|8723056|P2|Overall Study|Adverse Event|5
2520066|NCT01728246|8723057|P1|Overall Study|Adverse Event|8
2520067|NCT01728246|8723056|P2|Overall Study|Lack of Efficacy|1
2520068|NCT01728246|8723057|P1|Overall Study|Lack of Efficacy|1
2520069|NCT01728246|8723056|P2|Overall Study|Lost to Follow-up|22
2520070|NCT01728246|8723057|P1|Overall Study|Lost to Follow-up|23
2520071|NCT01728246|8723056|P2|Overall Study|Withdrawal by Subject|3
2520072|NCT01728246|8723057|P1|Overall Study|Withdrawal by Subject|2
2520073|NCT01728246|8723056|P2|Overall Study|Protocol Violation|0
2520074|NCT01728246|8723057|P1|Overall Study|Protocol Violation|1
2520075|NCT01728246|8723056|P2|Overall Study|Participant needed rescue medication|5
2520076|NCT01728246|8723057|P1|Overall Study|Participant needed rescue medication|1
2520077|NCT01728116|8723075|P2|Overall Study|various not noted previously|0
2520078|NCT01728116|8723076|P1|Overall Study|various not noted previously|5
2520079|NCT01728116|8723075|P2|Overall Study|Incorrectly enrolled in Study|1
2520080|NCT01728116|8723076|P1|Overall Study|Incorrectly enrolled in Study|0
2520081|NCT01728116|8723075|P2|Overall Study|Inter-current finding at procedure|0
2520082|NCT01728116|8723076|P1|Overall Study|Inter-current finding at procedure|1
2520083|NCT01728116|8723075|P2|Overall Study|Subject Non-Compliance|0
2520084|NCT01728116|8723076|P1|Overall Study|Subject Non-Compliance|2
2520085|NCT01728116|8723075|P2|Overall Study|Physician Decision|0
2520086|NCT01728116|8723076|P1|Overall Study|Physician Decision|2
2520087|NCT01728116|8723075|P2|Overall Study|Lost to Follow-up|2
2520088|NCT01728116|8723076|P1|Overall Study|Lost to Follow-up|9
2520089|NCT01728116|8723075|P2|Overall Study|Procedure/device failure|0
2520090|NCT01728116|8723076|P1|Overall Study|Procedure/device failure|7
2520091|NCT01728116|8723075|P2|Overall Study|Adverse Event|0
2520092|NCT01728116|8723076|P1|Overall Study|Adverse Event|13
2520093|NCT01728116|8723075|P2|Overall Study|Withdrawal by Subject|9
2520094|NCT01728116|8723076|P1|Overall Study|Withdrawal by Subject|16
2520095|NCT01728116|8723075|P2|Overall Study|Sponsor Terminated Study|35
2520096|NCT01728116|8723076|P1|Overall Study|Sponsor Terminated Study|106
2520097|NCT01728077|8723101|P2|Overall Study|Non compliance|0
2520098|NCT01728077|8723102|P1|Overall Study|Non compliance|1
2520099|NCT01728077|8723101|P2|Overall Study|Patient moving|0
2520100|NCT01728077|8723102|P1|Overall Study|Patient moving|1
2520101|NCT01728077|8723101|P2|Overall Study|Death|1
2520102|NCT01728077|8723102|P1|Overall Study|Death|0
2520103|NCT01728077|8723101|P2|Overall Study|Subject choice|3
2520104|NCT01728077|8723102|P1|Overall Study|Subject choice|2
2520105|NCT01728077|8723101|P2|Overall Study|Lost to Follow-up|0
2520106|NCT01728077|8723102|P1|Overall Study|Lost to Follow-up|1
2520107|NCT01728077|8723101|P2|Overall Study|Lack of Efficacy|1
2520108|NCT01728077|8723102|P1|Overall Study|Lack of Efficacy|3
2520109|NCT01727713|8723200|P1|Overall Study|Protocol Deviation|2
2520110|NCT01727713|8723200|P1|Overall Study|Withdrawal by Subject|13
2520111|NCT01727713|8723200|P1|Overall Study|Participant Met Withdrawal Criteria|5
2520112|NCT01727713|8723200|P1|Overall Study|Adverse Event|10
2520113|NCT01727713|8723200|P1|Overall Study|Lost to Follow-up|5
2520114|NCT01727700|8723227|P3|Overall Study|Protocol Violation|0
2520115|NCT01727700|8723228|P2|Overall Study|Protocol Violation|0
2520116|NCT01727700|8723229|P1|Overall Study|Protocol Violation|2
2520117|NCT01727700|8723227|P3|Overall Study|Particpant withdrew consent|1
2520118|NCT01727700|8723228|P2|Overall Study|Particpant withdrew consent|3
2520119|NCT01727700|8723229|P1|Overall Study|Particpant withdrew consent|0
2520120|NCT01727700|8723227|P3|Overall Study|Adverse Event|1
2520121|NCT01727700|8723228|P2|Overall Study|Adverse Event|7
2520122|NCT01727700|8723229|P1|Overall Study|Adverse Event|0
2520123|NCT01727505|8723252|P2|Second 24 Hours|Missing data|1
2520124|NCT01727505|8723253|P1|Second 24 Hours|Missing data|0
2520125|NCT01727505|8723252|P2|First 24 Hours|Adverse Event|1
2520126|NCT01727505|8723253|P1|First 24 Hours|Adverse Event|0
2520127|NCT01727297|8723278|P2|Overall Study|Other (e.g. AF detection pre-implant)|8
2520128|NCT01727297|8723279|P1|Overall Study|Other (e.g. AF detection pre-implant)|29
2520129|NCT01727297|8723278|P2|Overall Study|Physician Decision|5
2520130|NCT01727297|8723279|P1|Overall Study|Physician Decision|19
2520131|NCT01727297|8723278|P2|Overall Study|Withdrawal by Subject|27
2520132|NCT01727297|8723279|P1|Overall Study|Withdrawal by Subject|26
2520133|NCT01727297|8723278|P2|Overall Study|Lost to Follow-up|0
2520134|NCT01727297|8723279|P1|Overall Study|Lost to Follow-up|11
2520135|NCT01727297|8723278|P2|Overall Study|Adverse Event|1
2520136|NCT01727297|8723279|P1|Overall Study|Adverse Event|3
2520137|NCT01727297|8723278|P2|Overall Study|Protocol Violation|10
2520138|NCT01727297|8723279|P1|Overall Study|Protocol Violation|1
2520139|NCT01727297|8723278|P2|Overall Study|Death|0
2520140|NCT01727297|8723279|P1|Overall Study|Death|13
2520141|NCT01727258|8723295|P3|Overall Study|Lost to Follow-up|0
2520142|NCT01727258|8723296|P2|Overall Study|Lost to Follow-up|0
2520143|NCT01727258|8723297|P1|Overall Study|Lost to Follow-up|1
2520144|NCT01727258|8723295|P3|Overall Study|Withdrawal by Subject|0
2520145|NCT01727258|8723296|P2|Overall Study|Withdrawal by Subject|1
2520146|NCT01727258|8723297|P1|Overall Study|Withdrawal by Subject|1
2520147|NCT01727258|8723295|P3|Overall Study|Noncompliance with Study Drug|1
2520148|NCT01727258|8723296|P2|Overall Study|Noncompliance with Study Drug|0
2520149|NCT01727258|8723297|P1|Overall Study|Noncompliance with Study Drug|0
2520150|NCT01727258|8723295|P3|Overall Study|Adverse Event|0
2520151|NCT01727258|8723296|P2|Overall Study|Adverse Event|2
2520152|NCT01727258|8723297|P1|Overall Study|Adverse Event|0
2520153|NCT01727154|8723335|P1|Overall Study|No Discontinuation Documentation|4
2520154|NCT01727154|8723335|P1|Overall Study|Study Terminated|6
2520155|NCT01727154|8723335|P1|Overall Study|Subject Withdrew Consent|18
2520156|NCT01727154|8723335|P1|Overall Study|Withdrawal by Subject|14
2520157|NCT01727154|8723335|P1|Overall Study|Death|17
2520158|NCT01727141|8723343|P4|Overall Study|Withdrawal by Subject|11
2520159|NCT01727141|8723344|P3|Overall Study|Withdrawal by Subject|2
2520160|NCT01727141|8723345|P2|Overall Study|Withdrawal by Subject|4
2520161|NCT01727141|8723346|P1|Overall Study|Withdrawal by Subject|4
2520162|NCT01727141|8723343|P4|Overall Study|Protocol deviation|1
2520163|NCT01727141|8723344|P3|Overall Study|Protocol deviation|0
2520164|NCT01727141|8723345|P2|Overall Study|Protocol deviation|1
2520165|NCT01727141|8723346|P1|Overall Study|Protocol deviation|1
2520166|NCT01727141|8723343|P4|Overall Study|Death|1
2520167|NCT01727141|8723344|P3|Overall Study|Death|1
2520168|NCT01727141|8723345|P2|Overall Study|Death|1
2520169|NCT01727141|8723346|P1|Overall Study|Death|0
2520170|NCT01727141|8723343|P4|Overall Study|Lost to Follow-up|0
2520171|NCT01727141|8723344|P3|Overall Study|Lost to Follow-up|0
2520172|NCT01727141|8723345|P2|Overall Study|Lost to Follow-up|2
2520173|NCT01727141|8723346|P1|Overall Study|Lost to Follow-up|0
2520174|NCT01727141|8723343|P4|Overall Study|Physician Decision|2
2520175|NCT01727141|8723344|P3|Overall Study|Physician Decision|0
2520176|NCT01727141|8723345|P2|Overall Study|Physician Decision|1
2520177|NCT01727141|8723346|P1|Overall Study|Physician Decision|0
2520178|NCT01727024|8723411|P2|Period 1|Withdrawal by Subject|3
2520179|NCT01727024|8723412|P1|Period 1|Withdrawal by Subject|2
2520180|NCT01727024|8723411|P2|Period 1|Lost to Follow-up|1
2520181|NCT01727024|8723412|P1|Period 1|Lost to Follow-up|1
2520182|NCT01726803|8723427|P2|Overall Study|Withdrawal by Subject|0
2520183|NCT01726803|8723428|P1|Overall Study|Withdrawal by Subject|1
2520184|NCT01726803|8723427|P2|Overall Study|Lost to Follow-up|1
2520185|NCT01726803|8723428|P1|Overall Study|Lost to Follow-up|6
2520186|NCT01726517|8723470|P5|Overall Study|Withdrawal by Subject|0
2520187|NCT01726517|8723471|P4|Overall Study|Withdrawal by Subject|0
2520188|NCT01726517|8723472|P3|Overall Study|Withdrawal by Subject|1
2520189|NCT01726517|8723473|P2|Overall Study|Withdrawal by Subject|0
2520190|NCT01726517|8723474|P1|Overall Study|Withdrawal by Subject|0
2520191|NCT01726335|8723530|P1|Overall Study|Exacerbation of psychotic symptoms|1
2520192|NCT01726335|8723530|P1|Overall Study|Lost to Follow-up|2
2520193|NCT01726335|8723530|P1|Overall Study|Adverse Event|4
2520194|NCT01726335|8723530|P1|Overall Study|Withdrawal by Subject|15
2520195|NCT01726335|8723530|P1|Overall Study|Lost to Follow-up|2
2520196|NCT01726270|8723546|P1|Part 2, Actual-Use Phase|Other than reason specified above|7
2520197|NCT01726270|8723546|P1|Part 2, Actual-Use Phase|Lost to Follow-up|5
2520198|NCT01726270|8723546|P1|Part 2, Actual-Use Phase|Adverse Event|6
2520199|NCT01726270|8723546|P1|Part 2, Actual-Use Phase|Withdrawal by Subject|21
2520200|NCT01726270|8723546|P1|Eligibility for Part 2|Eligible but did not enter Part 2|20
2520201|NCT01726270|8723546|P1|Part 1, Self-Selection Phase|Withdrawal by Subject|10
2520202|NCT01726049|8723559|P2|Overall Study|refused second HC|2
2520203|NCT01726049|8723560|P1|Overall Study|refused second HC|0
2520204|NCT01726049|8723559|P2|Overall Study|Adverse Event|1
2520205|NCT01726049|8723560|P1|Overall Study|Adverse Event|4
2520206|NCT01726049|8723559|P2|Overall Study|Death|1
2520207|NCT01726049|8723560|P1|Overall Study|Death|1
2520208|NCT01726023|8723585|P2|Overall Study|Withdrawal by Subject|8
2520209|NCT01726023|8723586|P1|Overall Study|Withdrawal by Subject|16
2520210|NCT01726023|8723585|P2|Overall Study|Other Eligibility criteria|7
2520211|NCT01726023|8723586|P1|Overall Study|Other Eligibility criteria|7
2520212|NCT01726023|8723585|P2|Overall Study|Lost to Follow-up|10
2520213|NCT01726023|8723586|P1|Overall Study|Lost to Follow-up|5
2520214|NCT01726023|8723585|P2|Overall Study|Death|1
2520215|NCT01726023|8723586|P1|Overall Study|Death|1
2520216|NCT01725750|8723720|P2|Overall Study|Withdrawal by Subject|9
2520217|NCT01725750|8723721|P1|Overall Study|Withdrawal by Subject|0
2520218|NCT01725750|8723720|P2|Overall Study|Lost to Follow-up|1
2520219|NCT01725750|8723721|P1|Overall Study|Lost to Follow-up|1
2520220|NCT01725750|8723720|P2|Overall Study|Adverse Event|0
2520221|NCT01725750|8723721|P1|Overall Study|Adverse Event|1
2520222|NCT01725529|8723754|P3|Overall Study|Withdrawal by Subject|8
2520223|NCT01725529|8723755|P2|Overall Study|Withdrawal by Subject|14
2520224|NCT01725529|8723756|P1|Overall Study|Withdrawal by Subject|12
2520225|NCT01725529|8723754|P3|Overall Study|Protocol Violation|1
2520226|NCT01725529|8723755|P2|Overall Study|Protocol Violation|1
2520227|NCT01725529|8723756|P1|Overall Study|Protocol Violation|0
2520228|NCT01725529|8723754|P3|Overall Study|Lost to Follow-up|1
2520229|NCT01725529|8723755|P2|Overall Study|Lost to Follow-up|1
2520230|NCT01725529|8723756|P1|Overall Study|Lost to Follow-up|2
2520231|NCT01725529|8723754|P3|Overall Study|Adverse Event|0
2520232|NCT01725529|8723755|P2|Overall Study|Adverse Event|0
2520233|NCT01725529|8723756|P1|Overall Study|Adverse Event|1
2520234|NCT01725451|8723782|P4|Period 4|Adverse Event|0
2520235|NCT01725451|8723783|P3|Period 4|Adverse Event|1
2520236|NCT01725451|8723784|P2|Period 4|Adverse Event|0
2520237|NCT01725451|8723785|P1|Period 4|Adverse Event|0
2520238|NCT01725451|8723782|P4|Washout From Period 3|Adverse Event|0
2520239|NCT01725451|8723783|P3|Washout From Period 3|Adverse Event|0
2520240|NCT01725451|8723784|P2|Washout From Period 3|Adverse Event|1
2520241|NCT01725451|8723785|P1|Washout From Period 3|Adverse Event|0
2520242|NCT01725451|8723782|P4|Washout From Period 3|Protocol Violation|0
2520243|NCT01725451|8723783|P3|Washout From Period 3|Protocol Violation|1
2520244|NCT01725451|8723784|P2|Washout From Period 3|Protocol Violation|0
2520245|NCT01725451|8723785|P1|Washout From Period 3|Protocol Violation|0
2520246|NCT01725451|8723782|P4|Period 1|Withdrawal by Subject|0
2520247|NCT01725451|8723783|P3|Period 1|Withdrawal by Subject|0
2520248|NCT01725451|8723784|P2|Period 1|Withdrawal by Subject|0
2520249|NCT01725451|8723785|P1|Period 1|Withdrawal by Subject|1
2520250|NCT01725386|8723807|P2|Overall Study|Withdrawal by Subject|0
2520251|NCT01725386|8723808|P1|Overall Study|Withdrawal by Subject|10
2520252|NCT01725386|8723807|P2|Overall Study|Lost to Follow-up|6
2520253|NCT01725386|8723808|P1|Overall Study|Lost to Follow-up|81
2520254|NCT01725386|8723807|P2|Overall Study|Death|40
2520255|NCT01725386|8723808|P1|Overall Study|Death|84
2520256|NCT01725308|8723827|P3|Treatment Period II|Miscellaneous|7
2520257|NCT01725308|8723828|P2|Treatment Period II|Miscellaneous|3
2520258|NCT01725308|8723829|P1|Treatment Period II|Miscellaneous|5
2520259|NCT01725308|8723827|P3|Treatment Period II|Protocol Deviations|1
2520260|NCT01725308|8723828|P2|Treatment Period II|Protocol Deviations|0
2520261|NCT01725308|8723829|P1|Treatment Period II|Protocol Deviations|0
2520262|NCT01725308|8723827|P3|Treatment Period II|Lost to Follow-up|3
2520263|NCT01725308|8723828|P2|Treatment Period II|Lost to Follow-up|5
2520264|NCT01725308|8723829|P1|Treatment Period II|Lost to Follow-up|1
2520265|NCT01725308|8723827|P3|Treatment Period II|Withdrawal of Consent|16
2520266|NCT01725308|8723828|P2|Treatment Period II|Withdrawal of Consent|2
2520267|NCT01725308|8723829|P1|Treatment Period II|Withdrawal of Consent|28
2520268|NCT01725308|8723827|P3|Treatment Period II|Changes in the Episodes|5
2520269|NCT01725308|8723828|P2|Treatment Period II|Changes in the Episodes|0
2520270|NCT01725308|8723829|P1|Treatment Period II|Changes in the Episodes|1
2520271|NCT01725308|8723827|P3|Treatment Period II|Worsening of the Target Disease|2
2520272|NCT01725308|8723828|P2|Treatment Period II|Worsening of the Target Disease|4
2520273|NCT01725308|8723829|P1|Treatment Period II|Worsening of the Target Disease|1
2520274|NCT01725308|8723827|P3|Treatment Period II|Insufficient Response|6
2520275|NCT01725308|8723828|P2|Treatment Period II|Insufficient Response|4
2520276|NCT01725308|8723829|P1|Treatment Period II|Insufficient Response|2
2520277|NCT01725308|8723827|P3|Treatment Period II|Adverse Event|20
2520278|NCT01725308|8723828|P2|Treatment Period II|Adverse Event|8
2520279|NCT01725308|8723829|P1|Treatment Period II|Adverse Event|13
2520280|NCT01725308|8723827|P3|Treatment Period II|Did Not Receive Drug|0
2520281|NCT01725308|8723828|P2|Treatment Period II|Did Not Receive Drug|0
2520282|NCT01725308|8723829|P1|Treatment Period II|Did Not Receive Drug|4
2520283|NCT01725308|8723827|P3|Treatment Period II|Did Not Meet Transition Criteria|4
2520284|NCT01725308|8723828|P2|Treatment Period II|Did Not Meet Transition Criteria|3
2520285|NCT01725308|8723829|P1|Treatment Period II|Did Not Meet Transition Criteria|0
2520286|NCT01725308|8723827|P3|Treatment Period I|Miscellaneous|3
2520287|NCT01725308|8723828|P2|Treatment Period I|Miscellaneous|0
2520288|NCT01725308|8723829|P1|Treatment Period I|Miscellaneous|2
2520289|NCT01725308|8723827|P3|Treatment Period I|Protocol Deviations|1
2520290|NCT01725308|8723828|P2|Treatment Period I|Protocol Deviations|1
2520291|NCT01725308|8723829|P1|Treatment Period I|Protocol Deviations|3
2520292|NCT01725308|8723827|P3|Treatment Period I|Lost to Follow-up|2
2520293|NCT01725308|8723828|P2|Treatment Period I|Lost to Follow-up|2
2520294|NCT01725308|8723829|P1|Treatment Period I|Lost to Follow-up|3
2520295|NCT01725308|8723827|P3|Treatment Period I|Withdrawal of Consent|5
2520296|NCT01725308|8723828|P2|Treatment Period I|Withdrawal of Consent|7
2520297|NCT01725308|8723829|P1|Treatment Period I|Withdrawal of Consent|12
2520298|NCT01725308|8723827|P3|Treatment Period I|Changes in the Episodes|2
2520299|NCT01725308|8723828|P2|Treatment Period I|Changes in the Episodes|0
2520300|NCT01725308|8723829|P1|Treatment Period I|Changes in the Episodes|3
2520301|NCT01725308|8723827|P3|Treatment Period I|Worsening of the Target Disease|2
2520302|NCT01725308|8723828|P2|Treatment Period I|Worsening of the Target Disease|0
2520303|NCT01725308|8723829|P1|Treatment Period I|Worsening of the Target Disease|8
2520304|NCT01725308|8723827|P3|Treatment Period I|Insufficient Response|5
2520305|NCT01725308|8723828|P2|Treatment Period I|Insufficient Response|0
2520306|NCT01725308|8723829|P1|Treatment Period I|Insufficient Response|7
2520307|NCT01725308|8723827|P3|Treatment Period I|Adverse Event|21
2520308|NCT01725308|8723828|P2|Treatment Period I|Adverse Event|4
2520309|NCT01725308|8723829|P1|Treatment Period I|Adverse Event|5
2520310|NCT01725308|8723827|P3|Treatment Period I|Did Not Receive Drug|0
2520311|NCT01725308|8723828|P2|Treatment Period I|Did Not Receive Drug|0
2520312|NCT01725308|8723829|P1|Treatment Period I|Did Not Receive Drug|1
2520313|NCT01725282|8723976|P4|Overall Study|Lack of Efficacy|1
2520314|NCT01725282|8723977|P3|Overall Study|Lack of Efficacy|0
2520315|NCT01725282|8723978|P2|Overall Study|Lack of Efficacy|1
2520316|NCT01725282|8723979|P1|Overall Study|Lack of Efficacy|0
2520317|NCT01725282|8723976|P4|Overall Study|Withdrawal by Subject|1
2520318|NCT01725282|8723977|P3|Overall Study|Withdrawal by Subject|1
2520319|NCT01725282|8723978|P2|Overall Study|Withdrawal by Subject|0
2520320|NCT01725282|8723979|P1|Overall Study|Withdrawal by Subject|0
2520321|NCT01725282|8723976|P4|Overall Study|Study Site Withdrawal|0
2520322|NCT01725282|8723977|P3|Overall Study|Study Site Withdrawal|0
2520323|NCT01725282|8723978|P2|Overall Study|Study Site Withdrawal|1
2520324|NCT01725282|8723979|P1|Overall Study|Study Site Withdrawal|0
2520325|NCT01725282|8723976|P4|Overall Study|Met Exclusion Criteria|0
2520326|NCT01725282|8723977|P3|Overall Study|Met Exclusion Criteria|1
2520327|NCT01725282|8723978|P2|Overall Study|Met Exclusion Criteria|0
2520328|NCT01725282|8723979|P1|Overall Study|Met Exclusion Criteria|0
2520329|NCT01725282|8723976|P4|Overall Study|Exacerbation of Target Disease|1
2520330|NCT01725282|8723977|P3|Overall Study|Exacerbation of Target Disease|0
2520331|NCT01725282|8723978|P2|Overall Study|Exacerbation of Target Disease|0
2520332|NCT01725282|8723979|P1|Overall Study|Exacerbation of Target Disease|1
2520333|NCT01725282|8723976|P4|Overall Study|Adverse Event|4
2520334|NCT01725282|8723977|P3|Overall Study|Adverse Event|6
2520335|NCT01725282|8723978|P2|Overall Study|Adverse Event|3
2520336|NCT01725282|8723979|P1|Overall Study|Adverse Event|1
2520337|NCT01725217|8724012|P3|Overall Study|Withdrawal by Subject|0
2520338|NCT01725217|8724013|P2|Overall Study|Withdrawal by Subject|0
2520339|NCT01725217|8724014|P1|Overall Study|Withdrawal by Subject|1
2520340|NCT01725126|8724048|P6|Overall Study|Withdrawal by Subject|0
2520341|NCT01725126|8724049|P5|Overall Study|Withdrawal by Subject|0
2520342|NCT01725126|8724050|P4|Overall Study|Withdrawal by Subject|1
2520343|NCT01725126|8724051|P3|Overall Study|Withdrawal by Subject|0
2520344|NCT01725126|8724052|P2|Overall Study|Withdrawal by Subject|0
2520345|NCT01725126|8724053|P1|Overall Study|Withdrawal by Subject|0
2520346|NCT01725126|8724048|P6|Overall Study|Protocol Violation|0
2520347|NCT01725126|8724049|P5|Overall Study|Protocol Violation|0
2520348|NCT01725126|8724050|P4|Overall Study|Protocol Violation|0
2520349|NCT01725126|8724051|P3|Overall Study|Protocol Violation|0
2520350|NCT01725126|8724052|P2|Overall Study|Protocol Violation|1
2520351|NCT01725126|8724053|P1|Overall Study|Protocol Violation|0
2520352|NCT01724528|8724251|P2|Overall Study|Patient refused to attend last visit|0
2520353|NCT01724528|8724252|P1|Overall Study|Patient refused to attend last visit|1
2520354|NCT01724528|8724251|P2|Overall Study|Protocol Violation|1
2520355|NCT01724528|8724252|P1|Overall Study|Protocol Violation|0
2520356|NCT01724528|8724251|P2|Overall Study|Withdrawal by Subject|2
2520357|NCT01724528|8724252|P1|Overall Study|Withdrawal by Subject|0
2520358|NCT01724528|8724251|P2|Overall Study|Death|0
2520359|NCT01724528|8724252|P1|Overall Study|Death|3
2520360|NCT01724489|8724268|P2|Overall Study|Withdrawal by Subject|6
2520361|NCT01724489|8724269|P1|Overall Study|Withdrawal by Subject|6
2520362|NCT01724489|8724268|P2|Overall Study|Lost to Follow-up|2
2520363|NCT01724489|8724269|P1|Overall Study|Lost to Follow-up|1
2520364|NCT01724489|8724268|P2|Overall Study|Surgery, medication|1
2520365|NCT01724489|8724269|P1|Overall Study|Surgery, medication|1
2520366|NCT01724489|8724268|P2|Overall Study|Adverse Event|3
2520367|NCT01724489|8724269|P1|Overall Study|Adverse Event|8
2520368|NCT01724359|8724275|P1|Overall Study|Other|20
2520369|NCT01724359|8724275|P1|Overall Study|Death|1
2520370|NCT01724359|8724275|P1|Overall Study|Adverse Event|10
2520371|NCT01724216|8724288|P1|Overall Study|Scan was not completed|1
2520372|NCT01724177|8724292|P1|Overall Study|Serious Adverse Event Related|1
2520373|NCT01724177|8724292|P1|Overall Study|Nervous participant|1
2520374|NCT01724177|8724292|P1|Overall Study|Progressive disease or Relapsed Disease|16
2520375|NCT01724177|8724292|P1|Overall Study|Adverse Event|8
2520376|NCT01724021|8724338|P2|Overall Study|Missing|1
2520377|NCT01724021|8724339|P1|Overall Study|Missing|1
2520378|NCT01724021|8724338|P2|Overall Study|Reason Not Specified|39
2520379|NCT01724021|8724339|P1|Overall Study|Reason Not Specified|36
2520380|NCT01724021|8724338|P2|Overall Study|Lost to Follow-up|15
2520381|NCT01724021|8724339|P1|Overall Study|Lost to Follow-up|15
2520382|NCT01724021|8724338|P2|Overall Study|Participant request/ Withdrew consent|14
2520383|NCT01724021|8724339|P1|Overall Study|Participant request/ Withdrew consent|18
2520384|NCT01724021|8724338|P2|Overall Study|Death|58
2520385|NCT01724021|8724339|P1|Overall Study|Death|46
2520386|NCT01724021|8724338|P2|Overall Study|Adverse Event|6
2520387|NCT01724021|8724339|P1|Overall Study|Adverse Event|11
2520388|NCT01723904|8724371|P1|Overall Study|Unable to follow protocol/ judged by inv|3
2520389|NCT01723904|8724371|P1|Overall Study|Adverse Event|5
2520390|NCT01723904|8724371|P1|Overall Study|Noncompliant|3
2520391|NCT01723826|8724385|P4|Overall Study|Withdrawal by Subject|48
2520392|NCT01723826|8724386|P3|Overall Study|Withdrawal by Subject|27
2520393|NCT01723826|8724387|P2|Overall Study|Withdrawal by Subject|17
2520394|NCT01723826|8724388|P1|Overall Study|Withdrawal by Subject|10
2520395|NCT01723826|8724385|P4|Overall Study|Protocol Violation|1
2520396|NCT01723826|8724386|P3|Overall Study|Protocol Violation|3
2520397|NCT01723826|8724387|P2|Overall Study|Protocol Violation|1
2520398|NCT01723826|8724388|P1|Overall Study|Protocol Violation|1
2520399|NCT01723826|8724385|P4|Overall Study|Physician Decision|11
2520400|NCT01723826|8724386|P3|Overall Study|Physician Decision|4
2520401|NCT01723826|8724387|P2|Overall Study|Physician Decision|3
2520402|NCT01723826|8724388|P1|Overall Study|Physician Decision|1
2520403|NCT01723826|8724385|P4|Overall Study|Other Reason|14
2520404|NCT01723826|8724386|P3|Overall Study|Other Reason|12
2520405|NCT01723826|8724387|P2|Overall Study|Other Reason|6
2520406|NCT01723826|8724388|P1|Overall Study|Other Reason|8
2520407|NCT01723826|8724385|P4|Overall Study|Non-compliance With Study Drug|0
2520408|NCT01723826|8724386|P3|Overall Study|Non-compliance With Study Drug|0
2520409|NCT01723826|8724387|P2|Overall Study|Non-compliance With Study Drug|1
2520410|NCT01723826|8724388|P1|Overall Study|Non-compliance With Study Drug|0
2520411|NCT01723826|8724385|P4|Overall Study|Non-compliance|3
2520412|NCT01723826|8724386|P3|Overall Study|Non-compliance|3
2520413|NCT01723826|8724387|P2|Overall Study|Non-compliance|1
2520414|NCT01723826|8724388|P1|Overall Study|Non-compliance|0
2520415|NCT01723826|8724385|P4|Overall Study|Lost to Follow-up|1
2520416|NCT01723826|8724386|P3|Overall Study|Lost to Follow-up|1
2520417|NCT01723826|8724387|P2|Overall Study|Lost to Follow-up|3
2520418|NCT01723826|8724388|P1|Overall Study|Lost to Follow-up|1
2520419|NCT01723826|8724385|P4|Overall Study|Death according to AE eCRF|7
2520420|NCT01723826|8724386|P3|Overall Study|Death according to AE eCRF|3
2520421|NCT01723826|8724387|P2|Overall Study|Death according to AE eCRF|3
2520422|NCT01723826|8724388|P1|Overall Study|Death according to AE eCRF|2
2520423|NCT01723826|8724385|P4|Overall Study|Adverse Event|5
2520424|NCT01723826|8724386|P3|Overall Study|Adverse Event|4
2520425|NCT01723826|8724387|P2|Overall Study|Adverse Event|1
2520426|NCT01723826|8724388|P1|Overall Study|Adverse Event|4
2520427|NCT01723397|8724533|P2|Study Period 2|Protocol Violation|1
2520428|NCT01723397|8724534|P1|Study Period 2|Protocol Violation|0
2520429|NCT01723397|8724533|P2|Study Period 1|Protocol Violation|1
2520430|NCT01723397|8724534|P1|Study Period 1|Protocol Violation|0
2520431|NCT01723254|8724561|P8|Overall Study|Withdrawal by Subject|2
2520432|NCT01723254|8724562|P7|Overall Study|Withdrawal by Subject|1
2520433|NCT01723254|8724563|P6|Overall Study|Withdrawal by Subject|1
2520434|NCT01723254|8724564|P5|Overall Study|Withdrawal by Subject|1
2520435|NCT01723254|8724565|P4|Overall Study|Withdrawal by Subject|0
2520436|NCT01723254|8724566|P3|Overall Study|Withdrawal by Subject|1
2520437|NCT01723254|8724567|P2|Overall Study|Withdrawal by Subject|2
2520438|NCT01723254|8724568|P1|Overall Study|Withdrawal by Subject|1
2520439|NCT01723254|8724561|P8|Overall Study|Protocol Violation|0
2520440|NCT01723254|8724562|P7|Overall Study|Protocol Violation|0
2520441|NCT01723254|8724563|P6|Overall Study|Protocol Violation|0
2520442|NCT01723254|8724564|P5|Overall Study|Protocol Violation|0
2520443|NCT01723254|8724565|P4|Overall Study|Protocol Violation|0
2520444|NCT01723254|8724566|P3|Overall Study|Protocol Violation|0
2520445|NCT01723254|8724567|P2|Overall Study|Protocol Violation|1
2520446|NCT01723254|8724568|P1|Overall Study|Protocol Violation|0
2520447|NCT01723254|8724561|P8|Overall Study|Move/Left to another country/city|0
2520448|NCT01723254|8724562|P7|Overall Study|Move/Left to another country/city|0
2520449|NCT01723254|8724563|P6|Overall Study|Move/Left to another country/city|0
2520450|NCT01723254|8724564|P5|Overall Study|Move/Left to another country/city|1
2520451|NCT01723254|8724565|P4|Overall Study|Move/Left to another country/city|1
2520452|NCT01723254|8724566|P3|Overall Study|Move/Left to another country/city|2
2520453|NCT01723254|8724567|P2|Overall Study|Move/Left to another country/city|0
2520454|NCT01723254|8724568|P1|Overall Study|Move/Left to another country/city|0
2520455|NCT01723254|8724561|P8|Overall Study|No longer have time to participate|0
2520456|NCT01723254|8724562|P7|Overall Study|No longer have time to participate|0
2520457|NCT01723254|8724563|P6|Overall Study|No longer have time to participate|0
2520458|NCT01723254|8724564|P5|Overall Study|No longer have time to participate|0
2520459|NCT01723254|8724565|P4|Overall Study|No longer have time to participate|1
2520460|NCT01723254|8724566|P3|Overall Study|No longer have time to participate|0
2520461|NCT01723254|8724567|P2|Overall Study|No longer have time to participate|0
2520462|NCT01723254|8724568|P1|Overall Study|No longer have time to participate|0
2520463|NCT01723254|8724561|P8|Overall Study|Personal issues|0
2520464|NCT01723254|8724562|P7|Overall Study|Personal issues|0
2520465|NCT01723254|8724563|P6|Overall Study|Personal issues|1
2520466|NCT01723254|8724564|P5|Overall Study|Personal issues|0
2520467|NCT01723254|8724565|P4|Overall Study|Personal issues|0
2520468|NCT01723254|8724566|P3|Overall Study|Personal issues|0
2520469|NCT01723254|8724567|P2|Overall Study|Personal issues|0
2520470|NCT01723254|8724568|P1|Overall Study|Personal issues|0
2520471|NCT01723254|8724561|P8|Overall Study|Conflict with work schedule|1
2520472|NCT01723254|8724562|P7|Overall Study|Conflict with work schedule|0
2520473|NCT01723254|8724563|P6|Overall Study|Conflict with work schedule|0
2520474|NCT01723254|8724564|P5|Overall Study|Conflict with work schedule|0
2520475|NCT01723254|8724565|P4|Overall Study|Conflict with work schedule|0
2520476|NCT01723254|8724566|P3|Overall Study|Conflict with work schedule|0
2520477|NCT01723254|8724567|P2|Overall Study|Conflict with work schedule|0
2520478|NCT01723254|8724568|P1|Overall Study|Conflict with work schedule|0
2520479|NCT01723228|8724620|P2|Overall Study|Other|1
2520480|NCT01723228|8724621|P1|Overall Study|Other|2
2520481|NCT01723228|8724620|P2|Overall Study|Lost to Follow-up|1
2520482|NCT01723228|8724621|P1|Overall Study|Lost to Follow-up|2
2520483|NCT01723228|8724620|P2|Overall Study|Protocol Violation|2
2520484|NCT01723228|8724621|P1|Overall Study|Protocol Violation|0
2520485|NCT01723228|8724620|P2|Overall Study|Withdrawal by Subject|1
2520486|NCT01723228|8724621|P1|Overall Study|Withdrawal by Subject|2
2520487|NCT01723228|8724620|P2|Overall Study|Adverse Event|6
2520488|NCT01723228|8724621|P1|Overall Study|Adverse Event|2
2520489|NCT01723163|8724639|P2|12-Month Follow-up|Unable to Contact|28
2520490|NCT01723163|8724640|P1|12-Month Follow-up|Unable to Contact|23
2520491|NCT01723163|8724639|P2|12-Month Follow-up|Death|0
2520492|NCT01723163|8724640|P1|12-Month Follow-up|Death|1
2520493|NCT01723163|8724639|P2|6-Month Follow-up|Unable to Contact|15
2520494|NCT01723163|8724640|P1|6-Month Follow-up|Unable to Contact|17
2520495|NCT01723163|8724639|P2|6-Month Follow-up|Death|0
2520496|NCT01723163|8724640|P1|6-Month Follow-up|Death|1
2520497|NCT01723163|8724639|P2|3-Month Follow-up|Unable to Contact|19
2520498|NCT01723163|8724640|P1|3-Month Follow-up|Unable to Contact|12
2520499|NCT01723163|8724639|P2|3-Month Follow-up|Withdrawal by Subject|0
2520500|NCT01723163|8724640|P1|3-Month Follow-up|Withdrawal by Subject|1
2520501|NCT01723163|8724639|P2|Treatment Phase|Withdrawal by PI|1
2520502|NCT01723163|8724640|P1|Treatment Phase|Withdrawal by PI|5
2520503|NCT01723163|8724639|P2|Treatment Phase|Withdrawal by Subject|6
2520504|NCT01723163|8724640|P1|Treatment Phase|Withdrawal by Subject|14
2520505|NCT01722994|8724648|P2|Overall Study|Missing data|17
2520506|NCT01722994|8724649|P1|Overall Study|Missing data|25
2520507|NCT01722877|8724668|P1|Overall Study|Lost to Follow-up|1
2520508|NCT01722877|8724668|P1|Overall Study|Death|1
2520509|NCT01722331|8724739|P7|Part 3|Other Protocol Specified Criteria|0
2520510|NCT01722331|8724740|P6|Part 3|Other Protocol Specified Criteria|0
2520511|NCT01722331|8724741|P5|Part 3|Other Protocol Specified Criteria|0
2520512|NCT01722331|8724742|P4|Part 3|Other Protocol Specified Criteria|0
2520513|NCT01722331|8724743|P3|Part 3|Other Protocol Specified Criteria|0
2520514|NCT01722331|8724744|P2|Part 3|Other Protocol Specified Criteria|1
2520515|NCT01722331|8724745|P1|Part 3|Other Protocol Specified Criteria|1
2520516|NCT01722331|8724739|P7|Part 3|Withdrawal by Subject|1
2520517|NCT01722331|8724740|P6|Part 3|Withdrawal by Subject|2
2520518|NCT01722331|8724741|P5|Part 3|Withdrawal by Subject|0
2520519|NCT01722331|8724742|P4|Part 3|Withdrawal by Subject|0
2520520|NCT01722331|8724743|P3|Part 3|Withdrawal by Subject|0
2520521|NCT01722331|8724744|P2|Part 3|Withdrawal by Subject|7
2520522|NCT01722331|8724745|P1|Part 3|Withdrawal by Subject|4
2520523|NCT01722331|8724739|P7|Part 3|Protocol Violation|0
2520524|NCT01722331|8724740|P6|Part 3|Protocol Violation|0
2520525|NCT01722331|8724741|P5|Part 3|Protocol Violation|0
2520526|NCT01722331|8724742|P4|Part 3|Protocol Violation|0
2520527|NCT01722331|8724743|P3|Part 3|Protocol Violation|0
2520528|NCT01722331|8724744|P2|Part 3|Protocol Violation|1
2520529|NCT01722331|8724745|P1|Part 3|Protocol Violation|2
2520530|NCT01722331|8724739|P7|Part 3|Physician Decision|1
2520531|NCT01722331|8724740|P6|Part 3|Physician Decision|0
2520532|NCT01722331|8724741|P5|Part 3|Physician Decision|0
2520533|NCT01722331|8724742|P4|Part 3|Physician Decision|0
2520534|NCT01722331|8724743|P3|Part 3|Physician Decision|0
2520535|NCT01722331|8724744|P2|Part 3|Physician Decision|1
2520536|NCT01722331|8724745|P1|Part 3|Physician Decision|1
2520537|NCT01722331|8724739|P7|Part 3|Non-Compliance with Study Drug|0
2520538|NCT01722331|8724740|P6|Part 3|Non-Compliance with Study Drug|0
2520539|NCT01722331|8724741|P5|Part 3|Non-Compliance with Study Drug|0
2520540|NCT01722331|8724742|P4|Part 3|Non-Compliance with Study Drug|0
2520541|NCT01722331|8724743|P3|Part 3|Non-Compliance with Study Drug|0
2520542|NCT01722331|8724744|P2|Part 3|Non-Compliance with Study Drug|1
2520543|NCT01722331|8724745|P1|Part 3|Non-Compliance with Study Drug|0
2520544|NCT01722331|8724739|P7|Part 3|Lost to Follow-up|0
2520545|NCT01722331|8724740|P6|Part 3|Lost to Follow-up|1
2520546|NCT01722331|8724741|P5|Part 3|Lost to Follow-up|0
2520547|NCT01722331|8724742|P4|Part 3|Lost to Follow-up|0
2520548|NCT01722331|8724743|P3|Part 3|Lost to Follow-up|0
2520549|NCT01722331|8724744|P2|Part 3|Lost to Follow-up|4
2520550|NCT01722331|8724745|P1|Part 3|Lost to Follow-up|3
2520551|NCT01722331|8724739|P7|Part 3|Lack of Efficacy|0
2520552|NCT01722331|8724740|P6|Part 3|Lack of Efficacy|0
2520553|NCT01722331|8724741|P5|Part 3|Lack of Efficacy|0
2520554|NCT01722331|8724742|P4|Part 3|Lack of Efficacy|0
2520555|NCT01722331|8724743|P3|Part 3|Lack of Efficacy|0
2520556|NCT01722331|8724744|P2|Part 3|Lack of Efficacy|0
2520557|NCT01722331|8724745|P1|Part 3|Lack of Efficacy|1
2520558|NCT01722331|8724739|P7|Part 3|Death|0
2520559|NCT01722331|8724740|P6|Part 3|Death|0
2520560|NCT01722331|8724741|P5|Part 3|Death|0
2520561|NCT01722331|8724742|P4|Part 3|Death|0
2520562|NCT01722331|8724743|P3|Part 3|Death|0
2520563|NCT01722331|8724744|P2|Part 3|Death|0
2520564|NCT01722331|8724745|P1|Part 3|Death|1
2520565|NCT01722331|8724739|P7|Part 3|Adverse Event|0
2520566|NCT01722331|8724740|P6|Part 3|Adverse Event|0
2520567|NCT01722331|8724741|P5|Part 3|Adverse Event|0
2520568|NCT01722331|8724742|P4|Part 3|Adverse Event|1
2520569|NCT01722331|8724743|P3|Part 3|Adverse Event|0
2520570|NCT01722331|8724744|P2|Part 3|Adverse Event|2
2520571|NCT01722331|8724745|P1|Part 3|Adverse Event|2
2520572|NCT01722331|8724739|P7|Part 2|Other Protocol Specified Criteria|1
2520573|NCT01722331|8724740|P6|Part 2|Other Protocol Specified Criteria|2
2520574|NCT01722331|8724741|P5|Part 2|Other Protocol Specified Criteria|0
2520575|NCT01722331|8724742|P4|Part 2|Other Protocol Specified Criteria|0
2520576|NCT01722331|8724743|P3|Part 2|Other Protocol Specified Criteria|10
2520577|NCT01722331|8724744|P2|Part 2|Other Protocol Specified Criteria|0
2520578|NCT01722331|8724745|P1|Part 2|Other Protocol Specified Criteria|6
2520579|NCT01722331|8724739|P7|Part 2|Withdrawal by Subject|2
2520580|NCT01722331|8724740|P6|Part 2|Withdrawal by Subject|2
2520581|NCT01722331|8724741|P5|Part 2|Withdrawal by Subject|0
2520582|NCT01722331|8724742|P4|Part 2|Withdrawal by Subject|0
2520583|NCT01722331|8724743|P3|Part 2|Withdrawal by Subject|3
2520584|NCT01722331|8724744|P2|Part 2|Withdrawal by Subject|0
2520585|NCT01722331|8724745|P1|Part 2|Withdrawal by Subject|5
2520586|NCT01722331|8724739|P7|Part 2|Protocol Violation|0
2520587|NCT01722331|8724740|P6|Part 2|Protocol Violation|0
2520588|NCT01722331|8724741|P5|Part 2|Protocol Violation|0
2520589|NCT01722331|8724742|P4|Part 2|Protocol Violation|0
2520590|NCT01722331|8724743|P3|Part 2|Protocol Violation|0
2520591|NCT01722331|8724744|P2|Part 2|Protocol Violation|0
2520592|NCT01722331|8724745|P1|Part 2|Protocol Violation|1
2520593|NCT01722331|8724739|P7|Part 2|Progressive Disease|0
2520594|NCT01722331|8724740|P6|Part 2|Progressive Disease|0
2520595|NCT01722331|8724741|P5|Part 2|Progressive Disease|0
2520596|NCT01722331|8724742|P4|Part 2|Progressive Disease|0
2520597|NCT01722331|8724743|P3|Part 2|Progressive Disease|1
2520598|NCT01722331|8724744|P2|Part 2|Progressive Disease|0
2520599|NCT01722331|8724745|P1|Part 2|Progressive Disease|0
2520600|NCT01722331|8724739|P7|Part 2|Pregnancy|0
2520601|NCT01722331|8724740|P6|Part 2|Pregnancy|1
2520602|NCT01722331|8724741|P5|Part 2|Pregnancy|0
2520603|NCT01722331|8724742|P4|Part 2|Pregnancy|0
2520604|NCT01722331|8724743|P3|Part 2|Pregnancy|0
2520605|NCT01722331|8724744|P2|Part 2|Pregnancy|0
2520606|NCT01722331|8724745|P1|Part 2|Pregnancy|0
2520607|NCT01722331|8724739|P7|Part 2|Physician Decision|0
2520608|NCT01722331|8724740|P6|Part 2|Physician Decision|0
2520609|NCT01722331|8724741|P5|Part 2|Physician Decision|0
2520610|NCT01722331|8724742|P4|Part 2|Physician Decision|0
2520611|NCT01722331|8724743|P3|Part 2|Physician Decision|2
2520612|NCT01722331|8724744|P2|Part 2|Physician Decision|0
2520613|NCT01722331|8724745|P1|Part 2|Physician Decision|0
2520614|NCT01722331|8724739|P7|Part 2|Non-Compliance with Study Drug|0
2520615|NCT01722331|8724740|P6|Part 2|Non-Compliance with Study Drug|0
2520616|NCT01722331|8724741|P5|Part 2|Non-Compliance with Study Drug|0
2520617|NCT01722331|8724742|P4|Part 2|Non-Compliance with Study Drug|0
2520618|NCT01722331|8724743|P3|Part 2|Non-Compliance with Study Drug|1
2520619|NCT01722331|8724744|P2|Part 2|Non-Compliance with Study Drug|0
2520620|NCT01722331|8724745|P1|Part 2|Non-Compliance with Study Drug|1
2520621|NCT01722331|8724739|P7|Part 2|Lost to Follow-up|1
2520622|NCT01722331|8724740|P6|Part 2|Lost to Follow-up|1
2520623|NCT01722331|8724741|P5|Part 2|Lost to Follow-up|0
2520624|NCT01722331|8724742|P4|Part 2|Lost to Follow-up|0
2520625|NCT01722331|8724743|P3|Part 2|Lost to Follow-up|3
2520626|NCT01722331|8724744|P2|Part 2|Lost to Follow-up|0
2520627|NCT01722331|8724745|P1|Part 2|Lost to Follow-up|0
2520628|NCT01722331|8724739|P7|Part 2|Lack of Efficacy|3
2520629|NCT01722331|8724740|P6|Part 2|Lack of Efficacy|3
2520630|NCT01722331|8724741|P5|Part 2|Lack of Efficacy|0
2520631|NCT01722331|8724742|P4|Part 2|Lack of Efficacy|0
2520632|NCT01722331|8724743|P3|Part 2|Lack of Efficacy|11
2520633|NCT01722331|8724744|P2|Part 2|Lack of Efficacy|0
2520634|NCT01722331|8724745|P1|Part 2|Lack of Efficacy|3
2520635|NCT01722331|8724739|P7|Part 2|Adverse Event|0
2520636|NCT01722331|8724740|P6|Part 2|Adverse Event|1
2520637|NCT01722331|8724741|P5|Part 2|Adverse Event|0
2520638|NCT01722331|8724742|P4|Part 2|Adverse Event|0
2520639|NCT01722331|8724743|P3|Part 2|Adverse Event|0
2520640|NCT01722331|8724744|P2|Part 2|Adverse Event|0
2520641|NCT01722331|8724745|P1|Part 2|Adverse Event|3
2520642|NCT01722331|8724739|P7|Part 1|Withdrawal by Subject|0
2520643|NCT01722331|8724740|P6|Part 1|Withdrawal by Subject|0
2520644|NCT01722331|8724741|P5|Part 1|Withdrawal by Subject|3
2520645|NCT01722331|8724742|P4|Part 1|Withdrawal by Subject|0
2520646|NCT01722331|8724743|P3|Part 1|Withdrawal by Subject|3
2520647|NCT01722331|8724744|P2|Part 1|Withdrawal by Subject|0
2520648|NCT01722331|8724745|P1|Part 1|Withdrawal by Subject|2
2520649|NCT01722331|8724739|P7|Part 1|Protocol Violation|0
2520650|NCT01722331|8724740|P6|Part 1|Protocol Violation|0
2520651|NCT01722331|8724741|P5|Part 1|Protocol Violation|1
2520652|NCT01722331|8724742|P4|Part 1|Protocol Violation|0
2520653|NCT01722331|8724743|P3|Part 1|Protocol Violation|0
2520654|NCT01722331|8724744|P2|Part 1|Protocol Violation|0
2520655|NCT01722331|8724745|P1|Part 1|Protocol Violation|1
2520656|NCT01722331|8724739|P7|Part 1|Progressive Disease|0
2520657|NCT01722331|8724740|P6|Part 1|Progressive Disease|0
2520658|NCT01722331|8724741|P5|Part 1|Progressive Disease|1
2520659|NCT01722331|8724742|P4|Part 1|Progressive Disease|0
2520660|NCT01722331|8724743|P3|Part 1|Progressive Disease|0
2520661|NCT01722331|8724744|P2|Part 1|Progressive Disease|0
2520662|NCT01722331|8724745|P1|Part 1|Progressive Disease|0
2520663|NCT01722331|8724739|P7|Part 1|Pregnancy|0
2520664|NCT01722331|8724740|P6|Part 1|Pregnancy|0
2520665|NCT01722331|8724741|P5|Part 1|Pregnancy|0
2520666|NCT01722331|8724742|P4|Part 1|Pregnancy|0
2520667|NCT01722331|8724743|P3|Part 1|Pregnancy|0
2520668|NCT01722331|8724744|P2|Part 1|Pregnancy|0
2520669|NCT01722331|8724745|P1|Part 1|Pregnancy|1
2520670|NCT01722331|8724739|P7|Part 1|Physician Decision|0
2520671|NCT01722331|8724740|P6|Part 1|Physician Decision|0
2520672|NCT01722331|8724741|P5|Part 1|Physician Decision|1
2520673|NCT01722331|8724742|P4|Part 1|Physician Decision|0
2520674|NCT01722331|8724743|P3|Part 1|Physician Decision|3
2520675|NCT01722331|8724744|P2|Part 1|Physician Decision|0
2520676|NCT01722331|8724745|P1|Part 1|Physician Decision|0
2520677|NCT01722331|8724739|P7|Part 1|Lost to Follow-up|0
2520678|NCT01722331|8724740|P6|Part 1|Lost to Follow-up|0
2520679|NCT01722331|8724741|P5|Part 1|Lost to Follow-up|1
2520680|NCT01722331|8724742|P4|Part 1|Lost to Follow-up|0
2520681|NCT01722331|8724743|P3|Part 1|Lost to Follow-up|2
2520682|NCT01722331|8724744|P2|Part 1|Lost to Follow-up|0
2520683|NCT01722331|8724745|P1|Part 1|Lost to Follow-up|1
2520684|NCT01722331|8724739|P7|Part 1|Lack of Efficacy|0
2520685|NCT01722331|8724740|P6|Part 1|Lack of Efficacy|0
2520686|NCT01722331|8724741|P5|Part 1|Lack of Efficacy|2
2520687|NCT01722331|8724742|P4|Part 1|Lack of Efficacy|0
2520688|NCT01722331|8724743|P3|Part 1|Lack of Efficacy|1
2520689|NCT01722331|8724744|P2|Part 1|Lack of Efficacy|0
2520690|NCT01722331|8724745|P1|Part 1|Lack of Efficacy|0
2520691|NCT01722331|8724739|P7|Part 1|Adverse Event|0
2520692|NCT01722331|8724740|P6|Part 1|Adverse Event|0
2520693|NCT01722331|8724741|P5|Part 1|Adverse Event|0
2520694|NCT01722331|8724742|P4|Part 1|Adverse Event|0
2520695|NCT01722331|8724743|P3|Part 1|Adverse Event|0
2520696|NCT01722331|8724744|P2|Part 1|Adverse Event|0
2520697|NCT01722331|8724745|P1|Part 1|Adverse Event|5
2520698|NCT01722266|8724861|P4|Overall Study|Dropped out due to Nausea|0
2520699|NCT01722266|8724862|P3|Overall Study|Dropped out due to Nausea|2
2520700|NCT01722266|8724863|P2|Overall Study|Dropped out due to Nausea|0
2520701|NCT01722266|8724864|P1|Overall Study|Dropped out due to Nausea|0
2520702|NCT01722266|8724861|P4|Overall Study|Tolerated only 0.6 mg liraglutide|0
2520703|NCT01722266|8724862|P3|Overall Study|Tolerated only 0.6 mg liraglutide|3
2520704|NCT01722266|8724863|P2|Overall Study|Tolerated only 0.6 mg liraglutide|1
2520705|NCT01722266|8724864|P1|Overall Study|Tolerated only 0.6 mg liraglutide|0
2520706|NCT01722266|8724861|P4|Overall Study|Withdrawal by Subject|0
2520707|NCT01722266|8724862|P3|Overall Study|Withdrawal by Subject|0
2520708|NCT01722266|8724863|P2|Overall Study|Withdrawal by Subject|2
2520709|NCT01722266|8724864|P1|Overall Study|Withdrawal by Subject|1
2520710|NCT01722162|8724892|P2|Overall Study|Noncompliance|1
2520711|NCT01722162|8724893|P1|Overall Study|Noncompliance|0
2520712|NCT01722162|8724892|P2|Overall Study|Insurance denial post enrollment|1
2520713|NCT01722162|8724893|P1|Overall Study|Insurance denial post enrollment|0
2520714|NCT01722162|8724892|P2|Overall Study|Adverse Event|1
2520715|NCT01722162|8724893|P1|Overall Study|Adverse Event|1
2520716|NCT01722162|8724892|P2|Overall Study|Unrelated to study adverse event|2
2520717|NCT01722162|8724893|P1|Overall Study|Unrelated to study adverse event|2
2520718|NCT01722162|8724892|P2|Overall Study|Found ineligible|0
2520719|NCT01722162|8724893|P1|Overall Study|Found ineligible|1
2520720|NCT01722162|8724892|P2|Overall Study|Withdrawal by Subject|1
2520721|NCT01722162|8724893|P1|Overall Study|Withdrawal by Subject|1
2520722|NCT01722097|8724903|P2|Overall Study|Patient sheets not returned|5
2520723|NCT01722097|8724904|P1|Overall Study|Patient sheets not returned|6
2520724|NCT01722071|8724912|P2|Overall Study|Protocol Violation|0
2520725|NCT01722071|8724913|P1|Overall Study|Protocol Violation|1
2520726|NCT01722045|8724919|P1|Overall Study|Relocation (did not wish to transfer)|1
2520727|NCT01722045|8724919|P1|Overall Study|Physician Decision|3
2520728|NCT01722045|8724919|P1|Overall Study|Protocol Deviation|1
2520729|NCT01722045|8724919|P1|Overall Study|Lost to Follow-up|4
2520730|NCT01722045|8724919|P1|Overall Study|Withdrawal by Subject|8
2520731|NCT01722045|8724919|P1|Overall Study|Death|3
2520732|NCT01722045|8724919|P1|Overall Study|Adverse Event|8
2520733|NCT01721954|8724940|P2|Overall Study|Lost to Follow-up|1
2520734|NCT01721954|8724941|P1|Overall Study|Lost to Follow-up|2
2520735|NCT01721954|8724940|P2|Overall Study|Adverse Event|0
2520736|NCT01721954|8724941|P1|Overall Study|Adverse Event|2
2520737|NCT01721954|8724940|P2|Overall Study|Withdrawal by Subject|4
2520738|NCT01721954|8724941|P1|Overall Study|Withdrawal by Subject|8
2520739|NCT01721954|8724940|P2|Overall Study|Death|64
2520740|NCT01721954|8724941|P1|Overall Study|Death|58
2520741|NCT01721772|8724955|P2|Overall Study|Other|1
2520742|NCT01721772|8724956|P1|Overall Study|Other|0
2520743|NCT01721772|8724955|P2|Overall Study|Maximum clinical benefit|1
2520744|NCT01721772|8724956|P1|Overall Study|Maximum clinical benefit|1
2520745|NCT01721772|8724955|P2|Overall Study|Withdrawal by Subject|5
2520746|NCT01721772|8724956|P1|Overall Study|Withdrawal by Subject|7
2520747|NCT01721772|8724955|P2|Overall Study|Unrelated adverse event|3
2520748|NCT01721772|8724956|P1|Overall Study|Unrelated adverse event|2
2520749|NCT01721772|8724955|P2|Overall Study|Study drug toxicity|7
2520750|NCT01721772|8724956|P1|Overall Study|Study drug toxicity|5
2520751|NCT01721772|8724955|P2|Overall Study|Disease progression|175
2520752|NCT01721772|8724956|P1|Overall Study|Disease progression|96
2520753|NCT01721759|8724976|P1|Overall Study|Withdrawal by Subject|1
2520754|NCT01721759|8724976|P1|Overall Study|Adverse event unrelated to study drug|9
2520755|NCT01721759|8724976|P1|Overall Study|Study drug toxicity|14
2520756|NCT01721759|8724976|P1|Overall Study|Disease progression|78
2520757|NCT01721746|8724984|P3|Treatment Period|Other|1
2520758|NCT01721746|8724985|P2|Treatment Period|Other|1
2520759|NCT01721746|8724986|P1|Treatment Period|Other|2
2520760|NCT01721746|8724984|P3|Treatment Period|Subject No Longer Met Study Criteria|0
2520761|NCT01721746|8724985|P2|Treatment Period|Subject No Longer Met Study Criteria|0
2520762|NCT01721746|8724986|P1|Treatment Period|Subject No Longer Met Study Criteria|4
2520763|NCT01721746|8724984|P3|Treatment Period|Poor/Non-compliance|0
2520764|NCT01721746|8724985|P2|Treatment Period|Poor/Non-compliance|0
2520765|NCT01721746|8724986|P1|Treatment Period|Poor/Non-compliance|1
2520766|NCT01721746|8724984|P3|Treatment Period|Maximum Clinical Benefit|3
2520767|NCT01721746|8724985|P2|Treatment Period|Maximum Clinical Benefit|0
2520768|NCT01721746|8724986|P1|Treatment Period|Maximum Clinical Benefit|1
2520769|NCT01721746|8724984|P3|Treatment Period|Subject Withdrew Consent|2
2520770|NCT01721746|8724985|P2|Treatment Period|Subject Withdrew Consent|0
2520771|NCT01721746|8724986|P1|Treatment Period|Subject Withdrew Consent|3
2520772|NCT01721746|8724984|P3|Treatment Period|Subject Request to Discontinue Treatment|6
2520773|NCT01721746|8724985|P2|Treatment Period|Subject Request to Discontinue Treatment|1
2520774|NCT01721746|8724986|P1|Treatment Period|Subject Request to Discontinue Treatment|19
2520775|NCT01721746|8724984|P3|Treatment Period|Adverse Event Unrelated to Study Drug|2
2520776|NCT01721746|8724985|P2|Treatment Period|Adverse Event Unrelated to Study Drug|1
2520777|NCT01721746|8724986|P1|Treatment Period|Adverse Event Unrelated to Study Drug|6
2520778|NCT01721746|8724984|P3|Treatment Period|Study Drug Toxicity|9
2520779|NCT01721746|8724985|P2|Treatment Period|Study Drug Toxicity|2
2520780|NCT01721746|8724986|P1|Treatment Period|Study Drug Toxicity|15
2520781|NCT01721746|8724984|P3|Treatment Period|Disease Progression|34
2520782|NCT01721746|8724985|P2|Treatment Period|Disease Progression|40
2520783|NCT01721746|8724986|P1|Treatment Period|Disease Progression|182
2520784|NCT01721486|8725026|P2|Overall Study|Physician Decision|1
2520785|NCT01721486|8725027|P1|Overall Study|Physician Decision|0
2520786|NCT01721486|8725026|P2|Overall Study|Protocol Violation|0
2520787|NCT01721486|8725027|P1|Overall Study|Protocol Violation|1
2520788|NCT01721408|8725075|P2|Overall Study|Does not meet entrance criteria|0
2520789|NCT01721408|8725076|P1|Overall Study|Does not meet entrance criteria|1
2520790|NCT01721408|8725075|P2|Overall Study|Lost to Follow-up|2
2520791|NCT01721408|8725076|P1|Overall Study|Lost to Follow-up|1
2520792|NCT01721408|8725075|P2|Overall Study|Other|3
2520793|NCT01721408|8725076|P1|Overall Study|Other|3
2520794|NCT01721408|8725075|P2|Overall Study|Protocol Violation|2
2520795|NCT01721408|8725076|P1|Overall Study|Protocol Violation|0
2520796|NCT01721408|8725075|P2|Overall Study|No longer willing to participate study|10
2520797|NCT01721408|8725076|P1|Overall Study|No longer willing to participate study|9
2520798|NCT01721408|8725075|P2|Overall Study|Insufficient clinical response|6
2520799|NCT01721408|8725076|P1|Overall Study|Insufficient clinical response|15
2520800|NCT01721408|8725075|P2|Overall Study|Death|0
2520801|NCT01721408|8725076|P1|Overall Study|Death|1
2520802|NCT01721408|8725075|P2|Overall Study|Adverse Event|1
2520803|NCT01721408|8725076|P1|Overall Study|Adverse Event|6
2520804|NCT01721330|8725092|P2|Overall Study|Withdrawal by Subject|1
2520805|NCT01721330|8725093|P1|Overall Study|Withdrawal by Subject|0
2520806|NCT01721317|8725101|P2|Overall Study|Withdrawal by Subject|1
2520807|NCT01721317|8725102|P1|Overall Study|Withdrawal by Subject|0
2520808|NCT01721317|8725101|P2|Overall Study|Physician Decision|1
2520809|NCT01721317|8725102|P1|Overall Study|Physician Decision|0
2520810|NCT01721317|8725101|P2|Overall Study|Study Closed / Terminated|2
2520811|NCT01721317|8725102|P1|Overall Study|Study Closed / Terminated|2
2520812|NCT01721200|8725181|P2|Overall Study|Lost to Follow-up|5
2520813|NCT01721200|8725182|P1|Overall Study|Lost to Follow-up|3
2520814|NCT01721161|8725207|P2|Overall Study|Other|1
2520815|NCT01721161|8725208|P1|Overall Study|Other|0
2520816|NCT01721161|8725207|P2|Overall Study|Withdrawal by Subject|1
2520817|NCT01721161|8725208|P1|Overall Study|Withdrawal by Subject|1
2520818|NCT01721161|8725207|P2|Overall Study|Lost to Follow-up|2
2520819|NCT01721161|8725208|P1|Overall Study|Lost to Follow-up|1
2520820|NCT01721161|8725207|P2|Overall Study|Adverse Event|3
2520821|NCT01721161|8725208|P1|Overall Study|Adverse Event|2
2520822|NCT01721109|8725231|P1|Overall Study|Lost to Follow-up|2
2520823|NCT01721109|8725231|P1|Overall Study|Withdrew Consent|1
2520824|NCT01721109|8725231|P1|Overall Study|Non- Compliance with Study Drug|3
2520825|NCT01721109|8725231|P1|Overall Study|Lack of Efficacy|1
2520826|NCT01721070|8725426|P1|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1
2520827|NCT01721057|8725437|P7|Rescue Period|Lack of Efficacy|0
2520828|NCT01721057|8725438|P6|Rescue Period|Lack of Efficacy|0
2520829|NCT01721057|8725439|P5|Rescue Period|Lack of Efficacy|0
2520830|NCT01721057|8725440|P4|Rescue Period|Lack of Efficacy|2
2520831|NCT01721057|8725441|P3|Rescue Period|Lack of Efficacy|0
2520832|NCT01721057|8725442|P2|Rescue Period|Lack of Efficacy|0
2520833|NCT01721057|8725443|P1|Rescue Period|Lack of Efficacy|0
2520834|NCT01721057|8725437|P7|Rescue Period|Adverse Event|0
2520835|NCT01721057|8725438|P6|Rescue Period|Adverse Event|0
2520836|NCT01721057|8725439|P5|Rescue Period|Adverse Event|0
2520837|NCT01721057|8725440|P4|Rescue Period|Adverse Event|1
2520838|NCT01721057|8725441|P3|Rescue Period|Adverse Event|0
2520839|NCT01721057|8725442|P2|Rescue Period|Adverse Event|0
2520840|NCT01721057|8725443|P1|Rescue Period|Adverse Event|0
2520841|NCT01721057|8725437|P7|Treatment Period|Death|0
2520842|NCT01721057|8725438|P6|Treatment Period|Death|0
2520843|NCT01721057|8725439|P5|Treatment Period|Death|0
2520844|NCT01721057|8725440|P4|Treatment Period|Death|0
2520845|NCT01721057|8725441|P3|Treatment Period|Death|0
2520846|NCT01721057|8725442|P2|Treatment Period|Death|0
2520847|NCT01721057|8725443|P1|Treatment Period|Death|2
2520848|NCT01721057|8725437|P7|Treatment Period|Physician Decision|0
2520849|NCT01721057|8725438|P6|Treatment Period|Physician Decision|0
2520850|NCT01721057|8725439|P5|Treatment Period|Physician Decision|0
2520851|NCT01721057|8725440|P4|Treatment Period|Physician Decision|0
2520852|NCT01721057|8725441|P3|Treatment Period|Physician Decision|3
2520853|NCT01721057|8725442|P2|Treatment Period|Physician Decision|1
2520854|NCT01721057|8725443|P1|Treatment Period|Physician Decision|0
2520855|NCT01721057|8725437|P7|Treatment Period|Lost to Follow-up|0
2520856|NCT01721057|8725438|P6|Treatment Period|Lost to Follow-up|0
2520857|NCT01721057|8725439|P5|Treatment Period|Lost to Follow-up|0
2520858|NCT01721057|8725440|P4|Treatment Period|Lost to Follow-up|0
2520859|NCT01721057|8725441|P3|Treatment Period|Lost to Follow-up|0
2520860|NCT01721057|8725442|P2|Treatment Period|Lost to Follow-up|0
2520861|NCT01721057|8725443|P1|Treatment Period|Lost to Follow-up|1
2520862|NCT01721057|8725437|P7|Treatment Period|Lack of Efficacy|0
2520863|NCT01721057|8725438|P6|Treatment Period|Lack of Efficacy|0
2520864|NCT01721057|8725439|P5|Treatment Period|Lack of Efficacy|0
2520865|NCT01721057|8725440|P4|Treatment Period|Lack of Efficacy|0
2520866|NCT01721057|8725441|P3|Treatment Period|Lack of Efficacy|0
2520867|NCT01721057|8725442|P2|Treatment Period|Lack of Efficacy|3
2520868|NCT01721057|8725443|P1|Treatment Period|Lack of Efficacy|7
2520869|NCT01721057|8725437|P7|Treatment Period|Adverse Event|0
2520870|NCT01721057|8725438|P6|Treatment Period|Adverse Event|0
2520871|NCT01721057|8725439|P5|Treatment Period|Adverse Event|0
2520872|NCT01721057|8725440|P4|Treatment Period|Adverse Event|0
2520873|NCT01721057|8725441|P3|Treatment Period|Adverse Event|12
2520874|NCT01721057|8725442|P2|Treatment Period|Adverse Event|10
2520875|NCT01721057|8725443|P1|Treatment Period|Adverse Event|7
2520876|NCT01721057|8725437|P7|Treatment Period|Withdrawal by Subject|0
2520877|NCT01721057|8725438|P6|Treatment Period|Withdrawal by Subject|0
2520878|NCT01721057|8725439|P5|Treatment Period|Withdrawal by Subject|0
2520879|NCT01721057|8725440|P4|Treatment Period|Withdrawal by Subject|0
2520880|NCT01721057|8725441|P3|Treatment Period|Withdrawal by Subject|8
2520881|NCT01721057|8725442|P2|Treatment Period|Withdrawal by Subject|5
2520882|NCT01721057|8725443|P1|Treatment Period|Withdrawal by Subject|11
2520883|NCT01721044|8725516|P3|Treatment Period|Withdrawal by Subject|1
2520884|NCT01721044|8725517|P2|Treatment Period|Withdrawal by Subject|6
2520885|NCT01721044|8725518|P1|Treatment Period|Withdrawal by Subject|7
2520886|NCT01721044|8725516|P3|Treatment Period|Protocol Violation|0
2520887|NCT01721044|8725517|P2|Treatment Period|Protocol Violation|0
2520888|NCT01721044|8725518|P1|Treatment Period|Protocol Violation|1
2520889|NCT01721044|8725516|P3|Treatment Period|Physician Decision|2
2520890|NCT01721044|8725517|P2|Treatment Period|Physician Decision|0
2520891|NCT01721044|8725518|P1|Treatment Period|Physician Decision|1
2520892|NCT01721044|8725516|P3|Treatment Period|Lost to Follow-up|1
2520893|NCT01721044|8725517|P2|Treatment Period|Lost to Follow-up|0
2520894|NCT01721044|8725518|P1|Treatment Period|Lost to Follow-up|0
2520895|NCT01721044|8725516|P3|Treatment Period|Lack of Efficacy|4
2520896|NCT01721044|8725517|P2|Treatment Period|Lack of Efficacy|4
2520897|NCT01721044|8725518|P1|Treatment Period|Lack of Efficacy|16
2520898|NCT01721044|8725516|P3|Treatment Period|Death|1
2520899|NCT01721044|8725517|P2|Treatment Period|Death|0
2520900|NCT01721044|8725518|P1|Treatment Period|Death|0
2520901|NCT01721044|8725516|P3|Treatment Period|Adverse Event|10
2520902|NCT01721044|8725517|P2|Treatment Period|Adverse Event|7
2520903|NCT01721044|8725518|P1|Treatment Period|Adverse Event|7
2520904|NCT01720797|8725591|P2|Overall Study|Withdrawal by Subject|0
2520905|NCT01720797|8725592|P1|Overall Study|Withdrawal by Subject|3
2520906|NCT01720667|8725600|P2|Overall Study|Withdrawal by Subject|0
2520907|NCT01720667|8725601|P1|Overall Study|Withdrawal by Subject|3
2520908|NCT01720667|8725600|P2|Overall Study|Adverse Event|1
2520909|NCT01720667|8725601|P1|Overall Study|Adverse Event|1
2520910|NCT01720602|8725615|P1|Overall Study|Progressive disease on therapy|2
2520911|NCT01720602|8725615|P1|Overall Study|Adverse Event|3
2520912|NCT01720524|8725625|P2|Part B|Death|2
2520913|NCT01720524|8725626|P1|Part B|Death|0
2520914|NCT01720524|8725625|P2|Part B|Lost to Follow-up|3
2520915|NCT01720524|8725626|P1|Part B|Lost to Follow-up|1
2520916|NCT01720524|8725625|P2|Part B|Other|0
2520917|NCT01720524|8725626|P1|Part B|Other|2
2520918|NCT01720524|8725625|P2|Part B|Withdrawal by Subject|4
2520919|NCT01720524|8725626|P1|Part B|Withdrawal by Subject|1
2520920|NCT01720524|8725625|P2|Part B|Ongoing|5
2520921|NCT01720524|8725626|P1|Part B|Ongoing|3
2520922|NCT01720524|8725625|P2|Part A|Lost to Follow-up|1
2520923|NCT01720524|8725626|P1|Part A|Lost to Follow-up|0
2520924|NCT01720524|8725625|P2|Part A|Other|1
2520925|NCT01720524|8725626|P1|Part A|Other|0
2520926|NCT01720524|8725625|P2|Part A|Withdrawal by Subject|1
2520927|NCT01720524|8725626|P1|Part A|Withdrawal by Subject|0
2520928|NCT01720524|8725625|P2|Part A|Missed 28 day follow-up visit|1
2520929|NCT01720524|8725626|P1|Part A|Missed 28 day follow-up visit|1
2520930|NCT01720524|8725625|P2|Part A|Lost to Follow-up|1
2520931|NCT01720524|8725626|P1|Part A|Lost to Follow-up|0
2520932|NCT01720524|8725625|P2|Part A|Death|1
2520933|NCT01720524|8725626|P1|Part A|Death|2
2520934|NCT01720524|8725625|P2|Part A|Adverse Event|2
2520935|NCT01720524|8725626|P1|Part A|Adverse Event|2
2520936|NCT01720524|8725625|P2|Part A|Insufficient Clinical Response|4
2520937|NCT01720524|8725626|P1|Part A|Insufficient Clinical Response|2
2520938|NCT01720446|8725659|P4|Overall Study|Withdrawal by Subject|4
2520939|NCT01720446|8725660|P3|Overall Study|Withdrawal by Subject|4
2520940|NCT01720446|8725661|P2|Overall Study|Withdrawal by Subject|5
2520941|NCT01720446|8725662|P1|Overall Study|Withdrawal by Subject|2
2520942|NCT01720446|8725659|P4|Overall Study|Lost to Follow-up|16
2520943|NCT01720446|8725660|P3|Overall Study|Lost to Follow-up|16
2520944|NCT01720446|8725661|P2|Overall Study|Lost to Follow-up|6
2520945|NCT01720446|8725662|P1|Overall Study|Lost to Follow-up|12
2520946|NCT01720264|8725783|P1|Post-transplant (Day 16) to 1 Year|Disease Progression|4
2520947|NCT01720264|8725783|P1|Post-transplant (Day 16) to 1 Year|Death|8
2520948|NCT01720264|8725783|P1|Transplant With Sitagliptin for 15 Days|Adverse Event|1
2520949|NCT01720069|8725814|P3|Overall Study|Lost to Follow-up|1
2520950|NCT01720069|8725815|P2|Overall Study|Lost to Follow-up|0
2520951|NCT01720069|8725816|P1|Overall Study|Lost to Follow-up|0
2520952|NCT01720069|8725814|P3|Overall Study|Non-compliance on using e-diary|1
2520953|NCT01720069|8725815|P2|Overall Study|Non-compliance on using e-diary|0
2520954|NCT01720069|8725816|P1|Overall Study|Non-compliance on using e-diary|0
2520955|NCT01720069|8725814|P3|Overall Study|OCS bursts occured, discontinued in line|0
2520956|NCT01720069|8725815|P2|Overall Study|OCS bursts occured, discontinued in line|0
2520957|NCT01720069|8725816|P1|Overall Study|OCS bursts occured, discontinued in line|1
2520958|NCT01720069|8725814|P3|Overall Study|Withdrawal by Subject|1
2520959|NCT01720069|8725815|P2|Overall Study|Withdrawal by Subject|2
2520960|NCT01720069|8725816|P1|Overall Study|Withdrawal by Subject|0
2520961|NCT01720069|8725814|P3|Overall Study|Treatment period withdrawal criteria met|9
2520962|NCT01720069|8725815|P2|Overall Study|Treatment period withdrawal criteria met|8
2520963|NCT01720069|8725816|P1|Overall Study|Treatment period withdrawal criteria met|4
2520964|NCT01720069|8725814|P3|Overall Study|Lack of Efficacy|0
2520965|NCT01720069|8725815|P2|Overall Study|Lack of Efficacy|4
2520966|NCT01720069|8725816|P1|Overall Study|Lack of Efficacy|0
2520967|NCT01720069|8725814|P3|Overall Study|Adverse Event|1
2520968|NCT01720069|8725815|P2|Overall Study|Adverse Event|0
2520969|NCT01720069|8725816|P1|Overall Study|Adverse Event|0
2520970|NCT01720069|8725814|P3|Overall Study|Randomised without baseline values|1
2520971|NCT01720069|8725815|P2|Overall Study|Randomised without baseline values|0
2520972|NCT01720069|8725816|P1|Overall Study|Randomised without baseline values|0
2520973|NCT01720069|8725814|P3|Overall Study|Could not use e-diary correctly|1
2520974|NCT01720069|8725815|P2|Overall Study|Could not use e-diary correctly|1
2520975|NCT01720069|8725816|P1|Overall Study|Could not use e-diary correctly|0
2520976|NCT01720043|8725842|P1|Overall Study|Withdrawal by Subject|1
2520977|NCT01719861|8725871|P1|Cycle 2|Death|1
2520978|NCT01719861|8725871|P1|Cycle 1|Death|4
2520979|NCT01719783|8725881|P2|Dose 2|Physician Decision|0
2520980|NCT01719783|8725882|P1|Dose 2|Physician Decision|1
2520981|NCT01719757|8725968|P1|Overall Study|well controlled pain|27
2520982|NCT01719757|8725968|P1|Overall Study|Protocol Violation|1
2520983|NCT01719757|8725968|P1|Overall Study|Lost to Follow-up|20
2520984|NCT01719757|8725968|P1|Overall Study|Withdrawal by Subject|15
2520985|NCT01719757|8725968|P1|Overall Study|Adverse Event|38
2520986|NCT01719224|8726022|P2|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2
2520987|NCT01719224|8726023|P1|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4
2520988|NCT01719172|8726032|P1|Overall Study|Death|1
2520989|NCT01719172|8726032|P1|Overall Study|Lost to Follow-up|1
2520990|NCT01719003|8726046|P9|Overall Study|Lack of Efficacy|0
2520991|NCT01719003|8726047|P8|Overall Study|Lack of Efficacy|0
2520992|NCT01719003|8726048|P7|Overall Study|Lack of Efficacy|1
2520993|NCT01719003|8726049|P6|Overall Study|Lack of Efficacy|0
2520994|NCT01719003|8726050|P5|Overall Study|Lack of Efficacy|0
2520995|NCT01719003|8726051|P4|Overall Study|Lack of Efficacy|0
2520996|NCT01719003|8726052|P3|Overall Study|Lack of Efficacy|0
2520997|NCT01719003|8726053|P2|Overall Study|Lack of Efficacy|0
2520998|NCT01719003|8726054|P1|Overall Study|Lack of Efficacy|0
2520999|NCT01719003|8726046|P9|Overall Study|Reason other than those specified|1
2521000|NCT01719003|8726047|P8|Overall Study|Reason other than those specified|3
2521001|NCT01719003|8726048|P7|Overall Study|Reason other than those specified|0
2521002|NCT01719003|8726049|P6|Overall Study|Reason other than those specified|1
2521003|NCT01719003|8726050|P5|Overall Study|Reason other than those specified|4
2521004|NCT01719003|8726051|P4|Overall Study|Reason other than those specified|3
2521005|NCT01719003|8726052|P3|Overall Study|Reason other than those specified|2
2521006|NCT01719003|8726053|P2|Overall Study|Reason other than those specified|0
2521007|NCT01719003|8726054|P1|Overall Study|Reason other than those specified|0
2521008|NCT01719003|8726046|P9|Overall Study|Refusal to continue, not due to AE|1
2521009|NCT01719003|8726047|P8|Overall Study|Refusal to continue, not due to AE|7
2521010|NCT01719003|8726048|P7|Overall Study|Refusal to continue, not due to AE|8
2521011|NCT01719003|8726049|P6|Overall Study|Refusal to continue, not due to AE|3
2521012|NCT01719003|8726050|P5|Overall Study|Refusal to continue, not due to AE|4
2521013|NCT01719003|8726051|P4|Overall Study|Refusal to continue, not due to AE|4
2521014|NCT01719003|8726052|P3|Overall Study|Refusal to continue, not due to AE|4
2521015|NCT01719003|8726053|P2|Overall Study|Refusal to continue, not due to AE|5
2521016|NCT01719003|8726054|P1|Overall Study|Refusal to continue, not due to AE|2
2521017|NCT01719003|8726046|P9|Overall Study|Lost to Follow-up|2
2521018|NCT01719003|8726047|P8|Overall Study|Lost to Follow-up|2
2521019|NCT01719003|8726048|P7|Overall Study|Lost to Follow-up|3
2521020|NCT01719003|8726049|P6|Overall Study|Lost to Follow-up|4
2521021|NCT01719003|8726050|P5|Overall Study|Lost to Follow-up|3
2521022|NCT01719003|8726051|P4|Overall Study|Lost to Follow-up|2
2521023|NCT01719003|8726052|P3|Overall Study|Lost to Follow-up|7
2521024|NCT01719003|8726053|P2|Overall Study|Lost to Follow-up|6
2521025|NCT01719003|8726054|P1|Overall Study|Lost to Follow-up|0
2521026|NCT01719003|8726046|P9|Overall Study|Adverse Event|0
2521027|NCT01719003|8726047|P8|Overall Study|Adverse Event|5
2521028|NCT01719003|8726048|P7|Overall Study|Adverse Event|6
2521029|NCT01719003|8726049|P6|Overall Study|Adverse Event|3
2521030|NCT01719003|8726050|P5|Overall Study|Adverse Event|4
2521031|NCT01719003|8726051|P4|Overall Study|Adverse Event|3
2521032|NCT01719003|8726052|P3|Overall Study|Adverse Event|4
2521033|NCT01719003|8726053|P2|Overall Study|Adverse Event|5
2521034|NCT01719003|8726054|P1|Overall Study|Adverse Event|6
2521035|NCT01719003|8726046|P9|Overall Study|Non compliant with protocol|0
2521036|NCT01719003|8726047|P8|Overall Study|Non compliant with protocol|3
2521037|NCT01719003|8726048|P7|Overall Study|Non compliant with protocol|2
2521038|NCT01719003|8726049|P6|Overall Study|Non compliant with protocol|1
2521039|NCT01719003|8726050|P5|Overall Study|Non compliant with protocol|2
2521040|NCT01719003|8726051|P4|Overall Study|Non compliant with protocol|1
2521041|NCT01719003|8726052|P3|Overall Study|Non compliant with protocol|0
2521042|NCT01719003|8726053|P2|Overall Study|Non compliant with protocol|1
2521043|NCT01719003|8726054|P1|Overall Study|Non compliant with protocol|1
2521044|NCT01718535|8726135|P10|Overall Study|Bidirectional Sequencing not possible|0
2521045|NCT01718535|8726136|P9|Overall Study|Bidirectional Sequencing not possible|0
2521046|NCT01718535|8726137|P8|Overall Study|Bidirectional Sequencing not possible|0
2521047|NCT01718535|8726138|P7|Overall Study|Bidirectional Sequencing not possible|0
2521048|NCT01718535|8726139|P6|Overall Study|Bidirectional Sequencing not possible|0
2521049|NCT01718535|8726140|P5|Overall Study|Bidirectional Sequencing not possible|0
2521050|NCT01718535|8726141|P4|Overall Study|Bidirectional Sequencing not possible|1
2521051|NCT01718535|8726142|P3|Overall Study|Bidirectional Sequencing not possible|0
2521052|NCT01718535|8726143|P2|Overall Study|Bidirectional Sequencing not possible|0
2521053|NCT01718535|8726144|P1|Overall Study|Bidirectional Sequencing not possible|1
2521054|NCT01718509|8726182|P2|Overall Study|Lack of Efficacy|0
2521055|NCT01718509|8726183|P1|Overall Study|Lack of Efficacy|1
2521056|NCT01718509|8726182|P2|Overall Study|Protocol Violation|2
2521057|NCT01718509|8726183|P1|Overall Study|Protocol Violation|4
2521058|NCT01718509|8726182|P2|Overall Study|Other|11
2521059|NCT01718509|8726183|P1|Overall Study|Other|13
2521060|NCT01718509|8726182|P2|Overall Study|Adverse Event|7
2521061|NCT01718509|8726183|P1|Overall Study|Adverse Event|5
2521062|NCT01718509|8726182|P2|Overall Study|Withdrawal by Subject|13
2521063|NCT01718509|8726183|P1|Overall Study|Withdrawal by Subject|7
2521064|NCT01718509|8726182|P2|Overall Study|Lost to Follow-up|15
2521065|NCT01718509|8726183|P1|Overall Study|Lost to Follow-up|18
2521066|NCT01718483|8726229|P2|Overall Study|Lack of Efficacy|0
2521067|NCT01718483|8726230|P1|Overall Study|Lack of Efficacy|1
2521068|NCT01718483|8726229|P2|Overall Study|Pregnancy|1
2521069|NCT01718483|8726230|P1|Overall Study|Pregnancy|1
2521070|NCT01718483|8726229|P2|Overall Study|Other|4
2521071|NCT01718483|8726230|P1|Overall Study|Other|1
2521072|NCT01718483|8726229|P2|Overall Study|Protocol Violation|2
2521073|NCT01718483|8726230|P1|Overall Study|Protocol Violation|4
2521074|NCT01718483|8726229|P2|Overall Study|Lost to Follow-up|3
2521075|NCT01718483|8726230|P1|Overall Study|Lost to Follow-up|8
2521076|NCT01718483|8726229|P2|Overall Study|Adverse Event|12
2521077|NCT01718483|8726230|P1|Overall Study|Adverse Event|5
2521078|NCT01718483|8726229|P2|Overall Study|Withdrawal by Subject|12
2521079|NCT01718483|8726230|P1|Overall Study|Withdrawal by Subject|14
2521080|NCT01718353|8726276|P2|Overall Study|Randomized but not treated|0
2521081|NCT01718353|8726277|P1|Overall Study|Randomized but not treated|2
2521082|NCT01718353|8726276|P2|Overall Study|Principal Investigator's Decision|4
2521083|NCT01718353|8726277|P1|Overall Study|Principal Investigator's Decision|10
2521084|NCT01718353|8726276|P2|Overall Study|Lost to Follow-up|1
2521085|NCT01718353|8726277|P1|Overall Study|Lost to Follow-up|0
2521086|NCT01717989|8726308|P1|Overall Study|Other|40
2521087|NCT01717989|8726308|P1|Overall Study|Protocol-specified criteria|551
2521088|NCT01717989|8726308|P1|Overall Study|Death|439
2521089|NCT01717989|8726308|P1|Overall Study|Lost to Follow-up|11
2521090|NCT01717989|8726308|P1|Overall Study|Physician Decision|2
2521091|NCT01717989|8726308|P1|Overall Study|Withdrawal by Subject|11
2521092|NCT01717989|8726308|P1|Overall Study|Protocol deviation|6
2521093|NCT01717989|8726308|P1|Overall Study|Ineligibility determined|6
2521094|NCT01717976|8726376|P2|Overall Study|Protocol Violation|1
2521095|NCT01717976|8726377|P1|Overall Study|Protocol Violation|0
2521096|NCT01717859|8726432|P1|Overall Study|Withdrawal by Subject|2
2521097|NCT01717859|8726432|P1|Overall Study|Lost to Follow-up|1
2521098|NCT01717859|8726432|P1|Overall Study|Patient concerned about mental health|1
2521099|NCT01717859|8726432|P1|Overall Study|Moved out of state|1
2521100|NCT01717859|8726432|P1|Overall Study|Adverse Event|5
2521101|NCT01717768|8726453|P12|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2521102|NCT01717768|8726454|P11|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2521103|NCT01717768|8726455|P10|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1
2521104|NCT01717768|8726456|P9|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2521105|NCT01717768|8726457|P8|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2521106|NCT01717768|8726458|P7|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2521107|NCT01717768|8726459|P6|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2521108|NCT01717768|8726460|P5|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2521109|NCT01717768|8726461|P4|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2521110|NCT01717768|8726462|P3|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2521111|NCT01717768|8726463|P2|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2521112|NCT01717768|8726464|P1|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
2521113|NCT01717768|8726453|P12|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2521114|NCT01717768|8726454|P11|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2521115|NCT01717768|8726455|P10|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2521116|NCT01717768|8726456|P9|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2521117|NCT01717768|8726457|P8|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2
2521118|NCT01717768|8726458|P7|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2521119|NCT01717768|8726459|P6|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2521120|NCT01717768|8726460|P5|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2521121|NCT01717768|8726461|P4|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2521122|NCT01717768|8726462|P3|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2521123|NCT01717768|8726463|P2|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2521124|NCT01717768|8726464|P1|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
2521125|NCT01717768|8726453|P12|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1
2521126|NCT01717768|8726454|P11|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2521127|NCT01717768|8726455|P10|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2521128|NCT01717768|8726456|P9|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2521129|NCT01717768|8726457|P8|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2521130|NCT01717768|8726458|P7|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2521131|NCT01717768|8726459|P6|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2521132|NCT01717768|8726460|P5|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2521133|NCT01717768|8726461|P4|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2521134|NCT01717768|8726462|P3|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2521135|NCT01717768|8726463|P2|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2521136|NCT01717768|8726464|P1|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
2521137|NCT01717768|8726453|P12|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2521138|NCT01717768|8726454|P11|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2521139|NCT01717768|8726455|P10|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2521140|NCT01717768|8726456|P9|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2521141|NCT01717768|8726457|P8|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2521142|NCT01717768|8726458|P7|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2521143|NCT01717768|8726459|P6|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2521144|NCT01717768|8726460|P5|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2521145|NCT01717768|8726461|P4|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2521146|NCT01717768|8726462|P3|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2521147|NCT01717768|8726463|P2|Part 1 (Duration of 15 Days)|Lost to Follow-up|1
2521148|NCT01717768|8726464|P1|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
2521149|NCT01717638|8726544|P13|Overall Study|Withdrawal by Subject|18
2521150|NCT01717638|8726545|P12|Overall Study|Withdrawal by Subject|0
2521151|NCT01717638|8726546|P11|Overall Study|Withdrawal by Subject|0
2521152|NCT01717638|8726547|P10|Overall Study|Withdrawal by Subject|1
2521153|NCT01717638|8726548|P9|Overall Study|Withdrawal by Subject|2
2521154|NCT01717638|8726549|P8|Overall Study|Withdrawal by Subject|1
2521155|NCT01717638|8726550|P7|Overall Study|Withdrawal by Subject|2
2521156|NCT01717638|8726551|P6|Overall Study|Withdrawal by Subject|0
2521157|NCT01717638|8726552|P5|Overall Study|Withdrawal by Subject|1
2521158|NCT01717638|8726553|P4|Overall Study|Withdrawal by Subject|0
2521159|NCT01717638|8726554|P3|Overall Study|Withdrawal by Subject|1
2521160|NCT01717638|8726555|P2|Overall Study|Withdrawal by Subject|1
2521161|NCT01717638|8726556|P1|Overall Study|Withdrawal by Subject|0
2521162|NCT01717638|8726544|P13|Overall Study|Father in hospital|1
2521163|NCT01717638|8726545|P12|Overall Study|Father in hospital|0
2521164|NCT01717638|8726546|P11|Overall Study|Father in hospital|0
2521165|NCT01717638|8726547|P10|Overall Study|Father in hospital|0
2521166|NCT01717638|8726548|P9|Overall Study|Father in hospital|0
2521167|NCT01717638|8726549|P8|Overall Study|Father in hospital|0
2521168|NCT01717638|8726550|P7|Overall Study|Father in hospital|0
2521169|NCT01717638|8726551|P6|Overall Study|Father in hospital|0
2521170|NCT01717638|8726552|P5|Overall Study|Father in hospital|0
2521171|NCT01717638|8726553|P4|Overall Study|Father in hospital|0
2521172|NCT01717638|8726554|P3|Overall Study|Father in hospital|0
2521173|NCT01717638|8726555|P2|Overall Study|Father in hospital|0
2521174|NCT01717638|8726556|P1|Overall Study|Father in hospital|0
2521175|NCT01717638|8726544|P13|Overall Study|Lost to Follow-up|0
2521176|NCT01717638|8726545|P12|Overall Study|Lost to Follow-up|0
2521177|NCT01717638|8726546|P11|Overall Study|Lost to Follow-up|0
2521178|NCT01717638|8726547|P10|Overall Study|Lost to Follow-up|0
2521179|NCT01717638|8726548|P9|Overall Study|Lost to Follow-up|0
2521180|NCT01717638|8726549|P8|Overall Study|Lost to Follow-up|0
2521181|NCT01717638|8726550|P7|Overall Study|Lost to Follow-up|0
2521182|NCT01717638|8726551|P6|Overall Study|Lost to Follow-up|1
2521183|NCT01717638|8726552|P5|Overall Study|Lost to Follow-up|0
2521184|NCT01717638|8726553|P4|Overall Study|Lost to Follow-up|0
2521185|NCT01717638|8726554|P3|Overall Study|Lost to Follow-up|0
2521186|NCT01717638|8726555|P2|Overall Study|Lost to Follow-up|0
2521187|NCT01717638|8726556|P1|Overall Study|Lost to Follow-up|0
2521188|NCT01717456|8726732|P2|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
2521189|NCT01717456|8726733|P1|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
2521190|NCT01717456|8726732|P2|End of Treatment|Lost to Follow-up|1
2521191|NCT01717456|8726733|P1|End of Treatment|Lost to Follow-up|0
2521192|NCT01717456|8726732|P2|End of Treatment|Physician Decision|1
2521193|NCT01717456|8726733|P1|End of Treatment|Physician Decision|0
2521194|NCT01717391|8726801|P1|Overall Study|FLT technical failure|3
2521195|NCT01717391|8726801|P1|Overall Study|Physician Decision|1
2521196|NCT01717391|8726801|P1|Overall Study|Withdrawal by Subject|5
2521197|NCT01717326|8726830|P20|Overall Study|Withdrawal by Subject|3
2521198|NCT01717326|8726831|P19|Overall Study|Withdrawal by Subject|2
2521199|NCT01717326|8726832|P18|Overall Study|Withdrawal by Subject|0
2521200|NCT01717326|8726833|P17|Overall Study|Withdrawal by Subject|0
2521201|NCT01717326|8726834|P16|Overall Study|Withdrawal by Subject|1
2521202|NCT01717326|8726835|P15|Overall Study|Withdrawal by Subject|0
2521203|NCT01717326|8726836|P14|Overall Study|Withdrawal by Subject|0
2521204|NCT01717326|8726837|P13|Overall Study|Withdrawal by Subject|1
2521205|NCT01717326|8726838|P12|Overall Study|Withdrawal by Subject|0
2521206|NCT01717326|8726839|P11|Overall Study|Withdrawal by Subject|0
2521207|NCT01717326|8726840|P10|Overall Study|Withdrawal by Subject|1
2521208|NCT01717326|8726841|P9|Overall Study|Withdrawal by Subject|0
2521209|NCT01717326|8726842|P8|Overall Study|Withdrawal by Subject|0
2521210|NCT01717326|8726843|P7|Overall Study|Withdrawal by Subject|0
2521211|NCT01717326|8726844|P6|Overall Study|Withdrawal by Subject|0
2521212|NCT01717326|8726845|P5|Overall Study|Withdrawal by Subject|0
2521213|NCT01717326|8726846|P4|Overall Study|Withdrawal by Subject|0
2521214|NCT01717326|8726847|P3|Overall Study|Withdrawal by Subject|0
2521215|NCT01717326|8726848|P2|Overall Study|Withdrawal by Subject|1
2521216|NCT01717326|8726849|P1|Overall Study|Withdrawal by Subject|0
2521217|NCT01717326|8726830|P20|Overall Study|Protocol Violation|0
2521218|NCT01717326|8726831|P19|Overall Study|Protocol Violation|0
2521219|NCT01717326|8726832|P18|Overall Study|Protocol Violation|0
2521220|NCT01717326|8726833|P17|Overall Study|Protocol Violation|0
2521221|NCT01717326|8726834|P16|Overall Study|Protocol Violation|0
2521222|NCT01717326|8726835|P15|Overall Study|Protocol Violation|0
2521223|NCT01717326|8726836|P14|Overall Study|Protocol Violation|0
2521224|NCT01717326|8726837|P13|Overall Study|Protocol Violation|0
2521225|NCT01717326|8726838|P12|Overall Study|Protocol Violation|0
2521226|NCT01717326|8726839|P11|Overall Study|Protocol Violation|0
2521227|NCT01717326|8726840|P10|Overall Study|Protocol Violation|0
2521228|NCT01717326|8726841|P9|Overall Study|Protocol Violation|0
2521229|NCT01717326|8726842|P8|Overall Study|Protocol Violation|0
2521230|NCT01717326|8726843|P7|Overall Study|Protocol Violation|0
2521231|NCT01717326|8726844|P6|Overall Study|Protocol Violation|0
2521232|NCT01717326|8726845|P5|Overall Study|Protocol Violation|1
2521233|NCT01717326|8726846|P4|Overall Study|Protocol Violation|0
2521234|NCT01717326|8726847|P3|Overall Study|Protocol Violation|0
2521235|NCT01717326|8726848|P2|Overall Study|Protocol Violation|0
2521236|NCT01717326|8726849|P1|Overall Study|Protocol Violation|0
2521237|NCT01717326|8726830|P20|Overall Study|Physician Decision|0
2521238|NCT01717326|8726831|P19|Overall Study|Physician Decision|0
2521239|NCT01717326|8726832|P18|Overall Study|Physician Decision|0
2521240|NCT01717326|8726833|P17|Overall Study|Physician Decision|0
2521241|NCT01717326|8726834|P16|Overall Study|Physician Decision|0
2521242|NCT01717326|8726835|P15|Overall Study|Physician Decision|0
2521243|NCT01717326|8726836|P14|Overall Study|Physician Decision|0
2521244|NCT01717326|8726837|P13|Overall Study|Physician Decision|0
2521245|NCT01717326|8726838|P12|Overall Study|Physician Decision|0
2521246|NCT01717326|8726839|P11|Overall Study|Physician Decision|0
2521247|NCT01717326|8726840|P10|Overall Study|Physician Decision|1
2521248|NCT01717326|8726841|P9|Overall Study|Physician Decision|0
2521249|NCT01717326|8726842|P8|Overall Study|Physician Decision|0
2521250|NCT01717326|8726843|P7|Overall Study|Physician Decision|0
2521251|NCT01717326|8726844|P6|Overall Study|Physician Decision|0
2521252|NCT01717326|8726845|P5|Overall Study|Physician Decision|0
2521253|NCT01717326|8726846|P4|Overall Study|Physician Decision|0
2521254|NCT01717326|8726847|P3|Overall Study|Physician Decision|0
2521255|NCT01717326|8726848|P2|Overall Study|Physician Decision|0
2521256|NCT01717326|8726849|P1|Overall Study|Physician Decision|0
2521257|NCT01717326|8726830|P20|Overall Study|Lost to Follow-up|3
2521258|NCT01717326|8726831|P19|Overall Study|Lost to Follow-up|2
2521259|NCT01717326|8726832|P18|Overall Study|Lost to Follow-up|0
2521260|NCT01717326|8726833|P17|Overall Study|Lost to Follow-up|1
2521261|NCT01717326|8726834|P16|Overall Study|Lost to Follow-up|2
2521262|NCT01717326|8726835|P15|Overall Study|Lost to Follow-up|0
2521263|NCT01717326|8726836|P14|Overall Study|Lost to Follow-up|0
2521264|NCT01717326|8726837|P13|Overall Study|Lost to Follow-up|0
2521265|NCT01717326|8726838|P12|Overall Study|Lost to Follow-up|0
2521266|NCT01717326|8726839|P11|Overall Study|Lost to Follow-up|1
2521267|NCT01717326|8726840|P10|Overall Study|Lost to Follow-up|0
2521268|NCT01717326|8726841|P9|Overall Study|Lost to Follow-up|0
2521269|NCT01717326|8726842|P8|Overall Study|Lost to Follow-up|0
2521270|NCT01717326|8726843|P7|Overall Study|Lost to Follow-up|1
2521271|NCT01717326|8726844|P6|Overall Study|Lost to Follow-up|0
2521272|NCT01717326|8726845|P5|Overall Study|Lost to Follow-up|1
2521273|NCT01717326|8726846|P4|Overall Study|Lost to Follow-up|2
2521274|NCT01717326|8726847|P3|Overall Study|Lost to Follow-up|0
2521275|NCT01717326|8726848|P2|Overall Study|Lost to Follow-up|0
2521276|NCT01717326|8726849|P1|Overall Study|Lost to Follow-up|3
2521277|NCT01717326|8726830|P20|Overall Study|Death|0
2521278|NCT01717326|8726831|P19|Overall Study|Death|0
2521279|NCT01717326|8726832|P18|Overall Study|Death|0
2521280|NCT01717326|8726833|P17|Overall Study|Death|0
2521281|NCT01717326|8726834|P16|Overall Study|Death|0
2521282|NCT01717326|8726835|P15|Overall Study|Death|0
2521283|NCT01717326|8726836|P14|Overall Study|Death|0
2521284|NCT01717326|8726837|P13|Overall Study|Death|0
2521285|NCT01717326|8726838|P12|Overall Study|Death|0
2521286|NCT01717326|8726839|P11|Overall Study|Death|1
2521287|NCT01717326|8726840|P10|Overall Study|Death|0
2521288|NCT01717326|8726841|P9|Overall Study|Death|0
2521289|NCT01717326|8726842|P8|Overall Study|Death|0
2521290|NCT01717326|8726843|P7|Overall Study|Death|0
2521291|NCT01717326|8726844|P6|Overall Study|Death|0
2521292|NCT01717326|8726845|P5|Overall Study|Death|0
2521293|NCT01717326|8726846|P4|Overall Study|Death|0
2521294|NCT01717326|8726847|P3|Overall Study|Death|0
2521295|NCT01717326|8726848|P2|Overall Study|Death|0
2521296|NCT01717326|8726849|P1|Overall Study|Death|0
2521297|NCT01717313|8727113|P2|Phase B (Weeks 24 to 54)|Lost to Follow-up|3
2521298|NCT01717313|8727114|P1|Phase B (Weeks 24 to 54)|Lost to Follow-up|1
2521299|NCT01717313|8727113|P2|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9
2521300|NCT01717313|8727114|P1|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7
2521301|NCT01717313|8727113|P2|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
2521302|NCT01717313|8727114|P1|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
2521303|NCT01717313|8727113|P2|Interphase|Completed Phase A Did Not Enter Phase B|0
2521304|NCT01717313|8727114|P1|Interphase|Completed Phase A Did Not Enter Phase B|1
2521305|NCT01717313|8727113|P2|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
2521306|NCT01717313|8727114|P1|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
2521307|NCT01717313|8727113|P2|Phase A (Weeks 0 to 24)|Adverse Event|2
2521308|NCT01717313|8727114|P1|Phase A (Weeks 0 to 24)|Adverse Event|4
2521309|NCT01717313|8727113|P2|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6
2521310|NCT01717313|8727114|P1|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12
2521311|NCT01717313|8727113|P2|Phase A (Weeks 0 to 24)|Lost to Follow-up|3
2521312|NCT01717313|8727114|P1|Phase A (Weeks 0 to 24)|Lost to Follow-up|1
2521313|NCT01717313|8727113|P2|Phase A (Weeks 0 to 24)|Death|1
2521314|NCT01717313|8727114|P1|Phase A (Weeks 0 to 24)|Death|0
2521315|NCT01717287|8727152|P2|Overall Study|Protocol Violation|1
2521316|NCT01717287|8727153|P1|Overall Study|Protocol Violation|0
2521317|NCT01717287|8727152|P2|Overall Study|Lost to Follow-up|2
2521318|NCT01717287|8727153|P1|Overall Study|Lost to Follow-up|0
2521319|NCT01717040|8727193|P2|Overall Study|New Substance Use Disorder|0
2521320|NCT01717040|8727194|P1|Overall Study|New Substance Use Disorder|1
2521321|NCT01717040|8727193|P2|Overall Study|Required Medication Change|1
2521322|NCT01717040|8727194|P1|Overall Study|Required Medication Change|0
2521323|NCT01717040|8727193|P2|Overall Study|Adverse Event|0
2521324|NCT01717040|8727194|P1|Overall Study|Adverse Event|1
2521325|NCT01717040|8727193|P2|Overall Study|Lack of Efficacy|1
2521326|NCT01717040|8727194|P1|Overall Study|Lack of Efficacy|1
2521327|NCT01717040|8727193|P2|Overall Study|Lost to Follow-up|3
2521328|NCT01717040|8727194|P1|Overall Study|Lost to Follow-up|2
2521329|NCT01716754|8727212|P4|Overall Study|Withdrawal by Subject|3
2521330|NCT01716754|8727213|P3|Overall Study|Withdrawal by Subject|4
2521331|NCT01716754|8727214|P2|Overall Study|Withdrawal by Subject|0
2521332|NCT01716754|8727215|P1|Overall Study|Withdrawal by Subject|5
2521333|NCT01716754|8727212|P4|Overall Study|Adverse Event|1
2521334|NCT01716754|8727213|P3|Overall Study|Adverse Event|2
2521335|NCT01716754|8727214|P2|Overall Study|Adverse Event|2
2521336|NCT01716754|8727215|P1|Overall Study|Adverse Event|4
2521337|NCT01716754|8727212|P4|Overall Study|Lost to Follow-up|1
2521338|NCT01716754|8727213|P3|Overall Study|Lost to Follow-up|0
2521339|NCT01716754|8727214|P2|Overall Study|Lost to Follow-up|0
2521340|NCT01716754|8727215|P1|Overall Study|Lost to Follow-up|1
2521341|NCT01716754|8727212|P4|Overall Study|Physician Decision|0
2521342|NCT01716754|8727213|P3|Overall Study|Physician Decision|0
2521343|NCT01716754|8727214|P2|Overall Study|Physician Decision|0
2521344|NCT01716754|8727215|P1|Overall Study|Physician Decision|1
2521345|NCT01716754|8727212|P4|Overall Study|Non-compliance with study treatment|0
2521346|NCT01716754|8727213|P3|Overall Study|Non-compliance with study treatment|1
2521347|NCT01716754|8727214|P2|Overall Study|Non-compliance with study treatment|0
2521348|NCT01716754|8727215|P1|Overall Study|Non-compliance with study treatment|0
2521349|NCT01716754|8727212|P4|Overall Study|Protocol deviation|2
2521350|NCT01716754|8727213|P3|Overall Study|Protocol deviation|7
2521351|NCT01716754|8727214|P2|Overall Study|Protocol deviation|2
2521352|NCT01716754|8727215|P1|Overall Study|Protocol deviation|0
2521353|NCT01716754|8727212|P4|Overall Study|Death|1
2521354|NCT01716754|8727213|P3|Overall Study|Death|0
2521355|NCT01716754|8727214|P2|Overall Study|Death|0
2521356|NCT01716754|8727215|P1|Overall Study|Death|0
2521357|NCT01716715|8727238|P2|Overall Study|Never Treated|4
2521358|NCT01716715|8727239|P1|Overall Study|Never Treated|2
2521359|NCT01716663|8727255|P1|Overall Study|Treated with non-study catheter|2
2521360|NCT01716663|8727255|P1|Overall Study|Withdrawn prior to procedure|4
2521361|NCT01716585|8727265|P2|Open-label Treatment|Withdrawal by Subject|3
2521362|NCT01716585|8727266|P1|Open-label Treatment|Withdrawal by Subject|0
2521363|NCT01716585|8727265|P2|Open-label Treatment|Virologic Failure|2
2521364|NCT01716585|8727266|P1|Open-label Treatment|Virologic Failure|0
2521365|NCT01716585|8727265|P2|Open-label Treatment|Adverse Event|2
2521366|NCT01716585|8727266|P1|Open-label Treatment|Adverse Event|0
2521367|NCT01716585|8727265|P2|Double-blind Treatment|Other|0
2521368|NCT01716585|8727266|P1|Double-blind Treatment|Other|1
2521369|NCT01716585|8727265|P2|Double-blind Treatment|Subject Noncompliant|0
2521370|NCT01716585|8727266|P1|Double-blind Treatment|Subject Noncompliant|1
2521371|NCT01716585|8727265|P2|Double-blind Treatment|Lost to Follow-up|0
2521372|NCT01716585|8727266|P1|Double-blind Treatment|Lost to Follow-up|2
2521373|NCT01716585|8727265|P2|Double-blind Treatment|Withdrawal by Subject|0
2521374|NCT01716585|8727266|P1|Double-blind Treatment|Withdrawal by Subject|3
2521375|NCT01716585|8727265|P2|Double-blind Treatment|Adverse Event|1
2521376|NCT01716585|8727266|P1|Double-blind Treatment|Adverse Event|2
2521377|NCT01716585|8727265|P2|Double-blind Treatment|Did Not Receive Study Drug|1
2521378|NCT01716585|8727266|P1|Double-blind Treatment|Did Not Receive Study Drug|4
2521379|NCT01716559|8727278|P1|Overall Study|Other withdrawal reason|75
2521380|NCT01716559|8727278|P1|Overall Study|Withdrawal by Subject|4
2521381|NCT01716559|8727278|P1|Overall Study|Death|21
2521382|NCT01716559|8727278|P1|Overall Study|Adverse Event|11
2521383|NCT01716533|8727290|P4|Overall Study|Immunosuppressants>14days past 6months|1
2521384|NCT01716533|8727291|P3|Overall Study|Immunosuppressants>14days past 6months|0
2521385|NCT01716533|8727292|P2|Overall Study|Immunosuppressants>14days past 6months|0
2521386|NCT01716533|8727293|P1|Overall Study|Immunosuppressants>14days past 6months|0
2521387|NCT01716533|8727290|P4|Overall Study|Death|2
2521388|NCT01716533|8727291|P3|Overall Study|Death|0
2521389|NCT01716533|8727292|P2|Overall Study|Death|0
2521390|NCT01716533|8727293|P1|Overall Study|Death|0
2521391|NCT01716533|8727290|P4|Overall Study|Withdrawal by Subject|5
2521392|NCT01716533|8727291|P3|Overall Study|Withdrawal by Subject|0
2521393|NCT01716533|8727292|P2|Overall Study|Withdrawal by Subject|0
2521394|NCT01716533|8727293|P1|Overall Study|Withdrawal by Subject|0
2521395|NCT01716533|8727290|P4|Overall Study|Failure of antibiotic treatment to treat|0
2521396|NCT01716533|8727291|P3|Overall Study|Failure of antibiotic treatment to treat|5
2521397|NCT01716533|8727292|P2|Overall Study|Failure of antibiotic treatment to treat|0
2521398|NCT01716533|8727293|P1|Overall Study|Failure of antibiotic treatment to treat|0
2521399|NCT01716520|8727347|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
2521400|NCT01716520|8727348|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
2521401|NCT01716520|8727349|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
2521402|NCT01716520|8727350|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
2521403|NCT01716520|8727351|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
2521404|NCT01716520|8727352|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
2521405|NCT01716520|8727347|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|2
2521406|NCT01716520|8727348|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
2521407|NCT01716520|8727349|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
2521408|NCT01716520|8727350|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
2521409|NCT01716520|8727351|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
2521410|NCT01716520|8727352|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
2521411|NCT01716520|8727347|P6|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
2521412|NCT01716520|8727348|P5|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
2521413|NCT01716520|8727349|P4|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
2521414|NCT01716520|8727350|P3|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
2521415|NCT01716520|8727351|P2|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1
2521416|NCT01716520|8727352|P1|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
2521417|NCT01716520|8727347|P6|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1
2521418|NCT01716520|8727348|P5|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
2521419|NCT01716520|8727349|P4|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
2521420|NCT01716520|8727350|P3|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
2521421|NCT01716520|8727351|P2|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
2521422|NCT01716520|8727352|P1|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
2521423|NCT01716520|8727347|P6|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
2521424|NCT01716520|8727348|P5|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
2521425|NCT01716520|8727349|P4|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
2521426|NCT01716520|8727350|P3|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
2521427|NCT01716520|8727351|P2|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
2521428|NCT01716520|8727352|P1|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1
2521429|NCT01716520|8727347|P6|Washout Period 2 (10 to 14 Days)|Adverse Event|1
2521430|NCT01716520|8727348|P5|Washout Period 2 (10 to 14 Days)|Adverse Event|0
2521431|NCT01716520|8727349|P4|Washout Period 2 (10 to 14 Days)|Adverse Event|0
2521432|NCT01716520|8727350|P3|Washout Period 2 (10 to 14 Days)|Adverse Event|1
2521433|NCT01716520|8727351|P2|Washout Period 2 (10 to 14 Days)|Adverse Event|0
2521434|NCT01716520|8727352|P1|Washout Period 2 (10 to 14 Days)|Adverse Event|1
2521435|NCT01716520|8727347|P6|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
2521436|NCT01716520|8727348|P5|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
2521437|NCT01716520|8727349|P4|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1
2521438|NCT01716520|8727350|P3|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
2521439|NCT01716520|8727351|P2|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
2521440|NCT01716520|8727352|P1|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
2521441|NCT01716520|8727347|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
2521442|NCT01716520|8727348|P5|Treatment Period 2 (14 Days)|Protocol Violation|1
2521443|NCT01716520|8727349|P4|Treatment Period 2 (14 Days)|Protocol Violation|0
2521444|NCT01716520|8727350|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
2521445|NCT01716520|8727351|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
2521446|NCT01716520|8727352|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
2521447|NCT01716520|8727347|P6|Treatment Period 2 (14 Days)|Adverse Event|0
2521448|NCT01716520|8727348|P5|Treatment Period 2 (14 Days)|Adverse Event|1
2521449|NCT01716520|8727349|P4|Treatment Period 2 (14 Days)|Adverse Event|0
2521450|NCT01716520|8727350|P3|Treatment Period 2 (14 Days)|Adverse Event|0
2521451|NCT01716520|8727351|P2|Treatment Period 2 (14 Days)|Adverse Event|0
2521452|NCT01716520|8727352|P1|Treatment Period 2 (14 Days)|Adverse Event|0
2521453|NCT01716520|8727347|P6|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
2521454|NCT01716520|8727348|P5|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
2521455|NCT01716520|8727349|P4|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
2521456|NCT01716520|8727350|P3|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
2521457|NCT01716520|8727351|P2|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
2521458|NCT01716520|8727352|P1|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
2521459|NCT01716520|8727347|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
2521460|NCT01716520|8727348|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
2521461|NCT01716520|8727349|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
2521462|NCT01716520|8727350|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
2521463|NCT01716520|8727351|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
2521464|NCT01716520|8727352|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
2521465|NCT01716520|8727347|P6|Washout Period 1 (10 to 14 Days)|Adverse Event|0
2521466|NCT01716520|8727348|P5|Washout Period 1 (10 to 14 Days)|Adverse Event|0
2521467|NCT01716520|8727349|P4|Washout Period 1 (10 to 14 Days)|Adverse Event|0
2521468|NCT01716520|8727350|P3|Washout Period 1 (10 to 14 Days)|Adverse Event|0
2521469|NCT01716520|8727351|P2|Washout Period 1 (10 to 14 Days)|Adverse Event|1
2521470|NCT01716520|8727352|P1|Washout Period 1 (10 to 14 Days)|Adverse Event|0
2521471|NCT01716520|8727347|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2521472|NCT01716520|8727348|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2521473|NCT01716520|8727349|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2521474|NCT01716520|8727350|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2521475|NCT01716520|8727351|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
2521476|NCT01716520|8727352|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2521477|NCT01716520|8727347|P6|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
2521478|NCT01716520|8727348|P5|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
2521479|NCT01716520|8727349|P4|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
2521480|NCT01716520|8727350|P3|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2
2521481|NCT01716520|8727351|P2|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
2521482|NCT01716520|8727352|P1|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
2521483|NCT01716520|8727347|P6|Treatment Period 1 (14 Days)|Adverse Event|0
2521484|NCT01716520|8727348|P5|Treatment Period 1 (14 Days)|Adverse Event|0
2521485|NCT01716520|8727349|P4|Treatment Period 1 (14 Days)|Adverse Event|0
2521486|NCT01716520|8727350|P3|Treatment Period 1 (14 Days)|Adverse Event|0
2521487|NCT01716520|8727351|P2|Treatment Period 1 (14 Days)|Adverse Event|0
2521488|NCT01716520|8727352|P1|Treatment Period 1 (14 Days)|Adverse Event|1
2521489|NCT01716234|8727407|P7|Overall Study|Withdrawal by Subject|0
2521490|NCT01716234|8727408|P6|Overall Study|Withdrawal by Subject|3
2521491|NCT01716234|8727409|P5|Overall Study|Withdrawal by Subject|1
2521492|NCT01716234|8727410|P4|Overall Study|Withdrawal by Subject|2
2521493|NCT01716234|8727411|P3|Overall Study|Withdrawal by Subject|2
2521494|NCT01716234|8727412|P2|Overall Study|Withdrawal by Subject|0
2521495|NCT01716234|8727413|P1|Overall Study|Withdrawal by Subject|3
2521496|NCT01716234|8727407|P7|Overall Study|Adverse Event|0
2521497|NCT01716234|8727408|P6|Overall Study|Adverse Event|6
2521498|NCT01716234|8727409|P5|Overall Study|Adverse Event|3
2521499|NCT01716234|8727410|P4|Overall Study|Adverse Event|8
2521500|NCT01716234|8727411|P3|Overall Study|Adverse Event|2
2521501|NCT01716234|8727412|P2|Overall Study|Adverse Event|10
2521502|NCT01716234|8727413|P1|Overall Study|Adverse Event|7
2521503|NCT01716234|8727407|P7|Overall Study|Did not meet protocol eligibility|0
2521504|NCT01716234|8727408|P6|Overall Study|Did not meet protocol eligibility|4
2521505|NCT01716234|8727409|P5|Overall Study|Did not meet protocol eligibility|0
2521506|NCT01716234|8727410|P4|Overall Study|Did not meet protocol eligibility|0
2521507|NCT01716234|8727411|P3|Overall Study|Did not meet protocol eligibility|1
2521508|NCT01716234|8727412|P2|Overall Study|Did not meet protocol eligibility|0
2521509|NCT01716234|8727413|P1|Overall Study|Did not meet protocol eligibility|0
2521510|NCT01716234|8727407|P7|Overall Study|Lack of Efficacy|0
2521511|NCT01716234|8727408|P6|Overall Study|Lack of Efficacy|0
2521512|NCT01716234|8727409|P5|Overall Study|Lack of Efficacy|0
2521513|NCT01716234|8727410|P4|Overall Study|Lack of Efficacy|1
2521514|NCT01716234|8727411|P3|Overall Study|Lack of Efficacy|0
2521515|NCT01716234|8727412|P2|Overall Study|Lack of Efficacy|0
2521516|NCT01716234|8727413|P1|Overall Study|Lack of Efficacy|0
2521517|NCT01716234|8727407|P7|Overall Study|Protocol Violation|0
2521518|NCT01716234|8727408|P6|Overall Study|Protocol Violation|1
2521519|NCT01716234|8727409|P5|Overall Study|Protocol Violation|1
2521520|NCT01716234|8727410|P4|Overall Study|Protocol Violation|1
2521521|NCT01716234|8727411|P3|Overall Study|Protocol Violation|0
2521522|NCT01716234|8727412|P2|Overall Study|Protocol Violation|0
2521523|NCT01716234|8727413|P1|Overall Study|Protocol Violation|0
2521524|NCT01716169|8727476|P1|Overall Study|inconsistent dressing application|1
2521525|NCT01716169|8727476|P1|Overall Study|Withdrawal by Subject|1
2521526|NCT01716169|8727476|P1|Overall Study|Lost to Follow-up|1
2521527|NCT01716169|8727476|P1|Overall Study|Adverse Event|1
2521528|NCT01716156|8727485|P3|Overall Study|Lost to Follow-up|0
2521529|NCT01716156|8727486|P2|Overall Study|Lost to Follow-up|0
2521530|NCT01716156|8727487|P1|Overall Study|Lost to Follow-up|1
2521531|NCT01716156|8727485|P3|Overall Study|Withdrawal by Subject|2
2521532|NCT01716156|8727486|P2|Overall Study|Withdrawal by Subject|1
2521533|NCT01716156|8727487|P1|Overall Study|Withdrawal by Subject|0
2521534|NCT01716156|8727485|P3|Overall Study|Protocol Violation|0
2521535|NCT01716156|8727486|P2|Overall Study|Protocol Violation|0
2521536|NCT01716156|8727487|P1|Overall Study|Protocol Violation|1
2521537|NCT01716117|8727513|P2|Overall Study|Withdrawal by Subject|0
2521538|NCT01716117|8727514|P1|Overall Study|Withdrawal by Subject|2
2521539|NCT01716117|8727513|P2|Overall Study|Death|2
2521540|NCT01716117|8727514|P1|Overall Study|Death|5
2521541|NCT01716104|8727533|P2|Overall Study|Do not meet inclusion criteria|7
2521542|NCT01716104|8727534|P1|Overall Study|Do not meet inclusion criteria|6
2521543|NCT01716052|8727560|P2|Overall Study|Withdrawal of funding|1
2521544|NCT01716052|8727561|P1|Overall Study|Withdrawal of funding|1
2521545|NCT01715896|8727603|P2|Overall Study|Other|5
2521546|NCT01715896|8727604|P1|Overall Study|Other|2
2521547|NCT01715896|8727603|P2|Overall Study|Withdrawal by Subject|4
2521548|NCT01715896|8727604|P1|Overall Study|Withdrawal by Subject|1
2521549|NCT01715896|8727603|P2|Overall Study|Lost to Follow-up|2
2521550|NCT01715896|8727604|P1|Overall Study|Lost to Follow-up|0
2521551|NCT01715857|8727677|P1|Overall Study|Did Not Meet Eligibility Criteria|96
2521552|NCT01715831|8727687|P1|Overall Study|Adverse Event|1
2521553|NCT01715805|8727703|P4|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
2521554|NCT01715805|8727704|P3|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
2521555|NCT01715805|8727705|P2|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3
2521556|NCT01715805|8727706|P1|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
2521557|NCT01715805|8727703|P4|Double-Blind or Continued Treatment|Other Reason Not Specified|3
2521558|NCT01715805|8727704|P3|Double-Blind or Continued Treatment|Other Reason Not Specified|0
2521559|NCT01715805|8727705|P2|Double-Blind or Continued Treatment|Other Reason Not Specified|1
2521560|NCT01715805|8727706|P1|Double-Blind or Continued Treatment|Other Reason Not Specified|0
2521561|NCT01715805|8727703|P4|Double-Blind or Continued Treatment|Lost to Follow-up|10
2521562|NCT01715805|8727704|P3|Double-Blind or Continued Treatment|Lost to Follow-up|10
2521563|NCT01715805|8727705|P2|Double-Blind or Continued Treatment|Lost to Follow-up|7
2521564|NCT01715805|8727706|P1|Double-Blind or Continued Treatment|Lost to Follow-up|0
2521565|NCT01715805|8727703|P4|Double-Blind or Continued Treatment|Withdrawal of consent|13
2521566|NCT01715805|8727704|P3|Double-Blind or Continued Treatment|Withdrawal of consent|11
2521567|NCT01715805|8727705|P2|Double-Blind or Continued Treatment|Withdrawal of consent|11
2521568|NCT01715805|8727706|P1|Double-Blind or Continued Treatment|Withdrawal of consent|0
2521569|NCT01715805|8727703|P4|Double-Blind or Continued Treatment|Protocol Violation|19
2521570|NCT01715805|8727704|P3|Double-Blind or Continued Treatment|Protocol Violation|12
2521571|NCT01715805|8727705|P2|Double-Blind or Continued Treatment|Protocol Violation|14
2521572|NCT01715805|8727706|P1|Double-Blind or Continued Treatment|Protocol Violation|0
2521573|NCT01715805|8727703|P4|Double-Blind or Continued Treatment|Adverse Event|2
2521574|NCT01715805|8727704|P3|Double-Blind or Continued Treatment|Adverse Event|23
2521575|NCT01715805|8727705|P2|Double-Blind or Continued Treatment|Adverse Event|3
2521576|NCT01715805|8727706|P1|Double-Blind or Continued Treatment|Adverse Event|0
2521577|NCT01715805|8727703|P4|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1
2521578|NCT01715805|8727704|P3|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
2521579|NCT01715805|8727705|P2|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
2521580|NCT01715805|8727706|P1|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
2521581|NCT01715805|8727703|P4|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
2521582|NCT01715805|8727704|P3|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
2521583|NCT01715805|8727705|P2|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
2521584|NCT01715805|8727706|P1|Placebo + ADT Lead-in Period|Other Reason Not Specified|10
2521585|NCT01715805|8727703|P4|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
2521586|NCT01715805|8727704|P3|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
2521587|NCT01715805|8727705|P2|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
2521588|NCT01715805|8727706|P1|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1
2521589|NCT01715805|8727703|P4|Placebo + ADT Lead-in Period|Lost to Follow-up|0
2521590|NCT01715805|8727704|P3|Placebo + ADT Lead-in Period|Lost to Follow-up|0
2521591|NCT01715805|8727705|P2|Placebo + ADT Lead-in Period|Lost to Follow-up|0
2521592|NCT01715805|8727706|P1|Placebo + ADT Lead-in Period|Lost to Follow-up|34
2521593|NCT01715805|8727703|P4|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
2521594|NCT01715805|8727704|P3|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
2521595|NCT01715805|8727705|P2|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
2521596|NCT01715805|8727706|P1|Placebo + ADT Lead-in Period|Withdrawal of Consent|49
2521597|NCT01715805|8727703|P4|Placebo + ADT Lead-in Period|Protocol Violation|0
2521598|NCT01715805|8727704|P3|Placebo + ADT Lead-in Period|Protocol Violation|0
2521599|NCT01715805|8727705|P2|Placebo + ADT Lead-in Period|Protocol Violation|0
2521600|NCT01715805|8727706|P1|Placebo + ADT Lead-in Period|Protocol Violation|74
2521601|NCT01715805|8727703|P4|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
2521602|NCT01715805|8727704|P3|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
2521603|NCT01715805|8727705|P2|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
2521604|NCT01715805|8727706|P1|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6
2521605|NCT01715805|8727703|P4|Placebo + ADT Lead-in Period|Adverse Event|0
2521606|NCT01715805|8727704|P3|Placebo + ADT Lead-in Period|Adverse Event|0
2521607|NCT01715805|8727705|P2|Placebo + ADT Lead-in Period|Adverse Event|0
2521608|NCT01715805|8727706|P1|Placebo + ADT Lead-in Period|Adverse Event|41
2521609|NCT01715415|8727720|P2|Open-label Treatment|Subject Noncompliant|1
2521610|NCT01715415|8727721|P1|Open-label Treatment|Subject Noncompliant|0
2521611|NCT01715415|8727720|P2|Open-label Treatment|Adverse Event|1
2521612|NCT01715415|8727721|P1|Open-label Treatment|Adverse Event|0
2521613|NCT01715415|8727720|P2|Double-blind Treatment|Other|0
2521614|NCT01715415|8727721|P1|Double-blind Treatment|Other|1
2521615|NCT01715415|8727720|P2|Double-blind Treatment|Withdrawal by Subject|1
2521616|NCT01715415|8727721|P1|Double-blind Treatment|Withdrawal by Subject|1
2521617|NCT01715415|8727720|P2|Double-blind Treatment|Adverse Event|0
2521618|NCT01715415|8727721|P1|Double-blind Treatment|Adverse Event|3
2521619|NCT01715415|8727720|P2|Double-blind Treatment|Did Not Receive Study Drug|1
2521620|NCT01715415|8727721|P1|Double-blind Treatment|Did Not Receive Study Drug|0
2521621|NCT01715298|8727735|P2|Overall Study|Patient/guardian decision|9
2521622|NCT01715298|8727736|P1|Overall Study|Patient/guardian decision|7
2521623|NCT01715298|8727735|P2|Overall Study|Lost to Follow-up|2
2521624|NCT01715298|8727736|P1|Overall Study|Lost to Follow-up|0
2521625|NCT01715285|8727774|P3|Open-label (OL) Extension Phase|Ongoing|72
2521626|NCT01715285|8727775|P2|Open-label (OL) Extension Phase|Ongoing|0
2521627|NCT01715285|8727776|P1|Open-label (OL) Extension Phase|Ongoing|157
2521628|NCT01715285|8727774|P3|Treatment Period|Placebo Cross-over|0
2521629|NCT01715285|8727775|P2|Treatment Period|Placebo Cross-over|72
2521630|NCT01715285|8727776|P1|Treatment Period|Placebo Cross-over|0
2521631|NCT01715285|8727774|P3|Treatment Period|Other|0
2521632|NCT01715285|8727775|P2|Treatment Period|Other|12
2521633|NCT01715285|8727776|P1|Treatment Period|Other|10
2521634|NCT01715285|8727774|P3|Treatment Period|Ongoing|0
2521635|NCT01715285|8727775|P2|Treatment Period|Ongoing|0
2521636|NCT01715285|8727776|P1|Treatment Period|Ongoing|157
2521637|NCT01715285|8727774|P3|Treatment Period|Physician Decision|0
2521638|NCT01715285|8727775|P2|Treatment Period|Physician Decision|23
2521639|NCT01715285|8727776|P1|Treatment Period|Physician Decision|21
2521640|NCT01715285|8727774|P3|Treatment Period|Withdrawal Of Consent|0
2521641|NCT01715285|8727775|P2|Treatment Period|Withdrawal Of Consent|47
2521642|NCT01715285|8727776|P1|Treatment Period|Withdrawal Of Consent|52
2521643|NCT01715285|8727774|P3|Treatment Period|Progressive Disease|0
2521644|NCT01715285|8727775|P2|Treatment Period|Progressive Disease|388
2521645|NCT01715285|8727776|P1|Treatment Period|Progressive Disease|254
2521646|NCT01715285|8727774|P3|Treatment Period|Noncompliance With Study Drug|0
2521647|NCT01715285|8727775|P2|Treatment Period|Noncompliance With Study Drug|2
2521648|NCT01715285|8727776|P1|Treatment Period|Noncompliance With Study Drug|4
2521649|NCT01715285|8727774|P3|Treatment Period|Death|0
2521650|NCT01715285|8727775|P2|Treatment Period|Death|23
2521651|NCT01715285|8727776|P1|Treatment Period|Death|36
2521652|NCT01715285|8727774|P3|Treatment Period|Lost to Follow-up|0
2521653|NCT01715285|8727775|P2|Treatment Period|Lost to Follow-up|2
2521654|NCT01715285|8727776|P1|Treatment Period|Lost to Follow-up|3
2521655|NCT01715285|8727774|P3|Treatment Period|Adverse Event|0
2521656|NCT01715285|8727775|P2|Treatment Period|Adverse Event|33
2521657|NCT01715285|8727776|P1|Treatment Period|Adverse Event|60
2521658|NCT01715129|8727812|P1|Overall Study|Other|1
2521659|NCT01715129|8727812|P1|Overall Study|Lost to Follow-up|1
2521660|NCT01715129|8727812|P1|Overall Study|Consent Withdrawn|2
2521661|NCT01715129|8727812|P1|Overall Study|Protocol Violation|1
2521662|NCT01715129|8727812|P1|Overall Study|Lack of Efficacy|3
2521663|NCT01715129|8727812|P1|Overall Study|Adverse Event, fatal|1
2521664|NCT01714947|8727838|P1|Part B|Progressive Disease|3
2521665|NCT01714817|8727879|P2|Overall Study|Hypersensitivity to the medication|1
2521666|NCT01714817|8727880|P1|Overall Study|Hypersensitivity to the medication|0
2521667|NCT01714817|8727879|P2|Overall Study|Antiproteinuric changed/dose increased|1
2521668|NCT01714817|8727880|P1|Overall Study|Antiproteinuric changed/dose increased|0
2521669|NCT01714817|8727879|P2|Overall Study|Need of use of Prohibited Medications|0
2521670|NCT01714817|8727880|P1|Overall Study|Need of use of Prohibited Medications|1
2521671|NCT01714817|8727879|P2|Overall Study|Change in Concomitant Medication|1
2521672|NCT01714817|8727880|P1|Overall Study|Change in Concomitant Medication|0
2521673|NCT01714817|8727879|P2|Overall Study|Not treated- received ACE inhibition|0
2521674|NCT01714817|8727880|P1|Overall Study|Not treated- received ACE inhibition|1
2521675|NCT01714817|8727879|P2|Overall Study|Participant no longer meets criteria|2
2521676|NCT01714817|8727880|P1|Overall Study|Participant no longer meets criteria|6
2521677|NCT01714817|8727879|P2|Overall Study|Pregnancy|0
2521678|NCT01714817|8727880|P1|Overall Study|Pregnancy|2
2521679|NCT01714817|8727879|P2|Overall Study|Poor / non-compliance|1
2521680|NCT01714817|8727880|P1|Overall Study|Poor / non-compliance|0
2521681|NCT01714817|8727879|P2|Overall Study|Lost to Follow-up|2
2521682|NCT01714817|8727880|P1|Overall Study|Lost to Follow-up|0
2521683|NCT01714817|8727879|P2|Overall Study|Death|1
2521684|NCT01714817|8727880|P1|Overall Study|Death|1
2521685|NCT01714817|8727879|P2|Overall Study|Withdrawal by Subject|7
2521686|NCT01714817|8727880|P1|Overall Study|Withdrawal by Subject|6
2521687|NCT01714817|8727879|P2|Overall Study|Adverse Event|17
2521688|NCT01714817|8727880|P1|Overall Study|Adverse Event|20
2521689|NCT01714817|8727879|P2|Overall Study|Lack of Efficacy|9
2521690|NCT01714817|8727880|P1|Overall Study|Lack of Efficacy|11
2521691|NCT01714726|8727912|P4|Open-Label Period|Lost to Follow-up|4
2521692|NCT01714726|8727913|P3|Open-Label Period|Lost to Follow-up|3
2521693|NCT01714726|8727914|P2|Open-Label Period|Lost to Follow-up|0
2521694|NCT01714726|8727915|P1|Open-Label Period|Lost to Follow-up|0
2521695|NCT01714726|8727912|P4|Open-Label Period|Developed specific withdrawal criteria|2
2521696|NCT01714726|8727913|P3|Open-Label Period|Developed specific withdrawal criteria|5
2521697|NCT01714726|8727914|P2|Open-Label Period|Developed specific withdrawal criteria|0
2521698|NCT01714726|8727915|P1|Open-Label Period|Developed specific withdrawal criteria|0
2521699|NCT01714726|8727912|P4|Open-Label Period|Withdrawal by Subject|19
2521700|NCT01714726|8727913|P3|Open-Label Period|Withdrawal by Subject|9
2521701|NCT01714726|8727914|P2|Open-Label Period|Withdrawal by Subject|0
2521702|NCT01714726|8727915|P1|Open-Label Period|Withdrawal by Subject|0
2521703|NCT01714726|8727912|P4|Open-Label Period|Adverse Event|0
2521704|NCT01714726|8727913|P3|Open-Label Period|Adverse Event|1
2521705|NCT01714726|8727914|P2|Open-Label Period|Adverse Event|0
2521706|NCT01714726|8727915|P1|Open-Label Period|Adverse Event|0
2521707|NCT01714726|8727912|P4|Open-Label Period|Other|3
2521708|NCT01714726|8727913|P3|Open-Label Period|Other|1
2521709|NCT01714726|8727914|P2|Open-Label Period|Other|0
2521710|NCT01714726|8727915|P1|Open-Label Period|Other|0
2521711|NCT01714726|8727912|P4|Double-Blinded Induction Period|Lost to Follow-up|0
2521712|NCT01714726|8727913|P3|Double-Blinded Induction Period|Lost to Follow-up|0
2521713|NCT01714726|8727914|P2|Double-Blinded Induction Period|Lost to Follow-up|2
2521714|NCT01714726|8727915|P1|Double-Blinded Induction Period|Lost to Follow-up|0
2521715|NCT01714726|8727912|P4|Double-Blinded Induction Period|Withdrawal by Subject|0
2521716|NCT01714726|8727913|P3|Double-Blinded Induction Period|Withdrawal by Subject|0
2521717|NCT01714726|8727914|P2|Double-Blinded Induction Period|Withdrawal by Subject|3
2521718|NCT01714726|8727915|P1|Double-Blinded Induction Period|Withdrawal by Subject|5
2521719|NCT01714726|8727912|P4|Double-Blinded Induction Period|Adverse Event|0
2521720|NCT01714726|8727913|P3|Double-Blinded Induction Period|Adverse Event|0
2521721|NCT01714726|8727914|P2|Double-Blinded Induction Period|Adverse Event|1
2521722|NCT01714726|8727915|P1|Double-Blinded Induction Period|Adverse Event|0
2521723|NCT01714726|8727912|P4|Double-Blinded Induction Period|Subject not in open label period|0
2521724|NCT01714726|8727913|P3|Double-Blinded Induction Period|Subject not in open label period|0
2521725|NCT01714726|8727914|P2|Double-Blinded Induction Period|Subject not in open label period|1
2521726|NCT01714726|8727915|P1|Double-Blinded Induction Period|Subject not in open label period|3
2521727|NCT01714687|8727995|P2|Overall Study|Lost to Follow-up|4
2521728|NCT01714687|8727996|P1|Overall Study|Lost to Follow-up|2
2521729|NCT01714687|8727995|P2|Overall Study|Withdrawal by Subject|0
2521730|NCT01714687|8727996|P1|Overall Study|Withdrawal by Subject|1
2521731|NCT01714635|8728020|P3|Overall Study|Missed 6-month exam|0
2521732|NCT01714635|8728021|P2|Overall Study|Missed 6-month exam|0
2521733|NCT01714635|8728022|P1|Overall Study|Missed 6-month exam|1
2521734|NCT01714635|8728020|P3|Overall Study|Discontinued|2
2521735|NCT01714635|8728021|P2|Overall Study|Discontinued|0
2521736|NCT01714635|8728022|P1|Overall Study|Discontinued|1
2521737|NCT01714609|8728038|P2|Overall Study|Protocol Violation|0
2521738|NCT01714609|8728039|P1|Overall Study|Protocol Violation|1
2521739|NCT01714544|8728045|P1|Overall Study|Withdrawal by Subject|1
2521740|NCT01714544|8728045|P1|Overall Study|Physician Decision|1
2521741|NCT01714544|8728045|P1|Overall Study|Lost to Follow-up|1
2521742|NCT01714310|8728116|P3|Double Blind Adjunctive Treatment|Protocol Violation|0
2521743|NCT01714310|8728117|P2|Double Blind Adjunctive Treatment|Protocol Violation|2
2521744|NCT01714310|8728118|P1|Double Blind Adjunctive Treatment|Protocol Violation|1
2521745|NCT01714310|8728116|P3|Double Blind Adjunctive Treatment|Adverse Event|0
2521746|NCT01714310|8728117|P2|Double Blind Adjunctive Treatment|Adverse Event|1
2521747|NCT01714310|8728118|P1|Double Blind Adjunctive Treatment|Adverse Event|1
2521748|NCT01714310|8728116|P3|Open Lisdexamfetamine Titration|Adverse Event|3
2521749|NCT01714310|8728117|P2|Open Lisdexamfetamine Titration|Adverse Event|0
2521750|NCT01714310|8728118|P1|Open Lisdexamfetamine Titration|Adverse Event|0
2521751|NCT01714310|8728116|P3|Open Lisdexamfetamine Titration|Protocol Violation|1
2521752|NCT01714310|8728117|P2|Open Lisdexamfetamine Titration|Protocol Violation|0
2521753|NCT01714310|8728118|P1|Open Lisdexamfetamine Titration|Protocol Violation|0
2521754|NCT01714063|8728171|P1|Overall Study|Equipment malfunction|2
2521755|NCT01713998|8728208|P3|Overall Study|Withdrawal by Subject|0
2521756|NCT01713998|8728209|P2|Overall Study|Withdrawal by Subject|0
2521757|NCT01713998|8728210|P1|Overall Study|Withdrawal by Subject|1
2521758|NCT01713998|8728208|P3|Overall Study|Lost to Follow-up|2
2521759|NCT01713998|8728209|P2|Overall Study|Lost to Follow-up|0
2521760|NCT01713998|8728210|P1|Overall Study|Lost to Follow-up|2
2521761|NCT01713946|8728231|P3|Overall Study|Patients never switched to everolimus|5
2521762|NCT01713946|8728232|P2|Overall Study|Patients never switched to everolimus|0
2521763|NCT01713946|8728233|P1|Overall Study|Patients never switched to everolimus|0
2521764|NCT01713946|8728231|P3|Overall Study|Did not continue in Post-Ext. Phase|0
2521765|NCT01713946|8728232|P2|Overall Study|Did not continue in Post-Ext. Phase|2
2521766|NCT01713946|8728233|P1|Overall Study|Did not continue in Post-Ext. Phase|1
2521767|NCT01713946|8728231|P3|Overall Study|Did not continue in Ext|0
2521768|NCT01713946|8728232|P2|Overall Study|Did not continue in Ext|3
2521769|NCT01713946|8728233|P1|Overall Study|Did not continue in Ext|0
2521770|NCT01713946|8728231|P3|Overall Study|Administrative problems|0
2521771|NCT01713946|8728232|P2|Overall Study|Administrative problems|0
2521772|NCT01713946|8728233|P1|Overall Study|Administrative problems|1
2521773|NCT01713946|8728231|P3|Overall Study|Lost to Follow-up|1
2521774|NCT01713946|8728232|P2|Overall Study|Lost to Follow-up|0
2521775|NCT01713946|8728233|P1|Overall Study|Lost to Follow-up|0
2521776|NCT01713946|8728231|P3|Overall Study|Protocol Violation|1
2521777|NCT01713946|8728232|P2|Overall Study|Protocol Violation|4
2521778|NCT01713946|8728233|P1|Overall Study|Protocol Violation|2
2521779|NCT01713946|8728231|P3|Overall Study|Lack of Efficacy|14
2521780|NCT01713946|8728232|P2|Overall Study|Lack of Efficacy|8
2521781|NCT01713946|8728233|P1|Overall Study|Lack of Efficacy|8
2521782|NCT01713946|8728231|P3|Overall Study|Withdrawal by Subject|8
2521783|NCT01713946|8728232|P2|Overall Study|Withdrawal by Subject|12
2521784|NCT01713946|8728233|P1|Overall Study|Withdrawal by Subject|12
2521785|NCT01713946|8728231|P3|Overall Study|Adverse Event|13
2521786|NCT01713946|8728232|P2|Overall Study|Adverse Event|14
2521787|NCT01713946|8728233|P1|Overall Study|Adverse Event|19
2521788|NCT01713946|8728231|P3|Overall Study|Death|2
2521789|NCT01713946|8728232|P2|Overall Study|Death|2
2521790|NCT01713946|8728233|P1|Overall Study|Death|0
2521791|NCT01713933|8728324|P1|Overall Study|Excluded from analysis as a BMI outlier|1
2521792|NCT01713933|8728324|P1|Overall Study|Withdrawal by Subject|3
2521793|NCT01713933|8728324|P1|Overall Study|Lost to Follow-up|2
2521794|NCT01713686|8728373|P1|Overall Study|Withdrawal by Subject|6
2521795|NCT01713686|8728373|P1|Overall Study|Lost to Follow-up|9
2521796|NCT01713582|8728443|P21|Overall Study|Disease progression and adverse event|0
2521797|NCT01713582|8728444|P20|Overall Study|Disease progression and adverse event|0
2521798|NCT01713582|8728445|P19|Overall Study|Disease progression and adverse event|0
2521799|NCT01713582|8728446|P18|Overall Study|Disease progression and adverse event|0
2521800|NCT01713582|8728447|P17|Overall Study|Disease progression and adverse event|1
2521801|NCT01713582|8728448|P16|Overall Study|Disease progression and adverse event|0
2521802|NCT01713582|8728449|P15|Overall Study|Disease progression and adverse event|0
2521803|NCT01713582|8728450|P14|Overall Study|Disease progression and adverse event|0
2521804|NCT01713582|8728451|P13|Overall Study|Disease progression and adverse event|0
2521805|NCT01713582|8728452|P12|Overall Study|Disease progression and adverse event|0
2521806|NCT01713582|8728453|P11|Overall Study|Disease progression and adverse event|0
2521807|NCT01713582|8728454|P10|Overall Study|Disease progression and adverse event|0
2521808|NCT01713582|8728455|P9|Overall Study|Disease progression and adverse event|0
2521809|NCT01713582|8728456|P8|Overall Study|Disease progression and adverse event|0
2521810|NCT01713582|8728457|P7|Overall Study|Disease progression and adverse event|0
2521811|NCT01713582|8728458|P6|Overall Study|Disease progression and adverse event|0
2521812|NCT01713582|8728459|P5|Overall Study|Disease progression and adverse event|0
2521813|NCT01713582|8728460|P4|Overall Study|Disease progression and adverse event|0
2521814|NCT01713582|8728461|P3|Overall Study|Disease progression and adverse event|0
2521815|NCT01713582|8728462|P2|Overall Study|Disease progression and adverse event|0
2521816|NCT01713582|8728463|P1|Overall Study|Disease progression and adverse event|0
2521817|NCT01713582|8728443|P21|Overall Study|Stopped to receive bone marrow graft|0
2521818|NCT01713582|8728444|P20|Overall Study|Stopped to receive bone marrow graft|0
2521819|NCT01713582|8728445|P19|Overall Study|Stopped to receive bone marrow graft|0
2521820|NCT01713582|8728446|P18|Overall Study|Stopped to receive bone marrow graft|0
2521821|NCT01713582|8728447|P17|Overall Study|Stopped to receive bone marrow graft|1
2521822|NCT01713582|8728448|P16|Overall Study|Stopped to receive bone marrow graft|0
2521823|NCT01713582|8728449|P15|Overall Study|Stopped to receive bone marrow graft|0
2521824|NCT01713582|8728450|P14|Overall Study|Stopped to receive bone marrow graft|0
2521825|NCT01713582|8728451|P13|Overall Study|Stopped to receive bone marrow graft|0
2521826|NCT01713582|8728452|P12|Overall Study|Stopped to receive bone marrow graft|0
2521827|NCT01713582|8728453|P11|Overall Study|Stopped to receive bone marrow graft|0
2521828|NCT01713582|8728454|P10|Overall Study|Stopped to receive bone marrow graft|0
2521829|NCT01713582|8728455|P9|Overall Study|Stopped to receive bone marrow graft|0
2521830|NCT01713582|8728456|P8|Overall Study|Stopped to receive bone marrow graft|0
2521831|NCT01713582|8728457|P7|Overall Study|Stopped to receive bone marrow graft|0
2521832|NCT01713582|8728458|P6|Overall Study|Stopped to receive bone marrow graft|0
2521833|NCT01713582|8728459|P5|Overall Study|Stopped to receive bone marrow graft|0
2521834|NCT01713582|8728460|P4|Overall Study|Stopped to receive bone marrow graft|0
2521835|NCT01713582|8728461|P3|Overall Study|Stopped to receive bone marrow graft|0
2521836|NCT01713582|8728462|P2|Overall Study|Stopped to receive bone marrow graft|0
2521837|NCT01713582|8728463|P1|Overall Study|Stopped to receive bone marrow graft|0
2521838|NCT01713582|8728443|P21|Overall Study|Withdrawal by Subject|0
2521839|NCT01713582|8728444|P20|Overall Study|Withdrawal by Subject|0
2521840|NCT01713582|8728445|P19|Overall Study|Withdrawal by Subject|0
2521841|NCT01713582|8728446|P18|Overall Study|Withdrawal by Subject|1
2521842|NCT01713582|8728447|P17|Overall Study|Withdrawal by Subject|0
2521843|NCT01713582|8728448|P16|Overall Study|Withdrawal by Subject|0
2521844|NCT01713582|8728449|P15|Overall Study|Withdrawal by Subject|0
2521845|NCT01713582|8728450|P14|Overall Study|Withdrawal by Subject|0
2521846|NCT01713582|8728451|P13|Overall Study|Withdrawal by Subject|0
2521847|NCT01713582|8728452|P12|Overall Study|Withdrawal by Subject|0
2521848|NCT01713582|8728453|P11|Overall Study|Withdrawal by Subject|0
2521849|NCT01713582|8728454|P10|Overall Study|Withdrawal by Subject|0
2521850|NCT01713582|8728455|P9|Overall Study|Withdrawal by Subject|0
2521851|NCT01713582|8728456|P8|Overall Study|Withdrawal by Subject|0
2521852|NCT01713582|8728457|P7|Overall Study|Withdrawal by Subject|0
2521853|NCT01713582|8728458|P6|Overall Study|Withdrawal by Subject|0
2521854|NCT01713582|8728459|P5|Overall Study|Withdrawal by Subject|0
2521855|NCT01713582|8728460|P4|Overall Study|Withdrawal by Subject|0
2521856|NCT01713582|8728461|P3|Overall Study|Withdrawal by Subject|0
2521857|NCT01713582|8728462|P2|Overall Study|Withdrawal by Subject|0
2521858|NCT01713582|8728463|P1|Overall Study|Withdrawal by Subject|0
2521859|NCT01713582|8728443|P21|Overall Study|Lack of Efficacy|0
2521860|NCT01713582|8728444|P20|Overall Study|Lack of Efficacy|0
2521861|NCT01713582|8728445|P19|Overall Study|Lack of Efficacy|0
2521862|NCT01713582|8728446|P18|Overall Study|Lack of Efficacy|0
2521863|NCT01713582|8728447|P17|Overall Study|Lack of Efficacy|0
2521864|NCT01713582|8728448|P16|Overall Study|Lack of Efficacy|0
2521865|NCT01713582|8728449|P15|Overall Study|Lack of Efficacy|0
2521866|NCT01713582|8728450|P14|Overall Study|Lack of Efficacy|0
2521867|NCT01713582|8728451|P13|Overall Study|Lack of Efficacy|0
2521868|NCT01713582|8728452|P12|Overall Study|Lack of Efficacy|0
2521869|NCT01713582|8728453|P11|Overall Study|Lack of Efficacy|2
2521870|NCT01713582|8728454|P10|Overall Study|Lack of Efficacy|1
2521871|NCT01713582|8728455|P9|Overall Study|Lack of Efficacy|0
2521872|NCT01713582|8728456|P8|Overall Study|Lack of Efficacy|0
2521873|NCT01713582|8728457|P7|Overall Study|Lack of Efficacy|0
2521874|NCT01713582|8728458|P6|Overall Study|Lack of Efficacy|0
2521875|NCT01713582|8728459|P5|Overall Study|Lack of Efficacy|0
2521876|NCT01713582|8728460|P4|Overall Study|Lack of Efficacy|0
2521877|NCT01713582|8728461|P3|Overall Study|Lack of Efficacy|0
2521878|NCT01713582|8728462|P2|Overall Study|Lack of Efficacy|0
2521879|NCT01713582|8728463|P1|Overall Study|Lack of Efficacy|0
2521880|NCT01713582|8728443|P21|Overall Study|Withdrawal of consent|0
2521881|NCT01713582|8728444|P20|Overall Study|Withdrawal of consent|0
2521882|NCT01713582|8728445|P19|Overall Study|Withdrawal of consent|1
2521883|NCT01713582|8728446|P18|Overall Study|Withdrawal of consent|0
2521884|NCT01713582|8728447|P17|Overall Study|Withdrawal of consent|0
2521885|NCT01713582|8728448|P16|Overall Study|Withdrawal of consent|0
2521886|NCT01713582|8728449|P15|Overall Study|Withdrawal of consent|0
2521887|NCT01713582|8728450|P14|Overall Study|Withdrawal of consent|0
2521888|NCT01713582|8728451|P13|Overall Study|Withdrawal of consent|0
2521889|NCT01713582|8728452|P12|Overall Study|Withdrawal of consent|0
2521890|NCT01713582|8728453|P11|Overall Study|Withdrawal of consent|0
2521891|NCT01713582|8728454|P10|Overall Study|Withdrawal of consent|1
2521892|NCT01713582|8728455|P9|Overall Study|Withdrawal of consent|0
2521893|NCT01713582|8728456|P8|Overall Study|Withdrawal of consent|0
2521894|NCT01713582|8728457|P7|Overall Study|Withdrawal of consent|0
2521895|NCT01713582|8728458|P6|Overall Study|Withdrawal of consent|1
2521896|NCT01713582|8728459|P5|Overall Study|Withdrawal of consent|0
2521897|NCT01713582|8728460|P4|Overall Study|Withdrawal of consent|0
2521898|NCT01713582|8728461|P3|Overall Study|Withdrawal of consent|1
2521899|NCT01713582|8728462|P2|Overall Study|Withdrawal of consent|0
2521900|NCT01713582|8728463|P1|Overall Study|Withdrawal of consent|0
2521901|NCT01713582|8728443|P21|Overall Study|Adverse event-unrelated|0
2521902|NCT01713582|8728444|P20|Overall Study|Adverse event-unrelated|0
2521903|NCT01713582|8728445|P19|Overall Study|Adverse event-unrelated|0
2521904|NCT01713582|8728446|P18|Overall Study|Adverse event-unrelated|0
2521905|NCT01713582|8728447|P17|Overall Study|Adverse event-unrelated|0
2521906|NCT01713582|8728448|P16|Overall Study|Adverse event-unrelated|0
2521907|NCT01713582|8728449|P15|Overall Study|Adverse event-unrelated|1
2521908|NCT01713582|8728450|P14|Overall Study|Adverse event-unrelated|1
2521909|NCT01713582|8728451|P13|Overall Study|Adverse event-unrelated|0
2521910|NCT01713582|8728452|P12|Overall Study|Adverse event-unrelated|0
2521911|NCT01713582|8728453|P11|Overall Study|Adverse event-unrelated|0
2521912|NCT01713582|8728454|P10|Overall Study|Adverse event-unrelated|0
2521913|NCT01713582|8728455|P9|Overall Study|Adverse event-unrelated|0
2521914|NCT01713582|8728456|P8|Overall Study|Adverse event-unrelated|1
2521915|NCT01713582|8728457|P7|Overall Study|Adverse event-unrelated|1
2521916|NCT01713582|8728458|P6|Overall Study|Adverse event-unrelated|1
2521917|NCT01713582|8728459|P5|Overall Study|Adverse event-unrelated|0
2521918|NCT01713582|8728460|P4|Overall Study|Adverse event-unrelated|0
2521919|NCT01713582|8728461|P3|Overall Study|Adverse event-unrelated|0
2521920|NCT01713582|8728462|P2|Overall Study|Adverse event-unrelated|0
2521921|NCT01713582|8728463|P1|Overall Study|Adverse event-unrelated|0
2521922|NCT01713582|8728443|P21|Overall Study|Adverse event-related|0
2521923|NCT01713582|8728444|P20|Overall Study|Adverse event-related|0
2521924|NCT01713582|8728445|P19|Overall Study|Adverse event-related|1
2521925|NCT01713582|8728446|P18|Overall Study|Adverse event-related|0
2521926|NCT01713582|8728447|P17|Overall Study|Adverse event-related|0
2521927|NCT01713582|8728448|P16|Overall Study|Adverse event-related|0
2521928|NCT01713582|8728449|P15|Overall Study|Adverse event-related|0
2521929|NCT01713582|8728450|P14|Overall Study|Adverse event-related|0
2521930|NCT01713582|8728451|P13|Overall Study|Adverse event-related|0
2521931|NCT01713582|8728452|P12|Overall Study|Adverse event-related|0
2521932|NCT01713582|8728453|P11|Overall Study|Adverse event-related|1
2521933|NCT01713582|8728454|P10|Overall Study|Adverse event-related|1
2521934|NCT01713582|8728455|P9|Overall Study|Adverse event-related|0
2521935|NCT01713582|8728456|P8|Overall Study|Adverse event-related|0
2521936|NCT01713582|8728457|P7|Overall Study|Adverse event-related|0
2521937|NCT01713582|8728458|P6|Overall Study|Adverse event-related|0
2521938|NCT01713582|8728459|P5|Overall Study|Adverse event-related|0
2521939|NCT01713582|8728460|P4|Overall Study|Adverse event-related|0
2521940|NCT01713582|8728461|P3|Overall Study|Adverse event-related|0
2521941|NCT01713582|8728462|P2|Overall Study|Adverse event-related|0
2521942|NCT01713582|8728463|P1|Overall Study|Adverse event-related|0
2521943|NCT01713582|8728443|P21|Overall Study|Death|0
2521944|NCT01713582|8728444|P20|Overall Study|Death|0
2521945|NCT01713582|8728445|P19|Overall Study|Death|0
2521946|NCT01713582|8728446|P18|Overall Study|Death|0
2521947|NCT01713582|8728447|P17|Overall Study|Death|0
2521948|NCT01713582|8728448|P16|Overall Study|Death|0
2521949|NCT01713582|8728449|P15|Overall Study|Death|0
2521950|NCT01713582|8728450|P14|Overall Study|Death|0
2521951|NCT01713582|8728451|P13|Overall Study|Death|0
2521952|NCT01713582|8728452|P12|Overall Study|Death|0
2521953|NCT01713582|8728453|P11|Overall Study|Death|3
2521954|NCT01713582|8728454|P10|Overall Study|Death|4
2521955|NCT01713582|8728455|P9|Overall Study|Death|3
2521956|NCT01713582|8728456|P8|Overall Study|Death|2
2521957|NCT01713582|8728457|P7|Overall Study|Death|3
2521958|NCT01713582|8728458|P6|Overall Study|Death|3
2521959|NCT01713582|8728459|P5|Overall Study|Death|1
2521960|NCT01713582|8728460|P4|Overall Study|Death|1
2521961|NCT01713582|8728461|P3|Overall Study|Death|0
2521962|NCT01713582|8728462|P2|Overall Study|Death|0
2521963|NCT01713582|8728463|P1|Overall Study|Death|0
2521964|NCT01713582|8728443|P21|Overall Study|Disease progression|15
2521965|NCT01713582|8728444|P20|Overall Study|Disease progression|5
2521966|NCT01713582|8728445|P19|Overall Study|Disease progression|3
2521967|NCT01713582|8728446|P18|Overall Study|Disease progression|2
2521968|NCT01713582|8728447|P17|Overall Study|Disease progression|5
2521969|NCT01713582|8728448|P16|Overall Study|Disease progression|6
2521970|NCT01713582|8728449|P15|Overall Study|Disease progression|6
2521971|NCT01713582|8728450|P14|Overall Study|Disease progression|3
2521972|NCT01713582|8728451|P13|Overall Study|Disease progression|3
2521973|NCT01713582|8728452|P12|Overall Study|Disease progression|5
2521974|NCT01713582|8728453|P11|Overall Study|Disease progression|10
2521975|NCT01713582|8728454|P10|Overall Study|Disease progression|11
2521976|NCT01713582|8728455|P9|Overall Study|Disease progression|3
2521977|NCT01713582|8728456|P8|Overall Study|Disease progression|3
2521978|NCT01713582|8728457|P7|Overall Study|Disease progression|3
2521979|NCT01713582|8728458|P6|Overall Study|Disease progression|3
2521980|NCT01713582|8728459|P5|Overall Study|Disease progression|3
2521981|NCT01713582|8728460|P4|Overall Study|Disease progression|2
2521982|NCT01713582|8728461|P3|Overall Study|Disease progression|3
2521983|NCT01713582|8728462|P2|Overall Study|Disease progression|3
2521984|NCT01713582|8728463|P1|Overall Study|Disease progression|3
2521985|NCT01713530|8728626|P2|Overall Study|Unclassified|2
2521986|NCT01713530|8728627|P1|Overall Study|Unclassified|4
2521987|NCT01713530|8728626|P2|Overall Study|Withdrawal criteria|12
2521988|NCT01713530|8728627|P1|Overall Study|Withdrawal criteria|21
2521989|NCT01713530|8728626|P2|Overall Study|Adverse Event|5
2521990|NCT01713530|8728627|P1|Overall Study|Adverse Event|0
2521991|NCT01713348|8728658|P4|Overall Study|Lost to Follow-up|0
2521992|NCT01713348|8728659|P3|Overall Study|Lost to Follow-up|0
2521993|NCT01713348|8728660|P2|Overall Study|Lost to Follow-up|0
2521994|NCT01713348|8728661|P1|Overall Study|Lost to Follow-up|1
2521995|NCT01713348|8728658|P4|Overall Study|Withdrawal by Subject|0
2521996|NCT01713348|8728659|P3|Overall Study|Withdrawal by Subject|2
2521997|NCT01713348|8728660|P2|Overall Study|Withdrawal by Subject|2
2521998|NCT01713348|8728661|P1|Overall Study|Withdrawal by Subject|3
2521999|NCT01713283|8728691|P2|Overall Study|Lost to Follow-up|1
2522000|NCT01713283|8728692|P1|Overall Study|Lost to Follow-up|1
2522001|NCT01713283|8728691|P2|Overall Study|Lack of Efficacy|2
2522002|NCT01713283|8728692|P1|Overall Study|Lack of Efficacy|10
2522003|NCT01713036|8728714|P1|Overall Study|Death|1
2522004|NCT01712984|8728754|P3|Overall Study|Withdrawal by Subject|7
2522005|NCT01712984|8728755|P2|Overall Study|Withdrawal by Subject|6
2522006|NCT01712984|8728756|P1|Overall Study|Withdrawal by Subject|6
2522007|NCT01712984|8728754|P3|Overall Study|Lost to Follow-up|1
2522008|NCT01712984|8728755|P2|Overall Study|Lost to Follow-up|10
2522009|NCT01712984|8728756|P1|Overall Study|Lost to Follow-up|8
2522010|NCT01712984|8728754|P3|Overall Study|Protocol Violation|1
2522011|NCT01712984|8728755|P2|Overall Study|Protocol Violation|0
2522012|NCT01712984|8728756|P1|Overall Study|Protocol Violation|2
2522013|NCT01712984|8728754|P3|Overall Study|Adverse Event|1
2522014|NCT01712984|8728755|P2|Overall Study|Adverse Event|0
2522015|NCT01712984|8728756|P1|Overall Study|Adverse Event|0
2522016|NCT01712854|8728776|P1|Overall Study|Physician Decision|1
2522017|NCT01712685|8728799|P1|Overall Study|pt declined to participate before trmt|1
2522018|NCT01712516|8728815|P4|Overall Study|Withdrawal by Subject|9
2522019|NCT01712516|8728816|P3|Overall Study|Withdrawal by Subject|3
2522020|NCT01712516|8728817|P2|Overall Study|Withdrawal by Subject|9
2522021|NCT01712516|8728818|P1|Overall Study|Withdrawal by Subject|3
2522022|NCT01712516|8728815|P4|Overall Study|Physician Decision|1
2522023|NCT01712516|8728816|P3|Overall Study|Physician Decision|0
2522024|NCT01712516|8728817|P2|Overall Study|Physician Decision|0
2522025|NCT01712516|8728818|P1|Overall Study|Physician Decision|2
2522026|NCT01712516|8728815|P4|Overall Study|Protocol deviation|0
2522027|NCT01712516|8728816|P3|Overall Study|Protocol deviation|1
2522028|NCT01712516|8728817|P2|Overall Study|Protocol deviation|0
2522029|NCT01712516|8728818|P1|Overall Study|Protocol deviation|1
2522030|NCT01712516|8728815|P4|Overall Study|Death|0
2522031|NCT01712516|8728816|P3|Overall Study|Death|0
2522032|NCT01712516|8728817|P2|Overall Study|Death|1
2522033|NCT01712516|8728818|P1|Overall Study|Death|0
2522034|NCT01712516|8728815|P4|Overall Study|Lost to Follow-up|1
2522035|NCT01712516|8728816|P3|Overall Study|Lost to Follow-up|2
2522036|NCT01712516|8728817|P2|Overall Study|Lost to Follow-up|0
2522037|NCT01712516|8728818|P1|Overall Study|Lost to Follow-up|0
2522038|NCT01712516|8728815|P4|Overall Study|Technical problems|2
2522039|NCT01712516|8728816|P3|Overall Study|Technical problems|0
2522040|NCT01712516|8728817|P2|Overall Study|Technical problems|0
2522041|NCT01712516|8728818|P1|Overall Study|Technical problems|0
2522042|NCT01712490|8728870|P2|Overall Study|Lost to Follow-up|29
2522043|NCT01712490|8728871|P1|Overall Study|Lost to Follow-up|16
2522044|NCT01712490|8728870|P2|Overall Study|Withdrawal by Subject|44
2522045|NCT01712490|8728871|P1|Overall Study|Withdrawal by Subject|36
2522046|NCT01712490|8728870|P2|Overall Study|Other|11
2522047|NCT01712490|8728871|P1|Overall Study|Other|11
2522048|NCT01712490|8728870|P2|Overall Study|Ongoing|586
2522049|NCT01712490|8728871|P1|Overall Study|Ongoing|601
2522050|NCT01712438|8728908|P1|Overall Study|Prematurely Discontinued|25
2522051|NCT01712438|8728908|P1|Overall Study|Violated inclusion & exclusion criteria|4
2522052|NCT01712438|8728908|P1|Overall Study|Ongoing ITI treatment|6
2522053|NCT01712438|8728908|P1|Overall Study|Not treated with Human-cl rhFVIII|2
2522054|NCT01712399|8728918|P1|Overall Study|Study closure|345
2522055|NCT01712399|8728918|P1|Overall Study|Adverse Event|11
2522056|NCT01712399|8728918|P1|Overall Study|Death|1
2522057|NCT01712399|8728918|P1|Overall Study|Withdrawal by Subject|39
2522058|NCT01712399|8728918|P1|Overall Study|Lost to Follow-up|1
2522059|NCT01712334|8728964|P2|Treatment Period 1|Randomized in Error|2
2522060|NCT01712334|8728965|P1|Treatment Period 1|Randomized in Error|0
2522061|NCT01712256|8728973|P1|Overall Study|Lost to Follow-up|1
2522062|NCT01712204|8729003|P2|Overall Study|Protocol Violation|1
2522063|NCT01712204|8729004|P1|Overall Study|Protocol Violation|1
2522064|NCT01712204|8729003|P2|Overall Study|Lost to Follow-up|0
2522065|NCT01712204|8729004|P1|Overall Study|Lost to Follow-up|1
2522066|NCT01712204|8729003|P2|Overall Study|Withdrawal by Subject|3
2522067|NCT01712204|8729004|P1|Overall Study|Withdrawal by Subject|3
2522068|NCT01712204|8729003|P2|Overall Study|Adverse Event|1
2522069|NCT01712204|8729004|P1|Overall Study|Adverse Event|3
2522070|NCT01712178|8729012|P2|Overall Study|Lost to Follow-up|1
2522071|NCT01712178|8729013|P1|Overall Study|Lost to Follow-up|0
2522072|NCT01712178|8729012|P2|Overall Study|Serious adverse event/withdrew consent|1
2522073|NCT01712178|8729013|P1|Overall Study|Serious adverse event/withdrew consent|0
2522074|NCT01712178|8729012|P2|Overall Study|Withdrew consent due to an adverse event|1
2522075|NCT01712178|8729013|P1|Overall Study|Withdrew consent due to an adverse event|1
2522076|NCT01712074|8729038|P3|Double Blind Period|No longer met eligibility criteria|0
2522077|NCT01712074|8729039|P2|Double Blind Period|No longer met eligibility criteria|3
2522078|NCT01712074|8729040|P1|Double Blind Period|No longer met eligibility criteria|0
2522079|NCT01712074|8729038|P3|Double Blind Period|Protocol Violation|1
2522080|NCT01712074|8729039|P2|Double Blind Period|Protocol Violation|0
2522081|NCT01712074|8729040|P1|Double Blind Period|Protocol Violation|0
2522082|NCT01712074|8729038|P3|Double Blind Period|Other|1
2522083|NCT01712074|8729039|P2|Double Blind Period|Other|4
2522084|NCT01712074|8729040|P1|Double Blind Period|Other|0
2522085|NCT01712074|8729038|P3|Double Blind Period|Lost to Follow-up|1
2522086|NCT01712074|8729039|P2|Double Blind Period|Lost to Follow-up|2
2522087|NCT01712074|8729040|P1|Double Blind Period|Lost to Follow-up|0
2522088|NCT01712074|8729038|P3|Double Blind Period|Death|0
2522089|NCT01712074|8729039|P2|Double Blind Period|Death|1
2522090|NCT01712074|8729040|P1|Double Blind Period|Death|0
2522091|NCT01712074|8729038|P3|Double Blind Period|No longer willing to participate|4
2522092|NCT01712074|8729039|P2|Double Blind Period|No longer willing to participate|2
2522093|NCT01712074|8729040|P1|Double Blind Period|No longer willing to participate|0
2522094|NCT01712074|8729038|P3|Double Blind Period|Adverse Event|1
2522095|NCT01712074|8729039|P2|Double Blind Period|Adverse Event|2
2522096|NCT01712074|8729040|P1|Double Blind Period|Adverse Event|0
2522097|NCT01712074|8729038|P3|Placebo Run-in Period|No longer willing to participate|0
2522098|NCT01712074|8729039|P2|Placebo Run-in Period|No longer willing to participate|0
2522099|NCT01712074|8729040|P1|Placebo Run-in Period|No longer willing to participate|1
2522100|NCT01712074|8729038|P3|Placebo Run-in Period|Other|0
2522101|NCT01712074|8729039|P2|Placebo Run-in Period|Other|0
2522102|NCT01712074|8729040|P1|Placebo Run-in Period|Other|1
2522103|NCT01712074|8729038|P3|Placebo Run-in Period|No longer meets eligibility criteria|0
2522104|NCT01712074|8729039|P2|Placebo Run-in Period|No longer meets eligibility criteria|0
2522105|NCT01712074|8729040|P1|Placebo Run-in Period|No longer meets eligibility criteria|5
2522106|NCT01712074|8729038|P3|Placebo Run-in Period|Lost to Follow-up|0
2522107|NCT01712074|8729039|P2|Placebo Run-in Period|Lost to Follow-up|0
2522108|NCT01712074|8729040|P1|Placebo Run-in Period|Lost to Follow-up|1
2522109|NCT01712074|8729038|P3|Placebo Run-in Period|Adverse Event|0
2522110|NCT01712074|8729039|P2|Placebo Run-in Period|Adverse Event|0
2522111|NCT01712074|8729040|P1|Placebo Run-in Period|Adverse Event|2
2522112|NCT01712061|8729096|P3|Overall Study|Other|0
2522113|NCT01712061|8729097|P2|Overall Study|Other|3
2522114|NCT01712061|8729098|P1|Overall Study|Other|0
2522115|NCT01712061|8729096|P3|Overall Study|Withdrawal by Subject|1
2522116|NCT01712061|8729097|P2|Overall Study|Withdrawal by Subject|7
2522117|NCT01712061|8729098|P1|Overall Study|Withdrawal by Subject|1
2522118|NCT01712061|8729096|P3|Overall Study|Medication Error Without Associated AE|0
2522119|NCT01712061|8729097|P2|Overall Study|Medication Error Without Associated AE|1
2522120|NCT01712061|8729098|P1|Overall Study|Medication Error Without Associated AE|0
2522121|NCT01712061|8729096|P3|Overall Study|Did Not Meet Entrance Criteria|3
2522122|NCT01712061|8729097|P2|Overall Study|Did Not Meet Entrance Criteria|6
2522123|NCT01712061|8729098|P1|Overall Study|Did Not Meet Entrance Criteria|4
2522124|NCT01712061|8729096|P3|Overall Study|Lost to Follow-up|1
2522125|NCT01712061|8729097|P2|Overall Study|Lost to Follow-up|0
2522126|NCT01712061|8729098|P1|Overall Study|Lost to Follow-up|1
2522127|NCT01712061|8729096|P3|Overall Study|Death|1
2522128|NCT01712061|8729097|P2|Overall Study|Death|0
2522129|NCT01712061|8729098|P1|Overall Study|Death|0
2522130|NCT01712061|8729096|P3|Overall Study|Adverse Event|5
2522131|NCT01712061|8729097|P2|Overall Study|Adverse Event|9
2522132|NCT01712061|8729098|P1|Overall Study|Adverse Event|4
2522133|NCT01712009|8729138|P3|Overall Study|Decision by Sponsor|12
2522134|NCT01712009|8729139|P2|Overall Study|Decision by Sponsor|14
2522135|NCT01712009|8729140|P1|Overall Study|Decision by Sponsor|12
2522136|NCT01712009|8729138|P3|Overall Study|Lost to Follow-up|1
2522137|NCT01712009|8729139|P2|Overall Study|Lost to Follow-up|0
2522138|NCT01712009|8729140|P1|Overall Study|Lost to Follow-up|2
2522139|NCT01712009|8729138|P3|Overall Study|Withdrawal by Subject|8
2522140|NCT01712009|8729139|P2|Overall Study|Withdrawal by Subject|15
2522141|NCT01712009|8729140|P1|Overall Study|Withdrawal by Subject|24
2522142|NCT01711866|8729174|P1|Overall Study|Adverse Event|2
2522143|NCT01711866|8729174|P1|Overall Study|Withdrawal by Subject|3
2522144|NCT01711866|8729174|P1|Overall Study|Noncompliant|3
2522145|NCT01711853|8729179|P1|Overall Study|Not treated|3
2522146|NCT01711736|8729186|P2|Overall Study|Migrated/moved from study area|1
2522147|NCT01711736|8729187|P1|Overall Study|Migrated/moved from study area|2
2522148|NCT01711736|8729186|P2|Overall Study|Withdrawal by Subject|6
2522149|NCT01711736|8729187|P1|Overall Study|Withdrawal by Subject|6
2522150|NCT01711736|8729186|P2|Overall Study|Lost to Follow-up|1
2522151|NCT01711736|8729187|P1|Overall Study|Lost to Follow-up|4
2522152|NCT01711645|8729215|P1|Overall Study|Physician Decision|5
2522153|NCT01711645|8729215|P1|Overall Study|Lost to Follow-up|6
2522154|NCT01711645|8729215|P1|Overall Study|Withdrawal by Subject|8
2522155|NCT01711619|8729252|P2|Overall Study|Lost to Follow-up|0
2522156|NCT01711619|8729253|P1|Overall Study|Lost to Follow-up|1
2522157|NCT01711619|8729252|P2|Overall Study|Adverse Event|0
2522158|NCT01711619|8729253|P1|Overall Study|Adverse Event|2
2522159|NCT01711619|8729252|P2|Overall Study|Protocol Violation|3
2522160|NCT01711619|8729253|P1|Overall Study|Protocol Violation|2
2522161|NCT01711619|8729252|P2|Overall Study|Withdrawal by Subject|7
2522162|NCT01711619|8729253|P1|Overall Study|Withdrawal by Subject|3
2522163|NCT01711619|8729252|P2|Overall Study|Early study termination|14
2522164|NCT01711619|8729253|P1|Overall Study|Early study termination|10
2522165|NCT01711541|8729270|P5|Overall Study|Ineligible|0
2522166|NCT01711541|8729271|P4|Overall Study|Ineligible|0
2522167|NCT01711541|8729272|P3|Overall Study|Ineligible|0
2522168|NCT01711541|8729273|P2|Overall Study|Ineligible|1
2522169|NCT01711541|8729274|P1|Overall Study|Ineligible|0
2522170|NCT01711541|8729270|P5|Overall Study|Cancel prior to treatment|0
2522171|NCT01711541|8729271|P4|Overall Study|Cancel prior to treatment|1
2522172|NCT01711541|8729272|P3|Overall Study|Cancel prior to treatment|0
2522173|NCT01711541|8729273|P2|Overall Study|Cancel prior to treatment|0
2522174|NCT01711541|8729274|P1|Overall Study|Cancel prior to treatment|0
2522175|NCT01711359|8729323|P3|Treatment Period|Randomized, Not Treated|0
2522176|NCT01711359|8729324|P2|Treatment Period|Randomized, Not Treated|1
2522177|NCT01711359|8729325|P1|Treatment Period|Randomized, Not Treated|3
2522178|NCT01711359|8729323|P3|Treatment Period|Lost to Follow-up|1
2522179|NCT01711359|8729324|P2|Treatment Period|Lost to Follow-up|1
2522180|NCT01711359|8729325|P1|Treatment Period|Lost to Follow-up|1
2522181|NCT01711359|8729323|P3|Treatment Period|Sponsor Decision|0
2522182|NCT01711359|8729324|P2|Treatment Period|Sponsor Decision|0
2522183|NCT01711359|8729325|P1|Treatment Period|Sponsor Decision|1
2522184|NCT01711359|8729323|P3|Treatment Period|Entry Criteria Not Met|0
2522185|NCT01711359|8729324|P2|Treatment Period|Entry Criteria Not Met|0
2522186|NCT01711359|8729325|P1|Treatment Period|Entry Criteria Not Met|1
2522187|NCT01711359|8729323|P3|Treatment Period|Death|0
2522188|NCT01711359|8729324|P2|Treatment Period|Death|0
2522189|NCT01711359|8729325|P1|Treatment Period|Death|3
2522190|NCT01711359|8729323|P3|Treatment Period|Physician Decision|2
2522191|NCT01711359|8729324|P2|Treatment Period|Physician Decision|3
2522192|NCT01711359|8729325|P1|Treatment Period|Physician Decision|4
2522193|NCT01711359|8729323|P3|Treatment Period|Adverse Event|24
2522194|NCT01711359|8729324|P2|Treatment Period|Adverse Event|10
2522195|NCT01711359|8729325|P1|Treatment Period|Adverse Event|8
2522196|NCT01711359|8729323|P3|Treatment Period|Lack of Efficacy|2
2522197|NCT01711359|8729324|P2|Treatment Period|Lack of Efficacy|2
2522198|NCT01711359|8729325|P1|Treatment Period|Lack of Efficacy|13
2522199|NCT01711359|8729323|P3|Treatment Period|Withdrawal by Subject|13
2522200|NCT01711359|8729324|P2|Treatment Period|Withdrawal by Subject|7
2522201|NCT01711359|8729325|P1|Treatment Period|Withdrawal by Subject|18
2522202|NCT01711216|8729396|P1|Overall Study|no reason specified|22
2522203|NCT01711216|8729396|P1|Overall Study|variety of other minor reasons|83
2522204|NCT01711216|8729396|P1|Overall Study|Lost to Follow-up|46
2522205|NCT01711216|8729396|P1|Overall Study|Withdrawal by Subject|6
2522206|NCT01711216|8729396|P1|Overall Study|Pregnancy|56
2522207|NCT01711216|8729396|P1|Overall Study|Adverse Event|4
2522208|NCT01710800|8729474|P1|Overall Study|Protocol Violation|1
2522209|NCT01710800|8729474|P1|Overall Study|Withdrawal by Subject|21
2522210|NCT01710709|8729538|P1|Overall Study|Lack of Efficacy|3
2522211|NCT01710709|8729538|P1|Overall Study|Protocol Violation|5
2522212|NCT01710709|8729538|P1|Overall Study|Withdrawal by Subject|53
2522213|NCT01710709|8729538|P1|Overall Study|Participant withdrawn by investigator|2
2522214|NCT01710709|8729538|P1|Overall Study|Participant met withdrawal criteria|33
2522215|NCT01710709|8729538|P1|Overall Study|Adverse Event|48
2522216|NCT01710709|8729538|P1|Overall Study|Lost to Follow-up|29
2522217|NCT01710657|8729553|P3|Overall Study|Lack of Efficacy|1
2522218|NCT01710657|8729554|P2|Overall Study|Lack of Efficacy|1
2522219|NCT01710657|8729555|P1|Overall Study|Lack of Efficacy|0
2522220|NCT01710657|8729553|P3|Overall Study|Withdrawal by Subject|2
2522221|NCT01710657|8729554|P2|Overall Study|Withdrawal by Subject|1
2522222|NCT01710657|8729555|P1|Overall Study|Withdrawal by Subject|0
2522223|NCT01710657|8729553|P3|Overall Study|Adverse Event|28
2522224|NCT01710657|8729554|P2|Overall Study|Adverse Event|8
2522225|NCT01710657|8729555|P1|Overall Study|Adverse Event|14
2522226|NCT01710657|8729553|P3|Overall Study|Protocol Violation|0
2522227|NCT01710657|8729554|P2|Overall Study|Protocol Violation|2
2522228|NCT01710657|8729555|P1|Overall Study|Protocol Violation|2
2522229|NCT01710657|8729553|P3|Overall Study|Lost to Follow-up|1
2522230|NCT01710657|8729554|P2|Overall Study|Lost to Follow-up|0
2522231|NCT01710657|8729555|P1|Overall Study|Lost to Follow-up|2
2522232|NCT01710527|8729572|P2|Period 2: Washout Period (7 Days)|Personal reasons|1
2522233|NCT01710527|8729573|P1|Period 2: Washout Period (7 Days)|Personal reasons|0
2522234|NCT01710514|8729599|P2|Overall Study|Withdrawal by Subject|0
2522235|NCT01710514|8729600|P1|Overall Study|Withdrawal by Subject|1
2522236|NCT01710514|8729599|P2|Overall Study|Adverse Event|7
2522237|NCT01710514|8729600|P1|Overall Study|Adverse Event|6
2522238|NCT01710501|8729621|P3|Overall Study|Lost to Follow-up|0
2522239|NCT01710501|8729622|P2|Overall Study|Lost to Follow-up|0
2522240|NCT01710501|8729623|P1|Overall Study|Lost to Follow-up|2
2522241|NCT01710358|8729655|P3|Rescue Period|Withdrawal by Subject|0
2522242|NCT01710358|8729656|P2|Rescue Period|Withdrawal by Subject|8
2522243|NCT01710358|8729657|P1|Rescue Period|Withdrawal by Subject|0
2522244|NCT01710358|8729655|P3|Rescue Period|Lack of Efficacy|0
2522245|NCT01710358|8729656|P2|Rescue Period|Lack of Efficacy|7
2522246|NCT01710358|8729657|P1|Rescue Period|Lack of Efficacy|0
2522247|NCT01710358|8729655|P3|Rescue Period|Death|0
2522248|NCT01710358|8729656|P2|Rescue Period|Death|1
2522249|NCT01710358|8729657|P1|Rescue Period|Death|0
2522250|NCT01710358|8729655|P3|Rescue Period|Adverse Event|0
2522251|NCT01710358|8729656|P2|Rescue Period|Adverse Event|15
2522252|NCT01710358|8729657|P1|Rescue Period|Adverse Event|0
2522253|NCT01710358|8729655|P3|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7
2522254|NCT01710358|8729656|P2|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3
2522255|NCT01710358|8729657|P1|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4
2522256|NCT01710358|8729655|P3|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0
2522257|NCT01710358|8729656|P2|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2
2522258|NCT01710358|8729657|P1|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1
2522259|NCT01710358|8729655|P3|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
2522260|NCT01710358|8729656|P2|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1
2522261|NCT01710358|8729657|P1|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
2522262|NCT01710358|8729655|P3|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1
2522263|NCT01710358|8729656|P2|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
2522264|NCT01710358|8729657|P1|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
2522265|NCT01710358|8729655|P3|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1
2522266|NCT01710358|8729656|P2|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
2522267|NCT01710358|8729657|P1|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
2522268|NCT01710358|8729655|P3|Treatment Period Part B (Weeks 24 to 52)|Death|1
2522269|NCT01710358|8729656|P2|Treatment Period Part B (Weeks 24 to 52)|Death|0
2522270|NCT01710358|8729657|P1|Treatment Period Part B (Weeks 24 to 52)|Death|1
2522271|NCT01710358|8729655|P3|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5
2522272|NCT01710358|8729656|P2|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16
2522273|NCT01710358|8729657|P1|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10
2522274|NCT01710358|8729655|P3|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0
2522275|NCT01710358|8729656|P2|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
2522276|NCT01710358|8729657|P1|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
2522277|NCT01710358|8729655|P3|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12
2522278|NCT01710358|8729656|P2|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5
2522279|NCT01710358|8729657|P1|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15
2522280|NCT01710358|8729655|P3|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
2522281|NCT01710358|8729656|P2|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
2522282|NCT01710358|8729657|P1|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4
2522283|NCT01710358|8729655|P3|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
2522284|NCT01710358|8729656|P2|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
2522285|NCT01710358|8729657|P1|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1
2522286|NCT01710358|8729655|P3|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
2522287|NCT01710358|8729656|P2|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1
2522288|NCT01710358|8729657|P1|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
2522289|NCT01710358|8729655|P3|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3
2522290|NCT01710358|8729656|P2|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1
2522291|NCT01710358|8729657|P1|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15
2522292|NCT01710358|8729655|P3|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
2522293|NCT01710358|8729656|P2|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
2522294|NCT01710358|8729657|P1|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0
2522295|NCT01710358|8729655|P3|Treatment Period Part A (Weeks 0 to 24)|Death|0
2522296|NCT01710358|8729656|P2|Treatment Period Part A (Weeks 0 to 24)|Death|2
2522297|NCT01710358|8729657|P1|Treatment Period Part A (Weeks 0 to 24)|Death|0
2522298|NCT01710358|8729655|P3|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7
2522299|NCT01710358|8729656|P2|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18
2522300|NCT01710358|8729657|P1|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15
2522301|NCT01710345|8729728|P3|Overall Study|Drug Dosing Error|0
2522302|NCT01710345|8729729|P2|Overall Study|Drug Dosing Error|0
2522303|NCT01710345|8729730|P1|Overall Study|Drug Dosing Error|1
2522304|NCT01710345|8729728|P3|Overall Study|Lack of Efficacy|1
2522305|NCT01710345|8729729|P2|Overall Study|Lack of Efficacy|3
2522306|NCT01710345|8729730|P1|Overall Study|Lack of Efficacy|2
2522307|NCT01710345|8729728|P3|Overall Study|Adverse Event|0
2522308|NCT01710345|8729729|P2|Overall Study|Adverse Event|2
2522309|NCT01710345|8729730|P1|Overall Study|Adverse Event|0
2522310|NCT01710046|8729789|P2|Overall Study|Lost to Follow-up|0
2522311|NCT01710046|8729790|P1|Overall Study|Lost to Follow-up|1
2522312|NCT01710033|8729830|P5|Stage 2|Adverse Event|1
2522313|NCT01710033|8729831|P4|Stage 2|Adverse Event|0
2522314|NCT01710033|8729832|P3|Stage 2|Adverse Event|0
2522315|NCT01710033|8729833|P2|Stage 2|Adverse Event|0
2522316|NCT01710033|8729834|P1|Stage 2|Adverse Event|0
2522317|NCT01710020|8729915|P1|Period 1|Protocol Violation|1
2522318|NCT01709903|8729934|P2|Overall Study|Adverse Event|18
2522319|NCT01709903|8729935|P1|Overall Study|Adverse Event|11
2522320|NCT01709903|8729934|P2|Overall Study|Withdrawal by Subject|6
2522321|NCT01709903|8729935|P1|Overall Study|Withdrawal by Subject|6
2522322|NCT01709903|8729934|P2|Overall Study|Lack of Efficacy|3
2522323|NCT01709903|8729935|P1|Overall Study|Lack of Efficacy|3
2522324|NCT01709903|8729934|P2|Overall Study|Protocol Violation|2
2522325|NCT01709903|8729935|P1|Overall Study|Protocol Violation|3
2522326|NCT01709903|8729934|P2|Overall Study|Death|0
2522327|NCT01709903|8729935|P1|Overall Study|Death|2
2522328|NCT01709903|8729934|P2|Overall Study|Lost to Follow-up|2
2522329|NCT01709903|8729935|P1|Overall Study|Lost to Follow-up|0
2522330|NCT01709903|8729934|P2|Overall Study|no longer needed study drug|1
2522331|NCT01709903|8729935|P1|Overall Study|no longer needed study drug|0
2522332|NCT01709903|8729934|P2|Overall Study|In ability to use device|1
2522333|NCT01709903|8729935|P1|Overall Study|In ability to use device|1
2522334|NCT01709903|8729934|P2|Overall Study|Abnormal test procedure results|0
2522335|NCT01709903|8729935|P1|Overall Study|Abnormal test procedure results|1
2522336|NCT01709903|8729934|P2|Overall Study|administrative problems|6
2522337|NCT01709903|8729935|P1|Overall Study|administrative problems|2
2522338|NCT01709864|8729959|P2|Overall Study|Death|1
2522339|NCT01709864|8729960|P1|Overall Study|Death|0
2522340|NCT01709864|8729959|P2|Overall Study|Adverse Event|2
2522341|NCT01709864|8729960|P1|Overall Study|Adverse Event|0
2522342|NCT01709864|8729959|P2|Overall Study|non-compliance with study treatment|1
2522343|NCT01709864|8729960|P1|Overall Study|non-compliance with study treatment|1
2522344|NCT01709864|8729959|P2|Overall Study|Lost to Follow-up|0
2522345|NCT01709864|8729960|P1|Overall Study|Lost to Follow-up|1
2522346|NCT01709864|8729959|P2|Overall Study|subject/guardian decision|6
2522347|NCT01709864|8729960|P1|Overall Study|subject/guardian decision|5
2522348|NCT01709864|8729959|P2|Overall Study|Physician Decision|1
2522349|NCT01709864|8729960|P1|Overall Study|Physician Decision|0
2522350|NCT01709838|8729994|P1|Overall Study|Protocol Violation|1
2522351|NCT01709838|8729994|P1|Overall Study|Death|3
2522352|NCT01709838|8729994|P1|Overall Study|Physician Decision|4
2522353|NCT01709838|8729994|P1|Overall Study|Adverse Event|4
2522354|NCT01709838|8729994|P1|Overall Study|Subject/guardian decision|8
2522355|NCT01709838|8729994|P1|Overall Study|Pregnancy|10
2522356|NCT01709838|8729994|P1|Overall Study|Lost to Follow-up|16
2522357|NCT01709838|8729994|P1|Overall Study|Withdrawal by Subject|21
2522358|NCT01709708|8730051|P2|Overall Study|Protocol Violation|2
2522359|NCT01709708|8730052|P1|Overall Study|Protocol Violation|1
2522360|NCT01709695|8730076|P2|Overall Study|Withdrawal by Subject|1
2522361|NCT01709695|8730077|P1|Overall Study|Withdrawal by Subject|1
2522362|NCT01709578|8730102|P3|Overall Study|Other, not related to safety or efficacy|5
2522363|NCT01709578|8730103|P2|Overall Study|Other, not related to safety or efficacy|7
2522364|NCT01709578|8730104|P1|Overall Study|Other, not related to safety or efficacy|2
2522365|NCT01709578|8730102|P3|Overall Study|Poor compliance to protocol|1
2522366|NCT01709578|8730103|P2|Overall Study|Poor compliance to protocol|2
2522367|NCT01709578|8730104|P1|Overall Study|Poor compliance to protocol|1
2522368|NCT01709578|8730102|P3|Overall Study|Lack of Efficacy|2
2522369|NCT01709578|8730103|P2|Overall Study|Lack of Efficacy|4
2522370|NCT01709578|8730104|P1|Overall Study|Lack of Efficacy|5
2522371|NCT01709578|8730102|P3|Overall Study|Adverse Event|17
2522372|NCT01709578|8730103|P2|Overall Study|Adverse Event|18
2522373|NCT01709578|8730104|P1|Overall Study|Adverse Event|9
2522374|NCT01709578|8730102|P3|Overall Study|Rescued and entered in long term safety|26
2522375|NCT01709578|8730103|P2|Overall Study|Rescued and entered in long term safety|25
2522376|NCT01709578|8730104|P1|Overall Study|Rescued and entered in long term safety|63
2522377|NCT01709513|8730235|P3|Overall Study|Other|7
2522378|NCT01709513|8730236|P2|Overall Study|Other|11
2522379|NCT01709513|8730237|P1|Overall Study|Other|3
2522380|NCT01709513|8730235|P3|Overall Study|Poor compliance to protocol|0
2522381|NCT01709513|8730236|P2|Overall Study|Poor compliance to protocol|0
2522382|NCT01709513|8730237|P1|Overall Study|Poor compliance to protocol|2
2522383|NCT01709513|8730235|P3|Overall Study|Adverse Event|23
2522384|NCT01709513|8730236|P2|Overall Study|Adverse Event|31
2522385|NCT01709513|8730237|P1|Overall Study|Adverse Event|16
2522386|NCT01709513|8730235|P3|Overall Study|Randomized but not treated|0
2522387|NCT01709513|8730236|P2|Overall Study|Randomized but not treated|1
2522388|NCT01709513|8730237|P1|Overall Study|Randomized but not treated|0
2522389|NCT01709500|8730298|P2|Overall Study|Treatment ongoing|78
2522390|NCT01709500|8730299|P1|Overall Study|Treatment ongoing|156
2522391|NCT01709500|8730298|P2|Overall Study|Related to IMP administration|0
2522392|NCT01709500|8730299|P1|Overall Study|Related to IMP administration|1
2522393|NCT01709500|8730298|P2|Overall Study|Other|1
2522394|NCT01709500|8730299|P1|Overall Study|Other|3
2522395|NCT01709500|8730298|P2|Overall Study|Poor compliance to protocol|1
2522396|NCT01709500|8730299|P1|Overall Study|Poor compliance to protocol|2
2522397|NCT01709500|8730298|P2|Overall Study|Adverse Event|1
2522398|NCT01709500|8730299|P1|Overall Study|Adverse Event|5
2522399|NCT01709500|8730298|P2|Overall Study|Randomized but not treated|1
2522400|NCT01709500|8730299|P1|Overall Study|Randomized but not treated|0
2522401|NCT01709409|8730377|P2|Overall Study|Protocol Violation|0
2522402|NCT01709409|8730378|P1|Overall Study|Protocol Violation|1
2522403|NCT01709383|8730386|P2|Overall Study|Lost to Follow-up|0
2522404|NCT01709383|8730387|P1|Overall Study|Lost to Follow-up|1
2522405|NCT01709331|8730405|P1|Overall Study|Adverse Event|1
2522406|NCT01709318|8730418|P7|Overall Study|Other Protocol Specified Criteria|0
2522407|NCT01709318|8730419|P6|Overall Study|Other Protocol Specified Criteria|0
2522408|NCT01709318|8730420|P5|Overall Study|Other Protocol Specified Criteria|0
2522409|NCT01709318|8730421|P4|Overall Study|Other Protocol Specified Criteria|0
2522410|NCT01709318|8730422|P3|Overall Study|Other Protocol Specified Criteria|0
2522411|NCT01709318|8730423|P2|Overall Study|Other Protocol Specified Criteria|1
2522412|NCT01709318|8730424|P1|Overall Study|Other Protocol Specified Criteria|0
2522413|NCT01709318|8730418|P7|Overall Study|Withdrawal by Subject|4
2522414|NCT01709318|8730419|P6|Overall Study|Withdrawal by Subject|2
2522415|NCT01709318|8730420|P5|Overall Study|Withdrawal by Subject|0
2522416|NCT01709318|8730421|P4|Overall Study|Withdrawal by Subject|3
2522417|NCT01709318|8730422|P3|Overall Study|Withdrawal by Subject|3
2522418|NCT01709318|8730423|P2|Overall Study|Withdrawal by Subject|0
2522419|NCT01709318|8730424|P1|Overall Study|Withdrawal by Subject|3
2522420|NCT01709318|8730418|P7|Overall Study|Technical Problems|0
2522421|NCT01709318|8730419|P6|Overall Study|Technical Problems|0
2522422|NCT01709318|8730420|P5|Overall Study|Technical Problems|0
2522423|NCT01709318|8730421|P4|Overall Study|Technical Problems|0
2522424|NCT01709318|8730422|P3|Overall Study|Technical Problems|0
2522425|NCT01709318|8730423|P2|Overall Study|Technical Problems|0
2522426|NCT01709318|8730424|P1|Overall Study|Technical Problems|1
2522427|NCT01709318|8730418|P7|Overall Study|Protocol Violation|1
2522428|NCT01709318|8730419|P6|Overall Study|Protocol Violation|0
2522429|NCT01709318|8730420|P5|Overall Study|Protocol Violation|2
2522430|NCT01709318|8730421|P4|Overall Study|Protocol Violation|0
2522431|NCT01709318|8730422|P3|Overall Study|Protocol Violation|0
2522432|NCT01709318|8730423|P2|Overall Study|Protocol Violation|0
2522433|NCT01709318|8730424|P1|Overall Study|Protocol Violation|0
2522434|NCT01709318|8730418|P7|Overall Study|Pregnancy|0
2522435|NCT01709318|8730419|P6|Overall Study|Pregnancy|0
2522436|NCT01709318|8730420|P5|Overall Study|Pregnancy|1
2522437|NCT01709318|8730421|P4|Overall Study|Pregnancy|0
2522438|NCT01709318|8730422|P3|Overall Study|Pregnancy|0
2522439|NCT01709318|8730423|P2|Overall Study|Pregnancy|0
2522440|NCT01709318|8730424|P1|Overall Study|Pregnancy|0
2522441|NCT01709318|8730418|P7|Overall Study|Physician Decision|1
2522442|NCT01709318|8730419|P6|Overall Study|Physician Decision|0
2522443|NCT01709318|8730420|P5|Overall Study|Physician Decision|0
2522444|NCT01709318|8730421|P4|Overall Study|Physician Decision|0
2522445|NCT01709318|8730422|P3|Overall Study|Physician Decision|0
2522446|NCT01709318|8730423|P2|Overall Study|Physician Decision|0
2522447|NCT01709318|8730424|P1|Overall Study|Physician Decision|0
2522448|NCT01709318|8730418|P7|Overall Study|Non-compliance with Study Drug|2
2522449|NCT01709318|8730419|P6|Overall Study|Non-compliance with Study Drug|0
2522450|NCT01709318|8730420|P5|Overall Study|Non-compliance with Study Drug|0
2522451|NCT01709318|8730421|P4|Overall Study|Non-compliance with Study Drug|1
2522452|NCT01709318|8730422|P3|Overall Study|Non-compliance with Study Drug|1
2522453|NCT01709318|8730423|P2|Overall Study|Non-compliance with Study Drug|2
2522454|NCT01709318|8730424|P1|Overall Study|Non-compliance with Study Drug|0
2522455|NCT01709318|8730418|P7|Overall Study|Lost to Follow-up|1
2522456|NCT01709318|8730419|P6|Overall Study|Lost to Follow-up|1
2522457|NCT01709318|8730420|P5|Overall Study|Lost to Follow-up|1
2522458|NCT01709318|8730421|P4|Overall Study|Lost to Follow-up|0
2522459|NCT01709318|8730422|P3|Overall Study|Lost to Follow-up|0
2522460|NCT01709318|8730423|P2|Overall Study|Lost to Follow-up|0
2522461|NCT01709318|8730424|P1|Overall Study|Lost to Follow-up|2
2522462|NCT01709318|8730418|P7|Overall Study|Adverse Event|2
2522463|NCT01709318|8730419|P6|Overall Study|Adverse Event|1
2522464|NCT01709318|8730420|P5|Overall Study|Adverse Event|0
2522465|NCT01709318|8730421|P4|Overall Study|Adverse Event|2
2522466|NCT01709318|8730422|P3|Overall Study|Adverse Event|2
2522467|NCT01709318|8730423|P2|Overall Study|Adverse Event|4
2522468|NCT01709318|8730424|P1|Overall Study|Adverse Event|3
2522469|NCT01709305|8730517|P5|Phase 2|Withdrawal by Subject|12
2522470|NCT01709305|8730518|P4|Phase 2|Withdrawal by Subject|15
2522471|NCT01709305|8730519|P3|Phase 2|Withdrawal by Subject|6
2522472|NCT01709305|8730520|P2|Phase 2|Withdrawal by Subject|8
2522473|NCT01709305|8730521|P1|Phase 2|Withdrawal by Subject|0
2522474|NCT01709305|8730517|P5|Phase 2|Protocol Violation|9
2522475|NCT01709305|8730518|P4|Phase 2|Protocol Violation|13
2522476|NCT01709305|8730519|P3|Phase 2|Protocol Violation|19
2522477|NCT01709305|8730520|P2|Phase 2|Protocol Violation|19
2522478|NCT01709305|8730521|P1|Phase 2|Protocol Violation|0
2522479|NCT01709305|8730517|P5|Phase 2|Physician Decision|2
2522480|NCT01709305|8730518|P4|Phase 2|Physician Decision|1
2522481|NCT01709305|8730519|P3|Phase 2|Physician Decision|0
2522482|NCT01709305|8730520|P2|Phase 2|Physician Decision|2
2522483|NCT01709305|8730521|P1|Phase 2|Physician Decision|0
2522484|NCT01709305|8730517|P5|Phase 2|Travel, moving, etc.|5
2522485|NCT01709305|8730518|P4|Phase 2|Travel, moving, etc.|3
2522486|NCT01709305|8730519|P3|Phase 2|Travel, moving, etc.|3
2522487|NCT01709305|8730520|P2|Phase 2|Travel, moving, etc.|2
2522488|NCT01709305|8730521|P1|Phase 2|Travel, moving, etc.|0
2522489|NCT01709305|8730517|P5|Phase 2|Lost to Follow-up|5
2522490|NCT01709305|8730518|P4|Phase 2|Lost to Follow-up|9
2522491|NCT01709305|8730519|P3|Phase 2|Lost to Follow-up|6
2522492|NCT01709305|8730520|P2|Phase 2|Lost to Follow-up|10
2522493|NCT01709305|8730521|P1|Phase 2|Lost to Follow-up|0
2522494|NCT01709305|8730517|P5|Phase 2|Laboratory Adverse Event|1
2522495|NCT01709305|8730518|P4|Phase 2|Laboratory Adverse Event|1
2522496|NCT01709305|8730519|P3|Phase 2|Laboratory Adverse Event|0
2522497|NCT01709305|8730520|P2|Phase 2|Laboratory Adverse Event|1
2522498|NCT01709305|8730521|P1|Phase 2|Laboratory Adverse Event|0
2522499|NCT01709305|8730517|P5|Phase 2|Hyperglycemia (lack of efficacy)|2
2522500|NCT01709305|8730518|P4|Phase 2|Hyperglycemia (lack of efficacy)|0
2522501|NCT01709305|8730519|P3|Phase 2|Hyperglycemia (lack of efficacy)|0
2522502|NCT01709305|8730520|P2|Phase 2|Hyperglycemia (lack of efficacy)|0
2522503|NCT01709305|8730521|P1|Phase 2|Hyperglycemia (lack of efficacy)|0
2522504|NCT01709305|8730517|P5|Phase 2|Death|0
2522505|NCT01709305|8730518|P4|Phase 2|Death|0
2522506|NCT01709305|8730519|P3|Phase 2|Death|1
2522507|NCT01709305|8730520|P2|Phase 2|Death|0
2522508|NCT01709305|8730521|P1|Phase 2|Death|0
2522509|NCT01709305|8730517|P5|Phase 2|Clinical Adverse Event|11
2522510|NCT01709305|8730518|P4|Phase 2|Clinical Adverse Event|6
2522511|NCT01709305|8730519|P3|Phase 2|Clinical Adverse Event|10
2522512|NCT01709305|8730520|P2|Phase 2|Clinical Adverse Event|10
2522513|NCT01709305|8730521|P1|Phase 2|Clinical Adverse Event|0
2522514|NCT01709305|8730517|P5|Phase 1|Withdrawal by Subject|0
2522515|NCT01709305|8730518|P4|Phase 1|Withdrawal by Subject|0
2522516|NCT01709305|8730519|P3|Phase 1|Withdrawal by Subject|0
2522517|NCT01709305|8730520|P2|Phase 1|Withdrawal by Subject|0
2522518|NCT01709305|8730521|P1|Phase 1|Withdrawal by Subject|218
2522519|NCT01709305|8730517|P5|Phase 1|Protocol Violation|0
2522520|NCT01709305|8730518|P4|Phase 1|Protocol Violation|0
2522521|NCT01709305|8730519|P3|Phase 1|Protocol Violation|0
2522522|NCT01709305|8730520|P2|Phase 1|Protocol Violation|0
2522523|NCT01709305|8730521|P1|Phase 1|Protocol Violation|118
2522524|NCT01709305|8730517|P5|Phase 1|Physician Decision|0
2522525|NCT01709305|8730518|P4|Phase 1|Physician Decision|0
2522526|NCT01709305|8730519|P3|Phase 1|Physician Decision|0
2522527|NCT01709305|8730520|P2|Phase 1|Physician Decision|0
2522528|NCT01709305|8730521|P1|Phase 1|Physician Decision|13
2522529|NCT01709305|8730517|P5|Phase 1|Travel, moving, etc.|0
2522530|NCT01709305|8730518|P4|Phase 1|Travel, moving, etc.|0
2522531|NCT01709305|8730519|P3|Phase 1|Travel, moving, etc.|0
2522532|NCT01709305|8730520|P2|Phase 1|Travel, moving, etc.|0
2522533|NCT01709305|8730521|P1|Phase 1|Travel, moving, etc.|30
2522534|NCT01709305|8730517|P5|Phase 1|Lost to Follow-up|0
2522535|NCT01709305|8730518|P4|Phase 1|Lost to Follow-up|0
2522536|NCT01709305|8730519|P3|Phase 1|Lost to Follow-up|0
2522537|NCT01709305|8730520|P2|Phase 1|Lost to Follow-up|0
2522538|NCT01709305|8730521|P1|Phase 1|Lost to Follow-up|147
2522539|NCT01709305|8730517|P5|Phase 1|Laboratory Adverse Event|0
2522540|NCT01709305|8730518|P4|Phase 1|Laboratory Adverse Event|0
2522541|NCT01709305|8730519|P3|Phase 1|Laboratory Adverse Event|0
2522542|NCT01709305|8730520|P2|Phase 1|Laboratory Adverse Event|0
2522543|NCT01709305|8730521|P1|Phase 1|Laboratory Adverse Event|16
2522544|NCT01709305|8730517|P5|Phase 1|Hyperglycemia (lack of efficacy)|0
2522545|NCT01709305|8730518|P4|Phase 1|Hyperglycemia (lack of efficacy)|0
2522546|NCT01709305|8730519|P3|Phase 1|Hyperglycemia (lack of efficacy)|0
2522547|NCT01709305|8730520|P2|Phase 1|Hyperglycemia (lack of efficacy)|0
2522548|NCT01709305|8730521|P1|Phase 1|Hyperglycemia (lack of efficacy)|13
2522549|NCT01709305|8730517|P5|Phase 1|Death|0
2522550|NCT01709305|8730518|P4|Phase 1|Death|0
2522551|NCT01709305|8730519|P3|Phase 1|Death|0
2522552|NCT01709305|8730520|P2|Phase 1|Death|0
2522553|NCT01709305|8730521|P1|Phase 1|Death|2
2522554|NCT01709305|8730517|P5|Phase 1|Clinical Adverse Event|0
2522555|NCT01709305|8730518|P4|Phase 1|Clinical Adverse Event|0
2522556|NCT01709305|8730519|P3|Phase 1|Clinical Adverse Event|0
2522557|NCT01709305|8730520|P2|Phase 1|Clinical Adverse Event|0
2522558|NCT01709305|8730521|P1|Phase 1|Clinical Adverse Event|80
2522559|NCT01709227|8730558|P2|Overall Study|Pleural Peritoneal communication|9
2522560|NCT01709227|8730559|P1|Overall Study|Pleural Peritoneal communication|0
2522561|NCT01709227|8730558|P2|Overall Study|Physician Decision|0
2522562|NCT01709227|8730559|P1|Overall Study|Physician Decision|1
2522563|NCT01709162|8730585|P2|Overall Study|Withdrawal by Subject|1
2522564|NCT01709162|8730586|P1|Overall Study|Withdrawal by Subject|0
2522565|NCT01709162|8730585|P2|Overall Study|Other|0
2522566|NCT01709162|8730586|P1|Overall Study|Other|1
2522567|NCT01709162|8730585|P2|Overall Study|Administrative reason by sponsor|1
2522568|NCT01709162|8730586|P1|Overall Study|Administrative reason by sponsor|0
2522569|NCT01709162|8730585|P2|Overall Study|Study drug toxicity|0
2522570|NCT01709162|8730586|P1|Overall Study|Study drug toxicity|2
2522571|NCT01709162|8730585|P2|Overall Study|Disease progression|3
2522572|NCT01709162|8730586|P1|Overall Study|Disease progression|3
2522573|NCT01709149|8730601|P3|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
2522574|NCT01709149|8730602|P2|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
2522575|NCT01709149|8730603|P1|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
2522576|NCT01709149|8730601|P3|Double-blind, Placebo-controlled Phase|not defined|2
2522577|NCT01709149|8730602|P2|Double-blind, Placebo-controlled Phase|not defined|1
2522578|NCT01709149|8730603|P1|Double-blind, Placebo-controlled Phase|not defined|0
2522579|NCT01709149|8730601|P3|Double-blind, Placebo-controlled Phase|Death|0
2522580|NCT01709149|8730602|P2|Double-blind, Placebo-controlled Phase|Death|2
2522581|NCT01709149|8730603|P1|Double-blind, Placebo-controlled Phase|Death|0
2522582|NCT01709149|8730601|P3|Double-blind, Placebo-controlled Phase|Physician Decision|5
2522583|NCT01709149|8730602|P2|Double-blind, Placebo-controlled Phase|Physician Decision|2
2522584|NCT01709149|8730603|P1|Double-blind, Placebo-controlled Phase|Physician Decision|0
2522585|NCT01709149|8730601|P3|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12
2522586|NCT01709149|8730602|P2|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7
2522587|NCT01709149|8730603|P1|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
2522588|NCT01709149|8730601|P3|Double-blind, Placebo-controlled Phase|Adverse Event|78
2522589|NCT01709149|8730602|P2|Double-blind, Placebo-controlled Phase|Adverse Event|12
2522590|NCT01709149|8730603|P1|Double-blind, Placebo-controlled Phase|Adverse Event|0
2522591|NCT01709149|8730601|P3|Open-label Lead-in Phase|Protocol Violation|0
2522592|NCT01709149|8730602|P2|Open-label Lead-in Phase|Protocol Violation|0
2522593|NCT01709149|8730603|P1|Open-label Lead-in Phase|Protocol Violation|3
2522594|NCT01709149|8730601|P3|Open-label Lead-in Phase|Death|0
2522595|NCT01709149|8730602|P2|Open-label Lead-in Phase|Death|0
2522596|NCT01709149|8730603|P1|Open-label Lead-in Phase|Death|1
2522597|NCT01709149|8730601|P3|Open-label Lead-in Phase|Withdrawal by Subject|0
2522598|NCT01709149|8730602|P2|Open-label Lead-in Phase|Withdrawal by Subject|0
2522599|NCT01709149|8730603|P1|Open-label Lead-in Phase|Withdrawal by Subject|2
2522600|NCT01709149|8730601|P3|Open-label Lead-in Phase|Adverse Event|0
2522601|NCT01709149|8730602|P2|Open-label Lead-in Phase|Adverse Event|0
2522602|NCT01709149|8730603|P1|Open-label Lead-in Phase|Adverse Event|109
2522603|NCT01709110|8730631|P2|Overall Study|Caregiver Decision|1
2522604|NCT01709110|8730632|P1|Overall Study|Caregiver Decision|1
2522605|NCT01709110|8730631|P2|Overall Study|Lack of Efficacy|1
2522606|NCT01709110|8730632|P1|Overall Study|Lack of Efficacy|1
2522607|NCT01709110|8730631|P2|Overall Study|Sponsor Decision|2
2522608|NCT01709110|8730632|P1|Overall Study|Sponsor Decision|2
2522609|NCT01709110|8730631|P2|Overall Study|Physician Decision|10
2522610|NCT01709110|8730632|P1|Overall Study|Physician Decision|4
2522611|NCT01709110|8730631|P2|Overall Study|Withdrawal by Subject|89
2522612|NCT01709110|8730632|P1|Overall Study|Withdrawal by Subject|96
2522613|NCT01709110|8730631|P2|Overall Study|Protocol Violation|6
2522614|NCT01709110|8730632|P1|Overall Study|Protocol Violation|4
2522615|NCT01709110|8730631|P2|Overall Study|Lost to Follow-up|5
2522616|NCT01709110|8730632|P1|Overall Study|Lost to Follow-up|7
2522617|NCT01709110|8730631|P2|Overall Study|Death|6
2522618|NCT01709110|8730632|P1|Overall Study|Death|14
2522619|NCT01709110|8730631|P2|Overall Study|Adverse Event|48
2522620|NCT01709110|8730632|P1|Overall Study|Adverse Event|56
2522621|NCT01709084|8730662|P2|Overall Study|Not Treated|2
2522622|NCT01709084|8730663|P1|Overall Study|Not Treated|0
2522623|NCT01709084|8730662|P2|Overall Study|Participant Reached a Virologic Endpoint|1
2522624|NCT01709084|8730663|P1|Overall Study|Participant Reached a Virologic Endpoint|0
2522625|NCT01709084|8730662|P2|Overall Study|Other|3
2522626|NCT01709084|8730663|P1|Overall Study|Other|5
2522627|NCT01709084|8730662|P2|Overall Study|Adverse Event|0
2522628|NCT01709084|8730663|P1|Overall Study|Adverse Event|5
2522629|NCT01709084|8730662|P2|Overall Study|Withdrawal by Subject|2
2522630|NCT01709084|8730663|P1|Overall Study|Withdrawal by Subject|2
2522631|NCT01709084|8730662|P2|Overall Study|Lost to Follow-up|7
2522632|NCT01709084|8730663|P1|Overall Study|Lost to Follow-up|4
2522633|NCT01708954|8730696|P3|Step 2|Withdrawal by Subject|0
2522634|NCT01708954|8730697|P2|Step 2|Withdrawal by Subject|1
2522635|NCT01708954|8730698|P1|Step 2|Withdrawal by Subject|1
2522636|NCT01708954|8730696|P3|Step 2|Adverse Event|0
2522637|NCT01708954|8730697|P2|Step 2|Adverse Event|2
2522638|NCT01708954|8730698|P1|Step 2|Adverse Event|3
2522639|NCT01708954|8730696|P3|Step 2|Disease progression|0
2522640|NCT01708954|8730697|P2|Step 2|Disease progression|4
2522641|NCT01708954|8730698|P1|Step 2|Disease progression|9
2522642|NCT01708954|8730696|P3|Step 1|Ineligible or never received treatment|8
2522643|NCT01708954|8730697|P2|Step 1|Ineligible or never received treatment|2
2522644|NCT01708954|8730698|P1|Step 1|Ineligible or never received treatment|4
2522645|NCT01708954|8730696|P3|Step 1|Off-treatment reason not submitted|1
2522646|NCT01708954|8730697|P2|Step 1|Off-treatment reason not submitted|1
2522647|NCT01708954|8730698|P1|Step 1|Off-treatment reason not submitted|1
2522648|NCT01708954|8730696|P3|Step 1|Symptomatic deterioration|1
2522649|NCT01708954|8730697|P2|Step 1|Symptomatic deterioration|0
2522650|NCT01708954|8730698|P1|Step 1|Symptomatic deterioration|1
2522651|NCT01708954|8730696|P3|Step 1|Crossed over to Step 2|0
2522652|NCT01708954|8730697|P2|Step 1|Crossed over to Step 2|0
2522653|NCT01708954|8730698|P1|Step 1|Crossed over to Step 2|2
2522654|NCT01708954|8730696|P3|Step 1|Other complicating disease|0
2522655|NCT01708954|8730697|P2|Step 1|Other complicating disease|2
2522656|NCT01708954|8730698|P1|Step 1|Other complicating disease|0
2522657|NCT01708954|8730696|P3|Step 1|Withdrawal by Subject|3
2522658|NCT01708954|8730697|P2|Step 1|Withdrawal by Subject|5
2522659|NCT01708954|8730698|P1|Step 1|Withdrawal by Subject|2
2522660|NCT01708954|8730696|P3|Step 1|Death|3
2522661|NCT01708954|8730697|P2|Step 1|Death|2
2522662|NCT01708954|8730698|P1|Step 1|Death|3
2522663|NCT01708954|8730696|P3|Step 1|Adverse Event|13
2522664|NCT01708954|8730697|P2|Step 1|Adverse Event|11
2522665|NCT01708954|8730698|P1|Step 1|Adverse Event|3
2522666|NCT01708954|8730696|P3|Step 1|Disease progression|14
2522667|NCT01708954|8730697|P2|Step 1|Disease progression|17
2522668|NCT01708954|8730698|P1|Step 1|Disease progression|26
2522669|NCT01708941|8730723|P4|Overall Study|Ineligible|0
2522670|NCT01708941|8730724|P3|Overall Study|Ineligible|2
2522671|NCT01708941|8730725|P2|Overall Study|Ineligible|0
2522672|NCT01708941|8730726|P1|Overall Study|Ineligible|0
2522673|NCT01708941|8730723|P4|Overall Study|Never started treatment|0
2522674|NCT01708941|8730724|P3|Overall Study|Never started treatment|0
2522675|NCT01708941|8730725|P2|Overall Study|Never started treatment|1
2522676|NCT01708941|8730726|P1|Overall Study|Never started treatment|2
2522677|NCT01708941|8730723|P4|Overall Study|Ineligible and never started treatment|0
2522678|NCT01708941|8730724|P3|Overall Study|Ineligible and never started treatment|1
2522679|NCT01708941|8730725|P2|Overall Study|Ineligible and never started treatment|0
2522680|NCT01708941|8730726|P1|Overall Study|Ineligible and never started treatment|1
2522681|NCT01708941|8730723|P4|Overall Study|Alternative therapy|0
2522682|NCT01708941|8730724|P3|Overall Study|Alternative therapy|2
2522683|NCT01708941|8730725|P2|Overall Study|Alternative therapy|0
2522684|NCT01708941|8730726|P1|Overall Study|Alternative therapy|0
2522685|NCT01708941|8730723|P4|Overall Study|Disease progression|0
2522686|NCT01708941|8730724|P3|Overall Study|Disease progression|8
2522687|NCT01708941|8730725|P2|Overall Study|Disease progression|10
2522688|NCT01708941|8730726|P1|Overall Study|Disease progression|9
2522689|NCT01708941|8730723|P4|Overall Study|Withdrawal by Subject|4
2522690|NCT01708941|8730724|P3|Overall Study|Withdrawal by Subject|3
2522691|NCT01708941|8730725|P2|Overall Study|Withdrawal by Subject|0
2522692|NCT01708941|8730726|P1|Overall Study|Withdrawal by Subject|1
2522693|NCT01708941|8730723|P4|Overall Study|Death|14
2522694|NCT01708941|8730724|P3|Overall Study|Death|2
2522695|NCT01708941|8730725|P2|Overall Study|Death|1
2522696|NCT01708941|8730726|P1|Overall Study|Death|1
2522697|NCT01708941|8730723|P4|Overall Study|Adverse Event|0
2522698|NCT01708941|8730724|P3|Overall Study|Adverse Event|1
2522699|NCT01708941|8730725|P2|Overall Study|Adverse Event|6
2522700|NCT01708941|8730726|P1|Overall Study|Adverse Event|4
2522701|NCT01708915|8730744|P4|Overall Study|Other reasons than stated above|2
2522702|NCT01708915|8730745|P3|Overall Study|Other reasons than stated above|0
2522703|NCT01708915|8730746|P2|Overall Study|Other reasons than stated above|1
2522704|NCT01708915|8730747|P1|Overall Study|Other reasons than stated above|1
2522705|NCT01708915|8730744|P4|Overall Study|Withdrawal by Subject|2
2522706|NCT01708915|8730745|P3|Overall Study|Withdrawal by Subject|2
2522707|NCT01708915|8730746|P2|Overall Study|Withdrawal by Subject|1
2522708|NCT01708915|8730747|P1|Overall Study|Withdrawal by Subject|0
2522709|NCT01708915|8730744|P4|Overall Study|Protocol Violation|1
2522710|NCT01708915|8730745|P3|Overall Study|Protocol Violation|0
2522711|NCT01708915|8730746|P2|Overall Study|Protocol Violation|0
2522712|NCT01708915|8730747|P1|Overall Study|Protocol Violation|0
2522713|NCT01708915|8730744|P4|Overall Study|Lack of Efficacy|15
2522714|NCT01708915|8730745|P3|Overall Study|Lack of Efficacy|35
2522715|NCT01708915|8730746|P2|Overall Study|Lack of Efficacy|60
2522716|NCT01708915|8730747|P1|Overall Study|Lack of Efficacy|84
2522717|NCT01708915|8730744|P4|Overall Study|Adverse Event|13
2522718|NCT01708915|8730745|P3|Overall Study|Adverse Event|9
2522719|NCT01708915|8730746|P2|Overall Study|Adverse Event|0
2522720|NCT01708915|8730747|P1|Overall Study|Adverse Event|1
2522721|NCT01708902|8730776|P7|Overall Study|Other Reason|0
2522722|NCT01708902|8730777|P6|Overall Study|Other Reason|2
2522723|NCT01708902|8730778|P5|Overall Study|Other Reason|1
2522724|NCT01708902|8730779|P4|Overall Study|Other Reason|1
2522725|NCT01708902|8730780|P3|Overall Study|Other Reason|1
2522726|NCT01708902|8730781|P2|Overall Study|Other Reason|0
2522727|NCT01708902|8730782|P1|Overall Study|Other Reason|1
2522728|NCT01708902|8730776|P7|Overall Study|Refused to continue trial medication|1
2522729|NCT01708902|8730777|P6|Overall Study|Refused to continue trial medication|1
2522730|NCT01708902|8730778|P5|Overall Study|Refused to continue trial medication|8
2522731|NCT01708902|8730779|P4|Overall Study|Refused to continue trial medication|2
2522732|NCT01708902|8730780|P3|Overall Study|Refused to continue trial medication|4
2522733|NCT01708902|8730781|P2|Overall Study|Refused to continue trial medication|0
2522734|NCT01708902|8730782|P1|Overall Study|Refused to continue trial medication|8
2522735|NCT01708902|8730776|P7|Overall Study|Lost to Follow-up|1
2522736|NCT01708902|8730777|P6|Overall Study|Lost to Follow-up|0
2522737|NCT01708902|8730778|P5|Overall Study|Lost to Follow-up|0
2522738|NCT01708902|8730779|P4|Overall Study|Lost to Follow-up|2
2522739|NCT01708902|8730780|P3|Overall Study|Lost to Follow-up|2
2522740|NCT01708902|8730781|P2|Overall Study|Lost to Follow-up|1
2522741|NCT01708902|8730782|P1|Overall Study|Lost to Follow-up|2
2522742|NCT01708902|8730776|P7|Overall Study|Non compliance with protocol|0
2522743|NCT01708902|8730777|P6|Overall Study|Non compliance with protocol|0
2522744|NCT01708902|8730778|P5|Overall Study|Non compliance with protocol|0
2522745|NCT01708902|8730779|P4|Overall Study|Non compliance with protocol|3
2522746|NCT01708902|8730780|P3|Overall Study|Non compliance with protocol|1
2522747|NCT01708902|8730781|P2|Overall Study|Non compliance with protocol|2
2522748|NCT01708902|8730782|P1|Overall Study|Non compliance with protocol|0
2522749|NCT01708902|8730776|P7|Overall Study|Lack of Efficacy|0
2522750|NCT01708902|8730777|P6|Overall Study|Lack of Efficacy|1
2522751|NCT01708902|8730778|P5|Overall Study|Lack of Efficacy|0
2522752|NCT01708902|8730779|P4|Overall Study|Lack of Efficacy|0
2522753|NCT01708902|8730780|P3|Overall Study|Lack of Efficacy|0
2522754|NCT01708902|8730781|P2|Overall Study|Lack of Efficacy|1
2522755|NCT01708902|8730782|P1|Overall Study|Lack of Efficacy|3
2522756|NCT01708902|8730776|P7|Overall Study|Adverse Event|5
2522757|NCT01708902|8730777|P6|Overall Study|Adverse Event|3
2522758|NCT01708902|8730778|P5|Overall Study|Adverse Event|7
2522759|NCT01708902|8730779|P4|Overall Study|Adverse Event|2
2522760|NCT01708902|8730780|P3|Overall Study|Adverse Event|9
2522761|NCT01708902|8730781|P2|Overall Study|Adverse Event|4
2522762|NCT01708902|8730782|P1|Overall Study|Adverse Event|3
2522763|NCT01708291|8730924|P2|Overall Study|fighting|1
2522764|NCT01708291|8730925|P1|Overall Study|fighting|2
2522765|NCT01708187|8730964|P2|Overall Study|Lost to Follow-up|1
2522766|NCT01708187|8730965|P1|Overall Study|Lost to Follow-up|0
2522767|NCT01708174|8730974|P3|Treatment Period|Adverse Event|0
2522768|NCT01708174|8730975|P2|Treatment Period|Adverse Event|1
2522769|NCT01708174|8730976|P1|Treatment Period|Adverse Event|0
2522770|NCT01708174|8730974|P3|Treatment Period|Death|1
2522771|NCT01708174|8730975|P2|Treatment Period|Death|0
2522772|NCT01708174|8730976|P1|Treatment Period|Death|0
2522773|NCT01708174|8730974|P3|Treatment Period|Progressive disease|0
2522774|NCT01708174|8730975|P2|Treatment Period|Progressive disease|1
2522775|NCT01708174|8730976|P1|Treatment Period|Progressive disease|0
2522776|NCT01708174|8730974|P3|Treatment Period|Withdrawal by Subject|0
2522777|NCT01708174|8730975|P2|Treatment Period|Withdrawal by Subject|0
2522778|NCT01708174|8730976|P1|Treatment Period|Withdrawal by Subject|1
2522779|NCT01708161|8731008|P6|Overall Study|Disease progression|0
2522780|NCT01708161|8731009|P5|Overall Study|Disease progression|3
2522781|NCT01708161|8731010|P4|Overall Study|Disease progression|13
2522782|NCT01708161|8731011|P3|Overall Study|Disease progression|5
2522783|NCT01708161|8731012|P2|Overall Study|Disease progression|5
2522784|NCT01708161|8731013|P1|Overall Study|Disease progression|3
2522785|NCT01708161|8731008|P6|Overall Study|Administrative problems|0
2522786|NCT01708161|8731009|P5|Overall Study|Administrative problems|0
2522787|NCT01708161|8731010|P4|Overall Study|Administrative problems|0
2522788|NCT01708161|8731011|P3|Overall Study|Administrative problems|0
2522789|NCT01708161|8731012|P2|Overall Study|Administrative problems|1
2522790|NCT01708161|8731013|P1|Overall Study|Administrative problems|0
2522791|NCT01708161|8731008|P6|Overall Study|Withdrawal by Subject|0
2522792|NCT01708161|8731009|P5|Overall Study|Withdrawal by Subject|0
2522793|NCT01708161|8731010|P4|Overall Study|Withdrawal by Subject|0
2522794|NCT01708161|8731011|P3|Overall Study|Withdrawal by Subject|1
2522795|NCT01708161|8731012|P2|Overall Study|Withdrawal by Subject|1
2522796|NCT01708161|8731013|P1|Overall Study|Withdrawal by Subject|0
2522797|NCT01708161|8731008|P6|Overall Study|Death|1
2522798|NCT01708161|8731009|P5|Overall Study|Death|0
2522799|NCT01708161|8731010|P4|Overall Study|Death|1
2522800|NCT01708161|8731011|P3|Overall Study|Death|0
2522801|NCT01708161|8731012|P2|Overall Study|Death|0
2522802|NCT01708161|8731013|P1|Overall Study|Death|0
2522803|NCT01708161|8731008|P6|Overall Study|Adverse Event|0
2522804|NCT01708161|8731009|P5|Overall Study|Adverse Event|3
2522805|NCT01708161|8731010|P4|Overall Study|Adverse Event|2
2522806|NCT01708161|8731011|P3|Overall Study|Adverse Event|4
2522807|NCT01708161|8731012|P2|Overall Study|Adverse Event|3
2522808|NCT01708161|8731013|P1|Overall Study|Adverse Event|1
2522809|NCT01708057|8731064|P3|Overall Study|Withdrawal due to study termination.|1
2522810|NCT01708057|8731065|P2|Overall Study|Withdrawal due to study termination.|1
2522811|NCT01708057|8731066|P1|Overall Study|Withdrawal due to study termination.|1
2522812|NCT01707992|8731125|P6|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
2522813|NCT01707992|8731126|P5|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4
2522814|NCT01707992|8731127|P4|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
2522815|NCT01707992|8731128|P3|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
2522816|NCT01707992|8731129|P2|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
2522817|NCT01707992|8731130|P1|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
2522818|NCT01707992|8731125|P6|Active Treatment Phase (24 Months)|Study terminated by sponsor|174
2522819|NCT01707992|8731126|P5|Active Treatment Phase (24 Months)|Study terminated by sponsor|243
2522820|NCT01707992|8731127|P4|Active Treatment Phase (24 Months)|Study terminated by sponsor|809
2522821|NCT01707992|8731128|P3|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
2522822|NCT01707992|8731129|P2|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
2522823|NCT01707992|8731130|P1|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
2522824|NCT01707992|8731125|P6|Active Treatment Phase (24 Months)|Noncompliance|2
2522825|NCT01707992|8731126|P5|Active Treatment Phase (24 Months)|Noncompliance|4
2522826|NCT01707992|8731127|P4|Active Treatment Phase (24 Months)|Noncompliance|0
2522827|NCT01707992|8731128|P3|Active Treatment Phase (24 Months)|Noncompliance|0
2522828|NCT01707992|8731129|P2|Active Treatment Phase (24 Months)|Noncompliance|0
2522829|NCT01707992|8731130|P1|Active Treatment Phase (24 Months)|Noncompliance|0
2522830|NCT01707992|8731125|P6|Active Treatment Phase (24 Months)|Other than specified|2
2522831|NCT01707992|8731126|P5|Active Treatment Phase (24 Months)|Other than specified|5
2522832|NCT01707992|8731127|P4|Active Treatment Phase (24 Months)|Other than specified|1
2522833|NCT01707992|8731128|P3|Active Treatment Phase (24 Months)|Other than specified|0
2522834|NCT01707992|8731129|P2|Active Treatment Phase (24 Months)|Other than specified|0
2522835|NCT01707992|8731130|P1|Active Treatment Phase (24 Months)|Other than specified|0
2522836|NCT01707992|8731125|P6|Active Treatment Phase (24 Months)|Death|0
2522837|NCT01707992|8731126|P5|Active Treatment Phase (24 Months)|Death|0
2522838|NCT01707992|8731127|P4|Active Treatment Phase (24 Months)|Death|2
2522839|NCT01707992|8731128|P3|Active Treatment Phase (24 Months)|Death|0
2522840|NCT01707992|8731129|P2|Active Treatment Phase (24 Months)|Death|0
2522841|NCT01707992|8731130|P1|Active Treatment Phase (24 Months)|Death|0
2522842|NCT01707992|8731125|P6|Active Treatment Phase (24 Months)|Lost to Follow-up|1
2522843|NCT01707992|8731126|P5|Active Treatment Phase (24 Months)|Lost to Follow-up|11
2522844|NCT01707992|8731127|P4|Active Treatment Phase (24 Months)|Lost to Follow-up|5
2522845|NCT01707992|8731128|P3|Active Treatment Phase (24 Months)|Lost to Follow-up|0
2522846|NCT01707992|8731129|P2|Active Treatment Phase (24 Months)|Lost to Follow-up|0
2522847|NCT01707992|8731130|P1|Active Treatment Phase (24 Months)|Lost to Follow-up|0
2522848|NCT01707992|8731125|P6|Active Treatment Phase (24 Months)|Pregnancy|2
2522849|NCT01707992|8731126|P5|Active Treatment Phase (24 Months)|Pregnancy|5
2522850|NCT01707992|8731127|P4|Active Treatment Phase (24 Months)|Pregnancy|2
2522851|NCT01707992|8731128|P3|Active Treatment Phase (24 Months)|Pregnancy|0
2522852|NCT01707992|8731129|P2|Active Treatment Phase (24 Months)|Pregnancy|0
2522853|NCT01707992|8731130|P1|Active Treatment Phase (24 Months)|Pregnancy|0
2522854|NCT01707992|8731125|P6|Active Treatment Phase (24 Months)|Withdrawal by Subject|32
2522855|NCT01707992|8731126|P5|Active Treatment Phase (24 Months)|Withdrawal by Subject|220
2522856|NCT01707992|8731127|P4|Active Treatment Phase (24 Months)|Withdrawal by Subject|58
2522857|NCT01707992|8731128|P3|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
2522858|NCT01707992|8731129|P2|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
2522859|NCT01707992|8731130|P1|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
2522860|NCT01707992|8731125|P6|Active Treatment Phase (24 Months)|Lack of Efficacy|2
2522861|NCT01707992|8731126|P5|Active Treatment Phase (24 Months)|Lack of Efficacy|1
2522862|NCT01707992|8731127|P4|Active Treatment Phase (24 Months)|Lack of Efficacy|3
2522863|NCT01707992|8731128|P3|Active Treatment Phase (24 Months)|Lack of Efficacy|0
2522864|NCT01707992|8731129|P2|Active Treatment Phase (24 Months)|Lack of Efficacy|0
2522865|NCT01707992|8731130|P1|Active Treatment Phase (24 Months)|Lack of Efficacy|0
2522866|NCT01707992|8731125|P6|Active Treatment Phase (24 Months)|Adverse Event|0
2522867|NCT01707992|8731126|P5|Active Treatment Phase (24 Months)|Adverse Event|1
2522868|NCT01707992|8731127|P4|Active Treatment Phase (24 Months)|Adverse Event|4
2522869|NCT01707992|8731128|P3|Active Treatment Phase (24 Months)|Adverse Event|0
2522870|NCT01707992|8731129|P2|Active Treatment Phase (24 Months)|Adverse Event|0
2522871|NCT01707992|8731130|P1|Active Treatment Phase (24 Months)|Adverse Event|0
2522872|NCT01707992|8731125|P6|Placebo-Controlled Phase (24 Months)|Other than specified|0
2522873|NCT01707992|8731126|P5|Placebo-Controlled Phase (24 Months)|Other than specified|0
2522874|NCT01707992|8731127|P4|Placebo-Controlled Phase (24 Months)|Other than specified|0
2522875|NCT01707992|8731128|P3|Placebo-Controlled Phase (24 Months)|Other than specified|10
2522876|NCT01707992|8731129|P2|Placebo-Controlled Phase (24 Months)|Other than specified|9
2522877|NCT01707992|8731130|P1|Placebo-Controlled Phase (24 Months)|Other than specified|11
2522878|NCT01707992|8731125|P6|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
2522879|NCT01707992|8731126|P5|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
2522880|NCT01707992|8731127|P4|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
2522881|NCT01707992|8731128|P3|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6
2522882|NCT01707992|8731129|P2|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1
2522883|NCT01707992|8731130|P1|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2
2522884|NCT01707992|8731125|P6|Placebo-Controlled Phase (24 Months)|Death|0
2522885|NCT01707992|8731126|P5|Placebo-Controlled Phase (24 Months)|Death|0
2522886|NCT01707992|8731127|P4|Placebo-Controlled Phase (24 Months)|Death|0
2522887|NCT01707992|8731128|P3|Placebo-Controlled Phase (24 Months)|Death|1
2522888|NCT01707992|8731129|P2|Placebo-Controlled Phase (24 Months)|Death|1
2522889|NCT01707992|8731130|P1|Placebo-Controlled Phase (24 Months)|Death|2
2522890|NCT01707992|8731125|P6|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
2522891|NCT01707992|8731126|P5|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
2522892|NCT01707992|8731127|P4|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
2522893|NCT01707992|8731128|P3|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9
2522894|NCT01707992|8731129|P2|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4
2522895|NCT01707992|8731130|P1|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10
2522896|NCT01707992|8731125|P6|Placebo-Controlled Phase (24 Months)|Pregnancy|0
2522897|NCT01707992|8731126|P5|Placebo-Controlled Phase (24 Months)|Pregnancy|0
2522898|NCT01707992|8731127|P4|Placebo-Controlled Phase (24 Months)|Pregnancy|0
2522899|NCT01707992|8731128|P3|Placebo-Controlled Phase (24 Months)|Pregnancy|9
2522900|NCT01707992|8731129|P2|Placebo-Controlled Phase (24 Months)|Pregnancy|5
2522901|NCT01707992|8731130|P1|Placebo-Controlled Phase (24 Months)|Pregnancy|12
2522902|NCT01707992|8731125|P6|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
2522903|NCT01707992|8731126|P5|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
2522904|NCT01707992|8731127|P4|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
2522905|NCT01707992|8731128|P3|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
2522906|NCT01707992|8731129|P2|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
2522907|NCT01707992|8731130|P1|Placebo-Controlled Phase (24 Months)|Protocol Violation|1
2522908|NCT01707992|8731125|P6|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
2522909|NCT01707992|8731126|P5|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
2522910|NCT01707992|8731127|P4|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
2522911|NCT01707992|8731128|P3|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154
2522912|NCT01707992|8731129|P2|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68
2522913|NCT01707992|8731130|P1|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88
2522914|NCT01707992|8731125|P6|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
2522915|NCT01707992|8731126|P5|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
2522916|NCT01707992|8731127|P4|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
2522917|NCT01707992|8731128|P3|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2
2522918|NCT01707992|8731129|P2|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3
2522919|NCT01707992|8731130|P1|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10
2522920|NCT01707992|8731125|P6|Placebo-Controlled Phase (24 Months)|Adverse Event|0
2522921|NCT01707992|8731126|P5|Placebo-Controlled Phase (24 Months)|Adverse Event|0
2522922|NCT01707992|8731127|P4|Placebo-Controlled Phase (24 Months)|Adverse Event|0
2522923|NCT01707992|8731128|P3|Placebo-Controlled Phase (24 Months)|Adverse Event|9
2522924|NCT01707992|8731129|P2|Placebo-Controlled Phase (24 Months)|Adverse Event|13
2522925|NCT01707992|8731130|P1|Placebo-Controlled Phase (24 Months)|Adverse Event|8
2522926|NCT01707693|8731182|P2|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2
2522927|NCT01707693|8731183|P1|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0
2522928|NCT01707693|8731182|P2|Time 3 Measures @ 6 Mth|Lost to Follow-up|3
2522929|NCT01707693|8731183|P1|Time 3 Measures @ 6 Mth|Lost to Follow-up|0
2522930|NCT01707693|8731182|P2|Overall Study Allocation|Protocol Violation|3
2522931|NCT01707693|8731183|P1|Overall Study Allocation|Protocol Violation|4
2522932|NCT01707693|8731182|P2|Overall Study Allocation|Withdrawal by Subject|5
2522933|NCT01707693|8731183|P1|Overall Study Allocation|Withdrawal by Subject|9
2522934|NCT01707667|8731197|P2|Period 1|expulsion of colonic sensor catheter|0
2522935|NCT01707667|8731198|P1|Period 1|expulsion of colonic sensor catheter|1
2522936|NCT01707290|8731268|P2|Overall Study|Other unspecified|0
2522937|NCT01707290|8731269|P1|Overall Study|Other unspecified|17
2522938|NCT01707290|8731268|P2|Overall Study|Commercial drug available|1
2522939|NCT01707290|8731269|P1|Overall Study|Commercial drug available|60
2522940|NCT01707290|8731268|P2|Overall Study|Withdrawal of Consent (Not Due to AE)|0
2522941|NCT01707290|8731269|P1|Overall Study|Withdrawal of Consent (Not Due to AE)|4
2522942|NCT01707290|8731268|P2|Overall Study|Lost to Follow-up|0
2522943|NCT01707290|8731269|P1|Overall Study|Lost to Follow-up|3
2522944|NCT01707290|8731268|P2|Overall Study|Physician Decision|0
2522945|NCT01707290|8731269|P1|Overall Study|Physician Decision|1
2522946|NCT01707290|8731268|P2|Overall Study|Adverse event (AE)|0
2522947|NCT01707290|8731269|P1|Overall Study|Adverse event (AE)|1
2522948|NCT01707147|8731314|P1|Overall Study|Violated inclusion/exclusion criteria|77
2522949|NCT01707147|8731314|P1|Overall Study|Follow-up failure|17
2522950|NCT01707147|8731314|P1|Overall Study|Patients who have not taken Trajenta|1
2522951|NCT01707147|8731314|P1|Overall Study|Administered Trajenta prior to contract|5
2522952|NCT01707030|8731346|P2|Overall Study|Lost to Follow-up|13
2522953|NCT01707030|8731347|P1|Overall Study|Lost to Follow-up|8
2522954|NCT01707030|8731346|P2|Overall Study|Withdrawal by Subject|3
2522955|NCT01707030|8731347|P1|Overall Study|Withdrawal by Subject|2
2522956|NCT01707030|8731346|P2|Overall Study|Death|1
2522957|NCT01707030|8731347|P1|Overall Study|Death|1
2522958|NCT01707004|8731363|P1|Overall Study|Physician Decision|3
2522959|NCT01706926|8731402|P4|Overall Study|Other|3
2522960|NCT01706926|8731403|P3|Overall Study|Other|4
2522961|NCT01706926|8731404|P2|Overall Study|Other|4
2522962|NCT01706926|8731405|P1|Overall Study|Other|4
2522963|NCT01706926|8731402|P4|Overall Study|Withdrawal by Subject|2
2522964|NCT01706926|8731403|P3|Overall Study|Withdrawal by Subject|1
2522965|NCT01706926|8731404|P2|Overall Study|Withdrawal by Subject|0
2522966|NCT01706926|8731405|P1|Overall Study|Withdrawal by Subject|2
2522967|NCT01706926|8731402|P4|Overall Study|Lost to Follow-up|0
2522968|NCT01706926|8731403|P3|Overall Study|Lost to Follow-up|1
2522969|NCT01706926|8731404|P2|Overall Study|Lost to Follow-up|0
2522970|NCT01706926|8731405|P1|Overall Study|Lost to Follow-up|0
2522971|NCT01706770|8731524|P2|Overall Study|Physician Decision|0
2522972|NCT01706770|8731525|P1|Overall Study|Physician Decision|1
2522973|NCT01706770|8731524|P2|Overall Study|Lost to Follow-up|0
2522974|NCT01706770|8731525|P1|Overall Study|Lost to Follow-up|1
2522975|NCT01706575|8731573|P1|Overall Study|Started but not Treated|6
2522976|NCT01706575|8731573|P1|Overall Study|Lost to Follow-up|2
2522977|NCT01706575|8731573|P1|Overall Study|Participant Withdrew Consent|4
2522978|NCT01706536|8731594|P5|Overall Study|non compliance|0
2522979|NCT01706536|8731595|P4|Overall Study|non compliance|0
2522980|NCT01706536|8731596|P3|Overall Study|non compliance|0
2522981|NCT01706536|8731597|P2|Overall Study|non compliance|1
2522982|NCT01706536|8731598|P1|Overall Study|non compliance|0
2522983|NCT01706536|8731594|P5|Overall Study|Lack of Efficacy|0
2522984|NCT01706536|8731595|P4|Overall Study|Lack of Efficacy|1
2522985|NCT01706536|8731596|P3|Overall Study|Lack of Efficacy|0
2522986|NCT01706536|8731597|P2|Overall Study|Lack of Efficacy|0
2522987|NCT01706536|8731598|P1|Overall Study|Lack of Efficacy|1
2522988|NCT01706536|8731594|P5|Overall Study|Adverse Event|2
2522989|NCT01706536|8731595|P4|Overall Study|Adverse Event|3
2522990|NCT01706536|8731596|P3|Overall Study|Adverse Event|4
2522991|NCT01706536|8731597|P2|Overall Study|Adverse Event|3
2522992|NCT01706536|8731598|P1|Overall Study|Adverse Event|2
2522993|NCT01706536|8731594|P5|Overall Study|Withdrawal by Subject|0
2522994|NCT01706536|8731595|P4|Overall Study|Withdrawal by Subject|0
2522995|NCT01706536|8731596|P3|Overall Study|Withdrawal by Subject|1
2522996|NCT01706536|8731597|P2|Overall Study|Withdrawal by Subject|0
2522997|NCT01706536|8731598|P1|Overall Study|Withdrawal by Subject|1
2522998|NCT01706458|8731665|P2|Overall Study|Physician Decision|4
2522999|NCT01706458|8731666|P1|Overall Study|Physician Decision|3
2523000|NCT01706328|8731690|P3|12-week Double-blind Treatment Period|Withdrawal by Subject|11
2523001|NCT01706328|8731691|P2|12-week Double-blind Treatment Period|Withdrawal by Subject|8
2523002|NCT01706328|8731692|P1|12-week Double-blind Treatment Period|Withdrawal by Subject|0
2523003|NCT01706328|8731690|P3|12-week Double-blind Treatment Period|Physician Decision|2
2523004|NCT01706328|8731691|P2|12-week Double-blind Treatment Period|Physician Decision|2
2523005|NCT01706328|8731692|P1|12-week Double-blind Treatment Period|Physician Decision|0
2523006|NCT01706328|8731690|P3|12-week Double-blind Treatment Period|Lost to Follow-up|1
2523007|NCT01706328|8731691|P2|12-week Double-blind Treatment Period|Lost to Follow-up|3
2523008|NCT01706328|8731692|P1|12-week Double-blind Treatment Period|Lost to Follow-up|0
2523009|NCT01706328|8731690|P3|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9
2523010|NCT01706328|8731691|P2|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11
2523011|NCT01706328|8731692|P1|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0
2523012|NCT01706328|8731690|P3|12-week Double-blind Treatment Period|Protocol Violation|2
2523013|NCT01706328|8731691|P2|12-week Double-blind Treatment Period|Protocol Violation|4
2523014|NCT01706328|8731692|P1|12-week Double-blind Treatment Period|Protocol Violation|0
2523015|NCT01706328|8731690|P3|12-week Double-blind Treatment Period|Lack of Efficacy|4
2523016|NCT01706328|8731691|P2|12-week Double-blind Treatment Period|Lack of Efficacy|4
2523017|NCT01706328|8731692|P1|12-week Double-blind Treatment Period|Lack of Efficacy|0
2523018|NCT01706328|8731690|P3|12-week Double-blind Treatment Period|Adverse Event|16
2523019|NCT01706328|8731691|P2|12-week Double-blind Treatment Period|Adverse Event|14
2523020|NCT01706328|8731692|P1|12-week Double-blind Treatment Period|Adverse Event|0
2523021|NCT01706328|8731690|P3|2-week Run-in Period|Lost to Follow-up|0
2523022|NCT01706328|8731691|P2|2-week Run-in Period|Lost to Follow-up|0
2523023|NCT01706328|8731692|P1|2-week Run-in Period|Lost to Follow-up|2
2523024|NCT01706328|8731690|P3|2-week Run-in Period|Adverse Event|0
2523025|NCT01706328|8731691|P2|2-week Run-in Period|Adverse Event|0
2523026|NCT01706328|8731692|P1|2-week Run-in Period|Adverse Event|4
2523027|NCT01706328|8731690|P3|2-week Run-in Period|Physician Decision|0
2523028|NCT01706328|8731691|P2|2-week Run-in Period|Physician Decision|0
2523029|NCT01706328|8731692|P1|2-week Run-in Period|Physician Decision|4
2523030|NCT01706328|8731690|P3|2-week Run-in Period|Withdrawal by Subject|0
2523031|NCT01706328|8731691|P2|2-week Run-in Period|Withdrawal by Subject|0
2523032|NCT01706328|8731692|P1|2-week Run-in Period|Withdrawal by Subject|15
2523033|NCT01706328|8731690|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
2523034|NCT01706328|8731691|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
2523035|NCT01706328|8731692|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140
2523036|NCT01706250|8731711|P1|Overall Study|Lost to Follow-up|2
2523037|NCT01706198|8731742|P2|Overall Study|Withdrawal by Subject|31
2523038|NCT01706198|8731743|P1|Overall Study|Withdrawal by Subject|23
2523039|NCT01706198|8731742|P2|Overall Study|Physician Decision|37
2523040|NCT01706198|8731743|P1|Overall Study|Physician Decision|23
2523041|NCT01706198|8731742|P2|Overall Study|Lost to Follow-up|93
2523042|NCT01706198|8731743|P1|Overall Study|Lost to Follow-up|97
2523043|NCT01706198|8731742|P2|Overall Study|Other: Subject reached stopping criteria|13
2523044|NCT01706198|8731743|P1|Overall Study|Other: Subject reached stopping criteria|11
2523045|NCT01706198|8731742|P2|Overall Study|Protocol Violation|5
2523046|NCT01706198|8731743|P1|Overall Study|Protocol Violation|7
2523047|NCT01706198|8731742|P2|Overall Study|Adverse Event|15
2523048|NCT01706198|8731743|P1|Overall Study|Adverse Event|12
2523049|NCT01706159|8731795|P2|Overall Study|Unclassified|1
2523050|NCT01706159|8731796|P1|Overall Study|Unclassified|6
2523051|NCT01706159|8731795|P2|Overall Study|Withdrawal Criteria|1
2523052|NCT01706159|8731796|P1|Overall Study|Withdrawal Criteria|2
2523053|NCT01706146|8731810|P1|Overall Study|Developed AF and need for antiplatelets|2
2523054|NCT01706146|8731810|P1|Overall Study|Adverse Event|3
2523055|NCT01706146|8731810|P1|Overall Study|Withdrawal by Subject|1
2523056|NCT01706003|8731830|P2|Overall Study|Lost to Follow-up|4
2523057|NCT01706003|8731831|P1|Overall Study|Lost to Follow-up|6
2523058|NCT01706003|8731830|P2|Overall Study|Not scheduled|0
2523059|NCT01706003|8731831|P1|Overall Study|Not scheduled|3
2523060|NCT01706003|8731830|P2|Overall Study|Withdrawal by Subject|0
2523061|NCT01706003|8731831|P1|Overall Study|Withdrawal by Subject|2
2523062|NCT01705977|8731839|P2|Overall Study|Missing study conclusion form|2
2523063|NCT01705977|8731840|P1|Overall Study|Missing study conclusion form|2
2523064|NCT01705977|8731839|P2|Overall Study|Physician Decision|38
2523065|NCT01705977|8731840|P1|Overall Study|Physician Decision|48
2523066|NCT01705977|8731839|P2|Overall Study|Lost to Follow-up|37
2523067|NCT01705977|8731840|P1|Overall Study|Lost to Follow-up|33
2523068|NCT01705977|8731839|P2|Overall Study|Site closure|2
2523069|NCT01705977|8731840|P1|Overall Study|Site closure|3
2523070|NCT01705977|8731839|P2|Overall Study|Protocol Violation|4
2523071|NCT01705977|8731840|P1|Overall Study|Protocol Violation|2
2523072|NCT01705977|8731839|P2|Overall Study|Adverse Event|49
2523073|NCT01705977|8731840|P1|Overall Study|Adverse Event|57
2523074|NCT01705977|8731839|P2|Overall Study|Withdrawal by Subject|128
2523075|NCT01705977|8731840|P1|Overall Study|Withdrawal by Subject|128
2523076|NCT01705730|8731858|P1|Overall Study|Reason not Specified|4
2523077|NCT01705730|8731858|P1|Overall Study|Lost to Follow-up|1
2523078|NCT01705730|8731858|P1|Overall Study|Adverse Event|3
2523079|NCT01705730|8731858|P1|Overall Study|Lack of Efficacy|1
2523080|NCT01705717|8731898|P2|Overall Study|Other|2
2523081|NCT01705717|8731899|P1|Overall Study|Other|0
2523082|NCT01705717|8731898|P2|Overall Study|Lack of Efficacy|1
2523083|NCT01705717|8731899|P1|Overall Study|Lack of Efficacy|0
2523084|NCT01705717|8731898|P2|Overall Study|Adverse Event|2
2523085|NCT01705717|8731899|P1|Overall Study|Adverse Event|2
2523086|NCT01705691|8731916|P2|Overall Study|Other|1
2523087|NCT01705691|8731917|P1|Overall Study|Other|0
2523088|NCT01705691|8731916|P2|Overall Study|Lost to Follow-up|1
2523089|NCT01705691|8731917|P1|Overall Study|Lost to Follow-up|1
2523090|NCT01705691|8731916|P2|Overall Study|Withdrawal by Subject|2
2523091|NCT01705691|8731917|P1|Overall Study|Withdrawal by Subject|1
2523092|NCT01705691|8731916|P2|Overall Study|Death|2
2523093|NCT01705691|8731917|P1|Overall Study|Death|1
2523094|NCT01705652|8731937|P2|Overall Study|non-compliance|1
2523095|NCT01705652|8731938|P1|Overall Study|non-compliance|1
2523096|NCT01705652|8731937|P2|Overall Study|Withdrawal by Subject|2
2523097|NCT01705652|8731938|P1|Overall Study|Withdrawal by Subject|1
2523098|NCT01705652|8731937|P2|Overall Study|Adverse Event|0
2523099|NCT01705652|8731938|P1|Overall Study|Adverse Event|1
2523100|NCT01705587|8731946|P2|Overall Study|Withdrawal by Subject|1
2523101|NCT01705587|8731947|P1|Overall Study|Withdrawal by Subject|0
2523102|NCT01705574|8731965|P4|Open-Label Extension Phase|Pregnancy|1
2523103|NCT01705574|8731966|P3|Open-Label Extension Phase|Pregnancy|1
2523104|NCT01705574|8731967|P2|Open-Label Extension Phase|Pregnancy|0
2523105|NCT01705574|8731968|P1|Open-Label Extension Phase|Pregnancy|0
2523106|NCT01705574|8731965|P4|Open-Label Extension Phase|Physician Decision|0
2523107|NCT01705574|8731966|P3|Open-Label Extension Phase|Physician Decision|2
2523108|NCT01705574|8731967|P2|Open-Label Extension Phase|Physician Decision|0
2523109|NCT01705574|8731968|P1|Open-Label Extension Phase|Physician Decision|0
2523110|NCT01705574|8731965|P4|Open-Label Extension Phase|Non-Compliance with Study Drug|0
2523111|NCT01705574|8731966|P3|Open-Label Extension Phase|Non-Compliance with Study Drug|1
2523112|NCT01705574|8731967|P2|Open-Label Extension Phase|Non-Compliance with Study Drug|0
2523113|NCT01705574|8731968|P1|Open-Label Extension Phase|Non-Compliance with Study Drug|0
2523114|NCT01705574|8731965|P4|Open-Label Extension Phase|Death|0
2523115|NCT01705574|8731966|P3|Open-Label Extension Phase|Death|1
2523116|NCT01705574|8731967|P2|Open-Label Extension Phase|Death|0
2523117|NCT01705574|8731968|P1|Open-Label Extension Phase|Death|2
2523118|NCT01705574|8731965|P4|Open-Label Extension Phase|Adverse Event|1
2523119|NCT01705574|8731966|P3|Open-Label Extension Phase|Adverse Event|0
2523120|NCT01705574|8731967|P2|Open-Label Extension Phase|Adverse Event|0
2523121|NCT01705574|8731968|P1|Open-Label Extension Phase|Adverse Event|3
2523122|NCT01705574|8731965|P4|Open-Label Extension Phase|Withdrew Consent|1
2523123|NCT01705574|8731966|P3|Open-Label Extension Phase|Withdrew Consent|4
2523124|NCT01705574|8731967|P2|Open-Label Extension Phase|Withdrew Consent|0
2523125|NCT01705574|8731968|P1|Open-Label Extension Phase|Withdrew Consent|4
2523126|NCT01705574|8731965|P4|Open-Label Extension Phase|Lost to Follow-up|2
2523127|NCT01705574|8731966|P3|Open-Label Extension Phase|Lost to Follow-up|2
2523128|NCT01705574|8731967|P2|Open-Label Extension Phase|Lost to Follow-up|0
2523129|NCT01705574|8731968|P1|Open-Label Extension Phase|Lost to Follow-up|6
2523130|NCT01705574|8731965|P4|Double-Blind Phase|Randomized but Not Treated|0
2523131|NCT01705574|8731966|P3|Double-Blind Phase|Randomized but Not Treated|0
2523132|NCT01705574|8731967|P2|Double-Blind Phase|Randomized but Not Treated|4
2523133|NCT01705574|8731968|P1|Double-Blind Phase|Randomized but Not Treated|4
2523134|NCT01705574|8731965|P4|Double-Blind Phase|Protocol Violation|0
2523135|NCT01705574|8731966|P3|Double-Blind Phase|Protocol Violation|0
2523136|NCT01705574|8731967|P2|Double-Blind Phase|Protocol Violation|0
2523137|NCT01705574|8731968|P1|Double-Blind Phase|Protocol Violation|1
2523138|NCT01705574|8731965|P4|Double-Blind Phase|Pregnancy|0
2523139|NCT01705574|8731966|P3|Double-Blind Phase|Pregnancy|0
2523140|NCT01705574|8731967|P2|Double-Blind Phase|Pregnancy|1
2523141|NCT01705574|8731968|P1|Double-Blind Phase|Pregnancy|1
2523142|NCT01705574|8731965|P4|Double-Blind Phase|Non-Compliance with Study Drug|0
2523143|NCT01705574|8731966|P3|Double-Blind Phase|Non-Compliance with Study Drug|0
2523144|NCT01705574|8731967|P2|Double-Blind Phase|Non-Compliance with Study Drug|5
2523145|NCT01705574|8731968|P1|Double-Blind Phase|Non-Compliance with Study Drug|4
2523146|NCT01705574|8731965|P4|Double-Blind Phase|Withdrew Consent|0
2523147|NCT01705574|8731966|P3|Double-Blind Phase|Withdrew Consent|0
2523148|NCT01705574|8731967|P2|Double-Blind Phase|Withdrew Consent|5
2523149|NCT01705574|8731968|P1|Double-Blind Phase|Withdrew Consent|8
2523150|NCT01705574|8731965|P4|Double-Blind Phase|Adverse Event|0
2523151|NCT01705574|8731966|P3|Double-Blind Phase|Adverse Event|0
2523152|NCT01705574|8731967|P2|Double-Blind Phase|Adverse Event|10
2523153|NCT01705574|8731968|P1|Double-Blind Phase|Adverse Event|3
2523154|NCT01705574|8731965|P4|Double-Blind Phase|Lost to Follow-up|0
2523155|NCT01705574|8731966|P3|Double-Blind Phase|Lost to Follow-up|0
2523156|NCT01705574|8731967|P2|Double-Blind Phase|Lost to Follow-up|16
2523157|NCT01705574|8731968|P1|Double-Blind Phase|Lost to Follow-up|12
2523158|NCT01705509|8731985|P1|CPET w/ Ranexa|Screen Failure|2
2523159|NCT01705509|8731985|P1|Inclusion CPET|Withdrawal by Subject|2
2523160|NCT01705509|8731985|P1|Inclusion CPET|Screen Failure|5
2523161|NCT01705236|8732012|P1|Overall Study|Adverse Event|5
2523162|NCT01705236|8732012|P1|Overall Study|Withdrawal by Subject|5
2523163|NCT01705236|8732012|P1|Overall Study|Abnormal laboratory value(s)|4
2523164|NCT01705236|8732012|P1|Overall Study|Abnormal test procedure result(s)|4
2523165|NCT01705236|8732012|P1|Overall Study|Protocol Violation|3
2523166|NCT01705236|8732012|P1|Overall Study|Unsatisfactory therapeutic effect|3
2523167|NCT01705236|8732012|P1|Overall Study|Administrative problems|2
2523168|NCT01705236|8732012|P1|Overall Study|Lost to Follow-up|1
2523169|NCT01705145|8732021|P1|Part B|Adverse Event|1
2523170|NCT01705080|8732061|P4|Overall Study|Missed 6 Month Visit|0
2523171|NCT01705080|8732062|P3|Overall Study|Missed 6 Month Visit|1
2523172|NCT01705080|8732063|P2|Overall Study|Missed 6 Month Visit|1
2523173|NCT01705080|8732064|P1|Overall Study|Missed 6 Month Visit|3
2523174|NCT01705080|8732061|P4|Overall Study|Protocol Violation|0
2523175|NCT01705080|8732062|P3|Overall Study|Protocol Violation|0
2523176|NCT01705080|8732063|P2|Overall Study|Protocol Violation|0
2523177|NCT01705080|8732064|P1|Overall Study|Protocol Violation|2
2523178|NCT01705080|8732061|P4|Overall Study|Lost to Follow-up|2
2523179|NCT01705080|8732062|P3|Overall Study|Lost to Follow-up|0
2523180|NCT01705080|8732063|P2|Overall Study|Lost to Follow-up|0
2523181|NCT01705080|8732064|P1|Overall Study|Lost to Follow-up|0
2523182|NCT01705080|8732061|P4|Overall Study|Physician Decision|8
2523183|NCT01705080|8732062|P3|Overall Study|Physician Decision|1
2523184|NCT01705080|8732063|P2|Overall Study|Physician Decision|2
2523185|NCT01705080|8732064|P1|Overall Study|Physician Decision|1
2523186|NCT01705080|8732061|P4|Overall Study|Withdrawal by Subject|12
2523187|NCT01705080|8732062|P3|Overall Study|Withdrawal by Subject|0
2523188|NCT01705080|8732063|P2|Overall Study|Withdrawal by Subject|1
2523189|NCT01705080|8732064|P1|Overall Study|Withdrawal by Subject|1
2523190|NCT01705080|8732061|P4|Overall Study|Death|0
2523191|NCT01705080|8732062|P3|Overall Study|Death|0
2523192|NCT01705080|8732063|P2|Overall Study|Death|1
2523193|NCT01705080|8732064|P1|Overall Study|Death|0
2523194|NCT01705080|8732061|P4|Overall Study|Failed Procedure|0
2523195|NCT01705080|8732062|P3|Overall Study|Failed Procedure|0
2523196|NCT01705080|8732063|P2|Overall Study|Failed Procedure|2
2523197|NCT01705080|8732064|P1|Overall Study|Failed Procedure|0
2523198|NCT01705080|8732061|P4|Overall Study|Screen Failure Post Consent|20
2523199|NCT01705080|8732062|P3|Overall Study|Screen Failure Post Consent|3
2523200|NCT01705080|8732063|P2|Overall Study|Screen Failure Post Consent|9
2523201|NCT01705080|8732064|P1|Overall Study|Screen Failure Post Consent|8
2523202|NCT01704846|8732193|P2|Treatment Period 2|Withdrawal by Subject|1
2523203|NCT01704846|8732194|P1|Treatment Period 2|Withdrawal by Subject|0
2523204|NCT01704755|8732249|P2|Overall Study|Withdrew consent and personal issues|0
2523205|NCT01704755|8732250|P1|Overall Study|Withdrew consent and personal issues|1
2523206|NCT01704755|8732249|P2|Overall Study|Other (not specified)|1
2523207|NCT01704755|8732250|P1|Overall Study|Other (not specified)|3
2523208|NCT01704755|8732249|P2|Overall Study|Withdrew consent|1
2523209|NCT01704755|8732250|P1|Overall Study|Withdrew consent|1
2523210|NCT01704755|8732249|P2|Overall Study|Lost to Follow-up|4
2523211|NCT01704755|8732250|P1|Overall Study|Lost to Follow-up|3
2523212|NCT01704755|8732249|P2|Overall Study|Adverse Event|1
2523213|NCT01704755|8732250|P1|Overall Study|Adverse Event|4
2523214|NCT01704651|8732264|P2|Overall Study|Post-op did not have laparotomy|1
2523215|NCT01704651|8732265|P1|Overall Study|Post-op did not have laparotomy|2
2523216|NCT01704651|8732264|P2|Overall Study|Nasogastric tube placement in surgery|1
2523217|NCT01704651|8732265|P1|Overall Study|Nasogastric tube placement in surgery|1
2523218|NCT01704651|8732264|P2|Overall Study|Pre-op change in treatment plan|4
2523219|NCT01704651|8732265|P1|Overall Study|Pre-op change in treatment plan|1
2523220|NCT01704651|8732264|P2|Overall Study|Pre-op withdrawal by subject|1
2523221|NCT01704651|8732265|P1|Overall Study|Pre-op withdrawal by subject|1
2523222|NCT01704599|8732273|P1|Overall Study|Adverse Event|1
2523223|NCT01704495|8732313|P4|Optional Safety Extension|Withdrawal by Subject|2
2523224|NCT01704495|8732314|P3|Optional Safety Extension|Withdrawal by Subject|1
2523225|NCT01704495|8732315|P2|Optional Safety Extension|Withdrawal by Subject|0
2523226|NCT01704495|8732316|P1|Optional Safety Extension|Withdrawal by Subject|2
2523227|NCT01704495|8732313|P4|Optional Safety Extension|Other reason|28
2523228|NCT01704495|8732314|P3|Optional Safety Extension|Other reason|30
2523229|NCT01704495|8732315|P2|Optional Safety Extension|Other reason|29
2523230|NCT01704495|8732316|P1|Optional Safety Extension|Other reason|27
2523231|NCT01704495|8732313|P4|Optional Safety Extension|Adverse Event|1
2523232|NCT01704495|8732314|P3|Optional Safety Extension|Adverse Event|0
2523233|NCT01704495|8732315|P2|Optional Safety Extension|Adverse Event|4
2523234|NCT01704495|8732316|P1|Optional Safety Extension|Adverse Event|0
2523235|NCT01704495|8732313|P4|Subjects Randomized|Eligibility criteria not fulfilled|3
2523236|NCT01704495|8732314|P3|Subjects Randomized|Eligibility criteria not fulfilled|4
2523237|NCT01704495|8732315|P2|Subjects Randomized|Eligibility criteria not fulfilled|3
2523238|NCT01704495|8732316|P1|Subjects Randomized|Eligibility criteria not fulfilled|1
2523239|NCT01704495|8732313|P4|Subjects Randomized|Protocol Violation|0
2523240|NCT01704495|8732314|P3|Subjects Randomized|Protocol Violation|2
2523241|NCT01704495|8732315|P2|Subjects Randomized|Protocol Violation|1
2523242|NCT01704495|8732316|P1|Subjects Randomized|Protocol Violation|1
2523243|NCT01704495|8732313|P4|Subjects Randomized|Withdrawal by Subject|5
2523244|NCT01704495|8732314|P3|Subjects Randomized|Withdrawal by Subject|5
2523245|NCT01704495|8732315|P2|Subjects Randomized|Withdrawal by Subject|5
2523246|NCT01704495|8732316|P1|Subjects Randomized|Withdrawal by Subject|5
2523247|NCT01704495|8732313|P4|Subjects Randomized|Adverse Event|7
2523248|NCT01704495|8732314|P3|Subjects Randomized|Adverse Event|0
2523249|NCT01704495|8732315|P2|Subjects Randomized|Adverse Event|2
2523250|NCT01704495|8732316|P1|Subjects Randomized|Adverse Event|8
2523251|NCT01704495|8732313|P4|Subjects Randomized|Discontinuation criteria met|0
2523252|NCT01704495|8732314|P3|Subjects Randomized|Discontinuation criteria met|2
2523253|NCT01704495|8732315|P2|Subjects Randomized|Discontinuation criteria met|2
2523254|NCT01704495|8732316|P1|Subjects Randomized|Discontinuation criteria met|4
2523255|NCT01704495|8732313|P4|Subjects Randomized|Other Reason|2
2523256|NCT01704495|8732314|P3|Subjects Randomized|Other Reason|3
2523257|NCT01704495|8732315|P2|Subjects Randomized|Other Reason|2
2523258|NCT01704495|8732316|P1|Subjects Randomized|Other Reason|3
2523259|NCT01704456|8732492|P2|Overall Study|Lost to Follow-up|14
2523260|NCT01704456|8732493|P1|Overall Study|Lost to Follow-up|8
2523261|NCT01704287|8732555|P5|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
2523262|NCT01704287|8732556|P4|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1
2523263|NCT01704287|8732557|P3|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
2523264|NCT01704287|8732558|P2|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
2523265|NCT01704287|8732559|P1|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
2523266|NCT01704287|8732555|P5|Switch to Pembrolizumab Treatment Period|Death|37
2523267|NCT01704287|8732556|P4|Switch to Pembrolizumab Treatment Period|Death|35
2523268|NCT01704287|8732557|P3|Switch to Pembrolizumab Treatment Period|Death|0
2523269|NCT01704287|8732558|P2|Switch to Pembrolizumab Treatment Period|Death|0
2523270|NCT01704287|8732559|P1|Switch to Pembrolizumab Treatment Period|Death|0
2523271|NCT01704287|8732555|P5|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1
2523272|NCT01704287|8732556|P4|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2
2523273|NCT01704287|8732557|P3|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
2523274|NCT01704287|8732558|P2|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
2523275|NCT01704287|8732559|P1|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
2523276|NCT01704287|8732555|P5|Initial Treatment Period|Switched to Pembrolizumab|0
2523277|NCT01704287|8732556|P4|Initial Treatment Period|Switched to Pembrolizumab|0
2523278|NCT01704287|8732557|P3|Initial Treatment Period|Switched to Pembrolizumab|98
2523279|NCT01704287|8732558|P2|Initial Treatment Period|Switched to Pembrolizumab|0
2523280|NCT01704287|8732559|P1|Initial Treatment Period|Switched to Pembrolizumab|0
2523281|NCT01704287|8732555|P5|Initial Treatment Period|Lost to Follow-up|0
2523282|NCT01704287|8732556|P4|Initial Treatment Period|Lost to Follow-up|0
2523283|NCT01704287|8732557|P3|Initial Treatment Period|Lost to Follow-up|0
2523284|NCT01704287|8732558|P2|Initial Treatment Period|Lost to Follow-up|3
2523285|NCT01704287|8732559|P1|Initial Treatment Period|Lost to Follow-up|5
2523286|NCT01704287|8732555|P5|Initial Treatment Period|Withdrawal by Subject|0
2523287|NCT01704287|8732556|P4|Initial Treatment Period|Withdrawal by Subject|0
2523288|NCT01704287|8732557|P3|Initial Treatment Period|Withdrawal by Subject|4
2523289|NCT01704287|8732558|P2|Initial Treatment Period|Withdrawal by Subject|2
2523290|NCT01704287|8732559|P1|Initial Treatment Period|Withdrawal by Subject|3
2523291|NCT01704287|8732555|P5|Initial Treatment Period|Death|0
2523292|NCT01704287|8732556|P4|Initial Treatment Period|Death|0
2523293|NCT01704287|8732557|P3|Initial Treatment Period|Death|71
2523294|NCT01704287|8732558|P2|Initial Treatment Period|Death|129
2523295|NCT01704287|8732559|P1|Initial Treatment Period|Death|139
2523296|NCT01704261|8732607|P2|Overall Study|Lost to Follow-up|0
2523297|NCT01704261|8732608|P1|Overall Study|Lost to Follow-up|1
2523298|NCT01704261|8732607|P2|Overall Study|Withdrawal by Subject|15
2523299|NCT01704261|8732608|P1|Overall Study|Withdrawal by Subject|12
2523300|NCT01704079|8732635|P2|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1
2523301|NCT01704079|8732636|P1|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0
2523302|NCT01704079|8732635|P2|Overall Study|Subject noncompliance|3
2523303|NCT01704079|8732636|P1|Overall Study|Subject noncompliance|2
2523304|NCT01704079|8732635|P2|Overall Study|Protocol Violation|0
2523305|NCT01704079|8732636|P1|Overall Study|Protocol Violation|1
2523306|NCT01704079|8732635|P2|Overall Study|Adverse Event|7
2523307|NCT01704079|8732636|P1|Overall Study|Adverse Event|4
2523308|NCT01704079|8732635|P2|Overall Study|Lost to Follow-up|5
2523309|NCT01704079|8732636|P1|Overall Study|Lost to Follow-up|2
2523310|NCT01704079|8732635|P2|Overall Study|Withdrawal by Subject|7
2523311|NCT01704079|8732636|P1|Overall Study|Withdrawal by Subject|5
2523312|NCT01703988|8732652|P4|Overall Study|Investigator Judgment|1
2523313|NCT01703988|8732653|P3|Overall Study|Investigator Judgment|0
2523314|NCT01703988|8732654|P2|Overall Study|Investigator Judgment|0
2523315|NCT01703988|8732655|P1|Overall Study|Investigator Judgment|0
2523316|NCT01703858|8732685|P3|Overall Study|Withdrawal by Subject|0
2523317|NCT01703858|8732686|P2|Overall Study|Withdrawal by Subject|1
2523318|NCT01703858|8732687|P1|Overall Study|Withdrawal by Subject|0
2523319|NCT01703845|8732712|P2|Overall Study|other than stated above|0
2523320|NCT01703845|8732713|P1|Overall Study|other than stated above|1
2523321|NCT01703845|8732712|P2|Overall Study|Protocol Violation|0
2523322|NCT01703845|8732713|P1|Overall Study|Protocol Violation|1
2523323|NCT01703845|8732712|P2|Overall Study|Adverse Event|0
2523324|NCT01703845|8732713|P1|Overall Study|Adverse Event|1
2523325|NCT01703832|8732750|P2|Overall Study|Withdrawal by Subject|0
2523326|NCT01703832|8732751|P1|Overall Study|Withdrawal by Subject|1
2523327|NCT01703819|8732783|P2|Overall Study|Withdrawal by Subject|1
2523328|NCT01703819|8732784|P1|Overall Study|Withdrawal by Subject|0
2523329|NCT01703819|8732783|P2|Overall Study|Adverse Event|1
2523330|NCT01703819|8732784|P1|Overall Study|Adverse Event|0
2523331|NCT01703741|8732814|P1|Overall Study|Subject started testosterone injections|1
2523332|NCT01703741|8732814|P1|Overall Study|Subject cannot comply with study visits|1
2523333|NCT01703741|8732814|P1|Overall Study|Subject did not want to continue|2
2523334|NCT01703741|8732814|P1|Overall Study|Lost to Follow-up|3
2523335|NCT01703741|8732814|P1|Overall Study|Protocol Violation|1
2523336|NCT01703741|8732814|P1|Overall Study|Physician Decision|2
2523337|NCT01703741|8732814|P1|Overall Study|Adverse Event|2
2523338|NCT01703741|8732814|P1|Overall Study|Withdrawal by Subject|6
2523339|NCT01703286|8732880|P6|Period 2 Including Washout|Adverse Event|0
2523340|NCT01703286|8732881|P5|Period 2 Including Washout|Adverse Event|0
2523341|NCT01703286|8732882|P4|Period 2 Including Washout|Adverse Event|1
2523342|NCT01703286|8732883|P3|Period 2 Including Washout|Adverse Event|0
2523343|NCT01703286|8732884|P2|Period 2 Including Washout|Adverse Event|0
2523344|NCT01703286|8732885|P1|Period 2 Including Washout|Adverse Event|0
2523345|NCT01703286|8732880|P6|Period 1 Including Washout|Withdrawal by Subject|1
2523346|NCT01703286|8732881|P5|Period 1 Including Washout|Withdrawal by Subject|0
2523347|NCT01703286|8732882|P4|Period 1 Including Washout|Withdrawal by Subject|1
2523348|NCT01703286|8732883|P3|Period 1 Including Washout|Withdrawal by Subject|0
2523349|NCT01703286|8732884|P2|Period 1 Including Washout|Withdrawal by Subject|0
2523350|NCT01703286|8732885|P1|Period 1 Including Washout|Withdrawal by Subject|0
2523351|NCT01703260|8732908|P3|Overall Study|Study Termination|0
2523352|NCT01703260|8732909|P2|Overall Study|Study Termination|2
2523353|NCT01703260|8732910|P1|Overall Study|Study Termination|1
2523354|NCT01703260|8732908|P3|Overall Study|Withdrawal by Subject|1
2523355|NCT01703260|8732909|P2|Overall Study|Withdrawal by Subject|0
2523356|NCT01703260|8732910|P1|Overall Study|Withdrawal by Subject|0
2523357|NCT01703260|8732908|P3|Overall Study|Lost to Follow-up|0
2523358|NCT01703260|8732909|P2|Overall Study|Lost to Follow-up|0
2523359|NCT01703260|8732910|P1|Overall Study|Lost to Follow-up|1
2523360|NCT01703260|8732908|P3|Overall Study|Adverse Event|2
2523361|NCT01703260|8732909|P2|Overall Study|Adverse Event|2
2523362|NCT01703260|8732910|P1|Overall Study|Adverse Event|1
2523363|NCT01703221|8732936|P3|Phase B - (Week 25 to 52)|Lack of Efficacy|3
2523364|NCT01703221|8732937|P2|Phase B - (Week 25 to 52)|Lack of Efficacy|10
2523365|NCT01703221|8732938|P1|Phase B - (Week 25 to 52)|Lack of Efficacy|12
2523366|NCT01703221|8732936|P3|Phase B - (Week 25 to 52)|Adverse Event|2
2523367|NCT01703221|8732937|P2|Phase B - (Week 25 to 52)|Adverse Event|3
2523368|NCT01703221|8732938|P1|Phase B - (Week 25 to 52)|Adverse Event|2
2523369|NCT01703221|8732936|P3|Phase B - (Week 25 to 52)|Withdrawal by Subject|0
2523370|NCT01703221|8732937|P2|Phase B - (Week 25 to 52)|Withdrawal by Subject|1
2523371|NCT01703221|8732938|P1|Phase B - (Week 25 to 52)|Withdrawal by Subject|2
2523372|NCT01703221|8732936|P3|Phase A (Up to 24 Weeks)|Protocol Violation|1
2523373|NCT01703221|8732937|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
2523374|NCT01703221|8732938|P1|Phase A (Up to 24 Weeks)|Protocol Violation|0
2523375|NCT01703221|8732936|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
2523376|NCT01703221|8732937|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
2523377|NCT01703221|8732938|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2
2523378|NCT01703221|8732936|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
2523379|NCT01703221|8732937|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
2523380|NCT01703221|8732938|P1|Phase A (Up to 24 Weeks)|Physician Decision|1
2523381|NCT01703221|8732936|P3|Phase A (Up to 24 Weeks)|Lack of Efficacy|1
2523382|NCT01703221|8732937|P2|Phase A (Up to 24 Weeks)|Lack of Efficacy|0
2523383|NCT01703221|8732938|P1|Phase A (Up to 24 Weeks)|Lack of Efficacy|2
2523384|NCT01703221|8732936|P3|Phase A (Up to 24 Weeks)|Adverse Event|0
2523385|NCT01703221|8732937|P2|Phase A (Up to 24 Weeks)|Adverse Event|4
2523386|NCT01703221|8732938|P1|Phase A (Up to 24 Weeks)|Adverse Event|2
2523387|NCT01703208|8732969|P2|Overall Study|Protocol Deviation|0
2523388|NCT01703208|8732970|P1|Overall Study|Protocol Deviation|2
2523389|NCT01703208|8732969|P2|Overall Study|Technical Problems|1
2523390|NCT01703208|8732970|P1|Overall Study|Technical Problems|0
2523391|NCT01703208|8732969|P2|Overall Study|Adverse Event|19
2523392|NCT01703208|8732970|P1|Overall Study|Adverse Event|14
2523393|NCT01703208|8732969|P2|Overall Study|Withdrawal by Subject|209
2523394|NCT01703208|8732970|P1|Overall Study|Withdrawal by Subject|205
2523395|NCT01703208|8732969|P2|Overall Study|Study Terminated by Sponsor|1716
2523396|NCT01703208|8732970|P1|Overall Study|Study Terminated by Sponsor|1710
2523397|NCT01703208|8732969|P2|Overall Study|Protocol Violation|1
2523398|NCT01703208|8732970|P1|Overall Study|Protocol Violation|1
2523399|NCT01703208|8732969|P2|Overall Study|Progressive disease|2
2523400|NCT01703208|8732970|P1|Overall Study|Progressive disease|2
2523401|NCT01703208|8732969|P2|Overall Study|Physician Decision|13
2523402|NCT01703208|8732970|P1|Overall Study|Physician Decision|11
2523403|NCT01703208|8732969|P2|Overall Study|Site Discontinued Study Participation|27
2523404|NCT01703208|8732970|P1|Overall Study|Site Discontinued Study Participation|23
2523405|NCT01703208|8732969|P2|Overall Study|Excluded Medication|2
2523406|NCT01703208|8732970|P1|Overall Study|Excluded Medication|1
2523407|NCT01703208|8732969|P2|Overall Study|Non-Compliance with Study Drug|0
2523408|NCT01703208|8732970|P1|Overall Study|Non-Compliance with Study Drug|1
2523409|NCT01703208|8732969|P2|Overall Study|Lost to Follow-up|62
2523410|NCT01703208|8732970|P1|Overall Study|Lost to Follow-up|68
2523411|NCT01703208|8732969|P2|Overall Study|Lack of Efficacy|2
2523412|NCT01703208|8732970|P1|Overall Study|Lack of Efficacy|1
2523413|NCT01703208|8732969|P2|Overall Study|Death|48
2523414|NCT01703208|8732970|P1|Overall Study|Death|61
2523415|NCT01703091|8733034|P2|Overall Study|Sponsor Decision|0
2523416|NCT01703091|8733035|P1|Overall Study|Sponsor Decision|1
2523417|NCT01703091|8733034|P2|Overall Study|Withdrawal by Subject|0
2523418|NCT01703091|8733035|P1|Overall Study|Withdrawal by Subject|1
2523419|NCT01703091|8733034|P2|Overall Study|Physician Decision|1
2523420|NCT01703091|8733035|P1|Overall Study|Physician Decision|2
2523421|NCT01703091|8733034|P2|Overall Study|Adverse Event|3
2523422|NCT01703091|8733035|P1|Overall Study|Adverse Event|5
2523423|NCT01703065|8733053|P2|Overall Study|Lack of Efficacy|0
2523424|NCT01703065|8733054|P1|Overall Study|Lack of Efficacy|1
2523425|NCT01703000|8733084|P1|Overall Study|Death|1
2523426|NCT01702987|8733117|P2|Overall Study|Withdrawal by Subject|0
2523427|NCT01702987|8733118|P1|Overall Study|Withdrawal by Subject|1
2523428|NCT01702961|8733124|P1|Overall Study|Ongoing|11
2523429|NCT01702961|8733124|P1|Overall Study|Lost to Follow-up|2
2523430|NCT01702961|8733124|P1|Overall Study|Death|6
2523431|NCT01702961|8733124|P1|Overall Study|Relapse|20
2523432|NCT01702961|8733124|P1|Overall Study|Progressive disease|5
2523433|NCT01702961|8733124|P1|Overall Study|Additional treatment|3
2523434|NCT01702558|8733147|P5|Overall Study|Other|17
2523435|NCT01702558|8733148|P4|Overall Study|Other|16
2523436|NCT01702558|8733149|P3|Overall Study|Other|0
2523437|NCT01702558|8733150|P2|Overall Study|Other|0
2523438|NCT01702558|8733151|P1|Overall Study|Other|0
2523439|NCT01702558|8733147|P5|Overall Study|Study Terminated by Sponsor|1
2523440|NCT01702558|8733148|P4|Overall Study|Study Terminated by Sponsor|0
2523441|NCT01702558|8733149|P3|Overall Study|Study Terminated by Sponsor|0
2523442|NCT01702558|8733150|P2|Overall Study|Study Terminated by Sponsor|1
2523443|NCT01702558|8733151|P1|Overall Study|Study Terminated by Sponsor|0
2523444|NCT01702558|8733147|P5|Overall Study|Safety Follow-Up less than 3 Months|0
2523445|NCT01702558|8733148|P4|Overall Study|Safety Follow-Up less than 3 Months|0
2523446|NCT01702558|8733149|P3|Overall Study|Safety Follow-Up less than 3 Months|2
2523447|NCT01702558|8733150|P2|Overall Study|Safety Follow-Up less than 3 Months|0
2523448|NCT01702558|8733151|P1|Overall Study|Safety Follow-Up less than 3 Months|0
2523449|NCT01702558|8733147|P5|Overall Study|Death|20
2523450|NCT01702558|8733148|P4|Overall Study|Death|16
2523451|NCT01702558|8733149|P3|Overall Study|Death|3
2523452|NCT01702558|8733150|P2|Overall Study|Death|3
2523453|NCT01702558|8733151|P1|Overall Study|Death|4
2523454|NCT01702558|8733147|P5|Overall Study|Lost to Follow-up|0
2523455|NCT01702558|8733148|P4|Overall Study|Lost to Follow-up|3
2523456|NCT01702558|8733149|P3|Overall Study|Lost to Follow-up|0
2523457|NCT01702558|8733150|P2|Overall Study|Lost to Follow-up|0
2523458|NCT01702558|8733151|P1|Overall Study|Lost to Follow-up|0
2523459|NCT01702558|8733147|P5|Overall Study|Withdrawal by Subject|4
2523460|NCT01702558|8733148|P4|Overall Study|Withdrawal by Subject|12
2523461|NCT01702558|8733149|P3|Overall Study|Withdrawal by Subject|0
2523462|NCT01702558|8733150|P2|Overall Study|Withdrawal by Subject|0
2523463|NCT01702558|8733151|P1|Overall Study|Withdrawal by Subject|0
2523464|NCT01702532|8733216|P2|Overall Study|Adverse Event|1
2523465|NCT01702532|8733217|P1|Overall Study|Adverse Event|0
2523466|NCT01702519|8733227|P2|Washout Period|Withdrawal by Subject|2
2523467|NCT01702519|8733228|P1|Washout Period|Withdrawal by Subject|0
2523468|NCT01702519|8733227|P2|Washout Period|Lost to Follow-up|0
2523469|NCT01702519|8733228|P1|Washout Period|Lost to Follow-up|1
2523470|NCT01702454|8733246|P2|Overall Study|Lost to Follow-up|6
2523471|NCT01702454|8733247|P1|Overall Study|Lost to Follow-up|3
2523472|NCT01702454|8733246|P2|Overall Study|Migrated/moved from study area|1
2523473|NCT01702454|8733247|P1|Overall Study|Migrated/moved from study area|0
2523474|NCT01702454|8733246|P2|Overall Study|Consent withdrawal|1
2523475|NCT01702454|8733247|P1|Overall Study|Consent withdrawal|0
2523476|NCT01702428|8733329|P4|Overall Study|Withdrawal by Subject|10
2523477|NCT01702428|8733330|P3|Overall Study|Withdrawal by Subject|14
2523478|NCT01702428|8733331|P2|Overall Study|Withdrawal by Subject|23
2523479|NCT01702428|8733332|P1|Overall Study|Withdrawal by Subject|21
2523480|NCT01702428|8733329|P4|Overall Study|Protocol Violation|0
2523481|NCT01702428|8733330|P3|Overall Study|Protocol Violation|1
2523482|NCT01702428|8733331|P2|Overall Study|Protocol Violation|0
2523483|NCT01702428|8733332|P1|Overall Study|Protocol Violation|3
2523484|NCT01702428|8733329|P4|Overall Study|Parents too busy|0
2523485|NCT01702428|8733330|P3|Overall Study|Parents too busy|0
2523486|NCT01702428|8733331|P2|Overall Study|Parents too busy|0
2523487|NCT01702428|8733332|P1|Overall Study|Parents too busy|1
2523488|NCT01702428|8733329|P4|Overall Study|Mother transferred care|0
2523489|NCT01702428|8733330|P3|Overall Study|Mother transferred care|0
2523490|NCT01702428|8733331|P2|Overall Study|Mother transferred care|1
2523491|NCT01702428|8733332|P1|Overall Study|Mother transferred care|0
2523492|NCT01702428|8733329|P4|Overall Study|Lost Health Plan|2
2523493|NCT01702428|8733330|P3|Overall Study|Lost Health Plan|0
2523494|NCT01702428|8733331|P2|Overall Study|Lost Health Plan|5
2523495|NCT01702428|8733332|P1|Overall Study|Lost Health Plan|3
2523496|NCT01702428|8733329|P4|Overall Study|Lost Coverage|1
2523497|NCT01702428|8733330|P3|Overall Study|Lost Coverage|0
2523498|NCT01702428|8733331|P2|Overall Study|Lost Coverage|0
2523499|NCT01702428|8733332|P1|Overall Study|Lost Coverage|0
2523500|NCT01702428|8733329|P4|Overall Study|Parents cannot assist to site|0
2523501|NCT01702428|8733330|P3|Overall Study|Parents cannot assist to site|1
2523502|NCT01702428|8733331|P2|Overall Study|Parents cannot assist to site|0
2523503|NCT01702428|8733332|P1|Overall Study|Parents cannot assist to site|1
2523504|NCT01702428|8733329|P4|Overall Study|Lost to Follow-up|44
2523505|NCT01702428|8733330|P3|Overall Study|Lost to Follow-up|37
2523506|NCT01702428|8733331|P2|Overall Study|Lost to Follow-up|41
2523507|NCT01702428|8733332|P1|Overall Study|Lost to Follow-up|33
2523508|NCT01702428|8733329|P4|Overall Study|Adverse Event|0
2523509|NCT01702428|8733330|P3|Overall Study|Adverse Event|0
2523510|NCT01702428|8733331|P2|Overall Study|Adverse Event|0
2523511|NCT01702428|8733332|P1|Overall Study|Adverse Event|2
2523512|NCT01702363|8733419|P1|Overall Study|Withdrawal by Subject|2
2523513|NCT01702363|8733419|P1|Overall Study|Lack of Efficacy|4
2523514|NCT01702363|8733419|P1|Overall Study|Adverse Event|14
2523515|NCT01702311|8733436|P2|Overall Study|Physician Decision|4
2523516|NCT01702311|8733437|P1|Overall Study|Physician Decision|3
2523517|NCT01702311|8733436|P2|Overall Study|Discharge less than 24 hours|7
2523518|NCT01702311|8733437|P1|Overall Study|Discharge less than 24 hours|10
2523519|NCT01702311|8733436|P2|Overall Study|Withdrawal by Subject|2
2523520|NCT01702311|8733437|P1|Overall Study|Withdrawal by Subject|3
2523521|NCT01702298|8733467|P1|Overall Study|Withdrawal by Subject|1
2523522|NCT01702246|8733495|P1|Overall Study|Physician Decision|1
2523523|NCT01702246|8733495|P1|Overall Study|Withdrawal by Subject|2
2523524|NCT01702246|8733495|P1|Overall Study|Lost to Follow-up|2
2523525|NCT01702025|8733549|P4|Overall Study|Adverse Event|0
2523526|NCT01702025|8733550|P3|Overall Study|Adverse Event|1
2523527|NCT01702025|8733551|P2|Overall Study|Adverse Event|1
2523528|NCT01702025|8733552|P1|Overall Study|Adverse Event|1
2523529|NCT01702025|8733549|P4|Overall Study|Equipment failure|0
2523530|NCT01702025|8733550|P3|Overall Study|Equipment failure|0
2523531|NCT01702025|8733551|P2|Overall Study|Equipment failure|0
2523532|NCT01702025|8733552|P1|Overall Study|Equipment failure|1
2523533|NCT01701973|8733581|P8|Aim 1: First Intervention (1 Day)|Adverse Event|0
2523534|NCT01701973|8733582|P7|Aim 1: First Intervention (1 Day)|Adverse Event|0
2523535|NCT01701973|8733583|P6|Aim 1: First Intervention (1 Day)|Adverse Event|0
2523536|NCT01701973|8733584|P5|Aim 1: First Intervention (1 Day)|Adverse Event|0
2523537|NCT01701973|8733585|P4|Aim 1: First Intervention (1 Day)|Adverse Event|0
2523538|NCT01701973|8733586|P3|Aim 1: First Intervention (1 Day)|Adverse Event|0
2523539|NCT01701973|8733587|P2|Aim 1: First Intervention (1 Day)|Adverse Event|1
2523540|NCT01701973|8733588|P1|Aim 1: First Intervention (1 Day)|Adverse Event|0
2523541|NCT01701674|8733635|P1|Overall Study|Unable to safely complete treatment|1
2523542|NCT01701401|8733721|P4|Overall Study|Protocol Violation|0
2523543|NCT01701401|8733722|P3|Overall Study|Protocol Violation|1
2523544|NCT01701401|8733723|P2|Overall Study|Protocol Violation|0
2523545|NCT01701401|8733724|P1|Overall Study|Protocol Violation|0
2523546|NCT01701401|8733721|P4|Overall Study|Adverse Event|0
2523547|NCT01701401|8733722|P3|Overall Study|Adverse Event|0
2523548|NCT01701401|8733723|P2|Overall Study|Adverse Event|0
2523549|NCT01701401|8733724|P1|Overall Study|Adverse Event|1
2523550|NCT01701401|8733721|P4|Overall Study|Lack of Efficacy|0
2523551|NCT01701401|8733722|P3|Overall Study|Lack of Efficacy|2
2523552|NCT01701401|8733723|P2|Overall Study|Lack of Efficacy|0
2523553|NCT01701401|8733724|P1|Overall Study|Lack of Efficacy|1
2523554|NCT01701401|8733721|P4|Overall Study|Withdrew Consent|2
2523555|NCT01701401|8733722|P3|Overall Study|Withdrew Consent|1
2523556|NCT01701401|8733723|P2|Overall Study|Withdrew Consent|3
2523557|NCT01701401|8733724|P1|Overall Study|Withdrew Consent|0
2523558|NCT01701401|8733721|P4|Overall Study|Lost to Follow-up|3
2523559|NCT01701401|8733722|P3|Overall Study|Lost to Follow-up|1
2523560|NCT01701401|8733723|P2|Overall Study|Lost to Follow-up|5
2523561|NCT01701401|8733724|P1|Overall Study|Lost to Follow-up|5
2523562|NCT01701401|8733721|P4|Overall Study|Randomized But Not Treated|1
2523563|NCT01701401|8733722|P3|Overall Study|Randomized But Not Treated|0
2523564|NCT01701401|8733723|P2|Overall Study|Randomized But Not Treated|1
2523565|NCT01701401|8733724|P1|Overall Study|Randomized But Not Treated|3
2523566|NCT01701362|8733776|P2|Overall Study|Reasons other than those mentioned above|5
2523567|NCT01701362|8733777|P1|Overall Study|Reasons other than those mentioned above|3
2523568|NCT01701362|8733776|P2|Overall Study|Randomized but not treated|2
2523569|NCT01701362|8733777|P1|Overall Study|Randomized but not treated|1
2523570|NCT01701362|8733776|P2|Overall Study|Death|1
2523571|NCT01701362|8733777|P1|Overall Study|Death|0
2523572|NCT01701362|8733776|P2|Overall Study|Insufficient clinical response|6
2523573|NCT01701362|8733777|P1|Overall Study|Insufficient clinical response|6
2523574|NCT01701362|8733776|P2|Overall Study|Lost to Follow-up|9
2523575|NCT01701362|8733777|P1|Overall Study|Lost to Follow-up|6
2523576|NCT01701362|8733776|P2|Overall Study|No longer willing to participate|14
2523577|NCT01701362|8733777|P1|Overall Study|No longer willing to participate|8
2523578|NCT01701362|8733776|P2|Overall Study|Protocol Violation|3
2523579|NCT01701362|8733777|P1|Overall Study|Protocol Violation|5
2523580|NCT01701362|8733776|P2|Overall Study|Adverse events related to study drug|10
2523581|NCT01701362|8733777|P1|Overall Study|Adverse events related to study drug|12
2523582|NCT01701362|8733776|P2|Overall Study|Adverse events not related to study drug|6
2523583|NCT01701362|8733777|P1|Overall Study|Adverse events not related to study drug|1
2523584|NCT01701258|8733815|P13|Assessment and Scheduling|Investigator Terminated|0
2523585|NCT01701258|8733816|P12|Assessment and Scheduling|Investigator Terminated|0
2523586|NCT01701258|8733817|P11|Assessment and Scheduling|Investigator Terminated|0
2523587|NCT01701258|8733818|P10|Assessment and Scheduling|Investigator Terminated|0
2523588|NCT01701258|8733819|P9|Assessment and Scheduling|Investigator Terminated|0
2523589|NCT01701258|8733820|P8|Assessment and Scheduling|Investigator Terminated|0
2523590|NCT01701258|8733821|P7|Assessment and Scheduling|Investigator Terminated|0
2523591|NCT01701258|8733822|P6|Assessment and Scheduling|Investigator Terminated|0
2523592|NCT01701258|8733823|P5|Assessment and Scheduling|Investigator Terminated|0
2523593|NCT01701258|8733824|P4|Assessment and Scheduling|Investigator Terminated|0
2523594|NCT01701258|8733825|P3|Assessment and Scheduling|Investigator Terminated|0
2523595|NCT01701258|8733826|P2|Assessment and Scheduling|Investigator Terminated|0
2523596|NCT01701258|8733827|P1|Assessment and Scheduling|Investigator Terminated|2
2523597|NCT01701258|8733815|P13|Assessment and Scheduling|Withdrawal by Subject|0
2523598|NCT01701258|8733816|P12|Assessment and Scheduling|Withdrawal by Subject|0
2523599|NCT01701258|8733817|P11|Assessment and Scheduling|Withdrawal by Subject|0
2523600|NCT01701258|8733818|P10|Assessment and Scheduling|Withdrawal by Subject|0
2523601|NCT01701258|8733819|P9|Assessment and Scheduling|Withdrawal by Subject|0
2523602|NCT01701258|8733820|P8|Assessment and Scheduling|Withdrawal by Subject|0
2523603|NCT01701258|8733821|P7|Assessment and Scheduling|Withdrawal by Subject|0
2523604|NCT01701258|8733822|P6|Assessment and Scheduling|Withdrawal by Subject|0
2523605|NCT01701258|8733823|P5|Assessment and Scheduling|Withdrawal by Subject|0
2523606|NCT01701258|8733824|P4|Assessment and Scheduling|Withdrawal by Subject|0
2523607|NCT01701258|8733825|P3|Assessment and Scheduling|Withdrawal by Subject|0
2523608|NCT01701258|8733826|P2|Assessment and Scheduling|Withdrawal by Subject|0
2523609|NCT01701258|8733827|P1|Assessment and Scheduling|Withdrawal by Subject|14
2523610|NCT01701258|8733815|P13|Assessment and Scheduling|Lost to Follow-up|0
2523611|NCT01701258|8733816|P12|Assessment and Scheduling|Lost to Follow-up|0
2523612|NCT01701258|8733817|P11|Assessment and Scheduling|Lost to Follow-up|0
2523613|NCT01701258|8733818|P10|Assessment and Scheduling|Lost to Follow-up|0
2523614|NCT01701258|8733819|P9|Assessment and Scheduling|Lost to Follow-up|0
2523615|NCT01701258|8733820|P8|Assessment and Scheduling|Lost to Follow-up|0
2523616|NCT01701258|8733821|P7|Assessment and Scheduling|Lost to Follow-up|0
2523617|NCT01701258|8733822|P6|Assessment and Scheduling|Lost to Follow-up|0
2523618|NCT01701258|8733823|P5|Assessment and Scheduling|Lost to Follow-up|0
2523619|NCT01701258|8733824|P4|Assessment and Scheduling|Lost to Follow-up|0
2523620|NCT01701258|8733825|P3|Assessment and Scheduling|Lost to Follow-up|0
2523621|NCT01701258|8733826|P2|Assessment and Scheduling|Lost to Follow-up|0
2523622|NCT01701258|8733827|P1|Assessment and Scheduling|Lost to Follow-up|10
2523623|NCT01701258|8733815|P13|Assessment and Scheduling|Found to be Ineligible|0
2523624|NCT01701258|8733816|P12|Assessment and Scheduling|Found to be Ineligible|0
2523625|NCT01701258|8733817|P11|Assessment and Scheduling|Found to be Ineligible|0
2523626|NCT01701258|8733818|P10|Assessment and Scheduling|Found to be Ineligible|0
2523627|NCT01701258|8733819|P9|Assessment and Scheduling|Found to be Ineligible|0
2523628|NCT01701258|8733820|P8|Assessment and Scheduling|Found to be Ineligible|0
2523629|NCT01701258|8733821|P7|Assessment and Scheduling|Found to be Ineligible|0
2523630|NCT01701258|8733822|P6|Assessment and Scheduling|Found to be Ineligible|0
2523631|NCT01701258|8733823|P5|Assessment and Scheduling|Found to be Ineligible|0
2523632|NCT01701258|8733824|P4|Assessment and Scheduling|Found to be Ineligible|0
2523633|NCT01701258|8733825|P3|Assessment and Scheduling|Found to be Ineligible|0
2523634|NCT01701258|8733826|P2|Assessment and Scheduling|Found to be Ineligible|0
2523635|NCT01701258|8733827|P1|Assessment and Scheduling|Found to be Ineligible|57
2523636|NCT01701245|8733881|P2|Overall Study|Did not complete the open label period|12
2523637|NCT01701245|8733882|P1|Overall Study|Did not complete the open label period|11
2523638|NCT01701245|8733881|P2|Overall Study|Protocol Violation|3
2523639|NCT01701245|8733882|P1|Overall Study|Protocol Violation|1
2523640|NCT01701063|8733929|P3|Overall Study|Other|1
2523641|NCT01701063|8733930|P2|Overall Study|Other|0
2523642|NCT01701063|8733931|P1|Overall Study|Other|0
2523643|NCT01701063|8733929|P3|Overall Study|Withdrawal by Subject|1
2523644|NCT01701063|8733930|P2|Overall Study|Withdrawal by Subject|0
2523645|NCT01701063|8733931|P1|Overall Study|Withdrawal by Subject|0
2523646|NCT01701063|8733929|P3|Overall Study|Lost to Follow-up|0
2523647|NCT01701063|8733930|P2|Overall Study|Lost to Follow-up|1
2523648|NCT01701063|8733931|P1|Overall Study|Lost to Follow-up|0
2523649|NCT01700985|8734015|P2|Overall Study|Incarcerated|1
2523650|NCT01700985|8734016|P1|Overall Study|Incarcerated|0
2523651|NCT01700959|8734038|P6|Overall Study|Side effects|1
2523652|NCT01700959|8734039|P5|Overall Study|Side effects|4
2523653|NCT01700959|8734040|P4|Overall Study|Side effects|4
2523654|NCT01700959|8734041|P3|Overall Study|Side effects|8
2523655|NCT01700959|8734042|P2|Overall Study|Side effects|4
2523656|NCT01700959|8734043|P1|Overall Study|Side effects|1
2523657|NCT01700959|8734038|P6|Overall Study|Noncompliant|9
2523658|NCT01700959|8734039|P5|Overall Study|Noncompliant|15
2523659|NCT01700959|8734040|P4|Overall Study|Noncompliant|18
2523660|NCT01700959|8734041|P3|Overall Study|Noncompliant|17
2523661|NCT01700959|8734042|P2|Overall Study|Noncompliant|9
2523662|NCT01700959|8734043|P1|Overall Study|Noncompliant|9
2523663|NCT01700959|8734038|P6|Overall Study|Ineligible|1
2523664|NCT01700959|8734039|P5|Overall Study|Ineligible|0
2523665|NCT01700959|8734040|P4|Overall Study|Ineligible|0
2523666|NCT01700959|8734041|P3|Overall Study|Ineligible|2
2523667|NCT01700959|8734042|P2|Overall Study|Ineligible|1
2523668|NCT01700959|8734043|P1|Overall Study|Ineligible|2
2523669|NCT01700959|8734038|P6|Overall Study|Withdrawal by Subject|12
2523670|NCT01700959|8734039|P5|Overall Study|Withdrawal by Subject|8
2523671|NCT01700959|8734040|P4|Overall Study|Withdrawal by Subject|11
2523672|NCT01700959|8734041|P3|Overall Study|Withdrawal by Subject|12
2523673|NCT01700959|8734042|P2|Overall Study|Withdrawal by Subject|9
2523674|NCT01700959|8734043|P1|Overall Study|Withdrawal by Subject|15
2523675|NCT01700959|8734038|P6|Overall Study|Adverse Event|2
2523676|NCT01700959|8734039|P5|Overall Study|Adverse Event|0
2523677|NCT01700959|8734040|P4|Overall Study|Adverse Event|2
2523678|NCT01700959|8734041|P3|Overall Study|Adverse Event|1
2523679|NCT01700959|8734042|P2|Overall Study|Adverse Event|1
2523680|NCT01700959|8734043|P1|Overall Study|Adverse Event|0
2523681|NCT01700829|8734084|P2|Overall Study|Withdrawal by Subject|1
2523682|NCT01700829|8734085|P1|Overall Study|Withdrawal by Subject|1
2523683|NCT01700621|8734145|P2|Analyzed for Immunogenicity|Baseline measles measure high|2
2523684|NCT01700621|8734146|P1|Analyzed for Immunogenicity|Baseline measles measure high|1
2523685|NCT01700621|8734145|P2|Analyzed for Immunogenicity|Protocol Violation|1
2523686|NCT01700621|8734146|P1|Analyzed for Immunogenicity|Protocol Violation|5
2523687|NCT01700621|8734145|P2|Analyzed for Immunogenicity|Lost to Follow-up|4
2523688|NCT01700621|8734146|P1|Analyzed for Immunogenicity|Lost to Follow-up|7
2523689|NCT01700530|8734184|P3|Overall Study|Withdrawal by Subject|1
2523690|NCT01700530|8734185|P2|Overall Study|Withdrawal by Subject|3
2523691|NCT01700530|8734186|P1|Overall Study|Withdrawal by Subject|0
2523692|NCT01700387|8734235|P2|Overall Study|Lost to Follow-up|1
2523693|NCT01700387|8734236|P1|Overall Study|Lost to Follow-up|2
2523694|NCT01700387|8734235|P2|Overall Study|Adverse Event|1
2523695|NCT01700387|8734236|P1|Overall Study|Adverse Event|1
2523696|NCT01700387|8734235|P2|Overall Study|Withdrawal by Subject|2
2523697|NCT01700387|8734236|P1|Overall Study|Withdrawal by Subject|1
2523698|NCT01700348|8734246|P1|Overall Study|Lost to Follow-up|1
2523699|NCT01700348|8734246|P1|Overall Study|Withdrawal by Subject|22
2523700|NCT01700205|8734269|P2|Overall Study|Protocol Violation|2
2523701|NCT01700205|8734270|P1|Overall Study|Protocol Violation|2
2523702|NCT01700205|8734269|P2|Overall Study|Withdrawal by Subject|13
2523703|NCT01700205|8734270|P1|Overall Study|Withdrawal by Subject|13
2523704|NCT01700192|8734292|P2|Overall Study|Never received study drug|0
2523705|NCT01700192|8734293|P1|Overall Study|Never received study drug|1
2523706|NCT01700192|8734292|P2|Overall Study|Withdrawal by Subject|64
2523707|NCT01700192|8734293|P1|Overall Study|Withdrawal by Subject|56
2523708|NCT01700192|8734292|P2|Overall Study|Technical problems|1
2523709|NCT01700192|8734293|P1|Overall Study|Technical problems|0
2523710|NCT01700192|8734292|P2|Overall Study|Protocol Violation|4
2523711|NCT01700192|8734293|P1|Overall Study|Protocol Violation|3
2523712|NCT01700192|8734292|P2|Overall Study|Progressive disease|0
2523713|NCT01700192|8734293|P1|Overall Study|Progressive disease|1
2523714|NCT01700192|8734292|P2|Overall Study|Pregnancy|4
2523715|NCT01700192|8734293|P1|Overall Study|Pregnancy|1
2523716|NCT01700192|8734292|P2|Overall Study|Physician Decision|3
2523717|NCT01700192|8734293|P1|Overall Study|Physician Decision|2
2523718|NCT01700192|8734292|P2|Overall Study|Noncompliance with study drug|5
2523719|NCT01700192|8734293|P1|Overall Study|Noncompliance with study drug|0
2523720|NCT01700192|8734292|P2|Overall Study|Lost to Follow-up|29
2523721|NCT01700192|8734293|P1|Overall Study|Lost to Follow-up|42
2523722|NCT01700192|8734292|P2|Overall Study|Lack of Efficacy|0
2523723|NCT01700192|8734293|P1|Overall Study|Lack of Efficacy|1
2523724|NCT01700192|8734292|P2|Overall Study|Adverse Event|18
2523725|NCT01700192|8734293|P1|Overall Study|Adverse Event|73
2523726|NCT01700179|8734311|P1|Overall Study|Physician Decision|2
2523727|NCT01700140|8734318|P3|Overall Study|Inclusion/exclusion criteria deviation|0
2523728|NCT01700140|8734319|P2|Overall Study|Inclusion/exclusion criteria deviation|4
2523729|NCT01700140|8734320|P1|Overall Study|Inclusion/exclusion criteria deviation|1
2523730|NCT01700140|8734318|P3|Overall Study|Adverse Event|0
2523731|NCT01700140|8734319|P2|Overall Study|Adverse Event|1
2523732|NCT01700140|8734320|P1|Overall Study|Adverse Event|0
2523733|NCT01700140|8734318|P3|Overall Study|Aggravation of symptoms|0
2523734|NCT01700140|8734319|P2|Overall Study|Aggravation of symptoms|0
2523735|NCT01700140|8734320|P1|Overall Study|Aggravation of symptoms|1
2523736|NCT01700140|8734318|P3|Overall Study|Use of chemotherapy or surgical therapy|0
2523737|NCT01700140|8734319|P2|Overall Study|Use of chemotherapy or surgical therapy|1
2523738|NCT01700140|8734320|P1|Overall Study|Use of chemotherapy or surgical therapy|0
2523739|NCT01700140|8734318|P3|Overall Study|Discontinuation of radiotherapy|0
2523740|NCT01700140|8734319|P2|Overall Study|Discontinuation of radiotherapy|0
2523741|NCT01700140|8734320|P1|Overall Study|Discontinuation of radiotherapy|1
2523742|NCT01700140|8734318|P3|Overall Study|Use of rescue drugs|1
2523743|NCT01700140|8734319|P2|Overall Study|Use of rescue drugs|3
2523744|NCT01700140|8734320|P1|Overall Study|Use of rescue drugs|3
2523745|NCT01700049|8734352|P1|Overall Study|Withdrawal by Subject|1
2523746|NCT01699867|8734367|P1|Overall Study|Screening Failure|3
2523747|NCT01699815|8734374|P2|Overall Study|Adverse Event|1
2523748|NCT01699815|8734375|P1|Overall Study|Adverse Event|0
2523749|NCT01699815|8734374|P2|Overall Study|record could not be located|0
2523750|NCT01699815|8734375|P1|Overall Study|record could not be located|1
2523751|NCT01699815|8734374|P2|Overall Study|Protocol Violation|7
2523752|NCT01699815|8734375|P1|Overall Study|Protocol Violation|4
2523753|NCT01699789|8734387|P2|Overall Study|Lost to Follow-up|101
2523754|NCT01699789|8734388|P1|Overall Study|Lost to Follow-up|83
2523755|NCT01699789|8734387|P2|Overall Study|Death|2
2523756|NCT01699789|8734388|P1|Overall Study|Death|1
2523757|NCT01699789|8734387|P2|Overall Study|Withdrawal by Subject|23
2523758|NCT01699789|8734388|P1|Overall Study|Withdrawal by Subject|18
2523759|NCT01699750|8734458|P2|Overall Study|Other|2
2523760|NCT01699750|8734459|P1|Overall Study|Other|0
2523761|NCT01699750|8734458|P2|Overall Study|Withdrew Consent|1
2523762|NCT01699750|8734459|P1|Overall Study|Withdrew Consent|0
2523763|NCT01699685|8734494|P2|Period 2|Lost to Follow-up|0
2523764|NCT01699685|8734495|P1|Period 2|Lost to Follow-up|1
2523765|NCT01699685|8734494|P2|Period 1|Patient request|1
2523766|NCT01699685|8734495|P1|Period 1|Patient request|0
2523767|NCT01699685|8734494|P2|Period 1|Other|1
2523768|NCT01699685|8734495|P1|Period 1|Other|0
2523769|NCT01699685|8734494|P2|Period 1|Medical or ethical, noncompliance|0
2523770|NCT01699685|8734495|P1|Period 1|Medical or ethical, noncompliance|2
2523771|NCT01699685|8734494|P2|Period 1|Adverse Event|1
2523772|NCT01699685|8734495|P1|Period 1|Adverse Event|1
2523773|NCT01699503|8734521|P2|Overall Study|Excluded due to quality|791
2523774|NCT01699503|8734522|P1|Overall Study|Excluded due to quality|783
2523775|NCT01699503|8734521|P2|Overall Study|Lost to Follow-up|117
2523776|NCT01699503|8734522|P1|Overall Study|Lost to Follow-up|121
2523777|NCT01699503|8734521|P2|Overall Study|Withdrawal by Subject|57
2523778|NCT01699503|8734522|P1|Overall Study|Withdrawal by Subject|65
2523779|NCT01699503|8734521|P2|Overall Study|Death|40
2523780|NCT01699503|8734522|P1|Overall Study|Death|31
2523781|NCT01699178|8734547|P2|Overall Study|ineligible/noncompliant/ subject reason|4
2523782|NCT01699178|8734548|P1|Overall Study|ineligible/noncompliant/ subject reason|4
2523783|NCT01699178|8734547|P2|Overall Study|PSA increase of >1.4 ng/mL|3
2523784|NCT01699178|8734548|P1|Overall Study|PSA increase of >1.4 ng/mL|4
2523785|NCT01699178|8734547|P2|Overall Study|Hematocrit >54%|1
2523786|NCT01699178|8734548|P1|Overall Study|Hematocrit >54%|1
2523787|NCT01699178|8734547|P2|Overall Study|Withdrawal by Subject|12
2523788|NCT01699178|8734548|P1|Overall Study|Withdrawal by Subject|4
2523789|NCT01699178|8734547|P2|Overall Study|Physician Decision|0
2523790|NCT01699178|8734548|P1|Overall Study|Physician Decision|1
2523791|NCT01699178|8734547|P2|Overall Study|Non-compliance with Study Drug|1
2523792|NCT01699178|8734548|P1|Overall Study|Non-compliance with Study Drug|3
2523793|NCT01699178|8734547|P2|Overall Study|Lost to Follow-up|6
2523794|NCT01699178|8734548|P1|Overall Study|Lost to Follow-up|1
2523795|NCT01699178|8734547|P2|Overall Study|Adverse Event|5
2523796|NCT01699178|8734548|P1|Overall Study|Adverse Event|1
2523797|NCT01699087|8734564|P1|Overall Study|Unable to make future visits|2
2523798|NCT01699087|8734564|P1|Overall Study|Screen failure (prior to treatment)|15
2523799|NCT01699087|8734564|P1|Overall Study|Lost to Follow-up|7
2523800|NCT01699022|8734578|P1|Overall Study|Early discontinuation from the study|3
2523801|NCT01698814|8734593|P2|Overall Study|Randomized in error|0
2523802|NCT01698814|8734594|P1|Overall Study|Randomized in error|1
2523803|NCT01698814|8734593|P2|Overall Study|Pregnancy|0
2523804|NCT01698814|8734594|P1|Overall Study|Pregnancy|1
2523805|NCT01698814|8734593|P2|Overall Study|Lost to Follow-up|1
2523806|NCT01698814|8734594|P1|Overall Study|Lost to Follow-up|0
2523807|NCT01698814|8734593|P2|Overall Study|Adverse Event|2
2523808|NCT01698814|8734594|P1|Overall Study|Adverse Event|0
2523809|NCT01698801|8734600|P1|Follow Up Phase|Death|4
2523810|NCT01698801|8734600|P1|Follow Up Phase|Withdrawal by Subject|1
2523811|NCT01698801|8734600|P1|Treatment Phase|Disease progression|1
2523812|NCT01698801|8734600|P1|Treatment Phase|Withdrawal by Subject|1
2523813|NCT01698801|8734600|P1|Treatment Phase|Other|4
2523814|NCT01698801|8734600|P1|Treatment Phase|Protocol Violation|1
2523815|NCT01698801|8734600|P1|Treatment Phase|Adverse Event|4
2523816|NCT01698775|8734611|P2|Phase B|Withdrawal by Subject|2
2523817|NCT01698775|8734612|P1|Phase B|Withdrawal by Subject|6
2523818|NCT01698775|8734611|P2|Phase B|Protocol Violation|1
2523819|NCT01698775|8734612|P1|Phase B|Protocol Violation|1
2523820|NCT01698775|8734611|P2|Phase B|Physician Decision|1
2523821|NCT01698775|8734612|P1|Phase B|Physician Decision|1
2523822|NCT01698775|8734611|P2|Phase B|Lost to Follow-up|1
2523823|NCT01698775|8734612|P1|Phase B|Lost to Follow-up|0
2523824|NCT01698775|8734611|P2|Phase B|Lack of Efficacy|1
2523825|NCT01698775|8734612|P1|Phase B|Lack of Efficacy|0
2523826|NCT01698775|8734611|P2|Phase B|Death|1
2523827|NCT01698775|8734612|P1|Phase B|Death|0
2523828|NCT01698775|8734611|P2|Phase B|Adverse Event|3
2523829|NCT01698775|8734612|P1|Phase B|Adverse Event|6
2523830|NCT01698775|8734611|P2|Phase B|Hyperglycemia Discontinuation Criteria|1
2523831|NCT01698775|8734612|P1|Phase B|Hyperglycemia Discontinuation Criteria|0
2523832|NCT01698775|8734611|P2|Phase A|Kidney [transplant]|1
2523833|NCT01698775|8734612|P1|Phase A|Kidney [transplant]|0
2523834|NCT01698775|8734611|P2|Phase A|Withdrawal by Subject|4
2523835|NCT01698775|8734612|P1|Phase A|Withdrawal by Subject|3
2523836|NCT01698775|8734611|P2|Phase A|Protocol Violation|0
2523837|NCT01698775|8734612|P1|Phase A|Protocol Violation|1
2523838|NCT01698775|8734611|P2|Phase A|Lost to Follow-up|2
2523839|NCT01698775|8734612|P1|Phase A|Lost to Follow-up|1
2523840|NCT01698775|8734611|P2|Phase A|Lack of Efficacy|0
2523841|NCT01698775|8734612|P1|Phase A|Lack of Efficacy|1
2523842|NCT01698775|8734611|P2|Phase A|Death|1
2523843|NCT01698775|8734612|P1|Phase A|Death|1
2523844|NCT01698775|8734611|P2|Phase A|Adverse Event|1
2523845|NCT01698775|8734612|P1|Phase A|Adverse Event|2
2523846|NCT01698554|8734661|P4|Overall Study|Other Miscellaneous Reasons|0
2523847|NCT01698554|8734662|P3|Overall Study|Other Miscellaneous Reasons|0
2523848|NCT01698554|8734663|P2|Overall Study|Other Miscellaneous Reasons|0
2523849|NCT01698554|8734664|P1|Overall Study|Other Miscellaneous Reasons|1
2523850|NCT01698554|8734661|P4|Overall Study|Protocol Violation|0
2523851|NCT01698554|8734662|P3|Overall Study|Protocol Violation|1
2523852|NCT01698554|8734663|P2|Overall Study|Protocol Violation|0
2523853|NCT01698554|8734664|P1|Overall Study|Protocol Violation|2
2523854|NCT01698554|8734661|P4|Overall Study|Personal Reasons|1
2523855|NCT01698554|8734662|P3|Overall Study|Personal Reasons|1
2523856|NCT01698554|8734663|P2|Overall Study|Personal Reasons|5
2523857|NCT01698554|8734664|P1|Overall Study|Personal Reasons|0
2523858|NCT01698554|8734661|P4|Overall Study|Lost to Follow-up|0
2523859|NCT01698554|8734662|P3|Overall Study|Lost to Follow-up|0
2523860|NCT01698554|8734663|P2|Overall Study|Lost to Follow-up|0
2523861|NCT01698554|8734664|P1|Overall Study|Lost to Follow-up|1
2523862|NCT01698554|8734661|P4|Overall Study|Adverse Event|1
2523863|NCT01698554|8734662|P3|Overall Study|Adverse Event|0
2523864|NCT01698554|8734663|P2|Overall Study|Adverse Event|5
2523865|NCT01698554|8734664|P1|Overall Study|Adverse Event|2
2523866|NCT01698320|8734734|P3|40-Week Open-Label Period|Lost to Follow-up|0
2523867|NCT01698320|8734735|P2|40-Week Open-Label Period|Lost to Follow-up|2
2523868|NCT01698320|8734736|P1|40-Week Open-Label Period|Lost to Follow-up|0
2523869|NCT01698320|8734734|P3|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
2523870|NCT01698320|8734735|P2|40-Week Open-Label Period|Sponsor requested subject withdrawal|1
2523871|NCT01698320|8734736|P1|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
2523872|NCT01698320|8734734|P3|40-Week Open-Label Period|Pregnancy|1
2523873|NCT01698320|8734735|P2|40-Week Open-Label Period|Pregnancy|2
2523874|NCT01698320|8734736|P1|40-Week Open-Label Period|Pregnancy|0
2523875|NCT01698320|8734734|P3|40-Week Open-Label Period|Withdrawal by Subject|7
2523876|NCT01698320|8734735|P2|40-Week Open-Label Period|Withdrawal by Subject|11
2523877|NCT01698320|8734736|P1|40-Week Open-Label Period|Withdrawal by Subject|0
2523878|NCT01698320|8734734|P3|40-Week Open-Label Period|Adverse Event|2
2523879|NCT01698320|8734735|P2|40-Week Open-Label Period|Adverse Event|3
2523880|NCT01698320|8734736|P1|40-Week Open-Label Period|Adverse Event|0
2523881|NCT01698320|8734734|P3|12-Week Double-Blind Period|Lost to Follow-up|4
2523882|NCT01698320|8734735|P2|12-Week Double-Blind Period|Lost to Follow-up|0
2523883|NCT01698320|8734736|P1|12-Week Double-Blind Period|Lost to Follow-up|0
2523884|NCT01698320|8734734|P3|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2
2523885|NCT01698320|8734735|P2|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
2523886|NCT01698320|8734736|P1|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
2523887|NCT01698320|8734734|P3|12-Week Double-Blind Period|Pregnancy|1
2523888|NCT01698320|8734735|P2|12-Week Double-Blind Period|Pregnancy|1
2523889|NCT01698320|8734736|P1|12-Week Double-Blind Period|Pregnancy|0
2523890|NCT01698320|8734734|P3|12-Week Double-Blind Period|Protocol Violation|2
2523891|NCT01698320|8734735|P2|12-Week Double-Blind Period|Protocol Violation|0
2523892|NCT01698320|8734736|P1|12-Week Double-Blind Period|Protocol Violation|0
2523893|NCT01698320|8734734|P3|12-Week Double-Blind Period|Withdrawal by Subject|2
2523894|NCT01698320|8734735|P2|12-Week Double-Blind Period|Withdrawal by Subject|2
2523895|NCT01698320|8734736|P1|12-Week Double-Blind Period|Withdrawal by Subject|0
2523896|NCT01698320|8734734|P3|12-Week Double-Blind Period|Adverse Event|1
2523897|NCT01698320|8734735|P2|12-Week Double-Blind Period|Adverse Event|1
2523898|NCT01698320|8734736|P1|12-Week Double-Blind Period|Adverse Event|0
2523899|NCT01698320|8734734|P3|Run-In Period (Week -1 to Day 0)|Other|0
2523900|NCT01698320|8734735|P2|Run-In Period (Week -1 to Day 0)|Other|0
2523901|NCT01698320|8734736|P1|Run-In Period (Week -1 to Day 0)|Other|1
2523902|NCT01698320|8734734|P3|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
2523903|NCT01698320|8734735|P2|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
2523904|NCT01698320|8734736|P1|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1
2523905|NCT01698320|8734734|P3|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
2523906|NCT01698320|8734735|P2|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
2523907|NCT01698320|8734736|P1|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1
2523908|NCT01698320|8734734|P3|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
2523909|NCT01698320|8734735|P2|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
2523910|NCT01698320|8734736|P1|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24
2523911|NCT01698268|8734756|P2|Overall Study|Physician Decision|1
2523912|NCT01698268|8734757|P1|Overall Study|Physician Decision|2
2523913|NCT01698008|8734765|P2|Overall Study|Withdrawal by Subject|2
2523914|NCT01698008|8734766|P1|Overall Study|Withdrawal by Subject|1
2523915|NCT01697969|8734772|P1|Overall Study|Did not meet inc/exc criteria|3
2523916|NCT01697956|8734779|P2|Overall Study|Protocol Violation|1
2523917|NCT01697956|8734780|P1|Overall Study|Protocol Violation|1
2523918|NCT01697800|8734810|P2|Overall Study|Death|1
2523919|NCT01697800|8734811|P1|Overall Study|Death|0
2523920|NCT01697748|8734819|P2|Overall Study|Lost to Follow-up|65
2523921|NCT01697748|8734820|P1|Overall Study|Lost to Follow-up|53
2523922|NCT01697748|8734819|P2|Overall Study|ineligible uterine incision|1
2523923|NCT01697748|8734820|P1|Overall Study|ineligible uterine incision|4
2523924|NCT01697748|8734819|P2|Overall Study|ineligible skin incision|2
2523925|NCT01697748|8734820|P1|Overall Study|ineligible skin incision|1
2523926|NCT01697696|8734849|P2|Overall Study|Subject/guardian decision|35
2523927|NCT01697696|8734850|P1|Overall Study|Subject/guardian decision|31
2523928|NCT01697696|8734849|P2|Overall Study|Lost to Follow-up|7
2523929|NCT01697696|8734850|P1|Overall Study|Lost to Follow-up|10
2523930|NCT01697696|8734849|P2|Overall Study|Death|2
2523931|NCT01697696|8734850|P1|Overall Study|Death|4
2523932|NCT01697696|8734849|P2|Overall Study|Physician Decision|0
2523933|NCT01697696|8734850|P1|Overall Study|Physician Decision|1
2523934|NCT01697696|8734849|P2|Overall Study|Protocol deviation|0
2523935|NCT01697696|8734850|P1|Overall Study|Protocol deviation|1
2523936|NCT01697696|8734849|P2|Overall Study|Study terminated by sponsor|3
2523937|NCT01697696|8734850|P1|Overall Study|Study terminated by sponsor|0
2523938|NCT01697592|8734882|P10|Phase B (Week 25 to Week 52)|Adverse Event|0
2523939|NCT01697592|8734883|P9|Phase B (Week 25 to Week 52)|Adverse Event|2
2523940|NCT01697592|8734884|P8|Phase B (Week 25 to Week 52)|Adverse Event|0
2523941|NCT01697592|8734885|P7|Phase B (Week 25 to Week 52)|Adverse Event|1
2523942|NCT01697592|8734886|P6|Phase B (Week 25 to Week 52)|Adverse Event|1
2523943|NCT01697592|8734887|P5|Phase B (Week 25 to Week 52)|Adverse Event|0
2523944|NCT01697592|8734888|P4|Phase B (Week 25 to Week 52)|Adverse Event|2
2523945|NCT01697592|8734889|P3|Phase B (Week 25 to Week 52)|Adverse Event|1
2523946|NCT01697592|8734890|P2|Phase B (Week 25 to Week 52)|Adverse Event|1
2523947|NCT01697592|8734891|P1|Phase B (Week 25 to Week 52)|Adverse Event|2
2523948|NCT01697592|8734882|P10|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
2523949|NCT01697592|8734883|P9|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
2523950|NCT01697592|8734884|P8|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
2523951|NCT01697592|8734885|P7|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
2523952|NCT01697592|8734886|P6|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
2523953|NCT01697592|8734887|P5|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
2523954|NCT01697592|8734888|P4|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
2523955|NCT01697592|8734889|P3|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
2523956|NCT01697592|8734890|P2|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
2523957|NCT01697592|8734891|P1|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2
2523958|NCT01697592|8734882|P10|Phase B (Week 25 to Week 52)|Physician Decision|0
2523959|NCT01697592|8734883|P9|Phase B (Week 25 to Week 52)|Physician Decision|0
2523960|NCT01697592|8734884|P8|Phase B (Week 25 to Week 52)|Physician Decision|0
2523961|NCT01697592|8734885|P7|Phase B (Week 25 to Week 52)|Physician Decision|0
2523962|NCT01697592|8734886|P6|Phase B (Week 25 to Week 52)|Physician Decision|0
2523963|NCT01697592|8734887|P5|Phase B (Week 25 to Week 52)|Physician Decision|0
2523964|NCT01697592|8734888|P4|Phase B (Week 25 to Week 52)|Physician Decision|1
2523965|NCT01697592|8734889|P3|Phase B (Week 25 to Week 52)|Physician Decision|0
2523966|NCT01697592|8734890|P2|Phase B (Week 25 to Week 52)|Physician Decision|0
2523967|NCT01697592|8734891|P1|Phase B (Week 25 to Week 52)|Physician Decision|1
2523968|NCT01697592|8734882|P10|Phase A (Up to 24 Weeks)|Adverse Event|1
2523969|NCT01697592|8734883|P9|Phase A (Up to 24 Weeks)|Adverse Event|0
2523970|NCT01697592|8734884|P8|Phase A (Up to 24 Weeks)|Adverse Event|0
2523971|NCT01697592|8734885|P7|Phase A (Up to 24 Weeks)|Adverse Event|1
2523972|NCT01697592|8734886|P6|Phase A (Up to 24 Weeks)|Adverse Event|0
2523973|NCT01697592|8734887|P5|Phase A (Up to 24 Weeks)|Adverse Event|0
2523974|NCT01697592|8734888|P4|Phase A (Up to 24 Weeks)|Adverse Event|2
2523975|NCT01697592|8734889|P3|Phase A (Up to 24 Weeks)|Adverse Event|1
2523976|NCT01697592|8734890|P2|Phase A (Up to 24 Weeks)|Adverse Event|2
2523977|NCT01697592|8734891|P1|Phase A (Up to 24 Weeks)|Adverse Event|0
2523978|NCT01697592|8734882|P10|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
2523979|NCT01697592|8734883|P9|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
2523980|NCT01697592|8734884|P8|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
2523981|NCT01697592|8734885|P7|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
2523982|NCT01697592|8734886|P6|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
2523983|NCT01697592|8734887|P5|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
2523984|NCT01697592|8734888|P4|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
2523985|NCT01697592|8734889|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
2523986|NCT01697592|8734890|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
2523987|NCT01697592|8734891|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
2523988|NCT01697592|8734882|P10|Phase A (Up to 24 Weeks)|Protocol Violation|0
2523989|NCT01697592|8734883|P9|Phase A (Up to 24 Weeks)|Protocol Violation|0
2523990|NCT01697592|8734884|P8|Phase A (Up to 24 Weeks)|Protocol Violation|0
2523991|NCT01697592|8734885|P7|Phase A (Up to 24 Weeks)|Protocol Violation|0
2523992|NCT01697592|8734886|P6|Phase A (Up to 24 Weeks)|Protocol Violation|0
2523993|NCT01697592|8734887|P5|Phase A (Up to 24 Weeks)|Protocol Violation|0
2523994|NCT01697592|8734888|P4|Phase A (Up to 24 Weeks)|Protocol Violation|0
2523995|NCT01697592|8734889|P3|Phase A (Up to 24 Weeks)|Protocol Violation|0
2523996|NCT01697592|8734890|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
2523997|NCT01697592|8734891|P1|Phase A (Up to 24 Weeks)|Protocol Violation|1
2523998|NCT01697592|8734882|P10|Phase A (Up to 24 Weeks)|Physician Decision|0
2523999|NCT01697592|8734883|P9|Phase A (Up to 24 Weeks)|Physician Decision|0
2524000|NCT01697592|8734884|P8|Phase A (Up to 24 Weeks)|Physician Decision|0
2524001|NCT01697592|8734885|P7|Phase A (Up to 24 Weeks)|Physician Decision|0
2524002|NCT01697592|8734886|P6|Phase A (Up to 24 Weeks)|Physician Decision|1
2524003|NCT01697592|8734887|P5|Phase A (Up to 24 Weeks)|Physician Decision|0
2524004|NCT01697592|8734888|P4|Phase A (Up to 24 Weeks)|Physician Decision|0
2524005|NCT01697592|8734889|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
2524006|NCT01697592|8734890|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
2524007|NCT01697592|8734891|P1|Phase A (Up to 24 Weeks)|Physician Decision|0
2524008|NCT01697592|8734882|P10|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
2524009|NCT01697592|8734883|P9|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
2524010|NCT01697592|8734884|P8|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
2524011|NCT01697592|8734885|P7|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
2524012|NCT01697592|8734886|P6|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
2524013|NCT01697592|8734887|P5|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
2524014|NCT01697592|8734888|P4|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
2524015|NCT01697592|8734889|P3|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
2524016|NCT01697592|8734890|P2|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
2524017|NCT01697592|8734891|P1|Phase A (Up to 24 Weeks)|Lost to Follow-up|1
2524018|NCT01697579|8734960|P7|Optional Extension-Cycles 2-6|Lost to Follow-up|1
2524019|NCT01697579|8734961|P6|Optional Extension-Cycles 2-6|Lost to Follow-up|0
2524020|NCT01697579|8734962|P5|Optional Extension-Cycles 2-6|Lost to Follow-up|0
2524021|NCT01697579|8734963|P4|Optional Extension-Cycles 2-6|Lost to Follow-up|0
2524022|NCT01697579|8734964|P3|Optional Extension-Cycles 2-6|Lost to Follow-up|0
2524023|NCT01697579|8734965|P2|Optional Extension-Cycles 2-6|Lost to Follow-up|0
2524024|NCT01697579|8734966|P1|Optional Extension-Cycles 2-6|Lost to Follow-up|0
2524025|NCT01697579|8734960|P7|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4
2524026|NCT01697579|8734961|P6|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6
2524027|NCT01697579|8734962|P5|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
2524028|NCT01697579|8734963|P4|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
2524029|NCT01697579|8734964|P3|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
2524030|NCT01697579|8734965|P2|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
2524031|NCT01697579|8734966|P1|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
2524032|NCT01697579|8734960|P7|Optional Extension-Cycles 2-6|Participant Moved|2
2524033|NCT01697579|8734961|P6|Optional Extension-Cycles 2-6|Participant Moved|0
2524034|NCT01697579|8734962|P5|Optional Extension-Cycles 2-6|Participant Moved|0
2524035|NCT01697579|8734963|P4|Optional Extension-Cycles 2-6|Participant Moved|0
2524036|NCT01697579|8734964|P3|Optional Extension-Cycles 2-6|Participant Moved|0
2524037|NCT01697579|8734965|P2|Optional Extension-Cycles 2-6|Participant Moved|0
2524038|NCT01697579|8734966|P1|Optional Extension-Cycles 2-6|Participant Moved|0
2524039|NCT01697579|8734960|P7|Optional Extension-Cycles 2-6|Technical Problems|1
2524040|NCT01697579|8734961|P6|Optional Extension-Cycles 2-6|Technical Problems|0
2524041|NCT01697579|8734962|P5|Optional Extension-Cycles 2-6|Technical Problems|0
2524042|NCT01697579|8734963|P4|Optional Extension-Cycles 2-6|Technical Problems|0
2524043|NCT01697579|8734964|P3|Optional Extension-Cycles 2-6|Technical Problems|0
2524044|NCT01697579|8734965|P2|Optional Extension-Cycles 2-6|Technical Problems|0
2524045|NCT01697579|8734966|P1|Optional Extension-Cycles 2-6|Technical Problems|0
2524046|NCT01697579|8734960|P7|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2
2524047|NCT01697579|8734961|P6|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
2524048|NCT01697579|8734962|P5|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
2524049|NCT01697579|8734963|P4|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
2524050|NCT01697579|8734964|P3|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
2524051|NCT01697579|8734965|P2|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
2524052|NCT01697579|8734966|P1|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
2524053|NCT01697579|8734960|P7|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11
2524054|NCT01697579|8734961|P6|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4
2524055|NCT01697579|8734962|P5|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
2524056|NCT01697579|8734963|P4|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
2524057|NCT01697579|8734964|P3|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
2524058|NCT01697579|8734965|P2|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
2524059|NCT01697579|8734966|P1|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
2524060|NCT01697579|8734960|P7|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24
2524061|NCT01697579|8734961|P6|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15
2524062|NCT01697579|8734962|P5|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
2524063|NCT01697579|8734963|P4|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
2524064|NCT01697579|8734964|P3|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
2524065|NCT01697579|8734965|P2|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
2524066|NCT01697579|8734966|P1|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
2524067|NCT01697579|8734960|P7|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
2524068|NCT01697579|8734961|P6|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1
2524069|NCT01697579|8734962|P5|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
2524070|NCT01697579|8734963|P4|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
2524071|NCT01697579|8734964|P3|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
2524072|NCT01697579|8734965|P2|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
2524073|NCT01697579|8734966|P1|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
2524074|NCT01697579|8734960|P7|Optional Extension-Cycles 2-6|Excluded Medication|2
2524075|NCT01697579|8734961|P6|Optional Extension-Cycles 2-6|Excluded Medication|1
2524076|NCT01697579|8734962|P5|Optional Extension-Cycles 2-6|Excluded Medication|0
2524077|NCT01697579|8734963|P4|Optional Extension-Cycles 2-6|Excluded Medication|0
2524078|NCT01697579|8734964|P3|Optional Extension-Cycles 2-6|Excluded Medication|0
2524079|NCT01697579|8734965|P2|Optional Extension-Cycles 2-6|Excluded Medication|0
2524080|NCT01697579|8734966|P1|Optional Extension-Cycles 2-6|Excluded Medication|0
2524081|NCT01697579|8734960|P7|Optional Extension-Cycles 2-6|Protocol Violation|4
2524082|NCT01697579|8734961|P6|Optional Extension-Cycles 2-6|Protocol Violation|0
2524083|NCT01697579|8734962|P5|Optional Extension-Cycles 2-6|Protocol Violation|0
2524084|NCT01697579|8734963|P4|Optional Extension-Cycles 2-6|Protocol Violation|0
2524085|NCT01697579|8734964|P3|Optional Extension-Cycles 2-6|Protocol Violation|0
2524086|NCT01697579|8734965|P2|Optional Extension-Cycles 2-6|Protocol Violation|0
2524087|NCT01697579|8734966|P1|Optional Extension-Cycles 2-6|Protocol Violation|0
2524088|NCT01697579|8734960|P7|Optional Extension-Cycles 2-6|Physician Decision|11
2524089|NCT01697579|8734961|P6|Optional Extension-Cycles 2-6|Physician Decision|7
2524090|NCT01697579|8734962|P5|Optional Extension-Cycles 2-6|Physician Decision|0
2524091|NCT01697579|8734963|P4|Optional Extension-Cycles 2-6|Physician Decision|0
2524092|NCT01697579|8734964|P3|Optional Extension-Cycles 2-6|Physician Decision|0
2524093|NCT01697579|8734965|P2|Optional Extension-Cycles 2-6|Physician Decision|0
2524094|NCT01697579|8734966|P1|Optional Extension-Cycles 2-6|Physician Decision|0
2524095|NCT01697579|8734960|P7|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5
2524096|NCT01697579|8734961|P6|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1
2524097|NCT01697579|8734962|P5|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
2524098|NCT01697579|8734963|P4|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
2524099|NCT01697579|8734964|P3|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
2524100|NCT01697579|8734965|P2|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
2524101|NCT01697579|8734966|P1|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
2524102|NCT01697579|8734960|P7|Optional Extension-Cycles 2-6|Death|2
2524103|NCT01697579|8734961|P6|Optional Extension-Cycles 2-6|Death|0
2524104|NCT01697579|8734962|P5|Optional Extension-Cycles 2-6|Death|0
2524105|NCT01697579|8734963|P4|Optional Extension-Cycles 2-6|Death|0
2524106|NCT01697579|8734964|P3|Optional Extension-Cycles 2-6|Death|0
2524107|NCT01697579|8734965|P2|Optional Extension-Cycles 2-6|Death|0
2524108|NCT01697579|8734966|P1|Optional Extension-Cycles 2-6|Death|0
2524109|NCT01697579|8734960|P7|Base Study-Cycle 1|Technical Problems|0
2524110|NCT01697579|8734961|P6|Base Study-Cycle 1|Technical Problems|0
2524111|NCT01697579|8734962|P5|Base Study-Cycle 1|Technical Problems|0
2524112|NCT01697579|8734963|P4|Base Study-Cycle 1|Technical Problems|1
2524113|NCT01697579|8734964|P3|Base Study-Cycle 1|Technical Problems|1
2524114|NCT01697579|8734965|P2|Base Study-Cycle 1|Technical Problems|0
2524115|NCT01697579|8734966|P1|Base Study-Cycle 1|Technical Problems|0
2524116|NCT01697579|8734960|P7|Base Study-Cycle 1|Consent Withdrawn by Participant|0
2524117|NCT01697579|8734961|P6|Base Study-Cycle 1|Consent Withdrawn by Participant|0
2524118|NCT01697579|8734962|P5|Base Study-Cycle 1|Consent Withdrawn by Participant|0
2524119|NCT01697579|8734963|P4|Base Study-Cycle 1|Consent Withdrawn by Participant|0
2524120|NCT01697579|8734964|P3|Base Study-Cycle 1|Consent Withdrawn by Participant|0
2524121|NCT01697579|8734965|P2|Base Study-Cycle 1|Consent Withdrawn by Participant|1
2524122|NCT01697579|8734966|P1|Base Study-Cycle 1|Consent Withdrawn by Participant|0
2524123|NCT01697579|8734960|P7|Base Study-Cycle 1|Protocol Violation|0
2524124|NCT01697579|8734961|P6|Base Study-Cycle 1|Protocol Violation|0
2524125|NCT01697579|8734962|P5|Base Study-Cycle 1|Protocol Violation|3
2524126|NCT01697579|8734963|P4|Base Study-Cycle 1|Protocol Violation|0
2524127|NCT01697579|8734964|P3|Base Study-Cycle 1|Protocol Violation|0
2524128|NCT01697579|8734965|P2|Base Study-Cycle 1|Protocol Violation|0
2524129|NCT01697579|8734966|P1|Base Study-Cycle 1|Protocol Violation|0
2524130|NCT01697579|8734960|P7|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
2524131|NCT01697579|8734961|P6|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
2524132|NCT01697579|8734962|P5|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
2524133|NCT01697579|8734963|P4|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
2524134|NCT01697579|8734964|P3|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
2524135|NCT01697579|8734965|P2|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
2524136|NCT01697579|8734966|P1|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1
2524137|NCT01697579|8734960|P7|Base Study-Cycle 1|Adverse Event|0
2524138|NCT01697579|8734961|P6|Base Study-Cycle 1|Adverse Event|0
2524139|NCT01697579|8734962|P5|Base Study-Cycle 1|Adverse Event|0
2524140|NCT01697579|8734963|P4|Base Study-Cycle 1|Adverse Event|0
2524141|NCT01697579|8734964|P3|Base Study-Cycle 1|Adverse Event|0
2524142|NCT01697579|8734965|P2|Base Study-Cycle 1|Adverse Event|0
2524143|NCT01697579|8734966|P1|Base Study-Cycle 1|Adverse Event|1
2524144|NCT01697501|8735078|P1|Overall Study|Protocol Violation|2
2524145|NCT01697462|8735121|P1|Overall Study|Missing|5
2524146|NCT01697462|8735121|P1|Overall Study|Other|10
2524147|NCT01697462|8735121|P1|Overall Study|Death|1
2524148|NCT01697462|8735121|P1|Overall Study|Investigator Decision|21
2524149|NCT01697462|8735121|P1|Overall Study|Withdrawal by Subject|12
2524150|NCT01697462|8735121|P1|Overall Study|Lost to Follow-up|21
2524151|NCT01697462|8735121|P1|Overall Study|Adverse Event|6
2524152|NCT01697462|8735121|P1|Overall Study|Disease Progression|1
2524153|NCT01697449|8735128|P1|Overall Study|Missing|25
2524154|NCT01697449|8735128|P1|Overall Study|Other|1
2524155|NCT01697449|8735128|P1|Overall Study|Death|2
2524156|NCT01697449|8735128|P1|Overall Study|Physician Decision|1
2524157|NCT01697449|8735128|P1|Overall Study|Withdrawal by Subject|2
2524158|NCT01697449|8735128|P1|Overall Study|Lost to Follow-up|5
2524159|NCT01697449|8735128|P1|Overall Study|Adverse Event|7
2524160|NCT01697449|8735128|P1|Overall Study|Disease progression|47
2524161|NCT01697358|8735139|P2|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26
2524162|NCT01697358|8735140|P1|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34
2524163|NCT01697358|8735139|P2|Period II: 6-24M Long-term Follow-up|Adverse Event|3
2524164|NCT01697358|8735140|P1|Period II: 6-24M Long-term Follow-up|Adverse Event|0
2524165|NCT01697358|8735139|P2|Period II: 6-24M Long-term Follow-up|Death|1
2524166|NCT01697358|8735140|P1|Period II: 6-24M Long-term Follow-up|Death|1
2524167|NCT01697358|8735139|P2|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
2524168|NCT01697358|8735140|P1|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
2524169|NCT01697358|8735139|P2|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10
2524170|NCT01697358|8735140|P1|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8
2524171|NCT01697358|8735139|P2|Period II: 6-24M Long-term Follow-up|Physician Decision|12
2524172|NCT01697358|8735140|P1|Period II: 6-24M Long-term Follow-up|Physician Decision|3
2524173|NCT01697358|8735139|P2|Period I: Randomization to 6 Months|Lost to Follow-up|0
2524174|NCT01697358|8735140|P1|Period I: Randomization to 6 Months|Lost to Follow-up|2
2524175|NCT01697358|8735139|P2|Period I: Randomization to 6 Months|Adverse Event|1
2524176|NCT01697358|8735140|P1|Period I: Randomization to 6 Months|Adverse Event|1
2524177|NCT01697358|8735139|P2|Period I: Randomization to 6 Months|Physician Decision|0
2524178|NCT01697358|8735140|P1|Period I: Randomization to 6 Months|Physician Decision|4
2524179|NCT01697358|8735139|P2|Period I: Randomization to 6 Months|Withdrawal by Subject|0
2524180|NCT01697358|8735140|P1|Period I: Randomization to 6 Months|Withdrawal by Subject|6
2524181|NCT01697345|8735156|P1|Overall Study|Withdrawal by Subject|1
2524182|NCT01697319|8735181|P1|Extension Phase|Terminated by Sponsor|15
2524183|NCT01697319|8735181|P1|Primary Phase|Withdrawal by Subject|1
2524184|NCT01696994|8735190|P2|Overall Study|Refused Screen (Ovarian Screening)|3582
2524185|NCT01696994|8735191|P1|Overall Study|Refused Screen (Ovarian Screening)|0
2524186|NCT01696994|8735190|P2|Overall Study|Refused ASU (Control)|0
2524187|NCT01696994|8735191|P1|Overall Study|Refused ASU (Control)|311
2524188|NCT01696994|8735190|P2|Overall Study|No Ovaries at Baseline|4851
2524189|NCT01696994|8735191|P1|Overall Study|No Ovaries at Baseline|4807
2524190|NCT01696994|8735190|P2|Overall Study|Died Before ASU (Control)|0
2524191|NCT01696994|8735191|P1|Overall Study|Died Before ASU (Control)|73
2524192|NCT01696994|8735190|P2|Overall Study|Died Before Randomization|2
2524193|NCT01696994|8735191|P1|Overall Study|Died Before Randomization|1
2524194|NCT01696994|8735190|P2|Overall Study|Cancer Before Rand. (Ovarian Screening)|2
2524195|NCT01696994|8735191|P1|Overall Study|Cancer Before Rand. (Ovarian Screening)|0
2524196|NCT01696981|8735219|P2|Overall Study|Refused Screen (Colorectal Screening)|10346
2524197|NCT01696981|8735220|P1|Overall Study|Refused Screen (Colorectal Screening)|0
2524198|NCT01696981|8735219|P2|Overall Study|Refused ASU (Control)|0
2524199|NCT01696981|8735220|P1|Overall Study|Refused ASU (Control)|920
2524200|NCT01696981|8735219|P2|Overall Study|Died Before ASU (Control)|0
2524201|NCT01696981|8735220|P1|Overall Study|Died Before ASU (Control)|278
2524202|NCT01696981|8735219|P2|Overall Study|Died Before Randomization|8
2524203|NCT01696981|8735220|P1|Overall Study|Died Before Randomization|3
2524204|NCT01696981|8735219|P2|Overall Study|Cancer Before Rand. (Colo. Screening)|20
2524205|NCT01696981|8735220|P1|Overall Study|Cancer Before Rand. (Colo. Screening)|0
2524206|NCT01696968|8735240|P2|Overall Study|Refused Screen (Lung Screening)|6796
2524207|NCT01696968|8735241|P1|Overall Study|Refused Screen (Lung Screening)|0
2524208|NCT01696968|8735240|P2|Overall Study|Refused ASU (Control)|0
2524209|NCT01696968|8735241|P1|Overall Study|Refused ASU (Control)|920
2524210|NCT01696968|8735240|P2|Overall Study|Died Before ASU (Control)|0
2524211|NCT01696968|8735241|P1|Overall Study|Died Before ASU (Control)|278
2524212|NCT01696968|8735240|P2|Overall Study|Died Before Randomization|8
2524213|NCT01696968|8735241|P1|Overall Study|Died Before Randomization|3
2524214|NCT01696968|8735240|P2|Overall Study|Cancer Before Rand. (Lung Screening)|8
2524215|NCT01696968|8735241|P1|Overall Study|Cancer Before Rand. (Lung Screening)|0
2524216|NCT01696955|8735263|P2|Main Study|Withdrawal by Subject|1
2524217|NCT01696955|8735264|P1|Main Study|Withdrawal by Subject|1
2524218|NCT01696955|8735263|P2|Main Study|Protocol Violation|0
2524219|NCT01696955|8735264|P1|Main Study|Protocol Violation|1
2524220|NCT01696942|8735289|P2|Overall Study|screen failure|1
2524221|NCT01696942|8735290|P1|Overall Study|screen failure|0
2524222|NCT01696942|8735289|P2|Overall Study|Protocol Violation|2
2524223|NCT01696942|8735290|P1|Overall Study|Protocol Violation|1
2524224|NCT01696942|8735289|P2|Overall Study|Withdrawal by Subject|0
2524225|NCT01696942|8735290|P1|Overall Study|Withdrawal by Subject|1
2524226|NCT01696929|8735298|P1|Overall Study|Physician Decision|1
2524227|NCT01696877|8735305|P2|Overall Study|Adverse Event|1
2524228|NCT01696877|8735306|P1|Overall Study|Adverse Event|0
2524229|NCT01696773|8735328|P2|Days 15-27, Washout|Adverse Event|0
2524230|NCT01696773|8735329|P1|Days 15-27, Washout|Adverse Event|1
2524231|NCT01696695|8735356|P1|Overall Study|Major Protocol Violation|192
2524232|NCT01696695|8735356|P1|Overall Study|Other|74
2524233|NCT01696695|8735356|P1|Overall Study|Lost to Follow-up|48
2524234|NCT01696695|8735356|P1|Overall Study|Withdrawal by Subject|92
2524235|NCT01696695|8735356|P1|Overall Study|Adverse Event|74
2524236|NCT01696695|8735356|P1|Overall Study|Death|29
2524237|NCT01696695|8735356|P1|Overall Study|Disease progression|373
2524238|NCT01696643|8735368|P2|Overall Study|Participant Did Not Receive Study Drug|2
2524239|NCT01696643|8735369|P1|Overall Study|Participant Did Not Receive Study Drug|2
2524240|NCT01696643|8735368|P2|Overall Study|Medical Monitor Decision|2
2524241|NCT01696643|8735369|P1|Overall Study|Medical Monitor Decision|0
2524242|NCT01696643|8735368|P2|Overall Study|Participant Incarcerated|1
2524243|NCT01696643|8735369|P1|Overall Study|Participant Incarcerated|0
2524244|NCT01696643|8735368|P2|Overall Study|Site Error|1
2524245|NCT01696643|8735369|P1|Overall Study|Site Error|2
2524246|NCT01696643|8735368|P2|Overall Study|Participant on Restricted Bed Rest|0
2524247|NCT01696643|8735369|P1|Overall Study|Participant on Restricted Bed Rest|1
2524248|NCT01696643|8735368|P2|Overall Study|Withdrawal by Subject|149
2524249|NCT01696643|8735369|P1|Overall Study|Withdrawal by Subject|142
2524250|NCT01696643|8735368|P2|Overall Study|Study Terminated by Sponsor|294
2524251|NCT01696643|8735369|P1|Overall Study|Study Terminated by Sponsor|286
2524252|NCT01696643|8735368|P2|Overall Study|Protocol Violation|7
2524253|NCT01696643|8735369|P1|Overall Study|Protocol Violation|7
2524254|NCT01696643|8735368|P2|Overall Study|Pregnancy|1
2524255|NCT01696643|8735369|P1|Overall Study|Pregnancy|0
2524256|NCT01696643|8735368|P2|Overall Study|Physician Decision|2
2524257|NCT01696643|8735369|P1|Overall Study|Physician Decision|3
2524258|NCT01696643|8735368|P2|Overall Study|Lost to Follow-up|67
2524259|NCT01696643|8735369|P1|Overall Study|Lost to Follow-up|67
2524260|NCT01696643|8735368|P2|Overall Study|Lack of Efficacy|0
2524261|NCT01696643|8735369|P1|Overall Study|Lack of Efficacy|3
2524262|NCT01696643|8735368|P2|Overall Study|Death|2
2524263|NCT01696643|8735369|P1|Overall Study|Death|1
2524264|NCT01696643|8735368|P2|Overall Study|Adverse Event|7
2524265|NCT01696643|8735369|P1|Overall Study|Adverse Event|15
2524266|NCT01696396|8735388|P4|Overall Study|Death|0
2524267|NCT01696396|8735389|P3|Overall Study|Death|1
2524268|NCT01696396|8735390|P2|Overall Study|Death|0
2524269|NCT01696396|8735391|P1|Overall Study|Death|0
2524270|NCT01696396|8735388|P4|Overall Study|Lost to Follow-up|1
2524271|NCT01696396|8735389|P3|Overall Study|Lost to Follow-up|4
2524272|NCT01696396|8735390|P2|Overall Study|Lost to Follow-up|1
2524273|NCT01696396|8735391|P1|Overall Study|Lost to Follow-up|9
2524274|NCT01696396|8735388|P4|Overall Study|Decision by Sponsor|2
2524275|NCT01696396|8735389|P3|Overall Study|Decision by Sponsor|2
2524276|NCT01696396|8735390|P2|Overall Study|Decision by Sponsor|1
2524277|NCT01696396|8735391|P1|Overall Study|Decision by Sponsor|3
2524278|NCT01696396|8735388|P4|Overall Study|Withdrawal by Subject|11
2524279|NCT01696396|8735389|P3|Overall Study|Withdrawal by Subject|19
2524280|NCT01696396|8735390|P2|Overall Study|Withdrawal by Subject|5
2524281|NCT01696396|8735391|P1|Overall Study|Withdrawal by Subject|19
2524282|NCT01696279|8735442|P4|Part 3: Lanthanum Carbonate (6 Months)|Missing|1
2524283|NCT01696279|8735443|P3|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
2524284|NCT01696279|8735444|P2|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
2524285|NCT01696279|8735445|P1|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
2524286|NCT01696279|8735442|P4|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1
2524287|NCT01696279|8735443|P3|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
2524288|NCT01696279|8735444|P2|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
2524289|NCT01696279|8735445|P1|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
2524290|NCT01696279|8735442|P4|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6
2524291|NCT01696279|8735443|P3|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
2524292|NCT01696279|8735444|P2|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
2524293|NCT01696279|8735445|P1|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
2524294|NCT01696279|8735442|P4|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
2524295|NCT01696279|8735443|P3|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1
2524296|NCT01696279|8735444|P2|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
2524297|NCT01696279|8735445|P1|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
2524298|NCT01696279|8735442|P4|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
2524299|NCT01696279|8735443|P3|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
2524300|NCT01696279|8735444|P2|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2
2524301|NCT01696279|8735445|P1|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
2524302|NCT01696279|8735442|P4|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
2524303|NCT01696279|8735443|P3|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
2524304|NCT01696279|8735444|P2|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7
2524305|NCT01696279|8735445|P1|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
2524306|NCT01696279|8735442|P4|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
2524307|NCT01696279|8735443|P3|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
2524308|NCT01696279|8735444|P2|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3
2524309|NCT01696279|8735445|P1|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
2524310|NCT01696279|8735442|P4|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
2524311|NCT01696279|8735443|P3|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
2524312|NCT01696279|8735444|P2|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1
2524313|NCT01696279|8735445|P1|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
2524314|NCT01696279|8735442|P4|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
2524315|NCT01696279|8735443|P3|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
2524316|NCT01696279|8735444|P2|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1
2524317|NCT01696279|8735445|P1|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
2524318|NCT01696279|8735442|P4|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
2524319|NCT01696279|8735443|P3|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
2524320|NCT01696279|8735444|P2|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5
2524321|NCT01696279|8735445|P1|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
2524322|NCT01696279|8735442|P4|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
2524323|NCT01696279|8735443|P3|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
2524324|NCT01696279|8735444|P2|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
2524325|NCT01696279|8735445|P1|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1
2524326|NCT01696214|8735483|P4|Overall Study|Lost to Follow-up|0
2524327|NCT01696214|8735484|P3|Overall Study|Lost to Follow-up|0
2524328|NCT01696214|8735485|P2|Overall Study|Lost to Follow-up|0
2524329|NCT01696214|8735486|P1|Overall Study|Lost to Follow-up|1
2524330|NCT01696188|8735506|P2|Overall Study|Protocol Violation|1
2524331|NCT01696188|8735507|P1|Overall Study|Protocol Violation|1
2524332|NCT01696071|8735538|P2|Treatment Period 2: 4 Weeks|Adverse Event|0
2524333|NCT01696071|8735539|P1|Treatment Period 2: 4 Weeks|Adverse Event|1
2524334|NCT01696058|8735567|P2|Overall Study|Other reason prematurely discontinued|3
2524335|NCT01696058|8735568|P1|Overall Study|Other reason prematurely discontinued|5
2524336|NCT01696058|8735567|P2|Overall Study|Withdrawal by Subject|6
2524337|NCT01696058|8735568|P1|Overall Study|Withdrawal by Subject|4
2524338|NCT01696058|8735567|P2|Overall Study|Lost to Follow-up|5
2524339|NCT01696058|8735568|P1|Overall Study|Lost to Follow-up|2
2524340|NCT01696058|8735567|P2|Overall Study|Protocol Violation|3
2524341|NCT01696058|8735568|P1|Overall Study|Protocol Violation|9
2524342|NCT01696058|8735567|P2|Overall Study|Lack of Efficacy|3
2524343|NCT01696058|8735568|P1|Overall Study|Lack of Efficacy|2
2524344|NCT01696058|8735567|P2|Overall Study|Adverse Event|11
2524345|NCT01696058|8735568|P1|Overall Study|Adverse Event|21
2524346|NCT01696045|8735596|P2|Overall Study|Disease progression|2
2524347|NCT01696045|8735597|P1|Overall Study|Disease progression|2
2524348|NCT01696045|8735596|P2|Overall Study|Study drug toxicity|5
2524349|NCT01696045|8735597|P1|Overall Study|Study drug toxicity|1
2524350|NCT01695993|8735616|P3|Overall Study|Changed Medical Facility|1
2524351|NCT01695993|8735617|P2|Overall Study|Changed Medical Facility|0
2524352|NCT01695993|8735618|P1|Overall Study|Changed Medical Facility|0
2524353|NCT01695993|8735616|P3|Overall Study|To ill to continue|0
2524354|NCT01695993|8735617|P2|Overall Study|To ill to continue|2
2524355|NCT01695993|8735618|P1|Overall Study|To ill to continue|1
2524356|NCT01695993|8735616|P3|Overall Study|Withdrawal by Subject|2
2524357|NCT01695993|8735617|P2|Overall Study|Withdrawal by Subject|2
2524358|NCT01695993|8735618|P1|Overall Study|Withdrawal by Subject|2
2524359|NCT01695993|8735616|P3|Overall Study|Lost to Follow-up|3
2524360|NCT01695993|8735617|P2|Overall Study|Lost to Follow-up|1
2524361|NCT01695993|8735618|P1|Overall Study|Lost to Follow-up|2
2524362|NCT01695772|8735626|P1|Overall Study|Unspecified Reason|1
2524363|NCT01695772|8735626|P1|Overall Study|Protocol Violation|2
2524364|NCT01695772|8735626|P1|Overall Study|Lost to Follow-up|4
2524365|NCT01695772|8735626|P1|Overall Study|Investigator Decision|5
2524366|NCT01695772|8735626|P1|Overall Study|Progressive Disease|8
2524367|NCT01695772|8735626|P1|Overall Study|Withdrawal by Subject|18
2524368|NCT01695746|8735638|P1|Overall Study|Participant not willing to participate|3
2524369|NCT01695746|8735638|P1|Overall Study|Protocol Violation|5
2524370|NCT01695746|8735638|P1|Overall Study|Non-compliance by the participant|3
2524371|NCT01695746|8735638|P1|Overall Study|Adverse Event|1
2524372|NCT01695239|8735698|P14|Post-Treatment Follow-Up Period|Protocol Violation|1
2524373|NCT01695239|8735699|P13|Post-Treatment Follow-Up Period|Protocol Violation|0
2524374|NCT01695239|8735700|P12|Post-Treatment Follow-Up Period|Protocol Violation|0
2524375|NCT01695239|8735701|P11|Post-Treatment Follow-Up Period|Protocol Violation|0
2524376|NCT01695239|8735702|P10|Post-Treatment Follow-Up Period|Protocol Violation|0
2524377|NCT01695239|8735703|P9|Post-Treatment Follow-Up Period|Protocol Violation|0
2524378|NCT01695239|8735704|P8|Post-Treatment Follow-Up Period|Protocol Violation|0
2524379|NCT01695239|8735705|P7|Post-Treatment Follow-Up Period|Protocol Violation|0
2524380|NCT01695239|8735706|P6|Post-Treatment Follow-Up Period|Protocol Violation|0
2524381|NCT01695239|8735707|P5|Post-Treatment Follow-Up Period|Protocol Violation|0
2524382|NCT01695239|8735708|P4|Post-Treatment Follow-Up Period|Protocol Violation|0
2524383|NCT01695239|8735709|P3|Post-Treatment Follow-Up Period|Protocol Violation|0
2524384|NCT01695239|8735710|P2|Post-Treatment Follow-Up Period|Protocol Violation|0
2524385|NCT01695239|8735711|P1|Post-Treatment Follow-Up Period|Protocol Violation|0
2524386|NCT01695239|8735698|P14|Post-Treatment Follow-Up Period|Physician Decision|0
2524387|NCT01695239|8735699|P13|Post-Treatment Follow-Up Period|Physician Decision|2
2524388|NCT01695239|8735700|P12|Post-Treatment Follow-Up Period|Physician Decision|0
2524389|NCT01695239|8735701|P11|Post-Treatment Follow-Up Period|Physician Decision|0
2524390|NCT01695239|8735702|P10|Post-Treatment Follow-Up Period|Physician Decision|0
2524391|NCT01695239|8735703|P9|Post-Treatment Follow-Up Period|Physician Decision|0
2524392|NCT01695239|8735704|P8|Post-Treatment Follow-Up Period|Physician Decision|0
2524393|NCT01695239|8735705|P7|Post-Treatment Follow-Up Period|Physician Decision|0
2524394|NCT01695239|8735706|P6|Post-Treatment Follow-Up Period|Physician Decision|0
2524395|NCT01695239|8735707|P5|Post-Treatment Follow-Up Period|Physician Decision|0
2524396|NCT01695239|8735708|P4|Post-Treatment Follow-Up Period|Physician Decision|0
2524397|NCT01695239|8735709|P3|Post-Treatment Follow-Up Period|Physician Decision|0
2524398|NCT01695239|8735710|P2|Post-Treatment Follow-Up Period|Physician Decision|0
2524399|NCT01695239|8735711|P1|Post-Treatment Follow-Up Period|Physician Decision|0
2524400|NCT01695239|8735698|P14|Post-Treatment Follow-Up Period|Lost to Follow-up|1
2524401|NCT01695239|8735699|P13|Post-Treatment Follow-Up Period|Lost to Follow-up|1
2524402|NCT01695239|8735700|P12|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2524403|NCT01695239|8735701|P11|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2524404|NCT01695239|8735702|P10|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2524405|NCT01695239|8735703|P9|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2524406|NCT01695239|8735704|P8|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2524407|NCT01695239|8735705|P7|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2524408|NCT01695239|8735706|P6|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2524409|NCT01695239|8735707|P5|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2524410|NCT01695239|8735708|P4|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2524411|NCT01695239|8735709|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2524412|NCT01695239|8735710|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2524413|NCT01695239|8735711|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|0
2524414|NCT01695239|8735698|P14|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
2524415|NCT01695239|8735699|P13|Post-Treatment Follow-Up Period|Withdrawal by Subject|6
2524416|NCT01695239|8735700|P12|Post-Treatment Follow-Up Period|Withdrawal by Subject|1
2524417|NCT01695239|8735701|P11|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2524418|NCT01695239|8735702|P10|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2524419|NCT01695239|8735703|P9|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2524420|NCT01695239|8735704|P8|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2524421|NCT01695239|8735705|P7|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2524422|NCT01695239|8735706|P6|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2524423|NCT01695239|8735707|P5|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2524424|NCT01695239|8735708|P4|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2524425|NCT01695239|8735709|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2524426|NCT01695239|8735710|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2524427|NCT01695239|8735711|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
2524428|NCT01695239|8735698|P14|Extension Long-Term Extension Periods|Death|0
2524429|NCT01695239|8735699|P13|Extension Long-Term Extension Periods|Death|0
2524430|NCT01695239|8735700|P12|Extension Long-Term Extension Periods|Death|0
2524431|NCT01695239|8735701|P11|Extension Long-Term Extension Periods|Death|0
2524432|NCT01695239|8735702|P10|Extension Long-Term Extension Periods|Death|0
2524433|NCT01695239|8735703|P9|Extension Long-Term Extension Periods|Death|1
2524434|NCT01695239|8735704|P8|Extension Long-Term Extension Periods|Death|0
2524435|NCT01695239|8735705|P7|Extension Long-Term Extension Periods|Death|0
2524436|NCT01695239|8735706|P6|Extension Long-Term Extension Periods|Death|0
2524437|NCT01695239|8735707|P5|Extension Long-Term Extension Periods|Death|0
2524438|NCT01695239|8735708|P4|Extension Long-Term Extension Periods|Death|0
2524439|NCT01695239|8735709|P3|Extension Long-Term Extension Periods|Death|0
2524440|NCT01695239|8735710|P2|Extension Long-Term Extension Periods|Death|0
2524441|NCT01695239|8735711|P1|Extension Long-Term Extension Periods|Death|0
2524442|NCT01695239|8735698|P14|Extension Long-Term Extension Periods|Sponsor Decision|0
2524443|NCT01695239|8735699|P13|Extension Long-Term Extension Periods|Sponsor Decision|0
2524444|NCT01695239|8735700|P12|Extension Long-Term Extension Periods|Sponsor Decision|0
2524445|NCT01695239|8735701|P11|Extension Long-Term Extension Periods|Sponsor Decision|0
2524446|NCT01695239|8735702|P10|Extension Long-Term Extension Periods|Sponsor Decision|1
2524447|NCT01695239|8735703|P9|Extension Long-Term Extension Periods|Sponsor Decision|2
2524448|NCT01695239|8735704|P8|Extension Long-Term Extension Periods|Sponsor Decision|0
2524449|NCT01695239|8735705|P7|Extension Long-Term Extension Periods|Sponsor Decision|0
2524450|NCT01695239|8735706|P6|Extension Long-Term Extension Periods|Sponsor Decision|0
2524743|NCT01694485|8735991|P2|Overall Study|Death|0
2524451|NCT01695239|8735707|P5|Extension Long-Term Extension Periods|Sponsor Decision|0
2524452|NCT01695239|8735708|P4|Extension Long-Term Extension Periods|Sponsor Decision|0
2524453|NCT01695239|8735709|P3|Extension Long-Term Extension Periods|Sponsor Decision|0
2524454|NCT01695239|8735710|P2|Extension Long-Term Extension Periods|Sponsor Decision|0
2524455|NCT01695239|8735711|P1|Extension Long-Term Extension Periods|Sponsor Decision|0
2524456|NCT01695239|8735698|P14|Extension Long-Term Extension Periods|Lost to Follow-up|0
2524457|NCT01695239|8735699|P13|Extension Long-Term Extension Periods|Lost to Follow-up|0
2524458|NCT01695239|8735700|P12|Extension Long-Term Extension Periods|Lost to Follow-up|0
2524459|NCT01695239|8735701|P11|Extension Long-Term Extension Periods|Lost to Follow-up|0
2524460|NCT01695239|8735702|P10|Extension Long-Term Extension Periods|Lost to Follow-up|1
2524461|NCT01695239|8735703|P9|Extension Long-Term Extension Periods|Lost to Follow-up|2
2524462|NCT01695239|8735704|P8|Extension Long-Term Extension Periods|Lost to Follow-up|0
2524463|NCT01695239|8735705|P7|Extension Long-Term Extension Periods|Lost to Follow-up|0
2524464|NCT01695239|8735706|P6|Extension Long-Term Extension Periods|Lost to Follow-up|0
2524465|NCT01695239|8735707|P5|Extension Long-Term Extension Periods|Lost to Follow-up|0
2524466|NCT01695239|8735708|P4|Extension Long-Term Extension Periods|Lost to Follow-up|0
2524467|NCT01695239|8735709|P3|Extension Long-Term Extension Periods|Lost to Follow-up|0
2524468|NCT01695239|8735710|P2|Extension Long-Term Extension Periods|Lost to Follow-up|0
2524469|NCT01695239|8735711|P1|Extension Long-Term Extension Periods|Lost to Follow-up|0
2524470|NCT01695239|8735698|P14|Extension Long-Term Extension Periods|Physician Decision|0
2524471|NCT01695239|8735699|P13|Extension Long-Term Extension Periods|Physician Decision|0
2524472|NCT01695239|8735700|P12|Extension Long-Term Extension Periods|Physician Decision|0
2524473|NCT01695239|8735701|P11|Extension Long-Term Extension Periods|Physician Decision|0
2524474|NCT01695239|8735702|P10|Extension Long-Term Extension Periods|Physician Decision|0
2524475|NCT01695239|8735703|P9|Extension Long-Term Extension Periods|Physician Decision|3
2524476|NCT01695239|8735704|P8|Extension Long-Term Extension Periods|Physician Decision|0
2524477|NCT01695239|8735705|P7|Extension Long-Term Extension Periods|Physician Decision|0
2524478|NCT01695239|8735706|P6|Extension Long-Term Extension Periods|Physician Decision|0
2524479|NCT01695239|8735707|P5|Extension Long-Term Extension Periods|Physician Decision|0
2524480|NCT01695239|8735708|P4|Extension Long-Term Extension Periods|Physician Decision|0
2524481|NCT01695239|8735709|P3|Extension Long-Term Extension Periods|Physician Decision|0
2524482|NCT01695239|8735710|P2|Extension Long-Term Extension Periods|Physician Decision|0
2524483|NCT01695239|8735711|P1|Extension Long-Term Extension Periods|Physician Decision|0
2524484|NCT01695239|8735698|P14|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2524485|NCT01695239|8735699|P13|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2524486|NCT01695239|8735700|P12|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2524487|NCT01695239|8735701|P11|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2524488|NCT01695239|8735702|P10|Extension Long-Term Extension Periods|Withdrawal by Subject|7
2524489|NCT01695239|8735703|P9|Extension Long-Term Extension Periods|Withdrawal by Subject|6
2524490|NCT01695239|8735704|P8|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2524491|NCT01695239|8735705|P7|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2524492|NCT01695239|8735706|P6|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2524493|NCT01695239|8735707|P5|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2524494|NCT01695239|8735708|P4|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2524495|NCT01695239|8735709|P3|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2524496|NCT01695239|8735710|P2|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2524497|NCT01695239|8735711|P1|Extension Long-Term Extension Periods|Withdrawal by Subject|0
2524498|NCT01695239|8735698|P14|Extension Long-Term Extension Periods|Adverse Event|0
2524499|NCT01695239|8735699|P13|Extension Long-Term Extension Periods|Adverse Event|0
2524500|NCT01695239|8735700|P12|Extension Long-Term Extension Periods|Adverse Event|0
2524501|NCT01695239|8735701|P11|Extension Long-Term Extension Periods|Adverse Event|0
2524502|NCT01695239|8735702|P10|Extension Long-Term Extension Periods|Adverse Event|21
2524503|NCT01695239|8735703|P9|Extension Long-Term Extension Periods|Adverse Event|15
2524504|NCT01695239|8735704|P8|Extension Long-Term Extension Periods|Adverse Event|0
2524505|NCT01695239|8735705|P7|Extension Long-Term Extension Periods|Adverse Event|0
2524506|NCT01695239|8735706|P6|Extension Long-Term Extension Periods|Adverse Event|0
2524507|NCT01695239|8735707|P5|Extension Long-Term Extension Periods|Adverse Event|0
2524508|NCT01695239|8735708|P4|Extension Long-Term Extension Periods|Adverse Event|0
2524509|NCT01695239|8735709|P3|Extension Long-Term Extension Periods|Adverse Event|0
2524510|NCT01695239|8735710|P2|Extension Long-Term Extension Periods|Adverse Event|0
2524511|NCT01695239|8735711|P1|Extension Long-Term Extension Periods|Adverse Event|0
2524512|NCT01695239|8735698|P14|Extension Long-Term Extension Periods|Lack of Efficacy|0
2524513|NCT01695239|8735699|P13|Extension Long-Term Extension Periods|Lack of Efficacy|0
2524514|NCT01695239|8735700|P12|Extension Long-Term Extension Periods|Lack of Efficacy|0
2524515|NCT01695239|8735701|P11|Extension Long-Term Extension Periods|Lack of Efficacy|0
2524516|NCT01695239|8735702|P10|Extension Long-Term Extension Periods|Lack of Efficacy|31
2524517|NCT01695239|8735703|P9|Extension Long-Term Extension Periods|Lack of Efficacy|37
2524518|NCT01695239|8735704|P8|Extension Long-Term Extension Periods|Lack of Efficacy|0
2524519|NCT01695239|8735705|P7|Extension Long-Term Extension Periods|Lack of Efficacy|0
2524520|NCT01695239|8735706|P6|Extension Long-Term Extension Periods|Lack of Efficacy|0
2524521|NCT01695239|8735707|P5|Extension Long-Term Extension Periods|Lack of Efficacy|0
2524522|NCT01695239|8735708|P4|Extension Long-Term Extension Periods|Lack of Efficacy|0
2524523|NCT01695239|8735709|P3|Extension Long-Term Extension Periods|Lack of Efficacy|0
2524524|NCT01695239|8735710|P2|Extension Long-Term Extension Periods|Lack of Efficacy|0
2524525|NCT01695239|8735711|P1|Extension Long-Term Extension Periods|Lack of Efficacy|0
2524526|NCT01695239|8735698|P14|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2524527|NCT01695239|8735699|P13|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2524528|NCT01695239|8735700|P12|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2524529|NCT01695239|8735701|P11|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2524530|NCT01695239|8735702|P10|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2524531|NCT01695239|8735703|P9|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2524532|NCT01695239|8735704|P8|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1
2524533|NCT01695239|8735705|P7|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2524534|NCT01695239|8735706|P6|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2524535|NCT01695239|8735707|P5|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2524536|NCT01695239|8735708|P4|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2524537|NCT01695239|8735709|P3|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2524538|NCT01695239|8735710|P2|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2524539|NCT01695239|8735711|P1|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
2524540|NCT01695239|8735698|P14|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2524541|NCT01695239|8735699|P13|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2524542|NCT01695239|8735700|P12|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2524543|NCT01695239|8735701|P11|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2524544|NCT01695239|8735702|P10|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2524545|NCT01695239|8735703|P9|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2524546|NCT01695239|8735704|P8|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1
2524547|NCT01695239|8735705|P7|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2524548|NCT01695239|8735706|P6|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2524549|NCT01695239|8735707|P5|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2524550|NCT01695239|8735708|P4|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2524551|NCT01695239|8735709|P3|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2524552|NCT01695239|8735710|P2|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2524553|NCT01695239|8735711|P1|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
2524554|NCT01695239|8735698|P14|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2524555|NCT01695239|8735699|P13|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2524556|NCT01695239|8735700|P12|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2524557|NCT01695239|8735701|P11|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2524558|NCT01695239|8735702|P10|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2524559|NCT01695239|8735703|P9|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2524560|NCT01695239|8735704|P8|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9
2524561|NCT01695239|8735705|P7|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2524562|NCT01695239|8735706|P6|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2524563|NCT01695239|8735707|P5|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2524564|NCT01695239|8735708|P4|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2524565|NCT01695239|8735709|P3|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2524566|NCT01695239|8735710|P2|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2524567|NCT01695239|8735711|P1|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
2524568|NCT01695239|8735698|P14|Double-Blind (DB) Treatment Period|Protocol Violation|0
2524569|NCT01695239|8735699|P13|Double-Blind (DB) Treatment Period|Protocol Violation|0
2524570|NCT01695239|8735700|P12|Double-Blind (DB) Treatment Period|Protocol Violation|0
2524571|NCT01695239|8735701|P11|Double-Blind (DB) Treatment Period|Protocol Violation|0
2524572|NCT01695239|8735702|P10|Double-Blind (DB) Treatment Period|Protocol Violation|0
2524573|NCT01695239|8735703|P9|Double-Blind (DB) Treatment Period|Protocol Violation|0
2524574|NCT01695239|8735704|P8|Double-Blind (DB) Treatment Period|Protocol Violation|0
2524575|NCT01695239|8735705|P7|Double-Blind (DB) Treatment Period|Protocol Violation|0
2524576|NCT01695239|8735706|P6|Double-Blind (DB) Treatment Period|Protocol Violation|0
2524577|NCT01695239|8735707|P5|Double-Blind (DB) Treatment Period|Protocol Violation|0
2524578|NCT01695239|8735708|P4|Double-Blind (DB) Treatment Period|Protocol Violation|0
2524579|NCT01695239|8735709|P3|Double-Blind (DB) Treatment Period|Protocol Violation|0
2524580|NCT01695239|8735710|P2|Double-Blind (DB) Treatment Period|Protocol Violation|0
2524581|NCT01695239|8735711|P1|Double-Blind (DB) Treatment Period|Protocol Violation|1
2524582|NCT01695239|8735698|P14|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2524583|NCT01695239|8735699|P13|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2524584|NCT01695239|8735700|P12|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2524585|NCT01695239|8735701|P11|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2524586|NCT01695239|8735702|P10|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2524587|NCT01695239|8735703|P9|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2524588|NCT01695239|8735704|P8|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2524589|NCT01695239|8735705|P7|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2524590|NCT01695239|8735706|P6|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2524591|NCT01695239|8735707|P5|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2524592|NCT01695239|8735708|P4|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2524593|NCT01695239|8735709|P3|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
2524594|NCT01695239|8735710|P2|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2524595|NCT01695239|8735711|P1|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
2524596|NCT01695239|8735698|P14|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2524597|NCT01695239|8735699|P13|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2524598|NCT01695239|8735700|P12|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2524599|NCT01695239|8735701|P11|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2524600|NCT01695239|8735702|P10|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2524601|NCT01695239|8735703|P9|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2524602|NCT01695239|8735704|P8|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2524603|NCT01695239|8735705|P7|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2524604|NCT01695239|8735706|P6|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2524605|NCT01695239|8735707|P5|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2524606|NCT01695239|8735708|P4|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2524607|NCT01695239|8735709|P3|Double-Blind (DB) Treatment Period|Sponsor Decision|1
2524608|NCT01695239|8735710|P2|Double-Blind (DB) Treatment Period|Sponsor Decision|0
2524609|NCT01695239|8735711|P1|Double-Blind (DB) Treatment Period|Sponsor Decision|3
2524610|NCT01695239|8735698|P14|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2524611|NCT01695239|8735699|P13|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2524612|NCT01695239|8735700|P12|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2524613|NCT01695239|8735701|P11|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2524614|NCT01695239|8735702|P10|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2524615|NCT01695239|8735703|P9|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2524616|NCT01695239|8735704|P8|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2524617|NCT01695239|8735705|P7|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2524618|NCT01695239|8735706|P6|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2524619|NCT01695239|8735707|P5|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2524620|NCT01695239|8735708|P4|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2524621|NCT01695239|8735709|P3|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1
2524622|NCT01695239|8735710|P2|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1
2524623|NCT01695239|8735711|P1|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3
2524624|NCT01695239|8735698|P14|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2524625|NCT01695239|8735699|P13|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2524626|NCT01695239|8735700|P12|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2524627|NCT01695239|8735701|P11|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2524628|NCT01695239|8735702|P10|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2524629|NCT01695239|8735703|P9|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2524630|NCT01695239|8735704|P8|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2524631|NCT01695239|8735705|P7|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2524632|NCT01695239|8735706|P6|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2524633|NCT01695239|8735707|P5|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2524634|NCT01695239|8735708|P4|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2524635|NCT01695239|8735709|P3|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
2524636|NCT01695239|8735710|P2|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2524637|NCT01695239|8735711|P1|Double-Blind (DB) Treatment Period|Lack of Efficacy|4
2524638|NCT01695239|8735698|P14|Double-Blind (DB) Treatment Period|Adverse Event|0
2524639|NCT01695239|8735699|P13|Double-Blind (DB) Treatment Period|Adverse Event|0
2524640|NCT01695239|8735700|P12|Double-Blind (DB) Treatment Period|Adverse Event|0
2524641|NCT01695239|8735701|P11|Double-Blind (DB) Treatment Period|Adverse Event|0
2524642|NCT01695239|8735702|P10|Double-Blind (DB) Treatment Period|Adverse Event|0
2524643|NCT01695239|8735703|P9|Double-Blind (DB) Treatment Period|Adverse Event|0
2524644|NCT01695239|8735704|P8|Double-Blind (DB) Treatment Period|Adverse Event|0
2524645|NCT01695239|8735705|P7|Double-Blind (DB) Treatment Period|Adverse Event|0
2524646|NCT01695239|8735706|P6|Double-Blind (DB) Treatment Period|Adverse Event|0
2524647|NCT01695239|8735707|P5|Double-Blind (DB) Treatment Period|Adverse Event|0
2524648|NCT01695239|8735708|P4|Double-Blind (DB) Treatment Period|Adverse Event|3
2524649|NCT01695239|8735709|P3|Double-Blind (DB) Treatment Period|Adverse Event|2
2524650|NCT01695239|8735710|P2|Double-Blind (DB) Treatment Period|Adverse Event|2
2524651|NCT01695239|8735711|P1|Double-Blind (DB) Treatment Period|Adverse Event|2
2524652|NCT01695239|8735698|P14|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
2524653|NCT01695239|8735699|P13|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
2524654|NCT01695239|8735700|P12|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
2524655|NCT01695239|8735701|P11|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
2524656|NCT01695239|8735702|P10|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
2524657|NCT01695239|8735703|P9|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
2524658|NCT01695239|8735704|P8|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
2524659|NCT01695239|8735705|P7|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
2524660|NCT01695239|8735706|P6|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
2524661|NCT01695239|8735707|P5|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
2524662|NCT01695239|8735708|P4|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4
2524663|NCT01695239|8735709|P3|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3
2524664|NCT01695239|8735710|P2|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1
2524665|NCT01695239|8735711|P1|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1
2524666|NCT01695135|8735852|P4|Open Label Extension Treatment Phase|Noncompliance with study drug|1
2524667|NCT01695135|8735853|P3|Open Label Extension Treatment Phase|Noncompliance with study drug|0
2524668|NCT01695135|8735854|P2|Open Label Extension Treatment Phase|Noncompliance with study drug|0
2524669|NCT01695135|8735855|P1|Open Label Extension Treatment Phase|Noncompliance with study drug|0
2524670|NCT01695135|8735852|P4|Open Label Extension Treatment Phase|Death|7
2524671|NCT01695135|8735853|P3|Open Label Extension Treatment Phase|Death|2
2524672|NCT01695135|8735854|P2|Open Label Extension Treatment Phase|Death|0
2524673|NCT01695135|8735855|P1|Open Label Extension Treatment Phase|Death|0
2524674|NCT01695135|8735852|P4|Open Label Extension Treatment Phase|Physician Decision|1
2524675|NCT01695135|8735853|P3|Open Label Extension Treatment Phase|Physician Decision|4
2524676|NCT01695135|8735854|P2|Open Label Extension Treatment Phase|Physician Decision|0
2524677|NCT01695135|8735855|P1|Open Label Extension Treatment Phase|Physician Decision|0
2524678|NCT01695135|8735852|P4|Open Label Extension Treatment Phase|Other|7
2524679|NCT01695135|8735853|P3|Open Label Extension Treatment Phase|Other|4
2524680|NCT01695135|8735854|P2|Open Label Extension Treatment Phase|Other|0
2524681|NCT01695135|8735855|P1|Open Label Extension Treatment Phase|Other|0
2524682|NCT01695135|8735852|P4|Open Label Extension Treatment Phase|Adverse Event|16
2524683|NCT01695135|8735853|P3|Open Label Extension Treatment Phase|Adverse Event|11
2524684|NCT01695135|8735854|P2|Open Label Extension Treatment Phase|Adverse Event|0
2524685|NCT01695135|8735855|P1|Open Label Extension Treatment Phase|Adverse Event|0
2524686|NCT01695135|8735852|P4|Open Label Extension Treatment Phase|Withdrawal by Subject|16
2524687|NCT01695135|8735853|P3|Open Label Extension Treatment Phase|Withdrawal by Subject|6
2524688|NCT01695135|8735854|P2|Open Label Extension Treatment Phase|Withdrawal by Subject|0
2524689|NCT01695135|8735855|P1|Open Label Extension Treatment Phase|Withdrawal by Subject|0
2524690|NCT01695135|8735852|P4|Open Label Extension Treatment Phase|Progressive disease|22
2524691|NCT01695135|8735853|P3|Open Label Extension Treatment Phase|Progressive disease|13
2524692|NCT01695135|8735854|P2|Open Label Extension Treatment Phase|Progressive disease|0
2524693|NCT01695135|8735855|P1|Open Label Extension Treatment Phase|Progressive disease|0
2524694|NCT01695135|8735852|P4|Double-blind Treatment Phase|Noncompliance with study drug|0
2524695|NCT01695135|8735853|P3|Double-blind Treatment Phase|Noncompliance with study drug|0
2524696|NCT01695135|8735854|P2|Double-blind Treatment Phase|Noncompliance with study drug|1
2524697|NCT01695135|8735855|P1|Double-blind Treatment Phase|Noncompliance with study drug|0
2524698|NCT01695135|8735852|P4|Double-blind Treatment Phase|Death|0
2524699|NCT01695135|8735853|P3|Double-blind Treatment Phase|Death|0
2524700|NCT01695135|8735854|P2|Double-blind Treatment Phase|Death|1
2524701|NCT01695135|8735855|P1|Double-blind Treatment Phase|Death|1
2524702|NCT01695135|8735852|P4|Double-blind Treatment Phase|Physician Decision|0
2524703|NCT01695135|8735853|P3|Double-blind Treatment Phase|Physician Decision|0
2524704|NCT01695135|8735854|P2|Double-blind Treatment Phase|Physician Decision|3
2524705|NCT01695135|8735855|P1|Double-blind Treatment Phase|Physician Decision|6
2524706|NCT01695135|8735852|P4|Double-blind Treatment Phase|Other|0
2524707|NCT01695135|8735853|P3|Double-blind Treatment Phase|Other|0
2524708|NCT01695135|8735854|P2|Double-blind Treatment Phase|Other|3
2524709|NCT01695135|8735855|P1|Double-blind Treatment Phase|Other|1
2524710|NCT01695135|8735852|P4|Double-blind Treatment Phase|Adverse Event|0
2524711|NCT01695135|8735853|P3|Double-blind Treatment Phase|Adverse Event|0
2524712|NCT01695135|8735854|P2|Double-blind Treatment Phase|Adverse Event|7
2524713|NCT01695135|8735855|P1|Double-blind Treatment Phase|Adverse Event|7
2524714|NCT01695135|8735852|P4|Double-blind Treatment Phase|Withdrawal by Subject|0
2524715|NCT01695135|8735853|P3|Double-blind Treatment Phase|Withdrawal by Subject|0
2524716|NCT01695135|8735854|P2|Double-blind Treatment Phase|Withdrawal by Subject|14
2524717|NCT01695135|8735855|P1|Double-blind Treatment Phase|Withdrawal by Subject|6
2524718|NCT01695135|8735852|P4|Double-blind Treatment Phase|Progressive disease|0
2524719|NCT01695135|8735853|P3|Double-blind Treatment Phase|Progressive disease|0
2524720|NCT01695135|8735854|P2|Double-blind Treatment Phase|Progressive disease|110
2524721|NCT01695135|8735855|P1|Double-blind Treatment Phase|Progressive disease|50
2524722|NCT01694771|8735904|P2|Overall Study|Other reasons|6
2524723|NCT01694771|8735905|P1|Overall Study|Other reasons|5
2524724|NCT01694771|8735904|P2|Overall Study|Consent withdrawn|9
2524725|NCT01694771|8735905|P1|Overall Study|Consent withdrawn|7
2524726|NCT01694771|8735904|P2|Overall Study|Lost to Follow-up|3
2524727|NCT01694771|8735905|P1|Overall Study|Lost to Follow-up|2
2524728|NCT01694771|8735904|P2|Overall Study|Non compliance protocol|6
2524729|NCT01694771|8735905|P1|Overall Study|Non compliance protocol|7
2524730|NCT01694771|8735904|P2|Overall Study|Lack of Efficacy|0
2524731|NCT01694771|8735905|P1|Overall Study|Lack of Efficacy|1
2524732|NCT01694771|8735904|P2|Overall Study|Adverse Event|16
2524733|NCT01694771|8735905|P1|Overall Study|Adverse Event|18
2524734|NCT01694706|8735929|P3|Overall Study|other reason not defined above|0
2524735|NCT01694706|8735930|P2|Overall Study|other reason not defined above|0
2524736|NCT01694706|8735931|P1|Overall Study|other reason not defined above|1
2524737|NCT01694706|8735929|P3|Overall Study|Adverse Event|0
2524738|NCT01694706|8735930|P2|Overall Study|Adverse Event|1
2524739|NCT01694706|8735931|P1|Overall Study|Adverse Event|0
2524740|NCT01694485|8735988|P5|Overall Study|Death|0
2524741|NCT01694485|8735989|P4|Overall Study|Death|1
2524742|NCT01694485|8735990|P3|Overall Study|Death|0
2524744|NCT01694485|8735992|P1|Overall Study|Death|1
2524745|NCT01694485|8735988|P5|Overall Study|Lost to Follow-up|7
2524746|NCT01694485|8735989|P4|Overall Study|Lost to Follow-up|10
2524747|NCT01694485|8735990|P3|Overall Study|Lost to Follow-up|6
2524748|NCT01694485|8735991|P2|Overall Study|Lost to Follow-up|1
2524749|NCT01694485|8735992|P1|Overall Study|Lost to Follow-up|9
2524750|NCT01694485|8735988|P5|Overall Study|Sponsor Decision|0
2524751|NCT01694485|8735989|P4|Overall Study|Sponsor Decision|2
2524752|NCT01694485|8735990|P3|Overall Study|Sponsor Decision|0
2524753|NCT01694485|8735991|P2|Overall Study|Sponsor Decision|0
2524754|NCT01694485|8735992|P1|Overall Study|Sponsor Decision|3
2524755|NCT01694485|8735988|P5|Overall Study|Withdrawal by Subject|18
2524756|NCT01694485|8735989|P4|Overall Study|Withdrawal by Subject|25
2524757|NCT01694485|8735990|P3|Overall Study|Withdrawal by Subject|7
2524758|NCT01694485|8735991|P2|Overall Study|Withdrawal by Subject|6
2524759|NCT01694485|8735992|P1|Overall Study|Withdrawal by Subject|20
2524760|NCT01694433|8736026|P2|Overall Study|Withdrawal by Subject|4
2524761|NCT01694433|8736027|P1|Overall Study|Withdrawal by Subject|3
2524762|NCT01694433|8736026|P2|Overall Study|Physician Decision|0
2524763|NCT01694433|8736027|P1|Overall Study|Physician Decision|1
2524764|NCT01694433|8736026|P2|Overall Study|Adverse Event|0
2524765|NCT01694433|8736027|P1|Overall Study|Adverse Event|7
2524766|NCT01694420|8736035|P1|Overall Study|Lost to Follow-up|3
2524767|NCT01694121|8736072|P2|Overall Study|Participant used false ID, was withdrawn|0
2524768|NCT01694121|8736073|P1|Overall Study|Participant used false ID, was withdrawn|1
2524769|NCT01693614|8736187|P3|Overall Study|Withdrawal by Subject|5
2524770|NCT01693614|8736188|P2|Overall Study|Withdrawal by Subject|0
2524771|NCT01693614|8736189|P1|Overall Study|Withdrawal by Subject|1
2524772|NCT01693614|8736187|P3|Overall Study|Withdrawal by subject/guardian|2
2524773|NCT01693614|8736188|P2|Overall Study|Withdrawal by subject/guardian|0
2524774|NCT01693614|8736189|P1|Overall Study|Withdrawal by subject/guardian|0
2524775|NCT01693614|8736187|P3|Overall Study|Physician Decision|4
2524776|NCT01693614|8736188|P2|Overall Study|Physician Decision|1
2524777|NCT01693614|8736189|P1|Overall Study|Physician Decision|1
2524778|NCT01693614|8736187|P3|Overall Study|Death|0
2524779|NCT01693614|8736188|P2|Overall Study|Death|0
2524780|NCT01693614|8736189|P1|Overall Study|Death|1
2524781|NCT01693614|8736187|P3|Overall Study|Protocol Violation|1
2524782|NCT01693614|8736188|P2|Overall Study|Protocol Violation|2
2524783|NCT01693614|8736189|P1|Overall Study|Protocol Violation|5
2524784|NCT01693614|8736187|P3|Overall Study|Disease progression|7
2524785|NCT01693614|8736188|P2|Overall Study|Disease progression|8
2524786|NCT01693614|8736189|P1|Overall Study|Disease progression|11
2524787|NCT01693614|8736187|P3|Overall Study|Adverse Event|5
2524788|NCT01693614|8736188|P2|Overall Study|Adverse Event|11
2524789|NCT01693614|8736189|P1|Overall Study|Adverse Event|7
2524790|NCT01693523|8736214|P3|Overall Study|Chemotherapy was held|0
2524791|NCT01693523|8736215|P2|Overall Study|Chemotherapy was held|2
2524792|NCT01693523|8736216|P1|Overall Study|Chemotherapy was held|1
2524793|NCT01693523|8736214|P3|Overall Study|Lack of compliance study medication|0
2524794|NCT01693523|8736215|P2|Overall Study|Lack of compliance study medication|2
2524795|NCT01693523|8736216|P1|Overall Study|Lack of compliance study medication|1
2524796|NCT01693523|8736214|P3|Overall Study|Withdrawal by Subject|2
2524797|NCT01693523|8736215|P2|Overall Study|Withdrawal by Subject|2
2524798|NCT01693523|8736216|P1|Overall Study|Withdrawal by Subject|1
2524799|NCT01693523|8736214|P3|Overall Study|Physician Decision|1
2524800|NCT01693523|8736215|P2|Overall Study|Physician Decision|0
2524801|NCT01693523|8736216|P1|Overall Study|Physician Decision|0
2524802|NCT01693523|8736214|P3|Overall Study|Lost to Follow-up|4
2524803|NCT01693523|8736215|P2|Overall Study|Lost to Follow-up|0
2524804|NCT01693523|8736216|P1|Overall Study|Lost to Follow-up|0
2524805|NCT01693523|8736214|P3|Overall Study|Death|1
2524806|NCT01693523|8736215|P2|Overall Study|Death|1
2524807|NCT01693523|8736216|P1|Overall Study|Death|0
2524808|NCT01693523|8736214|P3|Overall Study|Adverse Event|0
2524809|NCT01693523|8736215|P2|Overall Study|Adverse Event|1
2524810|NCT01693523|8736216|P1|Overall Study|Adverse Event|2
2524811|NCT01693367|8736232|P2|Overall Study|Physician Decision|1
2524812|NCT01693367|8736233|P1|Overall Study|Physician Decision|0
2524813|NCT01693367|8736232|P2|Overall Study|Withdrawal by Subject|1
2524814|NCT01693367|8736233|P1|Overall Study|Withdrawal by Subject|1
2524815|NCT01693250|8736251|P2|Overall Study|Lost to Follow-up|2
2524816|NCT01693250|8736252|P1|Overall Study|Lost to Follow-up|2
2524817|NCT01693185|8736262|P2|Overall Study|diagnostic procedure after colonoscopy|6
2524818|NCT01693185|8736263|P1|Overall Study|diagnostic procedure after colonoscopy|0
2524819|NCT01693120|8736279|P1|Phased RF Study Procedure and Follow-up|Other reasons|7
2524820|NCT01693120|8736279|P1|Phased RF Study Procedure and Follow-up|Protocol Violation|1
2524821|NCT01693120|8736279|P1|Phased RF Study Procedure and Follow-up|Physician Decision|3
2524822|NCT01693120|8736279|P1|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5
2524823|NCT01693120|8736279|P1|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1
2524824|NCT01693120|8736279|P1|Enrollment|Other|1
2524825|NCT01693120|8736279|P1|Enrollment|Study closed|8
2524826|NCT01693120|8736279|P1|Enrollment|Adverse Event|1
2524827|NCT01693120|8736279|P1|Enrollment|Physician Decision|3
2524828|NCT01693120|8736279|P1|Enrollment|Protocol Violation|46
2524829|NCT01693120|8736279|P1|Enrollment|Withdrawal by Subject|10
2524830|NCT01693120|8736279|P1|Enrollment|Lost to Follow-up|1
2524919|NCT01692275|8736552|P1|Overall Study|Lost to Follow-up|57
2524831|NCT01693068|8736288|P3|Cross-over (Dacarbazine To Pimasertib)|On-study|1
2524832|NCT01693068|8736289|P2|Cross-over (Dacarbazine To Pimasertib)|On-study|0
2524833|NCT01693068|8736290|P1|Cross-over (Dacarbazine To Pimasertib)|On-study|0
2524834|NCT01693068|8736288|P3|Randomization Period|On-study|0
2524835|NCT01693068|8736289|P2|Randomization Period|On-study|5
2524836|NCT01693068|8736290|P1|Randomization Period|On-study|2
2524837|NCT01693029|8736322|P2|Overall Study|Non-compliance|1
2524838|NCT01693029|8736323|P1|Overall Study|Non-compliance|2
2524839|NCT01693029|8736322|P2|Overall Study|Death|8
2524840|NCT01693029|8736323|P1|Overall Study|Death|5
2524841|NCT01693029|8736322|P2|Overall Study|Adverse Event|6
2524842|NCT01693029|8736323|P1|Overall Study|Adverse Event|1
2524843|NCT01693029|8736322|P2|Overall Study|Lost to Follow-up|1
2524844|NCT01693029|8736323|P1|Overall Study|Lost to Follow-up|0
2524845|NCT01693029|8736322|P2|Overall Study|Physician Decision|2
2524846|NCT01693029|8736323|P1|Overall Study|Physician Decision|0
2524847|NCT01693029|8736322|P2|Overall Study|Change in dialysis modality|1
2524848|NCT01693029|8736323|P1|Overall Study|Change in dialysis modality|2
2524849|NCT01693029|8736322|P2|Overall Study|Protocol Violation|7
2524850|NCT01693029|8736323|P1|Overall Study|Protocol Violation|6
2524851|NCT01693029|8736322|P2|Overall Study|Bindinging anti-EPO antibodies|2
2524852|NCT01693029|8736323|P1|Overall Study|Bindinging anti-EPO antibodies|6
2524853|NCT01693029|8736322|P2|Overall Study|Kidney transplantation|7
2524854|NCT01693029|8736323|P1|Overall Study|Kidney transplantation|7
2524855|NCT01693029|8736322|P2|Overall Study|Withdrawal by Subject|22
2524856|NCT01693029|8736323|P1|Overall Study|Withdrawal by Subject|15
2524857|NCT01692938|8736354|P2|Overall Study|Study completed prior to site completion|3
2524858|NCT01692938|8736355|P1|Overall Study|Study completed prior to site completion|3
2524859|NCT01692938|8736354|P2|Overall Study|Protocol Deviation|1
2524860|NCT01692938|8736355|P1|Overall Study|Protocol Deviation|1
2524861|NCT01692782|8736366|P3|Overall Study|Withdrawal by Subject|3
2524862|NCT01692782|8736367|P2|Overall Study|Withdrawal by Subject|10
2524863|NCT01692782|8736368|P1|Overall Study|Withdrawal by Subject|3
2524864|NCT01692782|8736366|P3|Overall Study|SAE not related to study drug|0
2524865|NCT01692782|8736367|P2|Overall Study|SAE not related to study drug|1
2524866|NCT01692782|8736368|P1|Overall Study|SAE not related to study drug|0
2524867|NCT01692782|8736366|P3|Overall Study|Non-compliant with study visits|1
2524868|NCT01692782|8736367|P2|Overall Study|Non-compliant with study visits|0
2524869|NCT01692782|8736368|P1|Overall Study|Non-compliant with study visits|0
2524870|NCT01692782|8736366|P3|Overall Study|Non-complance with study drug|1
2524871|NCT01692782|8736367|P2|Overall Study|Non-complance with study drug|4
2524872|NCT01692782|8736368|P1|Overall Study|Non-complance with study drug|0
2524873|NCT01692782|8736366|P3|Overall Study|Protocol Violation|2
2524874|NCT01692782|8736367|P2|Overall Study|Protocol Violation|0
2524875|NCT01692782|8736368|P1|Overall Study|Protocol Violation|1
2524876|NCT01692782|8736366|P3|Overall Study|Pregnancy|0
2524877|NCT01692782|8736367|P2|Overall Study|Pregnancy|0
2524878|NCT01692782|8736368|P1|Overall Study|Pregnancy|1
2524879|NCT01692782|8736366|P3|Overall Study|Lost to Follow-up|1
2524880|NCT01692782|8736367|P2|Overall Study|Lost to Follow-up|7
2524881|NCT01692782|8736368|P1|Overall Study|Lost to Follow-up|2
2524882|NCT01692782|8736366|P3|Overall Study|Lack of Efficacy|0
2524883|NCT01692782|8736367|P2|Overall Study|Lack of Efficacy|2
2524884|NCT01692782|8736368|P1|Overall Study|Lack of Efficacy|1
2524885|NCT01692782|8736366|P3|Overall Study|Adverse Event|2
2524886|NCT01692782|8736367|P2|Overall Study|Adverse Event|32
2524887|NCT01692782|8736368|P1|Overall Study|Adverse Event|12
2524888|NCT01692730|8736477|P2|Overall Study|Lost to Follow-up|227
2524889|NCT01692730|8736478|P1|Overall Study|Lost to Follow-up|225
2524890|NCT01692626|8736492|P2|Overall Study|Withdrawal by Subject|0
2524891|NCT01692626|8736493|P1|Overall Study|Withdrawal by Subject|1
2524892|NCT01692626|8736492|P2|Overall Study|Protocol Violation|2
2524893|NCT01692626|8736493|P1|Overall Study|Protocol Violation|1
2524894|NCT01692626|8736492|P2|Overall Study|Adverse Event|3
2524895|NCT01692626|8736493|P1|Overall Study|Adverse Event|2
2524896|NCT01692626|8736492|P2|Overall Study|Death|1
2524897|NCT01692626|8736493|P1|Overall Study|Death|0
2524898|NCT01692301|8736518|P2|Overall Study|Lost to Follow-up|1
2524899|NCT01692301|8736519|P1|Overall Study|Lost to Follow-up|1
2524900|NCT01692301|8736518|P2|Overall Study|Physician Decision|2
2524901|NCT01692301|8736519|P1|Overall Study|Physician Decision|2
2524902|NCT01692301|8736518|P2|Overall Study|Technical problems|1
2524903|NCT01692301|8736519|P1|Overall Study|Technical problems|0
2524904|NCT01692301|8736518|P2|Overall Study|Patient/guardian decision|15
2524905|NCT01692301|8736519|P1|Overall Study|Patient/guardian decision|16
2524906|NCT01692301|8736518|P2|Overall Study|Protocol deviation|2
2524907|NCT01692301|8736519|P1|Overall Study|Protocol deviation|9
2524908|NCT01692301|8736518|P2|Overall Study|Non-compliance with study treatment|2
2524909|NCT01692301|8736519|P1|Overall Study|Non-compliance with study treatment|1
2524910|NCT01692301|8736518|P2|Overall Study|Lack of Efficacy|5
2524911|NCT01692301|8736519|P1|Overall Study|Lack of Efficacy|0
2524912|NCT01692301|8736518|P2|Overall Study|Death|2
2524913|NCT01692301|8736519|P1|Overall Study|Death|1
2524914|NCT01692301|8736518|P2|Overall Study|Adverse Event|12
2524915|NCT01692301|8736519|P1|Overall Study|Adverse Event|15
2524916|NCT01692275|8736551|P2|Overall Study|Withdrawal by Subject|11
2524917|NCT01692275|8736552|P1|Overall Study|Withdrawal by Subject|9
2524918|NCT01692275|8736551|P2|Overall Study|Lost to Follow-up|48
2524920|NCT01692197|8736612|P1|Overall Study|Failed Screening|3
2524921|NCT01691898|8736634|P6|Overall Study|Non-Compliance|0
2524922|NCT01691898|8736635|P5|Overall Study|Non-Compliance|1
2524923|NCT01691898|8736636|P4|Overall Study|Non-Compliance|0
2524924|NCT01691898|8736637|P3|Overall Study|Non-Compliance|0
2524925|NCT01691898|8736638|P2|Overall Study|Non-Compliance|0
2524926|NCT01691898|8736639|P1|Overall Study|Non-Compliance|0
2524927|NCT01691898|8736634|P6|Overall Study|Withdrawal by Subject|3
2524928|NCT01691898|8736635|P5|Overall Study|Withdrawal by Subject|3
2524929|NCT01691898|8736636|P4|Overall Study|Withdrawal by Subject|1
2524930|NCT01691898|8736637|P3|Overall Study|Withdrawal by Subject|2
2524931|NCT01691898|8736638|P2|Overall Study|Withdrawal by Subject|8
2524932|NCT01691898|8736639|P1|Overall Study|Withdrawal by Subject|9
2524933|NCT01691898|8736634|P6|Overall Study|Lost to Follow-up|0
2524934|NCT01691898|8736635|P5|Overall Study|Lost to Follow-up|1
2524935|NCT01691898|8736636|P4|Overall Study|Lost to Follow-up|0
2524936|NCT01691898|8736637|P3|Overall Study|Lost to Follow-up|0
2524937|NCT01691898|8736638|P2|Overall Study|Lost to Follow-up|1
2524938|NCT01691898|8736639|P1|Overall Study|Lost to Follow-up|3
2524939|NCT01691898|8736634|P6|Overall Study|Progression of Disease|1
2524940|NCT01691898|8736635|P5|Overall Study|Progression of Disease|0
2524941|NCT01691898|8736636|P4|Overall Study|Progression of Disease|0
2524942|NCT01691898|8736637|P3|Overall Study|Progression of Disease|1
2524943|NCT01691898|8736638|P2|Overall Study|Progression of Disease|2
2524944|NCT01691898|8736639|P1|Overall Study|Progression of Disease|1
2524945|NCT01691898|8736634|P6|Overall Study|Adverse Event|0
2524946|NCT01691898|8736635|P5|Overall Study|Adverse Event|1
2524947|NCT01691898|8736636|P4|Overall Study|Adverse Event|1
2524948|NCT01691898|8736637|P3|Overall Study|Adverse Event|0
2524949|NCT01691898|8736638|P2|Overall Study|Adverse Event|1
2524950|NCT01691898|8736639|P1|Overall Study|Adverse Event|0
2524951|NCT01691898|8736634|P6|Overall Study|Death|31
2524952|NCT01691898|8736635|P5|Overall Study|Death|8
2524953|NCT01691898|8736636|P4|Overall Study|Death|3
2524954|NCT01691898|8736637|P3|Overall Study|Death|6
2524955|NCT01691898|8736638|P2|Overall Study|Death|32
2524956|NCT01691898|8736639|P1|Overall Study|Death|34
2524957|NCT01691885|8736793|P2|Washout Period (7-9 Days)|Adverse Event|1
2524958|NCT01691885|8736794|P1|Washout Period (7-9 Days)|Adverse Event|0
2524959|NCT01691885|8736793|P2|Treatment Period 1(7-14 Days)|Adverse Event|1
2524960|NCT01691885|8736794|P1|Treatment Period 1(7-14 Days)|Adverse Event|1
2524961|NCT01691859|8736800|P1|Overall Study|Withdrawal by Subject|31
2524962|NCT01691859|8736800|P1|Overall Study|Physician Decision|6
2524963|NCT01691859|8736800|P1|Overall Study|Lost to Follow-up|5
2524964|NCT01691859|8736800|P1|Overall Study|Study closed/terminated|50
2524965|NCT01691859|8736800|P1|Overall Study|Product commercially available|221
2524966|NCT01691859|8736800|P1|Overall Study|Protocol Violation|4
2524967|NCT01691859|8736800|P1|Overall Study|Lack of Efficacy|11
2524968|NCT01691859|8736800|P1|Overall Study|Adverse Event|19
2524969|NCT01691820|8736847|P3|Overall Study|Other (unspecified)|1
2524970|NCT01691820|8736848|P2|Overall Study|Other (unspecified)|0
2524971|NCT01691820|8736849|P1|Overall Study|Other (unspecified)|5
2524972|NCT01691820|8736847|P3|Overall Study|Lost to Follow-up|0
2524973|NCT01691820|8736848|P2|Overall Study|Lost to Follow-up|15
2524974|NCT01691820|8736849|P1|Overall Study|Lost to Follow-up|8
2524975|NCT01691820|8736847|P3|Overall Study|Migrated/moved from study area|0
2524976|NCT01691820|8736848|P2|Overall Study|Migrated/moved from study area|4
2524977|NCT01691820|8736849|P1|Overall Study|Migrated/moved from study area|7
2524978|NCT01691820|8736847|P3|Overall Study|Consent withdrawal (not due to an AE)|0
2524979|NCT01691820|8736848|P2|Overall Study|Consent withdrawal (not due to an AE)|15
2524980|NCT01691820|8736849|P1|Overall Study|Consent withdrawal (not due to an AE)|9
2524981|NCT01691794|8736887|P3|Overall Study|Did not complete first 24 weeks of study|3
2524982|NCT01691794|8736888|P2|Overall Study|Did not complete first 24 weeks of study|3
2524983|NCT01691794|8736889|P1|Overall Study|Did not complete first 24 weeks of study|0
2524984|NCT01691794|8736887|P3|Overall Study|Completed Only first 24 weeks of study|3
2524985|NCT01691794|8736888|P2|Overall Study|Completed Only first 24 weeks of study|2
2524986|NCT01691794|8736889|P1|Overall Study|Completed Only first 24 weeks of study|0
2524987|NCT01691794|8736887|P3|Overall Study|Adverse Event|1
2524988|NCT01691794|8736888|P2|Overall Study|Adverse Event|1
2524989|NCT01691794|8736889|P1|Overall Study|Adverse Event|0
2524990|NCT01691794|8736887|P3|Overall Study|Participant request to discontinue|0
2524991|NCT01691794|8736888|P2|Overall Study|Participant request to discontinue|1
2524992|NCT01691794|8736889|P1|Overall Study|Participant request to discontinue|0
2524993|NCT01691794|8736887|P3|Overall Study|Lack of Efficacy|1
2524994|NCT01691794|8736888|P2|Overall Study|Lack of Efficacy|7
2524995|NCT01691794|8736889|P1|Overall Study|Lack of Efficacy|0
2524996|NCT01691794|8736887|P3|Overall Study|Death|1
2524997|NCT01691794|8736888|P2|Overall Study|Death|0
2524998|NCT01691794|8736889|P1|Overall Study|Death|0
2524999|NCT01691794|8736887|P3|Overall Study|Poor/Non-Compliance|1
2525000|NCT01691794|8736888|P2|Overall Study|Poor/Non-Compliance|4
2525001|NCT01691794|8736889|P1|Overall Study|Poor/Non-Compliance|1
2525002|NCT01691781|8736905|P2|Overall Study|Adverse Event|1
2525003|NCT01691781|8736906|P1|Overall Study|Adverse Event|0
2525004|NCT01691781|8736905|P2|Overall Study|Protocol Violation|2
2525005|NCT01691781|8736906|P1|Overall Study|Protocol Violation|2
2525006|NCT01691781|8736905|P2|Overall Study|Physician Decision|1
2525007|NCT01691781|8736906|P1|Overall Study|Physician Decision|1
2525008|NCT01691781|8736905|P2|Overall Study|Withdrawal by Subject|3
2525009|NCT01691781|8736906|P1|Overall Study|Withdrawal by Subject|4
2525010|NCT01691768|8736918|P2|Overall Study|Investigator decision|1
2525011|NCT01691768|8736919|P1|Overall Study|Investigator decision|1
2525012|NCT01691768|8736918|P2|Overall Study|Relocated|1
2525013|NCT01691768|8736919|P1|Overall Study|Relocated|0
2525014|NCT01691768|8736918|P2|Overall Study|Withdrawal by Subject|9
2525015|NCT01691768|8736919|P1|Overall Study|Withdrawal by Subject|10
2525016|NCT01691768|8736918|P2|Overall Study|Lost to Follow-up|3
2525017|NCT01691768|8736919|P1|Overall Study|Lost to Follow-up|4
2525018|NCT01691768|8736918|P2|Overall Study|Death|2
2525019|NCT01691768|8736919|P1|Overall Study|Death|0
2525020|NCT01691612|8736954|P1|Overall Study|Adverse Event|1
2525021|NCT01691612|8736954|P1|Overall Study|deemed ineligible after 1st visit|6
2525022|NCT01691521|8737065|P3|Overall Study|Withdrawal by Subject|4
2525023|NCT01691521|8737066|P2|Overall Study|Withdrawal by Subject|9
2525024|NCT01691521|8737067|P1|Overall Study|Withdrawal by Subject|5
2525025|NCT01691521|8737065|P3|Overall Study|Physician Decision|0
2525026|NCT01691521|8737066|P2|Overall Study|Physician Decision|1
2525027|NCT01691521|8737067|P1|Overall Study|Physician Decision|2
2525028|NCT01691521|8737065|P3|Overall Study|Lost to Follow-up|2
2525029|NCT01691521|8737066|P2|Overall Study|Lost to Follow-up|2
2525030|NCT01691521|8737067|P1|Overall Study|Lost to Follow-up|0
2525031|NCT01691521|8737065|P3|Overall Study|Protocol Violation|0
2525032|NCT01691521|8737066|P2|Overall Study|Protocol Violation|3
2525033|NCT01691521|8737067|P1|Overall Study|Protocol Violation|0
2525034|NCT01691521|8737065|P3|Overall Study|Lack of Efficacy|2
2525035|NCT01691521|8737066|P2|Overall Study|Lack of Efficacy|1
2525036|NCT01691521|8737067|P1|Overall Study|Lack of Efficacy|1
2525037|NCT01691521|8737065|P3|Overall Study|Adverse Event|1
2525038|NCT01691521|8737066|P2|Overall Study|Adverse Event|0
2525039|NCT01691521|8737067|P1|Overall Study|Adverse Event|4
2525040|NCT01691508|8737089|P2|Overall Study|Withdrawal by Subject|0
2525041|NCT01691508|8737090|P1|Overall Study|Withdrawal by Subject|1
2525042|NCT01691508|8737089|P2|Overall Study|Adverse Event|3
2525043|NCT01691508|8737090|P1|Overall Study|Adverse Event|3
2525044|NCT01691482|8737104|P2|Treatment Period 2|Protocol Violation|1
2525045|NCT01691482|8737105|P1|Treatment Period 2|Protocol Violation|1
2525046|NCT01691482|8737104|P2|Treatment Period 2|Adverse Event|1
2525047|NCT01691482|8737105|P1|Treatment Period 2|Adverse Event|0
2525048|NCT01691430|8737123|P2|Overall Study|Lost to Follow-up|3
2525049|NCT01691430|8737124|P1|Overall Study|Lost to Follow-up|0
2525050|NCT01691430|8737123|P2|Overall Study|Withdrawal by Subject|1
2525051|NCT01691430|8737124|P1|Overall Study|Withdrawal by Subject|5
2525052|NCT01691430|8737123|P2|Overall Study|Death|16
2525053|NCT01691430|8737124|P1|Overall Study|Death|17
2525054|NCT01691378|8737150|P2|Overall Study|Lost to Follow-up|2
2525055|NCT01691378|8737151|P1|Overall Study|Lost to Follow-up|5
2525056|NCT01691378|8737150|P2|Overall Study|Withdrawal by Subject|0
2525057|NCT01691378|8737151|P1|Overall Study|Withdrawal by Subject|2
2525058|NCT01691248|8737234|P2|Overall Study|Not Treated|7
2525059|NCT01691248|8737235|P1|Overall Study|Not Treated|4
2525060|NCT01691248|8737234|P2|Overall Study|Reason not provided|4
2525061|NCT01691248|8737235|P1|Overall Study|Reason not provided|4
2525062|NCT01691248|8737234|P2|Overall Study|Lost to Follow-up|5
2525063|NCT01691248|8737235|P1|Overall Study|Lost to Follow-up|2
2525064|NCT01691248|8737234|P2|Overall Study|Confirmed CDAD|31
2525065|NCT01691248|8737235|P1|Overall Study|Confirmed CDAD|14
2525066|NCT01691248|8737234|P2|Overall Study|Withdrawal by Subject|18
2525067|NCT01691248|8737235|P1|Overall Study|Withdrawal by Subject|20
2525068|NCT01691248|8737234|P2|Overall Study|Adverse Event|22
2525069|NCT01691248|8737235|P1|Overall Study|Adverse Event|24
2525070|NCT01691248|8737234|P2|Overall Study|Protocol Violation|27
2525071|NCT01691248|8737235|P1|Overall Study|Protocol Violation|43
2525072|NCT01691105|8737247|P2|12 Month Biochemical Verification|subject did not self-report abstinence|401
2525073|NCT01691105|8737248|P1|12 Month Biochemical Verification|subject did not self-report abstinence|352
2525074|NCT01691105|8737247|P2|12 Month Biochemical Verification|Lost to Follow-up|71
2525075|NCT01691105|8737248|P1|12 Month Biochemical Verification|Lost to Follow-up|50
2525076|NCT01691105|8737247|P2|12 Month Biochemical Verification|Death|30
2525077|NCT01691105|8737248|P1|12 Month Biochemical Verification|Death|22
2525078|NCT01691105|8737247|P2|12 Month Follow-up|Death|30
2525079|NCT01691105|8737248|P1|12 Month Follow-up|Death|22
2525080|NCT01691105|8737247|P2|12 Month Follow-up|Lost to Follow-up|71
2525081|NCT01691105|8737248|P1|12 Month Follow-up|Lost to Follow-up|50
2525082|NCT01691105|8737247|P2|6 Month Follow-up|Death|13
2525083|NCT01691105|8737248|P1|6 Month Follow-up|Death|13
2525084|NCT01691105|8737247|P2|6 Month Follow-up|Lost to Follow-up|58
2525085|NCT01691105|8737248|P1|6 Month Follow-up|Lost to Follow-up|39
2525086|NCT01691105|8737247|P2|1 Month Follow-up|Death|3
2525087|NCT01691105|8737248|P1|1 Month Follow-up|Death|2
2525088|NCT01691105|8737247|P2|1 Month Follow-up|Lost to Follow-up|38
2525089|NCT01691105|8737248|P1|1 Month Follow-up|Lost to Follow-up|41
2525090|NCT01691092|8737268|P1|Overall Study|screen fail|19
2525091|NCT01691092|8737268|P1|Overall Study|used for different study|2
2525092|NCT01691092|8737268|P1|Overall Study|non-compliance|3
2525093|NCT01691092|8737268|P1|Overall Study|Withdrawal by Subject|3
2525094|NCT01691092|8737268|P1|Overall Study|Physician Decision|4
2525095|NCT01691092|8737268|P1|Overall Study|Lost to Follow-up|10
2525096|NCT01691014|8737281|P4|Overall Study|Lack of Efficacy|0
2525097|NCT01691014|8737282|P3|Overall Study|Lack of Efficacy|7
2525098|NCT01691014|8737283|P2|Overall Study|Lack of Efficacy|3
2525099|NCT01691014|8737284|P1|Overall Study|Lack of Efficacy|2
2525100|NCT01691014|8737281|P4|Overall Study|Adverse Event|1
2525101|NCT01691014|8737282|P3|Overall Study|Adverse Event|1
2525102|NCT01691014|8737283|P2|Overall Study|Adverse Event|5
2525103|NCT01691014|8737284|P1|Overall Study|Adverse Event|0
2525104|NCT01691014|8737281|P4|Overall Study|Withdrawal by Subject|1
2525105|NCT01691014|8737282|P3|Overall Study|Withdrawal by Subject|1
2525106|NCT01691014|8737283|P2|Overall Study|Withdrawal by Subject|1
2525107|NCT01691014|8737284|P1|Overall Study|Withdrawal by Subject|0
2525108|NCT01691014|8737281|P4|Overall Study|Other|0
2525109|NCT01691014|8737282|P3|Overall Study|Other|2
2525110|NCT01691014|8737283|P2|Overall Study|Other|0
2525111|NCT01691014|8737284|P1|Overall Study|Other|0
2525112|NCT01691014|8737281|P4|Overall Study|Premature Termination|3
2525113|NCT01691014|8737282|P3|Overall Study|Premature Termination|0
2525114|NCT01691014|8737283|P2|Overall Study|Premature Termination|6
2525115|NCT01691014|8737284|P1|Overall Study|Premature Termination|1
2525116|NCT01690988|8737329|P3|Overall Study|Sedated|2
2525117|NCT01690988|8737330|P2|Overall Study|Sedated|1
2525118|NCT01690988|8737331|P1|Overall Study|Sedated|1
2525119|NCT01690988|8737329|P3|Overall Study|Death|1
2525120|NCT01690988|8737330|P2|Overall Study|Death|1
2525121|NCT01690988|8737331|P1|Overall Study|Death|1
2525122|NCT01690988|8737329|P3|Overall Study|Determined ineligible|0
2525123|NCT01690988|8737330|P2|Overall Study|Determined ineligible|0
2525124|NCT01690988|8737331|P1|Overall Study|Determined ineligible|1
2525125|NCT01690988|8737329|P3|Overall Study|Operation Cancelled|0
2525126|NCT01690988|8737330|P2|Overall Study|Operation Cancelled|1
2525127|NCT01690988|8737331|P1|Overall Study|Operation Cancelled|1
2525128|NCT01690988|8737329|P3|Overall Study|Physician Decision|1
2525129|NCT01690988|8737330|P2|Overall Study|Physician Decision|0
2525130|NCT01690988|8737331|P1|Overall Study|Physician Decision|0
2525131|NCT01690988|8737329|P3|Overall Study|Withdrawal by Subject|3
2525132|NCT01690988|8737330|P2|Overall Study|Withdrawal by Subject|2
2525133|NCT01690988|8737331|P1|Overall Study|Withdrawal by Subject|2
2525134|NCT01690299|8737399|P6|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1
2525135|NCT01690299|8737400|P5|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
2525136|NCT01690299|8737401|P4|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
2525137|NCT01690299|8737402|P3|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
2525138|NCT01690299|8737403|P2|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
2525139|NCT01690299|8737404|P1|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
2525140|NCT01690299|8737399|P6|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
2525141|NCT01690299|8737400|P5|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13
2525142|NCT01690299|8737401|P4|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
2525143|NCT01690299|8737402|P3|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
2525144|NCT01690299|8737403|P2|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
2525145|NCT01690299|8737404|P1|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
2525146|NCT01690299|8737399|P6|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11
2525147|NCT01690299|8737400|P5|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5
2525148|NCT01690299|8737401|P4|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8
2525149|NCT01690299|8737402|P3|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
2525150|NCT01690299|8737403|P2|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
2525151|NCT01690299|8737404|P1|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
2525152|NCT01690299|8737399|P6|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
2525153|NCT01690299|8737400|P5|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
2525154|NCT01690299|8737401|P4|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
2525155|NCT01690299|8737402|P3|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
2525156|NCT01690299|8737403|P2|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
2525157|NCT01690299|8737404|P1|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
2525158|NCT01690299|8737399|P6|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8
2525159|NCT01690299|8737400|P5|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10
2525160|NCT01690299|8737401|P4|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9
2525161|NCT01690299|8737402|P3|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
2525162|NCT01690299|8737403|P2|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
2525163|NCT01690299|8737404|P1|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
2525164|NCT01690299|8737399|P6|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
2525165|NCT01690299|8737400|P5|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4
2525166|NCT01690299|8737401|P4|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
2525167|NCT01690299|8737402|P3|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
2525168|NCT01690299|8737403|P2|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
2525169|NCT01690299|8737404|P1|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
2525170|NCT01690299|8737399|P6|Placebo-controlled Phase (Weeks 0-16)|Other|0
2525171|NCT01690299|8737400|P5|Placebo-controlled Phase (Weeks 0-16)|Other|0
2525172|NCT01690299|8737401|P4|Placebo-controlled Phase (Weeks 0-16)|Other|0
2525173|NCT01690299|8737402|P3|Placebo-controlled Phase (Weeks 0-16)|Other|1
2525174|NCT01690299|8737403|P2|Placebo-controlled Phase (Weeks 0-16)|Other|1
2525175|NCT01690299|8737404|P1|Placebo-controlled Phase (Weeks 0-16)|Other|2
2525176|NCT01690299|8737399|P6|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2525177|NCT01690299|8737400|P5|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2525178|NCT01690299|8737401|P4|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2525179|NCT01690299|8737402|P3|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2525180|NCT01690299|8737403|P2|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3
2525181|NCT01690299|8737404|P1|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1
2525182|NCT01690299|8737399|P6|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2525183|NCT01690299|8737400|P5|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2525184|NCT01690299|8737401|P4|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2525185|NCT01690299|8737402|P3|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2525186|NCT01690299|8737403|P2|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2525187|NCT01690299|8737404|P1|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4
2525188|NCT01690299|8737399|P6|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
2525189|NCT01690299|8737400|P5|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
2525190|NCT01690299|8737401|P4|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
2525191|NCT01690299|8737402|P3|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1
2525192|NCT01690299|8737403|P2|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
2525193|NCT01690299|8737404|P1|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
2525194|NCT01690143|8737501|P1|Overall Study|Withdrawal by Subject|1
2525195|NCT01690130|8737511|P2|Overall Study|Subject have cancelled visit.|0
2525196|NCT01690130|8737512|P1|Overall Study|Subject have cancelled visit.|1
2525197|NCT01690052|8737559|P2|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2
2525198|NCT01690052|8737560|P1|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1
2525199|NCT01689974|8737577|P2|Overall Study|Termination of Study|5
2525200|NCT01689974|8737578|P1|Overall Study|Termination of Study|5
2525201|NCT01689857|8737609|P2|Overall Study|Lost to Follow-up|2
2525202|NCT01689857|8737610|P1|Overall Study|Lost to Follow-up|5
2525203|NCT01689649|8737658|P1|Overall Study|Lost to Follow-up|5
2525204|NCT01689649|8737658|P1|Overall Study|Protocol Violation|3
2525205|NCT01689649|8737658|P1|Overall Study|Non-compliance|11
2525206|NCT01689649|8737658|P1|Overall Study|Lack of Efficacy|3
2525207|NCT01689532|8737670|P2|Overall Study|Physician Decision|0
2525208|NCT01689532|8737671|P1|Overall Study|Physician Decision|2
2525209|NCT01689532|8737670|P2|Overall Study|Withdrawal by Subject|2
2525210|NCT01689532|8737671|P1|Overall Study|Withdrawal by Subject|1
2525211|NCT01689532|8737670|P2|Overall Study|Lack of Efficacy|2
2525212|NCT01689532|8737671|P1|Overall Study|Lack of Efficacy|2
2525213|NCT01689532|8737670|P2|Overall Study|Adverse Event|5
2525214|NCT01689532|8737671|P1|Overall Study|Adverse Event|9
2525215|NCT01689519|8737735|P2|Overall Study|Physician Decision|3
2525216|NCT01689519|8737736|P1|Overall Study|Physician Decision|0
2525217|NCT01689519|8737735|P2|Overall Study|Withdrawal by Subject|17
2525218|NCT01689519|8737736|P1|Overall Study|Withdrawal by Subject|17
2525219|NCT01689519|8737735|P2|Overall Study|Lost to Follow-up|2
2525220|NCT01689519|8737736|P1|Overall Study|Lost to Follow-up|6
2525221|NCT01689519|8737735|P2|Overall Study|Death|116
2525222|NCT01689519|8737736|P1|Overall Study|Death|143
2525223|NCT01689363|8737763|P8|Overall Study|Protocol Violation|0
2525224|NCT01689363|8737764|P7|Overall Study|Protocol Violation|0
2525225|NCT01689363|8737765|P6|Overall Study|Protocol Violation|0
2525226|NCT01689363|8737766|P5|Overall Study|Protocol Violation|0
2525227|NCT01689363|8737767|P4|Overall Study|Protocol Violation|0
2525228|NCT01689363|8737768|P3|Overall Study|Protocol Violation|0
2525229|NCT01689363|8737769|P2|Overall Study|Protocol Violation|1
2525230|NCT01689363|8737770|P1|Overall Study|Protocol Violation|0
2525231|NCT01689337|8737825|P1|Overall Study|Study Discontinuation|1
2525232|NCT01689207|8737864|P11|Overall Study|Adverse Event|0
2525233|NCT01689207|8737865|P10|Overall Study|Adverse Event|0
2525234|NCT01689207|8737866|P9|Overall Study|Adverse Event|1
2525235|NCT01689207|8737867|P8|Overall Study|Adverse Event|0
2525236|NCT01689207|8737868|P7|Overall Study|Adverse Event|0
2525237|NCT01689207|8737869|P6|Overall Study|Adverse Event|1
2525238|NCT01689207|8737870|P5|Overall Study|Adverse Event|2
2525239|NCT01689207|8737871|P4|Overall Study|Adverse Event|0
2525240|NCT01689207|8737872|P3|Overall Study|Adverse Event|0
2525241|NCT01689207|8737873|P2|Overall Study|Adverse Event|1
2525242|NCT01689207|8737874|P1|Overall Study|Adverse Event|0
2525243|NCT01688973|8737981|P2|Overall Study|Ineligible|3
2525244|NCT01688973|8737982|P1|Overall Study|Ineligible|2
2525245|NCT01688921|8737996|P2|Overall Study|informed consent|0
2525246|NCT01688921|8737997|P1|Overall Study|informed consent|3
2525247|NCT01688921|8737996|P2|Overall Study|Protocol Violation|1
2525248|NCT01688921|8737997|P1|Overall Study|Protocol Violation|0
2525249|NCT01688921|8737996|P2|Overall Study|Physician Decision|1
2525250|NCT01688921|8737997|P1|Overall Study|Physician Decision|6
2525251|NCT01688921|8737996|P2|Overall Study|Lost to Follow-up|13
2525252|NCT01688921|8737997|P1|Overall Study|Lost to Follow-up|7
2525253|NCT01688882|8738029|P2|Overall Study|Administrative problems|0
2525254|NCT01688882|8738030|P1|Overall Study|Administrative problems|1
2525255|NCT01688882|8738029|P2|Overall Study|Unsatisfactory therapeutic effect|1
2525256|NCT01688882|8738030|P1|Overall Study|Unsatisfactory therapeutic effect|1
2525257|NCT01688882|8738029|P2|Overall Study|Adverse Event|0
2525258|NCT01688882|8738030|P1|Overall Study|Adverse Event|1
2525259|NCT01688830|8738101|P21|Overall Study|Lost to Follow-up|0
2525260|NCT01688830|8738102|P20|Overall Study|Lost to Follow-up|0
2525261|NCT01688830|8738103|P19|Overall Study|Lost to Follow-up|0
2525262|NCT01688830|8738104|P18|Overall Study|Lost to Follow-up|0
2525263|NCT01688830|8738105|P17|Overall Study|Lost to Follow-up|0
2525264|NCT01688830|8738106|P16|Overall Study|Lost to Follow-up|0
2525265|NCT01688830|8738107|P15|Overall Study|Lost to Follow-up|0
2525266|NCT01688830|8738108|P14|Overall Study|Lost to Follow-up|0
2525267|NCT01688830|8738109|P13|Overall Study|Lost to Follow-up|0
2525268|NCT01688830|8738110|P12|Overall Study|Lost to Follow-up|0
2525269|NCT01688830|8738111|P11|Overall Study|Lost to Follow-up|1
2525270|NCT01688830|8738112|P10|Overall Study|Lost to Follow-up|0
2525271|NCT01688830|8738113|P9|Overall Study|Lost to Follow-up|0
2525272|NCT01688830|8738114|P8|Overall Study|Lost to Follow-up|0
2525273|NCT01688830|8738115|P7|Overall Study|Lost to Follow-up|0
2525274|NCT01688830|8738116|P6|Overall Study|Lost to Follow-up|0
2525275|NCT01688830|8738117|P5|Overall Study|Lost to Follow-up|0
2525276|NCT01688830|8738118|P4|Overall Study|Lost to Follow-up|0
2525277|NCT01688830|8738119|P3|Overall Study|Lost to Follow-up|0
2525278|NCT01688830|8738120|P2|Overall Study|Lost to Follow-up|0
2525279|NCT01688830|8738121|P1|Overall Study|Lost to Follow-up|0
2525280|NCT01688739|8738275|P10|Overall Study|Administrative Decision|0
2525281|NCT01688739|8738276|P9|Overall Study|Administrative Decision|0
2525282|NCT01688739|8738277|P8|Overall Study|Administrative Decision|0
2525283|NCT01688739|8738278|P7|Overall Study|Administrative Decision|0
2525284|NCT01688739|8738279|P6|Overall Study|Administrative Decision|0
2525285|NCT01688739|8738280|P5|Overall Study|Administrative Decision|0
2525286|NCT01688739|8738281|P4|Overall Study|Administrative Decision|0
2525287|NCT01688739|8738282|P3|Overall Study|Administrative Decision|0
2525288|NCT01688739|8738283|P2|Overall Study|Administrative Decision|0
2525289|NCT01688739|8738284|P1|Overall Study|Administrative Decision|1
2525290|NCT01688726|8738360|P2|Overall Study|Relocated abroad|1
2525291|NCT01688726|8738361|P1|Overall Study|Relocated abroad|0
2525292|NCT01688726|8738360|P2|Overall Study|Adverse Event|0
2525293|NCT01688726|8738361|P1|Overall Study|Adverse Event|1
2525294|NCT01688635|8738373|P2|Washout 3|Withdrawal by Subject|0
2525295|NCT01688635|8738374|P1|Washout 3|Withdrawal by Subject|1
2525296|NCT01688635|8738373|P2|Washout 2|Sponsor Decision|2
2525297|NCT01688635|8738374|P1|Washout 2|Sponsor Decision|1
2525298|NCT01688635|8738373|P2|Washout 2|Withdrawal by Subject|0
2525299|NCT01688635|8738374|P1|Washout 2|Withdrawal by Subject|1
2525300|NCT01688635|8738373|P2|Washout 2|Physician Decision|0
2525301|NCT01688635|8738374|P1|Washout 2|Physician Decision|1
2525302|NCT01688635|8738373|P2|Washout 1|Physician Decision|1
2525303|NCT01688635|8738374|P1|Washout 1|Physician Decision|0
2525304|NCT01688635|8738373|P2|Washout 1|Adverse Event|1
2525305|NCT01688635|8738374|P1|Washout 1|Adverse Event|0
2525306|NCT01688635|8738373|P2|Washout 1|Withdrawal by Subject|0
2525307|NCT01688635|8738374|P1|Washout 1|Withdrawal by Subject|1
2525308|NCT01688466|8738421|P2|Overall Study|Not evaluable|1
2525309|NCT01688466|8738422|P1|Overall Study|Not evaluable|0
2525310|NCT01688466|8738421|P2|Overall Study|Adverse Event|4
2525311|NCT01688466|8738422|P1|Overall Study|Adverse Event|0
2525312|NCT01688466|8738421|P2|Overall Study|Death|1
2525313|NCT01688466|8738422|P1|Overall Study|Death|0
2525314|NCT01688466|8738421|P2|Overall Study|Withdrawal by Subject|1
2525315|NCT01688466|8738422|P1|Overall Study|Withdrawal by Subject|2
2525316|NCT01688050|8738513|P1|Overall Study|Still be eligible for follow-up|37
2525317|NCT01688050|8738513|P1|Overall Study|Withdrawal by Subject|2
2525318|NCT01688050|8738513|P1|Overall Study|Lost to Follow-up|5
2525319|NCT01688050|8738513|P1|Overall Study|Conversion to open repair|1
2525320|NCT01688050|8738513|P1|Overall Study|Death|5
2525321|NCT01688037|8738522|P3|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
2525322|NCT01688037|8738523|P2|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1
2525323|NCT01688037|8738524|P1|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
2525324|NCT01688037|8738522|P3|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1
2525325|NCT01688037|8738523|P2|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
2525326|NCT01688037|8738524|P1|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
2525327|NCT01688037|8738522|P3|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0
2525328|NCT01688037|8738523|P2|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2
2525329|NCT01688037|8738524|P1|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1
2525330|NCT01688037|8738522|P3|Open-Label Period (Week 6 to 12)|Non-compliance|2
2525331|NCT01688037|8738523|P2|Open-Label Period (Week 6 to 12)|Non-compliance|0
2525332|NCT01688037|8738524|P1|Open-Label Period (Week 6 to 12)|Non-compliance|0
2525333|NCT01688037|8738522|P3|Open-Label Period (Week 6 to 12)|Adverse Event|1
2525334|NCT01688037|8738523|P2|Open-Label Period (Week 6 to 12)|Adverse Event|1
2525335|NCT01688037|8738524|P1|Open-Label Period (Week 6 to 12)|Adverse Event|4
2525336|NCT01688037|8738522|P3|Double-Blind Period (Week 0 to 6)|Physician Decision|0
2525337|NCT01688037|8738523|P2|Double-Blind Period (Week 0 to 6)|Physician Decision|1
2525338|NCT01688037|8738524|P1|Double-Blind Period (Week 0 to 6)|Physician Decision|0
2525339|NCT01688037|8738522|P3|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
2525340|NCT01688037|8738523|P2|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
2525341|NCT01688037|8738524|P1|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
2525342|NCT01688037|8738522|P3|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
2525343|NCT01688037|8738523|P2|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0
2525344|NCT01688037|8738524|P1|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4
2525345|NCT01688037|8738522|P3|Double-Blind Period (Week 0 to 6)|Non-compliance|3
2525346|NCT01688037|8738523|P2|Double-Blind Period (Week 0 to 6)|Non-compliance|2
2525347|NCT01688037|8738524|P1|Double-Blind Period (Week 0 to 6)|Non-compliance|1
2525348|NCT01688037|8738522|P3|Double-Blind Period (Week 0 to 6)|Adverse Event|1
2525349|NCT01688037|8738523|P2|Double-Blind Period (Week 0 to 6)|Adverse Event|0
2525350|NCT01688037|8738524|P1|Double-Blind Period (Week 0 to 6)|Adverse Event|1
2525351|NCT01687998|8738540|P2|Overall Study|Lost to Follow-up|7
2525352|NCT01687998|8738541|P1|Overall Study|Lost to Follow-up|9
2525353|NCT01687998|8738540|P2|Overall Study|Known to be Alive at Study End|62
2525354|NCT01687998|8738541|P1|Overall Study|Known to be Alive at Study End|54
2525355|NCT01687998|8738540|P2|Overall Study|Withdrawal by Subject|51
2525356|NCT01687998|8738541|P1|Overall Study|Withdrawal by Subject|49
2525357|NCT01687712|8738577|P2|Cycle 3|Miscarriage/Spontaneous Abortion|0
2525358|NCT01687712|8738578|P1|Cycle 3|Miscarriage/Spontaneous Abortion|1
2525359|NCT01687712|8738577|P2|Cycle 3|Ectopic Pregnancy|0
2525360|NCT01687712|8738578|P1|Cycle 3|Ectopic Pregnancy|1
2525361|NCT01687712|8738577|P2|Cycle 3|Early Pregnancy Loss|2
2525362|NCT01687712|8738578|P1|Cycle 3|Early Pregnancy Loss|1
2525363|NCT01687712|8738577|P2|Cycle 3|Not Biochemically Pregnant|22
2525364|NCT01687712|8738578|P1|Cycle 3|Not Biochemically Pregnant|21
2525365|NCT01687712|8738577|P2|Cycle 2|Miscarriage/Spontaneous Abortion|1
2525366|NCT01687712|8738578|P1|Cycle 2|Miscarriage/Spontaneous Abortion|0
2525367|NCT01687712|8738577|P2|Cycle 2|Still Birth|0
2525368|NCT01687712|8738578|P1|Cycle 2|Still Birth|1
2525369|NCT01687712|8738577|P2|Cycle 2|Ectopic Pregnancy|1
2525370|NCT01687712|8738578|P1|Cycle 2|Ectopic Pregnancy|0
2525371|NCT01687712|8738577|P2|Cycle 2|Early Pregnancy Loss|16
2525372|NCT01687712|8738578|P1|Cycle 2|Early Pregnancy Loss|18
2525373|NCT01687712|8738577|P2|Cycle 2|Not Biochemically Pregnant|77
2525374|NCT01687712|8738578|P1|Cycle 2|Not Biochemically Pregnant|74
2525375|NCT01687712|8738577|P2|Cycle 1|Lost to Follow-up|1
2525376|NCT01687712|8738578|P1|Cycle 1|Lost to Follow-up|1
2525377|NCT01687712|8738577|P2|Cycle 1|Intrauterine Fetal Death|1
2525378|NCT01687712|8738578|P1|Cycle 1|Intrauterine Fetal Death|0
2525379|NCT01687712|8738577|P2|Cycle 1|Abortion|0
2525380|NCT01687712|8738578|P1|Cycle 1|Abortion|3
2525381|NCT01687712|8738577|P2|Cycle 1|Miscarriage/Spontaneous Abortion|14
2525382|NCT01687712|8738578|P1|Cycle 1|Miscarriage/Spontaneous Abortion|9
2525383|NCT01687712|8738577|P2|Cycle 1|Heterotropic Pregnancy|0
2525384|NCT01687712|8738578|P1|Cycle 1|Heterotropic Pregnancy|1
2525385|NCT01687712|8738577|P2|Cycle 1|Ectopic Pregnancy|5
2525386|NCT01687712|8738578|P1|Cycle 1|Ectopic Pregnancy|5
2525387|NCT01687712|8738577|P2|Cycle 1|Early Pregnancy Loss|60
2525388|NCT01687712|8738578|P1|Cycle 1|Early Pregnancy Loss|43
2525389|NCT01687712|8738577|P2|Cycle 1|Not Biochemically Pregnant|348
2525390|NCT01687712|8738578|P1|Cycle 1|Not Biochemically Pregnant|386
2525391|NCT01687478|8738618|P2|Overall Study|Entry Criteria Not Met|2
2525392|NCT01687478|8738619|P1|Overall Study|Entry Criteria Not Met|6
2525393|NCT01687478|8738618|P2|Overall Study|Physician Decision|3
2525394|NCT01687478|8738619|P1|Overall Study|Physician Decision|1
2525395|NCT01687478|8738618|P2|Overall Study|Withdrawal by Subject|19
2525396|NCT01687478|8738619|P1|Overall Study|Withdrawal by Subject|21
2525397|NCT01687478|8738618|P2|Overall Study|Protocol Violation|2
2525398|NCT01687478|8738619|P1|Overall Study|Protocol Violation|0
2525399|NCT01687478|8738618|P2|Overall Study|Lost to Follow-up|3
2525400|NCT01687478|8738619|P1|Overall Study|Lost to Follow-up|1
2525401|NCT01687478|8738618|P2|Overall Study|Adverse Event|10
2525402|NCT01687478|8738619|P1|Overall Study|Adverse Event|3
2525403|NCT01687296|8738670|P2|Overall Study|Withdrawal by Subject|3
2525404|NCT01687296|8738671|P1|Overall Study|Withdrawal by Subject|6
2525405|NCT01687296|8738670|P2|Overall Study|Protocol Violation|1
2525406|NCT01687296|8738671|P1|Overall Study|Protocol Violation|0
2525407|NCT01687296|8738670|P2|Overall Study|Lack of Efficacy|1
2525408|NCT01687296|8738671|P1|Overall Study|Lack of Efficacy|1
2525409|NCT01687283|8738693|P2|Overall Study|Withdrawal by Subject|8
2525410|NCT01687283|8738694|P1|Overall Study|Withdrawal by Subject|9
2525411|NCT01687283|8738693|P2|Overall Study|Investigator discretion|0
2525412|NCT01687283|8738694|P1|Overall Study|Investigator discretion|2
2525413|NCT01687283|8738693|P2|Overall Study|Lost to Follow-up|1
2525414|NCT01687283|8738694|P1|Overall Study|Lost to Follow-up|1
2525415|NCT01687283|8738693|P2|Overall Study|protocol defined stopping criteria|10
2525416|NCT01687283|8738694|P1|Overall Study|protocol defined stopping criteria|8
2525417|NCT01687283|8738693|P2|Overall Study|Protocol Violation|3
2525418|NCT01687283|8738694|P1|Overall Study|Protocol Violation|1
2525419|NCT01687283|8738693|P2|Overall Study|Lack of Efficacy|1
2525420|NCT01687283|8738694|P1|Overall Study|Lack of Efficacy|3
2525421|NCT01687283|8738693|P2|Overall Study|Adverse Event|4
2525422|NCT01687283|8738694|P1|Overall Study|Adverse Event|11
2525423|NCT01687270|8738717|P1|Overall Study|Lost to Follow-up|1
2525424|NCT01687270|8738717|P1|Overall Study|Lack of Efficacy|11
2525425|NCT01687257|8738728|P3|Overall Study|Investigator's Discretion|0
2525426|NCT01687257|8738729|P2|Overall Study|Investigator's Discretion|3
2525427|NCT01687257|8738730|P1|Overall Study|Investigator's Discretion|0
2525428|NCT01687257|8738728|P3|Overall Study|Adverse Event|0
2525429|NCT01687257|8738729|P2|Overall Study|Adverse Event|0
2525430|NCT01687257|8738730|P1|Overall Study|Adverse Event|1
2525431|NCT01687257|8738728|P3|Overall Study|Subject Withdrew Consent|1
2525432|NCT01687257|8738729|P2|Overall Study|Subject Withdrew Consent|1
2525433|NCT01687257|8738730|P1|Overall Study|Subject Withdrew Consent|1
2525434|NCT01687257|8738728|P3|Overall Study|Efficacy Failure|5
2525435|NCT01687257|8738729|P2|Overall Study|Efficacy Failure|0
2525436|NCT01687257|8738730|P1|Overall Study|Efficacy Failure|6
2525437|NCT01687218|8738795|P6|Overall Study|Relocated, no follow-up planned|0
2525438|NCT01687218|8738796|P5|Overall Study|Relocated, no follow-up planned|0
2525439|NCT01687218|8738797|P4|Overall Study|Relocated, no follow-up planned|1
2525440|NCT01687218|8738798|P3|Overall Study|Relocated, no follow-up planned|1
2525441|NCT01687218|8738799|P2|Overall Study|Relocated, no follow-up planned|0
2525442|NCT01687218|8738800|P1|Overall Study|Relocated, no follow-up planned|1
2525443|NCT01687218|8738795|P6|Overall Study|Withdrawal by Subject|0
2525444|NCT01687218|8738796|P5|Overall Study|Withdrawal by Subject|1
2525445|NCT01687218|8738797|P4|Overall Study|Withdrawal by Subject|1
2525446|NCT01687218|8738798|P3|Overall Study|Withdrawal by Subject|0
2525447|NCT01687218|8738799|P2|Overall Study|Withdrawal by Subject|3
2525448|NCT01687218|8738800|P1|Overall Study|Withdrawal by Subject|2
2525449|NCT01687166|8738852|P4|Overall Study|Insurance|1
2525450|NCT01687166|8738853|P3|Overall Study|Insurance|1
2525451|NCT01687166|8738854|P2|Overall Study|Insurance|0
2525452|NCT01687166|8738855|P1|Overall Study|Insurance|0
2525453|NCT01687166|8738852|P4|Overall Study|Physician choice to use different device|0
2525454|NCT01687166|8738853|P3|Overall Study|Physician choice to use different device|4
2525455|NCT01687166|8738854|P2|Overall Study|Physician choice to use different device|2
2525456|NCT01687166|8738855|P1|Overall Study|Physician choice to use different device|1
2525457|NCT01687166|8738852|P4|Overall Study|Patient unable to be compliant|0
2525458|NCT01687166|8738853|P3|Overall Study|Patient unable to be compliant|0
2525459|NCT01687166|8738854|P2|Overall Study|Patient unable to be compliant|0
2525460|NCT01687166|8738855|P1|Overall Study|Patient unable to be compliant|1
2525461|NCT01687166|8738852|P4|Overall Study|Subject moved out of state|0
2525462|NCT01687166|8738853|P3|Overall Study|Subject moved out of state|0
2525463|NCT01687166|8738854|P2|Overall Study|Subject moved out of state|1
2525464|NCT01687166|8738855|P1|Overall Study|Subject moved out of state|0
2525465|NCT01687166|8738852|P4|Overall Study|Protocol Violation|0
2525466|NCT01687166|8738853|P3|Overall Study|Protocol Violation|1
2525467|NCT01687166|8738854|P2|Overall Study|Protocol Violation|1
2525468|NCT01687166|8738855|P1|Overall Study|Protocol Violation|1
2525469|NCT01687166|8738852|P4|Overall Study|Death|0
2525470|NCT01687166|8738853|P3|Overall Study|Death|0
2525471|NCT01687166|8738854|P2|Overall Study|Death|1
2525472|NCT01687166|8738855|P1|Overall Study|Death|1
2525473|NCT01687166|8738852|P4|Overall Study|Equipment/Device Availability|0
2525474|NCT01687166|8738853|P3|Overall Study|Equipment/Device Availability|0
2525475|NCT01687166|8738854|P2|Overall Study|Equipment/Device Availability|1
2525476|NCT01687166|8738855|P1|Overall Study|Equipment/Device Availability|0
2525477|NCT01687166|8738852|P4|Overall Study|Lost to Follow-up|0
2525478|NCT01687166|8738853|P3|Overall Study|Lost to Follow-up|1
2525479|NCT01687166|8738854|P2|Overall Study|Lost to Follow-up|5
2525480|NCT01687166|8738855|P1|Overall Study|Lost to Follow-up|2
2525481|NCT01687166|8738852|P4|Overall Study|Withdrawal by Subject|0
2525482|NCT01687166|8738853|P3|Overall Study|Withdrawal by Subject|3
2525483|NCT01687166|8738854|P2|Overall Study|Withdrawal by Subject|4
2525484|NCT01687166|8738855|P1|Overall Study|Withdrawal by Subject|11
2525485|NCT01687166|8738852|P4|Overall Study|Physician Decision|0
2525486|NCT01687166|8738853|P3|Overall Study|Physician Decision|1
2525487|NCT01687166|8738854|P2|Overall Study|Physician Decision|2
2525488|NCT01687166|8738855|P1|Overall Study|Physician Decision|3
2525489|NCT01687166|8738852|P4|Overall Study|Adverse Event|0
2525490|NCT01687166|8738853|P3|Overall Study|Adverse Event|0
2525491|NCT01687166|8738854|P2|Overall Study|Adverse Event|1
2525492|NCT01687166|8738855|P1|Overall Study|Adverse Event|2
2525493|NCT01687166|8738852|P4|Overall Study|Did not meet eligibility criteria|1
2525494|NCT01687166|8738853|P3|Overall Study|Did not meet eligibility criteria|1
2525495|NCT01687166|8738854|P2|Overall Study|Did not meet eligibility criteria|6
2525496|NCT01687166|8738855|P1|Overall Study|Did not meet eligibility criteria|4
2525497|NCT01687166|8738852|P4|Overall Study|Attempt subject|0
2525498|NCT01687166|8738853|P3|Overall Study|Attempt subject|2
2525499|NCT01687166|8738854|P2|Overall Study|Attempt subject|3
2525500|NCT01687166|8738855|P1|Overall Study|Attempt subject|2
2525501|NCT01687101|8738871|P1|Overall Study|Lost to Follow-up|7
2525502|NCT01686958|8738896|P1|Overall Study|Withdrawal by Subject|1
2525503|NCT01686932|8738909|P2|Period 1|Adverse Event|1
2525504|NCT01686932|8738910|P1|Period 1|Adverse Event|1
2525505|NCT01686828|8738940|P4|Overall Study|Weight Loss|0
2525506|NCT01686828|8738941|P3|Overall Study|Weight Loss|1
2525507|NCT01686828|8738942|P2|Overall Study|Weight Loss|0
2525508|NCT01686828|8738943|P1|Overall Study|Weight Loss|0
2525509|NCT01686828|8738940|P4|Overall Study|New Job|0
2525510|NCT01686828|8738941|P3|Overall Study|New Job|0
2525511|NCT01686828|8738942|P2|Overall Study|New Job|1
2525512|NCT01686828|8738943|P1|Overall Study|New Job|0
2525513|NCT01686828|8738940|P4|Overall Study|Physician Decision|0
2525514|NCT01686828|8738941|P3|Overall Study|Physician Decision|0
2525515|NCT01686828|8738942|P2|Overall Study|Physician Decision|0
2525516|NCT01686828|8738943|P1|Overall Study|Physician Decision|1
2525517|NCT01686633|8739056|P3|Overall Study|Lost to Follow-up|1
2525518|NCT01686633|8739057|P2|Overall Study|Lost to Follow-up|1
2525519|NCT01686633|8739058|P1|Overall Study|Lost to Follow-up|0
2525520|NCT01686633|8739056|P3|Overall Study|Protocol-defined Stopping Criteria|1
2525521|NCT01686633|8739057|P2|Overall Study|Protocol-defined Stopping Criteria|0
2525522|NCT01686633|8739058|P1|Overall Study|Protocol-defined Stopping Criteria|1
2525523|NCT01686633|8739056|P3|Overall Study|Protocol Violation|0
2525524|NCT01686633|8739057|P2|Overall Study|Protocol Violation|3
2525525|NCT01686633|8739058|P1|Overall Study|Protocol Violation|2
2525526|NCT01686633|8739056|P3|Overall Study|Adverse Event|3
2525527|NCT01686633|8739057|P2|Overall Study|Adverse Event|3
2525528|NCT01686633|8739058|P1|Overall Study|Adverse Event|4
2525529|NCT01686633|8739056|P3|Overall Study|Physician Decision|4
2525530|NCT01686633|8739057|P2|Overall Study|Physician Decision|4
2525531|NCT01686633|8739058|P1|Overall Study|Physician Decision|3
2525532|NCT01686633|8739056|P3|Overall Study|Withdrawal by Subject|5
2525533|NCT01686633|8739057|P2|Overall Study|Withdrawal by Subject|8
2525534|NCT01686633|8739058|P1|Overall Study|Withdrawal by Subject|8
2525535|NCT01686633|8739056|P3|Overall Study|Lack of Efficacy|11
2525536|NCT01686633|8739057|P2|Overall Study|Lack of Efficacy|13
2525537|NCT01686633|8739058|P1|Overall Study|Lack of Efficacy|33
2525538|NCT01686581|8739081|P1|Overall Study|Reason Missing|1
2525539|NCT01686581|8739081|P1|Overall Study|Other Miscellaneous Reasons|36
2525540|NCT01686581|8739081|P1|Overall Study|Thinks it is Inconvenient|17
2525541|NCT01686581|8739081|P1|Overall Study|Trying to get Pregnant or Nursing|2
2525542|NCT01686581|8739081|P1|Overall Study|Thinks Injections Take Too Much Time|2
2525543|NCT01686581|8739081|P1|Overall Study|Thinks Injections Too Painful|8
2525544|NCT01686581|8739081|P1|Overall Study|Participant Concerned about Risks|6
2525545|NCT01686581|8739081|P1|Overall Study|Lack of Efficacy|90
2525546|NCT01686581|8739081|P1|Overall Study|Side-effects or Health Problems|15
2525547|NCT01686568|8739094|P2|Sub-Study|Not consented for sub-study|2
2525548|NCT01686568|8739095|P1|Sub-Study|Not consented for sub-study|2
2525549|NCT01686568|8739094|P2|Main Study|Liver enzymes above range of exclusion|0
2525550|NCT01686568|8739095|P1|Main Study|Liver enzymes above range of exclusion|1
2525551|NCT01686568|8739094|P2|Main Study|Noncompliance with protocol|1
2525552|NCT01686568|8739095|P1|Main Study|Noncompliance with protocol|0
2525553|NCT01686568|8739094|P2|Main Study|Withdrawal by Subject|3
2525554|NCT01686568|8739095|P1|Main Study|Withdrawal by Subject|1
2525555|NCT01686438|8739172|P3|Overall Study|Withdrawal by Subject|1
2525556|NCT01686438|8739173|P2|Overall Study|Withdrawal by Subject|0
2525557|NCT01686438|8739174|P1|Overall Study|Withdrawal by Subject|0
2525558|NCT01686438|8739172|P3|Overall Study|Protocol Violation|1
2525559|NCT01686438|8739173|P2|Overall Study|Protocol Violation|0
2525560|NCT01686438|8739174|P1|Overall Study|Protocol Violation|0
2525561|NCT01686438|8739172|P3|Overall Study|Adverse Event|1
2525562|NCT01686438|8739173|P2|Overall Study|Adverse Event|0
2525563|NCT01686438|8739174|P1|Overall Study|Adverse Event|0
2525564|NCT01686438|8739172|P3|Overall Study|Lost to Follow-up|10
2525565|NCT01686438|8739173|P2|Overall Study|Lost to Follow-up|9
2525566|NCT01686438|8739174|P1|Overall Study|Lost to Follow-up|8
2525567|NCT01686373|8739222|P2|Overall Study|Adverse Event|1
2525568|NCT01686373|8739223|P1|Overall Study|Adverse Event|0
2525569|NCT01686373|8739222|P2|Overall Study|Withdrawal by Subject|1
2525570|NCT01686373|8739223|P1|Overall Study|Withdrawal by Subject|0
2525571|NCT01686373|8739222|P2|Overall Study|Lost to Follow-up|0
2525572|NCT01686373|8739223|P1|Overall Study|Lost to Follow-up|3
2525573|NCT01685983|8739247|P1|Overall Study|Noncompliance with Study Drug|1
2525574|NCT01685983|8739247|P1|Overall Study|Progressive Disease|32
2525575|NCT01685983|8739247|P1|Overall Study|Other|7
2525576|NCT01685983|8739247|P1|Overall Study|Physician Decision|13
2525577|NCT01685983|8739247|P1|Overall Study|Protocol Violation|2
2525578|NCT01685983|8739247|P1|Overall Study|Withdrawal by Subject|19
2525579|NCT01685983|8739247|P1|Overall Study|Death|1
2525580|NCT01685983|8739247|P1|Overall Study|Adverse Event|7
2525581|NCT01685840|8739259|P2|Overall Study|Had VAD, Dialysis or Transplant|17
2525582|NCT01685840|8739260|P1|Overall Study|Had VAD, Dialysis or Transplant|11
2525583|NCT01685840|8739259|P2|Overall Study|Futility|200
2525584|NCT01685840|8739260|P1|Overall Study|Futility|197
2525585|NCT01685840|8739259|P2|Overall Study|Withdrawal by Subject|17
2525586|NCT01685840|8739260|P1|Overall Study|Withdrawal by Subject|14
2525587|NCT01685840|8739259|P2|Overall Study|Physician Decision|7
2525588|NCT01685840|8739260|P1|Overall Study|Physician Decision|3
2525589|NCT01685840|8739259|P2|Overall Study|Lost to Follow-up|25
2525590|NCT01685840|8739260|P1|Overall Study|Lost to Follow-up|27
2525591|NCT01685840|8739259|P2|Overall Study|Death|66
2525592|NCT01685840|8739260|P1|Overall Study|Death|77
2525593|NCT01685801|8739304|P4|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
2525594|NCT01685801|8739305|P3|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
2525595|NCT01685801|8739306|P2|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
2525596|NCT01685801|8739307|P1|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
2525597|NCT01685801|8739304|P4|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1
2525598|NCT01685801|8739305|P3|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
2525599|NCT01685801|8739306|P2|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
2525600|NCT01685801|8739307|P1|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
2525601|NCT01685697|8739329|P2|Overall Study|Protocol Violation|3
2525602|NCT01685697|8739330|P1|Overall Study|Protocol Violation|3
2525603|NCT01685606|8739364|P1|Overall Study|Withdrawal by Subject|1
2525604|NCT01685437|8739392|P1|Overall Study|Unable to make visits due to work|1
2525605|NCT01685437|8739392|P1|Overall Study|Protocol Violation|4
2525606|NCT01685437|8739392|P1|Overall Study|Adverse Event|1
2525607|NCT01685437|8739392|P1|Overall Study|Lost to Follow-up|3
2525608|NCT01685437|8739392|P1|Overall Study|Withdrawal by Subject|22
2525609|NCT01685372|8739406|P2|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4
2525610|NCT01685372|8739407|P1|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3
2525611|NCT01685229|8739497|P2|Overall Study|Death|0
2525612|NCT01685229|8739498|P1|Overall Study|Death|1
2525613|NCT01685229|8739497|P2|Overall Study|Withdrawal by Subject|5
2525614|NCT01685229|8739498|P1|Overall Study|Withdrawal by Subject|6
2525615|NCT01685229|8739497|P2|Overall Study|Lost to Follow-up|10
2525616|NCT01685229|8739498|P1|Overall Study|Lost to Follow-up|16
2525617|NCT01685229|8739497|P2|Overall Study|Subjects missing Study Exit form|1
2525618|NCT01685229|8739498|P1|Overall Study|Subjects missing Study Exit form|3
2525619|NCT01685216|8739524|P1|Overall Study|Did not receive study drug|1
2525620|NCT01685203|8739541|P7|Overall Study|Patient's decision|0
2525621|NCT01685203|8739542|P6|Overall Study|Patient's decision|1
2525622|NCT01685203|8739543|P5|Overall Study|Patient's decision|0
2525623|NCT01685203|8739544|P4|Overall Study|Patient's decision|0
2525624|NCT01685203|8739545|P3|Overall Study|Patient's decision|0
2525625|NCT01685203|8739546|P2|Overall Study|Patient's decision|0
2525626|NCT01685203|8739547|P1|Overall Study|Patient's decision|0
2525627|NCT01685203|8739541|P7|Overall Study|Adverse event and withdrew consent|0
2525628|NCT01685203|8739542|P6|Overall Study|Adverse event and withdrew consent|0
2525629|NCT01685203|8739543|P5|Overall Study|Adverse event and withdrew consent|0
2525630|NCT01685203|8739544|P4|Overall Study|Adverse event and withdrew consent|0
2525631|NCT01685203|8739545|P3|Overall Study|Adverse event and withdrew consent|0
2525632|NCT01685203|8739546|P2|Overall Study|Adverse event and withdrew consent|0
2525633|NCT01685203|8739547|P1|Overall Study|Adverse event and withdrew consent|1
2525634|NCT01685203|8739541|P7|Overall Study|Adverse Event|0
2525635|NCT01685203|8739542|P6|Overall Study|Adverse Event|2
2525636|NCT01685203|8739543|P5|Overall Study|Adverse Event|0
2525637|NCT01685203|8739544|P4|Overall Study|Adverse Event|0
2525638|NCT01685203|8739545|P3|Overall Study|Adverse Event|0
2525639|NCT01685203|8739546|P2|Overall Study|Adverse Event|0
2525640|NCT01685203|8739547|P1|Overall Study|Adverse Event|0
2525641|NCT01685203|8739541|P7|Overall Study|Lost to Follow-up|0
2525642|NCT01685203|8739542|P6|Overall Study|Lost to Follow-up|0
2525643|NCT01685203|8739543|P5|Overall Study|Lost to Follow-up|0
2525644|NCT01685203|8739544|P4|Overall Study|Lost to Follow-up|1
2525645|NCT01685203|8739545|P3|Overall Study|Lost to Follow-up|0
2525646|NCT01685203|8739546|P2|Overall Study|Lost to Follow-up|3
2525647|NCT01685203|8739547|P1|Overall Study|Lost to Follow-up|3
2525648|NCT01685138|8739591|P1|Overall Study|Progressive disease|53
2525649|NCT01685138|8739591|P1|Overall Study|Adverse Event|18
2525650|NCT01685138|8739591|P1|Overall Study|Death|10
2525651|NCT01685138|8739591|P1|Overall Study|Physician Decision|6
2525652|NCT01685138|8739591|P1|Overall Study|Subject/guardian decision|2
2525653|NCT01685138|8739591|P1|Overall Study|No longer requires treatment|1
2525654|NCT01685138|8739591|P1|Overall Study|Protocol Violation|1
2525655|NCT01685138|8739591|P1|Overall Study|Lost to Follow-up|1
2525656|NCT01685073|8739607|P2|Overall Study|Withdrawal by Subject|24
2525657|NCT01685073|8739608|P1|Overall Study|Withdrawal by Subject|24
2525658|NCT01685073|8739607|P2|Overall Study|Lost to Follow-up|8
2525659|NCT01685073|8739608|P1|Overall Study|Lost to Follow-up|6
2525660|NCT01685060|8739616|P1|Overall Study|Death|8
2525661|NCT01685060|8739616|P1|Overall Study|Lost to Follow-up|1
2525662|NCT01685060|8739616|P1|Overall Study|Subject/guardian decision|20
2525663|NCT01685060|8739616|P1|Overall Study|Physician Decision|14
2525664|NCT01685060|8739616|P1|Overall Study|Progressive disease|69
2525665|NCT01685060|8739616|P1|Overall Study|Adverse Event|12
2525666|NCT01685060|8739616|P1|Overall Study|Rollover patients|16
2525667|NCT01685047|8739631|P1|Overall Study|patient withdrawn by sponsor|1
2525668|NCT01685047|8739631|P1|Overall Study|Adverse Event|5
2525669|NCT01685047|8739631|P1|Overall Study|Physician Decision|25
2525670|NCT01685047|8739631|P1|Overall Study|Lost to Follow-up|8
2525671|NCT01685047|8739631|P1|Overall Study|Death|26
2525672|NCT01685047|8739631|P1|Overall Study|Withdrawal by Subject|20
2525673|NCT01684943|8739647|P3|Overall Study|Planning Pregnancy|0
2525674|NCT01684943|8739648|P2|Overall Study|Planning Pregnancy|0
2525675|NCT01684943|8739649|P1|Overall Study|Planning Pregnancy|1
2525676|NCT01684943|8739647|P3|Overall Study|Lost to Follow-up|0
2525677|NCT01684943|8739648|P2|Overall Study|Lost to Follow-up|0
2525678|NCT01684943|8739649|P1|Overall Study|Lost to Follow-up|3
2525679|NCT01684943|8739647|P3|Overall Study|Excluded from Analysis|1
2525680|NCT01684943|8739648|P2|Overall Study|Excluded from Analysis|1
2525681|NCT01684943|8739649|P1|Overall Study|Excluded from Analysis|1
2525682|NCT01684943|8739647|P3|Overall Study|Principal Investigator Determination|0
2525683|NCT01684943|8739648|P2|Overall Study|Principal Investigator Determination|0
2525684|NCT01684943|8739649|P1|Overall Study|Principal Investigator Determination|1
2525685|NCT01684943|8739647|P3|Overall Study|Inadequate Venous Access|0
2525686|NCT01684943|8739648|P2|Overall Study|Inadequate Venous Access|0
2525687|NCT01684943|8739649|P1|Overall Study|Inadequate Venous Access|3
2525688|NCT01684930|8739668|P2|Overall Study|Withdrawal by Subject|1
2525689|NCT01684930|8739669|P1|Overall Study|Withdrawal by Subject|3
2525690|NCT01684878|8739726|P4|Part 2: Randomized Phase|Participant noncompliance|1
2525691|NCT01684878|8739727|P3|Part 2: Randomized Phase|Participant noncompliance|0
2525775|NCT01683994|8740003|P5|Overall Study|Intercurrent illness|1
2525692|NCT01684878|8739728|P2|Part 2: Randomized Phase|Participant noncompliance|0
2525693|NCT01684878|8739729|P1|Part 2: Randomized Phase|Participant noncompliance|0
2525694|NCT01684878|8739726|P4|Part 2: Randomized Phase|Alive at data-cut|7
2525695|NCT01684878|8739727|P3|Part 2: Randomized Phase|Alive at data-cut|13
2525696|NCT01684878|8739728|P2|Part 2: Randomized Phase|Alive at data-cut|0
2525697|NCT01684878|8739729|P1|Part 2: Randomized Phase|Alive at data-cut|0
2525698|NCT01684878|8739726|P4|Part 2: Randomized Phase|Death|68
2525699|NCT01684878|8739727|P3|Part 2: Randomized Phase|Death|62
2525700|NCT01684878|8739728|P2|Part 2: Randomized Phase|Death|0
2525701|NCT01684878|8739729|P1|Part 2: Randomized Phase|Death|0
2525702|NCT01684878|8739726|P4|Part 2: Randomized Phase|Lost to Follow-up|0
2525703|NCT01684878|8739727|P3|Part 2: Randomized Phase|Lost to Follow-up|2
2525704|NCT01684878|8739728|P2|Part 2: Randomized Phase|Lost to Follow-up|0
2525705|NCT01684878|8739729|P1|Part 2: Randomized Phase|Lost to Follow-up|0
2525706|NCT01684878|8739726|P4|Part 2: Randomized Phase|Participant withdrew consent|2
2525707|NCT01684878|8739727|P3|Part 2: Randomized Phase|Participant withdrew consent|1
2525708|NCT01684878|8739728|P2|Part 2: Randomized Phase|Participant withdrew consent|0
2525709|NCT01684878|8739729|P1|Part 2: Randomized Phase|Participant withdrew consent|0
2525710|NCT01684878|8739726|P4|Part 1: Safety Run in Phase|Lost to Follow-up|0
2525711|NCT01684878|8739727|P3|Part 1: Safety Run in Phase|Lost to Follow-up|0
2525712|NCT01684878|8739728|P2|Part 1: Safety Run in Phase|Lost to Follow-up|2
2525713|NCT01684878|8739729|P1|Part 1: Safety Run in Phase|Lost to Follow-up|0
2525714|NCT01684878|8739726|P4|Part 1: Safety Run in Phase|Death|0
2525715|NCT01684878|8739727|P3|Part 1: Safety Run in Phase|Death|0
2525716|NCT01684878|8739728|P2|Part 1: Safety Run in Phase|Death|20
2525717|NCT01684878|8739729|P1|Part 1: Safety Run in Phase|Death|15
2525718|NCT01684878|8739726|P4|Part 1: Safety Run in Phase|Participants withdrawn consent|0
2525719|NCT01684878|8739727|P3|Part 1: Safety Run in Phase|Participants withdrawn consent|0
2525720|NCT01684878|8739728|P2|Part 1: Safety Run in Phase|Participants withdrawn consent|1
2525721|NCT01684878|8739729|P1|Part 1: Safety Run in Phase|Participants withdrawn consent|1
2525722|NCT01684423|8739833|P5|Overall Study|Withdrawal by Subject|0
2525723|NCT01684423|8739834|P4|Overall Study|Withdrawal by Subject|0
2525724|NCT01684423|8739835|P3|Overall Study|Withdrawal by Subject|1
2525725|NCT01684423|8739836|P2|Overall Study|Withdrawal by Subject|0
2525726|NCT01684423|8739837|P1|Overall Study|Withdrawal by Subject|0
2525727|NCT01684215|8739894|P4|Phase 2|Lost to Follow-up|4
2525728|NCT01684215|8739895|P3|Phase 2|Lost to Follow-up|0
2525729|NCT01684215|8739896|P2|Phase 2|Lost to Follow-up|0
2525730|NCT01684215|8739897|P1|Phase 2|Lost to Follow-up|0
2525731|NCT01684215|8739894|P4|Phase 2|Enrolled but not treated|1
2525732|NCT01684215|8739895|P3|Phase 2|Enrolled but not treated|0
2525733|NCT01684215|8739896|P2|Phase 2|Enrolled but not treated|0
2525734|NCT01684215|8739897|P1|Phase 2|Enrolled but not treated|0
2525735|NCT01684215|8739894|P4|Phase 2|Study terminated by sponsor|30
2525736|NCT01684215|8739895|P3|Phase 2|Study terminated by sponsor|0
2525737|NCT01684215|8739896|P2|Phase 2|Study terminated by sponsor|0
2525738|NCT01684215|8739897|P1|Phase 2|Study terminated by sponsor|0
2525739|NCT01684215|8739894|P4|Phase 2|Death|8
2525740|NCT01684215|8739895|P3|Phase 2|Death|0
2525741|NCT01684215|8739896|P2|Phase 2|Death|0
2525742|NCT01684215|8739897|P1|Phase 2|Death|0
2525743|NCT01684215|8739894|P4|Phase 1, Part 2|Withdrawal by Subject|0
2525744|NCT01684215|8739895|P3|Phase 1, Part 2|Withdrawal by Subject|1
2525745|NCT01684215|8739896|P2|Phase 1, Part 2|Withdrawal by Subject|0
2525746|NCT01684215|8739897|P1|Phase 1, Part 2|Withdrawal by Subject|0
2525747|NCT01684215|8739894|P4|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
2525748|NCT01684215|8739895|P3|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4
2525749|NCT01684215|8739896|P2|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
2525750|NCT01684215|8739897|P1|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
2525751|NCT01684215|8739894|P4|Phase 1, Part 2|Adverse Event|0
2525752|NCT01684215|8739895|P3|Phase 1, Part 2|Adverse Event|1
2525753|NCT01684215|8739896|P2|Phase 1, Part 2|Adverse Event|0
2525754|NCT01684215|8739897|P1|Phase 1, Part 2|Adverse Event|0
2525755|NCT01684215|8739894|P4|Phase 1, Part 1|Objective progression or relapse|0
2525756|NCT01684215|8739895|P3|Phase 1, Part 1|Objective progression or relapse|0
2525757|NCT01684215|8739896|P2|Phase 1, Part 1|Objective progression or relapse|6
2525758|NCT01684215|8739897|P1|Phase 1, Part 1|Objective progression or relapse|5
2525759|NCT01684215|8739894|P4|Phase 1, Part 1|Adverse Event|0
2525760|NCT01684215|8739895|P3|Phase 1, Part 1|Adverse Event|0
2525761|NCT01684215|8739896|P2|Phase 1, Part 1|Adverse Event|0
2525762|NCT01684215|8739897|P1|Phase 1, Part 1|Adverse Event|1
2525763|NCT01684046|8739971|P2|Period 1, First 30 Days|Adverse Event|2
2525764|NCT01684046|8739972|P1|Period 1, First 30 Days|Adverse Event|0
2525765|NCT01684033|8739978|P2|Period 2, Second 30 Days|Adverse Event|0
2525766|NCT01684033|8739979|P1|Period 2, Second 30 Days|Adverse Event|1
2525767|NCT01684033|8739978|P2|Period 1, First 30 Days|Lost to Follow-up|0
2525768|NCT01684033|8739979|P1|Period 1, First 30 Days|Lost to Follow-up|1
2525769|NCT01684033|8739978|P2|Period 1, First 30 Days|Withdrawal by Subject|0
2525770|NCT01684033|8739979|P1|Period 1, First 30 Days|Withdrawal by Subject|1
2525771|NCT01684033|8739978|P2|Period 1, First 30 Days|Noncompliance|0
2525772|NCT01684033|8739979|P1|Period 1, First 30 Days|Noncompliance|1
2525773|NCT01684033|8739978|P2|Period 1, First 30 Days|Adverse Event|1
2525774|NCT01684033|8739979|P1|Period 1, First 30 Days|Adverse Event|1
2525776|NCT01683994|8740004|P4|Overall Study|Intercurrent illness|2
2525777|NCT01683994|8740005|P3|Overall Study|Intercurrent illness|0
2525778|NCT01683994|8740006|P2|Overall Study|Intercurrent illness|0
2525779|NCT01683994|8740007|P1|Overall Study|Intercurrent illness|0
2525780|NCT01683994|8740003|P5|Overall Study|Withdrawal by Subject|0
2525781|NCT01683994|8740004|P4|Overall Study|Withdrawal by Subject|1
2525782|NCT01683994|8740005|P3|Overall Study|Withdrawal by Subject|0
2525783|NCT01683994|8740006|P2|Overall Study|Withdrawal by Subject|0
2525784|NCT01683994|8740007|P1|Overall Study|Withdrawal by Subject|1
2525785|NCT01683838|8740048|P2|Overall Study|Other|3
2525786|NCT01683838|8740049|P1|Overall Study|Other|4
2525787|NCT01683838|8740048|P2|Overall Study|Lost to Follow-up|1
2525788|NCT01683838|8740049|P1|Overall Study|Lost to Follow-up|1
2525789|NCT01683838|8740048|P2|Overall Study|Withdrawal by Subject|5
2525790|NCT01683838|8740049|P1|Overall Study|Withdrawal by Subject|6
2525791|NCT01683838|8740048|P2|Overall Study|Protocol Violation|1
2525792|NCT01683838|8740049|P1|Overall Study|Protocol Violation|3
2525793|NCT01683838|8740048|P2|Overall Study|Adverse Event|2
2525794|NCT01683838|8740049|P1|Overall Study|Adverse Event|12
2525795|NCT01683604|8740089|P1|Overall Study|Other|2
2525796|NCT01683604|8740089|P1|Overall Study|Lack of Efficacy|1
2525797|NCT01683604|8740089|P1|Overall Study|Adverse Event|2
2525798|NCT01683565|8740254|P2|Overall Study|Discontinued Intervention|1
2525799|NCT01683565|8740255|P1|Overall Study|Discontinued Intervention|1
2525800|NCT01683565|8740254|P2|Overall Study|Lost to Follow-up|0
2525801|NCT01683565|8740255|P1|Overall Study|Lost to Follow-up|2
2525802|NCT01683409|8740289|P5|Washout Period 2 (Weeks 29-32)|Physician Decision|0
2525803|NCT01683409|8740290|P4|Washout Period 2 (Weeks 29-32)|Physician Decision|0
2525804|NCT01683409|8740291|P3|Washout Period 2 (Weeks 29-32)|Physician Decision|1
2525805|NCT01683409|8740292|P2|Washout Period 2 (Weeks 29-32)|Physician Decision|0
2525806|NCT01683409|8740293|P1|Washout Period 2 (Weeks 29-32)|Physician Decision|0
2525807|NCT01683409|8740289|P5|Washout Period 2 (Weeks 29-32)|Adverse Event|3
2525808|NCT01683409|8740290|P4|Washout Period 2 (Weeks 29-32)|Adverse Event|0
2525809|NCT01683409|8740291|P3|Washout Period 2 (Weeks 29-32)|Adverse Event|0
2525810|NCT01683409|8740292|P2|Washout Period 2 (Weeks 29-32)|Adverse Event|0
2525811|NCT01683409|8740293|P1|Washout Period 2 (Weeks 29-32)|Adverse Event|0
2525812|NCT01683409|8740289|P5|Washout Period 1 (Weeks 25-28)|Adverse Event|2
2525813|NCT01683409|8740290|P4|Washout Period 1 (Weeks 25-28)|Adverse Event|1
2525814|NCT01683409|8740291|P3|Washout Period 1 (Weeks 25-28)|Adverse Event|0
2525815|NCT01683409|8740292|P2|Washout Period 1 (Weeks 25-28)|Adverse Event|4
2525816|NCT01683409|8740293|P1|Washout Period 1 (Weeks 25-28)|Adverse Event|0
2525817|NCT01683409|8740289|P5|Washout Period 1 (Weeks 25-28)|Physician Decision|0
2525818|NCT01683409|8740290|P4|Washout Period 1 (Weeks 25-28)|Physician Decision|0
2525819|NCT01683409|8740291|P3|Washout Period 1 (Weeks 25-28)|Physician Decision|0
2525820|NCT01683409|8740292|P2|Washout Period 1 (Weeks 25-28)|Physician Decision|0
2525821|NCT01683409|8740293|P1|Washout Period 1 (Weeks 25-28)|Physician Decision|1
2525822|NCT01683409|8740289|P5|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
2525823|NCT01683409|8740290|P4|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
2525824|NCT01683409|8740291|P3|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
2525825|NCT01683409|8740292|P2|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
2525826|NCT01683409|8740293|P1|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
2525827|NCT01683409|8740289|P5|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
2525828|NCT01683409|8740290|P4|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
2525829|NCT01683409|8740291|P3|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
2525830|NCT01683409|8740292|P2|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
2525831|NCT01683409|8740293|P1|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
2525832|NCT01683409|8740289|P5|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
2525833|NCT01683409|8740290|P4|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
2525834|NCT01683409|8740291|P3|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1
2525835|NCT01683409|8740292|P2|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
2525836|NCT01683409|8740293|P1|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
2525837|NCT01683409|8740289|P5|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
2525838|NCT01683409|8740290|P4|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
2525839|NCT01683409|8740291|P3|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
2525840|NCT01683409|8740292|P2|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
2525841|NCT01683409|8740293|P1|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
2525842|NCT01683409|8740289|P5|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
2525843|NCT01683409|8740290|P4|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
2525844|NCT01683409|8740291|P3|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
2525845|NCT01683409|8740292|P2|Treatment Period (Weeks 1-24)|Lost to Follow-up|1
2525846|NCT01683409|8740293|P1|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
2525847|NCT01683409|8740289|P5|Treatment Period (Weeks 1-24)|Adverse Event|1
2525848|NCT01683409|8740290|P4|Treatment Period (Weeks 1-24)|Adverse Event|1
2525849|NCT01683409|8740291|P3|Treatment Period (Weeks 1-24)|Adverse Event|0
2525850|NCT01683409|8740292|P2|Treatment Period (Weeks 1-24)|Adverse Event|3
2525851|NCT01683409|8740293|P1|Treatment Period (Weeks 1-24)|Adverse Event|0
2525852|NCT01683409|8740289|P5|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
2525853|NCT01683409|8740290|P4|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
2525854|NCT01683409|8740291|P3|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1
2525855|NCT01683409|8740292|P2|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
2525856|NCT01683409|8740293|P1|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
2525857|NCT01683383|8740336|P2|Overall Study|Infant was not transported|0
2525858|NCT01683383|8740337|P1|Overall Study|Infant was not transported|1
2525859|NCT01683266|8740364|P2|Overall Study|Serious Adverse Event of Hypoglycemia|1
2525860|NCT01683266|8740365|P1|Overall Study|Serious Adverse Event of Hypoglycemia|0
2525861|NCT01683266|8740364|P2|Overall Study|Possibly Hypoglycemia|0
2525862|NCT01683266|8740365|P1|Overall Study|Possibly Hypoglycemia|1
2525863|NCT01683266|8740364|P2|Overall Study|Perceived Lack of Efficacy|1
2525864|NCT01683266|8740365|P1|Overall Study|Perceived Lack of Efficacy|1
2525865|NCT01683266|8740364|P2|Overall Study|Nonserious Hypoglycemia|3
2525866|NCT01683266|8740365|P1|Overall Study|Nonserious Hypoglycemia|0
2525867|NCT01683266|8740364|P2|Overall Study|Site Closure / Site Withdrawal|3
2525868|NCT01683266|8740365|P1|Overall Study|Site Closure / Site Withdrawal|1
2525869|NCT01683266|8740364|P2|Overall Study|Lost to Follow-up|0
2525870|NCT01683266|8740365|P1|Overall Study|Lost to Follow-up|5
2525871|NCT01683266|8740364|P2|Overall Study|Selection Criterion / Protocol Violation|5
2525872|NCT01683266|8740365|P1|Overall Study|Selection Criterion / Protocol Violation|7
2525873|NCT01683266|8740364|P2|Overall Study|Personal Reason|25
2525874|NCT01683266|8740365|P1|Overall Study|Personal Reason|17
2525875|NCT01683266|8740364|P2|Overall Study|Protocol Violation|6
2525876|NCT01683266|8740365|P1|Overall Study|Protocol Violation|13
2525877|NCT01683266|8740364|P2|Overall Study|Lack of Efficacy|2
2525878|NCT01683266|8740365|P1|Overall Study|Lack of Efficacy|5
2525879|NCT01683266|8740364|P2|Overall Study|Adverse Event|4
2525880|NCT01683266|8740365|P1|Overall Study|Adverse Event|5
2525881|NCT01683058|8740393|P1|Overall Study|Lack of Efficacy|2
2525882|NCT01683058|8740393|P1|Overall Study|Withdrawal by Subject|7
2525883|NCT01683058|8740393|P1|Overall Study|Subject Met Withdrawal Criteria|5
2525884|NCT01683058|8740393|P1|Overall Study|Adverse Event|6
2525885|NCT01683058|8740393|P1|Overall Study|Lost to Follow-up|9
2525886|NCT01683019|8740424|P3|Overall Study|Withdrawal by Subject|4
2525887|NCT01683019|8740425|P2|Overall Study|Withdrawal by Subject|1
2525888|NCT01683019|8740426|P1|Overall Study|Withdrawal by Subject|2
2525889|NCT01682876|8740460|P4|Overall Study|Other|1
2525890|NCT01682876|8740461|P3|Overall Study|Other|1
2525891|NCT01682876|8740462|P2|Overall Study|Other|0
2525892|NCT01682876|8740463|P1|Overall Study|Other|1
2525893|NCT01682876|8740460|P4|Overall Study|Withdrawal by Subject|2
2525894|NCT01682876|8740461|P3|Overall Study|Withdrawal by Subject|0
2525895|NCT01682876|8740462|P2|Overall Study|Withdrawal by Subject|0
2525896|NCT01682876|8740463|P1|Overall Study|Withdrawal by Subject|4
2525897|NCT01682876|8740460|P4|Overall Study|Protocol Violation|1
2525898|NCT01682876|8740461|P3|Overall Study|Protocol Violation|1
2525899|NCT01682876|8740462|P2|Overall Study|Protocol Violation|1
2525900|NCT01682876|8740463|P1|Overall Study|Protocol Violation|1
2525901|NCT01682876|8740460|P4|Overall Study|Lost to Follow-up|11
2525902|NCT01682876|8740461|P3|Overall Study|Lost to Follow-up|9
2525903|NCT01682876|8740462|P2|Overall Study|Lost to Follow-up|15
2525904|NCT01682876|8740463|P1|Overall Study|Lost to Follow-up|11
2525905|NCT01682876|8740460|P4|Overall Study|Adverse Event|1
2525906|NCT01682876|8740461|P3|Overall Study|Adverse Event|0
2525907|NCT01682876|8740462|P2|Overall Study|Adverse Event|0
2525908|NCT01682876|8740463|P1|Overall Study|Adverse Event|0
2525909|NCT01682876|8740460|P4|Overall Study|Administrative reason|3
2525910|NCT01682876|8740461|P3|Overall Study|Administrative reason|0
2525911|NCT01682876|8740462|P2|Overall Study|Administrative reason|4
2525912|NCT01682876|8740463|P1|Overall Study|Administrative reason|4
2525913|NCT01682863|8740509|P3|Overall Study|Physician Decision|1
2525914|NCT01682863|8740510|P2|Overall Study|Physician Decision|0
2525915|NCT01682863|8740511|P1|Overall Study|Physician Decision|0
2525916|NCT01682863|8740509|P3|Overall Study|Adverse Event|2
2525917|NCT01682863|8740510|P2|Overall Study|Adverse Event|1
2525918|NCT01682863|8740511|P1|Overall Study|Adverse Event|0
2525919|NCT01682863|8740509|P3|Overall Study|Technical problems|0
2525920|NCT01682863|8740510|P2|Overall Study|Technical problems|0
2525921|NCT01682863|8740511|P1|Overall Study|Technical problems|1
2525922|NCT01682863|8740509|P3|Overall Study|Protocol deviation|1
2525923|NCT01682863|8740510|P2|Overall Study|Protocol deviation|0
2525924|NCT01682863|8740511|P1|Overall Study|Protocol deviation|1
2525925|NCT01682863|8740509|P3|Overall Study|Death|4
2525926|NCT01682863|8740510|P2|Overall Study|Death|3
2525927|NCT01682863|8740511|P1|Overall Study|Death|1
2525928|NCT01682863|8740509|P3|Overall Study|Lost to Follow-up|6
2525929|NCT01682863|8740510|P2|Overall Study|Lost to Follow-up|1
2525930|NCT01682863|8740511|P1|Overall Study|Lost to Follow-up|5
2525931|NCT01682863|8740509|P3|Overall Study|Subject/guardian decision|10
2525932|NCT01682863|8740510|P2|Overall Study|Subject/guardian decision|12
2525933|NCT01682863|8740511|P1|Overall Study|Subject/guardian decision|19
2525934|NCT01682837|8740540|P1|Baseline|Withdrawal by Subject|5
2525935|NCT01682759|8740584|P2|Overall Study|Withdrawal by Subject|55
2525936|NCT01682759|8740585|P1|Overall Study|Withdrawal by Subject|56
2525937|NCT01682759|8740584|P2|Overall Study|Physician Decision|1
2525938|NCT01682759|8740585|P1|Overall Study|Physician Decision|1
2525939|NCT01682759|8740584|P2|Overall Study|Lost to Follow-up|13
2525940|NCT01682759|8740585|P1|Overall Study|Lost to Follow-up|10
2525941|NCT01682759|8740584|P2|Overall Study|Death|1
2525942|NCT01682759|8740585|P1|Overall Study|Death|2
2525943|NCT01682720|8740609|P4|Overall Study|Adverse Event|1
2525944|NCT01682720|8740610|P3|Overall Study|Adverse Event|1
2525945|NCT01682720|8740611|P2|Overall Study|Adverse Event|0
2525946|NCT01682720|8740612|P1|Overall Study|Adverse Event|1
2525947|NCT01682720|8740609|P4|Overall Study|Subject Withdrew Consent|2
2525948|NCT01682720|8740610|P3|Overall Study|Subject Withdrew Consent|2
2525949|NCT01682720|8740611|P2|Overall Study|Subject Withdrew Consent|0
2525950|NCT01682720|8740612|P1|Overall Study|Subject Withdrew Consent|0
2525951|NCT01682720|8740609|P4|Overall Study|Lost to Follow-up|6
2525952|NCT01682720|8740610|P3|Overall Study|Lost to Follow-up|0
2525953|NCT01682720|8740611|P2|Overall Study|Lost to Follow-up|1
2525954|NCT01682720|8740612|P1|Overall Study|Lost to Follow-up|1
2525955|NCT01682720|8740609|P4|Overall Study|Efficacy Failure|30
2525956|NCT01682720|8740610|P3|Overall Study|Efficacy Failure|3
2525957|NCT01682720|8740611|P2|Overall Study|Efficacy Failure|3
2525958|NCT01682720|8740612|P1|Overall Study|Efficacy Failure|0
2525959|NCT01682720|8740609|P4|Overall Study|Terminated by Sponsor|0
2525960|NCT01682720|8740610|P3|Overall Study|Terminated by Sponsor|0
2525961|NCT01682720|8740611|P2|Overall Study|Terminated by Sponsor|0
2525962|NCT01682720|8740612|P1|Overall Study|Terminated by Sponsor|83
2525963|NCT01682720|8740609|P4|Overall Study|Randomized but Not Treated|0
2525964|NCT01682720|8740610|P3|Overall Study|Randomized but Not Treated|1
2525965|NCT01682720|8740611|P2|Overall Study|Randomized but Not Treated|1
2525966|NCT01682720|8740612|P1|Overall Study|Randomized but Not Treated|0
2525967|NCT01682681|8740629|P1|Overall Study|Low compliance|13
2525968|NCT01682681|8740629|P1|Overall Study|Other|21
2525969|NCT01682681|8740629|P1|Overall Study|tapering of topiramate|5
2525970|NCT01682681|8740629|P1|Overall Study|Adverse Event|46
2525971|NCT01682681|8740629|P1|Overall Study|Lost to Follow-up|174
2525972|NCT01682681|8740629|P1|Overall Study|Moved to other hospital|10
2525973|NCT01682681|8740629|P1|Overall Study|Withdrawal by Subject|1
2525974|NCT01682681|8740629|P1|Overall Study|Lack of Efficacy|62
2525975|NCT01682603|8740658|P1|Overall Study|Lost to Follow-up|3
2525976|NCT01682512|8740703|P3|Overall Study|Other than stated above|2
2525977|NCT01682512|8740704|P2|Overall Study|Other than stated above|4
2525978|NCT01682512|8740705|P1|Overall Study|Other than stated above|2
2525979|NCT01682512|8740703|P3|Overall Study|Secondary lack of efficacy|0
2525980|NCT01682512|8740704|P2|Overall Study|Secondary lack of efficacy|1
2525981|NCT01682512|8740705|P1|Overall Study|Secondary lack of efficacy|1
2525982|NCT01682512|8740703|P3|Overall Study|Primary lack of efficacy|7
2525983|NCT01682512|8740704|P2|Overall Study|Primary lack of efficacy|7
2525984|NCT01682512|8740705|P1|Overall Study|Primary lack of efficacy|10
2525985|NCT01682512|8740703|P3|Overall Study|Protocol Violation|2
2525986|NCT01682512|8740704|P2|Overall Study|Protocol Violation|3
2525987|NCT01682512|8740705|P1|Overall Study|Protocol Violation|2
2525988|NCT01682512|8740703|P3|Overall Study|Lost to Follow-up|2
2525989|NCT01682512|8740704|P2|Overall Study|Lost to Follow-up|0
2525990|NCT01682512|8740705|P1|Overall Study|Lost to Follow-up|3
2525991|NCT01682512|8740703|P3|Overall Study|Study terminated by sponsor|0
2525992|NCT01682512|8740704|P2|Overall Study|Study terminated by sponsor|43
2525993|NCT01682512|8740705|P1|Overall Study|Study terminated by sponsor|46
2525994|NCT01682512|8740703|P3|Overall Study|Physician Decision|0
2525995|NCT01682512|8740704|P2|Overall Study|Physician Decision|2
2525996|NCT01682512|8740705|P1|Overall Study|Physician Decision|0
2525997|NCT01682512|8740703|P3|Overall Study|Withdrawal by Subject|3
2525998|NCT01682512|8740704|P2|Overall Study|Withdrawal by Subject|6
2525999|NCT01682512|8740705|P1|Overall Study|Withdrawal by Subject|2
2526000|NCT01682512|8740703|P3|Overall Study|Adverse Event|2
2526001|NCT01682512|8740704|P2|Overall Study|Adverse Event|5
2526002|NCT01682512|8740705|P1|Overall Study|Adverse Event|6
2526003|NCT01682460|8740730|P1|Overall Study|Did not meet inclusion criteria|2
2526004|NCT01682460|8740730|P1|Overall Study|Withdrawal by Subject|2
2526005|NCT01682148|8740747|P2|Overall Study|Protocol Violation|1
2526006|NCT01682148|8740748|P1|Overall Study|Protocol Violation|1
2526007|NCT01682148|8740747|P2|Overall Study|Lost to Follow-up|2
2526008|NCT01682148|8740748|P1|Overall Study|Lost to Follow-up|1
2526009|NCT01682148|8740747|P2|Overall Study|Withdrawal by Subject|0
2526010|NCT01682148|8740748|P1|Overall Study|Withdrawal by Subject|2
2526011|NCT01682083|8740808|P2|Overall Study|Physician Decision|4
2526012|NCT01682083|8740809|P1|Overall Study|Physician Decision|5
2526013|NCT01682083|8740808|P2|Overall Study|Death|93
2526014|NCT01682083|8740809|P1|Overall Study|Death|60
2526015|NCT01682083|8740808|P2|Overall Study|Withdrawal by Subject|40
2526016|NCT01682083|8740809|P1|Overall Study|Withdrawal by Subject|31
2526017|NCT01682083|8740808|P2|Overall Study|Lost to Follow-up|18
2526018|NCT01682083|8740809|P1|Overall Study|Lost to Follow-up|11
2526019|NCT01682044|8740821|P1|Overall Study|Progression|3
2526020|NCT01682044|8740821|P1|Overall Study|Death|1
2526021|NCT01682031|8740833|P2|Overall Study|Patient stopped selenium on his own|1
2526022|NCT01682031|8740834|P1|Overall Study|Patient stopped selenium on his own|0
2526023|NCT01682031|8740833|P2|Overall Study|Patient could not swallow tablets|0
2526024|NCT01682031|8740834|P1|Overall Study|Patient could not swallow tablets|1
2526025|NCT01682031|8740833|P2|Overall Study|MRI results indicate increased nodul|1
2526026|NCT01682031|8740834|P1|Overall Study|MRI results indicate increased nodul|0
2526027|NCT01682031|8740833|P2|Overall Study|Adverse Event|2
2526028|NCT01682031|8740834|P1|Overall Study|Adverse Event|0
2526029|NCT01682031|8740833|P2|Overall Study|Withdrawal by Subject|1
2526030|NCT01682031|8740834|P1|Overall Study|Withdrawal by Subject|0
2526031|NCT01681992|8740857|P3|Overall Study|Withdrawal by Subject|25
2526032|NCT01681992|8740858|P2|Overall Study|Withdrawal by Subject|30
2526033|NCT01681992|8740859|P1|Overall Study|Withdrawal by Subject|27
2526034|NCT01681992|8740857|P3|Overall Study|Protocol Violation|1
2526035|NCT01681992|8740858|P2|Overall Study|Protocol Violation|0
2526036|NCT01681992|8740859|P1|Overall Study|Protocol Violation|0
2526037|NCT01681992|8740857|P3|Overall Study|As Per Sponsor Decision|1
2526038|NCT01681992|8740858|P2|Overall Study|As Per Sponsor Decision|0
2526039|NCT01681992|8740859|P1|Overall Study|As Per Sponsor Decision|0
2526040|NCT01681992|8740857|P3|Overall Study|Lost to Follow-up|53
2526041|NCT01681992|8740858|P2|Overall Study|Lost to Follow-up|38
2526042|NCT01681992|8740859|P1|Overall Study|Lost to Follow-up|36
2526043|NCT01681992|8740857|P3|Overall Study|Adverse Event|3
2526044|NCT01681992|8740858|P2|Overall Study|Adverse Event|2
2526045|NCT01681992|8740859|P1|Overall Study|Adverse Event|3
2526046|NCT01681849|8740948|P3|Overall Study|Lost to Follow-up|6
2526047|NCT01681849|8740949|P2|Overall Study|Lost to Follow-up|2
2526048|NCT01681849|8740950|P1|Overall Study|Lost to Follow-up|3
2526049|NCT01681849|8740948|P3|Overall Study|Withdrawal by Subject|33
2526050|NCT01681849|8740949|P2|Overall Study|Withdrawal by Subject|5
2526051|NCT01681849|8740950|P1|Overall Study|Withdrawal by Subject|3
2526052|NCT01681849|8740948|P3|Overall Study|Protocol Violation|0
2526053|NCT01681849|8740949|P2|Overall Study|Protocol Violation|0
2526054|NCT01681849|8740950|P1|Overall Study|Protocol Violation|2
2526055|NCT01681836|8740959|P2|Second Intervention|Withdrawal by Subject|1
2526056|NCT01681836|8740960|P1|Second Intervention|Withdrawal by Subject|0
2526057|NCT01681771|8740994|P2|Overall Study|Lost to Follow-up|2
2526058|NCT01681771|8740995|P1|Overall Study|Lost to Follow-up|4
2526059|NCT01681628|8741003|P2|19 Months Follow-up|Lost to Follow-up|43
2526060|NCT01681628|8741004|P1|19 Months Follow-up|Lost to Follow-up|61
2526061|NCT01681628|8741003|P2|19 Months Follow-up|Death|0
2526062|NCT01681628|8741004|P1|19 Months Follow-up|Death|1
2526063|NCT01681628|8741003|P2|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15
2526064|NCT01681628|8741004|P1|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0
2526065|NCT01681628|8741003|P2|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6
2526066|NCT01681628|8741004|P1|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14
2526067|NCT01681576|8741017|P2|Period 2|Non-compliance with study treatment|0
2526068|NCT01681576|8741018|P1|Period 2|Non-compliance with study treatment|1
2526069|NCT01681576|8741017|P2|Period 2|subject/guardian decision|1
2526070|NCT01681576|8741018|P1|Period 2|subject/guardian decision|3
2526071|NCT01681576|8741017|P2|Period 1|Protocol Deviation|0
2526072|NCT01681576|8741018|P1|Period 1|Protocol Deviation|1
2526073|NCT01681576|8741017|P2|Period 1|Adverse Event|0
2526074|NCT01681576|8741018|P1|Period 1|Adverse Event|1
2526075|NCT01681511|8741034|P2|Overall Study|No post-catheter sample collected|4
2526076|NCT01681511|8741035|P1|Overall Study|No post-catheter sample collected|11
2526077|NCT01681511|8741034|P2|Overall Study|No Daily Urine Sample Collected|1
2526078|NCT01681511|8741035|P1|Overall Study|No Daily Urine Sample Collected|0
2526079|NCT01681511|8741034|P2|Overall Study|No Baseline Dips Stick & Urine Culture|6
2526080|NCT01681511|8741035|P1|Overall Study|No Baseline Dips Stick & Urine Culture|3
2526081|NCT01681511|8741034|P2|Overall Study|Failed Inclusion/Exclusion|0
2526082|NCT01681511|8741035|P1|Overall Study|Failed Inclusion/Exclusion|3
2526083|NCT01681511|8741034|P2|Overall Study|No Treatment Received|3
2526084|NCT01681511|8741035|P1|Overall Study|No Treatment Received|1
2526085|NCT01681472|8741053|P4|Overall Study|Adverse Event|0
2526086|NCT01681472|8741054|P3|Overall Study|Adverse Event|0
2526087|NCT01681472|8741055|P2|Overall Study|Adverse Event|1
2526088|NCT01681472|8741056|P1|Overall Study|Adverse Event|0
2526089|NCT01681433|8741236|P2|Overall Study|Lost to Follow-up|1
2526090|NCT01681433|8741237|P1|Overall Study|Lost to Follow-up|0
2526091|NCT01681433|8741236|P2|Overall Study|Adverse Event|4
2526092|NCT01681433|8741237|P1|Overall Study|Adverse Event|2
2526093|NCT01681433|8741236|P2|Overall Study|Protocol Violation|0
2526094|NCT01681433|8741237|P1|Overall Study|Protocol Violation|2
2526095|NCT01681433|8741236|P2|Overall Study|Withdrawal by Subject|5
2526096|NCT01681433|8741237|P1|Overall Study|Withdrawal by Subject|5
2526097|NCT01681433|8741236|P2|Overall Study|Lack of Efficacy|23
2526098|NCT01681433|8741237|P1|Overall Study|Lack of Efficacy|23
2526099|NCT01681368|8741255|P1|Overall Study|Refused further follow up|1
2526100|NCT01681368|8741255|P1|Overall Study|Refused further treatment|1
2526101|NCT01681277|8741272|P5|Overall Study|Adverse Event|0
2526102|NCT01681277|8741273|P4|Overall Study|Adverse Event|0
2526103|NCT01681277|8741274|P3|Overall Study|Adverse Event|0
2526104|NCT01681277|8741275|P2|Overall Study|Adverse Event|0
2526105|NCT01681277|8741276|P1|Overall Study|Adverse Event|1
2526106|NCT01681212|8741317|P1|Overall Study|Administrative reason by sponsor|1
2526107|NCT01681212|8741317|P1|Overall Study|No longer met study criteria|5
2526108|NCT01681186|8741331|P8|Fourth Intervention|Protocol Violation|1
2526109|NCT01681186|8741332|P7|Fourth Intervention|Protocol Violation|0
2526110|NCT01681186|8741333|P6|Fourth Intervention|Protocol Violation|0
2526111|NCT01681186|8741334|P5|Fourth Intervention|Protocol Violation|0
2526112|NCT01681186|8741335|P4|Fourth Intervention|Protocol Violation|0
2526113|NCT01681186|8741336|P3|Fourth Intervention|Protocol Violation|0
2526114|NCT01681186|8741337|P2|Fourth Intervention|Protocol Violation|0
2526115|NCT01681186|8741338|P1|Fourth Intervention|Protocol Violation|0
2526116|NCT01681186|8741331|P8|Washout Period From Third Intervention|Lost to Follow-up|0
2526117|NCT01681186|8741332|P7|Washout Period From Third Intervention|Lost to Follow-up|1
2526118|NCT01681186|8741333|P6|Washout Period From Third Intervention|Lost to Follow-up|0
2526119|NCT01681186|8741334|P5|Washout Period From Third Intervention|Lost to Follow-up|0
2526120|NCT01681186|8741335|P4|Washout Period From Third Intervention|Lost to Follow-up|0
2526121|NCT01681186|8741336|P3|Washout Period From Third Intervention|Lost to Follow-up|0
2526122|NCT01681186|8741337|P2|Washout Period From Third Intervention|Lost to Follow-up|0
2526123|NCT01681186|8741338|P1|Washout Period From Third Intervention|Lost to Follow-up|0
2526124|NCT01681186|8741331|P8|Washout Period From Second Intervention|Protocol Violation|1
2526125|NCT01681186|8741332|P7|Washout Period From Second Intervention|Protocol Violation|0
2526126|NCT01681186|8741333|P6|Washout Period From Second Intervention|Protocol Violation|0
2526127|NCT01681186|8741334|P5|Washout Period From Second Intervention|Protocol Violation|0
2526128|NCT01681186|8741335|P4|Washout Period From Second Intervention|Protocol Violation|0
2526129|NCT01681186|8741336|P3|Washout Period From Second Intervention|Protocol Violation|0
2526130|NCT01681186|8741337|P2|Washout Period From Second Intervention|Protocol Violation|0
2526131|NCT01681186|8741338|P1|Washout Period From Second Intervention|Protocol Violation|0
2526132|NCT01681186|8741331|P8|Washout Period From Second Intervention|Adverse Event|0
2526133|NCT01681186|8741332|P7|Washout Period From Second Intervention|Adverse Event|1
2526134|NCT01681186|8741333|P6|Washout Period From Second Intervention|Adverse Event|0
2526135|NCT01681186|8741334|P5|Washout Period From Second Intervention|Adverse Event|0
2526136|NCT01681186|8741335|P4|Washout Period From Second Intervention|Adverse Event|0
2526137|NCT01681186|8741336|P3|Washout Period From Second Intervention|Adverse Event|0
2526138|NCT01681186|8741337|P2|Washout Period From Second Intervention|Adverse Event|0
2526139|NCT01681186|8741338|P1|Washout Period From Second Intervention|Adverse Event|0
2526140|NCT01681069|8741441|P2|Overall Study|Adverse Event|1
2526141|NCT01681069|8741442|P1|Overall Study|Adverse Event|0
2526142|NCT01681069|8741441|P2|Overall Study|Protocol Violation|1
2526143|NCT01681069|8741442|P1|Overall Study|Protocol Violation|1
2526144|NCT01681069|8741441|P2|Overall Study|Withdrawal by Subject|5
2526145|NCT01681069|8741442|P1|Overall Study|Withdrawal by Subject|4
2526146|NCT01681004|8741479|P2|Study Completion|Death|1
2526147|NCT01681004|8741480|P1|Study Completion|Death|1
2526148|NCT01681004|8741479|P2|Study Completion|Site Termination|1
2526149|NCT01681004|8741480|P1|Study Completion|Site Termination|2
2526150|NCT01681004|8741479|P2|Study Completion|Physician Decision|3
2526151|NCT01681004|8741480|P1|Study Completion|Physician Decision|1
2526152|NCT01681004|8741479|P2|Study Completion|Lost to Follow-up|3
2526153|NCT01681004|8741480|P1|Study Completion|Lost to Follow-up|8
2526154|NCT01681004|8741479|P2|Primary Endpoint: 6 Months|Withdrawal by Subject|2
2526155|NCT01681004|8741480|P1|Primary Endpoint: 6 Months|Withdrawal by Subject|1
2526156|NCT01680991|8741537|P3|Overall Study|PD confirmed in other hospital|0
2526157|NCT01680991|8741538|P2|Overall Study|PD confirmed in other hospital|0
2526158|NCT01680991|8741539|P1|Overall Study|PD confirmed in other hospital|1
2526159|NCT01680991|8741537|P3|Overall Study|Bad physical condition|1
2526160|NCT01680991|8741538|P2|Overall Study|Bad physical condition|0
2526161|NCT01680991|8741539|P1|Overall Study|Bad physical condition|0
2526162|NCT01680991|8741537|P3|Overall Study|Physician Decision|2
2526163|NCT01680991|8741538|P2|Overall Study|Physician Decision|7
2526164|NCT01680991|8741539|P1|Overall Study|Physician Decision|0
2526165|NCT01680991|8741537|P3|Overall Study|Progressive disease (PD)|0
2526166|NCT01680991|8741538|P2|Overall Study|Progressive disease (PD)|10
2526167|NCT01680991|8741539|P1|Overall Study|Progressive disease (PD)|0
2526168|NCT01680991|8741537|P3|Overall Study|Withdrawal by Subject|0
2526169|NCT01680991|8741538|P2|Overall Study|Withdrawal by Subject|1
2526170|NCT01680991|8741539|P1|Overall Study|Withdrawal by Subject|5
2526171|NCT01680991|8741537|P3|Overall Study|Protocol Violation|0
2526172|NCT01680991|8741538|P2|Overall Study|Protocol Violation|1
2526173|NCT01680991|8741539|P1|Overall Study|Protocol Violation|0
2526174|NCT01680991|8741537|P3|Overall Study|Death|1
2526175|NCT01680991|8741538|P2|Overall Study|Death|0
2526176|NCT01680991|8741539|P1|Overall Study|Death|1
2526177|NCT01680991|8741537|P3|Overall Study|Adverse Event|0
2526178|NCT01680991|8741538|P2|Overall Study|Adverse Event|0
2526179|NCT01680991|8741539|P1|Overall Study|Adverse Event|1
2526180|NCT01680861|8741630|P2|Early Post-transplant Period|Protocol Violation|1
2526181|NCT01680861|8741631|P1|Early Post-transplant Period|Protocol Violation|1
2526182|NCT01680497|8741718|P1|Overall Study|Lost to Follow-up|2
2526183|NCT01680458|8741728|P1|Overall Study|Protocol Violation|3
2526184|NCT01680341|8741739|P2|Overall Study|Unclassified|15
2526185|NCT01680341|8741740|P1|Overall Study|Unclassified|18
2526186|NCT01680341|8741739|P2|Overall Study|Adverse Event|2
2526187|NCT01680341|8741740|P1|Overall Study|Adverse Event|3
2526188|NCT01680159|8741811|P1|Increased Dose Period|Withdrawal by Subject|2
2526189|NCT01680159|8741811|P1|Increased Dose Period|Adverse Event|6
2526190|NCT01680159|8741811|P1|Screening Period|Not meet criteria for dose-up period|7
2526191|NCT01680016|8741838|P4|Overall Study|Withdrawal by Subject|1
2526192|NCT01680016|8741839|P3|Overall Study|Withdrawal by Subject|1
2526193|NCT01680016|8741840|P2|Overall Study|Withdrawal by Subject|7
2526194|NCT01680016|8741841|P1|Overall Study|Withdrawal by Subject|5
2526195|NCT01680016|8741838|P4|Overall Study|Protocol Violation|0
2526196|NCT01680016|8741839|P3|Overall Study|Protocol Violation|0
2526197|NCT01680016|8741840|P2|Overall Study|Protocol Violation|1
2526198|NCT01680016|8741841|P1|Overall Study|Protocol Violation|0
2526199|NCT01680016|8741838|P4|Overall Study|The Subject went out of The Trial|0
2526200|NCT01680016|8741839|P3|Overall Study|The Subject went out of The Trial|3
2526201|NCT01680016|8741840|P2|Overall Study|The Subject went out of The Trial|0
2526202|NCT01680016|8741841|P1|Overall Study|The Subject went out of The Trial|1
2526203|NCT01680016|8741838|P4|Overall Study|Adverse Event|4
2526204|NCT01680016|8741839|P3|Overall Study|Adverse Event|1
2526205|NCT01680016|8741840|P2|Overall Study|Adverse Event|0
2526206|NCT01680016|8741841|P1|Overall Study|Adverse Event|0
2526207|NCT01679613|8741903|P4|Overall Study|other than stated above|2
2526208|NCT01679613|8741904|P3|Overall Study|other than stated above|2
2526209|NCT01679613|8741905|P2|Overall Study|other than stated above|1
2526210|NCT01679613|8741906|P1|Overall Study|other than stated above|0
2526211|NCT01679405|8741928|P2|Overall Study|Death|5
2526212|NCT01679405|8741929|P1|Overall Study|Death|2
2526213|NCT01679301|8741964|P3|Screening Period|screen failure|0
2526214|NCT01679301|8741965|P2|Screening Period|screen failure|0
2526215|NCT01679301|8741966|P1|Screening Period|screen failure|3
2526216|NCT01679236|8741974|P2|Overall Study|Lost to Follow-up|15
2526217|NCT01679236|8741975|P1|Overall Study|Lost to Follow-up|15
2526218|NCT01679002|8742022|P3|Overall Study|Adverse Event|0
2526219|NCT01679002|8742023|P2|Overall Study|Adverse Event|1
2526220|NCT01679002|8742024|P1|Overall Study|Adverse Event|1
2526221|NCT01678924|8742055|P4|Overall Study|Unable to attend scheduled visits|1
2526222|NCT01678924|8742056|P3|Overall Study|Unable to attend scheduled visits|0
2526223|NCT01678924|8742057|P2|Overall Study|Unable to attend scheduled visits|0
2526224|NCT01678924|8742058|P1|Overall Study|Unable to attend scheduled visits|0
2526225|NCT01678924|8742055|P4|Overall Study|Withdrawal by Subject|2
2526226|NCT01678924|8742056|P3|Overall Study|Withdrawal by Subject|0
2526227|NCT01678924|8742057|P2|Overall Study|Withdrawal by Subject|3
2526228|NCT01678924|8742058|P1|Overall Study|Withdrawal by Subject|0
2526229|NCT01678924|8742055|P4|Overall Study|Personal Reasons|7
2526230|NCT01678924|8742056|P3|Overall Study|Personal Reasons|2
2526231|NCT01678924|8742057|P2|Overall Study|Personal Reasons|2
2526232|NCT01678924|8742058|P1|Overall Study|Personal Reasons|2
2526233|NCT01678924|8742055|P4|Overall Study|Lost to Follow-up|2
2526234|NCT01678924|8742056|P3|Overall Study|Lost to Follow-up|0
2526235|NCT01678924|8742057|P2|Overall Study|Lost to Follow-up|4
2526236|NCT01678924|8742058|P1|Overall Study|Lost to Follow-up|0
2526237|NCT01678924|8742055|P4|Overall Study|Lack of Efficacy|5
2526238|NCT01678924|8742056|P3|Overall Study|Lack of Efficacy|0
2526239|NCT01678924|8742057|P2|Overall Study|Lack of Efficacy|2
2526240|NCT01678924|8742058|P1|Overall Study|Lack of Efficacy|7
2526241|NCT01678924|8742055|P4|Overall Study|Adverse Event|1
2526242|NCT01678924|8742056|P3|Overall Study|Adverse Event|0
2526243|NCT01678924|8742057|P2|Overall Study|Adverse Event|1
2526244|NCT01678924|8742058|P1|Overall Study|Adverse Event|1
2526245|NCT01678911|8742189|P2|Second Intervention|Lost to Follow-up|0
2526246|NCT01678911|8742190|P1|Second Intervention|Lost to Follow-up|2
2526247|NCT01678898|8742207|P3|PB-102-F01|Physician Decision|0
2526248|NCT01678898|8742208|P2|PB-102-F01|Physician Decision|1
2526249|NCT01678898|8742209|P1|PB-102-F01|Physician Decision|0
2526250|NCT01678898|8742207|P3|PB-102-F01|Adverse Event|0
2526251|NCT01678898|8742208|P2|PB-102-F01|Adverse Event|1
2526252|NCT01678898|8742209|P1|PB-102-F01|Adverse Event|0
2526253|NCT01678820|8742319|P3|Overall Study|Not treated with double-blind study drug|2
2526254|NCT01678820|8742320|P2|Overall Study|Not treated with double-blind study drug|2
2526255|NCT01678820|8742321|P1|Overall Study|Not treated with double-blind study drug|0
2526256|NCT01678820|8742319|P3|Overall Study|Protocol Violation|4
2526257|NCT01678820|8742320|P2|Overall Study|Protocol Violation|5
2526258|NCT01678820|8742321|P1|Overall Study|Protocol Violation|4
2526259|NCT01678820|8742319|P3|Overall Study|Physician Decision|1
2526260|NCT01678820|8742320|P2|Overall Study|Physician Decision|0
2526261|NCT01678820|8742321|P1|Overall Study|Physician Decision|0
2526262|NCT01678820|8742319|P3|Overall Study|Non-compliance with study drug|0
2526263|NCT01678820|8742320|P2|Overall Study|Non-compliance with study drug|1
2526264|NCT01678820|8742321|P1|Overall Study|Non-compliance with study drug|0
2526265|NCT01678820|8742319|P3|Overall Study|Lost to Follow-up|2
2526266|NCT01678820|8742320|P2|Overall Study|Lost to Follow-up|2
2526267|NCT01678820|8742321|P1|Overall Study|Lost to Follow-up|7
2526268|NCT01678820|8742319|P3|Overall Study|Adverse Event|2
2526269|NCT01678820|8742320|P2|Overall Study|Adverse Event|2
2526270|NCT01678820|8742321|P1|Overall Study|Adverse Event|2
2526271|NCT01678820|8742319|P3|Overall Study|Protocol Specified Criteria|1
2526272|NCT01678820|8742320|P2|Overall Study|Protocol Specified Criteria|3
2526273|NCT01678820|8742321|P1|Overall Study|Protocol Specified Criteria|2
2526274|NCT01678820|8742319|P3|Overall Study|Withdrawal by Subject|2
2526275|NCT01678820|8742320|P2|Overall Study|Withdrawal by Subject|5
2526276|NCT01678820|8742321|P1|Overall Study|Withdrawal by Subject|2
2526277|NCT01678820|8742319|P3|Overall Study|Study Terminated by Sponsor|43
2526278|NCT01678820|8742320|P2|Overall Study|Study Terminated by Sponsor|43
2526279|NCT01678820|8742321|P1|Overall Study|Study Terminated by Sponsor|45
2526280|NCT01678807|8742366|P3|Overall Study|Withdrawn by Parent/Guardian|0
2526281|NCT01678807|8742367|P2|Overall Study|Withdrawn by Parent/Guardian|1
2526282|NCT01678807|8742368|P1|Overall Study|Withdrawn by Parent/Guardian|0
2526283|NCT01678807|8742366|P3|Overall Study|Adverse Event|0
2526284|NCT01678807|8742367|P2|Overall Study|Adverse Event|4
2526285|NCT01678807|8742368|P1|Overall Study|Adverse Event|4
2526286|NCT01678560|8742381|P2|Overall Study|Withdrawal by Subject|1
2526287|NCT01678560|8742382|P1|Overall Study|Withdrawal by Subject|0
2526288|NCT01678560|8742381|P2|Overall Study|Death|1
2526289|NCT01678560|8742382|P1|Overall Study|Death|0
2526290|NCT01678560|8742381|P2|Overall Study|Physician Decision|4
2526291|NCT01678560|8742382|P1|Overall Study|Physician Decision|4
2526292|NCT01678313|8742403|P2|Prostate Biopsy at 3 Months|Not received prostate biopsy|12
2526293|NCT01678313|8742404|P1|Prostate Biopsy at 3 Months|Not received prostate biopsy|11
2526294|NCT01678313|8742403|P2|PSA >4 ng/dL at 3 Months|PSA≦4|9
2526295|NCT01678313|8742404|P1|PSA >4 ng/dL at 3 Months|PSA≦4|8
2526296|NCT01678313|8742403|P2|Completed the 3-month Therapy|Physician Decision|4
2526297|NCT01678313|8742404|P1|Completed the 3-month Therapy|Physician Decision|3
2526298|NCT01678313|8742403|P2|Completed the 3-month Therapy|Lost to Follow-up|8
2526299|NCT01678313|8742404|P1|Completed the 3-month Therapy|Lost to Follow-up|3
2526300|NCT01678144|8742435|P1|Stage 1: MAR Classic|Adverse Event|1
2526301|NCT01678131|8742454|P3|Overall Study|Withdrawal by Subject|2
2526302|NCT01678131|8742455|P2|Overall Study|Withdrawal by Subject|0
2526303|NCT01678131|8742456|P1|Overall Study|Withdrawal by Subject|0
2526304|NCT01678131|8742454|P3|Overall Study|Adverse Event|0
2526305|NCT01678131|8742455|P2|Overall Study|Adverse Event|1
2526306|NCT01678131|8742456|P1|Overall Study|Adverse Event|0
2526307|NCT01677988|8742464|P1|Overall Study|Lack of Efficacy|2
2526308|NCT01677936|8742477|P2|Overall Study|Protocol Violation|4
2526309|NCT01677936|8742478|P1|Overall Study|Protocol Violation|0
2526310|NCT01677936|8742477|P2|Overall Study|Lost to Follow-up|0
2526311|NCT01677936|8742478|P1|Overall Study|Lost to Follow-up|1
2526312|NCT01677936|8742477|P2|Overall Study|Adverse Event|0
2526313|NCT01677936|8742478|P1|Overall Study|Adverse Event|1
2526314|NCT01677936|8742477|P2|Overall Study|Protocol Violation|0
2526315|NCT01677936|8742478|P1|Overall Study|Protocol Violation|3
2526316|NCT01677936|8742477|P2|Overall Study|Lost to Follow-up|1
2526317|NCT01677936|8742478|P1|Overall Study|Lost to Follow-up|4
2526318|NCT01677910|8742489|P4|Open-Label Extension Period (OLE)|Lost to Follow-up|1
2526319|NCT01677910|8742490|P3|Open-Label Extension Period (OLE)|Lost to Follow-up|0
2526320|NCT01677910|8742491|P2|Open-Label Extension Period (OLE)|Lost to Follow-up|0
2526321|NCT01677910|8742492|P1|Open-Label Extension Period (OLE)|Lost to Follow-up|0
2526322|NCT01677910|8742489|P4|Open-Label Extension Period (OLE)|Adverse Event|15
2526323|NCT01677910|8742490|P3|Open-Label Extension Period (OLE)|Adverse Event|0
2526324|NCT01677910|8742491|P2|Open-Label Extension Period (OLE)|Adverse Event|0
2526325|NCT01677910|8742492|P1|Open-Label Extension Period (OLE)|Adverse Event|0
2526326|NCT01677910|8742489|P4|Open-Label Extension Period (OLE)|Lack of Efficacy|5
2526327|NCT01677910|8742490|P3|Open-Label Extension Period (OLE)|Lack of Efficacy|0
2526328|NCT01677910|8742491|P2|Open-Label Extension Period (OLE)|Lack of Efficacy|0
2526329|NCT01677910|8742492|P1|Open-Label Extension Period (OLE)|Lack of Efficacy|0
2526330|NCT01677910|8742489|P4|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
2526331|NCT01677910|8742490|P3|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
2526332|NCT01677910|8742491|P2|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
2526333|NCT01677910|8742492|P1|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
2526334|NCT01677910|8742489|P4|Open-Label Extension Period (OLE)|Reason not Specified|2
2526335|NCT01677910|8742490|P3|Open-Label Extension Period (OLE)|Reason not Specified|0
2526336|NCT01677910|8742491|P2|Open-Label Extension Period (OLE)|Reason not Specified|0
2526337|NCT01677910|8742492|P1|Open-Label Extension Period (OLE)|Reason not Specified|0
2526338|NCT01677910|8742489|P4|Open-Label Extension Period (OLE)|Physician Decision|4
2526339|NCT01677910|8742490|P3|Open-Label Extension Period (OLE)|Physician Decision|0
2526340|NCT01677910|8742491|P2|Open-Label Extension Period (OLE)|Physician Decision|0
2526341|NCT01677910|8742492|P1|Open-Label Extension Period (OLE)|Physician Decision|0
2526342|NCT01677910|8742489|P4|Double-Blind Treatment Period|Reason Not Specified|0
2526343|NCT01677910|8742490|P3|Double-Blind Treatment Period|Reason Not Specified|0
2526344|NCT01677910|8742491|P2|Double-Blind Treatment Period|Reason Not Specified|1
2526345|NCT01677910|8742492|P1|Double-Blind Treatment Period|Reason Not Specified|0
2526346|NCT01677910|8742489|P4|Double-Blind Treatment Period|Withdrawal of consent|0
2526347|NCT01677910|8742490|P3|Double-Blind Treatment Period|Withdrawal of consent|3
2526348|NCT01677910|8742491|P2|Double-Blind Treatment Period|Withdrawal of consent|0
2526349|NCT01677910|8742492|P1|Double-Blind Treatment Period|Withdrawal of consent|1
2526350|NCT01677910|8742489|P4|Double-Blind Treatment Period|Physician Decision|0
2526351|NCT01677910|8742490|P3|Double-Blind Treatment Period|Physician Decision|1
2526352|NCT01677910|8742491|P2|Double-Blind Treatment Period|Physician Decision|0
2526353|NCT01677910|8742492|P1|Double-Blind Treatment Period|Physician Decision|0
2526354|NCT01677910|8742489|P4|Double-Blind Treatment Period|Adverse Event|0
2526355|NCT01677910|8742490|P3|Double-Blind Treatment Period|Adverse Event|3
2526356|NCT01677910|8742491|P2|Double-Blind Treatment Period|Adverse Event|2
2526357|NCT01677910|8742492|P1|Double-Blind Treatment Period|Adverse Event|6
2526358|NCT01677858|8742519|P5|Overall Study|Lost to Follow-up|1
2526359|NCT01677858|8742520|P4|Overall Study|Lost to Follow-up|0
2526360|NCT01677858|8742521|P3|Overall Study|Lost to Follow-up|0
2526361|NCT01677858|8742522|P2|Overall Study|Lost to Follow-up|0
2526362|NCT01677858|8742523|P1|Overall Study|Lost to Follow-up|0
2526363|NCT01677858|8742519|P5|Overall Study|Withdrawal by Subject|15
2526364|NCT01677858|8742520|P4|Overall Study|Withdrawal by Subject|0
2526365|NCT01677858|8742521|P3|Overall Study|Withdrawal by Subject|1
2526366|NCT01677858|8742522|P2|Overall Study|Withdrawal by Subject|1
2526367|NCT01677858|8742523|P1|Overall Study|Withdrawal by Subject|0
2526368|NCT01677858|8742519|P5|Overall Study|Progressive Disease|43
2526369|NCT01677858|8742520|P4|Overall Study|Progressive Disease|3
2526370|NCT01677858|8742521|P3|Overall Study|Progressive Disease|9
2526371|NCT01677858|8742522|P2|Overall Study|Progressive Disease|1
2526372|NCT01677858|8742523|P1|Overall Study|Progressive Disease|2
2526373|NCT01677858|8742519|P5|Overall Study|Physician Decision|12
2526374|NCT01677858|8742520|P4|Overall Study|Physician Decision|0
2526375|NCT01677858|8742521|P3|Overall Study|Physician Decision|2
2526376|NCT01677858|8742522|P2|Overall Study|Physician Decision|0
2526377|NCT01677858|8742523|P1|Overall Study|Physician Decision|1
2526378|NCT01677858|8742519|P5|Overall Study|Death|1
2526379|NCT01677858|8742520|P4|Overall Study|Death|0
2526380|NCT01677858|8742521|P3|Overall Study|Death|0
2526381|NCT01677858|8742522|P2|Overall Study|Death|0
2526382|NCT01677858|8742523|P1|Overall Study|Death|0
2526383|NCT01677858|8742519|P5|Overall Study|Adverse Event|13
2526384|NCT01677858|8742520|P4|Overall Study|Adverse Event|3
2526385|NCT01677858|8742521|P3|Overall Study|Adverse Event|2
2526386|NCT01677858|8742522|P2|Overall Study|Adverse Event|0
2526387|NCT01677858|8742523|P1|Overall Study|Adverse Event|0
2526388|NCT01677767|8742596|P1|Overall Study|Non-compliance by the participants|3
2526389|NCT01677767|8742596|P1|Overall Study|Withdrawal by Subject|10
2526390|NCT01677767|8742596|P1|Overall Study|Protocol Violation|4
2526391|NCT01677767|8742596|P1|Overall Study|Death|4
2526392|NCT01677767|8742596|P1|Overall Study|Adverse Event|1
2526393|NCT01677624|8742610|P1|Overall Study|Insuf Resp: intra-articular hemorrhage|1
2526394|NCT01677507|8742615|P2|Second Assigment|Adverse Event|3
2526395|NCT01677507|8742616|P1|Second Assigment|Adverse Event|1
2526396|NCT01677507|8742615|P2|Second Assigment|Withdrawal by Subject|2
2526397|NCT01677507|8742616|P1|Second Assigment|Withdrawal by Subject|2
2526398|NCT01677507|8742615|P2|Initial Assignment|Protocol Violation|1
2526399|NCT01677507|8742616|P1|Initial Assignment|Protocol Violation|0
2526400|NCT01677507|8742615|P2|Initial Assignment|Adverse Event|1
2526401|NCT01677507|8742616|P1|Initial Assignment|Adverse Event|0
2526402|NCT01677377|8742629|P3|Overall Study|Pregnancy|1
2526403|NCT01677377|8742630|P2|Overall Study|Pregnancy|0
2526404|NCT01677377|8742631|P1|Overall Study|Pregnancy|0
2526405|NCT01677377|8742629|P3|Overall Study|Lack of Efficacy|1
2526406|NCT01677377|8742630|P2|Overall Study|Lack of Efficacy|0
2526407|NCT01677377|8742631|P1|Overall Study|Lack of Efficacy|0
2526408|NCT01677377|8742629|P3|Overall Study|Withdrawal by Subject|3
2526409|NCT01677377|8742630|P2|Overall Study|Withdrawal by Subject|0
2526410|NCT01677377|8742631|P1|Overall Study|Withdrawal by Subject|0
2526411|NCT01677377|8742629|P3|Overall Study|Lost to Follow-up|1
2526412|NCT01677377|8742630|P2|Overall Study|Lost to Follow-up|1
2526413|NCT01677377|8742631|P1|Overall Study|Lost to Follow-up|0
2526414|NCT01677377|8742629|P3|Overall Study|Protocol Violation|0
2526415|NCT01677377|8742630|P2|Overall Study|Protocol Violation|0
2526416|NCT01677377|8742631|P1|Overall Study|Protocol Violation|1
2526417|NCT01677299|8742847|P4|Overall Study|Withdrawal by Subject|1
2526418|NCT01677299|8742848|P3|Overall Study|Withdrawal by Subject|0
2526419|NCT01677299|8742849|P2|Overall Study|Withdrawal by Subject|1
2526420|NCT01677299|8742850|P1|Overall Study|Withdrawal by Subject|0
2526421|NCT01677299|8742847|P4|Overall Study|Adverse Event|0
2526422|NCT01677299|8742848|P3|Overall Study|Adverse Event|1
2526423|NCT01677299|8742849|P2|Overall Study|Adverse Event|2
2526424|NCT01677299|8742850|P1|Overall Study|Adverse Event|0
2526425|NCT01677195|8742882|P3|Overall Study|Protocol Violation|4
2526426|NCT01677195|8742883|P2|Overall Study|Protocol Violation|3
2526427|NCT01677195|8742884|P1|Overall Study|Protocol Violation|7
2526428|NCT01677195|8742882|P3|Overall Study|Pregnancy|0
2526429|NCT01677195|8742883|P2|Overall Study|Pregnancy|1
2526430|NCT01677195|8742884|P1|Overall Study|Pregnancy|0
2526431|NCT01677195|8742882|P3|Overall Study|Physician Decision|2
2526432|NCT01677195|8742883|P2|Overall Study|Physician Decision|2
2526433|NCT01677195|8742884|P1|Overall Study|Physician Decision|1
2526434|NCT01677195|8742882|P3|Overall Study|Adverse Event|1
2526435|NCT01677195|8742883|P2|Overall Study|Adverse Event|4
2526436|NCT01677195|8742884|P1|Overall Study|Adverse Event|6
2526437|NCT01677195|8742882|P3|Overall Study|Withdrawal by Subject|1
2526438|NCT01677195|8742883|P2|Overall Study|Withdrawal by Subject|0
2526439|NCT01677195|8742884|P1|Overall Study|Withdrawal by Subject|1
2526440|NCT01677195|8742882|P3|Overall Study|Lost to Follow-up|22
2526441|NCT01677195|8742883|P2|Overall Study|Lost to Follow-up|22
2526442|NCT01677195|8742884|P1|Overall Study|Lost to Follow-up|14
2526443|NCT01677182|8742895|P3|Overall Study|Other reasons|2
2526444|NCT01677182|8742896|P2|Overall Study|Other reasons|5
2526445|NCT01677182|8742897|P1|Overall Study|Other reasons|1
2526446|NCT01677182|8742895|P3|Overall Study|Lack of Efficacy|1
2526447|NCT01677182|8742896|P2|Overall Study|Lack of Efficacy|0
2526448|NCT01677182|8742897|P1|Overall Study|Lack of Efficacy|3
2526449|NCT01677182|8742895|P3|Overall Study|Study termination|11
2526450|NCT01677182|8742896|P2|Overall Study|Study termination|9
2526451|NCT01677182|8742897|P1|Overall Study|Study termination|12
2526452|NCT01677182|8742895|P3|Overall Study|Withdrawal by Subject|10
2526453|NCT01677182|8742896|P2|Overall Study|Withdrawal by Subject|12
2526454|NCT01677182|8742897|P1|Overall Study|Withdrawal by Subject|7
2526455|NCT01677182|8742895|P3|Overall Study|Lost to Follow-up|3
2526456|NCT01677182|8742896|P2|Overall Study|Lost to Follow-up|0
2526457|NCT01677182|8742897|P1|Overall Study|Lost to Follow-up|4
2526458|NCT01677182|8742895|P3|Overall Study|Protocol Violation|4
2526459|NCT01677182|8742896|P2|Overall Study|Protocol Violation|1
2526460|NCT01677182|8742897|P1|Overall Study|Protocol Violation|5
2526461|NCT01677182|8742895|P3|Overall Study|Adverse Event|8
2526462|NCT01677182|8742896|P2|Overall Study|Adverse Event|1
2526463|NCT01677182|8742897|P1|Overall Study|Adverse Event|2
2526464|NCT01676961|8742929|P1|Overall Study|Withdrawal by Subject|1
2526465|NCT01676961|8742929|P1|Overall Study|Lost to Follow-up|1
2526466|NCT01676961|8742929|P1|Overall Study|Death|3
2526467|NCT01676909|8742936|P2|Overall Study|Lost to Follow-up|9
2526468|NCT01676909|8742937|P1|Overall Study|Lost to Follow-up|15
2526469|NCT01676909|8742936|P2|Overall Study|Withdrawal by Subject|5
2526470|NCT01676909|8742937|P1|Overall Study|Withdrawal by Subject|3
2526471|NCT01676896|8743002|P3|Overall Study|Withdrawal by Subject|19
2526472|NCT01676896|8743003|P2|Overall Study|Withdrawal by Subject|7
2526473|NCT01676896|8743004|P1|Overall Study|Withdrawal by Subject|12
2526474|NCT01676727|8743112|P1|Overall Study|Valve explanted|1
2526475|NCT01676727|8743112|P1|Overall Study|Not willing to attend 1-year visit|2
2526476|NCT01676727|8743112|P1|Overall Study|Screening failure|5
2526477|NCT01676727|8743112|P1|Overall Study|Withdrawal by Subject|6
2526478|NCT01676727|8743112|P1|Overall Study|Death|18
2526479|NCT01676701|8743126|P2|Overall Study|Sponsor Decision|4
2526480|NCT01676701|8743127|P1|Overall Study|Sponsor Decision|3
2526481|NCT01676701|8743126|P2|Overall Study|Protocol Violation|0
2526482|NCT01676701|8743127|P1|Overall Study|Protocol Violation|1
2526483|NCT01676220|8743229|P2|Overall Study|No More Need of Insulin|0
2526484|NCT01676220|8743230|P1|Overall Study|No More Need of Insulin|1
2526485|NCT01676220|8743229|P2|Overall Study|Non Serious Hypoglycemia|0
2526486|NCT01676220|8743230|P1|Overall Study|Non Serious Hypoglycemia|2
2526487|NCT01676220|8743229|P2|Overall Study|Perceived Lack of Efficacy|1
2526488|NCT01676220|8743230|P1|Overall Study|Perceived Lack of Efficacy|3
2526489|NCT01676220|8743229|P2|Overall Study|Site Closure/Site Withdrawal|4
2526490|NCT01676220|8743230|P1|Overall Study|Site Closure/Site Withdrawal|1
2526491|NCT01676220|8743229|P2|Overall Study|Selection Criterion/Protocol Violation|9
2526492|NCT01676220|8743230|P1|Overall Study|Selection Criterion/Protocol Violation|9
2526493|NCT01676220|8743229|P2|Overall Study|Lost to Follow-up|18
2526494|NCT01676220|8743230|P1|Overall Study|Lost to Follow-up|11
2526495|NCT01676220|8743229|P2|Overall Study|Personal Reason|45
2526496|NCT01676220|8743230|P1|Overall Study|Personal Reason|34
2526497|NCT01676220|8743229|P2|Overall Study|Received Rescue Therapy|22
2526498|NCT01676220|8743230|P1|Overall Study|Received Rescue Therapy|14
2526499|NCT01676220|8743229|P2|Overall Study|Protocol Violation|12
2526500|NCT01676220|8743230|P1|Overall Study|Protocol Violation|11
2526501|NCT01676220|8743229|P2|Overall Study|Lack of Efficacy|5
2526502|NCT01676220|8743230|P1|Overall Study|Lack of Efficacy|2
2526503|NCT01676220|8743229|P2|Overall Study|Adverse Event|8
2526504|NCT01676220|8743230|P1|Overall Study|Adverse Event|10
2526505|NCT01676220|8743229|P2|Overall Study|Randomized But Not Treated|1
2526506|NCT01676220|8743230|P1|Overall Study|Randomized But Not Treated|4
2526507|NCT01676116|8743262|P2|Overall Study|Protocol Violation|3
2526508|NCT01676116|8743263|P1|Overall Study|Protocol Violation|9
2526509|NCT01676116|8743262|P2|Overall Study|Unclassified|10
2526510|NCT01676116|8743263|P1|Overall Study|Unclassified|4
2526511|NCT01676116|8743262|P2|Overall Study|Adverse Event|2
2526512|NCT01676116|8743263|P1|Overall Study|Adverse Event|1
2526513|NCT01676116|8743262|P2|Overall Study|Withdrawal criteria|14
2526514|NCT01676116|8743263|P1|Overall Study|Withdrawal criteria|2
2526515|NCT01676012|8743285|P1|Overall Study|incomplete set of videos|1
2526516|NCT01676012|8743285|P1|Overall Study|Adverse Event|2
2526517|NCT01675661|8743307|P2|Overall Study|Other reason|2
2526518|NCT01675661|8743308|P1|Overall Study|Other reason|1
2526519|NCT01675661|8743307|P2|Overall Study|Death|1
2526520|NCT01675661|8743308|P1|Overall Study|Death|0
2526521|NCT01675661|8743307|P2|Overall Study|Physician Decision|2
2526522|NCT01675661|8743308|P1|Overall Study|Physician Decision|0
2526523|NCT01675661|8743307|P2|Overall Study|Withdrawal by Subject|7
2526524|NCT01675661|8743308|P1|Overall Study|Withdrawal by Subject|3
2526525|NCT01675661|8743307|P2|Overall Study|Moved away|6
2526526|NCT01675661|8743308|P1|Overall Study|Moved away|5
2526527|NCT01675661|8743307|P2|Overall Study|Practical problems|5
2526528|NCT01675661|8743308|P1|Overall Study|Practical problems|9
2526529|NCT01675661|8743307|P2|Overall Study|Lost to Follow-up|23
2526530|NCT01675661|8743308|P1|Overall Study|Lost to Follow-up|22
2526531|NCT01675622|8743337|P2|Overall Study|Other|4
2526532|NCT01675622|8743338|P1|Overall Study|Other|5
2526533|NCT01675622|8743337|P2|Overall Study|Lost to Follow-up|3
2526534|NCT01675622|8743338|P1|Overall Study|Lost to Follow-up|1
2526535|NCT01675622|8743337|P2|Overall Study|Lack of Efficacy|4
2526536|NCT01675622|8743338|P1|Overall Study|Lack of Efficacy|2
2526537|NCT01675622|8743337|P2|Overall Study|Protocol Violation|1
2526538|NCT01675622|8743338|P1|Overall Study|Protocol Violation|4
2526539|NCT01675622|8743337|P2|Overall Study|Adverse Event|10
2526540|NCT01675622|8743338|P1|Overall Study|Adverse Event|12
2526541|NCT01675622|8743337|P2|Overall Study|Withdrawal by Subject|2
2526542|NCT01675622|8743338|P1|Overall Study|Withdrawal by Subject|2
2526543|NCT01675596|8743362|P1|Overall Study|Missed Visit|1
2526544|NCT01675596|8743362|P1|Overall Study|Exit with other reason|1
2526545|NCT01675596|8743362|P1|Overall Study|Death|6
2526546|NCT01675544|8743368|P1|Overall Study|Withdrawal by Subject|2
2526547|NCT01675531|8743373|P1|Overall Study|Protocol Violation|8
2526548|NCT01675531|8743373|P1|Overall Study|Lack of Efficacy|1
2526549|NCT01675531|8743373|P1|Overall Study|Withdrawal by Subject|7
2526550|NCT01675531|8743373|P1|Overall Study|Adverse Event|9
2526551|NCT01675492|8743380|P1|Overall Study|study completed early - product approval|42
2526552|NCT01675479|8743385|P1|Overall Study|Lost to Follow-up|11
2526553|NCT01675427|8743399|P1|Overall Study|Other|2
2526554|NCT01675427|8743399|P1|Overall Study|Lost to Follow-up|5
2526555|NCT01675427|8743399|P1|Overall Study|Sample not Collected by Mistake|2
2526556|NCT01675427|8743399|P1|Overall Study|Participant Refused Sample Collection|18
2526557|NCT01675427|8743399|P1|Overall Study|Withdrawal by Subject|7
2526558|NCT01675167|8743699|P3|Double-blind Treatment Phase|Other|5
2526559|NCT01675167|8743700|P2|Double-blind Treatment Phase|Other|7
2526560|NCT01675167|8743701|P1|Double-blind Treatment Phase|Other|0
2526561|NCT01675167|8743699|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9
2526562|NCT01675167|8743700|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
2526563|NCT01675167|8743701|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
2526564|NCT01675167|8743699|P3|Double-blind Treatment Phase|Lost to Follow-up|5
2526565|NCT01675167|8743700|P2|Double-blind Treatment Phase|Lost to Follow-up|1
2526566|NCT01675167|8743701|P1|Double-blind Treatment Phase|Lost to Follow-up|0
2526567|NCT01675167|8743699|P3|Double-blind Treatment Phase|Protocol Violation|11
2526568|NCT01675167|8743700|P2|Double-blind Treatment Phase|Protocol Violation|4
2526569|NCT01675167|8743701|P1|Double-blind Treatment Phase|Protocol Violation|0
2526570|NCT01675167|8743699|P3|Double-blind Treatment Phase|Adverse Event|13
2526571|NCT01675167|8743700|P2|Double-blind Treatment Phase|Adverse Event|5
2526572|NCT01675167|8743701|P1|Double-blind Treatment Phase|Adverse Event|0
2526573|NCT01675167|8743699|P3|Double-blind Treatment Phase|Withdrawal by Subject|6
2526574|NCT01675167|8743700|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
2526575|NCT01675167|8743701|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
2526576|NCT01675167|8743699|P3|Double-blind Treatment Phase|Lack of Efficacy|61
2526577|NCT01675167|8743700|P2|Double-blind Treatment Phase|Lack of Efficacy|19
2526578|NCT01675167|8743701|P1|Double-blind Treatment Phase|Lack of Efficacy|0
2526579|NCT01675167|8743699|P3|Open-label Titration Phase|Other|0
2526580|NCT01675167|8743700|P2|Open-label Titration Phase|Other|0
2526581|NCT01675167|8743701|P1|Open-label Titration Phase|Other|55
2526582|NCT01675167|8743699|P3|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
2526583|NCT01675167|8743700|P2|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
2526584|NCT01675167|8743701|P1|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1
2526585|NCT01675167|8743699|P3|Open-label Titration Phase|Lost to Follow-up|0
2526586|NCT01675167|8743700|P2|Open-label Titration Phase|Lost to Follow-up|0
2526587|NCT01675167|8743701|P1|Open-label Titration Phase|Lost to Follow-up|15
2526588|NCT01675167|8743699|P3|Open-label Titration Phase|Protocol Violation|0
2526589|NCT01675167|8743700|P2|Open-label Titration Phase|Protocol Violation|0
2526590|NCT01675167|8743701|P1|Open-label Titration Phase|Protocol Violation|43
2526591|NCT01675167|8743699|P3|Open-label Titration Phase|Withdrawal by Subject|0
2526592|NCT01675167|8743700|P2|Open-label Titration Phase|Withdrawal by Subject|0
2526593|NCT01675167|8743701|P1|Open-label Titration Phase|Withdrawal by Subject|46
2526594|NCT01675167|8743699|P3|Open-label Titration Phase|Lack of Efficacy|0
2526595|NCT01675167|8743700|P2|Open-label Titration Phase|Lack of Efficacy|0
2526596|NCT01675167|8743701|P1|Open-label Titration Phase|Lack of Efficacy|63
2526597|NCT01675167|8743699|P3|Open-label Titration Phase|Adverse Event|0
2526598|NCT01675167|8743700|P2|Open-label Titration Phase|Adverse Event|0
2526599|NCT01675167|8743701|P1|Open-label Titration Phase|Adverse Event|81
2526600|NCT01675141|8743723|P1|Overall Study|No treatment, per protocol|1
2526601|NCT01675141|8743723|P1|Overall Study|Physician Decision|4
2526602|NCT01675141|8743723|P1|Overall Study|Withdrawal by Subject|3
2526603|NCT01675141|8743723|P1|Overall Study|Lenalidomide outside NIH|3
2526604|NCT01675128|8743736|P3|Overall Study|Pulmonary complication; off study|0
2526605|NCT01675128|8743737|P2|Overall Study|Pulmonary complication; off study|1
2526606|NCT01675128|8743738|P1|Overall Study|Pulmonary complication; off study|0
2526607|NCT01675128|8743736|P3|Overall Study|Refused further treatment|0
2526608|NCT01675128|8743737|P2|Overall Study|Refused further treatment|0
2526609|NCT01675128|8743738|P1|Overall Study|Refused further treatment|1
2526610|NCT01675128|8743736|P3|Overall Study|Disease progression on study|1
2526611|NCT01675128|8743737|P2|Overall Study|Disease progression on study|1
2526612|NCT01675128|8743738|P1|Overall Study|Disease progression on study|1
2526613|NCT01675050|8743766|P2|Period One Treatment|Withdrawal by Subject|0
2526614|NCT01675050|8743767|P1|Period One Treatment|Withdrawal by Subject|1
2526615|NCT01675011|8743777|P2|Overall Study|Trial terminated by Sponsor|1
2526616|NCT01675011|8743778|P1|Overall Study|Trial terminated by Sponsor|3
2526617|NCT01674725|8743786|P2|Overall Study|Lost to Follow-up|1
2526618|NCT01674725|8743787|P1|Overall Study|Lost to Follow-up|0
2526619|NCT01674725|8743786|P2|Overall Study|Withdrawal by Subject|0
2526620|NCT01674725|8743787|P1|Overall Study|Withdrawal by Subject|1
2526621|NCT01674725|8743786|P2|Overall Study|Did not receive study drug|0
2526622|NCT01674725|8743787|P1|Overall Study|Did not receive study drug|1
2526623|NCT01674725|8743786|P2|Overall Study|Adverse Event|0
2526624|NCT01674725|8743787|P1|Overall Study|Adverse Event|1
2526625|NCT01674712|8743806|P5|Overall Study|Lack of Efficacy|1
2526626|NCT01674712|8743807|P4|Overall Study|Lack of Efficacy|0
2526627|NCT01674712|8743808|P3|Overall Study|Lack of Efficacy|1
2526628|NCT01674712|8743809|P2|Overall Study|Lack of Efficacy|0
2526629|NCT01674712|8743810|P1|Overall Study|Lack of Efficacy|0
2526630|NCT01674712|8743806|P5|Overall Study|Administrative|1
2526631|NCT01674712|8743807|P4|Overall Study|Administrative|0
2526632|NCT01674712|8743808|P3|Overall Study|Administrative|0
2526633|NCT01674712|8743809|P2|Overall Study|Administrative|1
2526634|NCT01674712|8743810|P1|Overall Study|Administrative|0
2526635|NCT01674712|8743806|P5|Overall Study|Withdrawal by Subject|3
2526636|NCT01674712|8743807|P4|Overall Study|Withdrawal by Subject|4
2526637|NCT01674712|8743808|P3|Overall Study|Withdrawal by Subject|5
2526638|NCT01674712|8743809|P2|Overall Study|Withdrawal by Subject|2
2526639|NCT01674712|8743810|P1|Overall Study|Withdrawal by Subject|2
2526640|NCT01674712|8743806|P5|Overall Study|Protocol Violation|0
2526641|NCT01674712|8743807|P4|Overall Study|Protocol Violation|0
2526642|NCT01674712|8743808|P3|Overall Study|Protocol Violation|0
2526643|NCT01674712|8743809|P2|Overall Study|Protocol Violation|0
2526644|NCT01674712|8743810|P1|Overall Study|Protocol Violation|2
2526645|NCT01674712|8743806|P5|Overall Study|Lost to Follow-up|0
2526646|NCT01674712|8743807|P4|Overall Study|Lost to Follow-up|0
2526647|NCT01674712|8743808|P3|Overall Study|Lost to Follow-up|0
2526648|NCT01674712|8743809|P2|Overall Study|Lost to Follow-up|0
2526649|NCT01674712|8743810|P1|Overall Study|Lost to Follow-up|1
2526650|NCT01674712|8743806|P5|Overall Study|Adverse Event|6
2526651|NCT01674712|8743807|P4|Overall Study|Adverse Event|4
2526652|NCT01674712|8743808|P3|Overall Study|Adverse Event|3
2526653|NCT01674712|8743809|P2|Overall Study|Adverse Event|6
2526654|NCT01674712|8743810|P1|Overall Study|Adverse Event|5
2526655|NCT01674647|8743834|P2|30-day Safety Follow-up Period|Lost to Follow-up|5
2526656|NCT01674647|8743835|P1|30-day Safety Follow-up Period|Lost to Follow-up|8
2526657|NCT01674647|8743834|P2|30-day Safety Follow-up Period|Withdrawal by Subject|8
2526658|NCT01674647|8743835|P1|30-day Safety Follow-up Period|Withdrawal by Subject|7
2526659|NCT01674647|8743834|P2|30-day Safety Follow-up Period|Logistical difficulties|3
2526660|NCT01674647|8743835|P1|30-day Safety Follow-up Period|Logistical difficulties|1
2526661|NCT01674647|8743834|P2|30-day Safety Follow-up Period|Protocol Violation|22
2526662|NCT01674647|8743835|P1|30-day Safety Follow-up Period|Protocol Violation|39
2526663|NCT01674647|8743834|P2|30-day Safety Follow-up Period|Non-compliance with study drug|1
2526664|NCT01674647|8743835|P1|30-day Safety Follow-up Period|Non-compliance with study drug|0
2526665|NCT01674647|8743834|P2|30-day Safety Follow-up Period|Death|2
2526666|NCT01674647|8743835|P1|30-day Safety Follow-up Period|Death|3
2526667|NCT01674647|8743834|P2|Treatment Period|Protocol Violation|36
2526668|NCT01674647|8743835|P1|Treatment Period|Protocol Violation|56
2526669|NCT01674647|8743834|P2|Treatment Period|Treatment failure|14
2526670|NCT01674647|8743835|P1|Treatment Period|Treatment failure|0
2526671|NCT01674647|8743834|P2|Treatment Period|Logistical difficulties|8
2526672|NCT01674647|8743835|P1|Treatment Period|Logistical difficulties|5
2526673|NCT01674647|8743834|P2|Treatment Period|Switching to other therapy|2
2526674|NCT01674647|8743835|P1|Treatment Period|Switching to other therapy|5
2526675|NCT01674647|8743834|P2|Treatment Period|Withdrawal by Subject|16
2526676|NCT01674647|8743835|P1|Treatment Period|Withdrawal by Subject|19
2526677|NCT01674647|8743834|P2|Treatment Period|Lost to Follow-up|1
2526678|NCT01674647|8743835|P1|Treatment Period|Lost to Follow-up|1
2526679|NCT01674647|8743834|P2|Treatment Period|Non-compliance with study drug|0
2526680|NCT01674647|8743835|P1|Treatment Period|Non-compliance with study drug|3
2526681|NCT01674647|8743834|P2|Treatment Period|Adverse Event|22
2526682|NCT01674647|8743835|P1|Treatment Period|Adverse Event|60
2526683|NCT01674647|8743834|P2|Treatment Period|Physician Decision|1
2526684|NCT01674647|8743835|P1|Treatment Period|Physician Decision|3
2526685|NCT01674647|8743834|P2|Treatment Period|Efficacy outcome reached|1
2526686|NCT01674647|8743835|P1|Treatment Period|Efficacy outcome reached|0
2526687|NCT01674647|8743834|P2|Treatment Period|Death|1
2526688|NCT01674647|8743835|P1|Treatment Period|Death|4
2526689|NCT01674634|8743861|P1|Overall Study|Lost to Follow-up|3
2526690|NCT01674634|8743861|P1|Overall Study|Withdrawal by Subject|3
2526691|NCT01674569|8743962|P6|Overall Study|Withdrawal by Subject|0
2526692|NCT01674569|8743963|P5|Overall Study|Withdrawal by Subject|0
2526693|NCT01674569|8743964|P4|Overall Study|Withdrawal by Subject|0
2526694|NCT01674569|8743965|P3|Overall Study|Withdrawal by Subject|1
2526695|NCT01674569|8743966|P2|Overall Study|Withdrawal by Subject|0
2526696|NCT01674569|8743967|P1|Overall Study|Withdrawal by Subject|0
2526697|NCT01674569|8743962|P6|Overall Study|Protocol Violation|0
2526698|NCT01674569|8743963|P5|Overall Study|Protocol Violation|0
2526699|NCT01674569|8743964|P4|Overall Study|Protocol Violation|0
2526700|NCT01674569|8743965|P3|Overall Study|Protocol Violation|1
2526701|NCT01674569|8743966|P2|Overall Study|Protocol Violation|1
2526702|NCT01674569|8743967|P1|Overall Study|Protocol Violation|0
2526703|NCT01674569|8743962|P6|Overall Study|Adverse Event|2
2526704|NCT01674569|8743963|P5|Overall Study|Adverse Event|2
2526705|NCT01674569|8743964|P4|Overall Study|Adverse Event|1
2526706|NCT01674569|8743965|P3|Overall Study|Adverse Event|0
2526707|NCT01674569|8743966|P2|Overall Study|Adverse Event|2
2526708|NCT01674569|8743967|P1|Overall Study|Adverse Event|0
2526709|NCT01674062|8743988|P2|Overall Study|Programming Error|0
2526710|NCT01674062|8743989|P1|Overall Study|Programming Error|1
2526711|NCT01674062|8743988|P2|Overall Study|Death|1
2526712|NCT01674062|8743989|P1|Overall Study|Death|0
2526713|NCT01674062|8743988|P2|Overall Study|Adverse Event|1
2526714|NCT01674062|8743989|P1|Overall Study|Adverse Event|1
2526715|NCT01674062|8743988|P2|Overall Study|Other|1
2526716|NCT01674062|8743989|P1|Overall Study|Other|8
2526717|NCT01674062|8743988|P2|Overall Study|Insufficient Therapeutic Response|26
2526718|NCT01674062|8743989|P1|Overall Study|Insufficient Therapeutic Response|56
2526719|NCT01674010|8744004|P3|Randomization Phase 2|Withdrawal by Subject|7
2526720|NCT01674010|8744005|P2|Randomization Phase 2|Withdrawal by Subject|8
2526721|NCT01674010|8744006|P1|Randomization Phase 2|Withdrawal by Subject|0
2526722|NCT01674010|8744004|P3|Randomization Phase 2|Sponsor Decision|45
2526723|NCT01674010|8744005|P2|Randomization Phase 2|Sponsor Decision|42
2526724|NCT01674010|8744006|P1|Randomization Phase 2|Sponsor Decision|0
2526725|NCT01674010|8744004|P3|Randomization Phase 2|Protocol Violation|1
2526726|NCT01674010|8744005|P2|Randomization Phase 2|Protocol Violation|1
2526727|NCT01674010|8744006|P1|Randomization Phase 2|Protocol Violation|0
2526728|NCT01674010|8744004|P3|Randomization Phase 2|Pregnancy|1
2526729|NCT01674010|8744005|P2|Randomization Phase 2|Pregnancy|1
2526730|NCT01674010|8744006|P1|Randomization Phase 2|Pregnancy|0
2526731|NCT01674010|8744004|P3|Randomization Phase 2|Physician Decision|2
2526732|NCT01674010|8744005|P2|Randomization Phase 2|Physician Decision|0
2526733|NCT01674010|8744006|P1|Randomization Phase 2|Physician Decision|0
2526734|NCT01674010|8744004|P3|Randomization Phase 2|Mood episode recurrence|2
2526735|NCT01674010|8744005|P2|Randomization Phase 2|Mood episode recurrence|8
2526736|NCT01674010|8744006|P1|Randomization Phase 2|Mood episode recurrence|0
2526737|NCT01674010|8744004|P3|Randomization Phase 2|Lost to Follow-up|2
2526738|NCT01674010|8744005|P2|Randomization Phase 2|Lost to Follow-up|1
2526739|NCT01674010|8744006|P1|Randomization Phase 2|Lost to Follow-up|0
2526740|NCT01674010|8744004|P3|Randomization Phase 2|Adverse Event|1
2526741|NCT01674010|8744005|P2|Randomization Phase 2|Adverse Event|1
2526742|NCT01674010|8744006|P1|Randomization Phase 2|Adverse Event|0
2526743|NCT01674010|8744004|P3|Open Treatment Phase 1|Withdrawal by Subject|0
2526744|NCT01674010|8744005|P2|Open Treatment Phase 1|Withdrawal by Subject|0
2526745|NCT01674010|8744006|P1|Open Treatment Phase 1|Withdrawal by Subject|25
2526746|NCT01674010|8744004|P3|Open Treatment Phase 1|Did not remain in a stable remission|0
2526747|NCT01674010|8744005|P2|Open Treatment Phase 1|Did not remain in a stable remission|0
2526748|NCT01674010|8744006|P1|Open Treatment Phase 1|Did not remain in a stable remission|30
2526749|NCT01674010|8744004|P3|Open Treatment Phase 1|Sponsor Decision|0
2526750|NCT01674010|8744005|P2|Open Treatment Phase 1|Sponsor Decision|0
2526751|NCT01674010|8744006|P1|Open Treatment Phase 1|Sponsor Decision|79
2526752|NCT01674010|8744004|P3|Open Treatment Phase 1|Protocol Violation|0
2526753|NCT01674010|8744005|P2|Open Treatment Phase 1|Protocol Violation|0
2526754|NCT01674010|8744006|P1|Open Treatment Phase 1|Protocol Violation|7
2526755|NCT01674010|8744004|P3|Open Treatment Phase 1|Physician Decision|0
2526756|NCT01674010|8744005|P2|Open Treatment Phase 1|Physician Decision|0
2526757|NCT01674010|8744006|P1|Open Treatment Phase 1|Physician Decision|9
2526758|NCT01674010|8744004|P3|Open Treatment Phase 1|Lost to Follow-up|0
2526759|NCT01674010|8744005|P2|Open Treatment Phase 1|Lost to Follow-up|0
2526760|NCT01674010|8744006|P1|Open Treatment Phase 1|Lost to Follow-up|19
2526761|NCT01674010|8744004|P3|Open Treatment Phase 1|Death|0
2526762|NCT01674010|8744005|P2|Open Treatment Phase 1|Death|0
2526763|NCT01674010|8744006|P1|Open Treatment Phase 1|Death|1
2526764|NCT01674010|8744004|P3|Open Treatment Phase 1|Adverse Event|0
2526765|NCT01674010|8744005|P2|Open Treatment Phase 1|Adverse Event|0
2526766|NCT01674010|8744006|P1|Open Treatment Phase 1|Adverse Event|10
2526767|NCT01673984|8744025|P2|Overall Study|Study termination|6
2526768|NCT01673984|8744026|P1|Overall Study|Study termination|9
2526769|NCT01673984|8744025|P2|Overall Study|Adverse Event|0
2526770|NCT01673984|8744026|P1|Overall Study|Adverse Event|1
2526771|NCT01673867|8744076|P2|Treatment|Physician Decision|1
2526772|NCT01673867|8744077|P1|Treatment|Physician Decision|0
2526773|NCT01673867|8744076|P2|Treatment|Symptomatic deterioration|1
2526774|NCT01673867|8744077|P1|Treatment|Symptomatic deterioration|0
2526775|NCT01673867|8744076|P2|Treatment|Required prolonged hospitalization|1
2526776|NCT01673867|8744077|P1|Treatment|Required prolonged hospitalization|0
2526777|NCT01673867|8744076|P2|Treatment|Health status not improved|0
2526778|NCT01673867|8744077|P1|Treatment|Health status not improved|1
2526779|NCT01673867|8744076|P2|Treatment|Required steroid therapy|0
2526780|NCT01673867|8744077|P1|Treatment|Required steroid therapy|1
2526781|NCT01673867|8744076|P2|Treatment|No longer meets criteria|0
2526782|NCT01673867|8744077|P1|Treatment|No longer meets criteria|2
2526783|NCT01673867|8744076|P2|Treatment|Maximum clinical benefit|10
2526784|NCT01673867|8744077|P1|Treatment|Maximum clinical benefit|0
2526785|NCT01673867|8744076|P2|Treatment|Withdrawal by Subject|6
2526786|NCT01673867|8744077|P1|Treatment|Withdrawal by Subject|4
2526787|NCT01673867|8744076|P2|Treatment|Requested treatment discontinuation|16
2526788|NCT01673867|8744077|P1|Treatment|Requested treatment discontinuation|5
2526789|NCT01673867|8744076|P2|Treatment|AE unrelated to study drug|11
2526790|NCT01673867|8744077|P1|Treatment|AE unrelated to study drug|19
2526791|NCT01673867|8744076|P2|Treatment|Death|1
2526792|NCT01673867|8744077|P1|Treatment|Death|1
2526793|NCT01673867|8744076|P2|Treatment|Study Drug Toxicity|42
2526794|NCT01673867|8744077|P1|Treatment|Study Drug Toxicity|17
2526795|NCT01673867|8744076|P2|Treatment|Disease Progression|179
2526796|NCT01673867|8744077|P1|Treatment|Disease Progression|194
2526797|NCT01673867|8744076|P2|Randomization|No longer meets criteria|5
2526798|NCT01673867|8744077|P1|Randomization|No longer meets criteria|4
2526799|NCT01673867|8744076|P2|Randomization|Lost to Follow-up|1
2526800|NCT01673867|8744077|P1|Randomization|Lost to Follow-up|0
2526801|NCT01673867|8744076|P2|Randomization|Withdrawal by Subject|12
2526802|NCT01673867|8744077|P1|Randomization|Withdrawal by Subject|0
2526803|NCT01673867|8744076|P2|Randomization|Requested treatment discontinuation|4
2526804|NCT01673867|8744077|P1|Randomization|Requested treatment discontinuation|0
2526805|NCT01673867|8744076|P2|Randomization|AE unrelated to study drug|0
2526806|NCT01673867|8744077|P1|Randomization|AE unrelated to study drug|1
2526807|NCT01673854|8744103|P1|Vem 2 Phase (Vemurafenib Retreatment)|Death|1
2526808|NCT01673854|8744103|P1|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1
2526809|NCT01673854|8744103|P1|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5
2526810|NCT01673854|8744103|P1|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12
2526811|NCT01673854|8744103|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7
2526812|NCT01673854|8744103|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2
2526813|NCT01673854|8744103|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1
2526814|NCT01673854|8744103|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1
2526815|NCT01673854|8744103|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1
2526816|NCT01673854|8744103|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2
2526817|NCT01673854|8744103|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6
2526818|NCT01673854|8744103|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7
2526819|NCT01673698|8744126|P2|Overall Study|Lost to Follow-up|13
2526820|NCT01673698|8744127|P1|Overall Study|Lost to Follow-up|51
2526821|NCT01673646|8744138|P3|Overall Study|Completed Core/did not enter Ext.|1
2526822|NCT01673646|8744139|P2|Overall Study|Completed Core/did not enter Ext.|1
2526823|NCT01673646|8744140|P1|Overall Study|Completed Core/did not enter Ext.|2
2526824|NCT01673646|8744138|P3|Overall Study|Withdrawal by Subject|2
2526825|NCT01673646|8744139|P2|Overall Study|Withdrawal by Subject|2
2526826|NCT01673646|8744140|P1|Overall Study|Withdrawal by Subject|0
2526827|NCT01673646|8744138|P3|Overall Study|Condition no longer requires study drug|0
2526828|NCT01673646|8744139|P2|Overall Study|Condition no longer requires study drug|1
2526829|NCT01673646|8744140|P1|Overall Study|Condition no longer requires study drug|0
2526830|NCT01673646|8744138|P3|Overall Study|Unsatisfactory therapeutic effect|0
2526831|NCT01673646|8744139|P2|Overall Study|Unsatisfactory therapeutic effect|2
2526832|NCT01673646|8744140|P1|Overall Study|Unsatisfactory therapeutic effect|0
2526833|NCT01673646|8744138|P3|Overall Study|Adverse Event|1
2526834|NCT01673646|8744139|P2|Overall Study|Adverse Event|1
2526835|NCT01673646|8744140|P1|Overall Study|Adverse Event|2
2526836|NCT01673620|8744179|P2|Overall Study|Adverse Event|0
2526837|NCT01673620|8744180|P1|Overall Study|Adverse Event|1
2526838|NCT01673594|8744190|P2|Overall Study|Withdrawal by Subject|1
2526839|NCT01673594|8744191|P1|Overall Study|Withdrawal by Subject|0
2526840|NCT01673594|8744190|P2|Overall Study|Physician Decision|4
2526841|NCT01673594|8744191|P1|Overall Study|Physician Decision|2
2526842|NCT01673594|8744190|P2|Overall Study|Lost to Follow-up|0
2526843|NCT01673594|8744191|P1|Overall Study|Lost to Follow-up|1
2526844|NCT01673594|8744190|P2|Overall Study|Adverse Event|1
2526845|NCT01673594|8744191|P1|Overall Study|Adverse Event|3
2526846|NCT01673490|8744210|P1|Overall Study|Withdrawal by Subject|3
2526847|NCT01673490|8744210|P1|Overall Study|Adverse Event|3
2526848|NCT01673490|8744210|P1|Overall Study|Lost to Follow-up|1
2526849|NCT01673373|8744227|P1|Overall Study|Death|2
2526850|NCT01673347|8744243|P1|Overall Study|failure of allograft|7
2526851|NCT01673282|8744252|P2|Overall Study|Other|6
2526852|NCT01673282|8744253|P1|Overall Study|Other|1
2526853|NCT01673282|8744252|P2|Overall Study|Withdrawal by Subject|3
2526854|NCT01673282|8744253|P1|Overall Study|Withdrawal by Subject|3
2526855|NCT01673282|8744252|P2|Overall Study|Lost to Follow-up|10
2526856|NCT01673282|8744253|P1|Overall Study|Lost to Follow-up|11
2526857|NCT01673282|8744252|P2|Overall Study|Lack of Efficacy|2
2526858|NCT01673282|8744253|P1|Overall Study|Lack of Efficacy|9
2526859|NCT01673282|8744252|P2|Overall Study|Adverse Drug Reaction - Vimpat|5
2526860|NCT01673282|8744253|P1|Overall Study|Adverse Drug Reaction - Vimpat|9
2526861|NCT01673178|8744289|P5|Overall Study|Other|0
2526862|NCT01673178|8744290|P4|Overall Study|Other|1
2526863|NCT01673178|8744291|P3|Overall Study|Other|2
2526864|NCT01673178|8744292|P2|Overall Study|Other|0
2526865|NCT01673178|8744293|P1|Overall Study|Other|1
2526866|NCT01673178|8744289|P5|Overall Study|Adverse Event|0
2526867|NCT01673178|8744290|P4|Overall Study|Adverse Event|2
2526868|NCT01673178|8744291|P3|Overall Study|Adverse Event|0
2526869|NCT01673178|8744292|P2|Overall Study|Adverse Event|0
2526870|NCT01673178|8744293|P1|Overall Study|Adverse Event|1
2526871|NCT01673178|8744289|P5|Overall Study|Protocol Violation|0
2526872|NCT01673178|8744290|P4|Overall Study|Protocol Violation|1
2526873|NCT01673178|8744291|P3|Overall Study|Protocol Violation|0
2526874|NCT01673178|8744292|P2|Overall Study|Protocol Violation|1
2526875|NCT01673178|8744293|P1|Overall Study|Protocol Violation|1
2526876|NCT01673178|8744289|P5|Overall Study|Withdrawal by Subject|2
2526877|NCT01673178|8744290|P4|Overall Study|Withdrawal by Subject|4
2526878|NCT01673178|8744291|P3|Overall Study|Withdrawal by Subject|1
2526879|NCT01673178|8744292|P2|Overall Study|Withdrawal by Subject|0
2526880|NCT01673178|8744293|P1|Overall Study|Withdrawal by Subject|0
2526881|NCT01673178|8744289|P5|Overall Study|Lost to Follow-up|0
2526882|NCT01673178|8744290|P4|Overall Study|Lost to Follow-up|0
2526883|NCT01673178|8744291|P3|Overall Study|Lost to Follow-up|0
2526884|NCT01673178|8744292|P2|Overall Study|Lost to Follow-up|1
2526885|NCT01673178|8744293|P1|Overall Study|Lost to Follow-up|0
2526886|NCT01673126|8744532|P2|Overall Study|change of diagnosis|3
2526887|NCT01673126|8744533|P1|Overall Study|change of diagnosis|4
2526888|NCT01673009|8744572|P1|Overall Study|Withdrawal by Subject|8
2526889|NCT01673009|8744572|P1|Overall Study|Physician Decision|5
2526890|NCT01672970|8744657|P1|Overall Study|Enrolled but not treated|1
2526891|NCT01672970|8744657|P1|Overall Study|Other|9
2526892|NCT01672970|8744657|P1|Overall Study|Lost to Follow-up|5
2526893|NCT01672970|8744657|P1|Overall Study|Withdrawal by Subject|2
2526894|NCT01672970|8744657|P1|Overall Study|Adverse Event|18
2526895|NCT01672970|8744657|P1|Overall Study|Lack of Efficacy|12
2526896|NCT01672957|8744693|P1|Overall Study|ICF Signed After Transplantation|5
2526897|NCT01672957|8744693|P1|Overall Study|Death|2
2526898|NCT01672957|8744693|P1|Overall Study|Protocol Violation|48
2526899|NCT01672892|8744708|P2|Overall Study|Protocol Violation|3
2526900|NCT01672892|8744709|P1|Overall Study|Protocol Violation|7
2526901|NCT01672879|8744738|P3|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0
2526902|NCT01672879|8744739|P2|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0
2526903|NCT01672879|8744740|P1|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1
2526904|NCT01672879|8744738|P3|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1
2526905|NCT01672879|8744739|P2|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0
2526906|NCT01672879|8744740|P1|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1
2526907|NCT01672879|8744738|P3|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1
2526908|NCT01672879|8744739|P2|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1
2526909|NCT01672879|8744740|P1|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5
2526910|NCT01672879|8744738|P3|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6
2526911|NCT01672879|8744739|P2|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16
2526912|NCT01672879|8744740|P1|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8
2526913|NCT01672879|8744738|P3|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8
2526914|NCT01672879|8744739|P2|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17
2526915|NCT01672879|8744740|P1|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15
2526916|NCT01672879|8744738|P3|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1
2526917|NCT01672879|8744739|P2|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0
2526918|NCT01672879|8744740|P1|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0
2526919|NCT01672879|8744738|P3|Blinded Phase (Up to 240 Weeks)|Missing|0
2526920|NCT01672879|8744739|P2|Blinded Phase (Up to 240 Weeks)|Missing|0
2526921|NCT01672879|8744740|P1|Blinded Phase (Up to 240 Weeks)|Missing|1
2526922|NCT01672879|8744738|P3|Blinded Phase (Up to 240 Weeks)|Death|0
2526923|NCT01672879|8744739|P2|Blinded Phase (Up to 240 Weeks)|Death|2
2526924|NCT01672879|8744740|P1|Blinded Phase (Up to 240 Weeks)|Death|0
2526925|NCT01672879|8744738|P3|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2
2526926|NCT01672879|8744739|P2|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0
2526927|NCT01672879|8744740|P1|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5
2526928|NCT01672879|8744738|P3|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1
2526929|NCT01672879|8744739|P2|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3
2526930|NCT01672879|8744740|P1|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4
2526931|NCT01672879|8744738|P3|Blinded Phase (Up to 240 Weeks)|Adverse Event|7
2526932|NCT01672879|8744739|P2|Blinded Phase (Up to 240 Weeks)|Adverse Event|2
2526933|NCT01672879|8744740|P1|Blinded Phase (Up to 240 Weeks)|Adverse Event|5
2526934|NCT01672879|8744738|P3|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6
2526935|NCT01672879|8744739|P2|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7
2526936|NCT01672879|8744740|P1|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14
2526937|NCT01672879|8744738|P3|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61
2526938|NCT01672879|8744739|P2|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55
2526939|NCT01672879|8744740|P1|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43
2526940|NCT01672866|8744755|P3|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0
2526941|NCT01672866|8744756|P2|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0
2526942|NCT01672866|8744757|P1|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1
2526943|NCT01672866|8744755|P3|Open-Label Phase (up to 240 Weeks)|Death|0
2526944|NCT01672866|8744756|P2|Open-Label Phase (up to 240 Weeks)|Death|0
2526945|NCT01672866|8744757|P1|Open-Label Phase (up to 240 Weeks)|Death|1
2526946|NCT01672866|8744755|P3|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1
2526947|NCT01672866|8744756|P2|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0
2526948|NCT01672866|8744757|P1|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1
2526949|NCT01672866|8744755|P3|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15
2526950|NCT01672866|8744756|P2|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15
2526951|NCT01672866|8744757|P1|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8
2526952|NCT01672866|8744755|P3|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16
2526953|NCT01672866|8744756|P2|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15
2526954|NCT01672866|8744757|P1|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11
2526955|NCT01672866|8744755|P3|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0
2526956|NCT01672866|8744756|P2|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0
2526957|NCT01672866|8744757|P1|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3
2526958|NCT01672866|8744755|P3|Blinded Phase (up to 240 Weeks)|Death|1
2526959|NCT01672866|8744756|P2|Blinded Phase (up to 240 Weeks)|Death|0
2526960|NCT01672866|8744757|P1|Blinded Phase (up to 240 Weeks)|Death|0
2526961|NCT01672866|8744755|P3|Blinded Phase (up to 240 Weeks)|Protocol Violation|0
2526962|NCT01672866|8744756|P2|Blinded Phase (up to 240 Weeks)|Protocol Violation|0
2526963|NCT01672866|8744757|P1|Blinded Phase (up to 240 Weeks)|Protocol Violation|2
2526964|NCT01672866|8744755|P3|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2
2526965|NCT01672866|8744756|P2|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3
2526966|NCT01672866|8744757|P1|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3
2526967|NCT01672866|8744755|P3|Blinded Phase (up to 240 Weeks)|Adverse Event|3
2526968|NCT01672866|8744756|P2|Blinded Phase (up to 240 Weeks)|Adverse Event|3
2526969|NCT01672866|8744757|P1|Blinded Phase (up to 240 Weeks)|Adverse Event|3
2526970|NCT01672866|8744755|P3|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5
2526971|NCT01672866|8744756|P2|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3
2526972|NCT01672866|8744757|P1|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3
2526973|NCT01672866|8744755|P3|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12
2526974|NCT01672866|8744756|P2|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8
2526975|NCT01672866|8744757|P1|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9
2526976|NCT01672866|8744755|P3|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35
2526977|NCT01672866|8744756|P2|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42
2526978|NCT01672866|8744757|P1|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40
2526979|NCT01672853|8744772|P3|Overall Study|Randomized but Never Treated|1
2526980|NCT01672853|8744773|P2|Overall Study|Randomized but Never Treated|0
2526981|NCT01672853|8744774|P1|Overall Study|Randomized but Never Treated|0
2526982|NCT01672853|8744772|P3|Overall Study|Lost to Follow-up|0
2526983|NCT01672853|8744773|P2|Overall Study|Lost to Follow-up|1
2526984|NCT01672853|8744774|P1|Overall Study|Lost to Follow-up|0
2526985|NCT01672853|8744772|P3|Overall Study|Adverse Event|8
2526986|NCT01672853|8744773|P2|Overall Study|Adverse Event|6
2526987|NCT01672853|8744774|P1|Overall Study|Adverse Event|4
2526988|NCT01672853|8744772|P3|Overall Study|Withdrew Consent|5
2526989|NCT01672853|8744773|P2|Overall Study|Withdrew Consent|5
2526990|NCT01672853|8744774|P1|Overall Study|Withdrew Consent|5
2526991|NCT01672853|8744772|P3|Overall Study|Investigator's Discretion|0
2526992|NCT01672853|8744773|P2|Overall Study|Investigator's Discretion|0
2526993|NCT01672853|8744774|P1|Overall Study|Investigator's Discretion|1
2526994|NCT01672853|8744772|P3|Overall Study|Pregnancy|0
2526995|NCT01672853|8744773|P2|Overall Study|Pregnancy|1
2526996|NCT01672853|8744774|P1|Overall Study|Pregnancy|0
2526997|NCT01672853|8744772|P3|Overall Study|Protocol Specified Criteria for Withdraw|0
2526998|NCT01672853|8744773|P2|Overall Study|Protocol Specified Criteria for Withdraw|4
2526999|NCT01672853|8744774|P1|Overall Study|Protocol Specified Criteria for Withdraw|0
2527000|NCT01672788|8744797|P4|Washout Period 2 (7 Days)|Adverse Event|1
2527001|NCT01672788|8744798|P3|Washout Period 2 (7 Days)|Adverse Event|0
2527002|NCT01672788|8744799|P2|Washout Period 2 (7 Days)|Adverse Event|0
2527003|NCT01672788|8744800|P1|Washout Period 2 (7 Days)|Adverse Event|0
2527004|NCT01672736|8744830|P1|Overall Study|Available drug expired on 31 May 16|3
2527005|NCT01672723|8744834|P2|First Intervention|Adverse Event|0
2527006|NCT01672723|8744835|P1|First Intervention|Adverse Event|3
2527007|NCT01672710|8744847|P2|3 Month Follow up|follow up due after termination date|1
2527008|NCT01672710|8744848|P1|3 Month Follow up|follow up due after termination date|4
2527009|NCT01672710|8744847|P2|3 Month Follow up|Lost to Follow-up|3
2527010|NCT01672710|8744848|P1|3 Month Follow up|Lost to Follow-up|2
2527011|NCT01672710|8744847|P2|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1
2527012|NCT01672710|8744848|P1|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0
2527013|NCT01672294|8744883|P4|Overall Study|Lost to Follow-up|9
2527014|NCT01672294|8744884|P3|Overall Study|Lost to Follow-up|7
2527015|NCT01672294|8744885|P2|Overall Study|Lost to Follow-up|16
2527016|NCT01672294|8744886|P1|Overall Study|Lost to Follow-up|1
2527017|NCT01672294|8744883|P4|Overall Study|Excluded by study|0
2527018|NCT01672294|8744884|P3|Overall Study|Excluded by study|0
2527019|NCT01672294|8744885|P2|Overall Study|Excluded by study|1
2527020|NCT01672294|8744886|P1|Overall Study|Excluded by study|1
2527021|NCT01672294|8744883|P4|Overall Study|Withdrawal by Subject|4
2527022|NCT01672294|8744884|P3|Overall Study|Withdrawal by Subject|4
2527023|NCT01672294|8744885|P2|Overall Study|Withdrawal by Subject|4
2527024|NCT01672294|8744886|P1|Overall Study|Withdrawal by Subject|4
2527025|NCT01671748|8744931|P2|4 Week run-in Phase|Not eligible|0
2527026|NCT01671748|8744932|P1|4 Week run-in Phase|Not eligible|9
2527027|NCT01671748|8744931|P2|4 Week run-in Phase|Adverse Event|0
2527028|NCT01671748|8744932|P1|4 Week run-in Phase|Adverse Event|1
2527029|NCT01671748|8744931|P2|4 Week run-in Phase|Withdrawal by Subject|0
2527030|NCT01671748|8744932|P1|4 Week run-in Phase|Withdrawal by Subject|1
2527031|NCT01671488|8744959|P1|Overall Study|Withdrawal by Subject|1
2527032|NCT01671345|8744967|P2|Overall Study|visit with non-participating physician|3
2527033|NCT01671345|8744968|P1|Overall Study|visit with non-participating physician|3
2527034|NCT01671345|8744967|P2|Overall Study|Lost to Follow-up|6
2527035|NCT01671345|8744968|P1|Overall Study|Lost to Follow-up|10
2527036|NCT01671319|8744980|P1|Overall Study|Withdrawal by Subject|1
2527037|NCT01671280|8744995|P1|Overall Study|Withdrawal by Subject|2
2527038|NCT01671111|8745006|P1|Overall Study|Other|24
2527039|NCT01671111|8745006|P1|Overall Study|Physician Decision|1
2527040|NCT01671111|8745006|P1|Overall Study|Withdrawal by Subject|2
2527041|NCT01671111|8745006|P1|Overall Study|Lack of Efficacy|1
2527042|NCT01671111|8745006|P1|Overall Study|Adverse Event|2
2527043|NCT01671085|8745018|P2|Overall Study|Withdrawal by Subject|0
2527044|NCT01671085|8745019|P1|Overall Study|Withdrawal by Subject|1
2527045|NCT01671059|8745030|P1|Overall Study|Lack of Efficacy|1
2527046|NCT01671059|8745030|P1|Overall Study|Adverse Event|4
2527047|NCT01670721|8745122|P1|Overall Study|Other than specified above|38
2527048|NCT01670721|8745122|P1|Overall Study|Participant's decision|15
2527049|NCT01670656|8745134|P5|Overall Study|Subject moved|0
2527050|NCT01670656|8745135|P4|Overall Study|Subject moved|1
2527051|NCT01670656|8745136|P3|Overall Study|Subject moved|0
2527052|NCT01670656|8745137|P2|Overall Study|Subject moved|0
2527053|NCT01670656|8745138|P1|Overall Study|Subject moved|0
2527054|NCT01670656|8745134|P5|Overall Study|Lost to Follow-up|3
2527055|NCT01670656|8745135|P4|Overall Study|Lost to Follow-up|0
2527056|NCT01670656|8745136|P3|Overall Study|Lost to Follow-up|0
2527057|NCT01670656|8745137|P2|Overall Study|Lost to Follow-up|0
2527058|NCT01670656|8745138|P1|Overall Study|Lost to Follow-up|0
2527059|NCT01670656|8745134|P5|Overall Study|Subject withdrew consent|1
2527060|NCT01670656|8745135|P4|Overall Study|Subject withdrew consent|1
2527061|NCT01670656|8745136|P3|Overall Study|Subject withdrew consent|2
2527062|NCT01670656|8745137|P2|Overall Study|Subject withdrew consent|1
2527063|NCT01670656|8745138|P1|Overall Study|Subject withdrew consent|0
2527064|NCT01670656|8745134|P5|Overall Study|Adverse Event|3
2527065|NCT01670656|8745135|P4|Overall Study|Adverse Event|3
2527066|NCT01670656|8745136|P3|Overall Study|Adverse Event|2
2527067|NCT01670656|8745137|P2|Overall Study|Adverse Event|2
2527068|NCT01670656|8745138|P1|Overall Study|Adverse Event|2
2527069|NCT01670656|8745134|P5|Overall Study|Non-compliance with protocol|2
2527070|NCT01670656|8745135|P4|Overall Study|Non-compliance with protocol|1
2527071|NCT01670656|8745136|P3|Overall Study|Non-compliance with protocol|1
2527072|NCT01670656|8745137|P2|Overall Study|Non-compliance with protocol|3
2527073|NCT01670656|8745138|P1|Overall Study|Non-compliance with protocol|0
2527074|NCT01670656|8745134|P5|Overall Study|Withdrawal by Subject|0
2527075|NCT01670656|8745135|P4|Overall Study|Withdrawal by Subject|0
2527076|NCT01670656|8745136|P3|Overall Study|Withdrawal by Subject|0
2527077|NCT01670656|8745137|P2|Overall Study|Withdrawal by Subject|1
2527078|NCT01670656|8745138|P1|Overall Study|Withdrawal by Subject|1
2527079|NCT01670656|8745134|P5|Overall Study|Pregnancy|1
2527080|NCT01670656|8745135|P4|Overall Study|Pregnancy|0
2527081|NCT01670656|8745136|P3|Overall Study|Pregnancy|0
2527082|NCT01670656|8745137|P2|Overall Study|Pregnancy|0
2527083|NCT01670656|8745138|P1|Overall Study|Pregnancy|0
2527084|NCT01670656|8745134|P5|Overall Study|Non-compliance with study drug|1
2527085|NCT01670656|8745135|P4|Overall Study|Non-compliance with study drug|0
2527086|NCT01670656|8745136|P3|Overall Study|Non-compliance with study drug|3
2527087|NCT01670656|8745137|P2|Overall Study|Non-compliance with study drug|0
2527088|NCT01670656|8745138|P1|Overall Study|Non-compliance with study drug|0
2527089|NCT01670526|8745167|P2|Overall Study|Lost to Follow-up|5
2527090|NCT01670526|8745168|P1|Overall Study|Lost to Follow-up|9
2527091|NCT01670526|8745167|P2|Overall Study|Withdrawal by Subject|1
2527092|NCT01670526|8745168|P1|Overall Study|Withdrawal by Subject|3
2527093|NCT01670292|8745189|P1|Overall Study|Lost to Follow-up|14
2527094|NCT01670279|8745230|P4|Overall Study|Participant met withdrawal criteria|1
2527095|NCT01670279|8745231|P3|Overall Study|Participant met withdrawal criteria|0
2527096|NCT01670279|8745232|P2|Overall Study|Participant met withdrawal criteria|0
2527097|NCT01670279|8745233|P1|Overall Study|Participant met withdrawal criteria|0
2527098|NCT01670279|8745230|P4|Overall Study|Physician Decision|0
2527099|NCT01670279|8745231|P3|Overall Study|Physician Decision|0
2527100|NCT01670279|8745232|P2|Overall Study|Physician Decision|1
2527101|NCT01670279|8745233|P1|Overall Study|Physician Decision|0
2527102|NCT01670279|8745230|P4|Overall Study|Adverse Event|0
2527103|NCT01670279|8745231|P3|Overall Study|Adverse Event|0
2527104|NCT01670279|8745232|P2|Overall Study|Adverse Event|1
2527105|NCT01670279|8745233|P1|Overall Study|Adverse Event|0
2527106|NCT01670188|8745275|P2|Overall Study|Death|1
2527107|NCT01670188|8745276|P1|Overall Study|Death|0
2527108|NCT01670045|8745293|P1|Overall Study|Lost to Follow-up|11
2527109|NCT01670045|8745293|P1|Overall Study|Death|1
2527110|NCT01670045|8745293|P1|Overall Study|Adverse Event|1
2527111|NCT01670045|8745293|P1|Overall Study|Withdrawal by Subject|3
2527112|NCT01670019|8745311|P2|Overall Study|Withdrawal by Subject|0
2527113|NCT01670019|8745312|P1|Overall Study|Withdrawal by Subject|6
2527114|NCT01670019|8745311|P2|Overall Study|Adverse Event|0
2527115|NCT01670019|8745312|P1|Overall Study|Adverse Event|3
2527116|NCT01669902|8745326|P1|Overall Study|Other|8
2527117|NCT01669902|8745326|P1|Overall Study|Lack of Efficacy|10
2527118|NCT01669902|8745326|P1|Overall Study|Adverse Event|11
2527119|NCT01669811|8745361|P2|Overall Study|Eligibility Criteria Not Fulfilled|2
2527120|NCT01669811|8745362|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
2527121|NCT01669811|8745361|P2|Overall Study|Adverse Event|6
2527122|NCT01669811|8745362|P1|Overall Study|Adverse Event|2
2527123|NCT01669811|8745361|P2|Overall Study|Withdrawal by Subject|2
2527124|NCT01669811|8745362|P1|Overall Study|Withdrawal by Subject|1
2527125|NCT01669811|8745361|P2|Overall Study|Investigator decision|1
2527126|NCT01669811|8745362|P1|Overall Study|Investigator decision|0
2527127|NCT01669798|8745380|P1|Overall Study|Physician Decision|5
2527128|NCT01669629|8745486|P2|Period 1|protocol deviation|2
2527129|NCT01669629|8745487|P1|Period 1|protocol deviation|1
2527130|NCT01669577|8745510|P1|Overall Study|Physician Decision|34
2527131|NCT01669577|8745510|P1|Overall Study|Lost to Follow-up|78
2527132|NCT01669577|8745510|P1|Overall Study|Death|22
2527133|NCT01669421|8745548|P1|Phase 1: Standard Dose Therapy|Physician Decision|1
2527134|NCT01669421|8745548|P1|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1
2527135|NCT01669174|8745567|P2|Overall Study|Administrative problems|2
2527136|NCT01669174|8745568|P1|Overall Study|Administrative problems|1
2527137|NCT01669174|8745567|P2|Overall Study|Adverse Event|2
2527138|NCT01669174|8745568|P1|Overall Study|Adverse Event|2
2527139|NCT01669174|8745567|P2|Overall Study|Lost to Follow-up|0
2527140|NCT01669174|8745568|P1|Overall Study|Lost to Follow-up|1
2527141|NCT01669174|8745567|P2|Overall Study|Subject withdrew consent|2
2527142|NCT01669174|8745568|P1|Overall Study|Subject withdrew consent|2
2527143|NCT01669122|8745584|P1|Washout Period II|Protocol Violation|2
2527144|NCT01669122|8745584|P1|Period I|Lost to Follow-up|1
2527145|NCT01668966|8745651|P1|Overall Study|Not treated|2
2527146|NCT01668966|8745651|P1|Overall Study|Death|1
2527147|NCT01668966|8745651|P1|Overall Study|Withdrawal by Subject|1
2527148|NCT01668797|8745747|P4|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38
2527149|NCT01668797|8745748|P3|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49
2527150|NCT01668797|8745749|P2|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
2527151|NCT01668797|8745750|P1|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
2527152|NCT01668797|8745747|P4|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2
2527153|NCT01668797|8745748|P3|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4
2527154|NCT01668797|8745749|P2|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
2527155|NCT01668797|8745750|P1|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
2527156|NCT01668797|8745747|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30
2527157|NCT01668797|8745748|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11
2527158|NCT01668797|8745749|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
2527159|NCT01668797|8745750|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
2527160|NCT01668797|8745747|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10
2527161|NCT01668797|8745748|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2
2527162|NCT01668797|8745749|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
2527163|NCT01668797|8745750|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
2527164|NCT01668797|8745747|P4|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
2527165|NCT01668797|8745748|P3|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2
2527166|NCT01668797|8745749|P2|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
2527167|NCT01668797|8745750|P1|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
2527168|NCT01668797|8745747|P4|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5
2527169|NCT01668797|8745748|P3|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3
2527170|NCT01668797|8745749|P2|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
2527171|NCT01668797|8745750|P1|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
2527172|NCT01668797|8745747|P4|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2
2527173|NCT01668797|8745748|P3|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5
2527174|NCT01668797|8745749|P2|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
2527175|NCT01668797|8745750|P1|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
2527176|NCT01668797|8745747|P4|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
2527177|NCT01668797|8745748|P3|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
2527178|NCT01668797|8745749|P2|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
2527179|NCT01668797|8745750|P1|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
2527180|NCT01668797|8745747|P4|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6
2527181|NCT01668797|8745748|P3|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4
2527182|NCT01668797|8745749|P2|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
2527183|NCT01668797|8745750|P1|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
2527184|NCT01668797|8745747|P4|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
2527185|NCT01668797|8745748|P3|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
2527186|NCT01668797|8745749|P2|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86
2527187|NCT01668797|8745750|P1|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
2527188|NCT01668797|8745747|P4|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
2527189|NCT01668797|8745748|P3|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
2527190|NCT01668797|8745749|P2|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43
2527191|NCT01668797|8745750|P1|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
2527192|NCT01668797|8745747|P4|Phase B (Stabilization Phase)|Lack of Efficacy|0
2527193|NCT01668797|8745748|P3|Phase B (Stabilization Phase)|Lack of Efficacy|0
2527194|NCT01668797|8745749|P2|Phase B (Stabilization Phase)|Lack of Efficacy|21
2527195|NCT01668797|8745750|P1|Phase B (Stabilization Phase)|Lack of Efficacy|0
2527196|NCT01668797|8745747|P4|Phase B (Stabilization Phase)|Protocol Violation|0
2527197|NCT01668797|8745748|P3|Phase B (Stabilization Phase)|Protocol Violation|0
2527198|NCT01668797|8745749|P2|Phase B (Stabilization Phase)|Protocol Violation|3
2527199|NCT01668797|8745750|P1|Phase B (Stabilization Phase)|Protocol Violation|0
2527200|NCT01668797|8745747|P4|Phase B (Stabilization Phase)|Withdrawal by Subject|0
2527201|NCT01668797|8745748|P3|Phase B (Stabilization Phase)|Withdrawal by Subject|0
2527202|NCT01668797|8745749|P2|Phase B (Stabilization Phase)|Withdrawal by Subject|60
2527203|NCT01668797|8745750|P1|Phase B (Stabilization Phase)|Withdrawal by Subject|0
2527204|NCT01668797|8745747|P4|Phase B (Stabilization Phase)|Physician Decision|0
2527205|NCT01668797|8745748|P3|Phase B (Stabilization Phase)|Physician Decision|0
2527206|NCT01668797|8745749|P2|Phase B (Stabilization Phase)|Physician Decision|11
2527207|NCT01668797|8745750|P1|Phase B (Stabilization Phase)|Physician Decision|0
2527208|NCT01668797|8745747|P4|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
2527209|NCT01668797|8745748|P3|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
2527210|NCT01668797|8745749|P2|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22
2527211|NCT01668797|8745750|P1|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
2527212|NCT01668797|8745747|P4|Phase B (Stabilization Phase)|Lost to Follow-up|0
2527213|NCT01668797|8745748|P3|Phase B (Stabilization Phase)|Lost to Follow-up|0
2527214|NCT01668797|8745749|P2|Phase B (Stabilization Phase)|Lost to Follow-up|16
2527215|NCT01668797|8745750|P1|Phase B (Stabilization Phase)|Lost to Follow-up|0
2527216|NCT01668797|8745747|P4|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
2527217|NCT01668797|8745748|P3|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
2527218|NCT01668797|8745749|P2|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
2527219|NCT01668797|8745750|P1|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19
2527220|NCT01668797|8745747|P4|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
2527221|NCT01668797|8745748|P3|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
2527222|NCT01668797|8745749|P2|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
2527223|NCT01668797|8745750|P1|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8
2527224|NCT01668797|8745747|P4|Phase A (Conversion Phase)|Lack of Efficacy|0
2527225|NCT01668797|8745748|P3|Phase A (Conversion Phase)|Lack of Efficacy|0
2527226|NCT01668797|8745749|P2|Phase A (Conversion Phase)|Lack of Efficacy|0
2527227|NCT01668797|8745750|P1|Phase A (Conversion Phase)|Lack of Efficacy|7
2527228|NCT01668797|8745747|P4|Phase A (Conversion Phase)|Protocol Violation|0
2527229|NCT01668797|8745748|P3|Phase A (Conversion Phase)|Protocol Violation|0
2527230|NCT01668797|8745749|P2|Phase A (Conversion Phase)|Protocol Violation|0
2527231|NCT01668797|8745750|P1|Phase A (Conversion Phase)|Protocol Violation|2
2527232|NCT01668797|8745747|P4|Phase A (Conversion Phase)|Withdrawal by Subject|0
2527233|NCT01668797|8745748|P3|Phase A (Conversion Phase)|Withdrawal by Subject|0
2527234|NCT01668797|8745749|P2|Phase A (Conversion Phase)|Withdrawal by Subject|0
2527235|NCT01668797|8745750|P1|Phase A (Conversion Phase)|Withdrawal by Subject|16
2527236|NCT01668797|8745747|P4|Phase A (Conversion Phase)|Physician Decision|0
2527237|NCT01668797|8745748|P3|Phase A (Conversion Phase)|Physician Decision|0
2527238|NCT01668797|8745749|P2|Phase A (Conversion Phase)|Physician Decision|0
2527239|NCT01668797|8745750|P1|Phase A (Conversion Phase)|Physician Decision|2
2527240|NCT01668797|8745747|P4|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
2527241|NCT01668797|8745748|P3|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
2527242|NCT01668797|8745749|P2|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
2527243|NCT01668797|8745750|P1|Phase A (Conversion Phase)|Met Withdrawal Criteria|3
2527244|NCT01668797|8745747|P4|Phase A (Conversion Phase)|Lost to Follow-up|0
2527245|NCT01668797|8745748|P3|Phase A (Conversion Phase)|Lost to Follow-up|0
2527246|NCT01668797|8745749|P2|Phase A (Conversion Phase)|Lost to Follow-up|0
2527247|NCT01668797|8745750|P1|Phase A (Conversion Phase)|Lost to Follow-up|3
2527248|NCT01668784|8745815|P2|Treated (Overall)|Other|4
2527249|NCT01668784|8745816|P1|Treated (Overall)|Other|0
2527250|NCT01668784|8745815|P2|Treated (Overall)|Maximal Clinical Benefit|3
2527251|NCT01668784|8745816|P1|Treated (Overall)|Maximal Clinical Benefit|2
2527252|NCT01668784|8745815|P2|Treated (Overall)|Withdrawal by Subject|3
2527253|NCT01668784|8745816|P1|Treated (Overall)|Withdrawal by Subject|2
2527254|NCT01668784|8745815|P2|Treated (Overall)|Request to Discontinue Study Treatment|18
2527255|NCT01668784|8745816|P1|Treated (Overall)|Request to Discontinue Study Treatment|5
2527256|NCT01668784|8745815|P2|Treated (Overall)|Adverse Event Unrelated to Study Drug|14
2527257|NCT01668784|8745816|P1|Treated (Overall)|Adverse Event Unrelated to Study Drug|9
2527258|NCT01668784|8745815|P2|Treated (Overall)|Death|1
2527259|NCT01668784|8745816|P1|Treated (Overall)|Death|1
2527260|NCT01668784|8745815|P2|Treated (Overall)|Study Drug Toxicity|53
2527261|NCT01668784|8745816|P1|Treated (Overall)|Study Drug Toxicity|35
2527262|NCT01668784|8745815|P2|Treated (Overall)|Disease Progression|273
2527263|NCT01668784|8745816|P1|Treated (Overall)|Disease Progression|285
2527264|NCT01668784|8745815|P2|Randomized (Pre-treatment)|Other|1
2527265|NCT01668784|8745816|P1|Randomized (Pre-treatment)|Other|0
2527266|NCT01668784|8745815|P2|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1
2527267|NCT01668784|8745816|P1|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2
2527268|NCT01668784|8745815|P2|Randomized (Pre-treatment)|Poor/Non-Compliance|0
2527269|NCT01668784|8745816|P1|Randomized (Pre-treatment)|Poor/Non-Compliance|1
2527270|NCT01668784|8745815|P2|Randomized (Pre-treatment)|Withdrawal by Subject|8
2527271|NCT01668784|8745816|P1|Randomized (Pre-treatment)|Withdrawal by Subject|1
2527272|NCT01668784|8745815|P2|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3
2527273|NCT01668784|8745816|P1|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0
2527274|NCT01668784|8745815|P2|Randomized (Pre-treatment)|Disease Progression|1
2527275|NCT01668784|8745816|P1|Randomized (Pre-treatment)|Disease Progression|0
2527276|NCT01668667|8745844|P4|Overall Study|Withdrawal by Subject|5
2527277|NCT01668667|8745845|P3|Overall Study|Withdrawal by Subject|5
2527278|NCT01668667|8745846|P2|Overall Study|Withdrawal by Subject|4
2527279|NCT01668667|8745847|P1|Overall Study|Withdrawal by Subject|7
2527280|NCT01668667|8745844|P4|Overall Study|Physician Decision|0
2527281|NCT01668667|8745845|P3|Overall Study|Physician Decision|1
2527282|NCT01668667|8745846|P2|Overall Study|Physician Decision|0
2527283|NCT01668667|8745847|P1|Overall Study|Physician Decision|3
2527284|NCT01668667|8745844|P4|Overall Study|Lost to Follow-up|6
2527285|NCT01668667|8745845|P3|Overall Study|Lost to Follow-up|7
2527286|NCT01668667|8745846|P2|Overall Study|Lost to Follow-up|4
2527287|NCT01668667|8745847|P1|Overall Study|Lost to Follow-up|9
2527288|NCT01668667|8745844|P4|Overall Study|Protocol Violation|5
2527289|NCT01668667|8745845|P3|Overall Study|Protocol Violation|12
2527290|NCT01668667|8745846|P2|Overall Study|Protocol Violation|10
2527291|NCT01668667|8745847|P1|Overall Study|Protocol Violation|6
2527292|NCT01668667|8745844|P4|Overall Study|Lack of Efficacy|3
2527293|NCT01668667|8745845|P3|Overall Study|Lack of Efficacy|2
2527294|NCT01668667|8745846|P2|Overall Study|Lack of Efficacy|2
2527295|NCT01668667|8745847|P1|Overall Study|Lack of Efficacy|3
2527296|NCT01668667|8745844|P4|Overall Study|Adverse Event|4
2527297|NCT01668667|8745845|P3|Overall Study|Adverse Event|4
2527298|NCT01668667|8745846|P2|Overall Study|Adverse Event|6
2527299|NCT01668667|8745847|P1|Overall Study|Adverse Event|3
2527300|NCT01668654|8745869|P1|Overall Study|Withdrawal by Subject|1
2527301|NCT01668654|8745869|P1|Overall Study|Study Closed/Terminated|3
2527302|NCT01668589|8745930|P4|Overall Study|Other|15
2527303|NCT01668589|8745931|P3|Overall Study|Other|7
2527304|NCT01668589|8745932|P2|Overall Study|Other|10
2527305|NCT01668589|8745933|P1|Overall Study|Other|44
2527306|NCT01668589|8745930|P4|Overall Study|Death|11
2527307|NCT01668589|8745931|P3|Overall Study|Death|2
2527308|NCT01668589|8745932|P2|Overall Study|Death|3
2527309|NCT01668589|8745933|P1|Overall Study|Death|12
2527310|NCT01668589|8745930|P4|Overall Study|Full Consent/Agreement Withdrawn|4
2527311|NCT01668589|8745931|P3|Overall Study|Full Consent/Agreement Withdrawn|11
2527312|NCT01668589|8745932|P2|Overall Study|Full Consent/Agreement Withdrawn|8
2527313|NCT01668589|8745933|P1|Overall Study|Full Consent/Agreement Withdrawn|54
2527314|NCT01668589|8745930|P4|Overall Study|Lost to Follow-up|5
2527315|NCT01668589|8745931|P3|Overall Study|Lost to Follow-up|15
2527316|NCT01668589|8745932|P2|Overall Study|Lost to Follow-up|37
2527317|NCT01668589|8745933|P1|Overall Study|Lost to Follow-up|29
2527318|NCT01668355|8745973|P2|Overall Study|Withdrawal by Subject|1
2527319|NCT01668355|8745974|P1|Overall Study|Withdrawal by Subject|6
2527320|NCT01668355|8745973|P2|Overall Study|Death|1
2527321|NCT01668355|8745974|P1|Overall Study|Death|3
2527322|NCT01668173|8745994|P1|Overall Study|Trial suspension|4
2527323|NCT01668173|8745994|P1|Overall Study|Adverse Event|3
2527324|NCT01668147|8745998|P1|Overall Study|Withdrawal by Subject|6
2527325|NCT01668004|8746128|P1|Overall Study|Non-compliance with treatment|2
2527326|NCT01668004|8746128|P1|Overall Study|Lack of Efficacy|9
2527327|NCT01668004|8746128|P1|Overall Study|Lost to Follow-up|5
2527328|NCT01668004|8746128|P1|Overall Study|Withdrawal by Subject|2
2527329|NCT01668004|8746128|P1|Overall Study|Adverse Event|7
2527330|NCT01667926|8746150|P3|Overall Study|Side effects|0
2527331|NCT01667926|8746151|P2|Overall Study|Side effects|0
2527332|NCT01667926|8746152|P1|Overall Study|Side effects|3
2527333|NCT01667926|8746150|P3|Overall Study|Lost to Follow-up|1
2527334|NCT01667926|8746151|P2|Overall Study|Lost to Follow-up|2
2527335|NCT01667926|8746152|P1|Overall Study|Lost to Follow-up|1
2527336|NCT01667926|8746150|P3|Overall Study|Inclusion/Exclusion Criteria|5
2527337|NCT01667926|8746151|P2|Overall Study|Inclusion/Exclusion Criteria|0
2527338|NCT01667926|8746152|P1|Overall Study|Inclusion/Exclusion Criteria|0
2527339|NCT01667926|8746150|P3|Overall Study|Time committment|2
2527340|NCT01667926|8746151|P2|Overall Study|Time committment|0
2527341|NCT01667926|8746152|P1|Overall Study|Time committment|0
2527342|NCT01667926|8746150|P3|Overall Study|Physician Decision|1
2527343|NCT01667926|8746151|P2|Overall Study|Physician Decision|0
2527344|NCT01667926|8746152|P1|Overall Study|Physician Decision|0
2527345|NCT01667926|8746150|P3|Overall Study|Withdrawal by Subject|2
2527346|NCT01667926|8746151|P2|Overall Study|Withdrawal by Subject|2
2527347|NCT01667926|8746152|P1|Overall Study|Withdrawal by Subject|1
2527348|NCT01667900|8746165|P20|Part B|Death|0
2527349|NCT01667900|8746166|P19|Part B|Death|0
2527350|NCT01667900|8746167|P18|Part B|Death|0
2527351|NCT01667900|8746168|P17|Part B|Death|1
2527352|NCT01667900|8746169|P16|Part B|Death|0
2527353|NCT01667900|8746170|P15|Part B|Death|0
2527354|NCT01667900|8746171|P14|Part B|Death|0
2527355|NCT01667900|8746172|P13|Part B|Death|0
2527356|NCT01667900|8746173|P12|Part B|Death|0
2527357|NCT01667900|8746174|P11|Part B|Death|0
2527358|NCT01667900|8746175|P10|Part B|Death|0
2527359|NCT01667900|8746176|P9|Part B|Death|0
2527360|NCT01667900|8746177|P8|Part B|Death|0
2527361|NCT01667900|8746178|P7|Part B|Death|0
2527362|NCT01667900|8746179|P6|Part B|Death|0
2527363|NCT01667900|8746180|P5|Part B|Death|0
2527364|NCT01667900|8746181|P4|Part B|Death|0
2527365|NCT01667900|8746182|P3|Part B|Death|0
2527366|NCT01667900|8746183|P2|Part B|Death|0
2527367|NCT01667900|8746184|P1|Part B|Death|0
2527368|NCT01667731|8746254|P5|Overall Study|Death|0
2527369|NCT01667731|8746255|P4|Overall Study|Death|0
2527370|NCT01667731|8746256|P3|Overall Study|Death|0
2527371|NCT01667731|8746257|P2|Overall Study|Death|1
2527372|NCT01667731|8746258|P1|Overall Study|Death|0
2527373|NCT01667731|8746254|P5|Overall Study|Subject Withdrew Consent|1
2527374|NCT01667731|8746255|P4|Overall Study|Subject Withdrew Consent|0
2527375|NCT01667731|8746256|P3|Overall Study|Subject Withdrew Consent|1
2527376|NCT01667731|8746257|P2|Overall Study|Subject Withdrew Consent|0
2527377|NCT01667731|8746258|P1|Overall Study|Subject Withdrew Consent|2
2527378|NCT01667731|8746254|P5|Overall Study|Lost to Follow-up|2
2527379|NCT01667731|8746255|P4|Overall Study|Lost to Follow-up|1
2527380|NCT01667731|8746256|P3|Overall Study|Lost to Follow-up|1
2527381|NCT01667731|8746257|P2|Overall Study|Lost to Follow-up|3
2527382|NCT01667731|8746258|P1|Overall Study|Lost to Follow-up|2
2527383|NCT01667731|8746254|P5|Overall Study|Efficacy Failure|24
2527384|NCT01667731|8746255|P4|Overall Study|Efficacy Failure|1
2527385|NCT01667731|8746256|P3|Overall Study|Efficacy Failure|0
2527386|NCT01667731|8746257|P2|Overall Study|Efficacy Failure|12
2527387|NCT01667731|8746258|P1|Overall Study|Efficacy Failure|1
2527388|NCT01667731|8746254|P5|Overall Study|Enrolled but not treated|1
2527389|NCT01667731|8746255|P4|Overall Study|Enrolled but not treated|0
2527390|NCT01667731|8746256|P3|Overall Study|Enrolled but not treated|0
2527391|NCT01667731|8746257|P2|Overall Study|Enrolled but not treated|0
2527392|NCT01667731|8746258|P1|Overall Study|Enrolled but not treated|0
2527393|NCT01667679|8746313|P2|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1
2527394|NCT01667679|8746314|P1|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0
2527395|NCT01667679|8746313|P2|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1
2527396|NCT01667679|8746314|P1|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0
2527397|NCT01667679|8746313|P2|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1
2527398|NCT01667679|8746314|P1|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0
2527399|NCT01667679|8746313|P2|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1
2527400|NCT01667679|8746314|P1|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0
2527401|NCT01667679|8746313|P2|Treatment Period 2 (<=12 Weeks)|Adverse Event|0
2527402|NCT01667679|8746314|P1|Treatment Period 2 (<=12 Weeks)|Adverse Event|1
2527403|NCT01667679|8746313|P2|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0
2527404|NCT01667679|8746314|P1|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1
2527405|NCT01667679|8746313|P2|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0
2527406|NCT01667679|8746314|P1|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1
2527407|NCT01667679|8746313|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance|4
2527408|NCT01667679|8746314|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance|3
2527409|NCT01667679|8746313|P2|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10
2527410|NCT01667679|8746314|P1|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8
2527411|NCT01667679|8746313|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0
2527412|NCT01667679|8746314|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2
2527413|NCT01667679|8746313|P2|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4
2527414|NCT01667679|8746314|P1|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6
2527415|NCT01667679|8746313|P2|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1
2527416|NCT01667679|8746314|P1|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0
2527417|NCT01667679|8746313|P2|Treatment Period 1 (<=12 Weeks)|Non-compliance|3
2527418|NCT01667679|8746314|P1|Treatment Period 1 (<=12 Weeks)|Non-compliance|0
2527419|NCT01667679|8746313|P2|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2
2527420|NCT01667679|8746314|P1|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0
2527421|NCT01667679|8746313|P2|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2
2527422|NCT01667679|8746314|P1|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0
2527423|NCT01667679|8746313|P2|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
2527424|NCT01667679|8746314|P1|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
2527425|NCT01667679|8746313|P2|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13
2527426|NCT01667679|8746314|P1|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6
2527427|NCT01667679|8746313|P2|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0
2527428|NCT01667679|8746314|P1|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1
2527429|NCT01667679|8746313|P2|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0
2527430|NCT01667679|8746314|P1|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2
2527431|NCT01667679|8746313|P2|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0
2527432|NCT01667679|8746314|P1|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2
2527433|NCT01667679|8746313|P2|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6
2527434|NCT01667679|8746314|P1|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2
2527435|NCT01667562|8746372|P2|Erlotinib Phase|Switch to Commercial Drug|1
2527436|NCT01667562|8746373|P1|Erlotinib Phase|Switch to Commercial Drug|0
2527437|NCT01667562|8746372|P2|Erlotinib Phase|Adverse Event|1
2527438|NCT01667562|8746373|P1|Erlotinib Phase|Adverse Event|0
2527439|NCT01667562|8746372|P2|Erlotinib Phase|Lost to Follow-up|1
2527440|NCT01667562|8746373|P1|Erlotinib Phase|Lost to Follow-up|0
2527441|NCT01667562|8746372|P2|Diagnostic Phase|Started Erlotinib in Treatment Period|0
2527442|NCT01667562|8746373|P1|Diagnostic Phase|Started Erlotinib in Treatment Period|30
2527443|NCT01667549|8746387|P5|Overall Study|Withdrawal by Subject|1
2527444|NCT01667549|8746388|P4|Overall Study|Withdrawal by Subject|6
2527445|NCT01667549|8746389|P3|Overall Study|Withdrawal by Subject|7
2527446|NCT01667549|8746390|P2|Overall Study|Withdrawal by Subject|5
2527447|NCT01667549|8746391|P1|Overall Study|Withdrawal by Subject|3
2527448|NCT01667432|8746450|P1|Overall Study|Missing Information|4
2527449|NCT01667432|8746450|P1|Overall Study|Reason Not Specified|2
2527450|NCT01667432|8746450|P1|Overall Study|Principal Investigator Decision|1
2527451|NCT01667432|8746450|P1|Overall Study|Protocol Deviation|2
2527452|NCT01667432|8746450|P1|Overall Study|Adverse Event|1
2527453|NCT01667432|8746450|P1|Overall Study|Insufficient Therapeutic Response|4
2527454|NCT01667432|8746450|P1|Overall Study|Refused Treatment/Withdrew Consent|1
2527455|NCT01667432|8746450|P1|Overall Study|Lost to Follow-up|3
2527456|NCT01667432|8746450|P1|Overall Study|Moved to Another Center|3
2527457|NCT01667432|8746450|P1|Overall Study|Failure to Return|10
2527458|NCT01667432|8746450|P1|Overall Study|Premature Study Termination|26
2527459|NCT01667419|8746459|P4|Overall Study|Death|26
2527460|NCT01667419|8746460|P3|Overall Study|Death|25
2527461|NCT01667419|8746461|P2|Overall Study|Death|33
2527462|NCT01667419|8746462|P1|Overall Study|Death|18
2527463|NCT01667419|8746459|P4|Overall Study|Lost to Follow-up|4
2527464|NCT01667419|8746460|P3|Overall Study|Lost to Follow-up|2
2527465|NCT01667419|8746461|P2|Overall Study|Lost to Follow-up|6
2527466|NCT01667419|8746462|P1|Overall Study|Lost to Follow-up|7
2527467|NCT01667419|8746459|P4|Overall Study|Protocol Violation|0
2527468|NCT01667419|8746460|P3|Overall Study|Protocol Violation|0
2527469|NCT01667419|8746461|P2|Overall Study|Protocol Violation|0
2527470|NCT01667419|8746462|P1|Overall Study|Protocol Violation|1
2527471|NCT01667419|8746459|P4|Overall Study|Non-compliance|1
2527472|NCT01667419|8746460|P3|Overall Study|Non-compliance|0
2527473|NCT01667419|8746461|P2|Overall Study|Non-compliance|0
2527474|NCT01667419|8746462|P1|Overall Study|Non-compliance|0
2527475|NCT01667419|8746459|P4|Overall Study|Withdrawal by Subject|8
2527476|NCT01667419|8746460|P3|Overall Study|Withdrawal by Subject|9
2527477|NCT01667419|8746461|P2|Overall Study|Withdrawal by Subject|8
2527478|NCT01667419|8746462|P1|Overall Study|Withdrawal by Subject|16
2527479|NCT01667419|8746459|P4|Overall Study|Reason Not Specified|0
2527480|NCT01667419|8746460|P3|Overall Study|Reason Not Specified|0
2527481|NCT01667419|8746461|P2|Overall Study|Reason Not Specified|0
2527482|NCT01667419|8746462|P1|Overall Study|Reason Not Specified|1
2527483|NCT01667224|8746510|P2|Overall Study|Protocol Violation|1
2527484|NCT01667224|8746511|P1|Overall Study|Protocol Violation|1
2527485|NCT01667224|8746510|P2|Overall Study|Withdrawal by Subject|1
2527486|NCT01667224|8746511|P1|Overall Study|Withdrawal by Subject|3
2527487|NCT01667107|8746525|P2|Overall Study|Lack of Efficacy|1
2527488|NCT01667107|8746526|P1|Overall Study|Lack of Efficacy|0
2527489|NCT01667107|8746525|P2|Overall Study|Protocol Violation|1
2527490|NCT01667107|8746526|P1|Overall Study|Protocol Violation|0
2527491|NCT01667107|8746525|P2|Overall Study|Tolerability issues|2
2527492|NCT01667107|8746526|P1|Overall Study|Tolerability issues|0
2527493|NCT01667107|8746525|P2|Overall Study|Adverse Event|3
2527494|NCT01667107|8746526|P1|Overall Study|Adverse Event|4
2527495|NCT01666951|8746585|P2|Overall Study|Not dosed|1
2527496|NCT01666951|8746586|P1|Overall Study|Not dosed|1
2527497|NCT01666782|8746637|P2|Overall Study|Enrolled both years; year 1 data used|0
2527498|NCT01666782|8746638|P1|Overall Study|Enrolled both years; year 1 data used|4
2527499|NCT01666782|8746637|P2|Overall Study|Received 2 doses of vaccine|1
2527500|NCT01666782|8746638|P1|Overall Study|Received 2 doses of vaccine|0
2527501|NCT01666652|8746659|P5|Overall Study|Lost to Follow-up|0
2527502|NCT01666652|8746660|P4|Overall Study|Lost to Follow-up|1
2527503|NCT01666652|8746661|P3|Overall Study|Lost to Follow-up|1
2527504|NCT01666652|8746662|P2|Overall Study|Lost to Follow-up|1
2527505|NCT01666652|8746663|P1|Overall Study|Lost to Follow-up|1
2527506|NCT01666652|8746659|P5|Overall Study|Moved from study area|0
2527507|NCT01666652|8746660|P4|Overall Study|Moved from study area|2
2527508|NCT01666652|8746661|P3|Overall Study|Moved from study area|0
2527509|NCT01666652|8746662|P2|Overall Study|Moved from study area|0
2527510|NCT01666652|8746663|P1|Overall Study|Moved from study area|1
2527511|NCT01666652|8746659|P5|Overall Study|Withdrawal by Subject|1
2527512|NCT01666652|8746660|P4|Overall Study|Withdrawal by Subject|0
2527513|NCT01666652|8746661|P3|Overall Study|Withdrawal by Subject|0
2527514|NCT01666652|8746662|P2|Overall Study|Withdrawal by Subject|0
2527515|NCT01666652|8746663|P1|Overall Study|Withdrawal by Subject|0
2527516|NCT01666652|8746659|P5|Overall Study|Serious Adverse Event|0
2527517|NCT01666652|8746660|P4|Overall Study|Serious Adverse Event|1
2527518|NCT01666652|8746661|P3|Overall Study|Serious Adverse Event|0
2527519|NCT01666652|8746662|P2|Overall Study|Serious Adverse Event|0
2527520|NCT01666652|8746663|P1|Overall Study|Serious Adverse Event|0
2527521|NCT01666444|8746712|P2|Overall Study|Did not initiate treatment|1
2527522|NCT01666444|8746713|P1|Overall Study|Did not initiate treatment|2
2527523|NCT01666314|8746731|P4|Overall Study|Reason not Specified|5
2527524|NCT01666314|8746732|P3|Overall Study|Reason not Specified|5
2527525|NCT01666314|8746733|P2|Overall Study|Reason not Specified|7
2527526|NCT01666314|8746734|P1|Overall Study|Reason not Specified|10
2527527|NCT01666314|8746731|P4|Overall Study|Withdrawal by Subject|3
2527528|NCT01666314|8746732|P3|Overall Study|Withdrawal by Subject|2
2527529|NCT01666314|8746733|P2|Overall Study|Withdrawal by Subject|1
2527530|NCT01666314|8746734|P1|Overall Study|Withdrawal by Subject|1
2527531|NCT01666314|8746731|P4|Overall Study|Unsatisfactory Therapeutic Response|1
2527532|NCT01666314|8746732|P3|Overall Study|Unsatisfactory Therapeutic Response|1
2527533|NCT01666314|8746733|P2|Overall Study|Unsatisfactory Therapeutic Response|2
2527534|NCT01666314|8746734|P1|Overall Study|Unsatisfactory Therapeutic Response|7
2527535|NCT01666314|8746731|P4|Overall Study|Symptomatic Deterioration|0
2527536|NCT01666314|8746732|P3|Overall Study|Symptomatic Deterioration|2
2527537|NCT01666314|8746733|P2|Overall Study|Symptomatic Deterioration|0
2527538|NCT01666314|8746734|P1|Overall Study|Symptomatic Deterioration|1
2527539|NCT01666314|8746731|P4|Overall Study|Progressive Disease|20
2527540|NCT01666314|8746732|P3|Overall Study|Progressive Disease|19
2527541|NCT01666314|8746733|P2|Overall Study|Progressive Disease|9
2527542|NCT01666314|8746734|P1|Overall Study|Progressive Disease|11
2527543|NCT01666314|8746731|P4|Overall Study|Adverse Event|7
2527544|NCT01666314|8746732|P3|Overall Study|Adverse Event|7
2527545|NCT01666314|8746733|P2|Overall Study|Adverse Event|13
2527546|NCT01666314|8746734|P1|Overall Study|Adverse Event|3
2527547|NCT01666119|8746870|P1|Overall Study|Subject experiencing withdrawal symptoms|5
2527548|NCT01666119|8746870|P1|Overall Study|non compliance with study medication, pa|18
2527549|NCT01666119|8746870|P1|Overall Study|Lost to Follow-up|7
2527550|NCT01666119|8746870|P1|Overall Study|Withdrawal by Subject|16
2527551|NCT01666119|8746870|P1|Overall Study|Adverse Event|6
2527552|NCT01666002|8746877|P2|Overall Study|Lost to Follow-up|0
2527553|NCT01666002|8746878|P1|Overall Study|Lost to Follow-up|5
2527554|NCT01665911|8746899|P1|Overall Study|Adverse Event|1
2527555|NCT01665911|8746899|P1|Overall Study|Withdrawal by Subject|1
2527556|NCT01665911|8746899|P1|Overall Study|Protocol Violation|4
2527557|NCT01665807|8746925|P3|Overall Study|Withdrawal by Subject|1
2527558|NCT01665807|8746926|P2|Overall Study|Withdrawal by Subject|0
2527559|NCT01665807|8746927|P1|Overall Study|Withdrawal by Subject|2
2527560|NCT01665768|8746938|P1|Overall Study|Withdrawal by Subject|1
2527561|NCT01665768|8746938|P1|Overall Study|Lack of Efficacy|19
2527562|NCT01665768|8746938|P1|Overall Study|Adverse Event|3
2527563|NCT01665599|8746943|P1|Overall Study|Could Not Continue Due to Time Constrain|1
2527564|NCT01665599|8746943|P1|Overall Study|Participant Left for More Than 3 Months|1
2527565|NCT01665599|8746943|P1|Overall Study|Lost to Follow-up|2
2527566|NCT01665599|8746943|P1|Overall Study|Death|1
2527567|NCT01665599|8746943|P1|Overall Study|Investigator/Sponsor decision|1
2527568|NCT01665599|8746943|P1|Overall Study|Consent Withdrawn|1
2527569|NCT01665599|8746943|P1|Overall Study|Adverse Event|1
2527570|NCT01665430|8746979|P1|Overall Study|Other Unspecified|2
2527571|NCT01665430|8746979|P1|Overall Study|Withdrawal by Subject|6
2527572|NCT01665430|8746979|P1|Overall Study|Adverse Event|1
2527573|NCT01665144|8747077|P2|Overall Study|Withdrawal by Subject|77
2527574|NCT01665144|8747078|P1|Overall Study|Withdrawal by Subject|96
2527575|NCT01665144|8747077|P2|Overall Study|Adverse Event|18
2527576|NCT01665144|8747078|P1|Overall Study|Adverse Event|45
2527577|NCT01665144|8747077|P2|Overall Study|Lack of Efficacy|11
2527578|NCT01665144|8747078|P1|Overall Study|Lack of Efficacy|16
2527579|NCT01665144|8747077|P2|Overall Study|Physician Decision|1
2527580|NCT01665144|8747078|P1|Overall Study|Physician Decision|13
2527581|NCT01665144|8747077|P2|Overall Study|Lost to Follow-up|8
2527582|NCT01665144|8747078|P1|Overall Study|Lost to Follow-up|9
2527583|NCT01665144|8747077|P2|Overall Study|Progressive disease|4
2527584|NCT01665144|8747078|P1|Overall Study|Progressive disease|8
2527585|NCT01665144|8747077|P2|Overall Study|Non-compliance w/study treatment|0
2527586|NCT01665144|8747078|P1|Overall Study|Non-compliance w/study treatment|5
2527587|NCT01665144|8747077|P2|Overall Study|Protocol deviation|1
2527588|NCT01665144|8747078|P1|Overall Study|Protocol deviation|3
2527589|NCT01665144|8747077|P2|Overall Study|Death|1
2527590|NCT01665144|8747078|P1|Overall Study|Death|3
2527591|NCT01665144|8747077|P2|Overall Study|Technical problems|0
2527592|NCT01665144|8747078|P1|Overall Study|Technical problems|2
2527593|NCT01665144|8747077|P2|Overall Study|New therapy for study indication|1
2527594|NCT01665144|8747078|P1|Overall Study|New therapy for study indication|2
2527595|NCT01664949|8747158|P2|Overall Study|Other Miscellaneous Reasons|1
2527596|NCT01664949|8747159|P1|Overall Study|Other Miscellaneous Reasons|3
2527597|NCT01664949|8747158|P2|Overall Study|Protocol Violation|5
2527598|NCT01664949|8747159|P1|Overall Study|Protocol Violation|5
2527599|NCT01664949|8747158|P2|Overall Study|Personal Reasons|4
2527600|NCT01664949|8747159|P1|Overall Study|Personal Reasons|3
2527601|NCT01664949|8747158|P2|Overall Study|Lost to Follow-up|2
2527602|NCT01664949|8747159|P1|Overall Study|Lost to Follow-up|1
2527603|NCT01664949|8747158|P2|Overall Study|Lack of Efficacy|1
2527604|NCT01664949|8747159|P1|Overall Study|Lack of Efficacy|1
2527605|NCT01664949|8747158|P2|Overall Study|Adverse Event|12
2527606|NCT01664949|8747159|P1|Overall Study|Adverse Event|11
2527607|NCT01664923|8747175|P2|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4
2527608|NCT01664923|8747176|P1|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2
2527609|NCT01664923|8747175|P2|Period 2: Open-label Phase-36 Months|Adverse Event|7
2527610|NCT01664923|8747176|P1|Period 2: Open-label Phase-36 Months|Adverse Event|4
2527611|NCT01664923|8747175|P2|Period 2: Open-label Phase-36 Months|Other|1
2527612|NCT01664923|8747176|P1|Period 2: Open-label Phase-36 Months|Other|3
2527613|NCT01664923|8747175|P2|Period 2: Open-label Phase-36 Months|Disease progression|9
2527614|NCT01664923|8747176|P1|Period 2: Open-label Phase-36 Months|Disease progression|28
2527615|NCT01664923|8747175|P2|Period 2: Open-label Phase-36 Months|On Treatment|1
2527616|NCT01664923|8747176|P1|Period 2: Open-label Phase-36 Months|On Treatment|1
2527617|NCT01664923|8747175|P2|Period 2: Open-label Phase-36 Months|Death|1
2527618|NCT01664923|8747176|P1|Period 2: Open-label Phase-36 Months|Death|3
2527619|NCT01664923|8747175|P2|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0
2527620|NCT01664923|8747176|P1|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1
2527621|NCT01664923|8747175|P2|Period1:Double Blind Phase-29 Months|Other|4
2527622|NCT01664923|8747176|P1|Period1:Double Blind Phase-29 Months|Other|3
2527623|NCT01664923|8747175|P2|Period1:Double Blind Phase-29 Months|Adverse Event|9
2527624|NCT01664923|8747176|P1|Period1:Double Blind Phase-29 Months|Adverse Event|14
2527625|NCT01664923|8747175|P2|Period1:Double Blind Phase-29 Months|Disease Progression|132
2527626|NCT01664923|8747176|P1|Period1:Double Blind Phase-29 Months|Disease Progression|65
2527627|NCT01664923|8747175|P2|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8
2527628|NCT01664923|8747176|P1|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12
2527629|NCT01664923|8747175|P2|Period1:Double Blind Phase-29 Months|Protocol Violation|0
2527630|NCT01664923|8747176|P1|Period1:Double Blind Phase-29 Months|Protocol Violation|2
2527631|NCT01664923|8747175|P2|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1
2527632|NCT01664923|8747176|P1|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0
2527633|NCT01664923|8747175|P2|Period1:Double Blind Phase-29 Months|Death|6
2527634|NCT01664923|8747176|P1|Period1:Double Blind Phase-29 Months|Death|8
2527635|NCT01664624|8747267|P4|Overall Study|Adverse Event|0
2527636|NCT01664624|8747268|P3|Overall Study|Adverse Event|0
2527637|NCT01664624|8747269|P2|Overall Study|Adverse Event|1
2527638|NCT01664624|8747270|P1|Overall Study|Adverse Event|0
2527639|NCT01664533|8747317|P1|Overall Study|Protocol Violation|3
2527640|NCT01664533|8747317|P1|Overall Study|Study termination|9
2527641|NCT01664533|8747317|P1|Overall Study|Lost to Follow-up|3
2527642|NCT01664533|8747317|P1|Overall Study|Death|42
2527643|NCT01664494|8747325|P1|Overall Study|Lost to Follow-up|99
2527644|NCT01664494|8747325|P1|Overall Study|Other|49
2527645|NCT01664494|8747325|P1|Overall Study|Death|18
2527646|NCT01664494|8747325|P1|Overall Study|Withdrawal by Subject|27
2527647|NCT01664247|8747332|P2|Overall Study|Unclassified|29
2527648|NCT01664247|8747333|P1|Overall Study|Unclassified|5
2527649|NCT01664247|8747332|P2|Overall Study|Withdrawal Criteria|4
2527650|NCT01664247|8747333|P1|Overall Study|Withdrawal Criteria|1
2527651|NCT01664247|8747332|P2|Overall Study|Protocol Violation|5
2527652|NCT01664247|8747333|P1|Overall Study|Protocol Violation|3
2527653|NCT01664247|8747332|P2|Overall Study|Adverse Event|3
2527654|NCT01664247|8747333|P1|Overall Study|Adverse Event|5
2527655|NCT01664130|8747355|P1|Overall Study|competing secondary disease|2
2527656|NCT01664104|8747433|P1|Overall Study|Unknown: Reason Unrelated to TCZ|2
2527657|NCT01664104|8747433|P1|Overall Study|Other|1
2527658|NCT01664104|8747433|P1|Overall Study|Lost to Follow-up|4
2527659|NCT01664104|8747433|P1|Overall Study|Withdrawal by Subject|1
2527660|NCT01664104|8747433|P1|Overall Study|Lack of Efficacy|2
2527661|NCT01664104|8747433|P1|Overall Study|Adverse Event|6
2527662|NCT01664091|8747500|P1|Overall Study|Withdrawal by Subject|1
2527663|NCT01664091|8747500|P1|Overall Study|Lost to Follow-up|2
2527664|NCT01664091|8747500|P1|Overall Study|Disease Progression|2
2527665|NCT01664091|8747500|P1|Overall Study|Death|1
2527666|NCT01664052|8747510|P2|Phase 2|No device placement|4
2527667|NCT01664052|8747511|P1|Phase 2|No device placement|0
2527668|NCT01664052|8747510|P2|Phase 1|No HSG 1 hr post placement|0
2527669|NCT01664052|8747511|P1|Phase 1|No HSG 1 hr post placement|1
2527670|NCT01664052|8747510|P2|Phase 1|No device placement|0
2527671|NCT01664052|8747511|P1|Phase 1|No device placement|6
2527672|NCT01664039|8747529|P2|Overall Study|Noncompliance|1
2527673|NCT01664039|8747530|P1|Overall Study|Noncompliance|1
2527674|NCT01664039|8747529|P2|Overall Study|Withdrawal by Subject|3
2527675|NCT01664039|8747530|P1|Overall Study|Withdrawal by Subject|1
2527676|NCT01664039|8747529|P2|Overall Study|Lost to Follow-up|1
2527677|NCT01664039|8747530|P1|Overall Study|Lost to Follow-up|1
2527678|NCT01664039|8747529|P2|Overall Study|Adverse Event|4
2527679|NCT01664039|8747530|P1|Overall Study|Adverse Event|3
2527680|NCT01663987|8747552|P2|Overall Study|Other reason not defined above|0
2527681|NCT01663987|8747553|P1|Overall Study|Other reason not defined above|3
2527682|NCT01663987|8747552|P2|Overall Study|Withdrawal by Subject|3
2527683|NCT01663987|8747553|P1|Overall Study|Withdrawal by Subject|2
2527684|NCT01663987|8747552|P2|Overall Study|Lost to Follow-up|1
2527685|NCT01663987|8747553|P1|Overall Study|Lost to Follow-up|1
2527686|NCT01663987|8747552|P2|Overall Study|Adverse Event|2
2527687|NCT01663987|8747553|P1|Overall Study|Adverse Event|7
2527688|NCT01663857|8747596|P4|Overall Study|Lost to Follow-up|1
2527689|NCT01663857|8747597|P3|Overall Study|Lost to Follow-up|3
2527690|NCT01663857|8747598|P2|Overall Study|Lost to Follow-up|0
2527691|NCT01663857|8747599|P1|Overall Study|Lost to Follow-up|0
2527692|NCT01663857|8747596|P4|Overall Study|Withdrew Consent to Study Participation|3
2527693|NCT01663857|8747597|P3|Overall Study|Withdrew Consent to Study Participation|7
2527694|NCT01663857|8747598|P2|Overall Study|Withdrew Consent to Study Participation|1
2527695|NCT01663857|8747599|P1|Overall Study|Withdrew Consent to Study Participation|0
2527696|NCT01663740|8747627|P2|Overall Study|No end of study status|0
2527697|NCT01663740|8747628|P1|Overall Study|No end of study status|3
2527698|NCT01663740|8747627|P2|Overall Study|Withdrawal by Subject|1
2527699|NCT01663740|8747628|P1|Overall Study|Withdrawal by Subject|2
2527700|NCT01663740|8747627|P2|Overall Study|Death|1
2527701|NCT01663740|8747628|P1|Overall Study|Death|0
2527702|NCT01663740|8747627|P2|Overall Study|Inclusion/Exclusion not met|0
2527703|NCT01663740|8747628|P1|Overall Study|Inclusion/Exclusion not met|1
2527704|NCT01663740|8747627|P2|Overall Study|Other|2
2527705|NCT01663740|8747628|P1|Overall Study|Other|9
2527706|NCT01663740|8747627|P2|Overall Study|Lost to Follow-up|4
2527707|NCT01663740|8747628|P1|Overall Study|Lost to Follow-up|1
2527708|NCT01663727|8747688|P2|Overall Study|Withdrawal prior to dosing.|0
2527709|NCT01663727|8747689|P1|Overall Study|Withdrawal prior to dosing.|1
2527710|NCT01663727|8747688|P2|Overall Study|Withdrawal by subject and Adverse Event.|0
2527711|NCT01663727|8747689|P1|Overall Study|Withdrawal by subject and Adverse Event.|1
2527712|NCT01663727|8747688|P2|Overall Study|Study Terminated|50
2527713|NCT01663727|8747689|P1|Overall Study|Study Terminated|51
2527714|NCT01663727|8747688|P2|Overall Study|Withdrawal by Subject|25
2527715|NCT01663727|8747689|P1|Overall Study|Withdrawal by Subject|18
2527716|NCT01663727|8747688|P2|Overall Study|Lost to Follow-up|8
2527717|NCT01663727|8747689|P1|Overall Study|Lost to Follow-up|10
2527718|NCT01663727|8747688|P2|Overall Study|Death|155
2527719|NCT01663727|8747689|P1|Overall Study|Death|161
2527720|NCT01663714|8747721|P1|Long-Term Follow-Up|Non-compliance|1
2527721|NCT01663714|8747721|P1|Long-Term Follow-Up|Death|4
2527722|NCT01663714|8747721|P1|Long-Term Follow-Up|Lost to Follow-up|1
2527723|NCT01663714|8747721|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16
2527724|NCT01663714|8747721|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|11
2527725|NCT01663714|8747721|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
2527726|NCT01663636|8747750|P2|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31
2527727|NCT01663636|8747751|P1|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25
2527728|NCT01663623|8747759|P2|Overall Study|Withdrawal by Subject|1
2527729|NCT01663623|8747760|P1|Overall Study|Withdrawal by Subject|2
2527730|NCT01663623|8747759|P2|Overall Study|Physician Decision|4
2527731|NCT01663623|8747760|P1|Overall Study|Physician Decision|1
2527732|NCT01663623|8747759|P2|Overall Study|Other-Study closed/terminated|1
2527733|NCT01663623|8747760|P1|Overall Study|Other-Study closed/terminated|1
2527734|NCT01663623|8747759|P2|Overall Study|Protocol Violation|1
2527735|NCT01663623|8747760|P1|Overall Study|Protocol Violation|0
2527736|NCT01663623|8747759|P2|Overall Study|Lack of Efficacy|6
2527737|NCT01663623|8747760|P1|Overall Study|Lack of Efficacy|5
2527738|NCT01663623|8747759|P2|Overall Study|Adverse Event|7
2527739|NCT01663623|8747760|P1|Overall Study|Adverse Event|3
2527740|NCT01663532|8747770|P2|Overall Study|Lack of Efficacy|60
2527741|NCT01663532|8747771|P1|Overall Study|Lack of Efficacy|15
2527742|NCT01663532|8747770|P2|Overall Study|Withdrawal by Subject|17
2527743|NCT01663532|8747771|P1|Overall Study|Withdrawal by Subject|35
2527744|NCT01663532|8747770|P2|Overall Study|Physician Decision|1
2527745|NCT01663532|8747771|P1|Overall Study|Physician Decision|1
2527746|NCT01663532|8747770|P2|Overall Study|Met Withdrawal Criteria|6
2527747|NCT01663532|8747771|P1|Overall Study|Met Withdrawal Criteria|7
2527748|NCT01663532|8747770|P2|Overall Study|Adverse Event|13
2527749|NCT01663532|8747771|P1|Overall Study|Adverse Event|7
2527750|NCT01663532|8747770|P2|Overall Study|Lost to Follow-up|10
2527751|NCT01663532|8747771|P1|Overall Study|Lost to Follow-up|9
2527752|NCT01663506|8747789|P1|Overall Study|Switched to Subcutaneous Tocilizumab|2
2527753|NCT01663506|8747789|P1|Overall Study|Adverse Event|1
2527754|NCT01663506|8747789|P1|Overall Study|Lost to Follow-up|1
2527755|NCT01663506|8747789|P1|Overall Study|Consent Withdrawal by Subject|1
2527756|NCT01663506|8747789|P1|Overall Study|Lack of Efficacy|3
2527757|NCT01663402|8747820|P2|Overall Study|Other than specified above|147
2527758|NCT01663402|8747821|P1|Overall Study|Other than specified above|172
2527759|NCT01663402|8747820|P2|Overall Study|Lost to Follow-up|15
2527760|NCT01663402|8747821|P1|Overall Study|Lost to Follow-up|17
2527761|NCT01663402|8747820|P2|Overall Study|Related to study drug administration|105
2527762|NCT01663402|8747821|P1|Overall Study|Related to study drug administration|96
2527763|NCT01663402|8747820|P2|Overall Study|Withdrawal by Subject|91
2527764|NCT01663402|8747821|P1|Overall Study|Withdrawal by Subject|118
2527765|NCT01663402|8747820|P2|Overall Study|Participant moved|104
2527766|NCT01663402|8747821|P1|Overall Study|Participant moved|139
2527767|NCT01663402|8747820|P2|Overall Study|Site terminated by sponsor|3
2527768|NCT01663402|8747821|P1|Overall Study|Site terminated by sponsor|1
2527769|NCT01663402|8747820|P2|Overall Study|Physician Decision|62
2527770|NCT01663402|8747821|P1|Overall Study|Physician Decision|77
2527771|NCT01663402|8747820|P2|Overall Study|Poor compliance to protocol|454
2527772|NCT01663402|8747821|P1|Overall Study|Poor compliance to protocol|529
2527773|NCT01663402|8747820|P2|Overall Study|Two consecutive LDL-C <15 mg/dL|730
2527774|NCT01663402|8747821|P1|Overall Study|Two consecutive LDL-C <15 mg/dL|0
2527775|NCT01663402|8747820|P2|Overall Study|Adverse Event|362
2527776|NCT01663402|8747821|P1|Overall Study|Adverse Event|347
2527777|NCT01663402|8747820|P2|Overall Study|Randomized but not treated|11
2527778|NCT01663402|8747821|P1|Overall Study|Randomized but not treated|19
2527779|NCT01663233|8747875|P2|Overall Study|Lost to Follow-up|1
2527780|NCT01663233|8747876|P1|Overall Study|Lost to Follow-up|0
2527781|NCT01663233|8747875|P2|Overall Study|Protocol Deviation|4
2527782|NCT01663233|8747876|P1|Overall Study|Protocol Deviation|1
2527783|NCT01663233|8747875|P2|Overall Study|Withdrawal by Subject|2
2527784|NCT01663233|8747876|P1|Overall Study|Withdrawal by Subject|3
2527785|NCT01663103|8747900|P2|Overall Study|dog bite|0
2527786|NCT01663103|8747901|P1|Overall Study|dog bite|1
2527787|NCT01663103|8747900|P2|Overall Study|Adverse Event|0
2527788|NCT01663103|8747901|P1|Overall Study|Adverse Event|1
2527789|NCT01663103|8747900|P2|Overall Study|Withdrawal by Subject|2
2527790|NCT01663103|8747901|P1|Overall Study|Withdrawal by Subject|1
2527791|NCT01662999|8747929|P6|Period 3|Withdrawal by Subject|0
2527792|NCT01662999|8747930|P5|Period 3|Withdrawal by Subject|0
2527793|NCT01662999|8747931|P4|Period 3|Withdrawal by Subject|0
2527794|NCT01662999|8747932|P3|Period 3|Withdrawal by Subject|0
2527795|NCT01662999|8747933|P2|Period 3|Withdrawal by Subject|1
2527796|NCT01662999|8747934|P1|Period 3|Withdrawal by Subject|0
2527797|NCT01662986|8748005|P2|Overall Study|Other than stated above|0
2527798|NCT01662986|8748006|P1|Overall Study|Other than stated above|3
2527799|NCT01662986|8748005|P2|Overall Study|Not Treated|0
2527800|NCT01662986|8748006|P1|Overall Study|Not Treated|1
2527801|NCT01662986|8748005|P2|Overall Study|Withdrawal by Subject|2
2527802|NCT01662986|8748006|P1|Overall Study|Withdrawal by Subject|2
2527803|NCT01662986|8748005|P2|Overall Study|Lost to Follow-up|4
2527804|NCT01662986|8748006|P1|Overall Study|Lost to Follow-up|5
2527805|NCT01662986|8748005|P2|Overall Study|Protocol Violation|3
2527806|NCT01662986|8748006|P1|Overall Study|Protocol Violation|2
2527807|NCT01662986|8748005|P2|Overall Study|Adverse Event|4
2527808|NCT01662986|8748006|P1|Overall Study|Adverse Event|5
2527809|NCT01662895|8748094|P2|Overall Study|Lost to Follow-up|1
2527810|NCT01662895|8748095|P1|Overall Study|Lost to Follow-up|0
2527811|NCT01662648|8748219|P2|Overall Study|LOE and Participant non-compliant|1
2527812|NCT01662648|8748220|P1|Overall Study|LOE and Participant non-compliant|0
2527813|NCT01662648|8748219|P2|Overall Study|LOE and other reason unspecified|0
2527814|NCT01662648|8748220|P1|Overall Study|LOE and other reason unspecified|1
2527815|NCT01662648|8748219|P2|Overall Study|Adverse event and lack of efficacy (LOE)|0
2527816|NCT01662648|8748220|P1|Overall Study|Adverse event and lack of efficacy (LOE)|3
2527817|NCT01662648|8748219|P2|Overall Study|Other|11
2527818|NCT01662648|8748220|P1|Overall Study|Other|8
2527819|NCT01662648|8748219|P2|Overall Study|Participant non-compliant|20
2527820|NCT01662648|8748220|P1|Overall Study|Participant non-compliant|16
2527821|NCT01662648|8748219|P2|Overall Study|Withdrawal by Subject|53
2527822|NCT01662648|8748220|P1|Overall Study|Withdrawal by Subject|36
2527823|NCT01662648|8748219|P2|Overall Study|Lost to Follow-up|36
2527824|NCT01662648|8748220|P1|Overall Study|Lost to Follow-up|24
2527825|NCT01662648|8748219|P2|Overall Study|Participant ineligible to continue trial|1
2527826|NCT01662648|8748220|P1|Overall Study|Participant ineligible to continue trial|1
2527827|NCT01662648|8748219|P2|Overall Study|Lack of Efficacy|16
2527828|NCT01662648|8748220|P1|Overall Study|Lack of Efficacy|17
2527829|NCT01662648|8748219|P2|Overall Study|Adverse Event|37
2527830|NCT01662648|8748220|P1|Overall Study|Adverse Event|40
2527831|NCT01662648|8748219|P2|Overall Study|Death|3
2527832|NCT01662648|8748220|P1|Overall Study|Death|1
2527833|NCT01662635|8748242|P1|Overall Study|scarce samples for evaluation|30
2527834|NCT01662505|8748293|P3|Overall Study|Not specified above|2
2527835|NCT01662505|8748294|P2|Overall Study|Not specified above|3
2527836|NCT01662505|8748295|P1|Overall Study|Not specified above|1
2527837|NCT01662505|8748293|P3|Overall Study|Refused cont. medication|1
2527838|NCT01662505|8748294|P2|Overall Study|Refused cont. medication|0
2527839|NCT01662505|8748295|P1|Overall Study|Refused cont. medication|0
2527840|NCT01662505|8748293|P3|Overall Study|Progressive disease|5
2527841|NCT01662505|8748294|P2|Overall Study|Progressive disease|1
2527842|NCT01662505|8748295|P1|Overall Study|Progressive disease|6
2527843|NCT01662492|8748319|P3|Overall Study|Lack of Efficacy|2
2527844|NCT01662492|8748320|P2|Overall Study|Lack of Efficacy|1
2527845|NCT01662492|8748321|P1|Overall Study|Lack of Efficacy|1
2527846|NCT01662492|8748319|P3|Overall Study|Lost to Follow-up|2
2527847|NCT01662492|8748320|P2|Overall Study|Lost to Follow-up|0
2527848|NCT01662492|8748321|P1|Overall Study|Lost to Follow-up|0
2527849|NCT01662492|8748319|P3|Overall Study|Protocol Violation|0
2527850|NCT01662492|8748320|P2|Overall Study|Protocol Violation|0
2527851|NCT01662492|8748321|P1|Overall Study|Protocol Violation|1
2527852|NCT01662492|8748319|P3|Overall Study|Withdrawal by Subject|1
2527853|NCT01662492|8748320|P2|Overall Study|Withdrawal by Subject|0
2527854|NCT01662492|8748321|P1|Overall Study|Withdrawal by Subject|0
2527855|NCT01662492|8748319|P3|Overall Study|Other miscellaneous reasons.|1
2527856|NCT01662492|8748320|P2|Overall Study|Other miscellaneous reasons.|0
2527857|NCT01662492|8748321|P1|Overall Study|Other miscellaneous reasons.|1
2527858|NCT01662440|8748345|P4|Overall Study|Withdrawal by Subject|2
2527859|NCT01662440|8748346|P3|Overall Study|Withdrawal by Subject|2
2527860|NCT01662440|8748347|P2|Overall Study|Withdrawal by Subject|2
2527861|NCT01662440|8748348|P1|Overall Study|Withdrawal by Subject|5
2527862|NCT01662440|8748345|P4|Overall Study|Protocol Violation|0
2527863|NCT01662440|8748346|P3|Overall Study|Protocol Violation|0
2527864|NCT01662440|8748347|P2|Overall Study|Protocol Violation|0
2527865|NCT01662440|8748348|P1|Overall Study|Protocol Violation|1
2527866|NCT01662440|8748345|P4|Overall Study|Subject moved to another country.|0
2527867|NCT01662440|8748346|P3|Overall Study|Subject moved to another country.|0
2527868|NCT01662440|8748347|P2|Overall Study|Subject moved to another country.|1
2527869|NCT01662440|8748348|P1|Overall Study|Subject moved to another country.|0
2527870|NCT01662440|8748345|P4|Overall Study|Lost to Follow-up|1
2527871|NCT01662440|8748346|P3|Overall Study|Lost to Follow-up|4
2527872|NCT01662440|8748347|P2|Overall Study|Lost to Follow-up|2
2527873|NCT01662440|8748348|P1|Overall Study|Lost to Follow-up|2
2527874|NCT01662440|8748345|P4|Overall Study|Death|0
2527875|NCT01662440|8748346|P3|Overall Study|Death|0
2527876|NCT01662440|8748347|P2|Overall Study|Death|1
2527877|NCT01662440|8748348|P1|Overall Study|Death|0
2527878|NCT01662440|8748345|P4|Overall Study|Adverse Event|1
2527879|NCT01662440|8748346|P3|Overall Study|Adverse Event|0
2527880|NCT01662440|8748347|P2|Overall Study|Adverse Event|0
2527881|NCT01662440|8748348|P1|Overall Study|Adverse Event|1
2527882|NCT01662362|8748396|P1|Overall Study|Lost to Follow-up|38
2527883|NCT01662336|8748401|P1|Overall Study|Withdrawal by Subject|6
2527884|NCT01662336|8748401|P1|Overall Study|Other|29
2527885|NCT01662336|8748401|P1|Overall Study|No longer on LPV/r|30
2527886|NCT01662336|8748401|P1|Overall Study|Adverse Event|1
2527887|NCT01662310|8748427|P5|Open-Label Extension Phase|Withdrawal by Subject|7
2527888|NCT01662310|8748428|P4|Open-Label Extension Phase|Withdrawal by Subject|2
2527889|NCT01662310|8748429|P3|Open-Label Extension Phase|Withdrawal by Subject|0
2527890|NCT01662310|8748430|P2|Open-Label Extension Phase|Withdrawal by Subject|0
2527891|NCT01662310|8748431|P1|Open-Label Extension Phase|Withdrawal by Subject|0
2527892|NCT01662310|8748427|P5|Open-Label Extension Phase|Pregnancy|0
2527893|NCT01662310|8748428|P4|Open-Label Extension Phase|Pregnancy|1
2527894|NCT01662310|8748429|P3|Open-Label Extension Phase|Pregnancy|0
2527895|NCT01662310|8748430|P2|Open-Label Extension Phase|Pregnancy|0
2527896|NCT01662310|8748431|P1|Open-Label Extension Phase|Pregnancy|0
2527897|NCT01662310|8748427|P5|Open-Label Extension Phase|Lost to Follow-up|1
2527898|NCT01662310|8748428|P4|Open-Label Extension Phase|Lost to Follow-up|2
2527899|NCT01662310|8748429|P3|Open-Label Extension Phase|Lost to Follow-up|0
2527900|NCT01662310|8748430|P2|Open-Label Extension Phase|Lost to Follow-up|0
2527901|NCT01662310|8748431|P1|Open-Label Extension Phase|Lost to Follow-up|0
2527902|NCT01662310|8748427|P5|Open-Label Extension Phase|Lack of Efficacy|2
2527903|NCT01662310|8748428|P4|Open-Label Extension Phase|Lack of Efficacy|2
2527904|NCT01662310|8748429|P3|Open-Label Extension Phase|Lack of Efficacy|0
2527905|NCT01662310|8748430|P2|Open-Label Extension Phase|Lack of Efficacy|0
2527906|NCT01662310|8748431|P1|Open-Label Extension Phase|Lack of Efficacy|0
2527907|NCT01662310|8748427|P5|Open-Label Extension Phase|Death|0
2527908|NCT01662310|8748428|P4|Open-Label Extension Phase|Death|1
2527909|NCT01662310|8748429|P3|Open-Label Extension Phase|Death|0
2527910|NCT01662310|8748430|P2|Open-Label Extension Phase|Death|0
2527911|NCT01662310|8748431|P1|Open-Label Extension Phase|Death|0
2527912|NCT01662310|8748427|P5|Open-Label Extension Phase|Adverse Event|0
2527913|NCT01662310|8748428|P4|Open-Label Extension Phase|Adverse Event|3
2527914|NCT01662310|8748429|P3|Open-Label Extension Phase|Adverse Event|0
2527915|NCT01662310|8748430|P2|Open-Label Extension Phase|Adverse Event|0
2527916|NCT01662310|8748431|P1|Open-Label Extension Phase|Adverse Event|0
2527917|NCT01662310|8748427|P5|Double-Blind Phase|Randomized but not treated|0
2527918|NCT01662310|8748428|P4|Double-Blind Phase|Randomized but not treated|0
2527919|NCT01662310|8748429|P3|Double-Blind Phase|Randomized but not treated|0
2527920|NCT01662310|8748430|P2|Double-Blind Phase|Randomized but not treated|1
2527921|NCT01662310|8748431|P1|Double-Blind Phase|Randomized but not treated|0
2527922|NCT01662310|8748427|P5|Double-Blind Phase|Other|0
2527923|NCT01662310|8748428|P4|Double-Blind Phase|Other|0
2527924|NCT01662310|8748429|P3|Double-Blind Phase|Other|1
2527925|NCT01662310|8748430|P2|Double-Blind Phase|Other|0
2527926|NCT01662310|8748431|P1|Double-Blind Phase|Other|0
2527927|NCT01662310|8748427|P5|Double-Blind Phase|Withdrawal by Subject|0
2527928|NCT01662310|8748428|P4|Double-Blind Phase|Withdrawal by Subject|0
2527929|NCT01662310|8748429|P3|Double-Blind Phase|Withdrawal by Subject|3
2527930|NCT01662310|8748430|P2|Double-Blind Phase|Withdrawal by Subject|9
2527931|NCT01662310|8748431|P1|Double-Blind Phase|Withdrawal by Subject|0
2527932|NCT01662310|8748427|P5|Double-Blind Phase|Pregnancy|0
2527933|NCT01662310|8748428|P4|Double-Blind Phase|Pregnancy|0
2527934|NCT01662310|8748429|P3|Double-Blind Phase|Pregnancy|0
2527935|NCT01662310|8748430|P2|Double-Blind Phase|Pregnancy|2
2527936|NCT01662310|8748431|P1|Double-Blind Phase|Pregnancy|0
2527937|NCT01662310|8748427|P5|Double-Blind Phase|Lost to Follow-up|0
2527938|NCT01662310|8748428|P4|Double-Blind Phase|Lost to Follow-up|0
2527939|NCT01662310|8748429|P3|Double-Blind Phase|Lost to Follow-up|0
2527940|NCT01662310|8748430|P2|Double-Blind Phase|Lost to Follow-up|3
2527941|NCT01662310|8748431|P1|Double-Blind Phase|Lost to Follow-up|0
2527942|NCT01662310|8748427|P5|Double-Blind Phase|Adverse Event|0
2527943|NCT01662310|8748428|P4|Double-Blind Phase|Adverse Event|0
2527944|NCT01662310|8748429|P3|Double-Blind Phase|Adverse Event|1
2527945|NCT01662310|8748430|P2|Double-Blind Phase|Adverse Event|0
2527946|NCT01662310|8748431|P1|Double-Blind Phase|Adverse Event|0
2527947|NCT01662310|8748427|P5|Run-In or Stabilization Phase|Other|0
2527948|NCT01662310|8748428|P4|Run-In or Stabilization Phase|Other|0
2527949|NCT01662310|8748429|P3|Run-In or Stabilization Phase|Other|0
2527950|NCT01662310|8748430|P2|Run-In or Stabilization Phase|Other|0
2527951|NCT01662310|8748431|P1|Run-In or Stabilization Phase|Other|1
2527952|NCT01662310|8748427|P5|Run-In or Stabilization Phase|Withdrawal by Subject|0
2527953|NCT01662310|8748428|P4|Run-In or Stabilization Phase|Withdrawal by Subject|0
2527954|NCT01662310|8748429|P3|Run-In or Stabilization Phase|Withdrawal by Subject|0
2527955|NCT01662310|8748430|P2|Run-In or Stabilization Phase|Withdrawal by Subject|0
2527956|NCT01662310|8748431|P1|Run-In or Stabilization Phase|Withdrawal by Subject|25
2527957|NCT01662310|8748427|P5|Run-In or Stabilization Phase|Protocol Violation|0
2527958|NCT01662310|8748428|P4|Run-In or Stabilization Phase|Protocol Violation|0
2527959|NCT01662310|8748429|P3|Run-In or Stabilization Phase|Protocol Violation|0
2527960|NCT01662310|8748430|P2|Run-In or Stabilization Phase|Protocol Violation|0
2527961|NCT01662310|8748431|P1|Run-In or Stabilization Phase|Protocol Violation|15
2527962|NCT01662310|8748427|P5|Run-In or Stabilization Phase|Lost to Follow-up|0
2527963|NCT01662310|8748428|P4|Run-In or Stabilization Phase|Lost to Follow-up|0
2527964|NCT01662310|8748429|P3|Run-In or Stabilization Phase|Lost to Follow-up|0
2527965|NCT01662310|8748430|P2|Run-In or Stabilization Phase|Lost to Follow-up|0
2527966|NCT01662310|8748431|P1|Run-In or Stabilization Phase|Lost to Follow-up|4
2527967|NCT01662310|8748427|P5|Run-In or Stabilization Phase|Lack of Efficacy|0
2527968|NCT01662310|8748428|P4|Run-In or Stabilization Phase|Lack of Efficacy|0
2527969|NCT01662310|8748429|P3|Run-In or Stabilization Phase|Lack of Efficacy|0
2527970|NCT01662310|8748430|P2|Run-In or Stabilization Phase|Lack of Efficacy|0
2527971|NCT01662310|8748431|P1|Run-In or Stabilization Phase|Lack of Efficacy|9
2527972|NCT01662310|8748427|P5|Run-In or Stabilization Phase|Adverse Event|0
2527973|NCT01662310|8748428|P4|Run-In or Stabilization Phase|Adverse Event|0
2527974|NCT01662310|8748429|P3|Run-In or Stabilization Phase|Adverse Event|0
2527975|NCT01662310|8748430|P2|Run-In or Stabilization Phase|Adverse Event|0
2527976|NCT01662310|8748431|P1|Run-In or Stabilization Phase|Adverse Event|11
2527977|NCT01662102|8748512|P2|Overall Study|Sponsor's decision|0
2527978|NCT01662102|8748513|P1|Overall Study|Sponsor's decision|1
2527979|NCT01662063|8748521|P3|Overall Study|Other|0
2527980|NCT01662063|8748522|P2|Overall Study|Other|1
2527981|NCT01662063|8748523|P1|Overall Study|Other|0
2527982|NCT01662063|8748521|P3|Overall Study|Physician Decision|0
2527983|NCT01662063|8748522|P2|Overall Study|Physician Decision|2
2527984|NCT01662063|8748523|P1|Overall Study|Physician Decision|0
2527985|NCT01662063|8748521|P3|Overall Study|Withdrawal by Subject|1
2527986|NCT01662063|8748522|P2|Overall Study|Withdrawal by Subject|4
2527987|NCT01662063|8748523|P1|Overall Study|Withdrawal by Subject|2
2527988|NCT01662063|8748521|P3|Overall Study|Protocol Violation|0
2527989|NCT01662063|8748522|P2|Overall Study|Protocol Violation|0
2527990|NCT01662063|8748523|P1|Overall Study|Protocol Violation|1
2527991|NCT01662063|8748521|P3|Overall Study|Lost to Follow-up|0
2527992|NCT01662063|8748522|P2|Overall Study|Lost to Follow-up|4
2527993|NCT01662063|8748523|P1|Overall Study|Lost to Follow-up|0
2527994|NCT01662063|8748521|P3|Overall Study|Lack of Efficacy|0
2527995|NCT01662063|8748522|P2|Overall Study|Lack of Efficacy|6
2527996|NCT01662063|8748523|P1|Overall Study|Lack of Efficacy|1
2527997|NCT01662063|8748521|P3|Overall Study|Adverse Event or Intercurrent Illness|0
2527998|NCT01662063|8748522|P2|Overall Study|Adverse Event or Intercurrent Illness|12
2527999|NCT01662063|8748523|P1|Overall Study|Adverse Event or Intercurrent Illness|1
2528000|NCT01662024|8748602|P1|Overall Study|Withdrawal by Subject|3
2528001|NCT01662024|8748602|P1|Overall Study|Pregnancy|2
2528002|NCT01661972|8748614|P2|Overall Study|Withdrawal by Subject|1
2528003|NCT01661972|8748615|P1|Overall Study|Withdrawal by Subject|0
2528004|NCT01661972|8748614|P2|Overall Study|Death during Treatment period|1
2528005|NCT01661972|8748615|P1|Overall Study|Death during Treatment period|1
2528006|NCT01661972|8748614|P2|Overall Study|Adverse Event|2
2528007|NCT01661972|8748615|P1|Overall Study|Adverse Event|1
2528008|NCT01661933|8748634|P1|High-dose Gluten Challenge|Withdrawal by Subject|2
2528009|NCT01661933|8748634|P1|Low-dose Gluten Challenge|Physician Decision|2
2528010|NCT01661881|8748641|P1|Overall Study|Disease Progression|1
2528011|NCT01661790|8748649|P2|Overall Study|Lost to Follow-up|2
2528012|NCT01661790|8748650|P1|Overall Study|Lost to Follow-up|0
2528013|NCT01661686|8748750|P2|Overall Study|did not receive allocated intervention|1
2528014|NCT01661686|8748751|P1|Overall Study|did not receive allocated intervention|0
2528015|NCT01661686|8748750|P2|Overall Study|Lost to Follow-up|1
2528016|NCT01661686|8748751|P1|Overall Study|Lost to Follow-up|2
2528017|NCT01661595|8748792|P4|Phase 2: Week 5-8.|Protocol Violation|0
2528018|NCT01661595|8748793|P3|Phase 2: Week 5-8.|Protocol Violation|1
2528019|NCT01661595|8748794|P2|Phase 2: Week 5-8.|Protocol Violation|0
2528020|NCT01661595|8748795|P1|Phase 2: Week 5-8.|Protocol Violation|0
2528021|NCT01661595|8748792|P4|Phase 1: Week 0-4|Adverse Event|0
2528022|NCT01661595|8748793|P3|Phase 1: Week 0-4|Adverse Event|0
2528023|NCT01661595|8748794|P2|Phase 1: Week 0-4|Adverse Event|0
2528024|NCT01661595|8748795|P1|Phase 1: Week 0-4|Adverse Event|1
2528025|NCT01661205|8748923|P1|Overall Study|Physician Decision|2
2528026|NCT01661179|8748934|P1|Overall Study|Other Eligibility criteria|4
2528027|NCT01661179|8748934|P1|Overall Study|Withdrawal by Subject|1
2528028|NCT01661179|8748934|P1|Overall Study|Death|1
2528029|NCT01661140|8748938|P3|Double-Blind Period|Administrative/Other|6
2528030|NCT01661140|8748939|P2|Double-Blind Period|Administrative/Other|7
2528031|NCT01661140|8748940|P1|Double-Blind Period|Administrative/Other|0
2528032|NCT01661140|8748938|P3|Double-Blind Period|Sponsor Termination|17
2528033|NCT01661140|8748939|P2|Double-Blind Period|Sponsor Termination|14
2528034|NCT01661140|8748940|P1|Double-Blind Period|Sponsor Termination|0
2528035|NCT01661140|8748938|P3|Double-Blind Period|Investigator's Decision|2
2528036|NCT01661140|8748939|P2|Double-Blind Period|Investigator's Decision|1
2528037|NCT01661140|8748940|P1|Double-Blind Period|Investigator's Decision|0
2528038|NCT01661140|8748938|P3|Double-Blind Period|Withdrawal by Subject|3
2528039|NCT01661140|8748939|P2|Double-Blind Period|Withdrawal by Subject|1
2528040|NCT01661140|8748940|P1|Double-Blind Period|Withdrawal by Subject|0
2528041|NCT01661140|8748938|P3|Double-Blind Period|Protocol Violation|3
2528042|NCT01661140|8748939|P2|Double-Blind Period|Protocol Violation|2
2528043|NCT01661140|8748940|P1|Double-Blind Period|Protocol Violation|0
2528044|NCT01661140|8748938|P3|Double-Blind Period|Adverse Event|18
2528045|NCT01661140|8748939|P2|Double-Blind Period|Adverse Event|16
2528046|NCT01661140|8748940|P1|Double-Blind Period|Adverse Event|0
2528047|NCT01661140|8748938|P3|Double-Blind Period|Refused Treatment|1
2528048|NCT01661140|8748939|P2|Double-Blind Period|Refused Treatment|0
2528049|NCT01661140|8748940|P1|Double-Blind Period|Refused Treatment|0
2528050|NCT01661140|8748938|P3|Open-Label Period|Lost to Follow-up|0
2528051|NCT01661140|8748939|P2|Open-Label Period|Lost to Follow-up|0
2528052|NCT01661140|8748940|P1|Open-Label Period|Lost to Follow-up|2
2528053|NCT01661140|8748938|P3|Open-Label Period|Did not meet EULAR criteria|0
2528054|NCT01661140|8748939|P2|Open-Label Period|Did not meet EULAR criteria|0
2528055|NCT01661140|8748940|P1|Open-Label Period|Did not meet EULAR criteria|1
2528056|NCT01661140|8748938|P3|Open-Label Period|Sponsor termination|0
2528057|NCT01661140|8748939|P2|Open-Label Period|Sponsor termination|0
2528058|NCT01661140|8748940|P1|Open-Label Period|Sponsor termination|16
2528059|NCT01661140|8748938|P3|Open-Label Period|Administrative/Other|0
2528060|NCT01661140|8748939|P2|Open-Label Period|Administrative/Other|0
2528061|NCT01661140|8748940|P1|Open-Label Period|Administrative/Other|1
2528062|NCT01661140|8748938|P3|Open-Label Period|Death|0
2528063|NCT01661140|8748939|P2|Open-Label Period|Death|0
2528064|NCT01661140|8748940|P1|Open-Label Period|Death|1
2528065|NCT01661140|8748938|P3|Open-Label Period|Investigator Decision|0
2528066|NCT01661140|8748939|P2|Open-Label Period|Investigator Decision|0
2528067|NCT01661140|8748940|P1|Open-Label Period|Investigator Decision|3
2528068|NCT01661140|8748938|P3|Open-Label Period|Withdrawal by Subject|0
2528069|NCT01661140|8748939|P2|Open-Label Period|Withdrawal by Subject|0
2528070|NCT01661140|8748940|P1|Open-Label Period|Withdrawal by Subject|5
2528071|NCT01661140|8748938|P3|Open-Label Period|Protocol Violation|0
2528072|NCT01661140|8748939|P2|Open-Label Period|Protocol Violation|0
2528073|NCT01661140|8748940|P1|Open-Label Period|Protocol Violation|3
2528074|NCT01661140|8748938|P3|Open-Label Period|Adverse Event|0
2528075|NCT01661140|8748939|P2|Open-Label Period|Adverse Event|0
2528076|NCT01661140|8748940|P1|Open-Label Period|Adverse Event|44
2528077|NCT01661062|8748992|P1|Overall Study|Withdrawal by Subject|2
2528078|NCT01661062|8748992|P1|Overall Study|Completed Treatment Off Study|3
2528079|NCT01660906|8748997|P1|Overall Study|Discontinued due to study drug toxicity|3
2528080|NCT01660763|8749080|P2|Overall Study|Patient ready for early discharge|4
2528081|NCT01660763|8749081|P1|Overall Study|Patient ready for early discharge|28
2528082|NCT01660763|8749080|P2|Overall Study|Withdrawal by Subject|0
2528083|NCT01660763|8749081|P1|Overall Study|Withdrawal by Subject|4
2528084|NCT01660763|8749080|P2|Overall Study|Protocol Violation|0
2528085|NCT01660763|8749081|P1|Overall Study|Protocol Violation|1
2528086|NCT01660763|8749080|P2|Overall Study|Adverse Event|7
2528087|NCT01660763|8749081|P1|Overall Study|Adverse Event|22
2528088|NCT01660763|8749080|P2|Overall Study|Lack of Efficacy|50
2528089|NCT01660763|8749081|P1|Overall Study|Lack of Efficacy|45
2528090|NCT01660451|8749129|P3|Overall Study|Ongoing with treatment|46
2528091|NCT01660451|8749130|P2|Overall Study|Ongoing with treatment|3
2528092|NCT01660451|8749131|P1|Overall Study|Ongoing with treatment|3
2528093|NCT01660451|8749129|P3|Overall Study|Withdrawal by Subject|16
2528094|NCT01660451|8749130|P2|Overall Study|Withdrawal by Subject|0
2528095|NCT01660451|8749131|P1|Overall Study|Withdrawal by Subject|1
2528096|NCT01660451|8749129|P3|Overall Study|Physician Decision|5
2528097|NCT01660451|8749130|P2|Overall Study|Physician Decision|2
2528098|NCT01660451|8749131|P1|Overall Study|Physician Decision|1
2528099|NCT01660451|8749129|P3|Overall Study|Protocol Deviation|1
2528100|NCT01660451|8749130|P2|Overall Study|Protocol Deviation|0
2528101|NCT01660451|8749131|P1|Overall Study|Protocol Deviation|0
2528102|NCT01660451|8749129|P3|Overall Study|Sponsor Decision|1
2528103|NCT01660451|8749130|P2|Overall Study|Sponsor Decision|0
2528104|NCT01660451|8749131|P1|Overall Study|Sponsor Decision|0
2528105|NCT01660451|8749129|P3|Overall Study|AE with Clinical PD|9
2528106|NCT01660451|8749130|P2|Overall Study|AE with Clinical PD|3
2528107|NCT01660451|8749131|P1|Overall Study|AE with Clinical PD|1
2528108|NCT01660451|8749129|P3|Overall Study|Adverse Event (AE) without Clinical PD|26
2528109|NCT01660451|8749130|P2|Overall Study|Adverse Event (AE) without Clinical PD|8
2528110|NCT01660451|8749131|P1|Overall Study|Adverse Event (AE) without Clinical PD|11
2528111|NCT01660451|8749129|P3|Overall Study|Protocol Violation|1
2528112|NCT01660451|8749130|P2|Overall Study|Protocol Violation|1
2528113|NCT01660451|8749131|P1|Overall Study|Protocol Violation|0
2528114|NCT01660412|8749159|P2|Overall Study|Protocol Violation|3
2528115|NCT01660412|8749160|P1|Overall Study|Protocol Violation|0
2528116|NCT01660334|8749166|P1|Overall Study|Lost to Follow-up|1
2528117|NCT01660022|8749409|P6|First Sequence (7 Days)|Protocol Violation|1
2528118|NCT01660022|8749410|P5|First Sequence (7 Days)|Protocol Violation|0
2528119|NCT01660022|8749411|P4|First Sequence (7 Days)|Protocol Violation|0
2528120|NCT01660022|8749412|P3|First Sequence (7 Days)|Protocol Violation|0
2528121|NCT01660022|8749413|P2|First Sequence (7 Days)|Protocol Violation|0
2528122|NCT01660022|8749414|P1|First Sequence (7 Days)|Protocol Violation|0
2528123|NCT01660022|8749409|P6|First Sequence (7 Days)|Adverse Event|3
2528124|NCT01660022|8749410|P5|First Sequence (7 Days)|Adverse Event|1
2528125|NCT01660022|8749411|P4|First Sequence (7 Days)|Adverse Event|0
2528126|NCT01660022|8749412|P3|First Sequence (7 Days)|Adverse Event|0
2528127|NCT01660022|8749413|P2|First Sequence (7 Days)|Adverse Event|0
2528128|NCT01660022|8749414|P1|First Sequence (7 Days)|Adverse Event|0
2528129|NCT01660022|8749409|P6|First Sequence (7 Days)|Withdrawal by Subject|0
2528130|NCT01660022|8749410|P5|First Sequence (7 Days)|Withdrawal by Subject|0
2528131|NCT01660022|8749411|P4|First Sequence (7 Days)|Withdrawal by Subject|1
2528132|NCT01660022|8749412|P3|First Sequence (7 Days)|Withdrawal by Subject|0
2528133|NCT01660022|8749413|P2|First Sequence (7 Days)|Withdrawal by Subject|1
2528134|NCT01660022|8749414|P1|First Sequence (7 Days)|Withdrawal by Subject|0
2528135|NCT01659996|8749473|P3|Overall Study|Withdrawal by Subject|5
2528136|NCT01659996|8749474|P2|Overall Study|Withdrawal by Subject|1
2528137|NCT01659996|8749475|P1|Overall Study|Withdrawal by Subject|4
2528138|NCT01659996|8749473|P3|Overall Study|Adverse Event|1
2528139|NCT01659996|8749474|P2|Overall Study|Adverse Event|0
2528140|NCT01659996|8749475|P1|Overall Study|Adverse Event|0
2528141|NCT01659996|8749473|P3|Overall Study|Lost to Follow-up|2
2528142|NCT01659996|8749474|P2|Overall Study|Lost to Follow-up|3
2528143|NCT01659996|8749475|P1|Overall Study|Lost to Follow-up|1
2528144|NCT01659996|8749473|P3|Overall Study|Protocol Violation|3
2528145|NCT01659996|8749474|P2|Overall Study|Protocol Violation|3
2528146|NCT01659996|8749475|P1|Overall Study|Protocol Violation|3
2528147|NCT01659853|8749516|P2|Washout , 3 to 7 Days|Protocol Violation|0
2528148|NCT01659853|8749517|P1|Washout , 3 to 7 Days|Protocol Violation|1
2528149|NCT01659853|8749516|P2|Washout , 3 to 7 Days|Adverse Event|0
2528150|NCT01659853|8749517|P1|Washout , 3 to 7 Days|Adverse Event|1
2528151|NCT01659736|8749527|P2|3-month Follow-up|Lost to Follow-up|1
2528152|NCT01659736|8749528|P1|3-month Follow-up|Lost to Follow-up|0
2528153|NCT01659736|8749527|P2|Treatment Period|Withdrawal by Subject|0
2528154|NCT01659736|8749528|P1|Treatment Period|Withdrawal by Subject|1
2528155|NCT01659736|8749527|P2|Treatment Period|Protocol Violation|1
2528156|NCT01659736|8749528|P1|Treatment Period|Protocol Violation|3
2528157|NCT01659736|8749527|P2|Treatment Period|Adverse Event|1
2528158|NCT01659736|8749528|P1|Treatment Period|Adverse Event|1
2528159|NCT01659567|8749542|P1|Overall Study|Other|13
2528160|NCT01659567|8749542|P1|Overall Study|Progression of the main disease|1
2528161|NCT01659567|8749542|P1|Overall Study|Withdrawal by Subject|64
2528162|NCT01659567|8749542|P1|Overall Study|Good result at early stage of treatment|5
2528163|NCT01659567|8749542|P1|Overall Study|Adverse Event|12
2528164|NCT01659567|8749542|P1|Overall Study|Switched to Pegferon|6
2528165|NCT01659567|8749542|P1|Overall Study|Lack of Efficacy|22
2528166|NCT01659554|8749559|P1|Overall Study|Study Termination|4
2528167|NCT01659320|8749566|P1|Overall Study|Physician Decision|1
2528168|NCT01659320|8749566|P1|Overall Study|Withdrawal by Subject|2
2528169|NCT01659125|8749585|P1|Overall Study|Failed to Start Treatment|2
2528170|NCT01659125|8749585|P1|Overall Study|Time Constraints|2
2528171|NCT01659125|8749585|P1|Overall Study|Technical Problem|1
2528172|NCT01659125|8749585|P1|Overall Study|Lost to Follow-up|7
2528173|NCT01659125|8749585|P1|Overall Study|Withdrawal by Subject|2
2528174|NCT01659021|8749592|P2|Long-Term Follow Up|Withdrawal by Subject|1
2528175|NCT01659021|8749593|P1|Long-Term Follow Up|Withdrawal by Subject|2
2528176|NCT01659021|8749592|P2|Long-Term Follow Up|Lost to Follow-up|3
2528177|NCT01659021|8749593|P1|Long-Term Follow Up|Lost to Follow-up|3
2528178|NCT01659021|8749592|P2|Main Study|Study Terminated by Sponsor|1
2528179|NCT01659021|8749593|P1|Main Study|Study Terminated by Sponsor|16
2528180|NCT01659021|8749592|P2|Main Study|Withdrawal by Subject|16
2528181|NCT01659021|8749593|P1|Main Study|Withdrawal by Subject|19
2528182|NCT01659021|8749592|P2|Main Study|Physician Decision|16
2528183|NCT01659021|8749593|P1|Main Study|Physician Decision|34
2528184|NCT01659021|8749592|P2|Main Study|Unknown Reasons|1
2528185|NCT01659021|8749593|P1|Main Study|Unknown Reasons|2
2528186|NCT01659021|8749592|P2|Main Study|Lost to Follow-up|0
2528187|NCT01659021|8749593|P1|Main Study|Lost to Follow-up|1
2528188|NCT01659021|8749592|P2|Main Study|Adverse Event|3
2528189|NCT01659021|8749593|P1|Main Study|Adverse Event|2
2528190|NCT01658943|8749611|P2|Overall Study|Withdrew prior to beginning protocol Tx|0
2528191|NCT01658943|8749612|P1|Overall Study|Withdrew prior to beginning protocol Tx|1
2528192|NCT01658943|8749611|P2|Overall Study|Not eligible|9
2528193|NCT01658943|8749612|P1|Overall Study|Not eligible|7
2528194|NCT01658943|8749611|P2|Overall Study|not protocol specified|1
2528195|NCT01658943|8749612|P1|Overall Study|not protocol specified|4
2528196|NCT01658943|8749611|P2|Overall Study|Death|2
2528197|NCT01658943|8749612|P1|Overall Study|Death|4
2528198|NCT01658943|8749611|P2|Overall Study|Progression/Relapse|40
2528199|NCT01658943|8749612|P1|Overall Study|Progression/Relapse|39
2528200|NCT01658943|8749611|P2|Overall Study|Withdrawal by Subject|2
2528201|NCT01658943|8749612|P1|Overall Study|Withdrawal by Subject|9
2528202|NCT01658943|8749611|P2|Overall Study|Adverse Event|13
2528203|NCT01658943|8749612|P1|Overall Study|Adverse Event|6
2528204|NCT01658904|8749627|P3|Overall Study|Principal Investigator discretion|0
2528205|NCT01658904|8749628|P2|Overall Study|Principal Investigator discretion|0
2528206|NCT01658904|8749629|P1|Overall Study|Principal Investigator discretion|2
2528207|NCT01658813|8749655|P1|Overall Study|Disease progression|3
2528208|NCT01658735|8749666|P3|Overall Study|Withdrawal by Subject|3
2528209|NCT01658735|8749667|P2|Overall Study|Withdrawal by Subject|5
2528210|NCT01658735|8749668|P1|Overall Study|Withdrawal by Subject|3
2528211|NCT01658735|8749666|P3|Overall Study|Protocol Violation|0
2528212|NCT01658735|8749667|P2|Overall Study|Protocol Violation|1
2528213|NCT01658735|8749668|P1|Overall Study|Protocol Violation|0
2528214|NCT01658735|8749666|P3|Overall Study|Lost to Follow-up|0
2528215|NCT01658735|8749667|P2|Overall Study|Lost to Follow-up|1
2528216|NCT01658735|8749668|P1|Overall Study|Lost to Follow-up|1
2528217|NCT01658735|8749666|P3|Overall Study|Lack of Efficacy|1
2528218|NCT01658735|8749667|P2|Overall Study|Lack of Efficacy|0
2528219|NCT01658735|8749668|P1|Overall Study|Lack of Efficacy|1
2528220|NCT01658579|8749710|P4|Treatment Period B|Other|1
2528221|NCT01658579|8749711|P3|Treatment Period B|Other|0
2528222|NCT01658579|8749712|P2|Treatment Period B|Other|0
2528223|NCT01658579|8749713|P1|Treatment Period B|Other|0
2528224|NCT01658579|8749710|P4|Treatment Period A|Adverse Event|0
2528225|NCT01658579|8749711|P3|Treatment Period A|Adverse Event|0
2528226|NCT01658579|8749712|P2|Treatment Period A|Adverse Event|0
2528227|NCT01658579|8749713|P1|Treatment Period A|Adverse Event|1
2528228|NCT01658579|8749710|P4|Treatment Period A|Other|1
2528229|NCT01658579|8749711|P3|Treatment Period A|Other|1
2528230|NCT01658579|8749712|P2|Treatment Period A|Other|0
2528231|NCT01658579|8749713|P1|Treatment Period A|Other|0
2528232|NCT01658514|8749741|P3|Overall Study|Protocol Violation|2
2528233|NCT01658514|8749742|P2|Overall Study|Protocol Violation|0
2528234|NCT01658514|8749743|P1|Overall Study|Protocol Violation|1
2528235|NCT01658436|8749754|P2|Overall Study|Death|0
2528236|NCT01658436|8749755|P1|Overall Study|Death|1
2528237|NCT01658436|8749754|P2|Overall Study|Subject/guardian decision|1
2528238|NCT01658436|8749755|P1|Overall Study|Subject/guardian decision|0
2528239|NCT01658436|8749754|P2|Overall Study|Study terminated by sponsor|1
2528240|NCT01658436|8749755|P1|Overall Study|Study terminated by sponsor|0
2528241|NCT01658436|8749754|P2|Overall Study|Progressive disease|4
2528242|NCT01658436|8749755|P1|Overall Study|Progressive disease|12
2528243|NCT01658436|8749754|P2|Overall Study|Physician Decision|0
2528244|NCT01658436|8749755|P1|Overall Study|Physician Decision|1
2528245|NCT01658436|8749754|P2|Overall Study|Adverse Event|5
2528246|NCT01658436|8749755|P1|Overall Study|Adverse Event|6
2528247|NCT01658150|8749775|P1|Overall Study|Withdrawal by Subject|1
2528248|NCT01658072|8749797|P2|Overall Study|Protocol Violation|2
2528249|NCT01658072|8749798|P1|Overall Study|Protocol Violation|4
2528250|NCT01658020|8749813|P2|Overall Study|Protocol Violation|1
2528251|NCT01658020|8749814|P1|Overall Study|Protocol Violation|0
2528252|NCT01658020|8749813|P2|Overall Study|Withdrawal by Subject|5
2528253|NCT01658020|8749814|P1|Overall Study|Withdrawal by Subject|4
2528254|NCT01658020|8749813|P2|Overall Study|Lost to Follow-up|0
2528255|NCT01658020|8749814|P1|Overall Study|Lost to Follow-up|1
2528256|NCT01658020|8749813|P2|Overall Study|Adverse Event|3
2528257|NCT01658020|8749814|P1|Overall Study|Adverse Event|3
2528258|NCT01657903|8749830|P1|Overall Study|Withdrawal by Subject|1
2528259|NCT01657903|8749830|P1|Overall Study|Lost to Follow-up|1
2528260|NCT01657877|8749852|P1|Overall Study|Other Reason|2
2528261|NCT01657877|8749852|P1|Overall Study|Adverse Event|2
2528262|NCT01657877|8749852|P1|Overall Study|Protocol Violation|6
2528263|NCT01657877|8749852|P1|Overall Study|Withdrawal by Subject|4
2528264|NCT01657799|8749872|P3|Overall Study|Other|49
2528265|NCT01657799|8749873|P2|Overall Study|Other|62
2528266|NCT01657799|8749874|P1|Overall Study|Other|52
2528267|NCT01657799|8749872|P3|Overall Study|Radiographic & Clinical Progression|15
2528268|NCT01657799|8749873|P2|Overall Study|Radiographic & Clinical Progression|11
2528269|NCT01657799|8749874|P1|Overall Study|Radiographic & Clinical Progression|16
2528270|NCT01657799|8749872|P3|Overall Study|Progressive Disease Clinical|7
2528271|NCT01657799|8749873|P2|Overall Study|Progressive Disease Clinical|4
2528272|NCT01657799|8749874|P1|Overall Study|Progressive Disease Clinical|7
2528273|NCT01657799|8749872|P3|Overall Study|Disease Progression|4
2528274|NCT01657799|8749873|P2|Overall Study|Disease Progression|4
2528275|NCT01657799|8749874|P1|Overall Study|Disease Progression|2
2528276|NCT01657799|8749872|P3|Overall Study|Lost to Follow-up|1
2528277|NCT01657799|8749873|P2|Overall Study|Lost to Follow-up|0
2528278|NCT01657799|8749874|P1|Overall Study|Lost to Follow-up|1
2528279|NCT01657799|8749872|P3|Overall Study|Withdrawal by Subject|10
2528280|NCT01657799|8749873|P2|Overall Study|Withdrawal by Subject|10
2528281|NCT01657799|8749874|P1|Overall Study|Withdrawal by Subject|13
2528282|NCT01657799|8749872|P3|Overall Study|Adverse Event Not Related to Progression|4
2528283|NCT01657799|8749873|P2|Overall Study|Adverse Event Not Related to Progression|4
2528284|NCT01657799|8749874|P1|Overall Study|Adverse Event Not Related to Progression|5
2528285|NCT01657799|8749872|P3|Overall Study|Adverse Event Related to progression|12
2528286|NCT01657799|8749873|P2|Overall Study|Adverse Event Related to progression|8
2528287|NCT01657799|8749874|P1|Overall Study|Adverse Event Related to progression|6
2528288|NCT01657760|8749893|P4|Overall Study|Physician Decision|2
2528289|NCT01657760|8749894|P3|Overall Study|Physician Decision|1
2528290|NCT01657760|8749895|P2|Overall Study|Physician Decision|1
2528291|NCT01657760|8749896|P1|Overall Study|Physician Decision|1
2528292|NCT01657760|8749893|P4|Overall Study|Withdrawal by Subject|1
2528293|NCT01657760|8749894|P3|Overall Study|Withdrawal by Subject|0
2528294|NCT01657760|8749895|P2|Overall Study|Withdrawal by Subject|0
2528295|NCT01657760|8749896|P1|Overall Study|Withdrawal by Subject|0
2528296|NCT01657461|8749915|P2|Overall Study|Withdrawal by Subject|3
2528297|NCT01657461|8749916|P1|Overall Study|Withdrawal by Subject|1
2528298|NCT01657461|8749915|P2|Overall Study|Physician Decision|2
2528299|NCT01657461|8749916|P1|Overall Study|Physician Decision|0
2528300|NCT01657461|8749915|P2|Overall Study|Lost to Follow-up|3
2528301|NCT01657461|8749916|P1|Overall Study|Lost to Follow-up|0
2528302|NCT01657461|8749915|P2|Overall Study|Death|12
2528303|NCT01657461|8749916|P1|Overall Study|Death|9
2528304|NCT01657370|8749946|P6|Overall Study|Lost to Follow-up|1
2528305|NCT01657370|8749947|P5|Overall Study|Lost to Follow-up|0
2528306|NCT01657370|8749948|P4|Overall Study|Lost to Follow-up|0
2528307|NCT01657370|8749949|P3|Overall Study|Lost to Follow-up|1
2528308|NCT01657370|8749950|P2|Overall Study|Lost to Follow-up|0
2528309|NCT01657370|8749951|P1|Overall Study|Lost to Follow-up|2
2528310|NCT01657370|8749946|P6|Overall Study|Protocol Violation|0
2528311|NCT01657370|8749947|P5|Overall Study|Protocol Violation|0
2528312|NCT01657370|8749948|P4|Overall Study|Protocol Violation|1
2528313|NCT01657370|8749949|P3|Overall Study|Protocol Violation|1
2528314|NCT01657370|8749950|P2|Overall Study|Protocol Violation|1
2528315|NCT01657370|8749951|P1|Overall Study|Protocol Violation|1
2528316|NCT01657370|8749946|P6|Overall Study|Adverse Event|0
2528317|NCT01657370|8749947|P5|Overall Study|Adverse Event|1
2528318|NCT01657370|8749948|P4|Overall Study|Adverse Event|0
2528319|NCT01657370|8749949|P3|Overall Study|Adverse Event|0
2528320|NCT01657370|8749950|P2|Overall Study|Adverse Event|0
2528321|NCT01657370|8749951|P1|Overall Study|Adverse Event|0
2528322|NCT01657370|8749946|P6|Overall Study|Lack of Qualifying Event|2
2528323|NCT01657370|8749947|P5|Overall Study|Lack of Qualifying Event|1
2528324|NCT01657370|8749948|P4|Overall Study|Lack of Qualifying Event|2
2528325|NCT01657370|8749949|P3|Overall Study|Lack of Qualifying Event|3
2528326|NCT01657370|8749950|P2|Overall Study|Lack of Qualifying Event|0
2528327|NCT01657370|8749951|P1|Overall Study|Lack of Qualifying Event|1
2528328|NCT01657370|8749946|P6|Overall Study|Physician Decision|0
2528329|NCT01657370|8749947|P5|Overall Study|Physician Decision|5
2528330|NCT01657370|8749948|P4|Overall Study|Physician Decision|2
2528331|NCT01657370|8749949|P3|Overall Study|Physician Decision|1
2528332|NCT01657370|8749950|P2|Overall Study|Physician Decision|3
2528333|NCT01657370|8749951|P1|Overall Study|Physician Decision|2
2528334|NCT01657370|8749946|P6|Overall Study|Withdrawal by Subject|1
2528335|NCT01657370|8749947|P5|Overall Study|Withdrawal by Subject|0
2528336|NCT01657370|8749948|P4|Overall Study|Withdrawal by Subject|0
2528337|NCT01657370|8749949|P3|Overall Study|Withdrawal by Subject|1
2528338|NCT01657370|8749950|P2|Overall Study|Withdrawal by Subject|0
2528339|NCT01657370|8749951|P1|Overall Study|Withdrawal by Subject|0
2528340|NCT01657305|8750049|P1|Overall Study|Did not Adhere to Protocol/Procedures|4
2528341|NCT01657305|8750049|P1|Overall Study|Lost to Follow-up|1
2528342|NCT01657305|8750049|P1|Overall Study|Adverse Event|1
2528343|NCT01657305|8750049|P1|Overall Study|Withdrawal by Subject|4
2528344|NCT01657305|8750049|P1|Overall Study|Lack of Wound Closure at Day 28|15
2528345|NCT01657292|8750099|P1|Overall Study|Change of therapy|1
2528346|NCT01657292|8750099|P1|Overall Study|Violation of eligibility criteria|1
2528347|NCT01657292|8750099|P1|Overall Study|Withdrawal by Subject|2
2528348|NCT01657292|8750099|P1|Overall Study|Adverse Event|6
2528349|NCT01657266|8750108|P2|Overall Study|Adverse Event|3
2528350|NCT01657266|8750109|P1|Overall Study|Adverse Event|2
2528351|NCT01657266|8750108|P2|Overall Study|Lost to Follow-up|2
2528352|NCT01657266|8750109|P1|Overall Study|Lost to Follow-up|2
2528353|NCT01657253|8750131|P2|Overall Study|Adverse Event|1
2528354|NCT01657253|8750132|P1|Overall Study|Adverse Event|0
2528355|NCT01657253|8750131|P2|Overall Study|Withdrawal by Subject|12
2528356|NCT01657253|8750132|P1|Overall Study|Withdrawal by Subject|11
2528357|NCT01657253|8750131|P2|Overall Study|Lost to Follow-up|5
2528358|NCT01657253|8750132|P1|Overall Study|Lost to Follow-up|6
2528359|NCT01657032|8750144|P2|Overall Study|Lost to Follow-up|7
2528360|NCT01657032|8750145|P1|Overall Study|Lost to Follow-up|0
2528361|NCT01657019|8750171|P1|Overall Study|Other|58
2528362|NCT01657019|8750171|P1|Overall Study|Lack of Efficacy|3
2528363|NCT01657019|8750171|P1|Overall Study|Protocol Violation|6
2528364|NCT01657019|8750171|P1|Overall Study|Lost to Follow-up|48
2528365|NCT01657019|8750171|P1|Overall Study|Adverse Event|55
2528366|NCT01657019|8750171|P1|Overall Study|Withdrawal by Subject|65
2528367|NCT01656967|8750185|P2|Overall Study|unsuccessful ETT insertion|2
2528368|NCT01656967|8750186|P1|Overall Study|unsuccessful ETT insertion|3
2528369|NCT01656967|8750185|P2|Overall Study|faulty monitor|0
2528370|NCT01656967|8750186|P1|Overall Study|faulty monitor|1
2528371|NCT01656889|8750212|P2|Post Treatment Follow-Up, 3 Months|Site Closure|1
2528372|NCT01656889|8750213|P1|Post Treatment Follow-Up, 3 Months|Site Closure|0
2528373|NCT01656889|8750212|P2|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1
2528374|NCT01656889|8750213|P1|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2
2528375|NCT01656889|8750212|P2|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2
2528376|NCT01656889|8750213|P1|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1
2528377|NCT01656889|8750212|P2|Post Treatment Follow-Up, 3 Months|Death|5
2528378|NCT01656889|8750213|P1|Post Treatment Follow-Up, 3 Months|Death|1
2528379|NCT01656889|8750212|P2|Treatment Period, 12 Weeks|Moved out of the area|2
2528380|NCT01656889|8750213|P1|Treatment Period, 12 Weeks|Moved out of the area|0
2528381|NCT01656889|8750212|P2|Treatment Period, 12 Weeks|Protocol Violation|1
2528382|NCT01656889|8750213|P1|Treatment Period, 12 Weeks|Protocol Violation|0
2528383|NCT01656889|8750212|P2|Treatment Period, 12 Weeks|Withdrawal by Subject|2
2528384|NCT01656889|8750213|P1|Treatment Period, 12 Weeks|Withdrawal by Subject|1
2528385|NCT01656889|8750212|P2|Treatment Period, 12 Weeks|Lost to Follow-up|1
2528386|NCT01656889|8750213|P1|Treatment Period, 12 Weeks|Lost to Follow-up|1
2528387|NCT01656889|8750212|P2|Treatment Period, 12 Weeks|Death|1
2528388|NCT01656889|8750213|P1|Treatment Period, 12 Weeks|Death|0
2528389|NCT01656889|8750212|P2|Treatment Period, 12 Weeks|Adverse Event|4
2528390|NCT01656889|8750213|P1|Treatment Period, 12 Weeks|Adverse Event|10
2528391|NCT01656850|8750233|P2|First Intervention (3 Months)|Withdrawal by Subject|4
2528392|NCT01656850|8750234|P1|First Intervention (3 Months)|Withdrawal by Subject|3
2528393|NCT01656759|8750325|P2|Overall Study|Protocol Violation|3
2528394|NCT01656759|8750326|P1|Overall Study|Protocol Violation|2
2528395|NCT01656733|8750340|P2|Overall Study|Spontaneous abortion|1
2528396|NCT01656733|8750341|P1|Overall Study|Spontaneous abortion|0
2528397|NCT01656733|8750340|P2|Overall Study|Delivery at another hospital|2
2528398|NCT01656733|8750341|P1|Overall Study|Delivery at another hospital|0
2528399|NCT01656733|8750340|P2|Overall Study|No permission to collect birth outcomes|1
2528400|NCT01656733|8750341|P1|Overall Study|No permission to collect birth outcomes|0
2528401|NCT01656434|8750385|P2|Overall Study|Withdrawal by Subject|7
2528402|NCT01656434|8750386|P1|Overall Study|Withdrawal by Subject|64
2528403|NCT01656434|8750385|P2|Overall Study|Participant withdrew consent|9
2528404|NCT01656434|8750386|P1|Overall Study|Participant withdrew consent|28
2528405|NCT01656434|8750385|P2|Overall Study|Participant moved|12
2528406|NCT01656434|8750386|P1|Overall Study|Participant moved|40
2528407|NCT01656434|8750385|P2|Overall Study|Non-compliance with protocol|15
2528408|NCT01656434|8750386|P1|Overall Study|Non-compliance with protocol|39
2528409|NCT01656434|8750385|P2|Overall Study|Part. discontinued; unrelated to drug|10
2528410|NCT01656434|8750386|P1|Overall Study|Part. discontinued; unrelated to drug|55
2528411|NCT01656434|8750385|P2|Overall Study|Participant discontinued; drug related|4
2528412|NCT01656434|8750386|P1|Overall Study|Participant discontinued; drug related|13
2528413|NCT01656434|8750385|P2|Overall Study|Study terminated by sponsor|348
2528414|NCT01656434|8750386|P1|Overall Study|Study terminated by sponsor|1501
2528415|NCT01656434|8750385|P2|Overall Study|Non-compliance with study drug|9
2528416|NCT01656434|8750386|P1|Overall Study|Non-compliance with study drug|48
2528417|NCT01656434|8750385|P2|Overall Study|Physician Decision|2
2528418|NCT01656434|8750386|P1|Overall Study|Physician Decision|7
2528419|NCT01656434|8750385|P2|Overall Study|Pregnancy|10
2528420|NCT01656434|8750386|P1|Overall Study|Pregnancy|45
2528421|NCT01656434|8750385|P2|Overall Study|Pregnancy wish|6
2528422|NCT01656434|8750386|P1|Overall Study|Pregnancy wish|18
2528423|NCT01656434|8750385|P2|Overall Study|Protocol Violation|0
2528424|NCT01656434|8750386|P1|Overall Study|Protocol Violation|7
2528425|NCT01656434|8750385|P2|Overall Study|Screen failure|0
2528426|NCT01656434|8750386|P1|Overall Study|Screen failure|2
2528427|NCT01656434|8750385|P2|Overall Study|Site discontinued study participation|9
2528428|NCT01656434|8750386|P1|Overall Study|Site discontinued study participation|24
2528429|NCT01656434|8750385|P2|Overall Study|Lost to Follow-up|76
2528430|NCT01656434|8750386|P1|Overall Study|Lost to Follow-up|309
2528431|NCT01656434|8750385|P2|Overall Study|Enrollment terminated at trial site|0
2528432|NCT01656434|8750386|P1|Overall Study|Enrollment terminated at trial site|2
2528433|NCT01656434|8750385|P2|Overall Study|Adverse Event|63
2528434|NCT01656434|8750386|P1|Overall Study|Adverse Event|199
2528435|NCT01656408|8750412|P10|Overall Study|Physician Decision|3
2528436|NCT01656408|8750413|P9|Overall Study|Physician Decision|1
2528437|NCT01656408|8750414|P8|Overall Study|Physician Decision|1
2528438|NCT01656408|8750415|P7|Overall Study|Physician Decision|0
2528439|NCT01656408|8750416|P6|Overall Study|Physician Decision|1
2528440|NCT01656408|8750417|P5|Overall Study|Physician Decision|1
2528441|NCT01656408|8750418|P4|Overall Study|Physician Decision|0
2528442|NCT01656408|8750419|P3|Overall Study|Physician Decision|1
2528443|NCT01656408|8750420|P2|Overall Study|Physician Decision|0
2528444|NCT01656408|8750421|P1|Overall Study|Physician Decision|1
2528445|NCT01656408|8750412|P10|Overall Study|Adverse Event|0
2528446|NCT01656408|8750413|P9|Overall Study|Adverse Event|1
2528447|NCT01656408|8750414|P8|Overall Study|Adverse Event|0
2528448|NCT01656408|8750415|P7|Overall Study|Adverse Event|1
2528449|NCT01656408|8750416|P6|Overall Study|Adverse Event|1
2528450|NCT01656408|8750417|P5|Overall Study|Adverse Event|0
2528451|NCT01656408|8750418|P4|Overall Study|Adverse Event|0
2528452|NCT01656408|8750419|P3|Overall Study|Adverse Event|1
2528453|NCT01656408|8750420|P2|Overall Study|Adverse Event|0
2528454|NCT01656408|8750421|P1|Overall Study|Adverse Event|0
2528455|NCT01656395|8750616|P8|Overall Study|Withdrawal by Subject|0
2528456|NCT01656395|8750617|P7|Overall Study|Withdrawal by Subject|0
2528457|NCT01656395|8750618|P6|Overall Study|Withdrawal by Subject|3
2528458|NCT01656395|8750619|P5|Overall Study|Withdrawal by Subject|0
2528459|NCT01656395|8750620|P4|Overall Study|Withdrawal by Subject|2
2528460|NCT01656395|8750621|P3|Overall Study|Withdrawal by Subject|4
2528461|NCT01656395|8750622|P2|Overall Study|Withdrawal by Subject|1
2528462|NCT01656395|8750623|P1|Overall Study|Withdrawal by Subject|3
2528463|NCT01656395|8750616|P8|Overall Study|Screen Failure|0
2528464|NCT01656395|8750617|P7|Overall Study|Screen Failure|0
2528465|NCT01656395|8750618|P6|Overall Study|Screen Failure|8
2528466|NCT01656395|8750619|P5|Overall Study|Screen Failure|0
2528467|NCT01656395|8750620|P4|Overall Study|Screen Failure|1
2528468|NCT01656395|8750621|P3|Overall Study|Screen Failure|7
2528469|NCT01656395|8750622|P2|Overall Study|Screen Failure|1
2528470|NCT01656395|8750623|P1|Overall Study|Screen Failure|2
2528471|NCT01656395|8750616|P8|Overall Study|Protocol Violation|0
2528472|NCT01656395|8750617|P7|Overall Study|Protocol Violation|0
2528473|NCT01656395|8750618|P6|Overall Study|Protocol Violation|10
2528474|NCT01656395|8750619|P5|Overall Study|Protocol Violation|4
2528475|NCT01656395|8750620|P4|Overall Study|Protocol Violation|2
2528476|NCT01656395|8750621|P3|Overall Study|Protocol Violation|9
2528477|NCT01656395|8750622|P2|Overall Study|Protocol Violation|6
2528478|NCT01656395|8750623|P1|Overall Study|Protocol Violation|6
2528479|NCT01656395|8750616|P8|Overall Study|Progressive Disease|0
2528480|NCT01656395|8750617|P7|Overall Study|Progressive Disease|0
2528481|NCT01656395|8750618|P6|Overall Study|Progressive Disease|1
2528482|NCT01656395|8750619|P5|Overall Study|Progressive Disease|0
2528483|NCT01656395|8750620|P4|Overall Study|Progressive Disease|0
2528484|NCT01656395|8750621|P3|Overall Study|Progressive Disease|0
2528485|NCT01656395|8750622|P2|Overall Study|Progressive Disease|0
2528486|NCT01656395|8750623|P1|Overall Study|Progressive Disease|0
2528487|NCT01656395|8750616|P8|Overall Study|Pregnancy|0
2528488|NCT01656395|8750617|P7|Overall Study|Pregnancy|0
2528489|NCT01656395|8750618|P6|Overall Study|Pregnancy|0
2528490|NCT01656395|8750619|P5|Overall Study|Pregnancy|0
2528491|NCT01656395|8750620|P4|Overall Study|Pregnancy|0
2528492|NCT01656395|8750621|P3|Overall Study|Pregnancy|1
2528493|NCT01656395|8750622|P2|Overall Study|Pregnancy|0
2528494|NCT01656395|8750623|P1|Overall Study|Pregnancy|0
2528495|NCT01656395|8750616|P8|Overall Study|Physician Decision|0
2528496|NCT01656395|8750617|P7|Overall Study|Physician Decision|0
2528497|NCT01656395|8750618|P6|Overall Study|Physician Decision|3
2528498|NCT01656395|8750619|P5|Overall Study|Physician Decision|3
2528499|NCT01656395|8750620|P4|Overall Study|Physician Decision|2
2528500|NCT01656395|8750621|P3|Overall Study|Physician Decision|3
2528501|NCT01656395|8750622|P2|Overall Study|Physician Decision|3
2528502|NCT01656395|8750623|P1|Overall Study|Physician Decision|2
2528503|NCT01656395|8750616|P8|Overall Study|Other|0
2528504|NCT01656395|8750617|P7|Overall Study|Other|0
2528505|NCT01656395|8750618|P6|Overall Study|Other|1
2528506|NCT01656395|8750619|P5|Overall Study|Other|0
2528507|NCT01656395|8750620|P4|Overall Study|Other|0
2528508|NCT01656395|8750621|P3|Overall Study|Other|1
2528509|NCT01656395|8750622|P2|Overall Study|Other|0
2528510|NCT01656395|8750623|P1|Overall Study|Other|0
2528511|NCT01656395|8750616|P8|Overall Study|Non-Compliance with Study Drug|0
2528512|NCT01656395|8750617|P7|Overall Study|Non-Compliance with Study Drug|0
2528513|NCT01656395|8750618|P6|Overall Study|Non-Compliance with Study Drug|1
2528514|NCT01656395|8750619|P5|Overall Study|Non-Compliance with Study Drug|1
2528515|NCT01656395|8750620|P4|Overall Study|Non-Compliance with Study Drug|0
2528516|NCT01656395|8750621|P3|Overall Study|Non-Compliance with Study Drug|0
2528517|NCT01656395|8750622|P2|Overall Study|Non-Compliance with Study Drug|1
2528518|NCT01656395|8750623|P1|Overall Study|Non-Compliance with Study Drug|1
2528519|NCT01656395|8750616|P8|Overall Study|Lost to Follow-up|0
2528520|NCT01656395|8750617|P7|Overall Study|Lost to Follow-up|0
2528521|NCT01656395|8750618|P6|Overall Study|Lost to Follow-up|0
2528522|NCT01656395|8750619|P5|Overall Study|Lost to Follow-up|0
2528523|NCT01656395|8750620|P4|Overall Study|Lost to Follow-up|0
2528524|NCT01656395|8750621|P3|Overall Study|Lost to Follow-up|0
2528525|NCT01656395|8750622|P2|Overall Study|Lost to Follow-up|0
2528526|NCT01656395|8750623|P1|Overall Study|Lost to Follow-up|1
2528527|NCT01656395|8750616|P8|Overall Study|Lack of Efficacy|0
2528528|NCT01656395|8750617|P7|Overall Study|Lack of Efficacy|0
2528529|NCT01656395|8750618|P6|Overall Study|Lack of Efficacy|6
2528530|NCT01656395|8750619|P5|Overall Study|Lack of Efficacy|1
2528531|NCT01656395|8750620|P4|Overall Study|Lack of Efficacy|1
2528532|NCT01656395|8750621|P3|Overall Study|Lack of Efficacy|6
2528533|NCT01656395|8750622|P2|Overall Study|Lack of Efficacy|8
2528534|NCT01656395|8750623|P1|Overall Study|Lack of Efficacy|1
2528535|NCT01656395|8750616|P8|Overall Study|Adverse Event|0
2528536|NCT01656395|8750617|P7|Overall Study|Adverse Event|0
2528537|NCT01656395|8750618|P6|Overall Study|Adverse Event|7
2528538|NCT01656395|8750619|P5|Overall Study|Adverse Event|5
2528539|NCT01656395|8750620|P4|Overall Study|Adverse Event|4
2528540|NCT01656395|8750621|P3|Overall Study|Adverse Event|5
2528541|NCT01656395|8750622|P2|Overall Study|Adverse Event|14
2528542|NCT01656395|8750623|P1|Overall Study|Adverse Event|1
2528543|NCT01656304|8750709|P1|Overall Study|Ineligible, uncontrolled hypertension|1
2528544|NCT01656200|8750750|P1|Overall Study|Withdrawal by Subject|1
2528545|NCT01656161|8750765|P1|Overall Study|Withdrawal by Subject|1
2528546|NCT01656161|8750765|P1|Overall Study|Protocol Violation|1
2528547|NCT01656161|8750765|P1|Overall Study|Adverse Event|2
2528548|NCT01656161|8750765|P1|Overall Study|Death|3
2528549|NCT01655901|8750783|P6|Third Intervention (Hour 3)|Lost to Follow-up|0
2528550|NCT01655901|8750784|P5|Third Intervention (Hour 3)|Lost to Follow-up|1
2528551|NCT01655901|8750785|P4|Third Intervention (Hour 3)|Lost to Follow-up|0
2528552|NCT01655901|8750786|P3|Third Intervention (Hour 3)|Lost to Follow-up|1
2528553|NCT01655901|8750787|P2|Third Intervention (Hour 3)|Lost to Follow-up|1
2528554|NCT01655901|8750788|P1|Third Intervention (Hour 3)|Lost to Follow-up|1
2528555|NCT01655823|8750802|P5|Overall Study|Withdrawal by Subject|0
2528556|NCT01655823|8750803|P4|Overall Study|Withdrawal by Subject|1
2528557|NCT01655823|8750804|P3|Overall Study|Withdrawal by Subject|0
2528558|NCT01655823|8750805|P2|Overall Study|Withdrawal by Subject|1
2528559|NCT01655823|8750806|P1|Overall Study|Withdrawal by Subject|0
2528560|NCT01655823|8750802|P5|Overall Study|Lost to Follow-up|1
2528561|NCT01655823|8750803|P4|Overall Study|Lost to Follow-up|0
2528562|NCT01655823|8750804|P3|Overall Study|Lost to Follow-up|0
2528563|NCT01655823|8750805|P2|Overall Study|Lost to Follow-up|1
2528564|NCT01655823|8750806|P1|Overall Study|Lost to Follow-up|0
2528565|NCT01655498|8750837|P1|Overall Study|Withdrawal by Subject|1
2528566|NCT01655498|8750837|P1|Overall Study|Protocol Violation|2
2528567|NCT01655498|8750837|P1|Overall Study|Unrelated health issue|2
2528568|NCT01655381|8750844|P1|Overall Study|Insufficient Treatment Response|1
2528569|NCT01655381|8750844|P1|Overall Study|Moved to Another City|1
2528570|NCT01655381|8750844|P1|Overall Study|Investigator Decision|1
2528571|NCT01655069|8750884|P4|Overall Study|Withdrawal by Subject|0
2528572|NCT01655069|8750885|P3|Overall Study|Withdrawal by Subject|0
2528573|NCT01655069|8750886|P2|Overall Study|Withdrawal by Subject|3
2528574|NCT01655069|8750887|P1|Overall Study|Withdrawal by Subject|2
2528575|NCT01655069|8750884|P4|Overall Study|No Treatment Needed|0
2528576|NCT01655069|8750885|P3|Overall Study|No Treatment Needed|0
2528577|NCT01655069|8750886|P2|Overall Study|No Treatment Needed|1
2528578|NCT01655069|8750887|P1|Overall Study|No Treatment Needed|0
2528579|NCT01655069|8750884|P4|Overall Study|Lack of Efficacy|0
2528580|NCT01655069|8750885|P3|Overall Study|Lack of Efficacy|0
2528581|NCT01655069|8750886|P2|Overall Study|Lack of Efficacy|1
2528582|NCT01655069|8750887|P1|Overall Study|Lack of Efficacy|0
2528583|NCT01655069|8750884|P4|Overall Study|Adverse Event|3
2528584|NCT01655069|8750885|P3|Overall Study|Adverse Event|2
2528585|NCT01655069|8750886|P2|Overall Study|Adverse Event|7
2528586|NCT01655069|8750887|P1|Overall Study|Adverse Event|6
2528587|NCT01655069|8750884|P4|Overall Study|Physician Decision|1
2528588|NCT01655069|8750885|P3|Overall Study|Physician Decision|0
2528589|NCT01655069|8750886|P2|Overall Study|Physician Decision|0
2528590|NCT01655069|8750887|P1|Overall Study|Physician Decision|0
2528591|NCT01654666|8750947|P3|Overall Study|Withdrawal by Subject|1
2528592|NCT01654666|8750948|P2|Overall Study|Withdrawal by Subject|4
2528593|NCT01654666|8750949|P1|Overall Study|Withdrawal by Subject|4
2528594|NCT01654666|8750947|P3|Overall Study|Lost to Follow-up|5
2528595|NCT01654666|8750948|P2|Overall Study|Lost to Follow-up|5
2528596|NCT01654666|8750949|P1|Overall Study|Lost to Follow-up|4
2528597|NCT01654666|8750947|P3|Overall Study|Protocol Violation|8
2528598|NCT01654666|8750948|P2|Overall Study|Protocol Violation|4
2528599|NCT01654666|8750949|P1|Overall Study|Protocol Violation|7
2528600|NCT01654601|8750974|P2|2nd Administration|Protocol Violation|1
2528601|NCT01654601|8750975|P1|2nd Administration|Protocol Violation|0
2528602|NCT01654601|8750974|P2|2nd Administration|Adverse Event|0
2528603|NCT01654601|8750975|P1|2nd Administration|Adverse Event|1
2528604|NCT01654601|8750974|P2|1st Administration|Protocol Violation|2
2528605|NCT01654601|8750975|P1|1st Administration|Protocol Violation|0
2528606|NCT01654601|8750974|P2|1st Administration|Withdrawal by Subject|0
2528607|NCT01654601|8750975|P1|1st Administration|Withdrawal by Subject|2
2528608|NCT01654549|8750989|P2|Overall Study|H.pylori eradication not successful|1
2528609|NCT01654549|8750990|P1|Overall Study|H.pylori eradication not successful|0
2528610|NCT01654536|8751002|P2|Overall Study|Withdrawal by Subject|25
2528611|NCT01654536|8751003|P1|Overall Study|Withdrawal by Subject|27
2528612|NCT01654536|8751002|P2|Overall Study|Physician Decision|8
2528613|NCT01654536|8751003|P1|Overall Study|Physician Decision|12
2528614|NCT01654536|8751002|P2|Overall Study|Lost to Follow-up|5
2528615|NCT01654536|8751003|P1|Overall Study|Lost to Follow-up|5
2528616|NCT01654523|8751039|P1|Overall Study|Withdrawal by Subject|1
2528617|NCT01654380|8751045|P4|Part B, Period 1|Physician Decision|0
2528618|NCT01654380|8751046|P3|Part B, Period 1|Physician Decision|1
2528619|NCT01654380|8751047|P2|Part B, Period 1|Physician Decision|0
2528620|NCT01654380|8751048|P1|Part B, Period 1|Physician Decision|0
2528621|NCT01654302|8751091|P2|Second Intervention (Day 7)|Lost to Follow-up|1
2528622|NCT01654302|8751092|P1|Second Intervention (Day 7)|Lost to Follow-up|1
2528623|NCT01654289|8751101|P3|Overall Study|Withdrew from intervention only|0
2528624|NCT01654289|8751102|P2|Overall Study|Withdrew from intervention only|20
2528625|NCT01654289|8751103|P1|Overall Study|Withdrew from intervention only|17
2528626|NCT01654289|8751101|P3|Overall Study|Withdrawal by Subject|5
2528627|NCT01654289|8751102|P2|Overall Study|Withdrawal by Subject|8
2528628|NCT01654289|8751103|P1|Overall Study|Withdrawal by Subject|10
2528629|NCT01654276|8751141|P1|Overall Study|Withdrawal by Subject|1
2528630|NCT01654276|8751141|P1|Overall Study|Lost to Follow-up|4
2528631|NCT01654276|8751141|P1|Overall Study|Lack of Efficacy|1
2528632|NCT01654250|8751195|P2|Overall Study|Lost to Follow-up|0
2528633|NCT01654250|8751196|P1|Overall Study|Lost to Follow-up|1
2528634|NCT01654224|8751213|P2|Overall Study|Insufficient blood sample|2
2528635|NCT01654224|8751214|P1|Overall Study|Insufficient blood sample|3
2528636|NCT01654224|8751213|P2|Overall Study|Did not receive allocation|8
2528637|NCT01654224|8751214|P1|Overall Study|Did not receive allocation|1
2528638|NCT01654224|8751213|P2|Overall Study|Lost to Follow-up|2
2528639|NCT01654224|8751214|P1|Overall Study|Lost to Follow-up|2
2528640|NCT01653912|8751245|P6|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1
2528641|NCT01653912|8751246|P5|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
2528642|NCT01653912|8751247|P4|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
2528643|NCT01653912|8751248|P3|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
2528644|NCT01653912|8751249|P2|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
2528645|NCT01653912|8751250|P1|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
2528646|NCT01653912|8751245|P6|Phase 2: GSK2110183 125 mg|Clinical Progression|6
2528647|NCT01653912|8751246|P5|Phase 2: GSK2110183 125 mg|Clinical Progression|0
2528648|NCT01653912|8751247|P4|Phase 2: GSK2110183 125 mg|Clinical Progression|0
2528649|NCT01653912|8751248|P3|Phase 2: GSK2110183 125 mg|Clinical Progression|0
2528650|NCT01653912|8751249|P2|Phase 2: GSK2110183 125 mg|Clinical Progression|0
2528651|NCT01653912|8751250|P1|Phase 2: GSK2110183 125 mg|Clinical Progression|0
2528652|NCT01653912|8751245|P6|Phase 2: GSK2110183 125 mg|Adverse Event|1
2528653|NCT01653912|8751246|P5|Phase 2: GSK2110183 125 mg|Adverse Event|0
2528654|NCT01653912|8751247|P4|Phase 2: GSK2110183 125 mg|Adverse Event|0
2528655|NCT01653912|8751248|P3|Phase 2: GSK2110183 125 mg|Adverse Event|0
2528656|NCT01653912|8751249|P2|Phase 2: GSK2110183 125 mg|Adverse Event|0
2528657|NCT01653912|8751250|P1|Phase 2: GSK2110183 125 mg|Adverse Event|0
2528658|NCT01653912|8751245|P6|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
2528659|NCT01653912|8751246|P5|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
2528660|NCT01653912|8751247|P4|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1
2528661|NCT01653912|8751248|P3|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
2528662|NCT01653912|8751249|P2|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
2528663|NCT01653912|8751250|P1|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
2528664|NCT01653912|8751245|P6|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
2528665|NCT01653912|8751246|P5|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
2528666|NCT01653912|8751247|P4|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1
2528667|NCT01653912|8751248|P3|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
2528668|NCT01653912|8751249|P2|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
2528669|NCT01653912|8751250|P1|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
2528670|NCT01653912|8751245|P6|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
2528671|NCT01653912|8751246|P5|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
2528672|NCT01653912|8751247|P4|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
2528673|NCT01653912|8751248|P3|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2
2528674|NCT01653912|8751249|P2|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
2528675|NCT01653912|8751250|P1|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
2528676|NCT01653912|8751245|P6|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
2528677|NCT01653912|8751246|P5|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
2528678|NCT01653912|8751247|P4|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
2528679|NCT01653912|8751248|P3|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
2528680|NCT01653912|8751249|P2|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1
2528681|NCT01653912|8751250|P1|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
2528682|NCT01653782|8751268|P3|Overall Study|Lost to Follow-up|2
2528683|NCT01653782|8751269|P2|Overall Study|Lost to Follow-up|3
2528684|NCT01653782|8751270|P1|Overall Study|Lost to Follow-up|7
2528685|NCT01653782|8751268|P3|Overall Study|Withdrawal by Subject|4
2528686|NCT01653782|8751269|P2|Overall Study|Withdrawal by Subject|15
2528687|NCT01653782|8751270|P1|Overall Study|Withdrawal by Subject|9
2528688|NCT01653743|8751280|P2|Overall Study|Investigator discretion|0
2528689|NCT01653743|8751281|P1|Overall Study|Investigator discretion|3
2528690|NCT01653743|8751280|P2|Overall Study|Withdrawal by Subject|0
2528691|NCT01653743|8751281|P1|Overall Study|Withdrawal by Subject|1
2528692|NCT01653704|8751297|P2|Overall Study|Performance not reflective of training|0
2528693|NCT01653704|8751298|P1|Overall Study|Performance not reflective of training|1
2528694|NCT01653704|8751297|P2|Overall Study|Technical failure during recording|1
2528695|NCT01653704|8751298|P1|Overall Study|Technical failure during recording|1
2528696|NCT01653327|8751367|P1|Overall Study|Withdrawal by Subject|1
2528697|NCT01653262|8751392|P1|Overall Study|AE, non-serious non-fatal|1
2528698|NCT01653262|8751392|P1|Overall Study|SAE, non-fatal|1
2528699|NCT01653262|8751392|P1|Overall Study|Lack of Efficacy|1
2528700|NCT01653158|8751410|P8|Overall Study|Withdrawal by Subject|0
2528701|NCT01653158|8751411|P7|Overall Study|Withdrawal by Subject|0
2528702|NCT01653158|8751412|P6|Overall Study|Withdrawal by Subject|0
2528703|NCT01653158|8751413|P5|Overall Study|Withdrawal by Subject|0
2528704|NCT01653158|8751414|P4|Overall Study|Withdrawal by Subject|0
2528705|NCT01653158|8751415|P3|Overall Study|Withdrawal by Subject|0
2528706|NCT01653158|8751416|P2|Overall Study|Withdrawal by Subject|0
2528707|NCT01653158|8751417|P1|Overall Study|Withdrawal by Subject|1
2528708|NCT01653158|8751410|P8|Overall Study|Progressive disease|9
2528709|NCT01653158|8751411|P7|Overall Study|Progressive disease|2
2528710|NCT01653158|8751412|P6|Overall Study|Progressive disease|1
2528711|NCT01653158|8751413|P5|Overall Study|Progressive disease|1
2528712|NCT01653158|8751414|P4|Overall Study|Progressive disease|0
2528713|NCT01653158|8751415|P3|Overall Study|Progressive disease|0
2528714|NCT01653158|8751416|P2|Overall Study|Progressive disease|0
2528715|NCT01653158|8751417|P1|Overall Study|Progressive disease|0
2528716|NCT01653158|8751410|P8|Overall Study|Other|1
2528717|NCT01653158|8751411|P7|Overall Study|Other|0
2528718|NCT01653158|8751412|P6|Overall Study|Other|0
2528719|NCT01653158|8751413|P5|Overall Study|Other|0
2528720|NCT01653158|8751414|P4|Overall Study|Other|0
2528721|NCT01653158|8751415|P3|Overall Study|Other|0
2528722|NCT01653158|8751416|P2|Overall Study|Other|0
2528723|NCT01653158|8751417|P1|Overall Study|Other|0
2528724|NCT01653158|8751410|P8|Overall Study|Adverse Event|3
2528725|NCT01653158|8751411|P7|Overall Study|Adverse Event|0
2528726|NCT01653158|8751412|P6|Overall Study|Adverse Event|0
2528727|NCT01653158|8751413|P5|Overall Study|Adverse Event|0
2528728|NCT01653158|8751414|P4|Overall Study|Adverse Event|1
2528729|NCT01653158|8751415|P3|Overall Study|Adverse Event|0
2528730|NCT01653158|8751416|P2|Overall Study|Adverse Event|0
2528731|NCT01653158|8751417|P1|Overall Study|Adverse Event|0
2528732|NCT01653158|8751410|P8|Overall Study|Death|2
2528733|NCT01653158|8751411|P7|Overall Study|Death|0
2528734|NCT01653158|8751412|P6|Overall Study|Death|0
2528735|NCT01653158|8751413|P5|Overall Study|Death|0
2528736|NCT01653158|8751414|P4|Overall Study|Death|1
2528737|NCT01653158|8751415|P3|Overall Study|Death|0
2528738|NCT01653158|8751416|P2|Overall Study|Death|0
2528739|NCT01653158|8751417|P1|Overall Study|Death|0
2528740|NCT01653132|8751689|P2|First Intervention|Protocol Violation|0
2528741|NCT01653132|8751690|P1|First Intervention|Protocol Violation|1
2528742|NCT01652885|8751754|P1|Overall Study|Adverse Event|1
2528743|NCT01652872|8751781|P2|Overall Study|Withdrawal by Subject|84
2528744|NCT01652872|8751782|P1|Overall Study|Withdrawal by Subject|76
2528745|NCT01652872|8751781|P2|Overall Study|Decision by sponsor|7
2528746|NCT01652872|8751782|P1|Overall Study|Decision by sponsor|5
2528747|NCT01652872|8751781|P2|Overall Study|Lost to Follow-up|23
2528748|NCT01652872|8751782|P1|Overall Study|Lost to Follow-up|28
2528749|NCT01652872|8751781|P2|Overall Study|Death|39
2528750|NCT01652872|8751782|P1|Overall Study|Death|36
2528751|NCT01652729|8751799|P3|Overall Study|Administrative|0
2528752|NCT01652729|8751800|P2|Overall Study|Administrative|0
2528753|NCT01652729|8751801|P1|Overall Study|Administrative|1
2528754|NCT01652729|8751799|P3|Overall Study|Lost to Follow-up|3
2528755|NCT01652729|8751800|P2|Overall Study|Lost to Follow-up|6
2528756|NCT01652729|8751801|P1|Overall Study|Lost to Follow-up|6
2528757|NCT01652729|8751799|P3|Overall Study|Protocol Violation|0
2528758|NCT01652729|8751800|P2|Overall Study|Protocol Violation|0
2528759|NCT01652729|8751801|P1|Overall Study|Protocol Violation|1
2528760|NCT01652729|8751799|P3|Overall Study|Physician Decision|1
2528761|NCT01652729|8751800|P2|Overall Study|Physician Decision|0
2528762|NCT01652729|8751801|P1|Overall Study|Physician Decision|1
2528763|NCT01652729|8751799|P3|Overall Study|Adverse Event|3
2528764|NCT01652729|8751800|P2|Overall Study|Adverse Event|0
2528765|NCT01652729|8751801|P1|Overall Study|Adverse Event|4
2528766|NCT01652729|8751799|P3|Overall Study|Withdrawal by Subject|7
2528767|NCT01652729|8751800|P2|Overall Study|Withdrawal by Subject|7
2528768|NCT01652729|8751801|P1|Overall Study|Withdrawal by Subject|14
2528769|NCT01652716|8751823|P2|Overall Study|Withdrawal by Subject|18
2528770|NCT01652716|8751824|P1|Overall Study|Withdrawal by Subject|33
2528771|NCT01652716|8751823|P2|Overall Study|Adverse Event|10
2528772|NCT01652716|8751824|P1|Overall Study|Adverse Event|7
2528773|NCT01652716|8751823|P2|Overall Study|Protocol Violation|1
2528774|NCT01652716|8751824|P1|Overall Study|Protocol Violation|2
2528775|NCT01652716|8751823|P2|Overall Study|Lost to Follow-up|11
2528776|NCT01652716|8751824|P1|Overall Study|Lost to Follow-up|12
2528777|NCT01652716|8751823|P2|Overall Study|Investigator decision|4
2528778|NCT01652716|8751824|P1|Overall Study|Investigator decision|1
2528779|NCT01652716|8751823|P2|Overall Study|Administrative|2
2528780|NCT01652716|8751824|P1|Overall Study|Administrative|0
2528781|NCT01652716|8751823|P2|Overall Study|Loss of glucose control|0
2528782|NCT01652716|8751824|P1|Overall Study|Loss of glucose control|1
2528783|NCT01652703|8751844|P6|Overall Study|Other|1
2528784|NCT01652703|8751845|P5|Overall Study|Other|1
2528785|NCT01652703|8751846|P4|Overall Study|Other|1
2528786|NCT01652703|8751847|P3|Overall Study|Other|0
2528787|NCT01652703|8751848|P2|Overall Study|Other|0
2528788|NCT01652703|8751849|P1|Overall Study|Other|0
2528789|NCT01652703|8751844|P6|Overall Study|Withdrawal by Subject|1
2528790|NCT01652703|8751845|P5|Overall Study|Withdrawal by Subject|0
2528791|NCT01652703|8751846|P4|Overall Study|Withdrawal by Subject|1
2528792|NCT01652703|8751847|P3|Overall Study|Withdrawal by Subject|3
2528793|NCT01652703|8751848|P2|Overall Study|Withdrawal by Subject|1
2528794|NCT01652703|8751849|P1|Overall Study|Withdrawal by Subject|0
2528795|NCT01652690|8751907|P2|Overall Study|Death|2
2528796|NCT01652690|8751908|P1|Overall Study|Death|5
2528797|NCT01652690|8751907|P2|Overall Study|Lost to Follow-up|6
2528798|NCT01652690|8751908|P1|Overall Study|Lost to Follow-up|6
2528799|NCT01652690|8751907|P2|Overall Study|Other|9
2528800|NCT01652690|8751908|P1|Overall Study|Other|8
2528801|NCT01652690|8751907|P2|Overall Study|Withdrawal by Subject|4
2528802|NCT01652690|8751908|P1|Overall Study|Withdrawal by Subject|16
2528803|NCT01652664|8751942|P2|Overall Study|Inadequate IOP control|0
2528804|NCT01652664|8751943|P1|Overall Study|Inadequate IOP control|1
2528805|NCT01652664|8751942|P2|Overall Study|Treatment Failure|1
2528806|NCT01652664|8751943|P1|Overall Study|Treatment Failure|5
2528807|NCT01652573|8751952|P2|Overall Study|Adverse Event|1
2528808|NCT01652573|8751953|P1|Overall Study|Adverse Event|0
2528809|NCT01652534|8751995|P2|Overall Study|Lack of Efficacy|0
2528810|NCT01652534|8751996|P1|Overall Study|Lack of Efficacy|1
2528811|NCT01652469|8752037|P2|Overall Study|Lost to Follow-up|2
2528812|NCT01652469|8752038|P1|Overall Study|Lost to Follow-up|0
2528813|NCT01652469|8752037|P2|Overall Study|Withdrawal by Subject|4
2528814|NCT01652469|8752038|P1|Overall Study|Withdrawal by Subject|1
2528815|NCT01652287|8752054|P2|Overall Study|Withdrawal by Subject|0
2528816|NCT01652287|8752055|P1|Overall Study|Withdrawal by Subject|2
2528817|NCT01651949|8752086|P3|Overall Study|Withdrawal by Subject|9
2528818|NCT01651949|8752087|P2|Overall Study|Withdrawal by Subject|18
2528819|NCT01651949|8752088|P1|Overall Study|Withdrawal by Subject|17
2528820|NCT01651949|8752086|P3|Overall Study|Screen failure|0
2528821|NCT01651949|8752087|P2|Overall Study|Screen failure|2
2528822|NCT01651949|8752088|P1|Overall Study|Screen failure|2
2528823|NCT01651949|8752086|P3|Overall Study|Adverse Event|1
2528824|NCT01651949|8752087|P2|Overall Study|Adverse Event|2
2528825|NCT01651949|8752088|P1|Overall Study|Adverse Event|0
2528826|NCT01651949|8752086|P3|Overall Study|Physician Decision|0
2528827|NCT01651949|8752087|P2|Overall Study|Physician Decision|2
2528828|NCT01651949|8752088|P1|Overall Study|Physician Decision|0
2528829|NCT01651949|8752086|P3|Overall Study|Protocol Violation|1
2528830|NCT01651949|8752087|P2|Overall Study|Protocol Violation|2
2528831|NCT01651949|8752088|P1|Overall Study|Protocol Violation|0
2528832|NCT01651949|8752086|P3|Overall Study|Lost to Follow-up|20
2528833|NCT01651949|8752087|P2|Overall Study|Lost to Follow-up|56
2528834|NCT01651949|8752088|P1|Overall Study|Lost to Follow-up|30
2528835|NCT01651949|8752086|P3|Overall Study|Unknown status|0
2528836|NCT01651949|8752087|P2|Overall Study|Unknown status|4
2528837|NCT01651949|8752088|P1|Overall Study|Unknown status|4
2528838|NCT01651936|8752108|P3|Extension Study|Study terminated by sponsor|13
2528839|NCT01651936|8752109|P2|Extension Study|Study terminated by sponsor|0
2528840|NCT01651936|8752110|P1|Extension Study|Study terminated by sponsor|0
2528841|NCT01651936|8752108|P3|Extension Study|Lack of Efficacy|1
2528842|NCT01651936|8752109|P2|Extension Study|Lack of Efficacy|0
2528843|NCT01651936|8752110|P1|Extension Study|Lack of Efficacy|0
2528844|NCT01651936|8752108|P3|Base Study|Study terminated by sponsor|0
2528845|NCT01651936|8752109|P2|Base Study|Study terminated by sponsor|16
2528846|NCT01651936|8752110|P1|Base Study|Study terminated by sponsor|21
2528847|NCT01651936|8752108|P3|Base Study|Early Escape|0
2528848|NCT01651936|8752109|P2|Base Study|Early Escape|8
2528849|NCT01651936|8752110|P1|Base Study|Early Escape|2
2528850|NCT01651936|8752108|P3|Base Study|Withdrawal by Subject|0
2528851|NCT01651936|8752109|P2|Base Study|Withdrawal by Subject|1
2528852|NCT01651936|8752110|P1|Base Study|Withdrawal by Subject|1
2528853|NCT01651936|8752108|P3|Base Study|Adverse Event|0
2528854|NCT01651936|8752109|P2|Base Study|Adverse Event|0
2528855|NCT01651936|8752110|P1|Base Study|Adverse Event|3
2528856|NCT01651780|8752180|P2|Overall Study|Physician decision: Day 30 visit <23 day|5
2528857|NCT01651780|8752181|P1|Overall Study|Physician decision: Day 30 visit <23 day|1
2528858|NCT01651780|8752180|P2|Overall Study|Lost to Follow-up|2
2528859|NCT01651780|8752181|P1|Overall Study|Lost to Follow-up|1
2528860|NCT01651780|8752180|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
2528861|NCT01651780|8752181|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
2528862|NCT01651780|8752180|P2|Overall Study|Withdrawal by Subject|0
2528863|NCT01651780|8752181|P1|Overall Study|Withdrawal by Subject|2
2528864|NCT01651780|8752180|P2|Overall Study|Reason Not Specified: No 30-day visit|2
2528865|NCT01651780|8752181|P1|Overall Study|Reason Not Specified: No 30-day visit|2
2528866|NCT01651780|8752180|P2|Overall Study|Physician decision: No 30-day visit|1
2528867|NCT01651780|8752181|P1|Overall Study|Physician decision: No 30-day visit|2
2528868|NCT01651403|8752232|P2|Open-Label TDF Phase (Weeks 49/73-96)|Withdrew consent/assent|2
2528869|NCT01651403|8752233|P1|Open-Label TDF Phase (Weeks 49/73-96)|Withdrew consent/assent|0
2528870|NCT01651403|8752232|P2|Open-Label TDF Phase (Weeks 49/73-96)|Investigator decision|0
2528871|NCT01651403|8752233|P1|Open-Label TDF Phase (Weeks 49/73-96)|Investigator decision|1
2528872|NCT01651403|8752232|P2|Open-Label TDF Phase (Weeks 49/73-96)|Continuing Study|20
2528873|NCT01651403|8752233|P1|Open-Label TDF Phase (Weeks 49/73-96)|Continuing Study|46
2528874|NCT01651403|8752232|P2|Double-Blind Period (Through Week 48/72)|Enrolled but not Treated|1
2528875|NCT01651403|8752233|P1|Double-Blind Period (Through Week 48/72)|Enrolled but not Treated|0
2528876|NCT01651403|8752232|P2|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3
2528877|NCT01651403|8752233|P1|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3
2528878|NCT01651403|8752232|P2|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|0
2528879|NCT01651403|8752233|P1|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1
2528880|NCT01651260|8752281|P1|Overall Study|unable to apply product|3
2528881|NCT01651208|8752288|P2|Overall Study|Lost to Follow-up|16
2528882|NCT01651208|8752289|P1|Overall Study|Lost to Follow-up|14
2528883|NCT01651117|8752301|P4|Overall Study|Death|2
2528884|NCT01651117|8752302|P3|Overall Study|Death|2
2528885|NCT01651117|8752303|P2|Overall Study|Death|3
2528886|NCT01651117|8752304|P1|Overall Study|Death|2
2528887|NCT01651052|8752384|P1|Overall Study|Lost to Follow-up|3
2528888|NCT01651052|8752384|P1|Overall Study|Withdrawal by Subject|1
2528889|NCT01651052|8752384|P1|Overall Study|Explant|1
2528890|NCT01651052|8752384|P1|Overall Study|Death|21
2528891|NCT01651039|8752404|P1|Overall Study|Progressive Disease|22
2528892|NCT01651039|8752404|P1|Overall Study|Withdrawal by Subject|1
2528893|NCT01651039|8752404|P1|Overall Study|Physician Decision|2
2528894|NCT01651039|8752404|P1|Overall Study|Non-evaluables|5
2528895|NCT01651000|8752417|P2|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1
2528896|NCT01651000|8752418|P1|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0
2528897|NCT01651000|8752417|P2|Overall Study|Administrative reason|0
2528898|NCT01651000|8752418|P1|Overall Study|Administrative reason|1
2528899|NCT01651000|8752417|P2|Overall Study|Physician Decision|0
2528900|NCT01651000|8752418|P1|Overall Study|Physician Decision|1
2528901|NCT01651000|8752417|P2|Overall Study|Lack of Efficacy|1
2528902|NCT01651000|8752418|P1|Overall Study|Lack of Efficacy|1
2528903|NCT01651000|8752417|P2|Overall Study|Subject noncompliance|3
2528904|NCT01651000|8752418|P1|Overall Study|Subject noncompliance|0
2528905|NCT01651000|8752417|P2|Overall Study|Withdrawal by Subject|10
2528906|NCT01651000|8752418|P1|Overall Study|Withdrawal by Subject|2
2528907|NCT01651000|8752417|P2|Overall Study|Protocol Violation|3
2528908|NCT01651000|8752418|P1|Overall Study|Protocol Violation|0
2528909|NCT01651000|8752417|P2|Overall Study|Lost to Follow-up|2
2528910|NCT01651000|8752418|P1|Overall Study|Lost to Follow-up|3
2528911|NCT01651000|8752417|P2|Overall Study|Adverse Event|8
2528912|NCT01651000|8752418|P1|Overall Study|Adverse Event|2
2528913|NCT01650831|8752439|P1|Overall Study|Screen failure|1
2528914|NCT01650805|8752449|P2|Overall Study|Withdrawal by Subject|0
2528915|NCT01650805|8752450|P1|Overall Study|Withdrawal by Subject|1
2528916|NCT01650779|8752460|P1|Overall Study|Withdrawal by Subject|1
2528917|NCT01650636|8752469|P2|Washout up to 9 Months|Lost to Follow-up|1
2528918|NCT01650636|8752470|P1|Washout up to 9 Months|Lost to Follow-up|2
2528919|NCT01650636|8752469|P2|Washout up to 9 Months|Withdrawal by Subject|2
2528920|NCT01650636|8752470|P1|Washout up to 9 Months|Withdrawal by Subject|4
2528921|NCT01650636|8752469|P2|Washout up to 5 Months|Lost to Follow-up|8
2528922|NCT01650636|8752470|P1|Washout up to 5 Months|Lost to Follow-up|2
2528923|NCT01650636|8752469|P2|Washout up to 5 Months|Death|0
2528924|NCT01650636|8752470|P1|Washout up to 5 Months|Death|1
2528925|NCT01650636|8752469|P2|Washout up to 5 Months|Physician Decision|2
2528926|NCT01650636|8752470|P1|Washout up to 5 Months|Physician Decision|2
2528927|NCT01650636|8752469|P2|Washout up to 5 Months|Withdrawal by Subject|8
2528928|NCT01650636|8752470|P1|Washout up to 5 Months|Withdrawal by Subject|4
2528929|NCT01650519|8752503|P2|Overall Study|Withdrawal by Subject|0
2528930|NCT01650519|8752504|P1|Overall Study|Withdrawal by Subject|1
2528931|NCT01650285|8752566|P1|Overall Study|Adverse Event|1
2528932|NCT01650259|8752573|P2|Overall Study|Other than listed|146
2528933|NCT01650259|8752574|P1|Overall Study|Other than listed|64
2528934|NCT01650259|8752573|P2|Overall Study|Not treated|7
2528935|NCT01650259|8752574|P1|Overall Study|Not treated|1
2528936|NCT01650259|8752573|P2|Overall Study|CRF not collected|82
2528937|NCT01650259|8752574|P1|Overall Study|CRF not collected|98
2528938|NCT01650259|8752573|P2|Overall Study|Patients had no visit after entry|0
2528939|NCT01650259|8752574|P1|Overall Study|Patients had no visit after entry|70
2528940|NCT01650259|8752573|P2|Overall Study|Lost to Follow-up|0
2528941|NCT01650259|8752574|P1|Overall Study|Lost to Follow-up|435
2528942|NCT01650259|8752573|P2|Overall Study|Lack of Efficacy|0
2528943|NCT01650259|8752574|P1|Overall Study|Lack of Efficacy|143
2528944|NCT01650259|8752573|P2|Overall Study|Adverse Event|0
2528945|NCT01650259|8752574|P1|Overall Study|Adverse Event|127
2528946|NCT01650259|8752573|P2|Overall Study|Improvement|0
2528947|NCT01650259|8752574|P1|Overall Study|Improvement|105
2528948|NCT01650246|8752579|P1|Overall Study|Lack of Efficacy|30
2528949|NCT01650246|8752579|P1|Overall Study|Death|1
2528950|NCT01650246|8752579|P1|Overall Study|Withdrawal by Subject|26
2528951|NCT01650246|8752579|P1|Overall Study|Lost to Follow-up|5
2528952|NCT01650246|8752579|P1|Overall Study|Sponsor terminated study|53
2528953|NCT01650246|8752579|P1|Overall Study|Protocol Violation|5
2528954|NCT01650246|8752579|P1|Overall Study|Adverse Event|23
2528955|NCT01650194|8752584|P1|Overall Study|Miscellaneous|10
2528956|NCT01650194|8752584|P1|Overall Study|Withdrawal by Subject|2
2528957|NCT01650194|8752584|P1|Overall Study|Progressive Disease (PD)|35
2528958|NCT01649856|8752620|P2|Overall Study|Other|5
2528959|NCT01649856|8752621|P1|Overall Study|Other|20
2528960|NCT01649856|8752620|P2|Overall Study|Lack of Compliance|1
2528961|NCT01649856|8752621|P1|Overall Study|Lack of Compliance|6
2528962|NCT01649856|8752620|P2|Overall Study|Lost to Follow-up|16
2528963|NCT01649856|8752621|P1|Overall Study|Lost to Follow-up|20
2528964|NCT01649856|8752620|P2|Overall Study|Stable or Progressed Disease|3
2528965|NCT01649856|8752621|P1|Overall Study|Stable or Progressed Disease|5
2528966|NCT01649856|8752620|P2|Overall Study|Death|34
2528967|NCT01649856|8752621|P1|Overall Study|Death|69
2528968|NCT01649856|8752620|P2|Overall Study|Treatment Failure|1
2528969|NCT01649856|8752621|P1|Overall Study|Treatment Failure|1
2528970|NCT01649856|8752620|P2|Overall Study|Protocol Violation|4
2528971|NCT01649856|8752621|P1|Overall Study|Protocol Violation|4
2528972|NCT01649856|8752620|P2|Overall Study|Withdrawal by Subject|14
2528973|NCT01649856|8752621|P1|Overall Study|Withdrawal by Subject|14
2528974|NCT01649804|8752653|P1|Overall Study|Administrative/Other|8
2528975|NCT01649791|8752665|P1|Overall Study|Adverse Event|1
2528976|NCT01649791|8752665|P1|Overall Study|Disease Progression|2
2528977|NCT01649765|8752674|P2|Overall Study|Withdrawal by Subject|1
2528978|NCT01649765|8752675|P1|Overall Study|Withdrawal by Subject|2
2528979|NCT01649765|8752674|P2|Overall Study|Protocol Violation|0
2528980|NCT01649765|8752675|P1|Overall Study|Protocol Violation|1
2528981|NCT01649765|8752674|P2|Overall Study|Physician Decision|3
2528982|NCT01649765|8752675|P1|Overall Study|Physician Decision|0
2528983|NCT01649765|8752674|P2|Overall Study|Lack of Efficacy|1
2528984|NCT01649765|8752675|P1|Overall Study|Lack of Efficacy|1
2528985|NCT01649765|8752674|P2|Overall Study|Adverse Event|3
2528986|NCT01649765|8752675|P1|Overall Study|Adverse Event|5
2528987|NCT01649557|8752726|P3|Overall Study|Lack of Efficacy|0
2528988|NCT01649557|8752727|P2|Overall Study|Lack of Efficacy|0
2528989|NCT01649557|8752728|P1|Overall Study|Lack of Efficacy|5
2528990|NCT01649557|8752726|P3|Overall Study|Protocol deviation|0
2528991|NCT01649557|8752727|P2|Overall Study|Protocol deviation|2
2528992|NCT01649557|8752728|P1|Overall Study|Protocol deviation|0
2528993|NCT01649557|8752726|P3|Overall Study|Withdrawal by Subject|4
2528994|NCT01649557|8752727|P2|Overall Study|Withdrawal by Subject|5
2528995|NCT01649557|8752728|P1|Overall Study|Withdrawal by Subject|15
2528996|NCT01649557|8752726|P3|Overall Study|Physician Decision|1
2528997|NCT01649557|8752727|P2|Overall Study|Physician Decision|2
2528998|NCT01649557|8752728|P1|Overall Study|Physician Decision|8
2528999|NCT01649557|8752726|P3|Overall Study|Met withdrawal criteria|0
2529000|NCT01649557|8752727|P2|Overall Study|Met withdrawal criteria|0
2529001|NCT01649557|8752728|P1|Overall Study|Met withdrawal criteria|4
2529002|NCT01649557|8752726|P3|Overall Study|Adverse Event|1
2529003|NCT01649557|8752727|P2|Overall Study|Adverse Event|5
2529004|NCT01649557|8752728|P1|Overall Study|Adverse Event|7
2529005|NCT01649557|8752726|P3|Overall Study|Lost to Follow-up|3
2529006|NCT01649557|8752727|P2|Overall Study|Lost to Follow-up|0
2529007|NCT01649557|8752728|P1|Overall Study|Lost to Follow-up|5
2529008|NCT01649427|8752774|P2|Overall Study|Surgical problems during nephrectomy|2
2529009|NCT01649427|8752775|P1|Overall Study|Surgical problems during nephrectomy|2
2529010|NCT01649427|8752774|P2|Overall Study|Graft loss|1
2529011|NCT01649427|8752775|P1|Overall Study|Graft loss|0
2529012|NCT01649427|8752774|P2|Overall Study|Lost to Follow-up|1
2529013|NCT01649427|8752775|P1|Overall Study|Lost to Follow-up|0
2529014|NCT01649427|8752774|P2|Overall Study|Withdrawal by Subject|7
2529015|NCT01649427|8752775|P1|Overall Study|Withdrawal by Subject|8
2529016|NCT01649427|8752774|P2|Overall Study|Adverse Event|1
2529017|NCT01649427|8752775|P1|Overall Study|Adverse Event|1
2529018|NCT01649375|8752794|P5|Week 16 up to Week 260|Adverse Event|2
2529019|NCT01649375|8752795|P4|Week 16 up to Week 260|Adverse Event|3
2529020|NCT01649375|8752796|P3|Week 16 up to Week 260|Adverse Event|0
2529021|NCT01649375|8752797|P2|Week 16 up to Week 260|Adverse Event|2
2529022|NCT01649375|8752798|P1|Week 16 up to Week 260|Adverse Event|5
2529023|NCT01649375|8752794|P5|Week 16 up to Week 260|Death|0
2529024|NCT01649375|8752795|P4|Week 16 up to Week 260|Death|0
2529025|NCT01649375|8752796|P3|Week 16 up to Week 260|Death|0
2529026|NCT01649375|8752797|P2|Week 16 up to Week 260|Death|1
2529027|NCT01649375|8752798|P1|Week 16 up to Week 260|Death|1
2529028|NCT01649375|8752794|P5|Week 16 up to Week 260|Withdrawal by Subject|1
2529029|NCT01649375|8752795|P4|Week 16 up to Week 260|Withdrawal by Subject|3
2529030|NCT01649375|8752796|P3|Week 16 up to Week 260|Withdrawal by Subject|0
2529031|NCT01649375|8752797|P2|Week 16 up to Week 260|Withdrawal by Subject|2
2529032|NCT01649375|8752798|P1|Week 16 up to Week 260|Withdrawal by Subject|7
2529033|NCT01649375|8752794|P5|Week 16 up to Week 260|Technical issues|0
2529034|NCT01649375|8752795|P4|Week 16 up to Week 260|Technical issues|1
2529035|NCT01649375|8752796|P3|Week 16 up to Week 260|Technical issues|0
2529036|NCT01649375|8752797|P2|Week 16 up to Week 260|Technical issues|1
2529037|NCT01649375|8752798|P1|Week 16 up to Week 260|Technical issues|0
2529038|NCT01649375|8752794|P5|Week 16 up to Week 260|Physician Decision|0
2529039|NCT01649375|8752795|P4|Week 16 up to Week 260|Physician Decision|0
2529040|NCT01649375|8752796|P3|Week 16 up to Week 260|Physician Decision|0
2529041|NCT01649375|8752797|P2|Week 16 up to Week 260|Physician Decision|2
2529042|NCT01649375|8752798|P1|Week 16 up to Week 260|Physician Decision|0
2529043|NCT01649375|8752794|P5|Week 16 up to Week 260|Non-compliance|0
2529044|NCT01649375|8752795|P4|Week 16 up to Week 260|Non-compliance|1
2529045|NCT01649375|8752796|P3|Week 16 up to Week 260|Non-compliance|0
2529046|NCT01649375|8752797|P2|Week 16 up to Week 260|Non-compliance|1
2529047|NCT01649375|8752798|P1|Week 16 up to Week 260|Non-compliance|0
2529048|NCT01649375|8752794|P5|Week 16 up to Week 260|Lack of Efficacy|2
2529049|NCT01649375|8752795|P4|Week 16 up to Week 260|Lack of Efficacy|4
2529050|NCT01649375|8752796|P3|Week 16 up to Week 260|Lack of Efficacy|0
2529051|NCT01649375|8752797|P2|Week 16 up to Week 260|Lack of Efficacy|4
2529052|NCT01649375|8752798|P1|Week 16 up to Week 260|Lack of Efficacy|7
2529053|NCT01649375|8752794|P5|Up to Week 16|Death|0
2529054|NCT01649375|8752795|P4|Up to Week 16|Death|0
2529055|NCT01649375|8752796|P3|Up to Week 16|Death|0
2529056|NCT01649375|8752797|P2|Up to Week 16|Death|0
2529057|NCT01649375|8752798|P1|Up to Week 16|Death|1
2529058|NCT01649375|8752794|P5|Up to Week 16|Withdrawal by Subject|0
2529059|NCT01649375|8752795|P4|Up to Week 16|Withdrawal by Subject|0
2529060|NCT01649375|8752796|P3|Up to Week 16|Withdrawal by Subject|2
2529061|NCT01649375|8752797|P2|Up to Week 16|Withdrawal by Subject|1
2529062|NCT01649375|8752798|P1|Up to Week 16|Withdrawal by Subject|2
2529063|NCT01649375|8752794|P5|Up to Week 16|Physician Decision|0
2529064|NCT01649375|8752795|P4|Up to Week 16|Physician Decision|0
2529065|NCT01649375|8752796|P3|Up to Week 16|Physician Decision|1
2529066|NCT01649375|8752797|P2|Up to Week 16|Physician Decision|0
2529067|NCT01649375|8752798|P1|Up to Week 16|Physician Decision|0
2529068|NCT01649375|8752794|P5|Up to Week 16|Lack of Efficacy|0
2529069|NCT01649375|8752795|P4|Up to Week 16|Lack of Efficacy|0
2529070|NCT01649375|8752796|P3|Up to Week 16|Lack of Efficacy|1
2529071|NCT01649375|8752797|P2|Up to Week 16|Lack of Efficacy|0
2529072|NCT01649375|8752798|P1|Up to Week 16|Lack of Efficacy|0
2529073|NCT01649375|8752794|P5|Up to Week 16|Adverse Event|0
2529074|NCT01649375|8752795|P4|Up to Week 16|Adverse Event|0
2529075|NCT01649375|8752796|P3|Up to Week 16|Adverse Event|4
2529076|NCT01649375|8752797|P2|Up to Week 16|Adverse Event|5
2529077|NCT01649375|8752798|P1|Up to Week 16|Adverse Event|2
2529078|NCT01649297|8752845|P5|Overall Study|For other reason|0
2529079|NCT01649297|8752846|P4|Overall Study|For other reason|0
2529080|NCT01649297|8752847|P3|Overall Study|For other reason|2
2529081|NCT01649297|8752848|P2|Overall Study|For other reason|1
2529082|NCT01649297|8752849|P1|Overall Study|For other reason|4
2529083|NCT01649297|8752845|P5|Overall Study|Patient withdrawal (not due to AE)|1
2529084|NCT01649297|8752846|P4|Overall Study|Patient withdrawal (not due to AE)|1
2529085|NCT01649297|8752847|P3|Overall Study|Patient withdrawal (not due to AE)|4
2529086|NCT01649297|8752848|P2|Overall Study|Patient withdrawal (not due to AE)|6
2529087|NCT01649297|8752849|P1|Overall Study|Patient withdrawal (not due to AE)|3
2529088|NCT01649297|8752845|P5|Overall Study|Lost to Follow-up|0
2529089|NCT01649297|8752846|P4|Overall Study|Lost to Follow-up|3
2529090|NCT01649297|8752847|P3|Overall Study|Lost to Follow-up|4
2529091|NCT01649297|8752848|P2|Overall Study|Lost to Follow-up|1
2529092|NCT01649297|8752849|P1|Overall Study|Lost to Follow-up|1
2529093|NCT01649297|8752845|P5|Overall Study|Non compliant with Protocol|1
2529094|NCT01649297|8752846|P4|Overall Study|Non compliant with Protocol|2
2529095|NCT01649297|8752847|P3|Overall Study|Non compliant with Protocol|3
2529096|NCT01649297|8752848|P2|Overall Study|Non compliant with Protocol|0
2529097|NCT01649297|8752849|P1|Overall Study|Non compliant with Protocol|1
2529098|NCT01649297|8752845|P5|Overall Study|Lack of Efficacy|1
2529099|NCT01649297|8752846|P4|Overall Study|Lack of Efficacy|0
2529100|NCT01649297|8752847|P3|Overall Study|Lack of Efficacy|0
2529101|NCT01649297|8752848|P2|Overall Study|Lack of Efficacy|0
2529102|NCT01649297|8752849|P1|Overall Study|Lack of Efficacy|0
2529103|NCT01649297|8752845|P5|Overall Study|Adverse Event|1
2529104|NCT01649297|8752846|P4|Overall Study|Adverse Event|13
2529105|NCT01649297|8752847|P3|Overall Study|Adverse Event|4
2529106|NCT01649297|8752848|P2|Overall Study|Adverse Event|5
2529107|NCT01649297|8752849|P1|Overall Study|Adverse Event|5
2529108|NCT01649271|8752868|P2|Overall Study|Other than stated above|0
2529109|NCT01649271|8752869|P1|Overall Study|Other than stated above|1
2529110|NCT01649271|8752868|P2|Overall Study|Withdrawal by Subject|0
2529111|NCT01649271|8752869|P1|Overall Study|Withdrawal by Subject|1
2529112|NCT01649271|8752868|P2|Overall Study|Other Adverse Event|2
2529113|NCT01649271|8752869|P1|Overall Study|Other Adverse Event|0
2529114|NCT01649271|8752868|P2|Overall Study|Progressive disease|5
2529115|NCT01649271|8752869|P1|Overall Study|Progressive disease|4
2529116|NCT01649232|8752884|P2|Overall Study|Physician Decision|0
2529117|NCT01649232|8752885|P1|Overall Study|Physician Decision|2
2529118|NCT01648790|8752937|P5|Treatment 3|Withdrawal by Subject|0
2529119|NCT01648790|8752938|P4|Treatment 3|Withdrawal by Subject|1
2529120|NCT01648790|8752939|P3|Treatment 3|Withdrawal by Subject|0
2529121|NCT01648790|8752940|P2|Treatment 3|Withdrawal by Subject|0
2529122|NCT01648790|8752941|P1|Treatment 3|Withdrawal by Subject|0
2529123|NCT01648764|8752976|P14|Overall Study|Investigator Decision|0
2529124|NCT01648764|8752977|P13|Overall Study|Investigator Decision|0
2529125|NCT01648764|8752978|P12|Overall Study|Investigator Decision|1
2529126|NCT01648764|8752979|P11|Overall Study|Investigator Decision|0
2529127|NCT01648764|8752980|P10|Overall Study|Investigator Decision|0
2529128|NCT01648764|8752981|P9|Overall Study|Investigator Decision|0
2529129|NCT01648764|8752982|P8|Overall Study|Investigator Decision|0
2529130|NCT01648764|8752983|P7|Overall Study|Investigator Decision|1
2529131|NCT01648764|8752984|P6|Overall Study|Investigator Decision|0
2529132|NCT01648764|8752985|P5|Overall Study|Investigator Decision|0
2529133|NCT01648764|8752986|P4|Overall Study|Investigator Decision|0
2529134|NCT01648764|8752987|P3|Overall Study|Investigator Decision|0
2529135|NCT01648764|8752988|P2|Overall Study|Investigator Decision|0
2529136|NCT01648764|8752989|P1|Overall Study|Investigator Decision|0
2529137|NCT01648764|8752976|P14|Overall Study|Withdrawal by Subject|0
2529138|NCT01648764|8752977|P13|Overall Study|Withdrawal by Subject|1
2529139|NCT01648764|8752978|P12|Overall Study|Withdrawal by Subject|0
2529140|NCT01648764|8752979|P11|Overall Study|Withdrawal by Subject|0
2529141|NCT01648764|8752980|P10|Overall Study|Withdrawal by Subject|0
2529142|NCT01648764|8752981|P9|Overall Study|Withdrawal by Subject|0
2529143|NCT01648764|8752982|P8|Overall Study|Withdrawal by Subject|0
2529144|NCT01648764|8752983|P7|Overall Study|Withdrawal by Subject|2
2529145|NCT01648764|8752984|P6|Overall Study|Withdrawal by Subject|0
2529146|NCT01648764|8752985|P5|Overall Study|Withdrawal by Subject|0
2529147|NCT01648764|8752986|P4|Overall Study|Withdrawal by Subject|0
2529148|NCT01648764|8752987|P3|Overall Study|Withdrawal by Subject|0
2529149|NCT01648764|8752988|P2|Overall Study|Withdrawal by Subject|0
2529150|NCT01648764|8752989|P1|Overall Study|Withdrawal by Subject|0
2529151|NCT01648764|8752976|P14|Overall Study|Death|1
2529152|NCT01648764|8752977|P13|Overall Study|Death|0
2529153|NCT01648764|8752978|P12|Overall Study|Death|0
2529154|NCT01648764|8752979|P11|Overall Study|Death|0
2529155|NCT01648764|8752980|P10|Overall Study|Death|0
2529156|NCT01648764|8752981|P9|Overall Study|Death|0
2529157|NCT01648764|8752982|P8|Overall Study|Death|0
2529158|NCT01648764|8752983|P7|Overall Study|Death|1
2529159|NCT01648764|8752984|P6|Overall Study|Death|0
2529160|NCT01648764|8752985|P5|Overall Study|Death|0
2529161|NCT01648764|8752986|P4|Overall Study|Death|0
2529162|NCT01648764|8752987|P3|Overall Study|Death|0
2529163|NCT01648764|8752988|P2|Overall Study|Death|0
2529164|NCT01648764|8752989|P1|Overall Study|Death|0
2529165|NCT01648764|8752976|P14|Overall Study|Adverse Event|1
2529166|NCT01648764|8752977|P13|Overall Study|Adverse Event|1
2529167|NCT01648764|8752978|P12|Overall Study|Adverse Event|3
2529168|NCT01648764|8752979|P11|Overall Study|Adverse Event|0
2529169|NCT01648764|8752980|P10|Overall Study|Adverse Event|1
2529170|NCT01648764|8752981|P9|Overall Study|Adverse Event|0
2529171|NCT01648764|8752982|P8|Overall Study|Adverse Event|0
2529172|NCT01648764|8752983|P7|Overall Study|Adverse Event|0
2529173|NCT01648764|8752984|P6|Overall Study|Adverse Event|1
2529174|NCT01648764|8752985|P5|Overall Study|Adverse Event|0
2529175|NCT01648764|8752986|P4|Overall Study|Adverse Event|0
2529176|NCT01648764|8752987|P3|Overall Study|Adverse Event|0
2529177|NCT01648764|8752988|P2|Overall Study|Adverse Event|0
2529178|NCT01648764|8752989|P1|Overall Study|Adverse Event|0
2529179|NCT01648764|8752976|P14|Overall Study|Progressive Disease|1
2529180|NCT01648764|8752977|P13|Overall Study|Progressive Disease|2
2529181|NCT01648764|8752978|P12|Overall Study|Progressive Disease|1
2529182|NCT01648764|8752979|P11|Overall Study|Progressive Disease|0
2529183|NCT01648764|8752980|P10|Overall Study|Progressive Disease|2
2529184|NCT01648764|8752981|P9|Overall Study|Progressive Disease|0
2529185|NCT01648764|8752982|P8|Overall Study|Progressive Disease|0
2529186|NCT01648764|8752983|P7|Overall Study|Progressive Disease|1
2529187|NCT01648764|8752984|P6|Overall Study|Progressive Disease|1
2529188|NCT01648764|8752985|P5|Overall Study|Progressive Disease|0
2529189|NCT01648764|8752986|P4|Overall Study|Progressive Disease|0
2529190|NCT01648764|8752987|P3|Overall Study|Progressive Disease|0
2529191|NCT01648764|8752988|P2|Overall Study|Progressive Disease|1
2529192|NCT01648764|8752989|P1|Overall Study|Progressive Disease|0
2529193|NCT01648699|8753141|P1|Overall Study|Unspecified/unable to complete 4 visits|2
2529194|NCT01648699|8753141|P1|Overall Study|Lost to Follow-up|2
2529195|NCT01648699|8753141|P1|Overall Study|Death|1
2529196|NCT01648582|8753170|P3|Overall Study|Sponsor Decision|1
2529197|NCT01648582|8753171|P2|Overall Study|Sponsor Decision|1
2529198|NCT01648582|8753172|P1|Overall Study|Sponsor Decision|0
2529199|NCT01648582|8753170|P3|Overall Study|Death|0
2529200|NCT01648582|8753171|P2|Overall Study|Death|0
2529201|NCT01648582|8753172|P1|Overall Study|Death|1
2529202|NCT01648582|8753170|P3|Overall Study|Physician Decision|3
2529203|NCT01648582|8753171|P2|Overall Study|Physician Decision|1
2529204|NCT01648582|8753172|P1|Overall Study|Physician Decision|0
2529205|NCT01648582|8753170|P3|Overall Study|Withdrawal by Subject|17
2529206|NCT01648582|8753171|P2|Overall Study|Withdrawal by Subject|17
2529207|NCT01648582|8753172|P1|Overall Study|Withdrawal by Subject|15
2529208|NCT01648582|8753170|P3|Overall Study|Protocol Violation|1
2529209|NCT01648582|8753171|P2|Overall Study|Protocol Violation|2
2529210|NCT01648582|8753172|P1|Overall Study|Protocol Violation|1
2529211|NCT01648582|8753170|P3|Overall Study|Lost to Follow-up|8
2529212|NCT01648582|8753171|P2|Overall Study|Lost to Follow-up|6
2529213|NCT01648582|8753172|P1|Overall Study|Lost to Follow-up|9
2529214|NCT01648582|8753170|P3|Overall Study|Adverse Event|2
2529215|NCT01648582|8753171|P2|Overall Study|Adverse Event|11
2529216|NCT01648582|8753172|P1|Overall Study|Adverse Event|6
2529217|NCT01648348|8753275|P6|Overall Study|Replaced for MTD analysis|0
2529218|NCT01648348|8753276|P5|Overall Study|Replaced for MTD analysis|0
2529219|NCT01648348|8753277|P4|Overall Study|Replaced for MTD analysis|0
2529220|NCT01648348|8753278|P3|Overall Study|Replaced for MTD analysis|1
2529221|NCT01648348|8753279|P2|Overall Study|Replaced for MTD analysis|0
2529222|NCT01648348|8753280|P1|Overall Study|Replaced for MTD analysis|1
2529223|NCT01648348|8753275|P6|Overall Study|Cancel|6
2529224|NCT01648348|8753276|P5|Overall Study|Cancel|3
2529225|NCT01648348|8753277|P4|Overall Study|Cancel|0
2529226|NCT01648348|8753278|P3|Overall Study|Cancel|0
2529227|NCT01648348|8753279|P2|Overall Study|Cancel|0
2529228|NCT01648348|8753280|P1|Overall Study|Cancel|1
2529229|NCT01648283|8753367|P1|Overall Study|Withdrawal by Subject|14
2529230|NCT01648270|8753373|P1|Intravenous Buprenorphine|Withdrawal by Subject|12
2529231|NCT01648166|8753385|P2|Overall Study|inadequate toenail samples|100
2529232|NCT01648166|8753386|P1|Overall Study|inadequate toenail samples|53
2529233|NCT01648140|8753396|P4|Overall Study|Lost to Follow-up|0
2529234|NCT01648140|8753397|P3|Overall Study|Lost to Follow-up|2
2529235|NCT01648140|8753398|P2|Overall Study|Lost to Follow-up|1
2529236|NCT01648140|8753399|P1|Overall Study|Lost to Follow-up|2
2529237|NCT01648140|8753396|P4|Overall Study|Withdrawal by Subject|2
2529238|NCT01648140|8753397|P3|Overall Study|Withdrawal by Subject|3
2529239|NCT01648140|8753398|P2|Overall Study|Withdrawal by Subject|3
2529240|NCT01648140|8753399|P1|Overall Study|Withdrawal by Subject|2
2529241|NCT01648140|8753396|P4|Overall Study|Adverse Event|0
2529242|NCT01648140|8753397|P3|Overall Study|Adverse Event|2
2529243|NCT01648140|8753398|P2|Overall Study|Adverse Event|1
2529244|NCT01648140|8753399|P1|Overall Study|Adverse Event|3
2529245|NCT01648140|8753396|P4|Overall Study|Lack of Efficacy|0
2529246|NCT01648140|8753397|P3|Overall Study|Lack of Efficacy|1
2529247|NCT01648140|8753398|P2|Overall Study|Lack of Efficacy|7
2529248|NCT01648140|8753399|P1|Overall Study|Lack of Efficacy|4
2529249|NCT01648140|8753396|P4|Overall Study|Physician Decision|0
2529250|NCT01648140|8753397|P3|Overall Study|Physician Decision|0
2529251|NCT01648140|8753398|P2|Overall Study|Physician Decision|0
2529252|NCT01648140|8753399|P1|Overall Study|Physician Decision|1
2529253|NCT01648101|8753564|P3|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
2529254|NCT01648101|8753565|P2|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1
2529255|NCT01648101|8753566|P1|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
2529256|NCT01648101|8753564|P3|Transition Phase (4 Weeks)|Study Terminated|0
2529257|NCT01648101|8753565|P2|Transition Phase (4 Weeks)|Study Terminated|0
2529258|NCT01648101|8753566|P1|Transition Phase (4 Weeks)|Study Terminated|1
2529259|NCT01648101|8753564|P3|Transition Phase (4 Weeks)|Withdrawal by Subject|2
2529260|NCT01648101|8753565|P2|Transition Phase (4 Weeks)|Withdrawal by Subject|0
2529261|NCT01648101|8753566|P1|Transition Phase (4 Weeks)|Withdrawal by Subject|0
2529262|NCT01648101|8753564|P3|Transition Phase (4 Weeks)|Lack of Efficacy|0
2529263|NCT01648101|8753565|P2|Transition Phase (4 Weeks)|Lack of Efficacy|2
2529264|NCT01648101|8753566|P1|Transition Phase (4 Weeks)|Lack of Efficacy|0
2529265|NCT01648101|8753564|P3|Transition Phase (4 Weeks)|Adverse Event|2
2529266|NCT01648101|8753565|P2|Transition Phase (4 Weeks)|Adverse Event|3
2529267|NCT01648101|8753566|P1|Transition Phase (4 Weeks)|Adverse Event|4
2529268|NCT01648101|8753564|P3|Maintenance Phase (12 Weeks)|Adverse Event|4
2529269|NCT01648101|8753565|P2|Maintenance Phase (12 Weeks)|Adverse Event|3
2529270|NCT01648101|8753566|P1|Maintenance Phase (12 Weeks)|Adverse Event|1
2529271|NCT01648101|8753564|P3|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
2529272|NCT01648101|8753565|P2|Maintenance Phase (12 Weeks)|Lack of Efficacy|0
2529273|NCT01648101|8753566|P1|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
2529274|NCT01648101|8753564|P3|Maintenance Phase (12 Weeks)|Withdrew Consent|1
2529275|NCT01648101|8753565|P2|Maintenance Phase (12 Weeks)|Withdrew Consent|0
2529276|NCT01648101|8753566|P1|Maintenance Phase (12 Weeks)|Withdrew Consent|1
2529277|NCT01648101|8753564|P3|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1
2529278|NCT01648101|8753565|P2|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
2529279|NCT01648101|8753566|P1|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
2529280|NCT01648101|8753564|P3|Titration Phase (4 Weeks)|Adverse Event|3
2529281|NCT01648101|8753565|P2|Titration Phase (4 Weeks)|Adverse Event|2
2529282|NCT01648101|8753566|P1|Titration Phase (4 Weeks)|Adverse Event|0
2529283|NCT01648101|8753564|P3|Titration Phase (4 Weeks)|Protocol Violation|2
2529284|NCT01648101|8753565|P2|Titration Phase (4 Weeks)|Protocol Violation|1
2529285|NCT01648101|8753566|P1|Titration Phase (4 Weeks)|Protocol Violation|2
2529286|NCT01647711|8753653|P5|Overall Study|Other reason not defined|0
2529287|NCT01647711|8753654|P4|Overall Study|Other reason not defined|1
2529288|NCT01647711|8753655|P3|Overall Study|Other reason not defined|1
2529289|NCT01647711|8753656|P2|Overall Study|Other reason not defined|1
2529290|NCT01647711|8753657|P1|Overall Study|Other reason not defined|0
2529291|NCT01647711|8753653|P5|Overall Study|Refused to continue taking medication|1
2529292|NCT01647711|8753654|P4|Overall Study|Refused to continue taking medication|2
2529293|NCT01647711|8753655|P3|Overall Study|Refused to continue taking medication|0
2529294|NCT01647711|8753656|P2|Overall Study|Refused to continue taking medication|0
2529295|NCT01647711|8753657|P1|Overall Study|Refused to continue taking medication|0
2529296|NCT01647711|8753653|P5|Overall Study|Protocol Violation|1
2529297|NCT01647711|8753654|P4|Overall Study|Protocol Violation|0
2529298|NCT01647711|8753655|P3|Overall Study|Protocol Violation|0
2529299|NCT01647711|8753656|P2|Overall Study|Protocol Violation|0
2529300|NCT01647711|8753657|P1|Overall Study|Protocol Violation|0
2529301|NCT01647711|8753653|P5|Overall Study|Other adverse event|2
2529302|NCT01647711|8753654|P4|Overall Study|Other adverse event|0
2529303|NCT01647711|8753655|P3|Overall Study|Other adverse event|2
2529304|NCT01647711|8753656|P2|Overall Study|Other adverse event|0
2529305|NCT01647711|8753657|P1|Overall Study|Other adverse event|0
2529306|NCT01647711|8753653|P5|Overall Study|Progressive disease|2
2529307|NCT01647711|8753654|P4|Overall Study|Progressive disease|8
2529308|NCT01647711|8753655|P3|Overall Study|Progressive disease|6
2529309|NCT01647711|8753656|P2|Overall Study|Progressive disease|2
2529310|NCT01647711|8753657|P1|Overall Study|Progressive disease|6
2529311|NCT01647542|8753694|P3|Overall Study|Death|1
2529312|NCT01647542|8753695|P2|Overall Study|Death|0
2529313|NCT01647542|8753696|P1|Overall Study|Death|0
2529314|NCT01647542|8753694|P3|Overall Study|Lack of Efficacy|0
2529315|NCT01647542|8753695|P2|Overall Study|Lack of Efficacy|1
2529316|NCT01647542|8753696|P1|Overall Study|Lack of Efficacy|1
2529317|NCT01647542|8753694|P3|Overall Study|Study Termination|65
2529318|NCT01647542|8753695|P2|Overall Study|Study Termination|61
2529319|NCT01647542|8753696|P1|Overall Study|Study Termination|64
2529320|NCT01647542|8753694|P3|Overall Study|Withdrawal by Subject|0
2529321|NCT01647542|8753695|P2|Overall Study|Withdrawal by Subject|4
2529322|NCT01647542|8753696|P1|Overall Study|Withdrawal by Subject|6
2529323|NCT01647542|8753694|P3|Overall Study|Lost to Follow-up|2
2529324|NCT01647542|8753695|P2|Overall Study|Lost to Follow-up|2
2529325|NCT01647542|8753696|P1|Overall Study|Lost to Follow-up|0
2529326|NCT01647542|8753694|P3|Overall Study|Adverse Event|4
2529327|NCT01647542|8753695|P2|Overall Study|Adverse Event|5
2529328|NCT01647542|8753696|P1|Overall Study|Adverse Event|4
2529329|NCT01647542|8753694|P3|Overall Study|Major Protocol Deviation|0
2529330|NCT01647542|8753695|P2|Overall Study|Major Protocol Deviation|0
2529331|NCT01647542|8753696|P1|Overall Study|Major Protocol Deviation|1
2529332|NCT01647282|8753730|P2|Overall Study|Physician Decision|5
2529333|NCT01647282|8753731|P1|Overall Study|Physician Decision|7
2529334|NCT01646827|8753752|P2|Overall Study|Withdrawal by Subject|0
2529335|NCT01646827|8753753|P1|Overall Study|Withdrawal by Subject|1
2529336|NCT01646827|8753752|P2|Overall Study|Physician Decision|2
2529337|NCT01646827|8753753|P1|Overall Study|Physician Decision|1
2529338|NCT01646827|8753752|P2|Overall Study|Lost to Follow-up|3
2529339|NCT01646827|8753753|P1|Overall Study|Lost to Follow-up|0
2529340|NCT01646398|8753840|P2|Overall Study|Withdrawal by Subject|0
2529341|NCT01646398|8753841|P1|Overall Study|Withdrawal by Subject|1
2529342|NCT01646385|8753857|P2|Overall Study|Switched to alternate biologic|649
2529343|NCT01646385|8753858|P1|Overall Study|Switched to alternate biologic|636
2529344|NCT01646385|8753857|P2|Overall Study|Death|222
2529345|NCT01646385|8753858|P1|Overall Study|Death|202
2529346|NCT01646320|8753901|P2|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2
2529347|NCT01646320|8753902|P1|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0
2529348|NCT01646320|8753901|P2|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1
2529349|NCT01646320|8753902|P1|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0
2529350|NCT01646320|8753901|P2|Long-term Period (Weeks 24 to 52)|Adverse Event|2
2529351|NCT01646320|8753902|P1|Long-term Period (Weeks 24 to 52)|Adverse Event|4
2529352|NCT01646320|8753901|P2|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2
2529353|NCT01646320|8753902|P1|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0
2529354|NCT01646320|8753901|P2|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0
2529355|NCT01646320|8753902|P1|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2
2529356|NCT01646320|8753901|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0
2529357|NCT01646320|8753902|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2
2529358|NCT01646320|8753901|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
2529359|NCT01646320|8753902|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
2529360|NCT01646320|8753901|P2|Short-term Period (Day 1 to Week 24)|Other|0
2529361|NCT01646320|8753902|P1|Short-term Period (Day 1 to Week 24)|Other|1
2529362|NCT01646320|8753901|P2|Short-term Period (Day 1 to Week 24)|Not reported|2
2529363|NCT01646320|8753902|P1|Short-term Period (Day 1 to Week 24)|Not reported|2
2529364|NCT01646320|8753901|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1
2529365|NCT01646320|8753902|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
2529366|NCT01646320|8753901|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|0
2529367|NCT01646320|8753902|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|3
2529368|NCT01646268|8753918|P2|Overall Study|Other|0
2529369|NCT01646268|8753919|P1|Overall Study|Other|2
2529370|NCT01646268|8753918|P2|Overall Study|Withdrawal by Subject|5
2529371|NCT01646268|8753919|P1|Overall Study|Withdrawal by Subject|2
2529372|NCT01646268|8753918|P2|Overall Study|Protocol Violation|1
2529373|NCT01646268|8753919|P1|Overall Study|Protocol Violation|0
2529374|NCT01646268|8753918|P2|Overall Study|Lack of Efficacy|3
2529375|NCT01646268|8753919|P1|Overall Study|Lack of Efficacy|1
2529376|NCT01646268|8753918|P2|Overall Study|Adverse Event|7
2529377|NCT01646268|8753919|P1|Overall Study|Adverse Event|6
2529378|NCT01646255|8753933|P2|Overall Study|Inclusion Criteria Deviation|0
2529379|NCT01646255|8753934|P1|Overall Study|Inclusion Criteria Deviation|1
2529380|NCT01646255|8753933|P2|Overall Study|Compliance is not well|0
2529381|NCT01646255|8753934|P1|Overall Study|Compliance is not well|1
2529382|NCT01646255|8753933|P2|Overall Study|Withdrawal by Subject|6
2529383|NCT01646255|8753934|P1|Overall Study|Withdrawal by Subject|10
2529384|NCT01646255|8753933|P2|Overall Study|Lack of Efficacy|0
2529385|NCT01646255|8753934|P1|Overall Study|Lack of Efficacy|2
2529386|NCT01646255|8753933|P2|Overall Study|Adverse Event|8
2529387|NCT01646255|8753934|P1|Overall Study|Adverse Event|7
2529388|NCT01646216|8753966|P2|Overall Study|Investigator decision|1
2529389|NCT01646216|8753967|P1|Overall Study|Investigator decision|1
2529390|NCT01646216|8753966|P2|Overall Study|Did not complete training|2
2529391|NCT01646216|8753967|P1|Overall Study|Did not complete training|0
2529392|NCT01646216|8753966|P2|Overall Study|Baseline step length difference (<5cm)|10
2529393|NCT01646216|8753967|P1|Overall Study|Baseline step length difference (<5cm)|10
2529394|NCT01646203|8753989|P3|Overall Study|Physician's Decision|0
2529395|NCT01646203|8753990|P2|Overall Study|Physician's Decision|1
2529396|NCT01646203|8753991|P1|Overall Study|Physician's Decision|0
2529397|NCT01646203|8753989|P3|Overall Study|Withdrawal by Subject|0
2529398|NCT01646203|8753990|P2|Overall Study|Withdrawal by Subject|1
2529399|NCT01646203|8753991|P1|Overall Study|Withdrawal by Subject|0
2529400|NCT01646203|8753989|P3|Overall Study|Adverse Event|1
2529401|NCT01646203|8753990|P2|Overall Study|Adverse Event|0
2529402|NCT01646203|8753991|P1|Overall Study|Adverse Event|2
2529403|NCT01646177|8754020|P4|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
2529404|NCT01646177|8754021|P3|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
2529405|NCT01646177|8754022|P2|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
2529406|NCT01646177|8754023|P1|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3
2529407|NCT01646177|8754020|P4|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1
2529408|NCT01646177|8754021|P3|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2
2529409|NCT01646177|8754022|P2|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
2529410|NCT01646177|8754023|P1|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
2529411|NCT01646177|8754020|P4|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
2529412|NCT01646177|8754021|P3|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
2529413|NCT01646177|8754022|P2|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
2529414|NCT01646177|8754023|P1|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
2529415|NCT01646177|8754020|P4|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
2529416|NCT01646177|8754021|P3|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
2529417|NCT01646177|8754022|P2|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2
2529418|NCT01646177|8754023|P1|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3
2529419|NCT01646177|8754020|P4|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7
2529420|NCT01646177|8754021|P3|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8
2529421|NCT01646177|8754022|P2|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3
2529422|NCT01646177|8754023|P1|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1
2529423|NCT01646177|8754020|P4|Blinded Induction Dosing (Week 0-12)|Adverse Event|8
2529424|NCT01646177|8754021|P3|Blinded Induction Dosing (Week 0-12)|Adverse Event|9
2529425|NCT01646177|8754022|P2|Blinded Induction Dosing (Week 0-12)|Adverse Event|4
2529426|NCT01646177|8754023|P1|Blinded Induction Dosing (Week 0-12)|Adverse Event|2
2529427|NCT01646138|8754117|P5|Overall Study|Lost to Follow-up|2
2529428|NCT01646138|8754118|P4|Overall Study|Lost to Follow-up|0
2529429|NCT01646138|8754119|P3|Overall Study|Lost to Follow-up|0
2529430|NCT01646138|8754120|P2|Overall Study|Lost to Follow-up|0
2529431|NCT01646138|8754121|P1|Overall Study|Lost to Follow-up|0
2529432|NCT01646125|8754135|P2|Overall Study|Subject/Guardian decision|1
2529433|NCT01646125|8754136|P1|Overall Study|Subject/Guardian decision|1
2529434|NCT01646125|8754135|P2|Overall Study|Study terminated by sponsor|1
2529435|NCT01646125|8754136|P1|Overall Study|Study terminated by sponsor|2
2529436|NCT01646125|8754135|P2|Overall Study|Progressive disease|16
2529437|NCT01646125|8754136|P1|Overall Study|Progressive disease|22
2529438|NCT01646125|8754135|P2|Overall Study|Physician Decision|3
2529439|NCT01646125|8754136|P1|Overall Study|Physician Decision|1
2529440|NCT01646125|8754135|P2|Overall Study|Death|1
2529441|NCT01646125|8754136|P1|Overall Study|Death|1
2529442|NCT01646125|8754135|P2|Overall Study|Adverse Event|1
2529443|NCT01646125|8754136|P1|Overall Study|Adverse Event|2
2529444|NCT01646125|8754135|P2|Overall Study|Untreated|5
2529445|NCT01646125|8754136|P1|Overall Study|Untreated|2
2529446|NCT01646073|8754161|P2|Period B (12 Weeks)|Lost to Follow-up|1
2529447|NCT01646073|8754162|P1|Period B (12 Weeks)|Lost to Follow-up|0
2529448|NCT01646073|8754161|P2|Period B (12 Weeks)|Withdrawal by Subject|5
2529449|NCT01646073|8754162|P1|Period B (12 Weeks)|Withdrawal by Subject|1
2529450|NCT01646073|8754161|P2|Period B (12 Weeks)|Adverse Event|7
2529451|NCT01646073|8754162|P1|Period B (12 Weeks)|Adverse Event|0
2529452|NCT01646073|8754161|P2|Period A (12 Weeks)|Other|1
2529453|NCT01646073|8754162|P1|Period A (12 Weeks)|Other|0
2529454|NCT01646073|8754161|P2|Period A (12 Weeks)|Protocol Violation|1
2529455|NCT01646073|8754162|P1|Period A (12 Weeks)|Protocol Violation|0
2529456|NCT01646073|8754161|P2|Period A (12 Weeks)|Lack of Efficacy|0
2529457|NCT01646073|8754162|P1|Period A (12 Weeks)|Lack of Efficacy|1
2529458|NCT01646073|8754161|P2|Period A (12 Weeks)|Withdrawal by Subject|1
2529459|NCT01646073|8754162|P1|Period A (12 Weeks)|Withdrawal by Subject|1
2529460|NCT01646073|8754161|P2|Period A (12 Weeks)|Adverse Event|2
2529461|NCT01646073|8754162|P1|Period A (12 Weeks)|Adverse Event|0
2529462|NCT01646021|8754203|P2|Overall Study|Withdrawal by Subject|15
2529463|NCT01646021|8754204|P1|Overall Study|Withdrawal by Subject|10
2529464|NCT01646021|8754203|P2|Overall Study|Lost to Follow-up|2
2529465|NCT01646021|8754204|P1|Overall Study|Lost to Follow-up|2
2529466|NCT01646021|8754203|P2|Overall Study|Study Terminated by Sponsor|41
2529467|NCT01646021|8754204|P1|Overall Study|Study Terminated by Sponsor|50
2529468|NCT01646021|8754203|P2|Overall Study|Death|83
2529469|NCT01646021|8754204|P1|Overall Study|Death|77
2529470|NCT01645930|8754241|P1|Overall Study|Reason not Defined|1
2529471|NCT01645930|8754241|P1|Overall Study|Withdrawal by Participant|2
2529472|NCT01645930|8754241|P1|Overall Study|Unsatisfactory Therapeutic Response|2
2529473|NCT01645930|8754241|P1|Overall Study|Adverse Event|4
2529474|NCT01645930|8754241|P1|Overall Study|Progressive Disease|12
2529475|NCT01645930|8754241|P1|Overall Study|Participants Ongoing on Study Treatment|22
2529476|NCT01645735|8754258|P2|Overall Study|Adverse Event|1
2529477|NCT01645735|8754259|P1|Overall Study|Adverse Event|0
2529478|NCT01645735|8754258|P2|Overall Study|Protocol Violation|0
2529479|NCT01645735|8754259|P1|Overall Study|Protocol Violation|1
2529480|NCT01645735|8754258|P2|Overall Study|Withdrawal by Subject|0
2529481|NCT01645735|8754259|P1|Overall Study|Withdrawal by Subject|1
2529482|NCT01645735|8754258|P2|Overall Study|Physician Decision|0
2529483|NCT01645735|8754259|P1|Overall Study|Physician Decision|2
2529484|NCT01645280|8754301|P5|Overall Study|Treatment not completed/Completed f/u|2
2529485|NCT01645280|8754302|P4|Overall Study|Treatment not completed/Completed f/u|0
2529486|NCT01645280|8754303|P3|Overall Study|Treatment not completed/Completed f/u|2
2529487|NCT01645280|8754304|P2|Overall Study|Treatment not completed/Completed f/u|1
2529488|NCT01645280|8754305|P1|Overall Study|Treatment not completed/Completed f/u|1
2529489|NCT01645280|8754301|P5|Overall Study|Other|0
2529490|NCT01645280|8754302|P4|Overall Study|Other|0
2529491|NCT01645280|8754303|P3|Overall Study|Other|2
2529492|NCT01645280|8754304|P2|Overall Study|Other|1
2529493|NCT01645280|8754305|P1|Overall Study|Other|1
2529494|NCT01645280|8754301|P5|Overall Study|Lost to Follow-up|1
2529495|NCT01645280|8754302|P4|Overall Study|Lost to Follow-up|2
2529496|NCT01645280|8754303|P3|Overall Study|Lost to Follow-up|0
2529497|NCT01645280|8754304|P2|Overall Study|Lost to Follow-up|0
2529498|NCT01645280|8754305|P1|Overall Study|Lost to Follow-up|0
2529499|NCT01645280|8754301|P5|Overall Study|Withdrawal by Subject|5
2529500|NCT01645280|8754302|P4|Overall Study|Withdrawal by Subject|4
2529501|NCT01645280|8754303|P3|Overall Study|Withdrawal by Subject|2
2529502|NCT01645280|8754304|P2|Overall Study|Withdrawal by Subject|0
2529503|NCT01645280|8754305|P1|Overall Study|Withdrawal by Subject|4
2529504|NCT01645280|8754301|P5|Overall Study|Death|0
2529505|NCT01645280|8754302|P4|Overall Study|Death|0
2529506|NCT01645280|8754303|P3|Overall Study|Death|0
2529507|NCT01645280|8754304|P2|Overall Study|Death|1
2529508|NCT01645280|8754305|P1|Overall Study|Death|0
2529509|NCT01645176|8754333|P1|Overall Study|did not complete final MRI|1
2529510|NCT01645176|8754333|P1|Overall Study|Lack of Efficacy|4
2529511|NCT01645111|8754337|P1|Overall Study|Did not require Clevidipine|15
2529512|NCT01644890|8754378|P2|Overall Study|Other|9
2529513|NCT01644890|8754379|P1|Overall Study|Other|8
2529514|NCT01644890|8754378|P2|Overall Study|> 28 days since last dose of study drug|3
2529515|NCT01644890|8754379|P1|Overall Study|> 28 days since last dose of study drug|6
2529516|NCT01644890|8754378|P2|Overall Study|Clinical Progression|6
2529517|NCT01644890|8754379|P1|Overall Study|Clinical Progression|6
2529518|NCT01644890|8754378|P2|Overall Study|Progression Disease|131
2529519|NCT01644890|8754379|P1|Overall Study|Progression Disease|160
2529520|NCT01644890|8754378|P2|Overall Study|Withdrawal by Subject|27
2529521|NCT01644890|8754379|P1|Overall Study|Withdrawal by Subject|19
2529522|NCT01644890|8754378|P2|Overall Study|Protocol Violation|7
2529523|NCT01644890|8754379|P1|Overall Study|Protocol Violation|6
2529524|NCT01644890|8754378|P2|Overall Study|Physician Decision|9
2529525|NCT01644890|8754379|P1|Overall Study|Physician Decision|3
2529526|NCT01644890|8754378|P2|Overall Study|Death|3
2529527|NCT01644890|8754379|P1|Overall Study|Death|1
2529528|NCT01644890|8754378|P2|Overall Study|Adverse Event|20
2529529|NCT01644890|8754379|P1|Overall Study|Adverse Event|7
2529530|NCT01644734|8754389|P1|Overall Study|Missing documentation|238
2529531|NCT01644734|8754389|P1|Overall Study|Reasons other than stated above|7
2529532|NCT01644734|8754389|P1|Overall Study|Lost to Follow-up|17
2529533|NCT01644734|8754389|P1|Overall Study|Adverse Event|4
2529534|NCT01644643|8754403|P4|Overall Study|Other Eligibility criteria|2
2529535|NCT01644643|8754404|P3|Overall Study|Other Eligibility criteria|0
2529536|NCT01644643|8754405|P2|Overall Study|Other Eligibility criteria|0
2529537|NCT01644643|8754406|P1|Overall Study|Other Eligibility criteria|0
2529538|NCT01644643|8754403|P4|Overall Study|Withdrawal by Subject|1
2529539|NCT01644643|8754404|P3|Overall Study|Withdrawal by Subject|2
2529540|NCT01644643|8754405|P2|Overall Study|Withdrawal by Subject|0
2529541|NCT01644643|8754406|P1|Overall Study|Withdrawal by Subject|1
2529542|NCT01644643|8754403|P4|Overall Study|Lost to Follow-up|4
2529543|NCT01644643|8754404|P3|Overall Study|Lost to Follow-up|0
2529544|NCT01644643|8754405|P2|Overall Study|Lost to Follow-up|0
2529545|NCT01644643|8754406|P1|Overall Study|Lost to Follow-up|0
2529546|NCT01644643|8754403|P4|Overall Study|Death|3
2529547|NCT01644643|8754404|P3|Overall Study|Death|3
2529548|NCT01644643|8754405|P2|Overall Study|Death|0
2529549|NCT01644643|8754406|P1|Overall Study|Death|1
2529550|NCT01644617|8754571|P3|Overall Study|Adverse Event|6
2529551|NCT01644617|8754572|P2|Overall Study|Adverse Event|0
2529552|NCT01644617|8754573|P1|Overall Study|Adverse Event|3
2529553|NCT01644617|8754571|P3|Overall Study|Lost to Follow-up|0
2529554|NCT01644617|8754572|P2|Overall Study|Lost to Follow-up|1
2529555|NCT01644617|8754573|P1|Overall Study|Lost to Follow-up|0
2529556|NCT01644617|8754571|P3|Overall Study|Withdrawal by Subject|1
2529557|NCT01644617|8754572|P2|Overall Study|Withdrawal by Subject|4
2529558|NCT01644617|8754573|P1|Overall Study|Withdrawal by Subject|3
2529559|NCT01644565|8754623|P9|Overall Study|Relocation|1
2529560|NCT01644565|8754624|P8|Overall Study|Relocation|0
2529561|NCT01644565|8754625|P7|Overall Study|Relocation|0
2529562|NCT01644565|8754626|P6|Overall Study|Relocation|0
2529563|NCT01644565|8754627|P5|Overall Study|Relocation|0
2529564|NCT01644565|8754628|P4|Overall Study|Relocation|0
2529565|NCT01644565|8754629|P3|Overall Study|Relocation|0
2529566|NCT01644565|8754630|P2|Overall Study|Relocation|0
2529567|NCT01644565|8754631|P1|Overall Study|Relocation|0
2529568|NCT01644565|8754623|P9|Overall Study|Family emergency|0
2529569|NCT01644565|8754624|P8|Overall Study|Family emergency|0
2529570|NCT01644565|8754625|P7|Overall Study|Family emergency|0
2529571|NCT01644565|8754626|P6|Overall Study|Family emergency|0
2529572|NCT01644565|8754627|P5|Overall Study|Family emergency|1
2529573|NCT01644565|8754628|P4|Overall Study|Family emergency|0
2529574|NCT01644565|8754629|P3|Overall Study|Family emergency|0
2529575|NCT01644565|8754630|P2|Overall Study|Family emergency|0
2529576|NCT01644565|8754631|P1|Overall Study|Family emergency|0
2529577|NCT01644565|8754623|P9|Overall Study|Lost to Follow-up|0
2529578|NCT01644565|8754624|P8|Overall Study|Lost to Follow-up|2
2529579|NCT01644565|8754625|P7|Overall Study|Lost to Follow-up|0
2529580|NCT01644565|8754626|P6|Overall Study|Lost to Follow-up|0
2529581|NCT01644565|8754627|P5|Overall Study|Lost to Follow-up|0
2529582|NCT01644565|8754628|P4|Overall Study|Lost to Follow-up|1
2529583|NCT01644565|8754629|P3|Overall Study|Lost to Follow-up|0
2529584|NCT01644565|8754630|P2|Overall Study|Lost to Follow-up|0
2529585|NCT01644565|8754631|P1|Overall Study|Lost to Follow-up|0
2529586|NCT01644565|8754623|P9|Overall Study|Undisclosed Medical History|0
2529587|NCT01644565|8754624|P8|Overall Study|Undisclosed Medical History|0
2529588|NCT01644565|8754625|P7|Overall Study|Undisclosed Medical History|0
2529589|NCT01644565|8754626|P6|Overall Study|Undisclosed Medical History|0
2529590|NCT01644565|8754627|P5|Overall Study|Undisclosed Medical History|0
2529591|NCT01644565|8754628|P4|Overall Study|Undisclosed Medical History|0
2529592|NCT01644565|8754629|P3|Overall Study|Undisclosed Medical History|0
2529593|NCT01644565|8754630|P2|Overall Study|Undisclosed Medical History|0
2529594|NCT01644565|8754631|P1|Overall Study|Undisclosed Medical History|1
2529595|NCT01644500|8754672|P3|Overall Study|Physician Decision|1
2529596|NCT01644500|8754673|P2|Overall Study|Physician Decision|1
2529597|NCT01644500|8754674|P1|Overall Study|Physician Decision|1
2529598|NCT01644500|8754672|P3|Overall Study|Withdrawal by Subject|12
2529599|NCT01644500|8754673|P2|Overall Study|Withdrawal by Subject|12
2529600|NCT01644500|8754674|P1|Overall Study|Withdrawal by Subject|11
2529601|NCT01644500|8754672|P3|Overall Study|Protocol Violation|0
2529602|NCT01644500|8754673|P2|Overall Study|Protocol Violation|1
2529603|NCT01644500|8754674|P1|Overall Study|Protocol Violation|1
2529604|NCT01644500|8754672|P3|Overall Study|Lost to Follow-up|0
2529605|NCT01644500|8754673|P2|Overall Study|Lost to Follow-up|8
2529606|NCT01644500|8754674|P1|Overall Study|Lost to Follow-up|3
2529607|NCT01644500|8754672|P3|Overall Study|Death|0
2529608|NCT01644500|8754673|P2|Overall Study|Death|1
2529609|NCT01644500|8754674|P1|Overall Study|Death|0
2529610|NCT01644500|8754672|P3|Overall Study|Adverse Event|2
2529611|NCT01644500|8754673|P2|Overall Study|Adverse Event|1
2529612|NCT01644500|8754674|P1|Overall Study|Adverse Event|6
2529613|NCT01644474|8754744|P2|Overall Study|Protocol Violation|0
2529614|NCT01644474|8754745|P1|Overall Study|Protocol Violation|1
2529615|NCT01644474|8754744|P2|Overall Study|Site scheduling error|1
2529616|NCT01644474|8754745|P1|Overall Study|Site scheduling error|1
2529617|NCT01644474|8754744|P2|Overall Study|Adverse Event|5
2529618|NCT01644474|8754745|P1|Overall Study|Adverse Event|4
2529619|NCT01644474|8754744|P2|Overall Study|Participant moved|1
2529620|NCT01644474|8754745|P1|Overall Study|Participant moved|0
2529621|NCT01644474|8754744|P2|Overall Study|Consent withdrawn by participant|1
2529622|NCT01644474|8754745|P1|Overall Study|Consent withdrawn by participant|0
2529623|NCT01644474|8754744|P2|Overall Study|Poor compliance to protocol|0
2529624|NCT01644474|8754745|P1|Overall Study|Poor compliance to protocol|1
2529625|NCT01644188|8754929|P2|Overall Study|Other than specified above|7
2529626|NCT01644188|8754930|P1|Overall Study|Other than specified above|6
2529627|NCT01644188|8754929|P2|Overall Study|Site closure|1
2529628|NCT01644188|8754930|P1|Overall Study|Site closure|1
2529629|NCT01644188|8754929|P2|Overall Study|Last visit outside protocol visit window|16
2529630|NCT01644188|8754930|P1|Overall Study|Last visit outside protocol visit window|14
2529631|NCT01644188|8754929|P2|Overall Study|Death|3
2529632|NCT01644188|8754930|P1|Overall Study|Death|4
2529633|NCT01644188|8754929|P2|Overall Study|Lost to Follow-up|0
2529634|NCT01644188|8754930|P1|Overall Study|Lost to Follow-up|1
2529635|NCT01644188|8754929|P2|Overall Study|Selection criteria finally not met|0
2529636|NCT01644188|8754930|P1|Overall Study|Selection criteria finally not met|2
2529637|NCT01644188|8754929|P2|Overall Study|Consent withdrawn by participant|7
2529638|NCT01644188|8754930|P1|Overall Study|Consent withdrawn by participant|14
2529639|NCT01644188|8754929|P2|Overall Study|Related to auto-injector administration|2
2529640|NCT01644188|8754930|P1|Overall Study|Related to auto-injector administration|2
2529641|NCT01644188|8754929|P2|Overall Study|Participant moved|2
2529642|NCT01644188|8754930|P1|Overall Study|Participant moved|7
2529643|NCT01644188|8754929|P2|Overall Study|Physician Decision|3
2529644|NCT01644188|8754930|P1|Overall Study|Physician Decision|1
2529645|NCT01644188|8754929|P2|Overall Study|Poor compliance to protocol|14
2529646|NCT01644188|8754930|P1|Overall Study|Poor compliance to protocol|26
2529647|NCT01644188|8754929|P2|Overall Study|Adverse Event|20
2529648|NCT01644188|8754930|P1|Overall Study|Adverse Event|44
2529649|NCT01644175|8754988|P2|Overall Study|Other than specified above|3
2529650|NCT01644175|8754989|P1|Overall Study|Other than specified above|0
2529651|NCT01644175|8754988|P2|Overall Study|Lost to Follow-up|0
2529652|NCT01644175|8754989|P1|Overall Study|Lost to Follow-up|1
2529653|NCT01644175|8754988|P2|Overall Study|Site closure|2
2529654|NCT01644175|8754989|P1|Overall Study|Site closure|2
2529655|NCT01644175|8754988|P2|Overall Study|Selection criteria finally not met|1
2529656|NCT01644175|8754989|P1|Overall Study|Selection criteria finally not met|0
2529657|NCT01644175|8754988|P2|Overall Study|Last visit outside protocol visit window|11
2529658|NCT01644175|8754989|P1|Overall Study|Last visit outside protocol visit window|4
2529659|NCT01644175|8754988|P2|Overall Study|Related to Autoinjector Administration|1
2529660|NCT01644175|8754989|P1|Overall Study|Related to Autoinjector Administration|2
2529661|NCT01644175|8754988|P2|Overall Study|Consent withdrawn by participant|4
2529662|NCT01644175|8754989|P1|Overall Study|Consent withdrawn by participant|3
2529663|NCT01644175|8754988|P2|Overall Study|Participant Moved|2
2529664|NCT01644175|8754989|P1|Overall Study|Participant Moved|1
2529665|NCT01644175|8754988|P2|Overall Study|Physician Decision|2
2529666|NCT01644175|8754989|P1|Overall Study|Physician Decision|1
2529667|NCT01644175|8754988|P2|Overall Study|Poor compliance to protocol|10
2529668|NCT01644175|8754989|P1|Overall Study|Poor compliance to protocol|9
2529669|NCT01644175|8754988|P2|Overall Study|Death|2
2529670|NCT01644175|8754989|P1|Overall Study|Death|1
2529671|NCT01644175|8754988|P2|Overall Study|Adverse Event|13
2529672|NCT01644175|8754989|P1|Overall Study|Adverse Event|8
2529673|NCT01644175|8754988|P2|Overall Study|Randomized But Not Treated|2
2529674|NCT01644175|8754989|P1|Overall Study|Randomized But Not Treated|0
2529675|NCT01644149|8755041|P2|Overall Study|Lost to Follow-up|1
2529676|NCT01644149|8755042|P1|Overall Study|Lost to Follow-up|3
2529677|NCT01644149|8755041|P2|Overall Study|Withdrawal by Subject|0
2529678|NCT01644149|8755042|P1|Overall Study|Withdrawal by Subject|1
2529679|NCT01643928|8755062|P5|Overall Study|Adverse Event|2
2529680|NCT01643928|8755063|P4|Overall Study|Adverse Event|1
2529681|NCT01643928|8755064|P3|Overall Study|Adverse Event|0
2529682|NCT01643928|8755065|P2|Overall Study|Adverse Event|1
2529683|NCT01643928|8755066|P1|Overall Study|Adverse Event|2
2529684|NCT01643928|8755062|P5|Overall Study|Other|0
2529685|NCT01643928|8755063|P4|Overall Study|Other|0
2529686|NCT01643928|8755064|P3|Overall Study|Other|1
2529687|NCT01643928|8755065|P2|Overall Study|Other|1
2529688|NCT01643928|8755066|P1|Overall Study|Other|5
2529689|NCT01643928|8755062|P5|Overall Study|Pregnancy|0
2529690|NCT01643928|8755063|P4|Overall Study|Pregnancy|1
2529691|NCT01643928|8755064|P3|Overall Study|Pregnancy|0
2529692|NCT01643928|8755065|P2|Overall Study|Pregnancy|0
2529693|NCT01643928|8755066|P1|Overall Study|Pregnancy|0
2529694|NCT01643928|8755062|P5|Overall Study|Withdrawal by Subject|0
2529695|NCT01643928|8755063|P4|Overall Study|Withdrawal by Subject|1
2529696|NCT01643928|8755064|P3|Overall Study|Withdrawal by Subject|0
2529697|NCT01643928|8755065|P2|Overall Study|Withdrawal by Subject|0
2529698|NCT01643928|8755066|P1|Overall Study|Withdrawal by Subject|2
2529699|NCT01643928|8755062|P5|Overall Study|Lost to Follow-up|0
2529700|NCT01643928|8755063|P4|Overall Study|Lost to Follow-up|0
2529701|NCT01643928|8755064|P3|Overall Study|Lost to Follow-up|2
2529702|NCT01643928|8755065|P2|Overall Study|Lost to Follow-up|0
2529703|NCT01643928|8755066|P1|Overall Study|Lost to Follow-up|1
2529704|NCT01643850|8755370|P9|Overall Study|Administrative Problems|0
2529705|NCT01643850|8755371|P8|Overall Study|Administrative Problems|0
2529706|NCT01643850|8755372|P7|Overall Study|Administrative Problems|0
2529707|NCT01643850|8755373|P6|Overall Study|Administrative Problems|0
2529708|NCT01643850|8755374|P5|Overall Study|Administrative Problems|1
2529709|NCT01643850|8755375|P4|Overall Study|Administrative Problems|0
2529710|NCT01643850|8755376|P3|Overall Study|Administrative Problems|1
2529711|NCT01643850|8755377|P2|Overall Study|Administrative Problems|0
2529712|NCT01643850|8755378|P1|Overall Study|Administrative Problems|0
2529713|NCT01643850|8755370|P9|Overall Study|Adverse Event|0
2529714|NCT01643850|8755371|P8|Overall Study|Adverse Event|0
2529715|NCT01643850|8755372|P7|Overall Study|Adverse Event|0
2529716|NCT01643850|8755373|P6|Overall Study|Adverse Event|0
2529717|NCT01643850|8755374|P5|Overall Study|Adverse Event|1
2529718|NCT01643850|8755375|P4|Overall Study|Adverse Event|0
2529719|NCT01643850|8755376|P3|Overall Study|Adverse Event|0
2529720|NCT01643850|8755377|P2|Overall Study|Adverse Event|0
2529721|NCT01643850|8755378|P1|Overall Study|Adverse Event|0
2529722|NCT01643850|8755370|P9|Overall Study|Lost to Follow-up|1
2529723|NCT01643850|8755371|P8|Overall Study|Lost to Follow-up|0
2529724|NCT01643850|8755372|P7|Overall Study|Lost to Follow-up|1
2529725|NCT01643850|8755373|P6|Overall Study|Lost to Follow-up|0
2529726|NCT01643850|8755374|P5|Overall Study|Lost to Follow-up|0
2529727|NCT01643850|8755375|P4|Overall Study|Lost to Follow-up|0
2529728|NCT01643850|8755376|P3|Overall Study|Lost to Follow-up|0
2529729|NCT01643850|8755377|P2|Overall Study|Lost to Follow-up|0
2529730|NCT01643850|8755378|P1|Overall Study|Lost to Follow-up|0
2529731|NCT01643850|8755370|P9|Overall Study|Withdrawal by Subject|0
2529732|NCT01643850|8755371|P8|Overall Study|Withdrawal by Subject|0
2529733|NCT01643850|8755372|P7|Overall Study|Withdrawal by Subject|0
2529734|NCT01643850|8755373|P6|Overall Study|Withdrawal by Subject|0
2529735|NCT01643850|8755374|P5|Overall Study|Withdrawal by Subject|1
2529736|NCT01643850|8755375|P4|Overall Study|Withdrawal by Subject|0
2529737|NCT01643850|8755376|P3|Overall Study|Withdrawal by Subject|0
2529738|NCT01643850|8755377|P2|Overall Study|Withdrawal by Subject|0
2529739|NCT01643850|8755378|P1|Overall Study|Withdrawal by Subject|0
2529740|NCT01643798|8755517|P2|Pretreatment 1 and Stimulation|Withdrawal by Subject|0
2529741|NCT01643798|8755518|P1|Pretreatment 1 and Stimulation|Withdrawal by Subject|1
2529742|NCT01643772|8755533|P4|Overall Study|Adverse Event|1
2529743|NCT01643772|8755534|P3|Overall Study|Adverse Event|0
2529744|NCT01643772|8755535|P2|Overall Study|Adverse Event|0
2529745|NCT01643772|8755536|P1|Overall Study|Adverse Event|0
2529746|NCT01643772|8755533|P4|Overall Study|Protocol Violation|1
2529747|NCT01643772|8755534|P3|Overall Study|Protocol Violation|0
2529748|NCT01643772|8755535|P2|Overall Study|Protocol Violation|0
2529749|NCT01643772|8755536|P1|Overall Study|Protocol Violation|0
2529750|NCT01643668|8755576|P1|Overall Study|Death|1
2529751|NCT01643473|8755607|P2|Overall Study|Lost to Follow-up|0
2529752|NCT01643473|8755608|P1|Overall Study|Lost to Follow-up|1
2529753|NCT01643044|8755631|P2|Overall Study|Delivered outside of hospital|2
2529754|NCT01643044|8755632|P1|Overall Study|Delivered outside of hospital|1
2529755|NCT01643044|8755631|P2|Overall Study|Miscarried baby|2
2529756|NCT01643044|8755632|P1|Overall Study|Miscarried baby|2
2529757|NCT01643044|8755631|P2|Overall Study|Lost to Follow-up|1
2529758|NCT01643044|8755632|P1|Overall Study|Lost to Follow-up|1
2529759|NCT01642914|8755641|P3|Overall Study|Other Reason|0
2529760|NCT01642914|8755642|P2|Overall Study|Other Reason|0
2529761|NCT01642914|8755643|P1|Overall Study|Other Reason|1
2529762|NCT01642914|8755641|P3|Overall Study|Lost to Follow-up|7
2529763|NCT01642914|8755642|P2|Overall Study|Lost to Follow-up|3
2529764|NCT01642914|8755643|P1|Overall Study|Lost to Follow-up|5
2529765|NCT01642914|8755641|P3|Overall Study|Withdrawal by Subject|10
2529766|NCT01642914|8755642|P2|Overall Study|Withdrawal by Subject|5
2529767|NCT01642914|8755643|P1|Overall Study|Withdrawal by Subject|5
2529768|NCT01642914|8755641|P3|Overall Study|Protocol Violation|6
2529769|NCT01642914|8755642|P2|Overall Study|Protocol Violation|13
2529770|NCT01642914|8755643|P1|Overall Study|Protocol Violation|15
2529771|NCT01642914|8755641|P3|Overall Study|Lack of Efficacy|2
2529772|NCT01642914|8755642|P2|Overall Study|Lack of Efficacy|4
2529773|NCT01642914|8755643|P1|Overall Study|Lack of Efficacy|9
2529774|NCT01642914|8755641|P3|Overall Study|Adverse Event|15
2529775|NCT01642914|8755642|P2|Overall Study|Adverse Event|7
2529776|NCT01642914|8755643|P1|Overall Study|Adverse Event|11
2529777|NCT01642732|8755718|P1|Overall Study|Withdrawal by Subject|1
2529778|NCT01642615|8755723|P3|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1
2529779|NCT01642615|8755724|P2|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
2529780|NCT01642615|8755725|P1|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
2529781|NCT01642615|8755723|P3|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
2529782|NCT01642615|8755724|P2|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1
2529783|NCT01642615|8755725|P1|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
2529784|NCT01642615|8755723|P3|Double Blind Maintenance Phase|Voluntary Withdrawal|2
2529785|NCT01642615|8755724|P2|Double Blind Maintenance Phase|Voluntary Withdrawal|5
2529786|NCT01642615|8755725|P1|Double Blind Maintenance Phase|Voluntary Withdrawal|0
2529787|NCT01642615|8755723|P3|Double Blind Maintenance Phase|Lack of Efficacy|3
2529788|NCT01642615|8755724|P2|Double Blind Maintenance Phase|Lack of Efficacy|1
2529789|NCT01642615|8755725|P1|Double Blind Maintenance Phase|Lack of Efficacy|0
2529790|NCT01642615|8755723|P3|Open Label Maintenance Phase|Did not receive treatment|0
2529791|NCT01642615|8755724|P2|Open Label Maintenance Phase|Did not receive treatment|0
2529792|NCT01642615|8755725|P1|Open Label Maintenance Phase|Did not receive treatment|1
2529793|NCT01642615|8755723|P3|Open Label Maintenance Phase|Voluntary Withdrawal|0
2529794|NCT01642615|8755724|P2|Open Label Maintenance Phase|Voluntary Withdrawal|0
2529795|NCT01642615|8755725|P1|Open Label Maintenance Phase|Voluntary Withdrawal|1
2529796|NCT01642615|8755723|P3|Open Label Maintenance Phase|Lost to Follow-up|0
2529797|NCT01642615|8755724|P2|Open Label Maintenance Phase|Lost to Follow-up|0
2529798|NCT01642615|8755725|P1|Open Label Maintenance Phase|Lost to Follow-up|1
2529799|NCT01642615|8755723|P3|Open Label Maintenance Phase|Major Protocol Deviation|0
2529800|NCT01642615|8755724|P2|Open Label Maintenance Phase|Major Protocol Deviation|0
2529801|NCT01642615|8755725|P1|Open Label Maintenance Phase|Major Protocol Deviation|1
2529802|NCT01642615|8755723|P3|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
2529803|NCT01642615|8755724|P2|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
2529804|NCT01642615|8755725|P1|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1
2529805|NCT01642602|8755739|P1|Overall Study|Adverse Event|2
2529806|NCT01642589|8755746|P2|Overall Study|Withdrawal by Subject|1
2529807|NCT01642589|8755747|P1|Overall Study|Withdrawal by Subject|1
2529808|NCT01642407|8755786|P1|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1
2529809|NCT01642407|8755786|P1|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1
2529810|NCT01642407|8755786|P1|Part 1 (Screening Till Week 16)|Insufficient clinical response|3
2529811|NCT01642277|8755833|P2|Overall Study|Withdrawal by Subject|0
2529812|NCT01642277|8755834|P1|Overall Study|Withdrawal by Subject|11
2529813|NCT01642277|8755833|P2|Overall Study|Protocol Violation|0
2529814|NCT01642277|8755834|P1|Overall Study|Protocol Violation|1
2529815|NCT01642277|8755833|P2|Overall Study|Physician Decision|0
2529816|NCT01642277|8755834|P1|Overall Study|Physician Decision|2
2529817|NCT01642277|8755833|P2|Overall Study|Adverse Event|0
2529818|NCT01642277|8755834|P1|Overall Study|Adverse Event|10
2529819|NCT01642251|8755846|P4|Overall Study|Ineligible/never start protocol therapy|8
2529820|NCT01642251|8755847|P3|Overall Study|Ineligible/never start protocol therapy|11
2529821|NCT01642251|8755848|P2|Overall Study|Ineligible/never start protocol therapy|0
2529822|NCT01642251|8755849|P1|Overall Study|Ineligible/never start protocol therapy|0
2529823|NCT01642251|8755846|P4|Overall Study|Other complicating disease|0
2529824|NCT01642251|8755847|P3|Overall Study|Other complicating disease|1
2529825|NCT01642251|8755848|P2|Overall Study|Other complicating disease|0
2529826|NCT01642251|8755849|P1|Overall Study|Other complicating disease|0
2529827|NCT01642251|8755846|P4|Overall Study|Alternative therapy|2
2529828|NCT01642251|8755847|P3|Overall Study|Alternative therapy|0
2529829|NCT01642251|8755848|P2|Overall Study|Alternative therapy|0
2529830|NCT01642251|8755849|P1|Overall Study|Alternative therapy|0
2529831|NCT01642251|8755846|P4|Overall Study|Withdrawal by Subject|3
2529832|NCT01642251|8755847|P3|Overall Study|Withdrawal by Subject|1
2529833|NCT01642251|8755848|P2|Overall Study|Withdrawal by Subject|0
2529834|NCT01642251|8755849|P1|Overall Study|Withdrawal by Subject|0
2529835|NCT01642251|8755846|P4|Overall Study|Death|3
2529836|NCT01642251|8755847|P3|Overall Study|Death|1
2529837|NCT01642251|8755848|P2|Overall Study|Death|0
2529838|NCT01642251|8755849|P1|Overall Study|Death|0
2529839|NCT01642251|8755846|P4|Overall Study|Adverse Event|4
2529840|NCT01642251|8755847|P3|Overall Study|Adverse Event|5
2529841|NCT01642251|8755848|P2|Overall Study|Adverse Event|0
2529842|NCT01642251|8755849|P1|Overall Study|Adverse Event|0
2529843|NCT01642251|8755846|P4|Overall Study|Progressive disease|3
2529844|NCT01642251|8755847|P3|Overall Study|Progressive disease|3
2529845|NCT01642251|8755848|P2|Overall Study|Progressive disease|0
2529846|NCT01642251|8755849|P1|Overall Study|Progressive disease|0
2529847|NCT01642212|8755887|P5|Open-label Extension|Other|1
2529848|NCT01642212|8755888|P4|Open-label Extension|Other|0
2529849|NCT01642212|8755889|P3|Open-label Extension|Other|0
2529850|NCT01642212|8755890|P2|Open-label Extension|Other|0
2529851|NCT01642212|8755891|P1|Open-label Extension|Other|0
2529852|NCT01642212|8755887|P5|Open-label Extension|Lost to Follow-up|1
2529853|NCT01642212|8755888|P4|Open-label Extension|Lost to Follow-up|0
2529854|NCT01642212|8755889|P3|Open-label Extension|Lost to Follow-up|0
2529855|NCT01642212|8755890|P2|Open-label Extension|Lost to Follow-up|0
2529856|NCT01642212|8755891|P1|Open-label Extension|Lost to Follow-up|0
2529857|NCT01642212|8755887|P5|Open-label Extension|Consent Withdrawn|2
2529858|NCT01642212|8755888|P4|Open-label Extension|Consent Withdrawn|0
2529859|NCT01642212|8755889|P3|Open-label Extension|Consent Withdrawn|0
2529860|NCT01642212|8755890|P2|Open-label Extension|Consent Withdrawn|0
2529861|NCT01642212|8755891|P1|Open-label Extension|Consent Withdrawn|0
2529862|NCT01642212|8755887|P5|Open-label Extension|Sponsor Decision|4
2529863|NCT01642212|8755888|P4|Open-label Extension|Sponsor Decision|7
2529864|NCT01642212|8755889|P3|Open-label Extension|Sponsor Decision|0
2529865|NCT01642212|8755890|P2|Open-label Extension|Sponsor Decision|0
2529866|NCT01642212|8755891|P1|Open-label Extension|Sponsor Decision|0
2529867|NCT01642212|8755887|P5|Open-label Extension|Adverse Event|0
2529868|NCT01642212|8755888|P4|Open-label Extension|Adverse Event|3
2529869|NCT01642212|8755889|P3|Open-label Extension|Adverse Event|0
2529870|NCT01642212|8755890|P2|Open-label Extension|Adverse Event|0
2529871|NCT01642212|8755891|P1|Open-label Extension|Adverse Event|0
2529872|NCT01642212|8755887|P5|Double-blind Treatment|Adverse Event|0
2529873|NCT01642212|8755888|P4|Double-blind Treatment|Adverse Event|0
2529874|NCT01642212|8755889|P3|Double-blind Treatment|Adverse Event|1
2529875|NCT01642212|8755890|P2|Double-blind Treatment|Adverse Event|0
2529876|NCT01642212|8755891|P1|Double-blind Treatment|Adverse Event|0
2529877|NCT01642212|8755887|P5|Double-blind Treatment|Non-compliance|0
2529878|NCT01642212|8755888|P4|Double-blind Treatment|Non-compliance|0
2529879|NCT01642212|8755889|P3|Double-blind Treatment|Non-compliance|0
2529880|NCT01642212|8755890|P2|Double-blind Treatment|Non-compliance|1
2529881|NCT01642212|8755891|P1|Double-blind Treatment|Non-compliance|0
2529882|NCT01642212|8755887|P5|Double-blind Treatment|Other|0
2529883|NCT01642212|8755888|P4|Double-blind Treatment|Other|0
2529884|NCT01642212|8755889|P3|Double-blind Treatment|Other|1
2529885|NCT01642212|8755890|P2|Double-blind Treatment|Other|2
2529886|NCT01642212|8755891|P1|Double-blind Treatment|Other|0
2529887|NCT01642212|8755887|P5|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
2529888|NCT01642212|8755888|P4|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
2529889|NCT01642212|8755889|P3|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
2529890|NCT01642212|8755890|P2|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
2529891|NCT01642212|8755891|P1|Single-blind Baseline|Did Not Meet Eligibility Criteria|26
2529892|NCT01642004|8755986|P2|Treatment|Missing from data|1
2529893|NCT01642004|8755987|P1|Treatment|Missing from data|0
2529894|NCT01642004|8755986|P2|Treatment|Other|2
2529895|NCT01642004|8755987|P1|Treatment|Other|1
2529896|NCT01642004|8755986|P2|Treatment|No longer meets study criteria|2
2529897|NCT01642004|8755987|P1|Treatment|No longer meets study criteria|1
2529898|NCT01642004|8755986|P2|Treatment|Poor/non-compliance|0
2529899|NCT01642004|8755987|P1|Treatment|Poor/non-compliance|1
2529900|NCT01642004|8755986|P2|Treatment|Maximum clinical benefit|7
2529901|NCT01642004|8755987|P1|Treatment|Maximum clinical benefit|2
2529902|NCT01642004|8755986|P2|Treatment|Withdrawal by Subject|9
2529903|NCT01642004|8755987|P1|Treatment|Withdrawal by Subject|5
2529904|NCT01642004|8755986|P2|Treatment|Adverse event unrelated to study drug|13
2529905|NCT01642004|8755987|P1|Treatment|Adverse event unrelated to study drug|6
2529906|NCT01642004|8755986|P2|Treatment|Death|0
2529907|NCT01642004|8755987|P1|Treatment|Death|1
2529908|NCT01642004|8755986|P2|Treatment|Study drug toxicity|13
2529909|NCT01642004|8755987|P1|Treatment|Study drug toxicity|5
2529910|NCT01642004|8755986|P2|Treatment|Disease progression|80
2529911|NCT01642004|8755987|P1|Treatment|Disease progression|88
2529912|NCT01642004|8755986|P2|Randomization|No longer meets study criteria|2
2529913|NCT01642004|8755987|P1|Randomization|No longer meets study criteria|2
2529914|NCT01642004|8755986|P2|Randomization|Withdrawal by Subject|6
2529915|NCT01642004|8755987|P1|Randomization|Withdrawal by Subject|1
2529916|NCT01642004|8755986|P2|Randomization|Adverse Event unrelated to study drug|0
2529917|NCT01642004|8755987|P1|Randomization|Adverse Event unrelated to study drug|1
2529918|NCT01641991|8756021|P4|Overall Study|no longer eligible|4
2529919|NCT01641991|8756022|P3|Overall Study|no longer eligible|0
2529920|NCT01641991|8756023|P2|Overall Study|no longer eligible|1
2529921|NCT01641991|8756024|P1|Overall Study|no longer eligible|2
2529922|NCT01641991|8756021|P4|Overall Study|Pregnancy|0
2529923|NCT01641991|8756022|P3|Overall Study|Pregnancy|1
2529924|NCT01641991|8756023|P2|Overall Study|Pregnancy|0
2529925|NCT01641991|8756024|P1|Overall Study|Pregnancy|0
2529926|NCT01641991|8756021|P4|Overall Study|Protocol Violation|0
2529927|NCT01641991|8756022|P3|Overall Study|Protocol Violation|3
2529928|NCT01641991|8756023|P2|Overall Study|Protocol Violation|1
2529929|NCT01641991|8756024|P1|Overall Study|Protocol Violation|1
2529930|NCT01641991|8756021|P4|Overall Study|Lost to Follow-up|1
2529931|NCT01641991|8756022|P3|Overall Study|Lost to Follow-up|3
2529932|NCT01641991|8756023|P2|Overall Study|Lost to Follow-up|2
2529933|NCT01641991|8756024|P1|Overall Study|Lost to Follow-up|0
2529934|NCT01641991|8756021|P4|Overall Study|Adverse Event|1
2529935|NCT01641991|8756022|P3|Overall Study|Adverse Event|2
2529936|NCT01641991|8756023|P2|Overall Study|Adverse Event|1
2529937|NCT01641991|8756024|P1|Overall Study|Adverse Event|2
2529938|NCT01641991|8756021|P4|Overall Study|Withdrawal by Subject|5
2529939|NCT01641991|8756022|P3|Overall Study|Withdrawal by Subject|1
2529940|NCT01641991|8756023|P2|Overall Study|Withdrawal by Subject|2
2529941|NCT01641991|8756024|P1|Overall Study|Withdrawal by Subject|4
2529942|NCT01641991|8756021|P4|Overall Study|Physician Decision|5
2529943|NCT01641991|8756022|P3|Overall Study|Physician Decision|7
2529944|NCT01641991|8756023|P2|Overall Study|Physician Decision|1
2529945|NCT01641991|8756024|P1|Overall Study|Physician Decision|0
2529946|NCT01641952|8756108|P1|Overall Study|Adverse Event|6
2529947|NCT01641952|8756108|P1|Overall Study|Lost to Follow-up|28
2529948|NCT01641939|8756124|P3|Overall Study|Study Terminated by Sponsor|3
2529949|NCT01641939|8756125|P2|Overall Study|Study Terminated by Sponsor|28
2529950|NCT01641939|8756126|P1|Overall Study|Study Terminated by Sponsor|10
2529951|NCT01641939|8756124|P3|Overall Study|Withdrawal by Subject|5
2529952|NCT01641939|8756125|P2|Overall Study|Withdrawal by Subject|11
2529953|NCT01641939|8756126|P1|Overall Study|Withdrawal by Subject|14
2529954|NCT01641939|8756124|P3|Overall Study|Lost to Follow-up|1
2529955|NCT01641939|8756125|P2|Overall Study|Lost to Follow-up|2
2529956|NCT01641939|8756126|P1|Overall Study|Lost to Follow-up|3
2529957|NCT01641939|8756124|P3|Overall Study|Death|61
2529958|NCT01641939|8756125|P2|Overall Study|Death|187
2529959|NCT01641939|8756126|P1|Overall Study|Death|90
2529960|NCT01641926|8756169|P4|Overall Study|Not Treated|0
2529961|NCT01641926|8756170|P3|Overall Study|Not Treated|1
2529962|NCT01641926|8756171|P2|Overall Study|Not Treated|1
2529963|NCT01641926|8756172|P1|Overall Study|Not Treated|1
2529964|NCT01641926|8756169|P4|Overall Study|Withdrawal by Subject|1
2529965|NCT01641926|8756170|P3|Overall Study|Withdrawal by Subject|6
2529966|NCT01641926|8756171|P2|Overall Study|Withdrawal by Subject|5
2529967|NCT01641926|8756172|P1|Overall Study|Withdrawal by Subject|13
2529968|NCT01641926|8756169|P4|Overall Study|Protocol Violation|1
2529969|NCT01641926|8756170|P3|Overall Study|Protocol Violation|0
2529970|NCT01641926|8756171|P2|Overall Study|Protocol Violation|0
2529971|NCT01641926|8756172|P1|Overall Study|Protocol Violation|1
2529972|NCT01641926|8756169|P4|Overall Study|Physician Decision|1
2529973|NCT01641926|8756170|P3|Overall Study|Physician Decision|0
2529974|NCT01641926|8756171|P2|Overall Study|Physician Decision|5
2529975|NCT01641926|8756172|P1|Overall Study|Physician Decision|6
2529976|NCT01641926|8756169|P4|Overall Study|Lost to Follow-up|0
2529977|NCT01641926|8756170|P3|Overall Study|Lost to Follow-up|1
2529978|NCT01641926|8756171|P2|Overall Study|Lost to Follow-up|2
2529979|NCT01641926|8756172|P1|Overall Study|Lost to Follow-up|2
2529980|NCT01641926|8756169|P4|Overall Study|Adverse Event|1
2529981|NCT01641926|8756170|P3|Overall Study|Adverse Event|3
2529982|NCT01641926|8756171|P2|Overall Study|Adverse Event|2
2529983|NCT01641926|8756172|P1|Overall Study|Adverse Event|5
2529984|NCT01641900|8756200|P2|Overall Study|Withdrawal by Subject|2
2529985|NCT01641900|8756201|P1|Overall Study|Withdrawal by Subject|2
2529986|NCT01641861|8756213|P2|Overall Study|Died due to drowning|1
2529987|NCT01641861|8756214|P1|Overall Study|Died due to drowning|0
2529988|NCT01641861|8756213|P2|Overall Study|Lost the tooth due to normal exfoliation|8
2529989|NCT01641861|8756214|P1|Overall Study|Lost the tooth due to normal exfoliation|14
2529990|NCT01641861|8756213|P2|Overall Study|Lost to Follow-up|16
2529991|NCT01641861|8756214|P1|Overall Study|Lost to Follow-up|21
2529992|NCT01641822|8756235|P3|Comparative Phase|Protocol-specified criteria for withdraw|1
2529993|NCT01641822|8756236|P2|Comparative Phase|Protocol-specified criteria for withdraw|1
2529994|NCT01641822|8756237|P1|Comparative Phase|Protocol-specified criteria for withdraw|0
2529995|NCT01641822|8756235|P3|Comparative Phase|Withdrew consent|7
2529996|NCT01641822|8756236|P2|Comparative Phase|Withdrew consent|3
2529997|NCT01641822|8756237|P1|Comparative Phase|Withdrew consent|0
2529998|NCT01641822|8756235|P3|Comparative Phase|Adverse event, serious fatal|0
2529999|NCT01641822|8756236|P2|Comparative Phase|Adverse event, serious fatal|1
2530000|NCT01641822|8756237|P1|Comparative Phase|Adverse event, serious fatal|0
2530001|NCT01641822|8756235|P3|Comparative Phase|Pregnancy|1
2530002|NCT01641822|8756236|P2|Comparative Phase|Pregnancy|0
2530003|NCT01641822|8756237|P1|Comparative Phase|Pregnancy|0
2530004|NCT01641822|8756235|P3|Comparative Phase|Investigator's discretion|1
2530005|NCT01641822|8756236|P2|Comparative Phase|Investigator's discretion|0
2530006|NCT01641822|8756237|P1|Comparative Phase|Investigator's discretion|0
2530007|NCT01641822|8756235|P3|Comparative Phase|Noncompliance with study drug|0
2530008|NCT01641822|8756236|P2|Comparative Phase|Noncompliance with study drug|1
2530009|NCT01641822|8756237|P1|Comparative Phase|Noncompliance with study drug|0
2530010|NCT01641822|8756235|P3|Run-in Phase|Protocol-specified criteria for withdraw|0
2530011|NCT01641822|8756236|P2|Run-in Phase|Protocol-specified criteria for withdraw|0
2530012|NCT01641822|8756237|P1|Run-in Phase|Protocol-specified criteria for withdraw|9
2530013|NCT01641822|8756235|P3|Run-in Phase|Withdrew consent|0
2530014|NCT01641822|8756236|P2|Run-in Phase|Withdrew consent|0
2530015|NCT01641822|8756237|P1|Run-in Phase|Withdrew consent|1
2530016|NCT01641822|8756235|P3|Run-in Phase|Adverse Event|0
2530017|NCT01641822|8756236|P2|Run-in Phase|Adverse Event|0
2530018|NCT01641822|8756237|P1|Run-in Phase|Adverse Event|3
2530019|NCT01641822|8756235|P3|Run-in Phase|Noncompliance with study drug|0
2530020|NCT01641822|8756236|P2|Run-in Phase|Noncompliance with study drug|0
2530021|NCT01641822|8756237|P1|Run-in Phase|Noncompliance with study drug|1
2530022|NCT01641809|8756258|P4|Open-label (Week 96 to Week 324)|Adverse Event|0
2530023|NCT01641809|8756259|P3|Open-label (Week 96 to Week 324)|Adverse Event|1
2530024|NCT01641809|8756260|P2|Open-label (Week 96 to Week 324)|Adverse Event|2
2530025|NCT01641809|8756261|P1|Open-label (Week 96 to Week 324)|Adverse Event|3
2530026|NCT01641809|8756258|P4|Open-label (Week 96 to Week 324)|Lack of Efficacy|0
2530027|NCT01641809|8756259|P3|Open-label (Week 96 to Week 324)|Lack of Efficacy|0
2530028|NCT01641809|8756260|P2|Open-label (Week 96 to Week 324)|Lack of Efficacy|1
2530029|NCT01641809|8756261|P1|Open-label (Week 96 to Week 324)|Lack of Efficacy|4
2530030|NCT01641809|8756258|P4|Open-label (Week 96 to Week 324)|Protocol Violation|0
2530031|NCT01641809|8756259|P3|Open-label (Week 96 to Week 324)|Protocol Violation|0
2530032|NCT01641809|8756260|P2|Open-label (Week 96 to Week 324)|Protocol Violation|1
2530033|NCT01641809|8756261|P1|Open-label (Week 96 to Week 324)|Protocol Violation|1
2530034|NCT01641809|8756258|P4|Open-label (Week 96 to Week 324)|Site closed|0
2530035|NCT01641809|8756259|P3|Open-label (Week 96 to Week 324)|Site closed|0
2530036|NCT01641809|8756260|P2|Open-label (Week 96 to Week 324)|Site closed|0
2530037|NCT01641809|8756261|P1|Open-label (Week 96 to Week 324)|Site closed|1
2530038|NCT01641809|8756258|P4|Open-label (Week 96 to Week 324)|Lost to Follow-up|0
2530039|NCT01641809|8756259|P3|Open-label (Week 96 to Week 324)|Lost to Follow-up|5
2530040|NCT01641809|8756260|P2|Open-label (Week 96 to Week 324)|Lost to Follow-up|4
2530041|NCT01641809|8756261|P1|Open-label (Week 96 to Week 324)|Lost to Follow-up|5
2530042|NCT01641809|8756258|P4|Open-label (Week 96 to Week 324)|Physician Decision|0
2530043|NCT01641809|8756259|P3|Open-label (Week 96 to Week 324)|Physician Decision|1
2530044|NCT01641809|8756260|P2|Open-label (Week 96 to Week 324)|Physician Decision|1
2530045|NCT01641809|8756261|P1|Open-label (Week 96 to Week 324)|Physician Decision|0
2530046|NCT01641809|8756258|P4|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0
2530047|NCT01641809|8756259|P3|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1
2530048|NCT01641809|8756260|P2|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3
2530049|NCT01641809|8756261|P1|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2
2530050|NCT01641809|8756258|P4|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2
2530051|NCT01641809|8756259|P3|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1
2530052|NCT01641809|8756260|P2|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0
2530053|NCT01641809|8756261|P1|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1
2530054|NCT01641809|8756258|P4|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2
2530055|NCT01641809|8756259|P3|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0
2530056|NCT01641809|8756260|P2|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1
2530057|NCT01641809|8756261|P1|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1
2530058|NCT01641809|8756258|P4|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2
2530059|NCT01641809|8756259|P3|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1
2530060|NCT01641809|8756260|P2|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0
2530061|NCT01641809|8756261|P1|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2
2530062|NCT01641809|8756258|P4|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
2530063|NCT01641809|8756259|P3|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
2530064|NCT01641809|8756260|P2|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1
2530065|NCT01641809|8756261|P1|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
2530066|NCT01641809|8756258|P4|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0
2530067|NCT01641809|8756259|P3|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1
2530068|NCT01641809|8756260|P2|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3
2530069|NCT01641809|8756261|P1|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2
2530070|NCT01641809|8756258|P4|Induction Phase (Day 1 to Week 24)|Adverse Event|7
2530071|NCT01641809|8756259|P3|Induction Phase (Day 1 to Week 24)|Adverse Event|3
2530072|NCT01641809|8756260|P2|Induction Phase (Day 1 to Week 24)|Adverse Event|1
2530073|NCT01641809|8756261|P1|Induction Phase (Day 1 to Week 24)|Adverse Event|0
2530074|NCT01641809|8756258|P4|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3
2530075|NCT01641809|8756259|P3|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2
2530076|NCT01641809|8756260|P2|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1
2530077|NCT01641809|8756261|P1|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4
2530078|NCT01641809|8756258|P4|Induction Phase (Day 1 to Week 24)|Protocol Violation|0
2530079|NCT01641809|8756259|P3|Induction Phase (Day 1 to Week 24)|Protocol Violation|1
2530080|NCT01641809|8756260|P2|Induction Phase (Day 1 to Week 24)|Protocol Violation|1
2530081|NCT01641809|8756261|P1|Induction Phase (Day 1 to Week 24)|Protocol Violation|2
2530082|NCT01641809|8756258|P4|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3
2530083|NCT01641809|8756259|P3|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0
2530084|NCT01641809|8756260|P2|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2
2530085|NCT01641809|8756261|P1|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1
2530086|NCT01641809|8756258|P4|Induction Phase (Day 1 to Week 24)|Physician Decision|1
2530087|NCT01641809|8756259|P3|Induction Phase (Day 1 to Week 24)|Physician Decision|0
2530088|NCT01641809|8756260|P2|Induction Phase (Day 1 to Week 24)|Physician Decision|1
2530089|NCT01641809|8756261|P1|Induction Phase (Day 1 to Week 24)|Physician Decision|0
2530090|NCT01641809|8756258|P4|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
2530091|NCT01641809|8756259|P3|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0
2530092|NCT01641809|8756260|P2|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
2530093|NCT01641809|8756261|P1|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
2530094|NCT01641692|8756445|P8|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
2530095|NCT01641692|8756446|P7|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
2530096|NCT01641692|8756447|P6|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
2530097|NCT01641692|8756448|P5|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
2530098|NCT01641692|8756449|P4|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
2530099|NCT01641692|8756450|P3|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
2530100|NCT01641692|8756451|P2|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
2530101|NCT01641692|8756452|P1|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
2530102|NCT01641692|8756445|P8|Washout Period 3 or Follow-up|Protocol Violation|0
2530103|NCT01641692|8756446|P7|Washout Period 3 or Follow-up|Protocol Violation|0
2530104|NCT01641692|8756447|P6|Washout Period 3 or Follow-up|Protocol Violation|1
2530105|NCT01641692|8756448|P5|Washout Period 3 or Follow-up|Protocol Violation|0
2530106|NCT01641692|8756449|P4|Washout Period 3 or Follow-up|Protocol Violation|0
2530107|NCT01641692|8756450|P3|Washout Period 3 or Follow-up|Protocol Violation|0
2530108|NCT01641692|8756451|P2|Washout Period 3 or Follow-up|Protocol Violation|0
2530109|NCT01641692|8756452|P1|Washout Period 3 or Follow-up|Protocol Violation|0
2530110|NCT01641692|8756445|P8|Treatment Period 3|Lost to Follow-up|0
2530111|NCT01641692|8756446|P7|Treatment Period 3|Lost to Follow-up|0
2530112|NCT01641692|8756447|P6|Treatment Period 3|Lost to Follow-up|0
2530113|NCT01641692|8756448|P5|Treatment Period 3|Lost to Follow-up|0
2530114|NCT01641692|8756449|P4|Treatment Period 3|Lost to Follow-up|0
2530115|NCT01641692|8756450|P3|Treatment Period 3|Lost to Follow-up|0
2530116|NCT01641692|8756451|P2|Treatment Period 3|Lost to Follow-up|1
2530117|NCT01641692|8756452|P1|Treatment Period 3|Lost to Follow-up|0
2530118|NCT01641692|8756445|P8|Treatment Period 3|Protocol-defined Stopping Criteria|0
2530119|NCT01641692|8756446|P7|Treatment Period 3|Protocol-defined Stopping Criteria|1
2530120|NCT01641692|8756447|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
2530121|NCT01641692|8756448|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
2530122|NCT01641692|8756449|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
2530123|NCT01641692|8756450|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
2530124|NCT01641692|8756451|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
2530125|NCT01641692|8756452|P1|Treatment Period 3|Protocol-defined Stopping Criteria|0
2530126|NCT01641692|8756445|P8|Treatment Period 3|Protocol Violation|0
2530127|NCT01641692|8756446|P7|Treatment Period 3|Protocol Violation|0
2530128|NCT01641692|8756447|P6|Treatment Period 3|Protocol Violation|0
2530129|NCT01641692|8756448|P5|Treatment Period 3|Protocol Violation|0
2530130|NCT01641692|8756449|P4|Treatment Period 3|Protocol Violation|0
2530131|NCT01641692|8756450|P3|Treatment Period 3|Protocol Violation|1
2530132|NCT01641692|8756451|P2|Treatment Period 3|Protocol Violation|0
2530133|NCT01641692|8756452|P1|Treatment Period 3|Protocol Violation|0
2530134|NCT01641692|8756445|P8|Treatment Period 3|Adverse Event|0
2530135|NCT01641692|8756446|P7|Treatment Period 3|Adverse Event|1
2530136|NCT01641692|8756447|P6|Treatment Period 3|Adverse Event|0
2530137|NCT01641692|8756448|P5|Treatment Period 3|Adverse Event|0
2530138|NCT01641692|8756449|P4|Treatment Period 3|Adverse Event|0
2530139|NCT01641692|8756450|P3|Treatment Period 3|Adverse Event|0
2530140|NCT01641692|8756451|P2|Treatment Period 3|Adverse Event|0
2530141|NCT01641692|8756452|P1|Treatment Period 3|Adverse Event|0
2530142|NCT01641692|8756445|P8|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
2530143|NCT01641692|8756446|P7|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
2530144|NCT01641692|8756447|P6|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
2530145|NCT01641692|8756448|P5|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
2530146|NCT01641692|8756449|P4|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
2530147|NCT01641692|8756450|P3|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
2530148|NCT01641692|8756451|P2|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
2530149|NCT01641692|8756452|P1|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
2530150|NCT01641692|8756445|P8|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
2530151|NCT01641692|8756446|P7|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1
2530152|NCT01641692|8756447|P6|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
2530153|NCT01641692|8756448|P5|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3
2530154|NCT01641692|8756449|P4|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
2530155|NCT01641692|8756450|P3|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
2530156|NCT01641692|8756451|P2|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
2530157|NCT01641692|8756452|P1|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
2530158|NCT01641692|8756445|P8|Treatment Period 2|Withdrawal by Subject|1
2530159|NCT01641692|8756446|P7|Treatment Period 2|Withdrawal by Subject|0
2530160|NCT01641692|8756447|P6|Treatment Period 2|Withdrawal by Subject|1
2530161|NCT01641692|8756448|P5|Treatment Period 2|Withdrawal by Subject|0
2530162|NCT01641692|8756449|P4|Treatment Period 2|Withdrawal by Subject|0
2530163|NCT01641692|8756450|P3|Treatment Period 2|Withdrawal by Subject|0
2530164|NCT01641692|8756451|P2|Treatment Period 2|Withdrawal by Subject|0
2530165|NCT01641692|8756452|P1|Treatment Period 2|Withdrawal by Subject|1
2530166|NCT01641692|8756445|P8|Treatment Period 2|Lost to Follow-up|0
2530167|NCT01641692|8756446|P7|Treatment Period 2|Lost to Follow-up|0
2530168|NCT01641692|8756447|P6|Treatment Period 2|Lost to Follow-up|1
2530169|NCT01641692|8756448|P5|Treatment Period 2|Lost to Follow-up|0
2530170|NCT01641692|8756449|P4|Treatment Period 2|Lost to Follow-up|0
2530171|NCT01641692|8756450|P3|Treatment Period 2|Lost to Follow-up|0
2530172|NCT01641692|8756451|P2|Treatment Period 2|Lost to Follow-up|0
2530173|NCT01641692|8756452|P1|Treatment Period 2|Lost to Follow-up|0
2530174|NCT01641692|8756445|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
2530175|NCT01641692|8756446|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
2530176|NCT01641692|8756447|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
2530177|NCT01641692|8756448|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
2530178|NCT01641692|8756449|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
2530179|NCT01641692|8756450|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
2530180|NCT01641692|8756451|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
2530181|NCT01641692|8756452|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
2530182|NCT01641692|8756445|P8|Treatment Period 2|Lack of Efficacy|0
2530183|NCT01641692|8756446|P7|Treatment Period 2|Lack of Efficacy|0
2530184|NCT01641692|8756447|P6|Treatment Period 2|Lack of Efficacy|0
2530185|NCT01641692|8756448|P5|Treatment Period 2|Lack of Efficacy|0
2530186|NCT01641692|8756449|P4|Treatment Period 2|Lack of Efficacy|0
2530187|NCT01641692|8756450|P3|Treatment Period 2|Lack of Efficacy|0
2530188|NCT01641692|8756451|P2|Treatment Period 2|Lack of Efficacy|0
2530189|NCT01641692|8756452|P1|Treatment Period 2|Lack of Efficacy|1
2530190|NCT01641692|8756445|P8|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
2530191|NCT01641692|8756446|P7|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
2530192|NCT01641692|8756447|P6|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
2530193|NCT01641692|8756448|P5|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
2530194|NCT01641692|8756449|P4|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
2530195|NCT01641692|8756450|P3|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
2530196|NCT01641692|8756451|P2|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
2530197|NCT01641692|8756452|P1|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
2530198|NCT01641692|8756445|P8|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
2530199|NCT01641692|8756446|P7|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
2530200|NCT01641692|8756447|P6|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
2530201|NCT01641692|8756448|P5|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
2530202|NCT01641692|8756449|P4|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
2530203|NCT01641692|8756450|P3|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
2530204|NCT01641692|8756451|P2|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
2530205|NCT01641692|8756452|P1|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
2530206|NCT01641692|8756445|P8|Washout Period 1 (12-14 Days)|Protocol Violation|0
2530207|NCT01641692|8756446|P7|Washout Period 1 (12-14 Days)|Protocol Violation|1
2530208|NCT01641692|8756447|P6|Washout Period 1 (12-14 Days)|Protocol Violation|0
2530209|NCT01641692|8756448|P5|Washout Period 1 (12-14 Days)|Protocol Violation|0
2530210|NCT01641692|8756449|P4|Washout Period 1 (12-14 Days)|Protocol Violation|0
2530211|NCT01641692|8756450|P3|Washout Period 1 (12-14 Days)|Protocol Violation|0
2530212|NCT01641692|8756451|P2|Washout Period 1 (12-14 Days)|Protocol Violation|0
2530213|NCT01641692|8756452|P1|Washout Period 1 (12-14 Days)|Protocol Violation|0
2530214|NCT01641692|8756445|P8|Washout Period 1 (12-14 Days)|Adverse Event|0
2530215|NCT01641692|8756446|P7|Washout Period 1 (12-14 Days)|Adverse Event|0
2530216|NCT01641692|8756447|P6|Washout Period 1 (12-14 Days)|Adverse Event|0
2530217|NCT01641692|8756448|P5|Washout Period 1 (12-14 Days)|Adverse Event|0
2530218|NCT01641692|8756449|P4|Washout Period 1 (12-14 Days)|Adverse Event|0
2530219|NCT01641692|8756450|P3|Washout Period 1 (12-14 Days)|Adverse Event|0
2530220|NCT01641692|8756451|P2|Washout Period 1 (12-14 Days)|Adverse Event|0
2530221|NCT01641692|8756452|P1|Washout Period 1 (12-14 Days)|Adverse Event|2
2530222|NCT01641692|8756445|P8|Treatment Period 1|Withdrawal by Subject|1
2530223|NCT01641692|8756446|P7|Treatment Period 1|Withdrawal by Subject|0
2530224|NCT01641692|8756447|P6|Treatment Period 1|Withdrawal by Subject|2
2530225|NCT01641692|8756448|P5|Treatment Period 1|Withdrawal by Subject|0
2530226|NCT01641692|8756449|P4|Treatment Period 1|Withdrawal by Subject|0
2530227|NCT01641692|8756450|P3|Treatment Period 1|Withdrawal by Subject|0
2530228|NCT01641692|8756451|P2|Treatment Period 1|Withdrawal by Subject|0
2530229|NCT01641692|8756452|P1|Treatment Period 1|Withdrawal by Subject|0
2530230|NCT01641692|8756445|P8|Treatment Period 1|Physician Decision|0
2530231|NCT01641692|8756446|P7|Treatment Period 1|Physician Decision|0
2530232|NCT01641692|8756447|P6|Treatment Period 1|Physician Decision|0
2530233|NCT01641692|8756448|P5|Treatment Period 1|Physician Decision|1
2530234|NCT01641692|8756449|P4|Treatment Period 1|Physician Decision|0
2530235|NCT01641692|8756450|P3|Treatment Period 1|Physician Decision|0
2530236|NCT01641692|8756451|P2|Treatment Period 1|Physician Decision|0
2530237|NCT01641692|8756452|P1|Treatment Period 1|Physician Decision|0
2530238|NCT01641692|8756445|P8|Treatment Period 1|Lost to Follow-up|0
2530239|NCT01641692|8756446|P7|Treatment Period 1|Lost to Follow-up|0
2530240|NCT01641692|8756447|P6|Treatment Period 1|Lost to Follow-up|0
2530241|NCT01641692|8756448|P5|Treatment Period 1|Lost to Follow-up|0
2530242|NCT01641692|8756449|P4|Treatment Period 1|Lost to Follow-up|0
2530243|NCT01641692|8756450|P3|Treatment Period 1|Lost to Follow-up|1
2530244|NCT01641692|8756451|P2|Treatment Period 1|Lost to Follow-up|0
2530245|NCT01641692|8756452|P1|Treatment Period 1|Lost to Follow-up|0
2530246|NCT01641692|8756445|P8|Treatment Period 1|Protocol-defined Stopping Criteria|1
2530247|NCT01641692|8756446|P7|Treatment Period 1|Protocol-defined Stopping Criteria|0
2530248|NCT01641692|8756447|P6|Treatment Period 1|Protocol-defined Stopping Criteria|0
2530249|NCT01641692|8756448|P5|Treatment Period 1|Protocol-defined Stopping Criteria|1
2530250|NCT01641692|8756449|P4|Treatment Period 1|Protocol-defined Stopping Criteria|0
2530251|NCT01641692|8756450|P3|Treatment Period 1|Protocol-defined Stopping Criteria|0
2530252|NCT01641692|8756451|P2|Treatment Period 1|Protocol-defined Stopping Criteria|0
2530253|NCT01641692|8756452|P1|Treatment Period 1|Protocol-defined Stopping Criteria|0
2530254|NCT01641692|8756445|P8|Treatment Period 1|Protocol Violation|0
2530255|NCT01641692|8756446|P7|Treatment Period 1|Protocol Violation|0
2530256|NCT01641692|8756447|P6|Treatment Period 1|Protocol Violation|0
2530257|NCT01641692|8756448|P5|Treatment Period 1|Protocol Violation|2
2530258|NCT01641692|8756449|P4|Treatment Period 1|Protocol Violation|0
2530259|NCT01641692|8756450|P3|Treatment Period 1|Protocol Violation|0
2530260|NCT01641692|8756451|P2|Treatment Period 1|Protocol Violation|0
2530261|NCT01641692|8756452|P1|Treatment Period 1|Protocol Violation|1
2530262|NCT01641692|8756445|P8|Treatment Period 1|Lack of Efficacy|1
2530263|NCT01641692|8756446|P7|Treatment Period 1|Lack of Efficacy|0
2530264|NCT01641692|8756447|P6|Treatment Period 1|Lack of Efficacy|0
2530265|NCT01641692|8756448|P5|Treatment Period 1|Lack of Efficacy|0
2530266|NCT01641692|8756449|P4|Treatment Period 1|Lack of Efficacy|0
2530267|NCT01641692|8756450|P3|Treatment Period 1|Lack of Efficacy|0
2530268|NCT01641692|8756451|P2|Treatment Period 1|Lack of Efficacy|0
2530269|NCT01641692|8756452|P1|Treatment Period 1|Lack of Efficacy|0
2530270|NCT01641692|8756445|P8|Treatment Period 1|Adverse Event|0
2530271|NCT01641692|8756446|P7|Treatment Period 1|Adverse Event|0
2530272|NCT01641692|8756447|P6|Treatment Period 1|Adverse Event|0
2530273|NCT01641692|8756448|P5|Treatment Period 1|Adverse Event|0
2530274|NCT01641692|8756449|P4|Treatment Period 1|Adverse Event|0
2530275|NCT01641692|8756450|P3|Treatment Period 1|Adverse Event|0
2530276|NCT01641692|8756451|P2|Treatment Period 1|Adverse Event|0
2530277|NCT01641692|8756452|P1|Treatment Period 1|Adverse Event|1
2530278|NCT01641640|8756652|P1|Overall Study|Adverse Event|1
2530279|NCT01641640|8756652|P1|Overall Study|Withdrawal by Subject|2
2530280|NCT01641640|8756652|P1|Overall Study|Lost to Follow-up|3
2530281|NCT01641640|8756652|P1|Overall Study|Efficacy failure|29
2530282|NCT01641640|8756652|P1|Overall Study|Enrolled but not treated|1
2530283|NCT01641471|8756663|P2|Overall Study|Protocol Violation|4
2530284|NCT01641471|8756664|P1|Overall Study|Protocol Violation|2
2530285|NCT01641471|8756663|P2|Overall Study|Lost to Follow-up|4
2530286|NCT01641471|8756664|P1|Overall Study|Lost to Follow-up|2
2530287|NCT01641471|8756663|P2|Overall Study|Withdrawal by Subject|19
2530288|NCT01641471|8756664|P1|Overall Study|Withdrawal by Subject|19
2530289|NCT01641367|8756696|P8|Randomized Adherence Intervention|Lost to Follow-up|12
2530290|NCT01641367|8756697|P7|Randomized Adherence Intervention|Lost to Follow-up|8
2530291|NCT01641367|8756698|P6|Randomized Adherence Intervention|Lost to Follow-up|0
2530292|NCT01641367|8756699|P5|Randomized Adherence Intervention|Lost to Follow-up|0
2530293|NCT01641367|8756700|P4|Randomized Adherence Intervention|Lost to Follow-up|0
2530294|NCT01641367|8756701|P3|Randomized Adherence Intervention|Lost to Follow-up|0
2530295|NCT01641367|8756702|P2|Randomized Adherence Intervention|Lost to Follow-up|0
2530296|NCT01641367|8756703|P1|Randomized Adherence Intervention|Lost to Follow-up|0
2530297|NCT01641367|8756696|P8|Randomized Adherence Intervention|Death|12
2530298|NCT01641367|8756697|P7|Randomized Adherence Intervention|Death|11
2530299|NCT01641367|8756698|P6|Randomized Adherence Intervention|Death|0
2530300|NCT01641367|8756699|P5|Randomized Adherence Intervention|Death|0
2530301|NCT01641367|8756700|P4|Randomized Adherence Intervention|Death|0
2530302|NCT01641367|8756701|P3|Randomized Adherence Intervention|Death|0
2530303|NCT01641367|8756702|P2|Randomized Adherence Intervention|Death|0
2530304|NCT01641367|8756703|P1|Randomized Adherence Intervention|Death|0
2530305|NCT01641367|8756696|P8|Cohorts|Lost to Follow-up|0
2530306|NCT01641367|8756697|P7|Cohorts|Lost to Follow-up|0
2530307|NCT01641367|8756698|P6|Cohorts|Lost to Follow-up|0
2530308|NCT01641367|8756699|P5|Cohorts|Lost to Follow-up|2
2530309|NCT01641367|8756700|P4|Cohorts|Lost to Follow-up|0
2530310|NCT01641367|8756701|P3|Cohorts|Lost to Follow-up|2
2530311|NCT01641367|8756702|P2|Cohorts|Lost to Follow-up|0
2530312|NCT01641367|8756703|P1|Cohorts|Lost to Follow-up|16
2530313|NCT01641367|8756696|P8|Cohorts|Death|0
2530314|NCT01641367|8756697|P7|Cohorts|Death|0
2530315|NCT01641367|8756698|P6|Cohorts|Death|1
2530316|NCT01641367|8756699|P5|Cohorts|Death|1
2530317|NCT01641367|8756700|P4|Cohorts|Death|0
2530318|NCT01641367|8756701|P3|Cohorts|Death|2
2530319|NCT01641367|8756702|P2|Cohorts|Death|1
2530320|NCT01641367|8756703|P1|Cohorts|Death|18
2530321|NCT01641237|8756954|P4|Period III|Lost to Follow-up|0
2530322|NCT01641237|8756955|P3|Period III|Lost to Follow-up|0
2530323|NCT01641237|8756956|P2|Period III|Lost to Follow-up|0
2530324|NCT01641237|8756957|P1|Period III|Lost to Follow-up|1
2530325|NCT01641237|8756954|P4|Period II|Withdrawal by Subject|0
2530326|NCT01641237|8756955|P3|Period II|Withdrawal by Subject|0
2530327|NCT01641237|8756956|P2|Period II|Withdrawal by Subject|0
2530328|NCT01641237|8756957|P1|Period II|Withdrawal by Subject|1
2530329|NCT01641198|8756982|P3|At 15-20 Years of Function|Death|1
2530330|NCT01641198|8756983|P2|At 15-20 Years of Function|Death|0
2530331|NCT01641198|8756984|P1|At 15-20 Years of Function|Death|1
2530332|NCT01641198|8756982|P3|At 15-20 Years of Function|Lost to Follow-up|1
2530333|NCT01641198|8756983|P2|At 15-20 Years of Function|Lost to Follow-up|1
2530334|NCT01641198|8756984|P1|At 15-20 Years of Function|Lost to Follow-up|5
2530335|NCT01641198|8756982|P3|After 24 Months of Function|Lost to Follow-up|6
2530336|NCT01641198|8756983|P2|After 24 Months of Function|Lost to Follow-up|9
2530337|NCT01641198|8756984|P1|After 24 Months of Function|Lost to Follow-up|4
2530338|NCT01641198|8756982|P3|After 12 Months of Function|Adverse Event|0
2530339|NCT01641198|8756983|P2|After 12 Months of Function|Adverse Event|1
2530340|NCT01641198|8756984|P1|After 12 Months of Function|Adverse Event|0
2530341|NCT01641198|8756982|P3|After 12 Months of Function|Protocol Violation|0
2530342|NCT01641198|8756983|P2|After 12 Months of Function|Protocol Violation|0
2530343|NCT01641198|8756984|P1|After 12 Months of Function|Protocol Violation|1
2530344|NCT01641198|8756982|P3|After 12 Months of Function|Lost to Follow-up|2
2530345|NCT01641198|8756983|P2|After 12 Months of Function|Lost to Follow-up|2
2530346|NCT01641198|8756984|P1|After 12 Months of Function|Lost to Follow-up|3
2530347|NCT01641159|8757000|P2|Overall Study|Withdrawal by Subject|1
2530348|NCT01641159|8757001|P1|Overall Study|Withdrawal by Subject|0
2530349|NCT01641159|8757000|P2|Overall Study|Lost to Follow-up|1
2530350|NCT01641159|8757001|P1|Overall Study|Lost to Follow-up|2
2530351|NCT01641133|8757012|P3|Overall Study|Lost to Follow-up|2
2530352|NCT01641133|8757013|P2|Overall Study|Lost to Follow-up|2
2530353|NCT01641133|8757014|P1|Overall Study|Lost to Follow-up|0
2530354|NCT01641133|8757012|P3|Overall Study|Withdrawal by Subject|3
2530355|NCT01641133|8757013|P2|Overall Study|Withdrawal by Subject|3
2530356|NCT01641133|8757014|P1|Overall Study|Withdrawal by Subject|5
2530357|NCT01641133|8757012|P3|Overall Study|Adverse Event|1
2530358|NCT01641133|8757013|P2|Overall Study|Adverse Event|0
2530359|NCT01641133|8757014|P1|Overall Study|Adverse Event|0
2530360|NCT01641133|8757012|P3|Overall Study|Migrated/moved from study area|1
2530361|NCT01641133|8757013|P2|Overall Study|Migrated/moved from study area|3
2530362|NCT01641133|8757014|P1|Overall Study|Migrated/moved from study area|5
2530363|NCT01641133|8757012|P3|Overall Study|Protocol Violation|1
2530364|NCT01641133|8757013|P2|Overall Study|Protocol Violation|1
2530365|NCT01641133|8757014|P1|Overall Study|Protocol Violation|0
2530366|NCT01641081|8757067|P10|Period 5|Adverse Event|0
2530367|NCT01641081|8757068|P9|Period 5|Adverse Event|0
2530368|NCT01641081|8757069|P8|Period 5|Adverse Event|0
2530369|NCT01641081|8757070|P7|Period 5|Adverse Event|0
2530370|NCT01641081|8757071|P6|Period 5|Adverse Event|0
2530371|NCT01641081|8757072|P5|Period 5|Adverse Event|0
2530372|NCT01641081|8757073|P4|Period 5|Adverse Event|0
2530373|NCT01641081|8757074|P3|Period 5|Adverse Event|2
2530374|NCT01641081|8757075|P2|Period 5|Adverse Event|0
2530375|NCT01641081|8757076|P1|Period 5|Adverse Event|0
2530376|NCT01641081|8757067|P10|Period 4|Adverse Event|0
2530377|NCT01641081|8757068|P9|Period 4|Adverse Event|0
2530378|NCT01641081|8757069|P8|Period 4|Adverse Event|0
2530379|NCT01641081|8757070|P7|Period 4|Adverse Event|0
2530380|NCT01641081|8757071|P6|Period 4|Adverse Event|0
2530381|NCT01641081|8757072|P5|Period 4|Adverse Event|0
2530382|NCT01641081|8757073|P4|Period 4|Adverse Event|1
2530383|NCT01641081|8757074|P3|Period 4|Adverse Event|0
2530384|NCT01641081|8757075|P2|Period 4|Adverse Event|1
2530385|NCT01641081|8757076|P1|Period 4|Adverse Event|0
2530386|NCT01641081|8757067|P10|Period 3|Withdrawal by Subject|0
2530387|NCT01641081|8757068|P9|Period 3|Withdrawal by Subject|1
2530388|NCT01641081|8757069|P8|Period 3|Withdrawal by Subject|0
2530389|NCT01641081|8757070|P7|Period 3|Withdrawal by Subject|0
2530390|NCT01641081|8757071|P6|Period 3|Withdrawal by Subject|0
2530391|NCT01641081|8757072|P5|Period 3|Withdrawal by Subject|0
2530392|NCT01641081|8757073|P4|Period 3|Withdrawal by Subject|0
2530393|NCT01641081|8757074|P3|Period 3|Withdrawal by Subject|0
2530394|NCT01641081|8757075|P2|Period 3|Withdrawal by Subject|0
2530395|NCT01641081|8757076|P1|Period 3|Withdrawal by Subject|0
2530396|NCT01641081|8757067|P10|Period 3|Adverse Event|0
2530397|NCT01641081|8757068|P9|Period 3|Adverse Event|0
2530398|NCT01641081|8757069|P8|Period 3|Adverse Event|0
2530399|NCT01641081|8757070|P7|Period 3|Adverse Event|0
2530400|NCT01641081|8757071|P6|Period 3|Adverse Event|0
2530401|NCT01641081|8757072|P5|Period 3|Adverse Event|0
2530402|NCT01641081|8757073|P4|Period 3|Adverse Event|0
2530403|NCT01641081|8757074|P3|Period 3|Adverse Event|1
2530404|NCT01641081|8757075|P2|Period 3|Adverse Event|0
2530405|NCT01641081|8757076|P1|Period 3|Adverse Event|0
2530406|NCT01641081|8757067|P10|Period 2|Protocol Violation|0
2530407|NCT01641081|8757068|P9|Period 2|Protocol Violation|0
2530408|NCT01641081|8757069|P8|Period 2|Protocol Violation|0
2530409|NCT01641081|8757070|P7|Period 2|Protocol Violation|0
2530410|NCT01641081|8757071|P6|Period 2|Protocol Violation|0
2530411|NCT01641081|8757072|P5|Period 2|Protocol Violation|0
2530412|NCT01641081|8757073|P4|Period 2|Protocol Violation|0
2530413|NCT01641081|8757074|P3|Period 2|Protocol Violation|0
2530414|NCT01641081|8757075|P2|Period 2|Protocol Violation|0
2530415|NCT01641081|8757076|P1|Period 2|Protocol Violation|1
2530416|NCT01641081|8757067|P10|Period 2|Withdrawal by Subject|0
2530417|NCT01641081|8757068|P9|Period 2|Withdrawal by Subject|0
2530418|NCT01641081|8757069|P8|Period 2|Withdrawal by Subject|0
2530419|NCT01641081|8757070|P7|Period 2|Withdrawal by Subject|2
2530420|NCT01641081|8757071|P6|Period 2|Withdrawal by Subject|0
2530421|NCT01641081|8757072|P5|Period 2|Withdrawal by Subject|0
2530422|NCT01641081|8757073|P4|Period 2|Withdrawal by Subject|1
2530423|NCT01641081|8757074|P3|Period 2|Withdrawal by Subject|0
2530424|NCT01641081|8757075|P2|Period 2|Withdrawal by Subject|0
2530425|NCT01641081|8757076|P1|Period 2|Withdrawal by Subject|0
2530426|NCT01641081|8757067|P10|Period 2|Adverse Event|0
2530427|NCT01641081|8757068|P9|Period 2|Adverse Event|0
2530428|NCT01641081|8757069|P8|Period 2|Adverse Event|0
2530429|NCT01641081|8757070|P7|Period 2|Adverse Event|0
2530430|NCT01641081|8757071|P6|Period 2|Adverse Event|1
2530431|NCT01641081|8757072|P5|Period 2|Adverse Event|0
2530432|NCT01641081|8757073|P4|Period 2|Adverse Event|0
2530433|NCT01641081|8757074|P3|Period 2|Adverse Event|0
2530434|NCT01641081|8757075|P2|Period 2|Adverse Event|0
2530435|NCT01641081|8757076|P1|Period 2|Adverse Event|0
2530436|NCT01641081|8757067|P10|Period 1|Adverse Event|0
2530437|NCT01641081|8757068|P9|Period 1|Adverse Event|0
2530438|NCT01641081|8757069|P8|Period 1|Adverse Event|2
2530439|NCT01641081|8757070|P7|Period 1|Adverse Event|0
2530440|NCT01641081|8757071|P6|Period 1|Adverse Event|0
2530441|NCT01641081|8757072|P5|Period 1|Adverse Event|0
2530442|NCT01641081|8757073|P4|Period 1|Adverse Event|0
2530443|NCT01641081|8757074|P3|Period 1|Adverse Event|0
2530444|NCT01641081|8757075|P2|Period 1|Adverse Event|0
2530445|NCT01641081|8757076|P1|Period 1|Adverse Event|1
2530446|NCT01641081|8757067|P10|Period 1|Protocol Violation|0
2530447|NCT01641081|8757068|P9|Period 1|Protocol Violation|0
2530448|NCT01641081|8757069|P8|Period 1|Protocol Violation|1
2530449|NCT01641081|8757070|P7|Period 1|Protocol Violation|0
2530450|NCT01641081|8757071|P6|Period 1|Protocol Violation|0
2530451|NCT01641081|8757072|P5|Period 1|Protocol Violation|1
2530452|NCT01641081|8757073|P4|Period 1|Protocol Violation|0
2530453|NCT01641081|8757074|P3|Period 1|Protocol Violation|0
2530454|NCT01641081|8757075|P2|Period 1|Protocol Violation|0
2530455|NCT01641081|8757076|P1|Period 1|Protocol Violation|0
2530456|NCT01641081|8757067|P10|Period 1|Sponsor request (potential unblinding)|0
2530457|NCT01641081|8757068|P9|Period 1|Sponsor request (potential unblinding)|0
2530458|NCT01641081|8757069|P8|Period 1|Sponsor request (potential unblinding)|0
2530459|NCT01641081|8757070|P7|Period 1|Sponsor request (potential unblinding)|1
2530460|NCT01641081|8757071|P6|Period 1|Sponsor request (potential unblinding)|0
2530461|NCT01641081|8757072|P5|Period 1|Sponsor request (potential unblinding)|0
2530462|NCT01641081|8757073|P4|Period 1|Sponsor request (potential unblinding)|0
2530463|NCT01641081|8757074|P3|Period 1|Sponsor request (potential unblinding)|0
2530464|NCT01641081|8757075|P2|Period 1|Sponsor request (potential unblinding)|0
2530465|NCT01641081|8757076|P1|Period 1|Sponsor request (potential unblinding)|0
2530466|NCT01640964|8757145|P3|Overall Study|Protocol Deviation|2
2530467|NCT01640964|8757146|P2|Overall Study|Protocol Deviation|1
2530468|NCT01640964|8757147|P1|Overall Study|Protocol Deviation|1
2530469|NCT01640964|8757145|P3|Overall Study|Lost to Follow-up|1
2530470|NCT01640964|8757146|P2|Overall Study|Lost to Follow-up|0
2530471|NCT01640964|8757147|P1|Overall Study|Lost to Follow-up|0
2530472|NCT01640951|8757170|P8|Overall Study|Death|2
2530473|NCT01640951|8757171|P7|Overall Study|Death|0
2530474|NCT01640951|8757172|P6|Overall Study|Death|0
2530475|NCT01640951|8757173|P5|Overall Study|Death|0
2530476|NCT01640951|8757174|P4|Overall Study|Death|0
2530477|NCT01640951|8757175|P3|Overall Study|Death|1
2530478|NCT01640951|8757176|P2|Overall Study|Death|1
2530479|NCT01640951|8757177|P1|Overall Study|Death|0
2530480|NCT01640951|8757170|P8|Overall Study|Subject/Guardian decision|4
2530481|NCT01640951|8757171|P7|Overall Study|Subject/Guardian decision|5
2530482|NCT01640951|8757172|P6|Overall Study|Subject/Guardian decision|19
2530483|NCT01640951|8757173|P5|Overall Study|Subject/Guardian decision|7
2530484|NCT01640951|8757174|P4|Overall Study|Subject/Guardian decision|15
2530485|NCT01640951|8757175|P3|Overall Study|Subject/Guardian decision|13
2530486|NCT01640951|8757176|P2|Overall Study|Subject/Guardian decision|4
2530487|NCT01640951|8757177|P1|Overall Study|Subject/Guardian decision|12
2530488|NCT01640951|8757170|P8|Overall Study|Protocol Deviation|0
2530489|NCT01640951|8757171|P7|Overall Study|Protocol Deviation|0
2530490|NCT01640951|8757172|P6|Overall Study|Protocol Deviation|1
2530491|NCT01640951|8757173|P5|Overall Study|Protocol Deviation|0
2530492|NCT01640951|8757174|P4|Overall Study|Protocol Deviation|1
2530493|NCT01640951|8757175|P3|Overall Study|Protocol Deviation|2
2530494|NCT01640951|8757176|P2|Overall Study|Protocol Deviation|1
2530495|NCT01640951|8757177|P1|Overall Study|Protocol Deviation|0
2530496|NCT01640951|8757170|P8|Overall Study|Pregnancy|0
2530497|NCT01640951|8757171|P7|Overall Study|Pregnancy|2
2530498|NCT01640951|8757172|P6|Overall Study|Pregnancy|0
2530499|NCT01640951|8757173|P5|Overall Study|Pregnancy|0
2530500|NCT01640951|8757174|P4|Overall Study|Pregnancy|4
2530501|NCT01640951|8757175|P3|Overall Study|Pregnancy|0
2530502|NCT01640951|8757176|P2|Overall Study|Pregnancy|0
2530503|NCT01640951|8757177|P1|Overall Study|Pregnancy|3
2530504|NCT01640951|8757170|P8|Overall Study|Physician Decision|0
2530505|NCT01640951|8757171|P7|Overall Study|Physician Decision|3
2530506|NCT01640951|8757172|P6|Overall Study|Physician Decision|3
2530507|NCT01640951|8757173|P5|Overall Study|Physician Decision|2
2530508|NCT01640951|8757174|P4|Overall Study|Physician Decision|2
2530509|NCT01640951|8757175|P3|Overall Study|Physician Decision|2
2530510|NCT01640951|8757176|P2|Overall Study|Physician Decision|5
2530511|NCT01640951|8757177|P1|Overall Study|Physician Decision|2
2530512|NCT01640951|8757170|P8|Overall Study|Non-compliance with study treatment|0
2530513|NCT01640951|8757171|P7|Overall Study|Non-compliance with study treatment|1
2530514|NCT01640951|8757172|P6|Overall Study|Non-compliance with study treatment|4
2530515|NCT01640951|8757173|P5|Overall Study|Non-compliance with study treatment|1
2530516|NCT01640951|8757174|P4|Overall Study|Non-compliance with study treatment|1
2530517|NCT01640951|8757175|P3|Overall Study|Non-compliance with study treatment|1
2530518|NCT01640951|8757176|P2|Overall Study|Non-compliance with study treatment|0
2530519|NCT01640951|8757177|P1|Overall Study|Non-compliance with study treatment|0
2530520|NCT01640951|8757170|P8|Overall Study|Lost to Follow-up|1
2530521|NCT01640951|8757171|P7|Overall Study|Lost to Follow-up|1
2530522|NCT01640951|8757172|P6|Overall Study|Lost to Follow-up|3
2530523|NCT01640951|8757173|P5|Overall Study|Lost to Follow-up|2
2530524|NCT01640951|8757174|P4|Overall Study|Lost to Follow-up|2
2530525|NCT01640951|8757175|P3|Overall Study|Lost to Follow-up|6
2530526|NCT01640951|8757176|P2|Overall Study|Lost to Follow-up|0
2530527|NCT01640951|8757177|P1|Overall Study|Lost to Follow-up|1
2530528|NCT01640951|8757170|P8|Overall Study|Lack of Efficacy|6
2530529|NCT01640951|8757171|P7|Overall Study|Lack of Efficacy|5
2530530|NCT01640951|8757172|P6|Overall Study|Lack of Efficacy|6
2530531|NCT01640951|8757173|P5|Overall Study|Lack of Efficacy|0
2530532|NCT01640951|8757174|P4|Overall Study|Lack of Efficacy|14
2530533|NCT01640951|8757175|P3|Overall Study|Lack of Efficacy|7
2530534|NCT01640951|8757176|P2|Overall Study|Lack of Efficacy|1
2530535|NCT01640951|8757177|P1|Overall Study|Lack of Efficacy|20
2530536|NCT01640951|8757170|P8|Overall Study|Adverse Event|3
2530537|NCT01640951|8757171|P7|Overall Study|Adverse Event|1
2530538|NCT01640951|8757172|P6|Overall Study|Adverse Event|11
2530539|NCT01640951|8757173|P5|Overall Study|Adverse Event|1
2530540|NCT01640951|8757174|P4|Overall Study|Adverse Event|6
2530541|NCT01640951|8757175|P3|Overall Study|Adverse Event|10
2530542|NCT01640951|8757176|P2|Overall Study|Adverse Event|3
2530543|NCT01640951|8757177|P1|Overall Study|Adverse Event|8
2530544|NCT01640925|8757279|P2|Overall Study|Previously enrolled in this trial|11
2530545|NCT01640925|8757280|P1|Overall Study|Previously enrolled in this trial|13
2530546|NCT01640925|8757279|P2|Overall Study|Withdrawal by Subject|0
2530547|NCT01640925|8757280|P1|Overall Study|Withdrawal by Subject|1
2530548|NCT01640873|8757294|P2|Overall Study|Protocol Violation|1
2530549|NCT01640873|8757295|P1|Overall Study|Protocol Violation|2
2530550|NCT01640366|8757368|P1|Overall Study|Lost to Follow-up|5
2530551|NCT01640366|8757368|P1|Overall Study|Protocol Violation|16
2530552|NCT01640366|8757368|P1|Overall Study|Withdrawal by Subject|1
2530553|NCT01640353|8757381|P1|Overall Study|Physician Decision|1
2530554|NCT01640353|8757381|P1|Overall Study|Lost to Follow-up|12
2530555|NCT01640353|8757381|P1|Overall Study|Early site termination|3
2530556|NCT01640353|8757381|P1|Overall Study|Death|2
2530557|NCT01640353|8757381|P1|Overall Study|Withdrawal by Subject|5
2530558|NCT01640353|8757381|P1|Overall Study|Withdrawn from analysis at term site|12
2530559|NCT01640353|8757381|P1|Overall Study|Withdrew prior to treatment|10
2530560|NCT01640314|8757429|P2|Overall Study|Protocol Violation|1
2530561|NCT01640314|8757430|P1|Overall Study|Protocol Violation|0
2530562|NCT01640249|8757451|P7|Period 1|Withdrawal by Subject|0
2530563|NCT01640249|8757452|P6|Period 1|Withdrawal by Subject|1
2530564|NCT01640249|8757453|P5|Period 1|Withdrawal by Subject|0
2530565|NCT01640249|8757454|P4|Period 1|Withdrawal by Subject|0
2530566|NCT01640249|8757455|P3|Period 1|Withdrawal by Subject|0
2530567|NCT01640249|8757456|P2|Period 1|Withdrawal by Subject|0
2530568|NCT01640249|8757457|P1|Period 1|Withdrawal by Subject|1
2530569|NCT01640184|8757505|P3|Overall Study|Protocol Violation|1
2530570|NCT01640184|8757506|P2|Overall Study|Protocol Violation|0
2530571|NCT01640184|8757507|P1|Overall Study|Protocol Violation|0
2530572|NCT01640184|8757505|P3|Overall Study|Withdrawal by Subject|1
2530573|NCT01640184|8757506|P2|Overall Study|Withdrawal by Subject|1
2530574|NCT01640184|8757507|P1|Overall Study|Withdrawal by Subject|0
2530575|NCT01640184|8757505|P3|Overall Study|Physician Decision|0
2530576|NCT01640184|8757506|P2|Overall Study|Physician Decision|0
2530577|NCT01640184|8757507|P1|Overall Study|Physician Decision|3
2530578|NCT01640184|8757505|P3|Overall Study|Lost to Follow-up|0
2530579|NCT01640184|8757506|P2|Overall Study|Lost to Follow-up|1
2530580|NCT01640184|8757507|P1|Overall Study|Lost to Follow-up|4
2530581|NCT01640184|8757505|P3|Overall Study|Death|0
2530582|NCT01640184|8757506|P2|Overall Study|Death|0
2530583|NCT01640184|8757507|P1|Overall Study|Death|1
2530584|NCT01640054|8757536|P1|Overall Study|Adverse Event|2
2530585|NCT01640054|8757536|P1|Overall Study|Lack of Efficacy|3
2530586|NCT01640054|8757536|P1|Overall Study|Study-specific disc criteria|1
2530587|NCT01639833|8757557|P2|Overall Study|Withdrawal by Subject|2
2530588|NCT01639833|8757558|P1|Overall Study|Withdrawal by Subject|2
2530589|NCT01639833|8757557|P2|Overall Study|Death|2
2530590|NCT01639833|8757558|P1|Overall Study|Death|4
2530591|NCT01639755|8757566|P1|Overall Study|Patient had device explantation|4
2530592|NCT01639755|8757566|P1|Overall Study|Study Ongoing|15
2530593|NCT01639742|8757574|P1|Overall Study|Lost to Follow-up|1
2530594|NCT01639742|8757574|P1|Overall Study|Study Ongoing|17
2530595|NCT01639729|8757582|P6|Overall Study|Withdrawal by Subject|0
2530596|NCT01639729|8757583|P5|Overall Study|Withdrawal by Subject|0
2530597|NCT01639729|8757584|P4|Overall Study|Withdrawal by Subject|1
2530598|NCT01639729|8757585|P3|Overall Study|Withdrawal by Subject|1
2530599|NCT01639729|8757586|P2|Overall Study|Withdrawal by Subject|0
2530600|NCT01639729|8757587|P1|Overall Study|Withdrawal by Subject|1
2530601|NCT01639703|8757609|P1|Overall Study|Other reason|7
2530602|NCT01639703|8757609|P1|Overall Study|Withdrawal by Subject|5
2530603|NCT01639560|8757652|P2|Overall Study|Adverse Event|2
2530604|NCT01639560|8757653|P1|Overall Study|Adverse Event|0
2530605|NCT01639560|8757652|P2|Overall Study|Lost to Follow-up|11
2530606|NCT01639560|8757653|P1|Overall Study|Lost to Follow-up|9
2530607|NCT01639560|8757652|P2|Overall Study|Lack of Efficacy|2
2530608|NCT01639560|8757653|P1|Overall Study|Lack of Efficacy|1
2530609|NCT01639560|8757652|P2|Overall Study|Withdrawal by Subject|14
2530610|NCT01639560|8757653|P1|Overall Study|Withdrawal by Subject|9
2530611|NCT01639495|8757665|P1|Overall Study|No radiofrequency energy applied|2
2530612|NCT01639495|8757665|P1|Overall Study|Not meeting inclusion/exclusion criteria|4
2530613|NCT01639495|8757665|P1|Overall Study|Consented but didn’t have study catheter|4
2530614|NCT01639495|8757665|P1|Overall Study|Lost to Follow-up|6
2530615|NCT01639469|8757675|P2|Overall Study|Lost to Follow-up|1
2530616|NCT01639469|8757676|P1|Overall Study|Lost to Follow-up|1
2530617|NCT01639469|8757675|P2|Overall Study|Death|2
2530618|NCT01639469|8757676|P1|Overall Study|Death|4
2530619|NCT01639144|8757781|P2|Overall Study|Met postoperative exclusion criteria|3
2530620|NCT01639144|8757782|P1|Overall Study|Met postoperative exclusion criteria|4
2530621|NCT01639144|8757781|P2|Overall Study|Physician Decision|0
2530622|NCT01639144|8757782|P1|Overall Study|Physician Decision|2
2530623|NCT01639144|8757781|P2|Overall Study|Withdrawal by Subject|2
2530624|NCT01639144|8757782|P1|Overall Study|Withdrawal by Subject|4
2530625|NCT01639040|8757790|P2|Overall Study|Adverse Event|0
2530626|NCT01639040|8757791|P1|Overall Study|Adverse Event|1
2530627|NCT01639001|8757809|P2|Overall Study|Death|35
2530628|NCT01639001|8757810|P1|Overall Study|Death|35
2530629|NCT01639001|8757809|P2|Overall Study|Lost to Follow-up|0
2530630|NCT01639001|8757810|P1|Overall Study|Lost to Follow-up|1
2530631|NCT01639001|8757809|P2|Overall Study|Refused further follow-up|6
2530632|NCT01639001|8757810|P1|Overall Study|Refused further follow-up|3
2530633|NCT01639001|8757809|P2|Overall Study|Ongoing at date of cutoff|60
2530634|NCT01639001|8757810|P1|Overall Study|Ongoing at date of cutoff|65
2530635|NCT01639001|8757809|P2|Overall Study|Randomized but not treated|2
2530636|NCT01639001|8757810|P1|Overall Study|Randomized but not treated|0
2530637|NCT01638819|8757856|P2|Overall Study|Lost to Follow-up|0
2530638|NCT01638819|8757857|P1|Overall Study|Lost to Follow-up|1
2530639|NCT01638559|8757866|P1|Overall Study|Subject declined to travel for biopsy|1
2530640|NCT01638559|8757866|P1|Overall Study|Withdrawal by Subject|1
2530641|NCT01638559|8757866|P1|Overall Study|Lost to Follow-up|1
2530642|NCT01638546|8757884|P2|Overall Study|Adverse Event|3
2530643|NCT01638546|8757885|P1|Overall Study|Adverse Event|1
2530644|NCT01638429|8757924|P1|Overall Study|Withdrawal by Subject|1
2530645|NCT01638390|8757952|P1|Overall Study|screening failures|21
2530646|NCT01638000|8757975|P2|Overall Study|Miscellaneous|2
2530647|NCT01638000|8757976|P1|Overall Study|Miscellaneous|2
2530648|NCT01638000|8757975|P2|Overall Study|Withdrawal by Subject|24
2530649|NCT01638000|8757976|P1|Overall Study|Withdrawal by Subject|21
2530650|NCT01638000|8757975|P2|Overall Study|Protocol Violation|13
2530651|NCT01638000|8757976|P1|Overall Study|Protocol Violation|11
2530652|NCT01638000|8757975|P2|Overall Study|Lack of Efficacy|6
2530653|NCT01638000|8757976|P1|Overall Study|Lack of Efficacy|5
2530654|NCT01638000|8757975|P2|Overall Study|Adverse Event|16
2530655|NCT01638000|8757976|P1|Overall Study|Adverse Event|14
2530656|NCT01638000|8757975|P2|Overall Study|Randomized but Never Received Drug|10
2530657|NCT01638000|8757976|P1|Overall Study|Randomized but Never Received Drug|7
2530658|NCT01637961|8758074|P1|Overall Study|Ineligible: inadequate pathology|1
2530659|NCT01637961|8758074|P1|Overall Study|Ineligible: wrong primary|1
2530660|NCT01637922|8758106|P2|Overall Study|Lost to Follow-up|0
2530661|NCT01637922|8758107|P1|Overall Study|Lost to Follow-up|2
2530662|NCT01637922|8758106|P2|Overall Study|Withdrawal by Subject|3
2530663|NCT01637922|8758107|P1|Overall Study|Withdrawal by Subject|0
2530664|NCT01637922|8758106|P2|Overall Study|Protocol Violation|1
2530665|NCT01637922|8758107|P1|Overall Study|Protocol Violation|0
2530666|NCT01637922|8758106|P2|Overall Study|Adverse Event|1
2530667|NCT01637922|8758107|P1|Overall Study|Adverse Event|0
2530668|NCT01637584|8758136|P2|Overall Study|Withdrawal by Subject|3
2530669|NCT01637584|8758137|P1|Overall Study|Withdrawal by Subject|1
2530670|NCT01637272|8758144|P1|Overall Study|Protocol Violation|2
2530671|NCT01637272|8758144|P1|Overall Study|Administrative problems|1
2530672|NCT01637272|8758144|P1|Overall Study|completed core, did not enter ext. phase|4
2530673|NCT01637272|8758144|P1|Overall Study|Lost to Follow-up|2
2530674|NCT01637272|8758144|P1|Overall Study|Withdrawal by Subject|3
2530675|NCT01637272|8758144|P1|Overall Study|Unsatisfactory therapeutic effect|2
2530676|NCT01637272|8758144|P1|Overall Study|Adverse Event|6
2530677|NCT01637077|8758224|P2|Overall Study|No cycle 1 questionnaire data|0
2530678|NCT01637077|8758225|P1|Overall Study|No cycle 1 questionnaire data|2
2530679|NCT01637077|8758224|P2|Overall Study|Withdrawal by Subject|0
2530680|NCT01637077|8758225|P1|Overall Study|Withdrawal by Subject|1
2530681|NCT01637077|8758224|P2|Overall Study|Cancel|1
2530682|NCT01637077|8758225|P1|Overall Study|Cancel|1
2530683|NCT01636986|8758253|P2|Overall Study|Corneal Staining|1
2530684|NCT01636986|8758254|P1|Overall Study|Corneal Staining|0
2530685|NCT01636986|8758253|P2|Overall Study|Withdrawal by Subject|1
2530686|NCT01636986|8758254|P1|Overall Study|Withdrawal by Subject|0
2530687|NCT01636960|8758260|P1|Maintenance Phase|Progressive disease|1
2530688|NCT01636960|8758260|P1|Maintenance Phase|Adverse Event|3
2530689|NCT01636960|8758260|P1|Maintenance Phase|Continued drug after regulatory approval|3
2530690|NCT01636960|8758260|P1|Induction Phase|Adverse Event|2
2530691|NCT01636947|8758268|P2|Overall Study|Did Not Meet Eligibility Criteria|4
2530692|NCT01636947|8758269|P1|Overall Study|Did Not Meet Eligibility Criteria|1
2530693|NCT01636947|8758268|P2|Overall Study|Adverse Event|1
2530694|NCT01636947|8758269|P1|Overall Study|Adverse Event|1
2530695|NCT01636947|8758268|P2|Overall Study|Withdrawal by Subject|3
2530696|NCT01636947|8758269|P1|Overall Study|Withdrawal by Subject|3
2530697|NCT01636947|8758268|P2|Overall Study|Protocol Violation|1
2530698|NCT01636947|8758269|P1|Overall Study|Protocol Violation|1
2530699|NCT01636947|8758268|P2|Overall Study|Lost to Follow-up|0
2530700|NCT01636947|8758269|P1|Overall Study|Lost to Follow-up|4
2530701|NCT01636947|8758268|P2|Overall Study|Not Treated|2
2530702|NCT01636947|8758269|P1|Overall Study|Not Treated|2
2530703|NCT01636778|8758293|P3|Follow-up Period After Part 2|Withdrawal by Subject|2
2530704|NCT01636778|8758294|P2|Follow-up Period After Part 2|Withdrawal by Subject|0
2530705|NCT01636778|8758295|P1|Follow-up Period After Part 2|Withdrawal by Subject|0
2530706|NCT01636778|8758293|P3|Follow-up Period After Part 2|Not entered FU period after withdrawal|1
2530707|NCT01636778|8758294|P2|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
2530708|NCT01636778|8758295|P1|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
2530709|NCT01636778|8758293|P3|Follow-up Period After Part 2|Other|1
2530710|NCT01636778|8758294|P2|Follow-up Period After Part 2|Other|0
2530711|NCT01636778|8758295|P1|Follow-up Period After Part 2|Other|0
2530712|NCT01636778|8758293|P3|Antiviral Treatment Period (Part 2)|Physician Decision|0
2530713|NCT01636778|8758294|P2|Antiviral Treatment Period (Part 2)|Physician Decision|2
2530714|NCT01636778|8758295|P1|Antiviral Treatment Period (Part 2)|Physician Decision|0
2530715|NCT01636778|8758293|P3|Antiviral Treatment Period (Part 2)|Protocol Violation|0
2530716|NCT01636778|8758294|P2|Antiviral Treatment Period (Part 2)|Protocol Violation|1
2530717|NCT01636778|8758295|P1|Antiviral Treatment Period (Part 2)|Protocol Violation|0
2530718|NCT01636778|8758293|P3|Antiviral Treatment Period (Part 2)|Adverse Event|0
2530719|NCT01636778|8758294|P2|Antiviral Treatment Period (Part 2)|Adverse Event|7
2530720|NCT01636778|8758295|P1|Antiviral Treatment Period (Part 2)|Adverse Event|0
2530721|NCT01636778|8758293|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
2530722|NCT01636778|8758294|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
2530723|NCT01636778|8758295|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1
2530724|NCT01636778|8758293|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
2530725|NCT01636778|8758294|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
2530726|NCT01636778|8758295|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3
2530727|NCT01636713|8758366|P3|Overall Study|Met Protocol-defined Stopping Criteria|4
2530728|NCT01636713|8758367|P2|Overall Study|Met Protocol-defined Stopping Criteria|2
2530729|NCT01636713|8758368|P1|Overall Study|Met Protocol-defined Stopping Criteria|2
2530730|NCT01636713|8758366|P3|Overall Study|Withdrawal by Subject|8
2530731|NCT01636713|8758367|P2|Overall Study|Withdrawal by Subject|4
2530732|NCT01636713|8758368|P1|Overall Study|Withdrawal by Subject|5
2530733|NCT01636713|8758366|P3|Overall Study|Lost to Follow-up|1
2530734|NCT01636713|8758367|P2|Overall Study|Lost to Follow-up|0
2530735|NCT01636713|8758368|P1|Overall Study|Lost to Follow-up|0
2530736|NCT01636713|8758366|P3|Overall Study|Protocol Violation|1
2530737|NCT01636713|8758367|P2|Overall Study|Protocol Violation|0
2530738|NCT01636713|8758368|P1|Overall Study|Protocol Violation|3
2530739|NCT01636713|8758366|P3|Overall Study|Lack of Efficacy|2
2530740|NCT01636713|8758367|P2|Overall Study|Lack of Efficacy|6
2530741|NCT01636713|8758368|P1|Overall Study|Lack of Efficacy|6
2530742|NCT01636713|8758366|P3|Overall Study|Adverse Event|7
2530743|NCT01636713|8758367|P2|Overall Study|Adverse Event|16
2530744|NCT01636713|8758368|P1|Overall Study|Adverse Event|16
2530745|NCT01636687|8758385|P5|Follow-up Period|Withdrawal by Subject|1
2530746|NCT01636687|8758386|P4|Follow-up Period|Withdrawal by Subject|0
2530747|NCT01636687|8758387|P3|Follow-up Period|Withdrawal by Subject|0
2530748|NCT01636687|8758388|P2|Follow-up Period|Withdrawal by Subject|0
2530749|NCT01636687|8758389|P1|Follow-up Period|Withdrawal by Subject|1
2530750|NCT01636687|8758385|P5|Extension Period|Withdrawal by Subject|0
2530751|NCT01636687|8758386|P4|Extension Period|Withdrawal by Subject|1
2530752|NCT01636687|8758387|P3|Extension Period|Withdrawal by Subject|1
2530753|NCT01636687|8758388|P2|Extension Period|Withdrawal by Subject|0
2530754|NCT01636687|8758389|P1|Extension Period|Withdrawal by Subject|1
2530755|NCT01636687|8758385|P5|Extension Period|study terminated by sponsor|0
2530756|NCT01636687|8758386|P4|Extension Period|study terminated by sponsor|23
2530757|NCT01636687|8758387|P3|Extension Period|study terminated by sponsor|17
2530758|NCT01636687|8758388|P2|Extension Period|study terminated by sponsor|50
2530759|NCT01636687|8758389|P1|Extension Period|study terminated by sponsor|33
2530760|NCT01636687|8758385|P5|Extension Period|Physician Decision|0
2530761|NCT01636687|8758386|P4|Extension Period|Physician Decision|1
2530762|NCT01636687|8758387|P3|Extension Period|Physician Decision|0
2530763|NCT01636687|8758388|P2|Extension Period|Physician Decision|0
2530764|NCT01636687|8758389|P1|Extension Period|Physician Decision|1
2530765|NCT01636687|8758385|P5|Extension Period|Lost to Follow-up|0
2530766|NCT01636687|8758386|P4|Extension Period|Lost to Follow-up|0
2530767|NCT01636687|8758387|P3|Extension Period|Lost to Follow-up|1
2530768|NCT01636687|8758388|P2|Extension Period|Lost to Follow-up|0
2530769|NCT01636687|8758389|P1|Extension Period|Lost to Follow-up|1
2530770|NCT01636687|8758385|P5|Extension Period|Lack of Efficacy|0
2530771|NCT01636687|8758386|P4|Extension Period|Lack of Efficacy|1
2530772|NCT01636687|8758387|P3|Extension Period|Lack of Efficacy|2
2530773|NCT01636687|8758388|P2|Extension Period|Lack of Efficacy|0
2530774|NCT01636687|8758389|P1|Extension Period|Lack of Efficacy|7
2530775|NCT01636687|8758385|P5|Extension Period|Adverse Event|0
2530776|NCT01636687|8758386|P4|Extension Period|Adverse Event|1
2530777|NCT01636687|8758387|P3|Extension Period|Adverse Event|2
2530778|NCT01636687|8758388|P2|Extension Period|Adverse Event|3
2530779|NCT01636687|8758389|P1|Extension Period|Adverse Event|4
2530780|NCT01636687|8758385|P5|Extension Period|technical problems|0
2530781|NCT01636687|8758386|P4|Extension Period|technical problems|1
2530782|NCT01636687|8758387|P3|Extension Period|technical problems|2
2530783|NCT01636687|8758388|P2|Extension Period|technical problems|1
2530784|NCT01636687|8758389|P1|Extension Period|technical problems|0
2530785|NCT01636687|8758385|P5|Maintenance Period|Physician Decision|1
2530786|NCT01636687|8758386|P4|Maintenance Period|Physician Decision|0
2530787|NCT01636687|8758387|P3|Maintenance Period|Physician Decision|0
2530788|NCT01636687|8758388|P2|Maintenance Period|Physician Decision|0
2530789|NCT01636687|8758389|P1|Maintenance Period|Physician Decision|0
2530790|NCT01636687|8758385|P5|Maintenance Period|Lost to Follow-up|1
2530791|NCT01636687|8758386|P4|Maintenance Period|Lost to Follow-up|0
2530792|NCT01636687|8758387|P3|Maintenance Period|Lost to Follow-up|0
2530793|NCT01636687|8758388|P2|Maintenance Period|Lost to Follow-up|1
2530794|NCT01636687|8758389|P1|Maintenance Period|Lost to Follow-up|1
2530795|NCT01636687|8758385|P5|Maintenance Period|Lack of Efficacy|0
2530796|NCT01636687|8758386|P4|Maintenance Period|Lack of Efficacy|0
2530797|NCT01636687|8758387|P3|Maintenance Period|Lack of Efficacy|0
2530798|NCT01636687|8758388|P2|Maintenance Period|Lack of Efficacy|1
2530799|NCT01636687|8758389|P1|Maintenance Period|Lack of Efficacy|4
2530800|NCT01636687|8758385|P5|Maintenance Period|Adverse Event|0
2530801|NCT01636687|8758386|P4|Maintenance Period|Adverse Event|0
2530802|NCT01636687|8758387|P3|Maintenance Period|Adverse Event|0
2530803|NCT01636687|8758388|P2|Maintenance Period|Adverse Event|0
2530804|NCT01636687|8758389|P1|Maintenance Period|Adverse Event|1
2530805|NCT01636687|8758385|P5|Maintenance Period|Withdrawal by Subject|0
2530806|NCT01636687|8758386|P4|Maintenance Period|Withdrawal by Subject|0
2530807|NCT01636687|8758387|P3|Maintenance Period|Withdrawal by Subject|2
2530808|NCT01636687|8758388|P2|Maintenance Period|Withdrawal by Subject|0
2530809|NCT01636687|8758389|P1|Maintenance Period|Withdrawal by Subject|2
2530810|NCT01636687|8758385|P5|Induction Period|Physician Decision|0
2530811|NCT01636687|8758386|P4|Induction Period|Physician Decision|0
2530812|NCT01636687|8758387|P3|Induction Period|Physician Decision|0
2530813|NCT01636687|8758388|P2|Induction Period|Physician Decision|0
2530814|NCT01636687|8758389|P1|Induction Period|Physician Decision|1
2530815|NCT01636687|8758385|P5|Induction Period|Lack of Efficacy|1
2530816|NCT01636687|8758386|P4|Induction Period|Lack of Efficacy|0
2530817|NCT01636687|8758387|P3|Induction Period|Lack of Efficacy|0
2530818|NCT01636687|8758388|P2|Induction Period|Lack of Efficacy|0
2530819|NCT01636687|8758389|P1|Induction Period|Lack of Efficacy|0
2530820|NCT01636687|8758385|P5|Induction Period|Adverse Event|1
2530821|NCT01636687|8758386|P4|Induction Period|Adverse Event|0
2530822|NCT01636687|8758387|P3|Induction Period|Adverse Event|0
2530823|NCT01636687|8758388|P2|Induction Period|Adverse Event|0
2530824|NCT01636687|8758389|P1|Induction Period|Adverse Event|1
2530825|NCT01636687|8758385|P5|Induction Period|Withdrawal by Subject|0
2530826|NCT01636687|8758386|P4|Induction Period|Withdrawal by Subject|0
2530827|NCT01636687|8758387|P3|Induction Period|Withdrawal by Subject|0
2530828|NCT01636687|8758388|P2|Induction Period|Withdrawal by Subject|0
2530829|NCT01636687|8758389|P1|Induction Period|Withdrawal by Subject|1
2530830|NCT01636362|8758530|P1|Overall Study|Withdrawal by Subject|1
2530831|NCT01636362|8758530|P1|Overall Study|Subject healed, not returning|1
2530832|NCT01636362|8758530|P1|Overall Study|Physician Decision|6
2530833|NCT01636258|8758557|P2|Overall Study|Lost to Follow-up|0
2530834|NCT01636258|8758558|P1|Overall Study|Lost to Follow-up|1
2530835|NCT01636076|8758598|P2|Overall Study|Withdrawal by Subject|10
2530836|NCT01636076|8758599|P1|Overall Study|Withdrawal by Subject|7
2530837|NCT01636076|8758598|P2|Overall Study|Adverse Event|11
2530838|NCT01636076|8758599|P1|Overall Study|Adverse Event|6
2530839|NCT01636076|8758598|P2|Overall Study|Non-compliance with study treatment|1
2530840|NCT01636076|8758599|P1|Overall Study|Non-compliance with study treatment|1
2530841|NCT01636076|8758598|P2|Overall Study|Physician Decision|1
2530842|NCT01636076|8758599|P1|Overall Study|Physician Decision|1
2530843|NCT01636076|8758598|P2|Overall Study|Lost to Follow-up|0
2530844|NCT01636076|8758599|P1|Overall Study|Lost to Follow-up|1
2530845|NCT01636076|8758598|P2|Overall Study|Lack of Efficacy|1
2530846|NCT01636076|8758599|P1|Overall Study|Lack of Efficacy|0
2530847|NCT01636076|8758598|P2|Overall Study|Terminated by sponsor|1
2530848|NCT01636076|8758599|P1|Overall Study|Terminated by sponsor|1
2530849|NCT01635933|8758670|P2|Overall Study|No longer had transportation|1
2530850|NCT01635933|8758671|P1|Overall Study|No longer had transportation|0
2530851|NCT01635933|8758670|P2|Overall Study|Noncompliance|1
2530852|NCT01635933|8758671|P1|Overall Study|Noncompliance|0
2530853|NCT01635933|8758670|P2|Overall Study|Subject decision|1
2530854|NCT01635933|8758671|P1|Overall Study|Subject decision|1
2530855|NCT01635933|8758670|P2|Overall Study|Lost to Follow-up|5
2530856|NCT01635933|8758671|P1|Overall Study|Lost to Follow-up|0
2530857|NCT01635933|8758670|P2|Overall Study|Adverse Event|0
2530858|NCT01635933|8758671|P1|Overall Study|Adverse Event|1
2530859|NCT01635920|8758683|P2|Overall Study|Subject decision|0
2530860|NCT01635920|8758684|P1|Overall Study|Subject decision|2
2530861|NCT01635920|8758683|P2|Overall Study|Lost to Follow-up|1
2530862|NCT01635920|8758684|P1|Overall Study|Lost to Follow-up|0
2530863|NCT01635920|8758683|P2|Overall Study|Adverse Event|0
2530864|NCT01635920|8758684|P1|Overall Study|Adverse Event|1
2530865|NCT01635855|8758697|P1|Overall Study|Withdrawal by Subject|4
2530866|NCT01635764|8758706|P1|Overall Study|Other|28
2530867|NCT01635764|8758706|P1|Overall Study|Lost to Follow-up|53
2530868|NCT01635764|8758706|P1|Overall Study|Withdrew Consent|67
2530869|NCT01635764|8758706|P1|Overall Study|Protocol Deviation|1
2530870|NCT01635764|8758706|P1|Overall Study|Exceed Protocol-specified Interventions|2
2530871|NCT01635764|8758706|P1|Overall Study|Lack of Efficacy|76
2530872|NCT01635764|8758706|P1|Overall Study|Adverse Event|46
2530873|NCT01635218|8758772|P3|Overall Study|Lost to Follow-up|6
2530874|NCT01635218|8758773|P2|Overall Study|Lost to Follow-up|7
2530875|NCT01635218|8758774|P1|Overall Study|Lost to Follow-up|3
2530876|NCT01634854|8758837|P2|Overall Study|Cesarean delivery|7
2530877|NCT01634854|8758838|P1|Overall Study|Cesarean delivery|2
2530878|NCT01634659|8758858|P2|Period 2 - Second 8 Days of Wear|Physician Decision|0
2530879|NCT01634659|8758859|P1|Period 2 - Second 8 Days of Wear|Physician Decision|1
2530880|NCT01634659|8758858|P2|Period 2 - Second 8 Days of Wear|Adverse Event|0
2530881|NCT01634659|8758859|P1|Period 2 - Second 8 Days of Wear|Adverse Event|2
2530882|NCT01634555|8758889|P1|Overall Study|Physician Decision|1
2530883|NCT01634555|8758889|P1|Overall Study|Adverse Event|3
2530884|NCT01634360|8758900|P2|Overall Study|Study termination by sponsor|44
2530885|NCT01634360|8758901|P1|Overall Study|Study termination by sponsor|18
2530886|NCT01634360|8758900|P2|Overall Study|Other|20
2530887|NCT01634360|8758901|P1|Overall Study|Other|3
2530888|NCT01634360|8758900|P2|Overall Study|Lack of Efficacy|14
2530889|NCT01634360|8758901|P1|Overall Study|Lack of Efficacy|4
2530890|NCT01634360|8758900|P2|Overall Study|Protocol Violation|1
2530891|NCT01634360|8758901|P1|Overall Study|Protocol Violation|1
2530892|NCT01634360|8758900|P2|Overall Study|subject withdrew consent|23
2530893|NCT01634360|8758901|P1|Overall Study|subject withdrew consent|13
2530894|NCT01634360|8758900|P2|Overall Study|Adverse Event|34
2530895|NCT01634360|8758901|P1|Overall Study|Adverse Event|10
2530896|NCT01634243|8758975|P2|Overall Study|Lack of Efficacy|0
2530897|NCT01634243|8758976|P1|Overall Study|Lack of Efficacy|1
2530898|NCT01634243|8758975|P2|Overall Study|Adverse Event|5
2530899|NCT01634243|8758976|P1|Overall Study|Adverse Event|5
2530900|NCT01634165|8759002|P4|Period 2|Adverse Event|0
2530901|NCT01634165|8759003|P3|Period 2|Adverse Event|0
2530902|NCT01634165|8759004|P2|Period 2|Adverse Event|1
2530903|NCT01634165|8759005|P1|Period 2|Adverse Event|0
2530904|NCT01634152|8759038|P3|Overall Study|Other reason not defined above|1
2530905|NCT01634152|8759039|P2|Overall Study|Other reason not defined above|0
2530906|NCT01634152|8759040|P1|Overall Study|Other reason not defined above|1
2530907|NCT01634152|8759038|P3|Overall Study|Not treated|0
2530908|NCT01634152|8759039|P2|Overall Study|Not treated|1
2530909|NCT01634152|8759040|P1|Overall Study|Not treated|0
2530910|NCT01634152|8759038|P3|Overall Study|Consent withdrawn not due to AE|1
2530911|NCT01634152|8759039|P2|Overall Study|Consent withdrawn not due to AE|0
2530912|NCT01634152|8759040|P1|Overall Study|Consent withdrawn not due to AE|1
2530913|NCT01634152|8759038|P3|Overall Study|Adverse Event|2
2530914|NCT01634152|8759039|P2|Overall Study|Adverse Event|0
2530915|NCT01634152|8759040|P1|Overall Study|Adverse Event|2
2530916|NCT01634139|8759123|P3|Overall Study|Not treated|0
2530917|NCT01634139|8759124|P2|Overall Study|Not treated|1
2530918|NCT01634139|8759125|P1|Overall Study|Not treated|1
2530919|NCT01634139|8759123|P3|Overall Study|Lost to Follow-up|0
2530920|NCT01634139|8759124|P2|Overall Study|Lost to Follow-up|2
2530921|NCT01634139|8759125|P1|Overall Study|Lost to Follow-up|0
2530922|NCT01634139|8759123|P3|Overall Study|Other|3
2530923|NCT01634139|8759124|P2|Overall Study|Other|0
2530924|NCT01634139|8759125|P1|Overall Study|Other|4
2530925|NCT01634139|8759123|P3|Overall Study|Consent withdrawn not due to AE|2
2530926|NCT01634139|8759124|P2|Overall Study|Consent withdrawn not due to AE|3
2530927|NCT01634139|8759125|P1|Overall Study|Consent withdrawn not due to AE|4
2530928|NCT01634139|8759123|P3|Overall Study|Non compliant with protocol|0
2530929|NCT01634139|8759124|P2|Overall Study|Non compliant with protocol|0
2530930|NCT01634139|8759125|P1|Overall Study|Non compliant with protocol|1
2530931|NCT01634113|8759226|P3|Overall Study|Not treated|1
2530932|NCT01634113|8759227|P2|Overall Study|Not treated|0
2530933|NCT01634113|8759228|P1|Overall Study|Not treated|0
2530934|NCT01634100|8759272|P6|Overall Study|Withdrawal by Subject|0
2530935|NCT01634100|8759273|P5|Overall Study|Withdrawal by Subject|0
2530936|NCT01634100|8759274|P4|Overall Study|Withdrawal by Subject|0
2530937|NCT01634100|8759275|P3|Overall Study|Withdrawal by Subject|1
2530938|NCT01634100|8759276|P2|Overall Study|Withdrawal by Subject|0
2530939|NCT01634100|8759277|P1|Overall Study|Withdrawal by Subject|1
2530940|NCT01633944|8759293|P3|Double-blind Treatment Phase|Other|0
2530941|NCT01633944|8759294|P2|Double-blind Treatment Phase|Other|7
2530942|NCT01633944|8759295|P1|Double-blind Treatment Phase|Other|0
2530943|NCT01633944|8759293|P3|Double-blind Treatment Phase|Not exposed to DB study medication|0
2530944|NCT01633944|8759294|P2|Double-blind Treatment Phase|Not exposed to DB study medication|1
2530945|NCT01633944|8759295|P1|Double-blind Treatment Phase|Not exposed to DB study medication|0
2530946|NCT01633944|8759293|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
2530947|NCT01633944|8759294|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3
2530948|NCT01633944|8759295|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
2530949|NCT01633944|8759293|P3|Double-blind Treatment Phase|Lost to Follow-up|9
2530950|NCT01633944|8759294|P2|Double-blind Treatment Phase|Lost to Follow-up|4
2530951|NCT01633944|8759295|P1|Double-blind Treatment Phase|Lost to Follow-up|0
2530952|NCT01633944|8759293|P3|Double-blind Treatment Phase|Protocol Violation|10
2530953|NCT01633944|8759294|P2|Double-blind Treatment Phase|Protocol Violation|7
2530954|NCT01633944|8759295|P1|Double-blind Treatment Phase|Protocol Violation|0
2530955|NCT01633944|8759293|P3|Double-blind Treatment Phase|Withdrawal by Subject|8
2530956|NCT01633944|8759294|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
2530957|NCT01633944|8759295|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
2530958|NCT01633944|8759293|P3|Double-blind Treatment Phase|Lack of Efficacy|23
2530959|NCT01633944|8759294|P2|Double-blind Treatment Phase|Lack of Efficacy|8
2530960|NCT01633944|8759295|P1|Double-blind Treatment Phase|Lack of Efficacy|0
2530961|NCT01633944|8759293|P3|Double-blind Treatment Phase|Adverse Event|7
2530962|NCT01633944|8759294|P2|Double-blind Treatment Phase|Adverse Event|13
2530963|NCT01633944|8759295|P1|Double-blind Treatment Phase|Adverse Event|0
2530964|NCT01633944|8759293|P3|Open-label Titration Phase|Other|0
2530965|NCT01633944|8759294|P2|Open-label Titration Phase|Other|0
2530966|NCT01633944|8759295|P1|Open-label Titration Phase|Other|68
2530967|NCT01633944|8759293|P3|Open-label Titration Phase|Lost to Follow-up|0
2530968|NCT01633944|8759294|P2|Open-label Titration Phase|Lost to Follow-up|0
2530969|NCT01633944|8759295|P1|Open-label Titration Phase|Lost to Follow-up|22
2530970|NCT01633944|8759293|P3|Open-label Titration Phase|Protocol Violation|0
2530971|NCT01633944|8759294|P2|Open-label Titration Phase|Protocol Violation|0
2530972|NCT01633944|8759295|P1|Open-label Titration Phase|Protocol Violation|24
2530973|NCT01633944|8759293|P3|Open-label Titration Phase|Withdrawal by Subject|0
2530974|NCT01633944|8759294|P2|Open-label Titration Phase|Withdrawal by Subject|0
2530975|NCT01633944|8759295|P1|Open-label Titration Phase|Withdrawal by Subject|34
2530976|NCT01633944|8759293|P3|Open-label Titration Phase|Lack of Efficacy|0
2530977|NCT01633944|8759294|P2|Open-label Titration Phase|Lack of Efficacy|0
2530978|NCT01633944|8759295|P1|Open-label Titration Phase|Lack of Efficacy|33
2530979|NCT01633944|8759293|P3|Open-label Titration Phase|Adverse Event|0
2530980|NCT01633944|8759294|P2|Open-label Titration Phase|Adverse Event|0
2530981|NCT01633944|8759295|P1|Open-label Titration Phase|Adverse Event|109
2530982|NCT01633788|8759363|P4|Overall Study|Other Reasons|7
2530983|NCT01633788|8759364|P3|Overall Study|Other Reasons|3
2530984|NCT01633788|8759365|P2|Overall Study|Other Reasons|2
2530985|NCT01633788|8759366|P1|Overall Study|Other Reasons|0
2530986|NCT01633788|8759363|P4|Overall Study|Protocol Violation|0
2530987|NCT01633788|8759364|P3|Overall Study|Protocol Violation|1
2530988|NCT01633788|8759365|P2|Overall Study|Protocol Violation|0
2530989|NCT01633788|8759366|P1|Overall Study|Protocol Violation|1
2530990|NCT01633788|8759363|P4|Overall Study|Personal Reasons|3
2530991|NCT01633788|8759364|P3|Overall Study|Personal Reasons|1
2530992|NCT01633788|8759365|P2|Overall Study|Personal Reasons|1
2530993|NCT01633788|8759366|P1|Overall Study|Personal Reasons|3
2530994|NCT01633788|8759363|P4|Overall Study|Lost to Follow-up|0
2530995|NCT01633788|8759364|P3|Overall Study|Lost to Follow-up|2
2530996|NCT01633788|8759365|P2|Overall Study|Lost to Follow-up|2
2530997|NCT01633788|8759366|P1|Overall Study|Lost to Follow-up|2
2530998|NCT01633788|8759363|P4|Overall Study|Adverse Event|3
2530999|NCT01633788|8759364|P3|Overall Study|Adverse Event|3
2531000|NCT01633788|8759365|P2|Overall Study|Adverse Event|3
2531001|NCT01633788|8759366|P1|Overall Study|Adverse Event|1
2531002|NCT01633112|8759398|P3|Overall Study|missing Study Completion CRF|4
2531003|NCT01633112|8759399|P2|Overall Study|missing Study Completion CRF|1
2531004|NCT01633112|8759400|P1|Overall Study|missing Study Completion CRF|1
2531005|NCT01633112|8759398|P3|Overall Study|Withdrawal by Subject|41
2531006|NCT01633112|8759399|P2|Overall Study|Withdrawal by Subject|12
2531007|NCT01633112|8759400|P1|Overall Study|Withdrawal by Subject|20
2531008|NCT01633112|8759398|P3|Overall Study|Subject no longer requires study drug|1
2531009|NCT01633112|8759399|P2|Overall Study|Subject no longer requires study drug|0
2531010|NCT01633112|8759400|P1|Overall Study|Subject no longer requires study drug|0
2531011|NCT01633112|8759398|P3|Overall Study|Protocol Violation|2
2531012|NCT01633112|8759399|P2|Overall Study|Protocol Violation|0
2531013|NCT01633112|8759400|P1|Overall Study|Protocol Violation|4
2531014|NCT01633112|8759398|P3|Overall Study|Lost to Follow-up|6
2531015|NCT01633112|8759399|P2|Overall Study|Lost to Follow-up|19
2531016|NCT01633112|8759400|P1|Overall Study|Lost to Follow-up|7
2531017|NCT01633112|8759398|P3|Overall Study|Adverse Event|20
2531018|NCT01633112|8759399|P2|Overall Study|Adverse Event|18
2531019|NCT01633112|8759400|P1|Overall Study|Adverse Event|16
2531020|NCT01633112|8759398|P3|Overall Study|Administrative problems|5
2531021|NCT01633112|8759399|P2|Overall Study|Administrative problems|2
2531022|NCT01633112|8759400|P1|Overall Study|Administrative problems|1
2531023|NCT01633112|8759398|P3|Overall Study|Abnormal test procedure result(s)|0
2531024|NCT01633112|8759399|P2|Overall Study|Abnormal test procedure result(s)|1
2531025|NCT01633112|8759400|P1|Overall Study|Abnormal test procedure result(s)|0
2531026|NCT01633112|8759398|P3|Overall Study|Abnormal laboratory value(s)|0
2531027|NCT01633112|8759399|P2|Overall Study|Abnormal laboratory value(s)|1
2531028|NCT01633112|8759400|P1|Overall Study|Abnormal laboratory value(s)|3
2531029|NCT01633112|8759398|P3|Overall Study|Lack of Efficacy|13
2531030|NCT01633112|8759399|P2|Overall Study|Lack of Efficacy|6
2531031|NCT01633112|8759400|P1|Overall Study|Lack of Efficacy|1
2531032|NCT01633060|8759435|P2|Post-Treatment Efficacy Follow-Up Phase|Death|0
2531033|NCT01633060|8759436|P1|Post-Treatment Efficacy Follow-Up Phase|Death|1
2531034|NCT01633060|8759435|P2|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
2531035|NCT01633060|8759436|P1|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
2531036|NCT01633060|8759435|P2|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0
2531037|NCT01633060|8759436|P1|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1
2531038|NCT01633060|8759435|P2|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1
2531039|NCT01633060|8759436|P1|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10
2531040|NCT01633060|8759435|P2|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0
2531041|NCT01633060|8759436|P1|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1
2531042|NCT01633060|8759435|P2|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
2531043|NCT01633060|8759436|P1|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2
2531044|NCT01633060|8759435|P2|Treatment Phase|Death|3
2531045|NCT01633060|8759436|P1|Treatment Phase|Death|4
2531046|NCT01633060|8759435|P2|Treatment Phase|Subject/guardian decision|4
2531047|NCT01633060|8759436|P1|Treatment Phase|Subject/guardian decision|25
2531048|NCT01633060|8759435|P2|Treatment Phase|Study Terminated by sponsor|3
2531049|NCT01633060|8759436|P1|Treatment Phase|Study Terminated by sponsor|7
2531050|NCT01633060|8759435|P2|Treatment Phase|Protocol Deviation|0
2531051|NCT01633060|8759436|P1|Treatment Phase|Protocol Deviation|1
2531052|NCT01633060|8759435|P2|Treatment Phase|Progressive Disease|120
2531053|NCT01633060|8759436|P1|Treatment Phase|Progressive Disease|210
2531054|NCT01633060|8759435|P2|Treatment Phase|Physician Decision|7
2531055|NCT01633060|8759436|P1|Treatment Phase|Physician Decision|16
2531056|NCT01633060|8759435|P2|Treatment Phase|Lost to Follow-up|0
2531057|NCT01633060|8759436|P1|Treatment Phase|Lost to Follow-up|1
2531058|NCT01633060|8759435|P2|Treatment Phase|Adverse Event|3
2531059|NCT01633060|8759436|P1|Treatment Phase|Adverse Event|24
2531060|NCT01633060|8759435|P2|Randomization Phase|Technical problem|1
2531061|NCT01633060|8759436|P1|Randomization Phase|Technical problem|0
2531062|NCT01633060|8759435|P2|Randomization Phase|Protocol deviation|2
2531063|NCT01633060|8759436|P1|Randomization Phase|Protocol deviation|1
2531064|NCT01632904|8759476|P2|Overall Study|Reason for discontinuation not available|1
2531065|NCT01632904|8759477|P1|Overall Study|Reason for discontinuation not available|0
2531066|NCT01632904|8759476|P2|Overall Study|Disease Progression|1
2531067|NCT01632904|8759477|P1|Overall Study|Disease Progression|0
2531068|NCT01632904|8759476|P2|Overall Study|Subject decision|2
2531069|NCT01632904|8759477|P1|Overall Study|Subject decision|3
2531070|NCT01632904|8759476|P2|Overall Study|Physician Decision|1
2531071|NCT01632904|8759477|P1|Overall Study|Physician Decision|0
2531072|NCT01632904|8759476|P2|Overall Study|Adverse Event|1
2531073|NCT01632904|8759477|P1|Overall Study|Adverse Event|4
2531074|NCT01632891|8759488|P2|Overall Study|Withdrawal by Subject|0
2531075|NCT01632891|8759489|P1|Overall Study|Withdrawal by Subject|1
2531076|NCT01632891|8759488|P2|Overall Study|Lost to Follow-up|1
2531077|NCT01632891|8759489|P1|Overall Study|Lost to Follow-up|0
2531078|NCT01632878|8759513|P1|Treatment|no information on study completion|43
2531079|NCT01632878|8759513|P1|Treatment|missing information|4
2531080|NCT01632878|8759513|P1|Treatment|Physician Decision|34
2531081|NCT01632878|8759513|P1|Treatment|Withdrawal by Subject|36
2531082|NCT01632878|8759513|P1|Treatment|Lost to Follow-up|41
2531083|NCT01632878|8759513|P1|Screening|Physician Decision|268
2531084|NCT01632800|8759517|P1|Overall Study|Subject did not fit in apparatus|1
2531085|NCT01632579|8759584|P9|Period 2 (Second Intervention)|Adverse Event|0
2531086|NCT01632579|8759585|P8|Period 2 (Second Intervention)|Adverse Event|0
2531087|NCT01632579|8759586|P7|Period 2 (Second Intervention)|Adverse Event|0
2531088|NCT01632579|8759587|P6|Period 2 (Second Intervention)|Adverse Event|0
2531089|NCT01632579|8759588|P5|Period 2 (Second Intervention)|Adverse Event|0
2531090|NCT01632579|8759589|P4|Period 2 (Second Intervention)|Adverse Event|0
2531091|NCT01632579|8759590|P3|Period 2 (Second Intervention)|Adverse Event|0
2531092|NCT01632579|8759591|P2|Period 2 (Second Intervention)|Adverse Event|0
2531093|NCT01632579|8759592|P1|Period 2 (Second Intervention)|Adverse Event|1
2531094|NCT01632579|8759584|P9|Washout Period|Adverse Event|0
2531095|NCT01632579|8759585|P8|Washout Period|Adverse Event|0
2531096|NCT01632579|8759586|P7|Washout Period|Adverse Event|0
2531097|NCT01632579|8759587|P6|Washout Period|Adverse Event|0
2531098|NCT01632579|8759588|P5|Washout Period|Adverse Event|0
2531099|NCT01632579|8759589|P4|Washout Period|Adverse Event|0
2531100|NCT01632579|8759590|P3|Washout Period|Adverse Event|0
2531101|NCT01632579|8759591|P2|Washout Period|Adverse Event|0
2531102|NCT01632579|8759592|P1|Washout Period|Adverse Event|1
2531103|NCT01632566|8759659|P5|Overall Study|Sponsor Decision|2
2531104|NCT01632566|8759660|P4|Overall Study|Sponsor Decision|2
2531105|NCT01632566|8759661|P3|Overall Study|Sponsor Decision|9
2531106|NCT01632566|8759662|P2|Overall Study|Sponsor Decision|2
2531107|NCT01632566|8759663|P1|Overall Study|Sponsor Decision|0
2531108|NCT01632566|8759659|P5|Overall Study|Withdrawal by Subject|0
2531109|NCT01632566|8759660|P4|Overall Study|Withdrawal by Subject|0
2531110|NCT01632566|8759661|P3|Overall Study|Withdrawal by Subject|0
2531111|NCT01632566|8759662|P2|Overall Study|Withdrawal by Subject|1
2531112|NCT01632566|8759663|P1|Overall Study|Withdrawal by Subject|0
2531113|NCT01632345|8759714|P7|Treatment: Part II|Withdrawal by Subject|2
2531114|NCT01632345|8759715|P6|Treatment: Part II|Withdrawal by Subject|2
2531115|NCT01632345|8759716|P5|Treatment: Part II|Withdrawal by Subject|0
2531116|NCT01632345|8759717|P4|Treatment: Part II|Withdrawal by Subject|0
2531117|NCT01632345|8759718|P3|Treatment: Part II|Withdrawal by Subject|0
2531118|NCT01632345|8759719|P2|Treatment: Part II|Withdrawal by Subject|0
2531119|NCT01632345|8759720|P1|Treatment: Part II|Withdrawal by Subject|0
2531120|NCT01632345|8759714|P7|Treatment: Part II|Non-Compliance with Study Drug|0
2531121|NCT01632345|8759715|P6|Treatment: Part II|Non-Compliance with Study Drug|3
2531122|NCT01632345|8759716|P5|Treatment: Part II|Non-Compliance with Study Drug|0
2531123|NCT01632345|8759717|P4|Treatment: Part II|Non-Compliance with Study Drug|0
2531124|NCT01632345|8759718|P3|Treatment: Part II|Non-Compliance with Study Drug|0
2531125|NCT01632345|8759719|P2|Treatment: Part II|Non-Compliance with Study Drug|0
2531126|NCT01632345|8759720|P1|Treatment: Part II|Non-Compliance with Study Drug|0
2531127|NCT01632345|8759714|P7|Treatment: Part II|Lost to Follow-up|1
2531128|NCT01632345|8759715|P6|Treatment: Part II|Lost to Follow-up|3
2531129|NCT01632345|8759716|P5|Treatment: Part II|Lost to Follow-up|0
2531130|NCT01632345|8759717|P4|Treatment: Part II|Lost to Follow-up|0
2531131|NCT01632345|8759718|P3|Treatment: Part II|Lost to Follow-up|0
2531132|NCT01632345|8759719|P2|Treatment: Part II|Lost to Follow-up|0
2531133|NCT01632345|8759720|P1|Treatment: Part II|Lost to Follow-up|0
2531134|NCT01632345|8759714|P7|Treatment: Part II|Adverse Event|8
2531135|NCT01632345|8759715|P6|Treatment: Part II|Adverse Event|3
2531136|NCT01632345|8759716|P5|Treatment: Part II|Adverse Event|0
2531137|NCT01632345|8759717|P4|Treatment: Part II|Adverse Event|0
2531138|NCT01632345|8759718|P3|Treatment: Part II|Adverse Event|0
2531139|NCT01632345|8759719|P2|Treatment: Part II|Adverse Event|0
2531140|NCT01632345|8759720|P1|Treatment: Part II|Adverse Event|0
2531141|NCT01632345|8759714|P7|Treatment: Part I|Withdrawal by Subject|0
2531142|NCT01632345|8759715|P6|Treatment: Part I|Withdrawal by Subject|0
2531143|NCT01632345|8759716|P5|Treatment: Part I|Withdrawal by Subject|4
2531144|NCT01632345|8759717|P4|Treatment: Part I|Withdrawal by Subject|1
2531145|NCT01632345|8759718|P3|Treatment: Part I|Withdrawal by Subject|4
2531146|NCT01632345|8759719|P2|Treatment: Part I|Withdrawal by Subject|4
2531147|NCT01632345|8759720|P1|Treatment: Part I|Withdrawal by Subject|3
2531148|NCT01632345|8759714|P7|Treatment: Part I|Protocol Deviation|0
2531149|NCT01632345|8759715|P6|Treatment: Part I|Protocol Deviation|0
2531150|NCT01632345|8759716|P5|Treatment: Part I|Protocol Deviation|0
2531151|NCT01632345|8759717|P4|Treatment: Part I|Protocol Deviation|1
2531152|NCT01632345|8759718|P3|Treatment: Part I|Protocol Deviation|1
2531153|NCT01632345|8759719|P2|Treatment: Part I|Protocol Deviation|0
2531154|NCT01632345|8759720|P1|Treatment: Part I|Protocol Deviation|0
2531155|NCT01632345|8759714|P7|Treatment: Part I|Pregnancy|0
2531156|NCT01632345|8759715|P6|Treatment: Part I|Pregnancy|0
2531157|NCT01632345|8759716|P5|Treatment: Part I|Pregnancy|0
2531158|NCT01632345|8759717|P4|Treatment: Part I|Pregnancy|0
2531159|NCT01632345|8759718|P3|Treatment: Part I|Pregnancy|0
2531160|NCT01632345|8759719|P2|Treatment: Part I|Pregnancy|1
2531161|NCT01632345|8759720|P1|Treatment: Part I|Pregnancy|0
2531162|NCT01632345|8759714|P7|Treatment: Part I|Physician Decision|0
2531163|NCT01632345|8759715|P6|Treatment: Part I|Physician Decision|0
2531164|NCT01632345|8759716|P5|Treatment: Part I|Physician Decision|1
2531165|NCT01632345|8759717|P4|Treatment: Part I|Physician Decision|0
2531166|NCT01632345|8759718|P3|Treatment: Part I|Physician Decision|0
2531167|NCT01632345|8759719|P2|Treatment: Part I|Physician Decision|1
2531168|NCT01632345|8759720|P1|Treatment: Part I|Physician Decision|2
2531169|NCT01632345|8759714|P7|Treatment: Part I|Non-Compliance with Study Drug|0
2531170|NCT01632345|8759715|P6|Treatment: Part I|Non-Compliance with Study Drug|0
2531171|NCT01632345|8759716|P5|Treatment: Part I|Non-Compliance with Study Drug|0
2531172|NCT01632345|8759717|P4|Treatment: Part I|Non-Compliance with Study Drug|1
2531173|NCT01632345|8759718|P3|Treatment: Part I|Non-Compliance with Study Drug|2
2531174|NCT01632345|8759719|P2|Treatment: Part I|Non-Compliance with Study Drug|2
2531175|NCT01632345|8759720|P1|Treatment: Part I|Non-Compliance with Study Drug|3
2531176|NCT01632345|8759714|P7|Treatment: Part I|Lost to Follow-up|0
2531177|NCT01632345|8759715|P6|Treatment: Part I|Lost to Follow-up|0
2531178|NCT01632345|8759716|P5|Treatment: Part I|Lost to Follow-up|4
2531179|NCT01632345|8759717|P4|Treatment: Part I|Lost to Follow-up|3
2531180|NCT01632345|8759718|P3|Treatment: Part I|Lost to Follow-up|1
2531181|NCT01632345|8759719|P2|Treatment: Part I|Lost to Follow-up|2
2531182|NCT01632345|8759720|P1|Treatment: Part I|Lost to Follow-up|3
2531183|NCT01632345|8759714|P7|Treatment: Part I|Lack of Efficacy|0
2531184|NCT01632345|8759715|P6|Treatment: Part I|Lack of Efficacy|0
2531185|NCT01632345|8759716|P5|Treatment: Part I|Lack of Efficacy|1
2531186|NCT01632345|8759717|P4|Treatment: Part I|Lack of Efficacy|1
2531187|NCT01632345|8759718|P3|Treatment: Part I|Lack of Efficacy|0
2531188|NCT01632345|8759719|P2|Treatment: Part I|Lack of Efficacy|1
2531189|NCT01632345|8759720|P1|Treatment: Part I|Lack of Efficacy|0
2531190|NCT01632345|8759714|P7|Treatment: Part I|Adverse Event|0
2531191|NCT01632345|8759715|P6|Treatment: Part I|Adverse Event|0
2531192|NCT01632345|8759716|P5|Treatment: Part I|Adverse Event|3
2531193|NCT01632345|8759717|P4|Treatment: Part I|Adverse Event|1
2531194|NCT01632345|8759718|P3|Treatment: Part I|Adverse Event|2
2531195|NCT01632345|8759719|P2|Treatment: Part I|Adverse Event|4
2531196|NCT01632345|8759720|P1|Treatment: Part I|Adverse Event|1
2531197|NCT01632306|8759782|P3|Overall Study|Protocol Violation|0
2531198|NCT01632306|8759783|P2|Overall Study|Protocol Violation|0
2531199|NCT01632306|8759784|P1|Overall Study|Protocol Violation|1
2531200|NCT01632280|8759800|P2|Overall Study|Withdrawal by Subject|0
2531201|NCT01632280|8759801|P1|Overall Study|Withdrawal by Subject|1
2531202|NCT01632241|8759817|P2|Open-label (Week 52 to Week 76)|Adverse Event|0
2531203|NCT01632241|8759818|P1|Open-label (Week 52 to Week 76)|Adverse Event|1
2531204|NCT01632241|8759817|P2|Open-label (Week 52 to Week 76)|Lack of Efficacy|2
2531205|NCT01632241|8759818|P1|Open-label (Week 52 to Week 76)|Lack of Efficacy|0
2531206|NCT01632241|8759817|P2|Open-label (Week 52 to Week 76)|Protocol Violation|2
2531207|NCT01632241|8759818|P1|Open-label (Week 52 to Week 76)|Protocol Violation|0
2531208|NCT01632241|8759817|P2|Open-label (Week 52 to Week 76)|Site Closed|8
2531209|NCT01632241|8759818|P1|Open-label (Week 52 to Week 76)|Site Closed|2
2531210|NCT01632241|8759817|P2|Open-label (Week 52 to Week 76)|Lost to Follow-up|4
2531211|NCT01632241|8759818|P1|Open-label (Week 52 to Week 76)|Lost to Follow-up|1
2531212|NCT01632241|8759817|P2|Open-label (Week 52 to Week 76)|Physician Decision|4
2531213|NCT01632241|8759818|P1|Open-label (Week 52 to Week 76)|Physician Decision|1
2531214|NCT01632241|8759817|P2|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2
2531215|NCT01632241|8759818|P1|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5
2531216|NCT01632241|8759817|P2|Double-blinded (Up to Week 52)|Adverse Event|19
2531217|NCT01632241|8759818|P1|Double-blinded (Up to Week 52)|Adverse Event|10
2531218|NCT01632241|8759817|P2|Double-blinded (Up to Week 52)|Withdrawal by Subject|14
2531219|NCT01632241|8759818|P1|Double-blinded (Up to Week 52)|Withdrawal by Subject|10
2531220|NCT01632241|8759817|P2|Double-blinded (Up to Week 52)|Lack of Efficacy|15
2531221|NCT01632241|8759818|P1|Double-blinded (Up to Week 52)|Lack of Efficacy|9
2531222|NCT01632241|8759817|P2|Double-blinded (Up to Week 52)|Physician Decision|12
2531223|NCT01632241|8759818|P1|Double-blinded (Up to Week 52)|Physician Decision|9
2531224|NCT01632241|8759817|P2|Double-blinded (Up to Week 52)|Lost to Follow-up|8
2531225|NCT01632241|8759818|P1|Double-blinded (Up to Week 52)|Lost to Follow-up|1
2531226|NCT01632241|8759817|P2|Double-blinded (Up to Week 52)|Protocol Violation|6
2531227|NCT01632241|8759818|P1|Double-blinded (Up to Week 52)|Protocol Violation|2
2531228|NCT01632241|8759817|P2|Double-blinded (Up to Week 52)|Site Closed|5
2531229|NCT01632241|8759818|P1|Double-blinded (Up to Week 52)|Site Closed|3
2531230|NCT01632150|8759877|P1|Overall Study|Moved to compassionate program|2
2531231|NCT01632150|8759877|P1|Overall Study|Patient underwent autologous transplant|1
2531232|NCT01632150|8759877|P1|Overall Study|Withdrawal by Subject|2
2531233|NCT01632150|8759877|P1|Overall Study|Unrelated adverse event|7
2531234|NCT01632150|8759877|P1|Overall Study|Study drug toxicity|1
2531235|NCT01632150|8759877|P1|Overall Study|Disease progression|27
2531236|NCT01632020|8759886|P2|Overall Study|Adverse Event|0
2531237|NCT01632020|8759887|P1|Overall Study|Adverse Event|1
2531238|NCT01632020|8759886|P2|Overall Study|Withdrawal by Subject|0
2531239|NCT01632020|8759887|P1|Overall Study|Withdrawal by Subject|1
2531240|NCT01631864|8759906|P2|Overall Study|Adverse Event|3
2531241|NCT01631864|8759907|P1|Overall Study|Adverse Event|2
2531242|NCT01631864|8759906|P2|Overall Study|Withdrawal by Subject|1
2531243|NCT01631864|8759907|P1|Overall Study|Withdrawal by Subject|0
2531244|NCT01631825|8759919|P1|Overall Study|Physician Decision|2
2531245|NCT01631825|8759919|P1|Overall Study|Discontinuation criteria|1
2531246|NCT01631825|8759919|P1|Overall Study|Protocol Violation|4
2531247|NCT01631825|8759919|P1|Overall Study|Withdrawal by Subject|9
2531248|NCT01631825|8759919|P1|Overall Study|Lack of Efficacy|7
2531249|NCT01631825|8759919|P1|Overall Study|Adverse Event|42
2531250|NCT01631812|8759939|P1|Overall Study|Physician Decision|3
2531251|NCT01631812|8759939|P1|Overall Study|Withdrawal by Subject|4
2531252|NCT01631812|8759939|P1|Overall Study|Lack of Efficacy|5
2531253|NCT01631812|8759939|P1|Overall Study|Adverse Event|25
2531254|NCT01631747|8759949|P2|One Year Infant Outcomes|Patient Refused|9
2531255|NCT01631747|8759950|P1|One Year Infant Outcomes|Patient Refused|13
2531256|NCT01631747|8759949|P2|Live Birth|Stillbirth|1
2531257|NCT01631747|8759950|P1|Live Birth|Stillbirth|1
2531258|NCT01631747|8759949|P2|Live Birth|MIscarriage|0
2531259|NCT01631747|8759950|P1|Live Birth|MIscarriage|2
2531260|NCT01631747|8759949|P2|Live Birth|Pregnancy Termination|0
2531261|NCT01631747|8759950|P1|Live Birth|Pregnancy Termination|1
2531262|NCT01631747|8759949|P2|Randomization Through End of Pregnancy|Lost to Follow-up|0
2531263|NCT01631747|8759950|P1|Randomization Through End of Pregnancy|Lost to Follow-up|1
2531264|NCT01631435|8760127|P1|Overall Study|incomplete study procedure|5
2531265|NCT01631435|8760127|P1|Overall Study|Withdrawal by Subject|2
2531266|NCT01631435|8760127|P1|Overall Study|Adverse Event|2
2531267|NCT01631227|8760141|P2|Overall Study|administrative|1
2531268|NCT01631227|8760142|P1|Overall Study|administrative|2
2531269|NCT01631227|8760141|P2|Overall Study|Adverse Event|0
2531270|NCT01631227|8760142|P1|Overall Study|Adverse Event|1
2531271|NCT01631227|8760141|P2|Overall Study|withdrawn consent|21
2531272|NCT01631227|8760142|P1|Overall Study|withdrawn consent|27
2531273|NCT01631214|8760150|P2|Overall Study|Administrative Decision|0
2531274|NCT01631214|8760151|P1|Overall Study|Administrative Decision|1
2531275|NCT01631214|8760150|P2|Overall Study|Ineligibility determined|2
2531276|NCT01631214|8760151|P1|Overall Study|Ineligibility determined|5
2531277|NCT01631214|8760150|P2|Overall Study|Protocol Deviation|3
2531278|NCT01631214|8760151|P1|Overall Study|Protocol Deviation|4
2531279|NCT01631214|8760150|P2|Overall Study|Requirement for Alternative Therapy|3
2531280|NCT01631214|8760151|P1|Overall Study|Requirement for Alternative Therapy|8
2531281|NCT01631214|8760150|P2|Overall Study|Noncompliance|15
2531282|NCT01631214|8760151|P1|Overall Study|Noncompliance|16
2531283|NCT01631214|8760150|P2|Overall Study|Other|19
2531284|NCT01631214|8760151|P1|Overall Study|Other|22
2531285|NCT01631214|8760150|P2|Overall Study|Adverse Event|45
2531286|NCT01631214|8760151|P1|Overall Study|Adverse Event|45
2531287|NCT01631214|8760150|P2|Overall Study|Lost to Follow-up|40
2531288|NCT01631214|8760151|P1|Overall Study|Lost to Follow-up|54
2531289|NCT01631214|8760150|P2|Overall Study|Death|106
2531290|NCT01631214|8760151|P1|Overall Study|Death|113
2531291|NCT01631214|8760150|P2|Overall Study|Withdrawal by Subject|290
2531292|NCT01631214|8760151|P1|Overall Study|Withdrawal by Subject|276
2531293|NCT01630811|8760260|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|0
2531294|NCT01630811|8760261|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|1
2531295|NCT01630616|8760288|P6|Overall Study|Withdrawal by Subject|0
2531296|NCT01630616|8760289|P5|Overall Study|Withdrawal by Subject|0
2531297|NCT01630616|8760290|P4|Overall Study|Withdrawal by Subject|2
2531298|NCT01630616|8760291|P3|Overall Study|Withdrawal by Subject|0
2531299|NCT01630616|8760292|P2|Overall Study|Withdrawal by Subject|0
2531300|NCT01630616|8760293|P1|Overall Study|Withdrawal by Subject|0
2531301|NCT01630616|8760288|P6|Overall Study|Adverse Event|0
2531302|NCT01630616|8760289|P5|Overall Study|Adverse Event|0
2531303|NCT01630616|8760290|P4|Overall Study|Adverse Event|1
2531304|NCT01630616|8760291|P3|Overall Study|Adverse Event|0
2531305|NCT01630616|8760292|P2|Overall Study|Adverse Event|0
2531306|NCT01630616|8760293|P1|Overall Study|Adverse Event|0
2531307|NCT01630135|8760393|P2|Overall Study|Protocol-defined Stopping Criteria Met|2
2531308|NCT01630135|8760394|P1|Overall Study|Protocol-defined Stopping Criteria Met|0
2531309|NCT01629966|8760458|P3|Overall Study|Adverse Event|30
2531310|NCT01629966|8760459|P2|Overall Study|Adverse Event|18
2531311|NCT01629966|8760460|P1|Overall Study|Adverse Event|11
2531312|NCT01629966|8760458|P3|Overall Study|Lack of Efficacy|4
2531313|NCT01629966|8760459|P2|Overall Study|Lack of Efficacy|2
2531314|NCT01629966|8760460|P1|Overall Study|Lack of Efficacy|5
2531315|NCT01629966|8760458|P3|Overall Study|Protocol Violation|7
2531316|NCT01629966|8760459|P2|Overall Study|Protocol Violation|9
2531317|NCT01629966|8760460|P1|Overall Study|Protocol Violation|7
2531318|NCT01629966|8760458|P3|Overall Study|Withdrawal by Subject|16
2531319|NCT01629966|8760459|P2|Overall Study|Withdrawal by Subject|9
2531320|NCT01629966|8760460|P1|Overall Study|Withdrawal by Subject|8
2531321|NCT01629966|8760458|P3|Overall Study|Lost to Follow-up|9
2531322|NCT01629966|8760459|P2|Overall Study|Lost to Follow-up|13
2531323|NCT01629966|8760460|P1|Overall Study|Lost to Follow-up|10
2531324|NCT01629966|8760458|P3|Overall Study|Pregnancy|0
2531325|NCT01629966|8760459|P2|Overall Study|Pregnancy|1
2531326|NCT01629966|8760460|P1|Overall Study|Pregnancy|0
2531327|NCT01629953|8760473|P2|Overall Study|Lost to Follow-up|14
2531328|NCT01629953|8760474|P1|Overall Study|Lost to Follow-up|10
2531329|NCT01629953|8760473|P2|Overall Study|Death|1
2531330|NCT01629953|8760474|P1|Overall Study|Death|3
2531331|NCT01629823|8760494|P3|Washout Period|Protocol Violation|0
2531332|NCT01629823|8760495|P2|Washout Period|Protocol Violation|1
2531333|NCT01629823|8760496|P1|Washout Period|Protocol Violation|0
2531334|NCT01629823|8760494|P3|Washout Period|Pregnancy|0
2531335|NCT01629823|8760495|P2|Washout Period|Pregnancy|0
2531336|NCT01629823|8760496|P1|Washout Period|Pregnancy|1
2531337|NCT01629823|8760494|P3|Washout Period|Safety|0
2531338|NCT01629823|8760495|P2|Washout Period|Safety|5
2531339|NCT01629823|8760496|P1|Washout Period|Safety|2
2531340|NCT01629823|8760494|P3|Trial Period|Failed to hold medication|1
2531341|NCT01629823|8760495|P2|Trial Period|Failed to hold medication|0
2531342|NCT01629823|8760496|P1|Trial Period|Failed to hold medication|0
2531343|NCT01629823|8760494|P3|Trial Period|Out-of-window visit|0
2531344|NCT01629823|8760495|P2|Trial Period|Out-of-window visit|2
2531345|NCT01629823|8760496|P1|Trial Period|Out-of-window visit|0
2531346|NCT01629823|8760494|P3|Trial Period|Adverse Event|0
2531347|NCT01629823|8760495|P2|Trial Period|Adverse Event|1
2531348|NCT01629823|8760496|P1|Trial Period|Adverse Event|0
2531349|NCT01629823|8760494|P3|Trial Period|Pregnancy|0
2531350|NCT01629823|8760495|P2|Trial Period|Pregnancy|0
2531351|NCT01629823|8760496|P1|Trial Period|Pregnancy|1
2531352|NCT01629823|8760494|P3|Trial Period|Pre-diluent FEV₁ predicted <70%|1
2531353|NCT01629823|8760495|P2|Trial Period|Pre-diluent FEV₁ predicted <70%|1
2531354|NCT01629823|8760496|P1|Trial Period|Pre-diluent FEV₁ predicted <70%|1
2531355|NCT01629823|8760494|P3|Trial Period|Missed visit|8
2531356|NCT01629823|8760495|P2|Trial Period|Missed visit|9
2531357|NCT01629823|8760496|P1|Trial Period|Missed visit|11
2531358|NCT01629706|8760531|P1|Phase 2 Habitual|Lost to Follow Up after Dispense|1
2531359|NCT01629706|8760531|P1|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1
2531360|NCT01629706|8760531|P1|Phase 2 Habitual|Relocation prior to Dispense|1
2531361|NCT01629706|8760531|P1|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1
2531362|NCT01629706|8760531|P1|Phase 2 Habitual|Screen Failure|6
2531363|NCT01629706|8760531|P1|Phase 1 PureVision|No Solution-Induced Corneal Staining|3
2531364|NCT01629706|8760531|P1|Phase 1 PureVision|Inconvenience prior to Dispense|1
2531365|NCT01629706|8760531|P1|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1
2531366|NCT01629706|8760531|P1|Phase 1 PureVision|Screen Failure|4
2531367|NCT01629693|8760559|P2|Overall Study|Subject decision unrelated to AE|1
2531368|NCT01629693|8760560|P1|Overall Study|Subject decision unrelated to AE|0
2531369|NCT01629693|8760559|P2|Overall Study|Poor comfort of study lenses|2
2531370|NCT01629693|8760560|P1|Overall Study|Poor comfort of study lenses|0
2531371|NCT01629693|8760559|P2|Overall Study|Investigator decision|1
2531372|NCT01629693|8760560|P1|Overall Study|Investigator decision|0
2531373|NCT01629693|8760559|P2|Overall Study|Adverse Event|0
2531374|NCT01629693|8760560|P1|Overall Study|Adverse Event|1
2531375|NCT01629693|8760559|P2|Overall Study|Withdrawal by Subject|2
2531376|NCT01629693|8760560|P1|Overall Study|Withdrawal by Subject|2
2531377|NCT01629693|8760559|P2|Overall Study|Lost to Follow-up|4
2531378|NCT01629693|8760560|P1|Overall Study|Lost to Follow-up|2
2531379|NCT01629667|8760569|P3|Overall Study|Code break|0
2531380|NCT01629667|8760570|P2|Overall Study|Code break|0
2531381|NCT01629667|8760571|P1|Overall Study|Code break|1
2531382|NCT01629667|8760569|P3|Overall Study|Enrolled in another clinical study|0
2531383|NCT01629667|8760570|P2|Overall Study|Enrolled in another clinical study|1
2531384|NCT01629667|8760571|P1|Overall Study|Enrolled in another clinical study|0
2531385|NCT01629667|8760569|P3|Overall Study|Site error in safety follow-up|1
2531386|NCT01629667|8760570|P2|Overall Study|Site error in safety follow-up|0
2531387|NCT01629667|8760571|P1|Overall Study|Site error in safety follow-up|0
2531388|NCT01629667|8760569|P3|Overall Study|Started other medicine|1
2531389|NCT01629667|8760570|P2|Overall Study|Started other medicine|0
2531390|NCT01629667|8760571|P1|Overall Study|Started other medicine|1
2531391|NCT01629667|8760569|P3|Overall Study|Early tretmt termntd, cmpltd safety f-up|8
2531392|NCT01629667|8760570|P2|Overall Study|Early tretmt termntd, cmpltd safety f-up|11
2531393|NCT01629667|8760571|P1|Overall Study|Early tretmt termntd, cmpltd safety f-up|9
2531394|NCT01629667|8760569|P3|Overall Study|Requiring lung transplant|3
2531395|NCT01629667|8760570|P2|Overall Study|Requiring lung transplant|1
2531396|NCT01629667|8760571|P1|Overall Study|Requiring lung transplant|2
2531397|NCT01629667|8760569|P3|Overall Study|Ongoing AE worsening right heart failure|0
2531398|NCT01629667|8760570|P2|Overall Study|Ongoing AE worsening right heart failure|1
2531399|NCT01629667|8760571|P1|Overall Study|Ongoing AE worsening right heart failure|0
2531400|NCT01629667|8760569|P3|Overall Study|Randomized, not treated|0
2531401|NCT01629667|8760570|P2|Overall Study|Randomized, not treated|1
2531402|NCT01629667|8760571|P1|Overall Study|Randomized, not treated|2
2531403|NCT01629667|8760569|P3|Overall Study|Death|3
2531404|NCT01629667|8760570|P2|Overall Study|Death|5
2531405|NCT01629667|8760571|P1|Overall Study|Death|1
2531406|NCT01629667|8760569|P3|Overall Study|Withdrawal by Subject|28
2531407|NCT01629667|8760570|P2|Overall Study|Withdrawal by Subject|20
2531408|NCT01629667|8760571|P1|Overall Study|Withdrawal by Subject|31
2531409|NCT01629667|8760569|P3|Overall Study|Lost to Follow-up|1
2531410|NCT01629667|8760570|P2|Overall Study|Lost to Follow-up|1
2531411|NCT01629667|8760571|P1|Overall Study|Lost to Follow-up|0
2531412|NCT01629589|8760655|P2|Overall Study|Did not receive study vaccine|1
2531413|NCT01629589|8760656|P1|Overall Study|Did not receive study vaccine|0
2531414|NCT01629589|8760655|P2|Overall Study|Withdrawal by Subject|3
2531415|NCT01629589|8760656|P1|Overall Study|Withdrawal by Subject|2
2531416|NCT01629589|8760655|P2|Overall Study|Lost to Follow-up|1
2531417|NCT01629589|8760656|P1|Overall Study|Lost to Follow-up|2
2531418|NCT01629589|8760655|P2|Overall Study|Protocol Violation|2
2531419|NCT01629589|8760656|P1|Overall Study|Protocol Violation|4
2531420|NCT01629563|8760674|P2|Overall Study|Protocol Violation|1
2531421|NCT01629563|8760675|P1|Overall Study|Protocol Violation|0
2531422|NCT01629563|8760674|P2|Overall Study|Lack of return of menses|7
2531423|NCT01629563|8760675|P1|Overall Study|Lack of return of menses|12
2531424|NCT01629563|8760674|P2|Overall Study|surgery|3
2531425|NCT01629563|8760675|P1|Overall Study|surgery|0
2531426|NCT01629563|8760674|P2|Overall Study|Withdrawal by Subject|20
2531427|NCT01629563|8760675|P1|Overall Study|Withdrawal by Subject|27
2531428|NCT01629563|8760674|P2|Overall Study|Protocol Violation|1
2531429|NCT01629563|8760675|P1|Overall Study|Protocol Violation|0
2531430|NCT01629563|8760674|P2|Overall Study|Pregnancy|2
2531431|NCT01629563|8760675|P1|Overall Study|Pregnancy|1
2531432|NCT01629563|8760674|P2|Overall Study|Lost to Follow-up|0
2531433|NCT01629563|8760675|P1|Overall Study|Lost to Follow-up|1
2531434|NCT01629563|8760674|P2|Overall Study|Lack of Efficacy|3
2531435|NCT01629563|8760675|P1|Overall Study|Lack of Efficacy|2
2531436|NCT01629563|8760674|P2|Overall Study|Death|0
2531437|NCT01629563|8760675|P1|Overall Study|Death|2
2531438|NCT01629563|8760674|P2|Overall Study|Adverse Event|16
2531439|NCT01629563|8760675|P1|Overall Study|Adverse Event|16
2531440|NCT01628965|8760764|P1|Overall Study|Discontinuation criteria|8
2531441|NCT01628965|8760764|P1|Overall Study|Lost to Follow-up|1
2531442|NCT01628965|8760764|P1|Overall Study|Withdrawal by Subject|3
2531443|NCT01628965|8760764|P1|Overall Study|Lack of Efficacy|7
2531444|NCT01628965|8760764|P1|Overall Study|Adverse Event|30
2531445|NCT01628926|8760773|P3|Overall Study|Physician Decision|1
2531446|NCT01628926|8760774|P2|Overall Study|Physician Decision|2
2531447|NCT01628926|8760775|P1|Overall Study|Physician Decision|2
2531448|NCT01628926|8760773|P3|Overall Study|Discontinuation criteria|0
2531449|NCT01628926|8760774|P2|Overall Study|Discontinuation criteria|4
2531450|NCT01628926|8760775|P1|Overall Study|Discontinuation criteria|3
2531451|NCT01628926|8760773|P3|Overall Study|Protocol Violation|0
2531452|NCT01628926|8760774|P2|Overall Study|Protocol Violation|1
2531453|NCT01628926|8760775|P1|Overall Study|Protocol Violation|0
2531454|NCT01628926|8760773|P3|Overall Study|Withdrawal by Subject|2
2531455|NCT01628926|8760774|P2|Overall Study|Withdrawal by Subject|4
2531456|NCT01628926|8760775|P1|Overall Study|Withdrawal by Subject|6
2531457|NCT01628926|8760773|P3|Overall Study|Lack of Efficacy|5
2531458|NCT01628926|8760774|P2|Overall Study|Lack of Efficacy|1
2531459|NCT01628926|8760775|P1|Overall Study|Lack of Efficacy|2
2531460|NCT01628926|8760773|P3|Overall Study|Adverse Event|9
2531461|NCT01628926|8760774|P2|Overall Study|Adverse Event|11
2531462|NCT01628926|8760775|P1|Overall Study|Adverse Event|13
2531463|NCT01628913|8760824|P2|Overall Study|Physician Decision|3
2531464|NCT01628913|8760825|P1|Overall Study|Physician Decision|1
2531465|NCT01628913|8760824|P2|Overall Study|Withdrawal by Subject|0
2531466|NCT01628913|8760825|P1|Overall Study|Withdrawal by Subject|1
2531467|NCT01628913|8760824|P2|Overall Study|study terminated by Sponsor|9
2531468|NCT01628913|8760825|P1|Overall Study|study terminated by Sponsor|4
2531469|NCT01628913|8760824|P2|Overall Study|Death|0
2531470|NCT01628913|8760825|P1|Overall Study|Death|1
2531471|NCT01628913|8760824|P2|Overall Study|Protocol Violation|0
2531472|NCT01628913|8760825|P1|Overall Study|Protocol Violation|1
2531473|NCT01628913|8760824|P2|Overall Study|Disease Progression|14
2531474|NCT01628913|8760825|P1|Overall Study|Disease Progression|11
2531475|NCT01628913|8760824|P2|Overall Study|Adverse Event|5
2531476|NCT01628913|8760825|P1|Overall Study|Adverse Event|12
2531477|NCT01628874|8760839|P2|Overall Study|Age >4 months|2
2531478|NCT01628874|8760840|P1|Overall Study|Age >4 months|4
2531479|NCT01628874|8760839|P2|Overall Study|Physician Decision|1
2531480|NCT01628874|8760840|P1|Overall Study|Physician Decision|1
2531481|NCT01628848|8760856|P2|Overall Study|Physician Decision|1
2531482|NCT01628848|8760857|P1|Overall Study|Physician Decision|3
2531483|NCT01628848|8760856|P2|Overall Study|Withdrawal by Subject|2
2531484|NCT01628848|8760857|P1|Overall Study|Withdrawal by Subject|0
2531485|NCT01628848|8760856|P2|Overall Study|Lack of Efficacy|4
2531486|NCT01628848|8760857|P1|Overall Study|Lack of Efficacy|0
2531487|NCT01628848|8760856|P2|Overall Study|Adverse Event|7
2531488|NCT01628848|8760857|P1|Overall Study|Adverse Event|9
2531489|NCT01628692|8760900|P6|Overall Study|Completed 12 Week only|1
2531490|NCT01628692|8760901|P5|Overall Study|Completed 12 Week only|0
2531491|NCT01628692|8760902|P4|Overall Study|Completed 12 Week only|0
2531492|NCT01628692|8760903|P3|Overall Study|Completed 12 Week only|0
2531493|NCT01628692|8760904|P2|Overall Study|Completed 12 Week only|0
2531494|NCT01628692|8760905|P1|Overall Study|Completed 12 Week only|0
2531495|NCT01628692|8760900|P6|Overall Study|Administrative reason by sponsor|1
2531496|NCT01628692|8760901|P5|Overall Study|Administrative reason by sponsor|0
2531497|NCT01628692|8760902|P4|Overall Study|Administrative reason by sponsor|0
2531498|NCT01628692|8760903|P3|Overall Study|Administrative reason by sponsor|0
2531499|NCT01628692|8760904|P2|Overall Study|Administrative reason by sponsor|0
2531500|NCT01628692|8760905|P1|Overall Study|Administrative reason by sponsor|0
2531501|NCT01628692|8760900|P6|Overall Study|Poor compliance/noncompliance|0
2531502|NCT01628692|8760901|P5|Overall Study|Poor compliance/noncompliance|0
2531503|NCT01628692|8760902|P4|Overall Study|Poor compliance/noncompliance|0
2531504|NCT01628692|8760903|P3|Overall Study|Poor compliance/noncompliance|0
2531505|NCT01628692|8760904|P2|Overall Study|Poor compliance/noncompliance|0
2531506|NCT01628692|8760905|P1|Overall Study|Poor compliance/noncompliance|1
2531507|NCT01628692|8760900|P6|Overall Study|Death|0
2531508|NCT01628692|8760901|P5|Overall Study|Death|0
2531509|NCT01628692|8760902|P4|Overall Study|Death|0
2531510|NCT01628692|8760903|P3|Overall Study|Death|0
2531511|NCT01628692|8760904|P2|Overall Study|Death|1
2531512|NCT01628692|8760905|P1|Overall Study|Death|0
2531513|NCT01628692|8760900|P6|Overall Study|Withdrawal by Subject|0
2531514|NCT01628692|8760901|P5|Overall Study|Withdrawal by Subject|0
2531515|NCT01628692|8760902|P4|Overall Study|Withdrawal by Subject|0
2531516|NCT01628692|8760903|P3|Overall Study|Withdrawal by Subject|1
2531517|NCT01628692|8760904|P2|Overall Study|Withdrawal by Subject|1
2531518|NCT01628692|8760905|P1|Overall Study|Withdrawal by Subject|0
2531519|NCT01628692|8760900|P6|Overall Study|Adverse Event|0
2531520|NCT01628692|8760901|P5|Overall Study|Adverse Event|0
2531521|NCT01628692|8760902|P4|Overall Study|Adverse Event|0
2531522|NCT01628692|8760903|P3|Overall Study|Adverse Event|2
2531523|NCT01628692|8760904|P2|Overall Study|Adverse Event|0
2531524|NCT01628692|8760905|P1|Overall Study|Adverse Event|2
2531525|NCT01628692|8760900|P6|Overall Study|Lack of Efficacy|7
2531526|NCT01628692|8760901|P5|Overall Study|Lack of Efficacy|4
2531527|NCT01628692|8760902|P4|Overall Study|Lack of Efficacy|1
2531528|NCT01628692|8760903|P3|Overall Study|Lack of Efficacy|5
2531529|NCT01628692|8760904|P2|Overall Study|Lack of Efficacy|4
2531530|NCT01628692|8760905|P1|Overall Study|Lack of Efficacy|4
2531531|NCT01628549|8760975|P4|Overall Study|positive pregnancy test|1
2531532|NCT01628549|8760976|P3|Overall Study|positive pregnancy test|0
2531533|NCT01628549|8760977|P2|Overall Study|positive pregnancy test|0
2531534|NCT01628549|8760978|P1|Overall Study|positive pregnancy test|0
2531535|NCT01628549|8760975|P4|Overall Study|abnormal laboratory test results|0
2531536|NCT01628549|8760976|P3|Overall Study|abnormal laboratory test results|1
2531537|NCT01628549|8760977|P2|Overall Study|abnormal laboratory test results|0
2531538|NCT01628549|8760978|P1|Overall Study|abnormal laboratory test results|0
2531539|NCT01628549|8760975|P4|Overall Study|withdrawn for noncompliance|0
2531540|NCT01628549|8760976|P3|Overall Study|withdrawn for noncompliance|1
2531541|NCT01628549|8760977|P2|Overall Study|withdrawn for noncompliance|2
2531542|NCT01628549|8760978|P1|Overall Study|withdrawn for noncompliance|0
2531543|NCT01628549|8760975|P4|Overall Study|Protocol Violation|0
2531544|NCT01628549|8760976|P3|Overall Study|Protocol Violation|1
2531545|NCT01628549|8760977|P2|Overall Study|Protocol Violation|1
2531546|NCT01628549|8760978|P1|Overall Study|Protocol Violation|2
2531547|NCT01628549|8760975|P4|Overall Study|Withdrawal by Subject|1
2531548|NCT01628549|8760976|P3|Overall Study|Withdrawal by Subject|4
2531549|NCT01628549|8760977|P2|Overall Study|Withdrawal by Subject|4
2531550|NCT01628549|8760978|P1|Overall Study|Withdrawal by Subject|3
2531551|NCT01628549|8760975|P4|Overall Study|Lost to Follow-up|3
2531552|NCT01628549|8760976|P3|Overall Study|Lost to Follow-up|3
2531553|NCT01628549|8760977|P2|Overall Study|Lost to Follow-up|4
2531554|NCT01628549|8760978|P1|Overall Study|Lost to Follow-up|3
2531555|NCT01628549|8760975|P4|Overall Study|Adverse Event|4
2531556|NCT01628549|8760976|P3|Overall Study|Adverse Event|0
2531557|NCT01628549|8760977|P2|Overall Study|Adverse Event|1
2531558|NCT01628549|8760978|P1|Overall Study|Adverse Event|1
2531559|NCT01628510|8761019|P2|Overall Study|Death|1
2531560|NCT01628510|8761020|P1|Overall Study|Death|3
2531561|NCT01628510|8761019|P2|Overall Study|Withdrawal by Subject|4
2531562|NCT01628510|8761020|P1|Overall Study|Withdrawal by Subject|0
2531563|NCT01628367|8761030|P2|Overall Study|Adverse Event|0
2531564|NCT01628367|8761031|P1|Overall Study|Adverse Event|1
2531565|NCT01628198|8761050|P1|Overall Study|Screen failure|1
2531566|NCT01628198|8761050|P1|Overall Study|Withdrawal by Subject|10
2531567|NCT01628198|8761050|P1|Overall Study|Lost to Follow-up|7
2531568|NCT01628120|8761077|P1|Overall Study|Use of Standard of Care|1
2531569|NCT01628120|8761077|P1|Overall Study|Kidney Transplant|2
2531570|NCT01628120|8761077|P1|Overall Study|Moved or Relocated|5
2531571|NCT01628120|8761077|P1|Overall Study|Missed Study Drug More than 2 Weeks|3
2531572|NCT01628120|8761077|P1|Overall Study|Switched Dialysis Method|2
2531573|NCT01628120|8761077|P1|Overall Study|Sponsor Decision|5
2531574|NCT01628120|8761077|P1|Overall Study|Not Treated|3
2531575|NCT01628120|8761077|P1|Overall Study|Non-compliant with Study Procedures|1
2531576|NCT01628120|8761077|P1|Overall Study|Not met Inclusion/Exclusion Criteria|2
2531577|NCT01628120|8761077|P1|Overall Study|Lost to Follow-up|1
2531578|NCT01628120|8761077|P1|Overall Study|Adverse Event|12
2531579|NCT01628120|8761077|P1|Overall Study|Withdrawal by Subject|7
2531580|NCT01628107|8761102|P1|Overall Study|Use of Standard of Care|9
2531581|NCT01628107|8761102|P1|Overall Study|Kidney Transplant|9
2531582|NCT01628107|8761102|P1|Overall Study|Relocated|8
2531583|NCT01628107|8761102|P1|Overall Study|Missed Study Drug More than 2 Weeks|7
2531584|NCT01628107|8761102|P1|Overall Study|Sponsor Decision|11
2531585|NCT01628107|8761102|P1|Overall Study|Not Treated|8
2531586|NCT01628107|8761102|P1|Overall Study|Non-compliant with Study Procedures|10
2531587|NCT01628107|8761102|P1|Overall Study|Not met Inclusion/Exclusion Criteria|1
2531588|NCT01628107|8761102|P1|Overall Study|Physician Decision|2
2531589|NCT01628107|8761102|P1|Overall Study|Adverse Event|33
2531590|NCT01628107|8761102|P1|Overall Study|Lost to Follow-up|4
2531591|NCT01628107|8761102|P1|Overall Study|Withdrawal by Subject|17
2531592|NCT01627899|8761168|P1|Overall Study|Study terminated early by sponsor.|5
2531593|NCT01627860|8761178|P2|Overall Study|Protocol Violation|0
2531594|NCT01627860|8761179|P1|Overall Study|Protocol Violation|1
2531595|NCT01627860|8761178|P2|Overall Study|Seizure frequency doubled|1
2531596|NCT01627860|8761179|P1|Overall Study|Seizure frequency doubled|0
2531597|NCT01627860|8761178|P2|Overall Study|Withdrawal by Subject|1
2531598|NCT01627860|8761179|P1|Overall Study|Withdrawal by Subject|2
2531599|NCT01627860|8761178|P2|Overall Study|Adverse Event|4
2531600|NCT01627860|8761179|P1|Overall Study|Adverse Event|9
2531601|NCT01627782|8761193|P4|Overall Study|Randomized But Not Treated|0
2531602|NCT01627782|8761194|P3|Overall Study|Randomized But Not Treated|0
2531603|NCT01627782|8761195|P2|Overall Study|Randomized But Not Treated|0
2531604|NCT01627782|8761196|P1|Overall Study|Randomized But Not Treated|1
2531605|NCT01627782|8761193|P4|Overall Study|Other|3
2531606|NCT01627782|8761194|P3|Overall Study|Other|0
2531607|NCT01627782|8761195|P2|Overall Study|Other|2
2531608|NCT01627782|8761196|P1|Overall Study|Other|0
2531609|NCT01627782|8761193|P4|Overall Study|Withdrawal by Subject|0
2531610|NCT01627782|8761194|P3|Overall Study|Withdrawal by Subject|0
2531611|NCT01627782|8761195|P2|Overall Study|Withdrawal by Subject|1
2531612|NCT01627782|8761196|P1|Overall Study|Withdrawal by Subject|2
2531613|NCT01627782|8761193|P4|Overall Study|Protocol Violation|0
2531614|NCT01627782|8761194|P3|Overall Study|Protocol Violation|0
2531615|NCT01627782|8761195|P2|Overall Study|Protocol Violation|0
2531616|NCT01627782|8761196|P1|Overall Study|Protocol Violation|1
2531617|NCT01627782|8761193|P4|Overall Study|Lack of Efficacy|2
2531618|NCT01627782|8761194|P3|Overall Study|Lack of Efficacy|15
2531619|NCT01627782|8761195|P2|Overall Study|Lack of Efficacy|1
2531620|NCT01627782|8761196|P1|Overall Study|Lack of Efficacy|11
2531621|NCT01627782|8761193|P4|Overall Study|Adverse Event|1
2531622|NCT01627782|8761194|P3|Overall Study|Adverse Event|0
2531623|NCT01627782|8761195|P2|Overall Study|Adverse Event|2
2531624|NCT01627782|8761196|P1|Overall Study|Adverse Event|1
2531625|NCT01627691|8761252|P1|Overall Study|Missed the visit|3
2531626|NCT01627691|8761252|P1|Overall Study|Withdrawal by Subject|1
2531627|NCT01627691|8761252|P1|Overall Study|Lost to Follow-up|3
2531628|NCT01627691|8761252|P1|Overall Study|Death|11
2531629|NCT01627561|8761259|P2|Overall Study|Migrated/moved from study area|2
2531630|NCT01627561|8761260|P1|Overall Study|Migrated/moved from study area|0
2531631|NCT01627561|8761259|P2|Overall Study|Withdrawal by Subject|1
2531632|NCT01627561|8761260|P1|Overall Study|Withdrawal by Subject|0
2531633|NCT01627561|8761259|P2|Overall Study|Lost to Follow-up|0
2531634|NCT01627561|8761260|P1|Overall Study|Lost to Follow-up|1
2531635|NCT01627340|8761326|P2|Overall Study|Withdrawal by Subject|0
2531636|NCT01627340|8761327|P1|Overall Study|Withdrawal by Subject|2
2531637|NCT01627340|8761326|P2|Overall Study|Pregnancy|0
2531638|NCT01627340|8761327|P1|Overall Study|Pregnancy|1
2531639|NCT01627340|8761326|P2|Overall Study|Lost to Follow-up|4
2531640|NCT01627340|8761327|P1|Overall Study|Lost to Follow-up|8
2531641|NCT01627340|8761326|P2|Overall Study|Adverse Event|0
2531642|NCT01627340|8761327|P1|Overall Study|Adverse Event|1
2531643|NCT01627327|8761345|P2|Overall Study|Withdrawal by Subject|3
2531644|NCT01627327|8761346|P1|Overall Study|Withdrawal by Subject|3
2531645|NCT01627327|8761345|P2|Overall Study|Physician Decision|0
2531646|NCT01627327|8761346|P1|Overall Study|Physician Decision|1
2531647|NCT01627327|8761345|P2|Overall Study|Lost to Follow-up|3
2531648|NCT01627327|8761346|P1|Overall Study|Lost to Follow-up|1
2531649|NCT01627327|8761345|P2|Overall Study|Protocol Violation|10
2531650|NCT01627327|8761346|P1|Overall Study|Protocol Violation|4
2531651|NCT01627327|8761345|P2|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9
2531652|NCT01627327|8761346|P1|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4
2531653|NCT01627327|8761345|P2|Overall Study|Lack of Efficacy-No Sub-Reason|2
2531654|NCT01627327|8761346|P1|Overall Study|Lack of Efficacy-No Sub-Reason|0
2531655|NCT01627327|8761345|P2|Overall Study|Adverse Event|12
2531656|NCT01627327|8761346|P1|Overall Study|Adverse Event|6
2531657|NCT01627249|8761396|P3|Overall Study|Missed Visit|0
2531658|NCT01627249|8761397|P2|Overall Study|Missed Visit|1
2531659|NCT01627249|8761398|P1|Overall Study|Missed Visit|1
2531660|NCT01627249|8761396|P3|Overall Study|Withdrawal by Subject|9
2531661|NCT01627249|8761397|P2|Overall Study|Withdrawal by Subject|6
2531662|NCT01627249|8761398|P1|Overall Study|Withdrawal by Subject|12
2531663|NCT01627249|8761396|P3|Overall Study|Death|3
2531664|NCT01627249|8761397|P2|Overall Study|Death|5
2531665|NCT01627249|8761398|P1|Overall Study|Death|3
2531666|NCT01626989|8761494|P3|Screening Period|Withdrawal by Subject|0
2531667|NCT01626989|8761495|P2|Screening Period|Withdrawal by Subject|0
2531668|NCT01626989|8761496|P1|Screening Period|Withdrawal by Subject|2
2531669|NCT01626989|8761494|P3|Screening Period|Screen Failure|0
2531670|NCT01626989|8761495|P2|Screening Period|Screen Failure|0
2531671|NCT01626989|8761496|P1|Screening Period|Screen Failure|15
2531672|NCT01626690|8761568|P2|Overall Study|Adverse Event|0
2531673|NCT01626690|8761569|P1|Overall Study|Adverse Event|1
2531674|NCT01626690|8761568|P2|Overall Study|Protocol Violation|0
2531675|NCT01626690|8761569|P1|Overall Study|Protocol Violation|1
2531676|NCT01626495|8761606|P1|Overall Study|Manufacturing failure|1
2531677|NCT01626495|8761606|P1|Overall Study|New cancer therapy|16
2531678|NCT01626495|8761606|P1|Overall Study|Physician Decision|1
2531679|NCT01626495|8761606|P1|Overall Study|Death|2
2531680|NCT01626495|8761606|P1|Overall Study|Administrative problem|1
2531681|NCT01626495|8761606|P1|Overall Study|Withdrawal by Subject|1
2531682|NCT01626495|8761606|P1|Overall Study|Disease progression|27
2531683|NCT01626495|8761606|P1|Overall Study|Adverse Event|3
2531684|NCT01626456|8761615|P2|Overall Study|Incarceration|2
2531685|NCT01626456|8761616|P1|Overall Study|Incarceration|0
2531686|NCT01626456|8761615|P2|Overall Study|Site Closure|3
2531687|NCT01626456|8761616|P1|Overall Study|Site Closure|2
2531688|NCT01626456|8761615|P2|Overall Study|Protocol Violation|1
2531689|NCT01626456|8761616|P1|Overall Study|Protocol Violation|1
2531690|NCT01626456|8761615|P2|Overall Study|Physician Decision|4
2531691|NCT01626456|8761616|P1|Overall Study|Physician Decision|1
2531692|NCT01626456|8761615|P2|Overall Study|Lack of Efficacy|7
2531693|NCT01626456|8761616|P1|Overall Study|Lack of Efficacy|6
2531694|NCT01626456|8761615|P2|Overall Study|Lost to Follow-up|27
2531695|NCT01626456|8761616|P1|Overall Study|Lost to Follow-up|2
2531696|NCT01626456|8761615|P2|Overall Study|Adverse Event|27
2531697|NCT01626456|8761616|P1|Overall Study|Adverse Event|2
2531698|NCT01626456|8761615|P2|Overall Study|Withdrawal by Subject|46
2531699|NCT01626456|8761616|P1|Overall Study|Withdrawal by Subject|21
2531700|NCT01626391|8761646|P2|Overall Study|Withdrawal by Subject|0
2531701|NCT01626391|8761647|P1|Overall Study|Withdrawal by Subject|1
2531702|NCT01626391|8761646|P2|Overall Study|Physician Decision|0
2531703|NCT01626391|8761647|P1|Overall Study|Physician Decision|1
2531704|NCT01626352|8761653|P1|Overall Study|Never Treated|1
2531705|NCT01626352|8761653|P1|Overall Study|Non-Compliance|1
2531706|NCT01626352|8761653|P1|Overall Study|Withdrawal by Subject|1
2531707|NCT01626352|8761653|P1|Overall Study|Death|2
2531708|NCT01626352|8761653|P1|Overall Study|Intercurrent Illness|2
2531709|NCT01626352|8761653|P1|Overall Study|Disease Progression|3
2531710|NCT01626118|8761667|P4|Overall Study|Investigator Decision|0
2531711|NCT01626118|8761668|P3|Overall Study|Investigator Decision|0
2531712|NCT01626118|8761669|P2|Overall Study|Investigator Decision|1
2531713|NCT01626118|8761670|P1|Overall Study|Investigator Decision|0
2531714|NCT01626118|8761667|P4|Overall Study|Adverse Event|0
2531715|NCT01626118|8761668|P3|Overall Study|Adverse Event|1
2531716|NCT01626118|8761669|P2|Overall Study|Adverse Event|1
2531717|NCT01626118|8761670|P1|Overall Study|Adverse Event|0
2531718|NCT01626118|8761667|P4|Overall Study|Lost to Follow-up|0
2531719|NCT01626118|8761668|P3|Overall Study|Lost to Follow-up|0
2531720|NCT01626118|8761669|P2|Overall Study|Lost to Follow-up|0
2531721|NCT01626118|8761670|P1|Overall Study|Lost to Follow-up|1
2531722|NCT01626118|8761667|P4|Overall Study|Lack of Efficacy|3
2531723|NCT01626118|8761668|P3|Overall Study|Lack of Efficacy|1
2531724|NCT01626118|8761669|P2|Overall Study|Lack of Efficacy|0
2531725|NCT01626118|8761670|P1|Overall Study|Lack of Efficacy|1
2531726|NCT01625988|8761716|P2|Overall Study|Protocol Violation|2
2531727|NCT01625988|8761717|P1|Overall Study|Protocol Violation|0
2531728|NCT01625988|8761716|P2|Overall Study|Randomized Inappropriately|0
2531729|NCT01625988|8761717|P1|Overall Study|Randomized Inappropriately|1
2531730|NCT01625988|8761716|P2|Overall Study|Lack of Efficacy|1
2531731|NCT01625988|8761717|P1|Overall Study|Lack of Efficacy|0
2531732|NCT01625988|8761716|P2|Overall Study|Adverse Event|1
2531733|NCT01625988|8761717|P1|Overall Study|Adverse Event|0
2531734|NCT01625988|8761716|P2|Overall Study|Withdrawal by Subject|3
2531735|NCT01625988|8761717|P1|Overall Study|Withdrawal by Subject|8
2531736|NCT01625988|8761716|P2|Overall Study|Lost to Follow-up|6
2531737|NCT01625988|8761717|P1|Overall Study|Lost to Follow-up|5
2531738|NCT01625910|8761741|P2|Overall Study|Lost to Follow-up|4
2531739|NCT01625910|8761742|P1|Overall Study|Lost to Follow-up|3
2531740|NCT01625845|8761752|P2|Overall Study|Withdrawal by Subject|0
2531741|NCT01625845|8761753|P1|Overall Study|Withdrawal by Subject|2
2531742|NCT01625845|8761752|P2|Overall Study|Lost to Follow-up|1
2531743|NCT01625845|8761753|P1|Overall Study|Lost to Follow-up|2
2531744|NCT01625845|8761752|P2|Overall Study|Adverse Event|2
2531745|NCT01625845|8761753|P1|Overall Study|Adverse Event|1
2531746|NCT01625689|8761773|P2|Overall Study|Migration|1
2531747|NCT01625689|8761774|P1|Overall Study|Migration|2
2531748|NCT01625377|8761829|P2|Overall Study|Abnormal laboratory values|0
2531749|NCT01625377|8761830|P1|Overall Study|Abnormal laboratory values|1
2531750|NCT01625377|8761829|P2|Overall Study|Unsatisfactory therapeutic effect|1
2531751|NCT01625377|8761830|P1|Overall Study|Unsatisfactory therapeutic effect|0
2531752|NCT01625377|8761829|P2|Overall Study|Graft loss|0
2531753|NCT01625377|8761830|P1|Overall Study|Graft loss|1
2531754|NCT01625377|8761829|P2|Overall Study|Adverse Event|16
2531755|NCT01625377|8761830|P1|Overall Study|Adverse Event|3
2531756|NCT01625377|8761829|P2|Overall Study|Protocol Violation|3
2531757|NCT01625377|8761830|P1|Overall Study|Protocol Violation|0
2531758|NCT01625377|8761829|P2|Overall Study|Administrative Problem|1
2531759|NCT01625377|8761830|P1|Overall Study|Administrative Problem|1
2531760|NCT01625377|8761829|P2|Overall Study|Death|1
2531761|NCT01625377|8761830|P1|Overall Study|Death|1
2531762|NCT01625338|8761863|P3|Overall Study|Study Discontinued by Sponsor|1
2531763|NCT01625338|8761864|P2|Overall Study|Study Discontinued by Sponsor|0
2531764|NCT01625338|8761865|P1|Overall Study|Study Discontinued by Sponsor|0
2531765|NCT01625338|8761863|P3|Overall Study|Adverse Event|1
2531766|NCT01625338|8761864|P2|Overall Study|Adverse Event|0
2531767|NCT01625338|8761865|P1|Overall Study|Adverse Event|1
2531768|NCT01625338|8761863|P3|Overall Study|Subject Withdrew Consent|2
2531769|NCT01625338|8761864|P2|Overall Study|Subject Withdrew Consent|0
2531770|NCT01625338|8761865|P1|Overall Study|Subject Withdrew Consent|1
2531771|NCT01625338|8761863|P3|Overall Study|Investigator Decision|1
2531772|NCT01625338|8761864|P2|Overall Study|Investigator Decision|2
2531773|NCT01625338|8761865|P1|Overall Study|Investigator Decision|0
2531774|NCT01625338|8761863|P3|Overall Study|Lost to Follow-up|2
2531775|NCT01625338|8761864|P2|Overall Study|Lost to Follow-up|3
2531776|NCT01625338|8761865|P1|Overall Study|Lost to Follow-up|3
2531777|NCT01625338|8761863|P3|Overall Study|Efficacy Failure|31
2531778|NCT01625338|8761864|P2|Overall Study|Efficacy Failure|39
2531779|NCT01625338|8761865|P1|Overall Study|Efficacy Failure|27
2531780|NCT01625338|8761863|P3|Overall Study|Enrolled but not Treated|1
2531781|NCT01625338|8761864|P2|Overall Study|Enrolled but not Treated|0
2531782|NCT01625338|8761865|P1|Overall Study|Enrolled but not Treated|0
2531783|NCT01625286|8761892|P7|Overall Study|Ongoing on-treatment at DCO|6
2531784|NCT01625286|8761893|P6|Overall Study|Ongoing on-treatment at DCO|8
2531785|NCT01625286|8761894|P5|Overall Study|Ongoing on-treatment at DCO|0
2531786|NCT01625286|8761895|P4|Overall Study|Ongoing on-treatment at DCO|0
2531787|NCT01625286|8761896|P3|Overall Study|Ongoing on-treatment at DCO|0
2531788|NCT01625286|8761897|P2|Overall Study|Ongoing on-treatment at DCO|4
2531789|NCT01625286|8761898|P1|Overall Study|Ongoing on-treatment at DCO|6
2531790|NCT01625286|8761892|P7|Overall Study|Ongoing off-treatment at DCO|31
2531791|NCT01625286|8761893|P6|Overall Study|Ongoing off-treatment at DCO|32
2531792|NCT01625286|8761894|P5|Overall Study|Ongoing off-treatment at DCO|0
2531793|NCT01625286|8761895|P4|Overall Study|Ongoing off-treatment at DCO|0
2531794|NCT01625286|8761896|P3|Overall Study|Ongoing off-treatment at DCO|0
2531795|NCT01625286|8761897|P2|Overall Study|Ongoing off-treatment at DCO|0
2531796|NCT01625286|8761898|P1|Overall Study|Ongoing off-treatment at DCO|0
2531797|NCT01625286|8761892|P7|Overall Study|Lost to Follow-up|1
2531798|NCT01625286|8761893|P6|Overall Study|Lost to Follow-up|0
2531799|NCT01625286|8761894|P5|Overall Study|Lost to Follow-up|0
2531800|NCT01625286|8761895|P4|Overall Study|Lost to Follow-up|0
2531801|NCT01625286|8761896|P3|Overall Study|Lost to Follow-up|0
2531802|NCT01625286|8761897|P2|Overall Study|Lost to Follow-up|0
2531803|NCT01625286|8761898|P1|Overall Study|Lost to Follow-up|0
2531804|NCT01625286|8761892|P7|Overall Study|Progressive disease|0
2531805|NCT01625286|8761893|P6|Overall Study|Progressive disease|0
2531806|NCT01625286|8761894|P5|Overall Study|Progressive disease|5
2531807|NCT01625286|8761895|P4|Overall Study|Progressive disease|5
2531808|NCT01625286|8761896|P3|Overall Study|Progressive disease|4
2531809|NCT01625286|8761897|P2|Overall Study|Progressive disease|3
2531810|NCT01625286|8761898|P1|Overall Study|Progressive disease|6
2531811|NCT01625286|8761892|P7|Overall Study|Any reason not specifically recorded|0
2531812|NCT01625286|8761893|P6|Overall Study|Any reason not specifically recorded|1
2531813|NCT01625286|8761894|P5|Overall Study|Any reason not specifically recorded|0
2531814|NCT01625286|8761895|P4|Overall Study|Any reason not specifically recorded|0
2531815|NCT01625286|8761896|P3|Overall Study|Any reason not specifically recorded|0
2531816|NCT01625286|8761897|P2|Overall Study|Any reason not specifically recorded|0
2531817|NCT01625286|8761898|P1|Overall Study|Any reason not specifically recorded|0
2531818|NCT01625286|8761892|P7|Overall Study|Withdrawal by Subject|1
2531819|NCT01625286|8761893|P6|Overall Study|Withdrawal by Subject|0
2531820|NCT01625286|8761894|P5|Overall Study|Withdrawal by Subject|0
2531821|NCT01625286|8761895|P4|Overall Study|Withdrawal by Subject|1
2531822|NCT01625286|8761896|P3|Overall Study|Withdrawal by Subject|0
2531823|NCT01625286|8761897|P2|Overall Study|Withdrawal by Subject|1
2531824|NCT01625286|8761898|P1|Overall Study|Withdrawal by Subject|0
2531825|NCT01625286|8761892|P7|Overall Study|Death|16
2531826|NCT01625286|8761893|P6|Overall Study|Death|11
2531827|NCT01625286|8761894|P5|Overall Study|Death|0
2531828|NCT01625286|8761895|P4|Overall Study|Death|1
2531829|NCT01625286|8761896|P3|Overall Study|Death|1
2531830|NCT01625286|8761897|P2|Overall Study|Death|0
2531831|NCT01625286|8761898|P1|Overall Study|Death|0
2531832|NCT01625286|8761892|P7|Overall Study|Adverse Event|1
2531833|NCT01625286|8761893|P6|Overall Study|Adverse Event|2
2531834|NCT01625286|8761894|P5|Overall Study|Adverse Event|1
2531835|NCT01625286|8761895|P4|Overall Study|Adverse Event|0
2531836|NCT01625286|8761896|P3|Overall Study|Adverse Event|0
2531837|NCT01625286|8761897|P2|Overall Study|Adverse Event|0
2531838|NCT01625286|8761898|P1|Overall Study|Adverse Event|0
2531839|NCT01625182|8761984|P2|Overall Study|Lack of Efficacy|8
2531840|NCT01625182|8761985|P1|Overall Study|Lack of Efficacy|12
2531841|NCT01625182|8761984|P2|Overall Study|Withdrawal by Subject|1
2531842|NCT01625182|8761985|P1|Overall Study|Withdrawal by Subject|5
2531843|NCT01625182|8761984|P2|Overall Study|Adverse Event|0
2531844|NCT01625182|8761985|P1|Overall Study|Adverse Event|2
2531845|NCT01625182|8761984|P2|Overall Study|Protocol deviation|2
2531846|NCT01625182|8761985|P1|Overall Study|Protocol deviation|0
2531847|NCT01625182|8761984|P2|Overall Study|Administrative problems|0
2531848|NCT01625182|8761985|P1|Overall Study|Administrative problems|1
2531849|NCT01625091|8762022|P2|Post-intervention|Study termination|1
2531850|NCT01625091|8762023|P1|Post-intervention|Study termination|2
2531851|NCT01625091|8762022|P2|Post-intervention|Lost to Follow-up|0
2531852|NCT01625091|8762023|P1|Post-intervention|Lost to Follow-up|2
2531853|NCT01625091|8762022|P2|Post-intervention|Death|1
2531854|NCT01625091|8762023|P1|Post-intervention|Death|0
2531855|NCT01625091|8762022|P2|Intervention|Study termination|3
2531856|NCT01625091|8762023|P1|Intervention|Study termination|2
2531857|NCT01625091|8762022|P2|Intervention|Lost to Follow-up|4
2531858|NCT01625091|8762023|P1|Intervention|Lost to Follow-up|4
2531859|NCT01625091|8762022|P2|Intervention|Adverse Event|2
2531860|NCT01625091|8762023|P1|Intervention|Adverse Event|0
2531861|NCT01625091|8762022|P2|Intervention|Withdrawal by Subject|1
2531862|NCT01625091|8762023|P1|Intervention|Withdrawal by Subject|4
2531863|NCT01625091|8762022|P2|Intervention|Death|1
2531864|NCT01625091|8762023|P1|Intervention|Death|1
2531865|NCT01624974|8762041|P2|Period V of Treatment (4 Weeks)|Adverse Event|0
2531866|NCT01624974|8762042|P1|Period V of Treatment (4 Weeks)|Adverse Event|1
2531867|NCT01624974|8762041|P2|Period V of Treatment (4 Weeks)|Physician Decision|0
2531868|NCT01624974|8762042|P1|Period V of Treatment (4 Weeks)|Physician Decision|3
2531869|NCT01624974|8762041|P2|Period V of Treatment (4 Weeks)|Lack of Efficacy|0
2531870|NCT01624974|8762042|P1|Period V of Treatment (4 Weeks)|Lack of Efficacy|1
2531871|NCT01624974|8762041|P2|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1
2531872|NCT01624974|8762042|P1|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0
2531873|NCT01624974|8762041|P2|Period IV Washout (4 Weeks)|Adverse Event|0
2531874|NCT01624974|8762042|P1|Period IV Washout (4 Weeks)|Adverse Event|2
2531875|NCT01624974|8762041|P2|Period IV Washout (4 Weeks)|Withdrawal by Subject|1
2531876|NCT01624974|8762042|P1|Period IV Washout (4 Weeks)|Withdrawal by Subject|0
2531877|NCT01624974|8762041|P2|Period IV Washout (4 Weeks)|Lack of Efficacy|1
2531878|NCT01624974|8762042|P1|Period IV Washout (4 Weeks)|Lack of Efficacy|1
2531879|NCT01624974|8762041|P2|Period III of Treatment (4 Weeks)|Adverse Event|1
2531880|NCT01624974|8762042|P1|Period III of Treatment (4 Weeks)|Adverse Event|0
2531881|NCT01624974|8762041|P2|Period III of Treatment (4 Weeks)|Protocol Violation|0
2531882|NCT01624974|8762042|P1|Period III of Treatment (4 Weeks)|Protocol Violation|1
2531883|NCT01624974|8762041|P2|Period III of Treatment (4 Weeks)|Physician Decision|3
2531884|NCT01624974|8762042|P1|Period III of Treatment (4 Weeks)|Physician Decision|5
2531885|NCT01624974|8762041|P2|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2
2531886|NCT01624974|8762042|P1|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1
2531887|NCT01624974|8762041|P2|Period III of Treatment (4 Weeks)|Lack of Efficacy|2
2531888|NCT01624974|8762042|P1|Period III of Treatment (4 Weeks)|Lack of Efficacy|0
2531889|NCT01624870|8762083|P1|Overall Study|Lost to follow up|1
2531890|NCT01624870|8762083|P1|Overall Study|CoreValve not implanted|6
2531891|NCT01624870|8762083|P1|Overall Study|Withdrawal by Subject|1
2531892|NCT01624870|8762083|P1|Overall Study|Death|19
2531893|NCT01624662|8762103|P4|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
2531894|NCT01624662|8762104|P3|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
2531895|NCT01624662|8762105|P2|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
2531896|NCT01624662|8762106|P1|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
2531897|NCT01624662|8762103|P4|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
2531898|NCT01624662|8762104|P3|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
2531899|NCT01624662|8762105|P2|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1
2531900|NCT01624662|8762106|P1|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
2531901|NCT01624662|8762103|P4|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
2531902|NCT01624662|8762104|P3|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
2531903|NCT01624662|8762105|P2|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
2531904|NCT01624662|8762106|P1|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
2531905|NCT01624662|8762103|P4|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
2531906|NCT01624662|8762104|P3|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3
2531907|NCT01624662|8762105|P2|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
2531908|NCT01624662|8762106|P1|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3
2531909|NCT01624662|8762103|P4|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
2531910|NCT01624662|8762104|P3|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
2531911|NCT01624662|8762105|P2|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1
2531912|NCT01624662|8762106|P1|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
2531913|NCT01624662|8762103|P4|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
2531914|NCT01624662|8762104|P3|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
2531915|NCT01624662|8762105|P2|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1
2531916|NCT01624662|8762106|P1|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5
2531917|NCT01624662|8762103|P4|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0
2531918|NCT01624662|8762104|P3|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
2531919|NCT01624662|8762105|P2|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
2531920|NCT01624662|8762106|P1|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2
2531921|NCT01624467|8762177|P1|Overall Study|Subject Withdrew from Treatment|1
2531922|NCT01624467|8762177|P1|Overall Study|Per Sponsor Requirement|1
2531923|NCT01624467|8762177|P1|Overall Study|Progressive Disease|19
2531924|NCT01624467|8762177|P1|Overall Study|Adverse Event|7
2531925|NCT01624467|8762177|P1|Overall Study|Lost to Follow-up|1
2531926|NCT01624467|8762177|P1|Overall Study|Withdrawal by Subject|2
2531927|NCT01624259|8762216|P2|Overall Study|Abnormal laboratory measure|0
2531928|NCT01624259|8762217|P1|Overall Study|Abnormal laboratory measure|3
2531929|NCT01624259|8762216|P2|Overall Study|Lost to Follow-up|3
2531930|NCT01624259|8762217|P1|Overall Study|Lost to Follow-up|2
2531931|NCT01624259|8762216|P2|Overall Study|Physician Decision|1
2531932|NCT01624259|8762217|P1|Overall Study|Physician Decision|1
2531933|NCT01624259|8762216|P2|Overall Study|Withdrawal by Subject|7
2531934|NCT01624259|8762217|P1|Overall Study|Withdrawal by Subject|5
2531935|NCT01624259|8762216|P2|Overall Study|Protocol Violation|2
2531936|NCT01624259|8762217|P1|Overall Study|Protocol Violation|1
2531937|NCT01624259|8762216|P2|Overall Study|Adverse Event|18
2531938|NCT01624259|8762217|P1|Overall Study|Adverse Event|18
2531939|NCT01624233|8762266|P1|Period 6: Follow-up|Withdrawal by Subject|3
2531940|NCT01624233|8762266|P1|Period 6: Follow-up|Physician Decision|1
2531941|NCT01624233|8762266|P1|Period 6: Follow-up|Lack of Efficacy|2
2531942|NCT01624233|8762266|P1|Period 6: Follow-up|Adverse Event|3
2531943|NCT01624233|8762266|P1|Period 5 - Retreatment Period|Withdrawal by Subject|3
2531944|NCT01624233|8762266|P1|Period 5 - Retreatment Period|Physician Decision|1
2531945|NCT01624233|8762266|P1|Period 5 - Retreatment Period|Lack of Efficacy|1
2531946|NCT01624233|8762266|P1|Period 5 - Retreatment Period|Adverse Event|5
2531947|NCT01624233|8762266|P1|Period 4 - Drug Free Period|Relapsed|61
2531948|NCT01624233|8762266|P1|Period 3 - Maintenance|Withdrawal by Subject|2
2531949|NCT01624233|8762266|P1|Period 3 - Maintenance|Physician Decision|2
2531950|NCT01624233|8762266|P1|Period 3 - Maintenance|Lack of Efficacy|1
2531951|NCT01624233|8762266|P1|Period 3 - Maintenance|Adverse Event|2
2531952|NCT01624233|8762266|P1|Period 2 - Induction|Adverse Event|1
2531953|NCT01624194|8762298|P2|Overall Study|Withdrawal by Subject|0
2531954|NCT01624194|8762299|P1|Overall Study|Withdrawal by Subject|1
2531955|NCT01624194|8762298|P2|Overall Study|Lost to Follow-up|0
2531956|NCT01624194|8762299|P1|Overall Study|Lost to Follow-up|1
2531957|NCT01624142|8762367|P2|Overall Study|Other|0
2531958|NCT01624142|8762368|P1|Overall Study|Other|1
2531959|NCT01624142|8762367|P2|Overall Study|Lost to Follow-up|0
2531960|NCT01624142|8762368|P1|Overall Study|Lost to Follow-up|2
2531961|NCT01624142|8762367|P2|Overall Study|Study Closure|6
2531962|NCT01624142|8762368|P1|Overall Study|Study Closure|12
2531963|NCT01624142|8762367|P2|Overall Study|Death|6
2531964|NCT01624142|8762368|P1|Overall Study|Death|3
2531965|NCT01624142|8762367|P2|Overall Study|Withdrawal by Subject|4
2531966|NCT01624142|8762368|P1|Overall Study|Withdrawal by Subject|14
2531967|NCT01624090|8762393|P4|Overall Study|Dose escalated|0
2531968|NCT01624090|8762394|P3|Overall Study|Dose escalated|3
2531969|NCT01624090|8762395|P2|Overall Study|Dose escalated|0
2531970|NCT01624090|8762396|P1|Overall Study|Dose escalated|0
2531971|NCT01624090|8762393|P4|Overall Study|Did not complete 1 crse of therapy|0
2531972|NCT01624090|8762394|P3|Overall Study|Did not complete 1 crse of therapy|2
2531973|NCT01624090|8762395|P2|Overall Study|Did not complete 1 crse of therapy|0
2531974|NCT01624090|8762396|P1|Overall Study|Did not complete 1 crse of therapy|0
2531975|NCT01624090|8762393|P4|Overall Study|Died on study|0
2531976|NCT01624090|8762394|P3|Overall Study|Died on study|2
2531977|NCT01624090|8762395|P2|Overall Study|Died on study|0
2531978|NCT01624090|8762396|P1|Overall Study|Died on study|0
2531979|NCT01624090|8762393|P4|Overall Study|Withdrew prior to treatment|0
2531980|NCT01624090|8762394|P3|Overall Study|Withdrew prior to treatment|0
2531981|NCT01624090|8762395|P2|Overall Study|Withdrew prior to treatment|1
2531982|NCT01624090|8762396|P1|Overall Study|Withdrew prior to treatment|0
2531983|NCT01624090|8762393|P4|Overall Study|DLT, taken off therapy|0
2531984|NCT01624090|8762394|P3|Overall Study|DLT, taken off therapy|0
2531985|NCT01624090|8762395|P2|Overall Study|DLT, taken off therapy|1
2531986|NCT01624090|8762396|P1|Overall Study|DLT, taken off therapy|0
2531987|NCT01623830|8762418|P2|Overall Study|Exclusion from Study|2
2531988|NCT01623830|8762419|P1|Overall Study|Exclusion from Study|1
2531989|NCT01623830|8762418|P2|Overall Study|Withdrawal by Subject|7
2531990|NCT01623830|8762419|P1|Overall Study|Withdrawal by Subject|6
2531991|NCT01623752|8762436|P3|Phase 2 (78 Weeks)|Adverse Event|0
2531992|NCT01623752|8762437|P2|Phase 2 (78 Weeks)|Adverse Event|4
2531993|NCT01623752|8762438|P1|Phase 2 (78 Weeks)|Adverse Event|4
2531994|NCT01623752|8762436|P3|Phase 2 (78 Weeks)|No Data|0
2531995|NCT01623752|8762437|P2|Phase 2 (78 Weeks)|No Data|11
2531996|NCT01623752|8762438|P1|Phase 2 (78 Weeks)|No Data|43
2531997|NCT01623752|8762436|P3|Phase 2 (78 Weeks)|Other|0
2531998|NCT01623752|8762437|P2|Phase 2 (78 Weeks)|Other|1
2531999|NCT01623752|8762438|P1|Phase 2 (78 Weeks)|Other|5
2532000|NCT01623752|8762436|P3|Phase 2 (78 Weeks)|Lack of Efficacy|0
2532001|NCT01623752|8762437|P2|Phase 2 (78 Weeks)|Lack of Efficacy|2
2532002|NCT01623752|8762438|P1|Phase 2 (78 Weeks)|Lack of Efficacy|14
2532003|NCT01623752|8762436|P3|Phase 1 (78 Weeks)|Lack of Efficacy|0
2532004|NCT01623752|8762437|P2|Phase 1 (78 Weeks)|Lack of Efficacy|82
2532005|NCT01623752|8762438|P1|Phase 1 (78 Weeks)|Lack of Efficacy|227
2532006|NCT01623752|8762436|P3|Phase 1 (78 Weeks)|Adverse Event|0
2532007|NCT01623752|8762437|P2|Phase 1 (78 Weeks)|Adverse Event|39
2532008|NCT01623752|8762438|P1|Phase 1 (78 Weeks)|Adverse Event|122
2532009|NCT01623752|8762436|P3|Phase 1 (78 Weeks)|Other|0
2532010|NCT01623752|8762437|P2|Phase 1 (78 Weeks)|Other|20
2532011|NCT01623752|8762438|P1|Phase 1 (78 Weeks)|Other|33
2532012|NCT01623752|8762436|P3|Phase 1 (78 Weeks)|No Data|2
2532013|NCT01623752|8762437|P2|Phase 1 (78 Weeks)|No Data|66
2532014|NCT01623752|8762438|P1|Phase 1 (78 Weeks)|No Data|249
2532015|NCT01623596|8762541|P2|Overall Study|Lack of Efficacy|3
2532016|NCT01623596|8762542|P1|Overall Study|Lack of Efficacy|5
2532017|NCT01623596|8762541|P2|Overall Study|Protocol Violation|6
2532018|NCT01623596|8762542|P1|Overall Study|Protocol Violation|0
2532019|NCT01623596|8762541|P2|Overall Study|Patient no longer requires study drug|0
2532020|NCT01623596|8762542|P1|Overall Study|Patient no longer requires study drug|1
2532021|NCT01623596|8762541|P2|Overall Study|Withdrawal by Subject|31
2532022|NCT01623596|8762542|P1|Overall Study|Withdrawal by Subject|13
2532023|NCT01623596|8762541|P2|Overall Study|Lost to Follow-up|16
2532024|NCT01623596|8762542|P1|Overall Study|Lost to Follow-up|12
2532025|NCT01623596|8762541|P2|Overall Study|Death|2
2532026|NCT01623596|8762542|P1|Overall Study|Death|0
2532027|NCT01623596|8762541|P2|Overall Study|Adverse Event|29
2532028|NCT01623596|8762542|P1|Overall Study|Adverse Event|20
2532029|NCT01623596|8762541|P2|Overall Study|Administrative problems|13
2532030|NCT01623596|8762542|P1|Overall Study|Administrative problems|9
2532031|NCT01623596|8762541|P2|Overall Study|Abnormal laboratory values|0
2532032|NCT01623596|8762542|P1|Overall Study|Abnormal laboratory values|2
2532033|NCT01623310|8762585|P1|Overall Study|Investigators Discretion-Noncompliant|1
2532034|NCT01623310|8762585|P1|Overall Study|Diagnoses of bilateral cateracts|1
2532035|NCT01623310|8762585|P1|Overall Study|Became potentially child-bearing|1
2532036|NCT01623310|8762585|P1|Overall Study|Withdrawal by Subject|25
2532037|NCT01623310|8762585|P1|Overall Study|Protocol Violation|6
2532038|NCT01623310|8762585|P1|Overall Study|Lack of Efficacy|6
2532039|NCT01623310|8762585|P1|Overall Study|Lost to Follow-up|18
2532040|NCT01623310|8762585|P1|Overall Study|Adverse Event|21
2532041|NCT01623271|8762594|P1|Overall Study|Withdrawal by Subject|2
2532042|NCT01623154|8762598|P1|Overall Study|Did not drink Pranactin Citric|4
2532043|NCT01623115|8762606|P2|Overall Study|Other than specified above|3
2532044|NCT01623115|8762607|P1|Overall Study|Other than specified above|0
2532045|NCT01623115|8762606|P2|Overall Study|Death|4
2532046|NCT01623115|8762607|P1|Overall Study|Death|0
2532047|NCT01623115|8762606|P2|Overall Study|Site closure|7
2532048|NCT01623115|8762607|P1|Overall Study|Site closure|1
2532049|NCT01623115|8762606|P2|Overall Study|Last visit outside protocol visit window|26
2532050|NCT01623115|8762607|P1|Overall Study|Last visit outside protocol visit window|14
2532051|NCT01623115|8762606|P2|Overall Study|Related to study drug administration|2
2532052|NCT01623115|8762607|P1|Overall Study|Related to study drug administration|0
2532053|NCT01623115|8762606|P2|Overall Study|Consent withdrawn by participant|6
2532054|NCT01623115|8762607|P1|Overall Study|Consent withdrawn by participant|2
2532055|NCT01623115|8762606|P2|Overall Study|Poor compliance to protocol|10
2532056|NCT01623115|8762607|P1|Overall Study|Poor compliance to protocol|4
2532057|NCT01623115|8762606|P2|Overall Study|Adverse Event|13
2532058|NCT01623115|8762607|P1|Overall Study|Adverse Event|10
2532059|NCT01623115|8762606|P2|Overall Study|Participants moved|5
2532060|NCT01623115|8762607|P1|Overall Study|Participants moved|1
2532061|NCT01623115|8762606|P2|Overall Study|Physician Decision|0
2532062|NCT01623115|8762607|P1|Overall Study|Physician Decision|1
2532063|NCT01623115|8762606|P2|Overall Study|Randomized but not treated|1
2532064|NCT01623115|8762607|P1|Overall Study|Randomized but not treated|0
2532065|NCT01623050|8762667|P1|Overall Study|Lost to Follow-up|9
2532066|NCT01622673|8762696|P6|Treatment Period 3|Protocol Violation|0
2532067|NCT01622673|8762697|P5|Treatment Period 3|Protocol Violation|0
2532068|NCT01622673|8762698|P4|Treatment Period 3|Protocol Violation|0
2532069|NCT01622673|8762699|P3|Treatment Period 3|Protocol Violation|0
2532070|NCT01622673|8762700|P2|Treatment Period 3|Protocol Violation|1
2532071|NCT01622673|8762701|P1|Treatment Period 3|Protocol Violation|0
2532072|NCT01622673|8762696|P6|Treatment Period 2|Withdrawal by Subject|0
2532073|NCT01622673|8762697|P5|Treatment Period 2|Withdrawal by Subject|0
2532074|NCT01622673|8762698|P4|Treatment Period 2|Withdrawal by Subject|1
2532075|NCT01622673|8762699|P3|Treatment Period 2|Withdrawal by Subject|0
2532076|NCT01622673|8762700|P2|Treatment Period 2|Withdrawal by Subject|0
2532077|NCT01622673|8762701|P1|Treatment Period 2|Withdrawal by Subject|0
2532078|NCT01622673|8762696|P6|Treatment Period 1|Protocol Violation|0
2532079|NCT01622673|8762697|P5|Treatment Period 1|Protocol Violation|0
2532080|NCT01622673|8762698|P4|Treatment Period 1|Protocol Violation|0
2532081|NCT01622673|8762699|P3|Treatment Period 1|Protocol Violation|0
2532082|NCT01622673|8762700|P2|Treatment Period 1|Protocol Violation|1
2532083|NCT01622673|8762701|P1|Treatment Period 1|Protocol Violation|0
2532084|NCT01622673|8762696|P6|Treatment Period 1|Withdrawal by Subject|0
2532085|NCT01622673|8762697|P5|Treatment Period 1|Withdrawal by Subject|0
2532086|NCT01622673|8762698|P4|Treatment Period 1|Withdrawal by Subject|1
2532087|NCT01622673|8762699|P3|Treatment Period 1|Withdrawal by Subject|0
2532088|NCT01622673|8762700|P2|Treatment Period 1|Withdrawal by Subject|0
2532089|NCT01622673|8762701|P1|Treatment Period 1|Withdrawal by Subject|0
2532090|NCT01622660|8762736|P1|Overall Study|Adverse Event|1
2532091|NCT01622569|8762744|P4|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1
2532092|NCT01622569|8762745|P3|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
2532093|NCT01622569|8762746|P2|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
2532094|NCT01622569|8762747|P1|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
2532095|NCT01622569|8762744|P4|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
2532096|NCT01622569|8762745|P3|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2
2532097|NCT01622569|8762746|P2|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
2532098|NCT01622569|8762747|P1|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
2532099|NCT01622569|8762744|P4|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
2532100|NCT01622569|8762745|P3|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
2532101|NCT01622569|8762746|P2|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2
2532102|NCT01622569|8762747|P1|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
2532103|NCT01622569|8762744|P4|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
2532104|NCT01622569|8762745|P3|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
2532105|NCT01622569|8762746|P2|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
2532106|NCT01622569|8762747|P1|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
2532107|NCT01622569|8762744|P4|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1
2532108|NCT01622569|8762745|P3|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
2532109|NCT01622569|8762746|P2|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2
2532110|NCT01622569|8762747|P1|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
2532111|NCT01622569|8762744|P4|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2
2532112|NCT01622569|8762745|P3|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3
2532113|NCT01622569|8762746|P2|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
2532114|NCT01622569|8762747|P1|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6
2532115|NCT01622569|8762744|P4|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
2532116|NCT01622569|8762745|P3|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1
2532117|NCT01622569|8762746|P2|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
2532118|NCT01622569|8762747|P1|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
2532119|NCT01622569|8762744|P4|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
2532120|NCT01622569|8762745|P3|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3
2532121|NCT01622569|8762746|P2|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2
2532122|NCT01622569|8762747|P1|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4
2532123|NCT01622348|8762832|P3|Overall Study|Withdrawal by Subject|1
2532124|NCT01622348|8762833|P2|Overall Study|Withdrawal by Subject|0
2532125|NCT01622348|8762834|P1|Overall Study|Withdrawal by Subject|1
2532126|NCT01622231|8762873|P1|Overall Study|Withdrawal by Subject|1
2532127|NCT01622231|8762873|P1|Overall Study|Physician Decision|1
2532128|NCT01621880|8762903|P2|Overall Study|Withdrawal by Subject|4
2532129|NCT01621880|8762904|P1|Overall Study|Withdrawal by Subject|5
2532130|NCT01621880|8762903|P2|Overall Study|Adverse Event|1
2532131|NCT01621880|8762904|P1|Overall Study|Adverse Event|5
2532132|NCT01621802|8762918|P6|Overall Study|Lost to Follow-up|11
2532133|NCT01621802|8762919|P5|Overall Study|Lost to Follow-up|31
2532134|NCT01621802|8762920|P4|Overall Study|Lost to Follow-up|7
2532135|NCT01621802|8762921|P3|Overall Study|Lost to Follow-up|24
2532136|NCT01621802|8762922|P2|Overall Study|Lost to Follow-up|16
2532137|NCT01621802|8762923|P1|Overall Study|Lost to Follow-up|36
2532138|NCT01621802|8762918|P6|Overall Study|Others|0
2532139|NCT01621802|8762919|P5|Overall Study|Others|1
2532140|NCT01621802|8762920|P4|Overall Study|Others|2
2532141|NCT01621802|8762921|P3|Overall Study|Others|3
2532142|NCT01621802|8762922|P2|Overall Study|Others|3
2532143|NCT01621802|8762923|P1|Overall Study|Others|3
2532144|NCT01621802|8762918|P6|Overall Study|Migrated/moved from study area|0
2532145|NCT01621802|8762919|P5|Overall Study|Migrated/moved from study area|1
2532146|NCT01621802|8762920|P4|Overall Study|Migrated/moved from study area|0
2532147|NCT01621802|8762921|P3|Overall Study|Migrated/moved from study area|2
2532148|NCT01621802|8762922|P2|Overall Study|Migrated/moved from study area|0
2532149|NCT01621802|8762923|P1|Overall Study|Migrated/moved from study area|0
2532150|NCT01621802|8762918|P6|Overall Study|Withdrawal by Subject|0
2532151|NCT01621802|8762919|P5|Overall Study|Withdrawal by Subject|2
2532152|NCT01621802|8762920|P4|Overall Study|Withdrawal by Subject|2
2532153|NCT01621802|8762921|P3|Overall Study|Withdrawal by Subject|4
2532154|NCT01621802|8762922|P2|Overall Study|Withdrawal by Subject|4
2532155|NCT01621802|8762923|P1|Overall Study|Withdrawal by Subject|8
2532156|NCT01621802|8762918|P6|Overall Study|Protocol Violation|1
2532157|NCT01621802|8762919|P5|Overall Study|Protocol Violation|0
2532158|NCT01621802|8762920|P4|Overall Study|Protocol Violation|0
2532159|NCT01621802|8762921|P3|Overall Study|Protocol Violation|0
2532160|NCT01621802|8762922|P2|Overall Study|Protocol Violation|0
2532161|NCT01621802|8762923|P1|Overall Study|Protocol Violation|0
2532162|NCT01621542|8763108|P6|Overall Study|study stopped by sponsor|0
2532163|NCT01621542|8763109|P5|Overall Study|study stopped by sponsor|0
2532164|NCT01621542|8763110|P4|Overall Study|study stopped by sponsor|1
2532165|NCT01621542|8763111|P3|Overall Study|study stopped by sponsor|0
2532166|NCT01621542|8763112|P2|Overall Study|study stopped by sponsor|0
2532167|NCT01621542|8763113|P1|Overall Study|study stopped by sponsor|0
2532168|NCT01621542|8763108|P6|Overall Study|Protocol Violation|0
2532169|NCT01621542|8763109|P5|Overall Study|Protocol Violation|0
2532170|NCT01621542|8763110|P4|Overall Study|Protocol Violation|1
2532171|NCT01621542|8763111|P3|Overall Study|Protocol Violation|0
2532172|NCT01621542|8763112|P2|Overall Study|Protocol Violation|0
2532173|NCT01621542|8763113|P1|Overall Study|Protocol Violation|0
2532174|NCT01621542|8763108|P6|Overall Study|progression/treatment failure|5
2532175|NCT01621542|8763109|P5|Overall Study|progression/treatment failure|3
2532176|NCT01621542|8763110|P4|Overall Study|progression/treatment failure|7
2532177|NCT01621542|8763111|P3|Overall Study|progression/treatment failure|3
2532178|NCT01621542|8763112|P2|Overall Study|progression/treatment failure|4
2532179|NCT01621542|8763113|P1|Overall Study|progression/treatment failure|2
2532180|NCT01621542|8763108|P6|Overall Study|Withdrawal by Subject|3
2532181|NCT01621542|8763109|P5|Overall Study|Withdrawal by Subject|3
2532182|NCT01621542|8763110|P4|Overall Study|Withdrawal by Subject|3
2532183|NCT01621542|8763111|P3|Overall Study|Withdrawal by Subject|1
2532184|NCT01621542|8763112|P2|Overall Study|Withdrawal by Subject|0
2532185|NCT01621542|8763113|P1|Overall Study|Withdrawal by Subject|2
2532186|NCT01621542|8763108|P6|Overall Study|Physician Decision|1
2532187|NCT01621542|8763109|P5|Overall Study|Physician Decision|3
2532188|NCT01621542|8763110|P4|Overall Study|Physician Decision|13
2532189|NCT01621542|8763111|P3|Overall Study|Physician Decision|1
2532190|NCT01621542|8763112|P2|Overall Study|Physician Decision|0
2532191|NCT01621542|8763113|P1|Overall Study|Physician Decision|1
2532192|NCT01621542|8763108|P6|Overall Study|Death|0
2532193|NCT01621542|8763109|P5|Overall Study|Death|0
2532194|NCT01621542|8763110|P4|Overall Study|Death|0
2532195|NCT01621542|8763111|P3|Overall Study|Death|0
2532196|NCT01621542|8763112|P2|Overall Study|Death|1
2532197|NCT01621542|8763113|P1|Overall Study|Death|0
2532198|NCT01621542|8763108|P6|Overall Study|Adverse Event|0
2532199|NCT01621542|8763109|P5|Overall Study|Adverse Event|0
2532200|NCT01621542|8763110|P4|Overall Study|Adverse Event|3
2532201|NCT01621542|8763111|P3|Overall Study|Adverse Event|1
2532202|NCT01621542|8763112|P2|Overall Study|Adverse Event|0
2532203|NCT01621542|8763113|P1|Overall Study|Adverse Event|0
2532204|NCT01621490|8763154|P9|Overall Study|Patient delayed due to toxicity|0
2532205|NCT01621490|8763155|P8|Overall Study|Patient delayed due to toxicity|0
2532206|NCT01621490|8763156|P7|Overall Study|Patient delayed due to toxicity|0
2532207|NCT01621490|8763157|P6|Overall Study|Patient delayed due to toxicity|1
2532208|NCT01621490|8763158|P5|Overall Study|Patient delayed due to toxicity|0
2532209|NCT01621490|8763159|P4|Overall Study|Patient delayed due to toxicity|0
2532210|NCT01621490|8763160|P3|Overall Study|Patient delayed due to toxicity|0
2532211|NCT01621490|8763161|P2|Overall Study|Patient delayed due to toxicity|0
2532212|NCT01621490|8763162|P1|Overall Study|Patient delayed due to toxicity|0
2532213|NCT01621490|8763154|P9|Overall Study|Complete response|1
2532214|NCT01621490|8763155|P8|Overall Study|Complete response|0
2532215|NCT01621490|8763156|P7|Overall Study|Complete response|0
2532216|NCT01621490|8763157|P6|Overall Study|Complete response|0
2532217|NCT01621490|8763158|P5|Overall Study|Complete response|0
2532218|NCT01621490|8763159|P4|Overall Study|Complete response|0
2532219|NCT01621490|8763160|P3|Overall Study|Complete response|0
2532220|NCT01621490|8763161|P2|Overall Study|Complete response|0
2532221|NCT01621490|8763162|P1|Overall Study|Complete response|0
2532222|NCT01621490|8763154|P9|Overall Study|Clinical deterioration|0
2532223|NCT01621490|8763155|P8|Overall Study|Clinical deterioration|0
2532224|NCT01621490|8763156|P7|Overall Study|Clinical deterioration|0
2532225|NCT01621490|8763157|P6|Overall Study|Clinical deterioration|0
2532226|NCT01621490|8763158|P5|Overall Study|Clinical deterioration|0
2532227|NCT01621490|8763159|P4|Overall Study|Clinical deterioration|0
2532228|NCT01621490|8763160|P3|Overall Study|Clinical deterioration|0
2532229|NCT01621490|8763161|P2|Overall Study|Clinical deterioration|1
2532230|NCT01621490|8763162|P1|Overall Study|Clinical deterioration|0
2532231|NCT01621490|8763154|P9|Overall Study|Patient reached treatment 2 yr limit|0
2532232|NCT01621490|8763155|P8|Overall Study|Patient reached treatment 2 yr limit|0
2532233|NCT01621490|8763156|P7|Overall Study|Patient reached treatment 2 yr limit|0
2532234|NCT01621490|8763157|P6|Overall Study|Patient reached treatment 2 yr limit|0
2532235|NCT01621490|8763158|P5|Overall Study|Patient reached treatment 2 yr limit|0
2532236|NCT01621490|8763159|P4|Overall Study|Patient reached treatment 2 yr limit|0
2532237|NCT01621490|8763160|P3|Overall Study|Patient reached treatment 2 yr limit|0
2532238|NCT01621490|8763161|P2|Overall Study|Patient reached treatment 2 yr limit|1
2532239|NCT01621490|8763162|P1|Overall Study|Patient reached treatment 2 yr limit|0
2532240|NCT01621490|8763154|P9|Overall Study|Documented disease progression|0
2532241|NCT01621490|8763155|P8|Overall Study|Documented disease progression|0
2532242|NCT01621490|8763156|P7|Overall Study|Documented disease progression|0
2532243|NCT01621490|8763157|P6|Overall Study|Documented disease progression|0
2532244|NCT01621490|8763158|P5|Overall Study|Documented disease progression|0
2532245|NCT01621490|8763159|P4|Overall Study|Documented disease progression|0
2532246|NCT01621490|8763160|P3|Overall Study|Documented disease progression|1
2532247|NCT01621490|8763161|P2|Overall Study|Documented disease progression|0
2532248|NCT01621490|8763162|P1|Overall Study|Documented disease progression|0
2532249|NCT01621490|8763154|P9|Overall Study|Investigator decision|0
2532250|NCT01621490|8763155|P8|Overall Study|Investigator decision|0
2532251|NCT01621490|8763156|P7|Overall Study|Investigator decision|1
2532252|NCT01621490|8763157|P6|Overall Study|Investigator decision|0
2532253|NCT01621490|8763158|P5|Overall Study|Investigator decision|1
2532254|NCT01621490|8763159|P4|Overall Study|Investigator decision|0
2532255|NCT01621490|8763160|P3|Overall Study|Investigator decision|1
2532256|NCT01621490|8763161|P2|Overall Study|Investigator decision|0
2532257|NCT01621490|8763162|P1|Overall Study|Investigator decision|0
2532258|NCT01621490|8763154|P9|Overall Study|BMS informed of patient status|0
2532259|NCT01621490|8763155|P8|Overall Study|BMS informed of patient status|0
2532260|NCT01621490|8763156|P7|Overall Study|BMS informed of patient status|0
2532261|NCT01621490|8763157|P6|Overall Study|BMS informed of patient status|0
2532262|NCT01621490|8763158|P5|Overall Study|BMS informed of patient status|0
2532263|NCT01621490|8763159|P4|Overall Study|BMS informed of patient status|0
2532264|NCT01621490|8763160|P3|Overall Study|BMS informed of patient status|1
2532265|NCT01621490|8763161|P2|Overall Study|BMS informed of patient status|0
2532266|NCT01621490|8763162|P1|Overall Study|BMS informed of patient status|0
2532267|NCT01621490|8763154|P9|Overall Study|Grade 4 Lipase elevation|0
2532268|NCT01621490|8763155|P8|Overall Study|Grade 4 Lipase elevation|0
2532269|NCT01621490|8763156|P7|Overall Study|Grade 4 Lipase elevation|0
2532270|NCT01621490|8763157|P6|Overall Study|Grade 4 Lipase elevation|0
2532271|NCT01621490|8763158|P5|Overall Study|Grade 4 Lipase elevation|0
2532272|NCT01621490|8763159|P4|Overall Study|Grade 4 Lipase elevation|0
2532273|NCT01621490|8763160|P3|Overall Study|Grade 4 Lipase elevation|0
2532274|NCT01621490|8763161|P2|Overall Study|Grade 4 Lipase elevation|0
2532275|NCT01621490|8763162|P1|Overall Study|Grade 4 Lipase elevation|1
2532276|NCT01621490|8763154|P9|Overall Study|Death|0
2532277|NCT01621490|8763155|P8|Overall Study|Death|1
2532278|NCT01621490|8763156|P7|Overall Study|Death|0
2532279|NCT01621490|8763157|P6|Overall Study|Death|0
2532280|NCT01621490|8763158|P5|Overall Study|Death|0
2532281|NCT01621490|8763159|P4|Overall Study|Death|0
2532282|NCT01621490|8763160|P3|Overall Study|Death|0
2532283|NCT01621490|8763161|P2|Overall Study|Death|0
2532284|NCT01621490|8763162|P1|Overall Study|Death|0
2532285|NCT01621490|8763154|P9|Overall Study|Study drug toxicity|1
2532286|NCT01621490|8763155|P8|Overall Study|Study drug toxicity|4
2532287|NCT01621490|8763156|P7|Overall Study|Study drug toxicity|1
2532288|NCT01621490|8763157|P6|Overall Study|Study drug toxicity|10
2532289|NCT01621490|8763158|P5|Overall Study|Study drug toxicity|1
2532290|NCT01621490|8763159|P4|Overall Study|Study drug toxicity|3
2532291|NCT01621490|8763160|P3|Overall Study|Study drug toxicity|5
2532292|NCT01621490|8763161|P2|Overall Study|Study drug toxicity|4
2532293|NCT01621490|8763162|P1|Overall Study|Study drug toxicity|1
2532294|NCT01621490|8763154|P9|Overall Study|Disease progression|4
2532295|NCT01621490|8763155|P8|Overall Study|Disease progression|0
2532296|NCT01621490|8763156|P7|Overall Study|Disease progression|7
2532297|NCT01621490|8763157|P6|Overall Study|Disease progression|8
2532298|NCT01621490|8763158|P5|Overall Study|Disease progression|3
2532299|NCT01621490|8763159|P4|Overall Study|Disease progression|5
2532300|NCT01621490|8763160|P3|Overall Study|Disease progression|1
2532301|NCT01621490|8763161|P2|Overall Study|Disease progression|28
2532302|NCT01621490|8763162|P1|Overall Study|Disease progression|27
2532303|NCT01621490|8763154|P9|Overall Study|Adverse event unrelated to study drug|1
2532304|NCT01621490|8763155|P8|Overall Study|Adverse event unrelated to study drug|2
2532305|NCT01621490|8763156|P7|Overall Study|Adverse event unrelated to study drug|0
2532306|NCT01621490|8763157|P6|Overall Study|Adverse event unrelated to study drug|0
2532307|NCT01621490|8763158|P5|Overall Study|Adverse event unrelated to study drug|0
2532308|NCT01621490|8763159|P4|Overall Study|Adverse event unrelated to study drug|0
2532309|NCT01621490|8763160|P3|Overall Study|Adverse event unrelated to study drug|0
2532310|NCT01621490|8763161|P2|Overall Study|Adverse event unrelated to study drug|1
2532311|NCT01621490|8763162|P1|Overall Study|Adverse event unrelated to study drug|2
2532312|NCT01621490|8763154|P9|Overall Study|Subject request to discontinue study|1
2532313|NCT01621490|8763155|P8|Overall Study|Subject request to discontinue study|0
2532314|NCT01621490|8763156|P7|Overall Study|Subject request to discontinue study|1
2532315|NCT01621490|8763157|P6|Overall Study|Subject request to discontinue study|2
2532316|NCT01621490|8763158|P5|Overall Study|Subject request to discontinue study|0
2532317|NCT01621490|8763159|P4|Overall Study|Subject request to discontinue study|1
2532318|NCT01621490|8763160|P3|Overall Study|Subject request to discontinue study|1
2532319|NCT01621490|8763161|P2|Overall Study|Subject request to discontinue study|3
2532320|NCT01621490|8763162|P1|Overall Study|Subject request to discontinue study|1
2532321|NCT01621490|8763154|P9|Overall Study|Withdrawal by Subject|0
2532322|NCT01621490|8763155|P8|Overall Study|Withdrawal by Subject|0
2532323|NCT01621490|8763156|P7|Overall Study|Withdrawal by Subject|0
2532324|NCT01621490|8763157|P6|Overall Study|Withdrawal by Subject|3
2532325|NCT01621490|8763158|P5|Overall Study|Withdrawal by Subject|0
2532326|NCT01621490|8763159|P4|Overall Study|Withdrawal by Subject|0
2532327|NCT01621490|8763160|P3|Overall Study|Withdrawal by Subject|0
2532328|NCT01621490|8763161|P2|Overall Study|Withdrawal by Subject|0
2532329|NCT01621490|8763162|P1|Overall Study|Withdrawal by Subject|1
2532330|NCT01621490|8763154|P9|Overall Study|Maximum clinical benefit|0
2532331|NCT01621490|8763155|P8|Overall Study|Maximum clinical benefit|2
2532332|NCT01621490|8763156|P7|Overall Study|Maximum clinical benefit|1
2532333|NCT01621490|8763157|P6|Overall Study|Maximum clinical benefit|0
2532334|NCT01621490|8763158|P5|Overall Study|Maximum clinical benefit|0
2532335|NCT01621490|8763159|P4|Overall Study|Maximum clinical benefit|0
2532336|NCT01621490|8763160|P3|Overall Study|Maximum clinical benefit|0
2532337|NCT01621490|8763161|P2|Overall Study|Maximum clinical benefit|2
2532338|NCT01621490|8763162|P1|Overall Study|Maximum clinical benefit|3
2532339|NCT01621490|8763154|P9|Overall Study|Subject no longer meets study criteria|0
2532340|NCT01621490|8763155|P8|Overall Study|Subject no longer meets study criteria|0
2532341|NCT01621490|8763156|P7|Overall Study|Subject no longer meets study criteria|0
2532342|NCT01621490|8763157|P6|Overall Study|Subject no longer meets study criteria|0
2532343|NCT01621490|8763158|P5|Overall Study|Subject no longer meets study criteria|1
2532344|NCT01621490|8763159|P4|Overall Study|Subject no longer meets study criteria|0
2532345|NCT01621490|8763160|P3|Overall Study|Subject no longer meets study criteria|0
2532346|NCT01621490|8763161|P2|Overall Study|Subject no longer meets study criteria|0
2532347|NCT01621490|8763162|P1|Overall Study|Subject no longer meets study criteria|0
2532348|NCT01621490|8763154|P9|Overall Study|Patient could not travel|0
2532349|NCT01621490|8763155|P8|Overall Study|Patient could not travel|0
2532350|NCT01621490|8763156|P7|Overall Study|Patient could not travel|0
2532351|NCT01621490|8763157|P6|Overall Study|Patient could not travel|0
2532352|NCT01621490|8763158|P5|Overall Study|Patient could not travel|0
2532353|NCT01621490|8763159|P4|Overall Study|Patient could not travel|0
2532354|NCT01621490|8763160|P3|Overall Study|Patient could not travel|0
2532355|NCT01621490|8763161|P2|Overall Study|Patient could not travel|0
2532356|NCT01621490|8763162|P1|Overall Study|Patient could not travel|1
2532357|NCT01621490|8763154|P9|Overall Study|Participant completed treatment|0
2532358|NCT01621490|8763155|P8|Overall Study|Participant completed treatment|1
2532359|NCT01621490|8763156|P7|Overall Study|Participant completed treatment|0
2532360|NCT01621490|8763157|P6|Overall Study|Participant completed treatment|0
2532361|NCT01621490|8763158|P5|Overall Study|Participant completed treatment|0
2532362|NCT01621490|8763159|P4|Overall Study|Participant completed treatment|0
2532363|NCT01621490|8763160|P3|Overall Study|Participant completed treatment|1
2532364|NCT01621490|8763161|P2|Overall Study|Participant completed treatment|4
2532365|NCT01621490|8763162|P1|Overall Study|Participant completed treatment|4
2532366|NCT01621191|8763398|P1|Overall Study|Site Removed From Study|1
2532367|NCT01621191|8763398|P1|Overall Study|Lost to Follow-up|1
2532368|NCT01621191|8763398|P1|Overall Study|Lack of Efficacy|6
2532369|NCT01621191|8763398|P1|Overall Study|Withdrawal by Subject|8
2532370|NCT01621191|8763398|P1|Overall Study|Adverse Event|9
2532371|NCT01621178|8763412|P3|Overall Study|Physician Decision|7
2532372|NCT01621178|8763413|P2|Overall Study|Physician Decision|2
2532373|NCT01621178|8763414|P1|Overall Study|Physician Decision|5
2532374|NCT01621178|8763412|P3|Overall Study|Withdrawal by Subject|18
2532375|NCT01621178|8763413|P2|Overall Study|Withdrawal by Subject|17
2532376|NCT01621178|8763414|P1|Overall Study|Withdrawal by Subject|14
2532377|NCT01621178|8763412|P3|Overall Study|Lost to Follow-up|1
2532378|NCT01621178|8763413|P2|Overall Study|Lost to Follow-up|2
2532379|NCT01621178|8763414|P1|Overall Study|Lost to Follow-up|1
2532380|NCT01621178|8763412|P3|Overall Study|Death|2
2532381|NCT01621178|8763413|P2|Overall Study|Death|7
2532382|NCT01621178|8763414|P1|Overall Study|Death|6
2532383|NCT01621178|8763412|P3|Overall Study|Adverse Event|8
2532384|NCT01621178|8763413|P2|Overall Study|Adverse Event|2
2532385|NCT01621178|8763414|P1|Overall Study|Adverse Event|5
2532386|NCT01621126|8763506|P1|Overall Study|Physician Decision|6
2532387|NCT01620983|8763528|P3|Overall Study|Physician Decision|5
2532388|NCT01620983|8763529|P2|Overall Study|Physician Decision|10
2532389|NCT01620983|8763530|P1|Overall Study|Physician Decision|3
2532390|NCT01620983|8763528|P3|Overall Study|Death|0
2532391|NCT01620983|8763529|P2|Overall Study|Death|0
2532392|NCT01620983|8763530|P1|Overall Study|Death|2
2532393|NCT01620983|8763528|P3|Overall Study|Withdrawal by Subject|1
2532394|NCT01620983|8763529|P2|Overall Study|Withdrawal by Subject|8
2532395|NCT01620983|8763530|P1|Overall Study|Withdrawal by Subject|6
2532396|NCT01620983|8763528|P3|Overall Study|Lost to Follow-up|9
2532397|NCT01620983|8763529|P2|Overall Study|Lost to Follow-up|4
2532398|NCT01620983|8763530|P1|Overall Study|Lost to Follow-up|8
2532399|NCT01620762|8763559|P3|Overall Study|Use of prohibted therapies|1
2532400|NCT01620762|8763560|P2|Overall Study|Use of prohibted therapies|1
2532401|NCT01620762|8763561|P1|Overall Study|Use of prohibted therapies|0
2532402|NCT01620762|8763559|P3|Overall Study|Non-specified|5
2532403|NCT01620762|8763560|P2|Overall Study|Non-specified|6
2532404|NCT01620762|8763561|P1|Overall Study|Non-specified|3
2532405|NCT01620762|8763559|P3|Overall Study|Subject deterioration|1
2532406|NCT01620762|8763560|P2|Overall Study|Subject deterioration|1
2532407|NCT01620762|8763561|P1|Overall Study|Subject deterioration|0
2532408|NCT01620762|8763559|P3|Overall Study|Protocol deviation|6
2532409|NCT01620762|8763560|P2|Overall Study|Protocol deviation|1
2532410|NCT01620762|8763561|P1|Overall Study|Protocol deviation|1
2532411|NCT01620762|8763559|P3|Overall Study|Lost to Follow-up|10
2532412|NCT01620762|8763560|P2|Overall Study|Lost to Follow-up|17
2532413|NCT01620762|8763561|P1|Overall Study|Lost to Follow-up|11
2532414|NCT01620762|8763559|P3|Overall Study|Withdrawal by Subject|27
2532415|NCT01620762|8763560|P2|Overall Study|Withdrawal by Subject|26
2532416|NCT01620762|8763561|P1|Overall Study|Withdrawal by Subject|23
2532417|NCT01620762|8763559|P3|Overall Study|Adverse Event|2
2532418|NCT01620762|8763560|P2|Overall Study|Adverse Event|5
2532419|NCT01620762|8763561|P1|Overall Study|Adverse Event|9
2532420|NCT01620762|8763559|P3|Overall Study|Protocol Violation|1
2532421|NCT01620762|8763560|P2|Overall Study|Protocol Violation|1
2532422|NCT01620762|8763561|P1|Overall Study|Protocol Violation|1
2532423|NCT01620528|8763622|P3|Post-Treatment Follow-Up Period|Other|2
2532424|NCT01620528|8763623|P2|Post-Treatment Follow-Up Period|Other|4
2532425|NCT01620528|8763624|P1|Post-Treatment Follow-Up Period|Other|6
2532426|NCT01620528|8763622|P3|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4
2532427|NCT01620528|8763623|P2|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3
2532428|NCT01620528|8763624|P1|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8
2532429|NCT01620528|8763622|P3|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
2532430|NCT01620528|8763623|P2|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
2532431|NCT01620528|8763624|P1|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0
2532432|NCT01620528|8763622|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|4
2532433|NCT01620528|8763623|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|2
2532434|NCT01620528|8763624|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|3
2532435|NCT01620528|8763622|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
2532436|NCT01620528|8763623|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|7
2532437|NCT01620528|8763624|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
2532438|NCT01620528|8763622|P3|Treatment Period|Exclusionary Medication Received|0
2532439|NCT01620528|8763623|P2|Treatment Period|Exclusionary Medication Received|1
2532440|NCT01620528|8763624|P1|Treatment Period|Exclusionary Medication Received|0
2532441|NCT01620528|8763622|P3|Treatment Period|Surgery/Invasive Intervention|3
2532442|NCT01620528|8763623|P2|Treatment Period|Surgery/Invasive Intervention|1
2532443|NCT01620528|8763624|P1|Treatment Period|Surgery/Invasive Intervention|5
2532444|NCT01620528|8763622|P3|Treatment Period|Pregnancy|2
2532445|NCT01620528|8763623|P2|Treatment Period|Pregnancy|2
2532446|NCT01620528|8763624|P1|Treatment Period|Pregnancy|7
2532447|NCT01620528|8763622|P3|Treatment Period|Subject Noncompliant|2
2532448|NCT01620528|8763623|P2|Treatment Period|Subject Noncompliant|2
2532449|NCT01620528|8763624|P1|Treatment Period|Subject Noncompliant|11
2532450|NCT01620528|8763622|P3|Treatment Period|Other|7
2532451|NCT01620528|8763623|P2|Treatment Period|Other|5
2532452|NCT01620528|8763624|P1|Treatment Period|Other|9
2532453|NCT01620528|8763622|P3|Treatment Period|Lost to Follow-up|14
2532454|NCT01620528|8763623|P2|Treatment Period|Lost to Follow-up|8
2532455|NCT01620528|8763624|P1|Treatment Period|Lost to Follow-up|16
2532456|NCT01620528|8763622|P3|Treatment Period|Adverse Event|21
2532457|NCT01620528|8763623|P2|Treatment Period|Adverse Event|13
2532458|NCT01620528|8763624|P1|Treatment Period|Adverse Event|17
2532459|NCT01620528|8763622|P3|Treatment Period|Withdrawal by Subject|16
2532460|NCT01620528|8763623|P2|Treatment Period|Withdrawal by Subject|21
2532461|NCT01620528|8763624|P1|Treatment Period|Withdrawal by Subject|35
2532462|NCT01620528|8763622|P3|Treatment Period|Did Not Receive Study Drug|1
2532463|NCT01620528|8763623|P2|Treatment Period|Did Not Receive Study Drug|0
2532464|NCT01620528|8763624|P1|Treatment Period|Did Not Receive Study Drug|0
2532465|NCT01620489|8763964|P2|Overall Study|Unclassified|2
2532466|NCT01620489|8763965|P1|Overall Study|Unclassified|1
2532467|NCT01620489|8763964|P2|Overall Study|Withdrawal Criteria|25
2532468|NCT01620489|8763965|P1|Overall Study|Withdrawal Criteria|17
2532469|NCT01620489|8763964|P2|Overall Study|Protocol Violation|3
2532470|NCT01620489|8763965|P1|Overall Study|Protocol Violation|0
2532471|NCT01620489|8763964|P2|Overall Study|Adverse Event|4
2532472|NCT01620489|8763965|P1|Overall Study|Adverse Event|17
2532473|NCT01620255|8763986|P5|Overall Study|Withdrawn at discretion of investigator|1
2532474|NCT01620255|8763987|P4|Overall Study|Withdrawn at discretion of investigator|0
2532475|NCT01620255|8763988|P3|Overall Study|Withdrawn at discretion of investigator|0
2532476|NCT01620255|8763989|P2|Overall Study|Withdrawn at discretion of investigator|0
2532477|NCT01620255|8763990|P1|Overall Study|Withdrawn at discretion of investigator|0
2532478|NCT01620255|8763986|P5|Overall Study|Adverse Event|1
2532479|NCT01620255|8763987|P4|Overall Study|Adverse Event|1
2532480|NCT01620255|8763988|P3|Overall Study|Adverse Event|0
2532481|NCT01620255|8763989|P2|Overall Study|Adverse Event|4
2532482|NCT01620255|8763990|P1|Overall Study|Adverse Event|0
2532483|NCT01620255|8763986|P5|Overall Study|Non-compliance|0
2532484|NCT01620255|8763987|P4|Overall Study|Non-compliance|0
2532485|NCT01620255|8763988|P3|Overall Study|Non-compliance|0
2532486|NCT01620255|8763989|P2|Overall Study|Non-compliance|1
2532487|NCT01620255|8763990|P1|Overall Study|Non-compliance|0
2532488|NCT01620255|8763986|P5|Overall Study|Participant underwent fecal transplant|0
2532489|NCT01620255|8763987|P4|Overall Study|Participant underwent fecal transplant|0
2532490|NCT01620255|8763988|P3|Overall Study|Participant underwent fecal transplant|1
2532491|NCT01620255|8763989|P2|Overall Study|Participant underwent fecal transplant|0
2532492|NCT01620255|8763990|P1|Overall Study|Participant underwent fecal transplant|0
2532493|NCT01620255|8763986|P5|Overall Study|Withdrawal by Subject|4
2532494|NCT01620255|8763987|P4|Overall Study|Withdrawal by Subject|2
2532495|NCT01620255|8763988|P3|Overall Study|Withdrawal by Subject|1
2532496|NCT01620255|8763989|P2|Overall Study|Withdrawal by Subject|1
2532497|NCT01620255|8763990|P1|Overall Study|Withdrawal by Subject|4
2532498|NCT01620177|8764067|P1|Overall Study|Randomized, Not Active due to Scheduling|1
2532499|NCT01620177|8764067|P1|Overall Study|Physician Decision|2
2532500|NCT01620177|8764067|P1|Overall Study|Lost to Follow-up|7
2532501|NCT01620177|8764067|P1|Overall Study|Withdrawal by Subject|26
2532502|NCT01620177|8764067|P1|Overall Study|Failure at Screening Visit|43
2532503|NCT01620138|8764092|P2|Overall Study|Adverse Event|0
2532504|NCT01620138|8764093|P1|Overall Study|Adverse Event|2
2532505|NCT01620138|8764092|P2|Overall Study|Lack of Efficacy|0
2532506|NCT01620138|8764093|P1|Overall Study|Lack of Efficacy|1
2532507|NCT01620138|8764092|P2|Overall Study|Withdrawal by Subject|0
2532508|NCT01620138|8764093|P1|Overall Study|Withdrawal by Subject|3
2532509|NCT01620086|8764101|P3|Overall Study|Physician Decision|0
2532510|NCT01620086|8764102|P2|Overall Study|Physician Decision|0
2532511|NCT01620086|8764103|P1|Overall Study|Physician Decision|1
2532512|NCT01620086|8764101|P3|Overall Study|failed study criteria|0
2532513|NCT01620086|8764102|P2|Overall Study|failed study criteria|4
2532514|NCT01620086|8764103|P1|Overall Study|failed study criteria|1
2532515|NCT01620086|8764101|P3|Overall Study|Withdrawal by Subject|0
2532516|NCT01620086|8764102|P2|Overall Study|Withdrawal by Subject|3
2532517|NCT01620086|8764103|P1|Overall Study|Withdrawal by Subject|3
2532518|NCT01620060|8764122|P1|Overall Study|Per Sponsor Decision|2
2532519|NCT01620060|8764122|P1|Overall Study|Family emergency|1
2532520|NCT01620060|8764122|P1|Overall Study|Did not comply with Study Produre|1
2532521|NCT01620060|8764122|P1|Overall Study|Withdrawal by Subject|1
2532522|NCT01620060|8764122|P1|Overall Study|Protocol Violation|1
2532523|NCT01620060|8764122|P1|Overall Study|Adverse Event|9
2532524|NCT01619878|8764160|P1|Follow-up at 12 Months of Age|Death|2
2532525|NCT01619878|8764160|P1|Follow-up at 12 Months of Age|Lost to Follow-up|1
2532526|NCT01619878|8764160|P1|6 Week Follow-up Phase|Adverse Event|1
2532527|NCT01619852|8764174|P2|3 Month Follow up|Lost to Follow-up|34
2532528|NCT01619852|8764175|P1|3 Month Follow up|Lost to Follow-up|31
2532529|NCT01619852|8764174|P2|24 Hour Assessment|Withdrawal by Subject|1
2532530|NCT01619852|8764175|P1|24 Hour Assessment|Withdrawal by Subject|1
2532531|NCT01619800|8764191|P2|Overall Study|study terminated|0
2532532|NCT01619800|8764192|P1|Overall Study|study terminated|2
2532533|NCT01619787|8764200|P1|Overall Study|Lost to Follow-up|5
2532534|NCT01619579|8764217|P2|Overall Study|Withdrawal by Subject|3
2532535|NCT01619579|8764218|P1|Overall Study|Withdrawal by Subject|0
2532536|NCT01619423|8764232|P4|Part 1 (Dose Escalation)|High basal Mn|0
2532537|NCT01619423|8764233|P3|Part 1 (Dose Escalation)|High basal Mn|0
2532538|NCT01619423|8764234|P2|Part 1 (Dose Escalation)|High basal Mn|2
2532539|NCT01619423|8764235|P1|Part 1 (Dose Escalation)|High basal Mn|0
2532540|NCT01619410|8764248|P2|Overall Study|Lost to Follow-up|4
2532541|NCT01619410|8764249|P1|Overall Study|Lost to Follow-up|7
2532542|NCT01619085|8764261|P1|Overall Study|Ongoing on trial|27
2532543|NCT01619085|8764261|P1|Overall Study|Not treated|1
2532544|NCT01619085|8764261|P1|Overall Study|Other than specified|94
2532545|NCT01619085|8764261|P1|Overall Study|Withdrawal by Subject|15
2532546|NCT01619085|8764261|P1|Overall Study|Lost to Follow-up|10
2532547|NCT01619085|8764261|P1|Overall Study|Protocol Violation|10
2532548|NCT01619085|8764261|P1|Overall Study|Adverse Event|212
2532549|NCT01619059|8764267|P2|Long-Term (LT) Treatment Period|Not Met Study Criteria|1
2532550|NCT01619059|8764268|P1|Long-Term (LT) Treatment Period|Not Met Study Criteria|0
2532551|NCT01619059|8764267|P2|Long-Term (LT) Treatment Period|Lost to Follow-up|2
2532552|NCT01619059|8764268|P1|Long-Term (LT) Treatment Period|Lost to Follow-up|2
2532553|NCT01619059|8764267|P2|Long-Term (LT) Treatment Period|Death|0
2532554|NCT01619059|8764268|P1|Long-Term (LT) Treatment Period|Death|1
2532555|NCT01619059|8764267|P2|Long-Term (LT) Treatment Period|Withdrawal by Subject|2
2532556|NCT01619059|8764268|P1|Long-Term (LT) Treatment Period|Withdrawal by Subject|3
2532557|NCT01619059|8764267|P2|Long-Term (LT) Treatment Period|Adverse Event|3
2532558|NCT01619059|8764268|P1|Long-Term (LT) Treatment Period|Adverse Event|2
2532559|NCT01619059|8764267|P2|Long-Term (LT) Treatment Period|Lack of Efficacy|1
2532560|NCT01619059|8764268|P1|Long-Term (LT) Treatment Period|Lack of Efficacy|0
2532561|NCT01619059|8764267|P2|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2
2532562|NCT01619059|8764268|P1|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1
2532563|NCT01619059|8764267|P2|Short-Term (ST) Treatment Period|Lost to Follow-up|4
2532564|NCT01619059|8764268|P1|Short-Term (ST) Treatment Period|Lost to Follow-up|2
2532565|NCT01619059|8764267|P2|Short-Term (ST) Treatment Period|Withdrawal by Subject|5
2532566|NCT01619059|8764268|P1|Short-Term (ST) Treatment Period|Withdrawal by Subject|2
2532567|NCT01619059|8764267|P2|Short-Term (ST) Treatment Period|Adverse Event|0
2532568|NCT01619059|8764268|P1|Short-Term (ST) Treatment Period|Adverse Event|1
2532569|NCT01618968|8764284|P4|Overall Study|Death|1
2532570|NCT01618968|8764285|P3|Overall Study|Death|0
2532571|NCT01618968|8764286|P2|Overall Study|Death|0
2532572|NCT01618968|8764287|P1|Overall Study|Death|0
2532573|NCT01618968|8764284|P4|Overall Study|Adverse Event|0
2532574|NCT01618968|8764285|P3|Overall Study|Adverse Event|0
2532575|NCT01618968|8764286|P2|Overall Study|Adverse Event|0
2532576|NCT01618968|8764287|P1|Overall Study|Adverse Event|1
2532577|NCT01618916|8764360|P6|Overall Study|Lost to Follow-up|0
2532578|NCT01618916|8764361|P5|Overall Study|Lost to Follow-up|0
2532579|NCT01618916|8764362|P4|Overall Study|Lost to Follow-up|2
2532580|NCT01618916|8764363|P3|Overall Study|Lost to Follow-up|0
2532581|NCT01618916|8764364|P2|Overall Study|Lost to Follow-up|0
2532582|NCT01618916|8764365|P1|Overall Study|Lost to Follow-up|1
2532583|NCT01618916|8764360|P6|Overall Study|Withdrawal by Subject|0
2532584|NCT01618916|8764361|P5|Overall Study|Withdrawal by Subject|1
2532585|NCT01618916|8764362|P4|Overall Study|Withdrawal by Subject|0
2532586|NCT01618916|8764363|P3|Overall Study|Withdrawal by Subject|1
2532587|NCT01618916|8764364|P2|Overall Study|Withdrawal by Subject|1
2532588|NCT01618916|8764365|P1|Overall Study|Withdrawal by Subject|0
2532589|NCT01618916|8764360|P6|Overall Study|Adverse Event|0
2532590|NCT01618916|8764361|P5|Overall Study|Adverse Event|0
2532591|NCT01618916|8764362|P4|Overall Study|Adverse Event|0
2532592|NCT01618916|8764363|P3|Overall Study|Adverse Event|0
2532593|NCT01618916|8764364|P2|Overall Study|Adverse Event|0
2532594|NCT01618916|8764365|P1|Overall Study|Adverse Event|1
2532595|NCT01618864|8764395|P1|Overall Study|Lost to Follow-up|2
2532596|NCT01618864|8764395|P1|Overall Study|Withdrawal by Subject|2
2532597|NCT01618838|8764404|P1|Overall Study|slow accrual, trial closed prematurely.|4
2532598|NCT01618708|8764412|P2|Overall Study|Randomized but not treated|2
2532599|NCT01618708|8764413|P1|Overall Study|Randomized but not treated|3
2532600|NCT01618708|8764412|P2|Overall Study|Other than specified above|1
2532601|NCT01618708|8764413|P1|Overall Study|Other than specified above|1
2532602|NCT01618708|8764412|P2|Overall Study|Technical problems|0
2532603|NCT01618708|8764413|P1|Overall Study|Technical problems|2
2532604|NCT01618708|8764412|P2|Overall Study|Lack of Efficacy|8
2532605|NCT01618708|8764413|P1|Overall Study|Lack of Efficacy|8
2532606|NCT01618708|8764412|P2|Overall Study|Withdrawal by Subject|22
2532607|NCT01618708|8764413|P1|Overall Study|Withdrawal by Subject|17
2532608|NCT01618708|8764412|P2|Overall Study|Lost to Follow-up|3
2532609|NCT01618708|8764413|P1|Overall Study|Lost to Follow-up|3
2532610|NCT01618708|8764412|P2|Overall Study|Adverse Event|10
2532611|NCT01618708|8764413|P1|Overall Study|Adverse Event|10
2532612|NCT01618669|8764427|P2|Overall Study|Miscellaneous Reason|1
2532613|NCT01618669|8764428|P1|Overall Study|Miscellaneous Reason|0
2532614|NCT01618669|8764427|P2|Overall Study|Withdrawal by Subject|9
2532615|NCT01618669|8764428|P1|Overall Study|Withdrawal by Subject|9
2532616|NCT01618669|8764427|P2|Overall Study|Protocol Violation|3
2532617|NCT01618669|8764428|P1|Overall Study|Protocol Violation|5
2532618|NCT01618669|8764427|P2|Overall Study|Adverse Event|7
2532619|NCT01618669|8764428|P1|Overall Study|Adverse Event|16
2532620|NCT01618669|8764427|P2|Overall Study|Randomized but Never Received Study Drug|2
2532621|NCT01618669|8764428|P1|Overall Study|Randomized but Never Received Study Drug|3
2532622|NCT01618669|8764427|P2|Overall Study|Lost to Follow-up|1
2532623|NCT01618669|8764428|P1|Overall Study|Lost to Follow-up|1
2532624|NCT01618305|8764487|P2|Overall Study|Withdrawal by Subject|2
2532625|NCT01618305|8764488|P1|Overall Study|Withdrawal by Subject|3
2532626|NCT01618305|8764487|P2|Overall Study|Protocol Violation|0
2532627|NCT01618305|8764488|P1|Overall Study|Protocol Violation|1
2532628|NCT01618305|8764487|P2|Overall Study|Lost to Follow-up|7
2532629|NCT01618305|8764488|P1|Overall Study|Lost to Follow-up|11
2532630|NCT01618305|8764487|P2|Overall Study|Death|1
2532631|NCT01618305|8764488|P1|Overall Study|Death|0
2532632|NCT01618266|8764530|P1|Overall Study|Protocol Violation|43
2532633|NCT01618266|8764530|P1|Overall Study|Lack of Efficacy|23
2532634|NCT01618266|8764530|P1|Overall Study|Other reasons|11
2532635|NCT01618266|8764530|P1|Overall Study|Treatment satisfaction|10
2532636|NCT01618266|8764530|P1|Overall Study|Lost to Follow-up|9
2532637|NCT01618214|8764567|P2|Overall Study|Unclassified|5
2532638|NCT01618214|8764568|P1|Overall Study|Unclassified|4
2532639|NCT01618214|8764567|P2|Overall Study|Withdrawal Criteria|2
2532640|NCT01618214|8764568|P1|Overall Study|Withdrawal Criteria|1
2532641|NCT01618214|8764567|P2|Overall Study|Protocol Violation|4
2532642|NCT01618214|8764568|P1|Overall Study|Protocol Violation|1
2532643|NCT01618214|8764567|P2|Overall Study|Lack of Efficacy|1
2532644|NCT01618214|8764568|P1|Overall Study|Lack of Efficacy|1
2532645|NCT01618214|8764567|P2|Overall Study|Adverse Event|1
2532646|NCT01618214|8764568|P1|Overall Study|Adverse Event|3
2532647|NCT01618162|8764584|P2|Overall Study|Unclassified|13
2532648|NCT01618162|8764585|P1|Overall Study|Unclassified|14
2532649|NCT01618162|8764584|P2|Overall Study|Withdrawal Criteria|10
2532650|NCT01618162|8764585|P1|Overall Study|Withdrawal Criteria|2
2532651|NCT01618162|8764584|P2|Overall Study|Adverse Event|2
2532652|NCT01618162|8764585|P1|Overall Study|Adverse Event|9
2532653|NCT01618162|8764584|P2|Overall Study|Protocol Violation|10
2532654|NCT01618162|8764585|P1|Overall Study|Protocol Violation|13
2532655|NCT01618019|8764605|P2|Overall Study|Withdrawal by Subject|14
2532656|NCT01618019|8764606|P1|Overall Study|Withdrawal by Subject|14
2532657|NCT01617967|8764632|P6|Overall Study|Dosing Suspended by Sponsor|0
2532658|NCT01617967|8764633|P5|Overall Study|Dosing Suspended by Sponsor|0
2532659|NCT01617967|8764634|P4|Overall Study|Dosing Suspended by Sponsor|0
2532660|NCT01617967|8764635|P3|Overall Study|Dosing Suspended by Sponsor|0
2532661|NCT01617967|8764636|P2|Overall Study|Dosing Suspended by Sponsor|0
2532662|NCT01617967|8764637|P1|Overall Study|Dosing Suspended by Sponsor|1
2532663|NCT01617967|8764632|P6|Overall Study|Withdrawal by Subject|1
2532664|NCT01617967|8764633|P5|Overall Study|Withdrawal by Subject|0
2532665|NCT01617967|8764634|P4|Overall Study|Withdrawal by Subject|0
2532666|NCT01617967|8764635|P3|Overall Study|Withdrawal by Subject|0
2532667|NCT01617967|8764636|P2|Overall Study|Withdrawal by Subject|0
2532668|NCT01617967|8764637|P1|Overall Study|Withdrawal by Subject|0
2532669|NCT01617967|8764632|P6|Overall Study|Protocol Violation|0
2532670|NCT01617967|8764633|P5|Overall Study|Protocol Violation|0
2532671|NCT01617967|8764634|P4|Overall Study|Protocol Violation|1
2532672|NCT01617967|8764635|P3|Overall Study|Protocol Violation|0
2532673|NCT01617967|8764636|P2|Overall Study|Protocol Violation|0
2532674|NCT01617967|8764637|P1|Overall Study|Protocol Violation|0
2532675|NCT01617681|8764691|P5|Period 2 Open Label|Withdrawal by Subject|3
2532676|NCT01617681|8764692|P4|Period 2 Open Label|Withdrawal by Subject|0
2532677|NCT01617681|8764693|P3|Period 2 Open Label|Withdrawal by Subject|0
2532678|NCT01617681|8764694|P2|Period 2 Open Label|Withdrawal by Subject|0
2532679|NCT01617681|8764695|P1|Period 2 Open Label|Withdrawal by Subject|0
2532680|NCT01617681|8764691|P5|Period 2 Open Label|Adverse Event|3
2532681|NCT01617681|8764692|P4|Period 2 Open Label|Adverse Event|0
2532682|NCT01617681|8764693|P3|Period 2 Open Label|Adverse Event|0
2532683|NCT01617681|8764694|P2|Period 2 Open Label|Adverse Event|0
2532684|NCT01617681|8764695|P1|Period 2 Open Label|Adverse Event|0
2532685|NCT01617681|8764691|P5|Period 1 Double Blind|Withdrawal by Subject|0
2532686|NCT01617681|8764692|P4|Period 1 Double Blind|Withdrawal by Subject|0
2532687|NCT01617681|8764693|P3|Period 1 Double Blind|Withdrawal by Subject|1
2532688|NCT01617681|8764694|P2|Period 1 Double Blind|Withdrawal by Subject|1
2532689|NCT01617681|8764695|P1|Period 1 Double Blind|Withdrawal by Subject|1
2532690|NCT01617681|8764691|P5|Period 1 Double Blind|Adverse Event|0
2532691|NCT01617681|8764692|P4|Period 1 Double Blind|Adverse Event|2
2532692|NCT01617681|8764693|P3|Period 1 Double Blind|Adverse Event|0
2532693|NCT01617681|8764694|P2|Period 1 Double Blind|Adverse Event|0
2532694|NCT01617681|8764695|P1|Period 1 Double Blind|Adverse Event|2
2532695|NCT01617668|8764716|P4|Overall Study|Subject/guardian decision|1
2532696|NCT01617668|8764717|P3|Overall Study|Subject/guardian decision|2
2532697|NCT01617668|8764718|P2|Overall Study|Subject/guardian decision|3
2532698|NCT01617668|8764719|P1|Overall Study|Subject/guardian decision|1
2532699|NCT01617668|8764716|P4|Overall Study|Progressive Disease|9
2532700|NCT01617668|8764717|P3|Overall Study|Progressive Disease|6
2532701|NCT01617668|8764718|P2|Overall Study|Progressive Disease|4
2532702|NCT01617668|8764719|P1|Overall Study|Progressive Disease|4
2532703|NCT01617668|8764716|P4|Overall Study|Physician Decision|0
2532704|NCT01617668|8764717|P3|Overall Study|Physician Decision|3
2532705|NCT01617668|8764718|P2|Overall Study|Physician Decision|2
2532706|NCT01617668|8764719|P1|Overall Study|Physician Decision|1
2532707|NCT01617668|8764716|P4|Overall Study|Adverse Event|5
2532708|NCT01617668|8764717|P3|Overall Study|Adverse Event|12
2532709|NCT01617668|8764718|P2|Overall Study|Adverse Event|0
2532710|NCT01617668|8764719|P1|Overall Study|Adverse Event|7
2532711|NCT01617655|8764760|P2|Overall Study|Other than specified above|2
2532712|NCT01617655|8764761|P1|Overall Study|Other than specified above|1
2532713|NCT01617655|8764760|P2|Overall Study|Site closure|5
2532714|NCT01617655|8764761|P1|Overall Study|Site closure|3
2532715|NCT01617655|8764760|P2|Overall Study|Last visit outside protocol visit window|10
2532716|NCT01617655|8764761|P1|Overall Study|Last visit outside protocol visit window|1
2532717|NCT01617655|8764760|P2|Overall Study|Consent withdrawn by participant|1
2532718|NCT01617655|8764761|P1|Overall Study|Consent withdrawn by participant|1
2532719|NCT01617655|8764760|P2|Overall Study|Participants moved|4
2532720|NCT01617655|8764761|P1|Overall Study|Participants moved|0
2532721|NCT01617655|8764760|P2|Overall Study|Poor compliance to protocol|4
2532722|NCT01617655|8764761|P1|Overall Study|Poor compliance to protocol|1
2532723|NCT01617655|8764760|P2|Overall Study|Adverse Event|3
2532724|NCT01617655|8764761|P1|Overall Study|Adverse Event|2
2532725|NCT01617629|8764821|P1|Overall Study|Participant Withdrew Consent|2
2532726|NCT01617629|8764821|P1|Overall Study|Reason Not Specified|1
2532727|NCT01617629|8764821|P1|Overall Study|Investigator's Clinical Judgement|1
2532728|NCT01617629|8764821|P1|Overall Study|Death|2
2532729|NCT01617460|8764849|P1|Overall Study|Withdrawal by Subject|9
2532730|NCT01617460|8764849|P1|Overall Study|Protocol Violation|5
2532731|NCT01617460|8764849|P1|Overall Study|Physician Decision|16
2532732|NCT01617460|8764849|P1|Overall Study|Adverse Event|10
2532733|NCT01617447|8764855|P2|Overall Study|Physician Decision|2
2532734|NCT01617447|8764856|P1|Overall Study|Physician Decision|0
2532735|NCT01617447|8764855|P2|Overall Study|Adverse Event|1
2532736|NCT01617447|8764856|P1|Overall Study|Adverse Event|0
2532737|NCT01617434|8764864|P2|Overall Study|Unclassified|4
2532738|NCT01617434|8764865|P1|Overall Study|Unclassified|3
2532739|NCT01617434|8764864|P2|Overall Study|Withdrawal Criteria|37
2532740|NCT01617434|8764865|P1|Overall Study|Withdrawal Criteria|12
2532741|NCT01617434|8764864|P2|Overall Study|Protocol Violation|7
2532742|NCT01617434|8764865|P1|Overall Study|Protocol Violation|8
2532743|NCT01617434|8764864|P2|Overall Study|Adverse Event|3
2532744|NCT01617434|8764865|P1|Overall Study|Adverse Event|12
2532745|NCT01617187|8764904|P4|Treatment Through Study Completion|Protocol Violation|1
2532746|NCT01617187|8764905|P3|Treatment Through Study Completion|Protocol Violation|0
2532747|NCT01617187|8764906|P2|Treatment Through Study Completion|Protocol Violation|0
2532748|NCT01617187|8764907|P1|Treatment Through Study Completion|Protocol Violation|1
2532749|NCT01617187|8764904|P4|Treatment Through Study Completion|Withdrawal by Subject|6
2532750|NCT01617187|8764905|P3|Treatment Through Study Completion|Withdrawal by Subject|3
2532751|NCT01617187|8764906|P2|Treatment Through Study Completion|Withdrawal by Subject|8
2532752|NCT01617187|8764907|P1|Treatment Through Study Completion|Withdrawal by Subject|5
2532753|NCT01617187|8764904|P4|Treatment Through Study Completion|Lost to Follow-up|2
2532754|NCT01617187|8764905|P3|Treatment Through Study Completion|Lost to Follow-up|2
2532755|NCT01617187|8764906|P2|Treatment Through Study Completion|Lost to Follow-up|2
2532756|NCT01617187|8764907|P1|Treatment Through Study Completion|Lost to Follow-up|4
2532757|NCT01617187|8764904|P4|Treatment Through Study Completion|Adverse Event|1
2532758|NCT01617187|8764905|P3|Treatment Through Study Completion|Adverse Event|0
2532759|NCT01617187|8764906|P2|Treatment Through Study Completion|Adverse Event|1
2532760|NCT01617187|8764907|P1|Treatment Through Study Completion|Adverse Event|1
2532761|NCT01617187|8764904|P4|Randomization Through Start Treatment|Not Treated: Completed study in database|0
2532762|NCT01617187|8764905|P3|Randomization Through Start Treatment|Not Treated: Completed study in database|0
2532763|NCT01617187|8764906|P2|Randomization Through Start Treatment|Not Treated: Completed study in database|0
2532764|NCT01617187|8764907|P1|Randomization Through Start Treatment|Not Treated: Completed study in database|1
2532765|NCT01617187|8764904|P4|Randomization Through Start Treatment|Not Treated: Adverse Event|1
2532766|NCT01617187|8764905|P3|Randomization Through Start Treatment|Not Treated: Adverse Event|0
2532767|NCT01617187|8764906|P2|Randomization Through Start Treatment|Not Treated: Adverse Event|0
2532768|NCT01617187|8764907|P1|Randomization Through Start Treatment|Not Treated: Adverse Event|0
2532769|NCT01617187|8764904|P4|Randomization Through Start Treatment|Not Treated: Administrative Reason|1
2532770|NCT01617187|8764905|P3|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
2532771|NCT01617187|8764906|P2|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
2532772|NCT01617187|8764907|P1|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
2532773|NCT01617070|8765004|P1|BH4 and LNAA (4 Weeks)|started medication interfere with study|1
2532774|NCT01617005|8765022|P1|Overall Study|Lack of motivation for treatment|1
2532775|NCT01617005|8765022|P1|Overall Study|Pregnancy|1
2532776|NCT01616953|8765031|P2|Overall Study|lack of bone and soft tissue|0
2532777|NCT01616953|8765032|P1|Overall Study|lack of bone and soft tissue|1
2532778|NCT01616953|8765031|P2|Overall Study|Lost to Follow-up|0
2532779|NCT01616953|8765032|P1|Overall Study|Lost to Follow-up|1
2532780|NCT01616771|8765040|P1|Smaller Sized GVL for 5 Sec|lack of GVL size|4
2532781|NCT01616693|8765053|P4|Blood Analyzed for Immunogenicity|Protocol Violation|1
2532782|NCT01616693|8765054|P3|Blood Analyzed for Immunogenicity|Protocol Violation|6
2532783|NCT01616693|8765055|P2|Blood Analyzed for Immunogenicity|Protocol Violation|2
2532784|NCT01616693|8765056|P1|Blood Analyzed for Immunogenicity|Protocol Violation|4
2532785|NCT01616693|8765053|P4|Received Both Vaccines|Lost to Follow-up|4
2532786|NCT01616693|8765054|P3|Received Both Vaccines|Lost to Follow-up|4
2532787|NCT01616693|8765055|P2|Received Both Vaccines|Lost to Follow-up|3
2532788|NCT01616693|8765056|P1|Received Both Vaccines|Lost to Follow-up|4
2532789|NCT01616693|8765053|P4|Received Both Vaccines|Withdrawal by Subject|15
2532790|NCT01616693|8765054|P3|Received Both Vaccines|Withdrawal by Subject|8
2532791|NCT01616693|8765055|P2|Received Both Vaccines|Withdrawal by Subject|7
2532792|NCT01616693|8765056|P1|Received Both Vaccines|Withdrawal by Subject|7
2532793|NCT01616693|8765053|P4|Received Both Vaccines|Adverse Event|0
2532794|NCT01616693|8765054|P3|Received Both Vaccines|Adverse Event|0
2532795|NCT01616693|8765055|P2|Received Both Vaccines|Adverse Event|0
2532796|NCT01616693|8765056|P1|Received Both Vaccines|Adverse Event|2
2532797|NCT01616693|8765053|P4|Evaluated for Safety|Physician Decision|0
2532798|NCT01616693|8765054|P3|Evaluated for Safety|Physician Decision|1
2532799|NCT01616693|8765055|P2|Evaluated for Safety|Physician Decision|0
2532800|NCT01616693|8765056|P1|Evaluated for Safety|Physician Decision|1
2532801|NCT01616459|8765122|P4|Overall Study|Other reason|0
2532802|NCT01616459|8765123|P3|Overall Study|Other reason|1
2532803|NCT01616459|8765124|P2|Overall Study|Other reason|1
2532804|NCT01616459|8765125|P1|Overall Study|Other reason|0
2532805|NCT01616459|8765122|P4|Overall Study|Withdrawal by Subject|4
2532806|NCT01616459|8765123|P3|Overall Study|Withdrawal by Subject|4
2532807|NCT01616459|8765124|P2|Overall Study|Withdrawal by Subject|4
2532808|NCT01616459|8765125|P1|Overall Study|Withdrawal by Subject|2
2532809|NCT01616459|8765122|P4|Overall Study|Protocol Violation|2
2532810|NCT01616459|8765123|P3|Overall Study|Protocol Violation|0
2532811|NCT01616459|8765124|P2|Overall Study|Protocol Violation|0
2532812|NCT01616459|8765125|P1|Overall Study|Protocol Violation|0
2532813|NCT01616459|8765122|P4|Overall Study|Lost to Follow-up|2
2532814|NCT01616459|8765123|P3|Overall Study|Lost to Follow-up|3
2532815|NCT01616459|8765124|P2|Overall Study|Lost to Follow-up|11
2532816|NCT01616459|8765125|P1|Overall Study|Lost to Follow-up|1
2532817|NCT01616459|8765122|P4|Overall Study|Adverse Event|0
2532818|NCT01616459|8765123|P3|Overall Study|Adverse Event|2
2532819|NCT01616459|8765124|P2|Overall Study|Adverse Event|1
2532820|NCT01616459|8765125|P1|Overall Study|Adverse Event|1
2532821|NCT01616173|8765226|P3|Overall Study|Lost to Follow-up|0
2532822|NCT01616173|8765227|P2|Overall Study|Lost to Follow-up|2
2532823|NCT01616173|8765228|P1|Overall Study|Lost to Follow-up|0
2532824|NCT01615939|8765261|P2|Overall Study|Lost to Follow-up|0
2532825|NCT01615939|8765262|P1|Overall Study|Lost to Follow-up|5
2532826|NCT01615822|8765275|P3|Period 2|Lost to Follow-up|2
2532827|NCT01615822|8765276|P2|Period 2|Lost to Follow-up|1
2532828|NCT01615822|8765277|P1|Period 2|Lost to Follow-up|0
2532829|NCT01615822|8765275|P3|Period 1|Adverse Event|0
2532830|NCT01615822|8765276|P2|Period 1|Adverse Event|1
2532831|NCT01615822|8765277|P1|Period 1|Adverse Event|1
2532832|NCT01615822|8765275|P3|Period 1|Withdrawal by Subject|0
2532833|NCT01615822|8765276|P2|Period 1|Withdrawal by Subject|1
2532834|NCT01615822|8765277|P1|Period 1|Withdrawal by Subject|0
2532835|NCT01615328|8765365|P2|Overall Study|Lost to Follow-up|5
2532836|NCT01615328|8765366|P1|Overall Study|Lost to Follow-up|3
2532837|NCT01615263|8765378|P2|Overall Study|Post-randomization exclusion|2
2532838|NCT01615263|8765379|P1|Overall Study|Post-randomization exclusion|0
2532839|NCT01615198|8765393|P2|Overall Study|Adverse Event|5
2532840|NCT01615198|8765394|P1|Overall Study|Adverse Event|11
2532841|NCT01615198|8765393|P2|Overall Study|Lack of Efficacy|6
2532842|NCT01615198|8765394|P1|Overall Study|Lack of Efficacy|1
2532843|NCT01615198|8765393|P2|Overall Study|Lost to Follow-up|1
2532844|NCT01615198|8765394|P1|Overall Study|Lost to Follow-up|1
2532845|NCT01615198|8765393|P2|Overall Study|Physician Decision|1
2532846|NCT01615198|8765394|P1|Overall Study|Physician Decision|5
2532847|NCT01615198|8765393|P2|Overall Study|Protocol deviation|1
2532848|NCT01615198|8765394|P1|Overall Study|Protocol deviation|1
2532849|NCT01615198|8765393|P2|Overall Study|Withdrawal by Subject|5
2532850|NCT01615198|8765394|P1|Overall Study|Withdrawal by Subject|5
2532851|NCT01615029|8765427|P5|Overall Study|Ongoing|23
2532852|NCT01615029|8765428|P4|Overall Study|Ongoing|2
2532853|NCT01615029|8765429|P3|Overall Study|Ongoing|3
2532854|NCT01615029|8765430|P2|Overall Study|Ongoing|2
2532855|NCT01615029|8765431|P1|Overall Study|Ongoing|1
2532856|NCT01615029|8765427|P5|Overall Study|Physician Decision|1
2532857|NCT01615029|8765428|P4|Overall Study|Physician Decision|0
2532858|NCT01615029|8765429|P3|Overall Study|Physician Decision|0
2532859|NCT01615029|8765430|P2|Overall Study|Physician Decision|0
2532860|NCT01615029|8765431|P1|Overall Study|Physician Decision|0
2532861|NCT01615029|8765427|P5|Overall Study|Progressive disease|5
2532862|NCT01615029|8765428|P4|Overall Study|Progressive disease|1
2532863|NCT01615029|8765429|P3|Overall Study|Progressive disease|1
2532864|NCT01615029|8765430|P2|Overall Study|Progressive disease|1
2532865|NCT01615029|8765431|P1|Overall Study|Progressive disease|2
2532866|NCT01615029|8765427|P5|Overall Study|Lost to Follow-up|1
2532867|NCT01615029|8765428|P4|Overall Study|Lost to Follow-up|0
2532868|NCT01615029|8765429|P3|Overall Study|Lost to Follow-up|0
2532869|NCT01615029|8765430|P2|Overall Study|Lost to Follow-up|0
2532870|NCT01615029|8765431|P1|Overall Study|Lost to Follow-up|0
2532871|NCT01615029|8765427|P5|Overall Study|Death|1
2532872|NCT01615029|8765428|P4|Overall Study|Death|0
2532873|NCT01615029|8765429|P3|Overall Study|Death|0
2532874|NCT01615029|8765430|P2|Overall Study|Death|0
2532875|NCT01615029|8765431|P1|Overall Study|Death|0
2532876|NCT01615029|8765427|P5|Overall Study|Adverse Event|1
2532877|NCT01615029|8765428|P4|Overall Study|Adverse Event|0
2532878|NCT01615029|8765429|P3|Overall Study|Adverse Event|0
2532879|NCT01615029|8765430|P2|Overall Study|Adverse Event|0
2532880|NCT01615029|8765431|P1|Overall Study|Adverse Event|0
2532881|NCT01614886|8765499|P2|Overall Study|Protocol deviation|2
2532882|NCT01614886|8765500|P1|Overall Study|Protocol deviation|0
2532883|NCT01614886|8765499|P2|Overall Study|Death|0
2532884|NCT01614886|8765500|P1|Overall Study|Death|1
2532885|NCT01614886|8765499|P2|Overall Study|Withdrawal by Subject|4
2532886|NCT01614886|8765500|P1|Overall Study|Withdrawal by Subject|4
2532887|NCT01614886|8765499|P2|Overall Study|Adverse Event|20
2532888|NCT01614886|8765500|P1|Overall Study|Adverse Event|15
2532889|NCT01614795|8765541|P4|Overall Study|Ineligible|0
2532890|NCT01614795|8765542|P3|Overall Study|Ineligible|0
2532891|NCT01614795|8765543|P2|Overall Study|Ineligible|1
2532892|NCT01614795|8765544|P1|Overall Study|Ineligible|0
2532893|NCT01614795|8765541|P4|Overall Study|Withdrawal by Subject|2
2532894|NCT01614795|8765542|P3|Overall Study|Withdrawal by Subject|0
2532895|NCT01614795|8765543|P2|Overall Study|Withdrawal by Subject|1
2532896|NCT01614795|8765544|P1|Overall Study|Withdrawal by Subject|0
2532897|NCT01614795|8765541|P4|Overall Study|Physician Decision|1
2532898|NCT01614795|8765542|P3|Overall Study|Physician Decision|1
2532899|NCT01614795|8765543|P2|Overall Study|Physician Decision|0
2532900|NCT01614795|8765544|P1|Overall Study|Physician Decision|1
2532901|NCT01614795|8765541|P4|Overall Study|Lack of Efficacy|8
2532902|NCT01614795|8765542|P3|Overall Study|Lack of Efficacy|9
2532903|NCT01614795|8765543|P2|Overall Study|Lack of Efficacy|10
2532904|NCT01614795|8765544|P1|Overall Study|Lack of Efficacy|10
2532905|NCT01614795|8765541|P4|Overall Study|Adverse Event|1
2532906|NCT01614795|8765542|P3|Overall Study|Adverse Event|1
2532907|NCT01614795|8765543|P2|Overall Study|Adverse Event|0
2532908|NCT01614795|8765544|P1|Overall Study|Adverse Event|0
2532909|NCT01614769|8765564|P6|Period 3|Withdrawal by Subject|0
2532910|NCT01614769|8765565|P5|Period 3|Withdrawal by Subject|0
2532911|NCT01614769|8765566|P4|Period 3|Withdrawal by Subject|0
2532912|NCT01614769|8765567|P3|Period 3|Withdrawal by Subject|1
2532913|NCT01614769|8765568|P2|Period 3|Withdrawal by Subject|0
2532914|NCT01614769|8765569|P1|Period 3|Withdrawal by Subject|0
2532915|NCT01614769|8765564|P6|Period 1|Withdrawal by Subject|0
2532916|NCT01614769|8765565|P5|Period 1|Withdrawal by Subject|0
2532917|NCT01614769|8765566|P4|Period 1|Withdrawal by Subject|0
2532918|NCT01614769|8765567|P3|Period 1|Withdrawal by Subject|0
2532919|NCT01614769|8765568|P2|Period 1|Withdrawal by Subject|0
2532920|NCT01614769|8765569|P1|Period 1|Withdrawal by Subject|1
2532921|NCT01614769|8765564|P6|Period 1|Protocol Violation|0
2532922|NCT01614769|8765565|P5|Period 1|Protocol Violation|0
2532923|NCT01614769|8765566|P4|Period 1|Protocol Violation|1
2532924|NCT01614769|8765567|P3|Period 1|Protocol Violation|0
2532925|NCT01614769|8765568|P2|Period 1|Protocol Violation|0
2532926|NCT01614769|8765569|P1|Period 1|Protocol Violation|0
2532927|NCT01614769|8765564|P6|Period 1|Discontinued due to Hypoglycemia|1
2532928|NCT01614769|8765565|P5|Period 1|Discontinued due to Hypoglycemia|0
2532929|NCT01614769|8765566|P4|Period 1|Discontinued due to Hypoglycemia|1
2532930|NCT01614769|8765567|P3|Period 1|Discontinued due to Hypoglycemia|0
2532931|NCT01614769|8765568|P2|Period 1|Discontinued due to Hypoglycemia|0
2532932|NCT01614769|8765569|P1|Period 1|Discontinued due to Hypoglycemia|0
2532933|NCT01614600|8765591|P1|Overall Study|Protocol deviation|1
2532934|NCT01614600|8765591|P1|Overall Study|Unable to remove lens at the end of day|1
2532935|NCT01614600|8765591|P1|Overall Study|Discomfort|1
2532936|NCT01614600|8765591|P1|Overall Study|Unacceptable fit|1
2532937|NCT01614470|8765622|P3|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0
2532938|NCT01614470|8765623|P2|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
2532939|NCT01614470|8765624|P1|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
2532940|NCT01614470|8765622|P3|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
2532941|NCT01614470|8765623|P2|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
2532942|NCT01614470|8765624|P1|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
2532943|NCT01614457|8765646|P2|Overall Study|Pregnancy (Self or Partner)|0
2532944|NCT01614457|8765647|P1|Overall Study|Pregnancy (Self or Partner)|1
2532945|NCT01614457|8765646|P2|Overall Study|Non-Compliance|0
2532946|NCT01614457|8765647|P1|Overall Study|Non-Compliance|1
2532947|NCT01614249|8765674|P2|Overall Study|Lost to Follow-up|23
2532948|NCT01614249|8765675|P1|Overall Study|Lost to Follow-up|11
2532949|NCT01614093|8765689|P1|Overall Study|Withdrawal by Subject|1
2532950|NCT01613716|8765702|P1|Overall Study|Lost to Follow-up|4
2532951|NCT01613716|8765702|P1|Overall Study|screen failures|3
2532952|NCT01613599|8765707|P1|Overall Study|Reason not specified|3
2532953|NCT01613599|8765707|P1|Overall Study|Withdrawal by Subject|8
2532954|NCT01613599|8765707|P1|Overall Study|Lost to Follow-up|5
2532955|NCT01613599|8765707|P1|Overall Study|Death|9
2532956|NCT01613417|8765722|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|7
2532957|NCT01613417|8765723|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|13
2532958|NCT01613378|8765760|P1|Overall Study|Other Reason|4
2532959|NCT01613378|8765760|P1|Overall Study|Lost to Follow-up|1
2532960|NCT01613378|8765760|P1|Overall Study|Death|2
2532961|NCT01613378|8765760|P1|Overall Study|Withdrawal by Subject|8
2532962|NCT01613378|8765760|P1|Overall Study|Adverse Event|11
2532963|NCT01613378|8765760|P1|Overall Study|Lack of Efficacy|13
2532964|NCT01613326|8765790|P2|Overall Study|Protocol Violation|1
2532965|NCT01613326|8765791|P1|Overall Study|Protocol Violation|0
2532966|NCT01613326|8765790|P2|Overall Study|Administrative|2
2532967|NCT01613326|8765791|P1|Overall Study|Administrative|0
2532968|NCT01613326|8765790|P2|Overall Study|Lost to Follow-up|1
2532969|NCT01613326|8765791|P1|Overall Study|Lost to Follow-up|0
2532970|NCT01613326|8765790|P2|Overall Study|Lack of Efficacy|1
2532971|NCT01613326|8765791|P1|Overall Study|Lack of Efficacy|0
2532972|NCT01613326|8765790|P2|Overall Study|inability to use device|0
2532973|NCT01613326|8765791|P1|Overall Study|inability to use device|1
2532974|NCT01613326|8765790|P2|Overall Study|Abnormal test procedure result(s)|0
2532975|NCT01613326|8765791|P1|Overall Study|Abnormal test procedure result(s)|2
2532976|NCT01613326|8765790|P2|Overall Study|Withdrawal by Subject|4
2532977|NCT01613326|8765791|P1|Overall Study|Withdrawal by Subject|3
2532978|NCT01613326|8765790|P2|Overall Study|Adverse Event|5
2532979|NCT01613326|8765791|P1|Overall Study|Adverse Event|7
2532980|NCT01613248|8765848|P6|Overall Study|Pregnancy|0
2532981|NCT01613248|8765849|P5|Overall Study|Pregnancy|0
2532982|NCT01613248|8765850|P4|Overall Study|Pregnancy|1
2532983|NCT01613248|8765851|P3|Overall Study|Pregnancy|0
2532984|NCT01613248|8765852|P2|Overall Study|Pregnancy|0
2532985|NCT01613248|8765853|P1|Overall Study|Pregnancy|0
2532986|NCT01613248|8765848|P6|Overall Study|Lack of Qualifying Event|18
2532987|NCT01613248|8765849|P5|Overall Study|Lack of Qualifying Event|15
2532988|NCT01613248|8765850|P4|Overall Study|Lack of Qualifying Event|11
2532989|NCT01613248|8765851|P3|Overall Study|Lack of Qualifying Event|10
2532990|NCT01613248|8765852|P2|Overall Study|Lack of Qualifying Event|11
2532991|NCT01613248|8765853|P1|Overall Study|Lack of Qualifying Event|9
2532992|NCT01613248|8765848|P6|Overall Study|Physician Decision|6
2532993|NCT01613248|8765849|P5|Overall Study|Physician Decision|7
2532994|NCT01613248|8765850|P4|Overall Study|Physician Decision|4
2532995|NCT01613248|8765851|P3|Overall Study|Physician Decision|9
2532996|NCT01613248|8765852|P2|Overall Study|Physician Decision|8
2532997|NCT01613248|8765853|P1|Overall Study|Physician Decision|8
2532998|NCT01613248|8765848|P6|Overall Study|Study Terminated by Sponsor|11
2532999|NCT01613248|8765849|P5|Overall Study|Study Terminated by Sponsor|9
2533000|NCT01613248|8765850|P4|Overall Study|Study Terminated by Sponsor|8
2533001|NCT01613248|8765851|P3|Overall Study|Study Terminated by Sponsor|8
2533002|NCT01613248|8765852|P2|Overall Study|Study Terminated by Sponsor|6
2533003|NCT01613248|8765853|P1|Overall Study|Study Terminated by Sponsor|4
2533004|NCT01613248|8765848|P6|Overall Study|Lost to Follow-up|2
2533005|NCT01613248|8765849|P5|Overall Study|Lost to Follow-up|4
2533006|NCT01613248|8765850|P4|Overall Study|Lost to Follow-up|8
2533007|NCT01613248|8765851|P3|Overall Study|Lost to Follow-up|4
2533008|NCT01613248|8765852|P2|Overall Study|Lost to Follow-up|7
2533009|NCT01613248|8765853|P1|Overall Study|Lost to Follow-up|5
2533010|NCT01613248|8765848|P6|Overall Study|Withdrawal by Subject|1
2533011|NCT01613248|8765849|P5|Overall Study|Withdrawal by Subject|0
2533012|NCT01613248|8765850|P4|Overall Study|Withdrawal by Subject|5
2533013|NCT01613248|8765851|P3|Overall Study|Withdrawal by Subject|2
2533014|NCT01613248|8765852|P2|Overall Study|Withdrawal by Subject|2
2533015|NCT01613248|8765853|P1|Overall Study|Withdrawal by Subject|3
2533016|NCT01613248|8765848|P6|Overall Study|Adverse Event|0
2533017|NCT01613248|8765849|P5|Overall Study|Adverse Event|0
2533018|NCT01613248|8765850|P4|Overall Study|Adverse Event|1
2533019|NCT01613248|8765851|P3|Overall Study|Adverse Event|0
2533020|NCT01613248|8765852|P2|Overall Study|Adverse Event|0
2533021|NCT01613248|8765853|P1|Overall Study|Adverse Event|0
2533022|NCT01613222|8765951|P1|Overall Study|Reused disposable sensors|10
2533023|NCT01613222|8765951|P1|Overall Study|Unable to place arterial line|1
2533024|NCT01613222|8765951|P1|Overall Study|Physician Decision|1
2533025|NCT01613131|8765966|P2|Overall Study|Withdrawal by Subject|5
2533026|NCT01613131|8765967|P1|Overall Study|Withdrawal by Subject|3
2533027|NCT01613027|8765995|P1|Overall Study|Patient’s Decision Due to Adverse Event|1
2533028|NCT01613027|8765995|P1|Overall Study|Lack of Efficacy|1
2533029|NCT01613027|8765995|P1|Overall Study|Switched Physician|1
2533030|NCT01613027|8765995|P1|Overall Study|Lost to Follow-up|5
2533031|NCT01612858|8766038|P2|Overall Study|Withdrawal by Subject|1
2533032|NCT01612858|8766039|P1|Overall Study|Withdrawal by Subject|5
2533033|NCT01612702|8766112|P2|Overall Study|Protocol Violation|11
2533034|NCT01612702|8766113|P1|Overall Study|Protocol Violation|11
2533035|NCT01612676|8766127|P4|Overall Study|Protocol Violation|0
2533036|NCT01612676|8766128|P3|Overall Study|Protocol Violation|0
2533037|NCT01612676|8766129|P2|Overall Study|Protocol Violation|1
2533038|NCT01612676|8766130|P1|Overall Study|Protocol Violation|0
2533039|NCT01612676|8766127|P4|Overall Study|Adverse Event|3
2533040|NCT01612676|8766128|P3|Overall Study|Adverse Event|1
2533041|NCT01612676|8766129|P2|Overall Study|Adverse Event|3
2533042|NCT01612676|8766130|P1|Overall Study|Adverse Event|2
2533043|NCT01612156|8766228|P2|Overall Study|Protocol Violation|0
2533044|NCT01612156|8766229|P1|Overall Study|Protocol Violation|2
2533045|NCT01612000|8766241|P4|Overall Study|Withdrawal by Subject|2
2533046|NCT01612000|8766242|P3|Overall Study|Withdrawal by Subject|2
2533047|NCT01612000|8766243|P2|Overall Study|Withdrawal by Subject|1
2533048|NCT01612000|8766244|P1|Overall Study|Withdrawal by Subject|3
2533049|NCT01612000|8766241|P4|Overall Study|Physician Decision|0
2533050|NCT01612000|8766242|P3|Overall Study|Physician Decision|1
2533051|NCT01612000|8766243|P2|Overall Study|Physician Decision|0
2533052|NCT01612000|8766244|P1|Overall Study|Physician Decision|0
2533053|NCT01612000|8766241|P4|Overall Study|Lost to Follow-up|8
2533054|NCT01612000|8766242|P3|Overall Study|Lost to Follow-up|4
2533055|NCT01612000|8766243|P2|Overall Study|Lost to Follow-up|4
2533056|NCT01612000|8766244|P1|Overall Study|Lost to Follow-up|6
2533057|NCT01611974|8766269|P3|Overall Study|Withdrawal by Subject|4
2533058|NCT01611974|8766270|P2|Overall Study|Withdrawal by Subject|1
2533059|NCT01611974|8766271|P1|Overall Study|Withdrawal by Subject|0
2533060|NCT01611974|8766269|P3|Overall Study|Physician Decision|2
2533061|NCT01611974|8766270|P2|Overall Study|Physician Decision|1
2533062|NCT01611974|8766271|P1|Overall Study|Physician Decision|5
2533063|NCT01611974|8766269|P3|Overall Study|Lost to Follow-up|0
2533064|NCT01611974|8766270|P2|Overall Study|Lost to Follow-up|1
2533065|NCT01611974|8766271|P1|Overall Study|Lost to Follow-up|0
2533066|NCT01611974|8766269|P3|Overall Study|Death|10
2533067|NCT01611974|8766270|P2|Overall Study|Death|12
2533068|NCT01611974|8766271|P1|Overall Study|Death|10
2533069|NCT01611935|8766317|P2|Overall Study|Family Declined Participation|0
2533070|NCT01611935|8766318|P1|Overall Study|Family Declined Participation|1
2533071|NCT01611883|8766330|P2|Overall Study|Adverse Event|1
2533072|NCT01611883|8766331|P1|Overall Study|Adverse Event|1
2533073|NCT01611857|8766357|P2|Overall Study|Withdrawal by Subject|2
2533074|NCT01611857|8766358|P1|Overall Study|Withdrawal by Subject|0
2533075|NCT01611792|8766370|P2|Followup: at 6 Months|Lost to Follow-up|13
2533076|NCT01611792|8766371|P1|Followup: at 6 Months|Lost to Follow-up|6
2533077|NCT01611792|8766370|P2|Initial Period: Time 0|unable to schedule 10 consecutive appts|9
2533078|NCT01611792|8766371|P1|Initial Period: Time 0|unable to schedule 10 consecutive appts|12
2533079|NCT01611558|8766425|P1|Maintenance Phase|Study drug toxicity|1
2533080|NCT01611558|8766425|P1|Maintenance Phase|Withdrawal by Subject|1
2533081|NCT01611558|8766425|P1|Induction Phase|Death|1
2533082|NCT01611558|8766425|P1|Induction Phase|Adverse event unrelated to study drug|1
2533083|NCT01611558|8766425|P1|Induction Phase|Not reported|5
2533084|NCT01611558|8766425|P1|Induction Phase|Disease progression|14
2533085|NCT01611558|8766425|P1|Induction Phase|Study drug toxicity|17
2533086|NCT01611298|8766431|P1|Overall Study|Relapsed|2
2533087|NCT01611259|8766436|P1|Overall Study|Withdrawal by Subject|7
2533088|NCT01611259|8766436|P1|Overall Study|Adverse Event|4
2533089|NCT01611259|8766436|P1|Overall Study|Lack of Efficacy|2
2533090|NCT01611259|8766436|P1|Overall Study|Physician Decision|1
2533091|NCT01611194|8766442|P2|Overall Study|drug use|1
2533092|NCT01611194|8766443|P1|Overall Study|drug use|0
2533093|NCT01611194|8766442|P2|Overall Study|Withdrawal by Subject|1
2533094|NCT01611194|8766443|P1|Overall Study|Withdrawal by Subject|0
2533095|NCT01611194|8766442|P2|Overall Study|Lost to Follow-up|1
2533096|NCT01611194|8766443|P1|Overall Study|Lost to Follow-up|0
2533097|NCT01611155|8766481|P2|Overall Study|Ineligible patient|1
2533098|NCT01611155|8766482|P1|Overall Study|Ineligible patient|0
2533099|NCT01611155|8766481|P2|Overall Study|Alternative treatment|1
2533100|NCT01611155|8766482|P1|Overall Study|Alternative treatment|0
2533101|NCT01611155|8766481|P2|Overall Study|Withdrawal by Subject|0
2533102|NCT01611155|8766482|P1|Overall Study|Withdrawal by Subject|1
2533103|NCT01611155|8766481|P2|Overall Study|Disease progression|0
2533104|NCT01611155|8766482|P1|Overall Study|Disease progression|1
2533105|NCT01611155|8766481|P2|Overall Study|Refused further treatment|4
2533106|NCT01611155|8766482|P1|Overall Study|Refused further treatment|6
2533107|NCT01611155|8766481|P2|Overall Study|Adverse Event|1
2533108|NCT01611155|8766482|P1|Overall Study|Adverse Event|1
2533109|NCT01611090|8766492|P3|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1
2533110|NCT01611090|8766493|P2|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0
2533111|NCT01611090|8766494|P1|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0
2533112|NCT01611090|8766492|P3|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4
2533113|NCT01611090|8766493|P2|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0
2533114|NCT01611090|8766494|P1|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0
2533115|NCT01611090|8766492|P3|Randomized Period|Withdrawal by Subject|0
2533116|NCT01611090|8766493|P2|Randomized Period|Withdrawal by Subject|26
2533117|NCT01611090|8766494|P1|Randomized Period|Withdrawal by Subject|22
2533118|NCT01611090|8766492|P3|Randomized Period|Lost to Follow-up|0
2533119|NCT01611090|8766493|P2|Randomized Period|Lost to Follow-up|3
2533120|NCT01611090|8766494|P1|Randomized Period|Lost to Follow-up|8
2533121|NCT01610791|8766527|P1|Overall Study|Not determined|5
2533122|NCT01610791|8766527|P1|Overall Study|Death|1
2533123|NCT01610791|8766527|P1|Overall Study|Adverse event and Investigator decision|1
2533124|NCT01610791|8766527|P1|Overall Study|Physician Decision|1
2533125|NCT01610791|8766527|P1|Overall Study|Adverse Event|6
2533126|NCT01610791|8766527|P1|Overall Study|Lost to Follow-up|7
2533127|NCT01610752|8766551|P3|Overall Study|Miscarriage/Pregnancy loss|4
2533128|NCT01610752|8766552|P2|Overall Study|Miscarriage/Pregnancy loss|0
2533129|NCT01610752|8766553|P1|Overall Study|Miscarriage/Pregnancy loss|0
2533130|NCT01610713|8766575|P2|Overall Study|Lost to Follow-up|1
2533131|NCT01610713|8766576|P1|Overall Study|Lost to Follow-up|0
2533132|NCT01610713|8766575|P2|Overall Study|adv. to use original dose/amitriptyline|0
2533133|NCT01610713|8766576|P1|Overall Study|adv. to use original dose/amitriptyline|1
2533134|NCT01610713|8766575|P2|Overall Study|low mood and poor motivation|0
2533135|NCT01610713|8766576|P1|Overall Study|low mood and poor motivation|1
2533136|NCT01610713|8766575|P2|Overall Study|Lack of Efficacy|0
2533137|NCT01610713|8766576|P1|Overall Study|Lack of Efficacy|1
2533138|NCT01610713|8766575|P2|Overall Study|Adverse Event|0
2533139|NCT01610713|8766576|P1|Overall Study|Adverse Event|3
2533140|NCT01610700|8766634|P2|Overall Study|subject took one dose of street cannabis|1
2533141|NCT01610700|8766635|P1|Overall Study|subject took one dose of street cannabis|0
2533142|NCT01610700|8766634|P2|Overall Study|Withdrawal by Subject|1
2533143|NCT01610700|8766635|P1|Overall Study|Withdrawal by Subject|0
2533144|NCT01610700|8766634|P2|Overall Study|Adverse Event|1
2533145|NCT01610700|8766635|P1|Overall Study|Adverse Event|3
2533146|NCT01610687|8766689|P1|Overall Study|Felt more alter without study medication|1
2533147|NCT01610687|8766689|P1|Overall Study|Cannabis affecting job|1
2533148|NCT01610687|8766689|P1|Overall Study|Death|1
2533149|NCT01610687|8766689|P1|Overall Study|Unable to make journey|1
2533150|NCT01610687|8766689|P1|Overall Study|Symptom control without study medication|2
2533151|NCT01610687|8766689|P1|Overall Study|Lost to Follow-up|4
2533152|NCT01610687|8766689|P1|Overall Study|Withdrawal by Subject|7
2533153|NCT01610687|8766689|P1|Overall Study|Moved out of area|6
2533154|NCT01610687|8766689|P1|Overall Study|Adverse Event|18
2533155|NCT01610687|8766689|P1|Overall Study|Lack of Efficacy|26
2533156|NCT01610596|8766702|P2|Overall Study|Lost to Follow-up|1
2533157|NCT01610596|8766703|P1|Overall Study|Lost to Follow-up|0
2533158|NCT01610557|8766761|P5|Post-36-Week Extension Phase|Withdrawal by Subject|3
2533159|NCT01610557|8766762|P4|Post-36-Week Extension Phase|Withdrawal by Subject|0
2533160|NCT01610557|8766763|P3|Post-36-Week Extension Phase|Withdrawal by Subject|0
2533161|NCT01610557|8766764|P2|Post-36-Week Extension Phase|Withdrawal by Subject|0
2533162|NCT01610557|8766765|P1|Post-36-Week Extension Phase|Withdrawal by Subject|0
2533163|NCT01610557|8766761|P5|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
2533164|NCT01610557|8766762|P4|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
2533165|NCT01610557|8766763|P3|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
2533166|NCT01610557|8766764|P2|36-Week Randomized Crossover Phase|Withdrawal by Subject|1
2533167|NCT01610557|8766765|P1|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
2533168|NCT01610492|8766778|P1|Overall Study|Other:Treatment stopped due to remission|1
2533169|NCT01610492|8766778|P1|Overall Study|Other: Reached stopping criteria|1
2533170|NCT01610492|8766778|P1|Overall Study|Lack of Efficacy|3
2533171|NCT01610492|8766778|P1|Overall Study|Adverse Event|1
2533172|NCT01610414|8766844|P2|After Month 25|Study end not reached|53
2533173|NCT01610414|8766845|P1|After Month 25|Study end not reached|48
2533174|NCT01610414|8766844|P2|Month 13 - Month 25|Other reasons for withdrawal|7
2533175|NCT01610414|8766845|P1|Month 13 - Month 25|Other reasons for withdrawal|6
2533176|NCT01610414|8766844|P2|Month 13 - Month 25|Lost to Follow-up|9
2533177|NCT01610414|8766845|P1|Month 13 - Month 25|Lost to Follow-up|5
2533178|NCT01610414|8766844|P2|Month 13 - Month 25|Protocol Violation|2
2533179|NCT01610414|8766845|P1|Month 13 - Month 25|Protocol Violation|0
2533180|NCT01610414|8766844|P2|Month 13 - Month 25|Migrated/moved from study area|2
2533181|NCT01610414|8766845|P1|Month 13 - Month 25|Migrated/moved from study area|4
2533182|NCT01610414|8766844|P2|Month 13 - Month 25|Withdrawal by Subject|8
2533183|NCT01610414|8766845|P1|Month 13 - Month 25|Withdrawal by Subject|7
2533184|NCT01610414|8766844|P2|Month 13 - Month 25|Adverse Event|4
2533185|NCT01610414|8766845|P1|Month 13 - Month 25|Adverse Event|8
2533186|NCT01610414|8766844|P2|Month 13 - Month 25|Serious Adverse Event|38
2533187|NCT01610414|8766845|P1|Month 13 - Month 25|Serious Adverse Event|35
2533188|NCT01610414|8766844|P2|Study Start - Month 13|Other reasons for withdrawal|4
2533189|NCT01610414|8766845|P1|Study Start - Month 13|Other reasons for withdrawal|3
2533190|NCT01610414|8766844|P2|Study Start - Month 13|Suspected HZ episode|3
2533191|NCT01610414|8766845|P1|Study Start - Month 13|Suspected HZ episode|1
2533192|NCT01610414|8766844|P2|Study Start - Month 13|Lost to Follow-up|6
2533193|NCT01610414|8766845|P1|Study Start - Month 13|Lost to Follow-up|4
2533194|NCT01610414|8766844|P2|Study Start - Month 13|Migrated/moved from study area|4
2533195|NCT01610414|8766845|P1|Study Start - Month 13|Migrated/moved from study area|2
2533196|NCT01610414|8766844|P2|Study Start - Month 13|Withdrawal by Subject|30
2533197|NCT01610414|8766845|P1|Study Start - Month 13|Withdrawal by Subject|23
2533198|NCT01610414|8766844|P2|Study Start - Month 13|Protocol Violation|1
2533199|NCT01610414|8766845|P1|Study Start - Month 13|Protocol Violation|3
2533200|NCT01610414|8766844|P2|Study Start - Month 13|Adverse Event|14
2533201|NCT01610414|8766845|P1|Study Start - Month 13|Adverse Event|14
2533202|NCT01610414|8766844|P2|Study Start - Month 13|Serious Adverse Event|67
2533203|NCT01610414|8766845|P1|Study Start - Month 13|Serious Adverse Event|65
2533204|NCT01610297|8766874|P1|Overall Study|Lost to Follow-up|1
2533205|NCT01610271|8766884|P2|Overall Study|Prosthesis not implanted|3
2533206|NCT01610271|8766885|P1|Overall Study|Prosthesis not implanted|2
2533207|NCT01610271|8766884|P2|Overall Study|Surgery not complete|1
2533208|NCT01610271|8766885|P1|Overall Study|Surgery not complete|0
2533209|NCT01610167|8766900|P3|Overall Study|Scheduling conflict.|2
2533210|NCT01610167|8766901|P2|Overall Study|Scheduling conflict.|0
2533211|NCT01610167|8766902|P1|Overall Study|Scheduling conflict.|0
2533212|NCT01610076|8766939|P2|Overall Study|Lost to Follow-up|4
2533213|NCT01610076|8766940|P1|Overall Study|Lost to Follow-up|3
2533214|NCT01610076|8766939|P2|Overall Study|Technical issue with video|1
2533215|NCT01610076|8766940|P1|Overall Study|Technical issue with video|0
2533216|NCT01610063|8766951|P2|Overall Study|Lost to Follow-up|20
2533217|NCT01610063|8766952|P1|Overall Study|Lost to Follow-up|42
2533218|NCT01610037|8766975|P3|Treatment and Follow up Period|Lost to Follow-up|4
2533219|NCT01610037|8766976|P2|Treatment and Follow up Period|Lost to Follow-up|6
2533220|NCT01610037|8766977|P1|Treatment and Follow up Period|Lost to Follow-up|1
2533221|NCT01610037|8766975|P3|Treatment and Follow up Period|Administrative problems|2
2533222|NCT01610037|8766976|P2|Treatment and Follow up Period|Administrative problems|3
2533223|NCT01610037|8766977|P1|Treatment and Follow up Period|Administrative problems|1
2533224|NCT01610037|8766975|P3|Treatment and Follow up Period|Death|4
2533225|NCT01610037|8766976|P2|Treatment and Follow up Period|Death|5
2533226|NCT01610037|8766977|P1|Treatment and Follow up Period|Death|10
2533227|NCT01610037|8766975|P3|Treatment and Follow up Period|Subject withdrew consent|16
2533228|NCT01610037|8766976|P2|Treatment and Follow up Period|Subject withdrew consent|14
2533229|NCT01610037|8766977|P1|Treatment and Follow up Period|Subject withdrew consent|13
2533230|NCT01610037|8766975|P3|All Patients|Abnormal test procedure result(s)|3
2533231|NCT01610037|8766976|P2|All Patients|Abnormal test procedure result(s)|1
2533232|NCT01610037|8766977|P1|All Patients|Abnormal test procedure result(s)|0
2533233|NCT01610037|8766975|P3|All Patients|Lost to Follow-up|0
2533234|NCT01610037|8766976|P2|All Patients|Lost to Follow-up|0
2533235|NCT01610037|8766977|P1|All Patients|Lost to Follow-up|1
2533236|NCT01610037|8766975|P3|All Patients|Administrative problems|4
2533237|NCT01610037|8766976|P2|All Patients|Administrative problems|4
2533238|NCT01610037|8766977|P1|All Patients|Administrative problems|1
2533239|NCT01610037|8766975|P3|All Patients|Abnormal laboratory value|0
2533240|NCT01610037|8766976|P2|All Patients|Abnormal laboratory value|1
2533241|NCT01610037|8766977|P1|All Patients|Abnormal laboratory value|1
2533242|NCT01610037|8766975|P3|All Patients|Protocol deviation|3
2533243|NCT01610037|8766976|P2|All Patients|Protocol deviation|3
2533244|NCT01610037|8766977|P1|All Patients|Protocol deviation|4
2533245|NCT01610037|8766975|P3|All Patients|Death|1
2533246|NCT01610037|8766976|P2|All Patients|Death|2
2533247|NCT01610037|8766977|P1|All Patients|Death|4
2533248|NCT01610037|8766975|P3|All Patients|Unsatisfactory therapeutic effect|27
2533249|NCT01610037|8766976|P2|All Patients|Unsatisfactory therapeutic effect|8
2533250|NCT01610037|8766977|P1|All Patients|Unsatisfactory therapeutic effect|9
2533251|NCT01610037|8766975|P3|All Patients|Withdrawal by Subject|20
2533252|NCT01610037|8766976|P2|All Patients|Withdrawal by Subject|10
2533253|NCT01610037|8766977|P1|All Patients|Withdrawal by Subject|12
2533254|NCT01610037|8766975|P3|All Patients|Adverse Event|26
2533255|NCT01610037|8766976|P2|All Patients|Adverse Event|22
2533256|NCT01610037|8766977|P1|All Patients|Adverse Event|27
2533257|NCT01609933|8767027|P1|Overall Study|Withdrawal by Subject|3
2533258|NCT01609933|8767027|P1|Overall Study|Adverse Event|1
2533259|NCT01609842|8767038|P2|Concurrent Intervention Control|pharmacy data not available|0
2533260|NCT01609842|8767039|P1|Concurrent Intervention Control|pharmacy data not available|2
2533261|NCT01609790|8767066|P3|Overall Study|Protocol Violation|8
2533262|NCT01609790|8767067|P2|Overall Study|Protocol Violation|7
2533263|NCT01609790|8767068|P1|Overall Study|Protocol Violation|1
2533264|NCT01609582|8767087|P2|Overall Study|Randomized, but not treated|3
2533265|NCT01609582|8767088|P1|Overall Study|Randomized, but not treated|0
2533266|NCT01609582|8767087|P2|Overall Study|Other|10
2533267|NCT01609582|8767088|P1|Overall Study|Other|9
2533268|NCT01609582|8767087|P2|Overall Study|Study Terminated by Sponsor|1548
2533269|NCT01609582|8767088|P1|Overall Study|Study Terminated by Sponsor|1543
2533270|NCT01609582|8767087|P2|Overall Study|Withdrawal by Subject|15
2533271|NCT01609582|8767088|P1|Overall Study|Withdrawal by Subject|21
2533272|NCT01609582|8767087|P2|Overall Study|Lost to Follow-up|10
2533273|NCT01609582|8767088|P1|Overall Study|Lost to Follow-up|10
2533274|NCT01609582|8767087|P2|Overall Study|Adverse Event|18
2533275|NCT01609582|8767088|P1|Overall Study|Adverse Event|20
2533276|NCT01609543|8767096|P1|Overall Study|Death|7
2533277|NCT01609543|8767096|P1|Overall Study|Protocol Violation|1
2533278|NCT01609543|8767096|P1|Overall Study|Withdrawal by Subject|1
2533279|NCT01609543|8767096|P1|Overall Study|Adverse Event|5
2533280|NCT01609543|8767096|P1|Overall Study|Disease Progression|28
2533281|NCT01609478|8767105|P3|Overall Study|Withdrawal by Subject|2
2533282|NCT01609478|8767106|P2|Overall Study|Withdrawal by Subject|0
2533283|NCT01609478|8767107|P1|Overall Study|Withdrawal by Subject|2
2533284|NCT01609478|8767105|P3|Overall Study|Physician Decision|1
2533285|NCT01609478|8767106|P2|Overall Study|Physician Decision|0
2533286|NCT01609478|8767107|P1|Overall Study|Physician Decision|1
2533287|NCT01609478|8767105|P3|Overall Study|Non-Compliance with study treatment|0
2533288|NCT01609478|8767106|P2|Overall Study|Non-Compliance with study treatment|0
2533289|NCT01609478|8767107|P1|Overall Study|Non-Compliance with study treatment|1
2533290|NCT01609478|8767105|P3|Overall Study|Protocol Deviation|1
2533291|NCT01609478|8767106|P2|Overall Study|Protocol Deviation|1
2533292|NCT01609478|8767107|P1|Overall Study|Protocol Deviation|0
2533293|NCT01609478|8767105|P3|Overall Study|Adverse Event|5
2533294|NCT01609478|8767106|P2|Overall Study|Adverse Event|1
2533295|NCT01609478|8767107|P1|Overall Study|Adverse Event|3
2533296|NCT01609296|8767180|P1|Overall Study|Withdrawal by Subject|71
2533297|NCT01609296|8767180|P1|Overall Study|Death|49
2533298|NCT01609257|8767193|P2|Overall Study|Non-compliance/Protocol deviation|6
2533299|NCT01609257|8767194|P1|Overall Study|Non-compliance/Protocol deviation|4
2533300|NCT01609257|8767193|P2|Overall Study|Voluntary Withdrawal by Subject|1
2533301|NCT01609257|8767194|P1|Overall Study|Voluntary Withdrawal by Subject|0
2533302|NCT01609257|8767193|P2|Overall Study|Lost to Follow-up|1
2533303|NCT01609257|8767194|P1|Overall Study|Lost to Follow-up|2
2533304|NCT01609062|8767266|P2|Extension Phase|Anticipated surgery & transition to EAP|1
2533305|NCT01609062|8767267|P1|Extension Phase|Anticipated surgery & transition to EAP|0
2533306|NCT01609062|8767266|P2|Extension Phase|Discontinued drug and then was pregnant|0
2533307|NCT01609062|8767267|P1|Extension Phase|Discontinued drug and then was pregnant|1
2533308|NCT01609062|8767266|P2|Extension Phase|Terminated by Sponsor|9
2533309|NCT01609062|8767267|P1|Extension Phase|Terminated by Sponsor|14
2533310|NCT01609023|8767310|P1|Overall Study|Personal reasons|1
2533311|NCT01609023|8767310|P1|Overall Study|Death|2
2533312|NCT01609023|8767310|P1|Overall Study|Physician Decision|2
2533313|NCT01609023|8767310|P1|Overall Study|Disease progression|10
2533314|NCT01609023|8767310|P1|Overall Study|Toxicity|3
2533315|NCT01609023|8767310|P1|Overall Study|Lost to Follow-up|8
2533316|NCT01609023|8767310|P1|Overall Study|Withdrawal by Subject|4
2533317|NCT01609023|8767310|P1|Overall Study|Lack of Efficacy|3
2533318|NCT01609010|8767322|P2|Overall Study|Lost to Follow-up|1
2533319|NCT01609010|8767323|P1|Overall Study|Lost to Follow-up|1
2533320|NCT01609010|8767322|P2|Overall Study|New cancer|0
2533321|NCT01609010|8767323|P1|Overall Study|New cancer|1
2533322|NCT01609010|8767322|P2|Overall Study|Protocol Violation|1
2533323|NCT01609010|8767323|P1|Overall Study|Protocol Violation|1
2533324|NCT01609010|8767322|P2|Overall Study|Pathology review|1
2533325|NCT01609010|8767323|P1|Overall Study|Pathology review|2
2533326|NCT01609010|8767322|P2|Overall Study|Other malignancy|0
2533327|NCT01609010|8767323|P1|Overall Study|Other malignancy|1
2533328|NCT01609010|8767322|P2|Overall Study|Other|0
2533329|NCT01609010|8767323|P1|Overall Study|Other|2
2533330|NCT01609010|8767322|P2|Overall Study|Withdrawal by Subject|2
2533331|NCT01609010|8767323|P1|Overall Study|Withdrawal by Subject|2
2533332|NCT01609010|8767322|P2|Overall Study|Adverse Event|6
2533333|NCT01609010|8767323|P1|Overall Study|Adverse Event|3
2533334|NCT01609010|8767322|P2|Overall Study|Progressive disease (PD)|10
2533335|NCT01609010|8767323|P1|Overall Study|Progressive disease (PD)|8
2533336|NCT01609010|8767322|P2|Overall Study|Stable disease (SD)|16
2533337|NCT01609010|8767323|P1|Overall Study|Stable disease (SD)|22
2533338|NCT01608724|8767384|P1|Overall Study|Safety reasons|1
2533339|NCT01608724|8767384|P1|Overall Study|bood sugar too high, etc.|3
2533340|NCT01608724|8767384|P1|Overall Study|Protocol Violation|6
2533341|NCT01608724|8767384|P1|Overall Study|Adverse Event|29
2533342|NCT01608724|8767384|P1|Overall Study|Study-specific discontinuation criteria|32
2533343|NCT01608724|8767384|P1|Overall Study|Lost to Follow-up|41
2533344|NCT01608724|8767384|P1|Overall Study|Withdrawal by Subject|131
2533345|NCT01608321|8767416|P2|Overall Study|Withdrawal by Subject|0
2533346|NCT01608321|8767417|P1|Overall Study|Withdrawal by Subject|1
2533347|NCT01608308|8767425|P2|Overall Study|pretreatment medical and billing reasons|2
2533348|NCT01608308|8767426|P1|Overall Study|pretreatment medical and billing reasons|0
2533349|NCT01608087|8767489|P3|Overall Study|Other Reason|0
2533350|NCT01608087|8767490|P2|Overall Study|Other Reason|1
2533351|NCT01608087|8767491|P1|Overall Study|Other Reason|0
2533352|NCT01608087|8767489|P3|Overall Study|Lost to Follow-up|0
2533353|NCT01608087|8767490|P2|Overall Study|Lost to Follow-up|1
2533354|NCT01608087|8767491|P1|Overall Study|Lost to Follow-up|0
2533355|NCT01607957|8767507|P2|Overall Study|Participant refusal|0
2533356|NCT01607957|8767508|P1|Overall Study|Participant refusal|1
2533357|NCT01607957|8767507|P2|Overall Study|Lost to Follow-up|3
2533358|NCT01607957|8767508|P1|Overall Study|Lost to Follow-up|3
2533359|NCT01607957|8767507|P2|Overall Study|Death|211
2533360|NCT01607957|8767508|P1|Overall Study|Death|367
2533361|NCT01607957|8767507|P2|Overall Study|Not treated|1
2533362|NCT01607957|8767508|P1|Overall Study|Not treated|1
2533363|NCT01607593|8767687|P1|Overall Study|Other|4
2533364|NCT01607593|8767687|P1|Overall Study|Continuation|33
2533365|NCT01607593|8767687|P1|Overall Study|Lost to Follow-up|25
2533366|NCT01607593|8767687|P1|Overall Study|Lack of Efficacy|16
2533367|NCT01607593|8767687|P1|Overall Study|Adverse Event|15
2533368|NCT01607554|8767693|P1|Overall Study|Disease progression|2
2533369|NCT01607476|8767706|P3|Overall Study|Lost to Follow-up|2
2533370|NCT01607476|8767707|P2|Overall Study|Lost to Follow-up|0
2533371|NCT01607476|8767708|P1|Overall Study|Lost to Follow-up|0
2533372|NCT01607476|8767706|P3|Overall Study|Withdrawal by Subject|1
2533373|NCT01607476|8767707|P2|Overall Study|Withdrawal by Subject|0
2533374|NCT01607476|8767708|P1|Overall Study|Withdrawal by Subject|1
2533375|NCT01607398|8767802|P2|Overall Study|Severe COPD|0
2533376|NCT01607398|8767803|P1|Overall Study|Severe COPD|2
2533377|NCT01607398|8767802|P2|Overall Study|Adverse Event|2
2533378|NCT01607398|8767803|P1|Overall Study|Adverse Event|0
2533379|NCT01607346|8767847|P1|Overall Study|Adverse Event|3
2533380|NCT01606800|8767945|P2|Overall Study|Missing completion status|0
2533381|NCT01606800|8767946|P1|Overall Study|Missing completion status|2
2533382|NCT01606800|8767945|P2|Overall Study|Participant withdrew consent|1
2533383|NCT01606800|8767946|P1|Overall Study|Participant withdrew consent|0
2533384|NCT01606800|8767945|P2|Overall Study|Adverse Event|1
2533385|NCT01606800|8767946|P1|Overall Study|Adverse Event|3
2533386|NCT01606787|8767954|P2|Overall Study|Surgery canceled|2
2533387|NCT01606787|8767955|P1|Overall Study|Surgery canceled|0
2533388|NCT01606787|8767954|P2|Overall Study|Withdrawal by Subject|5
2533389|NCT01606787|8767955|P1|Overall Study|Withdrawal by Subject|4
2533390|NCT01606761|8767966|P5|Safety Follow-up Period (Week 52-68)|Other|3
2533391|NCT01606761|8767967|P4|Safety Follow-up Period (Week 52-68)|Other|1
2533392|NCT01606761|8767968|P3|Safety Follow-up Period (Week 52-68)|Other|9
2533393|NCT01606761|8767969|P2|Safety Follow-up Period (Week 52-68)|Other|3
2533394|NCT01606761|8767970|P1|Safety Follow-up Period (Week 52-68)|Other|0
2533395|NCT01606761|8767966|P5|Safety Follow-up Period (Week 52-68)|Death|1
2533396|NCT01606761|8767967|P4|Safety Follow-up Period (Week 52-68)|Death|0
2533397|NCT01606761|8767968|P3|Safety Follow-up Period (Week 52-68)|Death|0
2533398|NCT01606761|8767969|P2|Safety Follow-up Period (Week 52-68)|Death|0
2533399|NCT01606761|8767970|P1|Safety Follow-up Period (Week 52-68)|Death|0
2533400|NCT01606761|8767966|P5|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3
2533401|NCT01606761|8767967|P4|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1
2533402|NCT01606761|8767968|P3|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
2533403|NCT01606761|8767969|P2|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
2533404|NCT01606761|8767970|P1|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4
2533405|NCT01606761|8767966|P5|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
2533406|NCT01606761|8767967|P4|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
2533407|NCT01606761|8767968|P3|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2
2533408|NCT01606761|8767969|P2|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
2533409|NCT01606761|8767970|P1|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
2533410|NCT01606761|8767966|P5|Week 24 to Week 52|Other|2
2533411|NCT01606761|8767967|P4|Week 24 to Week 52|Other|2
2533412|NCT01606761|8767968|P3|Week 24 to Week 52|Other|5
2533413|NCT01606761|8767969|P2|Week 24 to Week 52|Other|1
2533414|NCT01606761|8767970|P1|Week 24 to Week 52|Other|0
2533415|NCT01606761|8767966|P5|Week 24 to Week 52|Physician Decision|0
2533416|NCT01606761|8767967|P4|Week 24 to Week 52|Physician Decision|0
2533417|NCT01606761|8767968|P3|Week 24 to Week 52|Physician Decision|1
2533418|NCT01606761|8767969|P2|Week 24 to Week 52|Physician Decision|1
2533419|NCT01606761|8767970|P1|Week 24 to Week 52|Physician Decision|0
2533420|NCT01606761|8767966|P5|Week 24 to Week 52|Lack of Efficacy|3
2533421|NCT01606761|8767967|P4|Week 24 to Week 52|Lack of Efficacy|10
2533422|NCT01606761|8767968|P3|Week 24 to Week 52|Lack of Efficacy|7
2533423|NCT01606761|8767969|P2|Week 24 to Week 52|Lack of Efficacy|13
2533424|NCT01606761|8767970|P1|Week 24 to Week 52|Lack of Efficacy|0
2533425|NCT01606761|8767966|P5|Week 24 to Week 52|Death|0
2533426|NCT01606761|8767967|P4|Week 24 to Week 52|Death|1
2533427|NCT01606761|8767968|P3|Week 24 to Week 52|Death|2
2533428|NCT01606761|8767969|P2|Week 24 to Week 52|Death|0
2533429|NCT01606761|8767970|P1|Week 24 to Week 52|Death|0
2533430|NCT01606761|8767966|P5|Week 24 to Week 52|Adverse Event|15
2533431|NCT01606761|8767967|P4|Week 24 to Week 52|Adverse Event|3
2533432|NCT01606761|8767968|P3|Week 24 to Week 52|Adverse Event|14
2533433|NCT01606761|8767969|P2|Week 24 to Week 52|Adverse Event|11
2533434|NCT01606761|8767970|P1|Week 24 to Week 52|Adverse Event|0
2533435|NCT01606761|8767966|P5|Week 24 to Week 52|Withdrawal by Subject|0
2533436|NCT01606761|8767967|P4|Week 24 to Week 52|Withdrawal by Subject|0
2533437|NCT01606761|8767968|P3|Week 24 to Week 52|Withdrawal by Subject|3
2533438|NCT01606761|8767969|P2|Week 24 to Week 52|Withdrawal by Subject|6
2533439|NCT01606761|8767970|P1|Week 24 to Week 52|Withdrawal by Subject|0
2533440|NCT01606761|8767966|P5|Week 24 to Week 52|Lost to Follow-up|0
2533441|NCT01606761|8767967|P4|Week 24 to Week 52|Lost to Follow-up|1
2533442|NCT01606761|8767968|P3|Week 24 to Week 52|Lost to Follow-up|1
2533443|NCT01606761|8767969|P2|Week 24 to Week 52|Lost to Follow-up|1
2533444|NCT01606761|8767970|P1|Week 24 to Week 52|Lost to Follow-up|0
2533445|NCT01606761|8767966|P5|Prior to Week 24|Other|0
2533446|NCT01606761|8767967|P4|Prior to Week 24|Other|0
2533447|NCT01606761|8767968|P3|Prior to Week 24|Other|5
2533448|NCT01606761|8767969|P2|Prior to Week 24|Other|7
2533449|NCT01606761|8767970|P1|Prior to Week 24|Other|4
2533450|NCT01606761|8767966|P5|Prior to Week 24|Physician Decision|0
2533451|NCT01606761|8767967|P4|Prior to Week 24|Physician Decision|0
2533452|NCT01606761|8767968|P3|Prior to Week 24|Physician Decision|1
2533453|NCT01606761|8767969|P2|Prior to Week 24|Physician Decision|3
2533454|NCT01606761|8767970|P1|Prior to Week 24|Physician Decision|0
2533455|NCT01606761|8767966|P5|Prior to Week 24|Lack of Efficacy|0
2533456|NCT01606761|8767967|P4|Prior to Week 24|Lack of Efficacy|0
2533457|NCT01606761|8767968|P3|Prior to Week 24|Lack of Efficacy|8
2533458|NCT01606761|8767969|P2|Prior to Week 24|Lack of Efficacy|14
2533459|NCT01606761|8767970|P1|Prior to Week 24|Lack of Efficacy|15
2533460|NCT01606761|8767966|P5|Prior to Week 24|Adverse Event|0
2533461|NCT01606761|8767967|P4|Prior to Week 24|Adverse Event|0
2533462|NCT01606761|8767968|P3|Prior to Week 24|Adverse Event|22
2533463|NCT01606761|8767969|P2|Prior to Week 24|Adverse Event|18
2533464|NCT01606761|8767970|P1|Prior to Week 24|Adverse Event|11
2533465|NCT01606761|8767966|P5|Prior to Week 24|Withdrawal by Subject|0
2533466|NCT01606761|8767967|P4|Prior to Week 24|Withdrawal by Subject|0
2533467|NCT01606761|8767968|P3|Prior to Week 24|Withdrawal by Subject|9
2533468|NCT01606761|8767969|P2|Prior to Week 24|Withdrawal by Subject|10
2533469|NCT01606761|8767970|P1|Prior to Week 24|Withdrawal by Subject|12
2533470|NCT01606761|8767966|P5|Prior to Week 24|Lost to Follow-up|0
2533471|NCT01606761|8767967|P4|Prior to Week 24|Lost to Follow-up|0
2533472|NCT01606761|8767968|P3|Prior to Week 24|Lost to Follow-up|2
2533473|NCT01606761|8767969|P2|Prior to Week 24|Lost to Follow-up|3
2533474|NCT01606761|8767970|P1|Prior to Week 24|Lost to Follow-up|0
2533475|NCT01606748|8767996|P2|Overall Study|Withdrawal by Subject|0
2533476|NCT01606748|8767997|P1|Overall Study|Withdrawal by Subject|1
2533477|NCT01606748|8767996|P2|Overall Study|Progressive Disease|0
2533478|NCT01606748|8767997|P1|Overall Study|Progressive Disease|1
2533479|NCT01606748|8767996|P2|Overall Study|Adverse Event|0
2533480|NCT01606748|8767997|P1|Overall Study|Adverse Event|1
2533481|NCT01606670|8768049|P1|Overall Study|Other Reason|2
2533482|NCT01606670|8768049|P1|Overall Study|Withdrawal by Subject|3
2533483|NCT01606670|8768049|P1|Overall Study|Lost to Follow-up|3
2533484|NCT01606670|8768049|P1|Overall Study|Lack of Efficacy|2
2533485|NCT01606670|8768049|P1|Overall Study|Adverse Event|6
2533486|NCT01606319|8768059|P2|Overall Study|Adverse Event|4
2533487|NCT01606319|8768060|P1|Overall Study|Adverse Event|1
2533488|NCT01606319|8768059|P2|Overall Study|Lack of Efficacy|8
2533489|NCT01606319|8768060|P1|Overall Study|Lack of Efficacy|6
2533490|NCT01606319|8768059|P2|Overall Study|Physician Decision|2
2533491|NCT01606319|8768060|P1|Overall Study|Physician Decision|1
2533492|NCT01606319|8768059|P2|Overall Study|Withdrawal by Subject|12
2533493|NCT01606319|8768060|P1|Overall Study|Withdrawal by Subject|9
2533494|NCT01606319|8768059|P2|Overall Study|Lost to Follow-up|14
2533495|NCT01606319|8768060|P1|Overall Study|Lost to Follow-up|17
2533496|NCT01606306|8768078|P6|Overall Study|Physician Decision|0
2533497|NCT01606306|8768079|P5|Overall Study|Physician Decision|0
2533498|NCT01606306|8768080|P4|Overall Study|Physician Decision|0
2533499|NCT01606306|8768081|P3|Overall Study|Physician Decision|0
2533500|NCT01606306|8768082|P2|Overall Study|Physician Decision|2
2533501|NCT01606306|8768083|P1|Overall Study|Physician Decision|1
2533502|NCT01606306|8768078|P6|Overall Study|Withdrawal by Subject|4
2533503|NCT01606306|8768079|P5|Overall Study|Withdrawal by Subject|5
2533504|NCT01606306|8768080|P4|Overall Study|Withdrawal by Subject|4
2533505|NCT01606306|8768081|P3|Overall Study|Withdrawal by Subject|4
2533506|NCT01606306|8768082|P2|Overall Study|Withdrawal by Subject|3
2533507|NCT01606306|8768083|P1|Overall Study|Withdrawal by Subject|4
2533508|NCT01606306|8768078|P6|Overall Study|Lost to Follow-up|5
2533509|NCT01606306|8768079|P5|Overall Study|Lost to Follow-up|3
2533510|NCT01606306|8768080|P4|Overall Study|Lost to Follow-up|4
2533511|NCT01606306|8768081|P3|Overall Study|Lost to Follow-up|5
2533512|NCT01606306|8768082|P2|Overall Study|Lost to Follow-up|4
2533513|NCT01606306|8768083|P1|Overall Study|Lost to Follow-up|7
2533514|NCT01606306|8768078|P6|Overall Study|Adverse Event|0
2533515|NCT01606306|8768079|P5|Overall Study|Adverse Event|2
2533516|NCT01606306|8768080|P4|Overall Study|Adverse Event|1
2533517|NCT01606306|8768081|P3|Overall Study|Adverse Event|1
2533518|NCT01606306|8768082|P2|Overall Study|Adverse Event|0
2533519|NCT01606306|8768083|P1|Overall Study|Adverse Event|1
2533520|NCT01606306|8768078|P6|Overall Study|Lack of Efficacy|2
2533521|NCT01606306|8768079|P5|Overall Study|Lack of Efficacy|1
2533522|NCT01606306|8768080|P4|Overall Study|Lack of Efficacy|4
2533523|NCT01606306|8768081|P3|Overall Study|Lack of Efficacy|4
2533524|NCT01606306|8768082|P2|Overall Study|Lack of Efficacy|1
2533525|NCT01606306|8768083|P1|Overall Study|Lack of Efficacy|2
2533526|NCT01606254|8768093|P4|Overall Study|Adverse Event|1
2533527|NCT01606254|8768094|P3|Overall Study|Adverse Event|0
2533528|NCT01606254|8768095|P2|Overall Study|Adverse Event|1
2533529|NCT01606254|8768096|P1|Overall Study|Adverse Event|1
2533530|NCT01606254|8768093|P4|Overall Study|Withdrawal by Subject|2
2533531|NCT01606254|8768094|P3|Overall Study|Withdrawal by Subject|0
2533532|NCT01606254|8768095|P2|Overall Study|Withdrawal by Subject|3
2533533|NCT01606254|8768096|P1|Overall Study|Withdrawal by Subject|1
2533534|NCT01606228|8768178|P1|Overall Study|Adverse Event|1
2533535|NCT01606228|8768178|P1|Overall Study|Lack of Efficacy|2
2533536|NCT01606228|8768178|P1|Overall Study|Non-compliant|3
2533537|NCT01606228|8768178|P1|Overall Study|Withdrawal by Subject|3
2533538|NCT01606228|8768178|P1|Overall Study|Lost to Follow-up|20
2533539|NCT01606202|8768195|P2|Overall Study|Problems with administration|1
2533540|NCT01606202|8768196|P1|Overall Study|Problems with administration|0
2533541|NCT01606202|8768195|P2|Overall Study|Personal problems|1
2533542|NCT01606202|8768196|P1|Overall Study|Personal problems|0
2533543|NCT01606202|8768195|P2|Overall Study|Withdrawal by Subject|1
2533544|NCT01606202|8768196|P1|Overall Study|Withdrawal by Subject|2
2533545|NCT01606202|8768195|P2|Overall Study|Adverse Event|0
2533546|NCT01606202|8768196|P1|Overall Study|Adverse Event|5
2533547|NCT01606189|8768228|P6|Third Intenvention (14-20 Days)|Withdrawal by Subject|1
2533548|NCT01606189|8768229|P5|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
2533549|NCT01606189|8768230|P4|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
2533550|NCT01606189|8768231|P3|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
2533551|NCT01606189|8768232|P2|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
2533552|NCT01606189|8768233|P1|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
2533553|NCT01606189|8768228|P6|Second Intenvention (14-20 Days)|Adverse Event|1
2533554|NCT01606189|8768229|P5|Second Intenvention (14-20 Days)|Adverse Event|0
2533555|NCT01606189|8768230|P4|Second Intenvention (14-20 Days)|Adverse Event|0
2533556|NCT01606189|8768231|P3|Second Intenvention (14-20 Days)|Adverse Event|0
2533557|NCT01606189|8768232|P2|Second Intenvention (14-20 Days)|Adverse Event|0
2533558|NCT01606189|8768233|P1|Second Intenvention (14-20 Days)|Adverse Event|0
2533559|NCT01606176|8768267|P2|Overall Study|Withdrawal by Subject|0
2533560|NCT01606176|8768268|P1|Overall Study|Withdrawal by Subject|1
2533561|NCT01606176|8768267|P2|Overall Study|Disease progression|0
2533562|NCT01606176|8768268|P1|Overall Study|Disease progression|1
2533563|NCT01606176|8768267|P2|Overall Study|Adverse Event|3
2533564|NCT01606176|8768268|P1|Overall Study|Adverse Event|2
2533565|NCT01606137|8768313|P1|Overall Study|Unable to collect consistent data|1
2533566|NCT01606137|8768313|P1|Overall Study|Patient moving|1
2533567|NCT01606137|8768313|P1|Overall Study|Unable to tolerate study med. taste|1
2533568|NCT01606137|8768313|P1|Overall Study|Personal reasons|1
2533569|NCT01606137|8768313|P1|Overall Study|Patient leaving country|1
2533570|NCT01606137|8768313|P1|Overall Study|Wanted to try another treatment|1
2533571|NCT01606137|8768313|P1|Overall Study|Not enough improvement|4
2533572|NCT01606137|8768313|P1|Overall Study|Spray causes nausea|1
2533573|NCT01606137|8768313|P1|Overall Study|Increased bilirubin|1
2533574|NCT01606137|8768313|P1|Overall Study|multiple sclerosis less stable|1
2533575|NCT01606137|8768313|P1|Overall Study|Issues with driving|4
2533576|NCT01606137|8768313|P1|Overall Study|Decreased/no pain|4
2533577|NCT01606137|8768313|P1|Overall Study|Death|1
2533578|NCT01606137|8768313|P1|Overall Study|Patient non-compliance|9
2533579|NCT01606137|8768313|P1|Overall Study|Protocol Violation|1
2533580|NCT01606137|8768313|P1|Overall Study|Lost to Follow-up|15
2533581|NCT01606137|8768313|P1|Overall Study|Lack of Efficacy|56
2533582|NCT01606137|8768313|P1|Overall Study|Withdrawal by Subject|74
2533583|NCT01606137|8768313|P1|Overall Study|Adverse Event|85
2533584|NCT01606007|8768347|P3|Overall Study|Poor/Non-compliance|0
2533585|NCT01606007|8768348|P2|Overall Study|Poor/Non-compliance|0
2533586|NCT01606007|8768349|P1|Overall Study|Poor/Non-compliance|1
2533587|NCT01606007|8768347|P3|Overall Study|Lost to Follow-up|5
2533588|NCT01606007|8768348|P2|Overall Study|Lost to Follow-up|8
2533589|NCT01606007|8768349|P1|Overall Study|Lost to Follow-up|6
2533590|NCT01606007|8768347|P3|Overall Study|discontinue study treatment|1
2533591|NCT01606007|8768348|P2|Overall Study|discontinue study treatment|2
2533592|NCT01606007|8768349|P1|Overall Study|discontinue study treatment|0
2533593|NCT01606007|8768347|P3|Overall Study|Adverse Event|1
2533594|NCT01606007|8768348|P2|Overall Study|Adverse Event|1
2533595|NCT01606007|8768349|P1|Overall Study|Adverse Event|0
2533596|NCT01606007|8768347|P3|Overall Study|Withdrawal by Subject|1
2533597|NCT01606007|8768348|P2|Overall Study|Withdrawal by Subject|6
2533598|NCT01606007|8768349|P1|Overall Study|Withdrawal by Subject|8
2533599|NCT01606007|8768347|P3|Overall Study|Pregnancy|1
2533600|NCT01606007|8768348|P2|Overall Study|Pregnancy|1
2533601|NCT01606007|8768349|P1|Overall Study|Pregnancy|0
2533602|NCT01606007|8768347|P3|Overall Study|Reason 'Other' in the protocol|1
2533603|NCT01606007|8768348|P2|Overall Study|Reason 'Other' in the protocol|1
2533604|NCT01606007|8768349|P1|Overall Study|Reason 'Other' in the protocol|0
2533605|NCT01605916|8768384|P5|Overall Study|Withdrawal by Subject|2
2533606|NCT01605916|8768385|P4|Overall Study|Withdrawal by Subject|0
2533607|NCT01605916|8768386|P3|Overall Study|Withdrawal by Subject|0
2533608|NCT01605916|8768387|P2|Overall Study|Withdrawal by Subject|1
2533609|NCT01605916|8768388|P1|Overall Study|Withdrawal by Subject|1
2533610|NCT01605916|8768384|P5|Overall Study|Lack of Efficacy|4
2533611|NCT01605916|8768385|P4|Overall Study|Lack of Efficacy|5
2533612|NCT01605916|8768386|P3|Overall Study|Lack of Efficacy|3
2533613|NCT01605916|8768387|P2|Overall Study|Lack of Efficacy|3
2533614|NCT01605916|8768388|P1|Overall Study|Lack of Efficacy|2
2533615|NCT01605916|8768384|P5|Overall Study|Adverse Event|0
2533616|NCT01605916|8768385|P4|Overall Study|Adverse Event|1
2533617|NCT01605916|8768386|P3|Overall Study|Adverse Event|0
2533618|NCT01605916|8768387|P2|Overall Study|Adverse Event|0
2533619|NCT01605916|8768388|P1|Overall Study|Adverse Event|1
2533620|NCT01605877|8768485|P1|Overall Study|Withdrawal by Subject|1
2533621|NCT01605825|8768549|P2|Overall Study|Non-Compliance with Protocol|0
2533622|NCT01605825|8768550|P1|Overall Study|Non-Compliance with Protocol|3
2533623|NCT01605825|8768549|P2|Overall Study|Non-Compliance -Investigational Drug|0
2533624|NCT01605825|8768550|P1|Overall Study|Non-Compliance -Investigational Drug|3
2533625|NCT01605825|8768549|P2|Overall Study|Withdrawal by Subject|1
2533626|NCT01605825|8768550|P1|Overall Study|Withdrawal by Subject|0
2533627|NCT01605825|8768549|P2|Overall Study|Adverse Event|2
2533628|NCT01605825|8768550|P1|Overall Study|Adverse Event|4
2533629|NCT01605799|8768558|P2|Overall Study|Withdrawal by Subject|1
2533630|NCT01605799|8768559|P1|Overall Study|Withdrawal by Subject|2
2533631|NCT01605617|8768574|P2|Washout Period of 4 Weeks|Study Terminated|1
2533632|NCT01605617|8768575|P1|Washout Period of 4 Weeks|Study Terminated|2
2533633|NCT01605617|8768574|P2|First Intervention|Adverse Event|1
2533634|NCT01605617|8768575|P1|First Intervention|Adverse Event|0
2533635|NCT01605461|8768634|P1|Overall Study|Withdrawal by Subject|1
2533636|NCT01605461|8768634|P1|Overall Study|Lost to Follow-up|3
2533637|NCT01605396|8768693|P2|Overall Study|Transfer Off Study|5
2533638|NCT01605396|8768694|P1|Overall Study|Transfer Off Study|4
2533639|NCT01605396|8768693|P2|Overall Study|Withdrawal by Subject|2
2533640|NCT01605396|8768694|P1|Overall Study|Withdrawal by Subject|4
2533641|NCT01605396|8768693|P2|Overall Study|Progressive Disease|27
2533642|NCT01605396|8768694|P1|Overall Study|Progressive Disease|23
2533643|NCT01605396|8768693|P2|Overall Study|Physician Decision|2
2533644|NCT01605396|8768694|P1|Overall Study|Physician Decision|2
2533645|NCT01605396|8768693|P2|Overall Study|Non-Compliance With Study Drug|1
2533646|NCT01605396|8768694|P1|Overall Study|Non-Compliance With Study Drug|1
2533647|NCT01605396|8768693|P2|Overall Study|Lost to Follow-up|0
2533648|NCT01605396|8768694|P1|Overall Study|Lost to Follow-up|1
2533649|NCT01605396|8768693|P2|Overall Study|Adverse Event|3
2533650|NCT01605396|8768694|P1|Overall Study|Adverse Event|5
2533651|NCT01605370|8768708|P2|Overall Study|Adverse Event|0
2533652|NCT01605370|8768709|P1|Overall Study|Adverse Event|1
2533653|NCT01605227|8768744|P2|Overall Study|Dose Held >6 weeks|1
2533654|NCT01605227|8768745|P1|Overall Study|Dose Held >6 weeks|0
2533655|NCT01605227|8768744|P2|Overall Study|Subject Decision|1
2533656|NCT01605227|8768745|P1|Overall Study|Subject Decision|0
2533657|NCT01605227|8768744|P2|Overall Study|Started New Therapy|0
2533658|NCT01605227|8768745|P1|Overall Study|Started New Therapy|1
2533659|NCT01605227|8768744|P2|Overall Study|Sponsor Decision|0
2533660|NCT01605227|8768745|P1|Overall Study|Sponsor Decision|2
2533661|NCT01605227|8768744|P2|Overall Study|Withdrawal by Subject|14
2533662|NCT01605227|8768745|P1|Overall Study|Withdrawal by Subject|18
2533663|NCT01605227|8768744|P2|Overall Study|Physician Decision|7
2533664|NCT01605227|8768745|P1|Overall Study|Physician Decision|9
2533665|NCT01605227|8768744|P2|Overall Study|Protocol Violation|0
2533666|NCT01605227|8768745|P1|Overall Study|Protocol Violation|1
2533667|NCT01605227|8768744|P2|Overall Study|Lost to Follow-up|0
2533668|NCT01605227|8768745|P1|Overall Study|Lost to Follow-up|1
2533669|NCT01605227|8768744|P2|Overall Study|Clinical Deterioration|133
2533670|NCT01605227|8768745|P1|Overall Study|Clinical Deterioration|227
2533671|NCT01605227|8768744|P2|Overall Study|Progressive Disease|128
2533672|NCT01605227|8768745|P1|Overall Study|Progressive Disease|132
2533673|NCT01605227|8768744|P2|Overall Study|Adverse Event|42
2533674|NCT01605227|8768745|P1|Overall Study|Adverse Event|228
2533675|NCT01605227|8768744|P2|Overall Study|Did not receive study treatment|3
2533676|NCT01605227|8768745|P1|Overall Study|Did not receive study treatment|2
2533677|NCT01605136|8768757|P2|Safety Follow-Up Period|Withdrawal by Subject|2
2533678|NCT01605136|8768758|P1|Safety Follow-Up Period|Withdrawal by Subject|1
2533679|NCT01605136|8768757|P2|Study Period|Lost to Follow-up|2
2533680|NCT01605136|8768758|P1|Study Period|Lost to Follow-up|0
2533681|NCT01605136|8768757|P2|Study Period|Physician Decision|1
2533682|NCT01605136|8768758|P1|Study Period|Physician Decision|1
2533683|NCT01605136|8768757|P2|Study Period|Withdrawal by Subject|0
2533684|NCT01605136|8768758|P1|Study Period|Withdrawal by Subject|2
2533685|NCT01605019|8768778|P2|Overall Study|pt did not meet transplant endpoint|0
2533686|NCT01605019|8768779|P1|Overall Study|pt did not meet transplant endpoint|3
2533687|NCT01604941|8768789|P6|Overall Study|Early Study Termination|0
2533688|NCT01604941|8768790|P5|Overall Study|Early Study Termination|0
2533689|NCT01604941|8768791|P4|Overall Study|Early Study Termination|3
2533690|NCT01604941|8768792|P3|Overall Study|Early Study Termination|3
2533691|NCT01604941|8768793|P2|Overall Study|Early Study Termination|2
2533692|NCT01604941|8768794|P1|Overall Study|Early Study Termination|9
2533693|NCT01604941|8768789|P6|Overall Study|Participant Decision|2
2533694|NCT01604941|8768790|P5|Overall Study|Participant Decision|0
2533695|NCT01604941|8768791|P4|Overall Study|Participant Decision|0
2533696|NCT01604941|8768792|P3|Overall Study|Participant Decision|0
2533697|NCT01604941|8768793|P2|Overall Study|Participant Decision|0
2533698|NCT01604941|8768794|P1|Overall Study|Participant Decision|0
2533699|NCT01604941|8768789|P6|Overall Study|Non-compliance|0
2533700|NCT01604941|8768790|P5|Overall Study|Non-compliance|0
2533701|NCT01604941|8768791|P4|Overall Study|Non-compliance|0
2533702|NCT01604941|8768792|P3|Overall Study|Non-compliance|0
2533703|NCT01604941|8768793|P2|Overall Study|Non-compliance|0
2533704|NCT01604941|8768794|P1|Overall Study|Non-compliance|1
2533705|NCT01604941|8768789|P6|Overall Study|Adverse Event|5
2533706|NCT01604941|8768790|P5|Overall Study|Adverse Event|1
2533707|NCT01604941|8768791|P4|Overall Study|Adverse Event|0
2533708|NCT01604941|8768792|P3|Overall Study|Adverse Event|0
2533709|NCT01604941|8768793|P2|Overall Study|Adverse Event|2
2533710|NCT01604941|8768794|P1|Overall Study|Adverse Event|1
2533711|NCT01604850|8768822|P2|Overall Study|Subject withdrew consent|0
2533712|NCT01604850|8768823|P1|Overall Study|Subject withdrew consent|1
2533713|NCT01604850|8768822|P2|Overall Study|Lost to Follow-up|0
2533714|NCT01604850|8768823|P1|Overall Study|Lost to Follow-up|1
2533715|NCT01604850|8768822|P2|Overall Study|Efficacy Failure|29
2533716|NCT01604850|8768823|P1|Overall Study|Efficacy Failure|50
2533717|NCT01604850|8768822|P2|Overall Study|Enrolled but never treated|1
2533718|NCT01604850|8768823|P1|Overall Study|Enrolled but never treated|0
2533719|NCT01604785|8768841|P2|Overall Study|Repeat Visits Not Included in Analysis|1
2533720|NCT01604785|8768842|P1|Overall Study|Repeat Visits Not Included in Analysis|7
2533721|NCT01604408|8768861|P2|Observation Period|Withdrawal by Subject|2
2533722|NCT01604408|8768862|P1|Observation Period|Withdrawal by Subject|0
2533723|NCT01604408|8768861|P2|Observation Period|Adverse Event|1
2533724|NCT01604408|8768862|P1|Observation Period|Adverse Event|1
2533725|NCT01604408|8768861|P2|Treatment Period 6|Sponsor decision|1
2533726|NCT01604408|8768862|P1|Treatment Period 6|Sponsor decision|0
2533727|NCT01604408|8768861|P2|Treatment Period 6|Adverse Event|0
2533728|NCT01604408|8768862|P1|Treatment Period 6|Adverse Event|2
2533729|NCT01604408|8768861|P2|Treatment Period 6|Lost to Follow-up|1
2533730|NCT01604408|8768862|P1|Treatment Period 6|Lost to Follow-up|0
2533731|NCT01604408|8768861|P2|Treatment Period 5|Adverse Event|0
2533732|NCT01604408|8768862|P1|Treatment Period 5|Adverse Event|4
2533733|NCT01604408|8768861|P2|Treatment Period 4|Adverse Event|1
2533734|NCT01604408|8768862|P1|Treatment Period 4|Adverse Event|0
2533735|NCT01604408|8768861|P2|Treatment Period 4|Withdrawal by Subject|1
2533736|NCT01604408|8768862|P1|Treatment Period 4|Withdrawal by Subject|2
2533737|NCT01604408|8768861|P2|Treatment Period 4|Death|0
2533738|NCT01604408|8768862|P1|Treatment Period 4|Death|1
2533739|NCT01604408|8768861|P2|Treatment Period 3|Sponsor Decision|0
2533740|NCT01604408|8768862|P1|Treatment Period 3|Sponsor Decision|1
2533741|NCT01604408|8768861|P2|Treatment Period 3|Withdrawal by Subject|1
2533742|NCT01604408|8768862|P1|Treatment Period 3|Withdrawal by Subject|3
2533743|NCT01604408|8768861|P2|Treatment Period 3|Adverse Event|3
2533744|NCT01604408|8768862|P1|Treatment Period 3|Adverse Event|0
2533745|NCT01604408|8768861|P2|Treatment Period 3|Protocol Violation|1
2533746|NCT01604408|8768862|P1|Treatment Period 3|Protocol Violation|1
2533747|NCT01604408|8768861|P2|Treatment Period 2|Adverse Event|1
2533748|NCT01604408|8768862|P1|Treatment Period 2|Adverse Event|0
2533749|NCT01604408|8768861|P2|Treatment Period 2|Protocol Violation|0
2533750|NCT01604408|8768862|P1|Treatment Period 2|Protocol Violation|1
2533751|NCT01604408|8768861|P2|Treatment Period 2|Withdrawal by Subject|1
2533752|NCT01604408|8768862|P1|Treatment Period 2|Withdrawal by Subject|1
2533753|NCT01604408|8768861|P2|Treatment Period 1|Protocol Violation|1
2533754|NCT01604408|8768862|P1|Treatment Period 1|Protocol Violation|0
2533755|NCT01604343|8768877|P5|Safety Follow-up Period (Week 104-120)|Other|14
2533756|NCT01604343|8768878|P4|Safety Follow-up Period (Week 104-120)|Other|6
2533757|NCT01604343|8768879|P3|Safety Follow-up Period (Week 104-120)|Other|20
2533758|NCT01604343|8768880|P2|Safety Follow-up Period (Week 104-120)|Other|2
2533759|NCT01604343|8768881|P1|Safety Follow-up Period (Week 104-120)|Other|15
2533760|NCT01604343|8768877|P5|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14
2533761|NCT01604343|8768878|P4|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3
2533762|NCT01604343|8768879|P3|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11
2533763|NCT01604343|8768880|P2|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4
2533764|NCT01604343|8768881|P1|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12
2533765|NCT01604343|8768877|P5|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
2533766|NCT01604343|8768878|P4|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
2533767|NCT01604343|8768879|P3|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2
2533768|NCT01604343|8768880|P2|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
2533769|NCT01604343|8768881|P1|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3
2533770|NCT01604343|8768877|P5|Week 52 to Week 104|Other|3
2533771|NCT01604343|8768878|P4|Week 52 to Week 104|Other|6
2533772|NCT01604343|8768879|P3|Week 52 to Week 104|Other|11
2533773|NCT01604343|8768880|P2|Week 52 to Week 104|Other|11
2533774|NCT01604343|8768881|P1|Week 52 to Week 104|Other|0
2533775|NCT01604343|8768877|P5|Week 52 to Week 104|Pregnancy|1
2533776|NCT01604343|8768878|P4|Week 52 to Week 104|Pregnancy|2
2533777|NCT01604343|8768879|P3|Week 52 to Week 104|Pregnancy|1
2533778|NCT01604343|8768880|P2|Week 52 to Week 104|Pregnancy|0
2533779|NCT01604343|8768881|P1|Week 52 to Week 104|Pregnancy|0
2533780|NCT01604343|8768877|P5|Week 52 to Week 104|Physician Decision|2
2533781|NCT01604343|8768878|P4|Week 52 to Week 104|Physician Decision|0
2533782|NCT01604343|8768879|P3|Week 52 to Week 104|Physician Decision|0
2533783|NCT01604343|8768880|P2|Week 52 to Week 104|Physician Decision|1
2533784|NCT01604343|8768881|P1|Week 52 to Week 104|Physician Decision|0
2533785|NCT01604343|8768877|P5|Week 52 to Week 104|Lack of Efficacy|3
2533786|NCT01604343|8768878|P4|Week 52 to Week 104|Lack of Efficacy|2
2533787|NCT01604343|8768879|P3|Week 52 to Week 104|Lack of Efficacy|11
2533788|NCT01604343|8768880|P2|Week 52 to Week 104|Lack of Efficacy|6
2533789|NCT01604343|8768881|P1|Week 52 to Week 104|Lack of Efficacy|0
2533790|NCT01604343|8768877|P5|Week 52 to Week 104|Death|0
2533791|NCT01604343|8768878|P4|Week 52 to Week 104|Death|5
2533792|NCT01604343|8768879|P3|Week 52 to Week 104|Death|2
2533793|NCT01604343|8768880|P2|Week 52 to Week 104|Death|4
2533794|NCT01604343|8768881|P1|Week 52 to Week 104|Death|0
2533795|NCT01604343|8768877|P5|Week 52 to Week 104|Adverse Event|27
2533796|NCT01604343|8768878|P4|Week 52 to Week 104|Adverse Event|21
2533797|NCT01604343|8768879|P3|Week 52 to Week 104|Adverse Event|26
2533798|NCT01604343|8768880|P2|Week 52 to Week 104|Adverse Event|12
2533799|NCT01604343|8768881|P1|Week 52 to Week 104|Adverse Event|0
2533800|NCT01604343|8768877|P5|Week 52 to Week 104|Withdrawal by Subject|4
2533801|NCT01604343|8768878|P4|Week 52 to Week 104|Withdrawal by Subject|8
2533802|NCT01604343|8768879|P3|Week 52 to Week 104|Withdrawal by Subject|12
2533803|NCT01604343|8768880|P2|Week 52 to Week 104|Withdrawal by Subject|7
2533804|NCT01604343|8768881|P1|Week 52 to Week 104|Withdrawal by Subject|0
2533805|NCT01604343|8768877|P5|Week 52 to Week 104|Lost to Follow-up|1
2533806|NCT01604343|8768878|P4|Week 52 to Week 104|Lost to Follow-up|2
2533807|NCT01604343|8768879|P3|Week 52 to Week 104|Lost to Follow-up|4
2533808|NCT01604343|8768880|P2|Week 52 to Week 104|Lost to Follow-up|2
2533809|NCT01604343|8768881|P1|Week 52 to Week 104|Lost to Follow-up|0
2533810|NCT01604343|8768877|P5|Prior to W52 Administration(Through W52)|Other|6
2533811|NCT01604343|8768878|P4|Prior to W52 Administration(Through W52)|Other|0
2533812|NCT01604343|8768879|P3|Prior to W52 Administration(Through W52)|Other|10
2533813|NCT01604343|8768880|P2|Prior to W52 Administration(Through W52)|Other|0
2533814|NCT01604343|8768881|P1|Prior to W52 Administration(Through W52)|Other|15
2533815|NCT01604343|8768877|P5|Prior to W52 Administration(Through W52)|Pregnancy|0
2533816|NCT01604343|8768878|P4|Prior to W52 Administration(Through W52)|Pregnancy|0
2533817|NCT01604343|8768879|P3|Prior to W52 Administration(Through W52)|Pregnancy|1
2533818|NCT01604343|8768880|P2|Prior to W52 Administration(Through W52)|Pregnancy|0
2533819|NCT01604343|8768881|P1|Prior to W52 Administration(Through W52)|Pregnancy|1
2533820|NCT01604343|8768877|P5|Prior to W52 Administration(Through W52)|Physician Decision|2
2533821|NCT01604343|8768878|P4|Prior to W52 Administration(Through W52)|Physician Decision|0
2533822|NCT01604343|8768879|P3|Prior to W52 Administration(Through W52)|Physician Decision|1
2533823|NCT01604343|8768880|P2|Prior to W52 Administration(Through W52)|Physician Decision|0
2533824|NCT01604343|8768881|P1|Prior to W52 Administration(Through W52)|Physician Decision|4
2533825|NCT01604343|8768877|P5|Prior to W52 Administration(Through W52)|Lack of Efficacy|14
2533826|NCT01604343|8768878|P4|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
2533827|NCT01604343|8768879|P3|Prior to W52 Administration(Through W52)|Lack of Efficacy|5
2533828|NCT01604343|8768880|P2|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
2533829|NCT01604343|8768881|P1|Prior to W52 Administration(Through W52)|Lack of Efficacy|24
2533830|NCT01604343|8768877|P5|Prior to W52 Administration(Through W52)|Death|4
2533831|NCT01604343|8768878|P4|Prior to W52 Administration(Through W52)|Death|0
2533832|NCT01604343|8768879|P3|Prior to W52 Administration(Through W52)|Death|2
2533833|NCT01604343|8768880|P2|Prior to W52 Administration(Through W52)|Death|0
2533834|NCT01604343|8768881|P1|Prior to W52 Administration(Through W52)|Death|5
2533835|NCT01604343|8768877|P5|Prior to W52 Administration(Through W52)|Adverse Event|42
2533836|NCT01604343|8768878|P4|Prior to W52 Administration(Through W52)|Adverse Event|0
2533837|NCT01604343|8768879|P3|Prior to W52 Administration(Through W52)|Adverse Event|41
2533838|NCT01604343|8768880|P2|Prior to W52 Administration(Through W52)|Adverse Event|0
2533839|NCT01604343|8768881|P1|Prior to W52 Administration(Through W52)|Adverse Event|25
2533840|NCT01604343|8768877|P5|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16
2533841|NCT01604343|8768878|P4|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
2533842|NCT01604343|8768879|P3|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12
2533843|NCT01604343|8768880|P2|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
2533844|NCT01604343|8768881|P1|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19
2533845|NCT01604343|8768877|P5|Prior to W52 Administration(Through W52)|Lost to Follow-up|3
2533846|NCT01604343|8768878|P4|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
2533847|NCT01604343|8768879|P3|Prior to W52 Administration(Through W52)|Lost to Follow-up|4
2533848|NCT01604343|8768880|P2|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
2533849|NCT01604343|8768881|P1|Prior to W52 Administration(Through W52)|Lost to Follow-up|5
2533850|NCT01604278|8769046|P2|Overall Study|Protocol Deviation|3
2533851|NCT01604278|8769047|P1|Overall Study|Protocol Deviation|5
2533852|NCT01604278|8769046|P2|Overall Study|Adverse Event|5
2533853|NCT01604278|8769047|P1|Overall Study|Adverse Event|3
2533854|NCT01604278|8769046|P2|Overall Study|Withdrawal by Subject|3
2533855|NCT01604278|8769047|P1|Overall Study|Withdrawal by Subject|3
2533856|NCT01604278|8769046|P2|Overall Study|Administrative problems|1
2533857|NCT01604278|8769047|P1|Overall Study|Administrative problems|2
2533858|NCT01604278|8769046|P2|Overall Study|Lost to Follow-up|0
2533859|NCT01604278|8769047|P1|Overall Study|Lost to Follow-up|1
2533860|NCT01604278|8769046|P2|Overall Study|Lack of Efficacy|1
2533861|NCT01604278|8769047|P1|Overall Study|Lack of Efficacy|0
2533862|NCT01604265|8769073|P2|Overall Study|Withdrawal by Subject|0
2533863|NCT01604265|8769074|P1|Overall Study|Withdrawal by Subject|1
2533864|NCT01604265|8769073|P2|Overall Study|Adverse Event|0
2533865|NCT01604265|8769074|P1|Overall Study|Adverse Event|1
2533866|NCT01603875|8769185|P3|Overall Study|Protocol Violation|0
2533867|NCT01603875|8769186|P2|Overall Study|Protocol Violation|1
2533868|NCT01603875|8769187|P1|Overall Study|Protocol Violation|0
2533869|NCT01603875|8769185|P3|Overall Study|Lost to Follow-up|6
2533870|NCT01603875|8769186|P2|Overall Study|Lost to Follow-up|3
2533871|NCT01603875|8769187|P1|Overall Study|Lost to Follow-up|4
2533872|NCT01603875|8769185|P3|Overall Study|Preexisting rabies antibody|3
2533873|NCT01603875|8769186|P2|Overall Study|Preexisting rabies antibody|4
2533874|NCT01603875|8769187|P1|Overall Study|Preexisting rabies antibody|3
2533875|NCT01603641|8769207|P1|Overall Study|Other Miscellaneous Reasons|6
2533876|NCT01603641|8769207|P1|Overall Study|Personal Reasons|18
2533877|NCT01603641|8769207|P1|Overall Study|Lost to Follow-up|6
2533878|NCT01603641|8769207|P1|Overall Study|Lack of Efficacy|1
2533879|NCT01603641|8769207|P1|Overall Study|Adverse Event|1
2533880|NCT01603641|8769207|P1|Overall Study|Did not Receive Treatment|3
2533881|NCT01603628|8769214|P3|Overall Study|Other Miscellaneous Reason|0
2533882|NCT01603628|8769215|P2|Overall Study|Other Miscellaneous Reason|0
2533883|NCT01603628|8769216|P1|Overall Study|Other Miscellaneous Reason|1
2533884|NCT01603628|8769214|P3|Overall Study|Lost to Follow-up|0
2533885|NCT01603628|8769215|P2|Overall Study|Lost to Follow-up|1
2533886|NCT01603628|8769216|P1|Overall Study|Lost to Follow-up|0
2533887|NCT01603628|8769214|P3|Overall Study|Protocol Violation|0
2533888|NCT01603628|8769215|P2|Overall Study|Protocol Violation|1
2533889|NCT01603628|8769216|P1|Overall Study|Protocol Violation|1
2533890|NCT01603628|8769214|P3|Overall Study|Personal Reasons|2
2533891|NCT01603628|8769215|P2|Overall Study|Personal Reasons|1
2533892|NCT01603628|8769216|P1|Overall Study|Personal Reasons|1
2533893|NCT01603615|8769233|P1|Overall Study|Other Miscellaneous|1
2533894|NCT01603615|8769233|P1|Overall Study|Personal Reasons|17
2533895|NCT01603615|8769233|P1|Overall Study|Lost to Follow-up|9
2533896|NCT01603615|8769233|P1|Overall Study|Did not Receive Treatment|7
2533897|NCT01603602|8769240|P3|Overall Study|Personal Reasons|1
2533898|NCT01603602|8769241|P2|Overall Study|Personal Reasons|0
2533899|NCT01603602|8769242|P1|Overall Study|Personal Reasons|1
2533900|NCT01603602|8769240|P3|Overall Study|Adverse Event|0
2533901|NCT01603602|8769241|P2|Overall Study|Adverse Event|0
2533902|NCT01603602|8769242|P1|Overall Study|Adverse Event|1
2533903|NCT01603459|8769262|P1|Overall Study|Administrative reason|1
2533904|NCT01603459|8769262|P1|Overall Study|Non-compliance|1
2533905|NCT01603459|8769262|P1|Overall Study|Predefined discontinuation criteria|3
2533906|NCT01603459|8769262|P1|Overall Study|Lost to Follow-up|3
2533907|NCT01603459|8769262|P1|Overall Study|Withdrawal by Subject|5
2533908|NCT01603459|8769262|P1|Overall Study|Adverse Event|5
2533909|NCT01603394|8769413|P1|Overall Study|Adverse Event|1
2533910|NCT01603355|8769467|P1|Overall Study|Lack of Efficacy|2
2533911|NCT01603277|8769473|P2|Overall Study|Non-Compliance|1
2533912|NCT01603277|8769474|P1|Overall Study|Non-Compliance|2
2533913|NCT01603277|8769473|P2|Overall Study|Withdrawal by Subject|4
2533914|NCT01603277|8769474|P1|Overall Study|Withdrawal by Subject|5
2533915|NCT01603277|8769473|P2|Overall Study|Protocol Violation|10
2533916|NCT01603277|8769474|P1|Overall Study|Protocol Violation|6
2533917|NCT01603277|8769473|P2|Overall Study|Physician Decision|1
2533918|NCT01603277|8769474|P1|Overall Study|Physician Decision|0
2533919|NCT01603277|8769473|P2|Overall Study|Adverse Event|2
2533920|NCT01603277|8769474|P1|Overall Study|Adverse Event|1
2533921|NCT01603121|8769480|P2|Second Intervention, 10 Hours|Adverse Event|0
2533922|NCT01603121|8769481|P1|Second Intervention, 10 Hours|Adverse Event|1
2533923|NCT01603082|8769493|P2|Overall Study|Failed inclusion criterion after dosed|0
2533924|NCT01603082|8769494|P1|Overall Study|Failed inclusion criterion after dosed|1
2533925|NCT01603082|8769493|P2|Overall Study|Withdrawal by Subject|0
2533926|NCT01603082|8769494|P1|Overall Study|Withdrawal by Subject|1
2533927|NCT01603082|8769493|P2|Overall Study|Adverse Event|1
2533928|NCT01603082|8769494|P1|Overall Study|Adverse Event|0
2533929|NCT01603043|8769535|P2|Overall Study|Study Futility|3
2533930|NCT01603043|8769536|P1|Overall Study|Study Futility|7
2533931|NCT01602965|8769548|P2|Overall Study|Lost to Follow-up|2
2533932|NCT01602965|8769549|P1|Overall Study|Lost to Follow-up|4
2533933|NCT01602744|8769557|P2|Overall Study|Lost to Follow-up|8
2533934|NCT01602744|8769558|P1|Overall Study|Lost to Follow-up|13
2533935|NCT01602744|8769557|P2|Overall Study|Death|15
2533936|NCT01602744|8769558|P1|Overall Study|Death|17
2533937|NCT01602562|8769595|P2|Overall Study|Withdrawal by Subject|1
2533938|NCT01602562|8769596|P1|Overall Study|Withdrawal by Subject|1
2533939|NCT01602562|8769595|P2|Overall Study|Physician Decision|1
2533940|NCT01602562|8769596|P1|Overall Study|Physician Decision|1
2533941|NCT01602562|8769595|P2|Overall Study|Adverse Event|1
2533942|NCT01602562|8769596|P1|Overall Study|Adverse Event|3
2533943|NCT01602549|8769632|P2|Overall Study|Withdrawal by Subject|0
2533944|NCT01602549|8769633|P1|Overall Study|Withdrawal by Subject|1
2533945|NCT01602549|8769632|P2|Overall Study|Protocol Violation|1
2533946|NCT01602549|8769633|P1|Overall Study|Protocol Violation|0
2533947|NCT01602510|8769712|P3|Randomized Phase|Withdrawal by Subject|7
2533948|NCT01602510|8769713|P2|Randomized Phase|Withdrawal by Subject|6
2533949|NCT01602510|8769714|P1|Randomized Phase|Withdrawal by Subject|0
2533950|NCT01602510|8769712|P3|Randomized Phase|Physician Decision|2
2533951|NCT01602510|8769713|P2|Randomized Phase|Physician Decision|0
2533952|NCT01602510|8769714|P1|Randomized Phase|Physician Decision|0
2533953|NCT01602510|8769712|P3|Randomized Phase|Lost to Follow-up|3
2533954|NCT01602510|8769713|P2|Randomized Phase|Lost to Follow-up|1
2533955|NCT01602510|8769714|P1|Randomized Phase|Lost to Follow-up|0
2533956|NCT01602510|8769712|P3|Randomized Phase|Met protocol-defined stopping criteria|48
2533957|NCT01602510|8769713|P2|Randomized Phase|Met protocol-defined stopping criteria|58
2533958|NCT01602510|8769714|P1|Randomized Phase|Met protocol-defined stopping criteria|0
2533959|NCT01602510|8769712|P3|Randomized Phase|Protocol Violation|3
2533960|NCT01602510|8769713|P2|Randomized Phase|Protocol Violation|3
2533961|NCT01602510|8769714|P1|Randomized Phase|Protocol Violation|0
2533962|NCT01602510|8769712|P3|Randomized Phase|Lack of Efficacy|4
2533963|NCT01602510|8769713|P2|Randomized Phase|Lack of Efficacy|4
2533964|NCT01602510|8769714|P1|Randomized Phase|Lack of Efficacy|0
2533965|NCT01602510|8769712|P3|Randomized Phase|Adverse Event|6
2533966|NCT01602510|8769713|P2|Randomized Phase|Adverse Event|2
2533967|NCT01602510|8769714|P1|Randomized Phase|Adverse Event|0
2533968|NCT01602510|8769712|P3|Open Label Phase|Withdrawal by Subject|0
2533969|NCT01602510|8769713|P2|Open Label Phase|Withdrawal by Subject|0
2533970|NCT01602510|8769714|P1|Open Label Phase|Withdrawal by Subject|57
2533971|NCT01602510|8769712|P3|Open Label Phase|Physician Decision|0
2533972|NCT01602510|8769713|P2|Open Label Phase|Physician Decision|0
2533973|NCT01602510|8769714|P1|Open Label Phase|Physician Decision|19
2533974|NCT01602510|8769712|P3|Open Label Phase|Lost to Follow-up|0
2533975|NCT01602510|8769713|P2|Open Label Phase|Lost to Follow-up|0
2533976|NCT01602510|8769714|P1|Open Label Phase|Lost to Follow-up|22
2533977|NCT01602510|8769712|P3|Open Label Phase|Met protocol-defined stopping criteria|0
2533978|NCT01602510|8769713|P2|Open Label Phase|Met protocol-defined stopping criteria|0
2533979|NCT01602510|8769714|P1|Open Label Phase|Met protocol-defined stopping criteria|122
2533980|NCT01602510|8769712|P3|Open Label Phase|Protocol Violation|0
2533981|NCT01602510|8769713|P2|Open Label Phase|Protocol Violation|0
2533982|NCT01602510|8769714|P1|Open Label Phase|Protocol Violation|15
2533983|NCT01602510|8769712|P3|Open Label Phase|Lack of Efficacy|0
2533984|NCT01602510|8769713|P2|Open Label Phase|Lack of Efficacy|0
2533985|NCT01602510|8769714|P1|Open Label Phase|Lack of Efficacy|22
2533986|NCT01602510|8769712|P3|Open Label Phase|Adverse Event|0
2533987|NCT01602510|8769713|P2|Open Label Phase|Adverse Event|0
2533988|NCT01602510|8769714|P1|Open Label Phase|Adverse Event|46
2533989|NCT01602484|8769740|P2|Overall Study|Airway issues unrelated to study|1
2533990|NCT01602484|8769741|P1|Overall Study|Airway issues unrelated to study|0
2533991|NCT01602419|8769757|P1|Overall Study|Lost to Follow-up|6
2533992|NCT01602419|8769757|P1|Overall Study|Withdrawal by Subject|5
2533993|NCT01602419|8769757|P1|Overall Study|Treatment centre closed|1
2533994|NCT01602419|8769757|P1|Overall Study|Changed treatment centre|1
2533995|NCT01602419|8769757|P1|Overall Study|Insurance issues|3
2533996|NCT01602419|8769757|P1|Overall Study|Adverse Drug Reaction|4
2533997|NCT01602419|8769757|P1|Overall Study|Not treated with Wilate|9
2533998|NCT01602380|8769812|P2|Overall Study|Eligibility criteria not fulfilled|3
2533999|NCT01602380|8769813|P1|Overall Study|Eligibility criteria not fulfilled|2
2534000|NCT01602380|8769812|P2|Overall Study|Lost to Follow-up|1
2534001|NCT01602380|8769813|P1|Overall Study|Lost to Follow-up|6
2534002|NCT01602380|8769812|P2|Overall Study|Withdrawal by Subject|29
2534003|NCT01602380|8769813|P1|Overall Study|Withdrawal by Subject|22
2534004|NCT01602380|8769812|P2|Overall Study|Death|68
2534005|NCT01602380|8769813|P1|Overall Study|Death|63
2534006|NCT01602341|8769837|P2|Overall Study|Adverse Event|1
2534007|NCT01602341|8769838|P1|Overall Study|Adverse Event|0
2534008|NCT01602315|8769879|P7|Overall Study|Cross-over patients to combo treatment|0
2534009|NCT01602315|8769880|P6|Overall Study|Cross-over patients to combo treatment|16
2534010|NCT01602315|8769881|P5|Overall Study|Cross-over patients to combo treatment|0
2534011|NCT01602315|8769882|P4|Overall Study|Cross-over patients to combo treatment|0
2534012|NCT01602315|8769883|P3|Overall Study|Cross-over patients to combo treatment|0
2534013|NCT01602315|8769884|P2|Overall Study|Cross-over patients to combo treatment|0
2534014|NCT01602315|8769885|P1|Overall Study|Cross-over patients to combo treatment|0
2534015|NCT01602315|8769879|P7|Overall Study|Subject/guardian decision|1
2534016|NCT01602315|8769880|P6|Overall Study|Subject/guardian decision|0
2534017|NCT01602315|8769881|P5|Overall Study|Subject/guardian decision|0
2534018|NCT01602315|8769882|P4|Overall Study|Subject/guardian decision|0
2534019|NCT01602315|8769883|P3|Overall Study|Subject/guardian decision|0
2534020|NCT01602315|8769884|P2|Overall Study|Subject/guardian decision|0
2534021|NCT01602315|8769885|P1|Overall Study|Subject/guardian decision|0
2534022|NCT01602315|8769879|P7|Overall Study|Adverse Event|9
2534023|NCT01602315|8769880|P6|Overall Study|Adverse Event|3
2534024|NCT01602315|8769881|P5|Overall Study|Adverse Event|15
2534025|NCT01602315|8769882|P4|Overall Study|Adverse Event|4
2534026|NCT01602315|8769883|P3|Overall Study|Adverse Event|5
2534027|NCT01602315|8769884|P2|Overall Study|Adverse Event|1
2534028|NCT01602315|8769885|P1|Overall Study|Adverse Event|5
2534029|NCT01602315|8769879|P7|Overall Study|Withdrawal by Subject|1
2534030|NCT01602315|8769880|P6|Overall Study|Withdrawal by Subject|0
2534031|NCT01602315|8769881|P5|Overall Study|Withdrawal by Subject|6
2534032|NCT01602315|8769882|P4|Overall Study|Withdrawal by Subject|0
2534033|NCT01602315|8769883|P3|Overall Study|Withdrawal by Subject|2
2534034|NCT01602315|8769884|P2|Overall Study|Withdrawal by Subject|0
2534035|NCT01602315|8769885|P1|Overall Study|Withdrawal by Subject|2
2534036|NCT01602315|8769879|P7|Overall Study|Death|2
2534037|NCT01602315|8769880|P6|Overall Study|Death|2
2534038|NCT01602315|8769881|P5|Overall Study|Death|7
2534039|NCT01602315|8769882|P4|Overall Study|Death|1
2534040|NCT01602315|8769883|P3|Overall Study|Death|1
2534041|NCT01602315|8769884|P2|Overall Study|Death|1
2534042|NCT01602315|8769885|P1|Overall Study|Death|1
2534043|NCT01602315|8769879|P7|Overall Study|Disease progression|15
2534044|NCT01602315|8769880|P6|Overall Study|Disease progression|12
2534045|NCT01602315|8769881|P5|Overall Study|Disease progression|41
2534046|NCT01602315|8769882|P4|Overall Study|Disease progression|1
2534047|NCT01602315|8769883|P3|Overall Study|Disease progression|10
2534048|NCT01602315|8769884|P2|Overall Study|Disease progression|3
2534049|NCT01602315|8769885|P1|Overall Study|Disease progression|6
2534050|NCT01602315|8769879|P7|Overall Study|Physician Decision|1
2534051|NCT01602315|8769880|P6|Overall Study|Physician Decision|1
2534052|NCT01602315|8769881|P5|Overall Study|Physician Decision|2
2534053|NCT01602315|8769882|P4|Overall Study|Physician Decision|0
2534054|NCT01602315|8769883|P3|Overall Study|Physician Decision|0
2534055|NCT01602315|8769884|P2|Overall Study|Physician Decision|0
2534056|NCT01602315|8769885|P1|Overall Study|Physician Decision|2
2534057|NCT01602315|8769879|P7|Overall Study|Protocol Violation|0
2534058|NCT01602315|8769880|P6|Overall Study|Protocol Violation|1
2534059|NCT01602315|8769881|P5|Overall Study|Protocol Violation|0
2534060|NCT01602315|8769882|P4|Overall Study|Protocol Violation|0
2534061|NCT01602315|8769883|P3|Overall Study|Protocol Violation|0
2534062|NCT01602315|8769884|P2|Overall Study|Protocol Violation|0
2534063|NCT01602315|8769885|P1|Overall Study|Protocol Violation|0
2534064|NCT01602224|8769974|P3|Overall Study|Withdrawal by Subject|3
2534065|NCT01602224|8769975|P2|Overall Study|Withdrawal by Subject|3
2534066|NCT01602224|8769976|P1|Overall Study|Withdrawal by Subject|5
2534067|NCT01602224|8769974|P3|Overall Study|Sponsor Decision|2
2534068|NCT01602224|8769975|P2|Overall Study|Sponsor Decision|3
2534069|NCT01602224|8769976|P1|Overall Study|Sponsor Decision|2
2534070|NCT01602224|8769974|P3|Overall Study|Protocol Violation|0
2534071|NCT01602224|8769975|P2|Overall Study|Protocol Violation|1
2534072|NCT01602224|8769976|P1|Overall Study|Protocol Violation|0
2534073|NCT01602224|8769974|P3|Overall Study|Lost to Follow-up|1
2534074|NCT01602224|8769975|P2|Overall Study|Lost to Follow-up|0
2534075|NCT01602224|8769976|P1|Overall Study|Lost to Follow-up|0
2534076|NCT01602224|8769974|P3|Overall Study|Investigator Decison|0
2534077|NCT01602224|8769975|P2|Overall Study|Investigator Decison|0
2534078|NCT01602224|8769976|P1|Overall Study|Investigator Decison|1
2534079|NCT01602224|8769974|P3|Overall Study|Adverse Event|0
2534080|NCT01602224|8769975|P2|Overall Study|Adverse Event|1
2534081|NCT01602224|8769976|P1|Overall Study|Adverse Event|0
2534082|NCT01602120|8770061|P4|Overall Study|Unspecified Reason|2
2534083|NCT01602120|8770062|P3|Overall Study|Unspecified Reason|0
2534084|NCT01602120|8770063|P2|Overall Study|Unspecified Reason|1
2534085|NCT01602120|8770064|P1|Overall Study|Unspecified Reason|3
2534086|NCT01602120|8770061|P4|Overall Study|Physician Decision|0
2534087|NCT01602120|8770062|P3|Overall Study|Physician Decision|0
2534088|NCT01602120|8770063|P2|Overall Study|Physician Decision|3
2534089|NCT01602120|8770064|P1|Overall Study|Physician Decision|2
2534090|NCT01602120|8770061|P4|Overall Study|Study Terminated by Sponsor|44
2534091|NCT01602120|8770062|P3|Overall Study|Study Terminated by Sponsor|17
2534092|NCT01602120|8770063|P2|Overall Study|Study Terminated by Sponsor|24
2534093|NCT01602120|8770064|P1|Overall Study|Study Terminated by Sponsor|12
2534094|NCT01602120|8770061|P4|Overall Study|Withdrawal by Subject|3
2534095|NCT01602120|8770062|P3|Overall Study|Withdrawal by Subject|0
2534096|NCT01602120|8770063|P2|Overall Study|Withdrawal by Subject|17
2534097|NCT01602120|8770064|P1|Overall Study|Withdrawal by Subject|8
2534098|NCT01602120|8770061|P4|Overall Study|Non-compliance|1
2534099|NCT01602120|8770062|P3|Overall Study|Non-compliance|0
2534100|NCT01602120|8770063|P2|Overall Study|Non-compliance|3
2534101|NCT01602120|8770064|P1|Overall Study|Non-compliance|0
2534102|NCT01602120|8770061|P4|Overall Study|Protocol Violation|0
2534103|NCT01602120|8770062|P3|Overall Study|Protocol Violation|0
2534104|NCT01602120|8770063|P2|Overall Study|Protocol Violation|1
2534105|NCT01602120|8770064|P1|Overall Study|Protocol Violation|1
2534106|NCT01602120|8770061|P4|Overall Study|Lost to Follow-up|1
2534107|NCT01602120|8770062|P3|Overall Study|Lost to Follow-up|0
2534108|NCT01602120|8770063|P2|Overall Study|Lost to Follow-up|1
2534109|NCT01602120|8770064|P1|Overall Study|Lost to Follow-up|0
2534110|NCT01602120|8770061|P4|Overall Study|Death|0
2534111|NCT01602120|8770062|P3|Overall Study|Death|0
2534112|NCT01602120|8770063|P2|Overall Study|Death|4
2534113|NCT01602120|8770064|P1|Overall Study|Death|0
2534114|NCT01602120|8770061|P4|Overall Study|Adverse Event|2
2534115|NCT01602120|8770062|P3|Overall Study|Adverse Event|0
2534116|NCT01602120|8770063|P2|Overall Study|Adverse Event|6
2534117|NCT01602120|8770064|P1|Overall Study|Adverse Event|3
2534118|NCT01601873|8770112|P2|Overall Study|Lost to Follow-up|3
2534119|NCT01601873|8770113|P1|Overall Study|Lost to Follow-up|2
2534120|NCT01601847|8770139|P2|Overall Study|Lost to Follow-up|3
2534121|NCT01601847|8770140|P1|Overall Study|Lost to Follow-up|1
2534122|NCT01601847|8770139|P2|Overall Study|Withdrawal by Subject|7
2534123|NCT01601847|8770140|P1|Overall Study|Withdrawal by Subject|11
2534124|NCT01601847|8770139|P2|Overall Study|Death|0
2534125|NCT01601847|8770140|P1|Overall Study|Death|1
2534126|NCT01601821|8770152|P2|Overall Study|Other|1
2534127|NCT01601821|8770153|P1|Overall Study|Other|5
2534128|NCT01601821|8770152|P2|Overall Study|Study Events|1
2534129|NCT01601821|8770153|P1|Overall Study|Study Events|7
2534130|NCT01601821|8770152|P2|Overall Study|Graft Loss|6
2534131|NCT01601821|8770153|P1|Overall Study|Graft Loss|6
2534132|NCT01601821|8770152|P2|Overall Study|Withdrawal by Subject|0
2534133|NCT01601821|8770153|P1|Overall Study|Withdrawal by Subject|1
2534134|NCT01601821|8770152|P2|Overall Study|Lost to Follow-up|14
2534135|NCT01601821|8770153|P1|Overall Study|Lost to Follow-up|6
2534136|NCT01601821|8770152|P2|Overall Study|Protocol Violation|2
2534137|NCT01601821|8770153|P1|Overall Study|Protocol Violation|2
2534138|NCT01601821|8770152|P2|Overall Study|Death|5
2534139|NCT01601821|8770153|P1|Overall Study|Death|2
2534140|NCT01601704|8770189|P2|Overall Study|Randomized but not dispensed study med|4
2534141|NCT01601704|8770190|P1|Overall Study|Randomized but not dispensed study med|1
2534142|NCT01601626|8770211|P3|Overall Study|Not Willing to Adhere to Requirements|0
2534143|NCT01601626|8770212|P2|Overall Study|Not Willing to Adhere to Requirements|0
2534144|NCT01601626|8770213|P1|Overall Study|Not Willing to Adhere to Requirements|1
2534145|NCT01601626|8770211|P3|Overall Study|Withdrawal by Subject|1
2534146|NCT01601626|8770212|P2|Overall Study|Withdrawal by Subject|1
2534147|NCT01601626|8770213|P1|Overall Study|Withdrawal by Subject|0
2534148|NCT01601626|8770211|P3|Overall Study|Unable to Get to Clinic|0
2534149|NCT01601626|8770212|P2|Overall Study|Unable to Get to Clinic|1
2534150|NCT01601626|8770213|P1|Overall Study|Unable to Get to Clinic|0
2534151|NCT01601626|8770211|P3|Overall Study|Lost to Follow-up|0
2534152|NCT01601626|8770212|P2|Overall Study|Lost to Follow-up|2
2534153|NCT01601626|8770213|P1|Overall Study|Lost to Follow-up|1
2534154|NCT01601626|8770211|P3|Overall Study|Death|1
2534155|NCT01601626|8770212|P2|Overall Study|Death|1
2534156|NCT01601626|8770213|P1|Overall Study|Death|1
2534157|NCT01601535|8770302|P6|Phase 2|Started Another Treatment|2
2534158|NCT01601535|8770303|P5|Phase 2|Started Another Treatment|1
2534159|NCT01601535|8770304|P4|Phase 2|Started Another Treatment|0
2534160|NCT01601535|8770305|P3|Phase 2|Started Another Treatment|0
2534161|NCT01601535|8770306|P2|Phase 2|Started Another Treatment|0
2534162|NCT01601535|8770307|P1|Phase 2|Started Another Treatment|0
2534163|NCT01601535|8770302|P6|Phase 2|Progressive Disease|7
2534164|NCT01601535|8770303|P5|Phase 2|Progressive Disease|5
2534165|NCT01601535|8770304|P4|Phase 2|Progressive Disease|0
2534166|NCT01601535|8770305|P3|Phase 2|Progressive Disease|0
2534167|NCT01601535|8770306|P2|Phase 2|Progressive Disease|0
2534168|NCT01601535|8770307|P1|Phase 2|Progressive Disease|0
2534169|NCT01601535|8770302|P6|Phase 2|Withdrawal by Subject|2
2534170|NCT01601535|8770303|P5|Phase 2|Withdrawal by Subject|8
2534171|NCT01601535|8770304|P4|Phase 2|Withdrawal by Subject|0
2534172|NCT01601535|8770305|P3|Phase 2|Withdrawal by Subject|0
2534173|NCT01601535|8770306|P2|Phase 2|Withdrawal by Subject|0
2534174|NCT01601535|8770307|P1|Phase 2|Withdrawal by Subject|0
2534175|NCT01601535|8770302|P6|Phase 2|Adverse Event|1
2534176|NCT01601535|8770303|P5|Phase 2|Adverse Event|5
2534177|NCT01601535|8770304|P4|Phase 2|Adverse Event|0
2534178|NCT01601535|8770305|P3|Phase 2|Adverse Event|0
2534179|NCT01601535|8770306|P2|Phase 2|Adverse Event|0
2534180|NCT01601535|8770307|P1|Phase 2|Adverse Event|0
2534181|NCT01601535|8770302|P6|Phase 1|Started Another Treatment|0
2534182|NCT01601535|8770303|P5|Phase 1|Started Another Treatment|0
2534183|NCT01601535|8770304|P4|Phase 1|Started Another Treatment|0
2534184|NCT01601535|8770305|P3|Phase 1|Started Another Treatment|0
2534185|NCT01601535|8770306|P2|Phase 1|Started Another Treatment|2
2534186|NCT01601535|8770307|P1|Phase 1|Started Another Treatment|1
2534187|NCT01601535|8770302|P6|Phase 1|Progressive Disease|0
2534188|NCT01601535|8770303|P5|Phase 1|Progressive Disease|0
2534189|NCT01601535|8770304|P4|Phase 1|Progressive Disease|1
2534190|NCT01601535|8770305|P3|Phase 1|Progressive Disease|2
2534191|NCT01601535|8770306|P2|Phase 1|Progressive Disease|3
2534192|NCT01601535|8770307|P1|Phase 1|Progressive Disease|2
2534193|NCT01601535|8770302|P6|Phase 1|Withdrawal by Subject|0
2534194|NCT01601535|8770303|P5|Phase 1|Withdrawal by Subject|0
2534195|NCT01601535|8770304|P4|Phase 1|Withdrawal by Subject|2
2534196|NCT01601535|8770305|P3|Phase 1|Withdrawal by Subject|1
2534197|NCT01601535|8770306|P2|Phase 1|Withdrawal by Subject|1
2534198|NCT01601535|8770307|P1|Phase 1|Withdrawal by Subject|2
2534199|NCT01601535|8770302|P6|Phase 1|Adverse Event|0
2534200|NCT01601535|8770303|P5|Phase 1|Adverse Event|0
2534201|NCT01601535|8770304|P4|Phase 1|Adverse Event|1
2534202|NCT01601535|8770305|P3|Phase 1|Adverse Event|2
2534203|NCT01601535|8770306|P2|Phase 1|Adverse Event|0
2534204|NCT01601535|8770307|P1|Phase 1|Adverse Event|1
2534205|NCT01601470|8770363|P1|Period 2 - LCZ696|Physician Decision|1
2534206|NCT01601132|8770434|P1|Overall Study|Protocol deviation|1
2534207|NCT01601132|8770434|P1|Overall Study|Patient withdrew consent|1
2534208|NCT01600885|8770479|P2|First Period|moved out of area|0
2534209|NCT01600885|8770480|P1|First Period|moved out of area|1
2534210|NCT01600885|8770479|P2|First Period|Adverse Event|1
2534211|NCT01600885|8770480|P1|First Period|Adverse Event|1
2534212|NCT01600716|8770497|P2|Overall Study|Adverse Event|1
2534213|NCT01600716|8770498|P1|Overall Study|Adverse Event|1
2534214|NCT01600716|8770497|P2|Overall Study|Lack of Efficacy|1
2534215|NCT01600716|8770498|P1|Overall Study|Lack of Efficacy|2
2534216|NCT01600716|8770497|P2|Overall Study|Pregnancy|0
2534217|NCT01600716|8770498|P1|Overall Study|Pregnancy|1
2534218|NCT01600716|8770497|P2|Overall Study|Lost to Follow-up|2
2534219|NCT01600716|8770498|P1|Overall Study|Lost to Follow-up|0
2534220|NCT01600716|8770497|P2|Overall Study|Personal Reasons|2
2534221|NCT01600716|8770498|P1|Overall Study|Personal Reasons|0
2534222|NCT01600716|8770497|P2|Overall Study|Other Reasons|1
2534223|NCT01600716|8770498|P1|Overall Study|Other Reasons|3
2534224|NCT01600586|8770538|P2|Overall Study|Physician Decision|3
2534225|NCT01600586|8770539|P1|Overall Study|Physician Decision|3
2534226|NCT01600326|8770591|P2|Overall Study|Lost to Follow-up|1
2534227|NCT01600326|8770592|P1|Overall Study|Lost to Follow-up|1
2534228|NCT01600105|8770668|P2|Sub Study V|Poor Image Quality|0
2534229|NCT01600105|8770669|P1|Sub Study V|Poor Image Quality|2
2534230|NCT01600105|8770668|P2|Sub Study III|Insufficient image quality|0
2534231|NCT01600105|8770669|P1|Sub Study III|Insufficient image quality|5
2534232|NCT01600105|8770668|P2|Sub Study II|Insufficient image quality|0
2534233|NCT01600105|8770669|P1|Sub Study II|Insufficient image quality|3
2534234|NCT01600105|8770668|P2|Sub Study II|No images in PACS|0
2534235|NCT01600105|8770669|P1|Sub Study II|No images in PACS|1
2534236|NCT01600105|8770668|P2|Sub Study II|Withdrawal by Subject|0
2534237|NCT01600105|8770669|P1|Sub Study II|Withdrawal by Subject|1
2534238|NCT01600105|8770668|P2|Sub Study I|Insufficient image quality|10
2534239|NCT01600105|8770669|P1|Sub Study I|Insufficient image quality|0
2534240|NCT01600105|8770668|P2|Total Participants|Insufficient image quality|10
2534241|NCT01600105|8770669|P1|Total Participants|Insufficient image quality|30
2534242|NCT01600105|8770668|P2|Total Participants|No images in PACS|0
2534243|NCT01600105|8770669|P1|Total Participants|No images in PACS|10
2534244|NCT01600105|8770668|P2|Total Participants|Withdrawal by Subject|0
2534245|NCT01600105|8770669|P1|Total Participants|Withdrawal by Subject|1
2534246|NCT01600092|8770697|P2|Overall Study|Randomized but not vaccinated|3
2534247|NCT01600092|8770698|P1|Overall Study|Randomized but not vaccinated|3
2534248|NCT01600092|8770697|P2|Overall Study|Physician Decision|1
2534249|NCT01600092|8770698|P1|Overall Study|Physician Decision|1
2534250|NCT01600092|8770697|P2|Overall Study|Withdrawal by parent/guardian|6
2534251|NCT01600092|8770698|P1|Overall Study|Withdrawal by parent/guardian|8
2534252|NCT01600092|8770697|P2|Overall Study|Lost to Follow-up|6
2534253|NCT01600092|8770698|P1|Overall Study|Lost to Follow-up|4
2534254|NCT01600092|8770697|P2|Overall Study|Adverse Event|0
2534255|NCT01600092|8770698|P1|Overall Study|Adverse Event|2
2534256|NCT01600053|8770712|P1|Overall Study|trial will not meet the interim endpoint|9
2534257|NCT01600053|8770712|P1|Overall Study|Adverse Event|2
2534258|NCT01600014|8770717|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0
2534259|NCT01600014|8770718|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1
2534260|NCT01600014|8770717|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0
2534261|NCT01600014|8770718|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1
2534262|NCT01600014|8770717|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0
2534263|NCT01600014|8770718|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1
2534264|NCT01600014|8770717|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3
2534265|NCT01600014|8770718|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1
2534266|NCT01600014|8770717|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
2534267|NCT01600014|8770718|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
2534268|NCT01600014|8770717|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0
2534269|NCT01600014|8770718|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5
2534270|NCT01600014|8770717|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0
2534271|NCT01600014|8770718|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1
2534272|NCT01600014|8770717|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1
2534273|NCT01600014|8770718|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2
2534274|NCT01600014|8770717|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3
2534275|NCT01600014|8770718|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1
2534276|NCT01600014|8770717|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2
2534277|NCT01600014|8770718|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1
2534278|NCT01600014|8770717|P2|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0
2534279|NCT01600014|8770718|P1|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8
2534280|NCT01600014|8770717|P2|1. Cycle & Observation Period D1 to W52|Protocol Violation|0
2534281|NCT01600014|8770718|P1|1. Cycle & Observation Period D1 to W52|Protocol Violation|6
2534282|NCT01600014|8770717|P2|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0
2534283|NCT01600014|8770718|P1|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14
2534284|NCT01600014|8770717|P2|1. Cycle & Observation Period D1 to W52|Other|0
2534285|NCT01600014|8770718|P1|1. Cycle & Observation Period D1 to W52|Other|27
2534286|NCT01600014|8770717|P2|1. Cycle & Observation Period D1 to W52|Adverse Event|0
2534287|NCT01600014|8770718|P1|1. Cycle & Observation Period D1 to W52|Adverse Event|6
2534288|NCT01600014|8770717|P2|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0
2534289|NCT01600014|8770718|P1|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203
2534290|NCT01600014|8770717|P2|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0
2534291|NCT01600014|8770718|P1|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24
2534292|NCT01599806|8770746|P2|Overall Study|Other Eligibility criteria|9
2534293|NCT01599806|8770747|P1|Overall Study|Other Eligibility criteria|11
2534294|NCT01599806|8770746|P2|Overall Study|Withdrawal by Subject|12
2534295|NCT01599806|8770747|P1|Overall Study|Withdrawal by Subject|12
2534296|NCT01599806|8770746|P2|Overall Study|Lost to Follow-up|20
2534297|NCT01599806|8770747|P1|Overall Study|Lost to Follow-up|20
2534298|NCT01599793|8770871|P1|Overall Study|Adverse Event|2
2534299|NCT01599754|8770883|P2|Overall Study|Study terminated by sponsor|285
2534300|NCT01599754|8770884|P1|Overall Study|Study terminated by sponsor|282
2534301|NCT01599754|8770883|P2|Overall Study|Withdrawal by Subject|25
2534302|NCT01599754|8770884|P1|Overall Study|Withdrawal by Subject|24
2534303|NCT01599754|8770883|P2|Overall Study|Investigator decision|3
2534304|NCT01599754|8770884|P1|Overall Study|Investigator decision|1
2534305|NCT01599754|8770883|P2|Overall Study|Adverse Event|2
2534306|NCT01599754|8770884|P1|Overall Study|Adverse Event|3
2534307|NCT01599754|8770883|P2|Overall Study|Death|33
2534308|NCT01599754|8770884|P1|Overall Study|Death|31
2534309|NCT01599754|8770883|P2|Overall Study|Lost to Follow-up|6
2534310|NCT01599754|8770884|P1|Overall Study|Lost to Follow-up|13
2534311|NCT01599754|8770883|P2|Overall Study|Participant noncompliance|4
2534312|NCT01599754|8770884|P1|Overall Study|Participant noncompliance|4
2534313|NCT01599754|8770883|P2|Overall Study|Anticancer therapy need not in protocol|2
2534314|NCT01599754|8770884|P1|Overall Study|Anticancer therapy need not in protocol|5
2534315|NCT01599650|8770915|P3|Overall Study|Adverse Event|4
2534316|NCT01599650|8770916|P2|Overall Study|Adverse Event|8
2534317|NCT01599650|8770917|P1|Overall Study|Adverse Event|3
2534318|NCT01599650|8770915|P3|Overall Study|Withdrawal by Subject|10
2534319|NCT01599650|8770916|P2|Overall Study|Withdrawal by Subject|11
2534320|NCT01599650|8770917|P1|Overall Study|Withdrawal by Subject|11
2534321|NCT01599650|8770915|P3|Overall Study|Lost to Follow-up|3
2534322|NCT01599650|8770916|P2|Overall Study|Lost to Follow-up|3
2534323|NCT01599650|8770917|P1|Overall Study|Lost to Follow-up|3
2534324|NCT01599650|8770915|P3|Overall Study|Death|2
2534325|NCT01599650|8770916|P2|Overall Study|Death|1
2534326|NCT01599650|8770917|P1|Overall Study|Death|2
2534327|NCT01599650|8770915|P3|Overall Study|Protocol Violation|0
2534328|NCT01599650|8770916|P2|Overall Study|Protocol Violation|3
2534329|NCT01599650|8770917|P1|Overall Study|Protocol Violation|0
2534330|NCT01599650|8770915|P3|Overall Study|Physician Decision|7
2534331|NCT01599650|8770916|P2|Overall Study|Physician Decision|0
2534332|NCT01599650|8770917|P1|Overall Study|Physician Decision|2
2534333|NCT01599650|8770915|P3|Overall Study|Administrative issue|1
2534334|NCT01599650|8770916|P2|Overall Study|Administrative issue|0
2534335|NCT01599650|8770917|P1|Overall Study|Administrative issue|1
2534336|NCT01599637|8770956|P3|Overall Study|Adverse Event|0
2534337|NCT01599637|8770957|P2|Overall Study|Adverse Event|0
2534338|NCT01599637|8770958|P1|Overall Study|Adverse Event|1
2534339|NCT01599637|8770956|P3|Overall Study|administrative problems|0
2534340|NCT01599637|8770957|P2|Overall Study|administrative problems|2
2534341|NCT01599637|8770958|P1|Overall Study|administrative problems|0
2534342|NCT01599585|8771005|P2|Overall Study|randomized did not start treatment|3
2534343|NCT01599585|8771006|P1|Overall Study|randomized did not start treatment|3
2534344|NCT01599585|8771005|P2|Overall Study|Lost to Follow-up|5
2534345|NCT01599585|8771006|P1|Overall Study|Lost to Follow-up|3
2534346|NCT01599585|8771005|P2|Overall Study|Withdrawal by Subject|9
2534347|NCT01599585|8771006|P1|Overall Study|Withdrawal by Subject|16
2534348|NCT01599325|8771044|P1|Extension Phase|Withdrawal by Subject|8
2534349|NCT01599325|8771044|P1|Extension Phase|Disease Progression|1
2534350|NCT01599325|8771044|P1|Extension Phase|Lack of Therapeutic Effect|4
2534351|NCT01599325|8771044|P1|Extension Phase|Stopped to Receive Stem Cell Transplant|1
2534352|NCT01599325|8771044|P1|Extension Phase|Study Closure|1
2534353|NCT01599325|8771044|P1|Primary Parent Phase|Other|2
2534354|NCT01599325|8771044|P1|Primary Parent Phase|Lack of Therapeutic Effect|9
2534355|NCT01599325|8771044|P1|Primary Parent Phase|Protocol Violation|1
2534356|NCT01599325|8771044|P1|Primary Parent Phase|Death|13
2534357|NCT01599325|8771044|P1|Primary Parent Phase|Withdrawal by Subject|20
2534358|NCT01599325|8771044|P1|Primary Parent Phase|Disease Progression|7
2534359|NCT01599325|8771044|P1|Primary Parent Phase|Adverse Event|5
2534360|NCT01599234|8771068|P2|Overall Study|Pregnancy|1
2534361|NCT01599234|8771069|P1|Overall Study|Pregnancy|0
2534362|NCT01599234|8771068|P2|Overall Study|Contra-indication discovered|1
2534363|NCT01599234|8771069|P1|Overall Study|Contra-indication discovered|0
2534364|NCT01599234|8771068|P2|Overall Study|Patient would not stop driving|0
2534365|NCT01599234|8771069|P1|Overall Study|Patient would not stop driving|1
2534366|NCT01599234|8771068|P2|Overall Study|Death|0
2534367|NCT01599234|8771069|P1|Overall Study|Death|1
2534368|NCT01599234|8771068|P2|Overall Study|Sponsor request as creatinine levels <50|1
2534369|NCT01599234|8771069|P1|Overall Study|Sponsor request as creatinine levels <50|0
2534370|NCT01599234|8771068|P2|Overall Study|Unable to operate spray|0
2534371|NCT01599234|8771069|P1|Overall Study|Unable to operate spray|1
2534372|NCT01599234|8771068|P2|Overall Study|Lack of Efficacy|4
2534373|NCT01599234|8771069|P1|Overall Study|Lack of Efficacy|2
2534374|NCT01599234|8771068|P2|Overall Study|Lost to Follow-up|2
2534375|NCT01599234|8771069|P1|Overall Study|Lost to Follow-up|1
2534376|NCT01599234|8771068|P2|Overall Study|Withdrawal by Subject|1
2534377|NCT01599234|8771069|P1|Overall Study|Withdrawal by Subject|2
2534378|NCT01599234|8771068|P2|Overall Study|Adverse Event|5
2534379|NCT01599234|8771069|P1|Overall Study|Adverse Event|9
2534380|NCT01599104|8771094|P3|Overall Study|Adverse Event|12
2534381|NCT01599104|8771095|P2|Overall Study|Adverse Event|6
2534382|NCT01599104|8771096|P1|Overall Study|Adverse Event|7
2534383|NCT01599104|8771094|P3|Overall Study|Lack of Efficacy|10
2534384|NCT01599104|8771095|P2|Overall Study|Lack of Efficacy|4
2534385|NCT01599104|8771096|P1|Overall Study|Lack of Efficacy|4
2534386|NCT01599104|8771094|P3|Overall Study|Non-compliance with study treatment|0
2534387|NCT01599104|8771095|P2|Overall Study|Non-compliance with study treatment|1
2534388|NCT01599104|8771096|P1|Overall Study|Non-compliance with study treatment|0
2534389|NCT01599104|8771094|P3|Overall Study|Physician Decision|2
2534390|NCT01599104|8771095|P2|Overall Study|Physician Decision|2
2534391|NCT01599104|8771096|P1|Overall Study|Physician Decision|3
2534392|NCT01599104|8771094|P3|Overall Study|Technical Problems|0
2534393|NCT01599104|8771095|P2|Overall Study|Technical Problems|0
2534394|NCT01599104|8771096|P1|Overall Study|Technical Problems|1
2534395|NCT01599104|8771094|P3|Overall Study|Withdrawal by Subject|2
2534396|NCT01599104|8771095|P2|Overall Study|Withdrawal by Subject|1
2534397|NCT01599104|8771096|P1|Overall Study|Withdrawal by Subject|1
2534398|NCT01598987|8771134|P1|Baseline to 24 Month|Lost to Follow-up|1
2534399|NCT01598987|8771134|P1|Baseline to 24 Month|Administrative problems|2
2534400|NCT01598987|8771134|P1|Baseline to 24 Month|Withdrawal by Subject|5
2534401|NCT01598987|8771134|P1|Baseline to Month 12|Withdrawal by Subject|4
2534402|NCT01598987|8771134|P1|Baseline to Month 12|Administrative problems|2
2534403|NCT01598896|8771170|P2|Overall Study|Lack of Efficacy|1
2534404|NCT01598896|8771171|P1|Overall Study|Lack of Efficacy|0
2534405|NCT01598896|8771170|P2|Overall Study|Withdrawal by Subject|1
2534406|NCT01598896|8771171|P1|Overall Study|Withdrawal by Subject|0
2534407|NCT01598753|8771210|P4|Overall Study|Withdrawal by Subject|1
2534408|NCT01598753|8771211|P3|Overall Study|Withdrawal by Subject|0
2534409|NCT01598753|8771212|P2|Overall Study|Withdrawal by Subject|2
2534410|NCT01598753|8771213|P1|Overall Study|Withdrawal by Subject|7
2534411|NCT01598753|8771210|P4|Overall Study|Physician Decision|2
2534412|NCT01598753|8771211|P3|Overall Study|Physician Decision|0
2534413|NCT01598753|8771212|P2|Overall Study|Physician Decision|1
2534414|NCT01598753|8771213|P1|Overall Study|Physician Decision|0
2534415|NCT01598753|8771210|P4|Overall Study|Lost to Follow-up|5
2534416|NCT01598753|8771211|P3|Overall Study|Lost to Follow-up|7
2534417|NCT01598753|8771212|P2|Overall Study|Lost to Follow-up|3
2534418|NCT01598753|8771213|P1|Overall Study|Lost to Follow-up|4
2534419|NCT01598753|8771210|P4|Overall Study|Adverse Event|7
2534420|NCT01598753|8771211|P3|Overall Study|Adverse Event|1
2534421|NCT01598753|8771212|P2|Overall Study|Adverse Event|9
2534422|NCT01598753|8771213|P1|Overall Study|Adverse Event|1
2534423|NCT01598662|8771253|P2|Overall Study|IUD expelled before month 6|2
2534424|NCT01598662|8771254|P1|Overall Study|IUD expelled before month 6|0
2534425|NCT01598662|8771253|P2|Overall Study|Physician Decision|2
2534426|NCT01598662|8771254|P1|Overall Study|Physician Decision|1
2534427|NCT01598662|8771253|P2|Overall Study|Lost to Follow-up|17
2534428|NCT01598662|8771254|P1|Overall Study|Lost to Follow-up|10
2534429|NCT01598610|8771260|P1|Overall Study|Adverse Event|1
2534430|NCT01598532|8771277|P1|Overall Study|Did not meet inclusion criteria|8
2534431|NCT01598532|8771277|P1|Overall Study|Lost to Follow-up|3
2534432|NCT01598506|8771286|P1|Overall Study|Withdrawal by Subject|2
2534433|NCT01598311|8771306|P2|Overall Study|Assigned to CB but received vancomycin|0
2534434|NCT01598311|8771307|P1|Overall Study|Assigned to CB but received vancomycin|1
2534435|NCT01598311|8771306|P2|Overall Study|Treated but no confirmed CDAD|8
2534436|NCT01598311|8771307|P1|Overall Study|Treated but no confirmed CDAD|9
2534437|NCT01598311|8771306|P2|Overall Study|Randomized but never treated|5
2534438|NCT01598311|8771307|P1|Overall Study|Randomized but never treated|8
2534439|NCT01598311|8771306|P2|Overall Study|No reason provided.|5
2534440|NCT01598311|8771307|P1|Overall Study|No reason provided.|0
2534441|NCT01598311|8771306|P2|Overall Study|Withdrawal by Subject|13
2534442|NCT01598311|8771307|P1|Overall Study|Withdrawal by Subject|9
2534443|NCT01598311|8771306|P2|Overall Study|Lost to Follow-up|12
2534444|NCT01598311|8771307|P1|Overall Study|Lost to Follow-up|7
2534445|NCT01598311|8771306|P2|Overall Study|Adverse Event|13
2534446|NCT01598311|8771307|P1|Overall Study|Adverse Event|9
2534447|NCT01598311|8771306|P2|Overall Study|Physician Decision|5
2534448|NCT01598311|8771307|P1|Overall Study|Physician Decision|4
2534449|NCT01598298|8771323|P2|Overall Study|Other reason (not protocol specified)|0
2534450|NCT01598298|8771324|P1|Overall Study|Other reason (not protocol specified)|4
2534451|NCT01598298|8771323|P2|Overall Study|Withdrawal by Subject|15
2534452|NCT01598298|8771324|P1|Overall Study|Withdrawal by Subject|10
2534453|NCT01598298|8771323|P2|Overall Study|Progression/relapse|2
2534454|NCT01598298|8771324|P1|Overall Study|Progression/relapse|0
2534455|NCT01598298|8771323|P2|Overall Study|Adverse Event|19
2534456|NCT01598298|8771324|P1|Overall Study|Adverse Event|21
2534457|NCT01598298|8771323|P2|Overall Study|Not eligible|5
2534458|NCT01598298|8771324|P1|Overall Study|Not eligible|5
2534459|NCT01598129|8771368|P1|Overall Study|Withdrawal by Subject|1
2534460|NCT01598129|8771368|P1|Overall Study|Deterioration of WHO status to WHO 4|2
2534461|NCT01598129|8771368|P1|Overall Study|Disease progression|6
2534462|NCT01598090|8771380|P3|Follow-up Period|Lost to Follow-up|12
2534463|NCT01598090|8771381|P2|Follow-up Period|Lost to Follow-up|10
2534464|NCT01598090|8771382|P1|Follow-up Period|Lost to Follow-up|2
2534465|NCT01598090|8771380|P3|Follow-up Period|Other reasons|8
2534466|NCT01598090|8771381|P2|Follow-up Period|Other reasons|8
2534467|NCT01598090|8771382|P1|Follow-up Period|Other reasons|2
2534468|NCT01598090|8771380|P3|Follow-up Period|Withdrawal by Subject|2
2534469|NCT01598090|8771381|P2|Follow-up Period|Withdrawal by Subject|3
2534470|NCT01598090|8771382|P1|Follow-up Period|Withdrawal by Subject|0
2534471|NCT01598090|8771380|P3|Follow-up Period|Not reported|4
2534472|NCT01598090|8771381|P2|Follow-up Period|Not reported|10
2534473|NCT01598090|8771382|P1|Follow-up Period|Not reported|0
2534474|NCT01598090|8771380|P3|Follow-up Period|No longer required per protocol|2
2534475|NCT01598090|8771381|P2|Follow-up Period|No longer required per protocol|3
2534476|NCT01598090|8771382|P1|Follow-up Period|No longer required per protocol|1
2534477|NCT01598090|8771380|P3|Follow-up Period|Death|0
2534478|NCT01598090|8771381|P2|Follow-up Period|Death|1
2534479|NCT01598090|8771382|P1|Follow-up Period|Death|0
2534480|NCT01598090|8771380|P3|Treatment Period|Lost to Follow-up|1
2534481|NCT01598090|8771381|P2|Treatment Period|Lost to Follow-up|5
2534482|NCT01598090|8771382|P1|Treatment Period|Lost to Follow-up|1
2534483|NCT01598090|8771380|P3|Treatment Period|Withdrawal by Subject|10
2534484|NCT01598090|8771381|P2|Treatment Period|Withdrawal by Subject|13
2534485|NCT01598090|8771382|P1|Treatment Period|Withdrawal by Subject|3
2534486|NCT01598090|8771380|P3|Treatment Period|Other reasons|1
2534487|NCT01598090|8771381|P2|Treatment Period|Other reasons|4
2534488|NCT01598090|8771382|P1|Treatment Period|Other reasons|0
2534489|NCT01598090|8771380|P3|Treatment Period|Adverse Event|17
2534490|NCT01598090|8771381|P2|Treatment Period|Adverse Event|33
2534491|NCT01598090|8771382|P1|Treatment Period|Adverse Event|2
2534492|NCT01598090|8771380|P3|Treatment Period|Lack of Efficacy|6
2534493|NCT01598090|8771381|P2|Treatment Period|Lack of Efficacy|14
2534494|NCT01598090|8771382|P1|Treatment Period|Lack of Efficacy|5
2534495|NCT01598090|8771380|P3|Treatment Period|No longer meet study criteria|0
2534496|NCT01598090|8771381|P2|Treatment Period|No longer meet study criteria|1
2534497|NCT01598090|8771382|P1|Treatment Period|No longer meet study criteria|0
2534498|NCT01598090|8771380|P3|Treatment Period|Poor/non-compliance|0
2534499|NCT01598090|8771381|P2|Treatment Period|Poor/non-compliance|2
2534500|NCT01598090|8771382|P1|Treatment Period|Poor/non-compliance|0
2534501|NCT01597908|8771429|P2|Overall Study|Ongoing|202
2534502|NCT01597908|8771430|P1|Overall Study|Ongoing|236
2534503|NCT01597908|8771429|P2|Overall Study|Withdrawal by Subject|18
2534504|NCT01597908|8771430|P1|Overall Study|Withdrawal by Subject|10
2534505|NCT01597908|8771429|P2|Overall Study|Physician Decision|1
2534506|NCT01597908|8771430|P1|Overall Study|Physician Decision|2
2534507|NCT01597908|8771429|P2|Overall Study|Lost to Follow-up|9
2534508|NCT01597908|8771430|P1|Overall Study|Lost to Follow-up|4
2534509|NCT01597908|8771429|P2|Overall Study|Death|122
2534510|NCT01597908|8771430|P1|Overall Study|Death|100
2534511|NCT01597791|8771476|P2|Overall Study|Protocol Violation|1
2534512|NCT01597791|8771477|P1|Overall Study|Protocol Violation|0
2534513|NCT01597791|8771476|P2|Overall Study|Subject withdrawal|1
2534514|NCT01597791|8771477|P1|Overall Study|Subject withdrawal|0
2534515|NCT01597791|8771476|P2|Overall Study|Cesarean Section|7
2534516|NCT01597791|8771477|P1|Overall Study|Cesarean Section|6
2534517|NCT01597791|8771476|P2|Overall Study|Physician Decision|1
2534518|NCT01597791|8771477|P1|Overall Study|Physician Decision|2
2534519|NCT01597635|8771564|P3|Part B|Withdrawal by Subject|0
2534520|NCT01597635|8771565|P2|Part B|Withdrawal by Subject|1
2534521|NCT01597635|8771566|P1|Part B|Withdrawal by Subject|0
2534522|NCT01597635|8771564|P3|Part B|Protocol-defined stopping criteria|3
2534523|NCT01597635|8771565|P2|Part B|Protocol-defined stopping criteria|4
2534524|NCT01597635|8771566|P1|Part B|Protocol-defined stopping criteria|0
2534525|NCT01597635|8771564|P3|Part B|Protocol Violation|0
2534526|NCT01597635|8771565|P2|Part B|Protocol Violation|1
2534527|NCT01597635|8771566|P1|Part B|Protocol Violation|0
2534528|NCT01597635|8771564|P3|Part B|Adverse Event|1
2534529|NCT01597635|8771565|P2|Part B|Adverse Event|0
2534530|NCT01597635|8771566|P1|Part B|Adverse Event|0
2534531|NCT01597635|8771564|P3|Part A|Adverse Event|0
2534532|NCT01597635|8771565|P2|Part A|Adverse Event|0
2534533|NCT01597635|8771566|P1|Part A|Adverse Event|3
2534534|NCT01597622|8771629|P1|Overall Study|Death|1
2534535|NCT01597622|8771629|P1|Overall Study|Withdrawal by Subject|20
2534536|NCT01597622|8771629|P1|Overall Study|Investigator Discretion|5
2534537|NCT01597622|8771629|P1|Overall Study|Lost to Follow-up|1
2534538|NCT01597622|8771629|P1|Overall Study|Protocol Violation|1
2534539|NCT01597622|8771629|P1|Overall Study|Lack of Efficacy|3
2534540|NCT01597622|8771629|P1|Overall Study|Adverse Event|7
2534541|NCT01597596|8771636|P2|Overall Study|Physician Decision|1
2534542|NCT01597596|8771637|P1|Overall Study|Physician Decision|0
2534543|NCT01597596|8771636|P2|Overall Study|Study terminated by sponsor|0
2534544|NCT01597596|8771637|P1|Overall Study|Study terminated by sponsor|1
2534545|NCT01597505|8771651|P2|Overall Study|Missing|0
2534546|NCT01597505|8771652|P1|Overall Study|Missing|1
2534547|NCT01597505|8771651|P2|Overall Study|Other|6
2534548|NCT01597505|8771652|P1|Overall Study|Other|5
2534549|NCT01597505|8771651|P2|Overall Study|Withdrawal by Subject|18
2534550|NCT01597505|8771652|P1|Overall Study|Withdrawal by Subject|10
2534551|NCT01597505|8771651|P2|Overall Study|Lost to Follow-up|2
2534552|NCT01597505|8771652|P1|Overall Study|Lost to Follow-up|4
2534553|NCT01597505|8771651|P2|Overall Study|Adverse Event|7
2534554|NCT01597505|8771652|P1|Overall Study|Adverse Event|19
2534555|NCT01597505|8771651|P2|Overall Study|Physician Decision|0
2534556|NCT01597505|8771652|P1|Overall Study|Physician Decision|5
2534557|NCT01597492|8771686|P2|Overall Study|Other Reason|0
2534558|NCT01597492|8771687|P1|Overall Study|Other Reason|2
2534559|NCT01597492|8771686|P2|Overall Study|Lost to Follow-up|2
2534560|NCT01597492|8771687|P1|Overall Study|Lost to Follow-up|0
2534561|NCT01597492|8771686|P2|Overall Study|Adverse Event|0
2534562|NCT01597492|8771687|P1|Overall Study|Adverse Event|3
2534563|NCT01597492|8771686|P2|Overall Study|Withdrawal by Subject|2
2534564|NCT01597492|8771687|P1|Overall Study|Withdrawal by Subject|1
2534565|NCT01597479|8771695|P2|Overall Study|Lost to Follow-up|0
2534566|NCT01597479|8771696|P1|Overall Study|Lost to Follow-up|1
2534567|NCT01597479|8771695|P2|Overall Study|Protocol Violation|0
2534568|NCT01597479|8771696|P1|Overall Study|Protocol Violation|1
2534569|NCT01597375|8771982|P2|Second Intervention|Failed to react at both Aspirin|1
2534570|NCT01597375|8771983|P1|Second Intervention|Failed to react at both Aspirin|1
2534571|NCT01597375|8771982|P2|Washout (2 Weeks)|Adverse Event|0
2534572|NCT01597375|8771983|P1|Washout (2 Weeks)|Adverse Event|1
2534573|NCT01597375|8771982|P2|First Intervention (4 Weeks)|Lost to Follow-up|1
2534574|NCT01597375|8771983|P1|First Intervention (4 Weeks)|Lost to Follow-up|0
2534575|NCT01597375|8771982|P2|First Intervention (4 Weeks)|Needed surgery|0
2534576|NCT01597375|8771983|P1|First Intervention (4 Weeks)|Needed surgery|1
2534577|NCT01597375|8771982|P2|First Intervention (4 Weeks)|Uncontrolled Asthma|0
2534578|NCT01597375|8771983|P1|First Intervention (4 Weeks)|Uncontrolled Asthma|1
2534579|NCT01597258|8772000|P1|Overall Study|No Drug Administration|1
2534580|NCT01597245|8772009|P13|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2534581|NCT01597245|8772010|P12|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2534582|NCT01597245|8772011|P11|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1
2534583|NCT01597245|8772012|P10|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2534584|NCT01597245|8772013|P9|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2534585|NCT01597245|8772014|P8|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2534586|NCT01597245|8772015|P7|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2534587|NCT01597245|8772016|P6|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2534588|NCT01597245|8772017|P5|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2534589|NCT01597245|8772018|P4|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2534590|NCT01597245|8772019|P3|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2534591|NCT01597245|8772020|P2|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2534592|NCT01597245|8772021|P1|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
2534593|NCT01597245|8772009|P13|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
2534594|NCT01597245|8772010|P12|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
2534595|NCT01597245|8772011|P11|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
2534596|NCT01597245|8772012|P10|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
2534597|NCT01597245|8772013|P9|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
2534598|NCT01597245|8772014|P8|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
2534599|NCT01597245|8772015|P7|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
2534600|NCT01597245|8772016|P6|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
2534601|NCT01597245|8772017|P5|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
2534602|NCT01597245|8772018|P4|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
2534603|NCT01597245|8772019|P3|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
2534604|NCT01597245|8772020|P2|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
2534605|NCT01597245|8772021|P1|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
2534606|NCT01597245|8772009|P13|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
2534607|NCT01597245|8772010|P12|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
2534608|NCT01597245|8772011|P11|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
2534609|NCT01597245|8772012|P10|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
2534610|NCT01597245|8772013|P9|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
2534611|NCT01597245|8772014|P8|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
2534612|NCT01597245|8772015|P7|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4
2534613|NCT01597245|8772016|P6|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
2534614|NCT01597245|8772017|P5|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3
2534615|NCT01597245|8772018|P4|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
2534616|NCT01597245|8772019|P3|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
2534617|NCT01597245|8772020|P2|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
2534618|NCT01597245|8772021|P1|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
2534619|NCT01597245|8772009|P13|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
2534620|NCT01597245|8772010|P12|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
2534621|NCT01597245|8772011|P11|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2
2534622|NCT01597245|8772012|P10|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
2534623|NCT01597245|8772013|P9|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3
2534624|NCT01597245|8772014|P8|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
2534625|NCT01597245|8772015|P7|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
2534626|NCT01597245|8772016|P6|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
2534627|NCT01597245|8772017|P5|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
2534628|NCT01597245|8772018|P4|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
2534629|NCT01597245|8772019|P3|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
2534630|NCT01597245|8772020|P2|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
2534631|NCT01597245|8772021|P1|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
2534632|NCT01597245|8772009|P13|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
2534633|NCT01597245|8772010|P12|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5
2534634|NCT01597245|8772011|P11|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6
2534635|NCT01597245|8772012|P10|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
2534636|NCT01597245|8772013|P9|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
2534860|NCT01595009|8772714|P1|Extension|Patients completed per protocol|0
2534637|NCT01597245|8772014|P8|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
2534638|NCT01597245|8772015|P7|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
2534639|NCT01597245|8772016|P6|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
2534640|NCT01597245|8772017|P5|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
2534641|NCT01597245|8772018|P4|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
2534642|NCT01597245|8772019|P3|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
2534643|NCT01597245|8772020|P2|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
2534644|NCT01597245|8772021|P1|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
2534645|NCT01597245|8772009|P13|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
2534646|NCT01597245|8772010|P12|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
2534647|NCT01597245|8772011|P11|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
2534648|NCT01597245|8772012|P10|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
2534649|NCT01597245|8772013|P9|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
2534650|NCT01597245|8772014|P8|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
2534651|NCT01597245|8772015|P7|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
2534652|NCT01597245|8772016|P6|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
2534653|NCT01597245|8772017|P5|Maintenance Period (Week 12 to Week 60)|Adverse Event|4
2534654|NCT01597245|8772018|P4|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
2534655|NCT01597245|8772019|P3|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
2534656|NCT01597245|8772020|P2|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
2534657|NCT01597245|8772021|P1|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
2534658|NCT01597245|8772009|P13|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4
2534659|NCT01597245|8772010|P12|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10
2534660|NCT01597245|8772011|P11|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2
2534661|NCT01597245|8772012|P10|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
2534662|NCT01597245|8772013|P9|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3
2534663|NCT01597245|8772014|P8|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
2534664|NCT01597245|8772015|P7|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1
2534665|NCT01597245|8772016|P6|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
2534666|NCT01597245|8772017|P5|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
2534667|NCT01597245|8772018|P4|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
2534668|NCT01597245|8772019|P3|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
2534669|NCT01597245|8772020|P2|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
2534670|NCT01597245|8772021|P1|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
2534671|NCT01597245|8772009|P13|Maintenance Period (Week 12 to Week 60)|Relapsed|0
2534672|NCT01597245|8772010|P12|Maintenance Period (Week 12 to Week 60)|Relapsed|0
2534673|NCT01597245|8772011|P11|Maintenance Period (Week 12 to Week 60)|Relapsed|0
2534674|NCT01597245|8772012|P10|Maintenance Period (Week 12 to Week 60)|Relapsed|111
2534675|NCT01597245|8772013|P9|Maintenance Period (Week 12 to Week 60)|Relapsed|0
2534676|NCT01597245|8772014|P8|Maintenance Period (Week 12 to Week 60)|Relapsed|2
2534677|NCT01597245|8772015|P7|Maintenance Period (Week 12 to Week 60)|Relapsed|21
2534678|NCT01597245|8772016|P6|Maintenance Period (Week 12 to Week 60)|Relapsed|80
2534679|NCT01597245|8772017|P5|Maintenance Period (Week 12 to Week 60)|Relapsed|148
2534680|NCT01597245|8772018|P4|Maintenance Period (Week 12 to Week 60)|Relapsed|0
2534681|NCT01597245|8772019|P3|Maintenance Period (Week 12 to Week 60)|Relapsed|0
2534682|NCT01597245|8772020|P2|Maintenance Period (Week 12 to Week 60)|Relapsed|0
2534683|NCT01597245|8772021|P1|Maintenance Period (Week 12 to Week 60)|Relapsed|0
2534684|NCT01597245|8772009|P13|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2534685|NCT01597245|8772010|P12|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2534686|NCT01597245|8772011|P11|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2534687|NCT01597245|8772012|P10|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2534688|NCT01597245|8772013|P9|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2534689|NCT01597245|8772014|P8|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2534690|NCT01597245|8772015|P7|Maintenance Period (Week 12 to Week 60)|On study treatment|1
2534691|NCT01597245|8772016|P6|Maintenance Period (Week 12 to Week 60)|On study treatment|1
2534692|NCT01597245|8772017|P5|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2534693|NCT01597245|8772018|P4|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2534694|NCT01597245|8772019|P3|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2534695|NCT01597245|8772020|P2|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2534696|NCT01597245|8772021|P1|Maintenance Period (Week 12 to Week 60)|On study treatment|0
2534697|NCT01597245|8772009|P13|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2534698|NCT01597245|8772010|P12|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2534699|NCT01597245|8772011|P11|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2534700|NCT01597245|8772012|P10|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2534701|NCT01597245|8772013|P9|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2534702|NCT01597245|8772014|P8|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2534703|NCT01597245|8772015|P7|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2534704|NCT01597245|8772016|P6|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2534705|NCT01597245|8772017|P5|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2534706|NCT01597245|8772018|P4|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
2534707|NCT01597245|8772019|P3|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1
2534708|NCT01597245|8772020|P2|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
2534709|NCT01597245|8772021|P1|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
2534710|NCT01597245|8772009|P13|Induction Period (Week 0 - Week 12)|Physician Decision|0
2534711|NCT01597245|8772010|P12|Induction Period (Week 0 - Week 12)|Physician Decision|0
2534712|NCT01597245|8772011|P11|Induction Period (Week 0 - Week 12)|Physician Decision|0
2534713|NCT01597245|8772012|P10|Induction Period (Week 0 - Week 12)|Physician Decision|0
2534714|NCT01597245|8772013|P9|Induction Period (Week 0 - Week 12)|Physician Decision|0
2534715|NCT01597245|8772014|P8|Induction Period (Week 0 - Week 12)|Physician Decision|0
2534716|NCT01597245|8772015|P7|Induction Period (Week 0 - Week 12)|Physician Decision|0
2534717|NCT01597245|8772016|P6|Induction Period (Week 0 - Week 12)|Physician Decision|0
2534718|NCT01597245|8772017|P5|Induction Period (Week 0 - Week 12)|Physician Decision|0
2534719|NCT01597245|8772018|P4|Induction Period (Week 0 - Week 12)|Physician Decision|1
2534720|NCT01597245|8772019|P3|Induction Period (Week 0 - Week 12)|Physician Decision|0
2534721|NCT01597245|8772020|P2|Induction Period (Week 0 - Week 12)|Physician Decision|0
2534722|NCT01597245|8772021|P1|Induction Period (Week 0 - Week 12)|Physician Decision|1
2534723|NCT01597245|8772009|P13|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2534724|NCT01597245|8772010|P12|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2534725|NCT01597245|8772011|P11|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2534726|NCT01597245|8772012|P10|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2534727|NCT01597245|8772013|P9|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2534728|NCT01597245|8772014|P8|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2534729|NCT01597245|8772015|P7|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2534730|NCT01597245|8772016|P6|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2534731|NCT01597245|8772017|P5|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2534732|NCT01597245|8772018|P4|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
2534733|NCT01597245|8772019|P3|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2
2534734|NCT01597245|8772020|P2|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5
2534735|NCT01597245|8772021|P1|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1
2534736|NCT01597245|8772009|P13|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2534737|NCT01597245|8772010|P12|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2534738|NCT01597245|8772011|P11|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2534739|NCT01597245|8772012|P10|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2534740|NCT01597245|8772013|P9|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2534741|NCT01597245|8772014|P8|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2534742|NCT01597245|8772015|P7|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2534743|NCT01597245|8772016|P6|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2534744|NCT01597245|8772017|P5|Induction Period (Week 0 - Week 12)|Protocol Violation|0
2534745|NCT01597245|8772018|P4|Induction Period (Week 0 - Week 12)|Protocol Violation|2
2534746|NCT01597245|8772019|P3|Induction Period (Week 0 - Week 12)|Protocol Violation|5
2534747|NCT01597245|8772020|P2|Induction Period (Week 0 - Week 12)|Protocol Violation|4
2534748|NCT01597245|8772021|P1|Induction Period (Week 0 - Week 12)|Protocol Violation|2
2534749|NCT01597245|8772009|P13|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2534750|NCT01597245|8772010|P12|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2534751|NCT01597245|8772011|P11|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2534752|NCT01597245|8772012|P10|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2534753|NCT01597245|8772013|P9|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2534754|NCT01597245|8772014|P8|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2534755|NCT01597245|8772015|P7|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2534756|NCT01597245|8772016|P6|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2534757|NCT01597245|8772017|P5|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
2534758|NCT01597245|8772018|P4|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
2534759|NCT01597245|8772019|P3|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6
2534760|NCT01597245|8772020|P2|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8
2534761|NCT01597245|8772021|P1|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
2534762|NCT01597245|8772009|P13|Induction Period (Week 0 - Week 12)|Adverse Event|0
2534763|NCT01597245|8772010|P12|Induction Period (Week 0 - Week 12)|Adverse Event|0
2534764|NCT01597245|8772011|P11|Induction Period (Week 0 - Week 12)|Adverse Event|0
2534765|NCT01597245|8772012|P10|Induction Period (Week 0 - Week 12)|Adverse Event|0
2534766|NCT01597245|8772013|P9|Induction Period (Week 0 - Week 12)|Adverse Event|0
2534767|NCT01597245|8772014|P8|Induction Period (Week 0 - Week 12)|Adverse Event|0
2534768|NCT01597245|8772015|P7|Induction Period (Week 0 - Week 12)|Adverse Event|0
2534769|NCT01597245|8772016|P6|Induction Period (Week 0 - Week 12)|Adverse Event|0
2534770|NCT01597245|8772017|P5|Induction Period (Week 0 - Week 12)|Adverse Event|0
2534771|NCT01597245|8772018|P4|Induction Period (Week 0 - Week 12)|Adverse Event|4
2534772|NCT01597245|8772019|P3|Induction Period (Week 0 - Week 12)|Adverse Event|5
2534773|NCT01597245|8772020|P2|Induction Period (Week 0 - Week 12)|Adverse Event|5
2534774|NCT01597245|8772021|P1|Induction Period (Week 0 - Week 12)|Adverse Event|1
2534775|NCT01597193|8772111|P7|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
2534776|NCT01597193|8772112|P6|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1
2534777|NCT01597193|8772113|P5|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
2534778|NCT01597193|8772114|P4|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1
2534779|NCT01597193|8772115|P3|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
2534780|NCT01597193|8772116|P2|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
2534781|NCT01597193|8772117|P1|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
2534782|NCT01597193|8772111|P7|Stage 2: Dose Expansion (1067 Days)|Other|0
2534783|NCT01597193|8772112|P6|Stage 2: Dose Expansion (1067 Days)|Other|1
2534784|NCT01597193|8772113|P5|Stage 2: Dose Expansion (1067 Days)|Other|0
2534785|NCT01597193|8772114|P4|Stage 2: Dose Expansion (1067 Days)|Other|0
2534786|NCT01597193|8772115|P3|Stage 2: Dose Expansion (1067 Days)|Other|0
2534787|NCT01597193|8772116|P2|Stage 2: Dose Expansion (1067 Days)|Other|0
2534788|NCT01597193|8772117|P1|Stage 2: Dose Expansion (1067 Days)|Other|0
2534789|NCT01597193|8772111|P7|Stage 2: Dose Expansion (1067 Days)|Disease progression|11
2534790|NCT01597193|8772112|P6|Stage 2: Dose Expansion (1067 Days)|Disease progression|18
2534791|NCT01597193|8772113|P5|Stage 2: Dose Expansion (1067 Days)|Disease progression|14
2534792|NCT01597193|8772114|P4|Stage 2: Dose Expansion (1067 Days)|Disease progression|18
2534793|NCT01597193|8772115|P3|Stage 2: Dose Expansion (1067 Days)|Disease progression|14
2534794|NCT01597193|8772116|P2|Stage 2: Dose Expansion (1067 Days)|Disease progression|0
2534795|NCT01597193|8772117|P1|Stage 2: Dose Expansion (1067 Days)|Disease progression|0
2534796|NCT01597193|8772111|P7|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
2534797|NCT01597193|8772112|P6|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3
2534798|NCT01597193|8772113|P5|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2
2534799|NCT01597193|8772114|P4|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1
2534800|NCT01597193|8772115|P3|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
2534801|NCT01597193|8772116|P2|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
2534802|NCT01597193|8772117|P1|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
2534803|NCT01597193|8772111|P7|Stage 1: Dose Escalation (141 Days)|Disease progression|0
2534804|NCT01597193|8772112|P6|Stage 1: Dose Escalation (141 Days)|Disease progression|0
2534805|NCT01597193|8772113|P5|Stage 1: Dose Escalation (141 Days)|Disease progression|0
2534806|NCT01597193|8772114|P4|Stage 1: Dose Escalation (141 Days)|Disease progression|0
2534807|NCT01597193|8772115|P3|Stage 1: Dose Escalation (141 Days)|Disease progression|0
2534808|NCT01597193|8772116|P2|Stage 1: Dose Escalation (141 Days)|Disease progression|8
2534809|NCT01597193|8772117|P1|Stage 1: Dose Escalation (141 Days)|Disease progression|7
2534810|NCT01597050|8772236|P2|Overall Study|Withdrawal by Subject|0
2534811|NCT01597050|8772237|P1|Overall Study|Withdrawal by Subject|1
2534812|NCT01596972|8772245|P2|Overall Study|Withdrawal by Subject|1
2534813|NCT01596972|8772246|P1|Overall Study|Withdrawal by Subject|0
2534814|NCT01596972|8772245|P2|Overall Study|Lost to Follow-up|4
2534815|NCT01596972|8772246|P1|Overall Study|Lost to Follow-up|0
2534816|NCT01596972|8772245|P2|Overall Study|Physician Decision|9
2534817|NCT01596972|8772246|P1|Overall Study|Physician Decision|1
2534818|NCT01596582|8772282|P2|Overall Study|Missing all outcome data|1
2534819|NCT01596582|8772283|P1|Overall Study|Missing all outcome data|1
2534820|NCT01596582|8772282|P2|Overall Study|Deemed ineligible after study visit|6
2534821|NCT01596582|8772283|P1|Overall Study|Deemed ineligible after study visit|3
2534822|NCT01596504|8772310|P3|Overall Study|Withdrawal by Subject|0
2534823|NCT01596504|8772311|P2|Overall Study|Withdrawal by Subject|0
2534824|NCT01596504|8772312|P1|Overall Study|Withdrawal by Subject|1
2534825|NCT01596504|8772310|P3|Overall Study|Adverse Event|1
2534826|NCT01596504|8772311|P2|Overall Study|Adverse Event|2
2534827|NCT01596504|8772312|P1|Overall Study|Adverse Event|1
2534828|NCT01596504|8772310|P3|Overall Study|Participant's Private Reason|0
2534829|NCT01596504|8772311|P2|Overall Study|Participant's Private Reason|1
2534830|NCT01596504|8772312|P1|Overall Study|Participant's Private Reason|0
2534831|NCT01596335|8772370|P2|Overall Study|exacerbation of primary disease|9
2534832|NCT01596335|8772371|P1|Overall Study|exacerbation of primary disease|5
2534833|NCT01596127|8772407|P1|Overall Study|Patient Ineligible|1
2534834|NCT01596062|8772419|P3|Overall Study|Lack of Efficacy|1
2534835|NCT01596062|8772420|P2|Overall Study|Lack of Efficacy|0
2534836|NCT01596062|8772421|P1|Overall Study|Lack of Efficacy|0
2534837|NCT01596062|8772419|P3|Overall Study|Adverse Event|2
2534838|NCT01596062|8772420|P2|Overall Study|Adverse Event|0
2534839|NCT01596062|8772421|P1|Overall Study|Adverse Event|1
2534840|NCT01595646|8772485|P3|Overall Study|Withdrawal by Subject|0
2534841|NCT01595646|8772486|P2|Overall Study|Withdrawal by Subject|0
2534842|NCT01595646|8772487|P1|Overall Study|Withdrawal by Subject|1
2534843|NCT01595438|8772542|P2|Overall Study|Other Eligibility criteria|9
2534844|NCT01595438|8772543|P1|Overall Study|Other Eligibility criteria|11
2534845|NCT01595438|8772542|P2|Overall Study|Withdrawal by Subject|12
2534846|NCT01595438|8772543|P1|Overall Study|Withdrawal by Subject|12
2534847|NCT01595438|8772542|P2|Overall Study|Lost to Follow-up|20
2534848|NCT01595438|8772543|P1|Overall Study|Lost to Follow-up|20
2534849|NCT01595009|8772711|P4|Extension|Adverse Event|1
2534850|NCT01595009|8772712|P3|Extension|Adverse Event|0
2534851|NCT01595009|8772713|P2|Extension|Adverse Event|0
2534852|NCT01595009|8772714|P1|Extension|Adverse Event|0
2534853|NCT01595009|8772711|P4|Extension|Disease progression|7
2534854|NCT01595009|8772712|P3|Extension|Disease progression|4
2534855|NCT01595009|8772713|P2|Extension|Disease progression|0
2534856|NCT01595009|8772714|P1|Extension|Disease progression|0
2534857|NCT01595009|8772711|P4|Extension|Patients completed per protocol|2
2534858|NCT01595009|8772712|P3|Extension|Patients completed per protocol|0
2534859|NCT01595009|8772713|P2|Extension|Patients completed per protocol|0
2534861|NCT01595009|8772711|P4|Extension|Administrative problems|1
2534862|NCT01595009|8772712|P3|Extension|Administrative problems|0
2534863|NCT01595009|8772713|P2|Extension|Administrative problems|0
2534864|NCT01595009|8772714|P1|Extension|Administrative problems|0
2534865|NCT01595009|8772711|P4|Core|Administrative problems|0
2534866|NCT01595009|8772712|P3|Core|Administrative problems|0
2534867|NCT01595009|8772713|P2|Core|Administrative problems|1
2534868|NCT01595009|8772714|P1|Core|Administrative problems|0
2534869|NCT01595009|8772711|P4|Core|Protocol deviation|0
2534870|NCT01595009|8772712|P3|Core|Protocol deviation|0
2534871|NCT01595009|8772713|P2|Core|Protocol deviation|1
2534872|NCT01595009|8772714|P1|Core|Protocol deviation|0
2534873|NCT01595009|8772711|P4|Core|Lost to Follow-up|0
2534874|NCT01595009|8772712|P3|Core|Lost to Follow-up|0
2534875|NCT01595009|8772713|P2|Core|Lost to Follow-up|2
2534876|NCT01595009|8772714|P1|Core|Lost to Follow-up|1
2534877|NCT01595009|8772711|P4|Core|Death|0
2534878|NCT01595009|8772712|P3|Core|Death|0
2534879|NCT01595009|8772713|P2|Core|Death|6
2534880|NCT01595009|8772714|P1|Core|Death|3
2534881|NCT01595009|8772711|P4|Core|Withdrawal by Subject|0
2534882|NCT01595009|8772712|P3|Core|Withdrawal by Subject|0
2534883|NCT01595009|8772713|P2|Core|Withdrawal by Subject|17
2534884|NCT01595009|8772714|P1|Core|Withdrawal by Subject|4
2534885|NCT01595009|8772711|P4|Core|Disease progression|0
2534886|NCT01595009|8772712|P3|Core|Disease progression|0
2534887|NCT01595009|8772713|P2|Core|Disease progression|26
2534888|NCT01595009|8772714|P1|Core|Disease progression|14
2534889|NCT01595009|8772711|P4|Core|Adverse Event|0
2534890|NCT01595009|8772712|P3|Core|Adverse Event|0
2534891|NCT01595009|8772713|P2|Core|Adverse Event|23
2534892|NCT01595009|8772714|P1|Core|Adverse Event|19
2534893|NCT01595009|8772711|P4|Core|Patients completed per protocol|0
2534894|NCT01595009|8772712|P3|Core|Patients completed per protocol|0
2534895|NCT01595009|8772713|P2|Core|Patients completed per protocol|44
2534896|NCT01595009|8772714|P1|Core|Patients completed per protocol|85
2534897|NCT01594970|8772749|P3|Overall Study|Lost to Follow-up|37
2534898|NCT01594970|8772750|P2|Overall Study|Lost to Follow-up|54
2534899|NCT01594970|8772751|P1|Overall Study|Lost to Follow-up|54
2534900|NCT01594970|8772749|P3|Overall Study|Adverse Event|23
2534901|NCT01594970|8772750|P2|Overall Study|Adverse Event|23
2534902|NCT01594970|8772751|P1|Overall Study|Adverse Event|17
2534903|NCT01594970|8772749|P3|Overall Study|Non-Adverse Event Related|6
2534904|NCT01594970|8772750|P2|Overall Study|Non-Adverse Event Related|5
2534905|NCT01594970|8772751|P1|Overall Study|Non-Adverse Event Related|4
2534906|NCT01594853|8772770|P2|Overall Study|noncompliance with exercise|1
2534907|NCT01594853|8772771|P1|Overall Study|noncompliance with exercise|0
2534908|NCT01594853|8772770|P2|Overall Study|Lost to Follow-up|1
2534909|NCT01594853|8772771|P1|Overall Study|Lost to Follow-up|1
2534910|NCT01594853|8772770|P2|Overall Study|Withdrawal by Subject|1
2534911|NCT01594853|8772771|P1|Overall Study|Withdrawal by Subject|1
2534912|NCT01594827|8772779|P2|Overall Study|Physician Decision|0
2534913|NCT01594827|8772780|P1|Overall Study|Physician Decision|3
2534914|NCT01594827|8772779|P2|Overall Study|Adverse Event|0
2534915|NCT01594827|8772780|P1|Overall Study|Adverse Event|1
2534916|NCT01594762|8772804|P2|Overall Study|Lost to Follow-up|10
2534917|NCT01594762|8772805|P1|Overall Study|Lost to Follow-up|10
2534918|NCT01594762|8772804|P2|Overall Study|Withdrawal by Subject|0
2534919|NCT01594762|8772805|P1|Overall Study|Withdrawal by Subject|1
2534920|NCT01594749|8772817|P2|Overall Study|Lost Source Documentation|0
2534921|NCT01594749|8772818|P1|Overall Study|Lost Source Documentation|1
2534922|NCT01594749|8772817|P2|Overall Study|Not Treated|10
2534923|NCT01594749|8772818|P1|Overall Study|Not Treated|4
2534924|NCT01594749|8772817|P2|Overall Study|Death|3
2534925|NCT01594749|8772818|P1|Overall Study|Death|9
2534926|NCT01594749|8772817|P2|Overall Study|Lost to Follow-up|0
2534927|NCT01594749|8772818|P1|Overall Study|Lost to Follow-up|1
2534928|NCT01594749|8772817|P2|Overall Study|Non-compliance with Protocol|1
2534929|NCT01594749|8772818|P1|Overall Study|Non-compliance with Protocol|0
2534930|NCT01594749|8772817|P2|Overall Study|Physician Decision|1
2534931|NCT01594749|8772818|P1|Overall Study|Physician Decision|1
2534932|NCT01594749|8772817|P2|Overall Study|Protocol Violation|0
2534933|NCT01594749|8772818|P1|Overall Study|Protocol Violation|2
2534934|NCT01594749|8772817|P2|Overall Study|Withdrawal by Subject|2
2534935|NCT01594749|8772818|P1|Overall Study|Withdrawal by Subject|2
2534936|NCT01594749|8772817|P2|Overall Study|Adverse Event|1
2534937|NCT01594749|8772818|P1|Overall Study|Adverse Event|2
2534938|NCT01594476|8772956|P2|Overall Study|Protocol Violation|3
2534939|NCT01594476|8772957|P1|Overall Study|Protocol Violation|1
2534940|NCT01594411|8772979|P1|Overall Study|Lost to Follow-up|2
2534941|NCT01594281|8773031|P3|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1
2534942|NCT01594281|8773032|P2|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0
2534943|NCT01594281|8773033|P1|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1
2534944|NCT01594281|8773031|P3|Non-Interventional Follow Up Phase|Administrative Problems|1
2534945|NCT01594281|8773032|P2|Non-Interventional Follow Up Phase|Administrative Problems|0
2534946|NCT01594281|8773033|P1|Non-Interventional Follow Up Phase|Administrative Problems|0
2534947|NCT01594281|8773031|P3|Non-Interventional Follow Up Phase|Lost to Follow-up|0
2534948|NCT01594281|8773032|P2|Non-Interventional Follow Up Phase|Lost to Follow-up|2
2534949|NCT01594281|8773033|P1|Non-Interventional Follow Up Phase|Lost to Follow-up|2
2534950|NCT01594281|8773031|P3|Interventional Core Phase|Adverse Event|4
2534951|NCT01594281|8773032|P2|Interventional Core Phase|Adverse Event|4
2534952|NCT01594281|8773033|P1|Interventional Core Phase|Adverse Event|4
2534953|NCT01594281|8773031|P3|Interventional Core Phase|Lost to Follow-up|1
2534954|NCT01594281|8773032|P2|Interventional Core Phase|Lost to Follow-up|4
2534955|NCT01594281|8773033|P1|Interventional Core Phase|Lost to Follow-up|1
2534956|NCT01594281|8773031|P3|Interventional Core Phase|Death|2
2534957|NCT01594281|8773032|P2|Interventional Core Phase|Death|1
2534958|NCT01594281|8773033|P1|Interventional Core Phase|Death|1
2534959|NCT01594281|8773031|P3|Interventional Core Phase|Subject Withdrew Consent|1
2534960|NCT01594281|8773032|P2|Interventional Core Phase|Subject Withdrew Consent|1
2534961|NCT01594281|8773033|P1|Interventional Core Phase|Subject Withdrew Consent|0
2534962|NCT01594281|8773031|P3|Interventional Core Phase|Protocol Deviation|0
2534963|NCT01594281|8773032|P2|Interventional Core Phase|Protocol Deviation|0
2534964|NCT01594281|8773033|P1|Interventional Core Phase|Protocol Deviation|1
2534965|NCT01594125|8773073|P5|Overall Study|Progressive Disease|7
2534966|NCT01594125|8773074|P4|Overall Study|Progressive Disease|3
2534967|NCT01594125|8773075|P3|Overall Study|Progressive Disease|3
2534968|NCT01594125|8773076|P2|Overall Study|Progressive Disease|12
2534969|NCT01594125|8773077|P1|Overall Study|Progressive Disease|3
2534970|NCT01594125|8773073|P5|Overall Study|Withdrawal by Subject|0
2534971|NCT01594125|8773074|P4|Overall Study|Withdrawal by Subject|1
2534972|NCT01594125|8773075|P3|Overall Study|Withdrawal by Subject|0
2534973|NCT01594125|8773076|P2|Overall Study|Withdrawal by Subject|0
2534974|NCT01594125|8773077|P1|Overall Study|Withdrawal by Subject|1
2534975|NCT01593787|8773137|P3|Overall Study|Adverse Event|0
2534976|NCT01593787|8773138|P2|Overall Study|Adverse Event|0
2534977|NCT01593787|8773139|P1|Overall Study|Adverse Event|1
2534978|NCT01593254|8773234|P2|Follow-Up Period|Study Drug Side Effects|1
2534979|NCT01593254|8773235|P1|Follow-Up Period|Study Drug Side Effects|0
2534980|NCT01593254|8773234|P2|Follow-Up Period|Disease Progression|1
2534981|NCT01593254|8773235|P1|Follow-Up Period|Disease Progression|0
2534982|NCT01593254|8773234|P2|Follow-Up Period|Fundus Hemorrhage|1
2534983|NCT01593254|8773235|P1|Follow-Up Period|Fundus Hemorrhage|0
2534984|NCT01593254|8773234|P2|Follow-Up Period|Patient refused to return|1
2534985|NCT01593254|8773235|P1|Follow-Up Period|Patient refused to return|0
2534986|NCT01593254|8773234|P2|Follow-Up Period|Study Drug Toxicity|1
2534987|NCT01593254|8773235|P1|Follow-Up Period|Study Drug Toxicity|0
2534988|NCT01593254|8773234|P2|Follow-Up Period|Pregnancy|1
2534989|NCT01593254|8773235|P1|Follow-Up Period|Pregnancy|0
2534990|NCT01593254|8773234|P2|Follow-Up Period|Subject request to Discontinue|1
2534991|NCT01593254|8773235|P1|Follow-Up Period|Subject request to Discontinue|0
2534992|NCT01593254|8773234|P2|Follow-Up Period|Death|2
2534993|NCT01593254|8773235|P1|Follow-Up Period|Death|2
2534994|NCT01593254|8773234|P2|Follow-Up Period|Non-Compliance|0
2534995|NCT01593254|8773235|P1|Follow-Up Period|Non-Compliance|1
2534996|NCT01593254|8773234|P2|Follow-Up Period|Withdrawal by Subject|2
2534997|NCT01593254|8773235|P1|Follow-Up Period|Withdrawal by Subject|0
2534998|NCT01593254|8773234|P2|Treatment Period|Investigator Decision|1
2534999|NCT01593254|8773235|P1|Treatment Period|Investigator Decision|2
2535000|NCT01593254|8773234|P2|Treatment Period|T315I MUTATION|1
2535001|NCT01593254|8773235|P1|Treatment Period|T315I MUTATION|0
2535002|NCT01593254|8773234|P2|Treatment Period|No Response|0
2535003|NCT01593254|8773235|P1|Treatment Period|No Response|1
2535004|NCT01593254|8773234|P2|Treatment Period|Patient Refused to Return|1
2535005|NCT01593254|8773235|P1|Treatment Period|Patient Refused to Return|0
2535006|NCT01593254|8773234|P2|Treatment Period|Did Not Achieve RCC|1
2535007|NCT01593254|8773235|P1|Treatment Period|Did Not Achieve RCC|0
2535008|NCT01593254|8773234|P2|Treatment Period|Disease Progression|6
2535009|NCT01593254|8773235|P1|Treatment Period|Disease Progression|1
2535010|NCT01593254|8773234|P2|Treatment Period|Study Drug Toxicity|9
2535011|NCT01593254|8773235|P1|Treatment Period|Study Drug Toxicity|3
2535012|NCT01593254|8773234|P2|Treatment Period|Death|1
2535013|NCT01593254|8773235|P1|Treatment Period|Death|2
2535014|NCT01593254|8773234|P2|Treatment Period|AE unrelated to Study Drug|1
2535015|NCT01593254|8773235|P1|Treatment Period|AE unrelated to Study Drug|0
2535016|NCT01593254|8773234|P2|Treatment Period|Subject Request to Discontinue|1
2535017|NCT01593254|8773235|P1|Treatment Period|Subject Request to Discontinue|1
2535018|NCT01593254|8773234|P2|Treatment Period|Subject withdrew consent|5
2535019|NCT01593254|8773235|P1|Treatment Period|Subject withdrew consent|0
2535020|NCT01593254|8773234|P2|Treatment Period|Maximum clinical benefit|0
2535021|NCT01593254|8773235|P1|Treatment Period|Maximum clinical benefit|1
2535022|NCT01593254|8773234|P2|Treatment Period|Poor/Non-Compliance|1
2535023|NCT01593254|8773235|P1|Treatment Period|Poor/Non-Compliance|2
2535024|NCT01593254|8773234|P2|Treatment Period|Pregnancy|1
2535025|NCT01593254|8773235|P1|Treatment Period|Pregnancy|0
2535026|NCT01593254|8773234|P2|Treatment Period|Treatment Failure|2
2535027|NCT01593254|8773235|P1|Treatment Period|Treatment Failure|1
2535028|NCT01592864|8773253|P2|Overall Study|Withdrawal by Subject|1
2535029|NCT01592864|8773254|P1|Overall Study|Withdrawal by Subject|0
2535030|NCT01592786|8773315|P1|Overall Study|Other|3
2535031|NCT01592786|8773315|P1|Overall Study|Lost to Follow-up|19
2535032|NCT01592786|8773315|P1|Overall Study|Withdrawal by Subject|23
2535033|NCT01592786|8773315|P1|Overall Study|Protocol Violation|14
2535034|NCT01592786|8773315|P1|Overall Study|Lack of Efficacy|19
2535035|NCT01592786|8773315|P1|Overall Study|Adverse Event|60
2535036|NCT01592773|8773319|P1|Overall Study|Other Reason|1
2535037|NCT01592773|8773319|P1|Overall Study|Inclusion/exclusion not meet|1
2535038|NCT01592773|8773319|P1|Overall Study|Protocol Violation|2
2535039|NCT01592773|8773319|P1|Overall Study|Lack of Efficacy|9
2535040|NCT01592773|8773319|P1|Overall Study|Adverse Event|17
2535041|NCT01592773|8773319|P1|Overall Study|Lost to Follow-up|19
2535042|NCT01592773|8773319|P1|Overall Study|Withdrawal by Subject|35
2535043|NCT01592773|8773319|P1|Overall Study|Study Terminated by Sponsor|582
2535044|NCT01592760|8773326|P3|24-hour Follow-Up|Lost to Follow-up|2
2535045|NCT01592760|8773327|P2|24-hour Follow-Up|Lost to Follow-up|3
2535046|NCT01592760|8773328|P1|24-hour Follow-Up|Lost to Follow-up|4
2535047|NCT01592747|8773372|P3|Overall Study|Other Reasons|0
2535048|NCT01592747|8773373|P2|Overall Study|Other Reasons|1
2535049|NCT01592747|8773374|P1|Overall Study|Other Reasons|1
2535050|NCT01592747|8773372|P3|Overall Study|Lost to Follow-up|1
2535051|NCT01592747|8773373|P2|Overall Study|Lost to Follow-up|0
2535052|NCT01592747|8773374|P1|Overall Study|Lost to Follow-up|1
2535053|NCT01592747|8773372|P3|Overall Study|Withdrawal by Subject|2
2535054|NCT01592747|8773373|P2|Overall Study|Withdrawal by Subject|0
2535055|NCT01592747|8773374|P1|Overall Study|Withdrawal by Subject|2
2535056|NCT01592747|8773372|P3|Overall Study|Lack of Efficacy|0
2535057|NCT01592747|8773373|P2|Overall Study|Lack of Efficacy|1
2535058|NCT01592747|8773374|P1|Overall Study|Lack of Efficacy|0
2535059|NCT01592747|8773372|P3|Overall Study|Protocol Violation|4
2535060|NCT01592747|8773373|P2|Overall Study|Protocol Violation|0
2535061|NCT01592747|8773374|P1|Overall Study|Protocol Violation|4
2535062|NCT01592747|8773372|P3|Overall Study|Adverse Event|0
2535063|NCT01592747|8773373|P2|Overall Study|Adverse Event|0
2535064|NCT01592747|8773374|P1|Overall Study|Adverse Event|1
2535065|NCT01592747|8773372|P3|Overall Study|Inclusion/Exclusion criteria not met|1
2535066|NCT01592747|8773373|P2|Overall Study|Inclusion/Exclusion criteria not met|1
2535067|NCT01592747|8773374|P1|Overall Study|Inclusion/Exclusion criteria not met|0
2535068|NCT01592747|8773372|P3|Overall Study|Loss of Therapeutic Response|100
2535069|NCT01592747|8773373|P2|Overall Study|Loss of Therapeutic Response|108
2535070|NCT01592747|8773374|P1|Overall Study|Loss of Therapeutic Response|107
2535071|NCT01592708|8773417|P2|Overall Study|Protocol Violation|0
2535072|NCT01592708|8773418|P1|Overall Study|Protocol Violation|3
2535073|NCT01592695|8773434|P2|Overall Study|Lost to Follow-up|4
2535074|NCT01592695|8773435|P1|Overall Study|Lost to Follow-up|8
2535075|NCT01592409|8773490|P2|Overall Study|Withdrawal by Subject|1
2535076|NCT01592409|8773491|P1|Overall Study|Withdrawal by Subject|0
2535077|NCT01592383|8773515|P1|Overall Study|Adverse Event|1
2535078|NCT01592344|8773526|P2|Overall Study|not available at primary outcome visit|4
2535079|NCT01592344|8773527|P1|Overall Study|not available at primary outcome visit|2
2535080|NCT01592344|8773526|P2|Overall Study|Lack of Efficacy|0
2535081|NCT01592344|8773527|P1|Overall Study|Lack of Efficacy|1
2535082|NCT01592344|8773526|P2|Overall Study|Adverse Event|1
2535083|NCT01592344|8773527|P1|Overall Study|Adverse Event|1
2535084|NCT01592292|8773541|P4|Overall Study|Other|1
2535085|NCT01592292|8773542|P3|Overall Study|Other|2
2535086|NCT01592292|8773543|P2|Overall Study|Other|1
2535087|NCT01592292|8773544|P1|Overall Study|Other|1
2535088|NCT01592292|8773541|P4|Overall Study|Withdrew consent|0
2535089|NCT01592292|8773542|P3|Overall Study|Withdrew consent|0
2535090|NCT01592292|8773543|P2|Overall Study|Withdrew consent|1
2535091|NCT01592292|8773544|P1|Overall Study|Withdrew consent|2
2535092|NCT01592292|8773541|P4|Overall Study|Follow-up loss|0
2535093|NCT01592292|8773542|P3|Overall Study|Follow-up loss|1
2535094|NCT01592292|8773543|P2|Overall Study|Follow-up loss|3
2535095|NCT01592292|8773544|P1|Overall Study|Follow-up loss|3
2535096|NCT01592240|8773583|P7|Overall Study|Did Not Meet Entrance Criteria|0
2535097|NCT01592240|8773584|P6|Overall Study|Did Not Meet Entrance Criteria|0
2535098|NCT01592240|8773585|P5|Overall Study|Did Not Meet Entrance Criteria|0
2535099|NCT01592240|8773586|P4|Overall Study|Did Not Meet Entrance Criteria|0
2535100|NCT01592240|8773587|P3|Overall Study|Did Not Meet Entrance Criteria|1
2535101|NCT01592240|8773588|P2|Overall Study|Did Not Meet Entrance Criteria|0
2535102|NCT01592240|8773589|P1|Overall Study|Did Not Meet Entrance Criteria|1
2535103|NCT01592240|8773583|P7|Overall Study|Other|1
2535104|NCT01592240|8773584|P6|Overall Study|Other|0
2535105|NCT01592240|8773585|P5|Overall Study|Other|0
2535106|NCT01592240|8773586|P4|Overall Study|Other|1
2535107|NCT01592240|8773587|P3|Overall Study|Other|1
2535108|NCT01592240|8773588|P2|Overall Study|Other|3
2535109|NCT01592240|8773589|P1|Overall Study|Other|0
2535110|NCT01592240|8773583|P7|Overall Study|Withdrawal by Subject|2
2535111|NCT01592240|8773584|P6|Overall Study|Withdrawal by Subject|0
2535112|NCT01592240|8773585|P5|Overall Study|Withdrawal by Subject|3
2535113|NCT01592240|8773586|P4|Overall Study|Withdrawal by Subject|1
2535114|NCT01592240|8773587|P3|Overall Study|Withdrawal by Subject|4
2535115|NCT01592240|8773588|P2|Overall Study|Withdrawal by Subject|4
2535116|NCT01592240|8773589|P1|Overall Study|Withdrawal by Subject|0
2535117|NCT01592240|8773583|P7|Overall Study|Protocol Violation|0
2535118|NCT01592240|8773584|P6|Overall Study|Protocol Violation|1
2535119|NCT01592240|8773585|P5|Overall Study|Protocol Violation|0
2535120|NCT01592240|8773586|P4|Overall Study|Protocol Violation|0
2535121|NCT01592240|8773587|P3|Overall Study|Protocol Violation|0
2535122|NCT01592240|8773588|P2|Overall Study|Protocol Violation|0
2535123|NCT01592240|8773589|P1|Overall Study|Protocol Violation|0
2535124|NCT01592240|8773583|P7|Overall Study|Lost to Follow-up|0
2535125|NCT01592240|8773584|P6|Overall Study|Lost to Follow-up|2
2535126|NCT01592240|8773585|P5|Overall Study|Lost to Follow-up|3
2535127|NCT01592240|8773586|P4|Overall Study|Lost to Follow-up|0
2535128|NCT01592240|8773587|P3|Overall Study|Lost to Follow-up|1
2535129|NCT01592240|8773588|P2|Overall Study|Lost to Follow-up|3
2535130|NCT01592240|8773589|P1|Overall Study|Lost to Follow-up|1
2535131|NCT01592240|8773583|P7|Overall Study|Death|0
2535132|NCT01592240|8773584|P6|Overall Study|Death|0
2535133|NCT01592240|8773585|P5|Overall Study|Death|0
2535134|NCT01592240|8773586|P4|Overall Study|Death|0
2535135|NCT01592240|8773587|P3|Overall Study|Death|0
2535136|NCT01592240|8773588|P2|Overall Study|Death|1
2535137|NCT01592240|8773589|P1|Overall Study|Death|0
2535138|NCT01592240|8773583|P7|Overall Study|Adverse Event|0
2535139|NCT01592240|8773584|P6|Overall Study|Adverse Event|0
2535140|NCT01592240|8773585|P5|Overall Study|Adverse Event|1
2535141|NCT01592240|8773586|P4|Overall Study|Adverse Event|1
2535142|NCT01592240|8773587|P3|Overall Study|Adverse Event|0
2535143|NCT01592240|8773588|P2|Overall Study|Adverse Event|0
2535144|NCT01592240|8773589|P1|Overall Study|Adverse Event|1
2535145|NCT01592045|8773782|P2|Overall Study|Moved out of country|0
2535146|NCT01592045|8773783|P1|Overall Study|Moved out of country|2
2535147|NCT01592045|8773782|P2|Overall Study|Withdrawal by Subject|0
2535148|NCT01592045|8773783|P1|Overall Study|Withdrawal by Subject|1
2535149|NCT01592045|8773782|P2|Overall Study|Adverse Event|1
2535150|NCT01592045|8773783|P1|Overall Study|Adverse Event|1
2535151|NCT01592045|8773782|P2|Overall Study|Disease Progression|1
2535152|NCT01592045|8773783|P1|Overall Study|Disease Progression|1
2535153|NCT01591863|8773801|P1|Overall Study|Lack of Efficacy|1
2535154|NCT01591863|8773801|P1|Overall Study|recurrence|9
2535155|NCT01591863|8773801|P1|Overall Study|Withdrawal by Subject|1
2535156|NCT01591863|8773801|P1|Overall Study|Adverse Event|3
2535157|NCT01591681|8773858|P1|Overall Study|Failed to use system during run-in|1
2535158|NCT01591681|8773858|P1|Overall Study|Didn't meet min hypoglycemia requirement|3
2535159|NCT01591616|8773884|P1|Overall Study|Withdrawal by Subject|1
2535160|NCT01591499|8774025|P4|Second Intervention (up to 24 Days)|Lost to Follow-up|3
2535161|NCT01591499|8774026|P3|Second Intervention (up to 24 Days)|Lost to Follow-up|1
2535162|NCT01591499|8774027|P2|Second Intervention (up to 24 Days)|Lost to Follow-up|3
2535163|NCT01591499|8774028|P1|Second Intervention (up to 24 Days)|Lost to Follow-up|4
2535164|NCT01591499|8774025|P4|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
2535165|NCT01591499|8774026|P3|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
2535166|NCT01591499|8774027|P2|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
2535167|NCT01591499|8774028|P1|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
2535168|NCT01591499|8774025|P4|Baseline Visit|Withdrawal by Subject|2
2535169|NCT01591499|8774026|P3|Baseline Visit|Withdrawal by Subject|0
2535170|NCT01591499|8774027|P2|Baseline Visit|Withdrawal by Subject|2
2535171|NCT01591499|8774028|P1|Baseline Visit|Withdrawal by Subject|0
2535172|NCT01591460|8774094|P1|Overall Study|Protocol Violation|1
2535173|NCT01591460|8774094|P1|Overall Study|Withdrawal by Subject|1
2535174|NCT01591460|8774094|P1|Overall Study|Participant Refusal|3
2535175|NCT01591460|8774094|P1|Overall Study|Noncompliance|1
2535176|NCT01591460|8774094|P1|Overall Study|Lost to Follow-up|1
2535177|NCT01591460|8774094|P1|Overall Study|Treatment Discontinued by Error|1
2535178|NCT01591460|8774094|P1|Overall Study|Rebound or Breakthrough|3
2535179|NCT01591460|8774094|P1|Overall Study|Futility Rule (Week 24)|3
2535180|NCT01591460|8774094|P1|Overall Study|Futility Rule (Week 12)|7
2535181|NCT01591460|8774094|P1|Overall Study|Adverse Event or Intercurrent Illness|5
2535182|NCT01591382|8774185|P2|Overall Study|Participant Opted for Morphine PCA|1
2535183|NCT01591382|8774186|P1|Overall Study|Participant Opted for Morphine PCA|1
2535184|NCT01591382|8774185|P2|Overall Study|Discharged Prior to Study Completion|1
2535185|NCT01591382|8774186|P1|Overall Study|Discharged Prior to Study Completion|2
2535186|NCT01591096|8774231|P1|Overall Study|Adverse Event|1
2535187|NCT01590888|8774316|P3|Overall Study|Lost to Follow-up|0
2535188|NCT01590888|8774317|P2|Overall Study|Lost to Follow-up|0
2535189|NCT01590888|8774318|P1|Overall Study|Lost to Follow-up|1
2535190|NCT01590888|8774316|P3|Overall Study|Adverse Event|1
2535191|NCT01590888|8774317|P2|Overall Study|Adverse Event|0
2535192|NCT01590888|8774318|P1|Overall Study|Adverse Event|3
2535193|NCT01590810|8774378|P5|Overall Study|Physician Decision|0
2535194|NCT01590810|8774379|P4|Overall Study|Physician Decision|0
2535195|NCT01590810|8774380|P3|Overall Study|Physician Decision|1
2535196|NCT01590810|8774381|P2|Overall Study|Physician Decision|1
2535197|NCT01590810|8774382|P1|Overall Study|Physician Decision|0
2535198|NCT01590797|8774527|P2|Overall Study|Other Protocol Specified Criteria|4
2535199|NCT01590797|8774528|P1|Overall Study|Other Protocol Specified Criteria|2
2535200|NCT01590797|8774527|P2|Overall Study|Withdrawal by Subject|5
2535201|NCT01590797|8774528|P1|Overall Study|Withdrawal by Subject|7
2535202|NCT01590797|8774527|P2|Overall Study|Protocol Violation|1
2535203|NCT01590797|8774528|P1|Overall Study|Protocol Violation|4
2535204|NCT01590797|8774527|P2|Overall Study|Lost to Follow-up|1
2535205|NCT01590797|8774528|P1|Overall Study|Lost to Follow-up|0
2535206|NCT01590797|8774527|P2|Overall Study|Lack of Efficacy|2
2535207|NCT01590797|8774528|P1|Overall Study|Lack of Efficacy|0
2535208|NCT01590797|8774527|P2|Overall Study|Adverse Event|3
2535209|NCT01590797|8774528|P1|Overall Study|Adverse Event|4
2535210|NCT01590771|8774544|P2|Overall Study|Adverse Event|7
2535211|NCT01590771|8774545|P1|Overall Study|Adverse Event|3
2535212|NCT01590771|8774544|P2|Overall Study|Lack of Efficacy|0
2535213|NCT01590771|8774545|P1|Overall Study|Lack of Efficacy|1
2535214|NCT01590771|8774544|P2|Overall Study|Lost to Follow-up|1
2535215|NCT01590771|8774545|P1|Overall Study|Lost to Follow-up|1
2535216|NCT01590771|8774544|P2|Overall Study|Protocol Violation|2
2535217|NCT01590771|8774545|P1|Overall Study|Protocol Violation|1
2535218|NCT01590771|8774544|P2|Overall Study|Withdrawal by Subject|15
2535219|NCT01590771|8774545|P1|Overall Study|Withdrawal by Subject|8
2535220|NCT01590771|8774544|P2|Overall Study|Other Protocol Specified Criteria|14
2535221|NCT01590771|8774545|P1|Overall Study|Other Protocol Specified Criteria|5
2535222|NCT01590758|8774573|P2|Overall Study|Lost to Follow-up|2
2535223|NCT01590758|8774574|P1|Overall Study|Lost to Follow-up|4
2535224|NCT01590758|8774573|P2|Overall Study|Physician Decision|2
2535225|NCT01590758|8774574|P1|Overall Study|Physician Decision|1
2535226|NCT01590758|8774573|P2|Overall Study|Withdrawal by Subject|3
2535227|NCT01590758|8774574|P1|Overall Study|Withdrawal by Subject|0
2535228|NCT01590563|8774584|P1|Overall Study|simple uterine hyperplasia - not related|1
2535229|NCT01590433|8774598|P2|Overall Study|Adverse Event|3
2535230|NCT01590433|8774599|P1|Overall Study|Adverse Event|11
2535231|NCT01590433|8774598|P2|Overall Study|Withdrawal by Subject|11
2535232|NCT01590433|8774599|P1|Overall Study|Withdrawal by Subject|21
2535233|NCT01590433|8774598|P2|Overall Study|Lost to Follow-up|8
2535234|NCT01590433|8774599|P1|Overall Study|Lost to Follow-up|20
2535235|NCT01590212|8774621|P3|Overall Study|Lost to Follow-up|3
2535236|NCT01590212|8774622|P2|Overall Study|Lost to Follow-up|2
2535237|NCT01590212|8774623|P1|Overall Study|Lost to Follow-up|1
2535238|NCT01590212|8774621|P3|Overall Study|Withdrawal by Subject|2
2535239|NCT01590212|8774622|P2|Overall Study|Withdrawal by Subject|2
2535240|NCT01590212|8774623|P1|Overall Study|Withdrawal by Subject|2
2535241|NCT01590017|8774640|P1|Overall Study|Physician Decision|1
2535242|NCT01590017|8774640|P1|Overall Study|Lack of Efficacy|1
2535243|NCT01590017|8774640|P1|Overall Study|Withdrawal by Subject|1
2535244|NCT01590017|8774640|P1|Overall Study|Adverse Event|1
2535245|NCT01589822|8774693|P3|Overall Study|Missed 90 day visit|1
2535246|NCT01589822|8774694|P2|Overall Study|Missed 90 day visit|1
2535247|NCT01589822|8774695|P1|Overall Study|Missed 90 day visit|2
2535248|NCT01589822|8774693|P3|Overall Study|Death|0
2535249|NCT01589822|8774694|P2|Overall Study|Death|0
2535250|NCT01589822|8774695|P1|Overall Study|Death|1
2535251|NCT01589822|8774693|P3|Overall Study|Withdrawal by Subject|0
2535252|NCT01589822|8774694|P2|Overall Study|Withdrawal by Subject|2
2535253|NCT01589822|8774695|P1|Overall Study|Withdrawal by Subject|1
2535254|NCT01589770|8774714|P2|Overall Study|claustrophobic when entering cardiac MRI|1
2535255|NCT01589770|8774715|P1|Overall Study|claustrophobic when entering cardiac MRI|2
2535256|NCT01589770|8774714|P2|Overall Study|EGFR <60ml/min|4
2535257|NCT01589770|8774715|P1|Overall Study|EGFR <60ml/min|6
2535258|NCT01589653|8774725|P2|Overall Study|Unclassified|3
2535259|NCT01589653|8774726|P1|Overall Study|Unclassified|0
2535260|NCT01589653|8774725|P2|Overall Study|Withdrawal criteria|7
2535261|NCT01589653|8774726|P1|Overall Study|Withdrawal criteria|4
2535262|NCT01589653|8774725|P2|Overall Study|Protocol Violation|1
2535263|NCT01589653|8774726|P1|Overall Study|Protocol Violation|3
2535264|NCT01589497|8774776|P4|Overall Study|Pre-entry overnight sputum< 10ML|0
2535265|NCT01589497|8774777|P3|Overall Study|Pre-entry overnight sputum< 10ML|1
2535266|NCT01589497|8774778|P2|Overall Study|Pre-entry overnight sputum< 10ML|0
2535267|NCT01589497|8774779|P1|Overall Study|Pre-entry overnight sputum< 10ML|0
2535268|NCT01589497|8774776|P4|Overall Study|Death|0
2535269|NCT01589497|8774777|P3|Overall Study|Death|0
2535270|NCT01589497|8774778|P2|Overall Study|Death|0
2535271|NCT01589497|8774779|P1|Overall Study|Death|1
2535272|NCT01589497|8774776|P4|Overall Study|Withdrawal by Subject|1
2535273|NCT01589497|8774777|P3|Overall Study|Withdrawal by Subject|0
2535274|NCT01589497|8774778|P2|Overall Study|Withdrawal by Subject|1
2535275|NCT01589497|8774779|P1|Overall Study|Withdrawal by Subject|0
2535276|NCT01589445|8774885|P1|002 (Metformin)-3 Months|Husbands of female patients refrained|2
2535277|NCT01589445|8774885|P1|002 (Metformin)-3 Months|Adverse Event|2
2535278|NCT01589445|8774885|P1|002 (Metformin)-3 Months|Protocol Violation|2
2535279|NCT01589445|8774885|P1|002 (Metformin)-3 Months|Lost to Follow-up|2
2535280|NCT01589445|8774885|P1|002 (Metformin)-3 Months|Lack of Efficacy|1
2535281|NCT01589445|8774885|P1|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2
2535282|NCT01589445|8774885|P1|001 (Pioglitazone) -3 Months|Lack of Efficacy|1
2535283|NCT01589445|8774885|P1|001 (Pioglitazone) -3 Months|Lost to Follow-up|2
2535284|NCT01589445|8774885|P1|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1
2535285|NCT01589445|8774885|P1|001 (Pioglitazone) -3 Months|Protocol Violation|1
2535286|NCT01589237|8774928|P4|Part B (Planned for 78 Week-terminated)|Physician Decision|1
2535287|NCT01589237|8774929|P3|Part B (Planned for 78 Week-terminated)|Physician Decision|0
2535288|NCT01589237|8774930|P2|Part B (Planned for 78 Week-terminated)|Physician Decision|0
2535289|NCT01589237|8774931|P1|Part B (Planned for 78 Week-terminated)|Physician Decision|0
2535290|NCT01589237|8774928|P4|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3
2535291|NCT01589237|8774929|P3|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4
2535292|NCT01589237|8774930|P2|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
2535293|NCT01589237|8774931|P1|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
2535294|NCT01589237|8774928|P4|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
2535295|NCT01589237|8774929|P3|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
2535296|NCT01589237|8774930|P2|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1
2535297|NCT01589237|8774931|P1|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
2535298|NCT01589237|8774928|P4|Part A (52 Weeks)|Subject/guardian decision|0
2535299|NCT01589237|8774929|P3|Part A (52 Weeks)|Subject/guardian decision|2
2535300|NCT01589237|8774930|P2|Part A (52 Weeks)|Subject/guardian decision|3
2535301|NCT01589237|8774931|P1|Part A (52 Weeks)|Subject/guardian decision|2
2535302|NCT01589185|8774982|P5|Overall Study|Lost to Follow-up|0
2535303|NCT01589185|8774983|P4|Overall Study|Lost to Follow-up|3
2535304|NCT01589185|8774984|P3|Overall Study|Lost to Follow-up|2
2535305|NCT01589185|8774985|P2|Overall Study|Lost to Follow-up|0
2535306|NCT01589185|8774986|P1|Overall Study|Lost to Follow-up|1
2535307|NCT01589185|8774982|P5|Overall Study|Death|1
2535308|NCT01589185|8774983|P4|Overall Study|Death|0
2535309|NCT01589185|8774984|P3|Overall Study|Death|2
2535310|NCT01589185|8774985|P2|Overall Study|Death|2
2535311|NCT01589185|8774986|P1|Overall Study|Death|1
2535312|NCT01589094|8775019|P1|Overall Study|Did not receive treatment|2
2535313|NCT01588990|8775026|P1|Phase B|Other|2
2535314|NCT01588990|8775026|P1|Phase B|Physician Decision|4
2535315|NCT01588990|8775026|P1|Phase B|Withdrawal by Subject|3
2535316|NCT01588990|8775026|P1|Phase B|Still on therapy at end of study|5
2535317|NCT01588990|8775026|P1|Phase B|Adverse Event|2
2535318|NCT01588990|8775026|P1|Phase A|Still on therapy at end of study|6
2535319|NCT01588990|8775026|P1|Phase A|Adverse Event|28
2535320|NCT01588990|8775026|P1|Phase A|Death|5
2535321|NCT01588990|8775026|P1|Phase A|Lost to Follow-up|1
2535322|NCT01588990|8775026|P1|Phase A|Other|14
2535323|NCT01588990|8775026|P1|Phase A|Physician Decision|11
2535324|NCT01588990|8775026|P1|Phase A|Withdrawal by Subject|5
2535325|NCT01588951|8775054|P3|Overall Study|Ineligible in retrospect|1
2535326|NCT01588951|8775055|P2|Overall Study|Ineligible in retrospect|0
2535327|NCT01588951|8775056|P1|Overall Study|Ineligible in retrospect|0
2535328|NCT01588548|8775087|P6|Overall Study|Condition Under Investigation Worsened|3
2535329|NCT01588548|8775088|P5|Overall Study|Condition Under Investigation Worsened|3
2535330|NCT01588548|8775089|P4|Overall Study|Condition Under Investigation Worsened|4
2535331|NCT01588548|8775090|P3|Overall Study|Condition Under Investigation Worsened|4
2535332|NCT01588548|8775091|P2|Overall Study|Condition Under Investigation Worsened|6
2535333|NCT01588548|8775092|P1|Overall Study|Condition Under Investigation Worsened|3
2535334|NCT01588548|8775087|P6|Overall Study|Adverse Event|0
2535335|NCT01588548|8775088|P5|Overall Study|Adverse Event|1
2535336|NCT01588548|8775089|P4|Overall Study|Adverse Event|2
2535337|NCT01588548|8775090|P3|Overall Study|Adverse Event|1
2535338|NCT01588548|8775091|P2|Overall Study|Adverse Event|0
2535339|NCT01588548|8775092|P1|Overall Study|Adverse Event|0
2535340|NCT01588548|8775087|P6|Overall Study|Withdrawal by Subject|3
2535341|NCT01588548|8775088|P5|Overall Study|Withdrawal by Subject|2
2535342|NCT01588548|8775089|P4|Overall Study|Withdrawal by Subject|1
2535343|NCT01588548|8775090|P3|Overall Study|Withdrawal by Subject|1
2535344|NCT01588548|8775091|P2|Overall Study|Withdrawal by Subject|1
2535345|NCT01588548|8775092|P1|Overall Study|Withdrawal by Subject|0
2535346|NCT01588509|8775108|P2|Overall Study|Lost to Follow-up|0
2535347|NCT01588509|8775109|P1|Overall Study|Lost to Follow-up|1
2535348|NCT01588496|8775132|P3|Overall Study|Withdrawal by Subject|0
2535349|NCT01588496|8775133|P2|Overall Study|Withdrawal by Subject|1
2535350|NCT01588496|8775134|P1|Overall Study|Withdrawal by Subject|0
2535351|NCT01588405|8775184|P1|Overall Study|Clinical Worsening|1
2535352|NCT01588405|8775184|P1|Overall Study|Adverse Event|1
2535353|NCT01588366|8775213|P6|Overall Study|Adverse Event|2
2535354|NCT01588366|8775214|P5|Overall Study|Adverse Event|0
2535355|NCT01588366|8775215|P4|Overall Study|Adverse Event|1
2535356|NCT01588366|8775216|P3|Overall Study|Adverse Event|0
2535357|NCT01588366|8775217|P2|Overall Study|Adverse Event|1
2535358|NCT01588366|8775218|P1|Overall Study|Adverse Event|0
2535359|NCT01588353|8775246|P3|Step3|Adverse Event|2
2535360|NCT01588353|8775247|P2|Step3|Adverse Event|0
2535361|NCT01588353|8775248|P1|Step3|Adverse Event|0
2535362|NCT01588353|8775246|P3|Step2|Withdrawal by Subject|0
2535363|NCT01588353|8775247|P2|Step2|Withdrawal by Subject|1
2535364|NCT01588353|8775248|P1|Step2|Withdrawal by Subject|0
2535365|NCT01588197|8775297|P2|Overall Study|No MRI|0
2535366|NCT01588197|8775298|P1|Overall Study|No MRI|1
2535367|NCT01588197|8775297|P2|Overall Study|Lack of Efficacy|1
2535368|NCT01588197|8775298|P1|Overall Study|Lack of Efficacy|0
2535369|NCT01588106|8775335|P2|Overall Study|Withdrawal by Subject|4
2535370|NCT01588106|8775336|P1|Overall Study|Withdrawal by Subject|5
2535371|NCT01587989|8775344|P3|Randomized Study Treatment|Physician Decision|1
2535372|NCT01587989|8775345|P2|Randomized Study Treatment|Physician Decision|0
2535373|NCT01587989|8775346|P1|Randomized Study Treatment|Physician Decision|0
2535374|NCT01587989|8775344|P3|Randomized Study Treatment|Screening failure|0
2535375|NCT01587989|8775345|P2|Randomized Study Treatment|Screening failure|1
2535376|NCT01587989|8775346|P1|Randomized Study Treatment|Screening failure|0
2535377|NCT01587989|8775344|P3|Randomized Study Treatment|Withdrawal by Subject|0
2535378|NCT01587989|8775345|P2|Randomized Study Treatment|Withdrawal by Subject|1
2535379|NCT01587989|8775346|P1|Randomized Study Treatment|Withdrawal by Subject|0
2535380|NCT01587989|8775344|P3|12-Week Open-Label Run-In Period|No EULAR Response|0
2535381|NCT01587989|8775345|P2|12-Week Open-Label Run-In Period|No EULAR Response|0
2535382|NCT01587989|8775346|P1|12-Week Open-Label Run-In Period|No EULAR Response|4
2535383|NCT01587989|8775344|P3|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
2535384|NCT01587989|8775345|P2|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
2535385|NCT01587989|8775346|P1|12-Week Open-Label Run-In Period|Withdrawal by Subject|1
2535386|NCT01587989|8775344|P3|12-Week Open-Label Run-In Period|Physician Decision|0
2535387|NCT01587989|8775345|P2|12-Week Open-Label Run-In Period|Physician Decision|0
2535388|NCT01587989|8775346|P1|12-Week Open-Label Run-In Period|Physician Decision|7
2535389|NCT01587924|8775411|P4|Overall Study|Withdrawal by Subject|0
2535390|NCT01587924|8775412|P3|Overall Study|Withdrawal by Subject|1
2535391|NCT01587924|8775413|P2|Overall Study|Withdrawal by Subject|1
2535392|NCT01587924|8775414|P1|Overall Study|Withdrawal by Subject|0
2535393|NCT01587924|8775411|P4|Overall Study|Met Hemoglobin stopping criteria|0
2535394|NCT01587924|8775412|P3|Overall Study|Met Hemoglobin stopping criteria|1
2535395|NCT01587924|8775413|P2|Overall Study|Met Hemoglobin stopping criteria|0
2535396|NCT01587924|8775414|P1|Overall Study|Met Hemoglobin stopping criteria|2
2535397|NCT01587924|8775411|P4|Overall Study|Protocol Violation|1
2535398|NCT01587924|8775412|P3|Overall Study|Protocol Violation|2
2535399|NCT01587924|8775413|P2|Overall Study|Protocol Violation|1
2535400|NCT01587924|8775414|P1|Overall Study|Protocol Violation|2
2535401|NCT01587924|8775411|P4|Overall Study|Adverse Event|0
2535402|NCT01587924|8775412|P3|Overall Study|Adverse Event|0
2535403|NCT01587924|8775413|P2|Overall Study|Adverse Event|2
2535404|NCT01587924|8775414|P1|Overall Study|Adverse Event|0
2535405|NCT01587898|8775515|P4|Overall Study|Met haemoglobin stopping criteria|0
2535406|NCT01587898|8775516|P3|Overall Study|Met haemoglobin stopping criteria|1
2535407|NCT01587898|8775517|P2|Overall Study|Met haemoglobin stopping criteria|1
2535408|NCT01587898|8775518|P1|Overall Study|Met haemoglobin stopping criteria|1
2535409|NCT01587898|8775515|P4|Overall Study|Withdrawal by Subject|0
2535410|NCT01587898|8775516|P3|Overall Study|Withdrawal by Subject|0
2535411|NCT01587898|8775517|P2|Overall Study|Withdrawal by Subject|1
2535412|NCT01587898|8775518|P1|Overall Study|Withdrawal by Subject|2
2535413|NCT01587898|8775515|P4|Overall Study|Lost to Follow-up|1
2535414|NCT01587898|8775516|P3|Overall Study|Lost to Follow-up|0
2535415|NCT01587898|8775517|P2|Overall Study|Lost to Follow-up|0
2535416|NCT01587898|8775518|P1|Overall Study|Lost to Follow-up|0
2535417|NCT01587898|8775515|P4|Overall Study|Protocol Violation|1
2535418|NCT01587898|8775516|P3|Overall Study|Protocol Violation|1
2535419|NCT01587898|8775517|P2|Overall Study|Protocol Violation|2
2535420|NCT01587898|8775518|P1|Overall Study|Protocol Violation|0
2535421|NCT01587898|8775515|P4|Overall Study|Adverse Event|0
2535422|NCT01587898|8775516|P3|Overall Study|Adverse Event|0
2535423|NCT01587898|8775517|P2|Overall Study|Adverse Event|1
2535424|NCT01587898|8775518|P1|Overall Study|Adverse Event|1
2535425|NCT01587885|8775694|P2|Treatment Period 1|Protocol Violation|2
2535426|NCT01587885|8775695|P1|Treatment Period 1|Protocol Violation|0
2535427|NCT01587885|8775694|P2|Treatment Period 1|Failure to Return|1
2535428|NCT01587885|8775695|P1|Treatment Period 1|Failure to Return|0
2535429|NCT01587703|8775726|P19|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2535430|NCT01587703|8775727|P18|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2535431|NCT01587703|8775728|P17|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2535432|NCT01587703|8775729|P16|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2535433|NCT01587703|8775730|P15|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2535434|NCT01587703|8775731|P14|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2535435|NCT01587703|8775732|P13|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2535436|NCT01587703|8775733|P12|Part2(Median Exposure of 1.41 Months)|Physician Decision|1
2535437|NCT01587703|8775734|P11|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2535438|NCT01587703|8775735|P10|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2535439|NCT01587703|8775736|P9|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2535440|NCT01587703|8775737|P8|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2535441|NCT01587703|8775738|P7|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2535442|NCT01587703|8775739|P6|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2535443|NCT01587703|8775740|P5|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2535444|NCT01587703|8775741|P4|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2535445|NCT01587703|8775742|P3|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2535446|NCT01587703|8775743|P2|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2535447|NCT01587703|8775744|P1|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
2535448|NCT01587703|8775726|P19|Part2(Median Exposure of 1.41 Months)|Death|0
2535449|NCT01587703|8775727|P18|Part2(Median Exposure of 1.41 Months)|Death|0
2535450|NCT01587703|8775728|P17|Part2(Median Exposure of 1.41 Months)|Death|5
2535451|NCT01587703|8775729|P16|Part2(Median Exposure of 1.41 Months)|Death|17
2535452|NCT01587703|8775730|P15|Part2(Median Exposure of 1.41 Months)|Death|16
2535453|NCT01587703|8775731|P14|Part2(Median Exposure of 1.41 Months)|Death|21
2535454|NCT01587703|8775732|P13|Part2(Median Exposure of 1.41 Months)|Death|12
2535455|NCT01587703|8775733|P12|Part2(Median Exposure of 1.41 Months)|Death|8
2535456|NCT01587703|8775734|P11|Part2(Median Exposure of 1.41 Months)|Death|0
2535457|NCT01587703|8775735|P10|Part2(Median Exposure of 1.41 Months)|Death|0
2535458|NCT01587703|8775736|P9|Part2(Median Exposure of 1.41 Months)|Death|0
2535459|NCT01587703|8775737|P8|Part2(Median Exposure of 1.41 Months)|Death|0
2535460|NCT01587703|8775738|P7|Part2(Median Exposure of 1.41 Months)|Death|0
2535461|NCT01587703|8775739|P6|Part2(Median Exposure of 1.41 Months)|Death|0
2535462|NCT01587703|8775740|P5|Part2(Median Exposure of 1.41 Months)|Death|0
2535463|NCT01587703|8775741|P4|Part2(Median Exposure of 1.41 Months)|Death|0
2535464|NCT01587703|8775742|P3|Part2(Median Exposure of 1.41 Months)|Death|0
2535465|NCT01587703|8775743|P2|Part2(Median Exposure of 1.41 Months)|Death|0
2535466|NCT01587703|8775744|P1|Part2(Median Exposure of 1.41 Months)|Death|0
2535467|NCT01587703|8775726|P19|Part2(Median Exposure of 1.41 Months)|Site closed|0
2535468|NCT01587703|8775727|P18|Part2(Median Exposure of 1.41 Months)|Site closed|0
2535469|NCT01587703|8775728|P17|Part2(Median Exposure of 1.41 Months)|Site closed|8
2535470|NCT01587703|8775729|P16|Part2(Median Exposure of 1.41 Months)|Site closed|3
2535471|NCT01587703|8775730|P15|Part2(Median Exposure of 1.41 Months)|Site closed|1
2535472|NCT01587703|8775731|P14|Part2(Median Exposure of 1.41 Months)|Site closed|1
2535473|NCT01587703|8775732|P13|Part2(Median Exposure of 1.41 Months)|Site closed|2
2535474|NCT01587703|8775733|P12|Part2(Median Exposure of 1.41 Months)|Site closed|2
2535475|NCT01587703|8775734|P11|Part2(Median Exposure of 1.41 Months)|Site closed|0
2535476|NCT01587703|8775735|P10|Part2(Median Exposure of 1.41 Months)|Site closed|0
2535477|NCT01587703|8775736|P9|Part2(Median Exposure of 1.41 Months)|Site closed|0
2535478|NCT01587703|8775737|P8|Part2(Median Exposure of 1.41 Months)|Site closed|0
2535479|NCT01587703|8775738|P7|Part2(Median Exposure of 1.41 Months)|Site closed|0
2535480|NCT01587703|8775739|P6|Part2(Median Exposure of 1.41 Months)|Site closed|0
2535481|NCT01587703|8775740|P5|Part2(Median Exposure of 1.41 Months)|Site closed|0
2535482|NCT01587703|8775741|P4|Part2(Median Exposure of 1.41 Months)|Site closed|0
2535483|NCT01587703|8775742|P3|Part2(Median Exposure of 1.41 Months)|Site closed|0
2535484|NCT01587703|8775743|P2|Part2(Median Exposure of 1.41 Months)|Site closed|0
2535485|NCT01587703|8775744|P1|Part2(Median Exposure of 1.41 Months)|Site closed|0
2535486|NCT01587703|8775726|P19|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2535487|NCT01587703|8775727|P18|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2535488|NCT01587703|8775728|P17|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2535489|NCT01587703|8775729|P16|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2535490|NCT01587703|8775730|P15|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2
2535491|NCT01587703|8775731|P14|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2535492|NCT01587703|8775732|P13|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2535493|NCT01587703|8775733|P12|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1
2535494|NCT01587703|8775734|P11|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2535495|NCT01587703|8775735|P10|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2535496|NCT01587703|8775736|P9|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2535497|NCT01587703|8775737|P8|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2535498|NCT01587703|8775738|P7|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2535499|NCT01587703|8775739|P6|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2535500|NCT01587703|8775740|P5|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2535501|NCT01587703|8775741|P4|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2535502|NCT01587703|8775742|P3|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2535503|NCT01587703|8775743|P2|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2535504|NCT01587703|8775744|P1|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
2535505|NCT01587703|8775726|P19|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2535506|NCT01587703|8775727|P18|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2535507|NCT01587703|8775728|P17|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2535508|NCT01587703|8775729|P16|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1
2535509|NCT01587703|8775730|P15|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2535510|NCT01587703|8775731|P14|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2535511|NCT01587703|8775732|P13|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2535512|NCT01587703|8775733|P12|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2535513|NCT01587703|8775734|P11|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2535514|NCT01587703|8775735|P10|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2535515|NCT01587703|8775736|P9|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2535516|NCT01587703|8775737|P8|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2535517|NCT01587703|8775738|P7|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2535518|NCT01587703|8775739|P6|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2535519|NCT01587703|8775740|P5|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2535520|NCT01587703|8775741|P4|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2535521|NCT01587703|8775742|P3|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2535522|NCT01587703|8775743|P2|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2535523|NCT01587703|8775744|P1|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
2535524|NCT01587703|8775726|P19|Substudy-P4,Maximum Exposure of 5.5month|Death|4
2535525|NCT01587703|8775727|P18|Substudy-P4,Maximum Exposure of 5.5month|Death|5
2535526|NCT01587703|8775728|P17|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2535527|NCT01587703|8775729|P16|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2535528|NCT01587703|8775730|P15|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2535529|NCT01587703|8775731|P14|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2535530|NCT01587703|8775732|P13|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2535531|NCT01587703|8775733|P12|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2535532|NCT01587703|8775734|P11|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2535533|NCT01587703|8775735|P10|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2535534|NCT01587703|8775736|P9|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2535535|NCT01587703|8775737|P8|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2535536|NCT01587703|8775738|P7|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2535759|NCT01586910|8776410|P2|Overall Study|Withdrawal by Subject|43
2535537|NCT01587703|8775739|P6|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2535538|NCT01587703|8775740|P5|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2535539|NCT01587703|8775741|P4|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2535540|NCT01587703|8775742|P3|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2535541|NCT01587703|8775743|P2|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2535542|NCT01587703|8775744|P1|Substudy-P4,Maximum Exposure of 5.5month|Death|0
2535543|NCT01587703|8775726|P19|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1
2535544|NCT01587703|8775727|P18|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2535545|NCT01587703|8775728|P17|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2535546|NCT01587703|8775729|P16|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2535547|NCT01587703|8775730|P15|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2535548|NCT01587703|8775731|P14|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2535549|NCT01587703|8775732|P13|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2535550|NCT01587703|8775733|P12|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2535551|NCT01587703|8775734|P11|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2535552|NCT01587703|8775735|P10|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2535553|NCT01587703|8775736|P9|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2535554|NCT01587703|8775737|P8|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2535555|NCT01587703|8775738|P7|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2535556|NCT01587703|8775739|P6|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2535557|NCT01587703|8775740|P5|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2535558|NCT01587703|8775741|P4|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2535559|NCT01587703|8775742|P3|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2535560|NCT01587703|8775743|P2|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2535561|NCT01587703|8775744|P1|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
2535562|NCT01587703|8775726|P19|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2535563|NCT01587703|8775727|P18|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2535564|NCT01587703|8775728|P17|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2535565|NCT01587703|8775729|P16|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2535566|NCT01587703|8775730|P15|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2535567|NCT01587703|8775731|P14|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2535568|NCT01587703|8775732|P13|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2535569|NCT01587703|8775733|P12|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2535570|NCT01587703|8775734|P11|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2535571|NCT01587703|8775735|P10|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2535572|NCT01587703|8775736|P9|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1
2535573|NCT01587703|8775737|P8|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2535574|NCT01587703|8775738|P7|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2535575|NCT01587703|8775739|P6|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2535576|NCT01587703|8775740|P5|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2535577|NCT01587703|8775741|P4|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2535578|NCT01587703|8775742|P3|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2535579|NCT01587703|8775743|P2|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2535580|NCT01587703|8775744|P1|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
2535581|NCT01587703|8775726|P19|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2535582|NCT01587703|8775727|P18|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2535583|NCT01587703|8775728|P17|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2535584|NCT01587703|8775729|P16|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2535585|NCT01587703|8775730|P15|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2535586|NCT01587703|8775731|P14|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2535587|NCT01587703|8775732|P13|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2535588|NCT01587703|8775733|P12|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2535589|NCT01587703|8775734|P11|Part1 BID(Median Exposure of 1.41months)|Site closed|1
2535590|NCT01587703|8775735|P10|Part1 BID(Median Exposure of 1.41months)|Site closed|1
2535591|NCT01587703|8775736|P9|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2535592|NCT01587703|8775737|P8|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2535593|NCT01587703|8775738|P7|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2535594|NCT01587703|8775739|P6|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2535595|NCT01587703|8775740|P5|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2535596|NCT01587703|8775741|P4|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2535597|NCT01587703|8775742|P3|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2535598|NCT01587703|8775743|P2|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2535599|NCT01587703|8775744|P1|Part1 BID(Median Exposure of 1.41months)|Site closed|0
2535600|NCT01587703|8775726|P19|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2535601|NCT01587703|8775727|P18|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2535602|NCT01587703|8775728|P17|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2535603|NCT01587703|8775729|P16|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2535604|NCT01587703|8775730|P15|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2535605|NCT01587703|8775731|P14|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2535606|NCT01587703|8775732|P13|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2535607|NCT01587703|8775733|P12|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2535608|NCT01587703|8775734|P11|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1
2535609|NCT01587703|8775735|P10|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2535610|NCT01587703|8775736|P9|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1
2535611|NCT01587703|8775737|P8|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2535612|NCT01587703|8775738|P7|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2535613|NCT01587703|8775739|P6|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2535614|NCT01587703|8775740|P5|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2535615|NCT01587703|8775741|P4|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2535616|NCT01587703|8775742|P3|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2535617|NCT01587703|8775743|P2|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2535618|NCT01587703|8775744|P1|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
2535619|NCT01587703|8775726|P19|Part1 BID(Median Exposure of 1.41months)|Death|0
2535620|NCT01587703|8775727|P18|Part1 BID(Median Exposure of 1.41months)|Death|0
2535621|NCT01587703|8775728|P17|Part1 BID(Median Exposure of 1.41months)|Death|0
2535622|NCT01587703|8775729|P16|Part1 BID(Median Exposure of 1.41months)|Death|0
2535623|NCT01587703|8775730|P15|Part1 BID(Median Exposure of 1.41months)|Death|0
2535624|NCT01587703|8775731|P14|Part1 BID(Median Exposure of 1.41months)|Death|0
2535625|NCT01587703|8775732|P13|Part1 BID(Median Exposure of 1.41months)|Death|0
2535626|NCT01587703|8775733|P12|Part1 BID(Median Exposure of 1.41months)|Death|0
2535627|NCT01587703|8775734|P11|Part1 BID(Median Exposure of 1.41months)|Death|3
2535628|NCT01587703|8775735|P10|Part1 BID(Median Exposure of 1.41months)|Death|9
2535629|NCT01587703|8775736|P9|Part1 BID(Median Exposure of 1.41months)|Death|1
2535630|NCT01587703|8775737|P8|Part1 BID(Median Exposure of 1.41months)|Death|0
2535631|NCT01587703|8775738|P7|Part1 BID(Median Exposure of 1.41months)|Death|0
2535632|NCT01587703|8775739|P6|Part1 BID(Median Exposure of 1.41months)|Death|0
2535633|NCT01587703|8775740|P5|Part1 BID(Median Exposure of 1.41months)|Death|0
2535634|NCT01587703|8775741|P4|Part1 BID(Median Exposure of 1.41months)|Death|0
2535635|NCT01587703|8775742|P3|Part1 BID(Median Exposure of 1.41months)|Death|0
2535636|NCT01587703|8775743|P2|Part1 BID(Median Exposure of 1.41months)|Death|0
2535637|NCT01587703|8775744|P1|Part1 BID(Median Exposure of 1.41months)|Death|0
2535638|NCT01587703|8775726|P19|Part1 QD(Median Exposure of 1.38months)|Death|0
2535639|NCT01587703|8775727|P18|Part1 QD(Median Exposure of 1.38months)|Death|0
2535640|NCT01587703|8775728|P17|Part1 QD(Median Exposure of 1.38months)|Death|0
2535641|NCT01587703|8775729|P16|Part1 QD(Median Exposure of 1.38months)|Death|0
2535642|NCT01587703|8775730|P15|Part1 QD(Median Exposure of 1.38months)|Death|0
2535643|NCT01587703|8775731|P14|Part1 QD(Median Exposure of 1.38months)|Death|0
2535644|NCT01587703|8775732|P13|Part1 QD(Median Exposure of 1.38months)|Death|0
2535645|NCT01587703|8775733|P12|Part1 QD(Median Exposure of 1.38months)|Death|0
2535646|NCT01587703|8775734|P11|Part1 QD(Median Exposure of 1.38months)|Death|0
2535647|NCT01587703|8775735|P10|Part1 QD(Median Exposure of 1.38months)|Death|0
2535648|NCT01587703|8775736|P9|Part1 QD(Median Exposure of 1.38months)|Death|0
2535649|NCT01587703|8775737|P8|Part1 QD(Median Exposure of 1.38months)|Death|7
2535650|NCT01587703|8775738|P7|Part1 QD(Median Exposure of 1.38months)|Death|30
2535651|NCT01587703|8775739|P6|Part1 QD(Median Exposure of 1.38months)|Death|7
2535652|NCT01587703|8775740|P5|Part1 QD(Median Exposure of 1.38months)|Death|4
2535653|NCT01587703|8775741|P4|Part1 QD(Median Exposure of 1.38months)|Death|3
2535654|NCT01587703|8775742|P3|Part1 QD(Median Exposure of 1.38months)|Death|1
2535655|NCT01587703|8775743|P2|Part1 QD(Median Exposure of 1.38months)|Death|4
2535656|NCT01587703|8775744|P1|Part1 QD(Median Exposure of 1.38months)|Death|2
2535657|NCT01587703|8775726|P19|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2535658|NCT01587703|8775727|P18|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2535659|NCT01587703|8775728|P17|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2535660|NCT01587703|8775729|P16|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2535661|NCT01587703|8775730|P15|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2535662|NCT01587703|8775731|P14|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2535663|NCT01587703|8775732|P13|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2535664|NCT01587703|8775733|P12|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2535665|NCT01587703|8775734|P11|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2535666|NCT01587703|8775735|P10|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2535667|NCT01587703|8775736|P9|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2535668|NCT01587703|8775737|P8|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2535669|NCT01587703|8775738|P7|Part1 QD(Median Exposure of 1.38months)|Site closed|2
2535670|NCT01587703|8775739|P6|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2535671|NCT01587703|8775740|P5|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2535672|NCT01587703|8775741|P4|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2535673|NCT01587703|8775742|P3|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2535674|NCT01587703|8775743|P2|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2535675|NCT01587703|8775744|P1|Part1 QD(Median Exposure of 1.38months)|Site closed|0
2535676|NCT01587703|8775726|P19|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2535677|NCT01587703|8775727|P18|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2535678|NCT01587703|8775728|P17|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2535679|NCT01587703|8775729|P16|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2535680|NCT01587703|8775730|P15|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2535681|NCT01587703|8775731|P14|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2535682|NCT01587703|8775732|P13|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2535683|NCT01587703|8775733|P12|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2535684|NCT01587703|8775734|P11|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2535685|NCT01587703|8775735|P10|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2535686|NCT01587703|8775736|P9|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2535687|NCT01587703|8775737|P8|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2
2535688|NCT01587703|8775738|P7|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2535689|NCT01587703|8775739|P6|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1
2535690|NCT01587703|8775740|P5|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2535691|NCT01587703|8775741|P4|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2535692|NCT01587703|8775742|P3|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2535693|NCT01587703|8775743|P2|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2535694|NCT01587703|8775744|P1|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
2535695|NCT01587703|8775726|P19|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2535696|NCT01587703|8775727|P18|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2535697|NCT01587703|8775728|P17|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2535698|NCT01587703|8775729|P16|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2535699|NCT01587703|8775730|P15|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2535700|NCT01587703|8775731|P14|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2535701|NCT01587703|8775732|P13|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2535702|NCT01587703|8775733|P12|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2535703|NCT01587703|8775734|P11|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2535704|NCT01587703|8775735|P10|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2535705|NCT01587703|8775736|P9|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2535706|NCT01587703|8775737|P8|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2535707|NCT01587703|8775738|P7|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2535708|NCT01587703|8775739|P6|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2535709|NCT01587703|8775740|P5|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2535710|NCT01587703|8775741|P4|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2535711|NCT01587703|8775742|P3|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2535712|NCT01587703|8775743|P2|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
2535713|NCT01587703|8775744|P1|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1
2535714|NCT01587651|8776151|P3|Overall Study|Withdrawal by Subject|0
2535715|NCT01587651|8776152|P2|Overall Study|Withdrawal by Subject|1
2535716|NCT01587651|8776153|P1|Overall Study|Withdrawal by Subject|0
2535717|NCT01587651|8776151|P3|Overall Study|Protocol Violation|1
2535718|NCT01587651|8776152|P2|Overall Study|Protocol Violation|1
2535719|NCT01587651|8776153|P1|Overall Study|Protocol Violation|0
2535720|NCT01587651|8776151|P3|Overall Study|Adverse Event|0
2535721|NCT01587651|8776152|P2|Overall Study|Adverse Event|1
2535722|NCT01587651|8776153|P1|Overall Study|Adverse Event|0
2535723|NCT01587274|8776183|P3|Overall Study|Lost to Follow-up|3
2535724|NCT01587274|8776184|P2|Overall Study|Lost to Follow-up|5
2535725|NCT01587274|8776185|P1|Overall Study|Lost to Follow-up|4
2535726|NCT01587118|8776193|P1|Overall Study|nonresponse|1
2535727|NCT01587118|8776193|P1|Overall Study|Relocation|1
2535728|NCT01587118|8776193|P1|Overall Study|Lost to Follow-up|2
2535729|NCT01587118|8776193|P1|Overall Study|Adverse Event|3
2535730|NCT01587079|8776217|P1|Overall Study|Adverse Event|14
2535731|NCT01587079|8776217|P1|Overall Study|Withdrawal by Subject|7
2535732|NCT01587079|8776217|P1|Overall Study|Physician Decision|2
2535733|NCT01587079|8776217|P1|Overall Study|Lost to Follow-up|2
2535734|NCT01587079|8776217|P1|Overall Study|Protocol Violation|5
2535735|NCT01587079|8776217|P1|Overall Study|Protocol-specified criteria|9
2535736|NCT01587040|8776343|P4|Overall Study|Other than specified|1
2535737|NCT01587040|8776344|P3|Overall Study|Other than specified|11
2535738|NCT01587040|8776345|P2|Overall Study|Other than specified|1
2535739|NCT01587040|8776346|P1|Overall Study|Other than specified|5
2535740|NCT01587040|8776343|P4|Overall Study|Disease progression|3
2535741|NCT01587040|8776344|P3|Overall Study|Disease progression|15
2535742|NCT01587040|8776345|P2|Overall Study|Disease progression|1
2535743|NCT01587040|8776346|P1|Overall Study|Disease progression|12
2535744|NCT01587040|8776343|P4|Overall Study|Adverse Event|0
2535745|NCT01587040|8776344|P3|Overall Study|Adverse Event|10
2535746|NCT01587040|8776345|P2|Overall Study|Adverse Event|1
2535747|NCT01587040|8776346|P1|Overall Study|Adverse Event|0
2535748|NCT01587040|8776343|P4|Overall Study|Protocol Violation|0
2535749|NCT01587040|8776344|P3|Overall Study|Protocol Violation|1
2535750|NCT01587040|8776345|P2|Overall Study|Protocol Violation|0
2535751|NCT01587040|8776346|P1|Overall Study|Protocol Violation|0
2535752|NCT01587014|8776373|P1|Overall Study|Death|2
2535753|NCT01587001|8776380|P2|Overall Study|Insufficient samples to complete testing|1
2535754|NCT01587001|8776381|P1|Overall Study|Insufficient samples to complete testing|4
2535755|NCT01587001|8776380|P2|Overall Study|Lost to Follow-up|0
2535756|NCT01587001|8776381|P1|Overall Study|Lost to Follow-up|2
2535757|NCT01586910|8776410|P2|Overall Study|Physician withdrew Subject|24
2535758|NCT01586910|8776411|P1|Overall Study|Physician withdrew Subject|5
2535760|NCT01586910|8776411|P1|Overall Study|Withdrawal by Subject|6
2535761|NCT01586910|8776410|P2|Overall Study|Death|4
2535762|NCT01586910|8776411|P1|Overall Study|Death|4
2535763|NCT01586819|8776485|P2|Overall Study|Withdrawal by Subject|0
2535764|NCT01586819|8776486|P1|Overall Study|Withdrawal by Subject|1
2535765|NCT01586806|8776497|P3|Overall Study|Lost to Follow-up|2
2535766|NCT01586806|8776498|P2|Overall Study|Lost to Follow-up|3
2535767|NCT01586806|8776499|P1|Overall Study|Lost to Follow-up|2
2535768|NCT01586806|8776497|P3|Overall Study|Withdrawal by Subject|0
2535769|NCT01586806|8776498|P2|Overall Study|Withdrawal by Subject|0
2535770|NCT01586806|8776499|P1|Overall Study|Withdrawal by Subject|1
2535771|NCT01586806|8776497|P3|Overall Study|Protocol Violation|0
2535772|NCT01586806|8776498|P2|Overall Study|Protocol Violation|1
2535773|NCT01586806|8776499|P1|Overall Study|Protocol Violation|0
2535774|NCT01586364|8776519|P1|Overall Study|Other-Not specified|1
2535775|NCT01586364|8776519|P1|Overall Study|Other-PI discretion, site closing|2
2535776|NCT01586364|8776519|P1|Overall Study|Other-Site closure due to PI illness|1
2535777|NCT01586364|8776519|P1|Overall Study|Other-Subject wasn't getting much relief|1
2535778|NCT01586364|8776519|P1|Overall Study|Other-Did not feel better post-treatment|1
2535779|NCT01586364|8776519|P1|Overall Study|Lack of Efficacy|1
2535780|NCT01586364|8776519|P1|Overall Study|Protocol Violation|16
2535781|NCT01586364|8776519|P1|Overall Study|Lost to Follow-up|17
2535782|NCT01586364|8776519|P1|Overall Study|Adverse Event|37
2535783|NCT01586364|8776519|P1|Overall Study|Withdrawal by Subject|40
2535784|NCT01586338|8776572|P1|Overall Study|Other|1
2535785|NCT01586338|8776572|P1|Overall Study|Withdrawal by participant|3
2535786|NCT01586338|8776572|P1|Overall Study|Lost to Follow-up|1
2535787|NCT01586338|8776572|P1|Overall Study|Adverse Event|3
2535788|NCT01586195|8776595|P1|Overall Study|Reason not specified|9
2535789|NCT01586195|8776595|P1|Overall Study|Started new anti-melanoma therapy|1
2535790|NCT01586195|8776595|P1|Overall Study|Withdrawal of Consent|5
2535791|NCT01586195|8776595|P1|Overall Study|Death|11
2535792|NCT01586156|8776609|P3|Overall Study|Pregnancy|0
2535793|NCT01586156|8776610|P2|Overall Study|Pregnancy|1
2535794|NCT01586156|8776611|P1|Overall Study|Pregnancy|0
2535795|NCT01585987|8776668|P2|Treated|Poor/Non-Compliance|1
2535796|NCT01585987|8776669|P1|Treated|Poor/Non-Compliance|0
2535797|NCT01585987|8776668|P2|Treated|Subject Request|1
2535798|NCT01585987|8776669|P1|Treated|Subject Request|0
2535799|NCT01585987|8776668|P2|Treated|Non-Specified|2
2535800|NCT01585987|8776669|P1|Treated|Non-Specified|1
2535801|NCT01585987|8776668|P2|Treated|Maximum Clinical Benefit|1
2535802|NCT01585987|8776669|P1|Treated|Maximum Clinical Benefit|0
2535803|NCT01585987|8776668|P2|Treated|Lost to Follow-up|1
2535804|NCT01585987|8776669|P1|Treated|Lost to Follow-up|0
2535805|NCT01585987|8776668|P2|Treated|Death|0
2535806|NCT01585987|8776669|P1|Treated|Death|1
2535807|NCT01585987|8776668|P2|Treated|Withdrawal by Subject|2
2535808|NCT01585987|8776669|P1|Treated|Withdrawal by Subject|1
2535809|NCT01585987|8776668|P2|Treated|Adverse Event|0
2535810|NCT01585987|8776669|P1|Treated|Adverse Event|3
2535811|NCT01585987|8776668|P2|Treated|Study Drug Toxicity|5
2535812|NCT01585987|8776669|P1|Treated|Study Drug Toxicity|9
2535813|NCT01585987|8776668|P2|Treated|Disease Progression|36
2535814|NCT01585987|8776669|P1|Treated|Disease Progression|39
2535815|NCT01585987|8776668|P2|Randomized|No longer met criteria|2
2535816|NCT01585987|8776669|P1|Randomized|No longer met criteria|0
2535817|NCT01585987|8776668|P2|Randomized|Withdrawal by Subject|4
2535818|NCT01585987|8776669|P1|Randomized|Withdrawal by Subject|0
2535819|NCT01585961|8776684|P1|Overall Study|Ablation cancelled for slow-heal wound|1
2535820|NCT01585961|8776684|P1|Overall Study|Lost to Follow-up|23
2535821|NCT01585961|8776684|P1|Overall Study|Withdrawal by Subject|1
2535822|NCT01585961|8776684|P1|Overall Study|Decision to use non-study catheter|1
2535823|NCT01585961|8776684|P1|Overall Study|Physician Decision|1
2535824|NCT01585961|8776684|P1|Overall Study|Death|6
2535825|NCT01585766|8776762|P6|Overall Study|Physician Decision|0
2535826|NCT01585766|8776763|P5|Overall Study|Physician Decision|0
2535827|NCT01585766|8776764|P4|Overall Study|Physician Decision|0
2535828|NCT01585766|8776765|P3|Overall Study|Physician Decision|1
2535829|NCT01585766|8776766|P2|Overall Study|Physician Decision|0
2535830|NCT01585766|8776767|P1|Overall Study|Physician Decision|0
2535831|NCT01585766|8776762|P6|Overall Study|Death|0
2535832|NCT01585766|8776763|P5|Overall Study|Death|0
2535833|NCT01585766|8776764|P4|Overall Study|Death|0
2535834|NCT01585766|8776765|P3|Overall Study|Death|0
2535835|NCT01585766|8776766|P2|Overall Study|Death|1
2535836|NCT01585766|8776767|P1|Overall Study|Death|0
2535837|NCT01585766|8776762|P6|Overall Study|Withdrawal by Subject|0
2535838|NCT01585766|8776763|P5|Overall Study|Withdrawal by Subject|0
2535839|NCT01585766|8776764|P4|Overall Study|Withdrawal by Subject|0
2535840|NCT01585766|8776765|P3|Overall Study|Withdrawal by Subject|1
2535841|NCT01585766|8776766|P2|Overall Study|Withdrawal by Subject|1
2535842|NCT01585766|8776767|P1|Overall Study|Withdrawal by Subject|0
2535843|NCT01585584|8776871|P1|Overall Study|Physician Decision|2
2535844|NCT01585584|8776871|P1|Overall Study|Withdrawal by Subject|1
2535845|NCT01585584|8776871|P1|Overall Study|Lack of Efficacy|1
2535846|NCT01585558|8776878|P3|Overall Study|Lack of Efficacy|1
2535847|NCT01585558|8776879|P2|Overall Study|Lack of Efficacy|0
2535848|NCT01585558|8776880|P1|Overall Study|Lack of Efficacy|0
2535849|NCT01585558|8776878|P3|Overall Study|Protocol Violation|2
2535850|NCT01585558|8776879|P2|Overall Study|Protocol Violation|3
2535851|NCT01585558|8776880|P1|Overall Study|Protocol Violation|4
2535852|NCT01585558|8776878|P3|Overall Study|Adverse Event|1
2535853|NCT01585558|8776879|P2|Overall Study|Adverse Event|4
2535854|NCT01585558|8776880|P1|Overall Study|Adverse Event|3
2535855|NCT01585558|8776878|P3|Overall Study|Lost to Follow-up|3
2535856|NCT01585558|8776879|P2|Overall Study|Lost to Follow-up|0
2535857|NCT01585558|8776880|P1|Overall Study|Lost to Follow-up|2
2535858|NCT01585558|8776878|P3|Overall Study|Withdrawal by Subject|8
2535859|NCT01585558|8776879|P2|Overall Study|Withdrawal by Subject|5
2535860|NCT01585558|8776880|P1|Overall Study|Withdrawal by Subject|4
2535861|NCT01585428|8777114|P2|Overall Study|Death during treatment|0
2535862|NCT01585428|8777115|P1|Overall Study|Death during treatment|1
2535863|NCT01585298|8777139|P1|Overall Study|Adverse Event|24
2535864|NCT01585298|8777139|P1|Overall Study|Abnormal test procedure results|1
2535865|NCT01585298|8777139|P1|Overall Study|Withdrawal by Subject|4
2535866|NCT01585298|8777139|P1|Overall Study|Lost to Follow-up|2
2535867|NCT01585298|8777139|P1|Overall Study|Administrative problems|4
2535868|NCT01585298|8777139|P1|Overall Study|Protocol deviation|1
2535869|NCT01585298|8777139|P1|Overall Study|Study completion was not documented.|1
2535870|NCT01585272|8777147|P1|Overall Study|Withdrawal by Subject|10
2535871|NCT01585272|8777147|P1|Overall Study|Protocol Violation|7
2535872|NCT01585272|8777147|P1|Overall Study|Adverse Event|22
2535873|NCT01585246|8777160|P5|Overall Study|Other|0
2535874|NCT01585246|8777161|P4|Overall Study|Other|1
2535875|NCT01585246|8777162|P3|Overall Study|Other|1
2535876|NCT01585246|8777163|P2|Overall Study|Other|1
2535877|NCT01585246|8777164|P1|Overall Study|Other|0
2535878|NCT01585246|8777160|P5|Overall Study|Withdrawal by Subject|1
2535879|NCT01585246|8777161|P4|Overall Study|Withdrawal by Subject|2
2535880|NCT01585246|8777162|P3|Overall Study|Withdrawal by Subject|1
2535881|NCT01585246|8777163|P2|Overall Study|Withdrawal by Subject|0
2535882|NCT01585246|8777164|P1|Overall Study|Withdrawal by Subject|0
2535883|NCT01585246|8777160|P5|Overall Study|Protocol Violation|1
2535884|NCT01585246|8777161|P4|Overall Study|Protocol Violation|0
2535885|NCT01585246|8777162|P3|Overall Study|Protocol Violation|0
2535886|NCT01585246|8777163|P2|Overall Study|Protocol Violation|0
2535887|NCT01585246|8777164|P1|Overall Study|Protocol Violation|0
2535888|NCT01585246|8777160|P5|Overall Study|Lost to Follow-up|0
2535889|NCT01585246|8777161|P4|Overall Study|Lost to Follow-up|1
2535890|NCT01585246|8777162|P3|Overall Study|Lost to Follow-up|2
2535891|NCT01585246|8777163|P2|Overall Study|Lost to Follow-up|0
2535892|NCT01585246|8777164|P1|Overall Study|Lost to Follow-up|0
2535893|NCT01585168|8777185|P4|Overall Study|Lost to Follow-up|1
2535894|NCT01585168|8777186|P3|Overall Study|Lost to Follow-up|1
2535895|NCT01585168|8777187|P2|Overall Study|Lost to Follow-up|1
2535896|NCT01585168|8777188|P1|Overall Study|Lost to Follow-up|3
2535897|NCT01585155|8777208|P1|Overall Study|Worsening ulcerative colitis|2
2535898|NCT01585155|8777208|P1|Overall Study|Lack of Efficacy|2
2535899|NCT01585155|8777208|P1|Overall Study|Adverse Event|1
2535900|NCT01585038|8777230|P2|Overall Study|Adverse Event|2
2535901|NCT01585038|8777231|P1|Overall Study|Adverse Event|2
2535902|NCT01585025|8777246|P3|Overall Study|Withdrawal by Subject|4
2535903|NCT01585025|8777247|P2|Overall Study|Withdrawal by Subject|3
2535904|NCT01585025|8777248|P1|Overall Study|Withdrawal by Subject|0
2535905|NCT01584843|8777278|P6|Second Treatment Period|Withdrawal by Subject|1
2535906|NCT01584843|8777279|P5|Second Treatment Period|Withdrawal by Subject|0
2535907|NCT01584843|8777280|P4|Second Treatment Period|Withdrawal by Subject|0
2535908|NCT01584843|8777281|P3|Second Treatment Period|Withdrawal by Subject|0
2535909|NCT01584843|8777282|P2|Second Treatment Period|Withdrawal by Subject|0
2535910|NCT01584843|8777283|P1|Second Treatment Period|Withdrawal by Subject|0
2535911|NCT01584843|8777278|P6|First Treatment Period|Met Protocol-defined Stopping Criteria|1
2535912|NCT01584843|8777279|P5|First Treatment Period|Met Protocol-defined Stopping Criteria|0
2535913|NCT01584843|8777280|P4|First Treatment Period|Met Protocol-defined Stopping Criteria|0
2535914|NCT01584843|8777281|P3|First Treatment Period|Met Protocol-defined Stopping Criteria|0
2535915|NCT01584843|8777282|P2|First Treatment Period|Met Protocol-defined Stopping Criteria|0
2535916|NCT01584843|8777283|P1|First Treatment Period|Met Protocol-defined Stopping Criteria|0
2535917|NCT01584843|8777278|P6|First Treatment Period|Protocol Violation|1
2535918|NCT01584843|8777279|P5|First Treatment Period|Protocol Violation|0
2535919|NCT01584843|8777280|P4|First Treatment Period|Protocol Violation|0
2535920|NCT01584843|8777281|P3|First Treatment Period|Protocol Violation|0
2535921|NCT01584843|8777282|P2|First Treatment Period|Protocol Violation|0
2535922|NCT01584843|8777283|P1|First Treatment Period|Protocol Violation|0
2535923|NCT01584843|8777278|P6|First Treatment Period|Adverse Event|0
2535924|NCT01584843|8777279|P5|First Treatment Period|Adverse Event|0
2535925|NCT01584843|8777280|P4|First Treatment Period|Adverse Event|0
2535926|NCT01584843|8777281|P3|First Treatment Period|Adverse Event|1
2535927|NCT01584843|8777282|P2|First Treatment Period|Adverse Event|0
2535928|NCT01584843|8777283|P1|First Treatment Period|Adverse Event|0
2535929|NCT01584648|8777394|P2|Overall Study|Ongoing|147
2535930|NCT01584648|8777395|P1|Overall Study|Ongoing|154
2535931|NCT01584648|8777394|P2|Overall Study|Death|55
2535932|NCT01584648|8777395|P1|Overall Study|Death|40
2535933|NCT01584648|8777394|P2|Overall Study|Withdrawal by Subject|5
2535934|NCT01584648|8777395|P1|Overall Study|Withdrawal by Subject|11
2535935|NCT01584648|8777394|P2|Overall Study|Physician Decision|2
2535936|NCT01584648|8777395|P1|Overall Study|Physician Decision|2
2535937|NCT01584648|8777394|P2|Overall Study|Lost to Follow-up|3
2535938|NCT01584648|8777395|P1|Overall Study|Lost to Follow-up|4
2535939|NCT01584232|8777523|P2|Overall Study|Lost to Follow-up|0
2535940|NCT01584232|8777524|P1|Overall Study|Lost to Follow-up|1
2535941|NCT01584232|8777523|P2|Overall Study|Physician Decision|1
2535942|NCT01584232|8777524|P1|Overall Study|Physician Decision|2
2535943|NCT01584232|8777523|P2|Overall Study|Withdrawal by Subject|1
2535944|NCT01584232|8777524|P1|Overall Study|Withdrawal by Subject|2
2535945|NCT01584232|8777523|P2|Overall Study|Adverse Event|1
2535946|NCT01584232|8777524|P1|Overall Study|Adverse Event|3
2535947|NCT01584024|8777540|P1|Overall Study|Withdrawal by Subject|3
2535948|NCT01584024|8777540|P1|Overall Study|Lost to Follow-up|10
2535949|NCT01583530|8777620|P6|Overall Study|Lack of compliance|0
2535950|NCT01583530|8777621|P5|Overall Study|Lack of compliance|1
2535951|NCT01583530|8777622|P4|Overall Study|Lack of compliance|0
2535952|NCT01583530|8777623|P3|Overall Study|Lack of compliance|0
2535953|NCT01583530|8777624|P2|Overall Study|Lack of compliance|0
2535954|NCT01583530|8777625|P1|Overall Study|Lack of compliance|0
2535955|NCT01583530|8777620|P6|Overall Study|Lost to Follow-up|0
2535956|NCT01583530|8777621|P5|Overall Study|Lost to Follow-up|3
2535957|NCT01583530|8777622|P4|Overall Study|Lost to Follow-up|0
2535958|NCT01583530|8777623|P3|Overall Study|Lost to Follow-up|0
2535959|NCT01583530|8777624|P2|Overall Study|Lost to Follow-up|0
2535960|NCT01583530|8777625|P1|Overall Study|Lost to Follow-up|0
2535961|NCT01583530|8777620|P6|Overall Study|Withdrawal by Subject|2
2535962|NCT01583530|8777621|P5|Overall Study|Withdrawal by Subject|1
2535963|NCT01583530|8777622|P4|Overall Study|Withdrawal by Subject|1
2535964|NCT01583530|8777623|P3|Overall Study|Withdrawal by Subject|0
2535965|NCT01583530|8777624|P2|Overall Study|Withdrawal by Subject|3
2535966|NCT01583530|8777625|P1|Overall Study|Withdrawal by Subject|0
2535967|NCT01583530|8777620|P6|Overall Study|Adverse Event|1
2535968|NCT01583530|8777621|P5|Overall Study|Adverse Event|0
2535969|NCT01583530|8777622|P4|Overall Study|Adverse Event|0
2535970|NCT01583530|8777623|P3|Overall Study|Adverse Event|0
2535971|NCT01583530|8777624|P2|Overall Study|Adverse Event|0
2535972|NCT01583530|8777625|P1|Overall Study|Adverse Event|0
2535973|NCT01583374|8777687|P9|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
2535974|NCT01583374|8777688|P8|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
2535975|NCT01583374|8777689|P7|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5
2535976|NCT01583374|8777690|P6|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
2535977|NCT01583374|8777691|P5|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
2535978|NCT01583374|8777692|P4|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2
2535979|NCT01583374|8777693|P3|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
2535980|NCT01583374|8777694|P2|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5
2535981|NCT01583374|8777695|P1|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
2535982|NCT01583374|8777687|P9|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
2535983|NCT01583374|8777688|P8|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
2535984|NCT01583374|8777689|P7|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
2535985|NCT01583374|8777690|P6|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
2535986|NCT01583374|8777691|P5|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
2535987|NCT01583374|8777692|P4|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
2535988|NCT01583374|8777693|P3|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
2535989|NCT01583374|8777694|P2|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
2535990|NCT01583374|8777695|P1|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
2535991|NCT01583374|8777687|P9|Long-Term Extension Phase Weeks 52-260|Death|0
2535992|NCT01583374|8777688|P8|Long-Term Extension Phase Weeks 52-260|Death|0
2535993|NCT01583374|8777689|P7|Long-Term Extension Phase Weeks 52-260|Death|1
2535994|NCT01583374|8777690|P6|Long-Term Extension Phase Weeks 52-260|Death|0
2535995|NCT01583374|8777691|P5|Long-Term Extension Phase Weeks 52-260|Death|1
2535996|NCT01583374|8777692|P4|Long-Term Extension Phase Weeks 52-260|Death|0
2535997|NCT01583374|8777693|P3|Long-Term Extension Phase Weeks 52-260|Death|0
2535998|NCT01583374|8777694|P2|Long-Term Extension Phase Weeks 52-260|Death|0
2535999|NCT01583374|8777695|P1|Long-Term Extension Phase Weeks 52-260|Death|0
2536000|NCT01583374|8777687|P9|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3
2536001|NCT01583374|8777688|P8|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3
2536002|NCT01583374|8777689|P7|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5
2536003|NCT01583374|8777690|P6|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7
2536004|NCT01583374|8777691|P5|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12
2536005|NCT01583374|8777692|P4|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1
2536006|NCT01583374|8777693|P3|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11
2536007|NCT01583374|8777694|P2|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11
2536008|NCT01583374|8777695|P1|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0
2536009|NCT01583374|8777687|P9|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
2536010|NCT01583374|8777688|P8|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
2536011|NCT01583374|8777689|P7|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
2536012|NCT01583374|8777690|P6|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
2536013|NCT01583374|8777691|P5|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
2536014|NCT01583374|8777692|P4|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
2536015|NCT01583374|8777693|P3|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
2536016|NCT01583374|8777694|P2|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
2536017|NCT01583374|8777695|P1|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
2536018|NCT01583374|8777687|P9|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
2536019|NCT01583374|8777688|P8|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2
2536020|NCT01583374|8777689|P7|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
2536021|NCT01583374|8777690|P6|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7
2536022|NCT01583374|8777691|P5|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10
2536023|NCT01583374|8777692|P4|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7
2536024|NCT01583374|8777693|P3|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6
2536025|NCT01583374|8777694|P2|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
2536026|NCT01583374|8777695|P1|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0
2536027|NCT01583374|8777687|P9|Long-Term Extension Phase Weeks 52-260|Adverse Event|1
2536028|NCT01583374|8777688|P8|Long-Term Extension Phase Weeks 52-260|Adverse Event|3
2536029|NCT01583374|8777689|P7|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
2536030|NCT01583374|8777690|P6|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
2536031|NCT01583374|8777691|P5|Long-Term Extension Phase Weeks 52-260|Adverse Event|6
2536032|NCT01583374|8777692|P4|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
2536033|NCT01583374|8777693|P3|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
2536034|NCT01583374|8777694|P2|Long-Term Extension Phase Weeks 52-260|Adverse Event|5
2536035|NCT01583374|8777695|P1|Long-Term Extension Phase Weeks 52-260|Adverse Event|0
2536036|NCT01583374|8777687|P9|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
2536037|NCT01583374|8777688|P8|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
2536038|NCT01583374|8777689|P7|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
2536039|NCT01583374|8777690|P6|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2
2536040|NCT01583374|8777691|P5|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
2536041|NCT01583374|8777692|P4|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
2536042|NCT01583374|8777693|P3|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
2536043|NCT01583374|8777694|P2|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
2536044|NCT01583374|8777695|P1|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
2536045|NCT01583374|8777687|P9|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
2536046|NCT01583374|8777688|P8|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
2536047|NCT01583374|8777689|P7|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
2536048|NCT01583374|8777690|P6|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
2536049|NCT01583374|8777691|P5|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1
2536050|NCT01583374|8777692|P4|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
2536051|NCT01583374|8777693|P3|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1
2536052|NCT01583374|8777694|P2|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2
2536053|NCT01583374|8777695|P1|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
2536054|NCT01583374|8777687|P9|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
2536055|NCT01583374|8777688|P8|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
2536056|NCT01583374|8777689|P7|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5
2536057|NCT01583374|8777690|P6|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
2536058|NCT01583374|8777691|P5|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3
2536059|NCT01583374|8777692|P4|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6
2536060|NCT01583374|8777693|P3|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
2536061|NCT01583374|8777694|P2|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
2536062|NCT01583374|8777695|P1|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
2536063|NCT01583374|8777687|P9|Extension Phase (Weeks 24 to 52)|Adverse Event|0
2536064|NCT01583374|8777688|P8|Extension Phase (Weeks 24 to 52)|Adverse Event|1
2536065|NCT01583374|8777689|P7|Extension Phase (Weeks 24 to 52)|Adverse Event|0
2536066|NCT01583374|8777690|P6|Extension Phase (Weeks 24 to 52)|Adverse Event|1
2536067|NCT01583374|8777691|P5|Extension Phase (Weeks 24 to 52)|Adverse Event|1
2536068|NCT01583374|8777692|P4|Extension Phase (Weeks 24 to 52)|Adverse Event|0
2536069|NCT01583374|8777693|P3|Extension Phase (Weeks 24 to 52)|Adverse Event|2
2536070|NCT01583374|8777694|P2|Extension Phase (Weeks 24 to 52)|Adverse Event|1
2536071|NCT01583374|8777695|P1|Extension Phase (Weeks 24 to 52)|Adverse Event|0
2536072|NCT01583374|8777687|P9|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
2536073|NCT01583374|8777688|P8|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
2536074|NCT01583374|8777689|P7|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
2536075|NCT01583374|8777690|P6|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
2536076|NCT01583374|8777691|P5|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
2536077|NCT01583374|8777692|P4|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
2536078|NCT01583374|8777693|P3|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
2536079|NCT01583374|8777694|P2|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
2536080|NCT01583374|8777695|P1|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
2536081|NCT01583374|8777687|P9|Placebo-controlled Phase (Week 0-24)|Other|0
2536082|NCT01583374|8777688|P8|Placebo-controlled Phase (Week 0-24)|Other|0
2536083|NCT01583374|8777689|P7|Placebo-controlled Phase (Week 0-24)|Other|0
2536084|NCT01583374|8777690|P6|Placebo-controlled Phase (Week 0-24)|Other|0
2536085|NCT01583374|8777691|P5|Placebo-controlled Phase (Week 0-24)|Other|0
2536086|NCT01583374|8777692|P4|Placebo-controlled Phase (Week 0-24)|Other|0
2536087|NCT01583374|8777693|P3|Placebo-controlled Phase (Week 0-24)|Other|0
2536088|NCT01583374|8777694|P2|Placebo-controlled Phase (Week 0-24)|Other|1
2536089|NCT01583374|8777695|P1|Placebo-controlled Phase (Week 0-24)|Other|0
2536090|NCT01583374|8777687|P9|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2536091|NCT01583374|8777688|P8|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2536092|NCT01583374|8777689|P7|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2536093|NCT01583374|8777690|P6|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2536094|NCT01583374|8777691|P5|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2536095|NCT01583374|8777692|P4|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2536096|NCT01583374|8777693|P3|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3
2536097|NCT01583374|8777694|P2|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2536098|NCT01583374|8777695|P1|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2536099|NCT01583374|8777687|P9|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
2536100|NCT01583374|8777688|P8|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
2536101|NCT01583374|8777689|P7|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
2536102|NCT01583374|8777690|P6|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
2536103|NCT01583374|8777691|P5|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
2536104|NCT01583374|8777692|P4|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
2536105|NCT01583374|8777693|P3|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
2536106|NCT01583374|8777694|P2|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2
2536107|NCT01583374|8777695|P1|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1
2536108|NCT01583374|8777687|P9|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2536109|NCT01583374|8777688|P8|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2536110|NCT01583374|8777689|P7|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2536111|NCT01583374|8777690|P6|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2536112|NCT01583374|8777691|P5|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2536113|NCT01583374|8777692|P4|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2536114|NCT01583374|8777693|P3|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
2536115|NCT01583374|8777694|P2|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
2536116|NCT01583374|8777695|P1|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8
2536117|NCT01583374|8777687|P9|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2536118|NCT01583374|8777688|P8|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2536119|NCT01583374|8777689|P7|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2536120|NCT01583374|8777690|P6|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2536121|NCT01583374|8777691|P5|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2536122|NCT01583374|8777692|P4|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2536123|NCT01583374|8777693|P3|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2536124|NCT01583374|8777694|P2|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
2536125|NCT01583374|8777695|P1|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
2536126|NCT01583374|8777687|P9|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2536127|NCT01583374|8777688|P8|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2536128|NCT01583374|8777689|P7|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2536129|NCT01583374|8777690|P6|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2536130|NCT01583374|8777691|P5|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2536131|NCT01583374|8777692|P4|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2536132|NCT01583374|8777693|P3|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
2536133|NCT01583374|8777694|P2|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2
2536134|NCT01583374|8777695|P1|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3
2536135|NCT01583374|8777687|P9|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2536136|NCT01583374|8777688|P8|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2536137|NCT01583374|8777689|P7|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2536138|NCT01583374|8777690|P6|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2536139|NCT01583374|8777691|P5|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2536140|NCT01583374|8777692|P4|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2536141|NCT01583374|8777693|P3|Placebo-controlled Phase (Week 0-24)|Adverse Event|12
2536142|NCT01583374|8777694|P2|Placebo-controlled Phase (Week 0-24)|Adverse Event|7
2536143|NCT01583374|8777695|P1|Placebo-controlled Phase (Week 0-24)|Adverse Event|6
2536144|NCT01583218|8777737|P2|Overall Study|Withdraw of consent on day of random|0
2536145|NCT01583218|8777738|P1|Overall Study|Withdraw of consent on day of random|1
2536146|NCT01583218|8777737|P2|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1
2536147|NCT01583218|8777738|P1|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0
2536148|NCT01583218|8777737|P2|Overall Study|Patient was randomized due to mistake|0
2536149|NCT01583218|8777738|P1|Overall Study|Patient was randomized due to mistake|1
2536150|NCT01583218|8777737|P2|Overall Study|Patient was early terminated from study|1
2536151|NCT01583218|8777738|P1|Overall Study|Patient was early terminated from study|0
2536152|NCT01583218|8777737|P2|Overall Study|Patient deemed ineligible after random|0
2536153|NCT01583218|8777738|P1|Overall Study|Patient deemed ineligible after random|2
2536154|NCT01583218|8777737|P2|Overall Study|Patient was assessed via phone in person|0
2536155|NCT01583218|8777738|P1|Overall Study|Patient was assessed via phone in person|1
2536156|NCT01583218|8777737|P2|Overall Study|Patient randomized but not dosed|16
2536157|NCT01583218|8777738|P1|Overall Study|Patient randomized but not dosed|17
2536158|NCT01583218|8777737|P2|Overall Study|Patient did not wish to attend visits|1
2536159|NCT01583218|8777738|P1|Overall Study|Patient did not wish to attend visits|0
2536160|NCT01583218|8777737|P2|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2
2536161|NCT01583218|8777738|P1|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0
2536162|NCT01583218|8777737|P2|Overall Study|Cannot contact patient directly|2
2536163|NCT01583218|8777738|P1|Overall Study|Cannot contact patient directly|1
2536164|NCT01583218|8777737|P2|Overall Study|Patient /Family decision|0
2536165|NCT01583218|8777738|P1|Overall Study|Patient /Family decision|3
2536166|NCT01583218|8777737|P2|Overall Study|Adverse event or serious adverse event|3
2536167|NCT01583218|8777738|P1|Overall Study|Adverse event or serious adverse event|3
2536168|NCT01583218|8777737|P2|Overall Study|Lost to Follow-up|17
2536169|NCT01583218|8777738|P1|Overall Study|Lost to Follow-up|11
2536170|NCT01583218|8777737|P2|Overall Study|Death|211
2536171|NCT01583218|8777738|P1|Overall Study|Death|206
2536172|NCT01583218|8777737|P2|Overall Study|Withdrawal by Subject|29
2536173|NCT01583218|8777738|P1|Overall Study|Withdrawal by Subject|43
2536174|NCT01583179|8777758|P2|Overall Study|Screen failure|2
2536175|NCT01583179|8777759|P1|Overall Study|Screen failure|1
2536176|NCT01583166|8777769|P2|Overall Study|Withdrawal by Subject|6
2536177|NCT01583166|8777770|P1|Overall Study|Withdrawal by Subject|4
2536178|NCT01582971|8777793|P2|Overall Study|Other|13
2536179|NCT01582971|8777794|P1|Overall Study|Other|15
2536180|NCT01582971|8777793|P2|Overall Study|Withdrawal by Subject|2
2536181|NCT01582971|8777794|P1|Overall Study|Withdrawal by Subject|4
2536182|NCT01582971|8777793|P2|Overall Study|Lost to Follow-up|21
2536183|NCT01582971|8777794|P1|Overall Study|Lost to Follow-up|18
2536184|NCT01582971|8777793|P2|Overall Study|Death|1
2536185|NCT01582971|8777794|P1|Overall Study|Death|2
2536186|NCT01582945|8777812|P1|Overall Study|Scheduling conflicts|1
2536187|NCT01582945|8777812|P1|Overall Study|Intolerable side-effects|1
2536188|NCT01582854|8777826|P2|Overall Study|Other Miscellaneous Reason|0
2536189|NCT01582854|8777827|P1|Overall Study|Other Miscellaneous Reason|1
2536190|NCT01582854|8777826|P2|Overall Study|General Anaesthesia|1
2536191|NCT01582854|8777827|P1|Overall Study|General Anaesthesia|0
2536192|NCT01582854|8777826|P2|Overall Study|Carotid or Neurosurgery|1
2536193|NCT01582854|8777827|P1|Overall Study|Carotid or Neurosurgery|0
2536194|NCT01582854|8777826|P2|Overall Study|Disallowed Concomitant Medication|2
2536195|NCT01582854|8777827|P1|Overall Study|Disallowed Concomitant Medication|3
2536196|NCT01582854|8777826|P2|Overall Study|Recurrent Stroke|8
2536197|NCT01582854|8777827|P1|Overall Study|Recurrent Stroke|13
2536198|NCT01582854|8777826|P2|Overall Study|Physician Decision|1
2536199|NCT01582854|8777827|P1|Overall Study|Physician Decision|0
2536200|NCT01582854|8777826|P2|Overall Study|Lost to Follow-up|2
2536201|NCT01582854|8777827|P1|Overall Study|Lost to Follow-up|1
2536202|NCT01582854|8777826|P2|Overall Study|Withdrawal by Participant|11
2536203|NCT01582854|8777827|P1|Overall Study|Withdrawal by Participant|8
2536204|NCT01582854|8777826|P2|Overall Study|Adverse Event|3
2536205|NCT01582854|8777827|P1|Overall Study|Adverse Event|2
2536206|NCT01582854|8777826|P2|Overall Study|Death|5
2536207|NCT01582854|8777827|P1|Overall Study|Death|8
2536208|NCT01582789|8777855|P2|Second Intervention (14 Days)|Withdrawal by Subject|0
2536209|NCT01582789|8777856|P1|Second Intervention (14 Days)|Withdrawal by Subject|1
2536210|NCT01582451|8777916|P2|Overall Study|Sponsor Decision|0
2536211|NCT01582451|8777917|P1|Overall Study|Sponsor Decision|1
2536212|NCT01582451|8777916|P2|Overall Study|Physician Decision|0
2536213|NCT01582451|8777917|P1|Overall Study|Physician Decision|3
2536214|NCT01582451|8777916|P2|Overall Study|Withdrawal by Subject|9
2536215|NCT01582451|8777917|P1|Overall Study|Withdrawal by Subject|13
2536216|NCT01582451|8777916|P2|Overall Study|Protocol Violation|3
2536217|NCT01582451|8777917|P1|Overall Study|Protocol Violation|11
2536218|NCT01582451|8777916|P2|Overall Study|Lost to Follow-up|2
2536219|NCT01582451|8777917|P1|Overall Study|Lost to Follow-up|0
2536220|NCT01582451|8777916|P2|Overall Study|Death|3
2536221|NCT01582451|8777917|P1|Overall Study|Death|3
2536222|NCT01582451|8777916|P2|Overall Study|Adverse Event|3
2536223|NCT01582451|8777917|P1|Overall Study|Adverse Event|1
2536224|NCT01582308|8777959|P10|Period 4|Physician Decision|1
2536225|NCT01582308|8777960|P9|Period 4|Physician Decision|0
2536226|NCT01582308|8777961|P8|Period 4|Physician Decision|0
2536227|NCT01582308|8777962|P7|Period 4|Physician Decision|0
2536228|NCT01582308|8777963|P6|Period 4|Physician Decision|1
2536229|NCT01582308|8777964|P5|Period 4|Physician Decision|0
2536230|NCT01582308|8777965|P4|Period 4|Physician Decision|0
2536231|NCT01582308|8777966|P3|Period 4|Physician Decision|0
2536232|NCT01582308|8777967|P2|Period 4|Physician Decision|0
2536233|NCT01582308|8777968|P1|Period 4|Physician Decision|1
2536234|NCT01582308|8777959|P10|10-day Washout Following Period 1|Physician Decision|0
2536235|NCT01582308|8777960|P9|10-day Washout Following Period 1|Physician Decision|0
2536236|NCT01582308|8777961|P8|10-day Washout Following Period 1|Physician Decision|0
2536237|NCT01582308|8777962|P7|10-day Washout Following Period 1|Physician Decision|0
2536238|NCT01582308|8777963|P6|10-day Washout Following Period 1|Physician Decision|0
2536239|NCT01582308|8777964|P5|10-day Washout Following Period 1|Physician Decision|1
2536240|NCT01582308|8777965|P4|10-day Washout Following Period 1|Physician Decision|0
2536241|NCT01582308|8777966|P3|10-day Washout Following Period 1|Physician Decision|0
2536242|NCT01582308|8777967|P2|10-day Washout Following Period 1|Physician Decision|0
2536243|NCT01582308|8777968|P1|10-day Washout Following Period 1|Physician Decision|0
2536244|NCT01582308|8777959|P10|Period 1|Withdrawal by Subject|0
2536245|NCT01582308|8777960|P9|Period 1|Withdrawal by Subject|0
2536246|NCT01582308|8777961|P8|Period 1|Withdrawal by Subject|0
2536247|NCT01582308|8777962|P7|Period 1|Withdrawal by Subject|1
2536248|NCT01582308|8777963|P6|Period 1|Withdrawal by Subject|0
2536249|NCT01582308|8777964|P5|Period 1|Withdrawal by Subject|0
2536250|NCT01582308|8777965|P4|Period 1|Withdrawal by Subject|0
2536251|NCT01582308|8777966|P3|Period 1|Withdrawal by Subject|0
2536252|NCT01582308|8777967|P2|Period 1|Withdrawal by Subject|0
2536253|NCT01582308|8777968|P1|Period 1|Withdrawal by Subject|0
2536254|NCT01582282|8777996|P3|Overall Study|fasting blood glucose outside Protocol|0
2536255|NCT01582282|8777997|P2|Overall Study|fasting blood glucose outside Protocol|1
2536256|NCT01582282|8777998|P1|Overall Study|fasting blood glucose outside Protocol|0
2536257|NCT01582282|8777996|P3|Overall Study|Lost to Follow-up|0
2536258|NCT01582282|8777997|P2|Overall Study|Lost to Follow-up|0
2536259|NCT01582282|8777998|P1|Overall Study|Lost to Follow-up|1
2536260|NCT01582282|8777996|P3|Overall Study|Adverse Event|0
2536261|NCT01582282|8777997|P2|Overall Study|Adverse Event|1
2536262|NCT01582282|8777998|P1|Overall Study|Adverse Event|1
2536263|NCT01582243|8778021|P1|Overall Study|Lost to Follow-up|1
2536264|NCT01582243|8778021|P1|Overall Study|Adverse Event|1
2536265|NCT01582243|8778021|P1|Overall Study|Withdrawal by Subject|1
2536266|NCT01582178|8778032|P2|Overall Study|Physician Decision|5
2536267|NCT01582178|8778033|P1|Overall Study|Physician Decision|6
2536268|NCT01582152|8778041|P2|Overall Study|Adverse Event|1
2536269|NCT01582152|8778042|P1|Overall Study|Adverse Event|2
2536270|NCT01582152|8778041|P2|Overall Study|Disease Progression|5
2536271|NCT01582152|8778042|P1|Overall Study|Disease Progression|4
2536272|NCT01582100|8778065|P1|Overall Study|Withdrawal by Subject|1
2536273|NCT01582100|8778065|P1|Overall Study|Adverse Event|1
2536274|NCT01582061|8778071|P2|Overall Study|Lost to Follow-up|0
2536275|NCT01582061|8778072|P1|Overall Study|Lost to Follow-up|1
2536276|NCT01582061|8778071|P2|Overall Study|condition no longer requires study drug|0
2536277|NCT01582061|8778072|P1|Overall Study|condition no longer requires study drug|1
2536278|NCT01582061|8778071|P2|Overall Study|Death|1
2536279|NCT01582061|8778072|P1|Overall Study|Death|0
2536280|NCT01582061|8778071|P2|Overall Study|Abnormal laboratory value(s)|0
2536281|NCT01582061|8778072|P1|Overall Study|Abnormal laboratory value(s)|1
2536282|NCT01582061|8778071|P2|Overall Study|Withdrawal by Subject|4
2536283|NCT01582061|8778072|P1|Overall Study|Withdrawal by Subject|10
2536284|NCT01582061|8778071|P2|Overall Study|Adverse Event|8
2536285|NCT01582061|8778072|P1|Overall Study|Adverse Event|12
2536286|NCT01582061|8778071|P2|Overall Study|Lack of Efficacy|23
2536287|NCT01582061|8778072|P1|Overall Study|Lack of Efficacy|3
2536288|NCT01582009|8778122|P1|Overall Study|Physician Decision|1
2536289|NCT01582009|8778122|P1|Overall Study|Withdrawal by Subject|1
2536290|NCT01581931|8778139|P2|Washout|Adverse Event|1
2536291|NCT01581931|8778140|P1|Washout|Adverse Event|0
2536292|NCT01581684|8778193|P10|Overall Study|Other reason not defined|0
2536293|NCT01581684|8778194|P9|Overall Study|Other reason not defined|1
2536294|NCT01581684|8778195|P8|Overall Study|Other reason not defined|0
2536295|NCT01581684|8778196|P7|Overall Study|Other reason not defined|0
2536296|NCT01581684|8778197|P6|Overall Study|Other reason not defined|0
2536297|NCT01581684|8778198|P5|Overall Study|Other reason not defined|0
2536298|NCT01581684|8778199|P4|Overall Study|Other reason not defined|0
2536299|NCT01581684|8778200|P3|Overall Study|Other reason not defined|0
2536300|NCT01581684|8778201|P2|Overall Study|Other reason not defined|0
2536301|NCT01581684|8778202|P1|Overall Study|Other reason not defined|0
2536302|NCT01581619|8778298|P1|Overall Study|Lost to Follow-up|1
2536303|NCT01581619|8778298|P1|Overall Study|Withdrawal by Subject|1
2536304|NCT01581307|8778451|P1|Overall Study|Withdrawal by Subject|1
2536305|NCT01581281|8778460|P3|Overall Study|Early Study Closure|12
2536306|NCT01581281|8778461|P2|Overall Study|Early Study Closure|6
2536307|NCT01581281|8778462|P1|Overall Study|Early Study Closure|15
2536308|NCT01581021|8778484|P2|Overall Study|Lack of Efficacy|1
2536309|NCT01581021|8778485|P1|Overall Study|Lack of Efficacy|0
2536310|NCT01581021|8778484|P2|Overall Study|Lenke 6 Classification|1
2536311|NCT01581021|8778485|P1|Overall Study|Lenke 6 Classification|0
2536312|NCT01581021|8778484|P2|Overall Study|Not Randomized|2
2536313|NCT01581021|8778485|P1|Overall Study|Not Randomized|1
2536314|NCT01581021|8778484|P2|Overall Study|Neuromuscular|1
2536315|NCT01581021|8778485|P1|Overall Study|Neuromuscular|2
2536316|NCT01581021|8778484|P2|Overall Study|More than 2 hooks in thoracic|0
2536317|NCT01581021|8778485|P1|Overall Study|More than 2 hooks in thoracic|3
2536318|NCT01581021|8778484|P2|Overall Study|Lost to Follow-up|6
2536319|NCT01581021|8778485|P1|Overall Study|Lost to Follow-up|4
2536320|NCT01580995|8778512|P2|Overall Study|Lost to Follow-up|2
2536321|NCT01580995|8778513|P1|Overall Study|Lost to Follow-up|2
2536322|NCT01580969|8778522|P3|Overall Study|Physician Decision|0
2536323|NCT01580969|8778523|P2|Overall Study|Physician Decision|0
2536324|NCT01580969|8778524|P1|Overall Study|Physician Decision|3
2536325|NCT01580670|8778571|P1|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1
2536326|NCT01580670|8778571|P1|Maintenance Period (Week 14 to 54)|Adverse Event|1
2536327|NCT01580488|8778612|P1|Overall Study|Withdrawal by Subject|1
2536328|NCT01580293|8778718|P3|Part B|Part B ongoing|1
2536329|NCT01580293|8778719|P2|Part B|Part B ongoing|0
2536330|NCT01580293|8778720|P1|Part B|Part B ongoing|0
2536331|NCT01580293|8778718|P3|Part B|Other reason|1
2536332|NCT01580293|8778719|P2|Part B|Other reason|0
2536333|NCT01580293|8778720|P1|Part B|Other reason|0
2536334|NCT01580293|8778718|P3|Part B|Withdrawal by Subject|1
2536335|NCT01580293|8778719|P2|Part B|Withdrawal by Subject|0
2536336|NCT01580293|8778720|P1|Part B|Withdrawal by Subject|0
2536337|NCT01580293|8778718|P3|Part A_Extension|Extension ongoing|0
2536338|NCT01580293|8778719|P2|Part A_Extension|Extension ongoing|69
2536339|NCT01580293|8778720|P1|Part A_Extension|Extension ongoing|9
2536340|NCT01580293|8778718|P3|Part A_Extension|Other Reason|0
2536341|NCT01580293|8778719|P2|Part A_Extension|Other Reason|1
2536342|NCT01580293|8778720|P1|Part A_Extension|Other Reason|0
2536343|NCT01580293|8778718|P3|Part A_Extension|Lost to Follow-up|0
2536344|NCT01580293|8778719|P2|Part A_Extension|Lost to Follow-up|1
2536345|NCT01580293|8778720|P1|Part A_Extension|Lost to Follow-up|0
2536346|NCT01580293|8778718|P3|Part A_Extension|Withdrawal by Subject|0
2536347|NCT01580293|8778719|P2|Part A_Extension|Withdrawal by Subject|2
2536348|NCT01580293|8778720|P1|Part A_Extension|Withdrawal by Subject|0
2536349|NCT01580293|8778718|P3|Part A_Extension|Adverse Event|0
2536350|NCT01580293|8778719|P2|Part A_Extension|Adverse Event|2
2536351|NCT01580293|8778720|P1|Part A_Extension|Adverse Event|0
2536352|NCT01580293|8778718|P3|Part A_Main Trial|Non-adherence to the protocol|0
2536353|NCT01580293|8778719|P2|Part A_Main Trial|Non-adherence to the protocol|0
2536354|NCT01580293|8778720|P1|Part A_Main Trial|Non-adherence to the protocol|1
2536355|NCT01580293|8778718|P3|Part A_Main Trial|Withdrawal by Subject|0
2536356|NCT01580293|8778719|P2|Part A_Main Trial|Withdrawal by Subject|4
2536357|NCT01580293|8778720|P1|Part A_Main Trial|Withdrawal by Subject|1
2536358|NCT01580293|8778718|P3|Part A_Main Trial|Adverse Event|0
2536359|NCT01580293|8778719|P2|Part A_Main Trial|Adverse Event|2
2536360|NCT01580293|8778720|P1|Part A_Main Trial|Adverse Event|0
2536361|NCT01580020|8778860|P4|Overall Study|Lost to Follow-up|0
2536362|NCT01580020|8778861|P3|Overall Study|Lost to Follow-up|1
2536363|NCT01580020|8778862|P2|Overall Study|Lost to Follow-up|0
2536364|NCT01580020|8778863|P1|Overall Study|Lost to Follow-up|0
2536365|NCT01580020|8778860|P4|Overall Study|Administrative Problems|0
2536366|NCT01580020|8778861|P3|Overall Study|Administrative Problems|1
2536367|NCT01580020|8778862|P2|Overall Study|Administrative Problems|0
2536368|NCT01580020|8778863|P1|Overall Study|Administrative Problems|0
2536369|NCT01580020|8778860|P4|Overall Study|Adverse Event|1
2536370|NCT01580020|8778861|P3|Overall Study|Adverse Event|1
2536371|NCT01580020|8778862|P2|Overall Study|Adverse Event|1
2536372|NCT01580020|8778863|P1|Overall Study|Adverse Event|1
2536373|NCT01580020|8778860|P4|Overall Study|Withdrawal by Subject|0
2536374|NCT01580020|8778861|P3|Overall Study|Withdrawal by Subject|1
2536375|NCT01580020|8778862|P2|Overall Study|Withdrawal by Subject|1
2536376|NCT01580020|8778863|P1|Overall Study|Withdrawal by Subject|0
2536377|NCT01580020|8778860|P4|Overall Study|Lack of Efficacy|1
2536378|NCT01580020|8778861|P3|Overall Study|Lack of Efficacy|0
2536379|NCT01580020|8778862|P2|Overall Study|Lack of Efficacy|5
2536380|NCT01580020|8778863|P1|Overall Study|Lack of Efficacy|0
2536381|NCT01579916|8778907|P2|Overall Study|Death|0
2536382|NCT01579916|8778908|P1|Overall Study|Death|1
2536383|NCT01579916|8778907|P2|Overall Study|Withdrawal by Subject|1
2536384|NCT01579916|8778908|P1|Overall Study|Withdrawal by Subject|1
2536385|NCT01579916|8778907|P2|Overall Study|Lost to Follow-up|1
2536386|NCT01579916|8778908|P1|Overall Study|Lost to Follow-up|6
2536387|NCT01579812|8778934|P1|Overall Study|Withdrawal by Subject|6
2536388|NCT01579812|8778934|P1|Overall Study|Noncompliance|3
2536389|NCT01579812|8778934|P1|Overall Study|Patient choice|3
2536390|NCT01579812|8778934|P1|Overall Study|Ineligible after treatment start|40
2536391|NCT01579578|8778968|P2|Overall Study|Ongoing|0
2536392|NCT01579578|8778969|P1|Overall Study|Ongoing|3
2536393|NCT01579578|8778968|P2|Overall Study|Eligibility criteria|9
2536394|NCT01579578|8778969|P1|Overall Study|Eligibility criteria|3
2536395|NCT01579578|8778968|P2|Overall Study|Withdrawal by Subject|1
2536396|NCT01579578|8778969|P1|Overall Study|Withdrawal by Subject|2
2536397|NCT01579578|8778968|P2|Overall Study|Lost to Follow-up|1
2536398|NCT01579578|8778969|P1|Overall Study|Lost to Follow-up|1
2536399|NCT01579578|8778968|P2|Overall Study|Death|1
2536400|NCT01579578|8778969|P1|Overall Study|Death|4
2536401|NCT01579565|8778981|P2|Treated|declined to return for final visit|1
2536402|NCT01579565|8778982|P1|Treated|declined to return for final visit|0
2536403|NCT01579565|8778981|P2|Treated|Lost to Follow-up|1
2536404|NCT01579565|8778982|P1|Treated|Lost to Follow-up|2
2536405|NCT01579565|8778981|P2|Treated|Physician Decision|1
2536406|NCT01579565|8778982|P1|Treated|Physician Decision|0
2536407|NCT01579565|8778981|P2|Randomized|prohibited preoperative medication|1
2536408|NCT01579565|8778982|P1|Randomized|prohibited preoperative medication|0
2536409|NCT01579565|8778981|P2|Randomized|prohibited preoperative eating|0
2536410|NCT01579565|8778982|P1|Randomized|prohibited preoperative eating|1
2536411|NCT01579565|8778981|P2|Randomized|inadequate preoperative pupil dilation|1
2536412|NCT01579565|8778982|P1|Randomized|inadequate preoperative pupil dilation|0
2536413|NCT01579565|8778981|P2|Randomized|Withdrawal by Subject|0
2536414|NCT01579565|8778982|P1|Randomized|Withdrawal by Subject|3
2536415|NCT01579565|8778981|P2|Randomized|Adverse Event|3
2536416|NCT01579565|8778982|P1|Randomized|Adverse Event|1
2536417|NCT01579474|8779033|P6|Overall Study|Withdrawal by Subject|0
2536418|NCT01579474|8779034|P5|Overall Study|Withdrawal by Subject|0
2536419|NCT01579474|8779035|P4|Overall Study|Withdrawal by Subject|0
2536420|NCT01579474|8779036|P3|Overall Study|Withdrawal by Subject|0
2536421|NCT01579474|8779037|P2|Overall Study|Withdrawal by Subject|0
2536422|NCT01579474|8779038|P1|Overall Study|Withdrawal by Subject|1
2536423|NCT01579474|8779033|P6|Overall Study|Lack of Efficacy|0
2536424|NCT01579474|8779034|P5|Overall Study|Lack of Efficacy|1
2536425|NCT01579474|8779035|P4|Overall Study|Lack of Efficacy|0
2536426|NCT01579474|8779036|P3|Overall Study|Lack of Efficacy|0
2536427|NCT01579474|8779037|P2|Overall Study|Lack of Efficacy|0
2536428|NCT01579474|8779038|P1|Overall Study|Lack of Efficacy|1
2536429|NCT01579474|8779033|P6|Overall Study|Adverse Event|1
2536430|NCT01579474|8779034|P5|Overall Study|Adverse Event|0
2536431|NCT01579474|8779035|P4|Overall Study|Adverse Event|0
2536432|NCT01579474|8779036|P3|Overall Study|Adverse Event|2
2536433|NCT01579474|8779037|P2|Overall Study|Adverse Event|13
2536434|NCT01579474|8779038|P1|Overall Study|Adverse Event|1
2536435|NCT01579318|8779112|P1|Overall Study|Disease Progression|1
2536436|NCT01579006|8779207|P1|Overall Study|Scheduled surgery|1
2536437|NCT01579006|8779207|P1|Overall Study|Due to participant's health fund|1
2536438|NCT01579006|8779207|P1|Overall Study|Non-compliance|3
2536439|NCT01579006|8779207|P1|Overall Study|Withdrawal by Subject|5
2536440|NCT01579006|8779207|P1|Overall Study|Adverse Event|13
2536441|NCT01579006|8779207|P1|Overall Study|Lack of Efficacy|10
2536442|NCT01578850|8779266|P3|Period 2|Unspecified Reasons|0
2536443|NCT01578850|8779267|P2|Period 2|Unspecified Reasons|1
2536444|NCT01578850|8779268|P1|Period 2|Unspecified Reasons|0
2536445|NCT01578850|8779266|P3|Period 2|Study Terminated by Sponsor|4
2536446|NCT01578850|8779267|P2|Period 2|Study Terminated by Sponsor|5
2536447|NCT01578850|8779268|P1|Period 2|Study Terminated by Sponsor|0
2536448|NCT01578850|8779266|P3|Period 2|Withdrawal by Subject|2
2536449|NCT01578850|8779267|P2|Period 2|Withdrawal by Subject|2
2536450|NCT01578850|8779268|P1|Period 2|Withdrawal by Subject|0
2536451|NCT01578850|8779266|P3|Period 2|Lost to Follow-up|2
2536452|NCT01578850|8779267|P2|Period 2|Lost to Follow-up|1
2536453|NCT01578850|8779268|P1|Period 2|Lost to Follow-up|0
2536454|NCT01578850|8779266|P3|Period 2|Adverse Event|6
2536455|NCT01578850|8779267|P2|Period 2|Adverse Event|3
2536456|NCT01578850|8779268|P1|Period 2|Adverse Event|0
2536457|NCT01578850|8779266|P3|Period 2|Insufficient Clinical Response|0
2536458|NCT01578850|8779267|P2|Period 2|Insufficient Clinical Response|1
2536459|NCT01578850|8779268|P1|Period 2|Insufficient Clinical Response|0
2536460|NCT01578850|8779266|P3|Period 1|Study Terminated by Sponsor|0
2536461|NCT01578850|8779267|P2|Period 1|Study Terminated by Sponsor|0
2536462|NCT01578850|8779268|P1|Period 1|Study Terminated by Sponsor|3
2536463|NCT01578850|8779266|P3|Period 1|Withdrawal by Subject|0
2536464|NCT01578850|8779267|P2|Period 1|Withdrawal by Subject|0
2536465|NCT01578850|8779268|P1|Period 1|Withdrawal by Subject|9
2536466|NCT01578850|8779266|P3|Period 1|Does Not Meet Entrance Criteria|0
2536467|NCT01578850|8779267|P2|Period 1|Does Not Meet Entrance Criteria|0
2536468|NCT01578850|8779268|P1|Period 1|Does Not Meet Entrance Criteria|12
2536469|NCT01578850|8779266|P3|Period 1|Death|0
2536470|NCT01578850|8779267|P2|Period 1|Death|0
2536471|NCT01578850|8779268|P1|Period 1|Death|1
2536472|NCT01578850|8779266|P3|Period 1|Adverse Event|0
2536473|NCT01578850|8779267|P2|Period 1|Adverse Event|0
2536474|NCT01578850|8779268|P1|Period 1|Adverse Event|11
2536475|NCT01578850|8779266|P3|Period 1|Insufficient Clinical Response|0
2536476|NCT01578850|8779267|P2|Period 1|Insufficient Clinical Response|0
2536477|NCT01578850|8779268|P1|Period 1|Insufficient Clinical Response|1
2536478|NCT01578785|8779320|P2|Overall Study|Study terminated by sponsor|118
2536479|NCT01578785|8779321|P1|Overall Study|Study terminated by sponsor|59
2536480|NCT01578785|8779320|P2|Overall Study|Withdrawal by Subject|1
2536481|NCT01578785|8779321|P1|Overall Study|Withdrawal by Subject|0
2536482|NCT01578551|8779386|P2|Overall Study|Adverse Event|0
2536483|NCT01578551|8779387|P1|Overall Study|Adverse Event|1
2536484|NCT01578499|8779399|P2|Overall Study|Died and End of Study Page not Completed|0
2536485|NCT01578499|8779400|P1|Overall Study|Died and End of Study Page not Completed|2
2536486|NCT01578499|8779399|P2|Overall Study|Death|25
2536487|NCT01578499|8779400|P1|Overall Study|Death|20
2536488|NCT01578499|8779399|P2|Overall Study|Withdrawal by Subject|16
2536489|NCT01578499|8779400|P1|Overall Study|Withdrawal by Subject|10
2536490|NCT01578499|8779399|P2|Overall Study|Lost to Follow-up|1
2536491|NCT01578499|8779400|P1|Overall Study|Lost to Follow-up|2
2536492|NCT01578499|8779399|P2|Overall Study|Reason not Specified|1
2536493|NCT01578499|8779400|P1|Overall Study|Reason not Specified|0
2536494|NCT01578486|8779434|P1|Overall Study|Withdrawal by Subject|2
2536495|NCT01578486|8779434|P1|Overall Study|Physician Decision|3
2536496|NCT01578330|8779445|P1|Overall Study|Protocol Violation|5
2536497|NCT01578330|8779445|P1|Overall Study|Adverse Event|2
2536498|NCT01578187|8779470|P1|Usability Phase|Withdrawal by Subject|1
2536499|NCT01577758|8779512|P8|mCRC Expansion Phase|Progression Disease|19
2536500|NCT01577758|8779513|P7|mCRC Expansion Phase|Progression Disease|0
2536501|NCT01577758|8779514|P6|mCRC Expansion Phase|Progression Disease|0
2536502|NCT01577758|8779515|P5|mCRC Expansion Phase|Progression Disease|0
2536503|NCT01577758|8779516|P4|mCRC Expansion Phase|Progression Disease|0
2536504|NCT01577758|8779517|P3|mCRC Expansion Phase|Progression Disease|0
2536505|NCT01577758|8779518|P2|mCRC Expansion Phase|Progression Disease|0
2536506|NCT01577758|8779519|P1|mCRC Expansion Phase|Progression Disease|0
2536507|NCT01577758|8779512|P8|mCRC Expansion Phase|Withdrawal by Subject|2
2536508|NCT01577758|8779513|P7|mCRC Expansion Phase|Withdrawal by Subject|0
2536509|NCT01577758|8779514|P6|mCRC Expansion Phase|Withdrawal by Subject|0
2536510|NCT01577758|8779515|P5|mCRC Expansion Phase|Withdrawal by Subject|0
2536511|NCT01577758|8779516|P4|mCRC Expansion Phase|Withdrawal by Subject|0
2536512|NCT01577758|8779517|P3|mCRC Expansion Phase|Withdrawal by Subject|0
2536513|NCT01577758|8779518|P2|mCRC Expansion Phase|Withdrawal by Subject|0
2536514|NCT01577758|8779519|P1|mCRC Expansion Phase|Withdrawal by Subject|0
2536515|NCT01577758|8779512|P8|mCRC Expansion Phase|Symptomatic Deterioration|4
2536516|NCT01577758|8779513|P7|mCRC Expansion Phase|Symptomatic Deterioration|0
2536517|NCT01577758|8779514|P6|mCRC Expansion Phase|Symptomatic Deterioration|0
2536518|NCT01577758|8779515|P5|mCRC Expansion Phase|Symptomatic Deterioration|0
2536519|NCT01577758|8779516|P4|mCRC Expansion Phase|Symptomatic Deterioration|0
2536520|NCT01577758|8779517|P3|mCRC Expansion Phase|Symptomatic Deterioration|0
2536521|NCT01577758|8779518|P2|mCRC Expansion Phase|Symptomatic Deterioration|0
2536522|NCT01577758|8779519|P1|mCRC Expansion Phase|Symptomatic Deterioration|0
2536523|NCT01577758|8779512|P8|Dose Escalation Phase|Progression Disease|0
2536524|NCT01577758|8779513|P7|Dose Escalation Phase|Progression Disease|0
2536525|NCT01577758|8779514|P6|Dose Escalation Phase|Progression Disease|0
2536526|NCT01577758|8779515|P5|Dose Escalation Phase|Progression Disease|5
2536527|NCT01577758|8779516|P4|Dose Escalation Phase|Progression Disease|2
2536528|NCT01577758|8779517|P3|Dose Escalation Phase|Progression Disease|1
2536529|NCT01577758|8779518|P2|Dose Escalation Phase|Progression Disease|2
2536530|NCT01577758|8779519|P1|Dose Escalation Phase|Progression Disease|2
2536531|NCT01577758|8779512|P8|Dose Escalation Phase|Withdrawal by Subject|0
2536532|NCT01577758|8779513|P7|Dose Escalation Phase|Withdrawal by Subject|0
2536533|NCT01577758|8779514|P6|Dose Escalation Phase|Withdrawal by Subject|1
2536534|NCT01577758|8779515|P5|Dose Escalation Phase|Withdrawal by Subject|0
2536535|NCT01577758|8779516|P4|Dose Escalation Phase|Withdrawal by Subject|0
2536536|NCT01577758|8779517|P3|Dose Escalation Phase|Withdrawal by Subject|0
2536537|NCT01577758|8779518|P2|Dose Escalation Phase|Withdrawal by Subject|0
2536538|NCT01577758|8779519|P1|Dose Escalation Phase|Withdrawal by Subject|0
2536539|NCT01577758|8779512|P8|Dose Escalation Phase|Symptomatic Deterioration|0
2536540|NCT01577758|8779513|P7|Dose Escalation Phase|Symptomatic Deterioration|0
2536541|NCT01577758|8779514|P6|Dose Escalation Phase|Symptomatic Deterioration|1
2536542|NCT01577758|8779515|P5|Dose Escalation Phase|Symptomatic Deterioration|1
2536543|NCT01577758|8779516|P4|Dose Escalation Phase|Symptomatic Deterioration|0
2536544|NCT01577758|8779517|P3|Dose Escalation Phase|Symptomatic Deterioration|1
2536545|NCT01577758|8779518|P2|Dose Escalation Phase|Symptomatic Deterioration|0
2536546|NCT01577758|8779519|P1|Dose Escalation Phase|Symptomatic Deterioration|0
2536547|NCT01577758|8779512|P8|Dose Escalation Phase|Adverse Event|0
2536548|NCT01577758|8779513|P7|Dose Escalation Phase|Adverse Event|1
2536549|NCT01577758|8779514|P6|Dose Escalation Phase|Adverse Event|2
2536550|NCT01577758|8779515|P5|Dose Escalation Phase|Adverse Event|0
2536551|NCT01577758|8779516|P4|Dose Escalation Phase|Adverse Event|0
2536552|NCT01577758|8779517|P3|Dose Escalation Phase|Adverse Event|0
2536553|NCT01577758|8779518|P2|Dose Escalation Phase|Adverse Event|0
2536554|NCT01577758|8779519|P1|Dose Escalation Phase|Adverse Event|0
2536555|NCT01577745|8779558|P6|Overall Study|Alternative Therapy|0
2536556|NCT01577745|8779559|P5|Overall Study|Alternative Therapy|1
2536557|NCT01577745|8779560|P4|Overall Study|Alternative Therapy|1
2536558|NCT01577745|8779561|P3|Overall Study|Alternative Therapy|0
2536559|NCT01577745|8779562|P2|Overall Study|Alternative Therapy|0
2536560|NCT01577745|8779563|P1|Overall Study|Alternative Therapy|0
2536561|NCT01577745|8779558|P6|Overall Study|Lost to Follow-up|1
2536562|NCT01577745|8779559|P5|Overall Study|Lost to Follow-up|0
2536563|NCT01577745|8779560|P4|Overall Study|Lost to Follow-up|0
2536564|NCT01577745|8779561|P3|Overall Study|Lost to Follow-up|0
2536565|NCT01577745|8779562|P2|Overall Study|Lost to Follow-up|0
2536566|NCT01577745|8779563|P1|Overall Study|Lost to Follow-up|0
2536567|NCT01577745|8779558|P6|Overall Study|Physician Decision|0
2536568|NCT01577745|8779559|P5|Overall Study|Physician Decision|1
2536569|NCT01577745|8779560|P4|Overall Study|Physician Decision|1
2536570|NCT01577745|8779561|P3|Overall Study|Physician Decision|0
2536571|NCT01577745|8779562|P2|Overall Study|Physician Decision|0
2536572|NCT01577745|8779563|P1|Overall Study|Physician Decision|0
2536573|NCT01577745|8779558|P6|Overall Study|Death|3
2536574|NCT01577745|8779559|P5|Overall Study|Death|1
2536575|NCT01577745|8779560|P4|Overall Study|Death|1
2536576|NCT01577745|8779561|P3|Overall Study|Death|2
2536577|NCT01577745|8779562|P2|Overall Study|Death|2
2536578|NCT01577745|8779563|P1|Overall Study|Death|3
2536579|NCT01577745|8779558|P6|Overall Study|Withdrawal by Subject|0
2536580|NCT01577745|8779559|P5|Overall Study|Withdrawal by Subject|2
2536581|NCT01577745|8779560|P4|Overall Study|Withdrawal by Subject|3
2536582|NCT01577745|8779561|P3|Overall Study|Withdrawal by Subject|0
2536583|NCT01577745|8779562|P2|Overall Study|Withdrawal by Subject|1
2536584|NCT01577745|8779563|P1|Overall Study|Withdrawal by Subject|0
2536585|NCT01577381|8779764|P4|Overall Study|Ongoing at Date of Cut-Off|0
2536586|NCT01577381|8779765|P3|Overall Study|Ongoing at Date of Cut-Off|1
2536587|NCT01577381|8779766|P2|Overall Study|Ongoing at Date of Cut-Off|2
2536588|NCT01577381|8779767|P1|Overall Study|Ongoing at Date of Cut-Off|0
2536589|NCT01577381|8779764|P4|Overall Study|Discontinued|2
2536590|NCT01577381|8779765|P3|Overall Study|Discontinued|2
2536591|NCT01577381|8779766|P2|Overall Study|Discontinued|1
2536592|NCT01577381|8779767|P1|Overall Study|Discontinued|2
2536593|NCT01577186|8779922|P1|Overall Study|Other|2
2536594|NCT01577186|8779922|P1|Overall Study|Non-Compliant|8
2536595|NCT01577186|8779922|P1|Overall Study|Ineligible to Continue|15
2536596|NCT01577186|8779922|P1|Overall Study|Insufficient Response|18
2536597|NCT01577186|8779922|P1|Overall Study|Withdrawal by Subject|35
2536598|NCT01577186|8779922|P1|Overall Study|Lost to Follow-up|28
2536599|NCT01577186|8779922|P1|Overall Study|Death|1
2536600|NCT01577186|8779922|P1|Overall Study|Adverse Event|23
2536601|NCT01577160|8779930|P1|Overall Study|Other|9
2536602|NCT01577160|8779930|P1|Overall Study|Subject Uncooperative|7
2536603|NCT01577160|8779930|P1|Overall Study|Withdrawal by Subject|18
2536604|NCT01577160|8779930|P1|Overall Study|Lost to Follow-up|40
2536605|NCT01577160|8779930|P1|Overall Study|Lack of Efficacy|15
2536606|NCT01577160|8779930|P1|Overall Study|Adverse Event|9
2536607|NCT01576783|8779985|P2|Overall Study|Withdrawal by Subject|1
2536608|NCT01576783|8779986|P1|Overall Study|Withdrawal by Subject|5
2536609|NCT01576783|8779985|P2|Overall Study|Lost to Follow-up|16
2536610|NCT01576783|8779986|P1|Overall Study|Lost to Follow-up|14
2536611|NCT01576783|8779985|P2|Overall Study|Change in Medical Care|0
2536612|NCT01576783|8779986|P1|Overall Study|Change in Medical Care|1
2536613|NCT01576718|8780012|P7|Treatment Period|Noncompliance to study medication|1
2536614|NCT01576718|8780013|P6|Treatment Period|Noncompliance to study medication|1
2536615|NCT01576718|8780014|P5|Treatment Period|Noncompliance to study medication|0
2536616|NCT01576718|8780015|P4|Treatment Period|Noncompliance to study medication|0
2536617|NCT01576718|8780016|P3|Treatment Period|Noncompliance to study medication|0
2536618|NCT01576718|8780017|P2|Treatment Period|Noncompliance to study medication|0
2536619|NCT01576718|8780018|P1|Treatment Period|Noncompliance to study medication|0
2536620|NCT01576718|8780012|P7|Treatment Period|Lost to Follow-up|0
2536621|NCT01576718|8780013|P6|Treatment Period|Lost to Follow-up|0
2536622|NCT01576718|8780014|P5|Treatment Period|Lost to Follow-up|1
2536623|NCT01576718|8780015|P4|Treatment Period|Lost to Follow-up|0
2536624|NCT01576718|8780016|P3|Treatment Period|Lost to Follow-up|0
2536625|NCT01576718|8780017|P2|Treatment Period|Lost to Follow-up|0
2536626|NCT01576718|8780018|P1|Treatment Period|Lost to Follow-up|0
2536627|NCT01576718|8780012|P7|Treatment Period|Met stopping criteria|15
2536628|NCT01576718|8780013|P6|Treatment Period|Met stopping criteria|33
2536629|NCT01576718|8780014|P5|Treatment Period|Met stopping criteria|16
2536630|NCT01576718|8780015|P4|Treatment Period|Met stopping criteria|19
2536631|NCT01576718|8780016|P3|Treatment Period|Met stopping criteria|13
2536632|NCT01576718|8780017|P2|Treatment Period|Met stopping criteria|16
2536633|NCT01576718|8780018|P1|Treatment Period|Met stopping criteria|0
2536634|NCT01576718|8780012|P7|Treatment Period|Sponsor request|0
2536635|NCT01576718|8780013|P6|Treatment Period|Sponsor request|1
2536636|NCT01576718|8780014|P5|Treatment Period|Sponsor request|0
2536637|NCT01576718|8780015|P4|Treatment Period|Sponsor request|0
2536638|NCT01576718|8780016|P3|Treatment Period|Sponsor request|0
2536639|NCT01576718|8780017|P2|Treatment Period|Sponsor request|1
2536640|NCT01576718|8780018|P1|Treatment Period|Sponsor request|0
2536641|NCT01576718|8780012|P7|Treatment Period|Protocol Violation|12
2536642|NCT01576718|8780013|P6|Treatment Period|Protocol Violation|8
2536643|NCT01576718|8780014|P5|Treatment Period|Protocol Violation|6
2536644|NCT01576718|8780015|P4|Treatment Period|Protocol Violation|10
2536645|NCT01576718|8780016|P3|Treatment Period|Protocol Violation|4
2536646|NCT01576718|8780017|P2|Treatment Period|Protocol Violation|5
2536647|NCT01576718|8780018|P1|Treatment Period|Protocol Violation|0
2536648|NCT01576718|8780012|P7|Treatment Period|Physician Decision|0
2536649|NCT01576718|8780013|P6|Treatment Period|Physician Decision|0
2536650|NCT01576718|8780014|P5|Treatment Period|Physician Decision|1
2536651|NCT01576718|8780015|P4|Treatment Period|Physician Decision|1
2536652|NCT01576718|8780016|P3|Treatment Period|Physician Decision|1
2536653|NCT01576718|8780017|P2|Treatment Period|Physician Decision|1
2536654|NCT01576718|8780018|P1|Treatment Period|Physician Decision|0
2536655|NCT01576718|8780012|P7|Treatment Period|Withdrawal by Subject|2
2536656|NCT01576718|8780013|P6|Treatment Period|Withdrawal by Subject|4
2536657|NCT01576718|8780014|P5|Treatment Period|Withdrawal by Subject|2
2536658|NCT01576718|8780015|P4|Treatment Period|Withdrawal by Subject|0
2536659|NCT01576718|8780016|P3|Treatment Period|Withdrawal by Subject|1
2536660|NCT01576718|8780017|P2|Treatment Period|Withdrawal by Subject|1
2536661|NCT01576718|8780018|P1|Treatment Period|Withdrawal by Subject|0
2536662|NCT01576718|8780012|P7|Treatment Period|Adverse Event|0
2536663|NCT01576718|8780013|P6|Treatment Period|Adverse Event|1
2536664|NCT01576718|8780014|P5|Treatment Period|Adverse Event|1
2536665|NCT01576718|8780015|P4|Treatment Period|Adverse Event|1
2536666|NCT01576718|8780016|P3|Treatment Period|Adverse Event|1
2536667|NCT01576718|8780017|P2|Treatment Period|Adverse Event|1
2536668|NCT01576718|8780018|P1|Treatment Period|Adverse Event|0
2536669|NCT01576718|8780012|P7|Pre-Assignment Period (Run-In Placebo)|Other|0
2536670|NCT01576718|8780013|P6|Pre-Assignment Period (Run-In Placebo)|Other|0
2536671|NCT01576718|8780014|P5|Pre-Assignment Period (Run-In Placebo)|Other|0
2536672|NCT01576718|8780015|P4|Pre-Assignment Period (Run-In Placebo)|Other|0
2536673|NCT01576718|8780016|P3|Pre-Assignment Period (Run-In Placebo)|Other|0
2536674|NCT01576718|8780017|P2|Pre-Assignment Period (Run-In Placebo)|Other|0
2536675|NCT01576718|8780018|P1|Pre-Assignment Period (Run-In Placebo)|Other|15
2536676|NCT01576718|8780012|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2536677|NCT01576718|8780013|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2536678|NCT01576718|8780014|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2536679|NCT01576718|8780015|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2536680|NCT01576718|8780016|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2536681|NCT01576718|8780017|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2536682|NCT01576718|8780018|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2
2536683|NCT01576718|8780012|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2536684|NCT01576718|8780013|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2536685|NCT01576718|8780014|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2536686|NCT01576718|8780015|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2536687|NCT01576718|8780016|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2536688|NCT01576718|8780017|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2536689|NCT01576718|8780018|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166
2536690|NCT01576718|8780012|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2536691|NCT01576718|8780013|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2536692|NCT01576718|8780014|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2536693|NCT01576718|8780015|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2536694|NCT01576718|8780016|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2536695|NCT01576718|8780017|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2536696|NCT01576718|8780018|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17
2536697|NCT01576718|8780012|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2536698|NCT01576718|8780013|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2536699|NCT01576718|8780014|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2536700|NCT01576718|8780015|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2536701|NCT01576718|8780016|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2536702|NCT01576718|8780017|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2536703|NCT01576718|8780018|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49
2536704|NCT01576575|8780117|P1|Buprenorphine + Grapefruit|Withdrawal by Subject|1
2536705|NCT01576575|8780117|P1|Buprenorphine + Rifampin|Withdrawal by Subject|3
2536706|NCT01576575|8780117|P1|Buprenorphine Control|Withdrawal by Subject|3
2536707|NCT01576549|8780127|P1|Overall Study|Sponsor Decision|2
2536708|NCT01576406|8780156|P6|Overall Study|Other|0
2536709|NCT01576406|8780157|P5|Overall Study|Other|0
2536710|NCT01576406|8780158|P4|Overall Study|Other|2
2536711|NCT01576406|8780159|P3|Overall Study|Other|2
2536712|NCT01576406|8780160|P2|Overall Study|Other|0
2536713|NCT01576406|8780161|P1|Overall Study|Other|0
2536714|NCT01576406|8780156|P6|Overall Study|Withdrawal the consent|3
2536715|NCT01576406|8780157|P5|Overall Study|Withdrawal the consent|1
2536716|NCT01576406|8780158|P4|Overall Study|Withdrawal the consent|1
2536717|NCT01576406|8780159|P3|Overall Study|Withdrawal the consent|5
2536718|NCT01576406|8780160|P2|Overall Study|Withdrawal the consent|2
2536719|NCT01576406|8780161|P1|Overall Study|Withdrawal the consent|2
2536720|NCT01576406|8780156|P6|Overall Study|Non-clinical trial supply of Crizotinib|0
2536721|NCT01576406|8780157|P5|Overall Study|Non-clinical trial supply of Crizotinib|0
2536722|NCT01576406|8780158|P4|Overall Study|Non-clinical trial supply of Crizotinib|1
2536723|NCT01576406|8780159|P3|Overall Study|Non-clinical trial supply of Crizotinib|1
2536724|NCT01576406|8780160|P2|Overall Study|Non-clinical trial supply of Crizotinib|0
2536725|NCT01576406|8780161|P1|Overall Study|Non-clinical trial supply of Crizotinib|0
2536726|NCT01576406|8780156|P6|Overall Study|Death|9
2536727|NCT01576406|8780157|P5|Overall Study|Death|7
2536728|NCT01576406|8780158|P4|Overall Study|Death|5
2536729|NCT01576406|8780159|P3|Overall Study|Death|8
2536730|NCT01576406|8780160|P2|Overall Study|Death|4
2536731|NCT01576406|8780161|P1|Overall Study|Death|3
2536732|NCT01576406|8780156|P6|Overall Study|Lost to Follow-up|0
2536733|NCT01576406|8780157|P5|Overall Study|Lost to Follow-up|0
2536734|NCT01576406|8780158|P4|Overall Study|Lost to Follow-up|0
2536735|NCT01576406|8780159|P3|Overall Study|Lost to Follow-up|0
2536736|NCT01576406|8780160|P2|Overall Study|Lost to Follow-up|2
2536737|NCT01576406|8780161|P1|Overall Study|Lost to Follow-up|1
2536738|NCT01576367|8780409|P1|Overall Study|Moved to commercial use after 6 months|1
2536739|NCT01576367|8780409|P1|Overall Study|Unsatisfactory therapeutic effect|2
2536740|NCT01576341|8780417|P1|Overall Study|Other|12
2536741|NCT01576341|8780417|P1|Overall Study|Protocol Violation|12
2536742|NCT01576341|8780417|P1|Overall Study|Kidney transplantation|10
2536743|NCT01576341|8780417|P1|Overall Study|Lost to Follow-up|2
2536744|NCT01576341|8780417|P1|Overall Study|Physician Decision|2
2536745|NCT01576341|8780417|P1|Overall Study|Death|21
2536746|NCT01576341|8780417|P1|Overall Study|Adverse Event|10
2536747|NCT01576341|8780417|P1|Overall Study|Withdrawal by Subject|24
2536748|NCT01576159|8780438|P4|Overall Study|Protocol Violation|0
2536749|NCT01576159|8780439|P3|Overall Study|Protocol Violation|0
2536750|NCT01576159|8780440|P2|Overall Study|Protocol Violation|0
2536751|NCT01576159|8780441|P1|Overall Study|Protocol Violation|1
2536752|NCT01576159|8780438|P4|Overall Study|Lost to Follow-up|1
2536753|NCT01576159|8780439|P3|Overall Study|Lost to Follow-up|0
2536754|NCT01576159|8780440|P2|Overall Study|Lost to Follow-up|0
2536755|NCT01576159|8780441|P1|Overall Study|Lost to Follow-up|0
2536756|NCT01576159|8780438|P4|Overall Study|Physician Decision|0
2536757|NCT01576159|8780439|P3|Overall Study|Physician Decision|1
2536758|NCT01576159|8780440|P2|Overall Study|Physician Decision|0
2536759|NCT01576159|8780441|P1|Overall Study|Physician Decision|0
2536760|NCT01576159|8780438|P4|Overall Study|Withdrawal by Subject|0
2536761|NCT01576159|8780439|P3|Overall Study|Withdrawal by Subject|0
2536762|NCT01576159|8780440|P2|Overall Study|Withdrawal by Subject|1
2536763|NCT01576159|8780441|P1|Overall Study|Withdrawal by Subject|0
2536764|NCT01576146|8780459|P1|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1
2536765|NCT01576146|8780459|P1|Extension Period 2|Renal Transplant|1
2536766|NCT01576146|8780459|P1|Extension Period 2|Adverse Event|1
2536767|NCT01576146|8780459|P1|Extension Period 2|Death|1
2536768|NCT01576146|8780459|P1|Extension Period 2|Sponsor Decision|13
2536769|NCT01576146|8780459|P1|Extension Period 1|Renal Transplant|1
2536770|NCT01576146|8780459|P1|Extension Period 1|Parathyroidectomy|1
2536771|NCT01576146|8780459|P1|Extension Period 1|Lost to Follow-up|1
2536772|NCT01576146|8780459|P1|Extension Period 1|Withdrawal by Subject|1
2536773|NCT01576146|8780459|P1|Extension Period 1|Physician Decision|2
2536774|NCT01576146|8780459|P1|Extension Period 1|Death|2
2536775|NCT01576146|8780459|P1|Extension Period 1|Adverse Event|2
2536776|NCT01576042|8780492|P2|Overall Study|Physician Decision|0
2536777|NCT01576042|8780493|P1|Overall Study|Physician Decision|2
2536778|NCT01575899|8780529|P3|Overall Study|Protocol Violation|0
2536779|NCT01575899|8780530|P2|Overall Study|Protocol Violation|1
2536780|NCT01575899|8780531|P1|Overall Study|Protocol Violation|2
2536781|NCT01575899|8780529|P3|Overall Study|Lost to Follow-up|2
2536782|NCT01575899|8780530|P2|Overall Study|Lost to Follow-up|4
2536783|NCT01575899|8780531|P1|Overall Study|Lost to Follow-up|3
2536784|NCT01575873|8780545|P4|Overall Study|Other|2
2536785|NCT01575873|8780546|P3|Overall Study|Other|4
2536786|NCT01575873|8780547|P2|Overall Study|Other|0
2536787|NCT01575873|8780548|P1|Overall Study|Other|0
2536788|NCT01575873|8780545|P4|Overall Study|Requirement for Alternative Therapy|1
2536789|NCT01575873|8780546|P3|Overall Study|Requirement for Alternative Therapy|1
2536790|NCT01575873|8780547|P2|Overall Study|Requirement for Alternative Therapy|0
2536791|NCT01575873|8780548|P1|Overall Study|Requirement for Alternative Therapy|0
2536792|NCT01575873|8780545|P4|Overall Study|Protocol deviation|1
2536793|NCT01575873|8780546|P3|Overall Study|Protocol deviation|0
2536794|NCT01575873|8780547|P2|Overall Study|Protocol deviation|1
2536795|NCT01575873|8780548|P1|Overall Study|Protocol deviation|0
2536796|NCT01575873|8780545|P4|Overall Study|Administrative decision|0
2536797|NCT01575873|8780546|P3|Overall Study|Administrative decision|1
2536798|NCT01575873|8780547|P2|Overall Study|Administrative decision|1
2536799|NCT01575873|8780548|P1|Overall Study|Administrative decision|1
2536800|NCT01575873|8780545|P4|Overall Study|Noncompliance|3
2536801|NCT01575873|8780546|P3|Overall Study|Noncompliance|4
2536802|NCT01575873|8780547|P2|Overall Study|Noncompliance|2
2536803|NCT01575873|8780548|P1|Overall Study|Noncompliance|1
2536804|NCT01575873|8780545|P4|Overall Study|Death|9
2536805|NCT01575873|8780546|P3|Overall Study|Death|8
2536806|NCT01575873|8780547|P2|Overall Study|Death|2
2536807|NCT01575873|8780548|P1|Overall Study|Death|3
2536808|NCT01575873|8780545|P4|Overall Study|Lost to Follow-up|5
2536809|NCT01575873|8780546|P3|Overall Study|Lost to Follow-up|13
2536810|NCT01575873|8780547|P2|Overall Study|Lost to Follow-up|3
2536811|NCT01575873|8780548|P1|Overall Study|Lost to Follow-up|1
2536812|NCT01575873|8780545|P4|Overall Study|Adverse Event|12
2536813|NCT01575873|8780546|P3|Overall Study|Adverse Event|9
2536814|NCT01575873|8780547|P2|Overall Study|Adverse Event|7
2536815|NCT01575873|8780548|P1|Overall Study|Adverse Event|7
2536816|NCT01575873|8780545|P4|Overall Study|Withdrawal by Subject|34
2536817|NCT01575873|8780546|P3|Overall Study|Withdrawal by Subject|34
2536818|NCT01575873|8780547|P2|Overall Study|Withdrawal by Subject|20
2536819|NCT01575873|8780548|P1|Overall Study|Withdrawal by Subject|15
2536820|NCT01575834|8780574|P2|Overall Study|Requirement for Alternative Therapy|4
2536821|NCT01575834|8780575|P1|Overall Study|Requirement for Alternative Therapy|2
2536822|NCT01575834|8780574|P2|Overall Study|Protocol Deviation|3
2536823|NCT01575834|8780575|P1|Overall Study|Protocol Deviation|4
2536824|NCT01575834|8780574|P2|Overall Study|Ineligibility Determined|8
2536825|NCT01575834|8780575|P1|Overall Study|Ineligibility Determined|5
2536826|NCT01575834|8780574|P2|Overall Study|Administrative decision|33
2536827|NCT01575834|8780575|P1|Overall Study|Administrative decision|15
2536828|NCT01575834|8780574|P2|Overall Study|Noncompliance|27
2536829|NCT01575834|8780575|P1|Overall Study|Noncompliance|52
2536830|NCT01575834|8780574|P2|Overall Study|Lost to Follow-up|68
2536831|NCT01575834|8780575|P1|Overall Study|Lost to Follow-up|55
2536832|NCT01575834|8780574|P2|Overall Study|Adverse Event|61
2536833|NCT01575834|8780575|P1|Overall Study|Adverse Event|63
2536834|NCT01575834|8780574|P2|Overall Study|Other|70
2536835|NCT01575834|8780575|P1|Overall Study|Other|70
2536836|NCT01575834|8780574|P2|Overall Study|Death|74
2536837|NCT01575834|8780575|P1|Overall Study|Death|81
2536838|NCT01575834|8780574|P2|Overall Study|Withdrawal by Subject|390
2536839|NCT01575834|8780575|P1|Overall Study|Withdrawal by Subject|352
2536840|NCT01575808|8780627|P2|Overall Study|Withdrawal by Subject|0
2536841|NCT01575808|8780628|P1|Overall Study|Withdrawal by Subject|1
2536842|NCT01575808|8780627|P2|Overall Study|Death|0
2536843|NCT01575808|8780628|P1|Overall Study|Death|2
2536844|NCT01575769|8780675|P1|Overall Study|Study terminated by sponsor|40
2536845|NCT01575769|8780675|P1|Overall Study|Adverse Event|1
2536846|NCT01575561|8780733|P1|Overall Study|administration|1
2536847|NCT01575561|8780733|P1|Overall Study|Withdrawal by Subject|11
2536848|NCT01575561|8780733|P1|Overall Study|Protocol Violation|4
2536849|NCT01575561|8780733|P1|Overall Study|Lost to Follow-up|6
2536850|NCT01575561|8780733|P1|Overall Study|Lack of Efficacy|8
2536851|NCT01575561|8780733|P1|Overall Study|Adverse Event|9
2536852|NCT01575197|8780763|P3|Overall Study|Protocol Violation|1
2536853|NCT01575197|8780764|P2|Overall Study|Protocol Violation|1
2536854|NCT01575197|8780765|P1|Overall Study|Protocol Violation|2
2536855|NCT01575197|8780763|P3|Overall Study|Withdrawal by Subject|1
2536856|NCT01575197|8780764|P2|Overall Study|Withdrawal by Subject|1
2536857|NCT01575197|8780765|P1|Overall Study|Withdrawal by Subject|0
2536858|NCT01575197|8780763|P3|Overall Study|Lost to Follow-up|0
2536859|NCT01575197|8780764|P2|Overall Study|Lost to Follow-up|1
2536860|NCT01575197|8780765|P1|Overall Study|Lost to Follow-up|0
2536861|NCT01575197|8780763|P3|Overall Study|SAE|0
2536862|NCT01575197|8780764|P2|Overall Study|SAE|1
2536863|NCT01575197|8780765|P1|Overall Study|SAE|0
2536864|NCT01575197|8780763|P3|Overall Study|Migration out of study area|4
2536865|NCT01575197|8780764|P2|Overall Study|Migration out of study area|5
2536866|NCT01575197|8780765|P1|Overall Study|Migration out of study area|1
2536867|NCT01575054|8780793|P2|Overall Study|Adverse Event|8
2536868|NCT01575054|8780794|P1|Overall Study|Adverse Event|9
2536869|NCT01575054|8780793|P2|Overall Study|Lost to Follow-up|3
2536870|NCT01575054|8780794|P1|Overall Study|Lost to Follow-up|3
2536871|NCT01575054|8780793|P2|Overall Study|Personal Reasons|11
2536872|NCT01575054|8780794|P1|Overall Study|Personal Reasons|10
2536873|NCT01575054|8780793|P2|Overall Study|Protocol Violation|1
2536874|NCT01575054|8780794|P1|Overall Study|Protocol Violation|2
2536875|NCT01575054|8780793|P2|Overall Study|Other Reasons|3
2536876|NCT01575054|8780794|P1|Overall Study|Other Reasons|5
2536877|NCT01575028|8780810|P2|Overall Study|Physician Decision|1
2536878|NCT01575028|8780811|P1|Overall Study|Physician Decision|0
2536879|NCT01574716|8780822|P5|Part 2|Lost to Follow-up|0
2536880|NCT01574716|8780823|P4|Part 2|Lost to Follow-up|3
2536881|NCT01574716|8780824|P3|Part 2|Lost to Follow-up|0
2536882|NCT01574716|8780825|P2|Part 2|Lost to Follow-up|0
2536883|NCT01574716|8780826|P1|Part 2|Lost to Follow-up|0
2536884|NCT01574716|8780822|P5|Part 2|Brain metastases|0
2536885|NCT01574716|8780823|P4|Part 2|Brain metastases|1
2536886|NCT01574716|8780824|P3|Part 2|Brain metastases|0
2536887|NCT01574716|8780825|P2|Part 2|Brain metastases|0
2536888|NCT01574716|8780826|P1|Part 2|Brain metastases|0
2536889|NCT01574716|8780822|P5|Part 2|Withdrawal by Subject|4
2536890|NCT01574716|8780823|P4|Part 2|Withdrawal by Subject|5
2536891|NCT01574716|8780824|P3|Part 2|Withdrawal by Subject|0
2536892|NCT01574716|8780825|P2|Part 2|Withdrawal by Subject|0
2536893|NCT01574716|8780826|P1|Part 2|Withdrawal by Subject|0
2536894|NCT01574716|8780822|P5|Part 2|Discontinuation of study by sponsor|31
2536895|NCT01574716|8780823|P4|Part 2|Discontinuation of study by sponsor|51
2536896|NCT01574716|8780824|P3|Part 2|Discontinuation of study by sponsor|0
2536897|NCT01574716|8780825|P2|Part 2|Discontinuation of study by sponsor|0
2536898|NCT01574716|8780826|P1|Part 2|Discontinuation of study by sponsor|0
2536899|NCT01574716|8780822|P5|Part 2|Death|35
2536900|NCT01574716|8780823|P4|Part 2|Death|76
2536901|NCT01574716|8780824|P3|Part 2|Death|0
2536902|NCT01574716|8780825|P2|Part 2|Death|0
2536903|NCT01574716|8780826|P1|Part 2|Death|0
2536904|NCT01574716|8780822|P5|Part 2|Progressive disease|0
2536905|NCT01574716|8780823|P4|Part 2|Progressive disease|1
2536906|NCT01574716|8780824|P3|Part 2|Progressive disease|0
2536907|NCT01574716|8780825|P2|Part 2|Progressive disease|0
2536908|NCT01574716|8780826|P1|Part 2|Progressive disease|0
2536909|NCT01574716|8780822|P5|Part 1|Lost to Follow-up|0
2536910|NCT01574716|8780823|P4|Part 1|Lost to Follow-up|0
2536911|NCT01574716|8780824|P3|Part 1|Lost to Follow-up|0
2536912|NCT01574716|8780825|P2|Part 1|Lost to Follow-up|1
2536913|NCT01574716|8780826|P1|Part 1|Lost to Follow-up|0
2536914|NCT01574716|8780822|P5|Part 1|Withdrawal by Subject|0
2536915|NCT01574716|8780823|P4|Part 1|Withdrawal by Subject|0
2536916|NCT01574716|8780824|P3|Part 1|Withdrawal by Subject|0
2536917|NCT01574716|8780825|P2|Part 1|Withdrawal by Subject|2
2536918|NCT01574716|8780826|P1|Part 1|Withdrawal by Subject|0
2536919|NCT01574716|8780822|P5|Part 1|Discontinuation of study by sponsor|0
2536920|NCT01574716|8780823|P4|Part 1|Discontinuation of study by sponsor|0
2536921|NCT01574716|8780824|P3|Part 1|Discontinuation of study by sponsor|1
2536922|NCT01574716|8780825|P2|Part 1|Discontinuation of study by sponsor|0
2536923|NCT01574716|8780826|P1|Part 1|Discontinuation of study by sponsor|0
2536924|NCT01574716|8780822|P5|Part 1|Death|0
2536925|NCT01574716|8780823|P4|Part 1|Death|0
2536926|NCT01574716|8780824|P3|Part 1|Death|8
2536927|NCT01574716|8780825|P2|Part 1|Death|1
2536928|NCT01574716|8780826|P1|Part 1|Death|3
2536929|NCT01574703|8780849|P4|Overall Study|Death|0
2536930|NCT01574703|8780850|P3|Overall Study|Death|1
2536931|NCT01574703|8780851|P2|Overall Study|Death|1
2536932|NCT01574703|8780852|P1|Overall Study|Death|2
2536933|NCT01574703|8780849|P4|Overall Study|Lost to Follow-up|35
2536934|NCT01574703|8780850|P3|Overall Study|Lost to Follow-up|46
2536935|NCT01574703|8780851|P2|Overall Study|Lost to Follow-up|41
2536936|NCT01574703|8780852|P1|Overall Study|Lost to Follow-up|43
2536937|NCT01574703|8780849|P4|Overall Study|Met Withdrawal Criteria|0
2536938|NCT01574703|8780850|P3|Overall Study|Met Withdrawal Criteria|1
2536939|NCT01574703|8780851|P2|Overall Study|Met Withdrawal Criteria|1
2536940|NCT01574703|8780852|P1|Overall Study|Met Withdrawal Criteria|0
2536941|NCT01574703|8780849|P4|Overall Study|Withdrawal by Subject|61
2536942|NCT01574703|8780850|P3|Overall Study|Withdrawal by Subject|36
2536943|NCT01574703|8780851|P2|Overall Study|Withdrawal by Subject|52
2536944|NCT01574703|8780852|P1|Overall Study|Withdrawal by Subject|53
2536945|NCT01574703|8780849|P4|Overall Study|Unspecified Reason|16
2536946|NCT01574703|8780850|P3|Overall Study|Unspecified Reason|20
2536947|NCT01574703|8780851|P2|Overall Study|Unspecified Reason|15
2536948|NCT01574703|8780852|P1|Overall Study|Unspecified Reason|27
2536949|NCT01574703|8780849|P4|Overall Study|Protocol Violation|1
2536950|NCT01574703|8780850|P3|Overall Study|Protocol Violation|0
2536951|NCT01574703|8780851|P2|Overall Study|Protocol Violation|0
2536952|NCT01574703|8780852|P1|Overall Study|Protocol Violation|0
2536953|NCT01574703|8780849|P4|Overall Study|Adverse Event|1
2536954|NCT01574703|8780850|P3|Overall Study|Adverse Event|1
2536955|NCT01574703|8780851|P2|Overall Study|Adverse Event|2
2536956|NCT01574703|8780852|P1|Overall Study|Adverse Event|0
2536957|NCT01574651|8780896|P2|Overall Study|Withdrawal by Subject|10
2536958|NCT01574651|8780897|P1|Overall Study|Withdrawal by Subject|9
2536959|NCT01574651|8780896|P2|Overall Study|Protocol Violation|5
2536960|NCT01574651|8780897|P1|Overall Study|Protocol Violation|3
2536961|NCT01574651|8780896|P2|Overall Study|Unsatisfactory therapeutic effect|0
2536962|NCT01574651|8780897|P1|Overall Study|Unsatisfactory therapeutic effect|6
2536963|NCT01574651|8780896|P2|Overall Study|Abnormal test procedure result(s)|1
2536964|NCT01574651|8780897|P1|Overall Study|Abnormal test procedure result(s)|1
2536965|NCT01574651|8780896|P2|Overall Study|Abnormal laboratory value(s)|0
2536966|NCT01574651|8780897|P1|Overall Study|Abnormal laboratory value(s)|1
2536967|NCT01574651|8780896|P2|Overall Study|Adverse Event|27
2536968|NCT01574651|8780897|P1|Overall Study|Adverse Event|36
2536969|NCT01574651|8780896|P2|Overall Study|Patient's inability to use the device|1
2536970|NCT01574651|8780897|P1|Overall Study|Patient's inability to use the device|0
2536971|NCT01574651|8780896|P2|Overall Study|Death|3
2536972|NCT01574651|8780897|P1|Overall Study|Death|3
2536973|NCT01574651|8780896|P2|Overall Study|Administrative problems|1
2536974|NCT01574651|8780897|P1|Overall Study|Administrative problems|0
2536975|NCT01574651|8780896|P2|Overall Study|Lost to Follow-up|4
2536976|NCT01574651|8780897|P1|Overall Study|Lost to Follow-up|2
2536977|NCT01574612|8780919|P1|Overall Study|Lost to Follow-up|2
2536978|NCT01574612|8780919|P1|Overall Study|Withdrawal by Subject|1
2536979|NCT01574612|8780919|P1|Overall Study|non compliant with drug|2
2536980|NCT01574612|8780919|P1|Overall Study|Adverse Event|3
2536981|NCT01574326|8780925|P2|Overall Study|Other: Mainly kidney transplant|8
2536982|NCT01574326|8780926|P1|Overall Study|Other: Mainly kidney transplant|8
2536983|NCT01574326|8780925|P2|Overall Study|Adverse Event|3
2536984|NCT01574326|8780926|P1|Overall Study|Adverse Event|1
2536985|NCT01574326|8780925|P2|Overall Study|Physician Decision|3
2536986|NCT01574326|8780926|P1|Overall Study|Physician Decision|5
2536987|NCT01574326|8780925|P2|Overall Study|Withdrawal by Participant|4
2536988|NCT01574326|8780926|P1|Overall Study|Withdrawal by Participant|2
2536989|NCT01574326|8780925|P2|Overall Study|Randomized but not treated|1
2536990|NCT01574326|8780926|P1|Overall Study|Randomized but not treated|0
2536991|NCT01574248|8780944|P2|Overall Study|Missing primary endpoint data|0
2536992|NCT01574248|8780945|P1|Overall Study|Missing primary endpoint data|1
2536993|NCT01574248|8780944|P2|Overall Study|Withdrawal by Subject|0
2536994|NCT01574248|8780945|P1|Overall Study|Withdrawal by Subject|2
2536995|NCT01574157|8780978|P2|Overall Study|Lost to Follow-up|3
2536996|NCT01574157|8780979|P1|Overall Study|Lost to Follow-up|0
2536997|NCT01574157|8780978|P2|Overall Study|Withdrawal by Subject|5
2536998|NCT01574157|8780979|P1|Overall Study|Withdrawal by Subject|4
2536999|NCT01574079|8781013|P2|Overall Study|Lost to Follow-up|0
2537000|NCT01574079|8781014|P1|Overall Study|Lost to Follow-up|1
2537001|NCT01574079|8781013|P2|Overall Study|Physician Decision|2
2537002|NCT01574079|8781014|P1|Overall Study|Physician Decision|0
2537003|NCT01573910|8781026|P2|Overall Study|Patient decision unrelated to Advs Event|11
2537004|NCT01573910|8781027|P1|Overall Study|Patient decision unrelated to Advs Event|11
2537005|NCT01573910|8781026|P2|Overall Study|Protocol Violation|0
2537006|NCT01573910|8781027|P1|Overall Study|Protocol Violation|3
2537007|NCT01573910|8781026|P2|Overall Study|Withdrawal by Subject|1
2537008|NCT01573910|8781027|P1|Overall Study|Withdrawal by Subject|0
2537009|NCT01573910|8781026|P2|Overall Study|Lost to Follow-up|1
2537010|NCT01573910|8781027|P1|Overall Study|Lost to Follow-up|2
2537011|NCT01573910|8781026|P2|Overall Study|Adverse Event|4
2537012|NCT01573910|8781027|P1|Overall Study|Adverse Event|4
2537013|NCT01573767|8781039|P4|Overall Study|Withdrawal by Subject|0
2537014|NCT01573767|8781040|P3|Overall Study|Withdrawal by Subject|0
2537015|NCT01573767|8781041|P2|Overall Study|Withdrawal by Subject|1
2537016|NCT01573767|8781042|P1|Overall Study|Withdrawal by Subject|0
2537017|NCT01573767|8781039|P4|Overall Study|Physician Decision|2
2537018|NCT01573767|8781040|P3|Overall Study|Physician Decision|0
2537019|NCT01573767|8781041|P2|Overall Study|Physician Decision|2
2537020|NCT01573767|8781042|P1|Overall Study|Physician Decision|1
2537021|NCT01573767|8781039|P4|Overall Study|Lost to Follow-up|1
2537022|NCT01573767|8781040|P3|Overall Study|Lost to Follow-up|1
2537023|NCT01573767|8781041|P2|Overall Study|Lost to Follow-up|1
2537024|NCT01573767|8781042|P1|Overall Study|Lost to Follow-up|0
2537025|NCT01573767|8781039|P4|Overall Study|Protocol Violation|3
2537026|NCT01573767|8781040|P3|Overall Study|Protocol Violation|1
2537027|NCT01573767|8781041|P2|Overall Study|Protocol Violation|1
2537028|NCT01573767|8781042|P1|Overall Study|Protocol Violation|3
2537029|NCT01573767|8781039|P4|Overall Study|Lack of Efficacy|17
2537030|NCT01573767|8781040|P3|Overall Study|Lack of Efficacy|12
2537031|NCT01573767|8781041|P2|Overall Study|Lack of Efficacy|15
2537032|NCT01573767|8781042|P1|Overall Study|Lack of Efficacy|18
2537033|NCT01573767|8781039|P4|Overall Study|Adverse Event|1
2537034|NCT01573767|8781040|P3|Overall Study|Adverse Event|0
2537035|NCT01573767|8781041|P2|Overall Study|Adverse Event|1
2537036|NCT01573767|8781042|P1|Overall Study|Adverse Event|0
2537037|NCT01573624|8781076|P7|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
2537038|NCT01573624|8781077|P6|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
2537039|NCT01573624|8781078|P5|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
2537040|NCT01573624|8781079|P4|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
2537041|NCT01573624|8781080|P3|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
2537042|NCT01573624|8781081|P2|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
2537043|NCT01573624|8781082|P1|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1
2537044|NCT01573624|8781076|P7|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
2537045|NCT01573624|8781077|P6|Period 6 : Follow-up Period (7 Days)|Adverse Event|1
2537046|NCT01573624|8781078|P5|Period 6 : Follow-up Period (7 Days)|Adverse Event|2
2537047|NCT01573624|8781079|P4|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
2537048|NCT01573624|8781080|P3|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
2537049|NCT01573624|8781081|P2|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
2537050|NCT01573624|8781082|P1|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
2537051|NCT01573624|8781076|P7|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
2537052|NCT01573624|8781077|P6|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
2537053|NCT01573624|8781078|P5|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
2537054|NCT01573624|8781079|P4|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
2537055|NCT01573624|8781080|P3|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
2537056|NCT01573624|8781081|P2|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
2537057|NCT01573624|8781082|P1|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1
2537058|NCT01573624|8781076|P7|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
2537059|NCT01573624|8781077|P6|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
2537060|NCT01573624|8781078|P5|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
2537061|NCT01573624|8781079|P4|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
2537062|NCT01573624|8781080|P3|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
2537063|NCT01573624|8781081|P2|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
2537064|NCT01573624|8781082|P1|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
2537065|NCT01573624|8781076|P7|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4
2537066|NCT01573624|8781077|P6|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
2537067|NCT01573624|8781078|P5|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
2537068|NCT01573624|8781079|P4|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
2537069|NCT01573624|8781080|P3|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
2537070|NCT01573624|8781081|P2|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
2537071|NCT01573624|8781082|P1|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2
2537072|NCT01573624|8781076|P7|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
2537073|NCT01573624|8781077|P6|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
2537074|NCT01573624|8781078|P5|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
2537075|NCT01573624|8781079|P4|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
2537076|NCT01573624|8781080|P3|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
2537077|NCT01573624|8781081|P2|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
2537078|NCT01573624|8781082|P1|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
2537079|NCT01573624|8781076|P7|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
2537080|NCT01573624|8781077|P6|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
2537081|NCT01573624|8781078|P5|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
2537082|NCT01573624|8781079|P4|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
2537083|NCT01573624|8781080|P3|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
2537084|NCT01573624|8781081|P2|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
2537085|NCT01573624|8781082|P1|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
2537086|NCT01573624|8781076|P7|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
2537087|NCT01573624|8781077|P6|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
2537088|NCT01573624|8781078|P5|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
2537089|NCT01573624|8781079|P4|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
2537090|NCT01573624|8781080|P3|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
2537091|NCT01573624|8781081|P2|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1
2537092|NCT01573624|8781082|P1|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
2537093|NCT01573624|8781076|P7|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
2537094|NCT01573624|8781077|P6|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
2537095|NCT01573624|8781078|P5|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
2537096|NCT01573624|8781079|P4|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
2537097|NCT01573624|8781080|P3|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
2537098|NCT01573624|8781081|P2|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1
2537099|NCT01573624|8781082|P1|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
2537100|NCT01573624|8781076|P7|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
2537101|NCT01573624|8781077|P6|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
2537102|NCT01573624|8781078|P5|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
2537103|NCT01573624|8781079|P4|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
2537104|NCT01573624|8781080|P3|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
2537105|NCT01573624|8781081|P2|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
2537106|NCT01573624|8781082|P1|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
2537107|NCT01573624|8781076|P7|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
2537108|NCT01573624|8781077|P6|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
2537109|NCT01573624|8781078|P5|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
2537110|NCT01573624|8781079|P4|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
2537111|NCT01573624|8781080|P3|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
2537112|NCT01573624|8781081|P2|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
2537113|NCT01573624|8781082|P1|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
2537114|NCT01573624|8781076|P7|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
2537115|NCT01573624|8781077|P6|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
2537116|NCT01573624|8781078|P5|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
2537117|NCT01573624|8781079|P4|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
2537118|NCT01573624|8781080|P3|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
2537119|NCT01573624|8781081|P2|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
2537120|NCT01573624|8781082|P1|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1
2537121|NCT01573624|8781076|P7|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
2537122|NCT01573624|8781077|P6|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
2537123|NCT01573624|8781078|P5|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
2537124|NCT01573624|8781079|P4|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
2537125|NCT01573624|8781080|P3|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
2537126|NCT01573624|8781081|P2|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
2537127|NCT01573624|8781082|P1|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
2537128|NCT01573624|8781076|P7|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
2537129|NCT01573624|8781077|P6|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
2537130|NCT01573624|8781078|P5|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
2537131|NCT01573624|8781079|P4|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
2537132|NCT01573624|8781080|P3|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
2537133|NCT01573624|8781081|P2|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
2537134|NCT01573624|8781082|P1|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1
2537135|NCT01573624|8781076|P7|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
2537136|NCT01573624|8781077|P6|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2
2537137|NCT01573624|8781078|P5|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
2537138|NCT01573624|8781079|P4|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
2537139|NCT01573624|8781080|P3|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
2537140|NCT01573624|8781081|P2|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1
2537141|NCT01573624|8781082|P1|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
2537142|NCT01573624|8781076|P7|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0
2537143|NCT01573624|8781077|P6|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
2537144|NCT01573624|8781078|P5|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3
2537145|NCT01573624|8781079|P4|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1
2537146|NCT01573624|8781080|P3|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
2537147|NCT01573624|8781081|P2|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4
2537148|NCT01573624|8781082|P1|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5
2537149|NCT01573624|8781076|P7|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
2537150|NCT01573624|8781077|P6|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
2537151|NCT01573624|8781078|P5|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
2537152|NCT01573624|8781079|P4|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
2537153|NCT01573624|8781080|P3|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
2537154|NCT01573624|8781081|P2|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
2537155|NCT01573624|8781082|P1|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
2537156|NCT01573624|8781076|P7|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
2537157|NCT01573624|8781077|P6|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
2537158|NCT01573624|8781078|P5|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
2537159|NCT01573624|8781079|P4|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2
2537160|NCT01573624|8781080|P3|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
2537161|NCT01573624|8781081|P2|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
2537162|NCT01573624|8781082|P1|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
2537163|NCT01573624|8781076|P7|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
2537164|NCT01573624|8781077|P6|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1
2537165|NCT01573624|8781078|P5|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
2537166|NCT01573624|8781079|P4|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
2537167|NCT01573624|8781080|P3|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
2537168|NCT01573624|8781081|P2|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
2537169|NCT01573624|8781082|P1|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
2537170|NCT01573624|8781076|P7|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
2537171|NCT01573624|8781077|P6|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
2537172|NCT01573624|8781078|P5|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
2537173|NCT01573624|8781079|P4|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
2537174|NCT01573624|8781080|P3|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2
2537175|NCT01573624|8781081|P2|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
2537176|NCT01573624|8781082|P1|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
2537177|NCT01573624|8781076|P7|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
2537178|NCT01573624|8781077|P6|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
2537179|NCT01573624|8781078|P5|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
2537180|NCT01573624|8781079|P4|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
2537181|NCT01573624|8781080|P3|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
2537182|NCT01573624|8781081|P2|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
2537183|NCT01573624|8781082|P1|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
2537184|NCT01573624|8781076|P7|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
2537185|NCT01573624|8781077|P6|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1
2537186|NCT01573624|8781078|P5|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
2537187|NCT01573624|8781079|P4|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
2537188|NCT01573624|8781080|P3|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
2537189|NCT01573624|8781081|P2|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
2537190|NCT01573624|8781082|P1|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
2537191|NCT01573624|8781076|P7|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
2537192|NCT01573624|8781077|P6|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
2537193|NCT01573624|8781078|P5|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
2537194|NCT01573624|8781079|P4|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
2537195|NCT01573624|8781080|P3|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
2537196|NCT01573624|8781081|P2|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
2537197|NCT01573624|8781082|P1|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
2537198|NCT01573624|8781076|P7|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2537199|NCT01573624|8781077|P6|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2
2537200|NCT01573624|8781078|P5|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2537201|NCT01573624|8781079|P4|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2537202|NCT01573624|8781080|P3|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
2537203|NCT01573624|8781081|P2|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
2537204|NCT01573624|8781082|P1|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
2537205|NCT01573624|8781076|P7|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
2537206|NCT01573624|8781077|P6|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
2537207|NCT01573624|8781078|P5|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
2537208|NCT01573624|8781079|P4|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
2537209|NCT01573624|8781080|P3|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
2537210|NCT01573624|8781081|P2|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
2537211|NCT01573624|8781082|P1|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1
2537212|NCT01573624|8781076|P7|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
2537213|NCT01573624|8781077|P6|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0
2537214|NCT01573624|8781078|P5|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2
2537215|NCT01573624|8781079|P4|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
2537216|NCT01573624|8781080|P3|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6
2537217|NCT01573624|8781081|P2|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3
2537218|NCT01573624|8781082|P1|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4
2537219|NCT01573624|8781076|P7|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
2537220|NCT01573624|8781077|P6|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
2537221|NCT01573624|8781078|P5|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
2537222|NCT01573624|8781079|P4|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
2537223|NCT01573624|8781080|P3|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
2537224|NCT01573624|8781081|P2|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
2537225|NCT01573624|8781082|P1|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
2537226|NCT01573442|8781138|P2|Overall Study|Cancels|10
2537227|NCT01573442|8781139|P1|Overall Study|Cancels|9
2537228|NCT01573000|8781270|P2|Long-Term Follow-Up|Lost to Follow-up|1
2537229|NCT01573000|8781271|P1|Long-Term Follow-Up|Lost to Follow-up|0
2537230|NCT01573000|8781270|P2|Long-Term Follow-Up|Death|0
2537231|NCT01573000|8781271|P1|Long-Term Follow-Up|Death|3
2537232|NCT01573000|8781270|P2|Crossover Phase|Death|3
2537233|NCT01573000|8781271|P1|Crossover Phase|Death|0
2537234|NCT01573000|8781270|P2|Crossover Phase|Lost to Follow-up|2
2537235|NCT01573000|8781271|P1|Crossover Phase|Lost to Follow-up|0
2537236|NCT01573000|8781270|P2|Crossover Phase|Lack of Efficacy|13
2537237|NCT01573000|8781271|P1|Crossover Phase|Lack of Efficacy|0
2537238|NCT01573000|8781270|P2|Dosimetric and Therapeutic Treatment|Received Other Treatment|0
2537239|NCT01573000|8781271|P1|Dosimetric and Therapeutic Treatment|Received Other Treatment|2
2537240|NCT01573000|8781270|P2|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0
2537241|NCT01573000|8781271|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2
2537242|NCT01573000|8781270|P2|Dosimetric and Therapeutic Treatment|Death|1
2537243|NCT01573000|8781271|P1|Dosimetric and Therapeutic Treatment|Death|0
2537244|NCT01573000|8781270|P2|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
2537245|NCT01573000|8781271|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4
2537246|NCT01573000|8781270|P2|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32
2537247|NCT01573000|8781271|P1|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27
2537248|NCT01572948|8781367|P2|Overall Study|unable to contact|1
2537249|NCT01572948|8781368|P1|Overall Study|unable to contact|0
2537250|NCT01572948|8781367|P2|Overall Study|Lost to Follow-up|0
2537251|NCT01572948|8781368|P1|Overall Study|Lost to Follow-up|1
2537252|NCT01572922|8781384|P1|Overall Study|Death|1
2537253|NCT01572922|8781384|P1|Overall Study|Protocol Violation|1
2537254|NCT01572922|8781384|P1|Overall Study|Adverse Event|1
2537255|NCT01572844|8781394|P2|Overall Study|Physician Decision|1
2537256|NCT01572844|8781395|P1|Overall Study|Physician Decision|1
2537257|NCT01572792|8781413|P5|Extension Study|Site termination/COPD exacerbation/other|6
2537258|NCT01572792|8781414|P4|Extension Study|Site termination/COPD exacerbation/other|6
2537259|NCT01572792|8781415|P3|Extension Study|Site termination/COPD exacerbation/other|4
2537260|NCT01572792|8781416|P2|Extension Study|Site termination/COPD exacerbation/other|8
2537261|NCT01572792|8781417|P1|Extension Study|Site termination/COPD exacerbation/other|3
2537262|NCT01572792|8781413|P5|Extension Study|Adverse Event|4
2537263|NCT01572792|8781414|P4|Extension Study|Adverse Event|6
2537264|NCT01572792|8781415|P3|Extension Study|Adverse Event|5
2537265|NCT01572792|8781416|P2|Extension Study|Adverse Event|6
2537266|NCT01572792|8781417|P1|Extension Study|Adverse Event|7
2537267|NCT01572792|8781413|P5|Extension Study|Lack of Efficacy|2
2537268|NCT01572792|8781414|P4|Extension Study|Lack of Efficacy|2
2537269|NCT01572792|8781415|P3|Extension Study|Lack of Efficacy|3
2537270|NCT01572792|8781416|P2|Extension Study|Lack of Efficacy|3
2537271|NCT01572792|8781417|P1|Extension Study|Lack of Efficacy|2
2537272|NCT01572792|8781413|P5|Extension Study|Protocol Violation|3
2537273|NCT01572792|8781414|P4|Extension Study|Protocol Violation|4
2537274|NCT01572792|8781415|P3|Extension Study|Protocol Violation|3
2537275|NCT01572792|8781416|P2|Extension Study|Protocol Violation|4
2537276|NCT01572792|8781417|P1|Extension Study|Protocol Violation|0
2537277|NCT01572792|8781413|P5|Extension Study|Withdrawal by Subject|14
2537278|NCT01572792|8781414|P4|Extension Study|Withdrawal by Subject|8
2537279|NCT01572792|8781415|P3|Extension Study|Withdrawal by Subject|11
2537280|NCT01572792|8781416|P2|Extension Study|Withdrawal by Subject|6
2537281|NCT01572792|8781417|P1|Extension Study|Withdrawal by Subject|7
2537282|NCT01572792|8781413|P5|Extension Study|Lost to Follow-up|3
2537283|NCT01572792|8781414|P4|Extension Study|Lost to Follow-up|3
2537284|NCT01572792|8781415|P3|Extension Study|Lost to Follow-up|0
2537285|NCT01572792|8781416|P2|Extension Study|Lost to Follow-up|2
2537286|NCT01572792|8781417|P1|Extension Study|Lost to Follow-up|6
2537287|NCT01572792|8781413|P5|Lead-in Study|Site termination/COPD exacerbation/other|9
2537288|NCT01572792|8781414|P4|Lead-in Study|Site termination/COPD exacerbation/other|9
2537289|NCT01572792|8781415|P3|Lead-in Study|Site termination/COPD exacerbation/other|8
2537290|NCT01572792|8781416|P2|Lead-in Study|Site termination/COPD exacerbation/other|10
2537291|NCT01572792|8781417|P1|Lead-in Study|Site termination/COPD exacerbation/other|14
2537292|NCT01572792|8781413|P5|Lead-in Study|Adverse Event|14
2537293|NCT01572792|8781414|P4|Lead-in Study|Adverse Event|16
2537294|NCT01572792|8781415|P3|Lead-in Study|Adverse Event|22
2537295|NCT01572792|8781416|P2|Lead-in Study|Adverse Event|21
2537296|NCT01572792|8781417|P1|Lead-in Study|Adverse Event|21
2537297|NCT01572792|8781413|P5|Lead-in Study|Lack of Efficacy|10
2537298|NCT01572792|8781414|P4|Lead-in Study|Lack of Efficacy|8
2537299|NCT01572792|8781415|P3|Lead-in Study|Lack of Efficacy|4
2537300|NCT01572792|8781416|P2|Lead-in Study|Lack of Efficacy|5
2537301|NCT01572792|8781417|P1|Lead-in Study|Lack of Efficacy|20
2537302|NCT01572792|8781413|P5|Lead-in Study|Protocol Violation|21
2537303|NCT01572792|8781414|P4|Lead-in Study|Protocol Violation|13
2537304|NCT01572792|8781415|P3|Lead-in Study|Protocol Violation|12
2537305|NCT01572792|8781416|P2|Lead-in Study|Protocol Violation|10
2537306|NCT01572792|8781417|P1|Lead-in Study|Protocol Violation|19
2537307|NCT01572792|8781413|P5|Lead-in Study|Withdrawal by Subject|11
2537308|NCT01572792|8781414|P4|Lead-in Study|Withdrawal by Subject|24
2537309|NCT01572792|8781415|P3|Lead-in Study|Withdrawal by Subject|12
2537310|NCT01572792|8781416|P2|Lead-in Study|Withdrawal by Subject|11
2537311|NCT01572792|8781417|P1|Lead-in Study|Withdrawal by Subject|22
2537312|NCT01572792|8781413|P5|Lead-in Study|Lost to Follow-up|4
2537313|NCT01572792|8781414|P4|Lead-in Study|Lost to Follow-up|2
2537314|NCT01572792|8781415|P3|Lead-in Study|Lost to Follow-up|4
2537315|NCT01572792|8781416|P2|Lead-in Study|Lost to Follow-up|9
2537316|NCT01572792|8781417|P1|Lead-in Study|Lost to Follow-up|5
2537317|NCT01572740|8781466|P2|Overall Study|unclassified|3
2537318|NCT01572740|8781467|P1|Overall Study|unclassified|4
2537319|NCT01572740|8781466|P2|Overall Study|Withdrawal by Subject|1
2537320|NCT01572740|8781467|P1|Overall Study|Withdrawal by Subject|1
2537321|NCT01572740|8781466|P2|Overall Study|Adverse Event|1
2537322|NCT01572740|8781467|P1|Overall Study|Adverse Event|1
2537323|NCT01572727|8781497|P2|Overall Study|Untreated|7
2537324|NCT01572727|8781498|P1|Overall Study|Untreated|4
2537325|NCT01572727|8781497|P2|Overall Study|Death|2
2537326|NCT01572727|8781498|P1|Overall Study|Death|2
2537327|NCT01572727|8781497|P2|Overall Study|Parent/guardian decision|9
2537328|NCT01572727|8781498|P1|Overall Study|Parent/guardian decision|14
2537329|NCT01572727|8781497|P2|Overall Study|Study terminated by sponsor|83
2537330|NCT01572727|8781498|P1|Overall Study|Study terminated by sponsor|61
2537331|NCT01572727|8781497|P2|Overall Study|Protocol Violation|1
2537332|NCT01572727|8781498|P1|Overall Study|Protocol Violation|0
2537333|NCT01572727|8781497|P2|Overall Study|Progressive disease|82
2537334|NCT01572727|8781498|P1|Overall Study|Progressive disease|59
2537335|NCT01572727|8781497|P2|Overall Study|Physician Decision|9
2537336|NCT01572727|8781498|P1|Overall Study|Physician Decision|23
2537337|NCT01572727|8781497|P2|Overall Study|Lost to Follow-up|1
2537338|NCT01572727|8781498|P1|Overall Study|Lost to Follow-up|1
2537339|NCT01572727|8781497|P2|Overall Study|Adverse Event|15
2537340|NCT01572727|8781498|P1|Overall Study|Adverse Event|43
2537341|NCT01572675|8781520|P2|Overall Study|Lost to Follow-up|27
2537342|NCT01572675|8781521|P1|Overall Study|Lost to Follow-up|22
2537343|NCT01572675|8781520|P2|Overall Study|Missing data|4
2537344|NCT01572675|8781521|P1|Overall Study|Missing data|1
2537345|NCT01572675|8781520|P2|Overall Study|Rheumatologist new evaluation|1
2537346|NCT01572675|8781521|P1|Overall Study|Rheumatologist new evaluation|0
2537347|NCT01572675|8781520|P2|Overall Study|Unknown reason|1
2537348|NCT01572675|8781521|P1|Overall Study|Unknown reason|1
2537349|NCT01572675|8781520|P2|Overall Study|Other disease detected|1
2537350|NCT01572675|8781521|P1|Overall Study|Other disease detected|1
2537351|NCT01572675|8781520|P2|Overall Study|Death unrelated to coxibs|1
2537352|NCT01572675|8781521|P1|Overall Study|Death unrelated to coxibs|1
2537353|NCT01572675|8781520|P2|Overall Study|Physician Decision|2
2537354|NCT01572675|8781521|P1|Overall Study|Physician Decision|2
2537355|NCT01572675|8781520|P2|Overall Study|Withdrawal by Subject|1
2537356|NCT01572675|8781521|P1|Overall Study|Withdrawal by Subject|5
2537357|NCT01572675|8781520|P2|Overall Study|Surgical intervention|6
2537358|NCT01572675|8781521|P1|Overall Study|Surgical intervention|3
2537359|NCT01572675|8781520|P2|Overall Study|Improved symptoms|2
2537360|NCT01572675|8781521|P1|Overall Study|Improved symptoms|8
2537361|NCT01572675|8781520|P2|Overall Study|Intolerance|5
2537362|NCT01572675|8781521|P1|Overall Study|Intolerance|6
2537363|NCT01572675|8781520|P2|Overall Study|Lack of Efficacy|31
2537364|NCT01572675|8781521|P1|Overall Study|Lack of Efficacy|31
2537365|NCT01572675|8781520|P2|Overall Study|Recovery|23
2537366|NCT01572675|8781521|P1|Overall Study|Recovery|16
2537367|NCT01572675|8781520|P2|Overall Study|End of prescribed treatment|118
2537368|NCT01572675|8781521|P1|Overall Study|End of prescribed treatment|140
2537369|NCT01572389|8781639|P2|Overall Study|Only A1C or Assessment was Collected|2
2537370|NCT01572389|8781640|P1|Overall Study|Only A1C or Assessment was Collected|6
2537371|NCT01572389|8781639|P2|Overall Study|Lost to Follow-up|14
2537372|NCT01572389|8781640|P1|Overall Study|Lost to Follow-up|25
2537373|NCT01572389|8781639|P2|Overall Study|Withdrawal by Subject|2
2537374|NCT01572389|8781640|P1|Overall Study|Withdrawal by Subject|14
2537375|NCT01572389|8781639|P2|Overall Study|Death|3
2537376|NCT01572389|8781640|P1|Overall Study|Death|1
2537377|NCT01571453|8781681|P2|Overall Study|Administrative or other reason(s)|3
2537378|NCT01571453|8781682|P1|Overall Study|Administrative or other reason(s)|4
2537379|NCT01571453|8781681|P2|Overall Study|Lost to Follow-up|2
2537380|NCT01571453|8781682|P1|Overall Study|Lost to Follow-up|4
2537381|NCT01571453|8781681|P2|Overall Study|Withdrawal of consent|13
2537382|NCT01571453|8781682|P1|Overall Study|Withdrawal of consent|5
2537383|NCT01571453|8781681|P2|Overall Study|Protocol Violation|5
2537384|NCT01571453|8781682|P1|Overall Study|Protocol Violation|1
2537385|NCT01571453|8781681|P2|Overall Study|Non-compliance|4
2537386|NCT01571453|8781682|P1|Overall Study|Non-compliance|2
2537387|NCT01571453|8781681|P2|Overall Study|Lack of Efficacy|3
2537388|NCT01571453|8781682|P1|Overall Study|Lack of Efficacy|8
2537389|NCT01571453|8781681|P2|Overall Study|Adverse Event|32
2537390|NCT01571453|8781682|P1|Overall Study|Adverse Event|14
2537391|NCT01571362|8781729|P3|Double-Blind Treatment Period|Other - unspecified|1
2537392|NCT01571362|8781730|P2|Double-Blind Treatment Period|Other - unspecified|6
2537393|NCT01571362|8781731|P1|Double-Blind Treatment Period|Other - unspecified|0
2537394|NCT01571362|8781729|P3|Double-Blind Treatment Period|Insufficient clinical response|4
2537395|NCT01571362|8781730|P2|Double-Blind Treatment Period|Insufficient clinical response|16
2537396|NCT01571362|8781731|P1|Double-Blind Treatment Period|Insufficient clinical response|0
2537397|NCT01571362|8781729|P3|Double-Blind Treatment Period|Lost to Follow-up|6
2537398|NCT01571362|8781730|P2|Double-Blind Treatment Period|Lost to Follow-up|3
2537399|NCT01571362|8781731|P1|Double-Blind Treatment Period|Lost to Follow-up|0
2537400|NCT01571362|8781729|P3|Double-Blind Treatment Period|Adverse Event|14
2537401|NCT01571362|8781730|P2|Double-Blind Treatment Period|Adverse Event|9
2537402|NCT01571362|8781731|P1|Double-Blind Treatment Period|Adverse Event|0
2537403|NCT01571362|8781729|P3|Double-Blind Treatment Period|Protocol Violation|9
2537404|NCT01571362|8781730|P2|Double-Blind Treatment Period|Protocol Violation|8
2537405|NCT01571362|8781731|P1|Double-Blind Treatment Period|Protocol Violation|0
2537406|NCT01571362|8781729|P3|Double-Blind Treatment Period|Withdrawal by Subject|5
2537407|NCT01571362|8781730|P2|Double-Blind Treatment Period|Withdrawal by Subject|11
2537408|NCT01571362|8781731|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
2537409|NCT01571362|8781729|P3|Open-Label Conversion + Titration Period|Other - unspecified|0
2537410|NCT01571362|8781730|P2|Open-Label Conversion + Titration Period|Other - unspecified|0
2537411|NCT01571362|8781731|P1|Open-Label Conversion + Titration Period|Other - unspecified|3
2537412|NCT01571362|8781729|P3|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
2537413|NCT01571362|8781730|P2|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
2537414|NCT01571362|8781731|P1|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41
2537415|NCT01571362|8781729|P3|Open-Label Conversion + Titration Period|Lost to Follow-up|0
2537416|NCT01571362|8781730|P2|Open-Label Conversion + Titration Period|Lost to Follow-up|0
2537417|NCT01571362|8781731|P1|Open-Label Conversion + Titration Period|Lost to Follow-up|10
2537418|NCT01571362|8781729|P3|Open-Label Conversion + Titration Period|Adverse Event|0
2537419|NCT01571362|8781730|P2|Open-Label Conversion + Titration Period|Adverse Event|0
2537420|NCT01571362|8781731|P1|Open-Label Conversion + Titration Period|Adverse Event|57
2537421|NCT01571362|8781729|P3|Open-Label Conversion + Titration Period|Protocol Violation|0
2537422|NCT01571362|8781730|P2|Open-Label Conversion + Titration Period|Protocol Violation|0
2537423|NCT01571362|8781731|P1|Open-Label Conversion + Titration Period|Protocol Violation|7
2537424|NCT01571362|8781729|P3|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
2537425|NCT01571362|8781730|P2|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
2537426|NCT01571362|8781731|P1|Open-Label Conversion + Titration Period|Withdrawal by Subject|11
2537427|NCT01571284|8781901|P1|Overall Study|Other than specified above|80
2537428|NCT01571284|8781901|P1|Overall Study|Enrolled but not treated|2
2537429|NCT01571284|8781901|P1|Overall Study|Lost to Follow-up|3
2537430|NCT01571284|8781901|P1|Overall Study|Participant's decision|84
2537431|NCT01571232|8781924|P2|Overall Study|Withdrawal by Subject|0
2537432|NCT01571232|8781925|P1|Overall Study|Withdrawal by Subject|1
2537433|NCT01571232|8781924|P2|Overall Study|Lost to Follow-up|1
2537434|NCT01571232|8781925|P1|Overall Study|Lost to Follow-up|0
2537435|NCT01570868|8781937|P2|Overall Study|Withdrawal by Subject|0
2537436|NCT01570868|8781938|P1|Overall Study|Withdrawal by Subject|1
2537437|NCT01570868|8781937|P2|Overall Study|Lost to Follow-up|0
2537438|NCT01570868|8781938|P1|Overall Study|Lost to Follow-up|1
2537439|NCT01570868|8781937|P2|Overall Study|Physician Decision|4
2537440|NCT01570868|8781938|P1|Overall Study|Physician Decision|10
2537441|NCT01570868|8781937|P2|Overall Study|FDA Recommendation|3
2537442|NCT01570868|8781938|P1|Overall Study|FDA Recommendation|23
2537443|NCT01570868|8781937|P2|Overall Study|Adverse Event|1
2537444|NCT01570868|8781938|P1|Overall Study|Adverse Event|8
2537445|NCT01570751|8781950|P2|Period B (16 Weeks)|Protocol Violation|1
2537446|NCT01570751|8781951|P1|Period B (16 Weeks)|Protocol Violation|0
2537447|NCT01570751|8781950|P2|Period B (16 Weeks)|Adverse Event|0
2537448|NCT01570751|8781951|P1|Period B (16 Weeks)|Adverse Event|1
2537449|NCT01570751|8781950|P2|Period A (16 Weeks)|Unclassified|3
2537450|NCT01570751|8781951|P1|Period A (16 Weeks)|Unclassified|2
2537451|NCT01570751|8781950|P2|Period A (16 Weeks)|Withdrawal criteria|1
2537452|NCT01570751|8781951|P1|Period A (16 Weeks)|Withdrawal criteria|0
2537453|NCT01570751|8781950|P2|Period A (16 Weeks)|Protocol Violation|1
2537454|NCT01570751|8781951|P1|Period A (16 Weeks)|Protocol Violation|1
2537455|NCT01570686|8781969|P2|Overall Study|Unsatisfactory therapeutic effect|1
2537456|NCT01570686|8781970|P1|Overall Study|Unsatisfactory therapeutic effect|2
2537457|NCT01570686|8781969|P2|Overall Study|Withdrawal by Subject|4
2537458|NCT01570686|8781970|P1|Overall Study|Withdrawal by Subject|4
2537459|NCT01570686|8781969|P2|Overall Study|Protocol Deviation|0
2537460|NCT01570686|8781970|P1|Overall Study|Protocol Deviation|3
2537461|NCT01570686|8781969|P2|Overall Study|Lost to Follow-up|3
2537462|NCT01570686|8781970|P1|Overall Study|Lost to Follow-up|4
2537463|NCT01570686|8781969|P2|Overall Study|Adverse Event|6
2537464|NCT01570686|8781970|P1|Overall Study|Adverse Event|8
2537465|NCT01570686|8781969|P2|Overall Study|Administrative problems|1
2537466|NCT01570686|8781970|P1|Overall Study|Administrative problems|0
2537467|NCT01570686|8781969|P2|Overall Study|Abnormal test procedure result(s)|1
2537468|NCT01570686|8781970|P1|Overall Study|Abnormal test procedure result(s)|1
2537469|NCT01570491|8782006|P2|Overall Study|treatment: not given or discontinued|0
2537470|NCT01570491|8782007|P1|Overall Study|treatment: not given or discontinued|2
2537471|NCT01570491|8782006|P2|Overall Study|Lost to Follow-up|1
2537472|NCT01570491|8782007|P1|Overall Study|Lost to Follow-up|3
2537473|NCT01570387|8782023|P4|Overall Study|Withdrawal by Subject|1
2537474|NCT01570387|8782024|P3|Overall Study|Withdrawal by Subject|0
2537475|NCT01570387|8782025|P2|Overall Study|Withdrawal by Subject|0
2537476|NCT01570387|8782026|P1|Overall Study|Withdrawal by Subject|0
2537477|NCT01570387|8782023|P4|Overall Study|Death|1
2537478|NCT01570387|8782024|P3|Overall Study|Death|0
2537479|NCT01570387|8782025|P2|Overall Study|Death|0
2537480|NCT01570387|8782026|P1|Overall Study|Death|0
2537481|NCT01570387|8782023|P4|Overall Study|Adverse Event|0
2537482|NCT01570387|8782024|P3|Overall Study|Adverse Event|0
2537483|NCT01570387|8782025|P2|Overall Study|Adverse Event|0
2537484|NCT01570387|8782026|P1|Overall Study|Adverse Event|1
2537485|NCT01570309|8782052|P2|Overall Study|Withdrawal by Subject|3
2537486|NCT01570309|8782053|P1|Overall Study|Withdrawal by Subject|3
2537487|NCT01570283|8782070|P6|Cohort 3: Dose Level 3|Received other hematopoietic cells|1
2537488|NCT01570283|8782071|P5|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
2537489|NCT01570283|8782072|P4|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
2537490|NCT01570283|8782073|P3|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
2537491|NCT01570283|8782074|P2|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
2537492|NCT01570283|8782075|P1|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
2537493|NCT01570283|8782070|P6|Cohort 3: Dose Level 3|Death|1
2537494|NCT01570283|8782071|P5|Cohort 3: Dose Level 3|Death|0
2537495|NCT01570283|8782072|P4|Cohort 3: Dose Level 3|Death|0
2537496|NCT01570283|8782073|P3|Cohort 3: Dose Level 3|Death|0
2537497|NCT01570283|8782074|P2|Cohort 3: Dose Level 3|Death|0
2537498|NCT01570283|8782075|P1|Cohort 3: Dose Level 3|Death|0
2537499|NCT01570283|8782070|P6|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
2537500|NCT01570283|8782071|P5|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
2537501|NCT01570283|8782072|P4|Cohort 2: Dose Level 2|Received other hematopoietic cells|1
2537502|NCT01570283|8782073|P3|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
2537503|NCT01570283|8782074|P2|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
2537504|NCT01570283|8782075|P1|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
2537505|NCT01570283|8782070|P6|Cohort 2: Dose Level 2|Death|0
2537506|NCT01570283|8782071|P5|Cohort 2: Dose Level 2|Death|0
2537507|NCT01570283|8782072|P4|Cohort 2: Dose Level 2|Death|0
2537508|NCT01570283|8782073|P3|Cohort 2: Dose Level 2|Death|1
2537509|NCT01570283|8782074|P2|Cohort 2: Dose Level 2|Death|0
2537510|NCT01570283|8782075|P1|Cohort 2: Dose Level 2|Death|0
2537511|NCT01570283|8782070|P6|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
2537512|NCT01570283|8782071|P5|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
2537513|NCT01570283|8782072|P4|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
2537514|NCT01570283|8782073|P3|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
2537515|NCT01570283|8782074|P2|Cohort 1: Dose Level 1|Received other hematopoietic cells|1
2537516|NCT01570283|8782075|P1|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
2537517|NCT01570283|8782070|P6|Cohort 1: Dose Level 1|Death|0
2537518|NCT01570283|8782071|P5|Cohort 1: Dose Level 1|Death|0
2537519|NCT01570283|8782072|P4|Cohort 1: Dose Level 1|Death|0
2537520|NCT01570283|8782073|P3|Cohort 1: Dose Level 1|Death|0
2537521|NCT01570283|8782074|P2|Cohort 1: Dose Level 1|Death|1
2537522|NCT01570283|8782075|P1|Cohort 1: Dose Level 1|Death|0
2537523|NCT01570244|8782092|P1|Microgynon+Faldaprevir|Adverse Event|1
2537524|NCT01570192|8782114|P2|Overall Study|Physician Decision|1
2537525|NCT01570192|8782115|P1|Overall Study|Physician Decision|0
2537526|NCT01570192|8782114|P2|Overall Study|changed to palliative care|0
2537527|NCT01570192|8782115|P1|Overall Study|changed to palliative care|1
2537528|NCT01570192|8782114|P2|Overall Study|no qualifying organism|12
2537529|NCT01570192|8782115|P1|Overall Study|no qualifying organism|6
2537530|NCT01569841|8782153|P2|Period A (6 Weeks)|Withdrawal by Subject|1
2537531|NCT01569841|8782154|P1|Period A (6 Weeks)|Withdrawal by Subject|0
2537532|NCT01569763|8782243|P2|Overall Study|Adverse Event|0
2537533|NCT01569763|8782244|P1|Overall Study|Adverse Event|1
2537534|NCT01569763|8782243|P2|Overall Study|Lack of Efficacy|7
2537535|NCT01569763|8782244|P1|Overall Study|Lack of Efficacy|2
2537536|NCT01569594|8782283|P1|Overall Study|No ECM used|9
2537537|NCT01569594|8782283|P1|Overall Study|Other|4
2537538|NCT01569594|8782283|P1|Overall Study|Withdrawal by Subject|13
2537539|NCT01569594|8782283|P1|Overall Study|Adverse Event|2
2537540|NCT01569594|8782283|P1|Overall Study|Lost to Follow-up|22
2537541|NCT01569594|8782283|P1|Overall Study|Death|13
2537542|NCT01569594|8782283|P1|Overall Study|Physician Decision|4
2537543|NCT01569568|8782289|P2|Overall Study|Physician Decision|2
2537544|NCT01569568|8782290|P1|Overall Study|Physician Decision|0
2537545|NCT01569464|8782313|P2|Overall Study|Other|1
2537546|NCT01569464|8782314|P1|Overall Study|Other|1
2537547|NCT01569464|8782313|P2|Overall Study|Withdrawal by Subject|1
2537548|NCT01569464|8782314|P1|Overall Study|Withdrawal by Subject|1
2537549|NCT01569464|8782313|P2|Overall Study|Lost to Follow-up|3
2537550|NCT01569464|8782314|P1|Overall Study|Lost to Follow-up|2
2537551|NCT01569464|8782313|P2|Overall Study|Protocol Violation|0
2537552|NCT01569464|8782314|P1|Overall Study|Protocol Violation|1
2537553|NCT01569464|8782313|P2|Overall Study|Lack of Efficacy|0
2537554|NCT01569464|8782314|P1|Overall Study|Lack of Efficacy|1
2537555|NCT01569464|8782313|P2|Overall Study|Adverse Event|0
2537556|NCT01569464|8782314|P1|Overall Study|Adverse Event|4
2537557|NCT01569438|8782381|P2|Overall Study|Protocol Violation|0
2537558|NCT01569438|8782382|P1|Overall Study|Protocol Violation|1
2537559|NCT01569438|8782381|P2|Overall Study|Withdrawal by Subject|1
2537560|NCT01569438|8782382|P1|Overall Study|Withdrawal by Subject|0
2537561|NCT01569438|8782381|P2|Overall Study|Lack of Efficacy|1
2537562|NCT01569438|8782382|P1|Overall Study|Lack of Efficacy|1
2537563|NCT01569438|8782381|P2|Overall Study|Adverse Event|7
2537564|NCT01569438|8782382|P1|Overall Study|Adverse Event|0
2537565|NCT01569295|8782396|P2|Overall Study|Lost to Follow-up|1
2537566|NCT01569295|8782397|P1|Overall Study|Lost to Follow-up|1
2537567|NCT01569295|8782396|P2|Overall Study|Other Anticancer/Experimental Therapy|2
2537568|NCT01569295|8782397|P1|Overall Study|Other Anticancer/Experimental Therapy|2
2537569|NCT01569295|8782396|P2|Overall Study|Non-Compliance with Study Drug|1
2537570|NCT01569295|8782397|P1|Overall Study|Non-Compliance with Study Drug|6
2537571|NCT01569295|8782396|P2|Overall Study|Other Reason not Specified|5
2537572|NCT01569295|8782397|P1|Overall Study|Other Reason not Specified|3
2537573|NCT01569295|8782396|P2|Overall Study|Study Terminated by Sponsor|2
2537574|NCT01569295|8782397|P1|Overall Study|Study Terminated by Sponsor|24
2537575|NCT01569295|8782396|P2|Overall Study|Physician Decision|18
2537576|NCT01569295|8782397|P1|Overall Study|Physician Decision|13
2537577|NCT01569295|8782396|P2|Overall Study|Death|15
2537578|NCT01569295|8782397|P1|Overall Study|Death|19
2537579|NCT01569295|8782396|P2|Overall Study|Withdrawal by Subject|12
2537580|NCT01569295|8782397|P1|Overall Study|Withdrawal by Subject|25
2537581|NCT01569295|8782396|P2|Overall Study|Adverse Event|14
2537582|NCT01569295|8782397|P1|Overall Study|Adverse Event|39
2537583|NCT01569295|8782396|P2|Overall Study|Progressive Disease|139
2537584|NCT01569295|8782397|P1|Overall Study|Progressive Disease|75
2537585|NCT01569152|8782434|P3|Safety Extension, Period 3|Study terminated by Sponsor|47
2537586|NCT01569152|8782435|P2|Safety Extension, Period 3|Study terminated by Sponsor|0
2537587|NCT01569152|8782436|P1|Safety Extension, Period 3|Study terminated by Sponsor|0
2537588|NCT01569152|8782434|P3|Safety Extension, Period 3|Physician Decision|2
2537589|NCT01569152|8782435|P2|Safety Extension, Period 3|Physician Decision|0
2537590|NCT01569152|8782436|P1|Safety Extension, Period 3|Physician Decision|0
2537591|NCT01569152|8782434|P3|Safety Extension, Period 3|Withdrawal by Subject|2
2537592|NCT01569152|8782435|P2|Safety Extension, Period 3|Withdrawal by Subject|0
2537593|NCT01569152|8782436|P1|Safety Extension, Period 3|Withdrawal by Subject|0
2537594|NCT01569152|8782434|P3|Safety Extension, Period 3|Adverse Event|4
2537595|NCT01569152|8782435|P2|Safety Extension, Period 3|Adverse Event|0
2537596|NCT01569152|8782436|P1|Safety Extension, Period 3|Adverse Event|0
2537597|NCT01569152|8782434|P3|Phase IIa, Period 1|Withdrawal by Subject|0
2537598|NCT01569152|8782435|P2|Phase IIa, Period 1|Withdrawal by Subject|1
2537599|NCT01569152|8782436|P1|Phase IIa, Period 1|Withdrawal by Subject|2
2537600|NCT01569152|8782434|P3|Phase IIa, Period 1|Protocol Violation|0
2537601|NCT01569152|8782435|P2|Phase IIa, Period 1|Protocol Violation|1
2537602|NCT01569152|8782436|P1|Phase IIa, Period 1|Protocol Violation|0
2537603|NCT01569152|8782434|P3|Phase IIa, Period 1|Study Terminated by Sponsor|0
2537604|NCT01569152|8782435|P2|Phase IIa, Period 1|Study Terminated by Sponsor|8
2537605|NCT01569152|8782436|P1|Phase IIa, Period 1|Study Terminated by Sponsor|9
2537606|NCT01569152|8782434|P3|Phase IIa, Period 1|Lost to Follow-up|0
2537607|NCT01569152|8782435|P2|Phase IIa, Period 1|Lost to Follow-up|0
2537608|NCT01569152|8782436|P1|Phase IIa, Period 1|Lost to Follow-up|1
2537609|NCT01569152|8782434|P3|Phase IIa, Period 1|Adverse Event|0
2537610|NCT01569152|8782435|P2|Phase IIa, Period 1|Adverse Event|0
2537611|NCT01569152|8782436|P1|Phase IIa, Period 1|Adverse Event|4
2537612|NCT01569152|8782434|P3|Phase IIa, Period 1|Early Escape|0
2537613|NCT01569152|8782435|P2|Phase IIa, Period 1|Early Escape|22
2537614|NCT01569152|8782436|P1|Phase IIa, Period 1|Early Escape|5
2537615|NCT01569074|8782572|P5|Overall Study|Adverse Event|0
2537616|NCT01569074|8782573|P4|Overall Study|Adverse Event|0
2537617|NCT01569074|8782574|P3|Overall Study|Adverse Event|3
2537618|NCT01569074|8782575|P2|Overall Study|Adverse Event|0
2537619|NCT01569074|8782576|P1|Overall Study|Adverse Event|1
2537620|NCT01569074|8782572|P5|Overall Study|eg change in circumstances|1
2537621|NCT01569074|8782573|P4|Overall Study|eg change in circumstances|1
2537622|NCT01569074|8782574|P3|Overall Study|eg change in circumstances|0
2537623|NCT01569074|8782575|P2|Overall Study|eg change in circumstances|2
2537624|NCT01569074|8782576|P1|Overall Study|eg change in circumstances|0
2537625|NCT01569074|8782572|P5|Overall Study|Severe non-compliance to protocol|0
2537626|NCT01569074|8782573|P4|Overall Study|Severe non-compliance to protocol|0
2537627|NCT01569074|8782574|P3|Overall Study|Severe non-compliance to protocol|1
2537628|NCT01569074|8782575|P2|Overall Study|Severe non-compliance to protocol|0
2537629|NCT01569074|8782576|P1|Overall Study|Severe non-compliance to protocol|0
2537630|NCT01569074|8782572|P5|Overall Study|Study-specific discontinuation criteria|0
2537631|NCT01569074|8782573|P4|Overall Study|Study-specific discontinuation criteria|0
2537632|NCT01569074|8782574|P3|Overall Study|Study-specific discontinuation criteria|0
2537633|NCT01569074|8782575|P2|Overall Study|Study-specific discontinuation criteria|1
2537634|NCT01569074|8782576|P1|Overall Study|Study-specific discontinuation criteria|0
2537635|NCT01569074|8782572|P5|Overall Study|Study stopped|7
2537636|NCT01569074|8782573|P4|Overall Study|Study stopped|7
2537637|NCT01569074|8782574|P3|Overall Study|Study stopped|8
2537638|NCT01569074|8782575|P2|Overall Study|Study stopped|6
2537639|NCT01569074|8782576|P1|Overall Study|Study stopped|6
2537640|NCT01569022|8782632|P2|Second Intervention|Lost to Follow-up|2
2537641|NCT01569022|8782633|P1|Second Intervention|Lost to Follow-up|2
2537642|NCT01569022|8782632|P2|First Intervention|Lost to Follow-up|1
2537643|NCT01569022|8782633|P1|First Intervention|Lost to Follow-up|2
2537644|NCT01568892|8782669|P2|Open-label Phase|Lost to Follow-up|1
2537645|NCT01568892|8782670|P1|Open-label Phase|Lost to Follow-up|0
2537646|NCT01568892|8782669|P2|Open-label Phase|Lack of Efficacy|2
2537647|NCT01568892|8782670|P1|Open-label Phase|Lack of Efficacy|4
2537648|NCT01568892|8782669|P2|Open-label Phase|Adverse Event|0
2537649|NCT01568892|8782670|P1|Open-label Phase|Adverse Event|2
2537650|NCT01568866|8782740|P2|Overall Study|Randomized but Not Dosed|1
2537651|NCT01568866|8782741|P1|Overall Study|Randomized but Not Dosed|9
2537652|NCT01568866|8782740|P2|Overall Study|Lost to Follow-up|0
2537653|NCT01568866|8782741|P1|Overall Study|Lost to Follow-up|1
2537654|NCT01568866|8782740|P2|Overall Study|Protocol Non-compliance|4
2537655|NCT01568866|8782741|P1|Overall Study|Protocol Non-compliance|2
2537656|NCT01568866|8782740|P2|Overall Study|Death|18
2537657|NCT01568866|8782741|P1|Overall Study|Death|10
2537658|NCT01568866|8782740|P2|Overall Study|Withdrawal by Subject|11
2537659|NCT01568866|8782741|P1|Overall Study|Withdrawal by Subject|19
2537660|NCT01568866|8782740|P2|Overall Study|Physician Decision|32
2537661|NCT01568866|8782741|P1|Overall Study|Physician Decision|40
2537662|NCT01568866|8782740|P2|Overall Study|Patient Request|71
2537663|NCT01568866|8782741|P1|Overall Study|Patient Request|55
2537664|NCT01568866|8782740|P2|Overall Study|Adverse Event|96
2537665|NCT01568866|8782741|P1|Overall Study|Adverse Event|94
2537666|NCT01568866|8782740|P2|Overall Study|Disease Progression|183
2537667|NCT01568866|8782741|P1|Overall Study|Disease Progression|208
2537668|NCT01568593|8782776|P2|Overall Study|Adverse Event|2
2537669|NCT01568593|8782777|P1|Overall Study|Adverse Event|3
2537670|NCT01568593|8782776|P2|Overall Study|Lack of Efficacy|1
2537671|NCT01568593|8782777|P1|Overall Study|Lack of Efficacy|4
2537672|NCT01568112|8782822|P4|Overall Study|Withdrawal by Physician|1
2537673|NCT01568112|8782823|P3|Overall Study|Withdrawal by Physician|1
2537674|NCT01568112|8782824|P2|Overall Study|Withdrawal by Physician|0
2537675|NCT01568112|8782825|P1|Overall Study|Withdrawal by Physician|1
2537676|NCT01568112|8782822|P4|Overall Study|Withdrawal by Subject|7
2537677|NCT01568112|8782823|P3|Overall Study|Withdrawal by Subject|0
2537678|NCT01568112|8782824|P2|Overall Study|Withdrawal by Subject|3
2537679|NCT01568112|8782825|P1|Overall Study|Withdrawal by Subject|2
2537680|NCT01568112|8782822|P4|Overall Study|Lost to Follow-up|1
2537681|NCT01568112|8782823|P3|Overall Study|Lost to Follow-up|0
2537682|NCT01568112|8782824|P2|Overall Study|Lost to Follow-up|0
2537683|NCT01568112|8782825|P1|Overall Study|Lost to Follow-up|0
2537684|NCT01568112|8782822|P4|Overall Study|Withdrew due to Adverse Event|3
2537685|NCT01568112|8782823|P3|Overall Study|Withdrew due to Adverse Event|6
2537686|NCT01568112|8782824|P2|Overall Study|Withdrew due to Adverse Event|4
2537687|NCT01568112|8782825|P1|Overall Study|Withdrew due to Adverse Event|2
2537688|NCT01568112|8782822|P4|Overall Study|Randomized But Not Treated|0
2537689|NCT01568112|8782823|P3|Overall Study|Randomized But Not Treated|0
2537690|NCT01568112|8782824|P2|Overall Study|Randomized But Not Treated|1
2537691|NCT01568112|8782825|P1|Overall Study|Randomized But Not Treated|0
2537692|NCT01568047|8782983|P4|Overall Study|Adverse Event|1
2537693|NCT01568047|8782984|P3|Overall Study|Adverse Event|1
2537694|NCT01568047|8782985|P2|Overall Study|Adverse Event|0
2537695|NCT01568047|8782986|P1|Overall Study|Adverse Event|0
2537696|NCT01568047|8782983|P4|Overall Study|Withdrawal by Subject|0
2537697|NCT01568047|8782984|P3|Overall Study|Withdrawal by Subject|0
2537698|NCT01568047|8782985|P2|Overall Study|Withdrawal by Subject|1
2537699|NCT01568047|8782986|P1|Overall Study|Withdrawal by Subject|0
2537700|NCT01568047|8782983|P4|Overall Study|Ineligibility|0
2537701|NCT01568047|8782984|P3|Overall Study|Ineligibility|0
2537702|NCT01568047|8782985|P2|Overall Study|Ineligibility|0
2537703|NCT01568047|8782986|P1|Overall Study|Ineligibility|1
2537704|NCT01568034|8783004|P4|Overall Study|Withdrawal by Subject|0
2537705|NCT01568034|8783005|P3|Overall Study|Withdrawal by Subject|0
2537706|NCT01568034|8783006|P2|Overall Study|Withdrawal by Subject|0
2537707|NCT01568034|8783007|P1|Overall Study|Withdrawal by Subject|1
2537708|NCT01567865|8783070|P4|Evaluated for Immunogenicity|Missing blood sample|28
2537709|NCT01567865|8783071|P3|Evaluated for Immunogenicity|Missing blood sample|16
2537710|NCT01567865|8783072|P2|Evaluated for Immunogenicity|Missing blood sample|24
2537711|NCT01567865|8783073|P1|Evaluated for Immunogenicity|Missing blood sample|17
2537712|NCT01567865|8783070|P4|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2
2537713|NCT01567865|8783071|P3|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3
2537714|NCT01567865|8783072|P2|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1
2537715|NCT01567865|8783073|P1|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0
2537716|NCT01567852|8783103|P2|Overall Study|ECT discontinued|1
2537717|NCT01567852|8783104|P1|Overall Study|ECT discontinued|1
2537718|NCT01567852|8783103|P2|Overall Study|Withdrawal by Subject|6
2537719|NCT01567852|8783104|P1|Overall Study|Withdrawal by Subject|3
2537720|NCT01567826|8783122|P2|Overall Study|Lost to Follow-up|2
2537721|NCT01567826|8783123|P1|Overall Study|Lost to Follow-up|3
2537722|NCT01567527|8783149|P5|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5
2537723|NCT01567527|8783150|P4|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8
2537724|NCT01567527|8783151|P3|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
2537725|NCT01567527|8783152|P2|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
2537726|NCT01567527|8783153|P1|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
2537727|NCT01567527|8783149|P5|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35
2537728|NCT01567527|8783150|P4|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19
2537729|NCT01567527|8783151|P3|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
2537730|NCT01567527|8783152|P2|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
2537731|NCT01567527|8783153|P1|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
2537732|NCT01567527|8783149|P5|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3
2537733|NCT01567527|8783150|P4|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1
2537734|NCT01567527|8783151|P3|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
2537735|NCT01567527|8783152|P2|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
2537736|NCT01567527|8783153|P1|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
2537737|NCT01567527|8783149|P5|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10
2537738|NCT01567527|8783150|P4|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13
2537739|NCT01567527|8783151|P3|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
2537740|NCT01567527|8783152|P2|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
2537741|NCT01567527|8783153|P1|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
2537742|NCT01567527|8783149|P5|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1
2537743|NCT01567527|8783150|P4|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7
2537744|NCT01567527|8783151|P3|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
2537745|NCT01567527|8783152|P2|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
2537746|NCT01567527|8783153|P1|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
2537747|NCT01567527|8783149|P5|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7
2537748|NCT01567527|8783150|P4|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4
2537749|NCT01567527|8783151|P3|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
2537750|NCT01567527|8783152|P2|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
2537751|NCT01567527|8783153|P1|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
2537752|NCT01567527|8783149|P5|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33
2537753|NCT01567527|8783150|P4|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16
2537754|NCT01567527|8783151|P3|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
2537755|NCT01567527|8783152|P2|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
2537756|NCT01567527|8783153|P1|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
2537757|NCT01567527|8783149|P5|Double-blind, Placebo-controlled Phase|Protocol deviation|1
2537758|NCT01567527|8783150|P4|Double-blind, Placebo-controlled Phase|Protocol deviation|1
2537759|NCT01567527|8783151|P3|Double-blind, Placebo-controlled Phase|Protocol deviation|0
2537760|NCT01567527|8783152|P2|Double-blind, Placebo-controlled Phase|Protocol deviation|0
2537761|NCT01567527|8783153|P1|Double-blind, Placebo-controlled Phase|Protocol deviation|0
2537762|NCT01567527|8783149|P5|IM Depot Stabilization.|Withdrawn by the investigator|0
2537763|NCT01567527|8783150|P4|IM Depot Stabilization.|Withdrawn by the investigator|0
2537764|NCT01567527|8783151|P3|IM Depot Stabilization.|Withdrawn by the investigator|6
2537765|NCT01567527|8783152|P2|IM Depot Stabilization.|Withdrawn by the investigator|0
2537766|NCT01567527|8783153|P1|IM Depot Stabilization.|Withdrawn by the investigator|0
2537767|NCT01567527|8783149|P5|IM Depot Stabilization.|Adverse Event|0
2537768|NCT01567527|8783150|P4|IM Depot Stabilization.|Adverse Event|0
2537769|NCT01567527|8783151|P3|IM Depot Stabilization.|Adverse Event|37
2537770|NCT01567527|8783152|P2|IM Depot Stabilization.|Adverse Event|0
2537771|NCT01567527|8783153|P1|IM Depot Stabilization.|Adverse Event|0
2537772|NCT01567527|8783149|P5|IM Depot Stabilization.|Lack of Efficacy|0
2537773|NCT01567527|8783150|P4|IM Depot Stabilization.|Lack of Efficacy|0
2537774|NCT01567527|8783151|P3|IM Depot Stabilization.|Lack of Efficacy|7
2537775|NCT01567527|8783152|P2|IM Depot Stabilization.|Lack of Efficacy|0
2537776|NCT01567527|8783153|P1|IM Depot Stabilization.|Lack of Efficacy|0
2537777|NCT01567527|8783149|P5|IM Depot Stabilization.|Lost to Follow-up|0
2537778|NCT01567527|8783150|P4|IM Depot Stabilization.|Lost to Follow-up|0
2537779|NCT01567527|8783151|P3|IM Depot Stabilization.|Lost to Follow-up|21
2537780|NCT01567527|8783152|P2|IM Depot Stabilization.|Lost to Follow-up|0
2537781|NCT01567527|8783153|P1|IM Depot Stabilization.|Lost to Follow-up|0
2537782|NCT01567527|8783149|P5|IM Depot Stabilization.|Sponsor discontinued study|0
2537783|NCT01567527|8783150|P4|IM Depot Stabilization.|Sponsor discontinued study|0
2537784|NCT01567527|8783151|P3|IM Depot Stabilization.|Sponsor discontinued study|1
2537785|NCT01567527|8783152|P2|IM Depot Stabilization.|Sponsor discontinued study|0
2537786|NCT01567527|8783153|P1|IM Depot Stabilization.|Sponsor discontinued study|0
2537787|NCT01567527|8783149|P5|IM Depot Stabilization.|Withdrawal by Subject|0
2537788|NCT01567527|8783150|P4|IM Depot Stabilization.|Withdrawal by Subject|0
2537789|NCT01567527|8783151|P3|IM Depot Stabilization.|Withdrawal by Subject|56
2537790|NCT01567527|8783152|P2|IM Depot Stabilization.|Withdrawal by Subject|0
2537791|NCT01567527|8783153|P1|IM Depot Stabilization.|Withdrawal by Subject|0
2537792|NCT01567527|8783149|P5|IM Depot Stabilization.|Met withdrawal criteria|0
2537793|NCT01567527|8783150|P4|IM Depot Stabilization.|Met withdrawal criteria|0
2537794|NCT01567527|8783151|P3|IM Depot Stabilization.|Met withdrawal criteria|26
2537795|NCT01567527|8783152|P2|IM Depot Stabilization.|Met withdrawal criteria|0
2537796|NCT01567527|8783153|P1|IM Depot Stabilization.|Met withdrawal criteria|0
2537797|NCT01567527|8783149|P5|IM Depot Stabilization.|Protocol deviation|0
2537798|NCT01567527|8783150|P4|IM Depot Stabilization.|Protocol deviation|0
2537799|NCT01567527|8783151|P3|IM Depot Stabilization.|Protocol deviation|5
2537800|NCT01567527|8783152|P2|IM Depot Stabilization.|Protocol deviation|0
2537801|NCT01567527|8783153|P1|IM Depot Stabilization.|Protocol deviation|0
2537802|NCT01567527|8783149|P5|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
2537803|NCT01567527|8783150|P4|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
2537804|NCT01567527|8783151|P3|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
2537805|NCT01567527|8783152|P2|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2
2537806|NCT01567527|8783153|P1|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
2537807|NCT01567527|8783149|P5|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
2537808|NCT01567527|8783150|P4|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
2537809|NCT01567527|8783151|P3|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
2537810|NCT01567527|8783152|P2|Oral Aripiprazole Stabilization Phase.|Adverse Event|63
2537811|NCT01567527|8783153|P1|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
2537812|NCT01567527|8783149|P5|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
2537813|NCT01567527|8783150|P4|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
2537814|NCT01567527|8783151|P3|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
2537815|NCT01567527|8783152|P2|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12
2537816|NCT01567527|8783153|P1|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
2537817|NCT01567527|8783149|P5|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
2537818|NCT01567527|8783150|P4|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
2537819|NCT01567527|8783151|P3|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
2537820|NCT01567527|8783152|P2|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44
2537821|NCT01567527|8783153|P1|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
2537822|NCT01567527|8783149|P5|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
2537823|NCT01567527|8783150|P4|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
2537824|NCT01567527|8783151|P3|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
2537825|NCT01567527|8783152|P2|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45
2537826|NCT01567527|8783153|P1|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
2537827|NCT01567527|8783149|P5|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
2537828|NCT01567527|8783150|P4|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
2537829|NCT01567527|8783151|P3|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
2537830|NCT01567527|8783152|P2|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41
2537831|NCT01567527|8783153|P1|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
2537832|NCT01567527|8783149|P5|Conversion Phase.|Withdrawn by the investigator|0
2537833|NCT01567527|8783150|P4|Conversion Phase.|Withdrawn by the investigator|0
2537834|NCT01567527|8783151|P3|Conversion Phase.|Withdrawn by the investigator|0
2537835|NCT01567527|8783152|P2|Conversion Phase.|Withdrawn by the investigator|0
2537836|NCT01567527|8783153|P1|Conversion Phase.|Withdrawn by the investigator|3
2537837|NCT01567527|8783149|P5|Conversion Phase.|Adverse Event|0
2537838|NCT01567527|8783150|P4|Conversion Phase.|Adverse Event|0
2537839|NCT01567527|8783151|P3|Conversion Phase.|Adverse Event|0
2537840|NCT01567527|8783152|P2|Conversion Phase.|Adverse Event|0
2537841|NCT01567527|8783153|P1|Conversion Phase.|Adverse Event|33
2537842|NCT01567527|8783149|P5|Conversion Phase.|Lack of Efficacy|0
2537843|NCT01567527|8783150|P4|Conversion Phase.|Lack of Efficacy|0
2537844|NCT01567527|8783151|P3|Conversion Phase.|Lack of Efficacy|0
2537845|NCT01567527|8783152|P2|Conversion Phase.|Lack of Efficacy|0
2537846|NCT01567527|8783153|P1|Conversion Phase.|Lack of Efficacy|2
2537847|NCT01567527|8783149|P5|Conversion Phase.|Lost to Follow-up|0
2537848|NCT01567527|8783150|P4|Conversion Phase.|Lost to Follow-up|0
2537849|NCT01567527|8783151|P3|Conversion Phase.|Lost to Follow-up|0
2537850|NCT01567527|8783152|P2|Conversion Phase.|Lost to Follow-up|0
2537851|NCT01567527|8783153|P1|Conversion Phase.|Lost to Follow-up|16
2537852|NCT01567527|8783149|P5|Conversion Phase.|Withdrawal by Subject|0
2537853|NCT01567527|8783150|P4|Conversion Phase.|Withdrawal by Subject|0
2537854|NCT01567527|8783151|P3|Conversion Phase.|Withdrawal by Subject|0
2537855|NCT01567527|8783152|P2|Conversion Phase.|Withdrawal by Subject|0
2537856|NCT01567527|8783153|P1|Conversion Phase.|Withdrawal by Subject|32
2537857|NCT01567527|8783149|P5|Conversion Phase.|Met withdrawal criteria|0
2537858|NCT01567527|8783150|P4|Conversion Phase.|Met withdrawal criteria|0
2537859|NCT01567527|8783151|P3|Conversion Phase.|Met withdrawal criteria|0
2537860|NCT01567527|8783152|P2|Conversion Phase.|Met withdrawal criteria|0
2537861|NCT01567527|8783153|P1|Conversion Phase.|Met withdrawal criteria|10
2537862|NCT01567527|8783149|P5|Conversion Phase.|Protocol deviation|0
2537863|NCT01567527|8783150|P4|Conversion Phase.|Protocol deviation|0
2537864|NCT01567527|8783151|P3|Conversion Phase.|Protocol deviation|0
2537865|NCT01567527|8783152|P2|Conversion Phase.|Protocol deviation|0
2537866|NCT01567527|8783153|P1|Conversion Phase.|Protocol deviation|3
2537867|NCT01567462|8783170|P2|Overall Study|Withdrawal by Subject|7
2537868|NCT01567462|8783171|P1|Overall Study|Withdrawal by Subject|4
2537869|NCT01567306|8783194|P6|Overall Study|Withdrawal by Subject|1
2537870|NCT01567306|8783195|P5|Overall Study|Withdrawal by Subject|0
2537871|NCT01567306|8783196|P4|Overall Study|Withdrawal by Subject|0
2537872|NCT01567306|8783197|P3|Overall Study|Withdrawal by Subject|0
2537873|NCT01567306|8783198|P2|Overall Study|Withdrawal by Subject|0
2537874|NCT01567306|8783199|P1|Overall Study|Withdrawal by Subject|0
2537875|NCT01567306|8783194|P6|Overall Study|Lost to Follow-up|0
2537876|NCT01567306|8783195|P5|Overall Study|Lost to Follow-up|2
2537877|NCT01567306|8783196|P4|Overall Study|Lost to Follow-up|0
2537878|NCT01567306|8783197|P3|Overall Study|Lost to Follow-up|0
2537879|NCT01567306|8783198|P2|Overall Study|Lost to Follow-up|0
2537880|NCT01567306|8783199|P1|Overall Study|Lost to Follow-up|0
2537881|NCT01567306|8783194|P6|Overall Study|Adverse Event|1
2537882|NCT01567306|8783195|P5|Overall Study|Adverse Event|4
2537883|NCT01567306|8783196|P4|Overall Study|Adverse Event|2
2537884|NCT01567306|8783197|P3|Overall Study|Adverse Event|0
2537885|NCT01567306|8783198|P2|Overall Study|Adverse Event|0
2537886|NCT01567306|8783199|P1|Overall Study|Adverse Event|0
2537887|NCT01567306|8783194|P6|Overall Study|Change site living|0
2537888|NCT01567306|8783195|P5|Overall Study|Change site living|0
2537889|NCT01567306|8783196|P4|Overall Study|Change site living|0
2537890|NCT01567306|8783197|P3|Overall Study|Change site living|0
2537891|NCT01567306|8783198|P2|Overall Study|Change site living|0
2537892|NCT01567306|8783199|P1|Overall Study|Change site living|1
2537893|NCT01567306|8783194|P6|Overall Study|Protocol Violation|1
2537894|NCT01567306|8783195|P5|Overall Study|Protocol Violation|1
2537895|NCT01567306|8783196|P4|Overall Study|Protocol Violation|3
2537896|NCT01567306|8783197|P3|Overall Study|Protocol Violation|0
2537897|NCT01567306|8783198|P2|Overall Study|Protocol Violation|2
2537898|NCT01567306|8783199|P1|Overall Study|Protocol Violation|2
2537899|NCT01567163|8783213|P1|Overall Study|Lost to Follow-up|2
2537900|NCT01567163|8783213|P1|Overall Study|Progressive Disease|2
2537901|NCT01567085|8783234|P1|Overall Study|Terminal chronic kidney dysfunction|1
2537902|NCT01567085|8783234|P1|Overall Study|Returned to chronic dialysis|1
2537903|NCT01567085|8783234|P1|Overall Study|Renal transplantectomy|1
2537904|NCT01567085|8783234|P1|Overall Study|Graft loss|2
2537905|NCT01567085|8783234|P1|Overall Study|Lost to Follow-up|3
2537906|NCT01567085|8783234|P1|Overall Study|Adverse Event|6
2537907|NCT01567085|8783234|P1|Overall Study|Death|6
2537908|NCT01566981|8783271|P2|Overall Study|Lost to Follow-up|8
2537909|NCT01566981|8783272|P1|Overall Study|Lost to Follow-up|5
2537910|NCT01566773|8783301|P1|Overall Study|Physician Decision|2
2537911|NCT01566773|8783301|P1|Overall Study|Adverse Event|10
2537912|NCT01566773|8783301|P1|Overall Study|Administrative reason|1
2537913|NCT01566773|8783301|P1|Overall Study|Withdrawal by Subject|9
2537914|NCT01566773|8783301|P1|Overall Study|Protocol Violation|4
2537915|NCT01566773|8783301|P1|Overall Study|Protocol specified criteria|4
2537916|NCT01566721|8783510|P2|Overall Study|Withdrew Prior to Treatment|1
2537917|NCT01566721|8783511|P1|Overall Study|Withdrew Prior to Treatment|3
2537918|NCT01566721|8783510|P2|Overall Study|Other|4
2537919|NCT01566721|8783511|P1|Overall Study|Other|10
2537920|NCT01566721|8783510|P2|Overall Study|Death|3
2537921|NCT01566721|8783511|P1|Overall Study|Death|6
2537922|NCT01566721|8783510|P2|Overall Study|Lost to Follow-up|0
2537923|NCT01566721|8783511|P1|Overall Study|Lost to Follow-up|18
2537924|NCT01566721|8783510|P2|Overall Study|Disease Progression/Recurrence|28
2537925|NCT01566721|8783511|P1|Overall Study|Disease Progression/Recurrence|123
2537926|NCT01566721|8783510|P2|Overall Study|Withdrawal by Subject|15
2537927|NCT01566721|8783511|P1|Overall Study|Withdrawal by Subject|58
2537928|NCT01566721|8783510|P2|Overall Study|Ongoing Study|659
2537929|NCT01566721|8783511|P1|Overall Study|Ongoing Study|1649
2537930|NCT01566695|8783536|P2|Overall Study|Miscellaneous|6
2537931|NCT01566695|8783537|P1|Overall Study|Miscellaneous|4
2537932|NCT01566695|8783536|P2|Overall Study|Progressive Disease|6
2537933|NCT01566695|8783537|P1|Overall Study|Progressive Disease|11
2537934|NCT01566695|8783536|P2|Overall Study|Withdrawal by Subject|7
2537935|NCT01566695|8783537|P1|Overall Study|Withdrawal by Subject|14
2537936|NCT01566695|8783536|P2|Overall Study|Death|8
2537937|NCT01566695|8783537|P1|Overall Study|Death|20
2537938|NCT01566695|8783536|P2|Overall Study|Adverse Event|27
2537939|NCT01566695|8783537|P1|Overall Study|Adverse Event|28
2537940|NCT01566695|8783536|P2|Overall Study|Lack of Efficacy|45
2537941|NCT01566695|8783537|P1|Overall Study|Lack of Efficacy|18
2537942|NCT01566604|8783702|P2|Overall Study|Withdrawal by Subject|6
2537943|NCT01566604|8783703|P1|Overall Study|Withdrawal by Subject|9
2537944|NCT01566604|8783702|P2|Overall Study|Adverse Event|2
2537945|NCT01566604|8783703|P1|Overall Study|Adverse Event|4
2537946|NCT01566604|8783702|P2|Overall Study|Death|1
2537947|NCT01566604|8783703|P1|Overall Study|Death|4
2537948|NCT01566604|8783702|P2|Overall Study|Abnormal laboratory value|0
2537949|NCT01566604|8783703|P1|Overall Study|Abnormal laboratory value|2
2537950|NCT01566604|8783702|P2|Overall Study|Protocol deviation|0
2537951|NCT01566604|8783703|P1|Overall Study|Protocol deviation|2
2537952|NCT01566604|8783702|P2|Overall Study|Lack of Efficacy|2
2537953|NCT01566604|8783703|P1|Overall Study|Lack of Efficacy|1
2537954|NCT01566604|8783702|P2|Overall Study|Administrative problems|0
2537955|NCT01566604|8783703|P1|Overall Study|Administrative problems|1
2537956|NCT01566604|8783702|P2|Overall Study|Patient's inability to use the device|0
2537957|NCT01566604|8783703|P1|Overall Study|Patient's inability to use the device|1
2537958|NCT01566435|8783859|P1|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1
2537959|NCT01566214|8783920|P2|Overall Study|Lost to Follow-up|0
2537960|NCT01566214|8783921|P1|Overall Study|Lost to Follow-up|3
2537961|NCT01566149|8783965|P2|Overall Study|Withdrawal by Subject|0
2537962|NCT01566149|8783966|P1|Overall Study|Withdrawal by Subject|1
2537963|NCT01566149|8783965|P2|Overall Study|Protocol Violation|1
2537964|NCT01566149|8783966|P1|Overall Study|Protocol Violation|0
2537965|NCT01566149|8783965|P2|Overall Study|Non-compliance with study medication|0
2537966|NCT01566149|8783966|P1|Overall Study|Non-compliance with study medication|2
2537967|NCT01566149|8783965|P2|Overall Study|Adverse Event|1
2537968|NCT01566149|8783966|P1|Overall Study|Adverse Event|0
2537969|NCT01565993|8783999|P2|Overall Study|Physician Decision|3
2537970|NCT01565993|8784000|P1|Overall Study|Physician Decision|0
2537971|NCT01565980|8784008|P2|Overall Study|Withdrawal by Subject|3
2537972|NCT01565980|8784009|P1|Overall Study|Withdrawal by Subject|0
2537973|NCT01565980|8784008|P2|Overall Study|stopped medical treatment|0
2537974|NCT01565980|8784009|P1|Overall Study|stopped medical treatment|1
2537975|NCT01565980|8784008|P2|Overall Study|health complications|1
2537976|NCT01565980|8784009|P1|Overall Study|health complications|1
2537977|NCT01565980|8784008|P2|Overall Study|Lost to Follow-up|0
2537978|NCT01565980|8784009|P1|Overall Study|Lost to Follow-up|1
2537979|NCT01565980|8784008|P2|Overall Study|Death|0
2537980|NCT01565980|8784009|P1|Overall Study|Death|1
2537981|NCT01565941|8784029|P2|Overall Study|Randomized; did not receive intevention|2
2537982|NCT01565941|8784030|P1|Overall Study|Randomized; did not receive intevention|8
2537983|NCT01565941|8784029|P2|Overall Study|Withdrawn by parent/guardian|2
2537984|NCT01565941|8784030|P1|Overall Study|Withdrawn by parent/guardian|3
2537985|NCT01565928|8784072|P1|Overall Study|Death|2
2537986|NCT01565928|8784072|P1|Overall Study|Withdrawal by Subject|1
2537987|NCT01565928|8784072|P1|Overall Study|Progressive Disease|13
2537988|NCT01565928|8784072|P1|Overall Study|Other|3
2537989|NCT01565928|8784072|P1|Overall Study|Adverse Event|3
2537990|NCT01565889|8784126|P6|Part B|Lost to Follow-up|1
2537991|NCT01565889|8784127|P5|Part B|Lost to Follow-up|0
2537992|NCT01565889|8784128|P4|Part B|Lost to Follow-up|0
2537993|NCT01565889|8784129|P3|Part B|Lost to Follow-up|0
2537994|NCT01565889|8784130|P2|Part B|Lost to Follow-up|0
2537995|NCT01565889|8784131|P1|Part B|Lost to Follow-up|0
2537996|NCT01565889|8784126|P6|Part B|Lack of Efficacy|2
2537997|NCT01565889|8784127|P5|Part B|Lack of Efficacy|0
2537998|NCT01565889|8784128|P4|Part B|Lack of Efficacy|0
2537999|NCT01565889|8784129|P3|Part B|Lack of Efficacy|0
2538000|NCT01565889|8784130|P2|Part B|Lack of Efficacy|0
2538001|NCT01565889|8784131|P1|Part B|Lack of Efficacy|0
2538002|NCT01565889|8784126|P6|Part B|Withdrawal by Subject|1
2538003|NCT01565889|8784127|P5|Part B|Withdrawal by Subject|0
2538004|NCT01565889|8784128|P4|Part B|Withdrawal by Subject|0
2538005|NCT01565889|8784129|P3|Part B|Withdrawal by Subject|0
2538006|NCT01565889|8784130|P2|Part B|Withdrawal by Subject|0
2538007|NCT01565889|8784131|P1|Part B|Withdrawal by Subject|0
2538008|NCT01565889|8784126|P6|Part A|Withdrawal by Subject|0
2538009|NCT01565889|8784127|P5|Part A|Withdrawal by Subject|0
2538010|NCT01565889|8784128|P4|Part A|Withdrawal by Subject|0
2538011|NCT01565889|8784129|P3|Part A|Withdrawal by Subject|0
2538012|NCT01565889|8784130|P2|Part A|Withdrawal by Subject|0
2538013|NCT01565889|8784131|P1|Part A|Withdrawal by Subject|1
2538014|NCT01565850|8784162|P2|Overall Study|Withdrew Consent|2
2538015|NCT01565850|8784163|P1|Overall Study|Withdrew Consent|4
2538016|NCT01565850|8784162|P2|Overall Study|Participant noncompliance|0
2538017|NCT01565850|8784163|P1|Overall Study|Participant noncompliance|2
2538018|NCT01565850|8784162|P2|Overall Study|Investigator’s Discretion|1
2538019|NCT01565850|8784163|P1|Overall Study|Investigator’s Discretion|2
2538020|NCT01565850|8784162|P2|Overall Study|Lost to Follow-up|4
2538021|NCT01565850|8784163|P1|Overall Study|Lost to Follow-up|12
2538022|NCT01565850|8784162|P2|Overall Study|Adverse Event|1
2538023|NCT01565850|8784163|P1|Overall Study|Adverse Event|0
2538024|NCT01565707|8784183|P4|Overall Study|Miscellaneous|2
2538025|NCT01565707|8784184|P3|Overall Study|Miscellaneous|0
2538026|NCT01565707|8784185|P2|Overall Study|Miscellaneous|1
2538027|NCT01565707|8784186|P1|Overall Study|Miscellaneous|1
2538028|NCT01565707|8784183|P4|Overall Study|Randomized but not evaluable|0
2538029|NCT01565707|8784184|P3|Overall Study|Randomized but not evaluable|0
2538030|NCT01565707|8784185|P2|Overall Study|Randomized but not evaluable|0
2538031|NCT01565707|8784186|P1|Overall Study|Randomized but not evaluable|2
2538032|NCT01565707|8784183|P4|Overall Study|Withdrawal by Subject|1
2538033|NCT01565707|8784184|P3|Overall Study|Withdrawal by Subject|1
2538034|NCT01565707|8784185|P2|Overall Study|Withdrawal by Subject|1
2538035|NCT01565707|8784186|P1|Overall Study|Withdrawal by Subject|3
2538036|NCT01565707|8784183|P4|Overall Study|Protocol Violation|1
2538037|NCT01565707|8784184|P3|Overall Study|Protocol Violation|0
2538038|NCT01565707|8784185|P2|Overall Study|Protocol Violation|0
2538039|NCT01565707|8784186|P1|Overall Study|Protocol Violation|1
2538040|NCT01565707|8784183|P4|Overall Study|Lost to Follow-up|0
2538041|NCT01565707|8784184|P3|Overall Study|Lost to Follow-up|0
2538042|NCT01565707|8784185|P2|Overall Study|Lost to Follow-up|0
2538043|NCT01565707|8784186|P1|Overall Study|Lost to Follow-up|1
2538044|NCT01565707|8784183|P4|Overall Study|Adverse Event|1
2538045|NCT01565707|8784184|P3|Overall Study|Adverse Event|2
2538046|NCT01565707|8784185|P2|Overall Study|Adverse Event|6
2538047|NCT01565707|8784186|P1|Overall Study|Adverse Event|1
2538048|NCT01565694|8784277|P1|Fixed-Dose Assessment Period|Withdrawal by Subject|4
2538049|NCT01565694|8784277|P1|Dose-Titration Period|Protocol Violation|10
2538050|NCT01565694|8784277|P1|Dose-Titration Period|Adverse Event|4
2538051|NCT01565668|8784298|P2|Overall Study|HSCT Transplant|15
2538052|NCT01565668|8784299|P1|Overall Study|HSCT Transplant|11
2538053|NCT01565668|8784298|P2|Overall Study|Withdrawal by Subject|3
2538054|NCT01565668|8784299|P1|Overall Study|Withdrawal by Subject|1
2538055|NCT01565668|8784298|P2|Overall Study|Progressive disease|14
2538056|NCT01565668|8784299|P1|Overall Study|Progressive disease|13
2538057|NCT01565668|8784298|P2|Overall Study|Randomized, but never received drug|2
2538058|NCT01565668|8784299|P1|Overall Study|Randomized, but never received drug|0
2538059|NCT01565668|8784298|P2|Overall Study|Adverse Event|1
2538060|NCT01565668|8784299|P1|Overall Study|Adverse Event|6
2538061|NCT01565668|8784298|P2|Overall Study|Participant went on Hospice Care|0
2538062|NCT01565668|8784299|P1|Overall Study|Participant went on Hospice Care|1
2538063|NCT01565668|8784298|P2|Overall Study|Lack of Efficacy|2
2538064|NCT01565668|8784299|P1|Overall Study|Lack of Efficacy|4
2538065|NCT01565668|8784298|P2|Overall Study|Death|1
2538066|NCT01565668|8784299|P1|Overall Study|Death|2
2538067|NCT01565642|8784323|P2|Overall Study|Withdrawal by Subject|1
2538068|NCT01565642|8784324|P1|Overall Study|Withdrawal by Subject|2
2538069|NCT01565564|8784359|P2|Overall Study|Lost to Follow-up|1
2538070|NCT01565564|8784360|P1|Overall Study|Lost to Follow-up|5
2538071|NCT01565343|8784410|P3|Overall Study|Administrative decision/technical issues|0
2538072|NCT01565343|8784411|P2|Overall Study|Administrative decision/technical issues|0
2538073|NCT01565343|8784412|P1|Overall Study|Administrative decision/technical issues|1
2538074|NCT01565291|8784442|P2|Overall Study|Withdrawal by Subject|0
2538075|NCT01565291|8784443|P1|Overall Study|Withdrawal by Subject|1
2538076|NCT01565148|8784455|P4|Overall Study|Physician Decision|0
2538077|NCT01565148|8784456|P3|Overall Study|Physician Decision|0
2538078|NCT01565148|8784457|P2|Overall Study|Physician Decision|5
2538079|NCT01565148|8784458|P1|Overall Study|Physician Decision|2
2538080|NCT01565148|8784455|P4|Overall Study|Death|0
2538081|NCT01565148|8784456|P3|Overall Study|Death|1
2538082|NCT01565148|8784457|P2|Overall Study|Death|0
2538083|NCT01565148|8784458|P1|Overall Study|Death|0
2538084|NCT01565148|8784455|P4|Overall Study|Rescue Therapy|8
2538085|NCT01565148|8784456|P3|Overall Study|Rescue Therapy|5
2538086|NCT01565148|8784457|P2|Overall Study|Rescue Therapy|5
2538087|NCT01565148|8784458|P1|Overall Study|Rescue Therapy|8
2538088|NCT01565148|8784455|P4|Overall Study|Lost to Follow-up|3
2538089|NCT01565148|8784456|P3|Overall Study|Lost to Follow-up|0
2538090|NCT01565148|8784457|P2|Overall Study|Lost to Follow-up|4
2538091|NCT01565148|8784458|P1|Overall Study|Lost to Follow-up|4
2538092|NCT01565148|8784455|P4|Overall Study|Withdrawal by Subject|2
2538093|NCT01565148|8784456|P3|Overall Study|Withdrawal by Subject|1
2538094|NCT01565148|8784457|P2|Overall Study|Withdrawal by Subject|1
2538095|NCT01565148|8784458|P1|Overall Study|Withdrawal by Subject|1
2538096|NCT01565083|8784494|P2|Overall Study|Other|5
2538097|NCT01565083|8784495|P1|Overall Study|Other|3
2538098|NCT01565083|8784494|P2|Overall Study|Death|23
2538099|NCT01565083|8784495|P1|Overall Study|Death|22
2538100|NCT01565083|8784494|P2|Overall Study|Lost to Follow-up|7
2538101|NCT01565083|8784495|P1|Overall Study|Lost to Follow-up|2
2538102|NCT01565083|8784494|P2|Overall Study|Withdrawal by Subject|4
2538103|NCT01565083|8784495|P1|Overall Study|Withdrawal by Subject|6
2538104|NCT01564862|8784546|P3|Overall Study|Other reason(s)|0
2538105|NCT01564862|8784547|P2|Overall Study|Other reason(s)|0
2538106|NCT01564862|8784548|P1|Overall Study|Other reason(s)|1
2538107|NCT01564862|8784546|P3|Overall Study|Lack of Efficacy|6
2538108|NCT01564862|8784547|P2|Overall Study|Lack of Efficacy|5
2538109|NCT01564862|8784548|P1|Overall Study|Lack of Efficacy|1
2538110|NCT01564862|8784546|P3|Overall Study|Voluntary Withdrawal|8
2538111|NCT01564862|8784547|P2|Overall Study|Voluntary Withdrawal|6
2538112|NCT01564862|8784548|P1|Overall Study|Voluntary Withdrawal|9
2538113|NCT01564862|8784546|P3|Overall Study|Lost to Follow-up|6
2538114|NCT01564862|8784547|P2|Overall Study|Lost to Follow-up|8
2538115|NCT01564862|8784548|P1|Overall Study|Lost to Follow-up|10
2538116|NCT01564862|8784546|P3|Overall Study|Major Protocol Deviation|4
2538117|NCT01564862|8784547|P2|Overall Study|Major Protocol Deviation|3
2538118|NCT01564862|8784548|P1|Overall Study|Major Protocol Deviation|3
2538119|NCT01564862|8784546|P3|Overall Study|Pretreatment Event or Adverse Event|6
2538120|NCT01564862|8784547|P2|Overall Study|Pretreatment Event or Adverse Event|12
2538121|NCT01564862|8784548|P1|Overall Study|Pretreatment Event or Adverse Event|6
2538122|NCT01564784|8784599|P2|Overall Study|Death|126
2538123|NCT01564784|8784600|P1|Overall Study|Death|131
2538124|NCT01564784|8784599|P2|Overall Study|Lost to Follow-up|1
2538125|NCT01564784|8784600|P1|Overall Study|Lost to Follow-up|1
2538126|NCT01564784|8784599|P2|Overall Study|Subject refused further follow-up|6
2538127|NCT01564784|8784600|P1|Overall Study|Subject refused further follow-up|1
2538128|NCT01564784|8784599|P2|Overall Study|Other|0
2538129|NCT01564784|8784600|P1|Overall Study|Other|1
2538130|NCT01564758|8784627|P1|Overall Study|Other|3
2538131|NCT01564758|8784627|P1|Overall Study|Adverse Event|3
2538132|NCT01564758|8784627|P1|Overall Study|Death|8
2538133|NCT01564732|8784634|P2|Overall Study|Early termination by the study sponsor|5
2538134|NCT01564732|8784635|P1|Overall Study|Early termination by the study sponsor|6
2538135|NCT01564537|8784676|P2|Overall Study|Other Miscellaneous Reasons|2
2538136|NCT01564537|8784677|P1|Overall Study|Other Miscellaneous Reasons|1
2538137|NCT01564537|8784676|P2|Overall Study|Lost to Follow-up|0
2538138|NCT01564537|8784677|P1|Overall Study|Lost to Follow-up|1
2538139|NCT01564537|8784676|P2|Overall Study|Withdrawal by Participant|4
2538140|NCT01564537|8784677|P1|Overall Study|Withdrawal by Participant|4
2538141|NCT01564459|8784700|P3|Double-blind Treatment|Adverse Event|1
2538142|NCT01564459|8784701|P2|Double-blind Treatment|Adverse Event|0
2538143|NCT01564459|8784702|P1|Double-blind Treatment|Adverse Event|0
2538144|NCT01564459|8784700|P3|Run-In|Withdrawal by Subject|0
2538145|NCT01564459|8784701|P2|Run-In|Withdrawal by Subject|0
2538146|NCT01564459|8784702|P1|Run-In|Withdrawal by Subject|1
2538147|NCT01564459|8784700|P3|Run-In|Protocol Violation|0
2538148|NCT01564459|8784701|P2|Run-In|Protocol Violation|0
2538149|NCT01564459|8784702|P1|Run-In|Protocol Violation|1
2538150|NCT01564459|8784700|P3|Run-In|Non-compliance with study drug|0
2538151|NCT01564459|8784701|P2|Run-In|Non-compliance with study drug|0
2538152|NCT01564459|8784702|P1|Run-In|Non-compliance with study drug|2
2538153|NCT01564459|8784700|P3|Run-In|Lost to Follow-up|0
2538154|NCT01564459|8784701|P2|Run-In|Lost to Follow-up|0
2538155|NCT01564459|8784702|P1|Run-In|Lost to Follow-up|1
2538156|NCT01564459|8784700|P3|Run-In|Adverse Event|0
2538157|NCT01564459|8784701|P2|Run-In|Adverse Event|0
2538158|NCT01564459|8784702|P1|Run-In|Adverse Event|7
2538159|NCT01564407|8784726|P5|Overall Study|funding lost, study ended|0
2538160|NCT01564407|8784727|P4|Overall Study|funding lost, study ended|1
2538161|NCT01564407|8784728|P3|Overall Study|funding lost, study ended|0
2538162|NCT01564407|8784729|P2|Overall Study|funding lost, study ended|0
2538163|NCT01564407|8784730|P1|Overall Study|funding lost, study ended|0
2538164|NCT01564407|8784726|P5|Overall Study|Withdrawal by Subject|0
2538165|NCT01564407|8784727|P4|Overall Study|Withdrawal by Subject|0
2538166|NCT01564407|8784728|P3|Overall Study|Withdrawal by Subject|0
2538167|NCT01564407|8784729|P2|Overall Study|Withdrawal by Subject|1
2538168|NCT01564407|8784730|P1|Overall Study|Withdrawal by Subject|0
2538169|NCT01564407|8784726|P5|Overall Study|Lost to Follow-up|0
2538170|NCT01564407|8784727|P4|Overall Study|Lost to Follow-up|0
2538171|NCT01564407|8784728|P3|Overall Study|Lost to Follow-up|0
2538172|NCT01564407|8784729|P2|Overall Study|Lost to Follow-up|1
2538173|NCT01564407|8784730|P1|Overall Study|Lost to Follow-up|0
2538174|NCT01564394|8784771|P2|Overall Study|Withdrawal by Subject|10
2538175|NCT01564394|8784772|P1|Overall Study|Withdrawal by Subject|6
2538176|NCT01564277|8784786|P2|Overall Study|Physician Decision|0
2538177|NCT01564277|8784787|P1|Overall Study|Physician Decision|1
2538178|NCT01564277|8784786|P2|Overall Study|Protocol Violation|1
2538179|NCT01564277|8784787|P1|Overall Study|Protocol Violation|0
2538180|NCT01563978|8784805|P2|Overall Study|Adverse Event|2
2538181|NCT01563978|8784806|P1|Overall Study|Adverse Event|1
2538182|NCT01563978|8784805|P2|Overall Study|Dev. of study specific discont. criteria|0
2538183|NCT01563978|8784806|P1|Overall Study|Dev. of study specific discont. criteria|1
2538184|NCT01563978|8784805|P2|Overall Study|Lost to Follow-up|0
2538185|NCT01563978|8784806|P1|Overall Study|Lost to Follow-up|1
2538186|NCT01563978|8784805|P2|Overall Study|Physician Decision|0
2538187|NCT01563978|8784806|P1|Overall Study|Physician Decision|1
2538188|NCT01563913|8784832|P2|Overall Study|Spouse Passed Away|0
2538189|NCT01563913|8784833|P1|Overall Study|Spouse Passed Away|1
2538190|NCT01563913|8784832|P2|Overall Study|Physician Decision|0
2538191|NCT01563913|8784833|P1|Overall Study|Physician Decision|1
2538192|NCT01563536|8784845|P2|Overall Study|Lost to Follow-up|0
2538193|NCT01563536|8784846|P1|Overall Study|Lost to Follow-up|1
2538194|NCT01563536|8784845|P2|Overall Study|Withdrawal by Subject|2
2538195|NCT01563536|8784846|P1|Overall Study|Withdrawal by Subject|0
2538196|NCT01563185|8784905|P1|Overall Study|Non-Compliance with study drug|1
2538197|NCT01563185|8784905|P1|Overall Study|Withdrawal by Subject|1
2538198|NCT01563172|8784919|P1|Overall Study|Other (Not specified)|1
2538199|NCT01563172|8784919|P1|Overall Study|Other (Protocol deviation)|5
2538200|NCT01563172|8784919|P1|Overall Study|Lost to Follow-up|2
2538201|NCT01563172|8784919|P1|Overall Study|Adverse Event|5
2538202|NCT01563029|8785025|P5|Overall Study|Withdrawal by Subject|3
2538203|NCT01563029|8785026|P4|Overall Study|Withdrawal by Subject|4
2538204|NCT01563029|8785027|P3|Overall Study|Withdrawal by Subject|3
2538205|NCT01563029|8785028|P2|Overall Study|Withdrawal by Subject|1
2538206|NCT01563029|8785029|P1|Overall Study|Withdrawal by Subject|4
2538207|NCT01563029|8785025|P5|Overall Study|Physician Decision|2
2538208|NCT01563029|8785026|P4|Overall Study|Physician Decision|4
2538209|NCT01563029|8785027|P3|Overall Study|Physician Decision|2
2538210|NCT01563029|8785028|P2|Overall Study|Physician Decision|5
2538211|NCT01563029|8785029|P1|Overall Study|Physician Decision|3
2538212|NCT01563029|8785025|P5|Overall Study|Lost to Follow-up|1
2538213|NCT01563029|8785026|P4|Overall Study|Lost to Follow-up|1
2538214|NCT01563029|8785027|P3|Overall Study|Lost to Follow-up|1
2538215|NCT01563029|8785028|P2|Overall Study|Lost to Follow-up|0
2538216|NCT01563029|8785029|P1|Overall Study|Lost to Follow-up|1
2538217|NCT01563029|8785025|P5|Overall Study|Protocol defined stopping criteria|0
2538218|NCT01563029|8785026|P4|Overall Study|Protocol defined stopping criteria|0
2538219|NCT01563029|8785027|P3|Overall Study|Protocol defined stopping criteria|0
2538220|NCT01563029|8785028|P2|Overall Study|Protocol defined stopping criteria|0
2538221|NCT01563029|8785029|P1|Overall Study|Protocol defined stopping criteria|1
2538222|NCT01563029|8785025|P5|Overall Study|Protocol Violation|3
2538223|NCT01563029|8785026|P4|Overall Study|Protocol Violation|1
2538224|NCT01563029|8785027|P3|Overall Study|Protocol Violation|3
2538225|NCT01563029|8785028|P2|Overall Study|Protocol Violation|2
2538226|NCT01563029|8785029|P1|Overall Study|Protocol Violation|1
2538227|NCT01563029|8785025|P5|Overall Study|Lack of Efficacy|19
2538228|NCT01563029|8785026|P4|Overall Study|Lack of Efficacy|21
2538229|NCT01563029|8785027|P3|Overall Study|Lack of Efficacy|23
2538230|NCT01563029|8785028|P2|Overall Study|Lack of Efficacy|16
2538231|NCT01563029|8785029|P1|Overall Study|Lack of Efficacy|42
2538232|NCT01563029|8785025|P5|Overall Study|Adverse Event|1
2538233|NCT01563029|8785026|P4|Overall Study|Adverse Event|2
2538234|NCT01563029|8785027|P3|Overall Study|Adverse Event|1
2538235|NCT01563029|8785028|P2|Overall Study|Adverse Event|0
2538236|NCT01563029|8785029|P1|Overall Study|Adverse Event|1
2538237|NCT01562873|8785095|P2|Overall Study|Clinical PD and adverse event|0
2538238|NCT01562873|8785096|P1|Overall Study|Clinical PD and adverse event|1
2538239|NCT01562873|8785095|P2|Overall Study|Clinical Disease Progression|0
2538240|NCT01562873|8785096|P1|Overall Study|Clinical Disease Progression|9
2538241|NCT01562873|8785095|P2|Overall Study|Adverse Event|0
2538242|NCT01562873|8785096|P1|Overall Study|Adverse Event|1
2538243|NCT01562873|8785095|P2|Overall Study|Disease Progression per RECIST|0
2538244|NCT01562873|8785096|P1|Overall Study|Disease Progression per RECIST|10
2538245|NCT01562782|8785105|P2|Overall Study|screen failure|2
2538246|NCT01562782|8785106|P1|Overall Study|screen failure|1
2538247|NCT01562782|8785105|P2|Overall Study|Withdrawal by Subject|3
2538248|NCT01562782|8785106|P1|Overall Study|Withdrawal by Subject|3
2538249|NCT01562743|8785135|P1|Overall Study|Physician Decision|2
2538250|NCT01562743|8785135|P1|Overall Study|Lost to Follow-up|2
2538251|NCT01562743|8785135|P1|Overall Study|Discontinuation criteria|2
2538252|NCT01562743|8785135|P1|Overall Study|Protocol Violation|1
2538253|NCT01562743|8785135|P1|Overall Study|Withdrawal by Subject|13
2538254|NCT01562743|8785135|P1|Overall Study|Lack of Efficacy|3
2538255|NCT01562743|8785135|P1|Overall Study|Adverse Event|29
2538256|NCT01562613|8785154|P1|Overall Study|Withdrawal by Subject|2
2538257|NCT01562613|8785154|P1|Overall Study|Lost to Follow-up|2
2538258|NCT01562548|8785164|P4|Overall Study|Lost to Follow-up|0
2538259|NCT01562548|8785165|P3|Overall Study|Lost to Follow-up|1
2538260|NCT01562548|8785166|P2|Overall Study|Lost to Follow-up|0
2538261|NCT01562548|8785167|P1|Overall Study|Lost to Follow-up|0
2538262|NCT01562444|8785220|P3|Overall Study|Protocol forbidden medication|0
2538263|NCT01562444|8785221|P2|Overall Study|Protocol forbidden medication|0
2538264|NCT01562444|8785222|P1|Overall Study|Protocol forbidden medication|1
2538265|NCT01562444|8785220|P3|Overall Study|Protocol forbidden concomitant vaccine|1
2538266|NCT01562444|8785221|P2|Overall Study|Protocol forbidden concomitant vaccine|0
2538267|NCT01562444|8785222|P1|Overall Study|Protocol forbidden concomitant vaccine|1
2538268|NCT01562444|8785220|P3|Overall Study|Unavailable serological results|2
2538269|NCT01562444|8785221|P2|Overall Study|Unavailable serological results|2
2538270|NCT01562444|8785222|P1|Overall Study|Unavailable serological results|0
2538271|NCT01562444|8785220|P3|Overall Study|Did not comply with blood draw schedule|1
2538272|NCT01562444|8785221|P2|Overall Study|Did not comply with blood draw schedule|0
2538273|NCT01562444|8785222|P1|Overall Study|Did not comply with blood draw schedule|1
2538274|NCT01562444|8785220|P3|Overall Study|Did not meet entry criteria|3
2538275|NCT01562444|8785221|P2|Overall Study|Did not meet entry criteria|0
2538276|NCT01562444|8785222|P1|Overall Study|Did not meet entry criteria|2
2538277|NCT01562327|8785488|P1|Overall Study|Infusion not received at 6 month window|4
2538278|NCT01562327|8785488|P1|Overall Study|Participant drop-out|1
2538279|NCT01562327|8785488|P1|Overall Study|Lack of Efficacy|1
2538280|NCT01562327|8785488|P1|Overall Study|Adverse Event|2
2538281|NCT01562314|8785518|P2|Overall Study|Withdrawal by Subject|1
2538282|NCT01562314|8785519|P1|Overall Study|Withdrawal by Subject|0
2538283|NCT01562314|8785518|P2|Overall Study|Met Withdrawal Criteria|2
2538284|NCT01562314|8785519|P1|Overall Study|Met Withdrawal Criteria|3
2538285|NCT01562314|8785518|P2|Overall Study|Adverse Event|5
2538286|NCT01562314|8785519|P1|Overall Study|Adverse Event|10
2538287|NCT01562275|8785576|P13|Stage 2|Progression of Disease|4
2538288|NCT01562275|8785577|P12|Stage 2|Progression of Disease|12
2538289|NCT01562275|8785578|P11|Stage 2|Progression of Disease|0
2538290|NCT01562275|8785579|P10|Stage 2|Progression of Disease|0
2538291|NCT01562275|8785580|P9|Stage 2|Progression of Disease|0
2538292|NCT01562275|8785581|P8|Stage 2|Progression of Disease|0
2538293|NCT01562275|8785582|P7|Stage 2|Progression of Disease|0
2538294|NCT01562275|8785583|P6|Stage 2|Progression of Disease|0
2538295|NCT01562275|8785584|P5|Stage 2|Progression of Disease|0
2538296|NCT01562275|8785585|P4|Stage 2|Progression of Disease|0
2538297|NCT01562275|8785586|P3|Stage 2|Progression of Disease|0
2538298|NCT01562275|8785587|P2|Stage 2|Progression of Disease|0
2538299|NCT01562275|8785588|P1|Stage 2|Progression of Disease|0
2538300|NCT01562275|8785576|P13|Stage 2|Death|1
2538301|NCT01562275|8785577|P12|Stage 2|Death|2
2538302|NCT01562275|8785578|P11|Stage 2|Death|0
2538303|NCT01562275|8785579|P10|Stage 2|Death|0
2538304|NCT01562275|8785580|P9|Stage 2|Death|0
2538305|NCT01562275|8785581|P8|Stage 2|Death|0
2538306|NCT01562275|8785582|P7|Stage 2|Death|0
2538307|NCT01562275|8785583|P6|Stage 2|Death|0
2538308|NCT01562275|8785584|P5|Stage 2|Death|0
2538309|NCT01562275|8785585|P4|Stage 2|Death|0
2538310|NCT01562275|8785586|P3|Stage 2|Death|0
2538311|NCT01562275|8785587|P2|Stage 2|Death|0
2538312|NCT01562275|8785588|P1|Stage 2|Death|0
2538313|NCT01562275|8785576|P13|Stage 1|Withdrawal by Subject|0
2538314|NCT01562275|8785577|P12|Stage 1|Withdrawal by Subject|0
2538315|NCT01562275|8785578|P11|Stage 1|Withdrawal by Subject|0
2538316|NCT01562275|8785579|P10|Stage 1|Withdrawal by Subject|1
2538317|NCT01562275|8785580|P9|Stage 1|Withdrawal by Subject|0
2538318|NCT01562275|8785581|P8|Stage 1|Withdrawal by Subject|0
2538319|NCT01562275|8785582|P7|Stage 1|Withdrawal by Subject|1
2538320|NCT01562275|8785583|P6|Stage 1|Withdrawal by Subject|0
2538321|NCT01562275|8785584|P5|Stage 1|Withdrawal by Subject|0
2538322|NCT01562275|8785585|P4|Stage 1|Withdrawal by Subject|2
2538323|NCT01562275|8785586|P3|Stage 1|Withdrawal by Subject|0
2538324|NCT01562275|8785587|P2|Stage 1|Withdrawal by Subject|1
2538325|NCT01562275|8785588|P1|Stage 1|Withdrawal by Subject|0
2538326|NCT01562275|8785576|P13|Stage 1|Progression of Disease|0
2538327|NCT01562275|8785577|P12|Stage 1|Progression of Disease|0
2538328|NCT01562275|8785578|P11|Stage 1|Progression of Disease|3
2538329|NCT01562275|8785579|P10|Stage 1|Progression of Disease|5
2538330|NCT01562275|8785580|P9|Stage 1|Progression of Disease|2
2538331|NCT01562275|8785581|P8|Stage 1|Progression of Disease|7
2538332|NCT01562275|8785582|P7|Stage 1|Progression of Disease|1
2538333|NCT01562275|8785583|P6|Stage 1|Progression of Disease|4
2538334|NCT01562275|8785584|P5|Stage 1|Progression of Disease|2
2538335|NCT01562275|8785585|P4|Stage 1|Progression of Disease|1
2538336|NCT01562275|8785586|P3|Stage 1|Progression of Disease|2
2538337|NCT01562275|8785587|P2|Stage 1|Progression of Disease|6
2538338|NCT01562275|8785588|P1|Stage 1|Progression of Disease|2
2538339|NCT01562275|8785576|P13|Stage 1|Physician Decision|0
2538340|NCT01562275|8785577|P12|Stage 1|Physician Decision|0
2538341|NCT01562275|8785578|P11|Stage 1|Physician Decision|0
2538342|NCT01562275|8785579|P10|Stage 1|Physician Decision|0
2538343|NCT01562275|8785580|P9|Stage 1|Physician Decision|1
2538344|NCT01562275|8785581|P8|Stage 1|Physician Decision|0
2538345|NCT01562275|8785582|P7|Stage 1|Physician Decision|1
2538346|NCT01562275|8785583|P6|Stage 1|Physician Decision|0
2538347|NCT01562275|8785584|P5|Stage 1|Physician Decision|1
2538348|NCT01562275|8785585|P4|Stage 1|Physician Decision|0
2538349|NCT01562275|8785586|P3|Stage 1|Physician Decision|0
2538350|NCT01562275|8785587|P2|Stage 1|Physician Decision|0
2538351|NCT01562275|8785588|P1|Stage 1|Physician Decision|0
2538352|NCT01562275|8785576|P13|Stage 1|Non Compliance|0
2538353|NCT01562275|8785577|P12|Stage 1|Non Compliance|0
2538354|NCT01562275|8785578|P11|Stage 1|Non Compliance|0
2538355|NCT01562275|8785579|P10|Stage 1|Non Compliance|0
2538356|NCT01562275|8785580|P9|Stage 1|Non Compliance|0
2538357|NCT01562275|8785581|P8|Stage 1|Non Compliance|0
2538358|NCT01562275|8785582|P7|Stage 1|Non Compliance|0
2538359|NCT01562275|8785583|P6|Stage 1|Non Compliance|0
2538360|NCT01562275|8785584|P5|Stage 1|Non Compliance|0
2538361|NCT01562275|8785585|P4|Stage 1|Non Compliance|0
2538362|NCT01562275|8785586|P3|Stage 1|Non Compliance|1
2538363|NCT01562275|8785587|P2|Stage 1|Non Compliance|0
2538364|NCT01562275|8785588|P1|Stage 1|Non Compliance|0
2538365|NCT01562275|8785576|P13|Stage 1|Death|0
2538366|NCT01562275|8785577|P12|Stage 1|Death|0
2538367|NCT01562275|8785578|P11|Stage 1|Death|0
2538368|NCT01562275|8785579|P10|Stage 1|Death|0
2538369|NCT01562275|8785580|P9|Stage 1|Death|0
2538370|NCT01562275|8785581|P8|Stage 1|Death|0
2538371|NCT01562275|8785582|P7|Stage 1|Death|0
2538372|NCT01562275|8785583|P6|Stage 1|Death|0
2538373|NCT01562275|8785584|P5|Stage 1|Death|0
2538374|NCT01562275|8785585|P4|Stage 1|Death|0
2538375|NCT01562275|8785586|P3|Stage 1|Death|0
2538376|NCT01562275|8785587|P2|Stage 1|Death|0
2538377|NCT01562275|8785588|P1|Stage 1|Death|1
2538378|NCT01562275|8785576|P13|Stage 1|Adverse Event|0
2538379|NCT01562275|8785577|P12|Stage 1|Adverse Event|0
2538380|NCT01562275|8785578|P11|Stage 1|Adverse Event|0
2538381|NCT01562275|8785579|P10|Stage 1|Adverse Event|1
2538382|NCT01562275|8785580|P9|Stage 1|Adverse Event|0
2538383|NCT01562275|8785581|P8|Stage 1|Adverse Event|0
2538384|NCT01562275|8785582|P7|Stage 1|Adverse Event|0
2538385|NCT01562275|8785583|P6|Stage 1|Adverse Event|0
2538386|NCT01562275|8785584|P5|Stage 1|Adverse Event|1
2538387|NCT01562275|8785585|P4|Stage 1|Adverse Event|1
2538388|NCT01562275|8785586|P3|Stage 1|Adverse Event|0
2538389|NCT01562275|8785587|P2|Stage 1|Adverse Event|0
2538390|NCT01562275|8785588|P1|Stage 1|Adverse Event|0
2538391|NCT01562028|8785729|P2|Overall Study|Lost to Follow-up|1
2538392|NCT01562028|8785730|P1|Overall Study|Lost to Follow-up|2
2538393|NCT01562028|8785729|P2|Overall Study|Withdrawal by Subject|1
2538394|NCT01562028|8785730|P1|Overall Study|Withdrawal by Subject|1
2538395|NCT01561989|8785750|P2|Overall Study|accural target not met.|6
2538396|NCT01561989|8785751|P1|Overall Study|accural target not met.|5
2538397|NCT01561976|8785773|P6|Washout Period 2 (7 Days)|Non-compliance|0
2538398|NCT01561976|8785774|P5|Washout Period 2 (7 Days)|Non-compliance|0
2538399|NCT01561976|8785775|P4|Washout Period 2 (7 Days)|Non-compliance|0
2538400|NCT01561976|8785776|P3|Washout Period 2 (7 Days)|Non-compliance|1
2538401|NCT01561976|8785777|P2|Washout Period 2 (7 Days)|Non-compliance|0
2538402|NCT01561976|8785778|P1|Washout Period 2 (7 Days)|Non-compliance|1
2538403|NCT01561976|8785773|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|1
2538404|NCT01561976|8785774|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2538405|NCT01561976|8785775|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2538406|NCT01561976|8785776|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2538407|NCT01561976|8785777|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2538408|NCT01561976|8785778|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2538409|NCT01561976|8785773|P6|Washout Period 1 (7 Days)|Adverse Event|0
2538410|NCT01561976|8785774|P5|Washout Period 1 (7 Days)|Adverse Event|0
2538411|NCT01561976|8785775|P4|Washout Period 1 (7 Days)|Adverse Event|1
2538412|NCT01561976|8785776|P3|Washout Period 1 (7 Days)|Adverse Event|0
2538413|NCT01561976|8785777|P2|Washout Period 1 (7 Days)|Adverse Event|0
2538414|NCT01561976|8785778|P1|Washout Period 1 (7 Days)|Adverse Event|0
2538415|NCT01561976|8785773|P6|Period 1|Adverse Event|0
2538416|NCT01561976|8785774|P5|Period 1|Adverse Event|0
2538417|NCT01561976|8785775|P4|Period 1|Adverse Event|0
2538418|NCT01561976|8785776|P3|Period 1|Adverse Event|1
2538419|NCT01561976|8785777|P2|Period 1|Adverse Event|0
2538420|NCT01561976|8785778|P1|Period 1|Adverse Event|0
2538421|NCT01561898|8785811|P4|Overall Study|Physician Decision|1
2538422|NCT01561898|8785812|P3|Overall Study|Physician Decision|7
2538423|NCT01561898|8785813|P2|Overall Study|Physician Decision|5
2538424|NCT01561898|8785814|P1|Overall Study|Physician Decision|1
2538425|NCT01561898|8785811|P4|Overall Study|Adverse Event|9
2538426|NCT01561898|8785812|P3|Overall Study|Adverse Event|14
2538427|NCT01561898|8785813|P2|Overall Study|Adverse Event|19
2538428|NCT01561898|8785814|P1|Overall Study|Adverse Event|1
2538429|NCT01561898|8785811|P4|Overall Study|Lost to Follow-up|0
2538430|NCT01561898|8785812|P3|Overall Study|Lost to Follow-up|1
2538431|NCT01561898|8785813|P2|Overall Study|Lost to Follow-up|0
2538432|NCT01561898|8785814|P1|Overall Study|Lost to Follow-up|0
2538433|NCT01561898|8785811|P4|Overall Study|Worsening of complications|0
2538434|NCT01561898|8785812|P3|Overall Study|Worsening of complications|0
2538435|NCT01561898|8785813|P2|Overall Study|Worsening of complications|1
2538436|NCT01561898|8785814|P1|Overall Study|Worsening of complications|0
2538437|NCT01561898|8785811|P4|Overall Study|Lack of Efficacy|5
2538438|NCT01561898|8785812|P3|Overall Study|Lack of Efficacy|10
2538439|NCT01561898|8785813|P2|Overall Study|Lack of Efficacy|8
2538440|NCT01561898|8785814|P1|Overall Study|Lack of Efficacy|0
2538441|NCT01561898|8785811|P4|Overall Study|Withdrawal by Subject|5
2538442|NCT01561898|8785812|P3|Overall Study|Withdrawal by Subject|12
2538443|NCT01561898|8785813|P2|Overall Study|Withdrawal by Subject|8
2538444|NCT01561898|8785814|P1|Overall Study|Withdrawal by Subject|0
2538445|NCT01561755|8785828|P2|Overall Study|Lost to Follow-up|1
2538446|NCT01561755|8785829|P1|Overall Study|Lost to Follow-up|0
2538447|NCT01561560|8785881|P2|Second Two Weeks of Wear|Adverse Event|1
2538448|NCT01561560|8785882|P1|Second Two Weeks of Wear|Adverse Event|0
2538449|NCT01561560|8785881|P2|First Two Weeks of Wear|Adverse Event|1
2538450|NCT01561560|8785882|P1|First Two Weeks of Wear|Adverse Event|0
2538451|NCT01561560|8785881|P2|First Two Weeks of Wear|Time/job conflict|1
2538452|NCT01561560|8785882|P1|First Two Weeks of Wear|Time/job conflict|0
2538453|NCT01561430|8785917|P4|Overall Study|Sponsor Decision|12
2538454|NCT01561430|8785918|P3|Overall Study|Sponsor Decision|13
2538455|NCT01561430|8785919|P2|Overall Study|Sponsor Decision|14
2538456|NCT01561430|8785920|P1|Overall Study|Sponsor Decision|1
2538457|NCT01561430|8785917|P4|Overall Study|Physician Decision|0
2538458|NCT01561430|8785918|P3|Overall Study|Physician Decision|0
2538459|NCT01561430|8785919|P2|Overall Study|Physician Decision|1
2538460|NCT01561430|8785920|P1|Overall Study|Physician Decision|0
2538461|NCT01561430|8785917|P4|Overall Study|Withdrawal by Subject|0
2538462|NCT01561430|8785918|P3|Overall Study|Withdrawal by Subject|1
2538463|NCT01561430|8785919|P2|Overall Study|Withdrawal by Subject|0
2538464|NCT01561430|8785920|P1|Overall Study|Withdrawal by Subject|0
2538465|NCT01561430|8785917|P4|Overall Study|Adverse Event|1
2538466|NCT01561430|8785918|P3|Overall Study|Adverse Event|3
2538467|NCT01561430|8785919|P2|Overall Study|Adverse Event|0
2538468|NCT01561430|8785920|P1|Overall Study|Adverse Event|0
2538469|NCT01561313|8785960|P2|Overall Study|Adverse event and withdrawal by subject|0
2538470|NCT01561313|8785961|P1|Overall Study|Adverse event and withdrawal by subject|1
2538471|NCT01561313|8785960|P2|Overall Study|Withdrawal by Subject|0
2538472|NCT01561313|8785961|P1|Overall Study|Withdrawal by Subject|1
2538473|NCT01561300|8785979|P2|Run in on Placebo|Adverse Event|0
2538474|NCT01561300|8785980|P1|Run in on Placebo|Adverse Event|1
2538475|NCT01561079|8785991|P1|Overall Study|Protocol Violation|2
2538476|NCT01561079|8785991|P1|Overall Study|Withdrawal by Subject|59
2538477|NCT01561079|8785991|P1|Overall Study|Physician Decision|17
2538478|NCT01560988|8786077|P2|Washout (Six Weeks)|Lost to Follow-up|2
2538479|NCT01560988|8786078|P1|Washout (Six Weeks)|Lost to Follow-up|2
2538480|NCT01560988|8786077|P2|First Intervention (Six Weeks)|Withdrawal by Subject|0
2538481|NCT01560988|8786078|P1|First Intervention (Six Weeks)|Withdrawal by Subject|3
2538482|NCT01560988|8786077|P2|First Intervention (Six Weeks)|Lost to Follow-up|4
2538483|NCT01560988|8786078|P1|First Intervention (Six Weeks)|Lost to Follow-up|7
2538484|NCT01560871|8786135|P2|Overall Study|Lost to Follow-up|0
2538485|NCT01560871|8786136|P1|Overall Study|Lost to Follow-up|1
2538486|NCT01560871|8786135|P2|Overall Study|readmission to a hospital|1
2538487|NCT01560871|8786136|P1|Overall Study|readmission to a hospital|2
2538488|NCT01560871|8786135|P2|Overall Study|relocation|0
2538489|NCT01560871|8786136|P1|Overall Study|relocation|1
2538490|NCT01560871|8786135|P2|Overall Study|transportation issues|1
2538491|NCT01560871|8786136|P1|Overall Study|transportation issues|2
2538492|NCT01560819|8786152|P2|Overall Study|Physician Decision|0
2538493|NCT01560819|8786153|P1|Overall Study|Physician Decision|1
2538494|NCT01560780|8786159|P2|Overall Study|Patient Preference|11
2538495|NCT01560780|8786160|P1|Overall Study|Patient Preference|11
2538496|NCT01560780|8786159|P2|Overall Study|Death|1
2538497|NCT01560780|8786160|P1|Overall Study|Death|2
2538498|NCT01560507|8786196|P3|Overall Study|Withdrawal by Subject|0
2538499|NCT01560507|8786197|P2|Overall Study|Withdrawal by Subject|1
2538500|NCT01560507|8786198|P1|Overall Study|Withdrawal by Subject|1
2538501|NCT01560507|8786196|P3|Overall Study|Lost to Follow-up|2
2538502|NCT01560507|8786197|P2|Overall Study|Lost to Follow-up|1
2538503|NCT01560507|8786198|P1|Overall Study|Lost to Follow-up|3
2538504|NCT01560429|8786211|P2|Overall Study|Protocol Violation|6
2538505|NCT01560429|8786212|P1|Overall Study|Protocol Violation|3
2538506|NCT01560416|8786222|P2|Randomized Phase|Crossover Participants|0
2538507|NCT01560416|8786223|P1|Randomized Phase|Crossover Participants|7
2538508|NCT01560403|8786241|P2|Overall Study|Lost to Follow-up|1
2538509|NCT01560403|8786242|P1|Overall Study|Lost to Follow-up|0
2538510|NCT01560234|8786290|P8|Overall Study|Lost to Follow-up|2
2538511|NCT01560234|8786291|P7|Overall Study|Lost to Follow-up|0
2538512|NCT01560234|8786292|P6|Overall Study|Lost to Follow-up|2
2538513|NCT01560234|8786293|P5|Overall Study|Lost to Follow-up|0
2538514|NCT01560234|8786294|P4|Overall Study|Lost to Follow-up|0
2538515|NCT01560234|8786295|P3|Overall Study|Lost to Follow-up|1
2538516|NCT01560234|8786296|P2|Overall Study|Lost to Follow-up|0
2538517|NCT01560234|8786297|P1|Overall Study|Lost to Follow-up|3
2538518|NCT01559935|8786392|P1|Maintenance Phase|Non-compliance|2
2538519|NCT01559935|8786392|P1|Maintenance Phase|Withdrawal by Subject|5
2538520|NCT01559935|8786392|P1|Maintenance Phase|Lack of Efficacy|18
2538521|NCT01559935|8786392|P1|Maintenance Phase|Toxicity|1
2538522|NCT01559935|8786392|P1|Maintenance Phase|Remains on study|28
2538523|NCT01559935|8786392|P1|BiRD Phase|Withdrawal by Subject|2
2538524|NCT01559935|8786392|P1|BiRD Phase|Lack of Efficacy|1
2538525|NCT01559935|8786392|P1|BiRD Phase|Toxicity|1
2538526|NCT01559935|8786392|P1|Car Phase|non-compliance|1
2538527|NCT01559935|8786392|P1|Car Phase|Insurance|1
2538528|NCT01559935|8786392|P1|Car Phase|Per protocol|1
2538529|NCT01559935|8786392|P1|Car Phase|Withdrawal by Subject|2
2538530|NCT01559935|8786392|P1|Car Phase|Physician Decision|1
2538531|NCT01559935|8786392|P1|Car Phase|Lost to Follow-up|1
2538532|NCT01559935|8786392|P1|Car Phase|Lack of Efficacy|2
2538533|NCT01559935|8786392|P1|Car Phase|Death|1
2538534|NCT01559935|8786392|P1|Car Phase|Toxicity|4
2538535|NCT01559844|8786428|P1|Overall Study|No Longer A Transplant Candidate|3
2538536|NCT01559844|8786428|P1|Overall Study|Efficacy Failure|10
2538537|NCT01559844|8786428|P1|Overall Study|Death|5
2538538|NCT01559844|8786428|P1|Overall Study|Consent Withdrawn|7
2538539|NCT01559675|8786441|P2|Overall Study|2nd operation on same patient excluded|12
2538540|NCT01559675|8786442|P1|Overall Study|2nd operation on same patient excluded|14
2538541|NCT01559675|8786441|P2|Overall Study|Protocol Violation|2
2538542|NCT01559675|8786442|P1|Overall Study|Protocol Violation|1
2538543|NCT01559454|8786473|P2|Overall Study|Lack of Efficacy|1
2538544|NCT01559454|8786474|P1|Overall Study|Lack of Efficacy|0
2538545|NCT01559454|8786473|P2|Overall Study|Protocol Violation|1
2538546|NCT01559454|8786474|P1|Overall Study|Protocol Violation|0
2538547|NCT01559454|8786473|P2|Overall Study|Physician Decision|1
2538548|NCT01559454|8786474|P1|Overall Study|Physician Decision|0
2538549|NCT01559454|8786473|P2|Overall Study|Withdrawal by Subject|1
2538550|NCT01559454|8786474|P1|Overall Study|Withdrawal by Subject|0
2538551|NCT01559454|8786473|P2|Overall Study|Lost to Follow-up|2
2538552|NCT01559454|8786474|P1|Overall Study|Lost to Follow-up|3
2538553|NCT01559389|8786492|P2|Overall Study|Withdrawal by Subject|20
2538554|NCT01559389|8786493|P1|Overall Study|Withdrawal by Subject|20
2538555|NCT01559311|8786506|P3|Overall Study|Adverse Event|1
2538556|NCT01559311|8786507|P2|Overall Study|Adverse Event|0
2538557|NCT01559311|8786508|P1|Overall Study|Adverse Event|0
2538558|NCT01559311|8786506|P3|Overall Study|Lost to Follow-up|2
2538559|NCT01559311|8786507|P2|Overall Study|Lost to Follow-up|3
2538560|NCT01559311|8786508|P1|Overall Study|Lost to Follow-up|0
2538561|NCT01559311|8786506|P3|Overall Study|Death|3
2538562|NCT01559311|8786507|P2|Overall Study|Death|2
2538563|NCT01559311|8786508|P1|Overall Study|Death|0
2538564|NCT01559311|8786506|P3|Overall Study|Withdrawal by Subject|0
2538565|NCT01559311|8786507|P2|Overall Study|Withdrawal by Subject|1
2538566|NCT01559311|8786508|P1|Overall Study|Withdrawal by Subject|2
2538567|NCT01559311|8786506|P3|Overall Study|Difficulty in cannulating the lateral ve|0
2538568|NCT01559311|8786507|P2|Overall Study|Difficulty in cannulating the lateral ve|0
2538569|NCT01559311|8786508|P1|Overall Study|Difficulty in cannulating the lateral ve|1
2538570|NCT01559311|8786506|P3|Overall Study|Protocol Violation|2
2538571|NCT01559311|8786507|P2|Overall Study|Protocol Violation|0
2538572|NCT01559311|8786508|P1|Overall Study|Protocol Violation|0
2538573|NCT01559129|8786521|P2|Open-label Extension Period|Study Terminated by Sponsor|2
2538574|NCT01559129|8786522|P1|Open-label Extension Period|Study Terminated by Sponsor|5
2538575|NCT01559129|8786521|P2|Open-label Extension Period|Adverse Event|0
2538576|NCT01559129|8786522|P1|Open-label Extension Period|Adverse Event|1
2538577|NCT01559129|8786521|P2|Treatment Phase|Did Not Receive Study Drug|1
2538578|NCT01559129|8786522|P1|Treatment Phase|Did Not Receive Study Drug|0
2538579|NCT01559129|8786521|P2|Treatment Phase|Protocol Exclusion Criteria|0
2538580|NCT01559129|8786522|P1|Treatment Phase|Protocol Exclusion Criteria|1
2538581|NCT01559129|8786521|P2|Treatment Phase|Study Terminated by Sponsor|2
2538582|NCT01559129|8786522|P1|Treatment Phase|Study Terminated by Sponsor|3
2538583|NCT01559129|8786521|P2|Treatment Phase|Lack of Efficacy|1
2538584|NCT01559129|8786522|P1|Treatment Phase|Lack of Efficacy|0
2538585|NCT01559129|8786521|P2|Treatment Phase|Progressive Disease|1
2538586|NCT01559129|8786522|P1|Treatment Phase|Progressive Disease|1
2538587|NCT01559129|8786521|P2|Treatment Phase|Adverse Event|2
2538588|NCT01559129|8786522|P1|Treatment Phase|Adverse Event|0
2538589|NCT01559116|8786598|P1|Overall Study|other than stated above|9
2538590|NCT01559116|8786598|P1|Overall Study|Withdrawal by Subject|4
2538591|NCT01559116|8786598|P1|Overall Study|Protocol Violation|1
2538592|NCT01559116|8786598|P1|Overall Study|Lost to Follow-up|1
2538593|NCT01559116|8786598|P1|Overall Study|Lack of Efficacy|1
2538594|NCT01559116|8786598|P1|Overall Study|Adverse Event|10
2538595|NCT01559090|8786669|P3|Stage II|Withdrawal by Subject|0
2538596|NCT01559090|8786670|P2|Stage II|Withdrawal by Subject|0
2538597|NCT01559090|8786671|P1|Stage II|Withdrawal by Subject|1
2538598|NCT01559090|8786669|P3|Stage I|Withdrawal by Subject|3
2538599|NCT01559090|8786670|P2|Stage I|Withdrawal by Subject|2
2538600|NCT01559090|8786671|P1|Stage I|Withdrawal by Subject|2
2538601|NCT01559012|8786703|P2|Overall Study|Withdrawal by Subject|1
2538602|NCT01559012|8786704|P1|Overall Study|Withdrawal by Subject|0
2538603|NCT01558739|8786742|P1|Overall Study|Protocol Violation|1
2538604|NCT01558739|8786742|P1|Overall Study|Disease Progression|4
2538605|NCT01558739|8786742|P1|Overall Study|Death|3
2538606|NCT01558739|8786742|P1|Overall Study|Withdrawal by Subject|2
2538607|NCT01558739|8786742|P1|Overall Study|Adverse Event|7
2538608|NCT01558674|8786767|P2|Part 1|Withdrawal by Subject|0
2538609|NCT01558674|8786768|P1|Part 1|Withdrawal by Subject|1
2538610|NCT01558674|8786767|P2|Part 1|Study Terminated by Sponsor|0
2538611|NCT01558674|8786768|P1|Part 1|Study Terminated by Sponsor|10
2538612|NCT01558635|8786819|P1|Overall Study|Reveal XT was explanted|1
2538613|NCT01558635|8786819|P1|Overall Study|Subject received other treatment|1
2538614|NCT01558635|8786819|P1|Overall Study|Physician Decision|1
2538615|NCT01558635|8786819|P1|Overall Study|Withdrawal by Subject|2
2538616|NCT01558635|8786819|P1|Overall Study|Death|1
2538617|NCT01558596|8786836|P2|Overall Study|Protocol Violation|0
2538618|NCT01558596|8786837|P1|Overall Study|Protocol Violation|1
2538619|NCT01558596|8786836|P2|Overall Study|surgery elsewhere or cancelled|1
2538620|NCT01558596|8786837|P1|Overall Study|surgery elsewhere or cancelled|1
2538621|NCT01558596|8786836|P2|Overall Study|Withdrawal by Subject|0
2538622|NCT01558596|8786837|P1|Overall Study|Withdrawal by Subject|1
2538623|NCT01558297|8786852|P3|Overall Study|Withdrawal by Subject|1
2538624|NCT01558297|8786853|P2|Overall Study|Withdrawal by Subject|2
2538625|NCT01558297|8786854|P1|Overall Study|Withdrawal by Subject|2
2538626|NCT01558271|8786871|P3|Overall Study|Physician Decision|1
2538627|NCT01558271|8786872|P2|Overall Study|Physician Decision|2
2538628|NCT01558271|8786873|P1|Overall Study|Physician Decision|0
2538629|NCT01558271|8786871|P3|Overall Study|Withdrawal by Subject|12
2538630|NCT01558271|8786872|P2|Overall Study|Withdrawal by Subject|6
2538631|NCT01558271|8786873|P1|Overall Study|Withdrawal by Subject|10
2538632|NCT01558271|8786871|P3|Overall Study|Protocol Violation|0
2538633|NCT01558271|8786872|P2|Overall Study|Protocol Violation|0
2538634|NCT01558271|8786873|P1|Overall Study|Protocol Violation|1
2538635|NCT01558271|8786871|P3|Overall Study|Lost to Follow-up|0
2538636|NCT01558271|8786872|P2|Overall Study|Lost to Follow-up|0
2538637|NCT01558271|8786873|P1|Overall Study|Lost to Follow-up|1
2538638|NCT01558271|8786871|P3|Overall Study|Adverse Event|4
2538639|NCT01558271|8786872|P2|Overall Study|Adverse Event|3
2538640|NCT01558271|8786873|P1|Overall Study|Adverse Event|6
2538641|NCT01558089|8786939|P1|Overall Study|Withdrawal by Subject|6
2538642|NCT01558089|8786939|P1|Overall Study|Lost to Follow-up|5
2538643|NCT01558089|8786939|P1|Overall Study|Lack of Efficacy|1
2538644|NCT01558089|8786939|P1|Overall Study|Adverse Event|1
2538645|NCT01557946|8786992|P2|Overall Study|Adverse Event|0
2538646|NCT01557946|8786993|P1|Overall Study|Adverse Event|3
2538647|NCT01557920|8786999|P2|Overall Study|Lack of Efficacy|0
2538648|NCT01557920|8787000|P1|Overall Study|Lack of Efficacy|1
2538649|NCT01557920|8786999|P2|Overall Study|Withdrawal by Subject|3
2538650|NCT01557920|8787000|P1|Overall Study|Withdrawal by Subject|2
2538651|NCT01557842|8787069|P2|Overall Study|Not Ablated|0
2538652|NCT01557842|8787070|P1|Overall Study|Not Ablated|2
2538653|NCT01557842|8787069|P2|Overall Study|Study Terminated by Sponsor|4
2538654|NCT01557842|8787070|P1|Overall Study|Study Terminated by Sponsor|3
2538655|NCT01557842|8787069|P2|Overall Study|Not Meet Inclusion/Exclusion Criteria|0
2538656|NCT01557842|8787070|P1|Overall Study|Not Meet Inclusion/Exclusion Criteria|3
2538657|NCT01557842|8787069|P2|Overall Study|Lack of Efficacy|1
2538658|NCT01557842|8787070|P1|Overall Study|Lack of Efficacy|0
2538659|NCT01557842|8787069|P2|Overall Study|Death|0
2538660|NCT01557842|8787070|P1|Overall Study|Death|1
2538661|NCT01557842|8787069|P2|Overall Study|Lost to Follow-up|1
2538662|NCT01557842|8787070|P1|Overall Study|Lost to Follow-up|0
2538663|NCT01557751|8787082|P1|Overall Study|Physician Decision|3
2538664|NCT01557582|8787127|P1|Overall Study|Operator error|2
2538665|NCT01557582|8787127|P1|Overall Study|Protocol Violation|4
2538666|NCT01557569|8787135|P2|Overall Study|noncompliance with rules of residential|1
2538667|NCT01557569|8787136|P1|Overall Study|noncompliance with rules of residential|0
2538668|NCT01557569|8787135|P2|Overall Study|Withdrawal by Subject|5
2538669|NCT01557569|8787136|P1|Overall Study|Withdrawal by Subject|3
2538670|NCT01557569|8787135|P2|Overall Study|high blood pressure|1
2538671|NCT01557569|8787136|P1|Overall Study|high blood pressure|0
2538672|NCT01557569|8787135|P2|Overall Study|Adverse Event|0
2538673|NCT01557569|8787136|P1|Overall Study|Adverse Event|2
2538674|NCT01557517|8787144|P2|Overall Study|Pt declined before treatment started|0
2538675|NCT01557517|8787145|P1|Overall Study|Pt declined before treatment started|1
2538676|NCT01557517|8787144|P2|Overall Study|Adverse Event|2
2538677|NCT01557517|8787145|P1|Overall Study|Adverse Event|0
2538678|NCT01557517|8787144|P2|Overall Study|Refused further treatment|2
2538679|NCT01557517|8787145|P1|Overall Study|Refused further treatment|0
2538680|NCT01557517|8787144|P2|Overall Study|Death|0
2538681|NCT01557517|8787145|P1|Overall Study|Death|1
2538682|NCT01557504|8787171|P2|Overall Study|Physician Decision|0
2538683|NCT01557504|8787172|P1|Overall Study|Physician Decision|1
2538684|NCT01557348|8787197|P2|Overall Study|Administrative|11
2538685|NCT01557348|8787198|P1|Overall Study|Administrative|18
2538686|NCT01557348|8787197|P2|Overall Study|Lost to Follow-up|22
2538687|NCT01557348|8787198|P1|Overall Study|Lost to Follow-up|26
2538688|NCT01557348|8787197|P2|Overall Study|Withdrawal by Subject|4
2538689|NCT01557348|8787198|P1|Overall Study|Withdrawal by Subject|5
2538690|NCT01557348|8787197|P2|Overall Study|Insufficient Therapeutic Response|28
2538691|NCT01557348|8787198|P1|Overall Study|Insufficient Therapeutic Response|13
2538692|NCT01557348|8787197|P2|Overall Study|Death|4
2538693|NCT01557348|8787198|P1|Overall Study|Death|7
2538694|NCT01557348|8787197|P2|Overall Study|Infusion reaction event|5
2538695|NCT01557348|8787198|P1|Overall Study|Infusion reaction event|5
2538696|NCT01557348|8787197|P2|Overall Study|Adverse Event|16
2538697|NCT01557348|8787198|P1|Overall Study|Adverse Event|6
2538698|NCT01557283|8787315|P1|Overall Study|Other|6
2538699|NCT01557283|8787315|P1|Overall Study|Worsening of psoriasis|1
2538700|NCT01557283|8787315|P1|Overall Study|Participant’s weight too high for dose|1
2538701|NCT01557283|8787315|P1|Overall Study|Withdrawal by Subject|1
2538702|NCT01557283|8787315|P1|Overall Study|Non-compliance|1
2538703|NCT01557283|8787315|P1|Overall Study|Lack of Efficacy|1
2538704|NCT01557283|8787315|P1|Overall Study|Adverse Event|7
2538705|NCT01557283|8787315|P1|Overall Study|Non-responder|19
2538706|NCT01557283|8787315|P1|Overall Study|Lost to Follow-up|7
2538707|NCT01557166|8787327|P2|Overall Study|Unclassified|5
2538708|NCT01557166|8787328|P1|Overall Study|Unclassified|2
2538709|NCT01557166|8787327|P2|Overall Study|Psychiatric disorder|0
2538710|NCT01557166|8787328|P1|Overall Study|Psychiatric disorder|1
2538711|NCT01557166|8787327|P2|Overall Study|Target dose not tolerated|0
2538712|NCT01557166|8787328|P1|Overall Study|Target dose not tolerated|1
2538713|NCT01557166|8787327|P2|Overall Study|Withdrawn consent|20
2538714|NCT01557166|8787328|P1|Overall Study|Withdrawn consent|12
2538715|NCT01557166|8787327|P2|Overall Study|Protocol Violation|5
2538716|NCT01557166|8787328|P1|Overall Study|Protocol Violation|8
2538717|NCT01557166|8787327|P2|Overall Study|Lack of Efficacy|1
2538718|NCT01557166|8787328|P1|Overall Study|Lack of Efficacy|2
2538719|NCT01557166|8787327|P2|Overall Study|Adverse Event|6
2538720|NCT01557166|8787328|P1|Overall Study|Adverse Event|20
2538721|NCT01556997|8787343|P3|Overall Study|Other|7
2538722|NCT01556997|8787344|P2|Overall Study|Other|3
2538723|NCT01556997|8787345|P1|Overall Study|Other|2
2538724|NCT01556997|8787343|P3|Overall Study|Withdrawal by Subject|8
2538725|NCT01556997|8787344|P2|Overall Study|Withdrawal by Subject|6
2538726|NCT01556997|8787345|P1|Overall Study|Withdrawal by Subject|7
2538727|NCT01556997|8787343|P3|Overall Study|Physician Decision|1
2538728|NCT01556997|8787344|P2|Overall Study|Physician Decision|1
2538729|NCT01556997|8787345|P1|Overall Study|Physician Decision|1
2538730|NCT01556997|8787343|P3|Overall Study|Lost to Follow-up|4
2538731|NCT01556997|8787344|P2|Overall Study|Lost to Follow-up|6
2538732|NCT01556997|8787345|P1|Overall Study|Lost to Follow-up|6
2538733|NCT01556997|8787343|P3|Overall Study|Adverse Event|12
2538734|NCT01556997|8787344|P2|Overall Study|Adverse Event|12
2538735|NCT01556997|8787345|P1|Overall Study|Adverse Event|10
2538736|NCT01556932|8787356|P2|Time Point 60 Minutes|Withdrawal by Subject|1
2538737|NCT01556932|8787357|P1|Time Point 60 Minutes|Withdrawal by Subject|1
2538738|NCT01556763|8787383|P3|Overall Study|Withdrawal by Subject|0
2538739|NCT01556763|8787384|P2|Overall Study|Withdrawal by Subject|1
2538740|NCT01556763|8787385|P1|Overall Study|Withdrawal by Subject|0
2538741|NCT01556438|8787511|P2|Overall Study|Death|1
2538742|NCT01556438|8787512|P1|Overall Study|Death|0
2538743|NCT01556438|8787511|P2|Overall Study|Progressive Disease|6
2538744|NCT01556438|8787512|P1|Overall Study|Progressive Disease|0
2538745|NCT01556438|8787511|P2|Overall Study|Sponsor Decision|2
2538746|NCT01556438|8787512|P1|Overall Study|Sponsor Decision|0
2538747|NCT01556438|8787511|P2|Overall Study|Adverse Event|2
2538748|NCT01556438|8787512|P1|Overall Study|Adverse Event|4
2538749|NCT01556165|8787599|P2|Overall Study|Withdrawal of Consent|1
2538750|NCT01556165|8787600|P1|Overall Study|Withdrawal of Consent|7
2538751|NCT01556165|8787599|P2|Overall Study|Protocol Violation|3
2538752|NCT01556165|8787600|P1|Overall Study|Protocol Violation|0
2538753|NCT01556165|8787599|P2|Overall Study|Adverse Event|3
2538754|NCT01556165|8787600|P1|Overall Study|Adverse Event|5
2538755|NCT01555983|8787630|P6|Overall Study|Withdrawal by Subject|1
2538756|NCT01555983|8787631|P5|Overall Study|Withdrawal by Subject|1
2538757|NCT01555983|8787632|P4|Overall Study|Withdrawal by Subject|0
2538758|NCT01555983|8787633|P3|Overall Study|Withdrawal by Subject|0
2538759|NCT01555983|8787634|P2|Overall Study|Withdrawal by Subject|0
2538760|NCT01555983|8787635|P1|Overall Study|Withdrawal by Subject|1
2538761|NCT01555931|8787645|P2|Overall Study|Lost to Follow-up|5
2538762|NCT01555931|8787646|P1|Overall Study|Lost to Follow-up|2
2538763|NCT01555762|8787654|P1|Overall Study|Death linked to an adverse event|14
2538764|NCT01555762|8787654|P1|Overall Study|Missing data|1
2538765|NCT01555762|8787654|P1|Overall Study|Participant not wishing to continue|5
2538766|NCT01555762|8787654|P1|Overall Study|Investigator's decision|10
2538767|NCT01555762|8787654|P1|Overall Study|Lost follow-up/moved house/changed team|35
2538768|NCT01555762|8787654|P1|Overall Study|Death linked to progression of disease|165
2538769|NCT01555762|8787654|P1|Overall Study|Treatment with Bevacizumab ticked No|24
2538770|NCT01555762|8787654|P1|Overall Study|75 years old or more ticked No|1
2538771|NCT01555762|8787654|P1|Overall Study|Missing start date of infusion|8
2538772|NCT01555762|8787654|P1|Overall Study|No information on Bevacizumab intake|11
2538773|NCT01555463|8787699|P2|Follow up|Other reason|3
2538774|NCT01555463|8787700|P1|Follow up|Other reason|3
2538775|NCT01555463|8787699|P2|Follow up|Protocol Violation|4
2538776|NCT01555463|8787700|P1|Follow up|Protocol Violation|2
2538777|NCT01555463|8787699|P2|Follow up|Lost to Follow-up|10
2538778|NCT01555463|8787700|P1|Follow up|Lost to Follow-up|9
2538779|NCT01555463|8787699|P2|Follow up|Withdrawal by Subject|22
2538780|NCT01555463|8787700|P1|Follow up|Withdrawal by Subject|22
2538781|NCT01555463|8787699|P2|Follow up|Death|1
2538782|NCT01555463|8787700|P1|Follow up|Death|0
2538783|NCT01555463|8787699|P2|Follow up|Adverse Event|5
2538784|NCT01555463|8787700|P1|Follow up|Adverse Event|2
2538785|NCT01555463|8787699|P2|Treatment|Other reason|3
2538786|NCT01555463|8787700|P1|Treatment|Other reason|2
2538787|NCT01555463|8787699|P2|Treatment|Protocol Violation|5
2538788|NCT01555463|8787700|P1|Treatment|Protocol Violation|4
2538789|NCT01555463|8787699|P2|Treatment|Lost to Follow-up|23
2538790|NCT01555463|8787700|P1|Treatment|Lost to Follow-up|28
2538791|NCT01555463|8787699|P2|Treatment|Withdrawal by Subject|36
2538792|NCT01555463|8787700|P1|Treatment|Withdrawal by Subject|24
2538793|NCT01555463|8787699|P2|Treatment|Adverse Event|12
2538794|NCT01555463|8787700|P1|Treatment|Adverse Event|6
2538795|NCT01555164|8787742|P2|Overall Study|Subject Withdrew Consent|11
2538796|NCT01555164|8787743|P1|Overall Study|Subject Withdrew Consent|6
2538797|NCT01555164|8787742|P2|Overall Study|Subject Non-compliance|6
2538798|NCT01555164|8787743|P1|Overall Study|Subject Non-compliance|14
2538799|NCT01555164|8787742|P2|Overall Study|Protocol Violation|5
2538800|NCT01555164|8787743|P1|Overall Study|Protocol Violation|9
2538801|NCT01555164|8787742|P2|Overall Study|Lost to Follow-up|3
2538802|NCT01555164|8787743|P1|Overall Study|Lost to Follow-up|4
2538803|NCT01555164|8787742|P2|Overall Study|Investigator's Discretion|2
2538804|NCT01555164|8787743|P1|Overall Study|Investigator's Discretion|2
2538805|NCT01555164|8787742|P2|Overall Study|Hyperglycemia|1
2538806|NCT01555164|8787743|P1|Overall Study|Hyperglycemia|0
2538807|NCT01555164|8787742|P2|Overall Study|Adverse Event|7
2538808|NCT01555164|8787743|P1|Overall Study|Adverse Event|5
2538809|NCT01555151|8787757|P4|Overall Study|Lost to Follow-up|1
2538810|NCT01555151|8787758|P3|Overall Study|Lost to Follow-up|0
2538811|NCT01555151|8787759|P2|Overall Study|Lost to Follow-up|0
2538812|NCT01555151|8787760|P1|Overall Study|Lost to Follow-up|0
2538813|NCT01555151|8787757|P4|Overall Study|Adverse Event|2
2538814|NCT01555151|8787758|P3|Overall Study|Adverse Event|1
2538815|NCT01555151|8787759|P2|Overall Study|Adverse Event|2
2538816|NCT01555151|8787760|P1|Overall Study|Adverse Event|1
2538817|NCT01555151|8787757|P4|Overall Study|Protocol Violation|5
2538818|NCT01555151|8787758|P3|Overall Study|Protocol Violation|3
2538819|NCT01555151|8787759|P2|Overall Study|Protocol Violation|3
2538820|NCT01555151|8787760|P1|Overall Study|Protocol Violation|3
2538821|NCT01555151|8787757|P4|Overall Study|Administrative|0
2538822|NCT01555151|8787758|P3|Overall Study|Administrative|2
2538823|NCT01555151|8787759|P2|Overall Study|Administrative|1
2538824|NCT01555151|8787760|P1|Overall Study|Administrative|3
2538825|NCT01555151|8787757|P4|Overall Study|Withdrawal by Subject|2
2538826|NCT01555151|8787758|P3|Overall Study|Withdrawal by Subject|0
2538827|NCT01555151|8787759|P2|Overall Study|Withdrawal by Subject|2
2538828|NCT01555151|8787760|P1|Overall Study|Withdrawal by Subject|6
2538829|NCT01555138|8787813|P2|Overall Study|Adverse Event|14
2538830|NCT01555138|8787814|P1|Overall Study|Adverse Event|14
2538831|NCT01555138|8787813|P2|Overall Study|Withdrawal by Subject|15
2538832|NCT01555138|8787814|P1|Overall Study|Withdrawal by Subject|16
2538833|NCT01555138|8787813|P2|Overall Study|Administrative problems|0
2538834|NCT01555138|8787814|P1|Overall Study|Administrative problems|8
2538835|NCT01555138|8787813|P2|Overall Study|Protocol Violation|3
2538836|NCT01555138|8787814|P1|Overall Study|Protocol Violation|5
2538837|NCT01555138|8787813|P2|Overall Study|Lack of Efficacy|2
2538838|NCT01555138|8787814|P1|Overall Study|Lack of Efficacy|2
2538839|NCT01555138|8787813|P2|Overall Study|Abnormal Lab reults|3
2538840|NCT01555138|8787814|P1|Overall Study|Abnormal Lab reults|1
2538841|NCT01555138|8787813|P2|Overall Study|Lost to Follow-up|0
2538842|NCT01555138|8787814|P1|Overall Study|Lost to Follow-up|1
2538843|NCT01555138|8787813|P2|Overall Study|Death|1
2538844|NCT01555138|8787814|P1|Overall Study|Death|0
2538845|NCT01555125|8787843|P5|Follow-Up Period|Subject / guardian decision|0
2538846|NCT01555125|8787844|P4|Follow-Up Period|Subject / guardian decision|1
2538847|NCT01555125|8787845|P3|Follow-Up Period|Subject / guardian decision|1
2538848|NCT01555125|8787846|P2|Follow-Up Period|Subject / guardian decision|1
2538849|NCT01555125|8787847|P1|Follow-Up Period|Subject / guardian decision|3
2538850|NCT01555125|8787843|P5|Follow-Up Period|Lost to Follow-up|0
2538851|NCT01555125|8787844|P4|Follow-Up Period|Lost to Follow-up|0
2538852|NCT01555125|8787845|P3|Follow-Up Period|Lost to Follow-up|0
2538853|NCT01555125|8787846|P2|Follow-Up Period|Lost to Follow-up|0
2538854|NCT01555125|8787847|P1|Follow-Up Period|Lost to Follow-up|1
2538855|NCT01555125|8787843|P5|Extension|Technical Problems|0
2538856|NCT01555125|8787844|P4|Extension|Technical Problems|1
2538857|NCT01555125|8787845|P3|Extension|Technical Problems|0
2538858|NCT01555125|8787846|P2|Extension|Technical Problems|0
2538859|NCT01555125|8787847|P1|Extension|Technical Problems|1
2538860|NCT01555125|8787843|P5|Extension|Subject/guardian decision|0
2538861|NCT01555125|8787844|P4|Extension|Subject/guardian decision|0
2538862|NCT01555125|8787845|P3|Extension|Subject/guardian decision|1
2538863|NCT01555125|8787846|P2|Extension|Subject/guardian decision|9
2538864|NCT01555125|8787847|P1|Extension|Subject/guardian decision|1
2538865|NCT01555125|8787843|P5|Extension|Study terminated by sponsor|0
2538866|NCT01555125|8787844|P4|Extension|Study terminated by sponsor|20
2538867|NCT01555125|8787845|P3|Extension|Study terminated by sponsor|16
2538868|NCT01555125|8787846|P2|Extension|Study terminated by sponsor|33
2538869|NCT01555125|8787847|P1|Extension|Study terminated by sponsor|32
2538870|NCT01555125|8787843|P5|Extension|Lost to Follow-up|0
2538871|NCT01555125|8787844|P4|Extension|Lost to Follow-up|0
2538872|NCT01555125|8787845|P3|Extension|Lost to Follow-up|2
2538873|NCT01555125|8787846|P2|Extension|Lost to Follow-up|1
2538874|NCT01555125|8787847|P1|Extension|Lost to Follow-up|2
2538875|NCT01555125|8787843|P5|Extension|Lack of Efficacy|0
2538876|NCT01555125|8787844|P4|Extension|Lack of Efficacy|0
2538877|NCT01555125|8787845|P3|Extension|Lack of Efficacy|3
2538878|NCT01555125|8787846|P2|Extension|Lack of Efficacy|6
2538879|NCT01555125|8787847|P1|Extension|Lack of Efficacy|7
2538880|NCT01555125|8787843|P5|Extension|Protocol deviation|0
2538881|NCT01555125|8787844|P4|Extension|Protocol deviation|0
2538882|NCT01555125|8787845|P3|Extension|Protocol deviation|0
2538883|NCT01555125|8787846|P2|Extension|Protocol deviation|0
2538884|NCT01555125|8787847|P1|Extension|Protocol deviation|1
2538885|NCT01555125|8787843|P5|Extension|Adverse Event|0
2538886|NCT01555125|8787844|P4|Extension|Adverse Event|1
2538887|NCT01555125|8787845|P3|Extension|Adverse Event|1
2538888|NCT01555125|8787846|P2|Extension|Adverse Event|2
2538889|NCT01555125|8787847|P1|Extension|Adverse Event|1
2538890|NCT01555125|8787843|P5|Maintenance Period|Death|0
2538891|NCT01555125|8787844|P4|Maintenance Period|Death|1
2538892|NCT01555125|8787845|P3|Maintenance Period|Death|0
2538893|NCT01555125|8787846|P2|Maintenance Period|Death|0
2538894|NCT01555125|8787847|P1|Maintenance Period|Death|0
2538895|NCT01555125|8787843|P5|Maintenance Period|Physician Decision|0
2538896|NCT01555125|8787844|P4|Maintenance Period|Physician Decision|0
2538897|NCT01555125|8787845|P3|Maintenance Period|Physician Decision|1
2538898|NCT01555125|8787846|P2|Maintenance Period|Physician Decision|0
2538899|NCT01555125|8787847|P1|Maintenance Period|Physician Decision|0
2538900|NCT01555125|8787843|P5|Maintenance Period|Lack of Efficacy|0
2538901|NCT01555125|8787844|P4|Maintenance Period|Lack of Efficacy|0
2538902|NCT01555125|8787845|P3|Maintenance Period|Lack of Efficacy|3
2538903|NCT01555125|8787846|P2|Maintenance Period|Lack of Efficacy|1
2538904|NCT01555125|8787847|P1|Maintenance Period|Lack of Efficacy|6
2538905|NCT01555125|8787843|P5|Maintenance Period|Lost to Follow-up|0
2538906|NCT01555125|8787844|P4|Maintenance Period|Lost to Follow-up|1
2538907|NCT01555125|8787845|P3|Maintenance Period|Lost to Follow-up|0
2538908|NCT01555125|8787846|P2|Maintenance Period|Lost to Follow-up|0
2538909|NCT01555125|8787847|P1|Maintenance Period|Lost to Follow-up|2
2538910|NCT01555125|8787843|P5|Maintenance Period|Subject / guardian decision|0
2538911|NCT01555125|8787844|P4|Maintenance Period|Subject / guardian decision|0
2538912|NCT01555125|8787845|P3|Maintenance Period|Subject / guardian decision|0
2538913|NCT01555125|8787846|P2|Maintenance Period|Subject / guardian decision|2
2538914|NCT01555125|8787847|P1|Maintenance Period|Subject / guardian decision|1
2538915|NCT01555125|8787843|P5|Maintenance Period|Adverse Event|0
2538916|NCT01555125|8787844|P4|Maintenance Period|Adverse Event|0
2538917|NCT01555125|8787845|P3|Maintenance Period|Adverse Event|0
2538918|NCT01555125|8787846|P2|Maintenance Period|Adverse Event|1
2538919|NCT01555125|8787847|P1|Maintenance Period|Adverse Event|1
2538920|NCT01555125|8787843|P5|Induction Period|Death|0
2538921|NCT01555125|8787844|P4|Induction Period|Death|0
2538922|NCT01555125|8787845|P3|Induction Period|Death|0
2538923|NCT01555125|8787846|P2|Induction Period|Death|0
2538924|NCT01555125|8787847|P1|Induction Period|Death|1
2538925|NCT01555125|8787843|P5|Induction Period|Subject / guardian decision|2
2538926|NCT01555125|8787844|P4|Induction Period|Subject / guardian decision|0
2538927|NCT01555125|8787845|P3|Induction Period|Subject / guardian decision|0
2538928|NCT01555125|8787846|P2|Induction Period|Subject / guardian decision|0
2538929|NCT01555125|8787847|P1|Induction Period|Subject / guardian decision|0
2538930|NCT01555125|8787843|P5|Induction Period|Adverse Event|1
2538931|NCT01555125|8787844|P4|Induction Period|Adverse Event|0
2538932|NCT01555125|8787845|P3|Induction Period|Adverse Event|0
2538933|NCT01555125|8787846|P2|Induction Period|Adverse Event|1
2538934|NCT01555125|8787847|P1|Induction Period|Adverse Event|0
2538935|NCT01555125|8787843|P5|Induction Period|Lost to Follow-up|0
2538936|NCT01555125|8787844|P4|Induction Period|Lost to Follow-up|0
2538937|NCT01555125|8787845|P3|Induction Period|Lost to Follow-up|0
2538938|NCT01555125|8787846|P2|Induction Period|Lost to Follow-up|2
2538939|NCT01555125|8787847|P1|Induction Period|Lost to Follow-up|0
2538940|NCT01555073|8787940|P4|Overall Study|Lost to Follow-up|5
2538941|NCT01555073|8787941|P3|Overall Study|Lost to Follow-up|0
2538942|NCT01555073|8787942|P2|Overall Study|Lost to Follow-up|2
2538943|NCT01555073|8787943|P1|Overall Study|Lost to Follow-up|1
2538944|NCT01555021|8787959|P2|Overall Study|Lost to Follow-up|2
2538945|NCT01555021|8787960|P1|Overall Study|Lost to Follow-up|1
2538946|NCT01554904|8787985|P1|Overall Study|Had sleep apnea on Home Study 1|1
2538947|NCT01554904|8787985|P1|Overall Study|Withdrawal by Subject|3
2538948|NCT01554579|8788005|P2|Overall Study|Withdrawal by Subject|1
2538949|NCT01554579|8788006|P1|Overall Study|Withdrawal by Subject|2
2538950|NCT01554579|8788005|P2|Overall Study|Lack of Efficacy|1
2538951|NCT01554579|8788006|P1|Overall Study|Lack of Efficacy|2
2538952|NCT01554579|8788005|P2|Overall Study|Adverse Event|25
2538953|NCT01554579|8788006|P1|Overall Study|Adverse Event|6
2538954|NCT01554527|8788019|P3|Overall Study|Physician Decision|1
2538955|NCT01554527|8788020|P2|Overall Study|Physician Decision|0
2538956|NCT01554527|8788021|P1|Overall Study|Physician Decision|0
2538957|NCT01554527|8788019|P3|Overall Study|Lost to Follow-up|4
2538958|NCT01554527|8788020|P2|Overall Study|Lost to Follow-up|0
2538959|NCT01554527|8788021|P1|Overall Study|Lost to Follow-up|0
2538960|NCT01554527|8788019|P3|Overall Study|Withdrawal by Subject|3
2538961|NCT01554527|8788020|P2|Overall Study|Withdrawal by Subject|0
2538962|NCT01554527|8788021|P1|Overall Study|Withdrawal by Subject|1
2538963|NCT01554241|8788077|P4|Overall Study|Withdrawal by Subject|0
2538964|NCT01554241|8788078|P3|Overall Study|Withdrawal by Subject|2
2538965|NCT01554241|8788079|P2|Overall Study|Withdrawal by Subject|0
2538966|NCT01554241|8788080|P1|Overall Study|Withdrawal by Subject|0
2538967|NCT01554241|8788077|P4|Overall Study|protocol specified change in eGFR|0
2538968|NCT01554241|8788078|P3|Overall Study|protocol specified change in eGFR|1
2538969|NCT01554241|8788079|P2|Overall Study|protocol specified change in eGFR|0
2538970|NCT01554241|8788080|P1|Overall Study|protocol specified change in eGFR|0
2538971|NCT01554241|8788077|P4|Overall Study|protocol specified renal stone|1
2538972|NCT01554241|8788078|P3|Overall Study|protocol specified renal stone|0
2538973|NCT01554241|8788079|P2|Overall Study|protocol specified renal stone|0
2538974|NCT01554241|8788080|P1|Overall Study|protocol specified renal stone|0
2538975|NCT01554241|8788077|P4|Overall Study|Death|0
2538976|NCT01554241|8788078|P3|Overall Study|Death|1
2538977|NCT01554241|8788079|P2|Overall Study|Death|1
2538978|NCT01554241|8788080|P1|Overall Study|Death|3
2538979|NCT01554176|8788096|P5|Run-out Phase|Protocol Violation|0
2538980|NCT01554176|8788097|P4|Run-out Phase|Protocol Violation|1
2538981|NCT01554176|8788098|P3|Run-out Phase|Protocol Violation|0
2538982|NCT01554176|8788099|P2|Run-out Phase|Protocol Violation|0
2538983|NCT01554176|8788100|P1|Run-out Phase|Protocol Violation|0
2538984|NCT01554176|8788096|P5|Treatment Phase|Lost to Follow-up|0
2538985|NCT01554176|8788097|P4|Treatment Phase|Lost to Follow-up|0
2538986|NCT01554176|8788098|P3|Treatment Phase|Lost to Follow-up|0
2538987|NCT01554176|8788099|P2|Treatment Phase|Lost to Follow-up|0
2538988|NCT01554176|8788100|P1|Treatment Phase|Lost to Follow-up|3
2538989|NCT01554176|8788096|P5|Treatment Phase|Withdrawal by Subject|0
2538990|NCT01554176|8788097|P4|Treatment Phase|Withdrawal by Subject|0
2538991|NCT01554176|8788098|P3|Treatment Phase|Withdrawal by Subject|0
2538992|NCT01554176|8788099|P2|Treatment Phase|Withdrawal by Subject|0
2538993|NCT01554176|8788100|P1|Treatment Phase|Withdrawal by Subject|1
2538994|NCT01554176|8788096|P5|Treatment Phase|Non-compliance with study drug|0
2538995|NCT01554176|8788097|P4|Treatment Phase|Non-compliance with study drug|0
2538996|NCT01554176|8788098|P3|Treatment Phase|Non-compliance with study drug|0
2538997|NCT01554176|8788099|P2|Treatment Phase|Non-compliance with study drug|0
2538998|NCT01554176|8788100|P1|Treatment Phase|Non-compliance with study drug|1
2538999|NCT01554176|8788096|P5|Treatment Phase|Adverse event, non-fatal|0
2539000|NCT01554176|8788097|P4|Treatment Phase|Adverse event, non-fatal|0
2539001|NCT01554176|8788098|P3|Treatment Phase|Adverse event, non-fatal|0
2539002|NCT01554176|8788099|P2|Treatment Phase|Adverse event, non-fatal|1
2539003|NCT01554176|8788100|P1|Treatment Phase|Adverse event, non-fatal|1
2539004|NCT01554176|8788096|P5|Treatment Phase|Lack of Efficacy|0
2539005|NCT01554176|8788097|P4|Treatment Phase|Lack of Efficacy|0
2539006|NCT01554176|8788098|P3|Treatment Phase|Lack of Efficacy|0
2539007|NCT01554176|8788099|P2|Treatment Phase|Lack of Efficacy|1
2539008|NCT01554176|8788100|P1|Treatment Phase|Lack of Efficacy|0
2539009|NCT01554176|8788096|P5|Treatment Phase|Physician Decision|0
2539010|NCT01554176|8788097|P4|Treatment Phase|Physician Decision|0
2539011|NCT01554176|8788098|P3|Treatment Phase|Physician Decision|0
2539012|NCT01554176|8788099|P2|Treatment Phase|Physician Decision|1
2539013|NCT01554176|8788100|P1|Treatment Phase|Physician Decision|1
2539014|NCT01554176|8788096|P5|Treatment Phase|Protocol Violation|0
2539015|NCT01554176|8788097|P4|Treatment Phase|Protocol Violation|0
2539016|NCT01554176|8788098|P3|Treatment Phase|Protocol Violation|0
2539017|NCT01554176|8788099|P2|Treatment Phase|Protocol Violation|2
2539018|NCT01554176|8788100|P1|Treatment Phase|Protocol Violation|1
2539019|NCT01554163|8788127|P2|Overall Study|Not Treated|0
2539020|NCT01554163|8788128|P1|Overall Study|Not Treated|1
2539021|NCT01554163|8788127|P2|Overall Study|Withdrawal by Subject|5
2539022|NCT01554163|8788128|P1|Overall Study|Withdrawal by Subject|1
2539023|NCT01554163|8788127|P2|Overall Study|Protocol Violation|4
2539024|NCT01554163|8788128|P1|Overall Study|Protocol Violation|0
2539025|NCT01554163|8788127|P2|Overall Study|Non-Compliance With Study Drug|1
2539026|NCT01554163|8788128|P1|Overall Study|Non-Compliance With Study Drug|1
2539027|NCT01554163|8788127|P2|Overall Study|Lost to Follow-up|0
2539028|NCT01554163|8788128|P1|Overall Study|Lost to Follow-up|1
2539029|NCT01554163|8788127|P2|Overall Study|Lack of Efficacy|0
2539030|NCT01554163|8788128|P1|Overall Study|Lack of Efficacy|1
2539031|NCT01554163|8788127|P2|Overall Study|Adverse Event|0
2539032|NCT01554163|8788128|P1|Overall Study|Adverse Event|3
2539033|NCT01553916|8788146|P1|Overall Study|Pre-treatment MRI metastatic disease|1
2539034|NCT01553916|8788146|P1|Overall Study|Withdrawal by Subject|2
2539035|NCT01553851|8788163|P1|Overall Study|constipation|1
2539036|NCT01553851|8788163|P1|Overall Study|Adverse Event|2
2539037|NCT01553747|8788178|P3|Overall Study|Physician decision: lack of efficacy|3
2539038|NCT01553747|8788179|P2|Overall Study|Physician decision: lack of efficacy|5
2539039|NCT01553747|8788180|P1|Overall Study|Physician decision: lack of efficacy|1
2539040|NCT01553747|8788178|P3|Overall Study|Sponsor decision, specify|0
2539041|NCT01553747|8788179|P2|Overall Study|Sponsor decision, specify|5
2539042|NCT01553747|8788180|P1|Overall Study|Sponsor decision, specify|7
2539043|NCT01553747|8788178|P3|Overall Study|Lost to Follow-up|6
2539044|NCT01553747|8788179|P2|Overall Study|Lost to Follow-up|5
2539045|NCT01553747|8788180|P1|Overall Study|Lost to Follow-up|11
2539046|NCT01553747|8788178|P3|Overall Study|Physician decision: other|7
2539047|NCT01553747|8788179|P2|Overall Study|Physician decision: other|8
2539048|NCT01553747|8788180|P1|Overall Study|Physician decision: other|10
2539049|NCT01553747|8788178|P3|Overall Study|Adverse event or SAE|19
2539050|NCT01553747|8788179|P2|Overall Study|Adverse event or SAE|28
2539051|NCT01553747|8788180|P1|Overall Study|Adverse event or SAE|32
2539052|NCT01553747|8788178|P3|Overall Study|Voluntarily withdrew|74
2539053|NCT01553747|8788179|P2|Overall Study|Voluntarily withdrew|66
2539054|NCT01553747|8788180|P1|Overall Study|Voluntarily withdrew|70
2539055|NCT01553747|8788178|P3|Overall Study|Protocol Violation|0
2539056|NCT01553747|8788179|P2|Overall Study|Protocol Violation|2
2539057|NCT01553747|8788180|P1|Overall Study|Protocol Violation|0
2539058|NCT01553591|8788242|P3|Overall Study|Randomized and never dispensed drug|0
2539059|NCT01553591|8788243|P2|Overall Study|Randomized and never dispensed drug|1
2539060|NCT01553591|8788244|P1|Overall Study|Randomized and never dispensed drug|0
2539061|NCT01553591|8788242|P3|Overall Study|Sponsor decision|3
2539062|NCT01553591|8788243|P2|Overall Study|Sponsor decision|0
2539063|NCT01553591|8788244|P1|Overall Study|Sponsor decision|1
2539064|NCT01553591|8788242|P3|Overall Study|Protocol Violation|4
2539065|NCT01553591|8788243|P2|Overall Study|Protocol Violation|4
2539066|NCT01553591|8788244|P1|Overall Study|Protocol Violation|3
2539067|NCT01553591|8788242|P3|Overall Study|Physician decision: lack of efficacy|7
2539068|NCT01553591|8788243|P2|Overall Study|Physician decision: lack of efficacy|3
2539069|NCT01553591|8788244|P1|Overall Study|Physician decision: lack of efficacy|2
2539070|NCT01553591|8788242|P3|Overall Study|Physician decision: other|16
2539071|NCT01553591|8788243|P2|Overall Study|Physician decision: other|14
2539072|NCT01553591|8788244|P1|Overall Study|Physician decision: other|11
2539073|NCT01553591|8788242|P3|Overall Study|Lost to Follow-up|16
2539074|NCT01553591|8788243|P2|Overall Study|Lost to Follow-up|23
2539075|NCT01553591|8788244|P1|Overall Study|Lost to Follow-up|25
2539076|NCT01553591|8788242|P3|Overall Study|Adverse Event|16
2539077|NCT01553591|8788243|P2|Overall Study|Adverse Event|45
2539078|NCT01553591|8788244|P1|Overall Study|Adverse Event|36
2539079|NCT01553591|8788242|P3|Overall Study|Voluntarily withdrew|96
2539080|NCT01553591|8788243|P2|Overall Study|Voluntarily withdrew|79
2539081|NCT01553591|8788244|P1|Overall Study|Voluntarily withdrew|94
2539082|NCT01553318|8788304|P2|Overall Study|Protocol Violation|2
2539083|NCT01553318|8788305|P1|Overall Study|Protocol Violation|3
2539084|NCT01553279|8788335|P2|Period 2: Toddler Vaccinations|Lost to Follow-up|2
2539085|NCT01553279|8788336|P1|Period 2: Toddler Vaccinations|Lost to Follow-up|3
2539086|NCT01553279|8788335|P2|Period 2: Toddler Vaccinations|Withdrawal by Subject|5
2539087|NCT01553279|8788336|P1|Period 2: Toddler Vaccinations|Withdrawal by Subject|0
2539088|NCT01553279|8788335|P2|Interim Period|Lost to Follow-up|0
2539089|NCT01553279|8788336|P1|Interim Period|Lost to Follow-up|1
2539090|NCT01553279|8788335|P2|Interim Period|Withdrawal by Subject|2
2539091|NCT01553279|8788336|P1|Interim Period|Withdrawal by Subject|2
2539092|NCT01553279|8788335|P2|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1
2539093|NCT01553279|8788336|P1|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1
2539094|NCT01553279|8788335|P2|Part 1 (Infant Vaccinations)|Lost to Follow-up|0
2539095|NCT01553279|8788336|P1|Part 1 (Infant Vaccinations)|Lost to Follow-up|1
2539096|NCT01553188|8788402|P4|Overall Study|Intercurrent illness and adverse event|0
2539097|NCT01553188|8788403|P3|Overall Study|Intercurrent illness and adverse event|2
2539098|NCT01553188|8788404|P2|Overall Study|Intercurrent illness and adverse event|1
2539099|NCT01553188|8788405|P1|Overall Study|Intercurrent illness and adverse event|0
2539100|NCT01553188|8788402|P4|Overall Study|Patient choice|0
2539101|NCT01553188|8788403|P3|Overall Study|Patient choice|0
2539102|NCT01553188|8788404|P2|Overall Study|Patient choice|0
2539103|NCT01553188|8788405|P1|Overall Study|Patient choice|1
2539104|NCT01553136|8788432|P2|Overall Study|Scheduling Difficulties|4
2539105|NCT01553136|8788433|P1|Overall Study|Scheduling Difficulties|5
2539106|NCT01553136|8788432|P2|Overall Study|Physician Decision|3
2539107|NCT01553136|8788433|P1|Overall Study|Physician Decision|2
2539108|NCT01553136|8788432|P2|Overall Study|Lost to Follow-up|10
2539109|NCT01553136|8788433|P1|Overall Study|Lost to Follow-up|4
2539110|NCT01553136|8788432|P2|Overall Study|Withdrawal by Subject|3
2539111|NCT01553136|8788433|P1|Overall Study|Withdrawal by Subject|2
2539112|NCT01553136|8788432|P2|Overall Study|Adverse Event|2
2539113|NCT01553136|8788433|P1|Overall Study|Adverse Event|3
2539114|NCT01553084|8788450|P3|Overall Study|Withdrawal by Subject|35
2539115|NCT01553084|8788451|P2|Overall Study|Withdrawal by Subject|13
2539116|NCT01553084|8788452|P1|Overall Study|Withdrawal by Subject|15
2539117|NCT01552954|8788534|P2|Overall Study|diagnosed DM|0
2539118|NCT01552954|8788535|P1|Overall Study|diagnosed DM|1
2539119|NCT01552954|8788534|P2|Overall Study|Protocol Violation|2
2539120|NCT01552954|8788535|P1|Overall Study|Protocol Violation|1
2539121|NCT01552954|8788534|P2|Overall Study|Withdrawal by Subject|1
2539122|NCT01552954|8788535|P1|Overall Study|Withdrawal by Subject|1
2539123|NCT01552954|8788534|P2|Overall Study|Lost to Follow-up|1
2539124|NCT01552954|8788535|P1|Overall Study|Lost to Follow-up|1
2539125|NCT01552954|8788534|P2|Overall Study|Adverse Event|2
2539126|NCT01552954|8788535|P1|Overall Study|Adverse Event|1
2539127|NCT01552928|8788551|P4|Period 3|Adverse Event|0
2539128|NCT01552928|8788552|P3|Period 3|Adverse Event|1
2539129|NCT01552928|8788553|P2|Period 3|Adverse Event|0
2539130|NCT01552928|8788554|P1|Period 3|Adverse Event|0
2539131|NCT01552915|8788601|P3|Overall Study|Other|6
2539132|NCT01552915|8788602|P2|Overall Study|Other|0
2539133|NCT01552915|8788603|P1|Overall Study|Other|2
2539134|NCT01552915|8788601|P3|Overall Study|Lack of Efficacy|4
2539135|NCT01552915|8788602|P2|Overall Study|Lack of Efficacy|1
2539136|NCT01552915|8788603|P1|Overall Study|Lack of Efficacy|8
2539137|NCT01552915|8788601|P3|Overall Study|Protocol Violation|4
2539138|NCT01552915|8788602|P2|Overall Study|Protocol Violation|4
2539139|NCT01552915|8788603|P1|Overall Study|Protocol Violation|0
2539140|NCT01552915|8788601|P3|Overall Study|Withdrawal by Subject|5
2539141|NCT01552915|8788602|P2|Overall Study|Withdrawal by Subject|4
2539142|NCT01552915|8788603|P1|Overall Study|Withdrawal by Subject|6
2539143|NCT01552915|8788601|P3|Overall Study|Lost to Follow-up|5
2539144|NCT01552915|8788602|P2|Overall Study|Lost to Follow-up|6
2539145|NCT01552915|8788603|P1|Overall Study|Lost to Follow-up|4
2539146|NCT01552915|8788601|P3|Overall Study|Adverse Event|3
2539147|NCT01552915|8788602|P2|Overall Study|Adverse Event|14
2539148|NCT01552915|8788603|P1|Overall Study|Adverse Event|3
2539149|NCT01552902|8788626|P3|Overall Study|Other|3
2539150|NCT01552902|8788627|P2|Overall Study|Other|4
2539151|NCT01552902|8788628|P1|Overall Study|Other|3
2539152|NCT01552902|8788626|P3|Overall Study|Lost to Follow-up|6
2539153|NCT01552902|8788627|P2|Overall Study|Lost to Follow-up|3
2539154|NCT01552902|8788628|P1|Overall Study|Lost to Follow-up|1
2539155|NCT01552902|8788626|P3|Overall Study|Withdrawal by Subject|6
2539156|NCT01552902|8788627|P2|Overall Study|Withdrawal by Subject|9
2539157|NCT01552902|8788628|P1|Overall Study|Withdrawal by Subject|1
2539158|NCT01552902|8788626|P3|Overall Study|Lack of Efficacy|1
2539159|NCT01552902|8788627|P2|Overall Study|Lack of Efficacy|3
2539160|NCT01552902|8788628|P1|Overall Study|Lack of Efficacy|4
2539161|NCT01552902|8788626|P3|Overall Study|Protocol Violation|3
2539162|NCT01552902|8788627|P2|Overall Study|Protocol Violation|3
2539163|NCT01552902|8788628|P1|Overall Study|Protocol Violation|3
2539164|NCT01552902|8788626|P3|Overall Study|Adverse Event|14
2539165|NCT01552902|8788627|P2|Overall Study|Adverse Event|15
2539166|NCT01552902|8788628|P1|Overall Study|Adverse Event|1
2539167|NCT01552772|8788678|P1|Overall Study|Protocol Deviation|1
2539168|NCT01552772|8788678|P1|Overall Study|Adverse Event|1
2539169|NCT01552772|8788678|P1|Overall Study|Lost to Follow-up|2
2539170|NCT01552694|8788694|P2|Overall Study|Protocol Violation|1
2539171|NCT01552694|8788695|P1|Overall Study|Protocol Violation|0
2539172|NCT01552694|8788694|P2|Overall Study|Lost to Follow-up|1
2539173|NCT01552694|8788695|P1|Overall Study|Lost to Follow-up|0
2539174|NCT01552681|8788711|P2|Overall Study|Subject moved away|1
2539175|NCT01552681|8788712|P1|Overall Study|Subject moved away|0
2539176|NCT01552681|8788711|P2|Overall Study|Physician Decision|0
2539177|NCT01552681|8788712|P1|Overall Study|Physician Decision|1
2539178|NCT01552681|8788711|P2|Overall Study|Withdrawal by Subject|0
2539179|NCT01552681|8788712|P1|Overall Study|Withdrawal by Subject|4
2539180|NCT01552603|8788760|P1|Overall Study|Physician Decision|1
2539181|NCT01552408|8788767|P2|Overall Study|Withdrawal by Subject|1
2539182|NCT01552408|8788768|P1|Overall Study|Withdrawal by Subject|2
2539183|NCT01552408|8788767|P2|Overall Study|Relocation|1
2539184|NCT01552408|8788768|P1|Overall Study|Relocation|0
2539185|NCT01552408|8788767|P2|Overall Study|Lost to Follow-up|0
2539186|NCT01552408|8788768|P1|Overall Study|Lost to Follow-up|2
2539187|NCT01552369|8788790|P2|Overall Study|Did not consent to extended follow up|9
2539188|NCT01552369|8788791|P1|Overall Study|Did not consent to extended follow up|8
2539189|NCT01552057|8788880|P2|Overall Study|Physician Decision|0
2539190|NCT01552057|8788881|P1|Overall Study|Physician Decision|1
2539191|NCT01552057|8788880|P2|Overall Study|Entry Criteria Not Met|2
2539192|NCT01552057|8788881|P1|Overall Study|Entry Criteria Not Met|2
2539193|NCT01552057|8788880|P2|Overall Study|Withdrawal by Subject|8
2539194|NCT01552057|8788881|P1|Overall Study|Withdrawal by Subject|5
2539195|NCT01552057|8788880|P2|Overall Study|Lack of Efficacy|23
2539196|NCT01552057|8788881|P1|Overall Study|Lack of Efficacy|8
2539197|NCT01552057|8788880|P2|Overall Study|Adverse Event|15
2539198|NCT01552057|8788881|P1|Overall Study|Adverse Event|14
2539199|NCT01551758|8788947|P2|Overall Study|Withdrawal by Subject|17
2539200|NCT01551758|8788948|P1|Overall Study|Withdrawal by Subject|14
2539201|NCT01551758|8788947|P2|Overall Study|Physician Decision|3
2539202|NCT01551758|8788948|P1|Overall Study|Physician Decision|9
2539203|NCT01551758|8788947|P2|Overall Study|Lost to Follow-up|25
2539204|NCT01551758|8788948|P1|Overall Study|Lost to Follow-up|29
2539205|NCT01551758|8788947|P2|Overall Study|Met Protocol-defined stopping criteria|10
2539206|NCT01551758|8788948|P1|Overall Study|Met Protocol-defined stopping criteria|8
2539207|NCT01551758|8788947|P2|Overall Study|Protocol Violation|6
2539208|NCT01551758|8788948|P1|Overall Study|Protocol Violation|5
2539209|NCT01551758|8788947|P2|Overall Study|Lack of Efficacy|1
2539210|NCT01551758|8788948|P1|Overall Study|Lack of Efficacy|0
2539211|NCT01551758|8788947|P2|Overall Study|Adverse Event|43
2539212|NCT01551758|8788948|P1|Overall Study|Adverse Event|29
2539213|NCT01551745|8788986|P1|Overall Study|Disease Progression|2
2539214|NCT01551745|8788986|P1|Overall Study|Withdrawal by Subject|1
2539215|NCT01551693|8788995|P2|Overall Study|Withdrawal by Subject|1
2539216|NCT01551693|8788996|P1|Overall Study|Withdrawal by Subject|0
2539217|NCT01551693|8788995|P2|Overall Study|Adverse Event|1
2539218|NCT01551693|8788996|P1|Overall Study|Adverse Event|0
2539219|NCT01551693|8788995|P2|Overall Study|Disease Progression|0
2539220|NCT01551693|8788996|P1|Overall Study|Disease Progression|1
2539221|NCT01551420|8789017|P2|Home Use (Part B)|Withdrawal by staff|1
2539222|NCT01551420|8789018|P1|Home Use (Part B)|Withdrawal by staff|0
2539223|NCT01551420|8789017|P2|Home Use (Part B)|Withdrawal by Subject|0
2539224|NCT01551420|8789018|P1|Home Use (Part B)|Withdrawal by Subject|6
2539225|NCT01551420|8789017|P2|Screened for Part B Eligibility|Deemed ineligible by staff|2
2539226|NCT01551420|8789018|P1|Screened for Part B Eligibility|Deemed ineligible by staff|1
2539227|NCT01551420|8789017|P2|Screened for Part B Eligibility|Declined participation|1
2539228|NCT01551420|8789018|P1|Screened for Part B Eligibility|Declined participation|8
2539229|NCT01551420|8789017|P2|In-laboratory (Part A)|Scheduling conflict|1
2539230|NCT01551420|8789018|P1|In-laboratory (Part A)|Scheduling conflict|2
2539231|NCT01551420|8789017|P2|In-laboratory (Part A)|Withdrawal by Subject|0
2539232|NCT01551420|8789018|P1|In-laboratory (Part A)|Withdrawal by Subject|2
2539233|NCT01551420|8789017|P2|In-laboratory (Part A)|Lost to Follow-up|1
2539234|NCT01551420|8789018|P1|In-laboratory (Part A)|Lost to Follow-up|2
2539235|NCT01551355|8789048|P6|Overall Study|Lost to Follow-up|6
2539236|NCT01551355|8789049|P5|Overall Study|Lost to Follow-up|9
2539237|NCT01551355|8789050|P4|Overall Study|Lost to Follow-up|24
2539238|NCT01551355|8789051|P3|Overall Study|Lost to Follow-up|34
2539239|NCT01551355|8789052|P2|Overall Study|Lost to Follow-up|49
2539240|NCT01551355|8789053|P1|Overall Study|Lost to Follow-up|51
2539241|NCT01551303|8789067|P2|Overall Study|failed awareness check on vision test|7
2539242|NCT01551303|8789068|P1|Overall Study|failed awareness check on vision test|4
2539243|NCT01551212|8789076|P2|Overall Study|Never Received Study Treatment|4
2539244|NCT01551212|8789077|P1|Overall Study|Never Received Study Treatment|2
2539245|NCT01551212|8789076|P2|Overall Study|Death|4
2539246|NCT01551212|8789077|P1|Overall Study|Death|2
2539247|NCT01551212|8789076|P2|Overall Study|Withdrawal by Subject|7
2539248|NCT01551212|8789077|P1|Overall Study|Withdrawal by Subject|0
2539249|NCT01551212|8789076|P2|Overall Study|Protocol Violation|1
2539250|NCT01551212|8789077|P1|Overall Study|Protocol Violation|0
2539251|NCT01551212|8789076|P2|Overall Study|Lost to Follow-up|1
2539252|NCT01551212|8789077|P1|Overall Study|Lost to Follow-up|0
2539253|NCT01551212|8789076|P2|Overall Study|Administrative problems|2
2539254|NCT01551212|8789077|P1|Overall Study|Administrative problems|1
2539255|NCT01551212|8789076|P2|Overall Study|Graft loss/Retransplantation|1
2539256|NCT01551212|8789077|P1|Overall Study|Graft loss/Retransplantation|0
2539257|NCT01551173|8789112|P2|Overall Study|Other|3
2539258|NCT01551173|8789113|P1|Overall Study|Other|5
2539259|NCT01551173|8789112|P2|Overall Study|Lost to Follow-up|7
2539260|NCT01551173|8789113|P1|Overall Study|Lost to Follow-up|5
2539261|NCT01551173|8789112|P2|Overall Study|Adverse Event|6
2539262|NCT01551173|8789113|P1|Overall Study|Adverse Event|7
2539263|NCT01551173|8789112|P2|Overall Study|Withdrawal by Subject|16
2539264|NCT01551173|8789113|P1|Overall Study|Withdrawal by Subject|11
2539265|NCT01550965|8789190|P1|Overall Study|Other|13
2539266|NCT01550965|8789190|P1|Overall Study|Lack of Efficacy|59
2539267|NCT01550965|8789190|P1|Overall Study|Lost to Follow-up|2
2539268|NCT01550965|8789190|P1|Overall Study|Withdrawal by Subject|10
2539269|NCT01550965|8789190|P1|Overall Study|Adverse Event|26
2539270|NCT01550757|8789234|P4|Overall Study|Withdrawal by Subject|1
2539271|NCT01550757|8789235|P3|Overall Study|Withdrawal by Subject|3
2539272|NCT01550757|8789236|P2|Overall Study|Withdrawal by Subject|0
2539273|NCT01550757|8789237|P1|Overall Study|Withdrawal by Subject|2
2539274|NCT01550757|8789234|P4|Overall Study|Lost to Follow-up|53
2539275|NCT01550757|8789235|P3|Overall Study|Lost to Follow-up|42
2539276|NCT01550757|8789236|P2|Overall Study|Lost to Follow-up|14
2539277|NCT01550757|8789237|P1|Overall Study|Lost to Follow-up|21
2539278|NCT01550744|8789247|P3|Double-Blind|Other|10
2539279|NCT01550744|8789248|P2|Double-Blind|Other|2
2539280|NCT01550744|8789249|P1|Double-Blind|Other|0
2539281|NCT01550744|8789247|P3|Double-Blind|Pregnancy|3
2539282|NCT01550744|8789248|P2|Double-Blind|Pregnancy|0
2539283|NCT01550744|8789249|P1|Double-Blind|Pregnancy|0
2539284|NCT01550744|8789247|P3|Double-Blind|Protocol Violation|4
2539285|NCT01550744|8789248|P2|Double-Blind|Protocol Violation|0
2539286|NCT01550744|8789249|P1|Double-Blind|Protocol Violation|0
2539287|NCT01550744|8789247|P3|Double-Blind|Lack of Efficacy|8
2539288|NCT01550744|8789248|P2|Double-Blind|Lack of Efficacy|2
2539289|NCT01550744|8789249|P1|Double-Blind|Lack of Efficacy|0
2539290|NCT01550744|8789247|P3|Double-Blind|Death|0
2539291|NCT01550744|8789248|P2|Double-Blind|Death|1
2539292|NCT01550744|8789249|P1|Double-Blind|Death|0
2539293|NCT01550744|8789247|P3|Double-Blind|Adverse Event|15
2539294|NCT01550744|8789248|P2|Double-Blind|Adverse Event|4
2539295|NCT01550744|8789249|P1|Double-Blind|Adverse Event|0
2539296|NCT01550744|8789247|P3|Double-Blind|Withdrawal by Subject|15
2539297|NCT01550744|8789248|P2|Double-Blind|Withdrawal by Subject|2
2539298|NCT01550744|8789249|P1|Double-Blind|Withdrawal by Subject|0
2539299|NCT01550744|8789247|P3|Double-Blind|Lost to Follow-up|12
2539300|NCT01550744|8789248|P2|Double-Blind|Lost to Follow-up|6
2539301|NCT01550744|8789249|P1|Double-Blind|Lost to Follow-up|0
2539302|NCT01550744|8789247|P3|Open-Label|Other|0
2539303|NCT01550744|8789248|P2|Open-Label|Other|0
2539304|NCT01550744|8789249|P1|Open-Label|Other|1
2539305|NCT01550744|8789247|P3|Open-Label|Static PGA-cleared/minimal not achieved|0
2539306|NCT01550744|8789248|P2|Open-Label|Static PGA-cleared/minimal not achieved|0
2539307|NCT01550744|8789249|P1|Open-Label|Static PGA-cleared/minimal not achieved|58
2539308|NCT01550744|8789247|P3|Open-Label|Not all 3 study drug injections received|0
2539309|NCT01550744|8789248|P2|Open-Label|Not all 3 study drug injections received|0
2539310|NCT01550744|8789249|P1|Open-Label|Not all 3 study drug injections received|2
2539311|NCT01550744|8789247|P3|Open-Label|Protocol Violation|0
2539312|NCT01550744|8789248|P2|Open-Label|Protocol Violation|0
2539313|NCT01550744|8789249|P1|Open-Label|Protocol Violation|4
2539314|NCT01550744|8789247|P3|Open-Label|Lack of Efficacy|0
2539315|NCT01550744|8789248|P2|Open-Label|Lack of Efficacy|0
2539316|NCT01550744|8789249|P1|Open-Label|Lack of Efficacy|4
2539317|NCT01550744|8789247|P3|Open-Label|Adverse Event|0
2539318|NCT01550744|8789248|P2|Open-Label|Adverse Event|0
2539319|NCT01550744|8789249|P1|Open-Label|Adverse Event|11
2539320|NCT01550744|8789247|P3|Open-Label|Withdrawal by Subject|0
2539321|NCT01550744|8789248|P2|Open-Label|Withdrawal by Subject|0
2539322|NCT01550744|8789249|P1|Open-Label|Withdrawal by Subject|13
2539323|NCT01550744|8789247|P3|Open-Label|Lost to Follow-up|0
2539324|NCT01550744|8789248|P2|Open-Label|Lost to Follow-up|0
2539325|NCT01550744|8789249|P1|Open-Label|Lost to Follow-up|7
2539326|NCT01550289|8789349|P2|Overall Study|Withdrawal by Subject|3
2539327|NCT01550289|8789350|P1|Overall Study|Withdrawal by Subject|11
2539328|NCT01550289|8789349|P2|Overall Study|Lost to Follow-up|1
2539329|NCT01550289|8789350|P1|Overall Study|Lost to Follow-up|1
2539330|NCT01550289|8789349|P2|Overall Study|Protocol Violation|0
2539331|NCT01550289|8789350|P1|Overall Study|Protocol Violation|1
2539332|NCT01549964|8789426|P4|80-Week Extension Period|Pretreatment Event/Adverse Event|2
2539333|NCT01549964|8789427|P3|80-Week Extension Period|Pretreatment Event/Adverse Event|1
2539334|NCT01549964|8789428|P2|80-Week Extension Period|Pretreatment Event/Adverse Event|0
2539335|NCT01549964|8789429|P1|80-Week Extension Period|Pretreatment Event/Adverse Event|0
2539336|NCT01549964|8789426|P4|80-Week Extension Period|Lost to Follow-up|1
2539337|NCT01549964|8789427|P3|80-Week Extension Period|Lost to Follow-up|2
2539338|NCT01549964|8789428|P2|80-Week Extension Period|Lost to Follow-up|0
2539339|NCT01549964|8789429|P1|80-Week Extension Period|Lost to Follow-up|1
2539340|NCT01549964|8789426|P4|80-Week Extension Period|Voluntary Withdrawal|2
2539341|NCT01549964|8789427|P3|80-Week Extension Period|Voluntary Withdrawal|4
2539342|NCT01549964|8789428|P2|80-Week Extension Period|Voluntary Withdrawal|1
2539343|NCT01549964|8789429|P1|80-Week Extension Period|Voluntary Withdrawal|0
2539344|NCT01549964|8789426|P4|80-Week Extension Period|Study Terminated by Sponsor|132
2539345|NCT01549964|8789427|P3|80-Week Extension Period|Study Terminated by Sponsor|132
2539346|NCT01549964|8789428|P2|80-Week Extension Period|Study Terminated by Sponsor|137
2539347|NCT01549964|8789429|P1|80-Week Extension Period|Study Terminated by Sponsor|65
2539348|NCT01549964|8789426|P4|80-Week Extension Period|Pregnancy|0
2539349|NCT01549964|8789427|P3|80-Week Extension Period|Pregnancy|1
2539350|NCT01549964|8789428|P2|80-Week Extension Period|Pregnancy|0
2539351|NCT01549964|8789429|P1|80-Week Extension Period|Pregnancy|0
2539352|NCT01549964|8789426|P4|24-Week Treatment Period|Completion Status Unknown|0
2539353|NCT01549964|8789427|P3|24-Week Treatment Period|Completion Status Unknown|1
2539354|NCT01549964|8789428|P2|24-Week Treatment Period|Completion Status Unknown|0
2539355|NCT01549964|8789429|P1|24-Week Treatment Period|Completion Status Unknown|1
2539356|NCT01549964|8789426|P4|24-Week Treatment Period|Randomized but Not Treated|1
2539357|NCT01549964|8789427|P3|24-Week Treatment Period|Randomized but Not Treated|0
2539358|NCT01549964|8789428|P2|24-Week Treatment Period|Randomized but Not Treated|0
2539359|NCT01549964|8789429|P1|24-Week Treatment Period|Randomized but Not Treated|0
2539360|NCT01549964|8789426|P4|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
2539361|NCT01549964|8789427|P3|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1
2539362|NCT01549964|8789428|P2|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
2539363|NCT01549964|8789429|P1|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
2539364|NCT01549964|8789426|P4|24-Week Treatment Period|Other|0
2539365|NCT01549964|8789427|P3|24-Week Treatment Period|Other|1
2539366|NCT01549964|8789428|P2|24-Week Treatment Period|Other|0
2539367|NCT01549964|8789429|P1|24-Week Treatment Period|Other|1
2539368|NCT01549964|8789426|P4|24-Week Treatment Period|Lack of Efficacy|1
2539369|NCT01549964|8789427|P3|24-Week Treatment Period|Lack of Efficacy|1
2539370|NCT01549964|8789428|P2|24-Week Treatment Period|Lack of Efficacy|0
2539371|NCT01549964|8789429|P1|24-Week Treatment Period|Lack of Efficacy|1
2539372|NCT01549964|8789426|P4|24-Week Treatment Period|Lost to Follow-up|2
2539373|NCT01549964|8789427|P3|24-Week Treatment Period|Lost to Follow-up|1
2539374|NCT01549964|8789428|P2|24-Week Treatment Period|Lost to Follow-up|0
2539375|NCT01549964|8789429|P1|24-Week Treatment Period|Lost to Follow-up|1
2539376|NCT01549964|8789426|P4|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
2539377|NCT01549964|8789427|P3|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
2539378|NCT01549964|8789428|P2|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
2539379|NCT01549964|8789429|P1|24-Week Treatment Period|Pretreatment Event/Adverse Event|1
2539380|NCT01549964|8789426|P4|24-Week Treatment Period|Voluntary Withdrawal|8
2539381|NCT01549964|8789427|P3|24-Week Treatment Period|Voluntary Withdrawal|3
2539382|NCT01549964|8789428|P2|24-Week Treatment Period|Voluntary Withdrawal|3
2539383|NCT01549964|8789429|P1|24-Week Treatment Period|Voluntary Withdrawal|6
2539384|NCT01549964|8789426|P4|24-Week Treatment Period|Study Terminated by Sponsor|105
2539385|NCT01549964|8789427|P3|24-Week Treatment Period|Study Terminated by Sponsor|104
2539386|NCT01549964|8789428|P2|24-Week Treatment Period|Study Terminated by Sponsor|104
2539387|NCT01549964|8789429|P1|24-Week Treatment Period|Study Terminated by Sponsor|50
2539388|NCT01549951|8789447|P1|Overall Study|Other|2
2539389|NCT01549951|8789447|P1|Overall Study|Symptomatic deterioration|1
2539390|NCT01549951|8789447|P1|Overall Study|Progressive disease|29
2539391|NCT01549951|8789447|P1|Overall Study|Unsatisfactory therapeutic response|1
2539392|NCT01549951|8789447|P1|Overall Study|Withdrawal by Subject|2
2539393|NCT01549951|8789447|P1|Overall Study|Adverse Event|15
2539394|NCT01549873|8789474|P2|Overall Study|Physician Decision|1
2539395|NCT01549873|8789475|P1|Overall Study|Physician Decision|0
2539396|NCT01549860|8789487|P2|Overall Study|Physician Decision|1
2539397|NCT01549860|8789488|P1|Overall Study|Physician Decision|1
2539398|NCT01549860|8789487|P2|Overall Study|Withdrawal by Subject|0
2539399|NCT01549860|8789488|P1|Overall Study|Withdrawal by Subject|1
2539400|NCT01549652|8789501|P4|Overall Study|Withdrawal by Subject|3
2539401|NCT01549652|8789502|P3|Overall Study|Withdrawal by Subject|5
2539402|NCT01549652|8789503|P2|Overall Study|Withdrawal by Subject|0
2539403|NCT01549652|8789504|P1|Overall Study|Withdrawal by Subject|0
2539404|NCT01549652|8789501|P4|Overall Study|Titration Side Effects|3
2539405|NCT01549652|8789502|P3|Overall Study|Titration Side Effects|6
2539406|NCT01549652|8789503|P2|Overall Study|Titration Side Effects|0
2539407|NCT01549652|8789504|P1|Overall Study|Titration Side Effects|0
2539408|NCT01549652|8789501|P4|Overall Study|Titration Non-Compliance|5
2539409|NCT01549652|8789502|P3|Overall Study|Titration Non-Compliance|4
2539410|NCT01549652|8789503|P2|Overall Study|Titration Non-Compliance|3
2539411|NCT01549652|8789504|P1|Overall Study|Titration Non-Compliance|1
2539412|NCT01549652|8789501|P4|Overall Study|Problem with Infusion|0
2539413|NCT01549652|8789502|P3|Overall Study|Problem with Infusion|0
2539414|NCT01549652|8789503|P2|Overall Study|Problem with Infusion|0
2539415|NCT01549652|8789504|P1|Overall Study|Problem with Infusion|1
2539416|NCT01549652|8789501|P4|Overall Study|Did Not Return Due to Withdrawal Effect|0
2539417|NCT01549652|8789502|P3|Overall Study|Did Not Return Due to Withdrawal Effect|0
2539418|NCT01549652|8789503|P2|Overall Study|Did Not Return Due to Withdrawal Effect|1
2539419|NCT01549652|8789504|P1|Overall Study|Did Not Return Due to Withdrawal Effect|5
2539420|NCT01549652|8789501|P4|Overall Study|Withdrawal Effect|0
2539421|NCT01549652|8789502|P3|Overall Study|Withdrawal Effect|0
2539422|NCT01549652|8789503|P2|Overall Study|Withdrawal Effect|2
2539423|NCT01549652|8789504|P1|Overall Study|Withdrawal Effect|0
2539424|NCT01549652|8789501|P4|Overall Study|Study Drug Titration Failure|0
2539425|NCT01549652|8789502|P3|Overall Study|Study Drug Titration Failure|0
2539426|NCT01549652|8789503|P2|Overall Study|Study Drug Titration Failure|6
2539427|NCT01549652|8789504|P1|Overall Study|Study Drug Titration Failure|5
2539428|NCT01549652|8789501|P4|Overall Study|Did Not Receive Allocated Intervention|0
2539429|NCT01549652|8789502|P3|Overall Study|Did Not Receive Allocated Intervention|2
2539430|NCT01549652|8789503|P2|Overall Study|Did Not Receive Allocated Intervention|0
2539431|NCT01549652|8789504|P1|Overall Study|Did Not Receive Allocated Intervention|0
2539432|NCT01549613|8789522|P2|Overall Study|Lost to Follow-up|11
2539433|NCT01549613|8789523|P1|Overall Study|Lost to Follow-up|11
2539434|NCT01549392|8789542|P2|Overall Study|Withdrawal by Subject|0
2539435|NCT01549392|8789543|P1|Overall Study|Withdrawal by Subject|1
2539436|NCT01549275|8789581|P2|Overall Study|Lost to Follow-up|0
2539437|NCT01549275|8789582|P1|Overall Study|Lost to Follow-up|1
2539438|NCT01549041|8789605|P2|Overall Study|Adverse Event|4
2539439|NCT01549041|8789606|P1|Overall Study|Adverse Event|0
2539440|NCT01549041|8789605|P2|Overall Study|Lack of Efficacy|4
2539441|NCT01549041|8789606|P1|Overall Study|Lack of Efficacy|2
2539442|NCT01549002|8789616|P2|Overall Study|Moderate sedation required|2
2539443|NCT01549002|8789617|P1|Overall Study|Moderate sedation required|0
2539444|NCT01549002|8789616|P2|Overall Study|Excessive pain|2
2539445|NCT01549002|8789617|P1|Overall Study|Excessive pain|0
2539446|NCT01548638|8789703|P1|Overall Study|Withdrawal by Subject|1
2539447|NCT01548638|8789703|P1|Overall Study|Protocol Violation|3
2539448|NCT01548599|8789715|P2|Overall Study|Death|1
2539449|NCT01548599|8789716|P1|Overall Study|Death|2
2539450|NCT01548599|8789715|P2|Overall Study|Withdrawal by Subject|0
2539451|NCT01548599|8789716|P1|Overall Study|Withdrawal by Subject|4
2539452|NCT01548599|8789715|P2|Overall Study|Lost to Follow-up|1
2539453|NCT01548599|8789716|P1|Overall Study|Lost to Follow-up|0
2539454|NCT01548573|8789732|P1|Overall Study|Withdrawal by Subject|2
2539455|NCT01548573|8789732|P1|Overall Study|Death|3
2539456|NCT01548417|8789741|P2|Overall Study|Withdrawal by Subject|2
2539457|NCT01548417|8789742|P1|Overall Study|Withdrawal by Subject|0
2539458|NCT01548404|8789752|P2|Overall Study|Other than specified above|2
2539459|NCT01548404|8789753|P1|Overall Study|Other than specified above|0
2539460|NCT01548404|8789752|P2|Overall Study|Withdrawal by Subject|3
2539461|NCT01548404|8789753|P1|Overall Study|Withdrawal by Subject|0
2539462|NCT01548404|8789752|P2|Overall Study|Lost to Follow-up|0
2539463|NCT01548404|8789753|P1|Overall Study|Lost to Follow-up|2
2539464|NCT01548404|8789752|P2|Overall Study|Inadequate response to study treatment|7
2539465|NCT01548404|8789753|P1|Overall Study|Inadequate response to study treatment|23
2539466|NCT01548404|8789752|P2|Overall Study|Physician Decision|1
2539467|NCT01548404|8789753|P1|Overall Study|Physician Decision|2
2539468|NCT01548404|8789752|P2|Overall Study|Adverse Event|1
2539469|NCT01548404|8789753|P1|Overall Study|Adverse Event|3
2539470|NCT01548287|8789792|P5|Randomized Period|Adverse Event|0
2539471|NCT01548287|8789793|P4|Randomized Period|Adverse Event|0
2539472|NCT01548287|8789794|P3|Randomized Period|Adverse Event|5
2539473|NCT01548287|8789795|P2|Randomized Period|Adverse Event|2
2539474|NCT01548287|8789796|P1|Randomized Period|Adverse Event|0
2539475|NCT01548287|8789792|P5|Randomized Period|Did not meet inclusion criteria|0
2539476|NCT01548287|8789793|P4|Randomized Period|Did not meet inclusion criteria|0
2539477|NCT01548287|8789794|P3|Randomized Period|Did not meet inclusion criteria|2
2539478|NCT01548287|8789795|P2|Randomized Period|Did not meet inclusion criteria|0
2539479|NCT01548287|8789796|P1|Randomized Period|Did not meet inclusion criteria|0
2539480|NCT01548287|8789792|P5|Screening|Did not meet eligibility criteria|74
2539481|NCT01548287|8789793|P4|Screening|Did not meet eligibility criteria|0
2539482|NCT01548287|8789794|P3|Screening|Did not meet eligibility criteria|0
2539483|NCT01548287|8789795|P2|Screening|Did not meet eligibility criteria|0
2539484|NCT01548287|8789796|P1|Screening|Did not meet eligibility criteria|0
2539485|NCT01548287|8789792|P5|Screening|No reason provided|9
2539486|NCT01548287|8789793|P4|Screening|No reason provided|0
2539487|NCT01548287|8789794|P3|Screening|No reason provided|0
2539488|NCT01548287|8789795|P2|Screening|No reason provided|0
2539489|NCT01548287|8789796|P1|Screening|No reason provided|0
2539490|NCT01547728|8789853|P1|Overall Study|Screen failure|39
2539491|NCT01547728|8789853|P1|Overall Study|Drug not ready for subject|1
2539492|NCT01547728|8789853|P1|Overall Study|Change in procedure and equipment|1
2539493|NCT01547598|8789962|P2|Overall Study|Other Miscellaneous Reasons|1
2539494|NCT01547598|8789963|P1|Overall Study|Other Miscellaneous Reasons|2
2539495|NCT01547598|8789962|P2|Overall Study|Protocol Violation|1
2539496|NCT01547598|8789963|P1|Overall Study|Protocol Violation|1
2539497|NCT01547598|8789962|P2|Overall Study|Adverse Event|1
2539498|NCT01547598|8789963|P1|Overall Study|Adverse Event|1
2539499|NCT01547598|8789962|P2|Overall Study|Lost to Follow-up|1
2539500|NCT01547598|8789963|P1|Overall Study|Lost to Follow-up|1
2539501|NCT01547598|8789962|P2|Overall Study|Withdrew consent|1
2539502|NCT01547598|8789963|P1|Overall Study|Withdrew consent|1
2539503|NCT01547390|8789980|P2|Overall Study|Adverse Event|0
2539504|NCT01547390|8789981|P1|Overall Study|Adverse Event|3
2539505|NCT01547390|8789980|P2|Overall Study|Lost to Follow-up|2
2539506|NCT01547390|8789981|P1|Overall Study|Lost to Follow-up|0
2539507|NCT01547390|8789980|P2|Overall Study|termination of pregnancy|1
2539508|NCT01547390|8789981|P1|Overall Study|termination of pregnancy|0
2539509|NCT01547390|8789980|P2|Overall Study|Withdrawal by Subject|7
2539510|NCT01547390|8789981|P1|Overall Study|Withdrawal by Subject|10
2539511|NCT01547299|8789991|P2|Overall Study|Withdrawal by Subject|2
2539512|NCT01547299|8789992|P1|Overall Study|Withdrawal by Subject|2
2539513|NCT01547286|8790058|P1|Overall Study|Physician Decision|1
2539514|NCT01547286|8790058|P1|Overall Study|Did not meet all eligibility criteria|1
2539515|NCT01547130|8790078|P2|Overall Study|Lost to Follow-up|5
2539516|NCT01547130|8790079|P1|Overall Study|Lost to Follow-up|9
2539517|NCT01546922|8790102|P2|Second Period of 10 Weeks|Withdrawal by Subject|2
2539518|NCT01546922|8790103|P1|Second Period of 10 Weeks|Withdrawal by Subject|0
2539519|NCT01546922|8790102|P2|Second Period of 10 Weeks|Protocol Violation|1
2539520|NCT01546922|8790103|P1|Second Period of 10 Weeks|Protocol Violation|3
2539521|NCT01546922|8790102|P2|First Period of 10 Weeks|Investigator's judgment|0
2539522|NCT01546922|8790103|P1|First Period of 10 Weeks|Investigator's judgment|1
2539523|NCT01546922|8790102|P2|First Period of 10 Weeks|Withdrawal by Subject|1
2539524|NCT01546922|8790103|P1|First Period of 10 Weeks|Withdrawal by Subject|1
2539525|NCT01546922|8790102|P2|First Period of 10 Weeks|Protocol Violation|1
2539526|NCT01546922|8790103|P1|First Period of 10 Weeks|Protocol Violation|3
2539527|NCT01546883|8790109|P1|Overall Study|other unrelated illness|1
2539528|NCT01546883|8790109|P1|Overall Study|early closure of study|2
2539529|NCT01546883|8790109|P1|Overall Study|Lost to Follow-up|2
2539530|NCT01546883|8790109|P1|Overall Study|Adverse Event|4
2539531|NCT01546883|8790109|P1|Overall Study|Withdrawal by Subject|3
2539532|NCT01546688|8790115|P2|Overall Study|Lack of Efficacy|0
2539533|NCT01546688|8790116|P1|Overall Study|Lack of Efficacy|1
2539534|NCT01546688|8790115|P2|Overall Study|Withdrawal by Subject|1
2539535|NCT01546688|8790116|P1|Overall Study|Withdrawal by Subject|2
2539536|NCT01546688|8790115|P2|Overall Study|Adverse Event|4
2539537|NCT01546688|8790116|P1|Overall Study|Adverse Event|0
2539538|NCT01546649|8790148|P2|Overall Study|Withdrawal by Subject|2
2539539|NCT01546649|8790149|P1|Overall Study|Withdrawal by Subject|1
2539540|NCT01546649|8790148|P2|Overall Study|Discovery of secondary cancer|1
2539541|NCT01546649|8790149|P1|Overall Study|Discovery of secondary cancer|0
2539542|NCT01546649|8790148|P2|Overall Study|Recurrence|1
2539543|NCT01546649|8790149|P1|Overall Study|Recurrence|1
2539544|NCT01546649|8790148|P2|Overall Study|Lack of Efficacy|0
2539545|NCT01546649|8790149|P1|Overall Study|Lack of Efficacy|1
2539546|NCT01546649|8790148|P2|Overall Study|Protocol Violation|0
2539547|NCT01546649|8790149|P1|Overall Study|Protocol Violation|1
2539548|NCT01546649|8790148|P2|Overall Study|Adverse Event|5
2539549|NCT01546649|8790149|P1|Overall Study|Adverse Event|4
2539550|NCT01546623|8790184|P2|Overall Study|Did Not Receive Study Drug|1
2539551|NCT01546623|8790185|P1|Overall Study|Did Not Receive Study Drug|1
2539552|NCT01546623|8790184|P2|Overall Study|High Prostate specific antigen|1
2539553|NCT01546623|8790185|P1|Overall Study|High Prostate specific antigen|2
2539554|NCT01546623|8790184|P2|Overall Study|Major Protocol Deviation|1
2539555|NCT01546623|8790185|P1|Overall Study|Major Protocol Deviation|1
2539556|NCT01546623|8790184|P2|Overall Study|Adverse Event|3
2539557|NCT01546623|8790185|P1|Overall Study|Adverse Event|2
2539558|NCT01546519|8790215|P4|Overall Study|Withdrawal by Subject|0
2539559|NCT01546519|8790216|P3|Overall Study|Withdrawal by Subject|0
2539560|NCT01546519|8790217|P2|Overall Study|Withdrawal by Subject|0
2539561|NCT01546519|8790218|P1|Overall Study|Withdrawal by Subject|1
2539562|NCT01546519|8790215|P4|Overall Study|Physician Decision|3
2539563|NCT01546519|8790216|P3|Overall Study|Physician Decision|2
2539564|NCT01546519|8790217|P2|Overall Study|Physician Decision|5
2539565|NCT01546519|8790218|P1|Overall Study|Physician Decision|6
2539566|NCT01546519|8790215|P4|Overall Study|related to disease progression|1
2539567|NCT01546519|8790216|P3|Overall Study|related to disease progression|2
2539568|NCT01546519|8790217|P2|Overall Study|related to disease progression|2
2539569|NCT01546519|8790218|P1|Overall Study|related to disease progression|2
2539570|NCT01546519|8790215|P4|Overall Study|Death|1
2539571|NCT01546519|8790216|P3|Overall Study|Death|3
2539572|NCT01546519|8790217|P2|Overall Study|Death|1
2539573|NCT01546519|8790218|P1|Overall Study|Death|0
2539574|NCT01546519|8790215|P4|Overall Study|Adverse Event|1
2539575|NCT01546519|8790216|P3|Overall Study|Adverse Event|1
2539576|NCT01546519|8790217|P2|Overall Study|Adverse Event|0
2539577|NCT01546519|8790218|P1|Overall Study|Adverse Event|0
2539578|NCT01546207|8790283|P1|Overall Study|Death|1
2539579|NCT01546168|8790298|P2|Overall Study|ineligible after signing consent|0
2539580|NCT01546168|8790299|P1|Overall Study|ineligible after signing consent|2
2539581|NCT01546168|8790298|P2|Overall Study|Withdrawal by Subject|0
2539582|NCT01546168|8790299|P1|Overall Study|Withdrawal by Subject|1
2539583|NCT01546168|8790298|P2|Overall Study|Lost to Follow-up|0
2539584|NCT01546168|8790299|P1|Overall Study|Lost to Follow-up|1
2539585|NCT01546155|8790311|P1|Overall Study|could not tolerate long scan duration|3
2539586|NCT01546142|8790317|P2|Overall Study|Subject Randomized but Not Treated|0
2539587|NCT01546142|8790318|P1|Overall Study|Subject Randomized but Not Treated|1
2539588|NCT01546142|8790317|P2|Overall Study|Consent Withdrawn (Subject Discomfort)|0
2539589|NCT01546142|8790318|P1|Overall Study|Consent Withdrawn (Subject Discomfort)|1
2539590|NCT01546142|8790317|P2|Overall Study|Lost to Follow-up|15
2539591|NCT01546142|8790318|P1|Overall Study|Lost to Follow-up|20
2539592|NCT01546142|8790317|P2|Overall Study|Adverse Event|3
2539593|NCT01546142|8790318|P1|Overall Study|Adverse Event|6
2539594|NCT01546142|8790317|P2|Overall Study|Subject Noncompliance|1
2539595|NCT01546142|8790318|P1|Overall Study|Subject Noncompliance|1
2539596|NCT01546142|8790317|P2|Overall Study|Consent Withdrawn (Subject Convenience)|15
2539597|NCT01546142|8790318|P1|Overall Study|Consent Withdrawn (Subject Convenience)|15
2539598|NCT01546038|8790336|P9|Overall Study|: Randomized, not treated|3
2539599|NCT01546038|8790337|P8|Overall Study|: Randomized, not treated|4
2539600|NCT01546038|8790338|P7|Overall Study|: Randomized, not treated|2
2539601|NCT01546038|8790339|P6|Overall Study|: Randomized, not treated|0
2539602|NCT01546038|8790340|P5|Overall Study|: Randomized, not treated|0
2539603|NCT01546038|8790341|P4|Overall Study|: Randomized, not treated|0
2539604|NCT01546038|8790342|P3|Overall Study|: Randomized, not treated|0
2539605|NCT01546038|8790343|P2|Overall Study|: Randomized, not treated|0
2539606|NCT01546038|8790344|P1|Overall Study|: Randomized, not treated|0
2539607|NCT01546038|8790336|P9|Overall Study|Withdrawal by Subject|1
2539608|NCT01546038|8790337|P8|Overall Study|Withdrawal by Subject|3
2539609|NCT01546038|8790338|P7|Overall Study|Withdrawal by Subject|3
2539610|NCT01546038|8790339|P6|Overall Study|Withdrawal by Subject|1
2539611|NCT01546038|8790340|P5|Overall Study|Withdrawal by Subject|0
2539612|NCT01546038|8790341|P4|Overall Study|Withdrawal by Subject|1
2539613|NCT01546038|8790342|P3|Overall Study|Withdrawal by Subject|0
2539614|NCT01546038|8790343|P2|Overall Study|Withdrawal by Subject|0
2539615|NCT01546038|8790344|P1|Overall Study|Withdrawal by Subject|1
2539616|NCT01546038|8790336|P9|Overall Study|Lost to Follow-up|0
2539617|NCT01546038|8790337|P8|Overall Study|Lost to Follow-up|1
2539618|NCT01546038|8790338|P7|Overall Study|Lost to Follow-up|2
2539619|NCT01546038|8790339|P6|Overall Study|Lost to Follow-up|0
2539620|NCT01546038|8790340|P5|Overall Study|Lost to Follow-up|1
2539621|NCT01546038|8790341|P4|Overall Study|Lost to Follow-up|0
2539622|NCT01546038|8790342|P3|Overall Study|Lost to Follow-up|0
2539623|NCT01546038|8790343|P2|Overall Study|Lost to Follow-up|0
2539624|NCT01546038|8790344|P1|Overall Study|Lost to Follow-up|0
2539625|NCT01546038|8790336|P9|Overall Study|Death|39
2539626|NCT01546038|8790337|P8|Overall Study|Death|76
2539627|NCT01546038|8790338|P7|Overall Study|Death|46
2539628|NCT01546038|8790339|P6|Overall Study|Death|3
2539629|NCT01546038|8790340|P5|Overall Study|Death|9
2539630|NCT01546038|8790341|P4|Overall Study|Death|2
2539631|NCT01546038|8790342|P3|Overall Study|Death|4
2539632|NCT01546038|8790343|P2|Overall Study|Death|6
2539633|NCT01546038|8790344|P1|Overall Study|Death|15
2539634|NCT01545817|8790538|P2|Everolimus|Adverse Event|6
2539635|NCT01545817|8790539|P1|Everolimus|Adverse Event|0
2539636|NCT01545817|8790538|P2|Everolimus|Disease progression|25
2539637|NCT01545817|8790539|P1|Everolimus|Disease progression|0
2539638|NCT01545817|8790538|P2|Everolimus|Other reason|7
2539639|NCT01545817|8790539|P1|Everolimus|Other reason|0
2539640|NCT01545817|8790538|P2|Pazopanib|Other reason|0
2539641|NCT01545817|8790539|P1|Pazopanib|Other reason|4
2539642|NCT01545817|8790538|P2|Pazopanib|Adverse Event|0
2539643|NCT01545817|8790539|P1|Pazopanib|Adverse Event|19
2539644|NCT01545817|8790538|P2|Pazopanib|Disease progression|0
2539645|NCT01545817|8790539|P1|Pazopanib|Disease progression|51
2539646|NCT01545388|8790688|P3|Overall Study|Other|0
2539647|NCT01545388|8790689|P2|Overall Study|Other|1
2539648|NCT01545388|8790690|P1|Overall Study|Other|1
2539649|NCT01545388|8790688|P3|Overall Study|Withdrawal by Subject|2
2539650|NCT01545388|8790689|P2|Overall Study|Withdrawal by Subject|4
2539651|NCT01545388|8790690|P1|Overall Study|Withdrawal by Subject|1
2539652|NCT01545388|8790688|P3|Overall Study|Participant moved or relocated|0
2539653|NCT01545388|8790689|P2|Overall Study|Participant moved or relocated|0
2539654|NCT01545388|8790690|P1|Overall Study|Participant moved or relocated|1
2539655|NCT01545388|8790688|P3|Overall Study|Lack of Efficacy|5
2539656|NCT01545388|8790689|P2|Overall Study|Lack of Efficacy|2
2539657|NCT01545388|8790690|P1|Overall Study|Lack of Efficacy|3
2539658|NCT01545388|8790688|P3|Overall Study|Adverse Event|1
2539659|NCT01545388|8790689|P2|Overall Study|Adverse Event|4
2539660|NCT01545388|8790690|P1|Overall Study|Adverse Event|2
2539661|NCT01545375|8790709|P2|Overall Study|Withdrawal by Subject|55
2539662|NCT01545375|8790710|P1|Overall Study|Withdrawal by Subject|58
2539663|NCT01545375|8790709|P2|Overall Study|Protocol Violation|3
2539664|NCT01545375|8790710|P1|Overall Study|Protocol Violation|3
2539665|NCT01545375|8790709|P2|Overall Study|Lost to Follow-up|31
2539666|NCT01545375|8790710|P1|Overall Study|Lost to Follow-up|34
2539667|NCT01545375|8790709|P2|Overall Study|Adverse Event|1
2539668|NCT01545375|8790710|P1|Overall Study|Adverse Event|2
2539669|NCT01545076|8790825|P5|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
2539670|NCT01545076|8790826|P4|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3
2539671|NCT01545076|8790827|P3|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2
2539672|NCT01545076|8790828|P2|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8
2539673|NCT01545076|8790829|P1|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
2539674|NCT01545076|8790825|P5|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
2539675|NCT01545076|8790826|P4|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
2539676|NCT01545076|8790827|P3|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
2539677|NCT01545076|8790828|P2|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
2539678|NCT01545076|8790829|P1|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
2539679|NCT01545076|8790825|P5|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
2539680|NCT01545076|8790826|P4|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32
2539681|NCT01545076|8790827|P3|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18
2539682|NCT01545076|8790828|P2|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10
2539683|NCT01545076|8790829|P1|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
2539684|NCT01545076|8790825|P5|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
2539685|NCT01545076|8790826|P4|IgPro20 Subcutaneous Treatment Period|Physician Decision|1
2539686|NCT01545076|8790827|P3|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
2539687|NCT01545076|8790828|P2|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
2539688|NCT01545076|8790829|P1|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
2539689|NCT01545076|8790825|P5|IgPro10 Restabilization Period|Withdrawal by Subject|0
2539690|NCT01545076|8790826|P4|IgPro10 Restabilization Period|Withdrawal by Subject|0
2539691|NCT01545076|8790827|P3|IgPro10 Restabilization Period|Withdrawal by Subject|0
2539692|NCT01545076|8790828|P2|IgPro10 Restabilization Period|Withdrawal by Subject|0
2539693|NCT01545076|8790829|P1|IgPro10 Restabilization Period|Withdrawal by Subject|7
2539694|NCT01545076|8790825|P5|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
2539695|NCT01545076|8790826|P4|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
2539696|NCT01545076|8790827|P3|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
2539697|NCT01545076|8790828|P2|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
2539698|NCT01545076|8790829|P1|IgPro10 Restabilization Period|Failure to meet randomization criteria|22
2539699|NCT01545076|8790825|P5|IgPro10 Restabilization Period|Protocol Violation|0
2539700|NCT01545076|8790826|P4|IgPro10 Restabilization Period|Protocol Violation|0
2539701|NCT01545076|8790827|P3|IgPro10 Restabilization Period|Protocol Violation|0
2539702|NCT01545076|8790828|P2|IgPro10 Restabilization Period|Protocol Violation|0
2539703|NCT01545076|8790829|P1|IgPro10 Restabilization Period|Protocol Violation|1
2539704|NCT01545076|8790825|P5|IgPro10 Restabilization Period|Physician Decision|0
2539705|NCT01545076|8790826|P4|IgPro10 Restabilization Period|Physician Decision|0
2539706|NCT01545076|8790827|P3|IgPro10 Restabilization Period|Physician Decision|0
2539707|NCT01545076|8790828|P2|IgPro10 Restabilization Period|Physician Decision|0
2539708|NCT01545076|8790829|P1|IgPro10 Restabilization Period|Physician Decision|2
2539709|NCT01545076|8790825|P5|IgPro10 Restabilization Period|Adverse Event|0
2539710|NCT01545076|8790826|P4|IgPro10 Restabilization Period|Adverse Event|0
2539711|NCT01545076|8790827|P3|IgPro10 Restabilization Period|Adverse Event|0
2539712|NCT01545076|8790828|P2|IgPro10 Restabilization Period|Adverse Event|0
2539713|NCT01545076|8790829|P1|IgPro10 Restabilization Period|Adverse Event|4
2539714|NCT01544920|8790900|P2|Overall Study|Withdrawal by Subject|4
2539715|NCT01544920|8790901|P1|Overall Study|Withdrawal by Subject|4
2539716|NCT01544920|8790900|P2|Overall Study|Physician Decision|1
2539717|NCT01544920|8790901|P1|Overall Study|Physician Decision|4
2539718|NCT01544920|8790900|P2|Overall Study|Protocol Violation|2
2539719|NCT01544920|8790901|P1|Overall Study|Protocol Violation|0
2539720|NCT01544920|8790900|P2|Overall Study|Lost to Follow-up|12
2539721|NCT01544920|8790901|P1|Overall Study|Lost to Follow-up|11
2539722|NCT01544920|8790900|P2|Overall Study|Death|1
2539723|NCT01544920|8790901|P1|Overall Study|Death|0
2539724|NCT01544920|8790900|P2|Overall Study|Adverse Event|3
2539725|NCT01544920|8790901|P1|Overall Study|Adverse Event|0
2539726|NCT01544595|8790915|P6|Status at Week 156|Lack of Efficacy|5
2539727|NCT01544595|8790916|P5|Status at Week 156|Lack of Efficacy|10
2539728|NCT01544595|8790917|P4|Status at Week 156|Lack of Efficacy|4
2539729|NCT01544595|8790918|P3|Status at Week 156|Lack of Efficacy|1
2539730|NCT01544595|8790919|P2|Status at Week 156|Lack of Efficacy|0
2539731|NCT01544595|8790920|P1|Status at Week 156|Lack of Efficacy|1
2539732|NCT01544595|8790915|P6|Status at Week 156|Moved to treatment period ≤ wk 156|0
2539733|NCT01544595|8790916|P5|Status at Week 156|Moved to treatment period ≤ wk 156|0
2539734|NCT01544595|8790917|P4|Status at Week 156|Moved to treatment period ≤ wk 156|145
2539735|NCT01544595|8790918|P3|Status at Week 156|Moved to treatment period ≤ wk 156|131
2539736|NCT01544595|8790919|P2|Status at Week 156|Moved to treatment period ≤ wk 156|44
2539737|NCT01544595|8790920|P1|Status at Week 156|Moved to treatment period ≤ wk 156|86
2539738|NCT01544595|8790915|P6|Status at Week 156|Technical problems|0
2539739|NCT01544595|8790916|P5|Status at Week 156|Technical problems|0
2539740|NCT01544595|8790917|P4|Status at Week 156|Technical problems|1
2539741|NCT01544595|8790918|P3|Status at Week 156|Technical problems|0
2539742|NCT01544595|8790919|P2|Status at Week 156|Technical problems|1
2539743|NCT01544595|8790920|P1|Status at Week 156|Technical problems|3
2539744|NCT01544595|8790915|P6|Status at Week 156|Protocol Violation|0
2539745|NCT01544595|8790916|P5|Status at Week 156|Protocol Violation|0
2539746|NCT01544595|8790917|P4|Status at Week 156|Protocol Violation|2
2539747|NCT01544595|8790918|P3|Status at Week 156|Protocol Violation|2
2539748|NCT01544595|8790919|P2|Status at Week 156|Protocol Violation|1
2539749|NCT01544595|8790920|P1|Status at Week 156|Protocol Violation|3
2539750|NCT01544595|8790915|P6|Status at Week 156|Pregnancy|0
2539751|NCT01544595|8790916|P5|Status at Week 156|Pregnancy|0
2539752|NCT01544595|8790917|P4|Status at Week 156|Pregnancy|0
2539753|NCT01544595|8790918|P3|Status at Week 156|Pregnancy|0
2539754|NCT01544595|8790919|P2|Status at Week 156|Pregnancy|3
2539755|NCT01544595|8790920|P1|Status at Week 156|Pregnancy|2
2539756|NCT01544595|8790915|P6|Status at Week 156|Physician Decision|0
2539757|NCT01544595|8790916|P5|Status at Week 156|Physician Decision|0
2539758|NCT01544595|8790917|P4|Status at Week 156|Physician Decision|0
2539759|NCT01544595|8790918|P3|Status at Week 156|Physician Decision|1
2539760|NCT01544595|8790919|P2|Status at Week 156|Physician Decision|3
2539761|NCT01544595|8790920|P1|Status at Week 156|Physician Decision|0
2539762|NCT01544595|8790915|P6|Status at Week 156|Non-compliance with study treatement|1
2539763|NCT01544595|8790916|P5|Status at Week 156|Non-compliance with study treatement|0
2539764|NCT01544595|8790917|P4|Status at Week 156|Non-compliance with study treatement|1
2539765|NCT01544595|8790918|P3|Status at Week 156|Non-compliance with study treatement|0
2539766|NCT01544595|8790919|P2|Status at Week 156|Non-compliance with study treatement|1
2539767|NCT01544595|8790920|P1|Status at Week 156|Non-compliance with study treatement|0
2539768|NCT01544595|8790915|P6|Status at Week 156|Lost to Follow-up|1
2539769|NCT01544595|8790916|P5|Status at Week 156|Lost to Follow-up|4
2539770|NCT01544595|8790917|P4|Status at Week 156|Lost to Follow-up|1
2539771|NCT01544595|8790918|P3|Status at Week 156|Lost to Follow-up|0
2539772|NCT01544595|8790919|P2|Status at Week 156|Lost to Follow-up|4
2539773|NCT01544595|8790920|P1|Status at Week 156|Lost to Follow-up|4
2539774|NCT01544595|8790915|P6|Status at Week 156|Adverse Event|2
2539775|NCT01544595|8790916|P5|Status at Week 156|Adverse Event|4
2539776|NCT01544595|8790917|P4|Status at Week 156|Adverse Event|3
2539777|NCT01544595|8790918|P3|Status at Week 156|Adverse Event|1
2539778|NCT01544595|8790919|P2|Status at Week 156|Adverse Event|11
2539779|NCT01544595|8790920|P1|Status at Week 156|Adverse Event|9
2539780|NCT01544595|8790915|P6|Status at Week 156|Withdrawal by Subject|6
2539781|NCT01544595|8790916|P5|Status at Week 156|Withdrawal by Subject|20
2539782|NCT01544595|8790917|P4|Status at Week 156|Withdrawal by Subject|9
2539783|NCT01544595|8790918|P3|Status at Week 156|Withdrawal by Subject|4
2539784|NCT01544595|8790919|P2|Status at Week 156|Withdrawal by Subject|10
2539785|NCT01544595|8790920|P1|Status at Week 156|Withdrawal by Subject|9
2539786|NCT01544595|8790915|P6|Status at Week 68|Moved to treatment period ≤ wk 68|0
2539787|NCT01544595|8790916|P5|Status at Week 68|Moved to treatment period ≤ wk 68|0
2539788|NCT01544595|8790917|P4|Status at Week 68|Moved to treatment period ≤ wk 68|46
2539789|NCT01544595|8790918|P3|Status at Week 68|Moved to treatment period ≤ wk 68|60
2539790|NCT01544595|8790919|P2|Status at Week 68|Moved to treatment period ≤ wk 68|13
2539791|NCT01544595|8790920|P1|Status at Week 68|Moved to treatment period ≤ wk 68|30
2539792|NCT01544595|8790915|P6|Status at Week 68|Withdrawal by Subject|0
2539793|NCT01544595|8790916|P5|Status at Week 68|Withdrawal by Subject|0
2539794|NCT01544595|8790917|P4|Status at Week 68|Withdrawal by Subject|2
2539795|NCT01544595|8790918|P3|Status at Week 68|Withdrawal by Subject|1
2539796|NCT01544595|8790919|P2|Status at Week 68|Withdrawal by Subject|1
2539797|NCT01544595|8790920|P1|Status at Week 68|Withdrawal by Subject|0
2539798|NCT01544595|8790915|P6|Status at Week 68|Technical problems|0
2539799|NCT01544595|8790916|P5|Status at Week 68|Technical problems|0
2539800|NCT01544595|8790917|P4|Status at Week 68|Technical problems|1
2539801|NCT01544595|8790918|P3|Status at Week 68|Technical problems|0
2539802|NCT01544595|8790919|P2|Status at Week 68|Technical problems|0
2539803|NCT01544595|8790920|P1|Status at Week 68|Technical problems|1
2539804|NCT01544595|8790915|P6|Status at Week 68|Protocol Violation|0
2539805|NCT01544595|8790916|P5|Status at Week 68|Protocol Violation|0
2539806|NCT01544595|8790917|P4|Status at Week 68|Protocol Violation|1
2539807|NCT01544595|8790918|P3|Status at Week 68|Protocol Violation|1
2539808|NCT01544595|8790919|P2|Status at Week 68|Protocol Violation|0
2539809|NCT01544595|8790920|P1|Status at Week 68|Protocol Violation|2
2539810|NCT01544595|8790915|P6|Status at Week 68|Non-compliance with study treatment|0
2539811|NCT01544595|8790916|P5|Status at Week 68|Non-compliance with study treatment|0
2539812|NCT01544595|8790917|P4|Status at Week 68|Non-compliance with study treatment|1
2539813|NCT01544595|8790918|P3|Status at Week 68|Non-compliance with study treatment|0
2539814|NCT01544595|8790919|P2|Status at Week 68|Non-compliance with study treatment|0
2539815|NCT01544595|8790920|P1|Status at Week 68|Non-compliance with study treatment|1
2539816|NCT01544595|8790915|P6|Status at Week 68|Lost to Follow-up|0
2539817|NCT01544595|8790916|P5|Status at Week 68|Lost to Follow-up|0
2539818|NCT01544595|8790917|P4|Status at Week 68|Lost to Follow-up|0
2539819|NCT01544595|8790918|P3|Status at Week 68|Lost to Follow-up|0
2539820|NCT01544595|8790919|P2|Status at Week 68|Lost to Follow-up|1
2539821|NCT01544595|8790920|P1|Status at Week 68|Lost to Follow-up|1
2539822|NCT01544595|8790915|P6|Status at Week 68|Lack of Efficacy|0
2539823|NCT01544595|8790916|P5|Status at Week 68|Lack of Efficacy|0
2539824|NCT01544595|8790917|P4|Status at Week 68|Lack of Efficacy|0
2539825|NCT01544595|8790918|P3|Status at Week 68|Lack of Efficacy|0
2539826|NCT01544595|8790919|P2|Status at Week 68|Lack of Efficacy|0
2539827|NCT01544595|8790920|P1|Status at Week 68|Lack of Efficacy|1
2539828|NCT01544595|8790915|P6|Status at Week 68|Adverse Event|0
2539829|NCT01544595|8790916|P5|Status at Week 68|Adverse Event|0
2539830|NCT01544595|8790917|P4|Status at Week 68|Adverse Event|0
2539831|NCT01544595|8790918|P3|Status at Week 68|Adverse Event|1
2539832|NCT01544595|8790919|P2|Status at Week 68|Adverse Event|2
2539833|NCT01544595|8790920|P1|Status at Week 68|Adverse Event|3
2539834|NCT01544582|8790996|P4|Analysis Population|Participant in Jail|0
2539835|NCT01544582|8790997|P3|Analysis Population|Participant in Jail|1
2539836|NCT01544582|8790998|P2|Analysis Population|Participant in Jail|0
2539837|NCT01544582|8790999|P1|Analysis Population|Participant in Jail|0
2539838|NCT01544582|8790996|P4|Analysis Population|Programmed Surgery|0
2539839|NCT01544582|8790997|P3|Analysis Population|Programmed Surgery|0
2539840|NCT01544582|8790998|P2|Analysis Population|Programmed Surgery|1
2539841|NCT01544582|8790999|P1|Analysis Population|Programmed Surgery|0
2539842|NCT01544582|8790996|P4|Analysis Population|Poor Participant Compliance|0
2539843|NCT01544582|8790997|P3|Analysis Population|Poor Participant Compliance|0
2539844|NCT01544582|8790998|P2|Analysis Population|Poor Participant Compliance|1
2539845|NCT01544582|8790999|P1|Analysis Population|Poor Participant Compliance|0
2539846|NCT01544582|8790996|P4|Analysis Population|Poor Adherence|0
2539847|NCT01544582|8790997|P3|Analysis Population|Poor Adherence|1
2539848|NCT01544582|8790998|P2|Analysis Population|Poor Adherence|0
2539849|NCT01544582|8790999|P1|Analysis Population|Poor Adherence|0
2539850|NCT01544582|8790996|P4|Analysis Population|No Social Insurance|0
2539851|NCT01544582|8790997|P3|Analysis Population|No Social Insurance|1
2539852|NCT01544582|8790998|P2|Analysis Population|No Social Insurance|0
2539853|NCT01544582|8790999|P1|Analysis Population|No Social Insurance|0
2539854|NCT01544582|8790996|P4|Analysis Population|Liver Transplantation|0
2539855|NCT01544582|8790997|P3|Analysis Population|Liver Transplantation|1
2539856|NCT01544582|8790998|P2|Analysis Population|Liver Transplantation|0
2539857|NCT01544582|8790999|P1|Analysis Population|Liver Transplantation|0
2539858|NCT01544582|8790996|P4|Analysis Population|Intolerance|0
2539859|NCT01544582|8790997|P3|Analysis Population|Intolerance|0
2539860|NCT01544582|8790998|P2|Analysis Population|Intolerance|1
2539861|NCT01544582|8790999|P1|Analysis Population|Intolerance|0
2539862|NCT01544582|8790996|P4|Analysis Population|Did Not Meet Inclusion Criteria|0
2539863|NCT01544582|8790997|P3|Analysis Population|Did Not Meet Inclusion Criteria|3
2539864|NCT01544582|8790998|P2|Analysis Population|Did Not Meet Inclusion Criteria|0
2539865|NCT01544582|8790999|P1|Analysis Population|Did Not Meet Inclusion Criteria|0
2539866|NCT01544582|8790996|P4|Analysis Population|Bad Tolerance to Treatment|0
2539867|NCT01544582|8790997|P3|Analysis Population|Bad Tolerance to Treatment|2
2539868|NCT01544582|8790998|P2|Analysis Population|Bad Tolerance to Treatment|0
2539869|NCT01544582|8790999|P1|Analysis Population|Bad Tolerance to Treatment|0
2539870|NCT01544582|8790996|P4|Analysis Population|Lost to Follow-up|5
2539871|NCT01544582|8790997|P3|Analysis Population|Lost to Follow-up|6
2539872|NCT01544582|8790998|P2|Analysis Population|Lost to Follow-up|6
2539873|NCT01544582|8790999|P1|Analysis Population|Lost to Follow-up|0
2539874|NCT01544582|8790996|P4|Analysis Population|New Contraindication-Alcohol Abuse|1
2539875|NCT01544582|8790997|P3|Analysis Population|New Contraindication-Alcohol Abuse|0
2539876|NCT01544582|8790998|P2|Analysis Population|New Contraindication-Alcohol Abuse|0
2539877|NCT01544582|8790999|P1|Analysis Population|New Contraindication-Alcohol Abuse|0
2539878|NCT01544582|8790996|P4|Analysis Population|Effectiveness Reason|12
2539879|NCT01544582|8790997|P3|Analysis Population|Effectiveness Reason|29
2539880|NCT01544582|8790998|P2|Analysis Population|Effectiveness Reason|48
2539881|NCT01544582|8790999|P1|Analysis Population|Effectiveness Reason|0
2539882|NCT01544582|8790996|P4|Analysis Population|Safety Reason|8
2539883|NCT01544582|8790997|P3|Analysis Population|Safety Reason|31
2539884|NCT01544582|8790998|P2|Analysis Population|Safety Reason|33
2539885|NCT01544582|8790999|P1|Analysis Population|Safety Reason|0
2539886|NCT01544582|8790996|P4|Analysis Population|Physician Decision|9
2539887|NCT01544582|8790997|P3|Analysis Population|Physician Decision|10
2539888|NCT01544582|8790998|P2|Analysis Population|Physician Decision|13
2539889|NCT01544582|8790999|P1|Analysis Population|Physician Decision|0
2539890|NCT01544582|8790996|P4|Analysis Population|Participant Refuses to Continue Study|4
2539891|NCT01544582|8790997|P3|Analysis Population|Participant Refuses to Continue Study|17
2539892|NCT01544582|8790998|P2|Analysis Population|Participant Refuses to Continue Study|15
2539893|NCT01544582|8790999|P1|Analysis Population|Participant Refuses to Continue Study|0
2539894|NCT01544582|8790996|P4|Screening/Eligibility|Eligibility Criteria Not Met|0
2539895|NCT01544582|8790997|P3|Screening/Eligibility|Eligibility Criteria Not Met|0
2539896|NCT01544582|8790998|P2|Screening/Eligibility|Eligibility Criteria Not Met|0
2539897|NCT01544582|8790999|P1|Screening/Eligibility|Eligibility Criteria Not Met|33
2539898|NCT01544582|8790996|P4|Screening/Eligibility|Initiated Different CHC Treatment|0
2539899|NCT01544582|8790997|P3|Screening/Eligibility|Initiated Different CHC Treatment|0
2539900|NCT01544582|8790998|P2|Screening/Eligibility|Initiated Different CHC Treatment|0
2539901|NCT01544582|8790999|P1|Screening/Eligibility|Initiated Different CHC Treatment|1
2539902|NCT01544491|8791059|P2|Overall Study|administrative problems|0
2539903|NCT01544491|8791060|P1|Overall Study|administrative problems|2
2539904|NCT01544491|8791059|P2|Overall Study|Lost to Follow-up|1
2539905|NCT01544491|8791060|P1|Overall Study|Lost to Follow-up|0
2539906|NCT01544491|8791059|P2|Overall Study|Withdrawal by Subject|2
2539907|NCT01544491|8791060|P1|Overall Study|Withdrawal by Subject|3
2539908|NCT01544478|8791086|P1|Overall Study|Withdrawal by Subject|52
2539909|NCT01544478|8791086|P1|Overall Study|Pregnancy|1
2539910|NCT01544478|8791086|P1|Overall Study|Physician Decision|15
2539911|NCT01544478|8791086|P1|Overall Study|Lost to Follow-up|48
2539912|NCT01544478|8791086|P1|Overall Study|Death|1
2539913|NCT01544478|8791086|P1|Overall Study|Adverse Event|1
2539914|NCT01544348|8791129|P8|Overall Study|Physician Decision|0
2539915|NCT01544348|8791130|P7|Overall Study|Physician Decision|0
2539916|NCT01544348|8791131|P6|Overall Study|Physician Decision|1
2539917|NCT01544348|8791132|P5|Overall Study|Physician Decision|0
2539918|NCT01544348|8791133|P4|Overall Study|Physician Decision|0
2539919|NCT01544348|8791134|P3|Overall Study|Physician Decision|0
2539920|NCT01544348|8791135|P2|Overall Study|Physician Decision|0
2539921|NCT01544348|8791136|P1|Overall Study|Physician Decision|0
2539922|NCT01544348|8791129|P8|Overall Study|Withdrawal by Subject|0
2539923|NCT01544348|8791130|P7|Overall Study|Withdrawal by Subject|1
2539924|NCT01544348|8791131|P6|Overall Study|Withdrawal by Subject|2
2539925|NCT01544348|8791132|P5|Overall Study|Withdrawal by Subject|1
2539926|NCT01544348|8791133|P4|Overall Study|Withdrawal by Subject|0
2539927|NCT01544348|8791134|P3|Overall Study|Withdrawal by Subject|0
2539928|NCT01544348|8791135|P2|Overall Study|Withdrawal by Subject|0
2539929|NCT01544348|8791136|P1|Overall Study|Withdrawal by Subject|1
2539930|NCT01544348|8791129|P8|Overall Study|Lost to Follow-up|0
2539931|NCT01544348|8791130|P7|Overall Study|Lost to Follow-up|1
2539932|NCT01544348|8791131|P6|Overall Study|Lost to Follow-up|0
2539933|NCT01544348|8791132|P5|Overall Study|Lost to Follow-up|0
2539934|NCT01544348|8791133|P4|Overall Study|Lost to Follow-up|0
2539935|NCT01544348|8791134|P3|Overall Study|Lost to Follow-up|0
2539936|NCT01544348|8791135|P2|Overall Study|Lost to Follow-up|0
2539937|NCT01544348|8791136|P1|Overall Study|Lost to Follow-up|1
2539938|NCT01544309|8791178|P2|Overall Study|Administered prohibit prior medication|0
2539939|NCT01544309|8791179|P1|Overall Study|Administered prohibit prior medication|1
2539940|NCT01544309|8791178|P2|Overall Study|Not performed pre-dose examination|2
2539941|NCT01544309|8791179|P1|Overall Study|Not performed pre-dose examination|1
2539942|NCT01544309|8791178|P2|Overall Study|Physician Decision|1
2539943|NCT01544309|8791179|P1|Overall Study|Physician Decision|4
2539944|NCT01544309|8791178|P2|Overall Study|Protocol Violation|1
2539945|NCT01544309|8791179|P1|Overall Study|Protocol Violation|2
2539946|NCT01544309|8791178|P2|Overall Study|Withdrawal by Subject|7
2539947|NCT01544309|8791179|P1|Overall Study|Withdrawal by Subject|12
2539948|NCT01544179|8791217|P2|Overall Study|Eligibility criteria not fulfilled|0
2539949|NCT01544179|8791218|P1|Overall Study|Eligibility criteria not fulfilled|1
2539950|NCT01544179|8791217|P2|Overall Study|Withdrawal by Subject|7
2539951|NCT01544179|8791218|P1|Overall Study|Withdrawal by Subject|12
2539952|NCT01544179|8791217|P2|Overall Study|Adverse Event|1
2539953|NCT01544179|8791218|P1|Overall Study|Adverse Event|0
2539954|NCT01544179|8791217|P2|Overall Study|Lost to Follow-up|1
2539955|NCT01544179|8791218|P1|Overall Study|Lost to Follow-up|0
2539956|NCT01544179|8791217|P2|Overall Study|Death|37
2539957|NCT01544179|8791218|P1|Overall Study|Death|50
2539958|NCT01544153|8791311|P4|Overall Study|Non-smoker|0
2539959|NCT01544153|8791312|P3|Overall Study|Non-smoker|1
2539960|NCT01544153|8791313|P2|Overall Study|Non-smoker|0
2539961|NCT01544153|8791314|P1|Overall Study|Non-smoker|0
2539962|NCT01544153|8791311|P4|Overall Study|Under 18|0
2539963|NCT01544153|8791312|P3|Overall Study|Under 18|0
2539964|NCT01544153|8791313|P2|Overall Study|Under 18|1
2539965|NCT01544153|8791314|P1|Overall Study|Under 18|0
2539966|NCT01544127|8791331|P3|Overall Study|Went active duty|1
2539967|NCT01544127|8791332|P2|Overall Study|Went active duty|0
2539968|NCT01544127|8791333|P1|Overall Study|Went active duty|0
2539969|NCT01544127|8791331|P3|Overall Study|Researcher withdrew|0
2539970|NCT01544127|8791332|P2|Overall Study|Researcher withdrew|0
2539971|NCT01544127|8791333|P1|Overall Study|Researcher withdrew|1
2539972|NCT01544127|8791331|P3|Overall Study|Became Psychotic|0
2539973|NCT01544127|8791332|P2|Overall Study|Became Psychotic|0
2539974|NCT01544127|8791333|P1|Overall Study|Became Psychotic|1
2539975|NCT01544127|8791331|P3|Overall Study|Jail or Prison|2
2539976|NCT01544127|8791332|P2|Overall Study|Jail or Prison|1
2539977|NCT01544127|8791333|P1|Overall Study|Jail or Prison|1
2539978|NCT01544127|8791331|P3|Overall Study|Death|0
2539979|NCT01544127|8791332|P2|Overall Study|Death|0
2539980|NCT01544127|8791333|P1|Overall Study|Death|1
2539981|NCT01544127|8791331|P3|Overall Study|Discharged out of catchment area|1
2539982|NCT01544127|8791332|P2|Overall Study|Discharged out of catchment area|1
2539983|NCT01544127|8791333|P1|Overall Study|Discharged out of catchment area|1
2539984|NCT01544127|8791331|P3|Overall Study|Withdrawal by Subject|1
2539985|NCT01544127|8791332|P2|Overall Study|Withdrawal by Subject|2
2539986|NCT01544127|8791333|P1|Overall Study|Withdrawal by Subject|2
2539987|NCT01544127|8791331|P3|Overall Study|Lost to Follow-up|9
2539988|NCT01544127|8791332|P2|Overall Study|Lost to Follow-up|2
2539989|NCT01544127|8791333|P1|Overall Study|Lost to Follow-up|4
2539990|NCT01544114|8791353|P3|Overall Study|Protocol Violation|0
2539991|NCT01544114|8791354|P2|Overall Study|Protocol Violation|1
2539992|NCT01544114|8791355|P1|Overall Study|Protocol Violation|0
2539993|NCT01544114|8791353|P3|Overall Study|Adverse Event|2
2539994|NCT01544114|8791354|P2|Overall Study|Adverse Event|1
2539995|NCT01544114|8791355|P1|Overall Study|Adverse Event|1
2539996|NCT01544114|8791353|P3|Overall Study|Lost to Follow-up|0
2539997|NCT01544114|8791354|P2|Overall Study|Lost to Follow-up|2
2539998|NCT01544114|8791355|P1|Overall Study|Lost to Follow-up|0
2539999|NCT01544114|8791353|P3|Overall Study|Withdrawal by Subject|3
2540000|NCT01544114|8791354|P2|Overall Study|Withdrawal by Subject|0
2540001|NCT01544114|8791355|P1|Overall Study|Withdrawal by Subject|0
2540002|NCT01543958|8791453|P1|Overall Study|ART initiation|1
2540003|NCT01543958|8791453|P1|Overall Study|Loss to follow-up|3
2540004|NCT01543828|8791508|P2|Treatment 2|Lost to Follow-up|0
2540005|NCT01543828|8791509|P1|Treatment 2|Lost to Follow-up|1
2540006|NCT01543776|8791519|P2|Overall Study|Withdrawal by Subject|2
2540007|NCT01543776|8791520|P1|Overall Study|Withdrawal by Subject|2
2540008|NCT01543685|8791539|P5|Overall Study|Adverse Event|2
2540009|NCT01543685|8791540|P4|Overall Study|Adverse Event|0
2540010|NCT01543685|8791541|P3|Overall Study|Adverse Event|0
2540011|NCT01543685|8791542|P2|Overall Study|Adverse Event|1
2540012|NCT01543685|8791543|P1|Overall Study|Adverse Event|2
2540013|NCT01543685|8791539|P5|Overall Study|Lack of Efficacy|2
2540014|NCT01543685|8791540|P4|Overall Study|Lack of Efficacy|0
2540015|NCT01543685|8791541|P3|Overall Study|Lack of Efficacy|2
2540016|NCT01543685|8791542|P2|Overall Study|Lack of Efficacy|2
2540017|NCT01543685|8791543|P1|Overall Study|Lack of Efficacy|1
2540018|NCT01543503|8791615|P2|Overall Study|Screen failure|0
2540019|NCT01543503|8791616|P1|Overall Study|Screen failure|1
2540020|NCT01543503|8791615|P2|Overall Study|Participant went to United States|0
2540021|NCT01543503|8791616|P1|Overall Study|Participant went to United States|1
2540022|NCT01543503|8791615|P2|Overall Study|Participant consented to another study|2
2540023|NCT01543503|8791616|P1|Overall Study|Participant consented to another study|0
2540024|NCT01543503|8791615|P2|Overall Study|Moved to other rheumatologic site|1
2540025|NCT01543503|8791616|P1|Overall Study|Moved to other rheumatologic site|0
2540026|NCT01543503|8791615|P2|Overall Study|Participant did not attend a visit|0
2540027|NCT01543503|8791616|P1|Overall Study|Participant did not attend a visit|1
2540028|NCT01543503|8791615|P2|Overall Study|Site stopped participation|1
2540029|NCT01543503|8791616|P1|Overall Study|Site stopped participation|5
2540030|NCT01543503|8791615|P2|Overall Study|Participant recruited after closing date|1
2540031|NCT01543503|8791616|P1|Overall Study|Participant recruited after closing date|0
2540032|NCT01543503|8791615|P2|Overall Study|Investigator did not wish to participate|1
2540033|NCT01543503|8791616|P1|Overall Study|Investigator did not wish to participate|1
2540034|NCT01543503|8791615|P2|Overall Study|Participant decision to stop treatment|0
2540035|NCT01543503|8791616|P1|Overall Study|Participant decision to stop treatment|1
2540036|NCT01543503|8791615|P2|Overall Study|Participant moved to Scotland|0
2540037|NCT01543503|8791616|P1|Overall Study|Participant moved to Scotland|1
2540038|NCT01543503|8791615|P2|Overall Study|Participant transferred to another city|0
2540039|NCT01543503|8791616|P1|Overall Study|Participant transferred to another city|1
2540040|NCT01543503|8791615|P2|Overall Study|Participant will not return for visits|2
2540041|NCT01543503|8791616|P1|Overall Study|Participant will not return for visits|0
2540042|NCT01543503|8791615|P2|Overall Study|Participant moved to another city|0
2540043|NCT01543503|8791616|P1|Overall Study|Participant moved to another city|2
2540044|NCT01543503|8791615|P2|Overall Study|Incorrect medication received|0
2540045|NCT01543503|8791616|P1|Overall Study|Incorrect medication received|1
2540046|NCT01543503|8791615|P2|Overall Study|Refused to continue treatment|0
2540047|NCT01543503|8791616|P1|Overall Study|Refused to continue treatment|7
2540048|NCT01543503|8791615|P2|Overall Study|Participant did not complete last visit|2
2540049|NCT01543503|8791616|P1|Overall Study|Participant did not complete last visit|0
2540050|NCT01543503|8791615|P2|Overall Study|Probable overlap of RA with fibromyalgia|0
2540051|NCT01543503|8791616|P1|Overall Study|Probable overlap of RA with fibromyalgia|1
2540052|NCT01543503|8791615|P2|Overall Study|Intolerance to the biologic treatment|1
2540053|NCT01543503|8791616|P1|Overall Study|Intolerance to the biologic treatment|0
2540054|NCT01543503|8791615|P2|Overall Study|Change of jobs|1
2540055|NCT01543503|8791616|P1|Overall Study|Change of jobs|0
2540056|NCT01543503|8791615|P2|Overall Study|Participant withdrew informed consent|10
2540057|NCT01543503|8791616|P1|Overall Study|Participant withdrew informed consent|8
2540058|NCT01543503|8791615|P2|Overall Study|Lack of Efficacy|16
2540059|NCT01543503|8791616|P1|Overall Study|Lack of Efficacy|4
2540060|NCT01543503|8791615|P2|Overall Study|Adverse Event|13
2540061|NCT01543503|8791616|P1|Overall Study|Adverse Event|9
2540062|NCT01543503|8791615|P2|Overall Study|Lost to Follow-up|36
2540063|NCT01543503|8791616|P1|Overall Study|Lost to Follow-up|32
2540064|NCT01543204|8791660|P1|Overall Study|Lost to Follow-up|1
2540065|NCT01543204|8791660|P1|Overall Study|Requirement for Alternative Therapy|1
2540066|NCT01543204|8791660|P1|Overall Study|Withdrawal by Subject|4
2540067|NCT01543204|8791660|P1|Overall Study|Adverse Event|1
2540068|NCT01543204|8791660|P1|Overall Study|Non-compliance|1
2540069|NCT01543087|8791722|P6|Booster Stage (26 Months)|Lost to Follow-up|0
2540070|NCT01543087|8791723|P5|Booster Stage (26 Months)|Lost to Follow-up|0
2540071|NCT01543087|8791724|P4|Booster Stage (26 Months)|Lost to Follow-up|0
2540072|NCT01543087|8791725|P3|Booster Stage (26 Months)|Lost to Follow-up|1
2540073|NCT01543087|8791726|P2|Booster Stage (26 Months)|Lost to Follow-up|0
2540074|NCT01543087|8791727|P1|Booster Stage (26 Months)|Lost to Follow-up|0
2540075|NCT01543087|8791722|P6|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
2540076|NCT01543087|8791723|P5|Booster Stage (26 Months)|Withdrawal before booster vaccination|2
2540077|NCT01543087|8791724|P4|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
2540078|NCT01543087|8791725|P3|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
2540079|NCT01543087|8791726|P2|Booster Stage (26 Months)|Withdrawal before booster vaccination|1
2540080|NCT01543087|8791727|P1|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
2540081|NCT01543087|8791722|P6|Stage 1 (48 Months)|Protocol Violation|0
2540082|NCT01543087|8791723|P5|Stage 1 (48 Months)|Protocol Violation|0
2540083|NCT01543087|8791724|P4|Stage 1 (48 Months)|Protocol Violation|0
2540084|NCT01543087|8791725|P3|Stage 1 (48 Months)|Protocol Violation|0
2540085|NCT01543087|8791726|P2|Stage 1 (48 Months)|Protocol Violation|3
2540086|NCT01543087|8791727|P1|Stage 1 (48 Months)|Protocol Violation|0
2540087|NCT01543087|8791722|P6|Stage 1 (48 Months)|Other than specified|0
2540088|NCT01543087|8791723|P5|Stage 1 (48 Months)|Other than specified|0
2540089|NCT01543087|8791724|P4|Stage 1 (48 Months)|Other than specified|0
2540090|NCT01543087|8791725|P3|Stage 1 (48 Months)|Other than specified|9
2540091|NCT01543087|8791726|P2|Stage 1 (48 Months)|Other than specified|0
2540092|NCT01543087|8791727|P1|Stage 1 (48 Months)|Other than specified|5
2540093|NCT01543087|8791722|P6|Stage 1 (48 Months)|No longer willing to participate|0
2540094|NCT01543087|8791723|P5|Stage 1 (48 Months)|No longer willing to participate|3
2540095|NCT01543087|8791724|P4|Stage 1 (48 Months)|No longer willing to participate|6
2540096|NCT01543087|8791725|P3|Stage 1 (48 Months)|No longer willing to participate|18
2540097|NCT01543087|8791726|P2|Stage 1 (48 Months)|No longer willing to participate|3
2540098|NCT01543087|8791727|P1|Stage 1 (48 Months)|No longer willing to participate|5
2540099|NCT01543087|8791722|P6|Stage 1 (48 Months)|No longer met eligibility criteria|0
2540100|NCT01543087|8791723|P5|Stage 1 (48 Months)|No longer met eligibility criteria|0
2540101|NCT01543087|8791724|P4|Stage 1 (48 Months)|No longer met eligibility criteria|2
2540102|NCT01543087|8791725|P3|Stage 1 (48 Months)|No longer met eligibility criteria|1
2540103|NCT01543087|8791726|P2|Stage 1 (48 Months)|No longer met eligibility criteria|0
2540104|NCT01543087|8791727|P1|Stage 1 (48 Months)|No longer met eligibility criteria|1
2540105|NCT01543087|8791722|P6|Stage 1 (48 Months)|Lost to Follow-up|0
2540106|NCT01543087|8791723|P5|Stage 1 (48 Months)|Lost to Follow-up|0
2540107|NCT01543087|8791724|P4|Stage 1 (48 Months)|Lost to Follow-up|0
2540108|NCT01543087|8791725|P3|Stage 1 (48 Months)|Lost to Follow-up|12
2540109|NCT01543087|8791726|P2|Stage 1 (48 Months)|Lost to Follow-up|4
2540110|NCT01543087|8791727|P1|Stage 1 (48 Months)|Lost to Follow-up|3
2540111|NCT01542788|8791904|P2|Overall Study|Withdrawal by Subject|0
2540112|NCT01542788|8791905|P1|Overall Study|Withdrawal by Subject|1
2540113|NCT01542788|8791904|P2|Overall Study|Physician Decision|0
2540114|NCT01542788|8791905|P1|Overall Study|Physician Decision|1
2540115|NCT01542788|8791904|P2|Overall Study|Protocol Violation|0
2540116|NCT01542788|8791905|P1|Overall Study|Protocol Violation|2
2540117|NCT01542788|8791904|P2|Overall Study|Death|0
2540118|NCT01542788|8791905|P1|Overall Study|Death|3
2540119|NCT01542788|8791904|P2|Overall Study|Lost to Follow-up|0
2540120|NCT01542788|8791905|P1|Overall Study|Lost to Follow-up|5
2540121|NCT01542788|8791904|P2|Overall Study|Lack of Efficacy|71
2540122|NCT01542788|8791905|P1|Overall Study|Lack of Efficacy|41
2540123|NCT01542788|8791904|P2|Overall Study|Randomized but Not Treated|0
2540124|NCT01542788|8791905|P1|Overall Study|Randomized but Not Treated|2
2540125|NCT01542632|8791952|P6|Overall Study|Sponsor/Investigator Decision|0
2540126|NCT01542632|8791953|P5|Overall Study|Sponsor/Investigator Decision|1
2540127|NCT01542632|8791954|P4|Overall Study|Sponsor/Investigator Decision|0
2540128|NCT01542632|8791955|P3|Overall Study|Sponsor/Investigator Decision|0
2540129|NCT01542632|8791956|P2|Overall Study|Sponsor/Investigator Decision|0
2540130|NCT01542632|8791957|P1|Overall Study|Sponsor/Investigator Decision|0
2540131|NCT01542632|8791952|P6|Overall Study|Lost to Follow-up|0
2540132|NCT01542632|8791953|P5|Overall Study|Lost to Follow-up|0
2540133|NCT01542632|8791954|P4|Overall Study|Lost to Follow-up|0
2540134|NCT01542632|8791955|P3|Overall Study|Lost to Follow-up|0
2540135|NCT01542632|8791956|P2|Overall Study|Lost to Follow-up|1
2540136|NCT01542632|8791957|P1|Overall Study|Lost to Follow-up|0
2540137|NCT01542632|8791952|P6|Overall Study|Adverse Event|0
2540138|NCT01542632|8791953|P5|Overall Study|Adverse Event|0
2540139|NCT01542632|8791954|P4|Overall Study|Adverse Event|0
2540140|NCT01542632|8791955|P3|Overall Study|Adverse Event|1
2540141|NCT01542632|8791956|P2|Overall Study|Adverse Event|0
2540142|NCT01542632|8791957|P1|Overall Study|Adverse Event|0
2540143|NCT01542632|8791952|P6|Overall Study|Withdrawal of Consent|0
2540144|NCT01542632|8791953|P5|Overall Study|Withdrawal of Consent|3
2540145|NCT01542632|8791954|P4|Overall Study|Withdrawal of Consent|2
2540146|NCT01542632|8791955|P3|Overall Study|Withdrawal of Consent|0
2540147|NCT01542632|8791956|P2|Overall Study|Withdrawal of Consent|0
2540148|NCT01542632|8791957|P1|Overall Study|Withdrawal of Consent|0
2540149|NCT01542528|8792014|P2|Overall Study|Withdrawal by Subject|6
2540150|NCT01542528|8792015|P1|Overall Study|Withdrawal by Subject|9
2540151|NCT01542528|8792014|P2|Overall Study|Physician Decision|0
2540152|NCT01542528|8792015|P1|Overall Study|Physician Decision|1
2540153|NCT01542528|8792014|P2|Overall Study|Lost to Follow-up|1
2540154|NCT01542528|8792015|P1|Overall Study|Lost to Follow-up|2
2540155|NCT01542034|8792123|P2|Overall Study|Lost to Follow-up|6
2540156|NCT01542034|8792124|P1|Overall Study|Lost to Follow-up|7
2540157|NCT01542034|8792123|P2|Overall Study|Adverse Event|2
2540158|NCT01542034|8792124|P1|Overall Study|Adverse Event|2
2540159|NCT01542034|8792123|P2|Overall Study|Subject Noncompliance|0
2540160|NCT01542034|8792124|P1|Overall Study|Subject Noncompliance|1
2540161|NCT01542034|8792123|P2|Overall Study|Administrative decision|3
2540162|NCT01542034|8792124|P1|Overall Study|Administrative decision|0
2540163|NCT01542034|8792123|P2|Overall Study|Consent Withdrawn (Subject Convenience)|12
2540164|NCT01542034|8792124|P1|Overall Study|Consent Withdrawn (Subject Convenience)|20
2540165|NCT01541969|8792138|P2|Open Label Extension (12-36 Weeks)|Adverse Event|3
2540166|NCT01541969|8792139|P1|Open Label Extension (12-36 Weeks)|Adverse Event|2
2540167|NCT01541969|8792138|P2|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8
2540168|NCT01541969|8792139|P1|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6
2540169|NCT01541969|8792138|P2|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
2540170|NCT01541969|8792139|P1|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
2540171|NCT01541969|8792138|P2|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0
2540172|NCT01541969|8792139|P1|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1
2540173|NCT01541969|8792138|P2|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
2540174|NCT01541969|8792139|P1|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
2540175|NCT01541969|8792138|P2|Double-blind (0-12 Weeks)|Adverse Event|0
2540176|NCT01541969|8792139|P1|Double-blind (0-12 Weeks)|Adverse Event|2
2540177|NCT01541969|8792138|P2|Double-blind (0-12 Weeks)|Lost to Follow-up|0
2540178|NCT01541969|8792139|P1|Double-blind (0-12 Weeks)|Lost to Follow-up|1
2540179|NCT01541969|8792138|P2|Double-blind (0-12 Weeks)|Withdrawal by Subject|0
2540180|NCT01541969|8792139|P1|Double-blind (0-12 Weeks)|Withdrawal by Subject|2
2540181|NCT01541969|8792138|P2|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
2540182|NCT01541969|8792139|P1|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
2540183|NCT01541969|8792138|P2|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1
2540184|NCT01541969|8792139|P1|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0
2540185|NCT01541930|8792155|P1|Overall Study|Withdrawal by Subject|1
2540186|NCT01541917|8792177|P2|Overall Study|Withdrawal by Subject|7
2540187|NCT01541917|8792178|P1|Overall Study|Withdrawal by Subject|13
2540188|NCT01541917|8792177|P2|Overall Study|Lost to Follow-up|2
2540189|NCT01541917|8792178|P1|Overall Study|Lost to Follow-up|2
2540190|NCT01541865|8792207|P1|Overall Study|Protocol Violation|1
2540191|NCT01541865|8792207|P1|Overall Study|Adverse Event|1
2540192|NCT01541865|8792207|P1|Overall Study|Withdrawal by Subject|9
2540193|NCT01541865|8792207|P1|Overall Study|Lost to Follow-up|11
2540194|NCT01541826|8792225|P3|Overall Study|Withdrawal by Subject|0
2540195|NCT01541826|8792226|P2|Overall Study|Withdrawal by Subject|0
2540196|NCT01541826|8792227|P1|Overall Study|Withdrawal by Subject|2
2540197|NCT01541826|8792225|P3|Overall Study|Lost to Follow-up|0
2540198|NCT01541826|8792226|P2|Overall Study|Lost to Follow-up|3
2540199|NCT01541826|8792227|P1|Overall Study|Lost to Follow-up|2
2540200|NCT01541644|8792309|P1|Overall Study|Withdrawal by Subject|3
2540201|NCT01541397|8792328|P2|Overall Study|Study ended prior to data collection|2
2540202|NCT01541397|8792329|P1|Overall Study|Study ended prior to data collection|4
2540203|NCT01541371|8792354|P1|Overall Study|Other|6
2540204|NCT01541371|8792354|P1|Overall Study|Study medication non-compliance|3
2540205|NCT01541371|8792354|P1|Overall Study|Protocol Violation|6
2540206|NCT01541371|8792354|P1|Overall Study|Lack of Efficacy|12
2540207|NCT01541371|8792354|P1|Overall Study|Adverse Event|15
2540208|NCT01541371|8792354|P1|Overall Study|Lost to Follow-up|21
2540209|NCT01541371|8792354|P1|Overall Study|Withdrawal by Subject|14
2540210|NCT01541254|8792383|P1|Overall Study|alternate stent used|1
2540211|NCT01541254|8792383|P1|Overall Study|stent not required|1
2540212|NCT01541254|8792383|P1|Overall Study|GI bleed prior to procedure|1
2540213|NCT01541254|8792383|P1|Overall Study|enrolled after study closed|1
2540214|NCT01541254|8792383|P1|Overall Study|excluded - metal allergy|1
2540215|NCT01541254|8792383|P1|Overall Study|Withdrawal by Subject|1
2540216|NCT01541215|8792390|P2|Overall Study|Unclassified|3
2540217|NCT01541215|8792391|P1|Overall Study|Unclassified|0
2540218|NCT01541215|8792390|P2|Overall Study|Adverse Event|1
2540219|NCT01541215|8792391|P1|Overall Study|Adverse Event|0
2540220|NCT01541215|8792390|P2|Overall Study|Non-compliance|4
2540221|NCT01541215|8792391|P1|Overall Study|Non-compliance|4
2540222|NCT01541215|8792390|P2|Overall Study|Withdrawal criteria|8
2540223|NCT01541215|8792391|P1|Overall Study|Withdrawal criteria|6
2540224|NCT01540981|8792529|P2|Overall Study|Withdrawal by Subject|0
2540225|NCT01540981|8792530|P1|Overall Study|Withdrawal by Subject|1
2540226|NCT01540851|8792540|P2|Overall Study|Withdrawal by Subject|3
2540227|NCT01540851|8792541|P1|Overall Study|Withdrawal by Subject|7
2540228|NCT01540851|8792540|P2|Overall Study|Lost to Follow-up|15
2540229|NCT01540851|8792541|P1|Overall Study|Lost to Follow-up|14
2540230|NCT01540838|8792553|P2|Overall Study|Not BM. Other treatment|1
2540231|NCT01540838|8792554|P1|Overall Study|Not BM. Other treatment|3
2540232|NCT01540838|8792553|P2|Overall Study|Died before treatment initiation|1
2540233|NCT01540838|8792554|P1|Overall Study|Died before treatment initiation|1
2540234|NCT01540838|8792553|P2|Overall Study|Additional antibiotic treatment|2
2540235|NCT01540838|8792554|P1|Overall Study|Additional antibiotic treatment|1
2540236|NCT01540838|8792553|P2|Overall Study|Treatment doses missing|12
2540237|NCT01540838|8792554|P1|Overall Study|Treatment doses missing|8
2540238|NCT01540838|8792553|P2|Overall Study|Open nasogastric tube|7
2540239|NCT01540838|8792554|P1|Overall Study|Open nasogastric tube|9
2540240|NCT01540565|8792704|P1|Overall Study|Ineligible|2
2540241|NCT01540487|8792723|P2|Overall Study|Protocol Violation|0
2540242|NCT01540487|8792724|P1|Overall Study|Protocol Violation|1
2540243|NCT01539759|8792871|P2|Overall Study|Lost to Follow-up|8
2540244|NCT01539759|8792872|P1|Overall Study|Lost to Follow-up|6
2540245|NCT01539642|8792884|P2|Overall Study|Withdrawal by Subject|2
2540246|NCT01539642|8792885|P1|Overall Study|Withdrawal by Subject|2
2540247|NCT01539642|8792884|P2|Overall Study|Adverse Event|4
2540248|NCT01539642|8792885|P1|Overall Study|Adverse Event|6
2540249|NCT01539642|8792884|P2|Overall Study|Patient ready for early discharge|7
2540250|NCT01539642|8792885|P1|Overall Study|Patient ready for early discharge|8
2540251|NCT01539642|8792884|P2|Overall Study|Lack of Efficacy|18
2540252|NCT01539642|8792885|P1|Overall Study|Lack of Efficacy|20
2540253|NCT01539538|8792902|P2|Overall Study|PCA no longer required or PCA problem|7
2540254|NCT01539538|8792903|P1|Overall Study|PCA no longer required or PCA problem|3
2540255|NCT01539538|8792902|P2|Overall Study|Withdrawal by Subject|3
2540256|NCT01539538|8792903|P1|Overall Study|Withdrawal by Subject|2
2540257|NCT01539538|8792902|P2|Overall Study|Lack of Efficacy|16
2540258|NCT01539538|8792903|P1|Overall Study|Lack of Efficacy|13
2540259|NCT01539538|8792902|P2|Overall Study|Adverse Event|18
2540260|NCT01539538|8792903|P1|Overall Study|Adverse Event|13
2540261|NCT01539525|8792912|P3|Overall Study|Protocol Violation|4
2540262|NCT01539525|8792913|P2|Overall Study|Protocol Violation|1
2540263|NCT01539525|8792914|P1|Overall Study|Protocol Violation|1
2540264|NCT01539525|8792912|P3|Overall Study|Withdrawal by Subject|2
2540265|NCT01539525|8792913|P2|Overall Study|Withdrawal by Subject|3
2540266|NCT01539525|8792914|P1|Overall Study|Withdrawal by Subject|0
2540267|NCT01539525|8792912|P3|Overall Study|Lost to Follow-up|11
2540268|NCT01539525|8792913|P2|Overall Study|Lost to Follow-up|12
2540269|NCT01539525|8792914|P1|Overall Study|Lost to Follow-up|19
2540270|NCT01539512|8792933|P2|Overall Study|Richter's Transformation|0
2540271|NCT01539512|8792934|P1|Overall Study|Richter's Transformation|1
2540272|NCT01539512|8792933|P2|Overall Study|Withdrawal by Subject|5
2540273|NCT01539512|8792934|P1|Overall Study|Withdrawal by Subject|12
2540274|NCT01539512|8792933|P2|Overall Study|Physician Decision|1
2540275|NCT01539512|8792934|P1|Overall Study|Physician Decision|1
2540276|NCT01539512|8792933|P2|Overall Study|Adverse Event|7
2540277|NCT01539512|8792934|P1|Overall Study|Adverse Event|9
2540278|NCT01539317|8792950|P2|Overall Study|Screening Error. Deleted from analysis.|0
2540279|NCT01539317|8792951|P1|Overall Study|Screening Error. Deleted from analysis.|1
2540280|NCT01539291|8792969|P4|Study GS-US-312-0117|Other|1
2540281|NCT01539291|8792970|P3|Study GS-US-312-0117|Other|1
2540282|NCT01539291|8792971|P2|Study GS-US-312-0117|Other|1
2540283|NCT01539291|8792972|P1|Study GS-US-312-0117|Other|2
2540284|NCT01539291|8792969|P4|Study GS-US-312-0117|Study Terminated by Sponsor|5
2540285|NCT01539291|8792970|P3|Study GS-US-312-0117|Study Terminated by Sponsor|0
2540286|NCT01539291|8792971|P2|Study GS-US-312-0117|Study Terminated by Sponsor|0
2540287|NCT01539291|8792972|P1|Study GS-US-312-0117|Study Terminated by Sponsor|3
2540288|NCT01539291|8792969|P4|Study GS-US-312-0117|Withdrawal by Subject|4
2540289|NCT01539291|8792970|P3|Study GS-US-312-0117|Withdrawal by Subject|6
2540290|NCT01539291|8792971|P2|Study GS-US-312-0117|Withdrawal by Subject|0
2540291|NCT01539291|8792972|P1|Study GS-US-312-0117|Withdrawal by Subject|5
2540292|NCT01539291|8792969|P4|Study GS-US-312-0117|Physician Decision|4
2540293|NCT01539291|8792970|P3|Study GS-US-312-0117|Physician Decision|6
2540294|NCT01539291|8792971|P2|Study GS-US-312-0117|Physician Decision|0
2540295|NCT01539291|8792972|P1|Study GS-US-312-0117|Physician Decision|9
2540296|NCT01539291|8792969|P4|Study GS-US-312-0117|Adverse Event|12
2540297|NCT01539291|8792970|P3|Study GS-US-312-0117|Adverse Event|9
2540298|NCT01539291|8792971|P2|Study GS-US-312-0117|Adverse Event|1
2540299|NCT01539291|8792972|P1|Study GS-US-312-0117|Adverse Event|22
2540300|NCT01539291|8792969|P4|Study GS-US-312-0116|Other|0
2540301|NCT01539291|8792970|P3|Study GS-US-312-0116|Other|0
2540302|NCT01539291|8792971|P2|Study GS-US-312-0116|Other|0
2540303|NCT01539291|8792972|P1|Study GS-US-312-0116|Other|1
2540304|NCT01539291|8792969|P4|Study GS-US-312-0116|Study Terminated by Sponsor|0
2540305|NCT01539291|8792970|P3|Study GS-US-312-0116|Study Terminated by Sponsor|0
2540306|NCT01539291|8792971|P2|Study GS-US-312-0116|Study Terminated by Sponsor|0
2540307|NCT01539291|8792972|P1|Study GS-US-312-0116|Study Terminated by Sponsor|2
2540308|NCT01539291|8792969|P4|Study GS-US-312-0116|Withdrawal by Subject|0
2540309|NCT01539291|8792970|P3|Study GS-US-312-0116|Withdrawal by Subject|0
2540310|NCT01539291|8792971|P2|Study GS-US-312-0116|Withdrawal by Subject|0
2540311|NCT01539291|8792972|P1|Study GS-US-312-0116|Withdrawal by Subject|12
2540312|NCT01539291|8792969|P4|Study GS-US-312-0116|Physician Decision|0
2540313|NCT01539291|8792970|P3|Study GS-US-312-0116|Physician Decision|0
2540314|NCT01539291|8792971|P2|Study GS-US-312-0116|Physician Decision|0
2540315|NCT01539291|8792972|P1|Study GS-US-312-0116|Physician Decision|1
2540316|NCT01539291|8792969|P4|Study GS-US-312-0116|Adverse Event|0
2540317|NCT01539291|8792970|P3|Study GS-US-312-0116|Adverse Event|0
2540318|NCT01539291|8792971|P2|Study GS-US-312-0116|Adverse Event|0
2540319|NCT01539291|8792972|P1|Study GS-US-312-0116|Adverse Event|9
2540320|NCT01539239|8793044|P2|Overall Study|Lost to Follow-up|12
2540321|NCT01539239|8793045|P1|Overall Study|Lost to Follow-up|7
2540322|NCT01539239|8793044|P2|Overall Study|Death|5
2540323|NCT01539239|8793045|P1|Overall Study|Death|5
2540324|NCT01539083|8793068|P3|After Randomization (TP and VTP)|Death|11
2540325|NCT01539083|8793069|P2|After Randomization (TP and VTP)|Death|6
2540326|NCT01539083|8793070|P1|After Randomization (TP and VTP)|Death|0
2540327|NCT01539083|8793068|P3|After Randomization (TP and VTP)|Progressive Disease|3
2540328|NCT01539083|8793069|P2|After Randomization (TP and VTP)|Progressive Disease|6
2540329|NCT01539083|8793070|P1|After Randomization (TP and VTP)|Progressive Disease|0
2540330|NCT01539083|8793068|P3|After Randomization (TP and VTP)|Withdrawal by Subject|4
2540331|NCT01539083|8793069|P2|After Randomization (TP and VTP)|Withdrawal by Subject|5
2540332|NCT01539083|8793070|P1|After Randomization (TP and VTP)|Withdrawal by Subject|0
2540333|NCT01539083|8793068|P3|After Randomization (TP and VTP)|Lost to Follow-up|2
2540334|NCT01539083|8793069|P2|After Randomization (TP and VTP)|Lost to Follow-up|2
2540335|NCT01539083|8793070|P1|After Randomization (TP and VTP)|Lost to Follow-up|0
2540336|NCT01539083|8793068|P3|After Randomization (TP and VTP)|Adverse Event|1
2540337|NCT01539083|8793069|P2|After Randomization (TP and VTP)|Adverse Event|1
2540338|NCT01539083|8793070|P1|After Randomization (TP and VTP)|Adverse Event|0
2540339|NCT01539083|8793068|P3|After Randomization (TP and VTP)|Other|1
2540340|NCT01539083|8793069|P2|After Randomization (TP and VTP)|Other|1
2540341|NCT01539083|8793070|P1|After Randomization (TP and VTP)|Other|0
2540342|NCT01539083|8793068|P3|After Randomization (TP and VTP)|Physician Decision|1
2540343|NCT01539083|8793069|P2|After Randomization (TP and VTP)|Physician Decision|0
2540344|NCT01539083|8793070|P1|After Randomization (TP and VTP)|Physician Decision|0
2540345|NCT01539083|8793068|P3|Before Randomization (VCD Induction)|Other|0
2540346|NCT01539083|8793069|P2|Before Randomization (VCD Induction)|Other|0
2540347|NCT01539083|8793070|P1|Before Randomization (VCD Induction)|Other|5
2540348|NCT01539083|8793068|P3|Before Randomization (VCD Induction)|Progressive Disease|0
2540349|NCT01539083|8793069|P2|Before Randomization (VCD Induction)|Progressive Disease|0
2540350|NCT01539083|8793070|P1|Before Randomization (VCD Induction)|Progressive Disease|8
2540351|NCT01539083|8793068|P3|Before Randomization (VCD Induction)|Physician Decision|0
2540352|NCT01539083|8793069|P2|Before Randomization (VCD Induction)|Physician Decision|0
2540353|NCT01539083|8793070|P1|Before Randomization (VCD Induction)|Physician Decision|14
2540354|NCT01539083|8793068|P3|Before Randomization (VCD Induction)|Protocol Violation|0
2540355|NCT01539083|8793069|P2|Before Randomization (VCD Induction)|Protocol Violation|0
2540356|NCT01539083|8793070|P1|Before Randomization (VCD Induction)|Protocol Violation|2
2540357|NCT01539083|8793068|P3|Before Randomization (VCD Induction)|Death|0
2540358|NCT01539083|8793069|P2|Before Randomization (VCD Induction)|Death|0
2540359|NCT01539083|8793070|P1|Before Randomization (VCD Induction)|Death|6
2540360|NCT01539083|8793068|P3|Before Randomization (VCD Induction)|Adverse Event|0
2540361|NCT01539083|8793069|P2|Before Randomization (VCD Induction)|Adverse Event|0
2540362|NCT01539083|8793070|P1|Before Randomization (VCD Induction)|Adverse Event|14
2540363|NCT01539083|8793068|P3|Before Randomization (VCD Induction)|Withdrawal by Subject|0
2540364|NCT01539083|8793069|P2|Before Randomization (VCD Induction)|Withdrawal by Subject|0
2540365|NCT01539083|8793070|P1|Before Randomization (VCD Induction)|Withdrawal by Subject|4
2540366|NCT01538719|8793114|P2|Overall Study|Lost to Follow-up|0
2540367|NCT01538719|8793115|P1|Overall Study|Lost to Follow-up|2
2540368|NCT01538472|8793138|P1|Overall Study|Death|1
2540369|NCT01538472|8793138|P1|Overall Study|Disease Progression|3
2540370|NCT01538199|8793149|P4|Overall Study|Lack of Efficacy|0
2540371|NCT01538199|8793150|P3|Overall Study|Lack of Efficacy|0
2540372|NCT01538199|8793151|P2|Overall Study|Lack of Efficacy|1
2540373|NCT01538199|8793152|P1|Overall Study|Lack of Efficacy|0
2540374|NCT01538199|8793149|P4|Overall Study|participant did not have time|2
2540375|NCT01538199|8793150|P3|Overall Study|participant did not have time|0
2540376|NCT01538199|8793151|P2|Overall Study|participant did not have time|0
2540377|NCT01538199|8793152|P1|Overall Study|participant did not have time|1
2540378|NCT01538199|8793149|P4|Overall Study|Lost to Follow-up|0
2540379|NCT01538199|8793150|P3|Overall Study|Lost to Follow-up|1
2540380|NCT01538199|8793151|P2|Overall Study|Lost to Follow-up|2
2540381|NCT01538199|8793152|P1|Overall Study|Lost to Follow-up|1
2540382|NCT01537887|8793186|P6|Period 3|Withdrawal by Subject|0
2540383|NCT01537887|8793187|P5|Period 3|Withdrawal by Subject|0
2540384|NCT01537887|8793188|P4|Period 3|Withdrawal by Subject|0
2540385|NCT01537887|8793189|P3|Period 3|Withdrawal by Subject|0
2540386|NCT01537887|8793190|P2|Period 3|Withdrawal by Subject|1
2540387|NCT01537887|8793191|P1|Period 3|Withdrawal by Subject|0
2540388|NCT01537887|8793186|P6|Period 3|Adverse Event|0
2540389|NCT01537887|8793187|P5|Period 3|Adverse Event|0
2540390|NCT01537887|8793188|P4|Period 3|Adverse Event|0
2540391|NCT01537887|8793189|P3|Period 3|Adverse Event|1
2540392|NCT01537887|8793190|P2|Period 3|Adverse Event|0
2540393|NCT01537887|8793191|P1|Period 3|Adverse Event|0
2540394|NCT01537887|8793186|P6|Period 2|Withdrawal by Subject|0
2540395|NCT01537887|8793187|P5|Period 2|Withdrawal by Subject|0
2540396|NCT01537887|8793188|P4|Period 2|Withdrawal by Subject|0
2540397|NCT01537887|8793189|P3|Period 2|Withdrawal by Subject|0
2540398|NCT01537887|8793190|P2|Period 2|Withdrawal by Subject|1
2540399|NCT01537887|8793191|P1|Period 2|Withdrawal by Subject|0
2540400|NCT01537887|8793186|P6|Period 1|Did not receive treatment|0
2540401|NCT01537887|8793187|P5|Period 1|Did not receive treatment|0
2540402|NCT01537887|8793188|P4|Period 1|Did not receive treatment|0
2540403|NCT01537887|8793189|P3|Period 1|Did not receive treatment|1
2540404|NCT01537887|8793190|P2|Period 1|Did not receive treatment|0
2540405|NCT01537887|8793191|P1|Period 1|Did not receive treatment|0
2540406|NCT01537887|8793186|P6|Period 1|Physician Decision|1
2540407|NCT01537887|8793187|P5|Period 1|Physician Decision|1
2540408|NCT01537887|8793188|P4|Period 1|Physician Decision|0
2540409|NCT01537887|8793189|P3|Period 1|Physician Decision|0
2540410|NCT01537887|8793190|P2|Period 1|Physician Decision|0
2540411|NCT01537887|8793191|P1|Period 1|Physician Decision|0
2540412|NCT01537783|8793220|P2|Overall Study|Lost to Follow-up|2
2540413|NCT01537783|8793221|P1|Overall Study|Lost to Follow-up|11
2540414|NCT01537549|8793272|P1|Overall Study|Withdrawal by Subject|2
2540415|NCT01537549|8793272|P1|Overall Study|Lost to Follow-up|1
2540416|NCT01537432|8793280|P2|Overall Study|Unsatisfactory therapeutic effect|0
2540417|NCT01537432|8793281|P1|Overall Study|Unsatisfactory therapeutic effect|1
2540418|NCT01537432|8793280|P2|Overall Study|Adverse Event|0
2540419|NCT01537432|8793281|P1|Overall Study|Adverse Event|1
2540420|NCT01537432|8793280|P2|Overall Study|Administrative problems|0
2540421|NCT01537432|8793281|P1|Overall Study|Administrative problems|1
2540422|NCT01537432|8793280|P2|Overall Study|Withdrawal by Subject|1
2540423|NCT01537432|8793281|P1|Overall Study|Withdrawal by Subject|0
2540424|NCT01537432|8793280|P2|Overall Study|Lost to Follow-up|1
2540425|NCT01537432|8793281|P1|Overall Study|Lost to Follow-up|3
2540426|NCT01537393|8793304|P2|Overall Study|Censored (severe event unrelated to PT)|1
2540427|NCT01537393|8793305|P1|Overall Study|Censored (severe event unrelated to PT)|1
2540428|NCT01537393|8793304|P2|Overall Study|Failure - Not regrafted|6
2540429|NCT01537393|8793305|P1|Overall Study|Failure - Not regrafted|2
2540430|NCT01537393|8793304|P2|Overall Study|Failure - Regrafted|43
2540431|NCT01537393|8793305|P1|Overall Study|Failure - Regrafted|28
2540432|NCT01537393|8793304|P2|Overall Study|Lost to Follow-up|48
2540433|NCT01537393|8793305|P1|Overall Study|Lost to Follow-up|53
2540434|NCT01537393|8793304|P2|Overall Study|Withdrawal by Subject|17
2540435|NCT01537393|8793305|P1|Overall Study|Withdrawal by Subject|18
2540436|NCT01537393|8793304|P2|Overall Study|Death|32
2540437|NCT01537393|8793305|P1|Overall Study|Death|20
2540438|NCT01537393|8793304|P2|Overall Study|Exclude prior to study|44
2540439|NCT01537393|8793305|P1|Overall Study|Exclude prior to study|32
2540440|NCT01537302|8793341|P1|Overall Study|Withdrawal by Subject|1
2540441|NCT01537302|8793341|P1|Overall Study|Lost to Follow-up|1
2540442|NCT01537211|8793350|P2|Overall Study|Lost to Follow-up|1
2540443|NCT01537211|8793351|P1|Overall Study|Lost to Follow-up|0
2540444|NCT01537198|8793385|P1|Overall Study|Other|111
2540445|NCT01537198|8793385|P1|Overall Study|No Further Visits to the Clinic|37
2540446|NCT01537198|8793385|P1|Overall Study|Adverse Event|4
2540447|NCT01537198|8793385|P1|Overall Study|RSV infection|2
2540448|NCT01537133|8793414|P4|Overall Study|Lost to Follow-up|0
2540449|NCT01537133|8793415|P3|Overall Study|Lost to Follow-up|0
2540450|NCT01537133|8793416|P2|Overall Study|Lost to Follow-up|0
2540451|NCT01537133|8793417|P1|Overall Study|Lost to Follow-up|1
2540452|NCT01537133|8793414|P4|Overall Study|Withdrawal by Subject|0
2540453|NCT01537133|8793415|P3|Overall Study|Withdrawal by Subject|0
2540454|NCT01537133|8793416|P2|Overall Study|Withdrawal by Subject|0
2540455|NCT01537133|8793417|P1|Overall Study|Withdrawal by Subject|2
2540456|NCT01537120|8793433|P1|3 Weeks Placebo|Withdrawal by Subject|1
2540457|NCT01537120|8793433|P1|8 Weeks Washout|Inclusion/exclusion criteria not met|1
2540458|NCT01537081|8793446|P3|Overall Study|Assigned but never dosed|0
2540459|NCT01537081|8793447|P2|Overall Study|Assigned but never dosed|0
2540460|NCT01537081|8793448|P1|Overall Study|Assigned but never dosed|1
2540461|NCT01537081|8793446|P3|Overall Study|Sponsor decision|0
2540462|NCT01537081|8793447|P2|Overall Study|Sponsor decision|1
2540463|NCT01537081|8793448|P1|Overall Study|Sponsor decision|0
2540464|NCT01537081|8793446|P3|Overall Study|Physician Decision|0
2540465|NCT01537081|8793447|P2|Overall Study|Physician Decision|6
2540466|NCT01537081|8793448|P1|Overall Study|Physician Decision|5
2540467|NCT01537081|8793446|P3|Overall Study|Withdrawal by Subject|3
2540468|NCT01537081|8793447|P2|Overall Study|Withdrawal by Subject|11
2540469|NCT01537081|8793448|P1|Overall Study|Withdrawal by Subject|6
2540470|NCT01537081|8793446|P3|Overall Study|Protocol Violation|2
2540471|NCT01537081|8793447|P2|Overall Study|Protocol Violation|2
2540472|NCT01537081|8793448|P1|Overall Study|Protocol Violation|3
2540473|NCT01537081|8793446|P3|Overall Study|Lost to Follow-up|9
2540474|NCT01537081|8793447|P2|Overall Study|Lost to Follow-up|15
2540475|NCT01537081|8793448|P1|Overall Study|Lost to Follow-up|17
2540476|NCT01537081|8793446|P3|Overall Study|Lack of Efficacy|0
2540477|NCT01537081|8793447|P2|Overall Study|Lack of Efficacy|1
2540478|NCT01537081|8793448|P1|Overall Study|Lack of Efficacy|2
2540479|NCT01537081|8793446|P3|Overall Study|Adverse Event|2
2540480|NCT01537081|8793447|P2|Overall Study|Adverse Event|2
2540481|NCT01537081|8793448|P1|Overall Study|Adverse Event|5
2540482|NCT01537068|8793461|P2|Overall Study|Lack of Efficacy|0
2540483|NCT01537068|8793462|P1|Overall Study|Lack of Efficacy|1
2540484|NCT01537068|8793461|P2|Overall Study|Withdrawal by Subject|1
2540485|NCT01537068|8793462|P1|Overall Study|Withdrawal by Subject|1
2540486|NCT01537068|8793461|P2|Overall Study|Adverse Event|1
2540487|NCT01537068|8793462|P1|Overall Study|Adverse Event|0
2540488|NCT01537068|8793461|P2|Overall Study|Lost to Follow-up|1
2540489|NCT01537068|8793462|P1|Overall Study|Lost to Follow-up|2
2540490|NCT01537042|8793474|P2|Overall Study|Other|1
2540491|NCT01537042|8793475|P1|Overall Study|Other|0
2540492|NCT01537042|8793474|P2|Overall Study|Protocol Violation|1
2540493|NCT01537042|8793475|P1|Overall Study|Protocol Violation|0
2540494|NCT01537042|8793474|P2|Overall Study|Lack of Efficacy|1
2540495|NCT01537042|8793475|P1|Overall Study|Lack of Efficacy|0
2540496|NCT01537042|8793474|P2|Overall Study|Adverse Event|2
2540497|NCT01537042|8793475|P1|Overall Study|Adverse Event|0
2540498|NCT01536951|8793517|P9|Second Intervention and Washout Period 2|Adverse Event|0
2540499|NCT01536951|8793518|P8|Second Intervention and Washout Period 2|Adverse Event|1
2540500|NCT01536951|8793519|P7|Second Intervention and Washout Period 2|Adverse Event|0
2540501|NCT01536951|8793520|P6|Second Intervention and Washout Period 2|Adverse Event|0
2540502|NCT01536951|8793521|P5|Second Intervention and Washout Period 2|Adverse Event|0
2540503|NCT01536951|8793522|P4|Second Intervention and Washout Period 2|Adverse Event|0
2540504|NCT01536951|8793523|P3|Second Intervention and Washout Period 2|Adverse Event|0
2540505|NCT01536951|8793524|P2|Second Intervention and Washout Period 2|Adverse Event|0
2540506|NCT01536951|8793525|P1|Second Intervention and Washout Period 2|Adverse Event|0
2540507|NCT01536951|8793517|P9|First Intervention and Washout Period 1|Withdrawal by Subject|0
2540508|NCT01536951|8793518|P8|First Intervention and Washout Period 1|Withdrawal by Subject|0
2540509|NCT01536951|8793519|P7|First Intervention and Washout Period 1|Withdrawal by Subject|0
2540510|NCT01536951|8793520|P6|First Intervention and Washout Period 1|Withdrawal by Subject|0
2540511|NCT01536951|8793521|P5|First Intervention and Washout Period 1|Withdrawal by Subject|0
2540512|NCT01536951|8793522|P4|First Intervention and Washout Period 1|Withdrawal by Subject|0
2540513|NCT01536951|8793523|P3|First Intervention and Washout Period 1|Withdrawal by Subject|1
2540514|NCT01536951|8793524|P2|First Intervention and Washout Period 1|Withdrawal by Subject|0
2540515|NCT01536951|8793525|P1|First Intervention and Washout Period 1|Withdrawal by Subject|0
2540516|NCT01536860|8793582|P3|Washout Period (3 Days)|Lost to Follow-up|0
2540517|NCT01536860|8793583|P2|Washout Period (3 Days)|Lost to Follow-up|0
2540518|NCT01536860|8793584|P1|Washout Period (3 Days)|Lost to Follow-up|1
2540519|NCT01536704|8793592|P4|Washout Period 3|Adverse Event|0
2540520|NCT01536704|8793593|P3|Washout Period 3|Adverse Event|1
2540521|NCT01536704|8793594|P2|Washout Period 3|Adverse Event|0
2540522|NCT01536704|8793595|P1|Washout Period 3|Adverse Event|0
2540523|NCT01536704|8793592|P4|Period 3|Adverse Event|1
2540524|NCT01536704|8793593|P3|Period 3|Adverse Event|0
2540525|NCT01536704|8793594|P2|Period 3|Adverse Event|0
2540526|NCT01536704|8793595|P1|Period 3|Adverse Event|0
2540527|NCT01536704|8793592|P4|Washout Period 2|Withdrawal by Subject|1
2540528|NCT01536704|8793593|P3|Washout Period 2|Withdrawal by Subject|0
2540529|NCT01536704|8793594|P2|Washout Period 2|Withdrawal by Subject|0
2540530|NCT01536704|8793595|P1|Washout Period 2|Withdrawal by Subject|0
2540531|NCT01536704|8793592|P4|Washout Period 2|Adverse Event|0
2540532|NCT01536704|8793593|P3|Washout Period 2|Adverse Event|0
2540533|NCT01536704|8793594|P2|Washout Period 2|Adverse Event|0
2540534|NCT01536704|8793595|P1|Washout Period 2|Adverse Event|1
2540535|NCT01536704|8793592|P4|Washout Period 1|Withdrawal by Subject|0
2540536|NCT01536704|8793593|P3|Washout Period 1|Withdrawal by Subject|0
2540537|NCT01536704|8793594|P2|Washout Period 1|Withdrawal by Subject|2
2540538|NCT01536704|8793595|P1|Washout Period 1|Withdrawal by Subject|1
2540539|NCT01536587|8793625|P1|Overall Study|Adverse Event|2
2540540|NCT01536574|8793664|P2|Overall Study|Lack of Efficacy|0
2540541|NCT01536574|8793665|P1|Overall Study|Lack of Efficacy|1
2540542|NCT01536574|8793664|P2|Overall Study|Withdrawal by Subject|2
2540543|NCT01536574|8793665|P1|Overall Study|Withdrawal by Subject|1
2540544|NCT01536574|8793664|P2|Overall Study|Adverse Event|5
2540545|NCT01536574|8793665|P1|Overall Study|Adverse Event|4
2540546|NCT01536561|8793683|P1|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13
2540547|NCT01536561|8793683|P1|Dosimetric and Therapeutic Treatment|Death|2
2540548|NCT01536561|8793683|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1
2540549|NCT01536561|8793683|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
2540550|NCT01536561|8793683|P1|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2
2540551|NCT01536561|8793683|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|40
2540552|NCT01536535|8793723|P2|Overall Study|Participant moved|1
2540553|NCT01536535|8793724|P1|Overall Study|Participant moved|0
2540554|NCT01536535|8793723|P2|Overall Study|Physician Decision|1
2540555|NCT01536535|8793724|P1|Overall Study|Physician Decision|1
2540556|NCT01536535|8793723|P2|Overall Study|Lost to Follow-up|6
2540557|NCT01536535|8793724|P1|Overall Study|Lost to Follow-up|4
2540558|NCT01536535|8793723|P2|Overall Study|Withdrawal by Subject|5
2540559|NCT01536535|8793724|P1|Overall Study|Withdrawal by Subject|10
2540560|NCT01536418|8793773|P2|Overall Study|Withdrawal by Subject|3
2540561|NCT01536418|8793774|P1|Overall Study|Withdrawal by Subject|5
2540562|NCT01536418|8793773|P2|Overall Study|Met Liver Chemistry Stopping criteria|0
2540563|NCT01536418|8793774|P1|Overall Study|Met Liver Chemistry Stopping criteria|1
2540564|NCT01536418|8793773|P2|Overall Study|Adverse Event|4
2540565|NCT01536418|8793774|P1|Overall Study|Adverse Event|9
2540566|NCT01536418|8793773|P2|Overall Study|Lack of Efficacy|16
2540567|NCT01536418|8793774|P1|Overall Study|Lack of Efficacy|10
2540568|NCT01536418|8793773|P2|Overall Study|Study closed/terminated|37
2540569|NCT01536418|8793774|P1|Overall Study|Study closed/terminated|41
2540570|NCT01536418|8793773|P2|Overall Study|Physician Decision|3
2540571|NCT01536418|8793774|P1|Overall Study|Physician Decision|1
2540572|NCT01536418|8793773|P2|Overall Study|Protocol Violation|3
2540573|NCT01536418|8793774|P1|Overall Study|Protocol Violation|2
2540574|NCT01536405|8793794|P2|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
2540575|NCT01536405|8793795|P1|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
2540576|NCT01536405|8793794|P2|Visit 4 to Extended Study Follow-up|Adverse Event|1
2540577|NCT01536405|8793795|P1|Visit 4 to Extended Study Follow-up|Adverse Event|0
2540578|NCT01536405|8793794|P2|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2
2540579|NCT01536405|8793795|P1|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0
2540580|NCT01536405|8793794|P2|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14
2540581|NCT01536405|8793795|P1|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16
2540582|NCT01536405|8793794|P2|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0
2540583|NCT01536405|8793795|P1|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1
2540584|NCT01536405|8793794|P2|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2
2540585|NCT01536405|8793795|P1|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3
2540586|NCT01536405|8793794|P2|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
2540587|NCT01536405|8793795|P1|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
2540588|NCT01536405|8793794|P2|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10
2540589|NCT01536405|8793795|P1|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9
2540590|NCT01536405|8793794|P2|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
2540591|NCT01536405|8793795|P1|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
2540592|NCT01536405|8793794|P2|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13
2540593|NCT01536405|8793795|P1|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17
2540594|NCT01536405|8793794|P2|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22
2540595|NCT01536405|8793795|P1|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20
2540596|NCT01536405|8793794|P2|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18
2540597|NCT01536405|8793795|P1|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12
2540598|NCT01536405|8793794|P2|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4
2540599|NCT01536405|8793795|P1|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8
2540600|NCT01536379|8793833|P2|Overall Study|Withdrawal by Subject|1
2540601|NCT01536379|8793834|P1|Overall Study|Withdrawal by Subject|1
2540602|NCT01536379|8793833|P2|Overall Study|Adverse Event|2
2540603|NCT01536379|8793834|P1|Overall Study|Adverse Event|1
2540604|NCT01536262|8793926|P3|Overall Study|Other than stated above|0
2540605|NCT01536262|8793927|P2|Overall Study|Other than stated above|0
2540606|NCT01536262|8793928|P1|Overall Study|Other than stated above|1
2540607|NCT01536262|8793926|P3|Overall Study|Withdrawal by Subject|0
2540608|NCT01536262|8793927|P2|Overall Study|Withdrawal by Subject|1
2540609|NCT01536262|8793928|P1|Overall Study|Withdrawal by Subject|1
2540610|NCT01536262|8793926|P3|Overall Study|Adverse Event|2
2540611|NCT01536262|8793927|P2|Overall Study|Adverse Event|1
2540612|NCT01536262|8793928|P1|Overall Study|Adverse Event|6
2540613|NCT01536171|8793970|P1|Overall Study|Withdrawal by Subject|1
2540614|NCT01536145|8793975|P11|Overall Study|Adverse Event|3
2540615|NCT01536145|8793976|P10|Overall Study|Adverse Event|0
2540616|NCT01536145|8793977|P9|Overall Study|Adverse Event|0
2540617|NCT01536145|8793978|P8|Overall Study|Adverse Event|2
2540618|NCT01536145|8793979|P7|Overall Study|Adverse Event|0
2540619|NCT01536145|8793980|P6|Overall Study|Adverse Event|0
2540620|NCT01536145|8793981|P5|Overall Study|Adverse Event|0
2540621|NCT01536145|8793982|P4|Overall Study|Adverse Event|0
2540622|NCT01536145|8793983|P3|Overall Study|Adverse Event|0
2540623|NCT01536145|8793984|P2|Overall Study|Adverse Event|0
2540624|NCT01536145|8793985|P1|Overall Study|Adverse Event|0
2540625|NCT01536145|8793975|P11|Overall Study|Death|0
2540626|NCT01536145|8793976|P10|Overall Study|Death|0
2540627|NCT01536145|8793977|P9|Overall Study|Death|0
2540628|NCT01536145|8793978|P8|Overall Study|Death|0
2540629|NCT01536145|8793979|P7|Overall Study|Death|1
2540630|NCT01536145|8793980|P6|Overall Study|Death|0
2540631|NCT01536145|8793981|P5|Overall Study|Death|0
2540632|NCT01536145|8793982|P4|Overall Study|Death|0
2540633|NCT01536145|8793983|P3|Overall Study|Death|0
2540634|NCT01536145|8793984|P2|Overall Study|Death|0
2540635|NCT01536145|8793985|P1|Overall Study|Death|0
2540636|NCT01536145|8793975|P11|Overall Study|Other|2
2540637|NCT01536145|8793976|P10|Overall Study|Other|3
2540638|NCT01536145|8793977|P9|Overall Study|Other|0
2540639|NCT01536145|8793978|P8|Overall Study|Other|0
2540640|NCT01536145|8793979|P7|Overall Study|Other|0
2540641|NCT01536145|8793980|P6|Overall Study|Other|0
2540642|NCT01536145|8793981|P5|Overall Study|Other|1
2540643|NCT01536145|8793982|P4|Overall Study|Other|0
2540644|NCT01536145|8793983|P3|Overall Study|Other|0
2540645|NCT01536145|8793984|P2|Overall Study|Other|0
2540646|NCT01536145|8793985|P1|Overall Study|Other|0
2540647|NCT01536145|8793975|P11|Overall Study|Withdrawal by Subject|2
2540648|NCT01536145|8793976|P10|Overall Study|Withdrawal by Subject|0
2540649|NCT01536145|8793977|P9|Overall Study|Withdrawal by Subject|2
2540650|NCT01536145|8793978|P8|Overall Study|Withdrawal by Subject|0
2540651|NCT01536145|8793979|P7|Overall Study|Withdrawal by Subject|0
2540652|NCT01536145|8793980|P6|Overall Study|Withdrawal by Subject|1
2540653|NCT01536145|8793981|P5|Overall Study|Withdrawal by Subject|0
2540654|NCT01536145|8793982|P4|Overall Study|Withdrawal by Subject|0
2540655|NCT01536145|8793983|P3|Overall Study|Withdrawal by Subject|1
2540656|NCT01536145|8793984|P2|Overall Study|Withdrawal by Subject|0
2540657|NCT01536145|8793985|P1|Overall Study|Withdrawal by Subject|0
2540658|NCT01536145|8793975|P11|Overall Study|Progressive disease|3
2540659|NCT01536145|8793976|P10|Overall Study|Progressive disease|3
2540660|NCT01536145|8793977|P9|Overall Study|Progressive disease|1
2540661|NCT01536145|8793978|P8|Overall Study|Progressive disease|2
2540662|NCT01536145|8793979|P7|Overall Study|Progressive disease|1
2540663|NCT01536145|8793980|P6|Overall Study|Progressive disease|2
2540664|NCT01536145|8793981|P5|Overall Study|Progressive disease|1
2540665|NCT01536145|8793982|P4|Overall Study|Progressive disease|2
2540666|NCT01536145|8793983|P3|Overall Study|Progressive disease|1
2540667|NCT01536145|8793984|P2|Overall Study|Progressive disease|4
2540668|NCT01536145|8793985|P1|Overall Study|Progressive disease|3
2540669|NCT01536119|8794092|P2|Overall Study|Lost to Follow-up|14
2540670|NCT01536119|8794093|P1|Overall Study|Lost to Follow-up|17
2540671|NCT01536093|8794119|P2|Overall Study|Withdrawal by Subject|1
2540672|NCT01536093|8794120|P1|Overall Study|Withdrawal by Subject|0
2540673|NCT01536093|8794119|P2|Overall Study|absence of maternal colostrum|0
2540674|NCT01536093|8794120|P1|Overall Study|absence of maternal colostrum|2
2540675|NCT01536093|8794119|P2|Overall Study|Death|2
2540676|NCT01536093|8794120|P1|Overall Study|Death|1
2540677|NCT01536067|8794136|P1|Overall Study|Disease Progression|1
2540678|NCT01536015|8794149|P2|Overall Study|Study closure|5
2540679|NCT01536015|8794150|P1|Overall Study|Study closure|5
2540680|NCT01536015|8794149|P2|Overall Study|Inclusion Criterion not met|0
2540681|NCT01536015|8794150|P1|Overall Study|Inclusion Criterion not met|2
2540682|NCT01536015|8794149|P2|Overall Study|Lost to Follow-up|1
2540683|NCT01536015|8794150|P1|Overall Study|Lost to Follow-up|0
2540684|NCT01536015|8794149|P2|Overall Study|Adverse Event|4
2540685|NCT01536015|8794150|P1|Overall Study|Adverse Event|1
2540686|NCT01535807|8794188|P2|Overall Study|Data collection error|1
2540687|NCT01535807|8794189|P1|Overall Study|Data collection error|1
2540688|NCT01535807|8794188|P2|Overall Study|Withdrawal by Subject|1
2540689|NCT01535807|8794189|P1|Overall Study|Withdrawal by Subject|1
2540690|NCT01535729|8794195|P1|Overall Study|No participant record available|5
2540691|NCT01535729|8794195|P1|Overall Study|Not treated|9
2540692|NCT01535729|8794195|P1|Overall Study|Screening failure|1
2540693|NCT01535729|8794195|P1|Overall Study|Protocol Violation|11
2540694|NCT01535729|8794195|P1|Overall Study|NSCLC grade IV histology not confirmed|20
2540695|NCT01535729|8794195|P1|Overall Study|No previous chemotherapy|33
2540696|NCT01535729|8794195|P1|Overall Study|Did not sign informed consent|1
2540697|NCT01535729|8794195|P1|Overall Study|Other|19
2540698|NCT01535729|8794195|P1|Overall Study|Death|52
2540699|NCT01535729|8794195|P1|Overall Study|Lost to Follow-up|8
2540700|NCT01535729|8794195|P1|Overall Study|Discontinued treatment|25
2540701|NCT01535729|8794195|P1|Overall Study|Disease progression|230
2540702|NCT01535729|8794195|P1|Overall Study|Withdrawal by Subject|2
2540703|NCT01535638|8794236|P6|Treatment 3 (Single Dose)|Protocol Violation|0
2540704|NCT01535638|8794237|P5|Treatment 3 (Single Dose)|Protocol Violation|0
2540705|NCT01535638|8794238|P4|Treatment 3 (Single Dose)|Protocol Violation|1
2540706|NCT01535638|8794239|P3|Treatment 3 (Single Dose)|Protocol Violation|0
2540707|NCT01535638|8794240|P2|Treatment 3 (Single Dose)|Protocol Violation|0
2540708|NCT01535638|8794241|P1|Treatment 3 (Single Dose)|Protocol Violation|0
2540709|NCT01535638|8794236|P6|Treatment 1 (Single Dose)|Protocol Violation|1
2540710|NCT01535638|8794237|P5|Treatment 1 (Single Dose)|Protocol Violation|0
2540711|NCT01535638|8794238|P4|Treatment 1 (Single Dose)|Protocol Violation|0
2540712|NCT01535638|8794239|P3|Treatment 1 (Single Dose)|Protocol Violation|0
2540713|NCT01535638|8794240|P2|Treatment 1 (Single Dose)|Protocol Violation|0
2540714|NCT01535638|8794241|P1|Treatment 1 (Single Dose)|Protocol Violation|0
2540715|NCT01535599|8794255|P2|Overall Study|Noncompliance|1
2540716|NCT01535599|8794256|P1|Overall Study|Noncompliance|0
2540717|NCT01535599|8794255|P2|Overall Study|Stopped medication|1
2540718|NCT01535599|8794256|P1|Overall Study|Stopped medication|0
2540719|NCT01535599|8794255|P2|Overall Study|Other|0
2540720|NCT01535599|8794256|P1|Overall Study|Other|1
2540721|NCT01535599|8794255|P2|Overall Study|Did not use product|0
2540722|NCT01535599|8794256|P1|Overall Study|Did not use product|1
2540723|NCT01535599|8794255|P2|Overall Study|Randomized in Error|4
2540724|NCT01535599|8794256|P1|Overall Study|Randomized in Error|2
2540725|NCT01535599|8794255|P2|Overall Study|BL Culture + for Yeast//Fungi|1
2540726|NCT01535599|8794256|P1|Overall Study|BL Culture + for Yeast//Fungi|0
2540727|NCT01535599|8794255|P2|Overall Study|BL Culture + for Group A Strep|1
2540728|NCT01535599|8794256|P1|Overall Study|BL Culture + for Group A Strep|0
2540729|NCT01535599|8794255|P2|Overall Study|Treatment Failure|66
2540730|NCT01535599|8794256|P1|Overall Study|Treatment Failure|33
2540731|NCT01535599|8794255|P2|Overall Study|Subj Decision Unrelated to Adverse Event|3
2540732|NCT01535599|8794256|P1|Overall Study|Subj Decision Unrelated to Adverse Event|4
2540733|NCT01535599|8794255|P2|Overall Study|Lost to Follow-up|4
2540734|NCT01535599|8794256|P1|Overall Study|Lost to Follow-up|3
2540735|NCT01535599|8794255|P2|Overall Study|Adverse Event|15
2540736|NCT01535599|8794256|P1|Overall Study|Adverse Event|6
2540737|NCT01535560|8794268|P2|Overall Study|Randomized in Error|1
2540738|NCT01535560|8794269|P1|Overall Study|Randomized in Error|0
2540739|NCT01535560|8794268|P2|Overall Study|Other|1
2540740|NCT01535560|8794269|P1|Overall Study|Other|0
2540741|NCT01535560|8794268|P2|Overall Study|Treatment Failure|83
2540742|NCT01535560|8794269|P1|Overall Study|Treatment Failure|21
2540743|NCT01535560|8794268|P2|Overall Study|Subj Decision Unrel to an Adverse Event|1
2540744|NCT01535560|8794269|P1|Overall Study|Subj Decision Unrel to an Adverse Event|3
2540745|NCT01535560|8794268|P2|Overall Study|Lost to Follow-up|3
2540746|NCT01535560|8794269|P1|Overall Study|Lost to Follow-up|1
2540747|NCT01535560|8794268|P2|Overall Study|Adverse Event|7
2540748|NCT01535560|8794269|P1|Overall Study|Adverse Event|12
2540749|NCT01535443|8794279|P1|Overall Study|Physician Decision|3
2540750|NCT01535287|8794329|P2|Overall Study|drug not prepared in time|6
2540751|NCT01535287|8794330|P1|Overall Study|drug not prepared in time|5
2540752|NCT01535261|8794346|P1|Overall Study|Adverse Event|12
2540753|NCT01535261|8794346|P1|Overall Study|Withdrawal by Subject|14
2540754|NCT01535261|8794346|P1|Overall Study|Lost to Follow-up|8
2540755|NCT01535261|8794346|P1|Overall Study|Death|5
2540756|NCT01535261|8794346|P1|Overall Study|Protocol Violation|3
2540757|NCT01535261|8794346|P1|Overall Study|Physician Decision|8
2540758|NCT01535235|8794359|P2|Overall Study|Adverse Event|0
2540759|NCT01535235|8794360|P1|Overall Study|Adverse Event|1
2540760|NCT01535222|8794374|P6|Overall Study|Inclusion/exclusion|0
2540761|NCT01535222|8794375|P5|Overall Study|Inclusion/exclusion|0
2540762|NCT01535222|8794376|P4|Overall Study|Inclusion/exclusion|0
2540763|NCT01535222|8794377|P3|Overall Study|Inclusion/exclusion|1
2540764|NCT01535222|8794378|P2|Overall Study|Inclusion/exclusion|0
2540765|NCT01535222|8794379|P1|Overall Study|Inclusion/exclusion|0
2540766|NCT01535053|8794410|P2|Overall Study|Ineligible|2
2540767|NCT01535053|8794411|P1|Overall Study|Ineligible|1
2540768|NCT01535040|8794429|P2|Overall Study|Multiple Reasons|1
2540769|NCT01535040|8794430|P1|Overall Study|Multiple Reasons|1
2540770|NCT01535040|8794429|P2|Overall Study|Toxicity|5
2540771|NCT01535040|8794430|P1|Overall Study|Toxicity|7
2540772|NCT01535040|8794429|P2|Overall Study|Never Started|4
2540773|NCT01535040|8794430|P1|Overall Study|Never Started|9
2540774|NCT01535040|8794429|P2|Overall Study|Withdrawal by Subject|10
2540775|NCT01535040|8794430|P1|Overall Study|Withdrawal by Subject|13
2540776|NCT01535040|8794429|P2|Overall Study|Physician Decision|1
2540777|NCT01535040|8794430|P1|Overall Study|Physician Decision|0
2540778|NCT01534962|8794527|P4|Overall Study|Discontinued at AF recurrence|31
2540779|NCT01534962|8794528|P3|Overall Study|Discontinued at AF recurrence|24
2540780|NCT01534962|8794529|P2|Overall Study|Discontinued at AF recurrence|26
2540781|NCT01534962|8794530|P1|Overall Study|Discontinued at AF recurrence|35
2540782|NCT01534962|8794527|P4|Overall Study|Randomized but did not start treatment|1
2540783|NCT01534962|8794528|P3|Overall Study|Randomized but did not start treatment|0
2540784|NCT01534962|8794529|P2|Overall Study|Randomized but did not start treatment|0
2540785|NCT01534962|8794530|P1|Overall Study|Randomized but did not start treatment|2
2540786|NCT01534676|8794587|P2|Overall Study|Study closed due to poor enrollment|1
2540787|NCT01534676|8794588|P1|Overall Study|Study closed due to poor enrollment|2
2540788|NCT01534637|8794594|P1|Overall Study|Liver Mets before treatment|1
2540789|NCT01534637|8794594|P1|Overall Study|Adverse Event|1
2540790|NCT01534637|8794594|P1|Overall Study|Withdrawal by Subject|1
2540791|NCT01534637|8794594|P1|Overall Study|Lack of Efficacy|3
2540792|NCT01534637|8794594|P1|Overall Study|Physician Decision|3
2540793|NCT01534533|8794604|P4|Overall Study|Withdrawal by Subject|1
2540794|NCT01534533|8794605|P3|Overall Study|Withdrawal by Subject|4
2540795|NCT01534533|8794606|P2|Overall Study|Withdrawal by Subject|3
2540796|NCT01534533|8794607|P1|Overall Study|Withdrawal by Subject|5
2540797|NCT01534533|8794604|P4|Overall Study|Lost to Follow-up|3
2540798|NCT01534533|8794605|P3|Overall Study|Lost to Follow-up|4
2540799|NCT01534533|8794606|P2|Overall Study|Lost to Follow-up|0
2540800|NCT01534533|8794607|P1|Overall Study|Lost to Follow-up|3
2540801|NCT01534520|8794635|P2|Overall Study|Adverse Event|1
2540802|NCT01534520|8794636|P1|Overall Study|Adverse Event|0
2540803|NCT01534351|8794670|P3|Overall Study|Study Terminated Early|0
2540804|NCT01534351|8794671|P2|Overall Study|Study Terminated Early|0
2540805|NCT01534351|8794672|P1|Overall Study|Study Terminated Early|1
2540806|NCT01534273|8794693|P7|Period 1|Physician Decision|0
2540807|NCT01534273|8794694|P6|Period 1|Physician Decision|0
2540808|NCT01534273|8794695|P5|Period 1|Physician Decision|0
2540809|NCT01534273|8794696|P4|Period 1|Physician Decision|1
2540810|NCT01534273|8794697|P3|Period 1|Physician Decision|0
2540811|NCT01534273|8794698|P2|Period 1|Physician Decision|0
2540812|NCT01534273|8794699|P1|Period 1|Physician Decision|0
2540813|NCT01534260|8794726|P2|Overall Study|No treatment, per protocol|1
2540814|NCT01534260|8794727|P1|Overall Study|No treatment, per protocol|0
2540815|NCT01534260|8794726|P2|Overall Study|Physician Decision|1
2540816|NCT01534260|8794727|P1|Overall Study|Physician Decision|3
2540817|NCT01534260|8794726|P2|Overall Study|Disease Progression|6
2540818|NCT01534260|8794727|P1|Overall Study|Disease Progression|8
2540819|NCT01534260|8794726|P2|Overall Study|Withdrawal by Subject|3
2540820|NCT01534260|8794727|P1|Overall Study|Withdrawal by Subject|1
2540821|NCT01534260|8794726|P2|Overall Study|Lack of Efficacy|1
2540822|NCT01534260|8794727|P1|Overall Study|Lack of Efficacy|1
2540823|NCT01534260|8794726|P2|Overall Study|Death|0
2540824|NCT01534260|8794727|P1|Overall Study|Death|2
2540825|NCT01534260|8794726|P2|Overall Study|Adverse Event|8
2540826|NCT01534260|8794727|P1|Overall Study|Adverse Event|1
2540827|NCT01534208|8794737|P2|Overall Study|Needed prohibited meds|0
2540828|NCT01534208|8794738|P1|Overall Study|Needed prohibited meds|1
2540829|NCT01534208|8794737|P2|Overall Study|PCP decision|0
2540830|NCT01534208|8794738|P1|Overall Study|PCP decision|1
2540831|NCT01534208|8794737|P2|Overall Study|Eligibility error|0
2540832|NCT01534208|8794738|P1|Overall Study|Eligibility error|3
2540833|NCT01534208|8794737|P2|Overall Study|Lab assessment|1
2540834|NCT01534208|8794738|P1|Overall Study|Lab assessment|2
2540835|NCT01534208|8794737|P2|Overall Study|Subject relocation|0
2540836|NCT01534208|8794738|P1|Overall Study|Subject relocation|2
2540837|NCT01534208|8794737|P2|Overall Study|Sponsor decision|1
2540838|NCT01534208|8794738|P1|Overall Study|Sponsor decision|4
2540839|NCT01534208|8794737|P2|Overall Study|Protocol Violation|2
2540840|NCT01534208|8794738|P1|Overall Study|Protocol Violation|2
2540841|NCT01534208|8794737|P2|Overall Study|Lack of Efficacy|3
2540842|NCT01534208|8794738|P1|Overall Study|Lack of Efficacy|0
2540843|NCT01534208|8794737|P2|Overall Study|Physician Decision|0
2540844|NCT01534208|8794738|P1|Overall Study|Physician Decision|2
2540845|NCT01534208|8794737|P2|Overall Study|Adverse Event|8
2540846|NCT01534208|8794738|P1|Overall Study|Adverse Event|15
2540847|NCT01534208|8794737|P2|Overall Study|Withdrawal by Subject|20
2540848|NCT01534208|8794738|P1|Overall Study|Withdrawal by Subject|6
2540849|NCT01534208|8794737|P2|Overall Study|Lost to Follow-up|14
2540850|NCT01534208|8794738|P1|Overall Study|Lost to Follow-up|19
2540851|NCT01534195|8794756|P2|Overall Study|Withdrawal by Subject|1
2540852|NCT01534195|8794757|P1|Overall Study|Withdrawal by Subject|1
2540853|NCT01534182|8794771|P2|Overall Study|Adverse Event|3
2540854|NCT01534182|8794772|P1|Overall Study|Adverse Event|7
2540855|NCT01534182|8794771|P2|Overall Study|Withdrawal by Subject|7
2540856|NCT01534182|8794772|P1|Overall Study|Withdrawal by Subject|4
2540857|NCT01534182|8794771|P2|Overall Study|Administrative problems|0
2540858|NCT01534182|8794772|P1|Overall Study|Administrative problems|1
2540859|NCT01534078|8794803|P1|Overall Study|Withdrawal by Subject|1
2540860|NCT01534078|8794803|P1|Overall Study|Death|1
2540861|NCT01533935|8794840|P5|Overall Study|Other reason not defined above|1
2540862|NCT01533935|8794841|P4|Overall Study|Other reason not defined above|0
2540863|NCT01533935|8794842|P3|Overall Study|Other reason not defined above|1
2540864|NCT01533935|8794843|P2|Overall Study|Other reason not defined above|0
2540865|NCT01533935|8794844|P1|Overall Study|Other reason not defined above|1
2540866|NCT01533935|8794840|P5|Overall Study|Withdrawal by Subject|4
2540867|NCT01533935|8794841|P4|Overall Study|Withdrawal by Subject|2
2540868|NCT01533935|8794842|P3|Overall Study|Withdrawal by Subject|5
2540869|NCT01533935|8794843|P2|Overall Study|Withdrawal by Subject|4
2540870|NCT01533935|8794844|P1|Overall Study|Withdrawal by Subject|0
2540871|NCT01533935|8794840|P5|Overall Study|Lost to Follow-up|0
2540872|NCT01533935|8794841|P4|Overall Study|Lost to Follow-up|0
2540873|NCT01533935|8794842|P3|Overall Study|Lost to Follow-up|1
2540874|NCT01533935|8794843|P2|Overall Study|Lost to Follow-up|0
2540875|NCT01533935|8794844|P1|Overall Study|Lost to Follow-up|0
2540876|NCT01533935|8794840|P5|Overall Study|Protocol Violation|0
2540877|NCT01533935|8794841|P4|Overall Study|Protocol Violation|0
2540878|NCT01533935|8794842|P3|Overall Study|Protocol Violation|0
2540879|NCT01533935|8794843|P2|Overall Study|Protocol Violation|2
2540880|NCT01533935|8794844|P1|Overall Study|Protocol Violation|0
2540881|NCT01533935|8794840|P5|Overall Study|Adverse Event|3
2540882|NCT01533935|8794841|P4|Overall Study|Adverse Event|5
2540883|NCT01533935|8794842|P3|Overall Study|Adverse Event|1
2540884|NCT01533935|8794843|P2|Overall Study|Adverse Event|7
2540885|NCT01533935|8794844|P1|Overall Study|Adverse Event|5
2540886|NCT01533922|8794871|P5|Overall Study|Other reason not defined above|0
2540887|NCT01533922|8794872|P4|Overall Study|Other reason not defined above|0
2540888|NCT01533922|8794873|P3|Overall Study|Other reason not defined above|1
2540889|NCT01533922|8794874|P2|Overall Study|Other reason not defined above|0
2540890|NCT01533922|8794875|P1|Overall Study|Other reason not defined above|2
2540891|NCT01533922|8794871|P5|Overall Study|Withdrawal by Subject|1
2540892|NCT01533922|8794872|P4|Overall Study|Withdrawal by Subject|2
2540893|NCT01533922|8794873|P3|Overall Study|Withdrawal by Subject|2
2540894|NCT01533922|8794874|P2|Overall Study|Withdrawal by Subject|1
2540895|NCT01533922|8794875|P1|Overall Study|Withdrawal by Subject|3
2540896|NCT01533922|8794871|P5|Overall Study|Protocol Violation|1
2540897|NCT01533922|8794872|P4|Overall Study|Protocol Violation|0
2540898|NCT01533922|8794873|P3|Overall Study|Protocol Violation|0
2540899|NCT01533922|8794874|P2|Overall Study|Protocol Violation|3
2540900|NCT01533922|8794875|P1|Overall Study|Protocol Violation|0
2540901|NCT01533922|8794871|P5|Overall Study|Lack of Efficacy|0
2540902|NCT01533922|8794872|P4|Overall Study|Lack of Efficacy|0
2540903|NCT01533922|8794873|P3|Overall Study|Lack of Efficacy|1
2540904|NCT01533922|8794874|P2|Overall Study|Lack of Efficacy|0
2540905|NCT01533922|8794875|P1|Overall Study|Lack of Efficacy|0
2540906|NCT01533922|8794871|P5|Overall Study|Adverse Event|4
2540907|NCT01533922|8794872|P4|Overall Study|Adverse Event|3
2540908|NCT01533922|8794873|P3|Overall Study|Adverse Event|6
2540909|NCT01533922|8794874|P2|Overall Study|Adverse Event|8
2540910|NCT01533922|8794875|P1|Overall Study|Adverse Event|5
2540911|NCT01533688|8794920|P3|Overall Study|Had colonoscopy at outside hospital|2
2540912|NCT01533688|8794921|P2|Overall Study|Had colonoscopy at outside hospital|3
2540913|NCT01533688|8794922|P1|Overall Study|Had colonoscopy at outside hospital|2
2540914|NCT01533688|8794920|P3|Overall Study|Medically unstable|3
2540915|NCT01533688|8794921|P2|Overall Study|Medically unstable|3
2540916|NCT01533688|8794922|P1|Overall Study|Medically unstable|1
2540917|NCT01533688|8794920|P3|Overall Study|Withdrawal by Subject|3
2540918|NCT01533688|8794921|P2|Overall Study|Withdrawal by Subject|4
2540919|NCT01533688|8794922|P1|Overall Study|Withdrawal by Subject|5
2540920|NCT01533493|8794954|P2|Overall Study|Lost to Follow-up|0
2540921|NCT01533493|8794955|P1|Overall Study|Lost to Follow-up|2
2540922|NCT01533493|8794954|P2|Overall Study|Withdrawal by Subject|2
2540923|NCT01533493|8794955|P1|Overall Study|Withdrawal by Subject|1
2540924|NCT01533493|8794954|P2|Overall Study|Adverse Event|1
2540925|NCT01533493|8794955|P1|Overall Study|Adverse Event|2
2540926|NCT01533428|8794963|P2|Overall Study|Withdrawal by Subject|6
2540927|NCT01533428|8794964|P1|Overall Study|Withdrawal by Subject|7
2540928|NCT01533428|8794963|P2|Overall Study|Lost to Follow-up|1
2540929|NCT01533428|8794964|P1|Overall Study|Lost to Follow-up|2
2540930|NCT01533428|8794963|P2|Overall Study|Adverse Event|1
2540931|NCT01533428|8794964|P1|Overall Study|Adverse Event|0
2540932|NCT01533246|8795010|P1|Overall Study|Withdrawal by Subject|1
2540933|NCT01533246|8795010|P1|Overall Study|Adverse Event|1
2540934|NCT01533181|8795034|P2|Overall Study|Patient withdrawal pre-active treatment|0
2540935|NCT01533181|8795035|P1|Overall Study|Patient withdrawal pre-active treatment|1
2540936|NCT01533181|8795034|P2|Overall Study|Disease progression pre-active treatment|1
2540937|NCT01533181|8795035|P1|Overall Study|Disease progression pre-active treatment|0
2540938|NCT01532999|8795152|P2|Overall Study|New job|2
2540939|NCT01532999|8795153|P1|Overall Study|New job|0
2540940|NCT01532999|8795152|P2|Overall Study|incarcerated|1
2540941|NCT01532999|8795153|P1|Overall Study|incarcerated|0
2540942|NCT01532999|8795152|P2|Overall Study|Adverse Event|1
2540943|NCT01532999|8795153|P1|Overall Study|Adverse Event|0
2540944|NCT01532999|8795152|P2|Overall Study|no show for week 9 assessments|4
2540945|NCT01532999|8795153|P1|Overall Study|no show for week 9 assessments|6
2540946|NCT01532999|8795152|P2|Overall Study|substantial noncompliance|0
2540947|NCT01532999|8795153|P1|Overall Study|substantial noncompliance|2
2540948|NCT01532999|8795152|P2|Overall Study|should not have been randomized|0
2540949|NCT01532999|8795153|P1|Overall Study|should not have been randomized|1
2540950|NCT01532999|8795152|P2|Overall Study|Relocated|0
2540951|NCT01532999|8795153|P1|Overall Study|Relocated|2
2540952|NCT01532999|8795152|P2|Overall Study|Withdrawal by Subject|0
2540953|NCT01532999|8795153|P1|Overall Study|Withdrawal by Subject|5
2540954|NCT01532999|8795152|P2|Overall Study|Physician Decision|2
2540955|NCT01532999|8795153|P1|Overall Study|Physician Decision|1
2540956|NCT01532999|8795152|P2|Overall Study|Lost to Follow-up|8
2540957|NCT01532999|8795153|P1|Overall Study|Lost to Follow-up|14
2540958|NCT01532986|8795177|P2|Overall Study|Physician Decision|5
2540959|NCT01532986|8795178|P1|Overall Study|Physician Decision|7
2540960|NCT01532986|8795177|P2|Overall Study|Withdrawal by Subject|10
2540961|NCT01532986|8795178|P1|Overall Study|Withdrawal by Subject|7
2540962|NCT01532986|8795177|P2|Overall Study|Death|9
2540963|NCT01532986|8795178|P1|Overall Study|Death|9
2540964|NCT01532934|8795262|P2|Overall Study|In controlled environment|2
2540965|NCT01532934|8795263|P1|Overall Study|In controlled environment|3
2540966|NCT01532934|8795262|P2|Overall Study|Lost to Follow-up|11
2540967|NCT01532934|8795263|P1|Overall Study|Lost to Follow-up|11
2540968|NCT01532921|8795273|P1|Overall Study|Device was explanted during procedure|1
2540969|NCT01532921|8795273|P1|Overall Study|Physician Decision|7
2540970|NCT01532921|8795273|P1|Overall Study|Lost to Follow-up|3
2540971|NCT01532921|8795273|P1|Overall Study|Withdrawal by Subject|2
2540972|NCT01532921|8795273|P1|Overall Study|Death|3
2540973|NCT01532869|8795295|P2|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
2540974|NCT01532869|8795296|P1|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
2540975|NCT01532869|8795295|P2|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
2540976|NCT01532869|8795296|P1|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
2540977|NCT01532869|8795295|P2|Open-label Period (Week 48 to Week 96)|Non-compliance|0
2540978|NCT01532869|8795296|P1|Open-label Period (Week 48 to Week 96)|Non-compliance|1
2540979|NCT01532869|8795295|P2|Open-label Period (Week 48 to Week 96)|Adverse Event|1
2540980|NCT01532869|8795296|P1|Open-label Period (Week 48 to Week 96)|Adverse Event|4
2540981|NCT01532869|8795295|P2|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0
2540982|NCT01532869|8795296|P1|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1
2540983|NCT01532869|8795295|P2|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3
2540984|NCT01532869|8795296|P1|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5
2540985|NCT01532869|8795295|P2|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1
2540986|NCT01532869|8795296|P1|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0
2540987|NCT01532869|8795295|P2|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0
2540988|NCT01532869|8795296|P1|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1
2540989|NCT01532869|8795295|P2|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1
2540990|NCT01532869|8795296|P1|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0
2540991|NCT01532869|8795295|P2|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5
2540992|NCT01532869|8795296|P1|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4
2540993|NCT01532869|8795295|P2|Blinded-Treatment Period (Up to Week 48)|Death|3
2540994|NCT01532869|8795296|P1|Blinded-Treatment Period (Up to Week 48)|Death|0
2540995|NCT01532869|8795295|P2|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2
2540996|NCT01532869|8795296|P1|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4
2540997|NCT01532869|8795295|P2|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
2540998|NCT01532869|8795296|P1|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
2540999|NCT01532869|8795295|P2|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0
2541000|NCT01532869|8795296|P1|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1
2541001|NCT01532869|8795295|P2|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1
2541002|NCT01532869|8795296|P1|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0
2541003|NCT01532869|8795295|P2|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3
2541004|NCT01532869|8795296|P1|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2
2541005|NCT01532869|8795295|P2|Blinded-Treatment Period (Up to Week 24)|Death|1
2541006|NCT01532869|8795296|P1|Blinded-Treatment Period (Up to Week 24)|Death|0
2541007|NCT01532648|8795355|P2|Overall Study|Withdrawal by Subject|2
2541008|NCT01532648|8795356|P1|Overall Study|Withdrawal by Subject|16
2541009|NCT01532648|8795355|P2|Overall Study|Adverse Event|9
2541010|NCT01532648|8795356|P1|Overall Study|Adverse Event|12
2541011|NCT01532648|8795355|P2|Overall Study|Protocol Violation|1
2541012|NCT01532648|8795356|P1|Overall Study|Protocol Violation|1
2541013|NCT01532648|8795355|P2|Overall Study|Lack of Efficacy|1
2541014|NCT01532648|8795356|P1|Overall Study|Lack of Efficacy|4
2541015|NCT01532648|8795355|P2|Overall Study|Lost to Follow-up|4
2541016|NCT01532648|8795356|P1|Overall Study|Lost to Follow-up|3
2541017|NCT01532570|8795390|P4|Overall Study|Withdrawal by Subject|0
2541018|NCT01532570|8795391|P3|Overall Study|Withdrawal by Subject|0
2541019|NCT01532570|8795392|P2|Overall Study|Withdrawal by Subject|1
2541020|NCT01532570|8795393|P1|Overall Study|Withdrawal by Subject|0
2541021|NCT01532570|8795390|P4|Overall Study|Lack of Efficacy|0
2541022|NCT01532570|8795391|P3|Overall Study|Lack of Efficacy|0
2541023|NCT01532570|8795392|P2|Overall Study|Lack of Efficacy|0
2541024|NCT01532570|8795393|P1|Overall Study|Lack of Efficacy|1
2541025|NCT01532414|8795438|P3|Overall Study|Withdrawn by sponsor|0
2541026|NCT01532414|8795439|P2|Overall Study|Withdrawn by sponsor|0
2541027|NCT01532414|8795440|P1|Overall Study|Withdrawn by sponsor|1
2541028|NCT01532414|8795438|P3|Overall Study|Unable to complete 24 hour PK|1
2541029|NCT01532414|8795439|P2|Overall Study|Unable to complete 24 hour PK|0
2541030|NCT01532414|8795440|P1|Overall Study|Unable to complete 24 hour PK|0
2541031|NCT01532414|8795438|P3|Overall Study|Adverse Event|1
2541032|NCT01532414|8795439|P2|Overall Study|Adverse Event|1
2541033|NCT01532414|8795440|P1|Overall Study|Adverse Event|0
2541034|NCT01532414|8795438|P3|Overall Study|No V6 semen sample|0
2541035|NCT01532414|8795439|P2|Overall Study|No V6 semen sample|1
2541036|NCT01532414|8795440|P1|Overall Study|No V6 semen sample|0
2541037|NCT01532414|8795438|P3|Overall Study|Withdrawal by Subject|0
2541038|NCT01532414|8795439|P2|Overall Study|Withdrawal by Subject|0
2541039|NCT01532414|8795440|P1|Overall Study|Withdrawal by Subject|3
2541040|NCT01532414|8795438|P3|Overall Study|Lost to Follow-up|1
2541041|NCT01532414|8795439|P2|Overall Study|Lost to Follow-up|0
2541042|NCT01532414|8795440|P1|Overall Study|Lost to Follow-up|3
2541043|NCT01531998|8795523|P1|Overall Study|Withdrawal by Subject|3
2541044|NCT01531894|8795528|P1|Overall Study|Death|1
2541045|NCT01531894|8795528|P1|Overall Study|Physician Decision|8
2541046|NCT01531725|8795532|P1|Overall Study|Protocol Violation|5
2541047|NCT01531673|8795550|P13|Overall Study|Other|0
2541048|NCT01531673|8795551|P12|Overall Study|Other|0
2541049|NCT01531673|8795552|P11|Overall Study|Other|0
2541050|NCT01531673|8795553|P10|Overall Study|Other|1
2541051|NCT01531673|8795554|P9|Overall Study|Other|0
2541052|NCT01531673|8795555|P8|Overall Study|Other|0
2541053|NCT01531673|8795556|P7|Overall Study|Other|0
2541054|NCT01531673|8795557|P6|Overall Study|Other|0
2541055|NCT01531673|8795558|P5|Overall Study|Other|0
2541056|NCT01531673|8795559|P4|Overall Study|Other|1
2541057|NCT01531673|8795560|P3|Overall Study|Other|0
2541058|NCT01531673|8795561|P2|Overall Study|Other|0
2541059|NCT01531673|8795562|P1|Overall Study|Other|0
2541060|NCT01531673|8795550|P13|Overall Study|Lost to Follow-up|0
2541061|NCT01531673|8795551|P12|Overall Study|Lost to Follow-up|0
2541062|NCT01531673|8795552|P11|Overall Study|Lost to Follow-up|0
2541063|NCT01531673|8795553|P10|Overall Study|Lost to Follow-up|0
2541064|NCT01531673|8795554|P9|Overall Study|Lost to Follow-up|0
2541065|NCT01531673|8795555|P8|Overall Study|Lost to Follow-up|0
2541066|NCT01531673|8795556|P7|Overall Study|Lost to Follow-up|0
2541067|NCT01531673|8795557|P6|Overall Study|Lost to Follow-up|0
2541068|NCT01531673|8795558|P5|Overall Study|Lost to Follow-up|1
2541069|NCT01531673|8795559|P4|Overall Study|Lost to Follow-up|0
2541070|NCT01531673|8795560|P3|Overall Study|Lost to Follow-up|0
2541071|NCT01531673|8795561|P2|Overall Study|Lost to Follow-up|0
2541072|NCT01531673|8795562|P1|Overall Study|Lost to Follow-up|0
2541073|NCT01531673|8795550|P13|Overall Study|Adverse Event|0
2541074|NCT01531673|8795551|P12|Overall Study|Adverse Event|0
2541075|NCT01531673|8795552|P11|Overall Study|Adverse Event|0
2541076|NCT01531673|8795553|P10|Overall Study|Adverse Event|0
2541077|NCT01531673|8795554|P9|Overall Study|Adverse Event|0
2541078|NCT01531673|8795555|P8|Overall Study|Adverse Event|0
2541079|NCT01531673|8795556|P7|Overall Study|Adverse Event|0
2541080|NCT01531673|8795557|P6|Overall Study|Adverse Event|0
2541081|NCT01531673|8795558|P5|Overall Study|Adverse Event|0
2541082|NCT01531673|8795559|P4|Overall Study|Adverse Event|0
2541083|NCT01531673|8795560|P3|Overall Study|Adverse Event|0
2541084|NCT01531673|8795561|P2|Overall Study|Adverse Event|1
2541085|NCT01531673|8795562|P1|Overall Study|Adverse Event|0
2541086|NCT01531673|8795550|P13|Overall Study|Non-Compliance|0
2541087|NCT01531673|8795551|P12|Overall Study|Non-Compliance|0
2541088|NCT01531673|8795552|P11|Overall Study|Non-Compliance|0
2541089|NCT01531673|8795553|P10|Overall Study|Non-Compliance|0
2541090|NCT01531673|8795554|P9|Overall Study|Non-Compliance|0
2541091|NCT01531673|8795555|P8|Overall Study|Non-Compliance|0
2541092|NCT01531673|8795556|P7|Overall Study|Non-Compliance|0
2541093|NCT01531673|8795557|P6|Overall Study|Non-Compliance|1
2541094|NCT01531673|8795558|P5|Overall Study|Non-Compliance|0
2541095|NCT01531673|8795559|P4|Overall Study|Non-Compliance|0
2541096|NCT01531673|8795560|P3|Overall Study|Non-Compliance|0
2541097|NCT01531673|8795561|P2|Overall Study|Non-Compliance|0
2541098|NCT01531673|8795562|P1|Overall Study|Non-Compliance|0
2541099|NCT01531387|8795673|P2|Overall Study|Early termination of study|11
2541100|NCT01531387|8795674|P1|Overall Study|Early termination of study|11
2541101|NCT01531205|8795766|P1|Overall Study|Did not proceed to surgery|1
2541102|NCT01531153|8795778|P3|Overall Study|Withdrawal by Subject|15
2541103|NCT01531153|8795779|P2|Overall Study|Withdrawal by Subject|9
2541104|NCT01531153|8795780|P1|Overall Study|Withdrawal by Subject|10
2541105|NCT01530997|8795836|P1|Overall Study|Withdrawal by Subject|1
2541106|NCT01530997|8795836|P1|Overall Study|Physician Decision|1
2541107|NCT01530464|8795880|P2|Washout (24h)|Withdrawal by Subject|1
2541108|NCT01530464|8795881|P1|Washout (24h)|Withdrawal by Subject|0
2541109|NCT01530464|8795880|P2|Washout (24h)|Withdrawal by Subject|0
2541110|NCT01530464|8795881|P1|Washout (24h)|Withdrawal by Subject|1
2541111|NCT01530334|8795933|P1|Overall Study|Progressive disease|47
2541112|NCT01530334|8795933|P1|Overall Study|unknown reason|1
2541113|NCT01530334|8795933|P1|Overall Study|Adverse Event|3
2541114|NCT01530087|8795980|P1|Overall Study|Physician Decision|2
2541115|NCT01529749|8795996|P4|Overall Study|Protocol Violation|1
2541116|NCT01529749|8795997|P3|Overall Study|Protocol Violation|0
2541117|NCT01529749|8795998|P2|Overall Study|Protocol Violation|0
2541118|NCT01529749|8795999|P1|Overall Study|Protocol Violation|0
2541119|NCT01529749|8795996|P4|Overall Study|Withdrawal by Subject|0
2541120|NCT01529749|8795997|P3|Overall Study|Withdrawal by Subject|1
2541121|NCT01529749|8795998|P2|Overall Study|Withdrawal by Subject|1
2541122|NCT01529749|8795999|P1|Overall Study|Withdrawal by Subject|0
2541123|NCT01529749|8795996|P4|Overall Study|Physician Decision|1
2541124|NCT01529749|8795997|P3|Overall Study|Physician Decision|0
2541125|NCT01529749|8795998|P2|Overall Study|Physician Decision|0
2541126|NCT01529749|8795999|P1|Overall Study|Physician Decision|0
2541127|NCT01529749|8795996|P4|Overall Study|Lost to Follow-up|0
2541128|NCT01529749|8795997|P3|Overall Study|Lost to Follow-up|1
2541129|NCT01529749|8795998|P2|Overall Study|Lost to Follow-up|1
2541130|NCT01529749|8795999|P1|Overall Study|Lost to Follow-up|0
2541131|NCT01529645|8796083|P10|Overall Study|Withdrawal by Subject|0
2541132|NCT01529645|8796084|P9|Overall Study|Withdrawal by Subject|0
2541133|NCT01529645|8796085|P8|Overall Study|Withdrawal by Subject|0
2541134|NCT01529645|8796086|P7|Overall Study|Withdrawal by Subject|0
2541135|NCT01529645|8796087|P6|Overall Study|Withdrawal by Subject|1
2541136|NCT01529645|8796088|P5|Overall Study|Withdrawal by Subject|1
2541137|NCT01529645|8796089|P4|Overall Study|Withdrawal by Subject|1
2541138|NCT01529645|8796090|P3|Overall Study|Withdrawal by Subject|0
2541139|NCT01529645|8796091|P2|Overall Study|Withdrawal by Subject|0
2541140|NCT01529645|8796092|P1|Overall Study|Withdrawal by Subject|2
2541141|NCT01529645|8796083|P10|Overall Study|SAE - Premature contractions|0
2541142|NCT01529645|8796084|P9|Overall Study|SAE - Premature contractions|0
2541143|NCT01529645|8796085|P8|Overall Study|SAE - Premature contractions|0
2541144|NCT01529645|8796086|P7|Overall Study|SAE - Premature contractions|0
2541145|NCT01529645|8796087|P6|Overall Study|SAE - Premature contractions|0
2541146|NCT01529645|8796088|P5|Overall Study|SAE - Premature contractions|0
2541147|NCT01529645|8796089|P4|Overall Study|SAE - Premature contractions|0
2541148|NCT01529645|8796090|P3|Overall Study|SAE - Premature contractions|1
2541149|NCT01529645|8796091|P2|Overall Study|SAE - Premature contractions|0
2541150|NCT01529645|8796092|P1|Overall Study|SAE - Premature contractions|0
2541151|NCT01529645|8796083|P10|Overall Study|Lost to Follow-up|0
2541152|NCT01529645|8796084|P9|Overall Study|Lost to Follow-up|1
2541153|NCT01529645|8796085|P8|Overall Study|Lost to Follow-up|0
2541154|NCT01529645|8796086|P7|Overall Study|Lost to Follow-up|2
2541155|NCT01529645|8796087|P6|Overall Study|Lost to Follow-up|0
2541156|NCT01529645|8796088|P5|Overall Study|Lost to Follow-up|1
2541157|NCT01529645|8796089|P4|Overall Study|Lost to Follow-up|1
2541158|NCT01529645|8796090|P3|Overall Study|Lost to Follow-up|1
2541159|NCT01529645|8796091|P2|Overall Study|Lost to Follow-up|1
2541160|NCT01529645|8796092|P1|Overall Study|Lost to Follow-up|0
2541161|NCT01529632|8796190|P2|Overall Study|Adverse Event|1
2541162|NCT01529632|8796191|P1|Overall Study|Adverse Event|1
2541163|NCT01529632|8796190|P2|Overall Study|Protocol Violation|1
2541164|NCT01529632|8796191|P1|Overall Study|Protocol Violation|0
2541165|NCT01529632|8796190|P2|Overall Study|Administrative problem|1
2541166|NCT01529632|8796191|P1|Overall Study|Administrative problem|2
2541167|NCT01529606|8796211|P2|Overall Study|Lost to Follow-up|18
2541168|NCT01529606|8796212|P1|Overall Study|Lost to Follow-up|21
2541169|NCT01529515|8796224|P4|DOUBLE BLIND PHASE|Other|2
2541170|NCT01529515|8796225|P3|DOUBLE BLIND PHASE|Other|9
2541171|NCT01529515|8796226|P2|DOUBLE BLIND PHASE|Other|0
2541172|NCT01529515|8796227|P1|DOUBLE BLIND PHASE|Other|0
2541173|NCT01529515|8796224|P4|DOUBLE BLIND PHASE|Protocol Violation|0
2541174|NCT01529515|8796225|P3|DOUBLE BLIND PHASE|Protocol Violation|1
2541175|NCT01529515|8796226|P2|DOUBLE BLIND PHASE|Protocol Violation|0
2541176|NCT01529515|8796227|P1|DOUBLE BLIND PHASE|Protocol Violation|0
2541177|NCT01529515|8796224|P4|DOUBLE BLIND PHASE|Withdrawal by Subject|7
2541178|NCT01529515|8796225|P3|DOUBLE BLIND PHASE|Withdrawal by Subject|10
2541179|NCT01529515|8796226|P2|DOUBLE BLIND PHASE|Withdrawal by Subject|0
2541180|NCT01529515|8796227|P1|DOUBLE BLIND PHASE|Withdrawal by Subject|0
2541181|NCT01529515|8796224|P4|DOUBLE BLIND PHASE|Pregnancy|0
2541182|NCT01529515|8796225|P3|DOUBLE BLIND PHASE|Pregnancy|1
2541183|NCT01529515|8796226|P2|DOUBLE BLIND PHASE|Pregnancy|0
2541184|NCT01529515|8796227|P1|DOUBLE BLIND PHASE|Pregnancy|0
2541185|NCT01529515|8796224|P4|DOUBLE BLIND PHASE|Lost to Follow-up|3
2541186|NCT01529515|8796225|P3|DOUBLE BLIND PHASE|Lost to Follow-up|1
2541187|NCT01529515|8796226|P2|DOUBLE BLIND PHASE|Lost to Follow-up|0
2541188|NCT01529515|8796227|P1|DOUBLE BLIND PHASE|Lost to Follow-up|0
2541189|NCT01529515|8796224|P4|DOUBLE BLIND PHASE|Adverse Event|0
2541190|NCT01529515|8796225|P3|DOUBLE BLIND PHASE|Adverse Event|1
2541191|NCT01529515|8796226|P2|DOUBLE BLIND PHASE|Adverse Event|0
2541192|NCT01529515|8796227|P1|DOUBLE BLIND PHASE|Adverse Event|0
2541193|NCT01529515|8796224|P4|MAINTENANCE PHASE|Other|0
2541194|NCT01529515|8796225|P3|MAINTENANCE PHASE|Other|0
2541195|NCT01529515|8796226|P2|MAINTENANCE PHASE|Other|10
2541196|NCT01529515|8796227|P1|MAINTENANCE PHASE|Other|0
2541197|NCT01529515|8796224|P4|MAINTENANCE PHASE|Failed Randomization Criteria|0
2541198|NCT01529515|8796225|P3|MAINTENANCE PHASE|Failed Randomization Criteria|0
2541199|NCT01529515|8796226|P2|MAINTENANCE PHASE|Failed Randomization Criteria|13
2541200|NCT01529515|8796227|P1|MAINTENANCE PHASE|Failed Randomization Criteria|0
2541201|NCT01529515|8796224|P4|MAINTENANCE PHASE|Withdrawal by Subject|0
2541202|NCT01529515|8796225|P3|MAINTENANCE PHASE|Withdrawal by Subject|0
2541203|NCT01529515|8796226|P2|MAINTENANCE PHASE|Withdrawal by Subject|15
2541204|NCT01529515|8796227|P1|MAINTENANCE PHASE|Withdrawal by Subject|0
2541205|NCT01529515|8796224|P4|MAINTENANCE PHASE|Protocol Violation|0
2541206|NCT01529515|8796225|P3|MAINTENANCE PHASE|Protocol Violation|0
2541207|NCT01529515|8796226|P2|MAINTENANCE PHASE|Protocol Violation|12
2541208|NCT01529515|8796227|P1|MAINTENANCE PHASE|Protocol Violation|0
2541209|NCT01529515|8796224|P4|MAINTENANCE PHASE|Lost to Follow-up|0
2541210|NCT01529515|8796225|P3|MAINTENANCE PHASE|Lost to Follow-up|0
2541211|NCT01529515|8796226|P2|MAINTENANCE PHASE|Lost to Follow-up|5
2541212|NCT01529515|8796227|P1|MAINTENANCE PHASE|Lost to Follow-up|0
2541213|NCT01529515|8796224|P4|MAINTENANCE PHASE|Lack of Efficacy|0
2541214|NCT01529515|8796225|P3|MAINTENANCE PHASE|Lack of Efficacy|0
2541215|NCT01529515|8796226|P2|MAINTENANCE PHASE|Lack of Efficacy|9
2541216|NCT01529515|8796227|P1|MAINTENANCE PHASE|Lack of Efficacy|0
2541217|NCT01529515|8796224|P4|MAINTENANCE PHASE|Adverse Event|0
2541218|NCT01529515|8796225|P3|MAINTENANCE PHASE|Adverse Event|0
2541219|NCT01529515|8796226|P2|MAINTENANCE PHASE|Adverse Event|10
2541220|NCT01529515|8796227|P1|MAINTENANCE PHASE|Adverse Event|0
2541221|NCT01529515|8796224|P4|TRANSITION PHASE|Other|0
2541222|NCT01529515|8796225|P3|TRANSITION PHASE|Other|0
2541223|NCT01529515|8796226|P2|TRANSITION PHASE|Other|0
2541224|NCT01529515|8796227|P1|TRANSITION PHASE|Other|9
2541225|NCT01529515|8796224|P4|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
2541226|NCT01529515|8796225|P3|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
2541227|NCT01529515|8796226|P2|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
2541228|NCT01529515|8796227|P1|TRANSITION PHASE|Failed Maintenance Phase Criteria|8
2541229|NCT01529515|8796224|P4|TRANSITION PHASE|Withdrawal by Subject|0
2541230|NCT01529515|8796225|P3|TRANSITION PHASE|Withdrawal by Subject|0
2541231|NCT01529515|8796226|P2|TRANSITION PHASE|Withdrawal by Subject|0
2541232|NCT01529515|8796227|P1|TRANSITION PHASE|Withdrawal by Subject|51
2541233|NCT01529515|8796224|P4|TRANSITION PHASE|Protocol Violation|0
2541234|NCT01529515|8796225|P3|TRANSITION PHASE|Protocol Violation|0
2541235|NCT01529515|8796226|P2|TRANSITION PHASE|Protocol Violation|0
2541236|NCT01529515|8796227|P1|TRANSITION PHASE|Protocol Violation|4
2541237|NCT01529515|8796224|P4|TRANSITION PHASE|Lost to Follow-up|0
2541238|NCT01529515|8796225|P3|TRANSITION PHASE|Lost to Follow-up|0
2541239|NCT01529515|8796226|P2|TRANSITION PHASE|Lost to Follow-up|0
2541240|NCT01529515|8796227|P1|TRANSITION PHASE|Lost to Follow-up|19
2541241|NCT01529515|8796224|P4|TRANSITION PHASE|Lack of Efficacy|0
2541242|NCT01529515|8796225|P3|TRANSITION PHASE|Lack of Efficacy|0
2541243|NCT01529515|8796226|P2|TRANSITION PHASE|Lack of Efficacy|0
2541244|NCT01529515|8796227|P1|TRANSITION PHASE|Lack of Efficacy|19
2541245|NCT01529515|8796224|P4|TRANSITION PHASE|Death|0
2541246|NCT01529515|8796225|P3|TRANSITION PHASE|Death|0
2541247|NCT01529515|8796226|P2|TRANSITION PHASE|Death|0
2541248|NCT01529515|8796227|P1|TRANSITION PHASE|Death|1
2541249|NCT01529515|8796224|P4|TRANSITION PHASE|Adverse Event|0
2541250|NCT01529515|8796225|P3|TRANSITION PHASE|Adverse Event|0
2541251|NCT01529515|8796226|P2|TRANSITION PHASE|Adverse Event|0
2541252|NCT01529515|8796227|P1|TRANSITION PHASE|Adverse Event|16
2541253|NCT01529385|8796274|P2|Overall Study|Lost to Follow-up|1
2541254|NCT01529385|8796275|P1|Overall Study|Lost to Follow-up|2
2541255|NCT01529346|8796304|P5|Overall Study|Other|0
2541256|NCT01529346|8796305|P4|Overall Study|Other|0
2541257|NCT01529346|8796306|P3|Overall Study|Other|1
2541258|NCT01529346|8796307|P2|Overall Study|Other|1
2541259|NCT01529346|8796308|P1|Overall Study|Other|0
2541260|NCT01529346|8796304|P5|Overall Study|Lost to Follow-up|0
2541261|NCT01529346|8796305|P4|Overall Study|Lost to Follow-up|0
2541262|NCT01529346|8796306|P3|Overall Study|Lost to Follow-up|1
2541263|NCT01529346|8796307|P2|Overall Study|Lost to Follow-up|0
2541264|NCT01529346|8796308|P1|Overall Study|Lost to Follow-up|2
2541265|NCT01529268|8796396|P2|Overall Study|Moved|0
2541266|NCT01529268|8796397|P1|Overall Study|Moved|3
2541267|NCT01529268|8796396|P2|Overall Study|Lost to Follow-up|3
2541268|NCT01529268|8796397|P1|Overall Study|Lost to Follow-up|9
2541269|NCT01529112|8796459|P2|Overall Study|Withdrawal by Subject|3
2541270|NCT01529112|8796460|P1|Overall Study|Withdrawal by Subject|7
2541271|NCT01529112|8796459|P2|Overall Study|Protocol Violation|0
2541272|NCT01529112|8796460|P1|Overall Study|Protocol Violation|1
2541273|NCT01529112|8796459|P2|Overall Study|Death|38
2541274|NCT01529112|8796460|P1|Overall Study|Death|59
2541275|NCT01529112|8796459|P2|Overall Study|Adverse Event|0
2541276|NCT01529112|8796460|P1|Overall Study|Adverse Event|2
2541277|NCT01529034|8796496|P1|Overall Study|Study drug not available|2
2541278|NCT01529034|8796496|P1|Overall Study|Investigator no longer available|2
2541279|NCT01529034|8796496|P1|Overall Study|Lack of Efficacy|4
2541280|NCT01529034|8796496|P1|Overall Study|Protocol Violation|4
2541281|NCT01529034|8796496|P1|Overall Study|Adverse Event|4
2541282|NCT01529034|8796496|P1|Overall Study|Caregiver no longer available|7
2541283|NCT01529034|8796496|P1|Overall Study|Noncompliance|8
2541284|NCT01529034|8796496|P1|Overall Study|No treated SCs within protocol window|13
2541285|NCT01529034|8796496|P1|Overall Study|Withdrawal by Subject|25
2541286|NCT01529034|8796496|P1|Overall Study|Study termination|29
2541287|NCT01529034|8796496|P1|Overall Study|Site closure|62
2541288|NCT01529034|8796496|P1|Overall Study|Discontinued prior to study treatment|14
2541289|NCT01528969|8796511|P2|Overall Study|absent from the school at baseline|0
2541290|NCT01528969|8796512|P1|Overall Study|absent from the school at baseline|2
2541291|NCT01528787|8796545|P4|Overall Study|Family Emergency|0
2541292|NCT01528787|8796546|P3|Overall Study|Family Emergency|1
2541293|NCT01528787|8796547|P2|Overall Study|Family Emergency|0
2541294|NCT01528787|8796548|P1|Overall Study|Family Emergency|0
2541295|NCT01528787|8796545|P4|Overall Study|Withdrawal by Subject|1
2541296|NCT01528787|8796546|P3|Overall Study|Withdrawal by Subject|0
2541297|NCT01528787|8796547|P2|Overall Study|Withdrawal by Subject|0
2541298|NCT01528787|8796548|P1|Overall Study|Withdrawal by Subject|0
2541299|NCT01528735|8796560|P2|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0
2541300|NCT01528735|8796561|P1|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1
2541301|NCT01528735|8796560|P2|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
2541302|NCT01528735|8796561|P1|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
2541303|NCT01528709|8796663|P2|Overall Study|allergy|0
2541304|NCT01528709|8796664|P1|Overall Study|allergy|1
2541305|NCT01528709|8796663|P2|Overall Study|Withdrawal by Subject|15
2541306|NCT01528709|8796664|P1|Overall Study|Withdrawal by Subject|10
2541307|NCT01528709|8796663|P2|Overall Study|Death|0
2541308|NCT01528709|8796664|P1|Overall Study|Death|2
2541309|NCT01528696|8796674|P2|Overall Study|See detailed description|19
2541310|NCT01528696|8796675|P1|Overall Study|See detailed description|18
2541311|NCT01528605|8796691|P6|Overall Study|Death|0
2541312|NCT01528605|8796692|P5|Overall Study|Death|0
2541313|NCT01528605|8796693|P4|Overall Study|Death|0
2541314|NCT01528605|8796694|P3|Overall Study|Death|0
2541315|NCT01528605|8796695|P2|Overall Study|Death|0
2541316|NCT01528605|8796696|P1|Overall Study|Death|1
2541317|NCT01528605|8796691|P6|Overall Study|Lost to Follow-up|0
2541318|NCT01528605|8796692|P5|Overall Study|Lost to Follow-up|0
2541319|NCT01528605|8796693|P4|Overall Study|Lost to Follow-up|1
2541320|NCT01528605|8796694|P3|Overall Study|Lost to Follow-up|1
2541321|NCT01528605|8796695|P2|Overall Study|Lost to Follow-up|0
2541322|NCT01528605|8796696|P1|Overall Study|Lost to Follow-up|1
2541323|NCT01528345|8796726|P2|Overall Study|Subject/Guardian Decision|0
2541324|NCT01528345|8796727|P1|Overall Study|Subject/Guardian Decision|5
2541325|NCT01528345|8796726|P2|Overall Study|Study Terminated by Sponsor|8
2541326|NCT01528345|8796727|P1|Overall Study|Study Terminated by Sponsor|4
2541327|NCT01528345|8796726|P2|Overall Study|Progressive Disease|40
2541328|NCT01528345|8796727|P1|Overall Study|Progressive Disease|26
2541329|NCT01528345|8796726|P2|Overall Study|Non-compliance with study treatment|0
2541330|NCT01528345|8796727|P1|Overall Study|Non-compliance with study treatment|1
2541331|NCT01528345|8796726|P2|Overall Study|Death|1
2541332|NCT01528345|8796727|P1|Overall Study|Death|1
2541333|NCT01528345|8796726|P2|Overall Study|Adverse Event|1
2541334|NCT01528345|8796727|P1|Overall Study|Adverse Event|10
2541335|NCT01528254|8796778|P2|Overall Study|No longer requires study drug|1
2541336|NCT01528254|8796779|P1|Overall Study|No longer requires study drug|1
2541337|NCT01528254|8796778|P2|Overall Study|Abnormal test procedure result(s)|0
2541338|NCT01528254|8796779|P1|Overall Study|Abnormal test procedure result(s)|1
2541339|NCT01528254|8796778|P2|Overall Study|Abnormal laboratory value(s)|7
2541340|NCT01528254|8796779|P1|Overall Study|Abnormal laboratory value(s)|3
2541341|NCT01528254|8796778|P2|Overall Study|Withdrawal by Subject|4
2541342|NCT01528254|8796779|P1|Overall Study|Withdrawal by Subject|5
2541343|NCT01528254|8796778|P2|Overall Study|Unsatisfactory therapeutic effect|8
2541344|NCT01528254|8796779|P1|Overall Study|Unsatisfactory therapeutic effect|6
2541345|NCT01528254|8796778|P2|Overall Study|New therapy for study indication|6
2541346|NCT01528254|8796779|P1|Overall Study|New therapy for study indication|8
2541347|NCT01528254|8796778|P2|Overall Study|Protocol deviation|19
2541348|NCT01528254|8796779|P1|Overall Study|Protocol deviation|9
2541349|NCT01528254|8796778|P2|Overall Study|Death|9
2541350|NCT01528254|8796779|P1|Overall Study|Death|13
2541351|NCT01528254|8796778|P2|Overall Study|Lost to Follow-up|24
2541352|NCT01528254|8796779|P1|Overall Study|Lost to Follow-up|17
2541353|NCT01528254|8796778|P2|Overall Study|Adverse Event|44
2541354|NCT01528254|8796779|P1|Overall Study|Adverse Event|28
2541355|NCT01528254|8796778|P2|Overall Study|Administrative problems|94
2541356|NCT01528254|8796779|P1|Overall Study|Administrative problems|96
2541357|NCT01528215|8796811|P2|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0
2541358|NCT01528215|8796812|P1|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3
2541359|NCT01528215|8796811|P2|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13
2541360|NCT01528215|8796812|P1|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10
2541361|NCT01528215|8796811|P2|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2
2541362|NCT01528215|8796812|P1|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2
2541363|NCT01528215|8796811|P2|Enrollment to 1 Year Follow-up|Adverse Event|1
2541364|NCT01528215|8796812|P1|Enrollment to 1 Year Follow-up|Adverse Event|4
2541365|NCT01528072|8796871|P1|Overall Study|Early Termination of Study|52
2541366|NCT01528072|8796871|P1|Overall Study|Death|2
2541367|NCT01528072|8796871|P1|Overall Study|Site Closure|4
2541368|NCT01528072|8796871|P1|Overall Study|Explanted|2
2541369|NCT01528072|8796871|P1|Overall Study|Lost to Follow-up|5
2541370|NCT01528072|8796871|P1|Overall Study|Missed Visit|2
2541371|NCT01528072|8796871|P1|Overall Study|Determined not eligible by AEAC|1
2541372|NCT01528072|8796871|P1|Overall Study|Physician Decision|1
2541373|NCT01528072|8796871|P1|Overall Study|Withdrawal by Subject|5
2541374|NCT01527682|8796888|P1|Overall Study|Protocol Violation|8
2541375|NCT01527500|8796911|P2|Part B|Adverse Event|0
2541376|NCT01527500|8796912|P1|Part B|Adverse Event|1
2541377|NCT01527500|8796911|P2|Part A|Withdrawal by Subject|0
2541378|NCT01527500|8796912|P1|Part A|Withdrawal by Subject|2
2541379|NCT01527500|8796911|P2|Part A|Protocol Deviation|2
2541380|NCT01527500|8796912|P1|Part A|Protocol Deviation|9
2541381|NCT01527500|8796911|P2|Part A|Lost to Follow-up|1
2541382|NCT01527500|8796912|P1|Part A|Lost to Follow-up|0
2541383|NCT01527500|8796911|P2|Part A|Death|1
2541384|NCT01527500|8796912|P1|Part A|Death|4
2541385|NCT01527500|8796911|P2|Part A|Adverse Event|2
2541386|NCT01527500|8796912|P1|Part A|Adverse Event|4
2541387|NCT01527500|8796911|P2|Part A|Administrative|7
2541388|NCT01527500|8796912|P1|Part A|Administrative|11
2541389|NCT01527487|8796942|P2|Overall Study|Death|1
2541390|NCT01527487|8796943|P1|Overall Study|Death|0
2541391|NCT01527487|8796942|P2|Overall Study|Adverse Event|1
2541392|NCT01527487|8796943|P1|Overall Study|Adverse Event|1
2541393|NCT01527487|8796942|P2|Overall Study|Disease Progression|1
2541394|NCT01527487|8796943|P1|Overall Study|Disease Progression|4
2541395|NCT01527487|8796942|P2|Overall Study|MD Discretion/Lack of Efficacy|4
2541396|NCT01527487|8796943|P1|Overall Study|MD Discretion/Lack of Efficacy|3
2541397|NCT01527383|8796957|P2|Overall Study|Withdrawal by Subject|3
2541398|NCT01527383|8796958|P1|Overall Study|Withdrawal by Subject|2
2541399|NCT01527383|8796957|P2|Overall Study|Participant moved|1
2541400|NCT01527383|8796958|P1|Overall Study|Participant moved|0
2541401|NCT01527383|8796957|P2|Overall Study|Screen failure|0
2541402|NCT01527383|8796958|P1|Overall Study|Screen failure|1
2541403|NCT01527383|8796957|P2|Overall Study|Protocol Violation|0
2541404|NCT01527383|8796958|P1|Overall Study|Protocol Violation|1
2541405|NCT01527383|8796957|P2|Overall Study|Pregnancy|0
2541406|NCT01527383|8796958|P1|Overall Study|Pregnancy|1
2541407|NCT01527383|8796957|P2|Overall Study|Physician Decision|0
2541408|NCT01527383|8796958|P1|Overall Study|Physician Decision|2
2541409|NCT01527383|8796957|P2|Overall Study|Lost to Follow-up|0
2541410|NCT01527383|8796958|P1|Overall Study|Lost to Follow-up|3
2541411|NCT01527383|8796957|P2|Overall Study|Adverse Event|0
2541412|NCT01527383|8796958|P1|Overall Study|Adverse Event|5
2541413|NCT01527370|8796972|P1|Overall Study|Death|1
2541414|NCT01527370|8796972|P1|Overall Study|Physician Decision|1
2541415|NCT01527370|8796972|P1|Overall Study|Withdrawal by Subject|4
2541416|NCT01527357|8796980|P2|Overall Study|Did Not Receive Treatment|0
2541417|NCT01527357|8796981|P1|Overall Study|Did Not Receive Treatment|2
2541418|NCT01527357|8796980|P2|Overall Study|No Day 29 Visit|1
2541419|NCT01527357|8796981|P1|Overall Study|No Day 29 Visit|0
2541420|NCT01527357|8796980|P2|Overall Study|Non-compliance|1
2541421|NCT01527357|8796981|P1|Overall Study|Non-compliance|0
2541422|NCT01527357|8796980|P2|Overall Study|Withdrew Consent|1
2541423|NCT01527357|8796981|P1|Overall Study|Withdrew Consent|1
2541424|NCT01527357|8796980|P2|Overall Study|Lost to Follow-up|4
2541425|NCT01527357|8796981|P1|Overall Study|Lost to Follow-up|6
2541426|NCT01527357|8796980|P2|Overall Study|Death|2
2541427|NCT01527357|8796981|P1|Overall Study|Death|8
2541428|NCT01527292|8797003|P2|Overall Study|Physician Decision|3
2541429|NCT01527292|8797004|P1|Overall Study|Physician Decision|0
2541430|NCT01527110|8797031|P1|Overall Study|Adverse Event|1
2541431|NCT01527006|8797112|P2|Extension Phase|Other|3
2541432|NCT01527006|8797113|P1|Extension Phase|Other|0
2541433|NCT01527006|8797112|P2|Extension Phase|Inadequate therapeutic effect|1
2541434|NCT01527006|8797113|P1|Extension Phase|Inadequate therapeutic effect|1
2541435|NCT01527006|8797112|P2|Extension Phase|Subject Choice|1
2541436|NCT01527006|8797113|P1|Extension Phase|Subject Choice|1
2541437|NCT01527006|8797112|P2|Extension Phase|Lost to Follow-up|1
2541438|NCT01527006|8797113|P1|Extension Phase|Lost to Follow-up|0
2541439|NCT01527006|8797112|P2|Extension Phase|Adverse Event|2
2541440|NCT01527006|8797113|P1|Extension Phase|Adverse Event|4
2541441|NCT01527006|8797112|P2|Core Study|Other|2
2541442|NCT01527006|8797113|P1|Core Study|Other|0
2541443|NCT01527006|8797112|P2|Core Study|Withdrawal by Subject|1
2541444|NCT01527006|8797113|P1|Core Study|Withdrawal by Subject|0
2541445|NCT01527006|8797112|P2|Core Study|Inadequate Therapeutic Effect|0
2541446|NCT01527006|8797113|P1|Core Study|Inadequate Therapeutic Effect|1
2541447|NCT01527006|8797112|P2|Core Study|Subject Choice|0
2541448|NCT01527006|8797113|P1|Core Study|Subject Choice|1
2541449|NCT01527006|8797112|P2|Core Study|Lost to Follow-up|1
2541450|NCT01527006|8797113|P1|Core Study|Lost to Follow-up|0
2541451|NCT01527006|8797112|P2|Core Study|Adverse Event|2
2541452|NCT01527006|8797113|P1|Core Study|Adverse Event|0
2541453|NCT01526928|8797169|P6|Overall Study|Missing|0
2541454|NCT01526928|8797170|P5|Overall Study|Missing|2
2541455|NCT01526928|8797171|P4|Overall Study|Missing|0
2541456|NCT01526928|8797172|P3|Overall Study|Missing|1
2541457|NCT01526928|8797173|P2|Overall Study|Missing|0
2541458|NCT01526928|8797174|P1|Overall Study|Missing|0
2541459|NCT01526928|8797169|P6|Overall Study|Protocol Deviation|0
2541460|NCT01526928|8797170|P5|Overall Study|Protocol Deviation|0
2541461|NCT01526928|8797171|P4|Overall Study|Protocol Deviation|2
2541462|NCT01526928|8797172|P3|Overall Study|Protocol Deviation|0
2541463|NCT01526928|8797173|P2|Overall Study|Protocol Deviation|0
2541464|NCT01526928|8797174|P1|Overall Study|Protocol Deviation|0
2541465|NCT01526928|8797169|P6|Overall Study|Lost to Follow-up|0
2541466|NCT01526928|8797170|P5|Overall Study|Lost to Follow-up|0
2541467|NCT01526928|8797171|P4|Overall Study|Lost to Follow-up|1
2541468|NCT01526928|8797172|P3|Overall Study|Lost to Follow-up|0
2541469|NCT01526928|8797173|P2|Overall Study|Lost to Follow-up|0
2541470|NCT01526928|8797174|P1|Overall Study|Lost to Follow-up|0
2541471|NCT01526928|8797169|P6|Overall Study|Other Reason|0
2541472|NCT01526928|8797170|P5|Overall Study|Other Reason|1
2541473|NCT01526928|8797171|P4|Overall Study|Other Reason|4
2541474|NCT01526928|8797172|P3|Overall Study|Other Reason|11
2541475|NCT01526928|8797173|P2|Overall Study|Other Reason|1
2541476|NCT01526928|8797174|P1|Overall Study|Other Reason|0
2541477|NCT01526928|8797169|P6|Overall Study|Physician Decision|0
2541478|NCT01526928|8797170|P5|Overall Study|Physician Decision|0
2541479|NCT01526928|8797171|P4|Overall Study|Physician Decision|5
2541480|NCT01526928|8797172|P3|Overall Study|Physician Decision|2
2541481|NCT01526928|8797173|P2|Overall Study|Physician Decision|0
2541482|NCT01526928|8797174|P1|Overall Study|Physician Decision|0
2541483|NCT01526928|8797169|P6|Overall Study|Withdrawal by Subject|0
2541484|NCT01526928|8797170|P5|Overall Study|Withdrawal by Subject|3
2541485|NCT01526928|8797171|P4|Overall Study|Withdrawal by Subject|11
2541486|NCT01526928|8797172|P3|Overall Study|Withdrawal by Subject|13
2541487|NCT01526928|8797173|P2|Overall Study|Withdrawal by Subject|0
2541488|NCT01526928|8797174|P1|Overall Study|Withdrawal by Subject|1
2541489|NCT01526928|8797169|P6|Overall Study|Death|0
2541490|NCT01526928|8797170|P5|Overall Study|Death|0
2541491|NCT01526928|8797171|P4|Overall Study|Death|0
2541492|NCT01526928|8797172|P3|Overall Study|Death|3
2541493|NCT01526928|8797173|P2|Overall Study|Death|0
2541494|NCT01526928|8797174|P1|Overall Study|Death|0
2541495|NCT01526928|8797169|P6|Overall Study|Adverse Event|2
2541496|NCT01526928|8797170|P5|Overall Study|Adverse Event|13
2541497|NCT01526928|8797171|P4|Overall Study|Adverse Event|40
2541498|NCT01526928|8797172|P3|Overall Study|Adverse Event|29
2541499|NCT01526928|8797173|P2|Overall Study|Adverse Event|1
2541500|NCT01526928|8797174|P1|Overall Study|Adverse Event|2
2541501|NCT01526928|8797169|P6|Overall Study|Progressive Disease|4
2541502|NCT01526928|8797170|P5|Overall Study|Progressive Disease|76
2541503|NCT01526928|8797171|P4|Overall Study|Progressive Disease|182
2541504|NCT01526928|8797172|P3|Overall Study|Progressive Disease|150
2541505|NCT01526928|8797173|P2|Overall Study|Progressive Disease|17
2541506|NCT01526928|8797174|P1|Overall Study|Progressive Disease|35
2541507|NCT01526889|8797312|P2|Treatment Extension Period|Administrative problems|0
2541508|NCT01526889|8797313|P1|Treatment Extension Period|Administrative problems|1
2541509|NCT01526889|8797312|P2|Treatment Period|Adverse Event|0
2541510|NCT01526889|8797313|P1|Treatment Period|Adverse Event|2
2541511|NCT01526785|8797334|P1|Overall Study|Withdrawal by Subject|2
2541512|NCT01526785|8797334|P1|Overall Study|Physician Decision|1
2541513|NCT01526785|8797334|P1|Overall Study|Death|2
2541514|NCT01526785|8797334|P1|Overall Study|Study Terminated by Sponsor|8
2541515|NCT01526733|8797344|P2|Phase 1|Withdrawal by Subject|1
2541516|NCT01526733|8797345|P1|Phase 1|Withdrawal by Subject|1
2541517|NCT01526733|8797344|P2|Phase 1|Protocol Violation|0
2541518|NCT01526733|8797345|P1|Phase 1|Protocol Violation|1
2541519|NCT01526551|8797384|P1|Overall Study|Lack of returned parental consent form|424
2541520|NCT01526148|8797431|P2|Overall Study|Incarcerated|2
2541521|NCT01526148|8797432|P1|Overall Study|Incarcerated|0
2541522|NCT01526148|8797431|P2|Overall Study|Moved out of state|0
2541523|NCT01526148|8797432|P1|Overall Study|Moved out of state|1
2541524|NCT01526148|8797431|P2|Overall Study|Unable to discontinue concomitant med|0
2541525|NCT01526148|8797432|P1|Overall Study|Unable to discontinue concomitant med|1
2541526|NCT01526148|8797431|P2|Overall Study|Unstable Medical Condition|0
2541527|NCT01526148|8797432|P1|Overall Study|Unstable Medical Condition|1
2541528|NCT01526148|8797431|P2|Overall Study|Withdrawal by Subject|0
2541529|NCT01526148|8797432|P1|Overall Study|Withdrawal by Subject|2
2541530|NCT01526148|8797431|P2|Overall Study|Lost to Follow-up|6
2541531|NCT01526148|8797432|P1|Overall Study|Lost to Follow-up|3
2541532|NCT01526148|8797431|P2|Overall Study|Adverse Event|5
2541533|NCT01526148|8797432|P1|Overall Study|Adverse Event|6
2541534|NCT01526057|8797443|P3|Overall Study|Protocol Violation|1
2541535|NCT01526057|8797444|P2|Overall Study|Protocol Violation|0
2541536|NCT01526057|8797445|P1|Overall Study|Protocol Violation|0
2541537|NCT01526057|8797443|P3|Overall Study|Other|1
2541538|NCT01526057|8797444|P2|Overall Study|Other|0
2541539|NCT01526057|8797445|P1|Overall Study|Other|1
2541540|NCT01526057|8797443|P3|Overall Study|Lost to Follow-up|1
2541541|NCT01526057|8797444|P2|Overall Study|Lost to Follow-up|0
2541542|NCT01526057|8797445|P1|Overall Study|Lost to Follow-up|1
2541543|NCT01526057|8797443|P3|Overall Study|Death|0
2541544|NCT01526057|8797444|P2|Overall Study|Death|0
2541545|NCT01526057|8797445|P1|Overall Study|Death|1
2541546|NCT01526057|8797443|P3|Overall Study|Adverse Event|1
2541547|NCT01526057|8797444|P2|Overall Study|Adverse Event|1
2541548|NCT01526057|8797445|P1|Overall Study|Adverse Event|3
2541549|NCT01526057|8797443|P3|Overall Study|Withdrawal by Subject|2
2541550|NCT01526057|8797444|P2|Overall Study|Withdrawal by Subject|2
2541551|NCT01526057|8797445|P1|Overall Study|Withdrawal by Subject|3
2541552|NCT01525875|8797544|P2|Open-label Period|Lost to Follow-up|2
2541553|NCT01525875|8797545|P1|Open-label Period|Lost to Follow-up|0
2541554|NCT01525875|8797544|P2|Placebo-controlled Period|Withdrawal by Subject|2
2541555|NCT01525875|8797545|P1|Placebo-controlled Period|Withdrawal by Subject|1
2541556|NCT01525849|8797561|P2|Overall Study|Anatomic exclusion criteria identified|3
2541557|NCT01525849|8797562|P1|Overall Study|Anatomic exclusion criteria identified|0
2541558|NCT01525849|8797561|P2|Overall Study|Unrelated medical issue (not treated)|2
2541559|NCT01525849|8797562|P1|Overall Study|Unrelated medical issue (not treated)|1
2541560|NCT01525849|8797561|P2|Overall Study|Withdrawal by Subject|9
2541561|NCT01525849|8797562|P1|Overall Study|Withdrawal by Subject|1
2541562|NCT01525849|8797561|P2|Overall Study|Lost to Follow-up|2
2541563|NCT01525849|8797562|P1|Overall Study|Lost to Follow-up|3
2541564|NCT01525641|8797618|P1|Overall Study|Other than stated above|7
2541565|NCT01525641|8797618|P1|Overall Study|Lost to follow-up (Changing hospital)|19
2541566|NCT01525641|8797618|P1|Overall Study|Lost to follow-up (Unknown reason)|10
2541567|NCT01525641|8797618|P1|Overall Study|Lost to follow-up (relocation)|1
2541568|NCT01525641|8797618|P1|Overall Study|Improvement|5
2541569|NCT01525641|8797618|P1|Overall Study|Lack of Efficacy|24
2541570|NCT01525641|8797618|P1|Overall Study|Adverse Event|73
2541571|NCT01525641|8797618|P1|Overall Study|No visit since the first visit|16
2541572|NCT01525641|8797618|P1|Overall Study|Case report form not collected|25
2541573|NCT01525628|8797632|P5|Overall Study|Other reason not defined above|0
2541574|NCT01525628|8797633|P4|Overall Study|Other reason not defined above|3
2541575|NCT01525628|8797634|P3|Overall Study|Other reason not defined above|0
2541576|NCT01525628|8797635|P2|Overall Study|Other reason not defined above|0
2541577|NCT01525628|8797636|P1|Overall Study|Other reason not defined above|0
2541578|NCT01525628|8797632|P5|Overall Study|Withdrawal by Subject|0
2541579|NCT01525628|8797633|P4|Overall Study|Withdrawal by Subject|0
2541580|NCT01525628|8797634|P3|Overall Study|Withdrawal by Subject|0
2541581|NCT01525628|8797635|P2|Overall Study|Withdrawal by Subject|1
2541582|NCT01525628|8797636|P1|Overall Study|Withdrawal by Subject|0
2541583|NCT01525628|8797632|P5|Overall Study|Lost to Follow-up|0
2541584|NCT01525628|8797633|P4|Overall Study|Lost to Follow-up|0
2541585|NCT01525628|8797634|P3|Overall Study|Lost to Follow-up|0
2541586|NCT01525628|8797635|P2|Overall Study|Lost to Follow-up|1
2541587|NCT01525628|8797636|P1|Overall Study|Lost to Follow-up|1
2541588|NCT01525628|8797632|P5|Overall Study|Protocol Violation|0
2541589|NCT01525628|8797633|P4|Overall Study|Protocol Violation|0
2541590|NCT01525628|8797634|P3|Overall Study|Protocol Violation|1
2541591|NCT01525628|8797635|P2|Overall Study|Protocol Violation|0
2541592|NCT01525628|8797636|P1|Overall Study|Protocol Violation|0
2541593|NCT01525628|8797632|P5|Overall Study|Lack of Efficacy|2
2541594|NCT01525628|8797633|P4|Overall Study|Lack of Efficacy|1
2541595|NCT01525628|8797634|P3|Overall Study|Lack of Efficacy|2
2541596|NCT01525628|8797635|P2|Overall Study|Lack of Efficacy|2
2541597|NCT01525628|8797636|P1|Overall Study|Lack of Efficacy|0
2541598|NCT01525628|8797632|P5|Overall Study|Adverse Event|1
2541599|NCT01525628|8797633|P4|Overall Study|Adverse Event|0
2541600|NCT01525628|8797634|P3|Overall Study|Adverse Event|2
2541601|NCT01525628|8797635|P2|Overall Study|Adverse Event|1
2541602|NCT01525628|8797636|P1|Overall Study|Adverse Event|1
2541603|NCT01525615|8797703|P3|Overall Study|Other reason not described above|1
2541604|NCT01525615|8797704|P2|Overall Study|Other reason not described above|0
2541605|NCT01525615|8797705|P1|Overall Study|Other reason not described above|1
2541606|NCT01525615|8797703|P3|Overall Study|Withdrawal by Subject|0
2541607|NCT01525615|8797704|P2|Overall Study|Withdrawal by Subject|0
2541608|NCT01525615|8797705|P1|Overall Study|Withdrawal by Subject|1
2541609|NCT01525615|8797703|P3|Overall Study|Lost to Follow-up|0
2541610|NCT01525615|8797704|P2|Overall Study|Lost to Follow-up|0
2541611|NCT01525615|8797705|P1|Overall Study|Lost to Follow-up|1
2541612|NCT01525615|8797703|P3|Overall Study|Adverse Event|5
2541613|NCT01525615|8797704|P2|Overall Study|Adverse Event|7
2541614|NCT01525615|8797705|P1|Overall Study|Adverse Event|11
2541615|NCT01525550|8797761|P2|Overall Study|Withdrawal by Subject|0
2541616|NCT01525550|8797762|P1|Overall Study|Withdrawal by Subject|4
2541617|NCT01525550|8797761|P2|Overall Study|Sponsor's Decision|11
2541618|NCT01525550|8797762|P1|Overall Study|Sponsor's Decision|30
2541619|NCT01525550|8797761|P2|Overall Study|Other|4
2541620|NCT01525550|8797762|P1|Overall Study|Other|0
2541621|NCT01525550|8797761|P2|Overall Study|Death|28
2541622|NCT01525550|8797762|P1|Overall Study|Death|19
2541623|NCT01525550|8797761|P2|Overall Study|Lost to Follow-up|2
2541624|NCT01525550|8797762|P1|Overall Study|Lost to Follow-up|8
2541625|NCT01525407|8797833|P2|Overall Study|Delay in Transplant|0
2541626|NCT01525407|8797834|P1|Overall Study|Delay in Transplant|1
2541627|NCT01525407|8797833|P2|Overall Study|Transplant was delayed|1
2541628|NCT01525407|8797834|P1|Overall Study|Transplant was delayed|0
2541629|NCT01525407|8797833|P2|Overall Study|Withdrawal by Subject|1
2541630|NCT01525407|8797834|P1|Overall Study|Withdrawal by Subject|0
2541631|NCT01525407|8797833|P2|Overall Study|Change in recipient treatment plan|2
2541632|NCT01525407|8797834|P1|Overall Study|Change in recipient treatment plan|2
2541633|NCT01525238|8797866|P3|Overall Study|Withdrawal by Subject|0
2541634|NCT01525238|8797867|P2|Overall Study|Withdrawal by Subject|0
2541635|NCT01525238|8797868|P1|Overall Study|Withdrawal by Subject|1
2541636|NCT01525225|8797933|P1|Enrollment|Other|1
2541637|NCT01525225|8797933|P1|Enrollment|No longer met study criteria|1
2541638|NCT01524991|8797947|P1|Overall Study|Symptomatic Deterioration|1
2541639|NCT01524991|8797947|P1|Overall Study|Withdrawal by Subject|2
2541640|NCT01524991|8797947|P1|Overall Study|Other complicating disease|1
2541641|NCT01524991|8797947|P1|Overall Study|Disease ProgressionDu|17
2541642|NCT01524991|8797947|P1|Overall Study|Death|1
2541643|NCT01524991|8797947|P1|Overall Study|Adverse Event|12
2541644|NCT01524978|8797965|P11|Overall Study|Death|17
2541645|NCT01524978|8797966|P10|Overall Study|Death|6
2541646|NCT01524978|8797967|P9|Overall Study|Death|5
2541647|NCT01524978|8797968|P8|Overall Study|Death|9
2541648|NCT01524978|8797969|P7|Overall Study|Death|1
2541649|NCT01524978|8797970|P6|Overall Study|Death|4
2541650|NCT01524978|8797971|P5|Overall Study|Death|4
2541651|NCT01524978|8797972|P4|Overall Study|Death|24
2541652|NCT01524978|8797973|P3|Overall Study|Death|5
2541653|NCT01524978|8797974|P2|Overall Study|Death|2
2541654|NCT01524978|8797975|P1|Overall Study|Death|34
2541655|NCT01524978|8797965|P11|Overall Study|Lost to Follow-up|1
2541656|NCT01524978|8797966|P10|Overall Study|Lost to Follow-up|1
2541657|NCT01524978|8797967|P9|Overall Study|Lost to Follow-up|1
2541658|NCT01524978|8797968|P8|Overall Study|Lost to Follow-up|0
2541659|NCT01524978|8797969|P7|Overall Study|Lost to Follow-up|2
2541660|NCT01524978|8797970|P6|Overall Study|Lost to Follow-up|1
2541661|NCT01524978|8797971|P5|Overall Study|Lost to Follow-up|1
2541662|NCT01524978|8797972|P4|Overall Study|Lost to Follow-up|0
2541663|NCT01524978|8797973|P3|Overall Study|Lost to Follow-up|3
2541664|NCT01524978|8797974|P2|Overall Study|Lost to Follow-up|0
2541665|NCT01524978|8797975|P1|Overall Study|Lost to Follow-up|0
2541666|NCT01524978|8797965|P11|Overall Study|Withdrawal by Subject|5
2541667|NCT01524978|8797966|P10|Overall Study|Withdrawal by Subject|0
2541668|NCT01524978|8797967|P9|Overall Study|Withdrawal by Subject|4
2541669|NCT01524978|8797968|P8|Overall Study|Withdrawal by Subject|2
2541670|NCT01524978|8797969|P7|Overall Study|Withdrawal by Subject|6
2541671|NCT01524978|8797970|P6|Overall Study|Withdrawal by Subject|1
2541672|NCT01524978|8797971|P5|Overall Study|Withdrawal by Subject|3
2541673|NCT01524978|8797972|P4|Overall Study|Withdrawal by Subject|1
2541674|NCT01524978|8797973|P3|Overall Study|Withdrawal by Subject|1
2541675|NCT01524978|8797974|P2|Overall Study|Withdrawal by Subject|0
2541676|NCT01524978|8797975|P1|Overall Study|Withdrawal by Subject|12
2541677|NCT01524978|8797965|P11|Overall Study|Other|5
2541678|NCT01524978|8797966|P10|Overall Study|Other|2
2541679|NCT01524978|8797967|P9|Overall Study|Other|2
2541680|NCT01524978|8797968|P8|Overall Study|Other|1
2541681|NCT01524978|8797969|P7|Overall Study|Other|17
2541682|NCT01524978|8797970|P6|Overall Study|Other|3
2541683|NCT01524978|8797971|P5|Overall Study|Other|1
2541684|NCT01524978|8797972|P4|Overall Study|Other|2
2541685|NCT01524978|8797973|P3|Overall Study|Other|1
2541686|NCT01524978|8797974|P2|Overall Study|Other|2
2541687|NCT01524978|8797975|P1|Overall Study|Other|16
2541688|NCT01524913|8798103|P3|Overall Study|Lost to Follow-up|0
2541689|NCT01524913|8798104|P2|Overall Study|Lost to Follow-up|0
2541690|NCT01524913|8798105|P1|Overall Study|Lost to Follow-up|4
2541691|NCT01524900|8798127|P5|Overall Study|No reason documented|0
2541692|NCT01524900|8798128|P4|Overall Study|No reason documented|1
2541693|NCT01524900|8798129|P3|Overall Study|No reason documented|0
2541694|NCT01524900|8798130|P2|Overall Study|No reason documented|1
2541695|NCT01524900|8798131|P1|Overall Study|No reason documented|2
2541696|NCT01524900|8798127|P5|Overall Study|Other reason than stated above|0
2541697|NCT01524900|8798128|P4|Overall Study|Other reason than stated above|0
2541698|NCT01524900|8798129|P3|Overall Study|Other reason than stated above|0
2541699|NCT01524900|8798130|P2|Overall Study|Other reason than stated above|1
2541700|NCT01524900|8798131|P1|Overall Study|Other reason than stated above|1
2541701|NCT01524900|8798127|P5|Overall Study|Lost to Follow-up|0
2541702|NCT01524900|8798128|P4|Overall Study|Lost to Follow-up|0
2541703|NCT01524900|8798129|P3|Overall Study|Lost to Follow-up|1
2541704|NCT01524900|8798130|P2|Overall Study|Lost to Follow-up|12
2541705|NCT01524900|8798131|P1|Overall Study|Lost to Follow-up|3
2541706|NCT01524887|8798176|P3|Overall Study|Use of prohibited medication|0
2541707|NCT01524887|8798177|P2|Overall Study|Use of prohibited medication|0
2541708|NCT01524887|8798178|P1|Overall Study|Use of prohibited medication|1
2541709|NCT01524887|8798176|P3|Overall Study|Withdrawal by Caregiver|2
2541710|NCT01524887|8798177|P2|Overall Study|Withdrawal by Caregiver|0
2541711|NCT01524887|8798178|P1|Overall Study|Withdrawal by Caregiver|0
2541712|NCT01524887|8798176|P3|Overall Study|Study termination|79
2541713|NCT01524887|8798177|P2|Overall Study|Study termination|87
2541714|NCT01524887|8798178|P1|Overall Study|Study termination|73
2541715|NCT01524887|8798176|P3|Overall Study|Protocol Violation|1
2541716|NCT01524887|8798177|P2|Overall Study|Protocol Violation|0
2541717|NCT01524887|8798178|P1|Overall Study|Protocol Violation|0
2541718|NCT01524887|8798176|P3|Overall Study|Adverse Event|1
2541719|NCT01524887|8798177|P2|Overall Study|Adverse Event|1
2541720|NCT01524887|8798178|P1|Overall Study|Adverse Event|5
2541721|NCT01524887|8798176|P3|Overall Study|Withdrawal by Subject|3
2541722|NCT01524887|8798177|P2|Overall Study|Withdrawal by Subject|2
2541723|NCT01524887|8798178|P1|Overall Study|Withdrawal by Subject|6
2541724|NCT01524796|8798222|P1|Overall Study|Adverse Event and Lack of Efficacy|1
2541725|NCT01524796|8798222|P1|Overall Study|Switch to carbamazapine|1
2541726|NCT01524796|8798222|P1|Overall Study|Nervous about confidentiality|1
2541727|NCT01524796|8798222|P1|Overall Study|Gall stone surgery|1
2541728|NCT01524796|8798222|P1|Overall Study|Deterioration of pains|1
2541729|NCT01524796|8798222|P1|Overall Study|Move|1
2541730|NCT01524796|8798222|P1|Overall Study|Withdrawal by Subject|4
2541731|NCT01524796|8798222|P1|Overall Study|The price|1
2541732|NCT01524796|8798222|P1|Overall Study|Lost to Follow-up|1
2541733|NCT01524796|8798222|P1|Overall Study|Lack of Efficacy|3
2541734|NCT01524796|8798222|P1|Overall Study|Adverse Event|13
2541735|NCT01524783|8798237|P2|Randomized and Treated|Death|1
2541736|NCT01524783|8798238|P1|Randomized and Treated|Death|4
2541737|NCT01524783|8798237|P2|Randomized and Treated|Protocol Violation|1
2541738|NCT01524783|8798238|P1|Randomized and Treated|Protocol Violation|1
2541739|NCT01524783|8798237|P2|Randomized and Treated|Withdrawal by Subject|5
2541740|NCT01524783|8798238|P1|Randomized and Treated|Withdrawal by Subject|15
2541741|NCT01524783|8798237|P2|Randomized and Treated|Disease Progression|70
2541742|NCT01524783|8798238|P1|Randomized and Treated|Disease Progression|76
2541743|NCT01524783|8798237|P2|Randomized and Treated|Adverse Event|7
2541744|NCT01524783|8798238|P1|Randomized and Treated|Adverse Event|59
2541745|NCT01524783|8798237|P2|Randomized But Not Treated|Randomized, did not receive drug|0
2541746|NCT01524783|8798238|P1|Randomized But Not Treated|Randomized, did not receive drug|2
2541747|NCT01524770|8798246|P2|First Intervention|Protocol Violation|0
2541748|NCT01524770|8798247|P1|First Intervention|Protocol Violation|1
2541749|NCT01524770|8798246|P2|First Intervention|Adverse Event|1
2541750|NCT01524770|8798247|P1|First Intervention|Adverse Event|1
2541751|NCT01524770|8798246|P2|First Intervention|Withdrawal by Subject|0
2541752|NCT01524770|8798247|P1|First Intervention|Withdrawal by Subject|1
2541753|NCT01524692|8798257|P1|Overall Study|Withdrawal by Subject|3
2541754|NCT01524679|8798267|P2|Overall Study|e.g.wish for children, relocation|1
2541755|NCT01524679|8798268|P1|Overall Study|e.g.wish for children, relocation|6
2541756|NCT01524679|8798267|P2|Overall Study|Lack of Efficacy|0
2541757|NCT01524679|8798268|P1|Overall Study|Lack of Efficacy|2
2541758|NCT01524679|8798267|P2|Overall Study|Protocol Violation|0
2541759|NCT01524679|8798268|P1|Overall Study|Protocol Violation|1
2541760|NCT01524679|8798267|P2|Overall Study|Adverse Event|0
2541761|NCT01524679|8798268|P1|Overall Study|Adverse Event|9
2541762|NCT01524679|8798267|P2|Overall Study|Withdrawal by Subject|4
2541763|NCT01524679|8798268|P1|Overall Study|Withdrawal by Subject|4
2541764|NCT01524679|8798267|P2|Overall Study|Lost to Follow-up|4
2541765|NCT01524679|8798268|P1|Overall Study|Lost to Follow-up|1
2541766|NCT01524627|8798280|P2|Overall Study|Lost to Follow-up|1
2541767|NCT01524627|8798281|P1|Overall Study|Lost to Follow-up|1
2541768|NCT01524627|8798280|P2|Overall Study|Physician Decision|1
2541769|NCT01524627|8798281|P1|Overall Study|Physician Decision|0
2541770|NCT01524289|8798308|P2|Overall Study|Did not take study medication|0
2541771|NCT01524289|8798309|P1|Overall Study|Did not take study medication|1
2541772|NCT01524289|8798308|P2|Overall Study|Adverse Event|5
2541773|NCT01524289|8798309|P1|Overall Study|Adverse Event|12
2541774|NCT01524289|8798308|P2|Overall Study|Withdrawal by Subject|7
2541775|NCT01524289|8798309|P1|Overall Study|Withdrawal by Subject|11
2541776|NCT01524289|8798308|P2|Overall Study|Protocol Violation|1
2541777|NCT01524289|8798309|P1|Overall Study|Protocol Violation|5
2541778|NCT01524289|8798308|P2|Overall Study|Physician Decision|0
2541779|NCT01524289|8798309|P1|Overall Study|Physician Decision|1
2541780|NCT01524289|8798308|P2|Overall Study|Lost to Follow-up|1
2541781|NCT01524289|8798309|P1|Overall Study|Lost to Follow-up|0
2541782|NCT01524224|8798367|P8|Overall Study|Sponsor Decision|0
2541783|NCT01524224|8798368|P7|Overall Study|Sponsor Decision|0
2541784|NCT01524224|8798369|P6|Overall Study|Sponsor Decision|0
2541785|NCT01524224|8798370|P5|Overall Study|Sponsor Decision|1
2541786|NCT01524224|8798371|P4|Overall Study|Sponsor Decision|0
2541787|NCT01524224|8798372|P3|Overall Study|Sponsor Decision|0
2541788|NCT01524224|8798373|P2|Overall Study|Sponsor Decision|0
2541789|NCT01524224|8798374|P1|Overall Study|Sponsor Decision|0
2541790|NCT01524224|8798367|P8|Overall Study|Physician Decision|1
2541791|NCT01524224|8798368|P7|Overall Study|Physician Decision|0
2541792|NCT01524224|8798369|P6|Overall Study|Physician Decision|0
2541793|NCT01524224|8798370|P5|Overall Study|Physician Decision|1
2541794|NCT01524224|8798371|P4|Overall Study|Physician Decision|1
2541795|NCT01524224|8798372|P3|Overall Study|Physician Decision|0
2541796|NCT01524224|8798373|P2|Overall Study|Physician Decision|0
2541797|NCT01524224|8798374|P1|Overall Study|Physician Decision|0
2541798|NCT01524224|8798367|P8|Overall Study|Adverse Event|0
2541799|NCT01524224|8798368|P7|Overall Study|Adverse Event|0
2541800|NCT01524224|8798369|P6|Overall Study|Adverse Event|1
2541801|NCT01524224|8798370|P5|Overall Study|Adverse Event|0
2541802|NCT01524224|8798371|P4|Overall Study|Adverse Event|0
2541803|NCT01524224|8798372|P3|Overall Study|Adverse Event|0
2541804|NCT01524224|8798373|P2|Overall Study|Adverse Event|1
2541805|NCT01524224|8798374|P1|Overall Study|Adverse Event|0
2541806|NCT01524224|8798367|P8|Overall Study|Withdrawal by Subject|0
2541807|NCT01524224|8798368|P7|Overall Study|Withdrawal by Subject|2
2541808|NCT01524224|8798369|P6|Overall Study|Withdrawal by Subject|0
2541809|NCT01524224|8798370|P5|Overall Study|Withdrawal by Subject|0
2541810|NCT01524224|8798371|P4|Overall Study|Withdrawal by Subject|0
2541811|NCT01524224|8798372|P3|Overall Study|Withdrawal by Subject|0
2541812|NCT01524224|8798373|P2|Overall Study|Withdrawal by Subject|0
2541813|NCT01524224|8798374|P1|Overall Study|Withdrawal by Subject|2
2541814|NCT01524224|8798367|P8|Overall Study|Progressive Disease|5
2541815|NCT01524224|8798368|P7|Overall Study|Progressive Disease|1
2541816|NCT01524224|8798369|P6|Overall Study|Progressive Disease|1
2541817|NCT01524224|8798370|P5|Overall Study|Progressive Disease|2
2541818|NCT01524224|8798371|P4|Overall Study|Progressive Disease|1
2541819|NCT01524224|8798372|P3|Overall Study|Progressive Disease|2
2541820|NCT01524224|8798373|P2|Overall Study|Progressive Disease|0
2541821|NCT01524224|8798374|P1|Overall Study|Progressive Disease|1
2541822|NCT01524198|8798410|P2|Overall Study|Withdrawal by Subject|10
2541823|NCT01524198|8798411|P1|Overall Study|Withdrawal by Subject|15
2541824|NCT01524198|8798410|P2|Overall Study|Protocol Violation|6
2541825|NCT01524198|8798411|P1|Overall Study|Protocol Violation|8
2541826|NCT01524133|8798422|P3|Overall Study 52 Weeks|Lost to Follow-up|15
2541827|NCT01524133|8798423|P2|Overall Study 52 Weeks|Lost to Follow-up|15
2541828|NCT01524133|8798424|P1|Overall Study 52 Weeks|Lost to Follow-up|16
2541829|NCT01524133|8798422|P3|Overall Study 52 Weeks|Physician Decision|2
2541830|NCT01524133|8798423|P2|Overall Study 52 Weeks|Physician Decision|0
2541831|NCT01524133|8798424|P1|Overall Study 52 Weeks|Physician Decision|1
2541832|NCT01524133|8798422|P3|Overall Study 52 Weeks|Withdrawal by Subject|10
2541833|NCT01524133|8798423|P2|Overall Study 52 Weeks|Withdrawal by Subject|5
2541834|NCT01524133|8798424|P1|Overall Study 52 Weeks|Withdrawal by Subject|4
2541835|NCT01524133|8798422|P3|Treatment Phase|Lost to Follow-up|2
2541836|NCT01524133|8798423|P2|Treatment Phase|Lost to Follow-up|1
2541837|NCT01524133|8798424|P1|Treatment Phase|Lost to Follow-up|0
2541838|NCT01524133|8798422|P3|Treatment Phase|Physician Decision|3
2541839|NCT01524133|8798423|P2|Treatment Phase|Physician Decision|3
2541840|NCT01524133|8798424|P1|Treatment Phase|Physician Decision|6
2541841|NCT01524133|8798422|P3|Treatment Phase|Withdrawal by Subject|31
2541842|NCT01524133|8798423|P2|Treatment Phase|Withdrawal by Subject|28
2541843|NCT01524133|8798424|P1|Treatment Phase|Withdrawal by Subject|13
2541844|NCT01523886|8798467|P2|Overall Study|surgery cancelled|1
2541845|NCT01523886|8798468|P1|Overall Study|surgery cancelled|0
2541846|NCT01523873|8798474|P1|Overall Study|Protocol Violation|422
2541847|NCT01523756|8798569|P2|Test Period 2|Withdrawal by Subject|1
2541848|NCT01523756|8798570|P1|Test Period 2|Withdrawal by Subject|0
2541849|NCT01523756|8798569|P2|Test Period 1|Adverse Event|0
2541850|NCT01523756|8798570|P1|Test Period 1|Adverse Event|1
2541851|NCT01523756|8798569|P2|Baseline Period|Adverse Event|1
2541852|NCT01523756|8798570|P1|Baseline Period|Adverse Event|0
2541853|NCT01523743|8798578|P2|Period 2|Adverse Event|0
2541854|NCT01523743|8798579|P1|Period 2|Adverse Event|1
2541855|NCT01523743|8798578|P2|Period 2|Withdrawal by Subject|2
2541856|NCT01523743|8798579|P1|Period 2|Withdrawal by Subject|0
2541857|NCT01523743|8798578|P2|Period 1|Felt unable to empty bladder|0
2541858|NCT01523743|8798579|P1|Period 1|Felt unable to empty bladder|1
2541859|NCT01523743|8798578|P2|Period 1|Lack of Efficacy|0
2541860|NCT01523743|8798579|P1|Period 1|Lack of Efficacy|1
2541861|NCT01523743|8798578|P2|Period 1|Lost to Follow-up|0
2541862|NCT01523743|8798579|P1|Period 1|Lost to Follow-up|1
2541863|NCT01523743|8798578|P2|Period 1|Withdrawal by Subject|2
2541864|NCT01523743|8798579|P1|Period 1|Withdrawal by Subject|6
2541865|NCT01523743|8798578|P2|Period 1|Adverse Event|0
2541866|NCT01523743|8798579|P1|Period 1|Adverse Event|1
2541867|NCT01523587|8798602|P2|Overall Study|Randomised but bot treated|2
2541868|NCT01523587|8798603|P1|Overall Study|Randomised but bot treated|6
2541869|NCT01523587|8798602|P2|Overall Study|Withdrew due to Progressive disease|279
2541870|NCT01523587|8798603|P1|Overall Study|Withdrew due to Progressive disease|265
2541871|NCT01523587|8798602|P2|Overall Study|Withdrawal by Subject|20
2541872|NCT01523587|8798603|P1|Overall Study|Withdrawal by Subject|28
2541873|NCT01523587|8798602|P2|Overall Study|Lost to Follow-up|2
2541874|NCT01523587|8798603|P1|Overall Study|Lost to Follow-up|2
2541875|NCT01523587|8798602|P2|Overall Study|Protocol Violation|3
2541876|NCT01523587|8798603|P1|Overall Study|Protocol Violation|5
2541877|NCT01523587|8798602|P2|Overall Study|Adverse Event|52
2541878|NCT01523587|8798603|P1|Overall Study|Adverse Event|68
2541879|NCT01523587|8798602|P2|Overall Study|Worsening of underlying cancer disease|34
2541880|NCT01523587|8798603|P1|Overall Study|Worsening of underlying cancer disease|19
2541881|NCT01523587|8798602|P2|Overall Study|Other than listed|5
2541882|NCT01523587|8798603|P1|Overall Study|Other than listed|5
2541883|NCT01523457|8798646|P2|Overall Study|Withdrawal by Subject|2
2541884|NCT01523457|8798647|P1|Overall Study|Withdrawal by Subject|7
2541885|NCT01523392|8798665|P2|Washout Period - 10 to 14 Days|Adverse Event|0
2541886|NCT01523392|8798666|P1|Washout Period - 10 to 14 Days|Adverse Event|1
2541974|NCT01521923|8799064|P2|Overall Study|AE, captured in Period 1|1
2541887|NCT01523392|8798665|P2|Treatment Period 1|Did not complete 7-9 days of treatment.|0
2541888|NCT01523392|8798666|P1|Treatment Period 1|Did not complete 7-9 days of treatment.|1
2541889|NCT01523392|8798665|P2|Treatment Period 1|Withdrawal by Subject|0
2541890|NCT01523392|8798666|P1|Treatment Period 1|Withdrawal by Subject|2
2541891|NCT01523366|8798682|P2|Treatment Period 2|Not completed at least 7 days treatment|0
2541892|NCT01523366|8798683|P1|Treatment Period 2|Not completed at least 7 days treatment|1
2541893|NCT01523366|8798682|P2|Treatment Period 1|Withdrawal by Subject|0
2541894|NCT01523366|8798683|P1|Treatment Period 1|Withdrawal by Subject|1
2541895|NCT01523301|8798699|P2|Overall Study|Other Reason|2
2541896|NCT01523301|8798700|P1|Overall Study|Other Reason|0
2541897|NCT01523301|8798699|P2|Overall Study|Withdrawal by Subject|8
2541898|NCT01523301|8798700|P1|Overall Study|Withdrawal by Subject|6
2541899|NCT01523301|8798699|P2|Overall Study|Lost to Follow-up|0
2541900|NCT01523301|8798700|P1|Overall Study|Lost to Follow-up|1
2541901|NCT01523301|8798699|P2|Overall Study|Protocol Violation|4
2541902|NCT01523301|8798700|P1|Overall Study|Protocol Violation|3
2541903|NCT01523301|8798699|P2|Overall Study|Lack of Efficacy|2
2541904|NCT01523301|8798700|P1|Overall Study|Lack of Efficacy|0
2541905|NCT01523301|8798699|P2|Overall Study|Adverse Event|16
2541906|NCT01523301|8798700|P1|Overall Study|Adverse Event|25
2541907|NCT01523275|8798720|P2|Overall Study|Withdrawal by Subject|0
2541908|NCT01523275|8798721|P1|Overall Study|Withdrawal by Subject|1
2541909|NCT01523275|8798720|P2|Overall Study|Lost to Follow-up|2
2541910|NCT01523275|8798721|P1|Overall Study|Lost to Follow-up|1
2541911|NCT01522976|8798734|P3|Overall Study|Not protocol specified|27
2541912|NCT01522976|8798735|P2|Overall Study|Not protocol specified|27
2541913|NCT01522976|8798736|P1|Overall Study|Not protocol specified|22
2541914|NCT01522976|8798734|P3|Overall Study|Refusal unrelated to adverse event|14
2541915|NCT01522976|8798735|P2|Overall Study|Refusal unrelated to adverse event|13
2541916|NCT01522976|8798736|P1|Overall Study|Refusal unrelated to adverse event|10
2541917|NCT01522976|8798734|P3|Overall Study|Adverse Event|18
2541918|NCT01522976|8798735|P2|Overall Study|Adverse Event|7
2541919|NCT01522976|8798736|P1|Overall Study|Adverse Event|17
2541920|NCT01522976|8798734|P3|Overall Study|Disease progression|25
2541921|NCT01522976|8798735|P2|Overall Study|Disease progression|30
2541922|NCT01522976|8798736|P1|Overall Study|Disease progression|28
2541923|NCT01522976|8798734|P3|Overall Study|Still on treatment|6
2541924|NCT01522976|8798735|P2|Overall Study|Still on treatment|9
2541925|NCT01522976|8798736|P1|Overall Study|Still on treatment|9
2541926|NCT01522976|8798734|P3|Overall Study|Death|2
2541927|NCT01522976|8798735|P2|Overall Study|Death|6
2541928|NCT01522976|8798736|P1|Overall Study|Death|7
2541929|NCT01522976|8798734|P3|Overall Study|Ineligible|1
2541930|NCT01522976|8798735|P2|Overall Study|Ineligible|0
2541931|NCT01522976|8798736|P1|Overall Study|Ineligible|4
2541932|NCT01522950|8798781|P3|Overall Study|Study Medication Sensitivity|0
2541933|NCT01522950|8798782|P2|Overall Study|Study Medication Sensitivity|1
2541934|NCT01522950|8798783|P1|Overall Study|Study Medication Sensitivity|0
2541935|NCT01522950|8798781|P3|Overall Study|Death|1
2541936|NCT01522950|8798782|P2|Overall Study|Death|1
2541937|NCT01522950|8798783|P1|Overall Study|Death|0
2541938|NCT01522950|8798781|P3|Overall Study|Protocol Violation|2
2541939|NCT01522950|8798782|P2|Overall Study|Protocol Violation|0
2541940|NCT01522950|8798783|P1|Overall Study|Protocol Violation|0
2541941|NCT01522950|8798781|P3|Overall Study|Adverse Event|1
2541942|NCT01522950|8798782|P2|Overall Study|Adverse Event|1
2541943|NCT01522950|8798783|P1|Overall Study|Adverse Event|3
2541944|NCT01522950|8798781|P3|Overall Study|Withdrawal by Subject|1
2541945|NCT01522950|8798782|P2|Overall Study|Withdrawal by Subject|2
2541946|NCT01522950|8798783|P1|Overall Study|Withdrawal by Subject|3
2541947|NCT01522456|8798846|P1|Overall Study|Tolerability Assessment|1
2541948|NCT01522456|8798846|P1|Overall Study|Pregnancy|1
2541949|NCT01522456|8798846|P1|Overall Study|Withdrawal by Subject|2
2541950|NCT01522456|8798846|P1|Overall Study|Lost to Follow-up|2
2541951|NCT01522456|8798846|P1|Overall Study|Adverse Event|2
2541952|NCT01522443|8798909|P2|Overall Study|Other|3
2541953|NCT01522443|8798910|P1|Overall Study|Other|1
2541954|NCT01522443|8798909|P2|Overall Study|No study treatment given|1
2541955|NCT01522443|8798910|P1|Overall Study|No study treatment given|1
2541956|NCT01522443|8798909|P2|Overall Study|Withdrawal by Subject|8
2541957|NCT01522443|8798910|P1|Overall Study|Withdrawal by Subject|5
2541958|NCT01522443|8798909|P2|Overall Study|Adverse Event|15
2541959|NCT01522443|8798910|P1|Overall Study|Adverse Event|10
2541960|NCT01522443|8798909|P2|Overall Study|No longer receiving clinical benefit|28
2541961|NCT01522443|8798910|P1|Overall Study|No longer receiving clinical benefit|36
2541962|NCT01522404|8798922|P2|Second Intervention (up to Week 58)|Withdrawal by Subject|0
2541963|NCT01522404|8798923|P1|Second Intervention (up to Week 58)|Withdrawal by Subject|1
2541964|NCT01522404|8798922|P2|First Intervention (up to Week 29)|Adverse Event|0
2541965|NCT01522404|8798923|P1|First Intervention (up to Week 29)|Adverse Event|1
2541966|NCT01522404|8798922|P2|First Intervention (up to Week 29)|Withdrawal by Subject|0
2541967|NCT01522404|8798923|P1|First Intervention (up to Week 29)|Withdrawal by Subject|1
2541968|NCT01522248|8799009|P2|Overall Study|Lost to Follow-up|0
2541969|NCT01522248|8799010|P1|Overall Study|Lost to Follow-up|1
2541970|NCT01522235|8799025|P2|Overall Study|Physician Decision|1
2541971|NCT01522235|8799026|P1|Overall Study|Physician Decision|1
2541972|NCT01521923|8799062|P4|Overall Study|AE, captured in Period 1|1
2541973|NCT01521923|8799063|P3|Overall Study|AE, captured in Period 1|0
2541975|NCT01521923|8799065|P1|Overall Study|AE, captured in Period 1|0
2541976|NCT01521923|8799062|P4|Overall Study|Other|6
2541977|NCT01521923|8799063|P3|Overall Study|Other|3
2541978|NCT01521923|8799064|P2|Overall Study|Other|1
2541979|NCT01521923|8799065|P1|Overall Study|Other|2
2541980|NCT01521923|8799062|P4|Overall Study|Withdrawal by Subject|2
2541981|NCT01521923|8799063|P3|Overall Study|Withdrawal by Subject|1
2541982|NCT01521923|8799064|P2|Overall Study|Withdrawal by Subject|1
2541983|NCT01521923|8799065|P1|Overall Study|Withdrawal by Subject|1
2541984|NCT01521923|8799062|P4|Overall Study|Lost to Follow-up|1
2541985|NCT01521923|8799063|P3|Overall Study|Lost to Follow-up|2
2541986|NCT01521923|8799064|P2|Overall Study|Lost to Follow-up|0
2541987|NCT01521923|8799065|P1|Overall Study|Lost to Follow-up|1
2541988|NCT01521923|8799062|P4|Overall Study|Protocol Violation|0
2541989|NCT01521923|8799063|P3|Overall Study|Protocol Violation|1
2541990|NCT01521923|8799064|P2|Overall Study|Protocol Violation|0
2541991|NCT01521923|8799065|P1|Overall Study|Protocol Violation|0
2541992|NCT01521923|8799062|P4|Overall Study|Lack of Efficacy|0
2541993|NCT01521923|8799063|P3|Overall Study|Lack of Efficacy|0
2541994|NCT01521923|8799064|P2|Overall Study|Lack of Efficacy|1
2541995|NCT01521923|8799065|P1|Overall Study|Lack of Efficacy|1
2541996|NCT01521923|8799062|P4|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1
2541997|NCT01521923|8799063|P3|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
2541998|NCT01521923|8799064|P2|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
2541999|NCT01521923|8799065|P1|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
2542000|NCT01521923|8799062|P4|Overall Study|AE, non-serious, non-fatal|2
2542001|NCT01521923|8799063|P3|Overall Study|AE, non-serious, non-fatal|6
2542002|NCT01521923|8799064|P2|Overall Study|AE, non-serious, non-fatal|3
2542003|NCT01521923|8799065|P1|Overall Study|AE, non-serious, non-fatal|1
2542004|NCT01521923|8799062|P4|Overall Study|SAE, non-fatal|0
2542005|NCT01521923|8799063|P3|Overall Study|SAE, non-fatal|2
2542006|NCT01521923|8799064|P2|Overall Study|SAE, non-fatal|2
2542007|NCT01521923|8799065|P1|Overall Study|SAE, non-fatal|0
2542008|NCT01521923|8799062|P4|Overall Study|AE, serious fatal|0
2542009|NCT01521923|8799063|P3|Overall Study|AE, serious fatal|0
2542010|NCT01521923|8799064|P2|Overall Study|AE, serious fatal|0
2542011|NCT01521923|8799065|P1|Overall Study|AE, serious fatal|1
2542012|NCT01521897|8799185|P1|Overall Study|Lost to Follow-up|5
2542013|NCT01521897|8799185|P1|Overall Study|Protocol Violation|18
2542014|NCT01521884|8799197|P1|Overall Study|Lost to Follow-up|4
2542015|NCT01521884|8799197|P1|Overall Study|Participant non-eligible|1
2542016|NCT01521884|8799197|P1|Overall Study|Protocol Violation|3
2542017|NCT01521884|8799197|P1|Overall Study|Physician Decision|2
2542018|NCT01521884|8799197|P1|Overall Study|Withdrawal by Subject|1
2542019|NCT01521884|8799197|P1|Overall Study|Pregnancy|1
2542020|NCT01521884|8799197|P1|Overall Study|Adverse Event|5
2542021|NCT01521884|8799197|P1|Overall Study|Non Responders|10
2542022|NCT01521559|8799294|P2|Overall Study|Other|2
2542023|NCT01521559|8799295|P1|Overall Study|Other|1
2542024|NCT01521559|8799294|P2|Overall Study|Protocol Violation|0
2542025|NCT01521559|8799295|P1|Overall Study|Protocol Violation|1
2542026|NCT01521559|8799294|P2|Overall Study|Lost to Follow-up|1
2542027|NCT01521559|8799295|P1|Overall Study|Lost to Follow-up|3
2542028|NCT01521559|8799294|P2|Overall Study|Withdrawal by Subject|11
2542029|NCT01521559|8799295|P1|Overall Study|Withdrawal by Subject|9
2542030|NCT01521559|8799294|P2|Overall Study|Death|0
2542031|NCT01521559|8799295|P1|Overall Study|Death|1
2542032|NCT01521559|8799294|P2|Overall Study|Adverse Event|4
2542033|NCT01521559|8799295|P1|Overall Study|Adverse Event|0
2542034|NCT01521507|8799318|P2|Stage 2: Observational Design|Physician Decision|0
2542035|NCT01521507|8799319|P1|Stage 2: Observational Design|Physician Decision|1
2542036|NCT01521507|8799318|P2|Stage 2: Observational Design|Withdrawal by Subject|1
2542037|NCT01521507|8799319|P1|Stage 2: Observational Design|Withdrawal by Subject|3
2542038|NCT01521507|8799318|P2|Stage 2: Observational Design|Device did not fit, No Treatment|1
2542039|NCT01521507|8799319|P1|Stage 2: Observational Design|Device did not fit, No Treatment|0
2542040|NCT01521507|8799318|P2|Stage 1: Randomized Design|Lost to Follow-up|2
2542041|NCT01521507|8799319|P1|Stage 1: Randomized Design|Lost to Follow-up|0
2542042|NCT01521507|8799318|P2|Stage 1: Randomized Design|Withdrawal by Subject|3
2542043|NCT01521507|8799319|P1|Stage 1: Randomized Design|Withdrawal by Subject|1
2542044|NCT01521507|8799318|P2|Stage 1: Randomized Design|Device did not fit, No Treatment|0
2542045|NCT01521507|8799319|P1|Stage 1: Randomized Design|Device did not fit, No Treatment|2
2542046|NCT01521494|8799341|P5|Overall Study|Physician Decision|2
2542047|NCT01521494|8799342|P4|Overall Study|Physician Decision|0
2542048|NCT01521494|8799343|P3|Overall Study|Physician Decision|0
2542049|NCT01521494|8799344|P2|Overall Study|Physician Decision|0
2542050|NCT01521494|8799345|P1|Overall Study|Physician Decision|0
2542051|NCT01521494|8799341|P5|Overall Study|Decrease in serum calcium|1
2542052|NCT01521494|8799342|P4|Overall Study|Decrease in serum calcium|1
2542053|NCT01521494|8799343|P3|Overall Study|Decrease in serum calcium|0
2542054|NCT01521494|8799344|P2|Overall Study|Decrease in serum calcium|0
2542055|NCT01521494|8799345|P1|Overall Study|Decrease in serum calcium|0
2542056|NCT01521494|8799341|P5|Overall Study|Decrease in serum phosphate|0
2542057|NCT01521494|8799342|P4|Overall Study|Decrease in serum phosphate|12
2542058|NCT01521494|8799343|P3|Overall Study|Decrease in serum phosphate|3
2542059|NCT01521494|8799344|P2|Overall Study|Decrease in serum phosphate|2
2542060|NCT01521494|8799345|P1|Overall Study|Decrease in serum phosphate|0
2542061|NCT01521494|8799341|P5|Overall Study|Withdrawal by Subject|0
2542062|NCT01521494|8799342|P4|Overall Study|Withdrawal by Subject|2
2542063|NCT01521494|8799343|P3|Overall Study|Withdrawal by Subject|0
2542064|NCT01521494|8799344|P2|Overall Study|Withdrawal by Subject|1
2542065|NCT01521494|8799345|P1|Overall Study|Withdrawal by Subject|1
2542066|NCT01521494|8799341|P5|Overall Study|Lack of Efficacy|2
2542067|NCT01521494|8799342|P4|Overall Study|Lack of Efficacy|0
2542068|NCT01521494|8799343|P3|Overall Study|Lack of Efficacy|0
2542069|NCT01521494|8799344|P2|Overall Study|Lack of Efficacy|0
2542070|NCT01521494|8799345|P1|Overall Study|Lack of Efficacy|0
2542071|NCT01521494|8799341|P5|Overall Study|Adverse Event|2
2542072|NCT01521494|8799342|P4|Overall Study|Adverse Event|6
2542073|NCT01521494|8799343|P3|Overall Study|Adverse Event|9
2542074|NCT01521494|8799344|P2|Overall Study|Adverse Event|2
2542075|NCT01521494|8799345|P1|Overall Study|Adverse Event|1
2542076|NCT01521364|8799367|P1|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1
2542077|NCT01521364|8799367|P1|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1
2542078|NCT01520987|8799443|P8|Overall Study|Withdrawal by Subject|0
2542079|NCT01520987|8799444|P7|Overall Study|Withdrawal by Subject|0
2542080|NCT01520987|8799445|P6|Overall Study|Withdrawal by Subject|1
2542081|NCT01520987|8799446|P5|Overall Study|Withdrawal by Subject|0
2542082|NCT01520987|8799447|P4|Overall Study|Withdrawal by Subject|0
2542083|NCT01520987|8799448|P3|Overall Study|Withdrawal by Subject|0
2542084|NCT01520987|8799449|P2|Overall Study|Withdrawal by Subject|0
2542085|NCT01520987|8799450|P1|Overall Study|Withdrawal by Subject|1
2542086|NCT01520922|8799510|P2|Survival Follow-up|Withdrawal by Subject|0
2542087|NCT01520922|8799511|P1|Survival Follow-up|Withdrawal by Subject|1
2542088|NCT01520922|8799510|P2|Follow up|Lost to Follow-up|1
2542089|NCT01520922|8799511|P1|Follow up|Lost to Follow-up|0
2542090|NCT01520922|8799510|P2|Treatment Phase|Adverse Event|5
2542091|NCT01520922|8799511|P1|Treatment Phase|Adverse Event|3
2542092|NCT01520922|8799510|P2|Treatment Phase|Progression|2
2542093|NCT01520922|8799511|P1|Treatment Phase|Progression|0
2542094|NCT01520922|8799510|P2|Treatment Phase|Physician Decision|1
2542095|NCT01520922|8799511|P1|Treatment Phase|Physician Decision|2
2542096|NCT01520909|8799573|P3|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1
2542097|NCT01520909|8799574|P2|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
2542098|NCT01520909|8799575|P1|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
2542099|NCT01520909|8799573|P3|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2
2542100|NCT01520909|8799574|P2|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
2542101|NCT01520909|8799575|P1|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
2542102|NCT01520909|8799573|P3|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4
2542103|NCT01520909|8799574|P2|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
2542104|NCT01520909|8799575|P1|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
2542105|NCT01520909|8799573|P3|Part 1 (Randomized Period)|Adverse Event|0
2542106|NCT01520909|8799574|P2|Part 1 (Randomized Period)|Adverse Event|2
2542107|NCT01520909|8799575|P1|Part 1 (Randomized Period)|Adverse Event|1
2542108|NCT01520714|8799692|P2|Overall Study|Lack of Efficacy|1
2542109|NCT01520714|8799693|P1|Overall Study|Lack of Efficacy|0
2542110|NCT01520714|8799692|P2|Overall Study|Adverse Event|2
2542111|NCT01520714|8799693|P1|Overall Study|Adverse Event|0
2542112|NCT01520714|8799692|P2|Overall Study|Protocol Violation|3
2542113|NCT01520714|8799693|P1|Overall Study|Protocol Violation|0
2542114|NCT01520506|8799723|P1|Overall Study|Withdrawal by Subject|1
2542115|NCT01520506|8799723|P1|Overall Study|Lost to Follow-up|1
2542116|NCT01520506|8799723|P1|Overall Study|Missed Visit|4
2542117|NCT01520402|8799778|P1|Overall Study|Physician Decision|3
2542118|NCT01520402|8799778|P1|Overall Study|Withdrawal by Subject|2
2542119|NCT01520363|8799791|P2|Overall Study|Withdrawal by Subject|0
2542120|NCT01520363|8799792|P1|Overall Study|Withdrawal by Subject|2
2542121|NCT01520324|8799866|P1|Overall Study|Subject discontinued (moderate illness)|1
2542122|NCT01519960|8799895|P3|Overall Study|Lost to Follow-up|0
2542123|NCT01519960|8799896|P2|Overall Study|Lost to Follow-up|1
2542124|NCT01519960|8799897|P1|Overall Study|Lost to Follow-up|0
2542125|NCT01519960|8799895|P3|Overall Study|Withdrawal by Subject|0
2542126|NCT01519960|8799896|P2|Overall Study|Withdrawal by Subject|4
2542127|NCT01519960|8799897|P1|Overall Study|Withdrawal by Subject|0
2542128|NCT01519960|8799895|P3|Overall Study|Adverse Event|0
2542129|NCT01519960|8799896|P2|Overall Study|Adverse Event|1
2542130|NCT01519960|8799897|P1|Overall Study|Adverse Event|0
2542131|NCT01519960|8799895|P3|Overall Study|Ongoing/Switched to PEG-IFN|0
2542132|NCT01519960|8799896|P2|Overall Study|Ongoing/Switched to PEG-IFN|33
2542133|NCT01519960|8799897|P1|Overall Study|Ongoing/Switched to PEG-IFN|0
2542134|NCT01519960|8799895|P3|Overall Study|Ongoing in Follow-Up|10
2542135|NCT01519960|8799896|P2|Overall Study|Ongoing in Follow-Up|11
2542136|NCT01519960|8799897|P1|Overall Study|Ongoing in Follow-Up|101
2542137|NCT01519947|8800007|P4|Overall Study|Adverse Event|1
2542138|NCT01519947|8800008|P3|Overall Study|Adverse Event|1
2542139|NCT01519947|8800009|P2|Overall Study|Adverse Event|0
2542140|NCT01519947|8800010|P1|Overall Study|Adverse Event|1
2542141|NCT01519947|8800007|P4|Overall Study|Poor Response|1
2542142|NCT01519947|8800008|P3|Overall Study|Poor Response|0
2542143|NCT01519947|8800009|P2|Overall Study|Poor Response|0
2542144|NCT01519947|8800010|P1|Overall Study|Poor Response|1
2542145|NCT01519947|8800007|P4|Overall Study|Lost to Follow-up|2
2542146|NCT01519947|8800008|P3|Overall Study|Lost to Follow-up|3
2542147|NCT01519947|8800009|P2|Overall Study|Lost to Follow-up|0
2542148|NCT01519947|8800010|P1|Overall Study|Lost to Follow-up|0
2542149|NCT01519947|8800007|P4|Overall Study|Withdrawal by Subject|1
2542150|NCT01519947|8800008|P3|Overall Study|Withdrawal by Subject|0
2542151|NCT01519947|8800009|P2|Overall Study|Withdrawal by Subject|1
2542152|NCT01519947|8800010|P1|Overall Study|Withdrawal by Subject|0
2542153|NCT01519947|8800007|P4|Overall Study|Blood Transfusion|0
2542154|NCT01519947|8800008|P3|Overall Study|Blood Transfusion|1
2542155|NCT01519947|8800009|P2|Overall Study|Blood Transfusion|1
2542156|NCT01519947|8800010|P1|Overall Study|Blood Transfusion|0
2542157|NCT01519947|8800007|P4|Overall Study|Development of Anemia|1
2542158|NCT01519947|8800008|P3|Overall Study|Development of Anemia|0
2542159|NCT01519947|8800009|P2|Overall Study|Development of Anemia|1
2542160|NCT01519947|8800010|P1|Overall Study|Development of Anemia|0
2542161|NCT01519947|8800007|P4|Overall Study|Peritoneal Dialysis Needed|0
2542162|NCT01519947|8800008|P3|Overall Study|Peritoneal Dialysis Needed|0
2542163|NCT01519947|8800009|P2|Overall Study|Peritoneal Dialysis Needed|1
2542164|NCT01519947|8800010|P1|Overall Study|Peritoneal Dialysis Needed|0
2542165|NCT01519947|8800007|P4|Overall Study|Protocol Violation|1
2542166|NCT01519947|8800008|P3|Overall Study|Protocol Violation|2
2542167|NCT01519947|8800009|P2|Overall Study|Protocol Violation|0
2542168|NCT01519947|8800010|P1|Overall Study|Protocol Violation|0
2542169|NCT01519947|8800007|P4|Overall Study|Death|1
2542170|NCT01519947|8800008|P3|Overall Study|Death|0
2542171|NCT01519947|8800009|P2|Overall Study|Death|0
2542172|NCT01519947|8800010|P1|Overall Study|Death|0
2542173|NCT01519934|8800040|P1|Overall Study|Lost to Follow-up|3
2542174|NCT01519921|8800049|P2|Overall Study|High alanine aminotransferase (ALT)|1
2542175|NCT01519921|8800050|P1|Overall Study|High alanine aminotransferase (ALT)|0
2542176|NCT01519921|8800049|P2|Overall Study|Treatment refusal|1
2542177|NCT01519921|8800050|P1|Overall Study|Treatment refusal|2
2542178|NCT01519921|8800049|P2|Overall Study|Lost to Follow-up|1
2542179|NCT01519921|8800050|P1|Overall Study|Lost to Follow-up|2
2542180|NCT01519921|8800049|P2|Overall Study|Withdrawal by Subject|0
2542181|NCT01519921|8800050|P1|Overall Study|Withdrawal by Subject|3
2542182|NCT01519921|8800049|P2|Overall Study|Lack of Efficacy|3
2542183|NCT01519921|8800050|P1|Overall Study|Lack of Efficacy|4
2542184|NCT01519921|8800049|P2|Overall Study|Adverse Event|9
2542185|NCT01519921|8800050|P1|Overall Study|Adverse Event|10
2542186|NCT01519817|8800099|P4|Overall Study|Off study due to infection|1
2542187|NCT01519817|8800100|P3|Overall Study|Off study due to infection|0
2542188|NCT01519817|8800101|P2|Overall Study|Off study due to infection|0
2542189|NCT01519817|8800102|P1|Overall Study|Off study due to infection|0
2542190|NCT01519817|8800099|P4|Overall Study|Withdrawal by Subject|0
2542191|NCT01519817|8800100|P3|Overall Study|Withdrawal by Subject|0
2542192|NCT01519817|8800101|P2|Overall Study|Withdrawal by Subject|0
2542193|NCT01519817|8800102|P1|Overall Study|Withdrawal by Subject|1
2542194|NCT01519791|8800142|P2|Overall Study|Lost to Follow-up|14
2542195|NCT01519791|8800143|P1|Overall Study|Lost to Follow-up|6
2542196|NCT01519791|8800142|P2|Overall Study|Withdrawal by Subject|37
2542197|NCT01519791|8800143|P1|Overall Study|Withdrawal by Subject|15
2542198|NCT01519791|8800142|P2|Overall Study|AE, non-serious non-fatal|31
2542199|NCT01519791|8800143|P1|Overall Study|AE, non-serious non-fatal|12
2542200|NCT01519791|8800142|P2|Overall Study|SAE, fatal + SAE, non-fatal|1
2542201|NCT01519791|8800143|P1|Overall Study|SAE, fatal + SAE, non-fatal|0
2542202|NCT01519791|8800142|P2|Overall Study|AE, serious fatal|1
2542203|NCT01519791|8800143|P1|Overall Study|AE, serious fatal|0
2542204|NCT01519791|8800142|P2|Overall Study|SAE, non-fatal|22
2542205|NCT01519791|8800143|P1|Overall Study|SAE, non-fatal|6
2542206|NCT01519791|8800142|P2|Overall Study|Lack of Efficacy|20
2542207|NCT01519791|8800143|P1|Overall Study|Lack of Efficacy|16
2542208|NCT01519791|8800142|P2|Overall Study|subjects randomized in error|0
2542209|NCT01519791|8800143|P1|Overall Study|subjects randomized in error|2
2542210|NCT01519791|8800142|P2|Overall Study|Other Reason|222
2542211|NCT01519791|8800143|P1|Overall Study|Other Reason|87
2542212|NCT01519791|8800142|P2|Overall Study|Protocol Violation|19
2542213|NCT01519791|8800143|P1|Overall Study|Protocol Violation|6
2542214|NCT01519791|8800142|P2|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1
2542215|NCT01519791|8800143|P1|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2
2542216|NCT01519778|8800207|P1|Overall Study|Physician Decision|1
2542217|NCT01519778|8800207|P1|Overall Study|Lost to Follow-up|10
2542218|NCT01519778|8800207|P1|Overall Study|Withdrawal by Subject|3
2542219|NCT01519765|8800213|P2|Overall Study|Withdrawal by Subject|1
2542220|NCT01519765|8800214|P1|Overall Study|Withdrawal by Subject|0
2542221|NCT01519765|8800213|P2|Overall Study|Protocol Violation|0
2542222|NCT01519765|8800214|P1|Overall Study|Protocol Violation|1
2542223|NCT01519765|8800213|P2|Overall Study|Lack of Efficacy|0
2542224|NCT01519765|8800214|P1|Overall Study|Lack of Efficacy|2
2542225|NCT01519765|8800213|P2|Overall Study|Adverse Event|1
2542226|NCT01519765|8800214|P1|Overall Study|Adverse Event|0
2542227|NCT01519700|8800292|P4|Overall Study|Other Reason|4
2542228|NCT01519700|8800293|P3|Overall Study|Other Reason|0
2542229|NCT01519700|8800294|P2|Overall Study|Other Reason|2
2542230|NCT01519700|8800295|P1|Overall Study|Other Reason|2
2542231|NCT01519700|8800292|P4|Overall Study|Withdrawal by Subject|2
2542232|NCT01519700|8800293|P3|Overall Study|Withdrawal by Subject|3
2542233|NCT01519700|8800294|P2|Overall Study|Withdrawal by Subject|3
2542234|NCT01519700|8800295|P1|Overall Study|Withdrawal by Subject|5
2542235|NCT01519700|8800292|P4|Overall Study|Physician Decision|0
2542236|NCT01519700|8800293|P3|Overall Study|Physician Decision|3
2542237|NCT01519700|8800294|P2|Overall Study|Physician Decision|1
2542238|NCT01519700|8800295|P1|Overall Study|Physician Decision|1
2542239|NCT01519700|8800292|P4|Overall Study|Lost to Follow-up|1
2542240|NCT01519700|8800293|P3|Overall Study|Lost to Follow-up|1
2542241|NCT01519700|8800294|P2|Overall Study|Lost to Follow-up|0
2542242|NCT01519700|8800295|P1|Overall Study|Lost to Follow-up|0
2542243|NCT01519700|8800292|P4|Overall Study|Death|0
2542244|NCT01519700|8800293|P3|Overall Study|Death|0
2542245|NCT01519700|8800294|P2|Overall Study|Death|0
2542246|NCT01519700|8800295|P1|Overall Study|Death|1
2542247|NCT01519674|8800330|P3|Overall Study|Unsclassified|3
2542248|NCT01519674|8800331|P2|Overall Study|Unsclassified|4
2542249|NCT01519674|8800332|P1|Overall Study|Unsclassified|10
2542250|NCT01519674|8800330|P3|Overall Study|Withdrawal Criteria|7
2542251|NCT01519674|8800331|P2|Overall Study|Withdrawal Criteria|2
2542252|NCT01519674|8800332|P1|Overall Study|Withdrawal Criteria|7
2542253|NCT01519674|8800330|P3|Overall Study|Protocol Violation|1
2542254|NCT01519674|8800331|P2|Overall Study|Protocol Violation|3
2542255|NCT01519674|8800332|P1|Overall Study|Protocol Violation|0
2542256|NCT01519674|8800330|P3|Overall Study|Lack of Efficacy|1
2542257|NCT01519674|8800331|P2|Overall Study|Lack of Efficacy|1
2542258|NCT01519674|8800332|P1|Overall Study|Lack of Efficacy|1
2542259|NCT01519674|8800330|P3|Overall Study|Adverse Event|0
2542260|NCT01519674|8800331|P2|Overall Study|Adverse Event|3
2542261|NCT01519674|8800332|P1|Overall Study|Adverse Event|3
2542262|NCT01519661|8800370|P1|Overall Study|Adverse Event|29
2542263|NCT01519661|8800370|P1|Overall Study|Lack of Efficacy|6
2542264|NCT01519661|8800370|P1|Overall Study|Withdrawal by Subject|17
2542265|NCT01519661|8800370|P1|Overall Study|Lost to Follow-up|3
2542266|NCT01519661|8800370|P1|Overall Study|Protocol deviation|6
2542267|NCT01519635|8800396|P2|Overall Study|No possibility to put a catheter|2
2542268|NCT01519635|8800397|P1|Overall Study|No possibility to put a catheter|1
2542269|NCT01519635|8800396|P2|Overall Study|Withdrawal by Subject|1
2542270|NCT01519635|8800397|P1|Overall Study|Withdrawal by Subject|0
2542271|NCT01519518|8800414|P2|Overall Study|Consent not available|10
2542272|NCT01519518|8800415|P1|Overall Study|Consent not available|7
2542273|NCT01519427|8800440|P1|Overall Study|disease progression|2
2542274|NCT01519323|8800472|P2|Overall Study|Study terminated by sponsor|1
2542275|NCT01519323|8800473|P1|Overall Study|Study terminated by sponsor|0
2542276|NCT01519323|8800472|P2|Overall Study|Death|2
2542277|NCT01519323|8800473|P1|Overall Study|Death|3
2542278|NCT01519245|8800533|P2|Overall Study|Met exclusion criteria, not analysed|2
2542279|NCT01519245|8800534|P1|Overall Study|Met exclusion criteria, not analysed|1
2542280|NCT01519206|8800546|P1|Overall Study|Missed Visit|2
2542281|NCT01519206|8800546|P1|Overall Study|Lost to Follow-up|3
2542282|NCT01519167|8800560|P2|Overall Study|Physician Decision|1
2542283|NCT01519167|8800561|P1|Overall Study|Physician Decision|0
2542284|NCT01519167|8800560|P2|Overall Study|Medical condition changes&deep sedation|2
2542285|NCT01519167|8800561|P1|Overall Study|Medical condition changes&deep sedation|0
2542286|NCT01519167|8800560|P2|Overall Study|Lack of Efficacy|1
2542287|NCT01519167|8800561|P1|Overall Study|Lack of Efficacy|0
2542288|NCT01519167|8800560|P2|Overall Study|Adverse Event|1
2542289|NCT01519167|8800561|P1|Overall Study|Adverse Event|0
2542290|NCT01519167|8800560|P2|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3
2542291|NCT01519167|8800561|P1|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0
2542292|NCT01519089|8800587|P2|Overall Study|Not received study drug|1
2542293|NCT01519089|8800588|P1|Overall Study|Not received study drug|0
2542294|NCT01519089|8800587|P2|Overall Study|Other|6
2542295|NCT01519089|8800588|P1|Overall Study|Other|2
2542296|NCT01519089|8800587|P2|Overall Study|Withdrawal by Subject|2
2542297|NCT01519089|8800588|P1|Overall Study|Withdrawal by Subject|0
2542298|NCT01519089|8800587|P2|Overall Study|Lost to Follow-up|0
2542299|NCT01519089|8800588|P1|Overall Study|Lost to Follow-up|1
2542300|NCT01519089|8800587|P2|Overall Study|Lack of Efficacy|2
2542301|NCT01519089|8800588|P1|Overall Study|Lack of Efficacy|0
2542302|NCT01519089|8800587|P2|Overall Study|Adverse Event|4
2542303|NCT01519089|8800588|P1|Overall Study|Adverse Event|4
2542304|NCT01518946|8800730|P3|Randomized Phase (First Intervention)|Other|0
2542305|NCT01518946|8800731|P2|Randomized Phase (First Intervention)|Other|1
2542306|NCT01518946|8800732|P1|Randomized Phase (First Intervention)|Other|0
2542307|NCT01518946|8800730|P3|Open-label Phase|Other|0
2542308|NCT01518946|8800731|P2|Open-label Phase|Other|0
2542309|NCT01518946|8800732|P1|Open-label Phase|Other|4
2542310|NCT01518374|8800743|P1|Overall Study|Lost to Follow-up|2
2542311|NCT01518374|8800743|P1|Overall Study|Protocol Violation|3
2542312|NCT01518374|8800743|P1|Overall Study|Withdrawal by Subject|2
2542313|NCT01518322|8800747|P1|Overall Study|FeNO measurement was missing|13
2542314|NCT01518257|8800768|P2|Overall Study|Other Miscellaneous Reason|0
2542315|NCT01518257|8800769|P1|Overall Study|Other Miscellaneous Reason|1
2542316|NCT01518257|8800768|P2|Overall Study|Lost to Follow-up|0
2542317|NCT01518257|8800769|P1|Overall Study|Lost to Follow-up|1
2542318|NCT01518244|8800791|P1|Overall Study|Adverse Event|3
2542319|NCT01518192|8800799|P3|Overall Study|Lost to Follow-up|35
2542320|NCT01518192|8800800|P2|Overall Study|Lost to Follow-up|26
2542321|NCT01518192|8800801|P1|Overall Study|Lost to Follow-up|29
2542322|NCT01518153|8800822|P3|Donor Lymphocyte Infusion|Death|1
2542323|NCT01518153|8800823|P2|Donor Lymphocyte Infusion|Death|2
2542324|NCT01518153|8800824|P1|Donor Lymphocyte Infusion|Death|0
2542325|NCT01518153|8800822|P3|Stem Cell Transplant|Adverse Event|0
2542326|NCT01518153|8800823|P2|Stem Cell Transplant|Adverse Event|0
2542327|NCT01518153|8800824|P1|Stem Cell Transplant|Adverse Event|1
2542328|NCT01518153|8800822|P3|Stem Cell Transplant|Secondary graft failure|0
2542329|NCT01518153|8800823|P2|Stem Cell Transplant|Secondary graft failure|0
2542330|NCT01518153|8800824|P1|Stem Cell Transplant|Secondary graft failure|1
2542331|NCT01518153|8800822|P3|Stem Cell Transplant|Death|0
2542332|NCT01518153|8800823|P2|Stem Cell Transplant|Death|0
2542333|NCT01518153|8800824|P1|Stem Cell Transplant|Death|2
2542334|NCT01518153|8800822|P3|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
2542335|NCT01518153|8800823|P2|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
2542336|NCT01518153|8800824|P1|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5
2542337|NCT01517984|8800835|P4|Overall Study|Ineligible for randomization|0
2542338|NCT01517984|8800836|P3|Overall Study|Ineligible for randomization|0
2542339|NCT01517984|8800837|P2|Overall Study|Ineligible for randomization|14
2542340|NCT01517984|8800838|P1|Overall Study|Ineligible for randomization|0
2542341|NCT01517984|8800835|P4|Overall Study|Screen Failure|0
2542342|NCT01517984|8800836|P3|Overall Study|Screen Failure|0
2542343|NCT01517984|8800837|P2|Overall Study|Screen Failure|0
2542344|NCT01517984|8800838|P1|Overall Study|Screen Failure|4
2542345|NCT01517984|8800835|P4|Overall Study|Withdrawal by Subject|1
2542346|NCT01517984|8800836|P3|Overall Study|Withdrawal by Subject|4
2542347|NCT01517984|8800837|P2|Overall Study|Withdrawal by Subject|8
2542348|NCT01517984|8800838|P1|Overall Study|Withdrawal by Subject|1
2542349|NCT01517984|8800835|P4|Overall Study|Lost to Follow-up|0
2542350|NCT01517984|8800836|P3|Overall Study|Lost to Follow-up|0
2542351|NCT01517984|8800837|P2|Overall Study|Lost to Follow-up|1
2542352|NCT01517984|8800838|P1|Overall Study|Lost to Follow-up|0
2542353|NCT01517893|8800864|P2|Overall Study|Withdrawal by Subject|0
2542354|NCT01517893|8800865|P1|Overall Study|Withdrawal by Subject|3
2542355|NCT01517867|8800887|P2|Overall Study|Still in treatment at study end|3
2542356|NCT01517867|8800888|P1|Overall Study|Still in treatment at study end|0
2542357|NCT01517867|8800887|P2|Overall Study|Withdrawal by Subject|30
2542358|NCT01517867|8800888|P1|Overall Study|Withdrawal by Subject|34
2542359|NCT01517867|8800887|P2|Overall Study|never started treatment|32
2542360|NCT01517867|8800888|P1|Overall Study|never started treatment|29
2542361|NCT01517750|8800916|P4|Overall Study|Lost to Follow-up|1
2542362|NCT01517750|8800917|P3|Overall Study|Lost to Follow-up|4
2542363|NCT01517750|8800918|P2|Overall Study|Lost to Follow-up|2
2542364|NCT01517750|8800919|P1|Overall Study|Lost to Follow-up|1
2542365|NCT01517412|8800956|P2|Overall Study|Other than specified above|5
2542366|NCT01517412|8800957|P1|Overall Study|Other than specified above|8
2542367|NCT01517412|8800956|P2|Overall Study|Poor compliance to protocol|3
2542368|NCT01517412|8800957|P1|Overall Study|Poor compliance to protocol|8
2542369|NCT01517412|8800956|P2|Overall Study|Lack of Efficacy|5
2542370|NCT01517412|8800957|P1|Overall Study|Lack of Efficacy|10
2542371|NCT01517412|8800956|P2|Overall Study|Adverse Event|11
2542372|NCT01517412|8800957|P1|Overall Study|Adverse Event|10
2542373|NCT01517373|8800986|P6|Treatment Period|Medication error without AEs|2
2542374|NCT01517373|8800987|P5|Treatment Period|Medication error without AEs|0
2542375|NCT01517373|8800988|P4|Treatment Period|Medication error without AEs|1
2542376|NCT01517373|8800989|P3|Treatment Period|Medication error without AEs|2
2542377|NCT01517373|8800990|P2|Treatment Period|Medication error without AEs|0
2542378|NCT01517373|8800991|P1|Treatment Period|Medication error without AEs|0
2542379|NCT01517373|8800986|P6|Treatment Period|Lack of Efficacy|0
2542380|NCT01517373|8800987|P5|Treatment Period|Lack of Efficacy|2
2542381|NCT01517373|8800988|P4|Treatment Period|Lack of Efficacy|3
2542382|NCT01517373|8800989|P3|Treatment Period|Lack of Efficacy|1
2542383|NCT01517373|8800990|P2|Treatment Period|Lack of Efficacy|1
2542384|NCT01517373|8800991|P1|Treatment Period|Lack of Efficacy|0
2542385|NCT01517373|8800986|P6|Treatment Period|Protocol Violation|0
2542386|NCT01517373|8800987|P5|Treatment Period|Protocol Violation|1
2542387|NCT01517373|8800988|P4|Treatment Period|Protocol Violation|0
2542388|NCT01517373|8800989|P3|Treatment Period|Protocol Violation|0
2542389|NCT01517373|8800990|P2|Treatment Period|Protocol Violation|0
2542390|NCT01517373|8800991|P1|Treatment Period|Protocol Violation|0
2542391|NCT01517373|8800986|P6|Treatment Period|Other|0
2542392|NCT01517373|8800987|P5|Treatment Period|Other|1
2542393|NCT01517373|8800988|P4|Treatment Period|Other|0
2542394|NCT01517373|8800989|P3|Treatment Period|Other|0
2542395|NCT01517373|8800990|P2|Treatment Period|Other|0
2542396|NCT01517373|8800991|P1|Treatment Period|Other|0
2542397|NCT01517373|8800986|P6|Treatment Period|Withdrawal by Subject|3
2542398|NCT01517373|8800987|P5|Treatment Period|Withdrawal by Subject|2
2542399|NCT01517373|8800988|P4|Treatment Period|Withdrawal by Subject|2
2542400|NCT01517373|8800989|P3|Treatment Period|Withdrawal by Subject|2
2542401|NCT01517373|8800990|P2|Treatment Period|Withdrawal by Subject|3
2542402|NCT01517373|8800991|P1|Treatment Period|Withdrawal by Subject|0
2542403|NCT01517373|8800986|P6|Treatment Period|Lost to Follow-up|0
2542404|NCT01517373|8800987|P5|Treatment Period|Lost to Follow-up|0
2542405|NCT01517373|8800988|P4|Treatment Period|Lost to Follow-up|1
2542406|NCT01517373|8800989|P3|Treatment Period|Lost to Follow-up|1
2542407|NCT01517373|8800990|P2|Treatment Period|Lost to Follow-up|0
2542408|NCT01517373|8800991|P1|Treatment Period|Lost to Follow-up|0
2542409|NCT01517373|8800986|P6|Treatment Period|Adverse Event|2
2542410|NCT01517373|8800987|P5|Treatment Period|Adverse Event|0
2542411|NCT01517373|8800988|P4|Treatment Period|Adverse Event|0
2542412|NCT01517373|8800989|P3|Treatment Period|Adverse Event|0
2542413|NCT01517373|8800990|P2|Treatment Period|Adverse Event|0
2542414|NCT01517373|8800991|P1|Treatment Period|Adverse Event|0
2542415|NCT01517373|8800986|P6|Run-in Period|Other|0
2542416|NCT01517373|8800987|P5|Run-in Period|Other|0
2542417|NCT01517373|8800988|P4|Run-in Period|Other|0
2542418|NCT01517373|8800989|P3|Run-in Period|Other|0
2542419|NCT01517373|8800990|P2|Run-in Period|Other|0
2542420|NCT01517373|8800991|P1|Run-in Period|Other|1
2542421|NCT01517373|8800986|P6|Run-in Period|Sponsor Decision|0
2542422|NCT01517373|8800987|P5|Run-in Period|Sponsor Decision|0
2542423|NCT01517373|8800988|P4|Run-in Period|Sponsor Decision|0
2542424|NCT01517373|8800989|P3|Run-in Period|Sponsor Decision|0
2542425|NCT01517373|8800990|P2|Run-in Period|Sponsor Decision|0
2542426|NCT01517373|8800991|P1|Run-in Period|Sponsor Decision|3
2542427|NCT01517373|8800986|P6|Run-in Period|Withdrawal by Subject|0
2542428|NCT01517373|8800987|P5|Run-in Period|Withdrawal by Subject|0
2542429|NCT01517373|8800988|P4|Run-in Period|Withdrawal by Subject|0
2542430|NCT01517373|8800989|P3|Run-in Period|Withdrawal by Subject|0
2542431|NCT01517373|8800990|P2|Run-in Period|Withdrawal by Subject|0
2542432|NCT01517373|8800991|P1|Run-in Period|Withdrawal by Subject|12
2542433|NCT01517373|8800986|P6|Run-in Period|Lost to Follow-up|0
2542434|NCT01517373|8800987|P5|Run-in Period|Lost to Follow-up|0
2542435|NCT01517373|8800988|P4|Run-in Period|Lost to Follow-up|0
2542436|NCT01517373|8800989|P3|Run-in Period|Lost to Follow-up|0
2542437|NCT01517373|8800990|P2|Run-in Period|Lost to Follow-up|0
2542438|NCT01517373|8800991|P1|Run-in Period|Lost to Follow-up|1
2542439|NCT01517373|8800986|P6|Run-in Period|Did not meet eligibility criteria|0
2542440|NCT01517373|8800987|P5|Run-in Period|Did not meet eligibility criteria|0
2542441|NCT01517373|8800988|P4|Run-in Period|Did not meet eligibility criteria|0
2542442|NCT01517373|8800989|P3|Run-in Period|Did not meet eligibility criteria|0
2542443|NCT01517373|8800990|P2|Run-in Period|Did not meet eligibility criteria|0
2542444|NCT01517373|8800991|P1|Run-in Period|Did not meet eligibility criteria|34
2542445|NCT01517373|8800986|P6|Run-in Period|Adverse Event|0
2542446|NCT01517373|8800987|P5|Run-in Period|Adverse Event|0
2542447|NCT01517373|8800988|P4|Run-in Period|Adverse Event|0
2542448|NCT01517373|8800989|P3|Run-in Period|Adverse Event|0
2542449|NCT01517373|8800990|P2|Run-in Period|Adverse Event|0
2542450|NCT01517373|8800991|P1|Run-in Period|Adverse Event|5
2542451|NCT01517373|8800986|P6|Run-in Period|Death|0
2542452|NCT01517373|8800987|P5|Run-in Period|Death|0
2542453|NCT01517373|8800988|P4|Run-in Period|Death|0
2542454|NCT01517373|8800989|P3|Run-in Period|Death|0
2542455|NCT01517373|8800990|P2|Run-in Period|Death|0
2542456|NCT01517373|8800991|P1|Run-in Period|Death|1
2542457|NCT01517295|8801061|P2|Overall Study|Physician Decision|0
2542458|NCT01517295|8801062|P1|Overall Study|Physician Decision|1
2542459|NCT01517282|8801076|P4|Overall Study|Physician Decision|0
2542460|NCT01517282|8801077|P3|Overall Study|Physician Decision|0
2542461|NCT01517282|8801078|P2|Overall Study|Physician Decision|0
2542462|NCT01517282|8801079|P1|Overall Study|Physician Decision|1
2542463|NCT01517282|8801076|P4|Overall Study|Consent withdrawn|1
2542464|NCT01517282|8801077|P3|Overall Study|Consent withdrawn|1
2542465|NCT01517282|8801078|P2|Overall Study|Consent withdrawn|1
2542466|NCT01517282|8801079|P1|Overall Study|Consent withdrawn|0
2542467|NCT01517178|8801113|P2|Period 2|E.g. study termination|2
2542468|NCT01517178|8801114|P1|Period 2|E.g. study termination|2
2542469|NCT01517178|8801113|P2|Period 2|Withdrawal by Subject|0
2542470|NCT01517178|8801114|P1|Period 2|Withdrawal by Subject|3
2542471|NCT01517178|8801113|P2|Period 2|Adverse Event|0
2542472|NCT01517178|8801114|P1|Period 2|Adverse Event|1
2542473|NCT01517178|8801113|P2|Period 1|Withdrawal by Subject|1
2542474|NCT01517178|8801114|P1|Period 1|Withdrawal by Subject|0
2542475|NCT01517178|8801113|P2|Period 1|E.g. study termination|1
2542476|NCT01517178|8801114|P1|Period 1|E.g. study termination|3
2542477|NCT01517178|8801113|P2|Period 1|Lack of Efficacy|1
2542478|NCT01517178|8801114|P1|Period 1|Lack of Efficacy|0
2542479|NCT01517178|8801113|P2|Period 1|Adverse Event|2
2542480|NCT01517178|8801114|P1|Period 1|Adverse Event|1
2542481|NCT01516970|8801133|P2|Overall Study|Other|7
2542482|NCT01516970|8801134|P1|Overall Study|Other|9
2542483|NCT01516970|8801133|P2|Overall Study|Withdrawal by Subject|1
2542484|NCT01516970|8801134|P1|Overall Study|Withdrawal by Subject|1
2542485|NCT01516970|8801133|P2|Overall Study|Adverse Event|5
2542486|NCT01516970|8801134|P1|Overall Study|Adverse Event|1
2542487|NCT01516970|8801133|P2|Overall Study|Lost to Follow-up|8
2542488|NCT01516970|8801134|P1|Overall Study|Lost to Follow-up|7
2542489|NCT01516892|8801146|P1|Overall Study|Missing|1
2542490|NCT01516892|8801146|P1|Overall Study|Other Miscellaneous Reasons|43
2542491|NCT01516892|8801146|P1|Overall Study|Protocol Violation|60
2542492|NCT01516892|8801146|P1|Overall Study|Subject Withdrew Consent|92
2542493|NCT01516892|8801146|P1|Overall Study|Lost to Follow-up|82
2542494|NCT01516892|8801146|P1|Overall Study|Pregnancy|5
2542495|NCT01516892|8801146|P1|Overall Study|Lack of Efficacy|35
2542496|NCT01516892|8801146|P1|Overall Study|Adverse Event|25
2542497|NCT01516879|8801154|P2|Overall Study|Other|10
2542498|NCT01516879|8801155|P1|Overall Study|Other|5
2542499|NCT01516879|8801154|P2|Overall Study|Lost to Follow-up|11
2542500|NCT01516879|8801155|P1|Overall Study|Lost to Follow-up|2
2542501|NCT01516879|8801154|P2|Overall Study|Death|2
2542502|NCT01516879|8801155|P1|Overall Study|Death|0
2542503|NCT01516879|8801154|P2|Overall Study|Withdrawal by Subject|11
2542504|NCT01516879|8801155|P1|Overall Study|Withdrawal by Subject|9
2542505|NCT01516749|8801189|P1|Follow-up Off Therapy|Lost to Follow-up|1
2542506|NCT01516749|8801189|P1|Active Therapy|Lost to Follow-up|1
2542507|NCT01516736|8801198|P2|Overall Study|Other (not specified)|1
2542508|NCT01516736|8801199|P1|Overall Study|Other (not specified)|0
2542509|NCT01516736|8801198|P2|Overall Study|Protocol Violation|1
2542510|NCT01516736|8801199|P1|Overall Study|Protocol Violation|0
2542511|NCT01516736|8801198|P2|Overall Study|Lack of Efficacy|0
2542512|NCT01516736|8801199|P1|Overall Study|Lack of Efficacy|1
2542513|NCT01516736|8801198|P2|Overall Study|Physician Decision|1
2542514|NCT01516736|8801199|P1|Overall Study|Physician Decision|2
2542515|NCT01516736|8801198|P2|Overall Study|Death|1
2542516|NCT01516736|8801199|P1|Overall Study|Death|3
2542517|NCT01516736|8801198|P2|Overall Study|Adverse Event|5
2542518|NCT01516736|8801199|P1|Overall Study|Adverse Event|4
2542519|NCT01516736|8801198|P2|Overall Study|Withdrawal by Subject|4
2542520|NCT01516736|8801199|P1|Overall Study|Withdrawal by Subject|10
2542521|NCT01516437|8801253|P4|Overall Study|Reason not specified|1
2542522|NCT01516437|8801254|P3|Overall Study|Reason not specified|1
2542523|NCT01516437|8801255|P2|Overall Study|Reason not specified|0
2542524|NCT01516437|8801256|P1|Overall Study|Reason not specified|0
2542525|NCT01516034|8801328|P1|Overall Study|Lack of Efficacy|7
2542526|NCT01516034|8801328|P1|Overall Study|Physician Decision|1
2542527|NCT01516008|8801335|P3|Overall Study|Reason not specified|1
2542528|NCT01516008|8801336|P2|Overall Study|Reason not specified|0
2542529|NCT01516008|8801337|P1|Overall Study|Reason not specified|0
2542530|NCT01516008|8801335|P3|Overall Study|Protocol Violation|0
2542531|NCT01516008|8801336|P2|Overall Study|Protocol Violation|0
2542532|NCT01516008|8801337|P1|Overall Study|Protocol Violation|1
2542533|NCT01516008|8801335|P3|Overall Study|Lack of Efficacy|10
2542534|NCT01516008|8801336|P2|Overall Study|Lack of Efficacy|14
2542535|NCT01516008|8801337|P1|Overall Study|Lack of Efficacy|44
2542536|NCT01516008|8801335|P3|Overall Study|Adverse Event|7
2542537|NCT01516008|8801336|P2|Overall Study|Adverse Event|2
2542538|NCT01516008|8801337|P1|Overall Study|Adverse Event|0
2542539|NCT01515865|8801442|P3|Part B (Open-label)|Other|0
2542540|NCT01515865|8801443|P2|Part B (Open-label)|Other|0
2542541|NCT01515865|8801444|P1|Part B (Open-label)|Other|1
2542542|NCT01515865|8801442|P3|Part B (Open-label)|Withdrawal by Subject|0
2542543|NCT01515865|8801443|P2|Part B (Open-label)|Withdrawal by Subject|0
2542544|NCT01515865|8801444|P1|Part B (Open-label)|Withdrawal by Subject|1
2542545|NCT01515865|8801442|P3|Part A (Open-label)|Other|0
2542546|NCT01515865|8801443|P2|Part A (Open-label)|Other|0
2542547|NCT01515865|8801444|P1|Part A (Open-label)|Other|3
2542548|NCT01515748|8801454|P2|Overall Study|Ongoing|90
2542549|NCT01515748|8801455|P1|Overall Study|Ongoing|86
2542550|NCT01515748|8801454|P2|Overall Study|Lost to Follow-up|4
2542551|NCT01515748|8801455|P1|Overall Study|Lost to Follow-up|2
2542552|NCT01515748|8801454|P2|Overall Study|Withdrawal by Subject|41
2542553|NCT01515748|8801455|P1|Overall Study|Withdrawal by Subject|32
2542554|NCT01515475|8801538|P4|Overall Study|Lost to Follow-up|12
2542555|NCT01515475|8801539|P3|Overall Study|Lost to Follow-up|12
2542556|NCT01515475|8801540|P2|Overall Study|Lost to Follow-up|15
2542557|NCT01515475|8801541|P1|Overall Study|Lost to Follow-up|20
2542558|NCT01515423|8801615|P3|DOUBLE BLIND|Blind broken by investigator|0
2542559|NCT01515423|8801616|P2|DOUBLE BLIND|Blind broken by investigator|1
2542560|NCT01515423|8801617|P1|DOUBLE BLIND|Blind broken by investigator|0
2542561|NCT01515423|8801615|P3|DOUBLE BLIND|Other|12
2542562|NCT01515423|8801616|P2|DOUBLE BLIND|Other|6
2542563|NCT01515423|8801617|P1|DOUBLE BLIND|Other|0
2542564|NCT01515423|8801615|P3|DOUBLE BLIND|Withdrawal by Subject|53
2542565|NCT01515423|8801616|P2|DOUBLE BLIND|Withdrawal by Subject|50
2542566|NCT01515423|8801617|P1|DOUBLE BLIND|Withdrawal by Subject|0
2542567|NCT01515423|8801615|P3|DOUBLE BLIND|Pregnancy|0
2542568|NCT01515423|8801616|P2|DOUBLE BLIND|Pregnancy|2
2542569|NCT01515423|8801617|P1|DOUBLE BLIND|Pregnancy|0
2542570|NCT01515423|8801615|P3|DOUBLE BLIND|Lost to Follow-up|12
2542571|NCT01515423|8801616|P2|DOUBLE BLIND|Lost to Follow-up|7
2542572|NCT01515423|8801617|P1|DOUBLE BLIND|Lost to Follow-up|0
2542573|NCT01515423|8801615|P3|DOUBLE BLIND|Death|2
2542574|NCT01515423|8801616|P2|DOUBLE BLIND|Death|1
2542575|NCT01515423|8801617|P1|DOUBLE BLIND|Death|0
2542576|NCT01515423|8801615|P3|DOUBLE BLIND|Adverse Event|13
2542577|NCT01515423|8801616|P2|DOUBLE BLIND|Adverse Event|15
2542578|NCT01515423|8801617|P1|DOUBLE BLIND|Adverse Event|0
2542579|NCT01515423|8801615|P3|Open Label Phase|Other|0
2542580|NCT01515423|8801616|P2|Open Label Phase|Other|0
2542581|NCT01515423|8801617|P1|Open Label Phase|Other|28
2542582|NCT01515423|8801615|P3|Open Label Phase|excluded from DB Phase|0
2542583|NCT01515423|8801616|P2|Open Label Phase|excluded from DB Phase|0
2542584|NCT01515423|8801617|P1|Open Label Phase|excluded from DB Phase|70
2542585|NCT01515423|8801615|P3|Open Label Phase|Withdrawal by Subject|0
2542586|NCT01515423|8801616|P2|Open Label Phase|Withdrawal by Subject|0
2542587|NCT01515423|8801617|P1|Open Label Phase|Withdrawal by Subject|118
2542588|NCT01515423|8801615|P3|Open Label Phase|Lost to Follow-up|0
2542589|NCT01515423|8801616|P2|Open Label Phase|Lost to Follow-up|0
2542590|NCT01515423|8801617|P1|Open Label Phase|Lost to Follow-up|21
2542591|NCT01515423|8801615|P3|Open Label Phase|Lack of Efficacy|0
2542592|NCT01515423|8801616|P2|Open Label Phase|Lack of Efficacy|0
2542593|NCT01515423|8801617|P1|Open Label Phase|Lack of Efficacy|117
2542594|NCT01515423|8801615|P3|Open Label Phase|Death|0
2542595|NCT01515423|8801616|P2|Open Label Phase|Death|0
2542596|NCT01515423|8801617|P1|Open Label Phase|Death|2
2542597|NCT01515423|8801615|P3|Open Label Phase|Adverse Event|0
2542598|NCT01515423|8801616|P2|Open Label Phase|Adverse Event|0
2542599|NCT01515423|8801617|P1|Open Label Phase|Adverse Event|57
2542600|NCT01515306|8801658|P2|Overall Study|Ongoing receiving treatment|14
2542601|NCT01515306|8801659|P1|Overall Study|Ongoing receiving treatment|9
2542602|NCT01515306|8801658|P2|Overall Study|Progressive Disease|0
2542603|NCT01515306|8801659|P1|Overall Study|Progressive Disease|1
2542604|NCT01515306|8801658|P2|Overall Study|Adverse Event|0
2542605|NCT01515306|8801659|P1|Overall Study|Adverse Event|2
2542606|NCT01515189|8801672|P2|First Re-Induction Phase|Other|0
2542607|NCT01515189|8801673|P1|First Re-Induction Phase|Other|1
2542608|NCT01515189|8801672|P2|First Re-Induction Phase|No longer meets study criteria|0
2542609|NCT01515189|8801673|P1|First Re-Induction Phase|No longer meets study criteria|1
2542610|NCT01515189|8801672|P2|First Re-Induction Phase|Withdrawal by Subject|1
2542611|NCT01515189|8801673|P1|First Re-Induction Phase|Withdrawal by Subject|1
2542612|NCT01515189|8801672|P2|First Re-Induction Phase|Study drug toxicity|0
2542613|NCT01515189|8801673|P1|First Re-Induction Phase|Study drug toxicity|5
2542614|NCT01515189|8801672|P2|First Re-Induction Phase|Disease progression|14
2542615|NCT01515189|8801673|P1|First Re-Induction Phase|Disease progression|6
2542616|NCT01515189|8801672|P2|Induction|Other|4
2542617|NCT01515189|8801673|P1|Induction|Other|0
2542618|NCT01515189|8801672|P2|Induction|Lost to Follow-up|0
2542619|NCT01515189|8801673|P1|Induction|Lost to Follow-up|1
2542620|NCT01515189|8801672|P2|Induction|No longer meets study criteria|2
2542621|NCT01515189|8801673|P1|Induction|No longer meets study criteria|0
2542622|NCT01515189|8801672|P2|Induction|Withdrawal by Subject|9
2542623|NCT01515189|8801673|P1|Induction|Withdrawal by Subject|3
2542624|NCT01515189|8801672|P2|Induction|Adverse Event|9
2542625|NCT01515189|8801673|P1|Induction|Adverse Event|14
2542626|NCT01515189|8801672|P2|Induction|Death|17
2542627|NCT01515189|8801673|P1|Induction|Death|24
2542628|NCT01515189|8801672|P2|Induction|Study drug toxicity|36
2542629|NCT01515189|8801673|P1|Induction|Study drug toxicity|86
2542630|NCT01515189|8801672|P2|Induction|Disease Progression|155
2542631|NCT01515189|8801673|P1|Induction|Disease Progression|109
2542632|NCT01514864|8801761|P2|Overall Study|Study drug toxicity|0
2542633|NCT01514864|8801762|P1|Overall Study|Study drug toxicity|2
2542634|NCT01514864|8801761|P2|Overall Study|Disease progression|5
2542635|NCT01514864|8801762|P1|Overall Study|Disease progression|7
2542636|NCT01514760|8801787|P1|Overall Study|Lost to Follow-up|2
2542637|NCT01514682|8801800|P2|Overall Study|Physician Decision|3
2542638|NCT01514682|8801801|P1|Overall Study|Physician Decision|4
2542639|NCT01514682|8801800|P2|Overall Study|Withdrawal by Subject|3
2542640|NCT01514682|8801801|P1|Overall Study|Withdrawal by Subject|2
2542641|NCT01514461|8801835|P3|Overall Study|Death|0
2542642|NCT01514461|8801836|P2|Overall Study|Death|0
2542643|NCT01514461|8801837|P1|Overall Study|Death|1
2542644|NCT01514461|8801835|P3|Overall Study|Patient/guardian decision|1
2542645|NCT01514461|8801836|P2|Overall Study|Patient/guardian decision|1
2542646|NCT01514461|8801837|P1|Overall Study|Patient/guardian decision|1
2542647|NCT01514461|8801835|P3|Overall Study|Physician Decision|0
2542648|NCT01514461|8801836|P2|Overall Study|Physician Decision|1
2542649|NCT01514461|8801837|P1|Overall Study|Physician Decision|1
2542650|NCT01514461|8801835|P3|Overall Study|Adverse Event|3
2542651|NCT01514461|8801836|P2|Overall Study|Adverse Event|1
2542652|NCT01514461|8801837|P1|Overall Study|Adverse Event|2
2542653|NCT01514448|8801876|P2|Overall Study|New Cancer Therapy|0
2542654|NCT01514448|8801877|P1|Overall Study|New Cancer Therapy|1
2542655|NCT01514448|8801876|P2|Overall Study|Lost to Follow-up|0
2542656|NCT01514448|8801877|P1|Overall Study|Lost to Follow-up|2
2542657|NCT01514448|8801876|P2|Overall Study|Withdrawal by Subject|0
2542658|NCT01514448|8801877|P1|Overall Study|Withdrawal by Subject|2
2542659|NCT01514448|8801876|P2|Overall Study|Death|8
2542660|NCT01514448|8801877|P1|Overall Study|Death|7
2542661|NCT01514422|8801892|P1|Overall Study|Lost to Follow-up|1
2542662|NCT01514370|8801910|P2|Overall Study|Other|7
2542663|NCT01514370|8801911|P1|Overall Study|Other|6
2542664|NCT01514370|8801910|P2|Overall Study|Adverse Event|3
2542665|NCT01514370|8801911|P1|Overall Study|Adverse Event|1
2542666|NCT01514370|8801910|P2|Overall Study|Withdrawal by Subject|1
2542667|NCT01514370|8801911|P1|Overall Study|Withdrawal by Subject|2
2542668|NCT01514370|8801910|P2|Overall Study|Lost to Follow-up|2
2542669|NCT01514370|8801911|P1|Overall Study|Lost to Follow-up|0
2542670|NCT01514370|8801910|P2|Overall Study|Protocol Violation|3
2542671|NCT01514370|8801911|P1|Overall Study|Protocol Violation|2
2542672|NCT01514357|8801957|P2|Overall Study|Withdrawal by Subject|0
2542673|NCT01514357|8801958|P1|Overall Study|Withdrawal by Subject|2
2542674|NCT01514357|8801957|P2|Overall Study|Screen failure|0
2542675|NCT01514357|8801958|P1|Overall Study|Screen failure|2
2542676|NCT01514240|8801976|P2|Overall Study|Subject Decision|7
2542677|NCT01514240|8801977|P1|Overall Study|Subject Decision|2
2542678|NCT01514240|8801976|P2|Overall Study|Adverse Event|4
2542679|NCT01514240|8801977|P1|Overall Study|Adverse Event|4
2542680|NCT01514201|8802055|P4|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22
2542681|NCT01514201|8802056|P3|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
2542682|NCT01514201|8802057|P2|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
2542683|NCT01514201|8802058|P1|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
2542684|NCT01514201|8802055|P4|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7
2542685|NCT01514201|8802056|P3|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
2542686|NCT01514201|8802057|P2|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
2542687|NCT01514201|8802058|P1|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
2542688|NCT01514201|8802055|P4|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4
2542689|NCT01514201|8802056|P3|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
2542690|NCT01514201|8802057|P2|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
2542691|NCT01514201|8802058|P1|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
2542692|NCT01514201|8802055|P4|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6
2542693|NCT01514201|8802056|P3|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
2542694|NCT01514201|8802057|P2|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
2542695|NCT01514201|8802058|P1|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
2542696|NCT01514201|8802055|P4|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2
2542697|NCT01514201|8802056|P3|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
2542698|NCT01514201|8802057|P2|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
2542699|NCT01514201|8802058|P1|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
2542700|NCT01514201|8802055|P4|PHASE II: Veliparib + Radiation Therapy|Death|1
2542701|NCT01514201|8802056|P3|PHASE II: Veliparib + Radiation Therapy|Death|0
2542702|NCT01514201|8802057|P2|PHASE II: Veliparib + Radiation Therapy|Death|0
2542703|NCT01514201|8802058|P1|PHASE II: Veliparib + Radiation Therapy|Death|0
2542704|NCT01514201|8802055|P4|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2
2542705|NCT01514201|8802056|P3|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
2542706|NCT01514201|8802057|P2|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
2542707|NCT01514201|8802058|P1|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
2542708|NCT01514201|8802055|P4|PHASE II: Veliparib + Radiation Therapy|Ineligible|1
2542709|NCT01514201|8802056|P3|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
2542710|NCT01514201|8802057|P2|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
2542711|NCT01514201|8802058|P1|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
2542712|NCT01514201|8802055|P4|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
2542713|NCT01514201|8802056|P3|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
2542714|NCT01514201|8802057|P2|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1
2542715|NCT01514201|8802058|P1|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1
2542716|NCT01514201|8802055|P4|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
2542717|NCT01514201|8802056|P3|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5
2542718|NCT01514201|8802057|P2|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4
2542719|NCT01514201|8802058|P1|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4
2542720|NCT01514201|8802055|P4|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0
2542721|NCT01514201|8802056|P3|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1
2542722|NCT01514201|8802057|P2|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1
2542723|NCT01514201|8802058|P1|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0
2542724|NCT01514201|8802055|P4|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
2542725|NCT01514201|8802056|P3|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
2542726|NCT01514201|8802057|P2|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
2542727|NCT01514201|8802058|P1|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1
2542728|NCT01514136|8802156|P8|Test Period 2; Test C*|Protocol Violation|0
2542729|NCT01514136|8802157|P7|Test Period 2; Test C*|Protocol Violation|1
2542730|NCT01514136|8802158|P6|Test Period 2; Test C*|Protocol Violation|0
2542731|NCT01514136|8802159|P5|Test Period 2; Test C*|Protocol Violation|0
2542732|NCT01514136|8802160|P4|Test Period 2; Test C*|Protocol Violation|0
2542733|NCT01514136|8802161|P3|Test Period 2; Test C*|Protocol Violation|0
2542734|NCT01514136|8802162|P2|Test Period 2; Test C*|Protocol Violation|0
2542735|NCT01514136|8802163|P1|Test Period 2; Test C*|Protocol Violation|0
2542736|NCT01514136|8802156|P8|Test Period 2; Test C*|holiday|0
2542737|NCT01514136|8802157|P7|Test Period 2; Test C*|holiday|1
2542738|NCT01514136|8802158|P6|Test Period 2; Test C*|holiday|0
2542739|NCT01514136|8802159|P5|Test Period 2; Test C*|holiday|0
2542740|NCT01514136|8802160|P4|Test Period 2; Test C*|holiday|0
2542741|NCT01514136|8802161|P3|Test Period 2; Test C*|holiday|0
2542742|NCT01514136|8802162|P2|Test Period 2; Test C*|holiday|0
2542743|NCT01514136|8802163|P1|Test Period 2; Test C*|holiday|0
2542744|NCT01514136|8802156|P8|Test Period 2; Test C*|Withdrawal by Subject|0
2542745|NCT01514136|8802157|P7|Test Period 2; Test C*|Withdrawal by Subject|1
2542746|NCT01514136|8802158|P6|Test Period 2; Test C*|Withdrawal by Subject|0
2542747|NCT01514136|8802159|P5|Test Period 2; Test C*|Withdrawal by Subject|0
2542748|NCT01514136|8802160|P4|Test Period 2; Test C*|Withdrawal by Subject|0
2542749|NCT01514136|8802161|P3|Test Period 2; Test C*|Withdrawal by Subject|0
2542750|NCT01514136|8802162|P2|Test Period 2; Test C*|Withdrawal by Subject|0
2542751|NCT01514136|8802163|P1|Test Period 2; Test C*|Withdrawal by Subject|0
2542752|NCT01514136|8802156|P8|Test Period 2; Test B*|Withdrawal by Subject|0
2542753|NCT01514136|8802157|P7|Test Period 2; Test B*|Withdrawal by Subject|0
2542754|NCT01514136|8802158|P6|Test Period 2; Test B*|Withdrawal by Subject|2
2542755|NCT01514136|8802159|P5|Test Period 2; Test B*|Withdrawal by Subject|0
2542756|NCT01514136|8802160|P4|Test Period 2; Test B*|Withdrawal by Subject|0
2542757|NCT01514136|8802161|P3|Test Period 2; Test B*|Withdrawal by Subject|0
2542758|NCT01514136|8802162|P2|Test Period 2; Test B*|Withdrawal by Subject|0
2542759|NCT01514136|8802163|P1|Test Period 2; Test B*|Withdrawal by Subject|0
2542760|NCT01514136|8802156|P8|Test Period 2; Test A*|Holiday|0
2542761|NCT01514136|8802157|P7|Test Period 2; Test A*|Holiday|0
2542762|NCT01514136|8802158|P6|Test Period 2; Test A*|Holiday|0
2542763|NCT01514136|8802159|P5|Test Period 2; Test A*|Holiday|1
2542764|NCT01514136|8802160|P4|Test Period 2; Test A*|Holiday|0
2542765|NCT01514136|8802161|P3|Test Period 2; Test A*|Holiday|0
2542766|NCT01514136|8802162|P2|Test Period 2; Test A*|Holiday|0
2542767|NCT01514136|8802163|P1|Test Period 2; Test A*|Holiday|0
2542768|NCT01514136|8802156|P8|Test Period 2; Test A*|Adverse Event|0
2542769|NCT01514136|8802157|P7|Test Period 2; Test A*|Adverse Event|0
2542770|NCT01514136|8802158|P6|Test Period 2; Test A*|Adverse Event|0
2542771|NCT01514136|8802159|P5|Test Period 2; Test A*|Adverse Event|1
2542772|NCT01514136|8802160|P4|Test Period 2; Test A*|Adverse Event|0
2542773|NCT01514136|8802161|P3|Test Period 2; Test A*|Adverse Event|0
2542774|NCT01514136|8802162|P2|Test Period 2; Test A*|Adverse Event|0
2542775|NCT01514136|8802163|P1|Test Period 2; Test A*|Adverse Event|0
2542776|NCT01514136|8802156|P8|Test Period 1; Test D|Subject took a break due to holiday|0
2542777|NCT01514136|8802157|P7|Test Period 1; Test D|Subject took a break due to holiday|0
2542778|NCT01514136|8802158|P6|Test Period 1; Test D|Subject took a break due to holiday|0
2542779|NCT01514136|8802159|P5|Test Period 1; Test D|Subject took a break due to holiday|0
2542780|NCT01514136|8802160|P4|Test Period 1; Test D|Subject took a break due to holiday|2
2542781|NCT01514136|8802161|P3|Test Period 1; Test D|Subject took a break due to holiday|0
2542782|NCT01514136|8802162|P2|Test Period 1; Test D|Subject took a break due to holiday|0
2542783|NCT01514136|8802163|P1|Test Period 1; Test D|Subject took a break due to holiday|0
2542784|NCT01514136|8802156|P8|Test Period 1; Test B|Withdrawal by Subject|0
2542785|NCT01514136|8802157|P7|Test Period 1; Test B|Withdrawal by Subject|0
2542786|NCT01514136|8802158|P6|Test Period 1; Test B|Withdrawal by Subject|0
2542787|NCT01514136|8802159|P5|Test Period 1; Test B|Withdrawal by Subject|0
2542788|NCT01514136|8802160|P4|Test Period 1; Test B|Withdrawal by Subject|0
2542789|NCT01514136|8802161|P3|Test Period 1; Test B|Withdrawal by Subject|0
2542790|NCT01514136|8802162|P2|Test Period 1; Test B|Withdrawal by Subject|1
2542791|NCT01514136|8802163|P1|Test Period 1; Test B|Withdrawal by Subject|0
2542792|NCT01514136|8802156|P8|Test Period 1; Test A|Break from study holiday|0
2542793|NCT01514136|8802157|P7|Test Period 1; Test A|Break from study holiday|0
2542794|NCT01514136|8802158|P6|Test Period 1; Test A|Break from study holiday|0
2542795|NCT01514136|8802159|P5|Test Period 1; Test A|Break from study holiday|0
2542796|NCT01514136|8802160|P4|Test Period 1; Test A|Break from study holiday|0
2542797|NCT01514136|8802161|P3|Test Period 1; Test A|Break from study holiday|0
2542798|NCT01514136|8802162|P2|Test Period 1; Test A|Break from study holiday|0
2542799|NCT01514136|8802163|P1|Test Period 1; Test A|Break from study holiday|2
2542800|NCT01514136|8802156|P8|Test Period 1; Test A|Protocol Violation|0
2542801|NCT01514136|8802157|P7|Test Period 1; Test A|Protocol Violation|0
2542802|NCT01514136|8802158|P6|Test Period 1; Test A|Protocol Violation|0
2542803|NCT01514136|8802159|P5|Test Period 1; Test A|Protocol Violation|0
2542804|NCT01514136|8802160|P4|Test Period 1; Test A|Protocol Violation|0
2542805|NCT01514136|8802161|P3|Test Period 1; Test A|Protocol Violation|0
2542806|NCT01514136|8802162|P2|Test Period 1; Test A|Protocol Violation|0
2542807|NCT01514136|8802163|P1|Test Period 1; Test A|Protocol Violation|1
2542808|NCT01513967|8802197|P8|Overall Study|Physician Decision|0
2542809|NCT01513967|8802198|P7|Overall Study|Physician Decision|0
2542810|NCT01513967|8802199|P6|Overall Study|Physician Decision|1
2542811|NCT01513967|8802200|P5|Overall Study|Physician Decision|0
2542812|NCT01513967|8802201|P4|Overall Study|Physician Decision|0
2542813|NCT01513967|8802202|P3|Overall Study|Physician Decision|0
2542814|NCT01513967|8802203|P2|Overall Study|Physician Decision|0
2542815|NCT01513967|8802204|P1|Overall Study|Physician Decision|0
2542816|NCT01513967|8802197|P8|Overall Study|excluded due to positive drug screen|2
2542817|NCT01513967|8802198|P7|Overall Study|excluded due to positive drug screen|0
2542818|NCT01513967|8802199|P6|Overall Study|excluded due to positive drug screen|0
2542819|NCT01513967|8802200|P5|Overall Study|excluded due to positive drug screen|0
2542820|NCT01513967|8802201|P4|Overall Study|excluded due to positive drug screen|0
2542821|NCT01513967|8802202|P3|Overall Study|excluded due to positive drug screen|0
2542822|NCT01513967|8802203|P2|Overall Study|excluded due to positive drug screen|0
2542823|NCT01513967|8802204|P1|Overall Study|excluded due to positive drug screen|0
2542824|NCT01513967|8802197|P8|Overall Study|missed a study visit|0
2542825|NCT01513967|8802198|P7|Overall Study|missed a study visit|1
2542826|NCT01513967|8802199|P6|Overall Study|missed a study visit|0
2542827|NCT01513967|8802200|P5|Overall Study|missed a study visit|0
2542828|NCT01513967|8802201|P4|Overall Study|missed a study visit|0
2542829|NCT01513967|8802202|P3|Overall Study|missed a study visit|0
2542830|NCT01513967|8802203|P2|Overall Study|missed a study visit|0
2542831|NCT01513967|8802204|P1|Overall Study|missed a study visit|0
2542832|NCT01513967|8802197|P8|Overall Study|Pregnancy|0
2542833|NCT01513967|8802198|P7|Overall Study|Pregnancy|1
2542834|NCT01513967|8802199|P6|Overall Study|Pregnancy|0
2542835|NCT01513967|8802200|P5|Overall Study|Pregnancy|0
2542836|NCT01513967|8802201|P4|Overall Study|Pregnancy|0
2542837|NCT01513967|8802202|P3|Overall Study|Pregnancy|0
2542838|NCT01513967|8802203|P2|Overall Study|Pregnancy|0
2542839|NCT01513967|8802204|P1|Overall Study|Pregnancy|0
2542840|NCT01513759|8802262|P1|Overall Study|Death during catheter placement|1
2542841|NCT01513759|8802262|P1|Overall Study|Protocol Violation|4
2542842|NCT01513590|8802273|P2|Overall Study|Unclassified|10
2542843|NCT01513590|8802274|P1|Overall Study|Unclassified|5
2542844|NCT01513590|8802273|P2|Overall Study|Withdrawal Criteria|0
2542845|NCT01513590|8802274|P1|Overall Study|Withdrawal Criteria|3
2542846|NCT01513590|8802273|P2|Overall Study|Adverse Event|3
2542847|NCT01513590|8802274|P1|Overall Study|Adverse Event|2
2542848|NCT01513551|8802295|P3|Overall Study|Randomized but not vaccinated|1
2542849|NCT01513551|8802296|P2|Overall Study|Randomized but not vaccinated|0
2542850|NCT01513551|8802297|P1|Overall Study|Randomized but not vaccinated|0
2542851|NCT01513551|8802295|P3|Overall Study|Withdrawal by Subject|2
2542852|NCT01513551|8802296|P2|Overall Study|Withdrawal by Subject|0
2542853|NCT01513551|8802297|P1|Overall Study|Withdrawal by Subject|1
2542854|NCT01513551|8802295|P3|Overall Study|Lost to Follow-up|2
2542855|NCT01513551|8802296|P2|Overall Study|Lost to Follow-up|5
2542856|NCT01513551|8802297|P1|Overall Study|Lost to Follow-up|3
2542857|NCT01513551|8802295|P3|Overall Study|Death|0
2542858|NCT01513551|8802296|P2|Overall Study|Death|1
2542859|NCT01513551|8802297|P1|Overall Study|Death|0
2542860|NCT01513473|8802329|P2|Extension Trial (26 Weeks)|Withdrawal by Subject|5
2542861|NCT01513473|8802330|P1|Extension Trial (26 Weeks)|Withdrawal by Subject|1
2542862|NCT01513473|8802329|P2|Extension Trial (26 Weeks)|Adverse Event|1
2542863|NCT01513473|8802330|P1|Extension Trial (26 Weeks)|Adverse Event|0
2542864|NCT01513473|8802329|P2|Main Trial (26 Weeks)|Unclassified|2
2542865|NCT01513473|8802330|P1|Main Trial (26 Weeks)|Unclassified|0
2542866|NCT01513473|8802329|P2|Main Trial (26 Weeks)|Withdrawal by Subject|7
2542867|NCT01513473|8802330|P1|Main Trial (26 Weeks)|Withdrawal by Subject|4
2542868|NCT01513473|8802329|P2|Main Trial (26 Weeks)|Adverse Event|2
2542869|NCT01513473|8802330|P1|Main Trial (26 Weeks)|Adverse Event|0
2542870|NCT01513460|8802357|P3|Overall Study|Abnormal test procedure|0
2542871|NCT01513460|8802358|P2|Overall Study|Abnormal test procedure|0
2542872|NCT01513460|8802359|P1|Overall Study|Abnormal test procedure|1
2542873|NCT01513460|8802357|P3|Overall Study|Adverse Event|23
2542874|NCT01513460|8802358|P2|Overall Study|Adverse Event|18
2542875|NCT01513460|8802359|P1|Overall Study|Adverse Event|16
2542876|NCT01513460|8802357|P3|Overall Study|Withdrawal by Subject|21
2542877|NCT01513460|8802358|P2|Overall Study|Withdrawal by Subject|8
2542878|NCT01513460|8802359|P1|Overall Study|Withdrawal by Subject|7
2542879|NCT01513460|8802357|P3|Overall Study|Protocol deviations|3
2542880|NCT01513460|8802358|P2|Overall Study|Protocol deviations|4
2542881|NCT01513460|8802359|P1|Overall Study|Protocol deviations|3
2542882|NCT01513460|8802357|P3|Overall Study|Lack of Efficacy|5
2542883|NCT01513460|8802358|P2|Overall Study|Lack of Efficacy|2
2542884|NCT01513460|8802359|P1|Overall Study|Lack of Efficacy|1
2542885|NCT01513460|8802357|P3|Overall Study|Abnormal laboratory value|1
2542886|NCT01513460|8802358|P2|Overall Study|Abnormal laboratory value|0
2542887|NCT01513460|8802359|P1|Overall Study|Abnormal laboratory value|1
2542888|NCT01513460|8802357|P3|Overall Study|Lost to Follow-up|2
2542889|NCT01513460|8802358|P2|Overall Study|Lost to Follow-up|0
2542890|NCT01513460|8802359|P1|Overall Study|Lost to Follow-up|0
2542891|NCT01513460|8802357|P3|Overall Study|Death|1
2542892|NCT01513460|8802358|P2|Overall Study|Death|0
2542893|NCT01513460|8802359|P1|Overall Study|Death|0
2542894|NCT01513330|8802394|P2|Standard Care First,|Other|0
2542895|NCT01513330|8802395|P1|Standard Care First,|Other|1
2542896|NCT01513330|8802394|P2|Standard Care First,|Withdrawal by Subject|2
2542897|NCT01513330|8802395|P1|Standard Care First,|Withdrawal by Subject|1
2542898|NCT01513330|8802394|P2|Standard Care First,|Lack of Efficacy|2
2542899|NCT01513330|8802395|P1|Standard Care First,|Lack of Efficacy|2
2542900|NCT01513330|8802394|P2|SenSura Mio First,|Other|0
2542901|NCT01513330|8802395|P1|SenSura Mio First,|Other|1
2542902|NCT01513330|8802394|P2|SenSura Mio First,|Withdrawal by Subject|1
2542903|NCT01513330|8802395|P1|SenSura Mio First,|Withdrawal by Subject|1
2542904|NCT01513330|8802394|P2|SenSura Mio First,|Lack of Efficacy|1
2542905|NCT01513330|8802395|P1|SenSura Mio First,|Lack of Efficacy|0
2542906|NCT01513330|8802394|P2|SenSura Mio First,|Adverse Event|0
2542907|NCT01513330|8802395|P1|SenSura Mio First,|Adverse Event|2
2542908|NCT01513317|8802403|P2|Overall Study|Other|1
2542909|NCT01513317|8802404|P1|Overall Study|Other|0
2542910|NCT01513317|8802403|P2|Overall Study|Study terminated by sponsor|18
2542911|NCT01513317|8802404|P1|Overall Study|Study terminated by sponsor|18
2542912|NCT01513317|8802403|P2|Overall Study|Death|1
2542913|NCT01513317|8802404|P1|Overall Study|Death|1
2542914|NCT01513317|8802403|P2|Overall Study|Withdrawal by Subject|4
2542915|NCT01513317|8802404|P1|Overall Study|Withdrawal by Subject|15
2542916|NCT01513291|8802422|P5|Run-out Period|Withdrawal by Subject|0
2542917|NCT01513291|8802423|P4|Run-out Period|Withdrawal by Subject|1
2542918|NCT01513291|8802424|P3|Run-out Period|Withdrawal by Subject|0
2542919|NCT01513291|8802425|P2|Run-out Period|Withdrawal by Subject|0
2542920|NCT01513291|8802426|P1|Run-out Period|Withdrawal by Subject|0
2542921|NCT01513291|8802422|P5|Run-out Period|Lost to Follow-up|0
2542922|NCT01513291|8802423|P4|Run-out Period|Lost to Follow-up|1
2542923|NCT01513291|8802424|P3|Run-out Period|Lost to Follow-up|0
2542924|NCT01513291|8802425|P2|Run-out Period|Lost to Follow-up|0
2542925|NCT01513291|8802426|P1|Run-out Period|Lost to Follow-up|0
2542926|NCT01513291|8802422|P5|Treatment Period|Randomized not treated|0
2542927|NCT01513291|8802423|P4|Treatment Period|Randomized not treated|0
2542928|NCT01513291|8802424|P3|Treatment Period|Randomized not treated|0
2542929|NCT01513291|8802425|P2|Treatment Period|Randomized not treated|2
2542930|NCT01513291|8802426|P1|Treatment Period|Randomized not treated|0
2542931|NCT01513291|8802422|P5|Treatment Period|Withdrawal by Subject|0
2542932|NCT01513291|8802423|P4|Treatment Period|Withdrawal by Subject|0
2542933|NCT01513291|8802424|P3|Treatment Period|Withdrawal by Subject|0
2542934|NCT01513291|8802425|P2|Treatment Period|Withdrawal by Subject|5
2542935|NCT01513291|8802426|P1|Treatment Period|Withdrawal by Subject|8
2542936|NCT01513291|8802422|P5|Treatment Period|Protocol Violation|0
2542937|NCT01513291|8802423|P4|Treatment Period|Protocol Violation|0
2542938|NCT01513291|8802424|P3|Treatment Period|Protocol Violation|0
2542939|NCT01513291|8802425|P2|Treatment Period|Protocol Violation|2
2542940|NCT01513291|8802426|P1|Treatment Period|Protocol Violation|1
2542941|NCT01513291|8802422|P5|Treatment Period|Physician Decision|0
2542942|NCT01513291|8802423|P4|Treatment Period|Physician Decision|0
2542943|NCT01513291|8802424|P3|Treatment Period|Physician Decision|0
2542944|NCT01513291|8802425|P2|Treatment Period|Physician Decision|0
2542945|NCT01513291|8802426|P1|Treatment Period|Physician Decision|1
2542946|NCT01513291|8802422|P5|Treatment Period|Lost to Follow-up|0
2542947|NCT01513291|8802423|P4|Treatment Period|Lost to Follow-up|0
2542948|NCT01513291|8802424|P3|Treatment Period|Lost to Follow-up|0
2542949|NCT01513291|8802425|P2|Treatment Period|Lost to Follow-up|3
2542950|NCT01513291|8802426|P1|Treatment Period|Lost to Follow-up|2
2542951|NCT01513291|8802422|P5|Treatment Period|Lack of Efficacy|0
2542952|NCT01513291|8802423|P4|Treatment Period|Lack of Efficacy|0
2542953|NCT01513291|8802424|P3|Treatment Period|Lack of Efficacy|0
2542954|NCT01513291|8802425|P2|Treatment Period|Lack of Efficacy|0
2542955|NCT01513291|8802426|P1|Treatment Period|Lack of Efficacy|3
2542956|NCT01513291|8802422|P5|Treatment Period|Adverse Event|0
2542957|NCT01513291|8802423|P4|Treatment Period|Adverse Event|0
2542958|NCT01513291|8802424|P3|Treatment Period|Adverse Event|0
2542959|NCT01513291|8802425|P2|Treatment Period|Adverse Event|4
2542960|NCT01513291|8802426|P1|Treatment Period|Adverse Event|8
2542961|NCT01513239|8802454|P6|Period 2: 9 Month Extension Phase|Technical Problems|1
2542962|NCT01513239|8802455|P5|Period 2: 9 Month Extension Phase|Technical Problems|1
2542963|NCT01513239|8802456|P4|Period 2: 9 Month Extension Phase|Technical Problems|0
2542964|NCT01513239|8802457|P3|Period 2: 9 Month Extension Phase|Technical Problems|0
2542965|NCT01513239|8802458|P2|Period 2: 9 Month Extension Phase|Technical Problems|0
2542966|NCT01513239|8802459|P1|Period 2: 9 Month Extension Phase|Technical Problems|0
2542967|NCT01513239|8802454|P6|Period 2: 9 Month Extension Phase|Physician Decision|0
2542968|NCT01513239|8802455|P5|Period 2: 9 Month Extension Phase|Physician Decision|0
2542969|NCT01513239|8802456|P4|Period 2: 9 Month Extension Phase|Physician Decision|1
2542970|NCT01513239|8802457|P3|Period 2: 9 Month Extension Phase|Physician Decision|0
2542971|NCT01513239|8802458|P2|Period 2: 9 Month Extension Phase|Physician Decision|0
2542972|NCT01513239|8802459|P1|Period 2: 9 Month Extension Phase|Physician Decision|0
2542973|NCT01513239|8802454|P6|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
2542974|NCT01513239|8802455|P5|Period 2: 9 Month Extension Phase|Lost to Follow-up|1
2542975|NCT01513239|8802456|P4|Period 2: 9 Month Extension Phase|Lost to Follow-up|2
2542976|NCT01513239|8802457|P3|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
2542977|NCT01513239|8802458|P2|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
2542978|NCT01513239|8802459|P1|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
2542979|NCT01513239|8802454|P6|Period 2: 9 Month Extension Phase|Death|2
2542980|NCT01513239|8802455|P5|Period 2: 9 Month Extension Phase|Death|5
2542981|NCT01513239|8802456|P4|Period 2: 9 Month Extension Phase|Death|2
2542982|NCT01513239|8802457|P3|Period 2: 9 Month Extension Phase|Death|0
2542983|NCT01513239|8802458|P2|Period 2: 9 Month Extension Phase|Death|0
2542984|NCT01513239|8802459|P1|Period 2: 9 Month Extension Phase|Death|0
2542985|NCT01513239|8802454|P6|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2
2542986|NCT01513239|8802455|P5|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3
2542987|NCT01513239|8802456|P4|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5
2542988|NCT01513239|8802457|P3|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
2542989|NCT01513239|8802458|P2|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
2542990|NCT01513239|8802459|P1|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
2542991|NCT01513239|8802454|P6|Period 1: Main Phase|Withdrawal by Subject|0
2542992|NCT01513239|8802455|P5|Period 1: Main Phase|Withdrawal by Subject|0
2542993|NCT01513239|8802456|P4|Period 1: Main Phase|Withdrawal by Subject|0
2542994|NCT01513239|8802457|P3|Period 1: Main Phase|Withdrawal by Subject|42
2542995|NCT01513239|8802458|P2|Period 1: Main Phase|Withdrawal by Subject|29
2542996|NCT01513239|8802459|P1|Period 1: Main Phase|Withdrawal by Subject|27
2542997|NCT01513239|8802454|P6|Period 1: Main Phase|Technical Problems|0
2542998|NCT01513239|8802455|P5|Period 1: Main Phase|Technical Problems|0
2542999|NCT01513239|8802456|P4|Period 1: Main Phase|Technical Problems|0
2543000|NCT01513239|8802457|P3|Period 1: Main Phase|Technical Problems|0
2543001|NCT01513239|8802458|P2|Period 1: Main Phase|Technical Problems|2
2543002|NCT01513239|8802459|P1|Period 1: Main Phase|Technical Problems|1
2543003|NCT01513239|8802454|P6|Period 1: Main Phase|Protocol Violation|0
2543004|NCT01513239|8802455|P5|Period 1: Main Phase|Protocol Violation|0
2543005|NCT01513239|8802456|P4|Period 1: Main Phase|Protocol Violation|0
2543006|NCT01513239|8802457|P3|Period 1: Main Phase|Protocol Violation|2
2543007|NCT01513239|8802458|P2|Period 1: Main Phase|Protocol Violation|2
2543008|NCT01513239|8802459|P1|Period 1: Main Phase|Protocol Violation|2
2543009|NCT01513239|8802454|P6|Period 1: Main Phase|Physician Decision|0
2543010|NCT01513239|8802455|P5|Period 1: Main Phase|Physician Decision|0
2543011|NCT01513239|8802456|P4|Period 1: Main Phase|Physician Decision|0
2543012|NCT01513239|8802457|P3|Period 1: Main Phase|Physician Decision|4
2543013|NCT01513239|8802458|P2|Period 1: Main Phase|Physician Decision|4
2543014|NCT01513239|8802459|P1|Period 1: Main Phase|Physician Decision|4
2543015|NCT01513239|8802454|P6|Period 1: Main Phase|Lost to Follow-up|0
2543016|NCT01513239|8802455|P5|Period 1: Main Phase|Lost to Follow-up|0
2543017|NCT01513239|8802456|P4|Period 1: Main Phase|Lost to Follow-up|0
2543018|NCT01513239|8802457|P3|Period 1: Main Phase|Lost to Follow-up|6
2543019|NCT01513239|8802458|P2|Period 1: Main Phase|Lost to Follow-up|10
2543020|NCT01513239|8802459|P1|Period 1: Main Phase|Lost to Follow-up|11
2543021|NCT01513239|8802454|P6|Period 1: Main Phase|Death|0
2543022|NCT01513239|8802455|P5|Period 1: Main Phase|Death|0
2543023|NCT01513239|8802456|P4|Period 1: Main Phase|Death|0
2543024|NCT01513239|8802457|P3|Period 1: Main Phase|Death|32
2543025|NCT01513239|8802458|P2|Period 1: Main Phase|Death|22
2543026|NCT01513239|8802459|P1|Period 1: Main Phase|Death|29
2543027|NCT01513239|8802454|P6|Period 1: Main Phase|Adverse Event|0
2543028|NCT01513239|8802455|P5|Period 1: Main Phase|Adverse Event|0
2543029|NCT01513239|8802456|P4|Period 1: Main Phase|Adverse Event|0
2543030|NCT01513239|8802457|P3|Period 1: Main Phase|Adverse Event|2
2543031|NCT01513239|8802458|P2|Period 1: Main Phase|Adverse Event|1
2543032|NCT01513239|8802459|P1|Period 1: Main Phase|Adverse Event|1
2543033|NCT01513148|8802512|P2|Overall Study|Protocol Violation|2
2543034|NCT01513148|8802513|P1|Overall Study|Protocol Violation|2
2543035|NCT01512979|8802580|P2|Overall Study|Reason other than stated above|9
2543036|NCT01512979|8802581|P1|Overall Study|Reason other than stated above|13
2543037|NCT01512979|8802580|P2|Overall Study|Withdrawal by Subject|2
2543038|NCT01512979|8802581|P1|Overall Study|Withdrawal by Subject|1
2543039|NCT01512979|8802580|P2|Overall Study|Lost to Follow-up|5
2543040|NCT01512979|8802581|P1|Overall Study|Lost to Follow-up|2
2543041|NCT01512979|8802580|P2|Overall Study|Protocol Violation|4
2543042|NCT01512979|8802581|P1|Overall Study|Protocol Violation|1
2543043|NCT01512979|8802580|P2|Overall Study|Adverse Event|2
2543044|NCT01512979|8802581|P1|Overall Study|Adverse Event|2
2543045|NCT01512745|8802681|P2|Overall Study|Protocol Violation|0
2543046|NCT01512745|8802682|P1|Overall Study|Protocol Violation|1
2543047|NCT01512745|8802681|P2|Overall Study|Lack of Efficacy|2
2543048|NCT01512745|8802682|P1|Overall Study|Lack of Efficacy|2
2543049|NCT01512745|8802681|P2|Overall Study|Lost to Follow-up|0
2543050|NCT01512745|8802682|P1|Overall Study|Lost to Follow-up|4
2543051|NCT01512745|8802681|P2|Overall Study|Withdrawal by Subject|2
2543052|NCT01512745|8802682|P1|Overall Study|Withdrawal by Subject|2
2543053|NCT01512745|8802681|P2|Overall Study|Death|13
2543054|NCT01512745|8802682|P1|Overall Study|Death|9
2543055|NCT01512745|8802681|P2|Overall Study|Adverse Event|3
2543056|NCT01512745|8802682|P1|Overall Study|Adverse Event|22
2543057|NCT01512693|8802698|P2|Overall Study|Withdrawal by Subject|1
2543058|NCT01512693|8802699|P1|Overall Study|Withdrawal by Subject|0
2543059|NCT01512368|8802739|P1|Overall Study|Protocol Violation|3
2543060|NCT01512264|8802752|P4|Overall Study|Lost to Follow-up|1
2543061|NCT01512264|8802753|P3|Overall Study|Lost to Follow-up|0
2543062|NCT01512264|8802754|P2|Overall Study|Lost to Follow-up|0
2543063|NCT01512264|8802755|P1|Overall Study|Lost to Follow-up|0
2543064|NCT01512160|8802894|P4|Overall Study|Withdrawal by Subject|1
2543065|NCT01512160|8802895|P3|Overall Study|Withdrawal by Subject|0
2543066|NCT01512160|8802896|P2|Overall Study|Withdrawal by Subject|0
2543067|NCT01512160|8802897|P1|Overall Study|Withdrawal by Subject|1
2543068|NCT01512160|8802894|P4|Overall Study|Lost to Follow-up|0
2543069|NCT01512160|8802895|P3|Overall Study|Lost to Follow-up|0
2543070|NCT01512160|8802896|P2|Overall Study|Lost to Follow-up|0
2543071|NCT01512160|8802897|P1|Overall Study|Lost to Follow-up|1
2543072|NCT01512108|8802989|P2|Overall Study|Unclassified|3
2543073|NCT01512108|8802990|P1|Overall Study|Unclassified|11
2543074|NCT01512108|8802989|P2|Overall Study|Withdrawal Criteria|0
2543075|NCT01512108|8802990|P1|Overall Study|Withdrawal Criteria|1
2543076|NCT01512108|8802989|P2|Overall Study|Protocol Violation|2
2543077|NCT01512108|8802990|P1|Overall Study|Protocol Violation|1
2543078|NCT01512108|8802989|P2|Overall Study|Adverse Event|4
2543079|NCT01512108|8802990|P1|Overall Study|Adverse Event|9
2543080|NCT01511939|8803016|P3|Overall Study|Withdrawal by Subject|0
2543081|NCT01511939|8803017|P2|Overall Study|Withdrawal by Subject|1
2543082|NCT01511939|8803018|P1|Overall Study|Withdrawal by Subject|2
2543083|NCT01511536|8803047|P3|Phase 2|Other|9
2543084|NCT01511536|8803048|P2|Phase 2|Other|0
2543085|NCT01511536|8803049|P1|Phase 2|Other|0
2543086|NCT01511536|8803047|P3|Phase 1|Other|0
2543087|NCT01511536|8803048|P2|Phase 1|Other|1
2543088|NCT01511536|8803049|P1|Phase 1|Other|0
2543089|NCT01511445|8803071|P2|Overall Study|Protocol Violation|0
2543090|NCT01511445|8803072|P1|Overall Study|Protocol Violation|1
2543091|NCT01511445|8803071|P2|Overall Study|Protocol Violation|3
2543092|NCT01511445|8803072|P1|Overall Study|Protocol Violation|1
2543093|NCT01511445|8803071|P2|Overall Study|Lost to Follow-up|1
2543094|NCT01511445|8803072|P1|Overall Study|Lost to Follow-up|3
2543095|NCT01511419|8803082|P2|Dose 2|Physician Decision|0
2543096|NCT01511419|8803083|P1|Dose 2|Physician Decision|1
2543097|NCT01511250|8803195|P10|Overall Study|Protocol Violation|0
2543098|NCT01511250|8803196|P9|Overall Study|Protocol Violation|0
2543099|NCT01511250|8803197|P8|Overall Study|Protocol Violation|0
2543100|NCT01511250|8803198|P7|Overall Study|Protocol Violation|0
2543101|NCT01511250|8803199|P6|Overall Study|Protocol Violation|0
2543102|NCT01511250|8803200|P5|Overall Study|Protocol Violation|0
2543103|NCT01511250|8803201|P4|Overall Study|Protocol Violation|0
2543104|NCT01511250|8803202|P3|Overall Study|Protocol Violation|1
2543105|NCT01511250|8803203|P2|Overall Study|Protocol Violation|2
2543106|NCT01511250|8803204|P1|Overall Study|Protocol Violation|0
2543107|NCT01511250|8803195|P10|Overall Study|Lost to Follow-up|5
2543108|NCT01511250|8803196|P9|Overall Study|Lost to Follow-up|13
2543109|NCT01511250|8803197|P8|Overall Study|Lost to Follow-up|3
2543110|NCT01511250|8803198|P7|Overall Study|Lost to Follow-up|2
2543111|NCT01511250|8803199|P6|Overall Study|Lost to Follow-up|0
2543112|NCT01511250|8803200|P5|Overall Study|Lost to Follow-up|0
2543113|NCT01511250|8803201|P4|Overall Study|Lost to Follow-up|3
2543114|NCT01511250|8803202|P3|Overall Study|Lost to Follow-up|3
2543115|NCT01511250|8803203|P2|Overall Study|Lost to Follow-up|3
2543116|NCT01511250|8803204|P1|Overall Study|Lost to Follow-up|7
2543117|NCT01511250|8803195|P10|Overall Study|Sponsor/Investigator Decision|0
2543118|NCT01511250|8803196|P9|Overall Study|Sponsor/Investigator Decision|0
2543119|NCT01511250|8803197|P8|Overall Study|Sponsor/Investigator Decision|0
2543120|NCT01511250|8803198|P7|Overall Study|Sponsor/Investigator Decision|0
2543121|NCT01511250|8803199|P6|Overall Study|Sponsor/Investigator Decision|0
2543122|NCT01511250|8803200|P5|Overall Study|Sponsor/Investigator Decision|0
2543123|NCT01511250|8803201|P4|Overall Study|Sponsor/Investigator Decision|0
2543124|NCT01511250|8803202|P3|Overall Study|Sponsor/Investigator Decision|0
2543125|NCT01511250|8803203|P2|Overall Study|Sponsor/Investigator Decision|0
2543126|NCT01511250|8803204|P1|Overall Study|Sponsor/Investigator Decision|1
2543127|NCT01511250|8803195|P10|Overall Study|Withdrawal of Consent|0
2543128|NCT01511250|8803196|P9|Overall Study|Withdrawal of Consent|1
2543129|NCT01511250|8803197|P8|Overall Study|Withdrawal of Consent|1
2543130|NCT01511250|8803198|P7|Overall Study|Withdrawal of Consent|0
2543131|NCT01511250|8803199|P6|Overall Study|Withdrawal of Consent|0
2543132|NCT01511250|8803200|P5|Overall Study|Withdrawal of Consent|0
2543133|NCT01511250|8803201|P4|Overall Study|Withdrawal of Consent|0
2543134|NCT01511250|8803202|P3|Overall Study|Withdrawal of Consent|0
2543135|NCT01511250|8803203|P2|Overall Study|Withdrawal of Consent|0
2543136|NCT01511250|8803204|P1|Overall Study|Withdrawal of Consent|1
2543137|NCT01511107|8803352|P2|Overall Study|Withdrawal by Subject|20
2543138|NCT01511107|8803353|P1|Overall Study|Withdrawal by Subject|9
2543139|NCT01511107|8803352|P2|Overall Study|Lost to Follow-up|19
2543140|NCT01511107|8803353|P1|Overall Study|Lost to Follow-up|10
2543141|NCT01511107|8803352|P2|Overall Study|Ineligible|2
2543142|NCT01511107|8803353|P1|Overall Study|Ineligible|3
2543143|NCT01510912|8803431|P1|Overall Study|Other, including joint replacement|5
2543144|NCT01510912|8803431|P1|Overall Study|Lost to Follow-up|26
2543145|NCT01510912|8803431|P1|Overall Study|Protocol Violation|27
2543146|NCT01510912|8803431|P1|Overall Study|Physician Decision|1
2543147|NCT01510912|8803431|P1|Overall Study|Withdrawal by Subject|49
2543148|NCT01510912|8803431|P1|Overall Study|Non-compliance with trial drug|23
2543149|NCT01510912|8803431|P1|Overall Study|Lack of Efficacy|12
2543150|NCT01510912|8803431|P1|Overall Study|Adverse Event|99
2543151|NCT01510769|8803447|P3|Overall Study|Death|0
2543152|NCT01510769|8803448|P2|Overall Study|Death|1
2543153|NCT01510769|8803449|P1|Overall Study|Death|1
2543154|NCT01510769|8803447|P3|Overall Study|Withdrawal by Subject|3
2543155|NCT01510769|8803448|P2|Overall Study|Withdrawal by Subject|4
2543156|NCT01510769|8803449|P1|Overall Study|Withdrawal by Subject|3
2543157|NCT01510769|8803447|P3|Overall Study|Lost to Follow-up|5
2543158|NCT01510769|8803448|P2|Overall Study|Lost to Follow-up|1
2543159|NCT01510769|8803449|P1|Overall Study|Lost to Follow-up|5
2543160|NCT01510769|8803447|P3|Overall Study|Protocol Violation|9
2543161|NCT01510769|8803448|P2|Overall Study|Protocol Violation|10
2543162|NCT01510769|8803449|P1|Overall Study|Protocol Violation|11
2543163|NCT01510769|8803447|P3|Overall Study|Gout Flare|1
2543164|NCT01510769|8803448|P2|Overall Study|Gout Flare|3
2543165|NCT01510769|8803449|P1|Overall Study|Gout Flare|0
2543166|NCT01510769|8803447|P3|Overall Study|Adverse Event|4
2543167|NCT01510769|8803448|P2|Overall Study|Adverse Event|6
2543168|NCT01510769|8803449|P1|Overall Study|Adverse Event|7
2543169|NCT01510756|8803466|P1|Overall Study|Physician Decision|1
2543170|NCT01510756|8803466|P1|Overall Study|Lack of Efficacy|2
2543171|NCT01510756|8803466|P1|Overall Study|Death|1
2543172|NCT01510717|8803474|P2|Overall Study|Withdrawal by Subject|2
2543173|NCT01510717|8803475|P1|Overall Study|Withdrawal by Subject|0
2543174|NCT01510717|8803474|P2|Overall Study|Lost to Follow-up|1
2543175|NCT01510717|8803475|P1|Overall Study|Lost to Follow-up|0
2543176|NCT01510717|8803474|P2|Overall Study|Death|0
2543177|NCT01510717|8803475|P1|Overall Study|Death|1
2543178|NCT01510717|8803474|P2|Overall Study|Adverse Event|2
2543179|NCT01510717|8803475|P1|Overall Study|Adverse Event|1
2543180|NCT01510158|8803595|P3|Overall Study|Death|0
2543181|NCT01510158|8803596|P2|Overall Study|Death|0
2543182|NCT01510158|8803597|P1|Overall Study|Death|1
2543183|NCT01510158|8803595|P3|Overall Study|Withdrawal by Subject|10
2543184|NCT01510158|8803596|P2|Overall Study|Withdrawal by Subject|13
2543185|NCT01510158|8803597|P1|Overall Study|Withdrawal by Subject|10
2543186|NCT01510158|8803595|P3|Overall Study|Lost to Follow-up|9
2543187|NCT01510158|8803596|P2|Overall Study|Lost to Follow-up|16
2543188|NCT01510158|8803597|P1|Overall Study|Lost to Follow-up|13
2543189|NCT01510158|8803595|P3|Overall Study|Sponsor terminated study.|2
2543190|NCT01510158|8803596|P2|Overall Study|Sponsor terminated study.|0
2543191|NCT01510158|8803597|P1|Overall Study|Sponsor terminated study.|2
2543192|NCT01510158|8803595|P3|Overall Study|Protocol Violation|24
2543193|NCT01510158|8803596|P2|Overall Study|Protocol Violation|16
2543194|NCT01510158|8803597|P1|Overall Study|Protocol Violation|17
2543195|NCT01510158|8803595|P3|Overall Study|Gout flare|0
2543196|NCT01510158|8803596|P2|Overall Study|Gout flare|0
2543197|NCT01510158|8803597|P1|Overall Study|Gout flare|1
2543198|NCT01510158|8803595|P3|Overall Study|Adverse Event|5
2543199|NCT01510158|8803596|P2|Overall Study|Adverse Event|8
2543200|NCT01510158|8803597|P1|Overall Study|Adverse Event|7
2543201|NCT01510145|8803611|P1|Overall Study|Relative reported subject withdrew|1
2543202|NCT01510145|8803611|P1|Overall Study|Withdrawal by Subject|6
2543203|NCT01510145|8803611|P1|Overall Study|Lost to Follow-up|5
2543204|NCT01510145|8803611|P1|Overall Study|Adverse Event|6
2543205|NCT01510028|8803620|P4|Overall Study|Lack of Efficacy|0
2543206|NCT01510028|8803621|P3|Overall Study|Lack of Efficacy|0
2543207|NCT01510028|8803622|P2|Overall Study|Lack of Efficacy|0
2543208|NCT01510028|8803623|P1|Overall Study|Lack of Efficacy|1
2543209|NCT01509664|8803884|P2|Overall Study|Lost to Follow-up|21
2543210|NCT01509664|8803885|P1|Overall Study|Lost to Follow-up|15
2543211|NCT01509547|8803945|P2|Overall Study|Physician Decision|1
2543212|NCT01509547|8803946|P1|Overall Study|Physician Decision|0
2543213|NCT01509547|8803945|P2|Overall Study|Withdrawal by Subject|24
2543214|NCT01509547|8803946|P1|Overall Study|Withdrawal by Subject|11
2543215|NCT01509547|8803945|P2|Overall Study|Lost to Follow-up|14
2543216|NCT01509547|8803946|P1|Overall Study|Lost to Follow-up|24
2543217|NCT01509079|8804013|P2|Overall Study|started an excluded medication|1
2543218|NCT01509079|8804014|P1|Overall Study|started an excluded medication|0
2543219|NCT01509079|8804013|P2|Overall Study|Lack of Efficacy|2
2543220|NCT01509079|8804014|P1|Overall Study|Lack of Efficacy|0
2543221|NCT01509053|8804034|P1|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3
2543222|NCT01509053|8804034|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1
2543223|NCT01509053|8804034|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1
2543224|NCT01509053|8804034|P1|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13
2543225|NCT01509053|8804034|P1|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1
2543226|NCT01509053|8804034|P1|Oral Aripirazole (Phase A)|Sponsor discontinued study|11
2543227|NCT01508936|8804096|P2|Overall Study|Data from 2 sites deemed invalid|11
2543228|NCT01508936|8804097|P1|Overall Study|Data from 2 sites deemed invalid|4
2543229|NCT01508936|8804096|P2|Overall Study|Other|5
2543230|NCT01508936|8804097|P1|Overall Study|Other|0
2543231|NCT01508936|8804096|P2|Overall Study|Lost to Follow-up|9
2543232|NCT01508936|8804097|P1|Overall Study|Lost to Follow-up|2
2543233|NCT01508936|8804096|P2|Overall Study|Protocol Violation|3
2543234|NCT01508936|8804097|P1|Overall Study|Protocol Violation|2
2543235|NCT01508936|8804096|P2|Overall Study|Withdrawal by Subject|18
2543236|NCT01508936|8804097|P1|Overall Study|Withdrawal by Subject|4
2543237|NCT01508936|8804096|P2|Overall Study|Lack of Efficacy|1
2543238|NCT01508936|8804097|P1|Overall Study|Lack of Efficacy|0
2543239|NCT01508936|8804096|P2|Overall Study|Adverse Event|32
2543240|NCT01508936|8804097|P1|Overall Study|Adverse Event|11
2543241|NCT01508910|8804136|P4|Treatment|Sponsor Decision|1
2543242|NCT01508910|8804137|P3|Treatment|Sponsor Decision|0
2543243|NCT01508910|8804138|P2|Treatment|Sponsor Decision|0
2543244|NCT01508910|8804139|P1|Treatment|Sponsor Decision|0
2543245|NCT01508910|8804136|P4|Treatment|Withdrawal by Subject|1
2543246|NCT01508910|8804137|P3|Treatment|Withdrawal by Subject|6
2543247|NCT01508910|8804138|P2|Treatment|Withdrawal by Subject|1
2543248|NCT01508910|8804139|P1|Treatment|Withdrawal by Subject|0
2543249|NCT01508910|8804136|P4|Treatment|Lost to Follow-up|1
2543250|NCT01508910|8804137|P3|Treatment|Lost to Follow-up|2
2543251|NCT01508910|8804138|P2|Treatment|Lost to Follow-up|0
2543252|NCT01508910|8804139|P1|Treatment|Lost to Follow-up|0
2543253|NCT01508910|8804136|P4|Treatment|Death|0
2543254|NCT01508910|8804137|P3|Treatment|Death|2
2543255|NCT01508910|8804138|P2|Treatment|Death|3
2543256|NCT01508910|8804139|P1|Treatment|Death|2
2543257|NCT01508702|8804172|P2|Overall Study|Withdrawal by Subject|7
2543258|NCT01508702|8804173|P1|Overall Study|Withdrawal by Subject|11
2543259|NCT01508702|8804172|P2|Overall Study|Lost to Follow-up|2
2543260|NCT01508702|8804173|P1|Overall Study|Lost to Follow-up|1
2543261|NCT01508702|8804172|P2|Overall Study|Protocol Violation|1
2543262|NCT01508702|8804173|P1|Overall Study|Protocol Violation|2
2543263|NCT01508702|8804172|P2|Overall Study|Gout flare|0
2543264|NCT01508702|8804173|P1|Overall Study|Gout flare|2
2543265|NCT01508702|8804172|P2|Overall Study|Adverse Event|3
2543266|NCT01508702|8804173|P1|Overall Study|Adverse Event|7
2543267|NCT01508676|8804181|P2|Phase II (2 Weeks)|Medication Exclusion|0
2543268|NCT01508676|8804182|P1|Phase II (2 Weeks)|Medication Exclusion|1
2543269|NCT01508676|8804181|P2|Phase II (2 Weeks)|Skin Sensitivity|1
2543270|NCT01508676|8804182|P1|Phase II (2 Weeks)|Skin Sensitivity|0
2543271|NCT01508676|8804181|P2|Phase I (2 Weeks)|Positive Drug Screen|2
2543272|NCT01508676|8804182|P1|Phase I (2 Weeks)|Positive Drug Screen|0
2543273|NCT01508676|8804181|P2|Phase I (2 Weeks)|Wrong Pain Type|0
2543274|NCT01508676|8804182|P1|Phase I (2 Weeks)|Wrong Pain Type|1
2543275|NCT01508676|8804181|P2|Phase I (2 Weeks)|Medication Exclusion|1
2543276|NCT01508676|8804182|P1|Phase I (2 Weeks)|Medication Exclusion|1
2543277|NCT01508650|8804194|P2|Overall Study|Lost to Follow-up|3
2543278|NCT01508650|8804195|P1|Overall Study|Lost to Follow-up|0
2543279|NCT01508325|8804214|P2|Overall Study|Other|2
2543280|NCT01508325|8804215|P1|Overall Study|Other|2
2543281|NCT01508325|8804214|P2|Overall Study|Lost to Follow-up|6
2543282|NCT01508325|8804215|P1|Overall Study|Lost to Follow-up|5
2543283|NCT01508325|8804214|P2|Overall Study|Adverse Event|0
2543284|NCT01508325|8804215|P1|Overall Study|Adverse Event|1
2543285|NCT01508325|8804214|P2|Overall Study|Physician Decision|1
2543286|NCT01508325|8804215|P1|Overall Study|Physician Decision|2
2543287|NCT01508325|8804214|P2|Overall Study|Protocol Violation|3
2543288|NCT01508325|8804215|P1|Overall Study|Protocol Violation|0
2543289|NCT01508325|8804214|P2|Overall Study|Withdrawal by Subject|9
2543290|NCT01508325|8804215|P1|Overall Study|Withdrawal by Subject|8
2543291|NCT01508169|8804245|P2|Overall Study|Lost to Follow-up|2
2543292|NCT01508169|8804246|P1|Overall Study|Lost to Follow-up|1
2543293|NCT01508169|8804245|P2|Overall Study|Withdrawal by Subject|0
2543294|NCT01508169|8804246|P1|Overall Study|Withdrawal by Subject|1
2543295|NCT01508169|8804245|P2|Overall Study|Adverse Event|0
2543296|NCT01508169|8804246|P1|Overall Study|Adverse Event|1
2543297|NCT01508130|8804260|P2|Overall Study|Administrative|3
2543298|NCT01508130|8804261|P1|Overall Study|Administrative|14
2543299|NCT01508130|8804260|P2|Overall Study|Insufficient therapeutic response|23
2543300|NCT01508130|8804261|P1|Overall Study|Insufficient therapeutic response|74
2543301|NCT01508130|8804260|P2|Overall Study|Subject’s substantial non-compliance|9
2543302|NCT01508130|8804261|P1|Overall Study|Subject’s substantial non-compliance|25
2543303|NCT01508130|8804260|P2|Overall Study|Withdrawal by Subject|3
2543304|NCT01508130|8804261|P1|Overall Study|Withdrawal by Subject|3
2543305|NCT01508130|8804260|P2|Overall Study|Lost to Follow-up|2
2543306|NCT01508130|8804261|P1|Overall Study|Lost to Follow-up|25
2543307|NCT01508130|8804260|P2|Overall Study|Protocol Violation|0
2543308|NCT01508130|8804261|P1|Overall Study|Protocol Violation|2
2543309|NCT01508130|8804260|P2|Overall Study|Death|1
2543310|NCT01508130|8804261|P1|Overall Study|Death|3
2543311|NCT01508130|8804260|P2|Overall Study|Adverse Event|28
2543312|NCT01508130|8804261|P1|Overall Study|Adverse Event|81
2543313|NCT01507896|8804329|P1|Overall Study|The surgery was denied by the sponsor.|1
2543314|NCT01507896|8804329|P1|Overall Study|Withdrawal by Subject|1
2543315|NCT01507831|8804372|P2|Overall Study|Other|6
2543316|NCT01507831|8804373|P1|Overall Study|Other|3
2543317|NCT01507831|8804372|P2|Overall Study|Potential lost to follow-up|0
2543318|NCT01507831|8804373|P1|Overall Study|Potential lost to follow-up|3
2543319|NCT01507831|8804372|P2|Overall Study|Site closure|3
2543320|NCT01507831|8804373|P1|Overall Study|Site closure|0
2543321|NCT01507831|8804372|P2|Overall Study|Selection criteria finally not met|1
2543322|NCT01507831|8804373|P1|Overall Study|Selection criteria finally not met|0
2543323|NCT01507831|8804372|P2|Overall Study|Last visit outside protocol visit window|143
2543324|NCT01507831|8804373|P1|Overall Study|Last visit outside protocol visit window|51
2543325|NCT01507831|8804372|P2|Overall Study|Related to study drug administration|14
2543326|NCT01507831|8804373|P1|Overall Study|Related to study drug administration|5
2543327|NCT01507831|8804372|P2|Overall Study|Consent withdrawn by participant|72
2543328|NCT01507831|8804373|P1|Overall Study|Consent withdrawn by participant|34
2543329|NCT01507831|8804372|P2|Overall Study|Participant moved|19
2543330|NCT01507831|8804373|P1|Overall Study|Participant moved|5
2543331|NCT01507831|8804372|P2|Overall Study|Physician Decision|4
2543332|NCT01507831|8804373|P1|Overall Study|Physician Decision|0
2543333|NCT01507831|8804372|P2|Overall Study|Poor compliance to protocol|60
2543334|NCT01507831|8804373|P1|Overall Study|Poor compliance to protocol|38
2543335|NCT01507831|8804372|P2|Overall Study|Death|2
2543336|NCT01507831|8804373|P1|Overall Study|Death|6
2543337|NCT01507831|8804372|P2|Overall Study|Adverse Event|113
2543338|NCT01507831|8804373|P1|Overall Study|Adverse Event|48
2543339|NCT01507831|8804372|P2|Overall Study|Randomized but not treated|3
2543340|NCT01507831|8804373|P1|Overall Study|Randomized but not treated|0
2543341|NCT01507662|8804493|P2|Overall Study|Proxy interview done|3
2543342|NCT01507662|8804494|P1|Overall Study|Proxy interview done|2
2543343|NCT01507662|8804493|P2|Overall Study|Lost to Follow-up|523
2543344|NCT01507662|8804494|P1|Overall Study|Lost to Follow-up|498
2543345|NCT01507662|8804493|P2|Overall Study|Withdrawal by Subject|287
2543346|NCT01507662|8804494|P1|Overall Study|Withdrawal by Subject|290
2543347|NCT01507662|8804493|P2|Overall Study|Death|18
2543348|NCT01507662|8804494|P1|Overall Study|Death|26
2543349|NCT01507298|8804525|P2|Overall Study|Protocol Violation|6
2543350|NCT01507298|8804526|P1|Overall Study|Protocol Violation|0
2543351|NCT01507246|8804536|P2|Overall Study|Required different surgical procedures|1
2543352|NCT01507246|8804537|P1|Overall Study|Required different surgical procedures|2
2543353|NCT01507090|8804635|P1|Overall Study|incomplete dataset|18
2543354|NCT01507051|8804674|P4|Overall Study|Adverse Event|0
2543355|NCT01507051|8804675|P3|Overall Study|Adverse Event|0
2543356|NCT01507051|8804676|P2|Overall Study|Adverse Event|0
2543357|NCT01507051|8804677|P1|Overall Study|Adverse Event|1
2543358|NCT01507051|8804674|P4|Overall Study|Physician Decision|1
2543359|NCT01507051|8804675|P3|Overall Study|Physician Decision|0
2543360|NCT01507051|8804676|P2|Overall Study|Physician Decision|0
2543361|NCT01507051|8804677|P1|Overall Study|Physician Decision|0
2543362|NCT01507051|8804674|P4|Overall Study|Withdrawal by Subject|6
2543363|NCT01507051|8804675|P3|Overall Study|Withdrawal by Subject|1
2543364|NCT01507051|8804676|P2|Overall Study|Withdrawal by Subject|3
2543365|NCT01507051|8804677|P1|Overall Study|Withdrawal by Subject|1
2543366|NCT01506960|8804795|P1|Overall Study|Did not meet angiographic criteria|47
2543367|NCT01506947|8804801|P1|Overall Study|Did Not Meet Eligibility Criteria|3
2543368|NCT01506947|8804801|P1|Overall Study|Death|1
2543369|NCT01506947|8804801|P1|Overall Study|Adverse Event|5
2543370|NCT01506947|8804801|P1|Overall Study|Lost to Follow-up|7
2543371|NCT01506908|8804819|P2|Overall Study|Adverse Event|0
2543372|NCT01506908|8804820|P1|Overall Study|Adverse Event|1
2543373|NCT01506882|8804838|P2|Overall Study|Other Reason|0
2543374|NCT01506882|8804839|P1|Overall Study|Other Reason|2
2543375|NCT01506882|8804838|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
2543376|NCT01506882|8804839|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
2543377|NCT01506882|8804838|P2|Overall Study|AE, non-serious non-fatal|1
2543378|NCT01506882|8804839|P1|Overall Study|AE, non-serious non-fatal|3
2543379|NCT01506882|8804838|P2|Overall Study|SAE, non-fatal|0
2543380|NCT01506882|8804839|P1|Overall Study|SAE, non-fatal|2
2543381|NCT01506882|8804838|P2|Overall Study|Withdrawal by Subject|3
2543382|NCT01506882|8804839|P1|Overall Study|Withdrawal by Subject|9
2543383|NCT01506882|8804838|P2|Overall Study|Lost to Follow-up|0
2543384|NCT01506882|8804839|P1|Overall Study|Lost to Follow-up|1
2543385|NCT01506882|8804838|P2|Overall Study|Lack of Efficacy|3
2543386|NCT01506882|8804839|P1|Overall Study|Lack of Efficacy|4
2543387|NCT01506726|8804853|P2|Overall Study|Adverse Event|2
2543388|NCT01506726|8804854|P1|Overall Study|Adverse Event|1
2543389|NCT01506596|8804894|P1|Overall Study|ineligible pathology|1
2543390|NCT01506479|8804905|P3|Overall Study|Adverse Event|0
2543391|NCT01506479|8804906|P2|Overall Study|Adverse Event|1
2543392|NCT01506479|8804907|P1|Overall Study|Adverse Event|0
2543393|NCT01506479|8804905|P3|Overall Study|Missing assessment|0
2543394|NCT01506479|8804906|P2|Overall Study|Missing assessment|0
2543395|NCT01506479|8804907|P1|Overall Study|Missing assessment|1
2543396|NCT01506479|8804905|P3|Overall Study|Withdrawal by Subject|1
2543397|NCT01506479|8804906|P2|Overall Study|Withdrawal by Subject|2
2543398|NCT01506479|8804907|P1|Overall Study|Withdrawal by Subject|1
2543399|NCT01506479|8804905|P3|Overall Study|Lost to Follow-up|2
2543400|NCT01506479|8804906|P2|Overall Study|Lost to Follow-up|2
2543401|NCT01506479|8804907|P1|Overall Study|Lost to Follow-up|1
2543402|NCT01506453|8804921|P2|Overall Study|Withdrawal prior to treatment|2
2543403|NCT01506453|8804922|P1|Overall Study|Withdrawal prior to treatment|0
2543404|NCT01506323|8804938|P2|Overall Study|Started another treatment|0
2543405|NCT01506323|8804939|P1|Overall Study|Started another treatment|1
2543406|NCT01506323|8804938|P2|Overall Study|Schedule or Transportation conflict|0
2543407|NCT01506323|8804939|P1|Overall Study|Schedule or Transportation conflict|8
2543408|NCT01506323|8804938|P2|Overall Study|Moved out of area|2
2543409|NCT01506323|8804939|P1|Overall Study|Moved out of area|5
2543410|NCT01506323|8804938|P2|Overall Study|Lack of Efficacy|3
2543411|NCT01506323|8804939|P1|Overall Study|Lack of Efficacy|1
2543412|NCT01506323|8804938|P2|Overall Study|Withdrawal by Subject|4
2543413|NCT01506323|8804939|P1|Overall Study|Withdrawal by Subject|4
2543414|NCT01506323|8804938|P2|Overall Study|Lost to Follow-up|4
2543415|NCT01506323|8804939|P1|Overall Study|Lost to Follow-up|5
2543416|NCT01506271|8804968|P3|Overall Study|Lost to Follow-up|2
2543417|NCT01506271|8804969|P2|Overall Study|Lost to Follow-up|1
2543418|NCT01506271|8804970|P1|Overall Study|Lost to Follow-up|0
2543419|NCT01506271|8804968|P3|Overall Study|Withdrawal by Subject|1
2543420|NCT01506271|8804969|P2|Overall Study|Withdrawal by Subject|1
2543421|NCT01506271|8804970|P1|Overall Study|Withdrawal by Subject|0
2543422|NCT01506271|8804968|P3|Overall Study|Insufficient supply of study drug|0
2543423|NCT01506271|8804969|P2|Overall Study|Insufficient supply of study drug|0
2543424|NCT01506271|8804970|P1|Overall Study|Insufficient supply of study drug|1
2543425|NCT01506271|8804968|P3|Overall Study|Adverse Event|0
2543426|NCT01506271|8804969|P2|Overall Study|Adverse Event|2
2543427|NCT01506271|8804970|P1|Overall Study|Adverse Event|0
2543428|NCT01506271|8804968|P3|Overall Study|Death|0
2543429|NCT01506271|8804969|P2|Overall Study|Death|1
2543430|NCT01506271|8804970|P1|Overall Study|Death|0
2543431|NCT01506271|8804968|P3|Overall Study|Protocol Violation|0
2543432|NCT01506271|8804969|P2|Overall Study|Protocol Violation|1
2543433|NCT01506271|8804970|P1|Overall Study|Protocol Violation|3
2543434|NCT01506271|8804968|P3|Overall Study|Progressive disease|0
2543435|NCT01506271|8804969|P2|Overall Study|Progressive disease|1
2543436|NCT01506271|8804970|P1|Overall Study|Progressive disease|0
2543437|NCT01506193|8805032|P3|Overall Study|Lost to Follow-up|3
2543438|NCT01506193|8805033|P2|Overall Study|Lost to Follow-up|3
2543439|NCT01506193|8805034|P1|Overall Study|Lost to Follow-up|8
2543440|NCT01506193|8805032|P3|Overall Study|Withdrawal by Subject|8
2543441|NCT01506193|8805033|P2|Overall Study|Withdrawal by Subject|1
2543442|NCT01506193|8805034|P1|Overall Study|Withdrawal by Subject|5
2543443|NCT01506193|8805032|P3|Overall Study|Adverse event, non-fatal|1
2543444|NCT01506193|8805033|P2|Overall Study|Adverse event, non-fatal|0
2543445|NCT01506193|8805034|P1|Overall Study|Adverse event, non-fatal|0
2543446|NCT01506193|8805032|P3|Overall Study|Migrated/moved from study area|1
2543447|NCT01506193|8805033|P2|Overall Study|Migrated/moved from study area|0
2543448|NCT01506193|8805034|P1|Overall Study|Migrated/moved from study area|0
2543449|NCT01506193|8805032|P3|Overall Study|Protocol Violation|1
2543450|NCT01506193|8805033|P2|Overall Study|Protocol Violation|0
2543451|NCT01506193|8805034|P1|Overall Study|Protocol Violation|1
2543452|NCT01505881|8805080|P2|Overall Study|Withdrawal by Subject|0
2543453|NCT01505881|8805081|P1|Overall Study|Withdrawal by Subject|2
2543454|NCT01505881|8805080|P2|Overall Study|Lost to Follow-up|0
2543455|NCT01505881|8805081|P1|Overall Study|Lost to Follow-up|2
2543456|NCT01505881|8805080|P2|Overall Study|Adverse Event|1
2543457|NCT01505881|8805081|P1|Overall Study|Adverse Event|0
2543458|NCT01505647|8805187|P2|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2
2543459|NCT01505647|8805188|P1|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1
2543460|NCT01505647|8805187|P2|Day 43 Through Day 182 Follow-up|Death|1
2543461|NCT01505647|8805188|P1|Day 43 Through Day 182 Follow-up|Death|0
2543462|NCT01505647|8805187|P2|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0
2543463|NCT01505647|8805188|P1|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1
2543464|NCT01505647|8805187|P2|Day 1 Through Day 42 Follow-up|Physician Decision|0
2543465|NCT01505647|8805188|P1|Day 1 Through Day 42 Follow-up|Physician Decision|1
2543466|NCT01505647|8805187|P2|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0
2543467|NCT01505647|8805188|P1|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1
2543468|NCT01505634|8805205|P3|Overall Study|In a conflict zone|1
2543469|NCT01505634|8805206|P2|Overall Study|In a conflict zone|0
2543470|NCT01505634|8805207|P1|Overall Study|In a conflict zone|0
2543471|NCT01505634|8805205|P3|Overall Study|Death|0
2543472|NCT01505634|8805206|P2|Overall Study|Death|0
2543473|NCT01505634|8805207|P1|Overall Study|Death|1
2543474|NCT01505634|8805205|P3|Overall Study|Lost to Follow-up|4
2543475|NCT01505634|8805206|P2|Overall Study|Lost to Follow-up|4
2543476|NCT01505634|8805207|P1|Overall Study|Lost to Follow-up|1
2543477|NCT01505634|8805205|P3|Overall Study|Protocol Violation|0
2543478|NCT01505634|8805206|P2|Overall Study|Protocol Violation|0
2543479|NCT01505634|8805207|P1|Overall Study|Protocol Violation|2
2543480|NCT01505634|8805205|P3|Overall Study|Insufficient supply of drug at site|0
2543481|NCT01505634|8805206|P2|Overall Study|Insufficient supply of drug at site|0
2543482|NCT01505634|8805207|P1|Overall Study|Insufficient supply of drug at site|1
2543483|NCT01505634|8805205|P3|Overall Study|Adverse Event|0
2543484|NCT01505634|8805206|P2|Overall Study|Adverse Event|0
2543485|NCT01505634|8805207|P1|Overall Study|Adverse Event|1
2543486|NCT01505634|8805205|P3|Overall Study|Physician Decision|0
2543487|NCT01505634|8805206|P2|Overall Study|Physician Decision|1
2543488|NCT01505634|8805207|P1|Overall Study|Physician Decision|1
2543489|NCT01505634|8805205|P3|Overall Study|Withdrawal by Subject|1
2543490|NCT01505634|8805206|P2|Overall Study|Withdrawal by Subject|5
2543491|NCT01505634|8805207|P1|Overall Study|Withdrawal by Subject|2
2543492|NCT01505608|8805262|P2|Phase II|Protocol Violation|1
2543493|NCT01505608|8805263|P1|Phase II|Protocol Violation|0
2543494|NCT01505608|8805262|P2|Phase II|Lack of Efficacy|1
2543495|NCT01505608|8805263|P1|Phase II|Lack of Efficacy|2
2543496|NCT01505608|8805262|P2|Phase I|Withdrawal by Subject|1
2543497|NCT01505608|8805263|P1|Phase I|Withdrawal by Subject|0
2543498|NCT01505608|8805262|P2|Phase I|Adverse Event|1
2543499|NCT01505608|8805263|P1|Phase I|Adverse Event|0
2543500|NCT01505608|8805262|P2|Phase I|Lack of Efficacy|4
2543501|NCT01505608|8805263|P1|Phase I|Lack of Efficacy|0
2543502|NCT01505530|8805282|P3|Overall Study|entry criteria not met|0
2543503|NCT01505530|8805283|P2|Overall Study|entry criteria not met|1
2543504|NCT01505530|8805284|P1|Overall Study|entry criteria not met|0
2543505|NCT01505530|8805282|P3|Overall Study|Death|5
2543506|NCT01505530|8805283|P2|Overall Study|Death|6
2543507|NCT01505530|8805284|P1|Overall Study|Death|7
2543508|NCT01505530|8805282|P3|Overall Study|Sponsor Decision|7
2543509|NCT01505530|8805283|P2|Overall Study|Sponsor Decision|8
2543510|NCT01505530|8805284|P1|Overall Study|Sponsor Decision|1
2543511|NCT01505530|8805282|P3|Overall Study|Physician Decision|5
2543512|NCT01505530|8805283|P2|Overall Study|Physician Decision|2
2543513|NCT01505530|8805284|P1|Overall Study|Physician Decision|6
2543514|NCT01505530|8805282|P3|Overall Study|Withdrawal by Subject|6
2543515|NCT01505530|8805283|P2|Overall Study|Withdrawal by Subject|8
2543516|NCT01505530|8805284|P1|Overall Study|Withdrawal by Subject|7
2543517|NCT01505530|8805282|P3|Overall Study|Adverse Event|0
2543518|NCT01505530|8805283|P2|Overall Study|Adverse Event|1
2543519|NCT01505530|8805284|P1|Overall Study|Adverse Event|1
2543520|NCT01505530|8805282|P3|Overall Study|Progressive Disease|18
2543521|NCT01505530|8805283|P2|Overall Study|Progressive Disease|17
2543522|NCT01505530|8805284|P1|Overall Study|Progressive Disease|19
2543523|NCT01505491|8805328|P3|Overall Study|Lost to Follow-up|1
2543524|NCT01505491|8805329|P2|Overall Study|Lost to Follow-up|0
2543525|NCT01505491|8805330|P1|Overall Study|Lost to Follow-up|0
2543526|NCT01505491|8805328|P3|Overall Study|Withdrawal by Subject|4
2543527|NCT01505491|8805329|P2|Overall Study|Withdrawal by Subject|1
2543528|NCT01505491|8805330|P1|Overall Study|Withdrawal by Subject|1
2543529|NCT01505491|8805328|P3|Overall Study|Other reason not listed|0
2543530|NCT01505491|8805329|P2|Overall Study|Other reason not listed|0
2543531|NCT01505491|8805330|P1|Overall Study|Other reason not listed|1
2543532|NCT01505387|8805369|P2|Overall Study|Withdrawal by Subject|1
2543533|NCT01505387|8805370|P1|Overall Study|Withdrawal by Subject|1
2543534|NCT01505387|8805369|P2|Overall Study|Protocol Violation|0
2543535|NCT01505387|8805370|P1|Overall Study|Protocol Violation|1
2543536|NCT01505374|8805376|P2|Overall Study|Lost to Follow-up|0
2543537|NCT01505374|8805377|P1|Overall Study|Lost to Follow-up|1
2543538|NCT01505114|8805427|P4|Overall Study|investigator decision|0
2543539|NCT01505114|8805428|P3|Overall Study|investigator decision|1
2543540|NCT01505114|8805429|P2|Overall Study|investigator decision|0
2543541|NCT01505114|8805430|P1|Overall Study|investigator decision|1
2543542|NCT01505114|8805427|P4|Overall Study|staff safety concerns|1
2543543|NCT01505114|8805428|P3|Overall Study|staff safety concerns|0
2543544|NCT01505114|8805429|P2|Overall Study|staff safety concerns|0
2543545|NCT01505114|8805430|P1|Overall Study|staff safety concerns|0
2543546|NCT01505114|8805427|P4|Overall Study|inadvertent enrollment due to peanut all|1
2543547|NCT01505114|8805428|P3|Overall Study|inadvertent enrollment due to peanut all|0
2543548|NCT01505114|8805429|P2|Overall Study|inadvertent enrollment due to peanut all|0
2543549|NCT01505114|8805430|P1|Overall Study|inadvertent enrollment due to peanut all|0
2543550|NCT01505114|8805427|P4|Overall Study|relocated|3
2543551|NCT01505114|8805428|P3|Overall Study|relocated|2
2543552|NCT01505114|8805429|P2|Overall Study|relocated|2
2543553|NCT01505114|8805430|P1|Overall Study|relocated|4
2543554|NCT01505114|8805427|P4|Overall Study|Lost to Follow-up|7
2543555|NCT01505114|8805428|P3|Overall Study|Lost to Follow-up|8
2543556|NCT01505114|8805429|P2|Overall Study|Lost to Follow-up|5
2543557|NCT01505114|8805430|P1|Overall Study|Lost to Follow-up|11
2543558|NCT01505114|8805427|P4|Overall Study|unable to adhere to visit schedule|3
2543559|NCT01505114|8805428|P3|Overall Study|unable to adhere to visit schedule|3
2543560|NCT01505114|8805429|P2|Overall Study|unable to adhere to visit schedule|2
2543561|NCT01505114|8805430|P1|Overall Study|unable to adhere to visit schedule|3
2543562|NCT01505114|8805427|P4|Overall Study|Death|1
2543563|NCT01505114|8805428|P3|Overall Study|Death|0
2543564|NCT01505114|8805429|P2|Overall Study|Death|0
2543565|NCT01505114|8805430|P1|Overall Study|Death|1
2543566|NCT01505114|8805427|P4|Overall Study|Withdrawal by Subject|7
2543567|NCT01505114|8805428|P3|Overall Study|Withdrawal by Subject|4
2543568|NCT01505114|8805429|P2|Overall Study|Withdrawal by Subject|4
2543569|NCT01505114|8805430|P1|Overall Study|Withdrawal by Subject|5
2543570|NCT01505010|8805458|P2|Overall Study|Lost to Follow-up|1
2543571|NCT01505010|8805459|P1|Overall Study|Lost to Follow-up|0
2543572|NCT01505010|8805458|P2|Overall Study|Protocol Violation|1
2543573|NCT01505010|8805459|P1|Overall Study|Protocol Violation|0
2543574|NCT01504971|8805473|P1|Overall Study|Physician Decision|13
2543575|NCT01504867|8805502|P2|Overall Study|Consent revoked|1
2543576|NCT01504867|8805503|P1|Overall Study|Consent revoked|5
2543577|NCT01504867|8805502|P2|Overall Study|Inclusion criteria not met|2
2543578|NCT01504867|8805503|P1|Overall Study|Inclusion criteria not met|2
2543579|NCT01504841|8805541|P3|Overall Study|On study due to Long-term Follow-up|0
2543580|NCT01504841|8805542|P2|Overall Study|On study due to Long-term Follow-up|3
2543581|NCT01504841|8805543|P1|Overall Study|On study due to Long-term Follow-up|15
2543582|NCT01504841|8805541|P3|Overall Study|Withdrawal by Subject|0
2543583|NCT01504841|8805542|P2|Overall Study|Withdrawal by Subject|1
2543584|NCT01504841|8805543|P1|Overall Study|Withdrawal by Subject|1
2543585|NCT01504412|8805589|P5|Overall Study|Death|0
2543586|NCT01504412|8805590|P4|Overall Study|Death|1
2543587|NCT01504412|8805591|P3|Overall Study|Death|0
2543588|NCT01504412|8805592|P2|Overall Study|Death|0
2543589|NCT01504412|8805593|P1|Overall Study|Death|0
2543590|NCT01504412|8805589|P5|Overall Study|Lack of Efficacy|1
2543591|NCT01504412|8805590|P4|Overall Study|Lack of Efficacy|0
2543592|NCT01504412|8805591|P3|Overall Study|Lack of Efficacy|1
2543593|NCT01504412|8805592|P2|Overall Study|Lack of Efficacy|0
2543594|NCT01504412|8805593|P1|Overall Study|Lack of Efficacy|0
2543595|NCT01504412|8805589|P5|Overall Study|Lost to Follow-up|0
2543596|NCT01504412|8805590|P4|Overall Study|Lost to Follow-up|0
2543597|NCT01504412|8805591|P3|Overall Study|Lost to Follow-up|0
2543598|NCT01504412|8805592|P2|Overall Study|Lost to Follow-up|2
2543599|NCT01504412|8805593|P1|Overall Study|Lost to Follow-up|0
2543600|NCT01504412|8805589|P5|Overall Study|Other|1
2543601|NCT01504412|8805590|P4|Overall Study|Other|6
2543602|NCT01504412|8805591|P3|Overall Study|Other|1
2543603|NCT01504412|8805592|P2|Overall Study|Other|1
2543604|NCT01504412|8805593|P1|Overall Study|Other|2
2543605|NCT01504412|8805589|P5|Overall Study|Withdrawal by Subject|1
2543606|NCT01504412|8805590|P4|Overall Study|Withdrawal by Subject|5
2543607|NCT01504412|8805591|P3|Overall Study|Withdrawal by Subject|1
2543608|NCT01504412|8805592|P2|Overall Study|Withdrawal by Subject|1
2543609|NCT01504412|8805593|P1|Overall Study|Withdrawal by Subject|2
2543610|NCT01504412|8805589|P5|Overall Study|Adverse Event|10
2543611|NCT01504412|8805590|P4|Overall Study|Adverse Event|7
2543612|NCT01504412|8805591|P3|Overall Study|Adverse Event|1
2543613|NCT01504412|8805592|P2|Overall Study|Adverse Event|8
2543614|NCT01504412|8805593|P1|Overall Study|Adverse Event|1
2543615|NCT01504204|8805612|P2|Overall Study|Lost to Follow-up|1
2543616|NCT01504204|8805613|P1|Overall Study|Lost to Follow-up|1
2543617|NCT01503164|8805670|P2|Overall Study|Withdrawal by Subject|1
2543618|NCT01503164|8805671|P1|Overall Study|Withdrawal by Subject|2
2543619|NCT01503021|8805701|P2|Overall Study|Moved, received transplant, etc.|7
2543620|NCT01503021|8805702|P1|Overall Study|Moved, received transplant, etc.|5
2543621|NCT01503021|8805701|P2|Overall Study|Withdrawal by Subject|8
2543622|NCT01503021|8805702|P1|Overall Study|Withdrawal by Subject|9
2543623|NCT01503021|8805701|P2|Overall Study|Protocol Violation|3
2543624|NCT01503021|8805702|P1|Overall Study|Protocol Violation|1
2543625|NCT01503021|8805701|P2|Overall Study|Physician Decision|0
2543626|NCT01503021|8805702|P1|Overall Study|Physician Decision|3
2543627|NCT01503021|8805701|P2|Overall Study|Lost to Follow-up|0
2543628|NCT01503021|8805702|P1|Overall Study|Lost to Follow-up|2
2543629|NCT01503021|8805701|P2|Overall Study|Death|2
2543630|NCT01503021|8805702|P1|Overall Study|Death|0
2543631|NCT01503021|8805701|P2|Overall Study|Adverse Event|6
2543632|NCT01503021|8805702|P1|Overall Study|Adverse Event|7
2543633|NCT01502956|8805751|P2|Overall Study|Withdrawal by Subject|10
2543634|NCT01502956|8805752|P1|Overall Study|Withdrawal by Subject|8
2543635|NCT01502956|8805751|P2|Overall Study|Physician Decision|3
2543636|NCT01502956|8805752|P1|Overall Study|Physician Decision|2
2543637|NCT01502956|8805751|P2|Overall Study|Lost to Follow-up|11
2543638|NCT01502956|8805752|P1|Overall Study|Lost to Follow-up|14
2543639|NCT01502956|8805751|P2|Overall Study|Death|2
2543640|NCT01502956|8805752|P1|Overall Study|Death|0
2543641|NCT01502709|8805810|P2|Overall Study|Lost to Follow-up|0
2543642|NCT01502709|8805811|P1|Overall Study|Lost to Follow-up|4
2543643|NCT01502644|8805824|P4|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
2543644|NCT01502644|8805825|P3|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
2543645|NCT01502644|8805826|P2|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
2543646|NCT01502644|8805827|P1|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
2543647|NCT01502644|8805824|P4|Assigned to NA Groups|Drop Out due to Side Effects|7
2543648|NCT01502644|8805825|P3|Assigned to NA Groups|Drop Out due to Side Effects|2
2543649|NCT01502644|8805826|P2|Assigned to NA Groups|Drop Out due to Side Effects|6
2543650|NCT01502644|8805827|P1|Assigned to NA Groups|Drop Out due to Side Effects|0
2543651|NCT01502644|8805824|P4|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
2543652|NCT01502644|8805825|P3|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
2543653|NCT01502644|8805826|P2|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
2543654|NCT01502644|8805827|P1|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6
2543655|NCT01502644|8805824|P4|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
2543656|NCT01502644|8805825|P3|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
2543657|NCT01502644|8805826|P2|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
2543658|NCT01502644|8805827|P1|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2
2543659|NCT01502644|8805824|P4|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
2543660|NCT01502644|8805825|P3|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
2543661|NCT01502644|8805826|P2|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
2543662|NCT01502644|8805827|P1|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1
2543663|NCT01502423|8805837|P2|Overall Study|Withdrawal by Subject|1
2543664|NCT01502423|8805838|P1|Overall Study|Withdrawal by Subject|0
2543665|NCT01502410|8805860|P4|Overall Study|Withdrawal by Subject|0
2543666|NCT01502410|8805861|P3|Overall Study|Withdrawal by Subject|0
2543667|NCT01502410|8805862|P2|Overall Study|Withdrawal by Subject|0
2543668|NCT01502410|8805863|P1|Overall Study|Withdrawal by Subject|2
2543669|NCT01502410|8805860|P4|Overall Study|Physician Decision|0
2543670|NCT01502410|8805861|P3|Overall Study|Physician Decision|0
2543671|NCT01502410|8805862|P2|Overall Study|Physician Decision|1
2543672|NCT01502410|8805863|P1|Overall Study|Physician Decision|0
2543673|NCT01502410|8805860|P4|Overall Study|Lack of Efficacy|0
2543674|NCT01502410|8805861|P3|Overall Study|Lack of Efficacy|0
2543675|NCT01502410|8805862|P2|Overall Study|Lack of Efficacy|7
2543676|NCT01502410|8805863|P1|Overall Study|Lack of Efficacy|7
2543677|NCT01502410|8805860|P4|Overall Study|Adverse Event|0
2543678|NCT01502410|8805861|P3|Overall Study|Adverse Event|0
2543679|NCT01502410|8805862|P2|Overall Study|Adverse Event|2
2543680|NCT01502410|8805863|P1|Overall Study|Adverse Event|1
2543681|NCT01502371|8805881|P5|Overall Study|Excluded Medication|1
2543682|NCT01502371|8805882|P4|Overall Study|Excluded Medication|0
2543683|NCT01502371|8805883|P3|Overall Study|Excluded Medication|1
2543684|NCT01502371|8805884|P2|Overall Study|Excluded Medication|1
2543685|NCT01502371|8805885|P1|Overall Study|Excluded Medication|0
2543686|NCT01502371|8805881|P5|Overall Study|Protocol Violation|10
2543687|NCT01502371|8805882|P4|Overall Study|Protocol Violation|5
2543688|NCT01502371|8805883|P3|Overall Study|Protocol Violation|6
2543689|NCT01502371|8805884|P2|Overall Study|Protocol Violation|5
2543690|NCT01502371|8805885|P1|Overall Study|Protocol Violation|9
2543691|NCT01502371|8805881|P5|Overall Study|Technical Problems|1
2543692|NCT01502371|8805882|P4|Overall Study|Technical Problems|4
2543693|NCT01502371|8805883|P3|Overall Study|Technical Problems|2
2543694|NCT01502371|8805884|P2|Overall Study|Technical Problems|0
2543695|NCT01502371|8805885|P1|Overall Study|Technical Problems|1
2543696|NCT01502371|8805881|P5|Overall Study|Noncompliance with Study Drug|1
2543697|NCT01502371|8805882|P4|Overall Study|Noncompliance with Study Drug|2
2543698|NCT01502371|8805883|P3|Overall Study|Noncompliance with Study Drug|1
2543699|NCT01502371|8805884|P2|Overall Study|Noncompliance with Study Drug|0
2543700|NCT01502371|8805885|P1|Overall Study|Noncompliance with Study Drug|0
2543701|NCT01502371|8805881|P5|Overall Study|Physician Decision|1
2543702|NCT01502371|8805882|P4|Overall Study|Physician Decision|0
2543703|NCT01502371|8805883|P3|Overall Study|Physician Decision|0
2543704|NCT01502371|8805884|P2|Overall Study|Physician Decision|0
2543705|NCT01502371|8805885|P1|Overall Study|Physician Decision|3
2543706|NCT01502371|8805881|P5|Overall Study|Lack of Efficacy|4
2543707|NCT01502371|8805882|P4|Overall Study|Lack of Efficacy|2
2543708|NCT01502371|8805883|P3|Overall Study|Lack of Efficacy|2
2543709|NCT01502371|8805884|P2|Overall Study|Lack of Efficacy|3
2543710|NCT01502371|8805885|P1|Overall Study|Lack of Efficacy|3
2543711|NCT01502371|8805881|P5|Overall Study|Treatment Failure|30
2543712|NCT01502371|8805882|P4|Overall Study|Treatment Failure|19
2543713|NCT01502371|8805883|P3|Overall Study|Treatment Failure|12
2543714|NCT01502371|8805884|P2|Overall Study|Treatment Failure|20
2543715|NCT01502371|8805885|P1|Overall Study|Treatment Failure|22
2543716|NCT01502371|8805881|P5|Overall Study|Adverse Event|3
2543717|NCT01502371|8805882|P4|Overall Study|Adverse Event|4
2543718|NCT01502371|8805883|P3|Overall Study|Adverse Event|0
2543719|NCT01502371|8805884|P2|Overall Study|Adverse Event|1
2543720|NCT01502371|8805885|P1|Overall Study|Adverse Event|2
2543721|NCT01502371|8805881|P5|Overall Study|Withdrawal by Subject|1
2543722|NCT01502371|8805882|P4|Overall Study|Withdrawal by Subject|1
2543723|NCT01502371|8805883|P3|Overall Study|Withdrawal by Subject|1
2543724|NCT01502371|8805884|P2|Overall Study|Withdrawal by Subject|2
2543725|NCT01502371|8805885|P1|Overall Study|Withdrawal by Subject|1
2543726|NCT01502293|8805950|P3|Overall Study|Physician Decision|1
2543727|NCT01502293|8805951|P2|Overall Study|Physician Decision|0
2543728|NCT01502293|8805952|P1|Overall Study|Physician Decision|0
2543729|NCT01502293|8805950|P3|Overall Study|Reason Not Specified|0
2543730|NCT01502293|8805951|P2|Overall Study|Reason Not Specified|0
2543731|NCT01502293|8805952|P1|Overall Study|Reason Not Specified|2
2543732|NCT01502293|8805950|P3|Overall Study|Adverse Event|0
2543733|NCT01502293|8805951|P2|Overall Study|Adverse Event|2
2543734|NCT01502293|8805952|P1|Overall Study|Adverse Event|0
2543735|NCT01502293|8805950|P3|Overall Study|Withdrawal by Subject|1
2543736|NCT01502293|8805951|P2|Overall Study|Withdrawal by Subject|3
2543737|NCT01502293|8805952|P1|Overall Study|Withdrawal by Subject|3
2543738|NCT01502293|8805950|P3|Overall Study|Progressive Disease|2
2543739|NCT01502293|8805951|P2|Overall Study|Progressive Disease|12
2543740|NCT01502293|8805952|P1|Overall Study|Progressive Disease|20
2543741|NCT01502228|8805981|P1|Overall Study|Death|1
2543742|NCT01502033|8805986|P1|Overall Study|1 participant went back to school|1
2543743|NCT01502033|8805986|P1|Overall Study|1 participant had worsening depression|1
2543744|NCT01502033|8805986|P1|Overall Study|1 participant had scalp discomfort|1
2543745|NCT01501955|8805994|P2|Overall Study|Adverse Event|3
2543746|NCT01501955|8805995|P1|Overall Study|Adverse Event|1
2543747|NCT01501955|8805994|P2|Overall Study|Withdrawal by Subject|0
2543748|NCT01501955|8805995|P1|Overall Study|Withdrawal by Subject|1
2543749|NCT01501110|8806059|P2|Overall Study|Death|1
2543750|NCT01501110|8806060|P1|Overall Study|Death|0
2543751|NCT01500720|8806093|P2|Overall Study|Other|8
2543752|NCT01500720|8806094|P1|Overall Study|Other|4
2543753|NCT01500720|8806093|P2|Overall Study|Randomized But Not Treated|1
2543754|NCT01500720|8806094|P1|Overall Study|Randomized But Not Treated|1
2543755|NCT01500694|8806108|P2|Overall Study|Other|3
2543756|NCT01500694|8806109|P1|Overall Study|Other|9
2543757|NCT01500694|8806108|P2|Overall Study|Lack of Efficacy|5
2543758|NCT01500694|8806109|P1|Overall Study|Lack of Efficacy|14
2543759|NCT01500694|8806108|P2|Overall Study|Lost to Follow-up|3
2543760|NCT01500694|8806109|P1|Overall Study|Lost to Follow-up|2
2543761|NCT01500694|8806108|P2|Overall Study|Withdrawal by Subject|14
2543762|NCT01500694|8806109|P1|Overall Study|Withdrawal by Subject|23
2543763|NCT01500694|8806108|P2|Overall Study|Protocol Violation|1
2543764|NCT01500694|8806109|P1|Overall Study|Protocol Violation|0
2543765|NCT01500694|8806108|P2|Overall Study|Adverse Event|3
2543766|NCT01500694|8806109|P1|Overall Study|Adverse Event|4
2543767|NCT01500629|8806135|P2|Washout Period of 14 to 30 Days|Pregnancy|0
2543768|NCT01500629|8806136|P1|Washout Period of 14 to 30 Days|Pregnancy|1
2543769|NCT01500434|8806220|P1|Overall Study|Missed 12-month follow-up|5
2543770|NCT01500434|8806220|P1|Overall Study|Withdrawal by Subject|1
2543771|NCT01500434|8806220|P1|Overall Study|Death|1
2543772|NCT01500382|8806253|P4|Washout Period|Study site went out of business|0
2543773|NCT01500382|8806254|P3|Washout Period|Study site went out of business|1
2543774|NCT01500382|8806255|P2|Washout Period|Study site went out of business|0
2543775|NCT01500382|8806256|P1|Washout Period|Study site went out of business|0
2543776|NCT01500317|8806281|P3|Overall Study|Withdrawal by Subject|0
2543777|NCT01500317|8806282|P2|Overall Study|Withdrawal by Subject|2
2543778|NCT01500317|8806283|P1|Overall Study|Withdrawal by Subject|3
2543779|NCT01500278|8806305|P2|Week 13 - Week 104|Adverse Event|54
2543780|NCT01500278|8806306|P1|Week 13 - Week 104|Adverse Event|54
2543781|NCT01500278|8806305|P2|Week 13 - Week 104|Death|4
2543782|NCT01500278|8806306|P1|Week 13 - Week 104|Death|2
2543783|NCT01500278|8806305|P2|Week 13 - Week 104|Not completed|1
2543784|NCT01500278|8806306|P1|Week 13 - Week 104|Not completed|0
2543785|NCT01500278|8806305|P2|Week 13 - Week 104|Personal reason|1
2543786|NCT01500278|8806306|P1|Week 13 - Week 104|Personal reason|0
2543787|NCT01500278|8806305|P2|Week 13 - Week 104|Medical monitor decision|2
2543788|NCT01500278|8806306|P1|Week 13 - Week 104|Medical monitor decision|0
2543789|NCT01500278|8806305|P2|Week 13 - Week 104|Sponsor decision|2
2543790|NCT01500278|8806306|P1|Week 13 - Week 104|Sponsor decision|0
2543791|NCT01500278|8806305|P2|Week 13 - Week 104|Relocation|1
2543792|NCT01500278|8806306|P1|Week 13 - Week 104|Relocation|0
2543793|NCT01500278|8806305|P2|Week 13 - Week 104|Abnormal questionable chest X-ray|2
2543794|NCT01500278|8806306|P1|Week 13 - Week 104|Abnormal questionable chest X-ray|0
2543795|NCT01500278|8806305|P2|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0
2543796|NCT01500278|8806306|P1|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1
2543797|NCT01500278|8806305|P2|Week 13 - Week 104|Principal investigator retiring|0
2543798|NCT01500278|8806306|P1|Week 13 - Week 104|Principal investigator retiring|1
2543799|NCT01500278|8806305|P2|Week 13 - Week 104|Protocol deviation|0
2543800|NCT01500278|8806306|P1|Week 13 - Week 104|Protocol deviation|1
2543801|NCT01500278|8806305|P2|Week 13 - Week 104|Exclusion criteria not met|0
2543802|NCT01500278|8806306|P1|Week 13 - Week 104|Exclusion criteria not met|1
2543803|NCT01500278|8806305|P2|Week 13 - Week 104|Withdrawn in error|0
2543804|NCT01500278|8806306|P1|Week 13 - Week 104|Withdrawn in error|1
2543805|NCT01500278|8806305|P2|Week 13 - Week 104|Sponsor request|0
2543806|NCT01500278|8806306|P1|Week 13 - Week 104|Sponsor request|4
2543807|NCT01500278|8806305|P2|Week 13 - Week 104|False positive test|2
2543808|NCT01500278|8806306|P1|Week 13 - Week 104|False positive test|1
2543809|NCT01500278|8806305|P2|Week 13 - Week 104|Recurrent infections|0
2543810|NCT01500278|8806306|P1|Week 13 - Week 104|Recurrent infections|1
2543811|NCT01500278|8806305|P2|Week 13 - Week 104|Non/bad compliance|5
2543812|NCT01500278|8806306|P1|Week 13 - Week 104|Non/bad compliance|7
2543813|NCT01500278|8806305|P2|Week 13 - Week 104|Week 24 Non-Responder|16
2543814|NCT01500278|8806306|P1|Week 13 - Week 104|Week 24 Non-Responder|20
2543815|NCT01500278|8806305|P2|Week 13 - Week 104|Withdrawal by Subject|13
2543816|NCT01500278|8806306|P1|Week 13 - Week 104|Withdrawal by Subject|22
2543817|NCT01500278|8806305|P2|Week 13 - Week 104|Lost to Follow-up|5
2543818|NCT01500278|8806306|P1|Week 13 - Week 104|Lost to Follow-up|6
2543819|NCT01500278|8806305|P2|Week 13 - Week 104|Protocol Violation|6
2543820|NCT01500278|8806306|P1|Week 13 - Week 104|Protocol Violation|6
2543821|NCT01500278|8806305|P2|Week 13 - Week 104|Lack of Efficacy|12
2543822|NCT01500278|8806306|P1|Week 13 - Week 104|Lack of Efficacy|11
2543823|NCT01500278|8806305|P2|Week 0 - Week 12|Adverse event (AE), not fatal|8
2543824|NCT01500278|8806306|P1|Week 0 - Week 12|Adverse event (AE), not fatal|7
2543825|NCT01500278|8806305|P2|Week 0 - Week 12|Other serious disease|1
2543826|NCT01500278|8806306|P1|Week 0 - Week 12|Other serious disease|0
2543827|NCT01500278|8806305|P2|Week 0 - Week 12|Personal reason|1
2543828|NCT01500278|8806306|P1|Week 0 - Week 12|Personal reason|0
2543829|NCT01500278|8806305|P2|Week 0 - Week 12|Sponsor decision|0
2543830|NCT01500278|8806306|P1|Week 0 - Week 12|Sponsor decision|1
2543831|NCT01500278|8806305|P2|Week 0 - Week 12|Prior history of serious disease|0
2543832|NCT01500278|8806306|P1|Week 0 - Week 12|Prior history of serious disease|1
2543833|NCT01500278|8806305|P2|Week 0 - Week 12|Investigator decision|0
2543834|NCT01500278|8806306|P1|Week 0 - Week 12|Investigator decision|1
2543835|NCT01500278|8806305|P2|Week 0 - Week 12|Exclusion criteria not met|0
2543836|NCT01500278|8806306|P1|Week 0 - Week 12|Exclusion criteria not met|1
2543837|NCT01500278|8806305|P2|Week 0 - Week 12|Patient decision|0
2543838|NCT01500278|8806306|P1|Week 0 - Week 12|Patient decision|1
2543839|NCT01500278|8806305|P2|Week 0 - Week 12|Protocol violation on screening X-ray|0
2543840|NCT01500278|8806306|P1|Week 0 - Week 12|Protocol violation on screening X-ray|1
2543841|NCT01500278|8806305|P2|Week 0 - Week 12|Withdrawal by Subject|2
2543842|NCT01500278|8806306|P1|Week 0 - Week 12|Withdrawal by Subject|7
2543843|NCT01500278|8806305|P2|Week 0 - Week 12|Lost to Follow-up|1
2543844|NCT01500278|8806306|P1|Week 0 - Week 12|Lost to Follow-up|1
2543845|NCT01500278|8806305|P2|Week 0 - Week 12|Protocol Violation|16
2543846|NCT01500278|8806306|P1|Week 0 - Week 12|Protocol Violation|10
2543847|NCT01500278|8806305|P2|Week 0 - Week 12|Lack of Efficacy|1
2543848|NCT01500278|8806306|P1|Week 0 - Week 12|Lack of Efficacy|0
2543849|NCT01500252|8806330|P2|Overall Study|Lost to Follow-up|4
2543850|NCT01500252|8806331|P1|Overall Study|Lost to Follow-up|5
2543851|NCT01500252|8806330|P2|Overall Study|Death|2
2543852|NCT01500252|8806331|P1|Overall Study|Death|4
2543853|NCT01500226|8806357|P2|Overall Study|Other Reasons|16
2543854|NCT01500226|8806358|P1|Overall Study|Other Reasons|19
2543855|NCT01500226|8806357|P2|Overall Study|Lost to Follow-up|5
2543856|NCT01500226|8806358|P1|Overall Study|Lost to Follow-up|9
2543857|NCT01500226|8806357|P2|Overall Study|Lack of Efficacy|30
2543858|NCT01500226|8806358|P1|Overall Study|Lack of Efficacy|14
2543859|NCT01500226|8806357|P2|Overall Study|Physician Decision|15
2543860|NCT01500226|8806358|P1|Overall Study|Physician Decision|17
2543861|NCT01500226|8806357|P2|Overall Study|Protocol Violation|39
2543862|NCT01500226|8806358|P1|Overall Study|Protocol Violation|53
2543863|NCT01500226|8806357|P2|Overall Study|Disease Progression|14
2543864|NCT01500226|8806358|P1|Overall Study|Disease Progression|16
2543865|NCT01500226|8806357|P2|Overall Study|Death|4
2543866|NCT01500226|8806358|P1|Overall Study|Death|12
2543867|NCT01500226|8806357|P2|Overall Study|Withdrawal by Subject|96
2543868|NCT01500226|8806358|P1|Overall Study|Withdrawal by Subject|93
2543869|NCT01500226|8806357|P2|Overall Study|Chemo Completed or Change in Therapy|237
2543870|NCT01500226|8806358|P1|Overall Study|Chemo Completed or Change in Therapy|235
2543871|NCT01500226|8806357|P2|Overall Study|Adverse Event|38
2543872|NCT01500226|8806358|P1|Overall Study|Adverse Event|31
2543873|NCT01500213|8806370|P2|Overall Study|Other Reasons|5
2543874|NCT01500213|8806371|P1|Overall Study|Other Reasons|7
2543875|NCT01500213|8806370|P2|Overall Study|Lost to Follow-up|6
2543876|NCT01500213|8806371|P1|Overall Study|Lost to Follow-up|3
2543877|NCT01500213|8806370|P2|Overall Study|Lack of Efficacy|7
2543878|NCT01500213|8806371|P1|Overall Study|Lack of Efficacy|9
2543879|NCT01500213|8806370|P2|Overall Study|Physician Decision|10
2543880|NCT01500213|8806371|P1|Overall Study|Physician Decision|12
2543881|NCT01500213|8806370|P2|Overall Study|Protocol Violation|19
2543882|NCT01500213|8806371|P1|Overall Study|Protocol Violation|19
2543883|NCT01500213|8806370|P2|Overall Study|Disease Progression|21
2543884|NCT01500213|8806371|P1|Overall Study|Disease Progression|13
2543885|NCT01500213|8806370|P2|Overall Study|Death|3
2543886|NCT01500213|8806371|P1|Overall Study|Death|7
2543887|NCT01500213|8806370|P2|Overall Study|Withdrawal by Subject|37
2543888|NCT01500213|8806371|P1|Overall Study|Withdrawal by Subject|28
2543889|NCT01500213|8806370|P2|Overall Study|Chemo Completed or Change in Therapy|81
2543890|NCT01500213|8806371|P1|Overall Study|Chemo Completed or Change in Therapy|84
2543891|NCT01500213|8806370|P2|Overall Study|Adverse Event|35
2543892|NCT01500213|8806371|P1|Overall Study|Adverse Event|35
2543893|NCT01500200|8806384|P6|Stage 2|Adverse Event|4
2543894|NCT01500200|8806385|P5|Stage 2|Adverse Event|5
2543895|NCT01500200|8806386|P4|Stage 2|Adverse Event|0
2543896|NCT01500200|8806387|P3|Stage 2|Adverse Event|0
2543897|NCT01500200|8806388|P2|Stage 2|Adverse Event|0
2543898|NCT01500200|8806389|P1|Stage 2|Adverse Event|0
2543899|NCT01500200|8806384|P6|Stage 1|Physician Decision|0
2543900|NCT01500200|8806385|P5|Stage 1|Physician Decision|0
2543901|NCT01500200|8806386|P4|Stage 1|Physician Decision|0
2543902|NCT01500200|8806387|P3|Stage 1|Physician Decision|0
2543903|NCT01500200|8806388|P2|Stage 1|Physician Decision|0
2543904|NCT01500200|8806389|P1|Stage 1|Physician Decision|1
2543905|NCT01500200|8806384|P6|Stage 1|Noncompliance with Study Drug|0
2543906|NCT01500200|8806385|P5|Stage 1|Noncompliance with Study Drug|0
2543907|NCT01500200|8806386|P4|Stage 1|Noncompliance with Study Drug|0
2543908|NCT01500200|8806387|P3|Stage 1|Noncompliance with Study Drug|0
2543909|NCT01500200|8806388|P2|Stage 1|Noncompliance with Study Drug|0
2543910|NCT01500200|8806389|P1|Stage 1|Noncompliance with Study Drug|1
2543911|NCT01500200|8806384|P6|Stage 1|Withdrawal by Subject|0
2543912|NCT01500200|8806385|P5|Stage 1|Withdrawal by Subject|0
2543913|NCT01500200|8806386|P4|Stage 1|Withdrawal by Subject|0
2543914|NCT01500200|8806387|P3|Stage 1|Withdrawal by Subject|0
2543915|NCT01500200|8806388|P2|Stage 1|Withdrawal by Subject|0
2543916|NCT01500200|8806389|P1|Stage 1|Withdrawal by Subject|3
2543917|NCT01500200|8806384|P6|Stage 1|Lost to Follow-up|0
2543918|NCT01500200|8806385|P5|Stage 1|Lost to Follow-up|0
2543919|NCT01500200|8806386|P4|Stage 1|Lost to Follow-up|0
2543920|NCT01500200|8806387|P3|Stage 1|Lost to Follow-up|1
2543921|NCT01500200|8806388|P2|Stage 1|Lost to Follow-up|2
2543922|NCT01500200|8806389|P1|Stage 1|Lost to Follow-up|2
2543923|NCT01500200|8806384|P6|Stage 1|Adverse Event|0
2543924|NCT01500200|8806385|P5|Stage 1|Adverse Event|0
2543925|NCT01500200|8806386|P4|Stage 1|Adverse Event|0
2543926|NCT01500200|8806387|P3|Stage 1|Adverse Event|5
2543927|NCT01500200|8806388|P2|Stage 1|Adverse Event|4
2543928|NCT01500200|8806389|P1|Stage 1|Adverse Event|1
2543929|NCT01500187|8806423|P2|Overall Study|Lost to Follow-up|0
2543930|NCT01500187|8806424|P1|Overall Study|Lost to Follow-up|6
2543931|NCT01500135|8806432|P2|Overall Study|Patient Unable to Make Follow-up Visit|1
2543932|NCT01500135|8806433|P1|Overall Study|Patient Unable to Make Follow-up Visit|0
2543933|NCT01500135|8806432|P2|Overall Study|Participant was a Safety Concern|0
2543934|NCT01500135|8806433|P1|Overall Study|Participant was a Safety Concern|1
2543935|NCT01500135|8806432|P2|Overall Study|Patient Missed Scheduled Appointments|1
2543936|NCT01500135|8806433|P1|Overall Study|Patient Missed Scheduled Appointments|0
2543937|NCT01500135|8806432|P2|Overall Study|Principal Investigator (PI) Discretion|0
2543938|NCT01500135|8806433|P1|Overall Study|Principal Investigator (PI) Discretion|1
2543939|NCT01500135|8806432|P2|Overall Study|Fatal Adverse Event (AE)|5
2543940|NCT01500135|8806433|P1|Overall Study|Fatal Adverse Event (AE)|5
2543941|NCT01500135|8806432|P2|Overall Study|Lost to Follow-up|4
2543942|NCT01500135|8806433|P1|Overall Study|Lost to Follow-up|6
2543943|NCT01500135|8806432|P2|Overall Study|Withdrawal of Consent|0
2543944|NCT01500135|8806433|P1|Overall Study|Withdrawal of Consent|4
2543945|NCT01500096|8806460|P4|Overall Study|Lost to Follow-up|2
2543946|NCT01500096|8806461|P3|Overall Study|Lost to Follow-up|0
2543947|NCT01500096|8806462|P2|Overall Study|Lost to Follow-up|0
2543948|NCT01500096|8806463|P1|Overall Study|Lost to Follow-up|1
2543949|NCT01500083|8806519|P2|Overall Study|Other Reasons|5
2543950|NCT01500083|8806520|P1|Overall Study|Other Reasons|2
2543951|NCT01500083|8806519|P2|Overall Study|Investigator Discretion|8
2543952|NCT01500083|8806520|P1|Overall Study|Investigator Discretion|3
2543953|NCT01500083|8806519|P2|Overall Study|Disease Progression|10
2543954|NCT01500083|8806520|P1|Overall Study|Disease Progression|2
2543955|NCT01500083|8806519|P2|Overall Study|Withdrawal of Consent|1
2543956|NCT01500083|8806520|P1|Overall Study|Withdrawal of Consent|0
2543957|NCT01500083|8806519|P2|Overall Study|Lost to Follow-up|0
2543958|NCT01500083|8806520|P1|Overall Study|Lost to Follow-up|1
2543959|NCT01500083|8806519|P2|Overall Study|Death|2
2543960|NCT01500083|8806520|P1|Overall Study|Death|0
2543961|NCT01500083|8806519|P2|Overall Study|Adverse Event|17
2543962|NCT01500083|8806520|P1|Overall Study|Adverse Event|4
2543963|NCT01500057|8806528|P2|Overall Study|Lost to Follow-up|4
2543964|NCT01500057|8806529|P1|Overall Study|Lost to Follow-up|6
2543965|NCT01500031|8806539|P1|Overall Study|Withdrawal by Subject|4
2543966|NCT01500031|8806539|P1|Overall Study|Death|1
2543967|NCT01499849|8806574|P2|Overall Study|Other Reasons|30
2543968|NCT01499849|8806575|P1|Overall Study|Other Reasons|27
2543969|NCT01499849|8806574|P2|Overall Study|Lost to Follow-up|3
2543970|NCT01499849|8806575|P1|Overall Study|Lost to Follow-up|6
2543971|NCT01499849|8806574|P2|Overall Study|Lack of Efficacy|4
2543972|NCT01499849|8806575|P1|Overall Study|Lack of Efficacy|3
2543973|NCT01499849|8806574|P2|Overall Study|Physician Decision|19
2543974|NCT01499849|8806575|P1|Overall Study|Physician Decision|20
2543975|NCT01499849|8806574|P2|Overall Study|Protocol Violation|11
2543976|NCT01499849|8806575|P1|Overall Study|Protocol Violation|11
2543977|NCT01499849|8806574|P2|Overall Study|Disease Progression|10
2543978|NCT01499849|8806575|P1|Overall Study|Disease Progression|11
2543979|NCT01499849|8806574|P2|Overall Study|Death|7
2543980|NCT01499849|8806575|P1|Overall Study|Death|5
2543981|NCT01499849|8806574|P2|Overall Study|Withdrawal by Subject|43
2543982|NCT01499849|8806575|P1|Overall Study|Withdrawal by Subject|43
2543983|NCT01499849|8806574|P2|Overall Study|Chemo completed or Change in Therapy|67
2543984|NCT01499849|8806575|P1|Overall Study|Chemo completed or Change in Therapy|70
2543985|NCT01499849|8806574|P2|Overall Study|Adverse Event|32
2543986|NCT01499849|8806575|P1|Overall Study|Adverse Event|28
2543987|NCT01499810|8806585|P1|Overall Study|Withdrawal by Subject|1
2543988|NCT01499810|8806585|P1|Overall Study|Protocol Violation|1
2543989|NCT01499810|8806585|P1|Overall Study|Lost to Follow-up|10
2543990|NCT01499667|8806635|P3|Overall Study|Lack of Efficacy|0
2543991|NCT01499667|8806636|P2|Overall Study|Lack of Efficacy|0
2543992|NCT01499667|8806637|P1|Overall Study|Lack of Efficacy|2
2543993|NCT01499667|8806635|P3|Overall Study|Withdrawal by Subject|1
2543994|NCT01499667|8806636|P2|Overall Study|Withdrawal by Subject|1
2543995|NCT01499667|8806637|P1|Overall Study|Withdrawal by Subject|2
2543996|NCT01499667|8806635|P3|Overall Study|Adverse Event|2
2543997|NCT01499667|8806636|P2|Overall Study|Adverse Event|2
2543998|NCT01499667|8806637|P1|Overall Study|Adverse Event|0
2543999|NCT01499667|8806635|P3|Overall Study|Protocol Violation|2
2544000|NCT01499667|8806636|P2|Overall Study|Protocol Violation|3
2544001|NCT01499667|8806637|P1|Overall Study|Protocol Violation|1
2544002|NCT01499667|8806635|P3|Overall Study|administrative problems|5
2544003|NCT01499667|8806636|P2|Overall Study|administrative problems|5
2544004|NCT01499667|8806637|P1|Overall Study|administrative problems|4
2544005|NCT01499576|8806685|P1|Overall Study|Withdrawal by Subject|9
2544006|NCT01499576|8806685|P1|Overall Study|Physician Decision|12
2544007|NCT01499511|8806693|P2|Overall Study|Death|0
2544008|NCT01499511|8806694|P1|Overall Study|Death|1
2544009|NCT01499355|8806719|P4|Double-Blind Period|Lost to Follow-up|0
2544010|NCT01499355|8806720|P3|Double-Blind Period|Lost to Follow-up|0
2544011|NCT01499355|8806721|P2|Double-Blind Period|Lost to Follow-up|1
2544012|NCT01499355|8806722|P1|Double-Blind Period|Lost to Follow-up|0
2544013|NCT01499355|8806719|P4|Double-Blind Period|Consent Withdrawn|2
2544014|NCT01499355|8806720|P3|Double-Blind Period|Consent Withdrawn|1
2544015|NCT01499355|8806721|P2|Double-Blind Period|Consent Withdrawn|0
2544016|NCT01499355|8806722|P1|Double-Blind Period|Consent Withdrawn|0
2544017|NCT01499355|8806719|P4|Double-Blind Period|Investigator Decision|3
2544018|NCT01499355|8806720|P3|Double-Blind Period|Investigator Decision|3
2544019|NCT01499355|8806721|P2|Double-Blind Period|Investigator Decision|0
2544020|NCT01499355|8806722|P1|Double-Blind Period|Investigator Decision|0
2544021|NCT01499355|8806719|P4|Double-Blind Period|Death|0
2544022|NCT01499355|8806720|P3|Double-Blind Period|Death|0
2544023|NCT01499355|8806721|P2|Double-Blind Period|Death|1
2544024|NCT01499355|8806722|P1|Double-Blind Period|Death|0
2544025|NCT01499355|8806719|P4|Double-Blind Period|Other|2
2544026|NCT01499355|8806720|P3|Double-Blind Period|Other|2
2544027|NCT01499355|8806721|P2|Double-Blind Period|Other|1
2544028|NCT01499355|8806722|P1|Double-Blind Period|Other|0
2544029|NCT01499355|8806719|P4|Double-Blind Period|Study Termination|14
2544030|NCT01499355|8806720|P3|Double-Blind Period|Study Termination|16
2544031|NCT01499355|8806721|P2|Double-Blind Period|Study Termination|18
2544032|NCT01499355|8806722|P1|Double-Blind Period|Study Termination|0
2544033|NCT01499355|8806719|P4|Double-Blind Period|Adverse Event|2
2544034|NCT01499355|8806720|P3|Double-Blind Period|Adverse Event|3
2544035|NCT01499355|8806721|P2|Double-Blind Period|Adverse Event|2
2544036|NCT01499355|8806722|P1|Double-Blind Period|Adverse Event|0
2544037|NCT01499355|8806719|P4|Run-In Period|Adverse Event|0
2544038|NCT01499355|8806720|P3|Run-In Period|Adverse Event|0
2544039|NCT01499355|8806721|P2|Run-In Period|Adverse Event|0
2544040|NCT01499355|8806722|P1|Run-In Period|Adverse Event|8
2544041|NCT01499355|8806719|P4|Run-In Period|Consent Withdrawn|0
2544042|NCT01499355|8806720|P3|Run-In Period|Consent Withdrawn|0
2544043|NCT01499355|8806721|P2|Run-In Period|Consent Withdrawn|0
2544044|NCT01499355|8806722|P1|Run-In Period|Consent Withdrawn|1
2544045|NCT01499355|8806719|P4|Run-In Period|Investigator Decision|0
2544046|NCT01499355|8806720|P3|Run-In Period|Investigator Decision|0
2544047|NCT01499355|8806721|P2|Run-In Period|Investigator Decision|0
2544048|NCT01499355|8806722|P1|Run-In Period|Investigator Decision|2
2544049|NCT01499355|8806719|P4|Run-In Period|Death|0
2544050|NCT01499355|8806720|P3|Run-In Period|Death|0
2544051|NCT01499355|8806721|P2|Run-In Period|Death|0
2544052|NCT01499355|8806722|P1|Run-In Period|Death|2
2544053|NCT01499355|8806719|P4|Run-In Period|Other|0
2544054|NCT01499355|8806720|P3|Run-In Period|Other|0
2544055|NCT01499355|8806721|P2|Run-In Period|Other|0
2544056|NCT01499355|8806722|P1|Run-In Period|Other|3
2544057|NCT01499355|8806719|P4|Run-In Period|Study Termination|0
2544058|NCT01499355|8806720|P3|Run-In Period|Study Termination|0
2544059|NCT01499355|8806721|P2|Run-In Period|Study Termination|0
2544060|NCT01499355|8806722|P1|Run-In Period|Study Termination|15
2544061|NCT01499303|8806755|P2|Overall Study|Other|1
2544062|NCT01499303|8806756|P1|Overall Study|Other|0
2544063|NCT01499303|8806755|P2|Overall Study|Adverse Event|4
2544064|NCT01499303|8806756|P1|Overall Study|Adverse Event|1
2544065|NCT01499303|8806755|P2|Overall Study|Withdrawal by Subject|1
2544066|NCT01499303|8806756|P1|Overall Study|Withdrawal by Subject|0
2544067|NCT01499303|8806755|P2|Overall Study|Ongoing|1
2544068|NCT01499303|8806756|P1|Overall Study|Ongoing|2
2544069|NCT01499290|8806764|P2|Overall Study|Adverse Event|7
2544070|NCT01499290|8806765|P1|Overall Study|Adverse Event|14
2544071|NCT01499290|8806764|P2|Overall Study|Lack of Efficacy|8
2544072|NCT01499290|8806765|P1|Overall Study|Lack of Efficacy|7
2544073|NCT01499290|8806764|P2|Overall Study|Condition improved/subject recovered|0
2544074|NCT01499290|8806765|P1|Overall Study|Condition improved/subject recovered|1
2544075|NCT01499290|8806764|P2|Overall Study|Not specified in study report|5
2544076|NCT01499290|8806765|P1|Overall Study|Not specified in study report|11
2544077|NCT01499290|8806764|P2|Overall Study|Withdrawal by Subject|15
2544078|NCT01499290|8806765|P1|Overall Study|Withdrawal by Subject|22
2544079|NCT01499277|8806815|P2|Overall Study|Lack of therapeutic response and other|7
2544080|NCT01499277|8806816|P1|Overall Study|Lack of therapeutic response and other|8
2544081|NCT01499277|8806815|P2|Overall Study|Withdrawal by Subject|6
2544082|NCT01499277|8806816|P1|Overall Study|Withdrawal by Subject|16
2544083|NCT01499277|8806815|P2|Overall Study|Protocol Violation|3
2544084|NCT01499277|8806816|P1|Overall Study|Protocol Violation|2
2544085|NCT01499277|8806815|P2|Overall Study|Lost to Follow-up|8
2544086|NCT01499277|8806816|P1|Overall Study|Lost to Follow-up|15
2544087|NCT01499277|8806815|P2|Overall Study|Death|2
2544088|NCT01499277|8806816|P1|Overall Study|Death|3
2544089|NCT01499277|8806815|P2|Overall Study|Adverse Event|6
2544090|NCT01499277|8806816|P1|Overall Study|Adverse Event|3
2544091|NCT01499199|8806838|P1|Overall Study|Lack of Efficacy|1
2544092|NCT01499199|8806838|P1|Overall Study|Adverse Event|1
2544093|NCT01499160|8806867|P1|Overall Study|Withdrawal by Subject|1
2544094|NCT01499160|8806867|P1|Overall Study|Adverse Event|1
2544095|NCT01499134|8806890|P2|Overall Study|Withdrawal by Subject|1
2544096|NCT01499134|8806891|P1|Overall Study|Withdrawal by Subject|0
2544097|NCT01499095|8806913|P2|Overall Study|Perceived Lack of Efficacy|1
2544098|NCT01499095|8806914|P1|Overall Study|Perceived Lack of Efficacy|1
2544099|NCT01499095|8806913|P2|Overall Study|Change in Injection Schedule|0
2544100|NCT01499095|8806914|P1|Overall Study|Change in Injection Schedule|2
2544101|NCT01499095|8806913|P2|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1
2544102|NCT01499095|8806914|P1|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2
2544103|NCT01499095|8806913|P2|Overall Study|Hypoglycemia|1
2544104|NCT01499095|8806914|P1|Overall Study|Hypoglycemia|3
2544105|NCT01499095|8806913|P2|Overall Study|Insulin Dropped Below Authorized Dose|5
2544106|NCT01499095|8806914|P1|Overall Study|Insulin Dropped Below Authorized Dose|0
2544107|NCT01499095|8806913|P2|Overall Study|Lost to Follow-up|4
2544108|NCT01499095|8806914|P1|Overall Study|Lost to Follow-up|6
2544109|NCT01499095|8806913|P2|Overall Study|Diverse Reasons|25
2544110|NCT01499095|8806914|P1|Overall Study|Diverse Reasons|22
2544111|NCT01499095|8806913|P2|Overall Study|Received Rescue Therapy|40
2544112|NCT01499095|8806914|P1|Overall Study|Received Rescue Therapy|32
2544113|NCT01499095|8806913|P2|Overall Study|Protocol Violation|7
2544114|NCT01499095|8806914|P1|Overall Study|Protocol Violation|6
2544115|NCT01499095|8806913|P2|Overall Study|Lack of Efficacy|1
2544116|NCT01499095|8806914|P1|Overall Study|Lack of Efficacy|2
2544117|NCT01499095|8806913|P2|Overall Study|Adverse Event|7
2544118|NCT01499095|8806914|P1|Overall Study|Adverse Event|12
2544119|NCT01499095|8806913|P2|Overall Study|Randomized But Not Treated|1
2544120|NCT01499095|8806914|P1|Overall Study|Randomized But Not Treated|1
2544121|NCT01499082|8806944|P2|Overall Study|Lost to Follow-up|3
2544122|NCT01499082|8806945|P1|Overall Study|Lost to Follow-up|1
2544123|NCT01499082|8806944|P2|Overall Study|Hypoglycemia|3
2544124|NCT01499082|8806945|P1|Overall Study|Hypoglycemia|2
2544125|NCT01499082|8806944|P2|Overall Study|Site Closure for Noncompliance|2
2544126|NCT01499082|8806945|P1|Overall Study|Site Closure for Noncompliance|5
2544127|NCT01499082|8806944|P2|Overall Study|Diverse Reasons|14
2544128|NCT01499082|8806945|P1|Overall Study|Diverse Reasons|18
2544129|NCT01499082|8806944|P2|Overall Study|Protocol Violation|8
2544130|NCT01499082|8806945|P1|Overall Study|Protocol Violation|6
2544131|NCT01499082|8806944|P2|Overall Study|Lack of Efficacy|1
2544132|NCT01499082|8806945|P1|Overall Study|Lack of Efficacy|1
2544133|NCT01499082|8806944|P2|Overall Study|Adverse Event|16
2544134|NCT01499082|8806945|P1|Overall Study|Adverse Event|12
2544135|NCT01499082|8806944|P2|Overall Study|Randomized but not Treated|1
2544136|NCT01499082|8806945|P1|Overall Study|Randomized but not Treated|0
2544137|NCT01499043|8806973|P1|Overall Study|Adverse Event|1
2544138|NCT01499043|8806973|P1|Overall Study|Withdrawal by Subject|2
2544139|NCT01499043|8806973|P1|Overall Study|Progressive disease (clinical)|1
2544140|NCT01499043|8806973|P1|Overall Study|Progressive disease (radiographic)|2
2544141|NCT01498952|8807016|P5|Overall Study|Death|0
2544142|NCT01498952|8807017|P4|Overall Study|Death|0
2544143|NCT01498952|8807018|P3|Overall Study|Death|0
2544144|NCT01498952|8807019|P2|Overall Study|Death|2
2544145|NCT01498952|8807020|P1|Overall Study|Death|2
2544146|NCT01498887|8807062|P2|Overall Study|Adverse Event|1
2544147|NCT01498887|8807063|P1|Overall Study|Adverse Event|4
2544148|NCT01498887|8807062|P2|Overall Study|Abnormal laboratory value|2
2544149|NCT01498887|8807063|P1|Overall Study|Abnormal laboratory value|2
2544150|NCT01498887|8807062|P2|Overall Study|Abnormal result from test procedure|1
2544151|NCT01498887|8807063|P1|Overall Study|Abnormal result from test procedure|1
2544152|NCT01498887|8807062|P2|Overall Study|Lack of Efficacy|3
2544153|NCT01498887|8807063|P1|Overall Study|Lack of Efficacy|5
2544154|NCT01498887|8807062|P2|Overall Study|Protocol Violation|3
2544155|NCT01498887|8807063|P1|Overall Study|Protocol Violation|1
2544156|NCT01498887|8807062|P2|Overall Study|Withdrawal by Subject|0
2544157|NCT01498887|8807063|P1|Overall Study|Withdrawal by Subject|1
2544158|NCT01498887|8807062|P2|Overall Study|Lost to Follow-up|1
2544159|NCT01498887|8807063|P1|Overall Study|Lost to Follow-up|1
2544160|NCT01498887|8807062|P2|Overall Study|Administrative problems|0
2544161|NCT01498887|8807063|P1|Overall Study|Administrative problems|1
2544162|NCT01498822|8807084|P2|Overall Study|Lost to Follow-up|3
2544163|NCT01498822|8807085|P1|Overall Study|Lost to Follow-up|8
2544164|NCT01498822|8807084|P2|Overall Study|Withdrawal by Subject|25
2544165|NCT01498822|8807085|P1|Overall Study|Withdrawal by Subject|15
2544166|NCT01498822|8807084|P2|Overall Study|Adverse Event, serious fatal|1
2544167|NCT01498822|8807085|P1|Overall Study|Adverse Event, serious fatal|1
2544168|NCT01498822|8807084|P2|Overall Study|SAE, non-fatal|2
2544169|NCT01498822|8807085|P1|Overall Study|SAE, non-fatal|2
2544170|NCT01498822|8807084|P2|Overall Study|AE, non-serious non-fatal|17
2544171|NCT01498822|8807085|P1|Overall Study|AE, non-serious non-fatal|8
2544172|NCT01498822|8807084|P2|Overall Study|Lack of Efficacy|2
2544173|NCT01498822|8807085|P1|Overall Study|Lack of Efficacy|7
2544174|NCT01498822|8807084|P2|Overall Study|Other Reason|2
2544175|NCT01498822|8807085|P1|Overall Study|Other Reason|5
2544176|NCT01498822|8807084|P2|Overall Study|Protocol Violation|4
2544177|NCT01498822|8807085|P1|Overall Study|Protocol Violation|8
2544178|NCT01498692|8807112|P1|Overall Study|Missed 12-month visit|3
2544179|NCT01498692|8807112|P1|Overall Study|Withdrawal by Subject|1
2544180|NCT01498692|8807112|P1|Overall Study|Death|4
2544181|NCT01498679|8807143|P2|Overall Study|Withdrawal by Subject|4
2544182|NCT01498679|8807144|P1|Overall Study|Withdrawal by Subject|12
2544183|NCT01498679|8807143|P2|Overall Study|Physician Decision|2
2544184|NCT01498679|8807144|P1|Overall Study|Physician Decision|0
2544185|NCT01498679|8807143|P2|Overall Study|Protocol Violation|0
2544186|NCT01498679|8807144|P1|Overall Study|Protocol Violation|4
2544187|NCT01498679|8807143|P2|Overall Study|Lack of Efficacy|12
2544188|NCT01498679|8807144|P1|Overall Study|Lack of Efficacy|72
2544189|NCT01498679|8807143|P2|Overall Study|Adverse Event|4
2544190|NCT01498679|8807144|P1|Overall Study|Adverse Event|1
2544191|NCT01498653|8807160|P2|Overall Study|Withdrawal by Subject|3
2544192|NCT01498653|8807161|P1|Overall Study|Withdrawal by Subject|2
2544193|NCT01498653|8807160|P2|Overall Study|Physician Decision|0
2544194|NCT01498653|8807161|P1|Overall Study|Physician Decision|2
2544195|NCT01498653|8807160|P2|Overall Study|Lost to Follow-up|0
2544196|NCT01498653|8807161|P1|Overall Study|Lost to Follow-up|1
2544197|NCT01498653|8807160|P2|Overall Study|Protocol Violation|4
2544198|NCT01498653|8807161|P1|Overall Study|Protocol Violation|0
2544199|NCT01498653|8807160|P2|Overall Study|Lack of Efficacy|26
2544200|NCT01498653|8807161|P1|Overall Study|Lack of Efficacy|12
2544201|NCT01498653|8807160|P2|Overall Study|Adverse Event|2
2544202|NCT01498653|8807161|P1|Overall Study|Adverse Event|2
2544203|NCT01498640|8807175|P1|Overall Study|Other|3
2544204|NCT01498640|8807175|P1|Overall Study|Death|1
2544205|NCT01498640|8807175|P1|Overall Study|Lost to Follow-up|1
2544206|NCT01498575|8807205|P2|On the Road Driving Assessment (ODA)|Protocol Violation|18
2544207|NCT01498575|8807206|P1|On the Road Driving Assessment (ODA)|Protocol Violation|23
2544208|NCT01498575|8807205|P2|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6
2544209|NCT01498575|8807206|P1|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19
2544210|NCT01498575|8807205|P2|Overall Sample|Withdrawal by Subject|14
2544211|NCT01498575|8807206|P1|Overall Sample|Withdrawal by Subject|60
2544212|NCT01498458|8807223|P1|Overall Study|Physician Decision|3
2544213|NCT01498458|8807223|P1|Overall Study|Adverse Event|4
2544214|NCT01498289|8807275|P2|Overall Study|Reason under review|1
2544215|NCT01498289|8807276|P1|Overall Study|Reason under review|0
2544216|NCT01498289|8807275|P2|Overall Study|Not protocol specified|2
2544217|NCT01498289|8807276|P1|Overall Study|Not protocol specified|7
2544218|NCT01498289|8807275|P2|Overall Study|Progression/relapse|59
2544219|NCT01498289|8807276|P1|Overall Study|Progression/relapse|53
2544220|NCT01498289|8807275|P2|Overall Study|Withdrawal unrelated to AE|16
2544221|NCT01498289|8807276|P1|Overall Study|Withdrawal unrelated to AE|16
2544222|NCT01498289|8807275|P2|Overall Study|Death|8
2544223|NCT01498289|8807276|P1|Overall Study|Death|6
2544224|NCT01498289|8807275|P2|Overall Study|Adverse Event|18
2544225|NCT01498289|8807276|P1|Overall Study|Adverse Event|16
2544226|NCT01498185|8807297|P5|Overall Study|No longer met criteria, etc|2
2544227|NCT01498185|8807298|P4|Overall Study|No longer met criteria, etc|0
2544228|NCT01498185|8807299|P3|Overall Study|No longer met criteria, etc|0
2544229|NCT01498185|8807300|P2|Overall Study|No longer met criteria, etc|0
2544230|NCT01498185|8807301|P1|Overall Study|No longer met criteria, etc|0
2544231|NCT01498185|8807297|P5|Overall Study|Withdrawal by Subject|1
2544232|NCT01498185|8807298|P4|Overall Study|Withdrawal by Subject|2
2544233|NCT01498185|8807299|P3|Overall Study|Withdrawal by Subject|0
2544234|NCT01498185|8807300|P2|Overall Study|Withdrawal by Subject|1
2544235|NCT01498185|8807301|P1|Overall Study|Withdrawal by Subject|1
2544236|NCT01498185|8807297|P5|Overall Study|Adverse Event|0
2544237|NCT01498185|8807298|P4|Overall Study|Adverse Event|1
2544238|NCT01498185|8807299|P3|Overall Study|Adverse Event|0
2544239|NCT01498185|8807300|P2|Overall Study|Adverse Event|0
2544240|NCT01498185|8807301|P1|Overall Study|Adverse Event|0
2544241|NCT01498120|8807341|P1|Overall Study|Other|4
2544242|NCT01498120|8807341|P1|Overall Study|AE, non-serious non-fatal|3
2544243|NCT01498120|8807341|P1|Overall Study|Withdrawal by Subject|5
2544244|NCT01498120|8807341|P1|Overall Study|Lost to Follow-up|1
2544245|NCT01498068|8807348|P2|Overall Study|Withdrawal by Subject|1
2544246|NCT01498068|8807349|P1|Overall Study|Withdrawal by Subject|1
2544247|NCT01497938|8807367|P2|Overall Study|Device Violation|0
2544248|NCT01497938|8807368|P1|Overall Study|Device Violation|1
2544249|NCT01497938|8807367|P2|Overall Study|Withdrawal by Subject|0
2544250|NCT01497938|8807368|P1|Overall Study|Withdrawal by Subject|4
2544251|NCT01497938|8807367|P2|Overall Study|Physician Decision|1
2544252|NCT01497938|8807368|P1|Overall Study|Physician Decision|0
2544253|NCT01497938|8807367|P2|Overall Study|Adverse Event|1
2544254|NCT01497938|8807368|P1|Overall Study|Adverse Event|0
2544255|NCT01497899|8807380|P4|Open-Label Extension Phase|Lost to Follow-up|5
2544256|NCT01497899|8807381|P3|Open-Label Extension Phase|Lost to Follow-up|5
2544257|NCT01497899|8807382|P2|Open-Label Extension Phase|Lost to Follow-up|3
2544258|NCT01497899|8807383|P1|Open-Label Extension Phase|Lost to Follow-up|9
2544259|NCT01497899|8807380|P4|Open-Label Extension Phase|Protocol Violation|0
2544260|NCT01497899|8807381|P3|Open-Label Extension Phase|Protocol Violation|1
2544261|NCT01497899|8807382|P2|Open-Label Extension Phase|Protocol Violation|0
2544262|NCT01497899|8807383|P1|Open-Label Extension Phase|Protocol Violation|0
2544263|NCT01497899|8807380|P4|Open-Label Extension Phase|Pregnancy|0
2544264|NCT01497899|8807381|P3|Open-Label Extension Phase|Pregnancy|1
2544265|NCT01497899|8807382|P2|Open-Label Extension Phase|Pregnancy|1
2544266|NCT01497899|8807383|P1|Open-Label Extension Phase|Pregnancy|0
2544267|NCT01497899|8807380|P4|Open-Label Extension Phase|Withdrew Consent|0
2544268|NCT01497899|8807381|P3|Open-Label Extension Phase|Withdrew Consent|2
2544269|NCT01497899|8807382|P2|Open-Label Extension Phase|Withdrew Consent|3
2544270|NCT01497899|8807383|P1|Open-Label Extension Phase|Withdrew Consent|8
2544271|NCT01497899|8807380|P4|Open-Label Extension Phase|Death|0
2544272|NCT01497899|8807381|P3|Open-Label Extension Phase|Death|0
2544273|NCT01497899|8807382|P2|Open-Label Extension Phase|Death|0
2544274|NCT01497899|8807383|P1|Open-Label Extension Phase|Death|1
2544275|NCT01497899|8807380|P4|Open-Label Extension Phase|Adverse Event|0
2544276|NCT01497899|8807381|P3|Open-Label Extension Phase|Adverse Event|0
2544277|NCT01497899|8807382|P2|Open-Label Extension Phase|Adverse Event|0
2544278|NCT01497899|8807383|P1|Open-Label Extension Phase|Adverse Event|1
2544279|NCT01497899|8807380|P4|Double-Blind Phase|Subject Non-Compliance|0
2544280|NCT01497899|8807381|P3|Double-Blind Phase|Subject Non-Compliance|0
2544281|NCT01497899|8807382|P2|Double-Blind Phase|Subject Non-Compliance|1
2544282|NCT01497899|8807383|P1|Double-Blind Phase|Subject Non-Compliance|0
2544283|NCT01497899|8807380|P4|Double-Blind Phase|Lost to Follow-up|0
2544284|NCT01497899|8807381|P3|Double-Blind Phase|Lost to Follow-up|0
2544285|NCT01497899|8807382|P2|Double-Blind Phase|Lost to Follow-up|2
2544286|NCT01497899|8807383|P1|Double-Blind Phase|Lost to Follow-up|3
2544287|NCT01497899|8807380|P4|Double-Blind Phase|Withdrew Consent|0
2544288|NCT01497899|8807381|P3|Double-Blind Phase|Withdrew Consent|0
2544289|NCT01497899|8807382|P2|Double-Blind Phase|Withdrew Consent|1
2544290|NCT01497899|8807383|P1|Double-Blind Phase|Withdrew Consent|0
2544291|NCT01497899|8807380|P4|Double-Blind Phase|Investigator's Discretion|0
2544292|NCT01497899|8807381|P3|Double-Blind Phase|Investigator's Discretion|0
2544293|NCT01497899|8807382|P2|Double-Blind Phase|Investigator's Discretion|0
2544294|NCT01497899|8807383|P1|Double-Blind Phase|Investigator's Discretion|1
2544295|NCT01497899|8807380|P4|Double-Blind Phase|Lack of Efficacy|0
2544296|NCT01497899|8807381|P3|Double-Blind Phase|Lack of Efficacy|0
2544297|NCT01497899|8807382|P2|Double-Blind Phase|Lack of Efficacy|1
2544298|NCT01497899|8807383|P1|Double-Blind Phase|Lack of Efficacy|0
2544299|NCT01497899|8807380|P4|Double-Blind Phase|Adverse Event|0
2544300|NCT01497899|8807381|P3|Double-Blind Phase|Adverse Event|0
2544301|NCT01497899|8807382|P2|Double-Blind Phase|Adverse Event|0
2544302|NCT01497899|8807383|P1|Double-Blind Phase|Adverse Event|1
2544303|NCT01497899|8807380|P4|Double-Blind Phase|Randomized but not Treated|0
2544304|NCT01497899|8807381|P3|Double-Blind Phase|Randomized but not Treated|0
2544305|NCT01497899|8807382|P2|Double-Blind Phase|Randomized but not Treated|0
2544306|NCT01497899|8807383|P1|Double-Blind Phase|Randomized but not Treated|1
2544307|NCT01497366|8807454|P2|Overall Study|Randomized but not treated|21
2544308|NCT01497366|8807455|P1|Overall Study|Randomized but not treated|7
2544309|NCT01497366|8807454|P2|Overall Study|Death|1
2544310|NCT01497366|8807455|P1|Overall Study|Death|1
2544311|NCT01497366|8807454|P2|Overall Study|Other|0
2544312|NCT01497366|8807455|P1|Overall Study|Other|5
2544313|NCT01497366|8807454|P2|Overall Study|Initiated Non-protocol HCV Treatment|0
2544314|NCT01497366|8807455|P1|Overall Study|Initiated Non-protocol HCV Treatment|7
2544315|NCT01497366|8807454|P2|Overall Study|Withdrawal by Subject|6
2544316|NCT01497366|8807455|P1|Overall Study|Withdrawal by Subject|6
2544317|NCT01497366|8807454|P2|Overall Study|Lost to Follow-up|10
2544318|NCT01497366|8807455|P1|Overall Study|Lost to Follow-up|11
2544319|NCT01497366|8807454|P2|Overall Study|Virologic failure|50
2544320|NCT01497366|8807455|P1|Overall Study|Virologic failure|2
2544321|NCT01497275|8807473|P1|Overall Study|Adverse Event|1
2544322|NCT01497275|8807473|P1|Overall Study|Death|1
2544323|NCT01497262|8807480|P1|Overall Study|Protocol Violation|1
2544324|NCT01497262|8807480|P1|Overall Study|Adverse Event|2
2544325|NCT01497262|8807480|P1|Overall Study|Withdrawal by Subject|2
2544326|NCT01497262|8807480|P1|Overall Study|Physician Decision|1
2544327|NCT01497262|8807480|P1|Overall Study|Abnormal Test Procedure Result|1
2544328|NCT01497262|8807480|P1|Overall Study|Abnormal Lab Values|4
2544329|NCT01497197|8807487|P2|Overall Study|Other|1
2544330|NCT01497197|8807488|P1|Overall Study|Other|3
2544331|NCT01497197|8807487|P2|Overall Study|All embryos discarded|3
2544332|NCT01497197|8807488|P1|Overall Study|All embryos discarded|0
2544333|NCT01497197|8807487|P2|Overall Study|Intention to freeze all embryos|1
2544334|NCT01497197|8807488|P1|Overall Study|Intention to freeze all embryos|0
2544335|NCT01497197|8807487|P2|Overall Study|No fertilisation|5
2544336|NCT01497197|8807488|P1|Overall Study|No fertilisation|6
2544337|NCT01497197|8807487|P2|Overall Study|No oocytes retrieved|2
2544338|NCT01497197|8807488|P1|Overall Study|No oocytes retrieved|3
2544339|NCT01497197|8807487|P2|Overall Study|Risk of OHSS|0
2544340|NCT01497197|8807488|P1|Overall Study|Risk of OHSS|1
2544341|NCT01497197|8807487|P2|Overall Study|Excessive/lack of response to treatment|0
2544342|NCT01497197|8807488|P1|Overall Study|Excessive/lack of response to treatment|1
2544343|NCT01497197|8807487|P2|Overall Study|Withdrawal by Subject|1
2544344|NCT01497197|8807488|P1|Overall Study|Withdrawal by Subject|2
2544345|NCT01497197|8807487|P2|Overall Study|Protocol Violation|2
2544346|NCT01497197|8807488|P1|Overall Study|Protocol Violation|0
2544347|NCT01497197|8807487|P2|Overall Study|Lost to Follow-up|0
2544348|NCT01497197|8807488|P1|Overall Study|Lost to Follow-up|1
2544349|NCT01497067|8807523|P1|Overall Study|Other|13
2544350|NCT01497067|8807523|P1|Overall Study|Patient decision unrel to Adverse Event|10
2544351|NCT01497067|8807523|P1|Overall Study|Adverse Event|3
2544352|NCT01497067|8807523|P1|Overall Study|Lost to Follow-up|56
2544353|NCT01496846|8807534|P6|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
2544354|NCT01496846|8807535|P5|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
2544355|NCT01496846|8807536|P4|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
2544356|NCT01496846|8807537|P3|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
2544357|NCT01496846|8807538|P2|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
2544358|NCT01496846|8807539|P1|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
2544359|NCT01496807|8807550|P1|Overall Study|Change in diagnosis|1
2544360|NCT01496807|8807550|P1|Overall Study|Participant preference/toxicity|8
2544361|NCT01496807|8807550|P1|Overall Study|Progressive Disease|21
2544362|NCT01496469|8807562|P2|Overall Study|Other|1
2544363|NCT01496469|8807563|P1|Overall Study|Other|1
2544364|NCT01496469|8807562|P2|Overall Study|BP exceeds protocol limits|2
2544365|NCT01496469|8807563|P1|Overall Study|BP exceeds protocol limits|1
2544366|NCT01496469|8807562|P2|Overall Study|Withdrawal by Subject|4
2544367|NCT01496469|8807563|P1|Overall Study|Withdrawal by Subject|4
2544368|NCT01496469|8807562|P2|Overall Study|Lost to Follow-up|1
2544369|NCT01496469|8807563|P1|Overall Study|Lost to Follow-up|1
2544370|NCT01496469|8807562|P2|Overall Study|Protocol Violation|0
2544371|NCT01496469|8807563|P1|Overall Study|Protocol Violation|2
2544372|NCT01496469|8807562|P2|Overall Study|Adverse Event|0
2544373|NCT01496469|8807563|P1|Overall Study|Adverse Event|1
2544374|NCT01496456|8807573|P1|Overall Study|Lost to Follow-up|7
2544375|NCT01496456|8807573|P1|Overall Study|Protocol Violation|1
2544376|NCT01496430|8807586|P3|Overall Study|Other|0
2544377|NCT01496430|8807587|P2|Overall Study|Other|0
2544378|NCT01496430|8807588|P1|Overall Study|Other|2
2544379|NCT01496430|8807586|P3|Overall Study|Principal Investigator Discretion|1
2544380|NCT01496430|8807587|P2|Overall Study|Principal Investigator Discretion|1
2544381|NCT01496430|8807588|P1|Overall Study|Principal Investigator Discretion|0
2544382|NCT01496430|8807586|P3|Overall Study|Voluntary Withdrawal|6
2544383|NCT01496430|8807587|P2|Overall Study|Voluntary Withdrawal|1
2544384|NCT01496430|8807588|P1|Overall Study|Voluntary Withdrawal|2
2544385|NCT01496430|8807586|P3|Overall Study|Lost to Follow-up|1
2544386|NCT01496430|8807587|P2|Overall Study|Lost to Follow-up|3
2544387|NCT01496430|8807588|P1|Overall Study|Lost to Follow-up|2
2544388|NCT01496430|8807586|P3|Overall Study|Major Protocol Deviation|1
2544389|NCT01496430|8807587|P2|Overall Study|Major Protocol Deviation|0
2544390|NCT01496430|8807588|P1|Overall Study|Major Protocol Deviation|0
2544391|NCT01496430|8807586|P3|Overall Study|Adverse Event|1
2544392|NCT01496430|8807587|P2|Overall Study|Adverse Event|0
2544393|NCT01496430|8807588|P1|Overall Study|Adverse Event|0
2544394|NCT01496287|8807700|P1|Overall Study|Incomplete anesthesia|5
2544395|NCT01496287|8807700|P1|Overall Study|Lost to Follow-up|1
2544396|NCT01496274|8807710|P2|Overall Study|Lost to Follow-up|3
2544397|NCT01496274|8807711|P1|Overall Study|Lost to Follow-up|0
2544398|NCT01496274|8807710|P2|Overall Study|Withdrawal by Subject|0
2544399|NCT01496274|8807711|P1|Overall Study|Withdrawal by Subject|2
2544400|NCT01496274|8807710|P2|Overall Study|Adverse Event|1
2544401|NCT01496274|8807711|P1|Overall Study|Adverse Event|1
2544402|NCT01496274|8807710|P2|Overall Study|Protocol Violation|1
2544403|NCT01496274|8807711|P1|Overall Study|Protocol Violation|0
2544404|NCT01496183|8807756|P2|Overall Study|Withdrawal by Subject|1
2544405|NCT01496183|8807757|P1|Overall Study|Withdrawal by Subject|0
2544406|NCT01496183|8807756|P2|Overall Study|Physician Decision|1
2544407|NCT01496183|8807757|P1|Overall Study|Physician Decision|3
2544408|NCT01496066|8807809|P2|Overall Study|Death|4
2544409|NCT01496066|8807810|P1|Overall Study|Death|1
2544410|NCT01496066|8807809|P2|Overall Study|Explant|0
2544411|NCT01496066|8807810|P1|Overall Study|Explant|3
2544412|NCT01496066|8807809|P2|Overall Study|Lost to Follow-up|5
2544413|NCT01496066|8807810|P1|Overall Study|Lost to Follow-up|8
2544414|NCT01495975|8807872|P2|Overall Study|Lost to Follow-up|0
2544415|NCT01495975|8807873|P1|Overall Study|Lost to Follow-up|1
2544416|NCT01495793|8807997|P1|Overall Study|Violation of inclusion criteria|1
2544417|NCT01495793|8807997|P1|Overall Study|Lost to Follow-up|1
2544418|NCT01495702|8808010|P2|Randomized Phase|Protocol Violation|1
2544419|NCT01495702|8808011|P1|Randomized Phase|Protocol Violation|3
2544420|NCT01495702|8808010|P2|Randomized Phase|Participant Noncompliance|0
2544421|NCT01495702|8808011|P1|Randomized Phase|Participant Noncompliance|1
2544422|NCT01495702|8808010|P2|Randomized Phase|Lost to Follow-up|3
2544423|NCT01495702|8808011|P1|Randomized Phase|Lost to Follow-up|4
2544424|NCT01495702|8808010|P2|Randomized Phase|Withdrew Consent|18
2544425|NCT01495702|8808011|P1|Randomized Phase|Withdrew Consent|10
2544426|NCT01495702|8808010|P2|Randomized Phase|Investigators Discretion|0
2544427|NCT01495702|8808011|P1|Randomized Phase|Investigators Discretion|2
2544428|NCT01495702|8808010|P2|Randomized Phase|Lack of Efficacy|0
2544429|NCT01495702|8808011|P1|Randomized Phase|Lack of Efficacy|2
2544430|NCT01495702|8808010|P2|Randomized Phase|Death|0
2544431|NCT01495702|8808011|P1|Randomized Phase|Death|1
2544432|NCT01495702|8808010|P2|Randomized Phase|Adverse Event|2
2544433|NCT01495702|8808011|P1|Randomized Phase|Adverse Event|2
2544434|NCT01495702|8808010|P2|Randomized Phase|Randomized But Not Treated|4
2544435|NCT01495702|8808011|P1|Randomized Phase|Randomized But Not Treated|1
2544436|NCT01495000|8808089|P2|Overall Study|Withdrawal by Subject|10
2544437|NCT01495000|8808090|P1|Overall Study|Withdrawal by Subject|10
2544438|NCT01495000|8808089|P2|Overall Study|Protocol Violation|0
2544439|NCT01495000|8808090|P1|Overall Study|Protocol Violation|1
2544440|NCT01495000|8808089|P2|Overall Study|Lost to Follow-up|2
2544441|NCT01495000|8808090|P1|Overall Study|Lost to Follow-up|2
2544442|NCT01494987|8808132|P2|Overall Study|Subject Withdrew Consent|3
2544443|NCT01494987|8808133|P1|Overall Study|Subject Withdrew Consent|2
2544444|NCT01494987|8808132|P2|Overall Study|Subject Non-Compliance|10
2544445|NCT01494987|8808133|P1|Overall Study|Subject Non-Compliance|9
2544446|NCT01494987|8808132|P2|Overall Study|Protocol Violation|3
2544447|NCT01494987|8808133|P1|Overall Study|Protocol Violation|3
2544448|NCT01494987|8808132|P2|Overall Study|Lost to Follow-up|1
2544449|NCT01494987|8808133|P1|Overall Study|Lost to Follow-up|1
2544450|NCT01494987|8808132|P2|Overall Study|Investigator's Discretion|2
2544451|NCT01494987|8808133|P1|Overall Study|Investigator's Discretion|1
2544452|NCT01494987|8808132|P2|Overall Study|Hyperglycemia|4
2544453|NCT01494987|8808133|P1|Overall Study|Hyperglycemia|6
2544454|NCT01494987|8808132|P2|Overall Study|Adverse Event|5
2544455|NCT01494987|8808133|P1|Overall Study|Adverse Event|6
2544456|NCT01494818|8808147|P2|Overall Study|Lost to Follow-up|0
2544457|NCT01494818|8808148|P1|Overall Study|Lost to Follow-up|1
2544458|NCT01494818|8808147|P2|Overall Study|Relocation|2
2544459|NCT01494818|8808148|P1|Overall Study|Relocation|1
2544460|NCT01494649|8808179|P2|Overall Study|Lost to Follow-up|1
2544461|NCT01494649|8808180|P1|Overall Study|Lost to Follow-up|0
2544462|NCT01494610|8808196|P2|Period 4|Protocol Violation|0
2544463|NCT01494610|8808197|P1|Period 4|Protocol Violation|1
2544464|NCT01494610|8808196|P2|Period 3|Withdrawal by Subject|0
2544465|NCT01494610|8808197|P1|Period 3|Withdrawal by Subject|1
2544466|NCT01494610|8808196|P2|Period 3|Adverse Event|0
2544467|NCT01494610|8808197|P1|Period 3|Adverse Event|1
2544468|NCT01494610|8808196|P2|Period 1|Withdrawal by Subject|1
2544469|NCT01494610|8808197|P1|Period 1|Withdrawal by Subject|1
2544470|NCT01494584|8808265|P1|Overall Study|Study Closed/Terminated|1
2544471|NCT01494532|8808397|P6|Overall Study|Withdrawal by Subject|0
2544472|NCT01494532|8808398|P5|Overall Study|Withdrawal by Subject|2
2544473|NCT01494532|8808399|P4|Overall Study|Withdrawal by Subject|3
2544474|NCT01494532|8808400|P3|Overall Study|Withdrawal by Subject|4
2544475|NCT01494532|8808401|P2|Overall Study|Withdrawal by Subject|1
2544476|NCT01494532|8808402|P1|Overall Study|Withdrawal by Subject|3
2544477|NCT01494532|8808397|P6|Overall Study|Physician Decision|0
2544478|NCT01494532|8808398|P5|Overall Study|Physician Decision|0
2544479|NCT01494532|8808399|P4|Overall Study|Physician Decision|2
2544480|NCT01494532|8808400|P3|Overall Study|Physician Decision|1
2544481|NCT01494532|8808401|P2|Overall Study|Physician Decision|1
2544482|NCT01494532|8808402|P1|Overall Study|Physician Decision|0
2544483|NCT01494532|8808397|P6|Overall Study|Lost to Follow-up|0
2544484|NCT01494532|8808398|P5|Overall Study|Lost to Follow-up|0
2544485|NCT01494532|8808399|P4|Overall Study|Lost to Follow-up|2
2544486|NCT01494532|8808400|P3|Overall Study|Lost to Follow-up|0
2544487|NCT01494532|8808401|P2|Overall Study|Lost to Follow-up|0
2544488|NCT01494532|8808402|P1|Overall Study|Lost to Follow-up|1
2544489|NCT01494532|8808397|P6|Overall Study|Protocol-defined stopping criteria|0
2544490|NCT01494532|8808398|P5|Overall Study|Protocol-defined stopping criteria|0
2544491|NCT01494532|8808399|P4|Overall Study|Protocol-defined stopping criteria|0
2544492|NCT01494532|8808400|P3|Overall Study|Protocol-defined stopping criteria|1
2544493|NCT01494532|8808401|P2|Overall Study|Protocol-defined stopping criteria|0
2544494|NCT01494532|8808402|P1|Overall Study|Protocol-defined stopping criteria|0
2544495|NCT01494532|8808397|P6|Overall Study|Protocol deviation|0
2544496|NCT01494532|8808398|P5|Overall Study|Protocol deviation|3
2544497|NCT01494532|8808399|P4|Overall Study|Protocol deviation|2
2544498|NCT01494532|8808400|P3|Overall Study|Protocol deviation|3
2544499|NCT01494532|8808401|P2|Overall Study|Protocol deviation|1
2544500|NCT01494532|8808402|P1|Overall Study|Protocol deviation|2
2544501|NCT01494532|8808397|P6|Overall Study|Lack of Efficacy|0
2544502|NCT01494532|8808398|P5|Overall Study|Lack of Efficacy|2
2544503|NCT01494532|8808399|P4|Overall Study|Lack of Efficacy|0
2544504|NCT01494532|8808400|P3|Overall Study|Lack of Efficacy|0
2544505|NCT01494532|8808401|P2|Overall Study|Lack of Efficacy|0
2544506|NCT01494532|8808402|P1|Overall Study|Lack of Efficacy|0
2544507|NCT01494532|8808397|P6|Overall Study|Adverse Event|0
2544508|NCT01494532|8808398|P5|Overall Study|Adverse Event|5
2544509|NCT01494532|8808399|P4|Overall Study|Adverse Event|6
2544510|NCT01494532|8808400|P3|Overall Study|Adverse Event|8
2544511|NCT01494532|8808401|P2|Overall Study|Adverse Event|1
2544512|NCT01494532|8808402|P1|Overall Study|Adverse Event|4
2544513|NCT01494506|8808557|P3|Overall Study|Other|1
2544514|NCT01494506|8808558|P2|Overall Study|Other|3
2544515|NCT01494506|8808559|P1|Overall Study|Other|0
2544516|NCT01494506|8808557|P3|Overall Study|Sponsor Decision|1
2544517|NCT01494506|8808558|P2|Overall Study|Sponsor Decision|0
2544518|NCT01494506|8808559|P1|Overall Study|Sponsor Decision|0
2544519|NCT01494506|8808557|P3|Overall Study|Clinical Deterioration|13
2544520|NCT01494506|8808558|P2|Overall Study|Clinical Deterioration|17
2544521|NCT01494506|8808559|P1|Overall Study|Clinical Deterioration|21
2544522|NCT01494506|8808557|P3|Overall Study|Withdrawal by Subject|14
2544523|NCT01494506|8808558|P2|Overall Study|Withdrawal by Subject|20
2544524|NCT01494506|8808559|P1|Overall Study|Withdrawal by Subject|17
2544525|NCT01494506|8808557|P3|Overall Study|Physician Decision|4
2544526|NCT01494506|8808558|P2|Overall Study|Physician Decision|5
2544527|NCT01494506|8808559|P1|Overall Study|Physician Decision|7
2544528|NCT01494506|8808557|P3|Overall Study|Death|2
2544529|NCT01494506|8808558|P2|Overall Study|Death|5
2544530|NCT01494506|8808559|P1|Overall Study|Death|9
2544531|NCT01494506|8808557|P3|Overall Study|Adverse Event|11
2544532|NCT01494506|8808558|P2|Overall Study|Adverse Event|10
2544533|NCT01494506|8808559|P1|Overall Study|Adverse Event|17
2544534|NCT01494506|8808557|P3|Overall Study|Lack of Efficacy|57
2544535|NCT01494506|8808558|P2|Overall Study|Lack of Efficacy|83
2544536|NCT01494506|8808559|P1|Overall Study|Lack of Efficacy|77
2544537|NCT01494467|8808596|P2|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2
2544538|NCT01494467|8808597|P1|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8
2544539|NCT01494467|8808596|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
2544540|NCT01494467|8808597|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26
2544541|NCT01494467|8808596|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|5
2544542|NCT01494467|8808597|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|3
2544543|NCT01494467|8808596|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24
2544544|NCT01494467|8808597|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32
2544545|NCT01494467|8808596|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|5
2544546|NCT01494467|8808597|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|3
2544547|NCT01494467|8808596|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
2544548|NCT01494467|8808597|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1
2544549|NCT01494467|8808596|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|0
2544550|NCT01494467|8808597|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|2
2544551|NCT01494467|8808596|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
2544552|NCT01494467|8808597|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
2544553|NCT01494467|8808596|P2|Part A Vehicle Control (12 Weeks)|Other|1
2544554|NCT01494467|8808597|P1|Part A Vehicle Control (12 Weeks)|Other|1
2544555|NCT01494467|8808596|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
2544556|NCT01494467|8808597|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
2544557|NCT01494467|8808596|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|0
2544558|NCT01494467|8808597|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|4
2544559|NCT01494467|8808596|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8
2544560|NCT01494467|8808597|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9
2544561|NCT01494467|8808596|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
2544562|NCT01494467|8808597|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|6
2544563|NCT01494467|8808596|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
2544564|NCT01494467|8808597|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|1
2544565|NCT01494350|8808613|P1|Overall Study|Worsening of lesion|1
2544566|NCT01494298|8808623|P2|Overall Study|Protocol Violation|8
2544567|NCT01494298|8808624|P1|Overall Study|Protocol Violation|2
2544568|NCT01494038|8808647|P2|Overall Study|Death|4
2544569|NCT01494038|8808648|P1|Overall Study|Death|2
2544570|NCT01494038|8808647|P2|Overall Study|Not willing to adhere to reqs|9
2544571|NCT01494038|8808648|P1|Overall Study|Not willing to adhere to reqs|2
2544572|NCT01494038|8808647|P2|Overall Study|Not able to get to clinic|15
2544573|NCT01494038|8808648|P1|Overall Study|Not able to get to clinic|21
2544574|NCT01494038|8808647|P2|Overall Study|Withdrawal by Subject|34
2544575|NCT01494038|8808648|P1|Overall Study|Withdrawal by Subject|44
2544576|NCT01494038|8808647|P2|Overall Study|Lost to Follow-up|20
2544577|NCT01494038|8808648|P1|Overall Study|Lost to Follow-up|18
2544578|NCT01494038|8808647|P2|Overall Study|Protocol Violation|1
2544579|NCT01494038|8808648|P1|Overall Study|Protocol Violation|1
2544580|NCT01493960|8808736|P2|Overall Study|Non-specified|4
2544581|NCT01493960|8808737|P1|Overall Study|Non-specified|4
2544582|NCT01493960|8808736|P2|Overall Study|Withdrawal by Subject|4
2544583|NCT01493960|8808737|P1|Overall Study|Withdrawal by Subject|10
2544584|NCT01493960|8808736|P2|Overall Study|Protocol Violation|0
2544585|NCT01493960|8808737|P1|Overall Study|Protocol Violation|3
2544586|NCT01493960|8808736|P2|Overall Study|Lack of Efficacy|9
2544587|NCT01493960|8808737|P1|Overall Study|Lack of Efficacy|15
2544588|NCT01493960|8808736|P2|Overall Study|Adverse Event|1
2544589|NCT01493960|8808737|P1|Overall Study|Adverse Event|0
2544590|NCT01493778|8808768|P1|Overall Study|Withdrawal by Subject|8
2544591|NCT01493687|8808830|P2|Part C Safety Follow up (4 Weeks)|Adverse Event|1
2544592|NCT01493687|8808831|P1|Part C Safety Follow up (4 Weeks)|Adverse Event|0
2544593|NCT01493687|8808830|P2|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1
2544594|NCT01493687|8808831|P1|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5
2544595|NCT01493687|8808830|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
2544596|NCT01493687|8808831|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16
2544597|NCT01493687|8808830|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|0
2544598|NCT01493687|8808831|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|1
2544599|NCT01493687|8808830|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16
2544600|NCT01493687|8808831|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27
2544601|NCT01493687|8808830|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|4
2544602|NCT01493687|8808831|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|5
2544603|NCT01493687|8808830|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
2544604|NCT01493687|8808831|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2
2544605|NCT01493687|8808830|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|1
2544606|NCT01493687|8808831|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|5
2544607|NCT01493687|8808830|P2|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
2544608|NCT01493687|8808831|P1|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
2544609|NCT01493687|8808830|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
2544610|NCT01493687|8808831|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7
2544611|NCT01493687|8808830|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|1
2544612|NCT01493687|8808831|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|2
2544613|NCT01493687|8808830|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7
2544614|NCT01493687|8808831|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18
2544615|NCT01493687|8808830|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
2544616|NCT01493687|8808831|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|7
2544617|NCT01493687|8808830|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
2544618|NCT01493687|8808831|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
2544619|NCT01493687|8808830|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
2544620|NCT01493687|8808831|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|2
2544621|NCT01493557|8808850|P3|Adding the Second Strategy|Withdrawal by Subject|0
2544622|NCT01493557|8808851|P2|Adding the Second Strategy|Withdrawal by Subject|1
2544623|NCT01493557|8808852|P1|Adding the Second Strategy|Withdrawal by Subject|0
2544624|NCT01493557|8808850|P3|Adding the Second Strategy|Other adverse event|0
2544625|NCT01493557|8808851|P2|Adding the Second Strategy|Other adverse event|2
2544626|NCT01493557|8808852|P1|Adding the Second Strategy|Other adverse event|1
2544627|NCT01493557|8808850|P3|Adding the Second Strategy|Worsening of events associate with GIS|0
2544628|NCT01493557|8808851|P2|Adding the Second Strategy|Worsening of events associate with GIS|1
2544629|NCT01493557|8808852|P1|Adding the Second Strategy|Worsening of events associate with GIS|1
2544630|NCT01493557|8808850|P3|Randomized to Management Strategies|Other than stated above|0
2544631|NCT01493557|8808851|P2|Randomized to Management Strategies|Other than stated above|3
2544632|NCT01493557|8808852|P1|Randomized to Management Strategies|Other than stated above|1
2544633|NCT01493557|8808850|P3|Randomized to Management Strategies|Withdrawal by Subject|0
2544634|NCT01493557|8808851|P2|Randomized to Management Strategies|Withdrawal by Subject|1
2544635|NCT01493557|8808852|P1|Randomized to Management Strategies|Withdrawal by Subject|0
2544636|NCT01493557|8808850|P3|Randomized to Management Strategies|Protocol Violation|0
2544637|NCT01493557|8808851|P2|Randomized to Management Strategies|Protocol Violation|0
2544638|NCT01493557|8808852|P1|Randomized to Management Strategies|Protocol Violation|3
2544639|NCT01493557|8808850|P3|Randomized to Management Strategies|Other adverse event|0
2544640|NCT01493557|8808851|P2|Randomized to Management Strategies|Other adverse event|5
2544641|NCT01493557|8808852|P1|Randomized to Management Strategies|Other adverse event|8
2544642|NCT01493557|8808850|P3|Randomized to Management Strategies|Worsening of events associate with GIS|0
2544643|NCT01493557|8808851|P2|Randomized to Management Strategies|Worsening of events associate with GIS|2
2544644|NCT01493557|8808852|P1|Randomized to Management Strategies|Worsening of events associate with GIS|3
2544645|NCT01493557|8808850|P3|Not Randomized to Management Strategies|Other than stated above|21
2544646|NCT01493557|8808851|P2|Not Randomized to Management Strategies|Other than stated above|0
2544647|NCT01493557|8808852|P1|Not Randomized to Management Strategies|Other than stated above|0
2544648|NCT01493557|8808850|P3|Not Randomized to Management Strategies|Early termination|34
2544649|NCT01493557|8808851|P2|Not Randomized to Management Strategies|Early termination|0
2544650|NCT01493557|8808852|P1|Not Randomized to Management Strategies|Early termination|0
2544651|NCT01493557|8808850|P3|Not Randomized to Management Strategies|Withdrawal by Subject|10
2544652|NCT01493557|8808851|P2|Not Randomized to Management Strategies|Withdrawal by Subject|0
2544736|NCT01492426|8809144|P1|Follow-Up|Death|1
2544653|NCT01493557|8808852|P1|Not Randomized to Management Strategies|Withdrawal by Subject|0
2544654|NCT01493557|8808850|P3|Not Randomized to Management Strategies|Lost to Follow-up|4
2544655|NCT01493557|8808851|P2|Not Randomized to Management Strategies|Lost to Follow-up|0
2544656|NCT01493557|8808852|P1|Not Randomized to Management Strategies|Lost to Follow-up|0
2544657|NCT01493557|8808850|P3|Not Randomized to Management Strategies|Protocol Violation|1
2544658|NCT01493557|8808851|P2|Not Randomized to Management Strategies|Protocol Violation|0
2544659|NCT01493557|8808852|P1|Not Randomized to Management Strategies|Protocol Violation|0
2544660|NCT01493557|8808850|P3|Not Randomized to Management Strategies|Other adverse event|54
2544661|NCT01493557|8808851|P2|Not Randomized to Management Strategies|Other adverse event|0
2544662|NCT01493557|8808852|P1|Not Randomized to Management Strategies|Other adverse event|0
2544663|NCT01493557|8808850|P3|Not Randomized to Management Strategies|Worsening of other pre−existing disease|9
2544664|NCT01493557|8808851|P2|Not Randomized to Management Strategies|Worsening of other pre−existing disease|0
2544665|NCT01493557|8808852|P1|Not Randomized to Management Strategies|Worsening of other pre−existing disease|0
2544666|NCT01493557|8808850|P3|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1
2544667|NCT01493557|8808851|P2|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
2544668|NCT01493557|8808852|P1|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
2544669|NCT01493531|8808880|P3|Overall Study|Death|0
2544670|NCT01493531|8808881|P2|Overall Study|Death|1
2544671|NCT01493531|8808882|P1|Overall Study|Death|0
2544672|NCT01493531|8808880|P3|Overall Study|Withdrawal by Subject|11
2544673|NCT01493531|8808881|P2|Overall Study|Withdrawal by Subject|13
2544674|NCT01493531|8808882|P1|Overall Study|Withdrawal by Subject|16
2544675|NCT01493531|8808880|P3|Overall Study|Lost to Follow-up|11
2544676|NCT01493531|8808881|P2|Overall Study|Lost to Follow-up|7
2544677|NCT01493531|8808882|P1|Overall Study|Lost to Follow-up|5
2544678|NCT01493531|8808880|P3|Overall Study|Sponsor terminated study|3
2544679|NCT01493531|8808881|P2|Overall Study|Sponsor terminated study|2
2544680|NCT01493531|8808882|P1|Overall Study|Sponsor terminated study|5
2544681|NCT01493531|8808880|P3|Overall Study|Protocol Violation|12
2544682|NCT01493531|8808881|P2|Overall Study|Protocol Violation|15
2544683|NCT01493531|8808882|P1|Overall Study|Protocol Violation|8
2544684|NCT01493531|8808880|P3|Overall Study|Gout flare|2
2544685|NCT01493531|8808881|P2|Overall Study|Gout flare|0
2544686|NCT01493531|8808882|P1|Overall Study|Gout flare|3
2544687|NCT01493531|8808880|P3|Overall Study|Adverse Event|9
2544688|NCT01493531|8808881|P2|Overall Study|Adverse Event|12
2544689|NCT01493531|8808882|P1|Overall Study|Adverse Event|4
2544690|NCT01493427|8808896|P1|Overall Study|Other|2
2544691|NCT01493427|8808896|P1|Overall Study|Inability to Follow Instructions|2
2544692|NCT01493427|8808896|P1|Overall Study|Lost to Follow-up|2
2544693|NCT01493427|8808896|P1|Overall Study|Personal Reasons|4
2544694|NCT01493427|8808896|P1|Overall Study|Adverse Event|10
2544695|NCT01493414|8808901|P1|Overall Study|Lost to Follow-up|16
2544696|NCT01493414|8808901|P1|Overall Study|Administrative problems|25
2544697|NCT01493414|8808901|P1|Overall Study|Protocol deviation|27
2544698|NCT01493414|8808901|P1|Overall Study|Withdrawal by Subject|79
2544699|NCT01493414|8808901|P1|Overall Study|Physician Decision|93
2544700|NCT01493414|8808901|P1|Overall Study|Death|101
2544701|NCT01493414|8808901|P1|Overall Study|Disease progression|204
2544702|NCT01493414|8808901|P1|Overall Study|Adverse Event|405
2544703|NCT01493284|8808914|P1|Overall Study|Withdrawal by Subject|32
2544704|NCT01493284|8808914|P1|Overall Study|Death|29
2544705|NCT01493089|8808936|P2|Overall Study|Physician Decision|1
2544706|NCT01493089|8808937|P1|Overall Study|Physician Decision|0
2544707|NCT01493089|8808936|P2|Overall Study|Withdrawal by Subject|0
2544708|NCT01493089|8808937|P1|Overall Study|Withdrawal by Subject|1
2544709|NCT01493089|8808936|P2|Overall Study|Protocol Violation|2
2544710|NCT01493089|8808937|P1|Overall Study|Protocol Violation|2
2544711|NCT01492686|8809036|P2|Open-label Phase|Due to a discontinuation criterion|9
2544712|NCT01492686|8809037|P1|Open-label Phase|Due to a discontinuation criterion|4
2544713|NCT01492686|8809036|P2|Open-label Phase|Withdrawal by Subject|7
2544714|NCT01492686|8809037|P1|Open-label Phase|Withdrawal by Subject|6
2544715|NCT01492686|8809036|P2|Open-label Phase|Physician Decision|0
2544716|NCT01492686|8809037|P1|Open-label Phase|Physician Decision|1
2544717|NCT01492686|8809036|P2|Open-label Phase|Adverse Event|2
2544718|NCT01492686|8809037|P1|Open-label Phase|Adverse Event|1
2544719|NCT01492686|8809036|P2|Double-blind Phase|Due to a discontinuation criterion|3
2544720|NCT01492686|8809037|P1|Double-blind Phase|Due to a discontinuation criterion|2
2544721|NCT01492686|8809036|P2|Double-blind Phase|Withdrawal by Subject|2
2544722|NCT01492686|8809037|P1|Double-blind Phase|Withdrawal by Subject|0
2544723|NCT01492686|8809036|P2|Double-blind Phase|Physician Decision|1
2544724|NCT01492686|8809037|P1|Double-blind Phase|Physician Decision|0
2544725|NCT01492686|8809036|P2|Double-blind Phase|Adverse Event|2
2544726|NCT01492686|8809037|P1|Double-blind Phase|Adverse Event|0
2544727|NCT01492439|8809094|P2|Overall Study|Withdrew from RTE|9
2544728|NCT01492439|8809095|P1|Overall Study|Withdrew from RTE|4
2544729|NCT01492426|8809143|P2|Follow-Up|Lost to Follow-up|6
2544730|NCT01492426|8809144|P1|Follow-Up|Lost to Follow-up|12
2544731|NCT01492426|8809143|P2|Follow-Up|Participant Withdrew Consent|1
2544732|NCT01492426|8809144|P1|Follow-Up|Participant Withdrew Consent|6
2544733|NCT01492426|8809143|P2|Follow-Up|Other|2
2544734|NCT01492426|8809144|P1|Follow-Up|Other|4
2544735|NCT01492426|8809143|P2|Follow-Up|Death|0
2544737|NCT01492426|8809143|P2|Follow-Up|Protocol Requires no Follow-Up|1
2544738|NCT01492426|8809144|P1|Follow-Up|Protocol Requires no Follow-Up|2
2544739|NCT01492426|8809143|P2|Treatment|Participant does not meet study criteria|0
2544740|NCT01492426|8809144|P1|Treatment|Participant does not meet study criteria|1
2544741|NCT01492426|8809143|P2|Treatment|Lost to Follow-up|4
2544742|NCT01492426|8809144|P1|Treatment|Lost to Follow-up|9
2544743|NCT01492426|8809143|P2|Treatment|Subject requested discontinue study drug|3
2544744|NCT01492426|8809144|P1|Treatment|Subject requested discontinue study drug|7
2544745|NCT01492426|8809143|P2|Treatment|Poor compliance/noncompliance|0
2544746|NCT01492426|8809144|P1|Treatment|Poor compliance/noncompliance|1
2544747|NCT01492426|8809143|P2|Treatment|Participant withdrew consent|2
2544748|NCT01492426|8809144|P1|Treatment|Participant withdrew consent|1
2544749|NCT01492426|8809143|P2|Treatment|Lack of Efficacy|5
2544750|NCT01492426|8809144|P1|Treatment|Lack of Efficacy|38
2544751|NCT01492426|8809143|P2|Treatment|Adverse Event|25
2544752|NCT01492426|8809144|P1|Treatment|Adverse Event|25
2544753|NCT01492426|8809143|P2|Treatment|Other|0
2544754|NCT01492426|8809144|P1|Treatment|Other|1
2544755|NCT01492426|8809143|P2|Treatment|Death|1
2544756|NCT01492426|8809144|P1|Treatment|Death|0
2544757|NCT01492400|8809162|P2|Overall Study|Adverse Event|5
2544758|NCT01492400|8809163|P1|Overall Study|Adverse Event|10
2544759|NCT01492400|8809162|P2|Overall Study|Lack of Efficacy|1
2544760|NCT01492400|8809163|P1|Overall Study|Lack of Efficacy|1
2544761|NCT01492400|8809162|P2|Overall Study|Pregnancy|1
2544762|NCT01492400|8809163|P1|Overall Study|Pregnancy|0
2544763|NCT01492400|8809162|P2|Overall Study|Lost to Follow-up|1
2544764|NCT01492400|8809163|P1|Overall Study|Lost to Follow-up|3
2544765|NCT01492400|8809162|P2|Overall Study|Personal Reasons|5
2544766|NCT01492400|8809163|P1|Overall Study|Personal Reasons|0
2544767|NCT01492400|8809162|P2|Overall Study|Miscellaneous Reasons|3
2544768|NCT01492400|8809163|P1|Overall Study|Miscellaneous Reasons|2
2544769|NCT01492088|8809187|P3|Overall Study|Alive at Last Follow-up|11
2544770|NCT01492088|8809188|P2|Overall Study|Alive at Last Follow-up|6
2544771|NCT01492088|8809189|P1|Overall Study|Alive at Last Follow-up|0
2544772|NCT01492088|8809187|P3|Overall Study|Completed Post Treatment Followup (PTFU)|1
2544773|NCT01492088|8809188|P2|Overall Study|Completed Post Treatment Followup (PTFU)|0
2544774|NCT01492088|8809189|P1|Overall Study|Completed Post Treatment Followup (PTFU)|2
2544775|NCT01492088|8809187|P3|Overall Study|Death|2
2544776|NCT01492088|8809188|P2|Overall Study|Death|6
2544777|NCT01492088|8809189|P1|Overall Study|Death|1
2544778|NCT01492088|8809187|P3|Overall Study|Withdrawal by Patient|0
2544779|NCT01492088|8809188|P2|Overall Study|Withdrawal by Patient|2
2544780|NCT01492088|8809189|P1|Overall Study|Withdrawal by Patient|0
2544781|NCT01491919|8809270|P3|Overall Study|Insufficient PK sampling|1
2544782|NCT01491919|8809271|P2|Overall Study|Insufficient PK sampling|2
2544783|NCT01491919|8809272|P1|Overall Study|Insufficient PK sampling|1
2544784|NCT01491854|8809343|P1|Overall Study|Lost to Follow-up|33
2544785|NCT01491854|8809343|P1|Overall Study|Withdrawal by Subject|3
2544786|NCT01491854|8809343|P1|Overall Study|Death|1
2544787|NCT01491854|8809343|P1|Overall Study|mainly due to premature termination|93
2544788|NCT01491841|8809354|P1|Overall Study|Withdrawal by Subject|1
2544789|NCT01491841|8809354|P1|Overall Study|Screen Failure|10
2544790|NCT01491802|8809368|P2|Overall Study|Withdrawal by Subject|1
2544791|NCT01491802|8809369|P1|Overall Study|Withdrawal by Subject|0
2544792|NCT01491802|8809368|P2|Overall Study|Adverse Event|1
2544793|NCT01491802|8809369|P1|Overall Study|Adverse Event|1
2544794|NCT01491737|8809396|P2|Overall Study|Reason not specified|3
2544795|NCT01491737|8809397|P1|Overall Study|Reason not specified|2
2544796|NCT01491737|8809396|P2|Overall Study|Death|28
2544797|NCT01491737|8809397|P1|Overall Study|Death|33
2544798|NCT01491737|8809396|P2|Overall Study|Lost to Follow-up|6
2544799|NCT01491737|8809397|P1|Overall Study|Lost to Follow-up|1
2544800|NCT01491737|8809396|P2|Overall Study|Withdrawal of consent|13
2544801|NCT01491737|8809397|P1|Overall Study|Withdrawal of consent|13
2544802|NCT01491672|8809420|P3|Overall Study|Death|0
2544803|NCT01491672|8809421|P2|Overall Study|Death|4
2544804|NCT01491672|8809422|P1|Overall Study|Death|0
2544805|NCT01491672|8809420|P3|Overall Study|Protocol deviation|0
2544806|NCT01491672|8809421|P2|Overall Study|Protocol deviation|1
2544807|NCT01491672|8809422|P1|Overall Study|Protocol deviation|0
2544808|NCT01491672|8809420|P3|Overall Study|Disease progression|6
2544809|NCT01491672|8809421|P2|Overall Study|Disease progression|34
2544810|NCT01491672|8809422|P1|Overall Study|Disease progression|42
2544811|NCT01491672|8809420|P3|Overall Study|Adverse Event|4
2544812|NCT01491672|8809421|P2|Overall Study|Adverse Event|10
2544813|NCT01491672|8809422|P1|Overall Study|Adverse Event|8
2544814|NCT01491672|8809420|P3|Overall Study|Withdrawal by Subject|0
2544815|NCT01491672|8809421|P2|Overall Study|Withdrawal by Subject|7
2544816|NCT01491672|8809422|P1|Overall Study|Withdrawal by Subject|6
2544817|NCT01491672|8809420|P3|Overall Study|Lost to Follow-up|1
2544818|NCT01491672|8809421|P2|Overall Study|Lost to Follow-up|4
2544819|NCT01491672|8809422|P1|Overall Study|Lost to Follow-up|0
2544820|NCT01491607|8809459|P1|Overall Study|Withdrawal by Subject|3
2544821|NCT01491607|8809459|P1|Overall Study|Lost to Follow-up|7
2544822|NCT01491178|8809564|P1|Overall Study|Other than specified above|657
2544823|NCT01491178|8809564|P1|Overall Study|To take a contraindication|20
2544824|NCT01491178|8809564|P1|Overall Study|Lost to follow−up (changing hospital)|545
2544825|NCT01491178|8809564|P1|Overall Study|Lost to follow−up (unknown reason)|287
2544826|NCT01491178|8809564|P1|Overall Study|To conduct invasive treatment|59
2544827|NCT01491178|8809564|P1|Overall Study|Improvement of NVAF|210
2544828|NCT01491178|8809564|P1|Overall Study|Adverse Event|1016
2544829|NCT01491035|8809673|P8|Overall Study|Lost to Follow-up|0
2544830|NCT01491035|8809674|P7|Overall Study|Lost to Follow-up|0
2544831|NCT01491035|8809675|P6|Overall Study|Lost to Follow-up|0
2544832|NCT01491035|8809676|P5|Overall Study|Lost to Follow-up|1
2544833|NCT01491035|8809677|P4|Overall Study|Lost to Follow-up|0
2544834|NCT01491035|8809678|P3|Overall Study|Lost to Follow-up|0
2544835|NCT01491035|8809679|P2|Overall Study|Lost to Follow-up|0
2544836|NCT01491035|8809680|P1|Overall Study|Lost to Follow-up|0
2544837|NCT01490866|8809786|P1|Axitinib Maintenance Therapy|Intercurrent illness|2
2544838|NCT01490866|8809786|P1|Axitinib Maintenance Therapy|Protocol Violation|2
2544839|NCT01490866|8809786|P1|Axitinib Maintenance Therapy|Withdrawal by Subject|3
2544840|NCT01490866|8809786|P1|Axitinib Maintenance Therapy|Adverse Event|12
2544841|NCT01490866|8809786|P1|Axitinib Maintenance Therapy|Disease Progression|30
2544842|NCT01490866|8809786|P1|FOLFOX/Bevacizumab Treatment|Physician Decision|2
2544843|NCT01490866|8809786|P1|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1
2544844|NCT01490866|8809786|P1|FOLFOX/Bevacizumab Treatment|Protocol Violation|1
2544845|NCT01490866|8809786|P1|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5
2544846|NCT01490866|8809786|P1|FOLFOX/Bevacizumab Treatment|Adverse Event|6
2544847|NCT01490866|8809786|P1|FOLFOX/Bevacizumab Treatment|Disease Progression|6
2544848|NCT01490840|8809797|P2|Phase 2|Adverse Event|1
2544849|NCT01490840|8809798|P1|Phase 2|Adverse Event|1
2544850|NCT01490840|8809797|P2|Phase 2|Lost to Follow-up|1
2544851|NCT01490840|8809798|P1|Phase 2|Lost to Follow-up|1
2544852|NCT01490840|8809797|P2|Phase 2|Permanent interruption of fingolimod|1
2544853|NCT01490840|8809798|P1|Phase 2|Permanent interruption of fingolimod|0
2544854|NCT01490840|8809797|P2|Phase 2|Withdrawal by Subject|3
2544855|NCT01490840|8809798|P1|Phase 2|Withdrawal by Subject|4
2544856|NCT01490840|8809797|P2|Phase 1|Visit 6a omitted|0
2544857|NCT01490840|8809798|P1|Phase 1|Visit 6a omitted|1
2544858|NCT01490840|8809797|P2|Phase 1|Withdrawal by Subject|5
2544859|NCT01490840|8809798|P1|Phase 1|Withdrawal by Subject|6
2544860|NCT01490840|8809797|P2|Phase 1|Adverse Event|1
2544861|NCT01490840|8809798|P1|Phase 1|Adverse Event|2
2544862|NCT01490840|8809797|P2|Phase 1|Lost to Follow-up|0
2544863|NCT01490840|8809798|P1|Phase 1|Lost to Follow-up|1
2544864|NCT01490814|8809822|P2|Overall Study|Withdrawal by Subject|5
2544865|NCT01490814|8809823|P1|Overall Study|Withdrawal by Subject|0
2544866|NCT01490814|8809822|P2|Overall Study|Physician Decision|0
2544867|NCT01490814|8809823|P1|Overall Study|Physician Decision|1
2544868|NCT01490814|8809822|P2|Overall Study|Inclusion/Exclusion Criteria Violation|3
2544869|NCT01490814|8809823|P1|Overall Study|Inclusion/Exclusion Criteria Violation|3
2544870|NCT01490697|8809861|P2|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2
2544871|NCT01490697|8809862|P1|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1
2544872|NCT01490632|8809882|P20|Part D: Re-Treatment Period|Withdrawal by Subject|1
2544873|NCT01490632|8809883|P19|Part D: Re-Treatment Period|Withdrawal by Subject|1
2544874|NCT01490632|8809884|P18|Part D: Re-Treatment Period|Withdrawal by Subject|1
2544875|NCT01490632|8809885|P17|Part D: Re-Treatment Period|Withdrawal by Subject|0
2544876|NCT01490632|8809886|P16|Part D: Re-Treatment Period|Withdrawal by Subject|0
2544877|NCT01490632|8809887|P15|Part D: Re-Treatment Period|Withdrawal by Subject|0
2544878|NCT01490632|8809888|P14|Part D: Re-Treatment Period|Withdrawal by Subject|0
2544879|NCT01490632|8809889|P13|Part D: Re-Treatment Period|Withdrawal by Subject|0
2544880|NCT01490632|8809890|P12|Part D: Re-Treatment Period|Withdrawal by Subject|0
2544881|NCT01490632|8809891|P11|Part D: Re-Treatment Period|Withdrawal by Subject|0
2544882|NCT01490632|8809892|P10|Part D: Re-Treatment Period|Withdrawal by Subject|0
2544883|NCT01490632|8809893|P9|Part D: Re-Treatment Period|Withdrawal by Subject|0
2544884|NCT01490632|8809894|P8|Part D: Re-Treatment Period|Withdrawal by Subject|0
2544885|NCT01490632|8809895|P7|Part D: Re-Treatment Period|Withdrawal by Subject|0
2544886|NCT01490632|8809896|P6|Part D: Re-Treatment Period|Withdrawal by Subject|0
2544887|NCT01490632|8809897|P5|Part D: Re-Treatment Period|Withdrawal by Subject|0
2544888|NCT01490632|8809898|P4|Part D: Re-Treatment Period|Withdrawal by Subject|0
2544889|NCT01490632|8809899|P3|Part D: Re-Treatment Period|Withdrawal by Subject|0
2544890|NCT01490632|8809900|P2|Part D: Re-Treatment Period|Withdrawal by Subject|0
2544891|NCT01490632|8809901|P1|Part D: Re-Treatment Period|Withdrawal by Subject|0
2544892|NCT01490632|8809882|P20|Part D: Re-Treatment Period|Protocol Violation|0
2544893|NCT01490632|8809883|P19|Part D: Re-Treatment Period|Protocol Violation|1
2544894|NCT01490632|8809884|P18|Part D: Re-Treatment Period|Protocol Violation|0
2544895|NCT01490632|8809885|P17|Part D: Re-Treatment Period|Protocol Violation|0
2544896|NCT01490632|8809886|P16|Part D: Re-Treatment Period|Protocol Violation|0
2544897|NCT01490632|8809887|P15|Part D: Re-Treatment Period|Protocol Violation|0
2544898|NCT01490632|8809888|P14|Part D: Re-Treatment Period|Protocol Violation|0
2544899|NCT01490632|8809889|P13|Part D: Re-Treatment Period|Protocol Violation|0
2544900|NCT01490632|8809890|P12|Part D: Re-Treatment Period|Protocol Violation|0
2544901|NCT01490632|8809891|P11|Part D: Re-Treatment Period|Protocol Violation|0
2544902|NCT01490632|8809892|P10|Part D: Re-Treatment Period|Protocol Violation|0
2544903|NCT01490632|8809893|P9|Part D: Re-Treatment Period|Protocol Violation|0
2544904|NCT01490632|8809894|P8|Part D: Re-Treatment Period|Protocol Violation|0
2544905|NCT01490632|8809895|P7|Part D: Re-Treatment Period|Protocol Violation|0
2544984|NCT01490632|8809894|P8|Part D: Re-Treatment Period|Death|0
2544906|NCT01490632|8809896|P6|Part D: Re-Treatment Period|Protocol Violation|0
2544907|NCT01490632|8809897|P5|Part D: Re-Treatment Period|Protocol Violation|0
2544908|NCT01490632|8809898|P4|Part D: Re-Treatment Period|Protocol Violation|0
2544909|NCT01490632|8809899|P3|Part D: Re-Treatment Period|Protocol Violation|0
2544910|NCT01490632|8809900|P2|Part D: Re-Treatment Period|Protocol Violation|0
2544911|NCT01490632|8809901|P1|Part D: Re-Treatment Period|Protocol Violation|0
2544912|NCT01490632|8809882|P20|Part D: Re-Treatment Period|Physician Decision|1
2544913|NCT01490632|8809883|P19|Part D: Re-Treatment Period|Physician Decision|1
2544914|NCT01490632|8809884|P18|Part D: Re-Treatment Period|Physician Decision|0
2544915|NCT01490632|8809885|P17|Part D: Re-Treatment Period|Physician Decision|0
2544916|NCT01490632|8809886|P16|Part D: Re-Treatment Period|Physician Decision|0
2544917|NCT01490632|8809887|P15|Part D: Re-Treatment Period|Physician Decision|0
2544918|NCT01490632|8809888|P14|Part D: Re-Treatment Period|Physician Decision|0
2544919|NCT01490632|8809889|P13|Part D: Re-Treatment Period|Physician Decision|0
2544920|NCT01490632|8809890|P12|Part D: Re-Treatment Period|Physician Decision|0
2544921|NCT01490632|8809891|P11|Part D: Re-Treatment Period|Physician Decision|0
2544922|NCT01490632|8809892|P10|Part D: Re-Treatment Period|Physician Decision|0
2544923|NCT01490632|8809893|P9|Part D: Re-Treatment Period|Physician Decision|0
2544924|NCT01490632|8809894|P8|Part D: Re-Treatment Period|Physician Decision|0
2544925|NCT01490632|8809895|P7|Part D: Re-Treatment Period|Physician Decision|0
2544926|NCT01490632|8809896|P6|Part D: Re-Treatment Period|Physician Decision|0
2544927|NCT01490632|8809897|P5|Part D: Re-Treatment Period|Physician Decision|0
2544928|NCT01490632|8809898|P4|Part D: Re-Treatment Period|Physician Decision|0
2544929|NCT01490632|8809899|P3|Part D: Re-Treatment Period|Physician Decision|0
2544930|NCT01490632|8809900|P2|Part D: Re-Treatment Period|Physician Decision|0
2544931|NCT01490632|8809901|P1|Part D: Re-Treatment Period|Physician Decision|0
2544932|NCT01490632|8809882|P20|Part D: Re-Treatment Period|Lost to Follow-up|0
2544933|NCT01490632|8809883|P19|Part D: Re-Treatment Period|Lost to Follow-up|1
2544934|NCT01490632|8809884|P18|Part D: Re-Treatment Period|Lost to Follow-up|0
2544935|NCT01490632|8809885|P17|Part D: Re-Treatment Period|Lost to Follow-up|0
2544936|NCT01490632|8809886|P16|Part D: Re-Treatment Period|Lost to Follow-up|0
2544937|NCT01490632|8809887|P15|Part D: Re-Treatment Period|Lost to Follow-up|0
2544938|NCT01490632|8809888|P14|Part D: Re-Treatment Period|Lost to Follow-up|0
2544939|NCT01490632|8809889|P13|Part D: Re-Treatment Period|Lost to Follow-up|0
2544940|NCT01490632|8809890|P12|Part D: Re-Treatment Period|Lost to Follow-up|0
2544941|NCT01490632|8809891|P11|Part D: Re-Treatment Period|Lost to Follow-up|0
2544942|NCT01490632|8809892|P10|Part D: Re-Treatment Period|Lost to Follow-up|0
2544943|NCT01490632|8809893|P9|Part D: Re-Treatment Period|Lost to Follow-up|0
2544944|NCT01490632|8809894|P8|Part D: Re-Treatment Period|Lost to Follow-up|0
2544945|NCT01490632|8809895|P7|Part D: Re-Treatment Period|Lost to Follow-up|0
2544946|NCT01490632|8809896|P6|Part D: Re-Treatment Period|Lost to Follow-up|0
2544947|NCT01490632|8809897|P5|Part D: Re-Treatment Period|Lost to Follow-up|0
2544948|NCT01490632|8809898|P4|Part D: Re-Treatment Period|Lost to Follow-up|0
2544949|NCT01490632|8809899|P3|Part D: Re-Treatment Period|Lost to Follow-up|0
2544950|NCT01490632|8809900|P2|Part D: Re-Treatment Period|Lost to Follow-up|0
2544951|NCT01490632|8809901|P1|Part D: Re-Treatment Period|Lost to Follow-up|0
2544952|NCT01490632|8809882|P20|Part D: Re-Treatment Period|Lack of Efficacy|2
2544953|NCT01490632|8809883|P19|Part D: Re-Treatment Period|Lack of Efficacy|1
2544954|NCT01490632|8809884|P18|Part D: Re-Treatment Period|Lack of Efficacy|3
2544955|NCT01490632|8809885|P17|Part D: Re-Treatment Period|Lack of Efficacy|0
2544956|NCT01490632|8809886|P16|Part D: Re-Treatment Period|Lack of Efficacy|0
2544957|NCT01490632|8809887|P15|Part D: Re-Treatment Period|Lack of Efficacy|0
2544958|NCT01490632|8809888|P14|Part D: Re-Treatment Period|Lack of Efficacy|0
2544959|NCT01490632|8809889|P13|Part D: Re-Treatment Period|Lack of Efficacy|0
2544960|NCT01490632|8809890|P12|Part D: Re-Treatment Period|Lack of Efficacy|0
2544961|NCT01490632|8809891|P11|Part D: Re-Treatment Period|Lack of Efficacy|0
2544962|NCT01490632|8809892|P10|Part D: Re-Treatment Period|Lack of Efficacy|0
2544963|NCT01490632|8809893|P9|Part D: Re-Treatment Period|Lack of Efficacy|0
2544964|NCT01490632|8809894|P8|Part D: Re-Treatment Period|Lack of Efficacy|0
2544965|NCT01490632|8809895|P7|Part D: Re-Treatment Period|Lack of Efficacy|0
2544966|NCT01490632|8809896|P6|Part D: Re-Treatment Period|Lack of Efficacy|0
2544967|NCT01490632|8809897|P5|Part D: Re-Treatment Period|Lack of Efficacy|0
2544968|NCT01490632|8809898|P4|Part D: Re-Treatment Period|Lack of Efficacy|0
2544969|NCT01490632|8809899|P3|Part D: Re-Treatment Period|Lack of Efficacy|0
2544970|NCT01490632|8809900|P2|Part D: Re-Treatment Period|Lack of Efficacy|0
2544971|NCT01490632|8809901|P1|Part D: Re-Treatment Period|Lack of Efficacy|0
2544972|NCT01490632|8809882|P20|Part D: Re-Treatment Period|Death|0
2544973|NCT01490632|8809883|P19|Part D: Re-Treatment Period|Death|1
2544974|NCT01490632|8809884|P18|Part D: Re-Treatment Period|Death|0
2544975|NCT01490632|8809885|P17|Part D: Re-Treatment Period|Death|0
2544976|NCT01490632|8809886|P16|Part D: Re-Treatment Period|Death|0
2544977|NCT01490632|8809887|P15|Part D: Re-Treatment Period|Death|0
2544978|NCT01490632|8809888|P14|Part D: Re-Treatment Period|Death|0
2544979|NCT01490632|8809889|P13|Part D: Re-Treatment Period|Death|0
2544980|NCT01490632|8809890|P12|Part D: Re-Treatment Period|Death|0
2544981|NCT01490632|8809891|P11|Part D: Re-Treatment Period|Death|0
2544982|NCT01490632|8809892|P10|Part D: Re-Treatment Period|Death|0
2544983|NCT01490632|8809893|P9|Part D: Re-Treatment Period|Death|0
2544985|NCT01490632|8809895|P7|Part D: Re-Treatment Period|Death|0
2544986|NCT01490632|8809896|P6|Part D: Re-Treatment Period|Death|0
2544987|NCT01490632|8809897|P5|Part D: Re-Treatment Period|Death|0
2544988|NCT01490632|8809898|P4|Part D: Re-Treatment Period|Death|0
2544989|NCT01490632|8809899|P3|Part D: Re-Treatment Period|Death|0
2544990|NCT01490632|8809900|P2|Part D: Re-Treatment Period|Death|0
2544991|NCT01490632|8809901|P1|Part D: Re-Treatment Period|Death|0
2544992|NCT01490632|8809882|P20|Part D: Re-Treatment Period|Adverse Event|3
2544993|NCT01490632|8809883|P19|Part D: Re-Treatment Period|Adverse Event|1
2544994|NCT01490632|8809884|P18|Part D: Re-Treatment Period|Adverse Event|1
2544995|NCT01490632|8809885|P17|Part D: Re-Treatment Period|Adverse Event|0
2544996|NCT01490632|8809886|P16|Part D: Re-Treatment Period|Adverse Event|0
2544997|NCT01490632|8809887|P15|Part D: Re-Treatment Period|Adverse Event|0
2544998|NCT01490632|8809888|P14|Part D: Re-Treatment Period|Adverse Event|0
2544999|NCT01490632|8809889|P13|Part D: Re-Treatment Period|Adverse Event|0
2545000|NCT01490632|8809890|P12|Part D: Re-Treatment Period|Adverse Event|0
2545001|NCT01490632|8809891|P11|Part D: Re-Treatment Period|Adverse Event|0
2545002|NCT01490632|8809892|P10|Part D: Re-Treatment Period|Adverse Event|0
2545003|NCT01490632|8809893|P9|Part D: Re-Treatment Period|Adverse Event|0
2545004|NCT01490632|8809894|P8|Part D: Re-Treatment Period|Adverse Event|0
2545005|NCT01490632|8809895|P7|Part D: Re-Treatment Period|Adverse Event|0
2545006|NCT01490632|8809896|P6|Part D: Re-Treatment Period|Adverse Event|0
2545007|NCT01490632|8809897|P5|Part D: Re-Treatment Period|Adverse Event|0
2545008|NCT01490632|8809898|P4|Part D: Re-Treatment Period|Adverse Event|0
2545009|NCT01490632|8809899|P3|Part D: Re-Treatment Period|Adverse Event|0
2545010|NCT01490632|8809900|P2|Part D: Re-Treatment Period|Adverse Event|0
2545011|NCT01490632|8809901|P1|Part D: Re-Treatment Period|Adverse Event|0
2545012|NCT01490632|8809882|P20|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2545013|NCT01490632|8809883|P19|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2545014|NCT01490632|8809884|P18|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2545015|NCT01490632|8809885|P17|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2545016|NCT01490632|8809886|P16|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34
2545017|NCT01490632|8809887|P15|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14
2545018|NCT01490632|8809888|P14|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9
2545019|NCT01490632|8809889|P13|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5
2545020|NCT01490632|8809890|P12|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2545021|NCT01490632|8809891|P11|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2545022|NCT01490632|8809892|P10|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2545023|NCT01490632|8809893|P9|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2545024|NCT01490632|8809894|P8|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2545025|NCT01490632|8809895|P7|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2545026|NCT01490632|8809896|P6|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2545027|NCT01490632|8809897|P5|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2545028|NCT01490632|8809898|P4|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2545029|NCT01490632|8809899|P3|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2545030|NCT01490632|8809900|P2|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2545031|NCT01490632|8809901|P1|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
2545032|NCT01490632|8809882|P20|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2545033|NCT01490632|8809883|P19|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2545034|NCT01490632|8809884|P18|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2545035|NCT01490632|8809885|P17|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2545036|NCT01490632|8809886|P16|Part C: Washout or Step-Down Period|Withdrawal by Subject|1
2545037|NCT01490632|8809887|P15|Part C: Washout or Step-Down Period|Withdrawal by Subject|2
2545038|NCT01490632|8809888|P14|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2545039|NCT01490632|8809889|P13|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2545040|NCT01490632|8809890|P12|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2545041|NCT01490632|8809891|P11|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2545042|NCT01490632|8809892|P10|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2545043|NCT01490632|8809893|P9|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2545044|NCT01490632|8809894|P8|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2545045|NCT01490632|8809895|P7|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2545046|NCT01490632|8809896|P6|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2545047|NCT01490632|8809897|P5|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2545048|NCT01490632|8809898|P4|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2545049|NCT01490632|8809899|P3|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2545050|NCT01490632|8809900|P2|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2545051|NCT01490632|8809901|P1|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
2545052|NCT01490632|8809882|P20|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2545053|NCT01490632|8809883|P19|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2545054|NCT01490632|8809884|P18|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2545055|NCT01490632|8809885|P17|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2545425|NCT01490125|8810343|P6|Period II|Adverse Event|2
2545056|NCT01490632|8809886|P16|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2545057|NCT01490632|8809887|P15|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2545058|NCT01490632|8809888|P14|Part C: Washout or Step-Down Period|Lost to Follow-up|1
2545059|NCT01490632|8809889|P13|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2545060|NCT01490632|8809890|P12|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2545061|NCT01490632|8809891|P11|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2545062|NCT01490632|8809892|P10|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2545063|NCT01490632|8809893|P9|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2545064|NCT01490632|8809894|P8|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2545065|NCT01490632|8809895|P7|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2545066|NCT01490632|8809896|P6|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2545067|NCT01490632|8809897|P5|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2545068|NCT01490632|8809898|P4|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2545069|NCT01490632|8809899|P3|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2545070|NCT01490632|8809900|P2|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2545071|NCT01490632|8809901|P1|Part C: Washout or Step-Down Period|Lost to Follow-up|0
2545072|NCT01490632|8809882|P20|Part C: Washout or Step-Down Period|Adverse Event|0
2545073|NCT01490632|8809883|P19|Part C: Washout or Step-Down Period|Adverse Event|0
2545074|NCT01490632|8809884|P18|Part C: Washout or Step-Down Period|Adverse Event|0
2545075|NCT01490632|8809885|P17|Part C: Washout or Step-Down Period|Adverse Event|0
2545076|NCT01490632|8809886|P16|Part C: Washout or Step-Down Period|Adverse Event|2
2545077|NCT01490632|8809887|P15|Part C: Washout or Step-Down Period|Adverse Event|2
2545078|NCT01490632|8809888|P14|Part C: Washout or Step-Down Period|Adverse Event|0
2545079|NCT01490632|8809889|P13|Part C: Washout or Step-Down Period|Adverse Event|0
2545080|NCT01490632|8809890|P12|Part C: Washout or Step-Down Period|Adverse Event|0
2545081|NCT01490632|8809891|P11|Part C: Washout or Step-Down Period|Adverse Event|0
2545082|NCT01490632|8809892|P10|Part C: Washout or Step-Down Period|Adverse Event|0
2545083|NCT01490632|8809893|P9|Part C: Washout or Step-Down Period|Adverse Event|0
2545084|NCT01490632|8809894|P8|Part C: Washout or Step-Down Period|Adverse Event|0
2545085|NCT01490632|8809895|P7|Part C: Washout or Step-Down Period|Adverse Event|0
2545086|NCT01490632|8809896|P6|Part C: Washout or Step-Down Period|Adverse Event|0
2545087|NCT01490632|8809897|P5|Part C: Washout or Step-Down Period|Adverse Event|0
2545088|NCT01490632|8809898|P4|Part C: Washout or Step-Down Period|Adverse Event|0
2545089|NCT01490632|8809899|P3|Part C: Washout or Step-Down Period|Adverse Event|0
2545090|NCT01490632|8809900|P2|Part C: Washout or Step-Down Period|Adverse Event|0
2545091|NCT01490632|8809901|P1|Part C: Washout or Step-Down Period|Adverse Event|0
2545092|NCT01490632|8809882|P20|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2545093|NCT01490632|8809883|P19|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2545094|NCT01490632|8809884|P18|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2545095|NCT01490632|8809885|P17|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2545096|NCT01490632|8809886|P16|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2545097|NCT01490632|8809887|P15|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2545098|NCT01490632|8809888|P14|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2545099|NCT01490632|8809889|P13|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2545100|NCT01490632|8809890|P12|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5
2545101|NCT01490632|8809891|P11|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16
2545102|NCT01490632|8809892|P10|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19
2545103|NCT01490632|8809893|P9|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8
2545104|NCT01490632|8809894|P8|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
2545105|NCT01490632|8809895|P7|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
2545106|NCT01490632|8809896|P6|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1
2545107|NCT01490632|8809897|P5|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2545108|NCT01490632|8809898|P4|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2545109|NCT01490632|8809899|P3|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2545110|NCT01490632|8809900|P2|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2545111|NCT01490632|8809901|P1|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
2545112|NCT01490632|8809882|P20|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2545113|NCT01490632|8809883|P19|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2545114|NCT01490632|8809884|P18|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2545115|NCT01490632|8809885|P17|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2545116|NCT01490632|8809886|P16|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2545117|NCT01490632|8809887|P15|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2545118|NCT01490632|8809888|P14|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2545119|NCT01490632|8809889|P13|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2545120|NCT01490632|8809890|P12|Part B: Extension or Step-Up Period|Withdrawal by Subject|2
2545121|NCT01490632|8809891|P11|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
2545122|NCT01490632|8809892|P10|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2545123|NCT01490632|8809893|P9|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
2545124|NCT01490632|8809894|P8|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2545125|NCT01490632|8809895|P7|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
2545126|NCT01490632|8809896|P6|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2545127|NCT01490632|8809897|P5|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2545128|NCT01490632|8809898|P4|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2545129|NCT01490632|8809899|P3|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2545130|NCT01490632|8809900|P2|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2545131|NCT01490632|8809901|P1|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
2545132|NCT01490632|8809882|P20|Part B: Extension or Step-Up Period|Sponsor Decision|0
2545133|NCT01490632|8809883|P19|Part B: Extension or Step-Up Period|Sponsor Decision|0
2545134|NCT01490632|8809884|P18|Part B: Extension or Step-Up Period|Sponsor Decision|0
2545135|NCT01490632|8809885|P17|Part B: Extension or Step-Up Period|Sponsor Decision|0
2545136|NCT01490632|8809886|P16|Part B: Extension or Step-Up Period|Sponsor Decision|0
2545137|NCT01490632|8809887|P15|Part B: Extension or Step-Up Period|Sponsor Decision|0
2545138|NCT01490632|8809888|P14|Part B: Extension or Step-Up Period|Sponsor Decision|0
2545139|NCT01490632|8809889|P13|Part B: Extension or Step-Up Period|Sponsor Decision|0
2545140|NCT01490632|8809890|P12|Part B: Extension or Step-Up Period|Sponsor Decision|0
2545141|NCT01490632|8809891|P11|Part B: Extension or Step-Up Period|Sponsor Decision|0
2545142|NCT01490632|8809892|P10|Part B: Extension or Step-Up Period|Sponsor Decision|0
2545143|NCT01490632|8809893|P9|Part B: Extension or Step-Up Period|Sponsor Decision|0
2545144|NCT01490632|8809894|P8|Part B: Extension or Step-Up Period|Sponsor Decision|0
2545145|NCT01490632|8809895|P7|Part B: Extension or Step-Up Period|Sponsor Decision|0
2545146|NCT01490632|8809896|P6|Part B: Extension or Step-Up Period|Sponsor Decision|1
2545147|NCT01490632|8809897|P5|Part B: Extension or Step-Up Period|Sponsor Decision|0
2545148|NCT01490632|8809898|P4|Part B: Extension or Step-Up Period|Sponsor Decision|0
2545149|NCT01490632|8809899|P3|Part B: Extension or Step-Up Period|Sponsor Decision|0
2545150|NCT01490632|8809900|P2|Part B: Extension or Step-Up Period|Sponsor Decision|0
2545151|NCT01490632|8809901|P1|Part B: Extension or Step-Up Period|Sponsor Decision|0
2545152|NCT01490632|8809882|P20|Part B: Extension or Step-Up Period|Physician Decision|0
2545153|NCT01490632|8809883|P19|Part B: Extension or Step-Up Period|Physician Decision|0
2545154|NCT01490632|8809884|P18|Part B: Extension or Step-Up Period|Physician Decision|0
2545155|NCT01490632|8809885|P17|Part B: Extension or Step-Up Period|Physician Decision|0
2545156|NCT01490632|8809886|P16|Part B: Extension or Step-Up Period|Physician Decision|0
2545157|NCT01490632|8809887|P15|Part B: Extension or Step-Up Period|Physician Decision|0
2545158|NCT01490632|8809888|P14|Part B: Extension or Step-Up Period|Physician Decision|0
2545159|NCT01490632|8809889|P13|Part B: Extension or Step-Up Period|Physician Decision|0
2545160|NCT01490632|8809890|P12|Part B: Extension or Step-Up Period|Physician Decision|0
2545161|NCT01490632|8809891|P11|Part B: Extension or Step-Up Period|Physician Decision|0
2545162|NCT01490632|8809892|P10|Part B: Extension or Step-Up Period|Physician Decision|0
2545163|NCT01490632|8809893|P9|Part B: Extension or Step-Up Period|Physician Decision|0
2545164|NCT01490632|8809894|P8|Part B: Extension or Step-Up Period|Physician Decision|0
2545165|NCT01490632|8809895|P7|Part B: Extension or Step-Up Period|Physician Decision|1
2545166|NCT01490632|8809896|P6|Part B: Extension or Step-Up Period|Physician Decision|0
2545167|NCT01490632|8809897|P5|Part B: Extension or Step-Up Period|Physician Decision|0
2545168|NCT01490632|8809898|P4|Part B: Extension or Step-Up Period|Physician Decision|0
2545169|NCT01490632|8809899|P3|Part B: Extension or Step-Up Period|Physician Decision|0
2545170|NCT01490632|8809900|P2|Part B: Extension or Step-Up Period|Physician Decision|0
2545171|NCT01490632|8809901|P1|Part B: Extension or Step-Up Period|Physician Decision|0
2545172|NCT01490632|8809882|P20|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2545173|NCT01490632|8809883|P19|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2545174|NCT01490632|8809884|P18|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2545175|NCT01490632|8809885|P17|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2545176|NCT01490632|8809886|P16|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2545177|NCT01490632|8809887|P15|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2545178|NCT01490632|8809888|P14|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2545179|NCT01490632|8809889|P13|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2545180|NCT01490632|8809890|P12|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2545181|NCT01490632|8809891|P11|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2545182|NCT01490632|8809892|P10|Part B: Extension or Step-Up Period|Lost to Follow-up|1
2545183|NCT01490632|8809893|P9|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2545184|NCT01490632|8809894|P8|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2545185|NCT01490632|8809895|P7|Part B: Extension or Step-Up Period|Lost to Follow-up|2
2545186|NCT01490632|8809896|P6|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2545187|NCT01490632|8809897|P5|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2545188|NCT01490632|8809898|P4|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2545189|NCT01490632|8809899|P3|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2545190|NCT01490632|8809900|P2|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2545191|NCT01490632|8809901|P1|Part B: Extension or Step-Up Period|Lost to Follow-up|0
2545192|NCT01490632|8809882|P20|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2545193|NCT01490632|8809883|P19|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2545194|NCT01490632|8809884|P18|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2545195|NCT01490632|8809885|P17|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2545196|NCT01490632|8809886|P16|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2545197|NCT01490632|8809887|P15|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2545198|NCT01490632|8809888|P14|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2545199|NCT01490632|8809889|P13|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2545200|NCT01490632|8809890|P12|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2545201|NCT01490632|8809891|P11|Part B: Extension or Step-Up Period|Lack of Efficacy|1
2545202|NCT01490632|8809892|P10|Part B: Extension or Step-Up Period|Lack of Efficacy|3
2545203|NCT01490632|8809893|P9|Part B: Extension or Step-Up Period|Lack of Efficacy|1
2545204|NCT01490632|8809894|P8|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2545205|NCT01490632|8809895|P7|Part B: Extension or Step-Up Period|Lack of Efficacy|1
2545206|NCT01490632|8809896|P6|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2545207|NCT01490632|8809897|P5|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2545208|NCT01490632|8809898|P4|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2545209|NCT01490632|8809899|P3|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2545210|NCT01490632|8809900|P2|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2545211|NCT01490632|8809901|P1|Part B: Extension or Step-Up Period|Lack of Efficacy|0
2545212|NCT01490632|8809882|P20|Part B: Extension or Step-Up Period|Adverse Event|0
2545213|NCT01490632|8809883|P19|Part B: Extension or Step-Up Period|Adverse Event|0
2545214|NCT01490632|8809884|P18|Part B: Extension or Step-Up Period|Adverse Event|0
2545215|NCT01490632|8809885|P17|Part B: Extension or Step-Up Period|Adverse Event|0
2545216|NCT01490632|8809886|P16|Part B: Extension or Step-Up Period|Adverse Event|0
2545217|NCT01490632|8809887|P15|Part B: Extension or Step-Up Period|Adverse Event|0
2545218|NCT01490632|8809888|P14|Part B: Extension or Step-Up Period|Adverse Event|0
2545219|NCT01490632|8809889|P13|Part B: Extension or Step-Up Period|Adverse Event|0
2545220|NCT01490632|8809890|P12|Part B: Extension or Step-Up Period|Adverse Event|1
2545221|NCT01490632|8809891|P11|Part B: Extension or Step-Up Period|Adverse Event|3
2545222|NCT01490632|8809892|P10|Part B: Extension or Step-Up Period|Adverse Event|2
2545223|NCT01490632|8809893|P9|Part B: Extension or Step-Up Period|Adverse Event|0
2545224|NCT01490632|8809894|P8|Part B: Extension or Step-Up Period|Adverse Event|0
2545225|NCT01490632|8809895|P7|Part B: Extension or Step-Up Period|Adverse Event|2
2545226|NCT01490632|8809896|P6|Part B: Extension or Step-Up Period|Adverse Event|2
2545227|NCT01490632|8809897|P5|Part B: Extension or Step-Up Period|Adverse Event|0
2545228|NCT01490632|8809898|P4|Part B: Extension or Step-Up Period|Adverse Event|0
2545229|NCT01490632|8809899|P3|Part B: Extension or Step-Up Period|Adverse Event|0
2545230|NCT01490632|8809900|P2|Part B: Extension or Step-Up Period|Adverse Event|0
2545231|NCT01490632|8809901|P1|Part B: Extension or Step-Up Period|Adverse Event|0
2545232|NCT01490632|8809882|P20|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2545233|NCT01490632|8809883|P19|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2545234|NCT01490632|8809884|P18|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2545235|NCT01490632|8809885|P17|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2545236|NCT01490632|8809886|P16|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2545237|NCT01490632|8809887|P15|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2545238|NCT01490632|8809888|P14|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2545239|NCT01490632|8809889|P13|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2545240|NCT01490632|8809890|P12|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2545241|NCT01490632|8809891|P11|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2545242|NCT01490632|8809892|P10|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2545243|NCT01490632|8809893|P9|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2545244|NCT01490632|8809894|P8|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2545245|NCT01490632|8809895|P7|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2545246|NCT01490632|8809896|P6|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2545247|NCT01490632|8809897|P5|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9
2545248|NCT01490632|8809898|P4|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2545249|NCT01490632|8809899|P3|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2545250|NCT01490632|8809900|P2|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2545251|NCT01490632|8809901|P1|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
2545252|NCT01490632|8809882|P20|Part A: Initial Treatment Period|Withdrawal by Subject|0
2545253|NCT01490632|8809883|P19|Part A: Initial Treatment Period|Withdrawal by Subject|0
2545254|NCT01490632|8809884|P18|Part A: Initial Treatment Period|Withdrawal by Subject|0
2545255|NCT01490632|8809885|P17|Part A: Initial Treatment Period|Withdrawal by Subject|0
2545256|NCT01490632|8809886|P16|Part A: Initial Treatment Period|Withdrawal by Subject|0
2545257|NCT01490632|8809887|P15|Part A: Initial Treatment Period|Withdrawal by Subject|0
2545258|NCT01490632|8809888|P14|Part A: Initial Treatment Period|Withdrawal by Subject|0
2545259|NCT01490632|8809889|P13|Part A: Initial Treatment Period|Withdrawal by Subject|0
2545260|NCT01490632|8809890|P12|Part A: Initial Treatment Period|Withdrawal by Subject|0
2545261|NCT01490632|8809891|P11|Part A: Initial Treatment Period|Withdrawal by Subject|0
2545262|NCT01490632|8809892|P10|Part A: Initial Treatment Period|Withdrawal by Subject|0
2545263|NCT01490632|8809893|P9|Part A: Initial Treatment Period|Withdrawal by Subject|0
2545264|NCT01490632|8809894|P8|Part A: Initial Treatment Period|Withdrawal by Subject|0
2545265|NCT01490632|8809895|P7|Part A: Initial Treatment Period|Withdrawal by Subject|0
2545266|NCT01490632|8809896|P6|Part A: Initial Treatment Period|Withdrawal by Subject|0
2545267|NCT01490632|8809897|P5|Part A: Initial Treatment Period|Withdrawal by Subject|2
2545268|NCT01490632|8809898|P4|Part A: Initial Treatment Period|Withdrawal by Subject|1
2545269|NCT01490632|8809899|P3|Part A: Initial Treatment Period|Withdrawal by Subject|0
2545270|NCT01490632|8809900|P2|Part A: Initial Treatment Period|Withdrawal by Subject|2
2545271|NCT01490632|8809901|P1|Part A: Initial Treatment Period|Withdrawal by Subject|2
2545272|NCT01490632|8809882|P20|Part A: Initial Treatment Period|Sponsor Decision|0
2545273|NCT01490632|8809883|P19|Part A: Initial Treatment Period|Sponsor Decision|0
2545274|NCT01490632|8809884|P18|Part A: Initial Treatment Period|Sponsor Decision|0
2545275|NCT01490632|8809885|P17|Part A: Initial Treatment Period|Sponsor Decision|0
2545276|NCT01490632|8809886|P16|Part A: Initial Treatment Period|Sponsor Decision|0
2545277|NCT01490632|8809887|P15|Part A: Initial Treatment Period|Sponsor Decision|0
2545278|NCT01490632|8809888|P14|Part A: Initial Treatment Period|Sponsor Decision|0
2545279|NCT01490632|8809889|P13|Part A: Initial Treatment Period|Sponsor Decision|0
2545280|NCT01490632|8809890|P12|Part A: Initial Treatment Period|Sponsor Decision|0
2545281|NCT01490632|8809891|P11|Part A: Initial Treatment Period|Sponsor Decision|0
2545282|NCT01490632|8809892|P10|Part A: Initial Treatment Period|Sponsor Decision|0
2545283|NCT01490632|8809893|P9|Part A: Initial Treatment Period|Sponsor Decision|0
2545284|NCT01490632|8809894|P8|Part A: Initial Treatment Period|Sponsor Decision|0
2545285|NCT01490632|8809895|P7|Part A: Initial Treatment Period|Sponsor Decision|0
2545286|NCT01490632|8809896|P6|Part A: Initial Treatment Period|Sponsor Decision|0
2545287|NCT01490632|8809897|P5|Part A: Initial Treatment Period|Sponsor Decision|0
2545288|NCT01490632|8809898|P4|Part A: Initial Treatment Period|Sponsor Decision|0
2545289|NCT01490632|8809899|P3|Part A: Initial Treatment Period|Sponsor Decision|0
2545290|NCT01490632|8809900|P2|Part A: Initial Treatment Period|Sponsor Decision|0
2545291|NCT01490632|8809901|P1|Part A: Initial Treatment Period|Sponsor Decision|2
2545292|NCT01490632|8809882|P20|Part A: Initial Treatment Period|Physician Decision|0
2545293|NCT01490632|8809883|P19|Part A: Initial Treatment Period|Physician Decision|0
2545294|NCT01490632|8809884|P18|Part A: Initial Treatment Period|Physician Decision|0
2545295|NCT01490632|8809885|P17|Part A: Initial Treatment Period|Physician Decision|0
2545296|NCT01490632|8809886|P16|Part A: Initial Treatment Period|Physician Decision|0
2545297|NCT01490632|8809887|P15|Part A: Initial Treatment Period|Physician Decision|0
2545298|NCT01490632|8809888|P14|Part A: Initial Treatment Period|Physician Decision|0
2545299|NCT01490632|8809889|P13|Part A: Initial Treatment Period|Physician Decision|0
2545300|NCT01490632|8809890|P12|Part A: Initial Treatment Period|Physician Decision|0
2545301|NCT01490632|8809891|P11|Part A: Initial Treatment Period|Physician Decision|0
2545302|NCT01490632|8809892|P10|Part A: Initial Treatment Period|Physician Decision|0
2545303|NCT01490632|8809893|P9|Part A: Initial Treatment Period|Physician Decision|0
2545304|NCT01490632|8809894|P8|Part A: Initial Treatment Period|Physician Decision|0
2545305|NCT01490632|8809895|P7|Part A: Initial Treatment Period|Physician Decision|0
2545306|NCT01490632|8809896|P6|Part A: Initial Treatment Period|Physician Decision|0
2545307|NCT01490632|8809897|P5|Part A: Initial Treatment Period|Physician Decision|0
2545308|NCT01490632|8809898|P4|Part A: Initial Treatment Period|Physician Decision|1
2545309|NCT01490632|8809899|P3|Part A: Initial Treatment Period|Physician Decision|0
2545310|NCT01490632|8809900|P2|Part A: Initial Treatment Period|Physician Decision|1
2545311|NCT01490632|8809901|P1|Part A: Initial Treatment Period|Physician Decision|0
2545312|NCT01490632|8809882|P20|Part A: Initial Treatment Period|Lost to Follow-up|0
2545313|NCT01490632|8809883|P19|Part A: Initial Treatment Period|Lost to Follow-up|0
2545314|NCT01490632|8809884|P18|Part A: Initial Treatment Period|Lost to Follow-up|0
2545315|NCT01490632|8809885|P17|Part A: Initial Treatment Period|Lost to Follow-up|0
2545316|NCT01490632|8809886|P16|Part A: Initial Treatment Period|Lost to Follow-up|0
2545317|NCT01490632|8809887|P15|Part A: Initial Treatment Period|Lost to Follow-up|0
2545318|NCT01490632|8809888|P14|Part A: Initial Treatment Period|Lost to Follow-up|0
2545319|NCT01490632|8809889|P13|Part A: Initial Treatment Period|Lost to Follow-up|0
2545320|NCT01490632|8809890|P12|Part A: Initial Treatment Period|Lost to Follow-up|0
2545321|NCT01490632|8809891|P11|Part A: Initial Treatment Period|Lost to Follow-up|0
2545322|NCT01490632|8809892|P10|Part A: Initial Treatment Period|Lost to Follow-up|0
2545323|NCT01490632|8809893|P9|Part A: Initial Treatment Period|Lost to Follow-up|0
2545324|NCT01490632|8809894|P8|Part A: Initial Treatment Period|Lost to Follow-up|0
2545325|NCT01490632|8809895|P7|Part A: Initial Treatment Period|Lost to Follow-up|0
2545326|NCT01490632|8809896|P6|Part A: Initial Treatment Period|Lost to Follow-up|0
2545327|NCT01490632|8809897|P5|Part A: Initial Treatment Period|Lost to Follow-up|2
2545328|NCT01490632|8809898|P4|Part A: Initial Treatment Period|Lost to Follow-up|1
2545329|NCT01490632|8809899|P3|Part A: Initial Treatment Period|Lost to Follow-up|1
2545330|NCT01490632|8809900|P2|Part A: Initial Treatment Period|Lost to Follow-up|0
2545331|NCT01490632|8809901|P1|Part A: Initial Treatment Period|Lost to Follow-up|0
2545332|NCT01490632|8809882|P20|Part A: Initial Treatment Period|Lack of Efficacy|0
2545333|NCT01490632|8809883|P19|Part A: Initial Treatment Period|Lack of Efficacy|0
2545334|NCT01490632|8809884|P18|Part A: Initial Treatment Period|Lack of Efficacy|0
2545335|NCT01490632|8809885|P17|Part A: Initial Treatment Period|Lack of Efficacy|0
2545336|NCT01490632|8809886|P16|Part A: Initial Treatment Period|Lack of Efficacy|0
2545337|NCT01490632|8809887|P15|Part A: Initial Treatment Period|Lack of Efficacy|0
2545338|NCT01490632|8809888|P14|Part A: Initial Treatment Period|Lack of Efficacy|0
2545339|NCT01490632|8809889|P13|Part A: Initial Treatment Period|Lack of Efficacy|0
2545340|NCT01490632|8809890|P12|Part A: Initial Treatment Period|Lack of Efficacy|0
2545341|NCT01490632|8809891|P11|Part A: Initial Treatment Period|Lack of Efficacy|0
2545342|NCT01490632|8809892|P10|Part A: Initial Treatment Period|Lack of Efficacy|0
2545343|NCT01490632|8809893|P9|Part A: Initial Treatment Period|Lack of Efficacy|0
2545344|NCT01490632|8809894|P8|Part A: Initial Treatment Period|Lack of Efficacy|0
2545345|NCT01490632|8809895|P7|Part A: Initial Treatment Period|Lack of Efficacy|0
2545346|NCT01490632|8809896|P6|Part A: Initial Treatment Period|Lack of Efficacy|0
2545347|NCT01490632|8809897|P5|Part A: Initial Treatment Period|Lack of Efficacy|0
2545348|NCT01490632|8809898|P4|Part A: Initial Treatment Period|Lack of Efficacy|2
2545349|NCT01490632|8809899|P3|Part A: Initial Treatment Period|Lack of Efficacy|2
2545350|NCT01490632|8809900|P2|Part A: Initial Treatment Period|Lack of Efficacy|1
2545351|NCT01490632|8809901|P1|Part A: Initial Treatment Period|Lack of Efficacy|3
2545352|NCT01490632|8809882|P20|Part A: Initial Treatment Period|Adverse Event|0
2545353|NCT01490632|8809883|P19|Part A: Initial Treatment Period|Adverse Event|0
2545354|NCT01490632|8809884|P18|Part A: Initial Treatment Period|Adverse Event|0
2545355|NCT01490632|8809885|P17|Part A: Initial Treatment Period|Adverse Event|0
2545356|NCT01490632|8809886|P16|Part A: Initial Treatment Period|Adverse Event|0
2545357|NCT01490632|8809887|P15|Part A: Initial Treatment Period|Adverse Event|0
2545358|NCT01490632|8809888|P14|Part A: Initial Treatment Period|Adverse Event|0
2545359|NCT01490632|8809889|P13|Part A: Initial Treatment Period|Adverse Event|0
2545360|NCT01490632|8809890|P12|Part A: Initial Treatment Period|Adverse Event|0
2545361|NCT01490632|8809891|P11|Part A: Initial Treatment Period|Adverse Event|0
2545362|NCT01490632|8809892|P10|Part A: Initial Treatment Period|Adverse Event|0
2545363|NCT01490632|8809893|P9|Part A: Initial Treatment Period|Adverse Event|0
2545364|NCT01490632|8809894|P8|Part A: Initial Treatment Period|Adverse Event|0
2545365|NCT01490632|8809895|P7|Part A: Initial Treatment Period|Adverse Event|0
2545366|NCT01490632|8809896|P6|Part A: Initial Treatment Period|Adverse Event|0
2545367|NCT01490632|8809897|P5|Part A: Initial Treatment Period|Adverse Event|4
2545368|NCT01490632|8809898|P4|Part A: Initial Treatment Period|Adverse Event|4
2545369|NCT01490632|8809899|P3|Part A: Initial Treatment Period|Adverse Event|2
2545370|NCT01490632|8809900|P2|Part A: Initial Treatment Period|Adverse Event|0
2545371|NCT01490632|8809901|P1|Part A: Initial Treatment Period|Adverse Event|0
2545372|NCT01490580|8810031|P2|Overall Study|Parents withdrew consent|2
2545373|NCT01490580|8810032|P1|Overall Study|Parents withdrew consent|0
2545374|NCT01490294|8810079|P4|Overall Study|Adverse Event|0
2545375|NCT01490294|8810080|P3|Overall Study|Adverse Event|0
2545376|NCT01490294|8810081|P2|Overall Study|Adverse Event|0
2545377|NCT01490294|8810082|P1|Overall Study|Adverse Event|1
2545378|NCT01490294|8810079|P4|Overall Study|Prematurely discontinuation|1
2545379|NCT01490294|8810080|P3|Overall Study|Prematurely discontinuation|1
2545380|NCT01490294|8810081|P2|Overall Study|Prematurely discontinuation|0
2545381|NCT01490294|8810082|P1|Overall Study|Prematurely discontinuation|4
2545382|NCT01490190|8810316|P1|Overall Study|Ring expulsion|2
2545383|NCT01490190|8810316|P1|Overall Study|Inconvenience|1
2545384|NCT01490190|8810316|P1|Overall Study|Relocation|1
2545385|NCT01490190|8810316|P1|Overall Study|Lost to Follow-up|13
2545386|NCT01490190|8810316|P1|Overall Study|Protocol Violation|5
2545387|NCT01490190|8810316|P1|Overall Study|Adverse Event|17
2545388|NCT01490190|8810316|P1|Overall Study|Withdrawal by Subject|9
2545389|NCT01490125|8810343|P6|Period III|Lack of Efficacy|0
2545390|NCT01490125|8810344|P5|Period III|Lack of Efficacy|1
2545391|NCT01490125|8810345|P4|Period III|Lack of Efficacy|0
2545392|NCT01490125|8810346|P3|Period III|Lack of Efficacy|0
2545393|NCT01490125|8810347|P2|Period III|Lack of Efficacy|0
2545394|NCT01490125|8810348|P1|Period III|Lack of Efficacy|0
2545395|NCT01490125|8810343|P6|Period III|Death|0
2545396|NCT01490125|8810344|P5|Period III|Death|0
2545397|NCT01490125|8810345|P4|Period III|Death|1
2545398|NCT01490125|8810346|P3|Period III|Death|0
2545399|NCT01490125|8810347|P2|Period III|Death|0
2545400|NCT01490125|8810348|P1|Period III|Death|0
2545401|NCT01490125|8810343|P6|Period III|Adverse Event|0
2545402|NCT01490125|8810344|P5|Period III|Adverse Event|0
2545403|NCT01490125|8810345|P4|Period III|Adverse Event|1
2545404|NCT01490125|8810346|P3|Period III|Adverse Event|0
2545405|NCT01490125|8810347|P2|Period III|Adverse Event|1
2545406|NCT01490125|8810348|P1|Period III|Adverse Event|3
2545407|NCT01490125|8810343|P6|Period II|Withdrawal by Subject|0
2545408|NCT01490125|8810344|P5|Period II|Withdrawal by Subject|0
2545409|NCT01490125|8810345|P4|Period II|Withdrawal by Subject|0
2545410|NCT01490125|8810346|P3|Period II|Withdrawal by Subject|0
2545411|NCT01490125|8810347|P2|Period II|Withdrawal by Subject|0
2545412|NCT01490125|8810348|P1|Period II|Withdrawal by Subject|1
2545413|NCT01490125|8810343|P6|Period II|Lost to Follow-up|0
2545414|NCT01490125|8810344|P5|Period II|Lost to Follow-up|0
2545415|NCT01490125|8810345|P4|Period II|Lost to Follow-up|0
2545416|NCT01490125|8810346|P3|Period II|Lost to Follow-up|0
2545417|NCT01490125|8810347|P2|Period II|Lost to Follow-up|1
2545418|NCT01490125|8810348|P1|Period II|Lost to Follow-up|0
2545419|NCT01490125|8810343|P6|Period II|Protocol Violation|0
2545420|NCT01490125|8810344|P5|Period II|Protocol Violation|0
2545421|NCT01490125|8810345|P4|Period II|Protocol Violation|1
2545422|NCT01490125|8810346|P3|Period II|Protocol Violation|1
2545423|NCT01490125|8810347|P2|Period II|Protocol Violation|0
2545424|NCT01490125|8810348|P1|Period II|Protocol Violation|0
2545426|NCT01490125|8810344|P5|Period II|Adverse Event|4
2545427|NCT01490125|8810345|P4|Period II|Adverse Event|2
2545428|NCT01490125|8810346|P3|Period II|Adverse Event|2
2545429|NCT01490125|8810347|P2|Period II|Adverse Event|3
2545430|NCT01490125|8810348|P1|Period II|Adverse Event|2
2545431|NCT01490125|8810343|P6|Period I|Withdrawal by Subject|1
2545432|NCT01490125|8810344|P5|Period I|Withdrawal by Subject|2
2545433|NCT01490125|8810345|P4|Period I|Withdrawal by Subject|1
2545434|NCT01490125|8810346|P3|Period I|Withdrawal by Subject|2
2545435|NCT01490125|8810347|P2|Period I|Withdrawal by Subject|3
2545436|NCT01490125|8810348|P1|Period I|Withdrawal by Subject|1
2545437|NCT01490125|8810343|P6|Period I|Protocol Violation|0
2545438|NCT01490125|8810344|P5|Period I|Protocol Violation|0
2545439|NCT01490125|8810345|P4|Period I|Protocol Violation|1
2545440|NCT01490125|8810346|P3|Period I|Protocol Violation|1
2545441|NCT01490125|8810347|P2|Period I|Protocol Violation|1
2545442|NCT01490125|8810348|P1|Period I|Protocol Violation|1
2545443|NCT01490125|8810343|P6|Period I|Adverse Event|4
2545444|NCT01490125|8810344|P5|Period I|Adverse Event|2
2545445|NCT01490125|8810345|P4|Period I|Adverse Event|3
2545446|NCT01490125|8810346|P3|Period I|Adverse Event|1
2545447|NCT01490125|8810347|P2|Period I|Adverse Event|1
2545448|NCT01490125|8810348|P1|Period I|Adverse Event|4
2545449|NCT01490086|8810376|P5|Overall Study|Subject left hospital|0
2545450|NCT01490086|8810377|P4|Overall Study|Subject left hospital|1
2545451|NCT01490086|8810378|P3|Overall Study|Subject left hospital|0
2545452|NCT01490086|8810379|P2|Overall Study|Subject left hospital|1
2545453|NCT01490086|8810380|P1|Overall Study|Subject left hospital|0
2545454|NCT01490086|8810376|P5|Overall Study|Subject uncontrollable and abusive|0
2545455|NCT01490086|8810377|P4|Overall Study|Subject uncontrollable and abusive|0
2545456|NCT01490086|8810378|P3|Overall Study|Subject uncontrollable and abusive|0
2545457|NCT01490086|8810379|P2|Overall Study|Subject uncontrollable and abusive|1
2545458|NCT01490086|8810380|P1|Overall Study|Subject uncontrollable and abusive|0
2545459|NCT01490086|8810376|P5|Overall Study|Worsening of symptoms|0
2545460|NCT01490086|8810377|P4|Overall Study|Worsening of symptoms|1
2545461|NCT01490086|8810378|P3|Overall Study|Worsening of symptoms|0
2545462|NCT01490086|8810379|P2|Overall Study|Worsening of symptoms|1
2545463|NCT01490086|8810380|P1|Overall Study|Worsening of symptoms|0
2545464|NCT01490086|8810376|P5|Overall Study|Lack of Efficacy|8
2545465|NCT01490086|8810377|P4|Overall Study|Lack of Efficacy|0
2545466|NCT01490086|8810378|P3|Overall Study|Lack of Efficacy|1
2545467|NCT01490086|8810379|P2|Overall Study|Lack of Efficacy|3
2545468|NCT01490086|8810380|P1|Overall Study|Lack of Efficacy|0
2545469|NCT01490086|8810376|P5|Overall Study|Adverse Event|0
2545470|NCT01490086|8810377|P4|Overall Study|Adverse Event|2
2545471|NCT01490086|8810378|P3|Overall Study|Adverse Event|1
2545472|NCT01490086|8810379|P2|Overall Study|Adverse Event|0
2545473|NCT01490086|8810380|P1|Overall Study|Adverse Event|0
2545474|NCT01490086|8810376|P5|Overall Study|Physician Decision|1
2545475|NCT01490086|8810377|P4|Overall Study|Physician Decision|3
2545476|NCT01490086|8810378|P3|Overall Study|Physician Decision|2
2545477|NCT01490086|8810379|P2|Overall Study|Physician Decision|4
2545478|NCT01490086|8810380|P1|Overall Study|Physician Decision|3
2545479|NCT01490086|8810376|P5|Overall Study|Lost to Follow-up|1
2545480|NCT01490086|8810377|P4|Overall Study|Lost to Follow-up|0
2545481|NCT01490086|8810378|P3|Overall Study|Lost to Follow-up|0
2545482|NCT01490086|8810379|P2|Overall Study|Lost to Follow-up|0
2545483|NCT01490086|8810380|P1|Overall Study|Lost to Follow-up|0
2545484|NCT01490086|8810376|P5|Overall Study|Abnormal laboratory findings|0
2545485|NCT01490086|8810377|P4|Overall Study|Abnormal laboratory findings|0
2545486|NCT01490086|8810378|P3|Overall Study|Abnormal laboratory findings|0
2545487|NCT01490086|8810379|P2|Overall Study|Abnormal laboratory findings|0
2545488|NCT01490086|8810380|P1|Overall Study|Abnormal laboratory findings|1
2545489|NCT01490086|8810376|P5|Overall Study|Non-compliance|0
2545490|NCT01490086|8810377|P4|Overall Study|Non-compliance|0
2545491|NCT01490086|8810378|P3|Overall Study|Non-compliance|0
2545492|NCT01490086|8810379|P2|Overall Study|Non-compliance|1
2545493|NCT01490086|8810380|P1|Overall Study|Non-compliance|0
2545494|NCT01490086|8810376|P5|Overall Study|Consent withdrawn|1
2545495|NCT01490086|8810377|P4|Overall Study|Consent withdrawn|0
2545496|NCT01490086|8810378|P3|Overall Study|Consent withdrawn|3
2545497|NCT01490086|8810379|P2|Overall Study|Consent withdrawn|4
2545498|NCT01490086|8810380|P1|Overall Study|Consent withdrawn|4
2545499|NCT01490060|8810425|P4|Cycle 2|Adverse Event Related to Chemotherapy|0
2545500|NCT01490060|8810426|P3|Cycle 2|Adverse Event Related to Chemotherapy|0
2545501|NCT01490060|8810427|P2|Cycle 2|Adverse Event Related to Chemotherapy|0
2545502|NCT01490060|8810428|P1|Cycle 2|Adverse Event Related to Chemotherapy|1
2545503|NCT01490060|8810425|P4|Cycle 2|Non-Compliance|0
2545504|NCT01490060|8810426|P3|Cycle 2|Non-Compliance|1
2545505|NCT01490060|8810427|P2|Cycle 2|Non-Compliance|0
2545506|NCT01490060|8810428|P1|Cycle 2|Non-Compliance|0
2545507|NCT01490060|8810425|P4|Cycle 2|Change of Treatment|0
2545508|NCT01490060|8810426|P3|Cycle 2|Change of Treatment|0
2545509|NCT01490060|8810427|P2|Cycle 2|Change of Treatment|1
2545510|NCT01490060|8810428|P1|Cycle 2|Change of Treatment|1
2545511|NCT01490060|8810425|P4|Cycle 1|Treatment at Another Facility|1
2545512|NCT01490060|8810426|P3|Cycle 1|Treatment at Another Facility|0
2545513|NCT01490060|8810427|P2|Cycle 1|Treatment at Another Facility|0
2545514|NCT01490060|8810428|P1|Cycle 1|Treatment at Another Facility|0
2545515|NCT01490060|8810425|P4|Cycle 1|Withdrawal by Subject|1
2545516|NCT01490060|8810426|P3|Cycle 1|Withdrawal by Subject|0
2545517|NCT01490060|8810427|P2|Cycle 1|Withdrawal by Subject|0
2545518|NCT01490060|8810428|P1|Cycle 1|Withdrawal by Subject|0
2545519|NCT01490060|8810425|P4|Cycle 1|Insurance Denied|0
2545520|NCT01490060|8810426|P3|Cycle 1|Insurance Denied|2
2545521|NCT01490060|8810427|P2|Cycle 1|Insurance Denied|0
2545522|NCT01490060|8810428|P1|Cycle 1|Insurance Denied|0
2545523|NCT01490060|8810425|P4|Cycle 1|Change of Treatment|1
2545524|NCT01490060|8810426|P3|Cycle 1|Change of Treatment|1
2545525|NCT01490060|8810427|P2|Cycle 1|Change of Treatment|1
2545526|NCT01490060|8810428|P1|Cycle 1|Change of Treatment|0
2545527|NCT01489956|8810457|P3|Overall Study|Withdrawal by Subject|1
2545528|NCT01489956|8810458|P2|Overall Study|Withdrawal by Subject|0
2545529|NCT01489956|8810459|P1|Overall Study|Withdrawal by Subject|0
2545530|NCT01489956|8810457|P3|Overall Study|Lost to Follow-up|0
2545531|NCT01489956|8810458|P2|Overall Study|Lost to Follow-up|0
2545532|NCT01489956|8810459|P1|Overall Study|Lost to Follow-up|1
2545533|NCT01489891|8810496|P2|Overall Study|Endoscopy failure|0
2545534|NCT01489891|8810497|P1|Overall Study|Endoscopy failure|1
2545535|NCT01489527|8810652|P2|Overall Study|Not compliant|0
2545536|NCT01489527|8810653|P1|Overall Study|Not compliant|1
2545537|NCT01489527|8810652|P2|Overall Study|Procedures|0
2545538|NCT01489527|8810653|P1|Overall Study|Procedures|1
2545539|NCT01489527|8810652|P2|Overall Study|Lost to Follow-up|1
2545540|NCT01489527|8810653|P1|Overall Study|Lost to Follow-up|5
2545541|NCT01489527|8810652|P2|Overall Study|Withdrawal by Subject|4
2545542|NCT01489527|8810653|P1|Overall Study|Withdrawal by Subject|0
2545543|NCT01489527|8810652|P2|Overall Study|Participant moved|7
2545544|NCT01489527|8810653|P1|Overall Study|Participant moved|6
2545545|NCT01489527|8810652|P2|Overall Study|Pregnancy|14
2545546|NCT01489527|8810653|P1|Overall Study|Pregnancy|9
2545547|NCT01489358|8810670|P3|Overall Study|Lost to Follow-up|2
2545548|NCT01489358|8810671|P2|Overall Study|Lost to Follow-up|0
2545549|NCT01489358|8810672|P1|Overall Study|Lost to Follow-up|0
2545550|NCT01489254|8810722|P4|Open-label Extension Part|Other reasons for not completing study|5
2545551|NCT01489254|8810723|P3|Open-label Extension Part|Other reasons for not completing study|0
2545552|NCT01489254|8810724|P2|Open-label Extension Part|Other reasons for not completing study|0
2545553|NCT01489254|8810725|P1|Open-label Extension Part|Other reasons for not completing study|0
2545554|NCT01489254|8810722|P4|Open-label Extension Part|Lost to Follow-up|9
2545555|NCT01489254|8810723|P3|Open-label Extension Part|Lost to Follow-up|0
2545556|NCT01489254|8810724|P2|Open-label Extension Part|Lost to Follow-up|0
2545557|NCT01489254|8810725|P1|Open-label Extension Part|Lost to Follow-up|0
2545558|NCT01489254|8810722|P4|Open-label Extension Part|Protocol Violation|1
2545559|NCT01489254|8810723|P3|Open-label Extension Part|Protocol Violation|0
2545560|NCT01489254|8810724|P2|Open-label Extension Part|Protocol Violation|0
2545561|NCT01489254|8810725|P1|Open-label Extension Part|Protocol Violation|0
2545562|NCT01489254|8810722|P4|Open-label Extension Part|Withdrawal by Subject|30
2545563|NCT01489254|8810723|P3|Open-label Extension Part|Withdrawal by Subject|0
2545564|NCT01489254|8810724|P2|Open-label Extension Part|Withdrawal by Subject|0
2545565|NCT01489254|8810725|P1|Open-label Extension Part|Withdrawal by Subject|0
2545566|NCT01489254|8810722|P4|Open-label Extension Part|Pregnancy|3
2545567|NCT01489254|8810723|P3|Open-label Extension Part|Pregnancy|0
2545568|NCT01489254|8810724|P2|Open-label Extension Part|Pregnancy|0
2545569|NCT01489254|8810725|P1|Open-label Extension Part|Pregnancy|0
2545570|NCT01489254|8810722|P4|Open-label Extension Part|Adverse Event|10
2545571|NCT01489254|8810723|P3|Open-label Extension Part|Adverse Event|0
2545572|NCT01489254|8810724|P2|Open-label Extension Part|Adverse Event|0
2545573|NCT01489254|8810725|P1|Open-label Extension Part|Adverse Event|0
2545574|NCT01489254|8810722|P4|Double-blind Part|Other reasons for not completing study|0
2545575|NCT01489254|8810723|P3|Double-blind Part|Other reasons for not completing study|0
2545576|NCT01489254|8810724|P2|Double-blind Part|Other reasons for not completing study|6
2545577|NCT01489254|8810725|P1|Double-blind Part|Other reasons for not completing study|4
2545578|NCT01489254|8810722|P4|Double-blind Part|Lost to Follow-up|0
2545579|NCT01489254|8810723|P3|Double-blind Part|Lost to Follow-up|0
2545580|NCT01489254|8810724|P2|Double-blind Part|Lost to Follow-up|2
2545581|NCT01489254|8810725|P1|Double-blind Part|Lost to Follow-up|1
2545582|NCT01489254|8810722|P4|Double-blind Part|Withdrawal by Subject|0
2545583|NCT01489254|8810723|P3|Double-blind Part|Withdrawal by Subject|1
2545584|NCT01489254|8810724|P2|Double-blind Part|Withdrawal by Subject|20
2545585|NCT01489254|8810725|P1|Double-blind Part|Withdrawal by Subject|12
2545586|NCT01489254|8810722|P4|Double-blind Part|Pregnancy|0
2545587|NCT01489254|8810723|P3|Double-blind Part|Pregnancy|0
2545588|NCT01489254|8810724|P2|Double-blind Part|Pregnancy|3
2545589|NCT01489254|8810725|P1|Double-blind Part|Pregnancy|1
2545590|NCT01489254|8810722|P4|Double-blind Part|Adverse Event|0
2545591|NCT01489254|8810723|P3|Double-blind Part|Adverse Event|2
2545592|NCT01489254|8810724|P2|Double-blind Part|Adverse Event|2
2545593|NCT01489254|8810725|P1|Double-blind Part|Adverse Event|7
2545594|NCT01489189|8810736|P2|Overall Study|Missed Visit|4
2545595|NCT01489189|8810737|P1|Overall Study|Missed Visit|1
2545596|NCT01489189|8810736|P2|Overall Study|Death|8
2545597|NCT01489189|8810737|P1|Overall Study|Death|10
2545598|NCT01489189|8810736|P2|Overall Study|Withdrawal by Subject|23
2545599|NCT01489189|8810737|P1|Overall Study|Withdrawal by Subject|20
2545600|NCT01489111|8810762|P1|Overall Study|Withdrawal criterion|1
2545601|NCT01489020|8810783|P6|Overall Study|Concomitant disease|0
2545602|NCT01489020|8810784|P5|Overall Study|Concomitant disease|3
2545603|NCT01489020|8810785|P4|Overall Study|Concomitant disease|0
2545604|NCT01489020|8810786|P3|Overall Study|Concomitant disease|0
2545605|NCT01489020|8810787|P2|Overall Study|Concomitant disease|0
2545606|NCT01489020|8810788|P1|Overall Study|Concomitant disease|0
2545607|NCT01489020|8810783|P6|Overall Study|Adverse Event|0
2545608|NCT01489020|8810784|P5|Overall Study|Adverse Event|3
2545609|NCT01489020|8810785|P4|Overall Study|Adverse Event|0
2545610|NCT01489020|8810786|P3|Overall Study|Adverse Event|3
2545611|NCT01489020|8810787|P2|Overall Study|Adverse Event|0
2545612|NCT01489020|8810788|P1|Overall Study|Adverse Event|0
2545613|NCT01489020|8810783|P6|Overall Study|Withdrawal by Subject|0
2545614|NCT01489020|8810784|P5|Overall Study|Withdrawal by Subject|0
2545615|NCT01489020|8810785|P4|Overall Study|Withdrawal by Subject|0
2545616|NCT01489020|8810786|P3|Overall Study|Withdrawal by Subject|0
2545617|NCT01489020|8810787|P2|Overall Study|Withdrawal by Subject|0
2545618|NCT01489020|8810788|P1|Overall Study|Withdrawal by Subject|1
2545619|NCT01488994|8810822|P2|Overall Study|Withdrawal by Subject|1
2545620|NCT01488994|8810823|P1|Overall Study|Withdrawal by Subject|0
2545621|NCT01488890|8810914|P4|Overall Study|Withdrawal by Subject|2
2545622|NCT01488890|8810915|P3|Overall Study|Withdrawal by Subject|11
2545623|NCT01488890|8810916|P2|Overall Study|Withdrawal by Subject|10
2545624|NCT01488890|8810917|P1|Overall Study|Withdrawal by Subject|14
2545625|NCT01488890|8810914|P4|Overall Study|Lost to Follow-up|3
2545626|NCT01488890|8810915|P3|Overall Study|Lost to Follow-up|20
2545627|NCT01488890|8810916|P2|Overall Study|Lost to Follow-up|10
2545628|NCT01488890|8810917|P1|Overall Study|Lost to Follow-up|13
2545629|NCT01488890|8810914|P4|Overall Study|Protocol Violation|0
2545630|NCT01488890|8810915|P3|Overall Study|Protocol Violation|4
2545631|NCT01488890|8810916|P2|Overall Study|Protocol Violation|0
2545632|NCT01488890|8810917|P1|Overall Study|Protocol Violation|3
2545633|NCT01488890|8810914|P4|Overall Study|Serious adverse event|0
2545634|NCT01488890|8810915|P3|Overall Study|Serious adverse event|0
2545635|NCT01488890|8810916|P2|Overall Study|Serious adverse event|0
2545636|NCT01488890|8810917|P1|Overall Study|Serious adverse event|2
2545637|NCT01488578|8810995|P1|Overall Study|Protocol Violation|1836
2545638|NCT01488487|8811029|P1|Overall Study|Withdrawal by Subject|2
2545639|NCT01488487|8811029|P1|Overall Study|Death|1
2545640|NCT01488487|8811029|P1|Overall Study|Adverse Event|6
2545641|NCT01488448|8811038|P2|Overall Study|Protocol Violation|3
2545642|NCT01488448|8811039|P1|Overall Study|Protocol Violation|4
2545643|NCT01488448|8811038|P2|Overall Study|Physician Decision|9
2545644|NCT01488448|8811039|P1|Overall Study|Physician Decision|4
2545645|NCT01488448|8811038|P2|Overall Study|Adverse Event|4
2545646|NCT01488448|8811039|P1|Overall Study|Adverse Event|9
2545647|NCT01488448|8811038|P2|Overall Study|Withdrawal by Subject|1
2545648|NCT01488448|8811039|P1|Overall Study|Withdrawal by Subject|3
2545649|NCT01488370|8811081|P3|Overall Study|Protocol Violation|1
2545650|NCT01488370|8811082|P2|Overall Study|Protocol Violation|1
2545651|NCT01488370|8811083|P1|Overall Study|Protocol Violation|0
2545652|NCT01488097|8811142|P1|Overall Study|Lost to Follow-up|1
2545653|NCT01488071|8811155|P2|Overall Study|Administrative or Other Reason(s)|4
2545654|NCT01488071|8811156|P1|Overall Study|Administrative or Other Reason(s)|5
2545655|NCT01488071|8811155|P2|Overall Study|Lost to Follow-up|0
2545656|NCT01488071|8811156|P1|Overall Study|Lost to Follow-up|1
2545657|NCT01488071|8811155|P2|Overall Study|Withdrawal of Consent|12
2545658|NCT01488071|8811156|P1|Overall Study|Withdrawal of Consent|14
2545659|NCT01488071|8811155|P2|Overall Study|Protocol Violation|7
2545660|NCT01488071|8811156|P1|Overall Study|Protocol Violation|5
2545661|NCT01488071|8811155|P2|Overall Study|Non-compliance with study drug|0
2545662|NCT01488071|8811156|P1|Overall Study|Non-compliance with study drug|2
2545663|NCT01488071|8811155|P2|Overall Study|Lack of Efficacy|17
2545664|NCT01488071|8811156|P1|Overall Study|Lack of Efficacy|11
2545665|NCT01488071|8811155|P2|Overall Study|Adverse Event|23
2545666|NCT01488071|8811156|P1|Overall Study|Adverse Event|15
2545667|NCT01487863|8811236|P2|Overall Study|Death|19
2545668|NCT01487863|8811237|P1|Overall Study|Death|19
2545669|NCT01487577|8811254|P1|Overall Study|Became ineligible after signing consent|1
2545670|NCT01487525|8811268|P2|Overall Study|Withdrawal by Subject|1
2545671|NCT01487525|8811269|P1|Overall Study|Withdrawal by Subject|0
2545672|NCT01487265|8811285|P1|Overall Study|Still on Treatment|1
2545673|NCT01487265|8811285|P1|Overall Study|Death|2
2545674|NCT01487265|8811285|P1|Overall Study|Disease Progression|21
2545675|NCT01487265|8811285|P1|Overall Study|Withdrawal by Subject|5
2545676|NCT01487265|8811285|P1|Overall Study|Adverse Event|8
2545677|NCT01487200|8811297|P4|Overall Study|Withdrawal by Subject|0
2545678|NCT01487200|8811298|P3|Overall Study|Withdrawal by Subject|0
2545679|NCT01487200|8811299|P2|Overall Study|Withdrawal by Subject|1
2545680|NCT01487200|8811300|P1|Overall Study|Withdrawal by Subject|0
2545681|NCT01487161|8811330|P4|Overall Study|missing data|0
2545682|NCT01487161|8811331|P3|Overall Study|missing data|0
2545683|NCT01487161|8811332|P2|Overall Study|missing data|1
2545684|NCT01487161|8811333|P1|Overall Study|missing data|0
2545685|NCT01487161|8811330|P4|Overall Study|Withdrawal by Subject|2
2545686|NCT01487161|8811331|P3|Overall Study|Withdrawal by Subject|1
2545687|NCT01487161|8811332|P2|Overall Study|Withdrawal by Subject|1
2545688|NCT01487161|8811333|P1|Overall Study|Withdrawal by Subject|1
2545689|NCT01487161|8811330|P4|Overall Study|Adverse Event|0
2545690|NCT01487161|8811331|P3|Overall Study|Adverse Event|0
2545691|NCT01487161|8811332|P2|Overall Study|Adverse Event|0
2545692|NCT01487161|8811333|P1|Overall Study|Adverse Event|1
2545693|NCT01486966|8811398|P2|Overall Study|Withdrawal by Subject|1
2545694|NCT01486966|8811399|P1|Overall Study|Withdrawal by Subject|0
2545695|NCT01486966|8811398|P2|Overall Study|Adverse Event|1
2545696|NCT01486966|8811399|P1|Overall Study|Adverse Event|0
2545697|NCT01486927|8811423|P1|Overall Study|Subject did not reach 6 mo of treatment|1
2545698|NCT01486927|8811423|P1|Overall Study|Withdrawal by Subject|8
2545699|NCT01486927|8811423|P1|Overall Study|50 Exposure days not reached|2
2545700|NCT01486927|8811423|P1|Overall Study|Physician Decision|1
2545701|NCT01486927|8811423|P1|Overall Study|Knee surgery (prior to surgery substudy)|1
2545702|NCT01486758|8811461|P2|Overall Study|Lost to Follow-up|1
2545703|NCT01486758|8811462|P1|Overall Study|Lost to Follow-up|0
2545704|NCT01486446|8811529|P2|Overall Study|Adverse Event|0
2545705|NCT01486446|8811530|P1|Overall Study|Adverse Event|1
2545706|NCT01486316|8811553|P4|Overall Study|Death|0
2545707|NCT01486316|8811554|P3|Overall Study|Death|0
2545708|NCT01486316|8811555|P2|Overall Study|Death|1
2545709|NCT01486316|8811556|P1|Overall Study|Death|0
2545710|NCT01486316|8811553|P4|Overall Study|Physician Decision|0
2545711|NCT01486316|8811554|P3|Overall Study|Physician Decision|1
2545712|NCT01486316|8811555|P2|Overall Study|Physician Decision|0
2545713|NCT01486316|8811556|P1|Overall Study|Physician Decision|0
2545714|NCT01486316|8811553|P4|Overall Study|Withdrawal by Subject|0
2545715|NCT01486316|8811554|P3|Overall Study|Withdrawal by Subject|3
2545716|NCT01486316|8811555|P2|Overall Study|Withdrawal by Subject|0
2545717|NCT01486316|8811556|P1|Overall Study|Withdrawal by Subject|1
2545718|NCT01486316|8811553|P4|Overall Study|Not meeting eligibility criteria|0
2545719|NCT01486316|8811554|P3|Overall Study|Not meeting eligibility criteria|1
2545720|NCT01486316|8811555|P2|Overall Study|Not meeting eligibility criteria|0
2545721|NCT01486316|8811556|P1|Overall Study|Not meeting eligibility criteria|0
2545722|NCT01486316|8811553|P4|Overall Study|Device explanted with/without re-implant|2
2545723|NCT01486316|8811554|P3|Overall Study|Device explanted with/without re-implant|0
2545724|NCT01486316|8811555|P2|Overall Study|Device explanted with/without re-implant|2
2545725|NCT01486316|8811556|P1|Overall Study|Device explanted with/without re-implant|3
2545726|NCT01486264|8811568|P2|Overall Study|Not treated|1
2545727|NCT01486264|8811569|P1|Overall Study|Not treated|0
2545728|NCT01486264|8811568|P2|Overall Study|Other|11
2545729|NCT01486264|8811569|P1|Overall Study|Other|5
2545730|NCT01486264|8811568|P2|Overall Study|Lost to Follow-up|2
2545731|NCT01486264|8811569|P1|Overall Study|Lost to Follow-up|3
2545732|NCT01486264|8811568|P2|Overall Study|Protocol Violation|0
2545733|NCT01486264|8811569|P1|Overall Study|Protocol Violation|3
2545734|NCT01486264|8811568|P2|Overall Study|Physician Decision|1
2545735|NCT01486264|8811569|P1|Overall Study|Physician Decision|1
2545736|NCT01486264|8811568|P2|Overall Study|Withdrawal by Subject|18
2545737|NCT01486264|8811569|P1|Overall Study|Withdrawal by Subject|7
2545738|NCT01486264|8811568|P2|Overall Study|Lack of Efficacy|10
2545739|NCT01486264|8811569|P1|Overall Study|Lack of Efficacy|6
2545740|NCT01486264|8811568|P2|Overall Study|Adverse Event|3
2545741|NCT01486264|8811569|P1|Overall Study|Adverse Event|3
2545742|NCT01486264|8811568|P2|Overall Study|Death|1
2545743|NCT01486264|8811569|P1|Overall Study|Death|1
2545744|NCT01486238|8811601|P2|Overall Study|Lost to Follow-up|3
2545745|NCT01486238|8811602|P1|Overall Study|Lost to Follow-up|0
2545746|NCT01486238|8811601|P2|Overall Study|Withdrawal by Subject|1
2545747|NCT01486238|8811602|P1|Overall Study|Withdrawal by Subject|2
2545748|NCT01486238|8811601|P2|Overall Study|Death|2
2545749|NCT01486238|8811602|P1|Overall Study|Death|0
2545750|NCT01486199|8811610|P2|Two Year Period Between Study Days|Physician Decision|0
2545751|NCT01486199|8811611|P1|Two Year Period Between Study Days|Physician Decision|1
2545752|NCT01485991|8811631|P2|Overall Study|randomized but not treated|2
2545753|NCT01485991|8811632|P1|Overall Study|randomized but not treated|6
2545754|NCT01485991|8811631|P2|Overall Study|Withdrawal by Subject|20
2545755|NCT01485991|8811632|P1|Overall Study|Withdrawal by Subject|13
2545756|NCT01485991|8811631|P2|Overall Study|Lost to Follow-up|10
2545757|NCT01485991|8811632|P1|Overall Study|Lost to Follow-up|13
2545758|NCT01485991|8811631|P2|Overall Study|Adverse Event|4
2545759|NCT01485991|8811632|P1|Overall Study|Adverse Event|0
2545760|NCT01485887|8811642|P1|Overall Study|Primary disease markedly improved|1
2545761|NCT01485887|8811642|P1|Overall Study|Deterioration of primary disease|1
2545762|NCT01485887|8811642|P1|Overall Study|Adverse Event|8
2545763|NCT01485887|8811642|P1|Overall Study|Withdrawal by Subject|2
2545764|NCT01485796|8811654|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2
2545765|NCT01485796|8811654|P1|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3
2545766|NCT01485796|8811654|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6
2545767|NCT01485796|8811654|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1
2545768|NCT01485796|8811654|P1|Period 2: Epoch 2|Switch to safety follow-up|26
2545769|NCT01485796|8811654|P1|Period 2: Epoch 2|Adverse Event|3
2545770|NCT01485796|8811654|P1|Period 2: Epoch 2|Withdrawal by Subject|6
2545771|NCT01485796|8811654|P1|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1
2545772|NCT01485640|8811676|P1|Overall Study|Terminated by Sponsor|95
2545773|NCT01485640|8811676|P1|Overall Study|Withdrawal by Subject|14
2545774|NCT01485640|8811676|P1|Overall Study|Protocol Violation|1
2545775|NCT01485640|8811676|P1|Overall Study|Lack of Efficacy|2
2545776|NCT01485640|8811676|P1|Overall Study|Adverse Event|10
2545777|NCT01485627|8811683|P2|Overall Study|caregiver was not bereaved|35
2545778|NCT01485627|8811684|P1|Overall Study|caregiver was not bereaved|42
2545779|NCT01485627|8811683|P2|Overall Study|Caregiver died|0
2545780|NCT01485627|8811684|P1|Overall Study|Caregiver died|1
2545781|NCT01485627|8811683|P2|Overall Study|Caregiver lost to follow up|12
2545782|NCT01485627|8811684|P1|Overall Study|Caregiver lost to follow up|11
2545783|NCT01485627|8811683|P2|Overall Study|Caregiver withdrew|3
2545784|NCT01485627|8811684|P1|Overall Study|Caregiver withdrew|3
2545785|NCT01485627|8811683|P2|Overall Study|Patient lost to followup|1
2545786|NCT01485627|8811684|P1|Overall Study|Patient lost to followup|0
2545787|NCT01485627|8811683|P2|Overall Study|Patient died|1
2545788|NCT01485627|8811684|P1|Overall Study|Patient died|3
2545789|NCT01485627|8811683|P2|Overall Study|Patient withdrew|5
2545790|NCT01485627|8811684|P1|Overall Study|Patient withdrew|6
2545791|NCT01485536|8811702|P1|Overall Study|Adverse Event|1
2545792|NCT01485536|8811702|P1|Overall Study|Withdrawal by Subject|3
2545793|NCT01485354|8811720|P1|Overall Study|Withdrawal by Subject|5
2545794|NCT01485172|8811734|P6|Overall Study|Withdrawal by Subject|1
2545795|NCT01485172|8811735|P5|Overall Study|Withdrawal by Subject|1
2545796|NCT01485172|8811736|P4|Overall Study|Withdrawal by Subject|1
2545797|NCT01485172|8811737|P3|Overall Study|Withdrawal by Subject|0
2545798|NCT01485172|8811738|P2|Overall Study|Withdrawal by Subject|0
2545799|NCT01485172|8811739|P1|Overall Study|Withdrawal by Subject|2
2545800|NCT01485172|8811734|P6|Overall Study|Physician Decision|0
2545801|NCT01485172|8811735|P5|Overall Study|Physician Decision|1
2545802|NCT01485172|8811736|P4|Overall Study|Physician Decision|0
2545803|NCT01485172|8811737|P3|Overall Study|Physician Decision|0
2545804|NCT01485172|8811738|P2|Overall Study|Physician Decision|0
2545805|NCT01485172|8811739|P1|Overall Study|Physician Decision|0
2545806|NCT01485172|8811734|P6|Overall Study|Lost to Follow-up|1
2545807|NCT01485172|8811735|P5|Overall Study|Lost to Follow-up|0
2545808|NCT01485172|8811736|P4|Overall Study|Lost to Follow-up|0
2545809|NCT01485172|8811737|P3|Overall Study|Lost to Follow-up|1
2545810|NCT01485172|8811738|P2|Overall Study|Lost to Follow-up|0
2545811|NCT01485172|8811739|P1|Overall Study|Lost to Follow-up|0
2545812|NCT01485172|8811734|P6|Overall Study|Protocol defined stopping criteria|0
2545813|NCT01485172|8811735|P5|Overall Study|Protocol defined stopping criteria|1
2545814|NCT01485172|8811736|P4|Overall Study|Protocol defined stopping criteria|0
2545815|NCT01485172|8811737|P3|Overall Study|Protocol defined stopping criteria|0
2545816|NCT01485172|8811738|P2|Overall Study|Protocol defined stopping criteria|0
2545817|NCT01485172|8811739|P1|Overall Study|Protocol defined stopping criteria|1
2545818|NCT01485172|8811734|P6|Overall Study|Protocol Violation|0
2545819|NCT01485172|8811735|P5|Overall Study|Protocol Violation|1
2545820|NCT01485172|8811736|P4|Overall Study|Protocol Violation|5
2545821|NCT01485172|8811737|P3|Overall Study|Protocol Violation|4
2545822|NCT01485172|8811738|P2|Overall Study|Protocol Violation|0
2545823|NCT01485172|8811739|P1|Overall Study|Protocol Violation|0
2545824|NCT01485172|8811734|P6|Overall Study|Lack of Efficacy|0
2545825|NCT01485172|8811735|P5|Overall Study|Lack of Efficacy|0
2545826|NCT01485172|8811736|P4|Overall Study|Lack of Efficacy|0
2545827|NCT01485172|8811737|P3|Overall Study|Lack of Efficacy|0
2545828|NCT01485172|8811738|P2|Overall Study|Lack of Efficacy|0
2545829|NCT01485172|8811739|P1|Overall Study|Lack of Efficacy|2
2545830|NCT01485172|8811734|P6|Overall Study|Adverse Event|2
2545831|NCT01485172|8811735|P5|Overall Study|Adverse Event|1
2545832|NCT01485172|8811736|P4|Overall Study|Adverse Event|2
2545833|NCT01485172|8811737|P3|Overall Study|Adverse Event|2
2545834|NCT01485172|8811738|P2|Overall Study|Adverse Event|1
2545835|NCT01485172|8811739|P1|Overall Study|Adverse Event|2
2545836|NCT01485120|8811813|P1|Overall Study|Withdrawal by Subject|2
2545837|NCT01485094|8811821|P3|Overall Study|Withdrawal by Subject|0
2545838|NCT01485094|8811822|P2|Overall Study|Withdrawal by Subject|1
2545839|NCT01485094|8811823|P1|Overall Study|Withdrawal by Subject|1
2545840|NCT01485094|8811821|P3|Overall Study|Lost to Follow-up|0
2545841|NCT01485094|8811822|P2|Overall Study|Lost to Follow-up|0
2545842|NCT01485094|8811823|P1|Overall Study|Lost to Follow-up|1
2545843|NCT01485094|8811821|P3|Overall Study|Adverse Event|1
2545844|NCT01485094|8811822|P2|Overall Study|Adverse Event|1
2545845|NCT01485094|8811823|P1|Overall Study|Adverse Event|1
2545846|NCT01484977|8811868|P1|Overall Study|Lack of Compliance|1
2545847|NCT01484977|8811868|P1|Overall Study|Low White Blood Cell Count|1
2545848|NCT01484977|8811868|P1|Overall Study|Moving Overseas|1
2545849|NCT01484977|8811868|P1|Overall Study|Subject Protocol Non-compliant|1
2545850|NCT01484977|8811868|P1|Overall Study|Withdrawal by Subject|4
2545851|NCT01484977|8811868|P1|Overall Study|Lost to Follow-up|1
2545852|NCT01484977|8811868|P1|Overall Study|Protocol Violation|6
2545853|NCT01484977|8811868|P1|Overall Study|Lack of Efficacy|4
2545854|NCT01484977|8811868|P1|Overall Study|Adverse Event|8
2545855|NCT01484951|8811872|P1|Overall Study|Non-Compliance|1
2545856|NCT01484951|8811872|P1|Overall Study|Personal Reasons|1
2545857|NCT01484951|8811872|P1|Overall Study|Adverse Event|3
2545858|NCT01484938|8811877|P1|Overall Study|Noncompliance|1
2545859|NCT01484938|8811877|P1|Overall Study|Lost to Follow-up|1
2545860|NCT01484938|8811877|P1|Overall Study|Adverse Event|2
2545861|NCT01484912|8811884|P2|Overall Study|Physician Decision|1
2545862|NCT01484912|8811885|P1|Overall Study|Physician Decision|0
2545863|NCT01484912|8811884|P2|Overall Study|Withdrawal by Subject|0
2545864|NCT01484912|8811885|P1|Overall Study|Withdrawal by Subject|1
2545865|NCT01484873|8811895|P1|Overall Study|Withdrawal by Subject|2
2545866|NCT01484834|8811907|P4|Overall Study|Lost to Follow-up|4
2545867|NCT01484834|8811908|P3|Overall Study|Lost to Follow-up|1
2545868|NCT01484834|8811909|P2|Overall Study|Lost to Follow-up|8
2545869|NCT01484834|8811910|P1|Overall Study|Lost to Follow-up|5
2545870|NCT01484561|8811951|P2|Overall Study|Adverse Event|4
2545871|NCT01484561|8811952|P1|Overall Study|Adverse Event|1
2545872|NCT01484561|8811951|P2|Overall Study|Other|1
2545873|NCT01484561|8811952|P1|Overall Study|Other|1
2545874|NCT01484561|8811951|P2|Overall Study|Withdrawal by Subject|0
2545875|NCT01484561|8811952|P1|Overall Study|Withdrawal by Subject|3
2545876|NCT01484561|8811951|P2|Overall Study|Lost to Follow-up|0
2545877|NCT01484561|8811952|P1|Overall Study|Lost to Follow-up|1
2545878|NCT01484561|8811951|P2|Overall Study|Lack of Efficacy|1
2545879|NCT01484561|8811952|P1|Overall Study|Lack of Efficacy|3
2545880|NCT01484496|8812042|P4|Period 2|Other|6
2545881|NCT01484496|8812043|P3|Period 2|Other|9
2545882|NCT01484496|8812044|P2|Period 2|Other|0
2545883|NCT01484496|8812045|P1|Period 2|Other|0
2545884|NCT01484496|8812042|P4|Period 2|Adverse Event|13
2545885|NCT01484496|8812043|P3|Period 2|Adverse Event|5
2545886|NCT01484496|8812044|P2|Period 2|Adverse Event|0
2545887|NCT01484496|8812045|P1|Period 2|Adverse Event|0
2545888|NCT01484496|8812042|P4|Period 2|Lack of Efficacy|3
2545889|NCT01484496|8812043|P3|Period 2|Lack of Efficacy|1
2545890|NCT01484496|8812044|P2|Period 2|Lack of Efficacy|0
2545891|NCT01484496|8812045|P1|Period 2|Lack of Efficacy|0
2545892|NCT01484496|8812042|P4|Period 1|Unable to Visit Site|0
2545893|NCT01484496|8812043|P3|Period 1|Unable to Visit Site|0
2545894|NCT01484496|8812044|P2|Period 1|Unable to Visit Site|2
2545895|NCT01484496|8812045|P1|Period 1|Unable to Visit Site|0
2545896|NCT01484496|8812042|P4|Period 1|Lack of Compliance|0
2545897|NCT01484496|8812043|P3|Period 1|Lack of Compliance|0
2545898|NCT01484496|8812044|P2|Period 1|Lack of Compliance|1
2545899|NCT01484496|8812045|P1|Period 1|Lack of Compliance|2
2545900|NCT01484496|8812042|P4|Period 1|Treatment Failure|0
2545901|NCT01484496|8812043|P3|Period 1|Treatment Failure|0
2545902|NCT01484496|8812044|P2|Period 1|Treatment Failure|6
2545903|NCT01484496|8812045|P1|Period 1|Treatment Failure|3
2545904|NCT01484496|8812042|P4|Period 1|Positive Pregnancy|0
2545905|NCT01484496|8812043|P3|Period 1|Positive Pregnancy|0
2545906|NCT01484496|8812044|P2|Period 1|Positive Pregnancy|6
2545907|NCT01484496|8812045|P1|Period 1|Positive Pregnancy|1
2545908|NCT01484496|8812042|P4|Period 1|Lost to Follow-up|0
2545909|NCT01484496|8812043|P3|Period 1|Lost to Follow-up|0
2545910|NCT01484496|8812044|P2|Period 1|Lost to Follow-up|6
2545911|NCT01484496|8812045|P1|Period 1|Lost to Follow-up|2
2545912|NCT01484496|8812042|P4|Period 1|Withdrawal by Subject|0
2545913|NCT01484496|8812043|P3|Period 1|Withdrawal by Subject|0
2545914|NCT01484496|8812044|P2|Period 1|Withdrawal by Subject|12
2545915|NCT01484496|8812045|P1|Period 1|Withdrawal by Subject|15
2545916|NCT01484496|8812042|P4|Period 1|Adverse Event|0
2545917|NCT01484496|8812043|P3|Period 1|Adverse Event|0
2545918|NCT01484496|8812044|P2|Period 1|Adverse Event|40
2545919|NCT01484496|8812045|P1|Period 1|Adverse Event|25
2545920|NCT01484496|8812042|P4|Period 1|Lack of Efficacy|0
2545921|NCT01484496|8812043|P3|Period 1|Lack of Efficacy|0
2545922|NCT01484496|8812044|P2|Period 1|Lack of Efficacy|15
2545923|NCT01484496|8812045|P1|Period 1|Lack of Efficacy|10
2545924|NCT01484496|8812042|P4|Period 1|Physician Decision|0
2545925|NCT01484496|8812043|P3|Period 1|Physician Decision|0
2545926|NCT01484496|8812044|P2|Period 1|Physician Decision|1
2545927|NCT01484496|8812045|P1|Period 1|Physician Decision|5
2545928|NCT01484496|8812042|P4|Period 1|Protocol Violation|0
2545929|NCT01484496|8812043|P3|Period 1|Protocol Violation|0
2545930|NCT01484496|8812044|P2|Period 1|Protocol Violation|4
2545931|NCT01484496|8812045|P1|Period 1|Protocol Violation|3
2545932|NCT01484431|8812060|P3|Period 2|Non-Compliance with Study Drug|0
2545933|NCT01484431|8812061|P2|Period 2|Non-Compliance with Study Drug|0
2545934|NCT01484431|8812062|P1|Period 2|Non-Compliance with Study Drug|1
2545935|NCT01484431|8812060|P3|Period 2|Physician Decision|1
2545936|NCT01484431|8812061|P2|Period 2|Physician Decision|0
2545937|NCT01484431|8812062|P1|Period 2|Physician Decision|0
2545938|NCT01484431|8812060|P3|Period 2|Death|1
2545939|NCT01484431|8812061|P2|Period 2|Death|1
2545940|NCT01484431|8812062|P1|Period 2|Death|0
2545941|NCT01484431|8812060|P3|Period 1: High Dose|Physician Decision|0
2545942|NCT01484431|8812061|P2|Period 1: High Dose|Physician Decision|1
2545943|NCT01484431|8812062|P1|Period 1: High Dose|Physician Decision|0
2545944|NCT01484275|8812100|P2|Overall Study|Lost to Follow-up|1
2545945|NCT01484275|8812101|P1|Overall Study|Lost to Follow-up|1
2545946|NCT01484275|8812100|P2|Overall Study|Withdrawal by Subject|5
2545947|NCT01484275|8812101|P1|Overall Study|Withdrawal by Subject|1
2545948|NCT01484275|8812100|P2|Overall Study|Death|4
2545949|NCT01484275|8812101|P1|Overall Study|Death|3
2545950|NCT01484275|8812100|P2|Overall Study|Other|0
2545951|NCT01484275|8812101|P1|Overall Study|Other|10
2545952|NCT01484275|8812100|P2|Overall Study|Study terminated by sponsor|32
2545953|NCT01484275|8812101|P1|Overall Study|Study terminated by sponsor|28
2545954|NCT01484197|8812123|P4|Treatment Period 2|Subject withdrew consent|1
2545955|NCT01484197|8812124|P3|Treatment Period 2|Subject withdrew consent|0
2545956|NCT01484197|8812125|P2|Treatment Period 2|Subject withdrew consent|0
2545957|NCT01484197|8812126|P1|Treatment Period 2|Subject withdrew consent|0
2545958|NCT01484197|8812123|P4|Treatment Period 1|Adverse Event|0
2545959|NCT01484197|8812124|P3|Treatment Period 1|Adverse Event|0
2545960|NCT01484197|8812125|P2|Treatment Period 1|Adverse Event|0
2545961|NCT01484197|8812126|P1|Treatment Period 1|Adverse Event|1
2545962|NCT01484132|8812209|P1|Overall Study|No post-treatment urine sample collected|10
2545963|NCT01484132|8812209|P1|Overall Study|No pre-treatment urine sample collected|1
2545964|NCT01484132|8812209|P1|Overall Study|Ineligible|1
2545965|NCT01484132|8812209|P1|Overall Study|Difficulty with time commitment|2
2545966|NCT01484132|8812209|P1|Overall Study|Lost to Follow-up|8
2545967|NCT01484054|8812217|P2|Period 1|Withdrawal by Subject|1
2545968|NCT01484054|8812218|P1|Period 1|Withdrawal by Subject|0
2545969|NCT01484028|8812236|P4|Period 1|Lens Discomfort|0
2545970|NCT01484028|8812237|P3|Period 1|Lens Discomfort|0
2545971|NCT01484028|8812238|P2|Period 1|Lens Discomfort|1
2545972|NCT01484028|8812239|P1|Period 1|Lens Discomfort|0
2545973|NCT01484028|8812236|P4|Period 1|Non-Compliance to Protocol|1
2545974|NCT01484028|8812237|P3|Period 1|Non-Compliance to Protocol|0
2545975|NCT01484028|8812238|P2|Period 1|Non-Compliance to Protocol|1
2545976|NCT01484028|8812239|P1|Period 1|Non-Compliance to Protocol|0
2545977|NCT01484028|8812236|P4|Period 1|Lost to Follow-up|0
2545978|NCT01484028|8812237|P3|Period 1|Lost to Follow-up|0
2545979|NCT01484028|8812238|P2|Period 1|Lost to Follow-up|1
2545980|NCT01484028|8812239|P1|Period 1|Lost to Follow-up|0
2545981|NCT01483937|8812332|P2|Overall Study|Withdrawal by Subject|3
2545982|NCT01483937|8812333|P1|Overall Study|Withdrawal by Subject|4
2545983|NCT01483924|8812360|P5|Overall Study|Sponsor concern over ECG result|0
2545984|NCT01483924|8812361|P4|Overall Study|Sponsor concern over ECG result|1
2545985|NCT01483924|8812362|P3|Overall Study|Sponsor concern over ECG result|0
2545986|NCT01483924|8812363|P2|Overall Study|Sponsor concern over ECG result|0
2545987|NCT01483924|8812364|P1|Overall Study|Sponsor concern over ECG result|0
2545988|NCT01483924|8812360|P5|Overall Study|Non-compliance|1
2545989|NCT01483924|8812361|P4|Overall Study|Non-compliance|1
2545990|NCT01483924|8812362|P3|Overall Study|Non-compliance|0
2545991|NCT01483924|8812363|P2|Overall Study|Non-compliance|0
2545992|NCT01483924|8812364|P1|Overall Study|Non-compliance|0
2545993|NCT01483924|8812360|P5|Overall Study|Adverse Event|0
2545994|NCT01483924|8812361|P4|Overall Study|Adverse Event|1
2545995|NCT01483924|8812362|P3|Overall Study|Adverse Event|1
2545996|NCT01483924|8812363|P2|Overall Study|Adverse Event|0
2545997|NCT01483924|8812364|P1|Overall Study|Adverse Event|0
2545998|NCT01483924|8812360|P5|Overall Study|Withdrawal by Subject|1
2545999|NCT01483924|8812361|P4|Overall Study|Withdrawal by Subject|1
2546000|NCT01483924|8812362|P3|Overall Study|Withdrawal by Subject|0
2546001|NCT01483924|8812363|P2|Overall Study|Withdrawal by Subject|0
2546002|NCT01483924|8812364|P1|Overall Study|Withdrawal by Subject|2
2546003|NCT01483820|8812417|P1|Overall Study|Death|1
2546004|NCT01483820|8812417|P1|Overall Study|Adverse Event|1
2546005|NCT01483820|8812417|P1|Overall Study|Lack of Efficacy|6
2546006|NCT01483651|8812438|P6|Overall Study|Withdrawal by Subject|1
2546007|NCT01483651|8812439|P5|Overall Study|Withdrawal by Subject|0
2546008|NCT01483651|8812440|P4|Overall Study|Withdrawal by Subject|0
2546009|NCT01483651|8812441|P3|Overall Study|Withdrawal by Subject|1
2546010|NCT01483651|8812442|P2|Overall Study|Withdrawal by Subject|1
2546011|NCT01483651|8812443|P1|Overall Study|Withdrawal by Subject|0
2546012|NCT01483625|8812453|P2|Overall Study|Due to other reason|0
2546013|NCT01483625|8812454|P1|Overall Study|Due to other reason|1
2546014|NCT01483625|8812453|P2|Overall Study|Refused to continue medication|1
2546015|NCT01483625|8812454|P1|Overall Study|Refused to continue medication|2
2546016|NCT01483625|8812453|P2|Overall Study|Adverse Event|1
2546017|NCT01483625|8812454|P1|Overall Study|Adverse Event|1
2546018|NCT01483599|8812477|P14|After Controlled Period(Week 16-Week 40)|Other|0
2546019|NCT01483599|8812478|P13|After Controlled Period(Week 16-Week 40)|Other|1
2546020|NCT01483599|8812479|P12|After Controlled Period(Week 16-Week 40)|Other|0
2546021|NCT01483599|8812480|P11|After Controlled Period(Week 16-Week 40)|Other|0
2546022|NCT01483599|8812481|P10|After Controlled Period(Week 16-Week 40)|Other|4
2546023|NCT01483599|8812482|P9|After Controlled Period(Week 16-Week 40)|Other|0
2546024|NCT01483599|8812483|P8|After Controlled Period(Week 16-Week 40)|Other|1
2546025|NCT01483599|8812484|P7|After Controlled Period(Week 16-Week 40)|Other|0
2546026|NCT01483599|8812485|P6|After Controlled Period(Week 16-Week 40)|Other|0
2546027|NCT01483599|8812486|P5|After Controlled Period(Week 16-Week 40)|Other|0
2546028|NCT01483599|8812487|P4|After Controlled Period(Week 16-Week 40)|Other|0
2546029|NCT01483599|8812488|P3|After Controlled Period(Week 16-Week 40)|Other|0
2546030|NCT01483599|8812489|P2|After Controlled Period(Week 16-Week 40)|Other|0
2546031|NCT01483599|8812490|P1|After Controlled Period(Week 16-Week 40)|Other|0
2546032|NCT01483599|8812477|P14|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4
2546033|NCT01483599|8812478|P13|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1
2546034|NCT01483599|8812479|P12|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2546035|NCT01483599|8812480|P11|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2546036|NCT01483599|8812481|P10|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2546037|NCT01483599|8812482|P9|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5
2546038|NCT01483599|8812483|P8|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2546039|NCT01483599|8812484|P7|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2546040|NCT01483599|8812485|P6|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2546041|NCT01483599|8812486|P5|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2546042|NCT01483599|8812487|P4|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2546043|NCT01483599|8812488|P3|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2546044|NCT01483599|8812489|P2|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2546045|NCT01483599|8812490|P1|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
2546046|NCT01483599|8812477|P14|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
2546047|NCT01483599|8812478|P13|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2546048|NCT01483599|8812479|P12|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2546049|NCT01483599|8812480|P11|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2
2546050|NCT01483599|8812481|P10|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2546051|NCT01483599|8812482|P9|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
2546052|NCT01483599|8812483|P8|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2546053|NCT01483599|8812484|P7|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2546054|NCT01483599|8812485|P6|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2546055|NCT01483599|8812486|P5|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2546056|NCT01483599|8812487|P4|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2546057|NCT01483599|8812488|P3|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2546058|NCT01483599|8812489|P2|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2546059|NCT01483599|8812490|P1|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
2546060|NCT01483599|8812477|P14|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
2546061|NCT01483599|8812478|P13|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2546062|NCT01483599|8812479|P12|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
2546063|NCT01483599|8812480|P11|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2546064|NCT01483599|8812481|P10|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2546065|NCT01483599|8812482|P9|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
2546066|NCT01483599|8812483|P8|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2546067|NCT01483599|8812484|P7|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2546068|NCT01483599|8812485|P6|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2546069|NCT01483599|8812486|P5|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2546070|NCT01483599|8812487|P4|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2546071|NCT01483599|8812488|P3|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2546072|NCT01483599|8812489|P2|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2546073|NCT01483599|8812490|P1|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
2546074|NCT01483599|8812477|P14|After Controlled Period(Week 16-Week 40)|Adverse Event|1
2546075|NCT01483599|8812478|P13|After Controlled Period(Week 16-Week 40)|Adverse Event|1
2546076|NCT01483599|8812479|P12|After Controlled Period(Week 16-Week 40)|Adverse Event|0
2546077|NCT01483599|8812480|P11|After Controlled Period(Week 16-Week 40)|Adverse Event|0
2546078|NCT01483599|8812481|P10|After Controlled Period(Week 16-Week 40)|Adverse Event|0
2546079|NCT01483599|8812482|P9|After Controlled Period(Week 16-Week 40)|Adverse Event|1
2546080|NCT01483599|8812483|P8|After Controlled Period(Week 16-Week 40)|Adverse Event|1
2546081|NCT01483599|8812484|P7|After Controlled Period(Week 16-Week 40)|Adverse Event|0
2546082|NCT01483599|8812485|P6|After Controlled Period(Week 16-Week 40)|Adverse Event|0
2546083|NCT01483599|8812486|P5|After Controlled Period(Week 16-Week 40)|Adverse Event|0
2546084|NCT01483599|8812487|P4|After Controlled Period(Week 16-Week 40)|Adverse Event|0
2546085|NCT01483599|8812488|P3|After Controlled Period(Week 16-Week 40)|Adverse Event|0
2546086|NCT01483599|8812489|P2|After Controlled Period(Week 16-Week 40)|Adverse Event|0
2546087|NCT01483599|8812490|P1|After Controlled Period(Week 16-Week 40)|Adverse Event|0
2546088|NCT01483599|8812477|P14|After Controlled Period(Week 16-Week 40)|Death|0
2546089|NCT01483599|8812478|P13|After Controlled Period(Week 16-Week 40)|Death|0
2546090|NCT01483599|8812479|P12|After Controlled Period(Week 16-Week 40)|Death|0
2546091|NCT01483599|8812480|P11|After Controlled Period(Week 16-Week 40)|Death|0
2546092|NCT01483599|8812481|P10|After Controlled Period(Week 16-Week 40)|Death|0
2546093|NCT01483599|8812482|P9|After Controlled Period(Week 16-Week 40)|Death|1
2546094|NCT01483599|8812483|P8|After Controlled Period(Week 16-Week 40)|Death|0
2546095|NCT01483599|8812484|P7|After Controlled Period(Week 16-Week 40)|Death|0
2546096|NCT01483599|8812485|P6|After Controlled Period(Week 16-Week 40)|Death|0
2546097|NCT01483599|8812486|P5|After Controlled Period(Week 16-Week 40)|Death|0
2546098|NCT01483599|8812487|P4|After Controlled Period(Week 16-Week 40)|Death|0
2546099|NCT01483599|8812488|P3|After Controlled Period(Week 16-Week 40)|Death|0
2546100|NCT01483599|8812489|P2|After Controlled Period(Week 16-Week 40)|Death|0
2546101|NCT01483599|8812490|P1|After Controlled Period(Week 16-Week 40)|Death|0
2546102|NCT01483599|8812477|P14|Controlled Period (CP) (up to Week 16)|Other|0
2546103|NCT01483599|8812478|P13|Controlled Period (CP) (up to Week 16)|Other|0
2546104|NCT01483599|8812479|P12|Controlled Period (CP) (up to Week 16)|Other|0
2546105|NCT01483599|8812480|P11|Controlled Period (CP) (up to Week 16)|Other|0
2546106|NCT01483599|8812481|P10|Controlled Period (CP) (up to Week 16)|Other|0
2546107|NCT01483599|8812482|P9|Controlled Period (CP) (up to Week 16)|Other|0
2546108|NCT01483599|8812483|P8|Controlled Period (CP) (up to Week 16)|Other|0
2546109|NCT01483599|8812484|P7|Controlled Period (CP) (up to Week 16)|Other|0
2546110|NCT01483599|8812485|P6|Controlled Period (CP) (up to Week 16)|Other|0
2546111|NCT01483599|8812486|P5|Controlled Period (CP) (up to Week 16)|Other|1
2546112|NCT01483599|8812487|P4|Controlled Period (CP) (up to Week 16)|Other|1
2546113|NCT01483599|8812488|P3|Controlled Period (CP) (up to Week 16)|Other|0
2546114|NCT01483599|8812489|P2|Controlled Period (CP) (up to Week 16)|Other|2
2546115|NCT01483599|8812490|P1|Controlled Period (CP) (up to Week 16)|Other|0
2546116|NCT01483599|8812477|P14|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2546117|NCT01483599|8812478|P13|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2546118|NCT01483599|8812479|P12|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2546119|NCT01483599|8812480|P11|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2546120|NCT01483599|8812481|P10|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2546121|NCT01483599|8812482|P9|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2546122|NCT01483599|8812483|P8|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2546123|NCT01483599|8812484|P7|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2546124|NCT01483599|8812485|P6|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2546125|NCT01483599|8812486|P5|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2546126|NCT01483599|8812487|P4|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2546127|NCT01483599|8812488|P3|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2546128|NCT01483599|8812489|P2|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
2546129|NCT01483599|8812490|P1|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1
2546130|NCT01483599|8812477|P14|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2546131|NCT01483599|8812478|P13|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2546132|NCT01483599|8812479|P12|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2546133|NCT01483599|8812480|P11|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2546134|NCT01483599|8812481|P10|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2546135|NCT01483599|8812482|P9|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2546136|NCT01483599|8812483|P8|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2546137|NCT01483599|8812484|P7|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
2546138|NCT01483599|8812485|P6|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2546139|NCT01483599|8812486|P5|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2546140|NCT01483599|8812487|P4|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
2546141|NCT01483599|8812488|P3|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2546142|NCT01483599|8812489|P2|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
2546143|NCT01483599|8812490|P1|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
2546144|NCT01483599|8812477|P14|Controlled Period (CP) (up to Week 16)|Adverse Event|0
2546145|NCT01483599|8812478|P13|Controlled Period (CP) (up to Week 16)|Adverse Event|0
2546146|NCT01483599|8812479|P12|Controlled Period (CP) (up to Week 16)|Adverse Event|0
2546147|NCT01483599|8812480|P11|Controlled Period (CP) (up to Week 16)|Adverse Event|0
2546148|NCT01483599|8812481|P10|Controlled Period (CP) (up to Week 16)|Adverse Event|0
2546149|NCT01483599|8812482|P9|Controlled Period (CP) (up to Week 16)|Adverse Event|0
2546150|NCT01483599|8812483|P8|Controlled Period (CP) (up to Week 16)|Adverse Event|0
2546151|NCT01483599|8812484|P7|Controlled Period (CP) (up to Week 16)|Adverse Event|3
2546152|NCT01483599|8812485|P6|Controlled Period (CP) (up to Week 16)|Adverse Event|4
2546153|NCT01483599|8812486|P5|Controlled Period (CP) (up to Week 16)|Adverse Event|1
2546154|NCT01483599|8812487|P4|Controlled Period (CP) (up to Week 16)|Adverse Event|1
2546155|NCT01483599|8812488|P3|Controlled Period (CP) (up to Week 16)|Adverse Event|0
2546156|NCT01483599|8812489|P2|Controlled Period (CP) (up to Week 16)|Adverse Event|0
2546157|NCT01483599|8812490|P1|Controlled Period (CP) (up to Week 16)|Adverse Event|2
2546158|NCT01483183|8812603|P10|Overall Study|Withdrawal by Subject|1
2546159|NCT01483183|8812604|P9|Overall Study|Withdrawal by Subject|0
2546160|NCT01483183|8812605|P8|Overall Study|Withdrawal by Subject|0
2546161|NCT01483183|8812606|P7|Overall Study|Withdrawal by Subject|0
2546162|NCT01483183|8812607|P6|Overall Study|Withdrawal by Subject|0
2546163|NCT01483183|8812608|P5|Overall Study|Withdrawal by Subject|0
2546164|NCT01483183|8812609|P4|Overall Study|Withdrawal by Subject|0
2546165|NCT01483183|8812610|P3|Overall Study|Withdrawal by Subject|0
2546166|NCT01483183|8812611|P2|Overall Study|Withdrawal by Subject|0
2546167|NCT01483183|8812612|P1|Overall Study|Withdrawal by Subject|0
2546168|NCT01483183|8812603|P10|Overall Study|Physician Decision|0
2546169|NCT01483183|8812604|P9|Overall Study|Physician Decision|0
2546170|NCT01483183|8812605|P8|Overall Study|Physician Decision|0
2546171|NCT01483183|8812606|P7|Overall Study|Physician Decision|2
2546172|NCT01483183|8812607|P6|Overall Study|Physician Decision|0
2546173|NCT01483183|8812608|P5|Overall Study|Physician Decision|0
2546174|NCT01483183|8812609|P4|Overall Study|Physician Decision|0
2546175|NCT01483183|8812610|P3|Overall Study|Physician Decision|0
2546176|NCT01483183|8812611|P2|Overall Study|Physician Decision|0
2546177|NCT01483183|8812612|P1|Overall Study|Physician Decision|0
2546178|NCT01483118|8812682|P2|Overall Study|Lost to Follow-up|16
2546179|NCT01483118|8812683|P1|Overall Study|Lost to Follow-up|12
2546180|NCT01482962|8812695|P2|Overall Study|Did not Receive Study Drug|6
2546181|NCT01482962|8812696|P1|Overall Study|Did not Receive Study Drug|1
2546182|NCT01482962|8812695|P2|Overall Study|Study Terminated by Sponsor|2
2546183|NCT01482962|8812696|P1|Overall Study|Study Terminated by Sponsor|5
2546184|NCT01482962|8812695|P2|Overall Study|Other Reason|5
2546185|NCT01482962|8812696|P1|Overall Study|Other Reason|1
2546186|NCT01482962|8812695|P2|Overall Study|Hematopoietic Stem Cell Transplant|9
2546187|NCT01482962|8812696|P1|Overall Study|Hematopoietic Stem Cell Transplant|3
2546188|NCT01482962|8812695|P2|Overall Study|Withdrawal by Participant|13
2546189|NCT01482962|8812696|P1|Overall Study|Withdrawal by Participant|8
2546190|NCT01482962|8812695|P2|Overall Study|Adverse Event|22
2546191|NCT01482962|8812696|P1|Overall Study|Adverse Event|18
2546192|NCT01482962|8812695|P2|Overall Study|Unsatisfactory Therapeutic Response|23
2546193|NCT01482962|8812696|P1|Overall Study|Unsatisfactory Therapeutic Response|37
2546194|NCT01482962|8812695|P2|Overall Study|Progressive Disease|53
2546195|NCT01482962|8812696|P1|Overall Study|Progressive Disease|65
2546196|NCT01482910|8812729|P2|Overall Study|Death|0
2546197|NCT01482910|8812730|P1|Overall Study|Death|1
2546198|NCT01482910|8812729|P2|Overall Study|Withdrawal by Subject|2
2546199|NCT01482910|8812730|P1|Overall Study|Withdrawal by Subject|7
2546200|NCT01482910|8812729|P2|Overall Study|Protocol Violation|1
2546201|NCT01482910|8812730|P1|Overall Study|Protocol Violation|1
2546202|NCT01482910|8812729|P2|Overall Study|Lost to Follow-up|1
2546203|NCT01482910|8812730|P1|Overall Study|Lost to Follow-up|0
2546204|NCT01482910|8812729|P2|Overall Study|Adverse Event|5
2546205|NCT01482910|8812730|P1|Overall Study|Adverse Event|6
2546206|NCT01482884|8812742|P2|Overall Study|Withdrawal by Subject|13
2546207|NCT01482884|8812743|P1|Overall Study|Withdrawal by Subject|8
2546208|NCT01482884|8812742|P2|Overall Study|Adverse Event|1
2546209|NCT01482884|8812743|P1|Overall Study|Adverse Event|2
2546210|NCT01482884|8812742|P2|Overall Study|Lack of Efficacy|1
2546211|NCT01482884|8812743|P1|Overall Study|Lack of Efficacy|0
2546212|NCT01482884|8812742|P2|Overall Study|Lost to Follow-up|2
2546213|NCT01482884|8812743|P1|Overall Study|Lost to Follow-up|2
2546214|NCT01482884|8812742|P2|Overall Study|Protocol Violation|0
2546215|NCT01482884|8812743|P1|Overall Study|Protocol Violation|1
2546216|NCT01482884|8812742|P2|Overall Study|Medical decision due to lack of efficacy|1
2546217|NCT01482884|8812743|P1|Overall Study|Medical decision due to lack of efficacy|0
2546218|NCT01482819|8812769|P1|Overall Study|Lost to Follow-up|2
2546219|NCT01482767|8812789|P2|Overall Study|Nurse error|0
2546220|NCT01482767|8812790|P1|Overall Study|Nurse error|1
2546221|NCT01482767|8812789|P2|Overall Study|Ineligible|5
2546222|NCT01482767|8812790|P1|Overall Study|Ineligible|0
2546223|NCT01482767|8812789|P2|Overall Study|Alternate HCV treatment|8
2546224|NCT01482767|8812790|P1|Overall Study|Alternate HCV treatment|7
2546225|NCT01482767|8812789|P2|Overall Study|Non-adherence to study requirements|7
2546226|NCT01482767|8812790|P1|Overall Study|Non-adherence to study requirements|4
2546227|NCT01482767|8812789|P2|Overall Study|Site closure|14
2546228|NCT01482767|8812790|P1|Overall Study|Site closure|22
2546229|NCT01482767|8812789|P2|Overall Study|Adverse Event|3
2546230|NCT01482767|8812790|P1|Overall Study|Adverse Event|0
2546231|NCT01482767|8812789|P2|Overall Study|Lost to Follow-up|6
2546232|NCT01482767|8812790|P1|Overall Study|Lost to Follow-up|12
2546233|NCT01482767|8812789|P2|Overall Study|Withdrawal by Subject|5
2546234|NCT01482767|8812790|P1|Overall Study|Withdrawal by Subject|7
2546235|NCT01482767|8812789|P2|Overall Study|Death|1
2546236|NCT01482767|8812790|P1|Overall Study|Death|1
2546237|NCT01482429|8812812|P2|Protocol|Protocol Violation|0
2546238|NCT01482429|8812813|P1|Protocol|Protocol Violation|275
2546239|NCT01482429|8812812|P2|Care Usual|Lost to Follow-up|1
2546240|NCT01482429|8812813|P1|Care Usual|Lost to Follow-up|0
2546241|NCT01482429|8812812|P2|Care Usual|Protocol Violation|172
2546242|NCT01482429|8812813|P1|Care Usual|Protocol Violation|0
2546243|NCT01482312|8812849|P3|Period 2, 90 Minutes of Wear|Other|0
2546244|NCT01482312|8812850|P2|Period 2, 90 Minutes of Wear|Other|0
2546245|NCT01482312|8812851|P1|Period 2, 90 Minutes of Wear|Other|1
2546246|NCT01482312|8812849|P3|Period 1, 90 Minutes of Wear|Other|0
2546247|NCT01482312|8812850|P2|Period 1, 90 Minutes of Wear|Other|0
2546248|NCT01482312|8812851|P1|Period 1, 90 Minutes of Wear|Other|1
2546249|NCT01482221|8812865|P3|Overall Study|Physician Decision|0
2546250|NCT01482221|8812866|P2|Overall Study|Physician Decision|1
2546251|NCT01482221|8812867|P1|Overall Study|Physician Decision|0
2546252|NCT01482221|8812865|P3|Overall Study|Incorrect randomization|0
2546253|NCT01482221|8812866|P2|Overall Study|Incorrect randomization|1
2546254|NCT01482221|8812867|P1|Overall Study|Incorrect randomization|0
2546255|NCT01482221|8812865|P3|Overall Study|Withdrawal by Subject|12
2546256|NCT01482221|8812866|P2|Overall Study|Withdrawal by Subject|7
2546257|NCT01482221|8812867|P1|Overall Study|Withdrawal by Subject|10
2546258|NCT01482221|8812865|P3|Overall Study|Adverse Event|3
2546259|NCT01482221|8812866|P2|Overall Study|Adverse Event|7
2546260|NCT01482221|8812867|P1|Overall Study|Adverse Event|1
2546261|NCT01482221|8812865|P3|Overall Study|Severe Non-Compliance to Protocol|1
2546262|NCT01482221|8812866|P2|Overall Study|Severe Non-Compliance to Protocol|0
2546263|NCT01482221|8812867|P1|Overall Study|Severe Non-Compliance to Protocol|1
2546264|NCT01482221|8812865|P3|Overall Study|Condition under Investigation Worsened|4
2546265|NCT01482221|8812866|P2|Overall Study|Condition under Investigation Worsened|2
2546266|NCT01482221|8812867|P1|Overall Study|Condition under Investigation Worsened|3
2546267|NCT01482221|8812865|P3|Overall Study|Study-Specific Withdrawal Criteria|1
2546268|NCT01482221|8812866|P2|Overall Study|Study-Specific Withdrawal Criteria|0
2546269|NCT01482221|8812867|P1|Overall Study|Study-Specific Withdrawal Criteria|2
2546270|NCT01482221|8812865|P3|Overall Study|Lost to Follow-up|1
2546271|NCT01482221|8812866|P2|Overall Study|Lost to Follow-up|2
2546272|NCT01482221|8812867|P1|Overall Study|Lost to Follow-up|3
2546273|NCT01482221|8812865|P3|Overall Study|Lack of Efficacy|1
2546274|NCT01482221|8812866|P2|Overall Study|Lack of Efficacy|0
2546275|NCT01482221|8812867|P1|Overall Study|Lack of Efficacy|1
2546276|NCT01482169|8812908|P1|Overall Study|Physician Decision|2
2546277|NCT01482065|8812950|P2|Overall Study|Withdrawal by Subject|1
2546278|NCT01482065|8812951|P1|Overall Study|Withdrawal by Subject|0
2546279|NCT01481896|8812972|P1|Overall Study|Lost to Follow-up|12
2546280|NCT01481779|8812988|P2|Overall Study|Sponsor Decision|1
2546281|NCT01481779|8812989|P1|Overall Study|Sponsor Decision|3
2546282|NCT01481779|8812988|P2|Overall Study|Physician Decision|4
2546283|NCT01481779|8812989|P1|Overall Study|Physician Decision|13
2546284|NCT01481779|8812988|P2|Overall Study|Withdrawal by Subject|13
2546285|NCT01481779|8812989|P1|Overall Study|Withdrawal by Subject|26
2546286|NCT01481779|8812988|P2|Overall Study|Protocol Violation|3
2546287|NCT01481779|8812989|P1|Overall Study|Protocol Violation|2
2546288|NCT01481779|8812988|P2|Overall Study|Lost to Follow-up|2
2546289|NCT01481779|8812989|P1|Overall Study|Lost to Follow-up|3
2546290|NCT01481779|8812988|P2|Overall Study|Adverse Event|5
2546291|NCT01481779|8812989|P1|Overall Study|Adverse Event|23
2546292|NCT01481324|8813074|P3|Overall Study|Missing Data|2
2546293|NCT01481324|8813075|P2|Overall Study|Missing Data|2
2546294|NCT01481324|8813076|P1|Overall Study|Missing Data|0
2546295|NCT01481116|8813095|P3|Overall Study|Hypoglycemic Event|0
2546296|NCT01481116|8813096|P2|Overall Study|Hypoglycemic Event|0
2546297|NCT01481116|8813097|P1|Overall Study|Hypoglycemic Event|4
2546298|NCT01481116|8813095|P3|Overall Study|Death|0
2546299|NCT01481116|8813096|P2|Overall Study|Death|1
2546300|NCT01481116|8813097|P1|Overall Study|Death|2
2546301|NCT01481116|8813095|P3|Overall Study|Investigator's Discretion|0
2546302|NCT01481116|8813096|P2|Overall Study|Investigator's Discretion|0
2546303|NCT01481116|8813097|P1|Overall Study|Investigator's Discretion|2
2546304|NCT01481116|8813095|P3|Overall Study|Non-Compliant With Study Drug|1
2546305|NCT01481116|8813096|P2|Overall Study|Non-Compliant With Study Drug|1
2546306|NCT01481116|8813097|P1|Overall Study|Non-Compliant With Study Drug|0
2546307|NCT01481116|8813095|P3|Overall Study|Sponsor Decision|3
2546308|NCT01481116|8813096|P2|Overall Study|Sponsor Decision|1
2546309|NCT01481116|8813097|P1|Overall Study|Sponsor Decision|0
2546310|NCT01481116|8813095|P3|Overall Study|Investigator Decision|1
2546311|NCT01481116|8813096|P2|Overall Study|Investigator Decision|2
2546312|NCT01481116|8813097|P1|Overall Study|Investigator Decision|3
2546313|NCT01481116|8813095|P3|Overall Study|Participant Moved Out of Country|1
2546314|NCT01481116|8813096|P2|Overall Study|Participant Moved Out of Country|0
2546315|NCT01481116|8813097|P1|Overall Study|Participant Moved Out of Country|1
2546316|NCT01481116|8813095|P3|Overall Study|Participant Moved Out of Area|1
2546317|NCT01481116|8813096|P2|Overall Study|Participant Moved Out of Area|0
2546318|NCT01481116|8813097|P1|Overall Study|Participant Moved Out of Area|2
2546319|NCT01481116|8813095|P3|Overall Study|Participant Started Taking Glipizide|0
2546320|NCT01481116|8813096|P2|Overall Study|Participant Started Taking Glipizide|0
2546321|NCT01481116|8813097|P1|Overall Study|Participant Started Taking Glipizide|1
2546322|NCT01481116|8813095|P3|Overall Study|Other|0
2546323|NCT01481116|8813096|P2|Overall Study|Other|1
2546324|NCT01481116|8813097|P1|Overall Study|Other|1
2546325|NCT01481116|8813095|P3|Overall Study|Contraindications|0
2546326|NCT01481116|8813096|P2|Overall Study|Contraindications|1
2546327|NCT01481116|8813097|P1|Overall Study|Contraindications|1
2546328|NCT01481116|8813095|P3|Overall Study|Lack of Efficacy|1
2546329|NCT01481116|8813096|P2|Overall Study|Lack of Efficacy|3
2546330|NCT01481116|8813097|P1|Overall Study|Lack of Efficacy|3
2546331|NCT01481116|8813095|P3|Overall Study|Pregnancy|1
2546332|NCT01481116|8813096|P2|Overall Study|Pregnancy|0
2546333|NCT01481116|8813097|P1|Overall Study|Pregnancy|0
2546334|NCT01481116|8813095|P3|Overall Study|Study Termination|713
2546335|NCT01481116|8813096|P2|Overall Study|Study Termination|729
2546336|NCT01481116|8813097|P1|Overall Study|Study Termination|730
2546337|NCT01481116|8813095|P3|Overall Study|Withdrawal by Subject|37
2546338|NCT01481116|8813096|P2|Overall Study|Withdrawal by Subject|33
2546339|NCT01481116|8813097|P1|Overall Study|Withdrawal by Subject|37
2546340|NCT01481116|8813095|P3|Overall Study|Lost to Follow-up|11
2546341|NCT01481116|8813096|P2|Overall Study|Lost to Follow-up|12
2546342|NCT01481116|8813097|P1|Overall Study|Lost to Follow-up|8
2546343|NCT01481116|8813095|P3|Overall Study|Major Protocol Deviation|1
2546344|NCT01481116|8813096|P2|Overall Study|Major Protocol Deviation|7
2546345|NCT01481116|8813097|P1|Overall Study|Major Protocol Deviation|3
2546346|NCT01481116|8813095|P3|Overall Study|Adverse Event|42
2546347|NCT01481116|8813096|P2|Overall Study|Adverse Event|26
2546348|NCT01481116|8813097|P1|Overall Study|Adverse Event|26
2546349|NCT01480674|8813128|P1|Overall Study|visit not done|10
2546350|NCT01480674|8813128|P1|Overall Study|Lost to Follow-up|2
2546351|NCT01480674|8813128|P1|Overall Study|Death|23
2546352|NCT01480596|8813142|P2|Overall Study|MG exacerbation or change in medication|2
2546353|NCT01480596|8813143|P1|Overall Study|MG exacerbation or change in medication|2
2546354|NCT01480596|8813142|P2|Overall Study|Adverse Event|0
2546355|NCT01480596|8813143|P1|Overall Study|Adverse Event|3
2546356|NCT01480284|8813191|P2|Overall Study|Physician Decision|0
2546357|NCT01480284|8813192|P1|Overall Study|Physician Decision|1
2546358|NCT01480284|8813191|P2|Overall Study|Lost to Follow-up|0
2546359|NCT01480284|8813192|P1|Overall Study|Lost to Follow-up|1
2546360|NCT01480284|8813191|P2|Overall Study|Study closed/terminated|0
2546361|NCT01480284|8813192|P1|Overall Study|Study closed/terminated|3
2546362|NCT01480284|8813191|P2|Overall Study|Adverse Event|0
2546363|NCT01480284|8813192|P1|Overall Study|Adverse Event|1
2546364|NCT01480284|8813191|P2|Overall Study|Withdrawal by Subject|0
2546365|NCT01480284|8813192|P1|Overall Study|Withdrawal by Subject|2
2546366|NCT01480258|8813222|P2|Interim Period|Withdrawal by Subject|6
2546367|NCT01480258|8813223|P1|Interim Period|Withdrawal by Subject|9
2546368|NCT01480258|8813222|P2|Interim Period|Protocol Violation|1
2546369|NCT01480258|8813223|P1|Interim Period|Protocol Violation|0
2546370|NCT01480258|8813222|P2|Interim Period|Physician Decision|0
2546371|NCT01480258|8813223|P1|Interim Period|Physician Decision|1
2546372|NCT01480258|8813222|P2|Interim Period|Lost to Follow-up|2
2546373|NCT01480258|8813223|P1|Interim Period|Lost to Follow-up|0
2546374|NCT01480258|8813222|P2|Infant Series|Withdrawal by Subject|6
2546375|NCT01480258|8813223|P1|Infant Series|Withdrawal by Subject|1
2546376|NCT01480258|8813222|P2|Infant Series|Adverse Event|1
2546377|NCT01480258|8813223|P1|Infant Series|Adverse Event|1
2546378|NCT01480258|8813222|P2|Infant Series|Not Vaccinated|0
2546379|NCT01480258|8813223|P1|Infant Series|Not Vaccinated|3
2546380|NCT01480258|8813222|P2|Infant Series|Physician Decision|1
2546381|NCT01480258|8813223|P1|Infant Series|Physician Decision|0
2546382|NCT01480258|8813222|P2|Infant Series|Protocol Violation|0
2546383|NCT01480258|8813223|P1|Infant Series|Protocol Violation|2
2546384|NCT01480180|8813289|P6|Extension Phase, Part 2|Unclassified|0
2546385|NCT01480180|8813290|P5|Extension Phase, Part 2|Unclassified|1
2546386|NCT01480180|8813291|P4|Extension Phase, Part 2|Unclassified|1
2546387|NCT01480180|8813292|P3|Extension Phase, Part 2|Unclassified|3
2546388|NCT01480180|8813293|P2|Extension Phase, Part 2|Unclassified|0
2546389|NCT01480180|8813294|P1|Extension Phase, Part 2|Unclassified|0
2546390|NCT01480180|8813289|P6|Extension Phase, Part 2|Lack of Efficacy|0
2546391|NCT01480180|8813290|P5|Extension Phase, Part 2|Lack of Efficacy|0
2546392|NCT01480180|8813291|P4|Extension Phase, Part 2|Lack of Efficacy|0
2546393|NCT01480180|8813292|P3|Extension Phase, Part 2|Lack of Efficacy|4
2546394|NCT01480180|8813293|P2|Extension Phase, Part 2|Lack of Efficacy|0
2546395|NCT01480180|8813294|P1|Extension Phase, Part 2|Lack of Efficacy|0
2546396|NCT01480180|8813289|P6|Extension Phase, Part 2|Withdrawal criteria|0
2546397|NCT01480180|8813290|P5|Extension Phase, Part 2|Withdrawal criteria|1
2546398|NCT01480180|8813291|P4|Extension Phase, Part 2|Withdrawal criteria|6
2546399|NCT01480180|8813292|P3|Extension Phase, Part 2|Withdrawal criteria|10
2546400|NCT01480180|8813293|P2|Extension Phase, Part 2|Withdrawal criteria|0
2546401|NCT01480180|8813294|P1|Extension Phase, Part 2|Withdrawal criteria|0
2546402|NCT01480180|8813289|P6|Extension Phase, Part 1|Change of treatment|0
2546403|NCT01480180|8813290|P5|Extension Phase, Part 1|Change of treatment|0
2546404|NCT01480180|8813291|P4|Extension Phase, Part 1|Change of treatment|9
2546405|NCT01480180|8813292|P3|Extension Phase, Part 1|Change of treatment|0
2546406|NCT01480180|8813293|P2|Extension Phase, Part 1|Change of treatment|0
2546407|NCT01480180|8813294|P1|Extension Phase, Part 1|Change of treatment|0
2546408|NCT01480180|8813289|P6|Extension Phase, Part 1|Adverse Event|0
2546409|NCT01480180|8813290|P5|Extension Phase, Part 1|Adverse Event|0
2546410|NCT01480180|8813291|P4|Extension Phase, Part 1|Adverse Event|1
2546411|NCT01480180|8813292|P3|Extension Phase, Part 1|Adverse Event|4
2546412|NCT01480180|8813293|P2|Extension Phase, Part 1|Adverse Event|0
2546413|NCT01480180|8813294|P1|Extension Phase, Part 1|Adverse Event|0
2546414|NCT01480180|8813289|P6|Extension Phase, Part 1|Unclassified|0
2546415|NCT01480180|8813290|P5|Extension Phase, Part 1|Unclassified|0
2546416|NCT01480180|8813291|P4|Extension Phase, Part 1|Unclassified|0
2546417|NCT01480180|8813292|P3|Extension Phase, Part 1|Unclassified|1
2546418|NCT01480180|8813293|P2|Extension Phase, Part 1|Unclassified|0
2546419|NCT01480180|8813294|P1|Extension Phase, Part 1|Unclassified|0
2546420|NCT01480180|8813289|P6|Extension Phase, Part 1|Withdrawal criteria|0
2546421|NCT01480180|8813290|P5|Extension Phase, Part 1|Withdrawal criteria|0
2546422|NCT01480180|8813291|P4|Extension Phase, Part 1|Withdrawal criteria|0
2546423|NCT01480180|8813292|P3|Extension Phase, Part 1|Withdrawal criteria|5
2546424|NCT01480180|8813293|P2|Extension Phase, Part 1|Withdrawal criteria|0
2546425|NCT01480180|8813294|P1|Extension Phase, Part 1|Withdrawal criteria|0
2546426|NCT01480180|8813289|P6|Main Phase|Unclassified|0
2546427|NCT01480180|8813290|P5|Main Phase|Unclassified|0
2546428|NCT01480180|8813291|P4|Main Phase|Unclassified|0
2546429|NCT01480180|8813292|P3|Main Phase|Unclassified|0
2546430|NCT01480180|8813293|P2|Main Phase|Unclassified|0
2546431|NCT01480180|8813294|P1|Main Phase|Unclassified|3
2546432|NCT01480180|8813289|P6|Main Phase|Non-compliance|0
2546433|NCT01480180|8813290|P5|Main Phase|Non-compliance|0
2546434|NCT01480180|8813291|P4|Main Phase|Non-compliance|0
2546435|NCT01480180|8813292|P3|Main Phase|Non-compliance|0
2546436|NCT01480180|8813293|P2|Main Phase|Non-compliance|0
2546437|NCT01480180|8813294|P1|Main Phase|Non-compliance|3
2546438|NCT01480180|8813289|P6|Main Phase|Lack of Efficacy|0
2546439|NCT01480180|8813290|P5|Main Phase|Lack of Efficacy|0
2546440|NCT01480180|8813291|P4|Main Phase|Lack of Efficacy|0
2546441|NCT01480180|8813292|P3|Main Phase|Lack of Efficacy|0
2546442|NCT01480180|8813293|P2|Main Phase|Lack of Efficacy|0
2546443|NCT01480180|8813294|P1|Main Phase|Lack of Efficacy|1
2546444|NCT01480180|8813289|P6|Main Phase|Withdrawal criteria|0
2546445|NCT01480180|8813290|P5|Main Phase|Withdrawal criteria|0
2546446|NCT01480180|8813291|P4|Main Phase|Withdrawal criteria|0
2546447|NCT01480180|8813292|P3|Main Phase|Withdrawal criteria|0
2546448|NCT01480180|8813293|P2|Main Phase|Withdrawal criteria|1
2546449|NCT01480180|8813294|P1|Main Phase|Withdrawal criteria|12
2546450|NCT01480076|8813462|P1|Overall Study|Other|52
2546451|NCT01480076|8813462|P1|Overall Study|Investigator Decision|13
2546452|NCT01480076|8813462|P1|Overall Study|Lost to Follow-up|7
2546453|NCT01480076|8813462|P1|Overall Study|Withdrawal by Subject|105
2546454|NCT01480076|8813462|P1|Overall Study|Non-compliance With Study Protocol|15
2546455|NCT01480076|8813462|P1|Overall Study|Disease Progression|5
2546456|NCT01480076|8813462|P1|Overall Study|Death|2
2546457|NCT01480076|8813462|P1|Overall Study|Adverse Event|39
2546458|NCT01480076|8813462|P1|Overall Study|Run-in Failure|52
2546459|NCT01479868|8813592|P1|Overall Study|Initiation of new HCV Therapy|1
2546460|NCT01479868|8813592|P1|Overall Study|Sponsor's Decision|1
2546461|NCT01479868|8813592|P1|Overall Study|Withdrawal by Subject|1
2546462|NCT01479868|8813592|P1|Overall Study|Protocol Violation|1
2546463|NCT01479868|8813592|P1|Overall Study|Lost to Follow-up|4
2546464|NCT01479868|8813592|P1|Overall Study|Adverse Event|1
2546465|NCT01479777|8813607|P1|Overall Study|Physician Decision|2
2546466|NCT01479764|8813619|P2|Treated|Lost to Follow-up|2
2546467|NCT01479764|8813620|P1|Treated|Lost to Follow-up|0
2546468|NCT01479764|8813619|P2|Randomized|Withdrawal by Subject|0
2546469|NCT01479764|8813620|P1|Randomized|Withdrawal by Subject|1
2546470|NCT01479764|8813619|P2|Randomized|Adverse Event|1
2546471|NCT01479764|8813620|P1|Randomized|Adverse Event|1
2546472|NCT01479621|8813643|P7|Treatment Period|Met stopping criteria|6
2546473|NCT01479621|8813644|P6|Treatment Period|Met stopping criteria|20
2546474|NCT01479621|8813645|P5|Treatment Period|Met stopping criteria|9
2546475|NCT01479621|8813646|P4|Treatment Period|Met stopping criteria|4
2546476|NCT01479621|8813647|P3|Treatment Period|Met stopping criteria|7
2546477|NCT01479621|8813648|P2|Treatment Period|Met stopping criteria|8
2546478|NCT01479621|8813649|P1|Treatment Period|Met stopping criteria|0
2546479|NCT01479621|8813643|P7|Treatment Period|Lost to Follow-up|1
2546480|NCT01479621|8813644|P6|Treatment Period|Lost to Follow-up|2
2546481|NCT01479621|8813645|P5|Treatment Period|Lost to Follow-up|2
2546482|NCT01479621|8813646|P4|Treatment Period|Lost to Follow-up|0
2546483|NCT01479621|8813647|P3|Treatment Period|Lost to Follow-up|1
2546484|NCT01479621|8813648|P2|Treatment Period|Lost to Follow-up|0
2546485|NCT01479621|8813649|P1|Treatment Period|Lost to Follow-up|0
2546486|NCT01479621|8813643|P7|Treatment Period|Sponsor request subject to be withdrawn|3
2546487|NCT01479621|8813644|P6|Treatment Period|Sponsor request subject to be withdrawn|1
2546488|NCT01479621|8813645|P5|Treatment Period|Sponsor request subject to be withdrawn|1
2546489|NCT01479621|8813646|P4|Treatment Period|Sponsor request subject to be withdrawn|1
2546490|NCT01479621|8813647|P3|Treatment Period|Sponsor request subject to be withdrawn|3
2546491|NCT01479621|8813648|P2|Treatment Period|Sponsor request subject to be withdrawn|2
2546492|NCT01479621|8813649|P1|Treatment Period|Sponsor request subject to be withdrawn|0
2546493|NCT01479621|8813643|P7|Treatment Period|Pregnancy|0
2546494|NCT01479621|8813644|P6|Treatment Period|Pregnancy|0
2546495|NCT01479621|8813645|P5|Treatment Period|Pregnancy|0
2546496|NCT01479621|8813646|P4|Treatment Period|Pregnancy|0
2546497|NCT01479621|8813647|P3|Treatment Period|Pregnancy|2
2546498|NCT01479621|8813648|P2|Treatment Period|Pregnancy|0
2546499|NCT01479621|8813649|P1|Treatment Period|Pregnancy|0
2546500|NCT01479621|8813643|P7|Treatment Period|Protocol Violation|6
2546501|NCT01479621|8813644|P6|Treatment Period|Protocol Violation|10
2546502|NCT01479621|8813645|P5|Treatment Period|Protocol Violation|2
2546503|NCT01479621|8813646|P4|Treatment Period|Protocol Violation|5
2546504|NCT01479621|8813647|P3|Treatment Period|Protocol Violation|6
2546505|NCT01479621|8813648|P2|Treatment Period|Protocol Violation|9
2546506|NCT01479621|8813649|P1|Treatment Period|Protocol Violation|0
2546507|NCT01479621|8813643|P7|Treatment Period|Non-compliance to study drug|1
2546508|NCT01479621|8813644|P6|Treatment Period|Non-compliance to study drug|0
2546509|NCT01479621|8813645|P5|Treatment Period|Non-compliance to study drug|0
2546510|NCT01479621|8813646|P4|Treatment Period|Non-compliance to study drug|0
2546511|NCT01479621|8813647|P3|Treatment Period|Non-compliance to study drug|0
2546512|NCT01479621|8813648|P2|Treatment Period|Non-compliance to study drug|1
2546513|NCT01479621|8813649|P1|Treatment Period|Non-compliance to study drug|0
2546514|NCT01479621|8813643|P7|Treatment Period|Physician Decision|0
2546515|NCT01479621|8813644|P6|Treatment Period|Physician Decision|1
2546516|NCT01479621|8813645|P5|Treatment Period|Physician Decision|1
2546517|NCT01479621|8813646|P4|Treatment Period|Physician Decision|0
2546518|NCT01479621|8813647|P3|Treatment Period|Physician Decision|0
2546519|NCT01479621|8813648|P2|Treatment Period|Physician Decision|0
2546520|NCT01479621|8813649|P1|Treatment Period|Physician Decision|0
2546521|NCT01479621|8813643|P7|Treatment Period|Withdrawal by Subject|1
2546522|NCT01479621|8813644|P6|Treatment Period|Withdrawal by Subject|5
2546523|NCT01479621|8813645|P5|Treatment Period|Withdrawal by Subject|5
2546524|NCT01479621|8813646|P4|Treatment Period|Withdrawal by Subject|2
2546525|NCT01479621|8813647|P3|Treatment Period|Withdrawal by Subject|2
2546526|NCT01479621|8813648|P2|Treatment Period|Withdrawal by Subject|4
2546527|NCT01479621|8813649|P1|Treatment Period|Withdrawal by Subject|0
2546528|NCT01479621|8813643|P7|Treatment Period|Adverse Event|2
2546529|NCT01479621|8813644|P6|Treatment Period|Adverse Event|2
2546530|NCT01479621|8813645|P5|Treatment Period|Adverse Event|1
2546531|NCT01479621|8813646|P4|Treatment Period|Adverse Event|0
2546532|NCT01479621|8813647|P3|Treatment Period|Adverse Event|0
2546533|NCT01479621|8813648|P2|Treatment Period|Adverse Event|0
2546534|NCT01479621|8813649|P1|Treatment Period|Adverse Event|0
2546535|NCT01479621|8813643|P7|Pre-Assignment Period (Run-In Placebo)|Other|0
2546536|NCT01479621|8813644|P6|Pre-Assignment Period (Run-In Placebo)|Other|0
2546537|NCT01479621|8813645|P5|Pre-Assignment Period (Run-In Placebo)|Other|0
2546538|NCT01479621|8813646|P4|Pre-Assignment Period (Run-In Placebo)|Other|0
2546539|NCT01479621|8813647|P3|Pre-Assignment Period (Run-In Placebo)|Other|0
2546540|NCT01479621|8813648|P2|Pre-Assignment Period (Run-In Placebo)|Other|0
2546541|NCT01479621|8813649|P1|Pre-Assignment Period (Run-In Placebo)|Other|15
2546542|NCT01479621|8813643|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2546543|NCT01479621|8813644|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2546544|NCT01479621|8813645|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2546545|NCT01479621|8813646|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2546546|NCT01479621|8813647|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2546547|NCT01479621|8813648|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
2546548|NCT01479621|8813649|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7
2546549|NCT01479621|8813643|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2546550|NCT01479621|8813644|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2546551|NCT01479621|8813645|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2546552|NCT01479621|8813646|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2546553|NCT01479621|8813647|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2546554|NCT01479621|8813648|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
2546555|NCT01479621|8813649|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153
2546556|NCT01479621|8813643|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2546557|NCT01479621|8813644|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2546558|NCT01479621|8813645|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2546559|NCT01479621|8813646|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2546560|NCT01479621|8813647|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2546561|NCT01479621|8813648|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
2546562|NCT01479621|8813649|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19
2546563|NCT01479621|8813643|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2546564|NCT01479621|8813644|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2546565|NCT01479621|8813645|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2546566|NCT01479621|8813646|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2546567|NCT01479621|8813647|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2546568|NCT01479621|8813648|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
2546569|NCT01479621|8813649|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93
2546570|NCT01479595|8813737|P2|Overall Study|Adverse Event|1
2546571|NCT01479595|8813738|P1|Overall Study|Adverse Event|2
2546572|NCT01479595|8813737|P2|Overall Study|Protocol deviation|1
2546573|NCT01479595|8813738|P1|Overall Study|Protocol deviation|0
2546574|NCT01479530|8813783|P2|Overall Study|Withdrawal of Consent|2
2546575|NCT01479530|8813784|P1|Overall Study|Withdrawal of Consent|3
2546576|NCT01479530|8813783|P2|Overall Study|Protocol Violation|3
2546577|NCT01479530|8813784|P1|Overall Study|Protocol Violation|2
2546578|NCT01479530|8813783|P2|Overall Study|Lack of Efficacy|1
2546579|NCT01479530|8813784|P1|Overall Study|Lack of Efficacy|0
2546580|NCT01479530|8813783|P2|Overall Study|Adverse Event|6
2546581|NCT01479530|8813784|P1|Overall Study|Adverse Event|5
2546582|NCT01479465|8813865|P4|Overall Study|Lost to Follow-up|0
2546583|NCT01479465|8813866|P3|Overall Study|Lost to Follow-up|1
2546584|NCT01479465|8813867|P2|Overall Study|Lost to Follow-up|0
2546585|NCT01479465|8813868|P1|Overall Study|Lost to Follow-up|0
2546586|NCT01479465|8813865|P4|Overall Study|Death|1
2546587|NCT01479465|8813866|P3|Overall Study|Death|0
2546588|NCT01479465|8813867|P2|Overall Study|Death|0
2546589|NCT01479465|8813868|P1|Overall Study|Death|0
2546590|NCT01479465|8813865|P4|Overall Study|Protocol Violation|0
2546591|NCT01479465|8813866|P3|Overall Study|Protocol Violation|1
2546592|NCT01479465|8813867|P2|Overall Study|Protocol Violation|1
2546593|NCT01479465|8813868|P1|Overall Study|Protocol Violation|0
2546594|NCT01479465|8813865|P4|Overall Study|Subject Withdrew Consent|1
2546595|NCT01479465|8813866|P3|Overall Study|Subject Withdrew Consent|2
2546596|NCT01479465|8813867|P2|Overall Study|Subject Withdrew Consent|5
2546597|NCT01479465|8813868|P1|Overall Study|Subject Withdrew Consent|0
2546598|NCT01479465|8813865|P4|Overall Study|Subject Request|2
2546599|NCT01479465|8813866|P3|Overall Study|Subject Request|4
2546600|NCT01479465|8813867|P2|Overall Study|Subject Request|3
2546601|NCT01479465|8813868|P1|Overall Study|Subject Request|1
2546602|NCT01479465|8813865|P4|Overall Study|Investigator Discretion|4
2546603|NCT01479465|8813866|P3|Overall Study|Investigator Discretion|2
2546604|NCT01479465|8813867|P2|Overall Study|Investigator Discretion|4
2546605|NCT01479465|8813868|P1|Overall Study|Investigator Discretion|1
2546606|NCT01479465|8813865|P4|Overall Study|Adverse Event|4
2546607|NCT01479465|8813866|P3|Overall Study|Adverse Event|6
2546608|NCT01479465|8813867|P2|Overall Study|Adverse Event|3
2546609|NCT01479465|8813868|P1|Overall Study|Adverse Event|0
2546610|NCT01479465|8813865|P4|Overall Study|Study Discontinued by Sponsor|3
2546611|NCT01479465|8813866|P3|Overall Study|Study Discontinued by Sponsor|5
2546612|NCT01479465|8813867|P2|Overall Study|Study Discontinued by Sponsor|7
2546613|NCT01479465|8813868|P1|Overall Study|Study Discontinued by Sponsor|0
2546614|NCT01479465|8813865|P4|Overall Study|Disease Progression|70
2546615|NCT01479465|8813866|P3|Overall Study|Disease Progression|65
2546616|NCT01479465|8813867|P2|Overall Study|Disease Progression|61
2546617|NCT01479465|8813868|P1|Overall Study|Disease Progression|9
2546618|NCT01479374|8813904|P3|Overall Study|Other|5
2546619|NCT01479374|8813905|P2|Overall Study|Other|4
2546620|NCT01479374|8813906|P1|Overall Study|Other|0
2546621|NCT01479374|8813904|P3|Overall Study|Decision Unrelated to Adverse Event|0
2546622|NCT01479374|8813905|P2|Overall Study|Decision Unrelated to Adverse Event|1
2546623|NCT01479374|8813906|P1|Overall Study|Decision Unrelated to Adverse Event|0
2546624|NCT01479374|8813904|P3|Overall Study|Lost to Follow-up|0
2546625|NCT01479374|8813905|P2|Overall Study|Lost to Follow-up|2
2546626|NCT01479374|8813906|P1|Overall Study|Lost to Follow-up|1
2546627|NCT01479374|8813904|P3|Overall Study|Adverse Event|0
2546628|NCT01479374|8813905|P2|Overall Study|Adverse Event|1
2546629|NCT01479374|8813906|P1|Overall Study|Adverse Event|2
2546630|NCT01478971|8813992|P1|Peginesatide Treatment Period|Other|4
2546631|NCT01478971|8813992|P1|Peginesatide Treatment Period|Lost to Follow-up|4
2546632|NCT01478971|8813992|P1|Peginesatide Treatment Period|Death|4
2546633|NCT01478971|8813992|P1|Peginesatide Treatment Period|Withdrawal by Subject|1
2546634|NCT01478971|8813992|P1|Peginesatide Treatment Period|Adverse Event|1
2546635|NCT01478971|8813992|P1|Standard of Care Period|Other|4
2546636|NCT01478971|8813992|P1|Standard of Care Period|Lost to Follow-up|9
2546637|NCT01478971|8813992|P1|Standard of Care Period|Death|8
2546638|NCT01478971|8813992|P1|Standard of Care Period|Withdrawal by Subject|3
2546639|NCT01478971|8813992|P1|Standard of Care Period|Adverse Event|1
2546640|NCT01478958|8814009|P3|Overall Study|Unable to comply|2
2546641|NCT01478958|8814010|P2|Overall Study|Unable to comply|0
2546642|NCT01478958|8814011|P1|Overall Study|Unable to comply|0
2546643|NCT01478958|8814009|P3|Overall Study|Re-located|0
2546644|NCT01478958|8814010|P2|Overall Study|Re-located|1
2546645|NCT01478958|8814011|P1|Overall Study|Re-located|0
2546646|NCT01478958|8814009|P3|Overall Study|Weight loss|0
2546647|NCT01478958|8814010|P2|Overall Study|Weight loss|0
2546648|NCT01478958|8814011|P1|Overall Study|Weight loss|1
2546649|NCT01478958|8814009|P3|Overall Study|Withdrawal by Subject|1
2546650|NCT01478958|8814010|P2|Overall Study|Withdrawal by Subject|1
2546651|NCT01478958|8814011|P1|Overall Study|Withdrawal by Subject|1
2546652|NCT01478828|8814031|P1|Overall Study|Adverse Event|1
2546653|NCT01478620|8814042|P1|Overall Study|Lost to Follow-up|6
2546654|NCT01478594|8814048|P2|Overall Study|Study Closed by Sponsor|5
2546655|NCT01478594|8814049|P1|Overall Study|Study Closed by Sponsor|8
2546656|NCT01478594|8814048|P2|Overall Study|Withdrawal by Subject|3
2546657|NCT01478594|8814049|P1|Overall Study|Withdrawal by Subject|9
2546658|NCT01478594|8814048|P2|Overall Study|Lost to Follow-up|1
2546659|NCT01478594|8814049|P1|Overall Study|Lost to Follow-up|3
2546660|NCT01478594|8814048|P2|Overall Study|Death|18
2546661|NCT01478594|8814049|P1|Overall Study|Death|45
2546662|NCT01478594|8814048|P2|Overall Study|Randomized but Never Received Study Drug|1
2546663|NCT01478594|8814049|P1|Overall Study|Randomized but Never Received Study Drug|0
2546664|NCT01478373|8814178|P1|Survival Phase|Progressive Disease|27
2546665|NCT01478373|8814178|P1|Survival Phase|crossover to another study|2
2546666|NCT01478373|8814178|P1|Survival Phase|Protocol Violation|1
2546667|NCT01478373|8814178|P1|Survival Phase|Adverse Event|8
2546668|NCT01478373|8814178|P1|Treatment Phase|Protocol Violation|1
2546669|NCT01478360|8814191|P2|Overall Study|Administrative problems|2
2546670|NCT01478360|8814192|P1|Overall Study|Administrative problems|1
2546671|NCT01478360|8814191|P2|Overall Study|Adverse Event|1
2546672|NCT01478360|8814192|P1|Overall Study|Adverse Event|0
2546673|NCT01478360|8814191|P2|Overall Study|Lost to Follow-up|0
2546674|NCT01478360|8814192|P1|Overall Study|Lost to Follow-up|1
2546675|NCT01478347|8814198|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4
2546676|NCT01478347|8814198|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4
2546677|NCT01478347|8814198|P1|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1
2546678|NCT01478321|8814203|P1|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8
2546679|NCT01478321|8814203|P1|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1
2546680|NCT01478321|8814203|P1|Adjuvant Therapy Until PD or Toxicity|Death|1
2546681|NCT01478321|8814203|P1|Started Adjuvant Therapy|Withdrawal by Subject|1
2546682|NCT01478321|8814203|P1|Concurrent Therapy (5 Weeks)|Progressive Disease|5
2546683|NCT01478321|8814203|P1|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5
2546684|NCT01478321|8814203|P1|Concurrent Therapy (5 Weeks)|Death|2
2546685|NCT01478321|8814203|P1|Concurrent Therapy (5 Weeks)|Adverse Event|4
2546686|NCT01478113|8814226|P2|Overall Study|Physician Decision|0
2546687|NCT01478113|8814227|P1|Overall Study|Physician Decision|1
2546688|NCT01478113|8814226|P2|Overall Study|Withdrawal by Subject|1
2546689|NCT01478113|8814227|P1|Overall Study|Withdrawal by Subject|0
2546690|NCT01478087|8814245|P1|Overall Study|due to sponsor closing study|1
2546691|NCT01478048|8814252|P2|Overall Study|no longer meets study criteria|0
2546692|NCT01478048|8814253|P1|Overall Study|no longer meets study criteria|1
2546693|NCT01478048|8814252|P2|Overall Study|poor/non-compliance|1
2546694|NCT01478048|8814253|P1|Overall Study|poor/non-compliance|0
2546695|NCT01478048|8814252|P2|Overall Study|non-specified|4
2546696|NCT01478048|8814253|P1|Overall Study|non-specified|6
2546697|NCT01478048|8814252|P2|Overall Study|Withdrawal by Subject|5
2546698|NCT01478048|8814253|P1|Overall Study|Withdrawal by Subject|2
2546699|NCT01478048|8814252|P2|Overall Study|subject request to discontinue treatment|5
2546700|NCT01478048|8814253|P1|Overall Study|subject request to discontinue treatment|3
2546701|NCT01478048|8814252|P2|Overall Study|Adverse Event|11
2546702|NCT01478048|8814253|P1|Overall Study|Adverse Event|2
2546703|NCT01478048|8814252|P2|Overall Study|study drug toxicity|14
2546704|NCT01478048|8814253|P1|Overall Study|study drug toxicity|11
2546705|NCT01478048|8814252|P2|Overall Study|Disease Progression|35
2546706|NCT01478048|8814253|P1|Overall Study|Disease Progression|52
2546707|NCT01477892|8814282|P2|Overall Study|Withdrawal by Subject|2
2546708|NCT01477892|8814283|P1|Overall Study|Withdrawal by Subject|0
2546709|NCT01477853|8814294|P3|Phase B|Study terminated by sponsor|11
2546710|NCT01477853|8814295|P2|Phase B|Study terminated by sponsor|10
2546711|NCT01477853|8814296|P1|Phase B|Study terminated by sponsor|12
2546712|NCT01477853|8814294|P3|Phase B|Lost to Follow-up|0
2546713|NCT01477853|8814295|P2|Phase B|Lost to Follow-up|1
2546714|NCT01477853|8814296|P1|Phase B|Lost to Follow-up|0
2546715|NCT01477853|8814294|P3|Phase A|Study terminated by sponsor|39
2546716|NCT01477853|8814295|P2|Phase A|Study terminated by sponsor|40
2546717|NCT01477853|8814296|P1|Phase A|Study terminated by sponsor|37
2546718|NCT01477853|8814294|P3|Phase A|Physician Decision|1
2546719|NCT01477853|8814295|P2|Phase A|Physician Decision|0
2546720|NCT01477853|8814296|P1|Phase A|Physician Decision|1
2546721|NCT01477853|8814294|P3|Phase A|Lost to Follow-up|2
2546722|NCT01477853|8814295|P2|Phase A|Lost to Follow-up|3
2546723|NCT01477853|8814296|P1|Phase A|Lost to Follow-up|4
2546724|NCT01477853|8814294|P3|Phase A|Adverse Event|2
2546725|NCT01477853|8814295|P2|Phase A|Adverse Event|2
2546726|NCT01477853|8814296|P1|Phase A|Adverse Event|1
2546727|NCT01477749|8814363|P1|Overall Study|Physician Decision|4
2546728|NCT01477333|8814471|P1|Overall Study|Clinical Deterioration|1
2546729|NCT01477333|8814471|P1|Overall Study|Withdrawal by Subject|1
2546730|NCT01477333|8814471|P1|Overall Study|Adverse Event|1
2546731|NCT01476722|8814522|P1|Overall Study|Adverse Event|1
2546732|NCT01476696|8814529|P3|Overall Study|Withdrawal by Subject|0
2546733|NCT01476696|8814530|P2|Overall Study|Withdrawal by Subject|0
2546734|NCT01476696|8814531|P1|Overall Study|Withdrawal by Subject|1
2546735|NCT01476696|8814529|P3|Overall Study|Sponsor decision|0
2546736|NCT01476696|8814530|P2|Overall Study|Sponsor decision|1
2546737|NCT01476696|8814531|P1|Overall Study|Sponsor decision|2
2546738|NCT01476644|8814545|P1|Overall Study|Withdrawal by Subject|13
2546739|NCT01476644|8814545|P1|Overall Study|Lost to Follow-up|19
2546740|NCT01476644|8814545|P1|Overall Study|moved to another state|2
2546741|NCT01476644|8814545|P1|Overall Study|Death|5
2546742|NCT01476475|8814552|P2|Overall Study|Other reasons|2
2546743|NCT01476475|8814553|P1|Overall Study|Other reasons|4
2546744|NCT01476475|8814552|P2|Overall Study|Poor compliance to protocol|1
2546745|NCT01476475|8814553|P1|Overall Study|Poor compliance to protocol|1
2546746|NCT01476475|8814552|P2|Overall Study|Adverse Event|0
2546747|NCT01476475|8814553|P1|Overall Study|Adverse Event|6
2546748|NCT01475851|8815004|P2|Overall Study|Protocol defined stopping criteria|0
2546749|NCT01475851|8815005|P1|Overall Study|Protocol defined stopping criteria|1
2546750|NCT01475838|8815033|P2|Extension Phase|Participant Noncompliance|0
2546751|NCT01475838|8815034|P1|Extension Phase|Participant Noncompliance|1
2546752|NCT01475838|8815033|P2|Randomized Phase|Protocol Violation|4
2546753|NCT01475838|8815034|P1|Randomized Phase|Protocol Violation|9
2546754|NCT01475838|8815033|P2|Randomized Phase|Participant Noncompliance|5
2546755|NCT01475838|8815034|P1|Randomized Phase|Participant Noncompliance|1
2546756|NCT01475838|8815033|P2|Randomized Phase|Lost to Follow-up|4
2546757|NCT01475838|8815034|P1|Randomized Phase|Lost to Follow-up|3
2546758|NCT01475838|8815033|P2|Randomized Phase|Withdrew Consent|14
2546759|NCT01475838|8815034|P1|Randomized Phase|Withdrew Consent|10
2546760|NCT01475838|8815033|P2|Randomized Phase|Investigators Discretion|2
2546761|NCT01475838|8815034|P1|Randomized Phase|Investigators Discretion|1
2546762|NCT01475838|8815033|P2|Randomized Phase|Pregnancy|1
2546763|NCT01475838|8815034|P1|Randomized Phase|Pregnancy|0
2546764|NCT01475838|8815033|P2|Randomized Phase|Adverse Event|1
2546765|NCT01475838|8815034|P1|Randomized Phase|Adverse Event|6
2546766|NCT01475838|8815033|P2|Randomized Phase|Randomized but Not Treated|5
2546767|NCT01475838|8815034|P1|Randomized Phase|Randomized but Not Treated|0
2546768|NCT01475825|8815051|P4|Overall Study|Did not enter OLC|11
2546769|NCT01475825|8815052|P3|Overall Study|Did not enter OLC|15
2546770|NCT01475825|8815053|P2|Overall Study|Did not enter OLC|11
2546771|NCT01475825|8815054|P1|Overall Study|Did not enter OLC|15
2546772|NCT01475825|8815051|P4|Overall Study|Withdrawal by Subject|7
2546773|NCT01475825|8815052|P3|Overall Study|Withdrawal by Subject|11
2546774|NCT01475825|8815053|P2|Overall Study|Withdrawal by Subject|3
2546775|NCT01475825|8815054|P1|Overall Study|Withdrawal by Subject|8
2546776|NCT01475825|8815051|P4|Overall Study|Physician Decision|0
2546777|NCT01475825|8815052|P3|Overall Study|Physician Decision|0
2546778|NCT01475825|8815053|P2|Overall Study|Physician Decision|1
2546779|NCT01475825|8815054|P1|Overall Study|Physician Decision|0
2546780|NCT01475825|8815051|P4|Overall Study|Protocol Violation|0
2546781|NCT01475825|8815052|P3|Overall Study|Protocol Violation|0
2546782|NCT01475825|8815053|P2|Overall Study|Protocol Violation|0
2546783|NCT01475825|8815054|P1|Overall Study|Protocol Violation|1
2546784|NCT01475825|8815051|P4|Overall Study|Other: Not available|0
2546785|NCT01475825|8815052|P3|Overall Study|Other: Not available|2
2546786|NCT01475825|8815053|P2|Overall Study|Other: Not available|0
2546787|NCT01475825|8815054|P1|Overall Study|Other: Not available|0
2546788|NCT01475825|8815051|P4|Overall Study|Non-compliance with Study Drug|0
2546789|NCT01475825|8815052|P3|Overall Study|Non-compliance with Study Drug|4
2546790|NCT01475825|8815053|P2|Overall Study|Non-compliance with Study Drug|2
2546791|NCT01475825|8815054|P1|Overall Study|Non-compliance with Study Drug|1
2546792|NCT01475825|8815051|P4|Overall Study|Lost to Follow-up|1
2546793|NCT01475825|8815052|P3|Overall Study|Lost to Follow-up|3
2546794|NCT01475825|8815053|P2|Overall Study|Lost to Follow-up|0
2546795|NCT01475825|8815054|P1|Overall Study|Lost to Follow-up|0
2546796|NCT01475825|8815051|P4|Overall Study|Lack of Efficacy|0
2546797|NCT01475825|8815052|P3|Overall Study|Lack of Efficacy|1
2546798|NCT01475825|8815053|P2|Overall Study|Lack of Efficacy|0
2546799|NCT01475825|8815054|P1|Overall Study|Lack of Efficacy|0
2546800|NCT01475825|8815051|P4|Overall Study|Death|0
2546801|NCT01475825|8815052|P3|Overall Study|Death|1
2546802|NCT01475825|8815053|P2|Overall Study|Death|0
2546803|NCT01475825|8815054|P1|Overall Study|Death|1
2546804|NCT01475825|8815051|P4|Overall Study|Adverse Event|11
2546805|NCT01475825|8815052|P3|Overall Study|Adverse Event|27
2546806|NCT01475825|8815053|P2|Overall Study|Adverse Event|15
2546807|NCT01475825|8815054|P1|Overall Study|Adverse Event|41
2546808|NCT01475734|8815086|P2|Overall Study|Physician Decision|1
2546809|NCT01475734|8815087|P1|Overall Study|Physician Decision|0
2546810|NCT01475734|8815086|P2|Overall Study|Protocol Violation|0
2546811|NCT01475734|8815087|P1|Overall Study|Protocol Violation|1
2546812|NCT01475734|8815086|P2|Overall Study|Withdrawal by Subject|0
2546813|NCT01475734|8815087|P1|Overall Study|Withdrawal by Subject|1
2546814|NCT01475721|8815115|P2|Overall Study|Withdrawal by Subject|8
2546815|NCT01475721|8815116|P1|Overall Study|Withdrawal by Subject|8
2546816|NCT01475721|8815115|P2|Overall Study|Death|6
2546817|NCT01475721|8815116|P1|Overall Study|Death|3
2546818|NCT01475487|8815182|P2|Overall Study|had to leave early for personal reasons|1
2546819|NCT01475487|8815183|P1|Overall Study|had to leave early for personal reasons|2
2546820|NCT01475474|8815195|P1|Baseline Period - 4 Weeks|Withdrawal by Subject|2
2546821|NCT01475474|8815195|P1|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4
2546822|NCT01475461|8815206|P7|Treatment Period|Adverse Event|0
2546823|NCT01475461|8815207|P6|Treatment Period|Adverse Event|0
2546824|NCT01475461|8815208|P5|Treatment Period|Adverse Event|0
2546825|NCT01475461|8815209|P4|Treatment Period|Adverse Event|1
2546826|NCT01475461|8815210|P3|Treatment Period|Adverse Event|0
2546827|NCT01475461|8815211|P2|Treatment Period|Adverse Event|0
2546828|NCT01475461|8815212|P1|Treatment Period|Adverse Event|0
2546829|NCT01475461|8815206|P7|Treatment Period|Medication Error|0
2546830|NCT01475461|8815207|P6|Treatment Period|Medication Error|0
2546831|NCT01475461|8815208|P5|Treatment Period|Medication Error|0
2546832|NCT01475461|8815209|P4|Treatment Period|Medication Error|1
2546833|NCT01475461|8815210|P3|Treatment Period|Medication Error|0
2546834|NCT01475461|8815211|P2|Treatment Period|Medication Error|0
2546835|NCT01475461|8815212|P1|Treatment Period|Medication Error|0
2546836|NCT01475461|8815206|P7|Treatment Period|Lack of Efficacy|0
2546837|NCT01475461|8815207|P6|Treatment Period|Lack of Efficacy|1
2546838|NCT01475461|8815208|P5|Treatment Period|Lack of Efficacy|1
2546839|NCT01475461|8815209|P4|Treatment Period|Lack of Efficacy|2
2546840|NCT01475461|8815210|P3|Treatment Period|Lack of Efficacy|0
2546841|NCT01475461|8815211|P2|Treatment Period|Lack of Efficacy|2
2546842|NCT01475461|8815212|P1|Treatment Period|Lack of Efficacy|0
2546843|NCT01475461|8815206|P7|Treatment Period|Protocol Violation|1
2546844|NCT01475461|8815207|P6|Treatment Period|Protocol Violation|0
2546845|NCT01475461|8815208|P5|Treatment Period|Protocol Violation|0
2546846|NCT01475461|8815209|P4|Treatment Period|Protocol Violation|0
2546847|NCT01475461|8815210|P3|Treatment Period|Protocol Violation|0
2546848|NCT01475461|8815211|P2|Treatment Period|Protocol Violation|1
2546849|NCT01475461|8815212|P1|Treatment Period|Protocol Violation|0
2546850|NCT01475461|8815206|P7|Treatment Period|Other|0
2546851|NCT01475461|8815207|P6|Treatment Period|Other|0
2546852|NCT01475461|8815208|P5|Treatment Period|Other|0
2546853|NCT01475461|8815209|P4|Treatment Period|Other|0
2546854|NCT01475461|8815210|P3|Treatment Period|Other|0
2546855|NCT01475461|8815211|P2|Treatment Period|Other|1
2546856|NCT01475461|8815212|P1|Treatment Period|Other|0
2546857|NCT01475461|8815206|P7|Treatment Period|Withdrawal by Subject|0
2546858|NCT01475461|8815207|P6|Treatment Period|Withdrawal by Subject|2
2546859|NCT01475461|8815208|P5|Treatment Period|Withdrawal by Subject|2
2546860|NCT01475461|8815209|P4|Treatment Period|Withdrawal by Subject|0
2546861|NCT01475461|8815210|P3|Treatment Period|Withdrawal by Subject|2
2546862|NCT01475461|8815211|P2|Treatment Period|Withdrawal by Subject|2
2546863|NCT01475461|8815212|P1|Treatment Period|Withdrawal by Subject|0
2546864|NCT01475461|8815206|P7|Treatment Period|Lost to Follow-up|1
2546865|NCT01475461|8815207|P6|Treatment Period|Lost to Follow-up|2
2546866|NCT01475461|8815208|P5|Treatment Period|Lost to Follow-up|1
2546867|NCT01475461|8815209|P4|Treatment Period|Lost to Follow-up|3
2546868|NCT01475461|8815210|P3|Treatment Period|Lost to Follow-up|2
2546869|NCT01475461|8815211|P2|Treatment Period|Lost to Follow-up|3
2546870|NCT01475461|8815212|P1|Treatment Period|Lost to Follow-up|0
2546871|NCT01475461|8815206|P7|Treatment Period|Death|0
2546872|NCT01475461|8815207|P6|Treatment Period|Death|0
2546873|NCT01475461|8815208|P5|Treatment Period|Death|0
2546874|NCT01475461|8815209|P4|Treatment Period|Death|1
2546875|NCT01475461|8815210|P3|Treatment Period|Death|0
2546876|NCT01475461|8815211|P2|Treatment Period|Death|0
2546877|NCT01475461|8815212|P1|Treatment Period|Death|0
2546878|NCT01475461|8815206|P7|Run-in Period|Protocol Violation|0
2546879|NCT01475461|8815207|P6|Run-in Period|Protocol Violation|0
2546880|NCT01475461|8815208|P5|Run-in Period|Protocol Violation|0
2546881|NCT01475461|8815209|P4|Run-in Period|Protocol Violation|0
2546882|NCT01475461|8815210|P3|Run-in Period|Protocol Violation|0
2546883|NCT01475461|8815211|P2|Run-in Period|Protocol Violation|0
2546884|NCT01475461|8815212|P1|Run-in Period|Protocol Violation|4
2546885|NCT01475461|8815206|P7|Run-in Period|Other|0
2546886|NCT01475461|8815207|P6|Run-in Period|Other|0
2546887|NCT01475461|8815208|P5|Run-in Period|Other|0
2546888|NCT01475461|8815209|P4|Run-in Period|Other|0
2546889|NCT01475461|8815210|P3|Run-in Period|Other|0
2546890|NCT01475461|8815211|P2|Run-in Period|Other|0
2546891|NCT01475461|8815212|P1|Run-in Period|Other|3
2546892|NCT01475461|8815206|P7|Run-in Period|Withdrawal by Subject|0
2546893|NCT01475461|8815207|P6|Run-in Period|Withdrawal by Subject|0
2546894|NCT01475461|8815208|P5|Run-in Period|Withdrawal by Subject|0
2546895|NCT01475461|8815209|P4|Run-in Period|Withdrawal by Subject|0
2546896|NCT01475461|8815210|P3|Run-in Period|Withdrawal by Subject|0
2546897|NCT01475461|8815211|P2|Run-in Period|Withdrawal by Subject|0
2546898|NCT01475461|8815212|P1|Run-in Period|Withdrawal by Subject|11
2546899|NCT01475461|8815206|P7|Run-in Period|Lost to Follow-up|0
2546900|NCT01475461|8815207|P6|Run-in Period|Lost to Follow-up|0
2546901|NCT01475461|8815208|P5|Run-in Period|Lost to Follow-up|0
2546902|NCT01475461|8815209|P4|Run-in Period|Lost to Follow-up|0
2546903|NCT01475461|8815210|P3|Run-in Period|Lost to Follow-up|0
2546904|NCT01475461|8815211|P2|Run-in Period|Lost to Follow-up|0
2546905|NCT01475461|8815212|P1|Run-in Period|Lost to Follow-up|7
2546906|NCT01475461|8815206|P7|Run-in Period|Not meet eligibility criteria|0
2546907|NCT01475461|8815207|P6|Run-in Period|Not meet eligibility criteria|0
2546908|NCT01475461|8815208|P5|Run-in Period|Not meet eligibility criteria|0
2546909|NCT01475461|8815209|P4|Run-in Period|Not meet eligibility criteria|0
2546910|NCT01475461|8815210|P3|Run-in Period|Not meet eligibility criteria|0
2546911|NCT01475461|8815211|P2|Run-in Period|Not meet eligibility criteria|0
2546912|NCT01475461|8815212|P1|Run-in Period|Not meet eligibility criteria|16
2546913|NCT01475331|8815292|P2|Overall Study|cyst found to be prohibitively small|1
2546914|NCT01475331|8815293|P1|Overall Study|cyst found to be prohibitively small|0
2546915|NCT01475331|8815292|P2|Overall Study|Sign of malignancy during the procedure|0
2546916|NCT01475331|8815293|P1|Overall Study|Sign of malignancy during the procedure|2
2546917|NCT01475331|8815292|P2|Overall Study|Loss of needle positioning due pt. cough|0
2546918|NCT01475331|8815293|P1|Overall Study|Loss of needle positioning due pt. cough|1
2546919|NCT01475331|8815292|P2|Overall Study|excessive main duct communication|1
2546920|NCT01475331|8815293|P1|Overall Study|excessive main duct communication|1
2546921|NCT01475331|8815292|P2|Overall Study|Osteophyte obstruction of the proximal|0
2546922|NCT01475331|8815293|P1|Overall Study|Osteophyte obstruction of the proximal|1
2546923|NCT01475253|8815345|P4|Randomized, Blinded Study|Lost to Follow-up|0
2546924|NCT01475253|8815346|P3|Randomized, Blinded Study|Lost to Follow-up|0
2546925|NCT01475253|8815347|P2|Randomized, Blinded Study|Lost to Follow-up|0
2546926|NCT01475253|8815348|P1|Randomized, Blinded Study|Lost to Follow-up|1
2546927|NCT01475253|8815345|P4|Randomized, Blinded Study|Withdrawal by Subject|0
2546928|NCT01475253|8815346|P3|Randomized, Blinded Study|Withdrawal by Subject|0
2546929|NCT01475253|8815347|P2|Randomized, Blinded Study|Withdrawal by Subject|1
2546930|NCT01475253|8815348|P1|Randomized, Blinded Study|Withdrawal by Subject|1
2546931|NCT01475214|8815377|P3|Overall Study|Withdrawal by Subject|1
2546932|NCT01475214|8815378|P2|Overall Study|Withdrawal by Subject|4
2546933|NCT01475214|8815379|P1|Overall Study|Withdrawal by Subject|2
2546934|NCT01475214|8815377|P3|Overall Study|Physician Decision|0
2546935|NCT01475214|8815378|P2|Overall Study|Physician Decision|0
2546936|NCT01475214|8815379|P1|Overall Study|Physician Decision|2
2546937|NCT01475214|8815377|P3|Overall Study|Lost to Follow-up|1
2546938|NCT01475214|8815378|P2|Overall Study|Lost to Follow-up|0
2546939|NCT01475214|8815379|P1|Overall Study|Lost to Follow-up|1
2546940|NCT01475162|8815402|P1|Overall Study|Study closed for safety|3
2546941|NCT01475162|8815402|P1|Overall Study|Death|10
2546942|NCT01475162|8815402|P1|Overall Study|Physician Decision|1
2546943|NCT01475097|8815415|P2|Overall Study|Protocol Violation|1
2546944|NCT01475097|8815416|P1|Overall Study|Protocol Violation|1
2546945|NCT01475071|8815424|P1|Overall Study|Lost to Follow-up|1
2546946|NCT01475071|8815424|P1|Overall Study|Withdrawal by Subject|6
2546947|NCT01475071|8815424|P1|Overall Study|Physician Decision|1
2546948|NCT01474993|8815434|P2|Overall Study|Adverse Event|1
2546949|NCT01474993|8815435|P1|Overall Study|Adverse Event|0
2546950|NCT01474993|8815434|P2|Overall Study|Lost to Follow-up|2
2546951|NCT01474993|8815435|P1|Overall Study|Lost to Follow-up|1
2546952|NCT01474876|8815477|P3|Overall Study|Investigator's decision and pt request|0
2546953|NCT01474876|8815478|P2|Overall Study|Investigator's decision and pt request|0
2546954|NCT01474876|8815479|P1|Overall Study|Investigator's decision and pt request|1
2546955|NCT01474876|8815477|P3|Overall Study|Patient's request|0
2546956|NCT01474876|8815478|P2|Overall Study|Patient's request|5
2546957|NCT01474876|8815479|P1|Overall Study|Patient's request|19
2546958|NCT01474876|8815477|P3|Overall Study|Investigator's decision|0
2546959|NCT01474876|8815478|P2|Overall Study|Investigator's decision|6
2546960|NCT01474876|8815479|P1|Overall Study|Investigator's decision|28
2546961|NCT01474876|8815477|P3|Overall Study|Lost to Follow-up|0
2546962|NCT01474876|8815478|P2|Overall Study|Lost to Follow-up|4
2546963|NCT01474876|8815479|P1|Overall Study|Lost to Follow-up|5
2546964|NCT01474876|8815477|P3|Overall Study|Serious Adverse Event|0
2546965|NCT01474876|8815478|P2|Overall Study|Serious Adverse Event|3
2546966|NCT01474876|8815479|P1|Overall Study|Serious Adverse Event|2
2546967|NCT01474876|8815477|P3|Overall Study|Adverse Event|0
2546968|NCT01474876|8815478|P2|Overall Study|Adverse Event|5
2546969|NCT01474876|8815479|P1|Overall Study|Adverse Event|11
2546970|NCT01474772|8815525|P2|Follow-up|AE not Related to Study Drug|1
2546971|NCT01474772|8815526|P1|Follow-up|AE not Related to Study Drug|0
2546972|NCT01474772|8815525|P2|Period 2|Reason not Specified|2
2546973|NCT01474772|8815526|P1|Period 2|Reason not Specified|0
2546974|NCT01474772|8815525|P2|Period 2|Lost to Follow-up|1
2546975|NCT01474772|8815526|P1|Period 2|Lost to Follow-up|1
2546976|NCT01474772|8815525|P2|Period 2|Withdrawal by Subject|4
2546977|NCT01474772|8815526|P1|Period 2|Withdrawal by Subject|3
2546978|NCT01474772|8815525|P2|Period 2|Lack of Efficacy|0
2546979|NCT01474772|8815526|P1|Period 2|Lack of Efficacy|1
2546980|NCT01474772|8815525|P2|Period 2|AE not Related to Study Drug|1
2546981|NCT01474772|8815526|P1|Period 2|AE not Related to Study Drug|4
2546982|NCT01474772|8815525|P2|Period 2|AE Related to Study Drug|1
2546983|NCT01474772|8815526|P1|Period 2|AE Related to Study Drug|0
2546984|NCT01474772|8815525|P2|Period 2|Death|1
2546985|NCT01474772|8815526|P1|Period 2|Death|0
2546986|NCT01474772|8815525|P2|Washout|Reason not Specified|1
2546987|NCT01474772|8815526|P1|Washout|Reason not Specified|0
2546988|NCT01474772|8815525|P2|Washout|Lost to Follow-up|1
2546989|NCT01474772|8815526|P1|Washout|Lost to Follow-up|0
2546990|NCT01474772|8815525|P2|Washout|Withdrawal by Subject|0
2546991|NCT01474772|8815526|P1|Washout|Withdrawal by Subject|1
2546992|NCT01474772|8815525|P2|Washout|AE not Related to Study Drug|0
2546993|NCT01474772|8815526|P1|Washout|AE not Related to Study Drug|2
2546994|NCT01474772|8815525|P2|Period 1|Reason not Specified|1
2546995|NCT01474772|8815526|P1|Period 1|Reason not Specified|1
2546996|NCT01474772|8815525|P2|Period 1|Lost to Follow-up|0
2546997|NCT01474772|8815526|P1|Period 1|Lost to Follow-up|1
2546998|NCT01474772|8815525|P2|Period 1|Withdrawal by Subject|1
2546999|NCT01474772|8815526|P1|Period 1|Withdrawal by Subject|3
2547000|NCT01474772|8815525|P2|Period 1|AE not Related to Study Drug|0
2547001|NCT01474772|8815526|P1|Period 1|AE not Related to Study Drug|1
2547002|NCT01474772|8815525|P2|Period 1|Adverse Event (AE) Related to Study Drug|1
2547003|NCT01474772|8815526|P1|Period 1|Adverse Event (AE) Related to Study Drug|6
2547004|NCT01474746|8815576|P2|Overall Study|Withdrawal by Subject|1
2547005|NCT01474746|8815577|P1|Overall Study|Withdrawal by Subject|2
2547006|NCT01474746|8815576|P2|Overall Study|Lost to Follow-up|1
2547007|NCT01474746|8815577|P1|Overall Study|Lost to Follow-up|1
2547008|NCT01474681|8815641|P4|Overall Study|Death|6
2547009|NCT01474681|8815642|P3|Overall Study|Death|2
2547010|NCT01474681|8815643|P2|Overall Study|Death|3
2547011|NCT01474681|8815644|P1|Overall Study|Death|0
2547012|NCT01474551|8815695|P1|Overall Study|Death|1
2547013|NCT01474538|8815701|P2|Treatment Period 2|Protocol Violation|0
2547014|NCT01474538|8815702|P1|Treatment Period 2|Protocol Violation|1
2547015|NCT01474538|8815701|P2|Treatment Period 2|Physician Decision|1
2547016|NCT01474538|8815702|P1|Treatment Period 2|Physician Decision|0
2547017|NCT01474538|8815701|P2|Treatment Period 2|Sponsor decision|0
2547018|NCT01474538|8815702|P1|Treatment Period 2|Sponsor decision|1
2547019|NCT01474538|8815701|P2|Treatment Period 2|Withdrawal by Subject|0
2547020|NCT01474538|8815702|P1|Treatment Period 2|Withdrawal by Subject|2
2547021|NCT01474538|8815701|P2|Treatment Period 2|Adverse Event|1
2547022|NCT01474538|8815702|P1|Treatment Period 2|Adverse Event|1
2547023|NCT01474538|8815701|P2|Treatment Period 2|Death|0
2547024|NCT01474538|8815702|P1|Treatment Period 2|Death|1
2547025|NCT01474538|8815701|P2|Treatment Period 1|Protocol Violation|1
2547026|NCT01474538|8815702|P1|Treatment Period 1|Protocol Violation|0
2547027|NCT01474538|8815701|P2|Treatment Period 1|Withdrawal by Subject|3
2547028|NCT01474538|8815702|P1|Treatment Period 1|Withdrawal by Subject|1
2547029|NCT01474538|8815701|P2|Treatment Period 1|Physician Decision|0
2547030|NCT01474538|8815702|P1|Treatment Period 1|Physician Decision|1
2547031|NCT01474538|8815701|P2|Treatment Period 1|Death|0
2547032|NCT01474538|8815702|P1|Treatment Period 1|Death|1
2547033|NCT01474512|8815719|P18|Post-Treatment Follow-Up|Death|0
2547034|NCT01474512|8815720|P17|Post-Treatment Follow-Up|Death|1
2547035|NCT01474512|8815721|P16|Post-Treatment Follow-Up|Death|0
2547036|NCT01474512|8815722|P15|Post-Treatment Follow-Up|Death|0
2547037|NCT01474512|8815723|P14|Post-Treatment Follow-Up|Death|0
2547038|NCT01474512|8815724|P13|Post-Treatment Follow-Up|Death|0
2547039|NCT01474512|8815725|P12|Post-Treatment Follow-Up|Death|0
2547040|NCT01474512|8815726|P11|Post-Treatment Follow-Up|Death|0
2547041|NCT01474512|8815727|P10|Post-Treatment Follow-Up|Death|0
2547042|NCT01474512|8815728|P9|Post-Treatment Follow-Up|Death|0
2547043|NCT01474512|8815729|P8|Post-Treatment Follow-Up|Death|0
2547044|NCT01474512|8815730|P7|Post-Treatment Follow-Up|Death|0
2547045|NCT01474512|8815731|P6|Post-Treatment Follow-Up|Death|0
2547046|NCT01474512|8815732|P5|Post-Treatment Follow-Up|Death|0
2547047|NCT01474512|8815733|P4|Post-Treatment Follow-Up|Death|0
2547048|NCT01474512|8815734|P3|Post-Treatment Follow-Up|Death|0
2547049|NCT01474512|8815735|P2|Post-Treatment Follow-Up|Death|0
2547050|NCT01474512|8815736|P1|Post-Treatment Follow-Up|Death|0
2547051|NCT01474512|8815719|P18|Post-Treatment Follow-Up|Parent/Caregiver Decision|1
2547052|NCT01474512|8815720|P17|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2547053|NCT01474512|8815721|P16|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2547054|NCT01474512|8815722|P15|Post-Treatment Follow-Up|Parent/Caregiver Decision|1
2547055|NCT01474512|8815723|P14|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2547056|NCT01474512|8815724|P13|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2547057|NCT01474512|8815725|P12|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2547058|NCT01474512|8815726|P11|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2547059|NCT01474512|8815727|P10|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2547060|NCT01474512|8815728|P9|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2547061|NCT01474512|8815729|P8|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2547062|NCT01474512|8815730|P7|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2547063|NCT01474512|8815731|P6|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2547064|NCT01474512|8815732|P5|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2547065|NCT01474512|8815733|P4|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2547066|NCT01474512|8815734|P3|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2547067|NCT01474512|8815735|P2|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2547068|NCT01474512|8815736|P1|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
2547069|NCT01474512|8815719|P18|Post-Treatment Follow-Up|Sponsor Decision|0
2547070|NCT01474512|8815720|P17|Post-Treatment Follow-Up|Sponsor Decision|4
2547071|NCT01474512|8815721|P16|Post-Treatment Follow-Up|Sponsor Decision|0
2547072|NCT01474512|8815722|P15|Post-Treatment Follow-Up|Sponsor Decision|1
2547073|NCT01474512|8815723|P14|Post-Treatment Follow-Up|Sponsor Decision|0
2547074|NCT01474512|8815724|P13|Post-Treatment Follow-Up|Sponsor Decision|0
2547075|NCT01474512|8815725|P12|Post-Treatment Follow-Up|Sponsor Decision|0
2547076|NCT01474512|8815726|P11|Post-Treatment Follow-Up|Sponsor Decision|0
2547077|NCT01474512|8815727|P10|Post-Treatment Follow-Up|Sponsor Decision|0
2547078|NCT01474512|8815728|P9|Post-Treatment Follow-Up|Sponsor Decision|0
2547079|NCT01474512|8815729|P8|Post-Treatment Follow-Up|Sponsor Decision|0
2547080|NCT01474512|8815730|P7|Post-Treatment Follow-Up|Sponsor Decision|0
2547081|NCT01474512|8815731|P6|Post-Treatment Follow-Up|Sponsor Decision|0
2547082|NCT01474512|8815732|P5|Post-Treatment Follow-Up|Sponsor Decision|0
2547083|NCT01474512|8815733|P4|Post-Treatment Follow-Up|Sponsor Decision|0
2547084|NCT01474512|8815734|P3|Post-Treatment Follow-Up|Sponsor Decision|0
2547085|NCT01474512|8815735|P2|Post-Treatment Follow-Up|Sponsor Decision|0
2547086|NCT01474512|8815736|P1|Post-Treatment Follow-Up|Sponsor Decision|0
2547087|NCT01474512|8815719|P18|Post-Treatment Follow-Up|Protocol Violation|0
2547088|NCT01474512|8815720|P17|Post-Treatment Follow-Up|Protocol Violation|4
2547089|NCT01474512|8815721|P16|Post-Treatment Follow-Up|Protocol Violation|2
2547090|NCT01474512|8815722|P15|Post-Treatment Follow-Up|Protocol Violation|2
2547091|NCT01474512|8815723|P14|Post-Treatment Follow-Up|Protocol Violation|0
2547092|NCT01474512|8815724|P13|Post-Treatment Follow-Up|Protocol Violation|0
2547093|NCT01474512|8815725|P12|Post-Treatment Follow-Up|Protocol Violation|0
2547094|NCT01474512|8815726|P11|Post-Treatment Follow-Up|Protocol Violation|0
2547095|NCT01474512|8815727|P10|Post-Treatment Follow-Up|Protocol Violation|0
2547096|NCT01474512|8815728|P9|Post-Treatment Follow-Up|Protocol Violation|0
2547097|NCT01474512|8815729|P8|Post-Treatment Follow-Up|Protocol Violation|0
2547098|NCT01474512|8815730|P7|Post-Treatment Follow-Up|Protocol Violation|0
2547099|NCT01474512|8815731|P6|Post-Treatment Follow-Up|Protocol Violation|0
2547100|NCT01474512|8815732|P5|Post-Treatment Follow-Up|Protocol Violation|0
2547101|NCT01474512|8815733|P4|Post-Treatment Follow-Up|Protocol Violation|0
2547102|NCT01474512|8815734|P3|Post-Treatment Follow-Up|Protocol Violation|0
2547103|NCT01474512|8815735|P2|Post-Treatment Follow-Up|Protocol Violation|0
2547104|NCT01474512|8815736|P1|Post-Treatment Follow-Up|Protocol Violation|0
2547105|NCT01474512|8815719|P18|Post-Treatment Follow-Up|Clinical Relapse|2
2547106|NCT01474512|8815720|P17|Post-Treatment Follow-Up|Clinical Relapse|6
2547107|NCT01474512|8815721|P16|Post-Treatment Follow-Up|Clinical Relapse|0
2547108|NCT01474512|8815722|P15|Post-Treatment Follow-Up|Clinical Relapse|0
2547109|NCT01474512|8815723|P14|Post-Treatment Follow-Up|Clinical Relapse|0
2547110|NCT01474512|8815724|P13|Post-Treatment Follow-Up|Clinical Relapse|0
2547111|NCT01474512|8815725|P12|Post-Treatment Follow-Up|Clinical Relapse|0
2547112|NCT01474512|8815726|P11|Post-Treatment Follow-Up|Clinical Relapse|0
2547113|NCT01474512|8815727|P10|Post-Treatment Follow-Up|Clinical Relapse|0
2547114|NCT01474512|8815728|P9|Post-Treatment Follow-Up|Clinical Relapse|0
2547115|NCT01474512|8815729|P8|Post-Treatment Follow-Up|Clinical Relapse|0
2547116|NCT01474512|8815730|P7|Post-Treatment Follow-Up|Clinical Relapse|0
2547117|NCT01474512|8815731|P6|Post-Treatment Follow-Up|Clinical Relapse|0
2547118|NCT01474512|8815732|P5|Post-Treatment Follow-Up|Clinical Relapse|0
2547119|NCT01474512|8815733|P4|Post-Treatment Follow-Up|Clinical Relapse|0
2547120|NCT01474512|8815734|P3|Post-Treatment Follow-Up|Clinical Relapse|0
2547121|NCT01474512|8815735|P2|Post-Treatment Follow-Up|Clinical Relapse|0
2547122|NCT01474512|8815736|P1|Post-Treatment Follow-Up|Clinical Relapse|0
2547123|NCT01474512|8815719|P18|Post-Treatment Follow-Up|Physician Decision|5
2547124|NCT01474512|8815720|P17|Post-Treatment Follow-Up|Physician Decision|4
2547125|NCT01474512|8815721|P16|Post-Treatment Follow-Up|Physician Decision|0
2547126|NCT01474512|8815722|P15|Post-Treatment Follow-Up|Physician Decision|0
2547127|NCT01474512|8815723|P14|Post-Treatment Follow-Up|Physician Decision|0
2547128|NCT01474512|8815724|P13|Post-Treatment Follow-Up|Physician Decision|0
2547129|NCT01474512|8815725|P12|Post-Treatment Follow-Up|Physician Decision|0
2547130|NCT01474512|8815726|P11|Post-Treatment Follow-Up|Physician Decision|0
2547131|NCT01474512|8815727|P10|Post-Treatment Follow-Up|Physician Decision|0
2547132|NCT01474512|8815728|P9|Post-Treatment Follow-Up|Physician Decision|0
2547133|NCT01474512|8815729|P8|Post-Treatment Follow-Up|Physician Decision|0
2547134|NCT01474512|8815730|P7|Post-Treatment Follow-Up|Physician Decision|0
2547135|NCT01474512|8815731|P6|Post-Treatment Follow-Up|Physician Decision|0
2547136|NCT01474512|8815732|P5|Post-Treatment Follow-Up|Physician Decision|0
2547137|NCT01474512|8815733|P4|Post-Treatment Follow-Up|Physician Decision|0
2547138|NCT01474512|8815734|P3|Post-Treatment Follow-Up|Physician Decision|0
2547139|NCT01474512|8815735|P2|Post-Treatment Follow-Up|Physician Decision|0
2547140|NCT01474512|8815736|P1|Post-Treatment Follow-Up|Physician Decision|0
2547141|NCT01474512|8815719|P18|Post-Treatment Follow-Up|Lost to Follow-up|7
2547142|NCT01474512|8815720|P17|Post-Treatment Follow-Up|Lost to Follow-up|12
2547143|NCT01474512|8815721|P16|Post-Treatment Follow-Up|Lost to Follow-up|0
2547144|NCT01474512|8815722|P15|Post-Treatment Follow-Up|Lost to Follow-up|0
2547145|NCT01474512|8815723|P14|Post-Treatment Follow-Up|Lost to Follow-up|0
2547146|NCT01474512|8815724|P13|Post-Treatment Follow-Up|Lost to Follow-up|0
2547147|NCT01474512|8815725|P12|Post-Treatment Follow-Up|Lost to Follow-up|0
2547148|NCT01474512|8815726|P11|Post-Treatment Follow-Up|Lost to Follow-up|0
2547149|NCT01474512|8815727|P10|Post-Treatment Follow-Up|Lost to Follow-up|0
2547150|NCT01474512|8815728|P9|Post-Treatment Follow-Up|Lost to Follow-up|0
2547151|NCT01474512|8815729|P8|Post-Treatment Follow-Up|Lost to Follow-up|0
2547152|NCT01474512|8815730|P7|Post-Treatment Follow-Up|Lost to Follow-up|0
2547153|NCT01474512|8815731|P6|Post-Treatment Follow-Up|Lost to Follow-up|0
2547154|NCT01474512|8815732|P5|Post-Treatment Follow-Up|Lost to Follow-up|0
2547155|NCT01474512|8815733|P4|Post-Treatment Follow-Up|Lost to Follow-up|0
2547156|NCT01474512|8815734|P3|Post-Treatment Follow-Up|Lost to Follow-up|0
2547157|NCT01474512|8815735|P2|Post-Treatment Follow-Up|Lost to Follow-up|0
2547158|NCT01474512|8815736|P1|Post-Treatment Follow-Up|Lost to Follow-up|0
2547159|NCT01474512|8815719|P18|Post-Treatment Follow-Up|Lack of Efficacy|3
2547160|NCT01474512|8815720|P17|Post-Treatment Follow-Up|Lack of Efficacy|31
2547161|NCT01474512|8815721|P16|Post-Treatment Follow-Up|Lack of Efficacy|2
2547162|NCT01474512|8815722|P15|Post-Treatment Follow-Up|Lack of Efficacy|3
2547163|NCT01474512|8815723|P14|Post-Treatment Follow-Up|Lack of Efficacy|0
2547164|NCT01474512|8815724|P13|Post-Treatment Follow-Up|Lack of Efficacy|0
2547165|NCT01474512|8815725|P12|Post-Treatment Follow-Up|Lack of Efficacy|0
2547166|NCT01474512|8815726|P11|Post-Treatment Follow-Up|Lack of Efficacy|0
2547167|NCT01474512|8815727|P10|Post-Treatment Follow-Up|Lack of Efficacy|0
2547168|NCT01474512|8815728|P9|Post-Treatment Follow-Up|Lack of Efficacy|0
2547169|NCT01474512|8815729|P8|Post-Treatment Follow-Up|Lack of Efficacy|0
2547170|NCT01474512|8815730|P7|Post-Treatment Follow-Up|Lack of Efficacy|0
2547171|NCT01474512|8815731|P6|Post-Treatment Follow-Up|Lack of Efficacy|0
2547172|NCT01474512|8815732|P5|Post-Treatment Follow-Up|Lack of Efficacy|0
2547173|NCT01474512|8815733|P4|Post-Treatment Follow-Up|Lack of Efficacy|0
2547174|NCT01474512|8815734|P3|Post-Treatment Follow-Up|Lack of Efficacy|0
2547175|NCT01474512|8815735|P2|Post-Treatment Follow-Up|Lack of Efficacy|0
2547176|NCT01474512|8815736|P1|Post-Treatment Follow-Up|Lack of Efficacy|0
2547177|NCT01474512|8815719|P18|Post-Treatment Follow-Up|Withdrawal by Subject|17
2547178|NCT01474512|8815720|P17|Post-Treatment Follow-Up|Withdrawal by Subject|36
2547179|NCT01474512|8815721|P16|Post-Treatment Follow-Up|Withdrawal by Subject|2
2547180|NCT01474512|8815722|P15|Post-Treatment Follow-Up|Withdrawal by Subject|3
2547181|NCT01474512|8815723|P14|Post-Treatment Follow-Up|Withdrawal by Subject|0
2547182|NCT01474512|8815724|P13|Post-Treatment Follow-Up|Withdrawal by Subject|0
2547183|NCT01474512|8815725|P12|Post-Treatment Follow-Up|Withdrawal by Subject|0
2547184|NCT01474512|8815726|P11|Post-Treatment Follow-Up|Withdrawal by Subject|0
2547185|NCT01474512|8815727|P10|Post-Treatment Follow-Up|Withdrawal by Subject|0
2547186|NCT01474512|8815728|P9|Post-Treatment Follow-Up|Withdrawal by Subject|0
2547187|NCT01474512|8815729|P8|Post-Treatment Follow-Up|Withdrawal by Subject|0
2547188|NCT01474512|8815730|P7|Post-Treatment Follow-Up|Withdrawal by Subject|0
2547189|NCT01474512|8815731|P6|Post-Treatment Follow-Up|Withdrawal by Subject|0
2547190|NCT01474512|8815732|P5|Post-Treatment Follow-Up|Withdrawal by Subject|0
2547191|NCT01474512|8815733|P4|Post-Treatment Follow-Up|Withdrawal by Subject|0
2547192|NCT01474512|8815734|P3|Post-Treatment Follow-Up|Withdrawal by Subject|0
2547193|NCT01474512|8815735|P2|Post-Treatment Follow-Up|Withdrawal by Subject|0
2547194|NCT01474512|8815736|P1|Post-Treatment Follow-Up|Withdrawal by Subject|0
2547195|NCT01474512|8815719|P18|Post-Treatment Follow-Up|Adverse Event|11
2547196|NCT01474512|8815720|P17|Post-Treatment Follow-Up|Adverse Event|58
2547197|NCT01474512|8815721|P16|Post-Treatment Follow-Up|Adverse Event|2
2547198|NCT01474512|8815722|P15|Post-Treatment Follow-Up|Adverse Event|8
2547199|NCT01474512|8815723|P14|Post-Treatment Follow-Up|Adverse Event|0
2547200|NCT01474512|8815724|P13|Post-Treatment Follow-Up|Adverse Event|0
2547201|NCT01474512|8815725|P12|Post-Treatment Follow-Up|Adverse Event|0
2547202|NCT01474512|8815726|P11|Post-Treatment Follow-Up|Adverse Event|0
2547203|NCT01474512|8815727|P10|Post-Treatment Follow-Up|Adverse Event|0
2547204|NCT01474512|8815728|P9|Post-Treatment Follow-Up|Adverse Event|0
2547205|NCT01474512|8815729|P8|Post-Treatment Follow-Up|Adverse Event|0
2547206|NCT01474512|8815730|P7|Post-Treatment Follow-Up|Adverse Event|0
2547207|NCT01474512|8815731|P6|Post-Treatment Follow-Up|Adverse Event|0
2547208|NCT01474512|8815732|P5|Post-Treatment Follow-Up|Adverse Event|0
2547209|NCT01474512|8815733|P4|Post-Treatment Follow-Up|Adverse Event|0
2547210|NCT01474512|8815734|P3|Post-Treatment Follow-Up|Adverse Event|0
2547211|NCT01474512|8815735|P2|Post-Treatment Follow-Up|Adverse Event|0
2547212|NCT01474512|8815736|P1|Post-Treatment Follow-Up|Adverse Event|0
2547213|NCT01474512|8815719|P18|Long-Term Extension Period|Switched From PBO to Ixe|0
2547214|NCT01474512|8815720|P17|Long-Term Extension Period|Switched From PBO to Ixe|0
2547215|NCT01474512|8815721|P16|Long-Term Extension Period|Switched From PBO to Ixe|0
2547216|NCT01474512|8815722|P15|Long-Term Extension Period|Switched From PBO to Ixe|0
2547217|NCT01474512|8815723|P14|Long-Term Extension Period|Switched From PBO to Ixe|0
2547218|NCT01474512|8815724|P13|Long-Term Extension Period|Switched From PBO to Ixe|0
2547219|NCT01474512|8815725|P12|Long-Term Extension Period|Switched From PBO to Ixe|21
2547220|NCT01474512|8815726|P11|Long-Term Extension Period|Switched From PBO to Ixe|0
2547221|NCT01474512|8815727|P10|Long-Term Extension Period|Switched From PBO to Ixe|0
2547222|NCT01474512|8815728|P9|Long-Term Extension Period|Switched From PBO to Ixe|0
2547223|NCT01474512|8815729|P8|Long-Term Extension Period|Switched From PBO to Ixe|0
2547224|NCT01474512|8815730|P7|Long-Term Extension Period|Switched From PBO to Ixe|0
2547225|NCT01474512|8815731|P6|Long-Term Extension Period|Switched From PBO to Ixe|0
2547226|NCT01474512|8815732|P5|Long-Term Extension Period|Switched From PBO to Ixe|0
2547227|NCT01474512|8815733|P4|Long-Term Extension Period|Switched From PBO to Ixe|0
2547228|NCT01474512|8815734|P3|Long-Term Extension Period|Switched From PBO to Ixe|0
2547229|NCT01474512|8815735|P2|Long-Term Extension Period|Switched From PBO to Ixe|0
2547230|NCT01474512|8815736|P1|Long-Term Extension Period|Switched From PBO to Ixe|0
2547231|NCT01474512|8815719|P18|Long-Term Extension Period|Parent/Caregiver Decision|0
2547232|NCT01474512|8815720|P17|Long-Term Extension Period|Parent/Caregiver Decision|0
2547233|NCT01474512|8815721|P16|Long-Term Extension Period|Parent/Caregiver Decision|0
2547234|NCT01474512|8815722|P15|Long-Term Extension Period|Parent/Caregiver Decision|0
2547235|NCT01474512|8815723|P14|Long-Term Extension Period|Parent/Caregiver Decision|1
2547236|NCT01474512|8815724|P13|Long-Term Extension Period|Parent/Caregiver Decision|1
2547237|NCT01474512|8815725|P12|Long-Term Extension Period|Parent/Caregiver Decision|0
2547238|NCT01474512|8815726|P11|Long-Term Extension Period|Parent/Caregiver Decision|0
2547239|NCT01474512|8815727|P10|Long-Term Extension Period|Parent/Caregiver Decision|0
2547240|NCT01474512|8815728|P9|Long-Term Extension Period|Parent/Caregiver Decision|0
2547241|NCT01474512|8815729|P8|Long-Term Extension Period|Parent/Caregiver Decision|0
2547242|NCT01474512|8815730|P7|Long-Term Extension Period|Parent/Caregiver Decision|0
2547243|NCT01474512|8815731|P6|Long-Term Extension Period|Parent/Caregiver Decision|0
2547244|NCT01474512|8815732|P5|Long-Term Extension Period|Parent/Caregiver Decision|0
2547245|NCT01474512|8815733|P4|Long-Term Extension Period|Parent/Caregiver Decision|0
2547246|NCT01474512|8815734|P3|Long-Term Extension Period|Parent/Caregiver Decision|0
2547247|NCT01474512|8815735|P2|Long-Term Extension Period|Parent/Caregiver Decision|0
2547248|NCT01474512|8815736|P1|Long-Term Extension Period|Parent/Caregiver Decision|0
2547249|NCT01474512|8815719|P18|Long-Term Extension Period|Protocol Violation|0
2547250|NCT01474512|8815720|P17|Long-Term Extension Period|Protocol Violation|0
2547251|NCT01474512|8815721|P16|Long-Term Extension Period|Protocol Violation|0
2547252|NCT01474512|8815722|P15|Long-Term Extension Period|Protocol Violation|0
2547253|NCT01474512|8815723|P14|Long-Term Extension Period|Protocol Violation|5
2547254|NCT01474512|8815724|P13|Long-Term Extension Period|Protocol Violation|5
2547255|NCT01474512|8815725|P12|Long-Term Extension Period|Protocol Violation|0
2547256|NCT01474512|8815726|P11|Long-Term Extension Period|Protocol Violation|0
2547257|NCT01474512|8815727|P10|Long-Term Extension Period|Protocol Violation|0
2547258|NCT01474512|8815728|P9|Long-Term Extension Period|Protocol Violation|0
2547259|NCT01474512|8815729|P8|Long-Term Extension Period|Protocol Violation|0
2547260|NCT01474512|8815730|P7|Long-Term Extension Period|Protocol Violation|0
2547261|NCT01474512|8815731|P6|Long-Term Extension Period|Protocol Violation|0
2547262|NCT01474512|8815732|P5|Long-Term Extension Period|Protocol Violation|0
2547263|NCT01474512|8815733|P4|Long-Term Extension Period|Protocol Violation|0
2547264|NCT01474512|8815734|P3|Long-Term Extension Period|Protocol Violation|0
2547265|NCT01474512|8815735|P2|Long-Term Extension Period|Protocol Violation|0
2547266|NCT01474512|8815736|P1|Long-Term Extension Period|Protocol Violation|0
2547267|NCT01474512|8815719|P18|Long-Term Extension Period|Sponsor Decision|0
2547268|NCT01474512|8815720|P17|Long-Term Extension Period|Sponsor Decision|0
2547269|NCT01474512|8815721|P16|Long-Term Extension Period|Sponsor Decision|0
2547270|NCT01474512|8815722|P15|Long-Term Extension Period|Sponsor Decision|0
2547271|NCT01474512|8815723|P14|Long-Term Extension Period|Sponsor Decision|6
2547272|NCT01474512|8815724|P13|Long-Term Extension Period|Sponsor Decision|6
2547273|NCT01474512|8815725|P12|Long-Term Extension Period|Sponsor Decision|0
2547274|NCT01474512|8815726|P11|Long-Term Extension Period|Sponsor Decision|0
2547275|NCT01474512|8815727|P10|Long-Term Extension Period|Sponsor Decision|0
2547276|NCT01474512|8815728|P9|Long-Term Extension Period|Sponsor Decision|0
2547277|NCT01474512|8815729|P8|Long-Term Extension Period|Sponsor Decision|0
2547278|NCT01474512|8815730|P7|Long-Term Extension Period|Sponsor Decision|0
2547279|NCT01474512|8815731|P6|Long-Term Extension Period|Sponsor Decision|0
2547280|NCT01474512|8815732|P5|Long-Term Extension Period|Sponsor Decision|0
2547281|NCT01474512|8815733|P4|Long-Term Extension Period|Sponsor Decision|0
2547282|NCT01474512|8815734|P3|Long-Term Extension Period|Sponsor Decision|0
2547283|NCT01474512|8815735|P2|Long-Term Extension Period|Sponsor Decision|0
2547284|NCT01474512|8815736|P1|Long-Term Extension Period|Sponsor Decision|0
2547285|NCT01474512|8815719|P18|Long-Term Extension Period|Death|0
2547286|NCT01474512|8815720|P17|Long-Term Extension Period|Death|0
2547287|NCT01474512|8815721|P16|Long-Term Extension Period|Death|0
2547288|NCT01474512|8815722|P15|Long-Term Extension Period|Death|0
2547289|NCT01474512|8815723|P14|Long-Term Extension Period|Death|9
2547290|NCT01474512|8815724|P13|Long-Term Extension Period|Death|9
2547291|NCT01474512|8815725|P12|Long-Term Extension Period|Death|0
2547292|NCT01474512|8815726|P11|Long-Term Extension Period|Death|0
2547293|NCT01474512|8815727|P10|Long-Term Extension Period|Death|0
2547294|NCT01474512|8815728|P9|Long-Term Extension Period|Death|0
2547295|NCT01474512|8815729|P8|Long-Term Extension Period|Death|0
2547296|NCT01474512|8815730|P7|Long-Term Extension Period|Death|0
2547297|NCT01474512|8815731|P6|Long-Term Extension Period|Death|0
2547298|NCT01474512|8815732|P5|Long-Term Extension Period|Death|0
2547299|NCT01474512|8815733|P4|Long-Term Extension Period|Death|0
2547300|NCT01474512|8815734|P3|Long-Term Extension Period|Death|0
2547301|NCT01474512|8815735|P2|Long-Term Extension Period|Death|0
2547302|NCT01474512|8815736|P1|Long-Term Extension Period|Death|0
2547303|NCT01474512|8815719|P18|Long-Term Extension Period|Clinical Relapse|0
2547304|NCT01474512|8815720|P17|Long-Term Extension Period|Clinical Relapse|0
2547305|NCT01474512|8815721|P16|Long-Term Extension Period|Clinical Relapse|0
2547306|NCT01474512|8815722|P15|Long-Term Extension Period|Clinical Relapse|0
2547307|NCT01474512|8815723|P14|Long-Term Extension Period|Clinical Relapse|9
2547308|NCT01474512|8815724|P13|Long-Term Extension Period|Clinical Relapse|9
2547309|NCT01474512|8815725|P12|Long-Term Extension Period|Clinical Relapse|0
2547310|NCT01474512|8815726|P11|Long-Term Extension Period|Clinical Relapse|0
2547311|NCT01474512|8815727|P10|Long-Term Extension Period|Clinical Relapse|0
2547312|NCT01474512|8815728|P9|Long-Term Extension Period|Clinical Relapse|0
2547313|NCT01474512|8815729|P8|Long-Term Extension Period|Clinical Relapse|0
2547314|NCT01474512|8815730|P7|Long-Term Extension Period|Clinical Relapse|0
2547315|NCT01474512|8815731|P6|Long-Term Extension Period|Clinical Relapse|0
2547316|NCT01474512|8815732|P5|Long-Term Extension Period|Clinical Relapse|0
2547317|NCT01474512|8815733|P4|Long-Term Extension Period|Clinical Relapse|0
2547318|NCT01474512|8815734|P3|Long-Term Extension Period|Clinical Relapse|0
2547319|NCT01474512|8815735|P2|Long-Term Extension Period|Clinical Relapse|0
2547320|NCT01474512|8815736|P1|Long-Term Extension Period|Clinical Relapse|0
2547321|NCT01474512|8815719|P18|Long-Term Extension Period|Physician Decision|0
2547322|NCT01474512|8815720|P17|Long-Term Extension Period|Physician Decision|0
2547323|NCT01474512|8815721|P16|Long-Term Extension Period|Physician Decision|0
2547324|NCT01474512|8815722|P15|Long-Term Extension Period|Physician Decision|0
2547325|NCT01474512|8815723|P14|Long-Term Extension Period|Physician Decision|21
2547326|NCT01474512|8815724|P13|Long-Term Extension Period|Physician Decision|21
2547327|NCT01474512|8815725|P12|Long-Term Extension Period|Physician Decision|0
2547328|NCT01474512|8815726|P11|Long-Term Extension Period|Physician Decision|0
2547329|NCT01474512|8815727|P10|Long-Term Extension Period|Physician Decision|0
2547330|NCT01474512|8815728|P9|Long-Term Extension Period|Physician Decision|0
2547331|NCT01474512|8815729|P8|Long-Term Extension Period|Physician Decision|0
2547332|NCT01474512|8815730|P7|Long-Term Extension Period|Physician Decision|0
2547333|NCT01474512|8815731|P6|Long-Term Extension Period|Physician Decision|0
2547334|NCT01474512|8815732|P5|Long-Term Extension Period|Physician Decision|0
2547335|NCT01474512|8815733|P4|Long-Term Extension Period|Physician Decision|0
2547336|NCT01474512|8815734|P3|Long-Term Extension Period|Physician Decision|0
2547337|NCT01474512|8815735|P2|Long-Term Extension Period|Physician Decision|0
2547338|NCT01474512|8815736|P1|Long-Term Extension Period|Physician Decision|0
2547339|NCT01474512|8815719|P18|Long-Term Extension Period|Lack of Efficacy|0
2547340|NCT01474512|8815720|P17|Long-Term Extension Period|Lack of Efficacy|0
2547341|NCT01474512|8815721|P16|Long-Term Extension Period|Lack of Efficacy|0
2547342|NCT01474512|8815722|P15|Long-Term Extension Period|Lack of Efficacy|0
2547343|NCT01474512|8815723|P14|Long-Term Extension Period|Lack of Efficacy|25
2547344|NCT01474512|8815724|P13|Long-Term Extension Period|Lack of Efficacy|24
2547345|NCT01474512|8815725|P12|Long-Term Extension Period|Lack of Efficacy|1
2547346|NCT01474512|8815726|P11|Long-Term Extension Period|Lack of Efficacy|0
2547347|NCT01474512|8815727|P10|Long-Term Extension Period|Lack of Efficacy|0
2547348|NCT01474512|8815728|P9|Long-Term Extension Period|Lack of Efficacy|0
2547349|NCT01474512|8815729|P8|Long-Term Extension Period|Lack of Efficacy|0
2547350|NCT01474512|8815730|P7|Long-Term Extension Period|Lack of Efficacy|0
2547351|NCT01474512|8815731|P6|Long-Term Extension Period|Lack of Efficacy|0
2547352|NCT01474512|8815732|P5|Long-Term Extension Period|Lack of Efficacy|0
2547353|NCT01474512|8815733|P4|Long-Term Extension Period|Lack of Efficacy|0
2547354|NCT01474512|8815734|P3|Long-Term Extension Period|Lack of Efficacy|0
2547355|NCT01474512|8815735|P2|Long-Term Extension Period|Lack of Efficacy|0
2547356|NCT01474512|8815736|P1|Long-Term Extension Period|Lack of Efficacy|0
2547357|NCT01474512|8815719|P18|Long-Term Extension Period|Lost to Follow-up|0
2547358|NCT01474512|8815720|P17|Long-Term Extension Period|Lost to Follow-up|0
2547359|NCT01474512|8815721|P16|Long-Term Extension Period|Lost to Follow-up|0
2547360|NCT01474512|8815722|P15|Long-Term Extension Period|Lost to Follow-up|0
2547361|NCT01474512|8815723|P14|Long-Term Extension Period|Lost to Follow-up|25
2547362|NCT01474512|8815724|P13|Long-Term Extension Period|Lost to Follow-up|25
2547363|NCT01474512|8815725|P12|Long-Term Extension Period|Lost to Follow-up|0
2547364|NCT01474512|8815726|P11|Long-Term Extension Period|Lost to Follow-up|0
2547365|NCT01474512|8815727|P10|Long-Term Extension Period|Lost to Follow-up|0
2547366|NCT01474512|8815728|P9|Long-Term Extension Period|Lost to Follow-up|0
2547367|NCT01474512|8815729|P8|Long-Term Extension Period|Lost to Follow-up|0
2547368|NCT01474512|8815730|P7|Long-Term Extension Period|Lost to Follow-up|0
2547369|NCT01474512|8815731|P6|Long-Term Extension Period|Lost to Follow-up|0
2547370|NCT01474512|8815732|P5|Long-Term Extension Period|Lost to Follow-up|0
2547371|NCT01474512|8815733|P4|Long-Term Extension Period|Lost to Follow-up|0
2547372|NCT01474512|8815734|P3|Long-Term Extension Period|Lost to Follow-up|0
2547373|NCT01474512|8815735|P2|Long-Term Extension Period|Lost to Follow-up|0
2547374|NCT01474512|8815736|P1|Long-Term Extension Period|Lost to Follow-up|0
2547375|NCT01474512|8815719|P18|Long-Term Extension Period|Adverse Event|0
2547376|NCT01474512|8815720|P17|Long-Term Extension Period|Adverse Event|0
2547377|NCT01474512|8815721|P16|Long-Term Extension Period|Adverse Event|0
2547378|NCT01474512|8815722|P15|Long-Term Extension Period|Adverse Event|0
2547379|NCT01474512|8815723|P14|Long-Term Extension Period|Adverse Event|58
2547380|NCT01474512|8815724|P13|Long-Term Extension Period|Adverse Event|57
2547381|NCT01474512|8815725|P12|Long-Term Extension Period|Adverse Event|1
2547382|NCT01474512|8815726|P11|Long-Term Extension Period|Adverse Event|0
2547383|NCT01474512|8815727|P10|Long-Term Extension Period|Adverse Event|0
2547384|NCT01474512|8815728|P9|Long-Term Extension Period|Adverse Event|0
2547385|NCT01474512|8815729|P8|Long-Term Extension Period|Adverse Event|0
2547386|NCT01474512|8815730|P7|Long-Term Extension Period|Adverse Event|0
2547387|NCT01474512|8815731|P6|Long-Term Extension Period|Adverse Event|0
2547388|NCT01474512|8815732|P5|Long-Term Extension Period|Adverse Event|0
2547389|NCT01474512|8815733|P4|Long-Term Extension Period|Adverse Event|0
2547390|NCT01474512|8815734|P3|Long-Term Extension Period|Adverse Event|0
2547391|NCT01474512|8815735|P2|Long-Term Extension Period|Adverse Event|0
2547392|NCT01474512|8815736|P1|Long-Term Extension Period|Adverse Event|0
2547393|NCT01474512|8815719|P18|Long-Term Extension Period|Withdrawal by Subject|0
2547394|NCT01474512|8815720|P17|Long-Term Extension Period|Withdrawal by Subject|0
2547395|NCT01474512|8815721|P16|Long-Term Extension Period|Withdrawal by Subject|0
2547396|NCT01474512|8815722|P15|Long-Term Extension Period|Withdrawal by Subject|0
2547397|NCT01474512|8815723|P14|Long-Term Extension Period|Withdrawal by Subject|61
2547398|NCT01474512|8815724|P13|Long-Term Extension Period|Withdrawal by Subject|61
2547399|NCT01474512|8815725|P12|Long-Term Extension Period|Withdrawal by Subject|3
2547400|NCT01474512|8815726|P11|Long-Term Extension Period|Withdrawal by Subject|0
2547401|NCT01474512|8815727|P10|Long-Term Extension Period|Withdrawal by Subject|0
2547402|NCT01474512|8815728|P9|Long-Term Extension Period|Withdrawal by Subject|0
2547403|NCT01474512|8815729|P8|Long-Term Extension Period|Withdrawal by Subject|0
2547404|NCT01474512|8815730|P7|Long-Term Extension Period|Withdrawal by Subject|0
2547405|NCT01474512|8815731|P6|Long-Term Extension Period|Withdrawal by Subject|0
2547406|NCT01474512|8815732|P5|Long-Term Extension Period|Withdrawal by Subject|0
2547407|NCT01474512|8815733|P4|Long-Term Extension Period|Withdrawal by Subject|0
2547408|NCT01474512|8815734|P3|Long-Term Extension Period|Withdrawal by Subject|0
2547409|NCT01474512|8815735|P2|Long-Term Extension Period|Withdrawal by Subject|0
2547410|NCT01474512|8815736|P1|Long-Term Extension Period|Withdrawal by Subject|0
2547411|NCT01474512|8815719|P18|Maintenance Period|Treated but Discontinued in Induction|0
2547412|NCT01474512|8815720|P17|Maintenance Period|Treated but Discontinued in Induction|0
2547413|NCT01474512|8815721|P16|Maintenance Period|Treated but Discontinued in Induction|0
2547414|NCT01474512|8815722|P15|Maintenance Period|Treated but Discontinued in Induction|0
2547415|NCT01474512|8815723|P14|Maintenance Period|Treated but Discontinued in Induction|0
2547416|NCT01474512|8815724|P13|Maintenance Period|Treated but Discontinued in Induction|0
2547417|NCT01474512|8815725|P12|Maintenance Period|Treated but Discontinued in Induction|0
2547418|NCT01474512|8815726|P11|Maintenance Period|Treated but Discontinued in Induction|0
2547419|NCT01474512|8815727|P10|Maintenance Period|Treated but Discontinued in Induction|0
2547420|NCT01474512|8815728|P9|Maintenance Period|Treated but Discontinued in Induction|0
2547421|NCT01474512|8815729|P8|Maintenance Period|Treated but Discontinued in Induction|0
2547422|NCT01474512|8815730|P7|Maintenance Period|Treated but Discontinued in Induction|0
2547423|NCT01474512|8815731|P6|Maintenance Period|Treated but Discontinued in Induction|0
2547424|NCT01474512|8815732|P5|Maintenance Period|Treated but Discontinued in Induction|1
2547425|NCT01474512|8815733|P4|Maintenance Period|Treated but Discontinued in Induction|0
2547426|NCT01474512|8815734|P3|Maintenance Period|Treated but Discontinued in Induction|0
2547427|NCT01474512|8815735|P2|Maintenance Period|Treated but Discontinued in Induction|0
2547428|NCT01474512|8815736|P1|Maintenance Period|Treated but Discontinued in Induction|0
2547429|NCT01474512|8815719|P18|Maintenance Period|Protocol Violation|0
2547430|NCT01474512|8815720|P17|Maintenance Period|Protocol Violation|0
2547431|NCT01474512|8815721|P16|Maintenance Period|Protocol Violation|0
2547432|NCT01474512|8815722|P15|Maintenance Period|Protocol Violation|0
2547433|NCT01474512|8815723|P14|Maintenance Period|Protocol Violation|0
2547434|NCT01474512|8815724|P13|Maintenance Period|Protocol Violation|0
2547435|NCT01474512|8815725|P12|Maintenance Period|Protocol Violation|0
2547436|NCT01474512|8815726|P11|Maintenance Period|Protocol Violation|0
2547437|NCT01474512|8815727|P10|Maintenance Period|Protocol Violation|1
2547438|NCT01474512|8815728|P9|Maintenance Period|Protocol Violation|0
2547439|NCT01474512|8815729|P8|Maintenance Period|Protocol Violation|1
2547440|NCT01474512|8815730|P7|Maintenance Period|Protocol Violation|0
2547441|NCT01474512|8815731|P6|Maintenance Period|Protocol Violation|0
2547442|NCT01474512|8815732|P5|Maintenance Period|Protocol Violation|0
2547443|NCT01474512|8815733|P4|Maintenance Period|Protocol Violation|1
2547444|NCT01474512|8815734|P3|Maintenance Period|Protocol Violation|0
2547445|NCT01474512|8815735|P2|Maintenance Period|Protocol Violation|0
2547446|NCT01474512|8815736|P1|Maintenance Period|Protocol Violation|0
2547447|NCT01474512|8815719|P18|Maintenance Period|Lack of Efficacy|0
2547448|NCT01474512|8815720|P17|Maintenance Period|Lack of Efficacy|0
2547449|NCT01474512|8815721|P16|Maintenance Period|Lack of Efficacy|0
2547450|NCT01474512|8815722|P15|Maintenance Period|Lack of Efficacy|0
2547451|NCT01474512|8815723|P14|Maintenance Period|Lack of Efficacy|0
2547452|NCT01474512|8815724|P13|Maintenance Period|Lack of Efficacy|0
2547453|NCT01474512|8815725|P12|Maintenance Period|Lack of Efficacy|0
2547454|NCT01474512|8815726|P11|Maintenance Period|Lack of Efficacy|0
2547455|NCT01474512|8815727|P10|Maintenance Period|Lack of Efficacy|12
2547456|NCT01474512|8815728|P9|Maintenance Period|Lack of Efficacy|11
2547457|NCT01474512|8815729|P8|Maintenance Period|Lack of Efficacy|11
2547458|NCT01474512|8815730|P7|Maintenance Period|Lack of Efficacy|0
2547459|NCT01474512|8815731|P6|Maintenance Period|Lack of Efficacy|0
2547460|NCT01474512|8815732|P5|Maintenance Period|Lack of Efficacy|0
2547461|NCT01474512|8815733|P4|Maintenance Period|Lack of Efficacy|1
2547462|NCT01474512|8815734|P3|Maintenance Period|Lack of Efficacy|0
2547463|NCT01474512|8815735|P2|Maintenance Period|Lack of Efficacy|0
2547464|NCT01474512|8815736|P1|Maintenance Period|Lack of Efficacy|0
2547465|NCT01474512|8815719|P18|Maintenance Period|Clinical Relapse|0
2547466|NCT01474512|8815720|P17|Maintenance Period|Clinical Relapse|0
2547467|NCT01474512|8815721|P16|Maintenance Period|Clinical Relapse|0
2547468|NCT01474512|8815722|P15|Maintenance Period|Clinical Relapse|0
2547469|NCT01474512|8815723|P14|Maintenance Period|Clinical Relapse|0
2547470|NCT01474512|8815724|P13|Maintenance Period|Clinical Relapse|0
2547471|NCT01474512|8815725|P12|Maintenance Period|Clinical Relapse|0
2547472|NCT01474512|8815726|P11|Maintenance Period|Clinical Relapse|0
2547473|NCT01474512|8815727|P10|Maintenance Period|Clinical Relapse|0
2547474|NCT01474512|8815728|P9|Maintenance Period|Clinical Relapse|0
2547475|NCT01474512|8815729|P8|Maintenance Period|Clinical Relapse|0
2547476|NCT01474512|8815730|P7|Maintenance Period|Clinical Relapse|0
2547477|NCT01474512|8815731|P6|Maintenance Period|Clinical Relapse|0
2547478|NCT01474512|8815732|P5|Maintenance Period|Clinical Relapse|0
2547479|NCT01474512|8815733|P4|Maintenance Period|Clinical Relapse|1
2547480|NCT01474512|8815734|P3|Maintenance Period|Clinical Relapse|0
2547481|NCT01474512|8815735|P2|Maintenance Period|Clinical Relapse|0
2547482|NCT01474512|8815736|P1|Maintenance Period|Clinical Relapse|0
2547483|NCT01474512|8815719|P18|Maintenance Period|Physician Decision|0
2547484|NCT01474512|8815720|P17|Maintenance Period|Physician Decision|0
2547485|NCT01474512|8815721|P16|Maintenance Period|Physician Decision|0
2547486|NCT01474512|8815722|P15|Maintenance Period|Physician Decision|0
2547487|NCT01474512|8815723|P14|Maintenance Period|Physician Decision|0
2547488|NCT01474512|8815724|P13|Maintenance Period|Physician Decision|0
2547489|NCT01474512|8815725|P12|Maintenance Period|Physician Decision|0
2547490|NCT01474512|8815726|P11|Maintenance Period|Physician Decision|0
2547491|NCT01474512|8815727|P10|Maintenance Period|Physician Decision|0
2547492|NCT01474512|8815728|P9|Maintenance Period|Physician Decision|0
2547493|NCT01474512|8815729|P8|Maintenance Period|Physician Decision|2
2547494|NCT01474512|8815730|P7|Maintenance Period|Physician Decision|0
2547495|NCT01474512|8815731|P6|Maintenance Period|Physician Decision|1
2547496|NCT01474512|8815732|P5|Maintenance Period|Physician Decision|0
2547497|NCT01474512|8815733|P4|Maintenance Period|Physician Decision|0
2547498|NCT01474512|8815734|P3|Maintenance Period|Physician Decision|0
2547499|NCT01474512|8815735|P2|Maintenance Period|Physician Decision|0
2547500|NCT01474512|8815736|P1|Maintenance Period|Physician Decision|0
2547501|NCT01474512|8815719|P18|Maintenance Period|Death|0
2547502|NCT01474512|8815720|P17|Maintenance Period|Death|0
2547503|NCT01474512|8815721|P16|Maintenance Period|Death|0
2547504|NCT01474512|8815722|P15|Maintenance Period|Death|0
2547505|NCT01474512|8815723|P14|Maintenance Period|Death|0
2547506|NCT01474512|8815724|P13|Maintenance Period|Death|0
2547507|NCT01474512|8815725|P12|Maintenance Period|Death|0
2547508|NCT01474512|8815726|P11|Maintenance Period|Death|0
2547509|NCT01474512|8815727|P10|Maintenance Period|Death|0
2547510|NCT01474512|8815728|P9|Maintenance Period|Death|0
2547511|NCT01474512|8815729|P8|Maintenance Period|Death|0
2547512|NCT01474512|8815730|P7|Maintenance Period|Death|0
2547513|NCT01474512|8815731|P6|Maintenance Period|Death|2
2547514|NCT01474512|8815732|P5|Maintenance Period|Death|0
2547515|NCT01474512|8815733|P4|Maintenance Period|Death|0
2547516|NCT01474512|8815734|P3|Maintenance Period|Death|0
2547517|NCT01474512|8815735|P2|Maintenance Period|Death|0
2547518|NCT01474512|8815736|P1|Maintenance Period|Death|0
2547519|NCT01474512|8815719|P18|Maintenance Period|Lost to Follow-up|0
2547520|NCT01474512|8815720|P17|Maintenance Period|Lost to Follow-up|0
2547521|NCT01474512|8815721|P16|Maintenance Period|Lost to Follow-up|0
2547522|NCT01474512|8815722|P15|Maintenance Period|Lost to Follow-up|0
2547523|NCT01474512|8815723|P14|Maintenance Period|Lost to Follow-up|0
2547524|NCT01474512|8815724|P13|Maintenance Period|Lost to Follow-up|0
2547525|NCT01474512|8815725|P12|Maintenance Period|Lost to Follow-up|0
2547526|NCT01474512|8815726|P11|Maintenance Period|Lost to Follow-up|0
2547527|NCT01474512|8815727|P10|Maintenance Period|Lost to Follow-up|1
2547528|NCT01474512|8815728|P9|Maintenance Period|Lost to Follow-up|1
2547529|NCT01474512|8815729|P8|Maintenance Period|Lost to Follow-up|2
2547530|NCT01474512|8815730|P7|Maintenance Period|Lost to Follow-up|0
2547531|NCT01474512|8815731|P6|Maintenance Period|Lost to Follow-up|0
2547532|NCT01474512|8815732|P5|Maintenance Period|Lost to Follow-up|3
2547533|NCT01474512|8815733|P4|Maintenance Period|Lost to Follow-up|3
2547534|NCT01474512|8815734|P3|Maintenance Period|Lost to Follow-up|0
2547535|NCT01474512|8815735|P2|Maintenance Period|Lost to Follow-up|0
2547536|NCT01474512|8815736|P1|Maintenance Period|Lost to Follow-up|0
2547537|NCT01474512|8815719|P18|Maintenance Period|Withdrawal by Subject|0
2547538|NCT01474512|8815720|P17|Maintenance Period|Withdrawal by Subject|0
2547539|NCT01474512|8815721|P16|Maintenance Period|Withdrawal by Subject|0
2547540|NCT01474512|8815722|P15|Maintenance Period|Withdrawal by Subject|0
2547541|NCT01474512|8815723|P14|Maintenance Period|Withdrawal by Subject|0
2547542|NCT01474512|8815724|P13|Maintenance Period|Withdrawal by Subject|0
2547543|NCT01474512|8815725|P12|Maintenance Period|Withdrawal by Subject|0
2547544|NCT01474512|8815726|P11|Maintenance Period|Withdrawal by Subject|0
2547545|NCT01474512|8815727|P10|Maintenance Period|Withdrawal by Subject|1
2547546|NCT01474512|8815728|P9|Maintenance Period|Withdrawal by Subject|3
2547547|NCT01474512|8815729|P8|Maintenance Period|Withdrawal by Subject|6
2547548|NCT01474512|8815730|P7|Maintenance Period|Withdrawal by Subject|1
2547549|NCT01474512|8815731|P6|Maintenance Period|Withdrawal by Subject|3
2547550|NCT01474512|8815732|P5|Maintenance Period|Withdrawal by Subject|2
2547551|NCT01474512|8815733|P4|Maintenance Period|Withdrawal by Subject|6
2547552|NCT01474512|8815734|P3|Maintenance Period|Withdrawal by Subject|0
2547553|NCT01474512|8815735|P2|Maintenance Period|Withdrawal by Subject|0
2547554|NCT01474512|8815736|P1|Maintenance Period|Withdrawal by Subject|0
2547555|NCT01474512|8815719|P18|Maintenance Period|Adverse Event|0
2547556|NCT01474512|8815720|P17|Maintenance Period|Adverse Event|0
2547557|NCT01474512|8815721|P16|Maintenance Period|Adverse Event|0
2547558|NCT01474512|8815722|P15|Maintenance Period|Adverse Event|0
2547559|NCT01474512|8815723|P14|Maintenance Period|Adverse Event|0
2547560|NCT01474512|8815724|P13|Maintenance Period|Adverse Event|0
2547561|NCT01474512|8815725|P12|Maintenance Period|Adverse Event|0
2547562|NCT01474512|8815726|P11|Maintenance Period|Adverse Event|0
2547563|NCT01474512|8815727|P10|Maintenance Period|Adverse Event|3
2547564|NCT01474512|8815728|P9|Maintenance Period|Adverse Event|1
2547565|NCT01474512|8815729|P8|Maintenance Period|Adverse Event|19
2547566|NCT01474512|8815730|P7|Maintenance Period|Adverse Event|0
2547567|NCT01474512|8815731|P6|Maintenance Period|Adverse Event|7
2547568|NCT01474512|8815732|P5|Maintenance Period|Adverse Event|2
2547569|NCT01474512|8815733|P4|Maintenance Period|Adverse Event|4
2547570|NCT01474512|8815734|P3|Maintenance Period|Adverse Event|0
2547571|NCT01474512|8815735|P2|Maintenance Period|Adverse Event|0
2547572|NCT01474512|8815736|P1|Maintenance Period|Adverse Event|0
2547573|NCT01474512|8815719|P18|Maintenance Period|Relapsed (sPGA ≥3)|0
2547574|NCT01474512|8815720|P17|Maintenance Period|Relapsed (sPGA ≥3)|0
2547575|NCT01474512|8815721|P16|Maintenance Period|Relapsed (sPGA ≥3)|0
2547576|NCT01474512|8815722|P15|Maintenance Period|Relapsed (sPGA ≥3)|0
2547577|NCT01474512|8815723|P14|Maintenance Period|Relapsed (sPGA ≥3)|0
2547578|NCT01474512|8815724|P13|Maintenance Period|Relapsed (sPGA ≥3)|0
2547579|NCT01474512|8815725|P12|Maintenance Period|Relapsed (sPGA ≥3)|0
2547580|NCT01474512|8815726|P11|Maintenance Period|Relapsed (sPGA ≥3)|0
2547581|NCT01474512|8815727|P10|Maintenance Period|Relapsed (sPGA ≥3)|0
2547582|NCT01474512|8815728|P9|Maintenance Period|Relapsed (sPGA ≥3)|0
2547583|NCT01474512|8815729|P8|Maintenance Period|Relapsed (sPGA ≥3)|0
2547584|NCT01474512|8815730|P7|Maintenance Period|Relapsed (sPGA ≥3)|9
2547585|NCT01474512|8815731|P6|Maintenance Period|Relapsed (sPGA ≥3)|39
2547586|NCT01474512|8815732|P5|Maintenance Period|Relapsed (sPGA ≥3)|111
2547587|NCT01474512|8815733|P4|Maintenance Period|Relapsed (sPGA ≥3)|186
2547588|NCT01474512|8815734|P3|Maintenance Period|Relapsed (sPGA ≥3)|0
2547589|NCT01474512|8815735|P2|Maintenance Period|Relapsed (sPGA ≥3)|0
2547590|NCT01474512|8815736|P1|Maintenance Period|Relapsed (sPGA ≥3)|0
2547591|NCT01474512|8815719|P18|Induction Period|Lost to Follow-up|0
2547592|NCT01474512|8815720|P17|Induction Period|Lost to Follow-up|0
2547593|NCT01474512|8815721|P16|Induction Period|Lost to Follow-up|0
2547594|NCT01474512|8815722|P15|Induction Period|Lost to Follow-up|0
2547595|NCT01474512|8815723|P14|Induction Period|Lost to Follow-up|0
2547596|NCT01474512|8815724|P13|Induction Period|Lost to Follow-up|0
2547597|NCT01474512|8815725|P12|Induction Period|Lost to Follow-up|0
2547598|NCT01474512|8815726|P11|Induction Period|Lost to Follow-up|0
2547599|NCT01474512|8815727|P10|Induction Period|Lost to Follow-up|0
2547600|NCT01474512|8815728|P9|Induction Period|Lost to Follow-up|0
2547601|NCT01474512|8815729|P8|Induction Period|Lost to Follow-up|0
2547602|NCT01474512|8815730|P7|Induction Period|Lost to Follow-up|0
2547603|NCT01474512|8815731|P6|Induction Period|Lost to Follow-up|0
2547604|NCT01474512|8815732|P5|Induction Period|Lost to Follow-up|0
2547605|NCT01474512|8815733|P4|Induction Period|Lost to Follow-up|0
2547606|NCT01474512|8815734|P3|Induction Period|Lost to Follow-up|2
2547607|NCT01474512|8815735|P2|Induction Period|Lost to Follow-up|0
2547608|NCT01474512|8815736|P1|Induction Period|Lost to Follow-up|1
2547609|NCT01474512|8815719|P18|Induction Period|Sponsor Decision|0
2547610|NCT01474512|8815720|P17|Induction Period|Sponsor Decision|0
2547611|NCT01474512|8815721|P16|Induction Period|Sponsor Decision|0
2547612|NCT01474512|8815722|P15|Induction Period|Sponsor Decision|0
2547613|NCT01474512|8815723|P14|Induction Period|Sponsor Decision|0
2547614|NCT01474512|8815724|P13|Induction Period|Sponsor Decision|0
2547615|NCT01474512|8815725|P12|Induction Period|Sponsor Decision|0
2547616|NCT01474512|8815726|P11|Induction Period|Sponsor Decision|0
2547617|NCT01474512|8815727|P10|Induction Period|Sponsor Decision|0
2547618|NCT01474512|8815728|P9|Induction Period|Sponsor Decision|0
2547619|NCT01474512|8815729|P8|Induction Period|Sponsor Decision|0
2547620|NCT01474512|8815730|P7|Induction Period|Sponsor Decision|0
2547621|NCT01474512|8815731|P6|Induction Period|Sponsor Decision|0
2547622|NCT01474512|8815732|P5|Induction Period|Sponsor Decision|0
2547623|NCT01474512|8815733|P4|Induction Period|Sponsor Decision|0
2547624|NCT01474512|8815734|P3|Induction Period|Sponsor Decision|1
2547625|NCT01474512|8815735|P2|Induction Period|Sponsor Decision|1
2547626|NCT01474512|8815736|P1|Induction Period|Sponsor Decision|1
2547627|NCT01474512|8815719|P18|Induction Period|Protocol Violation|0
2547628|NCT01474512|8815720|P17|Induction Period|Protocol Violation|0
2547629|NCT01474512|8815721|P16|Induction Period|Protocol Violation|0
2547630|NCT01474512|8815722|P15|Induction Period|Protocol Violation|0
2547631|NCT01474512|8815723|P14|Induction Period|Protocol Violation|0
2547632|NCT01474512|8815724|P13|Induction Period|Protocol Violation|0
2547633|NCT01474512|8815725|P12|Induction Period|Protocol Violation|0
2547634|NCT01474512|8815726|P11|Induction Period|Protocol Violation|0
2547635|NCT01474512|8815727|P10|Induction Period|Protocol Violation|0
2547636|NCT01474512|8815728|P9|Induction Period|Protocol Violation|0
2547637|NCT01474512|8815729|P8|Induction Period|Protocol Violation|0
2547638|NCT01474512|8815730|P7|Induction Period|Protocol Violation|0
2547639|NCT01474512|8815731|P6|Induction Period|Protocol Violation|0
2547640|NCT01474512|8815732|P5|Induction Period|Protocol Violation|0
2547641|NCT01474512|8815733|P4|Induction Period|Protocol Violation|0
2547642|NCT01474512|8815734|P3|Induction Period|Protocol Violation|0
2547643|NCT01474512|8815735|P2|Induction Period|Protocol Violation|6
2547644|NCT01474512|8815736|P1|Induction Period|Protocol Violation|3
2547645|NCT01474512|8815719|P18|Induction Period|Withdrawal by Subject|0
2547646|NCT01474512|8815720|P17|Induction Period|Withdrawal by Subject|0
2547647|NCT01474512|8815721|P16|Induction Period|Withdrawal by Subject|0
2547648|NCT01474512|8815722|P15|Induction Period|Withdrawal by Subject|0
2547649|NCT01474512|8815723|P14|Induction Period|Withdrawal by Subject|0
2547650|NCT01474512|8815724|P13|Induction Period|Withdrawal by Subject|0
2547651|NCT01474512|8815725|P12|Induction Period|Withdrawal by Subject|0
2547652|NCT01474512|8815726|P11|Induction Period|Withdrawal by Subject|0
2547653|NCT01474512|8815727|P10|Induction Period|Withdrawal by Subject|0
2547654|NCT01474512|8815728|P9|Induction Period|Withdrawal by Subject|0
2547655|NCT01474512|8815729|P8|Induction Period|Withdrawal by Subject|0
2547656|NCT01474512|8815730|P7|Induction Period|Withdrawal by Subject|0
2547657|NCT01474512|8815731|P6|Induction Period|Withdrawal by Subject|0
2547658|NCT01474512|8815732|P5|Induction Period|Withdrawal by Subject|0
2547659|NCT01474512|8815733|P4|Induction Period|Withdrawal by Subject|0
2547660|NCT01474512|8815734|P3|Induction Period|Withdrawal by Subject|5
2547661|NCT01474512|8815735|P2|Induction Period|Withdrawal by Subject|6
2547662|NCT01474512|8815736|P1|Induction Period|Withdrawal by Subject|6
2547663|NCT01474512|8815719|P18|Induction Period|Lack of Efficacy|0
2547664|NCT01474512|8815720|P17|Induction Period|Lack of Efficacy|0
2547665|NCT01474512|8815721|P16|Induction Period|Lack of Efficacy|0
2547666|NCT01474512|8815722|P15|Induction Period|Lack of Efficacy|0
2547667|NCT01474512|8815723|P14|Induction Period|Lack of Efficacy|0
2547668|NCT01474512|8815724|P13|Induction Period|Lack of Efficacy|0
2547669|NCT01474512|8815725|P12|Induction Period|Lack of Efficacy|0
2547670|NCT01474512|8815726|P11|Induction Period|Lack of Efficacy|0
2547671|NCT01474512|8815727|P10|Induction Period|Lack of Efficacy|0
2547672|NCT01474512|8815728|P9|Induction Period|Lack of Efficacy|0
2547673|NCT01474512|8815729|P8|Induction Period|Lack of Efficacy|0
2547674|NCT01474512|8815730|P7|Induction Period|Lack of Efficacy|0
2547675|NCT01474512|8815731|P6|Induction Period|Lack of Efficacy|0
2547676|NCT01474512|8815732|P5|Induction Period|Lack of Efficacy|0
2547677|NCT01474512|8815733|P4|Induction Period|Lack of Efficacy|0
2547678|NCT01474512|8815734|P3|Induction Period|Lack of Efficacy|0
2547679|NCT01474512|8815735|P2|Induction Period|Lack of Efficacy|1
2547680|NCT01474512|8815736|P1|Induction Period|Lack of Efficacy|7
2547681|NCT01474512|8815719|P18|Induction Period|Adverse Event|0
2547682|NCT01474512|8815720|P17|Induction Period|Adverse Event|0
2547683|NCT01474512|8815721|P16|Induction Period|Adverse Event|0
2547684|NCT01474512|8815722|P15|Induction Period|Adverse Event|0
2547685|NCT01474512|8815723|P14|Induction Period|Adverse Event|0
2547686|NCT01474512|8815724|P13|Induction Period|Adverse Event|0
2547687|NCT01474512|8815725|P12|Induction Period|Adverse Event|0
2547688|NCT01474512|8815726|P11|Induction Period|Adverse Event|0
2547689|NCT01474512|8815727|P10|Induction Period|Adverse Event|0
2547690|NCT01474512|8815728|P9|Induction Period|Adverse Event|0
2547691|NCT01474512|8815729|P8|Induction Period|Adverse Event|0
2547692|NCT01474512|8815730|P7|Induction Period|Adverse Event|0
2547693|NCT01474512|8815731|P6|Induction Period|Adverse Event|0
2547694|NCT01474512|8815732|P5|Induction Period|Adverse Event|0
2547695|NCT01474512|8815733|P4|Induction Period|Adverse Event|0
2547696|NCT01474512|8815734|P3|Induction Period|Adverse Event|10
2547697|NCT01474512|8815735|P2|Induction Period|Adverse Event|10
2547698|NCT01474512|8815736|P1|Induction Period|Adverse Event|6
2547699|NCT01474434|8815812|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
2547700|NCT01474434|8815813|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
2547701|NCT01474434|8815814|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
2547702|NCT01474434|8815815|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1
2547703|NCT01474434|8815812|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1
2547704|NCT01474434|8815813|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
2547705|NCT01474434|8815814|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
2547880|NCT01473381|8816645|P2|Overall Study|Withdrawal of Consent|21
2547706|NCT01474434|8815815|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
2547707|NCT01474434|8815812|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
2547708|NCT01474434|8815813|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
2547709|NCT01474434|8815814|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
2547710|NCT01474434|8815815|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
2547711|NCT01474317|8815857|P1|Overall Study|Subject ineligible for study|1
2547712|NCT01474317|8815857|P1|Overall Study|Adverse Event|1
2547713|NCT01474291|8815866|P1|Overall Study|Death|2
2547714|NCT01474291|8815866|P1|Overall Study|No Reason Reported|10
2547715|NCT01474291|8815866|P1|Overall Study|Patient No Longer Wanted to Participate|12
2547716|NCT01474291|8815866|P1|Overall Study|Lost to Follow-up|29
2547717|NCT01474291|8815866|P1|Overall Study|Adverse Event|53
2547718|NCT01474291|8815866|P1|Overall Study|Lack of Treatment Efficacy|88
2547719|NCT01474291|8815866|P1|Overall Study|Not Evaluable for Efficacy|26
2547720|NCT01474239|8815910|P2|Overall Study|Withdrawal for Economic Reason|0
2547721|NCT01474239|8815911|P1|Overall Study|Withdrawal for Economic Reason|1
2547722|NCT01474239|8815910|P2|Overall Study|Clinical Disease Progression|1
2547723|NCT01474239|8815911|P1|Overall Study|Clinical Disease Progression|7
2547724|NCT01474239|8815910|P2|Overall Study|Death|1
2547725|NCT01474239|8815911|P1|Overall Study|Death|1
2547726|NCT01474239|8815910|P2|Overall Study|Withdrawal by Subject|2
2547727|NCT01474239|8815911|P1|Overall Study|Withdrawal by Subject|1
2547728|NCT01474239|8815910|P2|Overall Study|Adverse Event|3
2547729|NCT01474239|8815911|P1|Overall Study|Adverse Event|12
2547730|NCT01474239|8815910|P2|Overall Study|Disease Progression|25
2547731|NCT01474239|8815911|P1|Overall Study|Disease Progression|37
2547732|NCT01474018|8816083|P2|Overall Study|Withdrawal by Subject|2
2547733|NCT01474018|8816084|P1|Overall Study|Withdrawal by Subject|0
2547734|NCT01474018|8816083|P2|Overall Study|Lost to Follow-up|1
2547735|NCT01474018|8816084|P1|Overall Study|Lost to Follow-up|0
2547736|NCT01473953|8816116|P5|Overall Study|Other|0
2547737|NCT01473953|8816117|P4|Overall Study|Other|0
2547738|NCT01473953|8816118|P3|Overall Study|Other|0
2547739|NCT01473953|8816119|P2|Overall Study|Other|0
2547740|NCT01473953|8816120|P1|Overall Study|Other|1
2547741|NCT01473940|8816166|P4|Maintenance Therapy|Progressive Disease|4
2547742|NCT01473940|8816167|P3|Maintenance Therapy|Progressive Disease|1
2547743|NCT01473940|8816168|P2|Maintenance Therapy|Progressive Disease|2
2547744|NCT01473940|8816169|P1|Maintenance Therapy|Progressive Disease|1
2547745|NCT01473940|8816166|P4|Induction Therapy|Progressive Disease|0
2547746|NCT01473940|8816167|P3|Induction Therapy|Progressive Disease|1
2547747|NCT01473940|8816168|P2|Induction Therapy|Progressive Disease|1
2547748|NCT01473940|8816169|P1|Induction Therapy|Progressive Disease|0
2547749|NCT01473940|8816166|P4|Induction Therapy|Death|1
2547750|NCT01473940|8816167|P3|Induction Therapy|Death|1
2547751|NCT01473940|8816168|P2|Induction Therapy|Death|0
2547752|NCT01473940|8816169|P1|Induction Therapy|Death|0
2547753|NCT01473836|8816199|P1|Overall Study|Does not meet entrance criteria|1
2547754|NCT01473836|8816199|P1|Overall Study|Lack of Efficacy|1
2547755|NCT01473836|8816199|P1|Overall Study|Adverse Event|4
2547756|NCT01473758|8816210|P4|Cycle 2|Adverse Event|0
2547757|NCT01473758|8816211|P3|Cycle 2|Adverse Event|5
2547758|NCT01473758|8816212|P2|Cycle 2|Adverse Event|0
2547759|NCT01473758|8816213|P1|Cycle 2|Adverse Event|0
2547760|NCT01473758|8816210|P4|Cycle 1|Withdrawal by Subject|0
2547761|NCT01473758|8816211|P3|Cycle 1|Withdrawal by Subject|0
2547762|NCT01473758|8816212|P2|Cycle 1|Withdrawal by Subject|1
2547763|NCT01473758|8816213|P1|Cycle 1|Withdrawal by Subject|1
2547764|NCT01473758|8816210|P4|Cycle 1|Adverse Event|0
2547765|NCT01473758|8816211|P3|Cycle 1|Adverse Event|0
2547766|NCT01473758|8816212|P2|Cycle 1|Adverse Event|2
2547767|NCT01473758|8816213|P1|Cycle 1|Adverse Event|10
2547768|NCT01473732|8816350|P2|Overall Study|Death|0
2547769|NCT01473732|8816351|P1|Overall Study|Death|1
2547770|NCT01473732|8816350|P2|Overall Study|Adverse Event|0
2547771|NCT01473732|8816351|P1|Overall Study|Adverse Event|1
2547772|NCT01473602|8816359|P2|Overall Study|Physician Decision|0
2547773|NCT01473602|8816360|P1|Overall Study|Physician Decision|1
2547774|NCT01473602|8816359|P2|Overall Study|Withdrawal by Subject|4
2547775|NCT01473602|8816360|P1|Overall Study|Withdrawal by Subject|5
2547776|NCT01473602|8816359|P2|Overall Study|Lost to Follow-up|1
2547777|NCT01473602|8816360|P1|Overall Study|Lost to Follow-up|1
2547778|NCT01473602|8816359|P2|Overall Study|Death|1
2547779|NCT01473602|8816360|P1|Overall Study|Death|0
2547780|NCT01473602|8816359|P2|Overall Study|Adverse Event|2
2547781|NCT01473602|8816360|P1|Overall Study|Adverse Event|1
2547782|NCT01473589|8816396|P2|Overall Study|Entry criteria not met|1
2547783|NCT01473589|8816397|P1|Overall Study|Entry criteria not met|0
2547784|NCT01473589|8816396|P2|Overall Study|Physician Decision|1
2547785|NCT01473589|8816397|P1|Overall Study|Physician Decision|0
2547786|NCT01473589|8816396|P2|Overall Study|Withdrawal by Subject|11
2547787|NCT01473589|8816397|P1|Overall Study|Withdrawal by Subject|5
2547788|NCT01473589|8816396|P2|Overall Study|Protocol Violation|0
2547789|NCT01473589|8816397|P1|Overall Study|Protocol Violation|1
2547790|NCT01473589|8816396|P2|Overall Study|Lost to Follow-up|2
2547791|NCT01473589|8816397|P1|Overall Study|Lost to Follow-up|2
2547792|NCT01473589|8816396|P2|Overall Study|Death|0
2547793|NCT01473589|8816397|P1|Overall Study|Death|2
2547794|NCT01473589|8816396|P2|Overall Study|Adverse Event|1
2547795|NCT01473589|8816397|P1|Overall Study|Adverse Event|1
2547796|NCT01473563|8816431|P1|Overall Study|Lost to FU post tx discontinuation|1
2547797|NCT01473524|8816453|P3|Overall Study|Withdrawal by Subject|1
2547798|NCT01473524|8816454|P2|Overall Study|Withdrawal by Subject|1
2547799|NCT01473524|8816455|P1|Overall Study|Withdrawal by Subject|2
2547800|NCT01473524|8816453|P3|Overall Study|Death|0
2547801|NCT01473524|8816454|P2|Overall Study|Death|0
2547802|NCT01473524|8816455|P1|Overall Study|Death|1
2547803|NCT01473524|8816453|P3|Overall Study|Adverse Event|2
2547804|NCT01473524|8816454|P2|Overall Study|Adverse Event|8
2547805|NCT01473524|8816455|P1|Overall Study|Adverse Event|4
2547806|NCT01473420|8816488|P2|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0
2547807|NCT01473420|8816489|P1|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1
2547808|NCT01473420|8816488|P2|Maintenance Period (16 Weeks)|Sponsor's Decision|0
2547809|NCT01473420|8816489|P1|Maintenance Period (16 Weeks)|Sponsor's Decision|1
2547810|NCT01473420|8816488|P2|Maintenance Period (16 Weeks)|Long term hospitalization|1
2547811|NCT01473420|8816489|P1|Maintenance Period (16 Weeks)|Long term hospitalization|0
2547812|NCT01473420|8816488|P2|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0
2547813|NCT01473420|8816489|P1|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1
2547814|NCT01473420|8816488|P2|Maintenance Period (16 Weeks)|Site closure|1
2547815|NCT01473420|8816489|P1|Maintenance Period (16 Weeks)|Site closure|3
2547816|NCT01473420|8816488|P2|Maintenance Period (16 Weeks)|Withdrawal by Subject|6
2547817|NCT01473420|8816489|P1|Maintenance Period (16 Weeks)|Withdrawal by Subject|4
2547818|NCT01473420|8816488|P2|Maintenance Period (16 Weeks)|Lost to Follow-up|2
2547819|NCT01473420|8816489|P1|Maintenance Period (16 Weeks)|Lost to Follow-up|1
2547820|NCT01473420|8816488|P2|Maintenance Period (16 Weeks)|Kidney transplant|1
2547821|NCT01473420|8816489|P1|Maintenance Period (16 Weeks)|Kidney transplant|3
2547822|NCT01473420|8816488|P2|Maintenance Period (16 Weeks)|Did not meet criteria|2
2547823|NCT01473420|8816489|P1|Maintenance Period (16 Weeks)|Did not meet criteria|0
2547824|NCT01473420|8816488|P2|Maintenance Period (16 Weeks)|Physician Decision|2
2547825|NCT01473420|8816489|P1|Maintenance Period (16 Weeks)|Physician Decision|1
2547826|NCT01473420|8816488|P2|Maintenance Period (16 Weeks)|Adverse Event|2
2547827|NCT01473420|8816489|P1|Maintenance Period (16 Weeks)|Adverse Event|3
2547828|NCT01473420|8816488|P2|Titration Period (18 Weeks)|Did not meet criteria|32
2547829|NCT01473420|8816489|P1|Titration Period (18 Weeks)|Did not meet criteria|32
2547830|NCT01473420|8816488|P2|Titration Period (18 Weeks)|Adverse Event|6
2547831|NCT01473420|8816489|P1|Titration Period (18 Weeks)|Adverse Event|4
2547832|NCT01473407|8816573|P2|Overall Study|Site Closure|0
2547833|NCT01473407|8816574|P1|Overall Study|Site Closure|1
2547834|NCT01473407|8816573|P2|Overall Study|Sponsor's Decision|10
2547835|NCT01473407|8816574|P1|Overall Study|Sponsor's Decision|10
2547836|NCT01473407|8816573|P2|Overall Study|Transfer to Another Facility/Unit|3
2547837|NCT01473407|8816574|P1|Overall Study|Transfer to Another Facility/Unit|4
2547838|NCT01473407|8816573|P2|Overall Study|Temperature Excursion|3
2547839|NCT01473407|8816574|P1|Overall Study|Temperature Excursion|2
2547840|NCT01473407|8816573|P2|Overall Study|Patient Lost Green Card Status|0
2547841|NCT01473407|8816574|P1|Overall Study|Patient Lost Green Card Status|1
2547842|NCT01473407|8816573|P2|Overall Study|Patient Received Aranesp|0
2547843|NCT01473407|8816574|P1|Overall Study|Patient Received Aranesp|1
2547844|NCT01473407|8816573|P2|Overall Study|Elevated Hemoglobin|0
2547845|NCT01473407|8816574|P1|Overall Study|Elevated Hemoglobin|1
2547846|NCT01473407|8816573|P2|Overall Study|Vacation/Travel|1
2547847|NCT01473407|8816574|P1|Overall Study|Vacation/Travel|1
2547848|NCT01473407|8816573|P2|Overall Study|Kidney Transplant|6
2547849|NCT01473407|8816574|P1|Overall Study|Kidney Transplant|7
2547850|NCT01473407|8816573|P2|Overall Study|Withdrawal by Subject|7
2547851|NCT01473407|8816574|P1|Overall Study|Withdrawal by Subject|4
2547852|NCT01473407|8816573|P2|Overall Study|Randomization Error|1
2547853|NCT01473407|8816574|P1|Overall Study|Randomization Error|3
2547854|NCT01473407|8816573|P2|Overall Study|Adverse Event|8
2547855|NCT01473407|8816574|P1|Overall Study|Adverse Event|8
2547856|NCT01473407|8816573|P2|Overall Study|Lost to Follow-up|4
2547857|NCT01473407|8816574|P1|Overall Study|Lost to Follow-up|10
2547858|NCT01473407|8816573|P2|Overall Study|Physician Decision|4
2547859|NCT01473407|8816574|P1|Overall Study|Physician Decision|1
2547860|NCT01473394|8816628|P2|Overall Study|Lost to Follow-up|11
2547861|NCT01473394|8816629|P1|Overall Study|Lost to Follow-up|9
2547862|NCT01473394|8816628|P2|Overall Study|Withdrew Consent|10
2547863|NCT01473394|8816629|P1|Overall Study|Withdrew Consent|12
2547864|NCT01473394|8816628|P2|Overall Study|Protocol Violation|5
2547865|NCT01473394|8816629|P1|Overall Study|Protocol Violation|7
2547866|NCT01473394|8816628|P2|Overall Study|Insufficient Therapeutic Response|1
2547867|NCT01473394|8816629|P1|Overall Study|Insufficient Therapeutic Response|4
2547868|NCT01473394|8816628|P2|Overall Study|Adverse Event|16
2547869|NCT01473394|8816629|P1|Overall Study|Adverse Event|13
2547870|NCT01473381|8816643|P4|Overall Study|Other Reasons|3
2547871|NCT01473381|8816644|P3|Overall Study|Other Reasons|1
2547872|NCT01473381|8816645|P2|Overall Study|Other Reasons|0
2547873|NCT01473381|8816646|P1|Overall Study|Other Reasons|0
2547874|NCT01473381|8816643|P4|Overall Study|Lost to Follow-up|23
2547875|NCT01473381|8816644|P3|Overall Study|Lost to Follow-up|35
2547876|NCT01473381|8816645|P2|Overall Study|Lost to Follow-up|28
2547877|NCT01473381|8816646|P1|Overall Study|Lost to Follow-up|25
2547878|NCT01473381|8816643|P4|Overall Study|Withdrawal of Consent|26
2547879|NCT01473381|8816644|P3|Overall Study|Withdrawal of Consent|20
2547881|NCT01473381|8816646|P1|Overall Study|Withdrawal of Consent|20
2547882|NCT01473381|8816643|P4|Overall Study|Protocol Violation|17
2547883|NCT01473381|8816644|P3|Overall Study|Protocol Violation|19
2547884|NCT01473381|8816645|P2|Overall Study|Protocol Violation|23
2547885|NCT01473381|8816646|P1|Overall Study|Protocol Violation|17
2547886|NCT01473381|8816643|P4|Overall Study|Insufficient Therapeutic Response|3
2547887|NCT01473381|8816644|P3|Overall Study|Insufficient Therapeutic Response|2
2547888|NCT01473381|8816645|P2|Overall Study|Insufficient Therapeutic Response|1
2547889|NCT01473381|8816646|P1|Overall Study|Insufficient Therapeutic Response|10
2547890|NCT01473381|8816643|P4|Overall Study|Adverse Event|17
2547891|NCT01473381|8816644|P3|Overall Study|Adverse Event|25
2547892|NCT01473381|8816645|P2|Overall Study|Adverse Event|20
2547893|NCT01473381|8816646|P1|Overall Study|Adverse Event|8
2547894|NCT01473355|8816708|P1|Overall Study|Lost to Follow-up|2
2547895|NCT01473355|8816708|P1|Overall Study|Adverse Event|2
2547896|NCT01473355|8816708|P1|Overall Study|Protocol Violation|2
2547897|NCT01472965|8816737|P2|Overall Study|Withdrawal by Subject|0
2547898|NCT01472965|8816738|P1|Overall Study|Withdrawal by Subject|1
2547899|NCT01472939|8816758|P4|Overall Study|Withdrawal by Subject|4
2547900|NCT01472939|8816759|P3|Overall Study|Withdrawal by Subject|1
2547901|NCT01472939|8816760|P2|Overall Study|Withdrawal by Subject|3
2547902|NCT01472939|8816761|P1|Overall Study|Withdrawal by Subject|9
2547903|NCT01472939|8816758|P4|Overall Study|Protocol Violation|1
2547904|NCT01472939|8816759|P3|Overall Study|Protocol Violation|0
2547905|NCT01472939|8816760|P2|Overall Study|Protocol Violation|3
2547906|NCT01472939|8816761|P1|Overall Study|Protocol Violation|3
2547907|NCT01472939|8816758|P4|Overall Study|Withdrawal By PI|0
2547908|NCT01472939|8816759|P3|Overall Study|Withdrawal By PI|0
2547909|NCT01472939|8816760|P2|Overall Study|Withdrawal By PI|0
2547910|NCT01472939|8816761|P1|Overall Study|Withdrawal By PI|1
2547911|NCT01472939|8816758|P4|Overall Study|Prohibited Medication|0
2547912|NCT01472939|8816759|P3|Overall Study|Prohibited Medication|0
2547913|NCT01472939|8816760|P2|Overall Study|Prohibited Medication|1
2547914|NCT01472939|8816761|P1|Overall Study|Prohibited Medication|0
2547915|NCT01472939|8816758|P4|Overall Study|Clinically Significant Pre-Dose ECG|0
2547916|NCT01472939|8816759|P3|Overall Study|Clinically Significant Pre-Dose ECG|1
2547917|NCT01472939|8816760|P2|Overall Study|Clinically Significant Pre-Dose ECG|0
2547918|NCT01472939|8816761|P1|Overall Study|Clinically Significant Pre-Dose ECG|0
2547919|NCT01472939|8816758|P4|Overall Study|Lost to Follow-up|0
2547920|NCT01472939|8816759|P3|Overall Study|Lost to Follow-up|2
2547921|NCT01472939|8816760|P2|Overall Study|Lost to Follow-up|0
2547922|NCT01472939|8816761|P1|Overall Study|Lost to Follow-up|3
2547923|NCT01472939|8816758|P4|Overall Study|Lack of Efficacy|1
2547924|NCT01472939|8816759|P3|Overall Study|Lack of Efficacy|0
2547925|NCT01472939|8816760|P2|Overall Study|Lack of Efficacy|0
2547926|NCT01472939|8816761|P1|Overall Study|Lack of Efficacy|1
2547927|NCT01472939|8816758|P4|Overall Study|Adverse Event|14
2547928|NCT01472939|8816759|P3|Overall Study|Adverse Event|7
2547929|NCT01472939|8816760|P2|Overall Study|Adverse Event|7
2547930|NCT01472939|8816761|P1|Overall Study|Adverse Event|3
2547931|NCT01472835|8816805|P2|Overall Study|Lost to Follow-up|0
2547932|NCT01472835|8816806|P1|Overall Study|Lost to Follow-up|2
2547933|NCT01472757|8816841|P4|Overall Study|Other reasons|2
2547934|NCT01472757|8816842|P3|Overall Study|Other reasons|2
2547935|NCT01472757|8816843|P2|Overall Study|Other reasons|0
2547936|NCT01472757|8816844|P1|Overall Study|Other reasons|1
2547937|NCT01472757|8816841|P4|Overall Study|Protocol Violation|4
2547938|NCT01472757|8816842|P3|Overall Study|Protocol Violation|4
2547939|NCT01472757|8816843|P2|Overall Study|Protocol Violation|2
2547940|NCT01472757|8816844|P1|Overall Study|Protocol Violation|3
2547941|NCT01472757|8816841|P4|Overall Study|Treatment period withdrawal criteria met|12
2547942|NCT01472757|8816842|P3|Overall Study|Treatment period withdrawal criteria met|9
2547943|NCT01472757|8816843|P2|Overall Study|Treatment period withdrawal criteria met|8
2547944|NCT01472757|8816844|P1|Overall Study|Treatment period withdrawal criteria met|21
2547945|NCT01472757|8816841|P4|Overall Study|Asthma exacerbation|1
2547946|NCT01472757|8816842|P3|Overall Study|Asthma exacerbation|2
2547947|NCT01472757|8816843|P2|Overall Study|Asthma exacerbation|1
2547948|NCT01472757|8816844|P1|Overall Study|Asthma exacerbation|4
2547949|NCT01472757|8816841|P4|Overall Study|Withdrawal by Subject|0
2547950|NCT01472757|8816842|P3|Overall Study|Withdrawal by Subject|2
2547951|NCT01472757|8816843|P2|Overall Study|Withdrawal by Subject|2
2547952|NCT01472757|8816844|P1|Overall Study|Withdrawal by Subject|1
2547953|NCT01472380|8816959|P1|1 Day Period Between Dosing|Protocol Violation|1
2547954|NCT01472380|8816959|P1|Efavirenz Alone|Withdrawal by Subject|1
2547955|NCT01472341|8816970|P1|Overall Study|Death|9
2547956|NCT01472341|8816970|P1|Overall Study|Laboratory parameters unavailable|25
2547957|NCT01472341|8816970|P1|Overall Study|Lost to Follow-up|52
2547958|NCT01472341|8816970|P1|Overall Study|Withdrawal by Subject|39
2547959|NCT01472341|8816970|P1|Overall Study|Started therapy with a DPP-IV/GLP-1|92
2547960|NCT01472341|8816970|P1|Overall Study|Started insulin therapy|55
2547961|NCT01472289|8816976|P1|Overall Study|Death|2
2547962|NCT01472185|8816988|P2|Overall Study|Subject Withdrew Consent|3
2547963|NCT01472185|8816989|P1|Overall Study|Subject Withdrew Consent|6
2547964|NCT01472185|8816988|P2|Overall Study|Subject Noncompliance|15
2547965|NCT01472185|8816989|P1|Overall Study|Subject Noncompliance|8
2547966|NCT01472185|8816988|P2|Overall Study|Protocol Violation|1
2547967|NCT01472185|8816989|P1|Overall Study|Protocol Violation|5
2547968|NCT01472185|8816988|P2|Overall Study|Lost to Follow-up|1
2547969|NCT01472185|8816989|P1|Overall Study|Lost to Follow-up|4
2547970|NCT01472185|8816988|P2|Overall Study|Investigator’s Discretion|1
2547971|NCT01472185|8816989|P1|Overall Study|Investigator’s Discretion|3
2547972|NCT01472185|8816988|P2|Overall Study|Hyperglycemia|2
2547973|NCT01472185|8816989|P1|Overall Study|Hyperglycemia|5
2547974|NCT01472185|8816988|P2|Overall Study|Adverse Event Other than Hyperglycemia|10
2547975|NCT01472185|8816989|P1|Overall Study|Adverse Event Other than Hyperglycemia|3
2547976|NCT01472185|8816988|P2|Overall Study|Randomized but Not Treated|1
2547977|NCT01472185|8816989|P1|Overall Study|Randomized but Not Treated|0
2547978|NCT01472081|8817009|P6|Overall Study|Subject request to discontinue treatment|0
2547979|NCT01472081|8817010|P5|Overall Study|Subject request to discontinue treatment|0
2547980|NCT01472081|8817011|P4|Overall Study|Subject request to discontinue treatment|1
2547981|NCT01472081|8817012|P3|Overall Study|Subject request to discontinue treatment|1
2547982|NCT01472081|8817013|P2|Overall Study|Subject request to discontinue treatment|3
2547983|NCT01472081|8817014|P1|Overall Study|Subject request to discontinue treatment|0
2547984|NCT01472081|8817009|P6|Overall Study|No longer meets study criteria|0
2547985|NCT01472081|8817010|P5|Overall Study|No longer meets study criteria|0
2547986|NCT01472081|8817011|P4|Overall Study|No longer meets study criteria|0
2547987|NCT01472081|8817012|P3|Overall Study|No longer meets study criteria|1
2547988|NCT01472081|8817013|P2|Overall Study|No longer meets study criteria|0
2547989|NCT01472081|8817014|P1|Overall Study|No longer meets study criteria|0
2547990|NCT01472081|8817009|P6|Overall Study|Poor/non-compliance|0
2547991|NCT01472081|8817010|P5|Overall Study|Poor/non-compliance|1
2547992|NCT01472081|8817011|P4|Overall Study|Poor/non-compliance|0
2547993|NCT01472081|8817012|P3|Overall Study|Poor/non-compliance|1
2547994|NCT01472081|8817013|P2|Overall Study|Poor/non-compliance|0
2547995|NCT01472081|8817014|P1|Overall Study|Poor/non-compliance|0
2547996|NCT01472081|8817009|P6|Overall Study|Withdrawal by Subject|1
2547997|NCT01472081|8817010|P5|Overall Study|Withdrawal by Subject|0
2547998|NCT01472081|8817011|P4|Overall Study|Withdrawal by Subject|0
2547999|NCT01472081|8817012|P3|Overall Study|Withdrawal by Subject|0
2548000|NCT01472081|8817013|P2|Overall Study|Withdrawal by Subject|0
2548001|NCT01472081|8817014|P1|Overall Study|Withdrawal by Subject|0
2548002|NCT01472081|8817009|P6|Overall Study|Adverse Event unrelated to study drug|0
2548003|NCT01472081|8817010|P5|Overall Study|Adverse Event unrelated to study drug|1
2548004|NCT01472081|8817011|P4|Overall Study|Adverse Event unrelated to study drug|0
2548005|NCT01472081|8817012|P3|Overall Study|Adverse Event unrelated to study drug|0
2548006|NCT01472081|8817013|P2|Overall Study|Adverse Event unrelated to study drug|0
2548007|NCT01472081|8817014|P1|Overall Study|Adverse Event unrelated to study drug|0
2548008|NCT01472081|8817009|P6|Overall Study|Death|0
2548009|NCT01472081|8817010|P5|Overall Study|Death|1
2548010|NCT01472081|8817011|P4|Overall Study|Death|0
2548011|NCT01472081|8817012|P3|Overall Study|Death|0
2548012|NCT01472081|8817013|P2|Overall Study|Death|0
2548013|NCT01472081|8817014|P1|Overall Study|Death|0
2548014|NCT01472081|8817009|P6|Overall Study|Study drug toxicity|2
2548015|NCT01472081|8817010|P5|Overall Study|Study drug toxicity|13
2548016|NCT01472081|8817011|P4|Overall Study|Study drug toxicity|6
2548017|NCT01472081|8817012|P3|Overall Study|Study drug toxicity|4
2548018|NCT01472081|8817013|P2|Overall Study|Study drug toxicity|9
2548019|NCT01472081|8817014|P1|Overall Study|Study drug toxicity|2
2548020|NCT01472081|8817009|P6|Overall Study|Disease Progression|3
2548021|NCT01472081|8817010|P5|Overall Study|Disease Progression|22
2548022|NCT01472081|8817011|P4|Overall Study|Disease Progression|31
2548023|NCT01472081|8817012|P3|Overall Study|Disease Progression|12
2548024|NCT01472081|8817013|P2|Overall Study|Disease Progression|10
2548025|NCT01472081|8817014|P1|Overall Study|Disease Progression|4
2548026|NCT01472081|8817009|P6|Overall Study|Continuing treatment at time of analysis|0
2548027|NCT01472081|8817010|P5|Overall Study|Continuing treatment at time of analysis|9
2548028|NCT01472081|8817011|P4|Overall Study|Continuing treatment at time of analysis|8
2548029|NCT01472081|8817012|P3|Overall Study|Continuing treatment at time of analysis|1
2548030|NCT01472081|8817013|P2|Overall Study|Continuing treatment at time of analysis|4
2548031|NCT01472081|8817014|P1|Overall Study|Continuing treatment at time of analysis|1
2548032|NCT01471782|8817063|P6|Overall Study|Death|1
2548033|NCT01471782|8817064|P5|Overall Study|Death|0
2548034|NCT01471782|8817065|P4|Overall Study|Death|0
2548035|NCT01471782|8817066|P3|Overall Study|Death|0
2548036|NCT01471782|8817067|P2|Overall Study|Death|0
2548037|NCT01471782|8817068|P1|Overall Study|Death|0
2548038|NCT01471782|8817063|P6|Overall Study|Withdrawal by Parent/Guardian|0
2548039|NCT01471782|8817064|P5|Overall Study|Withdrawal by Parent/Guardian|1
2548040|NCT01471782|8817065|P4|Overall Study|Withdrawal by Parent/Guardian|0
2548041|NCT01471782|8817066|P3|Overall Study|Withdrawal by Parent/Guardian|0
2548042|NCT01471782|8817067|P2|Overall Study|Withdrawal by Parent/Guardian|0
2548043|NCT01471782|8817068|P1|Overall Study|Withdrawal by Parent/Guardian|0
2548044|NCT01471782|8817063|P6|Overall Study|Physician Decision|8
2548045|NCT01471782|8817064|P5|Overall Study|Physician Decision|3
2548046|NCT01471782|8817065|P4|Overall Study|Physician Decision|0
2548047|NCT01471782|8817066|P3|Overall Study|Physician Decision|0
2548048|NCT01471782|8817067|P2|Overall Study|Physician Decision|0
2548049|NCT01471782|8817068|P1|Overall Study|Physician Decision|0
2548050|NCT01471782|8817063|P6|Overall Study|Disease Relapse|1
2548051|NCT01471782|8817064|P5|Overall Study|Disease Relapse|2
2548052|NCT01471782|8817065|P4|Overall Study|Disease Relapse|1
2548053|NCT01471782|8817066|P3|Overall Study|Disease Relapse|0
2548054|NCT01471782|8817067|P2|Overall Study|Disease Relapse|0
2548055|NCT01471782|8817068|P1|Overall Study|Disease Relapse|0
2548056|NCT01471782|8817063|P6|Overall Study|Change of Chemotherapy|4
2548057|NCT01471782|8817064|P5|Overall Study|Change of Chemotherapy|1
2548058|NCT01471782|8817065|P4|Overall Study|Change of Chemotherapy|0
2548059|NCT01471782|8817066|P3|Overall Study|Change of Chemotherapy|0
2548060|NCT01471782|8817067|P2|Overall Study|Change of Chemotherapy|1
2548061|NCT01471782|8817068|P1|Overall Study|Change of Chemotherapy|1
2548062|NCT01471782|8817063|P6|Overall Study|Other|5
2548063|NCT01471782|8817064|P5|Overall Study|Other|6
2548064|NCT01471782|8817065|P4|Overall Study|Other|1
2548065|NCT01471782|8817066|P3|Overall Study|Other|1
2548066|NCT01471782|8817067|P2|Overall Study|Other|0
2548067|NCT01471782|8817068|P1|Overall Study|Other|0
2548068|NCT01471782|8817063|P6|Overall Study|Adverse Event|1
2548069|NCT01471782|8817064|P5|Overall Study|Adverse Event|3
2548070|NCT01471782|8817065|P4|Overall Study|Adverse Event|2
2548071|NCT01471782|8817066|P3|Overall Study|Adverse Event|2
2548072|NCT01471782|8817067|P2|Overall Study|Adverse Event|1
2548073|NCT01471782|8817068|P1|Overall Study|Adverse Event|1
2548074|NCT01471782|8817063|P6|Overall Study|Lack of Efficacy|18
2548075|NCT01471782|8817064|P5|Overall Study|Lack of Efficacy|5
2548076|NCT01471782|8817065|P4|Overall Study|Lack of Efficacy|1
2548077|NCT01471782|8817066|P3|Overall Study|Lack of Efficacy|1
2548078|NCT01471782|8817067|P2|Overall Study|Lack of Efficacy|2
2548079|NCT01471782|8817068|P1|Overall Study|Lack of Efficacy|1
2548080|NCT01471782|8817063|P6|Overall Study|Hematopoietic Stem Cell Transplantation|3
2548081|NCT01471782|8817064|P5|Overall Study|Hematopoietic Stem Cell Transplantation|5
2548082|NCT01471782|8817065|P4|Overall Study|Hematopoietic Stem Cell Transplantation|0
2548083|NCT01471782|8817066|P3|Overall Study|Hematopoietic Stem Cell Transplantation|1
2548084|NCT01471782|8817067|P2|Overall Study|Hematopoietic Stem Cell Transplantation|2
2548085|NCT01471782|8817068|P1|Overall Study|Hematopoietic Stem Cell Transplantation|2
2548086|NCT01471691|8817122|P2|Overall Study|Lack of Efficacy|1
2548087|NCT01471691|8817123|P1|Overall Study|Lack of Efficacy|0
2548088|NCT01471379|8817132|P3|Overall Study|Study terminated|0
2548089|NCT01471379|8817133|P2|Overall Study|Study terminated|1
2548090|NCT01471379|8817134|P1|Overall Study|Study terminated|0
2548091|NCT01471379|8817132|P3|Overall Study|Adverse Event|0
2548092|NCT01471379|8817133|P2|Overall Study|Adverse Event|0
2548093|NCT01471379|8817134|P1|Overall Study|Adverse Event|1
2548094|NCT01471353|8817154|P1|Overall Study|remain on study|3
2548095|NCT01471340|8817165|P2|Overall Study|Invalid informed consent|0
2548096|NCT01471340|8817166|P1|Overall Study|Invalid informed consent|1
2548097|NCT01471340|8817165|P2|Overall Study|Investigational site closure|1
2548098|NCT01471340|8817166|P1|Overall Study|Investigational site closure|0
2548099|NCT01471340|8817165|P2|Overall Study|Lost to Follow-up|1
2548100|NCT01471340|8817166|P1|Overall Study|Lost to Follow-up|0
2548101|NCT01471340|8817165|P2|Overall Study|Death|4
2548102|NCT01471340|8817166|P1|Overall Study|Death|5
2548103|NCT01471574|8817189|P4|Follow-up Period|Follow-up no longer required|0
2548104|NCT01471574|8817190|P3|Follow-up Period|Follow-up no longer required|0
2548105|NCT01471574|8817191|P2|Follow-up Period|Follow-up no longer required|1
2548106|NCT01471574|8817192|P1|Follow-up Period|Follow-up no longer required|0
2548107|NCT01471574|8817189|P4|Follow-up Period|Death|0
2548108|NCT01471574|8817190|P3|Follow-up Period|Death|1
2548109|NCT01471574|8817191|P2|Follow-up Period|Death|0
2548110|NCT01471574|8817192|P1|Follow-up Period|Death|0
2548111|NCT01471574|8817189|P4|Follow-up Period|Lost to Follow-up|2
2548112|NCT01471574|8817190|P3|Follow-up Period|Lost to Follow-up|3
2548113|NCT01471574|8817191|P2|Follow-up Period|Lost to Follow-up|1
2548114|NCT01471574|8817192|P1|Follow-up Period|Lost to Follow-up|4
2548115|NCT01471574|8817189|P4|Follow-up Period|Withdrawal by Subject|1
2548116|NCT01471574|8817190|P3|Follow-up Period|Withdrawal by Subject|3
2548117|NCT01471574|8817191|P2|Follow-up Period|Withdrawal by Subject|0
2548118|NCT01471574|8817192|P1|Follow-up Period|Withdrawal by Subject|3
2548119|NCT01471574|8817189|P4|Treatment Period|Other|0
2548120|NCT01471574|8817190|P3|Treatment Period|Other|0
2548121|NCT01471574|8817191|P2|Treatment Period|Other|0
2548122|NCT01471574|8817192|P1|Treatment Period|Other|1
2548123|NCT01471574|8817189|P4|Treatment Period|Patient no Longer Meets Study Criteria|0
2548124|NCT01471574|8817190|P3|Treatment Period|Patient no Longer Meets Study Criteria|0
2548125|NCT01471574|8817191|P2|Treatment Period|Patient no Longer Meets Study Criteria|0
2548126|NCT01471574|8817192|P1|Treatment Period|Patient no Longer Meets Study Criteria|1
2548127|NCT01471574|8817189|P4|Treatment Period|Lost to Follow-up|0
2548128|NCT01471574|8817190|P3|Treatment Period|Lost to Follow-up|2
2548129|NCT01471574|8817191|P2|Treatment Period|Lost to Follow-up|2
2548130|NCT01471574|8817192|P1|Treatment Period|Lost to Follow-up|1
2548131|NCT01471574|8817189|P4|Treatment Period|Patient Requested Discontinue Study drug|1
2548132|NCT01471574|8817190|P3|Treatment Period|Patient Requested Discontinue Study drug|1
2548133|NCT01471574|8817191|P2|Treatment Period|Patient Requested Discontinue Study drug|0
2548134|NCT01471574|8817192|P1|Treatment Period|Patient Requested Discontinue Study drug|4
2548135|NCT01471574|8817189|P4|Treatment Period|Withdrawal by Subject|0
2548136|NCT01471574|8817190|P3|Treatment Period|Withdrawal by Subject|1
2548137|NCT01471574|8817191|P2|Treatment Period|Withdrawal by Subject|1
2548138|NCT01471574|8817192|P1|Treatment Period|Withdrawal by Subject|5
2548139|NCT01471574|8817189|P4|Treatment Period|Adverse Event|1
2548140|NCT01471574|8817190|P3|Treatment Period|Adverse Event|6
2548141|NCT01471574|8817191|P2|Treatment Period|Adverse Event|3
2548142|NCT01471574|8817192|P1|Treatment Period|Adverse Event|7
2548143|NCT01471574|8817189|P4|Treatment Period|Lack of Efficacy|1
2548144|NCT01471574|8817190|P3|Treatment Period|Lack of Efficacy|14
2548145|NCT01471574|8817191|P2|Treatment Period|Lack of Efficacy|4
2548146|NCT01471574|8817192|P1|Treatment Period|Lack of Efficacy|12
2548147|NCT01471197|8817234|P2|Overall Study|Study Drug Toxicity|0
2548148|NCT01471197|8817235|P1|Overall Study|Study Drug Toxicity|1
2548149|NCT01471197|8817234|P2|Overall Study|Death|0
2548150|NCT01471197|8817235|P1|Overall Study|Death|1
2548151|NCT01471197|8817234|P2|Overall Study|Disease Progression|2
2548152|NCT01471197|8817235|P1|Overall Study|Disease Progression|4
2548153|NCT01471171|8817245|P2|Treatment Period 2|Adverse Event|0
2548154|NCT01471171|8817246|P1|Treatment Period 2|Adverse Event|1
2548155|NCT01471171|8817245|P2|Treatment Period 1|Adverse Event|1
2548156|NCT01471171|8817246|P1|Treatment Period 1|Adverse Event|4
2548157|NCT01471054|8817258|P2|Overall Study|Study terminated prematurely|0
2548158|NCT01471054|8817259|P1|Overall Study|Study terminated prematurely|4
2548159|NCT01471028|8817282|P2|VTI-208E|Lost to Follow-up|2
2548160|NCT01471028|8817283|P1|VTI-208E|Lost to Follow-up|0
2548161|NCT01471028|8817282|P2|VTI-208E|Withdrawal by Subject|0
2548162|NCT01471028|8817283|P1|VTI-208E|Withdrawal by Subject|1
2548163|NCT01471028|8817282|P2|VTI-208E|Death|10
2548164|NCT01471028|8817283|P1|VTI-208E|Death|7
2548165|NCT01471028|8817282|P2|VTI-208|Lost to Follow-up|1
2548166|NCT01471028|8817283|P1|VTI-208|Lost to Follow-up|1
2548167|NCT01471028|8817282|P2|VTI-208|Withdrawal by Subject|2
2548168|NCT01471028|8817283|P1|VTI-208|Withdrawal by Subject|0
2548169|NCT01471028|8817282|P2|VTI-208|Adverse Event|41
2548170|NCT01471028|8817283|P1|VTI-208|Adverse Event|39
2548171|NCT01471015|8817298|P3|Overall Study|Death|1
2548172|NCT01471015|8817299|P2|Overall Study|Death|1
2548173|NCT01471015|8817300|P1|Overall Study|Death|0
2548174|NCT01470599|8817361|P2|Overall Study|Adverse event not related to study drug|5
2548175|NCT01470599|8817362|P1|Overall Study|Adverse event not related to study drug|1
2548176|NCT01470599|8817361|P2|Overall Study|Insufficient clinical response|27
2548177|NCT01470599|8817362|P1|Overall Study|Insufficient clinical response|6
2548178|NCT01470599|8817361|P2|Overall Study|Adverse event related to study drug|5
2548179|NCT01470599|8817362|P1|Overall Study|Adverse event related to study drug|2
2548180|NCT01470599|8817361|P2|Overall Study|Protocol Violation|1
2548181|NCT01470599|8817362|P1|Overall Study|Protocol Violation|3
2548182|NCT01470599|8817361|P2|Overall Study|Other|0
2548183|NCT01470599|8817362|P1|Overall Study|Other|1
2548184|NCT01470599|8817361|P2|Overall Study|Withdrawal by Subject|4
2548185|NCT01470599|8817362|P1|Overall Study|Withdrawal by Subject|3
2548186|NCT01470599|8817361|P2|Overall Study|Lost to Follow-up|1
2548187|NCT01470599|8817362|P1|Overall Study|Lost to Follow-up|2
2548188|NCT01470599|8817361|P2|Overall Study|Did not meet entrance criteria|0
2548189|NCT01470599|8817362|P1|Overall Study|Did not meet entrance criteria|1
2548190|NCT01470469|8817426|P2|Overall Study|Other|1
2548191|NCT01470469|8817427|P1|Overall Study|Other|2
2548192|NCT01470469|8817426|P2|Overall Study|Protocol Violation|1
2548193|NCT01470469|8817427|P1|Overall Study|Protocol Violation|1
2548194|NCT01470469|8817426|P2|Overall Study|Lost to Follow-up|2
2548195|NCT01470469|8817427|P1|Overall Study|Lost to Follow-up|2
2548196|NCT01470469|8817426|P2|Overall Study|Adverse Event|7
2548197|NCT01470469|8817427|P1|Overall Study|Adverse Event|0
2548198|NCT01470469|8817426|P2|Overall Study|Lack of Efficacy|7
2548199|NCT01470469|8817427|P1|Overall Study|Lack of Efficacy|1
2548200|NCT01470469|8817426|P2|Overall Study|Withdrawal by Subject|6
2548201|NCT01470469|8817427|P1|Overall Study|Withdrawal by Subject|4
2548202|NCT01470417|8817447|P2|Overall Study|Disease progression|2
2548203|NCT01470417|8817448|P1|Overall Study|Disease progression|0
2548204|NCT01470326|8817460|P1|Overall Study|No Visit After 1st Day of Treatment|119
2548205|NCT01470326|8817460|P1|Overall Study|No Drug Administration Information|2
2548206|NCT01470326|8817460|P1|Overall Study|Protocol Violation|32
2548207|NCT01470248|8817471|P1|Overall Study|Withdrawal by Subject|1
2548208|NCT01470144|8817527|P1|Overall Study|Patient’s and investigator’s decision|1
2548209|NCT01470144|8817527|P1|Overall Study|Lung transplant|6
2548210|NCT01470144|8817527|P1|Overall Study|Death|1
2548211|NCT01470144|8817527|P1|Overall Study|Adverse Event|2
2548212|NCT01470001|8817632|P2|Overall Study|Withdrawal by Subject|1
2548213|NCT01470001|8817633|P1|Overall Study|Withdrawal by Subject|2
2548214|NCT01470001|8817632|P2|Overall Study|Physician Decision|0
2548215|NCT01470001|8817633|P1|Overall Study|Physician Decision|2
2548216|NCT01470001|8817632|P2|Overall Study|Lost to Follow-up|1
2548217|NCT01470001|8817633|P1|Overall Study|Lost to Follow-up|1
2548218|NCT01469819|8817643|P1|Overall Study|Technical malfunction of SmartPill data|3
2548219|NCT01469819|8817643|P1|Overall Study|Could not swallow SmartPill|2
2548220|NCT01469819|8817643|P1|Overall Study|Did not meet inclusionary criteria|2
2548221|NCT01469819|8817643|P1|Overall Study|Withdrawal by Subject|1
2548222|NCT01469637|8817667|P2|Second Intervention|Incarcerated|0
2548223|NCT01469637|8817668|P1|Second Intervention|Incarcerated|1
2548224|NCT01469637|8817667|P2|First Intervention|Unacceptable behavior|1
2548225|NCT01469637|8817668|P1|First Intervention|Unacceptable behavior|0
2548226|NCT01469546|8817676|P1|Received 5 mg Dose|Physician Decision|3
2548227|NCT01469546|8817676|P1|Received 5 mg Dose|Progressive Disease|3
2548228|NCT01469546|8817676|P1|Received 5 mg Dose|Protocol Violation|2
2548229|NCT01469546|8817676|P1|Received 5 mg Dose|Death|2
2548230|NCT01469546|8817676|P1|Received 5 mg Dose|Adverse Event|13
2548231|NCT01469377|8817686|P3|Overall Study|Other Miscellaneous Reasons|0
2548232|NCT01469377|8817687|P2|Overall Study|Other Miscellaneous Reasons|0
2548233|NCT01469377|8817688|P1|Overall Study|Other Miscellaneous Reasons|2
2548234|NCT01469377|8817686|P3|Overall Study|Insufficient Therapeutic Response|0
2548235|NCT01469377|8817687|P2|Overall Study|Insufficient Therapeutic Response|4
2548236|NCT01469377|8817688|P1|Overall Study|Insufficient Therapeutic Response|3
2548237|NCT01469377|8817686|P3|Overall Study|Adverse Event|36
2548238|NCT01469377|8817687|P2|Overall Study|Adverse Event|18
2548239|NCT01469377|8817688|P1|Overall Study|Adverse Event|8
2548240|NCT01469377|8817686|P3|Overall Study|Withdrawal of Consent|15
2548241|NCT01469377|8817687|P2|Overall Study|Withdrawal of Consent|14
2548242|NCT01469377|8817688|P1|Overall Study|Withdrawal of Consent|12
2548243|NCT01469377|8817686|P3|Overall Study|Lost to Follow-up|5
2548244|NCT01469377|8817687|P2|Overall Study|Lost to Follow-up|2
2548245|NCT01469377|8817688|P1|Overall Study|Lost to Follow-up|3
2548246|NCT01469377|8817686|P3|Overall Study|Protocol Deviation|10
2548247|NCT01469377|8817687|P2|Overall Study|Protocol Deviation|10
2548248|NCT01469377|8817688|P1|Overall Study|Protocol Deviation|7
2548249|NCT01469364|8817699|P1|Overall Study|Withdrawal by Subject|1
2548250|NCT01469364|8817699|P1|Overall Study|Adverse Event|1
2548251|NCT01469221|8817750|P3|Double Blind Phase|Sponsor Terminate Study|0
2548252|NCT01469221|8817751|P2|Double Blind Phase|Sponsor Terminate Study|16
2548253|NCT01469221|8817752|P1|Double Blind Phase|Sponsor Terminate Study|12
2548254|NCT01469221|8817750|P3|Double Blind Phase|Physician Decision|0
2548255|NCT01469221|8817751|P2|Double Blind Phase|Physician Decision|1
2548256|NCT01469221|8817752|P1|Double Blind Phase|Physician Decision|1
2548257|NCT01469221|8817750|P3|Double Blind Phase|Protocol Violation|0
2548258|NCT01469221|8817751|P2|Double Blind Phase|Protocol Violation|0
2548259|NCT01469221|8817752|P1|Double Blind Phase|Protocol Violation|1
2548260|NCT01469182|8817763|P2|Overall Study|Did not meet Protocol Eligibility|0
2548261|NCT01469182|8817764|P1|Overall Study|Did not meet Protocol Eligibility|3
2548262|NCT01469182|8817763|P2|Overall Study|Protocol Violation|2
2548263|NCT01469182|8817764|P1|Overall Study|Protocol Violation|4
2548264|NCT01469182|8817763|P2|Overall Study|Withdrawal by Subject|1
2548265|NCT01469182|8817764|P1|Overall Study|Withdrawal by Subject|4
2548266|NCT01469182|8817763|P2|Overall Study|Lost to Follow-up|0
2548267|NCT01469182|8817764|P1|Overall Study|Lost to Follow-up|3
2548268|NCT01469182|8817763|P2|Overall Study|Adverse Event|3
2548269|NCT01469182|8817764|P1|Overall Study|Adverse Event|21
2548270|NCT01469065|8817791|P5|Overall Study|Other|0
2548271|NCT01469065|8817792|P4|Overall Study|Other|0
2548272|NCT01469065|8817793|P3|Overall Study|Other|0
2548273|NCT01469065|8817794|P2|Overall Study|Other|1
2548274|NCT01469065|8817795|P1|Overall Study|Other|0
2548275|NCT01469065|8817791|P5|Overall Study|Lack of Efficacy|1
2548276|NCT01469065|8817792|P4|Overall Study|Lack of Efficacy|0
2548277|NCT01469065|8817793|P3|Overall Study|Lack of Efficacy|0
2548278|NCT01469065|8817794|P2|Overall Study|Lack of Efficacy|0
2548279|NCT01469065|8817795|P1|Overall Study|Lack of Efficacy|0
2548280|NCT01469052|8817891|P6|Overall Study|Other|0
2548281|NCT01469052|8817892|P5|Overall Study|Other|1
2548282|NCT01469052|8817893|P4|Overall Study|Other|0
2548283|NCT01469052|8817894|P3|Overall Study|Other|0
2548284|NCT01469052|8817895|P2|Overall Study|Other|1
2548285|NCT01469052|8817896|P1|Overall Study|Other|0
2548286|NCT01469052|8817891|P6|Overall Study|Moved to rollover protocol|1
2548287|NCT01469052|8817892|P5|Overall Study|Moved to rollover protocol|0
2548288|NCT01469052|8817893|P4|Overall Study|Moved to rollover protocol|0
2548289|NCT01469052|8817894|P3|Overall Study|Moved to rollover protocol|1
2548290|NCT01469052|8817895|P2|Overall Study|Moved to rollover protocol|0
2548291|NCT01469052|8817896|P1|Overall Study|Moved to rollover protocol|1
2548292|NCT01469052|8817891|P6|Overall Study|Lack of Efficacy|2
2548293|NCT01469052|8817892|P5|Overall Study|Lack of Efficacy|0
2548294|NCT01469052|8817893|P4|Overall Study|Lack of Efficacy|0
2548295|NCT01469052|8817894|P3|Overall Study|Lack of Efficacy|0
2548296|NCT01469052|8817895|P2|Overall Study|Lack of Efficacy|0
2548297|NCT01469052|8817896|P1|Overall Study|Lack of Efficacy|0
2548298|NCT01469052|8817891|P6|Overall Study|Progressive disease|2
2548299|NCT01469052|8817892|P5|Overall Study|Progressive disease|7
2548300|NCT01469052|8817893|P4|Overall Study|Progressive disease|3
2548301|NCT01469052|8817894|P3|Overall Study|Progressive disease|5
2548302|NCT01469052|8817895|P2|Overall Study|Progressive disease|0
2548303|NCT01469052|8817896|P1|Overall Study|Progressive disease|3
2548304|NCT01469052|8817891|P6|Overall Study|Adverse Event|1
2548305|NCT01469052|8817892|P5|Overall Study|Adverse Event|0
2548306|NCT01469052|8817893|P4|Overall Study|Adverse Event|2
2548307|NCT01469052|8817894|P3|Overall Study|Adverse Event|0
2548308|NCT01469052|8817895|P2|Overall Study|Adverse Event|3
2548309|NCT01469052|8817896|P1|Overall Study|Adverse Event|2
2548310|NCT01469013|8817961|P13|Part B (Extension Period)|Withdrawal by Subject|3
2548311|NCT01469013|8817962|P12|Part B (Extension Period)|Withdrawal by Subject|0
2548312|NCT01469013|8817963|P11|Part B (Extension Period)|Withdrawal by Subject|1
2548313|NCT01469013|8817964|P10|Part B (Extension Period)|Withdrawal by Subject|0
2548314|NCT01469013|8817965|P9|Part B (Extension Period)|Withdrawal by Subject|1
2548315|NCT01469013|8817966|P8|Part B (Extension Period)|Withdrawal by Subject|0
2548316|NCT01469013|8817967|P7|Part B (Extension Period)|Withdrawal by Subject|0
2548317|NCT01469013|8817968|P6|Part B (Extension Period)|Withdrawal by Subject|0
2548318|NCT01469013|8817969|P5|Part B (Extension Period)|Withdrawal by Subject|0
2548319|NCT01469013|8817970|P4|Part B (Extension Period)|Withdrawal by Subject|0
2548320|NCT01469013|8817971|P3|Part B (Extension Period)|Withdrawal by Subject|0
2548321|NCT01469013|8817972|P2|Part B (Extension Period)|Withdrawal by Subject|0
2548322|NCT01469013|8817973|P1|Part B (Extension Period)|Withdrawal by Subject|0
2548323|NCT01469013|8817961|P13|Part B (Extension Period)|Adverse Event|3
2548324|NCT01469013|8817962|P12|Part B (Extension Period)|Adverse Event|6
2548325|NCT01469013|8817963|P11|Part B (Extension Period)|Adverse Event|1
2548326|NCT01469013|8817964|P10|Part B (Extension Period)|Adverse Event|3
2548327|NCT01469013|8817965|P9|Part B (Extension Period)|Adverse Event|3
2548328|NCT01469013|8817966|P8|Part B (Extension Period)|Adverse Event|5
2548329|NCT01469013|8817967|P7|Part B (Extension Period)|Adverse Event|5
2548330|NCT01469013|8817968|P6|Part B (Extension Period)|Adverse Event|2
2548331|NCT01469013|8817969|P5|Part B (Extension Period)|Adverse Event|0
2548332|NCT01469013|8817970|P4|Part B (Extension Period)|Adverse Event|0
2548333|NCT01469013|8817971|P3|Part B (Extension Period)|Adverse Event|0
2548334|NCT01469013|8817972|P2|Part B (Extension Period)|Adverse Event|0
2548335|NCT01469013|8817973|P1|Part B (Extension Period)|Adverse Event|0
2548336|NCT01469013|8817961|P13|Part A (Treatment Period)|Withdrawal by Subject|0
2548337|NCT01469013|8817962|P12|Part A (Treatment Period)|Withdrawal by Subject|0
2548338|NCT01469013|8817963|P11|Part A (Treatment Period)|Withdrawal by Subject|0
2548339|NCT01469013|8817964|P10|Part A (Treatment Period)|Withdrawal by Subject|0
2548340|NCT01469013|8817965|P9|Part A (Treatment Period)|Withdrawal by Subject|0
2548341|NCT01469013|8817966|P8|Part A (Treatment Period)|Withdrawal by Subject|0
2548342|NCT01469013|8817967|P7|Part A (Treatment Period)|Withdrawal by Subject|0
2548343|NCT01469013|8817968|P6|Part A (Treatment Period)|Withdrawal by Subject|0
2548344|NCT01469013|8817969|P5|Part A (Treatment Period)|Withdrawal by Subject|0
2548345|NCT01469013|8817970|P4|Part A (Treatment Period)|Withdrawal by Subject|0
2548346|NCT01469013|8817971|P3|Part A (Treatment Period)|Withdrawal by Subject|1
2548347|NCT01469013|8817972|P2|Part A (Treatment Period)|Withdrawal by Subject|0
2548348|NCT01469013|8817973|P1|Part A (Treatment Period)|Withdrawal by Subject|0
2548349|NCT01469013|8817961|P13|Part A (Treatment Period)|Adverse Event|0
2548350|NCT01469013|8817962|P12|Part A (Treatment Period)|Adverse Event|0
2548351|NCT01469013|8817963|P11|Part A (Treatment Period)|Adverse Event|0
2548352|NCT01469013|8817964|P10|Part A (Treatment Period)|Adverse Event|0
2548353|NCT01469013|8817965|P9|Part A (Treatment Period)|Adverse Event|0
2548354|NCT01469013|8817966|P8|Part A (Treatment Period)|Adverse Event|0
2548355|NCT01469013|8817967|P7|Part A (Treatment Period)|Adverse Event|0
2548356|NCT01469013|8817968|P6|Part A (Treatment Period)|Adverse Event|0
2548357|NCT01469013|8817969|P5|Part A (Treatment Period)|Adverse Event|1
2548358|NCT01469013|8817970|P4|Part A (Treatment Period)|Adverse Event|0
2548359|NCT01469013|8817971|P3|Part A (Treatment Period)|Adverse Event|0
2548360|NCT01469013|8817972|P2|Part A (Treatment Period)|Adverse Event|0
2548361|NCT01469013|8817973|P1|Part A (Treatment Period)|Adverse Event|1
2548362|NCT01469000|8818058|P2|Overall Study|Sponsor Decision|1
2548363|NCT01469000|8818059|P1|Overall Study|Sponsor Decision|4
2548364|NCT01469000|8818058|P2|Overall Study|Withdrawal by Subject|3
2548365|NCT01469000|8818059|P1|Overall Study|Withdrawal by Subject|16
2548366|NCT01468987|8818079|P2|Overall Study|Sponsor Decision|0
2548367|NCT01468987|8818080|P1|Overall Study|Sponsor Decision|1
2548368|NCT01468987|8818079|P2|Overall Study|Physician Decision|15
2548369|NCT01468987|8818080|P1|Overall Study|Physician Decision|8
2548370|NCT01468987|8818079|P2|Overall Study|Withdrawal by Subject|28
2548371|NCT01468987|8818080|P1|Overall Study|Withdrawal by Subject|28
2548372|NCT01468987|8818079|P2|Overall Study|Protocol Violation|2
2548373|NCT01468987|8818080|P1|Overall Study|Protocol Violation|8
2548374|NCT01468987|8818079|P2|Overall Study|Lost to Follow-up|5
2548375|NCT01468987|8818080|P1|Overall Study|Lost to Follow-up|10
2548376|NCT01468987|8818079|P2|Overall Study|Death|1
2548377|NCT01468987|8818080|P1|Overall Study|Death|4
2548378|NCT01468987|8818079|P2|Overall Study|Adverse Event|9
2548379|NCT01468987|8818080|P1|Overall Study|Adverse Event|12
2548380|NCT01468909|8818257|P2|Overall Study|Never Treated|2
2548381|NCT01468909|8818258|P1|Overall Study|Never Treated|2
2548382|NCT01468818|8818291|P1|Overall Study|Death during treatment|2
2548383|NCT01468311|8818349|P1|Overall Study|Withdrawal by Subject|1
2548384|NCT01468311|8818349|P1|Overall Study|mobilization failure|1
2548385|NCT01468233|8818361|P6|Treatment Period 2|Other|0
2548386|NCT01468233|8818362|P5|Treatment Period 2|Other|1
2548387|NCT01468233|8818363|P4|Treatment Period 2|Other|0
2548388|NCT01468233|8818364|P3|Treatment Period 2|Other|3
2548389|NCT01468233|8818365|P2|Treatment Period 2|Other|0
2548390|NCT01468233|8818366|P1|Treatment Period 2|Other|0
2548391|NCT01468233|8818361|P6|Treatment Period 2|Lost to Follow-up|0
2548392|NCT01468233|8818362|P5|Treatment Period 2|Lost to Follow-up|2
2548393|NCT01468233|8818363|P4|Treatment Period 2|Lost to Follow-up|0
2548394|NCT01468233|8818364|P3|Treatment Period 2|Lost to Follow-up|3
2548395|NCT01468233|8818365|P2|Treatment Period 2|Lost to Follow-up|0
2548396|NCT01468233|8818366|P1|Treatment Period 2|Lost to Follow-up|0
2548397|NCT01468233|8818361|P6|Treatment Period 2|Loss/absence of response (per protocol)|20
2548398|NCT01468233|8818362|P5|Treatment Period 2|Loss/absence of response (per protocol)|22
2548399|NCT01468233|8818363|P4|Treatment Period 2|Loss/absence of response (per protocol)|25
2548400|NCT01468233|8818364|P3|Treatment Period 2|Loss/absence of response (per protocol)|84
2548401|NCT01468233|8818365|P2|Treatment Period 2|Loss/absence of response (per protocol)|0
2548402|NCT01468233|8818366|P1|Treatment Period 2|Loss/absence of response (per protocol)|0
2548403|NCT01468233|8818361|P6|Treatment Period 2|Withdrawal by Subject|1
2548404|NCT01468233|8818362|P5|Treatment Period 2|Withdrawal by Subject|1
2548405|NCT01468233|8818363|P4|Treatment Period 2|Withdrawal by Subject|1
2548406|NCT01468233|8818364|P3|Treatment Period 2|Withdrawal by Subject|9
2548407|NCT01468233|8818365|P2|Treatment Period 2|Withdrawal by Subject|0
2548408|NCT01468233|8818366|P1|Treatment Period 2|Withdrawal by Subject|0
2548409|NCT01468233|8818361|P6|Treatment Period 2|Lack of Efficacy|1
2548410|NCT01468233|8818362|P5|Treatment Period 2|Lack of Efficacy|0
2548411|NCT01468233|8818363|P4|Treatment Period 2|Lack of Efficacy|2
2548412|NCT01468233|8818364|P3|Treatment Period 2|Lack of Efficacy|9
2548413|NCT01468233|8818365|P2|Treatment Period 2|Lack of Efficacy|0
2548414|NCT01468233|8818366|P1|Treatment Period 2|Lack of Efficacy|0
2548415|NCT01468233|8818361|P6|Treatment Period 2|Adverse Event|1
2548416|NCT01468233|8818362|P5|Treatment Period 2|Adverse Event|2
2548417|NCT01468233|8818363|P4|Treatment Period 2|Adverse Event|0
2548418|NCT01468233|8818364|P3|Treatment Period 2|Adverse Event|3
2548419|NCT01468233|8818365|P2|Treatment Period 2|Adverse Event|0
2548420|NCT01468233|8818366|P1|Treatment Period 2|Adverse Event|0
2548421|NCT01468233|8818361|P6|Treatment Period 1|Other|0
2548422|NCT01468233|8818362|P5|Treatment Period 1|Other|0
2548423|NCT01468233|8818363|P4|Treatment Period 1|Other|0
2548424|NCT01468233|8818364|P3|Treatment Period 1|Other|0
2548425|NCT01468233|8818365|P2|Treatment Period 1|Other|1
2548426|NCT01468233|8818366|P1|Treatment Period 1|Other|1
2548427|NCT01468233|8818361|P6|Treatment Period 1|Lost to Follow-up|0
2548428|NCT01468233|8818362|P5|Treatment Period 1|Lost to Follow-up|0
2548429|NCT01468233|8818363|P4|Treatment Period 1|Lost to Follow-up|0
2548430|NCT01468233|8818364|P3|Treatment Period 1|Lost to Follow-up|0
2548431|NCT01468233|8818365|P2|Treatment Period 1|Lost to Follow-up|0
2548432|NCT01468233|8818366|P1|Treatment Period 1|Lost to Follow-up|3
2548433|NCT01468233|8818361|P6|Treatment Period 1|Withdrawal by Subject|0
2548434|NCT01468233|8818362|P5|Treatment Period 1|Withdrawal by Subject|0
2548435|NCT01468233|8818363|P4|Treatment Period 1|Withdrawal by Subject|0
2548436|NCT01468233|8818364|P3|Treatment Period 1|Withdrawal by Subject|0
2548437|NCT01468233|8818365|P2|Treatment Period 1|Withdrawal by Subject|4
2548438|NCT01468233|8818366|P1|Treatment Period 1|Withdrawal by Subject|3
2548439|NCT01468233|8818361|P6|Treatment Period 1|Adverse Event|0
2548440|NCT01468233|8818362|P5|Treatment Period 1|Adverse Event|0
2548441|NCT01468233|8818363|P4|Treatment Period 1|Adverse Event|0
2548442|NCT01468233|8818364|P3|Treatment Period 1|Adverse Event|0
2548443|NCT01468233|8818365|P2|Treatment Period 1|Adverse Event|3
2548444|NCT01468233|8818366|P1|Treatment Period 1|Adverse Event|5
2548445|NCT01468207|8818388|P6|Treatment Period 2|Other|2
2548446|NCT01468207|8818389|P5|Treatment Period 2|Other|1
2548447|NCT01468207|8818390|P4|Treatment Period 2|Other|1
2548448|NCT01468207|8818391|P3|Treatment Period 2|Other|5
2548449|NCT01468207|8818392|P2|Treatment Period 2|Other|0
2548450|NCT01468207|8818393|P1|Treatment Period 2|Other|0
2548451|NCT01468207|8818388|P6|Treatment Period 2|Lost to Follow-up|0
2548452|NCT01468207|8818389|P5|Treatment Period 2|Lost to Follow-up|0
2548453|NCT01468207|8818390|P4|Treatment Period 2|Lost to Follow-up|1
2548454|NCT01468207|8818391|P3|Treatment Period 2|Lost to Follow-up|5
2548455|NCT01468207|8818392|P2|Treatment Period 2|Lost to Follow-up|0
2548456|NCT01468207|8818393|P1|Treatment Period 2|Lost to Follow-up|0
2548457|NCT01468207|8818388|P6|Treatment Period 2|Loss/abscence of response (per protocol)|13
2548458|NCT01468207|8818389|P5|Treatment Period 2|Loss/abscence of response (per protocol)|18
2548459|NCT01468207|8818390|P4|Treatment Period 2|Loss/abscence of response (per protocol)|23
2548460|NCT01468207|8818391|P3|Treatment Period 2|Loss/abscence of response (per protocol)|30
2548461|NCT01468207|8818392|P2|Treatment Period 2|Loss/abscence of response (per protocol)|0
2548462|NCT01468207|8818393|P1|Treatment Period 2|Loss/abscence of response (per protocol)|0
2548463|NCT01468207|8818388|P6|Treatment Period 2|Withdrawal by Subject|2
2548464|NCT01468207|8818389|P5|Treatment Period 2|Withdrawal by Subject|0
2548465|NCT01468207|8818390|P4|Treatment Period 2|Withdrawal by Subject|0
2548466|NCT01468207|8818391|P3|Treatment Period 2|Withdrawal by Subject|5
2548467|NCT01468207|8818392|P2|Treatment Period 2|Withdrawal by Subject|0
2548468|NCT01468207|8818393|P1|Treatment Period 2|Withdrawal by Subject|0
2548469|NCT01468207|8818388|P6|Treatment Period 2|Lack of Efficacy|2
2548470|NCT01468207|8818389|P5|Treatment Period 2|Lack of Efficacy|0
2548471|NCT01468207|8818390|P4|Treatment Period 2|Lack of Efficacy|1
2548472|NCT01468207|8818391|P3|Treatment Period 2|Lack of Efficacy|1
2548473|NCT01468207|8818392|P2|Treatment Period 2|Lack of Efficacy|0
2548474|NCT01468207|8818393|P1|Treatment Period 2|Lack of Efficacy|0
2548475|NCT01468207|8818388|P6|Treatment Period 2|Adverse Event|1
2548476|NCT01468207|8818389|P5|Treatment Period 2|Adverse Event|2
2548477|NCT01468207|8818390|P4|Treatment Period 2|Adverse Event|1
2548478|NCT01468207|8818391|P3|Treatment Period 2|Adverse Event|6
2548479|NCT01468207|8818392|P2|Treatment Period 2|Adverse Event|0
2548480|NCT01468207|8818393|P1|Treatment Period 2|Adverse Event|0
2548481|NCT01468207|8818388|P6|Treatment Period 1|Other|0
2548482|NCT01468207|8818389|P5|Treatment Period 1|Other|0
2548483|NCT01468207|8818390|P4|Treatment Period 1|Other|0
2548484|NCT01468207|8818391|P3|Treatment Period 1|Other|0
2548485|NCT01468207|8818392|P2|Treatment Period 1|Other|2
2548486|NCT01468207|8818393|P1|Treatment Period 1|Other|0
2548487|NCT01468207|8818388|P6|Treatment Period 1|Lost to Follow-up|0
2548488|NCT01468207|8818389|P5|Treatment Period 1|Lost to Follow-up|0
2548489|NCT01468207|8818390|P4|Treatment Period 1|Lost to Follow-up|0
2548490|NCT01468207|8818391|P3|Treatment Period 1|Lost to Follow-up|0
2548491|NCT01468207|8818392|P2|Treatment Period 1|Lost to Follow-up|1
2548492|NCT01468207|8818393|P1|Treatment Period 1|Lost to Follow-up|2
2548493|NCT01468207|8818388|P6|Treatment Period 1|Withdrawal by Subject|0
2548494|NCT01468207|8818389|P5|Treatment Period 1|Withdrawal by Subject|0
2548495|NCT01468207|8818390|P4|Treatment Period 1|Withdrawal by Subject|0
2548496|NCT01468207|8818391|P3|Treatment Period 1|Withdrawal by Subject|0
2548497|NCT01468207|8818392|P2|Treatment Period 1|Withdrawal by Subject|4
2548498|NCT01468207|8818393|P1|Treatment Period 1|Withdrawal by Subject|5
2548499|NCT01468207|8818388|P6|Treatment Period 1|Protocol Violation|0
2548500|NCT01468207|8818389|P5|Treatment Period 1|Protocol Violation|0
2548501|NCT01468207|8818390|P4|Treatment Period 1|Protocol Violation|0
2548502|NCT01468207|8818391|P3|Treatment Period 1|Protocol Violation|0
2548503|NCT01468207|8818392|P2|Treatment Period 1|Protocol Violation|1
2548504|NCT01468207|8818393|P1|Treatment Period 1|Protocol Violation|1
2548505|NCT01468207|8818388|P6|Treatment Period 1|Adverse Event|0
2548506|NCT01468207|8818389|P5|Treatment Period 1|Adverse Event|0
2548507|NCT01468207|8818390|P4|Treatment Period 1|Adverse Event|0
2548508|NCT01468207|8818391|P3|Treatment Period 1|Adverse Event|0
2548509|NCT01468207|8818392|P2|Treatment Period 1|Adverse Event|0
2548510|NCT01468207|8818393|P1|Treatment Period 1|Adverse Event|1
2548511|NCT01468181|8818418|P5|Overall Study|Withdrawal by Subject|0
2548512|NCT01468181|8818419|P4|Overall Study|Withdrawal by Subject|0
2548513|NCT01468181|8818420|P3|Overall Study|Withdrawal by Subject|0
2548514|NCT01468181|8818421|P2|Overall Study|Withdrawal by Subject|1
2548515|NCT01468181|8818422|P1|Overall Study|Withdrawal by Subject|0
2548516|NCT01468181|8818418|P5|Overall Study|Lost to Follow-up|1
2548517|NCT01468181|8818419|P4|Overall Study|Lost to Follow-up|0
2548518|NCT01468181|8818420|P3|Overall Study|Lost to Follow-up|1
2548519|NCT01468181|8818421|P2|Overall Study|Lost to Follow-up|0
2548520|NCT01468181|8818422|P1|Overall Study|Lost to Follow-up|0
2548521|NCT01468181|8818418|P5|Overall Study|Physician Decision|1
2548522|NCT01468181|8818419|P4|Overall Study|Physician Decision|1
2548523|NCT01468181|8818420|P3|Overall Study|Physician Decision|0
2548524|NCT01468181|8818421|P2|Overall Study|Physician Decision|0
2548525|NCT01468181|8818422|P1|Overall Study|Physician Decision|0
2548526|NCT01468181|8818418|P5|Overall Study|Protocol Violation|1
2548527|NCT01468181|8818419|P4|Overall Study|Protocol Violation|0
2548528|NCT01468181|8818420|P3|Overall Study|Protocol Violation|1
2548529|NCT01468181|8818421|P2|Overall Study|Protocol Violation|0
2548530|NCT01468181|8818422|P1|Overall Study|Protocol Violation|2
2548531|NCT01468181|8818418|P5|Overall Study|Adverse Event|2
2548532|NCT01468181|8818419|P4|Overall Study|Adverse Event|2
2548533|NCT01468181|8818420|P3|Overall Study|Adverse Event|6
2548534|NCT01468181|8818421|P2|Overall Study|Adverse Event|1
2548535|NCT01468181|8818422|P1|Overall Study|Adverse Event|8
2548536|NCT01468077|8818471|P2|Overall Study|Physician Decision|0
2548537|NCT01468077|8818472|P1|Overall Study|Physician Decision|1
2548538|NCT01468077|8818471|P2|Overall Study|Lack of Efficacy|1
2548539|NCT01468077|8818472|P1|Overall Study|Lack of Efficacy|1
2548540|NCT01468077|8818471|P2|Overall Study|Adverse Event|2
2548541|NCT01468077|8818472|P1|Overall Study|Adverse Event|2
2548542|NCT01467960|8818534|P6|Overall Study|Enrollment of patients (PD) in 09/2013|30
2548543|NCT01467960|8818535|P5|Overall Study|Enrollment of patients (PD) in 09/2013|30
2548544|NCT01467960|8818536|P4|Overall Study|Enrollment of patients (PD) in 09/2013|30
2548545|NCT01467960|8818537|P3|Overall Study|Enrollment of patients (PD) in 09/2013|0
2548546|NCT01467960|8818538|P2|Overall Study|Enrollment of patients (PD) in 09/2013|0
2548547|NCT01467960|8818539|P1|Overall Study|Enrollment of patients (PD) in 09/2013|0
2548548|NCT01467713|8818598|P4|Overall Study|Reason not Specified|7
2548549|NCT01467713|8818599|P3|Overall Study|Reason not Specified|8
2548550|NCT01467713|8818600|P2|Overall Study|Reason not Specified|11
2548551|NCT01467713|8818601|P1|Overall Study|Reason not Specified|6
2548552|NCT01467713|8818598|P4|Overall Study|Relapse|35
2548553|NCT01467713|8818599|P3|Overall Study|Relapse|28
2548554|NCT01467713|8818600|P2|Overall Study|Relapse|25
2548555|NCT01467713|8818601|P1|Overall Study|Relapse|35
2548556|NCT01467713|8818598|P4|Overall Study|Pregnancy|3
2548557|NCT01467713|8818599|P3|Overall Study|Pregnancy|1
2548558|NCT01467713|8818600|P2|Overall Study|Pregnancy|1
2548559|NCT01467713|8818601|P1|Overall Study|Pregnancy|0
2548560|NCT01467713|8818598|P4|Overall Study|Study Termination|29
2548561|NCT01467713|8818599|P3|Overall Study|Study Termination|28
2548562|NCT01467713|8818600|P2|Overall Study|Study Termination|33
2548563|NCT01467713|8818601|P1|Overall Study|Study Termination|23
2548564|NCT01467713|8818598|P4|Overall Study|Voluntary Withdrawal|20
2548565|NCT01467713|8818599|P3|Overall Study|Voluntary Withdrawal|21
2548566|NCT01467713|8818600|P2|Overall Study|Voluntary Withdrawal|14
2548567|NCT01467713|8818601|P1|Overall Study|Voluntary Withdrawal|18
2548568|NCT01467713|8818598|P4|Overall Study|Lost to Follow-up|9
2548569|NCT01467713|8818599|P3|Overall Study|Lost to Follow-up|6
2548570|NCT01467713|8818600|P2|Overall Study|Lost to Follow-up|12
2548571|NCT01467713|8818601|P1|Overall Study|Lost to Follow-up|9
2548572|NCT01467713|8818598|P4|Overall Study|Major Protocol Deviation|1
2548573|NCT01467713|8818599|P3|Overall Study|Major Protocol Deviation|4
2548574|NCT01467713|8818600|P2|Overall Study|Major Protocol Deviation|4
2548575|NCT01467713|8818601|P1|Overall Study|Major Protocol Deviation|2
2548576|NCT01467713|8818598|P4|Overall Study|Pretreatment Event or Adverse Event|5
2548577|NCT01467713|8818599|P3|Overall Study|Pretreatment Event or Adverse Event|6
2548578|NCT01467713|8818600|P2|Overall Study|Pretreatment Event or Adverse Event|4
2548579|NCT01467713|8818601|P1|Overall Study|Pretreatment Event or Adverse Event|9
2548580|NCT01467700|8818655|P4|Overall Study|Reason not Specified|8
2548581|NCT01467700|8818656|P3|Overall Study|Reason not Specified|2
2548582|NCT01467700|8818657|P2|Overall Study|Reason not Specified|3
2548583|NCT01467700|8818658|P1|Overall Study|Reason not Specified|1
2548584|NCT01467700|8818655|P4|Overall Study|Lack of Efficacy|1
2548585|NCT01467700|8818656|P3|Overall Study|Lack of Efficacy|2
2548586|NCT01467700|8818657|P2|Overall Study|Lack of Efficacy|0
2548587|NCT01467700|8818658|P1|Overall Study|Lack of Efficacy|2
2548588|NCT01467700|8818655|P4|Overall Study|Pregnancy|0
2548589|NCT01467700|8818656|P3|Overall Study|Pregnancy|1
2548590|NCT01467700|8818657|P2|Overall Study|Pregnancy|1
2548591|NCT01467700|8818658|P1|Overall Study|Pregnancy|0
2548592|NCT01467700|8818655|P4|Overall Study|Study Termination|7
2548593|NCT01467700|8818656|P3|Overall Study|Study Termination|10
2548594|NCT01467700|8818657|P2|Overall Study|Study Termination|5
2548595|NCT01467700|8818658|P1|Overall Study|Study Termination|6
2548596|NCT01467700|8818655|P4|Overall Study|Voluntary Withdrawal|2
2548597|NCT01467700|8818656|P3|Overall Study|Voluntary Withdrawal|6
2548598|NCT01467700|8818657|P2|Overall Study|Voluntary Withdrawal|7
2548599|NCT01467700|8818658|P1|Overall Study|Voluntary Withdrawal|5
2548600|NCT01467700|8818655|P4|Overall Study|Lost to Follow-up|3
2548601|NCT01467700|8818656|P3|Overall Study|Lost to Follow-up|2
2548602|NCT01467700|8818657|P2|Overall Study|Lost to Follow-up|5
2548603|NCT01467700|8818658|P1|Overall Study|Lost to Follow-up|6
2548604|NCT01467700|8818655|P4|Overall Study|Major Protocol Deviation|3
2548605|NCT01467700|8818656|P3|Overall Study|Major Protocol Deviation|2
2548606|NCT01467700|8818657|P2|Overall Study|Major Protocol Deviation|3
2548607|NCT01467700|8818658|P1|Overall Study|Major Protocol Deviation|3
2548608|NCT01467700|8818655|P4|Overall Study|Pretreatment Event or Adverse Event|3
2548609|NCT01467700|8818656|P3|Overall Study|Pretreatment Event or Adverse Event|2
2548610|NCT01467700|8818657|P2|Overall Study|Pretreatment Event or Adverse Event|4
2548611|NCT01467700|8818658|P1|Overall Study|Pretreatment Event or Adverse Event|6
2548612|NCT01467661|8818700|P1|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1
2548613|NCT01467661|8818700|P1|Overall Study|Lack of Efficacy|3
2548614|NCT01467661|8818700|P1|Overall Study|Withdrawal by Subject|1
2548615|NCT01467661|8818700|P1|Overall Study|Adverse Event|16
2548616|NCT01467583|8818720|P3|Overall Study|Protocol Violation|2
2548617|NCT01467583|8818721|P2|Overall Study|Protocol Violation|0
2548618|NCT01467583|8818722|P1|Overall Study|Protocol Violation|0
2548619|NCT01467583|8818720|P3|Overall Study|Withdrawal by Subject|0
2548620|NCT01467583|8818721|P2|Overall Study|Withdrawal by Subject|0
2548621|NCT01467583|8818722|P1|Overall Study|Withdrawal by Subject|1
2548622|NCT01467583|8818720|P3|Overall Study|Death|0
2548623|NCT01467583|8818721|P2|Overall Study|Death|1
2548624|NCT01467583|8818722|P1|Overall Study|Death|1
2548625|NCT01467570|8818735|P2|Overall Study|Lost to Follow-up|9
2548626|NCT01467570|8818736|P1|Overall Study|Lost to Follow-up|8
2548627|NCT01467505|8818773|P2|Overall Study|Study Terminated by Sponsor|3
2548628|NCT01467505|8818774|P1|Overall Study|Study Terminated by Sponsor|28
2548629|NCT01467505|8818773|P2|Overall Study|Withdrawal by Subject|0
2548630|NCT01467505|8818774|P1|Overall Study|Withdrawal by Subject|4
2548631|NCT01467505|8818773|P2|Overall Study|Adverse Event|0
2548632|NCT01467505|8818774|P1|Overall Study|Adverse Event|1
2548633|NCT01467492|8818806|P2|Overall Study|Enrolled But Not Treated|0
2548634|NCT01467492|8818807|P1|Overall Study|Enrolled But Not Treated|1
2548635|NCT01467492|8818806|P2|Overall Study|Undefined|0
2548636|NCT01467492|8818807|P1|Overall Study|Undefined|2
2548637|NCT01467492|8818806|P2|Overall Study|Lost to Follow-up|2
2548638|NCT01467492|8818807|P1|Overall Study|Lost to Follow-up|3
2548639|NCT01467492|8818806|P2|Overall Study|Adverse Event|3
2548640|NCT01467492|8818807|P1|Overall Study|Adverse Event|4
2548641|NCT01467492|8818806|P2|Overall Study|Study Terminated by Sponsor|4
2548642|NCT01467492|8818807|P1|Overall Study|Study Terminated by Sponsor|6
2548643|NCT01467492|8818806|P2|Overall Study|Withdrawal by Subject|4
2548644|NCT01467492|8818807|P1|Overall Study|Withdrawal by Subject|6
2548645|NCT01467479|8818831|P3|Overall Study|Other|0
2548646|NCT01467479|8818832|P2|Overall Study|Other|0
2548647|NCT01467479|8818833|P1|Overall Study|Other|1
2548648|NCT01467479|8818831|P3|Overall Study|Study Terminated by Sponsor|3
2548649|NCT01467479|8818832|P2|Overall Study|Study Terminated by Sponsor|3
2548650|NCT01467479|8818833|P1|Overall Study|Study Terminated by Sponsor|1
2548651|NCT01467479|8818831|P3|Overall Study|Withdrawal of Consent|7
2548652|NCT01467479|8818832|P2|Overall Study|Withdrawal of Consent|7
2548653|NCT01467479|8818833|P1|Overall Study|Withdrawal of Consent|3
2548654|NCT01467479|8818831|P3|Overall Study|Lost to Follow-up|3
2548655|NCT01467479|8818832|P2|Overall Study|Lost to Follow-up|5
2548656|NCT01467479|8818833|P1|Overall Study|Lost to Follow-up|2
2548657|NCT01467479|8818831|P3|Overall Study|Death|1
2548658|NCT01467479|8818832|P2|Overall Study|Death|0
2548659|NCT01467479|8818833|P1|Overall Study|Death|0
2548660|NCT01467479|8818831|P3|Overall Study|Adverse Event|0
2548661|NCT01467479|8818832|P2|Overall Study|Adverse Event|2
2548662|NCT01467479|8818833|P1|Overall Study|Adverse Event|1
2548663|NCT01467479|8818831|P3|Overall Study|No Study Medication|2
2548664|NCT01467479|8818832|P2|Overall Study|No Study Medication|0
2548665|NCT01467479|8818833|P1|Overall Study|No Study Medication|1
2548666|NCT01467466|8818864|P4|Overall Study|No Endpoint Blood Draw|43
2548667|NCT01467466|8818865|P3|Overall Study|No Endpoint Blood Draw|51
2548668|NCT01467466|8818866|P2|Overall Study|No Endpoint Blood Draw|32
2548669|NCT01467466|8818867|P1|Overall Study|No Endpoint Blood Draw|38
2548670|NCT01467466|8818864|P4|Overall Study|Procedure Cancelled|29
2548671|NCT01467466|8818865|P3|Overall Study|Procedure Cancelled|25
2548672|NCT01467466|8818866|P2|Overall Study|Procedure Cancelled|45
2548673|NCT01467466|8818867|P1|Overall Study|Procedure Cancelled|46
2548674|NCT01467466|8818864|P4|Overall Study|Revoked Consent Prior To Procedure|5
2548675|NCT01467466|8818865|P3|Overall Study|Revoked Consent Prior To Procedure|15
2548676|NCT01467466|8818866|P2|Overall Study|Revoked Consent Prior To Procedure|9
2548677|NCT01467466|8818867|P1|Overall Study|Revoked Consent Prior To Procedure|10
2548678|NCT01467466|8818864|P4|Overall Study|Withdrawal by Subject|11
2548679|NCT01467466|8818865|P3|Overall Study|Withdrawal by Subject|13
2548680|NCT01467466|8818866|P2|Overall Study|Withdrawal by Subject|18
2548681|NCT01467466|8818867|P1|Overall Study|Withdrawal by Subject|15
2548682|NCT01467427|8818879|P2|Overall Study|Not continuing in extension phase|2
2548683|NCT01467427|8818880|P1|Overall Study|Not continuing in extension phase|0
2548684|NCT01467427|8818879|P2|Overall Study|Entered extension phase|11
2548685|NCT01467427|8818880|P1|Overall Study|Entered extension phase|11
2548686|NCT01467427|8818879|P2|Overall Study|Withdrawal by Subject|0
2548687|NCT01467427|8818880|P1|Overall Study|Withdrawal by Subject|1
2548688|NCT01467271|8818898|P1|Overall Study|Other reason|14
2548689|NCT01467271|8818898|P1|Overall Study|Retraction of patient's consent|21
2548690|NCT01467271|8818898|P1|Overall Study|Lost to Follow-up|83
2548691|NCT01467271|8818898|P1|Overall Study|Death|84
2548692|NCT01467076|8818905|P3|Overall Study|Lost to Follow-up|0
2548693|NCT01467076|8818906|P2|Overall Study|Lost to Follow-up|0
2548694|NCT01467076|8818907|P1|Overall Study|Lost to Follow-up|1
2548695|NCT01466881|8818973|P1|Overall Study|Other reason not protocol specified|5
2548696|NCT01466881|8818973|P1|Overall Study|Death|4
2548697|NCT01466881|8818973|P1|Overall Study|Progression/relapse|20
2548698|NCT01466881|8818973|P1|Overall Study|Adverse Event|6
2548699|NCT01466881|8818973|P1|Overall Study|Ineligible|5
2548700|NCT01466790|8818990|P8|Overall Study|Withdrawal by Subject|1
2548701|NCT01466790|8818991|P7|Overall Study|Withdrawal by Subject|1
2548702|NCT01466790|8818992|P6|Overall Study|Withdrawal by Subject|0
2548703|NCT01466790|8818993|P5|Overall Study|Withdrawal by Subject|1
2548704|NCT01466790|8818994|P4|Overall Study|Withdrawal by Subject|0
2548705|NCT01466790|8818995|P3|Overall Study|Withdrawal by Subject|0
2548706|NCT01466790|8818996|P2|Overall Study|Withdrawal by Subject|1
2548707|NCT01466790|8818997|P1|Overall Study|Withdrawal by Subject|1
2548708|NCT01466790|8818990|P8|Overall Study|Lost to Follow-up|0
2548709|NCT01466790|8818991|P7|Overall Study|Lost to Follow-up|0
2548710|NCT01466790|8818992|P6|Overall Study|Lost to Follow-up|0
2548711|NCT01466790|8818993|P5|Overall Study|Lost to Follow-up|0
2548712|NCT01466790|8818994|P4|Overall Study|Lost to Follow-up|0
2548713|NCT01466790|8818995|P3|Overall Study|Lost to Follow-up|0
2548714|NCT01466790|8818996|P2|Overall Study|Lost to Follow-up|0
2548715|NCT01466790|8818997|P1|Overall Study|Lost to Follow-up|2
2548716|NCT01466790|8818990|P8|Overall Study|Adverse Event|0
2548717|NCT01466790|8818991|P7|Overall Study|Adverse Event|0
2548718|NCT01466790|8818992|P6|Overall Study|Adverse Event|0
2548719|NCT01466790|8818993|P5|Overall Study|Adverse Event|2
2548720|NCT01466790|8818994|P4|Overall Study|Adverse Event|0
2548721|NCT01466790|8818995|P3|Overall Study|Adverse Event|0
2548722|NCT01466790|8818996|P2|Overall Study|Adverse Event|0
2548723|NCT01466790|8818997|P1|Overall Study|Adverse Event|1
2548724|NCT01466673|8819093|P2|Overall Study|Adverse Event|1
2548725|NCT01466673|8819094|P1|Overall Study|Adverse Event|2
2548726|NCT01466673|8819093|P2|Overall Study|Lost to Follow-up|5
2548727|NCT01466673|8819094|P1|Overall Study|Lost to Follow-up|3
2548728|NCT01466673|8819093|P2|Overall Study|Non-compliance with study treatment|0
2548729|NCT01466673|8819094|P1|Overall Study|Non-compliance with study treatment|2
2548730|NCT01466660|8819120|P2|Overall Study|Other reason not defined above|8
2548731|NCT01466660|8819121|P1|Overall Study|Other reason not defined above|10
2548732|NCT01466660|8819120|P2|Overall Study|Refused continuation of trial medication|3
2548733|NCT01466660|8819121|P1|Overall Study|Refused continuation of trial medication|4
2548734|NCT01466660|8819120|P2|Overall Study|Protocol Violation|1
2548735|NCT01466660|8819121|P1|Overall Study|Protocol Violation|2
2548736|NCT01466660|8819120|P2|Overall Study|Other adverse event|18
2548737|NCT01466660|8819121|P1|Overall Study|Other adverse event|19
2548738|NCT01466660|8819120|P2|Overall Study|Worsening of underlying cancer disease|2
2548739|NCT01466660|8819121|P1|Overall Study|Worsening of underlying cancer disease|5
2548740|NCT01466660|8819120|P2|Overall Study|Progressive Disease (RECIST 1.1)|127
2548741|NCT01466660|8819121|P1|Overall Study|Progressive Disease (RECIST 1.1)|120
2548742|NCT01466595|8819147|P2|Overall Study|Withdrawal by Subject|1
2548743|NCT01466595|8819148|P1|Overall Study|Withdrawal by Subject|0
2548744|NCT01466491|8819242|P4|Overall Study|Missing Data|0
2548745|NCT01466491|8819243|P3|Overall Study|Missing Data|1
2548746|NCT01466491|8819244|P2|Overall Study|Missing Data|0
2548747|NCT01466491|8819245|P1|Overall Study|Missing Data|0
2548748|NCT01466491|8819242|P4|Overall Study|Protocol Violation|0
2548749|NCT01466491|8819243|P3|Overall Study|Protocol Violation|2
2548750|NCT01466491|8819244|P2|Overall Study|Protocol Violation|3
2548751|NCT01466491|8819245|P1|Overall Study|Protocol Violation|0
2548752|NCT01466387|8819265|P6|Overall Study|Protocol Violation|0
2548753|NCT01466387|8819266|P5|Overall Study|Protocol Violation|0
2548754|NCT01466387|8819267|P4|Overall Study|Protocol Violation|1
2548755|NCT01466387|8819268|P3|Overall Study|Protocol Violation|0
2548756|NCT01466387|8819269|P2|Overall Study|Protocol Violation|0
2548757|NCT01466387|8819270|P1|Overall Study|Protocol Violation|1
2548758|NCT01466387|8819265|P6|Overall Study|Lost to Follow-up|1
2548759|NCT01466387|8819266|P5|Overall Study|Lost to Follow-up|0
2548760|NCT01466387|8819267|P4|Overall Study|Lost to Follow-up|0
2548761|NCT01466387|8819268|P3|Overall Study|Lost to Follow-up|0
2548762|NCT01466387|8819269|P2|Overall Study|Lost to Follow-up|0
2548763|NCT01466387|8819270|P1|Overall Study|Lost to Follow-up|0
2548764|NCT01466387|8819265|P6|Overall Study|Adverse Event|0
2548765|NCT01466387|8819266|P5|Overall Study|Adverse Event|0
2548766|NCT01466387|8819267|P4|Overall Study|Adverse Event|1
2548767|NCT01466387|8819268|P3|Overall Study|Adverse Event|1
2548768|NCT01466387|8819269|P2|Overall Study|Adverse Event|0
2548769|NCT01466387|8819270|P1|Overall Study|Adverse Event|0
2548770|NCT01466348|8819331|P2|Period I - First Intervention|Withdrawal by Subject|1
2548771|NCT01466348|8819332|P1|Period I - First Intervention|Withdrawal by Subject|0
2548772|NCT01466270|8819360|P2|Overall Study|Multiple|1
2548773|NCT01466270|8819361|P1|Overall Study|Multiple|1
2548774|NCT01466270|8819360|P2|Overall Study|Toxicity|1
2548775|NCT01466270|8819361|P1|Overall Study|Toxicity|4
2548776|NCT01466270|8819360|P2|Overall Study|Progression|0
2548777|NCT01466270|8819361|P1|Overall Study|Progression|1
2548778|NCT01466270|8819360|P2|Overall Study|Lost to Follow-up|3
2548779|NCT01466270|8819361|P1|Overall Study|Lost to Follow-up|1
2548780|NCT01466270|8819360|P2|Overall Study|Physician Decision|0
2548781|NCT01466270|8819361|P1|Overall Study|Physician Decision|1
2548782|NCT01466270|8819360|P2|Overall Study|Withdrawal by Subject|1
2548783|NCT01466270|8819361|P1|Overall Study|Withdrawal by Subject|4
2548784|NCT01466192|8819373|P1|Overall Study|Withdrawal by Subject|3
2548785|NCT01466192|8819373|P1|Overall Study|Physician Decision|1
2548786|NCT01466179|8819377|P1|Overall Study|Other|3
2548787|NCT01466179|8819377|P1|Overall Study|Protocol Violation|2
2548788|NCT01466179|8819377|P1|Overall Study|Withdrawal by Subject|7
2548789|NCT01466179|8819377|P1|Overall Study|Death|7
2548790|NCT01466179|8819377|P1|Overall Study|Lack of Efficacy|14
2548791|NCT01466179|8819377|P1|Overall Study|Disease relapse|23
2548792|NCT01466179|8819377|P1|Overall Study|Adverse Event|32
2548793|NCT01466179|8819377|P1|Overall Study|Progressive disease|43
2548794|NCT01466179|8819377|P1|Overall Study|Physician Decision|46
2548795|NCT01466179|8819377|P1|Overall Study|Ongoing in core study|2
2548796|NCT01466166|8819397|P1|Overall Study|Other|20
2548797|NCT01466166|8819397|P1|Overall Study|Protocol Violation/Noncompliance|2
2548798|NCT01466166|8819397|P1|Overall Study|Sponsor Decision|4
2548799|NCT01466166|8819397|P1|Overall Study|Withdrawal by Subject|13
2548800|NCT01466166|8819397|P1|Overall Study|Elevated Serum Uric Acid|78
2548801|NCT01466166|8819397|P1|Overall Study|Adverse Event (Other than IR)|11
2548802|NCT01466166|8819397|P1|Overall Study|Infusion Reaction (IR)|27
2548803|NCT01466166|8819397|P1|Overall Study|Lost to Follow-up|7
2548804|NCT01466166|8819397|P1|Overall Study|Death|1
2548805|NCT01466153|8819411|P3|Overall Study|Other-Unspecified|2
2548806|NCT01466153|8819412|P2|Overall Study|Other-Unspecified|4
2548807|NCT01466153|8819413|P1|Overall Study|Other-Unspecified|6
2548808|NCT01466153|8819411|P3|Overall Study|Randomized-Not Treated|4
2548809|NCT01466153|8819412|P2|Overall Study|Randomized-Not Treated|3
2548810|NCT01466153|8819413|P1|Overall Study|Randomized-Not Treated|2
2548811|NCT01466153|8819411|P3|Overall Study|Investigator Discretion|2
2548812|NCT01466153|8819412|P2|Overall Study|Investigator Discretion|2
2548813|NCT01466153|8819413|P1|Overall Study|Investigator Discretion|3
2548814|NCT01466153|8819411|P3|Overall Study|Withdrawal of Consent|0
2548815|NCT01466153|8819412|P2|Overall Study|Withdrawal of Consent|0
2548816|NCT01466153|8819413|P1|Overall Study|Withdrawal of Consent|2
2548817|NCT01466153|8819411|P3|Overall Study|Adverse Event|17
2548818|NCT01466153|8819412|P2|Overall Study|Adverse Event|13
2548819|NCT01466153|8819413|P1|Overall Study|Adverse Event|14
2548820|NCT01466153|8819411|P3|Overall Study|Disease Progression|0
2548821|NCT01466153|8819412|P2|Overall Study|Disease Progression|2
2548822|NCT01466153|8819413|P1|Overall Study|Disease Progression|2
2548823|NCT01466062|8819468|P1|Overall Study|Withdrawal by Subject|1
2548824|NCT01466062|8819468|P1|Overall Study|Adverse Event|1
2548825|NCT01465997|8819491|P2|Overall Study|subject left participation SP0993|1
2548826|NCT01465997|8819492|P1|Overall Study|subject left participation SP0993|0
2548827|NCT01465997|8819491|P2|Overall Study|decision by site staff|1
2548828|NCT01465997|8819492|P1|Overall Study|decision by site staff|0
2548829|NCT01465997|8819491|P2|Overall Study|withdrew before follow-up|13
2548830|NCT01465997|8819492|P1|Overall Study|withdrew before follow-up|0
2548831|NCT01465997|8819491|P2|Overall Study|local lab unblinded site|0
2548832|NCT01465997|8819492|P1|Overall Study|local lab unblinded site|1
2548833|NCT01465997|8819491|P2|Overall Study|subject withdrew consent|0
2548834|NCT01465997|8819492|P1|Overall Study|subject withdrew consent|1
2548835|NCT01465997|8819491|P2|Overall Study|sponsor's decision|1
2548836|NCT01465997|8819492|P1|Overall Study|sponsor's decision|1
2548837|NCT01465997|8819491|P2|Overall Study|Death|1
2548838|NCT01465997|8819492|P1|Overall Study|Death|0
2548839|NCT01465997|8819491|P2|Overall Study|investigator's decision|1
2548840|NCT01465997|8819492|P1|Overall Study|investigator's decision|1
2548841|NCT01465997|8819491|P2|Overall Study|Withdrawal by Subject|35
2548842|NCT01465997|8819492|P1|Overall Study|Withdrawal by Subject|32
2548843|NCT01465997|8819491|P2|Overall Study|Lost to Follow-up|9
2548844|NCT01465997|8819492|P1|Overall Study|Lost to Follow-up|6
2548845|NCT01465997|8819491|P2|Overall Study|Protocol Violation|4
2548846|NCT01465997|8819492|P1|Overall Study|Protocol Violation|1
2548847|NCT01465997|8819491|P2|Overall Study|Lack of Efficacy|1
2548848|NCT01465997|8819492|P1|Overall Study|Lack of Efficacy|13
2548849|NCT01465997|8819491|P2|Overall Study|Adverse Event|22
2548850|NCT01465997|8819492|P1|Overall Study|Adverse Event|12
2548851|NCT01465958|8819502|P2|Subcutaneous (SC) Phase|Adverse Event|1
2548852|NCT01465958|8819503|P1|Subcutaneous (SC) Phase|Adverse Event|0
2548853|NCT01465958|8819502|P2|Run-in Phase|Protocol Violation|0
2548854|NCT01465958|8819503|P1|Run-in Phase|Protocol Violation|1
2548855|NCT01465802|8819516|P5|Overall Study|Death|2
2548856|NCT01465802|8819517|P4|Overall Study|Death|10
2548857|NCT01465802|8819518|P3|Overall Study|Death|0
2548858|NCT01465802|8819519|P2|Overall Study|Death|12
2548859|NCT01465802|8819520|P1|Overall Study|Death|15
2548860|NCT01465802|8819516|P5|Overall Study|Reason not specified|2
2548861|NCT01465802|8819517|P4|Overall Study|Reason not specified|10
2548862|NCT01465802|8819518|P3|Overall Study|Reason not specified|0
2548863|NCT01465802|8819519|P2|Overall Study|Reason not specified|4
2548864|NCT01465802|8819520|P1|Overall Study|Reason not specified|9
2548865|NCT01465802|8819516|P5|Overall Study|Lost to Follow-up|0
2548866|NCT01465802|8819517|P4|Overall Study|Lost to Follow-up|0
2548867|NCT01465802|8819518|P3|Overall Study|Lost to Follow-up|0
2548868|NCT01465802|8819519|P2|Overall Study|Lost to Follow-up|1
2548869|NCT01465802|8819520|P1|Overall Study|Lost to Follow-up|1
2548870|NCT01465802|8819516|P5|Overall Study|Withdrawal by Subject|1
2548871|NCT01465802|8819517|P4|Overall Study|Withdrawal by Subject|8
2548872|NCT01465802|8819518|P3|Overall Study|Withdrawal by Subject|0
2548873|NCT01465802|8819519|P2|Overall Study|Withdrawal by Subject|7
2548874|NCT01465802|8819520|P1|Overall Study|Withdrawal by Subject|7
2548875|NCT01465802|8819516|P5|Overall Study|Study terminated by sponsor|7
2548876|NCT01465802|8819517|P4|Overall Study|Study terminated by sponsor|1
2548877|NCT01465802|8819518|P3|Overall Study|Study terminated by sponsor|0
2548878|NCT01465802|8819519|P2|Overall Study|Study terminated by sponsor|0
2548879|NCT01465802|8819520|P1|Overall Study|Study terminated by sponsor|1
2548880|NCT01465763|8819572|P3|Overall Study|Death|0
2548881|NCT01465763|8819573|P2|Overall Study|Death|0
2548882|NCT01465763|8819574|P1|Overall Study|Death|1
2548883|NCT01465763|8819572|P3|Overall Study|Protocol Violation|1
2548884|NCT01465763|8819573|P2|Overall Study|Protocol Violation|1
2548885|NCT01465763|8819574|P1|Overall Study|Protocol Violation|4
2548886|NCT01465763|8819572|P3|Overall Study|Other|0
2548887|NCT01465763|8819573|P2|Overall Study|Other|0
2548888|NCT01465763|8819574|P1|Overall Study|Other|2
2548889|NCT01465763|8819572|P3|Overall Study|Adverse Event|1
2548890|NCT01465763|8819573|P2|Overall Study|Adverse Event|0
2548891|NCT01465763|8819574|P1|Overall Study|Adverse Event|9
2548892|NCT01465763|8819572|P3|Overall Study|Insufficient Clinical Response|1
2548893|NCT01465763|8819573|P2|Overall Study|Insufficient Clinical Response|0
2548894|NCT01465763|8819574|P1|Overall Study|Insufficient Clinical Response|11
2548895|NCT01465763|8819572|P3|Overall Study|Withdrawal by Subject|1
2548896|NCT01465763|8819573|P2|Overall Study|Withdrawal by Subject|0
2548897|NCT01465763|8819574|P1|Overall Study|Withdrawal by Subject|4
2548898|NCT01465464|8819601|P2|Overall Study|Ongoing treatment at cutoff date|166
2548899|NCT01465464|8819602|P1|Overall Study|Ongoing treatment at cutoff date|140
2548900|NCT01465464|8819601|P2|Overall Study|Other|3
2548901|NCT01465464|8819602|P1|Overall Study|Other|9
2548902|NCT01465464|8819601|P2|Overall Study|Withdrawal by Subject|30
2548903|NCT01465464|8819602|P1|Overall Study|Withdrawal by Subject|46
2548904|NCT01465464|8819601|P2|Overall Study|Protocol Violation|1
2548905|NCT01465464|8819602|P1|Overall Study|Protocol Violation|1
2548906|NCT01465464|8819601|P2|Overall Study|Physician Decision|5
2548907|NCT01465464|8819602|P1|Overall Study|Physician Decision|13
2548908|NCT01465464|8819601|P2|Overall Study|Lack of Efficacy|190
2548909|NCT01465464|8819602|P1|Overall Study|Lack of Efficacy|139
2548910|NCT01465464|8819601|P2|Overall Study|Adverse Event|49
2548911|NCT01465464|8819602|P1|Overall Study|Adverse Event|96
2548912|NCT01465386|8819655|P1|Overall Study|Adverse Event|1
2548913|NCT01465386|8819655|P1|Overall Study|Lack of Efficacy|3
2548914|NCT01465347|8819659|P2|Overall Study|Admitted to hospice|1
2548915|NCT01465347|8819660|P1|Overall Study|Admitted to hospice|0
2548916|NCT01465347|8819659|P2|Overall Study|Physician Decision|1
2548917|NCT01465347|8819660|P1|Overall Study|Physician Decision|0
2548918|NCT01465347|8819659|P2|Overall Study|Withdrawal by Subject|1
2548919|NCT01465347|8819660|P1|Overall Study|Withdrawal by Subject|1
2548920|NCT01465334|8819672|P2|Overall Study|Refractory Disease|3
2548921|NCT01465334|8819673|P1|Overall Study|Refractory Disease|0
2548922|NCT01465334|8819672|P2|Overall Study|Richter's transformation|3
2548923|NCT01465334|8819673|P1|Overall Study|Richter's transformation|0
2548924|NCT01465334|8819672|P2|Overall Study|Adverse Event|0
2548925|NCT01465334|8819673|P1|Overall Study|Adverse Event|1
2548926|NCT01465334|8819672|P2|Overall Study|Disease Progression|0
2548927|NCT01465334|8819673|P1|Overall Study|Disease Progression|1
2548928|NCT01465230|8819699|P1|Overall Study|Withdrawal by Subject|2
2548929|NCT01465178|8819705|P2|Overall Study|Withdrawal by Subject|0
2548930|NCT01465178|8819706|P1|Overall Study|Withdrawal by Subject|1
2548931|NCT01465022|8819730|P3|Overall Study|Not Randomized|70
2548932|NCT01465022|8819731|P2|Overall Study|Not Randomized|0
2548933|NCT01465022|8819732|P1|Overall Study|Not Randomized|0
2548934|NCT01465022|8819730|P3|Overall Study|Breastfeeding discontinuation before 8 w|0
2548935|NCT01465022|8819731|P2|Overall Study|Breastfeeding discontinuation before 8 w|9
2548936|NCT01465022|8819732|P1|Overall Study|Breastfeeding discontinuation before 8 w|8
2548937|NCT01465022|8819730|P3|Overall Study|Lost to Follow-up|0
2548938|NCT01465022|8819731|P2|Overall Study|Lost to Follow-up|14
2548939|NCT01465022|8819732|P1|Overall Study|Lost to Follow-up|15
2548940|NCT01464931|8819766|P2|Overall Study|Withdrawal by Subject|0
2548941|NCT01464931|8819767|P1|Overall Study|Withdrawal by Subject|1
2548942|NCT01464879|8819804|P1|Overall Study|Non-compliance|1
2548943|NCT01464879|8819804|P1|Overall Study|Physician Decision|1
2548944|NCT01464827|8819865|P14|Overall Study|Not Treated|2
2548945|NCT01464827|8819866|P13|Overall Study|Not Treated|0
2548946|NCT01464827|8819867|P12|Overall Study|Not Treated|1
2548947|NCT01464827|8819868|P11|Overall Study|Not Treated|0
2548948|NCT01464827|8819869|P10|Overall Study|Not Treated|2
2548949|NCT01464827|8819870|P9|Overall Study|Not Treated|0
2548950|NCT01464827|8819871|P8|Overall Study|Not Treated|0
2548951|NCT01464827|8819872|P7|Overall Study|Not Treated|1
2548952|NCT01464827|8819873|P6|Overall Study|Not Treated|0
2548953|NCT01464827|8819874|P5|Overall Study|Not Treated|1
2548954|NCT01464827|8819875|P4|Overall Study|Not Treated|0
2548955|NCT01464827|8819876|P3|Overall Study|Not Treated|0
2548956|NCT01464827|8819877|P2|Overall Study|Not Treated|2
2548957|NCT01464827|8819878|P1|Overall Study|Not Treated|0
2548958|NCT01464827|8819865|P14|Overall Study|Other|0
2548959|NCT01464827|8819866|P13|Overall Study|Other|1
2548960|NCT01464827|8819867|P12|Overall Study|Other|0
2548961|NCT01464827|8819868|P11|Overall Study|Other|2
2548962|NCT01464827|8819869|P10|Overall Study|Other|1
2548963|NCT01464827|8819870|P9|Overall Study|Other|3
2548964|NCT01464827|8819871|P8|Overall Study|Other|0
2548965|NCT01464827|8819872|P7|Overall Study|Other|1
2548966|NCT01464827|8819873|P6|Overall Study|Other|0
2548967|NCT01464827|8819874|P5|Overall Study|Other|3
2548968|NCT01464827|8819875|P4|Overall Study|Other|2
2548969|NCT01464827|8819876|P3|Overall Study|Other|0
2548970|NCT01464827|8819877|P2|Overall Study|Other|3
2548971|NCT01464827|8819878|P1|Overall Study|Other|2
2548972|NCT01464827|8819865|P14|Overall Study|Lost to Follow-up|1
2548973|NCT01464827|8819866|P13|Overall Study|Lost to Follow-up|0
2548974|NCT01464827|8819867|P12|Overall Study|Lost to Follow-up|1
2548975|NCT01464827|8819868|P11|Overall Study|Lost to Follow-up|0
2548976|NCT01464827|8819869|P10|Overall Study|Lost to Follow-up|0
2548977|NCT01464827|8819870|P9|Overall Study|Lost to Follow-up|0
2548978|NCT01464827|8819871|P8|Overall Study|Lost to Follow-up|2
2548979|NCT01464827|8819872|P7|Overall Study|Lost to Follow-up|2
2548980|NCT01464827|8819873|P6|Overall Study|Lost to Follow-up|1
2548981|NCT01464827|8819874|P5|Overall Study|Lost to Follow-up|3
2548982|NCT01464827|8819875|P4|Overall Study|Lost to Follow-up|2
2548983|NCT01464827|8819876|P3|Overall Study|Lost to Follow-up|0
2548984|NCT01464827|8819877|P2|Overall Study|Lost to Follow-up|2
2548985|NCT01464827|8819878|P1|Overall Study|Lost to Follow-up|0
2548986|NCT01464827|8819865|P14|Overall Study|Withdrawal by Subject|0
2548987|NCT01464827|8819866|P13|Overall Study|Withdrawal by Subject|0
2548988|NCT01464827|8819867|P12|Overall Study|Withdrawal by Subject|0
2548989|NCT01464827|8819868|P11|Overall Study|Withdrawal by Subject|0
2548990|NCT01464827|8819869|P10|Overall Study|Withdrawal by Subject|0
2548991|NCT01464827|8819870|P9|Overall Study|Withdrawal by Subject|0
2548992|NCT01464827|8819871|P8|Overall Study|Withdrawal by Subject|1
2548993|NCT01464827|8819872|P7|Overall Study|Withdrawal by Subject|0
2548994|NCT01464827|8819873|P6|Overall Study|Withdrawal by Subject|0
2548995|NCT01464827|8819874|P5|Overall Study|Withdrawal by Subject|1
2548996|NCT01464827|8819875|P4|Overall Study|Withdrawal by Subject|0
2548997|NCT01464827|8819876|P3|Overall Study|Withdrawal by Subject|0
2548998|NCT01464827|8819877|P2|Overall Study|Withdrawal by Subject|0
2548999|NCT01464827|8819878|P1|Overall Study|Withdrawal by Subject|1
2549000|NCT01464827|8819865|P14|Overall Study|Adverse Event|0
2549001|NCT01464827|8819866|P13|Overall Study|Adverse Event|1
2549002|NCT01464827|8819867|P12|Overall Study|Adverse Event|0
2549003|NCT01464827|8819868|P11|Overall Study|Adverse Event|0
2549004|NCT01464827|8819869|P10|Overall Study|Adverse Event|0
2549005|NCT01464827|8819870|P9|Overall Study|Adverse Event|0
2549006|NCT01464827|8819871|P8|Overall Study|Adverse Event|0
2549007|NCT01464827|8819872|P7|Overall Study|Adverse Event|0
2549008|NCT01464827|8819873|P6|Overall Study|Adverse Event|0
2549009|NCT01464827|8819874|P5|Overall Study|Adverse Event|0
2549010|NCT01464827|8819875|P4|Overall Study|Adverse Event|0
2549011|NCT01464827|8819876|P3|Overall Study|Adverse Event|0
2549012|NCT01464827|8819877|P2|Overall Study|Adverse Event|0
2549013|NCT01464827|8819878|P1|Overall Study|Adverse Event|0
2549014|NCT01464788|8819925|P3|Overall Study|Patient had hemorrhage after tPA started|0
2549015|NCT01464788|8819926|P2|Overall Study|Patient had hemorrhage after tPA started|1
2549016|NCT01464788|8819927|P1|Overall Study|Patient had hemorrhage after tPA started|0
2549017|NCT01464788|8819925|P3|Overall Study|Lost to Follow-up|0
2549018|NCT01464788|8819926|P2|Overall Study|Lost to Follow-up|1
2549019|NCT01464788|8819927|P1|Overall Study|Lost to Follow-up|0
2549020|NCT01464619|8820013|P2|Overall Study|Lost to Follow-up|4
2549021|NCT01464619|8820014|P1|Overall Study|Lost to Follow-up|3
2549022|NCT01464424|8820034|P2|Period 1, First 6 Weeks|Adverse Event|1
2549023|NCT01464424|8820035|P1|Period 1, First 6 Weeks|Adverse Event|0
2549024|NCT01464346|8820055|P3|Overall Study|Withdrawal by Subject|1
2549025|NCT01464346|8820056|P2|Overall Study|Withdrawal by Subject|0
2549026|NCT01464346|8820057|P1|Overall Study|Withdrawal by Subject|0
2549027|NCT01464333|8820066|P1|Overall Study|No Hospital Visit|42
2549028|NCT01464333|8820066|P1|Overall Study|Other|4
2549029|NCT01464333|8820066|P1|Overall Study|Withdrawal by Subject|11
2549030|NCT01464333|8820066|P1|Overall Study|Lack of Efficacy|72
2549031|NCT01464333|8820066|P1|Overall Study|Adverse Event|34
2549032|NCT01464307|8820079|P2|Open-Label Extension Period|Predefined discontinuation criteria|0
2549033|NCT01464307|8820080|P1|Open-Label Extension Period|Predefined discontinuation criteria|6
2549034|NCT01464307|8820079|P2|Open-Label Extension Period|Non-compliance|0
2549035|NCT01464307|8820080|P1|Open-Label Extension Period|Non-compliance|9
2549036|NCT01464307|8820079|P2|Open-Label Extension Period|Lost to Follow-up|0
2549037|NCT01464307|8820080|P1|Open-Label Extension Period|Lost to Follow-up|1
2549038|NCT01464307|8820079|P2|Open-Label Extension Period|Death|0
2549039|NCT01464307|8820080|P1|Open-Label Extension Period|Death|1
2549040|NCT01464307|8820079|P2|Open-Label Extension Period|Lack of Efficacy|0
2549041|NCT01464307|8820080|P1|Open-Label Extension Period|Lack of Efficacy|5
2549042|NCT01464307|8820079|P2|Open-Label Extension Period|Withdrawal by Subject|0
2549043|NCT01464307|8820080|P1|Open-Label Extension Period|Withdrawal by Subject|14
2549044|NCT01464307|8820079|P2|Open-Label Extension Period|Adverse Event|0
2549045|NCT01464307|8820080|P1|Open-Label Extension Period|Adverse Event|15
2549046|NCT01464307|8820079|P2|Main Period|Predefined discontinuation criteria|1
2549047|NCT01464307|8820080|P1|Main Period|Predefined discontinuation criteria|2
2549048|NCT01464307|8820079|P2|Main Period|Withdrawal by Subject|2
2549049|NCT01464307|8820080|P1|Main Period|Withdrawal by Subject|5
2549050|NCT01464307|8820079|P2|Main Period|Lack of Efficacy|0
2549051|NCT01464307|8820080|P1|Main Period|Lack of Efficacy|2
2549052|NCT01464307|8820079|P2|Main Period|Adverse Event|1
2549053|NCT01464307|8820080|P1|Main Period|Adverse Event|6
2549054|NCT01464307|8820079|P2|Main Period|Death|1
2549055|NCT01464307|8820080|P1|Main Period|Death|0
2549056|NCT01464255|8820095|P2|Overall Study|unresolve corneal staining|1
2549057|NCT01464255|8820096|P1|Overall Study|unresolve corneal staining|0
2549058|NCT01464021|8820141|P1|Overall Study|various|11
2549059|NCT01464021|8820141|P1|Overall Study|Lack of Efficacy|1
2549060|NCT01464021|8820141|P1|Overall Study|Lost to Follow-up|1
2549061|NCT01464021|8820141|P1|Overall Study|Withdrawal by Subject|13
2549062|NCT01463982|8820157|P4|Overall Study|Treatment delay over 5 week|0
2549063|NCT01463982|8820158|P3|Overall Study|Treatment delay over 5 week|1
2549064|NCT01463982|8820159|P2|Overall Study|Treatment delay over 5 week|0
2549065|NCT01463982|8820160|P1|Overall Study|Treatment delay over 5 week|0
2549066|NCT01463982|8820157|P4|Overall Study|Withdrawal by Subject|0
2549067|NCT01463982|8820158|P3|Overall Study|Withdrawal by Subject|1
2549068|NCT01463982|8820159|P2|Overall Study|Withdrawal by Subject|1
2549069|NCT01463982|8820160|P1|Overall Study|Withdrawal by Subject|0
2549070|NCT01463878|8820176|P2|Overall Study|no longer met criteria for tube feed|2
2549071|NCT01463878|8820177|P1|Overall Study|no longer met criteria for tube feed|2
2549072|NCT01463696|8820191|P8|Overall Study|Not Treated|0
2549073|NCT01463696|8820192|P7|Overall Study|Not Treated|1
2549074|NCT01463696|8820193|P6|Overall Study|Not Treated|0
2549075|NCT01463696|8820194|P5|Overall Study|Not Treated|0
2549076|NCT01463696|8820195|P4|Overall Study|Not Treated|0
2549077|NCT01463696|8820196|P3|Overall Study|Not Treated|0
2549078|NCT01463696|8820197|P2|Overall Study|Not Treated|0
2549079|NCT01463696|8820198|P1|Overall Study|Not Treated|0
2549080|NCT01463696|8820191|P8|Overall Study|Withdrawal by Subject|0
2549081|NCT01463696|8820192|P7|Overall Study|Withdrawal by Subject|2
2549082|NCT01463696|8820193|P6|Overall Study|Withdrawal by Subject|1
2549083|NCT01463696|8820194|P5|Overall Study|Withdrawal by Subject|1
2549084|NCT01463696|8820195|P4|Overall Study|Withdrawal by Subject|1
2549085|NCT01463696|8820196|P3|Overall Study|Withdrawal by Subject|0
2549086|NCT01463696|8820197|P2|Overall Study|Withdrawal by Subject|0
2549087|NCT01463696|8820198|P1|Overall Study|Withdrawal by Subject|0
2549088|NCT01463696|8820191|P8|Overall Study|Progressive Disease|2
2549089|NCT01463696|8820192|P7|Overall Study|Progressive Disease|4
2549090|NCT01463696|8820193|P6|Overall Study|Progressive Disease|1
2549091|NCT01463696|8820194|P5|Overall Study|Progressive Disease|0
2549092|NCT01463696|8820195|P4|Overall Study|Progressive Disease|1
2549093|NCT01463696|8820196|P3|Overall Study|Progressive Disease|0
2549094|NCT01463696|8820197|P2|Overall Study|Progressive Disease|1
2549095|NCT01463696|8820198|P1|Overall Study|Progressive Disease|0
2549096|NCT01463696|8820191|P8|Overall Study|Lost to Follow-up|0
2549097|NCT01463696|8820192|P7|Overall Study|Lost to Follow-up|0
2549098|NCT01463696|8820193|P6|Overall Study|Lost to Follow-up|0
2549099|NCT01463696|8820194|P5|Overall Study|Lost to Follow-up|0
2549100|NCT01463696|8820195|P4|Overall Study|Lost to Follow-up|0
2549101|NCT01463696|8820196|P3|Overall Study|Lost to Follow-up|1
2549102|NCT01463696|8820197|P2|Overall Study|Lost to Follow-up|0
2549103|NCT01463696|8820198|P1|Overall Study|Lost to Follow-up|0
2549104|NCT01463696|8820191|P8|Overall Study|Adverse Event|2
2549105|NCT01463696|8820192|P7|Overall Study|Adverse Event|3
2549106|NCT01463696|8820193|P6|Overall Study|Adverse Event|1
2549107|NCT01463696|8820194|P5|Overall Study|Adverse Event|0
2549108|NCT01463696|8820195|P4|Overall Study|Adverse Event|2
2549109|NCT01463696|8820196|P3|Overall Study|Adverse Event|0
2549110|NCT01463696|8820197|P2|Overall Study|Adverse Event|1
2549111|NCT01463696|8820198|P1|Overall Study|Adverse Event|0
2549112|NCT01463683|8820251|P3|Overall Study|Withdrawal by Subject|2
2549113|NCT01463683|8820252|P2|Overall Study|Withdrawal by Subject|17
2549114|NCT01463683|8820253|P1|Overall Study|Withdrawal by Subject|5
2549115|NCT01463683|8820251|P3|Overall Study|Pregnancy|1
2549116|NCT01463683|8820252|P2|Overall Study|Pregnancy|2
2549117|NCT01463683|8820253|P1|Overall Study|Pregnancy|2
2549118|NCT01463683|8820251|P3|Overall Study|Physician Decision|1
2549119|NCT01463683|8820252|P2|Overall Study|Physician Decision|3
2549120|NCT01463683|8820253|P1|Overall Study|Physician Decision|0
2549121|NCT01463683|8820251|P3|Overall Study|Lost to Follow-up|7
2549122|NCT01463683|8820252|P2|Overall Study|Lost to Follow-up|9
2549123|NCT01463683|8820253|P1|Overall Study|Lost to Follow-up|10
2549124|NCT01463683|8820251|P3|Overall Study|Adverse Event|0
2549125|NCT01463683|8820252|P2|Overall Study|Adverse Event|0
2549126|NCT01463683|8820253|P1|Overall Study|Adverse Event|2
2549127|NCT01463631|8820270|P4|Overall Study|Progressive Disease|5
2549128|NCT01463631|8820271|P3|Overall Study|Progressive Disease|0
2549129|NCT01463631|8820272|P2|Overall Study|Progressive Disease|0
2549130|NCT01463631|8820273|P1|Overall Study|Progressive Disease|0
2549131|NCT01463631|8820270|P4|Overall Study|Death|0
2549132|NCT01463631|8820271|P3|Overall Study|Death|1
2549133|NCT01463631|8820272|P2|Overall Study|Death|0
2549134|NCT01463631|8820273|P1|Overall Study|Death|0
2549135|NCT01463631|8820270|P4|Overall Study|Withdrawal by Subject|1
2549136|NCT01463631|8820271|P3|Overall Study|Withdrawal by Subject|0
2549137|NCT01463631|8820272|P2|Overall Study|Withdrawal by Subject|0
2549138|NCT01463631|8820273|P1|Overall Study|Withdrawal by Subject|0
2549139|NCT01463527|8820295|P2|Overall Study|Crying >20% of sedation|6
2549140|NCT01463527|8820296|P1|Overall Study|Crying >20% of sedation|5
2549141|NCT01463527|8820295|P2|Overall Study|Protocol Violation|1
2549142|NCT01463527|8820296|P1|Overall Study|Protocol Violation|1
2549143|NCT01463306|8820319|P3|Overall Study|Approval expiry at site|0
2549144|NCT01463306|8820320|P2|Overall Study|Approval expiry at site|0
2549145|NCT01463306|8820321|P1|Overall Study|Approval expiry at site|1
2549146|NCT01463306|8820319|P3|Overall Study|Other|0
2549147|NCT01463306|8820320|P2|Overall Study|Other|13
2549148|NCT01463306|8820321|P1|Overall Study|Other|26
2549149|NCT01463306|8820319|P3|Overall Study|Withdrawal by Subject|1
2549150|NCT01463306|8820320|P2|Overall Study|Withdrawal by Subject|9
2549151|NCT01463306|8820321|P1|Overall Study|Withdrawal by Subject|19
2549152|NCT01463306|8820319|P3|Overall Study|Protocol Violation|0
2549153|NCT01463306|8820320|P2|Overall Study|Protocol Violation|0
2549154|NCT01463306|8820321|P1|Overall Study|Protocol Violation|4
2549155|NCT01463306|8820319|P3|Overall Study|Lost to Follow-up|0
2549156|NCT01463306|8820320|P2|Overall Study|Lost to Follow-up|2
2549157|NCT01463306|8820321|P1|Overall Study|Lost to Follow-up|5
2549158|NCT01463306|8820319|P3|Overall Study|Lack of Efficacy|1
2549159|NCT01463306|8820320|P2|Overall Study|Lack of Efficacy|16
2549160|NCT01463306|8820321|P1|Overall Study|Lack of Efficacy|22
2549161|NCT01463306|8820319|P3|Overall Study|Death|0
2549162|NCT01463306|8820320|P2|Overall Study|Death|3
2549163|NCT01463306|8820321|P1|Overall Study|Death|3
2549164|NCT01463306|8820319|P3|Overall Study|Adverse Event|3
2549165|NCT01463306|8820320|P2|Overall Study|Adverse Event|9
2549166|NCT01463306|8820321|P1|Overall Study|Adverse Event|6
2549167|NCT01463293|8820392|P3|Overall Study|Other|2
2549168|NCT01463293|8820393|P2|Overall Study|Other|0
2549169|NCT01463293|8820394|P1|Overall Study|Other|0
2549170|NCT01463293|8820392|P3|Overall Study|Withdrawal by Subject|5
2549171|NCT01463293|8820393|P2|Overall Study|Withdrawal by Subject|10
2549172|NCT01463293|8820394|P1|Overall Study|Withdrawal by Subject|4
2549173|NCT01463293|8820392|P3|Overall Study|Adverse Event|0
2549174|NCT01463293|8820393|P2|Overall Study|Adverse Event|2
2549175|NCT01463293|8820394|P1|Overall Study|Adverse Event|1
2549176|NCT01463293|8820392|P3|Overall Study|Lost to Follow-up|5
2549177|NCT01463293|8820393|P2|Overall Study|Lost to Follow-up|4
2549178|NCT01463293|8820394|P1|Overall Study|Lost to Follow-up|1
2549179|NCT01463111|8820417|P1|Overall Study|Physician Decision|2
2549180|NCT01463111|8820417|P1|Overall Study|Lost to Follow-up|5
2549181|NCT01463111|8820417|P1|Overall Study|Withdrawal by Subject|2
2549182|NCT01463098|8820439|P14|Part B (11 Days)|Participant Choice|0
2549183|NCT01463098|8820440|P13|Part B (11 Days)|Participant Choice|0
2549184|NCT01463098|8820441|P12|Part B (11 Days)|Participant Choice|1
2549185|NCT01463098|8820442|P11|Part B (11 Days)|Participant Choice|0
2549186|NCT01463098|8820443|P10|Part B (11 Days)|Participant Choice|0
2549187|NCT01463098|8820444|P9|Part B (11 Days)|Participant Choice|0
2549188|NCT01463098|8820445|P8|Part B (11 Days)|Participant Choice|0
2549189|NCT01463098|8820446|P7|Part B (11 Days)|Participant Choice|0
2549190|NCT01463098|8820447|P6|Part B (11 Days)|Participant Choice|0
2549191|NCT01463098|8820448|P5|Part B (11 Days)|Participant Choice|0
2549192|NCT01463098|8820449|P4|Part B (11 Days)|Participant Choice|0
2549193|NCT01463098|8820450|P3|Part B (11 Days)|Participant Choice|0
2549194|NCT01463098|8820451|P2|Part B (11 Days)|Participant Choice|0
2549195|NCT01463098|8820452|P1|Part B (11 Days)|Participant Choice|0
2549196|NCT01463098|8820439|P14|Part A (11 Days)|Lost to Follow-up|0
2549197|NCT01463098|8820440|P13|Part A (11 Days)|Lost to Follow-up|0
2549198|NCT01463098|8820441|P12|Part A (11 Days)|Lost to Follow-up|0
2549199|NCT01463098|8820442|P11|Part A (11 Days)|Lost to Follow-up|0
2549200|NCT01463098|8820443|P10|Part A (11 Days)|Lost to Follow-up|0
2549201|NCT01463098|8820444|P9|Part A (11 Days)|Lost to Follow-up|0
2549202|NCT01463098|8820445|P8|Part A (11 Days)|Lost to Follow-up|0
2549203|NCT01463098|8820446|P7|Part A (11 Days)|Lost to Follow-up|0
2549204|NCT01463098|8820447|P6|Part A (11 Days)|Lost to Follow-up|0
2549205|NCT01463098|8820448|P5|Part A (11 Days)|Lost to Follow-up|1
2549206|NCT01463098|8820449|P4|Part A (11 Days)|Lost to Follow-up|0
2549207|NCT01463098|8820450|P3|Part A (11 Days)|Lost to Follow-up|0
2549208|NCT01463098|8820451|P2|Part A (11 Days)|Lost to Follow-up|0
2549209|NCT01463098|8820452|P1|Part A (11 Days)|Lost to Follow-up|0
2549210|NCT01463098|8820439|P14|Part A (11 Days)|Participant Choice|0
2549211|NCT01463098|8820440|P13|Part A (11 Days)|Participant Choice|0
2549212|NCT01463098|8820441|P12|Part A (11 Days)|Participant Choice|0
2549213|NCT01463098|8820442|P11|Part A (11 Days)|Participant Choice|0
2549214|NCT01463098|8820443|P10|Part A (11 Days)|Participant Choice|0
2549215|NCT01463098|8820444|P9|Part A (11 Days)|Participant Choice|1
2549216|NCT01463098|8820445|P8|Part A (11 Days)|Participant Choice|0
2549217|NCT01463098|8820446|P7|Part A (11 Days)|Participant Choice|0
2549218|NCT01463098|8820447|P6|Part A (11 Days)|Participant Choice|0
2549219|NCT01463098|8820448|P5|Part A (11 Days)|Participant Choice|0
2549220|NCT01463098|8820449|P4|Part A (11 Days)|Participant Choice|0
2549221|NCT01463098|8820450|P3|Part A (11 Days)|Participant Choice|0
2549222|NCT01463098|8820451|P2|Part A (11 Days)|Participant Choice|0
2549223|NCT01463098|8820452|P1|Part A (11 Days)|Participant Choice|2
2549224|NCT01463033|8820775|P2|Overall Study|Death|2
2549225|NCT01463033|8820776|P1|Overall Study|Death|3
2549226|NCT01463033|8820775|P2|Overall Study|Lost to Follow-up|4
2549227|NCT01463033|8820776|P1|Overall Study|Lost to Follow-up|4
2549228|NCT01463007|8820783|P1|Overall Study|Physician Decision|1
2549229|NCT01462942|8820794|P5|Overall Study|Protocol Violation|6
2549230|NCT01462942|8820795|P4|Overall Study|Protocol Violation|9
2549231|NCT01462942|8820796|P3|Overall Study|Protocol Violation|9
2549232|NCT01462942|8820797|P2|Overall Study|Protocol Violation|6
2549233|NCT01462942|8820798|P1|Overall Study|Protocol Violation|4
2549234|NCT01462942|8820794|P5|Overall Study|Lost to Follow-up|1
2549235|NCT01462942|8820795|P4|Overall Study|Lost to Follow-up|1
2549236|NCT01462942|8820796|P3|Overall Study|Lost to Follow-up|1
2549237|NCT01462942|8820797|P2|Overall Study|Lost to Follow-up|1
2549238|NCT01462942|8820798|P1|Overall Study|Lost to Follow-up|0
2549239|NCT01462942|8820794|P5|Overall Study|Lack of Efficacy|3
2549240|NCT01462942|8820795|P4|Overall Study|Lack of Efficacy|5
2549241|NCT01462942|8820796|P3|Overall Study|Lack of Efficacy|4
2549242|NCT01462942|8820797|P2|Overall Study|Lack of Efficacy|0
2549243|NCT01462942|8820798|P1|Overall Study|Lack of Efficacy|6
2549244|NCT01462942|8820794|P5|Overall Study|Withdrawal by Subject|19
2549245|NCT01462942|8820795|P4|Overall Study|Withdrawal by Subject|16
2549246|NCT01462942|8820796|P3|Overall Study|Withdrawal by Subject|14
2549247|NCT01462942|8820797|P2|Overall Study|Withdrawal by Subject|10
2549248|NCT01462942|8820798|P1|Overall Study|Withdrawal by Subject|14
2549249|NCT01462942|8820794|P5|Overall Study|Other, including COPD exacerbation|5
2549250|NCT01462942|8820795|P4|Overall Study|Other, including COPD exacerbation|8
2549251|NCT01462942|8820796|P3|Overall Study|Other, including COPD exacerbation|2
2549252|NCT01462942|8820797|P2|Overall Study|Other, including COPD exacerbation|5
2549253|NCT01462942|8820798|P1|Overall Study|Other, including COPD exacerbation|3
2549254|NCT01462942|8820794|P5|Overall Study|Adverse Event|11
2549255|NCT01462942|8820795|P4|Overall Study|Adverse Event|11
2549256|NCT01462942|8820796|P3|Overall Study|Adverse Event|10
2549257|NCT01462942|8820797|P2|Overall Study|Adverse Event|12
2549258|NCT01462942|8820798|P1|Overall Study|Adverse Event|7
2549259|NCT01462929|8820828|P3|Overall Study|Lack of Efficacy|1
2549260|NCT01462929|8820829|P2|Overall Study|Lack of Efficacy|0
2549261|NCT01462929|8820830|P1|Overall Study|Lack of Efficacy|0
2549262|NCT01462929|8820828|P3|Overall Study|Withdrawal by Subject|0
2549263|NCT01462929|8820829|P2|Overall Study|Withdrawal by Subject|1
2549264|NCT01462929|8820830|P1|Overall Study|Withdrawal by Subject|2
2549265|NCT01462929|8820828|P3|Overall Study|Adverse Event|4
2549266|NCT01462929|8820829|P2|Overall Study|Adverse Event|3
2549267|NCT01462929|8820830|P1|Overall Study|Adverse Event|3
2549268|NCT01462695|8820871|P2|Overall Study|Inevaluable (did not receive study drug)|0
2549269|NCT01462695|8820872|P1|Overall Study|Inevaluable (did not receive study drug)|1
2549270|NCT01462695|8820871|P2|Overall Study|Withdrawal by Subject|0
2549271|NCT01462695|8820872|P1|Overall Study|Withdrawal by Subject|2
2549272|NCT01462695|8820871|P2|Overall Study|Physician Decision|0
2549273|NCT01462695|8820872|P1|Overall Study|Physician Decision|5
2549274|NCT01462695|8820871|P2|Overall Study|Lack of Efficacy|12
2549275|NCT01462695|8820872|P1|Overall Study|Lack of Efficacy|6
2549276|NCT01462695|8820871|P2|Overall Study|Death|0
2549277|NCT01462695|8820872|P1|Overall Study|Death|2
2549278|NCT01462695|8820871|P2|Overall Study|Adverse Event|1
2549279|NCT01462695|8820872|P1|Overall Study|Adverse Event|1
2549280|NCT01462435|8820900|P4|Overall Study|Lost to Follow-up|1
2549281|NCT01462435|8820901|P3|Overall Study|Lost to Follow-up|0
2549282|NCT01462435|8820902|P2|Overall Study|Lost to Follow-up|0
2549283|NCT01462435|8820903|P1|Overall Study|Lost to Follow-up|0
2549284|NCT01462435|8820900|P4|Overall Study|Withdrawal by Subject|1
2549285|NCT01462435|8820901|P3|Overall Study|Withdrawal by Subject|0
2549286|NCT01462435|8820902|P2|Overall Study|Withdrawal by Subject|0
2549287|NCT01462435|8820903|P1|Overall Study|Withdrawal by Subject|0
2549288|NCT01462435|8820900|P4|Overall Study|Physician Decision|0
2549289|NCT01462435|8820901|P3|Overall Study|Physician Decision|1
2549290|NCT01462435|8820902|P2|Overall Study|Physician Decision|0
2549291|NCT01462435|8820903|P1|Overall Study|Physician Decision|0
2549292|NCT01462435|8820900|P4|Overall Study|Lack of Efficacy|3
2549293|NCT01462435|8820901|P3|Overall Study|Lack of Efficacy|0
2549294|NCT01462435|8820902|P2|Overall Study|Lack of Efficacy|0
2549295|NCT01462435|8820903|P1|Overall Study|Lack of Efficacy|1
2549296|NCT01462370|8820941|P2|Overall Study|Withdrawal by Subject|3
2549297|NCT01462370|8820942|P1|Overall Study|Withdrawal by Subject|0
2549298|NCT01462370|8820941|P2|Overall Study|Physician Decision|1
2549299|NCT01462370|8820942|P1|Overall Study|Physician Decision|0
2549300|NCT01462370|8820941|P2|Overall Study|Lack of Qualifying Event|1
2549301|NCT01462370|8820942|P1|Overall Study|Lack of Qualifying Event|1
2549302|NCT01462357|8820977|P3|Overall Study|Lost to Follow-up|7
2549303|NCT01462357|8820978|P2|Overall Study|Lost to Follow-up|5
2549304|NCT01462357|8820979|P1|Overall Study|Lost to Follow-up|3
2549305|NCT01462357|8820977|P3|Overall Study|Migrated/moved from study area|1
2549306|NCT01462357|8820978|P2|Overall Study|Migrated/moved from study area|3
2549307|NCT01462357|8820979|P1|Overall Study|Migrated/moved from study area|2
2549308|NCT01462357|8820977|P3|Overall Study|Withdrawal by Subject|3
2549309|NCT01462357|8820978|P2|Overall Study|Withdrawal by Subject|11
2549310|NCT01462357|8820979|P1|Overall Study|Withdrawal by Subject|3
2549311|NCT01462357|8820977|P3|Overall Study|Death|1
2549312|NCT01462357|8820978|P2|Overall Study|Death|0
2549313|NCT01462357|8820979|P1|Overall Study|Death|0
2549314|NCT01462344|8821052|P2|Overall Study|Lost to Follow-up|7
2549315|NCT01462344|8821053|P1|Overall Study|Lost to Follow-up|7
2549316|NCT01462344|8821052|P2|Overall Study|Protocol Violation|53
2549317|NCT01462344|8821053|P1|Overall Study|Protocol Violation|68
2549318|NCT01462344|8821052|P2|Overall Study|Lack of Efficacy|6
2549319|NCT01462344|8821053|P1|Overall Study|Lack of Efficacy|5
2549320|NCT01462344|8821052|P2|Overall Study|Asthma Exacerbation|35
2549321|NCT01462344|8821053|P1|Overall Study|Asthma Exacerbation|34
2549322|NCT01462344|8821052|P2|Overall Study|Adverse Event|23
2549323|NCT01462344|8821053|P1|Overall Study|Adverse Event|24
2549324|NCT01462344|8821052|P2|Overall Study|Withdrawal by Subject|226
2549325|NCT01462344|8821053|P1|Overall Study|Withdrawal by Subject|245
2549326|NCT01462318|8821075|P3|Extension Phase|Adverse Event|22
2549327|NCT01462318|8821076|P2|Extension Phase|Adverse Event|0
2549328|NCT01462318|8821077|P1|Extension Phase|Adverse Event|0
2549329|NCT01462318|8821075|P3|Extension Phase|Investigator Decision|5
2549330|NCT01462318|8821076|P2|Extension Phase|Investigator Decision|0
2549331|NCT01462318|8821077|P1|Extension Phase|Investigator Decision|0
2549332|NCT01462318|8821075|P3|Extension Phase|Withdrawal by Subject|15
2549333|NCT01462318|8821076|P2|Extension Phase|Withdrawal by Subject|0
2549334|NCT01462318|8821077|P1|Extension Phase|Withdrawal by Subject|0
2549335|NCT01462318|8821075|P3|Extension Phase|Disease Progression|1
2549336|NCT01462318|8821076|P2|Extension Phase|Disease Progression|0
2549337|NCT01462318|8821077|P1|Extension Phase|Disease Progression|0
2549338|NCT01462318|8821075|P3|Extension Phase|Other|1
2549339|NCT01462318|8821076|P2|Extension Phase|Other|0
2549340|NCT01462318|8821077|P1|Extension Phase|Other|0
2549341|NCT01462318|8821075|P3|Extension Phase|Lost to Follow-up|1
2549342|NCT01462318|8821076|P2|Extension Phase|Lost to Follow-up|0
2549343|NCT01462318|8821077|P1|Extension Phase|Lost to Follow-up|0
2549344|NCT01462318|8821075|P3|Main Study / TP-DI Study|Adverse Event|0
2549345|NCT01462318|8821076|P2|Main Study / TP-DI Study|Adverse Event|0
2549346|NCT01462318|8821077|P1|Main Study / TP-DI Study|Adverse Event|4
2549347|NCT01462318|8821075|P3|Main Study / TP-DI Study|Withdrawal by Subject|0
2549348|NCT01462318|8821076|P2|Main Study / TP-DI Study|Withdrawal by Subject|0
2549349|NCT01462318|8821077|P1|Main Study / TP-DI Study|Withdrawal by Subject|2
2549350|NCT01462318|8821075|P3|Main Study / TP-DI Study|Other|0
2549351|NCT01462318|8821076|P2|Main Study / TP-DI Study|Other|0
2549352|NCT01462318|8821077|P1|Main Study / TP-DI Study|Other|2
2549353|NCT01462266|8821178|P2|Overall Study|Screen failure|1
2549354|NCT01462266|8821179|P1|Overall Study|Screen failure|1
2549355|NCT01462266|8821178|P2|Overall Study|Withdrawal by Subject|2
2549356|NCT01462266|8821179|P1|Overall Study|Withdrawal by Subject|7
2549357|NCT01462266|8821178|P2|Overall Study|Protocol Violation|3
2549358|NCT01462266|8821179|P1|Overall Study|Protocol Violation|1
2549359|NCT01462266|8821178|P2|Overall Study|Physician Decision|5
2549360|NCT01462266|8821179|P1|Overall Study|Physician Decision|2
2549361|NCT01462266|8821178|P2|Overall Study|Creatinine and eGFR, excluded medication|4
2549362|NCT01462266|8821179|P1|Overall Study|Creatinine and eGFR, excluded medication|8
2549363|NCT01462266|8821178|P2|Overall Study|Non-compliance with study drug|0
2549364|NCT01462266|8821179|P1|Overall Study|Non-compliance with study drug|3
2549365|NCT01462266|8821178|P2|Overall Study|Lost to Follow-up|3
2549366|NCT01462266|8821179|P1|Overall Study|Lost to Follow-up|4
2549367|NCT01462266|8821178|P2|Overall Study|Lack of Efficacy|2
2549368|NCT01462266|8821179|P1|Overall Study|Lack of Efficacy|0
2549369|NCT01462266|8821178|P2|Overall Study|Death|1
2549370|NCT01462266|8821179|P1|Overall Study|Death|2
2549371|NCT01462266|8821178|P2|Overall Study|Adverse Event|6
2549372|NCT01462266|8821179|P1|Overall Study|Adverse Event|7
2549373|NCT01462227|8821204|P4|Second Assignment|Protocol Violation|0
2549374|NCT01462227|8821205|P3|Second Assignment|Protocol Violation|1
2549375|NCT01462227|8821206|P2|Second Assignment|Protocol Violation|1
2549376|NCT01462227|8821207|P1|Second Assignment|Protocol Violation|0
2549377|NCT01462227|8821204|P4|Second Assignment|Lost to Follow-up|0
2549378|NCT01462227|8821205|P3|Second Assignment|Lost to Follow-up|0
2549379|NCT01462227|8821206|P2|Second Assignment|Lost to Follow-up|0
2549380|NCT01462227|8821207|P1|Second Assignment|Lost to Follow-up|1
2549381|NCT01462162|8821225|P1|Overall Study|Other|2
2549382|NCT01462162|8821225|P1|Overall Study|Abnormal laboratory parameters|1
2549383|NCT01462162|8821225|P1|Overall Study|Lack of Efficacy|4
2549384|NCT01462162|8821225|P1|Overall Study|Adverse Event|5
2549385|NCT01462110|8821252|P2|Overall Study|Adverse Event|0
2549386|NCT01462110|8821253|P1|Overall Study|Adverse Event|1
2549387|NCT01462084|8821273|P2|Overall Study|Protocol Violation|1
2549388|NCT01462084|8821274|P1|Overall Study|Protocol Violation|1
2549389|NCT01462084|8821273|P2|Overall Study|Withdrawal by Subject|0
2549390|NCT01462084|8821274|P1|Overall Study|Withdrawal by Subject|1
2549391|NCT01462045|8821285|P3|Overall Study|Family matter|0
2549392|NCT01462045|8821286|P2|Overall Study|Family matter|1
2549393|NCT01462045|8821287|P1|Overall Study|Family matter|0
2549394|NCT01461993|8821301|P3|Overall Study|Other|6
2549395|NCT01461993|8821302|P2|Overall Study|Other|15
2549396|NCT01461993|8821303|P1|Overall Study|Other|13
2549397|NCT01461993|8821301|P3|Overall Study|Did not meet entrance criteria|0
2549398|NCT01461993|8821302|P2|Overall Study|Did not meet entrance criteria|3
2549399|NCT01461993|8821303|P1|Overall Study|Did not meet entrance criteria|2
2549400|NCT01461993|8821301|P3|Overall Study|No longer met eligibility criteria|10
2549401|NCT01461993|8821302|P2|Overall Study|No longer met eligibility criteria|18
2549402|NCT01461993|8821303|P1|Overall Study|No longer met eligibility criteria|13
2549403|NCT01461993|8821301|P3|Overall Study|Adverse Event|3
2549404|NCT01461993|8821302|P2|Overall Study|Adverse Event|11
2549405|NCT01461993|8821303|P1|Overall Study|Adverse Event|9
2549406|NCT01461993|8821301|P3|Overall Study|Protocol Violation|7
2549407|NCT01461993|8821302|P2|Overall Study|Protocol Violation|9
2549408|NCT01461993|8821303|P1|Overall Study|Protocol Violation|10
2549409|NCT01461993|8821301|P3|Overall Study|Lost to Follow-up|22
2549410|NCT01461993|8821302|P2|Overall Study|Lost to Follow-up|48
2549411|NCT01461993|8821303|P1|Overall Study|Lost to Follow-up|44
2549412|NCT01461993|8821301|P3|Overall Study|Withdrawal by Subject|16
2549413|NCT01461993|8821302|P2|Overall Study|Withdrawal by Subject|53
2549414|NCT01461993|8821303|P1|Overall Study|Withdrawal by Subject|60
2549415|NCT01461980|8821328|P3|Overall Study|Randomized but not vaccinated|7
2549416|NCT01461980|8821329|P2|Overall Study|Randomized but not vaccinated|8
2549417|NCT01461980|8821330|P1|Overall Study|Randomized but not vaccinated|4
2549418|NCT01461980|8821328|P3|Overall Study|No longer willing to participate|54
2549419|NCT01461980|8821329|P2|Overall Study|No longer willing to participate|38
2549420|NCT01461980|8821330|P1|Overall Study|No longer willing to participate|52
2549421|NCT01461980|8821328|P3|Overall Study|Lost to Follow-up|51
2549422|NCT01461980|8821329|P2|Overall Study|Lost to Follow-up|53
2549423|NCT01461980|8821330|P1|Overall Study|Lost to Follow-up|52
2549424|NCT01461980|8821328|P3|Overall Study|No longer meets eligibility criteria|19
2549425|NCT01461980|8821329|P2|Overall Study|No longer meets eligibility criteria|9
2549426|NCT01461980|8821330|P1|Overall Study|No longer meets eligibility criteria|18
2549427|NCT01461980|8821328|P3|Overall Study|Protocol Violation|16
2549428|NCT01461980|8821329|P2|Overall Study|Protocol Violation|19
2549429|NCT01461980|8821330|P1|Overall Study|Protocol Violation|12
2549430|NCT01461980|8821328|P3|Overall Study|Adverse Event|6
2549431|NCT01461980|8821329|P2|Overall Study|Adverse Event|5
2549432|NCT01461980|8821330|P1|Overall Study|Adverse Event|12
2549433|NCT01461980|8821328|P3|Overall Study|Medication error|6
2549434|NCT01461980|8821329|P2|Overall Study|Medication error|5
2549435|NCT01461980|8821330|P1|Overall Study|Medication error|7
2549436|NCT01461980|8821328|P3|Overall Study|Other|6
2549437|NCT01461980|8821329|P2|Overall Study|Other|8
2549438|NCT01461980|8821330|P1|Overall Study|Other|9
2549439|NCT01461928|8821360|P3|Maintenance II (15 Months)|Refused to be transferred to other site|1
2549440|NCT01461928|8821361|P2|Maintenance II (15 Months)|Refused to be transferred to other site|0
2549441|NCT01461928|8821362|P1|Maintenance II (15 Months)|Refused to be transferred to other site|0
2549442|NCT01461928|8821360|P3|Maintenance II (15 Months)|Withdrew informed consent|1
2549443|NCT01461928|8821361|P2|Maintenance II (15 Months)|Withdrew informed consent|0
2549444|NCT01461928|8821362|P1|Maintenance II (15 Months)|Withdrew informed consent|0
2549445|NCT01461928|8821360|P3|Maintenance II (15 Months)|Squamous lung carcinoma|1
2549446|NCT01461928|8821361|P2|Maintenance II (15 Months)|Squamous lung carcinoma|0
2549447|NCT01461928|8821362|P1|Maintenance II (15 Months)|Squamous lung carcinoma|0
2549448|NCT01461928|8821360|P3|Maintenance II (15 Months)|Changed physician in another hospital|1
2549449|NCT01461928|8821361|P2|Maintenance II (15 Months)|Changed physician in another hospital|0
2549450|NCT01461928|8821362|P1|Maintenance II (15 Months)|Changed physician in another hospital|0
2549451|NCT01461928|8821360|P3|Maintenance II (15 Months)|Withdrawal by Subject|8
2549452|NCT01461928|8821361|P2|Maintenance II (15 Months)|Withdrawal by Subject|9
2549453|NCT01461928|8821362|P1|Maintenance II (15 Months)|Withdrawal by Subject|0
2549454|NCT01461928|8821360|P3|Maintenance II (15 Months)|Disease progression|3
2549455|NCT01461928|8821361|P2|Maintenance II (15 Months)|Disease progression|0
2549456|NCT01461928|8821362|P1|Maintenance II (15 Months)|Disease progression|0
2549457|NCT01461928|8821360|P3|Maintenance II (15 Months)|Moved to another town|0
2549458|NCT01461928|8821361|P2|Maintenance II (15 Months)|Moved to another town|1
2549459|NCT01461928|8821362|P1|Maintenance II (15 Months)|Moved to another town|0
2549460|NCT01461928|8821360|P3|Maintenance II (15 Months)|Lost to Follow-up|0
2549461|NCT01461928|8821361|P2|Maintenance II (15 Months)|Lost to Follow-up|1
2549462|NCT01461928|8821362|P1|Maintenance II (15 Months)|Lost to Follow-up|0
2549463|NCT01461928|8821360|P3|Maintenance II (15 Months)|Physician Decision|4
2549464|NCT01461928|8821361|P2|Maintenance II (15 Months)|Physician Decision|0
2549465|NCT01461928|8821362|P1|Maintenance II (15 Months)|Physician Decision|0
2549466|NCT01461928|8821360|P3|Maintenance II (15 Months)|Death|8
2549467|NCT01461928|8821361|P2|Maintenance II (15 Months)|Death|10
2549468|NCT01461928|8821362|P1|Maintenance II (15 Months)|Death|0
2549469|NCT01461928|8821360|P3|Maintenance II (15 Months)|Adverse Event|0
2549470|NCT01461928|8821361|P2|Maintenance II (15 Months)|Adverse Event|2
2549471|NCT01461928|8821362|P1|Maintenance II (15 Months)|Adverse Event|0
2549472|NCT01461928|8821360|P3|Maintenance I (24 Months)|Did not meet criteria|0
2549473|NCT01461928|8821361|P2|Maintenance I (24 Months)|Did not meet criteria|0
2549474|NCT01461928|8821362|P1|Maintenance I (24 Months)|Did not meet criteria|5
2549475|NCT01461928|8821360|P3|Maintenance I (24 Months)|Not compliant|0
2549476|NCT01461928|8821361|P2|Maintenance I (24 Months)|Not compliant|0
2549477|NCT01461928|8821362|P1|Maintenance I (24 Months)|Not compliant|1
2549478|NCT01461928|8821360|P3|Maintenance I (24 Months)|Delay in rituximab administration|0
2549479|NCT01461928|8821361|P2|Maintenance I (24 Months)|Delay in rituximab administration|0
2549480|NCT01461928|8821362|P1|Maintenance I (24 Months)|Delay in rituximab administration|1
2549481|NCT01461928|8821360|P3|Maintenance I (24 Months)|Did not perform scheduled assessment|0
2549482|NCT01461928|8821361|P2|Maintenance I (24 Months)|Did not perform scheduled assessment|0
2549483|NCT01461928|8821362|P1|Maintenance I (24 Months)|Did not perform scheduled assessment|2
2549484|NCT01461928|8821360|P3|Maintenance I (24 Months)|Did not meet randomization criteria|0
2549485|NCT01461928|8821361|P2|Maintenance I (24 Months)|Did not meet randomization criteria|0
2549486|NCT01461928|8821362|P1|Maintenance I (24 Months)|Did not meet randomization criteria|2
2549487|NCT01461928|8821360|P3|Maintenance I (24 Months)|Physician Decision|0
2549488|NCT01461928|8821361|P2|Maintenance I (24 Months)|Physician Decision|0
2549489|NCT01461928|8821362|P1|Maintenance I (24 Months)|Physician Decision|9
2549490|NCT01461928|8821360|P3|Maintenance I (24 Months)|Adverse Event|0
2549491|NCT01461928|8821361|P2|Maintenance I (24 Months)|Adverse Event|0
2549492|NCT01461928|8821362|P1|Maintenance I (24 Months)|Adverse Event|70
2549493|NCT01461928|8821360|P3|Maintenance I (24 Months)|Diseases progression|0
2549494|NCT01461928|8821361|P2|Maintenance I (24 Months)|Diseases progression|0
2549495|NCT01461928|8821362|P1|Maintenance I (24 Months)|Diseases progression|91
2549496|NCT01461928|8821360|P3|Maintenance I (24 Months)|Lost to Follow-up|0
2549497|NCT01461928|8821361|P2|Maintenance I (24 Months)|Lost to Follow-up|0
2549498|NCT01461928|8821362|P1|Maintenance I (24 Months)|Lost to Follow-up|2
2549499|NCT01461928|8821360|P3|Maintenance I (24 Months)|Withdrawal by Subject|0
2549500|NCT01461928|8821361|P2|Maintenance I (24 Months)|Withdrawal by Subject|0
2549501|NCT01461928|8821362|P1|Maintenance I (24 Months)|Withdrawal by Subject|32
2549502|NCT01461928|8821360|P3|Maintenance I (24 Months)|Death|0
2549503|NCT01461928|8821361|P2|Maintenance I (24 Months)|Death|0
2549504|NCT01461928|8821362|P1|Maintenance I (24 Months)|Death|3
2549505|NCT01461928|8821360|P3|Induction (up to 8 Months)|Medical advisor request|0
2549506|NCT01461928|8821361|P2|Induction (up to 8 Months)|Medical advisor request|0
2549507|NCT01461928|8821362|P1|Induction (up to 8 Months)|Medical advisor request|1
2549508|NCT01461928|8821360|P3|Induction (up to 8 Months)|Exceeded time limit for next cycle|0
2549509|NCT01461928|8821361|P2|Induction (up to 8 Months)|Exceeded time limit for next cycle|0
2549510|NCT01461928|8821362|P1|Induction (up to 8 Months)|Exceeded time limit for next cycle|1
2549511|NCT01461928|8821360|P3|Induction (up to 8 Months)|Promotor request|0
2549512|NCT01461928|8821361|P2|Induction (up to 8 Months)|Promotor request|0
2549513|NCT01461928|8821362|P1|Induction (up to 8 Months)|Promotor request|1
2549514|NCT01461928|8821360|P3|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0
2549515|NCT01461928|8821361|P2|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0
2549516|NCT01461928|8821362|P1|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1
2549517|NCT01461928|8821360|P3|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0
2549518|NCT01461928|8821361|P2|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0
2549519|NCT01461928|8821362|P1|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1
2549520|NCT01461928|8821360|P3|Induction (up to 8 Months)|Protocol deviation|0
2549521|NCT01461928|8821361|P2|Induction (up to 8 Months)|Protocol deviation|0
2549522|NCT01461928|8821362|P1|Induction (up to 8 Months)|Protocol deviation|2
2549523|NCT01461928|8821360|P3|Induction (up to 8 Months)|Sponsor decision|0
2549524|NCT01461928|8821361|P2|Induction (up to 8 Months)|Sponsor decision|0
2549525|NCT01461928|8821362|P1|Induction (up to 8 Months)|Sponsor decision|1
2549526|NCT01461928|8821360|P3|Induction (up to 8 Months)|Treated before eligibility was confirmed|0
2549527|NCT01461928|8821361|P2|Induction (up to 8 Months)|Treated before eligibility was confirmed|0
2549528|NCT01461928|8821362|P1|Induction (up to 8 Months)|Treated before eligibility was confirmed|1
2549529|NCT01461928|8821360|P3|Induction (up to 8 Months)|Termination of study in Switzerland|0
2549530|NCT01461928|8821361|P2|Induction (up to 8 Months)|Termination of study in Switzerland|0
2549531|NCT01461928|8821362|P1|Induction (up to 8 Months)|Termination of study in Switzerland|1
2549532|NCT01461928|8821360|P3|Induction (up to 8 Months)|Not responding to treatment|0
2549533|NCT01461928|8821361|P2|Induction (up to 8 Months)|Not responding to treatment|0
2549534|NCT01461928|8821362|P1|Induction (up to 8 Months)|Not responding to treatment|11
2549535|NCT01461928|8821360|P3|Induction (up to 8 Months)|Completed Induction, no Maint I received|0
2549536|NCT01461928|8821361|P2|Induction (up to 8 Months)|Completed Induction, no Maint I received|0
2549537|NCT01461928|8821362|P1|Induction (up to 8 Months)|Completed Induction, no Maint I received|11
2549538|NCT01461928|8821360|P3|Induction (up to 8 Months)|Eligibility criteria deviation|0
2549539|NCT01461928|8821361|P2|Induction (up to 8 Months)|Eligibility criteria deviation|0
2549540|NCT01461928|8821362|P1|Induction (up to 8 Months)|Eligibility criteria deviation|10
2549541|NCT01461928|8821360|P3|Induction (up to 8 Months)|Disease progression|0
2549542|NCT01461928|8821361|P2|Induction (up to 8 Months)|Disease progression|0
2549543|NCT01461928|8821362|P1|Induction (up to 8 Months)|Disease progression|45
2549544|NCT01461928|8821360|P3|Induction (up to 8 Months)|Withdrawal by Subject|0
2549545|NCT01461928|8821361|P2|Induction (up to 8 Months)|Withdrawal by Subject|0
2549546|NCT01461928|8821362|P1|Induction (up to 8 Months)|Withdrawal by Subject|18
2549547|NCT01461928|8821360|P3|Induction (up to 8 Months)|Physician Decision|0
2549548|NCT01461928|8821361|P2|Induction (up to 8 Months)|Physician Decision|0
2549549|NCT01461928|8821362|P1|Induction (up to 8 Months)|Physician Decision|9
2549550|NCT01461928|8821360|P3|Induction (up to 8 Months)|Lost to Follow-up|0
2549551|NCT01461928|8821361|P2|Induction (up to 8 Months)|Lost to Follow-up|0
2549552|NCT01461928|8821362|P1|Induction (up to 8 Months)|Lost to Follow-up|5
2549553|NCT01461928|8821360|P3|Induction (up to 8 Months)|Death|0
2549554|NCT01461928|8821361|P2|Induction (up to 8 Months)|Death|0
2549555|NCT01461928|8821362|P1|Induction (up to 8 Months)|Death|3
2549556|NCT01461928|8821360|P3|Induction (up to 8 Months)|Adverse Event|0
2549557|NCT01461928|8821361|P2|Induction (up to 8 Months)|Adverse Event|0
2549558|NCT01461928|8821362|P1|Induction (up to 8 Months)|Adverse Event|76
2549559|NCT01461811|8821413|P2|Overall Study|Noncompliance|1
2549560|NCT01461811|8821414|P1|Overall Study|Noncompliance|1
2549561|NCT01461811|8821413|P2|Overall Study|Subject decision unrelated to an AE|1
2549562|NCT01461811|8821414|P1|Overall Study|Subject decision unrelated to an AE|1
2549563|NCT01461811|8821413|P2|Overall Study|Adverse Event|1
2549564|NCT01461811|8821414|P1|Overall Study|Adverse Event|2
2549565|NCT01461707|8821453|P2|Overall Study|Withdrawal by Subject|0
2549566|NCT01461707|8821454|P1|Overall Study|Withdrawal by Subject|1
2549567|NCT01461551|8821491|P3|Overall Study|Physician Decision|2
2549568|NCT01461551|8821492|P2|Overall Study|Physician Decision|1
2549569|NCT01461551|8821493|P1|Overall Study|Physician Decision|2
2549570|NCT01461538|8821504|P3|Overall Study|Withdrawal by Subject|0
2549571|NCT01461538|8821505|P2|Overall Study|Withdrawal by Subject|1
2549572|NCT01461538|8821506|P1|Overall Study|Withdrawal by Subject|1
2549573|NCT01461538|8821504|P3|Overall Study|Study Stopped by Sponsor|0
2549574|NCT01461538|8821505|P2|Overall Study|Study Stopped by Sponsor|1
2549575|NCT01461538|8821506|P1|Overall Study|Study Stopped by Sponsor|2
2549576|NCT01461538|8821504|P3|Overall Study|Death|2
2549577|NCT01461538|8821505|P2|Overall Study|Death|6
2549578|NCT01461538|8821506|P1|Overall Study|Death|15
2549579|NCT01461369|8821575|P3|Overall Study|Withdrawal by Subject|2
2549580|NCT01461369|8821576|P2|Overall Study|Withdrawal by Subject|3
2549581|NCT01461369|8821577|P1|Overall Study|Withdrawal by Subject|1
2549582|NCT01461369|8821575|P3|Overall Study|Protocol Violation|2
2549583|NCT01461369|8821576|P2|Overall Study|Protocol Violation|2
2549584|NCT01461369|8821577|P1|Overall Study|Protocol Violation|1
2549585|NCT01461369|8821575|P3|Overall Study|Adverse Event|4
2549586|NCT01461369|8821576|P2|Overall Study|Adverse Event|12
2549587|NCT01461369|8821577|P1|Overall Study|Adverse Event|9
2549588|NCT01461369|8821575|P3|Overall Study|Lost to Follow-up|3
2549589|NCT01461369|8821576|P2|Overall Study|Lost to Follow-up|0
2549590|NCT01461369|8821577|P1|Overall Study|Lost to Follow-up|0
2549591|NCT01461369|8821575|P3|Overall Study|Lack of Efficacy|6
2549592|NCT01461369|8821576|P2|Overall Study|Lack of Efficacy|0
2549593|NCT01461369|8821577|P1|Overall Study|Lack of Efficacy|2
2549594|NCT01461096|8821602|P2|Overall Study|Lost to Follow-up|4
2549595|NCT01461096|8821603|P1|Overall Study|Lost to Follow-up|8
2549596|NCT01461096|8821602|P2|Overall Study|Subj not willing to adhere to reqs|4
2549597|NCT01461096|8821603|P1|Overall Study|Subj not willing to adhere to reqs|3
2549598|NCT01461096|8821602|P2|Overall Study|Withdrawal by Subject|3
2549599|NCT01461096|8821603|P1|Overall Study|Withdrawal by Subject|5
2549600|NCT01461096|8821602|P2|Overall Study|Site is closing|30
2549601|NCT01461096|8821603|P1|Overall Study|Site is closing|27
2549602|NCT01461096|8821602|P2|Overall Study|Subj not able to get to clinic|13
2549603|NCT01461096|8821603|P1|Overall Study|Subj not able to get to clinic|15
2549604|NCT01461096|8821602|P2|Overall Study|Severe debilitation, unable to continue|1
2549605|NCT01461096|8821603|P1|Overall Study|Severe debilitation, unable to continue|1
2549606|NCT01461096|8821602|P2|Overall Study|Death|6
2549607|NCT01461096|8821603|P1|Overall Study|Death|3
2549608|NCT01461057|8821619|P2|Overall Study|Study Terminated by Sponsor|0
2549609|NCT01461057|8821620|P1|Overall Study|Study Terminated by Sponsor|2
2549610|NCT01461057|8821619|P2|Overall Study|Progression of Disease|0
2549611|NCT01461057|8821620|P1|Overall Study|Progression of Disease|1
2549612|NCT01461057|8821619|P2|Overall Study|Adverse Event|1
2549613|NCT01461057|8821620|P1|Overall Study|Adverse Event|0
2549614|NCT01461057|8821619|P2|Overall Study|Physician Decision|2
2549615|NCT01461057|8821620|P1|Overall Study|Physician Decision|0
2549616|NCT01461057|8821619|P2|Overall Study|Withdrawal by Subject|3
2549617|NCT01461057|8821620|P1|Overall Study|Withdrawal by Subject|2
2549618|NCT01461057|8821619|P2|Overall Study|Death|9
2549619|NCT01461057|8821620|P1|Overall Study|Death|10
2549620|NCT01461044|8821630|P2|Overall Study|Lost to Follow-up|5
2549621|NCT01461044|8821631|P1|Overall Study|Lost to Follow-up|12
2549622|NCT01461044|8821630|P2|Overall Study|Death|35
2549623|NCT01461044|8821631|P1|Overall Study|Death|58
2549624|NCT01461005|8821704|P1|Overall Study|FDA reclassified Dynamic Stabilization D|1
2549625|NCT01460901|8821727|P1|Overall Study|Withdrawal by Subject|2
2549626|NCT01460719|8821759|P1|Overall Study|Withdrawal by Subject|1
2549627|NCT01460719|8821759|P1|Overall Study|Adverse Event|1
2549628|NCT01460628|8821769|P1|Overall Study|Withdrawal by Subject|2
2549629|NCT01460628|8821769|P1|Overall Study|Adverse Event|3
2549630|NCT01460446|8821781|P2|Overall Study|Other Reasons Incl. Lost for Follow-Up|3
2549631|NCT01460446|8821782|P1|Overall Study|Other Reasons Incl. Lost for Follow-Up|0
2549632|NCT01460446|8821781|P2|Overall Study|Pregnancy|0
2549633|NCT01460446|8821782|P1|Overall Study|Pregnancy|1
2549634|NCT01460446|8821781|P2|Overall Study|Surgery/Illness|1
2549635|NCT01460446|8821782|P1|Overall Study|Surgery/Illness|1
2549636|NCT01460446|8821781|P2|Overall Study|Non-compliance & Consent Withdrawn|3
2549637|NCT01460446|8821782|P1|Overall Study|Non-compliance & Consent Withdrawn|1
2549638|NCT01460446|8821781|P2|Overall Study|Consent Withdrawn|4
2549639|NCT01460446|8821782|P1|Overall Study|Consent Withdrawn|0
2549640|NCT01460446|8821781|P2|Overall Study|Non-compliance|9
2549641|NCT01460446|8821782|P1|Overall Study|Non-compliance|2
2549642|NCT01460407|8821809|P2|Period 2: Day 6 to Day 14|Adverse Event|1
2549643|NCT01460407|8821810|P1|Period 2: Day 6 to Day 14|Adverse Event|0
2549644|NCT01460381|8821823|P2|Period 2 (Days 8-15)|Lost to Follow-up|0
2549645|NCT01460381|8821824|P1|Period 2 (Days 8-15)|Lost to Follow-up|1
2549646|NCT01460368|8821840|P7|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
2549647|NCT01460368|8821841|P6|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
2549648|NCT01460368|8821842|P5|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
2549649|NCT01460368|8821843|P4|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
2549650|NCT01460368|8821844|P3|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
2549651|NCT01460368|8821845|P2|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
2549652|NCT01460368|8821846|P1|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
2549653|NCT01460368|8821840|P7|Part B: Washout (up to 15 Days)|Protocol Violation|0
2549654|NCT01460368|8821841|P6|Part B: Washout (up to 15 Days)|Protocol Violation|0
2549655|NCT01460368|8821842|P5|Part B: Washout (up to 15 Days)|Protocol Violation|0
2549656|NCT01460368|8821843|P4|Part B: Washout (up to 15 Days)|Protocol Violation|0
2549657|NCT01460368|8821844|P3|Part B: Washout (up to 15 Days)|Protocol Violation|1
2549658|NCT01460368|8821845|P2|Part B: Washout (up to 15 Days)|Protocol Violation|0
2549659|NCT01460368|8821846|P1|Part B: Washout (up to 15 Days)|Protocol Violation|0
2549660|NCT01460368|8821840|P7|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
2549661|NCT01460368|8821841|P6|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
2549662|NCT01460368|8821842|P5|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
2549663|NCT01460368|8821843|P4|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
2549664|NCT01460368|8821844|P3|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
2549665|NCT01460368|8821845|P2|Part B: Second Intervention (Period 2)|Lost to Follow-up|1
2549666|NCT01460368|8821846|P1|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
2549667|NCT01460368|8821840|P7|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
2549668|NCT01460368|8821841|P6|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
2549669|NCT01460368|8821842|P5|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
2549670|NCT01460368|8821843|P4|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
2549671|NCT01460368|8821844|P3|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
2549672|NCT01460368|8821845|P2|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
2549673|NCT01460368|8821846|P1|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
2549674|NCT01460368|8821840|P7|Part B: First Intervention (Period 1)|Lost to Follow-up|0
2549675|NCT01460368|8821841|P6|Part B: First Intervention (Period 1)|Lost to Follow-up|0
2549676|NCT01460368|8821842|P5|Part B: First Intervention (Period 1)|Lost to Follow-up|1
2549677|NCT01460368|8821843|P4|Part B: First Intervention (Period 1)|Lost to Follow-up|0
2549678|NCT01460368|8821844|P3|Part B: First Intervention (Period 1)|Lost to Follow-up|0
2549679|NCT01460368|8821845|P2|Part B: First Intervention (Period 1)|Lost to Follow-up|0
2549680|NCT01460368|8821846|P1|Part B: First Intervention (Period 1)|Lost to Follow-up|0
2549681|NCT01460342|8821858|P2|Overall Study|Lack of Efficacy|0
2549682|NCT01460342|8821859|P1|Overall Study|Lack of Efficacy|1
2549683|NCT01460342|8821858|P2|Overall Study|Physician Decision|3
2549684|NCT01460342|8821859|P1|Overall Study|Physician Decision|1
2549685|NCT01460342|8821858|P2|Overall Study|Withdrawal by Subject|4
2549686|NCT01460342|8821859|P1|Overall Study|Withdrawal by Subject|3
2549687|NCT01460342|8821858|P2|Overall Study|Protocol Violation|1
2549688|NCT01460342|8821859|P1|Overall Study|Protocol Violation|0
2549689|NCT01460342|8821858|P2|Overall Study|Lost to Follow-up|2
2549690|NCT01460342|8821859|P1|Overall Study|Lost to Follow-up|1
2549691|NCT01460342|8821858|P2|Overall Study|Adverse Event|4
2549692|NCT01460342|8821859|P1|Overall Study|Adverse Event|5
2549693|NCT01460290|8821890|P1|Overall Study|Elevated liver function|1
2549694|NCT01460290|8821890|P1|Overall Study|Adverse Event|3
2549695|NCT01460160|8821917|P2|Follow-up|Lost to Follow-up|0
2549696|NCT01460160|8821918|P1|Follow-up|Lost to Follow-up|1
2549697|NCT01460160|8821917|P2|Follow-up|Death|2
2549698|NCT01460160|8821918|P1|Follow-up|Death|7
2549699|NCT01460160|8821917|P2|Follow-up|Withdrawal by Subject|0
2549700|NCT01460160|8821918|P1|Follow-up|Withdrawal by Subject|3
2549701|NCT01460160|8821917|P2|Treatment|Subject refused to continue Chemo|0
2549702|NCT01460160|8821918|P1|Treatment|Subject refused to continue Chemo|1
2549703|NCT01460160|8821917|P2|Treatment|Family did not wish to restart after SCT|0
2549704|NCT01460160|8821918|P1|Treatment|Family did not wish to restart after SCT|1
2549705|NCT01460160|8821917|P2|Treatment|PI decision to pursue other options|1
2549706|NCT01460160|8821918|P1|Treatment|PI decision to pursue other options|1
2549707|NCT01460160|8821917|P2|Treatment|PI not to follow protocol therapy|0
2549708|NCT01460160|8821918|P1|Treatment|PI not to follow protocol therapy|1
2549709|NCT01460160|8821917|P2|Treatment|PI decision to not re-initiate after SCT|2
2549710|NCT01460160|8821918|P1|Treatment|PI decision to not re-initiate after SCT|2
2549711|NCT01460160|8821917|P2|Treatment|Death|2
2549712|NCT01460160|8821918|P1|Treatment|Death|0
2549713|NCT01460160|8821917|P2|Treatment|Withdrawal by Subject|0
2549714|NCT01460160|8821918|P1|Treatment|Withdrawal by Subject|4
2549715|NCT01460160|8821917|P2|Treatment|Adverse Event|0
2549716|NCT01460160|8821918|P1|Treatment|Adverse Event|8
2549717|NCT01460160|8821917|P2|Treatment|Study Drug Toxicity|0
2549718|NCT01460160|8821918|P1|Treatment|Study Drug Toxicity|2
2549719|NCT01460160|8821917|P2|Treatment|Lack of Efficacy|0
2549720|NCT01460160|8821918|P1|Treatment|Lack of Efficacy|3
2549721|NCT01459913|8821959|P4|Overall Study|Did Not Meet Inclusion Criteria|1
2549722|NCT01459913|8821960|P3|Overall Study|Did Not Meet Inclusion Criteria|0
2549723|NCT01459913|8821961|P2|Overall Study|Did Not Meet Inclusion Criteria|0
2549724|NCT01459913|8821962|P1|Overall Study|Did Not Meet Inclusion Criteria|0
2549725|NCT01459913|8821959|P4|Overall Study|Other|1
2549726|NCT01459913|8821960|P3|Overall Study|Other|3
2549727|NCT01459913|8821961|P2|Overall Study|Other|0
2549728|NCT01459913|8821962|P1|Overall Study|Other|0
2549729|NCT01459913|8821959|P4|Overall Study|Study Terminated by Sponsor|11
2549730|NCT01459913|8821960|P3|Overall Study|Study Terminated by Sponsor|9
2549731|NCT01459913|8821961|P2|Overall Study|Study Terminated by Sponsor|15
2549732|NCT01459913|8821962|P1|Overall Study|Study Terminated by Sponsor|30
2549733|NCT01459913|8821959|P4|Overall Study|Physician Decision|0
2549734|NCT01459913|8821960|P3|Overall Study|Physician Decision|0
2549735|NCT01459913|8821961|P2|Overall Study|Physician Decision|1
2549736|NCT01459913|8821962|P1|Overall Study|Physician Decision|0
2549737|NCT01459913|8821959|P4|Overall Study|Non- Compliance|3
2549738|NCT01459913|8821960|P3|Overall Study|Non- Compliance|0
2549739|NCT01459913|8821961|P2|Overall Study|Non- Compliance|0
2549740|NCT01459913|8821962|P1|Overall Study|Non- Compliance|0
2549741|NCT01459913|8821959|P4|Overall Study|Death|1
2549742|NCT01459913|8821960|P3|Overall Study|Death|0
2549743|NCT01459913|8821961|P2|Overall Study|Death|0
2549744|NCT01459913|8821962|P1|Overall Study|Death|0
2549745|NCT01459913|8821959|P4|Overall Study|Lost to Follow-up|8
2549746|NCT01459913|8821960|P3|Overall Study|Lost to Follow-up|1
2549747|NCT01459913|8821961|P2|Overall Study|Lost to Follow-up|4
2549748|NCT01459913|8821962|P1|Overall Study|Lost to Follow-up|7
2549749|NCT01459913|8821959|P4|Overall Study|Withdrawal by Subject|5
2549750|NCT01459913|8821960|P3|Overall Study|Withdrawal by Subject|0
2549751|NCT01459913|8821961|P2|Overall Study|Withdrawal by Subject|0
2549752|NCT01459913|8821962|P1|Overall Study|Withdrawal by Subject|4
2549753|NCT01459913|8821959|P4|Overall Study|Adverse Event|3
2549754|NCT01459913|8821960|P3|Overall Study|Adverse Event|0
2549755|NCT01459913|8821961|P2|Overall Study|Adverse Event|0
2549756|NCT01459913|8821962|P1|Overall Study|Adverse Event|0
2549757|NCT01459796|8821993|P2|Overall Study|Decision by the sponsor|108
2549758|NCT01459796|8821994|P1|Overall Study|Decision by the sponsor|75
2549759|NCT01459796|8821993|P2|Overall Study|Reason unspecified|2
2549760|NCT01459796|8821994|P1|Overall Study|Reason unspecified|1
2549761|NCT01459796|8821993|P2|Overall Study|Lost to Follow-up|4
2549762|NCT01459796|8821994|P1|Overall Study|Lost to Follow-up|5
2549763|NCT01459796|8821993|P2|Overall Study|Withdrawal by Subject|3
2549764|NCT01459796|8821994|P1|Overall Study|Withdrawal by Subject|6
2549765|NCT01459796|8821993|P2|Overall Study|Adverse Event|5
2549766|NCT01459796|8821994|P1|Overall Study|Adverse Event|5
2549767|NCT01459796|8821993|P2|Overall Study|Non compliance with protocol|4
2549768|NCT01459796|8821994|P1|Overall Study|Non compliance with protocol|2
2549769|NCT01459783|8822012|P2|6 Months to 12 Months|Study ended before 12-month follow-up|17
2549770|NCT01459783|8822013|P1|6 Months to 12 Months|Study ended before 12-month follow-up|11
2549771|NCT01459783|8822012|P2|6 Months to 12 Months|Lost to Follow-up|7
2549772|NCT01459783|8822013|P1|6 Months to 12 Months|Lost to Follow-up|2
2549773|NCT01459783|8822012|P2|6 Months to 12 Months|Withdrawal by Subject|5
2549774|NCT01459783|8822013|P1|6 Months to 12 Months|Withdrawal by Subject|6
2549775|NCT01459783|8822012|P2|6 Months to 12 Months|Death|1
2549776|NCT01459783|8822013|P1|6 Months to 12 Months|Death|0
2549777|NCT01459783|8822012|P2|Baseline to 6 Months|Lost to Follow-up|14
2549778|NCT01459783|8822013|P1|Baseline to 6 Months|Lost to Follow-up|19
2549779|NCT01459783|8822012|P2|Baseline to 6 Months|Withdrawal by Subject|6
2549780|NCT01459783|8822013|P1|Baseline to 6 Months|Withdrawal by Subject|12
2549781|NCT01459783|8822012|P2|Baseline to 6 Months|Death|0
2549782|NCT01459783|8822013|P1|Baseline to 6 Months|Death|1
2549783|NCT01459718|8822021|P1|Overall Study|Adverse Event|1
2549784|NCT01459718|8822021|P1|Overall Study|Lost to Follow-up|1
2549785|NCT01459718|8822021|P1|Overall Study|Physician Decision|1
2549786|NCT01459614|8822203|P2|Overall Study|Adverse Event|0
2549787|NCT01459614|8822204|P1|Overall Study|Adverse Event|1
2549788|NCT01459068|8822251|P2|Overall Study|Death|1
2549789|NCT01459068|8822252|P1|Overall Study|Death|0
2549790|NCT01459068|8822251|P2|Overall Study|Lost to Follow-up|15
2549791|NCT01459068|8822252|P1|Overall Study|Lost to Follow-up|31
2549792|NCT01459068|8822251|P2|Overall Study|Withdrawal by Subject|18
2549793|NCT01459068|8822252|P1|Overall Study|Withdrawal by Subject|8
2549794|NCT01459016|8822268|P1|Overall Study|Amendment Discontinuation Criteria|4
2549795|NCT01459016|8822268|P1|Overall Study|Withdrawal by Subject|11
2549796|NCT01458951|8822296|P3|Overall Study|Insufficient Clinical Response|11
2549797|NCT01458951|8822297|P2|Overall Study|Insufficient Clinical Response|0
2549798|NCT01458951|8822298|P1|Overall Study|Insufficient Clinical Response|17
2549799|NCT01458951|8822296|P3|Overall Study|Adverse Event|2
2549800|NCT01458951|8822297|P2|Overall Study|Adverse Event|0
2549801|NCT01458951|8822298|P1|Overall Study|Adverse Event|7
2549802|NCT01458951|8822296|P3|Overall Study|Withdrawal by Subject|2
2549803|NCT01458951|8822297|P2|Overall Study|Withdrawal by Subject|0
2549804|NCT01458951|8822298|P1|Overall Study|Withdrawal by Subject|2
2549805|NCT01458951|8822296|P3|Overall Study|Protocol Violation|0
2549806|NCT01458951|8822297|P2|Overall Study|Protocol Violation|1
2549807|NCT01458951|8822298|P1|Overall Study|Protocol Violation|5
2549808|NCT01458951|8822296|P3|Overall Study|Other|0
2549809|NCT01458951|8822297|P2|Overall Study|Other|0
2549810|NCT01458951|8822298|P1|Overall Study|Other|1
2549811|NCT01458639|8822323|P1|Overall Study|Inability to obtain subject blood sample|1
2549812|NCT01458639|8822323|P1|Overall Study|Equipment issue|1
2549813|NCT01458639|8822323|P1|Overall Study|Physician Decision|4
2549814|NCT01458587|8822335|P2|Overall Study|Withdrawal by Subject|0
2549815|NCT01458587|8822336|P1|Overall Study|Withdrawal by Subject|1
2549816|NCT01458574|8822499|P3|Overall Study|Randomized but not treated|0
2549817|NCT01458574|8822500|P2|Overall Study|Randomized but not treated|1
2549818|NCT01458574|8822501|P1|Overall Study|Randomized but not treated|0
2549819|NCT01458574|8822499|P3|Overall Study|Other|0
2549820|NCT01458574|8822500|P2|Overall Study|Other|1
2549821|NCT01458574|8822501|P1|Overall Study|Other|2
2549822|NCT01458574|8822499|P3|Overall Study|Withdrawal by Subject|5
2549823|NCT01458574|8822500|P2|Overall Study|Withdrawal by Subject|3
2549824|NCT01458574|8822501|P1|Overall Study|Withdrawal by Subject|6
2549825|NCT01458574|8822499|P3|Overall Study|Protocol Violation|0
2549826|NCT01458574|8822500|P2|Overall Study|Protocol Violation|1
2549827|NCT01458574|8822501|P1|Overall Study|Protocol Violation|0
2549828|NCT01458574|8822499|P3|Overall Study|Pregnancy|0
2549829|NCT01458574|8822500|P2|Overall Study|Pregnancy|1
2549830|NCT01458574|8822501|P1|Overall Study|Pregnancy|1
2549831|NCT01458574|8822499|P3|Overall Study|Lost to Follow-up|1
2549832|NCT01458574|8822500|P2|Overall Study|Lost to Follow-up|2
2549833|NCT01458574|8822501|P1|Overall Study|Lost to Follow-up|3
2549834|NCT01458574|8822499|P3|Overall Study|Lack of Efficacy|132
2549835|NCT01458574|8822500|P2|Overall Study|Lack of Efficacy|53
2549836|NCT01458574|8822501|P1|Overall Study|Lack of Efficacy|70
2549837|NCT01458574|8822499|P3|Overall Study|Adverse Event|7
2549838|NCT01458574|8822500|P2|Overall Study|Adverse Event|9
2549839|NCT01458574|8822501|P1|Overall Study|Adverse Event|5
2549840|NCT01458535|8822631|P6|Overall Study|Adverse Event|0
2549841|NCT01458535|8822632|P5|Overall Study|Adverse Event|0
2549842|NCT01458535|8822633|P4|Overall Study|Adverse Event|1
2549843|NCT01458535|8822634|P3|Overall Study|Adverse Event|0
2549844|NCT01458535|8822635|P2|Overall Study|Adverse Event|0
2549845|NCT01458535|8822636|P1|Overall Study|Adverse Event|0
2549846|NCT01458535|8822631|P6|Overall Study|Lost to Follow-up|2
2549847|NCT01458535|8822632|P5|Overall Study|Lost to Follow-up|2
2549848|NCT01458535|8822633|P4|Overall Study|Lost to Follow-up|3
2549849|NCT01458535|8822634|P3|Overall Study|Lost to Follow-up|0
2549850|NCT01458535|8822635|P2|Overall Study|Lost to Follow-up|2
2549851|NCT01458535|8822636|P1|Overall Study|Lost to Follow-up|0
2549852|NCT01458535|8822631|P6|Overall Study|Withdrawal by Subject|1
2549853|NCT01458535|8822632|P5|Overall Study|Withdrawal by Subject|1
2549854|NCT01458535|8822633|P4|Overall Study|Withdrawal by Subject|0
2549855|NCT01458535|8822634|P3|Overall Study|Withdrawal by Subject|2
2549856|NCT01458535|8822635|P2|Overall Study|Withdrawal by Subject|0
2549857|NCT01458535|8822636|P1|Overall Study|Withdrawal by Subject|0
2549858|NCT01458535|8822631|P6|Overall Study|Other|1
2549859|NCT01458535|8822632|P5|Overall Study|Other|1
2549860|NCT01458535|8822633|P4|Overall Study|Other|0
2549861|NCT01458535|8822634|P3|Overall Study|Other|0
2549862|NCT01458535|8822635|P2|Overall Study|Other|0
2549863|NCT01458535|8822636|P1|Overall Study|Other|0
2549864|NCT01458522|8822688|P2|Overall Study|Physician Decision|9
2549865|NCT01458522|8822689|P1|Overall Study|Physician Decision|1
2549866|NCT01458522|8822688|P2|Overall Study|Withdrawal by Subject|2
2549867|NCT01458522|8822689|P1|Overall Study|Withdrawal by Subject|2
2549868|NCT01458392|8822718|P3|Overall Study|Patient unwilling to comply with protoco|2
2549869|NCT01458392|8822719|P2|Overall Study|Patient unwilling to comply with protoco|0
2549870|NCT01458392|8822720|P1|Overall Study|Patient unwilling to comply with protoco|0
2549871|NCT01458392|8822718|P3|Overall Study|At the discretion of the sponsor|7
2549872|NCT01458392|8822719|P2|Overall Study|At the discretion of the sponsor|2
2549873|NCT01458392|8822720|P1|Overall Study|At the discretion of the sponsor|0
2549874|NCT01458392|8822718|P3|Overall Study|Death|22
2549875|NCT01458392|8822719|P2|Overall Study|Death|11
2549876|NCT01458392|8822720|P1|Overall Study|Death|2
2549877|NCT01458366|8822745|P5|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1
2549878|NCT01458366|8822746|P4|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
2549879|NCT01458366|8822747|P3|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
2549880|NCT01458366|8822748|P2|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
2549881|NCT01458366|8822749|P1|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
2549882|NCT01458366|8822745|P5|Period 1: 70mg/m^2|Physician Decision|0
2549883|NCT01458366|8822746|P4|Period 1: 70mg/m^2|Physician Decision|0
2549884|NCT01458366|8822747|P3|Period 1: 70mg/m^2|Physician Decision|0
2549885|NCT01458366|8822748|P2|Period 1: 70mg/m^2|Physician Decision|0
2549886|NCT01458366|8822749|P1|Period 1: 70mg/m^2|Physician Decision|2
2549887|NCT01458275|8822776|P3|Overall Study|Withdrawal by Subject|1
2549888|NCT01458275|8822777|P2|Overall Study|Withdrawal by Subject|2
2549889|NCT01458275|8822778|P1|Overall Study|Withdrawal by Subject|3
2549890|NCT01458275|8822776|P3|Overall Study|Protocol Violation|2
2549891|NCT01458275|8822777|P2|Overall Study|Protocol Violation|5
2549892|NCT01458275|8822778|P1|Overall Study|Protocol Violation|5
2549893|NCT01458275|8822776|P3|Overall Study|Lost to Follow-up|5
2549894|NCT01458275|8822777|P2|Overall Study|Lost to Follow-up|2
2549895|NCT01458275|8822778|P1|Overall Study|Lost to Follow-up|3
2549896|NCT01458275|8822776|P3|Overall Study|Adverse Event|1
2549897|NCT01458275|8822777|P2|Overall Study|Adverse Event|4
2549898|NCT01458275|8822778|P1|Overall Study|Adverse Event|3
2549899|NCT01458249|8822820|P1|Overall Study|Ongoing|1
2549900|NCT01458249|8822820|P1|Overall Study|Other|2
2549901|NCT01458249|8822820|P1|Overall Study|Adverse Event|4
2549902|NCT01458249|8822820|P1|Overall Study|Not treated|1
2549903|NCT01458210|8822839|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1
2549904|NCT01458210|8822839|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2
2549905|NCT01458210|8822839|P1|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2
2549906|NCT01458210|8822839|P1|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2
2549907|NCT01458171|8822856|P1|Overall Study|Adverse Event|1
2549908|NCT01458132|8822879|P2|Overall Study|Other|3
2549909|NCT01458132|8822880|P1|Overall Study|Other|15
2549910|NCT01458119|8822888|P1|Overall Study|Non-compliance With Study Drug|3
2549911|NCT01458119|8822888|P1|Overall Study|Consent Withdrawn by Participant|8
2549912|NCT01458119|8822888|P1|Overall Study|Adverse Event|1
2549913|NCT01458119|8822888|P1|Overall Study|Death|2
2549914|NCT01458119|8822888|P1|Overall Study|Pregnancy|1
2549915|NCT01458119|8822888|P1|Overall Study|Withdrawal Due to Nonamenable Mutation|1
2549916|NCT01458119|8822888|P1|Overall Study|Physician Decision|4
2549917|NCT01458106|8822895|P2|Overall Study|Withdrawn Per Protocol|1
2549918|NCT01458106|8822896|P1|Overall Study|Withdrawn Per Protocol|0
2549919|NCT01458106|8822895|P2|Overall Study|Pre-rFVIIIFc Adverse Event|0
2549920|NCT01458106|8822896|P1|Overall Study|Pre-rFVIIIFc Adverse Event|1
2549921|NCT01458106|8822895|P2|Overall Study|Withdrawal by Subject|0
2549922|NCT01458106|8822896|P1|Overall Study|Withdrawal by Subject|2
2549923|NCT01457950|8822973|P4|Open-Label Phase|Withdrawal by Subject|0
2549924|NCT01457950|8822974|P3|Open-Label Phase|Withdrawal by Subject|2
2549925|NCT01457950|8822975|P2|Open-Label Phase|Withdrawal by Subject|0
2549926|NCT01457950|8822976|P1|Open-Label Phase|Withdrawal by Subject|0
2549927|NCT01457950|8822973|P4|Open-Label Phase|Protocol Violation|1
2549928|NCT01457950|8822974|P3|Open-Label Phase|Protocol Violation|0
2549929|NCT01457950|8822975|P2|Open-Label Phase|Protocol Violation|0
2549930|NCT01457950|8822976|P1|Open-Label Phase|Protocol Violation|0
2549931|NCT01457950|8822973|P4|Open-Label Phase|Adverse Event|1
2549932|NCT01457950|8822974|P3|Open-Label Phase|Adverse Event|0
2549933|NCT01457950|8822975|P2|Open-Label Phase|Adverse Event|0
2549934|NCT01457950|8822976|P1|Open-Label Phase|Adverse Event|0
2549935|NCT01457950|8822973|P4|Double-Blind Phase|Withdrawal by Subject|0
2549936|NCT01457950|8822974|P3|Double-Blind Phase|Withdrawal by Subject|0
2549937|NCT01457950|8822975|P2|Double-Blind Phase|Withdrawal by Subject|2
2549938|NCT01457950|8822976|P1|Double-Blind Phase|Withdrawal by Subject|6
2549939|NCT01457950|8822973|P4|Double-Blind Phase|Protocol Violation|0
2549940|NCT01457950|8822974|P3|Double-Blind Phase|Protocol Violation|0
2549941|NCT01457950|8822975|P2|Double-Blind Phase|Protocol Violation|1
2549942|NCT01457950|8822976|P1|Double-Blind Phase|Protocol Violation|2
2549943|NCT01457950|8822973|P4|Double-Blind Phase|Continuation Criteria Not Met|0
2549944|NCT01457950|8822974|P3|Double-Blind Phase|Continuation Criteria Not Met|0
2549945|NCT01457950|8822975|P2|Double-Blind Phase|Continuation Criteria Not Met|0
2549946|NCT01457950|8822976|P1|Double-Blind Phase|Continuation Criteria Not Met|1
2549947|NCT01457924|8823055|P5|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
2549948|NCT01457924|8823056|P4|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2
2549949|NCT01457924|8823057|P3|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
2549950|NCT01457924|8823058|P2|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0
2549951|NCT01457924|8823059|P1|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
2549952|NCT01457924|8823055|P5|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5
2549953|NCT01457924|8823056|P4|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
2549954|NCT01457924|8823057|P3|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2
2549955|NCT01457924|8823058|P2|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4
2549956|NCT01457924|8823059|P1|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
2549957|NCT01457924|8823055|P5|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
2549958|NCT01457924|8823056|P4|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
2549959|NCT01457924|8823057|P3|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
2549960|NCT01457924|8823058|P2|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
2549961|NCT01457924|8823059|P1|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
2549962|NCT01457924|8823055|P5|FUP (Weeks 24-48)|Withdrawal by Subject|2
2549963|NCT01457924|8823056|P4|FUP (Weeks 24-48)|Withdrawal by Subject|0
2549964|NCT01457924|8823057|P3|FUP (Weeks 24-48)|Withdrawal by Subject|0
2549965|NCT01457924|8823058|P2|FUP (Weeks 24-48)|Withdrawal by Subject|1
2549966|NCT01457924|8823059|P1|FUP (Weeks 24-48)|Withdrawal by Subject|2
2549967|NCT01457924|8823055|P5|FUP (Weeks 24-48)|Lost to Follow-up|0
2549968|NCT01457924|8823056|P4|FUP (Weeks 24-48)|Lost to Follow-up|1
2549969|NCT01457924|8823057|P3|FUP (Weeks 24-48)|Lost to Follow-up|0
2549970|NCT01457924|8823058|P2|FUP (Weeks 24-48)|Lost to Follow-up|0
2549971|NCT01457924|8823059|P1|FUP (Weeks 24-48)|Lost to Follow-up|0
2549972|NCT01457924|8823055|P5|FUP (Weeks 24-48)|Physician Decision|0
2549973|NCT01457924|8823056|P4|FUP (Weeks 24-48)|Physician Decision|0
2549974|NCT01457924|8823057|P3|FUP (Weeks 24-48)|Physician Decision|1
2549975|NCT01457924|8823058|P2|FUP (Weeks 24-48)|Physician Decision|0
2549976|NCT01457924|8823059|P1|FUP (Weeks 24-48)|Physician Decision|1
2549977|NCT01457924|8823055|P5|FUP (Weeks 24-48)|Adverse Event|0
2549978|NCT01457924|8823056|P4|FUP (Weeks 24-48)|Adverse Event|0
2549979|NCT01457924|8823057|P3|FUP (Weeks 24-48)|Adverse Event|1
2549980|NCT01457924|8823058|P2|FUP (Weeks 24-48)|Adverse Event|0
2549981|NCT01457924|8823059|P1|FUP (Weeks 24-48)|Adverse Event|0
2549982|NCT01457924|8823055|P5|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2
2549983|NCT01457924|8823056|P4|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
2549984|NCT01457924|8823057|P3|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
2549985|NCT01457924|8823058|P2|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
2549986|NCT01457924|8823059|P1|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
2549987|NCT01457924|8823055|P5|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
2549988|NCT01457924|8823056|P4|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
2549989|NCT01457924|8823057|P3|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
2549990|NCT01457924|8823058|P2|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
2549991|NCT01457924|8823059|P1|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
2549992|NCT01457924|8823055|P5|Treatment Phase (Weeks 0-24)|Protocol Violation|0
2549993|NCT01457924|8823056|P4|Treatment Phase (Weeks 0-24)|Protocol Violation|0
2549994|NCT01457924|8823057|P3|Treatment Phase (Weeks 0-24)|Protocol Violation|1
2549995|NCT01457924|8823058|P2|Treatment Phase (Weeks 0-24)|Protocol Violation|0
2549996|NCT01457924|8823059|P1|Treatment Phase (Weeks 0-24)|Protocol Violation|1
2549997|NCT01457924|8823055|P5|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
2549998|NCT01457924|8823056|P4|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
2549999|NCT01457924|8823057|P3|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
2550000|NCT01457924|8823058|P2|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
2550001|NCT01457924|8823059|P1|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1
2550002|NCT01457924|8823055|P5|Treatment Phase (Weeks 0-24)|Physician Decision|1
2550003|NCT01457924|8823056|P4|Treatment Phase (Weeks 0-24)|Physician Decision|0
2550004|NCT01457924|8823057|P3|Treatment Phase (Weeks 0-24)|Physician Decision|0
2550005|NCT01457924|8823058|P2|Treatment Phase (Weeks 0-24)|Physician Decision|0
2550006|NCT01457924|8823059|P1|Treatment Phase (Weeks 0-24)|Physician Decision|0
2550007|NCT01457924|8823055|P5|Treatment Phase (Weeks 0-24)|Adverse Event|2
2550008|NCT01457924|8823056|P4|Treatment Phase (Weeks 0-24)|Adverse Event|0
2550009|NCT01457924|8823057|P3|Treatment Phase (Weeks 0-24)|Adverse Event|1
2550010|NCT01457924|8823058|P2|Treatment Phase (Weeks 0-24)|Adverse Event|4
2550011|NCT01457924|8823059|P1|Treatment Phase (Weeks 0-24)|Adverse Event|0
2550012|NCT01457846|8823129|P2|Overall Study|Lost to Follow-up|0
2550013|NCT01457846|8823130|P1|Overall Study|Lost to Follow-up|1
2550014|NCT01457846|8823129|P2|Overall Study|Withdrawal by Subject|1
2550015|NCT01457846|8823130|P1|Overall Study|Withdrawal by Subject|1
2550016|NCT01457846|8823129|P2|Overall Study|Unclassified reason for not completed|10
2550017|NCT01457846|8823130|P1|Overall Study|Unclassified reason for not completed|11
2550018|NCT01457846|8823129|P2|Overall Study|Death|16
2550019|NCT01457846|8823130|P1|Overall Study|Death|27
2550020|NCT01457846|8823129|P2|Overall Study|Did not receive treatment|1
2550021|NCT01457846|8823130|P1|Overall Study|Did not receive treatment|0
2550022|NCT01457846|8823129|P2|Overall Study|Death before treatment|2
2550023|NCT01457846|8823130|P1|Overall Study|Death before treatment|1
2550024|NCT01457703|8823146|P2|Overall Study|Withdrawal by Subject|4
2550025|NCT01457703|8823147|P1|Overall Study|Withdrawal by Subject|1
2550026|NCT01457703|8823146|P2|Overall Study|Screen Failure|7
2550027|NCT01457703|8823147|P1|Overall Study|Screen Failure|5
2550028|NCT01457352|8823258|P2|Period 3|Sponsor's withdrawal|1
2550029|NCT01457352|8823259|P1|Period 3|Sponsor's withdrawal|0
2550030|NCT01457352|8823258|P2|Period 3|incorrect treatment|1
2550031|NCT01457352|8823259|P1|Period 3|incorrect treatment|0
2550032|NCT01457352|8823258|P2|Period 3|Withdrawal by Subject|2
2550033|NCT01457352|8823259|P1|Period 3|Withdrawal by Subject|0
2550034|NCT01457352|8823258|P2|Period 3|Adverse Event|1
2550035|NCT01457352|8823259|P1|Period 3|Adverse Event|1
2550036|NCT01457352|8823258|P2|Period 2|Did not meet eligibility criteria|0
2550037|NCT01457352|8823259|P1|Period 2|Did not meet eligibility criteria|3
2550038|NCT01457352|8823258|P2|Period 2|Physician Decision|0
2550039|NCT01457352|8823259|P1|Period 2|Physician Decision|1
2550040|NCT01457352|8823258|P2|Period 2|dose change|0
2550041|NCT01457352|8823259|P1|Period 2|dose change|1
2550042|NCT01457352|8823258|P2|Period 2|Lost to Follow-up|0
2550043|NCT01457352|8823259|P1|Period 2|Lost to Follow-up|1
2550044|NCT01457352|8823258|P2|Period 2|Sponsor's withdrawal|0
2550045|NCT01457352|8823259|P1|Period 2|Sponsor's withdrawal|7
2550046|NCT01457352|8823258|P2|Period 2|Protocol Violation|0
2550047|NCT01457352|8823259|P1|Period 2|Protocol Violation|4
2550048|NCT01457352|8823258|P2|Period 2|Lack of Efficacy|0
2550049|NCT01457352|8823259|P1|Period 2|Lack of Efficacy|8
2550050|NCT01457352|8823258|P2|Period 2|no analysis|0
2550051|NCT01457352|8823259|P1|Period 2|no analysis|10
2550052|NCT01457352|8823258|P2|Period 2|Adverse Event|0
2550053|NCT01457352|8823259|P1|Period 2|Adverse Event|22
2550054|NCT01457352|8823258|P2|Period 2|Withdrawal by Subject|0
2550055|NCT01457352|8823259|P1|Period 2|Withdrawal by Subject|23
2550056|NCT01457352|8823258|P2|Period 1|Did not meet eligibility criteria|0
2550057|NCT01457352|8823259|P1|Period 1|Did not meet eligibility criteria|3
2550058|NCT01457352|8823258|P2|Period 1|Protocol Violation|0
2550059|NCT01457352|8823259|P1|Period 1|Protocol Violation|4
2550060|NCT01457352|8823258|P2|Period 1|withdrew per sponsor|0
2550061|NCT01457352|8823259|P1|Period 1|withdrew per sponsor|1
2550062|NCT01457352|8823258|P2|Period 1|Withdrawn|0
2550063|NCT01457352|8823259|P1|Period 1|Withdrawn|1
2550064|NCT01457352|8823258|P2|Period 1|MS related disease progression|0
2550065|NCT01457352|8823259|P1|Period 1|MS related disease progression|1
2550066|NCT01457352|8823258|P2|Period 1|Physician Decision|0
2550067|NCT01457352|8823259|P1|Period 1|Physician Decision|2
2550068|NCT01457352|8823258|P2|Period 1|Withdrawal by Subject|0
2550069|NCT01457352|8823259|P1|Period 1|Withdrawal by Subject|2
2550070|NCT01457352|8823258|P2|Period 1|Adverse Event|0
2550071|NCT01457352|8823259|P1|Period 1|Adverse Event|2
2550072|NCT01457339|8823271|P2|Period 6 (250 mg)|Personal appointment|1
2550073|NCT01457339|8823272|P1|Period 6 (250 mg)|Personal appointment|0
2550074|NCT01457339|8823271|P2|Period 6 (250 mg)|Family Emergency|0
2550075|NCT01457339|8823272|P1|Period 6 (250 mg)|Family Emergency|1
2550076|NCT01457339|8823271|P2|Period 5 (200 mg)|Met stopping criteria for PANSS score|1
2550077|NCT01457339|8823272|P1|Period 5 (200 mg)|Met stopping criteria for PANSS score|0
2550078|NCT01457339|8823271|P2|Period 3 (100 mg)|Adverse Event|1
2550079|NCT01457339|8823272|P1|Period 3 (100 mg)|Adverse Event|0
2550080|NCT01457053|8823444|P2|Overall Study|Unable to undergo selected treatment|1
2550081|NCT01457053|8823445|P1|Overall Study|Unable to undergo selected treatment|1
2550082|NCT01457014|8823451|P4|First Night|Withdrawal by Subject|0
2550083|NCT01457014|8823452|P3|First Night|Withdrawal by Subject|0
2550084|NCT01457014|8823453|P2|First Night|Withdrawal by Subject|0
2550085|NCT01457014|8823454|P1|First Night|Withdrawal by Subject|3
2550086|NCT01457014|8823451|P4|First Night|Didn't meet inclusion/exclusion criteria|0
2550087|NCT01457014|8823452|P3|First Night|Didn't meet inclusion/exclusion criteria|0
2550088|NCT01457014|8823453|P2|First Night|Didn't meet inclusion/exclusion criteria|0
2550089|NCT01457014|8823454|P1|First Night|Didn't meet inclusion/exclusion criteria|37
2550090|NCT01456962|8823471|P2|Overall Study|Lost to Follow-up|1
2550091|NCT01456962|8823472|P1|Overall Study|Lost to Follow-up|2
2550092|NCT01456949|8823478|P1|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4
2550093|NCT01456949|8823478|P1|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6
2550094|NCT01456949|8823478|P1|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2
2550095|NCT01456949|8823478|P1|Study Cryoablation Procedure & Follow-up|Subject Relocation|10
2550096|NCT01456949|8823478|P1|Study Cryoablation Procedure & Follow-up|Physician Decision|1
2550097|NCT01456949|8823478|P1|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11
2550098|NCT01456949|8823478|P1|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23
2550099|NCT01456949|8823478|P1|Study Cryoablation Procedure & Follow-up|Death|5
2550100|NCT01456949|8823478|P1|Enrollment|Withdrawal by Subject|7
2550101|NCT01456949|8823478|P1|Enrollment|Physician Decision|10
2550102|NCT01456949|8823478|P1|Enrollment|I/E criteria not met prior to procedure|13
2550103|NCT01456949|8823478|P1|Enrollment|Death|1
2550104|NCT01456949|8823478|P1|Enrollment|PI death- incomplete data|6
2550105|NCT01456936|8823489|P4|Overall Study|Randomized but not treated|21
2550106|NCT01456936|8823490|P3|Overall Study|Randomized but not treated|16
2550107|NCT01456936|8823491|P2|Overall Study|Randomized but not treated|28
2550108|NCT01456936|8823492|P1|Overall Study|Randomized but not treated|21
2550109|NCT01456936|8823489|P4|Overall Study|Death|3
2550110|NCT01456936|8823490|P3|Overall Study|Death|1
2550111|NCT01456936|8823491|P2|Overall Study|Death|3
2550112|NCT01456936|8823492|P1|Overall Study|Death|0
2550113|NCT01456936|8823489|P4|Overall Study|Adverse event (study drug unrelated)|9
2550114|NCT01456936|8823490|P3|Overall Study|Adverse event (study drug unrelated)|9
2550115|NCT01456936|8823491|P2|Overall Study|Adverse event (study drug unrelated)|7
2550116|NCT01456936|8823492|P1|Overall Study|Adverse event (study drug unrelated)|9
2550117|NCT01456936|8823489|P4|Overall Study|Adverse event (study drug)|17
2550118|NCT01456936|8823490|P3|Overall Study|Adverse event (study drug)|26
2550119|NCT01456936|8823491|P2|Overall Study|Adverse event (study drug)|21
2550120|NCT01456936|8823492|P1|Overall Study|Adverse event (study drug)|25
2550121|NCT01456936|8823489|P4|Overall Study|Medication error|1
2550122|NCT01456936|8823490|P3|Overall Study|Medication error|0
2550123|NCT01456936|8823491|P2|Overall Study|Medication error|1
2550124|NCT01456936|8823492|P1|Overall Study|Medication error|0
2550125|NCT01456936|8823489|P4|Overall Study|Lost to Follow-up|127
2550126|NCT01456936|8823490|P3|Overall Study|Lost to Follow-up|144
2550127|NCT01456936|8823491|P2|Overall Study|Lost to Follow-up|126
2550128|NCT01456936|8823492|P1|Overall Study|Lost to Follow-up|135
2550129|NCT01456936|8823489|P4|Overall Study|No longer willing to participate|248
2550130|NCT01456936|8823490|P3|Overall Study|No longer willing to participate|224
2550131|NCT01456936|8823491|P2|Overall Study|No longer willing to participate|218
2550132|NCT01456936|8823492|P1|Overall Study|No longer willing to participate|195
2550133|NCT01456936|8823489|P4|Overall Study|Insufficient clinical response|13
2550134|NCT01456936|8823490|P3|Overall Study|Insufficient clinical response|14
2550135|NCT01456936|8823491|P2|Overall Study|Insufficient clinical response|4
2550136|NCT01456936|8823492|P1|Overall Study|Insufficient clinical response|4
2550137|NCT01456936|8823489|P4|Overall Study|Pregnancy|1
2550138|NCT01456936|8823490|P3|Overall Study|Pregnancy|0
2550139|NCT01456936|8823491|P2|Overall Study|Pregnancy|0
2550140|NCT01456936|8823492|P1|Overall Study|Pregnancy|1
2550141|NCT01456936|8823489|P4|Overall Study|Protocol Violation|5
2550142|NCT01456936|8823490|P3|Overall Study|Protocol Violation|5
2550143|NCT01456936|8823491|P2|Overall Study|Protocol Violation|2
2550144|NCT01456936|8823492|P1|Overall Study|Protocol Violation|4
2550145|NCT01456936|8823489|P4|Overall Study|No longer meets eligibility criteria|5
2550146|NCT01456936|8823490|P3|Overall Study|No longer meets eligibility criteria|6
2550147|NCT01456936|8823491|P2|Overall Study|No longer meets eligibility criteria|8
2550148|NCT01456936|8823492|P1|Overall Study|No longer meets eligibility criteria|4
2550149|NCT01456936|8823489|P4|Overall Study|Other reason|33
2550150|NCT01456936|8823490|P3|Overall Study|Other reason|36
2550151|NCT01456936|8823491|P2|Overall Study|Other reason|30
2550152|NCT01456936|8823492|P1|Overall Study|Other reason|41
2550153|NCT01456897|8823600|P2|Overall Study|Lack of Efficacy|11
2550154|NCT01456897|8823601|P1|Overall Study|Lack of Efficacy|4
2550155|NCT01456897|8823600|P2|Overall Study|Withdrawal by Subject|17
2550156|NCT01456897|8823601|P1|Overall Study|Withdrawal by Subject|44
2550157|NCT01456897|8823600|P2|Overall Study|Physician Decision|3
2550158|NCT01456897|8823601|P1|Overall Study|Physician Decision|5
2550159|NCT01456897|8823600|P2|Overall Study|Protocol Violation|4
2550160|NCT01456897|8823601|P1|Overall Study|Protocol Violation|3
2550161|NCT01456897|8823600|P2|Overall Study|Adverse Event|22
2550162|NCT01456897|8823601|P1|Overall Study|Adverse Event|19
2550163|NCT01456780|8823620|P3|Overall Study|Lost to Follow-up|0
2550164|NCT01456780|8823621|P2|Overall Study|Lost to Follow-up|3
2550165|NCT01456780|8823622|P1|Overall Study|Lost to Follow-up|3
2550166|NCT01456221|8823671|P2|Overall Study|Incomplete data|2
2550167|NCT01456221|8823672|P1|Overall Study|Incomplete data|4
2550168|NCT01456221|8823671|P2|Overall Study|Received medication|2
2550169|NCT01456221|8823672|P1|Overall Study|Received medication|3
2550170|NCT01456221|8823671|P2|Overall Study|Lost to Follow-up|4
2550171|NCT01456221|8823672|P1|Overall Study|Lost to Follow-up|1
2550172|NCT01456221|8823671|P2|Overall Study|Withdrawal by Subject|49
2550173|NCT01456221|8823672|P1|Overall Study|Withdrawal by Subject|56
2550174|NCT01456195|8823687|P3|Overall Study|Other Reasons|3
2550175|NCT01456195|8823688|P2|Overall Study|Other Reasons|1
2550176|NCT01456195|8823689|P1|Overall Study|Other Reasons|2
2550177|NCT01456195|8823687|P3|Overall Study|Lack of Efficacy|0
2550178|NCT01456195|8823688|P2|Overall Study|Lack of Efficacy|1
2550179|NCT01456195|8823689|P1|Overall Study|Lack of Efficacy|0
2550180|NCT01456195|8823687|P3|Overall Study|Voluntary Withdrawal|7
2550181|NCT01456195|8823688|P2|Overall Study|Voluntary Withdrawal|3
2550182|NCT01456195|8823689|P1|Overall Study|Voluntary Withdrawal|5
2550183|NCT01456195|8823687|P3|Overall Study|Lost to Follow-up|3
2550184|NCT01456195|8823688|P2|Overall Study|Lost to Follow-up|1
2550185|NCT01456195|8823689|P1|Overall Study|Lost to Follow-up|3
2550186|NCT01456195|8823687|P3|Overall Study|Pretreatment Event/Adverse Event|1
2550187|NCT01456195|8823688|P2|Overall Study|Pretreatment Event/Adverse Event|4
2550188|NCT01456195|8823689|P1|Overall Study|Pretreatment Event/Adverse Event|1
2550189|NCT01456169|8823709|P3|Overall Study|Other|0
2550190|NCT01456169|8823710|P2|Overall Study|Other|1
2550191|NCT01456169|8823711|P1|Overall Study|Other|1
2550192|NCT01456169|8823709|P3|Overall Study|Lack of Efficacy|0
2550193|NCT01456169|8823710|P2|Overall Study|Lack of Efficacy|0
2550194|NCT01456169|8823711|P1|Overall Study|Lack of Efficacy|2
2550195|NCT01456169|8823709|P3|Overall Study|Voluntary Withdrawal|2
2550196|NCT01456169|8823710|P2|Overall Study|Voluntary Withdrawal|0
2550197|NCT01456169|8823711|P1|Overall Study|Voluntary Withdrawal|3
2550198|NCT01456169|8823709|P3|Overall Study|Major Protocol Deviation|3
2550199|NCT01456169|8823710|P2|Overall Study|Major Protocol Deviation|2
2550200|NCT01456169|8823711|P1|Overall Study|Major Protocol Deviation|3
2550201|NCT01456169|8823709|P3|Overall Study|Adverse Event|7
2550202|NCT01456169|8823710|P2|Overall Study|Adverse Event|2
2550203|NCT01456169|8823711|P1|Overall Study|Adverse Event|1
2550204|NCT01456130|8823771|P1|Overall Study|Other|1
2550205|NCT01456130|8823771|P1|Overall Study|Lack of Efficacy|4
2550206|NCT01456130|8823771|P1|Overall Study|Voluntary Withdrawal|1
2550207|NCT01456130|8823771|P1|Overall Study|Adverse Event|4
2550208|NCT01456052|8823781|P3|Overall Study|Treatment Failure|1
2550209|NCT01456052|8823782|P2|Overall Study|Treatment Failure|1
2550210|NCT01456052|8823783|P1|Overall Study|Treatment Failure|0
2550211|NCT01456052|8823781|P3|Overall Study|Physician Decision|1
2550212|NCT01456052|8823782|P2|Overall Study|Physician Decision|0
2550213|NCT01456052|8823783|P1|Overall Study|Physician Decision|1
2550214|NCT01456052|8823781|P3|Overall Study|Protocol Violation|0
2550215|NCT01456052|8823782|P2|Overall Study|Protocol Violation|1
2550216|NCT01456052|8823783|P1|Overall Study|Protocol Violation|0
2550217|NCT01456052|8823781|P3|Overall Study|Consent withdrawn|1
2550218|NCT01456052|8823782|P2|Overall Study|Consent withdrawn|2
2550219|NCT01456052|8823783|P1|Overall Study|Consent withdrawn|0
2550220|NCT01456052|8823781|P3|Overall Study|Adverse Event|2
2550221|NCT01456052|8823782|P2|Overall Study|Adverse Event|1
2550222|NCT01456052|8823783|P1|Overall Study|Adverse Event|1
2550223|NCT01456039|8823803|P3|Phase 2 (Second Step)|Other|1
2550224|NCT01456039|8823804|P2|Phase 2 (Second Step)|Other|0
2550225|NCT01456039|8823805|P1|Phase 2 (Second Step)|Other|0
2550226|NCT01456039|8823803|P3|Phase 2 (Second Step)|Protocol Violation|1
2550227|NCT01456039|8823804|P2|Phase 2 (Second Step)|Protocol Violation|0
2550228|NCT01456039|8823805|P1|Phase 2 (Second Step)|Protocol Violation|0
2550229|NCT01456039|8823803|P3|Phase 2 (Second Step)|Withdrawal by Subject|4
2550230|NCT01456039|8823804|P2|Phase 2 (Second Step)|Withdrawal by Subject|0
2550231|NCT01456039|8823805|P1|Phase 2 (Second Step)|Withdrawal by Subject|0
2550232|NCT01456039|8823803|P3|Phase 2 (Second Step)|Adverse Event|10
2550233|NCT01456039|8823804|P2|Phase 2 (Second Step)|Adverse Event|0
2550234|NCT01456039|8823805|P1|Phase 2 (Second Step)|Adverse Event|0
2550235|NCT01456039|8823803|P3|Phase 2 (Second Step)|Disease Progression|17
2550236|NCT01456039|8823804|P2|Phase 2 (Second Step)|Disease Progression|0
2550237|NCT01456039|8823805|P1|Phase 2 (Second Step)|Disease Progression|0
2550238|NCT01456039|8823803|P3|Phase 1 (First Step)|Other|0
2550239|NCT01456039|8823804|P2|Phase 1 (First Step)|Other|1
2550240|NCT01456039|8823805|P1|Phase 1 (First Step)|Other|0
2550241|NCT01456039|8823803|P3|Phase 1 (First Step)|Adverse Event|0
2550242|NCT01456039|8823804|P2|Phase 1 (First Step)|Adverse Event|3
2550243|NCT01456039|8823805|P1|Phase 1 (First Step)|Adverse Event|0
2550244|NCT01456039|8823803|P3|Phase 1 (First Step)|Withdrawal by Subject|0
2550245|NCT01456039|8823804|P2|Phase 1 (First Step)|Withdrawal by Subject|2
2550246|NCT01456039|8823805|P1|Phase 1 (First Step)|Withdrawal by Subject|1
2550247|NCT01456039|8823803|P3|Phase 1 (First Step)|Disease Progression|0
2550248|NCT01456039|8823804|P2|Phase 1 (First Step)|Disease Progression|1
2550249|NCT01456039|8823805|P1|Phase 1 (First Step)|Disease Progression|1
2550250|NCT01455428|8823948|P2|Overall Study|Other|4
2550251|NCT01455428|8823949|P1|Overall Study|Other|2
2550252|NCT01455428|8823948|P2|Overall Study|Did not receive treatment|1
2550253|NCT01455428|8823949|P1|Overall Study|Did not receive treatment|1
2550254|NCT01455428|8823948|P2|Overall Study|Insufficient clinical response|2
2550255|NCT01455428|8823949|P1|Overall Study|Insufficient clinical response|0
2550256|NCT01455428|8823948|P2|Overall Study|Did not meet entrance criteria|2
2550257|NCT01455428|8823949|P1|Overall Study|Did not meet entrance criteria|0
2550258|NCT01455428|8823948|P2|Overall Study|Withdrawal by Subject|5
2550259|NCT01455428|8823949|P1|Overall Study|Withdrawal by Subject|2
2550260|NCT01455428|8823948|P2|Overall Study|Lost to Follow-up|1
2550261|NCT01455428|8823949|P1|Overall Study|Lost to Follow-up|1
2550262|NCT01455428|8823948|P2|Overall Study|Adverse Event|2
2550263|NCT01455428|8823949|P1|Overall Study|Adverse Event|6
2550264|NCT01455428|8823948|P2|Overall Study|Protocol Violation|1
2550265|NCT01455428|8823949|P1|Overall Study|Protocol Violation|2
2550266|NCT01455415|8824005|P2|Follow-up|Unspecified Reason|0
2550267|NCT01455415|8824006|P1|Follow-up|Unspecified Reason|1
2550268|NCT01455415|8824005|P2|Follow-up|Withdrawal by Subject|0
2550269|NCT01455415|8824006|P1|Follow-up|Withdrawal by Subject|2
2550270|NCT01455415|8824005|P2|Follow-up|Lack of Efficacy|1
2550271|NCT01455415|8824006|P1|Follow-up|Lack of Efficacy|0
2550272|NCT01455415|8824005|P2|Follow-up|AE Related to Study Drug|1
2550273|NCT01455415|8824006|P1|Follow-up|AE Related to Study Drug|0
2550274|NCT01455415|8824005|P2|Period 2|Protocol Violation|0
2550275|NCT01455415|8824006|P1|Period 2|Protocol Violation|2
2550276|NCT01455415|8824005|P2|Period 2|Unspecified Reason|3
2550277|NCT01455415|8824006|P1|Period 2|Unspecified Reason|2
2550278|NCT01455415|8824005|P2|Period 2|Withdrawal by Subject|3
2550279|NCT01455415|8824006|P1|Period 2|Withdrawal by Subject|2
2550280|NCT01455415|8824005|P2|Period 2|Lack of Efficacy|0
2550281|NCT01455415|8824006|P1|Period 2|Lack of Efficacy|2
2550282|NCT01455415|8824005|P2|Period 2|AE Not Related to Study Drug|1
2550283|NCT01455415|8824006|P1|Period 2|AE Not Related to Study Drug|2
2550284|NCT01455415|8824005|P2|Period 2|Lost to Follow-up|1
2550285|NCT01455415|8824006|P1|Period 2|Lost to Follow-up|2
2550286|NCT01455415|8824005|P2|Period 2|AE Related to Study Drug|2
2550287|NCT01455415|8824006|P1|Period 2|AE Related to Study Drug|1
2550288|NCT01455415|8824005|P2|Washout|Protocol Violation|1
2550289|NCT01455415|8824006|P1|Washout|Protocol Violation|0
2550290|NCT01455415|8824005|P2|Washout|Unspecified Reason|2
2550291|NCT01455415|8824006|P1|Washout|Unspecified Reason|1
2550292|NCT01455415|8824005|P2|Washout|AE Not Related to Study Drug|3
2550293|NCT01455415|8824006|P1|Washout|AE Not Related to Study Drug|2
2550294|NCT01455415|8824005|P2|Washout|Drug Error not Associated to AE|1
2550295|NCT01455415|8824006|P1|Washout|Drug Error not Associated to AE|2
2550296|NCT01455415|8824005|P2|Washout|Lost to Follow-up|0
2550297|NCT01455415|8824006|P1|Washout|Lost to Follow-up|1
2550298|NCT01455415|8824005|P2|Washout|AE Related to Study Drug|0
2550299|NCT01455415|8824006|P1|Washout|AE Related to Study Drug|2
2550300|NCT01455415|8824005|P2|Period 1|Protocol Violation|2
2550301|NCT01455415|8824006|P1|Period 1|Protocol Violation|0
2550302|NCT01455415|8824005|P2|Period 1|Unspecified Reason|1
2550303|NCT01455415|8824006|P1|Period 1|Unspecified Reason|1
2550304|NCT01455415|8824005|P2|Period 1|Withdrawal by Subject|5
2550305|NCT01455415|8824006|P1|Period 1|Withdrawal by Subject|4
2550306|NCT01455415|8824005|P2|Period 1|AE Not Related to Study Drug|6
2550307|NCT01455415|8824006|P1|Period 1|AE Not Related to Study Drug|2
2550308|NCT01455415|8824005|P2|Period 1|Drug Error not Associated to AE|1
2550309|NCT01455415|8824006|P1|Period 1|Drug Error not Associated to AE|0
2550310|NCT01455415|8824005|P2|Period 1|Lost To Follow-up Related to Study Drug|3
2550311|NCT01455415|8824006|P1|Period 1|Lost To Follow-up Related to Study Drug|3
2550312|NCT01455415|8824005|P2|Period 1|Adverse Event (AE) Related to Study Drug|6
2550313|NCT01455415|8824006|P1|Period 1|Adverse Event (AE) Related to Study Drug|9
2550314|NCT01455220|8824056|P1|Overall Study|screen fail|30
2550315|NCT01455194|8824066|P4|Overall Study|Miscellaneous|4
2550316|NCT01455194|8824067|P3|Overall Study|Miscellaneous|1
2550317|NCT01455194|8824068|P2|Overall Study|Miscellaneous|5
2550318|NCT01455194|8824069|P1|Overall Study|Miscellaneous|4
2550319|NCT01455194|8824066|P4|Overall Study|Discontinuation criterion fulfilled|2
2550320|NCT01455194|8824067|P3|Overall Study|Discontinuation criterion fulfilled|0
2550321|NCT01455194|8824068|P2|Overall Study|Discontinuation criterion fulfilled|2
2550322|NCT01455194|8824069|P1|Overall Study|Discontinuation criterion fulfilled|3
2550323|NCT01455194|8824066|P4|Overall Study|Pregnancy|0
2550324|NCT01455194|8824067|P3|Overall Study|Pregnancy|1
2550325|NCT01455194|8824068|P2|Overall Study|Pregnancy|1
2550326|NCT01455194|8824069|P1|Overall Study|Pregnancy|0
2550327|NCT01455194|8824066|P4|Overall Study|Lost to Follow-up|1
2550328|NCT01455194|8824067|P3|Overall Study|Lost to Follow-up|1
2550329|NCT01455194|8824068|P2|Overall Study|Lost to Follow-up|0
2550330|NCT01455194|8824069|P1|Overall Study|Lost to Follow-up|2
2550331|NCT01455194|8824066|P4|Overall Study|Withdrawal by Subject|9
2550332|NCT01455194|8824067|P3|Overall Study|Withdrawal by Subject|12
2550333|NCT01455194|8824068|P2|Overall Study|Withdrawal by Subject|16
2550334|NCT01455194|8824069|P1|Overall Study|Withdrawal by Subject|21
2550335|NCT01455194|8824066|P4|Overall Study|Adverse Event|3
2550336|NCT01455194|8824067|P3|Overall Study|Adverse Event|1
2550337|NCT01455194|8824068|P2|Overall Study|Adverse Event|1
2550338|NCT01455194|8824069|P1|Overall Study|Adverse Event|1
2550339|NCT01455194|8824066|P4|Overall Study|Deterioration in asthma|9
2550340|NCT01455194|8824067|P3|Overall Study|Deterioration in asthma|14
2550341|NCT01455194|8824068|P2|Overall Study|Deterioration in asthma|6
2550342|NCT01455194|8824069|P1|Overall Study|Deterioration in asthma|12
2550343|NCT01455194|8824066|P4|Overall Study|Randomisation Failure|0
2550344|NCT01455194|8824067|P3|Overall Study|Randomisation Failure|0
2550345|NCT01455194|8824068|P2|Overall Study|Randomisation Failure|0
2550346|NCT01455194|8824069|P1|Overall Study|Randomisation Failure|90
2550347|NCT01455194|8824066|P4|Overall Study|Screen Failure|0
2550348|NCT01455194|8824067|P3|Overall Study|Screen Failure|0
2550349|NCT01455194|8824068|P2|Overall Study|Screen Failure|0
2550350|NCT01455194|8824069|P1|Overall Study|Screen Failure|20
2550351|NCT01455012|8824132|P2|Overall Study|Unknown reason|0
2550352|NCT01455012|8824133|P1|Overall Study|Unknown reason|2
2550353|NCT01455012|8824132|P2|Overall Study|Withdrawal by Subject|1
2550354|NCT01455012|8824133|P1|Overall Study|Withdrawal by Subject|3
2550355|NCT01455012|8824132|P2|Overall Study|Lack of Efficacy|1
2550356|NCT01455012|8824133|P1|Overall Study|Lack of Efficacy|6
2550357|NCT01455012|8824132|P2|Overall Study|Adverse Event|2
2550358|NCT01455012|8824133|P1|Overall Study|Adverse Event|0
2550359|NCT01454934|8824200|P2|Overall Study|Not treated|2
2550360|NCT01454934|8824201|P1|Overall Study|Not treated|1
2550361|NCT01454934|8824200|P2|Overall Study|Lost to Follow-up|1
2550362|NCT01454934|8824201|P1|Overall Study|Lost to Follow-up|0
2550363|NCT01454934|8824200|P2|Overall Study|Disease progression|181
2550364|NCT01454934|8824201|P1|Overall Study|Disease progression|194
2550365|NCT01454934|8824200|P2|Overall Study|Withdrawal by Subject|15
2550366|NCT01454934|8824201|P1|Overall Study|Withdrawal by Subject|11
2550367|NCT01454934|8824200|P2|Overall Study|Withdrawn consent|5
2550368|NCT01454934|8824201|P1|Overall Study|Withdrawn consent|2
2550369|NCT01454934|8824200|P2|Overall Study|Adverse Event|24
2550370|NCT01454934|8824201|P1|Overall Study|Adverse Event|28
2550371|NCT01454934|8824200|P2|Overall Study|Other|17
2550372|NCT01454934|8824201|P1|Overall Study|Other|6
2550373|NCT01454934|8824200|P2|Overall Study|Clinical progression|25
2550374|NCT01454934|8824201|P1|Overall Study|Clinical progression|28
2550375|NCT01454830|8824213|P2|Overall Study|Withdrawal - no polysomnography|2
2550376|NCT01454830|8824214|P1|Overall Study|Withdrawal - no polysomnography|3
2550377|NCT01454830|8824213|P2|Overall Study|Post-allocation Exclude-other treatment|7
2550378|NCT01454830|8824214|P1|Overall Study|Post-allocation Exclude-other treatment|6
2550379|NCT01454830|8824213|P2|Overall Study|Post-allocation Exclude-refused PAP|2
2550380|NCT01454830|8824214|P1|Overall Study|Post-allocation Exclude-refused PAP|0
2550381|NCT01454830|8824213|P2|Overall Study|Post-allocation Exclude- AHI<10|12
2550382|NCT01454830|8824214|P1|Overall Study|Post-allocation Exclude- AHI<10|18
2550383|NCT01454830|8824213|P2|Overall Study|Withdrawal by Subject|4
2550384|NCT01454830|8824214|P1|Overall Study|Withdrawal by Subject|4
2550385|NCT01454778|8824245|P1|Overall Study|Death|1
2550386|NCT01454778|8824245|P1|Overall Study|Lost to Follow-up|2
2550387|NCT01454739|8824256|P2|Overall Study|Adverse Event|1
2550388|NCT01454739|8824257|P1|Overall Study|Adverse Event|0
2550389|NCT01454739|8824256|P2|Overall Study|Lost to Follow-up|1
2550390|NCT01454739|8824257|P1|Overall Study|Lost to Follow-up|0
2550391|NCT01454739|8824256|P2|Overall Study|Physician Decision|5
2550392|NCT01454739|8824257|P1|Overall Study|Physician Decision|0
2550393|NCT01454739|8824256|P2|Overall Study|Other|5
2550394|NCT01454739|8824257|P1|Overall Study|Other|3
2550395|NCT01454739|8824256|P2|Overall Study|Withdrawal by Subject|6
2550396|NCT01454739|8824257|P1|Overall Study|Withdrawal by Subject|2
2550397|NCT01454739|8824256|P2|Overall Study|Protocol Violation|3
2550398|NCT01454739|8824257|P1|Overall Study|Protocol Violation|2
2550399|NCT01454726|8824286|P2|Overall Study|Withdrawal by Subject|1
2550400|NCT01454726|8824287|P1|Overall Study|Withdrawal by Subject|0
2550401|NCT01454596|8824305|P12|Overall Study|Death|0
2550402|NCT01454596|8824306|P11|Overall Study|Death|1
2550403|NCT01454596|8824307|P10|Overall Study|Death|1
2550404|NCT01454596|8824308|P9|Overall Study|Death|0
2550405|NCT01454596|8824309|P8|Overall Study|Death|0
2550406|NCT01454596|8824310|P7|Overall Study|Death|0
2550407|NCT01454596|8824311|P6|Overall Study|Death|0
2550408|NCT01454596|8824312|P5|Overall Study|Death|0
2550409|NCT01454596|8824313|P4|Overall Study|Death|0
2550410|NCT01454596|8824314|P3|Overall Study|Death|0
2550411|NCT01454596|8824315|P2|Overall Study|Death|0
2550412|NCT01454596|8824316|P1|Overall Study|Death|0
2550413|NCT01454583|8824393|P3|3rd Year|Lost to Follow-up|297
2550414|NCT01454583|8824394|P2|3rd Year|Lost to Follow-up|512
2550415|NCT01454583|8824395|P1|3rd Year|Lost to Follow-up|1959
2550416|NCT01454583|8824393|P3|2nd Year|Lost to Follow-up|737
2550417|NCT01454583|8824394|P2|2nd Year|Lost to Follow-up|1049
2550418|NCT01454583|8824395|P1|2nd Year|Lost to Follow-up|3965
2550419|NCT01454583|8824393|P3|1st Year|Lost to Follow-up|180
2550420|NCT01454583|8824394|P2|1st Year|Lost to Follow-up|318
2550421|NCT01454583|8824395|P1|1st Year|Lost to Follow-up|1057
2550422|NCT01454531|8824463|P1|Overall Study|Other|1
2550423|NCT01454531|8824463|P1|Overall Study|Delay in IMP administration|1
2550424|NCT01454531|8824463|P1|Overall Study|Physician Decision|1
2550425|NCT01454531|8824463|P1|Overall Study|Lost to Follow-up|1
2550426|NCT01454531|8824463|P1|Overall Study|Withdrawal by Subject|5
2550427|NCT01454531|8824463|P1|Overall Study|Adverse Event|14
2550428|NCT01454401|8824499|P1|Overall Study|non-adherence|1
2550429|NCT01454401|8824499|P1|Overall Study|osteomyelitis|2
2550430|NCT01454401|8824499|P1|Overall Study|hospitalised|1
2550431|NCT01454401|8824499|P1|Overall Study|Death|1
2550432|NCT01454284|8824523|P2|Overall Study|Sponsor Decision|2
2550433|NCT01454284|8824524|P1|Overall Study|Sponsor Decision|0
2550434|NCT01454284|8824523|P2|Overall Study|Physician Decision|11
2550435|NCT01454284|8824524|P1|Overall Study|Physician Decision|16
2550436|NCT01454284|8824523|P2|Overall Study|Withdrawal by Subject|36
2550437|NCT01454284|8824524|P1|Overall Study|Withdrawal by Subject|58
2550438|NCT01454284|8824523|P2|Overall Study|Protocol Violation|6
2550439|NCT01454284|8824524|P1|Overall Study|Protocol Violation|9
2550440|NCT01454284|8824523|P2|Overall Study|Lost to Follow-up|8
2550441|NCT01454284|8824524|P1|Overall Study|Lost to Follow-up|13
2550442|NCT01454284|8824523|P2|Overall Study|Death|3
2550443|NCT01454284|8824524|P1|Overall Study|Death|0
2550444|NCT01454284|8824523|P2|Overall Study|Adverse Event|7
2550445|NCT01454284|8824524|P1|Overall Study|Adverse Event|20
2550446|NCT01454102|8824594|P16|Overall Study|Continuing in the treatment period|1
2550447|NCT01454102|8824595|P15|Overall Study|Continuing in the treatment period|3
2550448|NCT01454102|8824596|P14|Overall Study|Continuing in the treatment period|4
2550449|NCT01454102|8824597|P13|Overall Study|Continuing in the treatment period|7
2550450|NCT01454102|8824598|P12|Overall Study|Continuing in the treatment period|4
2550451|NCT01454102|8824599|P11|Overall Study|Continuing in the treatment period|0
2550452|NCT01454102|8824600|P10|Overall Study|Continuing in the treatment period|0
2550453|NCT01454102|8824601|P9|Overall Study|Continuing in the treatment period|1
2550454|NCT01454102|8824602|P8|Overall Study|Continuing in the treatment period|0
2550455|NCT01454102|8824603|P7|Overall Study|Continuing in the treatment period|2
2550456|NCT01454102|8824604|P6|Overall Study|Continuing in the treatment period|3
2550457|NCT01454102|8824605|P5|Overall Study|Continuing in the treatment period|3
2550458|NCT01454102|8824606|P4|Overall Study|Continuing in the treatment period|0
2550459|NCT01454102|8824607|P3|Overall Study|Continuing in the treatment period|0
2550460|NCT01454102|8824608|P2|Overall Study|Continuing in the treatment period|0
2550461|NCT01454102|8824609|P1|Overall Study|Continuing in the treatment period|0
2550462|NCT01454076|8824729|P5|Overall Study|Adverse Event|2
2550463|NCT01454076|8824730|P4|Overall Study|Adverse Event|0
2550464|NCT01454076|8824731|P3|Overall Study|Adverse Event|7
2550465|NCT01454076|8824732|P2|Overall Study|Adverse Event|2
2550466|NCT01454076|8824733|P1|Overall Study|Adverse Event|8
2550467|NCT01454076|8824729|P5|Overall Study|Withdrawal by Subject|2
2550468|NCT01454076|8824730|P4|Overall Study|Withdrawal by Subject|1
2550469|NCT01454076|8824731|P3|Overall Study|Withdrawal by Subject|2
2550470|NCT01454076|8824732|P2|Overall Study|Withdrawal by Subject|4
2550471|NCT01454076|8824733|P1|Overall Study|Withdrawal by Subject|3
2550472|NCT01454076|8824729|P5|Overall Study|Other|2
2550473|NCT01454076|8824730|P4|Overall Study|Other|1
2550474|NCT01454076|8824731|P3|Overall Study|Other|0
2550475|NCT01454076|8824732|P2|Overall Study|Other|0
2550476|NCT01454076|8824733|P1|Overall Study|Other|2
2550477|NCT01454063|8824786|P2|Randomized|Protocol Violation|1
2550478|NCT01454063|8824787|P1|Randomized|Protocol Violation|0
2550479|NCT01454063|8824786|P2|Randomized|Adverse Event|1
2550480|NCT01454063|8824787|P1|Randomized|Adverse Event|1
2550481|NCT01453998|8824808|P3|After Protocol Amendment 2.|Withdrawal by Subject|0
2550482|NCT01453998|8824809|P2|After Protocol Amendment 2.|Withdrawal by Subject|0
2550483|NCT01453998|8824810|P1|After Protocol Amendment 2.|Withdrawal by Subject|1
2550484|NCT01453946|8824875|P1|Overall Study|Adverse Event|3
2550485|NCT01453946|8824875|P1|Overall Study|Lack of Efficacy|3
2550486|NCT01453946|8824875|P1|Overall Study|Protocol Violation|2
2550487|NCT01453946|8824875|P1|Overall Study|Did not receive drug for the taper phase|1
2550488|NCT01453855|8824892|P2|Overall Study|Other|1
2550489|NCT01453855|8824893|P1|Overall Study|Other|0
2550490|NCT01453855|8824892|P2|Overall Study|Inadequate Control of IOP|5
2550491|NCT01453855|8824893|P1|Overall Study|Inadequate Control of IOP|1
2550492|NCT01453855|8824892|P2|Overall Study|Noncompliance|0
2550493|NCT01453855|8824893|P1|Overall Study|Noncompliance|1
2550494|NCT01453855|8824892|P2|Overall Study|Patient Decision Unrel to Adverse Event|3
2550495|NCT01453855|8824893|P1|Overall Study|Patient Decision Unrel to Adverse Event|3
2550496|NCT01453855|8824892|P2|Overall Study|Lost to Follow-up|1
2550497|NCT01453855|8824893|P1|Overall Study|Lost to Follow-up|2
2550498|NCT01453855|8824892|P2|Overall Study|Adverse Event|4
2550499|NCT01453855|8824893|P1|Overall Study|Adverse Event|3
2550500|NCT01453725|8824901|P2|Overall Study|Physician Decision|1
2550501|NCT01453725|8824902|P1|Overall Study|Physician Decision|1
2550502|NCT01453725|8824901|P2|Overall Study|Pregnancy|0
2550503|NCT01453725|8824902|P1|Overall Study|Pregnancy|1
2550504|NCT01453725|8824901|P2|Overall Study|Pregnancy Wish|2
2550505|NCT01453725|8824902|P1|Overall Study|Pregnancy Wish|0
2550506|NCT01453725|8824901|P2|Overall Study|Withdrawal by Subject|3
2550507|NCT01453725|8824902|P1|Overall Study|Withdrawal by Subject|2
2550508|NCT01453725|8824901|P2|Overall Study|Protocol Violation|0
2550509|NCT01453725|8824902|P1|Overall Study|Protocol Violation|1
2550510|NCT01453725|8824901|P2|Overall Study|Non-compliance With Protocol|2
2550511|NCT01453725|8824902|P1|Overall Study|Non-compliance With Protocol|1
2550512|NCT01453725|8824901|P2|Overall Study|Lost to Follow-up|0
2550513|NCT01453725|8824902|P1|Overall Study|Lost to Follow-up|4
2550514|NCT01453725|8824901|P2|Overall Study|Adverse Event|3
2550515|NCT01453725|8824902|P1|Overall Study|Adverse Event|3
2550516|NCT01453595|8824925|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
2550517|NCT01453595|8824926|P2|Overall Study|Dose Limiting Toxicity (DLT)|1
2550518|NCT01453595|8824927|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
2550519|NCT01453374|8825046|P1|Overall Study|Incarcerated|2
2550520|NCT01453374|8825046|P1|Overall Study|Withdrawal by Subject|5
2550521|NCT01453374|8825046|P1|Overall Study|Lost to Follow-up|3
2550522|NCT01453374|8825046|P1|Overall Study|Lack of Efficacy|1
2550523|NCT01453374|8825046|P1|Overall Study|Adverse Event|7
2550524|NCT01453361|8825062|P1|Overall Study|Screen-Failures|10
2550525|NCT01453361|8825062|P1|Overall Study|Disease Progression|6
2550526|NCT01453348|8825070|P3|Overall Study|Protocol Violation|0
2550527|NCT01453348|8825071|P2|Overall Study|Protocol Violation|0
2550528|NCT01453348|8825072|P1|Overall Study|Protocol Violation|1
2550529|NCT01453348|8825070|P3|Overall Study|Withdrawal by Subject|0
2550530|NCT01453348|8825071|P2|Overall Study|Withdrawal by Subject|1
2550531|NCT01453348|8825072|P1|Overall Study|Withdrawal by Subject|0
2550532|NCT01453348|8825070|P3|Overall Study|Death|1
2550533|NCT01453348|8825071|P2|Overall Study|Death|0
2550534|NCT01453348|8825072|P1|Overall Study|Death|0
2550535|NCT01453296|8825088|P2|Treatment Period 2|Withdrawal by Subject|0
2550536|NCT01453296|8825089|P1|Treatment Period 2|Withdrawal by Subject|1
2550537|NCT01453296|8825088|P2|Treatment Period 2|Adverse Event|0
2550538|NCT01453296|8825089|P1|Treatment Period 2|Adverse Event|1
2550539|NCT01453296|8825088|P2|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0
2550540|NCT01453296|8825089|P1|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1
2550541|NCT01453296|8825088|P2|Treatment Period 1|Adverse Event|1
2550542|NCT01453296|8825089|P1|Treatment Period 1|Adverse Event|0
2550543|NCT01453205|8825156|P3|Overall Study|Other|35
2550544|NCT01453205|8825157|P2|Overall Study|Other|27
2550545|NCT01453205|8825158|P1|Overall Study|Other|45
2550546|NCT01453205|8825156|P3|Overall Study|Death|18
2550547|NCT01453205|8825157|P2|Overall Study|Death|22
2550548|NCT01453205|8825158|P1|Overall Study|Death|24
2550549|NCT01453205|8825156|P3|Overall Study|Withdrawal by Subject|0
2550550|NCT01453205|8825157|P2|Overall Study|Withdrawal by Subject|3
2550551|NCT01453205|8825158|P1|Overall Study|Withdrawal by Subject|8
2550552|NCT01453205|8825156|P3|Overall Study|Lost to Follow-up|1
2550553|NCT01453205|8825157|P2|Overall Study|Lost to Follow-up|0
2550554|NCT01453205|8825158|P1|Overall Study|Lost to Follow-up|3
2550555|NCT01453153|8825234|P3|Overall Study|Adverse Event|1
2550556|NCT01453153|8825235|P2|Overall Study|Adverse Event|1
2550557|NCT01453153|8825236|P1|Overall Study|Adverse Event|1
2550558|NCT01453153|8825234|P3|Overall Study|Withdrawal by Subject|2
2550559|NCT01453153|8825235|P2|Overall Study|Withdrawal by Subject|1
2550560|NCT01453153|8825236|P1|Overall Study|Withdrawal by Subject|0
2550561|NCT01453153|8825234|P3|Overall Study|Progressive Disease|16
2550562|NCT01453153|8825235|P2|Overall Study|Progressive Disease|2
2550563|NCT01453153|8825236|P1|Overall Study|Progressive Disease|3
2550564|NCT01453153|8825234|P3|Overall Study|Physician Decision|1
2550565|NCT01453153|8825235|P2|Overall Study|Physician Decision|0
2550566|NCT01453153|8825236|P1|Overall Study|Physician Decision|0
2550567|NCT01453049|8825318|P2|Overall Study|Randomized in Error|0
2550568|NCT01453049|8825319|P1|Overall Study|Randomized in Error|1
2550569|NCT01453049|8825318|P2|Overall Study|Withdrawal by Subject|0
2550570|NCT01453049|8825319|P1|Overall Study|Withdrawal by Subject|1
2550571|NCT01453049|8825318|P2|Overall Study|Withdrawn When Sponsor Terminated Study|36
2550572|NCT01453049|8825319|P1|Overall Study|Withdrawn When Sponsor Terminated Study|35
2550573|NCT01453049|8825318|P2|Overall Study|Lost to Follow-up|1
2550574|NCT01453049|8825319|P1|Overall Study|Lost to Follow-up|2
2550575|NCT01453049|8825318|P2|Overall Study|Protocol Violation|5
2550576|NCT01453049|8825319|P1|Overall Study|Protocol Violation|2
2550577|NCT01453036|8825392|P3|Overall Study|Lost to Follow-up|31
2550578|NCT01453036|8825393|P2|Overall Study|Lost to Follow-up|115
2550579|NCT01453036|8825394|P1|Overall Study|Lost to Follow-up|26
2550580|NCT01453023|8825402|P2|Treatment Period 2|Protocol Violation|1
2550581|NCT01453023|8825403|P1|Treatment Period 2|Protocol Violation|0
2550582|NCT01453023|8825402|P2|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1
2550583|NCT01453023|8825403|P1|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0
2550584|NCT01453023|8825402|P2|Treatment Period (TP) 1|Protocol Violation|0
2550585|NCT01453023|8825403|P1|Treatment Period (TP) 1|Protocol Violation|1
2550586|NCT01452789|8825477|P2|Overall Study|Withdrawal by Subject|2
2550587|NCT01452789|8825478|P1|Overall Study|Withdrawal by Subject|3
2550588|NCT01452529|8825492|P3|Double-blind (DB) Period|Administrative|7
2550589|NCT01452529|8825493|P2|Double-blind (DB) Period|Administrative|11
2550590|NCT01452529|8825494|P1|Double-blind (DB) Period|Administrative|0
2550591|NCT01452529|8825492|P3|Double-blind (DB) Period|Confirmed or suspected diversion|3
2550592|NCT01452529|8825493|P2|Double-blind (DB) Period|Confirmed or suspected diversion|2
2550593|NCT01452529|8825494|P1|Double-blind (DB) Period|Confirmed or suspected diversion|0
2550594|NCT01452529|8825492|P3|Double-blind (DB) Period|Lack of Efficacy|44
2550595|NCT01452529|8825493|P2|Double-blind (DB) Period|Lack of Efficacy|16
2550596|NCT01452529|8825494|P1|Double-blind (DB) Period|Lack of Efficacy|0
2550597|NCT01452529|8825492|P3|Double-blind (DB) Period|Lost to Follow-up|3
2550598|NCT01452529|8825493|P2|Double-blind (DB) Period|Lost to Follow-up|5
2550599|NCT01452529|8825494|P1|Double-blind (DB) Period|Lost to Follow-up|0
2550600|NCT01452529|8825492|P3|Double-blind (DB) Period|Withdrawal by Subject|14
2550601|NCT01452529|8825493|P2|Double-blind (DB) Period|Withdrawal by Subject|15
2550602|NCT01452529|8825494|P1|Double-blind (DB) Period|Withdrawal by Subject|0
2550603|NCT01452529|8825492|P3|Double-blind (DB) Period|Adverse Event|11
2550604|NCT01452529|8825493|P2|Double-blind (DB) Period|Adverse Event|18
2550605|NCT01452529|8825494|P1|Double-blind (DB) Period|Adverse Event|0
2550606|NCT01452529|8825492|P3|Run-in Period|Did not qualify for Double-Blind Phase|0
2550607|NCT01452529|8825493|P2|Run-in Period|Did not qualify for Double-Blind Phase|0
2550608|NCT01452529|8825494|P1|Run-in Period|Did not qualify for Double-Blind Phase|59
2550609|NCT01452529|8825492|P3|Run-in Period|Administrative|0
2550610|NCT01452529|8825493|P2|Run-in Period|Administrative|0
2550611|NCT01452529|8825494|P1|Run-in Period|Administrative|21
2550612|NCT01452529|8825492|P3|Run-in Period|Confirmed or suspected diversion|0
2550613|NCT01452529|8825493|P2|Run-in Period|Confirmed or suspected diversion|0
2550614|NCT01452529|8825494|P1|Run-in Period|Confirmed or suspected diversion|23
2550615|NCT01452529|8825492|P3|Run-in Period|Lack of Efficacy|0
2550616|NCT01452529|8825493|P2|Run-in Period|Lack of Efficacy|0
2550617|NCT01452529|8825494|P1|Run-in Period|Lack of Efficacy|46
2550618|NCT01452529|8825492|P3|Run-in Period|Lost to Follow-up|0
2550619|NCT01452529|8825493|P2|Run-in Period|Lost to Follow-up|0
2550620|NCT01452529|8825494|P1|Run-in Period|Lost to Follow-up|19
2550621|NCT01452529|8825492|P3|Run-in Period|Withdrawal by Subject|0
2550622|NCT01452529|8825493|P2|Run-in Period|Withdrawal by Subject|0
2550623|NCT01452529|8825494|P1|Run-in Period|Withdrawal by Subject|49
2550624|NCT01452529|8825492|P3|Run-in Period|Adverse Event|0
2550625|NCT01452529|8825493|P2|Run-in Period|Adverse Event|0
2550626|NCT01452529|8825494|P1|Run-in Period|Adverse Event|96
2550627|NCT01452412|8825516|P2|Overall Study|Other|0
2550628|NCT01452412|8825517|P1|Overall Study|Other|2
2550629|NCT01452412|8825516|P2|Overall Study|Initiated dialysis|0
2550630|NCT01452412|8825517|P1|Overall Study|Initiated dialysis|1
2550631|NCT01452412|8825516|P2|Overall Study|Death|0
2550632|NCT01452412|8825517|P1|Overall Study|Death|1
2550633|NCT01452412|8825516|P2|Overall Study|Lost to Follow-up|3
2550634|NCT01452412|8825517|P1|Overall Study|Lost to Follow-up|5
2550635|NCT01452412|8825516|P2|Overall Study|Adverse Event|3
2550636|NCT01452412|8825517|P1|Overall Study|Adverse Event|4
2550637|NCT01452412|8825516|P2|Overall Study|Withdrawal by Subject|11
2550638|NCT01452412|8825517|P1|Overall Study|Withdrawal by Subject|15
2550639|NCT01452347|8825533|P2|Overall Study|Other reason not defined above|0
2550640|NCT01452347|8825534|P1|Overall Study|Other reason not defined above|2
2550641|NCT01452347|8825533|P2|Overall Study|Not treated|3
2550642|NCT01452347|8825534|P1|Overall Study|Not treated|6
2550643|NCT01452347|8825533|P2|Overall Study|Withdrawal by Subject|3
2550644|NCT01452347|8825534|P1|Overall Study|Withdrawal by Subject|3
2550645|NCT01452347|8825533|P2|Overall Study|Lost to Follow-up|0
2550646|NCT01452347|8825534|P1|Overall Study|Lost to Follow-up|2
2550647|NCT01452347|8825533|P2|Overall Study|Non compliance protocol|0
2550648|NCT01452347|8825534|P1|Overall Study|Non compliance protocol|2
2550649|NCT01452347|8825533|P2|Overall Study|Adverse Event|1
2550650|NCT01452347|8825534|P1|Overall Study|Adverse Event|2
2550651|NCT01452152|8825594|P3|Overall Study|Study termination by sponsor|4
2550652|NCT01452152|8825595|P2|Overall Study|Study termination by sponsor|0
2550653|NCT01452152|8825596|P1|Overall Study|Study termination by sponsor|5
2550654|NCT01451931|8825668|P3|Overall Study|Withdrawal by Subject|22
2550655|NCT01451931|8825669|P2|Overall Study|Withdrawal by Subject|22
2550656|NCT01451931|8825670|P1|Overall Study|Withdrawal by Subject|16
2550657|NCT01451931|8825668|P3|Overall Study|Lost to Follow-up|21
2550658|NCT01451931|8825669|P2|Overall Study|Lost to Follow-up|36
2550659|NCT01451931|8825670|P1|Overall Study|Lost to Follow-up|17
2550660|NCT01451827|8825694|P4|Overall Study|Withdrawal by Subject|1
2550661|NCT01451827|8825695|P3|Overall Study|Withdrawal by Subject|1
2550662|NCT01451827|8825696|P2|Overall Study|Withdrawal by Subject|0
2550663|NCT01451827|8825697|P1|Overall Study|Withdrawal by Subject|0
2550664|NCT01451827|8825694|P4|Overall Study|Participant met withdrawal criteria|0
2550665|NCT01451827|8825695|P3|Overall Study|Participant met withdrawal criteria|0
2550666|NCT01451827|8825696|P2|Overall Study|Participant met withdrawal criteria|2
2550667|NCT01451827|8825697|P1|Overall Study|Participant met withdrawal criteria|0
2550668|NCT01451827|8825694|P4|Overall Study|Lost to Follow-up|2
2550669|NCT01451827|8825695|P3|Overall Study|Lost to Follow-up|0
2550670|NCT01451827|8825696|P2|Overall Study|Lost to Follow-up|3
2550671|NCT01451827|8825697|P1|Overall Study|Lost to Follow-up|0
2550672|NCT01451827|8825694|P4|Overall Study|Protocol deviation|0
2550673|NCT01451827|8825695|P3|Overall Study|Protocol deviation|0
2550674|NCT01451827|8825696|P2|Overall Study|Protocol deviation|0
2550675|NCT01451827|8825697|P1|Overall Study|Protocol deviation|1
2550676|NCT01451827|8825694|P4|Overall Study|Adverse Event|1
2550677|NCT01451827|8825695|P3|Overall Study|Adverse Event|1
2550678|NCT01451827|8825696|P2|Overall Study|Adverse Event|0
2550679|NCT01451827|8825697|P1|Overall Study|Adverse Event|2
2550680|NCT01451814|8825717|P2|Overall Study|Lost to Follow-up|4
2550681|NCT01451814|8825718|P1|Overall Study|Lost to Follow-up|5
2550682|NCT01451814|8825717|P2|Overall Study|Withdrawal by Subject|1
2550683|NCT01451814|8825718|P1|Overall Study|Withdrawal by Subject|1
2550684|NCT01451762|8825750|P3|Overall Study|Lost to Follow-up|6
2550685|NCT01451762|8825751|P2|Overall Study|Lost to Follow-up|6
2550686|NCT01451762|8825752|P1|Overall Study|Lost to Follow-up|3
2550687|NCT01451749|8825762|P2|Overall Study|Withdrawal by Subject|1
2550688|NCT01451749|8825763|P1|Overall Study|Withdrawal by Subject|0
2550689|NCT01451749|8825762|P2|Overall Study|Adverse Event|0
2550690|NCT01451749|8825763|P1|Overall Study|Adverse Event|2
2550691|NCT01451749|8825762|P2|Overall Study|Meet the exclusion criteria,and|1
2550692|NCT01451749|8825763|P1|Overall Study|Meet the exclusion criteria,and|1
2550693|NCT01451749|8825762|P2|Overall Study|Lost to Follow-up|5
2550694|NCT01451749|8825763|P1|Overall Study|Lost to Follow-up|15
2550695|NCT01451749|8825762|P2|Overall Study|Protocol Violation|7
2550696|NCT01451749|8825763|P1|Overall Study|Protocol Violation|14
2550697|NCT01451723|8825775|P2|Overall Study|study halted|5
2550698|NCT01451723|8825776|P1|Overall Study|study halted|6
2550699|NCT01451645|8825786|P2|Overall Study|Lost to Follow-up|3
2550700|NCT01451645|8825787|P1|Overall Study|Lost to Follow-up|4
2550701|NCT01451645|8825786|P2|Overall Study|Withdrawal by Subject|2
2550702|NCT01451645|8825787|P1|Overall Study|Withdrawal by Subject|4
2550703|NCT01451645|8825786|P2|Overall Study|Adverse Event|3
2550704|NCT01451645|8825787|P1|Overall Study|Adverse Event|0
2550705|NCT01451645|8825786|P2|Overall Study|Protocol Violation|0
2550706|NCT01451645|8825787|P1|Overall Study|Protocol Violation|1
2550707|NCT01451606|8825858|P2|Overall Study|Withdrawal by Subject|3
2550708|NCT01451606|8825859|P1|Overall Study|Withdrawal by Subject|4
2550709|NCT01451554|8825869|P2|Overall Study|Withdrawal by Subject|9
2550710|NCT01451554|8825870|P1|Overall Study|Withdrawal by Subject|14
2550711|NCT01451541|8825881|P3|Overall Study|randomization error, noncompliance|8
2550712|NCT01451541|8825882|P2|Overall Study|randomization error, noncompliance|10
2550713|NCT01451541|8825883|P1|Overall Study|randomization error, noncompliance|11
2550714|NCT01451541|8825881|P3|Overall Study|Withdrawal by Subject|6
2550715|NCT01451541|8825882|P2|Overall Study|Withdrawal by Subject|8
2550716|NCT01451541|8825883|P1|Overall Study|Withdrawal by Subject|15
2550717|NCT01451541|8825881|P3|Overall Study|Lost to Follow-up|7
2550718|NCT01451541|8825882|P2|Overall Study|Lost to Follow-up|4
2550719|NCT01451541|8825883|P1|Overall Study|Lost to Follow-up|4
2550720|NCT01451541|8825881|P3|Overall Study|Lack of Efficacy|0
2550721|NCT01451541|8825882|P2|Overall Study|Lack of Efficacy|0
2550722|NCT01451541|8825883|P1|Overall Study|Lack of Efficacy|2
2550723|NCT01451541|8825881|P3|Overall Study|Adverse Event|6
2550724|NCT01451541|8825882|P2|Overall Study|Adverse Event|3
2550725|NCT01451541|8825883|P1|Overall Study|Adverse Event|4
2550726|NCT01451437|8825941|P9|Overall Study|Withdrawal by Subject|0
2550727|NCT01451437|8825942|P8|Overall Study|Withdrawal by Subject|0
2550728|NCT01451437|8825943|P7|Overall Study|Withdrawal by Subject|1
2550729|NCT01451437|8825944|P6|Overall Study|Withdrawal by Subject|0
2550730|NCT01451437|8825945|P5|Overall Study|Withdrawal by Subject|1
2550731|NCT01451437|8825946|P4|Overall Study|Withdrawal by Subject|0
2550732|NCT01451437|8825947|P3|Overall Study|Withdrawal by Subject|0
2550733|NCT01451437|8825948|P2|Overall Study|Withdrawal by Subject|0
2550734|NCT01451437|8825949|P1|Overall Study|Withdrawal by Subject|0
2550735|NCT01451437|8825941|P9|Overall Study|Protocol Violation|0
2550736|NCT01451437|8825942|P8|Overall Study|Protocol Violation|0
2550737|NCT01451437|8825943|P7|Overall Study|Protocol Violation|1
2550738|NCT01451437|8825944|P6|Overall Study|Protocol Violation|0
2550739|NCT01451437|8825945|P5|Overall Study|Protocol Violation|0
2550740|NCT01451437|8825946|P4|Overall Study|Protocol Violation|0
2550741|NCT01451437|8825947|P3|Overall Study|Protocol Violation|0
2550742|NCT01451437|8825948|P2|Overall Study|Protocol Violation|0
2550743|NCT01451437|8825949|P1|Overall Study|Protocol Violation|0
2550744|NCT01451437|8825941|P9|Overall Study|Disease Progression|3
2550745|NCT01451437|8825942|P8|Overall Study|Disease Progression|1
2550746|NCT01451437|8825943|P7|Overall Study|Disease Progression|3
2550747|NCT01451437|8825944|P6|Overall Study|Disease Progression|2
2550748|NCT01451437|8825945|P5|Overall Study|Disease Progression|3
2550749|NCT01451437|8825946|P4|Overall Study|Disease Progression|1
2550750|NCT01451437|8825947|P3|Overall Study|Disease Progression|1
2550751|NCT01451437|8825948|P2|Overall Study|Disease Progression|0
2550752|NCT01451437|8825949|P1|Overall Study|Disease Progression|0
2550753|NCT01451437|8825941|P9|Overall Study|Physician Decision|0
2550754|NCT01451437|8825942|P8|Overall Study|Physician Decision|0
2550755|NCT01451437|8825943|P7|Overall Study|Physician Decision|0
2550756|NCT01451437|8825944|P6|Overall Study|Physician Decision|0
2550757|NCT01451437|8825945|P5|Overall Study|Physician Decision|0
2550758|NCT01451437|8825946|P4|Overall Study|Physician Decision|0
2550759|NCT01451437|8825947|P3|Overall Study|Physician Decision|2
2550760|NCT01451437|8825948|P2|Overall Study|Physician Decision|1
2550761|NCT01451437|8825949|P1|Overall Study|Physician Decision|1
2550762|NCT01451437|8825941|P9|Overall Study|Adverse Event|1
2550763|NCT01451437|8825942|P8|Overall Study|Adverse Event|2
2550764|NCT01451437|8825943|P7|Overall Study|Adverse Event|1
2550765|NCT01451437|8825944|P6|Overall Study|Adverse Event|1
2550766|NCT01451437|8825945|P5|Overall Study|Adverse Event|0
2550767|NCT01451437|8825946|P4|Overall Study|Adverse Event|0
2550768|NCT01451437|8825947|P3|Overall Study|Adverse Event|0
2550769|NCT01451437|8825948|P2|Overall Study|Adverse Event|0
2550770|NCT01451437|8825949|P1|Overall Study|Adverse Event|0
2550771|NCT01451424|8826081|P4|Overall Study|Adverse Event|1
2550772|NCT01451424|8826082|P3|Overall Study|Adverse Event|0
2550773|NCT01451424|8826083|P2|Overall Study|Adverse Event|0
2550774|NCT01451424|8826084|P1|Overall Study|Adverse Event|0
2550775|NCT01451424|8826081|P4|Overall Study|Physician Decision|1
2550776|NCT01451424|8826082|P3|Overall Study|Physician Decision|1
2550777|NCT01451424|8826083|P2|Overall Study|Physician Decision|0
2550778|NCT01451424|8826084|P1|Overall Study|Physician Decision|0
2550779|NCT01451424|8826081|P4|Overall Study|Lost to Follow-up|1
2550780|NCT01451424|8826082|P3|Overall Study|Lost to Follow-up|0
2550781|NCT01451424|8826083|P2|Overall Study|Lost to Follow-up|1
2550782|NCT01451424|8826084|P1|Overall Study|Lost to Follow-up|0
2550783|NCT01451424|8826081|P4|Overall Study|Withdrawal by Subject|2
2550784|NCT01451424|8826082|P3|Overall Study|Withdrawal by Subject|0
2550785|NCT01451424|8826083|P2|Overall Study|Withdrawal by Subject|1
2550786|NCT01451424|8826084|P1|Overall Study|Withdrawal by Subject|1
2550787|NCT01451398|8826142|P2|Overall Study|Lack of Efficacy|1
2550788|NCT01451398|8826143|P1|Overall Study|Lack of Efficacy|0
2550789|NCT01451398|8826142|P2|Overall Study|Adverse Event + Elevated Fasting Glucose|1
2550790|NCT01451398|8826143|P1|Overall Study|Adverse Event + Elevated Fasting Glucose|0
2550791|NCT01451398|8826142|P2|Overall Study|Moved out of country|1
2550792|NCT01451398|8826143|P1|Overall Study|Moved out of country|0
2550793|NCT01451398|8826142|P2|Overall Study|Non-compliance with protocol|1
2550794|NCT01451398|8826143|P1|Overall Study|Non-compliance with protocol|1
2550795|NCT01451398|8826142|P2|Overall Study|Non-compliance with study drug|3
2550796|NCT01451398|8826143|P1|Overall Study|Non-compliance with study drug|1
2550797|NCT01451398|8826142|P2|Overall Study|Lost to Follow-up|4
2550798|NCT01451398|8826143|P1|Overall Study|Lost to Follow-up|6
2550799|NCT01451398|8826142|P2|Overall Study|Withdrawal by Subject|14
2550800|NCT01451398|8826143|P1|Overall Study|Withdrawal by Subject|10
2550801|NCT01451398|8826142|P2|Overall Study|Physician Decision|1
2550802|NCT01451398|8826143|P1|Overall Study|Physician Decision|1
2550803|NCT01451398|8826142|P2|Overall Study|Protocol Violation|2
2550804|NCT01451398|8826143|P1|Overall Study|Protocol Violation|1
2550805|NCT01451398|8826142|P2|Overall Study|Adverse Event|9
2550806|NCT01451398|8826143|P1|Overall Study|Adverse Event|7
2550807|NCT01451203|8826182|P2|Post-treatment Period|Investigator decision|1
2550808|NCT01451203|8826183|P1|Post-treatment Period|Investigator decision|0
2550809|NCT01451203|8826182|P2|Post-treatment Period|Adverse Event|1
2550810|NCT01451203|8826183|P1|Post-treatment Period|Adverse Event|0
2550811|NCT01451203|8826182|P2|Post-treatment Period|Lack of Efficacy|28
2550812|NCT01451203|8826183|P1|Post-treatment Period|Lack of Efficacy|12
2550813|NCT01451203|8826182|P2|Post-treatment Period|Consent withdrawn|4
2550814|NCT01451203|8826183|P1|Post-treatment Period|Consent withdrawn|2
2550815|NCT01451203|8826182|P2|Double-blind Treatment Period|Investigator decision|0
2550816|NCT01451203|8826183|P1|Double-blind Treatment Period|Investigator decision|2
2550817|NCT01451203|8826182|P2|Double-blind Treatment Period|Violation of eligibility criteria|0
2550818|NCT01451203|8826183|P1|Double-blind Treatment Period|Violation of eligibility criteria|1
2550819|NCT01451203|8826182|P2|Double-blind Treatment Period|Missing study medication ≥6 times|0
2550820|NCT01451203|8826183|P1|Double-blind Treatment Period|Missing study medication ≥6 times|1
2550821|NCT01451203|8826182|P2|Double-blind Treatment Period|Adverse Event|9
2550822|NCT01451203|8826183|P1|Double-blind Treatment Period|Adverse Event|6
2550823|NCT01451203|8826182|P2|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1
2550824|NCT01451203|8826183|P1|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0
2550825|NCT01451203|8826182|P2|Double-blind Treatment Period|Lack of Efficacy|36
2550826|NCT01451203|8826183|P1|Double-blind Treatment Period|Lack of Efficacy|71
2550827|NCT01451203|8826182|P2|Double-blind Treatment Period|Consent Withdrawn|2
2550828|NCT01451203|8826183|P1|Double-blind Treatment Period|Consent Withdrawn|3
2550829|NCT01451203|8826182|P2|Double-blind Treatment Period|Did not receive treatment|2
2550830|NCT01451203|8826183|P1|Double-blind Treatment Period|Did not receive treatment|1
2550831|NCT01451164|8826201|P4|Overall Study|Lack of Efficacy|7
2550832|NCT01451164|8826202|P3|Overall Study|Lack of Efficacy|9
2550833|NCT01451164|8826203|P2|Overall Study|Lack of Efficacy|9
2550834|NCT01451164|8826204|P1|Overall Study|Lack of Efficacy|7
2550835|NCT01451164|8826201|P4|Overall Study|Protocol Violation|0
2550836|NCT01451164|8826202|P3|Overall Study|Protocol Violation|0
2550837|NCT01451164|8826203|P2|Overall Study|Protocol Violation|1
2550838|NCT01451164|8826204|P1|Overall Study|Protocol Violation|0
2550839|NCT01451164|8826201|P4|Overall Study|Withdrawal by Subject|17
2550840|NCT01451164|8826202|P3|Overall Study|Withdrawal by Subject|16
2550841|NCT01451164|8826203|P2|Overall Study|Withdrawal by Subject|11
2550842|NCT01451164|8826204|P1|Overall Study|Withdrawal by Subject|14
2550843|NCT01451164|8826201|P4|Overall Study|Physician Decision|0
2550844|NCT01451164|8826202|P3|Overall Study|Physician Decision|1
2550845|NCT01451164|8826203|P2|Overall Study|Physician Decision|0
2550846|NCT01451164|8826204|P1|Overall Study|Physician Decision|2
2550847|NCT01451164|8826201|P4|Overall Study|Withdrawal Criteria|1
2550848|NCT01451164|8826202|P3|Overall Study|Withdrawal Criteria|1
2550849|NCT01451164|8826203|P2|Overall Study|Withdrawal Criteria|1
2550850|NCT01451164|8826204|P1|Overall Study|Withdrawal Criteria|1
2550851|NCT01451164|8826201|P4|Overall Study|Adverse Event|21
2550852|NCT01451164|8826202|P3|Overall Study|Adverse Event|18
2550853|NCT01451164|8826203|P2|Overall Study|Adverse Event|12
2550854|NCT01451164|8826204|P1|Overall Study|Adverse Event|19
2550855|NCT01450943|8826233|P3|Overall Study|Screen failure, loss to follow-up|6
2550856|NCT01450943|8826234|P2|Overall Study|Screen failure, loss to follow-up|7
2550857|NCT01450943|8826235|P1|Overall Study|Screen failure, loss to follow-up|2
2550858|NCT01450813|8826268|P4|Overall Study|Physician Decision|3
2550859|NCT01450813|8826269|P3|Overall Study|Physician Decision|0
2550860|NCT01450813|8826270|P2|Overall Study|Physician Decision|1
2550861|NCT01450813|8826271|P1|Overall Study|Physician Decision|1
2550862|NCT01450800|8826285|P2|Overall Study|Protocol Violation|3
2550863|NCT01450800|8826286|P1|Overall Study|Protocol Violation|1
2550864|NCT01450761|8826321|P2|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3
2550865|NCT01450761|8826322|P1|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2
2550866|NCT01450761|8826321|P2|Treatment With Blinded Study Therapy|Poor/non-compliance|0
2550867|NCT01450761|8826322|P1|Treatment With Blinded Study Therapy|Poor/non-compliance|1
2550868|NCT01450761|8826321|P2|Treatment With Blinded Study Therapy|Not reported|2
2550869|NCT01450761|8826322|P1|Treatment With Blinded Study Therapy|Not reported|2
2550870|NCT01450761|8826321|P2|Treatment With Blinded Study Therapy|No longer meets study criteria|2
2550871|NCT01450761|8826322|P1|Treatment With Blinded Study Therapy|No longer meets study criteria|1
2550872|NCT01450761|8826321|P2|Treatment With Blinded Study Therapy|Maximum clinical benefit|2
2550873|NCT01450761|8826322|P1|Treatment With Blinded Study Therapy|Maximum clinical benefit|1
2550874|NCT01450761|8826321|P2|Treatment With Blinded Study Therapy|Lost to Follow-up|1
2550875|NCT01450761|8826322|P1|Treatment With Blinded Study Therapy|Lost to Follow-up|2
2550876|NCT01450761|8826321|P2|Treatment With Blinded Study Therapy|Other/Unspecified|4
2550877|NCT01450761|8826322|P1|Treatment With Blinded Study Therapy|Other/Unspecified|5
2550878|NCT01450761|8826321|P2|Treatment With Blinded Study Therapy|Death|6
2550879|NCT01450761|8826322|P1|Treatment With Blinded Study Therapy|Death|5
2550880|NCT01450761|8826321|P2|Treatment With Blinded Study Therapy|Withdrawal by Subject|5
2550881|NCT01450761|8826322|P1|Treatment With Blinded Study Therapy|Withdrawal by Subject|12
2550882|NCT01450761|8826321|P2|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8
2550883|NCT01450761|8826322|P1|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15
2550884|NCT01450761|8826321|P2|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19
2550885|NCT01450761|8826322|P1|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27
2550886|NCT01450761|8826321|P2|Treatment With Blinded Study Therapy|Study drug toxicity|9
2550887|NCT01450761|8826322|P1|Treatment With Blinded Study Therapy|Study drug toxicity|87
2550888|NCT01450761|8826321|P2|Treatment With Blinded Study Therapy|Disease progression|415
2550889|NCT01450761|8826322|P1|Treatment With Blinded Study Therapy|Disease progression|318
2550890|NCT01450761|8826321|P2|Lead-in Chemotherapy|Lost to Follow-up|0
2550891|NCT01450761|8826322|P1|Lead-in Chemotherapy|Lost to Follow-up|2
2550892|NCT01450761|8826321|P2|Lead-in Chemotherapy|Other|2
2550893|NCT01450761|8826322|P1|Lead-in Chemotherapy|Other|2
2550894|NCT01450761|8826321|P2|Lead-in Chemotherapy|Death|3
2550895|NCT01450761|8826322|P1|Lead-in Chemotherapy|Death|3
2550896|NCT01450761|8826321|P2|Lead-in Chemotherapy|No longer meets study criteria|7
2550897|NCT01450761|8826322|P1|Lead-in Chemotherapy|No longer meets study criteria|3
2550898|NCT01450761|8826321|P2|Lead-in Chemotherapy|Study drug toxicity|10
2550899|NCT01450761|8826322|P1|Lead-in Chemotherapy|Study drug toxicity|6
2550900|NCT01450761|8826321|P2|Lead-in Chemotherapy|Withdrawal by Subject|12
2550901|NCT01450761|8826322|P1|Lead-in Chemotherapy|Withdrawal by Subject|14
2550902|NCT01450761|8826321|P2|Lead-in Chemotherapy|Adverse event unrelated to study drug|19
2550903|NCT01450761|8826322|P1|Lead-in Chemotherapy|Adverse event unrelated to study drug|21
2550904|NCT01450761|8826321|P2|Lead-in Chemotherapy|Disease progression|32
2550905|NCT01450761|8826322|P1|Lead-in Chemotherapy|Disease progression|33
2550906|NCT01450761|8826321|P2|Randomization|Other|1
2550907|NCT01450761|8826322|P1|Randomization|Other|0
2550908|NCT01450761|8826321|P2|Randomization|Adverse Event unrelated to study drug|0
2550909|NCT01450761|8826322|P1|Randomization|Adverse Event unrelated to study drug|1
2550910|NCT01450761|8826321|P2|Randomization|Disease progression|2
2550911|NCT01450761|8826322|P1|Randomization|Disease progression|0
2550912|NCT01450761|8826321|P2|Randomization|Withdrawal by Subject|0
2550913|NCT01450761|8826322|P1|Randomization|Withdrawal by Subject|2
2550914|NCT01450761|8826321|P2|Randomization|Subject no longer meets study criteria|2
2550915|NCT01450761|8826322|P1|Randomization|Subject no longer meets study criteria|1
2550916|NCT01450696|8826334|P2|Overall Study|Study Terminated by Sponsor|58
2550917|NCT01450696|8826335|P1|Overall Study|Study Terminated by Sponsor|53
2550918|NCT01450696|8826334|P2|Overall Study|Withdrawal by Subject|2
2550919|NCT01450696|8826335|P1|Overall Study|Withdrawal by Subject|13
2550920|NCT01450696|8826334|P2|Overall Study|Non-Compliance|0
2550921|NCT01450696|8826335|P1|Overall Study|Non-Compliance|1
2550922|NCT01450696|8826334|P2|Overall Study|Lost to Follow-up|3
2550923|NCT01450696|8826335|P1|Overall Study|Lost to Follow-up|3
2550924|NCT01450696|8826334|P2|Overall Study|Death|84
2550925|NCT01450696|8826335|P1|Overall Study|Death|77
2550926|NCT01450696|8826334|P2|Overall Study|Never Treated|1
2550927|NCT01450696|8826335|P1|Overall Study|Never Treated|1
2550928|NCT01450683|8826357|P1|Overall Study|Adverse Event|2
2550929|NCT01450631|8826363|P2|Overall Study|Withdrawal by Subject|0
2550930|NCT01450631|8826364|P1|Overall Study|Withdrawal by Subject|1
2550931|NCT01450631|8826363|P2|Overall Study|Lost to Follow-up|4
2550932|NCT01450631|8826364|P1|Overall Study|Lost to Follow-up|2
2550933|NCT01450137|8826494|P2|Week 12 to Study End|Withdrawal by Subject|1
2550934|NCT01450137|8826495|P1|Week 12 to Study End|Withdrawal by Subject|0
2550935|NCT01450137|8826494|P2|Week 12 to Study End|Death|1
2550936|NCT01450137|8826495|P1|Week 12 to Study End|Death|0
2550937|NCT01450137|8826494|P2|Up to Week 12|Withdrawal by Subject|2
2550938|NCT01450137|8826495|P1|Up to Week 12|Withdrawal by Subject|0
2550939|NCT01450137|8826494|P2|Up to Week 12|Adverse Event|1
2550940|NCT01450137|8826495|P1|Up to Week 12|Adverse Event|2
2550941|NCT01450098|8826509|P2|Period 3|Withdrawal by Subject|2
2550942|NCT01450098|8826510|P1|Period 3|Withdrawal by Subject|0
2550943|NCT01450098|8826509|P2|Period 3|Protocol Violation|1
2550944|NCT01450098|8826510|P1|Period 3|Protocol Violation|0
2550945|NCT01450007|8826529|P3|Overall Study|Adverse Event|0
2550946|NCT01450007|8826530|P2|Overall Study|Adverse Event|1
2550947|NCT01450007|8826531|P1|Overall Study|Adverse Event|0
2550948|NCT01450007|8826529|P3|Overall Study|Protocol Violation|1
2550949|NCT01450007|8826530|P2|Overall Study|Protocol Violation|1
2550950|NCT01450007|8826531|P1|Overall Study|Protocol Violation|0
2550951|NCT01450007|8826529|P3|Overall Study|Late exclusion before treatment|2
2550952|NCT01450007|8826530|P2|Overall Study|Late exclusion before treatment|3
2550953|NCT01450007|8826531|P1|Overall Study|Late exclusion before treatment|2
2550954|NCT01449955|8826550|P2|Overall Study|Withdrawal by Subject|2
2550955|NCT01449955|8826551|P1|Overall Study|Withdrawal by Subject|1
2550956|NCT01449929|8826579|P3|Extension Phase Approximately 3 Years|Lost to Follow-up|4
2550957|NCT01449929|8826580|P2|Extension Phase Approximately 3 Years|Lost to Follow-up|0
2550958|NCT01449929|8826581|P1|Extension Phase Approximately 3 Years|Lost to Follow-up|0
2550959|NCT01449929|8826579|P3|Extension Phase Approximately 3 Years|Lack of Efficacy|2
2550960|NCT01449929|8826580|P2|Extension Phase Approximately 3 Years|Lack of Efficacy|0
2550961|NCT01449929|8826581|P1|Extension Phase Approximately 3 Years|Lack of Efficacy|0
2550962|NCT01449929|8826579|P3|Extension Phase Approximately 3 Years|Adverse Event|2
2550963|NCT01449929|8826580|P2|Extension Phase Approximately 3 Years|Adverse Event|0
2550964|NCT01449929|8826581|P1|Extension Phase Approximately 3 Years|Adverse Event|0
2550965|NCT01449929|8826579|P3|Randomization Phase 96 Week|Other: study closed/terminated|0
2550966|NCT01449929|8826580|P2|Randomization Phase 96 Week|Other: study closed/terminated|1
2550967|NCT01449929|8826581|P1|Randomization Phase 96 Week|Other: study closed/terminated|0
2550968|NCT01449929|8826579|P3|Randomization Phase 96 Week|Physician Decision|0
2550969|NCT01449929|8826580|P2|Randomization Phase 96 Week|Physician Decision|3
2550970|NCT01449929|8826581|P1|Randomization Phase 96 Week|Physician Decision|2
2550971|NCT01449929|8826579|P3|Randomization Phase 96 Week|Withdrawal by Subject|0
2550972|NCT01449929|8826580|P2|Randomization Phase 96 Week|Withdrawal by Subject|8
2550973|NCT01449929|8826581|P1|Randomization Phase 96 Week|Withdrawal by Subject|2
2550974|NCT01449929|8826579|P3|Randomization Phase 96 Week|Lost to Follow-up|0
2550975|NCT01449929|8826580|P2|Randomization Phase 96 Week|Lost to Follow-up|18
2550976|NCT01449929|8826581|P1|Randomization Phase 96 Week|Lost to Follow-up|15
2550977|NCT01449929|8826579|P3|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
2550978|NCT01449929|8826580|P2|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
2550979|NCT01449929|8826581|P1|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1
2550980|NCT01449929|8826579|P3|Randomization Phase 96 Week|Protocol Violation|0
2550981|NCT01449929|8826580|P2|Randomization Phase 96 Week|Protocol Violation|6
2550982|NCT01449929|8826581|P1|Randomization Phase 96 Week|Protocol Violation|5
2550983|NCT01449929|8826579|P3|Randomization Phase 96 Week|Lack of Efficacy|0
2550984|NCT01449929|8826580|P2|Randomization Phase 96 Week|Lack of Efficacy|4
2550985|NCT01449929|8826581|P1|Randomization Phase 96 Week|Lack of Efficacy|3
2550986|NCT01449929|8826579|P3|Randomization Phase 96 Week|Adverse Event|0
2550987|NCT01449929|8826580|P2|Randomization Phase 96 Week|Adverse Event|13
2550988|NCT01449929|8826581|P1|Randomization Phase 96 Week|Adverse Event|5
2550989|NCT01449812|8826626|P3|Overall Study|Lost to Follow-up|0
2550990|NCT01449812|8826627|P2|Overall Study|Lost to Follow-up|0
2550991|NCT01449812|8826628|P1|Overall Study|Lost to Follow-up|1
2550992|NCT01449812|8826626|P3|Overall Study|Withdrawal by Subject|1
2550993|NCT01449812|8826627|P2|Overall Study|Withdrawal by Subject|0
2550994|NCT01449812|8826628|P1|Overall Study|Withdrawal by Subject|0
2550995|NCT01449812|8826626|P3|Overall Study|Migrated/moved from study area|0
2550996|NCT01449812|8826627|P2|Overall Study|Migrated/moved from study area|0
2550997|NCT01449812|8826628|P1|Overall Study|Migrated/moved from study area|1
2550998|NCT01449721|8826743|P2|Overall Study|Physician Decision|1
2550999|NCT01449721|8826744|P1|Overall Study|Physician Decision|0
2551000|NCT01449721|8826743|P2|Overall Study|Physician Decision|1
2551001|NCT01449721|8826744|P1|Overall Study|Physician Decision|0
2551002|NCT01449708|8826756|P2|Overall Study|respiratory failure|0
2551003|NCT01449708|8826757|P1|Overall Study|respiratory failure|1
2551004|NCT01449708|8826756|P2|Overall Study|surgical complication|2
2551005|NCT01449708|8826757|P1|Overall Study|surgical complication|1
2551006|NCT01449708|8826756|P2|Overall Study|Protocol Violation|1
2551007|NCT01449708|8826757|P1|Overall Study|Protocol Violation|0
2551008|NCT01449682|8826768|P2|Overall Study|Adverse Event|0
2551009|NCT01449682|8826769|P1|Overall Study|Adverse Event|1
2551010|NCT01449682|8826768|P2|Overall Study|Death|1
2551011|NCT01449682|8826769|P1|Overall Study|Death|0
2551012|NCT01449630|8826790|P9|Period 2|Sponsor Decision|0
2551013|NCT01449630|8826791|P8|Period 2|Sponsor Decision|0
2551014|NCT01449630|8826792|P7|Period 2|Sponsor Decision|1
2551015|NCT01449630|8826793|P6|Period 2|Sponsor Decision|0
2551016|NCT01449630|8826794|P5|Period 2|Sponsor Decision|0
2551017|NCT01449630|8826795|P4|Period 2|Sponsor Decision|0
2551018|NCT01449630|8826796|P3|Period 2|Sponsor Decision|0
2551019|NCT01449630|8826797|P2|Period 2|Sponsor Decision|0
2551020|NCT01449630|8826798|P1|Period 2|Sponsor Decision|0
2551021|NCT01449630|8826790|P9|Period 1|Sponsor Decision|0
2551022|NCT01449630|8826791|P8|Period 1|Sponsor Decision|0
2551023|NCT01449630|8826792|P7|Period 1|Sponsor Decision|0
2551024|NCT01449630|8826793|P6|Period 1|Sponsor Decision|1
2551025|NCT01449630|8826794|P5|Period 1|Sponsor Decision|0
2551026|NCT01449630|8826795|P4|Period 1|Sponsor Decision|0
2551027|NCT01449630|8826796|P3|Period 1|Sponsor Decision|0
2551028|NCT01449630|8826797|P2|Period 1|Sponsor Decision|0
2551029|NCT01449630|8826798|P1|Period 1|Sponsor Decision|0
2551030|NCT01449630|8826790|P9|Period 1|Physician Decision|0
2551031|NCT01449630|8826791|P8|Period 1|Physician Decision|0
2551032|NCT01449630|8826792|P7|Period 1|Physician Decision|0
2551033|NCT01449630|8826793|P6|Period 1|Physician Decision|0
2551034|NCT01449630|8826794|P5|Period 1|Physician Decision|0
2551035|NCT01449630|8826795|P4|Period 1|Physician Decision|1
2551036|NCT01449630|8826796|P3|Period 1|Physician Decision|0
2551037|NCT01449630|8826797|P2|Period 1|Physician Decision|0
2551038|NCT01449630|8826798|P1|Period 1|Physician Decision|1
2551039|NCT01449539|8826868|P1|Overall Study|Toxicity not study related|1
2551040|NCT01449539|8826868|P1|Overall Study|Withdrawal by Subject|3
2551041|NCT01449526|8826874|P2|Overall Study|Cannot maintain visits|1
2551042|NCT01449526|8826875|P1|Overall Study|Cannot maintain visits|0
2551043|NCT01449526|8826874|P2|Overall Study|Lack of Motivation|1
2551044|NCT01449526|8826875|P1|Overall Study|Lack of Motivation|0
2551045|NCT01449526|8826874|P2|Overall Study|Symptoms/complaints|1
2551046|NCT01449526|8826875|P1|Overall Study|Symptoms/complaints|0
2551047|NCT01449526|8826874|P2|Overall Study|Withdrawal by Subject|1
2551048|NCT01449526|8826875|P1|Overall Study|Withdrawal by Subject|1
2551049|NCT01449526|8826874|P2|Overall Study|Lost to Follow-up|2
2551050|NCT01449526|8826875|P1|Overall Study|Lost to Follow-up|1
2551051|NCT01449461|8826944|P6|Overall Study|Reason not specified|1
2551052|NCT01449461|8826945|P5|Overall Study|Reason not specified|0
2551053|NCT01449461|8826946|P4|Overall Study|Reason not specified|3
2551054|NCT01449461|8826947|P3|Overall Study|Reason not specified|0
2551055|NCT01449461|8826948|P2|Overall Study|Reason not specified|1
2551056|NCT01449461|8826949|P1|Overall Study|Reason not specified|0
2551057|NCT01449461|8826944|P6|Overall Study|Clinical progressive disease|3
2551058|NCT01449461|8826945|P5|Overall Study|Clinical progressive disease|3
2551059|NCT01449461|8826946|P4|Overall Study|Clinical progressive disease|0
2551060|NCT01449461|8826947|P3|Overall Study|Clinical progressive disease|0
2551061|NCT01449461|8826948|P2|Overall Study|Clinical progressive disease|1
2551062|NCT01449461|8826949|P1|Overall Study|Clinical progressive disease|2
2551063|NCT01449461|8826944|P6|Overall Study|Documented progressive disease|5
2551064|NCT01449461|8826945|P5|Overall Study|Documented progressive disease|21
2551065|NCT01449461|8826946|P4|Overall Study|Documented progressive disease|11
2551066|NCT01449461|8826947|P3|Overall Study|Documented progressive disease|14
2551067|NCT01449461|8826948|P2|Overall Study|Documented progressive disease|6
2551068|NCT01449461|8826949|P1|Overall Study|Documented progressive disease|4
2551069|NCT01449461|8826944|P6|Overall Study|Death|1
2551070|NCT01449461|8826945|P5|Overall Study|Death|4
2551071|NCT01449461|8826946|P4|Overall Study|Death|0
2551072|NCT01449461|8826947|P3|Overall Study|Death|0
2551073|NCT01449461|8826948|P2|Overall Study|Death|1
2551074|NCT01449461|8826949|P1|Overall Study|Death|0
2551075|NCT01449461|8826944|P6|Overall Study|Adverse Event|3
2551076|NCT01449461|8826945|P5|Overall Study|Adverse Event|3
2551077|NCT01449461|8826946|P4|Overall Study|Adverse Event|3
2551078|NCT01449461|8826947|P3|Overall Study|Adverse Event|2
2551079|NCT01449461|8826948|P2|Overall Study|Adverse Event|3
2551080|NCT01449461|8826949|P1|Overall Study|Adverse Event|0
2551081|NCT01449461|8826944|P6|Overall Study|Ongoing|2
2551082|NCT01449461|8826945|P5|Overall Study|Ongoing|17
2551083|NCT01449461|8826946|P4|Overall Study|Ongoing|15
2551084|NCT01449461|8826947|P3|Overall Study|Ongoing|2
2551085|NCT01449461|8826948|P2|Overall Study|Ongoing|6
2551086|NCT01449461|8826949|P1|Overall Study|Ongoing|0
2551087|NCT01449370|8827086|P25|Overall Study|Death|1
2551088|NCT01449370|8827087|P24|Overall Study|Death|0
2551089|NCT01449370|8827088|P23|Overall Study|Death|0
2551090|NCT01449370|8827089|P22|Overall Study|Death|0
2551091|NCT01449370|8827090|P21|Overall Study|Death|0
2551092|NCT01449370|8827091|P20|Overall Study|Death|0
2551093|NCT01449370|8827092|P19|Overall Study|Death|0
2551094|NCT01449370|8827093|P18|Overall Study|Death|0
2551095|NCT01449370|8827094|P17|Overall Study|Death|0
2551096|NCT01449370|8827095|P16|Overall Study|Death|0
2551097|NCT01449370|8827096|P15|Overall Study|Death|0
2551098|NCT01449370|8827097|P14|Overall Study|Death|0
2551099|NCT01449370|8827098|P13|Overall Study|Death|0
2551100|NCT01449370|8827099|P12|Overall Study|Death|0
2551101|NCT01449370|8827100|P11|Overall Study|Death|0
2551102|NCT01449370|8827101|P10|Overall Study|Death|0
2551103|NCT01449370|8827102|P9|Overall Study|Death|0
2551104|NCT01449370|8827103|P8|Overall Study|Death|0
2551105|NCT01449370|8827104|P7|Overall Study|Death|0
2551106|NCT01449370|8827105|P6|Overall Study|Death|0
2551107|NCT01449370|8827106|P5|Overall Study|Death|0
2551108|NCT01449370|8827107|P4|Overall Study|Death|0
2551109|NCT01449370|8827108|P3|Overall Study|Death|0
2551110|NCT01449370|8827109|P2|Overall Study|Death|0
2551111|NCT01449370|8827110|P1|Overall Study|Death|0
2551112|NCT01449370|8827086|P25|Overall Study|Medication Prohibited by Protocol|0
2551113|NCT01449370|8827087|P24|Overall Study|Medication Prohibited by Protocol|1
2551114|NCT01449370|8827088|P23|Overall Study|Medication Prohibited by Protocol|0
2551115|NCT01449370|8827089|P22|Overall Study|Medication Prohibited by Protocol|0
2551116|NCT01449370|8827090|P21|Overall Study|Medication Prohibited by Protocol|0
2551117|NCT01449370|8827091|P20|Overall Study|Medication Prohibited by Protocol|0
2551118|NCT01449370|8827092|P19|Overall Study|Medication Prohibited by Protocol|0
2551119|NCT01449370|8827093|P18|Overall Study|Medication Prohibited by Protocol|0
2551120|NCT01449370|8827094|P17|Overall Study|Medication Prohibited by Protocol|0
2551121|NCT01449370|8827095|P16|Overall Study|Medication Prohibited by Protocol|0
2551122|NCT01449370|8827096|P15|Overall Study|Medication Prohibited by Protocol|0
2551123|NCT01449370|8827097|P14|Overall Study|Medication Prohibited by Protocol|0
2551124|NCT01449370|8827098|P13|Overall Study|Medication Prohibited by Protocol|0
2551125|NCT01449370|8827099|P12|Overall Study|Medication Prohibited by Protocol|0
2551126|NCT01449370|8827100|P11|Overall Study|Medication Prohibited by Protocol|0
2551127|NCT01449370|8827101|P10|Overall Study|Medication Prohibited by Protocol|0
2551128|NCT01449370|8827102|P9|Overall Study|Medication Prohibited by Protocol|0
2551129|NCT01449370|8827103|P8|Overall Study|Medication Prohibited by Protocol|0
2551130|NCT01449370|8827104|P7|Overall Study|Medication Prohibited by Protocol|0
2551131|NCT01449370|8827105|P6|Overall Study|Medication Prohibited by Protocol|0
2551132|NCT01449370|8827106|P5|Overall Study|Medication Prohibited by Protocol|0
2551133|NCT01449370|8827107|P4|Overall Study|Medication Prohibited by Protocol|0
2551134|NCT01449370|8827108|P3|Overall Study|Medication Prohibited by Protocol|0
2551135|NCT01449370|8827109|P2|Overall Study|Medication Prohibited by Protocol|0
2551136|NCT01449370|8827110|P1|Overall Study|Medication Prohibited by Protocol|0
2551137|NCT01449370|8827086|P25|Overall Study|Other|0
2551138|NCT01449370|8827087|P24|Overall Study|Other|1
2551139|NCT01449370|8827088|P23|Overall Study|Other|1
2551140|NCT01449370|8827089|P22|Overall Study|Other|0
2551141|NCT01449370|8827090|P21|Overall Study|Other|0
2551142|NCT01449370|8827091|P20|Overall Study|Other|0
2551143|NCT01449370|8827092|P19|Overall Study|Other|0
2551144|NCT01449370|8827093|P18|Overall Study|Other|0
2551145|NCT01449370|8827094|P17|Overall Study|Other|0
2551146|NCT01449370|8827095|P16|Overall Study|Other|0
2551147|NCT01449370|8827096|P15|Overall Study|Other|0
2551148|NCT01449370|8827097|P14|Overall Study|Other|0
2551149|NCT01449370|8827098|P13|Overall Study|Other|0
2551150|NCT01449370|8827099|P12|Overall Study|Other|0
2551151|NCT01449370|8827100|P11|Overall Study|Other|0
2551152|NCT01449370|8827101|P10|Overall Study|Other|1
2551153|NCT01449370|8827102|P9|Overall Study|Other|1
2551154|NCT01449370|8827103|P8|Overall Study|Other|0
2551155|NCT01449370|8827104|P7|Overall Study|Other|0
2551156|NCT01449370|8827105|P6|Overall Study|Other|0
2551157|NCT01449370|8827106|P5|Overall Study|Other|0
2551158|NCT01449370|8827107|P4|Overall Study|Other|0
2551159|NCT01449370|8827108|P3|Overall Study|Other|0
2551160|NCT01449370|8827109|P2|Overall Study|Other|0
2551161|NCT01449370|8827110|P1|Overall Study|Other|0
2551162|NCT01449370|8827086|P25|Overall Study|Lost to Follow-up|0
2551163|NCT01449370|8827087|P24|Overall Study|Lost to Follow-up|0
2551164|NCT01449370|8827088|P23|Overall Study|Lost to Follow-up|0
2551165|NCT01449370|8827089|P22|Overall Study|Lost to Follow-up|0
2551166|NCT01449370|8827090|P21|Overall Study|Lost to Follow-up|1
2551167|NCT01449370|8827091|P20|Overall Study|Lost to Follow-up|0
2551168|NCT01449370|8827092|P19|Overall Study|Lost to Follow-up|0
2551169|NCT01449370|8827093|P18|Overall Study|Lost to Follow-up|0
2551170|NCT01449370|8827094|P17|Overall Study|Lost to Follow-up|0
2551171|NCT01449370|8827095|P16|Overall Study|Lost to Follow-up|0
2551172|NCT01449370|8827096|P15|Overall Study|Lost to Follow-up|0
2551173|NCT01449370|8827097|P14|Overall Study|Lost to Follow-up|0
2551174|NCT01449370|8827098|P13|Overall Study|Lost to Follow-up|0
2551175|NCT01449370|8827099|P12|Overall Study|Lost to Follow-up|0
2551176|NCT01449370|8827100|P11|Overall Study|Lost to Follow-up|0
2551177|NCT01449370|8827101|P10|Overall Study|Lost to Follow-up|0
2551178|NCT01449370|8827102|P9|Overall Study|Lost to Follow-up|0
2551179|NCT01449370|8827103|P8|Overall Study|Lost to Follow-up|0
2551180|NCT01449370|8827104|P7|Overall Study|Lost to Follow-up|0
2551181|NCT01449370|8827105|P6|Overall Study|Lost to Follow-up|0
2551182|NCT01449370|8827106|P5|Overall Study|Lost to Follow-up|0
2551183|NCT01449370|8827107|P4|Overall Study|Lost to Follow-up|0
2551184|NCT01449370|8827108|P3|Overall Study|Lost to Follow-up|0
2551185|NCT01449370|8827109|P2|Overall Study|Lost to Follow-up|0
2551186|NCT01449370|8827110|P1|Overall Study|Lost to Follow-up|0
2551187|NCT01449370|8827086|P25|Overall Study|Participant Decision|1
2551188|NCT01449370|8827087|P24|Overall Study|Participant Decision|0
2551189|NCT01449370|8827088|P23|Overall Study|Participant Decision|0
2551190|NCT01449370|8827089|P22|Overall Study|Participant Decision|1
2551191|NCT01449370|8827090|P21|Overall Study|Participant Decision|0
2551192|NCT01449370|8827091|P20|Overall Study|Participant Decision|0
2551193|NCT01449370|8827092|P19|Overall Study|Participant Decision|1
2551194|NCT01449370|8827093|P18|Overall Study|Participant Decision|0
2551195|NCT01449370|8827094|P17|Overall Study|Participant Decision|3
2551196|NCT01449370|8827095|P16|Overall Study|Participant Decision|1
2551197|NCT01449370|8827096|P15|Overall Study|Participant Decision|0
2551198|NCT01449370|8827097|P14|Overall Study|Participant Decision|1
2551199|NCT01449370|8827098|P13|Overall Study|Participant Decision|1
2551200|NCT01449370|8827099|P12|Overall Study|Participant Decision|0
2551201|NCT01449370|8827100|P11|Overall Study|Participant Decision|0
2551202|NCT01449370|8827101|P10|Overall Study|Participant Decision|0
2551203|NCT01449370|8827102|P9|Overall Study|Participant Decision|1
2551204|NCT01449370|8827103|P8|Overall Study|Participant Decision|1
2551205|NCT01449370|8827104|P7|Overall Study|Participant Decision|0
2551206|NCT01449370|8827105|P6|Overall Study|Participant Decision|0
2551207|NCT01449370|8827106|P5|Overall Study|Participant Decision|0
2551208|NCT01449370|8827107|P4|Overall Study|Participant Decision|0
2551209|NCT01449370|8827108|P3|Overall Study|Participant Decision|0
2551210|NCT01449370|8827109|P2|Overall Study|Participant Decision|0
2551211|NCT01449370|8827110|P1|Overall Study|Participant Decision|0
2551212|NCT01449370|8827086|P25|Overall Study|Adverse Event|3
2551213|NCT01449370|8827087|P24|Overall Study|Adverse Event|1
2551214|NCT01449370|8827088|P23|Overall Study|Adverse Event|0
2551215|NCT01449370|8827089|P22|Overall Study|Adverse Event|1
2551216|NCT01449370|8827090|P21|Overall Study|Adverse Event|0
2551217|NCT01449370|8827091|P20|Overall Study|Adverse Event|1
2551218|NCT01449370|8827092|P19|Overall Study|Adverse Event|1
2551219|NCT01449370|8827093|P18|Overall Study|Adverse Event|0
2551220|NCT01449370|8827094|P17|Overall Study|Adverse Event|0
2551221|NCT01449370|8827095|P16|Overall Study|Adverse Event|1
2551222|NCT01449370|8827096|P15|Overall Study|Adverse Event|0
2551223|NCT01449370|8827097|P14|Overall Study|Adverse Event|2
2551224|NCT01449370|8827098|P13|Overall Study|Adverse Event|0
2551225|NCT01449370|8827099|P12|Overall Study|Adverse Event|0
2551226|NCT01449370|8827100|P11|Overall Study|Adverse Event|0
2551227|NCT01449370|8827101|P10|Overall Study|Adverse Event|1
2551228|NCT01449370|8827102|P9|Overall Study|Adverse Event|1
2551229|NCT01449370|8827103|P8|Overall Study|Adverse Event|0
2551230|NCT01449370|8827104|P7|Overall Study|Adverse Event|0
2551231|NCT01449370|8827105|P6|Overall Study|Adverse Event|0
2551232|NCT01449370|8827106|P5|Overall Study|Adverse Event|0
2551233|NCT01449370|8827107|P4|Overall Study|Adverse Event|1
2551234|NCT01449370|8827108|P3|Overall Study|Adverse Event|0
2551235|NCT01449370|8827109|P2|Overall Study|Adverse Event|2
2551236|NCT01449370|8827110|P1|Overall Study|Adverse Event|1
2551237|NCT01449370|8827086|P25|Overall Study|Disease Progression|3
2551238|NCT01449370|8827087|P24|Overall Study|Disease Progression|7
2551239|NCT01449370|8827088|P23|Overall Study|Disease Progression|3
2551240|NCT01449370|8827089|P22|Overall Study|Disease Progression|2
2551241|NCT01449370|8827090|P21|Overall Study|Disease Progression|5
2551242|NCT01449370|8827091|P20|Overall Study|Disease Progression|2
2551243|NCT01449370|8827092|P19|Overall Study|Disease Progression|1
2551244|NCT01449370|8827093|P18|Overall Study|Disease Progression|3
2551245|NCT01449370|8827094|P17|Overall Study|Disease Progression|4
2551246|NCT01449370|8827095|P16|Overall Study|Disease Progression|1
2551247|NCT01449370|8827096|P15|Overall Study|Disease Progression|3
2551248|NCT01449370|8827097|P14|Overall Study|Disease Progression|8
2551249|NCT01449370|8827098|P13|Overall Study|Disease Progression|2
2551250|NCT01449370|8827099|P12|Overall Study|Disease Progression|3
2551251|NCT01449370|8827100|P11|Overall Study|Disease Progression|3
2551252|NCT01449370|8827101|P10|Overall Study|Disease Progression|1
2551253|NCT01449370|8827102|P9|Overall Study|Disease Progression|9
2551254|NCT01449370|8827103|P8|Overall Study|Disease Progression|2
2551255|NCT01449370|8827104|P7|Overall Study|Disease Progression|3
2551256|NCT01449370|8827105|P6|Overall Study|Disease Progression|3
2551257|NCT01449370|8827106|P5|Overall Study|Disease Progression|3
2551258|NCT01449370|8827107|P4|Overall Study|Disease Progression|3
2551259|NCT01449370|8827108|P3|Overall Study|Disease Progression|8
2551260|NCT01449370|8827109|P2|Overall Study|Disease Progression|4
2551261|NCT01449370|8827110|P1|Overall Study|Disease Progression|5
2551262|NCT01449279|8827488|P1|Overall Study|Toxicity|2
2551263|NCT01449279|8827488|P1|Overall Study|Lack of Efficacy|5
2551264|NCT01449006|8827513|P2|Overall Study|Protocol Violation|0
2551265|NCT01449006|8827514|P1|Overall Study|Protocol Violation|1
2551266|NCT01449006|8827513|P2|Overall Study|Withdrawal by Subject|0
2551267|NCT01449006|8827514|P1|Overall Study|Withdrawal by Subject|1
2551268|NCT01449006|8827513|P2|Overall Study|Lost to Follow-up|0
2551269|NCT01449006|8827514|P1|Overall Study|Lost to Follow-up|1
2551270|NCT01448850|8827528|P2|Overall Study|Other|12
2551271|NCT01448850|8827529|P1|Overall Study|Other|15
2551272|NCT01448850|8827528|P2|Overall Study|Lost to Follow-up|1
2551273|NCT01448850|8827529|P1|Overall Study|Lost to Follow-up|3
2551274|NCT01448850|8827528|P2|Overall Study|Withdrawal by Subject|21
2551275|NCT01448850|8827529|P1|Overall Study|Withdrawal by Subject|13
2551276|NCT01448850|8827528|P2|Overall Study|Death|6
2551277|NCT01448850|8827529|P1|Overall Study|Death|3
2551278|NCT01448824|8827560|P8|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1
2551279|NCT01448824|8827561|P7|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
2551280|NCT01448824|8827562|P6|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
2551281|NCT01448824|8827563|P5|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
2551282|NCT01448824|8827564|P4|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
2551283|NCT01448824|8827565|P3|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
2551284|NCT01448824|8827566|P2|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
2551285|NCT01448824|8827567|P1|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
2551286|NCT01448824|8827560|P8|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1
2551287|NCT01448824|8827561|P7|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
2551288|NCT01448824|8827562|P6|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
2551289|NCT01448824|8827563|P5|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
2551290|NCT01448824|8827564|P4|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
2551291|NCT01448824|8827565|P3|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
2551292|NCT01448824|8827566|P2|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
2551293|NCT01448824|8827567|P1|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
2551294|NCT01448824|8827560|P8|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1
2551295|NCT01448824|8827561|P7|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
2551296|NCT01448824|8827562|P6|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
2551297|NCT01448824|8827563|P5|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
2551298|NCT01448824|8827564|P4|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
2551299|NCT01448824|8827565|P3|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
2551300|NCT01448824|8827566|P2|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
2551301|NCT01448824|8827567|P1|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
2551302|NCT01448824|8827560|P8|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1
2551303|NCT01448824|8827561|P7|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
2551304|NCT01448824|8827562|P6|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
2551305|NCT01448824|8827563|P5|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
2551306|NCT01448824|8827564|P4|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
2551307|NCT01448824|8827565|P3|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
2551308|NCT01448824|8827566|P2|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
2551309|NCT01448824|8827567|P1|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
2551310|NCT01448824|8827560|P8|Part 1: Washout Period|Lost to Follow-up|0
2551311|NCT01448824|8827561|P7|Part 1: Washout Period|Lost to Follow-up|0
2551312|NCT01448824|8827562|P6|Part 1: Washout Period|Lost to Follow-up|0
2551313|NCT01448824|8827563|P5|Part 1: Washout Period|Lost to Follow-up|0
2551314|NCT01448824|8827564|P4|Part 1: Washout Period|Lost to Follow-up|0
2551315|NCT01448824|8827565|P3|Part 1: Washout Period|Lost to Follow-up|0
2551316|NCT01448824|8827566|P2|Part 1: Washout Period|Lost to Follow-up|0
2551317|NCT01448824|8827567|P1|Part 1: Washout Period|Lost to Follow-up|1
2551318|NCT01448824|8827560|P8|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
2551319|NCT01448824|8827561|P7|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
2551320|NCT01448824|8827562|P6|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1
2551321|NCT01448824|8827563|P5|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
2551322|NCT01448824|8827564|P4|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
2551323|NCT01448824|8827565|P3|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
2551324|NCT01448824|8827566|P2|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
2551325|NCT01448824|8827567|P1|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
2551326|NCT01448824|8827560|P8|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
2551327|NCT01448824|8827561|P7|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
2551328|NCT01448824|8827562|P6|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1
2551329|NCT01448824|8827563|P5|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2
2551330|NCT01448824|8827564|P4|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1
2551331|NCT01448824|8827565|P3|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
2551332|NCT01448824|8827566|P2|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
2551333|NCT01448824|8827567|P1|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
2551334|NCT01448824|8827560|P8|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
2551335|NCT01448824|8827561|P7|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1
2551336|NCT01448824|8827562|P6|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
2551337|NCT01448824|8827563|P5|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
2551338|NCT01448824|8827564|P4|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
2551339|NCT01448824|8827565|P3|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
2551340|NCT01448824|8827566|P2|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
2551341|NCT01448824|8827567|P1|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
2551342|NCT01448707|8827618|P2|Overall Study|Other|4
2551343|NCT01448707|8827619|P1|Overall Study|Other|7
2551344|NCT01448707|8827618|P2|Overall Study|Withdrawal by Subject|7
2551345|NCT01448707|8827619|P1|Overall Study|Withdrawal by Subject|6
2551346|NCT01448707|8827618|P2|Overall Study|Lost to Follow-up|6
2551347|NCT01448707|8827619|P1|Overall Study|Lost to Follow-up|2
2551348|NCT01448707|8827618|P2|Overall Study|Adverse Event|1
2551349|NCT01448707|8827619|P1|Overall Study|Adverse Event|3
2551350|NCT01448616|8827640|P4|Study Drug (Treatment Phase)|Withdrawal by Subject|2
2551351|NCT01448616|8827641|P3|Study Drug (Treatment Phase)|Withdrawal by Subject|2
2551352|NCT01448616|8827642|P2|Study Drug (Treatment Phase)|Withdrawal by Subject|1
2551353|NCT01448616|8827643|P1|Study Drug (Treatment Phase)|Withdrawal by Subject|0
2551354|NCT01448616|8827640|P4|Study Drug (Treatment Phase)|Never initiated study drug|2
2551355|NCT01448616|8827641|P3|Study Drug (Treatment Phase)|Never initiated study drug|1
2551356|NCT01448616|8827642|P2|Study Drug (Treatment Phase)|Never initiated study drug|0
2551357|NCT01448616|8827643|P1|Study Drug (Treatment Phase)|Never initiated study drug|0
2551358|NCT01448616|8827640|P4|Study Drug (Treatment Phase)|Adverse Event|0
2551359|NCT01448616|8827641|P3|Study Drug (Treatment Phase)|Adverse Event|1
2551360|NCT01448616|8827642|P2|Study Drug (Treatment Phase)|Adverse Event|1
2551361|NCT01448616|8827643|P1|Study Drug (Treatment Phase)|Adverse Event|0
2551362|NCT01448616|8827640|P4|Lead-In (Observational Phase)|Collected <90% of required swabs|0
2551363|NCT01448616|8827641|P3|Lead-In (Observational Phase)|Collected <90% of required swabs|0
2551364|NCT01448616|8827642|P2|Lead-In (Observational Phase)|Collected <90% of required swabs|0
2551365|NCT01448616|8827643|P1|Lead-In (Observational Phase)|Collected <90% of required swabs|6
2551366|NCT01448616|8827640|P4|Lead-In (Observational Phase)|Collected no genital swabs|0
2551367|NCT01448616|8827641|P3|Lead-In (Observational Phase)|Collected no genital swabs|0
2551368|NCT01448616|8827642|P2|Lead-In (Observational Phase)|Collected no genital swabs|0
2551369|NCT01448616|8827643|P1|Lead-In (Observational Phase)|Collected no genital swabs|3
2551370|NCT01448213|8827690|P2|Overall Study|Protocol Violation|2
2551371|NCT01448213|8827691|P1|Overall Study|Protocol Violation|1
2551372|NCT01448213|8827690|P2|Overall Study|Adverse Event|10
2551373|NCT01448213|8827691|P1|Overall Study|Adverse Event|4
2551374|NCT01448213|8827690|P2|Overall Study|Lost to Follow-up|10
2551375|NCT01448213|8827691|P1|Overall Study|Lost to Follow-up|12
2551376|NCT01448057|8827701|P2|Overall Study|Withdrawal by Subject|0
2551377|NCT01448057|8827702|P1|Overall Study|Withdrawal by Subject|2
2551378|NCT01448057|8827701|P2|Overall Study|Adverse Event|2
2551379|NCT01448057|8827702|P1|Overall Study|Adverse Event|0
2551380|NCT01448057|8827701|P2|Overall Study|Lost to Follow-up|0
2551381|NCT01448057|8827702|P1|Overall Study|Lost to Follow-up|3
2551382|NCT01448057|8827701|P2|Overall Study|Protocol Violation|2
2551383|NCT01448057|8827702|P1|Overall Study|Protocol Violation|3
2551384|NCT01448044|8827712|P2|Follow Up Period|Other|11
2551385|NCT01448044|8827713|P1|Follow Up Period|Other|5
2551386|NCT01448044|8827712|P2|Follow Up Period|Lost to Follow-up|2
2551387|NCT01448044|8827713|P1|Follow Up Period|Lost to Follow-up|6
2551388|NCT01448044|8827712|P2|Follow Up Period|Withdrawal by Subject|1
2551389|NCT01448044|8827713|P1|Follow Up Period|Withdrawal by Subject|1
2551390|NCT01448044|8827712|P2|Treatment Period|Other reason|0
2551391|NCT01448044|8827713|P1|Treatment Period|Other reason|2
2551392|NCT01448044|8827712|P2|Treatment Period|Lost to Follow-up|1
2551393|NCT01448044|8827713|P1|Treatment Period|Lost to Follow-up|2
2551394|NCT01448044|8827712|P2|Treatment Period|Participant does not meet study criteria|0
2551395|NCT01448044|8827713|P1|Treatment Period|Participant does not meet study criteria|1
2551396|NCT01448044|8827712|P2|Treatment Period|Completed 24 weeks treatment period only|0
2551397|NCT01448044|8827713|P1|Treatment Period|Completed 24 weeks treatment period only|8
2551398|NCT01448044|8827712|P2|Treatment Period|Subject requested discontinue study drug|0
2551399|NCT01448044|8827713|P1|Treatment Period|Subject requested discontinue study drug|1
2551400|NCT01448044|8827712|P2|Treatment Period|Lack of Efficacy|12
2551401|NCT01448044|8827713|P1|Treatment Period|Lack of Efficacy|5
2551402|NCT01448044|8827712|P2|Treatment Period|Adverse Event|3
2551403|NCT01448044|8827713|P1|Treatment Period|Adverse Event|4
2551404|NCT01447927|8827729|P2|Overall Study|Withdrawal by Subject|0
2551405|NCT01447927|8827730|P1|Overall Study|Withdrawal by Subject|1
2551406|NCT01447927|8827729|P2|Overall Study|Adverse Event|3
2551407|NCT01447927|8827730|P1|Overall Study|Adverse Event|4
2551408|NCT01447719|8827775|P1|Overall Study|Family withdrew autopsy consent|7
2551409|NCT01447719|8827775|P1|Overall Study|Withdrawal by Subject|2
2551410|NCT01447719|8827775|P1|Overall Study|Subject still living at end of study|79
2551411|NCT01447719|8827775|P1|Overall Study|Invalid image or not imaged|3
2551412|NCT01447719|8827775|P1|Overall Study|Image acquisition failure|2
2551413|NCT01447576|8827801|P1|Overall Study|Physician Decision|6
2551414|NCT01447576|8827801|P1|Overall Study|Lack of Efficacy|68
2551415|NCT01447576|8827801|P1|Overall Study|Protocol deviation|83
2551416|NCT01447576|8827801|P1|Overall Study|Withdrawal by Subject|100
2551417|NCT01447576|8827801|P1|Overall Study|Participant met withdrawal criteria|40
2551418|NCT01447576|8827801|P1|Overall Study|Adverse Event|127
2551419|NCT01447576|8827801|P1|Overall Study|Lost to Follow-up|52
2551420|NCT01447446|8827834|P6|Overall Study|Reason not Specified|0
2551421|NCT01447446|8827835|P5|Overall Study|Reason not Specified|1
2551422|NCT01447446|8827836|P4|Overall Study|Reason not Specified|1
2551423|NCT01447446|8827837|P3|Overall Study|Reason not Specified|1
2551424|NCT01447446|8827838|P2|Overall Study|Reason not Specified|1
2551425|NCT01447446|8827839|P1|Overall Study|Reason not Specified|1
2551426|NCT01447446|8827834|P6|Overall Study|New Treatment Started|0
2551427|NCT01447446|8827835|P5|Overall Study|New Treatment Started|2
2551428|NCT01447446|8827836|P4|Overall Study|New Treatment Started|0
2551429|NCT01447446|8827837|P3|Overall Study|New Treatment Started|1
2551430|NCT01447446|8827838|P2|Overall Study|New Treatment Started|2
2551431|NCT01447446|8827839|P1|Overall Study|New Treatment Started|8
2551432|NCT01447446|8827834|P6|Overall Study|SVR12 Assessment|5
2551433|NCT01447446|8827835|P5|Overall Study|SVR12 Assessment|5
2551434|NCT01447446|8827836|P4|Overall Study|SVR12 Assessment|1
2551435|NCT01447446|8827837|P3|Overall Study|SVR12 Assessment|2
2551436|NCT01447446|8827838|P2|Overall Study|SVR12 Assessment|1
2551437|NCT01447446|8827839|P1|Overall Study|SVR12 Assessment|13
2551438|NCT01447446|8827834|P6|Overall Study|Administrative/Other|4
2551439|NCT01447446|8827835|P5|Overall Study|Administrative/Other|33
2551440|NCT01447446|8827836|P4|Overall Study|Administrative/Other|2
2551441|NCT01447446|8827837|P3|Overall Study|Administrative/Other|10
2551442|NCT01447446|8827838|P2|Overall Study|Administrative/Other|9
2551443|NCT01447446|8827839|P1|Overall Study|Administrative/Other|34
2551444|NCT01447446|8827834|P6|Overall Study|Insuff. VR/TRT too Short to Expect VR|14
2551445|NCT01447446|8827835|P5|Overall Study|Insuff. VR/TRT too Short to Expect VR|92
2551446|NCT01447446|8827836|P4|Overall Study|Insuff. VR/TRT too Short to Expect VR|21
2551447|NCT01447446|8827837|P3|Overall Study|Insuff. VR/TRT too Short to Expect VR|52
2551448|NCT01447446|8827838|P2|Overall Study|Insuff. VR/TRT too Short to Expect VR|71
2551449|NCT01447446|8827839|P1|Overall Study|Insuff. VR/TRT too Short to Expect VR|300
2551450|NCT01447446|8827834|P6|Overall Study|Failure to Return/Consent Withdrawn|9
2551451|NCT01447446|8827835|P5|Overall Study|Failure to Return/Consent Withdrawn|69
2551452|NCT01447446|8827836|P4|Overall Study|Failure to Return/Consent Withdrawn|7
2551453|NCT01447446|8827837|P3|Overall Study|Failure to Return/Consent Withdrawn|31
2551454|NCT01447446|8827838|P2|Overall Study|Failure to Return/Consent Withdrawn|78
2551455|NCT01447446|8827839|P1|Overall Study|Failure to Return/Consent Withdrawn|357
2551456|NCT01447446|8827834|P6|Overall Study|Adverse Event|0
2551457|NCT01447446|8827835|P5|Overall Study|Adverse Event|2
2551458|NCT01447446|8827836|P4|Overall Study|Adverse Event|0
2551459|NCT01447446|8827837|P3|Overall Study|Adverse Event|1
2551460|NCT01447446|8827838|P2|Overall Study|Adverse Event|0
2551461|NCT01447446|8827839|P1|Overall Study|Adverse Event|3
2551462|NCT01447446|8827834|P6|Overall Study|Death|0
2551463|NCT01447446|8827835|P5|Overall Study|Death|7
2551464|NCT01447446|8827836|P4|Overall Study|Death|1
2551465|NCT01447446|8827837|P3|Overall Study|Death|2
2551466|NCT01447446|8827838|P2|Overall Study|Death|3
2551467|NCT01447446|8827839|P1|Overall Study|Death|6
2551468|NCT01447433|8827929|P2|Overall Study|Protocol Violation|1
2551469|NCT01447433|8827930|P1|Overall Study|Protocol Violation|1
2551470|NCT01447433|8827929|P2|Overall Study|Withdrawal by Subject|3
2551471|NCT01447433|8827930|P1|Overall Study|Withdrawal by Subject|3
2551472|NCT01447433|8827929|P2|Overall Study|Lost to Follow-up|2
2551473|NCT01447433|8827930|P1|Overall Study|Lost to Follow-up|0
2551474|NCT01447420|8827957|P3|Overall Study|Lack of Efficacy|8
2551475|NCT01447420|8827958|P2|Overall Study|Lack of Efficacy|19
2551476|NCT01447420|8827959|P1|Overall Study|Lack of Efficacy|1
2551477|NCT01447420|8827957|P3|Overall Study|Withdrawal by Subject|0
2551478|NCT01447420|8827958|P2|Overall Study|Withdrawal by Subject|1
2551479|NCT01447420|8827959|P1|Overall Study|Withdrawal by Subject|4
2551480|NCT01447420|8827957|P3|Overall Study|Protocol Violation|0
2551481|NCT01447420|8827958|P2|Overall Study|Protocol Violation|3
2551482|NCT01447420|8827959|P1|Overall Study|Protocol Violation|3
2551483|NCT01447420|8827957|P3|Overall Study|Adverse Event|2
2551484|NCT01447420|8827958|P2|Overall Study|Adverse Event|4
2551485|NCT01447420|8827959|P1|Overall Study|Adverse Event|2
2551486|NCT01447407|8827979|P4|Overall Study|Physician Decision|1
2551487|NCT01447407|8827980|P3|Overall Study|Physician Decision|1
2551488|NCT01447407|8827981|P2|Overall Study|Physician Decision|0
2551489|NCT01447407|8827982|P1|Overall Study|Physician Decision|0
2551490|NCT01447407|8827979|P4|Overall Study|Withdrawal by Subject|1
2551491|NCT01447407|8827980|P3|Overall Study|Withdrawal by Subject|0
2551492|NCT01447407|8827981|P2|Overall Study|Withdrawal by Subject|0
2551493|NCT01447407|8827982|P1|Overall Study|Withdrawal by Subject|2
2551494|NCT01446874|8828116|P3|Overall Study|Withdrawal by Subject|4
2551495|NCT01446874|8828117|P2|Overall Study|Withdrawal by Subject|0
2551496|NCT01446874|8828118|P1|Overall Study|Withdrawal by Subject|0
2551497|NCT01446874|8828116|P3|Overall Study|Antibiotics for pre-op infection|2
2551498|NCT01446874|8828117|P2|Overall Study|Antibiotics for pre-op infection|0
2551499|NCT01446874|8828118|P1|Overall Study|Antibiotics for pre-op infection|0
2551500|NCT01446874|8828116|P3|Overall Study|Non-compliance|0
2551501|NCT01446874|8828117|P2|Overall Study|Non-compliance|4
2551502|NCT01446874|8828118|P1|Overall Study|Non-compliance|0
2551503|NCT01446874|8828116|P3|Overall Study|No surgery/No qualifying surgery|12
2551504|NCT01446874|8828117|P2|Overall Study|No surgery/No qualifying surgery|0
2551505|NCT01446874|8828118|P1|Overall Study|No surgery/No qualifying surgery|1
2551506|NCT01446874|8828116|P3|Overall Study|Not eligible|0
2551507|NCT01446874|8828117|P2|Overall Study|Not eligible|0
2551508|NCT01446874|8828118|P1|Overall Study|Not eligible|1
2551509|NCT01446809|8828146|P3|Overall Study|Failure to complete study procedures|1
2551510|NCT01446809|8828147|P2|Overall Study|Failure to complete study procedures|0
2551511|NCT01446809|8828148|P1|Overall Study|Failure to complete study procedures|0
2551512|NCT01446809|8828146|P3|Overall Study|Adverse Event|1
2551513|NCT01446809|8828147|P2|Overall Study|Adverse Event|0
2551514|NCT01446809|8828148|P1|Overall Study|Adverse Event|0
2551515|NCT01446796|8828171|P2|Overall Study|Withdrawal by Subject|0
2551516|NCT01446796|8828172|P1|Overall Study|Withdrawal by Subject|1
2551517|NCT01446419|8828218|P2|Overall Study|Terminated per protocol|0
2551518|NCT01446419|8828219|P1|Overall Study|Terminated per protocol|3
2551519|NCT01446419|8828218|P2|Overall Study|Withdrawal by Subject|1
2551520|NCT01446419|8828219|P1|Overall Study|Withdrawal by Subject|1
2551521|NCT01446419|8828218|P2|Overall Study|Death|0
2551522|NCT01446419|8828219|P1|Overall Study|Death|1
2551523|NCT01446289|8828233|P4|Overall Study|Withdrawal by Subject|0
2551524|NCT01446289|8828234|P3|Overall Study|Withdrawal by Subject|1
2551525|NCT01446289|8828235|P2|Overall Study|Withdrawal by Subject|0
2551526|NCT01446289|8828236|P1|Overall Study|Withdrawal by Subject|1
2551527|NCT01446237|8828279|P1|Overall Study|Withdrawal by Subject|7
2551528|NCT01446237|8828279|P1|Overall Study|Lost to Follow-up|2
2551529|NCT01446237|8828279|P1|Overall Study|Adverse Event|1
2551530|NCT01446159|8828291|P4|Overall Study|Other|13
2551531|NCT01446159|8828292|P3|Overall Study|Other|14
2551532|NCT01446159|8828293|P2|Overall Study|Other|0
2551533|NCT01446159|8828294|P1|Overall Study|Other|0
2551534|NCT01446159|8828291|P4|Overall Study|Death|36
2551535|NCT01446159|8828292|P3|Overall Study|Death|43
2551536|NCT01446159|8828293|P2|Overall Study|Death|3
2551537|NCT01446159|8828294|P1|Overall Study|Death|2
2551538|NCT01446159|8828291|P4|Overall Study|Lost to Follow-up|2
2551539|NCT01446159|8828292|P3|Overall Study|Lost to Follow-up|1
2551540|NCT01446159|8828293|P2|Overall Study|Lost to Follow-up|0
2551541|NCT01446159|8828294|P1|Overall Study|Lost to Follow-up|0
2551542|NCT01446159|8828291|P4|Overall Study|Withdrawal by Subject|11
2551543|NCT01446159|8828292|P3|Overall Study|Withdrawal by Subject|14
2551544|NCT01446159|8828293|P2|Overall Study|Withdrawal by Subject|0
2551545|NCT01446159|8828294|P1|Overall Study|Withdrawal by Subject|1
2551546|NCT01446042|8828369|P3|Overall Study|Other reasons|1
2551547|NCT01446042|8828370|P2|Overall Study|Other reasons|1
2551548|NCT01446042|8828371|P1|Overall Study|Other reasons|2
2551549|NCT01446042|8828369|P3|Overall Study|Lost to Follow-up|0
2551550|NCT01446042|8828370|P2|Overall Study|Lost to Follow-up|0
2551551|NCT01446042|8828371|P1|Overall Study|Lost to Follow-up|5
2551552|NCT01446042|8828369|P3|Overall Study|Adverse Event|4
2551553|NCT01446042|8828370|P2|Overall Study|Adverse Event|0
2551554|NCT01446042|8828371|P1|Overall Study|Adverse Event|1
2551555|NCT01446042|8828369|P3|Overall Study|Withdrawal by Subject|4
2551556|NCT01446042|8828370|P2|Overall Study|Withdrawal by Subject|2
2551557|NCT01446042|8828371|P1|Overall Study|Withdrawal by Subject|12
2551558|NCT01446003|8828382|P2|Period 2|Adverse Event|0
2551559|NCT01446003|8828383|P1|Period 2|Adverse Event|1
2551560|NCT01446003|8828382|P2|Period 1|Protocol Violation|0
2551561|NCT01446003|8828383|P1|Period 1|Protocol Violation|2
2551562|NCT01445951|8828404|P3|Overall Study|Cough|0
2551563|NCT01445951|8828405|P2|Overall Study|Cough|1
2551564|NCT01445951|8828406|P1|Overall Study|Cough|0
2551565|NCT01445951|8828404|P3|Overall Study|Sponsor decision - subject travel|0
2551566|NCT01445951|8828405|P2|Overall Study|Sponsor decision - subject travel|1
2551567|NCT01445951|8828406|P1|Overall Study|Sponsor decision - subject travel|0
2551568|NCT01445951|8828404|P3|Overall Study|Non-compliance with protocol|0
2551569|NCT01445951|8828405|P2|Overall Study|Non-compliance with protocol|1
2551570|NCT01445951|8828406|P1|Overall Study|Non-compliance with protocol|0
2551571|NCT01445951|8828404|P3|Overall Study|Non-compliance with study drug|0
2551572|NCT01445951|8828405|P2|Overall Study|Non-compliance with study drug|2
2551573|NCT01445951|8828406|P1|Overall Study|Non-compliance with study drug|1
2551574|NCT01445951|8828404|P3|Overall Study|Death|1
2551575|NCT01445951|8828405|P2|Overall Study|Death|0
2551576|NCT01445951|8828406|P1|Overall Study|Death|0
2551577|NCT01445951|8828404|P3|Overall Study|Pregnancy|4
2551578|NCT01445951|8828405|P2|Overall Study|Pregnancy|1
2551579|NCT01445951|8828406|P1|Overall Study|Pregnancy|0
2551580|NCT01445951|8828404|P3|Overall Study|Lost to Follow-up|4
2551581|NCT01445951|8828405|P2|Overall Study|Lost to Follow-up|2
2551582|NCT01445951|8828406|P1|Overall Study|Lost to Follow-up|1
2551583|NCT01445951|8828404|P3|Overall Study|Physician Decision|0
2551584|NCT01445951|8828405|P2|Overall Study|Physician Decision|1
2551585|NCT01445951|8828406|P1|Overall Study|Physician Decision|3
2551586|NCT01445951|8828404|P3|Overall Study|Withdrawal by Subject|8
2551587|NCT01445951|8828405|P2|Overall Study|Withdrawal by Subject|16
2551588|NCT01445951|8828406|P1|Overall Study|Withdrawal by Subject|21
2551589|NCT01445951|8828404|P3|Overall Study|Protocol Violation|2
2551590|NCT01445951|8828405|P2|Overall Study|Protocol Violation|2
2551591|NCT01445951|8828406|P1|Overall Study|Protocol Violation|2
2551592|NCT01445951|8828404|P3|Overall Study|Adverse Event|0
2551593|NCT01445951|8828405|P2|Overall Study|Adverse Event|9
2551594|NCT01445951|8828406|P1|Overall Study|Adverse Event|16
2551595|NCT01445886|8828444|P1|Overall Study|Protocol Violation|3
2551596|NCT01445886|8828444|P1|Overall Study|Lost to Follow-up|2
2551597|NCT01445847|8828484|P2|Overall Study|Missed Data|0
2551598|NCT01445847|8828485|P1|Overall Study|Missed Data|1
2551599|NCT01445847|8828484|P2|Overall Study|Protocol Violation|14
2551600|NCT01445847|8828485|P1|Overall Study|Protocol Violation|13
2551601|NCT01445769|8828491|P1|Overall Study|Lost to Follow-up|5
2551602|NCT01445769|8828491|P1|Overall Study|Disease Progression|1
2551603|NCT01445769|8828491|P1|Overall Study|Consent Withdrawn|2
2551604|NCT01445678|8828511|P2|Overall Study|Withdrawal by Subject|5
2551605|NCT01445678|8828512|P1|Overall Study|Withdrawal by Subject|9
2551606|NCT01445678|8828511|P2|Overall Study|Protocol Violation|1
2551607|NCT01445678|8828512|P1|Overall Study|Protocol Violation|1
2551608|NCT01445678|8828511|P2|Overall Study|Lost to Follow-up|5
2551609|NCT01445678|8828512|P1|Overall Study|Lost to Follow-up|8
2551610|NCT01445678|8828511|P2|Overall Study|Lack of Efficacy|2
2551611|NCT01445678|8828512|P1|Overall Study|Lack of Efficacy|0
2551612|NCT01445678|8828511|P2|Overall Study|Adverse Event|8
2551613|NCT01445678|8828512|P1|Overall Study|Adverse Event|12
2551614|NCT01445652|8828530|P2|Overall Study|Adverse Event|0
2551615|NCT01445652|8828531|P1|Overall Study|Adverse Event|1
2551616|NCT01445652|8828530|P2|Overall Study|Failed teach session|0
2551617|NCT01445652|8828531|P1|Overall Study|Failed teach session|2
2551618|NCT01445652|8828530|P2|Overall Study|Failed to attend scheduled visit|3
2551619|NCT01445652|8828531|P1|Overall Study|Failed to attend scheduled visit|2
2551620|NCT01445652|8828530|P2|Overall Study|Not comfortable in lenses|0
2551621|NCT01445652|8828531|P1|Overall Study|Not comfortable in lenses|5
2551622|NCT01445613|8828549|P1|1-year Follow-up|Received a non-study stent|2
2551623|NCT01445613|8828549|P1|1-year Follow-up|Physician Decision|2
2551624|NCT01445613|8828549|P1|1-year Follow-up|Death|30
2551625|NCT01445613|8828549|P1|1-year Follow-up|Lost to Follow-up|2
2551626|NCT01445613|8828549|P1|1-year Follow-up|Missed visit|29
2551627|NCT01445613|8828549|P1|1-year Follow-up|Withdrawal by Subject|12
2551628|NCT01445613|8828549|P1|30-day Follow-up|Death|3
2551629|NCT01445613|8828549|P1|30-day Follow-up|Missed visit|23
2551630|NCT01445613|8828549|P1|30-day Follow-up|Physician Decision|3
2551631|NCT01445613|8828549|P1|30-day Follow-up|Withdrawal by Subject|6
2551632|NCT01445548|8828567|P1|Overall Study|Adverse Event|1
2551633|NCT01445301|8828592|P3|Overall Study|Withdrawal by Subject|4
2551634|NCT01445301|8828593|P2|Overall Study|Withdrawal by Subject|6
2551635|NCT01445301|8828594|P1|Overall Study|Withdrawal by Subject|5
2551636|NCT01445301|8828592|P3|Overall Study|Physician Decision|0
2551637|NCT01445301|8828593|P2|Overall Study|Physician Decision|2
2551638|NCT01445301|8828594|P1|Overall Study|Physician Decision|0
2551639|NCT01445301|8828592|P3|Overall Study|Protocol-Defined Stopping Criteria|1
2551640|NCT01445301|8828593|P2|Overall Study|Protocol-Defined Stopping Criteria|1
2551641|NCT01445301|8828594|P1|Overall Study|Protocol-Defined Stopping Criteria|0
2551642|NCT01445301|8828592|P3|Overall Study|Protocol Violation|0
2551643|NCT01445301|8828593|P2|Overall Study|Protocol Violation|0
2551644|NCT01445301|8828594|P1|Overall Study|Protocol Violation|1
2551645|NCT01445301|8828592|P3|Overall Study|Lack of Efficacy|0
2551646|NCT01445301|8828593|P2|Overall Study|Lack of Efficacy|1
2551647|NCT01445301|8828594|P1|Overall Study|Lack of Efficacy|0
2551648|NCT01445301|8828592|P3|Overall Study|Adverse Event|4
2551649|NCT01445301|8828593|P2|Overall Study|Adverse Event|25
2551650|NCT01445301|8828594|P1|Overall Study|Adverse Event|15
2551651|NCT01445171|8828629|P1|Overall Study|Consented but did not receive device|8
2551652|NCT01445171|8828629|P1|Overall Study|Subjects declined to return for followup|9
2551653|NCT01445171|8828629|P1|Overall Study|Death|51
2551654|NCT01445171|8828629|P1|Overall Study|Withdrawal by Subject|16
2551655|NCT01445171|8828629|P1|Overall Study|Lost to Follow-up|11
2551656|NCT01444898|8828685|P1|Overall Study|Withdrawal by Subject|1
2551657|NCT01444781|8828700|P3|Overall Study|Withdrawal by Subject|2
2551658|NCT01444781|8828701|P2|Overall Study|Withdrawal by Subject|1
2551659|NCT01444781|8828702|P1|Overall Study|Withdrawal by Subject|3
2551660|NCT01444781|8828700|P3|Overall Study|Lost to Follow-up|1
2551661|NCT01444781|8828701|P2|Overall Study|Lost to Follow-up|3
2551662|NCT01444781|8828702|P1|Overall Study|Lost to Follow-up|0
2551663|NCT01444742|8828740|P1|Overall Study|Death|1
2551664|NCT01444651|8828747|P2|Overall Study|Missing data|1
2551665|NCT01444651|8828748|P1|Overall Study|Missing data|1
2551666|NCT01444651|8828747|P2|Overall Study|Non-fasting|1
2551667|NCT01444651|8828748|P1|Overall Study|Non-fasting|2
2551668|NCT01444651|8828747|P2|Overall Study|Lost to Follow-up|5
2551669|NCT01444651|8828748|P1|Overall Study|Lost to Follow-up|5
2551670|NCT01444651|8828747|P2|Overall Study|Adverse Event|2
2551671|NCT01444651|8828748|P1|Overall Study|Adverse Event|3
2551672|NCT01444456|8828764|P1|Overall Study|Not treated|104
2551673|NCT01444456|8828764|P1|Overall Study|Other|18
2551674|NCT01444456|8828764|P1|Overall Study|Ineligibility determined|23
2551675|NCT01444456|8828764|P1|Overall Study|Death|73
2551676|NCT01444456|8828764|P1|Overall Study|Lost to Follow-up|37
2551677|NCT01444456|8828764|P1|Overall Study|Physician Decision|9
2551678|NCT01444456|8828764|P1|Overall Study|Withdrawal by Subject|21
2551679|NCT01444430|8828775|P2|Overall Study|CRF termination module not completed.|1
2551680|NCT01444430|8828776|P1|Overall Study|CRF termination module not completed.|0
2551681|NCT01444430|8828775|P2|Overall Study|Lost to Follow-up|0
2551682|NCT01444430|8828776|P1|Overall Study|Lost to Follow-up|2
2551683|NCT01444430|8828775|P2|Overall Study|Death|8
2551684|NCT01444430|8828776|P1|Overall Study|Death|6
2551685|NCT01444430|8828775|P2|Overall Study|Withdrawal by Subject|72
2551686|NCT01444430|8828776|P1|Overall Study|Withdrawal by Subject|53
2551687|NCT01444417|8828798|P2|Overall Study|Withdrawal by Subject|0
2551688|NCT01444417|8828799|P1|Overall Study|Withdrawal by Subject|2
2551689|NCT01444417|8828798|P2|Overall Study|Ineligibility Determined|1
2551690|NCT01444417|8828799|P1|Overall Study|Ineligibility Determined|0
2551691|NCT01444391|8828815|P1|Overall Study|Death|1
2551692|NCT01444378|8828823|P1|Overall Study|Missed Visits|10
2551693|NCT01444378|8828823|P1|Overall Study|Administrative Closure Of The Study|2
2551694|NCT01444378|8828823|P1|Overall Study|Death|3
2551695|NCT01444378|8828823|P1|Overall Study|Withdrawal by Subject|1
2551696|NCT01444378|8828823|P1|Overall Study|Lost to Follow-up|1
2551697|NCT01444300|8828935|P2|Overall Study|Adverse Event|0
2551698|NCT01444300|8828936|P1|Overall Study|Adverse Event|4
2551699|NCT01444092|8828968|P1|Overall Study|Other Eligibility criteria|7
2551700|NCT01444092|8828968|P1|Overall Study|Withdrawal by Subject|1
2551701|NCT01444092|8828968|P1|Overall Study|Protocol Violation|1
2551702|NCT01444092|8828968|P1|Overall Study|Adverse Event|8
2551703|NCT01444027|8828977|P3|Overall Study|Lost to Follow-up|14
2551704|NCT01444027|8828978|P2|Overall Study|Lost to Follow-up|20
2551705|NCT01444027|8828979|P1|Overall Study|Lost to Follow-up|26
2551706|NCT01444027|8828977|P3|Overall Study|Withdrawal by Subject|24
2551707|NCT01444027|8828978|P2|Overall Study|Withdrawal by Subject|10
2551708|NCT01444027|8828979|P1|Overall Study|Withdrawal by Subject|4
2551709|NCT01443923|8829001|P2|Overall Study|Adverse Event|0
2551710|NCT01443923|8829002|P1|Overall Study|Adverse Event|1
2551711|NCT01443858|8829019|P3|Overall Study|Lost to Follow-up|2
2551712|NCT01443858|8829020|P2|Overall Study|Lost to Follow-up|5
2551713|NCT01443858|8829021|P1|Overall Study|Lost to Follow-up|5
2551714|NCT01443858|8829019|P3|Overall Study|Lack of Efficacy|0
2551715|NCT01443858|8829020|P2|Overall Study|Lack of Efficacy|0
2551716|NCT01443858|8829021|P1|Overall Study|Lack of Efficacy|1
2551717|NCT01443858|8829019|P3|Overall Study|Withdrawal by Subject|5
2551718|NCT01443858|8829020|P2|Overall Study|Withdrawal by Subject|8
2551719|NCT01443858|8829021|P1|Overall Study|Withdrawal by Subject|9
2551720|NCT01443845|8829043|P2|Overall Study|Lost to Follow-up|13
2551721|NCT01443845|8829044|P1|Overall Study|Lost to Follow-up|9
2551722|NCT01443845|8829043|P2|Overall Study|Military Conflict - Site Terminated|21
2551723|NCT01443845|8829044|P1|Overall Study|Military Conflict - Site Terminated|20
2551724|NCT01443845|8829043|P2|Overall Study|Withdrawal by Subject|67
2551725|NCT01443845|8829044|P1|Overall Study|Withdrawal by Subject|63
2551726|NCT01443845|8829043|P2|Overall Study|Adverse Event|138
2551727|NCT01443845|8829044|P1|Overall Study|Adverse Event|64
2551728|NCT01443845|8829043|P2|Overall Study|Lack of Efficacy|5
2551729|NCT01443845|8829044|P1|Overall Study|Lack of Efficacy|10
2551730|NCT01443845|8829043|P2|Overall Study|Deterioration in pulmonary function|4
2551731|NCT01443845|8829044|P1|Overall Study|Deterioration in pulmonary function|1
2551732|NCT01443845|8829043|P2|Overall Study|Other reasons, such as COPD exacerbation|44
2551733|NCT01443845|8829044|P1|Overall Study|Other reasons, such as COPD exacerbation|44
2551734|NCT01443845|8829043|P2|Overall Study|Protocol Violation|45
2551735|NCT01443845|8829044|P1|Overall Study|Protocol Violation|43
2551736|NCT01443403|8829099|P4|Overall Study|Other - Miscellaneous|1
2551737|NCT01443403|8829100|P3|Overall Study|Other - Miscellaneous|0
2551738|NCT01443403|8829101|P2|Overall Study|Other - Miscellaneous|0
2551739|NCT01443403|8829102|P1|Overall Study|Other - Miscellaneous|1
2551740|NCT01443403|8829099|P4|Overall Study|Use of Prohibited Treatment|0
2551741|NCT01443403|8829100|P3|Overall Study|Use of Prohibited Treatment|0
2551742|NCT01443403|8829101|P2|Overall Study|Use of Prohibited Treatment|3
2551743|NCT01443403|8829102|P1|Overall Study|Use of Prohibited Treatment|2
2551744|NCT01443403|8829099|P4|Overall Study|Protocol Violation|1
2551745|NCT01443403|8829100|P3|Overall Study|Protocol Violation|1
2551746|NCT01443403|8829101|P2|Overall Study|Protocol Violation|1
2551747|NCT01443403|8829102|P1|Overall Study|Protocol Violation|2
2551748|NCT01443403|8829099|P4|Overall Study|Lost to Follow-up|1
2551749|NCT01443403|8829100|P3|Overall Study|Lost to Follow-up|0
2551750|NCT01443403|8829101|P2|Overall Study|Lost to Follow-up|0
2551751|NCT01443403|8829102|P1|Overall Study|Lost to Follow-up|0
2551752|NCT01443403|8829099|P4|Overall Study|Withdrawal by Subject|1
2551753|NCT01443403|8829100|P3|Overall Study|Withdrawal by Subject|2
2551754|NCT01443403|8829101|P2|Overall Study|Withdrawal by Subject|1
2551755|NCT01443403|8829102|P1|Overall Study|Withdrawal by Subject|0
2551756|NCT01443403|8829099|P4|Overall Study|Adverse Event|5
2551757|NCT01443403|8829100|P3|Overall Study|Adverse Event|4
2551758|NCT01443403|8829101|P2|Overall Study|Adverse Event|1
2551759|NCT01443403|8829102|P1|Overall Study|Adverse Event|1
2551760|NCT01443364|8829249|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
2551761|NCT01443364|8829249|P1|Overall Study|AE, non-serious non-fatal|8
2551762|NCT01443364|8829249|P1|Overall Study|SAE, non-fatal|6
2551763|NCT01443364|8829249|P1|Overall Study|Other Reason|4
2551764|NCT01443364|8829249|P1|Overall Study|Withdrawal by Subject|5
2551765|NCT01443364|8829249|P1|Overall Study|Lost to Follow-up|3
2551766|NCT01443364|8829249|P1|Overall Study|Lack of Efficacy|14
2551767|NCT01443130|8829378|P6|Overall Study|Death of Subject's Infant|0
2551768|NCT01443130|8829379|P5|Overall Study|Death of Subject's Infant|0
2551769|NCT01443130|8829380|P4|Overall Study|Death of Subject's Infant|0
2551770|NCT01443130|8829381|P3|Overall Study|Death of Subject's Infant|11
2551771|NCT01443130|8829382|P2|Overall Study|Death of Subject's Infant|10
2551772|NCT01443130|8829383|P1|Overall Study|Death of Subject's Infant|5
2551773|NCT01443130|8829378|P6|Overall Study|Withdrawal by Subject|2
2551774|NCT01443130|8829379|P5|Overall Study|Withdrawal by Subject|7
2551775|NCT01443130|8829380|P4|Overall Study|Withdrawal by Subject|7
2551776|NCT01443130|8829381|P3|Overall Study|Withdrawal by Subject|12
2551777|NCT01443130|8829382|P2|Overall Study|Withdrawal by Subject|14
2551778|NCT01443130|8829383|P1|Overall Study|Withdrawal by Subject|15
2551779|NCT01443130|8829378|P6|Overall Study|Protocol Violation|3
2551780|NCT01443130|8829379|P5|Overall Study|Protocol Violation|2
2551781|NCT01443130|8829380|P4|Overall Study|Protocol Violation|2
2551782|NCT01443130|8829381|P3|Overall Study|Protocol Violation|3
2551783|NCT01443130|8829382|P2|Overall Study|Protocol Violation|1
2551784|NCT01443130|8829383|P1|Overall Study|Protocol Violation|2
2551785|NCT01443130|8829378|P6|Overall Study|Adverse Event|0
2551786|NCT01443130|8829379|P5|Overall Study|Adverse Event|0
2551787|NCT01443130|8829380|P4|Overall Study|Adverse Event|0
2551788|NCT01443130|8829381|P3|Overall Study|Adverse Event|1
2551789|NCT01443130|8829382|P2|Overall Study|Adverse Event|1
2551790|NCT01443130|8829383|P1|Overall Study|Adverse Event|2
2551791|NCT01443130|8829378|P6|Overall Study|Death|8
2551792|NCT01443130|8829379|P5|Overall Study|Death|10
2551793|NCT01443130|8829380|P4|Overall Study|Death|7
2551794|NCT01443130|8829381|P3|Overall Study|Death|0
2551795|NCT01443130|8829382|P2|Overall Study|Death|1
2551796|NCT01443130|8829383|P1|Overall Study|Death|0
2551797|NCT01443130|8829378|P6|Overall Study|Lost to Follow-up|21
2551798|NCT01443130|8829379|P5|Overall Study|Lost to Follow-up|25
2551799|NCT01443130|8829380|P4|Overall Study|Lost to Follow-up|23
2551800|NCT01443130|8829381|P3|Overall Study|Lost to Follow-up|50
2551801|NCT01443130|8829382|P2|Overall Study|Lost to Follow-up|42
2551802|NCT01443130|8829383|P1|Overall Study|Lost to Follow-up|44
2551803|NCT01443078|8829433|P1|Overall Study|Patient had brain mets|1
2551804|NCT01443078|8829433|P1|Overall Study|Withdrawal by Subject|1
2551805|NCT01443078|8829433|P1|Overall Study|Responded to neoadjuvant platinum txt|27
2551806|NCT01443026|8829440|P2|Overall Study|Lost to Follow-up|1
2551807|NCT01443026|8829441|P1|Overall Study|Lost to Follow-up|2
2551808|NCT01443026|8829440|P2|Overall Study|Withdrawal by Subject|3
2551809|NCT01443026|8829441|P1|Overall Study|Withdrawal by Subject|0
2551810|NCT01443026|8829440|P2|Overall Study|Death|1
2551811|NCT01443026|8829441|P1|Overall Study|Death|0
2551812|NCT01443026|8829440|P2|Overall Study|Physician Decision|0
2551813|NCT01443026|8829441|P1|Overall Study|Physician Decision|1
2551814|NCT01442779|8829456|P1|Overall Study|Non-compliance|1
2551815|NCT01442779|8829456|P1|Overall Study|Death|3
2551816|NCT01442779|8829456|P1|Overall Study|Withdrawal by Subject|3
2551817|NCT01442714|8829462|P1|Overall Study|Withdrawal by Subject|1
2551818|NCT01442714|8829462|P1|Overall Study|Death|11
2551819|NCT01442688|8829470|P2|Second Intervention|Adverse Event|0
2551820|NCT01442688|8829471|P1|Second Intervention|Adverse Event|1
2551821|NCT01442688|8829470|P2|First Intervention|subject incarcerated|0
2551822|NCT01442688|8829471|P1|First Intervention|subject incarcerated|1
2551823|NCT01442688|8829470|P2|First Intervention|Withdrawal by Subject|0
2551824|NCT01442688|8829471|P1|First Intervention|Withdrawal by Subject|1
2551825|NCT01442675|8829479|P1|Overall Study|Withdrawal by Subject|4
2551826|NCT01442675|8829479|P1|Overall Study|Lost to Follow-up|2
2551827|NCT01442675|8829479|P1|Overall Study|Protocol Violation|6
2551828|NCT01442493|8829491|P2|Overall Study|withdrawn from study|2
2551829|NCT01442493|8829492|P1|Overall Study|withdrawn from study|3
2551830|NCT01442376|8829513|P3|Overall Study|Not eligible for subsequent cycles|0
2551831|NCT01442376|8829514|P2|Overall Study|Not eligible for subsequent cycles|2
2551832|NCT01442376|8829515|P1|Overall Study|Not eligible for subsequent cycles|1
2551833|NCT01442376|8829513|P3|Overall Study|Patients not treated|1
2551834|NCT01442376|8829514|P2|Overall Study|Patients not treated|3
2551835|NCT01442376|8829515|P1|Overall Study|Patients not treated|2
2551836|NCT01442376|8829513|P3|Overall Study|Withdrawal of consent|1
2551837|NCT01442376|8829514|P2|Overall Study|Withdrawal of consent|0
2551838|NCT01442376|8829515|P1|Overall Study|Withdrawal of consent|0
2551839|NCT01442376|8829513|P3|Overall Study|Death|1
2551840|NCT01442376|8829514|P2|Overall Study|Death|1
2551841|NCT01442376|8829515|P1|Overall Study|Death|0
2551842|NCT01442376|8829513|P3|Overall Study|Adverse Event|2
2551843|NCT01442376|8829514|P2|Overall Study|Adverse Event|3
2551844|NCT01442376|8829515|P1|Overall Study|Adverse Event|0
2551845|NCT01442181|8829528|P2|Overall Study|atrial fibrillation not noted|1
2551846|NCT01442181|8829529|P1|Overall Study|atrial fibrillation not noted|0
2551847|NCT01442181|8829528|P2|Overall Study|patient in an additional study|0
2551848|NCT01442181|8829529|P1|Overall Study|patient in an additional study|1
2551849|NCT01442181|8829528|P2|Overall Study|Lost to Follow-up|1
2551850|NCT01442181|8829529|P1|Overall Study|Lost to Follow-up|1
2551851|NCT01442181|8829528|P2|Overall Study|low ejection factor|1
2551852|NCT01442181|8829529|P1|Overall Study|low ejection factor|0
2551853|NCT01442181|8829528|P2|Overall Study|no insurance for surgery|0
2551854|NCT01442181|8829529|P1|Overall Study|no insurance for surgery|1
2551855|NCT01442181|8829528|P2|Overall Study|patient refused surgery|0
2551856|NCT01442181|8829529|P1|Overall Study|patient refused surgery|1
2551857|NCT01442155|8829553|P1|Overall Study|Lost to Follow-up|2
2551858|NCT01442155|8829553|P1|Overall Study|Adverse Event|2
2551859|NCT01442155|8829553|P1|Overall Study|Recurrence|26
2551860|NCT01442155|8829553|P1|Overall Study|Complete remission|35
2551861|NCT01442103|8829569|P1|Overall Study|Lost to Follow-up|2
2551862|NCT01442064|8829579|P6|Overall Study|Condition mandated other intervention|2
2551863|NCT01442064|8829580|P5|Overall Study|Condition mandated other intervention|0
2551864|NCT01442064|8829581|P4|Overall Study|Condition mandated other intervention|0
2551865|NCT01442064|8829582|P3|Overall Study|Condition mandated other intervention|2
2551866|NCT01442064|8829583|P2|Overall Study|Condition mandated other intervention|1
2551867|NCT01442064|8829584|P1|Overall Study|Condition mandated other intervention|1
2551868|NCT01442064|8829579|P6|Overall Study|Subject non-compliance|2
2551869|NCT01442064|8829580|P5|Overall Study|Subject non-compliance|0
2551870|NCT01442064|8829581|P4|Overall Study|Subject non-compliance|0
2551871|NCT01442064|8829582|P3|Overall Study|Subject non-compliance|0
2551872|NCT01442064|8829583|P2|Overall Study|Subject non-compliance|0
2551873|NCT01442064|8829584|P1|Overall Study|Subject non-compliance|0
2551874|NCT01442064|8829579|P6|Overall Study|Sponsor decision|87
2551875|NCT01442064|8829580|P5|Overall Study|Sponsor decision|95
2551876|NCT01442064|8829581|P4|Overall Study|Sponsor decision|88
2551877|NCT01442064|8829582|P3|Overall Study|Sponsor decision|92
2551878|NCT01442064|8829583|P2|Overall Study|Sponsor decision|88
2551879|NCT01442064|8829584|P1|Overall Study|Sponsor decision|82
2551880|NCT01442064|8829579|P6|Overall Study|Withdrawal by Subject|1
2551881|NCT01442064|8829580|P5|Overall Study|Withdrawal by Subject|2
2551882|NCT01442064|8829581|P4|Overall Study|Withdrawal by Subject|2
2551883|NCT01442064|8829582|P3|Overall Study|Withdrawal by Subject|2
2551884|NCT01442064|8829583|P2|Overall Study|Withdrawal by Subject|3
2551885|NCT01442064|8829584|P1|Overall Study|Withdrawal by Subject|6
2551886|NCT01442064|8829579|P6|Overall Study|Physician Decision|1
2551887|NCT01442064|8829580|P5|Overall Study|Physician Decision|3
2551888|NCT01442064|8829581|P4|Overall Study|Physician Decision|3
2551889|NCT01442064|8829582|P3|Overall Study|Physician Decision|2
2551890|NCT01442064|8829583|P2|Overall Study|Physician Decision|1
2551891|NCT01442064|8829584|P1|Overall Study|Physician Decision|1
2551892|NCT01442064|8829579|P6|Overall Study|Lost to Follow-up|3
2551893|NCT01442064|8829580|P5|Overall Study|Lost to Follow-up|3
2551894|NCT01442064|8829581|P4|Overall Study|Lost to Follow-up|1
2551895|NCT01442064|8829582|P3|Overall Study|Lost to Follow-up|1
2551896|NCT01442064|8829583|P2|Overall Study|Lost to Follow-up|5
2551897|NCT01442064|8829584|P1|Overall Study|Lost to Follow-up|5
2551898|NCT01442064|8829579|P6|Overall Study|Death|3
2551899|NCT01442064|8829580|P5|Overall Study|Death|1
2551900|NCT01442064|8829581|P4|Overall Study|Death|3
2551901|NCT01442064|8829582|P3|Overall Study|Death|3
2551902|NCT01442064|8829583|P2|Overall Study|Death|1
2551903|NCT01442064|8829584|P1|Overall Study|Death|0
2551904|NCT01442064|8829579|P6|Overall Study|Adverse Event|0
2551905|NCT01442064|8829580|P5|Overall Study|Adverse Event|2
2551906|NCT01442064|8829581|P4|Overall Study|Adverse Event|1
2551907|NCT01442064|8829582|P3|Overall Study|Adverse Event|2
2551908|NCT01442064|8829583|P2|Overall Study|Adverse Event|2
2551909|NCT01442064|8829584|P1|Overall Study|Adverse Event|2
2551910|NCT01442038|8829621|P2|Overall Study|Study Terminated By Sponsor|3
2551911|NCT01442038|8829622|P1|Overall Study|Study Terminated By Sponsor|2
2551912|NCT01442038|8829621|P2|Overall Study|Investigator's Discretion|16
2551913|NCT01442038|8829622|P1|Overall Study|Investigator's Discretion|13
2551914|NCT01442038|8829621|P2|Overall Study|Protocol Deviation|20
2551915|NCT01442038|8829622|P1|Overall Study|Protocol Deviation|9
2551916|NCT01442038|8829621|P2|Overall Study|Adverse Event|15
2551917|NCT01442038|8829622|P1|Overall Study|Adverse Event|26
2551918|NCT01442038|8829621|P2|Overall Study|Lost to Follow-up|51
2551919|NCT01442038|8829622|P1|Overall Study|Lost to Follow-up|37
2551920|NCT01442038|8829621|P2|Overall Study|Participant Withdrew Consent|102
2551921|NCT01442038|8829622|P1|Overall Study|Participant Withdrew Consent|137
2551922|NCT01442038|8829621|P2|Overall Study|Investigator-Initiated Early Closure|43
2551923|NCT01442038|8829622|P1|Overall Study|Investigator-Initiated Early Closure|44
2551924|NCT01442038|8829621|P2|Overall Study|Death|29
2551925|NCT01442038|8829622|P1|Overall Study|Death|35
2551926|NCT01441973|8829636|P2|Overall Study|Participant withdrew consent|1
2551927|NCT01441973|8829637|P1|Overall Study|Participant withdrew consent|0
2551928|NCT01441973|8829636|P2|Overall Study|Administrative reason by sponsor|5
2551929|NCT01441973|8829637|P1|Overall Study|Administrative reason by sponsor|3
2551930|NCT01441973|8829636|P2|Overall Study|Poor compliance/noncompliance|1
2551931|NCT01441973|8829637|P1|Overall Study|Poor compliance/noncompliance|0
2551932|NCT01441973|8829636|P2|Overall Study|Participant request to discontinue|1
2551933|NCT01441973|8829637|P1|Overall Study|Participant request to discontinue|1
2551934|NCT01441973|8829636|P2|Overall Study|Adverse event unrelated to study drug|2
2551935|NCT01441973|8829637|P1|Overall Study|Adverse event unrelated to study drug|3
2551936|NCT01441973|8829636|P2|Overall Study|Disease progression|6
2551937|NCT01441973|8829637|P1|Overall Study|Disease progression|8
2551938|NCT01441960|8829659|P2|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0
2551939|NCT01441960|8829660|P1|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1
2551940|NCT01441960|8829659|P2|First Neuromuscular Blocking Agent:|Protocol Violation|1
2551941|NCT01441960|8829660|P1|First Neuromuscular Blocking Agent:|Protocol Violation|1
2551942|NCT01441960|8829659|P2|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5
2552031|NCT01440569|8830090|P1|Open-Label Rollover Phase|Pregnancy|1
2551943|NCT01441960|8829660|P1|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6
2551944|NCT01441765|8829685|P2|Overall Study|Death|0
2551945|NCT01441765|8829686|P1|Overall Study|Death|1
2551946|NCT01441596|8829703|P3|Overall Study|Not treated|1
2551947|NCT01441596|8829704|P2|Overall Study|Not treated|1
2551948|NCT01441596|8829705|P1|Overall Study|Not treated|0
2551949|NCT01441596|8829703|P3|Overall Study|Withdrawal by Subject|2
2551950|NCT01441596|8829704|P2|Overall Study|Withdrawal by Subject|0
2551951|NCT01441596|8829705|P1|Overall Study|Withdrawal by Subject|4
2551952|NCT01441596|8829703|P3|Overall Study|Other reason not defined below|1
2551953|NCT01441596|8829704|P2|Overall Study|Other reason not defined below|2
2551954|NCT01441596|8829705|P1|Overall Study|Other reason not defined below|0
2551955|NCT01441440|8829752|P3|Overall Study|Difficllty in keeping the schedule|0
2551956|NCT01441440|8829753|P2|Overall Study|Difficllty in keeping the schedule|1
2551957|NCT01441440|8829754|P1|Overall Study|Difficllty in keeping the schedule|1
2551958|NCT01441440|8829752|P3|Overall Study|Work-related matter|0
2551959|NCT01441440|8829753|P2|Overall Study|Work-related matter|1
2551960|NCT01441440|8829754|P1|Overall Study|Work-related matter|0
2551961|NCT01441440|8829752|P3|Overall Study|Moving|1
2551962|NCT01441440|8829753|P2|Overall Study|Moving|1
2551963|NCT01441440|8829754|P1|Overall Study|Moving|0
2551964|NCT01441440|8829752|P3|Overall Study|Lack of Efficacy|1
2551965|NCT01441440|8829753|P2|Overall Study|Lack of Efficacy|0
2551966|NCT01441440|8829754|P1|Overall Study|Lack of Efficacy|1
2551967|NCT01441440|8829752|P3|Overall Study|Pregnancy|0
2551968|NCT01441440|8829753|P2|Overall Study|Pregnancy|0
2551969|NCT01441440|8829754|P1|Overall Study|Pregnancy|1
2551970|NCT01441440|8829752|P3|Overall Study|Withdrawal by Subject|9
2551971|NCT01441440|8829753|P2|Overall Study|Withdrawal by Subject|9
2551972|NCT01441440|8829754|P1|Overall Study|Withdrawal by Subject|11
2551973|NCT01441440|8829752|P3|Overall Study|Lost to Follow-up|1
2551974|NCT01441440|8829753|P2|Overall Study|Lost to Follow-up|2
2551975|NCT01441440|8829754|P1|Overall Study|Lost to Follow-up|0
2551976|NCT01441440|8829752|P3|Overall Study|Adverse Event|9
2551977|NCT01441440|8829753|P2|Overall Study|Adverse Event|9
2551978|NCT01441440|8829754|P1|Overall Study|Adverse Event|2
2551979|NCT01441440|8829752|P3|Overall Study|Death|1
2551980|NCT01441440|8829753|P2|Overall Study|Death|0
2551981|NCT01441440|8829754|P1|Overall Study|Death|1
2551982|NCT01441414|8829777|P1|Overall Study|Subject refused further follow-up|1
2551983|NCT01441414|8829777|P1|Overall Study|Study terminated by sponsor|2
2551984|NCT01441414|8829777|P1|Overall Study|Other reasons|3
2551985|NCT01441414|8829777|P1|Overall Study|Participant died|9
2551986|NCT01441180|8829856|P3|Overall Study|Discontinued|2
2551987|NCT01441180|8829857|P2|Overall Study|Discontinued|0
2551988|NCT01441180|8829858|P1|Overall Study|Discontinued|0
2551989|NCT01441180|8829856|P3|Overall Study|Lost to Follow-up|1
2551990|NCT01441180|8829857|P2|Overall Study|Lost to Follow-up|1
2551991|NCT01441180|8829858|P1|Overall Study|Lost to Follow-up|1
2551992|NCT01441102|8829869|P1|Overall Study|Withdrawal by Subject|2
2551993|NCT01441102|8829869|P1|Overall Study|Adverse Event|1
2551994|NCT01440972|8829913|P2|Overall Study|Withdrawal by Subject|2
2551995|NCT01440972|8829914|P1|Overall Study|Withdrawal by Subject|3
2551996|NCT01440946|8829938|P2|Overall Study|Physician Decision|0
2551997|NCT01440946|8829939|P1|Overall Study|Physician Decision|1
2551998|NCT01440946|8829938|P2|Overall Study|Lost to Follow-up|1
2551999|NCT01440946|8829939|P1|Overall Study|Lost to Follow-up|1
2552000|NCT01440881|8829978|P2|Overall Study|Death|1
2552001|NCT01440881|8829979|P1|Overall Study|Death|0
2552002|NCT01440816|8829993|P2|Overall Study|To Be Seen By Local Oncologist|2
2552003|NCT01440816|8829994|P1|Overall Study|To Be Seen By Local Oncologist|1
2552004|NCT01440816|8829993|P2|Overall Study|Disease Progression|9
2552005|NCT01440816|8829994|P1|Overall Study|Disease Progression|0
2552006|NCT01440803|8830010|P2|Overall Study|Withdrawal by Subject|1
2552007|NCT01440803|8830011|P1|Overall Study|Withdrawal by Subject|0
2552008|NCT01440803|8830010|P2|Overall Study|Lost to Follow-up|2
2552009|NCT01440803|8830011|P1|Overall Study|Lost to Follow-up|0
2552010|NCT01440803|8830010|P2|Overall Study|Met study stopping rule|1
2552011|NCT01440803|8830011|P1|Overall Study|Met study stopping rule|2
2552012|NCT01440647|8830047|P2|Overall Study|Death|3
2552013|NCT01440647|8830048|P1|Overall Study|Death|2
2552014|NCT01440595|8830067|P3|Overall Study|Study terminated by sponsor.|1
2552015|NCT01440595|8830068|P2|Overall Study|Study terminated by sponsor.|2
2552016|NCT01440595|8830069|P1|Overall Study|Study terminated by sponsor.|1
2552017|NCT01440595|8830067|P3|Overall Study|Lost to Follow-up|0
2552018|NCT01440595|8830068|P2|Overall Study|Lost to Follow-up|1
2552019|NCT01440595|8830069|P1|Overall Study|Lost to Follow-up|0
2552020|NCT01440569|8830089|P2|Open-Label Rollover Phase|Subject Non-Compliance|1
2552021|NCT01440569|8830090|P1|Open-Label Rollover Phase|Subject Non-Compliance|1
2552022|NCT01440569|8830089|P2|Open-Label Rollover Phase|Lost to Follow-up|3
2552023|NCT01440569|8830090|P1|Open-Label Rollover Phase|Lost to Follow-up|26
2552024|NCT01440569|8830089|P2|Open-Label Rollover Phase|Withdrew Consent|1
2552025|NCT01440569|8830090|P1|Open-Label Rollover Phase|Withdrew Consent|11
2552026|NCT01440569|8830089|P2|Open-Label Rollover Phase|Investigator’s Discretion|1
2552027|NCT01440569|8830090|P1|Open-Label Rollover Phase|Investigator’s Discretion|3
2552028|NCT01440569|8830089|P2|Open-Label Rollover Phase|Lack of Efficacy|0
2552029|NCT01440569|8830090|P1|Open-Label Rollover Phase|Lack of Efficacy|2
2552030|NCT01440569|8830089|P2|Open-Label Rollover Phase|Pregnancy|0
2552032|NCT01440569|8830089|P2|Open-Label Rollover Phase|Adverse Event|0
2552033|NCT01440569|8830090|P1|Open-Label Rollover Phase|Adverse Event|3
2552034|NCT01440569|8830089|P2|Main Study|Protocol Violation|0
2552035|NCT01440569|8830090|P1|Main Study|Protocol Violation|1
2552036|NCT01440569|8830089|P2|Main Study|Subject Non-Compliance|0
2552037|NCT01440569|8830090|P1|Main Study|Subject Non-Compliance|3
2552038|NCT01440569|8830089|P2|Main Study|Lost to Follow-up|2
2552039|NCT01440569|8830090|P1|Main Study|Lost to Follow-up|13
2552040|NCT01440569|8830089|P2|Main Study|Withdrew Consent|1
2552041|NCT01440569|8830090|P1|Main Study|Withdrew Consent|7
2552042|NCT01440569|8830089|P2|Main Study|Investigator's Discretion|1
2552043|NCT01440569|8830090|P1|Main Study|Investigator's Discretion|1
2552044|NCT01440569|8830089|P2|Main Study|Pregnancy|0
2552045|NCT01440569|8830090|P1|Main Study|Pregnancy|1
2552046|NCT01440569|8830089|P2|Main Study|Adverse Event|0
2552047|NCT01440569|8830090|P1|Main Study|Adverse Event|9
2552048|NCT01440569|8830089|P2|Main Study|Enrolled but not treated|0
2552049|NCT01440569|8830090|P1|Main Study|Enrolled but not treated|1
2552050|NCT01440517|8830125|P1|Overall Study|Subject withdrawn prior to dosing|1
2552051|NCT01440374|8830156|P4|Part 3: Extension|Physician Decision|14
2552052|NCT01440374|8830157|P3|Part 3: Extension|Physician Decision|0
2552053|NCT01440374|8830158|P2|Part 3: Extension|Physician Decision|0
2552054|NCT01440374|8830159|P1|Part 3: Extension|Physician Decision|0
2552055|NCT01440374|8830156|P4|Part 3: Extension|Adverse Event|13
2552056|NCT01440374|8830157|P3|Part 3: Extension|Adverse Event|0
2552057|NCT01440374|8830158|P2|Part 3: Extension|Adverse Event|0
2552058|NCT01440374|8830159|P1|Part 3: Extension|Adverse Event|0
2552059|NCT01440374|8830156|P4|Part 3: Extension|Withdrawal by Subject|5
2552060|NCT01440374|8830157|P3|Part 3: Extension|Withdrawal by Subject|0
2552061|NCT01440374|8830158|P2|Part 3: Extension|Withdrawal by Subject|0
2552062|NCT01440374|8830159|P1|Part 3: Extension|Withdrawal by Subject|0
2552063|NCT01440374|8830156|P4|Part 2; Double-blind Phase|Not treated|0
2552064|NCT01440374|8830157|P3|Part 2; Double-blind Phase|Not treated|1
2552065|NCT01440374|8830158|P2|Part 2; Double-blind Phase|Not treated|0
2552066|NCT01440374|8830159|P1|Part 2; Double-blind Phase|Not treated|0
2552067|NCT01440374|8830156|P4|Part 2; Double-blind Phase|Adverse Event|0
2552068|NCT01440374|8830157|P3|Part 2; Double-blind Phase|Adverse Event|31
2552069|NCT01440374|8830158|P2|Part 2; Double-blind Phase|Adverse Event|7
2552070|NCT01440374|8830159|P1|Part 2; Double-blind Phase|Adverse Event|0
2552071|NCT01440374|8830156|P4|Part 2; Double-blind Phase|Lack of Efficacy|0
2552072|NCT01440374|8830157|P3|Part 2; Double-blind Phase|Lack of Efficacy|0
2552073|NCT01440374|8830158|P2|Part 2; Double-blind Phase|Lack of Efficacy|1
2552074|NCT01440374|8830159|P1|Part 2; Double-blind Phase|Lack of Efficacy|0
2552075|NCT01440374|8830156|P4|Part 2; Double-blind Phase|Protocol Violation|0
2552076|NCT01440374|8830157|P3|Part 2; Double-blind Phase|Protocol Violation|1
2552077|NCT01440374|8830158|P2|Part 2; Double-blind Phase|Protocol Violation|0
2552078|NCT01440374|8830159|P1|Part 2; Double-blind Phase|Protocol Violation|0
2552079|NCT01440374|8830156|P4|Part 2; Double-blind Phase|Withdrawal by Subject|0
2552080|NCT01440374|8830157|P3|Part 2; Double-blind Phase|Withdrawal by Subject|5
2552081|NCT01440374|8830158|P2|Part 2; Double-blind Phase|Withdrawal by Subject|4
2552082|NCT01440374|8830159|P1|Part 2; Double-blind Phase|Withdrawal by Subject|0
2552083|NCT01440374|8830156|P4|Part 2; Double-blind Phase|Physician Decision|0
2552084|NCT01440374|8830157|P3|Part 2; Double-blind Phase|Physician Decision|17
2552085|NCT01440374|8830158|P2|Part 2; Double-blind Phase|Physician Decision|8
2552086|NCT01440374|8830159|P1|Part 2; Double-blind Phase|Physician Decision|0
2552087|NCT01440374|8830156|P4|Part 1: Open-label Phase|Physician Decision|0
2552088|NCT01440374|8830157|P3|Part 1: Open-label Phase|Physician Decision|0
2552089|NCT01440374|8830158|P2|Part 1: Open-label Phase|Physician Decision|0
2552090|NCT01440374|8830159|P1|Part 1: Open-label Phase|Physician Decision|1
2552091|NCT01440374|8830156|P4|Part 1: Open-label Phase|Adverse Event|0
2552092|NCT01440374|8830157|P3|Part 1: Open-label Phase|Adverse Event|0
2552093|NCT01440374|8830158|P2|Part 1: Open-label Phase|Adverse Event|0
2552094|NCT01440374|8830159|P1|Part 1: Open-label Phase|Adverse Event|5
2552095|NCT01440322|8830194|P2|Overall Study|Other Non-Product Related|0
2552096|NCT01440322|8830195|P1|Overall Study|Other Non-Product Related|1
2552097|NCT01440322|8830194|P2|Overall Study|Unrelated Medical Problem|1
2552098|NCT01440322|8830195|P1|Overall Study|Unrelated Medical Problem|0
2552099|NCT01440322|8830194|P2|Overall Study|Other Product Related|0
2552100|NCT01440322|8830195|P1|Overall Study|Other Product Related|1
2552101|NCT01440322|8830194|P2|Overall Study|Unacceptable Subjective Vision|0
2552102|NCT01440322|8830195|P1|Overall Study|Unacceptable Subjective Vision|1
2552103|NCT01440322|8830194|P2|Overall Study|Symptoms and Problems|0
2552104|NCT01440322|8830195|P1|Overall Study|Symptoms and Problems|1
2552105|NCT01440322|8830194|P2|Overall Study|Biomicroscopy|0
2552106|NCT01440322|8830195|P1|Overall Study|Biomicroscopy|1
2552107|NCT01440322|8830194|P2|Overall Study|Discomfort|0
2552108|NCT01440322|8830195|P1|Overall Study|Discomfort|2
2552109|NCT01440283|8830217|P1|Overall Study|Physician Decision|3
2552110|NCT01440283|8830217|P1|Overall Study|Withdrawal by Subject|4
2552111|NCT01440283|8830217|P1|Overall Study|Death|3
2552112|NCT01440101|8830232|P3|Overall Study|Other|0
2552113|NCT01440101|8830233|P2|Overall Study|Other|1
2552114|NCT01440101|8830234|P1|Overall Study|Other|0
2552115|NCT01440101|8830232|P3|Overall Study|Withdrawal by Subject|1
2552116|NCT01440101|8830233|P2|Overall Study|Withdrawal by Subject|3
2552117|NCT01440101|8830234|P1|Overall Study|Withdrawal by Subject|0
2552118|NCT01440101|8830232|P3|Overall Study|Adverse Event|0
2552119|NCT01440101|8830233|P2|Overall Study|Adverse Event|0
2552120|NCT01440101|8830234|P1|Overall Study|Adverse Event|2
2552121|NCT01440049|8830267|P1|Overall Study|Adverse Event|5
2552122|NCT01439971|8830299|P5|Overall Study|Required number in cohort dosed|1
2552123|NCT01439971|8830300|P4|Overall Study|Required number in cohort dosed|0
2552124|NCT01439971|8830301|P3|Overall Study|Required number in cohort dosed|2
2552125|NCT01439971|8830302|P2|Overall Study|Required number in cohort dosed|1
2552126|NCT01439971|8830303|P1|Overall Study|Required number in cohort dosed|0
2552127|NCT01439945|8830483|P4|Double-Blind Treatment Phase|Ineligible|1
2552128|NCT01439945|8830484|P3|Double-Blind Treatment Phase|Ineligible|0
2552129|NCT01439945|8830485|P2|Double-Blind Treatment Phase|Ineligible|2
2552130|NCT01439945|8830486|P1|Double-Blind Treatment Phase|Ineligible|1
2552131|NCT01439945|8830483|P4|Double-Blind Treatment Phase|Withdrawal by Subject|1
2552132|NCT01439945|8830484|P3|Double-Blind Treatment Phase|Withdrawal by Subject|3
2552133|NCT01439945|8830485|P2|Double-Blind Treatment Phase|Withdrawal by Subject|3
2552134|NCT01439945|8830486|P1|Double-Blind Treatment Phase|Withdrawal by Subject|3
2552135|NCT01439880|8830511|P2|All-IP Period (Years 2 to 5)|Reason Missing|0
2552136|NCT01439880|8830512|P1|All-IP Period (Years 2 to 5)|Reason Missing|1
2552137|NCT01439880|8830511|P2|All-IP Period (Years 2 to 5)|Other|31
2552138|NCT01439880|8830512|P1|All-IP Period (Years 2 to 5)|Other|14
2552139|NCT01439880|8830511|P2|All-IP Period (Years 2 to 5)|Sponsor Decision|0
2552140|NCT01439880|8830512|P1|All-IP Period (Years 2 to 5)|Sponsor Decision|1
2552141|NCT01439880|8830511|P2|All-IP Period (Years 2 to 5)|Death|13
2552142|NCT01439880|8830512|P1|All-IP Period (Years 2 to 5)|Death|3
2552143|NCT01439880|8830511|P2|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66
2552144|NCT01439880|8830512|P1|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30
2552145|NCT01439880|8830511|P2|All-IP Period (Years 2 to 5)|Lost to Follow-up|30
2552146|NCT01439880|8830512|P1|All-IP Period (Years 2 to 5)|Lost to Follow-up|21
2552147|NCT01439880|8830511|P2|SOC-controlled Period (Year 1)|Reason Missing|2
2552148|NCT01439880|8830512|P1|SOC-controlled Period (Year 1)|Reason Missing|0
2552149|NCT01439880|8830511|P2|SOC-controlled Period (Year 1)|Other|13
2552150|NCT01439880|8830512|P1|SOC-controlled Period (Year 1)|Other|8
2552151|NCT01439880|8830511|P2|SOC-controlled Period (Year 1)|Lost to Follow-up|5
2552152|NCT01439880|8830512|P1|SOC-controlled Period (Year 1)|Lost to Follow-up|10
2552153|NCT01439880|8830511|P2|SOC-controlled Period (Year 1)|Sponsor Decision|1
2552154|NCT01439880|8830512|P1|SOC-controlled Period (Year 1)|Sponsor Decision|0
2552155|NCT01439880|8830511|P2|SOC-controlled Period (Year 1)|Death|1
2552156|NCT01439880|8830512|P1|SOC-controlled Period (Year 1)|Death|2
2552157|NCT01439880|8830511|P2|SOC-controlled Period (Year 1)|Withdrawal by Subject|38
2552158|NCT01439880|8830512|P1|SOC-controlled Period (Year 1)|Withdrawal by Subject|24
2552159|NCT01439867|8830555|P2|Overall Study|Protocol-specified Criteria|0
2552160|NCT01439867|8830556|P1|Overall Study|Protocol-specified Criteria|1
2552161|NCT01439867|8830555|P2|Overall Study|Administrative Decision|5
2552162|NCT01439867|8830556|P1|Overall Study|Administrative Decision|4
2552163|NCT01439867|8830555|P2|Overall Study|Withdrawal by Subject|2
2552164|NCT01439867|8830556|P1|Overall Study|Withdrawal by Subject|1
2552165|NCT01439867|8830555|P2|Overall Study|Non-compliance|1
2552166|NCT01439867|8830556|P1|Overall Study|Non-compliance|0
2552167|NCT01439724|8830608|P2|Overall Study|missing consultation|8
2552168|NCT01439724|8830609|P1|Overall Study|missing consultation|9
2552169|NCT01439711|8830615|P1|Overall Study|No MRI|9
2552170|NCT01439711|8830615|P1|Overall Study|Noncompliance|3
2552171|NCT01439711|8830615|P1|Overall Study|Progression During Active Tx|3
2552172|NCT01439711|8830615|P1|Overall Study|Withdrawal by Subject|3
2552173|NCT01439711|8830615|P1|Overall Study|Adverse Event|5
2552174|NCT01439711|8830615|P1|Overall Study|Progression Prior to Beginning Tx|1
2552175|NCT01439711|8830615|P1|Overall Study|Cancel|3
2552176|NCT01439711|8830615|P1|Overall Study|Ineligible|13
2552177|NCT01439568|8830653|P2|Overall Study|Withdrawal by Subject|2
2552178|NCT01439568|8830654|P1|Overall Study|Withdrawal by Subject|2
2552179|NCT01439568|8830653|P2|Overall Study|Lost to Follow-up|0
2552180|NCT01439568|8830654|P1|Overall Study|Lost to Follow-up|1
2552181|NCT01439555|8830666|P1|Overall Study|Protocol Violation|1
2552182|NCT01439373|8830678|P2|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0
2552183|NCT01439373|8830679|P1|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2
2552184|NCT01439373|8830678|P2|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1
2552185|NCT01439373|8830679|P1|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0
2552186|NCT01439360|8830722|P2|Overall Study|Withdrawal by Subject|129
2552187|NCT01439360|8830723|P1|Overall Study|Withdrawal by Subject|140
2552188|NCT01439360|8830722|P2|Overall Study|Protocol Violation|0
2552189|NCT01439360|8830723|P1|Overall Study|Protocol Violation|1
2552190|NCT01439360|8830722|P2|Overall Study|Others|5
2552191|NCT01439360|8830723|P1|Overall Study|Others|10
2552192|NCT01439360|8830722|P2|Overall Study|Lost to Follow-up|58
2552193|NCT01439360|8830723|P1|Overall Study|Lost to Follow-up|43
2552194|NCT01439360|8830722|P2|Overall Study|Adverse Event|16
2552195|NCT01439360|8830723|P1|Overall Study|Adverse Event|4
2552196|NCT01439282|8830773|P2|Overall Study|Other|1
2552197|NCT01439282|8830774|P1|Overall Study|Other|1
2552198|NCT01439282|8830773|P2|Overall Study|Withdrawal by Subject|0
2552199|NCT01439282|8830774|P1|Overall Study|Withdrawal by Subject|2
2552200|NCT01439282|8830773|P2|Overall Study|Adverse Event|0
2552201|NCT01439282|8830774|P1|Overall Study|Adverse Event|5
2552202|NCT01439204|8830786|P2|Overall Study|poor/non-compliance|0
2552203|NCT01439204|8830787|P1|Overall Study|poor/non-compliance|3
2552204|NCT01439204|8830786|P2|Overall Study|No longer meets study criteria|0
2552205|NCT01439204|8830787|P1|Overall Study|No longer meets study criteria|1
2552206|NCT01439204|8830786|P2|Overall Study|Lost to Follow-up|2
2552207|NCT01439204|8830787|P1|Overall Study|Lost to Follow-up|0
2552208|NCT01439204|8830786|P2|Overall Study|Withdrawal by Subject|1
2552209|NCT01439204|8830787|P1|Overall Study|Withdrawal by Subject|0
2552210|NCT01439165|8830821|P2|Overall Study|Withdrawal by Subject|1
2552211|NCT01439165|8830822|P1|Overall Study|Withdrawal by Subject|7
2552212|NCT01439165|8830821|P2|Overall Study|Lost to Follow-up|1
2552213|NCT01439165|8830822|P1|Overall Study|Lost to Follow-up|11
2552214|NCT01439165|8830821|P2|Overall Study|Protocol Violation|0
2552215|NCT01439165|8830822|P1|Overall Study|Protocol Violation|3
2552216|NCT01439126|8830836|P2|Overall Study|Other-Miscellaneous|12
2552217|NCT01439126|8830837|P1|Overall Study|Other-Miscellaneous|12
2552218|NCT01439126|8830836|P2|Overall Study|Other-Use of prohibited treatment|2
2552219|NCT01439126|8830837|P1|Overall Study|Other-Use of prohibited treatment|0
2552220|NCT01439126|8830836|P2|Overall Study|Lost to Follow-up|3
2552221|NCT01439126|8830837|P1|Overall Study|Lost to Follow-up|6
2552222|NCT01439126|8830836|P2|Overall Study|Protocol Violation|4
2552223|NCT01439126|8830837|P1|Overall Study|Protocol Violation|6
2552224|NCT01439126|8830836|P2|Overall Study|Withdrawal by Subject|21
2552225|NCT01439126|8830837|P1|Overall Study|Withdrawal by Subject|5
2552226|NCT01439126|8830836|P2|Overall Study|Adverse Event|0
2552227|NCT01439126|8830837|P1|Overall Study|Adverse Event|2
2552228|NCT01439074|8830863|P2|Overall Study|Other|4
2552229|NCT01439074|8830864|P1|Overall Study|Other|4
2552230|NCT01439074|8830863|P2|Overall Study|Withdrawal by Subject|5
2552231|NCT01439074|8830864|P1|Overall Study|Withdrawal by Subject|1
2552232|NCT01439074|8830863|P2|Overall Study|Subject shedding|0
2552233|NCT01439074|8830864|P1|Overall Study|Subject shedding|1
2552234|NCT01439074|8830863|P2|Overall Study|Lost to Follow-up|4
2552235|NCT01439074|8830864|P1|Overall Study|Lost to Follow-up|3
2552236|NCT01439009|8830882|P2|Overall Study|Deviation of exclusion criteria|0
2552237|NCT01439009|8830883|P1|Overall Study|Deviation of exclusion criteria|1
2552238|NCT01439009|8830882|P2|Overall Study|Protocol Violation|0
2552239|NCT01439009|8830883|P1|Overall Study|Protocol Violation|2
2552240|NCT01439009|8830882|P2|Overall Study|Physician Decision|3
2552241|NCT01439009|8830883|P1|Overall Study|Physician Decision|5
2552242|NCT01438996|8830916|P3|Overall Study|Not meeting Inclusion Criteria|0
2552243|NCT01438996|8830917|P2|Overall Study|Not meeting Inclusion Criteria|1
2552244|NCT01438996|8830918|P1|Overall Study|Not meeting Inclusion Criteria|4
2552245|NCT01438840|8830952|P3|Extension Phase|Other|1
2552246|NCT01438840|8830953|P2|Extension Phase|Other|0
2552247|NCT01438840|8830954|P1|Extension Phase|Other|0
2552248|NCT01438840|8830952|P3|Extension Phase|Lack of Efficacy|2
2552249|NCT01438840|8830953|P2|Extension Phase|Lack of Efficacy|0
2552250|NCT01438840|8830954|P1|Extension Phase|Lack of Efficacy|0
2552251|NCT01438840|8830952|P3|Extension Phase|Withdrawal by Subject|3
2552252|NCT01438840|8830953|P2|Extension Phase|Withdrawal by Subject|0
2552253|NCT01438840|8830954|P1|Extension Phase|Withdrawal by Subject|0
2552254|NCT01438840|8830952|P3|Extension Phase|Lost to Follow-up|1
2552255|NCT01438840|8830953|P2|Extension Phase|Lost to Follow-up|0
2552256|NCT01438840|8830954|P1|Extension Phase|Lost to Follow-up|0
2552257|NCT01438840|8830952|P3|Extension Phase|Adverse Event|3
2552258|NCT01438840|8830953|P2|Extension Phase|Adverse Event|0
2552259|NCT01438840|8830954|P1|Extension Phase|Adverse Event|0
2552260|NCT01438840|8830952|P3|Core Study|Withdrawal of consent|0
2552261|NCT01438840|8830953|P2|Core Study|Withdrawal of consent|0
2552262|NCT01438840|8830954|P1|Core Study|Withdrawal of consent|1
2552263|NCT01438840|8830952|P3|Core Study|Lack of Efficacy|0
2552264|NCT01438840|8830953|P2|Core Study|Lack of Efficacy|7
2552265|NCT01438840|8830954|P1|Core Study|Lack of Efficacy|15
2552266|NCT01438840|8830952|P3|Core Study|Adverse Event|0
2552267|NCT01438840|8830953|P2|Core Study|Adverse Event|3
2552268|NCT01438840|8830954|P1|Core Study|Adverse Event|0
2552269|NCT01438814|8830967|P2|Overall Study|Other|4
2552270|NCT01438814|8830968|P1|Overall Study|Other|2
2552271|NCT01438814|8830967|P2|Overall Study|Withdrawal by Subject|2
2552272|NCT01438814|8830968|P1|Overall Study|Withdrawal by Subject|4
2552273|NCT01438814|8830967|P2|Overall Study|Lost to Follow-up|3
2552274|NCT01438814|8830968|P1|Overall Study|Lost to Follow-up|4
2552275|NCT01438814|8830967|P2|Overall Study|Protocol Violation|2
2552276|NCT01438814|8830968|P1|Overall Study|Protocol Violation|1
2552277|NCT01438814|8830967|P2|Overall Study|Adverse Event|3
2552278|NCT01438814|8830968|P1|Overall Study|Adverse Event|3
2552279|NCT01438541|8831004|P1|Overall Study|discharge from the hospital|5
2552280|NCT01438541|8831004|P1|Overall Study|Withdrawal by Subject|1
2552281|NCT01438541|8831004|P1|Overall Study|Physician Decision|1
2552282|NCT01438489|8831013|P3|Overall Study|Inadequate venous access|0
2552283|NCT01438489|8831014|P2|Overall Study|Inadequate venous access|2
2552284|NCT01438489|8831015|P1|Overall Study|Inadequate venous access|0
2552285|NCT01438489|8831013|P3|Overall Study|Did not complete all 3 follow-up visits|2
2552286|NCT01438489|8831014|P2|Overall Study|Did not complete all 3 follow-up visits|5
2552287|NCT01438489|8831015|P1|Overall Study|Did not complete all 3 follow-up visits|2
2552288|NCT01438489|8831013|P3|Overall Study|Received prohibited medication|0
2552289|NCT01438489|8831014|P2|Overall Study|Received prohibited medication|0
2552290|NCT01438489|8831015|P1|Overall Study|Received prohibited medication|1
2552291|NCT01438489|8831013|P3|Overall Study|AE/SAEs|1
2552292|NCT01438489|8831014|P2|Overall Study|AE/SAEs|1
2552293|NCT01438489|8831015|P1|Overall Study|AE/SAEs|2
2552294|NCT01438489|8831013|P3|Overall Study|Investigator decision|0
2552295|NCT01438489|8831014|P2|Overall Study|Investigator decision|1
2552296|NCT01438489|8831015|P1|Overall Study|Investigator decision|0
2552297|NCT01438489|8831013|P3|Overall Study|Subject choice/Subject moved|1
2552298|NCT01438489|8831014|P2|Overall Study|Subject choice/Subject moved|1
2552299|NCT01438489|8831015|P1|Overall Study|Subject choice/Subject moved|2
2552300|NCT01438489|8831013|P3|Overall Study|Sponsor decision|4
2552301|NCT01438489|8831014|P2|Overall Study|Sponsor decision|1
2552302|NCT01438489|8831015|P1|Overall Study|Sponsor decision|4
2552303|NCT01438489|8831013|P3|Overall Study|Death|1
2552304|NCT01438489|8831014|P2|Overall Study|Death|0
2552305|NCT01438489|8831015|P1|Overall Study|Death|0
2552306|NCT01438489|8831013|P3|Overall Study|Withdrawal by Subject|8
2552307|NCT01438489|8831014|P2|Overall Study|Withdrawal by Subject|3
2552308|NCT01438489|8831015|P1|Overall Study|Withdrawal by Subject|11
2552309|NCT01438489|8831013|P3|Overall Study|Lost to Follow-up|2
2552310|NCT01438489|8831014|P2|Overall Study|Lost to Follow-up|2
2552311|NCT01438489|8831015|P1|Overall Study|Lost to Follow-up|4
2552312|NCT01438476|8831060|P2|Overall Study|Communication barrier|1
2552313|NCT01438476|8831061|P1|Overall Study|Communication barrier|0
2552314|NCT01438476|8831060|P2|Overall Study|No Surgery- Disease|10
2552315|NCT01438476|8831061|P1|Overall Study|No Surgery- Disease|8
2552316|NCT01438476|8831060|P2|Overall Study|Withdrawal by Subject|0
2552317|NCT01438476|8831061|P1|Overall Study|Withdrawal by Subject|1
2552318|NCT01438476|8831060|P2|Overall Study|Protocol Violation|0
2552319|NCT01438476|8831061|P1|Overall Study|Protocol Violation|1
2552320|NCT01438424|8831067|P1|Overall Study|Participant noncompliance|20
2552321|NCT01438424|8831067|P1|Overall Study|No longer met inclusion criteria|1
2552322|NCT01438424|8831067|P1|Overall Study|Pregnancy|7
2552323|NCT01438424|8831067|P1|Overall Study|Need for drug prohibited by protocol|14
2552324|NCT01438424|8831067|P1|Overall Study|Abnormal laboratory test result|14
2552325|NCT01438424|8831067|P1|Overall Study|Lost to Follow-up|17
2552326|NCT01438424|8831067|P1|Overall Study|Adverse Event|17
2552327|NCT01438424|8831067|P1|Overall Study|Death|22
2552328|NCT01438424|8831067|P1|Overall Study|Progression of chronic hepatitis B|22
2552329|NCT01438424|8831067|P1|Overall Study|Withdrawal by Subject|104
2552330|NCT01438424|8831067|P1|Overall Study|Not identified|55
2552331|NCT01438424|8831067|P1|Overall Study|Minimal virologic response|95
2552332|NCT01438424|8831067|P1|Overall Study|Continuing treatment|29
2552333|NCT01438307|8831105|P2|Overall Study|Death|1
2552334|NCT01438307|8831106|P1|Overall Study|Death|1
2552335|NCT01438294|8831120|P2|Overall Study|Lost to Follow-up|7
2552336|NCT01438294|8831121|P1|Overall Study|Lost to Follow-up|3
2552337|NCT01438177|8831164|P1|Overall Study|Initiation of new therapy|1
2552338|NCT01438177|8831164|P1|Overall Study|Withdrawal by Subject|1
2552339|NCT01438151|8831171|P1|Overall Study|study terminated|8
2552340|NCT01438060|8831177|P2|On Study Beyond Week 140|Other Reason|3
2552341|NCT01438060|8831178|P1|On Study Beyond Week 140|Other Reason|0
2552342|NCT01438060|8831177|P2|On Study Beyond Week 140|Death|1
2552343|NCT01438060|8831178|P1|On Study Beyond Week 140|Death|0
2552344|NCT01438060|8831177|P2|On Study Beyond Week 140|Withdrawal by Subject|1
2552345|NCT01438060|8831178|P1|On Study Beyond Week 140|Withdrawal by Subject|0
2552346|NCT01438060|8831177|P2|On Study Beyond Week 140|Lack of Efficacy|1
2552347|NCT01438060|8831178|P1|On Study Beyond Week 140|Lack of Efficacy|0
2552348|NCT01438060|8831177|P2|On Study Beyond Week 140|Adverse Event|2
2552349|NCT01438060|8831178|P1|On Study Beyond Week 140|Adverse Event|0
2552350|NCT01438060|8831177|P2|Extension Phase: Week 10 to Week 130|Other Reason|15
2552351|NCT01438060|8831178|P1|Extension Phase: Week 10 to Week 130|Other Reason|7
2552352|NCT01438060|8831177|P2|Extension Phase: Week 10 to Week 130|Death|12
2552353|NCT01438060|8831178|P1|Extension Phase: Week 10 to Week 130|Death|22
2552354|NCT01438060|8831177|P2|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0
2552355|NCT01438060|8831178|P1|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2
2552356|NCT01438060|8831177|P2|Extension Phase: Week 10 to Week 130|Participant Unreliability|0
2552357|NCT01438060|8831178|P1|Extension Phase: Week 10 to Week 130|Participant Unreliability|1
2552358|NCT01438060|8831177|P2|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5
2552359|NCT01438060|8831178|P1|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3
2552360|NCT01438060|8831177|P2|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
2552361|NCT01438060|8831178|P1|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
2552362|NCT01438060|8831177|P2|Extension Phase: Week 10 to Week 130|Adverse Event|16
2552363|NCT01438060|8831178|P1|Extension Phase: Week 10 to Week 130|Adverse Event|15
2552364|NCT01438060|8831177|P2|Acute Phase: Double-blind, 10 Weeks|Other Reason|0
2552365|NCT01438060|8831178|P1|Acute Phase: Double-blind, 10 Weeks|Other Reason|1
2552366|NCT01438060|8831177|P2|Acute Phase: Double-blind, 10 Weeks|Death|2
2552367|NCT01438060|8831178|P1|Acute Phase: Double-blind, 10 Weeks|Death|0
2552368|NCT01438060|8831177|P2|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0
2552369|NCT01438060|8831178|P1|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1
2552370|NCT01438060|8831177|P2|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4
2552371|NCT01438060|8831178|P1|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3
2552372|NCT01438060|8831177|P2|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3
2552373|NCT01438060|8831178|P1|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6
2552374|NCT01438060|8831177|P2|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9
2552375|NCT01438060|8831178|P1|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7
2552376|NCT01437995|8831259|P3|Overall Study|Lost to Follow-up|20
2552377|NCT01437995|8831260|P2|Overall Study|Lost to Follow-up|18
2552378|NCT01437995|8831261|P1|Overall Study|Lost to Follow-up|11
2552379|NCT01437943|8831283|P2|Overall Study|Adverse Event|0
2552380|NCT01437943|8831284|P1|Overall Study|Adverse Event|2
2552381|NCT01437943|8831283|P2|Overall Study|Subject expressed pregnancy plans|0
2552382|NCT01437943|8831284|P1|Overall Study|Subject expressed pregnancy plans|1
2552383|NCT01437943|8831283|P2|Overall Study|Aliskiren trials terminated by Novartis|2
2552384|NCT01437943|8831284|P1|Overall Study|Aliskiren trials terminated by Novartis|4
2552385|NCT01437878|8831292|P2|Overall Study|Withdrawal by Subject|0
2552386|NCT01437878|8831293|P1|Overall Study|Withdrawal by Subject|1
2552387|NCT01437540|8831360|P2|Overall Study|Withdrawal by Subject|15
2552388|NCT01437540|8831361|P1|Overall Study|Withdrawal by Subject|31
2552389|NCT01437540|8831360|P2|Overall Study|Adverse Event|13
2552390|NCT01437540|8831361|P1|Overall Study|Adverse Event|26
2552391|NCT01437540|8831360|P2|Overall Study|Protocol Violation|12
2552392|NCT01437540|8831361|P1|Overall Study|Protocol Violation|24
2552393|NCT01437540|8831360|P2|Overall Study|Lack of Efficacy|11
2552394|NCT01437540|8831361|P1|Overall Study|Lack of Efficacy|23
2552395|NCT01437540|8831360|P2|Overall Study|Lost to Follow-up|5
2552396|NCT01437540|8831361|P1|Overall Study|Lost to Follow-up|3
2552397|NCT01437540|8831360|P2|Overall Study|COPD exacerbation|3
2552398|NCT01437540|8831361|P1|Overall Study|COPD exacerbation|13
2552399|NCT01437540|8831360|P2|Overall Study|Not listed below|6
2552400|NCT01437540|8831361|P1|Overall Study|Not listed below|7
2552401|NCT01437423|8831398|P1|Overall Study|Off label usage|3
2552402|NCT01437423|8831398|P1|Overall Study|Lost to Follow-up|12
2552403|NCT01437397|8831410|P5|Overall Study|Site termination/COPD exacerbation/other|14
2552404|NCT01437397|8831411|P4|Overall Study|Site termination/COPD exacerbation/other|9
2552405|NCT01437397|8831412|P3|Overall Study|Site termination/COPD exacerbation/other|9
2552406|NCT01437397|8831413|P2|Overall Study|Site termination/COPD exacerbation/other|8
2552407|NCT01437397|8831414|P1|Overall Study|Site termination/COPD exacerbation/other|10
2552408|NCT01437397|8831410|P5|Overall Study|Adverse Event|21
2552409|NCT01437397|8831411|P4|Overall Study|Adverse Event|14
2552410|NCT01437397|8831412|P3|Overall Study|Adverse Event|16
2552411|NCT01437397|8831413|P2|Overall Study|Adverse Event|22
2552412|NCT01437397|8831414|P1|Overall Study|Adverse Event|21
2552413|NCT01437397|8831410|P5|Overall Study|Lack of Efficacy|20
2552414|NCT01437397|8831411|P4|Overall Study|Lack of Efficacy|10
2552415|NCT01437397|8831412|P3|Overall Study|Lack of Efficacy|8
2552416|NCT01437397|8831413|P2|Overall Study|Lack of Efficacy|4
2552417|NCT01437397|8831414|P1|Overall Study|Lack of Efficacy|5
2552418|NCT01437397|8831410|P5|Overall Study|Protocol Violation|19
2552419|NCT01437397|8831411|P4|Overall Study|Protocol Violation|21
2552420|NCT01437397|8831412|P3|Overall Study|Protocol Violation|13
2552421|NCT01437397|8831413|P2|Overall Study|Protocol Violation|12
2552422|NCT01437397|8831414|P1|Overall Study|Protocol Violation|10
2552423|NCT01437397|8831410|P5|Overall Study|Withdrawal by Subject|22
2552424|NCT01437397|8831411|P4|Overall Study|Withdrawal by Subject|11
2552425|NCT01437397|8831412|P3|Overall Study|Withdrawal by Subject|24
2552426|NCT01437397|8831413|P2|Overall Study|Withdrawal by Subject|12
2552427|NCT01437397|8831414|P1|Overall Study|Withdrawal by Subject|11
2552428|NCT01437397|8831410|P5|Overall Study|Lost to Follow-up|5
2552429|NCT01437397|8831411|P4|Overall Study|Lost to Follow-up|4
2552430|NCT01437397|8831412|P3|Overall Study|Lost to Follow-up|2
2552431|NCT01437397|8831413|P2|Overall Study|Lost to Follow-up|4
2552432|NCT01437397|8831414|P1|Overall Study|Lost to Follow-up|9
2552433|NCT01437319|8831441|P3|Phase II|Protocol Violation|0
2552434|NCT01437319|8831442|P2|Phase II|Protocol Violation|1
2552435|NCT01437319|8831443|P1|Phase II|Protocol Violation|0
2552436|NCT01437319|8831441|P3|Phase II|Study related symptoms/complaints|19
2552437|NCT01437319|8831442|P2|Phase II|Study related symptoms/complaints|28
2552438|NCT01437319|8831443|P1|Phase II|Study related symptoms/complaints|0
2552439|NCT01437319|8831441|P3|Phase II|Lost to Follow-up|2
2552440|NCT01437319|8831442|P2|Phase II|Lost to Follow-up|7
2552441|NCT01437319|8831443|P1|Phase II|Lost to Follow-up|0
2552442|NCT01437319|8831441|P3|Phase II|Withdrawal by Subject|16
2552443|NCT01437319|8831442|P2|Phase II|Withdrawal by Subject|8
2552444|NCT01437319|8831443|P1|Phase II|Withdrawal by Subject|0
2552445|NCT01437319|8831441|P3|Phase I|Withdrawal by Subject|0
2552446|NCT01437319|8831442|P2|Phase I|Withdrawal by Subject|0
2552447|NCT01437319|8831443|P1|Phase I|Withdrawal by Subject|25
2552448|NCT01437319|8831441|P3|Phase I|Study related symptoms/complaints|0
2552449|NCT01437319|8831442|P2|Phase I|Study related symptoms/complaints|0
2552450|NCT01437319|8831443|P1|Phase I|Study related symptoms/complaints|27
2552451|NCT01437319|8831441|P3|Phase I|Protocol Violation|0
2552452|NCT01437319|8831442|P2|Phase I|Protocol Violation|0
2552453|NCT01437319|8831443|P1|Phase I|Protocol Violation|1
2552454|NCT01437319|8831441|P3|Phase I|Lost to Follow-up|0
2552455|NCT01437319|8831442|P2|Phase I|Lost to Follow-up|0
2552456|NCT01437319|8831443|P1|Phase I|Lost to Follow-up|2
2552457|NCT01437267|8831458|P6|Overall Study|Protocol Violation|0
2552458|NCT01437267|8831459|P5|Overall Study|Protocol Violation|0
2552459|NCT01437267|8831460|P4|Overall Study|Protocol Violation|0
2552460|NCT01437267|8831461|P3|Overall Study|Protocol Violation|0
2552461|NCT01437267|8831462|P2|Overall Study|Protocol Violation|1
2552462|NCT01437267|8831463|P1|Overall Study|Protocol Violation|0
2552463|NCT01437267|8831458|P6|Overall Study|Withdrawal by Subject|0
2552464|NCT01437267|8831459|P5|Overall Study|Withdrawal by Subject|0
2552465|NCT01437267|8831460|P4|Overall Study|Withdrawal by Subject|1
2552466|NCT01437267|8831461|P3|Overall Study|Withdrawal by Subject|0
2552467|NCT01437267|8831462|P2|Overall Study|Withdrawal by Subject|0
2552468|NCT01437267|8831463|P1|Overall Study|Withdrawal by Subject|0
2552469|NCT01437111|8831506|P1|Overall Study|Protocol Violation|1
2552470|NCT01437111|8831506|P1|Overall Study|Lost to Follow-up|5
2552471|NCT01437111|8831506|P1|Overall Study|Physician Decision|1
2552472|NCT01437111|8831506|P1|Overall Study|Not reported|5
2552473|NCT01437111|8831506|P1|Overall Study|Withdrawal by Subject|4
2552474|NCT01437111|8831506|P1|Overall Study|Adverse Event|2
2552475|NCT01436643|8831584|P4|Core Phase (16 Weeks)|Protocol Violation|0
2552476|NCT01436643|8831585|P3|Core Phase (16 Weeks)|Protocol Violation|1
2552477|NCT01436643|8831586|P2|Core Phase (16 Weeks)|Protocol Violation|1
2552478|NCT01436643|8831587|P1|Core Phase (16 Weeks)|Protocol Violation|1
2552479|NCT01436643|8831584|P4|Core Phase (16 Weeks)|Abnormal Test result|0
2552480|NCT01436643|8831585|P3|Core Phase (16 Weeks)|Abnormal Test result|1
2552481|NCT01436643|8831586|P2|Core Phase (16 Weeks)|Abnormal Test result|0
2552482|NCT01436643|8831587|P1|Core Phase (16 Weeks)|Abnormal Test result|0
2552483|NCT01436643|8831584|P4|Core Phase (16 Weeks)|Adverse Event|0
2552484|NCT01436643|8831585|P3|Core Phase (16 Weeks)|Adverse Event|1
2552485|NCT01436643|8831586|P2|Core Phase (16 Weeks)|Adverse Event|3
2552486|NCT01436643|8831587|P1|Core Phase (16 Weeks)|Adverse Event|0
2552487|NCT01436643|8831584|P4|2-week Pre-treatment|Protocol Violation|4
2552488|NCT01436643|8831585|P3|2-week Pre-treatment|Protocol Violation|0
2552489|NCT01436643|8831586|P2|2-week Pre-treatment|Protocol Violation|0
2552490|NCT01436643|8831587|P1|2-week Pre-treatment|Protocol Violation|0
2552491|NCT01436643|8831584|P4|2-week Pre-treatment|Adverse Event|5
2552492|NCT01436643|8831585|P3|2-week Pre-treatment|Adverse Event|0
2552493|NCT01436643|8831586|P2|2-week Pre-treatment|Adverse Event|0
2552494|NCT01436643|8831587|P1|2-week Pre-treatment|Adverse Event|0
2552495|NCT01436643|8831584|P4|2-week Pre-treatment|Abnormal test result|1
2552496|NCT01436643|8831585|P3|2-week Pre-treatment|Abnormal test result|0
2552497|NCT01436643|8831586|P2|2-week Pre-treatment|Abnormal test result|0
2552498|NCT01436643|8831587|P1|2-week Pre-treatment|Abnormal test result|0
2552499|NCT01436500|8831622|P5|Overall Study|Other|0
2552500|NCT01436500|8831623|P4|Overall Study|Other|1
2552501|NCT01436500|8831624|P3|Overall Study|Other|0
2552502|NCT01436500|8831625|P2|Overall Study|Other|1
2552503|NCT01436500|8831626|P1|Overall Study|Other|0
2552504|NCT01436500|8831622|P5|Overall Study|discontinued study drug|0
2552505|NCT01436500|8831623|P4|Overall Study|discontinued study drug|0
2552506|NCT01436500|8831624|P3|Overall Study|discontinued study drug|0
2552507|NCT01436500|8831625|P2|Overall Study|discontinued study drug|0
2552508|NCT01436500|8831626|P1|Overall Study|discontinued study drug|1
2552509|NCT01436500|8831622|P5|Overall Study|initiation of dialysis|1
2552510|NCT01436500|8831623|P4|Overall Study|initiation of dialysis|0
2552511|NCT01436500|8831624|P3|Overall Study|initiation of dialysis|0
2552512|NCT01436500|8831625|P2|Overall Study|initiation of dialysis|0
2552513|NCT01436500|8831626|P1|Overall Study|initiation of dialysis|0
2552514|NCT01436500|8831622|P5|Overall Study|liver transplant|0
2552515|NCT01436500|8831623|P4|Overall Study|liver transplant|0
2552516|NCT01436500|8831624|P3|Overall Study|liver transplant|0
2552517|NCT01436500|8831625|P2|Overall Study|liver transplant|0
2552518|NCT01436500|8831626|P1|Overall Study|liver transplant|1
2552519|NCT01436500|8831622|P5|Overall Study|Physician Decision|0
2552520|NCT01436500|8831623|P4|Overall Study|Physician Decision|0
2552521|NCT01436500|8831624|P3|Overall Study|Physician Decision|1
2552522|NCT01436500|8831625|P2|Overall Study|Physician Decision|0
2552523|NCT01436500|8831626|P1|Overall Study|Physician Decision|0
2552524|NCT01436500|8831622|P5|Overall Study|Withdrawal by Subject|2
2552525|NCT01436500|8831623|P4|Overall Study|Withdrawal by Subject|0
2552526|NCT01436500|8831624|P3|Overall Study|Withdrawal by Subject|2
2552527|NCT01436500|8831625|P2|Overall Study|Withdrawal by Subject|0
2552528|NCT01436500|8831626|P1|Overall Study|Withdrawal by Subject|0
2552529|NCT01436500|8831622|P5|Overall Study|Adverse Event|1
2552530|NCT01436500|8831623|P4|Overall Study|Adverse Event|0
2552531|NCT01436500|8831624|P3|Overall Study|Adverse Event|2
2552532|NCT01436500|8831625|P2|Overall Study|Adverse Event|2
2552533|NCT01436500|8831626|P1|Overall Study|Adverse Event|0
2552534|NCT01436500|8831622|P5|Overall Study|Death|0
2552535|NCT01436500|8831623|P4|Overall Study|Death|0
2552536|NCT01436500|8831624|P3|Overall Study|Death|0
2552537|NCT01436500|8831625|P2|Overall Study|Death|0
2552538|NCT01436500|8831626|P1|Overall Study|Death|1
2552539|NCT01436396|8831670|P2|Overall Study|Lost to Follow-up|3
2552540|NCT01436396|8831671|P1|Overall Study|Lost to Follow-up|3
2552541|NCT01436396|8831670|P2|Overall Study|Serious adverse event|3
2552542|NCT01436396|8831671|P1|Overall Study|Serious adverse event|2
2552543|NCT01436396|8831670|P2|Overall Study|Withdrawal by Subject|29
2552544|NCT01436396|8831671|P1|Overall Study|Withdrawal by Subject|19
2552545|NCT01436396|8831670|P2|Overall Study|Adverse Event|2
2552546|NCT01436396|8831671|P1|Overall Study|Adverse Event|1
2552547|NCT01436396|8831670|P2|Overall Study|Protocol Violation|5
2552548|NCT01436396|8831671|P1|Overall Study|Protocol Violation|7
2552549|NCT01436370|8831711|P8|Overall Study|Lost to Follow-up|0
2552550|NCT01436370|8831712|P7|Overall Study|Lost to Follow-up|0
2552551|NCT01436370|8831713|P6|Overall Study|Lost to Follow-up|0
2552552|NCT01436370|8831714|P5|Overall Study|Lost to Follow-up|1
2552553|NCT01436370|8831715|P4|Overall Study|Lost to Follow-up|0
2552554|NCT01436370|8831716|P3|Overall Study|Lost to Follow-up|0
2552555|NCT01436370|8831717|P2|Overall Study|Lost to Follow-up|0
2552556|NCT01436370|8831718|P1|Overall Study|Lost to Follow-up|0
2552557|NCT01436357|8831798|P2|Overall Study|Subject in rehab|1
2552558|NCT01436357|8831799|P1|Overall Study|Subject in rehab|0
2552559|NCT01436357|8831798|P2|Overall Study|Moved out of area|2
2552560|NCT01436357|8831799|P1|Overall Study|Moved out of area|1
2552561|NCT01436357|8831798|P2|Overall Study|Physician Decision|4
2552562|NCT01436357|8831799|P1|Overall Study|Physician Decision|3
2552563|NCT01436357|8831798|P2|Overall Study|Withdrawal by Subject|38
2552564|NCT01436357|8831799|P1|Overall Study|Withdrawal by Subject|26
2552565|NCT01436357|8831798|P2|Overall Study|Protocol Violation|0
2552566|NCT01436357|8831799|P1|Overall Study|Protocol Violation|1
2552567|NCT01436357|8831798|P2|Overall Study|Lost to Follow-up|61
2552568|NCT01436357|8831799|P1|Overall Study|Lost to Follow-up|67
2552569|NCT01436357|8831798|P2|Overall Study|Incarceration|20
2552570|NCT01436357|8831799|P1|Overall Study|Incarceration|18
2552571|NCT01436357|8831798|P2|Overall Study|Enrolled but not vaccinated|1
2552572|NCT01436357|8831799|P1|Overall Study|Enrolled but not vaccinated|1
2552573|NCT01436357|8831798|P2|Overall Study|Death|1
2552574|NCT01436357|8831799|P1|Overall Study|Death|5
2552575|NCT01436305|8831820|P3|Overall Study|Withdrawal by Subject|0
2552576|NCT01436305|8831821|P2|Overall Study|Withdrawal by Subject|3
2552577|NCT01436305|8831822|P1|Overall Study|Withdrawal by Subject|1
2552578|NCT01436305|8831820|P3|Overall Study|Lost to Follow-up|0
2552579|NCT01436305|8831821|P2|Overall Study|Lost to Follow-up|1
2552580|NCT01436305|8831822|P1|Overall Study|Lost to Follow-up|0
2552581|NCT01436305|8831820|P3|Overall Study|Death|0
2552582|NCT01436305|8831821|P2|Overall Study|Death|0
2552583|NCT01436305|8831822|P1|Overall Study|Death|1
2552584|NCT01436253|8831949|P1|Overall Study|Not meeting all eligibility criteria|117
2552585|NCT01436253|8831949|P1|Overall Study|Lost to Follow-up|182
2552586|NCT01436201|8831954|P1|Overall Study|Protocol Violation|1
2552587|NCT01436201|8831954|P1|Overall Study|Withdrawal by Subject|1
2552588|NCT01436201|8831954|P1|Overall Study|Adverse Event|2
2552589|NCT01436175|8831964|P1|Overall Study|Other|826
2552590|NCT01436175|8831964|P1|Overall Study|Met blood pressure or pulse withdrawal|63
2552591|NCT01436175|8831964|P1|Overall Study|Lack of Efficacy|24
2552592|NCT01436175|8831964|P1|Overall Study|Lost to Follow-up|89
2552593|NCT01436175|8831964|P1|Overall Study|Withdrawal by Subject|108
2552594|NCT01436175|8831964|P1|Overall Study|Protocol Violation|49
2552595|NCT01436175|8831964|P1|Overall Study|Adverse Event|111
2552596|NCT01436162|8831991|P3|Randomized Phase|Other|4
2552597|NCT01436162|8831992|P2|Randomized Phase|Other|5
2552598|NCT01436162|8831993|P1|Randomized Phase|Other|2
2552599|NCT01436162|8831991|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0
2552600|NCT01436162|8831992|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
2552601|NCT01436162|8831993|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4
2552602|NCT01436162|8831991|P3|Randomized Phase|Lack of Efficacy|1
2552603|NCT01436162|8831992|P2|Randomized Phase|Lack of Efficacy|1
2552604|NCT01436162|8831993|P1|Randomized Phase|Lack of Efficacy|0
2552605|NCT01436162|8831991|P3|Randomized Phase|Lost to Follow-up|4
2552606|NCT01436162|8831992|P2|Randomized Phase|Lost to Follow-up|5
2552607|NCT01436162|8831993|P1|Randomized Phase|Lost to Follow-up|17
2552608|NCT01436162|8831991|P3|Randomized Phase|Withdrawal by Subject|8
2552609|NCT01436162|8831992|P2|Randomized Phase|Withdrawal by Subject|9
2552610|NCT01436162|8831993|P1|Randomized Phase|Withdrawal by Subject|16
2552611|NCT01436162|8831991|P3|Randomized Phase|Protocol Violation|2
2552612|NCT01436162|8831992|P2|Randomized Phase|Protocol Violation|4
2552613|NCT01436162|8831993|P1|Randomized Phase|Protocol Violation|4
2552614|NCT01436162|8831991|P3|Randomized Phase|Adverse Event|6
2552615|NCT01436162|8831992|P2|Randomized Phase|Adverse Event|5
2552616|NCT01436162|8831993|P1|Randomized Phase|Adverse Event|1
2552617|NCT01436162|8831991|P3|Single-blind Lead-in Phase|Other|0
2552618|NCT01436162|8831992|P2|Single-blind Lead-in Phase|Other|0
2552619|NCT01436162|8831993|P1|Single-blind Lead-in Phase|Other|107
2552620|NCT01436162|8831991|P3|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
2552621|NCT01436162|8831992|P2|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
2552622|NCT01436162|8831993|P1|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13
2552623|NCT01436162|8831991|P3|Single-blind Lead-in Phase|Lost to Follow-up|0
2552624|NCT01436162|8831992|P2|Single-blind Lead-in Phase|Lost to Follow-up|0
2552625|NCT01436162|8831993|P1|Single-blind Lead-in Phase|Lost to Follow-up|43
2552626|NCT01436162|8831991|P3|Single-blind Lead-in Phase|Withdrawal by Subject|0
2552627|NCT01436162|8831992|P2|Single-blind Lead-in Phase|Withdrawal by Subject|0
2552628|NCT01436162|8831993|P1|Single-blind Lead-in Phase|Withdrawal by Subject|69
2552629|NCT01436162|8831991|P3|Single-blind Lead-in Phase|Protocol Violation|0
2552630|NCT01436162|8831992|P2|Single-blind Lead-in Phase|Protocol Violation|0
2552631|NCT01436162|8831993|P1|Single-blind Lead-in Phase|Protocol Violation|24
2552632|NCT01436162|8831991|P3|Single-blind Lead-in Phase|Adverse Event|0
2552633|NCT01436162|8831992|P2|Single-blind Lead-in Phase|Adverse Event|0
2552634|NCT01436162|8831993|P1|Single-blind Lead-in Phase|Adverse Event|26
2552635|NCT01436149|8832027|P3|Randomized Phase|Other|11
2552636|NCT01436149|8832028|P2|Randomized Phase|Other|5
2552637|NCT01436149|8832029|P1|Randomized Phase|Other|12
2552638|NCT01436149|8832027|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
2552639|NCT01436149|8832028|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
2552640|NCT01436149|8832029|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
2552641|NCT01436149|8832027|P3|Randomized Phase|Lack of Efficacy|1
2552642|NCT01436149|8832028|P2|Randomized Phase|Lack of Efficacy|0
2552643|NCT01436149|8832029|P1|Randomized Phase|Lack of Efficacy|0
2552644|NCT01436149|8832027|P3|Randomized Phase|Lost to Follow-up|6
2552645|NCT01436149|8832028|P2|Randomized Phase|Lost to Follow-up|5
2552646|NCT01436149|8832029|P1|Randomized Phase|Lost to Follow-up|34
2552647|NCT01436149|8832027|P3|Randomized Phase|Withdrawal by Subject|10
2552648|NCT01436149|8832028|P2|Randomized Phase|Withdrawal by Subject|10
2552649|NCT01436149|8832029|P1|Randomized Phase|Withdrawal by Subject|16
2552650|NCT01436149|8832027|P3|Randomized Phase|Protocol Violation|0
2552651|NCT01436149|8832028|P2|Randomized Phase|Protocol Violation|5
2552652|NCT01436149|8832029|P1|Randomized Phase|Protocol Violation|4
2552653|NCT01436149|8832027|P3|Randomized Phase|Adverse Event|11
2552654|NCT01436149|8832028|P2|Randomized Phase|Adverse Event|10
2552655|NCT01436149|8832029|P1|Randomized Phase|Adverse Event|9
2552656|NCT01436149|8832027|P3|Antidepressant Lead-in Phase|Other|0
2552657|NCT01436149|8832028|P2|Antidepressant Lead-in Phase|Other|0
2552658|NCT01436149|8832029|P1|Antidepressant Lead-in Phase|Other|119
2552659|NCT01436149|8832027|P3|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
2552660|NCT01436149|8832028|P2|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
2552661|NCT01436149|8832029|P1|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22
2552662|NCT01436149|8832027|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
2552663|NCT01436149|8832028|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
2552664|NCT01436149|8832029|P1|Antidepressant Lead-in Phase|Lost to Follow-up|96
2552665|NCT01436149|8832027|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
2552666|NCT01436149|8832028|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
2552667|NCT01436149|8832029|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|61
2552668|NCT01436149|8832027|P3|Antidepressant Lead-in Phase|Protocol Violation|0
2552669|NCT01436149|8832028|P2|Antidepressant Lead-in Phase|Protocol Violation|0
2552670|NCT01436149|8832029|P1|Antidepressant Lead-in Phase|Protocol Violation|29
2552671|NCT01436149|8832027|P3|Antidepressant Lead-in Phase|Adverse Event|0
2552672|NCT01436149|8832028|P2|Antidepressant Lead-in Phase|Adverse Event|0
2552673|NCT01436149|8832029|P1|Antidepressant Lead-in Phase|Adverse Event|39
2552674|NCT01436110|8832060|P3|Overall Study|Did Not Receive Trial Medication|3
2552675|NCT01436110|8832061|P2|Overall Study|Did Not Receive Trial Medication|0
2552676|NCT01436110|8832062|P1|Overall Study|Did Not Receive Trial Medication|1
2552677|NCT01436110|8832060|P3|Overall Study|Protocol Violation|1
2552678|NCT01436110|8832061|P2|Overall Study|Protocol Violation|1
2552679|NCT01436110|8832062|P1|Overall Study|Protocol Violation|3
2552680|NCT01436110|8832060|P3|Overall Study|Lost to Follow-up|3
2552681|NCT01436110|8832061|P2|Overall Study|Lost to Follow-up|1
2552682|NCT01436110|8832062|P1|Overall Study|Lost to Follow-up|1
2552683|NCT01436110|8832060|P3|Overall Study|Physician Decision|1
2552684|NCT01436110|8832061|P2|Overall Study|Physician Decision|1
2552685|NCT01436110|8832062|P1|Overall Study|Physician Decision|3
2552686|NCT01436110|8832060|P3|Overall Study|Adverse Event|2
2552687|NCT01436110|8832061|P2|Overall Study|Adverse Event|1
2552688|NCT01436110|8832062|P1|Overall Study|Adverse Event|2
2552689|NCT01436110|8832060|P3|Overall Study|Withdrawal by Subject|4
2552690|NCT01436110|8832061|P2|Overall Study|Withdrawal by Subject|8
2552691|NCT01436110|8832062|P1|Overall Study|Withdrawal by Subject|6
2552692|NCT01436110|8832060|P3|Overall Study|Lack of Efficacy|9
2552693|NCT01436110|8832061|P2|Overall Study|Lack of Efficacy|14
2552694|NCT01436110|8832062|P1|Overall Study|Lack of Efficacy|23
2552695|NCT01436084|8832085|P1|Overall Study|Early Closure of Study|1
2552696|NCT01436084|8832085|P1|Overall Study|Withdrawal by Subject|1
2552697|NCT01436084|8832085|P1|Overall Study|Disease Progression|2
2552698|NCT01436071|8832091|P2|Overall Study|Did Not Receive Trial Medication|3
2552699|NCT01436071|8832092|P1|Overall Study|Did Not Receive Trial Medication|3
2552700|NCT01436071|8832091|P2|Overall Study|Withdrawal by Subject|2
2552701|NCT01436071|8832092|P1|Overall Study|Withdrawal by Subject|2
2552702|NCT01436071|8832091|P2|Overall Study|Physician Decision|0
2552703|NCT01436071|8832092|P1|Overall Study|Physician Decision|1
2552704|NCT01436071|8832091|P2|Overall Study|Lost to Follow-up|1
2552705|NCT01436071|8832092|P1|Overall Study|Lost to Follow-up|3
2552706|NCT01436071|8832091|P2|Overall Study|Protocol Violation|1
2552707|NCT01436071|8832092|P1|Overall Study|Protocol Violation|0
2552708|NCT01436071|8832091|P2|Overall Study|Lack of Efficacy|7
2552709|NCT01436071|8832092|P1|Overall Study|Lack of Efficacy|16
2552710|NCT01436071|8832091|P2|Overall Study|Adverse Event|0
2552711|NCT01436071|8832092|P1|Overall Study|Adverse Event|1
2552712|NCT01435928|8832134|P3|Double Blind Phase - 28 Weeks|Administrative|2
2552713|NCT01435928|8832135|P2|Double Blind Phase - 28 Weeks|Administrative|5
2552714|NCT01435928|8832136|P1|Double Blind Phase - 28 Weeks|Administrative|0
2552715|NCT01435928|8832134|P3|Double Blind Phase - 28 Weeks|Relapse criteria met|58
2552716|NCT01435928|8832135|P2|Double Blind Phase - 28 Weeks|Relapse criteria met|43
2552717|NCT01435928|8832136|P1|Double Blind Phase - 28 Weeks|Relapse criteria met|0
2552718|NCT01435928|8832134|P3|Double Blind Phase - 28 Weeks|Terminated at study completion|39
2552719|NCT01435928|8832135|P2|Double Blind Phase - 28 Weeks|Terminated at study completion|47
2552720|NCT01435928|8832136|P1|Double Blind Phase - 28 Weeks|Terminated at study completion|0
2552721|NCT01435928|8832134|P3|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12
2552722|NCT01435928|8832135|P2|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5
2552723|NCT01435928|8832136|P1|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0
2552724|NCT01435928|8832134|P3|Double Blind Phase - 28 Weeks|Protocol Violation|4
2552725|NCT01435928|8832135|P2|Double Blind Phase - 28 Weeks|Protocol Violation|11
2552726|NCT01435928|8832136|P1|Double Blind Phase - 28 Weeks|Protocol Violation|0
2552727|NCT01435928|8832134|P3|Double Blind Phase - 28 Weeks|Lost to Follow-up|5
2552728|NCT01435928|8832135|P2|Double Blind Phase - 28 Weeks|Lost to Follow-up|2
2552729|NCT01435928|8832136|P1|Double Blind Phase - 28 Weeks|Lost to Follow-up|0
2552730|NCT01435928|8832134|P3|Double Blind Phase - 28 Weeks|Adverse Event|1
2552731|NCT01435928|8832135|P2|Double Blind Phase - 28 Weeks|Adverse Event|3
2552732|NCT01435928|8832136|P1|Double Blind Phase - 28 Weeks|Adverse Event|0
2552733|NCT01435928|8832134|P3|Open Label Phase - up to 24 Weeks|Administrative|0
2552734|NCT01435928|8832135|P2|Open Label Phase - up to 24 Weeks|Administrative|0
2552735|NCT01435928|8832136|P1|Open Label Phase - up to 24 Weeks|Administrative|14
2552736|NCT01435928|8832134|P3|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
2552737|NCT01435928|8832135|P2|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
2552738|NCT01435928|8832136|P1|Open Label Phase - up to 24 Weeks|Terminated at study completion|6
2552739|NCT01435928|8832134|P3|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
2552740|NCT01435928|8832135|P2|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
2552741|NCT01435928|8832136|P1|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44
2552742|NCT01435928|8832134|P3|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
2552743|NCT01435928|8832135|P2|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
2552744|NCT01435928|8832136|P1|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96
2552745|NCT01435928|8832134|P3|Open Label Phase - up to 24 Weeks|Protocol Violation|0
2552746|NCT01435928|8832135|P2|Open Label Phase - up to 24 Weeks|Protocol Violation|0
2552747|NCT01435928|8832136|P1|Open Label Phase - up to 24 Weeks|Protocol Violation|39
2552748|NCT01435928|8832134|P3|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
2552749|NCT01435928|8832135|P2|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
2552750|NCT01435928|8832136|P1|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60
2552751|NCT01435928|8832134|P3|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
2552752|NCT01435928|8832135|P2|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
2552753|NCT01435928|8832136|P1|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46
2552754|NCT01435928|8832134|P3|Open Label Phase - up to 24 Weeks|Death|0
2552755|NCT01435928|8832135|P2|Open Label Phase - up to 24 Weeks|Death|0
2552756|NCT01435928|8832136|P1|Open Label Phase - up to 24 Weeks|Death|1
2552757|NCT01435928|8832134|P3|Open Label Phase - up to 24 Weeks|Adverse Event|0
2552758|NCT01435928|8832135|P2|Open Label Phase - up to 24 Weeks|Adverse Event|0
2552759|NCT01435928|8832136|P1|Open Label Phase - up to 24 Weeks|Adverse Event|83
2552760|NCT01435798|8832182|P1|Overall Study|Withdrawal by Subject|1
2552761|NCT01435772|8832199|P3|Overall Study|Other - study termination|10
2552762|NCT01435772|8832200|P2|Overall Study|Other - study termination|2
2552763|NCT01435772|8832201|P1|Overall Study|Other - study termination|2
2552764|NCT01435772|8832199|P3|Overall Study|Withdrawal by Subject|3
2552765|NCT01435772|8832200|P2|Overall Study|Withdrawal by Subject|1
2552766|NCT01435772|8832201|P1|Overall Study|Withdrawal by Subject|0
2552767|NCT01435772|8832199|P3|Overall Study|Adverse Event|2
2552768|NCT01435772|8832200|P2|Overall Study|Adverse Event|0
2552769|NCT01435772|8832201|P1|Overall Study|Adverse Event|1
2552770|NCT01435759|8832251|P6|Double-blind Phase|Other|0
2552771|NCT01435759|8832252|P5|Double-blind Phase|Other|0
2552772|NCT01435759|8832253|P4|Double-blind Phase|Other|2
2552773|NCT01435759|8832254|P3|Double-blind Phase|Other|0
2552774|NCT01435759|8832255|P2|Double-blind Phase|Other|2
2552775|NCT01435759|8832256|P1|Double-blind Phase|Other|8
2552776|NCT01435759|8832251|P6|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
2552777|NCT01435759|8832252|P5|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3
2552778|NCT01435759|8832253|P4|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
2552779|NCT01435759|8832254|P3|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
2552780|NCT01435759|8832255|P2|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
2552781|NCT01435759|8832256|P1|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1
2552782|NCT01435759|8832251|P6|Double-blind Phase|Lost to Follow-up|3
2552783|NCT01435759|8832252|P5|Double-blind Phase|Lost to Follow-up|3
2552784|NCT01435759|8832253|P4|Double-blind Phase|Lost to Follow-up|0
2552785|NCT01435759|8832254|P3|Double-blind Phase|Lost to Follow-up|2
2552786|NCT01435759|8832255|P2|Double-blind Phase|Lost to Follow-up|1
2552787|NCT01435759|8832256|P1|Double-blind Phase|Lost to Follow-up|31
2552788|NCT01435759|8832251|P6|Double-blind Phase|Withdrawal by Subject|2
2552789|NCT01435759|8832252|P5|Double-blind Phase|Withdrawal by Subject|2
2552790|NCT01435759|8832253|P4|Double-blind Phase|Withdrawal by Subject|4
2552791|NCT01435759|8832254|P3|Double-blind Phase|Withdrawal by Subject|3
2552792|NCT01435759|8832255|P2|Double-blind Phase|Withdrawal by Subject|4
2552793|NCT01435759|8832256|P1|Double-blind Phase|Withdrawal by Subject|17
2552794|NCT01435759|8832251|P6|Double-blind Phase|Protocol Violation|1
2552795|NCT01435759|8832252|P5|Double-blind Phase|Protocol Violation|0
2552796|NCT01435759|8832253|P4|Double-blind Phase|Protocol Violation|2
2552797|NCT01435759|8832254|P3|Double-blind Phase|Protocol Violation|1
2552798|NCT01435759|8832255|P2|Double-blind Phase|Protocol Violation|0
2552799|NCT01435759|8832256|P1|Double-blind Phase|Protocol Violation|2
2552800|NCT01435759|8832251|P6|Double-blind Phase|Adverse Event|3
2552801|NCT01435759|8832252|P5|Double-blind Phase|Adverse Event|1
2552802|NCT01435759|8832253|P4|Double-blind Phase|Adverse Event|1
2552803|NCT01435759|8832254|P3|Double-blind Phase|Adverse Event|1
2552804|NCT01435759|8832255|P2|Double-blind Phase|Adverse Event|0
2552805|NCT01435759|8832256|P1|Double-blind Phase|Adverse Event|7
2552806|NCT01435759|8832251|P6|Antidepressant Lead-in Phase|Other|0
2552807|NCT01435759|8832252|P5|Antidepressant Lead-in Phase|Other|0
2552808|NCT01435759|8832253|P4|Antidepressant Lead-in Phase|Other|0
2552809|NCT01435759|8832254|P3|Antidepressant Lead-in Phase|Other|0
2552810|NCT01435759|8832255|P2|Antidepressant Lead-in Phase|Other|0
2552811|NCT01435759|8832256|P1|Antidepressant Lead-in Phase|Other|119
2552812|NCT01435759|8832251|P6|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
2552813|NCT01435759|8832252|P5|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
2552814|NCT01435759|8832253|P4|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
2552815|NCT01435759|8832254|P3|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
2552816|NCT01435759|8832255|P2|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
2552817|NCT01435759|8832256|P1|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10
2552818|NCT01435759|8832251|P6|Antidepressant Lead-in Phase|Lost to Follow-up|0
2552819|NCT01435759|8832252|P5|Antidepressant Lead-in Phase|Lost to Follow-up|0
2552820|NCT01435759|8832253|P4|Antidepressant Lead-in Phase|Lost to Follow-up|0
2552821|NCT01435759|8832254|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
2552822|NCT01435759|8832255|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
2552823|NCT01435759|8832256|P1|Antidepressant Lead-in Phase|Lost to Follow-up|83
2552824|NCT01435759|8832251|P6|Antidepressant Lead-in Phase|Withdrawal by Subject|0
2552825|NCT01435759|8832252|P5|Antidepressant Lead-in Phase|Withdrawal by Subject|0
2552826|NCT01435759|8832253|P4|Antidepressant Lead-in Phase|Withdrawal by Subject|0
2552827|NCT01435759|8832254|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
2552828|NCT01435759|8832255|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
2552829|NCT01435759|8832256|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|74
2552830|NCT01435759|8832251|P6|Antidepressant Lead-in Phase|Protocol Violation|0
2552831|NCT01435759|8832252|P5|Antidepressant Lead-in Phase|Protocol Violation|0
2552832|NCT01435759|8832253|P4|Antidepressant Lead-in Phase|Protocol Violation|0
2552833|NCT01435759|8832254|P3|Antidepressant Lead-in Phase|Protocol Violation|0
2552834|NCT01435759|8832255|P2|Antidepressant Lead-in Phase|Protocol Violation|0
2552835|NCT01435759|8832256|P1|Antidepressant Lead-in Phase|Protocol Violation|16
2552836|NCT01435759|8832251|P6|Antidepressant Lead-in Phase|Adverse Event|0
2552837|NCT01435759|8832252|P5|Antidepressant Lead-in Phase|Adverse Event|0
2552838|NCT01435759|8832253|P4|Antidepressant Lead-in Phase|Adverse Event|0
2552839|NCT01435759|8832254|P3|Antidepressant Lead-in Phase|Adverse Event|0
2552840|NCT01435759|8832255|P2|Antidepressant Lead-in Phase|Adverse Event|0
2552841|NCT01435759|8832256|P1|Antidepressant Lead-in Phase|Adverse Event|40
2552842|NCT01435655|8832283|P1|Overall Study|Other|1
2552843|NCT01435655|8832283|P1|Overall Study|Death|2
2552844|NCT01435616|8832297|P2|Overall Study|Sponsor Decision|0
2552845|NCT01435616|8832298|P1|Overall Study|Sponsor Decision|1
2552846|NCT01435616|8832297|P2|Overall Study|Physician Decision|7
2552847|NCT01435616|8832298|P1|Overall Study|Physician Decision|20
2552848|NCT01435616|8832297|P2|Overall Study|Withdrawal by Subject|24
2552849|NCT01435616|8832298|P1|Overall Study|Withdrawal by Subject|66
2552850|NCT01435616|8832297|P2|Overall Study|Protocol Violation|13
2552851|NCT01435616|8832298|P1|Overall Study|Protocol Violation|16
2552852|NCT01435616|8832297|P2|Overall Study|Lost to Follow-up|13
2552853|NCT01435616|8832298|P1|Overall Study|Lost to Follow-up|22
2552854|NCT01435616|8832297|P2|Overall Study|Death|2
2552855|NCT01435616|8832298|P1|Overall Study|Death|7
2552856|NCT01435616|8832297|P2|Overall Study|Adverse Event|21
2552857|NCT01435616|8832298|P1|Overall Study|Adverse Event|39
2552858|NCT01435577|8832353|P2|Overall Study|Alternative treatment started|1
2552859|NCT01435577|8832354|P1|Overall Study|Alternative treatment started|0
2552860|NCT01435577|8832353|P2|Overall Study|Lack of Efficacy|51
2552861|NCT01435577|8832354|P1|Overall Study|Lack of Efficacy|7
2552862|NCT01435577|8832353|P2|Overall Study|Adverse Event|0
2552863|NCT01435577|8832354|P1|Overall Study|Adverse Event|10
2552864|NCT01435460|8832404|P2|Overall Study|Did not meet eligibility criteria|0
2552865|NCT01435460|8832405|P1|Overall Study|Did not meet eligibility criteria|2
2552866|NCT01435460|8832404|P2|Overall Study|Protocol Violation|1
2552867|NCT01435460|8832405|P1|Overall Study|Protocol Violation|0
2552868|NCT01435460|8832404|P2|Overall Study|Withdrawal by Subject|3
2552869|NCT01435460|8832405|P1|Overall Study|Withdrawal by Subject|1
2552870|NCT01435460|8832404|P2|Overall Study|Lost to Follow-up|1
2552871|NCT01435460|8832405|P1|Overall Study|Lost to Follow-up|6
2552872|NCT01435460|8832404|P2|Overall Study|Adverse Event|1
2552873|NCT01435460|8832405|P1|Overall Study|Adverse Event|2
2552874|NCT01435382|8832421|P4|Overall Study|Withdrawal by Subject|1
2552875|NCT01435382|8832422|P3|Overall Study|Withdrawal by Subject|0
2552876|NCT01435382|8832423|P2|Overall Study|Withdrawal by Subject|2
2552877|NCT01435382|8832424|P1|Overall Study|Withdrawal by Subject|0
2552878|NCT01435382|8832421|P4|Overall Study|Lost to Follow-up|0
2552879|NCT01435382|8832422|P3|Overall Study|Lost to Follow-up|1
2552880|NCT01435382|8832423|P2|Overall Study|Lost to Follow-up|0
2552881|NCT01435382|8832424|P1|Overall Study|Lost to Follow-up|1
2552882|NCT01435356|8832513|P2|Overall Study|Patient moved to another city|1
2552883|NCT01435356|8832514|P1|Overall Study|Patient moved to another city|1
2552884|NCT01435356|8832513|P2|Overall Study|Patient decision|0
2552885|NCT01435356|8832514|P1|Overall Study|Patient decision|3
2552886|NCT01435356|8832513|P2|Overall Study|Physician Decision|0
2552887|NCT01435356|8832514|P1|Overall Study|Physician Decision|1
2552888|NCT01435356|8832513|P2|Overall Study|IC withdrawal due to study cancellation|0
2552889|NCT01435356|8832514|P1|Overall Study|IC withdrawal due to study cancellation|1
2552890|NCT01435356|8832513|P2|Overall Study|Facial palsy|0
2552891|NCT01435356|8832514|P1|Overall Study|Facial palsy|1
2552892|NCT01435356|8832513|P2|Overall Study|Withdrawal by Subject|1
2552893|NCT01435356|8832514|P1|Overall Study|Withdrawal by Subject|1
2552894|NCT01435356|8832513|P2|Overall Study|Study Discontinuation, amendment 4|11
2552895|NCT01435356|8832514|P1|Overall Study|Study Discontinuation, amendment 4|5
2552896|NCT01435356|8832513|P2|Overall Study|Protocol Violation|1
2552897|NCT01435356|8832514|P1|Overall Study|Protocol Violation|0
2552898|NCT01435356|8832513|P2|Overall Study|Disease progression/recurrence|10
2552899|NCT01435356|8832514|P1|Overall Study|Disease progression/recurrence|17
2552900|NCT01435356|8832513|P2|Overall Study|Adverse Event|0
2552901|NCT01435356|8832514|P1|Overall Study|Adverse Event|2
2552902|NCT01435265|8832547|P2|Overall Study|Lost to Follow-up|1
2552903|NCT01435265|8832548|P1|Overall Study|Lost to Follow-up|0
2552904|NCT01435122|8832562|P1|Overall Study|Early withdrawal due to toxicity|8
2552905|NCT01435031|8832571|P1|ITT at 4 Years|Lost to Follow-up|1
2552906|NCT01435031|8832571|P1|ITT at 4 Years|Withdrawal by Subject|2
2552907|NCT01435031|8832571|P1|ITT at 4 Years|Death|4
2552908|NCT01435031|8832571|P1|ITT at 3 Years|Lost to Follow-up|4
2552909|NCT01435031|8832571|P1|ITT at 3 Years|Withdrawal by Subject|2
2552910|NCT01435031|8832571|P1|ITT at 3 Years|Death|5
2552911|NCT01435031|8832571|P1|ITT at 2 Years|Lost to Follow-up|4
2552912|NCT01435031|8832571|P1|ITT at 2 Years|Withdrawal by Subject|2
2552913|NCT01435031|8832571|P1|ITT at 2 Years|Death|7
2552914|NCT01435031|8832571|P1|ITT at 1 Year|Lost to Follow-up|6
2552915|NCT01435031|8832571|P1|ITT at 1 Year|Withdrawal by Subject|2
2552916|NCT01435031|8832571|P1|ITT at 1 Year|Death|1
2552917|NCT01435031|8832571|P1|ITT at 6 Months|Lost to Follow-up|3
2552918|NCT01435031|8832571|P1|ITT at 6 Months|Death|2
2552919|NCT01435031|8832571|P1|ITT at 1 Month|Lost to Follow-up|4
2552920|NCT01435031|8832571|P1|ITT at 1 Month|Death|1
2552921|NCT01435031|8832571|P1|ITT at 1 Month|Withdrawal by Subject|1
2552922|NCT01435018|8832672|P3|Overall Study|Never started chemotherapy|1
2552923|NCT01435018|8832673|P2|Overall Study|Never started chemotherapy|0
2552924|NCT01435018|8832674|P1|Overall Study|Never started chemotherapy|3
2552925|NCT01435018|8832672|P3|Overall Study|Enrollment Violation|0
2552926|NCT01435018|8832673|P2|Overall Study|Enrollment Violation|1
2552927|NCT01435018|8832674|P1|Overall Study|Enrollment Violation|0
2552928|NCT01435018|8832672|P3|Overall Study|Unable to contact participant/parent|0
2552929|NCT01435018|8832673|P2|Overall Study|Unable to contact participant/parent|1
2552930|NCT01435018|8832674|P1|Overall Study|Unable to contact participant/parent|1
2552931|NCT01435018|8832672|P3|Overall Study|Severe debilitation, unable to continue|1
2552932|NCT01435018|8832673|P2|Overall Study|Severe debilitation, unable to continue|0
2552933|NCT01435018|8832674|P1|Overall Study|Severe debilitation, unable to continue|0
2552934|NCT01435018|8832672|P3|Overall Study|Not able to get to clinic|2
2552935|NCT01435018|8832673|P2|Overall Study|Not able to get to clinic|0
2552936|NCT01435018|8832674|P1|Overall Study|Not able to get to clinic|2
2552937|NCT01435018|8832672|P3|Overall Study|Not willing to adhere to requirements|1
2552938|NCT01435018|8832673|P2|Overall Study|Not willing to adhere to requirements|2
2552939|NCT01435018|8832674|P1|Overall Study|Not willing to adhere to requirements|0
2552940|NCT01435018|8832672|P3|Overall Study|Withdrew consent|1
2552941|NCT01435018|8832673|P2|Overall Study|Withdrew consent|3
2552942|NCT01435018|8832674|P1|Overall Study|Withdrew consent|0
2552943|NCT01435018|8832672|P3|Overall Study|Site is closing|7
2552944|NCT01435018|8832673|P2|Overall Study|Site is closing|9
2552945|NCT01435018|8832674|P1|Overall Study|Site is closing|4
2552946|NCT01435018|8832672|P3|Overall Study|Death|22
2552947|NCT01435018|8832673|P2|Overall Study|Death|18
2552948|NCT01435018|8832674|P1|Overall Study|Death|31
2552949|NCT01435018|8832672|P3|Overall Study|On study|73
2552950|NCT01435018|8832673|P2|Overall Study|On study|16
2552951|NCT01435018|8832674|P1|Overall Study|On study|69
2552952|NCT01434823|8832759|P2|Overall Study|Incomplete data in medical record|7
2552953|NCT01434823|8832760|P1|Overall Study|Incomplete data in medical record|4
2552954|NCT01434810|8832778|P2|Overall Study|Missing data/received <5hr phototherapy|7
2552955|NCT01434810|8832779|P1|Overall Study|Missing data/received <5hr phototherapy|12
2552956|NCT01434810|8832778|P2|Overall Study|Did not receive treatment|3
2552957|NCT01434810|8832779|P1|Overall Study|Did not receive treatment|11
2552958|NCT01434693|8832814|P4|Overall Study|Lost to Follow-up|0
2552959|NCT01434693|8832815|P3|Overall Study|Lost to Follow-up|0
2552960|NCT01434693|8832816|P2|Overall Study|Lost to Follow-up|0
2552961|NCT01434693|8832817|P1|Overall Study|Lost to Follow-up|1
2552962|NCT01434693|8832814|P4|Overall Study|Withdrawal by Subject|1
2552963|NCT01434693|8832815|P3|Overall Study|Withdrawal by Subject|1
2552964|NCT01434693|8832816|P2|Overall Study|Withdrawal by Subject|0
2552965|NCT01434693|8832817|P1|Overall Study|Withdrawal by Subject|1
2552966|NCT01434693|8832814|P4|Overall Study|Adverse Event|0
2552967|NCT01434693|8832815|P3|Overall Study|Adverse Event|0
2552968|NCT01434693|8832816|P2|Overall Study|Adverse Event|0
2552969|NCT01434693|8832817|P1|Overall Study|Adverse Event|1
2552970|NCT01434680|8832831|P4|Overall Study|Protocol Violation|0
2552971|NCT01434680|8832832|P3|Overall Study|Protocol Violation|0
2552972|NCT01434680|8832833|P2|Overall Study|Protocol Violation|1
2552973|NCT01434680|8832834|P1|Overall Study|Protocol Violation|1
2552974|NCT01434680|8832831|P4|Overall Study|Lost to Follow-up|0
2552975|NCT01434680|8832832|P3|Overall Study|Lost to Follow-up|0
2552976|NCT01434680|8832833|P2|Overall Study|Lost to Follow-up|1
2552977|NCT01434680|8832834|P1|Overall Study|Lost to Follow-up|1
2552978|NCT01434680|8832831|P4|Overall Study|Withdrawal by Subject|0
2552979|NCT01434680|8832832|P3|Overall Study|Withdrawal by Subject|2
2552980|NCT01434680|8832833|P2|Overall Study|Withdrawal by Subject|0
2552981|NCT01434680|8832834|P1|Overall Study|Withdrawal by Subject|1
2552982|NCT01434667|8832851|P2|Overall Study|Lost to Follow-up|10
2552983|NCT01434667|8832852|P1|Overall Study|Lost to Follow-up|5
2552984|NCT01434654|8832878|P2|Overall Study|Lost to Follow-up|0
2552985|NCT01434654|8832879|P1|Overall Study|Lost to Follow-up|1
2552986|NCT01434654|8832878|P2|Overall Study|Withdrawal by Subject|0
2552987|NCT01434654|8832879|P1|Overall Study|Withdrawal by Subject|1
2552988|NCT01434290|8832926|P2|Overall Study|No protocol treatment|4
2552989|NCT01434290|8832927|P1|Overall Study|No protocol treatment|2
2552990|NCT01434290|8832926|P2|Overall Study|Protocol Violation|3
2552991|NCT01434290|8832927|P1|Overall Study|Protocol Violation|6
2552992|NCT01433978|8833000|P3|Extension Phase|Study Terminated by Sponsor|4
2552993|NCT01433978|8833001|P2|Extension Phase|Study Terminated by Sponsor|0
2552994|NCT01433978|8833002|P1|Extension Phase|Study Terminated by Sponsor|0
2552995|NCT01433978|8833000|P3|Extension Phase|Lack of Efficacy|1
2552996|NCT01433978|8833001|P2|Extension Phase|Lack of Efficacy|0
2552997|NCT01433978|8833002|P1|Extension Phase|Lack of Efficacy|0
2552998|NCT01433978|8833000|P3|Extension Phase|Adverse Event, Non-Fatal|1
2552999|NCT01433978|8833001|P2|Extension Phase|Adverse Event, Non-Fatal|0
2553000|NCT01433978|8833002|P1|Extension Phase|Adverse Event, Non-Fatal|0
2553001|NCT01433978|8833000|P3|Core Study|Study Terminated by Sponsor|0
2553002|NCT01433978|8833001|P2|Core Study|Study Terminated by Sponsor|9
2553003|NCT01433978|8833002|P1|Core Study|Study Terminated by Sponsor|6
2553004|NCT01433978|8833000|P3|Core Study|Lack of Efficacy|0
2553005|NCT01433978|8833001|P2|Core Study|Lack of Efficacy|1
2553006|NCT01433978|8833002|P1|Core Study|Lack of Efficacy|5
2553007|NCT01433978|8833000|P3|Core Study|Adverse Event, Non-Fatal|0
2553008|NCT01433978|8833001|P2|Core Study|Adverse Event, Non-Fatal|1
2553009|NCT01433978|8833002|P1|Core Study|Adverse Event, Non-Fatal|0
2553010|NCT01433549|8833059|P2|Phase 2: Second Study Product|Adverse Event|1
2553011|NCT01433549|8833060|P1|Phase 2: Second Study Product|Adverse Event|0
2553012|NCT01433471|8833070|P2|Overall Study|Withdrawal by Subject|1
2553013|NCT01433471|8833071|P1|Overall Study|Withdrawal by Subject|0
2553014|NCT01433354|8833087|P1|Overall Study|Subject Withdrew Consent|3
2553015|NCT01433354|8833087|P1|Overall Study|Lack of Efficacy|17
2553016|NCT01433354|8833087|P1|Overall Study|Protocol Violation|2
2553017|NCT01433354|8833087|P1|Overall Study|Administrative problems|90
2553018|NCT01433354|8833087|P1|Overall Study|Lost to Follow-up|1
2553019|NCT01433354|8833087|P1|Overall Study|Adverse Event|6
2553020|NCT01433263|8833103|P2|Overall Study|Withdrawal by Subject|7
2553021|NCT01433263|8833104|P1|Overall Study|Withdrawal by Subject|10
2553022|NCT01433263|8833103|P2|Overall Study|Protocol Deviation|0
2553023|NCT01433263|8833104|P1|Overall Study|Protocol Deviation|1
2553024|NCT01433263|8833103|P2|Overall Study|Lost to Follow-up|1
2553025|NCT01433263|8833104|P1|Overall Study|Lost to Follow-up|0
2553026|NCT01433263|8833103|P2|Overall Study|Death|3
2553027|NCT01433263|8833104|P1|Overall Study|Death|5
2553028|NCT01433263|8833103|P2|Overall Study|Adverse Event|1
2553029|NCT01433263|8833104|P1|Overall Study|Adverse Event|3
2553030|NCT01433250|8833133|P2|Overall Study|Withdrawal by Subject|2
2553031|NCT01433250|8833134|P1|Overall Study|Withdrawal by Subject|3
2553032|NCT01433250|8833133|P2|Overall Study|Protocol Violation|1
2553033|NCT01433250|8833134|P1|Overall Study|Protocol Violation|0
2553034|NCT01433172|8833153|P3|Overall Study|Death|0
2553035|NCT01433172|8833154|P2|Overall Study|Death|2
2553036|NCT01433172|8833155|P1|Overall Study|Death|0
2553037|NCT01433172|8833153|P3|Overall Study|Disease Progression|1
2553038|NCT01433172|8833154|P2|Overall Study|Disease Progression|0
2553039|NCT01433172|8833155|P1|Overall Study|Disease Progression|0
2553040|NCT01433172|8833153|P3|Overall Study|Withdrawal by Subject|0
2553041|NCT01433172|8833154|P2|Overall Study|Withdrawal by Subject|1
2553042|NCT01433172|8833155|P1|Overall Study|Withdrawal by Subject|0
2553043|NCT01433159|8833167|P2|Overall Study|Protocol Violation|1
2553044|NCT01433159|8833168|P1|Overall Study|Protocol Violation|0
2553045|NCT01433159|8833167|P2|Overall Study|Physician Decision|0
2553046|NCT01433159|8833168|P1|Overall Study|Physician Decision|1
2553047|NCT01433159|8833167|P2|Overall Study|Adverse Event|0
2553048|NCT01433159|8833168|P1|Overall Study|Adverse Event|1
2553049|NCT01433055|8833200|P2|Overall Study|Severely elevated triglycerides at entry|0
2553050|NCT01433055|8833201|P1|Overall Study|Severely elevated triglycerides at entry|1
2553051|NCT01433055|8833200|P2|Overall Study|Diagnosed with cancer unrelated to study|0
2553052|NCT01433055|8833201|P1|Overall Study|Diagnosed with cancer unrelated to study|1
2553053|NCT01432938|8833223|P2|Second Intervention|Adverse Event|0
2553054|NCT01432938|8833224|P1|Second Intervention|Adverse Event|1
2553055|NCT01432938|8833223|P2|First Intervention|Physician Decision|0
2553056|NCT01432938|8833224|P1|First Intervention|Physician Decision|1
2553057|NCT01432938|8833223|P2|First Intervention|Protocol Violation|0
2553058|NCT01432938|8833224|P1|First Intervention|Protocol Violation|1
2553059|NCT01432756|8833254|P4|Overall Study|Lost to Follow-up|1
2553060|NCT01432756|8833255|P3|Overall Study|Lost to Follow-up|2
2553061|NCT01432756|8833256|P2|Overall Study|Lost to Follow-up|0
2553062|NCT01432756|8833257|P1|Overall Study|Lost to Follow-up|1
2553063|NCT01432626|8833265|P1|Overall Study|Imaging agent not available|1
2553064|NCT01432626|8833265|P1|Overall Study|Only 1 image competed|2
2553065|NCT01432626|8833265|P1|Overall Study|Withdrawal by Subject|2
2553066|NCT01432626|8833265|P1|Overall Study|LV function recovered|2
2553067|NCT01432600|8833272|P3|Overall Study|Rapid PD, allocated intv. not rec'd|1
2553068|NCT01432600|8833273|P2|Overall Study|Rapid PD, allocated intv. not rec'd|1
2553069|NCT01432600|8833274|P1|Overall Study|Rapid PD, allocated intv. not rec'd|0
2553070|NCT01432574|8833290|P1|Overall Study|Not interested|1
2553071|NCT01432574|8833290|P1|Overall Study|Moved|2
2553072|NCT01432457|8833336|P3|Overall Study|Did not take study drug|3
2553073|NCT01432457|8833337|P2|Overall Study|Did not take study drug|6
2553074|NCT01432457|8833338|P1|Overall Study|Did not take study drug|6
2553075|NCT01432457|8833336|P3|Overall Study|Reasons not defined|4
2553076|NCT01432457|8833337|P2|Overall Study|Reasons not defined|3
2553077|NCT01432457|8833338|P1|Overall Study|Reasons not defined|2
2553078|NCT01432457|8833336|P3|Overall Study|Withdrawal by Subject|9
2553079|NCT01432457|8833337|P2|Overall Study|Withdrawal by Subject|11
2553080|NCT01432457|8833338|P1|Overall Study|Withdrawal by Subject|6
2553081|NCT01432457|8833336|P3|Overall Study|Protocol Violation|6
2553082|NCT01432457|8833337|P2|Overall Study|Protocol Violation|2
2553083|NCT01432457|8833338|P1|Overall Study|Protocol Violation|3
2553084|NCT01432457|8833336|P3|Overall Study|Lost to Follow-up|20
2553085|NCT01432457|8833337|P2|Overall Study|Lost to Follow-up|15
2553086|NCT01432457|8833338|P1|Overall Study|Lost to Follow-up|11
2553087|NCT01432457|8833336|P3|Overall Study|Lack of Efficacy|1
2553088|NCT01432457|8833337|P2|Overall Study|Lack of Efficacy|1
2553089|NCT01432457|8833338|P1|Overall Study|Lack of Efficacy|2
2553090|NCT01432457|8833336|P3|Overall Study|Adverse Event|16
2553091|NCT01432457|8833337|P2|Overall Study|Adverse Event|10
2553092|NCT01432457|8833338|P1|Overall Study|Adverse Event|7
2553093|NCT01432444|8833367|P3|Extension Phase|Withdrawal by Subject|13
2553094|NCT01432444|8833368|P2|Extension Phase|Withdrawal by Subject|0
2553095|NCT01432444|8833369|P1|Extension Phase|Withdrawal by Subject|0
2553096|NCT01432444|8833367|P3|Extension Phase|Physician Decision|1
2553097|NCT01432444|8833368|P2|Extension Phase|Physician Decision|0
2553098|NCT01432444|8833369|P1|Extension Phase|Physician Decision|0
2553099|NCT01432444|8833367|P3|Extension Phase|Met Withdrawal Criteria|144
2553100|NCT01432444|8833368|P2|Extension Phase|Met Withdrawal Criteria|0
2553101|NCT01432444|8833369|P1|Extension Phase|Met Withdrawal Criteria|0
2553102|NCT01432444|8833367|P3|Extension Phase|Sponsor Discontinued Trial|7
2553103|NCT01432444|8833368|P2|Extension Phase|Sponsor Discontinued Trial|0
2553104|NCT01432444|8833369|P1|Extension Phase|Sponsor Discontinued Trial|0
2553105|NCT01432444|8833367|P3|Extension Phase|Adverse Event|10
2553106|NCT01432444|8833368|P2|Extension Phase|Adverse Event|0
2553107|NCT01432444|8833369|P1|Extension Phase|Adverse Event|0
2553108|NCT01432444|8833367|P3|Extension Phase|Lost to Follow-up|17
2553109|NCT01432444|8833368|P2|Extension Phase|Lost to Follow-up|0
2553110|NCT01432444|8833369|P1|Extension Phase|Lost to Follow-up|0
2553111|NCT01432444|8833367|P3|Treatment Phase|Lack of Efficacy|0
2553112|NCT01432444|8833368|P2|Treatment Phase|Lack of Efficacy|10
2553113|NCT01432444|8833369|P1|Treatment Phase|Lack of Efficacy|0
2553114|NCT01432444|8833367|P3|Treatment Phase|Protocol Deviation|0
2553115|NCT01432444|8833368|P2|Treatment Phase|Protocol Deviation|3
2553116|NCT01432444|8833369|P1|Treatment Phase|Protocol Deviation|0
2553117|NCT01432444|8833367|P3|Treatment Phase|Withdrawal by Subject|0
2553118|NCT01432444|8833368|P2|Treatment Phase|Withdrawal by Subject|41
2553119|NCT01432444|8833369|P1|Treatment Phase|Withdrawal by Subject|0
2553120|NCT01432444|8833367|P3|Treatment Phase|Physician Decision|0
2553121|NCT01432444|8833368|P2|Treatment Phase|Physician Decision|5
2553122|NCT01432444|8833369|P1|Treatment Phase|Physician Decision|0
2553123|NCT01432444|8833367|P3|Treatment Phase|Met Withdrawal Criteria|0
2553124|NCT01432444|8833368|P2|Treatment Phase|Met Withdrawal Criteria|11
2553125|NCT01432444|8833369|P1|Treatment Phase|Met Withdrawal Criteria|0
2553126|NCT01432444|8833367|P3|Treatment Phase|Adverse Event|0
2553127|NCT01432444|8833368|P2|Treatment Phase|Adverse Event|37
2553128|NCT01432444|8833369|P1|Treatment Phase|Adverse Event|0
2553129|NCT01432444|8833367|P3|Treatment Phase|Lost to Follow-up|0
2553130|NCT01432444|8833368|P2|Treatment Phase|Lost to Follow-up|33
2553131|NCT01432444|8833369|P1|Treatment Phase|Lost to Follow-up|0
2553132|NCT01432444|8833367|P3|Tolerability/Cross-titration Phase|Lack of Efficacy|0
2553133|NCT01432444|8833368|P2|Tolerability/Cross-titration Phase|Lack of Efficacy|0
2553134|NCT01432444|8833369|P1|Tolerability/Cross-titration Phase|Lack of Efficacy|5
2553135|NCT01432444|8833367|P3|Tolerability/Cross-titration Phase|Protocol Deviation|0
2553136|NCT01432444|8833368|P2|Tolerability/Cross-titration Phase|Protocol Deviation|0
2553137|NCT01432444|8833369|P1|Tolerability/Cross-titration Phase|Protocol Deviation|1
2553138|NCT01432444|8833367|P3|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
2553139|NCT01432444|8833368|P2|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
2553140|NCT01432444|8833369|P1|Tolerability/Cross-titration Phase|Withdrawal by Subject|15
2553141|NCT01432444|8833367|P3|Tolerability/Cross-titration Phase|Physician Decision|0
2553142|NCT01432444|8833368|P2|Tolerability/Cross-titration Phase|Physician Decision|0
2553143|NCT01432444|8833369|P1|Tolerability/Cross-titration Phase|Physician Decision|8
2553144|NCT01432444|8833367|P3|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
2553145|NCT01432444|8833368|P2|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
2553146|NCT01432444|8833369|P1|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5
2553147|NCT01432444|8833367|P3|Tolerability/Cross-titration Phase|Adverse Event|0
2553148|NCT01432444|8833368|P2|Tolerability/Cross-titration Phase|Adverse Event|0
2553149|NCT01432444|8833369|P1|Tolerability/Cross-titration Phase|Adverse Event|16
2553150|NCT01432444|8833367|P3|Tolerability/Cross-titration Phase|Lost to Follow-up|0
2553151|NCT01432444|8833368|P2|Tolerability/Cross-titration Phase|Lost to Follow-up|0
2553152|NCT01432444|8833369|P1|Tolerability/Cross-titration Phase|Lost to Follow-up|10
2553153|NCT01432366|8833395|P1|Overall Study|Other|14
2553154|NCT01432366|8833395|P1|Overall Study|Investigator Forget to Complete Visits|1
2553155|NCT01432366|8833395|P1|Overall Study|Site Closed|20
2553156|NCT01432366|8833395|P1|Overall Study|Lack of Efficacy|1
2553157|NCT01432366|8833395|P1|Overall Study|Lost to Follow-up|13
2553158|NCT01432366|8833395|P1|Overall Study|Pregnancy|1
2553159|NCT01432366|8833395|P1|Overall Study|Withdrawal Due to Non-Compliance|3
2553160|NCT01432366|8833395|P1|Overall Study|Adverse Event|8
2553161|NCT01432366|8833395|P1|Overall Study|Non-Responder|7
2553162|NCT01432327|8833417|P4|Posttest 1 Year|Allergic reaction|1
2553163|NCT01432327|8833418|P3|Posttest 1 Year|Allergic reaction|1
2553164|NCT01432327|8833419|P2|Posttest 1 Year|Allergic reaction|0
2553165|NCT01432327|8833420|P1|Posttest 1 Year|Allergic reaction|0
2553166|NCT01432327|8833417|P4|Posttest 1 Year|Lost to Follow-up|2
2553167|NCT01432327|8833418|P3|Posttest 1 Year|Lost to Follow-up|4
2553168|NCT01432327|8833419|P2|Posttest 1 Year|Lost to Follow-up|0
2553169|NCT01432327|8833420|P1|Posttest 1 Year|Lost to Follow-up|0
2553170|NCT01432327|8833417|P4|Posttest 1 Year|Measurement have to take place in future|20
2553171|NCT01432327|8833418|P3|Posttest 1 Year|Measurement have to take place in future|15
2553172|NCT01432327|8833419|P2|Posttest 1 Year|Measurement have to take place in future|28
2553173|NCT01432327|8833420|P1|Posttest 1 Year|Measurement have to take place in future|24
2553174|NCT01432327|8833417|P4|Posttest 6 Months|Withdrawal by Subject|0
2553175|NCT01432327|8833418|P3|Posttest 6 Months|Withdrawal by Subject|1
2553176|NCT01432327|8833419|P2|Posttest 6 Months|Withdrawal by Subject|0
2553177|NCT01432327|8833420|P1|Posttest 6 Months|Withdrawal by Subject|0
2553178|NCT01432327|8833417|P4|Posttest 6 Months|Allergic reaction|0
2553179|NCT01432327|8833418|P3|Posttest 6 Months|Allergic reaction|1
2553180|NCT01432327|8833419|P2|Posttest 6 Months|Allergic reaction|0
2553181|NCT01432327|8833420|P1|Posttest 6 Months|Allergic reaction|0
2553182|NCT01432327|8833417|P4|Posttest 6 Months|Lost to Follow-up|2
2553183|NCT01432327|8833418|P3|Posttest 6 Months|Lost to Follow-up|3
2553184|NCT01432327|8833419|P2|Posttest 6 Months|Lost to Follow-up|0
2553185|NCT01432327|8833420|P1|Posttest 6 Months|Lost to Follow-up|0
2553186|NCT01432327|8833417|P4|Posttest 3 Months|Allergic reaction|0
2553187|NCT01432327|8833418|P3|Posttest 3 Months|Allergic reaction|0
2553188|NCT01432327|8833419|P2|Posttest 3 Months|Allergic reaction|2
2553189|NCT01432327|8833420|P1|Posttest 3 Months|Allergic reaction|0
2553190|NCT01432327|8833417|P4|Posttest 3 Months|Lost to Follow-up|1
2553191|NCT01432327|8833418|P3|Posttest 3 Months|Lost to Follow-up|2
2553192|NCT01432327|8833419|P2|Posttest 3 Months|Lost to Follow-up|0
2553193|NCT01432327|8833420|P1|Posttest 3 Months|Lost to Follow-up|1
2553194|NCT01432327|8833417|P4|Posttest 3 Months|depression|0
2553195|NCT01432327|8833418|P3|Posttest 3 Months|depression|0
2553196|NCT01432327|8833419|P2|Posttest 3 Months|depression|0
2553197|NCT01432327|8833420|P1|Posttest 3 Months|depression|3
2553198|NCT01432275|8833430|P2|ADC With Calculator (10 Days)|Protocol Violation|1
2553199|NCT01432275|8833431|P1|ADC With Calculator (10 Days)|Protocol Violation|0
2553200|NCT01432275|8833430|P2|ADC With Calculator (10 Days)|Withdrawal by Subject|0
2553201|NCT01432275|8833431|P1|ADC With Calculator (10 Days)|Withdrawal by Subject|2
2553202|NCT01432275|8833430|P2|ADC With Calculator (10 Days)|Physician Decision|1
2553203|NCT01432275|8833431|P1|ADC With Calculator (10 Days)|Physician Decision|1
2553204|NCT01432275|8833430|P2|Second BG Meter System (7 Days)|Withdrawal by Subject|1
2553205|NCT01432275|8833431|P1|Second BG Meter System (7 Days)|Withdrawal by Subject|0
2553206|NCT01432275|8833430|P2|Second BG Meter System (7 Days)|Physician Decision|1
2553207|NCT01432275|8833431|P1|Second BG Meter System (7 Days)|Physician Decision|0
2553208|NCT01432275|8833430|P2|Second BG Meter System (7 Days)|Lost to Follow-up|0
2553209|NCT01432275|8833431|P1|Second BG Meter System (7 Days)|Lost to Follow-up|1
2553210|NCT01432275|8833430|P2|Second BG Meter System (7 Days)|Adverse Event|1
2553211|NCT01432275|8833431|P1|Second BG Meter System (7 Days)|Adverse Event|1
2553212|NCT01432275|8833430|P2|First BG Meter System (7 Days)|Withdrawal by Subject|1
2553213|NCT01432275|8833431|P1|First BG Meter System (7 Days)|Withdrawal by Subject|0
2553214|NCT01432275|8833430|P2|First BG Meter System (7 Days)|Adverse Event|2
2553215|NCT01432275|8833431|P1|First BG Meter System (7 Days)|Adverse Event|0
2553216|NCT01432262|8833440|P2|Overall Study|Withdrawal by Subject|1
2553217|NCT01432262|8833441|P1|Overall Study|Withdrawal by Subject|2
2553218|NCT01432171|8833507|P2|Overall Study|Patient moved to palliative care|0
2553219|NCT01432171|8833508|P1|Overall Study|Patient moved to palliative care|1
2553220|NCT01432171|8833507|P2|Overall Study|Insurance denial trial coverage|0
2553221|NCT01432171|8833508|P1|Overall Study|Insurance denial trial coverage|1
2553222|NCT01432171|8833507|P2|Overall Study|Noncompliance|3
2553223|NCT01432171|8833508|P1|Overall Study|Noncompliance|2
2553224|NCT01432171|8833507|P2|Overall Study|Withdrawal by Subject|1
2553225|NCT01432171|8833508|P1|Overall Study|Withdrawal by Subject|3
2553226|NCT01432171|8833507|P2|Overall Study|Lost to Follow-up|5
2553227|NCT01432171|8833508|P1|Overall Study|Lost to Follow-up|6
2553228|NCT01432171|8833507|P2|Overall Study|Death|2
2553229|NCT01432171|8833508|P1|Overall Study|Death|1
2553230|NCT01431976|8833549|P1|Overall Study|Withdrawal by Subject|1
2553231|NCT01431976|8833549|P1|Overall Study|Physician Decision|1
2553232|NCT01431976|8833549|P1|Overall Study|Met Protocol-defined Stopping Criteria|4
2553233|NCT01431976|8833549|P1|Overall Study|Lack of Efficacy|2
2553234|NCT01431976|8833549|P1|Overall Study|Adverse Event|6
2553235|NCT01431963|8833560|P1|Overall Study|Withdrawal by Subject|3
2553236|NCT01431963|8833560|P1|Overall Study|Physician Decision|4
2553237|NCT01431963|8833560|P1|Overall Study|Protocol-defined Stopping Criteria|2
2553238|NCT01431963|8833560|P1|Overall Study|Protocol Violation|1
2553239|NCT01431963|8833560|P1|Overall Study|Lack of Efficacy|7
2553240|NCT01431963|8833560|P1|Overall Study|Adverse Event|18
2553241|NCT01431950|8833568|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
2553242|NCT01431950|8833569|P1|Overall Study|Met Protocol-defined Stopping Criteria|0
2553243|NCT01431950|8833568|P2|Overall Study|Lost to Follow-up|1
2553244|NCT01431950|8833569|P1|Overall Study|Lost to Follow-up|0
2553245|NCT01431950|8833568|P2|Overall Study|Lack of Efficacy|1
2553246|NCT01431950|8833569|P1|Overall Study|Lack of Efficacy|2
2553247|NCT01431950|8833568|P2|Overall Study|Physician Decision|1
2553248|NCT01431950|8833569|P1|Overall Study|Physician Decision|2
2553249|NCT01431950|8833568|P2|Overall Study|Adverse Event|2
2553250|NCT01431950|8833569|P1|Overall Study|Adverse Event|2
2553251|NCT01431950|8833568|P2|Overall Study|Protocol Violation|3
2553252|NCT01431950|8833569|P1|Overall Study|Protocol Violation|2
2553253|NCT01431950|8833568|P2|Overall Study|Withdrawal by Subject|3
2553254|NCT01431950|8833569|P1|Overall Study|Withdrawal by Subject|4
2553255|NCT01431950|8833568|P2|Overall Study|Study Site Closed/Terminated|3
2553256|NCT01431950|8833569|P1|Overall Study|Study Site Closed/Terminated|7
2553257|NCT01431716|8833634|P1|Overall Study|Withdrawal of consent|1
2553258|NCT01431534|8833658|P3|Treatment Phase|Progressive Disease|10
2553259|NCT01431534|8833659|P2|Treatment Phase|Progressive Disease|3
2553260|NCT01431534|8833660|P1|Treatment Phase|Progressive Disease|4
2553261|NCT01431534|8833658|P3|Treatment Phase|Adverse Event|1
2553262|NCT01431534|8833659|P2|Treatment Phase|Adverse Event|0
2553263|NCT01431534|8833660|P1|Treatment Phase|Adverse Event|0
2553264|NCT01431521|8833675|P4|Overall Study|Withdrawal by Subject|0
2553265|NCT01431521|8833676|P3|Overall Study|Withdrawal by Subject|1
2553266|NCT01431521|8833677|P2|Overall Study|Withdrawal by Subject|0
2553267|NCT01431521|8833678|P1|Overall Study|Withdrawal by Subject|0
2553268|NCT01431508|8833699|P1|Overall Study|Unable to Follow Protocol Procedures|1
2553269|NCT01431508|8833699|P1|Overall Study|Lack of Efficacy|1
2553270|NCT01431287|8833784|P5|Overall Study|not stated above|1
2553271|NCT01431287|8833785|P4|Overall Study|not stated above|2
2553272|NCT01431287|8833786|P3|Overall Study|not stated above|2
2553273|NCT01431287|8833787|P2|Overall Study|not stated above|2
2553274|NCT01431287|8833788|P1|Overall Study|not stated above|4
2553275|NCT01431287|8833784|P5|Overall Study|Consent withdrawn not due to AE|29
2553276|NCT01431287|8833785|P4|Overall Study|Consent withdrawn not due to AE|19
2553277|NCT01431287|8833786|P3|Overall Study|Consent withdrawn not due to AE|34
2553278|NCT01431287|8833787|P2|Overall Study|Consent withdrawn not due to AE|30
2553279|NCT01431287|8833788|P1|Overall Study|Consent withdrawn not due to AE|29
2553280|NCT01431287|8833784|P5|Overall Study|Lost to Follow-up|1
2553281|NCT01431287|8833785|P4|Overall Study|Lost to Follow-up|3
2553282|NCT01431287|8833786|P3|Overall Study|Lost to Follow-up|2
2553283|NCT01431287|8833787|P2|Overall Study|Lost to Follow-up|3
2553284|NCT01431287|8833788|P1|Overall Study|Lost to Follow-up|0
2553285|NCT01431287|8833784|P5|Overall Study|Non compliant with protocol|5
2553286|NCT01431287|8833785|P4|Overall Study|Non compliant with protocol|6
2553287|NCT01431287|8833786|P3|Overall Study|Non compliant with protocol|5
2553288|NCT01431287|8833787|P2|Overall Study|Non compliant with protocol|6
2553289|NCT01431287|8833788|P1|Overall Study|Non compliant with protocol|6
2553290|NCT01431287|8833784|P5|Overall Study|Adverse Event|41
2553291|NCT01431287|8833785|P4|Overall Study|Adverse Event|33
2553292|NCT01431287|8833786|P3|Overall Study|Adverse Event|53
2553293|NCT01431287|8833787|P2|Overall Study|Adverse Event|57
2553294|NCT01431287|8833788|P1|Overall Study|Adverse Event|59
2553295|NCT01431287|8833784|P5|Overall Study|not treated|0
2553296|NCT01431287|8833785|P4|Overall Study|not treated|0
2553297|NCT01431287|8833786|P3|Overall Study|not treated|1
2553298|NCT01431287|8833787|P2|Overall Study|not treated|0
2553299|NCT01431287|8833788|P1|Overall Study|not treated|0
2553300|NCT01431274|8833950|P5|Overall Study|Other reason not stated above|4
2553301|NCT01431274|8833951|P4|Overall Study|Other reason not stated above|2
2553302|NCT01431274|8833952|P3|Overall Study|Other reason not stated above|7
2553303|NCT01431274|8833953|P2|Overall Study|Other reason not stated above|5
2553304|NCT01431274|8833954|P1|Overall Study|Other reason not stated above|6
2553305|NCT01431274|8833950|P5|Overall Study|Lost to Follow-up|0
2553306|NCT01431274|8833951|P4|Overall Study|Lost to Follow-up|4
2553307|NCT01431274|8833952|P3|Overall Study|Lost to Follow-up|1
2553308|NCT01431274|8833953|P2|Overall Study|Lost to Follow-up|7
2553309|NCT01431274|8833954|P1|Overall Study|Lost to Follow-up|6
2553310|NCT01431274|8833950|P5|Overall Study|Non compliant with protocol|4
2553311|NCT01431274|8833951|P4|Overall Study|Non compliant with protocol|4
2553312|NCT01431274|8833952|P3|Overall Study|Non compliant with protocol|4
2553313|NCT01431274|8833953|P2|Overall Study|Non compliant with protocol|8
2553314|NCT01431274|8833954|P1|Overall Study|Non compliant with protocol|5
2553315|NCT01431274|8833950|P5|Overall Study|Consent withdrawn not due to AE|11
2553316|NCT01431274|8833951|P4|Overall Study|Consent withdrawn not due to AE|20
2553317|NCT01431274|8833952|P3|Overall Study|Consent withdrawn not due to AE|17
2553318|NCT01431274|8833953|P2|Overall Study|Consent withdrawn not due to AE|20
2553319|NCT01431274|8833954|P1|Overall Study|Consent withdrawn not due to AE|29
2553320|NCT01431274|8833950|P5|Overall Study|Adverse Event|37
2553321|NCT01431274|8833951|P4|Overall Study|Adverse Event|30
2553322|NCT01431274|8833952|P3|Overall Study|Adverse Event|43
2553323|NCT01431274|8833953|P2|Overall Study|Adverse Event|37
2553324|NCT01431274|8833954|P1|Overall Study|Adverse Event|51
2553325|NCT01431144|8834132|P2|Overall Study|Implant mobility and removal|0
2553326|NCT01431144|8834133|P1|Overall Study|Implant mobility and removal|2
2553327|NCT01431079|8834156|P2|Overall Study|Lost to Follow-up|39
2553328|NCT01431079|8834157|P1|Overall Study|Lost to Follow-up|35
2553329|NCT01430754|8834236|P2|Run-In Phase|Lost to Follow-up|0
2553330|NCT01430754|8834237|P1|Run-In Phase|Lost to Follow-up|1
2553331|NCT01430754|8834236|P2|Run-In Phase|Withdrawal by Subject|0
2553332|NCT01430754|8834237|P1|Run-In Phase|Withdrawal by Subject|2
2553333|NCT01430754|8834236|P2|Run-In Phase|Other|0
2553334|NCT01430754|8834237|P1|Run-In Phase|Other|2
2553335|NCT01430754|8834236|P2|Run-In Phase|Adverse Event|0
2553336|NCT01430754|8834237|P1|Run-In Phase|Adverse Event|2
2553337|NCT01430754|8834236|P2|Run-In Phase|Protocol Violation|0
2553338|NCT01430754|8834237|P1|Run-In Phase|Protocol Violation|6
2553339|NCT01430754|8834236|P2|Run-In Phase|Circadian Period Ineligible|0
2553340|NCT01430754|8834237|P1|Run-In Phase|Circadian Period Ineligible|24
2553341|NCT01430624|8834295|P3|Overall Study|technical or eligibility|2
2553342|NCT01430624|8834296|P2|Overall Study|technical or eligibility|5
2553343|NCT01430624|8834297|P1|Overall Study|technical or eligibility|5
2553344|NCT01430624|8834295|P3|Overall Study|Lost to Follow-up|27
2553345|NCT01430624|8834296|P2|Overall Study|Lost to Follow-up|29
2553346|NCT01430624|8834297|P1|Overall Study|Lost to Follow-up|23
2553347|NCT01430611|8834328|P2|Overall Study|Withdrawal by Subject|14
2553348|NCT01430611|8834329|P1|Overall Study|Withdrawal by Subject|15
2553349|NCT01430611|8834328|P2|Overall Study|Lost to Follow-up|0
2553350|NCT01430611|8834329|P1|Overall Study|Lost to Follow-up|1
2553351|NCT01430611|8834328|P2|Overall Study|Protocol Violation|0
2553352|NCT01430611|8834329|P1|Overall Study|Protocol Violation|1
2553353|NCT01430611|8834328|P2|Overall Study|Adverse Event|1
2553354|NCT01430611|8834329|P1|Overall Study|Adverse Event|0
2553355|NCT01430585|8834347|P1|Overall Study|Other|7
2553356|NCT01430585|8834347|P1|Overall Study|Study Terminated by Sponsor|3
2553357|NCT01430585|8834347|P1|Overall Study|Objective Progression or Relapse|3
2553358|NCT01430585|8834347|P1|Overall Study|Death|1
2553359|NCT01430468|8834382|P2|Overall Study|Withdrawal by Subject|1
2553360|NCT01430468|8834383|P1|Overall Study|Withdrawal by Subject|1
2553361|NCT01430468|8834382|P2|Overall Study|Physician Decision|1
2553362|NCT01430468|8834383|P1|Overall Study|Physician Decision|2
2553363|NCT01430455|8834389|P1|Overall Study|Switched to follow-up phase|1
2553364|NCT01430455|8834389|P1|Overall Study|Withdrawal by Subject|1
2553365|NCT01430403|8834396|P3|Overall Study|Withdrawal by Subject|3
2553366|NCT01430403|8834397|P2|Overall Study|Withdrawal by Subject|1
2553367|NCT01430403|8834398|P1|Overall Study|Withdrawal by Subject|9
2553368|NCT01430403|8834396|P3|Overall Study|Protocol Violation|2
2553369|NCT01430403|8834397|P2|Overall Study|Protocol Violation|3
2553370|NCT01430403|8834398|P1|Overall Study|Protocol Violation|2
2553371|NCT01430403|8834396|P3|Overall Study|Physician Decision|0
2553372|NCT01430403|8834397|P2|Overall Study|Physician Decision|0
2553373|NCT01430403|8834398|P1|Overall Study|Physician Decision|1
2553374|NCT01430403|8834396|P3|Overall Study|Lost to Follow-up|3
2553375|NCT01430403|8834397|P2|Overall Study|Lost to Follow-up|5
2553376|NCT01430403|8834398|P1|Overall Study|Lost to Follow-up|5
2553377|NCT01430130|8834505|P1|Overall Study|Infection on Control Side of Incision|1
2553378|NCT01430130|8834505|P1|Overall Study|Lost to Follow-up|1
2553379|NCT01430104|8834511|P1|28-Day Teriparatide Treatment Period|Adverse Event|1
2553380|NCT01429792|8834578|P1|Overall Study|Lost to Follow-up|88
2553381|NCT01429792|8834578|P1|Overall Study|Withdrawal by Subject|70
2553382|NCT01429792|8834578|P1|Overall Study|Positive HCV-RNA at Week 24|50
2553383|NCT01429792|8834578|P1|Overall Study|Decrease of less than 2-log in HCV RNA|32
2553384|NCT01429792|8834578|P1|Overall Study|Negative HCV-RNA at Week 12|4
2553385|NCT01429792|8834578|P1|Overall Study|Negative HCV-RNA at Week 4|1
2553386|NCT01429792|8834578|P1|Overall Study|Unknown Disposition|94
2553387|NCT01429792|8834578|P1|Overall Study|Other Reasons|67
2553388|NCT01429623|8834592|P2|Overall Study|No post baseline data|4
2553389|NCT01429623|8834593|P1|Overall Study|No post baseline data|4
2553390|NCT01429623|8834592|P2|Overall Study|Conversion to Alzheimer's disease|21
2553391|NCT01429623|8834593|P1|Overall Study|Conversion to Alzheimer's disease|14
2553392|NCT01429623|8834592|P2|Overall Study|Assorted|2
2553393|NCT01429623|8834593|P1|Overall Study|Assorted|1
2553394|NCT01429623|8834592|P2|Overall Study|Protocol Violation|2
2553395|NCT01429623|8834593|P1|Overall Study|Protocol Violation|3
2553396|NCT01429623|8834592|P2|Overall Study|Physician Decision|3
2553397|NCT01429623|8834593|P1|Overall Study|Physician Decision|2
2553398|NCT01429623|8834592|P2|Overall Study|Withdrawal by Subject|13
2553399|NCT01429623|8834593|P1|Overall Study|Withdrawal by Subject|19
2553400|NCT01429623|8834592|P2|Overall Study|Adverse Event|14
2553401|NCT01429623|8834593|P1|Overall Study|Adverse Event|7
2553402|NCT01429623|8834592|P2|Overall Study|Death|0
2553403|NCT01429623|8834593|P1|Overall Study|Death|1
2553404|NCT01429584|8834607|P2|Overall Study|Protocol Violation|1
2553405|NCT01429584|8834608|P1|Overall Study|Protocol Violation|0
2553406|NCT01429584|8834607|P2|Overall Study|Withdrawal by Subject|0
2553407|NCT01429584|8834608|P1|Overall Study|Withdrawal by Subject|1
2553408|NCT01429441|8834639|P2|Overall Study|Withdrawal by Subject|18
2553409|NCT01429441|8834640|P1|Overall Study|Withdrawal by Subject|27
2553410|NCT01429441|8834639|P2|Overall Study|Physician Decision|0
2553411|NCT01429441|8834640|P1|Overall Study|Physician Decision|1
2553412|NCT01429441|8834639|P2|Overall Study|Lost to Follow-up|2
2553413|NCT01429441|8834640|P1|Overall Study|Lost to Follow-up|5
2553414|NCT01429441|8834639|P2|Overall Study|Death|2
2553415|NCT01429441|8834640|P1|Overall Study|Death|0
2553416|NCT01429441|8834639|P2|Overall Study|Adverse Event|1
2553417|NCT01429441|8834640|P1|Overall Study|Adverse Event|5
2553418|NCT01429298|8834650|P2|Overall Study|Protocol Violation|6
2553419|NCT01429298|8834651|P1|Overall Study|Protocol Violation|4
2553420|NCT01429285|8834667|P2|Overall Study|Erroneously Enrolled Twice|2
2553421|NCT01429285|8834668|P1|Overall Study|Erroneously Enrolled Twice|8
2553422|NCT01429285|8834667|P2|Overall Study|Missing Data|3
2553423|NCT01429285|8834668|P1|Overall Study|Missing Data|5
2553424|NCT01429285|8834667|P2|Overall Study|Protocol Violation|4
2553425|NCT01429285|8834668|P1|Overall Study|Protocol Violation|9
2553426|NCT01429077|8834714|P2|Overall Study|Lost to Follow-up|3
2553427|NCT01429077|8834715|P1|Overall Study|Lost to Follow-up|0
2553428|NCT01429051|8834738|P1|Tolerability Phase|Other|2
2553429|NCT01429051|8834738|P1|Tolerability Phase|Physician Decision|1
2553430|NCT01429051|8834738|P1|Tolerability Phase|Withdrawal by Subject|5
2553431|NCT01429051|8834738|P1|Tolerability Phase|Adverse Event|2
2553432|NCT01429051|8834738|P1|Tolerability Phase|Death|5
2553433|NCT01429051|8834738|P1|Efficacy Phase|Death|1
2553434|NCT01429051|8834738|P1|Efficacy Phase|Adverse Event|1
2553435|NCT01429051|8834738|P1|Titration Phase|Less than 3 BTP episodes per week|2
2553436|NCT01429051|8834738|P1|Titration Phase|Unsuccessful titration at any dose|1
2553437|NCT01429051|8834738|P1|Titration Phase|Physician Decision|1
2553438|NCT01429051|8834738|P1|Titration Phase|Withdrawal by Subject|7
2553439|NCT01429051|8834738|P1|Titration Phase|Death|1
2553440|NCT01428882|8834761|P2|Overall Study|Protocol Violation|3
2553441|NCT01428882|8834762|P1|Overall Study|Protocol Violation|4
2553442|NCT01428882|8834761|P2|Overall Study|Lack of Efficacy|7
2553443|NCT01428882|8834762|P1|Overall Study|Lack of Efficacy|2
2553444|NCT01428713|8834785|P2|Overall Study|Adverse Event|2
2553445|NCT01428713|8834786|P1|Overall Study|Adverse Event|0
2553446|NCT01428713|8834785|P2|Overall Study|Withdrawal by Subject|1
2553447|NCT01428713|8834786|P1|Overall Study|Withdrawal by Subject|1
2553448|NCT01428713|8834785|P2|Overall Study|Non-compliance|2
2553449|NCT01428713|8834786|P1|Overall Study|Non-compliance|2
2553450|NCT01428661|8834795|P3|Open Label Extension|**Various|185
2553451|NCT01428661|8834796|P2|Open Label Extension|**Various|0
2553452|NCT01428661|8834797|P1|Open Label Extension|**Various|0
2553453|NCT01428661|8834795|P3|Open Label Extension|Lack of Efficacy|24
2553454|NCT01428661|8834796|P2|Open Label Extension|Lack of Efficacy|0
2553455|NCT01428661|8834797|P1|Open Label Extension|Lack of Efficacy|0
2553456|NCT01428661|8834795|P3|Open Label Extension|Withdrawal by Subject|49
2553457|NCT01428661|8834796|P2|Open Label Extension|Withdrawal by Subject|0
2553458|NCT01428661|8834797|P1|Open Label Extension|Withdrawal by Subject|0
2553459|NCT01428661|8834795|P3|Open Label Extension|Lost to Follow-up|38
2553460|NCT01428661|8834796|P2|Open Label Extension|Lost to Follow-up|0
2553461|NCT01428661|8834797|P1|Open Label Extension|Lost to Follow-up|0
2553462|NCT01428661|8834795|P3|Open Label Extension|Adverse Event|15
2553463|NCT01428661|8834796|P2|Open Label Extension|Adverse Event|0
2553464|NCT01428661|8834797|P1|Open Label Extension|Adverse Event|0
2553465|NCT01428661|8834795|P3|Open Label Extension|Protocol Violation|9
2553466|NCT01428661|8834796|P2|Open Label Extension|Protocol Violation|0
2553467|NCT01428661|8834797|P1|Open Label Extension|Protocol Violation|0
2553468|NCT01428661|8834795|P3|Double-Masked Phase|*Various|0
2553469|NCT01428661|8834796|P2|Double-Masked Phase|*Various|6
2553470|NCT01428661|8834797|P1|Double-Masked Phase|*Various|1
2553471|NCT01428661|8834795|P3|Double-Masked Phase|Lack of Efficacy|0
2553472|NCT01428661|8834796|P2|Double-Masked Phase|Lack of Efficacy|1
2553473|NCT01428661|8834797|P1|Double-Masked Phase|Lack of Efficacy|2
2553474|NCT01428661|8834795|P3|Double-Masked Phase|Withdrawal by Subject|0
2553475|NCT01428661|8834796|P2|Double-Masked Phase|Withdrawal by Subject|20
2553476|NCT01428661|8834797|P1|Double-Masked Phase|Withdrawal by Subject|18
2553477|NCT01428661|8834795|P3|Double-Masked Phase|Lost to Follow-up|0
2553478|NCT01428661|8834796|P2|Double-Masked Phase|Lost to Follow-up|14
2553479|NCT01428661|8834797|P1|Double-Masked Phase|Lost to Follow-up|14
2553480|NCT01428661|8834795|P3|Double-Masked Phase|Adverse Event|0
2553481|NCT01428661|8834796|P2|Double-Masked Phase|Adverse Event|4
2553482|NCT01428661|8834797|P1|Double-Masked Phase|Adverse Event|13
2553483|NCT01428661|8834795|P3|Double-Masked Phase|Protocol Violation|0
2553484|NCT01428661|8834796|P2|Double-Masked Phase|Protocol Violation|4
2553485|NCT01428661|8834797|P1|Double-Masked Phase|Protocol Violation|9
2553486|NCT01428583|8834805|P1|Overall Study|Other|6
2553487|NCT01428583|8834805|P1|Overall Study|Sponsor’s request|3
2553488|NCT01428583|8834805|P1|Overall Study|Confirmed positive urine drug test|8
2553489|NCT01428583|8834805|P1|Overall Study|Non-compliant|25
2553490|NCT01428583|8834805|P1|Overall Study|Physician Decision|12
2553491|NCT01428583|8834805|P1|Overall Study|Protocol Violation|1
2553492|NCT01428583|8834805|P1|Overall Study|Pregnancy|1
2553493|NCT01428583|8834805|P1|Overall Study|Death|1
2553494|NCT01428583|8834805|P1|Overall Study|Lost to Follow-up|17
2553495|NCT01428583|8834805|P1|Overall Study|Lack of Efficacy|37
2553496|NCT01428583|8834805|P1|Overall Study|Withdrawal by Subject|51
2553497|NCT01428583|8834805|P1|Overall Study|Adverse Event|75
2553498|NCT01428453|8834829|P2|Overall Study|Withdrawal by Subject|1
2553499|NCT01428453|8834830|P1|Overall Study|Withdrawal by Subject|3
2553500|NCT01428453|8834829|P2|Overall Study|Lost to Follow-up|1
2553501|NCT01428453|8834830|P1|Overall Study|Lost to Follow-up|0
2553502|NCT01428453|8834829|P2|Overall Study|Protocol Violation|0
2553503|NCT01428453|8834830|P1|Overall Study|Protocol Violation|1
2553504|NCT01428453|8834829|P2|Overall Study|Adverse Event|7
2553505|NCT01428453|8834830|P1|Overall Study|Adverse Event|2
2553506|NCT01428258|8834869|P2|Intervention 1|Withdrawal by Subject|0
2553507|NCT01428258|8834870|P1|Intervention 1|Withdrawal by Subject|2
2553508|NCT01428219|8834888|P1|Overall Study|25 patients enrolled, 3 were not treated|3
2553509|NCT01428193|8834899|P1|Overall Study|Elevated screening liver enzymes|1
2553510|NCT01428193|8834899|P1|Overall Study|Physician Decision|1
2553511|NCT01428128|8834903|P1|Overall Study|Adverse Event|1
2553512|NCT01428128|8834903|P1|Overall Study|Received Neulasta in one cycle|2
2553513|NCT01428128|8834903|P1|Overall Study|Screen failure by p53|10
2553514|NCT01428128|8834903|P1|Overall Study|Withdrawal by Subject|4
2553515|NCT01428115|8834908|P1|Overall Study|Withdrawal by Subject|4
2553516|NCT01428115|8834908|P1|Overall Study|Protocol Violation|3
2553517|NCT01428115|8834908|P1|Overall Study|Pregnancy|1
2553518|NCT01428115|8834908|P1|Overall Study|Lost to Follow-up|10
2553519|NCT01428115|8834908|P1|Overall Study|Lack of Efficacy|3
2553520|NCT01428076|8834923|P2|Overall Study|Adverse Event|1
2553521|NCT01428076|8834924|P1|Overall Study|Adverse Event|0
2553522|NCT01428063|8834935|P3|Overall Study|No longer meets study criteria|0
2553523|NCT01428063|8834936|P2|Overall Study|No longer meets study criteria|1
2553524|NCT01428063|8834937|P1|Overall Study|No longer meets study criteria|0
2553525|NCT01428063|8834935|P3|Overall Study|Lost to Follow-up|0
2553526|NCT01428063|8834936|P2|Overall Study|Lost to Follow-up|2
2553527|NCT01428063|8834937|P1|Overall Study|Lost to Follow-up|0
2553528|NCT01428063|8834935|P3|Overall Study|Adverse Event|0
2553529|NCT01428063|8834936|P2|Overall Study|Adverse Event|3
2553530|NCT01428063|8834937|P1|Overall Study|Adverse Event|2
2553531|NCT01428063|8834935|P3|Overall Study|Lack of Efficacy|1
2553532|NCT01428063|8834936|P2|Overall Study|Lack of Efficacy|4
2553533|NCT01428063|8834937|P1|Overall Study|Lack of Efficacy|8
2553534|NCT01427972|8835038|P12|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2553535|NCT01427972|8835039|P11|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2553536|NCT01427972|8835040|P10|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2553537|NCT01427972|8835041|P9|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2553538|NCT01427972|8835042|P8|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2553539|NCT01427972|8835043|P7|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2553540|NCT01427972|8835044|P6|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2553541|NCT01427972|8835045|P5|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2553542|NCT01427972|8835046|P4|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2553543|NCT01427972|8835047|P3|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2553544|NCT01427972|8835048|P2|Treatment Period 2 (21 Days)|Withdrawal by Subject|1
2553545|NCT01427972|8835049|P1|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
2553546|NCT01427972|8835038|P12|Washout (at Least 28 Days)|Withdrawal by Subject|0
2553547|NCT01427972|8835039|P11|Washout (at Least 28 Days)|Withdrawal by Subject|0
2553548|NCT01427972|8835040|P10|Washout (at Least 28 Days)|Withdrawal by Subject|0
2553549|NCT01427972|8835041|P9|Washout (at Least 28 Days)|Withdrawal by Subject|0
2553550|NCT01427972|8835042|P8|Washout (at Least 28 Days)|Withdrawal by Subject|0
2553551|NCT01427972|8835043|P7|Washout (at Least 28 Days)|Withdrawal by Subject|0
2553552|NCT01427972|8835044|P6|Washout (at Least 28 Days)|Withdrawal by Subject|2
2553553|NCT01427972|8835045|P5|Washout (at Least 28 Days)|Withdrawal by Subject|0
2553554|NCT01427972|8835046|P4|Washout (at Least 28 Days)|Withdrawal by Subject|0
2553555|NCT01427972|8835047|P3|Washout (at Least 28 Days)|Withdrawal by Subject|0
2553556|NCT01427972|8835048|P2|Washout (at Least 28 Days)|Withdrawal by Subject|0
2553557|NCT01427972|8835049|P1|Washout (at Least 28 Days)|Withdrawal by Subject|0
2553558|NCT01427972|8835038|P12|Treatment Period 1 (21 Days)|Protocol Violation|0
2553559|NCT01427972|8835039|P11|Treatment Period 1 (21 Days)|Protocol Violation|0
2553560|NCT01427972|8835040|P10|Treatment Period 1 (21 Days)|Protocol Violation|0
2553561|NCT01427972|8835041|P9|Treatment Period 1 (21 Days)|Protocol Violation|0
2553562|NCT01427972|8835042|P8|Treatment Period 1 (21 Days)|Protocol Violation|1
2553563|NCT01427972|8835043|P7|Treatment Period 1 (21 Days)|Protocol Violation|0
2553564|NCT01427972|8835044|P6|Treatment Period 1 (21 Days)|Protocol Violation|0
2553565|NCT01427972|8835045|P5|Treatment Period 1 (21 Days)|Protocol Violation|0
2553566|NCT01427972|8835046|P4|Treatment Period 1 (21 Days)|Protocol Violation|0
2553567|NCT01427972|8835047|P3|Treatment Period 1 (21 Days)|Protocol Violation|0
2553568|NCT01427972|8835048|P2|Treatment Period 1 (21 Days)|Protocol Violation|0
2553569|NCT01427972|8835049|P1|Treatment Period 1 (21 Days)|Protocol Violation|0
2553570|NCT01427933|8835075|P2|Overall Study|Investigator's Decision|0
2553571|NCT01427933|8835076|P1|Overall Study|Investigator's Decision|1
2553572|NCT01427933|8835075|P2|Overall Study|Other|0
2553573|NCT01427933|8835076|P1|Overall Study|Other|1
2553574|NCT01427933|8835075|P2|Overall Study|Lost to Follow-up|5
2553575|NCT01427933|8835076|P1|Overall Study|Lost to Follow-up|1
2553576|NCT01427933|8835075|P2|Overall Study|Withdrawal by Subject|8
2553577|NCT01427933|8835076|P1|Overall Study|Withdrawal by Subject|5
2553578|NCT01427920|8835096|P2|Overall Study|Unclassified|8
2553579|NCT01427920|8835097|P1|Overall Study|Unclassified|2
2553580|NCT01427920|8835096|P2|Overall Study|Withdrawal Criteria|4
2553581|NCT01427920|8835097|P1|Overall Study|Withdrawal Criteria|4
2553582|NCT01427920|8835096|P2|Overall Study|Protocol Violation|3
2553583|NCT01427920|8835097|P1|Overall Study|Protocol Violation|1
2553584|NCT01427920|8835096|P2|Overall Study|Lack of Efficacy|0
2553585|NCT01427920|8835097|P1|Overall Study|Lack of Efficacy|1
2553586|NCT01427920|8835096|P2|Overall Study|Adverse Event|2
2553587|NCT01427920|8835097|P1|Overall Study|Adverse Event|1
2553588|NCT01427907|8835117|P2|Overall Study|Withdrawal by Subject|4
2553589|NCT01427907|8835118|P1|Overall Study|Withdrawal by Subject|3
2553590|NCT01427803|8835139|P2|Overall Study|did not take product|0
2553591|NCT01427803|8835140|P1|Overall Study|did not take product|1
2553592|NCT01427803|8835139|P2|Overall Study|Physician Decision|0
2553593|NCT01427803|8835140|P1|Overall Study|Physician Decision|3
2553594|NCT01427803|8835139|P2|Overall Study|Protocol Violation|0
2553595|NCT01427803|8835140|P1|Overall Study|Protocol Violation|1
2553596|NCT01427803|8835139|P2|Overall Study|Unable to complete full treatment period|0
2553597|NCT01427803|8835140|P1|Overall Study|Unable to complete full treatment period|6
2553598|NCT01427803|8835139|P2|Overall Study|Withdrawal by Subject|0
2553599|NCT01427803|8835140|P1|Overall Study|Withdrawal by Subject|20
2553600|NCT01427803|8835139|P2|Overall Study|Lost to Follow-up|26
2553601|NCT01427803|8835140|P1|Overall Study|Lost to Follow-up|32
2553602|NCT01427751|8835154|P2|Overall Study|Other miscellaneous reasons|4
2553603|NCT01427751|8835155|P1|Overall Study|Other miscellaneous reasons|6
2553604|NCT01427751|8835154|P2|Overall Study|Death|0
2553605|NCT01427751|8835155|P1|Overall Study|Death|2
2553606|NCT01427751|8835154|P2|Overall Study|Protocol Violation|4
2553607|NCT01427751|8835155|P1|Overall Study|Protocol Violation|6
2553608|NCT01427751|8835154|P2|Overall Study|Withdrawal of consent|2
2553609|NCT01427751|8835155|P1|Overall Study|Withdrawal of consent|2
2553610|NCT01427751|8835154|P2|Overall Study|Lost to Follow-up|1
2553611|NCT01427751|8835155|P1|Overall Study|Lost to Follow-up|3
2553612|NCT01427751|8835154|P2|Overall Study|No further treatment benefit expected|1
2553613|NCT01427751|8835155|P1|Overall Study|No further treatment benefit expected|5
2553614|NCT01427751|8835154|P2|Overall Study|Adverse Event|2
2553615|NCT01427751|8835155|P1|Overall Study|Adverse Event|18
2553616|NCT01427738|8835175|P2|Overall Study|Lost to Follow-up|5
2553617|NCT01427738|8835176|P1|Overall Study|Lost to Follow-up|1
2553618|NCT01427738|8835175|P2|Overall Study|Subject not willing to adhere to reqs|2
2553619|NCT01427738|8835176|P1|Overall Study|Subject not willing to adhere to reqs|1
2553620|NCT01427738|8835175|P2|Overall Study|Withdrawal by Subject|2
2553621|NCT01427738|8835176|P1|Overall Study|Withdrawal by Subject|0
2553622|NCT01427738|8835175|P2|Overall Study|Subject unable to get to clinic|2
2553623|NCT01427738|8835176|P1|Overall Study|Subject unable to get to clinic|5
2553624|NCT01427738|8835175|P2|Overall Study|Severe debilitation, unable to continue|1
2553625|NCT01427738|8835176|P1|Overall Study|Severe debilitation, unable to continue|0
2553626|NCT01427738|8835175|P2|Overall Study|Death|9
2553627|NCT01427738|8835176|P1|Overall Study|Death|12
2553628|NCT01427608|8835196|P2|Overall Study|Events not attributed to study meds|1
2553629|NCT01427608|8835197|P1|Overall Study|Events not attributed to study meds|0
2553630|NCT01427608|8835196|P2|Overall Study|Relapsed-all cause|34
2553631|NCT01427608|8835197|P1|Overall Study|Relapsed-all cause|13
2553632|NCT01427608|8835196|P2|Overall Study|Withdrawal by Subject|3
2553633|NCT01427608|8835197|P1|Overall Study|Withdrawal by Subject|7
2553634|NCT01427608|8835196|P2|Overall Study|Death|0
2553635|NCT01427608|8835197|P1|Overall Study|Death|1
2553636|NCT01427309|8835254|P4|Overall Study|Withdrawal by Subject|55
2553637|NCT01427309|8835255|P3|Overall Study|Withdrawal by Subject|61
2553638|NCT01427309|8835256|P2|Overall Study|Withdrawal by Subject|148
2553639|NCT01427309|8835257|P1|Overall Study|Withdrawal by Subject|148
2553640|NCT01427309|8835254|P4|Overall Study|Serious adverse event|61
2553641|NCT01427309|8835255|P3|Overall Study|Serious adverse event|50
2553642|NCT01427309|8835256|P2|Overall Study|Serious adverse event|45
2553643|NCT01427309|8835257|P1|Overall Study|Serious adverse event|52
2553644|NCT01427309|8835254|P4|Overall Study|Adverse Event|1
2553645|NCT01427309|8835255|P3|Overall Study|Adverse Event|3
2553646|NCT01427309|8835256|P2|Overall Study|Adverse Event|0
2553647|NCT01427309|8835257|P1|Overall Study|Adverse Event|0
2553648|NCT01427309|8835254|P4|Overall Study|Protocol Violation|124
2553649|NCT01427309|8835255|P3|Overall Study|Protocol Violation|125
2553650|NCT01427309|8835256|P2|Overall Study|Protocol Violation|69
2553651|NCT01427309|8835257|P1|Overall Study|Protocol Violation|42
2553652|NCT01427309|8835254|P4|Overall Study|Lost to Follow-up|135
2553653|NCT01427309|8835255|P3|Overall Study|Lost to Follow-up|122
2553654|NCT01427309|8835256|P2|Overall Study|Lost to Follow-up|145
2553655|NCT01427309|8835257|P1|Overall Study|Lost to Follow-up|130
2553656|NCT01426958|8835304|P1|Overall Study|Adverse Event|2
2553657|NCT01426854|8835333|P2|Overall Study|Other|2
2553658|NCT01426854|8835334|P1|Overall Study|Other|3
2553659|NCT01426854|8835333|P2|Overall Study|Protocol Deviation|1
2553660|NCT01426854|8835334|P1|Overall Study|Protocol Deviation|0
2553661|NCT01426854|8835333|P2|Overall Study|Treatment Failure|16
2553662|NCT01426854|8835334|P1|Overall Study|Treatment Failure|0
2553663|NCT01426854|8835333|P2|Overall Study|Noncompliance|1
2553664|NCT01426854|8835334|P1|Overall Study|Noncompliance|0
2553665|NCT01426854|8835333|P2|Overall Study|Lost to Follow-up|0
2553666|NCT01426854|8835334|P1|Overall Study|Lost to Follow-up|3
2553667|NCT01426854|8835333|P2|Overall Study|Subject Decision Unrelated to AE|6
2553668|NCT01426854|8835334|P1|Overall Study|Subject Decision Unrelated to AE|5
2553669|NCT01426854|8835333|P2|Overall Study|Adverse Event|5
2553670|NCT01426854|8835334|P1|Overall Study|Adverse Event|1
2553671|NCT01426789|8835344|P6|Part 2|Adverse Event|0
2553672|NCT01426789|8835345|P5|Part 2|Adverse Event|1
2553673|NCT01426789|8835346|P4|Part 2|Adverse Event|0
2553674|NCT01426789|8835347|P3|Part 2|Adverse Event|2
2553675|NCT01426789|8835348|P2|Part 2|Adverse Event|0
2553676|NCT01426789|8835349|P1|Part 2|Adverse Event|0
2553677|NCT01426789|8835344|P6|Part 2|Lack of Efficacy|0
2553678|NCT01426789|8835345|P5|Part 2|Lack of Efficacy|2
2553679|NCT01426789|8835346|P4|Part 2|Lack of Efficacy|0
2553680|NCT01426789|8835347|P3|Part 2|Lack of Efficacy|5
2553681|NCT01426789|8835348|P2|Part 2|Lack of Efficacy|0
2553682|NCT01426789|8835349|P1|Part 2|Lack of Efficacy|0
2553683|NCT01426789|8835344|P6|Part 2|Withdrawal by Subject|0
2553684|NCT01426789|8835345|P5|Part 2|Withdrawal by Subject|2
2553685|NCT01426789|8835346|P4|Part 2|Withdrawal by Subject|1
2553686|NCT01426789|8835347|P3|Part 2|Withdrawal by Subject|0
2553687|NCT01426789|8835348|P2|Part 2|Withdrawal by Subject|0
2553688|NCT01426789|8835349|P1|Part 2|Withdrawal by Subject|0
2553689|NCT01426789|8835344|P6|Part 2|Lost to Follow-up|0
2553690|NCT01426789|8835345|P5|Part 2|Lost to Follow-up|1
2553691|NCT01426789|8835346|P4|Part 2|Lost to Follow-up|0
2553692|NCT01426789|8835347|P3|Part 2|Lost to Follow-up|4
2553693|NCT01426789|8835348|P2|Part 2|Lost to Follow-up|0
2553694|NCT01426789|8835349|P1|Part 2|Lost to Follow-up|0
2553695|NCT01426789|8835344|P6|Part 2|Administrative problems|0
2553696|NCT01426789|8835345|P5|Part 2|Administrative problems|1
2553697|NCT01426789|8835346|P4|Part 2|Administrative problems|0
2553698|NCT01426789|8835347|P3|Part 2|Administrative problems|2
2553699|NCT01426789|8835348|P2|Part 2|Administrative problems|0
2553700|NCT01426789|8835349|P1|Part 2|Administrative problems|0
2553701|NCT01426789|8835344|P6|Part 2|Death|0
2553702|NCT01426789|8835345|P5|Part 2|Death|1
2553703|NCT01426789|8835346|P4|Part 2|Death|0
2553704|NCT01426789|8835347|P3|Part 2|Death|1
2553705|NCT01426789|8835348|P2|Part 2|Death|0
2553706|NCT01426789|8835349|P1|Part 2|Death|0
2553707|NCT01426789|8835344|P6|Part 2|Protocol deviation|0
2553708|NCT01426789|8835345|P5|Part 2|Protocol deviation|0
2553709|NCT01426789|8835346|P4|Part 2|Protocol deviation|0
2553710|NCT01426789|8835347|P3|Part 2|Protocol deviation|1
2553711|NCT01426789|8835348|P2|Part 2|Protocol deviation|0
2553712|NCT01426789|8835349|P1|Part 2|Protocol deviation|0
2553713|NCT01426789|8835344|P6|Part 1|Adverse Event|0
2553714|NCT01426789|8835345|P5|Part 1|Adverse Event|0
2553715|NCT01426789|8835346|P4|Part 1|Adverse Event|0
2553716|NCT01426789|8835347|P3|Part 1|Adverse Event|0
2553717|NCT01426789|8835348|P2|Part 1|Adverse Event|0
2553718|NCT01426789|8835349|P1|Part 1|Adverse Event|3
2553719|NCT01426789|8835344|P6|Part 1|Lack of Efficacy|0
2553720|NCT01426789|8835345|P5|Part 1|Lack of Efficacy|0
2553721|NCT01426789|8835346|P4|Part 1|Lack of Efficacy|0
2553722|NCT01426789|8835347|P3|Part 1|Lack of Efficacy|0
2553723|NCT01426789|8835348|P2|Part 1|Lack of Efficacy|1
2553724|NCT01426789|8835349|P1|Part 1|Lack of Efficacy|2
2553725|NCT01426789|8835344|P6|Part 1|Lost to Follow-up|0
2553726|NCT01426789|8835345|P5|Part 1|Lost to Follow-up|0
2553727|NCT01426789|8835346|P4|Part 1|Lost to Follow-up|0
2553728|NCT01426789|8835347|P3|Part 1|Lost to Follow-up|0
2553729|NCT01426789|8835348|P2|Part 1|Lost to Follow-up|2
2553730|NCT01426789|8835349|P1|Part 1|Lost to Follow-up|1
2553731|NCT01426789|8835344|P6|Part 1|Protocol deviation|0
2553732|NCT01426789|8835345|P5|Part 1|Protocol deviation|0
2553733|NCT01426789|8835346|P4|Part 1|Protocol deviation|0
2553734|NCT01426789|8835347|P3|Part 1|Protocol deviation|0
2553735|NCT01426789|8835348|P2|Part 1|Protocol deviation|1
2553736|NCT01426789|8835349|P1|Part 1|Protocol deviation|0
2553737|NCT01426438|8835411|P2|Overall Study|Missed Scan|2
2553738|NCT01426438|8835412|P1|Overall Study|Missed Scan|2
2553739|NCT01426438|8835411|P2|Overall Study|Poor scan quality|2
2553740|NCT01426438|8835412|P1|Overall Study|Poor scan quality|3
2553741|NCT01426438|8835411|P2|Overall Study|Off study Treatment|3
2553742|NCT01426438|8835412|P1|Overall Study|Off study Treatment|9
2553743|NCT01426438|8835411|P2|Overall Study|Lost to Follow-up|3
2553744|NCT01426438|8835412|P1|Overall Study|Lost to Follow-up|1
2553745|NCT01426425|8835444|P1|Overall Study|Met inclusion/exclusion, not treated|2
2553746|NCT01426425|8835444|P1|Overall Study|Inclusion/exclusion criteria not met|151
2553747|NCT01426425|8835444|P1|Overall Study|Exited prior to EP study|22
2553748|NCT01426412|8835459|P9|Overall Study|Withdrawal by Subject|1
2553749|NCT01426412|8835460|P8|Overall Study|Withdrawal by Subject|3
2553750|NCT01426412|8835461|P7|Overall Study|Withdrawal by Subject|0
2553751|NCT01426412|8835462|P6|Overall Study|Withdrawal by Subject|0
2553752|NCT01426412|8835463|P5|Overall Study|Withdrawal by Subject|1
2553753|NCT01426412|8835464|P4|Overall Study|Withdrawal by Subject|0
2553754|NCT01426412|8835465|P3|Overall Study|Withdrawal by Subject|0
2553755|NCT01426412|8835466|P2|Overall Study|Withdrawal by Subject|0
2553756|NCT01426412|8835467|P1|Overall Study|Withdrawal by Subject|1
2553757|NCT01426386|8835530|P6|Overall Study|Personal reasons|0
2553758|NCT01426386|8835531|P5|Overall Study|Personal reasons|1
2553759|NCT01426386|8835532|P4|Overall Study|Personal reasons|0
2553760|NCT01426386|8835533|P3|Overall Study|Personal reasons|0
2553761|NCT01426386|8835534|P2|Overall Study|Personal reasons|0
2553762|NCT01426386|8835535|P1|Overall Study|Personal reasons|0
2553763|NCT01426386|8835530|P6|Overall Study|Poor response|0
2553764|NCT01426386|8835531|P5|Overall Study|Poor response|1
2553765|NCT01426386|8835532|P4|Overall Study|Poor response|0
2553766|NCT01426386|8835533|P3|Overall Study|Poor response|2
2553767|NCT01426386|8835534|P2|Overall Study|Poor response|1
2553768|NCT01426386|8835535|P1|Overall Study|Poor response|2
2553769|NCT01426386|8835530|P6|Overall Study|Did not attend scheduled visit|1
2553770|NCT01426386|8835531|P5|Overall Study|Did not attend scheduled visit|2
2553771|NCT01426386|8835532|P4|Overall Study|Did not attend scheduled visit|0
2553772|NCT01426386|8835533|P3|Overall Study|Did not attend scheduled visit|0
2553773|NCT01426386|8835534|P2|Overall Study|Did not attend scheduled visit|4
2553774|NCT01426386|8835535|P1|Overall Study|Did not attend scheduled visit|1
2553775|NCT01426386|8835530|P6|Overall Study|Adverse Event|0
2553776|NCT01426386|8835531|P5|Overall Study|Adverse Event|0
2553777|NCT01426386|8835532|P4|Overall Study|Adverse Event|0
2553778|NCT01426386|8835533|P3|Overall Study|Adverse Event|0
2553779|NCT01426386|8835534|P2|Overall Study|Adverse Event|1
2553780|NCT01426386|8835535|P1|Overall Study|Adverse Event|0
2553781|NCT01426373|8835591|P1|Overall Study|Miscellaneous Reasons|4
2553782|NCT01426373|8835591|P1|Overall Study|Participant Convenience|10
2553783|NCT01426373|8835591|P1|Overall Study|Lost to Follow-up|14
2553784|NCT01426373|8835591|P1|Overall Study|Adverse Event|6
2553785|NCT01426347|8835624|P2|Overall Study|Withdrawal by Subject|0
2553786|NCT01426347|8835625|P1|Overall Study|Withdrawal by Subject|5
2553787|NCT01426347|8835624|P2|Overall Study|Protocol Violation|0
2553788|NCT01426347|8835625|P1|Overall Study|Protocol Violation|2
2553789|NCT01426347|8835624|P2|Overall Study|Lost to Follow-up|3
2553790|NCT01426347|8835625|P1|Overall Study|Lost to Follow-up|0
2553791|NCT01426269|8835633|P3|Period 2: 40 Weeks|Relapsed|18
2553792|NCT01426269|8835634|P2|Period 2: 40 Weeks|Relapsed|9
2553793|NCT01426269|8835635|P1|Period 2: 40 Weeks|Relapsed|0
2553794|NCT01426269|8835633|P3|Period 2: 40 Weeks|Site closed|5
2553795|NCT01426269|8835634|P2|Period 2: 40 Weeks|Site closed|6
2553796|NCT01426269|8835635|P1|Period 2: 40 Weeks|Site closed|0
2553797|NCT01426269|8835633|P3|Period 2: 40 Weeks|Lost to Follow-up|6
2553798|NCT01426269|8835634|P2|Period 2: 40 Weeks|Lost to Follow-up|8
2553799|NCT01426269|8835635|P1|Period 2: 40 Weeks|Lost to Follow-up|0
2553800|NCT01426269|8835633|P3|Period 2: 40 Weeks|Protocol Violation|5
2553801|NCT01426269|8835634|P2|Period 2: 40 Weeks|Protocol Violation|5
2553802|NCT01426269|8835635|P1|Period 2: 40 Weeks|Protocol Violation|0
2553803|NCT01426269|8835633|P3|Period 2: 40 Weeks|Withdrawal by Subject|11
2553804|NCT01426269|8835634|P2|Period 2: 40 Weeks|Withdrawal by Subject|9
2553805|NCT01426269|8835635|P1|Period 2: 40 Weeks|Withdrawal by Subject|0
2553806|NCT01426269|8835633|P3|Period 2: 40 Weeks|Adverse Event|2
2553807|NCT01426269|8835634|P2|Period 2: 40 Weeks|Adverse Event|1
2553808|NCT01426269|8835635|P1|Period 2: 40 Weeks|Adverse Event|0
2553809|NCT01426269|8835633|P3|Eligibility for Period 2, Randomization|Qualified, opted out|0
2553810|NCT01426269|8835634|P2|Eligibility for Period 2, Randomization|Qualified, opted out|0
2553811|NCT01426269|8835635|P1|Eligibility for Period 2, Randomization|Qualified, opted out|8
2553812|NCT01426269|8835633|P3|Eligibility for Period 2, Randomization|Did not qualify|0
2553813|NCT01426269|8835634|P2|Eligibility for Period 2, Randomization|Did not qualify|0
2553814|NCT01426269|8835635|P1|Eligibility for Period 2, Randomization|Did not qualify|42
2553815|NCT01426269|8835633|P3|Period 1: 12 Weeks|Pregnancy|0
2553816|NCT01426269|8835634|P2|Period 1: 12 Weeks|Pregnancy|0
2553817|NCT01426269|8835635|P1|Period 1: 12 Weeks|Pregnancy|1
2553818|NCT01426269|8835633|P3|Period 1: 12 Weeks|Lost to Follow-up|0
2553819|NCT01426269|8835634|P2|Period 1: 12 Weeks|Lost to Follow-up|0
2553820|NCT01426269|8835635|P1|Period 1: 12 Weeks|Lost to Follow-up|22
2553821|NCT01426269|8835633|P3|Period 1: 12 Weeks|Protocol Violation|0
2553822|NCT01426269|8835634|P2|Period 1: 12 Weeks|Protocol Violation|0
2553823|NCT01426269|8835635|P1|Period 1: 12 Weeks|Protocol Violation|5
2553824|NCT01426269|8835633|P3|Period 1: 12 Weeks|Withdrawal by Subject|0
2553825|NCT01426269|8835634|P2|Period 1: 12 Weeks|Withdrawal by Subject|0
2553826|NCT01426269|8835635|P1|Period 1: 12 Weeks|Withdrawal by Subject|22
2553827|NCT01426269|8835633|P3|Period 1: 12 Weeks|Adverse Event|0
2553828|NCT01426269|8835634|P2|Period 1: 12 Weeks|Adverse Event|0
2553829|NCT01426269|8835635|P1|Period 1: 12 Weeks|Adverse Event|5
2553830|NCT01426217|8835670|P2|Overall Study|lost sample|14
2553831|NCT01426217|8835671|P1|Overall Study|lost sample|8
2553832|NCT01426113|8835684|P2|Overall Study|Adverse Event|1
2553833|NCT01426113|8835685|P1|Overall Study|Adverse Event|0
2553834|NCT01426113|8835684|P2|Overall Study|Study Discontinued|1
2553835|NCT01426113|8835685|P1|Overall Study|Study Discontinued|1
2553836|NCT01426009|8835691|P1|Washout 4|Lost to Follow-up|1
2553837|NCT01426009|8835691|P1|Period 4-Fourth Intervention (7 Days)|personal reasons|1
2553838|NCT01426009|8835691|P1|Washout 3|personal reasons|1
2553839|NCT01426009|8835691|P1|Washout 2|electrive surgery|1
2553840|NCT01426009|8835691|P1|Period 2-Second Intervention (7 Days)|personal reasons|1
2553841|NCT01426009|8835691|P1|Period 2-Second Intervention (7 Days)|Adverse Event|4
2553842|NCT01426009|8835691|P1|Washout 1|Personal Reasons|1
2553843|NCT01426009|8835691|P1|Washout 1|Withdrawal by Subject|1
2553844|NCT01426009|8835691|P1|Period 1-First Intervention (7 Days)|Personal Reasons|1
2553845|NCT01426009|8835691|P1|Period 1-First Intervention (7 Days)|Adverse Event|1
2553846|NCT01425814|8835787|P6|Period 5|Stability criteria not fulfilled|1
2553847|NCT01425814|8835788|P5|Period 5|Stability criteria not fulfilled|0
2553848|NCT01425814|8835789|P4|Period 5|Stability criteria not fulfilled|0
2553849|NCT01425814|8835790|P3|Period 5|Stability criteria not fulfilled|1
2553850|NCT01425814|8835791|P2|Period 5|Stability criteria not fulfilled|0
2553851|NCT01425814|8835792|P1|Period 5|Stability criteria not fulfilled|0
2553852|NCT01425814|8835787|P6|Period 4|Adverse Event|0
2553853|NCT01425814|8835788|P5|Period 4|Adverse Event|0
2553854|NCT01425814|8835789|P4|Period 4|Adverse Event|0
2553855|NCT01425814|8835790|P3|Period 4|Adverse Event|1
2553856|NCT01425814|8835791|P2|Period 4|Adverse Event|0
2553857|NCT01425814|8835792|P1|Period 4|Adverse Event|1
2553858|NCT01425814|8835787|P6|Period 3|Adverse Event|1
2553859|NCT01425814|8835788|P5|Period 3|Adverse Event|0
2553860|NCT01425814|8835789|P4|Period 3|Adverse Event|0
2553861|NCT01425814|8835790|P3|Period 3|Adverse Event|0
2553862|NCT01425814|8835791|P2|Period 3|Adverse Event|0
2553863|NCT01425814|8835792|P1|Period 3|Adverse Event|0
2553864|NCT01425814|8835787|P6|Period 2|Stability criteria not fulfilled|0
2553865|NCT01425814|8835788|P5|Period 2|Stability criteria not fulfilled|0
2553866|NCT01425814|8835789|P4|Period 2|Stability criteria not fulfilled|0
2553867|NCT01425814|8835790|P3|Period 2|Stability criteria not fulfilled|0
2553868|NCT01425814|8835791|P2|Period 2|Stability criteria not fulfilled|1
2553869|NCT01425814|8835792|P1|Period 2|Stability criteria not fulfilled|0
2553870|NCT01425814|8835787|P6|Period 1|Stability criteria not fulfilled|0
2553871|NCT01425814|8835788|P5|Period 1|Stability criteria not fulfilled|0
2553872|NCT01425814|8835789|P4|Period 1|Stability criteria not fulfilled|0
2553873|NCT01425814|8835790|P3|Period 1|Stability criteria not fulfilled|0
2553874|NCT01425814|8835791|P2|Period 1|Stability criteria not fulfilled|1
2553875|NCT01425814|8835792|P1|Period 1|Stability criteria not fulfilled|0
2553876|NCT01425801|8835884|P6|Period 4|Not able to maintain visit schedule|0
2553877|NCT01425801|8835885|P5|Period 4|Not able to maintain visit schedule|0
2553878|NCT01425801|8835886|P4|Period 4|Not able to maintain visit schedule|0
2553879|NCT01425801|8835887|P3|Period 4|Not able to maintain visit schedule|1
2553880|NCT01425801|8835888|P2|Period 4|Not able to maintain visit schedule|0
2553881|NCT01425801|8835889|P1|Period 4|Not able to maintain visit schedule|0
2553882|NCT01425801|8835884|P6|Period 3|Stability criteria not fullfilled|0
2553883|NCT01425801|8835885|P5|Period 3|Stability criteria not fullfilled|0
2553884|NCT01425801|8835886|P4|Period 3|Stability criteria not fullfilled|0
2553885|NCT01425801|8835887|P3|Period 3|Stability criteria not fullfilled|1
2553886|NCT01425801|8835888|P2|Period 3|Stability criteria not fullfilled|0
2553887|NCT01425801|8835889|P1|Period 3|Stability criteria not fullfilled|0
2553888|NCT01425801|8835884|P6|Period 2|Withdrawal by Subject|0
2553889|NCT01425801|8835885|P5|Period 2|Withdrawal by Subject|1
2553890|NCT01425801|8835886|P4|Period 2|Withdrawal by Subject|0
2553891|NCT01425801|8835887|P3|Period 2|Withdrawal by Subject|0
2553892|NCT01425801|8835888|P2|Period 2|Withdrawal by Subject|0
2553893|NCT01425801|8835889|P1|Period 2|Withdrawal by Subject|0
2553894|NCT01425801|8835884|P6|Period 1|Withdrawal by Subject|0
2553895|NCT01425801|8835885|P5|Period 1|Withdrawal by Subject|1
2553896|NCT01425801|8835886|P4|Period 1|Withdrawal by Subject|0
2553897|NCT01425801|8835887|P3|Period 1|Withdrawal by Subject|0
2553898|NCT01425801|8835888|P2|Period 1|Withdrawal by Subject|0
2553899|NCT01425801|8835889|P1|Period 1|Withdrawal by Subject|0
2553900|NCT01425749|8835995|P2|Overall Study|progression of melanoma|1
2553901|NCT01425749|8835996|P1|Overall Study|progression of melanoma|0
2553902|NCT01425723|8836013|P2|Overall Study|Other|10
2553903|NCT01425723|8836014|P1|Overall Study|Other|1
2553904|NCT01425723|8836013|P2|Overall Study|Physician Decision|0
2553905|NCT01425723|8836014|P1|Overall Study|Physician Decision|2
2553906|NCT01425723|8836013|P2|Overall Study|Lost to Follow-up|3
2553907|NCT01425723|8836014|P1|Overall Study|Lost to Follow-up|0
2553908|NCT01425723|8836013|P2|Overall Study|Withdrawal by Subject|4
2553909|NCT01425723|8836014|P1|Overall Study|Withdrawal by Subject|1
2553910|NCT01425723|8836013|P2|Overall Study|Lack of Efficacy|1
2553911|NCT01425723|8836014|P1|Overall Study|Lack of Efficacy|0
2553912|NCT01425632|8836044|P3|Overall Study|Withdrawal by Subject|1
2553913|NCT01425632|8836045|P2|Overall Study|Withdrawal by Subject|0
2553914|NCT01425632|8836046|P1|Overall Study|Withdrawal by Subject|0
2553915|NCT01425632|8836044|P3|Overall Study|Protocol Violation|2
2553916|NCT01425632|8836045|P2|Overall Study|Protocol Violation|0
2553917|NCT01425632|8836046|P1|Overall Study|Protocol Violation|0
2553918|NCT01425632|8836044|P3|Overall Study|Physician Decision|0
2553919|NCT01425632|8836045|P2|Overall Study|Physician Decision|0
2553920|NCT01425632|8836046|P1|Overall Study|Physician Decision|1
2553921|NCT01425632|8836044|P3|Overall Study|Adverse Event|1
2553922|NCT01425632|8836045|P2|Overall Study|Adverse Event|1
2553923|NCT01425632|8836046|P1|Overall Study|Adverse Event|0
2553924|NCT01425528|8836056|P2|Overall Study|Withdrawal by Subject|1
2553925|NCT01425528|8836057|P1|Overall Study|Withdrawal by Subject|1
2553926|NCT01425463|8836065|P2|Overall Study|Unknown Reason|7
2553927|NCT01425463|8836066|P1|Overall Study|Unknown Reason|4
2553928|NCT01425463|8836065|P2|Overall Study|Withdrawal by Subject|5
2553929|NCT01425463|8836066|P1|Overall Study|Withdrawal by Subject|7
2553930|NCT01425463|8836065|P2|Overall Study|Lost to Follow-up|2
2553931|NCT01425463|8836066|P1|Overall Study|Lost to Follow-up|5
2553932|NCT01425463|8836065|P2|Overall Study|Protocol Violation|2
2553933|NCT01425463|8836066|P1|Overall Study|Protocol Violation|2
2553934|NCT01425463|8836065|P2|Overall Study|Lack of Efficacy|1
2553935|NCT01425463|8836066|P1|Overall Study|Lack of Efficacy|1
2553936|NCT01425463|8836065|P2|Overall Study|Adverse Event|7
2553937|NCT01425463|8836066|P1|Overall Study|Adverse Event|5
2553938|NCT01425359|8836082|P2|Overall Study|Did Not Meet Qualifying Criteria|5
2553939|NCT01425359|8836083|P1|Overall Study|Did Not Meet Qualifying Criteria|3
2553940|NCT01425359|8836082|P2|Overall Study|Investigator’s Discretion|0
2553941|NCT01425359|8836083|P1|Overall Study|Investigator’s Discretion|2
2553942|NCT01425359|8836082|P2|Overall Study|Subject Withdrew Consent|2
2553943|NCT01425359|8836083|P1|Overall Study|Subject Withdrew Consent|1
2553944|NCT01425359|8836082|P2|Overall Study|Protocol Violation|2
2553945|NCT01425359|8836083|P1|Overall Study|Protocol Violation|1
2553946|NCT01425359|8836082|P2|Overall Study|Unsatisfactory Response|0
2553947|NCT01425359|8836083|P1|Overall Study|Unsatisfactory Response|1
2553948|NCT01425359|8836082|P2|Overall Study|Death|1
2553949|NCT01425359|8836083|P1|Overall Study|Death|0
2553950|NCT01425359|8836082|P2|Overall Study|Revascularization|1
2553951|NCT01425359|8836083|P1|Overall Study|Revascularization|0
2553952|NCT01425359|8836082|P2|Overall Study|Adverse Event|8
2553953|NCT01425359|8836083|P1|Overall Study|Adverse Event|9
2553954|NCT01425359|8836082|P2|Overall Study|Randomized but Not Treated|3
2553955|NCT01425359|8836083|P1|Overall Study|Randomized but Not Treated|2
2553956|NCT01425281|8836114|P2|At 5-year Clinical Follow-up|Refused/terminated|3
2553957|NCT01425281|8836115|P1|At 5-year Clinical Follow-up|Refused/terminated|9
2553958|NCT01425281|8836114|P2|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7
2553959|NCT01425281|8836115|P1|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19
2553960|NCT01425281|8836114|P2|At 5-year Clinical Follow-up|Lost to Follow-up|1
2553961|NCT01425281|8836115|P1|At 5-year Clinical Follow-up|Lost to Follow-up|2
2553962|NCT01425281|8836114|P2|At 5-year Clinical Follow-up|Death|0
2553963|NCT01425281|8836115|P1|At 5-year Clinical Follow-up|Death|2
2553964|NCT01425281|8836114|P2|At 4-year Clinical Follow-up|Lost to Follow-up|1
2553965|NCT01425281|8836115|P1|At 4-year Clinical Follow-up|Lost to Follow-up|4
2553966|NCT01425281|8836114|P2|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5
2553967|NCT01425281|8836115|P1|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6
2553968|NCT01425281|8836114|P2|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10
2553969|NCT01425281|8836115|P1|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10
2553970|NCT01425281|8836114|P2|At 4-year Clinical Follow-up|Withdrawal by Subject|2
2553971|NCT01425281|8836115|P1|At 4-year Clinical Follow-up|Withdrawal by Subject|3
2553972|NCT01425281|8836114|P2|At 4-year Clinical Follow-up|Death|3
2553973|NCT01425281|8836115|P1|At 4-year Clinical Follow-up|Death|7
2553974|NCT01425281|8836114|P2|At 3-year Clinical Follow-up|Death|3
2553975|NCT01425281|8836115|P1|At 3-year Clinical Follow-up|Death|2
2553976|NCT01425281|8836114|P2|At 3-year Clinical Follow-up|Withdrawal by Subject|3
2553977|NCT01425281|8836115|P1|At 3-year Clinical Follow-up|Withdrawal by Subject|3
2553978|NCT01425281|8836114|P2|At 2-year Clinical Follow-up|Patient did not want to participate in t|0
2553979|NCT01425281|8836115|P1|At 2-year Clinical Follow-up|Patient did not want to participate in t|1
2553980|NCT01425281|8836114|P2|At 2-year Clinical Follow-up|Lost to Follow-up|0
2553981|NCT01425281|8836115|P1|At 2-year Clinical Follow-up|Lost to Follow-up|1
2553982|NCT01425281|8836114|P2|At 2-year Clinical Follow-up|Death|0
2553983|NCT01425281|8836115|P1|At 2-year Clinical Follow-up|Death|2
2553984|NCT01425281|8836114|P2|At 2-year Clinical Follow-up|Withdrawal by Subject|1
2553985|NCT01425281|8836115|P1|At 2-year Clinical Follow-up|Withdrawal by Subject|2
2553986|NCT01425281|8836114|P2|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0
2553987|NCT01425281|8836115|P1|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1
2553988|NCT01425281|8836114|P2|At 1-year Clinical Follow-up|Withdrawal by Subject|1
2553989|NCT01425281|8836115|P1|At 1-year Clinical Follow-up|Withdrawal by Subject|1
2553990|NCT01425281|8836114|P2|At 180-day Clinical Follow-up|Death|1
2553991|NCT01425281|8836115|P1|At 180-day Clinical Follow-up|Death|0
2553992|NCT01425281|8836114|P2|At 180-day Clinical Follow-up|Withdrawal by Subject|0
2553993|NCT01425281|8836115|P1|At 180-day Clinical Follow-up|Withdrawal by Subject|3
2553994|NCT01425281|8836114|P2|At 30-day Clinical Follow-up|Withdrawal by Subject|0
2553995|NCT01425281|8836115|P1|At 30-day Clinical Follow-up|Withdrawal by Subject|1
2553996|NCT01425268|8836333|P2|Overall Study|Physician Decision|0
2553997|NCT01425268|8836334|P1|Overall Study|Physician Decision|1
2553998|NCT01425268|8836333|P2|Overall Study|Sponsor Decision|0
2553999|NCT01425268|8836334|P1|Overall Study|Sponsor Decision|5
2554000|NCT01425268|8836333|P2|Overall Study|Withdrawal by Subject|0
2554001|NCT01425268|8836334|P1|Overall Study|Withdrawal by Subject|2
2554002|NCT01425203|8836355|P3|Crossover Phase|Other virologic failure criteria|3
2554003|NCT01425203|8836356|P2|Crossover Phase|Other virologic failure criteria|0
2554004|NCT01425203|8836357|P1|Crossover Phase|Other virologic failure criteria|0
2554005|NCT01425203|8836355|P3|Crossover Phase|Failure at futility timepoint|3
2554006|NCT01425203|8836356|P2|Crossover Phase|Failure at futility timepoint|0
2554007|NCT01425203|8836357|P1|Crossover Phase|Failure at futility timepoint|0
2554008|NCT01425203|8836355|P3|Treatment Phase|Did not receive treatment|0
2554009|NCT01425203|8836356|P2|Treatment Phase|Did not receive treatment|1
2554010|NCT01425203|8836357|P1|Treatment Phase|Did not receive treatment|0
2554011|NCT01425203|8836355|P3|Treatment Phase|Unidentified reasons|0
2554012|NCT01425203|8836356|P2|Treatment Phase|Unidentified reasons|5
2554013|NCT01425203|8836357|P1|Treatment Phase|Unidentified reasons|11
2554014|NCT01425203|8836355|P3|Treatment Phase|Other virologic failure criteria|0
2554015|NCT01425203|8836356|P2|Treatment Phase|Other virologic failure criteria|3
2554016|NCT01425203|8836357|P1|Treatment Phase|Other virologic failure criteria|5
2554017|NCT01425203|8836355|P3|Treatment Phase|Failure at futility timepoint|0
2554018|NCT01425203|8836356|P2|Treatment Phase|Failure at futility timepoint|27
2554019|NCT01425203|8836357|P1|Treatment Phase|Failure at futility timepoint|8
2554020|NCT01425203|8836355|P3|Treatment Phase|DC during PR Lead-in Phase|0
2554021|NCT01425203|8836356|P2|Treatment Phase|DC during PR Lead-in Phase|1
2554022|NCT01425203|8836357|P1|Treatment Phase|DC during PR Lead-in Phase|3
2554023|NCT01425190|8836374|P3|Overall Study|Full dose not consumed.|0
2554024|NCT01425190|8836375|P2|Overall Study|Full dose not consumed.|0
2554025|NCT01425190|8836376|P1|Overall Study|Full dose not consumed.|1
2554026|NCT01424930|8836412|P2|Overall Study|Reason not specified|6
2554027|NCT01424930|8836413|P1|Overall Study|Reason not specified|0
2554028|NCT01424930|8836412|P2|Overall Study|Screen Failure|1
2554029|NCT01424930|8836413|P1|Overall Study|Screen Failure|0
2554030|NCT01424930|8836412|P2|Overall Study|Progressive Disease|6
2554031|NCT01424930|8836413|P1|Overall Study|Progressive Disease|3
2554032|NCT01424930|8836412|P2|Overall Study|Death|0
2554033|NCT01424930|8836413|P1|Overall Study|Death|1
2554034|NCT01424930|8836412|P2|Overall Study|Adverse Event|1
2554035|NCT01424930|8836413|P1|Overall Study|Adverse Event|0
2554036|NCT01424813|8836427|P2|Overall Study|Other|2
2554037|NCT01424813|8836428|P1|Overall Study|Other|1
2554038|NCT01424813|8836427|P2|Overall Study|Protocol Violation|0
2554039|NCT01424813|8836428|P1|Overall Study|Protocol Violation|1
2554040|NCT01424813|8836427|P2|Overall Study|Withdrawal by Subject|0
2554041|NCT01424813|8836428|P1|Overall Study|Withdrawal by Subject|3
2554042|NCT01424670|8836448|P2|Continuation Period|Withdrawal by Subject|4
2554043|NCT01424670|8836449|P1|Continuation Period|Withdrawal by Subject|13
2554044|NCT01424670|8836448|P2|Continuation Period|Physician Decision|4
2554045|NCT01424670|8836449|P1|Continuation Period|Physician Decision|5
2554046|NCT01424670|8836448|P2|Continuation Period|Met Protocol Withdrawal Criteria|1
2554047|NCT01424670|8836449|P1|Continuation Period|Met Protocol Withdrawal Criteria|1
2554048|NCT01424670|8836448|P2|Continuation Period|Lost to Follow-up|0
2554049|NCT01424670|8836449|P1|Continuation Period|Lost to Follow-up|2
2554050|NCT01424670|8836448|P2|Continuation Period|Adverse Event|5
2554051|NCT01424670|8836449|P1|Continuation Period|Adverse Event|13
2554052|NCT01424670|8836448|P2|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7
2554053|NCT01424670|8836449|P1|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13
2554054|NCT01424670|8836448|P2|6-Month Intensive Period (182 Days)|Physician Decision|3
2554055|NCT01424670|8836449|P1|6-Month Intensive Period (182 Days)|Physician Decision|2
2554056|NCT01424670|8836448|P2|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1
2554057|NCT01424670|8836449|P1|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2
2554058|NCT01424670|8836448|P2|6-Month Intensive Period (182 Days)|Lost to Follow-up|1
2554059|NCT01424670|8836449|P1|6-Month Intensive Period (182 Days)|Lost to Follow-up|0
2554060|NCT01424670|8836448|P2|6-Month Intensive Period (182 Days)|Adverse Event|2
2554061|NCT01424670|8836449|P1|6-Month Intensive Period (182 Days)|Adverse Event|2
2554062|NCT01424644|8836471|P2|Overall Study|Unable to Classify|0
2554063|NCT01424644|8836472|P1|Overall Study|Unable to Classify|1
2554064|NCT01424644|8836471|P2|Overall Study|Administrative Reason|0
2554065|NCT01424644|8836472|P1|Overall Study|Administrative Reason|1
2554066|NCT01424644|8836471|P2|Overall Study|Protocol Violation|3
2554067|NCT01424644|8836472|P1|Overall Study|Protocol Violation|4
2554068|NCT01424644|8836471|P2|Overall Study|Lost to Follow-up|12
2554069|NCT01424644|8836472|P1|Overall Study|Lost to Follow-up|16
2554070|NCT01424644|8836471|P2|Overall Study|Withdrawal by Subject|12
2554071|NCT01424644|8836472|P1|Overall Study|Withdrawal by Subject|9
2554072|NCT01424644|8836471|P2|Overall Study|Adverse Event|0
2554073|NCT01424644|8836472|P1|Overall Study|Adverse Event|2
2554074|NCT01424566|8836486|P3|Double-blind Treatment|Lack of Efficacy|1
2554075|NCT01424566|8836487|P2|Double-blind Treatment|Lack of Efficacy|1
2554076|NCT01424566|8836488|P1|Double-blind Treatment|Lack of Efficacy|0
2554077|NCT01424566|8836486|P3|Double-blind Treatment|Withdrawal by Investigator|1
2554078|NCT01424566|8836487|P2|Double-blind Treatment|Withdrawal by Investigator|1
2554079|NCT01424566|8836488|P1|Double-blind Treatment|Withdrawal by Investigator|0
2554080|NCT01424566|8836486|P3|Double-blind Treatment|Withdrawal by Subject|0
2554081|NCT01424566|8836487|P2|Double-blind Treatment|Withdrawal by Subject|2
2554082|NCT01424566|8836488|P1|Double-blind Treatment|Withdrawal by Subject|0
2554083|NCT01424566|8836486|P3|Double-blind Treatment|Adverse Event|13
2554084|NCT01424566|8836487|P2|Double-blind Treatment|Adverse Event|21
2554085|NCT01424566|8836488|P1|Double-blind Treatment|Adverse Event|0
2554086|NCT01424566|8836486|P3|Single-blind Treatment|Did Not Administer Any Study Drug|0
2554087|NCT01424566|8836487|P2|Single-blind Treatment|Did Not Administer Any Study Drug|0
2554088|NCT01424566|8836488|P1|Single-blind Treatment|Did Not Administer Any Study Drug|2
2554089|NCT01424566|8836486|P3|Single-blind Treatment|Met Exclusion Criteria|0
2554090|NCT01424566|8836487|P2|Single-blind Treatment|Met Exclusion Criteria|0
2554091|NCT01424566|8836488|P1|Single-blind Treatment|Met Exclusion Criteria|1
2554092|NCT01424566|8836486|P3|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
2554093|NCT01424566|8836487|P2|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
2554094|NCT01424566|8836488|P1|Single-blind Treatment|Did Not Meet Inclusion Criteria|108
2554095|NCT01424566|8836486|P3|Single-blind Treatment|Withdrawal by Investigator|0
2554096|NCT01424566|8836487|P2|Single-blind Treatment|Withdrawal by Investigator|0
2554097|NCT01424566|8836488|P1|Single-blind Treatment|Withdrawal by Investigator|2
2554098|NCT01424566|8836486|P3|Single-blind Treatment|Withdrawal by Subject|0
2554099|NCT01424566|8836487|P2|Single-blind Treatment|Withdrawal by Subject|0
2554100|NCT01424566|8836488|P1|Single-blind Treatment|Withdrawal by Subject|16
2554101|NCT01424566|8836486|P3|Single-blind Treatment|Adverse Event|0
2554102|NCT01424566|8836487|P2|Single-blind Treatment|Adverse Event|0
2554103|NCT01424566|8836488|P1|Single-blind Treatment|Adverse Event|71
2554104|NCT01424514|8836515|P2|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0
2554105|NCT01424514|8836516|P1|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1
2554106|NCT01424514|8836515|P2|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
2554107|NCT01424514|8836516|P1|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
2554108|NCT01424501|8836561|P6|Overall Study|Lost to Follow-up|0
2554109|NCT01424501|8836562|P5|Overall Study|Lost to Follow-up|0
2554110|NCT01424501|8836563|P4|Overall Study|Lost to Follow-up|0
2554111|NCT01424501|8836564|P3|Overall Study|Lost to Follow-up|1
2554112|NCT01424501|8836565|P2|Overall Study|Lost to Follow-up|1
2554113|NCT01424501|8836566|P1|Overall Study|Lost to Follow-up|0
2554114|NCT01424501|8836561|P6|Overall Study|Withdrawal by Subject|0
2554115|NCT01424501|8836562|P5|Overall Study|Withdrawal by Subject|0
2554116|NCT01424501|8836563|P4|Overall Study|Withdrawal by Subject|0
2554117|NCT01424501|8836564|P3|Overall Study|Withdrawal by Subject|1
2554118|NCT01424501|8836565|P2|Overall Study|Withdrawal by Subject|0
2554119|NCT01424501|8836566|P1|Overall Study|Withdrawal by Subject|1
2554120|NCT01424397|8836742|P12|Period-2 (8 Days)|Withdrawal by Subject|0
2554121|NCT01424397|8836743|P11|Period-2 (8 Days)|Withdrawal by Subject|0
2554122|NCT01424397|8836744|P10|Period-2 (8 Days)|Withdrawal by Subject|0
2554123|NCT01424397|8836745|P9|Period-2 (8 Days)|Withdrawal by Subject|0
2554124|NCT01424397|8836746|P8|Period-2 (8 Days)|Withdrawal by Subject|0
2554125|NCT01424397|8836747|P7|Period-2 (8 Days)|Withdrawal by Subject|0
2554126|NCT01424397|8836748|P6|Period-2 (8 Days)|Withdrawal by Subject|0
2554127|NCT01424397|8836749|P5|Period-2 (8 Days)|Withdrawal by Subject|0
2554128|NCT01424397|8836750|P4|Period-2 (8 Days)|Withdrawal by Subject|0
2554129|NCT01424397|8836751|P3|Period-2 (8 Days)|Withdrawal by Subject|1
2554130|NCT01424397|8836752|P2|Period-2 (8 Days)|Withdrawal by Subject|0
2554131|NCT01424397|8836753|P1|Period-2 (8 Days)|Withdrawal by Subject|0
2554132|NCT01424306|8836799|P6|Overall Study|Protocol Violation|0
2554133|NCT01424306|8836800|P5|Overall Study|Protocol Violation|1
2554134|NCT01424306|8836801|P4|Overall Study|Protocol Violation|0
2554135|NCT01424306|8836802|P3|Overall Study|Protocol Violation|0
2554136|NCT01424306|8836803|P2|Overall Study|Protocol Violation|0
2554137|NCT01424306|8836804|P1|Overall Study|Protocol Violation|0
2554138|NCT01424228|8836853|P2|Overall Study|Unplanned journey|1
2554139|NCT01424228|8836854|P1|Overall Study|Unplanned journey|0
2554140|NCT01424228|8836853|P2|Overall Study|Worsening of symptoms|0
2554141|NCT01424228|8836854|P1|Overall Study|Worsening of symptoms|1
2554142|NCT01424228|8836853|P2|Overall Study|Non-compliance|0
2554143|NCT01424228|8836854|P1|Overall Study|Non-compliance|2
2554144|NCT01424228|8836853|P2|Overall Study|inclusion/exclusion criteria not met|2
2554145|NCT01424228|8836854|P1|Overall Study|inclusion/exclusion criteria not met|2
2554146|NCT01424228|8836853|P2|Overall Study|Lack of Efficacy|7
2554147|NCT01424228|8836854|P1|Overall Study|Lack of Efficacy|5
2554148|NCT01424228|8836853|P2|Overall Study|Sponsor's decision|12
2554149|NCT01424228|8836854|P1|Overall Study|Sponsor's decision|9
2554150|NCT01424228|8836853|P2|Overall Study|Adverse Event|14
2554151|NCT01424228|8836854|P1|Overall Study|Adverse Event|10
2554152|NCT01424228|8836853|P2|Overall Study|Withdrawal by Subject|11
2554153|NCT01424228|8836854|P1|Overall Study|Withdrawal by Subject|27
2554154|NCT01424189|8836894|P2|Overall Study|Death|1
2554155|NCT01424189|8836895|P1|Overall Study|Death|3
2554156|NCT01424189|8836894|P2|Overall Study|Subject moved|0
2554157|NCT01424189|8836895|P1|Overall Study|Subject moved|1
2554158|NCT01424189|8836894|P2|Overall Study|Withdrawal by Subject|4
2554159|NCT01424189|8836895|P1|Overall Study|Withdrawal by Subject|4
2554160|NCT01424189|8836894|P2|Overall Study|Lost to Follow-up|1
2554161|NCT01424189|8836895|P1|Overall Study|Lost to Follow-up|4
2554162|NCT01424189|8836894|P2|Overall Study|Adverse Event|0
2554163|NCT01424189|8836895|P1|Overall Study|Adverse Event|1
2554164|NCT01423916|8836936|P3|Overall Study|Protocol Deviation|0
2554165|NCT01423916|8836937|P2|Overall Study|Protocol Deviation|0
2554166|NCT01423916|8836938|P1|Overall Study|Protocol Deviation|1
2554167|NCT01423916|8836936|P3|Overall Study|Withdrawal by Subject|3
2554168|NCT01423916|8836937|P2|Overall Study|Withdrawal by Subject|10
2554169|NCT01423916|8836938|P1|Overall Study|Withdrawal by Subject|3
2554170|NCT01423916|8836936|P3|Overall Study|Physician Decision|1
2554171|NCT01423916|8836937|P2|Overall Study|Physician Decision|0
2554172|NCT01423916|8836938|P1|Overall Study|Physician Decision|1
2554173|NCT01423916|8836936|P3|Overall Study|Met Withdrawal Criteria|1
2554174|NCT01423916|8836937|P2|Overall Study|Met Withdrawal Criteria|1
2554175|NCT01423916|8836938|P1|Overall Study|Met Withdrawal Criteria|1
2554176|NCT01423916|8836936|P3|Overall Study|Adverse Event|2
2554177|NCT01423916|8836937|P2|Overall Study|Adverse Event|9
2554178|NCT01423916|8836938|P1|Overall Study|Adverse Event|5
2554179|NCT01423812|8836994|P2|Overall Study|Withdrawal by Subject|2
2554180|NCT01423812|8836995|P1|Overall Study|Withdrawal by Subject|1
2554181|NCT01423812|8836994|P2|Overall Study|Lost to Follow-up|2
2554182|NCT01423812|8836995|P1|Overall Study|Lost to Follow-up|2
2554183|NCT01423617|8837023|P2|Overall Study|Lost to Follow-up|1
2554184|NCT01423617|8837024|P1|Overall Study|Lost to Follow-up|0
2554185|NCT01423604|8837041|P2|Randomized|Patient decision|9
2554186|NCT01423604|8837042|P1|Randomized|Patient decision|5
2554187|NCT01423604|8837041|P2|Randomized|Other - unspecified|31
2554188|NCT01423604|8837042|P1|Randomized|Other - unspecified|37
2554189|NCT01423604|8837041|P2|Randomized|Physician Decision|13
2554190|NCT01423604|8837042|P1|Randomized|Physician Decision|16
2554191|NCT01423604|8837041|P2|Randomized|Death|0
2554192|NCT01423604|8837042|P1|Randomized|Death|1
2554193|NCT01423604|8837041|P2|Randomized|Adverse Event|10
2554194|NCT01423604|8837042|P1|Randomized|Adverse Event|4
2554195|NCT01423604|8837041|P2|Safety Run-In|Patient decision|0
2554196|NCT01423604|8837042|P1|Safety Run-In|Patient decision|1
2554197|NCT01423604|8837041|P2|Safety Run-In|Disease progression|0
2554198|NCT01423604|8837042|P1|Safety Run-In|Disease progression|3
2554199|NCT01423604|8837041|P2|Safety Run-In|Physician Decision|0
2554200|NCT01423604|8837042|P1|Safety Run-In|Physician Decision|1
2554201|NCT01423604|8837041|P2|Safety Run-In|Death|0
2554202|NCT01423604|8837042|P1|Safety Run-In|Death|1
2554203|NCT01423604|8837041|P2|Safety Run-In|Adverse Event|0
2554204|NCT01423604|8837042|P1|Safety Run-In|Adverse Event|3
2554205|NCT01423253|8837057|P1|Overall Study|Withdrawal by Subject|2
2554206|NCT01423253|8837057|P1|Overall Study|Protocol Violation|2
2554207|NCT01423253|8837057|P1|Overall Study|Lost to Follow-up|1
2554208|NCT01423253|8837057|P1|Overall Study|Lack of Efficacy|2
2554209|NCT01423253|8837057|P1|Overall Study|Adverse Event|2
2554210|NCT01423084|8837079|P2|Overall Study|Withdrawal by Subject|3
2554211|NCT01423084|8837080|P1|Overall Study|Withdrawal by Subject|2
2554212|NCT01423084|8837079|P2|Overall Study|Adverse Event|1
2554213|NCT01423084|8837080|P1|Overall Study|Adverse Event|0
2554214|NCT01422915|8837110|P1|Overall Study|Adverse Event|1
2554215|NCT01422889|8837115|P1|Overall Study|No Data Entered for Study Stent|9
2554216|NCT01422876|8837130|P10|Week 52|Death|0
2554217|NCT01422876|8837131|P9|Week 52|Death|1
2554218|NCT01422876|8837132|P8|Week 52|Death|3
2554219|NCT01422876|8837133|P7|Week 52|Death|1
2554220|NCT01422876|8837134|P6|Week 52|Death|0
2554221|NCT01422876|8837135|P5|Week 52|Death|0
2554222|NCT01422876|8837136|P4|Week 52|Death|1
2554223|NCT01422876|8837137|P3|Week 52|Death|0
2554224|NCT01422876|8837138|P2|Week 52|Death|1
2554225|NCT01422876|8837139|P1|Week 52|Death|0
2554226|NCT01422876|8837130|P10|Week 52|Consent withdrawn|9
2554227|NCT01422876|8837131|P9|Week 52|Consent withdrawn|13
2554228|NCT01422876|8837132|P8|Week 52|Consent withdrawn|12
2554229|NCT01422876|8837133|P7|Week 52|Consent withdrawn|10
2554230|NCT01422876|8837134|P6|Week 52|Consent withdrawn|12
2554231|NCT01422876|8837135|P5|Week 52|Consent withdrawn|7
2554232|NCT01422876|8837136|P4|Week 52|Consent withdrawn|12
2554233|NCT01422876|8837137|P3|Week 52|Consent withdrawn|6
2554234|NCT01422876|8837138|P2|Week 52|Consent withdrawn|4
2554235|NCT01422876|8837139|P1|Week 52|Consent withdrawn|9
2554236|NCT01422876|8837130|P10|Week 52|Lost to Follow-up|8
2554237|NCT01422876|8837131|P9|Week 52|Lost to Follow-up|7
2554238|NCT01422876|8837132|P8|Week 52|Lost to Follow-up|8
2554239|NCT01422876|8837133|P7|Week 52|Lost to Follow-up|5
2554240|NCT01422876|8837134|P6|Week 52|Lost to Follow-up|5
2554241|NCT01422876|8837135|P5|Week 52|Lost to Follow-up|8
2554242|NCT01422876|8837136|P4|Week 52|Lost to Follow-up|5
2554243|NCT01422876|8837137|P3|Week 52|Lost to Follow-up|7
2554244|NCT01422876|8837138|P2|Week 52|Lost to Follow-up|5
2554245|NCT01422876|8837139|P1|Week 52|Lost to Follow-up|3
2554246|NCT01422876|8837130|P10|Week 24|Death|0
2554247|NCT01422876|8837131|P9|Week 24|Death|0
2554248|NCT01422876|8837132|P8|Week 24|Death|0
2554249|NCT01422876|8837133|P7|Week 24|Death|0
2554250|NCT01422876|8837134|P6|Week 24|Death|0
2554251|NCT01422876|8837135|P5|Week 24|Death|0
2554252|NCT01422876|8837136|P4|Week 24|Death|0
2554253|NCT01422876|8837137|P3|Week 24|Death|0
2554254|NCT01422876|8837138|P2|Week 24|Death|1
2554255|NCT01422876|8837139|P1|Week 24|Death|0
2554256|NCT01422876|8837130|P10|Week 24|Consent withdrawn|6
2554257|NCT01422876|8837131|P9|Week 24|Consent withdrawn|3
2554258|NCT01422876|8837132|P8|Week 24|Consent withdrawn|4
2554259|NCT01422876|8837133|P7|Week 24|Consent withdrawn|5
2554260|NCT01422876|8837134|P6|Week 24|Consent withdrawn|6
2554261|NCT01422876|8837135|P5|Week 24|Consent withdrawn|5
2554262|NCT01422876|8837136|P4|Week 24|Consent withdrawn|4
2554263|NCT01422876|8837137|P3|Week 24|Consent withdrawn|3
2554264|NCT01422876|8837138|P2|Week 24|Consent withdrawn|1
2554265|NCT01422876|8837139|P1|Week 24|Consent withdrawn|5
2554266|NCT01422876|8837130|P10|Week 24|Lost to Follow-up|4
2554267|NCT01422876|8837131|P9|Week 24|Lost to Follow-up|3
2554268|NCT01422876|8837132|P8|Week 24|Lost to Follow-up|3
2554269|NCT01422876|8837133|P7|Week 24|Lost to Follow-up|1
2554270|NCT01422876|8837134|P6|Week 24|Lost to Follow-up|0
2554271|NCT01422876|8837135|P5|Week 24|Lost to Follow-up|2
2554272|NCT01422876|8837136|P4|Week 24|Lost to Follow-up|4
2554273|NCT01422876|8837137|P3|Week 24|Lost to Follow-up|2
2554274|NCT01422876|8837138|P2|Week 24|Lost to Follow-up|1
2554275|NCT01422876|8837139|P1|Week 24|Lost to Follow-up|1
2554276|NCT01422850|8837186|P1|Overall Study|Physician Decision|3
2554277|NCT01422824|8837192|P1|Overall Study|Lost to Follow-up|37
2554278|NCT01422824|8837192|P1|Overall Study|Case record form not evaluated|1
2554279|NCT01422720|8837197|P1|Overall Study|Ineligibility|1
2554280|NCT01422720|8837197|P1|Overall Study|Withdrawal by Subject|4
2554281|NCT01422720|8837197|P1|Overall Study|Lack of Efficacy|1
2554282|NCT01422720|8837197|P1|Overall Study|Adverse Event|16
2554283|NCT01422538|8837208|P3|Overall Study|Missed visit|1
2554284|NCT01422538|8837209|P2|Overall Study|Missed visit|1
2554285|NCT01422538|8837210|P1|Overall Study|Missed visit|0
2554286|NCT01422538|8837208|P3|Overall Study|Lost to Follow-up|1
2554287|NCT01422538|8837209|P2|Overall Study|Lost to Follow-up|1
2554288|NCT01422538|8837210|P1|Overall Study|Lost to Follow-up|0
2554289|NCT01422408|8837254|P1|Overall Study|Withdrawal by Subject|3
2554290|NCT01422408|8837254|P1|Overall Study|Adverse Event|1
2554291|NCT01422382|8837283|P1|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1
2554292|NCT01422304|8837299|P2|Overall Study|Not Treated|11
2554293|NCT01422304|8837300|P1|Overall Study|Not Treated|3
2554294|NCT01422304|8837299|P2|Overall Study|Did Not Meet Protocol Eligibility|2
2554295|NCT01422304|8837300|P1|Overall Study|Did Not Meet Protocol Eligibility|0
2554296|NCT01422304|8837299|P2|Overall Study|Withdrawal by Subject|2
2554297|NCT01422304|8837300|P1|Overall Study|Withdrawal by Subject|4
2554298|NCT01422304|8837299|P2|Overall Study|Protocol Violation|0
2554299|NCT01422304|8837300|P1|Overall Study|Protocol Violation|1
2554300|NCT01422304|8837299|P2|Overall Study|Never Entered Follow-up|1
2554301|NCT01422304|8837300|P1|Overall Study|Never Entered Follow-up|2
2554302|NCT01422304|8837299|P2|Overall Study|Lost to Follow-up|20
2554303|NCT01422304|8837300|P1|Overall Study|Lost to Follow-up|14
2554304|NCT01422304|8837299|P2|Overall Study|Adverse Event|1
2554305|NCT01422304|8837300|P1|Overall Study|Adverse Event|0
2554306|NCT01422239|8837332|P2|Overall Study|Lost to Follow-up|3
2554307|NCT01422239|8837333|P1|Overall Study|Lost to Follow-up|4
2554308|NCT01422213|8837355|P3|Overall Study|Administrative or Other Reason(s)|2
2554309|NCT01422213|8837356|P2|Overall Study|Administrative or Other Reason(s)|4
2554310|NCT01422213|8837357|P1|Overall Study|Administrative or Other Reason(s)|5
2554311|NCT01422213|8837355|P3|Overall Study|Lost to Follow-up|5
2554312|NCT01422213|8837356|P2|Overall Study|Lost to Follow-up|3
2554313|NCT01422213|8837357|P1|Overall Study|Lost to Follow-up|3
2554314|NCT01422213|8837355|P3|Overall Study|Withdrawal of Consent|5
2554315|NCT01422213|8837356|P2|Overall Study|Withdrawal of Consent|3
2554316|NCT01422213|8837357|P1|Overall Study|Withdrawal of Consent|7
2554317|NCT01422213|8837355|P3|Overall Study|Protocol Violation|4
2554318|NCT01422213|8837356|P2|Overall Study|Protocol Violation|2
2554319|NCT01422213|8837357|P1|Overall Study|Protocol Violation|0
2554320|NCT01422213|8837355|P3|Overall Study|Non-compliance with study drug|0
2554321|NCT01422213|8837356|P2|Overall Study|Non-compliance with study drug|1
2554322|NCT01422213|8837357|P1|Overall Study|Non-compliance with study drug|0
2554323|NCT01422213|8837355|P3|Overall Study|Lack of Efficacy|2
2554324|NCT01422213|8837356|P2|Overall Study|Lack of Efficacy|2
2554325|NCT01422213|8837357|P1|Overall Study|Lack of Efficacy|10
2554326|NCT01422213|8837355|P3|Overall Study|Adverse Event|11
2554327|NCT01422213|8837356|P2|Overall Study|Adverse Event|7
2554328|NCT01422213|8837357|P1|Overall Study|Adverse Event|8
2554329|NCT01422187|8837418|P3|Overall Study|Lost to Follow-up|0
2554330|NCT01422187|8837419|P2|Overall Study|Lost to Follow-up|1
2554331|NCT01422187|8837420|P1|Overall Study|Lost to Follow-up|0
2554332|NCT01422187|8837418|P3|Overall Study|Personal reason|0
2554333|NCT01422187|8837419|P2|Overall Study|Personal reason|0
2554334|NCT01422187|8837420|P1|Overall Study|Personal reason|1
2554335|NCT01421719|8837484|P1|Overall Study|Withdrawal by Subject|4
2554336|NCT01421667|8837493|P4|Overall Study|Lost to Follow-up|0
2554337|NCT01421667|8837494|P3|Overall Study|Lost to Follow-up|0
2554338|NCT01421667|8837495|P2|Overall Study|Lost to Follow-up|1
2554339|NCT01421667|8837496|P1|Overall Study|Lost to Follow-up|0
2554340|NCT01421667|8837493|P4|Overall Study|Withdrawal by Subject|1
2554341|NCT01421667|8837494|P3|Overall Study|Withdrawal by Subject|2
2554342|NCT01421667|8837495|P2|Overall Study|Withdrawal by Subject|1
2554343|NCT01421667|8837496|P1|Overall Study|Withdrawal by Subject|0
2554344|NCT01421641|8837557|P2|Overall Study|Protocol Violation|2
2554345|NCT01421641|8837558|P1|Overall Study|Protocol Violation|2
2554346|NCT01421511|8837580|P2|Overall Study|Death|1
2554347|NCT01421511|8837581|P1|Overall Study|Death|1
2554348|NCT01421511|8837580|P2|Overall Study|Withdrawal by Subject|5
2554349|NCT01421511|8837581|P1|Overall Study|Withdrawal by Subject|6
2554350|NCT01421511|8837580|P2|Overall Study|Physician Decision|1
2554351|NCT01421511|8837581|P1|Overall Study|Physician Decision|0
2554352|NCT01421511|8837580|P2|Overall Study|Randomized but didn't receive study drug|7
2554353|NCT01421511|8837581|P1|Overall Study|Randomized but didn't receive study drug|1
2554354|NCT01421511|8837580|P2|Overall Study|Lost to Follow-up|14
2554355|NCT01421511|8837581|P1|Overall Study|Lost to Follow-up|11
2554356|NCT01421459|8837631|P2|Overall Study|Withdrawal by Subject|16
2554357|NCT01421459|8837632|P1|Overall Study|Withdrawal by Subject|12
2554358|NCT01421459|8837631|P2|Overall Study|Protocol Violation|5
2554359|NCT01421459|8837632|P1|Overall Study|Protocol Violation|8
2554360|NCT01421459|8837631|P2|Overall Study|Physician Decision|9
2554361|NCT01421459|8837632|P1|Overall Study|Physician Decision|9
2554362|NCT01421459|8837631|P2|Overall Study|Lost to Follow-up|9
2554363|NCT01421459|8837632|P1|Overall Study|Lost to Follow-up|8
2554364|NCT01421459|8837631|P2|Overall Study|Lack of Efficacy|2
2554365|NCT01421459|8837632|P1|Overall Study|Lack of Efficacy|1
2554366|NCT01421459|8837631|P2|Overall Study|Death|1
2554367|NCT01421459|8837632|P1|Overall Study|Death|1
2554368|NCT01421459|8837631|P2|Overall Study|Adverse Event|10
2554369|NCT01421459|8837632|P1|Overall Study|Adverse Event|6
2554370|NCT01421342|8837673|P3|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7
2554371|NCT01421342|8837674|P2|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0
2554372|NCT01421342|8837675|P1|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6
2554373|NCT01421342|8837673|P3|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
2554374|NCT01421342|8837674|P2|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
2554375|NCT01421342|8837675|P1|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
2554376|NCT01421342|8837673|P3|Continuation of Treatment (Week 12 - 36)|Participant moved away|3
2554377|NCT01421342|8837674|P2|Continuation of Treatment (Week 12 - 36)|Participant moved away|1
2554378|NCT01421342|8837675|P1|Continuation of Treatment (Week 12 - 36)|Participant moved away|4
2554379|NCT01421342|8837673|P3|Continuation of Treatment (Week 12 - 36)|End of Study Time|14
2554380|NCT01421342|8837674|P2|Continuation of Treatment (Week 12 - 36)|End of Study Time|20
2554381|NCT01421342|8837675|P1|Continuation of Treatment (Week 12 - 36)|End of Study Time|15
2554382|NCT01421342|8837673|P3|Continuation of Treatment (Week 12 - 36)|Non-adherence|4
2554383|NCT01421342|8837674|P2|Continuation of Treatment (Week 12 - 36)|Non-adherence|8
2554384|NCT01421342|8837675|P1|Continuation of Treatment (Week 12 - 36)|Non-adherence|3
2554385|NCT01421342|8837673|P3|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9
2554386|NCT01421342|8837674|P2|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11
2554387|NCT01421342|8837675|P1|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4
2554388|NCT01421342|8837673|P3|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4
2554389|NCT01421342|8837674|P2|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6
2554390|NCT01421342|8837675|P1|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7
2554391|NCT01421342|8837673|P3|Continuation of Treatment (Week 12 - 36)|Adverse Event|11
2554392|NCT01421342|8837674|P2|Continuation of Treatment (Week 12 - 36)|Adverse Event|6
2554393|NCT01421342|8837675|P1|Continuation of Treatment (Week 12 - 36)|Adverse Event|0
2554394|NCT01421342|8837673|P3|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
2554395|NCT01421342|8837674|P2|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5
2554396|NCT01421342|8837675|P1|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
2554397|NCT01421342|8837673|P3|Completed to Week 12 But Then Withdrawn|End of Study Time|2
2554398|NCT01421342|8837674|P2|Completed to Week 12 But Then Withdrawn|End of Study Time|0
2554399|NCT01421342|8837675|P1|Completed to Week 12 But Then Withdrawn|End of Study Time|0
2554400|NCT01421342|8837673|P3|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4
2554401|NCT01421342|8837674|P2|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
2554402|NCT01421342|8837675|P1|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
2554403|NCT01421342|8837673|P3|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
2554404|NCT01421342|8837674|P2|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
2554405|NCT01421342|8837675|P1|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1
2554406|NCT01421342|8837673|P3|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2
2554407|NCT01421342|8837674|P2|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0
2554408|NCT01421342|8837675|P1|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1
2554409|NCT01421342|8837673|P3|Completed to Week 12 But Then Withdrawn|Non-adherence|5
2554410|NCT01421342|8837674|P2|Completed to Week 12 But Then Withdrawn|Non-adherence|4
2554411|NCT01421342|8837675|P1|Completed to Week 12 But Then Withdrawn|Non-adherence|5
2554412|NCT01421342|8837673|P3|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
2554413|NCT01421342|8837674|P2|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
2554414|NCT01421342|8837675|P1|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4
2554415|NCT01421342|8837673|P3|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11
2554416|NCT01421342|8837674|P2|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4
2554417|NCT01421342|8837675|P1|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13
2554418|NCT01421342|8837673|P3|Completed to Week 12 But Then Withdrawn|Adverse Event|6
2554419|NCT01421342|8837674|P2|Completed to Week 12 But Then Withdrawn|Adverse Event|3
2554420|NCT01421342|8837675|P1|Completed to Week 12 But Then Withdrawn|Adverse Event|4
2554421|NCT01421342|8837673|P3|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12
2554422|NCT01421342|8837674|P2|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10
2554423|NCT01421342|8837675|P1|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7
2554424|NCT01421342|8837673|P3|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88
2554425|NCT01421342|8837674|P2|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93
2554426|NCT01421342|8837675|P1|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111
2554427|NCT01421342|8837673|P3|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4
2554428|NCT01421342|8837674|P2|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9
2554429|NCT01421342|8837675|P1|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8
2554430|NCT01421342|8837673|P3|Acute Treatment Phase (12 Weeks)|Participant moved away|1
2554431|NCT01421342|8837674|P2|Acute Treatment Phase (12 Weeks)|Participant moved away|6
2554432|NCT01421342|8837675|P1|Acute Treatment Phase (12 Weeks)|Participant moved away|1
2554433|NCT01421342|8837673|P3|Acute Treatment Phase (12 Weeks)|Dure to other illness|4
2554434|NCT01421342|8837674|P2|Acute Treatment Phase (12 Weeks)|Dure to other illness|2
2554435|NCT01421342|8837675|P1|Acute Treatment Phase (12 Weeks)|Dure to other illness|3
2554436|NCT01421342|8837673|P3|Acute Treatment Phase (12 Weeks)|Non-adherence|13
2554437|NCT01421342|8837674|P2|Acute Treatment Phase (12 Weeks)|Non-adherence|7
2554438|NCT01421342|8837675|P1|Acute Treatment Phase (12 Weeks)|Non-adherence|15
2554439|NCT01421342|8837673|P3|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21
2554440|NCT01421342|8837674|P2|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18
2554441|NCT01421342|8837675|P1|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6
2554442|NCT01421342|8837673|P3|Acute Treatment Phase (12 Weeks)|Death|3
2554443|NCT01421342|8837674|P2|Acute Treatment Phase (12 Weeks)|Death|0
2554444|NCT01421342|8837675|P1|Acute Treatment Phase (12 Weeks)|Death|0
2554445|NCT01421342|8837673|P3|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13
2554446|NCT01421342|8837674|P2|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20
2554447|NCT01421342|8837675|P1|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23
2554448|NCT01421342|8837673|P3|Acute Treatment Phase (12 Weeks)|Adverse Event|27
2554449|NCT01421342|8837674|P2|Acute Treatment Phase (12 Weeks)|Adverse Event|38
2554450|NCT01421342|8837675|P1|Acute Treatment Phase (12 Weeks)|Adverse Event|53
2554451|NCT01421342|8837673|P3|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13
2554452|NCT01421342|8837674|P2|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28
2554453|NCT01421342|8837675|P1|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49
2554454|NCT01421303|8837692|P1|Overall Study|Withdrawal by Subject|1
2554455|NCT01421303|8837692|P1|Overall Study|Other|7
2554456|NCT01421303|8837692|P1|Overall Study|Non compliance with study procedure|1
2554457|NCT01421303|8837692|P1|Overall Study|Lost to Follow-up|13
2554458|NCT01421277|8837719|P2|Overall Study|Incomplete baseline data|31
2554459|NCT01421277|8837720|P1|Overall Study|Incomplete baseline data|0
2554460|NCT01421277|8837719|P2|Overall Study|Lack of qualifying event|61
2554461|NCT01421277|8837720|P1|Overall Study|Lack of qualifying event|0
2554462|NCT01421225|8837732|P2|Overall Study|Withdrawal by Subject|1
2554463|NCT01421225|8837733|P1|Overall Study|Withdrawal by Subject|0
2554464|NCT01421147|8837747|P2|Extension Period|Withdrawal by Subject|3
2554465|NCT01421147|8837748|P1|Extension Period|Withdrawal by Subject|5
2554466|NCT01421147|8837747|P2|Extension Period|Physician Decision|0
2554467|NCT01421147|8837748|P1|Extension Period|Physician Decision|1
2554468|NCT01421147|8837747|P2|Extension Period|Lost to Follow-up|5
2554469|NCT01421147|8837748|P1|Extension Period|Lost to Follow-up|2
2554470|NCT01421147|8837747|P2|Extension Period|Death|1
2554471|NCT01421147|8837748|P1|Extension Period|Death|0
2554472|NCT01421147|8837747|P2|Extension Period|Adverse Event|2
2554473|NCT01421147|8837748|P1|Extension Period|Adverse Event|0
2554474|NCT01421147|8837747|P2|Treatment Period|Withdrawal by Subject|5
2554475|NCT01421147|8837748|P1|Treatment Period|Withdrawal by Subject|10
2554476|NCT01421147|8837747|P2|Treatment Period|Physician Decision|2
2554477|NCT01421147|8837748|P1|Treatment Period|Physician Decision|2
2554478|NCT01421147|8837747|P2|Treatment Period|Lost to Follow-up|1
2554479|NCT01421147|8837748|P1|Treatment Period|Lost to Follow-up|2
2554480|NCT01421147|8837747|P2|Treatment Period|Adverse Event|3
2554481|NCT01421147|8837748|P1|Treatment Period|Adverse Event|2
2554482|NCT01421134|8837780|P2|Overall Study|Lost to Follow-up|1
2554483|NCT01421134|8837781|P1|Overall Study|Lost to Follow-up|1
2554484|NCT01421134|8837780|P2|Overall Study|Administrative|1
2554485|NCT01421134|8837781|P1|Overall Study|Administrative|0
2554486|NCT01421134|8837780|P2|Overall Study|Withdrawal by Subject|1
2554487|NCT01421134|8837781|P1|Overall Study|Withdrawal by Subject|1
2554488|NCT01421134|8837780|P2|Overall Study|Protocol Violation|3
2554489|NCT01421134|8837781|P1|Overall Study|Protocol Violation|0
2554490|NCT01421134|8837780|P2|Overall Study|Lack of Efficacy|4
2554491|NCT01421134|8837781|P1|Overall Study|Lack of Efficacy|2
2554492|NCT01421134|8837780|P2|Overall Study|Adverse Event|5
2554493|NCT01421134|8837781|P1|Overall Study|Adverse Event|3
2554494|NCT01420965|8837802|P3|Overall Study|Adverse Event|0
2554495|NCT01420965|8837803|P2|Overall Study|Adverse Event|1
2554496|NCT01420965|8837804|P1|Overall Study|Adverse Event|0
2554497|NCT01420965|8837802|P3|Overall Study|Withdrawal by Subject|0
2554498|NCT01420965|8837803|P2|Overall Study|Withdrawal by Subject|0
2554499|NCT01420965|8837804|P1|Overall Study|Withdrawal by Subject|1
2554500|NCT01420926|8837817|P2|Overall Study|Continues on active treatment|3
2554501|NCT01420926|8837818|P1|Overall Study|Continues on active treatment|1
2554502|NCT01420926|8837817|P2|Overall Study|Physician Decision|5
2554503|NCT01420926|8837818|P1|Overall Study|Physician Decision|7
2554504|NCT01420926|8837817|P2|Overall Study|Non-protocol treatment|20
2554505|NCT01420926|8837818|P1|Overall Study|Non-protocol treatment|17
2554506|NCT01420926|8837817|P2|Overall Study|Withdrawal by Subject|16
2554507|NCT01420926|8837818|P1|Overall Study|Withdrawal by Subject|11
2554508|NCT01420926|8837817|P2|Overall Study|Death|17
2554509|NCT01420926|8837818|P1|Overall Study|Death|18
2554510|NCT01420926|8837817|P2|Overall Study|Adverse Event|4
2554511|NCT01420926|8837818|P1|Overall Study|Adverse Event|6
2554512|NCT01420627|8837865|P1|EZN-2279 Treatment Period|Adverse Event|1
2554513|NCT01420549|8837881|P2|Overall Study|Non-adherence to medication|1
2554514|NCT01420549|8837882|P1|Overall Study|Non-adherence to medication|4
2554515|NCT01420549|8837881|P2|Overall Study|Protocol Violation|1
2554516|NCT01420549|8837882|P1|Overall Study|Protocol Violation|0
2554517|NCT01420549|8837881|P2|Overall Study|Lost to Follow-up|2
2554518|NCT01420549|8837882|P1|Overall Study|Lost to Follow-up|2
2554519|NCT01420549|8837881|P2|Overall Study|Adverse Event|1
2554520|NCT01420549|8837882|P1|Overall Study|Adverse Event|1
2554521|NCT01420081|8837916|P9|Overall Study|Other Reasons|0
2554522|NCT01420081|8837917|P8|Overall Study|Other Reasons|0
2554523|NCT01420081|8837918|P7|Overall Study|Other Reasons|0
2554524|NCT01420081|8837919|P6|Overall Study|Other Reasons|0
2554525|NCT01420081|8837920|P5|Overall Study|Other Reasons|0
2554526|NCT01420081|8837921|P4|Overall Study|Other Reasons|0
2554527|NCT01420081|8837922|P3|Overall Study|Other Reasons|1
2554528|NCT01420081|8837923|P2|Overall Study|Other Reasons|0
2554529|NCT01420081|8837924|P1|Overall Study|Other Reasons|0
2554530|NCT01420081|8837916|P9|Overall Study|Subject Refused Futher Follow-up|0
2554531|NCT01420081|8837917|P8|Overall Study|Subject Refused Futher Follow-up|0
2554532|NCT01420081|8837918|P7|Overall Study|Subject Refused Futher Follow-up|0
2554533|NCT01420081|8837919|P6|Overall Study|Subject Refused Futher Follow-up|0
2554534|NCT01420081|8837920|P5|Overall Study|Subject Refused Futher Follow-up|1
2554535|NCT01420081|8837921|P4|Overall Study|Subject Refused Futher Follow-up|0
2554536|NCT01420081|8837922|P3|Overall Study|Subject Refused Futher Follow-up|1
2554537|NCT01420081|8837923|P2|Overall Study|Subject Refused Futher Follow-up|0
2554538|NCT01420081|8837924|P1|Overall Study|Subject Refused Futher Follow-up|0
2554539|NCT01420081|8837916|P9|Overall Study|Study Terminated by Sponsor|2
2554540|NCT01420081|8837917|P8|Overall Study|Study Terminated by Sponsor|2
2554541|NCT01420081|8837918|P7|Overall Study|Study Terminated by Sponsor|3
2554542|NCT01420081|8837919|P6|Overall Study|Study Terminated by Sponsor|7
2554543|NCT01420081|8837920|P5|Overall Study|Study Terminated by Sponsor|11
2554544|NCT01420081|8837921|P4|Overall Study|Study Terminated by Sponsor|3
2554545|NCT01420081|8837922|P3|Overall Study|Study Terminated by Sponsor|1
2554546|NCT01420081|8837923|P2|Overall Study|Study Terminated by Sponsor|1
2554547|NCT01420081|8837924|P1|Overall Study|Study Terminated by Sponsor|2
2554548|NCT01420081|8837916|P9|Overall Study|Lost to Follow-up|0
2554549|NCT01420081|8837917|P8|Overall Study|Lost to Follow-up|0
2554550|NCT01420081|8837918|P7|Overall Study|Lost to Follow-up|0
2554551|NCT01420081|8837919|P6|Overall Study|Lost to Follow-up|1
2554552|NCT01420081|8837920|P5|Overall Study|Lost to Follow-up|1
2554553|NCT01420081|8837921|P4|Overall Study|Lost to Follow-up|0
2554554|NCT01420081|8837922|P3|Overall Study|Lost to Follow-up|0
2554555|NCT01420081|8837923|P2|Overall Study|Lost to Follow-up|0
2554556|NCT01420081|8837924|P1|Overall Study|Lost to Follow-up|0
2554557|NCT01420081|8837916|P9|Overall Study|Death|1
2554558|NCT01420081|8837917|P8|Overall Study|Death|1
2554559|NCT01420081|8837918|P7|Overall Study|Death|0
2554560|NCT01420081|8837919|P6|Overall Study|Death|12
2554561|NCT01420081|8837920|P5|Overall Study|Death|7
2554562|NCT01420081|8837921|P4|Overall Study|Death|0
2554563|NCT01420081|8837922|P3|Overall Study|Death|8
2554564|NCT01420081|8837923|P2|Overall Study|Death|0
2554565|NCT01420081|8837924|P1|Overall Study|Death|1
2554566|NCT01420068|8838005|P2|Overall Study|Withdrawal by Subject|2
2554567|NCT01420068|8838006|P1|Overall Study|Withdrawal by Subject|1
2554568|NCT01420068|8838005|P2|Overall Study|Administrative problems|3
2554569|NCT01420068|8838006|P1|Overall Study|Administrative problems|1
2554570|NCT01419769|8838077|P1|Overall Study|Not evaluable due to pigtail stents|1
2554571|NCT01419769|8838077|P1|Overall Study|Did not receive the AXIOS stent|3
2554572|NCT01419717|8838090|P1|Overall Study|Noncompliance|1
2554573|NCT01419717|8838090|P1|Overall Study|Administrative Decision|1
2554574|NCT01419717|8838090|P1|Overall Study|Lost to Follow-up|2
2554575|NCT01419717|8838090|P1|Overall Study|Other|4
2554576|NCT01419717|8838090|P1|Overall Study|Disease Progression|9
2554577|NCT01419717|8838090|P1|Overall Study|Withdrawal by Subject|10
2554578|NCT01419717|8838090|P1|Overall Study|Death|17
2554579|NCT01419717|8838090|P1|Overall Study|Adverse Event|19
2554580|NCT01419717|8838090|P1|Overall Study|Protocol-specified Criteria|62
2554581|NCT01419626|8838104|P3|Overall Study|Lost to Follow-up|1
2554582|NCT01419626|8838105|P2|Overall Study|Lost to Follow-up|1
2554583|NCT01419626|8838106|P1|Overall Study|Lost to Follow-up|0
2554584|NCT01419626|8838104|P3|Overall Study|Withdrawal by Subject|0
2554585|NCT01419626|8838105|P2|Overall Study|Withdrawal by Subject|0
2554586|NCT01419626|8838106|P1|Overall Study|Withdrawal by Subject|1
2554587|NCT01419626|8838104|P3|Overall Study|Protocol Violation|2
2554588|NCT01419626|8838105|P2|Overall Study|Protocol Violation|2
2554589|NCT01419626|8838106|P1|Overall Study|Protocol Violation|3
2554590|NCT01419314|8838137|P2|Follow-up at Week 6 of the Trial|Lost to Follow-up|2
2554591|NCT01419314|8838138|P1|Follow-up at Week 6 of the Trial|Lost to Follow-up|1
2554592|NCT01419314|8838137|P2|Follow-up at Week 3 of the Trial|Lost to Follow-up|0
2554593|NCT01419314|8838138|P1|Follow-up at Week 3 of the Trial|Lost to Follow-up|3
2554594|NCT01419314|8838137|P2|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1
2554595|NCT01419314|8838138|P1|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3
2554596|NCT01419236|8838179|P2|Overall Study|Entry Criteria Not Met|0
2554597|NCT01419236|8838180|P1|Overall Study|Entry Criteria Not Met|1
2554598|NCT01419236|8838179|P2|Overall Study|Withdrawal by Subject|4
2554599|NCT01419236|8838180|P1|Overall Study|Withdrawal by Subject|1
2554600|NCT01419236|8838179|P2|Overall Study|Physician Decision|0
2554601|NCT01419236|8838180|P1|Overall Study|Physician Decision|1
2554602|NCT01419236|8838179|P2|Overall Study|Lost to Follow-up|0
2554603|NCT01419236|8838180|P1|Overall Study|Lost to Follow-up|1
2554604|NCT01419236|8838179|P2|Overall Study|Lack of Efficacy|1
2554605|NCT01419236|8838180|P1|Overall Study|Lack of Efficacy|0
2554606|NCT01419236|8838179|P2|Overall Study|Adverse Event|0
2554607|NCT01419236|8838180|P1|Overall Study|Adverse Event|1
2554608|NCT01419197|8838204|P2|Overall Study|Lost to Follow-up|4
2554609|NCT01419197|8838205|P1|Overall Study|Lost to Follow-up|14
2554610|NCT01419197|8838204|P2|Overall Study|Reason Not Specified|1
2554611|NCT01419197|8838205|P1|Overall Study|Reason Not Specified|0
2554612|NCT01419197|8838204|P2|Overall Study|Study Completed by Sponsor|34
2554613|NCT01419197|8838205|P1|Overall Study|Study Completed by Sponsor|103
2554614|NCT01419197|8838204|P2|Overall Study|Withdrawal by Subject|32
2554615|NCT01419197|8838205|P1|Overall Study|Withdrawal by Subject|33
2554616|NCT01419197|8838204|P2|Overall Study|Non-compliance|1
2554617|NCT01419197|8838205|P1|Overall Study|Non-compliance|3
2554618|NCT01419197|8838204|P2|Overall Study|Physician Decision|4
2554619|NCT01419197|8838205|P1|Overall Study|Physician Decision|4
2554620|NCT01419197|8838204|P2|Overall Study|Death|122
2554621|NCT01419197|8838205|P1|Overall Study|Death|247
2554622|NCT01419184|8838230|P2|Overall Study|Participant randomized, not treated|0
2554623|NCT01419184|8838231|P1|Overall Study|Participant randomized, not treated|1
2554624|NCT01419184|8838230|P2|Overall Study|No IRLOS-No adverse event treatment date|1
2554625|NCT01419184|8838231|P1|Overall Study|No IRLOS-No adverse event treatment date|0
2554626|NCT01419184|8838230|P2|Overall Study|No IRLOS-non trial antibiotic used|2
2554627|NCT01419184|8838231|P1|Overall Study|No IRLOS-non trial antibiotic used|1
2554628|NCT01419184|8838230|P2|Overall Study|No IRLOS-randomized, not treated|4
2554629|NCT01419184|8838231|P1|Overall Study|No IRLOS-randomized, not treated|2
2554630|NCT01419184|8838230|P2|Overall Study|No IRLOS-No in-patient end date reported|6
2554631|NCT01419184|8838231|P1|Overall Study|No IRLOS-No in-patient end date reported|3
2554632|NCT01419184|8838230|P2|Overall Study|Site data not available|2
2554633|NCT01419184|8838231|P1|Overall Study|Site data not available|3
2554634|NCT01419080|8838264|P1|Overall Study|Too Ill|3
2554635|NCT01419080|8838264|P1|Overall Study|Lost to Follow-up|23
2554636|NCT01419080|8838264|P1|Overall Study|Death|30
2554637|NCT01419080|8838264|P1|Overall Study|Withdrawal by Subject|75
2554638|NCT01418937|8838275|P1|Overall Study|Withdrawal by Subject|1
2554639|NCT01418937|8838275|P1|Overall Study|Pregnancy|1
2554640|NCT01418937|8838275|P1|Overall Study|Protocol Violation|1
2554641|NCT01418937|8838275|P1|Overall Study|Lost to Follow-up|5
2554642|NCT01418378|8838306|P2|Overall Study|developed chronic myopathy|1
2554643|NCT01418378|8838307|P1|Overall Study|developed chronic myopathy|0
2554644|NCT01418378|8838306|P2|Overall Study|ligament imbalance|1
2554645|NCT01418378|8838307|P1|Overall Study|ligament imbalance|0
2554646|NCT01418378|8838306|P2|Overall Study|Physician Decision|1
2554647|NCT01418378|8838307|P1|Overall Study|Physician Decision|0
2554648|NCT01418378|8838306|P2|Overall Study|Death|2
2554649|NCT01418378|8838307|P1|Overall Study|Death|1
2554650|NCT01418365|8838381|P2|Second Intervention|Withdrawal by Subject|1
2554651|NCT01418365|8838382|P1|Second Intervention|Withdrawal by Subject|0
2554652|NCT01418365|8838381|P2|First Intervention|Non-compliance|0
2554653|NCT01418365|8838382|P1|First Intervention|Non-compliance|1
2554654|NCT01418365|8838381|P2|First Intervention|Withdrawal by Subject|1
2554655|NCT01418365|8838382|P1|First Intervention|Withdrawal by Subject|0
2554656|NCT01418209|8838393|P3|Overall Study|Did not provide hot flash diary data|3
2554657|NCT01418209|8838394|P2|Overall Study|Did not provide hot flash diary data|3
2554658|NCT01418209|8838395|P1|Overall Study|Did not provide hot flash diary data|1
2554659|NCT01418209|8838393|P3|Overall Study|Withdrawal by Subject|1
2554660|NCT01418209|8838394|P2|Overall Study|Withdrawal by Subject|0
2554661|NCT01418209|8838395|P1|Overall Study|Withdrawal by Subject|1
2554662|NCT01417481|8838459|P2|First Intervention (8 Weeks)|Withdrawal by Subject|2
2554663|NCT01417481|8838460|P1|First Intervention (8 Weeks)|Withdrawal by Subject|0
2554664|NCT01417377|8838525|P1|Overall Study|Enrolled, but not treated|1
2554665|NCT01417377|8838525|P1|Overall Study|Lost to Follow-up|12
2554666|NCT01417195|8838534|P2|Overall Study|No transfer due to elevated progesterone|0
2554667|NCT01417195|8838535|P1|Overall Study|No transfer due to elevated progesterone|1
2554668|NCT01417195|8838534|P2|Overall Study|No transfer due to risk of OHSS|0
2554669|NCT01417195|8838535|P1|Overall Study|No transfer due to risk of OHSS|1
2554670|NCT01417195|8838534|P2|Overall Study|No embryos for transfer|1
2554671|NCT01417195|8838535|P1|Overall Study|No embryos for transfer|0
2554672|NCT01417195|8838534|P2|Overall Study|Stimulation failure|0
2554673|NCT01417195|8838535|P1|Overall Study|Stimulation failure|1
2554674|NCT01417156|8838551|P1|Overall Study|Protocol Violation|2
2554675|NCT01417156|8838551|P1|Overall Study|Adverse Event|12
2554676|NCT01417104|8838561|P2|Overall Study|Adverse Event|0
2554677|NCT01417104|8838562|P1|Overall Study|Adverse Event|1
2554678|NCT01417104|8838561|P2|Overall Study|Failure to make contact|1
2554679|NCT01417104|8838562|P1|Overall Study|Failure to make contact|0
2554680|NCT01417104|8838561|P2|Overall Study|Withdrawal by Subject|1
2554681|NCT01417104|8838562|P1|Overall Study|Withdrawal by Subject|5
2554682|NCT01417078|8838572|P1|Overall Study|Withdrawal by Subject|1
2554683|NCT01417000|8838597|P2|Overall Study|Study Terminated by Sponsor|1
2554684|NCT01417000|8838598|P1|Overall Study|Study Terminated by Sponsor|1
2554685|NCT01417000|8838597|P2|Overall Study|Lost to Follow-up|0
2554686|NCT01417000|8838598|P1|Overall Study|Lost to Follow-up|1
2554687|NCT01417000|8838597|P2|Overall Study|Death|28
2554688|NCT01417000|8838598|P1|Overall Study|Death|59
2554689|NCT01416805|8838615|P2|Overall Study|Lost to Follow-up|4
2554690|NCT01416805|8838616|P1|Overall Study|Lost to Follow-up|4
2554691|NCT01416610|8838655|P1|Overall Study|Sufficient treatment duration (PCR neg.)|7
2554692|NCT01416610|8838655|P1|Overall Study|Lost to Follow-up|7
2554693|NCT01416610|8838655|P1|Overall Study|Withdrawal by Subject|13
2554694|NCT01416610|8838655|P1|Overall Study|No reason given|5
2554695|NCT01416610|8838655|P1|Overall Study|Lack of Efficacy|4
2554696|NCT01416610|8838655|P1|Overall Study|Adverse Event -Patient decision|3
2554697|NCT01416610|8838655|P1|Overall Study|Adverse Event|4
2554698|NCT01416571|8838709|P1|Overall Study|Lost to Follow-up|2
2554699|NCT01416389|8838738|P2|Overall Study|Started New Therapy|0
2554700|NCT01416389|8838739|P1|Overall Study|Started New Therapy|2
2554701|NCT01416389|8838738|P2|Overall Study|Lost to Follow-up|0
2554702|NCT01416389|8838739|P1|Overall Study|Lost to Follow-up|1
2554703|NCT01416272|8838756|P1|Overall Study|Study related complaints|1
2554704|NCT01416272|8838756|P1|Overall Study|Lost to Follow-up|1
2554705|NCT01416272|8838756|P1|Overall Study|Unacceptable distance visual acuity|2
2554706|NCT01416181|8838764|P2|Part 2|Lost to Follow-up|2
2554707|NCT01416181|8838765|P1|Part 2|Lost to Follow-up|2
2554708|NCT01416181|8838764|P2|Part 2|Lack of Efficacy|1
2554709|NCT01416181|8838765|P1|Part 2|Lack of Efficacy|4
2554710|NCT01416181|8838764|P2|Part 2|Withdrawal by Subject|5
2554711|NCT01416181|8838765|P1|Part 2|Withdrawal by Subject|14
2554712|NCT01416181|8838764|P2|Part 2|Investigator Decision|7
2554713|NCT01416181|8838765|P1|Part 2|Investigator Decision|6
2554714|NCT01416181|8838764|P2|Part 2|Other|267
2554715|NCT01416181|8838765|P1|Part 2|Other|234
2554716|NCT01416181|8838764|P2|Part 2|Adverse Event|4
2554717|NCT01416181|8838765|P1|Part 2|Adverse Event|11
2554718|NCT01416181|8838764|P2|Part 1|Ongoing in Follow-Up|8
2554719|NCT01416181|8838765|P1|Part 1|Ongoing in Follow-Up|14
2554720|NCT01416181|8838764|P2|Part 1|Adverse Event|18
2554721|NCT01416181|8838765|P1|Part 1|Adverse Event|15
2554722|NCT01416181|8838764|P2|Part 1|Lost to Follow-up|1
2554723|NCT01416181|8838765|P1|Part 1|Lost to Follow-up|1
2554724|NCT01416181|8838764|P2|Part 1|Lack of Efficacy|8
2554725|NCT01416181|8838765|P1|Part 1|Lack of Efficacy|16
2554726|NCT01416181|8838764|P2|Part 1|Withdrawal by Subject|48
2554727|NCT01416181|8838765|P1|Part 1|Withdrawal by Subject|74
2554728|NCT01416181|8838764|P2|Part 1|Investigator Decision|6
2554729|NCT01416181|8838765|P1|Part 1|Investigator Decision|7
2554730|NCT01416181|8838764|P2|Part 1|Death|1
2554731|NCT01416181|8838765|P1|Part 1|Death|0
2554732|NCT01416181|8838764|P2|Part 1|Other|24
2554733|NCT01416181|8838765|P1|Part 1|Other|10
2554734|NCT01416155|8838827|P1|Overall Study|Other|7
2554735|NCT01416155|8838827|P1|Overall Study|Investigator decision|8
2554736|NCT01416155|8838827|P1|Overall Study|Withdrawal by Subject|33
2554737|NCT01416155|8838827|P1|Overall Study|Positive for anti-BG00002 antibodies|2
2554738|NCT01416155|8838827|P1|Overall Study|Adverse Event|8
2554739|NCT01416142|8838834|P3|PureVision2 HD|Inability to maintain lens wear|1
2554740|NCT01416142|8838835|P2|PureVision2 HD|Inability to maintain lens wear|0
2554741|NCT01416142|8838836|P1|PureVision2 HD|Inability to maintain lens wear|0
2554742|NCT01415986|8838863|P1|Overall Study|Lost to Follow-up|1
2554743|NCT01415921|8838889|P2|Overall Study|Other|0
2554744|NCT01415921|8838890|P1|Overall Study|Other|2
2554745|NCT01415921|8838889|P2|Overall Study|Withdrawal by Subject|1
2554746|NCT01415921|8838890|P1|Overall Study|Withdrawal by Subject|0
2554747|NCT01415921|8838889|P2|Overall Study|Physician Decision|1
2554748|NCT01415921|8838890|P1|Overall Study|Physician Decision|1
2554749|NCT01415921|8838889|P2|Overall Study|Adverse Event|1
2554750|NCT01415921|8838890|P1|Overall Study|Adverse Event|0
2554751|NCT01415908|8838900|P2|Overall Study|Withdrawal by Subject|0
2554752|NCT01415908|8838901|P1|Overall Study|Withdrawal by Subject|1
2554753|NCT01415531|8838938|P2|Overall Study|Other Reasons|2
2554754|NCT01415531|8838939|P1|Overall Study|Other Reasons|3
2554755|NCT01415531|8838938|P2|Overall Study|Lack of Compliance|4
2554756|NCT01415531|8838939|P1|Overall Study|Lack of Compliance|1
2554757|NCT01415531|8838938|P2|Overall Study|Lost to Follow-up|14
2554758|NCT01415531|8838939|P1|Overall Study|Lost to Follow-up|6
2554759|NCT01415531|8838938|P2|Overall Study|Withdrawal by Subject|4
2554760|NCT01415531|8838939|P1|Overall Study|Withdrawal by Subject|5
2554761|NCT01415531|8838938|P2|Overall Study|Protocol Violation|1
2554762|NCT01415531|8838939|P1|Overall Study|Protocol Violation|0
2554763|NCT01415531|8838938|P2|Overall Study|Lack of Efficacy|2
2554764|NCT01415531|8838939|P1|Overall Study|Lack of Efficacy|3
2554765|NCT01415531|8838938|P2|Overall Study|Adverse Event|10
2554766|NCT01415531|8838939|P1|Overall Study|Adverse Event|7
2554767|NCT01415518|8838949|P2|Overall Study|Condition under Investigation Worsened|1
2554768|NCT01415518|8838950|P1|Overall Study|Condition under Investigation Worsened|1
2554769|NCT01415518|8838949|P2|Overall Study|Death|1
2554770|NCT01415518|8838950|P1|Overall Study|Death|1
2554771|NCT01415518|8838949|P2|Overall Study|Adverse Event|4
2554772|NCT01415518|8838950|P1|Overall Study|Adverse Event|3
2554773|NCT01415518|8838949|P2|Overall Study|Lost to Follow-up|5
2554774|NCT01415518|8838950|P1|Overall Study|Lost to Follow-up|3
2554775|NCT01415518|8838949|P2|Overall Study|Protocol Violation|8
2554776|NCT01415518|8838950|P1|Overall Study|Protocol Violation|6
2554777|NCT01415518|8838949|P2|Overall Study|Withdrawal by Subject|12
2554778|NCT01415518|8838950|P1|Overall Study|Withdrawal by Subject|2
2554779|NCT01415440|8839009|P3|Overall Study|Withdrawal by Subject|0
2554780|NCT01415440|8839010|P2|Overall Study|Withdrawal by Subject|0
2554781|NCT01415440|8839011|P1|Overall Study|Withdrawal by Subject|1
2554782|NCT01415440|8839009|P3|Overall Study|Physician Decision|0
2554783|NCT01415440|8839010|P2|Overall Study|Physician Decision|0
2554784|NCT01415440|8839011|P1|Overall Study|Physician Decision|3
2554785|NCT01415440|8839009|P3|Overall Study|Lost to Follow-up|2
2554786|NCT01415440|8839010|P2|Overall Study|Lost to Follow-up|1
2554787|NCT01415440|8839011|P1|Overall Study|Lost to Follow-up|0
2554788|NCT01415401|8839062|P1|Overall Study|Terminated by Sponsor|1
2554789|NCT01415401|8839062|P1|Overall Study|DId not meet inclusion/exclusion criteri|1
2554790|NCT01415401|8839062|P1|Overall Study|Adverse Event|5
2554791|NCT01415349|8839067|P2|Treatment Period 1|Withdrawal by Subject|1
2554792|NCT01415349|8839068|P1|Treatment Period 1|Withdrawal by Subject|0
2554793|NCT01415349|8839067|P2|Treatment Period 1|Adverse Event|1
2554794|NCT01415349|8839068|P1|Treatment Period 1|Adverse Event|0
2554795|NCT01414855|8839080|P1|Overall Study|Withdrawal by Subject|7
2554796|NCT01414855|8839080|P1|Overall Study|Lost to Follow-up|5
2554797|NCT01414855|8839080|P1|Overall Study|Death|17
2554798|NCT01414257|8839129|P1|Overall Study|Protocol Violation|10
2554799|NCT01414257|8839129|P1|Overall Study|No Visit After First Day of Treatment|12
2554800|NCT01414205|8839157|P2|Overall Study|Randomized but not Treated|1
2554801|NCT01414205|8839158|P1|Overall Study|Randomized but not Treated|1
2554802|NCT01414205|8839157|P2|Overall Study|Physician Decision|1
2554803|NCT01414205|8839158|P1|Overall Study|Physician Decision|0
2554804|NCT01414205|8839157|P2|Overall Study|Lost to Follow-up|4
2554805|NCT01414205|8839158|P1|Overall Study|Lost to Follow-up|1
2554806|NCT01414205|8839157|P2|Overall Study|Death|1
2554807|NCT01414205|8839158|P1|Overall Study|Death|5
2554808|NCT01414166|8839227|P2|Overall Study|Withdrawal by Subject|5
2554809|NCT01414166|8839228|P1|Overall Study|Withdrawal by Subject|3
2554810|NCT01414166|8839227|P2|Overall Study|Study terminated by Sponsor|75
2554811|NCT01414166|8839228|P1|Overall Study|Study terminated by Sponsor|68
2554812|NCT01414166|8839227|P2|Overall Study|Protocol Violation|0
2554813|NCT01414166|8839228|P1|Overall Study|Protocol Violation|2
2554814|NCT01414166|8839227|P2|Overall Study|Physician Decision|0
2554815|NCT01414166|8839228|P1|Overall Study|Physician Decision|2
2554816|NCT01414166|8839227|P2|Overall Study|Non-compliance with study drug|0
2554817|NCT01414166|8839228|P1|Overall Study|Non-compliance with study drug|2
2554818|NCT01414166|8839227|P2|Overall Study|Lost to Follow-up|1
2554819|NCT01414166|8839228|P1|Overall Study|Lost to Follow-up|4
2554820|NCT01414166|8839227|P2|Overall Study|Adverse Event|2
2554821|NCT01414166|8839228|P1|Overall Study|Adverse Event|10
2554822|NCT01414114|8839291|P1|Overall Study|Other|2
2554823|NCT01414114|8839291|P1|Overall Study|Withdrawal by Subject|1
2554824|NCT01414114|8839291|P1|Overall Study|Adverse Event|2
2554825|NCT01413958|8839347|P2|Overall Study|Lost to Follow-up|1
2554826|NCT01413958|8839348|P1|Overall Study|Lost to Follow-up|0
2554827|NCT01413542|8839399|P4|Overall Study|Adverse Event|1
2554828|NCT01413542|8839400|P3|Overall Study|Adverse Event|0
2554829|NCT01413542|8839401|P2|Overall Study|Adverse Event|0
2554830|NCT01413542|8839402|P1|Overall Study|Adverse Event|0
2554831|NCT01413542|8839399|P4|Overall Study|Physician Decision|0
2554832|NCT01413542|8839400|P3|Overall Study|Physician Decision|3
2554833|NCT01413542|8839401|P2|Overall Study|Physician Decision|0
2554834|NCT01413542|8839402|P1|Overall Study|Physician Decision|1
2554835|NCT01413503|8839424|P1|Overall Study|Lost to Follow-up|1
2554836|NCT01413360|8839428|P1|Overall Study|Adverse Event|1
2554837|NCT01413360|8839428|P1|Overall Study|Lost to Follow-up|2
2554838|NCT01413204|8839436|P3|Overall Study|Fasting plasma glucose level increased|10
2554839|NCT01413204|8839437|P2|Overall Study|Fasting plasma glucose level increased|0
2554840|NCT01413204|8839438|P1|Overall Study|Fasting plasma glucose level increased|1
2554841|NCT01413204|8839436|P3|Overall Study|Clearly not eligible for the study|1
2554842|NCT01413204|8839437|P2|Overall Study|Clearly not eligible for the study|0
2554843|NCT01413204|8839438|P1|Overall Study|Clearly not eligible for the study|0
2554844|NCT01413204|8839436|P3|Overall Study|Withdrawal by Subject|4
2554845|NCT01413204|8839437|P2|Overall Study|Withdrawal by Subject|4
2554846|NCT01413204|8839438|P1|Overall Study|Withdrawal by Subject|1
2554847|NCT01413204|8839436|P3|Overall Study|Physician Decision|2
2554848|NCT01413204|8839437|P2|Overall Study|Physician Decision|0
2554849|NCT01413204|8839438|P1|Overall Study|Physician Decision|3
2554850|NCT01413204|8839436|P3|Overall Study|Adverse Event|2
2554851|NCT01413204|8839437|P2|Overall Study|Adverse Event|2
2554852|NCT01413204|8839438|P1|Overall Study|Adverse Event|1
2554853|NCT01413191|8839446|P1|Overall Study|Death|1
2554854|NCT01413191|8839446|P1|Overall Study|Disease Progression|5
2554855|NCT01413191|8839446|P1|Overall Study|Lost to Follow-up|5
2554856|NCT01413178|8839458|P2|Overall Study|Ineligible|2
2554857|NCT01413178|8839459|P1|Overall Study|Ineligible|0
2554858|NCT01413178|8839458|P2|Overall Study|Toxicity|0
2554859|NCT01413178|8839459|P1|Overall Study|Toxicity|1
2554860|NCT01412983|8839502|P2|1st Period|Inability to maintain wear|1
2554861|NCT01412983|8839503|P1|1st Period|Inability to maintain wear|0
2554862|NCT01412983|8839502|P2|1st Period|Unacceptable lens movement|1
2554863|NCT01412983|8839503|P1|1st Period|Unacceptable lens movement|0
2554864|NCT01412983|8839502|P2|1st Period|Positive slit lamp finding|1
2554865|NCT01412983|8839503|P1|1st Period|Positive slit lamp finding|0
2554866|NCT01412983|8839502|P2|1st Period|Ineligible|1
2554867|NCT01412983|8839503|P1|1st Period|Ineligible|0
2554868|NCT01412957|8839513|P2|Overall Study|Death|133
2554869|NCT01412957|8839514|P1|Overall Study|Death|136
2554870|NCT01412957|8839513|P2|Overall Study|Lost to Follow-up|2
2554871|NCT01412957|8839514|P1|Overall Study|Lost to Follow-up|7
2554872|NCT01412957|8839513|P2|Overall Study|Withdrawal by Subject|22
2554873|NCT01412957|8839514|P1|Overall Study|Withdrawal by Subject|6
2554874|NCT01412944|8839536|P6|Entire: IV + Maintenance|Adverse Event|0
2554875|NCT01412944|8839537|P5|Entire: IV + Maintenance|Adverse Event|0
2554876|NCT01412944|8839538|P4|Entire: IV + Maintenance|Adverse Event|0
2554877|NCT01412944|8839539|P3|Entire: IV + Maintenance|Adverse Event|0
2554878|NCT01412944|8839540|P2|Entire: IV + Maintenance|Adverse Event|1
2554879|NCT01412944|8839541|P1|Entire: IV + Maintenance|Adverse Event|0
2554880|NCT01412944|8839536|P6|Entire: IV + Maintenance|Lack of Efficacy|0
2554881|NCT01412944|8839537|P5|Entire: IV + Maintenance|Lack of Efficacy|0
2554882|NCT01412944|8839538|P4|Entire: IV + Maintenance|Lack of Efficacy|0
2554883|NCT01412944|8839539|P3|Entire: IV + Maintenance|Lack of Efficacy|0
2554884|NCT01412944|8839540|P2|Entire: IV + Maintenance|Lack of Efficacy|1
2554885|NCT01412944|8839541|P1|Entire: IV + Maintenance|Lack of Efficacy|0
2554886|NCT01412944|8839536|P6|Entire: IV + Maintenance|Lost to Follow-up|0
2554887|NCT01412944|8839537|P5|Entire: IV + Maintenance|Lost to Follow-up|0
2554888|NCT01412944|8839538|P4|Entire: IV + Maintenance|Lost to Follow-up|0
2554889|NCT01412944|8839539|P3|Entire: IV + Maintenance|Lost to Follow-up|0
2554890|NCT01412944|8839540|P2|Entire: IV + Maintenance|Lost to Follow-up|1
2554891|NCT01412944|8839541|P1|Entire: IV + Maintenance|Lost to Follow-up|0
2554892|NCT01412944|8839536|P6|Entire: IV + Maintenance|Protocol deviation|0
2554893|NCT01412944|8839537|P5|Entire: IV + Maintenance|Protocol deviation|0
2554894|NCT01412944|8839538|P4|Entire: IV + Maintenance|Protocol deviation|0
2554895|NCT01412944|8839539|P3|Entire: IV + Maintenance|Protocol deviation|0
2554896|NCT01412944|8839540|P2|Entire: IV + Maintenance|Protocol deviation|1
2554897|NCT01412944|8839541|P1|Entire: IV + Maintenance|Protocol deviation|0
2554898|NCT01412944|8839536|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
2554899|NCT01412944|8839537|P5|Entire: IV + Maintenance|Withdrawal by Subject|0
2554900|NCT01412944|8839538|P4|Entire: IV + Maintenance|Withdrawal by Subject|0
2554901|NCT01412944|8839539|P3|Entire: IV + Maintenance|Withdrawal by Subject|0
2554902|NCT01412944|8839540|P2|Entire: IV + Maintenance|Withdrawal by Subject|1
2554903|NCT01412944|8839541|P1|Entire: IV + Maintenance|Withdrawal by Subject|2
2554904|NCT01412944|8839536|P6|Entire: IV + Maintenance|Lack of Efficacy|0
2554905|NCT01412944|8839537|P5|Entire: IV + Maintenance|Lack of Efficacy|1
2554906|NCT01412944|8839538|P4|Entire: IV + Maintenance|Lack of Efficacy|0
2554907|NCT01412944|8839539|P3|Entire: IV + Maintenance|Lack of Efficacy|0
2554908|NCT01412944|8839540|P2|Entire: IV + Maintenance|Lack of Efficacy|0
2554909|NCT01412944|8839541|P1|Entire: IV + Maintenance|Lack of Efficacy|0
2554910|NCT01412944|8839536|P6|Entire: IV + Maintenance|Lost to Follow-up|1
2554911|NCT01412944|8839537|P5|Entire: IV + Maintenance|Lost to Follow-up|0
2554912|NCT01412944|8839538|P4|Entire: IV + Maintenance|Lost to Follow-up|0
2554913|NCT01412944|8839539|P3|Entire: IV + Maintenance|Lost to Follow-up|0
2554914|NCT01412944|8839540|P2|Entire: IV + Maintenance|Lost to Follow-up|0
2554915|NCT01412944|8839541|P1|Entire: IV + Maintenance|Lost to Follow-up|0
2554916|NCT01412944|8839536|P6|Entire: IV + Maintenance|Protocol deviation|1
2554917|NCT01412944|8839537|P5|Entire: IV + Maintenance|Protocol deviation|0
2554918|NCT01412944|8839538|P4|Entire: IV + Maintenance|Protocol deviation|0
2554919|NCT01412944|8839539|P3|Entire: IV + Maintenance|Protocol deviation|0
2554920|NCT01412944|8839540|P2|Entire: IV + Maintenance|Protocol deviation|0
2554921|NCT01412944|8839541|P1|Entire: IV + Maintenance|Protocol deviation|0
2554922|NCT01412944|8839536|P6|Entire: IV + Maintenance|Adverse Event|0
2554923|NCT01412944|8839537|P5|Entire: IV + Maintenance|Adverse Event|1
2554924|NCT01412944|8839538|P4|Entire: IV + Maintenance|Adverse Event|0
2554925|NCT01412944|8839539|P3|Entire: IV + Maintenance|Adverse Event|0
2554926|NCT01412944|8839540|P2|Entire: IV + Maintenance|Adverse Event|0
2554927|NCT01412944|8839541|P1|Entire: IV + Maintenance|Adverse Event|0
2554928|NCT01412944|8839536|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
2554929|NCT01412944|8839537|P5|Entire: IV + Maintenance|Withdrawal by Subject|1
2554930|NCT01412944|8839538|P4|Entire: IV + Maintenance|Withdrawal by Subject|1
2554931|NCT01412944|8839539|P3|Entire: IV + Maintenance|Withdrawal by Subject|1
2554932|NCT01412944|8839540|P2|Entire: IV + Maintenance|Withdrawal by Subject|0
2554933|NCT01412944|8839541|P1|Entire: IV + Maintenance|Withdrawal by Subject|0
2554934|NCT01412944|8839536|P6|IV: Per CAIN457A2307|Lost to Follow-up|0
2554935|NCT01412944|8839537|P5|IV: Per CAIN457A2307|Lost to Follow-up|0
2554936|NCT01412944|8839538|P4|IV: Per CAIN457A2307|Lost to Follow-up|0
2554937|NCT01412944|8839539|P3|IV: Per CAIN457A2307|Lost to Follow-up|0
2554938|NCT01412944|8839540|P2|IV: Per CAIN457A2307|Lost to Follow-up|1
2554939|NCT01412944|8839541|P1|IV: Per CAIN457A2307|Lost to Follow-up|0
2554940|NCT01412944|8839536|P6|IV: Per CAIN457A2307|Protocol deviation|0
2554941|NCT01412944|8839537|P5|IV: Per CAIN457A2307|Protocol deviation|0
2554942|NCT01412944|8839538|P4|IV: Per CAIN457A2307|Protocol deviation|0
2554943|NCT01412944|8839539|P3|IV: Per CAIN457A2307|Protocol deviation|0
2554944|NCT01412944|8839540|P2|IV: Per CAIN457A2307|Protocol deviation|1
2554945|NCT01412944|8839541|P1|IV: Per CAIN457A2307|Protocol deviation|0
2554946|NCT01412944|8839536|P6|IV: Per CAIN457A2307|Withdrawal by Subject|0
2554947|NCT01412944|8839537|P5|IV: Per CAIN457A2307|Withdrawal by Subject|0
2554948|NCT01412944|8839538|P4|IV: Per CAIN457A2307|Withdrawal by Subject|0
2554949|NCT01412944|8839539|P3|IV: Per CAIN457A2307|Withdrawal by Subject|0
2554950|NCT01412944|8839540|P2|IV: Per CAIN457A2307|Withdrawal by Subject|0
2554951|NCT01412944|8839541|P1|IV: Per CAIN457A2307|Withdrawal by Subject|1
2554952|NCT01412944|8839536|P6|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1
2554953|NCT01412944|8839537|P5|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
2554954|NCT01412944|8839538|P4|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
2554955|NCT01412944|8839539|P3|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
2554956|NCT01412944|8839540|P2|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
2554957|NCT01412944|8839541|P1|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
2554958|NCT01412944|8839536|P6|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1
2554959|NCT01412944|8839537|P5|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
2554960|NCT01412944|8839538|P4|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
2554961|NCT01412944|8839539|P3|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
2554962|NCT01412944|8839540|P2|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
2554963|NCT01412944|8839541|P1|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
2554964|NCT01412944|8839536|P6|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
2554965|NCT01412944|8839537|P5|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
2554966|NCT01412944|8839538|P4|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
2554967|NCT01412944|8839539|P3|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1
2554968|NCT01412944|8839540|P2|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
2554969|NCT01412944|8839541|P1|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
2554970|NCT01412879|8839587|P3|Initial Registration (Induction Therapy)|Treatment not Given|0
2554971|NCT01412879|8839588|P2|Initial Registration (Induction Therapy)|Treatment not Given|0
2554972|NCT01412879|8839589|P1|Initial Registration (Induction Therapy)|Treatment not Given|1
2554973|NCT01412879|8839587|P3|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0
2554974|NCT01412879|8839588|P2|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1
2554975|NCT01412879|8839589|P1|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6
2554976|NCT01412879|8839587|P3|Initial Registration (Induction Therapy)|Progression/Relapse|0
2554977|NCT01412879|8839588|P2|Initial Registration (Induction Therapy)|Progression/Relapse|1
2554978|NCT01412879|8839589|P1|Initial Registration (Induction Therapy)|Progression/Relapse|0
2554979|NCT01412879|8839587|P3|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0
2554980|NCT01412879|8839588|P2|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3
2554981|NCT01412879|8839589|P1|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1
2554982|NCT01412879|8839587|P3|Initial Registration (Induction Therapy)|Adverse Event|0
2554983|NCT01412879|8839588|P2|Initial Registration (Induction Therapy)|Adverse Event|3
2554984|NCT01412879|8839589|P1|Initial Registration (Induction Therapy)|Adverse Event|5
2554985|NCT01412801|8839618|P6|Overall Study|Relocated to another area|0
2554986|NCT01412801|8839619|P5|Overall Study|Relocated to another area|0
2554987|NCT01412801|8839620|P4|Overall Study|Relocated to another area|0
2554988|NCT01412801|8839621|P3|Overall Study|Relocated to another area|2
2554989|NCT01412801|8839622|P2|Overall Study|Relocated to another area|0
2554990|NCT01412801|8839623|P1|Overall Study|Relocated to another area|0
2554991|NCT01412801|8839618|P6|Overall Study|Withdrawal by Subject|0
2554992|NCT01412801|8839619|P5|Overall Study|Withdrawal by Subject|0
2554993|NCT01412801|8839620|P4|Overall Study|Withdrawal by Subject|0
2554994|NCT01412801|8839621|P3|Overall Study|Withdrawal by Subject|1
2554995|NCT01412801|8839622|P2|Overall Study|Withdrawal by Subject|2
2554996|NCT01412801|8839623|P1|Overall Study|Withdrawal by Subject|3
2554997|NCT01412801|8839618|P6|Overall Study|Lost to Follow-up|1
2554998|NCT01412801|8839619|P5|Overall Study|Lost to Follow-up|1
2554999|NCT01412801|8839620|P4|Overall Study|Lost to Follow-up|0
2555000|NCT01412801|8839621|P3|Overall Study|Lost to Follow-up|4
2555001|NCT01412801|8839622|P2|Overall Study|Lost to Follow-up|2
2555002|NCT01412801|8839623|P1|Overall Study|Lost to Follow-up|1
2555003|NCT01412801|8839618|P6|Overall Study|Death|2
2555004|NCT01412801|8839619|P5|Overall Study|Death|2
2555005|NCT01412801|8839620|P4|Overall Study|Death|4
2555006|NCT01412801|8839621|P3|Overall Study|Death|0
2555007|NCT01412801|8839622|P2|Overall Study|Death|1
2555008|NCT01412801|8839623|P1|Overall Study|Death|0
2555009|NCT01412424|8839786|P1|Extension Treatment Period|Patient Request|2
2555010|NCT01412424|8839786|P1|Extension Treatment Period|Treatment Failure|2
2555011|NCT01412424|8839786|P1|Extension Treatment Period|Adverse Event|2
2555012|NCT01412424|8839786|P1|Core Treatment Period|Sponsor Request|1
2555013|NCT01412424|8839786|P1|Core Treatment Period|Lost to Follow-up|2
2555014|NCT01412424|8839786|P1|Core Treatment Period|Patient Request|5
2555015|NCT01412424|8839786|P1|Core Treatment Period|Adverse Event|21
2555016|NCT01412424|8839786|P1|Core Treatment Period|Treatment Failure|24
2555017|NCT01412333|8839804|P2|Overall Study|Lost to Follow-up|6
2555018|NCT01412333|8839805|P1|Overall Study|Lost to Follow-up|10
2555019|NCT01412333|8839804|P2|Overall Study|Adverse Event|16
2555020|NCT01412333|8839805|P1|Overall Study|Adverse Event|25
2555021|NCT01412333|8839804|P2|Overall Study|Consent withdrawn by participant|12
2555022|NCT01412333|8839805|P1|Overall Study|Consent withdrawn by participant|25
2555023|NCT01412333|8839804|P2|Overall Study|Pregnancy|0
2555024|NCT01412333|8839805|P1|Overall Study|Pregnancy|3
2555025|NCT01412333|8839804|P2|Overall Study|Lack of Efficacy|6
2555026|NCT01412333|8839805|P1|Overall Study|Lack of Efficacy|15
2555027|NCT01412333|8839804|P2|Overall Study|Non-compliance|3
2555028|NCT01412333|8839805|P1|Overall Study|Non-compliance|1
2555029|NCT01412333|8839804|P2|Overall Study|Protocol Violation|1
2555030|NCT01412333|8839805|P1|Overall Study|Protocol Violation|1
2555031|NCT01412333|8839804|P2|Overall Study|Non-compliance with study drug|1
2555032|NCT01412333|8839805|P1|Overall Study|Non-compliance with study drug|1
2555033|NCT01412333|8839804|P2|Overall Study|Reason not specified|10
2555034|NCT01412333|8839805|P1|Overall Study|Reason not specified|16
2555035|NCT01412333|8839804|P2|Overall Study|Physician Decision|1
2555036|NCT01412333|8839805|P1|Overall Study|Physician Decision|0
2555037|NCT01412333|8839804|P2|Overall Study|Death|1
2555038|NCT01412333|8839805|P1|Overall Study|Death|1
2555039|NCT01412229|8839865|P1|Overall Study|Physician Decision|1
2555040|NCT01412151|8839888|P1|Week 306 - 310 - Washout Period|Withdrawal by Subject|2
2555041|NCT01412151|8839888|P1|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3
2555042|NCT01412151|8839888|P1|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1
2555043|NCT01412151|8839888|P1|Week 0 - 306 - Treatment Period|Death|1
2555044|NCT01412060|8839899|P3|Double-blind Treatment Phase (DBP)|Relapse|25
2555045|NCT01412060|8839900|P2|Double-blind Treatment Phase (DBP)|Relapse|47
2555046|NCT01412060|8839901|P1|Double-blind Treatment Phase (DBP)|Relapse|0
2555047|NCT01412060|8839899|P3|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27
2555048|NCT01412060|8839900|P2|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11
2555049|NCT01412060|8839901|P1|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0
2555050|NCT01412060|8839899|P3|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5
2555051|NCT01412060|8839900|P2|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6
2555052|NCT01412060|8839901|P1|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0
2555053|NCT01412060|8839899|P3|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15
2555054|NCT01412060|8839900|P2|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10
2555055|NCT01412060|8839901|P1|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0
2555056|NCT01412060|8839899|P3|Double-blind Treatment Phase (DBP)|Protocol Violation|5
2555057|NCT01412060|8839900|P2|Double-blind Treatment Phase (DBP)|Protocol Violation|4
2555058|NCT01412060|8839901|P1|Double-blind Treatment Phase (DBP)|Protocol Violation|0
2555059|NCT01412060|8839899|P3|Double-blind Treatment Phase (DBP)|Adverse Event|6
2555060|NCT01412060|8839900|P2|Double-blind Treatment Phase (DBP)|Adverse Event|5
2555061|NCT01412060|8839901|P1|Double-blind Treatment Phase (DBP)|Adverse Event|0
2555062|NCT01412060|8839899|P3|Period Between SP and DBP|Other Miscellaneous Reasons|0
2555063|NCT01412060|8839900|P2|Period Between SP and DBP|Other Miscellaneous Reasons|0
2555064|NCT01412060|8839901|P1|Period Between SP and DBP|Other Miscellaneous Reasons|55
2555065|NCT01412060|8839899|P3|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
2555066|NCT01412060|8839900|P2|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
2555067|NCT01412060|8839901|P1|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4
2555068|NCT01412060|8839899|P3|Period Between SP and DBP|Lost to Follow-up|0
2555069|NCT01412060|8839900|P2|Period Between SP and DBP|Lost to Follow-up|0
2555070|NCT01412060|8839901|P1|Period Between SP and DBP|Lost to Follow-up|1
2555071|NCT01412060|8839899|P3|Period Between SP and DBP|Withdrawal of Consent|0
2555072|NCT01412060|8839900|P2|Period Between SP and DBP|Withdrawal of Consent|0
2555073|NCT01412060|8839901|P1|Period Between SP and DBP|Withdrawal of Consent|2
2555074|NCT01412060|8839899|P3|Period Between SP and DBP|Protocol Violation|0
2555075|NCT01412060|8839900|P2|Period Between SP and DBP|Protocol Violation|0
2555076|NCT01412060|8839901|P1|Period Between SP and DBP|Protocol Violation|2
2555077|NCT01412060|8839899|P3|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
2555078|NCT01412060|8839900|P2|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
2555079|NCT01412060|8839901|P1|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19
2555080|NCT01412060|8839899|P3|Open-label Stabilization Period (SP)|Lost to Follow-up|0
2555081|NCT01412060|8839900|P2|Open-label Stabilization Period (SP)|Lost to Follow-up|0
2555082|NCT01412060|8839901|P1|Open-label Stabilization Period (SP)|Lost to Follow-up|9
2555083|NCT01412060|8839899|P3|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
2555084|NCT01412060|8839900|P2|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
2555085|NCT01412060|8839901|P1|Open-label Stabilization Period (SP)|Withdrawal of Consent|40
2555086|NCT01412060|8839899|P3|Open-label Stabilization Period (SP)|Protocol Violation|0
2555087|NCT01412060|8839900|P2|Open-label Stabilization Period (SP)|Protocol Violation|0
2555088|NCT01412060|8839901|P1|Open-label Stabilization Period (SP)|Protocol Violation|14
2555089|NCT01412060|8839899|P3|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
2555090|NCT01412060|8839900|P2|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
2555091|NCT01412060|8839901|P1|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9
2555092|NCT01412060|8839899|P3|Open-label Stabilization Period (SP)|Adverse Event|0
2555093|NCT01412060|8839900|P2|Open-label Stabilization Period (SP)|Adverse Event|0
2555094|NCT01412060|8839901|P1|Open-label Stabilization Period (SP)|Adverse Event|9
2555095|NCT01412060|8839899|P3|Period Between RIP and SP|Other Miscellaneous Reasons|0
2555096|NCT01412060|8839900|P2|Period Between RIP and SP|Other Miscellaneous Reasons|0
2555097|NCT01412060|8839901|P1|Period Between RIP and SP|Other Miscellaneous Reasons|23
2555098|NCT01412060|8839899|P3|Period Between RIP and SP|Lost to Follow-up|0
2555099|NCT01412060|8839900|P2|Period Between RIP and SP|Lost to Follow-up|0
2555100|NCT01412060|8839901|P1|Period Between RIP and SP|Lost to Follow-up|5
2555101|NCT01412060|8839899|P3|Period Between RIP and SP|Withdrawal of Consent|0
2555102|NCT01412060|8839900|P2|Period Between RIP and SP|Withdrawal of Consent|0
2555103|NCT01412060|8839901|P1|Period Between RIP and SP|Withdrawal of Consent|1
2555104|NCT01412060|8839899|P3|Period Between RIP and SP|Protocol Violation|0
2555105|NCT01412060|8839900|P2|Period Between RIP and SP|Protocol Violation|0
2555106|NCT01412060|8839901|P1|Period Between RIP and SP|Protocol Violation|2
2555107|NCT01412060|8839899|P3|Period Between RIP and SP|Insufficient Therapeutic Response|0
2555108|NCT01412060|8839900|P2|Period Between RIP and SP|Insufficient Therapeutic Response|0
2555109|NCT01412060|8839901|P1|Period Between RIP and SP|Insufficient Therapeutic Response|19
2555110|NCT01412060|8839899|P3|Period Between RIP and SP|Adverse Event|0
2555111|NCT01412060|8839900|P2|Period Between RIP and SP|Adverse Event|0
2555112|NCT01412060|8839901|P1|Period Between RIP and SP|Adverse Event|4
2555113|NCT01412060|8839899|P3|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
2555114|NCT01412060|8839900|P2|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
2555115|NCT01412060|8839901|P1|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19
2555116|NCT01412060|8839899|P3|Open-label Run-in Period (RIP)|Lost to Follow-up|0
2555117|NCT01412060|8839900|P2|Open-label Run-in Period (RIP)|Lost to Follow-up|0
2555118|NCT01412060|8839901|P1|Open-label Run-in Period (RIP)|Lost to Follow-up|32
2555119|NCT01412060|8839899|P3|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
2555120|NCT01412060|8839900|P2|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
2555121|NCT01412060|8839901|P1|Open-label Run-in Period (RIP)|Withdrawal of Consent|117
2555122|NCT01412060|8839899|P3|Open-label Run-in Period (RIP)|Protocol Violation|0
2555123|NCT01412060|8839900|P2|Open-label Run-in Period (RIP)|Protocol Violation|0
2555124|NCT01412060|8839901|P1|Open-label Run-in Period (RIP)|Protocol Violation|27
2555125|NCT01412060|8839899|P3|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
2555126|NCT01412060|8839900|P2|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
2555127|NCT01412060|8839901|P1|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66
2555128|NCT01412060|8839899|P3|Open-label Run-in Period (RIP)|Adverse Event|0
2555129|NCT01412060|8839900|P2|Open-label Run-in Period (RIP)|Adverse Event|0
2555130|NCT01412060|8839901|P1|Open-label Run-in Period (RIP)|Adverse Event|86
2555131|NCT01412021|8839911|P1|Overall Study|Transferred to Other Hospital|9
2555132|NCT01412021|8839911|P1|Overall Study|Treatment Prior to Approval|3
2555133|NCT01412021|8839911|P1|Overall Study|Case Report Forms Not Retrieved|7
2555134|NCT01411995|8839948|P2|Overall Study|Failed IUD insertion|1
2555135|NCT01411995|8839949|P1|Overall Study|Failed IUD insertion|0
2555136|NCT01411917|8839957|P2|Overall Study|Patient did not undergo scheduled surger|1
2555137|NCT01411917|8839958|P1|Overall Study|Patient did not undergo scheduled surger|0
2555138|NCT01411891|8839980|P2|Overall Study|Catheter dislodgement or loss to follow-|2
2555139|NCT01411891|8839981|P1|Overall Study|Catheter dislodgement or loss to follow-|3
2555140|NCT01411852|8839991|P2|Hospital Intervention Phase|Vascular access failed|0
2555141|NCT01411852|8839992|P1|Hospital Intervention Phase|Vascular access failed|1
2555142|NCT01411852|8839991|P2|Hospital Intervention Phase|Withdrawal by Subject|0
2555143|NCT01411852|8839992|P1|Hospital Intervention Phase|Withdrawal by Subject|1
2555144|NCT01411852|8839991|P2|Hospital Intervention Phase|Spinal cord injury|0
2555145|NCT01411852|8839992|P1|Hospital Intervention Phase|Spinal cord injury|2
2555146|NCT01411852|8839991|P2|Hospital Intervention Phase|Other ineligible|2
2555147|NCT01411852|8839992|P1|Hospital Intervention Phase|Other ineligible|2
2555148|NCT01411852|8839991|P2|Hospital Intervention Phase|Physician/hospital staff noncompliance|4
2555149|NCT01411852|8839992|P1|Hospital Intervention Phase|Physician/hospital staff noncompliance|0
2555150|NCT01411852|8839991|P2|Hospital Intervention Phase|Diagnosis of dehydration|1
2555151|NCT01411852|8839992|P1|Hospital Intervention Phase|Diagnosis of dehydration|0
2555152|NCT01411852|8839991|P2|Hospital Intervention Phase|Diagnosis of sepsis|2
2555153|NCT01411852|8839992|P1|Hospital Intervention Phase|Diagnosis of sepsis|0
2555154|NCT01411852|8839991|P2|Hospital Intervention Phase|Misunderstanding of protocol|1
2555155|NCT01411852|8839992|P1|Hospital Intervention Phase|Misunderstanding of protocol|4
2555156|NCT01411852|8839991|P2|Hospital Intervention Phase|CPR administered|1
2555157|NCT01411852|8839992|P1|Hospital Intervention Phase|CPR administered|3
2555158|NCT01411852|8839991|P2|Hospital Intervention Phase|Miscommunication error|2
2555159|NCT01411852|8839992|P1|Hospital Intervention Phase|Miscommunication error|1
2555160|NCT01411852|8839991|P2|Hospital Intervention Phase|No qualifying SBP|1
2555161|NCT01411852|8839992|P1|Hospital Intervention Phase|No qualifying SBP|5
2555162|NCT01411852|8839991|P2|Hospital Intervention Phase|Severe head injury|4
2555163|NCT01411852|8839992|P1|Hospital Intervention Phase|Severe head injury|5
2555164|NCT01411852|8839991|P2|Prehospital Intervention Phase|Severe head injury with GCS≤8|0
2555165|NCT01411852|8839992|P1|Prehospital Intervention Phase|Severe head injury with GCS≤8|5
2555166|NCT01411852|8839991|P2|Prehospital Intervention Phase|Found to be under age|1
2555167|NCT01411852|8839992|P1|Prehospital Intervention Phase|Found to be under age|0
2555256|NCT01410227|8840584|P2|Overall Study|Withdrawal by Subject|0
2555168|NCT01411852|8839991|P2|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
2555169|NCT01411852|8839992|P1|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
2555170|NCT01411852|8839991|P2|Prehospital Intervention Phase|No qualifying SBP|4
2555171|NCT01411852|8839992|P1|Prehospital Intervention Phase|No qualifying SBP|5
2555172|NCT01411839|8840037|P2|Overall Study|Lost to Follow-up|3
2555173|NCT01411839|8840038|P1|Overall Study|Lost to Follow-up|4
2555174|NCT01411774|8840050|P2|Overall Study|Withdrawal by Subject|3
2555175|NCT01411774|8840051|P1|Overall Study|Withdrawal by Subject|0
2555176|NCT01411241|8840166|P2|Overall Study|Lost to Follow-up|4
2555177|NCT01411241|8840167|P1|Overall Study|Lost to Follow-up|2
2555178|NCT01411241|8840166|P2|Overall Study|Serious Adverse Event|3
2555179|NCT01411241|8840167|P1|Overall Study|Serious Adverse Event|0
2555180|NCT01411241|8840166|P2|Overall Study|Withdrawal by Subject|10
2555181|NCT01411241|8840167|P1|Overall Study|Withdrawal by Subject|9
2555182|NCT01411241|8840166|P2|Overall Study|Protocol Violation|5
2555183|NCT01411241|8840167|P1|Overall Study|Protocol Violation|0
2555184|NCT01411228|8840192|P3|Overall Study|Withdrawal by Subject|0
2555185|NCT01411228|8840193|P2|Overall Study|Withdrawal by Subject|0
2555186|NCT01411228|8840194|P1|Overall Study|Withdrawal by Subject|1
2555187|NCT01411228|8840192|P3|Overall Study|Lost to Follow-up|1
2555188|NCT01411228|8840193|P2|Overall Study|Lost to Follow-up|0
2555189|NCT01411228|8840194|P1|Overall Study|Lost to Follow-up|0
2555190|NCT01411215|8840216|P2|Overall Study|Screen failure|1
2555191|NCT01411215|8840217|P1|Overall Study|Screen failure|0
2555192|NCT01411215|8840216|P2|Overall Study|Other|17
2555193|NCT01411215|8840217|P1|Overall Study|Other|12
2555194|NCT01411215|8840216|P2|Overall Study|Withdrawal by Subject|21
2555195|NCT01411215|8840217|P1|Overall Study|Withdrawal by Subject|34
2555196|NCT01411215|8840216|P2|Overall Study|Protocol Violation|5
2555197|NCT01411215|8840217|P1|Overall Study|Protocol Violation|3
2555198|NCT01411215|8840216|P2|Overall Study|Study terminated by sponsor|15
2555199|NCT01411215|8840217|P1|Overall Study|Study terminated by sponsor|2
2555200|NCT01411215|8840216|P2|Overall Study|Did not meet entrance criteria|1
2555201|NCT01411215|8840217|P1|Overall Study|Did not meet entrance criteria|0
2555202|NCT01411215|8840216|P2|Overall Study|Lost to Follow-up|18
2555203|NCT01411215|8840217|P1|Overall Study|Lost to Follow-up|12
2555204|NCT01411215|8840216|P2|Overall Study|Lack of Efficacy|4
2555205|NCT01411215|8840217|P1|Overall Study|Lack of Efficacy|2
2555206|NCT01411215|8840216|P2|Overall Study|Adverse Event|2
2555207|NCT01411215|8840217|P1|Overall Study|Adverse Event|1
2555208|NCT01411085|8840269|P1|Overall Study|Adverse Event|1
2555209|NCT01411085|8840269|P1|Overall Study|Protocol Violation|1
2555210|NCT01411085|8840269|P1|Overall Study|Physician Decision|1
2555211|NCT01410799|8840289|P1|Overall Study|PI decision|13
2555212|NCT01410604|8840305|P2|Overall Study|Physician Decision|1
2555213|NCT01410604|8840306|P1|Overall Study|Physician Decision|0
2555214|NCT01410604|8840305|P2|Overall Study|Lost to Follow-up|0
2555215|NCT01410604|8840306|P1|Overall Study|Lost to Follow-up|1
2555216|NCT01410604|8840305|P2|Overall Study|Adverse Event|1
2555217|NCT01410604|8840306|P1|Overall Study|Adverse Event|2
2555218|NCT01410474|8840347|P2|Overall Study|Withdrawal by Subject|1
2555219|NCT01410474|8840348|P1|Overall Study|Withdrawal by Subject|0
2555220|NCT01410448|8840371|P2|Overall Study|Death|3
2555221|NCT01410448|8840372|P1|Overall Study|Death|2
2555222|NCT01410448|8840371|P2|Overall Study|Protocol Violation|4
2555223|NCT01410448|8840372|P1|Overall Study|Protocol Violation|0
2555224|NCT01410448|8840371|P2|Overall Study|Withdrawal by Subject|2
2555225|NCT01410448|8840372|P1|Overall Study|Withdrawal by Subject|3
2555226|NCT01410448|8840371|P2|Overall Study|Lost to Follow-up|0
2555227|NCT01410448|8840372|P1|Overall Study|Lost to Follow-up|1
2555228|NCT01410448|8840371|P2|Overall Study|Administrative issues|1
2555229|NCT01410448|8840372|P1|Overall Study|Administrative issues|2
2555230|NCT01410448|8840371|P2|Overall Study|Graft loss|1
2555231|NCT01410448|8840372|P1|Overall Study|Graft loss|4
2555232|NCT01410448|8840371|P2|Overall Study|No conversion to everolimus|24
2555233|NCT01410448|8840372|P1|Overall Study|No conversion to everolimus|0
2555234|NCT01410357|8840437|P2|Overall Study|Lost to Follow-up|21
2555235|NCT01410357|8840438|P1|Overall Study|Lost to Follow-up|23
2555236|NCT01410357|8840437|P2|Overall Study|Withdrawal by Subject|2
2555237|NCT01410357|8840438|P1|Overall Study|Withdrawal by Subject|1
2555238|NCT01410357|8840437|P2|Overall Study|Death|1
2555239|NCT01410357|8840438|P1|Overall Study|Death|2
2555240|NCT01410240|8840509|P3|Overall Study|Missed week 6 assessments|1
2555241|NCT01410240|8840510|P2|Overall Study|Missed week 6 assessments|1
2555242|NCT01410240|8840511|P1|Overall Study|Missed week 6 assessments|1
2555243|NCT01410240|8840509|P3|Overall Study|Physician Decision|1
2555244|NCT01410240|8840510|P2|Overall Study|Physician Decision|0
2555245|NCT01410240|8840511|P1|Overall Study|Physician Decision|0
2555246|NCT01410227|8840582|P4|Overall Study|Met Excl. Criteria After Starting Study|0
2555247|NCT01410227|8840583|P3|Overall Study|Met Excl. Criteria After Starting Study|1
2555248|NCT01410227|8840584|P2|Overall Study|Met Excl. Criteria After Starting Study|0
2555249|NCT01410227|8840585|P1|Overall Study|Met Excl. Criteria After Starting Study|0
2555250|NCT01410227|8840582|P4|Overall Study|Pregnancy|1
2555251|NCT01410227|8840583|P3|Overall Study|Pregnancy|0
2555252|NCT01410227|8840584|P2|Overall Study|Pregnancy|0
2555253|NCT01410227|8840585|P1|Overall Study|Pregnancy|0
2555254|NCT01410227|8840582|P4|Overall Study|Withdrawal by Subject|0
2555255|NCT01410227|8840583|P3|Overall Study|Withdrawal by Subject|1
2555257|NCT01410227|8840585|P1|Overall Study|Withdrawal by Subject|3
2555258|NCT01410227|8840582|P4|Overall Study|Adverse Event|0
2555259|NCT01410227|8840583|P3|Overall Study|Adverse Event|0
2555260|NCT01410227|8840584|P2|Overall Study|Adverse Event|0
2555261|NCT01410227|8840585|P1|Overall Study|Adverse Event|1
2555262|NCT01410110|8840657|P2|Overall Study|Withdrawal by Subject|2
2555263|NCT01410110|8840658|P1|Overall Study|Withdrawal by Subject|4
2555264|NCT01409993|8840733|P4|Overall Study|Lost to Follow-up|0
2555265|NCT01409993|8840734|P3|Overall Study|Lost to Follow-up|0
2555266|NCT01409993|8840735|P2|Overall Study|Lost to Follow-up|1
2555267|NCT01409993|8840736|P1|Overall Study|Lost to Follow-up|0
2555268|NCT01409993|8840733|P4|Overall Study|Withdrawal by Subject|4
2555269|NCT01409993|8840734|P3|Overall Study|Withdrawal by Subject|0
2555270|NCT01409993|8840735|P2|Overall Study|Withdrawal by Subject|0
2555271|NCT01409993|8840736|P1|Overall Study|Withdrawal by Subject|0
2555272|NCT01409993|8840733|P4|Overall Study|Adverse Event|1
2555273|NCT01409993|8840734|P3|Overall Study|Adverse Event|3
2555274|NCT01409993|8840735|P2|Overall Study|Adverse Event|4
2555275|NCT01409993|8840736|P1|Overall Study|Adverse Event|4
2555276|NCT01409928|8840754|P1|Overall Study|Physician Decision|12
2555277|NCT01409837|8840760|P2|Overall Study|Physician Decision|1
2555278|NCT01409837|8840761|P1|Overall Study|Physician Decision|0
2555279|NCT01409837|8840760|P2|Overall Study|Lost to Follow-up|0
2555280|NCT01409837|8840761|P1|Overall Study|Lost to Follow-up|1
2555281|NCT01409837|8840760|P2|Overall Study|Withdrawal by Subject|1
2555282|NCT01409837|8840761|P1|Overall Study|Withdrawal by Subject|2
2555283|NCT01409811|8840783|P1|Overall Study|Insurance denial|1
2555284|NCT01409707|8840790|P3|Overall Study|Withdrawal by Subject|16
2555285|NCT01409707|8840791|P2|Overall Study|Withdrawal by Subject|17
2555286|NCT01409707|8840792|P1|Overall Study|Withdrawal by Subject|5
2555287|NCT01409564|8840804|P2|Overall Study|brain abnormalities found in T1 MR|2
2555288|NCT01409564|8840805|P1|Overall Study|brain abnormalities found in T1 MR|1
2555289|NCT01409564|8840804|P2|Overall Study|low medication compliance|3
2555290|NCT01409564|8840805|P1|Overall Study|low medication compliance|4
2555291|NCT01409434|8840823|P1|Overall Study|Protocol Violation|4
2555292|NCT01409382|8840833|P2|Overall Study|Had a 2nd trimester loss after accident|0
2555293|NCT01409382|8840834|P1|Overall Study|Had a 2nd trimester loss after accident|1
2555294|NCT01409382|8840833|P2|Overall Study|Did not manage to get pregnant|70
2555295|NCT01409382|8840834|P1|Overall Study|Did not manage to get pregnant|64
2555296|NCT01409382|8840833|P2|Overall Study|Still pregnant when study ended|2
2555297|NCT01409382|8840834|P1|Overall Study|Still pregnant when study ended|13
2555298|NCT01409382|8840833|P2|Overall Study|Multiple pregnancy|4
2555299|NCT01409382|8840834|P1|Overall Study|Multiple pregnancy|2
2555300|NCT01409382|8840833|P2|Overall Study|Protocol Violation|3
2555301|NCT01409382|8840834|P1|Overall Study|Protocol Violation|0
2555302|NCT01409382|8840833|P2|Overall Study|Lost to Follow-up|1
2555303|NCT01409382|8840834|P1|Overall Study|Lost to Follow-up|1
2555304|NCT01409031|8840888|P2|Overall Study|transferred to other hosp|0
2555305|NCT01409031|8840889|P1|Overall Study|transferred to other hosp|1
2555306|NCT01408914|8840920|P3|Overall Study|Change in local TB/HIV norms|1
2555307|NCT01408914|8840921|P2|Overall Study|Change in local TB/HIV norms|1
2555308|NCT01408914|8840922|P1|Overall Study|Change in local TB/HIV norms|0
2555309|NCT01408914|8840920|P3|Overall Study|Late exclusion|3
2555310|NCT01408914|8840921|P2|Overall Study|Late exclusion|3
2555311|NCT01408914|8840922|P1|Overall Study|Late exclusion|0
2555312|NCT01408914|8840920|P3|Overall Study|Moved out of study jurisdiction|0
2555313|NCT01408914|8840921|P2|Overall Study|Moved out of study jurisdiction|1
2555314|NCT01408914|8840922|P1|Overall Study|Moved out of study jurisdiction|1
2555315|NCT01408914|8840920|P3|Overall Study|Withdrawal by Subject|1
2555316|NCT01408914|8840921|P2|Overall Study|Withdrawal by Subject|0
2555317|NCT01408914|8840922|P1|Overall Study|Withdrawal by Subject|1
2555318|NCT01408914|8840920|P3|Overall Study|Physician Decision|0
2555319|NCT01408914|8840921|P2|Overall Study|Physician Decision|1
2555320|NCT01408914|8840922|P1|Overall Study|Physician Decision|1
2555321|NCT01408914|8840920|P3|Overall Study|Lost to Follow-up|2
2555322|NCT01408914|8840921|P2|Overall Study|Lost to Follow-up|1
2555323|NCT01408914|8840922|P1|Overall Study|Lost to Follow-up|4
2555324|NCT01408914|8840920|P3|Overall Study|Could not complete tx in protocol period|6
2555325|NCT01408914|8840921|P2|Overall Study|Could not complete tx in protocol period|5
2555326|NCT01408914|8840922|P1|Overall Study|Could not complete tx in protocol period|5
2555327|NCT01408901|8840940|P4|26-Week Follow-Up|Death|0
2555328|NCT01408901|8840941|P3|26-Week Follow-Up|Death|0
2555329|NCT01408901|8840942|P2|26-Week Follow-Up|Death|1
2555330|NCT01408901|8840943|P1|26-Week Follow-Up|Death|0
2555331|NCT01408901|8840940|P4|26-Week Follow-Up|Lost to Follow-up|1
2555332|NCT01408901|8840941|P3|26-Week Follow-Up|Lost to Follow-up|0
2555333|NCT01408901|8840942|P2|26-Week Follow-Up|Lost to Follow-up|1
2555334|NCT01408901|8840943|P1|26-Week Follow-Up|Lost to Follow-up|1
2555335|NCT01408901|8840940|P4|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1
2555336|NCT01408901|8840941|P3|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0
2555337|NCT01408901|8840942|P2|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2
2555338|NCT01408901|8840943|P1|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0
2555339|NCT01408901|8840940|P4|12-Week Follow-Up (Primary Endpoint)|Death|0
2555340|NCT01408901|8840941|P3|12-Week Follow-Up (Primary Endpoint)|Death|0
2555341|NCT01408901|8840942|P2|12-Week Follow-Up (Primary Endpoint)|Death|0
2555342|NCT01408901|8840943|P1|12-Week Follow-Up (Primary Endpoint)|Death|1
2555343|NCT01408901|8840940|P4|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2
2555344|NCT01408901|8840941|P3|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
2555345|NCT01408901|8840942|P2|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
2555346|NCT01408901|8840943|P1|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
2555347|NCT01408901|8840940|P4|6-Week Follow-Up|Cancelled visit|2
2555348|NCT01408901|8840941|P3|6-Week Follow-Up|Cancelled visit|0
2555349|NCT01408901|8840942|P2|6-Week Follow-Up|Cancelled visit|1
2555350|NCT01408901|8840943|P1|6-Week Follow-Up|Cancelled visit|0
2555351|NCT01408901|8840940|P4|6-Week Follow-Up|Death|0
2555352|NCT01408901|8840941|P3|6-Week Follow-Up|Death|0
2555353|NCT01408901|8840942|P2|6-Week Follow-Up|Death|0
2555354|NCT01408901|8840943|P1|6-Week Follow-Up|Death|1
2555355|NCT01408901|8840940|P4|6-Week Follow-Up|Lost to Follow-up|2
2555356|NCT01408901|8840941|P3|6-Week Follow-Up|Lost to Follow-up|3
2555357|NCT01408901|8840942|P2|6-Week Follow-Up|Lost to Follow-up|1
2555358|NCT01408901|8840943|P1|6-Week Follow-Up|Lost to Follow-up|2
2555359|NCT01408888|8840969|P2|Second Intervention|Adverse Event|0
2555360|NCT01408888|8840970|P1|Second Intervention|Adverse Event|1
2555361|NCT01408888|8840969|P2|Second Intervention|Withdrawal by Subject|0
2555362|NCT01408888|8840970|P1|Second Intervention|Withdrawal by Subject|1
2555363|NCT01408888|8840969|P2|First Intervention|Withdrawal by Subject|2
2555364|NCT01408888|8840970|P1|First Intervention|Withdrawal by Subject|0
2555365|NCT01408888|8840969|P2|First Intervention|Adverse Event|1
2555366|NCT01408888|8840970|P1|First Intervention|Adverse Event|0
2555367|NCT01408732|8840998|P2|Overall Study|Withdrawal by Subject|2
2555368|NCT01408732|8840999|P1|Overall Study|Withdrawal by Subject|2
2555369|NCT01408706|8841056|P2|Overall Study|Physician Decision|0
2555370|NCT01408706|8841057|P1|Overall Study|Physician Decision|1
2555371|NCT01408641|8841069|P2|Overall Study|Physician Decision|0
2555372|NCT01408641|8841070|P1|Overall Study|Physician Decision|1
2555373|NCT01408628|8841078|P1|Completed 6 Month Follow-Up|Withdrawal by Subject|5
2555374|NCT01408628|8841078|P1|Completed 6 Month Follow-Up|Protocol Violation|6
2555375|NCT01408628|8841078|P1|Completed 6 Month Follow-Up|Lost to Follow-up|3
2555376|NCT01408628|8841078|P1|Consented|Withdrawal by Subject|12
2555377|NCT01408576|8841087|P3|Overall Study|Other|18
2555378|NCT01408576|8841088|P2|Overall Study|Other|16
2555379|NCT01408576|8841089|P1|Overall Study|Other|10
2555380|NCT01408576|8841087|P3|Overall Study|AE, unknown type|0
2555381|NCT01408576|8841088|P2|Overall Study|AE, unknown type|1
2555382|NCT01408576|8841089|P1|Overall Study|AE, unknown type|0
2555383|NCT01408576|8841087|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
2555384|NCT01408576|8841088|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
2555385|NCT01408576|8841089|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
2555386|NCT01408576|8841087|P3|Overall Study|AE, non-serious non-fatal|11
2555387|NCT01408576|8841088|P2|Overall Study|AE, non-serious non-fatal|19
2555388|NCT01408576|8841089|P1|Overall Study|AE, non-serious non-fatal|12
2555389|NCT01408576|8841087|P3|Overall Study|SAE, non-fatal|14
2555390|NCT01408576|8841088|P2|Overall Study|SAE, non-fatal|23
2555391|NCT01408576|8841089|P1|Overall Study|SAE, non-fatal|11
2555392|NCT01408576|8841087|P3|Overall Study|AE, serious fatal|1
2555393|NCT01408576|8841088|P2|Overall Study|AE, serious fatal|4
2555394|NCT01408576|8841089|P1|Overall Study|AE, serious fatal|4
2555395|NCT01408576|8841087|P3|Overall Study|Sponsor terminated study|330
2555396|NCT01408576|8841088|P2|Overall Study|Sponsor terminated study|333
2555397|NCT01408576|8841089|P1|Overall Study|Sponsor terminated study|89
2555398|NCT01408576|8841087|P3|Overall Study|Withdrawal by Subject|66
2555399|NCT01408576|8841088|P2|Overall Study|Withdrawal by Subject|60
2555400|NCT01408576|8841089|P1|Overall Study|Withdrawal by Subject|34
2555401|NCT01408576|8841087|P3|Overall Study|Lost to Follow-up|17
2555402|NCT01408576|8841088|P2|Overall Study|Lost to Follow-up|9
2555403|NCT01408576|8841089|P1|Overall Study|Lost to Follow-up|10
2555404|NCT01408576|8841087|P3|Overall Study|Protocol Violation|2
2555405|NCT01408576|8841088|P2|Overall Study|Protocol Violation|2
2555406|NCT01408576|8841089|P1|Overall Study|Protocol Violation|1
2555407|NCT01408576|8841087|P3|Overall Study|Lack of Efficacy|48
2555408|NCT01408576|8841088|P2|Overall Study|Lack of Efficacy|30
2555409|NCT01408576|8841089|P1|Overall Study|Lack of Efficacy|17
2555410|NCT01408563|8841136|P1|Overall Study|Ineligible after consent/ registration|2
2555411|NCT01408537|8841152|P1|Overall Study|Lost to Follow-up|3
2555412|NCT01408537|8841152|P1|Overall Study|Protocol Violation|3
2555413|NCT01408537|8841152|P1|Overall Study|Withdrawal by Subject|2
2555414|NCT01408485|8841168|P1|Overall Study|Withdrawal by Subject|21
2555415|NCT01408303|8841186|P3|Overall Study|Noncompliance|1
2555416|NCT01408303|8841187|P2|Overall Study|Noncompliance|0
2555417|NCT01408303|8841188|P1|Overall Study|Noncompliance|1
2555418|NCT01408303|8841186|P3|Overall Study|Protocol Violation|0
2555419|NCT01408303|8841187|P2|Overall Study|Protocol Violation|1
2555420|NCT01408303|8841188|P1|Overall Study|Protocol Violation|0
2555421|NCT01408303|8841186|P3|Overall Study|Withdrawal by Subject|1
2555422|NCT01408303|8841187|P2|Overall Study|Withdrawal by Subject|3
2555423|NCT01408303|8841188|P1|Overall Study|Withdrawal by Subject|2
2555424|NCT01408303|8841186|P3|Overall Study|Lost to Follow-up|2
2555425|NCT01408303|8841187|P2|Overall Study|Lost to Follow-up|1
2555426|NCT01408303|8841188|P1|Overall Study|Lost to Follow-up|0
2555427|NCT01408303|8841186|P3|Overall Study|Adverse Event|2
2555428|NCT01408303|8841187|P2|Overall Study|Adverse Event|7
2555429|NCT01408303|8841188|P1|Overall Study|Adverse Event|3
2555430|NCT01408277|8841198|P2|Overall Study|Protocol Violation|0
2555431|NCT01408277|8841199|P1|Overall Study|Protocol Violation|2
2555432|NCT01408277|8841198|P2|Overall Study|Withdrawal by Subject|0
2555433|NCT01408277|8841199|P1|Overall Study|Withdrawal by Subject|2
2555434|NCT01408277|8841198|P2|Overall Study|Lost to Follow-up|0
2555435|NCT01408277|8841199|P1|Overall Study|Lost to Follow-up|1
2555436|NCT01408277|8841198|P2|Overall Study|Adverse Event|4
2555437|NCT01408277|8841199|P1|Overall Study|Adverse Event|3
2555438|NCT01408043|8841205|P1|Overall Study|unable to collect cells|1
2555439|NCT01408030|8841224|P4|Observation Phase (Off Drug)|Other|1
2555440|NCT01408030|8841225|P3|Observation Phase (Off Drug)|Other|1
2555441|NCT01408030|8841226|P2|Observation Phase (Off Drug)|Other|1
2555442|NCT01408030|8841227|P1|Observation Phase (Off Drug)|Other|1
2555443|NCT01408030|8841224|P4|Observation Phase (Off Drug)|Physician Decision|0
2555444|NCT01408030|8841225|P3|Observation Phase (Off Drug)|Physician Decision|2
2555445|NCT01408030|8841226|P2|Observation Phase (Off Drug)|Physician Decision|1
2555446|NCT01408030|8841227|P1|Observation Phase (Off Drug)|Physician Decision|0
2555447|NCT01408030|8841224|P4|Observation Phase (Off Drug)|Withdrawal by Subject|3
2555448|NCT01408030|8841225|P3|Observation Phase (Off Drug)|Withdrawal by Subject|1
2555449|NCT01408030|8841226|P2|Observation Phase (Off Drug)|Withdrawal by Subject|2
2555450|NCT01408030|8841227|P1|Observation Phase (Off Drug)|Withdrawal by Subject|3
2555451|NCT01408030|8841224|P4|Observation Phase (Off Drug)|Lost to Follow-up|0
2555452|NCT01408030|8841225|P3|Observation Phase (Off Drug)|Lost to Follow-up|2
2555453|NCT01408030|8841226|P2|Observation Phase (Off Drug)|Lost to Follow-up|2
2555454|NCT01408030|8841227|P1|Observation Phase (Off Drug)|Lost to Follow-up|0
2555455|NCT01408030|8841224|P4|Treatment Phase (on Drug)|Protocol Violation|0
2555456|NCT01408030|8841225|P3|Treatment Phase (on Drug)|Protocol Violation|0
2555457|NCT01408030|8841226|P2|Treatment Phase (on Drug)|Protocol Violation|1
2555458|NCT01408030|8841227|P1|Treatment Phase (on Drug)|Protocol Violation|0
2555459|NCT01408030|8841224|P4|Treatment Phase (on Drug)|Lack of Efficacy|3
2555460|NCT01408030|8841225|P3|Treatment Phase (on Drug)|Lack of Efficacy|0
2555461|NCT01408030|8841226|P2|Treatment Phase (on Drug)|Lack of Efficacy|6
2555462|NCT01408030|8841227|P1|Treatment Phase (on Drug)|Lack of Efficacy|2
2555463|NCT01408030|8841224|P4|Treatment Phase (on Drug)|Lost to Follow-up|0
2555464|NCT01408030|8841225|P3|Treatment Phase (on Drug)|Lost to Follow-up|1
2555465|NCT01408030|8841226|P2|Treatment Phase (on Drug)|Lost to Follow-up|0
2555466|NCT01408030|8841227|P1|Treatment Phase (on Drug)|Lost to Follow-up|1
2555467|NCT01407926|8841286|P1|Overall Study|Lost to Follow-up|55
2555468|NCT01407367|8841334|P2|Overall Study|Lost to Follow-up|2
2555469|NCT01407367|8841335|P1|Overall Study|Lost to Follow-up|0
2555470|NCT01407367|8841334|P2|Overall Study|Withdrawal by Subject|15
2555471|NCT01407367|8841335|P1|Overall Study|Withdrawal by Subject|4
2555472|NCT01407367|8841334|P2|Overall Study|Renal Replacement Therapy (RRT)|29
2555473|NCT01407367|8841335|P1|Overall Study|Renal Replacement Therapy (RRT)|12
2555474|NCT01407367|8841334|P2|Overall Study|Death|32
2555475|NCT01407367|8841335|P1|Overall Study|Death|24
2555476|NCT01407354|8841349|P2|First Intervention|Physician Decision|0
2555477|NCT01407354|8841350|P1|First Intervention|Physician Decision|1
2555478|NCT01407354|8841349|P2|First Intervention|Adverse Event|0
2555479|NCT01407354|8841350|P1|First Intervention|Adverse Event|1
2555480|NCT01407354|8841349|P2|First Intervention|Withdrawal by Subject|2
2555481|NCT01407354|8841350|P1|First Intervention|Withdrawal by Subject|0
2555482|NCT01407276|8841366|P8|Overall Study|Withdrawal by Subject|1
2555483|NCT01407276|8841367|P7|Overall Study|Withdrawal by Subject|0
2555484|NCT01407276|8841368|P6|Overall Study|Withdrawal by Subject|0
2555485|NCT01407276|8841369|P5|Overall Study|Withdrawal by Subject|0
2555486|NCT01407276|8841370|P4|Overall Study|Withdrawal by Subject|0
2555487|NCT01407276|8841371|P3|Overall Study|Withdrawal by Subject|0
2555488|NCT01407276|8841372|P2|Overall Study|Withdrawal by Subject|0
2555489|NCT01407276|8841373|P1|Overall Study|Withdrawal by Subject|0
2555490|NCT01406938|8841525|P6|Follow up|Lost to Follow-up|1
2555491|NCT01406938|8841526|P5|Follow up|Lost to Follow-up|2
2555492|NCT01406938|8841527|P4|Follow up|Lost to Follow-up|1
2555493|NCT01406938|8841528|P3|Follow up|Lost to Follow-up|0
2555494|NCT01406938|8841529|P2|Follow up|Lost to Follow-up|1
2555495|NCT01406938|8841530|P1|Follow up|Lost to Follow-up|1
2555496|NCT01406938|8841525|P6|Follow up|Physician Decision|1
2555497|NCT01406938|8841526|P5|Follow up|Physician Decision|3
2555498|NCT01406938|8841527|P4|Follow up|Physician Decision|0
2555499|NCT01406938|8841528|P3|Follow up|Physician Decision|2
2555500|NCT01406938|8841529|P2|Follow up|Physician Decision|0
2555501|NCT01406938|8841530|P1|Follow up|Physician Decision|0
2555502|NCT01406938|8841525|P6|Follow up|Protocol Violation|0
2555503|NCT01406938|8841526|P5|Follow up|Protocol Violation|0
2555504|NCT01406938|8841527|P4|Follow up|Protocol Violation|0
2555505|NCT01406938|8841528|P3|Follow up|Protocol Violation|1
2555506|NCT01406938|8841529|P2|Follow up|Protocol Violation|0
2555507|NCT01406938|8841530|P1|Follow up|Protocol Violation|0
2555508|NCT01406938|8841525|P6|Follow up|Patient/guardian decision|1
2555509|NCT01406938|8841526|P5|Follow up|Patient/guardian decision|4
2555510|NCT01406938|8841527|P4|Follow up|Patient/guardian decision|2
2555511|NCT01406938|8841528|P3|Follow up|Patient/guardian decision|4
2555512|NCT01406938|8841529|P2|Follow up|Patient/guardian decision|2
2555513|NCT01406938|8841530|P1|Follow up|Patient/guardian decision|4
2555514|NCT01406938|8841525|P6|Follow up|Lack of Efficacy|0
2555515|NCT01406938|8841526|P5|Follow up|Lack of Efficacy|0
2555516|NCT01406938|8841527|P4|Follow up|Lack of Efficacy|0
2555517|NCT01406938|8841528|P3|Follow up|Lack of Efficacy|1
2555518|NCT01406938|8841529|P2|Follow up|Lack of Efficacy|2
2555519|NCT01406938|8841530|P1|Follow up|Lack of Efficacy|3
2555520|NCT01406938|8841525|P6|Maintenance Period|Lack of Efficacy|5
2555521|NCT01406938|8841526|P5|Maintenance Period|Lack of Efficacy|3
2555522|NCT01406938|8841527|P4|Maintenance Period|Lack of Efficacy|1
2555523|NCT01406938|8841528|P3|Maintenance Period|Lack of Efficacy|2
2555524|NCT01406938|8841529|P2|Maintenance Period|Lack of Efficacy|0
2555525|NCT01406938|8841530|P1|Maintenance Period|Lack of Efficacy|0
2555526|NCT01406938|8841525|P6|Maintenance Period|Lost to Follow-up|0
2555527|NCT01406938|8841526|P5|Maintenance Period|Lost to Follow-up|4
2555528|NCT01406938|8841527|P4|Maintenance Period|Lost to Follow-up|0
2555529|NCT01406938|8841528|P3|Maintenance Period|Lost to Follow-up|0
2555530|NCT01406938|8841529|P2|Maintenance Period|Lost to Follow-up|0
2555531|NCT01406938|8841530|P1|Maintenance Period|Lost to Follow-up|0
2555532|NCT01406938|8841525|P6|Maintenance Period|Pregnancy|0
2555533|NCT01406938|8841526|P5|Maintenance Period|Pregnancy|1
2555534|NCT01406938|8841527|P4|Maintenance Period|Pregnancy|0
2555535|NCT01406938|8841528|P3|Maintenance Period|Pregnancy|0
2555536|NCT01406938|8841529|P2|Maintenance Period|Pregnancy|0
2555537|NCT01406938|8841530|P1|Maintenance Period|Pregnancy|0
2555538|NCT01406938|8841525|P6|Maintenance Period|Protocol Violation|2
2555539|NCT01406938|8841526|P5|Maintenance Period|Protocol Violation|2
2555540|NCT01406938|8841527|P4|Maintenance Period|Protocol Violation|2
2555541|NCT01406938|8841528|P3|Maintenance Period|Protocol Violation|2
2555542|NCT01406938|8841529|P2|Maintenance Period|Protocol Violation|0
2555543|NCT01406938|8841530|P1|Maintenance Period|Protocol Violation|0
2555544|NCT01406938|8841525|P6|Maintenance Period|Subject/guardian decision|7
2555545|NCT01406938|8841526|P5|Maintenance Period|Subject/guardian decision|10
2555546|NCT01406938|8841527|P4|Maintenance Period|Subject/guardian decision|7
2555547|NCT01406938|8841528|P3|Maintenance Period|Subject/guardian decision|11
2555548|NCT01406938|8841529|P2|Maintenance Period|Subject/guardian decision|0
2555549|NCT01406938|8841530|P1|Maintenance Period|Subject/guardian decision|0
2555550|NCT01406938|8841525|P6|Maintenance Period|Death|0
2555551|NCT01406938|8841526|P5|Maintenance Period|Death|1
2555552|NCT01406938|8841527|P4|Maintenance Period|Death|0
2555553|NCT01406938|8841528|P3|Maintenance Period|Death|0
2555554|NCT01406938|8841529|P2|Maintenance Period|Death|0
2555555|NCT01406938|8841530|P1|Maintenance Period|Death|0
2555556|NCT01406938|8841525|P6|Maintenance Period|Adverse Event|2
2555557|NCT01406938|8841526|P5|Maintenance Period|Adverse Event|4
2555558|NCT01406938|8841527|P4|Maintenance Period|Adverse Event|8
2555559|NCT01406938|8841528|P3|Maintenance Period|Adverse Event|2
2555560|NCT01406938|8841529|P2|Maintenance Period|Adverse Event|0
2555561|NCT01406938|8841530|P1|Maintenance Period|Adverse Event|0
2555562|NCT01406938|8841525|P6|Induction Period|Lost to Follow-up|0
2555563|NCT01406938|8841526|P5|Induction Period|Lost to Follow-up|0
2555564|NCT01406938|8841527|P4|Induction Period|Lost to Follow-up|0
2555565|NCT01406938|8841528|P3|Induction Period|Lost to Follow-up|0
2555566|NCT01406938|8841529|P2|Induction Period|Lost to Follow-up|3
2555567|NCT01406938|8841530|P1|Induction Period|Lost to Follow-up|2
2555568|NCT01406938|8841525|P6|Induction Period|Lack of Efficacy|0
2555569|NCT01406938|8841526|P5|Induction Period|Lack of Efficacy|0
2555570|NCT01406938|8841527|P4|Induction Period|Lack of Efficacy|0
2555571|NCT01406938|8841528|P3|Induction Period|Lack of Efficacy|0
2555572|NCT01406938|8841529|P2|Induction Period|Lack of Efficacy|0
2555573|NCT01406938|8841530|P1|Induction Period|Lack of Efficacy|1
2555574|NCT01406938|8841525|P6|Induction Period|Adverse Event|0
2555575|NCT01406938|8841526|P5|Induction Period|Adverse Event|0
2555576|NCT01406938|8841527|P4|Induction Period|Adverse Event|0
2555577|NCT01406938|8841528|P3|Induction Period|Adverse Event|0
2555578|NCT01406938|8841529|P2|Induction Period|Adverse Event|9
2555579|NCT01406938|8841530|P1|Induction Period|Adverse Event|8
2555580|NCT01406938|8841525|P6|Induction Period|Protocol deviation|0
2555581|NCT01406938|8841526|P5|Induction Period|Protocol deviation|0
2555582|NCT01406938|8841527|P4|Induction Period|Protocol deviation|0
2555583|NCT01406938|8841528|P3|Induction Period|Protocol deviation|0
2555584|NCT01406938|8841529|P2|Induction Period|Protocol deviation|0
2555585|NCT01406938|8841530|P1|Induction Period|Protocol deviation|1
2555586|NCT01406938|8841525|P6|Induction Period|Subject/guardian decision|0
2555587|NCT01406938|8841526|P5|Induction Period|Subject/guardian decision|0
2555588|NCT01406938|8841527|P4|Induction Period|Subject/guardian decision|0
2555589|NCT01406938|8841528|P3|Induction Period|Subject/guardian decision|0
2555590|NCT01406938|8841529|P2|Induction Period|Subject/guardian decision|8
2555591|NCT01406938|8841530|P1|Induction Period|Subject/guardian decision|6
2555592|NCT01406873|8841648|P2|Overall Study|Withdrawal by Subject|1
2555593|NCT01406873|8841649|P1|Overall Study|Withdrawal by Subject|1
2555594|NCT01406795|8841680|P1|Overall Study|Withdrawal by Subject|1
2555595|NCT01406717|8841696|P2|Overall Study|Non-completion of visit activity|1
2555596|NCT01406717|8841697|P1|Overall Study|Non-completion of visit activity|0
2555597|NCT01406717|8841696|P2|Overall Study|Lack of Efficacy|1
2555598|NCT01406717|8841697|P1|Overall Study|Lack of Efficacy|0
2555599|NCT01406717|8841696|P2|Overall Study|Adverse Event|2
2555600|NCT01406717|8841697|P1|Overall Study|Adverse Event|1
2555601|NCT01406717|8841696|P2|Overall Study|Withdrawal by Subject|15
2555602|NCT01406717|8841697|P1|Overall Study|Withdrawal by Subject|19
2555603|NCT01406717|8841696|P2|Overall Study|Lost to Follow-up|8
2555604|NCT01406717|8841697|P1|Overall Study|Lost to Follow-up|14
2555605|NCT01406717|8841696|P2|Overall Study|Protocol Violation|1
2555606|NCT01406717|8841697|P1|Overall Study|Protocol Violation|5
2555607|NCT01406717|8841696|P2|Overall Study|Subject non-compliance|3
2555608|NCT01406717|8841697|P1|Overall Study|Subject non-compliance|4
2555609|NCT01406652|8841727|P2|Overall Study|Infection not sure|10
2555610|NCT01406652|8841728|P1|Overall Study|Infection not sure|10
2555611|NCT01406652|8841727|P2|Overall Study|Insufficient follow-up|4
2555612|NCT01406652|8841728|P1|Overall Study|Insufficient follow-up|5
2555613|NCT01406652|8841727|P2|Overall Study|Withdrawal by Subject|2
2555614|NCT01406652|8841728|P1|Overall Study|Withdrawal by Subject|2
2555615|NCT01406652|8841727|P2|Overall Study|Lost-to-follow-up|4
2555616|NCT01406652|8841728|P1|Overall Study|Lost-to-follow-up|3
2555617|NCT01406574|8841736|P4|Overall Study|Definite progression of primary disease|0
2555618|NCT01406574|8841737|P3|Overall Study|Definite progression of primary disease|0
2555619|NCT01406574|8841738|P2|Overall Study|Definite progression of primary disease|0
2555620|NCT01406574|8841739|P1|Overall Study|Definite progression of primary disease|1
2555621|NCT01406574|8841736|P4|Overall Study|Withdrawal by Subject|0
2555622|NCT01406574|8841737|P3|Overall Study|Withdrawal by Subject|0
2555623|NCT01406574|8841738|P2|Overall Study|Withdrawal by Subject|1
2555624|NCT01406574|8841739|P1|Overall Study|Withdrawal by Subject|0
2555625|NCT01406574|8841736|P4|Overall Study|Physician Decision|1
2555626|NCT01406574|8841737|P3|Overall Study|Physician Decision|0
2555627|NCT01406574|8841738|P2|Overall Study|Physician Decision|0
2555628|NCT01406574|8841739|P1|Overall Study|Physician Decision|0
2555629|NCT01406574|8841736|P4|Overall Study|Adverse Event|3
2555630|NCT01406574|8841737|P3|Overall Study|Adverse Event|1
2555631|NCT01406574|8841738|P2|Overall Study|Adverse Event|0
2555632|NCT01406574|8841739|P1|Overall Study|Adverse Event|0
2555633|NCT01406015|8841774|P2|Overall Study|Withdrawal by Subject|3
2555634|NCT01406015|8841775|P1|Overall Study|Withdrawal by Subject|3
2555635|NCT01405950|8841791|P4|Overall Study|Withdrawal by Subject|0
2555636|NCT01405950|8841792|P3|Overall Study|Withdrawal by Subject|0
2555637|NCT01405950|8841793|P2|Overall Study|Withdrawal by Subject|0
2555638|NCT01405950|8841794|P1|Overall Study|Withdrawal by Subject|1
2555639|NCT01405924|8841829|P1|Overall Study|Missing/Incomplete Data|2
2555640|NCT01405924|8841829|P1|Overall Study|Protocol Violation|8
2555641|NCT01405911|8841842|P3|Overall Study|Withdrawal by Subject|1
2555642|NCT01405911|8841843|P2|Overall Study|Withdrawal by Subject|1
2555643|NCT01405911|8841844|P1|Overall Study|Withdrawal by Subject|3
2555644|NCT01405911|8841842|P3|Overall Study|Protocol Violation|0
2555645|NCT01405911|8841843|P2|Overall Study|Protocol Violation|0
2555646|NCT01405911|8841844|P1|Overall Study|Protocol Violation|1
2555647|NCT01405911|8841842|P3|Overall Study|Lost to Follow-up|0
2555648|NCT01405911|8841843|P2|Overall Study|Lost to Follow-up|1
2555649|NCT01405911|8841844|P1|Overall Study|Lost to Follow-up|0
2555650|NCT01405911|8841842|P3|Overall Study|Pre-treatment lab AE|0
2555651|NCT01405911|8841843|P2|Overall Study|Pre-treatment lab AE|1
2555652|NCT01405911|8841844|P1|Overall Study|Pre-treatment lab AE|0
2555653|NCT01405898|8841863|P2|Overall Study|Withdrawal by Subject|2
2555654|NCT01405898|8841864|P1|Overall Study|Withdrawal by Subject|2
2555655|NCT01405820|8841888|P6|Open-Label Treatment Period|Adverse Event|0
2555656|NCT01405820|8841889|P5|Open-Label Treatment Period|Adverse Event|0
2555657|NCT01405820|8841890|P4|Open-Label Treatment Period|Adverse Event|1
2555658|NCT01405820|8841891|P3|Open-Label Treatment Period|Adverse Event|0
2555659|NCT01405820|8841892|P2|Open-Label Treatment Period|Adverse Event|0
2555660|NCT01405820|8841893|P1|Open-Label Treatment Period|Adverse Event|0
2555661|NCT01405820|8841888|P6|Open-Label Treatment Period|Physician Decision|0
2555662|NCT01405820|8841889|P5|Open-Label Treatment Period|Physician Decision|1
2555663|NCT01405820|8841890|P4|Open-Label Treatment Period|Physician Decision|2
2555664|NCT01405820|8841891|P3|Open-Label Treatment Period|Physician Decision|1
2555665|NCT01405820|8841892|P2|Open-Label Treatment Period|Physician Decision|0
2555666|NCT01405820|8841893|P1|Open-Label Treatment Period|Physician Decision|0
2555667|NCT01405820|8841888|P6|Open-Label Treatment Period|Other|1
2555668|NCT01405820|8841889|P5|Open-Label Treatment Period|Other|1
2555669|NCT01405820|8841890|P4|Open-Label Treatment Period|Other|1
2555670|NCT01405820|8841891|P3|Open-Label Treatment Period|Other|1
2555671|NCT01405820|8841892|P2|Open-Label Treatment Period|Other|1
2555672|NCT01405820|8841893|P1|Open-Label Treatment Period|Other|1
2555673|NCT01405820|8841888|P6|Open-Label Treatment Period|Withdrawal by Subject|1
2555674|NCT01405820|8841889|P5|Open-Label Treatment Period|Withdrawal by Subject|0
2555675|NCT01405820|8841890|P4|Open-Label Treatment Period|Withdrawal by Subject|1
2555676|NCT01405820|8841891|P3|Open-Label Treatment Period|Withdrawal by Subject|1
2555677|NCT01405820|8841892|P2|Open-Label Treatment Period|Withdrawal by Subject|1
2555678|NCT01405820|8841893|P1|Open-Label Treatment Period|Withdrawal by Subject|3
2555679|NCT01405820|8841888|P6|Randomized Treatment Period|Withdrew Prior to Dosing|0
2555680|NCT01405820|8841889|P5|Randomized Treatment Period|Withdrew Prior to Dosing|0
2555681|NCT01405820|8841890|P4|Randomized Treatment Period|Withdrew Prior to Dosing|1
2555682|NCT01405820|8841891|P3|Randomized Treatment Period|Withdrew Prior to Dosing|0
2555683|NCT01405820|8841892|P2|Randomized Treatment Period|Withdrew Prior to Dosing|0
2555684|NCT01405820|8841893|P1|Randomized Treatment Period|Withdrew Prior to Dosing|0
2555685|NCT01405820|8841888|P6|Randomized Treatment Period|Death|0
2555686|NCT01405820|8841889|P5|Randomized Treatment Period|Death|0
2555687|NCT01405820|8841890|P4|Randomized Treatment Period|Death|1
2555688|NCT01405820|8841891|P3|Randomized Treatment Period|Death|0
2555689|NCT01405820|8841892|P2|Randomized Treatment Period|Death|0
2555690|NCT01405820|8841893|P1|Randomized Treatment Period|Death|0
2555691|NCT01405820|8841888|P6|Randomized Treatment Period|Treatment Arm Closed|28
2555692|NCT01405820|8841889|P5|Randomized Treatment Period|Treatment Arm Closed|33
2555693|NCT01405820|8841890|P4|Randomized Treatment Period|Treatment Arm Closed|36
2555694|NCT01405820|8841891|P3|Randomized Treatment Period|Treatment Arm Closed|20
2555695|NCT01405820|8841892|P2|Randomized Treatment Period|Treatment Arm Closed|0
2555696|NCT01405820|8841893|P1|Randomized Treatment Period|Treatment Arm Closed|0
2555697|NCT01405820|8841888|P6|Randomized Treatment Period|Incorrect Study Treatment|0
2555698|NCT01405820|8841889|P5|Randomized Treatment Period|Incorrect Study Treatment|2
2555699|NCT01405820|8841890|P4|Randomized Treatment Period|Incorrect Study Treatment|0
2555700|NCT01405820|8841891|P3|Randomized Treatment Period|Incorrect Study Treatment|3
2555701|NCT01405820|8841892|P2|Randomized Treatment Period|Incorrect Study Treatment|0
2555702|NCT01405820|8841893|P1|Randomized Treatment Period|Incorrect Study Treatment|0
2555703|NCT01405820|8841888|P6|Randomized Treatment Period|Rescue|8
2555704|NCT01405820|8841889|P5|Randomized Treatment Period|Rescue|8
2555705|NCT01405820|8841890|P4|Randomized Treatment Period|Rescue|10
2555706|NCT01405820|8841891|P3|Randomized Treatment Period|Rescue|13
2555707|NCT01405820|8841892|P2|Randomized Treatment Period|Rescue|1
2555708|NCT01405820|8841893|P1|Randomized Treatment Period|Rescue|0
2555709|NCT01405820|8841888|P6|Randomized Treatment Period|Physician Decision|0
2555710|NCT01405820|8841889|P5|Randomized Treatment Period|Physician Decision|0
2555711|NCT01405820|8841890|P4|Randomized Treatment Period|Physician Decision|0
2555712|NCT01405820|8841891|P3|Randomized Treatment Period|Physician Decision|1
2555713|NCT01405820|8841892|P2|Randomized Treatment Period|Physician Decision|2
2555714|NCT01405820|8841893|P1|Randomized Treatment Period|Physician Decision|0
2555715|NCT01405820|8841888|P6|Randomized Treatment Period|Other|0
2555716|NCT01405820|8841889|P5|Randomized Treatment Period|Other|0
2555717|NCT01405820|8841890|P4|Randomized Treatment Period|Other|1
2555718|NCT01405820|8841891|P3|Randomized Treatment Period|Other|1
2555719|NCT01405820|8841892|P2|Randomized Treatment Period|Other|2
2555720|NCT01405820|8841893|P1|Randomized Treatment Period|Other|2
2555721|NCT01405820|8841888|P6|Randomized Treatment Period|Withdrawal by Subject|0
2555722|NCT01405820|8841889|P5|Randomized Treatment Period|Withdrawal by Subject|0
2555723|NCT01405820|8841890|P4|Randomized Treatment Period|Withdrawal by Subject|2
2555724|NCT01405820|8841891|P3|Randomized Treatment Period|Withdrawal by Subject|2
2555725|NCT01405820|8841892|P2|Randomized Treatment Period|Withdrawal by Subject|2
2555726|NCT01405820|8841893|P1|Randomized Treatment Period|Withdrawal by Subject|6
2555727|NCT01405820|8841888|P6|Randomized Treatment Period|Adverse Event|1
2555728|NCT01405820|8841889|P5|Randomized Treatment Period|Adverse Event|2
2555729|NCT01405820|8841890|P4|Randomized Treatment Period|Adverse Event|0
2555730|NCT01405820|8841891|P3|Randomized Treatment Period|Adverse Event|3
2555731|NCT01405820|8841892|P2|Randomized Treatment Period|Adverse Event|3
2555732|NCT01405820|8841893|P1|Randomized Treatment Period|Adverse Event|3
2555733|NCT01405768|8841989|P2|Overall Study|Didn't complete questionnaire correctly|0
2555734|NCT01405768|8841990|P1|Overall Study|Didn't complete questionnaire correctly|4
2555735|NCT01405742|8842002|P2|Overall Study|Lost to Follow-up|0
2555736|NCT01405742|8842003|P1|Overall Study|Lost to Follow-up|1
2555737|NCT01405560|8842013|P1|Overall Study|Physician Decision|1
2555738|NCT01405508|8842028|P4|Overall Study|AE, non-serious non-fatal|0
2555739|NCT01405508|8842029|P3|Overall Study|AE, non-serious non-fatal|0
2555740|NCT01405508|8842030|P2|Overall Study|AE, non-serious non-fatal|1
2555741|NCT01405508|8842031|P1|Overall Study|AE, non-serious non-fatal|1
2555742|NCT01405456|8842063|P2|Overall Study|Physician Decision|0
2555743|NCT01405456|8842064|P1|Overall Study|Physician Decision|1
2555744|NCT01405456|8842063|P2|Overall Study|Lost to Follow-up|1
2555745|NCT01405456|8842064|P1|Overall Study|Lost to Follow-up|2
2555746|NCT01405196|8842104|P4|Overall Study|Lost to Follow-up|1
2555747|NCT01405196|8842105|P3|Overall Study|Lost to Follow-up|3
2555748|NCT01405196|8842106|P2|Overall Study|Lost to Follow-up|2
2555749|NCT01405196|8842107|P1|Overall Study|Lost to Follow-up|2
2555750|NCT01405196|8842104|P4|Overall Study|Death|0
2555751|NCT01405196|8842105|P3|Overall Study|Death|3
2555752|NCT01405196|8842106|P2|Overall Study|Death|0
2555753|NCT01405196|8842107|P1|Overall Study|Death|1
2555754|NCT01405196|8842104|P4|Overall Study|Adverse Event|2
2555755|NCT01405196|8842105|P3|Overall Study|Adverse Event|0
2555756|NCT01405196|8842106|P2|Overall Study|Adverse Event|2
2555757|NCT01405196|8842107|P1|Overall Study|Adverse Event|2
2555758|NCT01405196|8842104|P4|Overall Study|Withdrawal by Subject|6
2555759|NCT01405196|8842105|P3|Overall Study|Withdrawal by Subject|3
2555760|NCT01405196|8842106|P2|Overall Study|Withdrawal by Subject|6
2555761|NCT01405196|8842107|P1|Overall Study|Withdrawal by Subject|4
2555762|NCT01405196|8842104|P4|Overall Study|Other|0
2555763|NCT01405196|8842105|P3|Overall Study|Other|5
2555764|NCT01405196|8842106|P2|Overall Study|Other|2
2555765|NCT01405196|8842107|P1|Overall Study|Other|2
2555766|NCT01405196|8842104|P4|Overall Study|Study Terminated by Sponsor|0
2555767|NCT01405196|8842105|P3|Overall Study|Study Terminated by Sponsor|9
2555768|NCT01405196|8842106|P2|Overall Study|Study Terminated by Sponsor|0
2555769|NCT01405196|8842107|P1|Overall Study|Study Terminated by Sponsor|0
2555770|NCT01405053|8842194|P2|Overall Study|Other|1
2555771|NCT01405053|8842195|P1|Overall Study|Other|0
2555772|NCT01405053|8842194|P2|Overall Study|Withdrawal by Subject|4
2555773|NCT01405053|8842195|P1|Overall Study|Withdrawal by Subject|3
2555774|NCT01405053|8842194|P2|Overall Study|Inadequate therapeutic effect|1
2555775|NCT01405053|8842195|P1|Overall Study|Inadequate therapeutic effect|2
2555776|NCT01405053|8842194|P2|Overall Study|Participant choice|1
2555777|NCT01405053|8842195|P1|Overall Study|Participant choice|2
2555778|NCT01405053|8842194|P2|Overall Study|Lost to Follow-up|1
2555779|NCT01405053|8842195|P1|Overall Study|Lost to Follow-up|0
2555780|NCT01405053|8842194|P2|Overall Study|Adverse Event|0
2555781|NCT01405053|8842195|P1|Overall Study|Adverse Event|3
2555782|NCT01405027|8842221|P2|Overall Study|Other or Unknown|25
2555783|NCT01405027|8842222|P1|Overall Study|Other or Unknown|12
2555784|NCT01405027|8842221|P2|Overall Study|Death|0
2555785|NCT01405027|8842222|P1|Overall Study|Death|1
2555786|NCT01405027|8842221|P2|Overall Study|Investigator judgement|2
2555787|NCT01405027|8842222|P1|Overall Study|Investigator judgement|0
2555788|NCT01405027|8842221|P2|Overall Study|Lost to Follow-up|24
2555789|NCT01405027|8842222|P1|Overall Study|Lost to Follow-up|16
2555790|NCT01405027|8842221|P2|Overall Study|Withdrawn consent|0
2555791|NCT01405027|8842222|P1|Overall Study|Withdrawn consent|3
2555792|NCT01404988|8842239|P3|Overall Study|Lost to Follow-up|1
2555793|NCT01404988|8842240|P2|Overall Study|Lost to Follow-up|2
2555794|NCT01404988|8842241|P1|Overall Study|Lost to Follow-up|1
2555795|NCT01404988|8842239|P3|Overall Study|Withdrawal by Subject|0
2555796|NCT01404988|8842240|P2|Overall Study|Withdrawal by Subject|2
2555797|NCT01404988|8842241|P1|Overall Study|Withdrawal by Subject|2
2555798|NCT01404988|8842239|P3|Overall Study|Adverse Event|0
2555799|NCT01404988|8842240|P2|Overall Study|Adverse Event|0
2555800|NCT01404988|8842241|P1|Overall Study|Adverse Event|1
2555801|NCT01404988|8842239|P3|Overall Study|Death|2
2555802|NCT01404988|8842240|P2|Overall Study|Death|0
2555803|NCT01404988|8842241|P1|Overall Study|Death|2
2555804|NCT01404325|8842362|P2|Overall Study|non-specified reason|2
2555805|NCT01404325|8842363|P1|Overall Study|non-specified reason|0
2555806|NCT01404325|8842362|P2|Overall Study|Graft loss/Retransplantation|0
2555807|NCT01404325|8842363|P1|Overall Study|Graft loss/Retransplantation|1
2555808|NCT01404325|8842362|P2|Overall Study|Death|0
2555809|NCT01404325|8842363|P1|Overall Study|Death|2
2555810|NCT01404325|8842362|P2|Overall Study|Lost to Follow-up|0
2555811|NCT01404325|8842363|P1|Overall Study|Lost to Follow-up|1
2555812|NCT01404312|8842421|P2|Overall Study|Severe debilitation, unable to continue|2
2555813|NCT01404312|8842422|P1|Overall Study|Severe debilitation, unable to continue|1
2555814|NCT01404312|8842421|P2|Overall Study|Participant not willing to adhere to req|29
2555815|NCT01404312|8842422|P1|Overall Study|Participant not willing to adhere to req|31
2555816|NCT01404312|8842421|P2|Overall Study|Site closed|21
2555817|NCT01404312|8842422|P1|Overall Study|Site closed|22
2555818|NCT01404312|8842421|P2|Overall Study|Lost to Follow-up|111
2555819|NCT01404312|8842422|P1|Overall Study|Lost to Follow-up|115
2555820|NCT01404312|8842421|P2|Overall Study|Participant Unable to get to clinic|103
2555821|NCT01404312|8842422|P1|Overall Study|Participant Unable to get to clinic|93
2555822|NCT01404312|8842421|P2|Overall Study|Withdrawal by Subject|18
2555823|NCT01404312|8842422|P1|Overall Study|Withdrawal by Subject|15
2555824|NCT01404312|8842421|P2|Overall Study|Death|27
2555825|NCT01404312|8842422|P1|Overall Study|Death|21
2555826|NCT01404234|8842451|P1|Overall Study|Withdrawal by Subject|2
2555827|NCT01404208|8842467|P2|Overall Study|Discontinued|0
2555828|NCT01404208|8842468|P1|Overall Study|Discontinued|3
2555829|NCT01403987|8842533|P3|Overall Study|Residents forgot their secret PIN|18
2555830|NCT01403987|8842534|P2|Overall Study|Residents forgot their secret PIN|17
2555831|NCT01403987|8842535|P1|Overall Study|Residents forgot their secret PIN|18
2555832|NCT01403805|8842551|P2|Overall Study|Death|1
2555833|NCT01403805|8842552|P1|Overall Study|Death|0
2555834|NCT01403805|8842551|P2|Overall Study|Lost to Follow-up|2
2555835|NCT01403805|8842552|P1|Overall Study|Lost to Follow-up|0
2555836|NCT01403805|8842551|P2|Overall Study|Withdrawal by Subject|4
2555837|NCT01403805|8842552|P1|Overall Study|Withdrawal by Subject|0
2555838|NCT01403610|8842568|P4|Overall Study|Didn't recover from surgery sufficiently|0
2555839|NCT01403610|8842569|P3|Overall Study|Didn't recover from surgery sufficiently|0
2555840|NCT01403610|8842570|P2|Overall Study|Didn't recover from surgery sufficiently|3
2555841|NCT01403610|8842571|P1|Overall Study|Didn't recover from surgery sufficiently|0
2555842|NCT01403610|8842568|P4|Overall Study|Withdrawal by Subject|0
2555843|NCT01403610|8842569|P3|Overall Study|Withdrawal by Subject|0
2555844|NCT01403610|8842570|P2|Overall Study|Withdrawal by Subject|0
2555845|NCT01403610|8842571|P1|Overall Study|Withdrawal by Subject|2
2555846|NCT01403194|8842617|P1|Overall Study|Lost to Follow-up|8
2555847|NCT01403194|8842617|P1|Overall Study|Screen Failure|2
2555848|NCT01403116|8842625|P2|Overall Study|unable to keep appointments|2
2555849|NCT01403116|8842626|P1|Overall Study|unable to keep appointments|0
2555850|NCT01403116|8842625|P2|Overall Study|Hct >54%|0
2555851|NCT01403116|8842626|P1|Overall Study|Hct >54%|2
2555852|NCT01403116|8842625|P2|Overall Study|undisclosed Hx of Prostate Ca|0
2555853|NCT01403116|8842626|P1|Overall Study|undisclosed Hx of Prostate Ca|1
2555854|NCT01403116|8842625|P2|Overall Study|Protocol Violation|1
2555855|NCT01403116|8842626|P1|Overall Study|Protocol Violation|0
2555856|NCT01403116|8842625|P2|Overall Study|Non-compliance of study drug|0
2555857|NCT01403116|8842626|P1|Overall Study|Non-compliance of study drug|3
2555858|NCT01403116|8842625|P2|Overall Study|Withdrawal by Subject|15
2555859|NCT01403116|8842626|P1|Overall Study|Withdrawal by Subject|12
2555860|NCT01403116|8842625|P2|Overall Study|Lost to Follow-up|5
2555861|NCT01403116|8842626|P1|Overall Study|Lost to Follow-up|7
2555862|NCT01403116|8842625|P2|Overall Study|Adverse Event|4
2555863|NCT01403116|8842626|P1|Overall Study|Adverse Event|7
2555864|NCT01403051|8842639|P2|Overall Study|Lost to Follow-up|5
2555865|NCT01403051|8842640|P1|Overall Study|Lost to Follow-up|5
2555866|NCT01403051|8842639|P2|Overall Study|Withdrawal by Subject|1
2555867|NCT01403051|8842640|P1|Overall Study|Withdrawal by Subject|2
2555868|NCT01403051|8842639|P2|Overall Study|Death|0
2555869|NCT01403051|8842640|P1|Overall Study|Death|1
2555870|NCT01403051|8842639|P2|Overall Study|Protocol Violation|0
2555871|NCT01403051|8842640|P1|Overall Study|Protocol Violation|2
2555872|NCT01402986|8842676|P4|Overall Study|Other|6
2555873|NCT01402986|8842677|P3|Overall Study|Other|1
2555874|NCT01402986|8842678|P2|Overall Study|Other|5
2555875|NCT01402986|8842679|P1|Overall Study|Other|2
2555876|NCT01402986|8842676|P4|Overall Study|Lost to Follow-up|1
2555877|NCT01402986|8842677|P3|Overall Study|Lost to Follow-up|0
2555878|NCT01402986|8842678|P2|Overall Study|Lost to Follow-up|0
2555879|NCT01402986|8842679|P1|Overall Study|Lost to Follow-up|0
2555880|NCT01402986|8842676|P4|Overall Study|Death|2
2555881|NCT01402986|8842677|P3|Overall Study|Death|0
2555882|NCT01402986|8842678|P2|Overall Study|Death|0
2555883|NCT01402986|8842679|P1|Overall Study|Death|0
2555884|NCT01402986|8842676|P4|Overall Study|Withdrawal by Subject|13
2555885|NCT01402986|8842677|P3|Overall Study|Withdrawal by Subject|7
2555886|NCT01402986|8842678|P2|Overall Study|Withdrawal by Subject|10
2555887|NCT01402986|8842679|P1|Overall Study|Withdrawal by Subject|7
2555888|NCT01402947|8842814|P2|First Intervention|Adverse Event|1
2555889|NCT01402947|8842815|P1|First Intervention|Adverse Event|0
2555890|NCT01402869|8842826|P3|Overall Study|Required Tooth Extraction|1
2555891|NCT01402869|8842827|P2|Overall Study|Required Tooth Extraction|0
2555892|NCT01402869|8842828|P1|Overall Study|Required Tooth Extraction|0
2555893|NCT01402817|8842842|P1|Overall Study|Study Suspended by FDA|8
2555894|NCT01402817|8842842|P1|Overall Study|Withdrawal by Subject|3
2555895|NCT01402700|8842847|P1|Overall Study|Missed Visit|1
2555896|NCT01402700|8842847|P1|Overall Study|Withdrawal by Subject|3
2555897|NCT01402700|8842847|P1|Overall Study|Death|3
2555898|NCT01402570|8842851|P1|Overall Study|Adverse Event|1
2555899|NCT01402544|8842858|P1|Overall Study|Withdrawal by Subject|6
2555900|NCT01402284|8842932|P1|Overall Study|Non compliance|2
2555901|NCT01402284|8842932|P1|Overall Study|Disease progression on study|8
2555902|NCT01402284|8842932|P1|Overall Study|Physician Decision|1
2555903|NCT01402284|8842932|P1|Overall Study|Follows up at Memorial Sloan Kettering|2
2555904|NCT01402284|8842932|P1|Overall Study|Withdrawal consent|1
2555905|NCT01402102|8843014|P2|Overall Study|Withdrawal by Subject|2
2555906|NCT01402102|8843015|P1|Overall Study|Withdrawal by Subject|0
2555907|NCT01402102|8843014|P2|Overall Study|Insufficiency of compliance|1
2555908|NCT01402102|8843015|P1|Overall Study|Insufficiency of compliance|1
2555909|NCT01402102|8843014|P2|Overall Study|Protocol Violation|0
2555910|NCT01402102|8843015|P1|Overall Study|Protocol Violation|1
2555911|NCT01402063|8843035|P2|Overall Study|Withdrawal by Subject|3
2555912|NCT01402063|8843036|P1|Overall Study|Withdrawal by Subject|3
2555913|NCT01402011|8843054|P3|Nine Month Follow-up|Withdrawal by Subject|0
2555914|NCT01402011|8843055|P2|Nine Month Follow-up|Withdrawal by Subject|1
2555915|NCT01402011|8843056|P1|Nine Month Follow-up|Withdrawal by Subject|0
2555916|NCT01402011|8843054|P3|Active Treatment Period|Withdrawal by Subject|0
2555917|NCT01402011|8843055|P2|Active Treatment Period|Withdrawal by Subject|3
2555918|NCT01402011|8843056|P1|Active Treatment Period|Withdrawal by Subject|1
2555919|NCT01402011|8843054|P3|Delayed Treatment Period|Withdrawal by Subject|0
2555920|NCT01402011|8843055|P2|Delayed Treatment Period|Withdrawal by Subject|0
2555921|NCT01402011|8843056|P1|Delayed Treatment Period|Withdrawal by Subject|1
2555922|NCT01401959|8843085|P3|Treated|Protocol Violation|0
2555923|NCT01401959|8843086|P2|Treated|Protocol Violation|1
2555924|NCT01401959|8843087|P1|Treated|Protocol Violation|0
2555925|NCT01401959|8843085|P3|Treated|Withdrawal by Subject|2
2555926|NCT01401959|8843086|P2|Treated|Withdrawal by Subject|2
2555927|NCT01401959|8843087|P1|Treated|Withdrawal by Subject|1
2555928|NCT01401959|8843085|P3|Treated|Adverse Event|2
2555929|NCT01401959|8843086|P2|Treated|Adverse Event|3
2555930|NCT01401959|8843087|P1|Treated|Adverse Event|4
2555931|NCT01401959|8843085|P3|Treated|Disease Progression|1
2555932|NCT01401959|8843086|P2|Treated|Disease Progression|2
2555933|NCT01401959|8843087|P1|Treated|Disease Progression|2
2555934|NCT01401959|8843085|P3|Enrolled|Withdrawal by Subject|0
2555935|NCT01401959|8843086|P2|Enrolled|Withdrawal by Subject|0
2555936|NCT01401959|8843087|P1|Enrolled|Withdrawal by Subject|1
2555937|NCT01401842|8843124|P2|Overall Study|other/unknown|17
2555938|NCT01401842|8843125|P1|Overall Study|other/unknown|28
2555939|NCT01401842|8843124|P2|Overall Study|on profile|5
2555940|NCT01401842|8843125|P1|Overall Study|on profile|9
2555941|NCT01401842|8843124|P2|Overall Study|invalid follow-up strength data|4
2555942|NCT01401842|8843125|P1|Overall Study|invalid follow-up strength data|1
2555943|NCT01401842|8843124|P2|Overall Study|discharged from US Army|4
2555944|NCT01401842|8843125|P1|Overall Study|discharged from US Army|3
2555945|NCT01401842|8843124|P2|Overall Study|changed companies|34
2555946|NCT01401842|8843125|P1|Overall Study|changed companies|20
2555947|NCT01401842|8843124|P2|Overall Study|academic reason|1
2555948|NCT01401842|8843125|P1|Overall Study|academic reason|4
2555949|NCT01401842|8843124|P2|Overall Study|Withdrawal by Subject|2
2555950|NCT01401842|8843125|P1|Overall Study|Withdrawal by Subject|3
2555951|NCT01401647|8843142|P3|Overall Study|Lost to Follow-up|1
2555952|NCT01401647|8843143|P2|Overall Study|Lost to Follow-up|3
2555953|NCT01401647|8843144|P1|Overall Study|Lost to Follow-up|3
2555954|NCT01401647|8843142|P3|Overall Study|Withdrawal by Subject|2
2555955|NCT01401647|8843143|P2|Overall Study|Withdrawal by Subject|5
2555956|NCT01401647|8843144|P1|Overall Study|Withdrawal by Subject|1
2555957|NCT01401530|8843214|P3|Overall Study|Physician Decision|0
2555958|NCT01401530|8843215|P2|Overall Study|Physician Decision|1
2555959|NCT01401530|8843216|P1|Overall Study|Physician Decision|0
2555960|NCT01401530|8843214|P3|Overall Study|Participant Choice|1
2555961|NCT01401530|8843215|P2|Overall Study|Participant Choice|2
2555962|NCT01401530|8843216|P1|Overall Study|Participant Choice|1
2555963|NCT01401530|8843214|P3|Overall Study|Adverse Event|1
2555964|NCT01401530|8843215|P2|Overall Study|Adverse Event|1
2555965|NCT01401530|8843216|P1|Overall Study|Adverse Event|1
2555966|NCT01401530|8843214|P3|Overall Study|Disease Progression|1
2555967|NCT01401530|8843215|P2|Overall Study|Disease Progression|2
2555968|NCT01401530|8843216|P1|Overall Study|Disease Progression|1
2555969|NCT01401478|8843275|P1|Overall Study|Serious adverse event|1
2555970|NCT01401478|8843275|P1|Overall Study|Low intact parathyroid hormone|1
2555971|NCT01401478|8843275|P1|Overall Study|Hyperphosphatemia and adverse event|1
2555972|NCT01401478|8843275|P1|Overall Study|Blood samples not available|1
2555973|NCT01401478|8843275|P1|Overall Study|Withdrawal by Subject|3
2555974|NCT01401478|8843275|P1|Overall Study|Kidney transplantation|3
2555975|NCT01401478|8843275|P1|Overall Study|Lost to Follow-up|5
2555976|NCT01401478|8843275|P1|Overall Study|Hyperphosphatemia|5
2555977|NCT01401478|8843275|P1|Overall Study|Adverse Event|5
2555978|NCT01401478|8843275|P1|Overall Study|Study drug not available|6
2555979|NCT01401465|8843288|P2|Treatment Period 2|Withdrawal by Subject|1
2555980|NCT01401465|8843289|P1|Treatment Period 2|Withdrawal by Subject|0
2555981|NCT01401465|8843288|P2|Treatment Period 2|Lost to Follow-up|1
2555982|NCT01401465|8843289|P1|Treatment Period 2|Lost to Follow-up|0
2555983|NCT01401465|8843288|P2|Treatment Period 1|Scheduling Difficulties|1
2555984|NCT01401465|8843289|P1|Treatment Period 1|Scheduling Difficulties|1
2555985|NCT01401465|8843288|P2|Treatment Period 1|Inability to Meet Continuation Criteria|9
2555986|NCT01401465|8843289|P1|Treatment Period 1|Inability to Meet Continuation Criteria|3
2555987|NCT01401465|8843288|P2|Treatment Period 1|Non-Compliance to Study Drug|0
2555988|NCT01401465|8843289|P1|Treatment Period 1|Non-Compliance to Study Drug|1
2555989|NCT01401465|8843288|P2|Treatment Period 1|Withdrawal by Subject|4
2555990|NCT01401465|8843289|P1|Treatment Period 1|Withdrawal by Subject|1
2555991|NCT01401465|8843288|P2|Treatment Period 1|Protocol Violation|0
2555992|NCT01401465|8843289|P1|Treatment Period 1|Protocol Violation|5
2555993|NCT01401465|8843288|P2|Treatment Period 1|Pregnancy|1
2555994|NCT01401465|8843289|P1|Treatment Period 1|Pregnancy|0
2555995|NCT01401465|8843288|P2|Treatment Period 1|Adverse Event|1
2555996|NCT01401465|8843289|P1|Treatment Period 1|Adverse Event|4
2555997|NCT01401452|8843352|P1|Overall Study|Participant withdrew consent|1
2555998|NCT01401452|8843352|P1|Overall Study|Subject chose to discontinue treatment|1
2555999|NCT01401452|8843352|P1|Overall Study|Subject withdrew because of Tx success|1
2556000|NCT01401452|8843352|P1|Overall Study|Unsatisfactory output|1
2556001|NCT01401452|8843352|P1|Overall Study|Treatment failure|1
2556002|NCT01401452|8843352|P1|Overall Study|Discontinuation for personal reasons|1
2556003|NCT01401452|8843352|P1|Overall Study|Participant stopped Tx|2
2556004|NCT01401452|8843352|P1|Overall Study|Psoriatic arthritis|1
2556005|NCT01401452|8843352|P1|Overall Study|Subject's wife wants to get pregnant|1
2556006|NCT01401452|8843352|P1|Overall Study|Subject moved to another city|1
2556007|NCT01401452|8843352|P1|Overall Study|Subject didn't return for routine visits|1
2556008|NCT01401452|8843352|P1|Overall Study|Subject did not come to follow up visits|2
2556009|NCT01401452|8843352|P1|Overall Study|No more visits within the 36 wk followup|4
2556010|NCT01401452|8843352|P1|Overall Study|Tx stopped by psychiatrist|1
2556011|NCT01401452|8843352|P1|Overall Study|Tx stopped due to financial reasons|1
2556012|NCT01401452|8843352|P1|Overall Study|Participant developed breast cancer|1
2556013|NCT01401452|8843352|P1|Overall Study|Lack of Efficacy|30
2556014|NCT01401452|8843352|P1|Overall Study|Lost to Follow-up|12
2556015|NCT01401452|8843352|P1|Overall Study|Adverse reaction|9
2556016|NCT01401361|8843364|P1|Overall Study|Subject/family decision post procedure|2
2556017|NCT01401361|8843364|P1|Overall Study|Lost to Follow-up|3
2556018|NCT01401361|8843364|P1|Overall Study|Physician Decision|1
2556019|NCT01401361|8843364|P1|Overall Study|Lack of Efficacy|6
2556020|NCT01401361|8843364|P1|Overall Study|Withdrawal by Subject|16
2556021|NCT01401322|8843370|P1|Overall Study|Physician Decision|1
2556022|NCT01401322|8843370|P1|Overall Study|Withdrawal by Subject|1
2556023|NCT01401283|8843376|P2|Overall Study|suspicion of malignant hyperthermia|1
2556024|NCT01401283|8843377|P1|Overall Study|suspicion of malignant hyperthermia|0
2556025|NCT01401283|8843376|P2|Overall Study|no central venous access|1
2556026|NCT01401283|8843377|P1|Overall Study|no central venous access|0
2556027|NCT01401283|8843376|P2|Overall Study|preoperative arrhythmia|0
2556028|NCT01401283|8843377|P1|Overall Study|preoperative arrhythmia|5
2556029|NCT01401283|8843376|P2|Overall Study|surgery cancelled|8
2556030|NCT01401283|8843377|P1|Overall Study|surgery cancelled|5
2556031|NCT01401153|8843443|P2|Second Test Day|illness|5
2556032|NCT01401153|8843444|P1|Second Test Day|illness|0
2556033|NCT01401153|8843443|P2|First Test Day|Learning disabilities; illness|10
2556034|NCT01401153|8843444|P1|First Test Day|Learning disabilities; illness|1
2556035|NCT01401062|8843491|P2|Overall Study|Withdrawal by Subject|1
2556036|NCT01401062|8843492|P1|Overall Study|Withdrawal by Subject|1
2556037|NCT01401062|8843491|P2|Overall Study|Physician Decision|0
2556038|NCT01401062|8843492|P1|Overall Study|Physician Decision|1
2556039|NCT01401062|8843491|P2|Overall Study|Death|7
2556040|NCT01401062|8843492|P1|Overall Study|Death|9
2556041|NCT01401010|8843519|P2|Overall Study|Could not interpret assay results|0
2556042|NCT01401010|8843520|P1|Overall Study|Could not interpret assay results|1
2556043|NCT01400971|8843543|P1|Overall Study|Other|422
2556044|NCT01400971|8843543|P1|Overall Study|Withdrawal by Subject|158
2556045|NCT01400971|8843543|P1|Overall Study|Physician Decision|57
2556046|NCT01400971|8843543|P1|Overall Study|Lost to follow up + Subject Decision|2
2556047|NCT01400971|8843543|P1|Overall Study|Lost to Follow-up|196
2556048|NCT01400971|8843543|P1|Overall Study|Death|82
2556049|NCT01400958|8843552|P2|Overall Study|Adverse Event|0
2556050|NCT01400958|8843553|P1|Overall Study|Adverse Event|1
2556051|NCT01400958|8843552|P2|Overall Study|Withdrawal by Subject|1
2556052|NCT01400958|8843553|P1|Overall Study|Withdrawal by Subject|0
2556053|NCT01400958|8843552|P2|Overall Study|Physician Decision|1
2556054|NCT01400958|8843553|P1|Overall Study|Physician Decision|0
2556055|NCT01400932|8843563|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
2556056|NCT01400932|8843564|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
2556057|NCT01400932|8843563|P2|Overall Study|Protocol Deviation|1
2556058|NCT01400932|8843564|P1|Overall Study|Protocol Deviation|0
2556059|NCT01400932|8843563|P2|Overall Study|Lost to Follow-up|0
2556060|NCT01400932|8843564|P1|Overall Study|Lost to Follow-up|1
2556061|NCT01400932|8843563|P2|Overall Study|Withdrawal by Subject|6
2556062|NCT01400932|8843564|P1|Overall Study|Withdrawal by Subject|2
2556063|NCT01400932|8843563|P2|Overall Study|Lack of Efficacy|3
2556064|NCT01400932|8843564|P1|Overall Study|Lack of Efficacy|0
2556065|NCT01400932|8843563|P2|Overall Study|Adverse Event|5
2556066|NCT01400932|8843564|P1|Overall Study|Adverse Event|10
2556067|NCT01400919|8843586|P1|Overall Study|Missed visit|2
2556068|NCT01400919|8843586|P1|Overall Study|Lost to Follow-up|2
2556069|NCT01400919|8843586|P1|Overall Study|Withdrawal by Subject|4
2556070|NCT01400893|8843629|P2|Overall Study|Lost to Follow-up|6
2556071|NCT01400893|8843630|P1|Overall Study|Lost to Follow-up|0
2556072|NCT01400893|8843629|P2|Overall Study|Death|21
2556073|NCT01400893|8843630|P1|Overall Study|Death|27
2556074|NCT01400841|8843642|P1|Extended Study Phase (2 Years)|Adverse Event|2
2556075|NCT01400841|8843642|P1|Initial Study Phase (6 Months)|Death|1
2556076|NCT01400698|8843680|P6|Overall Study|Other|0
2556077|NCT01400698|8843681|P5|Overall Study|Other|1
2556078|NCT01400698|8843682|P4|Overall Study|Other|2
2556079|NCT01400698|8843683|P3|Overall Study|Other|0
2556080|NCT01400698|8843684|P2|Overall Study|Other|2
2556081|NCT01400698|8843685|P1|Overall Study|Other|4
2556082|NCT01400698|8843680|P6|Overall Study|Adverse Event|0
2556083|NCT01400698|8843681|P5|Overall Study|Adverse Event|0
2556084|NCT01400698|8843682|P4|Overall Study|Adverse Event|0
2556085|NCT01400698|8843683|P3|Overall Study|Adverse Event|0
2556086|NCT01400698|8843684|P2|Overall Study|Adverse Event|0
2556087|NCT01400698|8843685|P1|Overall Study|Adverse Event|1
2556088|NCT01400698|8843680|P6|Overall Study|Non-compliance|0
2556089|NCT01400698|8843681|P5|Overall Study|Non-compliance|0
2556090|NCT01400698|8843682|P4|Overall Study|Non-compliance|1
2556091|NCT01400698|8843683|P3|Overall Study|Non-compliance|0
2556092|NCT01400698|8843684|P2|Overall Study|Non-compliance|1
2556093|NCT01400698|8843685|P1|Overall Study|Non-compliance|0
2556094|NCT01400698|8843680|P6|Overall Study|Protocol Violation|0
2556095|NCT01400698|8843681|P5|Overall Study|Protocol Violation|1
2556096|NCT01400698|8843682|P4|Overall Study|Protocol Violation|0
2556097|NCT01400698|8843683|P3|Overall Study|Protocol Violation|0
2556098|NCT01400698|8843684|P2|Overall Study|Protocol Violation|1
2556099|NCT01400698|8843685|P1|Overall Study|Protocol Violation|0
2556100|NCT01400698|8843680|P6|Overall Study|Withdrawal by Subject|3
2556101|NCT01400698|8843681|P5|Overall Study|Withdrawal by Subject|1
2556102|NCT01400698|8843682|P4|Overall Study|Withdrawal by Subject|4
2556103|NCT01400698|8843683|P3|Overall Study|Withdrawal by Subject|0
2556104|NCT01400698|8843684|P2|Overall Study|Withdrawal by Subject|2
2556105|NCT01400698|8843685|P1|Overall Study|Withdrawal by Subject|8
2556106|NCT01400698|8843680|P6|Overall Study|Lost to Follow-up|3
2556107|NCT01400698|8843681|P5|Overall Study|Lost to Follow-up|4
2556108|NCT01400698|8843682|P4|Overall Study|Lost to Follow-up|1
2556109|NCT01400698|8843683|P3|Overall Study|Lost to Follow-up|2
2556110|NCT01400698|8843684|P2|Overall Study|Lost to Follow-up|5
2556111|NCT01400698|8843685|P1|Overall Study|Lost to Follow-up|2
2556112|NCT01400516|8843709|P2|Primary Trial|Withdrawal by Subject|2
2556113|NCT01400516|8843710|P1|Primary Trial|Withdrawal by Subject|0
2556114|NCT01400503|8843720|P1|Overall Study|Other|1
2556115|NCT01400503|8843720|P1|Overall Study|Study Terminated by Sponsor|58
2556116|NCT01400503|8843720|P1|Overall Study|Withdrawal by Subject|1
2556117|NCT01400451|8843743|P3|Combination Treatment (or Intended)|Dose-limiting toxicity|0
2556118|NCT01400451|8843744|P2|Combination Treatment (or Intended)|Dose-limiting toxicity|1
2556119|NCT01400451|8843745|P1|Combination Treatment (or Intended)|Dose-limiting toxicity|0
2556120|NCT01400451|8843743|P3|Combination Treatment (or Intended)|Disease Progression|1
2556207|NCT01399619|8843990|P3|Overall Study|Lack of Efficacy|5
2556121|NCT01400451|8843744|P2|Combination Treatment (or Intended)|Disease Progression|1
2556122|NCT01400451|8843745|P1|Combination Treatment (or Intended)|Disease Progression|3
2556123|NCT01400451|8843743|P3|Combination Treatment (or Intended)|Adverse Event|0
2556124|NCT01400451|8843744|P2|Combination Treatment (or Intended)|Adverse Event|0
2556125|NCT01400451|8843745|P1|Combination Treatment (or Intended)|Adverse Event|1
2556126|NCT01400451|8843743|P3|Combination Treatment (or Intended)|Drug Toxicity|0
2556127|NCT01400451|8843744|P2|Combination Treatment (or Intended)|Drug Toxicity|1
2556128|NCT01400451|8843745|P1|Combination Treatment (or Intended)|Drug Toxicity|0
2556129|NCT01400451|8843743|P3|Combination Treatment (or Intended)|Withdrawal by Subject|1
2556130|NCT01400451|8843744|P2|Combination Treatment (or Intended)|Withdrawal by Subject|1
2556131|NCT01400451|8843745|P1|Combination Treatment (or Intended)|Withdrawal by Subject|2
2556132|NCT01400425|8843759|P1|Overall Study|Withdrawal by Subject|10
2556133|NCT01400412|8843772|P2|Overall Study|Never started study treatment|3
2556134|NCT01400412|8843773|P1|Overall Study|Never started study treatment|0
2556135|NCT01400412|8843772|P2|Overall Study|Unable to complete|3
2556136|NCT01400412|8843773|P1|Overall Study|Unable to complete|3
2556137|NCT01400412|8843772|P2|Overall Study|Withdrawal by Subject|4
2556138|NCT01400412|8843773|P1|Overall Study|Withdrawal by Subject|3
2556139|NCT01400412|8843772|P2|Overall Study|Lost to Follow-up|7
2556140|NCT01400412|8843773|P1|Overall Study|Lost to Follow-up|4
2556141|NCT01400243|8843819|P2|Overall Study|Protocol Violation|11
2556142|NCT01400243|8843820|P1|Overall Study|Protocol Violation|8
2556143|NCT01400139|8843842|P1|HYD Extension Period|Administrative|10
2556144|NCT01400139|8843842|P1|HYD Extension Period|Withdrawal by Subject|5
2556145|NCT01400139|8843842|P1|HYD Extension Period|Adverse Event|8
2556146|NCT01400139|8843842|P1|HYD Core Study|Did not qualify for Maintenance Period|14
2556147|NCT01400139|8843842|P1|HYD Core Study|Administrative|56
2556148|NCT01400139|8843842|P1|HYD Core Study|Confirmed or suspected diversion|20
2556149|NCT01400139|8843842|P1|HYD Core Study|Lost to Follow-up|39
2556150|NCT01400139|8843842|P1|HYD Core Study|Withdrawal by Subject|114
2556151|NCT01400139|8843842|P1|HYD Core Study|Lack of Efficacy|59
2556152|NCT01400139|8843842|P1|HYD Core Study|Adverse Event|210
2556153|NCT01400113|8843865|P2|Overall Study|Withdrawal by Subject|1
2556154|NCT01400113|8843866|P1|Overall Study|Withdrawal by Subject|1
2556155|NCT01399905|8843874|P2|Overall Study|Withdrawal by Subject|1
2556156|NCT01399905|8843875|P1|Overall Study|Withdrawal by Subject|1
2556157|NCT01399788|8843923|P2|First Intervention Period|Adverse Event|0
2556158|NCT01399788|8843924|P1|First Intervention Period|Adverse Event|1
2556159|NCT01399723|8843946|P2|Overall Study|Lost to Follow-up|1
2556160|NCT01399723|8843947|P1|Overall Study|Lost to Follow-up|0
2556161|NCT01399697|8843960|P3|Overall Study|Sponsor Decision|0
2556162|NCT01399697|8843961|P2|Overall Study|Sponsor Decision|0
2556163|NCT01399697|8843962|P1|Overall Study|Sponsor Decision|1
2556164|NCT01399697|8843960|P3|Overall Study|Clinical RA remission|0
2556165|NCT01399697|8843961|P2|Overall Study|Clinical RA remission|0
2556166|NCT01399697|8843962|P1|Overall Study|Clinical RA remission|1
2556167|NCT01399697|8843960|P3|Overall Study|Positive result for hepatitis B|0
2556168|NCT01399697|8843961|P2|Overall Study|Positive result for hepatitis B|0
2556169|NCT01399697|8843962|P1|Overall Study|Positive result for hepatitis B|1
2556170|NCT01399697|8843960|P3|Overall Study|Inclusion Error|0
2556171|NCT01399697|8843961|P2|Overall Study|Inclusion Error|0
2556172|NCT01399697|8843962|P1|Overall Study|Inclusion Error|2
2556173|NCT01399697|8843960|P3|Overall Study|Non-Compliant|0
2556174|NCT01399697|8843961|P2|Overall Study|Non-Compliant|0
2556175|NCT01399697|8843962|P1|Overall Study|Non-Compliant|1
2556176|NCT01399697|8843960|P3|Overall Study|Protocol Violation|0
2556177|NCT01399697|8843961|P2|Overall Study|Protocol Violation|0
2556178|NCT01399697|8843962|P1|Overall Study|Protocol Violation|2
2556179|NCT01399697|8843960|P3|Overall Study|Lack of Efficacy|1
2556180|NCT01399697|8843961|P2|Overall Study|Lack of Efficacy|0
2556181|NCT01399697|8843962|P1|Overall Study|Lack of Efficacy|9
2556182|NCT01399697|8843960|P3|Overall Study|Investigator Decisión|2
2556183|NCT01399697|8843961|P2|Overall Study|Investigator Decisión|0
2556184|NCT01399697|8843962|P1|Overall Study|Investigator Decisión|1
2556185|NCT01399697|8843960|P3|Overall Study|Withdrawal by Subject|0
2556186|NCT01399697|8843961|P2|Overall Study|Withdrawal by Subject|0
2556187|NCT01399697|8843962|P1|Overall Study|Withdrawal by Subject|8
2556188|NCT01399697|8843960|P3|Overall Study|Lost to Follow-up|0
2556189|NCT01399697|8843961|P2|Overall Study|Lost to Follow-up|0
2556190|NCT01399697|8843962|P1|Overall Study|Lost to Follow-up|2
2556191|NCT01399697|8843960|P3|Overall Study|Adverse Event|1
2556192|NCT01399697|8843961|P2|Overall Study|Adverse Event|3
2556193|NCT01399697|8843962|P1|Overall Study|Adverse Event|13
2556194|NCT01399619|8843989|P4|Overall Study|Not treated|2
2556195|NCT01399619|8843990|P3|Overall Study|Not treated|0
2556196|NCT01399619|8843991|P2|Overall Study|Not treated|0
2556197|NCT01399619|8843992|P1|Overall Study|Not treated|0
2556198|NCT01399619|8843989|P4|Overall Study|Protocol Violation|1
2556199|NCT01399619|8843990|P3|Overall Study|Protocol Violation|0
2556200|NCT01399619|8843991|P2|Overall Study|Protocol Violation|0
2556201|NCT01399619|8843992|P1|Overall Study|Protocol Violation|0
2556202|NCT01399619|8843989|P4|Overall Study|Withdrawal by Subject|4
2556203|NCT01399619|8843990|P3|Overall Study|Withdrawal by Subject|3
2556204|NCT01399619|8843991|P2|Overall Study|Withdrawal by Subject|0
2556205|NCT01399619|8843992|P1|Overall Study|Withdrawal by Subject|6
2556206|NCT01399619|8843989|P4|Overall Study|Lack of Efficacy|0
2556208|NCT01399619|8843991|P2|Overall Study|Lack of Efficacy|0
2556209|NCT01399619|8843992|P1|Overall Study|Lack of Efficacy|9
2556210|NCT01399619|8843989|P4|Overall Study|Adverse Event|10
2556211|NCT01399619|8843990|P3|Overall Study|Adverse Event|4
2556212|NCT01399619|8843991|P2|Overall Study|Adverse Event|0
2556213|NCT01399619|8843992|P1|Overall Study|Adverse Event|10
2556214|NCT01399593|8844055|P2|Overall Study|Transplantectomy|1
2556215|NCT01399593|8844056|P1|Overall Study|Transplantectomy|0
2556216|NCT01399593|8844055|P2|Overall Study|Death|1
2556217|NCT01399593|8844056|P1|Overall Study|Death|1
2556218|NCT01399593|8844055|P2|Overall Study|Adverse Event|0
2556219|NCT01399593|8844056|P1|Overall Study|Adverse Event|1
2556220|NCT01399593|8844055|P2|Overall Study|Physician Decision|0
2556221|NCT01399593|8844056|P1|Overall Study|Physician Decision|1
2556222|NCT01399190|8844089|P1|Overall Study|Physician Decision|2
2556223|NCT01399190|8844089|P1|Overall Study|Participant's Request|5
2556224|NCT01399190|8844089|P1|Overall Study|Adverse Event|8
2556225|NCT01399190|8844089|P1|Overall Study|Not Eligible for Final Analysis|5
2556226|NCT01399125|8844097|P2|Overall Study|Protocol Deviation|2
2556227|NCT01399125|8844098|P1|Overall Study|Protocol Deviation|5
2556228|NCT01399125|8844097|P2|Overall Study|Death|1
2556229|NCT01399125|8844098|P1|Overall Study|Death|0
2556230|NCT01399125|8844097|P2|Overall Study|Administrative Problems|11
2556231|NCT01399125|8844098|P1|Overall Study|Administrative Problems|7
2556232|NCT01399125|8844097|P2|Overall Study|Lost to Follow-up|3
2556233|NCT01399125|8844098|P1|Overall Study|Lost to Follow-up|2
2556234|NCT01399125|8844097|P2|Overall Study|Withdrawal by Subject|8
2556235|NCT01399125|8844098|P1|Overall Study|Withdrawal by Subject|5
2556236|NCT01399125|8844097|P2|Overall Study|Unsatisfactory Therapeutic Effect|4
2556237|NCT01399125|8844098|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
2556238|NCT01399125|8844097|P2|Overall Study|Abnormal Lab values|1
2556239|NCT01399125|8844098|P1|Overall Study|Abnormal Lab values|0
2556240|NCT01399125|8844097|P2|Overall Study|Adverse Event|30
2556241|NCT01399125|8844098|P1|Overall Study|Adverse Event|32
2556242|NCT01399099|8844112|P1|Overall Study|Miscellaneous|4
2556243|NCT01399099|8844112|P1|Overall Study|Infection|1
2556244|NCT01399099|8844112|P1|Overall Study|Skin Irritation|13
2556245|NCT01399099|8844112|P1|Overall Study|Protocol Violation|1
2556246|NCT01399099|8844112|P1|Overall Study|Physician Decision|1
2556247|NCT01399099|8844112|P1|Overall Study|Lost to Follow-up|11
2556248|NCT01399047|8844119|P2|Overall Study|Withdrawal by Subject|1
2556249|NCT01399047|8844120|P1|Overall Study|Withdrawal by Subject|0
2556250|NCT01398956|8844156|P1|Overall Study|Subject moved a long distance|1
2556251|NCT01398956|8844156|P1|Overall Study|Withdrawal Criteria No.3|1
2556252|NCT01398956|8844156|P1|Overall Study|AE, non-serious non-fatal|4
2556253|NCT01398956|8844156|P1|Overall Study|Withdrawal by Subject|4
2556254|NCT01398787|8844188|P1|Overall Study|Adverse Event|1
2556255|NCT01398514|8844206|P2|Overall Study|Failure to show a conditioned response|3
2556256|NCT01398514|8844207|P1|Overall Study|Failure to show a conditioned response|4
2556257|NCT01398514|8844206|P2|Overall Study|Physiologic non-responsiveness|3
2556258|NCT01398514|8844207|P1|Overall Study|Physiologic non-responsiveness|1
2556259|NCT01398514|8844206|P2|Overall Study|Non-compliance with study procedures|0
2556260|NCT01398514|8844207|P1|Overall Study|Non-compliance with study procedures|2
2556261|NCT01398514|8844206|P2|Overall Study|Adverse Event|0
2556262|NCT01398514|8844207|P1|Overall Study|Adverse Event|1
2556263|NCT01398410|8844242|P2|Overall Study|Other|29
2556264|NCT01398410|8844243|P1|Overall Study|Other|36
2556265|NCT01398410|8844242|P2|Overall Study|Inadequate Therapeutic Effect|0
2556266|NCT01398410|8844243|P1|Overall Study|Inadequate Therapeutic Effect|2
2556267|NCT01398410|8844242|P2|Overall Study|Participants Choice|11
2556268|NCT01398410|8844243|P1|Overall Study|Participants Choice|8
2556269|NCT01398410|8844242|P2|Overall Study|Adverse Event|16
2556270|NCT01398410|8844243|P1|Overall Study|Adverse Event|12
2556271|NCT01398358|8844254|P3|Overall Study|no longer eligible|1
2556272|NCT01398358|8844255|P2|Overall Study|no longer eligible|0
2556273|NCT01398358|8844256|P1|Overall Study|no longer eligible|1
2556274|NCT01398358|8844254|P3|Overall Study|Withdrawal by Subject|2
2556275|NCT01398358|8844255|P2|Overall Study|Withdrawal by Subject|2
2556276|NCT01398358|8844256|P1|Overall Study|Withdrawal by Subject|3
2556277|NCT01398358|8844254|P3|Overall Study|Lost to Follow-up|18
2556278|NCT01398358|8844255|P2|Overall Study|Lost to Follow-up|21
2556279|NCT01398358|8844256|P1|Overall Study|Lost to Follow-up|11
2556280|NCT01398176|8844278|P2|Overall Study|Physician Decision|3
2556281|NCT01398176|8844279|P1|Overall Study|Physician Decision|2
2556282|NCT01398176|8844278|P2|Overall Study|Lost to Follow-up|3
2556283|NCT01398176|8844279|P1|Overall Study|Lost to Follow-up|1
2556284|NCT01397890|8844312|P2|Overall Study|Others|1
2556285|NCT01397890|8844313|P1|Overall Study|Others|2
2556286|NCT01397890|8844312|P2|Overall Study|Severe Non-Compliance to Protocol|1
2556287|NCT01397890|8844313|P1|Overall Study|Severe Non-Compliance to Protocol|2
2556288|NCT01397890|8844312|P2|Overall Study|Adverse Event|2
2556289|NCT01397890|8844313|P1|Overall Study|Adverse Event|1
2556290|NCT01397890|8844312|P2|Overall Study|Condition under Investigation Worsened|3
2556291|NCT01397890|8844313|P1|Overall Study|Condition under Investigation Worsened|1
2556292|NCT01397890|8844312|P2|Overall Study|Lost to Follow-up|4
2556293|NCT01397890|8844313|P1|Overall Study|Lost to Follow-up|1
2556294|NCT01397890|8844312|P2|Overall Study|Death|3
2556295|NCT01397890|8844313|P1|Overall Study|Death|2
2556296|NCT01397890|8844312|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
2556297|NCT01397890|8844313|P1|Overall Study|Eligibility Criteria Not Fulfilled|7
2556298|NCT01397890|8844312|P2|Overall Study|Withdrawal by Subject|11
2556299|NCT01397890|8844313|P1|Overall Study|Withdrawal by Subject|7
2556300|NCT01397825|8844384|P5|Overall Study|Withdrawal by Subject|0
2556301|NCT01397825|8844385|P4|Overall Study|Withdrawal by Subject|1
2556302|NCT01397825|8844386|P3|Overall Study|Withdrawal by Subject|5
2556303|NCT01397825|8844387|P2|Overall Study|Withdrawal by Subject|0
2556304|NCT01397825|8844388|P1|Overall Study|Withdrawal by Subject|1
2556305|NCT01397825|8844384|P5|Overall Study|Adverse Event|0
2556306|NCT01397825|8844385|P4|Overall Study|Adverse Event|1
2556307|NCT01397825|8844386|P3|Overall Study|Adverse Event|5
2556308|NCT01397825|8844387|P2|Overall Study|Adverse Event|1
2556309|NCT01397825|8844388|P1|Overall Study|Adverse Event|0
2556310|NCT01397825|8844384|P5|Overall Study|Symptomatic Deterioration|0
2556311|NCT01397825|8844385|P4|Overall Study|Symptomatic Deterioration|0
2556312|NCT01397825|8844386|P3|Overall Study|Symptomatic Deterioration|4
2556313|NCT01397825|8844387|P2|Overall Study|Symptomatic Deterioration|0
2556314|NCT01397825|8844388|P1|Overall Study|Symptomatic Deterioration|2
2556315|NCT01397825|8844384|P5|Overall Study|Progressive Disease|0
2556316|NCT01397825|8844385|P4|Overall Study|Progressive Disease|1
2556317|NCT01397825|8844386|P3|Overall Study|Progressive Disease|11
2556318|NCT01397825|8844387|P2|Overall Study|Progressive Disease|3
2556319|NCT01397825|8844388|P1|Overall Study|Progressive Disease|10
2556320|NCT01397786|8844458|P3|Phase B|Lack of Efficacy|14
2556321|NCT01397786|8844459|P2|Phase B|Lack of Efficacy|7
2556322|NCT01397786|8844460|P1|Phase B|Lack of Efficacy|22
2556323|NCT01397786|8844458|P3|Phase B|Protocol Deviation|4
2556324|NCT01397786|8844459|P2|Phase B|Protocol Deviation|2
2556325|NCT01397786|8844460|P1|Phase B|Protocol Deviation|1
2556326|NCT01397786|8844458|P3|Phase B|Withdrawal by Subject|30
2556327|NCT01397786|8844459|P2|Phase B|Withdrawal by Subject|45
2556328|NCT01397786|8844460|P1|Phase B|Withdrawal by Subject|102
2556329|NCT01397786|8844458|P3|Phase B|Physician Decision|3
2556330|NCT01397786|8844459|P2|Phase B|Physician Decision|1
2556331|NCT01397786|8844460|P1|Phase B|Physician Decision|9
2556332|NCT01397786|8844458|P3|Phase B|Subject Met Withdrawal Criteria|38
2556333|NCT01397786|8844459|P2|Phase B|Subject Met Withdrawal Criteria|5
2556334|NCT01397786|8844460|P1|Phase B|Subject Met Withdrawal Criteria|38
2556335|NCT01397786|8844458|P3|Phase B|Adverse Event|27
2556336|NCT01397786|8844459|P2|Phase B|Adverse Event|23
2556337|NCT01397786|8844460|P1|Phase B|Adverse Event|109
2556338|NCT01397786|8844458|P3|Phase B|Lost to Follow-up|22
2556339|NCT01397786|8844459|P2|Phase B|Lost to Follow-up|12
2556340|NCT01397786|8844460|P1|Phase B|Lost to Follow-up|22
2556341|NCT01397786|8844458|P3|Phase A|Lack of Efficacy|1
2556342|NCT01397786|8844459|P2|Phase A|Lack of Efficacy|0
2556343|NCT01397786|8844460|P1|Phase A|Lack of Efficacy|0
2556344|NCT01397786|8844458|P3|Phase A|Withdrawal by Subject|5
2556345|NCT01397786|8844459|P2|Phase A|Withdrawal by Subject|0
2556346|NCT01397786|8844460|P1|Phase A|Withdrawal by Subject|0
2556347|NCT01397786|8844458|P3|Phase A|Physician Decision|1
2556348|NCT01397786|8844459|P2|Phase A|Physician Decision|0
2556349|NCT01397786|8844460|P1|Phase A|Physician Decision|0
2556350|NCT01397786|8844458|P3|Phase A|Subject Met Withdrawal Criteria|7
2556351|NCT01397786|8844459|P2|Phase A|Subject Met Withdrawal Criteria|0
2556352|NCT01397786|8844460|P1|Phase A|Subject Met Withdrawal Criteria|0
2556353|NCT01397786|8844458|P3|Phase A|Adverse Event|8
2556354|NCT01397786|8844459|P2|Phase A|Adverse Event|0
2556355|NCT01397786|8844460|P1|Phase A|Adverse Event|0
2556356|NCT01397786|8844458|P3|Phase A|Lost to Follow-up|6
2556357|NCT01397786|8844459|P2|Phase A|Lost to Follow-up|0
2556358|NCT01397786|8844460|P1|Phase A|Lost to Follow-up|0
2556359|NCT01397747|8844526|P1|Overall Study|FIT excluded|34
2556360|NCT01397747|8844526|P1|Overall Study|Colonoscopy excluded|304
2556361|NCT01397747|8844526|P1|Overall Study|Multitarget DNA test excluded|689
2556362|NCT01397552|8844576|P2|Overall Study|Withdrawal by Subject|1
2556363|NCT01397552|8844577|P1|Overall Study|Withdrawal by Subject|2
2556364|NCT01397552|8844576|P2|Overall Study|Adverse Event|0
2556365|NCT01397552|8844577|P1|Overall Study|Adverse Event|1
2556366|NCT01397461|8844586|P3|Overall Study|Not treated|1
2556367|NCT01397461|8844587|P2|Overall Study|Not treated|0
2556368|NCT01397461|8844588|P1|Overall Study|Not treated|0
2556369|NCT01397461|8844586|P3|Overall Study|Lack of Efficacy|0
2556370|NCT01397461|8844587|P2|Overall Study|Lack of Efficacy|3
2556371|NCT01397461|8844588|P1|Overall Study|Lack of Efficacy|0
2556372|NCT01397461|8844586|P3|Overall Study|Lost to Follow-up|1
2556373|NCT01397461|8844587|P2|Overall Study|Lost to Follow-up|2
2556374|NCT01397461|8844588|P1|Overall Study|Lost to Follow-up|0
2556375|NCT01397461|8844586|P3|Overall Study|Withdrawal by Subject|0
2556376|NCT01397461|8844587|P2|Overall Study|Withdrawal by Subject|1
2556377|NCT01397461|8844588|P1|Overall Study|Withdrawal by Subject|2
2556378|NCT01397448|8844599|P3|Overall Study|Other|4
2556379|NCT01397448|8844600|P2|Overall Study|Other|7
2556380|NCT01397448|8844601|P1|Overall Study|Other|8
2556381|NCT01397448|8844599|P3|Overall Study|Lack of Efficacy|5
2556382|NCT01397448|8844600|P2|Overall Study|Lack of Efficacy|0
2556383|NCT01397448|8844601|P1|Overall Study|Lack of Efficacy|2
2556384|NCT01397448|8844599|P3|Overall Study|Withdrawal by Subject|3
2556385|NCT01397448|8844600|P2|Overall Study|Withdrawal by Subject|4
2556386|NCT01397448|8844601|P1|Overall Study|Withdrawal by Subject|4
2556387|NCT01397448|8844599|P3|Overall Study|Adverse Event|6
2556388|NCT01397448|8844600|P2|Overall Study|Adverse Event|4
2556389|NCT01397448|8844601|P1|Overall Study|Adverse Event|4
2556390|NCT01397422|8844616|P4|Overall Study|Increased bradykinesia related to PD|0
2556391|NCT01397422|8844617|P3|Overall Study|Increased bradykinesia related to PD|0
2556392|NCT01397422|8844618|P2|Overall Study|Increased bradykinesia related to PD|0
2556393|NCT01397422|8844619|P1|Overall Study|Increased bradykinesia related to PD|1
2556394|NCT01397422|8844616|P4|Overall Study|Withdrawal by Subject|0
2556395|NCT01397422|8844617|P3|Overall Study|Withdrawal by Subject|0
2556396|NCT01397422|8844618|P2|Overall Study|Withdrawal by Subject|0
2556397|NCT01397422|8844619|P1|Overall Study|Withdrawal by Subject|1
2556398|NCT01397422|8844616|P4|Overall Study|Adverse Event|8
2556399|NCT01397422|8844617|P3|Overall Study|Adverse Event|3
2556400|NCT01397422|8844618|P2|Overall Study|Adverse Event|3
2556401|NCT01397422|8844619|P1|Overall Study|Adverse Event|0
2556402|NCT01397409|8844659|P10|Stage 3|Other Miscellaneous Reasons|0
2556403|NCT01397409|8844660|P9|Stage 3|Other Miscellaneous Reasons|0
2556404|NCT01397409|8844661|P8|Stage 3|Other Miscellaneous Reasons|1
2556405|NCT01397409|8844662|P7|Stage 3|Other Miscellaneous Reasons|0
2556406|NCT01397409|8844663|P6|Stage 3|Other Miscellaneous Reasons|0
2556407|NCT01397409|8844664|P5|Stage 3|Other Miscellaneous Reasons|0
2556408|NCT01397409|8844665|P4|Stage 3|Other Miscellaneous Reasons|0
2556409|NCT01397409|8844666|P3|Stage 3|Other Miscellaneous Reasons|0
2556410|NCT01397409|8844667|P2|Stage 3|Other Miscellaneous Reasons|0
2556411|NCT01397409|8844668|P1|Stage 3|Other Miscellaneous Reasons|0
2556412|NCT01397409|8844659|P10|Stage 3|Adverse Event|0
2556413|NCT01397409|8844660|P9|Stage 3|Adverse Event|0
2556414|NCT01397409|8844661|P8|Stage 3|Adverse Event|1
2556415|NCT01397409|8844662|P7|Stage 3|Adverse Event|0
2556416|NCT01397409|8844663|P6|Stage 3|Adverse Event|0
2556417|NCT01397409|8844664|P5|Stage 3|Adverse Event|0
2556418|NCT01397409|8844665|P4|Stage 3|Adverse Event|0
2556419|NCT01397409|8844666|P3|Stage 3|Adverse Event|0
2556420|NCT01397409|8844667|P2|Stage 3|Adverse Event|0
2556421|NCT01397409|8844668|P1|Stage 3|Adverse Event|0
2556422|NCT01397409|8844659|P10|Stage 2|Other Miscellaneous Reasons|0
2556423|NCT01397409|8844660|P9|Stage 2|Other Miscellaneous Reasons|0
2556424|NCT01397409|8844661|P8|Stage 2|Other Miscellaneous Reasons|0
2556425|NCT01397409|8844662|P7|Stage 2|Other Miscellaneous Reasons|0
2556426|NCT01397409|8844663|P6|Stage 2|Other Miscellaneous Reasons|1
2556427|NCT01397409|8844664|P5|Stage 2|Other Miscellaneous Reasons|1
2556428|NCT01397409|8844665|P4|Stage 2|Other Miscellaneous Reasons|0
2556429|NCT01397409|8844666|P3|Stage 2|Other Miscellaneous Reasons|0
2556430|NCT01397409|8844667|P2|Stage 2|Other Miscellaneous Reasons|0
2556431|NCT01397409|8844668|P1|Stage 2|Other Miscellaneous Reasons|0
2556432|NCT01397409|8844659|P10|Stage 2|Personal Reasons|0
2556433|NCT01397409|8844660|P9|Stage 2|Personal Reasons|0
2556434|NCT01397409|8844661|P8|Stage 2|Personal Reasons|0
2556435|NCT01397409|8844662|P7|Stage 2|Personal Reasons|0
2556436|NCT01397409|8844663|P6|Stage 2|Personal Reasons|0
2556437|NCT01397409|8844664|P5|Stage 2|Personal Reasons|1
2556438|NCT01397409|8844665|P4|Stage 2|Personal Reasons|0
2556439|NCT01397409|8844666|P3|Stage 2|Personal Reasons|0
2556440|NCT01397409|8844667|P2|Stage 2|Personal Reasons|0
2556441|NCT01397409|8844668|P1|Stage 2|Personal Reasons|0
2556442|NCT01397409|8844659|P10|Stage 2|Adverse Event|0
2556443|NCT01397409|8844660|P9|Stage 2|Adverse Event|0
2556444|NCT01397409|8844661|P8|Stage 2|Adverse Event|0
2556445|NCT01397409|8844662|P7|Stage 2|Adverse Event|0
2556446|NCT01397409|8844663|P6|Stage 2|Adverse Event|3
2556447|NCT01397409|8844664|P5|Stage 2|Adverse Event|6
2556448|NCT01397409|8844665|P4|Stage 2|Adverse Event|0
2556449|NCT01397409|8844666|P3|Stage 2|Adverse Event|0
2556450|NCT01397409|8844667|P2|Stage 2|Adverse Event|0
2556451|NCT01397409|8844668|P1|Stage 2|Adverse Event|0
2556452|NCT01397253|8844708|P2|Overall Study|Reviewed by only 1 pharmacist|149
2556453|NCT01397253|8844709|P1|Overall Study|Reviewed by only 1 pharmacist|126
2556454|NCT01397084|8844715|P1|Overall Study|Used other proton pump inhibitor|1
2556455|NCT01397084|8844715|P1|Overall Study|Lost to Follow-up|1
2556456|NCT01397084|8844715|P1|Overall Study|Withdrawal by Subject|1
2556457|NCT01397084|8844715|P1|Overall Study|Adverse Event|2
2556458|NCT01397084|8844715|P1|Overall Study|Protocol Violation|2
2556459|NCT01397084|8844715|P1|Overall Study|Severe Non-Compliance to Protocol|1
2556460|NCT01396525|8844734|P1|Overall Study|Lost to Follow-up|4
2556461|NCT01396525|8844734|P1|Overall Study|Death|14
2556462|NCT01396525|8844734|P1|Overall Study|Withdrawal by Subject|8
2556463|NCT01396512|8844834|P2|Overall Study|Withdrawal by Subject|1
2556464|NCT01396512|8844835|P1|Overall Study|Withdrawal by Subject|0
2556465|NCT01396447|8844867|P4|Overall Study|Other Miscellaneous Reasons|0
2556466|NCT01396447|8844868|P3|Overall Study|Other Miscellaneous Reasons|1
2556467|NCT01396447|8844869|P2|Overall Study|Other Miscellaneous Reasons|2
2556468|NCT01396447|8844870|P1|Overall Study|Other Miscellaneous Reasons|0
2556469|NCT01396447|8844867|P4|Overall Study|Lost to Follow-up|9
2556470|NCT01396447|8844868|P3|Overall Study|Lost to Follow-up|7
2556471|NCT01396447|8844869|P2|Overall Study|Lost to Follow-up|8
2556472|NCT01396447|8844870|P1|Overall Study|Lost to Follow-up|4
2556473|NCT01396447|8844867|P4|Overall Study|Withdrawal of Consent|15
2556474|NCT01396447|8844868|P3|Overall Study|Withdrawal of Consent|4
2556475|NCT01396447|8844869|P2|Overall Study|Withdrawal of Consent|9
2556476|NCT01396447|8844870|P1|Overall Study|Withdrawal of Consent|11
2556477|NCT01396447|8844867|P4|Overall Study|Protocol Violation|7
2556478|NCT01396447|8844868|P3|Overall Study|Protocol Violation|3
2556479|NCT01396447|8844869|P2|Overall Study|Protocol Violation|2
2556480|NCT01396447|8844870|P1|Overall Study|Protocol Violation|5
2556481|NCT01396447|8844867|P4|Overall Study|Insufficient Therapeutic Response|4
2556482|NCT01396447|8844868|P3|Overall Study|Insufficient Therapeutic Response|2
2556483|NCT01396447|8844869|P2|Overall Study|Insufficient Therapeutic Response|5
2556484|NCT01396447|8844870|P1|Overall Study|Insufficient Therapeutic Response|5
2556485|NCT01396447|8844867|P4|Overall Study|Adverse Event|17
2556486|NCT01396447|8844868|P3|Overall Study|Adverse Event|12
2556487|NCT01396447|8844869|P2|Overall Study|Adverse Event|12
2556488|NCT01396447|8844870|P1|Overall Study|Adverse Event|15
2556489|NCT01396447|8844867|P4|Overall Study|Did Not Receive Treatment|0
2556490|NCT01396447|8844868|P3|Overall Study|Did Not Receive Treatment|1
2556491|NCT01396447|8844869|P2|Overall Study|Did Not Receive Treatment|2
2556492|NCT01396447|8844870|P1|Overall Study|Did Not Receive Treatment|3
2556493|NCT01396434|8844887|P3|Overall Study|Other|0
2556494|NCT01396434|8844888|P2|Overall Study|Other|0
2556495|NCT01396434|8844889|P1|Overall Study|Other|10
2556496|NCT01396434|8844887|P3|Overall Study|Lost to Follow-up|0
2556497|NCT01396434|8844888|P2|Overall Study|Lost to Follow-up|0
2556498|NCT01396434|8844889|P1|Overall Study|Lost to Follow-up|1
2556499|NCT01396421|8844901|P4|Overall Study|Lack of Efficacy|18
2556500|NCT01396421|8844902|P3|Overall Study|Lack of Efficacy|7
2556501|NCT01396421|8844903|P2|Overall Study|Lack of Efficacy|17
2556502|NCT01396421|8844904|P1|Overall Study|Lack of Efficacy|7
2556503|NCT01396421|8844901|P4|Overall Study|Protocol Deviation|0
2556504|NCT01396421|8844902|P3|Overall Study|Protocol Deviation|1
2556505|NCT01396421|8844903|P2|Overall Study|Protocol Deviation|1
2556506|NCT01396421|8844904|P1|Overall Study|Protocol Deviation|2
2556507|NCT01396421|8844901|P4|Overall Study|Withdrawal by Subject|21
2556508|NCT01396421|8844902|P3|Overall Study|Withdrawal by Subject|13
2556509|NCT01396421|8844903|P2|Overall Study|Withdrawal by Subject|24
2556510|NCT01396421|8844904|P1|Overall Study|Withdrawal by Subject|31
2556511|NCT01396421|8844901|P4|Overall Study|Physician Decision|3
2556512|NCT01396421|8844902|P3|Overall Study|Physician Decision|0
2556513|NCT01396421|8844903|P2|Overall Study|Physician Decision|1
2556514|NCT01396421|8844904|P1|Overall Study|Physician Decision|1
2556515|NCT01396421|8844901|P4|Overall Study|Participant Met Withdrawal Criteria|0
2556516|NCT01396421|8844902|P3|Overall Study|Participant Met Withdrawal Criteria|1
2556517|NCT01396421|8844903|P2|Overall Study|Participant Met Withdrawal Criteria|0
2556518|NCT01396421|8844904|P1|Overall Study|Participant Met Withdrawal Criteria|1
2556519|NCT01396421|8844901|P4|Overall Study|Adverse Event|32
2556520|NCT01396421|8844902|P3|Overall Study|Adverse Event|12
2556521|NCT01396421|8844903|P2|Overall Study|Adverse Event|15
2556522|NCT01396421|8844904|P1|Overall Study|Adverse Event|17
2556523|NCT01396421|8844901|P4|Overall Study|Lost to Follow-up|1
2556524|NCT01396421|8844902|P3|Overall Study|Lost to Follow-up|0
2556525|NCT01396421|8844903|P2|Overall Study|Lost to Follow-up|0
2556526|NCT01396421|8844904|P1|Overall Study|Lost to Follow-up|0
2556527|NCT01396395|8844976|P2|Overall Study|Other|1
2556528|NCT01396395|8844977|P1|Overall Study|Other|0
2556529|NCT01396395|8844976|P2|Overall Study|Lost to Follow-up|11
2556530|NCT01396395|8844977|P1|Overall Study|Lost to Follow-up|17
2556531|NCT01396395|8844976|P2|Overall Study|Adverse Event|2
2556532|NCT01396395|8844977|P1|Overall Study|Adverse Event|10
2556533|NCT01396395|8844976|P2|Overall Study|Protocol Violation|1
2556534|NCT01396395|8844977|P1|Overall Study|Protocol Violation|3
2556535|NCT01396395|8844976|P2|Overall Study|Withdrawal by Subject|12
2556536|NCT01396395|8844977|P1|Overall Study|Withdrawal by Subject|10
2556537|NCT01396317|8845019|P2|Overall Study|Adverse Event|0
2556538|NCT01396317|8845020|P1|Overall Study|Adverse Event|1
2556539|NCT01396265|8845034|P1|Rifa+Afatinib|Withdrawal by Subject|1
2556540|NCT01396187|8845123|P5|Overall Study|Other|1
2556541|NCT01396187|8845124|P4|Overall Study|Other|0
2556542|NCT01396187|8845125|P3|Overall Study|Other|0
2556543|NCT01396187|8845126|P2|Overall Study|Other|1
2556544|NCT01396187|8845127|P1|Overall Study|Other|1
2556545|NCT01396187|8845123|P5|Overall Study|Withdrawal by Subject|0
2556546|NCT01396187|8845124|P4|Overall Study|Withdrawal by Subject|0
2556547|NCT01396187|8845125|P3|Overall Study|Withdrawal by Subject|1
2556548|NCT01396187|8845126|P2|Overall Study|Withdrawal by Subject|1
2556549|NCT01396187|8845127|P1|Overall Study|Withdrawal by Subject|0
2556550|NCT01396187|8845123|P5|Overall Study|Adverse Event|0
2556551|NCT01396187|8845124|P4|Overall Study|Adverse Event|0
2556552|NCT01396187|8845125|P3|Overall Study|Adverse Event|0
2556553|NCT01396187|8845126|P2|Overall Study|Adverse Event|1
2556554|NCT01396187|8845127|P1|Overall Study|Adverse Event|0
2556555|NCT01396161|8845227|P7|Overall Study|Other|1
2556556|NCT01396161|8845228|P6|Overall Study|Other|0
2556557|NCT01396161|8845229|P5|Overall Study|Other|0
2556558|NCT01396161|8845230|P4|Overall Study|Other|0
2556559|NCT01396161|8845231|P3|Overall Study|Other|0
2556560|NCT01396161|8845232|P2|Overall Study|Other|0
2556561|NCT01396161|8845233|P1|Overall Study|Other|0
2556562|NCT01396161|8845227|P7|Overall Study|Withdrawal by Subject|0
2556563|NCT01396161|8845228|P6|Overall Study|Withdrawal by Subject|0
2556564|NCT01396161|8845229|P5|Overall Study|Withdrawal by Subject|1
2556565|NCT01396161|8845230|P4|Overall Study|Withdrawal by Subject|0
2556566|NCT01396161|8845231|P3|Overall Study|Withdrawal by Subject|0
2556567|NCT01396161|8845232|P2|Overall Study|Withdrawal by Subject|0
2556568|NCT01396161|8845233|P1|Overall Study|Withdrawal by Subject|0
2556569|NCT01396148|8845286|P1|Overall Study|Patient Decision|1
2556570|NCT01396083|8845316|P2|Overall Study|Lost to Follow-up|0
2556571|NCT01396083|8845317|P1|Overall Study|Lost to Follow-up|1
2556572|NCT01396083|8845316|P2|Overall Study|Administrative problems|0
2556573|NCT01396083|8845317|P1|Overall Study|Administrative problems|1
2556574|NCT01396083|8845316|P2|Overall Study|Abnormal laboratory value(s)|0
2556575|NCT01396083|8845317|P1|Overall Study|Abnormal laboratory value(s)|1
2556576|NCT01396083|8845316|P2|Overall Study|Protocol deviation(s)|1
2556577|NCT01396083|8845317|P1|Overall Study|Protocol deviation(s)|0
2556578|NCT01396083|8845316|P2|Overall Study|Consent withdrawn|5
2556579|NCT01396083|8845317|P1|Overall Study|Consent withdrawn|4
2556580|NCT01396083|8845316|P2|Overall Study|Unsatisfactory therapeutic effect|13
2556581|NCT01396083|8845317|P1|Overall Study|Unsatisfactory therapeutic effect|2
2556582|NCT01396083|8845316|P2|Overall Study|Adverse Event|28
2556583|NCT01396083|8845317|P1|Overall Study|Adverse Event|2
2556584|NCT01396070|8845341|P1|Overall Study|Lack of Efficacy|4
2556585|NCT01396070|8845341|P1|Overall Study|Physician Decision|3
2556586|NCT01396070|8845341|P1|Overall Study|Adverse Event|8
2556587|NCT01396070|8845341|P1|Overall Study|Death|2
2556588|NCT01396070|8845341|P1|Overall Study|Withdrawal by Subject|2
2556589|NCT01396057|8845350|P2|Overall Study|Consent withdrawn|2
2556590|NCT01396057|8845351|P1|Overall Study|Consent withdrawn|3
2556591|NCT01396057|8845350|P2|Overall Study|Protocol deviation|4
2556592|NCT01396057|8845351|P1|Overall Study|Protocol deviation|4
2556593|NCT01396057|8845350|P2|Overall Study|Unsatisfactory therapeutic effect|6
2556594|NCT01396057|8845351|P1|Overall Study|Unsatisfactory therapeutic effect|2
2556595|NCT01396057|8845350|P2|Overall Study|Adverse Event|6
2556596|NCT01396057|8845351|P1|Overall Study|Adverse Event|2
2556597|NCT01396005|8845400|P2|Overall Study|Non-compliance with protocol|1
2556598|NCT01396005|8845401|P1|Overall Study|Non-compliance with protocol|0
2556599|NCT01396005|8845400|P2|Overall Study|Withdrawal by Subject|1
2556600|NCT01396005|8845401|P1|Overall Study|Withdrawal by Subject|0
2556601|NCT01395914|8845432|P2|Overall Study|Lost to Follow-up|2
2556602|NCT01395914|8845433|P1|Overall Study|Lost to Follow-up|6
2556603|NCT01395914|8845432|P2|Overall Study|Study drug-related AE|0
2556604|NCT01395914|8845433|P1|Overall Study|Study drug-related AE|1
2556605|NCT01395914|8845432|P2|Overall Study|Withdrawal by patient|14
2556606|NCT01395914|8845433|P1|Overall Study|Withdrawal by patient|27
2556607|NCT01395914|8845432|P2|Overall Study|Other|3
2556608|NCT01395914|8845433|P1|Overall Study|Other|9
2556609|NCT01395914|8845432|P2|Overall Study|Death|17
2556610|NCT01395914|8845433|P1|Overall Study|Death|23
2556611|NCT01395914|8845432|P2|Overall Study|Unrelated to study drug AE|1
2556612|NCT01395914|8845433|P1|Overall Study|Unrelated to study drug AE|6
2556613|NCT01395901|8845447|P2|Overall Study|Withdrawal of consent|0
2556614|NCT01395901|8845448|P1|Overall Study|Withdrawal of consent|1
2556615|NCT01395901|8845447|P2|Overall Study|Adverse Event|1
2556616|NCT01395901|8845448|P1|Overall Study|Adverse Event|0
2556617|NCT01395901|8845447|P2|Overall Study|Randomized but not received study drug|4
2556618|NCT01395901|8845448|P1|Overall Study|Randomized but not received study drug|5
2556619|NCT01395901|8845447|P2|Overall Study|Lost to Follow-up|0
2556620|NCT01395901|8845448|P1|Overall Study|Lost to Follow-up|4
2556621|NCT01395888|8845464|P3|Treatment Period (TP)|Withdrawal by Subject|3
2556622|NCT01395888|8845465|P2|Treatment Period (TP)|Withdrawal by Subject|2
2556623|NCT01395888|8845466|P1|Treatment Period (TP)|Withdrawal by Subject|0
2556624|NCT01395888|8845464|P3|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
2556625|NCT01395888|8845465|P2|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1
2556626|NCT01395888|8845466|P1|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
2556627|NCT01395888|8845464|P3|Treatment Period (TP)|Protocol Violation|5
2556628|NCT01395888|8845465|P2|Treatment Period (TP)|Protocol Violation|1
2556629|NCT01395888|8845466|P1|Treatment Period (TP)|Protocol Violation|0
2556630|NCT01395888|8845464|P3|Treatment Period (TP)|Lack of Efficacy|3
2556631|NCT01395888|8845465|P2|Treatment Period (TP)|Lack of Efficacy|4
2556632|NCT01395888|8845466|P1|Treatment Period (TP)|Lack of Efficacy|0
2556633|NCT01395888|8845464|P3|Treatment Period (TP)|Adverse Event|6
2556634|NCT01395888|8845465|P2|Treatment Period (TP)|Adverse Event|7
2556635|NCT01395888|8845466|P1|Treatment Period (TP)|Adverse Event|0
2556636|NCT01395888|8845464|P3|2-week Run-in Period|Withdrawal by Subject|0
2556637|NCT01395888|8845465|P2|2-week Run-in Period|Withdrawal by Subject|0
2556638|NCT01395888|8845466|P1|2-week Run-in Period|Withdrawal by Subject|4
2556639|NCT01395888|8845464|P3|2-week Run-in Period|Protocol Violation|0
2556640|NCT01395888|8845465|P2|2-week Run-in Period|Protocol Violation|0
2556641|NCT01395888|8845466|P1|2-week Run-in Period|Protocol Violation|2
2556642|NCT01395888|8845464|P3|2-week Run-in Period|Lost to Follow-up|0
2556643|NCT01395888|8845465|P2|2-week Run-in Period|Lost to Follow-up|0
2556644|NCT01395888|8845466|P1|2-week Run-in Period|Lost to Follow-up|1
2556645|NCT01395888|8845464|P3|2-week Run-in Period|Continuation Criteria Not Met|0
2556646|NCT01395888|8845465|P2|2-week Run-in Period|Continuation Criteria Not Met|0
2556647|NCT01395888|8845466|P1|2-week Run-in Period|Continuation Criteria Not Met|13
2556648|NCT01395888|8845464|P3|2-week Run-in Period|Adverse Event|0
2556649|NCT01395888|8845465|P2|2-week Run-in Period|Adverse Event|0
2556650|NCT01395888|8845466|P1|2-week Run-in Period|Adverse Event|2
2556651|NCT01395823|8845474|P2|Overall Study|Withdrawal by Subject|4
2556652|NCT01395823|8845475|P1|Overall Study|Withdrawal by Subject|5
2556653|NCT01395823|8845474|P2|Overall Study|GI symptoms|0
2556654|NCT01395823|8845475|P1|Overall Study|GI symptoms|1
2556655|NCT01395823|8845474|P2|Overall Study|Transplant|0
2556656|NCT01395823|8845475|P1|Overall Study|Transplant|1
2556657|NCT01395823|8845474|P2|Overall Study|Lost to Follow-up|0
2556658|NCT01395823|8845475|P1|Overall Study|Lost to Follow-up|1
2556659|NCT01395823|8845474|P2|Overall Study|Physician Decision|1
2556660|NCT01395823|8845475|P1|Overall Study|Physician Decision|3
2556661|NCT01395823|8845474|P2|Overall Study|Death|4
2556662|NCT01395823|8845475|P1|Overall Study|Death|4
2556663|NCT01395810|8845485|P4|Overall Study|Unclassified|0
2556664|NCT01395810|8845486|P3|Overall Study|Unclassified|0
2556665|NCT01395810|8845487|P2|Overall Study|Unclassified|0
2556666|NCT01395810|8845488|P1|Overall Study|Unclassified|2
2556667|NCT01395810|8845485|P4|Overall Study|Withdrawal criteria|0
2556668|NCT01395810|8845486|P3|Overall Study|Withdrawal criteria|0
2556669|NCT01395810|8845487|P2|Overall Study|Withdrawal criteria|2
2556670|NCT01395810|8845488|P1|Overall Study|Withdrawal criteria|0
2556671|NCT01395810|8845485|P4|Overall Study|Lack of Efficacy|0
2556672|NCT01395810|8845486|P3|Overall Study|Lack of Efficacy|0
2556673|NCT01395810|8845487|P2|Overall Study|Lack of Efficacy|1
2556674|NCT01395810|8845488|P1|Overall Study|Lack of Efficacy|0
2556675|NCT01395810|8845485|P4|Overall Study|Adverse Event|0
2556676|NCT01395810|8845486|P3|Overall Study|Adverse Event|0
2556677|NCT01395810|8845487|P2|Overall Study|Adverse Event|1
2556678|NCT01395810|8845488|P1|Overall Study|Adverse Event|0
2556679|NCT01395784|8845547|P1|Overall Study|Physician Decision|5
2556680|NCT01395784|8845547|P1|Overall Study|Withdrawal by Subject|3
2556681|NCT01395784|8845547|P1|Overall Study|Lost to Follow-up|7
2556682|NCT01395758|8845554|P3|Open-label Treatment Period|Withdrawal by Subject|0
2556683|NCT01395758|8845555|P2|Open-label Treatment Period|Withdrawal by Subject|0
2556684|NCT01395758|8845556|P1|Open-label Treatment Period|Withdrawal by Subject|4
2556685|NCT01395524|8845576|P3|Overall Study|Subject had spinal surgery|1
2556686|NCT01395524|8845577|P2|Overall Study|Subject had spinal surgery|0
2556687|NCT01395524|8845578|P1|Overall Study|Subject had spinal surgery|0
2556688|NCT01395524|8845576|P3|Overall Study|Did not receive treatment|3
2556689|NCT01395524|8845577|P2|Overall Study|Did not receive treatment|1
2556690|NCT01395524|8845578|P1|Overall Study|Did not receive treatment|1
2556691|NCT01395524|8845576|P3|Overall Study|Withdrawal by Subject|8
2556692|NCT01395524|8845577|P2|Overall Study|Withdrawal by Subject|8
2556693|NCT01395524|8845578|P1|Overall Study|Withdrawal by Subject|4
2556694|NCT01395524|8845576|P3|Overall Study|Eligibility Criteria Not Fulfilled|0
2556695|NCT01395524|8845577|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
2556696|NCT01395524|8845578|P1|Overall Study|Eligibility Criteria Not Fulfilled|2
2556697|NCT01395524|8845576|P3|Overall Study|Death|0
2556698|NCT01395524|8845577|P2|Overall Study|Death|0
2556699|NCT01395524|8845578|P1|Overall Study|Death|1
2556700|NCT01395524|8845576|P3|Overall Study|Adverse Event|3
2556701|NCT01395524|8845577|P2|Overall Study|Adverse Event|4
2556702|NCT01395524|8845578|P1|Overall Study|Adverse Event|4
2556703|NCT01395524|8845576|P3|Overall Study|Severe noncompliance with protocol|0
2556704|NCT01395524|8845577|P2|Overall Study|Severe noncompliance with protocol|0
2556705|NCT01395524|8845578|P1|Overall Study|Severe noncompliance with protocol|1
2556706|NCT01395524|8845576|P3|Overall Study|Study-Specific Withdrawal Criteria|0
2556707|NCT01395524|8845577|P2|Overall Study|Study-Specific Withdrawal Criteria|2
2556708|NCT01395524|8845578|P1|Overall Study|Study-Specific Withdrawal Criteria|1
2556709|NCT01395524|8845576|P3|Overall Study|Lost to Follow-up|1
2556710|NCT01395524|8845577|P2|Overall Study|Lost to Follow-up|1
2556711|NCT01395524|8845578|P1|Overall Study|Lost to Follow-up|3
2556712|NCT01395524|8845576|P3|Overall Study|Non-compliance with study schedule|1
2556713|NCT01395524|8845577|P2|Overall Study|Non-compliance with study schedule|0
2556714|NCT01395524|8845578|P1|Overall Study|Non-compliance with study schedule|1
2556715|NCT01395394|8845601|P3|Baseline Study Visit|Protocol Violation|0
2556716|NCT01395394|8845602|P2|Baseline Study Visit|Protocol Violation|0
2556717|NCT01395394|8845603|P1|Baseline Study Visit|Protocol Violation|1
2556718|NCT01395368|8845614|P1|Overall Study|Withdrawal by Subject|2
2556719|NCT01395368|8845614|P1|Overall Study|Physician Decision|14
2556720|NCT01395316|8845670|P1|Overall Study|poor MRI quality|1
2556721|NCT01395316|8845670|P1|Overall Study|Lost to Follow-up|2
2556722|NCT01395030|8845690|P1|Overall Study|Did not complete FCH PET/CT|7
2556723|NCT01395017|8845700|P2|Overall Study|Sponsor discontinued study|4
2556724|NCT01395017|8845701|P1|Overall Study|Sponsor discontinued study|1
2556725|NCT01395017|8845700|P2|Overall Study|Disease progression|58
2556726|NCT01395017|8845701|P1|Overall Study|Disease progression|42
2556727|NCT01395017|8845700|P2|Overall Study|Death|3
2556728|NCT01395017|8845701|P1|Overall Study|Death|4
2556729|NCT01395017|8845700|P2|Overall Study|Protocol deviation|2
2556730|NCT01395017|8845701|P1|Overall Study|Protocol deviation|1
2556731|NCT01395017|8845700|P2|Overall Study|Withdrawal by Subject|8
2556732|NCT01395017|8845701|P1|Overall Study|Withdrawal by Subject|14
2556733|NCT01395017|8845700|P2|Overall Study|Physician Decision|15
2556734|NCT01395017|8845701|P1|Overall Study|Physician Decision|11
2556735|NCT01395017|8845700|P2|Overall Study|Adverse Event|12
2556736|NCT01395017|8845701|P1|Overall Study|Adverse Event|26
2556737|NCT01395017|8845700|P2|Overall Study|Lost to Follow-up|0
2556738|NCT01395017|8845701|P1|Overall Study|Lost to Follow-up|1
2556739|NCT01394991|8845711|P2|Overall Study|Prematurely Termination of Trial|10
2556740|NCT01394991|8845712|P1|Overall Study|Prematurely Termination of Trial|9
2556741|NCT01394991|8845711|P2|Overall Study|Disease Progression|7
2556742|NCT01394991|8845712|P1|Overall Study|Disease Progression|7
2556743|NCT01394991|8845711|P2|Overall Study|Chemotherapy Termination|15
2556744|NCT01394991|8845712|P1|Overall Study|Chemotherapy Termination|10
2556745|NCT01394991|8845711|P2|Overall Study|Withdrawal by Subject|17
2556746|NCT01394991|8845712|P1|Overall Study|Withdrawal by Subject|20
2556747|NCT01394991|8845711|P2|Overall Study|Protocol Violation|1
2556748|NCT01394991|8845712|P1|Overall Study|Protocol Violation|1
2556749|NCT01394991|8845711|P2|Overall Study|Physician Decision|3
2556750|NCT01394991|8845712|P1|Overall Study|Physician Decision|1
2556751|NCT01394991|8845711|P2|Overall Study|Lost to Follow-up|8
2556752|NCT01394991|8845712|P1|Overall Study|Lost to Follow-up|6
2556753|NCT01394991|8845711|P2|Overall Study|Lack of Efficacy|7
2556754|NCT01394991|8845712|P1|Overall Study|Lack of Efficacy|5
2556755|NCT01394991|8845711|P2|Overall Study|Adverse Event|4
2556756|NCT01394991|8845712|P1|Overall Study|Adverse Event|0
2556757|NCT01394978|8845734|P2|Overall Study|Death|7
2556758|NCT01394978|8845735|P1|Overall Study|Death|6
2556759|NCT01394978|8845734|P2|Overall Study|Lost to Follow-up|20
2556760|NCT01394978|8845735|P1|Overall Study|Lost to Follow-up|13
2556761|NCT01394978|8845734|P2|Overall Study|Withdrawal by Subject|4
2556762|NCT01394978|8845735|P1|Overall Study|Withdrawal by Subject|2
2556763|NCT01394952|8845743|P2|Overall Study|Sponsor Decision|7
2556764|NCT01394952|8845744|P1|Overall Study|Sponsor Decision|5
2556765|NCT01394952|8845743|P2|Overall Study|Physician Decision|0
2556766|NCT01394952|8845744|P1|Overall Study|Physician Decision|2
2556767|NCT01394952|8845743|P2|Overall Study|Withdrawal by Subject|5
2556768|NCT01394952|8845744|P1|Overall Study|Withdrawal by Subject|10
2556769|NCT01394952|8845743|P2|Overall Study|Lost to Follow-up|5
2556770|NCT01394952|8845744|P1|Overall Study|Lost to Follow-up|0
2556771|NCT01394718|8845771|P2|Overall Study|Met protocol-specific stopping criteria|1
2556772|NCT01394718|8845772|P1|Overall Study|Met protocol-specific stopping criteria|2
2556773|NCT01394627|8845804|P2|Washout (1-3 Months)|concurrent enrollment in another study|0
2556774|NCT01394627|8845805|P1|Washout (1-3 Months)|concurrent enrollment in another study|1
2556775|NCT01394627|8845804|P2|First Intervention (1 Day)|poor intravenous access|1
2556776|NCT01394627|8845805|P1|First Intervention (1 Day)|poor intravenous access|0
2556777|NCT01394523|8845825|P3|Overall Study|Unable to place block|0
2556778|NCT01394523|8845826|P2|Overall Study|Unable to place block|0
2556779|NCT01394523|8845827|P1|Overall Study|Unable to place block|1
2556780|NCT01394276|8845841|P1|Overall Study|Symptoms of concurrent diseases|1
2556781|NCT01394276|8845841|P1|Overall Study|unavailability of drug at the Hospital|2
2556782|NCT01394276|8845841|P1|Overall Study|Pregnancy|1
2556783|NCT01394276|8845841|P1|Overall Study|Participant moved to another site|1
2556784|NCT01394276|8845841|P1|Overall Study|Lost to Follow-up|5
2556785|NCT01394276|8845841|P1|Overall Study|Insufficient compliance|9
2556786|NCT01394276|8845841|P1|Overall Study|Insufficient therapeutic effect|17
2556787|NCT01394276|8845841|P1|Overall Study|Remission of disease|2
2556788|NCT01394276|8845841|P1|Overall Study|Not related AEs|9
2556789|NCT01394276|8845841|P1|Overall Study|Related Adverse event (AEs)|15
2556790|NCT01394250|8845865|P2|Successful IV Placement & Follow-Up|Withdrawal by Subject|11
2556791|NCT01394250|8845866|P1|Successful IV Placement & Follow-Up|Withdrawal by Subject|6
2556792|NCT01394250|8845865|P2|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13
2556793|NCT01394250|8845866|P1|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14
2556794|NCT01394185|8845880|P6|Overall Study|Protocol Violation|1
2556795|NCT01394185|8845881|P5|Overall Study|Protocol Violation|0
2556796|NCT01394185|8845882|P4|Overall Study|Protocol Violation|1
2556797|NCT01394185|8845883|P3|Overall Study|Protocol Violation|0
2556798|NCT01394185|8845884|P2|Overall Study|Protocol Violation|0
2556799|NCT01394185|8845885|P1|Overall Study|Protocol Violation|1
2556800|NCT01394185|8845880|P6|Overall Study|Change in protocol|0
2556801|NCT01394185|8845881|P5|Overall Study|Change in protocol|3
2556802|NCT01394185|8845882|P4|Overall Study|Change in protocol|0
2556803|NCT01394185|8845883|P3|Overall Study|Change in protocol|0
2556804|NCT01394185|8845884|P2|Overall Study|Change in protocol|0
2556805|NCT01394185|8845885|P1|Overall Study|Change in protocol|3
2556806|NCT01394185|8845880|P6|Overall Study|Withdrawal by Subject|0
2556807|NCT01394185|8845881|P5|Overall Study|Withdrawal by Subject|1
2556808|NCT01394185|8845882|P4|Overall Study|Withdrawal by Subject|0
2556809|NCT01394185|8845883|P3|Overall Study|Withdrawal by Subject|0
2556810|NCT01394185|8845884|P2|Overall Study|Withdrawal by Subject|0
2556811|NCT01394185|8845885|P1|Overall Study|Withdrawal by Subject|2
2556812|NCT01393990|8845989|P18|Overall Study|Withdrawal by Subject|0
2556813|NCT01393990|8845990|P17|Overall Study|Withdrawal by Subject|0
2556814|NCT01393990|8845991|P16|Overall Study|Withdrawal by Subject|1
2556815|NCT01393990|8845992|P15|Overall Study|Withdrawal by Subject|1
2556816|NCT01393990|8845993|P14|Overall Study|Withdrawal by Subject|0
2556817|NCT01393990|8845994|P13|Overall Study|Withdrawal by Subject|0
2556818|NCT01393990|8845995|P12|Overall Study|Withdrawal by Subject|0
2556819|NCT01393990|8845996|P11|Overall Study|Withdrawal by Subject|0
2556820|NCT01393990|8845997|P10|Overall Study|Withdrawal by Subject|0
2556821|NCT01393990|8845998|P9|Overall Study|Withdrawal by Subject|0
2556822|NCT01393990|8845999|P8|Overall Study|Withdrawal by Subject|0
2556823|NCT01393990|8846000|P7|Overall Study|Withdrawal by Subject|0
2556824|NCT01393990|8846001|P6|Overall Study|Withdrawal by Subject|0
2556825|NCT01393990|8846002|P5|Overall Study|Withdrawal by Subject|0
2556826|NCT01393990|8846003|P4|Overall Study|Withdrawal by Subject|0
2556827|NCT01393990|8846004|P3|Overall Study|Withdrawal by Subject|0
2556828|NCT01393990|8846005|P2|Overall Study|Withdrawal by Subject|0
2556829|NCT01393990|8846006|P1|Overall Study|Withdrawal by Subject|0
2556830|NCT01393990|8845989|P18|Overall Study|Death|0
2556831|NCT01393990|8845990|P17|Overall Study|Death|0
2556832|NCT01393990|8845991|P16|Overall Study|Death|0
2556833|NCT01393990|8845992|P15|Overall Study|Death|1
2556834|NCT01393990|8845993|P14|Overall Study|Death|1
2556835|NCT01393990|8845994|P13|Overall Study|Death|0
2556836|NCT01393990|8845995|P12|Overall Study|Death|0
2556837|NCT01393990|8845996|P11|Overall Study|Death|0
2556838|NCT01393990|8845997|P10|Overall Study|Death|0
2556839|NCT01393990|8845998|P9|Overall Study|Death|0
2556840|NCT01393990|8845999|P8|Overall Study|Death|0
2556841|NCT01393990|8846000|P7|Overall Study|Death|0
2556842|NCT01393990|8846001|P6|Overall Study|Death|0
2556843|NCT01393990|8846002|P5|Overall Study|Death|1
2556844|NCT01393990|8846003|P4|Overall Study|Death|0
2556845|NCT01393990|8846004|P3|Overall Study|Death|0
2556846|NCT01393990|8846005|P2|Overall Study|Death|0
2556847|NCT01393990|8846006|P1|Overall Study|Death|0
2556848|NCT01393990|8845989|P18|Overall Study|Progressive Disease|0
2556849|NCT01393990|8845990|P17|Overall Study|Progressive Disease|0
2556850|NCT01393990|8845991|P16|Overall Study|Progressive Disease|1
2556851|NCT01393990|8845992|P15|Overall Study|Progressive Disease|6
2556852|NCT01393990|8845993|P14|Overall Study|Progressive Disease|1
2556853|NCT01393990|8845994|P13|Overall Study|Progressive Disease|0
2556854|NCT01393990|8845995|P12|Overall Study|Progressive Disease|0
2556855|NCT01393990|8845996|P11|Overall Study|Progressive Disease|0
2556856|NCT01393990|8845997|P10|Overall Study|Progressive Disease|1
2556857|NCT01393990|8845998|P9|Overall Study|Progressive Disease|3
2556858|NCT01393990|8845999|P8|Overall Study|Progressive Disease|1
2556859|NCT01393990|8846000|P7|Overall Study|Progressive Disease|1
2556860|NCT01393990|8846001|P6|Overall Study|Progressive Disease|1
2556861|NCT01393990|8846002|P5|Overall Study|Progressive Disease|1
2556862|NCT01393990|8846003|P4|Overall Study|Progressive Disease|1
2556863|NCT01393990|8846004|P3|Overall Study|Progressive Disease|0
2556864|NCT01393990|8846005|P2|Overall Study|Progressive Disease|0
2556865|NCT01393990|8846006|P1|Overall Study|Progressive Disease|1
2556866|NCT01393990|8845989|P18|Overall Study|Adverse Event|0
2556867|NCT01393990|8845990|P17|Overall Study|Adverse Event|0
2556868|NCT01393990|8845991|P16|Overall Study|Adverse Event|1
2556869|NCT01393990|8845992|P15|Overall Study|Adverse Event|1
2556870|NCT01393990|8845993|P14|Overall Study|Adverse Event|0
2556871|NCT01393990|8845994|P13|Overall Study|Adverse Event|0
2556872|NCT01393990|8845995|P12|Overall Study|Adverse Event|0
2556873|NCT01393990|8845996|P11|Overall Study|Adverse Event|0
2556874|NCT01393990|8845997|P10|Overall Study|Adverse Event|0
2556875|NCT01393990|8845998|P9|Overall Study|Adverse Event|0
2556876|NCT01393990|8845999|P8|Overall Study|Adverse Event|0
2556877|NCT01393990|8846000|P7|Overall Study|Adverse Event|0
2556878|NCT01393990|8846001|P6|Overall Study|Adverse Event|0
2556879|NCT01393990|8846002|P5|Overall Study|Adverse Event|0
2556880|NCT01393990|8846003|P4|Overall Study|Adverse Event|0
2556881|NCT01393990|8846004|P3|Overall Study|Adverse Event|0
2556882|NCT01393990|8846005|P2|Overall Study|Adverse Event|0
2556883|NCT01393990|8846006|P1|Overall Study|Adverse Event|0
2556884|NCT01393964|8846097|P3|Overall Study|Subject to receive non-protocol therapy|1
2556885|NCT01393964|8846098|P2|Overall Study|Subject to receive non-protocol therapy|0
2556886|NCT01393964|8846099|P1|Overall Study|Subject to receive non-protocol therapy|0
2556887|NCT01393964|8846097|P3|Overall Study|Subject converted to roll-over study|0
2556888|NCT01393964|8846098|P2|Overall Study|Subject converted to roll-over study|1
2556889|NCT01393964|8846099|P1|Overall Study|Subject converted to roll-over study|0
2556890|NCT01393964|8846097|P3|Overall Study|Investigator removed subject from study|0
2556891|NCT01393964|8846098|P2|Overall Study|Investigator removed subject from study|1
2556892|NCT01393964|8846099|P1|Overall Study|Investigator removed subject from study|0
2556893|NCT01393964|8846097|P3|Overall Study|Subject plateaued in terms of effect|0
2556894|NCT01393964|8846098|P2|Overall Study|Subject plateaued in terms of effect|0
2556895|NCT01393964|8846099|P1|Overall Study|Subject plateaued in terms of effect|1
2556896|NCT01393964|8846097|P3|Overall Study|Subject switched to commercial supply|2
2556897|NCT01393964|8846098|P2|Overall Study|Subject switched to commercial supply|0
2556898|NCT01393964|8846099|P1|Overall Study|Subject switched to commercial supply|1
2556899|NCT01393964|8846097|P3|Overall Study|Subject decided to move to transplant|0
2556900|NCT01393964|8846098|P2|Overall Study|Subject decided to move to transplant|0
2556901|NCT01393964|8846099|P1|Overall Study|Subject decided to move to transplant|1
2556902|NCT01393964|8846097|P3|Overall Study|Subject request stop study treatment|0
2556903|NCT01393964|8846098|P2|Overall Study|Subject request stop study treatment|1
2556904|NCT01393964|8846099|P1|Overall Study|Subject request stop study treatment|0
2556905|NCT01393964|8846097|P3|Overall Study|Adverse event unrelated to study drug|0
2556906|NCT01393964|8846098|P2|Overall Study|Adverse event unrelated to study drug|3
2556907|NCT01393964|8846099|P1|Overall Study|Adverse event unrelated to study drug|0
2556908|NCT01393964|8846097|P3|Overall Study|Withdrawal by Subject|1
2556909|NCT01393964|8846098|P2|Overall Study|Withdrawal by Subject|0
2556910|NCT01393964|8846099|P1|Overall Study|Withdrawal by Subject|0
2556911|NCT01393964|8846097|P3|Overall Study|Study drug toxicity|0
2556912|NCT01393964|8846098|P2|Overall Study|Study drug toxicity|0
2556913|NCT01393964|8846099|P1|Overall Study|Study drug toxicity|1
2556914|NCT01393964|8846097|P3|Overall Study|Disease Progression|5
2556915|NCT01393964|8846098|P2|Overall Study|Disease Progression|3
2556916|NCT01393964|8846099|P1|Overall Study|Disease Progression|4
2556917|NCT01393899|8846140|P3|Overall Study|Adverse Event|3
2556918|NCT01393899|8846141|P2|Overall Study|Adverse Event|5
2556919|NCT01393899|8846142|P1|Overall Study|Adverse Event|1
2556920|NCT01393899|8846140|P3|Overall Study|Lack of Efficacy|16
2556921|NCT01393899|8846141|P2|Overall Study|Lack of Efficacy|21
2556922|NCT01393899|8846142|P1|Overall Study|Lack of Efficacy|26
2556923|NCT01393899|8846140|P3|Overall Study|Does not meet entrance criteria|1
2556924|NCT01393899|8846141|P2|Overall Study|Does not meet entrance criteria|0
2556925|NCT01393899|8846142|P1|Overall Study|Does not meet entrance criteria|1
2556926|NCT01393899|8846140|P3|Overall Study|Lost to Follow-up|1
2556927|NCT01393899|8846141|P2|Overall Study|Lost to Follow-up|0
2556928|NCT01393899|8846142|P1|Overall Study|Lost to Follow-up|0
2556929|NCT01393899|8846140|P3|Overall Study|Withdrawal by Subject|1
2556930|NCT01393899|8846141|P2|Overall Study|Withdrawal by Subject|2
2556931|NCT01393899|8846142|P1|Overall Study|Withdrawal by Subject|2
2556932|NCT01393899|8846140|P3|Overall Study|Other|0
2556933|NCT01393899|8846141|P2|Overall Study|Other|0
2556934|NCT01393899|8846142|P1|Overall Study|Other|1
2556935|NCT01393899|8846140|P3|Overall Study|Study terminated by sponsor|1
2556936|NCT01393899|8846141|P2|Overall Study|Study terminated by sponsor|0
2556937|NCT01393899|8846142|P1|Overall Study|Study terminated by sponsor|1
2556938|NCT01393821|8846196|P2|Overall Study|not evaluable for primary endpoint|2
2556939|NCT01393821|8846197|P1|Overall Study|not evaluable for primary endpoint|4
2556940|NCT01393821|8846196|P2|Overall Study|Cancel|1
2556941|NCT01393821|8846197|P1|Overall Study|Cancel|1
2556942|NCT01393743|8846211|P3|Extension Phase|Other|14
2556943|NCT01393743|8846212|P2|Extension Phase|Other|0
2556944|NCT01393743|8846213|P1|Extension Phase|Other|0
2556945|NCT01393743|8846211|P3|Extension Phase|Pregnancy|1
2556946|NCT01393743|8846212|P2|Extension Phase|Pregnancy|0
2556947|NCT01393743|8846213|P1|Extension Phase|Pregnancy|0
2556948|NCT01393743|8846211|P3|Extension Phase|Withdrawal by Subject|8
2556949|NCT01393743|8846212|P2|Extension Phase|Withdrawal by Subject|0
2556950|NCT01393743|8846213|P1|Extension Phase|Withdrawal by Subject|0
2556951|NCT01393743|8846211|P3|Extension Phase|Inadequate therapeutic effect|7
2556952|NCT01393743|8846212|P2|Extension Phase|Inadequate therapeutic effect|0
2556953|NCT01393743|8846213|P1|Extension Phase|Inadequate therapeutic effect|0
2556954|NCT01393743|8846211|P3|Extension Phase|Participant choice|16
2556955|NCT01393743|8846212|P2|Extension Phase|Participant choice|0
2556956|NCT01393743|8846213|P1|Extension Phase|Participant choice|0
2556957|NCT01393743|8846211|P3|Extension Phase|Lost to Follow-up|2
2556958|NCT01393743|8846212|P2|Extension Phase|Lost to Follow-up|0
2556959|NCT01393743|8846213|P1|Extension Phase|Lost to Follow-up|0
2556960|NCT01393743|8846211|P3|Extension Phase|Adverse Event|12
2556961|NCT01393743|8846212|P2|Extension Phase|Adverse Event|0
2556962|NCT01393743|8846213|P1|Extension Phase|Adverse Event|0
2556963|NCT01393743|8846211|P3|Core Study|Inadequate therapeutic effect|0
2556964|NCT01393743|8846212|P2|Core Study|Inadequate therapeutic effect|0
2556965|NCT01393743|8846213|P1|Core Study|Inadequate therapeutic effect|2
2556966|NCT01393743|8846211|P3|Core Study|Participant's Choice|0
2556967|NCT01393743|8846212|P2|Core Study|Participant's Choice|3
2556968|NCT01393743|8846213|P1|Core Study|Participant's Choice|2
2556969|NCT01393743|8846211|P3|Core Study|Lost to Follow-up|0
2556970|NCT01393743|8846212|P2|Core Study|Lost to Follow-up|1
2556971|NCT01393743|8846213|P1|Core Study|Lost to Follow-up|1
2556972|NCT01393743|8846211|P3|Core Study|Adverse Event|0
2556973|NCT01393743|8846212|P2|Core Study|Adverse Event|9
2556974|NCT01393743|8846213|P1|Core Study|Adverse Event|5
2556975|NCT01393730|8846236|P1|Overall Study|Adverse Event|1
2556976|NCT01393730|8846236|P1|Overall Study|Other|2
2556977|NCT01393730|8846236|P1|Overall Study|Withdrawal by Subject|3
2556978|NCT01393626|8846282|P4|Overall Study|Protocol Violation|0
2556979|NCT01393626|8846283|P3|Overall Study|Protocol Violation|2
2556980|NCT01393626|8846284|P2|Overall Study|Protocol Violation|0
2556981|NCT01393626|8846285|P1|Overall Study|Protocol Violation|1
2556982|NCT01393626|8846282|P4|Overall Study|Other|0
2556983|NCT01393626|8846283|P3|Overall Study|Other|0
2556984|NCT01393626|8846284|P2|Overall Study|Other|0
2556985|NCT01393626|8846285|P1|Overall Study|Other|1
2556986|NCT01393626|8846282|P4|Overall Study|Withdrawal by Subject|0
2556987|NCT01393626|8846283|P3|Overall Study|Withdrawal by Subject|0
2556988|NCT01393626|8846284|P2|Overall Study|Withdrawal by Subject|4
2556989|NCT01393626|8846285|P1|Overall Study|Withdrawal by Subject|6
2556990|NCT01393626|8846282|P4|Overall Study|Lost to Follow-up|0
2556991|NCT01393626|8846283|P3|Overall Study|Lost to Follow-up|1
2556992|NCT01393626|8846284|P2|Overall Study|Lost to Follow-up|1
2556993|NCT01393626|8846285|P1|Overall Study|Lost to Follow-up|1
2556994|NCT01393626|8846282|P4|Overall Study|Lack of Efficacy|1
2556995|NCT01393626|8846283|P3|Overall Study|Lack of Efficacy|4
2556996|NCT01393626|8846284|P2|Overall Study|Lack of Efficacy|6
2556997|NCT01393626|8846285|P1|Overall Study|Lack of Efficacy|6
2556998|NCT01393626|8846282|P4|Overall Study|Did not meet entrance criteria|0
2556999|NCT01393626|8846283|P3|Overall Study|Did not meet entrance criteria|0
2557000|NCT01393626|8846284|P2|Overall Study|Did not meet entrance criteria|0
2557001|NCT01393626|8846285|P1|Overall Study|Did not meet entrance criteria|1
2557002|NCT01393626|8846282|P4|Overall Study|Adverse Event|0
2557003|NCT01393626|8846283|P3|Overall Study|Adverse Event|5
2557004|NCT01393626|8846284|P2|Overall Study|Adverse Event|1
2557005|NCT01393626|8846285|P1|Overall Study|Adverse Event|2
2557006|NCT01393613|8846365|P4|Overall Study|Lack of Efficacy|21
2557007|NCT01393613|8846366|P3|Overall Study|Lack of Efficacy|16
2557008|NCT01393613|8846367|P2|Overall Study|Lack of Efficacy|20
2557009|NCT01393613|8846368|P1|Overall Study|Lack of Efficacy|9
2557010|NCT01393613|8846365|P4|Overall Study|Protocol Deviation|0
2557011|NCT01393613|8846366|P3|Overall Study|Protocol Deviation|0
2557012|NCT01393613|8846367|P2|Overall Study|Protocol Deviation|1
2557013|NCT01393613|8846368|P1|Overall Study|Protocol Deviation|2
2557014|NCT01393613|8846365|P4|Overall Study|Withdrawal by Subject|21
2557015|NCT01393613|8846366|P3|Overall Study|Withdrawal by Subject|23
2557016|NCT01393613|8846367|P2|Overall Study|Withdrawal by Subject|25
2557017|NCT01393613|8846368|P1|Overall Study|Withdrawal by Subject|15
2557018|NCT01393613|8846365|P4|Overall Study|Physician Decision|1
2557019|NCT01393613|8846366|P3|Overall Study|Physician Decision|0
2557020|NCT01393613|8846367|P2|Overall Study|Physician Decision|0
2557021|NCT01393613|8846368|P1|Overall Study|Physician Decision|2
2557022|NCT01393613|8846365|P4|Overall Study|Participant Met Withdrawal Criteria|1
2557023|NCT01393613|8846366|P3|Overall Study|Participant Met Withdrawal Criteria|2
2557024|NCT01393613|8846367|P2|Overall Study|Participant Met Withdrawal Criteria|0
2557025|NCT01393613|8846368|P1|Overall Study|Participant Met Withdrawal Criteria|0
2557026|NCT01393613|8846365|P4|Overall Study|Adverse Event|22
2557027|NCT01393613|8846366|P3|Overall Study|Adverse Event|13
2557028|NCT01393613|8846367|P2|Overall Study|Adverse Event|11
2557029|NCT01393613|8846368|P1|Overall Study|Adverse Event|11
2557030|NCT01393600|8846430|P4|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
2557031|NCT01393600|8846431|P3|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1
2557032|NCT01393600|8846432|P2|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
2557033|NCT01393600|8846433|P1|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
2557034|NCT01393600|8846430|P4|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
2557035|NCT01393600|8846431|P3|Treatment Period 2 (Day 15 to 28)|Physician Decision|1
2557036|NCT01393600|8846432|P2|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
2557037|NCT01393600|8846433|P1|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
2557038|NCT01393600|8846430|P4|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
2557039|NCT01393600|8846431|P3|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1
2557040|NCT01393600|8846432|P2|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
2557041|NCT01393600|8846433|P1|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
2557042|NCT01393600|8846430|P4|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1
2557043|NCT01393600|8846431|P3|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
2557044|NCT01393600|8846432|P2|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
2557045|NCT01393600|8846433|P1|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
2557046|NCT01393600|8846430|P4|Treatment Period 1 (Day 1 to 14)|Adverse Event|1
2557047|NCT01393600|8846431|P3|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
2557048|NCT01393600|8846432|P2|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
2557049|NCT01393600|8846433|P1|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
2557050|NCT01393600|8846430|P4|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
2557051|NCT01393600|8846431|P3|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1
2557052|NCT01393600|8846432|P2|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
2557053|NCT01393600|8846433|P1|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
2557054|NCT01393600|8846430|P4|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
2557055|NCT01393600|8846431|P3|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
2557056|NCT01393600|8846432|P2|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1
2557057|NCT01393600|8846433|P1|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
2557058|NCT01393444|8846469|P1|Overall Study|Determined ineligible during screening.|2
2557059|NCT01393444|8846469|P1|Overall Study|Withdrawal by Subject|1
2557060|NCT01393405|8846474|P3|Maintenance Period Week|Lost to Follow-up|0
2557061|NCT01393405|8846475|P2|Maintenance Period Week|Lost to Follow-up|1
2557062|NCT01393405|8846476|P1|Maintenance Period Week|Lost to Follow-up|0
2557063|NCT01393405|8846474|P3|Maintenance Period Week|Withdrawal by Subject|0
2557064|NCT01393405|8846475|P2|Maintenance Period Week|Withdrawal by Subject|1
2557065|NCT01393405|8846476|P1|Maintenance Period Week|Withdrawal by Subject|0
2557066|NCT01393405|8846474|P3|Maintenance Period Week|Adverse Event|2
2557067|NCT01393405|8846475|P2|Maintenance Period Week|Adverse Event|5
2557068|NCT01393405|8846476|P1|Maintenance Period Week|Adverse Event|0
2557069|NCT01393405|8846474|P3|Maintenance Period Week|Lack of Efficacy|22
2557070|NCT01393405|8846475|P2|Maintenance Period Week|Lack of Efficacy|22
2557071|NCT01393405|8846476|P1|Maintenance Period Week|Lack of Efficacy|0
2557072|NCT01393405|8846474|P3|Induction Period (week1-16)|Withdrawal by Subject|0
2557073|NCT01393405|8846475|P2|Induction Period (week1-16)|Withdrawal by Subject|0
2557074|NCT01393405|8846476|P1|Induction Period (week1-16)|Withdrawal by Subject|9
2557075|NCT01393405|8846474|P3|Induction Period (week1-16)|Adverse Event|0
2557076|NCT01393405|8846475|P2|Induction Period (week1-16)|Adverse Event|0
2557077|NCT01393405|8846476|P1|Induction Period (week1-16)|Adverse Event|16
2557078|NCT01393405|8846474|P3|Induction Period (week1-16)|Lack of Efficacy|0
2557079|NCT01393405|8846475|P2|Induction Period (week1-16)|Lack of Efficacy|0
2557080|NCT01393405|8846476|P1|Induction Period (week1-16)|Lack of Efficacy|70
2557081|NCT01393301|8846514|P2|Overall Study|Completed <7 sessions (intervention)|0
2557082|NCT01393301|8846515|P1|Overall Study|Completed <7 sessions (intervention)|2
2557083|NCT01393301|8846514|P2|Overall Study|Withdrawal by Subject|0
2557084|NCT01393301|8846515|P1|Overall Study|Withdrawal by Subject|2
2557085|NCT01393301|8846514|P2|Overall Study|Lost to Follow-up|3
2557086|NCT01393301|8846515|P1|Overall Study|Lost to Follow-up|5
2557087|NCT01393158|8846528|P2|Overall Study|Adverse Event|0
2557088|NCT01393158|8846529|P1|Overall Study|Adverse Event|1
2557089|NCT01393106|8846556|P1|Overall Study|Lack of Efficacy|1
2557090|NCT01393106|8846556|P1|Overall Study|Withdrawal by Subject|1
2557091|NCT01393106|8846556|P1|Overall Study|Adverse Event|3
2557092|NCT01392963|8846583|P2|Week 24 Follow-up|Lost to Follow-up|0
2557093|NCT01392963|8846584|P1|Week 24 Follow-up|Lost to Follow-up|2
2557094|NCT01392963|8846583|P2|Week 0 (First Intervention)|Withdrawal by Subject|1
2557095|NCT01392963|8846584|P1|Week 0 (First Intervention)|Withdrawal by Subject|0
2557096|NCT01392963|8846583|P2|Week 0 (First Intervention)|Lost to Follow-up|1
2557097|NCT01392963|8846584|P1|Week 0 (First Intervention)|Lost to Follow-up|0
2557098|NCT01392742|8846592|P1|Overall Study|Missing information|13
2557099|NCT01392742|8846592|P1|Overall Study|Other|3
2557100|NCT01392742|8846592|P1|Overall Study|Protocol Violation|14
2557101|NCT01392742|8846592|P1|Overall Study|Adverse event/intercurrent illness|17
2557102|NCT01392742|8846592|P1|Overall Study|ITR and Protocol deviation|1
2557103|NCT01392742|8846592|P1|Overall Study|Insufficient therapeutic response (ITR)|30
2557104|NCT01392742|8846592|P1|Overall Study|Lost to Follow-up|34
2557105|NCT01392742|8846592|P1|Overall Study|No treatment/no cooperation/withdrew|12
2557106|NCT01392742|8846592|P1|Overall Study|Failure to return|35
2557107|NCT01392742|8846592|P1|Overall Study|Premature study termination|42
2557108|NCT01392677|8846638|P2|Overall Study|Other reason|2
2557109|NCT01392677|8846639|P1|Overall Study|Other reason|3
2557110|NCT01392677|8846638|P2|Overall Study|Incorrect enrollment|3
2557111|NCT01392677|8846639|P1|Overall Study|Incorrect enrollment|2
2557112|NCT01392677|8846638|P2|Overall Study|Withdrawal by Subject|2
2557113|NCT01392677|8846639|P1|Overall Study|Withdrawal by Subject|0
2557114|NCT01392677|8846638|P2|Overall Study|Adverse Event|1
2557115|NCT01392677|8846639|P1|Overall Study|Adverse Event|3
2557116|NCT01392573|8846674|P2|Overall Study|Unclassified|6
2557117|NCT01392573|8846675|P1|Overall Study|Unclassified|9
2557118|NCT01392573|8846674|P2|Overall Study|Site closure|7
2557119|NCT01392573|8846675|P1|Overall Study|Site closure|8
2557120|NCT01392573|8846674|P2|Overall Study|Withdrawal Criteria|15
2557121|NCT01392573|8846675|P1|Overall Study|Withdrawal Criteria|13
2557122|NCT01392573|8846674|P2|Overall Study|Protocol Violation|2
2557123|NCT01392573|8846675|P1|Overall Study|Protocol Violation|0
2557124|NCT01392573|8846674|P2|Overall Study|Lack of Efficacy|2
2557125|NCT01392573|8846675|P1|Overall Study|Lack of Efficacy|1
2557126|NCT01392573|8846674|P2|Overall Study|Adverse Event|3
2557127|NCT01392573|8846675|P1|Overall Study|Adverse Event|1
2557128|NCT01392560|8846683|P1|Overall Study|discontinued during placebo run-in|2
2557129|NCT01392560|8846683|P1|Overall Study|not entered|8
2557130|NCT01392560|8846683|P1|Overall Study|Adverse Event|2
2557131|NCT01392547|8846689|P1|Overall Study|Unclassified|1
2557132|NCT01392547|8846689|P1|Overall Study|Withdrawal criteria|3
2557133|NCT01392547|8846689|P1|Overall Study|Non-compliance|2
2557134|NCT01392547|8846689|P1|Overall Study|Adverse Event|2
2557135|NCT01392495|8846703|P1|Overall Study|Adverse Event|3
2557136|NCT01392495|8846703|P1|Overall Study|Withdrawal by Subject|2
2557137|NCT01392495|8846703|P1|Overall Study|Administrative problems|8
2557138|NCT01392495|8846703|P1|Overall Study|Death|3
2557139|NCT01392443|8846715|P1|Overall Study|Protocol Violation|1
2557140|NCT01392443|8846715|P1|Overall Study|Lost to Follow-up|1
2557141|NCT01392443|8846715|P1|Overall Study|Withdrawal by Subject|5
2557142|NCT01392443|8846715|P1|Overall Study|Death|7
2557143|NCT01392443|8846715|P1|Overall Study|Adverse Event|24
2557144|NCT01392443|8846715|P1|Overall Study|Disease progression|30
2557145|NCT01392378|8846728|P5|Toddler Dose|Withdrawal by Parent|1
2557146|NCT01392378|8846729|P4|Toddler Dose|Withdrawal by Parent|1
2557147|NCT01392378|8846730|P3|Toddler Dose|Withdrawal by Parent|0
2557148|NCT01392378|8846731|P2|Toddler Dose|Withdrawal by Parent|1
2557149|NCT01392378|8846732|P1|Toddler Dose|Withdrawal by Parent|0
2557150|NCT01392378|8846728|P5|Toddler Dose|Lost to Follow-up|0
2557151|NCT01392378|8846729|P4|Toddler Dose|Lost to Follow-up|1
2557152|NCT01392378|8846730|P3|Toddler Dose|Lost to Follow-up|0
2557153|NCT01392378|8846731|P2|Toddler Dose|Lost to Follow-up|0
2557154|NCT01392378|8846732|P1|Toddler Dose|Lost to Follow-up|0
2557155|NCT01392378|8846728|P5|After Infant Series|Withdrawal by Parent|1
2557156|NCT01392378|8846729|P4|After Infant Series|Withdrawal by Parent|0
2557157|NCT01392378|8846730|P3|After Infant Series|Withdrawal by Parent|1
2557158|NCT01392378|8846731|P2|After Infant Series|Withdrawal by Parent|1
2557159|NCT01392378|8846732|P1|After Infant Series|Withdrawal by Parent|0
2557160|NCT01392378|8846728|P5|After Infant Series|Lost to Follow-up|0
2557161|NCT01392378|8846729|P4|After Infant Series|Lost to Follow-up|0
2557162|NCT01392378|8846730|P3|After Infant Series|Lost to Follow-up|1
2557163|NCT01392378|8846731|P2|After Infant Series|Lost to Follow-up|0
2557164|NCT01392378|8846732|P1|After Infant Series|Lost to Follow-up|0
2557165|NCT01392378|8846728|P5|Infant Series|Withdrawal by Parent|0
2557166|NCT01392378|8846729|P4|Infant Series|Withdrawal by Parent|0
2557167|NCT01392378|8846730|P3|Infant Series|Withdrawal by Parent|0
2557168|NCT01392378|8846731|P2|Infant Series|Withdrawal by Parent|1
2557169|NCT01392378|8846732|P1|Infant Series|Withdrawal by Parent|4
2557170|NCT01392378|8846728|P5|Infant Series|Protocol Violation|0
2557171|NCT01392378|8846729|P4|Infant Series|Protocol Violation|0
2557172|NCT01392378|8846730|P3|Infant Series|Protocol Violation|0
2557173|NCT01392378|8846731|P2|Infant Series|Protocol Violation|1
2557174|NCT01392378|8846732|P1|Infant Series|Protocol Violation|0
2557175|NCT01392378|8846728|P5|Infant Series|Lost to Follow-up|0
2557176|NCT01392378|8846729|P4|Infant Series|Lost to Follow-up|1
2557177|NCT01392378|8846730|P3|Infant Series|Lost to Follow-up|0
2557178|NCT01392378|8846731|P2|Infant Series|Lost to Follow-up|0
2557179|NCT01392378|8846732|P1|Infant Series|Lost to Follow-up|0
2557180|NCT01392378|8846728|P5|Infant Series|Adverse Event|0
2557181|NCT01392378|8846729|P4|Infant Series|Adverse Event|1
2557182|NCT01392378|8846730|P3|Infant Series|Adverse Event|0
2557183|NCT01392378|8846731|P2|Infant Series|Adverse Event|0
2557184|NCT01392378|8846732|P1|Infant Series|Adverse Event|0
2557185|NCT01392326|8846872|P3|Overall Study|Adverse Event|11
2557186|NCT01392326|8846873|P2|Overall Study|Adverse Event|6
2557187|NCT01392326|8846874|P1|Overall Study|Adverse Event|9
2557188|NCT01392326|8846872|P3|Overall Study|Lack of Efficacy|15
2557189|NCT01392326|8846873|P2|Overall Study|Lack of Efficacy|10
2557190|NCT01392326|8846874|P1|Overall Study|Lack of Efficacy|14
2557191|NCT01392326|8846872|P3|Overall Study|Lost to Follow-up|4
2557192|NCT01392326|8846873|P2|Overall Study|Lost to Follow-up|3
2557193|NCT01392326|8846874|P1|Overall Study|Lost to Follow-up|1
2557194|NCT01392326|8846872|P3|Overall Study|Physician Decision|2
2557195|NCT01392326|8846873|P2|Overall Study|Physician Decision|5
2557196|NCT01392326|8846874|P1|Overall Study|Physician Decision|7
2557197|NCT01392326|8846872|P3|Overall Study|Pregnancy|1
2557198|NCT01392326|8846873|P2|Overall Study|Pregnancy|0
2557199|NCT01392326|8846874|P1|Overall Study|Pregnancy|0
2557200|NCT01392326|8846872|P3|Overall Study|Protocol Violation|0
2557201|NCT01392326|8846873|P2|Overall Study|Protocol Violation|0
2557202|NCT01392326|8846874|P1|Overall Study|Protocol Violation|2
2557203|NCT01392326|8846872|P3|Overall Study|Withdrawal by Subject|15
2557204|NCT01392326|8846873|P2|Overall Study|Withdrawal by Subject|11
2557205|NCT01392326|8846874|P1|Overall Study|Withdrawal by Subject|12
2557206|NCT01392326|8846872|P3|Overall Study|Death|0
2557207|NCT01392326|8846873|P2|Overall Study|Death|0
2557208|NCT01392326|8846874|P1|Overall Study|Death|2
2557209|NCT01392300|8846911|P3|Open Label Extension (OLEX) Period|Lost to Follow-up|6
2557210|NCT01392300|8846912|P2|Open Label Extension (OLEX) Period|Lost to Follow-up|0
2557211|NCT01392300|8846913|P1|Open Label Extension (OLEX) Period|Lost to Follow-up|0
2557212|NCT01392300|8846911|P3|Open Label Extension (OLEX) Period|Withdrawal by Subject|17
2557213|NCT01392300|8846912|P2|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
2557214|NCT01392300|8846913|P1|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
2557215|NCT01392300|8846911|P3|Open Label Extension (OLEX) Period|Adverse Event|7
2557216|NCT01392300|8846912|P2|Open Label Extension (OLEX) Period|Adverse Event|0
2557217|NCT01392300|8846913|P1|Open Label Extension (OLEX) Period|Adverse Event|0
2557218|NCT01392300|8846911|P3|Open Label Extension (OLEX) Period|Death|4
2557219|NCT01392300|8846912|P2|Open Label Extension (OLEX) Period|Death|0
2557220|NCT01392300|8846913|P1|Open Label Extension (OLEX) Period|Death|0
2557221|NCT01392300|8846911|P3|Open Label Extension (OLEX) Period|Non-compliance|1
2557222|NCT01392300|8846912|P2|Open Label Extension (OLEX) Period|Non-compliance|0
2557223|NCT01392300|8846913|P1|Open Label Extension (OLEX) Period|Non-compliance|0
2557224|NCT01392300|8846911|P3|Open Label Extension (OLEX) Period|Lack of Efficacy|3
2557225|NCT01392300|8846912|P2|Open Label Extension (OLEX) Period|Lack of Efficacy|0
2557226|NCT01392300|8846913|P1|Open Label Extension (OLEX) Period|Lack of Efficacy|0
2557227|NCT01392300|8846911|P3|Open Label Extension (OLEX) Period|Protocol Violation|13
2557228|NCT01392300|8846912|P2|Open Label Extension (OLEX) Period|Protocol Violation|0
2557229|NCT01392300|8846913|P1|Open Label Extension (OLEX) Period|Protocol Violation|0
2557230|NCT01392300|8846911|P3|Main Period (MP)|Non-compliance|0
2557231|NCT01392300|8846912|P2|Main Period (MP)|Non-compliance|0
2557232|NCT01392300|8846913|P1|Main Period (MP)|Non-compliance|1
2557233|NCT01392300|8846911|P3|Main Period (MP)|Lost to Follow-up|0
2557234|NCT01392300|8846912|P2|Main Period (MP)|Lost to Follow-up|3
2557235|NCT01392300|8846913|P1|Main Period (MP)|Lost to Follow-up|3
2557236|NCT01392300|8846911|P3|Main Period (MP)|Withdrawal by Subject|0
2557237|NCT01392300|8846912|P2|Main Period (MP)|Withdrawal by Subject|1
2557238|NCT01392300|8846913|P1|Main Period (MP)|Withdrawal by Subject|5
2557239|NCT01392300|8846911|P3|Main Period (MP)|Predefined discontinuation criteria|0
2557240|NCT01392300|8846912|P2|Main Period (MP)|Predefined discontinuation criteria|3
2557241|NCT01392300|8846913|P1|Main Period (MP)|Predefined discontinuation criteria|2
2557242|NCT01392170|8847018|P1|Overall Study|Ineligible|1
2557243|NCT01392170|8847018|P1|Overall Study|Withdrawal by Subject|1
2557244|NCT01391819|8847066|P1|Overall Study|Other|9
2557245|NCT01391819|8847066|P1|Overall Study|Death|3
2557246|NCT01391819|8847066|P1|Overall Study|Lost to Follow-up|252
2557247|NCT01391819|8847066|P1|Overall Study|Migrated/moved from study area|82
2557248|NCT01391819|8847066|P1|Overall Study|Withdrawal by Subject|56
2557249|NCT01391793|8847110|P2|Overall Study|No DMSA|57
2557250|NCT01391793|8847111|P1|Overall Study|No DMSA|73
2557251|NCT01391793|8847110|P2|Overall Study|Urine Culture Negative or Indeterminate|87
2557252|NCT01391793|8847111|P1|Overall Study|Urine Culture Negative or Indeterminate|71
2557253|NCT01391793|8847110|P2|Overall Study|Ineligible|0
2557254|NCT01391793|8847111|P1|Overall Study|Ineligible|3
2557255|NCT01391663|8847125|P4|Overall Study|Withdrawal by Subject|0
2557256|NCT01391663|8847126|P3|Overall Study|Withdrawal by Subject|1
2557257|NCT01391663|8847127|P2|Overall Study|Withdrawal by Subject|0
2557258|NCT01391663|8847128|P1|Overall Study|Withdrawal by Subject|0
2557259|NCT01391546|8847172|P2|Overall Study|History of Herpes Zoster (HZ)|0
2557260|NCT01391546|8847173|P1|Overall Study|History of Herpes Zoster (HZ)|1
2557261|NCT01391507|8847195|P4|Overall Study|Protocol Violation|2
2557262|NCT01391507|8847196|P3|Overall Study|Protocol Violation|1
2557263|NCT01391507|8847197|P2|Overall Study|Protocol Violation|1
2557264|NCT01391507|8847198|P1|Overall Study|Protocol Violation|2
2557265|NCT01391507|8847195|P4|Overall Study|Lack of Efficacy|1
2557266|NCT01391507|8847196|P3|Overall Study|Lack of Efficacy|0
2557267|NCT01391507|8847197|P2|Overall Study|Lack of Efficacy|0
2557268|NCT01391507|8847198|P1|Overall Study|Lack of Efficacy|0
2557269|NCT01391507|8847195|P4|Overall Study|Withdrawal by Subject|1
2557270|NCT01391507|8847196|P3|Overall Study|Withdrawal by Subject|1
2557271|NCT01391507|8847197|P2|Overall Study|Withdrawal by Subject|2
2557272|NCT01391507|8847198|P1|Overall Study|Withdrawal by Subject|1
2557273|NCT01391507|8847195|P4|Overall Study|Adverse Event|2
2557274|NCT01391507|8847196|P3|Overall Study|Adverse Event|2
2557275|NCT01391507|8847197|P2|Overall Study|Adverse Event|1
2557276|NCT01391507|8847198|P1|Overall Study|Adverse Event|1
2557277|NCT01391507|8847195|P4|Overall Study|Death|1
2557278|NCT01391507|8847196|P3|Overall Study|Death|0
2557279|NCT01391507|8847197|P2|Overall Study|Death|0
2557280|NCT01391507|8847198|P1|Overall Study|Death|0
2557281|NCT01391130|8847336|P2|Overall Study|Did not Receive Drug|1
2557282|NCT01391130|8847337|P1|Overall Study|Did not Receive Drug|1
2557283|NCT01391130|8847336|P2|Overall Study|Physician Decision|3
2557284|NCT01391130|8847337|P1|Overall Study|Physician Decision|2
2557285|NCT01391130|8847336|P2|Overall Study|Withdrawal by Subject|2
2557286|NCT01391130|8847337|P1|Overall Study|Withdrawal by Subject|3
2557287|NCT01391000|8847394|P2|Overall Study|Lost to Follow-up|0
2557288|NCT01391000|8847395|P1|Overall Study|Lost to Follow-up|2
2557289|NCT01390948|8847408|P3|Overall Study|Withdrew consent from survival follow-up|0
2557290|NCT01390948|8847409|P2|Overall Study|Withdrew consent from survival follow-up|5
2557291|NCT01390948|8847410|P1|Overall Study|Withdrew consent from survival follow-up|3
2557292|NCT01390948|8847408|P3|Overall Study|Ongoing|0
2557293|NCT01390948|8847409|P2|Overall Study|Ongoing|6
2557294|NCT01390948|8847410|P1|Overall Study|Ongoing|6
2557295|NCT01390948|8847408|P3|Overall Study|Death|2
2557296|NCT01390948|8847409|P2|Overall Study|Death|34
2557297|NCT01390948|8847410|P1|Overall Study|Death|30
2557298|NCT01390948|8847408|P3|Overall Study|Alive in follow-up|1
2557299|NCT01390948|8847409|P2|Overall Study|Alive in follow-up|17
2557300|NCT01390948|8847410|P1|Overall Study|Alive in follow-up|20
2557301|NCT01390857|8847476|P1|Overall Study|No Visit after the First Visit|7
2557302|NCT01390857|8847476|P1|Overall Study|Lost to Follow-up|1
2557303|NCT01390857|8847476|P1|Overall Study|Protocol Violation|2
2557304|NCT01390844|8847487|P4|Follow-Up Phase|Non-Medical Reasons|0
2557305|NCT01390844|8847488|P3|Follow-Up Phase|Non-Medical Reasons|1
2557306|NCT01390844|8847489|P2|Follow-Up Phase|Non-Medical Reasons|1
2557307|NCT01390844|8847490|P1|Follow-Up Phase|Non-Medical Reasons|1
2557308|NCT01390844|8847487|P4|Treatment Phase|Non-GCP Compliant|3
2557309|NCT01390844|8847488|P3|Treatment Phase|Non-GCP Compliant|10
2557310|NCT01390844|8847489|P2|Treatment Phase|Non-GCP Compliant|0
2557311|NCT01390844|8847490|P1|Treatment Phase|Non-GCP Compliant|0
2557312|NCT01390844|8847487|P4|Treatment Phase|Non-Medical Reasons|1
2557313|NCT01390844|8847488|P3|Treatment Phase|Non-Medical Reasons|8
2557314|NCT01390844|8847489|P2|Treatment Phase|Non-Medical Reasons|1
2557315|NCT01390844|8847490|P1|Treatment Phase|Non-Medical Reasons|5
2557316|NCT01390844|8847487|P4|Treatment Phase|Treatment Failure|13
2557317|NCT01390844|8847488|P3|Treatment Phase|Treatment Failure|10
2557318|NCT01390844|8847489|P2|Treatment Phase|Treatment Failure|25
2557319|NCT01390844|8847490|P1|Treatment Phase|Treatment Failure|23
2557320|NCT01390844|8847487|P4|Treatment Phase|Adverse Event|2
2557321|NCT01390844|8847488|P3|Treatment Phase|Adverse Event|3
2557322|NCT01390844|8847489|P2|Treatment Phase|Adverse Event|2
2557323|NCT01390844|8847490|P1|Treatment Phase|Adverse Event|12
2557324|NCT01390779|8847817|P1|Overall Study|Physician Decision|1
2557325|NCT01390649|8847822|P1|Overall Study|Physician Decision|1
2557326|NCT01390441|8847832|P5|Extension Period|Protocol Violation|0
2557327|NCT01390441|8847833|P4|Extension Period|Protocol Violation|1
2557328|NCT01390441|8847834|P3|Extension Period|Protocol Violation|0
2557329|NCT01390441|8847835|P2|Extension Period|Protocol Violation|1
2557330|NCT01390441|8847836|P1|Extension Period|Protocol Violation|3
2557331|NCT01390441|8847832|P5|Treatment Period|Lost to Follow-up|0
2557332|NCT01390441|8847833|P4|Treatment Period|Lost to Follow-up|0
2557333|NCT01390441|8847834|P3|Treatment Period|Lost to Follow-up|0
2557334|NCT01390441|8847835|P2|Treatment Period|Lost to Follow-up|0
2557335|NCT01390441|8847836|P1|Treatment Period|Lost to Follow-up|1
2557336|NCT01390441|8847832|P5|Treatment Period|Withdrawal by Subject|1
2557337|NCT01390441|8847833|P4|Treatment Period|Withdrawal by Subject|0
2557338|NCT01390441|8847834|P3|Treatment Period|Withdrawal by Subject|1
2557339|NCT01390441|8847835|P2|Treatment Period|Withdrawal by Subject|0
2557340|NCT01390441|8847836|P1|Treatment Period|Withdrawal by Subject|0
2557341|NCT01390441|8847832|P5|Treatment Period|Adverse Event|2
2557342|NCT01390441|8847833|P4|Treatment Period|Adverse Event|1
2557343|NCT01390441|8847834|P3|Treatment Period|Adverse Event|1
2557344|NCT01390441|8847835|P2|Treatment Period|Adverse Event|0
2557345|NCT01390441|8847836|P1|Treatment Period|Adverse Event|0
2557346|NCT01390441|8847832|P5|Treatment Period|Unknown due to early stopping of study|7
2557347|NCT01390441|8847833|P4|Treatment Period|Unknown due to early stopping of study|11
2557348|NCT01390441|8847834|P3|Treatment Period|Unknown due to early stopping of study|8
2557349|NCT01390441|8847835|P2|Treatment Period|Unknown due to early stopping of study|0
2557350|NCT01390441|8847836|P1|Treatment Period|Unknown due to early stopping of study|0
2557351|NCT01390441|8847832|P5|Treatment Period|Lack of Efficacy|1
2557352|NCT01390441|8847833|P4|Treatment Period|Lack of Efficacy|0
2557353|NCT01390441|8847834|P3|Treatment Period|Lack of Efficacy|0
2557354|NCT01390441|8847835|P2|Treatment Period|Lack of Efficacy|0
2557355|NCT01390441|8847836|P1|Treatment Period|Lack of Efficacy|0
2557356|NCT01390441|8847832|P5|Treatment Period|Physician Decision|0
2557357|NCT01390441|8847833|P4|Treatment Period|Physician Decision|1
2557358|NCT01390441|8847834|P3|Treatment Period|Physician Decision|0
2557359|NCT01390441|8847835|P2|Treatment Period|Physician Decision|0
2557360|NCT01390441|8847836|P1|Treatment Period|Physician Decision|0
2557361|NCT01390441|8847832|P5|Treatment Period|Protocol Violation|0
2557362|NCT01390441|8847833|P4|Treatment Period|Protocol Violation|0
2557363|NCT01390441|8847834|P3|Treatment Period|Protocol Violation|0
2557364|NCT01390441|8847835|P2|Treatment Period|Protocol Violation|1
2557365|NCT01390441|8847836|P1|Treatment Period|Protocol Violation|0
2557366|NCT01390428|8847901|P6|Overall Study|Withdrawal by Subject|0
2557367|NCT01390428|8847902|P5|Overall Study|Withdrawal by Subject|0
2557368|NCT01390428|8847903|P4|Overall Study|Withdrawal by Subject|0
2557369|NCT01390428|8847904|P3|Overall Study|Withdrawal by Subject|1
2557370|NCT01390428|8847905|P2|Overall Study|Withdrawal by Subject|0
2557371|NCT01390428|8847906|P1|Overall Study|Withdrawal by Subject|0
2557372|NCT01390428|8847901|P6|Overall Study|Elective Surgery|0
2557373|NCT01390428|8847902|P5|Overall Study|Elective Surgery|1
2557374|NCT01390428|8847903|P4|Overall Study|Elective Surgery|0
2557375|NCT01390428|8847904|P3|Overall Study|Elective Surgery|0
2557376|NCT01390428|8847905|P2|Overall Study|Elective Surgery|0
2557377|NCT01390428|8847906|P1|Overall Study|Elective Surgery|0
2557378|NCT01390402|8847969|P1|Overall Study|Disease Progression|4
2557379|NCT01390402|8847969|P1|Overall Study|Death|1
2557380|NCT01390389|8847975|P2|Overall Study|Screen Fail|1
2557381|NCT01390389|8847976|P1|Overall Study|Screen Fail|2
2557382|NCT01390389|8847975|P2|Overall Study|Withdrawal by Subject|0
2557383|NCT01390389|8847976|P1|Overall Study|Withdrawal by Subject|2
2557384|NCT01390298|8847986|P1|Overall Study|Surgery cancelled|1
2557385|NCT01390298|8847986|P1|Overall Study|Lost to Follow-up|7
2557386|NCT01390298|8847986|P1|Overall Study|Withdrawal by Subject|14
2557387|NCT01390298|8847986|P1|Overall Study|long term ICU admission|1
2557388|NCT01390298|8847986|P1|Overall Study|Death|1
2557389|NCT01390272|8847992|P2|Overall Study|Patient moved, no longer eligible|8
2557390|NCT01390272|8847993|P1|Overall Study|Patient moved, no longer eligible|5
2557391|NCT01390272|8847992|P2|Overall Study|Withdrawal by Subject|5
2557392|NCT01390272|8847993|P1|Overall Study|Withdrawal by Subject|9
2557393|NCT01390272|8847992|P2|Overall Study|Death|2
2557394|NCT01390272|8847993|P1|Overall Study|Death|3
2557395|NCT01390220|8848061|P3|Comparative Phase|Withdrawal by Subject|0
2557396|NCT01390220|8848062|P2|Comparative Phase|Withdrawal by Subject|1
2557397|NCT01390220|8848063|P1|Comparative Phase|Withdrawal by Subject|0
2557398|NCT01390220|8848061|P3|Test Dose Phase|Logistical|0
2557399|NCT01390220|8848062|P2|Test Dose Phase|Logistical|0
2557400|NCT01390220|8848063|P1|Test Dose Phase|Logistical|6
2557401|NCT01390220|8848061|P3|Test Dose Phase|Noncompliance|0
2557402|NCT01390220|8848062|P2|Test Dose Phase|Noncompliance|0
2557403|NCT01390220|8848063|P1|Test Dose Phase|Noncompliance|2
2557404|NCT01390220|8848061|P3|Test Dose Phase|Caregiver no longer available|0
2557405|NCT01390220|8848062|P2|Test Dose Phase|Caregiver no longer available|0
2557406|NCT01390220|8848063|P1|Test Dose Phase|Caregiver no longer available|5
2557407|NCT01390220|8848061|P3|Test Dose Phase|Study/Site closure|0
2557408|NCT01390220|8848062|P2|Test Dose Phase|Study/Site closure|0
2557409|NCT01390220|8848063|P1|Test Dose Phase|Study/Site closure|6
2557410|NCT01390220|8848061|P3|Test Dose Phase|No treated seizure cluster episode|0
2557411|NCT01390220|8848062|P2|Test Dose Phase|No treated seizure cluster episode|0
2557412|NCT01390220|8848063|P1|Test Dose Phase|No treated seizure cluster episode|37
2557413|NCT01390220|8848061|P3|Test Dose Phase|Protocol Violation|0
2557414|NCT01390220|8848062|P2|Test Dose Phase|Protocol Violation|0
2557415|NCT01390220|8848063|P1|Test Dose Phase|Protocol Violation|8
2557416|NCT01390220|8848061|P3|Test Dose Phase|Lost to Follow-up|0
2557417|NCT01390220|8848062|P2|Test Dose Phase|Lost to Follow-up|0
2557418|NCT01390220|8848063|P1|Test Dose Phase|Lost to Follow-up|2
2557419|NCT01390220|8848061|P3|Test Dose Phase|Withdrawal by Subject|0
2557420|NCT01390220|8848062|P2|Test Dose Phase|Withdrawal by Subject|0
2557421|NCT01390220|8848063|P1|Test Dose Phase|Withdrawal by Subject|8
2557422|NCT01390220|8848061|P3|Test Dose Phase|Adverse Event|0
2557423|NCT01390220|8848062|P2|Test Dose Phase|Adverse Event|0
2557424|NCT01390220|8848063|P1|Test Dose Phase|Adverse Event|17
2557425|NCT01390181|8848078|P1|Overall Study|Study Terminated due to Low Accrual|3
2557426|NCT01390181|8848078|P1|Overall Study|Lost to Follow-up|1
2557427|NCT01390038|8848091|P1|Overall Study|Simpliciti System Removal|2
2557428|NCT01390038|8848091|P1|Overall Study|Withdrawal by Subject|4
2557429|NCT01390038|8848091|P1|Overall Study|Lost to Follow-up|1
2557430|NCT01390038|8848091|P1|Overall Study|Death|1
2557431|NCT01389973|8848101|P1|Overall Study|Other|10
2557432|NCT01389973|8848101|P1|Overall Study|Trial Stopped by Sponsor|9
2557433|NCT01389973|8848101|P1|Overall Study|Lost to Follow-up|1
2557434|NCT01389882|8848111|P2|Overall Study|Withdrawal by Subject|1
2557435|NCT01389882|8848112|P1|Overall Study|Withdrawal by Subject|0
2557436|NCT01389882|8848111|P2|Overall Study|Respiratory rate > 80/min during study|3
2557437|NCT01389882|8848112|P1|Overall Study|Respiratory rate > 80/min during study|1
2557438|NCT01389817|8848200|P2|Overall Study|Withdrawal by Subject|0
2557439|NCT01389817|8848201|P1|Overall Study|Withdrawal by Subject|2
2557440|NCT01389817|8848200|P2|Overall Study|Lost to Follow-up|0
2557441|NCT01389817|8848201|P1|Overall Study|Lost to Follow-up|1
2557442|NCT01389817|8848200|P2|Overall Study|Physician Decision|0
2557443|NCT01389817|8848201|P1|Overall Study|Physician Decision|1
2557444|NCT01389752|8848218|P2|Study Period 2|Sponsor decision|0
2557445|NCT01389752|8848219|P1|Study Period 2|Sponsor decision|1
2557446|NCT01389752|8848218|P2|Study Period 1|Sponsor decision|2
2557447|NCT01389752|8848219|P1|Study Period 1|Sponsor decision|0
2557448|NCT01389596|8848232|P3|Overall Study|Other Unspecified|0
2557449|NCT01389596|8848233|P2|Overall Study|Other Unspecified|1
2557450|NCT01389596|8848234|P1|Overall Study|Other Unspecified|2
2557451|NCT01389596|8848232|P3|Overall Study|Death|0
2557452|NCT01389596|8848233|P2|Overall Study|Death|1
2557453|NCT01389596|8848234|P1|Overall Study|Death|0
2557454|NCT01389596|8848232|P3|Overall Study|Adverse Event|0
2557455|NCT01389596|8848233|P2|Overall Study|Adverse Event|4
2557456|NCT01389596|8848234|P1|Overall Study|Adverse Event|1
2557457|NCT01389596|8848232|P3|Overall Study|Insufficient Clinical Response|5
2557458|NCT01389596|8848233|P2|Overall Study|Insufficient Clinical Response|4
2557459|NCT01389596|8848234|P1|Overall Study|Insufficient Clinical Response|3
2557460|NCT01389596|8848232|P3|Overall Study|Withdrawal by Subject|2
2557461|NCT01389596|8848233|P2|Overall Study|Withdrawal by Subject|2
2557462|NCT01389596|8848234|P1|Overall Study|Withdrawal by Subject|1
2557463|NCT01389596|8848232|P3|Overall Study|Protocol Violation|3
2557464|NCT01389596|8848233|P2|Overall Study|Protocol Violation|4
2557465|NCT01389596|8848234|P1|Overall Study|Protocol Violation|3
2557466|NCT01389323|8848293|P1|Follow-up Period (up to 48 Weeks)|Other|3
2557467|NCT01389323|8848293|P1|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2
2557468|NCT01389323|8848293|P1|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22
2557469|NCT01389323|8848293|P1|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10
2557470|NCT01389323|8848293|P1|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2
2557471|NCT01389323|8848293|P1|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5
2557472|NCT01389323|8848293|P1|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10
2557473|NCT01389323|8848293|P1|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7
2557474|NCT01389323|8848293|P1|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6
2557475|NCT01389323|8848293|P1|Treatment Period (up to 48 Weeks)|Adverse Event|24
2557476|NCT01389323|8848293|P1|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41
2557477|NCT01389258|8848350|P1|Overall Study|Lost to Follow-up|5
2557478|NCT01389128|8848362|P2|Overall Study|Intolerance to procedure|2
2557479|NCT01389128|8848363|P1|Overall Study|Intolerance to procedure|0
2557480|NCT01389128|8848362|P2|Overall Study|Rapid labor evolution|2
2557481|NCT01389128|8848363|P1|Overall Study|Rapid labor evolution|3
2557482|NCT01389128|8848362|P2|Overall Study|Cervix dilation stop|2
2557483|NCT01389128|8848363|P1|Overall Study|Cervix dilation stop|1
2557484|NCT01389128|8848362|P2|Overall Study|Fetal distress|0
2557485|NCT01389128|8848363|P1|Overall Study|Fetal distress|1
2557486|NCT01389102|8848387|P6|Overall Study|Investigator Judgement|0
2557487|NCT01389102|8848388|P5|Overall Study|Investigator Judgement|0
2557488|NCT01389102|8848389|P4|Overall Study|Investigator Judgement|0
2557489|NCT01389102|8848390|P3|Overall Study|Investigator Judgement|0
2557490|NCT01389102|8848391|P2|Overall Study|Investigator Judgement|1
2557491|NCT01389102|8848392|P1|Overall Study|Investigator Judgement|0
2557492|NCT01389102|8848387|P6|Overall Study|Unavailable due to husband's illness|0
2557493|NCT01389102|8848388|P5|Overall Study|Unavailable due to husband's illness|0
2557494|NCT01389102|8848389|P4|Overall Study|Unavailable due to husband's illness|0
2557495|NCT01389102|8848390|P3|Overall Study|Unavailable due to husband's illness|0
2557496|NCT01389102|8848391|P2|Overall Study|Unavailable due to husband's illness|1
2557497|NCT01389102|8848392|P1|Overall Study|Unavailable due to husband's illness|0
2557498|NCT01389102|8848387|P6|Overall Study|Subject Moved|0
2557499|NCT01389102|8848388|P5|Overall Study|Subject Moved|0
2557500|NCT01389102|8848389|P4|Overall Study|Subject Moved|0
2557501|NCT01389102|8848390|P3|Overall Study|Subject Moved|1
2557502|NCT01389102|8848391|P2|Overall Study|Subject Moved|0
2557503|NCT01389102|8848392|P1|Overall Study|Subject Moved|2
2557504|NCT01389102|8848387|P6|Overall Study|Subject Traveling Out of Country|0
2557505|NCT01389102|8848388|P5|Overall Study|Subject Traveling Out of Country|0
2557506|NCT01389102|8848389|P4|Overall Study|Subject Traveling Out of Country|1
2557507|NCT01389102|8848390|P3|Overall Study|Subject Traveling Out of Country|0
2557508|NCT01389102|8848391|P2|Overall Study|Subject Traveling Out of Country|0
2557509|NCT01389102|8848392|P1|Overall Study|Subject Traveling Out of Country|0
2557510|NCT01389102|8848387|P6|Overall Study|Withdrawal by Subject|3
2557511|NCT01389102|8848388|P5|Overall Study|Withdrawal by Subject|3
2557512|NCT01389102|8848389|P4|Overall Study|Withdrawal by Subject|2
2557513|NCT01389102|8848390|P3|Overall Study|Withdrawal by Subject|9
2557514|NCT01389102|8848391|P2|Overall Study|Withdrawal by Subject|4
2557515|NCT01389102|8848392|P1|Overall Study|Withdrawal by Subject|7
2557516|NCT01389102|8848387|P6|Overall Study|Protocol Violation|1
2557517|NCT01389102|8848388|P5|Overall Study|Protocol Violation|1
2557518|NCT01389102|8848389|P4|Overall Study|Protocol Violation|0
2557519|NCT01389102|8848390|P3|Overall Study|Protocol Violation|3
2557520|NCT01389102|8848391|P2|Overall Study|Protocol Violation|0
2557521|NCT01389102|8848392|P1|Overall Study|Protocol Violation|0
2557522|NCT01389102|8848387|P6|Overall Study|Lost to Follow-up|1
2557523|NCT01389102|8848388|P5|Overall Study|Lost to Follow-up|4
2557524|NCT01389102|8848389|P4|Overall Study|Lost to Follow-up|2
2557525|NCT01389102|8848390|P3|Overall Study|Lost to Follow-up|1
2557526|NCT01389102|8848391|P2|Overall Study|Lost to Follow-up|1
2557527|NCT01389102|8848392|P1|Overall Study|Lost to Follow-up|4
2557528|NCT01389102|8848387|P6|Overall Study|Hurricane Katrina|1
2557529|NCT01389102|8848388|P5|Overall Study|Hurricane Katrina|3
2557530|NCT01389102|8848389|P4|Overall Study|Hurricane Katrina|0
2557531|NCT01389102|8848390|P3|Overall Study|Hurricane Katrina|3
2557532|NCT01389102|8848391|P2|Overall Study|Hurricane Katrina|2
2557533|NCT01389102|8848392|P1|Overall Study|Hurricane Katrina|4
2557534|NCT01389102|8848387|P6|Overall Study|Adverse Event|2
2557535|NCT01389102|8848388|P5|Overall Study|Adverse Event|2
2557536|NCT01389102|8848389|P4|Overall Study|Adverse Event|2
2557537|NCT01389102|8848390|P3|Overall Study|Adverse Event|2
2557538|NCT01389102|8848391|P2|Overall Study|Adverse Event|3
2557539|NCT01389102|8848392|P1|Overall Study|Adverse Event|1
2557540|NCT01388985|8848422|P2|Overall Study|Error of nurse|1
2557541|NCT01388985|8848423|P1|Overall Study|Error of nurse|5
2557542|NCT01388985|8848422|P2|Overall Study|Other (no reason)|1
2557543|NCT01388985|8848423|P1|Overall Study|Other (no reason)|0
2557544|NCT01388985|8848422|P2|Overall Study|Subject unavailable|1
2557545|NCT01388985|8848423|P1|Overall Study|Subject unavailable|1
2557546|NCT01388985|8848422|P2|Overall Study|Withdrawal by Subject|4
2557547|NCT01388985|8848423|P1|Overall Study|Withdrawal by Subject|13
2557548|NCT01388985|8848422|P2|Overall Study|Lost to Follow-up|30
2557549|NCT01388985|8848423|P1|Overall Study|Lost to Follow-up|30
2557550|NCT01388985|8848422|P2|Overall Study|Death|1
2557551|NCT01388985|8848423|P1|Overall Study|Death|0
2557552|NCT01388907|8848487|P2|Overall Study|Adverse Event|0
2557553|NCT01388907|8848488|P1|Overall Study|Adverse Event|2
2557554|NCT01388816|8848504|P4|Overall Study|Protocol Violation|0
2557555|NCT01388816|8848505|P3|Overall Study|Protocol Violation|2
2557556|NCT01388816|8848506|P2|Overall Study|Protocol Violation|0
2557557|NCT01388816|8848507|P1|Overall Study|Protocol Violation|0
2557558|NCT01388816|8848504|P4|Overall Study|Withdrawal by Subject|0
2557559|NCT01388816|8848505|P3|Overall Study|Withdrawal by Subject|1
2557560|NCT01388816|8848506|P2|Overall Study|Withdrawal by Subject|1
2557561|NCT01388816|8848507|P1|Overall Study|Withdrawal by Subject|2
2557562|NCT01388816|8848504|P4|Overall Study|Lost to Follow-up|0
2557563|NCT01388816|8848505|P3|Overall Study|Lost to Follow-up|0
2557564|NCT01388816|8848506|P2|Overall Study|Lost to Follow-up|1
2557565|NCT01388816|8848507|P1|Overall Study|Lost to Follow-up|0
2557566|NCT01388816|8848504|P4|Overall Study|Adverse Event|0
2557567|NCT01388816|8848505|P3|Overall Study|Adverse Event|0
2557568|NCT01388816|8848506|P2|Overall Study|Adverse Event|2
2557569|NCT01388816|8848507|P1|Overall Study|Adverse Event|0
2557570|NCT01388790|8848536|P1|Overall Study|Ongoing at data cut−off date|8
2557571|NCT01388647|8848547|P2|Overall Study|Adverse Event|2
2557572|NCT01388647|8848548|P1|Overall Study|Adverse Event|1
2557573|NCT01388543|8848561|P2|Day 14|Adverse Event|4
2557574|NCT01388543|8848562|P1|Day 14|Adverse Event|1
2557575|NCT01388530|8848568|P1|Overall Study|Lost to Follow-up|5
2557576|NCT01388491|8848577|P2|Overall Study|Pregnancy|0
2557577|NCT01388491|8848578|P1|Overall Study|Pregnancy|1
2557578|NCT01388491|8848577|P2|Overall Study|Noncompliance|0
2557579|NCT01388491|8848578|P1|Overall Study|Noncompliance|2
2557580|NCT01388491|8848577|P2|Overall Study|Protocol Violation|0
2557581|NCT01388491|8848578|P1|Overall Study|Protocol Violation|2
2557582|NCT01388491|8848577|P2|Overall Study|Lost to Follow-up|3
2557583|NCT01388491|8848578|P1|Overall Study|Lost to Follow-up|4
2557584|NCT01388491|8848577|P2|Overall Study|Withdrawal by Subject|10
2557585|NCT01388491|8848578|P1|Overall Study|Withdrawal by Subject|6
2557586|NCT01388491|8848577|P2|Overall Study|Sponsor Request|7
2557587|NCT01388491|8848578|P1|Overall Study|Sponsor Request|9
2557588|NCT01388491|8848577|P2|Overall Study|Adverse Event|9
2557589|NCT01388491|8848578|P1|Overall Study|Adverse Event|10
2557590|NCT01388361|8848613|P3|Overall Study|Unclassified|1
2557591|NCT01388361|8848614|P2|Overall Study|Unclassified|0
2557592|NCT01388361|8848615|P1|Overall Study|Unclassified|0
2557593|NCT01388361|8848613|P3|Overall Study|Withdrawal criteria|10
2557594|NCT01388361|8848614|P2|Overall Study|Withdrawal criteria|7
2557595|NCT01388361|8848615|P1|Overall Study|Withdrawal criteria|12
2557596|NCT01388361|8848613|P3|Overall Study|Protocol Violation|2
2557597|NCT01388361|8848614|P2|Overall Study|Protocol Violation|0
2557598|NCT01388361|8848615|P1|Overall Study|Protocol Violation|0
2557599|NCT01388361|8848613|P3|Overall Study|Adverse Event|1
2557600|NCT01388361|8848614|P2|Overall Study|Adverse Event|5
2557601|NCT01388361|8848615|P1|Overall Study|Adverse Event|0
2557602|NCT01388166|8848632|P1|Overall Study|Others than specified above|13
2557603|NCT01388166|8848632|P1|Overall Study|Lost to Follow-up|30
2557604|NCT01388166|8848632|P1|Overall Study|Adverse Event|16
2557605|NCT01387789|8848935|P1|Overall Study|Lost to Follow-up|1
2557606|NCT01387789|8848935|P1|Overall Study|Lack of Efficacy|2
2557607|NCT01387789|8848935|P1|Overall Study|Adverse Event|5
2557608|NCT01387737|8848949|P2|Overall Study|Clearly not eligible for the study|3
2557609|NCT01387737|8848950|P1|Overall Study|Clearly not eligible for the study|1
2557610|NCT01387737|8848949|P2|Overall Study|Withdrawal by Subject|31
2557611|NCT01387737|8848950|P1|Overall Study|Withdrawal by Subject|27
2557612|NCT01387737|8848949|P2|Overall Study|Physician Decision|10
2557613|NCT01387737|8848950|P1|Overall Study|Physician Decision|3
2557614|NCT01387737|8848949|P2|Overall Study|Lack of Efficacy|0
2557615|NCT01387737|8848950|P1|Overall Study|Lack of Efficacy|1
2557616|NCT01387737|8848949|P2|Overall Study|Adverse Event|30
2557617|NCT01387737|8848950|P1|Overall Study|Adverse Event|20
2557618|NCT01387607|8848984|P2|Overall Study|Randomized, not treated|6
2557619|NCT01387607|8848985|P1|Overall Study|Randomized, not treated|3
2557620|NCT01387607|8848984|P2|Overall Study|Other|1
2557621|NCT01387607|8848985|P1|Overall Study|Other|1
2557622|NCT01387607|8848984|P2|Overall Study|Withdrawal by Subject|14
2557623|NCT01387607|8848985|P1|Overall Study|Withdrawal by Subject|13
2557624|NCT01387607|8848984|P2|Overall Study|Protocol Violation|5
2557625|NCT01387607|8848985|P1|Overall Study|Protocol Violation|1
2557626|NCT01387607|8848984|P2|Overall Study|No longer meets eligibility criteria|1
2557627|NCT01387607|8848985|P1|Overall Study|No longer meets eligibility criteria|0
2557628|NCT01387607|8848984|P2|Overall Study|Lost to Follow-up|1
2557629|NCT01387607|8848985|P1|Overall Study|Lost to Follow-up|2
2557630|NCT01387607|8848984|P2|Overall Study|Lack of Efficacy|6
2557631|NCT01387607|8848985|P1|Overall Study|Lack of Efficacy|8
2557632|NCT01387607|8848984|P2|Overall Study|Adverse Event|11
2557633|NCT01387607|8848985|P1|Overall Study|Adverse Event|23
2557634|NCT01387594|8849039|P2|Overall Study|Lost to Follow-up|1
2557635|NCT01387594|8849040|P1|Overall Study|Lost to Follow-up|0
2557636|NCT01387594|8849039|P2|Overall Study|Withdrawal by Subject|2
2557637|NCT01387594|8849040|P1|Overall Study|Withdrawal by Subject|0
2557638|NCT01387542|8849068|P1|Overall Study|Lost to Follow-up|1
2557639|NCT01387542|8849068|P1|Overall Study|Non-compliant|1
2557640|NCT01387542|8849068|P1|Overall Study|Insufficient response|1
2557641|NCT01387542|8849068|P1|Overall Study|Changed diagnosis|1
2557642|NCT01387542|8849068|P1|Overall Study|Withdrawal by Subject|1
2557643|NCT01387542|8849068|P1|Overall Study|Adverse Event|3
2557644|NCT01387516|8849079|P4|Overall Study|Death|1
2557645|NCT01387516|8849080|P3|Overall Study|Death|0
2557646|NCT01387516|8849081|P2|Overall Study|Death|0
2557647|NCT01387516|8849082|P1|Overall Study|Death|0
2557648|NCT01387516|8849079|P4|Overall Study|Withdrawal by Subject|0
2557649|NCT01387516|8849080|P3|Overall Study|Withdrawal by Subject|2
2557650|NCT01387516|8849081|P2|Overall Study|Withdrawal by Subject|1
2557651|NCT01387516|8849082|P1|Overall Study|Withdrawal by Subject|1
2557652|NCT01387516|8849079|P4|Overall Study|Lost to Follow-up|3
2557653|NCT01387516|8849080|P3|Overall Study|Lost to Follow-up|2
2557654|NCT01387516|8849081|P2|Overall Study|Lost to Follow-up|4
2557655|NCT01387516|8849082|P1|Overall Study|Lost to Follow-up|4
2557656|NCT01387347|8849115|P2|Overall Study|Lost to Follow-up|1
2557657|NCT01387347|8849116|P1|Overall Study|Lost to Follow-up|2
2557658|NCT01387282|8849128|P2|Overall Study|Lost to Follow-up|1
2557659|NCT01387282|8849129|P1|Overall Study|Lost to Follow-up|4
2557660|NCT01387282|8849128|P2|Overall Study|Study drug-related AE|2
2557661|NCT01387282|8849129|P1|Overall Study|Study drug-related AE|2
2557662|NCT01387282|8849128|P2|Overall Study|Withdrawal by patient|23
2557663|NCT01387282|8849129|P1|Overall Study|Withdrawal by patient|33
2557664|NCT01387282|8849128|P2|Overall Study|Unrelated AE|4
2557665|NCT01387282|8849129|P1|Overall Study|Unrelated AE|6
2557666|NCT01387282|8849128|P2|Overall Study|Other|1
2557667|NCT01387282|8849129|P1|Overall Study|Other|5
2557668|NCT01387282|8849128|P2|Overall Study|Death|16
2557669|NCT01387282|8849129|P1|Overall Study|Death|47
2557670|NCT01387269|8849145|P2|Overall Study|Lost to Follow-up|0
2557671|NCT01387269|8849146|P1|Overall Study|Lost to Follow-up|1
2557672|NCT01387269|8849145|P2|Overall Study|Study drug-related AE|0
2557673|NCT01387269|8849146|P1|Overall Study|Study drug-related AE|1
2557674|NCT01387269|8849145|P2|Overall Study|Withdrawal by patient|10
2557675|NCT01387269|8849146|P1|Overall Study|Withdrawal by patient|32
2557676|NCT01387269|8849145|P2|Overall Study|Unrelated AE|3
2557677|NCT01387269|8849146|P1|Overall Study|Unrelated AE|12
2557678|NCT01387269|8849145|P2|Overall Study|Other|7
2557679|NCT01387269|8849146|P1|Overall Study|Other|8
2557680|NCT01387269|8849145|P2|Overall Study|Death|20
2557681|NCT01387269|8849146|P1|Overall Study|Death|38
2557682|NCT01387230|8849163|P3|Overall Study|Withdrawal by Subject|0
2557683|NCT01387230|8849164|P2|Overall Study|Withdrawal by Subject|1
2557684|NCT01387230|8849165|P1|Overall Study|Withdrawal by Subject|4
2557685|NCT01387230|8849163|P3|Overall Study|Lost to Follow-up|1
2557686|NCT01387230|8849164|P2|Overall Study|Lost to Follow-up|0
2557687|NCT01387230|8849165|P1|Overall Study|Lost to Follow-up|0
2557688|NCT01387230|8849163|P3|Overall Study|Protocol-defined Stopping Criteria|5
2557689|NCT01387230|8849164|P2|Overall Study|Protocol-defined Stopping Criteria|0
2557690|NCT01387230|8849165|P1|Overall Study|Protocol-defined Stopping Criteria|6
2557691|NCT01387230|8849163|P3|Overall Study|Lack of Efficacy|4
2557692|NCT01387230|8849164|P2|Overall Study|Lack of Efficacy|5
2557693|NCT01387230|8849165|P1|Overall Study|Lack of Efficacy|8
2557694|NCT01387230|8849163|P3|Overall Study|Adverse Event|3
2557695|NCT01387230|8849164|P2|Overall Study|Adverse Event|1
2557696|NCT01387230|8849165|P1|Overall Study|Adverse Event|0
2557697|NCT01387074|8849211|P1|Overall Study|Lack of Efficacy|1
2557698|NCT01387074|8849211|P1|Overall Study|Lost to Follow-up|7
2557699|NCT01387022|8849224|P2|Overall Study|Lost to Follow-up|3
2557700|NCT01387022|8849225|P1|Overall Study|Lost to Follow-up|0
2557701|NCT01387022|8849224|P2|Overall Study|Death|1
2557702|NCT01387022|8849225|P1|Overall Study|Death|1
2557703|NCT01386970|8849254|P2|Overall Study|Adverse Event|1
2557704|NCT01386970|8849255|P1|Overall Study|Adverse Event|4
2557705|NCT01386970|8849254|P2|Overall Study|Withdrawal by Subject|1
2557706|NCT01386970|8849255|P1|Overall Study|Withdrawal by Subject|0
2557707|NCT01386944|8849263|P1|Overall Study|Unspecified reason|8
2557708|NCT01386944|8849263|P1|Overall Study|Lost to Follow-up|8
2557709|NCT01386944|8849263|P1|Overall Study|Lack of Efficacy|14
2557710|NCT01386944|8849263|P1|Overall Study|Adverse Event|26
2557711|NCT01386788|8849273|P1|Overall Study|Lost to Follow-up|2
2557712|NCT01386684|8849278|P1|Overall Study|Missing|3
2557713|NCT01386684|8849278|P1|Overall Study|Protocol Violation|4
2557714|NCT01386684|8849278|P1|Overall Study|Noncompliance|8
2557715|NCT01386684|8849278|P1|Overall Study|Adverse Event|20
2557716|NCT01386684|8849278|P1|Overall Study|Disease Progression|28
2557717|NCT01386684|8849278|P1|Overall Study|Alternative Therapy Required|37
2557718|NCT01386684|8849278|P1|Overall Study|Withdrawal of Consent|44
2557719|NCT01386684|8849278|P1|Overall Study|Death|47
2557720|NCT01386684|8849278|P1|Overall Study|Other|51
2557721|NCT01386684|8849278|P1|Overall Study|Lost to Follow-up|51
2557722|NCT01386658|8849319|P2|Initial Icatibant Exposure|Lack of adherence and poor compliance|3
2557723|NCT01386658|8849320|P1|Initial Icatibant Exposure|Lack of adherence and poor compliance|0
2557724|NCT01386658|8849319|P2|Initial Icatibant Exposure|Withdrawal by Subject|9
2557725|NCT01386658|8849320|P1|Initial Icatibant Exposure|Withdrawal by Subject|0
2557726|NCT01386606|8849398|P4|Overall Study|T levels too high|0
2557727|NCT01386606|8849399|P3|Overall Study|T levels too high|1
2557728|NCT01386606|8849400|P2|Overall Study|T levels too high|1
2557729|NCT01386606|8849401|P1|Overall Study|T levels too high|0
2557730|NCT01386606|8849398|P4|Overall Study|Unable to draw PK|0
2557731|NCT01386606|8849399|P3|Overall Study|Unable to draw PK|0
2557732|NCT01386606|8849400|P2|Overall Study|Unable to draw PK|0
2557733|NCT01386606|8849401|P1|Overall Study|Unable to draw PK|1
2557734|NCT01386606|8849398|P4|Overall Study|Subject incarcerated|0
2557735|NCT01386606|8849399|P3|Overall Study|Subject incarcerated|0
2557736|NCT01386606|8849400|P2|Overall Study|Subject incarcerated|1
2557737|NCT01386606|8849401|P1|Overall Study|Subject incarcerated|0
2557738|NCT01386606|8849398|P4|Overall Study|Lost to Follow-up|0
2557739|NCT01386606|8849399|P3|Overall Study|Lost to Follow-up|0
2557740|NCT01386606|8849400|P2|Overall Study|Lost to Follow-up|0
2557741|NCT01386606|8849401|P1|Overall Study|Lost to Follow-up|2
2557742|NCT01386606|8849398|P4|Overall Study|Protocol Violation|1
2557743|NCT01386606|8849399|P3|Overall Study|Protocol Violation|1
2557744|NCT01386606|8849400|P2|Overall Study|Protocol Violation|0
2557745|NCT01386606|8849401|P1|Overall Study|Protocol Violation|1
2557746|NCT01386606|8849398|P4|Overall Study|Withdrawal by Subject|0
2557747|NCT01386606|8849399|P3|Overall Study|Withdrawal by Subject|1
2557748|NCT01386606|8849400|P2|Overall Study|Withdrawal by Subject|1
2557749|NCT01386606|8849401|P1|Overall Study|Withdrawal by Subject|0
2557750|NCT01386606|8849398|P4|Overall Study|Adverse Event|0
2557751|NCT01386606|8849399|P3|Overall Study|Adverse Event|0
2557752|NCT01386606|8849400|P2|Overall Study|Adverse Event|1
2557753|NCT01386606|8849401|P1|Overall Study|Adverse Event|0
2557754|NCT01386554|8849432|P3|Overall Study|Reason not collected|0
2557755|NCT01386554|8849433|P2|Overall Study|Reason not collected|1
2557756|NCT01386554|8849434|P1|Overall Study|Reason not collected|0
2557757|NCT01386554|8849432|P3|Overall Study|Investigator discretion|1
2557758|NCT01386554|8849433|P2|Overall Study|Investigator discretion|0
2557759|NCT01386554|8849434|P1|Overall Study|Investigator discretion|0
2557760|NCT01386554|8849432|P3|Overall Study|Administration of live vaccines|0
2557761|NCT01386554|8849433|P2|Overall Study|Administration of live vaccines|1
2557762|NCT01386554|8849434|P1|Overall Study|Administration of live vaccines|0
2557763|NCT01386554|8849432|P3|Overall Study|Progressive disease|2
2557764|NCT01386554|8849433|P2|Overall Study|Progressive disease|2
2557765|NCT01386554|8849434|P1|Overall Study|Progressive disease|1
2557766|NCT01386554|8849432|P3|Overall Study|Adverse Event|2
2557767|NCT01386554|8849433|P2|Overall Study|Adverse Event|5
2557768|NCT01386554|8849434|P1|Overall Study|Adverse Event|2
2557769|NCT01386554|8849432|P3|Overall Study|Lost to Follow-up|1
2557770|NCT01386554|8849433|P2|Overall Study|Lost to Follow-up|0
2557771|NCT01386554|8849434|P1|Overall Study|Lost to Follow-up|0
2557772|NCT01386125|8849457|P2|Overall Study|Participant Leaving Country|0
2557773|NCT01386125|8849458|P1|Overall Study|Participant Leaving Country|1
2557774|NCT01386125|8849457|P2|Overall Study|Lack of Efficacy|1
2557775|NCT01386125|8849458|P1|Overall Study|Lack of Efficacy|0
2557776|NCT01386125|8849457|P2|Overall Study|Adverse Event|5
2557777|NCT01386125|8849458|P1|Overall Study|Adverse Event|2
2557778|NCT01386125|8849457|P2|Overall Study|Withdrawal by Subject|12
2557779|NCT01386125|8849458|P1|Overall Study|Withdrawal by Subject|13
2557780|NCT01386125|8849457|P2|Overall Study|Disease Progress|2
2557781|NCT01386125|8849458|P1|Overall Study|Disease Progress|1
2557782|NCT01386125|8849457|P2|Overall Study|Protocol Violation|7
2557783|NCT01386125|8849458|P1|Overall Study|Protocol Violation|5
2557784|NCT01386125|8849457|P2|Overall Study|Physician Decision|1
2557785|NCT01386125|8849458|P1|Overall Study|Physician Decision|0
2557786|NCT01386125|8849457|P2|Overall Study|Lost to Follow-up|9
2557787|NCT01386125|8849458|P1|Overall Study|Lost to Follow-up|3
2557788|NCT01386008|8849466|P1|Overall Study|Adverse Event|3
2557789|NCT01386008|8849466|P1|Overall Study|exited w/o incident /study discontinued|17
2557790|NCT01385995|8849475|P2|Period 1, 2 Months|Physician Decision|0
2557791|NCT01385995|8849476|P1|Period 1, 2 Months|Physician Decision|1
2557792|NCT01385748|8849493|P3|Overall Study|Adverse Event|1
2557793|NCT01385748|8849494|P2|Overall Study|Adverse Event|2
2557794|NCT01385748|8849495|P1|Overall Study|Adverse Event|4
2557795|NCT01385748|8849493|P3|Overall Study|Other|1
2557796|NCT01385748|8849494|P2|Overall Study|Other|7
2557797|NCT01385748|8849495|P1|Overall Study|Other|1
2557798|NCT01385748|8849493|P3|Overall Study|Noncompliance|6
2557799|NCT01385748|8849494|P2|Overall Study|Noncompliance|1
2557800|NCT01385748|8849495|P1|Overall Study|Noncompliance|3
2557801|NCT01385748|8849493|P3|Overall Study|Withdrawal by Subject|5
2557802|NCT01385748|8849494|P2|Overall Study|Withdrawal by Subject|4
2557803|NCT01385748|8849495|P1|Overall Study|Withdrawal by Subject|7
2557804|NCT01385566|8849580|P6|Overall Study|Withdrawal by Subject|0
2557805|NCT01385566|8849581|P5|Overall Study|Withdrawal by Subject|0
2557806|NCT01385566|8849582|P4|Overall Study|Withdrawal by Subject|1
2557807|NCT01385566|8849583|P3|Overall Study|Withdrawal by Subject|0
2557808|NCT01385566|8849584|P2|Overall Study|Withdrawal by Subject|0
2557809|NCT01385566|8849585|P1|Overall Study|Withdrawal by Subject|0
2557810|NCT01385566|8849580|P6|Overall Study|Lost to Follow-up|0
2557811|NCT01385566|8849581|P5|Overall Study|Lost to Follow-up|0
2557812|NCT01385566|8849582|P4|Overall Study|Lost to Follow-up|0
2557813|NCT01385566|8849583|P3|Overall Study|Lost to Follow-up|0
2557814|NCT01385566|8849584|P2|Overall Study|Lost to Follow-up|0
2557815|NCT01385566|8849585|P1|Overall Study|Lost to Follow-up|1
2557816|NCT01385371|8849639|P2|Overall Study|Administrative|2
2557817|NCT01385371|8849640|P1|Overall Study|Administrative|2
2557818|NCT01385371|8849639|P2|Overall Study|Protocol Violation|21
2557819|NCT01385371|8849640|P1|Overall Study|Protocol Violation|25
2557820|NCT01385371|8849639|P2|Overall Study|Withdrawal by Subject|39
2557821|NCT01385371|8849640|P1|Overall Study|Withdrawal by Subject|52
2557822|NCT01385371|8849639|P2|Overall Study|Lost to Follow-up|16
2557823|NCT01385371|8849640|P1|Overall Study|Lost to Follow-up|16
2557824|NCT01385371|8849639|P2|Overall Study|Adverse Event|19
2557825|NCT01385371|8849640|P1|Overall Study|Adverse Event|54
2557826|NCT01385202|8849688|P1|Overall Study|Withdrawn|1
2557827|NCT01385202|8849688|P1|Overall Study|Not Eligible|11
2557828|NCT01385202|8849688|P1|Overall Study|Lost to Follow-up|6
2557829|NCT01385176|8849725|P2|6-18 Month All VNS Active|Heart Transplant|0
2557830|NCT01385176|8849726|P1|6-18 Month All VNS Active|Heart Transplant|1
2557831|NCT01385176|8849725|P2|6-18 Month All VNS Active|Withdrawal by Subject|0
2557832|NCT01385176|8849726|P1|6-18 Month All VNS Active|Withdrawal by Subject|2
2557833|NCT01385176|8849725|P2|6-18 Month All VNS Active|Physician Decision|1
2557834|NCT01385176|8849726|P1|6-18 Month All VNS Active|Physician Decision|0
2557835|NCT01385176|8849725|P2|6-18 Month All VNS Active|Death|2
2557836|NCT01385176|8849726|P1|6-18 Month All VNS Active|Death|1
2557837|NCT01385176|8849725|P2|Randomization Phase|Death|2
2557838|NCT01385176|8849726|P1|Randomization Phase|Death|1
2557839|NCT01385098|8849757|P1|Overall Study|Lost to Follow-up|4
2557840|NCT01385098|8849757|P1|Overall Study|Adverse Event|10
2557841|NCT01384877|8849779|P2|Treatment 2|Lost to Follow-up|2
2557842|NCT01384877|8849780|P1|Treatment 2|Lost to Follow-up|2
2557843|NCT01384760|8849806|P2|Overall Study|Protocol Violation|0
2557844|NCT01384760|8849807|P1|Overall Study|Protocol Violation|16
2557845|NCT01384760|8849806|P2|Overall Study|Lost to Follow-up|6
2557846|NCT01384760|8849807|P1|Overall Study|Lost to Follow-up|0
2557847|NCT01384734|8849820|P5|Overall Study|Physician Decision|0
2557848|NCT01384734|8849821|P4|Overall Study|Physician Decision|0
2557849|NCT01384734|8849822|P3|Overall Study|Physician Decision|0
2557850|NCT01384734|8849823|P2|Overall Study|Physician Decision|0
2557851|NCT01384734|8849824|P1|Overall Study|Physician Decision|1
2557852|NCT01384734|8849820|P5|Overall Study|Early termination|1
2557853|NCT01384734|8849821|P4|Overall Study|Early termination|0
2557854|NCT01384734|8849822|P3|Overall Study|Early termination|0
2557855|NCT01384734|8849823|P2|Overall Study|Early termination|0
2557856|NCT01384734|8849824|P1|Overall Study|Early termination|0
2557857|NCT01384734|8849820|P5|Overall Study|Adhesion problem|0
2557858|NCT01384734|8849821|P4|Overall Study|Adhesion problem|1
2557859|NCT01384734|8849822|P3|Overall Study|Adhesion problem|0
2557860|NCT01384734|8849823|P2|Overall Study|Adhesion problem|0
2557861|NCT01384734|8849824|P1|Overall Study|Adhesion problem|0
2557862|NCT01384734|8849820|P5|Overall Study|Missed End of treatment visit|0
2557863|NCT01384734|8849821|P4|Overall Study|Missed End of treatment visit|1
2557864|NCT01384734|8849822|P3|Overall Study|Missed End of treatment visit|0
2557865|NCT01384734|8849823|P2|Overall Study|Missed End of treatment visit|0
2557866|NCT01384734|8849824|P1|Overall Study|Missed End of treatment visit|0
2557867|NCT01384734|8849820|P5|Overall Study|As per Exclusion criteria|0
2557868|NCT01384734|8849821|P4|Overall Study|As per Exclusion criteria|0
2557869|NCT01384734|8849822|P3|Overall Study|As per Exclusion criteria|0
2557870|NCT01384734|8849823|P2|Overall Study|As per Exclusion criteria|1
2557871|NCT01384734|8849824|P1|Overall Study|As per Exclusion criteria|0
2557872|NCT01384734|8849820|P5|Overall Study|Prison|0
2557873|NCT01384734|8849821|P4|Overall Study|Prison|0
2557874|NCT01384734|8849822|P3|Overall Study|Prison|1
2557875|NCT01384734|8849823|P2|Overall Study|Prison|0
2557876|NCT01384734|8849824|P1|Overall Study|Prison|0
2557877|NCT01384734|8849820|P5|Overall Study|Unable to come back for visit|0
2557878|NCT01384734|8849821|P4|Overall Study|Unable to come back for visit|1
2557879|NCT01384734|8849822|P3|Overall Study|Unable to come back for visit|1
2557880|NCT01384734|8849823|P2|Overall Study|Unable to come back for visit|0
2557881|NCT01384734|8849824|P1|Overall Study|Unable to come back for visit|1
2557882|NCT01384734|8849820|P5|Overall Study|Investigator relocating|1
2557883|NCT01384734|8849821|P4|Overall Study|Investigator relocating|3
2557884|NCT01384734|8849822|P3|Overall Study|Investigator relocating|0
2557885|NCT01384734|8849823|P2|Overall Study|Investigator relocating|2
2557886|NCT01384734|8849824|P1|Overall Study|Investigator relocating|0
2557887|NCT01384734|8849820|P5|Overall Study|Withdrawal by Subject|9
2557888|NCT01384734|8849821|P4|Overall Study|Withdrawal by Subject|7
2557889|NCT01384734|8849822|P3|Overall Study|Withdrawal by Subject|6
2557890|NCT01384734|8849823|P2|Overall Study|Withdrawal by Subject|5
2557891|NCT01384734|8849824|P1|Overall Study|Withdrawal by Subject|5
2557892|NCT01384734|8849820|P5|Overall Study|Sponsor terminated|1
2557893|NCT01384734|8849821|P4|Overall Study|Sponsor terminated|0
2557894|NCT01384734|8849822|P3|Overall Study|Sponsor terminated|0
2557895|NCT01384734|8849823|P2|Overall Study|Sponsor terminated|0
2557896|NCT01384734|8849824|P1|Overall Study|Sponsor terminated|0
2557897|NCT01384734|8849820|P5|Overall Study|Pregnancy|1
2557898|NCT01384734|8849821|P4|Overall Study|Pregnancy|0
2557899|NCT01384734|8849822|P3|Overall Study|Pregnancy|0
2557900|NCT01384734|8849823|P2|Overall Study|Pregnancy|1
2557901|NCT01384734|8849824|P1|Overall Study|Pregnancy|0
2557902|NCT01384734|8849820|P5|Overall Study|Non-compliance with study drug|2
2557903|NCT01384734|8849821|P4|Overall Study|Non-compliance with study drug|0
2557904|NCT01384734|8849822|P3|Overall Study|Non-compliance with study drug|6
2557905|NCT01384734|8849823|P2|Overall Study|Non-compliance with study drug|2
2557906|NCT01384734|8849824|P1|Overall Study|Non-compliance with study drug|1
2557907|NCT01384734|8849820|P5|Overall Study|Lost to Follow-up|5
2557908|NCT01384734|8849821|P4|Overall Study|Lost to Follow-up|8
2557909|NCT01384734|8849822|P3|Overall Study|Lost to Follow-up|3
2557910|NCT01384734|8849823|P2|Overall Study|Lost to Follow-up|3
2557911|NCT01384734|8849824|P1|Overall Study|Lost to Follow-up|5
2557912|NCT01384734|8849820|P5|Overall Study|Lack of Efficacy|2
2557913|NCT01384734|8849821|P4|Overall Study|Lack of Efficacy|4
2557914|NCT01384734|8849822|P3|Overall Study|Lack of Efficacy|4
2557915|NCT01384734|8849823|P2|Overall Study|Lack of Efficacy|7
2557916|NCT01384734|8849824|P1|Overall Study|Lack of Efficacy|3
2557917|NCT01384734|8849820|P5|Overall Study|Continuation criteria not met|0
2557918|NCT01384734|8849821|P4|Overall Study|Continuation criteria not met|1
2557919|NCT01384734|8849822|P3|Overall Study|Continuation criteria not met|1
2557920|NCT01384734|8849823|P2|Overall Study|Continuation criteria not met|0
2557921|NCT01384734|8849824|P1|Overall Study|Continuation criteria not met|0
2557922|NCT01384734|8849820|P5|Overall Study|Death|0
2557923|NCT01384734|8849821|P4|Overall Study|Death|0
2557924|NCT01384734|8849822|P3|Overall Study|Death|1
2557925|NCT01384734|8849823|P2|Overall Study|Death|0
2557926|NCT01384734|8849824|P1|Overall Study|Death|1
2557927|NCT01384734|8849820|P5|Overall Study|Adverse Event|7
2557928|NCT01384734|8849821|P4|Overall Study|Adverse Event|2
2557929|NCT01384734|8849822|P3|Overall Study|Adverse Event|0
2557930|NCT01384734|8849823|P2|Overall Study|Adverse Event|3
2557931|NCT01384734|8849824|P1|Overall Study|Adverse Event|0
2557932|NCT01384292|8850053|P3|Part B|Severe non-compliance to protocol|0
2557933|NCT01384292|8850054|P2|Part B|Severe non-compliance to protocol|0
2557934|NCT01384292|8850055|P1|Part B|Severe non-compliance to protocol|1
2557935|NCT01384019|8850067|P2|Overall Study|MRI refusal|6
2557936|NCT01384019|8850068|P1|Overall Study|MRI refusal|6
2557937|NCT01384019|8850067|P2|Overall Study|Death|0
2557938|NCT01384019|8850068|P1|Overall Study|Death|1
2557939|NCT01384019|8850067|P2|Overall Study|Withdrawal by Subject|0
2557940|NCT01384019|8850068|P1|Overall Study|Withdrawal by Subject|3
2557941|NCT01383993|8850077|P3|Overall Study|Marketed voriconazole in post-therapy|0
2557942|NCT01383993|8850078|P2|Overall Study|Marketed voriconazole in post-therapy|0
2557943|NCT01383993|8850079|P1|Overall Study|Marketed voriconazole in post-therapy|2
2557944|NCT01383993|8850077|P3|Overall Study|Withdrawal by Subject|1
2557945|NCT01383993|8850078|P2|Overall Study|Withdrawal by Subject|0
2557946|NCT01383993|8850079|P1|Overall Study|Withdrawal by Subject|0
2557947|NCT01383993|8850077|P3|Overall Study|Adverse Event|0
2557948|NCT01383993|8850078|P2|Overall Study|Adverse Event|1
2557949|NCT01383993|8850079|P1|Overall Study|Adverse Event|1
2557950|NCT01383954|8850126|P1|Overall Study|Reason Not Specified|9
2557951|NCT01383954|8850126|P1|Overall Study|Adverse Event|1
2557952|NCT01383954|8850126|P1|Overall Study|Electronic Diary Too Cumbersome to Use|2
2557953|NCT01383954|8850126|P1|Overall Study|Lack of Efficacy|2
2557954|NCT01383928|8850134|P3|Overall Study|Unsatisfactory Therapeutic Response|1
2557955|NCT01383928|8850135|P2|Overall Study|Unsatisfactory Therapeutic Response|0
2557956|NCT01383928|8850136|P1|Overall Study|Unsatisfactory Therapeutic Response|0
2557957|NCT01383928|8850134|P3|Overall Study|Withdrawal by Subject|4
2557958|NCT01383928|8850135|P2|Overall Study|Withdrawal by Subject|0
2557959|NCT01383928|8850136|P1|Overall Study|Withdrawal by Subject|0
2557960|NCT01383928|8850134|P3|Overall Study|Progressive Disease|5
2557961|NCT01383928|8850135|P2|Overall Study|Progressive Disease|1
2557962|NCT01383928|8850136|P1|Overall Study|Progressive Disease|1
2557963|NCT01383928|8850134|P3|Overall Study|Other|4
2557964|NCT01383928|8850135|P2|Overall Study|Other|3
2557965|NCT01383928|8850136|P1|Overall Study|Other|1
2557966|NCT01383928|8850134|P3|Overall Study|Adverse Event|8
2557967|NCT01383928|8850135|P2|Overall Study|Adverse Event|2
2557968|NCT01383928|8850136|P1|Overall Study|Adverse Event|1
2557969|NCT01383928|8850134|P3|Overall Study|Initiation of ASCT|18
2557970|NCT01383928|8850135|P2|Overall Study|Initiation of ASCT|1
2557971|NCT01383928|8850136|P1|Overall Study|Initiation of ASCT|2
2557972|NCT01383707|8850217|P1|Overall Study|Progressive disease|23
2557973|NCT01383707|8850217|P1|Overall Study|Adverse Event|14
2557974|NCT01383707|8850217|P1|Overall Study|Sponsor's decision|2
2557975|NCT01383707|8850217|P1|Overall Study|Other|8
2557976|NCT01383707|8850217|P1|Overall Study|Death|19
2557977|NCT01383707|8850217|P1|Overall Study|Consent withdrawal|6
2557978|NCT01383499|8850257|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
2557979|NCT01383499|8850258|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
2557980|NCT01383499|8850259|P2|Period 1 (4 Weeks)|Withdrawal by Subject|0
2557981|NCT01383499|8850260|P1|Period 1 (4 Weeks)|Withdrawal by Subject|1
2557982|NCT01383486|8850310|P1|Overall Study|Did not take any product|6
2557983|NCT01383486|8850310|P1|Overall Study|Incomplete information for analysis|2
2557984|NCT01383486|8850310|P1|Overall Study|Lost to Follow-up|10
2557985|NCT01383356|8850387|P2|Period 1|Personal|2
2557986|NCT01383356|8850388|P1|Period 1|Personal|0
2557987|NCT01383356|8850387|P2|Period 1|Out of Range Mid-study-Test|1
2557988|NCT01383356|8850388|P1|Period 1|Out of Range Mid-study-Test|0
2557989|NCT01383356|8850387|P2|Period 1|Non-compliance|0
2557990|NCT01383356|8850388|P1|Period 1|Non-compliance|3
2557991|NCT01383356|8850387|P2|Period 1|Adverse Event|3
2557992|NCT01383356|8850388|P1|Period 1|Adverse Event|5
2557993|NCT01383317|8850400|P2|Overall Study|Adverse Event|1
2557994|NCT01383317|8850401|P1|Overall Study|Adverse Event|0
2557995|NCT01383317|8850400|P2|Overall Study|Death|0
2557996|NCT01383317|8850401|P1|Overall Study|Death|1
2557997|NCT01383317|8850400|P2|Overall Study|Lost to Follow-up|1
2557998|NCT01383317|8850401|P1|Overall Study|Lost to Follow-up|2
2557999|NCT01383174|8850443|P2|6 Month Assessment|Refused to complete|0
2558000|NCT01383174|8850444|P1|6 Month Assessment|Refused to complete|4
2558001|NCT01383174|8850443|P2|6 Month Assessment|Lost to Follow-up|1
2558002|NCT01383174|8850444|P1|6 Month Assessment|Lost to Follow-up|1
2558003|NCT01383174|8850443|P2|3 Month Assessment|Refused to complete|0
2558004|NCT01383174|8850444|P1|3 Month Assessment|Refused to complete|4
2558005|NCT01383174|8850443|P2|3 Month Assessment|Lost to Follow-up|0
2558006|NCT01383174|8850444|P1|3 Month Assessment|Lost to Follow-up|2
2558007|NCT01383174|8850443|P2|3 Month Assessment|Death|1
2558008|NCT01383174|8850444|P1|3 Month Assessment|Death|0
2558009|NCT01383161|8850470|P2|Overall Study|Lack of Efficacy|1
2558010|NCT01383161|8850471|P1|Overall Study|Lack of Efficacy|0
2558011|NCT01383161|8850470|P2|Overall Study|Withdrawal by Subject|2
2558012|NCT01383161|8850471|P1|Overall Study|Withdrawal by Subject|0
2558013|NCT01383161|8850470|P2|Overall Study|Adverse Event|1
2558014|NCT01383161|8850471|P1|Overall Study|Adverse Event|5
2558015|NCT01383096|8850490|P3|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
2558016|NCT01383096|8850491|P2|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
2558017|NCT01383096|8850492|P1|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1
2558018|NCT01383096|8850490|P3|Fifth Intervention (8 Days)|Withdrawal by Subject|0
2558019|NCT01383096|8850491|P2|Fifth Intervention (8 Days)|Withdrawal by Subject|0
2558020|NCT01383096|8850492|P1|Fifth Intervention (8 Days)|Withdrawal by Subject|1
2558021|NCT01383096|8850490|P3|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
2558022|NCT01383096|8850491|P2|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
2558023|NCT01383096|8850492|P1|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1
2558024|NCT01383096|8850490|P3|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
2558025|NCT01383096|8850491|P2|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
2558026|NCT01383096|8850492|P1|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
2558027|NCT01383096|8850490|P3|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
2558028|NCT01383096|8850491|P2|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
2558029|NCT01383096|8850492|P1|Third Intervention (8 Days)|QTcF was greater than 450 msec|1
2558030|NCT01383096|8850490|P3|Third Intervention (8 Days)|Withdrawal by Subject|0
2558031|NCT01383096|8850491|P2|Third Intervention (8 Days)|Withdrawal by Subject|0
2558032|NCT01383096|8850492|P1|Third Intervention (8 Days)|Withdrawal by Subject|1
2558033|NCT01383096|8850490|P3|Third Intervention (8 Days)|Adverse Event|0
2558034|NCT01383096|8850491|P2|Third Intervention (8 Days)|Adverse Event|0
2558035|NCT01383096|8850492|P1|Third Intervention (8 Days)|Adverse Event|1
2558036|NCT01383096|8850490|P3|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
2558037|NCT01383096|8850491|P2|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3
2558038|NCT01383096|8850492|P1|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
2558039|NCT01383096|8850490|P3|Third Intervention (8 Days)|Elevated AST|0
2558040|NCT01383096|8850491|P2|Third Intervention (8 Days)|Elevated AST|1
2558041|NCT01383096|8850492|P1|Third Intervention (8 Days)|Elevated AST|0
2558042|NCT01383096|8850490|P3|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
2558043|NCT01383096|8850491|P2|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
2558044|NCT01383096|8850492|P1|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
2558045|NCT01383096|8850490|P3|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
2558046|NCT01383096|8850491|P2|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
2558047|NCT01383096|8850492|P1|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
2558048|NCT01383018|8850538|P1|Overall Study|Subject Incarcerated|1
2558049|NCT01383018|8850538|P1|Overall Study|Patient moved away from site|1
2558050|NCT01383018|8850538|P1|Overall Study|Site closed early-not compliance related|7
2558051|NCT01383018|8850538|P1|Overall Study|Missed Visit|247
2558052|NCT01383018|8850538|P1|Overall Study|Subject not implanted|76
2558053|NCT01383018|8850538|P1|Overall Study|Withdrawal by Subject|9
2558054|NCT01383018|8850538|P1|Overall Study|Physician Decision|5
2558055|NCT01383018|8850538|P1|Overall Study|Lost to Follow-up|5
2558056|NCT01383018|8850538|P1|Overall Study|Death|10
2558057|NCT01383018|8850538|P1|Overall Study|Adverse Event|14
2558058|NCT01382940|8850600|P1|Overall Study|Protocol Violation|20
2558059|NCT01382940|8850600|P1|Overall Study|Withdrawal by Subject|23
2558060|NCT01382940|8850600|P1|Overall Study|Physician Decision|7
2558061|NCT01382940|8850600|P1|Overall Study|Lost to Follow-up|4
2558062|NCT01382940|8850600|P1|Overall Study|Adverse Event|19
2558063|NCT01382602|8850662|P2|Overall Study|Withdrawal by Subject|1
2558064|NCT01382602|8850663|P1|Overall Study|Withdrawal by Subject|0
2558065|NCT01382602|8850662|P2|Overall Study|Protocol Violation|3
2558066|NCT01382602|8850663|P1|Overall Study|Protocol Violation|0
2558067|NCT01382446|8850671|P2|Overall Study|Removal from Mechanical Ventilation|3
2558068|NCT01382446|8850672|P1|Overall Study|Removal from Mechanical Ventilation|3
2558069|NCT01382446|8850671|P2|Overall Study|Withdrawal by Subject|1
2558070|NCT01382446|8850672|P1|Overall Study|Withdrawal by Subject|0
2558071|NCT01382251|8850699|P2|Overall Study|Contacted after study closed|1
2558072|NCT01382251|8850700|P1|Overall Study|Contacted after study closed|1
2558073|NCT01382251|8850699|P2|Overall Study|Lost to Follow-up|4
2558074|NCT01382251|8850700|P1|Overall Study|Lost to Follow-up|4
2558075|NCT01382251|8850699|P2|Overall Study|Surgeries cancelled or delayed|16
2558076|NCT01382251|8850700|P1|Overall Study|Surgeries cancelled or delayed|16
2558077|NCT01382225|8850713|P2|Overall Study|Other|2
2558078|NCT01382225|8850714|P1|Overall Study|Other|4
2558079|NCT01382225|8850713|P2|Overall Study|Subject Withdrew Consent|2
2558080|NCT01382225|8850714|P1|Overall Study|Subject Withdrew Consent|5
2558081|NCT01382225|8850713|P2|Overall Study|Protocol Violation|1
2558082|NCT01382225|8850714|P1|Overall Study|Protocol Violation|2
2558083|NCT01382225|8850713|P2|Overall Study|Adverse Event|2
2558084|NCT01382225|8850714|P1|Overall Study|Adverse Event|3
2558085|NCT01382212|8850736|P1|Overall Study|Withdrew consent|1
2558086|NCT01382212|8850736|P1|Overall Study|Kidney transplant|1
2558087|NCT01381926|8850799|P2|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1
2558088|NCT01381926|8850800|P1|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0
2558089|NCT01381926|8850799|P2|Low/High Dose of 1st Treatment (2months)|Adverse Event|0
2558090|NCT01381926|8850800|P1|Low/High Dose of 1st Treatment (2months)|Adverse Event|2
2558091|NCT01381900|8850813|P3|Overall Study|Early withdraw|1
2558092|NCT01381900|8850814|P2|Overall Study|Early withdraw|1
2558093|NCT01381900|8850815|P1|Overall Study|Early withdraw|3
2558094|NCT01381900|8850813|P3|Overall Study|Withdrawal by Subject|1
2558095|NCT01381900|8850814|P2|Overall Study|Withdrawal by Subject|0
2558096|NCT01381900|8850815|P1|Overall Study|Withdrawal by Subject|0
2558097|NCT01381900|8850813|P3|Overall Study|Protocol Violation|1
2558098|NCT01381900|8850814|P2|Overall Study|Protocol Violation|1
2558099|NCT01381900|8850815|P1|Overall Study|Protocol Violation|0
2558100|NCT01381900|8850813|P3|Overall Study|Physician Decision|1
2558101|NCT01381900|8850814|P2|Overall Study|Physician Decision|1
2558102|NCT01381900|8850815|P1|Overall Study|Physician Decision|0
2558103|NCT01381900|8850813|P3|Overall Study|Noncompliance with study drug|1
2558104|NCT01381900|8850814|P2|Overall Study|Noncompliance with study drug|0
2558105|NCT01381900|8850815|P1|Overall Study|Noncompliance with study drug|0
2558106|NCT01381900|8850813|P3|Overall Study|Adverse Event|7
2558107|NCT01381900|8850814|P2|Overall Study|Adverse Event|6
2558108|NCT01381900|8850815|P1|Overall Study|Adverse Event|4
2558109|NCT01381900|8850813|P3|Overall Study|Subject meets glycemic withdrawal crit.|0
2558110|NCT01381900|8850814|P2|Overall Study|Subject meets glycemic withdrawal crit.|0
2558111|NCT01381900|8850815|P1|Overall Study|Subject meets glycemic withdrawal crit.|2
2558112|NCT01381874|8850838|P3|Overall Study|Other|67
2558113|NCT01381874|8850839|P2|Overall Study|Other|52
2558114|NCT01381874|8850840|P1|Overall Study|Other|67
2558115|NCT01381874|8850838|P3|Overall Study|Withdrawal by Subject|9
2558116|NCT01381874|8850839|P2|Overall Study|Withdrawal by Subject|10
2558117|NCT01381874|8850840|P1|Overall Study|Withdrawal by Subject|9
2558118|NCT01381874|8850838|P3|Overall Study|Lost to Follow-up|0
2558119|NCT01381874|8850839|P2|Overall Study|Lost to Follow-up|1
2558120|NCT01381874|8850840|P1|Overall Study|Lost to Follow-up|1
2558121|NCT01381679|8850877|P1|Overall Study|Lost to Follow-up|885
2558122|NCT01381679|8850877|P1|Overall Study|Adverse Event|3
2558123|NCT01381575|8850892|P3|Overall Study|Lost to Follow-up|9
2558124|NCT01381575|8850893|P2|Overall Study|Lost to Follow-up|17
2558125|NCT01381575|8850894|P1|Overall Study|Lost to Follow-up|8
2558126|NCT01381575|8850892|P3|Overall Study|Migrated/moved from study area|2
2558127|NCT01381575|8850893|P2|Overall Study|Migrated/moved from study area|12
2558128|NCT01381575|8850894|P1|Overall Study|Migrated/moved from study area|2
2558129|NCT01381575|8850892|P3|Overall Study|Withdrawal by Subject|7
2558130|NCT01381575|8850893|P2|Overall Study|Withdrawal by Subject|9
2558131|NCT01381575|8850894|P1|Overall Study|Withdrawal by Subject|15
2558132|NCT01381575|8850892|P3|Overall Study|Protocol Violation|1
2558133|NCT01381575|8850893|P2|Overall Study|Protocol Violation|1
2558134|NCT01381575|8850894|P1|Overall Study|Protocol Violation|0
2558135|NCT01381575|8850892|P3|Overall Study|Non-Serious Adverse Event|1
2558136|NCT01381575|8850893|P2|Overall Study|Non-Serious Adverse Event|0
2558137|NCT01381575|8850894|P1|Overall Study|Non-Serious Adverse Event|0
2558138|NCT01381575|8850892|P3|Overall Study|Serious Adverse Event|0
2558139|NCT01381575|8850893|P2|Overall Study|Serious Adverse Event|0
2558140|NCT01381575|8850894|P1|Overall Study|Serious Adverse Event|1
2558141|NCT01381562|8850951|P3|Overall Study|Adverse Event|0
2558142|NCT01381562|8850952|P2|Overall Study|Adverse Event|1
2558143|NCT01381562|8850953|P1|Overall Study|Adverse Event|0
2558144|NCT01381549|8851021|P3|Overall Study|Ineligible: No organisms isolated|1
2558145|NCT01381549|8851022|P2|Overall Study|Ineligible: No organisms isolated|0
2558146|NCT01381549|8851023|P1|Overall Study|Ineligible: No organisms isolated|0
2558147|NCT01381068|8851149|P2|Overall Study|Death|0
2558148|NCT01381068|8851150|P1|Overall Study|Death|1
2558149|NCT01381016|8851170|P2|Overall Study|Physician Decision|2
2558150|NCT01381016|8851171|P1|Overall Study|Physician Decision|0
2558151|NCT01381016|8851170|P2|Overall Study|Withdrawal by Subject|1
2558152|NCT01381016|8851171|P1|Overall Study|Withdrawal by Subject|0
2558153|NCT01381016|8851170|P2|Overall Study|Screen Failure|2
2558154|NCT01381016|8851171|P1|Overall Study|Screen Failure|2
2558155|NCT01381016|8851170|P2|Overall Study|Lost to Follow-up|1
2558156|NCT01381016|8851171|P1|Overall Study|Lost to Follow-up|1
2558157|NCT01380834|8851181|P2|Overall Study|Physician Decision|0
2558158|NCT01380834|8851182|P1|Overall Study|Physician Decision|1
2558159|NCT01380782|8851194|P4|Overall Study|Withdrawal by Subject|1
2558160|NCT01380782|8851195|P3|Overall Study|Withdrawal by Subject|1
2558161|NCT01380782|8851196|P2|Overall Study|Withdrawal by Subject|0
2558162|NCT01380782|8851197|P1|Overall Study|Withdrawal by Subject|0
2558163|NCT01380782|8851194|P4|Overall Study|Physician Decision|0
2558164|NCT01380782|8851195|P3|Overall Study|Physician Decision|0
2558165|NCT01380782|8851196|P2|Overall Study|Physician Decision|0
2558166|NCT01380782|8851197|P1|Overall Study|Physician Decision|1
2558167|NCT01380782|8851194|P4|Overall Study|Lack of Efficacy|3
2558168|NCT01380782|8851195|P3|Overall Study|Lack of Efficacy|10
2558169|NCT01380782|8851196|P2|Overall Study|Lack of Efficacy|9
2558170|NCT01380782|8851197|P1|Overall Study|Lack of Efficacy|10
2558171|NCT01380782|8851194|P4|Overall Study|Death|0
2558172|NCT01380782|8851195|P3|Overall Study|Death|0
2558173|NCT01380782|8851196|P2|Overall Study|Death|0
2558174|NCT01380782|8851197|P1|Overall Study|Death|1
2558175|NCT01380782|8851194|P4|Overall Study|Adverse Event|0
2558176|NCT01380782|8851195|P3|Overall Study|Adverse Event|0
2558177|NCT01380782|8851196|P2|Overall Study|Adverse Event|1
2558178|NCT01380782|8851197|P1|Overall Study|Adverse Event|0
2558179|NCT01380769|8851220|P2|Overall Study|Protocol Violation|1
2558180|NCT01380769|8851221|P1|Overall Study|Protocol Violation|0
2558181|NCT01380769|8851220|P2|Overall Study|Adverse Event|1
2558182|NCT01380769|8851221|P1|Overall Study|Adverse Event|1
2558183|NCT01380769|8851220|P2|Overall Study|Physician Decision|1
2558184|NCT01380769|8851221|P1|Overall Study|Physician Decision|1
2558185|NCT01380769|8851220|P2|Overall Study|Withdrawal by Subject|11
2558186|NCT01380769|8851221|P1|Overall Study|Withdrawal by Subject|7
2558187|NCT01380730|8851282|P8|Overall Study|Death|0
2558188|NCT01380730|8851283|P7|Overall Study|Death|0
2558189|NCT01380730|8851284|P6|Overall Study|Death|0
2558190|NCT01380730|8851285|P5|Overall Study|Death|1
2558191|NCT01380730|8851286|P4|Overall Study|Death|0
2558192|NCT01380730|8851287|P3|Overall Study|Death|0
2558193|NCT01380730|8851288|P2|Overall Study|Death|0
2558194|NCT01380730|8851289|P1|Overall Study|Death|0
2558195|NCT01380691|8851347|P4|Washout (7 Days)|Withdrawal by Subject|0
2558196|NCT01380691|8851348|P3|Washout (7 Days)|Withdrawal by Subject|1
2558197|NCT01380691|8851349|P2|Washout (7 Days)|Withdrawal by Subject|0
2558198|NCT01380691|8851350|P1|Washout (7 Days)|Withdrawal by Subject|0
2558199|NCT01380691|8851347|P4|Washout (7 Days)|Protocol Violation|1
2558200|NCT01380691|8851348|P3|Washout (7 Days)|Protocol Violation|0
2558201|NCT01380691|8851349|P2|Washout (7 Days)|Protocol Violation|0
2558202|NCT01380691|8851350|P1|Washout (7 Days)|Protocol Violation|0
2558203|NCT01380535|8851411|P2|Overall Study|Lack of Efficacy|3
2558204|NCT01380535|8851412|P1|Overall Study|Lack of Efficacy|0
2558205|NCT01380535|8851411|P2|Overall Study|Protocol Violation|2
2558206|NCT01380535|8851412|P1|Overall Study|Protocol Violation|0
2558207|NCT01380535|8851411|P2|Overall Study|Withdrawal by Subject|2
2558208|NCT01380535|8851412|P1|Overall Study|Withdrawal by Subject|1
2558209|NCT01380535|8851411|P2|Overall Study|Study site closed|5
2558210|NCT01380535|8851412|P1|Overall Study|Study site closed|0
2558211|NCT01380535|8851411|P2|Overall Study|Death|0
2558212|NCT01380535|8851412|P1|Overall Study|Death|3
2558213|NCT01380535|8851411|P2|Overall Study|Adverse Event|3
2558214|NCT01380535|8851412|P1|Overall Study|Adverse Event|3
2558215|NCT01380379|8851418|P1|Overall Study|Pregnancy|1
2558216|NCT01380327|8851431|P3|Overall Study|Questionable onset of epilepsy|1
2558217|NCT01380327|8851432|P2|Overall Study|Questionable onset of epilepsy|0
2558218|NCT01380327|8851433|P1|Overall Study|Questionable onset of epilepsy|0
2558219|NCT01380327|8851431|P3|Overall Study|Housing situation precluded ability to k|1
2558220|NCT01380327|8851432|P2|Overall Study|Housing situation precluded ability to k|0
2558221|NCT01380327|8851433|P1|Overall Study|Housing situation precluded ability to k|0
2558222|NCT01380327|8851431|P3|Overall Study|Withdrawal by Subject|1
2558223|NCT01380327|8851432|P2|Overall Study|Withdrawal by Subject|0
2558224|NCT01380327|8851433|P1|Overall Study|Withdrawal by Subject|0
2558225|NCT01380327|8851431|P3|Overall Study|Protocol Violation|3
2558226|NCT01380327|8851432|P2|Overall Study|Protocol Violation|2
2558227|NCT01380327|8851433|P1|Overall Study|Protocol Violation|3
2558228|NCT01380327|8851431|P3|Overall Study|Lost to Follow-up|1
2558229|NCT01380327|8851432|P2|Overall Study|Lost to Follow-up|1
2558230|NCT01380327|8851433|P1|Overall Study|Lost to Follow-up|0
2558231|NCT01380184|8851464|P1|Part 2|Lost to Follow-up|1
2558232|NCT01380184|8851464|P1|Part 2|Disease Progression|8
2558233|NCT01380184|8851464|P1|Part 2|Adverse Event|5
2558234|NCT01380184|8851464|P1|Part 1 (19 Days)|Adverse Event|1
2558235|NCT01380145|8851475|P1|Overall Study|Progressive disease|4
2558236|NCT01380093|8851483|P9|Treatment Phase: Third Intervention|Other|1
2558237|NCT01380093|8851484|P8|Treatment Phase: Third Intervention|Other|0
2558238|NCT01380093|8851485|P7|Treatment Phase: Third Intervention|Other|0
2558239|NCT01380093|8851486|P6|Treatment Phase: Third Intervention|Other|0
2558240|NCT01380093|8851487|P5|Treatment Phase: Third Intervention|Other|0
2558241|NCT01380093|8851488|P4|Treatment Phase: Third Intervention|Other|0
2558242|NCT01380093|8851489|P3|Treatment Phase: Third Intervention|Other|0
2558243|NCT01380093|8851490|P2|Treatment Phase: Third Intervention|Other|0
2558244|NCT01380093|8851491|P1|Treatment Phase: Third Intervention|Other|0
2558245|NCT01380093|8851483|P9|Treatment Phase: Third Intervention|Non-compliance|1
2558246|NCT01380093|8851484|P8|Treatment Phase: Third Intervention|Non-compliance|0
2558247|NCT01380093|8851485|P7|Treatment Phase: Third Intervention|Non-compliance|0
2558248|NCT01380093|8851486|P6|Treatment Phase: Third Intervention|Non-compliance|0
2558249|NCT01380093|8851487|P5|Treatment Phase: Third Intervention|Non-compliance|0
2558250|NCT01380093|8851488|P4|Treatment Phase: Third Intervention|Non-compliance|0
2558251|NCT01380093|8851489|P3|Treatment Phase: Third Intervention|Non-compliance|0
2558252|NCT01380093|8851490|P2|Treatment Phase: Third Intervention|Non-compliance|0
2558253|NCT01380093|8851491|P1|Treatment Phase: Third Intervention|Non-compliance|0
2558254|NCT01380093|8851483|P9|Treatment Phase: Second Intervention|Other|0
2558255|NCT01380093|8851484|P8|Treatment Phase: Second Intervention|Other|0
2558256|NCT01380093|8851485|P7|Treatment Phase: Second Intervention|Other|0
2558257|NCT01380093|8851486|P6|Treatment Phase: Second Intervention|Other|0
2558258|NCT01380093|8851487|P5|Treatment Phase: Second Intervention|Other|0
2558259|NCT01380093|8851488|P4|Treatment Phase: Second Intervention|Other|1
2558260|NCT01380093|8851489|P3|Treatment Phase: Second Intervention|Other|0
2558261|NCT01380093|8851490|P2|Treatment Phase: Second Intervention|Other|0
2558262|NCT01380093|8851491|P1|Treatment Phase: Second Intervention|Other|0
2558263|NCT01380093|8851483|P9|Drug Discrimination Phase: Day 2|Sponsor decision|0
2558264|NCT01380093|8851484|P8|Drug Discrimination Phase: Day 2|Sponsor decision|0
2558265|NCT01380093|8851485|P7|Drug Discrimination Phase: Day 2|Sponsor decision|0
2558266|NCT01380093|8851486|P6|Drug Discrimination Phase: Day 2|Sponsor decision|0
2558267|NCT01380093|8851487|P5|Drug Discrimination Phase: Day 2|Sponsor decision|0
2558268|NCT01380093|8851488|P4|Drug Discrimination Phase: Day 2|Sponsor decision|0
2558269|NCT01380093|8851489|P3|Drug Discrimination Phase: Day 2|Sponsor decision|1
2558270|NCT01380093|8851490|P2|Drug Discrimination Phase: Day 2|Sponsor decision|0
2558271|NCT01380093|8851491|P1|Drug Discrimination Phase: Day 2|Sponsor decision|0
2558272|NCT01380093|8851483|P9|Drug Discrimination Phase: Day 2|Backup participant|0
2558273|NCT01380093|8851484|P8|Drug Discrimination Phase: Day 2|Backup participant|0
2558274|NCT01380093|8851485|P7|Drug Discrimination Phase: Day 2|Backup participant|0
2558275|NCT01380093|8851486|P6|Drug Discrimination Phase: Day 2|Backup participant|0
2558276|NCT01380093|8851487|P5|Drug Discrimination Phase: Day 2|Backup participant|0
2558277|NCT01380093|8851488|P4|Drug Discrimination Phase: Day 2|Backup participant|0
2558278|NCT01380093|8851489|P3|Drug Discrimination Phase: Day 2|Backup participant|1
2558279|NCT01380093|8851490|P2|Drug Discrimination Phase: Day 2|Backup participant|0
2558280|NCT01380093|8851491|P1|Drug Discrimination Phase: Day 2|Backup participant|0
2558281|NCT01380093|8851483|P9|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
2558282|NCT01380093|8851484|P8|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
2558283|NCT01380093|8851485|P7|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
2558284|NCT01380093|8851486|P6|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
2558285|NCT01380093|8851487|P5|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
2558286|NCT01380093|8851488|P4|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
2558287|NCT01380093|8851489|P3|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
2558288|NCT01380093|8851490|P2|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
2558289|NCT01380093|8851491|P1|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
2558290|NCT01380093|8851483|P9|Drug Discrimination Phase: Day 2|Discrimination failure|0
2558291|NCT01380093|8851484|P8|Drug Discrimination Phase: Day 2|Discrimination failure|0
2558292|NCT01380093|8851485|P7|Drug Discrimination Phase: Day 2|Discrimination failure|0
2558293|NCT01380093|8851486|P6|Drug Discrimination Phase: Day 2|Discrimination failure|0
2558294|NCT01380093|8851487|P5|Drug Discrimination Phase: Day 2|Discrimination failure|0
2558295|NCT01380093|8851488|P4|Drug Discrimination Phase: Day 2|Discrimination failure|0
2558619|NCT01377012|8852735|P3|Core Study|Adverse Event|13
2558296|NCT01380093|8851489|P3|Drug Discrimination Phase: Day 2|Discrimination failure|9
2558297|NCT01380093|8851490|P2|Drug Discrimination Phase: Day 2|Discrimination failure|4
2558298|NCT01380093|8851491|P1|Drug Discrimination Phase: Day 2|Discrimination failure|0
2558299|NCT01380093|8851483|P9|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
2558300|NCT01380093|8851484|P8|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
2558301|NCT01380093|8851485|P7|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
2558302|NCT01380093|8851486|P6|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
2558303|NCT01380093|8851487|P5|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
2558304|NCT01380093|8851488|P4|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
2558305|NCT01380093|8851489|P3|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
2558306|NCT01380093|8851490|P2|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1
2558307|NCT01380093|8851491|P1|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
2558308|NCT01380093|8851483|P9|Drug Discrimination Phase: Day 2|Physician Decision|0
2558309|NCT01380093|8851484|P8|Drug Discrimination Phase: Day 2|Physician Decision|0
2558310|NCT01380093|8851485|P7|Drug Discrimination Phase: Day 2|Physician Decision|0
2558311|NCT01380093|8851486|P6|Drug Discrimination Phase: Day 2|Physician Decision|0
2558312|NCT01380093|8851487|P5|Drug Discrimination Phase: Day 2|Physician Decision|0
2558313|NCT01380093|8851488|P4|Drug Discrimination Phase: Day 2|Physician Decision|0
2558314|NCT01380093|8851489|P3|Drug Discrimination Phase: Day 2|Physician Decision|1
2558315|NCT01380093|8851490|P2|Drug Discrimination Phase: Day 2|Physician Decision|3
2558316|NCT01380093|8851491|P1|Drug Discrimination Phase: Day 2|Physician Decision|0
2558317|NCT01380093|8851483|P9|Drug Discrimination Phase: Day 1|Discrimination failure|0
2558318|NCT01380093|8851484|P8|Drug Discrimination Phase: Day 1|Discrimination failure|0
2558319|NCT01380093|8851485|P7|Drug Discrimination Phase: Day 1|Discrimination failure|0
2558320|NCT01380093|8851486|P6|Drug Discrimination Phase: Day 1|Discrimination failure|0
2558321|NCT01380093|8851487|P5|Drug Discrimination Phase: Day 1|Discrimination failure|0
2558322|NCT01380093|8851488|P4|Drug Discrimination Phase: Day 1|Discrimination failure|0
2558323|NCT01380093|8851489|P3|Drug Discrimination Phase: Day 1|Discrimination failure|0
2558324|NCT01380093|8851490|P2|Drug Discrimination Phase: Day 1|Discrimination failure|1
2558325|NCT01380093|8851491|P1|Drug Discrimination Phase: Day 1|Discrimination failure|0
2558326|NCT01380093|8851483|P9|Naloxone Challenge Phase|Screen failures|0
2558327|NCT01380093|8851484|P8|Naloxone Challenge Phase|Screen failures|0
2558328|NCT01380093|8851485|P7|Naloxone Challenge Phase|Screen failures|0
2558329|NCT01380093|8851486|P6|Naloxone Challenge Phase|Screen failures|0
2558330|NCT01380093|8851487|P5|Naloxone Challenge Phase|Screen failures|0
2558331|NCT01380093|8851488|P4|Naloxone Challenge Phase|Screen failures|0
2558332|NCT01380093|8851489|P3|Naloxone Challenge Phase|Screen failures|0
2558333|NCT01380093|8851490|P2|Naloxone Challenge Phase|Screen failures|0
2558334|NCT01380093|8851491|P1|Naloxone Challenge Phase|Screen failures|21
2558335|NCT01380080|8851783|P2|Overall Study|Lost to Follow-up|0
2558336|NCT01380080|8851784|P1|Overall Study|Lost to Follow-up|2
2558337|NCT01380080|8851783|P2|Overall Study|Not willing to adhere to requirements|1
2558338|NCT01380080|8851784|P1|Overall Study|Not willing to adhere to requirements|3
2558339|NCT01380080|8851783|P2|Overall Study|Not able to get to clinic|0
2558340|NCT01380080|8851784|P1|Overall Study|Not able to get to clinic|4
2558341|NCT01380080|8851783|P2|Overall Study|Withdrawal by Subject|0
2558342|NCT01380080|8851784|P1|Overall Study|Withdrawal by Subject|4
2558343|NCT01380080|8851783|P2|Overall Study|Death|22
2558344|NCT01380080|8851784|P1|Overall Study|Death|20
2558345|NCT01379937|8851809|P4|Overall Study|Lost to Follow-up|0
2558346|NCT01379937|8851810|P3|Overall Study|Lost to Follow-up|2
2558347|NCT01379937|8851811|P2|Overall Study|Lost to Follow-up|2
2558348|NCT01379937|8851812|P1|Overall Study|Lost to Follow-up|1
2558349|NCT01379937|8851809|P4|Overall Study|Consent withdrawal|0
2558350|NCT01379937|8851810|P3|Overall Study|Consent withdrawal|0
2558351|NCT01379937|8851811|P2|Overall Study|Consent withdrawal|1
2558352|NCT01379937|8851812|P1|Overall Study|Consent withdrawal|0
2558353|NCT01379937|8851809|P4|Overall Study|Protocol Violation|1
2558354|NCT01379937|8851810|P3|Overall Study|Protocol Violation|0
2558355|NCT01379937|8851811|P2|Overall Study|Protocol Violation|0
2558356|NCT01379937|8851812|P1|Overall Study|Protocol Violation|0
2558357|NCT01379781|8851894|P2|Overall Study|Lost to Follow-up|8
2558358|NCT01379781|8851895|P1|Overall Study|Lost to Follow-up|11
2558359|NCT01379768|8851904|P3|Overall Study|Lost to Follow-up|0
2558360|NCT01379768|8851905|P2|Overall Study|Lost to Follow-up|0
2558361|NCT01379768|8851906|P1|Overall Study|Lost to Follow-up|2
2558362|NCT01379768|8851904|P3|Overall Study|Adverse Event|0
2558363|NCT01379768|8851905|P2|Overall Study|Adverse Event|1
2558364|NCT01379768|8851906|P1|Overall Study|Adverse Event|1
2558365|NCT01379703|8851929|P3|9 Months Through 18 Months|Reason Unknown|0
2558366|NCT01379703|8851930|P2|9 Months Through 18 Months|Reason Unknown|23
2558367|NCT01379703|8851931|P1|9 Months Through 18 Months|Reason Unknown|0
2558368|NCT01379703|8851929|P3|9 Months Through 18 Months|Fatigue|0
2558369|NCT01379703|8851930|P2|9 Months Through 18 Months|Fatigue|1
2558370|NCT01379703|8851931|P1|9 Months Through 18 Months|Fatigue|0
2558371|NCT01379703|8851929|P3|9 Months Through 18 Months|Tuberculosis/TB treatment|0
2558372|NCT01379703|8851930|P2|9 Months Through 18 Months|Tuberculosis/TB treatment|2
2558373|NCT01379703|8851931|P1|9 Months Through 18 Months|Tuberculosis/TB treatment|0
2558374|NCT01379703|8851929|P3|9 Months Through 18 Months|Patient Noncompliance|0
2558620|NCT01377012|8852736|P2|Core Study|Adverse Event|14
2558375|NCT01379703|8851930|P2|9 Months Through 18 Months|Patient Noncompliance|4
2558376|NCT01379703|8851931|P1|9 Months Through 18 Months|Patient Noncompliance|0
2558377|NCT01379703|8851929|P3|9 Months Through 18 Months|Treatment failure|0
2558378|NCT01379703|8851930|P2|9 Months Through 18 Months|Treatment failure|5
2558379|NCT01379703|8851931|P1|9 Months Through 18 Months|Treatment failure|0
2558380|NCT01379703|8851929|P3|9 Months Through 18 Months|Adverse Event|0
2558381|NCT01379703|8851930|P2|9 Months Through 18 Months|Adverse Event|6
2558382|NCT01379703|8851931|P1|9 Months Through 18 Months|Adverse Event|0
2558383|NCT01379703|8851929|P3|9 Months Through 18 Months|Withdrawal by Subject|0
2558384|NCT01379703|8851930|P2|9 Months Through 18 Months|Withdrawal by Subject|11
2558385|NCT01379703|8851931|P1|9 Months Through 18 Months|Withdrawal by Subject|0
2558386|NCT01379703|8851929|P3|9 Months Through 18 Months|Lost to Follow-up|0
2558387|NCT01379703|8851930|P2|9 Months Through 18 Months|Lost to Follow-up|178
2558388|NCT01379703|8851931|P1|9 Months Through 18 Months|Lost to Follow-up|0
2558389|NCT01379703|8851929|P3|Study Start Through 9 Months|Reason unknown|24
2558390|NCT01379703|8851930|P2|Study Start Through 9 Months|Reason unknown|31
2558391|NCT01379703|8851931|P1|Study Start Through 9 Months|Reason unknown|2
2558392|NCT01379703|8851929|P3|Study Start Through 9 Months|Increased triglycerides|0
2558393|NCT01379703|8851930|P2|Study Start Through 9 Months|Increased triglycerides|1
2558394|NCT01379703|8851931|P1|Study Start Through 9 Months|Increased triglycerides|0
2558395|NCT01379703|8851929|P3|Study Start Through 9 Months|Poor general condition|0
2558396|NCT01379703|8851930|P2|Study Start Through 9 Months|Poor general condition|1
2558397|NCT01379703|8851931|P1|Study Start Through 9 Months|Poor general condition|0
2558398|NCT01379703|8851929|P3|Study Start Through 9 Months|Medication not available|1
2558399|NCT01379703|8851930|P2|Study Start Through 9 Months|Medication not available|2
2558400|NCT01379703|8851931|P1|Study Start Through 9 Months|Medication not available|0
2558401|NCT01379703|8851929|P3|Study Start Through 9 Months|Tuberculosis/TB treatment|0
2558402|NCT01379703|8851930|P2|Study Start Through 9 Months|Tuberculosis/TB treatment|4
2558403|NCT01379703|8851931|P1|Study Start Through 9 Months|Tuberculosis/TB treatment|0
2558404|NCT01379703|8851929|P3|Study Start Through 9 Months|Patient Noncompliance|1
2558405|NCT01379703|8851930|P2|Study Start Through 9 Months|Patient Noncompliance|0
2558406|NCT01379703|8851931|P1|Study Start Through 9 Months|Patient Noncompliance|0
2558407|NCT01379703|8851929|P3|Study Start Through 9 Months|Treatment Failure|2
2558408|NCT01379703|8851930|P2|Study Start Through 9 Months|Treatment Failure|2
2558409|NCT01379703|8851931|P1|Study Start Through 9 Months|Treatment Failure|0
2558410|NCT01379703|8851929|P3|Study Start Through 9 Months|Withdrawal by Subject|1
2558411|NCT01379703|8851930|P2|Study Start Through 9 Months|Withdrawal by Subject|6
2558412|NCT01379703|8851931|P1|Study Start Through 9 Months|Withdrawal by Subject|0
2558413|NCT01379703|8851929|P3|Study Start Through 9 Months|Adverse Event|10
2558414|NCT01379703|8851930|P2|Study Start Through 9 Months|Adverse Event|14
2558415|NCT01379703|8851931|P1|Study Start Through 9 Months|Adverse Event|0
2558416|NCT01379703|8851929|P3|Study Start Through 9 Months|Lost to Follow-up|104
2558417|NCT01379703|8851930|P2|Study Start Through 9 Months|Lost to Follow-up|61
2558418|NCT01379703|8851931|P1|Study Start Through 9 Months|Lost to Follow-up|2
2558419|NCT01379573|8852029|P1|Overall Study|Screen Failure|10
2558420|NCT01379573|8852029|P1|Overall Study|Lost to Follow-up|1
2558421|NCT01379534|8852043|P2|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0
2558422|NCT01379534|8852044|P1|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1
2558423|NCT01379534|8852043|P2|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1
2558424|NCT01379534|8852044|P1|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0
2558425|NCT01379534|8852043|P2|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0
2558426|NCT01379534|8852044|P1|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3
2558427|NCT01379534|8852043|P2|Tumor Assessment Follow-up (f/u) Phase|Death|1
2558428|NCT01379534|8852044|P1|Tumor Assessment Follow-up (f/u) Phase|Death|0
2558429|NCT01379534|8852043|P2|Treatment Phase|Adverse Event|7
2558430|NCT01379534|8852044|P1|Treatment Phase|Adverse Event|7
2558431|NCT01379534|8852043|P2|Treatment Phase|Progressive disease|22
2558432|NCT01379534|8852044|P1|Treatment Phase|Progressive disease|13
2558433|NCT01379534|8852043|P2|Treatment Phase|Withdrawal by Subject|2
2558434|NCT01379534|8852044|P1|Treatment Phase|Withdrawal by Subject|2
2558435|NCT01379521|8852064|P2|Post-Treatment Evaluations|Death|0
2558436|NCT01379521|8852065|P1|Post-Treatment Evaluations|Death|1
2558437|NCT01379521|8852064|P2|Post-Treatment Evaluations|Withdrawal by Subject|1
2558438|NCT01379521|8852065|P1|Post-Treatment Evaluations|Withdrawal by Subject|2
2558439|NCT01379521|8852064|P2|Post-Treatment Evaluations|Disease Progression|20
2558440|NCT01379521|8852065|P1|Post-Treatment Evaluations|Disease Progression|22
2558441|NCT01379521|8852064|P2|Overall Study -Treatment Period|Death|1
2558442|NCT01379521|8852065|P1|Overall Study -Treatment Period|Death|2
2558443|NCT01379521|8852064|P2|Overall Study -Treatment Period|Administrative Problems|0
2558444|NCT01379521|8852065|P1|Overall Study -Treatment Period|Administrative Problems|1
2558445|NCT01379521|8852064|P2|Overall Study -Treatment Period|Withdrawal by Subject|0
2558446|NCT01379521|8852065|P1|Overall Study -Treatment Period|Withdrawal by Subject|3
2558447|NCT01379521|8852064|P2|Overall Study -Treatment Period|Protocol Deviation|2
2558448|NCT01379521|8852065|P1|Overall Study -Treatment Period|Protocol Deviation|0
2558449|NCT01379521|8852064|P2|Overall Study -Treatment Period|New Cancer Therapy|0
2558450|NCT01379521|8852065|P1|Overall Study -Treatment Period|New Cancer Therapy|1
2558451|NCT01379521|8852064|P2|Overall Study -Treatment Period|Disease Progression|22
2558452|NCT01379521|8852065|P1|Overall Study -Treatment Period|Disease Progression|23
2558453|NCT01379521|8852064|P2|Overall Study -Treatment Period|Abnormal test procedure results|1
2558454|NCT01379521|8852065|P1|Overall Study -Treatment Period|Abnormal test procedure results|0
2558455|NCT01379521|8852064|P2|Overall Study -Treatment Period|Adverse Event|0
2558456|NCT01379521|8852065|P1|Overall Study -Treatment Period|Adverse Event|3
2558457|NCT01379508|8852087|P4|Extension Period Weeks 109-156|Protocol Violation|0
2558458|NCT01379508|8852088|P3|Extension Period Weeks 109-156|Protocol Violation|0
2558459|NCT01379508|8852089|P2|Extension Period Weeks 109-156|Protocol Violation|1
2558460|NCT01379508|8852090|P1|Extension Period Weeks 109-156|Protocol Violation|2
2558461|NCT01379508|8852087|P4|Extension Period Weeks 109-156|Administrative problems|0
2558462|NCT01379508|8852088|P3|Extension Period Weeks 109-156|Administrative problems|1
2558463|NCT01379508|8852089|P2|Extension Period Weeks 109-156|Administrative problems|0
2558464|NCT01379508|8852090|P1|Extension Period Weeks 109-156|Administrative problems|3
2558465|NCT01379508|8852087|P4|Extension Period Weeks 109-156|Lost to Follow-up|0
2558466|NCT01379508|8852088|P3|Extension Period Weeks 109-156|Lost to Follow-up|5
2558467|NCT01379508|8852089|P2|Extension Period Weeks 109-156|Lost to Follow-up|1
2558468|NCT01379508|8852090|P1|Extension Period Weeks 109-156|Lost to Follow-up|6
2558469|NCT01379508|8852087|P4|Extension Period Weeks 109-156|Withdrawal by Subject|0
2558470|NCT01379508|8852088|P3|Extension Period Weeks 109-156|Withdrawal by Subject|8
2558471|NCT01379508|8852089|P2|Extension Period Weeks 109-156|Withdrawal by Subject|1
2558472|NCT01379508|8852090|P1|Extension Period Weeks 109-156|Withdrawal by Subject|8
2558473|NCT01379508|8852087|P4|Treatment to Week 104|Protocol Violation|0
2558474|NCT01379508|8852088|P3|Treatment to Week 104|Protocol Violation|1
2558475|NCT01379508|8852089|P2|Treatment to Week 104|Protocol Violation|1
2558476|NCT01379508|8852090|P1|Treatment to Week 104|Protocol Violation|1
2558477|NCT01379508|8852087|P4|Treatment to Week 104|Administrative problems|0
2558478|NCT01379508|8852088|P3|Treatment to Week 104|Administrative problems|0
2558479|NCT01379508|8852089|P2|Treatment to Week 104|Administrative problems|1
2558480|NCT01379508|8852090|P1|Treatment to Week 104|Administrative problems|3
2558481|NCT01379508|8852087|P4|Treatment to Week 104|Lost to Follow-up|0
2558482|NCT01379508|8852088|P3|Treatment to Week 104|Lost to Follow-up|3
2558483|NCT01379508|8852089|P2|Treatment to Week 104|Lost to Follow-up|0
2558484|NCT01379508|8852090|P1|Treatment to Week 104|Lost to Follow-up|5
2558485|NCT01379508|8852087|P4|Treatment to Week 104|Withdrawal by Subject|0
2558486|NCT01379508|8852088|P3|Treatment to Week 104|Withdrawal by Subject|4
2558487|NCT01379508|8852089|P2|Treatment to Week 104|Withdrawal by Subject|1
2558488|NCT01379508|8852090|P1|Treatment to Week 104|Withdrawal by Subject|6
2558489|NCT01379508|8852087|P4|Treatment to Week 104|Abnormal test procedure result(s)|0
2558490|NCT01379508|8852088|P3|Treatment to Week 104|Abnormal test procedure result(s)|0
2558491|NCT01379508|8852089|P2|Treatment to Week 104|Abnormal test procedure result(s)|0
2558492|NCT01379508|8852090|P1|Treatment to Week 104|Abnormal test procedure result(s)|1
2558493|NCT01379508|8852087|P4|Treatment to Week 104|Abnormal lab value|0
2558494|NCT01379508|8852088|P3|Treatment to Week 104|Abnormal lab value|0
2558495|NCT01379508|8852089|P2|Treatment to Week 104|Abnormal lab value|0
2558496|NCT01379508|8852090|P1|Treatment to Week 104|Abnormal lab value|1
2558497|NCT01379508|8852087|P4|Treatment to Week 104|Adverse Event|0
2558498|NCT01379508|8852088|P3|Treatment to Week 104|Adverse Event|5
2558499|NCT01379508|8852089|P2|Treatment to Week 104|Adverse Event|0
2558500|NCT01379508|8852090|P1|Treatment to Week 104|Adverse Event|2
2558501|NCT01378975|8852172|P2|Overall Study|Withdrew Consent|3
2558502|NCT01378975|8852173|P1|Overall Study|Withdrew Consent|4
2558503|NCT01378975|8852172|P2|Overall Study|Lost to Follow-up|1
2558504|NCT01378975|8852173|P1|Overall Study|Lost to Follow-up|4
2558505|NCT01378975|8852172|P2|Overall Study|Investigator Request|0
2558506|NCT01378975|8852173|P1|Overall Study|Investigator Request|1
2558507|NCT01378975|8852172|P2|Overall Study|Death|46
2558508|NCT01378975|8852173|P1|Overall Study|Death|77
2558509|NCT01378962|8852199|P1|Overall Study|Other|2
2558510|NCT01378962|8852199|P1|Overall Study|Lost to Follow-up|1
2558511|NCT01378962|8852199|P1|Overall Study|Death|14
2558512|NCT01378429|8852225|P2|Overall Study|Noncompliance with study drug|0
2558513|NCT01378429|8852226|P1|Overall Study|Noncompliance with study drug|1
2558514|NCT01378325|8852339|P2|Overall Study|Protocol Violation|1
2558515|NCT01378325|8852340|P1|Overall Study|Protocol Violation|0
2558516|NCT01378195|8852394|P2|Overall Study|Lost to Follow-up|18
2558517|NCT01378195|8852395|P1|Overall Study|Lost to Follow-up|29
2558518|NCT01378117|8852408|P3|Overall Study|discharged before med given|1
2558519|NCT01378117|8852409|P2|Overall Study|discharged before med given|0
2558520|NCT01378117|8852410|P1|Overall Study|discharged before med given|2
2558521|NCT01378117|8852408|P3|Overall Study|withdrawal|2
2558522|NCT01378117|8852409|P2|Overall Study|withdrawal|1
2558523|NCT01378117|8852410|P1|Overall Study|withdrawal|2
2558524|NCT01378104|8852444|P2|Overall Study|Withdrawal by Subject|13
2558525|NCT01378104|8852445|P1|Overall Study|Withdrawal by Subject|12
2558526|NCT01378104|8852444|P2|Overall Study|Lack of Efficacy|5
2558527|NCT01378104|8852445|P1|Overall Study|Lack of Efficacy|7
2558528|NCT01378104|8852444|P2|Overall Study|Adverse Event|8
2558529|NCT01378104|8852445|P1|Overall Study|Adverse Event|8
2558530|NCT01377987|8852490|P2|Washout (7 Days)|Withdrawal by Subject|1
2558531|NCT01377987|8852491|P1|Washout (7 Days)|Withdrawal by Subject|1
2558532|NCT01377922|8852509|P2|Overall Study|rescue tx after part 2, entered part 4|0
2558533|NCT01377922|8852510|P1|Overall Study|rescue tx after part 2, entered part 4|1
2558534|NCT01377480|8852595|P4|Overall Study|Other|6
2558535|NCT01377480|8852596|P3|Overall Study|Other|7
2558536|NCT01377480|8852597|P2|Overall Study|Other|0
2558537|NCT01377480|8852598|P1|Overall Study|Other|0
2558538|NCT01377480|8852595|P4|Overall Study|Serious adverse event|1
2558539|NCT01377480|8852596|P3|Overall Study|Serious adverse event|1
2558540|NCT01377480|8852597|P2|Overall Study|Serious adverse event|0
2558541|NCT01377480|8852598|P1|Overall Study|Serious adverse event|0
2558542|NCT01377480|8852595|P4|Overall Study|Withdrawal by Subject|0
2558543|NCT01377480|8852596|P3|Overall Study|Withdrawal by Subject|1
2558544|NCT01377480|8852597|P2|Overall Study|Withdrawal by Subject|0
2558545|NCT01377480|8852598|P1|Overall Study|Withdrawal by Subject|0
2558546|NCT01377480|8852595|P4|Overall Study|Evidence of drug-induced hepatotoxicity|0
2558547|NCT01377480|8852596|P3|Overall Study|Evidence of drug-induced hepatotoxicity|1
2558548|NCT01377480|8852597|P2|Overall Study|Evidence of drug-induced hepatotoxicity|1
2558549|NCT01377480|8852598|P1|Overall Study|Evidence of drug-induced hepatotoxicity|0
2558550|NCT01377480|8852595|P4|Overall Study|Protocol Violation|4
2558551|NCT01377480|8852596|P3|Overall Study|Protocol Violation|0
2558552|NCT01377480|8852597|P2|Overall Study|Protocol Violation|0
2558553|NCT01377480|8852598|P1|Overall Study|Protocol Violation|0
2558554|NCT01377389|8852674|P1|Overall Study|Screen failure|2
2558555|NCT01377389|8852674|P1|Overall Study|Withdrawal by Subject|1
2558556|NCT01377233|8852688|P5|Double-blind|Administrative or other|1
2558557|NCT01377233|8852689|P4|Double-blind|Administrative or other|1
2558558|NCT01377233|8852690|P3|Double-blind|Administrative or other|0
2558559|NCT01377233|8852691|P2|Double-blind|Administrative or other|0
2558560|NCT01377233|8852692|P1|Double-blind|Administrative or other|0
2558561|NCT01377233|8852688|P5|Double-blind|Withdrawal by Subject|0
2558562|NCT01377233|8852689|P4|Double-blind|Withdrawal by Subject|1
2558563|NCT01377233|8852690|P3|Double-blind|Withdrawal by Subject|0
2558564|NCT01377233|8852691|P2|Double-blind|Withdrawal by Subject|0
2558565|NCT01377233|8852692|P1|Double-blind|Withdrawal by Subject|0
2558566|NCT01377233|8852688|P5|Double-blind|Protocol Violation|1
2558567|NCT01377233|8852689|P4|Double-blind|Protocol Violation|0
2558568|NCT01377233|8852690|P3|Double-blind|Protocol Violation|0
2558569|NCT01377233|8852691|P2|Double-blind|Protocol Violation|0
2558570|NCT01377233|8852692|P1|Double-blind|Protocol Violation|0
2558571|NCT01377233|8852688|P5|Double-blind|Adverse Event|0
2558572|NCT01377233|8852689|P4|Double-blind|Adverse Event|2
2558573|NCT01377233|8852690|P3|Double-blind|Adverse Event|2
2558574|NCT01377233|8852691|P2|Double-blind|Adverse Event|1
2558575|NCT01377233|8852692|P1|Double-blind|Adverse Event|0
2558576|NCT01377233|8852688|P5|Open-label|Withdrawal by Subject|0
2558577|NCT01377233|8852689|P4|Open-label|Withdrawal by Subject|0
2558578|NCT01377233|8852690|P3|Open-label|Withdrawal by Subject|0
2558579|NCT01377233|8852691|P2|Open-label|Withdrawal by Subject|0
2558580|NCT01377233|8852692|P1|Open-label|Withdrawal by Subject|3
2558581|NCT01377233|8852688|P5|Open-label|Adverse Event|0
2558582|NCT01377233|8852689|P4|Open-label|Adverse Event|0
2558583|NCT01377233|8852690|P3|Open-label|Adverse Event|0
2558584|NCT01377233|8852691|P2|Open-label|Adverse Event|0
2558585|NCT01377233|8852692|P1|Open-label|Adverse Event|1
2558586|NCT01377194|8852719|P3|Overall Study|Lost to Follow-up|11
2558587|NCT01377194|8852720|P2|Overall Study|Lost to Follow-up|8
2558588|NCT01377194|8852721|P1|Overall Study|Lost to Follow-up|14
2558589|NCT01377194|8852719|P3|Overall Study|Withdrawal by Subject|7
2558590|NCT01377194|8852720|P2|Overall Study|Withdrawal by Subject|10
2558591|NCT01377194|8852721|P1|Overall Study|Withdrawal by Subject|8
2558592|NCT01377194|8852719|P3|Overall Study|Protocol Violation|6
2558593|NCT01377194|8852720|P2|Overall Study|Protocol Violation|10
2558594|NCT01377194|8852721|P1|Overall Study|Protocol Violation|4
2558595|NCT01377194|8852719|P3|Overall Study|Lack of Efficacy|3
2558596|NCT01377194|8852720|P2|Overall Study|Lack of Efficacy|3
2558597|NCT01377194|8852721|P1|Overall Study|Lack of Efficacy|3
2558598|NCT01377194|8852719|P3|Overall Study|Adverse Event|19
2558599|NCT01377194|8852720|P2|Overall Study|Adverse Event|12
2558600|NCT01377194|8852721|P1|Overall Study|Adverse Event|3
2558601|NCT01377012|8852735|P3|Extension Study, Weeks 104-260|Adverse Event|1
2558602|NCT01377012|8852736|P2|Extension Study, Weeks 104-260|Adverse Event|2
2558603|NCT01377012|8852737|P1|Extension Study, Weeks 104-260|Adverse Event|0
2558604|NCT01377012|8852735|P3|Extension Study, Weeks 104-260|Lost to Follow-up|1
2558605|NCT01377012|8852736|P2|Extension Study, Weeks 104-260|Lost to Follow-up|0
2558606|NCT01377012|8852737|P1|Extension Study, Weeks 104-260|Lost to Follow-up|0
2558607|NCT01377012|8852735|P3|Extension Study, Weeks 104-260|Physician Decision|0
2558608|NCT01377012|8852736|P2|Extension Study, Weeks 104-260|Physician Decision|0
2558609|NCT01377012|8852737|P1|Extension Study, Weeks 104-260|Physician Decision|1
2558610|NCT01377012|8852735|P3|Extension Study, Weeks 104-260|Withdrawal by Subject|3
2558611|NCT01377012|8852736|P2|Extension Study, Weeks 104-260|Withdrawal by Subject|0
2558612|NCT01377012|8852737|P1|Extension Study, Weeks 104-260|Withdrawal by Subject|1
2558613|NCT01377012|8852735|P3|Extension Study, Weeks 104-260|Study terminated by sponsor|63
2558614|NCT01377012|8852736|P2|Extension Study, Weeks 104-260|Study terminated by sponsor|69
2558615|NCT01377012|8852737|P1|Extension Study, Weeks 104-260|Study terminated by sponsor|52
2558616|NCT01377012|8852735|P3|Extension Study, Weeks 104-260|Lack of Efficacy|0
2558617|NCT01377012|8852736|P2|Extension Study, Weeks 104-260|Lack of Efficacy|0
2558618|NCT01377012|8852737|P1|Extension Study, Weeks 104-260|Lack of Efficacy|3
2558621|NCT01377012|8852737|P1|Core Study|Adverse Event|10
2558622|NCT01377012|8852735|P3|Core Study|Death|1
2558623|NCT01377012|8852736|P2|Core Study|Death|1
2558624|NCT01377012|8852737|P1|Core Study|Death|1
2558625|NCT01377012|8852735|P3|Core Study|Lack of Efficacy|37
2558626|NCT01377012|8852736|P2|Core Study|Lack of Efficacy|28
2558627|NCT01377012|8852737|P1|Core Study|Lack of Efficacy|41
2558628|NCT01377012|8852735|P3|Core Study|Lost to Follow-up|4
2558629|NCT01377012|8852736|P2|Core Study|Lost to Follow-up|5
2558630|NCT01377012|8852737|P1|Core Study|Lost to Follow-up|7
2558631|NCT01377012|8852735|P3|Core Study|No Longer require treatment|1
2558632|NCT01377012|8852736|P2|Core Study|No Longer require treatment|0
2558633|NCT01377012|8852737|P1|Core Study|No Longer require treatment|0
2558634|NCT01377012|8852735|P3|Core Study|Non-Compliant with study treatment|1
2558635|NCT01377012|8852736|P2|Core Study|Non-Compliant with study treatment|0
2558636|NCT01377012|8852737|P1|Core Study|Non-Compliant with study treatment|0
2558637|NCT01377012|8852735|P3|Core Study|Physician Decision|10
2558638|NCT01377012|8852736|P2|Core Study|Physician Decision|4
2558639|NCT01377012|8852737|P1|Core Study|Physician Decision|5
2558640|NCT01377012|8852735|P3|Core Study|Pregnancy|1
2558641|NCT01377012|8852736|P2|Core Study|Pregnancy|0
2558642|NCT01377012|8852737|P1|Core Study|Pregnancy|0
2558643|NCT01377012|8852735|P3|Core Study|Protocol Violation|2
2558644|NCT01377012|8852736|P2|Core Study|Protocol Violation|3
2558645|NCT01377012|8852737|P1|Core Study|Protocol Violation|7
2558646|NCT01377012|8852735|P3|Core Study|Withdrawal by Subject|18
2558647|NCT01377012|8852736|P2|Core Study|Withdrawal by Subject|23
2558648|NCT01377012|8852737|P1|Core Study|Withdrawal by Subject|15
2558649|NCT01377012|8852735|P3|Core Study|Technical problems|0
2558650|NCT01377012|8852736|P2|Core Study|Technical problems|0
2558651|NCT01377012|8852737|P1|Core Study|Technical problems|1
2558652|NCT01377012|8852735|P3|Core Study|Study terminated by Sponsor|46
2558653|NCT01377012|8852736|P2|Core Study|Study terminated by Sponsor|54
2558654|NCT01377012|8852737|P1|Core Study|Study terminated by Sponsor|47
2558655|NCT01376908|8852774|P2|Overall Study|Withdrawal by Subject|2
2558656|NCT01376908|8852775|P1|Overall Study|Withdrawal by Subject|1
2558657|NCT01376908|8852774|P2|Overall Study|Protocol Violation|1
2558658|NCT01376908|8852775|P1|Overall Study|Protocol Violation|1
2558659|NCT01376804|8852808|P1|Treatment Period|Patient did not receive study drug|1
2558660|NCT01376804|8852808|P1|Treatment Period|Adverse Event|6
2558661|NCT01376804|8852808|P1|Treatment Period|Withdrawal by Subject|1
2558662|NCT01376700|8852819|P1|Overall Study|Low or high titer inhibitor|8
2558663|NCT01376700|8852819|P1|Overall Study|Sponsor terminated study early|8
2558664|NCT01376388|8852881|P1|Overall Study|Withdrawal by Subject|3
2558665|NCT01376388|8852881|P1|Overall Study|Lack of Efficacy|2
2558666|NCT01376388|8852881|P1|Overall Study|Adverse Event|13
2558667|NCT01376349|8852919|P3|Raondomized Treatment|Alternative Treatment|1
2558668|NCT01376349|8852920|P2|Raondomized Treatment|Alternative Treatment|0
2558669|NCT01376349|8852921|P1|Raondomized Treatment|Alternative Treatment|0
2558670|NCT01376349|8852919|P3|Raondomized Treatment|Unkown|1
2558671|NCT01376349|8852920|P2|Raondomized Treatment|Unkown|2
2558672|NCT01376349|8852921|P1|Raondomized Treatment|Unkown|1
2558673|NCT01376349|8852919|P3|Raondomized Treatment|Adverse Event|14
2558674|NCT01376349|8852920|P2|Raondomized Treatment|Adverse Event|17
2558675|NCT01376349|8852921|P1|Raondomized Treatment|Adverse Event|13
2558676|NCT01376349|8852919|P3|Raondomized Treatment|Withdrawal by Subject|13
2558677|NCT01376349|8852920|P2|Raondomized Treatment|Withdrawal by Subject|16
2558678|NCT01376349|8852921|P1|Raondomized Treatment|Withdrawal by Subject|10
2558679|NCT01376323|8852935|P5|Overall Study|Withdrawal by Subject|0
2558680|NCT01376323|8852936|P4|Overall Study|Withdrawal by Subject|0
2558681|NCT01376323|8852937|P3|Overall Study|Withdrawal by Subject|1
2558682|NCT01376323|8852938|P2|Overall Study|Withdrawal by Subject|1
2558683|NCT01376323|8852939|P1|Overall Study|Withdrawal by Subject|0
2558684|NCT01376323|8852935|P5|Overall Study|Physician Decision|1
2558685|NCT01376323|8852936|P4|Overall Study|Physician Decision|1
2558686|NCT01376323|8852937|P3|Overall Study|Physician Decision|2
2558687|NCT01376323|8852938|P2|Overall Study|Physician Decision|0
2558688|NCT01376323|8852939|P1|Overall Study|Physician Decision|1
2558689|NCT01376323|8852935|P5|Overall Study|Lost to Follow-up|0
2558690|NCT01376323|8852936|P4|Overall Study|Lost to Follow-up|2
2558691|NCT01376323|8852937|P3|Overall Study|Lost to Follow-up|0
2558692|NCT01376323|8852938|P2|Overall Study|Lost to Follow-up|0
2558693|NCT01376323|8852939|P1|Overall Study|Lost to Follow-up|0
2558694|NCT01376323|8852935|P5|Overall Study|Adverse Event|0
2558695|NCT01376323|8852936|P4|Overall Study|Adverse Event|2
2558696|NCT01376323|8852937|P3|Overall Study|Adverse Event|0
2558697|NCT01376323|8852938|P2|Overall Study|Adverse Event|0
2558698|NCT01376323|8852939|P1|Overall Study|Adverse Event|1
2558699|NCT01376310|8853023|P2|Overall Study|Lost to Follow-up|0
2558700|NCT01376310|8853024|P1|Overall Study|Lost to Follow-up|1
2558701|NCT01376310|8853023|P2|Overall Study|Physician Decision|7
2558702|NCT01376310|8853024|P1|Overall Study|Physician Decision|26
2558703|NCT01376310|8853023|P2|Overall Study|Withdrawal by Subject|2
2558704|NCT01376310|8853024|P1|Overall Study|Withdrawal by Subject|8
2558705|NCT01376310|8853023|P2|Overall Study|Study closed/terminated|2
2558706|NCT01376310|8853024|P1|Overall Study|Study closed/terminated|1
2558707|NCT01376245|8853043|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
2558708|NCT01376245|8853044|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
2558709|NCT01376245|8853045|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
2558710|NCT01376245|8853046|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
2558711|NCT01376245|8853047|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
2558712|NCT01376245|8853043|P5|24-week, Double-blind Treatment Period|Physician Decision|0
2558713|NCT01376245|8853044|P4|24-week, Double-blind Treatment Period|Physician Decision|1
2558714|NCT01376245|8853045|P3|24-week, Double-blind Treatment Period|Physician Decision|1
2558715|NCT01376245|8853046|P2|24-week, Double-blind Treatment Period|Physician Decision|0
2558716|NCT01376245|8853047|P1|24-week, Double-blind Treatment Period|Physician Decision|0
2558717|NCT01376245|8853043|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
2558718|NCT01376245|8853044|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|1
2558719|NCT01376245|8853045|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
2558720|NCT01376245|8853046|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|2
2558721|NCT01376245|8853047|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
2558722|NCT01376245|8853043|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
2558723|NCT01376245|8853044|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1
2558724|NCT01376245|8853045|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3
2558725|NCT01376245|8853046|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2
2558726|NCT01376245|8853047|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
2558727|NCT01376245|8853043|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
2558728|NCT01376245|8853044|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
2558729|NCT01376245|8853045|P3|24-week, Double-blind Treatment Period|Protocol Violation|0
2558730|NCT01376245|8853046|P2|24-week, Double-blind Treatment Period|Protocol Violation|2
2558731|NCT01376245|8853047|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
2558732|NCT01376245|8853043|P5|24-week, Double-blind Treatment Period|Lack of Efficacy|3
2558733|NCT01376245|8853044|P4|24-week, Double-blind Treatment Period|Lack of Efficacy|4
2558734|NCT01376245|8853045|P3|24-week, Double-blind Treatment Period|Lack of Efficacy|5
2558735|NCT01376245|8853046|P2|24-week, Double-blind Treatment Period|Lack of Efficacy|4
2558736|NCT01376245|8853047|P1|24-week, Double-blind Treatment Period|Lack of Efficacy|0
2558737|NCT01376245|8853043|P5|24-week, Double-blind Treatment Period|Adverse Event|18
2558738|NCT01376245|8853044|P4|24-week, Double-blind Treatment Period|Adverse Event|8
2558739|NCT01376245|8853045|P3|24-week, Double-blind Treatment Period|Adverse Event|7
2558740|NCT01376245|8853046|P2|24-week, Double-blind Treatment Period|Adverse Event|16
2558741|NCT01376245|8853047|P1|24-week, Double-blind Treatment Period|Adverse Event|0
2558742|NCT01376245|8853043|P5|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
2558743|NCT01376245|8853044|P4|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
2558744|NCT01376245|8853045|P3|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
2558745|NCT01376245|8853046|P2|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
2558746|NCT01376245|8853047|P1|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28
2558747|NCT01376245|8853043|P5|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
2558748|NCT01376245|8853044|P4|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
2558749|NCT01376245|8853045|P3|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
2558750|NCT01376245|8853046|P2|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
2558751|NCT01376245|8853047|P1|2-wk Single-blind Placebo Run-in Period|Physician Decision|2
2558752|NCT01376245|8853043|P5|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
2558753|NCT01376245|8853044|P4|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
2558754|NCT01376245|8853045|P3|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
2558755|NCT01376245|8853046|P2|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
2558756|NCT01376245|8853047|P1|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1
2558757|NCT01376245|8853043|P5|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
2558758|NCT01376245|8853044|P4|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
2558759|NCT01376245|8853045|P3|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
2558760|NCT01376245|8853046|P2|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
2558761|NCT01376245|8853047|P1|2-wk Single-blind Placebo Run-in Period|Adverse Event|4
2558762|NCT01376245|8853043|P5|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
2558763|NCT01376245|8853044|P4|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
2558764|NCT01376245|8853045|P3|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
2558765|NCT01376245|8853046|P2|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
2558766|NCT01376245|8853047|P1|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66
2558767|NCT01376167|8853064|P3|Overall Study|Withdrawal by Subject|4
2558768|NCT01376167|8853065|P2|Overall Study|Withdrawal by Subject|5
2558769|NCT01376167|8853066|P1|Overall Study|Withdrawal by Subject|1
2558770|NCT01376167|8853064|P3|Overall Study|Physician Decision|0
2558771|NCT01376167|8853065|P2|Overall Study|Physician Decision|1
2558772|NCT01376167|8853066|P1|Overall Study|Physician Decision|1
2558773|NCT01376167|8853064|P3|Overall Study|Lost to Follow-up|2
2558774|NCT01376167|8853065|P2|Overall Study|Lost to Follow-up|4
2558775|NCT01376167|8853066|P1|Overall Study|Lost to Follow-up|2
2558776|NCT01376089|8853137|P2|Overall Study|Patient received no contrast media|4
2558777|NCT01376089|8853138|P1|Overall Study|Patient received no contrast media|3
2558778|NCT01376037|8853161|P2|Overall Study|Lost to Follow-up|2
2558779|NCT01376037|8853162|P1|Overall Study|Lost to Follow-up|0
2558780|NCT01375777|8853190|P9|Overall Study|Other|1
2558781|NCT01375777|8853191|P8|Overall Study|Other|0
2558782|NCT01375777|8853192|P7|Overall Study|Other|0
2558783|NCT01375777|8853193|P6|Overall Study|Other|0
2558784|NCT01375777|8853194|P5|Overall Study|Other|0
2558785|NCT01375777|8853195|P4|Overall Study|Other|0
2558786|NCT01375777|8853196|P3|Overall Study|Other|0
2558787|NCT01375777|8853197|P2|Overall Study|Other|1
2558788|NCT01375777|8853198|P1|Overall Study|Other|1
2558789|NCT01375777|8853190|P9|Overall Study|Lost to Follow-up|0
2558790|NCT01375777|8853191|P8|Overall Study|Lost to Follow-up|0
2558791|NCT01375777|8853192|P7|Overall Study|Lost to Follow-up|1
2558792|NCT01375777|8853193|P6|Overall Study|Lost to Follow-up|0
2558793|NCT01375777|8853194|P5|Overall Study|Lost to Follow-up|0
2558794|NCT01375777|8853195|P4|Overall Study|Lost to Follow-up|0
2558795|NCT01375777|8853196|P3|Overall Study|Lost to Follow-up|0
2558796|NCT01375777|8853197|P2|Overall Study|Lost to Follow-up|0
2558797|NCT01375777|8853198|P1|Overall Study|Lost to Follow-up|1
2558798|NCT01375777|8853190|P9|Overall Study|Withdrawal by Subject|1
2558799|NCT01375777|8853191|P8|Overall Study|Withdrawal by Subject|2
2558800|NCT01375777|8853192|P7|Overall Study|Withdrawal by Subject|1
2558801|NCT01375777|8853193|P6|Overall Study|Withdrawal by Subject|1
2558802|NCT01375777|8853194|P5|Overall Study|Withdrawal by Subject|1
2558803|NCT01375777|8853195|P4|Overall Study|Withdrawal by Subject|0
2558804|NCT01375777|8853196|P3|Overall Study|Withdrawal by Subject|1
2558805|NCT01375777|8853197|P2|Overall Study|Withdrawal by Subject|2
2558806|NCT01375777|8853198|P1|Overall Study|Withdrawal by Subject|0
2558807|NCT01375764|8853268|P5|Overall Study|Other|0
2558808|NCT01375764|8853269|P4|Overall Study|Other|1
2558809|NCT01375764|8853270|P3|Overall Study|Other|0
2558810|NCT01375764|8853271|P2|Overall Study|Other|0
2558811|NCT01375764|8853272|P1|Overall Study|Other|0
2558812|NCT01375764|8853268|P5|Overall Study|Withdrawal by Subject|1
2558813|NCT01375764|8853269|P4|Overall Study|Withdrawal by Subject|0
2558814|NCT01375764|8853270|P3|Overall Study|Withdrawal by Subject|0
2558815|NCT01375764|8853271|P2|Overall Study|Withdrawal by Subject|0
2558816|NCT01375764|8853272|P1|Overall Study|Withdrawal by Subject|2
2558817|NCT01375764|8853268|P5|Overall Study|Lost to Follow-up|0
2558818|NCT01375764|8853269|P4|Overall Study|Lost to Follow-up|0
2558819|NCT01375764|8853270|P3|Overall Study|Lost to Follow-up|0
2558820|NCT01375764|8853271|P2|Overall Study|Lost to Follow-up|1
2558821|NCT01375764|8853272|P1|Overall Study|Lost to Follow-up|0
2558822|NCT01375751|8853318|P3|Overall Study|Other|0
2558823|NCT01375751|8853319|P2|Overall Study|Other|1
2558824|NCT01375751|8853320|P1|Overall Study|Other|0
2558825|NCT01375608|8853364|P1|Overall Study|Withdrawal by Subject|2
2558826|NCT01375374|8853392|P1|Overall Study|Adverse Event|1
2558827|NCT01375205|8853401|P2|Overall Study|Withdrawal by Subject|1
2558828|NCT01375205|8853402|P1|Overall Study|Withdrawal by Subject|6
2558829|NCT01375205|8853401|P2|Overall Study|Lost to Follow-up|12
2558830|NCT01375205|8853402|P1|Overall Study|Lost to Follow-up|15
2558831|NCT01375075|8853475|P6|Overall Study|Withdrawal by Subject|1
2558832|NCT01375075|8853476|P5|Overall Study|Withdrawal by Subject|0
2558833|NCT01375075|8853477|P4|Overall Study|Withdrawal by Subject|0
2558834|NCT01375075|8853478|P3|Overall Study|Withdrawal by Subject|0
2558835|NCT01375075|8853479|P2|Overall Study|Withdrawal by Subject|1
2558836|NCT01375075|8853480|P1|Overall Study|Withdrawal by Subject|0
2558837|NCT01375075|8853475|P6|Overall Study|Entry Criterion Not Met|1
2558838|NCT01375075|8853476|P5|Overall Study|Entry Criterion Not Met|0
2558839|NCT01375075|8853477|P4|Overall Study|Entry Criterion Not Met|0
2558840|NCT01375075|8853478|P3|Overall Study|Entry Criterion Not Met|0
2558841|NCT01375075|8853479|P2|Overall Study|Entry Criterion Not Met|0
2558842|NCT01375075|8853480|P1|Overall Study|Entry Criterion Not Met|1
2558843|NCT01375075|8853475|P6|Overall Study|Adverse Event|1
2558844|NCT01375075|8853476|P5|Overall Study|Adverse Event|0
2558845|NCT01375075|8853477|P4|Overall Study|Adverse Event|1
2558846|NCT01375075|8853478|P3|Overall Study|Adverse Event|3
2558847|NCT01375075|8853479|P2|Overall Study|Adverse Event|0
2558848|NCT01375075|8853480|P1|Overall Study|Adverse Event|0
2558849|NCT01375049|8853564|P1|Overall Study|Protocol-Specified Withdrawal Criteria|45
2558850|NCT01375049|8853564|P1|Overall Study|Withdrawal by Subject|2
2558851|NCT01375049|8853564|P1|Overall Study|Lost to Follow-up|1
2558852|NCT01375049|8853564|P1|Overall Study|Adverse Event|2
2558853|NCT01375010|8853581|P2|Overall Study|Withdrawal by Subject|2
2558854|NCT01375010|8853582|P1|Overall Study|Withdrawal by Subject|4
2558855|NCT01375010|8853581|P2|Overall Study|Lost to Follow-up|2
2558856|NCT01375010|8853582|P1|Overall Study|Lost to Follow-up|8
2558857|NCT01374971|8853596|P1|Overall Study|Withdrawal by Subject|1
2558858|NCT01374919|8853601|P1|Overall Study|Withdrawal by Subject|2
2558859|NCT01374906|8853608|P2|Overall Study|Unsatisfactory therapeutic effect|19
2558860|NCT01374906|8853609|P1|Overall Study|Unsatisfactory therapeutic effect|11
2558861|NCT01374906|8853608|P2|Overall Study|Withdrawal by Subject|9
2558862|NCT01374906|8853609|P1|Overall Study|Withdrawal by Subject|15
2558863|NCT01374906|8853608|P2|Overall Study|Protocol Violation|2
2558864|NCT01374906|8853609|P1|Overall Study|Protocol Violation|2
2558865|NCT01374906|8853608|P2|Overall Study|Death|2
2558866|NCT01374906|8853609|P1|Overall Study|Death|0
2558867|NCT01374906|8853608|P2|Overall Study|Adverse Event|11
2558868|NCT01374906|8853609|P1|Overall Study|Adverse Event|10
2558869|NCT01374906|8853608|P2|Overall Study|Administrative problems|2
2558870|NCT01374906|8853609|P1|Overall Study|Administrative problems|2
2558871|NCT01374906|8853608|P2|Overall Study|Abnormal laboratory value(s)|3
2558872|NCT01374906|8853609|P1|Overall Study|Abnormal laboratory value(s)|0
2558873|NCT01374568|8853690|P2|Overall Study|Lab unable to analyze BTM|2
2558874|NCT01374568|8853691|P1|Overall Study|Lab unable to analyze BTM|0
2558875|NCT01374516|8853701|P2|Surveillance Expansion Period|Serious adverse event|5
2558876|NCT01374516|8853702|P1|Surveillance Expansion Period|Serious adverse event|20
2558877|NCT01374516|8853701|P2|Surveillance Expansion Period|Lost to Follow-up|45
2558878|NCT01374516|8853702|P1|Surveillance Expansion Period|Lost to Follow-up|73
2558879|NCT01374516|8853701|P2|Surveillance Expansion Period|Withdrawal by Subject|986
2558880|NCT01374516|8853702|P1|Surveillance Expansion Period|Withdrawal by Subject|1870
2558881|NCT01374516|8853701|P2|Surveillance Expansion Period|Protocol Violation|217
2558882|NCT01374516|8853702|P1|Surveillance Expansion Period|Protocol Violation|386
2558883|NCT01374516|8853701|P2|Vaccination Phase (Up to 25 Months)|Serious adverse event|9
2558884|NCT01374516|8853702|P1|Vaccination Phase (Up to 25 Months)|Serious adverse event|7
2558885|NCT01374516|8853701|P2|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46
2558886|NCT01374516|8853702|P1|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106
2558887|NCT01374516|8853701|P2|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240
2558888|NCT01374516|8853702|P1|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480
2558889|NCT01374516|8853701|P2|Vaccination Phase (Up to 25 Months)|Adverse Event|0
2558890|NCT01374516|8853702|P1|Vaccination Phase (Up to 25 Months)|Adverse Event|3
2558891|NCT01374516|8853701|P2|Vaccination Phase (Up to 25 Months)|Protocol Violation|14
2558892|NCT01374516|8853702|P1|Vaccination Phase (Up to 25 Months)|Protocol Violation|43
2558893|NCT01374451|8853736|P2|Overall Study|Administrative problems|0
2558894|NCT01374451|8853737|P1|Overall Study|Administrative problems|1
2558895|NCT01374425|8853783|P2|Overall Study|Other|43
2558896|NCT01374425|8853784|P1|Overall Study|Other|41
2558897|NCT01374425|8853783|P2|Overall Study|Lost to Follow-up|1
2558898|NCT01374425|8853784|P1|Overall Study|Lost to Follow-up|2
2558899|NCT01374425|8853783|P2|Overall Study|Sponsor Decision|1
2558900|NCT01374425|8853784|P1|Overall Study|Sponsor Decision|0
2558901|NCT01374425|8853783|P2|Overall Study|Protocol Violation|3
2558902|NCT01374425|8853784|P1|Overall Study|Protocol Violation|2
2558903|NCT01374425|8853783|P2|Overall Study|Refused Treatment|24
2558904|NCT01374425|8853784|P1|Overall Study|Refused Treatment|10
2558905|NCT01374425|8853783|P2|Overall Study|Withdrawal by Subject|7
2558906|NCT01374425|8853784|P1|Overall Study|Withdrawal by Subject|6
2558907|NCT01374425|8853783|P2|Overall Study|Death (Adverse Event)|4
2558908|NCT01374425|8853784|P1|Overall Study|Death (Adverse Event)|2
2558909|NCT01374425|8853783|P2|Overall Study|Death (Progression of Disease)|0
2558910|NCT01374425|8853784|P1|Overall Study|Death (Progression of Disease)|1
2558911|NCT01374425|8853783|P2|Overall Study|Adverse Event|18
2558912|NCT01374425|8853784|P1|Overall Study|Adverse Event|29
2558913|NCT01374425|8853783|P2|Overall Study|Clinical Disease Progression|6
2558914|NCT01374425|8853784|P1|Overall Study|Clinical Disease Progression|9
2558915|NCT01374425|8853783|P2|Overall Study|Radiographic Disease Progression|81
2558916|NCT01374425|8853784|P1|Overall Study|Radiographic Disease Progression|86
2558917|NCT01374269|8853864|P2|Overall Study|closed research|2
2558918|NCT01374269|8853865|P1|Overall Study|closed research|1
2558919|NCT01374269|8853864|P2|Overall Study|Lost to Follow-up|3
2558920|NCT01374269|8853865|P1|Overall Study|Lost to Follow-up|1
2558921|NCT01374269|8853864|P2|Overall Study|Withdrawal by Subject|0
2558922|NCT01374269|8853865|P1|Overall Study|Withdrawal by Subject|4
2558923|NCT01374217|8853993|P1|Overall Study|Lack of Efficacy|13
2558924|NCT01374178|8854001|P2|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0
2558925|NCT01374178|8854002|P1|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2
2558926|NCT01374178|8854001|P2|Washout Period of at Least 7 Days|Withdrawal by Subject|0
2558927|NCT01374178|8854002|P1|Washout Period of at Least 7 Days|Withdrawal by Subject|1
2558928|NCT01374087|8854020|P2|Overall Study|Study discontinued|13
2558929|NCT01374087|8854021|P1|Overall Study|Study discontinued|13
2558930|NCT01374087|8854020|P2|Overall Study|Disease progression|2
2558931|NCT01374087|8854021|P1|Overall Study|Disease progression|2
2558932|NCT01374087|8854020|P2|Overall Study|Adverse Event|0
2558933|NCT01374087|8854021|P1|Overall Study|Adverse Event|1
2558934|NCT01373931|8854041|P2|Period 1|Withdrawal by Subject|2
2558935|NCT01373931|8854042|P1|Period 1|Withdrawal by Subject|0
2558936|NCT01373931|8854041|P2|Period 1|Adverse Event|0
2558937|NCT01373931|8854042|P1|Period 1|Adverse Event|2
2558938|NCT01373931|8854041|P2|Lead-in Period|Adverse Event|0
2558939|NCT01373931|8854042|P1|Lead-in Period|Adverse Event|2
2558940|NCT01373918|8854055|P2|Overall Study|Physician Decision|1
2558941|NCT01373918|8854056|P1|Overall Study|Physician Decision|0
2558942|NCT01373346|8854115|P1|Overall Study|Death|1
2558943|NCT01373294|8854138|P2|Overall Study|Adverse Event|0
2558944|NCT01373294|8854139|P1|Overall Study|Adverse Event|1
2558945|NCT01373281|8854148|P2|Surveillance Expansion Period|Serious adverse event|4
2558946|NCT01373281|8854149|P1|Surveillance Expansion Period|Serious adverse event|3
2558947|NCT01373281|8854148|P2|Surveillance Expansion Period|Lost to Follow-up|8
2558948|NCT01373281|8854149|P1|Surveillance Expansion Period|Lost to Follow-up|10
2558949|NCT01373281|8854148|P2|Surveillance Expansion Period|Protocol Violation|1
2558950|NCT01373281|8854149|P1|Surveillance Expansion Period|Protocol Violation|9
2558951|NCT01373281|8854148|P2|Surveillance Expansion Period|Withdrawal by Subject|105
2558952|NCT01373281|8854149|P1|Surveillance Expansion Period|Withdrawal by Subject|180
2558953|NCT01373281|8854148|P2|Vaccination Phase (Up to 25 Months)|Serious adverse event|1
2558954|NCT01373281|8854149|P1|Vaccination Phase (Up to 25 Months)|Serious adverse event|4
2558955|NCT01373281|8854148|P2|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1
2558956|NCT01373281|8854149|P1|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5
2558957|NCT01373281|8854148|P2|Vaccination Phase (Up to 25 Months)|Protocol Violation|2
2558958|NCT01373281|8854149|P1|Vaccination Phase (Up to 25 Months)|Protocol Violation|5
2558959|NCT01373281|8854148|P2|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23
2558960|NCT01373281|8854149|P1|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40
2558961|NCT01373229|8854197|P1|Overall Study|Physician Decision|3
2558962|NCT01373229|8854197|P1|Overall Study|Death|3
2558963|NCT01373164|8854211|P5|Overall Study|Withdrawal by Subject|2
2558964|NCT01373164|8854212|P4|Overall Study|Withdrawal by Subject|10
2558965|NCT01373164|8854213|P3|Overall Study|Withdrawal by Subject|0
2558966|NCT01373164|8854214|P2|Overall Study|Withdrawal by Subject|1
2558967|NCT01373164|8854215|P1|Overall Study|Withdrawal by Subject|0
2558968|NCT01373164|8854211|P5|Overall Study|Lost to Follow-up|0
2558969|NCT01373164|8854212|P4|Overall Study|Lost to Follow-up|2
2558970|NCT01373164|8854213|P3|Overall Study|Lost to Follow-up|1
2558971|NCT01373164|8854214|P2|Overall Study|Lost to Follow-up|0
2558972|NCT01373164|8854215|P1|Overall Study|Lost to Follow-up|0
2558973|NCT01372995|8854249|P3|Overall Study|Physician Decision|1
2558974|NCT01372995|8854250|P2|Overall Study|Physician Decision|0
2558975|NCT01372995|8854251|P1|Overall Study|Physician Decision|0
2558976|NCT01372995|8854249|P3|Overall Study|Spouse withdrew participant from study|0
2558977|NCT01372995|8854250|P2|Overall Study|Spouse withdrew participant from study|1
2558978|NCT01372995|8854251|P1|Overall Study|Spouse withdrew participant from study|0
2558979|NCT01372878|8854298|P1|Overall Study|incomplete study procedure|104
2558980|NCT01372878|8854298|P1|Overall Study|Protocol Violation|17
2558981|NCT01372878|8854298|P1|Overall Study|Withdrawal by Subject|63
2558982|NCT01372774|8854318|P2|Overall Study|Withdrawal prior to treatment|5
2558983|NCT01372774|8854319|P1|Overall Study|Withdrawal prior to treatment|4
2558984|NCT01372748|8854335|P2|Overall Study|Withdrawal by Subject|5
2558985|NCT01372748|8854336|P1|Overall Study|Withdrawal by Subject|7
2558986|NCT01372748|8854335|P2|Overall Study|Lost to Follow-up|34
2558987|NCT01372748|8854336|P1|Overall Study|Lost to Follow-up|16
2558988|NCT01372618|8854344|P1|Overall Study|PI Died. Study Terminated|9
2558989|NCT01372605|8854352|P2|Overall Study|Changed medical home|0
2558990|NCT01372605|8854353|P1|Overall Study|Changed medical home|2
2558991|NCT01372605|8854352|P2|Overall Study|Moved|0
2558992|NCT01372605|8854353|P1|Overall Study|Moved|3
2558993|NCT01372605|8854352|P2|Overall Study|Withdrawal by Subject|7
2558994|NCT01372605|8854353|P1|Overall Study|Withdrawal by Subject|4
2558995|NCT01372605|8854352|P2|Overall Study|Lost to Follow-up|1
2558996|NCT01372605|8854353|P1|Overall Study|Lost to Follow-up|2
2558997|NCT01372605|8854352|P2|Overall Study|Death|2
2558998|NCT01372605|8854353|P1|Overall Study|Death|1
2558999|NCT01372501|8854379|P1|Overall Study|Device migration|1
2559000|NCT01372501|8854379|P1|Overall Study|Adverse Event|4
2559001|NCT01372410|8854402|P8|Treatment Period 3 (7 Days)|Protocol Deviation|0
2559002|NCT01372410|8854403|P7|Treatment Period 3 (7 Days)|Protocol Deviation|0
2559003|NCT01372410|8854404|P6|Treatment Period 3 (7 Days)|Protocol Deviation|1
2559004|NCT01372410|8854405|P5|Treatment Period 3 (7 Days)|Protocol Deviation|0
2559005|NCT01372410|8854406|P4|Treatment Period 3 (7 Days)|Protocol Deviation|0
2559006|NCT01372410|8854407|P3|Treatment Period 3 (7 Days)|Protocol Deviation|0
2559007|NCT01372410|8854408|P2|Treatment Period 3 (7 Days)|Protocol Deviation|0
2559008|NCT01372410|8854409|P1|Treatment Period 3 (7 Days)|Protocol Deviation|0
2559009|NCT01372410|8854402|P8|Treatment Period 3 (7 Days)|Adverse Event|0
2559010|NCT01372410|8854403|P7|Treatment Period 3 (7 Days)|Adverse Event|0
2559011|NCT01372410|8854404|P6|Treatment Period 3 (7 Days)|Adverse Event|0
2559012|NCT01372410|8854405|P5|Treatment Period 3 (7 Days)|Adverse Event|0
2559013|NCT01372410|8854406|P4|Treatment Period 3 (7 Days)|Adverse Event|0
2559014|NCT01372410|8854407|P3|Treatment Period 3 (7 Days)|Adverse Event|1
2559015|NCT01372410|8854408|P2|Treatment Period 3 (7 Days)|Adverse Event|0
2559016|NCT01372410|8854409|P1|Treatment Period 3 (7 Days)|Adverse Event|0
2559017|NCT01372410|8854402|P8|Washout Period 2 (10-14 Days)|Lack of Efficacy|1
2559018|NCT01372410|8854403|P7|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
2559019|NCT01372410|8854404|P6|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
2559020|NCT01372410|8854405|P5|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
2559021|NCT01372410|8854406|P4|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
2559022|NCT01372410|8854407|P3|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
2559023|NCT01372410|8854408|P2|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
2559024|NCT01372410|8854409|P1|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
2559025|NCT01372410|8854402|P8|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
2559026|NCT01372410|8854403|P7|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
2559027|NCT01372410|8854404|P6|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
2559028|NCT01372410|8854405|P5|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
2559029|NCT01372410|8854406|P4|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
2559030|NCT01372410|8854407|P3|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
2559031|NCT01372410|8854408|P2|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
2559032|NCT01372410|8854409|P1|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
2559033|NCT01372410|8854402|P8|Washout Period 2 (10-14 Days)|Adverse Event|0
2559034|NCT01372410|8854403|P7|Washout Period 2 (10-14 Days)|Adverse Event|0
2559035|NCT01372410|8854404|P6|Washout Period 2 (10-14 Days)|Adverse Event|0
2559036|NCT01372410|8854405|P5|Washout Period 2 (10-14 Days)|Adverse Event|1
2559037|NCT01372410|8854406|P4|Washout Period 2 (10-14 Days)|Adverse Event|0
2559038|NCT01372410|8854407|P3|Washout Period 2 (10-14 Days)|Adverse Event|0
2559039|NCT01372410|8854408|P2|Washout Period 2 (10-14 Days)|Adverse Event|0
2559040|NCT01372410|8854409|P1|Washout Period 2 (10-14 Days)|Adverse Event|0
2559041|NCT01372410|8854402|P8|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
2559042|NCT01372410|8854403|P7|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
2559043|NCT01372410|8854404|P6|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
2559044|NCT01372410|8854405|P5|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
2559045|NCT01372410|8854406|P4|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
2559046|NCT01372410|8854407|P3|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
2559047|NCT01372410|8854408|P2|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
2559048|NCT01372410|8854409|P1|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
2559049|NCT01372410|8854402|P8|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
2559050|NCT01372410|8854403|P7|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1
2559051|NCT01372410|8854404|P6|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
2559052|NCT01372410|8854405|P5|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
2559053|NCT01372410|8854406|P4|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
2559054|NCT01372410|8854407|P3|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
2559055|NCT01372410|8854408|P2|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
2559056|NCT01372410|8854409|P1|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
2559057|NCT01372410|8854402|P8|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2559058|NCT01372410|8854403|P7|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2559059|NCT01372410|8854404|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2559060|NCT01372410|8854405|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|1
2559061|NCT01372410|8854406|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2559062|NCT01372410|8854407|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2559063|NCT01372410|8854408|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2559064|NCT01372410|8854409|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|0
2559065|NCT01372410|8854402|P8|Treatment Period 1 (7 Days)|Adverse Event|0
2559066|NCT01372410|8854403|P7|Treatment Period 1 (7 Days)|Adverse Event|1
2559067|NCT01372410|8854404|P6|Treatment Period 1 (7 Days)|Adverse Event|0
2559068|NCT01372410|8854405|P5|Treatment Period 1 (7 Days)|Adverse Event|0
2559069|NCT01372410|8854406|P4|Treatment Period 1 (7 Days)|Adverse Event|0
2559070|NCT01372410|8854407|P3|Treatment Period 1 (7 Days)|Adverse Event|0
2559071|NCT01372410|8854408|P2|Treatment Period 1 (7 Days)|Adverse Event|1
2559072|NCT01372410|8854409|P1|Treatment Period 1 (7 Days)|Adverse Event|0
2559073|NCT01372410|8854402|P8|Treatment Period 1 (7 Days)|Lack of Efficacy|0
2559074|NCT01372410|8854403|P7|Treatment Period 1 (7 Days)|Lack of Efficacy|0
2559075|NCT01372410|8854404|P6|Treatment Period 1 (7 Days)|Lack of Efficacy|0
2559076|NCT01372410|8854405|P5|Treatment Period 1 (7 Days)|Lack of Efficacy|1
2559077|NCT01372410|8854406|P4|Treatment Period 1 (7 Days)|Lack of Efficacy|0
2559078|NCT01372410|8854407|P3|Treatment Period 1 (7 Days)|Lack of Efficacy|0
2559079|NCT01372410|8854408|P2|Treatment Period 1 (7 Days)|Lack of Efficacy|1
2559080|NCT01372410|8854409|P1|Treatment Period 1 (7 Days)|Lack of Efficacy|1
2559081|NCT01372384|8854446|P1|Overall Study|Progression of disease|3
2559082|NCT01372150|8854478|P3|Overall Study|Randomized but not treated|0
2559083|NCT01372150|8854479|P2|Overall Study|Randomized but not treated|1
2559084|NCT01372150|8854480|P1|Overall Study|Randomized but not treated|0
2559085|NCT01372150|8854478|P3|Overall Study|Adverse Event|2
2559086|NCT01372150|8854479|P2|Overall Study|Adverse Event|1
2559087|NCT01372150|8854480|P1|Overall Study|Adverse Event|2
2559088|NCT01372150|8854478|P3|Overall Study|Other|2
2559089|NCT01372150|8854479|P2|Overall Study|Other|0
2559090|NCT01372150|8854480|P1|Overall Study|Other|1
2559091|NCT01372150|8854478|P3|Overall Study|Withdrawal by Subject|2
2559092|NCT01372150|8854479|P2|Overall Study|Withdrawal by Subject|7
2559093|NCT01372150|8854480|P1|Overall Study|Withdrawal by Subject|2
2559094|NCT01372150|8854478|P3|Overall Study|Protocol Violation|3
2559095|NCT01372150|8854479|P2|Overall Study|Protocol Violation|0
2559096|NCT01372150|8854480|P1|Overall Study|Protocol Violation|1
2559097|NCT01372150|8854478|P3|Overall Study|Lost to Follow-up|6
2559098|NCT01372150|8854479|P2|Overall Study|Lost to Follow-up|5
2559099|NCT01372150|8854480|P1|Overall Study|Lost to Follow-up|4
2559100|NCT01372150|8854478|P3|Overall Study|Lack of Efficacy|1
2559101|NCT01372150|8854479|P2|Overall Study|Lack of Efficacy|0
2559102|NCT01372150|8854480|P1|Overall Study|Lack of Efficacy|3
2559103|NCT01372085|8854507|P10|Washout Period 3|Withdrawal by Subject|0
2559104|NCT01372085|8854508|P9|Washout Period 3|Withdrawal by Subject|0
2559105|NCT01372085|8854509|P8|Washout Period 3|Withdrawal by Subject|0
2559106|NCT01372085|8854510|P7|Washout Period 3|Withdrawal by Subject|0
2559107|NCT01372085|8854511|P6|Washout Period 3|Withdrawal by Subject|2
2559108|NCT01372085|8854512|P5|Washout Period 3|Withdrawal by Subject|0
2559109|NCT01372085|8854513|P4|Washout Period 3|Withdrawal by Subject|0
2559110|NCT01372085|8854514|P3|Washout Period 3|Withdrawal by Subject|0
2559111|NCT01372085|8854515|P2|Washout Period 3|Withdrawal by Subject|0
2559112|NCT01372085|8854516|P1|Washout Period 3|Withdrawal by Subject|0
2559113|NCT01372085|8854507|P10|Washout Period 2|Physician Decision|0
2559114|NCT01372085|8854508|P9|Washout Period 2|Physician Decision|0
2559115|NCT01372085|8854509|P8|Washout Period 2|Physician Decision|0
2559116|NCT01372085|8854510|P7|Washout Period 2|Physician Decision|0
2559117|NCT01372085|8854511|P6|Washout Period 2|Physician Decision|0
2559118|NCT01372085|8854512|P5|Washout Period 2|Physician Decision|1
2559119|NCT01372085|8854513|P4|Washout Period 2|Physician Decision|0
2559120|NCT01372085|8854514|P3|Washout Period 2|Physician Decision|0
2559121|NCT01372085|8854515|P2|Washout Period 2|Physician Decision|0
2559122|NCT01372085|8854516|P1|Washout Period 2|Physician Decision|0
2559123|NCT01371994|8854548|P2|Overall Study|Miscellaneous Reasons|4
2559124|NCT01371994|8854549|P1|Overall Study|Miscellaneous Reasons|6
2559125|NCT01371994|8854548|P2|Overall Study|Physician Decision|1
2559126|NCT01371994|8854549|P1|Overall Study|Physician Decision|1
2559127|NCT01371994|8854548|P2|Overall Study|Randomized but Never Received Study Drug|6
2559128|NCT01371994|8854549|P1|Overall Study|Randomized but Never Received Study Drug|6
2559129|NCT01371994|8854548|P2|Overall Study|Protocol Violation|17
2559130|NCT01371994|8854549|P1|Overall Study|Protocol Violation|24
2559131|NCT01371994|8854548|P2|Overall Study|Lost to Follow-up|1
2559132|NCT01371994|8854549|P1|Overall Study|Lost to Follow-up|1
2559133|NCT01371994|8854548|P2|Overall Study|Withdrawal by Subject|7
2559134|NCT01371994|8854549|P1|Overall Study|Withdrawal by Subject|13
2559135|NCT01371994|8854548|P2|Overall Study|Lack of Efficacy|0
2559136|NCT01371994|8854549|P1|Overall Study|Lack of Efficacy|3
2559137|NCT01371994|8854548|P2|Overall Study|Adverse Event|6
2559138|NCT01371994|8854549|P1|Overall Study|Adverse Event|3
2559139|NCT01371877|8854593|P2|Overall Study|3 for unknown reasons and 1 pregnant|4
2559140|NCT01371877|8854594|P1|Overall Study|3 for unknown reasons and 1 pregnant|0
2559141|NCT01371851|8854606|P2|Overall Study|Blood Pressure outside study parameters|0
2559142|NCT01371851|8854607|P1|Overall Study|Blood Pressure outside study parameters|2
2559143|NCT01371851|8854606|P2|Overall Study|non study related adverse event|0
2559144|NCT01371851|8854607|P1|Overall Study|non study related adverse event|1
2559145|NCT01371851|8854606|P2|Overall Study|was arrested and put in jail|1
2559146|NCT01371851|8854607|P1|Overall Study|was arrested and put in jail|0
2559147|NCT01371851|8854606|P2|Overall Study|Lost to Follow-up|8
2559148|NCT01371851|8854607|P1|Overall Study|Lost to Follow-up|5
2559149|NCT01371838|8854615|P2|Overall Study|Surgery|0
2559150|NCT01371838|8854616|P1|Overall Study|Surgery|1
2559151|NCT01371838|8854615|P2|Overall Study|Lack of therapeutic response|1
2559152|NCT01371838|8854616|P1|Overall Study|Lack of therapeutic response|0
2559153|NCT01371838|8854615|P2|Overall Study|Last follow-up visit not conducted|0
2559154|NCT01371838|8854616|P1|Overall Study|Last follow-up visit not conducted|2
2559155|NCT01371838|8854615|P2|Overall Study|Investigator Decision|8
2559156|NCT01371838|8854616|P1|Overall Study|Investigator Decision|3
2559157|NCT01371838|8854615|P2|Overall Study|Protocol Violation|0
2559158|NCT01371838|8854616|P1|Overall Study|Protocol Violation|3
2559159|NCT01371838|8854615|P2|Overall Study|Death|4
2559160|NCT01371838|8854616|P1|Overall Study|Death|3
2559161|NCT01371838|8854615|P2|Overall Study|Lost to Follow-up|20
2559162|NCT01371838|8854616|P1|Overall Study|Lost to Follow-up|10
2559163|NCT01371838|8854615|P2|Overall Study|Withdrawal by Subject|33
2559164|NCT01371838|8854616|P1|Overall Study|Withdrawal by Subject|27
2559165|NCT01371825|8854652|P1|Overall Study|Death|4
2559166|NCT01371747|8854686|P6|Overall Study|Other Reasons|1
2559167|NCT01371747|8854687|P5|Overall Study|Other Reasons|0
2559168|NCT01371747|8854688|P4|Overall Study|Other Reasons|0
2559169|NCT01371747|8854689|P3|Overall Study|Other Reasons|2
2559170|NCT01371747|8854690|P2|Overall Study|Other Reasons|1
2559171|NCT01371747|8854691|P1|Overall Study|Other Reasons|2
2559172|NCT01371747|8854686|P6|Overall Study|Withdrawal by Subject|4
2559173|NCT01371747|8854687|P5|Overall Study|Withdrawal by Subject|2
2559174|NCT01371747|8854688|P4|Overall Study|Withdrawal by Subject|2
2559175|NCT01371747|8854689|P3|Overall Study|Withdrawal by Subject|5
2559176|NCT01371747|8854690|P2|Overall Study|Withdrawal by Subject|12
2559177|NCT01371747|8854691|P1|Overall Study|Withdrawal by Subject|6
2559178|NCT01371747|8854686|P6|Overall Study|Physician Decision|0
2559179|NCT01371747|8854687|P5|Overall Study|Physician Decision|1
2559180|NCT01371747|8854688|P4|Overall Study|Physician Decision|0
2559181|NCT01371747|8854689|P3|Overall Study|Physician Decision|0
2559182|NCT01371747|8854690|P2|Overall Study|Physician Decision|0
2559183|NCT01371747|8854691|P1|Overall Study|Physician Decision|0
2559184|NCT01371747|8854686|P6|Overall Study|Non-Compliance|1
2559185|NCT01371747|8854687|P5|Overall Study|Non-Compliance|0
2559186|NCT01371747|8854688|P4|Overall Study|Non-Compliance|0
2559187|NCT01371747|8854689|P3|Overall Study|Non-Compliance|3
2559188|NCT01371747|8854690|P2|Overall Study|Non-Compliance|4
2559189|NCT01371747|8854691|P1|Overall Study|Non-Compliance|3
2559190|NCT01371747|8854686|P6|Overall Study|Protocol Violation|0
2559191|NCT01371747|8854687|P5|Overall Study|Protocol Violation|0
2559192|NCT01371747|8854688|P4|Overall Study|Protocol Violation|0
2559193|NCT01371747|8854689|P3|Overall Study|Protocol Violation|1
2559194|NCT01371747|8854690|P2|Overall Study|Protocol Violation|0
2559195|NCT01371747|8854691|P1|Overall Study|Protocol Violation|0
2559196|NCT01371747|8854686|P6|Overall Study|Low Serum Potassium Results|3
2559197|NCT01371747|8854687|P5|Overall Study|Low Serum Potassium Results|0
2559198|NCT01371747|8854688|P4|Overall Study|Low Serum Potassium Results|1
2559199|NCT01371747|8854689|P3|Overall Study|Low Serum Potassium Results|1
2559200|NCT01371747|8854690|P2|Overall Study|Low Serum Potassium Results|1
2559201|NCT01371747|8854691|P1|Overall Study|Low Serum Potassium Results|1
2559202|NCT01371747|8854686|P6|Overall Study|High Serum Potassium Results|2
2559203|NCT01371747|8854687|P5|Overall Study|High Serum Potassium Results|0
2559204|NCT01371747|8854688|P4|Overall Study|High Serum Potassium Results|2
2559205|NCT01371747|8854689|P3|Overall Study|High Serum Potassium Results|1
2559206|NCT01371747|8854690|P2|Overall Study|High Serum Potassium Results|1
2559207|NCT01371747|8854691|P1|Overall Study|High Serum Potassium Results|1
2559208|NCT01371747|8854686|P6|Overall Study|Abnormal Renal Function|1
2559209|NCT01371747|8854687|P5|Overall Study|Abnormal Renal Function|0
2559210|NCT01371747|8854688|P4|Overall Study|Abnormal Renal Function|1
2559211|NCT01371747|8854689|P3|Overall Study|Abnormal Renal Function|0
2559212|NCT01371747|8854690|P2|Overall Study|Abnormal Renal Function|2
2559213|NCT01371747|8854691|P1|Overall Study|Abnormal Renal Function|0
2559214|NCT01371747|8854686|P6|Overall Study|Death|0
2559215|NCT01371747|8854687|P5|Overall Study|Death|2
2559216|NCT01371747|8854688|P4|Overall Study|Death|1
2559217|NCT01371747|8854689|P3|Overall Study|Death|4
2559218|NCT01371747|8854690|P2|Overall Study|Death|0
2559219|NCT01371747|8854691|P1|Overall Study|Death|1
2559220|NCT01371747|8854686|P6|Overall Study|Adverse Event|2
2559221|NCT01371747|8854687|P5|Overall Study|Adverse Event|2
2559222|NCT01371747|8854688|P4|Overall Study|Adverse Event|2
2559223|NCT01371747|8854689|P3|Overall Study|Adverse Event|7
2559224|NCT01371747|8854690|P2|Overall Study|Adverse Event|2
2559225|NCT01371747|8854691|P1|Overall Study|Adverse Event|4
2559226|NCT01371734|8854756|P3|Overall Study|Lack of Efficacy|0
2559227|NCT01371734|8854757|P2|Overall Study|Lack of Efficacy|2
2559228|NCT01371734|8854758|P1|Overall Study|Lack of Efficacy|2
2559229|NCT01371734|8854756|P3|Overall Study|Adverse Event|3
2559230|NCT01371734|8854757|P2|Overall Study|Adverse Event|8
2559231|NCT01371734|8854758|P1|Overall Study|Adverse Event|8
2559232|NCT01371734|8854756|P3|Overall Study|Protocol Violation|2
2559233|NCT01371734|8854757|P2|Overall Study|Protocol Violation|1
2559234|NCT01371734|8854758|P1|Overall Study|Protocol Violation|3
2559235|NCT01371734|8854756|P3|Overall Study|Lost to Follow-up|1
2559236|NCT01371734|8854757|P2|Overall Study|Lost to Follow-up|3
2559237|NCT01371734|8854758|P1|Overall Study|Lost to Follow-up|5
2559238|NCT01371734|8854756|P3|Overall Study|Withdrawal by Subject|9
2559239|NCT01371734|8854757|P2|Overall Study|Withdrawal by Subject|4
2559240|NCT01371734|8854758|P1|Overall Study|Withdrawal by Subject|3
2559241|NCT01371734|8854756|P3|Overall Study|Other|2
2559242|NCT01371734|8854757|P2|Overall Study|Other|1
2559243|NCT01371734|8854758|P1|Overall Study|Other|2
2559244|NCT01371721|8854778|P3|Overall Study|Randomized but not treated|0
2559245|NCT01371721|8854779|P2|Overall Study|Randomized but not treated|0
2559246|NCT01371721|8854780|P1|Overall Study|Randomized but not treated|1
2559247|NCT01371721|8854778|P3|Overall Study|Lack of Efficacy|3
2559248|NCT01371721|8854779|P2|Overall Study|Lack of Efficacy|4
2559249|NCT01371721|8854780|P1|Overall Study|Lack of Efficacy|2
2559250|NCT01371721|8854778|P3|Overall Study|Other|0
2559251|NCT01371721|8854779|P2|Overall Study|Other|3
2559252|NCT01371721|8854780|P1|Overall Study|Other|2
2559253|NCT01371721|8854778|P3|Overall Study|Withdrawal by Subject|11
2559254|NCT01371721|8854779|P2|Overall Study|Withdrawal by Subject|7
2559255|NCT01371721|8854780|P1|Overall Study|Withdrawal by Subject|5
2559256|NCT01371721|8854778|P3|Overall Study|Lost to Follow-up|6
2559257|NCT01371721|8854779|P2|Overall Study|Lost to Follow-up|2
2559258|NCT01371721|8854780|P1|Overall Study|Lost to Follow-up|8
2559259|NCT01371721|8854778|P3|Overall Study|Protocol Violation|5
2559260|NCT01371721|8854779|P2|Overall Study|Protocol Violation|4
2559261|NCT01371721|8854780|P1|Overall Study|Protocol Violation|6
2559262|NCT01371721|8854778|P3|Overall Study|Adverse Event|5
2559263|NCT01371721|8854779|P2|Overall Study|Adverse Event|4
2559264|NCT01371721|8854780|P1|Overall Study|Adverse Event|5
2559265|NCT01371708|8854813|P3|Overall Study|Started but did not receive treatment|1
2559266|NCT01371708|8854814|P2|Overall Study|Started but did not receive treatment|0
2559267|NCT01371708|8854815|P1|Overall Study|Started but did not receive treatment|1
2559268|NCT01371708|8854813|P3|Overall Study|Adverse Event|12
2559269|NCT01371708|8854814|P2|Overall Study|Adverse Event|8
2559270|NCT01371708|8854815|P1|Overall Study|Adverse Event|5
2559271|NCT01371708|8854813|P3|Overall Study|Other|4
2559272|NCT01371708|8854814|P2|Overall Study|Other|2
2559273|NCT01371708|8854815|P1|Overall Study|Other|3
2559274|NCT01371708|8854813|P3|Overall Study|Medication error/not related to AE|0
2559275|NCT01371708|8854814|P2|Overall Study|Medication error/not related to AE|1
2559276|NCT01371708|8854815|P1|Overall Study|Medication error/not related to AE|0
2559277|NCT01371708|8854813|P3|Overall Study|No longer willing to participate|13
2559278|NCT01371708|8854814|P2|Overall Study|No longer willing to participate|7
2559279|NCT01371708|8854815|P1|Overall Study|No longer willing to participate|7
2559280|NCT01371708|8854813|P3|Overall Study|Protocol Violation|2
2559281|NCT01371708|8854814|P2|Overall Study|Protocol Violation|1
2559282|NCT01371708|8854815|P1|Overall Study|Protocol Violation|2
2559283|NCT01371708|8854813|P3|Overall Study|Lost to Follow-up|7
2559284|NCT01371708|8854814|P2|Overall Study|Lost to Follow-up|9
2559285|NCT01371708|8854815|P1|Overall Study|Lost to Follow-up|5
2559286|NCT01371708|8854813|P3|Overall Study|Insufficient clinical response|0
2559287|NCT01371708|8854814|P2|Overall Study|Insufficient clinical response|2
2559288|NCT01371708|8854815|P1|Overall Study|Insufficient clinical response|3
2559289|NCT01371656|8854847|P2|Overall Study|Ineligible|3
2559290|NCT01371656|8854848|P1|Overall Study|Ineligible|4
2559291|NCT01371656|8854847|P2|Overall Study|Withdrawal by Subject|0
2559292|NCT01371656|8854848|P1|Overall Study|Withdrawal by Subject|7
2559293|NCT01371656|8854847|P2|Overall Study|Physician Decision|7
2559294|NCT01371656|8854848|P1|Overall Study|Physician Decision|46
2559295|NCT01371656|8854847|P2|Overall Study|Death|4
2559296|NCT01371656|8854848|P1|Overall Study|Death|7
2559297|NCT01371643|8854868|P2|Overall Study|Withdrawal by Subject|0
2559298|NCT01371643|8854869|P1|Overall Study|Withdrawal by Subject|3
2559299|NCT01371565|8854879|P1|Overall Study|Resection of neuroendocrine tumor|1
2559300|NCT01371565|8854879|P1|Overall Study|Death|1
2559301|NCT01371565|8854879|P1|Overall Study|Withdrawal by Subject|1
2559302|NCT01371552|8854883|P6|Part 1, First 3 Days|Inconvenience|0
2559303|NCT01371552|8854884|P5|Part 1, First 3 Days|Inconvenience|0
2559304|NCT01371552|8854885|P4|Part 1, First 3 Days|Inconvenience|0
2559305|NCT01371552|8854886|P3|Part 1, First 3 Days|Inconvenience|1
2559306|NCT01371552|8854887|P2|Part 1, First 3 Days|Inconvenience|0
2559307|NCT01371552|8854888|P1|Part 1, First 3 Days|Inconvenience|0
2559308|NCT01371539|8854915|P2|Period Two: One Week|Time/job conflict|1
2559309|NCT01371539|8854916|P1|Period Two: One Week|Time/job conflict|0
2559310|NCT01371539|8854915|P2|Period Two: One Week|Unacceptable Objective Visual Acuity|1
2559311|NCT01371539|8854916|P1|Period Two: One Week|Unacceptable Objective Visual Acuity|0
2559312|NCT01371539|8854915|P2|Period Two: One Week|Lost to Follow-up|1
2559313|NCT01371539|8854916|P1|Period Two: One Week|Lost to Follow-up|0
2559314|NCT01371539|8854915|P2|Period One: One Week|Lost to Follow-up|1
2559315|NCT01371539|8854916|P1|Period One: One Week|Lost to Follow-up|0
2559316|NCT01371305|8854930|P6|Overall Study|Subject request|1
2559317|NCT01371305|8854931|P5|Overall Study|Subject request|0
2559318|NCT01371305|8854932|P4|Overall Study|Subject request|0
2559319|NCT01371305|8854933|P3|Overall Study|Subject request|0
2559320|NCT01371305|8854934|P2|Overall Study|Subject request|0
2559321|NCT01371305|8854935|P1|Overall Study|Subject request|0
2559322|NCT01371305|8854930|P6|Overall Study|Study terminated by sponsor|1
2559323|NCT01371305|8854931|P5|Overall Study|Study terminated by sponsor|3
2559324|NCT01371305|8854932|P4|Overall Study|Study terminated by sponsor|0
2559325|NCT01371305|8854933|P3|Overall Study|Study terminated by sponsor|0
2559326|NCT01371305|8854934|P2|Overall Study|Study terminated by sponsor|0
2559327|NCT01371305|8854935|P1|Overall Study|Study terminated by sponsor|0
2559328|NCT01371305|8854930|P6|Overall Study|Adverse Event|0
2559329|NCT01371305|8854931|P5|Overall Study|Adverse Event|1
2559330|NCT01371305|8854932|P4|Overall Study|Adverse Event|2
2559331|NCT01371305|8854933|P3|Overall Study|Adverse Event|0
2559332|NCT01371305|8854934|P2|Overall Study|Adverse Event|0
2559333|NCT01371305|8854935|P1|Overall Study|Adverse Event|0
2559334|NCT01371006|8855019|P2|Overall Study|Adverse Event|0
2559335|NCT01371006|8855020|P1|Overall Study|Adverse Event|1
2559336|NCT01370863|8855061|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
2559337|NCT01370863|8855062|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
2559338|NCT01370863|8855061|P2|Overall Study|Did not want second pH/MII monitoring|1
2559339|NCT01370863|8855062|P1|Overall Study|Did not want second pH/MII monitoring|1
2559340|NCT01370863|8855061|P2|Overall Study|Adverse Event|1
2559341|NCT01370863|8855062|P1|Overall Study|Adverse Event|1
2559342|NCT01370733|8855087|P2|Overall Study|Protocol Violation|3
2559343|NCT01370733|8855088|P1|Overall Study|Protocol Violation|1
2559344|NCT01370733|8855087|P2|Overall Study|Physician Decision|2
2559345|NCT01370733|8855088|P1|Overall Study|Physician Decision|0
2559346|NCT01370733|8855087|P2|Overall Study|Lack of Efficacy|5
2559347|NCT01370733|8855088|P1|Overall Study|Lack of Efficacy|3
2559348|NCT01370733|8855087|P2|Overall Study|Adverse Event|4
2559349|NCT01370733|8855088|P1|Overall Study|Adverse Event|2
2559350|NCT01370733|8855087|P2|Overall Study|Lost to Follow-up|0
2559351|NCT01370733|8855088|P1|Overall Study|Lost to Follow-up|3
2559352|NCT01370733|8855087|P2|Overall Study|Withdrawal by Subject|8
2559353|NCT01370733|8855088|P1|Overall Study|Withdrawal by Subject|8
2559354|NCT01370694|8855110|P1|Overall Study|Progressive disease|2
2559355|NCT01370694|8855110|P1|Overall Study|Switched to rituximab|4
2559356|NCT01370655|8855132|P12|Period 2|Withdrawal by Subject|0
2559357|NCT01370655|8855133|P11|Period 2|Withdrawal by Subject|0
2559358|NCT01370655|8855134|P10|Period 2|Withdrawal by Subject|0
2559359|NCT01370655|8855135|P9|Period 2|Withdrawal by Subject|1
2559360|NCT01370655|8855136|P8|Period 2|Withdrawal by Subject|0
2559361|NCT01370655|8855137|P7|Period 2|Withdrawal by Subject|0
2559362|NCT01370655|8855138|P6|Period 2|Withdrawal by Subject|0
2559363|NCT01370655|8855139|P5|Period 2|Withdrawal by Subject|0
2559364|NCT01370655|8855140|P4|Period 2|Withdrawal by Subject|0
2559365|NCT01370655|8855141|P3|Period 2|Withdrawal by Subject|0
2559366|NCT01370655|8855142|P2|Period 2|Withdrawal by Subject|0
2559367|NCT01370655|8855143|P1|Period 2|Withdrawal by Subject|0
2559368|NCT01370655|8855132|P12|Period 2|met protocol specified stopping criteria|0
2559369|NCT01370655|8855133|P11|Period 2|met protocol specified stopping criteria|1
2559370|NCT01370655|8855134|P10|Period 2|met protocol specified stopping criteria|0
2559371|NCT01370655|8855135|P9|Period 2|met protocol specified stopping criteria|1
2559372|NCT01370655|8855136|P8|Period 2|met protocol specified stopping criteria|0
2559373|NCT01370655|8855137|P7|Period 2|met protocol specified stopping criteria|1
2559374|NCT01370655|8855138|P6|Period 2|met protocol specified stopping criteria|0
2559375|NCT01370655|8855139|P5|Period 2|met protocol specified stopping criteria|0
2559376|NCT01370655|8855140|P4|Period 2|met protocol specified stopping criteria|0
2559377|NCT01370655|8855141|P3|Period 2|met protocol specified stopping criteria|1
2559378|NCT01370655|8855142|P2|Period 2|met protocol specified stopping criteria|0
2559379|NCT01370655|8855143|P1|Period 2|met protocol specified stopping criteria|0
2559380|NCT01370655|8855132|P12|Period 2|Adverse Event|0
2559381|NCT01370655|8855133|P11|Period 2|Adverse Event|0
2559382|NCT01370655|8855134|P10|Period 2|Adverse Event|0
2559383|NCT01370655|8855135|P9|Period 2|Adverse Event|0
2559384|NCT01370655|8855136|P8|Period 2|Adverse Event|1
2559385|NCT01370655|8855137|P7|Period 2|Adverse Event|0
2559386|NCT01370655|8855138|P6|Period 2|Adverse Event|0
2559387|NCT01370655|8855139|P5|Period 2|Adverse Event|1
2559388|NCT01370655|8855140|P4|Period 2|Adverse Event|0
2559389|NCT01370655|8855141|P3|Period 2|Adverse Event|1
2559390|NCT01370655|8855142|P2|Period 2|Adverse Event|0
2559391|NCT01370655|8855143|P1|Period 2|Adverse Event|0
2559392|NCT01370655|8855132|P12|Period 1|Adverse Event|0
2559393|NCT01370655|8855133|P11|Period 1|Adverse Event|0
2559394|NCT01370655|8855134|P10|Period 1|Adverse Event|0
2559395|NCT01370655|8855135|P9|Period 1|Adverse Event|0
2559396|NCT01370655|8855136|P8|Period 1|Adverse Event|0
2559397|NCT01370655|8855137|P7|Period 1|Adverse Event|1
2559398|NCT01370655|8855138|P6|Period 1|Adverse Event|0
2559399|NCT01370655|8855139|P5|Period 1|Adverse Event|0
2559400|NCT01370655|8855140|P4|Period 1|Adverse Event|0
2559401|NCT01370655|8855141|P3|Period 1|Adverse Event|0
2559402|NCT01370655|8855142|P2|Period 1|Adverse Event|0
2559403|NCT01370655|8855143|P1|Period 1|Adverse Event|2
2559404|NCT01370642|8855180|P3|Overall Study|Withdrawal by Subject|3
2559405|NCT01370642|8855181|P2|Overall Study|Withdrawal by Subject|4
2559406|NCT01370642|8855182|P1|Overall Study|Withdrawal by Subject|2
2559407|NCT01370642|8855180|P3|Overall Study|Physician Decision|2
2559408|NCT01370642|8855181|P2|Overall Study|Physician Decision|1
2559409|NCT01370642|8855182|P1|Overall Study|Physician Decision|4
2559410|NCT01370642|8855180|P3|Overall Study|Lost to Follow-up|1
2559411|NCT01370642|8855181|P2|Overall Study|Lost to Follow-up|0
2559412|NCT01370642|8855182|P1|Overall Study|Lost to Follow-up|0
2559413|NCT01370642|8855180|P3|Overall Study|Detectable HCV RNA|22
2559414|NCT01370642|8855181|P2|Overall Study|Detectable HCV RNA|0
2559415|NCT01370642|8855182|P1|Overall Study|Detectable HCV RNA|0
2559416|NCT01370642|8855180|P3|Overall Study|Adverse Event|1
2559417|NCT01370642|8855181|P2|Overall Study|Adverse Event|1
2559418|NCT01370642|8855182|P1|Overall Study|Adverse Event|2
2559419|NCT01370616|8855221|P2|Overall Study|Withdrawal by Subject|34
2559420|NCT01370616|8855222|P1|Overall Study|Withdrawal by Subject|34
2559421|NCT01370616|8855221|P2|Overall Study|Technical Problems|5
2559422|NCT01370616|8855222|P1|Overall Study|Technical Problems|3
2559423|NCT01370616|8855221|P2|Overall Study|Recovery|0
2559424|NCT01370616|8855222|P1|Overall Study|Recovery|1
2559425|NCT01370616|8855221|P2|Overall Study|Progressive Disease|1
2559426|NCT01370616|8855222|P1|Overall Study|Progressive Disease|0
2559427|NCT01370616|8855221|P2|Overall Study|Physician Decision|6
2559428|NCT01370616|8855222|P1|Overall Study|Physician Decision|6
2559429|NCT01370616|8855221|P2|Overall Study|Lost to Follow-up|3
2559430|NCT01370616|8855222|P1|Overall Study|Lost to Follow-up|0
2559431|NCT01370616|8855221|P2|Overall Study|Lack of Efficacy|2
2559432|NCT01370616|8855222|P1|Overall Study|Lack of Efficacy|6
2559433|NCT01370616|8855221|P2|Overall Study|Death|0
2559434|NCT01370616|8855222|P1|Overall Study|Death|1
2559435|NCT01370616|8855221|P2|Overall Study|Adverse Event|16
2559436|NCT01370616|8855222|P1|Overall Study|Adverse Event|11
2559437|NCT01370603|8855246|P2|Period 2|Withdrawal by Subject|0
2559438|NCT01370603|8855247|P1|Period 2|Withdrawal by Subject|1
2559439|NCT01370603|8855246|P2|Period 2|Lost to Follow-up|0
2559440|NCT01370603|8855247|P1|Period 2|Lost to Follow-up|1
2559441|NCT01370603|8855246|P2|Period 2|Adverse Event|4
2559442|NCT01370603|8855247|P1|Period 2|Adverse Event|1
2559443|NCT01370603|8855246|P2|Crossover Washout|Non-compliance with Study Drug|2
2559444|NCT01370603|8855247|P1|Crossover Washout|Non-compliance with Study Drug|0
2559445|NCT01370603|8855246|P2|Crossover Washout|Withdrawal by Subject|1
2559446|NCT01370603|8855247|P1|Crossover Washout|Withdrawal by Subject|4
2559447|NCT01370603|8855246|P2|Crossover Washout|Protocol Violation|0
2559448|NCT01370603|8855247|P1|Crossover Washout|Protocol Violation|1
2559449|NCT01370603|8855246|P2|Crossover Washout|Lost to Follow-up|0
2559450|NCT01370603|8855247|P1|Crossover Washout|Lost to Follow-up|2
2559451|NCT01370603|8855246|P2|Crossover Washout|Adverse Event|1
2559452|NCT01370603|8855247|P1|Crossover Washout|Adverse Event|2
2559453|NCT01370603|8855246|P2|Period 1|Withdrawal by Subject|5
2559454|NCT01370603|8855247|P1|Period 1|Withdrawal by Subject|5
2559455|NCT01370603|8855246|P2|Period 1|Protocol Violation|2
2559456|NCT01370603|8855247|P1|Period 1|Protocol Violation|2
2559457|NCT01370603|8855246|P2|Period 1|Lost to Follow-up|0
2559458|NCT01370603|8855247|P1|Period 1|Lost to Follow-up|2
2559459|NCT01370603|8855246|P2|Period 1|Adverse Event|3
2559460|NCT01370603|8855247|P1|Period 1|Adverse Event|5
2559461|NCT01370590|8855265|P2|Period 2|Withdrawal by Subject|1
2559462|NCT01370590|8855266|P1|Period 2|Withdrawal by Subject|1
2559463|NCT01370590|8855265|P2|Period 2|Adverse Event|1
2559464|NCT01370590|8855266|P1|Period 2|Adverse Event|0
2559465|NCT01370590|8855265|P2|Crossover Washout Period|Withdrawal by Subject|2
2559466|NCT01370590|8855266|P1|Crossover Washout Period|Withdrawal by Subject|2
2559467|NCT01370590|8855265|P2|Crossover Washout Period|Non-compliance with Study Drug|0
2559468|NCT01370590|8855266|P1|Crossover Washout Period|Non-compliance with Study Drug|1
2559469|NCT01370590|8855265|P2|Crossover Washout Period|Lost to Follow-up|0
2559470|NCT01370590|8855266|P1|Crossover Washout Period|Lost to Follow-up|2
2559471|NCT01370590|8855265|P2|Crossover Washout Period|Adverse Event|4
2559472|NCT01370590|8855266|P1|Crossover Washout Period|Adverse Event|1
2559473|NCT01370590|8855265|P2|Period 1|Could not access randomization system|1
2559474|NCT01370590|8855266|P1|Period 1|Could not access randomization system|0
2559475|NCT01370590|8855265|P2|Period 1|Withdrawal by Subject|2
2559476|NCT01370590|8855266|P1|Period 1|Withdrawal by Subject|4
2559477|NCT01370590|8855265|P2|Period 1|Protocol Violation|2
2559478|NCT01370590|8855266|P1|Period 1|Protocol Violation|2
2559479|NCT01370590|8855265|P2|Period 1|Lost to Follow-up|2
2559480|NCT01370590|8855266|P1|Period 1|Lost to Follow-up|2
2559481|NCT01370590|8855265|P2|Period 1|Adverse Event|4
2559482|NCT01370590|8855266|P1|Period 1|Adverse Event|8
2559483|NCT01370538|8855294|P2|Overall Study|Lost to follow up|10
2559484|NCT01370538|8855295|P1|Overall Study|Lost to follow up|6
2559485|NCT01370538|8855294|P2|Overall Study|Development of study specific withdrawal|1
2559486|NCT01370538|8855295|P1|Overall Study|Development of study specific withdrawal|1
2559487|NCT01370538|8855294|P2|Overall Study|Protocol Violation|5
2559488|NCT01370538|8855295|P1|Overall Study|Protocol Violation|8
2559489|NCT01370538|8855294|P2|Overall Study|Adverse Event|0
2559490|NCT01370538|8855295|P1|Overall Study|Adverse Event|1
2559491|NCT01370538|8855294|P2|Overall Study|Eligibility criteria not fulfilled|1
2559492|NCT01370538|8855295|P1|Overall Study|Eligibility criteria not fulfilled|0
2559493|NCT01370538|8855294|P2|Overall Study|Voluntary Discontinuation by Subject|2
2559494|NCT01370538|8855295|P1|Overall Study|Voluntary Discontinuation by Subject|3
2559495|NCT01370525|8855311|P2|Overall Study|Lost to follow up|6
2559496|NCT01370525|8855312|P1|Overall Study|Lost to follow up|2
2559497|NCT01370525|8855311|P2|Overall Study|Protocol Violation|1
2559498|NCT01370525|8855312|P1|Overall Study|Protocol Violation|2
2559499|NCT01370525|8855311|P2|Overall Study|Adverse Event|1
2559500|NCT01370525|8855312|P1|Overall Study|Adverse Event|0
2559501|NCT01370525|8855311|P2|Overall Study|Eligibility criteria not fulfilled|0
2559502|NCT01370525|8855312|P1|Overall Study|Eligibility criteria not fulfilled|2
2559503|NCT01370525|8855311|P2|Overall Study|Voluntary Discontinuation by Subject|3
2559504|NCT01370525|8855312|P1|Overall Study|Voluntary Discontinuation by Subject|2
2559505|NCT01370499|8855328|P2|Overall Study|Sponsor Decision|15
2559506|NCT01370499|8855329|P1|Overall Study|Sponsor Decision|41
2559507|NCT01370499|8855328|P2|Overall Study|Withdrawal by Subject|7
2559508|NCT01370499|8855329|P1|Overall Study|Withdrawal by Subject|18
2559509|NCT01370499|8855328|P2|Overall Study|Protocol Violation|4
2559510|NCT01370499|8855329|P1|Overall Study|Protocol Violation|5
2559511|NCT01370499|8855328|P2|Overall Study|Physician Decision|3
2559512|NCT01370499|8855329|P1|Overall Study|Physician Decision|3
2559513|NCT01370499|8855328|P2|Overall Study|Lost to Follow-up|1
2559514|NCT01370499|8855329|P1|Overall Study|Lost to Follow-up|2
2559515|NCT01370499|8855328|P2|Overall Study|Lack of Efficacy|2
2559516|NCT01370499|8855329|P1|Overall Study|Lack of Efficacy|4
2559517|NCT01370499|8855328|P2|Overall Study|Adverse Event|12
2559518|NCT01370499|8855329|P1|Overall Study|Adverse Event|38
2559519|NCT01370408|8855371|P1|Overall Study|treatment failure|9
2559520|NCT01370356|8855431|P2|Overall Study|AE Not Related to Study Drug|4
2559521|NCT01370356|8855432|P1|Overall Study|AE Not Related to Study Drug|1
2559522|NCT01370356|8855431|P2|Overall Study|Adverse event (AE) Related to Study Drug|9
2559523|NCT01370356|8855432|P1|Overall Study|Adverse event (AE) Related to Study Drug|12
2559524|NCT01370356|8855431|P2|Overall Study|Protocol Violation|3
2559525|NCT01370356|8855432|P1|Overall Study|Protocol Violation|3
2559526|NCT01370356|8855431|P2|Overall Study|Reason not specified|43
2559527|NCT01370356|8855432|P1|Overall Study|Reason not specified|39
2559528|NCT01370356|8855431|P2|Overall Study|Withdrawal by Subject|59
2559529|NCT01370356|8855432|P1|Overall Study|Withdrawal by Subject|54
2559530|NCT01370356|8855431|P2|Overall Study|Lost to Follow-up|81
2559531|NCT01370356|8855432|P1|Overall Study|Lost to Follow-up|76
2559532|NCT01370356|8855431|P2|Overall Study|Lack of Efficacy|28
2559533|NCT01370356|8855432|P1|Overall Study|Lack of Efficacy|6
2559534|NCT01370356|8855431|P2|Overall Study|Death|0
2559535|NCT01370356|8855432|P1|Overall Study|Death|1
2559536|NCT01370317|8855448|P2|Overall Study|Protocol deviation|1
2559537|NCT01370317|8855449|P1|Overall Study|Protocol deviation|0
2559538|NCT01370317|8855448|P2|Overall Study|Participant withdrew consent|0
2559539|NCT01370317|8855449|P1|Overall Study|Participant withdrew consent|1
2559540|NCT01370265|8855460|P2|First Intervention|Adverse Event|1
2559541|NCT01370265|8855461|P1|First Intervention|Adverse Event|1
2559542|NCT01370213|8855481|P3|Overall Study|Not evaluable|0
2559543|NCT01370213|8855482|P2|Overall Study|Not evaluable|2
2559544|NCT01370213|8855483|P1|Overall Study|Not evaluable|0
2559545|NCT01370213|8855481|P3|Overall Study|Early Death|0
2559546|NCT01370213|8855482|P2|Overall Study|Early Death|0
2559547|NCT01370213|8855483|P1|Overall Study|Early Death|1
2559548|NCT01370083|8855503|P2|Overall Study|Adverse Event|1
2559549|NCT01370083|8855504|P1|Overall Study|Adverse Event|0
2559550|NCT01370083|8855503|P2|Overall Study|Lost to Follow-up|0
2559551|NCT01370083|8855504|P1|Overall Study|Lost to Follow-up|2
2559552|NCT01370005|8855517|P3|Overall Study|Other reason not defined above|2
2559553|NCT01370005|8855518|P2|Overall Study|Other reason not defined above|0
2559554|NCT01370005|8855519|P1|Overall Study|Other reason not defined above|3
2559555|NCT01370005|8855517|P3|Overall Study|Patient refusal to continue,not due toAE|0
2559556|NCT01370005|8855518|P2|Overall Study|Patient refusal to continue,not due toAE|4
2559557|NCT01370005|8855519|P1|Overall Study|Patient refusal to continue,not due toAE|5
2559558|NCT01370005|8855517|P3|Overall Study|Lost to Follow-up|1
2559559|NCT01370005|8855518|P2|Overall Study|Lost to Follow-up|1
2559560|NCT01370005|8855519|P1|Overall Study|Lost to Follow-up|1
2559561|NCT01370005|8855517|P3|Overall Study|Non compliant with protocol|2
2559562|NCT01370005|8855518|P2|Overall Study|Non compliant with protocol|1
2559563|NCT01370005|8855519|P1|Overall Study|Non compliant with protocol|0
2559564|NCT01370005|8855517|P3|Overall Study|Lack of Efficacy|0
2559565|NCT01370005|8855518|P2|Overall Study|Lack of Efficacy|0
2559566|NCT01370005|8855519|P1|Overall Study|Lack of Efficacy|1
2559567|NCT01370005|8855517|P3|Overall Study|Adverse Event|6
2559568|NCT01370005|8855518|P2|Overall Study|Adverse Event|5
2559569|NCT01370005|8855519|P1|Overall Study|Adverse Event|5
2559570|NCT01370005|8855517|P3|Overall Study|Not treated|0
2559571|NCT01370005|8855518|P2|Overall Study|Not treated|0
2559572|NCT01370005|8855519|P1|Overall Study|Not treated|1
2559573|NCT01369849|8855601|P3|Overall Study|Ineligible after receiving treatment|0
2559574|NCT01369849|8855602|P2|Overall Study|Ineligible after receiving treatment|1
2559575|NCT01369849|8855603|P1|Overall Study|Ineligible after receiving treatment|0
2559576|NCT01369849|8855601|P3|Overall Study|Ineligible prior to treatment|1
2559577|NCT01369849|8855602|P2|Overall Study|Ineligible prior to treatment|0
2559578|NCT01369849|8855603|P1|Overall Study|Ineligible prior to treatment|0
2559579|NCT01369784|8855625|P1|Overall Study|Protocol Violation|12
2559580|NCT01369680|8855713|P4|Overall Study|Lost to Follow-up|2
2559581|NCT01369680|8855714|P3|Overall Study|Lost to Follow-up|1
2559582|NCT01369680|8855715|P2|Overall Study|Lost to Follow-up|0
2559583|NCT01369680|8855716|P1|Overall Study|Lost to Follow-up|0
2559584|NCT01369641|8855737|P1|Overall Study|Withdrawal by Subject|1
2559585|NCT01369615|8855743|P2|Overall Study|Lost to Follow-up|1
2559586|NCT01369615|8855744|P1|Overall Study|Lost to Follow-up|0
2559587|NCT01369615|8855743|P2|Overall Study|Withdrawal by Subject|1
2559588|NCT01369615|8855744|P1|Overall Study|Withdrawal by Subject|0
2559589|NCT01369511|8855754|P4|Overall Study|Withdrawal by Subject|6
2559590|NCT01369511|8855755|P3|Overall Study|Withdrawal by Subject|4
2559591|NCT01369511|8855756|P2|Overall Study|Withdrawal by Subject|6
2559592|NCT01369511|8855757|P1|Overall Study|Withdrawal by Subject|5
2559593|NCT01369511|8855754|P4|Overall Study|Sponsor decision|0
2559594|NCT01369511|8855755|P3|Overall Study|Sponsor decision|1
2559595|NCT01369511|8855756|P2|Overall Study|Sponsor decision|0
2559596|NCT01369511|8855757|P1|Overall Study|Sponsor decision|2
2559597|NCT01369511|8855754|P4|Overall Study|Physician Decision|0
2559598|NCT01369511|8855755|P3|Overall Study|Physician Decision|0
2559599|NCT01369511|8855756|P2|Overall Study|Physician Decision|4
2559600|NCT01369511|8855757|P1|Overall Study|Physician Decision|3
2559601|NCT01369511|8855754|P4|Overall Study|Protocol Violation|2
2559602|NCT01369511|8855755|P3|Overall Study|Protocol Violation|0
2559603|NCT01369511|8855756|P2|Overall Study|Protocol Violation|1
2559604|NCT01369511|8855757|P1|Overall Study|Protocol Violation|0
2559605|NCT01369511|8855754|P4|Overall Study|Lost to Follow-up|2
2559606|NCT01369511|8855755|P3|Overall Study|Lost to Follow-up|1
2559607|NCT01369511|8855756|P2|Overall Study|Lost to Follow-up|1
2559608|NCT01369511|8855757|P1|Overall Study|Lost to Follow-up|0
2559609|NCT01369511|8855754|P4|Overall Study|Entry criteria not met|1
2559610|NCT01369511|8855755|P3|Overall Study|Entry criteria not met|0
2559611|NCT01369511|8855756|P2|Overall Study|Entry criteria not met|0
2559612|NCT01369511|8855757|P1|Overall Study|Entry criteria not met|2
2559613|NCT01369511|8855754|P4|Overall Study|Adverse Event|0
2559614|NCT01369511|8855755|P3|Overall Study|Adverse Event|5
2559615|NCT01369511|8855756|P2|Overall Study|Adverse Event|1
2559616|NCT01369511|8855757|P1|Overall Study|Adverse Event|1
2559617|NCT01369485|8855773|P2|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3
2559618|NCT01369485|8855774|P1|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0
2559619|NCT01369485|8855773|P2|Open Label Phase (Week 12 to Month 12)|Death|1
2559620|NCT01369485|8855774|P1|Open Label Phase (Week 12 to Month 12)|Death|0
2559621|NCT01369485|8855773|P2|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20
2559622|NCT01369485|8855774|P1|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17
2559623|NCT01369485|8855773|P2|Open Label Phase (Week 12 to Month 12)|Physician Decision|4
2559624|NCT01369485|8855774|P1|Open Label Phase (Week 12 to Month 12)|Physician Decision|3
2559625|NCT01369485|8855773|P2|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3
2559626|NCT01369485|8855774|P1|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2
2559627|NCT01369485|8855773|P2|Open Label Phase (Week 12 to Month 12)|Adverse Event|9
2559628|NCT01369485|8855774|P1|Open Label Phase (Week 12 to Month 12)|Adverse Event|11
2559629|NCT01369485|8855773|P2|Randomized Phase (Day 0 to Week 12)|expired patches|0
2559630|NCT01369485|8855774|P1|Randomized Phase (Day 0 to Week 12)|expired patches|2
2559631|NCT01369485|8855773|P2|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4
2559632|NCT01369485|8855774|P1|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2
2559633|NCT01369485|8855773|P2|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8
2559634|NCT01369485|8855774|P1|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12
2559726|NCT01369069|8856036|P1|Overall Study|Lost to Follow-up|8
2559635|NCT01369485|8855773|P2|Randomized Phase (Day 0 to Week 12)|Adverse Event|5
2559636|NCT01369485|8855774|P1|Randomized Phase (Day 0 to Week 12)|Adverse Event|7
2559637|NCT01369355|8855820|P6|Overall Study|Not Treated|0
2559638|NCT01369355|8855821|P5|Overall Study|Not Treated|0
2559639|NCT01369355|8855822|P4|Overall Study|Not Treated|0
2559640|NCT01369355|8855823|P3|Overall Study|Not Treated|1
2559641|NCT01369355|8855824|P2|Overall Study|Not Treated|0
2559642|NCT01369355|8855825|P1|Overall Study|Not Treated|0
2559643|NCT01369355|8855820|P6|Overall Study|Other|0
2559644|NCT01369355|8855821|P5|Overall Study|Other|1
2559645|NCT01369355|8855822|P4|Overall Study|Other|0
2559646|NCT01369355|8855823|P3|Overall Study|Other|0
2559647|NCT01369355|8855824|P2|Overall Study|Other|0
2559648|NCT01369355|8855825|P1|Overall Study|Other|0
2559649|NCT01369355|8855820|P6|Overall Study|Withdrawal by Subject|22
2559650|NCT01369355|8855821|P5|Overall Study|Withdrawal by Subject|8
2559651|NCT01369355|8855822|P4|Overall Study|Withdrawal by Subject|6
2559652|NCT01369355|8855823|P3|Overall Study|Withdrawal by Subject|7
2559653|NCT01369355|8855824|P2|Overall Study|Withdrawal by Subject|2
2559654|NCT01369355|8855825|P1|Overall Study|Withdrawal by Subject|6
2559655|NCT01369355|8855820|P6|Overall Study|Lost to Follow-up|6
2559656|NCT01369355|8855821|P5|Overall Study|Lost to Follow-up|5
2559657|NCT01369355|8855822|P4|Overall Study|Lost to Follow-up|2
2559658|NCT01369355|8855823|P3|Overall Study|Lost to Follow-up|1
2559659|NCT01369355|8855824|P2|Overall Study|Lost to Follow-up|0
2559660|NCT01369355|8855825|P1|Overall Study|Lost to Follow-up|1
2559661|NCT01369355|8855820|P6|Overall Study|Protocol Violation|2
2559662|NCT01369355|8855821|P5|Overall Study|Protocol Violation|0
2559663|NCT01369355|8855822|P4|Overall Study|Protocol Violation|0
2559664|NCT01369355|8855823|P3|Overall Study|Protocol Violation|1
2559665|NCT01369355|8855824|P2|Overall Study|Protocol Violation|1
2559666|NCT01369355|8855825|P1|Overall Study|Protocol Violation|0
2559667|NCT01369355|8855820|P6|Overall Study|Lack of Efficacy|217
2559668|NCT01369355|8855821|P5|Overall Study|Lack of Efficacy|126
2559669|NCT01369355|8855822|P4|Overall Study|Lack of Efficacy|15
2559670|NCT01369355|8855823|P3|Overall Study|Lack of Efficacy|15
2559671|NCT01369355|8855824|P2|Overall Study|Lack of Efficacy|14
2559672|NCT01369355|8855825|P1|Overall Study|Lack of Efficacy|15
2559673|NCT01369355|8855820|P6|Overall Study|Adverse Event|25
2559674|NCT01369355|8855821|P5|Overall Study|Adverse Event|14
2559675|NCT01369355|8855822|P4|Overall Study|Adverse Event|7
2559676|NCT01369355|8855823|P3|Overall Study|Adverse Event|6
2559677|NCT01369355|8855824|P2|Overall Study|Adverse Event|12
2559678|NCT01369355|8855825|P1|Overall Study|Adverse Event|9
2559679|NCT01369342|8855854|P3|Overall Study|Not Treated|0
2559680|NCT01369342|8855855|P2|Overall Study|Not Treated|0
2559681|NCT01369342|8855856|P1|Overall Study|Not Treated|1
2559682|NCT01369342|8855854|P3|Overall Study|Lost to Follow-up|1
2559683|NCT01369342|8855855|P2|Overall Study|Lost to Follow-up|2
2559684|NCT01369342|8855856|P1|Overall Study|Lost to Follow-up|5
2559685|NCT01369342|8855854|P3|Overall Study|Withdrawal by Subject|2
2559686|NCT01369342|8855855|P2|Overall Study|Withdrawal by Subject|7
2559687|NCT01369342|8855856|P1|Overall Study|Withdrawal by Subject|7
2559688|NCT01369329|8855879|P3|Overall Study|Other|2
2559689|NCT01369329|8855880|P2|Overall Study|Other|3
2559690|NCT01369329|8855881|P1|Overall Study|Other|2
2559691|NCT01369329|8855879|P3|Overall Study|Lost to Follow-up|2
2559692|NCT01369329|8855880|P2|Overall Study|Lost to Follow-up|2
2559693|NCT01369329|8855881|P1|Overall Study|Lost to Follow-up|2
2559694|NCT01369329|8855879|P3|Overall Study|Withdrawal by Subject|10
2559695|NCT01369329|8855880|P2|Overall Study|Withdrawal by Subject|6
2559696|NCT01369329|8855881|P1|Overall Study|Withdrawal by Subject|8
2559697|NCT01369225|8855907|P6|Overall Study|Adverse Event|0
2559698|NCT01369225|8855908|P5|Overall Study|Adverse Event|1
2559699|NCT01369225|8855909|P4|Overall Study|Adverse Event|1
2559700|NCT01369225|8855910|P3|Overall Study|Adverse Event|0
2559701|NCT01369225|8855911|P2|Overall Study|Adverse Event|0
2559702|NCT01369225|8855912|P1|Overall Study|Adverse Event|0
2559703|NCT01369225|8855907|P6|Overall Study|Other|0
2559704|NCT01369225|8855908|P5|Overall Study|Other|1
2559705|NCT01369225|8855909|P4|Overall Study|Other|0
2559706|NCT01369225|8855910|P3|Overall Study|Other|0
2559707|NCT01369225|8855911|P2|Overall Study|Other|0
2559708|NCT01369225|8855912|P1|Overall Study|Other|1
2559709|NCT01369225|8855907|P6|Overall Study|Does Not Meet Entrance Criteria|0
2559710|NCT01369225|8855908|P5|Overall Study|Does Not Meet Entrance Criteria|0
2559711|NCT01369225|8855909|P4|Overall Study|Does Not Meet Entrance Criteria|0
2559712|NCT01369225|8855910|P3|Overall Study|Does Not Meet Entrance Criteria|1
2559713|NCT01369225|8855911|P2|Overall Study|Does Not Meet Entrance Criteria|0
2559714|NCT01369225|8855912|P1|Overall Study|Does Not Meet Entrance Criteria|0
2559715|NCT01369225|8855907|P6|Overall Study|Withdrawal by Subject|0
2559716|NCT01369225|8855908|P5|Overall Study|Withdrawal by Subject|0
2559717|NCT01369225|8855909|P4|Overall Study|Withdrawal by Subject|1
2559718|NCT01369225|8855910|P3|Overall Study|Withdrawal by Subject|2
2559719|NCT01369225|8855911|P2|Overall Study|Withdrawal by Subject|0
2559720|NCT01369225|8855912|P1|Overall Study|Withdrawal by Subject|1
2559721|NCT01369199|8856004|P1|Overall Study|Lost to Follow-up|2
2559722|NCT01369199|8856004|P1|Overall Study|Withdrawal by Subject|1
2559723|NCT01369069|8856035|P2|Overall Study|Withdrawal by Subject|7
2559724|NCT01369069|8856036|P1|Overall Study|Withdrawal by Subject|9
2559725|NCT01369069|8856035|P2|Overall Study|Lost to Follow-up|9
2559727|NCT01368965|8856058|P1|Overall Study|Lost to Follow-up|12
2559728|NCT01368900|8856067|P1|Overall Study|Lost to Follow-up|7
2559729|NCT01368835|8856142|P1|Overall Study|Lost to Follow-up|11
2559730|NCT01368835|8856142|P1|Overall Study|Inclusion criteria/photography quality|22
2559731|NCT01368614|8856181|P4|Study Period|Lost to Follow-up|0
2559732|NCT01368614|8856182|P3|Study Period|Lost to Follow-up|1
2559733|NCT01368614|8856183|P2|Study Period|Lost to Follow-up|0
2559734|NCT01368614|8856184|P1|Study Period|Lost to Follow-up|0
2559735|NCT01368614|8856181|P4|Study Period|Withdrawal by Subject|3
2559736|NCT01368614|8856182|P3|Study Period|Withdrawal by Subject|1
2559737|NCT01368614|8856183|P2|Study Period|Withdrawal by Subject|1
2559738|NCT01368614|8856184|P1|Study Period|Withdrawal by Subject|0
2559739|NCT01368614|8856181|P4|Screening Period|Screen Failure|0
2559740|NCT01368614|8856182|P3|Screening Period|Screen Failure|0
2559741|NCT01368614|8856183|P2|Screening Period|Screen Failure|0
2559742|NCT01368614|8856184|P1|Screening Period|Screen Failure|58
2559743|NCT01368562|8856237|P1|Overall Study|Other than specified|2
2559744|NCT01368562|8856237|P1|Overall Study|Other|3
2559745|NCT01368562|8856237|P1|Overall Study|Unresponsive to treatment|5
2559746|NCT01368562|8856237|P1|Overall Study|Death|6
2559747|NCT01368562|8856237|P1|Overall Study|Lost to Follow-up|1
2559748|NCT01368562|8856237|P1|Overall Study|Disease progression|1
2559749|NCT01368562|8856237|P1|Overall Study|Adverse Event|1
2559750|NCT01368536|8856244|P3|Overall Study|Protocol deviation|1
2559751|NCT01368536|8856245|P2|Overall Study|Protocol deviation|3
2559752|NCT01368536|8856246|P1|Overall Study|Protocol deviation|0
2559753|NCT01368536|8856244|P3|Overall Study|Administrative problems|35
2559754|NCT01368536|8856245|P2|Overall Study|Administrative problems|39
2559755|NCT01368536|8856246|P1|Overall Study|Administrative problems|34
2559756|NCT01368536|8856244|P3|Overall Study|Lost to Follow-up|5
2559757|NCT01368536|8856245|P2|Overall Study|Lost to Follow-up|3
2559758|NCT01368536|8856246|P1|Overall Study|Lost to Follow-up|3
2559759|NCT01368536|8856244|P3|Overall Study|Withdrawal by Subject|4
2559760|NCT01368536|8856245|P2|Overall Study|Withdrawal by Subject|5
2559761|NCT01368536|8856246|P1|Overall Study|Withdrawal by Subject|2
2559762|NCT01368536|8856244|P3|Overall Study|No longer required study medication|1
2559763|NCT01368536|8856245|P2|Overall Study|No longer required study medication|0
2559764|NCT01368536|8856246|P1|Overall Study|No longer required study medication|0
2559765|NCT01368536|8856244|P3|Overall Study|Unsatisfactory therapeutic effect|2
2559766|NCT01368536|8856245|P2|Overall Study|Unsatisfactory therapeutic effect|2
2559767|NCT01368536|8856246|P1|Overall Study|Unsatisfactory therapeutic effect|7
2559768|NCT01368536|8856244|P3|Overall Study|Abnormal test procedure result(s)|1
2559769|NCT01368536|8856245|P2|Overall Study|Abnormal test procedure result(s)|0
2559770|NCT01368536|8856246|P1|Overall Study|Abnormal test procedure result(s)|0
2559771|NCT01368536|8856244|P3|Overall Study|Abnormal laboratory value(s)|2
2559772|NCT01368536|8856245|P2|Overall Study|Abnormal laboratory value(s)|1
2559773|NCT01368536|8856246|P1|Overall Study|Abnormal laboratory value(s)|0
2559774|NCT01368536|8856244|P3|Overall Study|Adverse Event|8
2559775|NCT01368536|8856245|P2|Overall Study|Adverse Event|6
2559776|NCT01368536|8856246|P1|Overall Study|Adverse Event|5
2559777|NCT01368497|8856267|P1|Overall Study|Lost to Follow-up|2
2559778|NCT01368432|8856295|P2|Overall Study|Lost to Follow-up|1
2559779|NCT01368432|8856296|P1|Overall Study|Lost to Follow-up|0
2559780|NCT01368406|8856330|P2|Overall Study|started working|3
2559781|NCT01368406|8856331|P1|Overall Study|started working|2
2559782|NCT01368406|8856330|P2|Overall Study|relapse of the disease|2
2559783|NCT01368406|8856331|P1|Overall Study|relapse of the disease|3
2559784|NCT01368406|8856330|P2|Overall Study|Withdrawal by Subject|4
2559785|NCT01368406|8856331|P1|Overall Study|Withdrawal by Subject|8
2559786|NCT01368406|8856330|P2|Overall Study|Lost to Follow-up|4
2559787|NCT01368406|8856331|P1|Overall Study|Lost to Follow-up|8
2559788|NCT01368276|8856339|P2|Overall Study|Death|10
2559789|NCT01368276|8856340|P1|Overall Study|Death|1
2559790|NCT01368211|8856377|P2|Second Platelets Transfusion|No need for additional transfusion|2
2559791|NCT01368211|8856378|P1|Second Platelets Transfusion|No need for additional transfusion|1
2559792|NCT01368081|8856406|P13|Overall Study|Other reason not defined above|3
2559793|NCT01368081|8856407|P12|Overall Study|Other reason not defined above|0
2559794|NCT01368081|8856408|P11|Overall Study|Other reason not defined above|0
2559795|NCT01368081|8856409|P10|Overall Study|Other reason not defined above|1
2559796|NCT01368081|8856410|P9|Overall Study|Other reason not defined above|0
2559797|NCT01368081|8856411|P8|Overall Study|Other reason not defined above|0
2559798|NCT01368081|8856412|P7|Overall Study|Other reason not defined above|2
2559799|NCT01368081|8856413|P6|Overall Study|Other reason not defined above|1
2559800|NCT01368081|8856414|P5|Overall Study|Other reason not defined above|0
2559801|NCT01368081|8856415|P4|Overall Study|Other reason not defined above|1
2559802|NCT01368081|8856416|P3|Overall Study|Other reason not defined above|0
2559803|NCT01368081|8856417|P2|Overall Study|Other reason not defined above|0
2559804|NCT01368081|8856418|P1|Overall Study|Other reason not defined above|2
2559805|NCT01368081|8856406|P13|Overall Study|Withdrawal by Subject|0
2559806|NCT01368081|8856407|P12|Overall Study|Withdrawal by Subject|2
2559807|NCT01368081|8856408|P11|Overall Study|Withdrawal by Subject|3
2559808|NCT01368081|8856409|P10|Overall Study|Withdrawal by Subject|4
2559809|NCT01368081|8856410|P9|Overall Study|Withdrawal by Subject|5
2559810|NCT01368081|8856411|P8|Overall Study|Withdrawal by Subject|2
2559811|NCT01368081|8856412|P7|Overall Study|Withdrawal by Subject|4
2559812|NCT01368081|8856413|P6|Overall Study|Withdrawal by Subject|3
2559813|NCT01368081|8856414|P5|Overall Study|Withdrawal by Subject|0
2559814|NCT01368081|8856415|P4|Overall Study|Withdrawal by Subject|1
2559815|NCT01368081|8856416|P3|Overall Study|Withdrawal by Subject|1
2559816|NCT01368081|8856417|P2|Overall Study|Withdrawal by Subject|4
2559817|NCT01368081|8856418|P1|Overall Study|Withdrawal by Subject|4
2559818|NCT01368081|8856406|P13|Overall Study|Lost to Follow-up|1
2559819|NCT01368081|8856407|P12|Overall Study|Lost to Follow-up|0
2559820|NCT01368081|8856408|P11|Overall Study|Lost to Follow-up|0
2559821|NCT01368081|8856409|P10|Overall Study|Lost to Follow-up|0
2559822|NCT01368081|8856410|P9|Overall Study|Lost to Follow-up|0
2559823|NCT01368081|8856411|P8|Overall Study|Lost to Follow-up|0
2559824|NCT01368081|8856412|P7|Overall Study|Lost to Follow-up|0
2559825|NCT01368081|8856413|P6|Overall Study|Lost to Follow-up|0
2559826|NCT01368081|8856414|P5|Overall Study|Lost to Follow-up|0
2559827|NCT01368081|8856415|P4|Overall Study|Lost to Follow-up|0
2559828|NCT01368081|8856416|P3|Overall Study|Lost to Follow-up|0
2559829|NCT01368081|8856417|P2|Overall Study|Lost to Follow-up|0
2559830|NCT01368081|8856418|P1|Overall Study|Lost to Follow-up|0
2559831|NCT01368081|8856406|P13|Overall Study|Protocol Violation|0
2559832|NCT01368081|8856407|P12|Overall Study|Protocol Violation|0
2559833|NCT01368081|8856408|P11|Overall Study|Protocol Violation|0
2559834|NCT01368081|8856409|P10|Overall Study|Protocol Violation|0
2559835|NCT01368081|8856410|P9|Overall Study|Protocol Violation|0
2559836|NCT01368081|8856411|P8|Overall Study|Protocol Violation|1
2559837|NCT01368081|8856412|P7|Overall Study|Protocol Violation|0
2559838|NCT01368081|8856413|P6|Overall Study|Protocol Violation|1
2559839|NCT01368081|8856414|P5|Overall Study|Protocol Violation|0
2559840|NCT01368081|8856415|P4|Overall Study|Protocol Violation|0
2559841|NCT01368081|8856416|P3|Overall Study|Protocol Violation|0
2559842|NCT01368081|8856417|P2|Overall Study|Protocol Violation|0
2559843|NCT01368081|8856418|P1|Overall Study|Protocol Violation|0
2559844|NCT01368081|8856406|P13|Overall Study|Lack of Efficacy|0
2559845|NCT01368081|8856407|P12|Overall Study|Lack of Efficacy|0
2559846|NCT01368081|8856408|P11|Overall Study|Lack of Efficacy|0
2559847|NCT01368081|8856409|P10|Overall Study|Lack of Efficacy|0
2559848|NCT01368081|8856410|P9|Overall Study|Lack of Efficacy|0
2559849|NCT01368081|8856411|P8|Overall Study|Lack of Efficacy|2
2559850|NCT01368081|8856412|P7|Overall Study|Lack of Efficacy|0
2559851|NCT01368081|8856413|P6|Overall Study|Lack of Efficacy|0
2559852|NCT01368081|8856414|P5|Overall Study|Lack of Efficacy|0
2559853|NCT01368081|8856415|P4|Overall Study|Lack of Efficacy|1
2559854|NCT01368081|8856416|P3|Overall Study|Lack of Efficacy|0
2559855|NCT01368081|8856417|P2|Overall Study|Lack of Efficacy|1
2559856|NCT01368081|8856418|P1|Overall Study|Lack of Efficacy|0
2559857|NCT01368081|8856406|P13|Overall Study|Adverse Event|3
2559858|NCT01368081|8856407|P12|Overall Study|Adverse Event|1
2559859|NCT01368081|8856408|P11|Overall Study|Adverse Event|6
2559860|NCT01368081|8856409|P10|Overall Study|Adverse Event|5
2559861|NCT01368081|8856410|P9|Overall Study|Adverse Event|3
2559862|NCT01368081|8856411|P8|Overall Study|Adverse Event|2
2559863|NCT01368081|8856412|P7|Overall Study|Adverse Event|6
2559864|NCT01368081|8856413|P6|Overall Study|Adverse Event|5
2559865|NCT01368081|8856414|P5|Overall Study|Adverse Event|2
2559866|NCT01368081|8856415|P4|Overall Study|Adverse Event|2
2559867|NCT01368081|8856416|P3|Overall Study|Adverse Event|3
2559868|NCT01368081|8856417|P2|Overall Study|Adverse Event|4
2559869|NCT01368081|8856418|P1|Overall Study|Adverse Event|4
2559870|NCT01368042|8856472|P1|Overall Study|Transplanted|1
2559871|NCT01368042|8856472|P1|Overall Study|Lost to Follow-up|4
2559872|NCT01368042|8856472|P1|Overall Study|Protocol Violation|11
2559873|NCT01368042|8856472|P1|Overall Study|Death|14
2559874|NCT01367886|8856492|P1|Overall Study|Death|1
2559875|NCT01367886|8856492|P1|Overall Study|Lack of Efficacy|2
2559876|NCT01367886|8856492|P1|Overall Study|Lost to Follow-up|4
2559877|NCT01367847|8856542|P2|Overall Study|Withdrawal by Subject|2
2559878|NCT01367847|8856543|P1|Overall Study|Withdrawal by Subject|2
2559879|NCT01367834|8856559|P2|Overall Study|Study was ended.|1
2559880|NCT01367834|8856560|P1|Overall Study|Study was ended.|0
2559881|NCT01367834|8856559|P2|Overall Study|Withdrawal by Subject|2
2559882|NCT01367834|8856560|P1|Overall Study|Withdrawal by Subject|2
2559883|NCT01367704|8856584|P2|Overall Study|Lost to Follow-up|161
2559884|NCT01367704|8856585|P1|Overall Study|Lost to Follow-up|47
2559885|NCT01367665|8856597|P2|Overall Study|Not Done|14
2559886|NCT01367665|8856598|P1|Overall Study|Not Done|118
2559887|NCT01367665|8856597|P2|Overall Study|Lost to Follow-up|22
2559888|NCT01367665|8856598|P1|Overall Study|Lost to Follow-up|222
2559889|NCT01367665|8856597|P2|Overall Study|Death|19
2559890|NCT01367665|8856598|P1|Overall Study|Death|102
2559891|NCT01367457|8856629|P3|Overall Study|Suspected DP/suspected active infection|0
2559892|NCT01367457|8856630|P2|Overall Study|Suspected DP/suspected active infection|0
2559893|NCT01367457|8856631|P1|Overall Study|Suspected DP/suspected active infection|1
2559894|NCT01367457|8856629|P3|Overall Study|Palliative. Overall decline|0
2559895|NCT01367457|8856630|P2|Overall Study|Palliative. Overall decline|0
2559896|NCT01367457|8856631|P1|Overall Study|Palliative. Overall decline|1
2559897|NCT01367457|8856629|P3|Overall Study|Patient's Wish|0
2559898|NCT01367457|8856630|P2|Overall Study|Patient's Wish|0
2559899|NCT01367457|8856631|P1|Overall Study|Patient's Wish|1
2559900|NCT01367457|8856629|P3|Overall Study|CD, Suspected disease progression (DP)|0
2559901|NCT01367457|8856630|P2|Overall Study|CD, Suspected disease progression (DP)|0
2559902|NCT01367457|8856631|P1|Overall Study|CD, Suspected disease progression (DP)|1
2559903|NCT01367457|8856629|P3|Overall Study|Death from septic shock|0
2559904|NCT01367457|8856630|P2|Overall Study|Death from septic shock|0
2559905|NCT01367457|8856631|P1|Overall Study|Death from septic shock|1
2559906|NCT01367457|8856629|P3|Overall Study|Lost to Follow-up|0
2559907|NCT01367457|8856630|P2|Overall Study|Lost to Follow-up|0
2559908|NCT01367457|8856631|P1|Overall Study|Lost to Follow-up|1
2559909|NCT01367457|8856629|P3|Overall Study|Rejection of treatment|0
2559910|NCT01367457|8856630|P2|Overall Study|Rejection of treatment|0
2559911|NCT01367457|8856631|P1|Overall Study|Rejection of treatment|1
2559912|NCT01367457|8856629|P3|Overall Study|Overall decline|0
2559913|NCT01367457|8856630|P2|Overall Study|Overall decline|0
2559914|NCT01367457|8856631|P1|Overall Study|Overall decline|1
2559915|NCT01367457|8856629|P3|Overall Study|Intestinal obstruction with necrosis|0
2559916|NCT01367457|8856630|P2|Overall Study|Intestinal obstruction with necrosis|0
2559917|NCT01367457|8856631|P1|Overall Study|Intestinal obstruction with necrosis|1
2559918|NCT01367457|8856629|P3|Overall Study|No clinical benefit|0
2559919|NCT01367457|8856630|P2|Overall Study|No clinical benefit|0
2559920|NCT01367457|8856631|P1|Overall Study|No clinical benefit|1
2559921|NCT01367457|8856629|P3|Overall Study|Stabilisation + frequent infections|0
2559922|NCT01367457|8856630|P2|Overall Study|Stabilisation + frequent infections|0
2559923|NCT01367457|8856631|P1|Overall Study|Stabilisation + frequent infections|1
2559924|NCT01367457|8856629|P3|Overall Study|Overall status worsens to grade 4|0
2559925|NCT01367457|8856630|P2|Overall Study|Overall status worsens to grade 4|0
2559926|NCT01367457|8856631|P1|Overall Study|Overall status worsens to grade 4|1
2559927|NCT01367457|8856629|P3|Overall Study|Uncontrolled pain|0
2559928|NCT01367457|8856630|P2|Overall Study|Uncontrolled pain|0
2559929|NCT01367457|8856631|P1|Overall Study|Uncontrolled pain|1
2559930|NCT01367457|8856629|P3|Overall Study|CD, associated leukaemia|0
2559931|NCT01367457|8856630|P2|Overall Study|CD, associated leukaemia|0
2559932|NCT01367457|8856631|P1|Overall Study|CD, associated leukaemia|1
2559933|NCT01367457|8856629|P3|Overall Study|Withdrawal by Subject|0
2559934|NCT01367457|8856630|P2|Overall Study|Withdrawal by Subject|0
2559935|NCT01367457|8856631|P1|Overall Study|Withdrawal by Subject|1
2559936|NCT01367457|8856629|P3|Overall Study|Choledocolithiasis and pancreatitis|0
2559937|NCT01367457|8856630|P2|Overall Study|Choledocolithiasis and pancreatitis|0
2559938|NCT01367457|8856631|P1|Overall Study|Choledocolithiasis and pancreatitis|1
2559939|NCT01367457|8856629|P3|Overall Study|low grade toxicities + stable disease|0
2559940|NCT01367457|8856630|P2|Overall Study|low grade toxicities + stable disease|0
2559941|NCT01367457|8856631|P1|Overall Study|low grade toxicities + stable disease|1
2559942|NCT01367457|8856629|P3|Overall Study|3 yr Temsirolimus treatment (no disease)|0
2559943|NCT01367457|8856630|P2|Overall Study|3 yr Temsirolimus treatment (no disease)|0
2559944|NCT01367457|8856631|P1|Overall Study|3 yr Temsirolimus treatment (no disease)|1
2559945|NCT01367457|8856629|P3|Overall Study|Bleeding from cavernous haemangioma|0
2559946|NCT01367457|8856630|P2|Overall Study|Bleeding from cavernous haemangioma|0
2559947|NCT01367457|8856631|P1|Overall Study|Bleeding from cavernous haemangioma|1
2559948|NCT01367457|8856629|P3|Overall Study|Investigator's opinion, stable disease|0
2559949|NCT01367457|8856630|P2|Overall Study|Investigator's opinion, stable disease|0
2559950|NCT01367457|8856631|P1|Overall Study|Investigator's opinion, stable disease|1
2559951|NCT01367457|8856629|P3|Overall Study|Patient asks for rest + slow progression|0
2559952|NCT01367457|8856630|P2|Overall Study|Patient asks for rest + slow progression|0
2559953|NCT01367457|8856631|P1|Overall Study|Patient asks for rest + slow progression|1
2559954|NCT01367457|8856629|P3|Overall Study|Progression|0
2559955|NCT01367457|8856630|P2|Overall Study|Progression|0
2559956|NCT01367457|8856631|P1|Overall Study|Progression|137
2559957|NCT01367457|8856629|P3|Overall Study|Toxicity|0
2559958|NCT01367457|8856630|P2|Overall Study|Toxicity|0
2559959|NCT01367457|8856631|P1|Overall Study|Toxicity|16
2559960|NCT01367457|8856629|P3|Overall Study|Progression and death|0
2559961|NCT01367457|8856630|P2|Overall Study|Progression and death|0
2559962|NCT01367457|8856631|P1|Overall Study|Progression and death|8
2559963|NCT01367457|8856629|P3|Overall Study|Clinical decline (CD)|0
2559964|NCT01367457|8856630|P2|Overall Study|Clinical decline (CD)|0
2559965|NCT01367457|8856631|P1|Overall Study|Clinical decline (CD)|2
2559966|NCT01367457|8856629|P3|Overall Study|Investigator's decision|0
2559967|NCT01367457|8856630|P2|Overall Study|Investigator's decision|0
2559968|NCT01367457|8856631|P1|Overall Study|Investigator's decision|2
2559969|NCT01367457|8856629|P3|Overall Study|Death|0
2559970|NCT01367457|8856630|P2|Overall Study|Death|0
2559971|NCT01367457|8856631|P1|Overall Study|Death|2
2559972|NCT01367249|8856664|P2|Overall Study|Other|10
2559973|NCT01367249|8856665|P1|Overall Study|Other|3
2559974|NCT01367249|8856664|P2|Overall Study|Withdrawal by Subject|6
2559975|NCT01367249|8856665|P1|Overall Study|Withdrawal by Subject|6
2559976|NCT01367236|8856675|P2|Overall Study|Withdrawal by Subject|1
2559977|NCT01367236|8856676|P1|Overall Study|Withdrawal by Subject|3
2559978|NCT01367158|8856695|P11|Overall Study|Protocol Violation|0
2559979|NCT01367158|8856696|P10|Overall Study|Protocol Violation|0
2559980|NCT01367158|8856697|P9|Overall Study|Protocol Violation|0
2559981|NCT01367158|8856698|P8|Overall Study|Protocol Violation|0
2559982|NCT01367158|8856699|P7|Overall Study|Protocol Violation|0
2559983|NCT01367158|8856700|P6|Overall Study|Protocol Violation|0
2559984|NCT01367158|8856701|P5|Overall Study|Protocol Violation|0
2559985|NCT01367158|8856702|P4|Overall Study|Protocol Violation|0
2559986|NCT01367158|8856703|P3|Overall Study|Protocol Violation|0
2559987|NCT01367158|8856704|P2|Overall Study|Protocol Violation|1
2559988|NCT01367158|8856705|P1|Overall Study|Protocol Violation|0
2559989|NCT01367158|8856695|P11|Overall Study|Lost to Follow-up|1
2559990|NCT01367158|8856696|P10|Overall Study|Lost to Follow-up|0
2559991|NCT01367158|8856697|P9|Overall Study|Lost to Follow-up|0
2559992|NCT01367158|8856698|P8|Overall Study|Lost to Follow-up|1
2559993|NCT01367158|8856699|P7|Overall Study|Lost to Follow-up|0
2559994|NCT01367158|8856700|P6|Overall Study|Lost to Follow-up|2
2559995|NCT01367158|8856701|P5|Overall Study|Lost to Follow-up|0
2559996|NCT01367158|8856702|P4|Overall Study|Lost to Follow-up|1
2559997|NCT01367158|8856703|P3|Overall Study|Lost to Follow-up|0
2559998|NCT01367158|8856704|P2|Overall Study|Lost to Follow-up|0
2559999|NCT01367158|8856705|P1|Overall Study|Lost to Follow-up|0
2560000|NCT01367158|8856695|P11|Overall Study|Withdrew consent|0
2560001|NCT01367158|8856696|P10|Overall Study|Withdrew consent|0
2560002|NCT01367158|8856697|P9|Overall Study|Withdrew consent|0
2560003|NCT01367158|8856698|P8|Overall Study|Withdrew consent|1
2560004|NCT01367158|8856699|P7|Overall Study|Withdrew consent|0
2560005|NCT01367158|8856700|P6|Overall Study|Withdrew consent|0
2560006|NCT01367158|8856701|P5|Overall Study|Withdrew consent|2
2560007|NCT01367158|8856702|P4|Overall Study|Withdrew consent|0
2560008|NCT01367158|8856703|P3|Overall Study|Withdrew consent|1
2560009|NCT01367158|8856704|P2|Overall Study|Withdrew consent|2
2560010|NCT01367158|8856705|P1|Overall Study|Withdrew consent|0
2560011|NCT01367119|8856849|P2|Overall Study|Withdrawal by Subject|1
2560012|NCT01367119|8856850|P1|Overall Study|Withdrawal by Subject|1
2560013|NCT01367119|8856849|P2|Overall Study|Adverse Event|0
2560014|NCT01367119|8856850|P1|Overall Study|Adverse Event|1
2560015|NCT01366846|8856905|P4|Overall Study|Scheduling Conflicts|0
2560016|NCT01366846|8856906|P3|Overall Study|Scheduling Conflicts|1
2560017|NCT01366846|8856907|P2|Overall Study|Scheduling Conflicts|0
2560018|NCT01366846|8856908|P1|Overall Study|Scheduling Conflicts|0
2560019|NCT01366846|8856905|P4|Overall Study|Communication Difficulties|1
2560020|NCT01366846|8856906|P3|Overall Study|Communication Difficulties|0
2560021|NCT01366846|8856907|P2|Overall Study|Communication Difficulties|4
2560022|NCT01366846|8856908|P1|Overall Study|Communication Difficulties|1
2560023|NCT01366846|8856905|P4|Overall Study|Withdrawal by Subject|0
2560024|NCT01366846|8856906|P3|Overall Study|Withdrawal by Subject|0
2560025|NCT01366846|8856907|P2|Overall Study|Withdrawal by Subject|0
2560026|NCT01366846|8856908|P1|Overall Study|Withdrawal by Subject|2
2560027|NCT01366638|8856931|P3|Overall Study|Other|0
2560028|NCT01366638|8856932|P2|Overall Study|Other|0
2560029|NCT01366638|8856933|P1|Overall Study|Other|1
2560030|NCT01366638|8856931|P3|Overall Study|Withdrawal by Subject|6
2560031|NCT01366638|8856932|P2|Overall Study|Withdrawal by Subject|0
2560032|NCT01366638|8856933|P1|Overall Study|Withdrawal by Subject|0
2560033|NCT01366534|8856970|P3|Overall Study|Declined challenged|0
2560034|NCT01366534|8856971|P2|Overall Study|Declined challenged|1
2560035|NCT01366534|8856972|P1|Overall Study|Declined challenged|0
2560036|NCT01366534|8856970|P3|Overall Study|Migrated|0
2560037|NCT01366534|8856971|P2|Overall Study|Migrated|1
2560038|NCT01366534|8856972|P1|Overall Study|Migrated|1
2560039|NCT01366534|8856970|P3|Overall Study|Lost to Follow-up|0
2560040|NCT01366534|8856971|P2|Overall Study|Lost to Follow-up|0
2560041|NCT01366534|8856972|P1|Overall Study|Lost to Follow-up|1
2560042|NCT01366521|8857022|P4|Overall Study|Withdrawal by Subject|0
2560043|NCT01366521|8857023|P3|Overall Study|Withdrawal by Subject|0
2560044|NCT01366521|8857024|P2|Overall Study|Withdrawal by Subject|1
2560045|NCT01366521|8857025|P1|Overall Study|Withdrawal by Subject|0
2560046|NCT01366521|8857022|P4|Overall Study|Physician Decision|0
2560047|NCT01366521|8857023|P3|Overall Study|Physician Decision|1
2560048|NCT01366521|8857024|P2|Overall Study|Physician Decision|0
2560049|NCT01366521|8857025|P1|Overall Study|Physician Decision|0
2560050|NCT01366521|8857022|P4|Overall Study|Protocol Violation|0
2560051|NCT01366521|8857023|P3|Overall Study|Protocol Violation|1
2560052|NCT01366521|8857024|P2|Overall Study|Protocol Violation|0
2560053|NCT01366521|8857025|P1|Overall Study|Protocol Violation|0
2560054|NCT01366521|8857022|P4|Overall Study|Adverse Event|0
2560055|NCT01366521|8857023|P3|Overall Study|Adverse Event|0
2560056|NCT01366521|8857024|P2|Overall Study|Adverse Event|0
2560057|NCT01366521|8857025|P1|Overall Study|Adverse Event|1
2560058|NCT01366443|8857121|P1|Overall Study|Under 18 yo|1
2560059|NCT01366443|8857121|P1|Overall Study|Lost to Follow-up|2
2560060|NCT01366209|8857135|P2|Overall Study|Withdrew consent|3
2560061|NCT01366209|8857136|P1|Overall Study|Withdrew consent|4
2560062|NCT01366209|8857135|P2|Overall Study|Sponsors decision|1
2560063|NCT01366209|8857136|P1|Overall Study|Sponsors decision|0
2560064|NCT01366209|8857135|P2|Overall Study|Physician Decision|0
2560065|NCT01366209|8857136|P1|Overall Study|Physician Decision|1
2560066|NCT01366209|8857135|P2|Overall Study|Lost to Follow-up|1
2560067|NCT01366209|8857136|P1|Overall Study|Lost to Follow-up|2
2560068|NCT01366209|8857135|P2|Overall Study|Lung transplantation|1
2560069|NCT01366209|8857136|P1|Overall Study|Lung transplantation|6
2560070|NCT01366209|8857135|P2|Overall Study|Death|19
2560071|NCT01366209|8857136|P1|Overall Study|Death|12
2560072|NCT01366209|8857135|P2|Overall Study|Withdrawal by Subject|4
2560073|NCT01366209|8857136|P1|Overall Study|Withdrawal by Subject|4
2560074|NCT01366209|8857135|P2|Overall Study|Adverse Event|7
2560075|NCT01366209|8857136|P1|Overall Study|Adverse Event|6
2560076|NCT01366092|8857159|P1|Overall Study|Withdrawal by Subject|1
2560077|NCT01366092|8857159|P1|Overall Study|Physician Decision|1
2560078|NCT01366092|8857159|P1|Overall Study|Progressive cGVHD|2
2560079|NCT01365910|8857168|P1|Overall Study|pt did not get tx, nausea/vomiting|1
2560080|NCT01365910|8857168|P1|Overall Study|other complicating disease|1
2560081|NCT01365910|8857168|P1|Overall Study|Adverse Event|3
2560082|NCT01365910|8857168|P1|Overall Study|disease progression|18
2560083|NCT01365910|8857168|P1|Overall Study|Withdrawal by Subject|7
2560084|NCT01365546|8857304|P1|Overall Study|Study termination|1
2560085|NCT01365546|8857304|P1|Overall Study|Screen failure|9
2560086|NCT01365546|8857304|P1|Overall Study|Withdrawal by Subject|1
2560087|NCT01365507|8857314|P2|Overall Study|Unclassified|4
2560088|NCT01365507|8857315|P1|Overall Study|Unclassified|1
2560089|NCT01365507|8857314|P2|Overall Study|Withdrawal Criteria|5
2560090|NCT01365507|8857315|P1|Overall Study|Withdrawal Criteria|8
2560091|NCT01365494|8857331|P2|Overall Study|Lost to Follow-up|2
2560092|NCT01365494|8857332|P1|Overall Study|Lost to Follow-up|1
2560093|NCT01365494|8857331|P2|Overall Study|Withdrawal by Subject|1
2560094|NCT01365494|8857332|P1|Overall Study|Withdrawal by Subject|0
2560095|NCT01365494|8857331|P2|Overall Study|Adverse Event|0
2560096|NCT01365494|8857332|P1|Overall Study|Adverse Event|1
2560097|NCT01365481|8857348|P4|Overall Study|Unsatisfactory therapeutic effect|0
2560098|NCT01365481|8857349|P3|Overall Study|Unsatisfactory therapeutic effect|1
2560099|NCT01365481|8857350|P2|Overall Study|Unsatisfactory therapeutic effect|0
2560100|NCT01365481|8857351|P1|Overall Study|Unsatisfactory therapeutic effect|0
2560101|NCT01365481|8857348|P4|Overall Study|Protocol deviation|1
2560102|NCT01365481|8857349|P3|Overall Study|Protocol deviation|0
2560103|NCT01365481|8857350|P2|Overall Study|Protocol deviation|1
2560104|NCT01365481|8857351|P1|Overall Study|Protocol deviation|0
2560105|NCT01365481|8857348|P4|Overall Study|Administrative problems|0
2560106|NCT01365481|8857349|P3|Overall Study|Administrative problems|0
2560107|NCT01365481|8857350|P2|Overall Study|Administrative problems|1
2560108|NCT01365481|8857351|P1|Overall Study|Administrative problems|0
2560109|NCT01365481|8857348|P4|Overall Study|Abnormal laboratory value(s)|0
2560110|NCT01365481|8857349|P3|Overall Study|Abnormal laboratory value(s)|0
2560111|NCT01365481|8857350|P2|Overall Study|Abnormal laboratory value(s)|1
2560112|NCT01365481|8857351|P1|Overall Study|Abnormal laboratory value(s)|0
2560113|NCT01365481|8857348|P4|Overall Study|Lost to Follow-up|3
2560114|NCT01365481|8857349|P3|Overall Study|Lost to Follow-up|2
2560115|NCT01365481|8857350|P2|Overall Study|Lost to Follow-up|1
2560116|NCT01365481|8857351|P1|Overall Study|Lost to Follow-up|1
2560117|NCT01365481|8857348|P4|Overall Study|Withdrawal by Subject|1
2560118|NCT01365481|8857349|P3|Overall Study|Withdrawal by Subject|1
2560119|NCT01365481|8857350|P2|Overall Study|Withdrawal by Subject|2
2560120|NCT01365481|8857351|P1|Overall Study|Withdrawal by Subject|0
2560121|NCT01365481|8857348|P4|Overall Study|Adverse Event|2
2560122|NCT01365481|8857349|P3|Overall Study|Adverse Event|0
2560123|NCT01365481|8857350|P2|Overall Study|Adverse Event|9
2560124|NCT01365481|8857351|P1|Overall Study|Adverse Event|6
2560125|NCT01365468|8857371|P2|Overall Study|Lost to Follow-up|0
2560126|NCT01365468|8857372|P1|Overall Study|Lost to Follow-up|2
2560127|NCT01365468|8857371|P2|Overall Study|Disease progression|0
2560128|NCT01365468|8857372|P1|Overall Study|Disease progression|1
2560129|NCT01365468|8857371|P2|Overall Study|Physician Decision|0
2560130|NCT01365468|8857372|P1|Overall Study|Physician Decision|1
2560131|NCT01365455|8857387|P5|Maintenance Period|Subject/guardian decision|1
2560132|NCT01365455|8857388|P4|Maintenance Period|Subject/guardian decision|4
2560133|NCT01365455|8857389|P3|Maintenance Period|Subject/guardian decision|2
2560134|NCT01365455|8857390|P2|Maintenance Period|Subject/guardian decision|6
2560135|NCT01365455|8857391|P1|Maintenance Period|Subject/guardian decision|4
2560136|NCT01365455|8857387|P5|Maintenance Period|Protocol deviation|0
2560137|NCT01365455|8857388|P4|Maintenance Period|Protocol deviation|0
2560138|NCT01365455|8857389|P3|Maintenance Period|Protocol deviation|0
2560139|NCT01365455|8857390|P2|Maintenance Period|Protocol deviation|1
2560140|NCT01365455|8857391|P1|Maintenance Period|Protocol deviation|1
2560141|NCT01365455|8857387|P5|Maintenance Period|Pregnancy|2
2560142|NCT01365455|8857388|P4|Maintenance Period|Pregnancy|0
2560143|NCT01365455|8857389|P3|Maintenance Period|Pregnancy|0
2560144|NCT01365455|8857390|P2|Maintenance Period|Pregnancy|4
2560145|NCT01365455|8857391|P1|Maintenance Period|Pregnancy|0
2560146|NCT01365455|8857387|P5|Maintenance Period|Physician Decision|1
2560147|NCT01365455|8857388|P4|Maintenance Period|Physician Decision|0
2560148|NCT01365455|8857389|P3|Maintenance Period|Physician Decision|0
2560149|NCT01365455|8857390|P2|Maintenance Period|Physician Decision|1
2560150|NCT01365455|8857391|P1|Maintenance Period|Physician Decision|0
2560151|NCT01365455|8857387|P5|Maintenance Period|Non-compliance with study treatment|0
2560152|NCT01365455|8857388|P4|Maintenance Period|Non-compliance with study treatment|1
2560153|NCT01365455|8857389|P3|Maintenance Period|Non-compliance with study treatment|0
2560154|NCT01365455|8857390|P2|Maintenance Period|Non-compliance with study treatment|0
2560155|NCT01365455|8857391|P1|Maintenance Period|Non-compliance with study treatment|0
2560156|NCT01365455|8857387|P5|Maintenance Period|Lost to Follow-up|3
2560157|NCT01365455|8857388|P4|Maintenance Period|Lost to Follow-up|0
2560158|NCT01365455|8857389|P3|Maintenance Period|Lost to Follow-up|0
2560159|NCT01365455|8857390|P2|Maintenance Period|Lost to Follow-up|4
2560160|NCT01365455|8857391|P1|Maintenance Period|Lost to Follow-up|2
2560161|NCT01365455|8857387|P5|Maintenance Period|Lack of Efficacy|2
2560162|NCT01365455|8857388|P4|Maintenance Period|Lack of Efficacy|2
2560163|NCT01365455|8857389|P3|Maintenance Period|Lack of Efficacy|0
2560164|NCT01365455|8857390|P2|Maintenance Period|Lack of Efficacy|2
2560165|NCT01365455|8857391|P1|Maintenance Period|Lack of Efficacy|10
2560166|NCT01365455|8857387|P5|Maintenance Period|Adverse Event|4
2560167|NCT01365455|8857388|P4|Maintenance Period|Adverse Event|2
2560168|NCT01365455|8857389|P3|Maintenance Period|Adverse Event|1
2560169|NCT01365455|8857390|P2|Maintenance Period|Adverse Event|5
2560170|NCT01365455|8857391|P1|Maintenance Period|Adverse Event|12
2560171|NCT01365455|8857387|P5|Induction Period|Lost to Follow-up|0
2560172|NCT01365455|8857388|P4|Induction Period|Lost to Follow-up|0
2560173|NCT01365455|8857389|P3|Induction Period|Lost to Follow-up|3
2560174|NCT01365455|8857390|P2|Induction Period|Lost to Follow-up|0
2560175|NCT01365455|8857391|P1|Induction Period|Lost to Follow-up|0
2560176|NCT01365455|8857387|P5|Induction Period|Subject/guardian decision|0
2560177|NCT01365455|8857388|P4|Induction Period|Subject/guardian decision|0
2560178|NCT01365455|8857389|P3|Induction Period|Subject/guardian decision|8
2560179|NCT01365455|8857390|P2|Induction Period|Subject/guardian decision|1
2560180|NCT01365455|8857391|P1|Induction Period|Subject/guardian decision|9
2560181|NCT01365455|8857387|P5|Induction Period|Protocol deviation|0
2560182|NCT01365455|8857388|P4|Induction Period|Protocol deviation|0
2560183|NCT01365455|8857389|P3|Induction Period|Protocol deviation|1
2560184|NCT01365455|8857390|P2|Induction Period|Protocol deviation|1
2560185|NCT01365455|8857391|P1|Induction Period|Protocol deviation|0
2560186|NCT01365455|8857387|P5|Induction Period|Pregnancy|0
2560187|NCT01365455|8857388|P4|Induction Period|Pregnancy|0
2560188|NCT01365455|8857389|P3|Induction Period|Pregnancy|0
2560189|NCT01365455|8857390|P2|Induction Period|Pregnancy|1
2560190|NCT01365455|8857391|P1|Induction Period|Pregnancy|0
2560191|NCT01365455|8857387|P5|Induction Period|Lack of Efficacy|0
2560192|NCT01365455|8857388|P4|Induction Period|Lack of Efficacy|0
2560193|NCT01365455|8857389|P3|Induction Period|Lack of Efficacy|0
2560194|NCT01365455|8857390|P2|Induction Period|Lack of Efficacy|1
2560195|NCT01365455|8857391|P1|Induction Period|Lack of Efficacy|1
2560196|NCT01365455|8857387|P5|Induction Period|Adverse Event|0
2560197|NCT01365455|8857388|P4|Induction Period|Adverse Event|0
2560198|NCT01365455|8857389|P3|Induction Period|Adverse Event|4
2560199|NCT01365455|8857390|P2|Induction Period|Adverse Event|3
2560200|NCT01365455|8857391|P1|Induction Period|Adverse Event|5
2560201|NCT01365273|8857481|P2|Overall Study|Physician Decision|0
2560202|NCT01365273|8857482|P1|Overall Study|Physician Decision|1
2560203|NCT01365273|8857481|P2|Overall Study|Protocol Violation|1
2560204|NCT01365273|8857482|P1|Overall Study|Protocol Violation|0
2560205|NCT01365273|8857481|P2|Overall Study|Lost to Follow-up|0
2560206|NCT01365273|8857482|P1|Overall Study|Lost to Follow-up|1
2560207|NCT01365130|8857492|P1|Overall Study|Progression/worsening of Dx prior to txt|2
2560208|NCT01365091|8857501|P4|Period 2|Adverse Event|0
2560209|NCT01365091|8857502|P3|Period 2|Adverse Event|1
2560210|NCT01365091|8857503|P2|Period 2|Adverse Event|0
2560211|NCT01365091|8857504|P1|Period 2|Adverse Event|0
2560212|NCT01365091|8857501|P4|Period 2|Withdrawal by Subject|0
2560213|NCT01365091|8857502|P3|Period 2|Withdrawal by Subject|0
2560214|NCT01365091|8857503|P2|Period 2|Withdrawal by Subject|0
2560215|NCT01365091|8857504|P1|Period 2|Withdrawal by Subject|1
2560216|NCT01365091|8857501|P4|Period 1|Personal reasons|0
2560217|NCT01365091|8857502|P3|Period 1|Personal reasons|1
2560218|NCT01365091|8857503|P2|Period 1|Personal reasons|0
2560219|NCT01365091|8857504|P1|Period 1|Personal reasons|0
2560220|NCT01365091|8857501|P4|Period 1|Withdrawal by Subject|0
2560221|NCT01365091|8857502|P3|Period 1|Withdrawal by Subject|0
2560222|NCT01365091|8857503|P2|Period 1|Withdrawal by Subject|1
2560223|NCT01365091|8857504|P1|Period 1|Withdrawal by Subject|0
2560224|NCT01365091|8857501|P4|Period 1|No longer met study criteria|0
2560225|NCT01365091|8857502|P3|Period 1|No longer met study criteria|0
2560226|NCT01365091|8857503|P2|Period 1|No longer met study criteria|1
2560227|NCT01365091|8857504|P1|Period 1|No longer met study criteria|0
2560228|NCT01365091|8857501|P4|Period 1|Positive test result for drugs of abuse|0
2560229|NCT01365091|8857502|P3|Period 1|Positive test result for drugs of abuse|0
2560230|NCT01365091|8857503|P2|Period 1|Positive test result for drugs of abuse|0
2560231|NCT01365091|8857504|P1|Period 1|Positive test result for drugs of abuse|1
2560232|NCT01365091|8857501|P4|Period 1|Adverse Event|3
2560233|NCT01365091|8857502|P3|Period 1|Adverse Event|2
2560234|NCT01365091|8857503|P2|Period 1|Adverse Event|0
2560235|NCT01365091|8857504|P1|Period 1|Adverse Event|1
2560236|NCT01365052|8857532|P2|Overall Study|Adverse Event|4
2560237|NCT01365052|8857533|P1|Overall Study|Adverse Event|4
2560238|NCT01365039|8857549|P2|Overall Study|Study related symptoms and complaints|0
2560239|NCT01365039|8857550|P1|Overall Study|Study related symptoms and complaints|1
2560240|NCT01364922|8857561|P3|Double-Blind (DB) Period|Other, Unspecified|0
2560241|NCT01364922|8857562|P2|Double-Blind (DB) Period|Other, Unspecified|1
2560242|NCT01364922|8857563|P1|Double-Blind (DB) Period|Other, Unspecified|0
2560243|NCT01364922|8857561|P3|Double-Blind (DB) Period|Adverse Event|1
2560244|NCT01364922|8857562|P2|Double-Blind (DB) Period|Adverse Event|0
2560245|NCT01364922|8857563|P1|Double-Blind (DB) Period|Adverse Event|0
2560246|NCT01364922|8857561|P3|Double-Blind (DB) Period|Subject Noncompliant|0
2560247|NCT01364922|8857562|P2|Double-Blind (DB) Period|Subject Noncompliant|1
2560248|NCT01364922|8857563|P1|Double-Blind (DB) Period|Subject Noncompliant|0
2560249|NCT01364922|8857561|P3|Double-Blind (DB) Period|Lack of Efficacy|4
2560250|NCT01364922|8857562|P2|Double-Blind (DB) Period|Lack of Efficacy|3
2560251|NCT01364922|8857563|P1|Double-Blind (DB) Period|Lack of Efficacy|0
2560252|NCT01364922|8857561|P3|Open-label (OL) Period|Other, Unspecified|0
2560253|NCT01364922|8857562|P2|Open-label (OL) Period|Other, Unspecified|0
2560254|NCT01364922|8857563|P1|Open-label (OL) Period|Other, Unspecified|1
2560255|NCT01364922|8857561|P3|Open-label (OL) Period|Lost to Follow-up|0
2560256|NCT01364922|8857562|P2|Open-label (OL) Period|Lost to Follow-up|0
2560257|NCT01364922|8857563|P1|Open-label (OL) Period|Lost to Follow-up|1
2560258|NCT01364922|8857561|P3|Open-label (OL) Period|Lack of Efficacy|0
2560259|NCT01364922|8857562|P2|Open-label (OL) Period|Lack of Efficacy|0
2560260|NCT01364922|8857563|P1|Open-label (OL) Period|Lack of Efficacy|3
2560261|NCT01364922|8857561|P3|Open-label (OL) Period|Withdrawal by Subject|0
2560262|NCT01364922|8857562|P2|Open-label (OL) Period|Withdrawal by Subject|0
2560263|NCT01364922|8857563|P1|Open-label (OL) Period|Withdrawal by Subject|4
2560264|NCT01364922|8857561|P3|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
2560265|NCT01364922|8857562|P2|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
2560266|NCT01364922|8857563|P1|Open-label (OL) Period|Did Not Meet Randomization Criteria|6
2560267|NCT01364922|8857561|P3|Open-label (OL) Period|Adverse Event|0
2560268|NCT01364922|8857562|P2|Open-label (OL) Period|Adverse Event|0
2560269|NCT01364922|8857563|P1|Open-label (OL) Period|Adverse Event|7
2560270|NCT01364870|8857585|P3|Overall Study|Protocol Violation|0
2560271|NCT01364870|8857586|P2|Overall Study|Protocol Violation|0
2560272|NCT01364870|8857587|P1|Overall Study|Protocol Violation|1
2560273|NCT01364870|8857585|P3|Overall Study|Adverse Event|4
2560274|NCT01364870|8857586|P2|Overall Study|Adverse Event|6
2560275|NCT01364870|8857587|P1|Overall Study|Adverse Event|8
2560276|NCT01364870|8857585|P3|Overall Study|Withdrawal by Subject|10
2560277|NCT01364870|8857586|P2|Overall Study|Withdrawal by Subject|24
2560278|NCT01364870|8857587|P1|Overall Study|Withdrawal by Subject|13
2560279|NCT01364727|8857606|P1|Overall Study|Not Eligible|2
2560280|NCT01364649|8857614|P2|Overall Study|Other|1
2560281|NCT01364649|8857615|P1|Overall Study|Other|4
2560282|NCT01364649|8857614|P2|Overall Study|Lost to Follow-up|13
2560283|NCT01364649|8857615|P1|Overall Study|Lost to Follow-up|12
2560284|NCT01364649|8857614|P2|Overall Study|Withdrawal of Consent|7
2560285|NCT01364649|8857615|P1|Overall Study|Withdrawal of Consent|9
2560286|NCT01364649|8857614|P2|Overall Study|Protocol Deviations|8
2560287|NCT01364649|8857615|P1|Overall Study|Protocol Deviations|4
2560288|NCT01364649|8857614|P2|Overall Study|Non-compliance with Investigational Drug|0
2560289|NCT01364649|8857615|P1|Overall Study|Non-compliance with Investigational Drug|1
2560290|NCT01364649|8857614|P2|Overall Study|Lack of Efficacy|0
2560291|NCT01364649|8857615|P1|Overall Study|Lack of Efficacy|6
2560292|NCT01364649|8857614|P2|Overall Study|Pretreatment Event or Adverse Event|14
2560293|NCT01364649|8857615|P1|Overall Study|Pretreatment Event or Adverse Event|20
2560294|NCT01364467|8857703|P2|Overall Study|Lost to Follow-up|2
2560295|NCT01364467|8857704|P1|Overall Study|Lost to Follow-up|1
2560296|NCT01364428|8857716|P2|Overall Study|Other|3
2560297|NCT01364428|8857717|P1|Overall Study|Other|3
2560298|NCT01364428|8857716|P2|Overall Study|Withdrawal Criteria|10
2560299|NCT01364428|8857717|P1|Overall Study|Withdrawal Criteria|14
2560300|NCT01364428|8857716|P2|Overall Study|Protocol Violation|0
2560301|NCT01364428|8857717|P1|Overall Study|Protocol Violation|2
2560302|NCT01364428|8857716|P2|Overall Study|Adverse Event|2
2560303|NCT01364428|8857717|P1|Overall Study|Adverse Event|1
2560304|NCT01364389|8857734|P3|Overall Study|Adverse Event|0
2560305|NCT01364389|8857735|P2|Overall Study|Adverse Event|0
2560306|NCT01364389|8857736|P1|Overall Study|Adverse Event|1
2560307|NCT01364389|8857734|P3|Overall Study|Administrative problems|0
2560308|NCT01364389|8857735|P2|Overall Study|Administrative problems|0
2560309|NCT01364389|8857736|P1|Overall Study|Administrative problems|1
2560310|NCT01364389|8857734|P3|Overall Study|Protocol deviation|1
2560311|NCT01364389|8857735|P2|Overall Study|Protocol deviation|0
2560312|NCT01364389|8857736|P1|Overall Study|Protocol deviation|0
2560313|NCT01364389|8857734|P3|Overall Study|Withdrawal by Subject|0
2560314|NCT01364389|8857735|P2|Overall Study|Withdrawal by Subject|1
2560315|NCT01364389|8857736|P1|Overall Study|Withdrawal by Subject|0
2560316|NCT01364298|8857755|P2|Overall Study|Other|3
2560317|NCT01364298|8857756|P1|Overall Study|Other|1
2560318|NCT01364298|8857755|P2|Overall Study|Withdrawal by Subject|3
2560319|NCT01364298|8857756|P1|Overall Study|Withdrawal by Subject|3
2560320|NCT01364298|8857755|P2|Overall Study|Lost to Follow-up|10
2560321|NCT01364298|8857756|P1|Overall Study|Lost to Follow-up|5
2560322|NCT01364298|8857755|P2|Overall Study|Lack of Efficacy|0
2560323|NCT01364298|8857756|P1|Overall Study|Lack of Efficacy|1
2560324|NCT01364298|8857755|P2|Overall Study|Lack of adherence to treatment|3
2560325|NCT01364298|8857756|P1|Overall Study|Lack of adherence to treatment|1
2560326|NCT01364298|8857755|P2|Overall Study|Adverse Event|4
2560327|NCT01364298|8857756|P1|Overall Study|Adverse Event|3
2560328|NCT01364233|8857789|P1|Overall Study|Lost to Follow-up|1
2560329|NCT01363986|8857834|P1|Overall Study|Disease progression|1
2560330|NCT01363908|8857844|P2|Chronic Dosing (CD) Phase|Early study termination|3
2560331|NCT01363908|8857845|P1|Chronic Dosing (CD) Phase|Early study termination|9
2560332|NCT01363908|8857844|P2|Chronic Dosing (CD) Phase|Physician Decision|1
2560333|NCT01363908|8857845|P1|Chronic Dosing (CD) Phase|Physician Decision|0
2560334|NCT01363908|8857844|P2|Chronic Dosing (CD) Phase|Patient decision|1
2560335|NCT01363908|8857845|P1|Chronic Dosing (CD) Phase|Patient decision|0
2560336|NCT01363908|8857844|P2|Chronic Dosing (CD) Phase|Adverse Event|1
2560337|NCT01363908|8857845|P1|Chronic Dosing (CD) Phase|Adverse Event|1
2560338|NCT01363765|8857882|P2|Overall Study|smear during intervention|0
2560339|NCT01363765|8857883|P1|Overall Study|smear during intervention|2170
2560340|NCT01363765|8857882|P2|Overall Study|age not recorded (used for cross-linkage|354
2560341|NCT01363765|8857883|P1|Overall Study|age not recorded (used for cross-linkage|117
2560342|NCT01363765|8857882|P2|Overall Study|non-resident|76
2560343|NCT01363765|8857883|P1|Overall Study|non-resident|156
2560344|NCT01363765|8857882|P2|Overall Study|duplicate records|3177
2560345|NCT01363765|8857883|P1|Overall Study|duplicate records|736
2560346|NCT01363765|8857882|P2|Overall Study|non-diagnostic|1124
2560347|NCT01363765|8857883|P1|Overall Study|non-diagnostic|2621
2560348|NCT01363713|8857895|P1|Overall Study|Withdrawal by Subject|2
2560349|NCT01363713|8857895|P1|Overall Study|Protocol Violation|3
2560350|NCT01363713|8857895|P1|Overall Study|Adverse Event|1
2560351|NCT01363700|8857904|P5|Epinastine vs Placebo Period1|Withdrawal by Subject|0
2560352|NCT01363700|8857905|P4|Epinastine vs Placebo Period1|Withdrawal by Subject|0
2560353|NCT01363700|8857906|P3|Epinastine vs Placebo Period1|Withdrawal by Subject|0
2560354|NCT01363700|8857907|P2|Epinastine vs Placebo Period1|Withdrawal by Subject|1
2560355|NCT01363700|8857908|P1|Epinastine vs Placebo Period1|Withdrawal by Subject|0
2560356|NCT01363661|8857927|P2|Overall Study|Lost to Follow-up|1
2560357|NCT01363661|8857928|P1|Overall Study|Lost to Follow-up|3
2560358|NCT01363661|8857927|P2|Overall Study|Protocol Violation|0
2560359|NCT01363661|8857928|P1|Overall Study|Protocol Violation|1
2560360|NCT01363661|8857927|P2|Overall Study|Withdrawal by Subject|1
2560361|NCT01363661|8857928|P1|Overall Study|Withdrawal by Subject|1
2560362|NCT01363661|8857927|P2|Overall Study|Adverse Event|2
2560363|NCT01363661|8857928|P1|Overall Study|Adverse Event|9
2560364|NCT01363440|8857969|P3|Overall Study|Other|2
2560365|NCT01363440|8857970|P2|Overall Study|Other|5
2560366|NCT01363440|8857971|P1|Overall Study|Other|4
2560367|NCT01363440|8857969|P3|Overall Study|Lost to Follow-up|5
2560368|NCT01363440|8857970|P2|Overall Study|Lost to Follow-up|4
2560369|NCT01363440|8857971|P1|Overall Study|Lost to Follow-up|2
2560370|NCT01363440|8857969|P3|Overall Study|Withdrawal by Subject|11
2560371|NCT01363440|8857970|P2|Overall Study|Withdrawal by Subject|11
2560372|NCT01363440|8857971|P1|Overall Study|Withdrawal by Subject|9
2560373|NCT01363440|8857969|P3|Overall Study|Death|5
2560374|NCT01363440|8857970|P2|Overall Study|Death|7
2560375|NCT01363440|8857971|P1|Overall Study|Death|3
2560376|NCT01363440|8857969|P3|Overall Study|Adverse Event|4
2560377|NCT01363440|8857970|P2|Overall Study|Adverse Event|4
2560378|NCT01363440|8857971|P1|Overall Study|Adverse Event|5
2560379|NCT01363349|8858017|P2|Overall Study|missing|2
2560380|NCT01363349|8858018|P1|Overall Study|missing|1
2560381|NCT01363349|8858017|P2|Overall Study|Not reported|37
2560382|NCT01363349|8858018|P1|Overall Study|Not reported|36
2560383|NCT01363349|8858017|P2|Overall Study|Lost to Follow-up|6
2560384|NCT01363349|8858018|P1|Overall Study|Lost to Follow-up|5
2560385|NCT01363349|8858017|P2|Overall Study|Withdrawal by Subject|6
2560386|NCT01363349|8858018|P1|Overall Study|Withdrawal by Subject|14
2560387|NCT01363349|8858017|P2|Overall Study|Non compliance/Protocol deviations|2
2560388|NCT01363349|8858018|P1|Overall Study|Non compliance/Protocol deviations|2
2560389|NCT01363349|8858017|P2|Overall Study|Lack of Efficacy|10
2560390|NCT01363349|8858018|P1|Overall Study|Lack of Efficacy|3
2560391|NCT01363349|8858017|P2|Overall Study|Adverse Event|7
2560392|NCT01363349|8858018|P1|Overall Study|Adverse Event|6
2560393|NCT01363297|8858029|P5|Overall Study|Death|30
2560394|NCT01363297|8858030|P4|Overall Study|Death|10
2560395|NCT01363297|8858031|P3|Overall Study|Death|6
2560396|NCT01363297|8858032|P2|Overall Study|Death|6
2560397|NCT01363297|8858033|P1|Overall Study|Death|3
2560398|NCT01363297|8858029|P5|Overall Study|Other|1
2560399|NCT01363297|8858030|P4|Overall Study|Other|0
2560400|NCT01363297|8858031|P3|Overall Study|Other|0
2560401|NCT01363297|8858032|P2|Overall Study|Other|0
2560402|NCT01363297|8858033|P1|Overall Study|Other|0
2560403|NCT01363076|8858136|P2|Overall Study|Withdrawal by Subject|1
2560404|NCT01363076|8858137|P1|Overall Study|Withdrawal by Subject|0
2560405|NCT01363011|8858169|P2|Extension Phase|Rolled Over to Another Gilead Study|1
2560406|NCT01363011|8858170|P1|Extension Phase|Rolled Over to Another Gilead Study|2
2560407|NCT01363011|8858169|P2|Extension Phase|Lost to Follow-up|2
2560408|NCT01363011|8858170|P1|Extension Phase|Lost to Follow-up|0
2560409|NCT01363011|8858169|P2|Extension Phase|Withdrew Consent|1
2560410|NCT01363011|8858170|P1|Extension Phase|Withdrew Consent|0
2560411|NCT01363011|8858169|P2|Extension Phase|Investigator's Discretion|2
2560412|NCT01363011|8858170|P1|Extension Phase|Investigator's Discretion|2
2560413|NCT01363011|8858169|P2|Extension Phase|Lack of Efficacy|1
2560414|NCT01363011|8858170|P1|Extension Phase|Lack of Efficacy|0
2560415|NCT01363011|8858169|P2|Extension Phase|Adverse Event|1
2560416|NCT01363011|8858170|P1|Extension Phase|Adverse Event|1
2560417|NCT01363011|8858169|P2|Main Study|Protocol Violation|1
2560418|NCT01363011|8858170|P1|Main Study|Protocol Violation|0
2560419|NCT01363011|8858169|P2|Main Study|Withdrew Consent|4
2560420|NCT01363011|8858170|P1|Main Study|Withdrew Consent|1
2560421|NCT01363011|8858169|P2|Main Study|Investigator's Discretion|1
2560422|NCT01363011|8858170|P1|Main Study|Investigator's Discretion|1
2560423|NCT01363011|8858169|P2|Main Study|Adverse Event|3
2560424|NCT01363011|8858170|P1|Main Study|Adverse Event|2
2560425|NCT01362790|8858297|P7|Dose De-escalation of Regimen A|Progressive disease|0
2560426|NCT01362790|8858298|P6|Dose De-escalation of Regimen A|Progressive disease|0
2560427|NCT01362790|8858299|P5|Dose De-escalation of Regimen A|Progressive disease|2
2560428|NCT01362790|8858300|P4|Dose De-escalation of Regimen A|Progressive disease|0
2560429|NCT01362790|8858301|P3|Dose De-escalation of Regimen A|Progressive disease|0
2560430|NCT01362790|8858302|P2|Dose De-escalation of Regimen A|Progressive disease|0
2560431|NCT01362790|8858303|P1|Dose De-escalation of Regimen A|Progressive disease|0
2560432|NCT01362790|8858297|P7|Dose De-escalation of Regimen A|Deveoped antibodies|0
2560433|NCT01362790|8858298|P6|Dose De-escalation of Regimen A|Deveoped antibodies|0
2560434|NCT01362790|8858299|P5|Dose De-escalation of Regimen A|Deveoped antibodies|3
2560435|NCT01362790|8858300|P4|Dose De-escalation of Regimen A|Deveoped antibodies|0
2560436|NCT01362790|8858301|P3|Dose De-escalation of Regimen A|Deveoped antibodies|0
2560437|NCT01362790|8858302|P2|Dose De-escalation of Regimen A|Deveoped antibodies|0
2560438|NCT01362790|8858303|P1|Dose De-escalation of Regimen A|Deveoped antibodies|0
2560439|NCT01362790|8858297|P7|Dose De-escalation of Regimen A|Adverse Event|0
2560440|NCT01362790|8858298|P6|Dose De-escalation of Regimen A|Adverse Event|0
2560441|NCT01362790|8858299|P5|Dose De-escalation of Regimen A|Adverse Event|1
2560442|NCT01362790|8858300|P4|Dose De-escalation of Regimen A|Adverse Event|0
2560443|NCT01362790|8858301|P3|Dose De-escalation of Regimen A|Adverse Event|0
2560444|NCT01362790|8858302|P2|Dose De-escalation of Regimen A|Adverse Event|0
2560445|NCT01362790|8858303|P1|Dose De-escalation of Regimen A|Adverse Event|0
2560446|NCT01362790|8858297|P7|Pilot Phase & Phase 2|Death on study|0
2560447|NCT01362790|8858298|P6|Pilot Phase & Phase 2|Death on study|0
2560448|NCT01362790|8858299|P5|Pilot Phase & Phase 2|Death on study|0
2560449|NCT01362790|8858300|P4|Pilot Phase & Phase 2|Death on study|1
2560450|NCT01362790|8858301|P3|Pilot Phase & Phase 2|Death on study|0
2560451|NCT01362790|8858302|P2|Pilot Phase & Phase 2|Death on study|0
2560452|NCT01362790|8858303|P1|Pilot Phase & Phase 2|Death on study|0
2560453|NCT01362790|8858297|P7|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
2560454|NCT01362790|8858298|P6|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
2560455|NCT01362790|8858299|P5|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
2560456|NCT01362790|8858300|P4|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
2560457|NCT01362790|8858301|P3|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
2560458|NCT01362790|8858302|P2|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2
2560459|NCT01362790|8858303|P1|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
2560460|NCT01362790|8858297|P7|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
2560461|NCT01362790|8858298|P6|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
2560462|NCT01362790|8858299|P5|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
2560463|NCT01362790|8858300|P4|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
2560464|NCT01362790|8858301|P3|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
2560465|NCT01362790|8858302|P2|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
2560466|NCT01362790|8858303|P1|Pilot Phase & Phase 2|Treatment delay >3 weeks|1
2560467|NCT01362790|8858297|P7|Pilot Phase & Phase 2|Progressive disease|0
2560468|NCT01362790|8858298|P6|Pilot Phase & Phase 2|Progressive disease|2
2560469|NCT01362790|8858299|P5|Pilot Phase & Phase 2|Progressive disease|0
2560470|NCT01362790|8858300|P4|Pilot Phase & Phase 2|Progressive disease|3
2560471|NCT01362790|8858301|P3|Pilot Phase & Phase 2|Progressive disease|2
2560472|NCT01362790|8858302|P2|Pilot Phase & Phase 2|Progressive disease|2
2560473|NCT01362790|8858303|P1|Pilot Phase & Phase 2|Progressive disease|1
2560474|NCT01362790|8858297|P7|Pilot Phase & Phase 2|Refused further treatment|0
2560475|NCT01362790|8858298|P6|Pilot Phase & Phase 2|Refused further treatment|0
2560476|NCT01362790|8858299|P5|Pilot Phase & Phase 2|Refused further treatment|0
2560477|NCT01362790|8858300|P4|Pilot Phase & Phase 2|Refused further treatment|0
2560478|NCT01362790|8858301|P3|Pilot Phase & Phase 2|Refused further treatment|0
2560479|NCT01362790|8858302|P2|Pilot Phase & Phase 2|Refused further treatment|1
2560480|NCT01362790|8858303|P1|Pilot Phase & Phase 2|Refused further treatment|0
2560481|NCT01362790|8858297|P7|Pilot Phase & Phase 2|Developed antibodies|0
2560482|NCT01362790|8858298|P6|Pilot Phase & Phase 2|Developed antibodies|0
2560483|NCT01362790|8858299|P5|Pilot Phase & Phase 2|Developed antibodies|0
2560484|NCT01362790|8858300|P4|Pilot Phase & Phase 2|Developed antibodies|8
2560485|NCT01362790|8858301|P3|Pilot Phase & Phase 2|Developed antibodies|3
2560486|NCT01362790|8858302|P2|Pilot Phase & Phase 2|Developed antibodies|2
2560487|NCT01362790|8858303|P1|Pilot Phase & Phase 2|Developed antibodies|7
2560488|NCT01362790|8858297|P7|Pilot Phase & Phase 2|Physician Decision|0
2560489|NCT01362790|8858298|P6|Pilot Phase & Phase 2|Physician Decision|0
2560490|NCT01362790|8858299|P5|Pilot Phase & Phase 2|Physician Decision|0
2560491|NCT01362790|8858300|P4|Pilot Phase & Phase 2|Physician Decision|1
2560492|NCT01362790|8858301|P3|Pilot Phase & Phase 2|Physician Decision|0
2560493|NCT01362790|8858302|P2|Pilot Phase & Phase 2|Physician Decision|0
2560494|NCT01362790|8858303|P1|Pilot Phase & Phase 2|Physician Decision|0
2560495|NCT01362790|8858297|P7|Pilot Phase & Phase 2|Adverse Event|0
2560496|NCT01362790|8858298|P6|Pilot Phase & Phase 2|Adverse Event|2
2560497|NCT01362790|8858299|P5|Pilot Phase & Phase 2|Adverse Event|0
2560498|NCT01362790|8858300|P4|Pilot Phase & Phase 2|Adverse Event|1
2560499|NCT01362790|8858301|P3|Pilot Phase & Phase 2|Adverse Event|0
2560500|NCT01362790|8858302|P2|Pilot Phase & Phase 2|Adverse Event|1
2560501|NCT01362790|8858303|P1|Pilot Phase & Phase 2|Adverse Event|0
2560502|NCT01362790|8858297|P7|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
2560503|NCT01362790|8858298|P6|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
2560504|NCT01362790|8858299|P5|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
2560505|NCT01362790|8858300|P4|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
2560506|NCT01362790|8858301|P3|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
2560507|NCT01362790|8858302|P2|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
2560508|NCT01362790|8858303|P1|Pilot Phase & Phase 2|Changed treatment, too early to assess|1
2560509|NCT01362608|8858371|P2|Overall Study|Adverse Event|2
2560510|NCT01362608|8858372|P1|Overall Study|Adverse Event|0
2560511|NCT01362608|8858371|P2|Overall Study|Lack of Efficacy|2
2560512|NCT01362608|8858372|P1|Overall Study|Lack of Efficacy|0
2560513|NCT01362608|8858371|P2|Overall Study|Withdrawal by Subject|2
2560514|NCT01362608|8858372|P1|Overall Study|Withdrawal by Subject|1
2560515|NCT01362608|8858371|P2|Overall Study|Lost to Follow-up|1
2560516|NCT01362608|8858372|P1|Overall Study|Lost to Follow-up|3
2560517|NCT01362608|8858371|P2|Overall Study|Protocol Violation|1
2560518|NCT01362608|8858372|P1|Overall Study|Protocol Violation|0
2560519|NCT01362530|8858410|P2|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0
2560520|NCT01362530|8858411|P1|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18
2560521|NCT01362530|8858410|P2|Optional Extension (Cycles 2-6)|Protocol Violation|0
2560522|NCT01362530|8858411|P1|Optional Extension (Cycles 2-6)|Protocol Violation|4
2560523|NCT01362530|8858410|P2|Optional Extension (Cycles 2-6)|Physician Decision|0
2560524|NCT01362530|8858411|P1|Optional Extension (Cycles 2-6)|Physician Decision|19
2560525|NCT01362530|8858410|P2|Optional Extension (Cycles 2-6)|Lost to Follow-up|0
2560526|NCT01362530|8858411|P1|Optional Extension (Cycles 2-6)|Lost to Follow-up|1
2560527|NCT01362530|8858410|P2|Optional Extension (Cycles 2-6)|Lack of Efficacy|0
2560528|NCT01362530|8858411|P1|Optional Extension (Cycles 2-6)|Lack of Efficacy|1
2560529|NCT01362530|8858410|P2|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0
2560530|NCT01362530|8858411|P1|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4
2560531|NCT01362530|8858410|P2|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0
2560532|NCT01362530|8858411|P1|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25
2560533|NCT01362530|8858410|P2|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0
2560534|NCT01362530|8858411|P1|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51
2560535|NCT01362530|8858410|P2|Optional Extension (Cycles 2-6)|Adverse Event|0
2560536|NCT01362530|8858411|P1|Optional Extension (Cycles 2-6)|Adverse Event|2
2560537|NCT01362530|8858410|P2|Base Study (Cycle 1)|Withdrawal by Subject|2
2560538|NCT01362530|8858411|P1|Base Study (Cycle 1)|Withdrawal by Subject|1
2560539|NCT01362530|8858410|P2|Base Study (Cycle 1)|Protocol Violation|0
2560540|NCT01362530|8858411|P1|Base Study (Cycle 1)|Protocol Violation|2
2560541|NCT01362530|8858410|P2|Base Study (Cycle 1)|Physician Decision|1
2560542|NCT01362530|8858411|P1|Base Study (Cycle 1)|Physician Decision|0
2560543|NCT01362530|8858410|P2|Base Study (Cycle 1)|Adverse Event|0
2560544|NCT01362530|8858411|P1|Base Study (Cycle 1)|Adverse Event|2
2560545|NCT01362517|8858424|P1|Overall Study|Lost to Follow-up|1
2560546|NCT01362517|8858424|P1|Overall Study|Protocol Violation|1
2560547|NCT01362491|8858435|P3|Overall Study|Ineligible|0
2560548|NCT01362491|8858436|P2|Overall Study|Ineligible|0
2560549|NCT01362491|8858437|P1|Overall Study|Ineligible|1
2560550|NCT01362439|8858485|P1|Overall Study|Participant who withdrew consent|8
2560551|NCT01362439|8858485|P1|Overall Study|Study medication non-compliant|1
2560552|NCT01362439|8858485|P1|Overall Study|Lost to Follow-up|2
2560553|NCT01362439|8858485|P1|Overall Study|Lack of Efficacy|3
2560554|NCT01362439|8858485|P1|Overall Study|Adverse Event|1
2560555|NCT01362348|8858500|P1|Overall Study|Study closed/terminated|5
2560556|NCT01362348|8858500|P1|Overall Study|Protocol-defined stopping criteria|9
2560557|NCT01362322|8858519|P2|Overall Study|Lost to Follow-up|6
2560558|NCT01362322|8858520|P1|Overall Study|Lost to Follow-up|2
2560559|NCT01362322|8858519|P2|Overall Study|Withdrawal by Subject|1
2560560|NCT01362322|8858520|P1|Overall Study|Withdrawal by Subject|3
2560561|NCT01362296|8858552|P4|Crossover Phase|Study Closed/Terminated|0
2560562|NCT01362296|8858553|P3|Crossover Phase|Study Closed/Terminated|1
2560563|NCT01362296|8858554|P2|Crossover Phase|Study Closed/Terminated|0
2560564|NCT01362296|8858555|P1|Crossover Phase|Study Closed/Terminated|0
2560565|NCT01362296|8858552|P4|Crossover Phase|Adverse Event|0
2560566|NCT01362296|8858553|P3|Crossover Phase|Adverse Event|4
2560567|NCT01362296|8858554|P2|Crossover Phase|Adverse Event|0
2560568|NCT01362296|8858555|P1|Crossover Phase|Adverse Event|0
2560569|NCT01362296|8858552|P4|Crossover Phase|Withdrawal by Subject|1
2560570|NCT01362296|8858553|P3|Crossover Phase|Withdrawal by Subject|2
2560571|NCT01362296|8858554|P2|Crossover Phase|Withdrawal by Subject|0
2560572|NCT01362296|8858555|P1|Crossover Phase|Withdrawal by Subject|0
2560573|NCT01362296|8858552|P4|Crossover Phase|PD including Death due to PD|1
2560574|NCT01362296|8858553|P3|Crossover Phase|PD including Death due to PD|16
2560575|NCT01362296|8858554|P2|Crossover Phase|PD including Death due to PD|0
2560576|NCT01362296|8858555|P1|Crossover Phase|PD including Death due to PD|0
2560577|NCT01362296|8858552|P4|Randomized Phase (RP)|Study Closed/Terminated|0
2560578|NCT01362296|8858553|P3|Randomized Phase (RP)|Study Closed/Terminated|0
2560579|NCT01362296|8858554|P2|Randomized Phase (RP)|Study Closed/Terminated|1
2560580|NCT01362296|8858555|P1|Randomized Phase (RP)|Study Closed/Terminated|8
2560581|NCT01362296|8858552|P4|Randomized Phase (RP)|Adverse Event|0
2560582|NCT01362296|8858553|P3|Randomized Phase (RP)|Adverse Event|0
2560583|NCT01362296|8858554|P2|Randomized Phase (RP)|Adverse Event|4
2560584|NCT01362296|8858555|P1|Randomized Phase (RP)|Adverse Event|20
2560585|NCT01362296|8858552|P4|Randomized Phase (RP)|Withdrawal by Subject|0
2560586|NCT01362296|8858553|P3|Randomized Phase (RP)|Withdrawal by Subject|0
2560587|NCT01362296|8858554|P2|Randomized Phase (RP)|Withdrawal by Subject|1
2560588|NCT01362296|8858555|P1|Randomized Phase (RP)|Withdrawal by Subject|2
2560589|NCT01362296|8858552|P4|Randomized Phase (RP)|Physician Decision|0
2560590|NCT01362296|8858553|P3|Randomized Phase (RP)|Physician Decision|0
2560591|NCT01362296|8858554|P2|Randomized Phase (RP)|Physician Decision|9
2560592|NCT01362296|8858555|P1|Randomized Phase (RP)|Physician Decision|1
2560593|NCT01362296|8858552|P4|Randomized Phase (RP)|PD including Death due to PD|0
2560594|NCT01362296|8858553|P3|Randomized Phase (RP)|PD including Death due to PD|0
2560595|NCT01362296|8858554|P2|Randomized Phase (RP)|PD including Death due to PD|28
2560596|NCT01362296|8858555|P1|Randomized Phase (RP)|PD including Death due to PD|56
2560597|NCT01362270|8858603|P2|Overall Study|Met excl. criteria before 1st session|1
2560598|NCT01362270|8858604|P1|Overall Study|Met excl. criteria before 1st session|1
2560599|NCT01362270|8858603|P2|Overall Study|Met exclusion criteria after 1st session|1
2560600|NCT01362270|8858604|P1|Overall Study|Met exclusion criteria after 1st session|0
2560601|NCT01362270|8858603|P2|Overall Study|Withdrawal by Subject|0
2560602|NCT01362270|8858604|P1|Overall Study|Withdrawal by Subject|1
2560603|NCT01362244|8858616|P2|Overall Study|Protocol Defined Stopping Criteria|1
2560604|NCT01362244|8858617|P1|Overall Study|Protocol Defined Stopping Criteria|0
2560605|NCT01362244|8858616|P2|Overall Study|Did not Meet Continuation Criteria|11
2560606|NCT01362244|8858617|P1|Overall Study|Did not Meet Continuation Criteria|17
2560607|NCT01362244|8858616|P2|Overall Study|Withdrawal by Subject|1
2560608|NCT01362244|8858617|P1|Overall Study|Withdrawal by Subject|2
2560609|NCT01362244|8858616|P2|Overall Study|Protocol Violation|1
2560610|NCT01362244|8858617|P1|Overall Study|Protocol Violation|5
2560611|NCT01362244|8858616|P2|Overall Study|Lost to Follow-up|2
2560612|NCT01362244|8858617|P1|Overall Study|Lost to Follow-up|0
2560613|NCT01362244|8858616|P2|Overall Study|Lack of Efficacy|11
2560614|NCT01362244|8858617|P1|Overall Study|Lack of Efficacy|5
2560615|NCT01362244|8858616|P2|Overall Study|Adverse Event|5
2560616|NCT01362244|8858617|P1|Overall Study|Adverse Event|3
2560617|NCT01362140|8858729|P2|Overall Study|Discontinued Without Receiving Treatment|1
2560618|NCT01362140|8858730|P1|Overall Study|Discontinued Without Receiving Treatment|0
2560619|NCT01362140|8858729|P2|Overall Study|Protocol-specified Criteria|2
2560620|NCT01362140|8858730|P1|Overall Study|Protocol-specified Criteria|1
2560621|NCT01362140|8858729|P2|Overall Study|Other|1
2560622|NCT01362140|8858730|P1|Overall Study|Other|1
2560623|NCT01362140|8858729|P2|Overall Study|Death|1
2560624|NCT01362140|8858730|P1|Overall Study|Death|2
2560625|NCT01362140|8858729|P2|Overall Study|Administrative Decision|1
2560626|NCT01362140|8858730|P1|Overall Study|Administrative Decision|0
2560627|NCT01362140|8858729|P2|Overall Study|Withdrawal by Subject|3
2560628|NCT01362140|8858730|P1|Overall Study|Withdrawal by Subject|3
2560629|NCT01362140|8858729|P2|Overall Study|Adverse Event|2
2560630|NCT01362140|8858730|P1|Overall Study|Adverse Event|2
2560631|NCT01362140|8858729|P2|Overall Study|Noncompliance|0
2560632|NCT01362140|8858730|P1|Overall Study|Noncompliance|1
2560633|NCT01362062|8858767|P2|Overall Study|Had significant improvement|0
2560634|NCT01362062|8858768|P1|Overall Study|Had significant improvement|9
2560635|NCT01362062|8858767|P2|Overall Study|Detected with Spondylo-arthritis|0
2560636|NCT01362062|8858768|P1|Overall Study|Detected with Spondylo-arthritis|1
2560637|NCT01362062|8858767|P2|Overall Study|Non-compliant participant|0
2560638|NCT01362062|8858768|P1|Overall Study|Non-compliant participant|2
2560639|NCT01362062|8858767|P2|Overall Study|Withdrawal by Subject|0
2560640|NCT01362062|8858768|P1|Overall Study|Withdrawal by Subject|2
2560641|NCT01362062|8858767|P2|Overall Study|Lost to Follow-up|0
2560642|NCT01362062|8858768|P1|Overall Study|Lost to Follow-up|11
2560643|NCT01362062|8858767|P2|Overall Study|Adverse Event|0
2560644|NCT01362062|8858768|P1|Overall Study|Adverse Event|1
2560645|NCT01362049|8858789|P4|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
2560646|NCT01362049|8858790|P3|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2
2560647|NCT01362049|8858791|P2|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
2560648|NCT01362049|8858792|P1|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5
2560649|NCT01362049|8858789|P4|Follow-Up at 7 Weeks|Lost to Follow-up|1
2560650|NCT01362049|8858790|P3|Follow-Up at 7 Weeks|Lost to Follow-up|2
2560651|NCT01362049|8858791|P2|Follow-Up at 7 Weeks|Lost to Follow-up|3
2560652|NCT01362049|8858792|P1|Follow-Up at 7 Weeks|Lost to Follow-up|3
2560653|NCT01361919|8858833|P3|Overall Study|technical issues|10
2560654|NCT01361919|8858834|P2|Overall Study|technical issues|12
2560655|NCT01361919|8858835|P1|Overall Study|technical issues|10
2560656|NCT01361607|8858876|P2|Overall Study|Met Withdrawal Criteria|1
2560657|NCT01361607|8858877|P1|Overall Study|Met Withdrawal Criteria|1
2560658|NCT01361607|8858876|P2|Overall Study|Lost to Follow-up|0
2560659|NCT01361607|8858877|P1|Overall Study|Lost to Follow-up|1
2560660|NCT01361607|8858876|P2|Overall Study|Withdrawal by Investigator|3
2560661|NCT01361607|8858877|P1|Overall Study|Withdrawal by Investigator|5
2560662|NCT01361607|8858876|P2|Overall Study|Withdrawal by Subject|8
2560663|NCT01361607|8858877|P1|Overall Study|Withdrawal by Subject|19
2560664|NCT01361607|8858876|P2|Overall Study|Adverse Event|29
2560665|NCT01361607|8858877|P1|Overall Study|Adverse Event|38
2560666|NCT01361594|8858905|P2|Overall Study|Withdrawal by Subject|2
2560667|NCT01361594|8858906|P1|Overall Study|Withdrawal by Subject|1
2560668|NCT01361568|8858920|P6|Overall Study|Withdrawal by Subject|1
2560669|NCT01361568|8858921|P5|Overall Study|Withdrawal by Subject|0
2560670|NCT01361568|8858922|P4|Overall Study|Withdrawal by Subject|0
2560671|NCT01361568|8858923|P3|Overall Study|Withdrawal by Subject|0
2560672|NCT01361568|8858924|P2|Overall Study|Withdrawal by Subject|1
2560673|NCT01361568|8858925|P1|Overall Study|Withdrawal by Subject|2
2560674|NCT01361568|8858920|P6|Overall Study|Physician Decision|1
2560675|NCT01361568|8858921|P5|Overall Study|Physician Decision|0
2560676|NCT01361568|8858922|P4|Overall Study|Physician Decision|0
2560677|NCT01361568|8858923|P3|Overall Study|Physician Decision|0
2560678|NCT01361568|8858924|P2|Overall Study|Physician Decision|0
2560679|NCT01361568|8858925|P1|Overall Study|Physician Decision|0
2560680|NCT01361568|8858920|P6|Overall Study|Adverse Event|0
2560681|NCT01361568|8858921|P5|Overall Study|Adverse Event|1
2560682|NCT01361568|8858922|P4|Overall Study|Adverse Event|0
2560683|NCT01361568|8858923|P3|Overall Study|Adverse Event|0
2560684|NCT01361568|8858924|P2|Overall Study|Adverse Event|0
2560685|NCT01361568|8858925|P1|Overall Study|Adverse Event|0
2560686|NCT01361464|8858955|P1|Overall Study|Withdrawal by Subject|2
2560687|NCT01361464|8858955|P1|Overall Study|Death|1
2560688|NCT01361308|8858964|P2|Overall Study|Other|1
2560689|NCT01361308|8858965|P1|Overall Study|Other|0
2560690|NCT01361308|8858964|P2|Overall Study|Failed C-SSRS|2
2560691|NCT01361308|8858965|P1|Overall Study|Failed C-SSRS|5
2560692|NCT01361308|8858964|P2|Overall Study|Eligibility Criteria Not Met|3
2560693|NCT01361308|8858965|P1|Overall Study|Eligibility Criteria Not Met|2
2560694|NCT01361308|8858964|P2|Overall Study|Adverse Event|4
2560695|NCT01361308|8858965|P1|Overall Study|Adverse Event|8
2560696|NCT01361308|8858964|P2|Overall Study|Lost to Follow-up|4
2560697|NCT01361308|8858965|P1|Overall Study|Lost to Follow-up|5
2560698|NCT01361308|8858964|P2|Overall Study|Protocol Violation|0
2560699|NCT01361308|8858965|P1|Overall Study|Protocol Violation|1
2560700|NCT01361308|8858964|P2|Overall Study|Lack of Efficacy|0
2560701|NCT01361308|8858965|P1|Overall Study|Lack of Efficacy|2
2560702|NCT01361308|8858964|P2|Overall Study|Physician Decision|3
2560703|NCT01361308|8858965|P1|Overall Study|Physician Decision|3
2560704|NCT01361308|8858964|P2|Overall Study|Withdrawal by Subject|13
2560705|NCT01361308|8858965|P1|Overall Study|Withdrawal by Subject|9
2560706|NCT01361178|8859013|P2|Overall Study|Death|0
2560707|NCT01361178|8859014|P1|Overall Study|Death|13
2560708|NCT01361126|8859022|P2|Overall Study|Sponsor decision|2
2560709|NCT01361126|8859023|P1|Overall Study|Sponsor decision|0
2560710|NCT01361009|8859062|P1|Overall Study|Protocol Violation|116
2560711|NCT01360996|8859072|P3|Overall Study|Noncompliant|0
2560712|NCT01360996|8859073|P2|Overall Study|Noncompliant|0
2560713|NCT01360996|8859074|P1|Overall Study|Noncompliant|2
2560714|NCT01360996|8859072|P3|Overall Study|Withdrawal by Subject|2
2560715|NCT01360996|8859073|P2|Overall Study|Withdrawal by Subject|3
2560716|NCT01360996|8859074|P1|Overall Study|Withdrawal by Subject|4
2560717|NCT01360866|8859097|P4|Overall Study|Lack of Efficacy|4
2560718|NCT01360866|8859098|P3|Overall Study|Lack of Efficacy|30
2560719|NCT01360866|8859099|P2|Overall Study|Lack of Efficacy|40
2560720|NCT01360866|8859100|P1|Overall Study|Lack of Efficacy|30
2560721|NCT01360866|8859097|P4|Overall Study|Protocol Deviation|2
2560722|NCT01360866|8859098|P3|Overall Study|Protocol Deviation|61
2560723|NCT01360866|8859099|P2|Overall Study|Protocol Deviation|33
2560724|NCT01360866|8859100|P1|Overall Study|Protocol Deviation|25
2560725|NCT01360866|8859097|P4|Overall Study|Withdrawal by participant|8
2560726|NCT01360866|8859098|P3|Overall Study|Withdrawal by participant|168
2560727|NCT01360866|8859099|P2|Overall Study|Withdrawal by participant|89
2560728|NCT01360866|8859100|P1|Overall Study|Withdrawal by participant|79
2560729|NCT01360866|8859097|P4|Overall Study|Withdrawn by Investigator|2
2560730|NCT01360866|8859098|P3|Overall Study|Withdrawn by Investigator|31
2560731|NCT01360866|8859099|P2|Overall Study|Withdrawn by Investigator|8
2560732|NCT01360866|8859100|P1|Overall Study|Withdrawn by Investigator|9
2560733|NCT01360866|8859097|P4|Overall Study|Paticipant met withdrawal criteria|0
2560734|NCT01360866|8859098|P3|Overall Study|Paticipant met withdrawal criteria|54
2560735|NCT01360866|8859099|P2|Overall Study|Paticipant met withdrawal criteria|28
2560736|NCT01360866|8859100|P1|Overall Study|Paticipant met withdrawal criteria|11
2560737|NCT01360866|8859097|P4|Overall Study|Adverse Event|6
2560738|NCT01360866|8859098|P3|Overall Study|Adverse Event|134
2560739|NCT01360866|8859099|P2|Overall Study|Adverse Event|61
2560740|NCT01360866|8859100|P1|Overall Study|Adverse Event|56
2560741|NCT01360866|8859097|P4|Overall Study|Lost to Follow-up|0
2560742|NCT01360866|8859098|P3|Overall Study|Lost to Follow-up|41
2560743|NCT01360866|8859099|P2|Overall Study|Lost to Follow-up|28
2560744|NCT01360866|8859100|P1|Overall Study|Lost to Follow-up|11
2560745|NCT01360840|8859129|P3|Overall Study|Ongoing at data cut-off|9
2560746|NCT01360840|8859130|P2|Overall Study|Ongoing at data cut-off|10
2560747|NCT01360840|8859131|P1|Overall Study|Ongoing at data cut-off|10
2560748|NCT01360762|8859181|P1|Whole Study Period|Discontinuation of study drug for safety|1
2560749|NCT01360762|8859181|P1|Whole Study Period|Patient relapsed|18
2560750|NCT01360762|8859181|P1|Whole Study Period|Death|7
2560751|NCT01360762|8859181|P1|Whole Study Period|Lost to Follow-up|10
2560752|NCT01360762|8859181|P1|Main Study Period (12-month Treatment)|Discontinuation|1
2560753|NCT01360762|8859181|P1|Main Study Period (12-month Treatment)|Patient relapsed|15
2560754|NCT01360762|8859181|P1|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1
2560755|NCT01360762|8859181|P1|Main Study Period (12-month Treatment)|Death|5
2560756|NCT01360762|8859181|P1|Main Study Period (12-month Treatment)|Lost to Follow-up|7
2560757|NCT01360645|8859191|P4|Phase A+|Protocol Deviation|4
2560758|NCT01360645|8859192|P3|Phase A+|Protocol Deviation|0
2560759|NCT01360645|8859193|P2|Phase A+|Protocol Deviation|0
2560760|NCT01360645|8859194|P1|Phase A+|Protocol Deviation|0
2560761|NCT01360645|8859191|P4|Phase A+|Withdrawal by Subject|5
2560762|NCT01360645|8859192|P3|Phase A+|Withdrawal by Subject|0
2560763|NCT01360645|8859193|P2|Phase A+|Withdrawal by Subject|0
2560764|NCT01360645|8859194|P1|Phase A+|Withdrawal by Subject|0
2560765|NCT01360645|8859191|P4|Phase A+|Physician Decision|2
2560766|NCT01360645|8859192|P3|Phase A+|Physician Decision|0
2560767|NCT01360645|8859193|P2|Phase A+|Physician Decision|0
2560768|NCT01360645|8859194|P1|Phase A+|Physician Decision|0
2560769|NCT01360645|8859191|P4|Phase A+|Met Withdrawal Criteria|4
2560770|NCT01360645|8859192|P3|Phase A+|Met Withdrawal Criteria|0
2560771|NCT01360645|8859193|P2|Phase A+|Met Withdrawal Criteria|0
2560772|NCT01360645|8859194|P1|Phase A+|Met Withdrawal Criteria|0
2560773|NCT01360645|8859191|P4|Phase A+|Adverse Event|2
2560774|NCT01360645|8859192|P3|Phase A+|Adverse Event|0
2560775|NCT01360645|8859193|P2|Phase A+|Adverse Event|0
2560776|NCT01360645|8859194|P1|Phase A+|Adverse Event|0
2560777|NCT01360645|8859191|P4|Phase A+|Lost to Follow-up|7
2560778|NCT01360645|8859192|P3|Phase A+|Lost to Follow-up|0
2560779|NCT01360645|8859193|P2|Phase A+|Lost to Follow-up|0
2560780|NCT01360645|8859194|P1|Phase A+|Lost to Follow-up|0
2560781|NCT01360645|8859191|P4|Phase B (6 Weeks)|Protocol Deviation|0
2560782|NCT01360645|8859192|P3|Phase B (6 Weeks)|Protocol Deviation|3
2560783|NCT01360645|8859193|P2|Phase B (6 Weeks)|Protocol Deviation|1
2560784|NCT01360645|8859194|P1|Phase B (6 Weeks)|Protocol Deviation|0
2560785|NCT01360645|8859191|P4|Phase B (6 Weeks)|Withdrawal by Subject|0
2560786|NCT01360645|8859192|P3|Phase B (6 Weeks)|Withdrawal by Subject|8
2560787|NCT01360645|8859193|P2|Phase B (6 Weeks)|Withdrawal by Subject|3
2560788|NCT01360645|8859194|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
2560789|NCT01360645|8859191|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|0
2560790|NCT01360645|8859192|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
2560791|NCT01360645|8859193|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|3
2560792|NCT01360645|8859194|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
2560793|NCT01360645|8859191|P4|Phase B (6 Weeks)|Adverse Event|0
2560794|NCT01360645|8859192|P3|Phase B (6 Weeks)|Adverse Event|0
2560795|NCT01360645|8859193|P2|Phase B (6 Weeks)|Adverse Event|6
2560796|NCT01360645|8859194|P1|Phase B (6 Weeks)|Adverse Event|0
2560797|NCT01360645|8859191|P4|Phase B (6 Weeks)|Lost to Follow-up|0
2560798|NCT01360645|8859192|P3|Phase B (6 Weeks)|Lost to Follow-up|0
2560799|NCT01360645|8859193|P2|Phase B (6 Weeks)|Lost to Follow-up|1
2560800|NCT01360645|8859194|P1|Phase B (6 Weeks)|Lost to Follow-up|0
2560801|NCT01360645|8859191|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
2560802|NCT01360645|8859192|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
2560803|NCT01360645|8859193|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
2560804|NCT01360645|8859194|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5
2560805|NCT01360645|8859191|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
2560806|NCT01360645|8859192|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
2560807|NCT01360645|8859193|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
2560808|NCT01360645|8859194|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24
2560809|NCT01360645|8859191|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
2560810|NCT01360645|8859192|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
2560811|NCT01360645|8859193|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
2560812|NCT01360645|8859194|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34
2560813|NCT01360645|8859191|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
2560814|NCT01360645|8859192|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
2560815|NCT01360645|8859193|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
2560816|NCT01360645|8859194|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16
2560817|NCT01360645|8859191|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
2560818|NCT01360645|8859192|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
2560819|NCT01360645|8859193|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
2560820|NCT01360645|8859194|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19
2560821|NCT01360645|8859191|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
2560822|NCT01360645|8859192|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
2560823|NCT01360645|8859193|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
2560824|NCT01360645|8859194|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16
2560825|NCT01360632|8859249|P5|Phase A+|Protocol Deviation|3
2560826|NCT01360632|8859250|P4|Phase A+|Protocol Deviation|0
2560827|NCT01360632|8859251|P3|Phase A+|Protocol Deviation|0
2560828|NCT01360632|8859252|P2|Phase A+|Protocol Deviation|0
2560829|NCT01360632|8859253|P1|Phase A+|Protocol Deviation|0
2560830|NCT01360632|8859249|P5|Phase A+|Withdrawal by Subject|8
2560831|NCT01360632|8859250|P4|Phase A+|Withdrawal by Subject|0
2560832|NCT01360632|8859251|P3|Phase A+|Withdrawal by Subject|0
2560833|NCT01360632|8859252|P2|Phase A+|Withdrawal by Subject|0
2560834|NCT01360632|8859253|P1|Phase A+|Withdrawal by Subject|0
2560835|NCT01360632|8859249|P5|Phase A+|Physician Decision|3
2560836|NCT01360632|8859250|P4|Phase A+|Physician Decision|0
2560837|NCT01360632|8859251|P3|Phase A+|Physician Decision|0
2560838|NCT01360632|8859252|P2|Phase A+|Physician Decision|0
2560839|NCT01360632|8859253|P1|Phase A+|Physician Decision|0
2560840|NCT01360632|8859249|P5|Phase A+|Met Withdrawal Criteria|7
2560841|NCT01360632|8859250|P4|Phase A+|Met Withdrawal Criteria|0
2560842|NCT01360632|8859251|P3|Phase A+|Met Withdrawal Criteria|0
2560843|NCT01360632|8859252|P2|Phase A+|Met Withdrawal Criteria|0
2560844|NCT01360632|8859253|P1|Phase A+|Met Withdrawal Criteria|0
2560845|NCT01360632|8859249|P5|Phase A+|Adverse Event|2
2560846|NCT01360632|8859250|P4|Phase A+|Adverse Event|0
2560847|NCT01360632|8859251|P3|Phase A+|Adverse Event|0
2560848|NCT01360632|8859252|P2|Phase A+|Adverse Event|0
2560849|NCT01360632|8859253|P1|Phase A+|Adverse Event|0
2560850|NCT01360632|8859249|P5|Phase A+|Lost to Follow-up|2
2560851|NCT01360632|8859250|P4|Phase A+|Lost to Follow-up|0
2560852|NCT01360632|8859251|P3|Phase A+|Lost to Follow-up|0
2560853|NCT01360632|8859252|P2|Phase A+|Lost to Follow-up|0
2560854|NCT01360632|8859253|P1|Phase A+|Lost to Follow-up|0
2560855|NCT01360632|8859249|P5|Phase B (6 Weeks)|Lack of Efficacy|0
2560856|NCT01360632|8859250|P4|Phase B (6 Weeks)|Lack of Efficacy|0
2560857|NCT01360632|8859251|P3|Phase B (6 Weeks)|Lack of Efficacy|0
2560858|NCT01360632|8859252|P2|Phase B (6 Weeks)|Lack of Efficacy|1
2560859|NCT01360632|8859253|P1|Phase B (6 Weeks)|Lack of Efficacy|0
2560860|NCT01360632|8859249|P5|Phase B (6 Weeks)|Protocol Deviation|0
2560861|NCT01360632|8859250|P4|Phase B (6 Weeks)|Protocol Deviation|1
2560862|NCT01360632|8859251|P3|Phase B (6 Weeks)|Protocol Deviation|4
2560863|NCT01360632|8859252|P2|Phase B (6 Weeks)|Protocol Deviation|1
2560864|NCT01360632|8859253|P1|Phase B (6 Weeks)|Protocol Deviation|0
2560865|NCT01360632|8859249|P5|Phase B (6 Weeks)|Withdrawal by Subject|0
2560866|NCT01360632|8859250|P4|Phase B (6 Weeks)|Withdrawal by Subject|7
2560867|NCT01360632|8859251|P3|Phase B (6 Weeks)|Withdrawal by Subject|4
2560868|NCT01360632|8859252|P2|Phase B (6 Weeks)|Withdrawal by Subject|4
2560869|NCT01360632|8859253|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
2560870|NCT01360632|8859249|P5|Phase B (6 Weeks)|Physician Decision|0
2560871|NCT01360632|8859250|P4|Phase B (6 Weeks)|Physician Decision|1
2560872|NCT01360632|8859251|P3|Phase B (6 Weeks)|Physician Decision|0
2560873|NCT01360632|8859252|P2|Phase B (6 Weeks)|Physician Decision|0
2560874|NCT01360632|8859253|P1|Phase B (6 Weeks)|Physician Decision|0
2560875|NCT01360632|8859249|P5|Phase B (6 Weeks)|Met Withdrawal Criteria|0
2560876|NCT01360632|8859250|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|1
2560877|NCT01360632|8859251|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
2560878|NCT01360632|8859252|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|0
2560879|NCT01360632|8859253|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
2560880|NCT01360632|8859249|P5|Phase B (6 Weeks)|Adverse Event|0
2560881|NCT01360632|8859250|P4|Phase B (6 Weeks)|Adverse Event|3
2560882|NCT01360632|8859251|P3|Phase B (6 Weeks)|Adverse Event|9
2560883|NCT01360632|8859252|P2|Phase B (6 Weeks)|Adverse Event|3
2560884|NCT01360632|8859253|P1|Phase B (6 Weeks)|Adverse Event|0
2560885|NCT01360632|8859249|P5|Phase B (6 Weeks)|Lost to Follow-up|0
2560886|NCT01360632|8859250|P4|Phase B (6 Weeks)|Lost to Follow-up|0
2560887|NCT01360632|8859251|P3|Phase B (6 Weeks)|Lost to Follow-up|1
2560888|NCT01360632|8859252|P2|Phase B (6 Weeks)|Lost to Follow-up|1
2560889|NCT01360632|8859253|P1|Phase B (6 Weeks)|Lost to Follow-up|0
2560890|NCT01360632|8859249|P5|Phase A (8 Weeks)|Protocol Deviation|0
2560891|NCT01360632|8859250|P4|Phase A (8 Weeks)|Protocol Deviation|0
2560892|NCT01360632|8859251|P3|Phase A (8 Weeks)|Protocol Deviation|0
2560893|NCT01360632|8859252|P2|Phase A (8 Weeks)|Protocol Deviation|0
2560894|NCT01360632|8859253|P1|Phase A (8 Weeks)|Protocol Deviation|39
2560895|NCT01360632|8859249|P5|Phase A (8 Weeks)|Withdrawal by Subject|0
2560896|NCT01360632|8859250|P4|Phase A (8 Weeks)|Withdrawal by Subject|0
2560897|NCT01360632|8859251|P3|Phase A (8 Weeks)|Withdrawal by Subject|0
2560898|NCT01360632|8859252|P2|Phase A (8 Weeks)|Withdrawal by Subject|0
2560899|NCT01360632|8859253|P1|Phase A (8 Weeks)|Withdrawal by Subject|74
2560900|NCT01360632|8859249|P5|Phase A (8 Weeks)|Physician Decision|0
2560901|NCT01360632|8859250|P4|Phase A (8 Weeks)|Physician Decision|0
2560902|NCT01360632|8859251|P3|Phase A (8 Weeks)|Physician Decision|0
2560903|NCT01360632|8859252|P2|Phase A (8 Weeks)|Physician Decision|0
2560904|NCT01360632|8859253|P1|Phase A (8 Weeks)|Physician Decision|10
2560905|NCT01360632|8859249|P5|Phase A (8 Weeks)|Met Withdrawal Criteria|0
2560906|NCT01360632|8859250|P4|Phase A (8 Weeks)|Met Withdrawal Criteria|0
2560907|NCT01360632|8859251|P3|Phase A (8 Weeks)|Met Withdrawal Criteria|0
2560908|NCT01360632|8859252|P2|Phase A (8 Weeks)|Met Withdrawal Criteria|0
2560909|NCT01360632|8859253|P1|Phase A (8 Weeks)|Met Withdrawal Criteria|45
2560910|NCT01360632|8859249|P5|Phase A (8 Weeks)|Adverse Event|0
2560911|NCT01360632|8859250|P4|Phase A (8 Weeks)|Adverse Event|0
2560912|NCT01360632|8859251|P3|Phase A (8 Weeks)|Adverse Event|0
2560913|NCT01360632|8859252|P2|Phase A (8 Weeks)|Adverse Event|0
2560914|NCT01360632|8859253|P1|Phase A (8 Weeks)|Adverse Event|60
2560915|NCT01360632|8859249|P5|Phase A (8 Weeks)|Lost to Follow-up|0
2560916|NCT01360632|8859250|P4|Phase A (8 Weeks)|Lost to Follow-up|0
2560917|NCT01360632|8859251|P3|Phase A (8 Weeks)|Lost to Follow-up|0
2560918|NCT01360632|8859252|P2|Phase A (8 Weeks)|Lost to Follow-up|0
2560919|NCT01360632|8859253|P1|Phase A (8 Weeks)|Lost to Follow-up|27
2560920|NCT01360554|8859332|P2|Overall Study|Randomized but not treated.|3
2560921|NCT01360554|8859333|P1|Overall Study|Randomized but not treated.|3
2560922|NCT01360554|8859332|P2|Overall Study|Other, not specified|0
2560923|NCT01360554|8859333|P1|Overall Study|Other, not specified|1
2560924|NCT01360554|8859332|P2|Overall Study|Study terminated by sponsor|37
2560925|NCT01360554|8859333|P1|Overall Study|Study terminated by sponsor|49
2560926|NCT01360554|8859332|P2|Overall Study|Withdrawal by Subject|24
2560927|NCT01360554|8859333|P1|Overall Study|Withdrawal by Subject|23
2560928|NCT01360554|8859332|P2|Overall Study|Lost to Follow-up|4
2560929|NCT01360554|8859333|P1|Overall Study|Lost to Follow-up|4
2560930|NCT01360554|8859332|P2|Overall Study|Death|371
2560931|NCT01360554|8859333|P1|Overall Study|Death|359
2560932|NCT01360398|8859382|P1|Overall Study|Migrated/moved from study area|1
2560933|NCT01360398|8859382|P1|Overall Study|Other|7
2560934|NCT01360398|8859382|P1|Overall Study|Withdrawal by Subject|14
2560935|NCT01360021|8859416|P3|Overall Study|Adverse Event|3
2560936|NCT01360021|8859417|P2|Overall Study|Adverse Event|3
2560937|NCT01360021|8859418|P1|Overall Study|Adverse Event|2
2560938|NCT01360021|8859416|P3|Overall Study|Withdrawal by Subject|2
2560939|NCT01360021|8859417|P2|Overall Study|Withdrawal by Subject|0
2560940|NCT01360021|8859418|P1|Overall Study|Withdrawal by Subject|4
2560941|NCT01360021|8859416|P3|Overall Study|Protocol Violation|1
2560942|NCT01360021|8859417|P2|Overall Study|Protocol Violation|0
2560943|NCT01360021|8859418|P1|Overall Study|Protocol Violation|0
2560944|NCT01360021|8859416|P3|Overall Study|Eligibility criteria + other|1
2560945|NCT01360021|8859417|P2|Overall Study|Eligibility criteria + other|1
2560946|NCT01360021|8859418|P1|Overall Study|Eligibility criteria + other|2
2560947|NCT01359943|8859444|P3|Follow-up (Weeks 52 - 60)|Adverse Event|1
2560948|NCT01359943|8859445|P2|Follow-up (Weeks 52 - 60)|Adverse Event|5
2560949|NCT01359943|8859446|P1|Follow-up (Weeks 52 - 60)|Adverse Event|3
2560950|NCT01359943|8859444|P3|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
2560951|NCT01359943|8859445|P2|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1
2560952|NCT01359943|8859446|P1|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
2560953|NCT01359943|8859444|P3|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
2560954|NCT01359943|8859445|P2|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
2560955|NCT01359943|8859446|P1|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
2560956|NCT01359943|8859444|P3|Follow-up (Weeks 52 - 60)|Protocol deviation|0
2560957|NCT01359943|8859445|P2|Follow-up (Weeks 52 - 60)|Protocol deviation|1
2560958|NCT01359943|8859446|P1|Follow-up (Weeks 52 - 60)|Protocol deviation|0
2560959|NCT01359943|8859444|P3|Follow-up (Weeks 52 - 60)|Administrative problems|0
2560960|NCT01359943|8859445|P2|Follow-up (Weeks 52 - 60)|Administrative problems|0
2560961|NCT01359943|8859446|P1|Follow-up (Weeks 52 - 60)|Administrative problems|1
2560962|NCT01359943|8859444|P3|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4
2560963|NCT01359943|8859445|P2|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5
2560964|NCT01359943|8859446|P1|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1
2560965|NCT01359943|8859444|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1
2560966|NCT01359943|8859445|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5
2560967|NCT01359943|8859446|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3
2560968|NCT01359943|8859444|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
2560969|NCT01359943|8859445|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1
2560970|NCT01359943|8859446|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
2560971|NCT01359943|8859444|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
2560972|NCT01359943|8859445|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
2560973|NCT01359943|8859446|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
2560974|NCT01359943|8859444|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
2560975|NCT01359943|8859445|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1
2560976|NCT01359943|8859446|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
2560977|NCT01359943|8859444|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4
2560978|NCT01359943|8859445|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3
2560979|NCT01359943|8859446|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1
2560980|NCT01359943|8859444|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
2560981|NCT01359943|8859445|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
2560982|NCT01359943|8859446|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1
2560983|NCT01359943|8859444|P3|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
2560984|NCT01359943|8859445|P2|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2
2560985|NCT01359943|8859446|P1|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
2560986|NCT01359943|8859444|P3|Double-blind (Weeks 0 - 16)|Adverse Event|0
2560987|NCT01359943|8859445|P2|Double-blind (Weeks 0 - 16)|Adverse Event|2
2560988|NCT01359943|8859446|P1|Double-blind (Weeks 0 - 16)|Adverse Event|1
2560989|NCT01359943|8859444|P3|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
2560990|NCT01359943|8859445|P2|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
2560991|NCT01359943|8859446|P1|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1
2560992|NCT01359904|8859494|P2|Overall Study|Withdrawal by Subject|0
2560993|NCT01359904|8859495|P1|Overall Study|Withdrawal by Subject|1
2560994|NCT01359644|8859549|P10|Follow-up Period|Lost to Follow-up|0
2560995|NCT01359644|8859550|P9|Follow-up Period|Lost to Follow-up|0
2560996|NCT01359644|8859551|P8|Follow-up Period|Lost to Follow-up|2
2560997|NCT01359644|8859552|P7|Follow-up Period|Lost to Follow-up|1
2560998|NCT01359644|8859553|P6|Follow-up Period|Lost to Follow-up|0
2560999|NCT01359644|8859554|P5|Follow-up Period|Lost to Follow-up|0
2561000|NCT01359644|8859555|P4|Follow-up Period|Lost to Follow-up|0
2561001|NCT01359644|8859556|P3|Follow-up Period|Lost to Follow-up|0
2561002|NCT01359644|8859557|P2|Follow-up Period|Lost to Follow-up|0
2561003|NCT01359644|8859558|P1|Follow-up Period|Lost to Follow-up|0
2561004|NCT01359644|8859549|P10|Follow-up Period|Withdrawal by Subject|0
2561005|NCT01359644|8859550|P9|Follow-up Period|Withdrawal by Subject|0
2561006|NCT01359644|8859551|P8|Follow-up Period|Withdrawal by Subject|0
2561007|NCT01359644|8859552|P7|Follow-up Period|Withdrawal by Subject|0
2561008|NCT01359644|8859553|P6|Follow-up Period|Withdrawal by Subject|1
2561009|NCT01359644|8859554|P5|Follow-up Period|Withdrawal by Subject|0
2561010|NCT01359644|8859555|P4|Follow-up Period|Withdrawal by Subject|0
2561011|NCT01359644|8859556|P3|Follow-up Period|Withdrawal by Subject|0
2561012|NCT01359644|8859557|P2|Follow-up Period|Withdrawal by Subject|0
2561013|NCT01359644|8859558|P1|Follow-up Period|Withdrawal by Subject|0
2561014|NCT01359644|8859549|P10|Treatment Period|Lost to Follow-up|0
2561015|NCT01359644|8859550|P9|Treatment Period|Lost to Follow-up|0
2561016|NCT01359644|8859551|P8|Treatment Period|Lost to Follow-up|0
2561017|NCT01359644|8859552|P7|Treatment Period|Lost to Follow-up|0
2561018|NCT01359644|8859553|P6|Treatment Period|Lost to Follow-up|1
2561019|NCT01359644|8859554|P5|Treatment Period|Lost to Follow-up|0
2561020|NCT01359644|8859555|P4|Treatment Period|Lost to Follow-up|0
2561021|NCT01359644|8859556|P3|Treatment Period|Lost to Follow-up|0
2561022|NCT01359644|8859557|P2|Treatment Period|Lost to Follow-up|0
2561023|NCT01359644|8859558|P1|Treatment Period|Lost to Follow-up|0
2561024|NCT01359644|8859549|P10|Treatment Period|Adverse Event|0
2561025|NCT01359644|8859550|P9|Treatment Period|Adverse Event|0
2561026|NCT01359644|8859551|P8|Treatment Period|Adverse Event|0
2561027|NCT01359644|8859552|P7|Treatment Period|Adverse Event|0
2561028|NCT01359644|8859553|P6|Treatment Period|Adverse Event|1
2561029|NCT01359644|8859554|P5|Treatment Period|Adverse Event|0
2561030|NCT01359644|8859555|P4|Treatment Period|Adverse Event|0
2561031|NCT01359644|8859556|P3|Treatment Period|Adverse Event|1
2561032|NCT01359644|8859557|P2|Treatment Period|Adverse Event|0
2561033|NCT01359644|8859558|P1|Treatment Period|Adverse Event|0
2561034|NCT01359644|8859549|P10|Treatment Period|Lack of Efficacy|0
2561035|NCT01359644|8859550|P9|Treatment Period|Lack of Efficacy|0
2561036|NCT01359644|8859551|P8|Treatment Period|Lack of Efficacy|0
2561037|NCT01359644|8859552|P7|Treatment Period|Lack of Efficacy|0
2561038|NCT01359644|8859553|P6|Treatment Period|Lack of Efficacy|0
2561039|NCT01359644|8859554|P5|Treatment Period|Lack of Efficacy|0
2561040|NCT01359644|8859555|P4|Treatment Period|Lack of Efficacy|0
2561041|NCT01359644|8859556|P3|Treatment Period|Lack of Efficacy|0
2561042|NCT01359644|8859557|P2|Treatment Period|Lack of Efficacy|1
2561043|NCT01359644|8859558|P1|Treatment Period|Lack of Efficacy|0
2561044|NCT01359449|8859602|P2|Overall Study|Withdrawal by Subject|2
2561045|NCT01359449|8859603|P1|Overall Study|Withdrawal by Subject|3
2561046|NCT01359449|8859602|P2|Overall Study|Protocol Violation|2
2561047|NCT01359449|8859603|P1|Overall Study|Protocol Violation|0
2561048|NCT01359449|8859602|P2|Overall Study|Lost to Follow-up|0
2561049|NCT01359449|8859603|P1|Overall Study|Lost to Follow-up|1
2561050|NCT01359254|8859649|P2|Overall Study|Death|0
2561051|NCT01359254|8859650|P1|Overall Study|Death|1
2561052|NCT01359150|8859660|P2|Overall Study|Other|0
2561053|NCT01359150|8859661|P1|Overall Study|Other|1
2561054|NCT01359150|8859660|P2|Overall Study|Adverse Event|3
2561055|NCT01359150|8859661|P1|Overall Study|Adverse Event|4
2561056|NCT01359150|8859660|P2|Overall Study|Withdrawal by Subject|1
2561057|NCT01359150|8859661|P1|Overall Study|Withdrawal by Subject|1
2561058|NCT01359150|8859660|P2|Overall Study|Lack of Efficacy|1
2561059|NCT01359150|8859661|P1|Overall Study|Lack of Efficacy|1
2561060|NCT01359046|8859692|P2|Overall Study|Physician Decision|11
2561061|NCT01359046|8859693|P1|Overall Study|Physician Decision|1
2561062|NCT01359046|8859692|P2|Overall Study|Did not receive allocated intervention|6
2561063|NCT01359046|8859693|P1|Overall Study|Did not receive allocated intervention|6
2561064|NCT01358981|8859716|P7|Period 1|Withdrawal by Subject|0
2561065|NCT01358981|8859717|P6|Period 1|Withdrawal by Subject|0
2561066|NCT01358981|8859718|P5|Period 1|Withdrawal by Subject|0
2561067|NCT01358981|8859719|P4|Period 1|Withdrawal by Subject|1
2561068|NCT01358981|8859720|P3|Period 1|Withdrawal by Subject|0
2561069|NCT01358981|8859721|P2|Period 1|Withdrawal by Subject|0
2561070|NCT01358981|8859722|P1|Period 1|Withdrawal by Subject|0
2561071|NCT01358968|8859783|P4|Continued Access Phase|Death|1
2561072|NCT01358968|8859784|P3|Continued Access Phase|Death|1
2561073|NCT01358968|8859785|P2|Continued Access Phase|Death|0
2561074|NCT01358968|8859786|P1|Continued Access Phase|Death|0
2561075|NCT01358968|8859783|P4|Continued Access Phase|Withdrawal by Subject|0
2561076|NCT01358968|8859784|P3|Continued Access Phase|Withdrawal by Subject|3
2561077|NCT01358968|8859785|P2|Continued Access Phase|Withdrawal by Subject|0
2561078|NCT01358968|8859786|P1|Continued Access Phase|Withdrawal by Subject|0
2561079|NCT01358968|8859783|P4|Continued Access Phase|Protocol Violation|2
2561080|NCT01358968|8859784|P3|Continued Access Phase|Protocol Violation|0
2561081|NCT01358968|8859785|P2|Continued Access Phase|Protocol Violation|0
2561082|NCT01358968|8859786|P1|Continued Access Phase|Protocol Violation|0
2561083|NCT01358968|8859783|P4|Continued Access Phase|Progression of Disease|4
2561084|NCT01358968|8859784|P3|Continued Access Phase|Progression of Disease|8
2561085|NCT01358968|8859785|P2|Continued Access Phase|Progression of Disease|0
2561086|NCT01358968|8859786|P1|Continued Access Phase|Progression of Disease|0
2561087|NCT01358968|8859783|P4|Period 2|Adverse Event|0
2561088|NCT01358968|8859784|P3|Period 2|Adverse Event|0
2561089|NCT01358968|8859785|P2|Period 2|Adverse Event|1
2561090|NCT01358968|8859786|P1|Period 2|Adverse Event|0
2561091|NCT01358877|8859802|P2|Overall Study|Other|129
2561092|NCT01358877|8859803|P1|Overall Study|Other|142
2561093|NCT01358877|8859802|P2|Overall Study|Ongoing follow-up for overall survival|5
2561094|NCT01358877|8859803|P1|Overall Study|Ongoing follow-up for overall survival|7
2561095|NCT01358877|8859802|P2|Overall Study|Ongoing follow-up for IDFS event|2073
2561096|NCT01358877|8859803|P1|Overall Study|Ongoing follow-up for IDFS event|2084
2561097|NCT01358877|8859802|P2|Overall Study|Ongoing follow-up for post-recurrence|108
2561098|NCT01358877|8859803|P1|Overall Study|Ongoing follow-up for post-recurrence|87
2561099|NCT01358877|8859802|P2|Overall Study|Death|89
2561100|NCT01358877|8859803|P1|Overall Study|Death|80
2561101|NCT01358864|8859873|P8|Overall Study|Not treated|0
2561102|NCT01358864|8859874|P7|Overall Study|Not treated|1
2561103|NCT01358864|8859875|P6|Overall Study|Not treated|0
2561104|NCT01358864|8859876|P5|Overall Study|Not treated|0
2561105|NCT01358864|8859877|P4|Overall Study|Not treated|0
2561106|NCT01358864|8859878|P3|Overall Study|Not treated|0
2561107|NCT01358864|8859879|P2|Overall Study|Not treated|0
2561108|NCT01358864|8859880|P1|Overall Study|Not treated|0
2561109|NCT01358864|8859873|P8|Overall Study|Other reason not defined above|0
2561110|NCT01358864|8859874|P7|Overall Study|Other reason not defined above|2
2561111|NCT01358864|8859875|P6|Overall Study|Other reason not defined above|0
2561112|NCT01358864|8859876|P5|Overall Study|Other reason not defined above|0
2561113|NCT01358864|8859877|P4|Overall Study|Other reason not defined above|0
2561114|NCT01358864|8859878|P3|Overall Study|Other reason not defined above|0
2561115|NCT01358864|8859879|P2|Overall Study|Other reason not defined above|0
2561116|NCT01358864|8859880|P1|Overall Study|Other reason not defined above|2
2561117|NCT01358864|8859873|P8|Overall Study|Withdrawal by Subject|3
2561118|NCT01358864|8859874|P7|Overall Study|Withdrawal by Subject|1
2561119|NCT01358864|8859875|P6|Overall Study|Withdrawal by Subject|1
2561120|NCT01358864|8859876|P5|Overall Study|Withdrawal by Subject|0
2561121|NCT01358864|8859877|P4|Overall Study|Withdrawal by Subject|0
2561122|NCT01358864|8859878|P3|Overall Study|Withdrawal by Subject|2
2561123|NCT01358864|8859879|P2|Overall Study|Withdrawal by Subject|4
2561124|NCT01358864|8859880|P1|Overall Study|Withdrawal by Subject|3
2561125|NCT01358864|8859873|P8|Overall Study|Lost to Follow-up|1
2561126|NCT01358864|8859874|P7|Overall Study|Lost to Follow-up|0
2561127|NCT01358864|8859875|P6|Overall Study|Lost to Follow-up|0
2561128|NCT01358864|8859876|P5|Overall Study|Lost to Follow-up|0
2561129|NCT01358864|8859877|P4|Overall Study|Lost to Follow-up|0
2561130|NCT01358864|8859878|P3|Overall Study|Lost to Follow-up|1
2561131|NCT01358864|8859879|P2|Overall Study|Lost to Follow-up|0
2561132|NCT01358864|8859880|P1|Overall Study|Lost to Follow-up|0
2561133|NCT01358864|8859873|P8|Overall Study|Lack of Efficacy|44
2561134|NCT01358864|8859874|P7|Overall Study|Lack of Efficacy|49
2561135|NCT01358864|8859875|P6|Overall Study|Lack of Efficacy|4
2561136|NCT01358864|8859876|P5|Overall Study|Lack of Efficacy|7
2561137|NCT01358864|8859877|P4|Overall Study|Lack of Efficacy|19
2561138|NCT01358864|8859878|P3|Overall Study|Lack of Efficacy|4
2561139|NCT01358864|8859879|P2|Overall Study|Lack of Efficacy|3
2561140|NCT01358864|8859880|P1|Overall Study|Lack of Efficacy|26
2561141|NCT01358864|8859873|P8|Overall Study|Adverse Event|7
2561142|NCT01358864|8859874|P7|Overall Study|Adverse Event|12
2561143|NCT01358864|8859875|P6|Overall Study|Adverse Event|8
2561144|NCT01358864|8859876|P5|Overall Study|Adverse Event|4
2561145|NCT01358864|8859877|P4|Overall Study|Adverse Event|0
2561146|NCT01358864|8859878|P3|Overall Study|Adverse Event|9
2561147|NCT01358864|8859879|P2|Overall Study|Adverse Event|6
2561148|NCT01358864|8859880|P1|Overall Study|Adverse Event|0
2561149|NCT01358825|8859971|P2|Overall Study|Blood sample not drawn|1
2561150|NCT01358825|8859972|P1|Overall Study|Blood sample not drawn|0
2561151|NCT01358760|8859996|P3|Overall Study|Entry criteria not met/Non-compliance|16
2561152|NCT01358760|8859997|P2|Overall Study|Entry criteria not met/Non-compliance|12
2561153|NCT01358760|8859998|P1|Overall Study|Entry criteria not met/Non-compliance|12
2561154|NCT01358760|8859996|P3|Overall Study|Physician Decision|1
2561155|NCT01358760|8859997|P2|Overall Study|Physician Decision|0
2561156|NCT01358760|8859998|P1|Overall Study|Physician Decision|1
2561157|NCT01358760|8859996|P3|Overall Study|Withdrawal by Subject|2
2561158|NCT01358760|8859997|P2|Overall Study|Withdrawal by Subject|3
2561159|NCT01358760|8859998|P1|Overall Study|Withdrawal by Subject|5
2561160|NCT01358760|8859996|P3|Overall Study|Lost to Follow-up|3
2561161|NCT01358760|8859997|P2|Overall Study|Lost to Follow-up|1
2561162|NCT01358760|8859998|P1|Overall Study|Lost to Follow-up|1
2561163|NCT01358760|8859996|P3|Overall Study|Adverse Event|3
2561164|NCT01358760|8859997|P2|Overall Study|Adverse Event|4
2561165|NCT01358760|8859998|P1|Overall Study|Adverse Event|3
2561166|NCT01358734|8860033|P3|Overall Study|Protocol Violation|2
2561167|NCT01358734|8860034|P2|Overall Study|Protocol Violation|0
2561168|NCT01358734|8860035|P1|Overall Study|Protocol Violation|0
2561169|NCT01358734|8860033|P3|Overall Study|Other|4
2561170|NCT01358734|8860034|P2|Overall Study|Other|5
2561171|NCT01358734|8860035|P1|Overall Study|Other|2
2561172|NCT01358734|8860033|P3|Overall Study|Non-compliance with study drug|1
2561173|NCT01358734|8860034|P2|Overall Study|Non-compliance with study drug|0
2561174|NCT01358734|8860035|P1|Overall Study|Non-compliance with study drug|0
2561175|NCT01358734|8860033|P3|Overall Study|Progressive Disease|16
2561176|NCT01358734|8860034|P2|Overall Study|Progressive Disease|13
2561177|NCT01358734|8860035|P1|Overall Study|Progressive Disease|5
2561178|NCT01358734|8860033|P3|Overall Study|Death|2
2561179|NCT01358734|8860034|P2|Overall Study|Death|7
2561180|NCT01358734|8860035|P1|Overall Study|Death|3
2561181|NCT01358734|8860033|P3|Overall Study|Withdrawal by Subject|3
2561182|NCT01358734|8860034|P2|Overall Study|Withdrawal by Subject|6
2561183|NCT01358734|8860035|P1|Overall Study|Withdrawal by Subject|1
2561184|NCT01358734|8860033|P3|Overall Study|Lack of Efficacy|3
2561185|NCT01358734|8860034|P2|Overall Study|Lack of Efficacy|1
2561186|NCT01358734|8860035|P1|Overall Study|Lack of Efficacy|0
2561187|NCT01358734|8860033|P3|Overall Study|Adverse Event|3
2561188|NCT01358734|8860034|P2|Overall Study|Adverse Event|7
2561189|NCT01358734|8860035|P1|Overall Study|Adverse Event|4
2561190|NCT01358721|8860083|P4|Overall Study|Out of State/Unmet Criteria|0
2561191|NCT01358721|8860084|P3|Overall Study|Out of State/Unmet Criteria|1
2561192|NCT01358721|8860085|P2|Overall Study|Out of State/Unmet Criteria|0
2561193|NCT01358721|8860086|P1|Overall Study|Out of State/Unmet Criteria|0
2561194|NCT01358721|8860083|P4|Overall Study|Disease Progression|15
2561195|NCT01358721|8860084|P3|Overall Study|Disease Progression|17
2561196|NCT01358721|8860085|P2|Overall Study|Disease Progression|15
2561197|NCT01358721|8860086|P1|Overall Study|Disease Progression|19
2561198|NCT01358721|8860083|P4|Overall Study|Adverse Event related to study drug|1
2561199|NCT01358721|8860084|P3|Overall Study|Adverse Event related to study drug|0
2561200|NCT01358721|8860085|P2|Overall Study|Adverse Event related to study drug|0
2561201|NCT01358721|8860086|P1|Overall Study|Adverse Event related to study drug|1
2561202|NCT01358721|8860083|P4|Overall Study|Subject No Longer Meets Study Criteria|1
2561203|NCT01358721|8860084|P3|Overall Study|Subject No Longer Meets Study Criteria|0
2561204|NCT01358721|8860085|P2|Overall Study|Subject No Longer Meets Study Criteria|2
2561205|NCT01358721|8860086|P1|Overall Study|Subject No Longer Meets Study Criteria|0
2561206|NCT01358721|8860083|P4|Overall Study|SUBJ request to discontinue study TRT|1
2561207|NCT01358721|8860084|P3|Overall Study|SUBJ request to discontinue study TRT|0
2561208|NCT01358721|8860085|P2|Overall Study|SUBJ request to discontinue study TRT|0
2561209|NCT01358721|8860086|P1|Overall Study|SUBJ request to discontinue study TRT|0
2561210|NCT01358721|8860083|P4|Overall Study|Study Drug Toxicity|5
2561211|NCT01358721|8860084|P3|Overall Study|Study Drug Toxicity|4
2561212|NCT01358721|8860085|P2|Overall Study|Study Drug Toxicity|3
2561213|NCT01358721|8860086|P1|Overall Study|Study Drug Toxicity|1
2561214|NCT01358721|8860083|P4|Overall Study|Death|0
2561215|NCT01358721|8860084|P3|Overall Study|Death|0
2561216|NCT01358721|8860085|P2|Overall Study|Death|2
2561217|NCT01358721|8860086|P1|Overall Study|Death|0
2561218|NCT01358721|8860083|P4|Overall Study|Withdrawal by Subject|1
2561219|NCT01358721|8860084|P3|Overall Study|Withdrawal by Subject|0
2561220|NCT01358721|8860085|P2|Overall Study|Withdrawal by Subject|0
2561221|NCT01358721|8860086|P1|Overall Study|Withdrawal by Subject|0
2561222|NCT01358708|8860138|P2|Double-Blind Treatment Phase|Protocol Violation|0
2561223|NCT01358708|8860139|P1|Double-Blind Treatment Phase|Protocol Violation|1
2561224|NCT01358708|8860138|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
2561225|NCT01358708|8860139|P1|Double-Blind Treatment Phase|Lost to Follow-up|2
2561226|NCT01358578|8860162|P6|Follow-up Period|Physician Decision|0
2561227|NCT01358578|8860163|P5|Follow-up Period|Physician Decision|0
2561228|NCT01358578|8860164|P4|Follow-up Period|Physician Decision|2
2561229|NCT01358578|8860165|P3|Follow-up Period|Physician Decision|0
2561230|NCT01358578|8860166|P2|Follow-up Period|Physician Decision|1
2561231|NCT01358578|8860167|P1|Follow-up Period|Physician Decision|1
2561232|NCT01358578|8860162|P6|Follow-up Period|Withdrawal by Subject|0
2561233|NCT01358578|8860163|P5|Follow-up Period|Withdrawal by Subject|0
2561234|NCT01358578|8860164|P4|Follow-up Period|Withdrawal by Subject|12
2561235|NCT01358578|8860165|P3|Follow-up Period|Withdrawal by Subject|1
2561236|NCT01358578|8860166|P2|Follow-up Period|Withdrawal by Subject|3
2561237|NCT01358578|8860167|P1|Follow-up Period|Withdrawal by Subject|3
2561238|NCT01358578|8860162|P6|Follow-up Period|Pregnancy|0
2561239|NCT01358578|8860163|P5|Follow-up Period|Pregnancy|0
2561240|NCT01358578|8860164|P4|Follow-up Period|Pregnancy|0
2561241|NCT01358578|8860165|P3|Follow-up Period|Pregnancy|0
2561242|NCT01358578|8860166|P2|Follow-up Period|Pregnancy|0
2561243|NCT01358578|8860167|P1|Follow-up Period|Pregnancy|1
2561244|NCT01358578|8860162|P6|Follow-up Period|non- compliance with study treatment|0
2561245|NCT01358578|8860163|P5|Follow-up Period|non- compliance with study treatment|0
2561246|NCT01358578|8860164|P4|Follow-up Period|non- compliance with study treatment|0
2561247|NCT01358578|8860165|P3|Follow-up Period|non- compliance with study treatment|0
2561248|NCT01358578|8860166|P2|Follow-up Period|non- compliance with study treatment|0
2561249|NCT01358578|8860167|P1|Follow-up Period|non- compliance with study treatment|1
2561250|NCT01358578|8860162|P6|Follow-up Period|Lost to Follow-up|0
2561251|NCT01358578|8860163|P5|Follow-up Period|Lost to Follow-up|0
2561252|NCT01358578|8860164|P4|Follow-up Period|Lost to Follow-up|4
2561253|NCT01358578|8860165|P3|Follow-up Period|Lost to Follow-up|0
2561254|NCT01358578|8860166|P2|Follow-up Period|Lost to Follow-up|1
2561255|NCT01358578|8860167|P1|Follow-up Period|Lost to Follow-up|0
2561256|NCT01358578|8860162|P6|Follow-up Period|Lack of Efficacy|0
2561257|NCT01358578|8860163|P5|Follow-up Period|Lack of Efficacy|0
2561258|NCT01358578|8860164|P4|Follow-up Period|Lack of Efficacy|1
2561259|NCT01358578|8860165|P3|Follow-up Period|Lack of Efficacy|4
2561260|NCT01358578|8860166|P2|Follow-up Period|Lack of Efficacy|0
2561261|NCT01358578|8860167|P1|Follow-up Period|Lack of Efficacy|3
2561262|NCT01358578|8860162|P6|Follow-up Period|Adverse Event|0
2561263|NCT01358578|8860163|P5|Follow-up Period|Adverse Event|0
2561264|NCT01358578|8860164|P4|Follow-up Period|Adverse Event|0
2561265|NCT01358578|8860165|P3|Follow-up Period|Adverse Event|0
2561266|NCT01358578|8860166|P2|Follow-up Period|Adverse Event|1
2561267|NCT01358578|8860167|P1|Follow-up Period|Adverse Event|1
2561268|NCT01358578|8860162|P6|Maintenance Period|Withdrawal by Subject|3
2561269|NCT01358578|8860163|P5|Maintenance Period|Withdrawal by Subject|6
2561270|NCT01358578|8860164|P4|Maintenance Period|Withdrawal by Subject|15
2561271|NCT01358578|8860165|P3|Maintenance Period|Withdrawal by Subject|2
2561272|NCT01358578|8860166|P2|Maintenance Period|Withdrawal by Subject|7
2561273|NCT01358578|8860167|P1|Maintenance Period|Withdrawal by Subject|12
2561274|NCT01358578|8860162|P6|Maintenance Period|Protocol deviation|2
2561275|NCT01358578|8860163|P5|Maintenance Period|Protocol deviation|2
2561276|NCT01358578|8860164|P4|Maintenance Period|Protocol deviation|2
2561277|NCT01358578|8860165|P3|Maintenance Period|Protocol deviation|0
2561278|NCT01358578|8860166|P2|Maintenance Period|Protocol deviation|4
2561279|NCT01358578|8860167|P1|Maintenance Period|Protocol deviation|7
2561280|NCT01358578|8860162|P6|Maintenance Period|Pregnancy|0
2561281|NCT01358578|8860163|P5|Maintenance Period|Pregnancy|0
2561282|NCT01358578|8860164|P4|Maintenance Period|Pregnancy|0
2561283|NCT01358578|8860165|P3|Maintenance Period|Pregnancy|0
2561284|NCT01358578|8860166|P2|Maintenance Period|Pregnancy|0
2561285|NCT01358578|8860167|P1|Maintenance Period|Pregnancy|1
2561286|NCT01358578|8860162|P6|Maintenance Period|Physician Decision|0
2561287|NCT01358578|8860163|P5|Maintenance Period|Physician Decision|0
2561288|NCT01358578|8860164|P4|Maintenance Period|Physician Decision|1
2561289|NCT01358578|8860165|P3|Maintenance Period|Physician Decision|0
2561290|NCT01358578|8860166|P2|Maintenance Period|Physician Decision|1
2561291|NCT01358578|8860167|P1|Maintenance Period|Physician Decision|0
2561292|NCT01358578|8860162|P6|Maintenance Period|Non-compliance with study treatment|2
2561293|NCT01358578|8860163|P5|Maintenance Period|Non-compliance with study treatment|1
2561294|NCT01358578|8860164|P4|Maintenance Period|Non-compliance with study treatment|2
2561295|NCT01358578|8860165|P3|Maintenance Period|Non-compliance with study treatment|0
2561296|NCT01358578|8860166|P2|Maintenance Period|Non-compliance with study treatment|1
2561297|NCT01358578|8860167|P1|Maintenance Period|Non-compliance with study treatment|3
2561298|NCT01358578|8860162|P6|Maintenance Period|Lost to Follow-up|1
2561299|NCT01358578|8860163|P5|Maintenance Period|Lost to Follow-up|1
2561300|NCT01358578|8860164|P4|Maintenance Period|Lost to Follow-up|5
2561301|NCT01358578|8860165|P3|Maintenance Period|Lost to Follow-up|0
2561302|NCT01358578|8860166|P2|Maintenance Period|Lost to Follow-up|0
2561303|NCT01358578|8860167|P1|Maintenance Period|Lost to Follow-up|4
2561304|NCT01358578|8860162|P6|Maintenance Period|Lack of Efficacy|0
2561305|NCT01358578|8860163|P5|Maintenance Period|Lack of Efficacy|3
2561306|NCT01358578|8860164|P4|Maintenance Period|Lack of Efficacy|11
2561307|NCT01358578|8860165|P3|Maintenance Period|Lack of Efficacy|0
2561308|NCT01358578|8860166|P2|Maintenance Period|Lack of Efficacy|2
2561309|NCT01358578|8860167|P1|Maintenance Period|Lack of Efficacy|10
2561310|NCT01358578|8860162|P6|Maintenance Period|Adverse Event|3
2561311|NCT01358578|8860163|P5|Maintenance Period|Adverse Event|4
2561312|NCT01358578|8860164|P4|Maintenance Period|Adverse Event|6
2561313|NCT01358578|8860165|P3|Maintenance Period|Adverse Event|0
2561314|NCT01358578|8860166|P2|Maintenance Period|Adverse Event|7
2561315|NCT01358578|8860167|P1|Maintenance Period|Adverse Event|2
2561316|NCT01358578|8860162|P6|Induction Period|Withdrawal by Subject|0
2561317|NCT01358578|8860163|P5|Induction Period|Withdrawal by Subject|0
2561318|NCT01358578|8860164|P4|Induction Period|Withdrawal by Subject|6
2561319|NCT01358578|8860165|P3|Induction Period|Withdrawal by Subject|10
2561320|NCT01358578|8860166|P2|Induction Period|Withdrawal by Subject|5
2561321|NCT01358578|8860167|P1|Induction Period|Withdrawal by Subject|5
2561322|NCT01358578|8860162|P6|Induction Period|technical problems|0
2561323|NCT01358578|8860163|P5|Induction Period|technical problems|0
2561324|NCT01358578|8860164|P4|Induction Period|technical problems|1
2561325|NCT01358578|8860165|P3|Induction Period|technical problems|1
2561326|NCT01358578|8860166|P2|Induction Period|technical problems|0
2561327|NCT01358578|8860167|P1|Induction Period|technical problems|0
2561328|NCT01358578|8860162|P6|Induction Period|Protocol Deviation|0
2561329|NCT01358578|8860163|P5|Induction Period|Protocol Deviation|0
2561330|NCT01358578|8860164|P4|Induction Period|Protocol Deviation|3
2561331|NCT01358578|8860165|P3|Induction Period|Protocol Deviation|0
2561332|NCT01358578|8860166|P2|Induction Period|Protocol Deviation|5
2561333|NCT01358578|8860167|P1|Induction Period|Protocol Deviation|3
2561334|NCT01358578|8860162|P6|Induction Period|Physician Decision|0
2561335|NCT01358578|8860163|P5|Induction Period|Physician Decision|0
2561336|NCT01358578|8860164|P4|Induction Period|Physician Decision|0
2561337|NCT01358578|8860165|P3|Induction Period|Physician Decision|2
2561338|NCT01358578|8860166|P2|Induction Period|Physician Decision|1
2561339|NCT01358578|8860167|P1|Induction Period|Physician Decision|2
2561340|NCT01358578|8860162|P6|Induction Period|Lost to Follow-up|0
2561341|NCT01358578|8860163|P5|Induction Period|Lost to Follow-up|0
2561342|NCT01358578|8860164|P4|Induction Period|Lost to Follow-up|4
2561343|NCT01358578|8860165|P3|Induction Period|Lost to Follow-up|1
2561344|NCT01358578|8860166|P2|Induction Period|Lost to Follow-up|0
2561345|NCT01358578|8860167|P1|Induction Period|Lost to Follow-up|0
2561346|NCT01358578|8860162|P6|Induction Period|Lack of Efficacy|0
2561347|NCT01358578|8860163|P5|Induction Period|Lack of Efficacy|0
2561348|NCT01358578|8860164|P4|Induction Period|Lack of Efficacy|1
2561349|NCT01358578|8860165|P3|Induction Period|Lack of Efficacy|9
2561350|NCT01358578|8860166|P2|Induction Period|Lack of Efficacy|0
2561351|NCT01358578|8860167|P1|Induction Period|Lack of Efficacy|0
2561352|NCT01358578|8860162|P6|Induction Period|Adverse Event|0
2561353|NCT01358578|8860163|P5|Induction Period|Adverse Event|0
2561354|NCT01358578|8860164|P4|Induction Period|Adverse Event|6
2561355|NCT01358578|8860165|P3|Induction Period|Adverse Event|2
2561356|NCT01358578|8860166|P2|Induction Period|Adverse Event|4
2561357|NCT01358578|8860167|P1|Induction Period|Adverse Event|2
2561358|NCT01358526|8860219|P3|Double-blind Phase|Administrative|10
2561359|NCT01358526|8860220|P2|Double-blind Phase|Administrative|6
2561360|NCT01358526|8860221|P1|Double-blind Phase|Administrative|0
2561361|NCT01358526|8860219|P3|Double-blind Phase|Confirmed or suspected diversion|6
2561362|NCT01358526|8860220|P2|Double-blind Phase|Confirmed or suspected diversion|5
2561363|NCT01358526|8860221|P1|Double-blind Phase|Confirmed or suspected diversion|0
2561364|NCT01358526|8860219|P3|Double-blind Phase|Lack of Efficacy|73
2561365|NCT01358526|8860220|P2|Double-blind Phase|Lack of Efficacy|31
2561366|NCT01358526|8860221|P1|Double-blind Phase|Lack of Efficacy|0
2561367|NCT01358526|8860219|P3|Double-blind Phase|Lost to Follow-up|1
2561368|NCT01358526|8860220|P2|Double-blind Phase|Lost to Follow-up|4
2561369|NCT01358526|8860221|P1|Double-blind Phase|Lost to Follow-up|0
2561370|NCT01358526|8860219|P3|Double-blind Phase|Withdrawal by Subject|8
2561371|NCT01358526|8860220|P2|Double-blind Phase|Withdrawal by Subject|10
2561372|NCT01358526|8860221|P1|Double-blind Phase|Withdrawal by Subject|0
2561373|NCT01358526|8860219|P3|Double-blind Phase|Adverse Event|23
2561374|NCT01358526|8860220|P2|Double-blind Phase|Adverse Event|24
2561375|NCT01358526|8860221|P1|Double-blind Phase|Adverse Event|0
2561376|NCT01358526|8860219|P3|Open-label Titration Period|Did not qualify|0
2561377|NCT01358526|8860220|P2|Open-label Titration Period|Did not qualify|0
2561378|NCT01358526|8860221|P1|Open-label Titration Period|Did not qualify|178
2561379|NCT01358526|8860219|P3|Open-label Titration Period|Administrative|0
2561380|NCT01358526|8860220|P2|Open-label Titration Period|Administrative|0
2561381|NCT01358526|8860221|P1|Open-label Titration Period|Administrative|8
2561382|NCT01358526|8860219|P3|Open-label Titration Period|Confirmed or suspected diversion|0
2561383|NCT01358526|8860220|P2|Open-label Titration Period|Confirmed or suspected diversion|0
2561384|NCT01358526|8860221|P1|Open-label Titration Period|Confirmed or suspected diversion|16
2561385|NCT01358526|8860219|P3|Open-label Titration Period|Lack of Efficacy|0
2561386|NCT01358526|8860220|P2|Open-label Titration Period|Lack of Efficacy|0
2561387|NCT01358526|8860221|P1|Open-label Titration Period|Lack of Efficacy|107
2561388|NCT01358526|8860219|P3|Open-label Titration Period|Lost to Follow-up|0
2561389|NCT01358526|8860220|P2|Open-label Titration Period|Lost to Follow-up|0
2561390|NCT01358526|8860221|P1|Open-label Titration Period|Lost to Follow-up|25
2561391|NCT01358526|8860219|P3|Open-label Titration Period|Withdrawal by Subject|0
2561392|NCT01358526|8860220|P2|Open-label Titration Period|Withdrawal by Subject|0
2561393|NCT01358526|8860221|P1|Open-label Titration Period|Withdrawal by Subject|65
2561394|NCT01358526|8860219|P3|Open-label Titration Period|Adverse Event|0
2561395|NCT01358526|8860220|P2|Open-label Titration Period|Adverse Event|0
2561396|NCT01358526|8860221|P1|Open-label Titration Period|Adverse Event|95
2561397|NCT01358357|8860238|P3|Double-Blind Phase|Administrative|0
2561398|NCT01358357|8860239|P2|Double-Blind Phase|Administrative|1
2561399|NCT01358357|8860240|P1|Double-Blind Phase|Administrative|0
2561400|NCT01358357|8860238|P3|Double-Blind Phase|Recurrence of mood event|0
2561401|NCT01358357|8860239|P2|Double-Blind Phase|Recurrence of mood event|64
2561402|NCT01358357|8860240|P1|Double-Blind Phase|Recurrence of mood event|48
2561403|NCT01358357|8860238|P3|Double-Blind Phase|Terminated at study completion|0
2561404|NCT01358357|8860239|P2|Double-Blind Phase|Terminated at study completion|0
2561405|NCT01358357|8860240|P1|Double-Blind Phase|Terminated at study completion|2
2561406|NCT01358357|8860238|P3|Double-Blind Phase|Protocol Violation|0
2561407|NCT01358357|8860239|P2|Double-Blind Phase|Protocol Violation|12
2561408|NCT01358357|8860240|P1|Double-Blind Phase|Protocol Violation|16
2561409|NCT01358357|8860238|P3|Double-Blind Phase|Protocol Violation|0
2561410|NCT01358357|8860239|P2|Double-Blind Phase|Protocol Violation|11
2561411|NCT01358357|8860240|P1|Double-Blind Phase|Protocol Violation|1
2561412|NCT01358357|8860238|P3|Double-Blind Phase|Lost to Follow-up|0
2561413|NCT01358357|8860239|P2|Double-Blind Phase|Lost to Follow-up|7
2561414|NCT01358357|8860240|P1|Double-Blind Phase|Lost to Follow-up|5
2561415|NCT01358357|8860238|P3|Double-Blind Phase|Adverse Event|0
2561416|NCT01358357|8860239|P2|Double-Blind Phase|Adverse Event|5
2561417|NCT01358357|8860240|P1|Double-Blind Phase|Adverse Event|8
2561418|NCT01358357|8860238|P3|Open Label Phase|Mood episode|42
2561419|NCT01358357|8860239|P2|Open Label Phase|Mood episode|0
2561420|NCT01358357|8860240|P1|Open Label Phase|Mood episode|0
2561421|NCT01358357|8860238|P3|Open Label Phase|Terminated at study completion|5
2561422|NCT01358357|8860239|P2|Open Label Phase|Terminated at study completion|0
2561423|NCT01358357|8860240|P1|Open Label Phase|Terminated at study completion|0
2561424|NCT01358357|8860238|P3|Open Label Phase|Did not meet criteria for DB phase|16
2561425|NCT01358357|8860239|P2|Open Label Phase|Did not meet criteria for DB phase|0
2561426|NCT01358357|8860240|P1|Open Label Phase|Did not meet criteria for DB phase|0
2561427|NCT01358357|8860238|P3|Open Label Phase|Withdrawal by Subject|112
2561428|NCT01358357|8860239|P2|Open Label Phase|Withdrawal by Subject|0
2561429|NCT01358357|8860240|P1|Open Label Phase|Withdrawal by Subject|0
2561430|NCT01358357|8860238|P3|Open Label Phase|Protocol Violation|45
2561431|NCT01358357|8860239|P2|Open Label Phase|Protocol Violation|0
2561432|NCT01358357|8860240|P1|Open Label Phase|Protocol Violation|0
2561433|NCT01358357|8860238|P3|Open Label Phase|Lost to Follow-up|76
2561434|NCT01358357|8860239|P2|Open Label Phase|Lost to Follow-up|0
2561435|NCT01358357|8860240|P1|Open Label Phase|Lost to Follow-up|0
2561436|NCT01358357|8860238|P3|Open Label Phase|Lack of Efficacy|107
2561437|NCT01358357|8860239|P2|Open Label Phase|Lack of Efficacy|0
2561438|NCT01358357|8860240|P1|Open Label Phase|Lack of Efficacy|0
2561439|NCT01358357|8860238|P3|Open Label Phase|Adverse Event|59
2561440|NCT01358357|8860239|P2|Open Label Phase|Adverse Event|0
2561441|NCT01358357|8860240|P1|Open Label Phase|Adverse Event|0
2561442|NCT01358331|8860279|P6|Overall Study|Progress of disease under investigation|0
2561443|NCT01358331|8860280|P5|Overall Study|Progress of disease under investigation|3
2561444|NCT01358331|8860281|P4|Overall Study|Progress of disease under investigation|1
2561445|NCT01358331|8860282|P3|Overall Study|Progress of disease under investigation|3
2561446|NCT01358331|8860283|P2|Overall Study|Progress of disease under investigation|2
2561447|NCT01358331|8860284|P1|Overall Study|Progress of disease under investigation|1
2561448|NCT01358331|8860279|P6|Overall Study|Participants did not wish to continue|0
2561449|NCT01358331|8860280|P5|Overall Study|Participants did not wish to continue|1
2561450|NCT01358331|8860281|P4|Overall Study|Participants did not wish to continue|0
2561451|NCT01358331|8860282|P3|Overall Study|Participants did not wish to continue|0
2561452|NCT01358331|8860283|P2|Overall Study|Participants did not wish to continue|0
2561453|NCT01358331|8860284|P1|Overall Study|Participants did not wish to continue|0
2561454|NCT01358331|8860279|P6|Overall Study|Symptomatic Deterioration|0
2561455|NCT01358331|8860280|P5|Overall Study|Symptomatic Deterioration|1
2561456|NCT01358331|8860281|P4|Overall Study|Symptomatic Deterioration|0
2561457|NCT01358331|8860282|P3|Overall Study|Symptomatic Deterioration|0
2561458|NCT01358331|8860283|P2|Overall Study|Symptomatic Deterioration|0
2561459|NCT01358331|8860284|P1|Overall Study|Symptomatic Deterioration|0
2561460|NCT01358331|8860279|P6|Overall Study|Adverse Events|5
2561461|NCT01358331|8860280|P5|Overall Study|Adverse Events|1
2561462|NCT01358331|8860281|P4|Overall Study|Adverse Events|0
2561463|NCT01358331|8860282|P3|Overall Study|Adverse Events|1
2561464|NCT01358331|8860283|P2|Overall Study|Adverse Events|1
2561465|NCT01358331|8860284|P1|Overall Study|Adverse Events|1
2561466|NCT01358331|8860279|P6|Overall Study|Withdrawal by Subject|1
2561467|NCT01358331|8860280|P5|Overall Study|Withdrawal by Subject|1
2561468|NCT01358331|8860281|P4|Overall Study|Withdrawal by Subject|1
2561469|NCT01358331|8860282|P3|Overall Study|Withdrawal by Subject|0
2561470|NCT01358331|8860283|P2|Overall Study|Withdrawal by Subject|0
2561471|NCT01358331|8860284|P1|Overall Study|Withdrawal by Subject|0
2561472|NCT01358331|8860279|P6|Overall Study|Lost to Follow-up|0
2561473|NCT01358331|8860280|P5|Overall Study|Lost to Follow-up|0
2561474|NCT01358331|8860281|P4|Overall Study|Lost to Follow-up|1
2561475|NCT01358331|8860282|P3|Overall Study|Lost to Follow-up|0
2561476|NCT01358331|8860283|P2|Overall Study|Lost to Follow-up|0
2561477|NCT01358331|8860284|P1|Overall Study|Lost to Follow-up|0
2561478|NCT01358175|8860336|P3|Overall Study|Adverse Event|11
2561479|NCT01358175|8860337|P2|Overall Study|Adverse Event|11
2561480|NCT01358175|8860338|P1|Overall Study|Adverse Event|6
2561481|NCT01358175|8860336|P3|Overall Study|Lack of Efficacy|6
2561482|NCT01358175|8860337|P2|Overall Study|Lack of Efficacy|8
2561483|NCT01358175|8860338|P1|Overall Study|Lack of Efficacy|3
2561484|NCT01358175|8860336|P3|Overall Study|Lost to Follow-up|3
2561485|NCT01358175|8860337|P2|Overall Study|Lost to Follow-up|1
2561486|NCT01358175|8860338|P1|Overall Study|Lost to Follow-up|1
2561487|NCT01358175|8860336|P3|Overall Study|Non Compliance with Study Treatment|1
2561488|NCT01358175|8860337|P2|Overall Study|Non Compliance with Study Treatment|1
2561489|NCT01358175|8860338|P1|Overall Study|Non Compliance with Study Treatment|0
2561490|NCT01358175|8860336|P3|Overall Study|Physician Decision|0
2561491|NCT01358175|8860337|P2|Overall Study|Physician Decision|0
2561492|NCT01358175|8860338|P1|Overall Study|Physician Decision|1
2561493|NCT01358175|8860336|P3|Overall Study|Pregnancy|0
2561494|NCT01358175|8860337|P2|Overall Study|Pregnancy|1
2561495|NCT01358175|8860338|P1|Overall Study|Pregnancy|0
2561496|NCT01358175|8860336|P3|Overall Study|Technical issues|0
2561497|NCT01358175|8860337|P2|Overall Study|Technical issues|1
2561498|NCT01358175|8860338|P1|Overall Study|Technical issues|0
2561499|NCT01358175|8860336|P3|Overall Study|Withdrawal by Subject|10
2561500|NCT01358175|8860337|P2|Overall Study|Withdrawal by Subject|5
2561501|NCT01358175|8860338|P1|Overall Study|Withdrawal by Subject|9
2561502|NCT01358175|8860336|P3|Overall Study|Death|1
2561503|NCT01358175|8860337|P2|Overall Study|Death|0
2561504|NCT01358175|8860338|P1|Overall Study|Death|1
2561505|NCT01357980|8860375|P4|Overall Study|Consent withdrawn|0
2561506|NCT01357980|8860376|P3|Overall Study|Consent withdrawn|1
2561507|NCT01357980|8860377|P2|Overall Study|Consent withdrawn|0
2561508|NCT01357980|8860378|P1|Overall Study|Consent withdrawn|0
2561509|NCT01357980|8860375|P4|Overall Study|Lack of Efficacy|0
2561510|NCT01357980|8860376|P3|Overall Study|Lack of Efficacy|0
2561511|NCT01357980|8860377|P2|Overall Study|Lack of Efficacy|1
2561512|NCT01357980|8860378|P1|Overall Study|Lack of Efficacy|0
2561513|NCT01357915|8860422|P2|Overall Study|Lost to Follow-up|0
2561514|NCT01357915|8860423|P1|Overall Study|Lost to Follow-up|3
2561515|NCT01357889|8860441|P2|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0
2561516|NCT01357889|8860442|P1|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1
2561517|NCT01357889|8860441|P2|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0
2561518|NCT01357889|8860442|P1|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1
2561519|NCT01357889|8860441|P2|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4
2561520|NCT01357889|8860442|P1|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0
2561521|NCT01357889|8860441|P2|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0
2561522|NCT01357889|8860442|P1|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1
2561523|NCT01357889|8860441|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
2561524|NCT01357889|8860442|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
2561525|NCT01357889|8860441|P2|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1
2561526|NCT01357889|8860442|P1|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2
2561527|NCT01357889|8860441|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2
2561528|NCT01357889|8860442|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5
2561529|NCT01357889|8860441|P2|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2
2561530|NCT01357889|8860442|P1|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0
2561531|NCT01357889|8860441|P2|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2
2561532|NCT01357889|8860442|P1|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0
2561533|NCT01357889|8860441|P2|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
2561534|NCT01357889|8860442|P1|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
2561535|NCT01357889|8860441|P2|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0
2561536|NCT01357889|8860442|P1|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1
2561537|NCT01357889|8860441|P2|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
2561538|NCT01357889|8860442|P1|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
2561539|NCT01357889|8860441|P2|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1
2561540|NCT01357889|8860442|P1|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2
2561541|NCT01357850|8860486|P4|Overall Study|Lost to Follow-up|0
2561542|NCT01357850|8860487|P3|Overall Study|Lost to Follow-up|0
2561543|NCT01357850|8860488|P2|Overall Study|Lost to Follow-up|0
2561544|NCT01357850|8860489|P1|Overall Study|Lost to Follow-up|1
2561545|NCT01357655|8860580|P2|Overall Study|Subject Withdrew Consent|0
2561546|NCT01357655|8860581|P1|Overall Study|Subject Withdrew Consent|1
2561547|NCT01357655|8860580|P2|Overall Study|Study Drug Toxicity|0
2561548|NCT01357655|8860581|P1|Overall Study|Study Drug Toxicity|11
2561549|NCT01357655|8860580|P2|Overall Study|Reason Unspecified|0
2561550|NCT01357655|8860581|P1|Overall Study|Reason Unspecified|1
2561551|NCT01357655|8860580|P2|Overall Study|Maximum Clinical Benefit|0
2561552|NCT01357655|8860581|P1|Overall Study|Maximum Clinical Benefit|2
2561553|NCT01357655|8860580|P2|Overall Study|Lost to Follow-up|0
2561554|NCT01357655|8860581|P1|Overall Study|Lost to Follow-up|2
2561555|NCT01357655|8860580|P2|Overall Study|Disease Progression|0
2561556|NCT01357655|8860581|P1|Overall Study|Disease Progression|1
2561557|NCT01357655|8860580|P2|Overall Study|Adverse Event Unrelated to Study Drug|0
2561558|NCT01357655|8860581|P1|Overall Study|Adverse Event Unrelated to Study Drug|3
2561559|NCT01357655|8860580|P2|Overall Study|Administrative Reason by Sponsor|0
2561560|NCT01357655|8860581|P1|Overall Study|Administrative Reason by Sponsor|45
2561561|NCT01357616|8860598|P2|Overall Study|Withdrawal by Subject|0
2561562|NCT01357616|8860599|P1|Overall Study|Withdrawal by Subject|1
2561563|NCT01357616|8860598|P2|Overall Study|Decision Unrelated to Adverse Event|1
2561564|NCT01357616|8860599|P1|Overall Study|Decision Unrelated to Adverse Event|3
2561565|NCT01357616|8860598|P2|Overall Study|Inadequate Control of IOP|2
2561566|NCT01357616|8860599|P1|Overall Study|Inadequate Control of IOP|1
2561567|NCT01357616|8860598|P2|Overall Study|Protocol Violation|2
2561568|NCT01357616|8860599|P1|Overall Study|Protocol Violation|0
2561569|NCT01357616|8860598|P2|Overall Study|Lost to Follow-up|3
2561570|NCT01357616|8860599|P1|Overall Study|Lost to Follow-up|4
2561571|NCT01357616|8860598|P2|Overall Study|Adverse Event|1
2561572|NCT01357616|8860599|P1|Overall Study|Adverse Event|1
2561573|NCT01357577|8860613|P2|Overall Study|look at data in database?|2
2561574|NCT01357577|8860614|P1|Overall Study|look at data in database?|1
2561575|NCT01357577|8860613|P2|Overall Study|Withdrawal by Subject|8
2561576|NCT01357577|8860614|P1|Overall Study|Withdrawal by Subject|16
2561577|NCT01357577|8860613|P2|Overall Study|Lost to Follow-up|16
2561578|NCT01357577|8860614|P1|Overall Study|Lost to Follow-up|20
2561579|NCT01357551|8860641|P2|Overall Study|Lost to Follow-up|6
2561580|NCT01357551|8860642|P1|Overall Study|Lost to Follow-up|16
2561581|NCT01357551|8860641|P2|Overall Study|Death|1
2561582|NCT01357551|8860642|P1|Overall Study|Death|0
2561583|NCT01357551|8860641|P2|Overall Study|Withdrawal by Subject|4
2561584|NCT01357551|8860642|P1|Overall Study|Withdrawal by Subject|6
2561585|NCT01357239|8860669|P4|Stratum II: Partially-Methylated|Subject withdrew consent|1
2561586|NCT01357239|8860670|P3|Stratum II: Partially-Methylated|Subject withdrew consent|1
2561587|NCT01357239|8860671|P2|Stratum II: Partially-Methylated|Subject withdrew consent|0
2561588|NCT01357239|8860672|P1|Stratum II: Partially-Methylated|Subject withdrew consent|0
2561589|NCT01357239|8860669|P4|Stratum II: Partially-Methylated|Adverse Event|1
2561590|NCT01357239|8860670|P3|Stratum II: Partially-Methylated|Adverse Event|0
2561591|NCT01357239|8860671|P2|Stratum II: Partially-Methylated|Adverse Event|0
2561592|NCT01357239|8860672|P1|Stratum II: Partially-Methylated|Adverse Event|0
2561593|NCT01357239|8860669|P4|Stratum I: Fully-Methylated|Adverse Event|0
2561594|NCT01357239|8860670|P3|Stratum I: Fully-Methylated|Adverse Event|1
2561595|NCT01357239|8860671|P2|Stratum I: Fully-Methylated|Adverse Event|0
2561596|NCT01357239|8860672|P1|Stratum I: Fully-Methylated|Adverse Event|0
2561597|NCT01357239|8860669|P4|Stratum: All Patients|Subject withdrew consent|1
2561598|NCT01357239|8860670|P3|Stratum: All Patients|Subject withdrew consent|1
2561599|NCT01357239|8860671|P2|Stratum: All Patients|Subject withdrew consent|0
2561600|NCT01357239|8860672|P1|Stratum: All Patients|Subject withdrew consent|0
2561601|NCT01357239|8860669|P4|Stratum: All Patients|Adverse Event|1
2561602|NCT01357239|8860670|P3|Stratum: All Patients|Adverse Event|1
2561603|NCT01357239|8860671|P2|Stratum: All Patients|Adverse Event|0
2561604|NCT01357239|8860672|P1|Stratum: All Patients|Adverse Event|0
2561605|NCT01357161|8860730|P3|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4
2561606|NCT01357161|8860731|P2|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5
2561607|NCT01357161|8860732|P1|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0
2561608|NCT01357161|8860730|P3|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26
2561609|NCT01357161|8860731|P2|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29
2561610|NCT01357161|8860732|P1|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0
2561611|NCT01357161|8860730|P3|Part 2 (Double-Blind Comparison)|Progressive Disease|3
2561612|NCT01357161|8860731|P2|Part 2 (Double-Blind Comparison)|Progressive Disease|1
2561613|NCT01357161|8860732|P1|Part 2 (Double-Blind Comparison)|Progressive Disease|0
2561614|NCT01357161|8860730|P3|Part 2 (Double-Blind Comparison)|Physician Decision|4
2561615|NCT01357161|8860731|P2|Part 2 (Double-Blind Comparison)|Physician Decision|1
2561616|NCT01357161|8860732|P1|Part 2 (Double-Blind Comparison)|Physician Decision|0
2561617|NCT01357161|8860730|P3|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6
2561618|NCT01357161|8860731|P2|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1
2561619|NCT01357161|8860732|P1|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0
2561620|NCT01357161|8860730|P3|Part 2 (Double-Blind Comparison)|Death|19
2561621|NCT01357161|8860731|P2|Part 2 (Double-Blind Comparison)|Death|22
2561622|NCT01357161|8860732|P1|Part 2 (Double-Blind Comparison)|Death|0
2561623|NCT01357161|8860730|P3|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
2561624|NCT01357161|8860731|P2|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
2561625|NCT01357161|8860732|P1|Part 1 (Open Label Run-in)|Withdrawal by Subject|1
2561626|NCT01357161|8860730|P3|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
2561627|NCT01357161|8860731|P2|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
2561628|NCT01357161|8860732|P1|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5
2561629|NCT01357161|8860730|P3|Part 1 (Open Label Run-in)|Physician Decision|0
2561630|NCT01357161|8860731|P2|Part 1 (Open Label Run-in)|Physician Decision|0
2561631|NCT01357161|8860732|P1|Part 1 (Open Label Run-in)|Physician Decision|1
2561632|NCT01357161|8860730|P3|Part 1 (Open Label Run-in)|Lost to Follow-up|0
2561633|NCT01357161|8860731|P2|Part 1 (Open Label Run-in)|Lost to Follow-up|0
2561634|NCT01357161|8860732|P1|Part 1 (Open Label Run-in)|Lost to Follow-up|3
2561635|NCT01357161|8860730|P3|Part 1 (Open Label Run-in)|Death|0
2561636|NCT01357161|8860731|P2|Part 1 (Open Label Run-in)|Death|0
2561637|NCT01357161|8860732|P1|Part 1 (Open Label Run-in)|Death|5
2561638|NCT01356966|8860784|P2|Overall Study|Physician Decision|0
2561639|NCT01356966|8860785|P1|Overall Study|Physician Decision|1
2561640|NCT01356966|8860784|P2|Overall Study|Withdrawal by Subject|2
2561641|NCT01356966|8860785|P1|Overall Study|Withdrawal by Subject|1
2561642|NCT01356940|8860797|P2|Second Intervention (28 Days)|Withdrawal by Subject|0
2561643|NCT01356940|8860798|P1|Second Intervention (28 Days)|Withdrawal by Subject|1
2561644|NCT01356940|8860797|P2|First Intervention (28 Days)|Adverse Event|0
2561645|NCT01356940|8860798|P1|First Intervention (28 Days)|Adverse Event|1
2561646|NCT01356602|8860827|P3|Overall Study|Adverse Event|1
2561647|NCT01356602|8860828|P2|Overall Study|Adverse Event|1
2561648|NCT01356602|8860829|P1|Overall Study|Adverse Event|0
2561649|NCT01356602|8860827|P3|Overall Study|Lack of Efficacy|4
2561650|NCT01356602|8860828|P2|Overall Study|Lack of Efficacy|1
2561651|NCT01356602|8860829|P1|Overall Study|Lack of Efficacy|0
2561652|NCT01356602|8860827|P3|Overall Study|Withdrawal by Subject|7
2561653|NCT01356602|8860828|P2|Overall Study|Withdrawal by Subject|3
2561654|NCT01356602|8860829|P1|Overall Study|Withdrawal by Subject|4
2561655|NCT01356602|8860827|P3|Overall Study|Lost to Follow-up|6
2561656|NCT01356602|8860828|P2|Overall Study|Lost to Follow-up|5
2561657|NCT01356602|8860829|P1|Overall Study|Lost to Follow-up|4
2561658|NCT01356602|8860827|P3|Overall Study|Administrative Problems|5
2561659|NCT01356602|8860828|P2|Overall Study|Administrative Problems|4
2561660|NCT01356602|8860829|P1|Overall Study|Administrative Problems|1
2561661|NCT01356602|8860827|P3|Overall Study|Protocol Deviation|1
2561662|NCT01356602|8860828|P2|Overall Study|Protocol Deviation|1
2561663|NCT01356602|8860829|P1|Overall Study|Protocol Deviation|0
2561664|NCT01356589|8860888|P1|Overall Study|Dose data not recorded|2
2561665|NCT01356589|8860888|P1|Overall Study|Enrolled, but not treated|3
2561666|NCT01356407|8860945|P2|Overall Study|Not complete Endoscopy|2
2561667|NCT01356407|8860946|P1|Overall Study|Not complete Endoscopy|2
2561668|NCT01356407|8860945|P2|Overall Study|Could not afford IMP administration|1
2561669|NCT01356407|8860946|P1|Overall Study|Could not afford IMP administration|0
2561670|NCT01356407|8860945|P2|Overall Study|Patient Withdrew Consent|1
2561671|NCT01356407|8860946|P1|Overall Study|Patient Withdrew Consent|2
2561672|NCT01356407|8860945|P2|Overall Study|Lost to Follow-up|0
2561673|NCT01356407|8860946|P1|Overall Study|Lost to Follow-up|2
2561674|NCT01355679|8861018|P1|Overall Study|benign tumor types found at biopsy|2
2561675|NCT01355627|8861027|P2|Overall Study|Other|1
2561676|NCT01355627|8861028|P1|Overall Study|Other|1
2561677|NCT01355627|8861027|P2|Overall Study|Fatal Adverse Event|23
2561678|NCT01355627|8861028|P1|Overall Study|Fatal Adverse Event|19
2561679|NCT01355627|8861027|P2|Overall Study|Lost to Follow-up|7
2561680|NCT01355627|8861028|P1|Overall Study|Lost to Follow-up|8
2561681|NCT01355627|8861027|P2|Overall Study|Request By the Patient to Discontinue|7
2561682|NCT01355627|8861028|P1|Overall Study|Request By the Patient to Discontinue|5
2561683|NCT01355523|8861067|P2|Overall Study|Adverse Event|2
2561684|NCT01355523|8861068|P1|Overall Study|Adverse Event|0
2561685|NCT01355523|8861067|P2|Overall Study|Protocol Violation|2
2561686|NCT01355523|8861068|P1|Overall Study|Protocol Violation|0
2561687|NCT01355523|8861067|P2|Overall Study|Lost to Follow-up|2
2561688|NCT01355523|8861068|P1|Overall Study|Lost to Follow-up|0
2561689|NCT01355523|8861067|P2|Overall Study|Withdrawal by Subject|4
2561690|NCT01355523|8861068|P1|Overall Study|Withdrawal by Subject|1
2561691|NCT01355302|8861144|P3|Phase 1b|Study terminated by sponsor|0
2561692|NCT01355302|8861145|P2|Phase 1b|Study terminated by sponsor|0
2561693|NCT01355302|8861146|P1|Phase 1b|Study terminated by sponsor|2
2561694|NCT01355302|8861144|P3|Phase 1b|Death|0
2561695|NCT01355302|8861145|P2|Phase 1b|Death|0
2561696|NCT01355302|8861146|P1|Phase 1b|Death|4
2561697|NCT01355289|8861161|P5|Open Label Extension|Other|3
2561698|NCT01355289|8861162|P4|Open Label Extension|Other|0
2561699|NCT01355289|8861163|P3|Open Label Extension|Other|0
2561700|NCT01355289|8861164|P2|Open Label Extension|Other|0
2561701|NCT01355289|8861165|P1|Open Label Extension|Other|0
2561702|NCT01355289|8861161|P5|Open Label Extension|Inadequate Therapeutic Effect|29
2561703|NCT01355289|8861162|P4|Open Label Extension|Inadequate Therapeutic Effect|0
2561704|NCT01355289|8861163|P3|Open Label Extension|Inadequate Therapeutic Effect|0
2561705|NCT01355289|8861164|P2|Open Label Extension|Inadequate Therapeutic Effect|0
2561706|NCT01355289|8861165|P1|Open Label Extension|Inadequate Therapeutic Effect|0
2561707|NCT01355289|8861161|P5|Open Label Extension|Lost to Follow-up|1
2561708|NCT01355289|8861162|P4|Open Label Extension|Lost to Follow-up|0
2561709|NCT01355289|8861163|P3|Open Label Extension|Lost to Follow-up|0
2561710|NCT01355289|8861164|P2|Open Label Extension|Lost to Follow-up|0
2561711|NCT01355289|8861165|P1|Open Label Extension|Lost to Follow-up|0
2561712|NCT01355289|8861161|P5|Open Label Extension|Adverse Event, Non-Fatal|1
2561713|NCT01355289|8861162|P4|Open Label Extension|Adverse Event, Non-Fatal|0
2561714|NCT01355289|8861163|P3|Open Label Extension|Adverse Event, Non-Fatal|0
2561715|NCT01355289|8861164|P2|Open Label Extension|Adverse Event, Non-Fatal|0
2561716|NCT01355289|8861165|P1|Open Label Extension|Adverse Event, Non-Fatal|0
2561717|NCT01355289|8861161|P5|Core Study|Other|0
2561718|NCT01355289|8861162|P4|Core Study|Other|1
2561719|NCT01355289|8861163|P3|Core Study|Other|0
2561720|NCT01355289|8861164|P2|Core Study|Other|0
2561721|NCT01355289|8861165|P1|Core Study|Other|0
2561722|NCT01355289|8861161|P5|Core Study|Inadequate Therapeutic Effect|0
2561723|NCT01355289|8861162|P4|Core Study|Inadequate Therapeutic Effect|1
2561724|NCT01355289|8861163|P3|Core Study|Inadequate Therapeutic Effect|0
2561725|NCT01355289|8861164|P2|Core Study|Inadequate Therapeutic Effect|0
2561726|NCT01355289|8861165|P1|Core Study|Inadequate Therapeutic Effect|0
2561727|NCT01355289|8861161|P5|Core Study|Adverse Event, Non-Fatal|0
2561728|NCT01355289|8861162|P4|Core Study|Adverse Event, Non-Fatal|0
2561729|NCT01355289|8861163|P3|Core Study|Adverse Event, Non-Fatal|0
2561730|NCT01355289|8861164|P2|Core Study|Adverse Event, Non-Fatal|0
2561731|NCT01355289|8861165|P1|Core Study|Adverse Event, Non-Fatal|1
2561732|NCT01355081|8861218|P3|Overall Study|Non Compliance with Study Medication|0
2561733|NCT01355081|8861219|P2|Overall Study|Non Compliance with Study Medication|1
2561734|NCT01355081|8861220|P1|Overall Study|Non Compliance with Study Medication|0
2561735|NCT01355081|8861218|P3|Overall Study|Lack of Efficacy|1
2561736|NCT01355081|8861219|P2|Overall Study|Lack of Efficacy|1
2561737|NCT01355081|8861220|P1|Overall Study|Lack of Efficacy|2
2561738|NCT01355081|8861218|P3|Overall Study|Withdrawal of Consent|3
2561739|NCT01355081|8861219|P2|Overall Study|Withdrawal of Consent|3
2561740|NCT01355081|8861220|P1|Overall Study|Withdrawal of Consent|2
2561741|NCT01355081|8861218|P3|Overall Study|Lost to Follow-up|1
2561742|NCT01355081|8861219|P2|Overall Study|Lost to Follow-up|0
2561743|NCT01355081|8861220|P1|Overall Study|Lost to Follow-up|0
2561744|NCT01355081|8861218|P3|Overall Study|Major Protocol Deviation|0
2561745|NCT01355081|8861219|P2|Overall Study|Major Protocol Deviation|1
2561746|NCT01355081|8861220|P1|Overall Study|Major Protocol Deviation|0
2561747|NCT01355081|8861218|P3|Overall Study|Pretreatment Event or Adverse Event|6
2561748|NCT01355081|8861219|P2|Overall Study|Pretreatment Event or Adverse Event|4
2561749|NCT01355081|8861220|P1|Overall Study|Pretreatment Event or Adverse Event|3
2561750|NCT01355068|8861243|P2|First Intervention Period|Withdrawal by Subject|1
2561751|NCT01355068|8861244|P1|First Intervention Period|Withdrawal by Subject|0
2561752|NCT01355068|8861243|P2|First Intervention Period|Adverse Event|1
2561753|NCT01355068|8861244|P1|First Intervention Period|Adverse Event|0
2561754|NCT01354964|8861269|P2|Overall Study|Physician Decision|0
2561755|NCT01354964|8861270|P1|Overall Study|Physician Decision|1
2561756|NCT01354964|8861269|P2|Overall Study|IV access issues|1
2561757|NCT01354964|8861270|P1|Overall Study|IV access issues|1
2561758|NCT01354964|8861269|P2|Overall Study|Lost to Follow-up|0
2561759|NCT01354964|8861270|P1|Overall Study|Lost to Follow-up|2
2561760|NCT01354938|8861293|P1|Overall Study|Lost to Follow-up|1
2561761|NCT01354899|8861299|P1|Overall Study|Protocol Violation|1
2561762|NCT01354899|8861299|P1|Overall Study|discharge from the hospital|2
2561763|NCT01354496|8861334|P6|Washout (at Least 14 Days)|Scheduling Conflict|0
2561764|NCT01354496|8861335|P5|Washout (at Least 14 Days)|Scheduling Conflict|0
2561765|NCT01354496|8861336|P4|Washout (at Least 14 Days)|Scheduling Conflict|1
2561766|NCT01354496|8861337|P3|Washout (at Least 14 Days)|Scheduling Conflict|0
2561767|NCT01354496|8861338|P2|Washout (at Least 14 Days)|Scheduling Conflict|1
2561768|NCT01354496|8861339|P1|Washout (at Least 14 Days)|Scheduling Conflict|0
2561769|NCT01354496|8861334|P6|Period 2|Adverse Event|0
2561770|NCT01354496|8861335|P5|Period 2|Adverse Event|0
2561771|NCT01354496|8861336|P4|Period 2|Adverse Event|1
2561772|NCT01354496|8861337|P3|Period 2|Adverse Event|0
2561773|NCT01354496|8861338|P2|Period 2|Adverse Event|0
2561774|NCT01354496|8861339|P1|Period 2|Adverse Event|0
2561775|NCT01354496|8861334|P6|Period 1|Physician Decision|0
2561776|NCT01354496|8861335|P5|Period 1|Physician Decision|0
2561777|NCT01354496|8861336|P4|Period 1|Physician Decision|0
2561778|NCT01354496|8861337|P3|Period 1|Physician Decision|1
2561779|NCT01354496|8861338|P2|Period 1|Physician Decision|0
2561780|NCT01354496|8861339|P1|Period 1|Physician Decision|0
2561781|NCT01354496|8861334|P6|Period 1|Adverse Event|0
2561782|NCT01354496|8861335|P5|Period 1|Adverse Event|0
2561783|NCT01354496|8861336|P4|Period 1|Adverse Event|0
2561784|NCT01354496|8861337|P3|Period 1|Adverse Event|1
2561785|NCT01354496|8861338|P2|Period 1|Adverse Event|0
2561786|NCT01354496|8861339|P1|Period 1|Adverse Event|0
2561787|NCT01354431|8861382|P3|Participants Treated|Withdrawal by Subject|1
2561788|NCT01354431|8861383|P2|Participants Treated|Withdrawal by Subject|2
2561789|NCT01354431|8861384|P1|Participants Treated|Withdrawal by Subject|1
2561790|NCT01354431|8861382|P3|Participants Treated|Adverse Event|4
2561791|NCT01354431|8861383|P2|Participants Treated|Adverse Event|2
2561792|NCT01354431|8861384|P1|Participants Treated|Adverse Event|1
2561793|NCT01354431|8861382|P3|Participants Treated|Death|0
2561794|NCT01354431|8861383|P2|Participants Treated|Death|1
2561795|NCT01354431|8861384|P1|Participants Treated|Death|0
2561796|NCT01354431|8861382|P3|Participants Treated|Study Drug Toxicity|4
2561797|NCT01354431|8861383|P2|Participants Treated|Study Drug Toxicity|7
2561798|NCT01354431|8861384|P1|Participants Treated|Study Drug Toxicity|2
2561799|NCT01354431|8861382|P3|Participants Treated|Disease Progression|41
2561800|NCT01354431|8861383|P2|Participants Treated|Disease Progression|40
2561801|NCT01354431|8861384|P1|Participants Treated|Disease Progression|49
2561802|NCT01354431|8861382|P3|Participants Treated|Continuing Treatment|4
2561803|NCT01354431|8861383|P2|Participants Treated|Continuing Treatment|2
2561804|NCT01354431|8861384|P1|Participants Treated|Continuing Treatment|6
2561805|NCT01354431|8861382|P3|Randomized to Enter Treatment Period|No longer met criteria|0
2561806|NCT01354431|8861383|P2|Randomized to Enter Treatment Period|No longer met criteria|0
2561807|NCT01354431|8861384|P1|Randomized to Enter Treatment Period|No longer met criteria|1
2561808|NCT01354314|8861408|P4|Overall Study|Less than 90% Adherence|4
2561809|NCT01354314|8861409|P3|Overall Study|Less than 90% Adherence|6
2561810|NCT01354314|8861410|P2|Overall Study|Less than 90% Adherence|2
2561811|NCT01354314|8861411|P1|Overall Study|Less than 90% Adherence|4
2561812|NCT01354314|8861408|P4|Overall Study|Protocol Violation|0
2561813|NCT01354314|8861409|P3|Overall Study|Protocol Violation|0
2561814|NCT01354314|8861410|P2|Overall Study|Protocol Violation|1
2561815|NCT01354314|8861411|P1|Overall Study|Protocol Violation|1
2561816|NCT01354314|8861408|P4|Overall Study|Adverse Event|1
2561817|NCT01354314|8861409|P3|Overall Study|Adverse Event|0
2561818|NCT01354314|8861410|P2|Overall Study|Adverse Event|0
2561819|NCT01354314|8861411|P1|Overall Study|Adverse Event|0
2561820|NCT01354314|8861408|P4|Overall Study|Withdrawal by Subject|0
2561821|NCT01354314|8861409|P3|Overall Study|Withdrawal by Subject|1
2561822|NCT01354314|8861410|P2|Overall Study|Withdrawal by Subject|0
2561823|NCT01354314|8861411|P1|Overall Study|Withdrawal by Subject|0
2561824|NCT01354314|8861408|P4|Overall Study|Lost to Follow-up|1
2561825|NCT01354314|8861409|P3|Overall Study|Lost to Follow-up|1
2561826|NCT01354314|8861410|P2|Overall Study|Lost to Follow-up|0
2561827|NCT01354314|8861411|P1|Overall Study|Lost to Follow-up|1
2561828|NCT01354223|8861547|P2|Overall Study|Withdrawal by Subject|1
2561829|NCT01354223|8861548|P1|Overall Study|Withdrawal by Subject|3
2561830|NCT01354132|8861607|P2|1 Month Post Study Medication|Withdrawal by Subject|3
2561831|NCT01354132|8861608|P1|1 Month Post Study Medication|Withdrawal by Subject|1
2561832|NCT01354132|8861607|P2|Double Blind (Visits 1-7)|Withdrawal by Subject|11
2561833|NCT01354132|8861608|P1|Double Blind (Visits 1-7)|Withdrawal by Subject|8
2561834|NCT01354132|8861607|P2|Double Blind (Visits 1-7)|Adverse Event|0
2561835|NCT01354132|8861608|P1|Double Blind (Visits 1-7)|Adverse Event|1
2561836|NCT01354132|8861607|P2|Randomization|Withdrawal by Subject|1
2561837|NCT01354132|8861608|P1|Randomization|Withdrawal by Subject|0
2561838|NCT01354132|8861607|P2|Randomization|Physician Decision|0
2561839|NCT01354132|8861608|P1|Randomization|Physician Decision|1
2561840|NCT01354106|8861646|P1|Overall Study|Withdrawal by Subject|2
2561841|NCT01354028|8861652|P2|Overall Study|No quiet alert state|1
2561842|NCT01354028|8861653|P1|Overall Study|No quiet alert state|0
2561843|NCT01354028|8861652|P2|Overall Study|Discharged before study start|2
2561844|NCT01354028|8861653|P1|Overall Study|Discharged before study start|2
2561845|NCT01354028|8861652|P2|Overall Study|Physician Decision|2
2561846|NCT01354028|8861653|P1|Overall Study|Physician Decision|0
2561847|NCT01353963|8861689|P1|Overall Study|Adverse Event|2
2561848|NCT01353911|8861707|P8|Overall Study|Status Not Recorded|0
2561849|NCT01353911|8861708|P7|Overall Study|Status Not Recorded|0
2561850|NCT01353911|8861709|P6|Overall Study|Status Not Recorded|0
2561851|NCT01353911|8861710|P5|Overall Study|Status Not Recorded|0
2561852|NCT01353911|8861711|P4|Overall Study|Status Not Recorded|0
2561853|NCT01353911|8861712|P3|Overall Study|Status Not Recorded|1
2561854|NCT01353911|8861713|P2|Overall Study|Status Not Recorded|0
2561855|NCT01353911|8861714|P1|Overall Study|Status Not Recorded|4
2561856|NCT01353911|8861707|P8|Overall Study|Withdrawal by Subject|9
2561857|NCT01353911|8861708|P7|Overall Study|Withdrawal by Subject|3
2561858|NCT01353911|8861709|P6|Overall Study|Withdrawal by Subject|3
2561859|NCT01353911|8861710|P5|Overall Study|Withdrawal by Subject|2
2561860|NCT01353911|8861711|P4|Overall Study|Withdrawal by Subject|2
2561861|NCT01353911|8861712|P3|Overall Study|Withdrawal by Subject|4
2561862|NCT01353911|8861713|P2|Overall Study|Withdrawal by Subject|3
2561863|NCT01353911|8861714|P1|Overall Study|Withdrawal by Subject|2
2561864|NCT01353911|8861707|P8|Overall Study|Lost to Follow-up|6
2561865|NCT01353911|8861708|P7|Overall Study|Lost to Follow-up|3
2561866|NCT01353911|8861709|P6|Overall Study|Lost to Follow-up|4
2561867|NCT01353911|8861710|P5|Overall Study|Lost to Follow-up|4
2561868|NCT01353911|8861711|P4|Overall Study|Lost to Follow-up|0
2561869|NCT01353911|8861712|P3|Overall Study|Lost to Follow-up|4
2561870|NCT01353911|8861713|P2|Overall Study|Lost to Follow-up|6
2561871|NCT01353911|8861714|P1|Overall Study|Lost to Follow-up|2
2561872|NCT01353898|8861794|P6|Overall Study|Study site terminated|1
2561873|NCT01353898|8861795|P5|Overall Study|Study site terminated|0
2561874|NCT01353898|8861796|P4|Overall Study|Study site terminated|0
2561875|NCT01353898|8861797|P3|Overall Study|Study site terminated|0
2561876|NCT01353898|8861798|P2|Overall Study|Study site terminated|0
2561877|NCT01353898|8861799|P1|Overall Study|Study site terminated|0
2561878|NCT01353859|8861825|P1|Overall Study|Lack of Efficacy|1
2561879|NCT01353859|8861825|P1|Overall Study|Adverse Event|3
2561880|NCT01353703|8861840|P2|Overall Study|Migrated/moved from study area|0
2561881|NCT01353703|8861841|P1|Overall Study|Migrated/moved from study area|1
2561882|NCT01353664|8861887|P1|Overall Study|Disease Progression|16
2561883|NCT01353664|8861887|P1|Overall Study|Other|3
2561884|NCT01353586|8861893|P2|Overall Study|Neurological exam not done|1
2561885|NCT01353586|8861894|P1|Overall Study|Neurological exam not done|0
2561886|NCT01353586|8861893|P2|Overall Study|Never had insertion of study catheter|1
2561887|NCT01353586|8861894|P1|Overall Study|Never had insertion of study catheter|4
2561888|NCT01353586|8861893|P2|Overall Study|Procedure terminated prior to ablation|0
2561889|NCT01353586|8861894|P1|Overall Study|Procedure terminated prior to ablation|3
2561890|NCT01353508|8861912|P4|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
2561891|NCT01353508|8861913|P3|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
2561892|NCT01353508|8861914|P2|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
2561893|NCT01353508|8861915|P1|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1
2561894|NCT01353508|8861912|P4|Period 1 - First Intervention (7 Days)|Adverse Event|1
2561895|NCT01353508|8861913|P3|Period 1 - First Intervention (7 Days)|Adverse Event|0
2561896|NCT01353508|8861914|P2|Period 1 - First Intervention (7 Days)|Adverse Event|0
2561897|NCT01353508|8861915|P1|Period 1 - First Intervention (7 Days)|Adverse Event|0
2561898|NCT01353274|8861993|P1|Overall Study|No case report form (CRF) collected|28
2561899|NCT01353222|8862003|P2|Overall Study|Site closed research department|0
2561900|NCT01353222|8862004|P1|Overall Study|Site closed research department|1
2561901|NCT01353222|8862003|P2|Overall Study|Study Terminated|37
2561902|NCT01353222|8862004|P1|Overall Study|Study Terminated|31
2561903|NCT01353222|8862003|P2|Overall Study|Withdrawal by Subject|5
2561904|NCT01353222|8862004|P1|Overall Study|Withdrawal by Subject|8
2561905|NCT01353222|8862003|P2|Overall Study|Death|30
2561906|NCT01353222|8862004|P1|Overall Study|Death|30
2561907|NCT01352845|8862047|P2|Overall Study|Death|0
2561908|NCT01352845|8862048|P1|Overall Study|Death|3
2561909|NCT01352845|8862047|P2|Overall Study|Protocol Violation|6
2561910|NCT01352845|8862048|P1|Overall Study|Protocol Violation|12
2561911|NCT01352845|8862047|P2|Overall Study|Other|7
2561912|NCT01352845|8862048|P1|Overall Study|Other|17
2561913|NCT01352845|8862047|P2|Overall Study|Adverse Event|6
2561914|NCT01352845|8862048|P1|Overall Study|Adverse Event|22
2561915|NCT01352845|8862047|P2|Overall Study|Pregnancy|7
2561916|NCT01352845|8862048|P1|Overall Study|Pregnancy|27
2561917|NCT01352845|8862047|P2|Overall Study|No Longer Meets Eligibility Criteria|11
2561918|NCT01352845|8862048|P1|Overall Study|No Longer Meets Eligibility Criteria|24
2561919|NCT01352845|8862047|P2|Overall Study|Withdrawal by Subject|16
2561920|NCT01352845|8862048|P1|Overall Study|Withdrawal by Subject|48
2561921|NCT01352845|8862047|P2|Overall Study|No Longer Willing to Participate|58
2561922|NCT01352845|8862048|P1|Overall Study|No Longer Willing to Participate|205
2561923|NCT01352845|8862047|P2|Overall Study|Lost to Follow-up|92
2561924|NCT01352845|8862048|P1|Overall Study|Lost to Follow-up|313
2561925|NCT01352793|8862137|P2|Overall Study|No longer meets eligibility criteria|15
2561926|NCT01352793|8862138|P1|Overall Study|No longer meets eligibility criteria|25
2561927|NCT01352793|8862137|P2|Overall Study|Randomized but not vaccinated|0
2561928|NCT01352793|8862138|P1|Overall Study|Randomized but not vaccinated|8
2561929|NCT01352793|8862137|P2|Overall Study|Death|0
2561930|NCT01352793|8862138|P1|Overall Study|Death|1
2561931|NCT01352793|8862137|P2|Overall Study|Medication error|2
2561932|NCT01352793|8862138|P1|Overall Study|Medication error|2
2561933|NCT01352793|8862137|P2|Overall Study|Other|7
2561934|NCT01352793|8862138|P1|Overall Study|Other|25
2561935|NCT01352793|8862137|P2|Overall Study|Pregnancy|8
2561936|NCT01352793|8862138|P1|Overall Study|Pregnancy|26
2561937|NCT01352793|8862137|P2|Overall Study|Physician Decision|0
2561938|NCT01352793|8862138|P1|Overall Study|Physician Decision|1
2561939|NCT01352793|8862137|P2|Overall Study|Adverse Event|10
2561940|NCT01352793|8862138|P1|Overall Study|Adverse Event|44
2561941|NCT01352793|8862137|P2|Overall Study|Protocol Violation|23
2561942|NCT01352793|8862138|P1|Overall Study|Protocol Violation|44
2561943|NCT01352793|8862137|P2|Overall Study|Withdrawal by Subject|55
2561944|NCT01352793|8862138|P1|Overall Study|Withdrawal by Subject|120
2561945|NCT01352793|8862137|P2|Overall Study|Lost to Follow-up|125
2561946|NCT01352793|8862138|P1|Overall Study|Lost to Follow-up|289
2561947|NCT01352741|8862162|P2|Open-Label Tapentadol Continuation Arm|Protocol Violation|0
2561948|NCT01352741|8862163|P1|Open-Label Tapentadol Continuation Arm|Protocol Violation|1
2561949|NCT01352741|8862162|P2|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0
2561950|NCT01352741|8862163|P1|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2
2561951|NCT01352741|8862162|P2|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0
2561952|NCT01352741|8862163|P1|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1
2561953|NCT01352741|8862162|P2|Open-Label Tapentadol Continuation Arm|Adverse Event|0
2561954|NCT01352741|8862163|P1|Open-Label Tapentadol Continuation Arm|Adverse Event|4
2561955|NCT01352741|8862162|P2|Double-blind Comparative Period|Other|2
2561956|NCT01352741|8862163|P1|Double-blind Comparative Period|Other|1
2561957|NCT01352741|8862162|P2|Double-blind Comparative Period|Withdrawal of consent|3
2561958|NCT01352741|8862163|P1|Double-blind Comparative Period|Withdrawal of consent|8
2561959|NCT01352741|8862162|P2|Double-blind Comparative Period|Death|1
2561960|NCT01352741|8862163|P1|Double-blind Comparative Period|Death|0
2561961|NCT01352741|8862162|P2|Double-blind Comparative Period|Lost to Follow-up|0
2561962|NCT01352741|8862163|P1|Double-blind Comparative Period|Lost to Follow-up|1
2561963|NCT01352741|8862162|P2|Double-blind Comparative Period|Adverse Event|17
2561964|NCT01352741|8862163|P1|Double-blind Comparative Period|Adverse Event|16
2561965|NCT01352741|8862162|P2|Double-blind Comparative Period|Lack of Efficacy|3
2561966|NCT01352741|8862163|P1|Double-blind Comparative Period|Lack of Efficacy|0
2561967|NCT01352741|8862162|P2|Double-blind Comparative Period|Protocol Violation|0
2561968|NCT01352741|8862163|P1|Double-blind Comparative Period|Protocol Violation|2
2561969|NCT01352741|8862162|P2|Open-label Tapentadol Titration Period|Other|0
2561970|NCT01352741|8862163|P1|Open-label Tapentadol Titration Period|Other|4
2561971|NCT01352741|8862162|P2|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0
2561972|NCT01352741|8862163|P1|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5
2561973|NCT01352741|8862162|P2|Open-label Tapentadol Titration Period|Withdrawal of consent|0
2561974|NCT01352741|8862163|P1|Open-label Tapentadol Titration Period|Withdrawal of consent|7
2561975|NCT01352741|8862162|P2|Open-label Tapentadol Titration Period|Adverse Event|0
2561976|NCT01352741|8862163|P1|Open-label Tapentadol Titration Period|Adverse Event|34
2561977|NCT01352741|8862162|P2|Open-label Tapentadol Titration Period|Lack of Efficacy|0
2561978|NCT01352741|8862163|P1|Open-label Tapentadol Titration Period|Lack of Efficacy|19
2561979|NCT01352741|8862162|P2|Open-label Tapentadol Titration Period|Protocol Violation|0
2561980|NCT01352741|8862163|P1|Open-label Tapentadol Titration Period|Protocol Violation|4
2561981|NCT01352715|8862257|P2|Overall Study|major ineligibility|1
2561982|NCT01352715|8862258|P1|Overall Study|major ineligibility|2
2561983|NCT01352715|8862257|P2|Overall Study|no final visit in closeout period|12
2561984|NCT01352715|8862258|P1|Overall Study|no final visit in closeout period|15
2561985|NCT01352715|8862257|P2|Overall Study|site closure|15
2561986|NCT01352715|8862258|P1|Overall Study|site closure|16
2561987|NCT01352715|8862257|P2|Overall Study|Withdrawal by Subject|8
2561988|NCT01352715|8862258|P1|Overall Study|Withdrawal by Subject|4
2561989|NCT01352715|8862257|P2|Overall Study|Lost to Follow-up|7
2561990|NCT01352715|8862258|P1|Overall Study|Lost to Follow-up|5
2561991|NCT01352715|8862257|P2|Overall Study|Death|3
2561992|NCT01352715|8862258|P1|Overall Study|Death|3
2561993|NCT01352585|8862297|P1|Overall Study|Other|7
2561994|NCT01352585|8862297|P1|Overall Study|Lost to Follow-up|1
2561995|NCT01352585|8862297|P1|Overall Study|Adverse Event|3
2561996|NCT01352507|8862314|P2|Treatment Period 2|Lack of Efficacy|0
2561997|NCT01352507|8862315|P1|Treatment Period 2|Lack of Efficacy|1
2561998|NCT01352507|8862314|P2|Treatment Period 2|Withdrawal by Subject|3
2561999|NCT01352507|8862315|P1|Treatment Period 2|Withdrawal by Subject|4
2562000|NCT01352507|8862314|P2|Treatment Period 2|Entry Criteria Not Met|0
2562001|NCT01352507|8862315|P1|Treatment Period 2|Entry Criteria Not Met|1
2562002|NCT01352507|8862314|P2|Washout Period|Withdrawal by Subject|1
2562003|NCT01352507|8862315|P1|Washout Period|Withdrawal by Subject|0
2562004|NCT01352507|8862314|P2|Treatment Period 1|Physician Decision|0
2562005|NCT01352507|8862315|P1|Treatment Period 1|Physician Decision|1
2562006|NCT01352507|8862314|P2|Treatment Period 1|Withdrawal by Subject|5
2562007|NCT01352507|8862315|P1|Treatment Period 1|Withdrawal by Subject|7
2562008|NCT01352507|8862314|P2|Treatment Period 1|Lost to Follow-up|4
2562009|NCT01352507|8862315|P1|Treatment Period 1|Lost to Follow-up|3
2562010|NCT01352507|8862314|P2|Treatment Period 1|Adverse Event|0
2562011|NCT01352507|8862315|P1|Treatment Period 1|Adverse Event|3
2562012|NCT01352416|8862368|P4|Overall Study|Physician Decision|1
2562013|NCT01352416|8862369|P3|Overall Study|Physician Decision|2
2562014|NCT01352416|8862370|P2|Overall Study|Physician Decision|2
2562015|NCT01352416|8862371|P1|Overall Study|Physician Decision|1
2562016|NCT01352221|8862393|P4|Open-label Phase|Worsening of IBD|0
2562017|NCT01352221|8862394|P3|Open-label Phase|Worsening of IBD|1
2562018|NCT01352221|8862395|P2|Open-label Phase|Worsening of IBD|0
2562019|NCT01352221|8862396|P1|Open-label Phase|Worsening of IBD|0
2562020|NCT01352221|8862393|P4|Open-label Phase|Withdrawal by Subject|6
2562021|NCT01352221|8862394|P3|Open-label Phase|Withdrawal by Subject|1
2562022|NCT01352221|8862395|P2|Open-label Phase|Withdrawal by Subject|0
2562023|NCT01352221|8862396|P1|Open-label Phase|Withdrawal by Subject|0
2562024|NCT01352221|8862393|P4|Open-label Phase|Adverse Event|4
2562025|NCT01352221|8862394|P3|Open-label Phase|Adverse Event|8
2562026|NCT01352221|8862395|P2|Open-label Phase|Adverse Event|0
2562027|NCT01352221|8862396|P1|Open-label Phase|Adverse Event|0
2562028|NCT01352221|8862393|P4|Open-label Phase|Pregnancy|0
2562029|NCT01352221|8862394|P3|Open-label Phase|Pregnancy|1
2562030|NCT01352221|8862395|P2|Open-label Phase|Pregnancy|0
2562031|NCT01352221|8862396|P1|Open-label Phase|Pregnancy|0
2562032|NCT01352221|8862393|P4|Open-label Phase|Physician Decision|1
2562033|NCT01352221|8862394|P3|Open-label Phase|Physician Decision|2
2562034|NCT01352221|8862395|P2|Open-label Phase|Physician Decision|0
2562035|NCT01352221|8862396|P1|Open-label Phase|Physician Decision|0
2562036|NCT01352221|8862393|P4|Double-blind Phase|Protocol Violation|0
2562037|NCT01352221|8862394|P3|Double-blind Phase|Protocol Violation|0
2562038|NCT01352221|8862395|P2|Double-blind Phase|Protocol Violation|1
2562039|NCT01352221|8862396|P1|Double-blind Phase|Protocol Violation|0
2562040|NCT01352221|8862393|P4|Double-blind Phase|Lost to Follow-up|0
2562041|NCT01352221|8862394|P3|Double-blind Phase|Lost to Follow-up|0
2562042|NCT01352221|8862395|P2|Double-blind Phase|Lost to Follow-up|1
2562043|NCT01352221|8862396|P1|Double-blind Phase|Lost to Follow-up|0
2562044|NCT01352221|8862393|P4|Double-blind Phase|Withdrawal by Subject|0
2562045|NCT01352221|8862394|P3|Double-blind Phase|Withdrawal by Subject|0
2562046|NCT01352221|8862395|P2|Double-blind Phase|Withdrawal by Subject|5
2562047|NCT01352221|8862396|P1|Double-blind Phase|Withdrawal by Subject|3
2562048|NCT01352221|8862393|P4|Double-blind Phase|Adverse Event|0
2562049|NCT01352221|8862394|P3|Double-blind Phase|Adverse Event|0
2562050|NCT01352221|8862395|P2|Double-blind Phase|Adverse Event|4
2562051|NCT01352221|8862396|P1|Double-blind Phase|Adverse Event|6
2562052|NCT01352117|8862456|P2|Overall Study|Ineligible (no KS diagnosis)|0
2562053|NCT01352117|8862457|P1|Overall Study|Ineligible (no KS diagnosis)|1
2562054|NCT01352117|8862456|P2|Overall Study|Did not initiate study treatment|0
2562055|NCT01352117|8862457|P1|Overall Study|Did not initiate study treatment|1
2562056|NCT01352117|8862456|P2|Overall Study|Non-adherent to study requirements|1
2562057|NCT01352117|8862457|P1|Overall Study|Non-adherent to study requirements|1
2562058|NCT01352117|8862456|P2|Overall Study|Lost to Follow-up|7
2562059|NCT01352117|8862457|P1|Overall Study|Lost to Follow-up|2
2562060|NCT01352117|8862456|P2|Overall Study|Withdrawal by Subject|0
2562061|NCT01352117|8862457|P1|Overall Study|Withdrawal by Subject|1
2562062|NCT01352117|8862456|P2|Overall Study|Death|16
2562063|NCT01352117|8862457|P1|Overall Study|Death|15
2562064|NCT01351623|8862520|P1|Overall Study|Death|2
2562065|NCT01351623|8862520|P1|Overall Study|Withdrawal by Subject|1
2562066|NCT01351623|8862520|P1|Overall Study|Adverse Event|4
2562067|NCT01351623|8862520|P1|Overall Study|Protocol Violation|2
2562068|NCT01351415|8862546|P2|Overall Study|Never Started|5
2562069|NCT01351415|8862547|P1|Overall Study|Never Started|5
2562070|NCT01351415|8862546|P2|Overall Study|Reason unknown|2
2562071|NCT01351415|8862547|P1|Overall Study|Reason unknown|0
2562072|NCT01351415|8862546|P2|Overall Study|Physician Decision|3
2562073|NCT01351415|8862547|P1|Overall Study|Physician Decision|2
2562074|NCT01351415|8862546|P2|Overall Study|Death|187
2562075|NCT01351415|8862547|P1|Overall Study|Death|190
2562076|NCT01351415|8862546|P2|Overall Study|Lost to Follow-up|7
2562077|NCT01351415|8862547|P1|Overall Study|Lost to Follow-up|5
2562078|NCT01351415|8862546|P2|Overall Study|Trial termination by the Sponsor|19
2562079|NCT01351415|8862547|P1|Overall Study|Trial termination by the Sponsor|28
2562080|NCT01351415|8862546|P2|Overall Study|Withdrawal by Subject|17
2562081|NCT01351415|8862547|P1|Overall Study|Withdrawal by Subject|15
2562082|NCT01351350|8862583|P5|Overall Study|Enrolled but not Treated|0
2562083|NCT01351350|8862584|P4|Overall Study|Enrolled but not Treated|0
2562084|NCT01351350|8862585|P3|Overall Study|Enrolled but not Treated|1
2562085|NCT01351350|8862586|P2|Overall Study|Enrolled but not Treated|0
2562086|NCT01351350|8862587|P1|Overall Study|Enrolled but not Treated|0
2562087|NCT01351350|8862583|P5|Overall Study|Participant Decision|2
2562088|NCT01351350|8862584|P4|Overall Study|Participant Decision|3
2562089|NCT01351350|8862585|P3|Overall Study|Participant Decision|3
2562090|NCT01351350|8862586|P2|Overall Study|Participant Decision|6
2562091|NCT01351350|8862587|P1|Overall Study|Participant Decision|2
2562092|NCT01351350|8862583|P5|Overall Study|Adverse Event|0
2562093|NCT01351350|8862584|P4|Overall Study|Adverse Event|2
2562094|NCT01351350|8862585|P3|Overall Study|Adverse Event|1
2562095|NCT01351350|8862586|P2|Overall Study|Adverse Event|10
2562096|NCT01351350|8862587|P1|Overall Study|Adverse Event|1
2562097|NCT01351350|8862583|P5|Overall Study|Disease Progression|5
2562098|NCT01351350|8862584|P4|Overall Study|Disease Progression|8
2562099|NCT01351350|8862585|P3|Overall Study|Disease Progression|6
2562100|NCT01351350|8862586|P2|Overall Study|Disease Progression|13
2562101|NCT01351350|8862587|P1|Overall Study|Disease Progression|5
2562102|NCT01351025|8862758|P2|Week 24 - 44|unable to get to clinic|1
2562103|NCT01351025|8862759|P1|Week 24 - 44|unable to get to clinic|1
2562104|NCT01351025|8862758|P2|Week 24 - 44|Site closed|1
2562105|NCT01351025|8862759|P1|Week 24 - 44|Site closed|0
2562106|NCT01351025|8862758|P2|Week 24 - 44|Lost to Follow-up|2
2562107|NCT01351025|8862759|P1|Week 24 - 44|Lost to Follow-up|0
2562108|NCT01351025|8862758|P2|Week 0 - 20|Withdrawal by Subject|0
2562109|NCT01351025|8862759|P1|Week 0 - 20|Withdrawal by Subject|1
2562110|NCT01351025|8862758|P2|Week 0 - 20|Lost to Follow-up|1
2562111|NCT01351025|8862759|P1|Week 0 - 20|Lost to Follow-up|2
2562112|NCT01350999|8862792|P3|Overall Study|Difficulty Making it to Study Visit|5
2562113|NCT01350999|8862793|P2|Overall Study|Difficulty Making it to Study Visit|1
2562114|NCT01350999|8862794|P1|Overall Study|Difficulty Making it to Study Visit|1
2562115|NCT01350999|8862792|P3|Overall Study|Voluntary withdrawal|6
2562116|NCT01350999|8862793|P2|Overall Study|Voluntary withdrawal|4
2562117|NCT01350999|8862794|P1|Overall Study|Voluntary withdrawal|3
2562118|NCT01350999|8862792|P3|Overall Study|Adverse Event|10
2562119|NCT01350999|8862793|P2|Overall Study|Adverse Event|9
2562120|NCT01350999|8862794|P1|Overall Study|Adverse Event|4
2562121|NCT01350973|8862832|P3|Overall Study|Voluntary Withdrawal|1
2562122|NCT01350973|8862833|P2|Overall Study|Voluntary Withdrawal|1
2562123|NCT01350973|8862834|P1|Overall Study|Voluntary Withdrawal|2
2562124|NCT01350973|8862832|P3|Overall Study|Adverse Event|7
2562125|NCT01350973|8862833|P2|Overall Study|Adverse Event|7
2562126|NCT01350973|8862834|P1|Overall Study|Adverse Event|4
2562127|NCT01350934|8862875|P2|Extension Study|Withdrawal by Subject|1
2562128|NCT01350934|8862876|P1|Extension Study|Withdrawal by Subject|0
2562129|NCT01350934|8862875|P2|Extension Study|Lack of Efficacy|1
2562130|NCT01350934|8862876|P1|Extension Study|Lack of Efficacy|0
2562131|NCT01350934|8862875|P2|Extension Study|Protocol Violation|1
2562132|NCT01350934|8862876|P1|Extension Study|Protocol Violation|1
2562133|NCT01350934|8862875|P2|Extension Study|Lost to Follow-up|0
2562134|NCT01350934|8862876|P1|Extension Study|Lost to Follow-up|2
2562135|NCT01350934|8862875|P2|Extension Study|Adverse Event|1
2562136|NCT01350934|8862876|P1|Extension Study|Adverse Event|2
2562137|NCT01350934|8862875|P2|Base Study|Non-Compliance With Study Drug|0
2562138|NCT01350934|8862876|P1|Base Study|Non-Compliance With Study Drug|2
2562139|NCT01350934|8862875|P2|Base Study|Withdrawal by Subject|2
2562140|NCT01350934|8862876|P1|Base Study|Withdrawal by Subject|1
2562141|NCT01350934|8862875|P2|Base Study|Protocol Violation|1
2562142|NCT01350934|8862876|P1|Base Study|Protocol Violation|1
2562143|NCT01350934|8862875|P2|Base Study|Lost to Follow-up|0
2562144|NCT01350934|8862876|P1|Base Study|Lost to Follow-up|1
2562145|NCT01350934|8862875|P2|Base Study|Adverse Event|0
2562146|NCT01350934|8862876|P1|Base Study|Adverse Event|6
2562147|NCT01350804|8862898|P4|Extension Study, Weeks 52 - 260|Adverse Event|3
2562148|NCT01350804|8862899|P3|Extension Study, Weeks 52 - 260|Adverse Event|2
2562149|NCT01350804|8862900|P2|Extension Study, Weeks 52 - 260|Adverse Event|1
2562150|NCT01350804|8862901|P1|Extension Study, Weeks 52 - 260|Adverse Event|3
2562151|NCT01350804|8862898|P4|Extension Study, Weeks 52 - 260|Lack of Efficacy|1
2562152|NCT01350804|8862899|P3|Extension Study, Weeks 52 - 260|Lack of Efficacy|0
2562153|NCT01350804|8862900|P2|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
2562154|NCT01350804|8862901|P1|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
2562155|NCT01350804|8862898|P4|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
2562156|NCT01350804|8862899|P3|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
2562157|NCT01350804|8862900|P2|Extension Study, Weeks 52 - 260|Lost to Follow-up|1
2562158|NCT01350804|8862901|P1|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
2562159|NCT01350804|8862898|P4|Extension Study, Weeks 52 - 260|Physician Decision|0
2562160|NCT01350804|8862899|P3|Extension Study, Weeks 52 - 260|Physician Decision|2
2562161|NCT01350804|8862900|P2|Extension Study, Weeks 52 - 260|Physician Decision|0
2562162|NCT01350804|8862901|P1|Extension Study, Weeks 52 - 260|Physician Decision|1
2562163|NCT01350804|8862898|P4|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16
2562164|NCT01350804|8862899|P3|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64
2562165|NCT01350804|8862900|P2|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
2562166|NCT01350804|8862901|P1|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
2562167|NCT01350804|8862898|P4|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3
2562168|NCT01350804|8862899|P3|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4
2562169|NCT01350804|8862900|P2|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6
2562170|NCT01350804|8862901|P1|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5
2562171|NCT01350804|8862898|P4|Core Study|Adverse Event|8
2562172|NCT01350804|8862899|P3|Core Study|Adverse Event|8
2562173|NCT01350804|8862900|P2|Core Study|Adverse Event|10
2562174|NCT01350804|8862901|P1|Core Study|Adverse Event|8
2562175|NCT01350804|8862898|P4|Core Study|Death|0
2562176|NCT01350804|8862899|P3|Core Study|Death|1
2562177|NCT01350804|8862900|P2|Core Study|Death|1
2562178|NCT01350804|8862901|P1|Core Study|Death|1
2562179|NCT01350804|8862898|P4|Core Study|Lack of Efficacy|5
2562180|NCT01350804|8862899|P3|Core Study|Lack of Efficacy|18
2562181|NCT01350804|8862900|P2|Core Study|Lack of Efficacy|19
2562182|NCT01350804|8862901|P1|Core Study|Lack of Efficacy|16
2562183|NCT01350804|8862898|P4|Core Study|Lost to Follow-up|1
2562184|NCT01350804|8862899|P3|Core Study|Lost to Follow-up|2
2562185|NCT01350804|8862900|P2|Core Study|Lost to Follow-up|0
2562186|NCT01350804|8862901|P1|Core Study|Lost to Follow-up|3
2562187|NCT01350804|8862898|P4|Core Study|Physician Decision|3
2562188|NCT01350804|8862899|P3|Core Study|Physician Decision|1
2562189|NCT01350804|8862900|P2|Core Study|Physician Decision|0
2562190|NCT01350804|8862901|P1|Core Study|Physician Decision|1
2562191|NCT01350804|8862898|P4|Core Study|Protocol deviation|0
2562192|NCT01350804|8862899|P3|Core Study|Protocol deviation|1
2562193|NCT01350804|8862900|P2|Core Study|Protocol deviation|0
2562194|NCT01350804|8862901|P1|Core Study|Protocol deviation|1
2562195|NCT01350804|8862898|P4|Core Study|Study terminated by Sponsor|2
2562196|NCT01350804|8862899|P3|Core Study|Study terminated by Sponsor|0
2562197|NCT01350804|8862900|P2|Core Study|Study terminated by Sponsor|0
2562198|NCT01350804|8862901|P1|Core Study|Study terminated by Sponsor|0
2562199|NCT01350804|8862898|P4|Core Study|Withdrawal by Subject|7
2562200|NCT01350804|8862899|P3|Core Study|Withdrawal by Subject|16
2562201|NCT01350804|8862900|P2|Core Study|Withdrawal by Subject|17
2562202|NCT01350804|8862901|P1|Core Study|Withdrawal by Subject|11
2562203|NCT01350544|8862998|P2|Overall Study|Lost to Follow-up|15
2562204|NCT01350544|8862999|P1|Overall Study|Lost to Follow-up|18
2562205|NCT01350544|8862998|P2|Overall Study|Incarceration|0
2562206|NCT01350544|8862999|P1|Overall Study|Incarceration|1
2562207|NCT01350544|8862998|P2|Overall Study|Withdrawal by Subject|1
2562208|NCT01350544|8862999|P1|Overall Study|Withdrawal by Subject|0
2562209|NCT01350544|8862998|P2|Overall Study|Medical Issues|1
2562210|NCT01350544|8862999|P1|Overall Study|Medical Issues|1
2562211|NCT01350544|8862998|P2|Overall Study|Moved out of LA County|2
2562212|NCT01350544|8862999|P1|Overall Study|Moved out of LA County|2
2562213|NCT01350544|8862998|P2|Overall Study|Death|2
2562214|NCT01350544|8862999|P1|Overall Study|Death|1
2562215|NCT01350544|8862998|P2|Overall Study|Administrative Withdrawal|1
2562216|NCT01350544|8862999|P1|Overall Study|Administrative Withdrawal|0
2562217|NCT01350505|8863005|P1|Overall Study|Lost to Follow-up|4
2562218|NCT01350414|8863035|P1|Overall Study|Physician Decision|2
2562219|NCT01350414|8863035|P1|Overall Study|Withdrawal by Subject|4
2562220|NCT01350414|8863035|P1|Overall Study|Lost to Follow-up|13
2562221|NCT01350271|8863084|P3|Overall Study|Lost to Follow-up|26
2562222|NCT01350271|8863085|P2|Overall Study|Lost to Follow-up|17
2562223|NCT01350271|8863086|P1|Overall Study|Lost to Follow-up|21
2562224|NCT01350141|8863128|P3|Overall Study|Randomized but not treated|0
2562225|NCT01350141|8863129|P2|Overall Study|Randomized but not treated|0
2562226|NCT01350141|8863130|P1|Overall Study|Randomized but not treated|1
2562227|NCT01350141|8863128|P3|Overall Study|Withdrawal by Subject|0
2562228|NCT01350141|8863129|P2|Overall Study|Withdrawal by Subject|0
2562229|NCT01350141|8863130|P1|Overall Study|Withdrawal by Subject|1
2562230|NCT01350141|8863128|P3|Overall Study|Lost to Follow-up|1
2562231|NCT01350141|8863129|P2|Overall Study|Lost to Follow-up|0
2562232|NCT01350141|8863130|P1|Overall Study|Lost to Follow-up|1
2562233|NCT01350128|8863164|P1|Overall Study|Lost to Follow-up|2
2562234|NCT01350128|8863164|P1|Overall Study|Physician Decision|1
2562235|NCT01350128|8863164|P1|Overall Study|Protocol discontinuation criteria|8
2562236|NCT01350128|8863164|P1|Overall Study|Withdrawal by Subject|3
2562237|NCT01350115|8863228|P2|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0
2562238|NCT01350115|8863229|P1|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1
2562239|NCT01350115|8863228|P2|Long Term Follow-Up (All Patients)|Adverse Event|1
2562240|NCT01350115|8863229|P1|Long Term Follow-Up (All Patients)|Adverse Event|0
2562241|NCT01350115|8863228|P2|Long Term Follow-Up (All Patients)|Lost to Follow-up|1
2562242|NCT01350115|8863229|P1|Long Term Follow-Up (All Patients)|Lost to Follow-up|0
2562243|NCT01350102|8863245|P4|Overall Study|Adverse Event|0
2562244|NCT01350102|8863246|P3|Overall Study|Adverse Event|1
2562245|NCT01350102|8863247|P2|Overall Study|Adverse Event|0
2562246|NCT01350102|8863248|P1|Overall Study|Adverse Event|0
2562247|NCT01349959|8863285|P1|Overall Study|Adverse Event|7
2562248|NCT01349907|8863326|P2|Overall Study|Administrative|1
2562249|NCT01349907|8863327|P1|Overall Study|Administrative|1
2562250|NCT01349907|8863326|P2|Overall Study|Protocol Violation|13
2562251|NCT01349907|8863327|P1|Overall Study|Protocol Violation|33
2562252|NCT01349907|8863326|P2|Overall Study|Withdrawal by Subject|8
2562253|NCT01349907|8863327|P1|Overall Study|Withdrawal by Subject|30
2562254|NCT01349907|8863326|P2|Overall Study|Lost to Follow-up|6
2562255|NCT01349907|8863327|P1|Overall Study|Lost to Follow-up|25
2562256|NCT01349907|8863326|P2|Overall Study|Treatment failure|4
2562257|NCT01349907|8863327|P1|Overall Study|Treatment failure|13
2562258|NCT01349907|8863326|P2|Overall Study|Adverse Event|11
2562259|NCT01349907|8863327|P1|Overall Study|Adverse Event|37
2562260|NCT01349829|8863365|P2|Overall Study|Migrated/moved|7
2562261|NCT01349829|8863366|P1|Overall Study|Migrated/moved|2
2562262|NCT01349829|8863365|P2|Overall Study|Consent withdrawal|8
2562263|NCT01349829|8863366|P1|Overall Study|Consent withdrawal|3
2562264|NCT01349829|8863365|P2|Overall Study|Lost to Follow-up|8
2562265|NCT01349829|8863366|P1|Overall Study|Lost to Follow-up|4
2562266|NCT01349816|8863384|P1|Overall Study|Protocol-specified criteria|8
2562267|NCT01349816|8863384|P1|Overall Study|Protocol Violation|1
2562268|NCT01349816|8863384|P1|Overall Study|Lost to Follow-up|2
2562269|NCT01349816|8863384|P1|Overall Study|Adverse Event|14
2562270|NCT01349816|8863384|P1|Overall Study|Physician Decision|1
2562271|NCT01349816|8863384|P1|Overall Study|Withdrawal by Subject|4
2562272|NCT01349803|8863450|P4|Overall Study|Protocol-specified criteria|0
2562273|NCT01349803|8863451|P3|Overall Study|Protocol-specified criteria|3
2562274|NCT01349803|8863452|P2|Overall Study|Protocol-specified criteria|1
2562275|NCT01349803|8863453|P1|Overall Study|Protocol-specified criteria|0
2562276|NCT01349803|8863450|P4|Overall Study|Withdrawal by Subject|0
2562277|NCT01349803|8863451|P3|Overall Study|Withdrawal by Subject|0
2562278|NCT01349803|8863452|P2|Overall Study|Withdrawal by Subject|0
2562279|NCT01349803|8863453|P1|Overall Study|Withdrawal by Subject|1
2562280|NCT01349803|8863450|P4|Overall Study|Adverse Event|2
2562281|NCT01349803|8863451|P3|Overall Study|Adverse Event|0
2562282|NCT01349803|8863452|P2|Overall Study|Adverse Event|0
2562283|NCT01349803|8863453|P1|Overall Study|Adverse Event|0
2562284|NCT01349790|8863523|P1|Overall Study|Lost to Follow-up|1
2562285|NCT01349790|8863523|P1|Overall Study|Adverse Event|1
2562286|NCT01349790|8863523|P1|Overall Study|Withdrawal by Patient|2
2562287|NCT01349790|8863523|P1|Overall Study|Death|2
2562288|NCT01349790|8863523|P1|Overall Study|Investigator Judgement|3
2562289|NCT01349673|8863542|P1|Overall Study|Lack of Efficacy|8
2562290|NCT01349673|8863542|P1|Overall Study|Study Terminated By Sponsor|50
2562291|NCT01349673|8863542|P1|Overall Study|Adverse Event|17
2562292|NCT01349673|8863542|P1|Overall Study|Lost to Follow-up|6
2562293|NCT01349673|8863542|P1|Overall Study|Withdrawal by Subject|21
2562294|NCT01349673|8863542|P1|Overall Study|Site Closure|10
2562295|NCT01349673|8863542|P1|Overall Study|No Longer Qualified For Study|1
2562296|NCT01349673|8863542|P1|Overall Study|Progression Of Disease Past 40 cm|1
2562297|NCT01349660|8863552|P3|Overall Study|Declining Performance Status|1
2562298|NCT01349660|8863553|P2|Overall Study|Declining Performance Status|0
2562299|NCT01349660|8863554|P1|Overall Study|Declining Performance Status|0
2562300|NCT01349660|8863552|P3|Overall Study|Study Compliance|1
2562301|NCT01349660|8863553|P2|Overall Study|Study Compliance|0
2562302|NCT01349660|8863554|P1|Overall Study|Study Compliance|0
2562303|NCT01349660|8863552|P3|Overall Study|Non-Permitted Interventions|2
2562304|NCT01349660|8863553|P2|Overall Study|Non-Permitted Interventions|0
2562305|NCT01349660|8863554|P1|Overall Study|Non-Permitted Interventions|0
2562306|NCT01349660|8863552|P3|Overall Study|Death|0
2562307|NCT01349660|8863553|P2|Overall Study|Death|1
2562308|NCT01349660|8863554|P1|Overall Study|Death|1
2562309|NCT01349660|8863552|P3|Overall Study|Withdrawal by Subject|9
2562310|NCT01349660|8863553|P2|Overall Study|Withdrawal by Subject|0
2562311|NCT01349660|8863554|P1|Overall Study|Withdrawal by Subject|2
2562312|NCT01349660|8863552|P3|Overall Study|Adverse Event|12
2562313|NCT01349660|8863553|P2|Overall Study|Adverse Event|1
2562314|NCT01349660|8863554|P1|Overall Study|Adverse Event|1
2562315|NCT01349660|8863552|P3|Overall Study|Disease Progression|50
2562316|NCT01349660|8863553|P2|Overall Study|Disease Progression|4
2562317|NCT01349660|8863554|P1|Overall Study|Disease Progression|2
2562318|NCT01349660|8863552|P3|Overall Study|Still Receiving Study Treatment|1
2562319|NCT01349660|8863553|P2|Overall Study|Still Receiving Study Treatment|0
2562320|NCT01349660|8863554|P1|Overall Study|Still Receiving Study Treatment|0
2562321|NCT01349595|8863572|P2|Overall Study|Lack of funding|2
2562322|NCT01349595|8863573|P1|Overall Study|Lack of funding|2
2562323|NCT01349569|8863579|P1|Overall Study|Lack of Efficacy|4
2562324|NCT01349465|8863600|P2|Overall Study|Subject Ineligible To Continue The Trial|19
2562325|NCT01349465|8863601|P1|Overall Study|Subject Ineligible To Continue The Trial|0
2562326|NCT01349465|8863600|P2|Overall Study|Withdrawal by Subject|2
2562327|NCT01349465|8863601|P1|Overall Study|Withdrawal by Subject|4
2562328|NCT01349465|8863600|P2|Overall Study|Lost to Follow-up|1
2562329|NCT01349465|8863601|P1|Overall Study|Lost to Follow-up|10
2562330|NCT01349465|8863600|P2|Overall Study|Death|0
2562331|NCT01349465|8863601|P1|Overall Study|Death|3
2562332|NCT01349465|8863600|P2|Overall Study|Adverse Event|0
2562333|NCT01349465|8863601|P1|Overall Study|Adverse Event|1
2562334|NCT01349192|8863622|P2|Overall Study|Failure to adhere to Protocol|0
2562335|NCT01349192|8863623|P1|Overall Study|Failure to adhere to Protocol|2
2562336|NCT01349192|8863622|P2|Overall Study|Lost to Follow-up|3
2562337|NCT01349192|8863623|P1|Overall Study|Lost to Follow-up|1
2562338|NCT01349192|8863622|P2|Overall Study|Withdrawal by Subject|2
2562339|NCT01349192|8863623|P1|Overall Study|Withdrawal by Subject|0
2562340|NCT01349192|8863622|P2|Overall Study|Protocol Violation|1
2562341|NCT01349192|8863623|P1|Overall Study|Protocol Violation|0
2562342|NCT01349049|8863655|P9|Overall Study|Withdrawal by Subject|6
2562343|NCT01349049|8863656|P8|Overall Study|Withdrawal by Subject|0
2562344|NCT01349049|8863657|P7|Overall Study|Withdrawal by Subject|0
2562345|NCT01349049|8863658|P6|Overall Study|Withdrawal by Subject|0
2562346|NCT01349049|8863659|P5|Overall Study|Withdrawal by Subject|0
2562347|NCT01349049|8863660|P4|Overall Study|Withdrawal by Subject|0
2562348|NCT01349049|8863661|P3|Overall Study|Withdrawal by Subject|0
2562349|NCT01349049|8863662|P2|Overall Study|Withdrawal by Subject|0
2562350|NCT01349049|8863663|P1|Overall Study|Withdrawal by Subject|0
2562351|NCT01349049|8863655|P9|Overall Study|Non-compliance|0
2562352|NCT01349049|8863656|P8|Overall Study|Non-compliance|0
2562353|NCT01349049|8863657|P7|Overall Study|Non-compliance|0
2562354|NCT01349049|8863658|P6|Overall Study|Non-compliance|0
2562355|NCT01349049|8863659|P5|Overall Study|Non-compliance|0
2562356|NCT01349049|8863660|P4|Overall Study|Non-compliance|1
2562357|NCT01349049|8863661|P3|Overall Study|Non-compliance|0
2562358|NCT01349049|8863662|P2|Overall Study|Non-compliance|0
2562359|NCT01349049|8863663|P1|Overall Study|Non-compliance|0
2562360|NCT01349049|8863655|P9|Overall Study|Death|5
2562361|NCT01349049|8863656|P8|Overall Study|Death|1
2562362|NCT01349049|8863657|P7|Overall Study|Death|0
2562363|NCT01349049|8863658|P6|Overall Study|Death|0
2562364|NCT01349049|8863659|P5|Overall Study|Death|0
2562365|NCT01349049|8863660|P4|Overall Study|Death|0
2562366|NCT01349049|8863661|P3|Overall Study|Death|0
2562367|NCT01349049|8863662|P2|Overall Study|Death|0
2562368|NCT01349049|8863663|P1|Overall Study|Death|0
2562369|NCT01349049|8863655|P9|Overall Study|Other|4
2562370|NCT01349049|8863656|P8|Overall Study|Other|0
2562371|NCT01349049|8863657|P7|Overall Study|Other|0
2562372|NCT01349049|8863658|P6|Overall Study|Other|1
2562373|NCT01349049|8863659|P5|Overall Study|Other|0
2562374|NCT01349049|8863660|P4|Overall Study|Other|0
2562375|NCT01349049|8863661|P3|Overall Study|Other|0
2562376|NCT01349049|8863662|P2|Overall Study|Other|0
2562377|NCT01349049|8863663|P1|Overall Study|Other|0
2562378|NCT01349049|8863655|P9|Overall Study|Hematopoietic stem cell transplant|0
2562379|NCT01349049|8863656|P8|Overall Study|Hematopoietic stem cell transplant|1
2562380|NCT01349049|8863657|P7|Overall Study|Hematopoietic stem cell transplant|1
2562381|NCT01349049|8863658|P6|Overall Study|Hematopoietic stem cell transplant|0
2562382|NCT01349049|8863659|P5|Overall Study|Hematopoietic stem cell transplant|1
2562383|NCT01349049|8863660|P4|Overall Study|Hematopoietic stem cell transplant|0
2562384|NCT01349049|8863661|P3|Overall Study|Hematopoietic stem cell transplant|0
2562385|NCT01349049|8863662|P2|Overall Study|Hematopoietic stem cell transplant|0
2562386|NCT01349049|8863663|P1|Overall Study|Hematopoietic stem cell transplant|0
2562387|NCT01349049|8863655|P9|Overall Study|Protocol Violation|1
2562388|NCT01349049|8863656|P8|Overall Study|Protocol Violation|0
2562389|NCT01349049|8863657|P7|Overall Study|Protocol Violation|0
2562390|NCT01349049|8863658|P6|Overall Study|Protocol Violation|0
2562391|NCT01349049|8863659|P5|Overall Study|Protocol Violation|0
2562392|NCT01349049|8863660|P4|Overall Study|Protocol Violation|0
2562393|NCT01349049|8863661|P3|Overall Study|Protocol Violation|0
2562394|NCT01349049|8863662|P2|Overall Study|Protocol Violation|0
2562395|NCT01349049|8863663|P1|Overall Study|Protocol Violation|0
2562396|NCT01349049|8863655|P9|Overall Study|Physician Decision|2
2562397|NCT01349049|8863656|P8|Overall Study|Physician Decision|0
2562398|NCT01349049|8863657|P7|Overall Study|Physician Decision|0
2562399|NCT01349049|8863658|P6|Overall Study|Physician Decision|0
2562400|NCT01349049|8863659|P5|Overall Study|Physician Decision|0
2562401|NCT01349049|8863660|P4|Overall Study|Physician Decision|0
2562402|NCT01349049|8863661|P3|Overall Study|Physician Decision|0
2562403|NCT01349049|8863662|P2|Overall Study|Physician Decision|1
2562404|NCT01349049|8863663|P1|Overall Study|Physician Decision|0
2562405|NCT01349049|8863655|P9|Overall Study|Adverse Event|4
2562406|NCT01349049|8863656|P8|Overall Study|Adverse Event|0
2562407|NCT01349049|8863657|P7|Overall Study|Adverse Event|1
2562408|NCT01349049|8863658|P6|Overall Study|Adverse Event|3
2562409|NCT01349049|8863659|P5|Overall Study|Adverse Event|0
2562410|NCT01349049|8863660|P4|Overall Study|Adverse Event|0
2562411|NCT01349049|8863661|P3|Overall Study|Adverse Event|0
2562412|NCT01349049|8863662|P2|Overall Study|Adverse Event|1
2562413|NCT01349049|8863663|P1|Overall Study|Adverse Event|0
2562414|NCT01349049|8863655|P9|Overall Study|Disease progression|33
2562415|NCT01349049|8863656|P8|Overall Study|Disease progression|2
2562416|NCT01349049|8863657|P7|Overall Study|Disease progression|3
2562417|NCT01349049|8863658|P6|Overall Study|Disease progression|2
2562418|NCT01349049|8863659|P5|Overall Study|Disease progression|2
2562419|NCT01349049|8863660|P4|Overall Study|Disease progression|2
2562420|NCT01349049|8863661|P3|Overall Study|Disease progression|3
2562421|NCT01349049|8863662|P2|Overall Study|Disease progression|5
2562422|NCT01349049|8863663|P1|Overall Study|Disease progression|3
2562423|NCT01349036|8863717|P2|Overall Study|Withdrawal by Subject|2
2562424|NCT01349036|8863718|P1|Overall Study|Withdrawal by Subject|0
2562425|NCT01349036|8863717|P2|Overall Study|Other|0
2562426|NCT01349036|8863718|P1|Overall Study|Other|1
2562427|NCT01349036|8863717|P2|Overall Study|Disease progression|22
2562428|NCT01349036|8863718|P1|Overall Study|Disease progression|13
2562429|NCT01348854|8863736|P2|Overall Study|Withdrawal by Subject|0
2562430|NCT01348854|8863737|P1|Overall Study|Withdrawal by Subject|1
2562431|NCT01348854|8863736|P2|Overall Study|Lost to Follow-up|1
2562432|NCT01348854|8863737|P1|Overall Study|Lost to Follow-up|2
2562433|NCT01348789|8863745|P1|Overall Study|Withdrawal by Subject|2
2562434|NCT01348789|8863745|P1|Overall Study|Protocol Violation|2
2562435|NCT01348776|8863756|P1|Overall Study|Lost to Follow-up|3
2562436|NCT01348763|8863769|P1|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1
2562437|NCT01348763|8863769|P1|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1
2562438|NCT01348698|8863774|P1|Overall Study|PI decision to close study|68
2562439|NCT01348698|8863774|P1|Overall Study|Death|3
2562440|NCT01348698|8863774|P1|Overall Study|Does not meet lesion size criteria|1
2562441|NCT01348542|8863799|P2|Overall Study|Withdrawal by Subject|0
2562442|NCT01348542|8863800|P1|Overall Study|Withdrawal by Subject|3
2562443|NCT01348490|8863816|P1|Overall Study|Other Unspecified|8
2562444|NCT01348490|8863816|P1|Overall Study|Termination of clinical trial by sponsor|1
2562445|NCT01348490|8863816|P1|Overall Study|Lost to Follow-up|1
2562446|NCT01348490|8863816|P1|Overall Study|Disease progression|3
2562447|NCT01348490|8863816|P1|Overall Study|Consent withdrawn|7
2562448|NCT01348490|8863816|P1|Overall Study|Adverse Event|3
2562449|NCT01348490|8863816|P1|Overall Study|Death|1
2562450|NCT01348425|8863874|P2|Overall Study|Imaging was not taken.|1
2562451|NCT01348425|8863875|P1|Overall Study|Imaging was not taken.|1
2562452|NCT01348347|8863883|P3|Overall Study|Progressive disease|5
2562453|NCT01348347|8863884|P2|Overall Study|Progressive disease|5
2562454|NCT01348347|8863885|P1|Overall Study|Progressive disease|2
2562455|NCT01348347|8863883|P3|Overall Study|Withdrawal by Subject|1
2562456|NCT01348347|8863884|P2|Overall Study|Withdrawal by Subject|1
2562457|NCT01348347|8863885|P1|Overall Study|Withdrawal by Subject|1
2562458|NCT01348165|8863916|P7|Overall Study|Adverse Event|1
2562459|NCT01348165|8863917|P6|Overall Study|Adverse Event|0
2562460|NCT01348165|8863918|P5|Overall Study|Adverse Event|0
2562461|NCT01348165|8863919|P4|Overall Study|Adverse Event|0
2562462|NCT01348165|8863920|P3|Overall Study|Adverse Event|0
2562463|NCT01348165|8863921|P2|Overall Study|Adverse Event|0
2562464|NCT01348165|8863922|P1|Overall Study|Adverse Event|0
2562465|NCT01348139|8864051|P6|Period 1|Adverse Event|0
2562466|NCT01348139|8864052|P5|Period 1|Adverse Event|0
2562467|NCT01348139|8864053|P4|Period 1|Adverse Event|0
2562468|NCT01348139|8864054|P3|Period 1|Adverse Event|0
2562469|NCT01348139|8864055|P2|Period 1|Adverse Event|0
2562470|NCT01348139|8864056|P1|Period 1|Adverse Event|1
2562471|NCT01348100|8864137|P7|Overall Study|Administrative Problems|1
2562472|NCT01348100|8864138|P6|Overall Study|Administrative Problems|1
2562473|NCT01348100|8864139|P5|Overall Study|Administrative Problems|0
2562474|NCT01348100|8864140|P4|Overall Study|Administrative Problems|0
2562475|NCT01348100|8864141|P3|Overall Study|Administrative Problems|0
2562476|NCT01348100|8864142|P2|Overall Study|Administrative Problems|0
2562477|NCT01348100|8864143|P1|Overall Study|Administrative Problems|0
2562478|NCT01348100|8864137|P7|Overall Study|Lost to Follow-up|1
2562479|NCT01348100|8864138|P6|Overall Study|Lost to Follow-up|0
2562480|NCT01348100|8864139|P5|Overall Study|Lost to Follow-up|0
2562481|NCT01348100|8864140|P4|Overall Study|Lost to Follow-up|0
2562482|NCT01348100|8864141|P3|Overall Study|Lost to Follow-up|0
2562483|NCT01348100|8864142|P2|Overall Study|Lost to Follow-up|0
2562484|NCT01348100|8864143|P1|Overall Study|Lost to Follow-up|0
2562485|NCT01348100|8864137|P7|Overall Study|Unsatisfactory Therapeutic Effect|0
2562486|NCT01348100|8864138|P6|Overall Study|Unsatisfactory Therapeutic Effect|1
2562487|NCT01348100|8864139|P5|Overall Study|Unsatisfactory Therapeutic Effect|0
2562488|NCT01348100|8864140|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
2562489|NCT01348100|8864141|P3|Overall Study|Unsatisfactory Therapeutic Effect|0
2562490|NCT01348100|8864142|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
2562491|NCT01348100|8864143|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
2562492|NCT01348100|8864137|P7|Overall Study|Protocol Deviation|0
2562493|NCT01348100|8864138|P6|Overall Study|Protocol Deviation|0
2562494|NCT01348100|8864139|P5|Overall Study|Protocol Deviation|0
2562495|NCT01348100|8864140|P4|Overall Study|Protocol Deviation|1
2562496|NCT01348100|8864141|P3|Overall Study|Protocol Deviation|0
2562497|NCT01348100|8864142|P2|Overall Study|Protocol Deviation|0
2562498|NCT01348100|8864143|P1|Overall Study|Protocol Deviation|0
2562499|NCT01348100|8864137|P7|Overall Study|Subject Withdrew Consent|1
2562500|NCT01348100|8864138|P6|Overall Study|Subject Withdrew Consent|0
2562501|NCT01348100|8864139|P5|Overall Study|Subject Withdrew Consent|1
2562502|NCT01348100|8864140|P4|Overall Study|Subject Withdrew Consent|0
2562503|NCT01348100|8864141|P3|Overall Study|Subject Withdrew Consent|2
2562504|NCT01348100|8864142|P2|Overall Study|Subject Withdrew Consent|0
2562505|NCT01348100|8864143|P1|Overall Study|Subject Withdrew Consent|0
2562506|NCT01348087|8864188|P1|Overall Study|Adverse Event|25
2562507|NCT01348087|8864188|P1|Overall Study|Subject withdrew consent|7
2562508|NCT01348087|8864188|P1|Overall Study|Lost to Follow-up|1
2562509|NCT01348087|8864188|P1|Overall Study|protocol deviation|1
2562510|NCT01348087|8864188|P1|Overall Study|Administrative problems|79
2562511|NCT01348087|8864188|P1|Overall Study|Unsatisfactory therapeutic effect|35
2562512|NCT01347931|8864202|P1|Standard Oxygen Therapy|Withdrawal by Subject|1
2562513|NCT01347879|8864214|P2|Overall Study|Other|3
2562514|NCT01347879|8864215|P1|Overall Study|Other|2
2562515|NCT01347879|8864214|P2|Overall Study|Withdrawal by Subject|2
2562516|NCT01347879|8864215|P1|Overall Study|Withdrawal by Subject|3
2562517|NCT01347879|8864214|P2|Overall Study|Lost to Follow-up|0
2562518|NCT01347879|8864215|P1|Overall Study|Lost to Follow-up|2
2562519|NCT01347879|8864214|P2|Overall Study|Adverse Event|12
2562520|NCT01347879|8864215|P1|Overall Study|Adverse Event|0
2562521|NCT01347866|8864264|P17|Overall Study|Subject refused further follow-up|2
2562522|NCT01347866|8864265|P16|Overall Study|Subject refused further follow-up|0
2562523|NCT01347866|8864266|P15|Overall Study|Subject refused further follow-up|1
2562524|NCT01347866|8864267|P14|Overall Study|Subject refused further follow-up|3
2562525|NCT01347866|8864268|P13|Overall Study|Subject refused further follow-up|1
2562526|NCT01347866|8864269|P12|Overall Study|Subject refused further follow-up|0
2562527|NCT01347866|8864270|P11|Overall Study|Subject refused further follow-up|0
2562528|NCT01347866|8864271|P10|Overall Study|Subject refused further follow-up|1
2562529|NCT01347866|8864272|P9|Overall Study|Subject refused further follow-up|4
2562530|NCT01347866|8864273|P8|Overall Study|Subject refused further follow-up|0
2562531|NCT01347866|8864274|P7|Overall Study|Subject refused further follow-up|0
2562532|NCT01347866|8864275|P6|Overall Study|Subject refused further follow-up|1
2562533|NCT01347866|8864276|P5|Overall Study|Subject refused further follow-up|0
2562534|NCT01347866|8864277|P4|Overall Study|Subject refused further follow-up|2
2562535|NCT01347866|8864278|P3|Overall Study|Subject refused further follow-up|0
2562536|NCT01347866|8864279|P2|Overall Study|Subject refused further follow-up|0
2562537|NCT01347866|8864280|P1|Overall Study|Subject refused further follow-up|2
2562538|NCT01347866|8864264|P17|Overall Study|Other|0
2562539|NCT01347866|8864265|P16|Overall Study|Other|3
2562540|NCT01347866|8864266|P15|Overall Study|Other|2
2562541|NCT01347866|8864267|P14|Overall Study|Other|4
2562542|NCT01347866|8864268|P13|Overall Study|Other|4
2562543|NCT01347866|8864269|P12|Overall Study|Other|3
2562544|NCT01347866|8864270|P11|Overall Study|Other|0
2562545|NCT01347866|8864271|P10|Overall Study|Other|5
2562546|NCT01347866|8864272|P9|Overall Study|Other|22
2562547|NCT01347866|8864273|P8|Overall Study|Other|3
2562548|NCT01347866|8864274|P7|Overall Study|Other|5
2562549|NCT01347866|8864275|P6|Overall Study|Other|0
2562550|NCT01347866|8864276|P5|Overall Study|Other|5
2562551|NCT01347866|8864277|P4|Overall Study|Other|4
2562552|NCT01347866|8864278|P3|Overall Study|Other|1
2562553|NCT01347866|8864279|P2|Overall Study|Other|1
2562554|NCT01347866|8864280|P1|Overall Study|Other|3
2562555|NCT01347866|8864264|P17|Overall Study|Lost to Follow-up|0
2562556|NCT01347866|8864265|P16|Overall Study|Lost to Follow-up|0
2562557|NCT01347866|8864266|P15|Overall Study|Lost to Follow-up|0
2562558|NCT01347866|8864267|P14|Overall Study|Lost to Follow-up|0
2562559|NCT01347866|8864268|P13|Overall Study|Lost to Follow-up|0
2562560|NCT01347866|8864269|P12|Overall Study|Lost to Follow-up|0
2562561|NCT01347866|8864270|P11|Overall Study|Lost to Follow-up|0
2562562|NCT01347866|8864271|P10|Overall Study|Lost to Follow-up|0
2562563|NCT01347866|8864272|P9|Overall Study|Lost to Follow-up|1
2562564|NCT01347866|8864273|P8|Overall Study|Lost to Follow-up|1
2562565|NCT01347866|8864274|P7|Overall Study|Lost to Follow-up|0
2562566|NCT01347866|8864275|P6|Overall Study|Lost to Follow-up|0
2562567|NCT01347866|8864276|P5|Overall Study|Lost to Follow-up|0
2562568|NCT01347866|8864277|P4|Overall Study|Lost to Follow-up|0
2562569|NCT01347866|8864278|P3|Overall Study|Lost to Follow-up|0
2562570|NCT01347866|8864279|P2|Overall Study|Lost to Follow-up|0
2562571|NCT01347866|8864280|P1|Overall Study|Lost to Follow-up|0
2562572|NCT01347866|8864264|P17|Overall Study|Death|0
2562573|NCT01347866|8864265|P16|Overall Study|Death|1
2562574|NCT01347866|8864266|P15|Overall Study|Death|0
2562575|NCT01347866|8864267|P14|Overall Study|Death|0
2562576|NCT01347866|8864268|P13|Overall Study|Death|2
2562577|NCT01347866|8864269|P12|Overall Study|Death|1
2562578|NCT01347866|8864270|P11|Overall Study|Death|3
2562579|NCT01347866|8864271|P10|Overall Study|Death|1
2562580|NCT01347866|8864272|P9|Overall Study|Death|4
2562581|NCT01347866|8864273|P8|Overall Study|Death|0
2562582|NCT01347866|8864274|P7|Overall Study|Death|1
2562583|NCT01347866|8864275|P6|Overall Study|Death|2
2562584|NCT01347866|8864276|P5|Overall Study|Death|2
2562585|NCT01347866|8864277|P4|Overall Study|Death|1
2562586|NCT01347866|8864278|P3|Overall Study|Death|0
2562587|NCT01347866|8864279|P2|Overall Study|Death|0
2562588|NCT01347866|8864280|P1|Overall Study|Death|0
2562589|NCT01347840|8864654|P1|Overall Study|Withdrawal by Subject|1
2562590|NCT01347762|8864681|P4|Overall Study|Withdrawal by Subject|3
2562591|NCT01347762|8864682|P3|Overall Study|Withdrawal by Subject|3
2562592|NCT01347762|8864683|P2|Overall Study|Withdrawal by Subject|1
2562593|NCT01347762|8864684|P1|Overall Study|Withdrawal by Subject|4
2562594|NCT01347762|8864681|P4|Overall Study|Lost to Follow-up|5
2562595|NCT01347762|8864682|P3|Overall Study|Lost to Follow-up|6
2562596|NCT01347762|8864683|P2|Overall Study|Lost to Follow-up|1
2562597|NCT01347762|8864684|P1|Overall Study|Lost to Follow-up|0
2562598|NCT01347710|8864710|P1|Overall Study|Other|3
2562599|NCT01347710|8864710|P1|Overall Study|Physician Decision|2
2562600|NCT01347710|8864710|P1|Overall Study|Lost to Follow-up|1
2562601|NCT01347710|8864710|P1|Overall Study|issue with vitals prior to dosing|1
2562602|NCT01347710|8864710|P1|Overall Study|Angio or SPECT not completed|18
2562603|NCT01347710|8864710|P1|Overall Study|Adverse Event|4
2562604|NCT01347710|8864710|P1|Overall Study|Withdrawal by Subject|2
2562605|NCT01347580|8864732|P2|Overall Study|Had other reason|6
2562606|NCT01347580|8864733|P1|Overall Study|Had other reason|9
2562607|NCT01347580|8864732|P2|Overall Study|Lost to Follow-up|1
2562608|NCT01347580|8864733|P1|Overall Study|Lost to Follow-up|3
2562609|NCT01347580|8864732|P2|Overall Study|Protocol Violation|7
2562610|NCT01347580|8864733|P1|Overall Study|Protocol Violation|10
2562611|NCT01347580|8864732|P2|Overall Study|Death|19
2562612|NCT01347580|8864733|P1|Overall Study|Death|30
2562613|NCT01347580|8864732|P2|Overall Study|Withdrawal by Subject|23
2562614|NCT01347580|8864733|P1|Overall Study|Withdrawal by Subject|13
2562615|NCT01347554|8864763|P2|Overall Study|Lack of Efficacy|11
2562616|NCT01347554|8864764|P1|Overall Study|Lack of Efficacy|7
2562617|NCT01347112|8864812|P2|Overall Study|Lost to Follow-up|5
2562618|NCT01347112|8864813|P1|Overall Study|Lost to Follow-up|3
2562619|NCT01347112|8864812|P2|Overall Study|Withdrawal by Subject|7
2562620|NCT01347112|8864813|P1|Overall Study|Withdrawal by Subject|1
2562621|NCT01347086|8864833|P10|Overall Study|failed screening visit|1
2562622|NCT01347086|8864834|P9|Overall Study|failed screening visit|0
2562623|NCT01347086|8864835|P8|Overall Study|failed screening visit|1
2562624|NCT01347086|8864836|P7|Overall Study|failed screening visit|1
2562625|NCT01347086|8864837|P6|Overall Study|failed screening visit|0
2562626|NCT01347086|8864838|P5|Overall Study|failed screening visit|0
2562627|NCT01347086|8864839|P4|Overall Study|failed screening visit|0
2562628|NCT01347086|8864840|P3|Overall Study|failed screening visit|1
2562629|NCT01347086|8864841|P2|Overall Study|failed screening visit|0
2562630|NCT01347086|8864842|P1|Overall Study|failed screening visit|0
2562631|NCT01347073|8864941|P1|Overall Study|Liver Transplant|1
2562632|NCT01347073|8864941|P1|Overall Study|Adverse Event|1
2562633|NCT01346774|8865020|P2|Overall Study|Adverse Event|2
2562634|NCT01346774|8865021|P1|Overall Study|Adverse Event|1
2562635|NCT01346774|8865020|P2|Overall Study|Protocol Violation|3
2562636|NCT01346774|8865021|P1|Overall Study|Protocol Violation|2
2562637|NCT01346774|8865020|P2|Overall Study|Withdrawal by Subject|4
2562638|NCT01346774|8865021|P1|Overall Study|Withdrawal by Subject|1
2562639|NCT01346774|8865020|P2|Overall Study|Lost to Follow-up|4
2562640|NCT01346774|8865021|P1|Overall Study|Lost to Follow-up|3
2562641|NCT01346774|8865020|P2|Overall Study|Did not take a single dose|4
2562642|NCT01346774|8865021|P1|Overall Study|Did not take a single dose|6
2562643|NCT01346696|8865027|P1|Overall Study|Death|1
2562644|NCT01346592|8865049|P3|Overall Study|Unable to Classify|6
2562645|NCT01346592|8865050|P2|Overall Study|Unable to Classify|3
2562646|NCT01346592|8865051|P1|Overall Study|Unable to Classify|7
2562647|NCT01346592|8865049|P3|Overall Study|Administrative reason|0
2562648|NCT01346592|8865050|P2|Overall Study|Administrative reason|0
2562649|NCT01346592|8865051|P1|Overall Study|Administrative reason|1
2562650|NCT01346592|8865049|P3|Overall Study|Inappropriate enrollment|1
2562651|NCT01346592|8865050|P2|Overall Study|Inappropriate enrollment|1
2562652|NCT01346592|8865051|P1|Overall Study|Inappropriate enrollment|3
2562653|NCT01346592|8865049|P3|Overall Study|Withdrawal by Subject|38
2562654|NCT01346592|8865050|P2|Overall Study|Withdrawal by Subject|51
2562655|NCT01346592|8865051|P1|Overall Study|Withdrawal by Subject|77
2562656|NCT01346592|8865049|P3|Overall Study|Adverse Event|0
2562657|NCT01346592|8865050|P2|Overall Study|Adverse Event|1
2562658|NCT01346592|8865051|P1|Overall Study|Adverse Event|0
2562659|NCT01346592|8865049|P3|Overall Study|Death|4
2562660|NCT01346592|8865050|P2|Overall Study|Death|3
2562661|NCT01346592|8865051|P1|Overall Study|Death|1
2562662|NCT01346592|8865049|P3|Overall Study|Protocol Violation|0
2562663|NCT01346592|8865050|P2|Overall Study|Protocol Violation|1
2562664|NCT01346592|8865051|P1|Overall Study|Protocol Violation|2
2562665|NCT01346592|8865049|P3|Overall Study|Lost to Follow-up|29
2562666|NCT01346592|8865050|P2|Overall Study|Lost to Follow-up|29
2562667|NCT01346592|8865051|P1|Overall Study|Lost to Follow-up|62
2562668|NCT01346540|8865143|P2|Overall Study|Adverse Event|4
2562669|NCT01346540|8865144|P1|Overall Study|Adverse Event|0
2562670|NCT01346540|8865143|P2|Overall Study|Progressive disease-RECIST 1.1 criteria|8
2562671|NCT01346540|8865144|P1|Overall Study|Progressive disease-RECIST 1.1 criteria|3
2562672|NCT01346514|8865155|P2|Overall Study|Death|4
2562673|NCT01346514|8865156|P1|Overall Study|Death|3
2562674|NCT01346514|8865155|P2|Overall Study|Withdrawal by Subject|3
2562675|NCT01346514|8865156|P1|Overall Study|Withdrawal by Subject|7
2562676|NCT01346514|8865155|P2|Overall Study|Lost to Follow-up|30
2562677|NCT01346514|8865156|P1|Overall Study|Lost to Follow-up|19
2562678|NCT01346501|8865176|P2|Overall Study|Other|12
2562679|NCT01346501|8865177|P1|Overall Study|Other|8
2562680|NCT01346501|8865176|P2|Overall Study|Initiated Other Biological Agents|1
2562681|NCT01346501|8865177|P1|Overall Study|Initiated Other Biological Agents|3
2562682|NCT01346475|8865210|P2|First Intervention|Lost to Follow-up|3
2562683|NCT01346475|8865211|P1|First Intervention|Lost to Follow-up|4
2562684|NCT01346410|8865223|P1|Overall Study|Death|1
2562685|NCT01346371|8865241|P2|Overall Study|Lost to Follow-up|0
2562686|NCT01346371|8865242|P1|Overall Study|Lost to Follow-up|2
2562687|NCT01346293|8865250|P2|Overall Study|Other|0
2562688|NCT01346293|8865251|P1|Overall Study|Other|1
2562689|NCT01346293|8865250|P2|Overall Study|Withdrawal by Subject|4
2562690|NCT01346293|8865251|P1|Overall Study|Withdrawal by Subject|15
2562691|NCT01346293|8865250|P2|Overall Study|Lost to Follow-up|8
2562692|NCT01346293|8865251|P1|Overall Study|Lost to Follow-up|21
2562693|NCT01346293|8865250|P2|Overall Study|Protocol Violation|9
2562694|NCT01346293|8865251|P1|Overall Study|Protocol Violation|30
2562695|NCT01346189|8865281|P4|Overall Study|Travel|3
2562696|NCT01346189|8865282|P3|Overall Study|Travel|0
2562697|NCT01346189|8865283|P2|Overall Study|Travel|0
2562698|NCT01346189|8865284|P1|Overall Study|Travel|0
2562699|NCT01346189|8865281|P4|Overall Study|Non-health system primary care physician|0
2562700|NCT01346189|8865282|P3|Overall Study|Non-health system primary care physician|0
2562701|NCT01346189|8865283|P2|Overall Study|Non-health system primary care physician|5
2562702|NCT01346189|8865284|P1|Overall Study|Non-health system primary care physician|0
2562703|NCT01346189|8865281|P4|Overall Study|Death|0
2562704|NCT01346189|8865282|P3|Overall Study|Death|0
2562705|NCT01346189|8865283|P2|Overall Study|Death|3
2562706|NCT01346189|8865284|P1|Overall Study|Death|0
2562707|NCT01346189|8865281|P4|Overall Study|Other|3
2562708|NCT01346189|8865282|P3|Overall Study|Other|7
2562709|NCT01346189|8865283|P2|Overall Study|Other|4
2562710|NCT01346189|8865284|P1|Overall Study|Other|2
2562711|NCT01346189|8865281|P4|Overall Study|Moved|0
2562712|NCT01346189|8865282|P3|Overall Study|Moved|4
2562713|NCT01346189|8865283|P2|Overall Study|Moved|0
2562714|NCT01346189|8865284|P1|Overall Study|Moved|3
2562715|NCT01346189|8865281|P4|Overall Study|Physician Decision|0
2562716|NCT01346189|8865282|P3|Overall Study|Physician Decision|0
2562717|NCT01346189|8865283|P2|Overall Study|Physician Decision|0
2562718|NCT01346189|8865284|P1|Overall Study|Physician Decision|4
2562719|NCT01346189|8865281|P4|Overall Study|Withdrawal by Subject|5
2562720|NCT01346189|8865282|P3|Overall Study|Withdrawal by Subject|3
2562721|NCT01346189|8865283|P2|Overall Study|Withdrawal by Subject|5
2562722|NCT01346189|8865284|P1|Overall Study|Withdrawal by Subject|7
2562723|NCT01346176|8865301|P3|Completed Satisfaction Survey|Lost to Follow-up|4
2562724|NCT01346176|8865302|P2|Completed Satisfaction Survey|Lost to Follow-up|4
2562725|NCT01346176|8865303|P1|Completed Satisfaction Survey|Lost to Follow-up|3
2562726|NCT01346176|8865301|P3|Completed Satisfaction Survey|Death|2
2562727|NCT01346176|8865302|P2|Completed Satisfaction Survey|Death|0
2562728|NCT01346176|8865303|P1|Completed Satisfaction Survey|Death|3
2562729|NCT01346176|8865301|P3|Completed Advance Directive|Other reason did not complete AD|7
2562730|NCT01346176|8865302|P2|Completed Advance Directive|Other reason did not complete AD|12
2562731|NCT01346176|8865303|P1|Completed Advance Directive|Other reason did not complete AD|7
2562732|NCT01346176|8865301|P3|Completed Advance Directive|Became Ineligible|1
2562733|NCT01346176|8865302|P2|Completed Advance Directive|Became Ineligible|0
2562734|NCT01346176|8865303|P1|Completed Advance Directive|Became Ineligible|3
2562735|NCT01346176|8865301|P3|Completed Advance Directive|Death|2
2562736|NCT01346176|8865302|P2|Completed Advance Directive|Death|2
2562737|NCT01346176|8865303|P1|Completed Advance Directive|Death|3
2562738|NCT01346176|8865301|P3|Recruited|Protocol Violation|0
2562739|NCT01346176|8865302|P2|Recruited|Protocol Violation|0
2562740|NCT01346176|8865303|P1|Recruited|Protocol Violation|1
2562741|NCT01346059|8865332|P2|Overall Study|Withdrawal by Subject|0
2562742|NCT01346059|8865333|P1|Overall Study|Withdrawal by Subject|1
2562743|NCT01345929|8865345|P2|Overall Study|Patient withdrawal|1
2562744|NCT01345929|8865346|P1|Overall Study|Patient withdrawal|0
2562745|NCT01345929|8865345|P2|Overall Study|40,000 CFU/ML|0
2562746|NCT01345929|8865346|P1|Overall Study|40,000 CFU/ML|1
2562747|NCT01345929|8865345|P2|Overall Study|Didn't meet eligibility criteria|0
2562748|NCT01345929|8865346|P1|Overall Study|Didn't meet eligibility criteria|2
2562749|NCT01345929|8865345|P2|Overall Study|Adverse Event|1
2562750|NCT01345929|8865346|P1|Overall Study|Adverse Event|0
2562751|NCT01345929|8865345|P2|Overall Study|Lost to Follow-up|9
2562752|NCT01345929|8865346|P1|Overall Study|Lost to Follow-up|9
2562753|NCT01345929|8865345|P2|Overall Study|Withdrawal by Subject|8
2562754|NCT01345929|8865346|P1|Overall Study|Withdrawal by Subject|9
2562755|NCT01345786|8865358|P4|Overall Study|Lost to Follow-up|2
2562756|NCT01345786|8865359|P3|Overall Study|Lost to Follow-up|0
2562757|NCT01345786|8865360|P2|Overall Study|Lost to Follow-up|0
2562758|NCT01345786|8865361|P1|Overall Study|Lost to Follow-up|0
2562759|NCT01345786|8865358|P4|Overall Study|Administrative|0
2562760|NCT01345786|8865359|P3|Overall Study|Administrative|0
2562761|NCT01345786|8865360|P2|Overall Study|Administrative|5
2562762|NCT01345786|8865361|P1|Overall Study|Administrative|3
2562763|NCT01345786|8865358|P4|Overall Study|Noncompliance with protocol|0
2562764|NCT01345786|8865359|P3|Overall Study|Noncompliance with protocol|1
2562765|NCT01345786|8865360|P2|Overall Study|Noncompliance with protocol|0
2562766|NCT01345786|8865361|P1|Overall Study|Noncompliance with protocol|1
2562767|NCT01345786|8865358|P4|Overall Study|Subject withdrew consent|0
2562768|NCT01345786|8865359|P3|Overall Study|Subject withdrew consent|1
2562769|NCT01345786|8865360|P2|Overall Study|Subject withdrew consent|2
2562770|NCT01345786|8865361|P1|Overall Study|Subject withdrew consent|2
2562771|NCT01345786|8865358|P4|Overall Study|Adverse Event|1
2562772|NCT01345786|8865359|P3|Overall Study|Adverse Event|3
2562773|NCT01345786|8865360|P2|Overall Study|Adverse Event|1
2562774|NCT01345786|8865361|P1|Overall Study|Adverse Event|0
2562775|NCT01345682|8865441|P2|Overall Study|Reason other than those specified above|3
2562776|NCT01345682|8865442|P1|Overall Study|Reason other than those specified above|4
2562777|NCT01345682|8865441|P2|Overall Study|Not treated|1
2562778|NCT01345682|8865442|P1|Overall Study|Not treated|2
2562779|NCT01345682|8865441|P2|Overall Study|Refused to continue trial medication|9
2562780|NCT01345682|8865442|P1|Overall Study|Refused to continue trial medication|16
2562781|NCT01345682|8865441|P2|Overall Study|Lost to Follow-up|1
2562782|NCT01345682|8865442|P1|Overall Study|Lost to Follow-up|0
2562783|NCT01345682|8865441|P2|Overall Study|Non-compliance with protocol|1
2562784|NCT01345682|8865442|P1|Overall Study|Non-compliance with protocol|0
2562785|NCT01345682|8865441|P2|Overall Study|Adverse Event|41
2562786|NCT01345682|8865442|P1|Overall Study|Adverse Event|51
2562787|NCT01345682|8865441|P2|Overall Study|Worsening of underlying cancer disease|12
2562788|NCT01345682|8865442|P1|Overall Study|Worsening of underlying cancer disease|23
2562789|NCT01345682|8865441|P2|Overall Study|Progressive disease per RECIST|93
2562790|NCT01345682|8865442|P1|Overall Study|Progressive disease per RECIST|226
2562791|NCT01345669|8865476|P2|Overall Study|Other Reasons|60
2562792|NCT01345669|8865477|P1|Overall Study|Other Reasons|111
2562793|NCT01345669|8865476|P2|Overall Study|Withdrawal by Subject|13
2562794|NCT01345669|8865477|P1|Overall Study|Withdrawal by Subject|52
2562795|NCT01345669|8865476|P2|Overall Study|Lost to Follow-up|1
2562796|NCT01345669|8865477|P1|Overall Study|Lost to Follow-up|1
2562797|NCT01345669|8865476|P2|Overall Study|Protocol Violation|1
2562798|NCT01345669|8865477|P1|Overall Study|Protocol Violation|3
2562799|NCT01345669|8865476|P2|Overall Study|Adverse Event|9
2562800|NCT01345669|8865477|P1|Overall Study|Adverse Event|63
2562801|NCT01345669|8865476|P2|Overall Study|Second primary tumour|3
2562802|NCT01345669|8865477|P1|Overall Study|Second primary tumour|4
2562803|NCT01345669|8865476|P2|Overall Study|Primary tumour recurrence|32
2562804|NCT01345669|8865477|P1|Overall Study|Primary tumour recurrence|53
2562805|NCT01345630|8865495|P2|Overall Study|Insufficient clinical response|11
2562806|NCT01345630|8865496|P1|Overall Study|Insufficient clinical response|48
2562807|NCT01345630|8865495|P2|Overall Study|No longer willing to participate|12
2562808|NCT01345630|8865496|P1|Overall Study|No longer willing to participate|9
2562809|NCT01345630|8865495|P2|Overall Study|Withdrawn due to pregnancy|2
2562810|NCT01345630|8865496|P1|Overall Study|Withdrawn due to pregnancy|1
2562811|NCT01345630|8865495|P2|Overall Study|Other reasons|8
2562812|NCT01345630|8865496|P1|Overall Study|Other reasons|6
2562813|NCT01345630|8865495|P2|Overall Study|Study terminated by sponsor|285
2562814|NCT01345630|8865496|P1|Overall Study|Study terminated by sponsor|254
2562815|NCT01345630|8865495|P2|Overall Study|Medication error without associated AE|1
2562816|NCT01345630|8865496|P1|Overall Study|Medication error without associated AE|0
2562817|NCT01345630|8865495|P2|Overall Study|Protocol Violation|1
2562818|NCT01345630|8865496|P1|Overall Study|Protocol Violation|4
2562819|NCT01345630|8865495|P2|Overall Study|Lost to Follow-up|16
2562820|NCT01345630|8865496|P1|Overall Study|Lost to Follow-up|17
2562821|NCT01345630|8865495|P2|Overall Study|Adverse Event|23
2562822|NCT01345630|8865496|P1|Overall Study|Adverse Event|22
2562823|NCT01345591|8865552|P1|Overall Study|Lost to Follow-up|1
2562824|NCT01345318|8865568|P1|Overall Study|Other|3
2562825|NCT01345318|8865568|P1|Overall Study|Withdrawal by Subject|41
2562826|NCT01345318|8865568|P1|Overall Study|Protocol Violation|1
2562827|NCT01345318|8865568|P1|Overall Study|Lost to Follow-up|2
2562828|NCT01345318|8865568|P1|Overall Study|Lack of Efficacy|17
2562829|NCT01345318|8865568|P1|Overall Study|Adverse Event|16
2562830|NCT01345292|8865576|P3|Overall Study|Withdrawal by Subject|1
2562831|NCT01345292|8865577|P2|Overall Study|Withdrawal by Subject|0
2562832|NCT01345292|8865578|P1|Overall Study|Withdrawal by Subject|2
2562833|NCT01345253|8865609|P2|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1
2562834|NCT01345253|8865610|P1|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1
2562835|NCT01345253|8865609|P2|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82
2562836|NCT01345253|8865610|P1|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37
2562837|NCT01345253|8865609|P2|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24
2562838|NCT01345253|8865610|P1|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11
2562839|NCT01345253|8865609|P2|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6
2562840|NCT01345253|8865610|P1|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4
2562841|NCT01345253|8865609|P2|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5
2562842|NCT01345253|8865610|P1|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2
2562843|NCT01345253|8865609|P2|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7
2562844|NCT01345253|8865610|P1|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3
2562845|NCT01345253|8865609|P2|Open-label Phase (Up to Year 5 Week 44)|Death|1
2562846|NCT01345253|8865610|P1|Open-label Phase (Up to Year 5 Week 44)|Death|0
2562847|NCT01345253|8865609|P2|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18
2562848|NCT01345253|8865610|P1|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7
2562849|NCT01345253|8865609|P2|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19
2562850|NCT01345253|8865610|P1|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9
2562851|NCT01345253|8865609|P2|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12
2562852|NCT01345253|8865610|P1|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4
2562853|NCT01345253|8865609|P2|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8
2562854|NCT01345253|8865610|P1|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3
2562855|NCT01345253|8865609|P2|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1
2562856|NCT01345253|8865610|P1|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6
2562857|NCT01345253|8865609|P2|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5
2562858|NCT01345253|8865610|P1|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1
2562859|NCT01345253|8865609|P2|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7
2562860|NCT01345253|8865610|P1|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11
2562861|NCT01345253|8865609|P2|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27
2562862|NCT01345253|8865610|P1|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22
2562863|NCT01345240|8865631|P5|Overall Study|Lost to Follow-up|9
2562864|NCT01345240|8865632|P4|Overall Study|Lost to Follow-up|7
2562865|NCT01345240|8865633|P3|Overall Study|Lost to Follow-up|14
2562866|NCT01345240|8865634|P2|Overall Study|Lost to Follow-up|9
2562867|NCT01345240|8865635|P1|Overall Study|Lost to Follow-up|8
2562868|NCT01345240|8865631|P5|Overall Study|Adverse Event|1
2562869|NCT01345240|8865632|P4|Overall Study|Adverse Event|2
2562870|NCT01345240|8865633|P3|Overall Study|Adverse Event|4
2562871|NCT01345240|8865634|P2|Overall Study|Adverse Event|5
2562872|NCT01345240|8865635|P1|Overall Study|Adverse Event|3
2562873|NCT01345188|8865755|P1|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1
2562874|NCT01345188|8865755|P1|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2
2562875|NCT01345162|8865767|P2|Overall Study|Protocol Violation|4
2562876|NCT01345162|8865768|P1|Overall Study|Protocol Violation|2
2562877|NCT01345123|8865777|P3|Overall Study|participants no longer with health plan|88
2562878|NCT01345123|8865778|P2|Overall Study|participants no longer with health plan|85
2562879|NCT01345123|8865779|P1|Overall Study|participants no longer with health plan|79
2562880|NCT01345058|8865801|P2|Overall Study|Participant No-Show at Multiple Visits|0
2562881|NCT01345058|8865802|P1|Overall Study|Participant No-Show at Multiple Visits|1
2562882|NCT01345058|8865801|P2|Overall Study|Participant Stopped Taking Study Drug|0
2562883|NCT01345058|8865802|P1|Overall Study|Participant Stopped Taking Study Drug|1
2562884|NCT01345058|8865801|P2|Overall Study|Side Effects of Hair Loss and Itchiness|0
2562885|NCT01345058|8865802|P1|Overall Study|Side Effects of Hair Loss and Itchiness|1
2562886|NCT01345058|8865801|P2|Overall Study|Participant Reported Increase in Events|0
2562887|NCT01345058|8865802|P1|Overall Study|Participant Reported Increase in Events|1
2562888|NCT01345058|8865801|P2|Overall Study|Withdrawal by Subject|0
2562889|NCT01345058|8865802|P1|Overall Study|Withdrawal by Subject|1
2562890|NCT01345019|8865818|P2|Open Label Treatment Phase|Protocol Violation|1
2562891|NCT01345019|8865819|P1|Open Label Treatment Phase|Protocol Violation|0
2562892|NCT01345019|8865818|P2|Open Label Treatment Phase|Other, Not Specified|7
2562893|NCT01345019|8865819|P1|Open Label Treatment Phase|Other, Not Specified|9
2562894|NCT01345019|8865818|P2|Open Label Treatment Phase|Pregnancy|0
2562895|NCT01345019|8865819|P1|Open Label Treatment Phase|Pregnancy|1
2562896|NCT01345019|8865818|P2|Open Label Treatment Phase|Lost to Follow-up|2
2562897|NCT01345019|8865819|P1|Open Label Treatment Phase|Lost to Follow-up|1
2562898|NCT01345019|8865818|P2|Open Label Treatment Phase|Noncompliance|4
2562899|NCT01345019|8865819|P1|Open Label Treatment Phase|Noncompliance|5
2562900|NCT01345019|8865818|P2|Open Label Treatment Phase|Disease Progression|18
2562901|NCT01345019|8865819|P1|Open Label Treatment Phase|Disease Progression|17
2562902|NCT01345019|8865818|P2|Open Label Treatment Phase|Administrative Decision|15
2562903|NCT01345019|8865819|P1|Open Label Treatment Phase|Administrative Decision|30
2562904|NCT01345019|8865818|P2|Open Label Treatment Phase|Adverse Event|51
2562905|NCT01345019|8865819|P1|Open Label Treatment Phase|Adverse Event|30
2562906|NCT01345019|8865818|P2|Open Label Treatment Phase|Withdrawal by Subject|47
2562907|NCT01345019|8865819|P1|Open Label Treatment Phase|Withdrawal by Subject|49
2562908|NCT01345019|8865818|P2|Open Label Treatment Phase|Death|48
2562909|NCT01345019|8865819|P1|Open Label Treatment Phase|Death|49
2562910|NCT01345019|8865818|P2|Blinded Treatment Phase|Lost to Follow-up|3
2562911|NCT01345019|8865819|P1|Blinded Treatment Phase|Lost to Follow-up|6
2562912|NCT01345019|8865818|P2|Blinded Treatment Phase|Other, Not Specified|3
2562913|NCT01345019|8865819|P1|Blinded Treatment Phase|Other, Not Specified|2
2562914|NCT01345019|8865818|P2|Blinded Treatment Phase|Protocol Deviation|0
2562915|NCT01345019|8865819|P1|Blinded Treatment Phase|Protocol Deviation|5
2562916|NCT01345019|8865818|P2|Blinded Treatment Phase|Ineligibility Determined|6
2562917|NCT01345019|8865819|P1|Blinded Treatment Phase|Ineligibility Determined|1
2562918|NCT01345019|8865818|P2|Blinded Treatment Phase|Noncompliance|3
2562919|NCT01345019|8865819|P1|Blinded Treatment Phase|Noncompliance|5
2562920|NCT01345019|8865818|P2|Blinded Treatment Phase|Administrative Decision|8
2562921|NCT01345019|8865819|P1|Blinded Treatment Phase|Administrative Decision|10
2562922|NCT01345019|8865818|P2|Blinded Treatment Phase|Adverse Event|13
2562923|NCT01345019|8865819|P1|Blinded Treatment Phase|Adverse Event|6
2562924|NCT01345019|8865818|P2|Blinded Treatment Phase|Disease Progression|10
2562925|NCT01345019|8865819|P1|Blinded Treatment Phase|Disease Progression|12
2562926|NCT01345019|8865818|P2|Blinded Treatment Phase|Completed Survival Follow-up|9
2562927|NCT01345019|8865819|P1|Blinded Treatment Phase|Completed Survival Follow-up|21
2562928|NCT01345019|8865818|P2|Blinded Treatment Phase|Withdrawal by Subject|112
2562929|NCT01345019|8865819|P1|Blinded Treatment Phase|Withdrawal by Subject|103
2562930|NCT01345019|8865818|P2|Blinded Treatment Phase|Death|137
2562931|NCT01345019|8865819|P1|Blinded Treatment Phase|Death|147
2562932|NCT01344876|8865841|P5|Overall Study|Definite progression of primary disease|0
2562933|NCT01344876|8865842|P4|Overall Study|Definite progression of primary disease|3
2562934|NCT01344876|8865843|P3|Overall Study|Definite progression of primary disease|0
2562935|NCT01344876|8865844|P2|Overall Study|Definite progression of primary disease|0
2562936|NCT01344876|8865845|P1|Overall Study|Definite progression of primary disease|1
2562937|NCT01344876|8865841|P5|Overall Study|Withdrawal by Subject|0
2562938|NCT01344876|8865842|P4|Overall Study|Withdrawal by Subject|0
2562939|NCT01344876|8865843|P3|Overall Study|Withdrawal by Subject|1
2562940|NCT01344876|8865844|P2|Overall Study|Withdrawal by Subject|0
2562941|NCT01344876|8865845|P1|Overall Study|Withdrawal by Subject|0
2562942|NCT01344876|8865841|P5|Overall Study|Adverse Event|1
2562943|NCT01344876|8865842|P4|Overall Study|Adverse Event|0
2562944|NCT01344876|8865843|P3|Overall Study|Adverse Event|0
2562945|NCT01344876|8865844|P2|Overall Study|Adverse Event|0
2562946|NCT01344876|8865845|P1|Overall Study|Adverse Event|0
2562947|NCT01344824|8865859|P1|Overall Study|Progression|15
2562948|NCT01344824|8865859|P1|Overall Study|Other complicating disease|1
2562949|NCT01344824|8865859|P1|Overall Study|Withdrawal by Subject|6
2562950|NCT01344824|8865859|P1|Overall Study|Adverse Event|15
2562951|NCT01344759|8865867|P2|Overall Study|Patients failed to reach sedation level|2
2562952|NCT01344759|8865868|P1|Overall Study|Patients failed to reach sedation level|0
2562953|NCT01344629|8865900|P2|Crossover Period 2|Withdrawal by Subject|1
2562954|NCT01344629|8865901|P1|Crossover Period 2|Withdrawal by Subject|0
2562955|NCT01344538|8865930|P2|Overall Study|Lost to Follow-up|0
2562956|NCT01344538|8865931|P1|Overall Study|Lost to Follow-up|1
2562957|NCT01344538|8865930|P2|Overall Study|Adverse Event|1
2562958|NCT01344538|8865931|P1|Overall Study|Adverse Event|1
2562959|NCT01344460|8865937|P1|Overall Study|Lost to Follow-up|2
2562960|NCT01344460|8865937|P1|Overall Study|Withdrawal by Subject|1
2562961|NCT01344447|8865982|P1|Overall Study|Error of power injector|1
2562962|NCT01344447|8865982|P1|Overall Study|Bolus tracking failed|1
2562963|NCT01344447|8865982|P1|Overall Study|MRA unsuccessful|1
2562964|NCT01344447|8865982|P1|Overall Study|Physician Decision|1
2562965|NCT01344447|8865982|P1|Overall Study|The contrast was not seen|1
2562966|NCT01344447|8865982|P1|Overall Study|Withdrawal by Subject|1
2562967|NCT01344447|8865982|P1|Overall Study|Protocol Violation|1
2562968|NCT01344447|8865982|P1|Overall Study|Adverse Event|1
2562969|NCT01344369|8866026|P2|Second Intervention|Emesis within 2 x Tmax|1
2562970|NCT01344369|8866027|P1|Second Intervention|Emesis within 2 x Tmax|0
2562971|NCT01344369|8866026|P2|Washout of 28 Days|Physician Decision|1
2562972|NCT01344369|8866027|P1|Washout of 28 Days|Physician Decision|0
2562973|NCT01344369|8866026|P2|Washout of 28 Days|Withdrawal by Subject|0
2562974|NCT01344369|8866027|P1|Washout of 28 Days|Withdrawal by Subject|1
2562975|NCT01344356|8866045|P2|Overall Study|Lost to Follow-up|6
2562976|NCT01344356|8866046|P1|Overall Study|Lost to Follow-up|0
2562977|NCT01344356|8866045|P2|Overall Study|Physician Decision|3
2562978|NCT01344356|8866046|P1|Overall Study|Physician Decision|0
2562979|NCT01344226|8866058|P1|Overall Study|Lack of Efficacy|3
2562980|NCT01344226|8866058|P1|Overall Study|Withdrawal by Subject|3
2562981|NCT01344226|8866058|P1|Overall Study|Protocol Violation|2
2562982|NCT01344161|8866067|P2|Overall Study|Protocol Violation|1
2562983|NCT01344161|8866068|P1|Overall Study|Protocol Violation|1
2562984|NCT01344161|8866067|P2|Overall Study|Pregnancy|1
2562985|NCT01344161|8866068|P1|Overall Study|Pregnancy|0
2562986|NCT01344161|8866067|P2|Overall Study|Lost to Follow-up|1
2562987|NCT01344161|8866068|P1|Overall Study|Lost to Follow-up|4
2562988|NCT01344057|8866080|P1|Overall Study|Premature Withdrawal|1
2562989|NCT01343901|8866087|P1|Overall Study|Participant decision|1
2562990|NCT01343901|8866087|P1|Overall Study|Management by another medical team|11
2562991|NCT01343901|8866087|P1|Overall Study|Lost to Follow-up|12
2562992|NCT01343901|8866087|P1|Overall Study|Physician Decision|4
2562993|NCT01343901|8866087|P1|Overall Study|Death|85
2562994|NCT01343888|8866111|P3|Overall Study|other than stated above|1
2562995|NCT01343888|8866112|P2|Overall Study|other than stated above|0
2562996|NCT01343888|8866113|P1|Overall Study|other than stated above|0
2562997|NCT01343888|8866111|P3|Overall Study|Withdrawal by Subject|2
2562998|NCT01343888|8866112|P2|Overall Study|Withdrawal by Subject|4
2562999|NCT01343888|8866113|P1|Overall Study|Withdrawal by Subject|4
2563000|NCT01343888|8866111|P3|Overall Study|Protocol Violation|0
2563001|NCT01343888|8866112|P2|Overall Study|Protocol Violation|2
2563002|NCT01343888|8866113|P1|Overall Study|Protocol Violation|0
2563003|NCT01343888|8866111|P3|Overall Study|Lost to Follow-up|1
2563004|NCT01343888|8866112|P2|Overall Study|Lost to Follow-up|2
2563005|NCT01343888|8866113|P1|Overall Study|Lost to Follow-up|0
2563006|NCT01343888|8866111|P3|Overall Study|Lack of Efficacy|13
2563007|NCT01343888|8866112|P2|Overall Study|Lack of Efficacy|9
2563008|NCT01343888|8866113|P1|Overall Study|Lack of Efficacy|9
2563009|NCT01343888|8866111|P3|Overall Study|Adverse Event|5
2563010|NCT01343888|8866112|P2|Overall Study|Adverse Event|22
2563011|NCT01343888|8866113|P1|Overall Study|Adverse Event|12
2563012|NCT01343823|8866155|P4|Overall Study|Withdrawal by Subject|0
2563013|NCT01343823|8866156|P3|Overall Study|Withdrawal by Subject|0
2563014|NCT01343823|8866157|P2|Overall Study|Withdrawal by Subject|0
2563015|NCT01343823|8866158|P1|Overall Study|Withdrawal by Subject|1
2563016|NCT01343823|8866155|P4|Overall Study|Study Terminated|1
2563017|NCT01343823|8866156|P3|Overall Study|Study Terminated|0
2563018|NCT01343823|8866157|P2|Overall Study|Study Terminated|0
2563019|NCT01343823|8866158|P1|Overall Study|Study Terminated|1
2563020|NCT01343693|8866172|P1|Overall Study|Lost to Follow-up|9
2563021|NCT01343407|8866195|P6|Second Washout (Part 2)|Withdrawal by Subject|0
2563022|NCT01343407|8866196|P5|Second Washout (Part 2)|Withdrawal by Subject|0
2563023|NCT01343407|8866197|P4|Second Washout (Part 2)|Withdrawal by Subject|0
2563024|NCT01343407|8866198|P3|Second Washout (Part 2)|Withdrawal by Subject|1
2563025|NCT01343407|8866199|P2|Second Washout (Part 2)|Withdrawal by Subject|0
2563026|NCT01343407|8866200|P1|Second Washout (Part 2)|Withdrawal by Subject|0
2563027|NCT01343407|8866195|P6|Second Treatment Period (Part 2)|Adverse Event|0
2563028|NCT01343407|8866196|P5|Second Treatment Period (Part 2)|Adverse Event|0
2563029|NCT01343407|8866197|P4|Second Treatment Period (Part 2)|Adverse Event|0
2563030|NCT01343407|8866198|P3|Second Treatment Period (Part 2)|Adverse Event|1
2563031|NCT01343407|8866199|P2|Second Treatment Period (Part 2)|Adverse Event|0
2563032|NCT01343407|8866200|P1|Second Treatment Period (Part 2)|Adverse Event|0
2563033|NCT01343368|8866228|P2|Overall Study|Lost to Follow-up|0
2563034|NCT01343368|8866229|P1|Overall Study|Lost to Follow-up|1
2563035|NCT01343368|8866228|P2|Overall Study|Death|0
2563036|NCT01343368|8866229|P1|Overall Study|Death|1
2563037|NCT01343277|8866265|P2|Overall Study|Subsequent anticancer therapy|0
2563038|NCT01343277|8866266|P1|Overall Study|Subsequent anticancer therapy|1
2563039|NCT01343277|8866265|P2|Overall Study|Treatment ongoing|2
2563040|NCT01343277|8866266|P1|Overall Study|Treatment ongoing|8
2563041|NCT01343277|8866265|P2|Overall Study|Randomized not treated|21
2563042|NCT01343277|8866266|P1|Overall Study|Randomized not treated|6
2563043|NCT01343277|8866265|P2|Overall Study|Disease progression|138
2563044|NCT01343277|8866266|P1|Overall Study|Disease progression|270
2563045|NCT01343277|8866265|P2|Overall Study|Adverse Event|13
2563046|NCT01343277|8866266|P1|Overall Study|Adverse Event|67
2563047|NCT01343277|8866265|P2|Overall Study|Death|1
2563048|NCT01343277|8866266|P1|Overall Study|Death|10
2563049|NCT01343277|8866265|P2|Overall Study|Physician Decision|2
2563050|NCT01343277|8866266|P1|Overall Study|Physician Decision|1
2563051|NCT01343277|8866265|P2|Overall Study|Withdrawal by Subject|13
2563052|NCT01343277|8866266|P1|Overall Study|Withdrawal by Subject|18
2563053|NCT01343277|8866265|P2|Overall Study|Other|3
2563054|NCT01343277|8866266|P1|Overall Study|Other|3
2563055|NCT01343082|8866327|P3|Treatment Period , Switched to DE-111|Withdrawal by Subject|5
2563056|NCT01343082|8866328|P2|Treatment Period , Switched to DE-111|Withdrawal by Subject|2
2563057|NCT01343082|8866329|P1|Treatment Period , Switched to DE-111|Withdrawal by Subject|4
2563058|NCT01343082|8866327|P3|Treatment Period , Switched to DE-111|Physician Decision|2
2563059|NCT01343082|8866328|P2|Treatment Period , Switched to DE-111|Physician Decision|2
2563060|NCT01343082|8866329|P1|Treatment Period , Switched to DE-111|Physician Decision|0
2563061|NCT01343082|8866327|P3|Treatment Period , Switched to DE-111|Lack of Efficacy|2
2563062|NCT01343082|8866328|P2|Treatment Period , Switched to DE-111|Lack of Efficacy|1
2563063|NCT01343082|8866329|P1|Treatment Period , Switched to DE-111|Lack of Efficacy|0
2563064|NCT01343082|8866327|P3|Treatment Period , Switched to DE-111|Adverse Event|3
2563065|NCT01343082|8866328|P2|Treatment Period , Switched to DE-111|Adverse Event|4
2563066|NCT01343082|8866329|P1|Treatment Period , Switched to DE-111|Adverse Event|1
2563067|NCT01343082|8866327|P3|The run-in Period|Not meeting criteria|5
2563068|NCT01343082|8866328|P2|The run-in Period|Not meeting criteria|4
2563069|NCT01343082|8866329|P1|The run-in Period|Not meeting criteria|3
2563070|NCT01343056|8866337|P4|Overall Study|Lost to Follow-up|9
2563071|NCT01343056|8866338|P3|Overall Study|Lost to Follow-up|3
2563072|NCT01343056|8866339|P2|Overall Study|Lost to Follow-up|5
2563073|NCT01343056|8866340|P1|Overall Study|Lost to Follow-up|7
2563074|NCT01342965|8866408|P2|Overall Study|Withdrawal by Subject|9
2563075|NCT01342965|8866409|P1|Overall Study|Withdrawal by Subject|2
2563076|NCT01342965|8866408|P2|Overall Study|Other Reasons- Unspecified|38
2563077|NCT01342965|8866409|P1|Overall Study|Other Reasons- Unspecified|44
2563078|NCT01342965|8866408|P2|Overall Study|Lost to Follow-up|3
2563079|NCT01342965|8866409|P1|Overall Study|Lost to Follow-up|5
2563080|NCT01342965|8866408|P2|Overall Study|Death|57
2563081|NCT01342965|8866409|P1|Overall Study|Death|58
2563082|NCT01342926|8866427|P4|Overall Study|Withdrawal by Subject|5
2563083|NCT01342926|8866428|P3|Overall Study|Withdrawal by Subject|3
2563084|NCT01342926|8866429|P2|Overall Study|Withdrawal by Subject|4
2563085|NCT01342926|8866430|P1|Overall Study|Withdrawal by Subject|2
2563086|NCT01342926|8866427|P4|Overall Study|Investigator Discretion|0
2563087|NCT01342926|8866428|P3|Overall Study|Investigator Discretion|0
2563088|NCT01342926|8866429|P2|Overall Study|Investigator Discretion|2
2563089|NCT01342926|8866430|P1|Overall Study|Investigator Discretion|2
2563090|NCT01342926|8866427|P4|Overall Study|Lost to Follow-up|0
2563091|NCT01342926|8866428|P3|Overall Study|Lost to Follow-up|1
2563092|NCT01342926|8866429|P2|Overall Study|Lost to Follow-up|1
2563093|NCT01342926|8866430|P1|Overall Study|Lost to Follow-up|0
2563094|NCT01342926|8866427|P4|Overall Study|Adverse Event|7
2563095|NCT01342926|8866428|P3|Overall Study|Adverse Event|10
2563096|NCT01342926|8866429|P2|Overall Study|Adverse Event|8
2563097|NCT01342926|8866430|P1|Overall Study|Adverse Event|5
2563098|NCT01342913|8866510|P3|Double-Blind Treatment Period|Withdrawal by Subject|2
2563099|NCT01342913|8866511|P2|Double-Blind Treatment Period|Withdrawal by Subject|2
2563100|NCT01342913|8866512|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
2563101|NCT01342913|8866510|P3|Double-Blind Treatment Period|Physician Decision|0
2563102|NCT01342913|8866511|P2|Double-Blind Treatment Period|Physician Decision|2
2563103|NCT01342913|8866512|P1|Double-Blind Treatment Period|Physician Decision|0
2563104|NCT01342913|8866510|P3|Double-Blind Treatment Period|Lost to Follow-up|3
2563105|NCT01342913|8866511|P2|Double-Blind Treatment Period|Lost to Follow-up|1
2563106|NCT01342913|8866512|P1|Double-Blind Treatment Period|Lost to Follow-up|0
2563107|NCT01342913|8866510|P3|Double-Blind Treatment Period|Protocol Violation|9
2563108|NCT01342913|8866511|P2|Double-Blind Treatment Period|Protocol Violation|6
2563109|NCT01342913|8866512|P1|Double-Blind Treatment Period|Protocol Violation|0
2563110|NCT01342913|8866510|P3|Double-Blind Treatment Period|Lack of Efficacy|3
2563111|NCT01342913|8866511|P2|Double-Blind Treatment Period|Lack of Efficacy|2
2563112|NCT01342913|8866512|P1|Double-Blind Treatment Period|Lack of Efficacy|0
2563113|NCT01342913|8866510|P3|Double-Blind Treatment Period|Adverse Event|6
2563114|NCT01342913|8866511|P2|Double-Blind Treatment Period|Adverse Event|3
2563115|NCT01342913|8866512|P1|Double-Blind Treatment Period|Adverse Event|0
2563116|NCT01342913|8866510|P3|2-week Run-in Period|Continuation Criteria Not Met|0
2563117|NCT01342913|8866511|P2|2-week Run-in Period|Continuation Criteria Not Met|0
2563118|NCT01342913|8866512|P1|2-week Run-in Period|Continuation Criteria Not Met|88
2563119|NCT01342913|8866510|P3|2-week Run-in Period|Protocol Violation|0
2563120|NCT01342913|8866511|P2|2-week Run-in Period|Protocol Violation|0
2563121|NCT01342913|8866512|P1|2-week Run-in Period|Protocol Violation|5
2563122|NCT01342913|8866510|P3|2-week Run-in Period|Adverse Event|0
2563123|NCT01342913|8866511|P2|2-week Run-in Period|Adverse Event|0
2563124|NCT01342913|8866512|P1|2-week Run-in Period|Adverse Event|2
2563125|NCT01342913|8866510|P3|2-week Run-in Period|Withdrawal by Subject|0
2563126|NCT01342913|8866511|P2|2-week Run-in Period|Withdrawal by Subject|0
2563127|NCT01342913|8866512|P1|2-week Run-in Period|Withdrawal by Subject|7
2563128|NCT01342913|8866510|P3|2-week Run-in Period|Physician Decision|0
2563129|NCT01342913|8866511|P2|2-week Run-in Period|Physician Decision|0
2563130|NCT01342913|8866512|P1|2-week Run-in Period|Physician Decision|6
2563131|NCT01342913|8866510|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
2563132|NCT01342913|8866511|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
2563133|NCT01342913|8866512|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66
2563134|NCT01342887|8866522|P1|Overall Study|Death|2
2563135|NCT01342640|8866563|P1|Overall Study|Other|1
2563136|NCT01342640|8866563|P1|Overall Study|Lost to Follow-up|21
2563137|NCT01342640|8866563|P1|Overall Study|Protocol Violation|16
2563138|NCT01342640|8866563|P1|Overall Study|Adverse Event|3
2563139|NCT01342510|8866658|P4|Overall Study|Protocol Violation|11
2563140|NCT01342510|8866659|P3|Overall Study|Protocol Violation|13
2563141|NCT01342510|8866660|P2|Overall Study|Protocol Violation|6
2563142|NCT01342510|8866661|P1|Overall Study|Protocol Violation|12
2563143|NCT01342484|8866678|P3|Overall Study|Withdrawal by Subject|0
2563144|NCT01342484|8866679|P2|Overall Study|Withdrawal by Subject|0
2563145|NCT01342484|8866680|P1|Overall Study|Withdrawal by Subject|1
2563146|NCT01342484|8866678|P3|Overall Study|Protocol Violation|1
2563147|NCT01342484|8866679|P2|Overall Study|Protocol Violation|0
2563148|NCT01342484|8866680|P1|Overall Study|Protocol Violation|0
2563149|NCT01342484|8866678|P3|Overall Study|Other Reasons|0
2563150|NCT01342484|8866679|P2|Overall Study|Other Reasons|0
2563151|NCT01342484|8866680|P1|Overall Study|Other Reasons|1
2563152|NCT01342445|8866736|P2|Overall Study|Experienced side effects|2
2563153|NCT01342445|8866737|P1|Overall Study|Experienced side effects|0
2563154|NCT01342341|8866753|P2|Overall Study|Lost to Follow-up|4
2563155|NCT01342341|8866754|P1|Overall Study|Lost to Follow-up|4
2563156|NCT01342211|8866765|P5|Overall Study|Randomized, but not Treated|1
2563157|NCT01342211|8866766|P4|Overall Study|Randomized, but not Treated|0
2563158|NCT01342211|8866767|P3|Overall Study|Randomized, but not Treated|0
2563159|NCT01342211|8866768|P2|Overall Study|Randomized, but not Treated|2
2563160|NCT01342211|8866769|P1|Overall Study|Randomized, but not Treated|0
2563161|NCT01342211|8866765|P5|Overall Study|Withdrawal by Subject|0
2563162|NCT01342211|8866766|P4|Overall Study|Withdrawal by Subject|1
2563163|NCT01342211|8866767|P3|Overall Study|Withdrawal by Subject|0
2563164|NCT01342211|8866768|P2|Overall Study|Withdrawal by Subject|0
2563165|NCT01342211|8866769|P1|Overall Study|Withdrawal by Subject|0
2563166|NCT01342211|8866765|P5|Overall Study|Adverse Event|1
2563167|NCT01342211|8866766|P4|Overall Study|Adverse Event|0
2563168|NCT01342211|8866767|P3|Overall Study|Adverse Event|0
2563169|NCT01342211|8866768|P2|Overall Study|Adverse Event|0
2563170|NCT01342211|8866769|P1|Overall Study|Adverse Event|0
2563171|NCT01342211|8866765|P5|Overall Study|Lost to Follow-up|0
2563172|NCT01342211|8866766|P4|Overall Study|Lost to Follow-up|1
2563173|NCT01342211|8866767|P3|Overall Study|Lost to Follow-up|0
2563174|NCT01342211|8866768|P2|Overall Study|Lost to Follow-up|0
2563175|NCT01342211|8866769|P1|Overall Study|Lost to Follow-up|0
2563176|NCT01342094|8866857|P2|Overall Study|Withdrawal by Subject|2
2563177|NCT01342094|8866858|P1|Overall Study|Withdrawal by Subject|0
2563178|NCT01342094|8866857|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
2563179|NCT01342094|8866858|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
2563180|NCT01342094|8866857|P2|Overall Study|Adverse Event|0
2563181|NCT01342094|8866858|P1|Overall Study|Adverse Event|5
2563182|NCT01342081|8866867|P3|Overall Study|Withdrawal by Subject|0
2563183|NCT01342081|8866868|P2|Overall Study|Withdrawal by Subject|1
2563184|NCT01342081|8866869|P1|Overall Study|Withdrawal by Subject|1
2563185|NCT01342081|8866867|P3|Overall Study|Physician Decision|0
2563186|NCT01342081|8866868|P2|Overall Study|Physician Decision|1
2563187|NCT01342081|8866869|P1|Overall Study|Physician Decision|0
2563188|NCT01342081|8866867|P3|Overall Study|Adverse Event|0
2563189|NCT01342081|8866868|P2|Overall Study|Adverse Event|0
2563190|NCT01342081|8866869|P1|Overall Study|Adverse Event|1
2563191|NCT01342081|8866867|P3|Overall Study|Did not receive allocated intervention|1
2563192|NCT01342081|8866868|P2|Overall Study|Did not receive allocated intervention|0
2563193|NCT01342081|8866869|P1|Overall Study|Did not receive allocated intervention|0
2563194|NCT01341990|8866888|P2|Overall Study|Withdrawal by Subject|0
2563195|NCT01341990|8866889|P1|Overall Study|Withdrawal by Subject|2
2563196|NCT01341990|8866888|P2|Overall Study|Torn Study Lens|0
2563197|NCT01341990|8866889|P1|Overall Study|Torn Study Lens|1
2563198|NCT01341990|8866888|P2|Overall Study|Adverse Event|1
2563199|NCT01341990|8866889|P1|Overall Study|Adverse Event|0
2563200|NCT01341782|8866913|P2|Overall Study|Other|0
2563201|NCT01341782|8866914|P1|Overall Study|Other|5
2563202|NCT01341782|8866913|P2|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
2563203|NCT01341782|8866914|P1|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
2563204|NCT01341782|8866913|P2|Overall Study|2 consecutive calcium values >11.5 mg/dL|1
2563205|NCT01341782|8866914|P1|Overall Study|2 consecutive calcium values >11.5 mg/dL|0
2563206|NCT01341782|8866913|P2|Overall Study|Missed 3 consecutive doses|4
2563207|NCT01341782|8866914|P1|Overall Study|Missed 3 consecutive doses|0
2563208|NCT01341782|8866913|P2|Overall Study|Withdrawal by Subject|5
2563209|NCT01341782|8866914|P1|Overall Study|Withdrawal by Subject|6
2563210|NCT01341782|8866913|P2|Overall Study|Adverse Event|1
2563211|NCT01341782|8866914|P1|Overall Study|Adverse Event|1
2563212|NCT01341639|8866932|P2|Post-Treatment|Adverse Event|2
2563213|NCT01341639|8866933|P1|Post-Treatment|Adverse Event|0
2563214|NCT01341639|8866932|P2|Post-Treatment|Withdrawal by Subject|1
2563215|NCT01341639|8866933|P1|Post-Treatment|Withdrawal by Subject|0
2563216|NCT01341639|8866932|P2|Interim Period|Protocol Violation|1
2563217|NCT01341639|8866933|P1|Interim Period|Protocol Violation|0
2563218|NCT01341639|8866932|P2|Interim Period|Physician Decision|1
2563219|NCT01341639|8866933|P1|Interim Period|Physician Decision|0
2563220|NCT01341639|8866932|P2|Interim Period|Lost to Follow-up|0
2563221|NCT01341639|8866933|P1|Interim Period|Lost to Follow-up|2
2563222|NCT01341639|8866932|P2|Interim Period|Withdrawal by Subject|7
2563223|NCT01341639|8866933|P1|Interim Period|Withdrawal by Subject|6
2563224|NCT01341639|8866932|P2|Infant Series|Site 0048 Participants|16
2563225|NCT01341639|8866933|P1|Infant Series|Site 0048 Participants|17
2563226|NCT01341639|8866932|P2|Infant Series|Lost to Follow-up|2
2563227|NCT01341639|8866933|P1|Infant Series|Lost to Follow-up|0
2563228|NCT01341639|8866932|P2|Infant Series|Withdrawal by Subject|8
2563229|NCT01341639|8866933|P1|Infant Series|Withdrawal by Subject|11
2563230|NCT01341639|8866932|P2|Infant Series|Adverse Event|5
2563231|NCT01341639|8866933|P1|Infant Series|Adverse Event|0
2563232|NCT01341639|8866932|P2|Infant Series|Not Vaccinated|1
2563233|NCT01341639|8866933|P1|Infant Series|Not Vaccinated|0
2563234|NCT01341639|8866932|P2|Infant Series|Protocol Violation|0
2563235|NCT01341639|8866933|P1|Infant Series|Protocol Violation|1
2563236|NCT01341587|8866978|P2|Overall Study|stopped using the meters|10
2563237|NCT01341587|8866979|P1|Overall Study|stopped using the meters|2
2563238|NCT01341587|8866978|P2|Overall Study|Lost to Follow-up|0
2563239|NCT01341587|8866979|P1|Overall Study|Lost to Follow-up|2
2563240|NCT01341470|8866991|P6|Overall Study|Sponsor decision|1
2563241|NCT01341470|8866992|P5|Overall Study|Sponsor decision|0
2563242|NCT01341470|8866993|P4|Overall Study|Sponsor decision|1
2563243|NCT01341470|8866994|P3|Overall Study|Sponsor decision|1
2563244|NCT01341470|8866995|P2|Overall Study|Sponsor decision|0
2563245|NCT01341470|8866996|P1|Overall Study|Sponsor decision|0
2563246|NCT01341457|8867030|P2|Overall Study|Adverse Event|0
2563247|NCT01341457|8867031|P1|Overall Study|Adverse Event|2
2563248|NCT01340976|8867076|P6|Overall Study|Adverse Event|0
2563249|NCT01340976|8867077|P5|Overall Study|Adverse Event|0
2563250|NCT01340976|8867078|P4|Overall Study|Adverse Event|0
2563251|NCT01340976|8867079|P3|Overall Study|Adverse Event|0
2563252|NCT01340976|8867080|P2|Overall Study|Adverse Event|1
2563253|NCT01340976|8867081|P1|Overall Study|Adverse Event|0
2563254|NCT01340976|8867076|P6|Overall Study|Other anemia treatment|1
2563255|NCT01340976|8867077|P5|Overall Study|Other anemia treatment|0
2563256|NCT01340976|8867078|P4|Overall Study|Other anemia treatment|1
2563257|NCT01340976|8867079|P3|Overall Study|Other anemia treatment|2
2563258|NCT01340976|8867080|P2|Overall Study|Other anemia treatment|0
2563259|NCT01340976|8867081|P1|Overall Study|Other anemia treatment|1
2563260|NCT01340976|8867076|P6|Overall Study|Withdrawal by Subject|0
2563261|NCT01340976|8867077|P5|Overall Study|Withdrawal by Subject|1
2563262|NCT01340976|8867078|P4|Overall Study|Withdrawal by Subject|1
2563263|NCT01340976|8867079|P3|Overall Study|Withdrawal by Subject|0
2563264|NCT01340976|8867080|P2|Overall Study|Withdrawal by Subject|0
2563265|NCT01340976|8867081|P1|Overall Study|Withdrawal by Subject|0
2563266|NCT01340976|8867076|P6|Overall Study|Dose Limiting Toxicity Stopping Rule|0
2563267|NCT01340976|8867077|P5|Overall Study|Dose Limiting Toxicity Stopping Rule|0
2563268|NCT01340976|8867078|P4|Overall Study|Dose Limiting Toxicity Stopping Rule|0
2563269|NCT01340976|8867079|P3|Overall Study|Dose Limiting Toxicity Stopping Rule|0
2563270|NCT01340976|8867080|P2|Overall Study|Dose Limiting Toxicity Stopping Rule|0
2563271|NCT01340976|8867081|P1|Overall Study|Dose Limiting Toxicity Stopping Rule|1
2563272|NCT01340976|8867076|P6|Overall Study|Death|0
2563273|NCT01340976|8867077|P5|Overall Study|Death|0
2563274|NCT01340976|8867078|P4|Overall Study|Death|0
2563275|NCT01340976|8867079|P3|Overall Study|Death|0
2563276|NCT01340976|8867080|P2|Overall Study|Death|1
2563277|NCT01340976|8867081|P1|Overall Study|Death|0
2563278|NCT01340976|8867076|P6|Overall Study|Physician Decision|0
2563279|NCT01340976|8867077|P5|Overall Study|Physician Decision|1
2563280|NCT01340976|8867078|P4|Overall Study|Physician Decision|1
2563281|NCT01340976|8867079|P3|Overall Study|Physician Decision|1
2563282|NCT01340976|8867080|P2|Overall Study|Physician Decision|0
2563283|NCT01340976|8867081|P1|Overall Study|Physician Decision|2
2563284|NCT01340937|8867119|P4|Period 3: Toddler Vaccinations|Technical problem|0
2563285|NCT01340937|8867120|P3|Period 3: Toddler Vaccinations|Technical problem|1
2563286|NCT01340937|8867121|P2|Period 3: Toddler Vaccinations|Technical problem|1
2563287|NCT01340937|8867122|P1|Period 3: Toddler Vaccinations|Technical problem|1
2563288|NCT01340937|8867119|P4|Period 3: Toddler Vaccinations|Protocol Violation|1
2563289|NCT01340937|8867120|P3|Period 3: Toddler Vaccinations|Protocol Violation|0
2563290|NCT01340937|8867121|P2|Period 3: Toddler Vaccinations|Protocol Violation|0
2563291|NCT01340937|8867122|P1|Period 3: Toddler Vaccinations|Protocol Violation|0
2563292|NCT01340937|8867119|P4|Period 3: Toddler Vaccinations|Lost to Follow-up|8
2563293|NCT01340937|8867120|P3|Period 3: Toddler Vaccinations|Lost to Follow-up|7
2563294|NCT01340937|8867121|P2|Period 3: Toddler Vaccinations|Lost to Follow-up|14
2563295|NCT01340937|8867122|P1|Period 3: Toddler Vaccinations|Lost to Follow-up|6
2563296|NCT01340937|8867119|P4|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
2563297|NCT01340937|8867120|P3|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
2563298|NCT01340937|8867121|P2|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
2563299|NCT01340937|8867122|P1|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
2563300|NCT01340937|8867119|P4|Period 2: Interim Period|Technical problems|3
2563301|NCT01340937|8867120|P3|Period 2: Interim Period|Technical problems|6
2563302|NCT01340937|8867121|P2|Period 2: Interim Period|Technical problems|4
2563303|NCT01340937|8867122|P1|Period 2: Interim Period|Technical problems|4
2563304|NCT01340937|8867119|P4|Period 2: Interim Period|Protocol Violation|3
2563305|NCT01340937|8867120|P3|Period 2: Interim Period|Protocol Violation|6
2563306|NCT01340937|8867121|P2|Period 2: Interim Period|Protocol Violation|3
2563307|NCT01340937|8867122|P1|Period 2: Interim Period|Protocol Violation|5
2563308|NCT01340937|8867119|P4|Period 2: Interim Period|Physician Decision|0
2563309|NCT01340937|8867120|P3|Period 2: Interim Period|Physician Decision|1
2563310|NCT01340937|8867121|P2|Period 2: Interim Period|Physician Decision|1
2563311|NCT01340937|8867122|P1|Period 2: Interim Period|Physician Decision|0
2563312|NCT01340937|8867119|P4|Period 2: Interim Period|Lost to Follow-up|23
2563313|NCT01340937|8867120|P3|Period 2: Interim Period|Lost to Follow-up|53
2563314|NCT01340937|8867121|P2|Period 2: Interim Period|Lost to Follow-up|48
2563315|NCT01340937|8867122|P1|Period 2: Interim Period|Lost to Follow-up|29
2563316|NCT01340937|8867119|P4|Period 2: Interim Period|Adverse Event|0
2563317|NCT01340937|8867120|P3|Period 2: Interim Period|Adverse Event|1
2563318|NCT01340937|8867121|P2|Period 2: Interim Period|Adverse Event|0
2563319|NCT01340937|8867122|P1|Period 2: Interim Period|Adverse Event|1
2563320|NCT01340937|8867119|P4|Period 2: Interim Period|Withdrawal by Subject|12
2563321|NCT01340937|8867120|P3|Period 2: Interim Period|Withdrawal by Subject|17
2563322|NCT01340937|8867121|P2|Period 2: Interim Period|Withdrawal by Subject|23
2563323|NCT01340937|8867122|P1|Period 2: Interim Period|Withdrawal by Subject|28
2563324|NCT01340937|8867119|P4|Period 1: Infant Series|Randomized but not vaccinated|1
2563325|NCT01340937|8867120|P3|Period 1: Infant Series|Randomized but not vaccinated|2
2563326|NCT01340937|8867121|P2|Period 1: Infant Series|Randomized but not vaccinated|5
2563327|NCT01340937|8867122|P1|Period 1: Infant Series|Randomized but not vaccinated|0
2563328|NCT01340937|8867119|P4|Period 1: Infant Series|Withdrawal by Subject|15
2563329|NCT01340937|8867120|P3|Period 1: Infant Series|Withdrawal by Subject|30
2563330|NCT01340937|8867121|P2|Period 1: Infant Series|Withdrawal by Subject|32
2563331|NCT01340937|8867122|P1|Period 1: Infant Series|Withdrawal by Subject|33
2563332|NCT01340937|8867119|P4|Period 1: Infant Series|Protocol Violation|3
2563333|NCT01340937|8867120|P3|Period 1: Infant Series|Protocol Violation|4
2563334|NCT01340937|8867121|P2|Period 1: Infant Series|Protocol Violation|4
2563335|NCT01340937|8867122|P1|Period 1: Infant Series|Protocol Violation|1
2563336|NCT01340937|8867119|P4|Period 1: Infant Series|Physician Decision|0
2563337|NCT01340937|8867120|P3|Period 1: Infant Series|Physician Decision|1
2563338|NCT01340937|8867121|P2|Period 1: Infant Series|Physician Decision|3
2563339|NCT01340937|8867122|P1|Period 1: Infant Series|Physician Decision|2
2563340|NCT01340937|8867119|P4|Period 1: Infant Series|Lost to Follow-up|13
2563341|NCT01340937|8867120|P3|Period 1: Infant Series|Lost to Follow-up|12
2563342|NCT01340937|8867121|P2|Period 1: Infant Series|Lost to Follow-up|14
2563343|NCT01340937|8867122|P1|Period 1: Infant Series|Lost to Follow-up|20
2563344|NCT01340937|8867119|P4|Period 1: Infant Series|Death|0
2563345|NCT01340937|8867120|P3|Period 1: Infant Series|Death|2
2563346|NCT01340937|8867121|P2|Period 1: Infant Series|Death|0
2563347|NCT01340937|8867122|P1|Period 1: Infant Series|Death|2
2563348|NCT01340937|8867119|P4|Period 1: Infant Series|Adverse Event|0
2563349|NCT01340937|8867120|P3|Period 1: Infant Series|Adverse Event|4
2563350|NCT01340937|8867121|P2|Period 1: Infant Series|Adverse Event|1
2563351|NCT01340937|8867122|P1|Period 1: Infant Series|Adverse Event|0
2563352|NCT01340937|8867119|P4|Period 1: Infant Series|Other protocol criterion not met|0
2563353|NCT01340937|8867120|P3|Period 1: Infant Series|Other protocol criterion not met|1
2563354|NCT01340937|8867121|P2|Period 1: Infant Series|Other protocol criterion not met|1
2563355|NCT01340937|8867122|P1|Period 1: Infant Series|Other protocol criterion not met|0
2563356|NCT01340898|8867282|P3|Booster Phase|Lost to Follow-up|3
2563357|NCT01340898|8867283|P2|Booster Phase|Lost to Follow-up|2
2563358|NCT01340898|8867284|P1|Booster Phase|Lost to Follow-up|4
2563359|NCT01340898|8867282|P3|Booster Phase|Migrated/moved from study area|0
2563360|NCT01340898|8867283|P2|Booster Phase|Migrated/moved from study area|0
2563361|NCT01340898|8867284|P1|Booster Phase|Migrated/moved from study area|3
2563362|NCT01340898|8867282|P3|Booster Phase|Withdrawal by Subject|4
2563363|NCT01340898|8867283|P2|Booster Phase|Withdrawal by Subject|0
2563364|NCT01340898|8867284|P1|Booster Phase|Withdrawal by Subject|3
2563365|NCT01340898|8867282|P3|Primary Phase|Lost to Follow-up|0
2563366|NCT01340898|8867283|P2|Primary Phase|Lost to Follow-up|1
2563367|NCT01340898|8867284|P1|Primary Phase|Lost to Follow-up|4
2563368|NCT01340898|8867282|P3|Primary Phase|Migrated/moved from study area|0
2563369|NCT01340898|8867283|P2|Primary Phase|Migrated/moved from study area|1
2563370|NCT01340898|8867284|P1|Primary Phase|Migrated/moved from study area|4
2563371|NCT01340898|8867282|P3|Primary Phase|Withdrawal by Subject|5
2563372|NCT01340898|8867283|P2|Primary Phase|Withdrawal by Subject|7
2563373|NCT01340898|8867284|P1|Primary Phase|Withdrawal by Subject|8
2563374|NCT01340898|8867282|P3|Primary Phase|Serious Adverse Events|1
2563375|NCT01340898|8867283|P2|Primary Phase|Serious Adverse Events|0
2563376|NCT01340898|8867284|P1|Primary Phase|Serious Adverse Events|0
2563377|NCT01340872|8867386|P4|Open-label Phase|Worsening of IBD|0
2563378|NCT01340872|8867387|P3|Open-label Phase|Worsening of IBD|1
2563379|NCT01340872|8867388|P2|Open-label Phase|Worsening of IBD|0
2563380|NCT01340872|8867389|P1|Open-label Phase|Worsening of IBD|0
2563381|NCT01340872|8867386|P4|Open-label Phase|Withdrawal by Subject|6
2563382|NCT01340872|8867387|P3|Open-label Phase|Withdrawal by Subject|1
2563383|NCT01340872|8867388|P2|Open-label Phase|Withdrawal by Subject|0
2563384|NCT01340872|8867389|P1|Open-label Phase|Withdrawal by Subject|0
2563385|NCT01340872|8867386|P4|Open-label Phase|Adverse Event|4
2563386|NCT01340872|8867387|P3|Open-label Phase|Adverse Event|8
2563387|NCT01340872|8867388|P2|Open-label Phase|Adverse Event|0
2563388|NCT01340872|8867389|P1|Open-label Phase|Adverse Event|0
2563389|NCT01340872|8867386|P4|Open-label Phase|Pregnancy|0
2563390|NCT01340872|8867387|P3|Open-label Phase|Pregnancy|1
2563391|NCT01340872|8867388|P2|Open-label Phase|Pregnancy|0
2563392|NCT01340872|8867389|P1|Open-label Phase|Pregnancy|0
2563393|NCT01340872|8867386|P4|Open-label Phase|Physician Decision|1
2563394|NCT01340872|8867387|P3|Open-label Phase|Physician Decision|2
2563395|NCT01340872|8867388|P2|Open-label Phase|Physician Decision|0
2563396|NCT01340872|8867389|P1|Open-label Phase|Physician Decision|0
2563397|NCT01340872|8867386|P4|Double-blind Phase|Protocol Violation|0
2563398|NCT01340872|8867387|P3|Double-blind Phase|Protocol Violation|0
2563399|NCT01340872|8867388|P2|Double-blind Phase|Protocol Violation|1
2563400|NCT01340872|8867389|P1|Double-blind Phase|Protocol Violation|0
2563401|NCT01340872|8867386|P4|Double-blind Phase|Lost to Follow-up|0
2563402|NCT01340872|8867387|P3|Double-blind Phase|Lost to Follow-up|0
2563403|NCT01340872|8867388|P2|Double-blind Phase|Lost to Follow-up|1
2563404|NCT01340872|8867389|P1|Double-blind Phase|Lost to Follow-up|0
2563405|NCT01340872|8867386|P4|Double-blind Phase|Withdrawal by Subject|0
2563406|NCT01340872|8867387|P3|Double-blind Phase|Withdrawal by Subject|0
2563407|NCT01340872|8867388|P2|Double-blind Phase|Withdrawal by Subject|5
2563408|NCT01340872|8867389|P1|Double-blind Phase|Withdrawal by Subject|3
2563409|NCT01340872|8867386|P4|Double-blind Phase|Adverse Event|0
2563410|NCT01340872|8867387|P3|Double-blind Phase|Adverse Event|0
2563411|NCT01340872|8867388|P2|Double-blind Phase|Adverse Event|4
2563412|NCT01340872|8867389|P1|Double-blind Phase|Adverse Event|6
2563413|NCT01340794|8867449|P2|Overall Study|Withdrawal by Subject|1
2563414|NCT01340794|8867450|P1|Overall Study|Withdrawal by Subject|0
2563415|NCT01340768|8867466|P2|Overall Study|Other|0
2563416|NCT01340768|8867467|P1|Overall Study|Other|2
2563417|NCT01340768|8867466|P2|Overall Study|Withdrawal by Subject|1
2563418|NCT01340768|8867467|P1|Overall Study|Withdrawal by Subject|5
2563419|NCT01340768|8867466|P2|Overall Study|Lost to Follow-up|4
2563420|NCT01340768|8867467|P1|Overall Study|Lost to Follow-up|10
2563421|NCT01340664|8867478|P3|Overall Study|Other|2
2563422|NCT01340664|8867479|P2|Overall Study|Other|2
2563423|NCT01340664|8867480|P1|Overall Study|Other|1
2563424|NCT01340664|8867478|P3|Overall Study|Creatinine or eGFR withdrawal criteria|2
2563425|NCT01340664|8867479|P2|Overall Study|Creatinine or eGFR withdrawal criteria|1
2563426|NCT01340664|8867480|P1|Overall Study|Creatinine or eGFR withdrawal criteria|0
2563427|NCT01340664|8867478|P3|Overall Study|Glycemic withdrawal criteria|0
2563428|NCT01340664|8867479|P2|Overall Study|Glycemic withdrawal criteria|0
2563429|NCT01340664|8867480|P1|Overall Study|Glycemic withdrawal criteria|2
2563430|NCT01340664|8867478|P3|Overall Study|Withdrawal by Subject|0
2563431|NCT01340664|8867479|P2|Overall Study|Withdrawal by Subject|4
2563432|NCT01340664|8867480|P1|Overall Study|Withdrawal by Subject|2
2563433|NCT01340664|8867478|P3|Overall Study|Lost to Follow-up|2
2563434|NCT01340664|8867479|P2|Overall Study|Lost to Follow-up|0
2563435|NCT01340664|8867480|P1|Overall Study|Lost to Follow-up|2
2563436|NCT01340664|8867478|P3|Overall Study|Adverse Event|7
2563437|NCT01340664|8867479|P2|Overall Study|Adverse Event|1
2563438|NCT01340664|8867480|P1|Overall Study|Adverse Event|0
2563439|NCT01340651|8867497|P1|Overall Study|Commercial Supply per Sponsor|12
2563440|NCT01340651|8867497|P1|Overall Study|Consent Withdrawn|2
2563441|NCT01340651|8867497|P1|Overall Study|Adverse Event|3
2563442|NCT01340625|8867513|P2|Washout Period of 28 Days|Withdrawal by Subject|0
2563443|NCT01340625|8867514|P1|Washout Period of 28 Days|Withdrawal by Subject|1
2563444|NCT01340625|8867513|P2|First Intervention|Adverse Event|0
2563445|NCT01340625|8867514|P1|First Intervention|Adverse Event|1
2563446|NCT01340495|8867619|P1|Overall Study|Withdrawal by Subject|1
2563447|NCT01340300|8867630|P4|Overall Study|Unrelated sickness|1
2563448|NCT01340300|8867631|P3|Overall Study|Unrelated sickness|0
2563449|NCT01340300|8867632|P2|Overall Study|Unrelated sickness|2
2563450|NCT01340300|8867633|P1|Overall Study|Unrelated sickness|0
2563451|NCT01340300|8867630|P4|Overall Study|Physician Decision|0
2563452|NCT01340300|8867631|P3|Overall Study|Physician Decision|0
2563453|NCT01340300|8867632|P2|Overall Study|Physician Decision|1
2563454|NCT01340300|8867633|P1|Overall Study|Physician Decision|0
2563455|NCT01340300|8867630|P4|Overall Study|Adverse Event|0
2563456|NCT01340300|8867631|P3|Overall Study|Adverse Event|4
2563457|NCT01340300|8867632|P2|Overall Study|Adverse Event|0
2563458|NCT01340300|8867633|P1|Overall Study|Adverse Event|1
2563459|NCT01340300|8867630|P4|Overall Study|Withdrawal by Subject|3
2563460|NCT01340300|8867631|P3|Overall Study|Withdrawal by Subject|6
2563461|NCT01340300|8867632|P2|Overall Study|Withdrawal by Subject|6
2563462|NCT01340300|8867633|P1|Overall Study|Withdrawal by Subject|5
2563463|NCT01340300|8867630|P4|Overall Study|Lost to Follow-up|10
2563464|NCT01340300|8867631|P3|Overall Study|Lost to Follow-up|5
2563465|NCT01340300|8867632|P2|Overall Study|Lost to Follow-up|0
2563466|NCT01340300|8867633|P1|Overall Study|Lost to Follow-up|3
2563467|NCT01340209|8867666|P3|Overall Study|Other reason not defined above|4
2563468|NCT01340209|8867667|P2|Overall Study|Other reason not defined above|5
2563469|NCT01340209|8867668|P1|Overall Study|Other reason not defined above|3
2563470|NCT01340209|8867666|P3|Overall Study|Withdrawal by Subject|1
2563471|NCT01340209|8867667|P2|Overall Study|Withdrawal by Subject|0
2563472|NCT01340209|8867668|P1|Overall Study|Withdrawal by Subject|0
2563473|NCT01340209|8867666|P3|Overall Study|Protocol Violation|1
2563474|NCT01340209|8867667|P2|Overall Study|Protocol Violation|2
2563475|NCT01340209|8867668|P1|Overall Study|Protocol Violation|1
2563476|NCT01340209|8867666|P3|Overall Study|Adverse Event|2
2563477|NCT01340209|8867667|P2|Overall Study|Adverse Event|1
2563478|NCT01340209|8867668|P1|Overall Study|Adverse Event|1
2563479|NCT01340196|8867703|P1|Treat. Period 3 (Faldaprevir)|Adverse Event|2
2563480|NCT01340066|8867743|P3|5 Week Double Blind Randomization Period|Withdrawal by Subject|1
2563481|NCT01340066|8867744|P2|5 Week Double Blind Randomization Period|Withdrawal by Subject|2
2563482|NCT01340066|8867745|P1|5 Week Double Blind Randomization Period|Withdrawal by Subject|0
2563483|NCT01340066|8867743|P3|5 Week Double Blind Randomization Period|Physician Decision|0
2563484|NCT01340066|8867744|P2|5 Week Double Blind Randomization Period|Physician Decision|1
2563485|NCT01340066|8867745|P1|5 Week Double Blind Randomization Period|Physician Decision|0
2563486|NCT01340066|8867743|P3|5 Week Double Blind Randomization Period|Adverse Event|2
2563487|NCT01340066|8867744|P2|5 Week Double Blind Randomization Period|Adverse Event|2
2563488|NCT01340066|8867745|P1|5 Week Double Blind Randomization Period|Adverse Event|0
2563489|NCT01340066|8867743|P3|Placebo Run in Period|Screen Failures|0
2563490|NCT01340066|8867744|P2|Placebo Run in Period|Screen Failures|0
2563491|NCT01340066|8867745|P1|Placebo Run in Period|Screen Failures|27
2563492|NCT01340027|8867785|P12|Overall Study|Miscellaneous|0
2563493|NCT01340027|8867786|P11|Overall Study|Miscellaneous|1
2563494|NCT01340027|8867787|P10|Overall Study|Miscellaneous|0
2563495|NCT01340027|8867788|P9|Overall Study|Miscellaneous|0
2563496|NCT01340027|8867789|P8|Overall Study|Miscellaneous|0
2563497|NCT01340027|8867790|P7|Overall Study|Miscellaneous|0
2563498|NCT01340027|8867791|P6|Overall Study|Miscellaneous|0
2563499|NCT01340027|8867792|P5|Overall Study|Miscellaneous|0
2563500|NCT01340027|8867793|P4|Overall Study|Miscellaneous|1
2563501|NCT01340027|8867794|P3|Overall Study|Miscellaneous|0
2563502|NCT01340027|8867795|P2|Overall Study|Miscellaneous|0
2563503|NCT01340027|8867796|P1|Overall Study|Miscellaneous|0
2563504|NCT01340027|8867785|P12|Overall Study|Withdrawal by Subject|1
2563505|NCT01340027|8867786|P11|Overall Study|Withdrawal by Subject|0
2563506|NCT01340027|8867787|P10|Overall Study|Withdrawal by Subject|2
2563507|NCT01340027|8867788|P9|Overall Study|Withdrawal by Subject|1
2563508|NCT01340027|8867789|P8|Overall Study|Withdrawal by Subject|4
2563509|NCT01340027|8867790|P7|Overall Study|Withdrawal by Subject|3
2563510|NCT01340027|8867791|P6|Overall Study|Withdrawal by Subject|2
2563511|NCT01340027|8867792|P5|Overall Study|Withdrawal by Subject|3
2563512|NCT01340027|8867793|P4|Overall Study|Withdrawal by Subject|3
2563513|NCT01340027|8867794|P3|Overall Study|Withdrawal by Subject|1
2563514|NCT01340027|8867795|P2|Overall Study|Withdrawal by Subject|3
2563515|NCT01340027|8867796|P1|Overall Study|Withdrawal by Subject|4
2563516|NCT01340027|8867785|P12|Overall Study|Protocol Violation|0
2563517|NCT01340027|8867786|P11|Overall Study|Protocol Violation|0
2563518|NCT01340027|8867787|P10|Overall Study|Protocol Violation|2
2563519|NCT01340027|8867788|P9|Overall Study|Protocol Violation|2
2563520|NCT01340027|8867789|P8|Overall Study|Protocol Violation|1
2563521|NCT01340027|8867790|P7|Overall Study|Protocol Violation|0
2563522|NCT01340027|8867791|P6|Overall Study|Protocol Violation|0
2563523|NCT01340027|8867792|P5|Overall Study|Protocol Violation|6
2563524|NCT01340027|8867793|P4|Overall Study|Protocol Violation|0
2563525|NCT01340027|8867794|P3|Overall Study|Protocol Violation|0
2563526|NCT01340027|8867795|P2|Overall Study|Protocol Violation|2
2563527|NCT01340027|8867796|P1|Overall Study|Protocol Violation|1
2563528|NCT01340027|8867785|P12|Overall Study|Lost to Follow-up|0
2563529|NCT01340027|8867786|P11|Overall Study|Lost to Follow-up|0
2563530|NCT01340027|8867787|P10|Overall Study|Lost to Follow-up|1
2563531|NCT01340027|8867788|P9|Overall Study|Lost to Follow-up|0
2563532|NCT01340027|8867789|P8|Overall Study|Lost to Follow-up|0
2563533|NCT01340027|8867790|P7|Overall Study|Lost to Follow-up|1
2563534|NCT01340027|8867791|P6|Overall Study|Lost to Follow-up|0
2563535|NCT01340027|8867792|P5|Overall Study|Lost to Follow-up|0
2563536|NCT01340027|8867793|P4|Overall Study|Lost to Follow-up|0
2563537|NCT01340027|8867794|P3|Overall Study|Lost to Follow-up|0
2563538|NCT01340027|8867795|P2|Overall Study|Lost to Follow-up|1
2563539|NCT01340027|8867796|P1|Overall Study|Lost to Follow-up|0
2563540|NCT01340027|8867785|P12|Overall Study|Lack of Efficacy|0
2563541|NCT01340027|8867786|P11|Overall Study|Lack of Efficacy|0
2563542|NCT01340027|8867787|P10|Overall Study|Lack of Efficacy|0
2563543|NCT01340027|8867788|P9|Overall Study|Lack of Efficacy|1
2563544|NCT01340027|8867789|P8|Overall Study|Lack of Efficacy|1
2563545|NCT01340027|8867790|P7|Overall Study|Lack of Efficacy|1
2563546|NCT01340027|8867791|P6|Overall Study|Lack of Efficacy|0
2563547|NCT01340027|8867792|P5|Overall Study|Lack of Efficacy|0
2563548|NCT01340027|8867793|P4|Overall Study|Lack of Efficacy|0
2563549|NCT01340027|8867794|P3|Overall Study|Lack of Efficacy|0
2563550|NCT01340027|8867795|P2|Overall Study|Lack of Efficacy|0
2563551|NCT01340027|8867796|P1|Overall Study|Lack of Efficacy|0
2563552|NCT01340027|8867785|P12|Overall Study|Adverse Event|3
2563553|NCT01340027|8867786|P11|Overall Study|Adverse Event|1
2563554|NCT01340027|8867787|P10|Overall Study|Adverse Event|1
2563555|NCT01340027|8867788|P9|Overall Study|Adverse Event|4
2563556|NCT01340027|8867789|P8|Overall Study|Adverse Event|1
2563557|NCT01340027|8867790|P7|Overall Study|Adverse Event|2
2563558|NCT01340027|8867791|P6|Overall Study|Adverse Event|2
2563559|NCT01340027|8867792|P5|Overall Study|Adverse Event|1
2563560|NCT01340027|8867793|P4|Overall Study|Adverse Event|0
2563561|NCT01340027|8867794|P3|Overall Study|Adverse Event|2
2563562|NCT01340027|8867795|P2|Overall Study|Adverse Event|1
2563563|NCT01340027|8867796|P1|Overall Study|Adverse Event|0
2563564|NCT01340027|8867785|P12|Overall Study|Randomized but Never Received Study Drug|0
2563565|NCT01340027|8867786|P11|Overall Study|Randomized but Never Received Study Drug|0
2563566|NCT01340027|8867787|P10|Overall Study|Randomized but Never Received Study Drug|0
2563567|NCT01340027|8867788|P9|Overall Study|Randomized but Never Received Study Drug|0
2563568|NCT01340027|8867789|P8|Overall Study|Randomized but Never Received Study Drug|0
2563569|NCT01340027|8867790|P7|Overall Study|Randomized but Never Received Study Drug|0
2563570|NCT01340027|8867791|P6|Overall Study|Randomized but Never Received Study Drug|0
2563571|NCT01340027|8867792|P5|Overall Study|Randomized but Never Received Study Drug|0
2563572|NCT01340027|8867793|P4|Overall Study|Randomized but Never Received Study Drug|0
2563573|NCT01340027|8867794|P3|Overall Study|Randomized but Never Received Study Drug|1
2563574|NCT01340027|8867795|P2|Overall Study|Randomized but Never Received Study Drug|0
2563575|NCT01340027|8867796|P1|Overall Study|Randomized but Never Received Study Drug|0
2563576|NCT01340014|8868172|P2|Period 2, Second 7 Days|Adverse Event|1
2563577|NCT01340014|8868173|P1|Period 2, Second 7 Days|Adverse Event|0
2563578|NCT01340014|8868172|P2|Period 1, First 7 Days|Personal Reasons|0
2563579|NCT01340014|8868173|P1|Period 1, First 7 Days|Personal Reasons|1
2563580|NCT01340014|8868172|P2|Period 1, First 7 Days|Adverse Event|0
2563581|NCT01340014|8868173|P1|Period 1, First 7 Days|Adverse Event|1
2563582|NCT01339923|8868194|P7|Overall Study|Withdrawal by Subject|2
2563583|NCT01339923|8868195|P6|Overall Study|Withdrawal by Subject|3
2563584|NCT01339923|8868196|P5|Overall Study|Withdrawal by Subject|4
2563585|NCT01339923|8868197|P4|Overall Study|Withdrawal by Subject|1
2563586|NCT01339923|8868198|P3|Overall Study|Withdrawal by Subject|6
2563587|NCT01339923|8868199|P2|Overall Study|Withdrawal by Subject|11
2563588|NCT01339923|8868200|P1|Overall Study|Withdrawal by Subject|7
2563589|NCT01339923|8868194|P7|Overall Study|Unable to Classify|5
2563590|NCT01339923|8868195|P6|Overall Study|Unable to Classify|1
2563591|NCT01339923|8868196|P5|Overall Study|Unable to Classify|0
2563592|NCT01339923|8868197|P4|Overall Study|Unable to Classify|0
2563593|NCT01339923|8868198|P3|Overall Study|Unable to Classify|1
2563594|NCT01339923|8868199|P2|Overall Study|Unable to Classify|0
2563595|NCT01339923|8868200|P1|Overall Study|Unable to Classify|1
2563596|NCT01339923|8868194|P7|Overall Study|Protocol Violation|1
2563597|NCT01339923|8868195|P6|Overall Study|Protocol Violation|3
2563598|NCT01339923|8868196|P5|Overall Study|Protocol Violation|0
2563599|NCT01339923|8868197|P4|Overall Study|Protocol Violation|0
2563600|NCT01339923|8868198|P3|Overall Study|Protocol Violation|0
2563601|NCT01339923|8868199|P2|Overall Study|Protocol Violation|0
2563602|NCT01339923|8868200|P1|Overall Study|Protocol Violation|0
2563603|NCT01339923|8868194|P7|Overall Study|Lost to Follow-up|5
2563604|NCT01339923|8868195|P6|Overall Study|Lost to Follow-up|1
2563605|NCT01339923|8868196|P5|Overall Study|Lost to Follow-up|1
2563606|NCT01339923|8868197|P4|Overall Study|Lost to Follow-up|3
2563607|NCT01339923|8868198|P3|Overall Study|Lost to Follow-up|0
2563608|NCT01339923|8868199|P2|Overall Study|Lost to Follow-up|4
2563609|NCT01339923|8868200|P1|Overall Study|Lost to Follow-up|4
2563610|NCT01339923|8868194|P7|Overall Study|Inappropriate Enrollment|0
2563611|NCT01339923|8868195|P6|Overall Study|Inappropriate Enrollment|1
2563612|NCT01339923|8868196|P5|Overall Study|Inappropriate Enrollment|0
2563613|NCT01339923|8868197|P4|Overall Study|Inappropriate Enrollment|0
2563614|NCT01339923|8868198|P3|Overall Study|Inappropriate Enrollment|0
2563615|NCT01339923|8868199|P2|Overall Study|Inappropriate Enrollment|0
2563616|NCT01339923|8868200|P1|Overall Study|Inappropriate Enrollment|1
2563617|NCT01339923|8868194|P7|Overall Study|Adverse Event|1
2563618|NCT01339923|8868195|P6|Overall Study|Adverse Event|0
2563619|NCT01339923|8868196|P5|Overall Study|Adverse Event|0
2563620|NCT01339923|8868197|P4|Overall Study|Adverse Event|0
2563621|NCT01339923|8868198|P3|Overall Study|Adverse Event|1
2563622|NCT01339923|8868199|P2|Overall Study|Adverse Event|1
2563623|NCT01339923|8868200|P1|Overall Study|Adverse Event|1
2563624|NCT01339910|8868271|P2|Overall Study|Disease relapse|4
2563625|NCT01339910|8868272|P1|Overall Study|Disease relapse|1
2563626|NCT01339910|8868271|P2|Overall Study|Physician Decision|0
2563627|NCT01339910|8868272|P1|Overall Study|Physician Decision|1
2563628|NCT01339910|8868271|P2|Overall Study|Withdrawal by Subject|0
2563629|NCT01339910|8868272|P1|Overall Study|Withdrawal by Subject|1
2563630|NCT01339897|8868310|P4|Overall Study|Adverse Event|1
2563631|NCT01339897|8868311|P3|Overall Study|Adverse Event|0
2563632|NCT01339897|8868312|P2|Overall Study|Adverse Event|0
2563633|NCT01339897|8868313|P1|Overall Study|Adverse Event|1
2563634|NCT01339832|8868366|P1|Overall Study|Death|11
2563635|NCT01339832|8868366|P1|Overall Study|Lost to Follow-up|3
2563636|NCT01339429|8868377|P1|Overall Study|Physician Decision|3
2563637|NCT01339429|8868377|P1|Overall Study|Withdrawal by Subject|1
2563638|NCT01339390|8868417|P2|Overall Study|Lost to Follow-up|127
2563639|NCT01339390|8868418|P1|Overall Study|Lost to Follow-up|125
2563640|NCT01339390|8868417|P2|Overall Study|Death|29
2563641|NCT01339390|8868418|P1|Overall Study|Death|32
2563642|NCT01339273|8868435|P2|Overall Study|Lost to Follow-up|8
2563643|NCT01339273|8868436|P1|Overall Study|Lost to Follow-up|8
2563644|NCT01339052|8868511|P2|Overall Study|Physician Decision|0
2563645|NCT01339052|8868512|P1|Overall Study|Physician Decision|1
2563646|NCT01339052|8868511|P2|Overall Study|Withdrawal by Subject|3
2563647|NCT01339052|8868512|P1|Overall Study|Withdrawal by Subject|0
2563648|NCT01339052|8868511|P2|Overall Study|Adverse Event|1
2563649|NCT01339052|8868512|P1|Overall Study|Adverse Event|1
2563650|NCT01339052|8868511|P2|Overall Study|Disease progression|46
2563651|NCT01339052|8868512|P1|Overall Study|Disease progression|13
2563652|NCT01339000|8868538|P2|Overall Study|study closed due to lack of drug supply|0
2563653|NCT01339000|8868539|P1|Overall Study|study closed due to lack of drug supply|1
2563654|NCT01338987|8868558|P5|Overall Study|Disease progression on study|0
2563655|NCT01338987|8868559|P4|Overall Study|Disease progression on study|0
2563656|NCT01338987|8868560|P3|Overall Study|Disease progression on study|1
2563657|NCT01338987|8868561|P2|Overall Study|Disease progression on study|1
2563658|NCT01338987|8868562|P1|Overall Study|Disease progression on study|2
2563659|NCT01338987|8868558|P5|Overall Study|enrolled on new protocol|0
2563660|NCT01338987|8868559|P4|Overall Study|enrolled on new protocol|0
2563661|NCT01338987|8868560|P3|Overall Study|enrolled on new protocol|1
2563662|NCT01338987|8868561|P2|Overall Study|enrolled on new protocol|0
2563663|NCT01338987|8868562|P1|Overall Study|enrolled on new protocol|0
2563664|NCT01338870|8868583|P6|Overall Study|Adverse Event|1
2563665|NCT01338870|8868584|P5|Overall Study|Adverse Event|4
2563666|NCT01338870|8868585|P4|Overall Study|Adverse Event|5
2563667|NCT01338870|8868586|P3|Overall Study|Adverse Event|1
2563668|NCT01338870|8868587|P2|Overall Study|Adverse Event|4
2563669|NCT01338870|8868588|P1|Overall Study|Adverse Event|4
2563670|NCT01338870|8868583|P6|Overall Study|Protocol Violation|1
2563671|NCT01338870|8868584|P5|Overall Study|Protocol Violation|1
2563672|NCT01338870|8868585|P4|Overall Study|Protocol Violation|2
2563673|NCT01338870|8868586|P3|Overall Study|Protocol Violation|2
2563674|NCT01338870|8868587|P2|Overall Study|Protocol Violation|2
2563675|NCT01338870|8868588|P1|Overall Study|Protocol Violation|0
2563676|NCT01338870|8868583|P6|Overall Study|Other|2
2563677|NCT01338870|8868584|P5|Overall Study|Other|0
2563678|NCT01338870|8868585|P4|Overall Study|Other|2
2563679|NCT01338870|8868586|P3|Overall Study|Other|3
2563680|NCT01338870|8868587|P2|Overall Study|Other|3
2563681|NCT01338870|8868588|P1|Overall Study|Other|3
2563682|NCT01338870|8868583|P6|Overall Study|Withdrawal by Subject|2
2563683|NCT01338870|8868584|P5|Overall Study|Withdrawal by Subject|0
2563684|NCT01338870|8868585|P4|Overall Study|Withdrawal by Subject|0
2563685|NCT01338870|8868586|P3|Overall Study|Withdrawal by Subject|4
2563686|NCT01338870|8868587|P2|Overall Study|Withdrawal by Subject|3
2563687|NCT01338870|8868588|P1|Overall Study|Withdrawal by Subject|2
2563688|NCT01338870|8868583|P6|Overall Study|Lost to Follow-up|0
2563689|NCT01338870|8868584|P5|Overall Study|Lost to Follow-up|1
2563690|NCT01338870|8868585|P4|Overall Study|Lost to Follow-up|0
2563691|NCT01338870|8868586|P3|Overall Study|Lost to Follow-up|1
2563692|NCT01338870|8868587|P2|Overall Study|Lost to Follow-up|0
2563693|NCT01338870|8868588|P1|Overall Study|Lost to Follow-up|0
2563694|NCT01338818|8868643|P1|Overall Study|Protocol Deviation|4
2563695|NCT01338818|8868643|P1|Overall Study|Administrative problems|3
2563696|NCT01338818|8868643|P1|Overall Study|Lost to Follow-up|4
2563697|NCT01338818|8868643|P1|Overall Study|Withdrawal by Subject|11
2563698|NCT01338818|8868643|P1|Overall Study|no longer require study drug|1
2563699|NCT01338818|8868643|P1|Overall Study|Lack of Efficacy|5
2563700|NCT01338818|8868643|P1|Overall Study|Adverse Event|8
2563701|NCT01338792|8868649|P1|Overall Study|Withdrawal by Subject|1
2563702|NCT01338792|8868649|P1|Overall Study|Death|1
2563703|NCT01338792|8868649|P1|Overall Study|Adverse Event|2
2563704|NCT01338636|8868664|P1|Overall Study|Withdrawn due to lack of improvement|8
2563705|NCT01338610|8868678|P3|Overall Study|Adverse Event|0
2563706|NCT01338610|8868679|P2|Overall Study|Adverse Event|0
2563707|NCT01338610|8868680|P1|Overall Study|Adverse Event|3
2563708|NCT01338610|8868678|P3|Overall Study|Protocol Violation|1
2563709|NCT01338610|8868679|P2|Overall Study|Protocol Violation|0
2563710|NCT01338610|8868680|P1|Overall Study|Protocol Violation|1
2563711|NCT01338610|8868678|P3|Overall Study|Patient Decision Unrelated to Advs Event|0
2563712|NCT01338610|8868679|P2|Overall Study|Patient Decision Unrelated to Advs Event|1
2563713|NCT01338610|8868680|P1|Overall Study|Patient Decision Unrelated to Advs Event|1
2563714|NCT01338493|8868706|P1|12 Months Follow up|Lost to Follow-up|9
2563715|NCT01338493|8868706|P1|6 Months Follow up|Missed visit|8
2563716|NCT01338493|8868706|P1|6 Months Follow up|Lost to Follow-up|11
2563717|NCT01338493|8868706|P1|Discharge|Missed visit|1
2563718|NCT01338493|8868706|P1|Discharge|Death|1
2563719|NCT01338493|8868706|P1|Enrolled|Patient not implanted|4
2563720|NCT01338493|8868706|P1|Enrolled|Withdrawal by Subject|1
2563721|NCT01338415|8868713|P2|Overall Study|Other (administrative reason)|0
2563722|NCT01338415|8868714|P1|Overall Study|Other (administrative reason)|1
2563723|NCT01338415|8868713|P2|Overall Study|Other (PAH not the main etiology of PH)|2
2563724|NCT01338415|8868714|P1|Overall Study|Other (PAH not the main etiology of PH)|0
2563725|NCT01338415|8868713|P2|Overall Study|Withdrawal by Subject|1
2563726|NCT01338415|8868714|P1|Overall Study|Withdrawal by Subject|1
2563727|NCT01338415|8868713|P2|Overall Study|Adverse Event|6
2563728|NCT01338415|8868714|P1|Overall Study|Adverse Event|8
2563729|NCT01338298|8868736|P2|Overall Study|Non-adherence|0
2563730|NCT01338298|8868737|P1|Overall Study|Non-adherence|1
2563731|NCT01338298|8868736|P2|Overall Study|Depressive symptoms and nausea|0
2563732|NCT01338298|8868737|P1|Overall Study|Depressive symptoms and nausea|1
2563733|NCT01338298|8868736|P2|Overall Study|Positive symptom worsening|0
2563734|NCT01338298|8868737|P1|Overall Study|Positive symptom worsening|1
2563735|NCT01338298|8868736|P2|Overall Study|Administrative error|1
2563736|NCT01338298|8868737|P1|Overall Study|Administrative error|0
2563737|NCT01338298|8868736|P2|Overall Study|Abdominal Pain and scheduled surgery|1
2563738|NCT01338298|8868737|P1|Overall Study|Abdominal Pain and scheduled surgery|0
2563739|NCT01338298|8868736|P2|Overall Study|Withdrawal by Subject|1
2563740|NCT01338298|8868737|P1|Overall Study|Withdrawal by Subject|1
2563741|NCT01338025|8868747|P2|Overall Study|Found ineligible after starting|0
2563742|NCT01338025|8868748|P1|Overall Study|Found ineligible after starting|1
2563743|NCT01338025|8868747|P2|Overall Study|Withdrawal by Subject|2
2563744|NCT01338025|8868748|P1|Overall Study|Withdrawal by Subject|0
2563745|NCT01338025|8868747|P2|Overall Study|Unexpected closure of study|9
2563746|NCT01338025|8868748|P1|Overall Study|Unexpected closure of study|10
2563747|NCT01338012|8868760|P1|Overall Study|Study terminated|4
2563748|NCT01338012|8868760|P1|Overall Study|Death|4
2563749|NCT01337986|8868766|P2|Overall Study|Protocol Violation|3
2563750|NCT01337986|8868767|P1|Overall Study|Protocol Violation|0
2563751|NCT01337986|8868766|P2|Overall Study|Lost to Follow-up|0
2563752|NCT01337986|8868767|P1|Overall Study|Lost to Follow-up|1
2563753|NCT01337986|8868766|P2|Overall Study|Adverse Event|2
2563754|NCT01337986|8868767|P1|Overall Study|Adverse Event|2
2563755|NCT01337973|8868804|P3|Overall Study|missing data on primary outcome|3
2563756|NCT01337973|8868805|P2|Overall Study|missing data on primary outcome|1
2563757|NCT01337973|8868806|P1|Overall Study|missing data on primary outcome|3
2563758|NCT01337973|8868804|P3|Overall Study|Withdrawal by Subject|4
2563759|NCT01337973|8868805|P2|Overall Study|Withdrawal by Subject|8
2563760|NCT01337973|8868806|P1|Overall Study|Withdrawal by Subject|10
2563761|NCT01337973|8868804|P3|Overall Study|Death|1
2563762|NCT01337973|8868805|P2|Overall Study|Death|2
2563763|NCT01337973|8868806|P1|Overall Study|Death|1
2563764|NCT01337973|8868804|P3|Overall Study|Lost to Follow-up|3
2563765|NCT01337973|8868805|P2|Overall Study|Lost to Follow-up|4
2563766|NCT01337973|8868806|P1|Overall Study|Lost to Follow-up|2
2563767|NCT01337960|8868820|P3|Overall Study|Withdrawal by Subject|0
2563768|NCT01337960|8868821|P2|Overall Study|Withdrawal by Subject|0
2563769|NCT01337960|8868822|P1|Overall Study|Withdrawal by Subject|1
2563770|NCT01337960|8868820|P3|Overall Study|Lost to Follow-up|0
2563771|NCT01337960|8868821|P2|Overall Study|Lost to Follow-up|0
2563772|NCT01337960|8868822|P1|Overall Study|Lost to Follow-up|1
2563773|NCT01337674|8868887|P4|Treatment Period 2|Withdrawal by Subject|0
2563774|NCT01337674|8868888|P3|Treatment Period 2|Withdrawal by Subject|1
2563775|NCT01337674|8868889|P2|Treatment Period 2|Withdrawal by Subject|0
2563776|NCT01337674|8868890|P1|Treatment Period 2|Withdrawal by Subject|0
2563777|NCT01337674|8868887|P4|Treatment Period 1|Discontinued due to blood draws|1
2563778|NCT01337674|8868888|P3|Treatment Period 1|Discontinued due to blood draws|0
2563779|NCT01337674|8868889|P2|Treatment Period 1|Discontinued due to blood draws|0
2563780|NCT01337674|8868890|P1|Treatment Period 1|Discontinued due to blood draws|0
2563781|NCT01337674|8868887|P4|Treatment Period 1|Adverse Event|0
2563782|NCT01337674|8868888|P3|Treatment Period 1|Adverse Event|0
2563783|NCT01337674|8868889|P2|Treatment Period 1|Adverse Event|1
2563784|NCT01337674|8868890|P1|Treatment Period 1|Adverse Event|0
2563785|NCT01337635|8868908|P2|Overall Study|Lost to Follow-up|1
2563786|NCT01337635|8868909|P1|Overall Study|Lost to Follow-up|0
2563787|NCT01337596|8868951|P9|Overall Study|Withdrawal by Subject|0
2563788|NCT01337596|8868952|P8|Overall Study|Withdrawal by Subject|0
2563789|NCT01337596|8868953|P7|Overall Study|Withdrawal by Subject|0
2563790|NCT01337596|8868954|P6|Overall Study|Withdrawal by Subject|0
2563791|NCT01337596|8868955|P5|Overall Study|Withdrawal by Subject|2
2563792|NCT01337596|8868956|P4|Overall Study|Withdrawal by Subject|0
2563793|NCT01337596|8868957|P3|Overall Study|Withdrawal by Subject|0
2563794|NCT01337596|8868958|P2|Overall Study|Withdrawal by Subject|0
2563795|NCT01337596|8868959|P1|Overall Study|Withdrawal by Subject|0
2563796|NCT01337297|8869010|P2|Overall Study|Lost to Follow-up|3
2563797|NCT01337297|8869011|P1|Overall Study|Lost to Follow-up|1
2563798|NCT01337297|8869010|P2|Overall Study|They entered to single anodal tDCS|3
2563799|NCT01337297|8869011|P1|Overall Study|They entered to single anodal tDCS|4
2563800|NCT01337167|8869019|P2|Toddler Vaccinations|Withdrawal by Subject|0
2563801|NCT01337167|8869020|P1|Toddler Vaccinations|Withdrawal by Subject|3
2563802|NCT01337167|8869019|P2|Toddler Vaccinations|Protocol Violation|1
2563803|NCT01337167|8869020|P1|Toddler Vaccinations|Protocol Violation|0
2563804|NCT01337167|8869019|P2|Toddler Vaccinations|Lost to Follow-up|12
2563805|NCT01337167|8869020|P1|Toddler Vaccinations|Lost to Follow-up|11
2563806|NCT01337167|8869019|P2|Interim Period|Other protocol criterion not met|1
2563807|NCT01337167|8869020|P1|Interim Period|Other protocol criterion not met|0
2563808|NCT01337167|8869019|P2|Interim Period|Withdrawal by Subject|10
2563809|NCT01337167|8869020|P1|Interim Period|Withdrawal by Subject|18
2563810|NCT01337167|8869019|P2|Interim Period|Protocol Violation|3
2563811|NCT01337167|8869020|P1|Interim Period|Protocol Violation|5
2563812|NCT01337167|8869019|P2|Interim Period|Physician Decision|3
2563813|NCT01337167|8869020|P1|Interim Period|Physician Decision|6
2563814|NCT01337167|8869019|P2|Interim Period|Non-compliance with study drug|0
2563815|NCT01337167|8869020|P1|Interim Period|Non-compliance with study drug|1
2563816|NCT01337167|8869019|P2|Interim Period|Lost to Follow-up|23
2563817|NCT01337167|8869020|P1|Interim Period|Lost to Follow-up|51
2563818|NCT01337167|8869019|P2|Infant Series|Randomized but not vaccinated|3
2563819|NCT01337167|8869020|P1|Infant Series|Randomized but not vaccinated|5
2563820|NCT01337167|8869019|P2|Infant Series|Withdrawal by Subject|4
2563821|NCT01337167|8869020|P1|Infant Series|Withdrawal by Subject|15
2563822|NCT01337167|8869019|P2|Infant Series|Protocol Violation|9
2563823|NCT01337167|8869020|P1|Infant Series|Protocol Violation|22
2563824|NCT01337167|8869019|P2|Infant Series|Physician Decision|1
2563825|NCT01337167|8869020|P1|Infant Series|Physician Decision|3
2563826|NCT01337167|8869019|P2|Infant Series|Non-compliance with study drug|1
2563827|NCT01337167|8869020|P1|Infant Series|Non-compliance with study drug|2
2563828|NCT01337167|8869019|P2|Infant Series|Lost to Follow-up|7
2563829|NCT01337167|8869020|P1|Infant Series|Lost to Follow-up|13
2563830|NCT01337167|8869019|P2|Infant Series|Death|1
2563831|NCT01337167|8869020|P1|Infant Series|Death|1
2563832|NCT01337167|8869019|P2|Infant Series|Adverse Event|1
2563833|NCT01337167|8869020|P1|Infant Series|Adverse Event|1
2563834|NCT01337115|8869088|P2|Overall Study|Protocol Violation|0
2563835|NCT01337115|8869089|P1|Overall Study|Protocol Violation|2
2563836|NCT01337089|8869101|P1|Overall Study|Lost to Follow-up|2
2563837|NCT01337089|8869101|P1|Overall Study|Met Withdrawal Criteria|3
2563838|NCT01337089|8869101|P1|Overall Study|Withdrawal by Investigator|33
2563839|NCT01337089|8869101|P1|Overall Study|Withdrawal by Subject|129
2563840|NCT01337089|8869101|P1|Overall Study|Adverse Event|237
2563841|NCT01337050|8869116|P3|Overall Study|Participants refused further follow-up|7
2563842|NCT01337050|8869117|P2|Overall Study|Participants refused further follow-up|7
2563843|NCT01337050|8869118|P1|Overall Study|Participants refused further follow-up|0
2563844|NCT01337050|8869116|P3|Overall Study|Other|8
2563845|NCT01337050|8869117|P2|Overall Study|Other|6
2563846|NCT01337050|8869118|P1|Overall Study|Other|4
2563847|NCT01337050|8869116|P3|Overall Study|Death|4
2563848|NCT01337050|8869117|P2|Overall Study|Death|0
2563849|NCT01337050|8869118|P1|Overall Study|Death|0
2563850|NCT01336972|8869179|P3|Overall Study|Adverse Event|0
2563851|NCT01336972|8869180|P2|Overall Study|Adverse Event|1
2563852|NCT01336972|8869181|P1|Overall Study|Adverse Event|1
2563853|NCT01336894|8869243|P2|Follow-up|Study terminated prematurely|7
2563854|NCT01336894|8869244|P1|Follow-up|Study terminated prematurely|2
2563855|NCT01336764|8869276|P2|Overall Study|Withdrawal by Subject|5
2563856|NCT01336764|8869277|P1|Overall Study|Withdrawal by Subject|5
2563857|NCT01336738|8869288|P5|Overall Study|Other|4
2563858|NCT01336738|8869289|P4|Overall Study|Other|3
2563859|NCT01336738|8869290|P3|Overall Study|Other|2
2563860|NCT01336738|8869291|P2|Overall Study|Other|3
2563861|NCT01336738|8869292|P1|Overall Study|Other|3
2563862|NCT01336738|8869288|P5|Overall Study|Withdrawal by Subject|1
2563863|NCT01336738|8869289|P4|Overall Study|Withdrawal by Subject|1
2563864|NCT01336738|8869290|P3|Overall Study|Withdrawal by Subject|2
2563865|NCT01336738|8869291|P2|Overall Study|Withdrawal by Subject|0
2563866|NCT01336738|8869292|P1|Overall Study|Withdrawal by Subject|2
2563867|NCT01336738|8869288|P5|Overall Study|Protocol Violation|0
2563868|NCT01336738|8869289|P4|Overall Study|Protocol Violation|0
2563869|NCT01336738|8869290|P3|Overall Study|Protocol Violation|0
2563870|NCT01336738|8869291|P2|Overall Study|Protocol Violation|1
2563871|NCT01336738|8869292|P1|Overall Study|Protocol Violation|0
2563872|NCT01336738|8869288|P5|Overall Study|Did not meet entrance criteria|0
2563873|NCT01336738|8869289|P4|Overall Study|Did not meet entrance criteria|0
2563874|NCT01336738|8869290|P3|Overall Study|Did not meet entrance criteria|0
2563875|NCT01336738|8869291|P2|Overall Study|Did not meet entrance criteria|1
2563876|NCT01336738|8869292|P1|Overall Study|Did not meet entrance criteria|0
2563877|NCT01336738|8869288|P5|Overall Study|Lost to Follow-up|2
2563878|NCT01336738|8869289|P4|Overall Study|Lost to Follow-up|2
2563879|NCT01336738|8869290|P3|Overall Study|Lost to Follow-up|2
2563880|NCT01336738|8869291|P2|Overall Study|Lost to Follow-up|1
2563881|NCT01336738|8869292|P1|Overall Study|Lost to Follow-up|2
2563882|NCT01336738|8869288|P5|Overall Study|Adverse Event|3
2563883|NCT01336738|8869289|P4|Overall Study|Adverse Event|1
2563884|NCT01336738|8869290|P3|Overall Study|Adverse Event|2
2563885|NCT01336738|8869291|P2|Overall Study|Adverse Event|3
2563886|NCT01336738|8869292|P1|Overall Study|Adverse Event|0
2563887|NCT01336712|8869334|P1|Overall Study|Lack of Efficacy|1
2563888|NCT01336712|8869334|P1|Overall Study|Death|2
2563889|NCT01336647|8869347|P3|Overall Study|Lost to Follow-up|3
2563890|NCT01336647|8869348|P2|Overall Study|Lost to Follow-up|1
2563891|NCT01336647|8869349|P1|Overall Study|Lost to Follow-up|4
2563892|NCT01336634|8869363|P3|Overall Study|Ongoing|24
2563893|NCT01336634|8869364|P2|Overall Study|Ongoing|22
2563894|NCT01336634|8869365|P1|Overall Study|Ongoing|15
2563895|NCT01336634|8869363|P3|Overall Study|Physician Decision|0
2563896|NCT01336634|8869364|P2|Overall Study|Physician Decision|1
2563897|NCT01336634|8869365|P1|Overall Study|Physician Decision|1
2563898|NCT01336634|8869363|P3|Overall Study|Withdrawal by Subject|1
2563899|NCT01336634|8869364|P2|Overall Study|Withdrawal by Subject|0
2563900|NCT01336634|8869365|P1|Overall Study|Withdrawal by Subject|6
2563901|NCT01336634|8869363|P3|Overall Study|Lost to Follow-up|1
2563902|NCT01336634|8869364|P2|Overall Study|Lost to Follow-up|1
2563903|NCT01336634|8869365|P1|Overall Study|Lost to Follow-up|2
2563904|NCT01336634|8869363|P3|Overall Study|Death|10
2563905|NCT01336634|8869364|P2|Overall Study|Death|33
2563906|NCT01336634|8869365|P1|Overall Study|Death|60
2563907|NCT01336621|8869406|P1|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3
2563908|NCT01336621|8869406|P1|SFUCP (up to 2.6 Years)|Physician Decision|1
2563909|NCT01336621|8869406|P1|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3
2563910|NCT01336621|8869406|P1|SFUCP (up to 2.6 Years)|Adverse Event|1
2563911|NCT01336621|8869406|P1|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1
2563912|NCT01336621|8869406|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9
2563913|NCT01336621|8869406|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2
2563914|NCT01336621|8869406|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22
2563915|NCT01336621|8869406|P1|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2
2563916|NCT01336621|8869406|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11
2563917|NCT01336621|8869406|P1|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27
2563918|NCT01336621|8869406|P1|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12
2563919|NCT01336621|8869406|P1|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2
2563920|NCT01336621|8869406|P1|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11
2563921|NCT01336608|8869456|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|1
2563922|NCT01336608|8869457|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|4
2563923|NCT01336608|8869458|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
2563924|NCT01336608|8869459|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
2563925|NCT01336608|8869456|P4|24-week, Double-blind Treatment Period|Physician Decision|1
2563926|NCT01336608|8869457|P3|24-week, Double-blind Treatment Period|Physician Decision|1
2563927|NCT01336608|8869458|P2|24-week, Double-blind Treatment Period|Physician Decision|3
2563928|NCT01336608|8869459|P1|24-week, Double-blind Treatment Period|Physician Decision|0
2563929|NCT01336608|8869456|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
2563930|NCT01336608|8869457|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
2563931|NCT01336608|8869458|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
2563932|NCT01336608|8869459|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
2563933|NCT01336608|8869456|P4|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6
2563934|NCT01336608|8869457|P3|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3
2563935|NCT01336608|8869458|P2|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
2563936|NCT01336608|8869459|P1|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
2563937|NCT01336608|8869456|P4|24-week, Double-blind Treatment Period|Protocol Violation|3
2563938|NCT01336608|8869457|P3|24-week, Double-blind Treatment Period|Protocol Violation|3
2563939|NCT01336608|8869458|P2|24-week, Double-blind Treatment Period|Protocol Violation|4
2563940|NCT01336608|8869459|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
2563941|NCT01336608|8869456|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6
2563942|NCT01336608|8869457|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
2563943|NCT01336608|8869458|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
2563944|NCT01336608|8869459|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
2563945|NCT01336608|8869456|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
2563946|NCT01336608|8869457|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
2563947|NCT01336608|8869458|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
2563948|NCT01336608|8869459|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
2563949|NCT01336608|8869456|P4|24-week, Double-blind Treatment Period|Adverse Event|7
2563950|NCT01336608|8869457|P3|24-week, Double-blind Treatment Period|Adverse Event|6
2563951|NCT01336608|8869458|P2|24-week, Double-blind Treatment Period|Adverse Event|8
2563952|NCT01336608|8869459|P1|24-week, Double-blind Treatment Period|Adverse Event|0
2563953|NCT01336608|8869456|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2563954|NCT01336608|8869457|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2563955|NCT01336608|8869458|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2563956|NCT01336608|8869459|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|2
2563957|NCT01336608|8869456|P4|2-week, Single-blind Run-In Period|Physician Decision|0
2563958|NCT01336608|8869457|P3|2-week, Single-blind Run-In Period|Physician Decision|0
2563959|NCT01336608|8869458|P2|2-week, Single-blind Run-In Period|Physician Decision|0
2563960|NCT01336608|8869459|P1|2-week, Single-blind Run-In Period|Physician Decision|1
2563961|NCT01336608|8869456|P4|2-week, Single-blind Run-In Period|Adverse Event|0
2563962|NCT01336608|8869457|P3|2-week, Single-blind Run-In Period|Adverse Event|0
2563963|NCT01336608|8869458|P2|2-week, Single-blind Run-In Period|Adverse Event|0
2563964|NCT01336608|8869459|P1|2-week, Single-blind Run-In Period|Adverse Event|1
2563965|NCT01336608|8869456|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2563966|NCT01336608|8869457|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2563967|NCT01336608|8869458|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2563968|NCT01336608|8869459|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|9
2563969|NCT01336608|8869456|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2563970|NCT01336608|8869457|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2563971|NCT01336608|8869458|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2563972|NCT01336608|8869459|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102
2563973|NCT01336569|8869473|P1|Overall Study|Lost to Follow-up|4
2563974|NCT01336205|8869521|P2|Overall Study|Did not receive treatment|0
2563975|NCT01336205|8869522|P1|Overall Study|Did not receive treatment|4
2563976|NCT01336205|8869521|P2|Overall Study|Withdrawal by Subject|38
2563977|NCT01336205|8869522|P1|Overall Study|Withdrawal by Subject|72
2563978|NCT01336205|8869521|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
2563979|NCT01336205|8869522|P1|Overall Study|Eligibility Criteria Not Fulfilled|9
2563980|NCT01336205|8869521|P2|Overall Study|Death|1
2563981|NCT01336205|8869522|P1|Overall Study|Death|1
2563982|NCT01336205|8869521|P2|Overall Study|Adverse Event|6
2563983|NCT01336205|8869522|P1|Overall Study|Adverse Event|56
2563984|NCT01336205|8869521|P2|Overall Study|Severe noncompliance with protocol|2
2563985|NCT01336205|8869522|P1|Overall Study|Severe noncompliance with protocol|9
2563986|NCT01336205|8869521|P2|Overall Study|Lack of Efficacy|0
2563987|NCT01336205|8869522|P1|Overall Study|Lack of Efficacy|4
2563988|NCT01336205|8869521|P2|Overall Study|Study-Specific Withdrawal Criteria|7
2563989|NCT01336205|8869522|P1|Overall Study|Study-Specific Withdrawal Criteria|16
2563990|NCT01336205|8869521|P2|Overall Study|Lost to Follow-up|20
2563991|NCT01336205|8869522|P1|Overall Study|Lost to Follow-up|40
2563992|NCT01336205|8869521|P2|Overall Study|Other|9
2563993|NCT01336205|8869522|P1|Overall Study|Other|22
2563994|NCT01336023|8869550|P3|Week 27 to 52|Unclassified|9
2563995|NCT01336023|8869551|P2|Week 27 to 52|Unclassified|18
2563996|NCT01336023|8869552|P1|Week 27 to 52|Unclassified|13
2563997|NCT01336023|8869550|P3|Week 27 to 52|Withdrawal Criteria|16
2563998|NCT01336023|8869551|P2|Week 27 to 52|Withdrawal Criteria|19
2563999|NCT01336023|8869552|P1|Week 27 to 52|Withdrawal Criteria|14
2564000|NCT01336023|8869550|P3|Week 27 to 52|Protocol Violation|1
2564001|NCT01336023|8869551|P2|Week 27 to 52|Protocol Violation|2
2564002|NCT01336023|8869552|P1|Week 27 to 52|Protocol Violation|0
2564003|NCT01336023|8869550|P3|Week 27 to 52|Adverse Event|2
2564004|NCT01336023|8869551|P2|Week 27 to 52|Adverse Event|5
2564005|NCT01336023|8869552|P1|Week 27 to 52|Adverse Event|1
2564006|NCT01336023|8869550|P3|Week 0 to Week 26|Unclassified|9
2564007|NCT01336023|8869551|P2|Week 0 to Week 26|Unclassified|16
2564008|NCT01336023|8869552|P1|Week 0 to Week 26|Unclassified|5
2564009|NCT01336023|8869550|P3|Week 0 to Week 26|Withdrawal Criteria|40
2564010|NCT01336023|8869551|P2|Week 0 to Week 26|Withdrawal Criteria|69
2564011|NCT01336023|8869552|P1|Week 0 to Week 26|Withdrawal Criteria|34
2564012|NCT01336023|8869550|P3|Week 0 to Week 26|Protocol Violation|0
2564013|NCT01336023|8869551|P2|Week 0 to Week 26|Protocol Violation|2
2564014|NCT01336023|8869552|P1|Week 0 to Week 26|Protocol Violation|1
2564015|NCT01336023|8869550|P3|Week 0 to Week 26|Lack of Efficacy|0
2564016|NCT01336023|8869551|P2|Week 0 to Week 26|Lack of Efficacy|1
2564017|NCT01336023|8869552|P1|Week 0 to Week 26|Lack of Efficacy|0
2564018|NCT01336023|8869550|P3|Week 0 to Week 26|Adverse Event|24
2564019|NCT01336023|8869551|P2|Week 0 to Week 26|Adverse Event|10
2564020|NCT01336023|8869552|P1|Week 0 to Week 26|Adverse Event|8
2564021|NCT01335997|8869573|P2|Period III|Lost to Follow-up|0
2564022|NCT01335997|8869574|P1|Period III|Lost to Follow-up|1
2564023|NCT01335997|8869573|P2|Period III|Protocol Violation|1
2564024|NCT01335997|8869574|P1|Period III|Protocol Violation|0
2564025|NCT01335997|8869573|P2|Period III|Study Terminated by Sponsor|76
2564026|NCT01335997|8869574|P1|Period III|Study Terminated by Sponsor|77
2564027|NCT01335997|8869573|P2|Period III|Adverse Event|2
2564028|NCT01335997|8869574|P1|Period III|Adverse Event|0
2564029|NCT01335997|8869573|P2|Period I and II|Physician Decision|1
2564030|NCT01335997|8869574|P1|Period I and II|Physician Decision|2
2564031|NCT01335997|8869573|P2|Period I and II|Protocol Violation|10
2564032|NCT01335997|8869574|P1|Period I and II|Protocol Violation|9
2564033|NCT01335997|8869573|P2|Period I and II|Study Terminated by Sponsor|415
2564034|NCT01335997|8869574|P1|Period I and II|Study Terminated by Sponsor|406
2564035|NCT01335997|8869573|P2|Period I and II|Withdrawal by Subject|4
2564036|NCT01335997|8869574|P1|Period I and II|Withdrawal by Subject|9
2564037|NCT01335997|8869573|P2|Period I and II|Lost to Follow-up|5
2564038|NCT01335997|8869574|P1|Period I and II|Lost to Follow-up|3
2564039|NCT01335997|8869573|P2|Period I and II|Noncompliance with Study Drug|1
2564040|NCT01335997|8869574|P1|Period I and II|Noncompliance with Study Drug|1
2564041|NCT01335997|8869573|P2|Period I and II|Adverse Event|43
2564042|NCT01335997|8869574|P1|Period I and II|Adverse Event|63
2564043|NCT01335971|8869587|P3|Overall Study|Did not complete bronchoscopy|1
2564044|NCT01335971|8869588|P2|Overall Study|Did not complete bronchoscopy|1
2564045|NCT01335971|8869589|P1|Overall Study|Did not complete bronchoscopy|1
2564046|NCT01335971|8869587|P3|Overall Study|Withdrawal by Subject|0
2564047|NCT01335971|8869588|P2|Overall Study|Withdrawal by Subject|0
2564048|NCT01335971|8869589|P1|Overall Study|Withdrawal by Subject|1
2564049|NCT01335698|8869832|P5|Treatment Stage 2|Switched to another formulation|0
2564050|NCT01335698|8869833|P4|Treatment Stage 2|Switched to another formulation|0
2564051|NCT01335698|8869834|P3|Treatment Stage 2|Switched to another formulation|0
2564052|NCT01335698|8869835|P2|Treatment Stage 2|Switched to another formulation|1
2564053|NCT01335698|8869836|P1|Treatment Stage 2|Switched to another formulation|1
2564054|NCT01335698|8869832|P5|Treatment Stage 2|Subject no longer meets study criteria|0
2564055|NCT01335698|8869833|P4|Treatment Stage 2|Subject no longer meets study criteria|1
2564056|NCT01335698|8869834|P3|Treatment Stage 2|Subject no longer meets study criteria|0
2564057|NCT01335698|8869835|P2|Treatment Stage 2|Subject no longer meets study criteria|0
2564058|NCT01335698|8869836|P1|Treatment Stage 2|Subject no longer meets study criteria|0
2564059|NCT01335698|8869832|P5|Treatment Stage 2|Capsules received at state hospital|0
2564060|NCT01335698|8869833|P4|Treatment Stage 2|Capsules received at state hospital|0
2564061|NCT01335698|8869834|P3|Treatment Stage 2|Capsules received at state hospital|0
2564062|NCT01335698|8869835|P2|Treatment Stage 2|Capsules received at state hospital|0
2564063|NCT01335698|8869836|P1|Treatment Stage 2|Capsules received at state hospital|1
2564064|NCT01335698|8869832|P5|Treatment Stage 2|Lost to Follow-up|0
2564065|NCT01335698|8869833|P4|Treatment Stage 2|Lost to Follow-up|0
2564066|NCT01335698|8869834|P3|Treatment Stage 2|Lost to Follow-up|0
2564067|NCT01335698|8869835|P2|Treatment Stage 2|Lost to Follow-up|0
2564068|NCT01335698|8869836|P1|Treatment Stage 2|Lost to Follow-up|1
2564069|NCT01335698|8869832|P5|Treatment Stage 2|Poor compliance/noncompliance|1
2564070|NCT01335698|8869833|P4|Treatment Stage 2|Poor compliance/noncompliance|3
2564071|NCT01335698|8869834|P3|Treatment Stage 2|Poor compliance/noncompliance|1
2564072|NCT01335698|8869835|P2|Treatment Stage 2|Poor compliance/noncompliance|0
2564073|NCT01335698|8869836|P1|Treatment Stage 2|Poor compliance/noncompliance|1
2564074|NCT01335698|8869832|P5|Treatment Stage 2|Withdrawal by Subject|0
2564075|NCT01335698|8869833|P4|Treatment Stage 2|Withdrawal by Subject|0
2564076|NCT01335698|8869834|P3|Treatment Stage 2|Withdrawal by Subject|1
2564077|NCT01335698|8869835|P2|Treatment Stage 2|Withdrawal by Subject|1
2564078|NCT01335698|8869836|P1|Treatment Stage 2|Withdrawal by Subject|3
2564079|NCT01335698|8869832|P5|Treatment Stage 2|Adverse Event|0
2564080|NCT01335698|8869833|P4|Treatment Stage 2|Adverse Event|3
2564081|NCT01335698|8869834|P3|Treatment Stage 2|Adverse Event|0
2564082|NCT01335698|8869835|P2|Treatment Stage 2|Adverse Event|0
2564083|NCT01335698|8869836|P1|Treatment Stage 2|Adverse Event|2
2564084|NCT01335698|8869832|P5|Treatment Stage 2|Lack of Efficacy|0
2564085|NCT01335698|8869833|P4|Treatment Stage 2|Lack of Efficacy|1
2564086|NCT01335698|8869834|P3|Treatment Stage 2|Lack of Efficacy|3
2564087|NCT01335698|8869835|P2|Treatment Stage 2|Lack of Efficacy|1
2564088|NCT01335698|8869836|P1|Treatment Stage 2|Lack of Efficacy|2
2564089|NCT01335698|8869832|P5|Treatment Stage 1|Other|0
2564090|NCT01335698|8869833|P4|Treatment Stage 1|Other|1
2564091|NCT01335698|8869834|P3|Treatment Stage 1|Other|0
2564092|NCT01335698|8869835|P2|Treatment Stage 1|Other|0
2564093|NCT01335698|8869836|P1|Treatment Stage 1|Other|1
2564094|NCT01335698|8869832|P5|Treatment Stage 1|No longer meets study criteria|0
2564095|NCT01335698|8869833|P4|Treatment Stage 1|No longer meets study criteria|1
2564096|NCT01335698|8869834|P3|Treatment Stage 1|No longer meets study criteria|0
2564097|NCT01335698|8869835|P2|Treatment Stage 1|No longer meets study criteria|1
2564098|NCT01335698|8869836|P1|Treatment Stage 1|No longer meets study criteria|1
2564099|NCT01335698|8869832|P5|Treatment Stage 1|Poor compliance/noncompliance|0
2564100|NCT01335698|8869833|P4|Treatment Stage 1|Poor compliance/noncompliance|2
2564101|NCT01335698|8869834|P3|Treatment Stage 1|Poor compliance/noncompliance|0
2564102|NCT01335698|8869835|P2|Treatment Stage 1|Poor compliance/noncompliance|1
2564103|NCT01335698|8869836|P1|Treatment Stage 1|Poor compliance/noncompliance|0
2564104|NCT01335698|8869832|P5|Treatment Stage 1|Lost to Follow-up|0
2564105|NCT01335698|8869833|P4|Treatment Stage 1|Lost to Follow-up|0
2564106|NCT01335698|8869834|P3|Treatment Stage 1|Lost to Follow-up|0
2564107|NCT01335698|8869835|P2|Treatment Stage 1|Lost to Follow-up|1
2564108|NCT01335698|8869836|P1|Treatment Stage 1|Lost to Follow-up|1
2564109|NCT01335698|8869832|P5|Treatment Stage 1|Withdrawal by Subject|0
2564110|NCT01335698|8869833|P4|Treatment Stage 1|Withdrawal by Subject|1
2564111|NCT01335698|8869834|P3|Treatment Stage 1|Withdrawal by Subject|0
2564112|NCT01335698|8869835|P2|Treatment Stage 1|Withdrawal by Subject|2
2564113|NCT01335698|8869836|P1|Treatment Stage 1|Withdrawal by Subject|1
2564114|NCT01335698|8869832|P5|Treatment Stage 1|Adverse Event|1
2564115|NCT01335698|8869833|P4|Treatment Stage 1|Adverse Event|1
2564116|NCT01335698|8869834|P3|Treatment Stage 1|Adverse Event|2
2564117|NCT01335698|8869835|P2|Treatment Stage 1|Adverse Event|2
2564118|NCT01335698|8869836|P1|Treatment Stage 1|Adverse Event|1
2564119|NCT01335698|8869832|P5|Treatment Stage 1|Lack of Efficacy|1
2564120|NCT01335698|8869833|P4|Treatment Stage 1|Lack of Efficacy|3
2564121|NCT01335698|8869834|P3|Treatment Stage 1|Lack of Efficacy|3
2564122|NCT01335698|8869835|P2|Treatment Stage 1|Lack of Efficacy|1
2564123|NCT01335698|8869836|P1|Treatment Stage 1|Lack of Efficacy|3
2564124|NCT01335685|8869901|P8|Overall Study|Reason not Specified|0
2564125|NCT01335685|8869902|P7|Overall Study|Reason not Specified|0
2564126|NCT01335685|8869903|P6|Overall Study|Reason not Specified|1
2564127|NCT01335685|8869904|P5|Overall Study|Reason not Specified|0
2564128|NCT01335685|8869905|P4|Overall Study|Reason not Specified|0
2564129|NCT01335685|8869906|P3|Overall Study|Reason not Specified|1
2564130|NCT01335685|8869907|P2|Overall Study|Reason not Specified|0
2564131|NCT01335685|8869908|P1|Overall Study|Reason not Specified|0
2564132|NCT01335685|8869901|P8|Overall Study|Withdrawal by Subject|0
2564133|NCT01335685|8869902|P7|Overall Study|Withdrawal by Subject|0
2564134|NCT01335685|8869903|P6|Overall Study|Withdrawal by Subject|0
2564135|NCT01335685|8869904|P5|Overall Study|Withdrawal by Subject|0
2564136|NCT01335685|8869905|P4|Overall Study|Withdrawal by Subject|1
2564137|NCT01335685|8869906|P3|Overall Study|Withdrawal by Subject|0
2564138|NCT01335685|8869907|P2|Overall Study|Withdrawal by Subject|0
2564139|NCT01335685|8869908|P1|Overall Study|Withdrawal by Subject|1
2564140|NCT01335685|8869901|P8|Overall Study|Study Terminated by Sponsor|3
2564141|NCT01335685|8869902|P7|Overall Study|Study Terminated by Sponsor|2
2564142|NCT01335685|8869903|P6|Overall Study|Study Terminated by Sponsor|4
2564143|NCT01335685|8869904|P5|Overall Study|Study Terminated by Sponsor|0
2564144|NCT01335685|8869905|P4|Overall Study|Study Terminated by Sponsor|10
2564145|NCT01335685|8869906|P3|Overall Study|Study Terminated by Sponsor|1
2564146|NCT01335685|8869907|P2|Overall Study|Study Terminated by Sponsor|1
2564147|NCT01335685|8869908|P1|Overall Study|Study Terminated by Sponsor|2
2564148|NCT01335477|8870028|P2|Overall Study|Reason other than those stated above|2
2564149|NCT01335477|8870029|P1|Overall Study|Reason other than those stated above|2
2564150|NCT01335477|8870028|P2|Overall Study|Not treated|2
2564151|NCT01335477|8870029|P1|Overall Study|Not treated|1
2564152|NCT01335477|8870028|P2|Overall Study|Consent withdrawn, not due to AE|9
2564153|NCT01335477|8870029|P1|Overall Study|Consent withdrawn, not due to AE|7
2564154|NCT01335477|8870028|P2|Overall Study|Lost to Follow-up|2
2564155|NCT01335477|8870029|P1|Overall Study|Lost to Follow-up|1
2564156|NCT01335477|8870028|P2|Overall Study|Non compliant with protocol|2
2564157|NCT01335477|8870029|P1|Overall Study|Non compliant with protocol|0
2564158|NCT01335477|8870028|P2|Overall Study|Adverse Event|42
2564159|NCT01335477|8870029|P1|Overall Study|Adverse Event|30
2564160|NCT01335464|8870093|P2|Overall Study|Reason other than those stated above|1
2564161|NCT01335464|8870094|P1|Overall Study|Reason other than those stated above|1
2564162|NCT01335464|8870093|P2|Overall Study|Not treated|0
2564163|NCT01335464|8870094|P1|Overall Study|Not treated|2
2564164|NCT01335464|8870093|P2|Overall Study|Consent withdrawn, not due to AE|23
2564165|NCT01335464|8870094|P1|Overall Study|Consent withdrawn, not due to AE|12
2564166|NCT01335464|8870093|P2|Overall Study|Non compliant with protocol|0
2564167|NCT01335464|8870094|P1|Overall Study|Non compliant with protocol|2
2564168|NCT01335464|8870093|P2|Overall Study|Adverse Event|25
2564169|NCT01335464|8870094|P1|Overall Study|Adverse Event|15
2564170|NCT01334918|8870263|P2|Overall Study|Withdrawal by Subject|1
2564171|NCT01334918|8870264|P1|Overall Study|Withdrawal by Subject|0
2564172|NCT01334918|8870263|P2|Overall Study|Adverse Event|0
2564173|NCT01334918|8870264|P1|Overall Study|Adverse Event|2
2564174|NCT01334918|8870263|P2|Overall Study|Did not receive study drug|0
2564175|NCT01334918|8870264|P1|Overall Study|Did not receive study drug|6
2564176|NCT01334866|8870290|P1|Overall Study|medically necessary post-procedure|1
2564177|NCT01334866|8870290|P1|Overall Study|medically necessary prior to procedure|2
2564178|NCT01334866|8870290|P1|Overall Study|Physician Decision|3
2564179|NCT01334866|8870290|P1|Overall Study|Lost to Follow-up|3
2564180|NCT01334866|8870290|P1|Overall Study|Withdrawal by Subject|10
2564181|NCT01334710|8870327|P1|Overall Study|Trial was terminated|3
2564182|NCT01334606|8870332|P1|Overall Study|Study Terminated due to slow enrolment|18
2564183|NCT01334554|8870340|P2|Overall Study|Adverse Event|2
2564184|NCT01334554|8870341|P1|Overall Study|Adverse Event|4
2564185|NCT01334515|8870351|P2|Overall Study|Withdrawal by Subject|1
2564186|NCT01334515|8870352|P1|Overall Study|Withdrawal by Subject|1
2564187|NCT01334515|8870351|P2|Overall Study|Physician Decision|1
2564188|NCT01334515|8870352|P1|Overall Study|Physician Decision|1
2564189|NCT01334515|8870351|P2|Overall Study|Lack of Efficacy|21
2564190|NCT01334515|8870352|P1|Overall Study|Lack of Efficacy|8
2564191|NCT01334515|8870351|P2|Overall Study|Death|0
2564192|NCT01334515|8870352|P1|Overall Study|Death|1
2564193|NCT01334515|8870351|P2|Overall Study|Adverse Event|6
2564194|NCT01334515|8870352|P1|Overall Study|Adverse Event|1
2564195|NCT01334125|8870390|P2|Overall Study|Lost to Follow-up|3
2564196|NCT01334125|8870391|P1|Overall Study|Lost to Follow-up|3
2564197|NCT01333956|8870407|P4|Overall Study|Withdrawal by Subject|0
2564198|NCT01333956|8870408|P3|Overall Study|Withdrawal by Subject|1
2564199|NCT01333956|8870409|P2|Overall Study|Withdrawal by Subject|2
2564200|NCT01333956|8870410|P1|Overall Study|Withdrawal by Subject|0
2564201|NCT01333956|8870407|P4|Overall Study|Unable to complete study procedure|1
2564202|NCT01333956|8870408|P3|Overall Study|Unable to complete study procedure|0
2564203|NCT01333956|8870409|P2|Overall Study|Unable to complete study procedure|0
2564204|NCT01333956|8870410|P1|Overall Study|Unable to complete study procedure|1
2564205|NCT01333956|8870407|P4|Overall Study|Lost to Follow-up|1
2564206|NCT01333956|8870408|P3|Overall Study|Lost to Follow-up|0
2564207|NCT01333956|8870409|P2|Overall Study|Lost to Follow-up|2
2564208|NCT01333956|8870410|P1|Overall Study|Lost to Follow-up|1
2564209|NCT01333943|8870446|P2|Overall Study|Known neuropathy|0
2564210|NCT01333943|8870447|P1|Overall Study|Known neuropathy|1
2564211|NCT01333865|8870463|P1|Overall Study|Adverse Event|2
2564212|NCT01333722|8870483|P2|Overall Study|Withdrawal by Subject|1
2564213|NCT01333722|8870484|P1|Overall Study|Withdrawal by Subject|0
2564214|NCT01333722|8870483|P2|Overall Study|Lack of Efficacy|2
2564215|NCT01333722|8870484|P1|Overall Study|Lack of Efficacy|0
2564216|NCT01333501|8870509|P2|Overall Study|Withdrawn consent|12
2564217|NCT01333501|8870510|P1|Overall Study|Withdrawn consent|3
2564218|NCT01333501|8870509|P2|Overall Study|Unsatisfactory therapeutic effect|7
2564219|NCT01333501|8870510|P1|Overall Study|Unsatisfactory therapeutic effect|1
2564220|NCT01333501|8870509|P2|Overall Study|Abnormal laboratory value|1
2564221|NCT01333501|8870510|P1|Overall Study|Abnormal laboratory value|2
2564222|NCT01333501|8870509|P2|Overall Study|Adverse Event|1
2564223|NCT01333501|8870510|P1|Overall Study|Adverse Event|3
2564224|NCT01333475|8870577|P2|Overall Study|Toxicity|3
2564225|NCT01333475|8870578|P1|Overall Study|Toxicity|1
2564226|NCT01333475|8870577|P2|Overall Study|pt withdrew-need emergent radiation trmt|0
2564227|NCT01333475|8870578|P1|Overall Study|pt withdrew-need emergent radiation trmt|1
2564228|NCT01333397|8870604|P5|Overall Study|Lost to Follow-up|0
2564229|NCT01333397|8870605|P4|Overall Study|Lost to Follow-up|1
2564230|NCT01333397|8870606|P3|Overall Study|Lost to Follow-up|0
2564231|NCT01333397|8870607|P2|Overall Study|Lost to Follow-up|0
2564232|NCT01333397|8870608|P1|Overall Study|Lost to Follow-up|1
2564233|NCT01333189|8870682|P2|Overall Study|Moved from region|1
2564234|NCT01333189|8870683|P1|Overall Study|Moved from region|0
2564235|NCT01333189|8870682|P2|Overall Study|Transportation difficulties|1
2564236|NCT01333189|8870683|P1|Overall Study|Transportation difficulties|0
2564237|NCT01333189|8870682|P2|Overall Study|Adverse Event|0
2564238|NCT01333189|8870683|P1|Overall Study|Adverse Event|1
2564239|NCT01333189|8870682|P2|Overall Study|Time constraints|0
2564240|NCT01333189|8870683|P1|Overall Study|Time constraints|1
2564241|NCT01333111|8870714|P3|Overall Study|Ineffective therapy|1
2564242|NCT01333111|8870715|P2|Overall Study|Ineffective therapy|0
2564243|NCT01333111|8870716|P1|Overall Study|Ineffective therapy|0
2564244|NCT01333111|8870714|P3|Overall Study|Non-compliance|0
2564245|NCT01333111|8870715|P2|Overall Study|Non-compliance|0
2564246|NCT01333111|8870716|P1|Overall Study|Non-compliance|1
2564247|NCT01333111|8870714|P3|Overall Study|withdrawal criteria|0
2564248|NCT01333111|8870715|P2|Overall Study|withdrawal criteria|1
2564249|NCT01333111|8870716|P1|Overall Study|withdrawal criteria|0
2564250|NCT01333111|8870714|P3|Overall Study|unclassified|0
2564251|NCT01333111|8870715|P2|Overall Study|unclassified|0
2564252|NCT01333111|8870716|P1|Overall Study|unclassified|1
2564253|NCT01333111|8870714|P3|Overall Study|personal reasons|1
2564254|NCT01333111|8870715|P2|Overall Study|personal reasons|0
2564255|NCT01333111|8870716|P1|Overall Study|personal reasons|0
2564256|NCT01333111|8870714|P3|Overall Study|patient undergoing major surgery|0
2564257|NCT01333111|8870715|P2|Overall Study|patient undergoing major surgery|2
2564258|NCT01333111|8870716|P1|Overall Study|patient undergoing major surgery|0
2564259|NCT01333072|8870751|P2|Overall Study|Physician Decision|0
2564260|NCT01333072|8870752|P1|Overall Study|Physician Decision|1
2564261|NCT01333072|8870751|P2|Overall Study|Adverse Event|4
2564262|NCT01333072|8870752|P1|Overall Study|Adverse Event|2
2564263|NCT01333072|8870751|P2|Overall Study|Lost to Follow-up|0
2564264|NCT01333072|8870752|P1|Overall Study|Lost to Follow-up|3
2564265|NCT01333059|8870760|P2|Overall Study|Protocol Violation|0
2564266|NCT01333059|8870761|P1|Overall Study|Protocol Violation|3
2564267|NCT01333059|8870760|P2|Overall Study|Physician Decision|3
2564268|NCT01333059|8870761|P1|Overall Study|Physician Decision|3
2564269|NCT01332994|8870771|P1|Overall Study|Other|8
2564270|NCT01332994|8870771|P1|Overall Study|Administrative Problem|2
2564271|NCT01332994|8870771|P1|Overall Study|Withdrawal by Subject|15
2564272|NCT01332994|8870771|P1|Overall Study|Protocol Violation|6
2564273|NCT01332994|8870771|P1|Overall Study|Lost to Follow-up|4
2564274|NCT01332994|8870771|P1|Overall Study|Lack of Efficacy|1
2564275|NCT01332994|8870771|P1|Overall Study|Death|1
2564276|NCT01332994|8870771|P1|Overall Study|Adverse Event|34
2564277|NCT01332968|8870840|P8|Follow-Up Period|Lost to Follow-up|2
2564278|NCT01332968|8870841|P7|Follow-Up Period|Lost to Follow-up|1
2564279|NCT01332968|8870842|P6|Follow-Up Period|Lost to Follow-up|0
2564280|NCT01332968|8870843|P5|Follow-Up Period|Lost to Follow-up|0
2564281|NCT01332968|8870844|P4|Follow-Up Period|Lost to Follow-up|0
2564282|NCT01332968|8870845|P3|Follow-Up Period|Lost to Follow-up|0
2564283|NCT01332968|8870846|P2|Follow-Up Period|Lost to Follow-up|0
2564284|NCT01332968|8870847|P1|Follow-Up Period|Lost to Follow-up|0
2564285|NCT01332968|8870840|P8|Follow-Up Period|Withdrawal by Subject|2
2564286|NCT01332968|8870841|P7|Follow-Up Period|Withdrawal by Subject|1
2564287|NCT01332968|8870842|P6|Follow-Up Period|Withdrawal by Subject|0
2564288|NCT01332968|8870843|P5|Follow-Up Period|Withdrawal by Subject|0
2564289|NCT01332968|8870844|P4|Follow-Up Period|Withdrawal by Subject|0
2564290|NCT01332968|8870845|P3|Follow-Up Period|Withdrawal by Subject|0
2564291|NCT01332968|8870846|P2|Follow-Up Period|Withdrawal by Subject|0
2564292|NCT01332968|8870847|P1|Follow-Up Period|Withdrawal by Subject|0
2564293|NCT01332968|8870840|P8|Follow-Up Period|Follow-up ongoing|505
2564294|NCT01332968|8870841|P7|Follow-Up Period|Follow-up ongoing|502
2564295|NCT01332968|8870842|P6|Follow-Up Period|Follow-up ongoing|0
2564296|NCT01332968|8870843|P5|Follow-Up Period|Follow-up ongoing|0
2564297|NCT01332968|8870844|P4|Follow-Up Period|Follow-up ongoing|0
2564298|NCT01332968|8870845|P3|Follow-Up Period|Follow-up ongoing|0
2564299|NCT01332968|8870846|P2|Follow-Up Period|Follow-up ongoing|0
2564300|NCT01332968|8870847|P1|Follow-Up Period|Follow-up ongoing|0
2564301|NCT01332968|8870840|P8|Follow-Up Period|Death|22
2564302|NCT01332968|8870841|P7|Follow-Up Period|Death|38
2564303|NCT01332968|8870842|P6|Follow-Up Period|Death|0
2564304|NCT01332968|8870843|P5|Follow-Up Period|Death|0
2564305|NCT01332968|8870844|P4|Follow-Up Period|Death|0
2564306|NCT01332968|8870845|P3|Follow-Up Period|Death|0
2564307|NCT01332968|8870846|P2|Follow-Up Period|Death|0
2564308|NCT01332968|8870847|P1|Follow-Up Period|Death|0
2564309|NCT01332968|8870840|P8|Maintenance/Observation Period|Treatment ongoing|0
2564310|NCT01332968|8870841|P7|Maintenance/Observation Period|Treatment ongoing|0
2564311|NCT01332968|8870842|P6|Maintenance/Observation Period|Treatment ongoing|8
2564312|NCT01332968|8870843|P5|Maintenance/Observation Period|Treatment ongoing|10
2564313|NCT01332968|8870844|P4|Maintenance/Observation Period|Treatment ongoing|62
2564314|NCT01332968|8870845|P3|Maintenance/Observation Period|Treatment ongoing|54
2564315|NCT01332968|8870846|P2|Maintenance/Observation Period|Treatment ongoing|0
2564316|NCT01332968|8870847|P1|Maintenance/Observation Period|Treatment ongoing|0
2564317|NCT01332968|8870840|P8|Maintenance/Observation Period|Adverse Event|0
2564318|NCT01332968|8870841|P7|Maintenance/Observation Period|Adverse Event|0
2564319|NCT01332968|8870842|P6|Maintenance/Observation Period|Adverse Event|0
2564320|NCT01332968|8870843|P5|Maintenance/Observation Period|Adverse Event|0
2564321|NCT01332968|8870844|P4|Maintenance/Observation Period|Adverse Event|65
2564322|NCT01332968|8870845|P3|Maintenance/Observation Period|Adverse Event|50
2564323|NCT01332968|8870846|P2|Maintenance/Observation Period|Adverse Event|0
2564324|NCT01332968|8870847|P1|Maintenance/Observation Period|Adverse Event|0
2564325|NCT01332968|8870840|P8|Maintenance/Observation Period|Death|0
2564326|NCT01332968|8870841|P7|Maintenance/Observation Period|Death|0
2564327|NCT01332968|8870842|P6|Maintenance/Observation Period|Death|0
2564328|NCT01332968|8870843|P5|Maintenance/Observation Period|Death|0
2564329|NCT01332968|8870844|P4|Maintenance/Observation Period|Death|6
2564330|NCT01332968|8870845|P3|Maintenance/Observation Period|Death|5
2564331|NCT01332968|8870846|P2|Maintenance/Observation Period|Death|0
2564332|NCT01332968|8870847|P1|Maintenance/Observation Period|Death|0
2564333|NCT01332968|8870840|P8|Maintenance/Observation Period|Lost to Follow-up|0
2564334|NCT01332968|8870841|P7|Maintenance/Observation Period|Lost to Follow-up|0
2564335|NCT01332968|8870842|P6|Maintenance/Observation Period|Lost to Follow-up|0
2564336|NCT01332968|8870843|P5|Maintenance/Observation Period|Lost to Follow-up|0
2564337|NCT01332968|8870844|P4|Maintenance/Observation Period|Lost to Follow-up|2
2564338|NCT01332968|8870845|P3|Maintenance/Observation Period|Lost to Follow-up|1
2564339|NCT01332968|8870846|P2|Maintenance/Observation Period|Lost to Follow-up|0
2564340|NCT01332968|8870847|P1|Maintenance/Observation Period|Lost to Follow-up|0
2564341|NCT01332968|8870840|P8|Maintenance/Observation Period|Non-compliance|0
2564342|NCT01332968|8870841|P7|Maintenance/Observation Period|Non-compliance|0
2564343|NCT01332968|8870842|P6|Maintenance/Observation Period|Non-compliance|1
2564344|NCT01332968|8870843|P5|Maintenance/Observation Period|Non-compliance|0
2564345|NCT01332968|8870844|P4|Maintenance/Observation Period|Non-compliance|3
2564346|NCT01332968|8870845|P3|Maintenance/Observation Period|Non-compliance|2
2564347|NCT01332968|8870846|P2|Maintenance/Observation Period|Non-compliance|0
2564348|NCT01332968|8870847|P1|Maintenance/Observation Period|Non-compliance|0
2564349|NCT01332968|8870840|P8|Maintenance/Observation Period|Other|0
2564350|NCT01332968|8870841|P7|Maintenance/Observation Period|Other|0
2564351|NCT01332968|8870842|P6|Maintenance/Observation Period|Other|0
2564352|NCT01332968|8870843|P5|Maintenance/Observation Period|Other|0
2564353|NCT01332968|8870844|P4|Maintenance/Observation Period|Other|5
2564354|NCT01332968|8870845|P3|Maintenance/Observation Period|Other|4
2564355|NCT01332968|8870846|P2|Maintenance/Observation Period|Other|0
2564356|NCT01332968|8870847|P1|Maintenance/Observation Period|Other|0
2564357|NCT01332968|8870840|P8|Maintenance/Observation Period|Physician Decision|0
2564358|NCT01332968|8870841|P7|Maintenance/Observation Period|Physician Decision|0
2564359|NCT01332968|8870842|P6|Maintenance/Observation Period|Physician Decision|0
2564360|NCT01332968|8870843|P5|Maintenance/Observation Period|Physician Decision|0
2564361|NCT01332968|8870844|P4|Maintenance/Observation Period|Physician Decision|19
2564362|NCT01332968|8870845|P3|Maintenance/Observation Period|Physician Decision|14
2564363|NCT01332968|8870846|P2|Maintenance/Observation Period|Physician Decision|0
2564364|NCT01332968|8870847|P1|Maintenance/Observation Period|Physician Decision|0
2564365|NCT01332968|8870840|P8|Maintenance/Observation Period|Progressive disease|0
2564366|NCT01332968|8870841|P7|Maintenance/Observation Period|Progressive disease|0
2564367|NCT01332968|8870842|P6|Maintenance/Observation Period|Progressive disease|0
2564368|NCT01332968|8870843|P5|Maintenance/Observation Period|Progressive disease|0
2564369|NCT01332968|8870844|P4|Maintenance/Observation Period|Progressive disease|39
2564370|NCT01332968|8870845|P3|Maintenance/Observation Period|Progressive disease|72
2564371|NCT01332968|8870846|P2|Maintenance/Observation Period|Progressive disease|0
2564372|NCT01332968|8870847|P1|Maintenance/Observation Period|Progressive disease|0
2564373|NCT01332968|8870840|P8|Maintenance/Observation Period|Protocol Violation|0
2564374|NCT01332968|8870841|P7|Maintenance/Observation Period|Protocol Violation|0
2564375|NCT01332968|8870842|P6|Maintenance/Observation Period|Protocol Violation|0
2564376|NCT01332968|8870843|P5|Maintenance/Observation Period|Protocol Violation|0
2564377|NCT01332968|8870844|P4|Maintenance/Observation Period|Protocol Violation|1
2564378|NCT01332968|8870845|P3|Maintenance/Observation Period|Protocol Violation|1
2564379|NCT01332968|8870846|P2|Maintenance/Observation Period|Protocol Violation|0
2564380|NCT01332968|8870847|P1|Maintenance/Observation Period|Protocol Violation|0
2564381|NCT01332968|8870840|P8|Maintenance/Observation Period|Withdrawal by Subject|0
2564382|NCT01332968|8870841|P7|Maintenance/Observation Period|Withdrawal by Subject|0
2564383|NCT01332968|8870842|P6|Maintenance/Observation Period|Withdrawal by Subject|0
2564384|NCT01332968|8870843|P5|Maintenance/Observation Period|Withdrawal by Subject|0
2564385|NCT01332968|8870844|P4|Maintenance/Observation Period|Withdrawal by Subject|5
2564386|NCT01332968|8870845|P3|Maintenance/Observation Period|Withdrawal by Subject|10
2564387|NCT01332968|8870846|P2|Maintenance/Observation Period|Withdrawal by Subject|0
2564388|NCT01332968|8870847|P1|Maintenance/Observation Period|Withdrawal by Subject|0
2564389|NCT01332968|8870840|P8|Induction Period|Randomized, but not treated|0
2564390|NCT01332968|8870841|P7|Induction Period|Randomized, but not treated|0
2564391|NCT01332968|8870842|P6|Induction Period|Randomized, but not treated|0
2564392|NCT01332968|8870843|P5|Induction Period|Randomized, but not treated|0
2564393|NCT01332968|8870844|P4|Induction Period|Randomized, but not treated|0
2564394|NCT01332968|8870845|P3|Induction Period|Randomized, but not treated|0
2564395|NCT01332968|8870846|P2|Induction Period|Randomized, but not treated|7
2564396|NCT01332968|8870847|P1|Induction Period|Randomized, but not treated|4
2564397|NCT01332968|8870840|P8|Induction Period|Adverse Event|0
2564398|NCT01332968|8870841|P7|Induction Period|Adverse Event|0
2564399|NCT01332968|8870842|P6|Induction Period|Adverse Event|0
2564400|NCT01332968|8870843|P5|Induction Period|Adverse Event|0
2564401|NCT01332968|8870844|P4|Induction Period|Adverse Event|0
2564402|NCT01332968|8870845|P3|Induction Period|Adverse Event|0
2564403|NCT01332968|8870846|P2|Induction Period|Adverse Event|26
2564404|NCT01332968|8870847|P1|Induction Period|Adverse Event|23
2564405|NCT01332968|8870840|P8|Induction Period|Death|0
2564406|NCT01332968|8870841|P7|Induction Period|Death|0
2564407|NCT01332968|8870842|P6|Induction Period|Death|0
2564408|NCT01332968|8870843|P5|Induction Period|Death|0
2564409|NCT01332968|8870844|P4|Induction Period|Death|0
2564410|NCT01332968|8870845|P3|Induction Period|Death|0
2564411|NCT01332968|8870846|P2|Induction Period|Death|4
2564412|NCT01332968|8870847|P1|Induction Period|Death|1
2564413|NCT01332968|8870840|P8|Induction Period|Non-compliance|0
2564414|NCT01332968|8870841|P7|Induction Period|Non-compliance|0
2564415|NCT01332968|8870842|P6|Induction Period|Non-compliance|0
2564416|NCT01332968|8870843|P5|Induction Period|Non-compliance|0
2564417|NCT01332968|8870844|P4|Induction Period|Non-compliance|0
2564418|NCT01332968|8870845|P3|Induction Period|Non-compliance|0
2564419|NCT01332968|8870846|P2|Induction Period|Non-compliance|0
2564420|NCT01332968|8870847|P1|Induction Period|Non-compliance|1
2564421|NCT01332968|8870840|P8|Induction Period|Other|0
2564422|NCT01332968|8870841|P7|Induction Period|Other|0
2564423|NCT01332968|8870842|P6|Induction Period|Other|0
2564424|NCT01332968|8870843|P5|Induction Period|Other|0
2564425|NCT01332968|8870844|P4|Induction Period|Other|0
2564426|NCT01332968|8870845|P3|Induction Period|Other|0
2564427|NCT01332968|8870846|P2|Induction Period|Other|2
2564428|NCT01332968|8870847|P1|Induction Period|Other|2
2564429|NCT01332968|8870840|P8|Induction Period|Physician Decision|0
2564430|NCT01332968|8870841|P7|Induction Period|Physician Decision|0
2564431|NCT01332968|8870842|P6|Induction Period|Physician Decision|0
2564432|NCT01332968|8870843|P5|Induction Period|Physician Decision|0
2564433|NCT01332968|8870844|P4|Induction Period|Physician Decision|0
2564434|NCT01332968|8870845|P3|Induction Period|Physician Decision|0
2564435|NCT01332968|8870846|P2|Induction Period|Physician Decision|1
2564436|NCT01332968|8870847|P1|Induction Period|Physician Decision|6
2564437|NCT01332968|8870840|P8|Induction Period|Progressive disease|0
2564438|NCT01332968|8870841|P7|Induction Period|Progressive disease|0
2564439|NCT01332968|8870842|P6|Induction Period|Progressive disease|0
2564440|NCT01332968|8870843|P5|Induction Period|Progressive disease|0
2564441|NCT01332968|8870844|P4|Induction Period|Progressive disease|0
2564442|NCT01332968|8870845|P3|Induction Period|Progressive disease|0
2564443|NCT01332968|8870846|P2|Induction Period|Progressive disease|7
2564444|NCT01332968|8870847|P1|Induction Period|Progressive disease|15
2564445|NCT01332968|8870840|P8|Induction Period|Protocol Violation|0
2564446|NCT01332968|8870841|P7|Induction Period|Protocol Violation|0
2564447|NCT01332968|8870842|P6|Induction Period|Protocol Violation|0
2564448|NCT01332968|8870843|P5|Induction Period|Protocol Violation|0
2564449|NCT01332968|8870844|P4|Induction Period|Protocol Violation|0
2564450|NCT01332968|8870845|P3|Induction Period|Protocol Violation|0
2564451|NCT01332968|8870846|P2|Induction Period|Protocol Violation|4
2564452|NCT01332968|8870847|P1|Induction Period|Protocol Violation|3
2564453|NCT01332968|8870840|P8|Induction Period|Withdrawal by Subject|0
2564454|NCT01332968|8870841|P7|Induction Period|Withdrawal by Subject|0
2564455|NCT01332968|8870842|P6|Induction Period|Withdrawal by Subject|0
2564456|NCT01332968|8870843|P5|Induction Period|Withdrawal by Subject|0
2564457|NCT01332968|8870844|P4|Induction Period|Withdrawal by Subject|0
2564458|NCT01332968|8870845|P3|Induction Period|Withdrawal by Subject|0
2564459|NCT01332968|8870846|P2|Induction Period|Withdrawal by Subject|5
2564460|NCT01332968|8870847|P1|Induction Period|Withdrawal by Subject|3
2564461|NCT01332851|8870913|P2|Overall Study|Lost to Follow-up|11
2564462|NCT01332851|8870914|P1|Overall Study|Lost to Follow-up|7
2564463|NCT01332851|8870913|P2|Overall Study|Withdrawal by Subject|2
2564464|NCT01332851|8870914|P1|Overall Study|Withdrawal by Subject|4
2564465|NCT01332799|8870948|P2|Overall Study|Insufficient funding|10
2564466|NCT01332799|8870949|P1|Overall Study|Insufficient funding|10
2564467|NCT01332630|8870965|P1|Overall Study|Withdrawal by Subject|3
2564468|NCT01332331|8871081|P2|Overall Study|Physician Decision|0
2564469|NCT01332331|8871082|P1|Overall Study|Physician Decision|1
2564470|NCT01332331|8871081|P2|Overall Study|Adverse Event|1
2564471|NCT01332331|8871082|P1|Overall Study|Adverse Event|1
2564472|NCT01332331|8871081|P2|Overall Study|Lost to Follow-up|1
2564473|NCT01332331|8871082|P1|Overall Study|Lost to Follow-up|0
2564474|NCT01332318|8871134|P4|Overall Study|Protocol Violation|1
2564475|NCT01332318|8871135|P3|Overall Study|Protocol Violation|1
2564476|NCT01332318|8871136|P2|Overall Study|Protocol Violation|0
2564477|NCT01332318|8871137|P1|Overall Study|Protocol Violation|1
2564478|NCT01332318|8871134|P4|Overall Study|Withdrawal by Subject|1
2564479|NCT01332318|8871135|P3|Overall Study|Withdrawal by Subject|0
2564480|NCT01332318|8871136|P2|Overall Study|Withdrawal by Subject|1
2564481|NCT01332318|8871137|P1|Overall Study|Withdrawal by Subject|1
2564482|NCT01332318|8871134|P4|Overall Study|Adverse Event|0
2564483|NCT01332318|8871135|P3|Overall Study|Adverse Event|0
2564484|NCT01332318|8871136|P2|Overall Study|Adverse Event|3
2564485|NCT01332318|8871137|P1|Overall Study|Adverse Event|0
2564486|NCT01332305|8871248|P5|Overall Study|Physician Decision|0
2564487|NCT01332305|8871249|P4|Overall Study|Physician Decision|1
2564488|NCT01332305|8871250|P3|Overall Study|Physician Decision|0
2564489|NCT01332305|8871251|P2|Overall Study|Physician Decision|0
2564490|NCT01332305|8871252|P1|Overall Study|Physician Decision|0
2564491|NCT01332305|8871248|P5|Overall Study|Treatment Failure|0
2564492|NCT01332305|8871249|P4|Overall Study|Treatment Failure|0
2564493|NCT01332305|8871250|P3|Overall Study|Treatment Failure|0
2564494|NCT01332305|8871251|P2|Overall Study|Treatment Failure|1
2564495|NCT01332305|8871252|P1|Overall Study|Treatment Failure|1
2564496|NCT01332305|8871248|P5|Overall Study|Withdrawal by Sponsor|1
2564497|NCT01332305|8871249|P4|Overall Study|Withdrawal by Sponsor|1
2564498|NCT01332305|8871250|P3|Overall Study|Withdrawal by Sponsor|0
2564499|NCT01332305|8871251|P2|Overall Study|Withdrawal by Sponsor|0
2564500|NCT01332305|8871252|P1|Overall Study|Withdrawal by Sponsor|1
2564501|NCT01332305|8871248|P5|Overall Study|Protocol Violation|3
2564502|NCT01332305|8871249|P4|Overall Study|Protocol Violation|0
2564503|NCT01332305|8871250|P3|Overall Study|Protocol Violation|1
2564504|NCT01332305|8871251|P2|Overall Study|Protocol Violation|2
2564505|NCT01332305|8871252|P1|Overall Study|Protocol Violation|1
2564506|NCT01332305|8871248|P5|Overall Study|Lost to Follow-up|3
2564507|NCT01332305|8871249|P4|Overall Study|Lost to Follow-up|2
2564508|NCT01332305|8871250|P3|Overall Study|Lost to Follow-up|3
2564509|NCT01332305|8871251|P2|Overall Study|Lost to Follow-up|2
2564510|NCT01332305|8871252|P1|Overall Study|Lost to Follow-up|0
2564511|NCT01332305|8871248|P5|Overall Study|Withdrawal by Subject|0
2564512|NCT01332305|8871249|P4|Overall Study|Withdrawal by Subject|1
2564513|NCT01332305|8871250|P3|Overall Study|Withdrawal by Subject|4
2564514|NCT01332305|8871251|P2|Overall Study|Withdrawal by Subject|5
2564515|NCT01332305|8871252|P1|Overall Study|Withdrawal by Subject|6
2564516|NCT01332305|8871248|P5|Overall Study|Adverse Event|5
2564517|NCT01332305|8871249|P4|Overall Study|Adverse Event|3
2564518|NCT01332305|8871250|P3|Overall Study|Adverse Event|6
2564519|NCT01332305|8871251|P2|Overall Study|Adverse Event|4
2564520|NCT01332305|8871252|P1|Overall Study|Adverse Event|1
2564521|NCT01332292|8871274|P2|Treatment Period 2 (14 Days)|Physician Decision|1
2564522|NCT01332292|8871275|P1|Treatment Period 2 (14 Days)|Physician Decision|1
2564523|NCT01332292|8871274|P2|Treatment Period 1 (14 Days)|Protocol Violation|1
2564524|NCT01332292|8871275|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
2564525|NCT01332292|8871274|P2|Treatment Period 1 (14 Days)|Adverse Event|0
2564526|NCT01332292|8871275|P1|Treatment Period 1 (14 Days)|Adverse Event|1
2564527|NCT01332227|8871366|P2|Overall Study|Patient began prohibited medication|1
2564528|NCT01332227|8871367|P1|Overall Study|Patient began prohibited medication|0
2564529|NCT01332227|8871366|P2|Overall Study|Patient moved from area|0
2564530|NCT01332227|8871367|P1|Overall Study|Patient moved from area|1
2564531|NCT01332227|8871366|P2|Overall Study|Poor compliance/noncompliance|1
2564532|NCT01332227|8871367|P1|Overall Study|Poor compliance/noncompliance|1
2564533|NCT01332227|8871366|P2|Overall Study|Lack of Efficacy|1
2564534|NCT01332227|8871367|P1|Overall Study|Lack of Efficacy|3
2564535|NCT01332227|8871366|P2|Overall Study|Lost to Follow-up|0
2564536|NCT01332227|8871367|P1|Overall Study|Lost to Follow-up|2
2564537|NCT01332227|8871366|P2|Overall Study|Withdrawal by Subject|1
2564538|NCT01332227|8871367|P1|Overall Study|Withdrawal by Subject|5
2564539|NCT01332227|8871366|P2|Overall Study|Adverse Event|1
2564540|NCT01332227|8871367|P1|Overall Study|Adverse Event|4
2564541|NCT01332149|8871548|P2|Overall Study|Randomized but not treated|2
2564542|NCT01332149|8871549|P1|Overall Study|Randomized but not treated|1
2564543|NCT01332149|8871548|P2|Overall Study|Did not meet entrance criteria|4
2564544|NCT01332149|8871549|P1|Overall Study|Did not meet entrance criteria|3
2564545|NCT01332149|8871548|P2|Overall Study|Insufficient clinical response|7
2564546|NCT01332149|8871549|P1|Overall Study|Insufficient clinical response|4
2564547|NCT01332149|8871548|P2|Overall Study|Lost to Follow-up|1
2564548|NCT01332149|8871549|P1|Overall Study|Lost to Follow-up|1
2564549|NCT01332149|8871548|P2|Overall Study|Withdrawal by Subject|5
2564550|NCT01332149|8871549|P1|Overall Study|Withdrawal by Subject|4
2564551|NCT01332149|8871548|P2|Overall Study|Protocol Violation|3
2564552|NCT01332149|8871549|P1|Overall Study|Protocol Violation|1
2564553|NCT01332149|8871548|P2|Overall Study|Other unspecified|7
2564554|NCT01332149|8871549|P1|Overall Study|Other unspecified|5
2564555|NCT01332149|8871548|P2|Overall Study|Adverse Event|9
2564556|NCT01332149|8871549|P1|Overall Study|Adverse Event|11
2564557|NCT01332019|8871627|P2|Overall Study|Adverse Event|22
2564558|NCT01332019|8871628|P1|Overall Study|Adverse Event|13
2564559|NCT01332019|8871627|P2|Overall Study|Lost to Follow-up|7
2564560|NCT01332019|8871628|P1|Overall Study|Lost to Follow-up|4
2564561|NCT01332019|8871627|P2|Overall Study|Withdrawal by Subject|71
2564562|NCT01332019|8871628|P1|Overall Study|Withdrawal by Subject|73
2564563|NCT01332019|8871627|P2|Overall Study|Physician Decision|3
2564564|NCT01332019|8871628|P1|Overall Study|Physician Decision|4
2564565|NCT01332019|8871627|P2|Overall Study|Death|1
2564566|NCT01332019|8871628|P1|Overall Study|Death|2
2564567|NCT01332019|8871627|P2|Overall Study|Other|18
2564568|NCT01332019|8871628|P1|Overall Study|Other|16
2564569|NCT01332019|8871627|P2|Overall Study|Was Not Dosed|0
2564570|NCT01332019|8871628|P1|Overall Study|Was Not Dosed|1
2564571|NCT01331837|8871712|P2|Overall Study|Withdrawal by Subject|16
2564572|NCT01331837|8871713|P1|Overall Study|Withdrawal by Subject|13
2564573|NCT01331837|8871712|P2|Overall Study|Info not recorded|16
2564574|NCT01331837|8871713|P1|Overall Study|Info not recorded|10
2564575|NCT01331837|8871712|P2|Overall Study|Lost to Follow-up|1
2564576|NCT01331837|8871713|P1|Overall Study|Lost to Follow-up|3
2564577|NCT01331837|8871712|P2|Overall Study|Death|34
2564578|NCT01331837|8871713|P1|Overall Study|Death|30
2564579|NCT01331824|8871753|P1|Overall Study|Withdrawal by Subject|1
2564580|NCT01331824|8871753|P1|Overall Study|Disease Progression|9
2564581|NCT01331824|8871753|P1|Overall Study|Death|1
2564582|NCT01331824|8871753|P1|Overall Study|Adverse Event|2
2564583|NCT01331681|8871788|P3|Overall Study|Not Received Study Treatment|2
2564584|NCT01331681|8871789|P2|Overall Study|Not Received Study Treatment|0
2564585|NCT01331681|8871790|P1|Overall Study|Not Received Study Treatment|0
2564586|NCT01331681|8871788|P3|Overall Study|Switching to other therapy|1
2564587|NCT01331681|8871789|P2|Overall Study|Switching to other therapy|0
2564588|NCT01331681|8871790|P1|Overall Study|Switching to other therapy|0
2564589|NCT01331681|8871788|P3|Overall Study|Sponsor decision|0
2564590|NCT01331681|8871789|P2|Overall Study|Sponsor decision|1
2564591|NCT01331681|8871790|P1|Overall Study|Sponsor decision|1
2564592|NCT01331681|8871788|P3|Overall Study|Therapeutic procedure required|0
2564593|NCT01331681|8871789|P2|Overall Study|Therapeutic procedure required|0
2564594|NCT01331681|8871790|P1|Overall Study|Therapeutic procedure required|1
2564595|NCT01331681|8871788|P3|Overall Study|Physician Decision|4
2564596|NCT01331681|8871789|P2|Overall Study|Physician Decision|0
2564597|NCT01331681|8871790|P1|Overall Study|Physician Decision|2
2564598|NCT01331681|8871788|P3|Overall Study|Lost to Follow-up|1
2564599|NCT01331681|8871789|P2|Overall Study|Lost to Follow-up|4
2564600|NCT01331681|8871790|P1|Overall Study|Lost to Follow-up|2
2564601|NCT01331681|8871788|P3|Overall Study|Protocol Violation|0
2564602|NCT01331681|8871789|P2|Overall Study|Protocol Violation|1
2564603|NCT01331681|8871790|P1|Overall Study|Protocol Violation|1
2564604|NCT01331681|8871788|P3|Overall Study|Withdrawal by Subject|15
2564605|NCT01331681|8871789|P2|Overall Study|Withdrawal by Subject|8
2564606|NCT01331681|8871790|P1|Overall Study|Withdrawal by Subject|12
2564607|NCT01331681|8871788|P3|Overall Study|Lack of Efficacy|0
2564608|NCT01331681|8871789|P2|Overall Study|Lack of Efficacy|1
2564609|NCT01331681|8871790|P1|Overall Study|Lack of Efficacy|0
2564610|NCT01331681|8871788|P3|Overall Study|Death|2
2564611|NCT01331681|8871789|P2|Overall Study|Death|6
2564612|NCT01331681|8871790|P1|Overall Study|Death|6
2564613|NCT01331681|8871788|P3|Overall Study|Adverse Event|10
2564614|NCT01331681|8871789|P2|Overall Study|Adverse Event|13
2564615|NCT01331681|8871790|P1|Overall Study|Adverse Event|10
2564616|NCT01331291|8871839|P2|Overall Study|Death|1
2564617|NCT01331291|8871840|P1|Overall Study|Death|0
2564618|NCT01331291|8871839|P2|Overall Study|Lack of Efficacy|8
2564619|NCT01331291|8871840|P1|Overall Study|Lack of Efficacy|2
2564620|NCT01331161|8871874|P2|Overall Study|Pregnancy|1
2564621|NCT01331161|8871875|P1|Overall Study|Pregnancy|0
2564622|NCT01331161|8871874|P2|Overall Study|Lost to Follow-up|1
2564623|NCT01331161|8871875|P1|Overall Study|Lost to Follow-up|0
2564624|NCT01331161|8871874|P2|Overall Study|Physician Decision|0
2564625|NCT01331161|8871875|P1|Overall Study|Physician Decision|1
2564626|NCT01331109|8871883|P1|Overall Study|Study Terminated by Sponsor|38
2564627|NCT01331109|8871883|P1|Overall Study|Lost to Follow-up|1
2564628|NCT01331109|8871883|P1|Overall Study|Withdrawal by Subject|7
2564629|NCT01331109|8871883|P1|Overall Study|Protocol Violation|3
2564630|NCT01331109|8871883|P1|Overall Study|Lack of Efficacy|2
2564631|NCT01331109|8871883|P1|Overall Study|Adverse Event|6
2564632|NCT01331005|8871895|P2|Overall Study|Withdrawal by Subject|3
2564633|NCT01331005|8871896|P1|Overall Study|Withdrawal by Subject|2
2564634|NCT01331005|8871895|P2|Overall Study|Lost to Follow-up|1
2564635|NCT01331005|8871896|P1|Overall Study|Lost to Follow-up|2
2564636|NCT01330914|8871967|P1|Overall Study|No longer eligible (sleeve gastrectomy)|3
2564637|NCT01330914|8871967|P1|Overall Study|Withdrawal by Subject|4
2564638|NCT01330628|8871975|P2|Overall Study|Didn't receive study treatment|0
2564639|NCT01330628|8871976|P1|Overall Study|Didn't receive study treatment|1
2564640|NCT01330628|8871975|P2|Overall Study|Withdrawn|6
2564641|NCT01330628|8871976|P1|Overall Study|Withdrawn|18
2564642|NCT01330628|8871975|P2|Overall Study|Adverse Event|25
2564643|NCT01330628|8871976|P1|Overall Study|Adverse Event|44
2564644|NCT01330628|8871975|P2|Overall Study|Lost to Follow-up|6
2564645|NCT01330628|8871976|P1|Overall Study|Lost to Follow-up|5
2564646|NCT01330628|8871975|P2|Overall Study|Death|3
2564647|NCT01330628|8871976|P1|Overall Study|Death|2
2564648|NCT01330459|8871986|P2|Overall Study|Physician Decision|2
2564649|NCT01330459|8871987|P1|Overall Study|Physician Decision|0
2564650|NCT01330433|8872003|P2|Overall Study|Lost to Follow-up|0
2564651|NCT01330433|8872004|P1|Overall Study|Lost to Follow-up|1
2564652|NCT01330433|8872003|P2|Overall Study|Death|3
2564653|NCT01330433|8872004|P1|Overall Study|Death|1
2564654|NCT01330381|8872043|P3|Open-label Treatment Period (16 Weeks)|Non-compliance|1
2564655|NCT01330381|8872044|P2|Open-label Treatment Period (16 Weeks)|Non-compliance|0
2564656|NCT01330381|8872045|P1|Open-label Treatment Period (16 Weeks)|Non-compliance|0
2564657|NCT01330381|8872043|P3|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
2564658|NCT01330381|8872044|P2|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0
2564659|NCT01330381|8872045|P1|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
2564660|NCT01330381|8872043|P3|Open-label Treatment Period (16 Weeks)|Adverse Event|0
2564661|NCT01330381|8872044|P2|Open-label Treatment Period (16 Weeks)|Adverse Event|0
2564662|NCT01330381|8872045|P1|Open-label Treatment Period (16 Weeks)|Adverse Event|2
2564663|NCT01330381|8872043|P3|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16
2564664|NCT01330381|8872044|P2|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0
2564665|NCT01330381|8872045|P1|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7
2564666|NCT01330381|8872043|P3|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0
2564667|NCT01330381|8872044|P2|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
2564668|NCT01330381|8872045|P1|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
2564669|NCT01330381|8872043|P3|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
2564670|NCT01330381|8872044|P2|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
2564671|NCT01330381|8872045|P1|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1
2564672|NCT01330381|8872043|P3|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
2564673|NCT01330381|8872044|P2|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
2564674|NCT01330381|8872045|P1|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1
2564675|NCT01330381|8872043|P3|Double-blind Treatment Period (8 Weeks)|Adverse Event|0
2564676|NCT01330381|8872044|P2|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
2564677|NCT01330381|8872045|P1|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
2564678|NCT01330381|8872043|P3|Double-blind Treatment Period (8 Weeks)|Non-compliance|0
2564679|NCT01330381|8872044|P2|Double-blind Treatment Period (8 Weeks)|Non-compliance|1
2564680|NCT01330381|8872045|P1|Double-blind Treatment Period (8 Weeks)|Non-compliance|2
2564681|NCT01330381|8872043|P3|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0
2564682|NCT01330381|8872044|P2|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4
2564683|NCT01330381|8872045|P1|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5
2564684|NCT01330316|8872106|P2|Overall Study|other than above|1
2564685|NCT01330316|8872107|P1|Overall Study|other than above|0
2564686|NCT01330316|8872106|P2|Overall Study|Withdrawal by Subject|1
2564687|NCT01330316|8872107|P1|Overall Study|Withdrawal by Subject|0
2564688|NCT01330316|8872106|P2|Overall Study|Lost to Follow-up|1
2564689|NCT01330316|8872107|P1|Overall Study|Lost to Follow-up|0
2564690|NCT01330316|8872106|P2|Overall Study|Lack of Efficacy|10
2564691|NCT01330316|8872107|P1|Overall Study|Lack of Efficacy|0
2564692|NCT01330316|8872106|P2|Overall Study|Adverse Event|2
2564693|NCT01330316|8872107|P1|Overall Study|Adverse Event|2
2564694|NCT01330303|8872143|P2|Period 1|Withdrawal by Subject|1
2564695|NCT01330303|8872144|P1|Period 1|Withdrawal by Subject|0
2564696|NCT01330303|8872143|P2|Period 1|Protocol Violation|1
2564697|NCT01330303|8872144|P1|Period 1|Protocol Violation|0
2564698|NCT01330303|8872143|P2|Period 1|Adverse Event|0
2564699|NCT01330303|8872144|P1|Period 1|Adverse Event|1
2564700|NCT01330108|8872191|P1|Overall Study|Withdrawal by Subject|4
2564701|NCT01330030|8872209|P2|Overall Study|Lost to Follow-up|17
2564702|NCT01330030|8872210|P1|Overall Study|Lost to Follow-up|16
2564703|NCT01330017|8872221|P5|Overall Study|Unknown Reason|2
2564704|NCT01330017|8872222|P4|Overall Study|Unknown Reason|7
2564705|NCT01330017|8872223|P3|Overall Study|Unknown Reason|5
2564706|NCT01330017|8872224|P2|Overall Study|Unknown Reason|3
2564707|NCT01330017|8872225|P1|Overall Study|Unknown Reason|5
2564708|NCT01330017|8872221|P5|Overall Study|Protocol Violation|0
2564709|NCT01330017|8872222|P4|Overall Study|Protocol Violation|1
2564710|NCT01330017|8872223|P3|Overall Study|Protocol Violation|0
2564711|NCT01330017|8872224|P2|Overall Study|Protocol Violation|0
2564712|NCT01330017|8872225|P1|Overall Study|Protocol Violation|0
2564713|NCT01330017|8872221|P5|Overall Study|Lost to Follow-up|0
2564714|NCT01330017|8872222|P4|Overall Study|Lost to Follow-up|0
2564715|NCT01330017|8872223|P3|Overall Study|Lost to Follow-up|1
2564716|NCT01330017|8872224|P2|Overall Study|Lost to Follow-up|0
2564717|NCT01330017|8872225|P1|Overall Study|Lost to Follow-up|0
2564718|NCT01330017|8872221|P5|Overall Study|Withdrawal by Subject|1
2564719|NCT01330017|8872222|P4|Overall Study|Withdrawal by Subject|0
2564720|NCT01330017|8872223|P3|Overall Study|Withdrawal by Subject|1
2564721|NCT01330017|8872224|P2|Overall Study|Withdrawal by Subject|0
2564722|NCT01330017|8872225|P1|Overall Study|Withdrawal by Subject|0
2564723|NCT01330017|8872221|P5|Overall Study|Adverse Event|0
2564724|NCT01330017|8872222|P4|Overall Study|Adverse Event|4
2564725|NCT01330017|8872223|P3|Overall Study|Adverse Event|1
2564726|NCT01330017|8872224|P2|Overall Study|Adverse Event|1
2564727|NCT01330017|8872225|P1|Overall Study|Adverse Event|0
2564728|NCT01329978|8872274|P5|Rerandomization Treatment Period|Withdrawal by Subject|1
2564729|NCT01329978|8872275|P4|Rerandomization Treatment Period|Withdrawal by Subject|0
2564730|NCT01329978|8872276|P3|Rerandomization Treatment Period|Withdrawal by Subject|0
2564731|NCT01329978|8872277|P2|Rerandomization Treatment Period|Withdrawal by Subject|0
2564732|NCT01329978|8872278|P1|Rerandomization Treatment Period|Withdrawal by Subject|0
2564733|NCT01329978|8872274|P5|Rerandomization Treatment Period|Lost to Follow-up|3
2564734|NCT01329978|8872275|P4|Rerandomization Treatment Period|Lost to Follow-up|5
2564735|NCT01329978|8872276|P3|Rerandomization Treatment Period|Lost to Follow-up|0
2564736|NCT01329978|8872277|P2|Rerandomization Treatment Period|Lost to Follow-up|0
2564737|NCT01329978|8872278|P1|Rerandomization Treatment Period|Lost to Follow-up|0
2564738|NCT01329978|8872274|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
2564739|NCT01329978|8872275|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
2564740|NCT01329978|8872276|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
2564741|NCT01329978|8872277|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1
2564742|NCT01329978|8872278|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
2564743|NCT01329978|8872274|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
2564744|NCT01329978|8872275|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
2564745|NCT01329978|8872276|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
2564746|NCT01329978|8872277|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1
2564747|NCT01329978|8872278|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
2564748|NCT01329978|8872274|P5|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
2564749|NCT01329978|8872275|P4|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
2564750|NCT01329978|8872276|P3|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3
2564751|NCT01329978|8872277|P2|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
2564752|NCT01329978|8872278|P1|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
2564753|NCT01329978|8872274|P5|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
2564754|NCT01329978|8872275|P4|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
2564755|NCT01329978|8872276|P3|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
2564756|NCT01329978|8872277|P2|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8
2564757|NCT01329978|8872278|P1|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
2564758|NCT01329978|8872274|P5|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
2564759|NCT01329978|8872275|P4|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
2564760|NCT01329978|8872276|P3|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
2564761|NCT01329978|8872277|P2|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2
2564762|NCT01329978|8872278|P1|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1
2564763|NCT01329939|8872352|P4|Overall Study|Adverse Event|3
2564764|NCT01329939|8872353|P3|Overall Study|Adverse Event|0
2564765|NCT01329939|8872354|P2|Overall Study|Adverse Event|0
2564766|NCT01329939|8872355|P1|Overall Study|Adverse Event|0
2564767|NCT01329939|8872352|P4|Overall Study|Withdrawal by Subject|0
2564768|NCT01329939|8872353|P3|Overall Study|Withdrawal by Subject|0
2564769|NCT01329939|8872354|P2|Overall Study|Withdrawal by Subject|1
2564770|NCT01329939|8872355|P1|Overall Study|Withdrawal by Subject|0
2564771|NCT01329939|8872352|P4|Overall Study|Lost to Follow-up|2
2564772|NCT01329939|8872353|P3|Overall Study|Lost to Follow-up|1
2564773|NCT01329939|8872354|P2|Overall Study|Lost to Follow-up|0
2564774|NCT01329939|8872355|P1|Overall Study|Lost to Follow-up|3
2564775|NCT01329562|8872419|P2|Overall Study|Physician Decision|1
2564776|NCT01329562|8872420|P1|Overall Study|Physician Decision|0
2564777|NCT01329562|8872419|P2|Overall Study|Subject withdrew due to personal issues.|2
2564778|NCT01329562|8872420|P1|Overall Study|Subject withdrew due to personal issues.|3
2564779|NCT01329562|8872419|P2|Overall Study|Lost to Follow-up|1
2564780|NCT01329562|8872420|P1|Overall Study|Lost to Follow-up|1
2564781|NCT01329562|8872419|P2|Overall Study|Protocol Violation|3
2564782|NCT01329562|8872420|P1|Overall Study|Protocol Violation|5
2564783|NCT01329549|8872469|P1|Overall Study|Adverse Event|1
2564784|NCT01329549|8872469|P1|Overall Study|Withdrawal by Subject|1
2564785|NCT01329419|8872480|P1|Overall Study|Protocol Violation|235
2564786|NCT01329263|8872498|P2|Overall Study|Withdrawal by Subject|2
2564787|NCT01329263|8872499|P1|Overall Study|Withdrawal by Subject|1
2564788|NCT01329263|8872498|P2|Overall Study|Lost to Follow-up|21
2564789|NCT01329263|8872499|P1|Overall Study|Lost to Follow-up|4
2564790|NCT01329029|8872536|P2|Overall Study|Met Pre-defined Discontinuation Criteria|1
2564791|NCT01329029|8872537|P1|Overall Study|Met Pre-defined Discontinuation Criteria|5
2564792|NCT01329029|8872536|P2|Overall Study|Lost to Follow-up|5
2564793|NCT01329029|8872537|P1|Overall Study|Lost to Follow-up|8
2564794|NCT01329029|8872536|P2|Overall Study|Physician Decision|13
2564795|NCT01329029|8872537|P1|Overall Study|Physician Decision|16
2564796|NCT01329029|8872536|P2|Overall Study|COPD Exacerbation|18
2564797|NCT01329029|8872537|P1|Overall Study|COPD Exacerbation|11
2564798|NCT01329029|8872536|P2|Overall Study|Other|20
2564799|NCT01329029|8872537|P1|Overall Study|Other|14
2564800|NCT01329029|8872536|P2|Overall Study|Death|19
2564801|NCT01329029|8872537|P1|Overall Study|Death|16
2564802|NCT01329029|8872536|P2|Overall Study|Adverse Event|29
2564803|NCT01329029|8872537|P1|Overall Study|Adverse Event|82
2564804|NCT01329029|8872536|P2|Overall Study|Withdrawal by Subject|87
2564805|NCT01329029|8872537|P1|Overall Study|Withdrawal by Subject|117
2564806|NCT01328951|8872627|P2|Overall Study|Other|6
2564807|NCT01328951|8872628|P1|Overall Study|Other|11
2564808|NCT01328951|8872627|P2|Overall Study|Study Closed by the Sponsor|31
2564809|NCT01328951|8872628|P1|Overall Study|Study Closed by the Sponsor|36
2564810|NCT01328951|8872627|P2|Overall Study|Withdrawal by Subject|6
2564811|NCT01328951|8872628|P1|Overall Study|Withdrawal by Subject|6
2564812|NCT01328951|8872627|P2|Overall Study|Lost to Follow-up|7
2564813|NCT01328951|8872628|P1|Overall Study|Lost to Follow-up|6
2564814|NCT01328951|8872627|P2|Overall Study|Death|258
2564815|NCT01328951|8872628|P1|Overall Study|Death|243
2564816|NCT01328951|8872627|P2|Overall Study|Adverse Event|0
2564817|NCT01328951|8872628|P1|Overall Study|Adverse Event|2
2564818|NCT01328951|8872627|P2|Overall Study|Disease Progression|14
2564819|NCT01328951|8872628|P1|Overall Study|Disease Progression|17
2564820|NCT01328756|8872697|P1|Overall Study|Other|29
2564821|NCT01328756|8872697|P1|Overall Study|Lost to Follow-up|5
2564822|NCT01328756|8872697|P1|Overall Study|Withdrawal by Subject|41
2564823|NCT01328756|8872697|P1|Overall Study|Lack of Efficacy|5
2564824|NCT01328756|8872697|P1|Overall Study|Adverse Event|39
2564825|NCT01328756|8872697|P1|Overall Study|Protocol Violation|4
2564826|NCT01328717|8872733|P1|Overall Study|Adverse Event|1
2564827|NCT01328574|8872742|P1|Overall Study|Refused further treatment|1
2564828|NCT01328548|8872756|P2|Overall Study|Protocol Violation|0
2564829|NCT01328548|8872757|P1|Overall Study|Protocol Violation|1
2564830|NCT01328548|8872756|P2|Overall Study|Death|0
2564831|NCT01328548|8872757|P1|Overall Study|Death|3
2564832|NCT01328535|8872775|P1|Overall Study|Ineligible|1
2564833|NCT01328496|8872786|P2|Overall Study|Significant Change in Health Status|0
2564834|NCT01328496|8872787|P1|Overall Study|Significant Change in Health Status|1
2564835|NCT01328444|8872805|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
2564836|NCT01328444|8872806|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
2564837|NCT01328444|8872807|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
2564838|NCT01328444|8872808|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
2564839|NCT01328444|8872809|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
2564840|NCT01328444|8872810|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
2564841|NCT01328444|8872805|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
2564842|NCT01328444|8872806|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
2564843|NCT01328444|8872807|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
2564844|NCT01328444|8872808|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
2564845|NCT01328444|8872809|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
2564846|NCT01328444|8872810|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
2564847|NCT01328444|8872805|P6|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
2564848|NCT01328444|8872806|P5|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
2564849|NCT01328444|8872807|P4|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
2564850|NCT01328444|8872808|P3|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
2564851|NCT01328444|8872809|P2|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
2564852|NCT01328444|8872810|P1|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
2564853|NCT01328444|8872805|P6|Treatment Period 2 (12 Weeks)|Protocol Violation|0
2564854|NCT01328444|8872806|P5|Treatment Period 2 (12 Weeks)|Protocol Violation|1
2564855|NCT01328444|8872807|P4|Treatment Period 2 (12 Weeks)|Protocol Violation|0
2564856|NCT01328444|8872808|P3|Treatment Period 2 (12 Weeks)|Protocol Violation|0
2564857|NCT01328444|8872809|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|0
2564858|NCT01328444|8872810|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|1
2564859|NCT01328444|8872805|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4
2564860|NCT01328444|8872806|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
2564861|NCT01328444|8872807|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
2564862|NCT01328444|8872808|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
2564863|NCT01328444|8872809|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
2564864|NCT01328444|8872810|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5
2564865|NCT01328444|8872805|P6|Treatment Period 2 (12 Weeks)|Adverse Event|0
2564866|NCT01328444|8872806|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
2564867|NCT01328444|8872807|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
2564868|NCT01328444|8872808|P3|Treatment Period 2 (12 Weeks)|Adverse Event|1
2564869|NCT01328444|8872809|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
2564870|NCT01328444|8872810|P1|Treatment Period 2 (12 Weeks)|Adverse Event|5
2564871|NCT01328444|8872805|P6|Washout Period (14 Days)|Withdrawal by Subject|1
2564872|NCT01328444|8872806|P5|Washout Period (14 Days)|Withdrawal by Subject|0
2564873|NCT01328444|8872807|P4|Washout Period (14 Days)|Withdrawal by Subject|0
2564874|NCT01328444|8872808|P3|Washout Period (14 Days)|Withdrawal by Subject|0
2564875|NCT01328444|8872809|P2|Washout Period (14 Days)|Withdrawal by Subject|0
2564876|NCT01328444|8872810|P1|Washout Period (14 Days)|Withdrawal by Subject|0
2564877|NCT01328444|8872805|P6|Washout Period (14 Days)|Lack of Efficacy|1
2564878|NCT01328444|8872806|P5|Washout Period (14 Days)|Lack of Efficacy|0
2564879|NCT01328444|8872807|P4|Washout Period (14 Days)|Lack of Efficacy|0
2564880|NCT01328444|8872808|P3|Washout Period (14 Days)|Lack of Efficacy|0
2564881|NCT01328444|8872809|P2|Washout Period (14 Days)|Lack of Efficacy|0
2564882|NCT01328444|8872810|P1|Washout Period (14 Days)|Lack of Efficacy|0
2564883|NCT01328444|8872805|P6|Washout Period (14 Days)|Adverse Event|2
2564884|NCT01328444|8872806|P5|Washout Period (14 Days)|Adverse Event|1
2564885|NCT01328444|8872807|P4|Washout Period (14 Days)|Adverse Event|1
2564886|NCT01328444|8872808|P3|Washout Period (14 Days)|Adverse Event|0
2564887|NCT01328444|8872809|P2|Washout Period (14 Days)|Adverse Event|1
2564888|NCT01328444|8872810|P1|Washout Period (14 Days)|Adverse Event|1
2564889|NCT01328444|8872805|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
2564890|NCT01328444|8872806|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
2564891|NCT01328444|8872807|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
2564892|NCT01328444|8872808|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
2564893|NCT01328444|8872809|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
2564894|NCT01328444|8872810|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
2564895|NCT01328444|8872805|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
2564896|NCT01328444|8872806|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2564897|NCT01328444|8872807|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
2564898|NCT01328444|8872808|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2564899|NCT01328444|8872809|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2564900|NCT01328444|8872810|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2
2564901|NCT01328444|8872805|P6|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
2564902|NCT01328444|8872806|P5|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2
2564903|NCT01328444|8872807|P4|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
2564904|NCT01328444|8872808|P3|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
2564905|NCT01328444|8872809|P2|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1
2564906|NCT01328444|8872810|P1|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
2564907|NCT01328444|8872805|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|1
2564908|NCT01328444|8872806|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|0
2564909|NCT01328444|8872807|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
2564910|NCT01328444|8872808|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|0
2564911|NCT01328444|8872809|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
2564912|NCT01328444|8872810|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|0
2564913|NCT01328444|8872805|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
2564914|NCT01328444|8872806|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
2564915|NCT01328444|8872807|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
2564916|NCT01328444|8872808|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
2564917|NCT01328444|8872809|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
2564918|NCT01328444|8872810|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
2564919|NCT01328444|8872805|P6|Treatment Period 1 (12 Weeks)|Adverse Event|2
2564920|NCT01328444|8872806|P5|Treatment Period 1 (12 Weeks)|Adverse Event|5
2564921|NCT01328444|8872807|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
2564922|NCT01328444|8872808|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
2564923|NCT01328444|8872809|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
2564924|NCT01328444|8872810|P1|Treatment Period 1 (12 Weeks)|Adverse Event|3
2564925|NCT01328431|8872856|P2|12 Month (12M)|Lost to Follow-up|91
2564926|NCT01328431|8872857|P1|12 Month (12M)|Lost to Follow-up|82
2564927|NCT01328431|8872856|P2|12 Month (12M)|Death|6
2564928|NCT01328431|8872857|P1|12 Month (12M)|Death|2
2564929|NCT01328431|8872856|P2|3 Month (3M)|Lost to Follow-up|70
2564930|NCT01328431|8872857|P1|3 Month (3M)|Lost to Follow-up|75
2564931|NCT01328431|8872856|P2|3 Month (3M)|Death|2
2564932|NCT01328431|8872857|P1|3 Month (3M)|Death|2
2564933|NCT01328431|8872856|P2|1 Month (1M)|Lost to Follow-up|58
2564934|NCT01328431|8872857|P1|1 Month (1M)|Lost to Follow-up|55
2564935|NCT01328431|8872856|P2|Baseline|Protocol Violation|2
2564936|NCT01328431|8872857|P1|Baseline|Protocol Violation|0
2564937|NCT01328366|8872913|P1|Overall Study|Lost to Follow-up|7
2564938|NCT01328366|8872913|P1|Overall Study|Withdrawal by Subject|2
2564939|NCT01328366|8872913|P1|Overall Study|Death|1
2564940|NCT01328249|8872933|P2|Overall Study|Protocol Violation|1
2564941|NCT01328249|8872934|P1|Overall Study|Protocol Violation|0
2564942|NCT01328249|8872933|P2|Overall Study|Subject choice|1
2564943|NCT01328249|8872934|P1|Overall Study|Subject choice|1
2564944|NCT01328249|8872933|P2|Overall Study|Moved before end of treatment visit|0
2564945|NCT01328249|8872934|P1|Overall Study|Moved before end of treatment visit|1
2564946|NCT01328249|8872933|P2|Overall Study|Withdrawal by Subject|1
2564947|NCT01328249|8872934|P1|Overall Study|Withdrawal by Subject|1
2564948|NCT01328249|8872933|P2|Overall Study|Disease progression|0
2564949|NCT01328249|8872934|P1|Overall Study|Disease progression|1
2564950|NCT01328249|8872933|P2|Overall Study|Adverse Event|0
2564951|NCT01328249|8872934|P1|Overall Study|Adverse Event|3
2564952|NCT01328080|8873020|P1|Overall Study|Lost to Follow-up|5
2564953|NCT01328054|8873024|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2
2564954|NCT01328054|8873025|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0
2564955|NCT01328054|8873024|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1
2564956|NCT01328054|8873025|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0
2564957|NCT01328054|8873024|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2
2564958|NCT01328054|8873025|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0
2564959|NCT01328041|8873050|P1|Overall Study|Withdrawal by Subject|7
2564960|NCT01328041|8873050|P1|Overall Study|Physician Decision|2
2564961|NCT01328041|8873050|P1|Overall Study|Lost to Follow-up|7
2564962|NCT01328041|8873050|P1|Overall Study|Protocol Violation|7
2564963|NCT01328041|8873050|P1|Overall Study|Lack of Efficacy|27
2564964|NCT01328041|8873050|P1|Overall Study|Adverse Event|7
2564965|NCT01328002|8873072|P2|Double-Blind Period|Lack of Efficacy|0
2564966|NCT01328002|8873073|P1|Double-Blind Period|Lack of Efficacy|1
2564967|NCT01328002|8873072|P2|Double-Blind Period|Adverse Event|0
2564968|NCT01328002|8873073|P1|Double-Blind Period|Adverse Event|1
2564969|NCT01328002|8873072|P2|Open-Label Period|Other Reason|0
2564970|NCT01328002|8873073|P1|Open-Label Period|Other Reason|2
2564971|NCT01328002|8873072|P2|Open-Label Period|Lost to Follow-up|0
2564972|NCT01328002|8873073|P1|Open-Label Period|Lost to Follow-up|6
2564973|NCT01328002|8873072|P2|Open-Label Period|Withdrawal by Subject|0
2564974|NCT01328002|8873073|P1|Open-Label Period|Withdrawal by Subject|9
2564975|NCT01328002|8873072|P2|Open-Label Period|Protocol Violation|0
2564976|NCT01328002|8873073|P1|Open-Label Period|Protocol Violation|2
2564977|NCT01328002|8873072|P2|Open-Label Period|Lack of Efficacy|0
2564978|NCT01328002|8873073|P1|Open-Label Period|Lack of Efficacy|3
2564979|NCT01328002|8873072|P2|Open-Label Period|Adverse Event|0
2564980|NCT01328002|8873073|P1|Open-Label Period|Adverse Event|8
2564981|NCT01328002|8873072|P2|Open-Label Period|Inclusion/exclusion criteria not met|0
2564982|NCT01328002|8873073|P1|Open-Label Period|Inclusion/exclusion criteria not met|66
2564983|NCT01327885|8873109|P2|Overall Study|Ongoing|1
2564984|NCT01327885|8873110|P1|Overall Study|Ongoing|1
2564985|NCT01327885|8873109|P2|Overall Study|Not treated|1
2564986|NCT01327885|8873110|P1|Overall Study|Not treated|1
2564987|NCT01327885|8873109|P2|Overall Study|Withdrawal of consent from study|4
2564988|NCT01327885|8873110|P1|Overall Study|Withdrawal of consent from study|2
2564989|NCT01327885|8873109|P2|Overall Study|Other|6
2564990|NCT01327885|8873110|P1|Overall Study|Other|8
2564991|NCT01327885|8873109|P2|Overall Study|Subject choice|10
2564992|NCT01327885|8873110|P1|Overall Study|Subject choice|5
2564993|NCT01327885|8873109|P2|Overall Study|Adverse Event|10
2564994|NCT01327885|8873110|P1|Overall Study|Adverse Event|14
2564995|NCT01327885|8873109|P2|Overall Study|Clinical progression|27
2564996|NCT01327885|8873110|P1|Overall Study|Clinical progression|24
2564997|NCT01327885|8873109|P2|Overall Study|Disease progression-according to RECIST|165
2564998|NCT01327885|8873110|P1|Overall Study|Disease progression-according to RECIST|173
2564999|NCT01327846|8873126|P4|Extension Phase|Technical Problems|2
2565000|NCT01327846|8873127|P3|Extension Phase|Technical Problems|2
2565001|NCT01327846|8873128|P2|Extension Phase|Technical Problems|4
2565002|NCT01327846|8873129|P1|Extension Phase|Technical Problems|2
2565003|NCT01327846|8873126|P4|Extension Phase|Lost to Follow-up|7
2565004|NCT01327846|8873127|P3|Extension Phase|Lost to Follow-up|4
2565005|NCT01327846|8873128|P2|Extension Phase|Lost to Follow-up|3
2565006|NCT01327846|8873129|P1|Extension Phase|Lost to Follow-up|4
2565007|NCT01327846|8873126|P4|Extension Phase|Withdrawal by Subject|37
2565008|NCT01327846|8873127|P3|Extension Phase|Withdrawal by Subject|19
2565009|NCT01327846|8873128|P2|Extension Phase|Withdrawal by Subject|13
2565010|NCT01327846|8873129|P1|Extension Phase|Withdrawal by Subject|20
2565011|NCT01327846|8873126|P4|Extension Phase|Study terminated by sponsor|1660
2565012|NCT01327846|8873127|P3|Extension Phase|Study terminated by sponsor|1067
2565013|NCT01327846|8873128|P2|Extension Phase|Study terminated by sponsor|1124
2565014|NCT01327846|8873129|P1|Extension Phase|Study terminated by sponsor|1073
2565015|NCT01327846|8873126|P4|Core Phase|Lost to Follow-up|5
2565016|NCT01327846|8873127|P3|Core Phase|Lost to Follow-up|4
2565017|NCT01327846|8873128|P2|Core Phase|Lost to Follow-up|3
2565018|NCT01327846|8873129|P1|Core Phase|Lost to Follow-up|3
2565019|NCT01327846|8873126|P4|Core Phase|Subject decision (vital stat: alive)|20
2565020|NCT01327846|8873127|P3|Core Phase|Subject decision (vital stat: alive)|13
2565021|NCT01327846|8873128|P2|Core Phase|Subject decision (vital stat: alive)|24
2565022|NCT01327846|8873129|P1|Core Phase|Subject decision (vital stat: alive)|23
2565023|NCT01327846|8873126|P4|Core Phase|Subject decision (vital stat: dead)|4
2565024|NCT01327846|8873127|P3|Core Phase|Subject decision (vital stat: dead)|4
2565025|NCT01327846|8873128|P2|Core Phase|Subject decision (vital stat: dead)|3
2565026|NCT01327846|8873129|P1|Core Phase|Subject decision (vital stat: dead)|1
2565027|NCT01327846|8873126|P4|Core Phase|Subject decision (vital stat: unkn)|3
2565028|NCT01327846|8873127|P3|Core Phase|Subject decision (vital stat: unkn)|3
2565029|NCT01327846|8873128|P2|Core Phase|Subject decision (vital stat: unkn)|0
2565030|NCT01327846|8873129|P1|Core Phase|Subject decision (vital stat: unkn)|0
2565031|NCT01327846|8873126|P4|Core Phase|Subject decision (vital status: missing)|1
2565032|NCT01327846|8873127|P3|Core Phase|Subject decision (vital status: missing)|2
2565033|NCT01327846|8873128|P2|Core Phase|Subject decision (vital status: missing)|2
2565034|NCT01327846|8873129|P1|Core Phase|Subject decision (vital status: missing)|1
2565035|NCT01327703|8873204|P2|Second Treatment Period|Protocol Violation|1
2565036|NCT01327703|8873205|P1|Second Treatment Period|Protocol Violation|0
2565037|NCT01327703|8873204|P2|Second Treatment Period|Adverse Event|1
2565038|NCT01327703|8873205|P1|Second Treatment Period|Adverse Event|1
2565039|NCT01327651|8873261|P9|Post Study Follow-up|Lost to Follow-up|2
2565040|NCT01327651|8873262|P8|Post Study Follow-up|Lost to Follow-up|1
2565041|NCT01327651|8873263|P7|Post Study Follow-up|Lost to Follow-up|4
2565042|NCT01327651|8873264|P6|Post Study Follow-up|Lost to Follow-up|0
2565043|NCT01327651|8873265|P5|Post Study Follow-up|Lost to Follow-up|0
2565044|NCT01327651|8873266|P4|Post Study Follow-up|Lost to Follow-up|0
2565045|NCT01327651|8873267|P3|Post Study Follow-up|Lost to Follow-up|1
2565046|NCT01327651|8873268|P2|Post Study Follow-up|Lost to Follow-up|1
2565047|NCT01327651|8873269|P1|Post Study Follow-up|Lost to Follow-up|0
2565048|NCT01327651|8873261|P9|Self-administered Dosing Period|Withdrawal by Subject|1
2565049|NCT01327651|8873262|P8|Self-administered Dosing Period|Withdrawal by Subject|1
2565050|NCT01327651|8873263|P7|Self-administered Dosing Period|Withdrawal by Subject|2
2565051|NCT01327651|8873264|P6|Self-administered Dosing Period|Withdrawal by Subject|0
2565052|NCT01327651|8873265|P5|Self-administered Dosing Period|Withdrawal by Subject|0
2565053|NCT01327651|8873266|P4|Self-administered Dosing Period|Withdrawal by Subject|1
2565054|NCT01327651|8873267|P3|Self-administered Dosing Period|Withdrawal by Subject|0
2565055|NCT01327651|8873268|P2|Self-administered Dosing Period|Withdrawal by Subject|1
2565056|NCT01327651|8873269|P1|Self-administered Dosing Period|Withdrawal by Subject|0
2565057|NCT01327651|8873261|P9|Self-administered Dosing Period|Ineligible (retrospective result)|0
2565058|NCT01327651|8873262|P8|Self-administered Dosing Period|Ineligible (retrospective result)|0
2565059|NCT01327651|8873263|P7|Self-administered Dosing Period|Ineligible (retrospective result)|0
2565060|NCT01327651|8873264|P6|Self-administered Dosing Period|Ineligible (retrospective result)|0
2565061|NCT01327651|8873265|P5|Self-administered Dosing Period|Ineligible (retrospective result)|0
2565062|NCT01327651|8873266|P4|Self-administered Dosing Period|Ineligible (retrospective result)|0
2565063|NCT01327651|8873267|P3|Self-administered Dosing Period|Ineligible (retrospective result)|0
2565064|NCT01327651|8873268|P2|Self-administered Dosing Period|Ineligible (retrospective result)|0
2565065|NCT01327651|8873269|P1|Self-administered Dosing Period|Ineligible (retrospective result)|1
2565066|NCT01327651|8873261|P9|Self-administered Dosing Period|Lost to Follow-up|10
2565067|NCT01327651|8873262|P8|Self-administered Dosing Period|Lost to Follow-up|9
2565068|NCT01327651|8873263|P7|Self-administered Dosing Period|Lost to Follow-up|8
2565069|NCT01327651|8873264|P6|Self-administered Dosing Period|Lost to Follow-up|0
2565070|NCT01327651|8873265|P5|Self-administered Dosing Period|Lost to Follow-up|3
2565071|NCT01327651|8873266|P4|Self-administered Dosing Period|Lost to Follow-up|2
2565072|NCT01327651|8873267|P3|Self-administered Dosing Period|Lost to Follow-up|4
2565073|NCT01327651|8873268|P2|Self-administered Dosing Period|Lost to Follow-up|2
2565074|NCT01327651|8873269|P1|Self-administered Dosing Period|Lost to Follow-up|3
2565075|NCT01327599|8873388|P1|Overall Study|Withdrawal of Consent|1
2565076|NCT01327599|8873388|P1|Overall Study|Could Not Attend Visit|1
2565077|NCT01327599|8873388|P1|Overall Study|Adverse Event|1
2565078|NCT01327573|8873398|P2|Overall Study|Physician Decision|1
2565079|NCT01327573|8873399|P1|Overall Study|Physician Decision|3
2565080|NCT01327547|8873410|P2|Overall Study|By investigator in subject’s interest|1
2565081|NCT01327547|8873411|P1|Overall Study|By investigator in subject’s interest|0
2565082|NCT01327547|8873410|P2|Overall Study|Non-compliance with study procedures|0
2565083|NCT01327547|8873411|P1|Overall Study|Non-compliance with study procedures|1
2565084|NCT01327547|8873410|P2|Overall Study|Required prohibited medication|0
2565085|NCT01327547|8873411|P1|Overall Study|Required prohibited medication|2
2565086|NCT01327547|8873410|P2|Overall Study|Non-compliance due to alcohol intake|1
2565087|NCT01327547|8873411|P1|Overall Study|Non-compliance due to alcohol intake|0
2565088|NCT01327547|8873410|P2|Overall Study|Protocol Violation|0
2565089|NCT01327547|8873411|P1|Overall Study|Protocol Violation|1
2565090|NCT01327547|8873410|P2|Overall Study|Does Not Meet Entrance Criteria|2
2565091|NCT01327547|8873411|P1|Overall Study|Does Not Meet Entrance Criteria|2
2565092|NCT01327547|8873410|P2|Overall Study|Withdrawal by Subject|7
2565093|NCT01327547|8873411|P1|Overall Study|Withdrawal by Subject|3
2565094|NCT01327547|8873410|P2|Overall Study|Non-Compliance With Study Treatment|2
2565095|NCT01327547|8873411|P1|Overall Study|Non-Compliance With Study Treatment|0
2565096|NCT01327547|8873410|P2|Overall Study|Lost to Follow-up|6
2565097|NCT01327547|8873411|P1|Overall Study|Lost to Follow-up|6
2565098|NCT01327547|8873410|P2|Overall Study|Death|2
2565099|NCT01327547|8873411|P1|Overall Study|Death|1
2565100|NCT01327547|8873410|P2|Overall Study|Adverse Event|1
2565101|NCT01327547|8873411|P1|Overall Study|Adverse Event|4
2565102|NCT01327495|8873479|P6|Overall Study|Physician Decision|0
2565103|NCT01327495|8873480|P5|Overall Study|Physician Decision|2
2565104|NCT01327495|8873481|P4|Overall Study|Physician Decision|0
2565105|NCT01327495|8873482|P3|Overall Study|Physician Decision|0
2565106|NCT01327495|8873483|P2|Overall Study|Physician Decision|0
2565107|NCT01327495|8873484|P1|Overall Study|Physician Decision|0
2565108|NCT01327495|8873479|P6|Overall Study|Withdrawal by Subject|0
2565109|NCT01327495|8873480|P5|Overall Study|Withdrawal by Subject|1
2565110|NCT01327495|8873481|P4|Overall Study|Withdrawal by Subject|0
2565111|NCT01327495|8873482|P3|Overall Study|Withdrawal by Subject|1
2565112|NCT01327495|8873483|P2|Overall Study|Withdrawal by Subject|1
2565113|NCT01327495|8873484|P1|Overall Study|Withdrawal by Subject|0
2565114|NCT01327495|8873479|P6|Overall Study|Adverse Event|2
2565115|NCT01327495|8873480|P5|Overall Study|Adverse Event|0
2565116|NCT01327495|8873481|P4|Overall Study|Adverse Event|0
2565117|NCT01327495|8873482|P3|Overall Study|Adverse Event|1
2565118|NCT01327495|8873483|P2|Overall Study|Adverse Event|1
2565119|NCT01327495|8873484|P1|Overall Study|Adverse Event|2
2565120|NCT01327482|8873576|P1|Overall Study|Adverse Event|1
2565121|NCT01327339|8873581|P1|Overall Study|Protocol Violation|8
2565122|NCT01327300|8873716|P2|Washout (3 Weeks)|Withdrawal by Subject|0
2565123|NCT01327300|8873717|P1|Washout (3 Weeks)|Withdrawal by Subject|1
2565124|NCT01327053|8873757|P2|Overall Study|Untreated|1
2565125|NCT01327053|8873758|P1|Overall Study|Untreated|0
2565126|NCT01327053|8873757|P2|Overall Study|Protocol Violation|1
2565127|NCT01327053|8873758|P1|Overall Study|Protocol Violation|0
2565128|NCT01327053|8873757|P2|Overall Study|Progressive disease|26
2565129|NCT01327053|8873758|P1|Overall Study|Progressive disease|31
2565130|NCT01327053|8873757|P2|Overall Study|Study terminated by Sponsor|3
2565131|NCT01327053|8873758|P1|Overall Study|Study terminated by Sponsor|1
2565132|NCT01327053|8873757|P2|Overall Study|Non-compliance with study treatment|5
2565133|NCT01327053|8873758|P1|Overall Study|Non-compliance with study treatment|0
2565134|NCT01327053|8873757|P2|Overall Study|Lost to Follow-up|4
2565135|NCT01327053|8873758|P1|Overall Study|Lost to Follow-up|2
2565136|NCT01327053|8873757|P2|Overall Study|Death|5
2565137|NCT01327053|8873758|P1|Overall Study|Death|1
2565138|NCT01327053|8873757|P2|Overall Study|Physician Decision|14
2565139|NCT01327053|8873758|P1|Overall Study|Physician Decision|10
2565140|NCT01327053|8873757|P2|Overall Study|Patient/guardian decision|35
2565141|NCT01327053|8873758|P1|Overall Study|Patient/guardian decision|11
2565142|NCT01327053|8873757|P2|Overall Study|Adverse Event|57
2565143|NCT01327053|8873758|P1|Overall Study|Adverse Event|23
2565144|NCT01326962|8873832|P1|Overall Study|Other|2
2565145|NCT01326962|8873832|P1|Overall Study|Lost to Follow-up|3
2565146|NCT01326962|8873832|P1|Overall Study|Withdrawal by Subject|1
2565147|NCT01326962|8873832|P1|Overall Study|Adverse Event|1
2565148|NCT01326910|8873850|P2|Overall Study|Protocol Violation|1
2565149|NCT01326910|8873851|P1|Overall Study|Protocol Violation|1
2565150|NCT01326910|8873850|P2|Overall Study|Withdrawal by Subject|2
2565151|NCT01326910|8873851|P1|Overall Study|Withdrawal by Subject|3
2565152|NCT01326845|8873865|P2|Overall Study|Misisng|3
2565153|NCT01326845|8873866|P1|Overall Study|Misisng|1
2565154|NCT01326845|8873865|P2|Overall Study|Adverse Event|0
2565155|NCT01326845|8873866|P1|Overall Study|Adverse Event|1
2565156|NCT01326845|8873865|P2|Overall Study|Administrative Problems|2
2565157|NCT01326845|8873866|P1|Overall Study|Administrative Problems|5
2565158|NCT01326728|8873927|P2|Overall Study|Early closure of study|9
2565159|NCT01326728|8873928|P1|Overall Study|Early closure of study|34
2565160|NCT01326728|8873927|P2|Overall Study|Death|0
2565161|NCT01326728|8873928|P1|Overall Study|Death|13
2565162|NCT01326702|8873952|P7|Overall Study|Not Treated|0
2565163|NCT01326702|8873953|P6|Overall Study|Not Treated|1
2565164|NCT01326702|8873954|P5|Overall Study|Not Treated|0
2565165|NCT01326702|8873955|P4|Overall Study|Not Treated|1
2565166|NCT01326702|8873956|P3|Overall Study|Not Treated|0
2565167|NCT01326702|8873957|P2|Overall Study|Not Treated|0
2565168|NCT01326702|8873958|P1|Overall Study|Not Treated|0
2565169|NCT01326702|8873952|P7|Overall Study|Withdrawal by Subject|3
2565170|NCT01326702|8873953|P6|Overall Study|Withdrawal by Subject|1
2565171|NCT01326702|8873954|P5|Overall Study|Withdrawal by Subject|1
2565172|NCT01326702|8873955|P4|Overall Study|Withdrawal by Subject|0
2565173|NCT01326702|8873956|P3|Overall Study|Withdrawal by Subject|1
2565174|NCT01326702|8873957|P2|Overall Study|Withdrawal by Subject|0
2565175|NCT01326702|8873958|P1|Overall Study|Withdrawal by Subject|0
2565176|NCT01326702|8873952|P7|Overall Study|Adverse Event|1
2565177|NCT01326702|8873953|P6|Overall Study|Adverse Event|3
2565178|NCT01326702|8873954|P5|Overall Study|Adverse Event|0
2565179|NCT01326702|8873955|P4|Overall Study|Adverse Event|1
2565180|NCT01326702|8873956|P3|Overall Study|Adverse Event|1
2565181|NCT01326702|8873957|P2|Overall Study|Adverse Event|0
2565182|NCT01326702|8873958|P1|Overall Study|Adverse Event|0
2565183|NCT01326702|8873952|P7|Overall Study|Death|0
2565184|NCT01326702|8873953|P6|Overall Study|Death|0
2565185|NCT01326702|8873954|P5|Overall Study|Death|0
2565186|NCT01326702|8873955|P4|Overall Study|Death|0
2565187|NCT01326702|8873956|P3|Overall Study|Death|0
2565188|NCT01326702|8873957|P2|Overall Study|Death|1
2565189|NCT01326702|8873958|P1|Overall Study|Death|0
2565190|NCT01326702|8873952|P7|Overall Study|progressive disease|3
2565191|NCT01326702|8873953|P6|Overall Study|progressive disease|2
2565192|NCT01326702|8873954|P5|Overall Study|progressive disease|3
2565193|NCT01326702|8873955|P4|Overall Study|progressive disease|1
2565194|NCT01326702|8873956|P3|Overall Study|progressive disease|3
2565195|NCT01326702|8873957|P2|Overall Study|progressive disease|1
2565196|NCT01326702|8873958|P1|Overall Study|progressive disease|1
2565197|NCT01326702|8873952|P7|Overall Study|Other|0
2565198|NCT01326702|8873953|P6|Overall Study|Other|1
2565199|NCT01326702|8873954|P5|Overall Study|Other|0
2565200|NCT01326702|8873955|P4|Overall Study|Other|0
2565201|NCT01326702|8873956|P3|Overall Study|Other|0
2565202|NCT01326702|8873957|P2|Overall Study|Other|0
2565203|NCT01326702|8873958|P1|Overall Study|Other|1
2565204|NCT01326546|8874014|P2|Overall Study|Withdrawal by Subject|1
2565205|NCT01326546|8874015|P1|Overall Study|Withdrawal by Subject|5
2565206|NCT01326546|8874014|P2|Overall Study|Adverse Event|0
2565207|NCT01326546|8874015|P1|Overall Study|Adverse Event|1
2565208|NCT01326546|8874014|P2|Overall Study|Pregnancy|1
2565209|NCT01326546|8874015|P1|Overall Study|Pregnancy|0
2565210|NCT01326546|8874014|P2|Overall Study|Protocol Violation|4
2565211|NCT01326546|8874015|P1|Overall Study|Protocol Violation|3
2565212|NCT01326546|8874014|P2|Overall Study|Lost to Follow-up|7
2565213|NCT01326546|8874015|P1|Overall Study|Lost to Follow-up|8
2565214|NCT01326533|8874023|P2|Overall Study|Adverse Event|0
2565215|NCT01326533|8874024|P1|Overall Study|Adverse Event|1
2565216|NCT01326533|8874023|P2|Overall Study|Withdrawal by Subject|0
2565217|NCT01326533|8874024|P1|Overall Study|Withdrawal by Subject|1
2565218|NCT01326533|8874023|P2|Overall Study|Lost to Follow-up|0
2565219|NCT01326533|8874024|P1|Overall Study|Lost to Follow-up|2
2565220|NCT01326481|8874032|P1|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1
2565221|NCT01326026|8874041|P2|Overall Study|Other|3
2565222|NCT01326026|8874042|P1|Overall Study|Other|3
2565223|NCT01326026|8874041|P2|Overall Study|Withdrawal Criteria|7
2565224|NCT01326026|8874042|P1|Overall Study|Withdrawal Criteria|5
2565225|NCT01326026|8874041|P2|Overall Study|Adverse Event|3
2565226|NCT01326026|8874042|P1|Overall Study|Adverse Event|4
2565227|NCT01325701|8874107|P2|Overall Study|Rollerover Extension Study|0
2565228|NCT01325701|8874108|P1|Overall Study|Rollerover Extension Study|4
2565229|NCT01325701|8874107|P2|Overall Study|Withdrawal by Subject|1
2565230|NCT01325701|8874108|P1|Overall Study|Withdrawal by Subject|2
2565231|NCT01325701|8874107|P2|Overall Study|Physician Decision|2
2565232|NCT01325701|8874108|P1|Overall Study|Physician Decision|2
2565233|NCT01325701|8874107|P2|Overall Study|Protocol Violation|0
2565234|NCT01325701|8874108|P1|Overall Study|Protocol Violation|1
2565235|NCT01325701|8874107|P2|Overall Study|Adverse Event|0
2565236|NCT01325701|8874108|P1|Overall Study|Adverse Event|12
2565237|NCT01325623|8874118|P1|Overall Study|Withdrawal by Subject|3
2565238|NCT01325584|8874160|P1|Overall Study|Death|1
2565239|NCT01325532|8874170|P2|Overall Study|Withdrawal by Subject|0
2565240|NCT01325532|8874171|P1|Overall Study|Withdrawal by Subject|2
2565241|NCT01325493|8874183|P2|Overall Study|Allergy|0
2565242|NCT01325493|8874184|P1|Overall Study|Allergy|1
2565243|NCT01325493|8874183|P2|Overall Study|loss of neuromonitoring signals|2
2565244|NCT01325493|8874184|P1|Overall Study|loss of neuromonitoring signals|0
2565245|NCT01325493|8874183|P2|Overall Study|Protocol Violation|1
2565246|NCT01325493|8874184|P1|Overall Study|Protocol Violation|0
2565247|NCT01325428|8874196|P1|Part B|Other reason not defined above|1
2565248|NCT01325428|8874196|P1|Part B|Refused continue taking trial medication|2
2565249|NCT01325428|8874196|P1|Part A|Other reason not defined above|2
2565250|NCT01325428|8874196|P1|Part A|Refused continue taking trial medication|2
2565251|NCT01325428|8874196|P1|Part A|Other adverse event|1
2565252|NCT01325428|8874196|P1|Part A|Clinical signs, symptoms of progression|2
2565253|NCT01325428|8874196|P1|Part A|Progressive disease according to RECIST|9
2565254|NCT01325350|8874216|P5|Overall Study|Did Not Receive Treatment|1
2565255|NCT01325350|8874217|P4|Overall Study|Did Not Receive Treatment|0
2565256|NCT01325350|8874218|P3|Overall Study|Did Not Receive Treatment|1
2565257|NCT01325350|8874219|P2|Overall Study|Did Not Receive Treatment|1
2565258|NCT01325350|8874220|P1|Overall Study|Did Not Receive Treatment|0
2565259|NCT01325350|8874216|P5|Overall Study|Withdrawal by Subject|0
2565260|NCT01325350|8874217|P4|Overall Study|Withdrawal by Subject|1
2565261|NCT01325350|8874218|P3|Overall Study|Withdrawal by Subject|1
2565262|NCT01325350|8874219|P2|Overall Study|Withdrawal by Subject|0
2565263|NCT01325350|8874220|P1|Overall Study|Withdrawal by Subject|0
2565264|NCT01325350|8874216|P5|Overall Study|Protocol Violation|0
2565265|NCT01325350|8874217|P4|Overall Study|Protocol Violation|1
2565266|NCT01325350|8874218|P3|Overall Study|Protocol Violation|0
2565267|NCT01325350|8874219|P2|Overall Study|Protocol Violation|0
2565268|NCT01325350|8874220|P1|Overall Study|Protocol Violation|0
2565269|NCT01325350|8874216|P5|Overall Study|Personal Reasons|3
2565270|NCT01325350|8874217|P4|Overall Study|Personal Reasons|5
2565271|NCT01325350|8874218|P3|Overall Study|Personal Reasons|6
2565272|NCT01325350|8874219|P2|Overall Study|Personal Reasons|1
2565273|NCT01325350|8874220|P1|Overall Study|Personal Reasons|2
2565274|NCT01325350|8874216|P5|Overall Study|Lost to Follow-up|5
2565275|NCT01325350|8874217|P4|Overall Study|Lost to Follow-up|1
2565276|NCT01325350|8874218|P3|Overall Study|Lost to Follow-up|5
2565277|NCT01325350|8874219|P2|Overall Study|Lost to Follow-up|0
2565278|NCT01325350|8874220|P1|Overall Study|Lost to Follow-up|1
2565279|NCT01325350|8874216|P5|Overall Study|Pregnancy|1
2565280|NCT01325350|8874217|P4|Overall Study|Pregnancy|0
2565281|NCT01325350|8874218|P3|Overall Study|Pregnancy|1
2565282|NCT01325350|8874219|P2|Overall Study|Pregnancy|0
2565283|NCT01325350|8874220|P1|Overall Study|Pregnancy|0
2565284|NCT01325350|8874216|P5|Overall Study|Adverse Event|2
2565285|NCT01325350|8874217|P4|Overall Study|Adverse Event|1
2565286|NCT01325350|8874218|P3|Overall Study|Adverse Event|3
2565287|NCT01325350|8874219|P2|Overall Study|Adverse Event|3
2565288|NCT01325350|8874220|P1|Overall Study|Adverse Event|3
2565289|NCT01325337|8874262|P5|Overall Study|Withdrawal by Subject|1
2565290|NCT01325337|8874263|P4|Overall Study|Withdrawal by Subject|0
2565291|NCT01325337|8874264|P3|Overall Study|Withdrawal by Subject|1
2565292|NCT01325337|8874265|P2|Overall Study|Withdrawal by Subject|0
2565293|NCT01325337|8874266|P1|Overall Study|Withdrawal by Subject|1
2565294|NCT01325337|8874262|P5|Overall Study|Personal Reasons|3
2565295|NCT01325337|8874263|P4|Overall Study|Personal Reasons|8
2565296|NCT01325337|8874264|P3|Overall Study|Personal Reasons|4
2565297|NCT01325337|8874265|P2|Overall Study|Personal Reasons|5
2565298|NCT01325337|8874266|P1|Overall Study|Personal Reasons|2
2565299|NCT01325337|8874262|P5|Overall Study|Lost to Follow-up|2
2565300|NCT01325337|8874263|P4|Overall Study|Lost to Follow-up|1
2565301|NCT01325337|8874264|P3|Overall Study|Lost to Follow-up|2
2565302|NCT01325337|8874265|P2|Overall Study|Lost to Follow-up|2
2565303|NCT01325337|8874266|P1|Overall Study|Lost to Follow-up|2
2565304|NCT01325337|8874262|P5|Overall Study|Adverse Event|2
2565305|NCT01325337|8874263|P4|Overall Study|Adverse Event|1
2565306|NCT01325337|8874264|P3|Overall Study|Adverse Event|2
2565307|NCT01325337|8874265|P2|Overall Study|Adverse Event|2
2565308|NCT01325337|8874266|P1|Overall Study|Adverse Event|0
2565309|NCT01325207|8874346|P6|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
2565310|NCT01325207|8874347|P5|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1
2565311|NCT01325207|8874348|P4|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
2565312|NCT01325207|8874349|P3|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
2565313|NCT01325207|8874350|P2|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
2565314|NCT01325207|8874351|P1|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
2565315|NCT01325207|8874346|P6|Follow-up Every 3 Months Until Death|Lost to Follow-up|1
2565316|NCT01325207|8874347|P5|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
2565317|NCT01325207|8874348|P4|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
2565318|NCT01325207|8874349|P3|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
2565319|NCT01325207|8874350|P2|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
2565320|NCT01325207|8874351|P1|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
2565321|NCT01325207|8874346|P6|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1
2565322|NCT01325207|8874347|P5|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
2565323|NCT01325207|8874348|P4|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
2565324|NCT01325207|8874349|P3|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
2565325|NCT01325207|8874350|P2|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
2565326|NCT01325207|8874351|P1|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
2565327|NCT01325207|8874346|P6|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
2565328|NCT01325207|8874347|P5|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
2565329|NCT01325207|8874348|P4|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
2565330|NCT01325207|8874349|P3|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
2565331|NCT01325207|8874350|P2|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1
2565332|NCT01325207|8874351|P1|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
2565333|NCT01325207|8874346|P6|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4
2565334|NCT01325207|8874347|P5|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0
2565335|NCT01325207|8874348|P4|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
2565336|NCT01325207|8874349|P3|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
2565337|NCT01325207|8874350|P2|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
2565338|NCT01325207|8874351|P1|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
2565339|NCT01325207|8874346|P6|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5
2565340|NCT01325207|8874347|P5|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2
2565341|NCT01325207|8874348|P4|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0
2565342|NCT01325207|8874349|P3|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0
2565343|NCT01325207|8874350|P2|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1
2565344|NCT01325207|8874351|P1|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1
2565345|NCT01325207|8874346|P6|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
2565346|NCT01325207|8874347|P5|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2
2565347|NCT01325207|8874348|P4|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
2565348|NCT01325207|8874349|P3|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
2565349|NCT01325207|8874350|P2|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
2565350|NCT01325207|8874351|P1|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
2565351|NCT01324999|8874383|P1|Overall Study|Withdrawal by Subject|2
2565352|NCT01324999|8874383|P1|Overall Study|Adverse Event|3
2565353|NCT01324947|8874394|P1|Overall Study|1 discontinued before starting drug|1
2565354|NCT01324947|8874394|P1|Overall Study|Withdrawal by Subject|3
2565355|NCT01324947|8874394|P1|Overall Study|Progressive Disease|50
2565356|NCT01324947|8874394|P1|Overall Study|Other|3
2565357|NCT01324947|8874394|P1|Overall Study|Death|10
2565358|NCT01324947|8874394|P1|Overall Study|Adverse Event|7
2565359|NCT01324830|8874435|P19|Overall Study|Withdrawal by Subject|1
2565360|NCT01324830|8874436|P18|Overall Study|Withdrawal by Subject|0
2565361|NCT01324830|8874437|P17|Overall Study|Withdrawal by Subject|0
2565362|NCT01324830|8874438|P16|Overall Study|Withdrawal by Subject|0
2565363|NCT01324830|8874439|P15|Overall Study|Withdrawal by Subject|0
2565364|NCT01324830|8874440|P14|Overall Study|Withdrawal by Subject|0
2565365|NCT01324830|8874441|P13|Overall Study|Withdrawal by Subject|0
2565366|NCT01324830|8874442|P12|Overall Study|Withdrawal by Subject|0
2565367|NCT01324830|8874443|P11|Overall Study|Withdrawal by Subject|1
2565368|NCT01324830|8874444|P10|Overall Study|Withdrawal by Subject|0
2565369|NCT01324830|8874445|P9|Overall Study|Withdrawal by Subject|0
2565370|NCT01324830|8874446|P8|Overall Study|Withdrawal by Subject|0
2565371|NCT01324830|8874447|P7|Overall Study|Withdrawal by Subject|0
2565372|NCT01324830|8874448|P6|Overall Study|Withdrawal by Subject|1
2565373|NCT01324830|8874449|P5|Overall Study|Withdrawal by Subject|0
2565374|NCT01324830|8874450|P4|Overall Study|Withdrawal by Subject|0
2565375|NCT01324830|8874451|P3|Overall Study|Withdrawal by Subject|0
2565376|NCT01324830|8874452|P2|Overall Study|Withdrawal by Subject|0
2565377|NCT01324830|8874453|P1|Overall Study|Withdrawal by Subject|0
2565378|NCT01324830|8874435|P19|Overall Study|Adverse Event, non-fatal|0
2565379|NCT01324830|8874436|P18|Overall Study|Adverse Event, non-fatal|1
2565380|NCT01324830|8874437|P17|Overall Study|Adverse Event, non-fatal|0
2565381|NCT01324830|8874438|P16|Overall Study|Adverse Event, non-fatal|0
2565382|NCT01324830|8874439|P15|Overall Study|Adverse Event, non-fatal|0
2565383|NCT01324830|8874440|P14|Overall Study|Adverse Event, non-fatal|0
2565384|NCT01324830|8874441|P13|Overall Study|Adverse Event, non-fatal|0
2565385|NCT01324830|8874442|P12|Overall Study|Adverse Event, non-fatal|0
2565386|NCT01324830|8874443|P11|Overall Study|Adverse Event, non-fatal|1
2565387|NCT01324830|8874444|P10|Overall Study|Adverse Event, non-fatal|0
2565388|NCT01324830|8874445|P9|Overall Study|Adverse Event, non-fatal|2
2565389|NCT01324830|8874446|P8|Overall Study|Adverse Event, non-fatal|0
2565390|NCT01324830|8874447|P7|Overall Study|Adverse Event, non-fatal|0
2565391|NCT01324830|8874448|P6|Overall Study|Adverse Event, non-fatal|0
2565392|NCT01324830|8874449|P5|Overall Study|Adverse Event, non-fatal|0
2565393|NCT01324830|8874450|P4|Overall Study|Adverse Event, non-fatal|0
2565394|NCT01324830|8874451|P3|Overall Study|Adverse Event, non-fatal|0
2565395|NCT01324830|8874452|P2|Overall Study|Adverse Event, non-fatal|0
2565396|NCT01324830|8874453|P1|Overall Study|Adverse Event, non-fatal|0
2565397|NCT01324830|8874435|P19|Overall Study|Adverse Event, serious fatal|0
2565398|NCT01324830|8874436|P18|Overall Study|Adverse Event, serious fatal|0
2565399|NCT01324830|8874437|P17|Overall Study|Adverse Event, serious fatal|0
2565400|NCT01324830|8874438|P16|Overall Study|Adverse Event, serious fatal|0
2565401|NCT01324830|8874439|P15|Overall Study|Adverse Event, serious fatal|0
2565402|NCT01324830|8874440|P14|Overall Study|Adverse Event, serious fatal|0
2565403|NCT01324830|8874441|P13|Overall Study|Adverse Event, serious fatal|0
2565404|NCT01324830|8874442|P12|Overall Study|Adverse Event, serious fatal|0
2565405|NCT01324830|8874443|P11|Overall Study|Adverse Event, serious fatal|0
2565406|NCT01324830|8874444|P10|Overall Study|Adverse Event, serious fatal|0
2565407|NCT01324830|8874445|P9|Overall Study|Adverse Event, serious fatal|0
2565408|NCT01324830|8874446|P8|Overall Study|Adverse Event, serious fatal|0
2565409|NCT01324830|8874447|P7|Overall Study|Adverse Event, serious fatal|0
2565410|NCT01324830|8874448|P6|Overall Study|Adverse Event, serious fatal|0
2565411|NCT01324830|8874449|P5|Overall Study|Adverse Event, serious fatal|0
2565412|NCT01324830|8874450|P4|Overall Study|Adverse Event, serious fatal|0
2565413|NCT01324830|8874451|P3|Overall Study|Adverse Event, serious fatal|0
2565414|NCT01324830|8874452|P2|Overall Study|Adverse Event, serious fatal|1
2565415|NCT01324830|8874453|P1|Overall Study|Adverse Event, serious fatal|0
2565416|NCT01324830|8874435|P19|Overall Study|Reason not mentioned above|0
2565417|NCT01324830|8874436|P18|Overall Study|Reason not mentioned above|1
2565418|NCT01324830|8874437|P17|Overall Study|Reason not mentioned above|0
2565419|NCT01324830|8874438|P16|Overall Study|Reason not mentioned above|0
2565420|NCT01324830|8874439|P15|Overall Study|Reason not mentioned above|0
2565421|NCT01324830|8874440|P14|Overall Study|Reason not mentioned above|0
2565422|NCT01324830|8874441|P13|Overall Study|Reason not mentioned above|0
2565423|NCT01324830|8874442|P12|Overall Study|Reason not mentioned above|0
2565424|NCT01324830|8874443|P11|Overall Study|Reason not mentioned above|0
2565425|NCT01324830|8874444|P10|Overall Study|Reason not mentioned above|0
2565426|NCT01324830|8874445|P9|Overall Study|Reason not mentioned above|0
2565427|NCT01324830|8874446|P8|Overall Study|Reason not mentioned above|0
2565428|NCT01324830|8874447|P7|Overall Study|Reason not mentioned above|0
2565429|NCT01324830|8874448|P6|Overall Study|Reason not mentioned above|0
2565430|NCT01324830|8874449|P5|Overall Study|Reason not mentioned above|0
2565431|NCT01324830|8874450|P4|Overall Study|Reason not mentioned above|0
2565432|NCT01324830|8874451|P3|Overall Study|Reason not mentioned above|0
2565433|NCT01324830|8874452|P2|Overall Study|Reason not mentioned above|0
2565434|NCT01324830|8874453|P1|Overall Study|Reason not mentioned above|0
2565435|NCT01324830|8874435|P19|Overall Study|Dose limiting toxicity|1
2565436|NCT01324830|8874436|P18|Overall Study|Dose limiting toxicity|1
2565437|NCT01324830|8874437|P17|Overall Study|Dose limiting toxicity|1
2565438|NCT01324830|8874438|P16|Overall Study|Dose limiting toxicity|0
2565439|NCT01324830|8874439|P15|Overall Study|Dose limiting toxicity|0
2565440|NCT01324830|8874440|P14|Overall Study|Dose limiting toxicity|0
2565441|NCT01324830|8874441|P13|Overall Study|Dose limiting toxicity|0
2565442|NCT01324830|8874442|P12|Overall Study|Dose limiting toxicity|0
2565443|NCT01324830|8874443|P11|Overall Study|Dose limiting toxicity|0
2565444|NCT01324830|8874444|P10|Overall Study|Dose limiting toxicity|0
2565445|NCT01324830|8874445|P9|Overall Study|Dose limiting toxicity|0
2565446|NCT01324830|8874446|P8|Overall Study|Dose limiting toxicity|0
2565447|NCT01324830|8874447|P7|Overall Study|Dose limiting toxicity|0
2565448|NCT01324830|8874448|P6|Overall Study|Dose limiting toxicity|0
2565449|NCT01324830|8874449|P5|Overall Study|Dose limiting toxicity|1
2565450|NCT01324830|8874450|P4|Overall Study|Dose limiting toxicity|0
2565451|NCT01324830|8874451|P3|Overall Study|Dose limiting toxicity|0
2565452|NCT01324830|8874452|P2|Overall Study|Dose limiting toxicity|0
2565453|NCT01324830|8874453|P1|Overall Study|Dose limiting toxicity|0
2565454|NCT01324830|8874435|P19|Overall Study|Progressive Disease|4
2565455|NCT01324830|8874436|P18|Overall Study|Progressive Disease|3
2565456|NCT01324830|8874437|P17|Overall Study|Progressive Disease|2
2565457|NCT01324830|8874438|P16|Overall Study|Progressive Disease|3
2565458|NCT01324830|8874439|P15|Overall Study|Progressive Disease|1
2565459|NCT01324830|8874440|P14|Overall Study|Progressive Disease|1
2565460|NCT01324830|8874441|P13|Overall Study|Progressive Disease|1
2565461|NCT01324830|8874442|P12|Overall Study|Progressive Disease|1
2565462|NCT01324830|8874443|P11|Overall Study|Progressive Disease|2
2565463|NCT01324830|8874444|P10|Overall Study|Progressive Disease|6
2565464|NCT01324830|8874445|P9|Overall Study|Progressive Disease|3
2565465|NCT01324830|8874446|P8|Overall Study|Progressive Disease|3
2565466|NCT01324830|8874447|P7|Overall Study|Progressive Disease|3
2565467|NCT01324830|8874448|P6|Overall Study|Progressive Disease|6
2565468|NCT01324830|8874449|P5|Overall Study|Progressive Disease|6
2565469|NCT01324830|8874450|P4|Overall Study|Progressive Disease|3
2565470|NCT01324830|8874451|P3|Overall Study|Progressive Disease|3
2565471|NCT01324830|8874452|P2|Overall Study|Progressive Disease|2
2565472|NCT01324830|8874453|P1|Overall Study|Progressive Disease|3
2565473|NCT01324622|8874599|P2|Overall Study|Lack of Efficacy|0
2565474|NCT01324622|8874600|P1|Overall Study|Lack of Efficacy|1
2565475|NCT01324622|8874599|P2|Overall Study|Death|0
2565476|NCT01324622|8874600|P1|Overall Study|Death|1
2565477|NCT01324622|8874599|P2|Overall Study|Lost to Follow-up|7
2565478|NCT01324622|8874600|P1|Overall Study|Lost to Follow-up|7
2565479|NCT01324570|8874630|P2|Overall Study|Administrative|2
2565480|NCT01324570|8874631|P1|Overall Study|Administrative|0
2565481|NCT01324570|8874630|P2|Overall Study|Confirmed or suspected diversion|1
2565482|NCT01324570|8874631|P1|Overall Study|Confirmed or suspected diversion|0
2565483|NCT01324570|8874630|P2|Overall Study|Lack of Efficacy|1
2565484|NCT01324570|8874631|P1|Overall Study|Lack of Efficacy|0
2565485|NCT01324570|8874630|P2|Overall Study|Withdrawal by Subject|3
2565486|NCT01324570|8874631|P1|Overall Study|Withdrawal by Subject|0
2565487|NCT01324570|8874630|P2|Overall Study|Adverse Event|7
2565488|NCT01324570|8874631|P1|Overall Study|Adverse Event|4
2565489|NCT01324440|8874668|P2|Overall Study|Subject moved|1
2565490|NCT01324440|8874669|P1|Overall Study|Subject moved|0
2565491|NCT01324401|8874683|P2|Overall Study|Adverse Event|3
2565492|NCT01324401|8874684|P1|Overall Study|Adverse Event|1
2565493|NCT01324401|8874683|P2|Overall Study|Withdrawn before any treatment|3
2565494|NCT01324401|8874684|P1|Overall Study|Withdrawn before any treatment|0
2565495|NCT01324388|8874695|P4|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
2565496|NCT01324388|8874696|P3|Part 2 of Study: Second Intervention|Withdrawal by Subject|1
2565497|NCT01324388|8874697|P2|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
2565498|NCT01324388|8874698|P1|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
2565499|NCT01324388|8874695|P4|Part 2 of Study: First Intervention|Protocol Violation|1
2565500|NCT01324388|8874696|P3|Part 2 of Study: First Intervention|Protocol Violation|0
2565501|NCT01324388|8874697|P2|Part 2 of Study: First Intervention|Protocol Violation|0
2565502|NCT01324388|8874698|P1|Part 2 of Study: First Intervention|Protocol Violation|0
2565503|NCT01324388|8874695|P4|Part 1 of Study|Physician Decision|0
2565504|NCT01324388|8874696|P3|Part 1 of Study|Physician Decision|0
2565505|NCT01324388|8874697|P2|Part 1 of Study|Physician Decision|0
2565506|NCT01324388|8874698|P1|Part 1 of Study|Physician Decision|1
2565507|NCT01324388|8874695|P4|Part 1 of Study|Protocol Violation|0
2565508|NCT01324388|8874696|P3|Part 1 of Study|Protocol Violation|0
2565509|NCT01324388|8874697|P2|Part 1 of Study|Protocol Violation|2
2565510|NCT01324388|8874698|P1|Part 1 of Study|Protocol Violation|1
2565511|NCT01324388|8874695|P4|Part 1 of Study|Adverse Event|0
2565512|NCT01324388|8874696|P3|Part 1 of Study|Adverse Event|0
2565513|NCT01324388|8874697|P2|Part 1 of Study|Adverse Event|0
2565514|NCT01324388|8874698|P1|Part 1 of Study|Adverse Event|2
2565515|NCT01324349|8874719|P2|Overall Study|Withdrawal by Subject|1
2565516|NCT01324349|8874720|P1|Overall Study|Withdrawal by Subject|0
2565517|NCT01324349|8874719|P2|Overall Study|Death|1
2565518|NCT01324349|8874720|P1|Overall Study|Death|1
2565519|NCT01324323|8874730|P1|Overall Study|Withdrawal by Subject|1
2565520|NCT01324310|8874750|P1|Overall Study|Disease Progression|1
2565521|NCT01324310|8874750|P1|Overall Study|Adverse Event|1
2565522|NCT01324271|8874770|P2|Overall Study|Physician Decision|0
2565523|NCT01324271|8874771|P1|Overall Study|Physician Decision|1
2565524|NCT01324271|8874770|P2|Overall Study|Lost to Follow-up|0
2565525|NCT01324271|8874771|P1|Overall Study|Lost to Follow-up|3
2565526|NCT01324102|8874794|P2|Overall Study|illness|6
2565527|NCT01324102|8874795|P1|Overall Study|illness|1
2565528|NCT01324024|8874802|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
2565529|NCT01324024|8874803|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|2
2565530|NCT01323972|8874841|P4|Overall Study|Lost to Follow-up|1
2565531|NCT01323972|8874842|P3|Overall Study|Lost to Follow-up|1
2565532|NCT01323972|8874843|P2|Overall Study|Lost to Follow-up|1
2565533|NCT01323972|8874844|P1|Overall Study|Lost to Follow-up|0
2565534|NCT01323972|8874841|P4|Overall Study|Migrated/moved from study area|0
2565535|NCT01323972|8874842|P3|Overall Study|Migrated/moved from study area|0
2565536|NCT01323972|8874843|P2|Overall Study|Migrated/moved from study area|2
2565537|NCT01323972|8874844|P1|Overall Study|Migrated/moved from study area|1
2565538|NCT01323972|8874841|P4|Overall Study|Withdrawal by Subject|0
2565539|NCT01323972|8874842|P3|Overall Study|Withdrawal by Subject|1
2565540|NCT01323972|8874843|P2|Overall Study|Withdrawal by Subject|0
2565541|NCT01323972|8874844|P1|Overall Study|Withdrawal by Subject|1
2565542|NCT01323946|8874940|P3|Overall Study|Withdrawal by Subject|0
2565543|NCT01323946|8874941|P2|Overall Study|Withdrawal by Subject|2
2565544|NCT01323946|8874942|P1|Overall Study|Withdrawal by Subject|2
2565545|NCT01323946|8874940|P3|Overall Study|Parents refused the last blood draw|0
2565546|NCT01323946|8874941|P2|Overall Study|Parents refused the last blood draw|0
2565547|NCT01323946|8874942|P1|Overall Study|Parents refused the last blood draw|1
2565548|NCT01323946|8874940|P3|Overall Study|Lost to Follow-up|0
2565549|NCT01323946|8874941|P2|Overall Study|Lost to Follow-up|1
2565550|NCT01323946|8874942|P1|Overall Study|Lost to Follow-up|0
2565551|NCT01323920|8875063|P1|Overall Study|Withdrawal by Subject|1
2565552|NCT01323920|8875063|P1|Overall Study|Death|5
2565553|NCT01323790|8875104|P3|Overall Study|Severe non-compliance with protocol|2
2565554|NCT01323790|8875105|P2|Overall Study|Severe non-compliance with protocol|2
2565555|NCT01323790|8875106|P1|Overall Study|Severe non-compliance with protocol|2
2565556|NCT01323790|8875104|P3|Overall Study|Did Not Receive Treatment|1
2565557|NCT01323790|8875105|P2|Overall Study|Did Not Receive Treatment|0
2565558|NCT01323790|8875106|P1|Overall Study|Did Not Receive Treatment|2
2565559|NCT01323790|8875104|P3|Overall Study|Withdrawal by Subject|13
2565560|NCT01323790|8875105|P2|Overall Study|Withdrawal by Subject|20
2565561|NCT01323790|8875106|P1|Overall Study|Withdrawal by Subject|23
2565562|NCT01323790|8875104|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
2565563|NCT01323790|8875105|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
2565564|NCT01323790|8875106|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
2565565|NCT01323790|8875104|P3|Overall Study|Adverse Event|12
2565566|NCT01323790|8875105|P2|Overall Study|Adverse Event|24
2565567|NCT01323790|8875106|P1|Overall Study|Adverse Event|11
2565568|NCT01323790|8875104|P3|Overall Study|Lack of Efficacy|3
2565569|NCT01323790|8875105|P2|Overall Study|Lack of Efficacy|0
2565570|NCT01323790|8875106|P1|Overall Study|Lack of Efficacy|3
2565571|NCT01323790|8875104|P3|Overall Study|Study-Specific Withdrawal Criteria|3
2565572|NCT01323790|8875105|P2|Overall Study|Study-Specific Withdrawal Criteria|3
2565573|NCT01323790|8875106|P1|Overall Study|Study-Specific Withdrawal Criteria|0
2565574|NCT01323790|8875104|P3|Overall Study|Lost to Follow-up|9
2565575|NCT01323790|8875105|P2|Overall Study|Lost to Follow-up|9
2565576|NCT01323790|8875106|P1|Overall Study|Lost to Follow-up|11
2565577|NCT01323790|8875104|P3|Overall Study|Other|1
2565578|NCT01323790|8875105|P2|Overall Study|Other|2
2565579|NCT01323790|8875106|P1|Overall Study|Other|3
2565580|NCT01323673|8875157|P2|Overall Study|Withdrawal by Subject|3
2565581|NCT01323673|8875158|P1|Overall Study|Withdrawal by Subject|2
2565582|NCT01323673|8875157|P2|Overall Study|Protocol Violation|0
2565583|NCT01323673|8875158|P1|Overall Study|Protocol Violation|1
2565584|NCT01323673|8875157|P2|Overall Study|Lost to Follow-up|1
2565585|NCT01323673|8875158|P1|Overall Study|Lost to Follow-up|0
2565586|NCT01323673|8875157|P2|Overall Study|Adverse Event|1
2565587|NCT01323673|8875158|P1|Overall Study|Adverse Event|0
2565588|NCT01323660|8875178|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
2565589|NCT01323660|8875179|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
2565590|NCT01323660|8875180|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
2565591|NCT01323660|8875181|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
2565592|NCT01323660|8875182|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
2565593|NCT01323660|8875183|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
2565594|NCT01323660|8875178|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
2565595|NCT01323660|8875179|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
2565596|NCT01323660|8875180|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
2565597|NCT01323660|8875181|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
2565598|NCT01323660|8875182|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
2565599|NCT01323660|8875183|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
2565600|NCT01323660|8875178|P6|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1
2565601|NCT01323660|8875179|P5|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
2565602|NCT01323660|8875180|P4|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
2565603|NCT01323660|8875181|P3|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
2565604|NCT01323660|8875182|P2|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
2565605|NCT01323660|8875183|P1|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
2565606|NCT01323660|8875178|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
2565607|NCT01323660|8875179|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
2565608|NCT01323660|8875180|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
2565609|NCT01323660|8875181|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
2565610|NCT01323660|8875182|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
2565611|NCT01323660|8875183|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9
2565612|NCT01323660|8875178|P6|Treatment Period 2 (12 Weeks)|Adverse Event|2
2565613|NCT01323660|8875179|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
2565614|NCT01323660|8875180|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
2565615|NCT01323660|8875181|P3|Treatment Period 2 (12 Weeks)|Adverse Event|0
2565616|NCT01323660|8875182|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
2565617|NCT01323660|8875183|P1|Treatment Period 2 (12 Weeks)|Adverse Event|1
2565618|NCT01323660|8875178|P6|Washout Period (14 Days)|Lack of Efficacy|2
2565619|NCT01323660|8875179|P5|Washout Period (14 Days)|Lack of Efficacy|2
2565620|NCT01323660|8875180|P4|Washout Period (14 Days)|Lack of Efficacy|3
2565621|NCT01323660|8875181|P3|Washout Period (14 Days)|Lack of Efficacy|1
2565622|NCT01323660|8875182|P2|Washout Period (14 Days)|Lack of Efficacy|0
2565623|NCT01323660|8875183|P1|Washout Period (14 Days)|Lack of Efficacy|0
2565624|NCT01323660|8875178|P6|Washout Period (14 Days)|Adverse Event|0
2565625|NCT01323660|8875179|P5|Washout Period (14 Days)|Adverse Event|1
2565626|NCT01323660|8875180|P4|Washout Period (14 Days)|Adverse Event|0
2565627|NCT01323660|8875181|P3|Washout Period (14 Days)|Adverse Event|0
2565628|NCT01323660|8875182|P2|Washout Period (14 Days)|Adverse Event|0
2565629|NCT01323660|8875183|P1|Washout Period (14 Days)|Adverse Event|0
2565630|NCT01323660|8875178|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
2565631|NCT01323660|8875179|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3
2565632|NCT01323660|8875180|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
2565633|NCT01323660|8875181|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
2565634|NCT01323660|8875182|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
2565635|NCT01323660|8875183|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5
2565636|NCT01323660|8875178|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2565637|NCT01323660|8875179|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
2565638|NCT01323660|8875180|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2565639|NCT01323660|8875181|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2565640|NCT01323660|8875182|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2565641|NCT01323660|8875183|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2565642|NCT01323660|8875178|P6|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
2565643|NCT01323660|8875179|P5|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1
2565644|NCT01323660|8875180|P4|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
2565645|NCT01323660|8875181|P3|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
2565646|NCT01323660|8875182|P2|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
2565647|NCT01323660|8875183|P1|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
2565648|NCT01323660|8875178|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|2
2565649|NCT01323660|8875179|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|1
2565650|NCT01323660|8875180|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
2565651|NCT01323660|8875181|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|1
2565652|NCT01323660|8875182|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
2565653|NCT01323660|8875183|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
2565654|NCT01323660|8875178|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3
2565655|NCT01323660|8875179|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
2565656|NCT01323660|8875180|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
2565657|NCT01323660|8875181|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
2565658|NCT01323660|8875182|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
2565659|NCT01323660|8875183|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
2565660|NCT01323660|8875178|P6|Treatment Period 1 (12 Weeks)|Adverse Event|4
2565661|NCT01323660|8875179|P5|Treatment Period 1 (12 Weeks)|Adverse Event|3
2565662|NCT01323660|8875180|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
2565663|NCT01323660|8875181|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
2565664|NCT01323660|8875182|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
2565665|NCT01323660|8875183|P1|Treatment Period 1 (12 Weeks)|Adverse Event|6
2565666|NCT01323647|8875229|P2|Overall Study|Lost to Follow-up|0
2565667|NCT01323647|8875230|P1|Overall Study|Lost to Follow-up|2
2565668|NCT01323647|8875229|P2|Overall Study|Withdrawal by Subject|0
2565669|NCT01323647|8875230|P1|Overall Study|Withdrawal by Subject|5
2565670|NCT01323647|8875229|P2|Overall Study|Migrated/moved from study area|0
2565671|NCT01323647|8875230|P1|Overall Study|Migrated/moved from study area|2
2565672|NCT01323634|8875247|P3|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
2565673|NCT01323634|8875248|P2|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
2565674|NCT01323634|8875249|P1|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0
2565675|NCT01323634|8875247|P3|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4
2565676|NCT01323634|8875248|P2|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7
2565677|NCT01323634|8875249|P1|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
2565678|NCT01323634|8875247|P3|Double-Blind (DB) Treatment Period|Physician Decision|3
2565679|NCT01323634|8875248|P2|Double-Blind (DB) Treatment Period|Physician Decision|2
2565680|NCT01323634|8875249|P1|Double-Blind (DB) Treatment Period|Physician Decision|0
2565681|NCT01323634|8875247|P3|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
2565682|NCT01323634|8875248|P2|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
2565683|NCT01323634|8875249|P1|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
2565684|NCT01323634|8875247|P3|Double-Blind (DB) Treatment Period|Protocol Violation|7
2565685|NCT01323634|8875248|P2|Double-Blind (DB) Treatment Period|Protocol Violation|6
2565686|NCT01323634|8875249|P1|Double-Blind (DB) Treatment Period|Protocol Violation|0
2565687|NCT01323634|8875247|P3|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
2565688|NCT01323634|8875248|P2|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2565689|NCT01323634|8875249|P1|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
2565690|NCT01323634|8875247|P3|Double-Blind (DB) Treatment Period|Adverse Event|4
2565691|NCT01323634|8875248|P2|Double-Blind (DB) Treatment Period|Adverse Event|8
2565692|NCT01323634|8875249|P1|Double-Blind (DB) Treatment Period|Adverse Event|0
2565693|NCT01323634|8875247|P3|2-week Run-in Period|Adverse Event|0
2565694|NCT01323634|8875248|P2|2-week Run-in Period|Adverse Event|0
2565695|NCT01323634|8875249|P1|2-week Run-in Period|Adverse Event|1
2565696|NCT01323634|8875247|P3|2-week Run-in Period|Protocol Violation|0
2565697|NCT01323634|8875248|P2|2-week Run-in Period|Protocol Violation|0
2565698|NCT01323634|8875249|P1|2-week Run-in Period|Protocol Violation|1
2565699|NCT01323634|8875247|P3|2-week Run-in Period|Physician Decision|0
2565700|NCT01323634|8875248|P2|2-week Run-in Period|Physician Decision|0
2565701|NCT01323634|8875249|P1|2-week Run-in Period|Physician Decision|5
2565702|NCT01323634|8875247|P3|2-week Run-in Period|Withdrawal by Subject|0
2565703|NCT01323634|8875248|P2|2-week Run-in Period|Withdrawal by Subject|0
2565704|NCT01323634|8875249|P1|2-week Run-in Period|Withdrawal by Subject|7
2565705|NCT01323634|8875247|P3|2-week Run-in Period|Continuation Criteria not Met|0
2565706|NCT01323634|8875248|P2|2-week Run-in Period|Continuation Criteria not Met|0
2565707|NCT01323634|8875249|P1|2-week Run-in Period|Continuation Criteria not Met|73
2565708|NCT01323634|8875247|P3|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
2565709|NCT01323634|8875248|P2|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
2565710|NCT01323634|8875249|P1|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125
2565711|NCT01323621|8875259|P3|12-week, Double-blind Treatment Period|Withdrawal by Subject|4
2565712|NCT01323621|8875260|P2|12-week, Double-blind Treatment Period|Withdrawal by Subject|5
2565713|NCT01323621|8875261|P1|12-week, Double-blind Treatment Period|Withdrawal by Subject|0
2565714|NCT01323621|8875259|P3|12-week, Double-blind Treatment Period|Physician Decision|1
2565715|NCT01323621|8875260|P2|12-week, Double-blind Treatment Period|Physician Decision|2
2565716|NCT01323621|8875261|P1|12-week, Double-blind Treatment Period|Physician Decision|0
2565717|NCT01323621|8875259|P3|12-week, Double-blind Treatment Period|Lost to Follow-up|0
2565718|NCT01323621|8875260|P2|12-week, Double-blind Treatment Period|Lost to Follow-up|1
2565719|NCT01323621|8875261|P1|12-week, Double-blind Treatment Period|Lost to Follow-up|0
2565720|NCT01323621|8875259|P3|12-week, Double-blind Treatment Period|Protocol Violation|4
2565721|NCT01323621|8875260|P2|12-week, Double-blind Treatment Period|Protocol Violation|4
2565722|NCT01323621|8875261|P1|12-week, Double-blind Treatment Period|Protocol Violation|0
2565723|NCT01323621|8875259|P3|12-week, Double-blind Treatment Period|Lack of Efficacy|6
2565724|NCT01323621|8875260|P2|12-week, Double-blind Treatment Period|Lack of Efficacy|2
2565725|NCT01323621|8875261|P1|12-week, Double-blind Treatment Period|Lack of Efficacy|0
2565726|NCT01323621|8875259|P3|12-week, Double-blind Treatment Period|Adverse Event|5
2565727|NCT01323621|8875260|P2|12-week, Double-blind Treatment Period|Adverse Event|1
2565728|NCT01323621|8875261|P1|12-week, Double-blind Treatment Period|Adverse Event|0
2565729|NCT01323621|8875259|P3|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
2565730|NCT01323621|8875260|P2|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
2565731|NCT01323621|8875261|P1|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86
2565732|NCT01323621|8875259|P3|2-week, Single-blind Run In Period|Lost to Follow-up|0
2565733|NCT01323621|8875260|P2|2-week, Single-blind Run In Period|Lost to Follow-up|0
2565734|NCT01323621|8875261|P1|2-week, Single-blind Run In Period|Lost to Follow-up|1
2565735|NCT01323621|8875259|P3|2-week, Single-blind Run In Period|Protocol Violation|0
2565736|NCT01323621|8875260|P2|2-week, Single-blind Run In Period|Protocol Violation|0
2565737|NCT01323621|8875261|P1|2-week, Single-blind Run In Period|Protocol Violation|1
2565738|NCT01323621|8875259|P3|2-week, Single-blind Run In Period|Withdrawal by Subject|0
2565739|NCT01323621|8875260|P2|2-week, Single-blind Run In Period|Withdrawal by Subject|0
2565740|NCT01323621|8875261|P1|2-week, Single-blind Run In Period|Withdrawal by Subject|12
2565741|NCT01323621|8875259|P3|2-week, Single-blind Run In Period|Physician Decision|0
2565742|NCT01323621|8875260|P2|2-week, Single-blind Run In Period|Physician Decision|0
2565743|NCT01323621|8875261|P1|2-week, Single-blind Run In Period|Physician Decision|7
2565744|NCT01323621|8875259|P3|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
2565745|NCT01323621|8875260|P2|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
2565746|NCT01323621|8875261|P1|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121
2565747|NCT01323582|8875282|P2|Weeks 8-11 (Period 2)|Withdrawal by Subject|1
2565748|NCT01323582|8875283|P1|Weeks 8-11 (Period 2)|Withdrawal by Subject|0
2565749|NCT01323582|8875282|P2|Weeks 5-7 (Washout)|Withdrawal by Subject|1
2565750|NCT01323582|8875283|P1|Weeks 5-7 (Washout)|Withdrawal by Subject|0
2565751|NCT01323582|8875282|P2|Weeks 1-4 (First Period)|Withdrawal by Subject|2
2565752|NCT01323582|8875283|P1|Weeks 1-4 (First Period)|Withdrawal by Subject|2
2565753|NCT01323478|8875306|P1|Overall Study|Administrative or Other Reasons|8
2565754|NCT01323478|8875306|P1|Overall Study|Withdrawal of Consent|1
2565755|NCT01323478|8875306|P1|Overall Study|Protocol Violation|1
2565756|NCT01323478|8875306|P1|Overall Study|Non-compliance With Study Product|3
2565757|NCT01323478|8875306|P1|Overall Study|Lack of Efficacy|4
2565758|NCT01323478|8875306|P1|Overall Study|Adverse Event|7
2565759|NCT01323387|8875319|P1|Overall Study|Randomized but Never Treated|16
2565760|NCT01323387|8875319|P1|Overall Study|Protocol Violation|12
2565761|NCT01323387|8875319|P1|Overall Study|Revision|14
2565762|NCT01323387|8875319|P1|Overall Study|Radiographic Data Unavailable|1
2565763|NCT01323387|8875319|P1|Overall Study|Withdrawal by Subject|41
2565764|NCT01323270|8875332|P2|Overall Study|Randomized, but not vaccinated|0
2565765|NCT01323270|8875333|P1|Overall Study|Randomized, but not vaccinated|1
2565766|NCT01323270|8875332|P2|Overall Study|Death|0
2565767|NCT01323270|8875333|P1|Overall Study|Death|1
2565768|NCT01323270|8875332|P2|Overall Study|Not eligible|1
2565769|NCT01323270|8875333|P1|Overall Study|Not eligible|1
2565770|NCT01323270|8875332|P2|Overall Study|Physician Decision|2
2565771|NCT01323270|8875333|P1|Overall Study|Physician Decision|0
2565772|NCT01323270|8875332|P2|Overall Study|Other|3
2565773|NCT01323270|8875333|P1|Overall Study|Other|0
2565774|NCT01323270|8875332|P2|Overall Study|Adverse Event|0
2565775|NCT01323270|8875333|P1|Overall Study|Adverse Event|8
2565776|NCT01323270|8875332|P2|Overall Study|Lost to Follow-up|6
2565777|NCT01323270|8875333|P1|Overall Study|Lost to Follow-up|4
2565778|NCT01323270|8875332|P2|Overall Study|Protocol Violation|7
2565779|NCT01323270|8875333|P1|Overall Study|Protocol Violation|9
2565780|NCT01323270|8875332|P2|Overall Study|Withdrawal by Subject|10
2565781|NCT01323270|8875333|P1|Overall Study|Withdrawal by Subject|19
2565782|NCT01323192|8875355|P2|Overall Study|Nonmedical reasons|1
2565783|NCT01323192|8875356|P1|Overall Study|Nonmedical reasons|0
2565784|NCT01323192|8875355|P2|Overall Study|Noncompliance with study medication|3
2565785|NCT01323192|8875356|P1|Overall Study|Noncompliance with study medication|0
2565786|NCT01323192|8875355|P2|Overall Study|Withdrawal by Subject|1
2565787|NCT01323192|8875356|P1|Overall Study|Withdrawal by Subject|3
2565788|NCT01323192|8875355|P2|Overall Study|Adverse Event|1
2565789|NCT01323192|8875356|P1|Overall Study|Adverse Event|6
2565790|NCT01322490|8875605|P3|Long Term Follow-up Period|Unknown/Missing|1
2565791|NCT01322490|8875606|P2|Long Term Follow-up Period|Unknown/Missing|1
2565792|NCT01322490|8875607|P1|Long Term Follow-up Period|Unknown/Missing|0
2565793|NCT01322490|8875605|P3|Long Term Follow-up Period|Other per report|2
2565794|NCT01322490|8875606|P2|Long Term Follow-up Period|Other per report|2
2565795|NCT01322490|8875607|P1|Long Term Follow-up Period|Other per report|3
2565796|NCT01322490|8875605|P3|Long Term Follow-up Period|Study Terminated by Sponsor|165
2565797|NCT01322490|8875606|P2|Long Term Follow-up Period|Study Terminated by Sponsor|158
2565798|NCT01322490|8875607|P1|Long Term Follow-up Period|Study Terminated by Sponsor|160
2565799|NCT01322490|8875605|P3|Long Term Follow-up Period|Withdrawal by Subject|6
2565800|NCT01322490|8875606|P2|Long Term Follow-up Period|Withdrawal by Subject|6
2565801|NCT01322490|8875607|P1|Long Term Follow-up Period|Withdrawal by Subject|9
2565802|NCT01322490|8875605|P3|Long Term Follow-up Period|Lost to Follow-up|3
2565803|NCT01322490|8875606|P2|Long Term Follow-up Period|Lost to Follow-up|2
2565804|NCT01322490|8875607|P1|Long Term Follow-up Period|Lost to Follow-up|2
2565805|NCT01322490|8875605|P3|Long Term Follow-up Period|Death|236
2565806|NCT01322490|8875606|P2|Long Term Follow-up Period|Death|239
2565807|NCT01322490|8875607|P1|Long Term Follow-up Period|Death|235
2565808|NCT01322490|8875605|P3|Treatment Period|Randomized but Not Treated|5
2565809|NCT01322490|8875606|P2|Treatment Period|Randomized but Not Treated|3
2565810|NCT01322490|8875607|P1|Treatment Period|Randomized but Not Treated|3
2565811|NCT01322490|8875605|P3|Treatment Period|Other per report|1
2565812|NCT01322490|8875606|P2|Treatment Period|Other per report|2
2565813|NCT01322490|8875607|P1|Treatment Period|Other per report|2
2565814|NCT01322490|8875605|P3|Treatment Period|Non-compliance with study drug|1
2565815|NCT01322490|8875606|P2|Treatment Period|Non-compliance with study drug|0
2565816|NCT01322490|8875607|P1|Treatment Period|Non-compliance with study drug|0
2565817|NCT01322490|8875605|P3|Treatment Period|Withdrawal by Subject|11
2565818|NCT01322490|8875606|P2|Treatment Period|Withdrawal by Subject|16
2565819|NCT01322490|8875607|P1|Treatment Period|Withdrawal by Subject|14
2565820|NCT01322490|8875605|P3|Treatment Period|Protocol Violation|4
2565821|NCT01322490|8875606|P2|Treatment Period|Protocol Violation|5
2565822|NCT01322490|8875607|P1|Treatment Period|Protocol Violation|7
2565823|NCT01322490|8875605|P3|Treatment Period|Physician Decision|1
2565824|NCT01322490|8875606|P2|Treatment Period|Physician Decision|2
2565825|NCT01322490|8875607|P1|Treatment Period|Physician Decision|0
2565826|NCT01322490|8875605|P3|Treatment Period|Lack of Efficacy|112
2565827|NCT01322490|8875606|P2|Treatment Period|Lack of Efficacy|100
2565828|NCT01322490|8875607|P1|Treatment Period|Lack of Efficacy|89
2565829|NCT01322490|8875605|P3|Treatment Period|Death|3
2565830|NCT01322490|8875606|P2|Treatment Period|Death|7
2565831|NCT01322490|8875607|P1|Treatment Period|Death|5
2565832|NCT01322490|8875605|P3|Treatment Period|Adverse Event|15
2565833|NCT01322490|8875606|P2|Treatment Period|Adverse Event|18
2565834|NCT01322490|8875607|P1|Treatment Period|Adverse Event|12
2565835|NCT01322386|8875620|P2|Overall Study|Physician Decision|1
2565836|NCT01322386|8875621|P1|Overall Study|Physician Decision|0
2565837|NCT01322386|8875620|P2|Overall Study|Protocol Violation|1
2565838|NCT01322386|8875621|P1|Overall Study|Protocol Violation|0
2565839|NCT01322347|8875636|P2|Overall Study|moved/changed dialysis|4
2565840|NCT01322347|8875637|P1|Overall Study|moved/changed dialysis|2
2565841|NCT01322347|8875636|P2|Overall Study|study drug withheld > 12 wks|1
2565842|NCT01322347|8875637|P1|Overall Study|study drug withheld > 12 wks|0
2565843|NCT01322347|8875636|P2|Overall Study|kidney transplant|1
2565844|NCT01322347|8875637|P1|Overall Study|kidney transplant|3
2565845|NCT01322347|8875636|P2|Overall Study|ineligible|3
2565846|NCT01322347|8875637|P1|Overall Study|ineligible|6
2565847|NCT01322347|8875636|P2|Overall Study|sponsor decision|3
2565848|NCT01322347|8875637|P1|Overall Study|sponsor decision|1
2565849|NCT01322347|8875636|P2|Overall Study|blood transfusion|5
2565850|NCT01322347|8875637|P1|Overall Study|blood transfusion|5
2565851|NCT01322347|8875636|P2|Overall Study|non-protocol change to ESA or IV iron|6
2565852|NCT01322347|8875637|P1|Overall Study|non-protocol change to ESA or IV iron|14
2565853|NCT01322347|8875636|P2|Overall Study|Withdrawal by Subject|4
2565854|NCT01322347|8875637|P1|Overall Study|Withdrawal by Subject|1
2565855|NCT01322347|8875636|P2|Overall Study|Protocol Violation|2
2565856|NCT01322347|8875637|P1|Overall Study|Protocol Violation|5
2565857|NCT01322347|8875636|P2|Overall Study|Physician Decision|1
2565858|NCT01322347|8875637|P1|Overall Study|Physician Decision|2
2565859|NCT01322347|8875636|P2|Overall Study|Death|3
2565860|NCT01322347|8875637|P1|Overall Study|Death|5
2565861|NCT01322347|8875636|P2|Overall Study|Adverse Event|2
2565862|NCT01322347|8875637|P1|Overall Study|Adverse Event|7
2565863|NCT01322009|8875700|P2|Overall Study|ng tube discontinued|1
2565864|NCT01322009|8875701|P1|Overall Study|ng tube discontinued|0
2565865|NCT01322009|8875700|P2|Overall Study|Adverse Event|1
2565866|NCT01322009|8875701|P1|Overall Study|Adverse Event|0
2565867|NCT01322009|8875700|P2|Overall Study|Death|1
2565868|NCT01322009|8875701|P1|Overall Study|Death|0
2565869|NCT01321879|8875709|P1|Overall Study|Withdrawal by Subject|1
2565870|NCT01321879|8875709|P1|Overall Study|Death|3
2565871|NCT01321879|8875709|P1|Overall Study|Adverse Event|5
2565872|NCT01321879|8875709|P1|Overall Study|Lack of Efficacy|5
2565873|NCT01321749|8875715|P2|Overall Study|Withdrawal by Subject|4
2565874|NCT01321749|8875716|P1|Overall Study|Withdrawal by Subject|5
2565875|NCT01321749|8875715|P2|Overall Study|Protocol Violation|7
2565876|NCT01321749|8875716|P1|Overall Study|Protocol Violation|4
2565877|NCT01321749|8875715|P2|Overall Study|Lost to Follow-up|11
2565878|NCT01321749|8875716|P1|Overall Study|Lost to Follow-up|4
2565879|NCT01321723|8875725|P3|Overall Study|Withdrawal by Subject|2
2565880|NCT01321723|8875726|P2|Overall Study|Withdrawal by Subject|0
2565881|NCT01321723|8875727|P1|Overall Study|Withdrawal by Subject|2
2565882|NCT01321723|8875725|P3|Overall Study|Adverse Event|2
2565883|NCT01321723|8875726|P2|Overall Study|Adverse Event|5
2565884|NCT01321723|8875727|P1|Overall Study|Adverse Event|3
2565885|NCT01321710|8875749|P3|Overall Study|Lost to Follow-up|0
2565886|NCT01321710|8875750|P2|Overall Study|Lost to Follow-up|5
2565887|NCT01321710|8875751|P1|Overall Study|Lost to Follow-up|4
2565888|NCT01321697|8875766|P1|Overall Study|Study Terminated|7
2565889|NCT01321606|8875772|P4|Overall Study|Lost to Follow-up|1
2565890|NCT01321606|8875773|P3|Overall Study|Lost to Follow-up|0
2565891|NCT01321606|8875774|P2|Overall Study|Lost to Follow-up|0
2565892|NCT01321606|8875775|P1|Overall Study|Lost to Follow-up|0
2565893|NCT01321073|8875811|P1|Overall Study|Death|3
2565894|NCT01321073|8875811|P1|Overall Study|Did not attempt implant|4
2565895|NCT01321008|8875815|P1|Overall Study|Early Study Termination|1
2565896|NCT01320943|8875821|P2|Overall Study|Randomized but not Treated|1
2565897|NCT01320943|8875822|P1|Overall Study|Randomized but not Treated|0
2565898|NCT01320943|8875821|P2|Overall Study|Physician Decision|1
2565899|NCT01320943|8875822|P1|Overall Study|Physician Decision|0
2565900|NCT01320943|8875821|P2|Overall Study|Lost to Follow-up|0
2565901|NCT01320943|8875822|P1|Overall Study|Lost to Follow-up|1
2565902|NCT01320735|8875856|P1|Overall Study|Investigator Unable to be Contacted|17
2565903|NCT01320735|8875856|P1|Overall Study|No Decrease of Prostate Specific Antigen|7
2565904|NCT01320735|8875856|P1|Overall Study|Other|1
2565905|NCT01320735|8875856|P1|Overall Study|Protocol Violation|1
2565906|NCT01320735|8875856|P1|Overall Study|Progression/Hormone-Refractory Pca|55
2565907|NCT01320735|8875856|P1|Overall Study|Administrative Reason|6
2565908|NCT01320735|8875856|P1|Overall Study|Lost to Follow-up|13
2565909|NCT01320735|8875856|P1|Overall Study|Withdrawal by Subject|3
2565910|NCT01320735|8875856|P1|Overall Study|Adverse Event|3
2565911|NCT01320722|8875878|P5|Overall Study|Withdrew due to Health Condition|1
2565912|NCT01320722|8875879|P4|Overall Study|Withdrew due to Health Condition|0
2565913|NCT01320722|8875880|P3|Overall Study|Withdrew due to Health Condition|0
2565914|NCT01320722|8875881|P2|Overall Study|Withdrew due to Health Condition|0
2565915|NCT01320722|8875882|P1|Overall Study|Withdrew due to Health Condition|0
2565916|NCT01320722|8875878|P5|Overall Study|Started an Exclusionary Medication|1
2565917|NCT01320722|8875879|P4|Overall Study|Started an Exclusionary Medication|0
2565918|NCT01320722|8875880|P3|Overall Study|Started an Exclusionary Medication|0
2565919|NCT01320722|8875881|P2|Overall Study|Started an Exclusionary Medication|0
2565920|NCT01320722|8875882|P1|Overall Study|Started an Exclusionary Medication|0
2565921|NCT01320722|8875878|P5|Overall Study|Pregnancy|0
2565922|NCT01320722|8875879|P4|Overall Study|Pregnancy|1
2565923|NCT01320722|8875880|P3|Overall Study|Pregnancy|0
2565924|NCT01320722|8875881|P2|Overall Study|Pregnancy|0
2565925|NCT01320722|8875882|P1|Overall Study|Pregnancy|0
2565926|NCT01320722|8875878|P5|Overall Study|Not Compliant with Study Procedures|0
2565927|NCT01320722|8875879|P4|Overall Study|Not Compliant with Study Procedures|4
2565928|NCT01320722|8875880|P3|Overall Study|Not Compliant with Study Procedures|0
2565929|NCT01320722|8875881|P2|Overall Study|Not Compliant with Study Procedures|0
2565930|NCT01320722|8875882|P1|Overall Study|Not Compliant with Study Procedures|0
2565931|NCT01320722|8875878|P5|Overall Study|Adverse Event|0
2565932|NCT01320722|8875879|P4|Overall Study|Adverse Event|6
2565933|NCT01320722|8875880|P3|Overall Study|Adverse Event|3
2565934|NCT01320722|8875881|P2|Overall Study|Adverse Event|0
2565935|NCT01320722|8875882|P1|Overall Study|Adverse Event|0
2565936|NCT01320722|8875878|P5|Overall Study|Non-compliant with Medication|0
2565937|NCT01320722|8875879|P4|Overall Study|Non-compliant with Medication|0
2565938|NCT01320722|8875880|P3|Overall Study|Non-compliant with Medication|1
2565939|NCT01320722|8875881|P2|Overall Study|Non-compliant with Medication|0
2565940|NCT01320722|8875882|P1|Overall Study|Non-compliant with Medication|0
2565941|NCT01320722|8875878|P5|Overall Study|Participant Developed a Rash|1
2565942|NCT01320722|8875879|P4|Overall Study|Participant Developed a Rash|1
2565943|NCT01320722|8875880|P3|Overall Study|Participant Developed a Rash|2
2565944|NCT01320722|8875881|P2|Overall Study|Participant Developed a Rash|0
2565945|NCT01320722|8875882|P1|Overall Study|Participant Developed a Rash|0
2565946|NCT01320722|8875878|P5|Overall Study|Not Available for the 8 Week Visit|0
2565947|NCT01320722|8875879|P4|Overall Study|Not Available for the 8 Week Visit|0
2565948|NCT01320722|8875880|P3|Overall Study|Not Available for the 8 Week Visit|0
2565949|NCT01320722|8875881|P2|Overall Study|Not Available for the 8 Week Visit|3
2565950|NCT01320722|8875882|P1|Overall Study|Not Available for the 8 Week Visit|0
2565951|NCT01320722|8875878|P5|Overall Study|Lost to Follow-up|3
2565952|NCT01320722|8875879|P4|Overall Study|Lost to Follow-up|1
2565953|NCT01320722|8875880|P3|Overall Study|Lost to Follow-up|0
2565954|NCT01320722|8875881|P2|Overall Study|Lost to Follow-up|1
2565955|NCT01320722|8875882|P1|Overall Study|Lost to Follow-up|0
2565956|NCT01320722|8875878|P5|Overall Study|Did not Receive Intervention|2
2565957|NCT01320722|8875879|P4|Overall Study|Did not Receive Intervention|1
2565958|NCT01320722|8875880|P3|Overall Study|Did not Receive Intervention|1
2565959|NCT01320722|8875881|P2|Overall Study|Did not Receive Intervention|2
2565960|NCT01320722|8875882|P1|Overall Study|Did not Receive Intervention|3
2565961|NCT01320683|8875919|P1|Overall Study|Positive antibody response|1
2565962|NCT01320293|8875945|P1|Overall Study|Adverse Event|1
2565963|NCT01320293|8875945|P1|Overall Study|Lack of Efficacy|1
2565964|NCT01320202|8875953|P2|Overall Study|regained renal function|0
2565965|NCT01320202|8875954|P1|Overall Study|regained renal function|1
2565966|NCT01320202|8875953|P2|Overall Study|ineligible|0
2565967|NCT01320202|8875954|P1|Overall Study|ineligible|3
2565968|NCT01320202|8875953|P2|Overall Study|sponsor request|0
2565969|NCT01320202|8875954|P1|Overall Study|sponsor request|2
2565970|NCT01320202|8875953|P2|Overall Study|moved/changed dialysis|2
2565971|NCT01320202|8875954|P1|Overall Study|moved/changed dialysis|5
2565972|NCT01320202|8875953|P2|Overall Study|blood transfusion|7
2565973|NCT01320202|8875954|P1|Overall Study|blood transfusion|1
2565974|NCT01320202|8875953|P2|Overall Study|kidney transplant|2
2565975|NCT01320202|8875954|P1|Overall Study|kidney transplant|1
2565976|NCT01320202|8875953|P2|Overall Study|non-protocol change to ESA or IV iron|20
2565977|NCT01320202|8875954|P1|Overall Study|non-protocol change to ESA or IV iron|17
2565978|NCT01320202|8875953|P2|Overall Study|Withdrawal by Subject|3
2565979|NCT01320202|8875954|P1|Overall Study|Withdrawal by Subject|10
2565980|NCT01320202|8875953|P2|Overall Study|Protocol Violation|1
2565981|NCT01320202|8875954|P1|Overall Study|Protocol Violation|2
2565982|NCT01320202|8875953|P2|Overall Study|Physician Decision|1
2565983|NCT01320202|8875954|P1|Overall Study|Physician Decision|3
2565984|NCT01320202|8875953|P2|Overall Study|Lost to Follow-up|0
2565985|NCT01320202|8875954|P1|Overall Study|Lost to Follow-up|1
2565986|NCT01320202|8875953|P2|Overall Study|Death|3
2565987|NCT01320202|8875954|P1|Overall Study|Death|5
2565988|NCT01320202|8875953|P2|Overall Study|Adverse Event|5
2565989|NCT01320202|8875954|P1|Overall Study|Adverse Event|5
2565990|NCT01320150|8875991|P1|Overall Study|Lost to Follow-up|44
2565991|NCT01320150|8875991|P1|Overall Study|Death|2
2565992|NCT01320150|8875991|P1|Overall Study|Withdrawal by Subject|5
2565993|NCT01320150|8875991|P1|Overall Study|Protocol Violation|15
2565994|NCT01320033|8876025|P3|Overall Study|Other|1
2565995|NCT01320033|8876026|P2|Overall Study|Other|3
2565996|NCT01320033|8876027|P1|Overall Study|Other|2
2565997|NCT01320033|8876025|P3|Overall Study|Lost to Follow-up|17
2565998|NCT01320033|8876026|P2|Overall Study|Lost to Follow-up|26
2565999|NCT01320033|8876027|P1|Overall Study|Lost to Follow-up|22
2566000|NCT01320033|8876025|P3|Overall Study|Protocol Violation|3
2566001|NCT01320033|8876026|P2|Overall Study|Protocol Violation|5
2566002|NCT01320033|8876027|P1|Overall Study|Protocol Violation|3
2566003|NCT01320033|8876025|P3|Overall Study|Withdrawal by Subject|23
2566004|NCT01320033|8876026|P2|Overall Study|Withdrawal by Subject|23
2566005|NCT01320033|8876027|P1|Overall Study|Withdrawal by Subject|22
2566006|NCT01320033|8876025|P3|Overall Study|Adverse Event|8
2566007|NCT01320033|8876026|P2|Overall Study|Adverse Event|7
2566008|NCT01320033|8876027|P1|Overall Study|Adverse Event|9
2566009|NCT01320033|8876025|P3|Overall Study|Lack of Efficacy|1
2566010|NCT01320033|8876026|P2|Overall Study|Lack of Efficacy|0
2566011|NCT01320033|8876027|P1|Overall Study|Lack of Efficacy|0
2566012|NCT01319994|8876055|P2|Overall Study|Protocol Violation|6
2566013|NCT01319994|8876056|P1|Overall Study|Protocol Violation|7
2566014|NCT01319877|8876066|P2|Overall Study|Reason Not Specified|5
2566015|NCT01319877|8876067|P1|Overall Study|Reason Not Specified|4
2566016|NCT01319877|8876066|P2|Overall Study|Withdrawal by Subject|1
2566017|NCT01319877|8876067|P1|Overall Study|Withdrawal by Subject|0
2566018|NCT01319877|8876066|P2|Overall Study|Disease Progression|2
2566019|NCT01319877|8876067|P1|Overall Study|Disease Progression|2
2566020|NCT01319877|8876066|P2|Overall Study|Physician Decision|0
2566021|NCT01319877|8876067|P1|Overall Study|Physician Decision|2
2566022|NCT01319877|8876066|P2|Overall Study|Lost to Follow-up|37
2566023|NCT01319877|8876067|P1|Overall Study|Lost to Follow-up|100
2566024|NCT01319721|8876235|P2|Overall Study|Lost to Follow-up|6
2566025|NCT01319721|8876236|P1|Overall Study|Lost to Follow-up|1
2566026|NCT01319422|8876289|P2|Overall Study|Withdrawal by Subject|0
2566027|NCT01319422|8876290|P1|Overall Study|Withdrawal by Subject|1
2566028|NCT01319383|8876308|P2|Overall Study|No in vivo response to interval doses|1
2566029|NCT01319383|8876309|P1|Overall Study|No in vivo response to interval doses|0
2566030|NCT01319383|8876308|P2|Overall Study|Lack of Efficacy|9
2566031|NCT01319383|8876309|P1|Overall Study|Lack of Efficacy|5
2566032|NCT01319383|8876308|P2|Overall Study|Physician Decision|0
2566033|NCT01319383|8876309|P1|Overall Study|Physician Decision|3
2566034|NCT01319383|8876308|P2|Overall Study|No ex vivo or in vivo response|0
2566035|NCT01319383|8876309|P1|Overall Study|No ex vivo or in vivo response|4
2566036|NCT01318993|8876348|P1|Overall Study|Withdrawal by Subject|24
2566037|NCT01318993|8876348|P1|Overall Study|Physician Decision|13
2566038|NCT01318993|8876348|P1|Overall Study|Lost to Follow-up|4
2566039|NCT01318993|8876348|P1|Overall Study|Study closed or terminated|174
2566040|NCT01318993|8876348|P1|Overall Study|Protocol based stopping criteria|6
2566041|NCT01318993|8876348|P1|Overall Study|Protocol Violation|3
2566042|NCT01318993|8876348|P1|Overall Study|Lack of Efficacy|121
2566043|NCT01318993|8876348|P1|Overall Study|Adverse Event|53
2566044|NCT01318915|8876369|P1|Overall Study|Lost to Follow-up|1
2566045|NCT01318902|8876398|P4|Overall Study|Terminated by Sponsor|0
2566046|NCT01318902|8876399|P3|Overall Study|Terminated by Sponsor|1
2566047|NCT01318902|8876400|P2|Overall Study|Terminated by Sponsor|0
2566048|NCT01318902|8876401|P1|Overall Study|Terminated by Sponsor|0
2566049|NCT01318902|8876398|P4|Overall Study|Adverse Event|0
2566050|NCT01318902|8876399|P3|Overall Study|Adverse Event|0
2566051|NCT01318902|8876400|P2|Overall Study|Adverse Event|1
2566052|NCT01318902|8876401|P1|Overall Study|Adverse Event|0
2566053|NCT01318902|8876398|P4|Overall Study|Unsatisfactory Therapeutic Response|1
2566054|NCT01318902|8876399|P3|Overall Study|Unsatisfactory Therapeutic Response|0
2566055|NCT01318902|8876400|P2|Overall Study|Unsatisfactory Therapeutic Response|0
2566056|NCT01318902|8876401|P1|Overall Study|Unsatisfactory Therapeutic Response|1
2566057|NCT01318902|8876398|P4|Overall Study|Withdrawal by Patient|3
2566058|NCT01318902|8876399|P3|Overall Study|Withdrawal by Patient|0
2566059|NCT01318902|8876400|P2|Overall Study|Withdrawal by Patient|1
2566060|NCT01318902|8876401|P1|Overall Study|Withdrawal by Patient|0
2566061|NCT01318902|8876398|P4|Overall Study|Symptomatic Deterioration|2
2566062|NCT01318902|8876399|P3|Overall Study|Symptomatic Deterioration|1
2566063|NCT01318902|8876400|P2|Overall Study|Symptomatic Deterioration|1
2566064|NCT01318902|8876401|P1|Overall Study|Symptomatic Deterioration|0
2566065|NCT01318876|8876478|P1|Day 29 Survey|survey not completed-don't know why|1825
2566066|NCT01318876|8876478|P1|Day 8 Survey|survey not completed-don't know why|1724
2566067|NCT01318876|8876478|P1|Day 8 Survey|email address invalid|96
2566068|NCT01318811|8876485|P2|Overall Study|CRRT stopped for head MRI|1
2566069|NCT01318811|8876486|P1|Overall Study|CRRT stopped for head MRI|0
2566070|NCT01318811|8876485|P2|Overall Study|Death|1
2566071|NCT01318811|8876486|P1|Overall Study|Death|0
2566072|NCT01318811|8876485|P2|Overall Study|CRRT stopped for head CT|1
2566073|NCT01318811|8876486|P1|Overall Study|CRRT stopped for head CT|0
2566074|NCT01318811|8876485|P2|Overall Study|Physician Decision|1
2566075|NCT01318811|8876486|P1|Overall Study|Physician Decision|1
2566076|NCT01318512|8876587|P1|Maintenance Period (6 Months)|Protocol Violation|9
2566077|NCT01318512|8876587|P1|Maintenance Period (6 Months)|Death|2
2566078|NCT01318499|8876606|P3|Overall Study|Other|22
2566079|NCT01318499|8876607|P2|Overall Study|Other|10
2566080|NCT01318499|8876608|P1|Overall Study|Other|7
2566081|NCT01318499|8876606|P3|Overall Study|Patient Did Not Use Study Medication|14
2566082|NCT01318499|8876607|P2|Overall Study|Patient Did Not Use Study Medication|28
2566083|NCT01318499|8876608|P1|Overall Study|Patient Did Not Use Study Medication|18
2566084|NCT01318499|8876606|P3|Overall Study|Protocol Violation|2
2566085|NCT01318499|8876607|P2|Overall Study|Protocol Violation|4
2566086|NCT01318499|8876608|P1|Overall Study|Protocol Violation|2
2566087|NCT01318499|8876606|P3|Overall Study|Treatment Failure|101
2566088|NCT01318499|8876607|P2|Overall Study|Treatment Failure|19
2566089|NCT01318499|8876608|P1|Overall Study|Treatment Failure|19
2566090|NCT01318499|8876606|P3|Overall Study|Noncompliance|0
2566091|NCT01318499|8876607|P2|Overall Study|Noncompliance|3
2566092|NCT01318499|8876608|P1|Overall Study|Noncompliance|2
2566093|NCT01318499|8876606|P3|Overall Study|Pt Decision Unrelated to Adverse Event|2
2566094|NCT01318499|8876607|P2|Overall Study|Pt Decision Unrelated to Adverse Event|1
2566095|NCT01318499|8876608|P1|Overall Study|Pt Decision Unrelated to Adverse Event|1
2566096|NCT01318499|8876606|P3|Overall Study|Adverse Event|6
2566097|NCT01318499|8876607|P2|Overall Study|Adverse Event|11
2566098|NCT01318499|8876608|P1|Overall Study|Adverse Event|16
2566099|NCT01318382|8876631|P1|Overall Study|Protocol Violation|1
2566100|NCT01318382|8876631|P1|Overall Study|Device Malfunction|10
2566101|NCT01318382|8876631|P1|Overall Study|Physician Decision|2
2566102|NCT01318135|8876689|P8|Entered - Long-Term Extension Study|Use of Excluded Medications|1
2566103|NCT01318135|8876690|P7|Entered - Long-Term Extension Study|Use of Excluded Medications|0
2566104|NCT01318135|8876691|P6|Entered - Long-Term Extension Study|Use of Excluded Medications|0
2566105|NCT01318135|8876692|P5|Entered - Long-Term Extension Study|Use of Excluded Medications|0
2566106|NCT01318135|8876693|P4|Entered - Long-Term Extension Study|Use of Excluded Medications|0
2566107|NCT01318135|8876694|P3|Entered - Long-Term Extension Study|Use of Excluded Medications|0
2566108|NCT01318135|8876695|P2|Entered - Long-Term Extension Study|Use of Excluded Medications|0
2566109|NCT01318135|8876696|P1|Entered - Long-Term Extension Study|Use of Excluded Medications|0
2566110|NCT01318135|8876689|P8|Entered - Long-Term Extension Study|Lack of Efficacy|1
2566111|NCT01318135|8876690|P7|Entered - Long-Term Extension Study|Lack of Efficacy|1
2566112|NCT01318135|8876691|P6|Entered - Long-Term Extension Study|Lack of Efficacy|2
2566113|NCT01318135|8876692|P5|Entered - Long-Term Extension Study|Lack of Efficacy|2
2566114|NCT01318135|8876693|P4|Entered - Long-Term Extension Study|Lack of Efficacy|3
2566115|NCT01318135|8876694|P3|Entered - Long-Term Extension Study|Lack of Efficacy|2
2566116|NCT01318135|8876695|P2|Entered - Long-Term Extension Study|Lack of Efficacy|7
2566117|NCT01318135|8876696|P1|Entered - Long-Term Extension Study|Lack of Efficacy|5
2566118|NCT01318135|8876689|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|1
2566119|NCT01318135|8876690|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|0
2566120|NCT01318135|8876691|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|0
2566121|NCT01318135|8876692|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|2
2566122|NCT01318135|8876693|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|1
2566123|NCT01318135|8876694|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|2
2566124|NCT01318135|8876695|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
2566125|NCT01318135|8876696|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
2566126|NCT01318135|8876689|P8|Entered - Long-Term Extension Study|Protocol Violation|0
2566127|NCT01318135|8876690|P7|Entered - Long-Term Extension Study|Protocol Violation|0
2566128|NCT01318135|8876691|P6|Entered - Long-Term Extension Study|Protocol Violation|0
2566129|NCT01318135|8876692|P5|Entered - Long-Term Extension Study|Protocol Violation|1
2566130|NCT01318135|8876693|P4|Entered - Long-Term Extension Study|Protocol Violation|0
2566131|NCT01318135|8876694|P3|Entered - Long-Term Extension Study|Protocol Violation|0
2566132|NCT01318135|8876695|P2|Entered - Long-Term Extension Study|Protocol Violation|1
2566133|NCT01318135|8876696|P1|Entered - Long-Term Extension Study|Protocol Violation|1
2566134|NCT01318135|8876689|P8|Entered - Long-Term Extension Study|Adverse Event|0
2566135|NCT01318135|8876690|P7|Entered - Long-Term Extension Study|Adverse Event|0
2566136|NCT01318135|8876691|P6|Entered - Long-Term Extension Study|Adverse Event|2
2566137|NCT01318135|8876692|P5|Entered - Long-Term Extension Study|Adverse Event|4
2566138|NCT01318135|8876693|P4|Entered - Long-Term Extension Study|Adverse Event|3
2566139|NCT01318135|8876694|P3|Entered - Long-Term Extension Study|Adverse Event|4
2566140|NCT01318135|8876695|P2|Entered - Long-Term Extension Study|Adverse Event|3
2566141|NCT01318135|8876696|P1|Entered - Long-Term Extension Study|Adverse Event|9
2566142|NCT01318135|8876689|P8|Enrolled - Long-Term Extension Study|Treatment Complications|0
2566143|NCT01318135|8876690|P7|Enrolled - Long-Term Extension Study|Treatment Complications|0
2566144|NCT01318135|8876691|P6|Enrolled - Long-Term Extension Study|Treatment Complications|0
2566145|NCT01318135|8876692|P5|Enrolled - Long-Term Extension Study|Treatment Complications|0
2566146|NCT01318135|8876693|P4|Enrolled - Long-Term Extension Study|Treatment Complications|0
2566147|NCT01318135|8876694|P3|Enrolled - Long-Term Extension Study|Treatment Complications|0
2566148|NCT01318135|8876695|P2|Enrolled - Long-Term Extension Study|Treatment Complications|0
2566149|NCT01318135|8876696|P1|Enrolled - Long-Term Extension Study|Treatment Complications|1
2566150|NCT01318135|8876689|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
2566151|NCT01318135|8876690|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
2566152|NCT01318135|8876691|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
2566153|NCT01318135|8876692|P5|Enrolled - Long-Term Extension Study|Adverse Event|0
2566154|NCT01318135|8876693|P4|Enrolled - Long-Term Extension Study|Adverse Event|0
2566155|NCT01318135|8876694|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
2566156|NCT01318135|8876695|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
2566157|NCT01318135|8876696|P1|Enrolled - Long-Term Extension Study|Adverse Event|1
2566158|NCT01318122|8876828|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
2566159|NCT01318122|8876829|P3|Entered - Long-Term Extension Study|Lack of Efficacy|3
2566160|NCT01318122|8876830|P2|Entered - Long-Term Extension Study|Lack of Efficacy|2
2566161|NCT01318122|8876831|P1|Entered - Long-Term Extension Study|Lack of Efficacy|0
2566162|NCT01318122|8876828|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
2566163|NCT01318122|8876829|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|1
2566164|NCT01318122|8876830|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|3
2566165|NCT01318122|8876831|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
2566166|NCT01318122|8876828|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
2566167|NCT01318122|8876829|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
2566168|NCT01318122|8876830|P2|Entered - Long-Term Extension Study|Lost to Follow-up|0
2566169|NCT01318122|8876831|P1|Entered - Long-Term Extension Study|Lost to Follow-up|1
2566170|NCT01318122|8876828|P4|Entered - Long-Term Extension Study|Adverse Event|4
2566171|NCT01318122|8876829|P3|Entered - Long-Term Extension Study|Adverse Event|2
2566172|NCT01318122|8876830|P2|Entered - Long-Term Extension Study|Adverse Event|6
2566173|NCT01318122|8876831|P1|Entered - Long-Term Extension Study|Adverse Event|6
2566174|NCT01318122|8876828|P4|Enrolled - Long-Term Extension Study|Other|0
2566175|NCT01318122|8876829|P3|Enrolled - Long-Term Extension Study|Other|0
2566176|NCT01318122|8876830|P2|Enrolled - Long-Term Extension Study|Other|0
2566177|NCT01318122|8876831|P1|Enrolled - Long-Term Extension Study|Other|1
2566178|NCT01318122|8876828|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
2566179|NCT01318122|8876829|P3|Enrolled - Long-Term Extension Study|Adverse Event|2
2566180|NCT01318122|8876830|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
2566181|NCT01318122|8876831|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
2566182|NCT01318109|8876900|P3|Overall Study|Schedule Conflict|0
2566183|NCT01318109|8876901|P2|Overall Study|Schedule Conflict|1
2566184|NCT01318109|8876902|P1|Overall Study|Schedule Conflict|0
2566185|NCT01318109|8876900|P3|Overall Study|Withdrawal by Subject|0
2566186|NCT01318109|8876901|P2|Overall Study|Withdrawal by Subject|0
2566187|NCT01318109|8876902|P1|Overall Study|Withdrawal by Subject|1
2566188|NCT01318109|8876900|P3|Overall Study|Adverse Event|0
2566189|NCT01318109|8876901|P2|Overall Study|Adverse Event|2
2566190|NCT01318109|8876902|P1|Overall Study|Adverse Event|0
2566191|NCT01318083|8876937|P3|Overall Study|Lack of Study Medication Compliance|0
2566192|NCT01318083|8876938|P2|Overall Study|Lack of Study Medication Compliance|1
2566193|NCT01318083|8876939|P1|Overall Study|Lack of Study Medication Compliance|0
2566194|NCT01318083|8876937|P3|Overall Study|Treatment Complications|0
2566195|NCT01318083|8876938|P2|Overall Study|Treatment Complications|0
2566196|NCT01318083|8876939|P1|Overall Study|Treatment Complications|1
2566197|NCT01318083|8876937|P3|Overall Study|Lack of Efficacy|1
2566198|NCT01318083|8876938|P2|Overall Study|Lack of Efficacy|0
2566199|NCT01318083|8876939|P1|Overall Study|Lack of Efficacy|0
2566200|NCT01318083|8876937|P3|Overall Study|Withdrawal by Subject|2
2566201|NCT01318083|8876938|P2|Overall Study|Withdrawal by Subject|0
2566202|NCT01318083|8876939|P1|Overall Study|Withdrawal by Subject|1
2566203|NCT01318083|8876937|P3|Overall Study|Adverse Event|2
2566204|NCT01318083|8876938|P2|Overall Study|Adverse Event|1
2566205|NCT01318083|8876939|P1|Overall Study|Adverse Event|4
2566206|NCT01318070|8876974|P3|Overall Study|Principal Investigator Discretion|0
2566207|NCT01318070|8876975|P2|Overall Study|Principal Investigator Discretion|0
2566208|NCT01318070|8876976|P1|Overall Study|Principal Investigator Discretion|1
2566209|NCT01318070|8876974|P3|Overall Study|Lack of Efficacy|1
2566210|NCT01318070|8876975|P2|Overall Study|Lack of Efficacy|0
2566211|NCT01318070|8876976|P1|Overall Study|Lack of Efficacy|0
2566212|NCT01318070|8876974|P3|Overall Study|Withdrawal by Subject|1
2566213|NCT01318070|8876975|P2|Overall Study|Withdrawal by Subject|1
2566214|NCT01318070|8876976|P1|Overall Study|Withdrawal by Subject|0
2566215|NCT01318070|8876974|P3|Overall Study|Adverse Event|5
2566216|NCT01318070|8876975|P2|Overall Study|Adverse Event|1
2566217|NCT01318070|8876976|P1|Overall Study|Adverse Event|1
2566218|NCT01317797|8877029|P3|Overall Study|Withdrawal of Patient|1
2566219|NCT01317797|8877030|P2|Overall Study|Withdrawal of Patient|0
2566220|NCT01317797|8877031|P1|Overall Study|Withdrawal of Patient|0
2566221|NCT01317797|8877029|P3|Overall Study|Other|0
2566222|NCT01317797|8877030|P2|Overall Study|Other|1
2566223|NCT01317797|8877031|P1|Overall Study|Other|0
2566224|NCT01317641|8877108|P9|Overall Study|Withdrawal by Subject|0
2566225|NCT01317641|8877109|P8|Overall Study|Withdrawal by Subject|0
2566226|NCT01317641|8877110|P7|Overall Study|Withdrawal by Subject|1
2566227|NCT01317641|8877111|P6|Overall Study|Withdrawal by Subject|0
2566228|NCT01317641|8877112|P5|Overall Study|Withdrawal by Subject|0
2566229|NCT01317641|8877113|P4|Overall Study|Withdrawal by Subject|0
2566230|NCT01317641|8877114|P3|Overall Study|Withdrawal by Subject|0
2566231|NCT01317641|8877115|P2|Overall Study|Withdrawal by Subject|0
2566232|NCT01317641|8877116|P1|Overall Study|Withdrawal by Subject|0
2566233|NCT01317641|8877108|P9|Overall Study|Disease progression|4
2566234|NCT01317641|8877109|P8|Overall Study|Disease progression|3
2566235|NCT01317641|8877110|P7|Overall Study|Disease progression|0
2566236|NCT01317641|8877111|P6|Overall Study|Disease progression|0
2566237|NCT01317641|8877112|P5|Overall Study|Disease progression|0
2566238|NCT01317641|8877113|P4|Overall Study|Disease progression|0
2566239|NCT01317641|8877114|P3|Overall Study|Disease progression|0
2566240|NCT01317641|8877115|P2|Overall Study|Disease progression|0
2566241|NCT01317641|8877116|P1|Overall Study|Disease progression|0
2566242|NCT01317641|8877108|P9|Overall Study|Protocol Violation|0
2566243|NCT01317641|8877109|P8|Overall Study|Protocol Violation|0
2566244|NCT01317641|8877110|P7|Overall Study|Protocol Violation|0
2566245|NCT01317641|8877111|P6|Overall Study|Protocol Violation|0
2566246|NCT01317641|8877112|P5|Overall Study|Protocol Violation|0
2566247|NCT01317641|8877113|P4|Overall Study|Protocol Violation|0
2566248|NCT01317641|8877114|P3|Overall Study|Protocol Violation|0
2566249|NCT01317641|8877115|P2|Overall Study|Protocol Violation|0
2566250|NCT01317641|8877116|P1|Overall Study|Protocol Violation|1
2566251|NCT01317641|8877108|P9|Overall Study|Adverse Event|0
2566252|NCT01317641|8877109|P8|Overall Study|Adverse Event|1
2566253|NCT01317641|8877110|P7|Overall Study|Adverse Event|2
2566254|NCT01317641|8877111|P6|Overall Study|Adverse Event|0
2566255|NCT01317641|8877112|P5|Overall Study|Adverse Event|0
2566256|NCT01317641|8877113|P4|Overall Study|Adverse Event|1
2566257|NCT01317641|8877114|P3|Overall Study|Adverse Event|0
2566258|NCT01317641|8877115|P2|Overall Study|Adverse Event|1
2566259|NCT01317641|8877116|P1|Overall Study|Adverse Event|0
2566260|NCT01317641|8877108|P9|Overall Study|Not treated|1
2566261|NCT01317641|8877109|P8|Overall Study|Not treated|1
2566262|NCT01317641|8877110|P7|Overall Study|Not treated|0
2566263|NCT01317641|8877111|P6|Overall Study|Not treated|0
2566264|NCT01317641|8877112|P5|Overall Study|Not treated|0
2566265|NCT01317641|8877113|P4|Overall Study|Not treated|0
2566266|NCT01317641|8877114|P3|Overall Study|Not treated|0
2566267|NCT01317641|8877115|P2|Overall Study|Not treated|0
2566268|NCT01317641|8877116|P1|Overall Study|Not treated|0
2566269|NCT01317615|8877218|P1|Overall Study|Adverse Event|7
2566270|NCT01317615|8877218|P1|Overall Study|Abnormal laboratory value(s)|1
2566271|NCT01317615|8877218|P1|Overall Study|Withdrawal by Subject|5
2566272|NCT01317615|8877218|P1|Overall Study|Death|6
2566273|NCT01317615|8877218|P1|Overall Study|New cancer therapy|5
2566274|NCT01317615|8877218|P1|Overall Study|Disease progression|25
2566275|NCT01317550|8877231|P4|Overall Study|Lack of compliance study med|0
2566276|NCT01317550|8877232|P3|Overall Study|Lack of compliance study med|0
2566277|NCT01317550|8877233|P2|Overall Study|Lack of compliance study med|0
2566278|NCT01317550|8877234|P1|Overall Study|Lack of compliance study med|1
2566279|NCT01317550|8877231|P4|Overall Study|Withdrawal by Subject|0
2566280|NCT01317550|8877232|P3|Overall Study|Withdrawal by Subject|0
2566281|NCT01317550|8877233|P2|Overall Study|Withdrawal by Subject|0
2566282|NCT01317550|8877234|P1|Overall Study|Withdrawal by Subject|1
2566283|NCT01317472|8877246|P2|Overall Study|Unrelated hospitalization|0
2566284|NCT01317472|8877247|P1|Overall Study|Unrelated hospitalization|1
2566285|NCT01317472|8877246|P2|Overall Study|Withdrawal by Subject|0
2566286|NCT01317472|8877247|P1|Overall Study|Withdrawal by Subject|1
2566287|NCT01317199|8877257|P4|Randomized Phase 2|Patient transferred to other facility|0
2566288|NCT01317199|8877258|P3|Randomized Phase 2|Patient transferred to other facility|1
2566289|NCT01317199|8877259|P2|Randomized Phase 2|Patient transferred to other facility|0
2566290|NCT01317199|8877260|P1|Randomized Phase 2|Patient transferred to other facility|0
2566291|NCT01317199|8877257|P4|Randomized Phase 2|Patient stopped taking study drug|1
2566292|NCT01317199|8877258|P3|Randomized Phase 2|Patient stopped taking study drug|0
2566293|NCT01317199|8877259|P2|Randomized Phase 2|Patient stopped taking study drug|0
2566294|NCT01317199|8877260|P1|Randomized Phase 2|Patient stopped taking study drug|0
2566295|NCT01317199|8877257|P4|Randomized Phase 2|Disenrolled before treatment|2
2566296|NCT01317199|8877258|P3|Randomized Phase 2|Disenrolled before treatment|1
2566297|NCT01317199|8877259|P2|Randomized Phase 2|Disenrolled before treatment|1
2566298|NCT01317199|8877260|P1|Randomized Phase 2|Disenrolled before treatment|0
2566299|NCT01317199|8877257|P4|Randomized Phase 2|Rising PSA, not as defined by protocol|2
2566300|NCT01317199|8877258|P3|Randomized Phase 2|Rising PSA, not as defined by protocol|5
2566301|NCT01317199|8877259|P2|Randomized Phase 2|Rising PSA, not as defined by protocol|2
2566302|NCT01317199|8877260|P1|Randomized Phase 2|Rising PSA, not as defined by protocol|0
2566303|NCT01317199|8877257|P4|Randomized Phase 2|Comorbidities|2
2566304|NCT01317199|8877258|P3|Randomized Phase 2|Comorbidities|2
2566305|NCT01317199|8877259|P2|Randomized Phase 2|Comorbidities|2
2566306|NCT01317199|8877260|P1|Randomized Phase 2|Comorbidities|0
2566307|NCT01317199|8877257|P4|Randomized Phase 2|Adverse Event|1
2566308|NCT01317199|8877258|P3|Randomized Phase 2|Adverse Event|0
2566309|NCT01317199|8877259|P2|Randomized Phase 2|Adverse Event|0
2566310|NCT01317199|8877260|P1|Randomized Phase 2|Adverse Event|0
2566311|NCT01317199|8877257|P4|Randomized Phase 2|Withdrawal by Subject|4
2566312|NCT01317199|8877258|P3|Randomized Phase 2|Withdrawal by Subject|5
2566313|NCT01317199|8877259|P2|Randomized Phase 2|Withdrawal by Subject|3
2566314|NCT01317199|8877260|P1|Randomized Phase 2|Withdrawal by Subject|0
2566315|NCT01317199|8877257|P4|Randomized Phase 2|Disease progression|5
2566316|NCT01317199|8877258|P3|Randomized Phase 2|Disease progression|7
2566317|NCT01317199|8877259|P2|Randomized Phase 2|Disease progression|3
2566318|NCT01317199|8877260|P1|Randomized Phase 2|Disease progression|0
2566319|NCT01317199|8877257|P4|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
2566320|NCT01317199|8877258|P3|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
2566321|NCT01317199|8877259|P2|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
2566322|NCT01317199|8877260|P1|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1
2566323|NCT01317199|8877257|P4|Dose-escalation Phase 1|Disease progression|0
2566324|NCT01317199|8877258|P3|Dose-escalation Phase 1|Disease progression|0
2566325|NCT01317199|8877259|P2|Dose-escalation Phase 1|Disease progression|0
2566326|NCT01317199|8877260|P1|Dose-escalation Phase 1|Disease progression|1
2566327|NCT01317199|8877257|P4|Dose-escalation Phase 1|Physician Decision|0
2566328|NCT01317199|8877258|P3|Dose-escalation Phase 1|Physician Decision|0
2566329|NCT01317199|8877259|P2|Dose-escalation Phase 1|Physician Decision|0
2566330|NCT01317199|8877260|P1|Dose-escalation Phase 1|Physician Decision|5
2566331|NCT01317160|8877289|P2|Overall Study|Withdrawal by Subject|2
2566332|NCT01317160|8877290|P1|Overall Study|Withdrawal by Subject|0
2566333|NCT01317160|8877289|P2|Overall Study|Lost to Follow-up|3
2566334|NCT01317160|8877290|P1|Overall Study|Lost to Follow-up|3
2566335|NCT01317160|8877289|P2|Overall Study|Incorrect inclusion|1
2566336|NCT01317160|8877290|P1|Overall Study|Incorrect inclusion|1
2566337|NCT01317004|8877324|P2|Overall Study|Adverse Event|3
2566338|NCT01317004|8877325|P1|Overall Study|Adverse Event|3
2566339|NCT01317004|8877324|P2|Overall Study|Protocol Violation|2
2566340|NCT01317004|8877325|P1|Overall Study|Protocol Violation|0
2566341|NCT01317004|8877324|P2|Overall Study|Withdrawal by Subject|4
2566342|NCT01317004|8877325|P1|Overall Study|Withdrawal by Subject|1
2566343|NCT01316939|8877346|P3|Overall Study|Protocol Violation|0
2566344|NCT01316939|8877347|P2|Overall Study|Protocol Violation|1
2566345|NCT01316939|8877348|P1|Overall Study|Protocol Violation|0
2566346|NCT01316939|8877346|P3|Overall Study|Met Liver chemistry stopping criteria|1
2566347|NCT01316939|8877347|P2|Overall Study|Met Liver chemistry stopping criteria|0
2566348|NCT01316939|8877348|P1|Overall Study|Met Liver chemistry stopping criteria|1
2566349|NCT01316939|8877346|P3|Overall Study|Lost to Follow-up|2
2566350|NCT01316939|8877347|P2|Overall Study|Lost to Follow-up|0
2566351|NCT01316939|8877348|P1|Overall Study|Lost to Follow-up|0
2566352|NCT01316939|8877346|P3|Overall Study|Physician Decision|1
2566353|NCT01316939|8877347|P2|Overall Study|Physician Decision|2
2566354|NCT01316939|8877348|P1|Overall Study|Physician Decision|2
2566355|NCT01316939|8877346|P3|Overall Study|Withdrawal by Subject|6
2566356|NCT01316939|8877347|P2|Overall Study|Withdrawal by Subject|3
2566357|NCT01316939|8877348|P1|Overall Study|Withdrawal by Subject|1
2566358|NCT01316939|8877346|P3|Overall Study|Adverse Event|11
2566359|NCT01316939|8877347|P2|Overall Study|Adverse Event|12
2566360|NCT01316939|8877348|P1|Overall Study|Adverse Event|9
2566361|NCT01316939|8877346|P3|Overall Study|Lack of Efficacy|25
2566362|NCT01316939|8877347|P2|Overall Study|Lack of Efficacy|25
2566363|NCT01316939|8877348|P1|Overall Study|Lack of Efficacy|24
2566364|NCT01316939|8877346|P3|Overall Study|Study closed/terminated|23
2566365|NCT01316939|8877347|P2|Overall Study|Study closed/terminated|25
2566366|NCT01316939|8877348|P1|Overall Study|Study closed/terminated|26
2566367|NCT01316913|8877443|P4|Overall Study|Withdrawal by Subject|6
2566368|NCT01316913|8877444|P3|Overall Study|Withdrawal by Subject|10
2566369|NCT01316913|8877445|P2|Overall Study|Withdrawal by Subject|9
2566370|NCT01316913|8877446|P1|Overall Study|Withdrawal by Subject|10
2566371|NCT01316913|8877443|P4|Overall Study|Lost to Follow-up|2
2566372|NCT01316913|8877444|P3|Overall Study|Lost to Follow-up|0
2566373|NCT01316913|8877445|P2|Overall Study|Lost to Follow-up|1
2566374|NCT01316913|8877446|P1|Overall Study|Lost to Follow-up|0
2566375|NCT01316913|8877443|P4|Overall Study|Protocol-defined Stopping Criteria|6
2566376|NCT01316913|8877444|P3|Overall Study|Protocol-defined Stopping Criteria|11
2566377|NCT01316913|8877445|P2|Overall Study|Protocol-defined Stopping Criteria|8
2566378|NCT01316913|8877446|P1|Overall Study|Protocol-defined Stopping Criteria|7
2566379|NCT01316913|8877443|P4|Overall Study|Protocol Violation|1
2566380|NCT01316913|8877444|P3|Overall Study|Protocol Violation|4
2566381|NCT01316913|8877445|P2|Overall Study|Protocol Violation|4
2566382|NCT01316913|8877446|P1|Overall Study|Protocol Violation|1
2566383|NCT01316913|8877443|P4|Overall Study|Lack of Efficacy|13
2566384|NCT01316913|8877444|P3|Overall Study|Lack of Efficacy|9
2566385|NCT01316913|8877445|P2|Overall Study|Lack of Efficacy|12
2566386|NCT01316913|8877446|P1|Overall Study|Lack of Efficacy|22
2566387|NCT01316913|8877443|P4|Overall Study|Adverse Event|11
2566388|NCT01316913|8877444|P3|Overall Study|Adverse Event|15
2566389|NCT01316913|8877445|P2|Overall Study|Adverse Event|20
2566390|NCT01316913|8877446|P1|Overall Study|Adverse Event|17
2566391|NCT01316900|8877468|P4|Overall Study|Withdrawal by Subject|9
2566392|NCT01316900|8877469|P3|Overall Study|Withdrawal by Subject|6
2566393|NCT01316900|8877470|P2|Overall Study|Withdrawal by Subject|8
2566394|NCT01316900|8877471|P1|Overall Study|Withdrawal by Subject|7
2566395|NCT01316900|8877468|P4|Overall Study|Lost to Follow-up|1
2566396|NCT01316900|8877469|P3|Overall Study|Lost to Follow-up|1
2566397|NCT01316900|8877470|P2|Overall Study|Lost to Follow-up|0
2566398|NCT01316900|8877471|P1|Overall Study|Lost to Follow-up|1
2566399|NCT01316900|8877468|P4|Overall Study|Protocol-defined Stopping Criteria|5
2566400|NCT01316900|8877469|P3|Overall Study|Protocol-defined Stopping Criteria|10
2566401|NCT01316900|8877470|P2|Overall Study|Protocol-defined Stopping Criteria|3
2566402|NCT01316900|8877471|P1|Overall Study|Protocol-defined Stopping Criteria|2
2566403|NCT01316900|8877468|P4|Overall Study|Protocol Violation|0
2566404|NCT01316900|8877469|P3|Overall Study|Protocol Violation|4
2566405|NCT01316900|8877470|P2|Overall Study|Protocol Violation|1
2566406|NCT01316900|8877471|P1|Overall Study|Protocol Violation|7
2566407|NCT01316900|8877468|P4|Overall Study|Lack of Efficacy|7
2566408|NCT01316900|8877469|P3|Overall Study|Lack of Efficacy|5
2566409|NCT01316900|8877470|P2|Overall Study|Lack of Efficacy|9
2566410|NCT01316900|8877471|P1|Overall Study|Lack of Efficacy|17
2566411|NCT01316900|8877468|P4|Overall Study|Adverse Event|9
2566412|NCT01316900|8877469|P3|Overall Study|Adverse Event|15
2566413|NCT01316900|8877470|P2|Overall Study|Adverse Event|10
2566414|NCT01316900|8877471|P1|Overall Study|Adverse Event|10
2566415|NCT01316887|8877492|P3|Overall Study|Withdrawal by Subject|15
2566416|NCT01316887|8877493|P2|Overall Study|Withdrawal by Subject|16
2566417|NCT01316887|8877494|P1|Overall Study|Withdrawal by Subject|8
2566418|NCT01316887|8877492|P3|Overall Study|Lost to Follow-up|5
2566419|NCT01316887|8877493|P2|Overall Study|Lost to Follow-up|7
2566420|NCT01316887|8877494|P1|Overall Study|Lost to Follow-up|1
2566421|NCT01316887|8877492|P3|Overall Study|Study Closed/Terminated|3
2566422|NCT01316887|8877493|P2|Overall Study|Study Closed/Terminated|4
2566423|NCT01316887|8877494|P1|Overall Study|Study Closed/Terminated|2
2566424|NCT01316887|8877492|P3|Overall Study|Protocol-defined Stopping Criteria|36
2566425|NCT01316887|8877493|P2|Overall Study|Protocol-defined Stopping Criteria|37
2566426|NCT01316887|8877494|P1|Overall Study|Protocol-defined Stopping Criteria|8
2566427|NCT01316887|8877492|P3|Overall Study|Protocol Violation|6
2566428|NCT01316887|8877493|P2|Overall Study|Protocol Violation|6
2566429|NCT01316887|8877494|P1|Overall Study|Protocol Violation|2
2566430|NCT01316887|8877492|P3|Overall Study|Lack of Efficacy|1
2566431|NCT01316887|8877493|P2|Overall Study|Lack of Efficacy|3
2566432|NCT01316887|8877494|P1|Overall Study|Lack of Efficacy|9
2566433|NCT01316887|8877492|P3|Overall Study|Adverse Event|17
2566434|NCT01316887|8877493|P2|Overall Study|Adverse Event|21
2566435|NCT01316887|8877494|P1|Overall Study|Adverse Event|13
2566436|NCT01316692|8877619|P1|Overall Study|Disease Progression|7
2566437|NCT01316692|8877619|P1|Overall Study|Adverse Event|5
2566438|NCT01316614|8877628|P1|Overall Study|Medically unstable|1
2566439|NCT01316614|8877628|P1|Overall Study|Inadequate number of passes|2
2566440|NCT01316614|8877628|P1|Overall Study|Cystic lesion|5
2566441|NCT01316614|8877628|P1|Overall Study|Cytology slides not available for review|4
2566442|NCT01316614|8877628|P1|Overall Study|No solid lesion and FNA not indicated|25
2566443|NCT01316575|8877645|P2|Overall Study|Required alternate treatment|1
2566444|NCT01316575|8877646|P1|Overall Study|Required alternate treatment|0
2566445|NCT01316575|8877645|P2|Overall Study|Withdrawal by Subject|0
2566446|NCT01316575|8877646|P1|Overall Study|Withdrawal by Subject|2
2566447|NCT01316419|8877669|P1|Overall Study|Lost to Follow-up|19
2566448|NCT01316419|8877669|P1|Overall Study|Violated inclusion/exclusion criterion|143
2566449|NCT01316419|8877669|P1|Overall Study|Not treated|103
2566450|NCT01316380|8877695|P3|Overall Study|Not treated|0
2566451|NCT01316380|8877696|P2|Overall Study|Not treated|0
2566452|NCT01316380|8877697|P1|Overall Study|Not treated|1
2566453|NCT01316380|8877695|P3|Overall Study|Other|1
2566454|NCT01316380|8877696|P2|Overall Study|Other|1
2566455|NCT01316380|8877697|P1|Overall Study|Other|0
2566456|NCT01316380|8877695|P3|Overall Study|Withdrawal by Subject|0
2566457|NCT01316380|8877696|P2|Overall Study|Withdrawal by Subject|2
2566458|NCT01316380|8877697|P1|Overall Study|Withdrawal by Subject|1
2566459|NCT01316380|8877695|P3|Overall Study|Protocol Violation|1
2566460|NCT01316380|8877696|P2|Overall Study|Protocol Violation|0
2566461|NCT01316380|8877697|P1|Overall Study|Protocol Violation|0
2566462|NCT01316380|8877695|P3|Overall Study|Adverse Event|1
2566463|NCT01316380|8877696|P2|Overall Study|Adverse Event|2
2566464|NCT01316380|8877697|P1|Overall Study|Adverse Event|0
2566465|NCT01316276|8877834|P1|Overall Study|Other|22
2566466|NCT01316276|8877834|P1|Overall Study|Lost to Follow-up|1
2566467|NCT01316276|8877834|P1|Overall Study|Withdrawal of consent|24
2566468|NCT01316276|8877834|P1|Overall Study|Adverse Event|19
2566469|NCT01316276|8877834|P1|Overall Study|Death|1
2566470|NCT01316224|8877882|P1|Overall Study|Other|1
2566471|NCT01316224|8877882|P1|Overall Study|Adverse Event With Treatment Failure|1
2566472|NCT01316224|8877882|P1|Overall Study|Withdrawal by Subject|1
2566473|NCT01316224|8877882|P1|Overall Study|Lack of Efficacy|1
2566474|NCT01316224|8877882|P1|Overall Study|Adverse Event|3
2566475|NCT01316224|8877882|P1|Overall Study|Protocol Violation|3
2566476|NCT01316055|8877899|P3|Overall Study|Lost to Follow-up|0
2566477|NCT01316055|8877900|P2|Overall Study|Lost to Follow-up|0
2566478|NCT01316055|8877901|P1|Overall Study|Lost to Follow-up|1
2566479|NCT01315847|8877932|P2|Part III, Period 1|[11C]MK-4232 synthesis failure|1
2566480|NCT01315847|8877933|P1|Part III, Period 1|[11C]MK-4232 synthesis failure|0
2566481|NCT01315847|8877932|P2|Part I, Period 1|Reached maximum number of arterial lines|0
2566482|NCT01315847|8877933|P1|Part I, Period 1|Reached maximum number of arterial lines|3
2566483|NCT01315678|8877947|P2|Overall Study|similar reason to those listed above|2
2566484|NCT01315678|8877948|P1|Overall Study|similar reason to those listed above|3
2566485|NCT01315678|8877947|P2|Overall Study|Lost to Follow-up|0
2566486|NCT01315678|8877948|P1|Overall Study|Lost to Follow-up|1
2566487|NCT01315678|8877947|P2|Overall Study|Adverse Event|1
2566488|NCT01315678|8877948|P1|Overall Study|Adverse Event|3
2566489|NCT01315678|8877947|P2|Overall Study|Withdrawal by Subject|3
2566490|NCT01315678|8877948|P1|Overall Study|Withdrawal by Subject|7
2566491|NCT01315353|8877999|P3|Overall Study|Inadvertent randomization/assignment|2
2566492|NCT01315353|8878000|P2|Overall Study|Inadvertent randomization/assignment|0
2566493|NCT01315353|8878001|P1|Overall Study|Inadvertent randomization/assignment|0
2566494|NCT01315353|8877999|P3|Overall Study|Taken off study by site in error|0
2566495|NCT01315353|8878000|P2|Overall Study|Taken off study by site in error|1
2566496|NCT01315353|8878001|P1|Overall Study|Taken off study by site in error|0
2566497|NCT01315353|8877999|P3|Overall Study|Site closing|0
2566498|NCT01315353|8878000|P2|Overall Study|Site closing|4
2566499|NCT01315353|8878001|P1|Overall Study|Site closing|7
2566500|NCT01315353|8877999|P3|Overall Study|Unwilling to adhere to requirements|4
2566501|NCT01315353|8878000|P2|Overall Study|Unwilling to adhere to requirements|5
2566502|NCT01315353|8878001|P1|Overall Study|Unwilling to adhere to requirements|5
2566503|NCT01315353|8877999|P3|Overall Study|Lost to Follow-up|6
2566504|NCT01315353|8878000|P2|Overall Study|Lost to Follow-up|6
2566505|NCT01315353|8878001|P1|Overall Study|Lost to Follow-up|13
2566506|NCT01315353|8877999|P3|Overall Study|Withdrawal by Subject|1
2566507|NCT01315353|8878000|P2|Overall Study|Withdrawal by Subject|6
2566508|NCT01315353|8878001|P1|Overall Study|Withdrawal by Subject|2
2566509|NCT01315353|8877999|P3|Overall Study|Death|0
2566510|NCT01315353|8878000|P2|Overall Study|Death|1
2566511|NCT01315353|8878001|P1|Overall Study|Death|2
2566512|NCT01315249|8878028|P2|Overall Study|Death|1
2566513|NCT01315249|8878029|P1|Overall Study|Death|0
2566514|NCT01315249|8878028|P2|Overall Study|Lost to Follow-up|2
2566515|NCT01315249|8878029|P1|Overall Study|Lost to Follow-up|0
2566516|NCT01315249|8878028|P2|Overall Study|Lack of Efficacy|1
2566517|NCT01315249|8878029|P1|Overall Study|Lack of Efficacy|0
2566518|NCT01315249|8878028|P2|Overall Study|inability to use device|0
2566519|NCT01315249|8878029|P1|Overall Study|inability to use device|1
2566520|NCT01315249|8878028|P2|Overall Study|Administrative problems|0
2566521|NCT01315249|8878029|P1|Overall Study|Administrative problems|1
2566522|NCT01315249|8878028|P2|Overall Study|Abnormal test results|2
2566523|NCT01315249|8878029|P1|Overall Study|Abnormal test results|1
2566524|NCT01315249|8878028|P2|Overall Study|Protocol Violation|5
2566525|NCT01315249|8878029|P1|Overall Study|Protocol Violation|8
2566526|NCT01315249|8878028|P2|Overall Study|Withdrawal by Subject|10
2566527|NCT01315249|8878029|P1|Overall Study|Withdrawal by Subject|11
2566528|NCT01315249|8878028|P2|Overall Study|Adverse Event|26
2566529|NCT01315249|8878029|P1|Overall Study|Adverse Event|22
2566530|NCT01315236|8878057|P2|12-Month Follow-up Period|Did not return to the site for Month 12|0
2566531|NCT01315236|8878058|P1|12-Month Follow-up Period|Did not return to the site for Month 12|1
2566532|NCT01315236|8878057|P2|12-Month Follow-up Period|Death|1
2566533|NCT01315236|8878058|P1|12-Month Follow-up Period|Death|0
2566534|NCT01315236|8878057|P2|Open-label Phase|Other|1
2566535|NCT01315236|8878058|P1|Open-label Phase|Other|0
2566536|NCT01315236|8878057|P2|Open-label Phase|Adverse Event|1
2566537|NCT01315236|8878058|P1|Open-label Phase|Adverse Event|0
2566538|NCT01315236|8878057|P2|Open-label Phase|Death|0
2566539|NCT01315236|8878058|P1|Open-label Phase|Death|1
2566540|NCT01315236|8878057|P2|Double-blind Phase|Lost to Follow-up|0
2566541|NCT01315236|8878058|P1|Double-blind Phase|Lost to Follow-up|1
2566542|NCT01315236|8878057|P2|Double-blind Phase|Withdrawal of Consent|0
2566543|NCT01315236|8878058|P1|Double-blind Phase|Withdrawal of Consent|1
2566544|NCT01315236|8878057|P2|Double-blind Phase|Adverse Event|0
2566545|NCT01315236|8878058|P1|Double-blind Phase|Adverse Event|1
2566546|NCT01315236|8878057|P2|Double-blind Phase|Death|0
2566547|NCT01315236|8878058|P1|Double-blind Phase|Death|1
2566548|NCT01315132|8878114|P1|Overall Study|not treated due to disease progression|1
2566549|NCT01315028|8878121|P2|Overall Study|Death|1
2566550|NCT01315028|8878122|P1|Overall Study|Death|0
2566551|NCT01315028|8878121|P2|Overall Study|Lost to Follow-up|0
2566552|NCT01315028|8878122|P1|Overall Study|Lost to Follow-up|1
2566553|NCT01314911|8878149|P2|Overall Study|Never Started Treatment|0
2566554|NCT01314911|8878150|P1|Overall Study|Never Started Treatment|1
2566555|NCT01314911|8878149|P2|Overall Study|Received Non-randomized Study Drug|1
2566556|NCT01314911|8878150|P1|Overall Study|Received Non-randomized Study Drug|0
2566557|NCT01314911|8878149|P2|Overall Study|Withdrawal by Subject|3
2566558|NCT01314911|8878150|P1|Overall Study|Withdrawal by Subject|1
2566559|NCT01314911|8878149|P2|Overall Study|Lost to Follow-up|2
2566560|NCT01314911|8878150|P1|Overall Study|Lost to Follow-up|3
2566561|NCT01314872|8878201|P15|Period 2|Lost to Follow-up|6
2566562|NCT01314872|8878202|P14|Period 2|Lost to Follow-up|2
2566563|NCT01314872|8878203|P13|Period 2|Lost to Follow-up|7
2566564|NCT01314872|8878204|P12|Period 2|Lost to Follow-up|6
2566565|NCT01314872|8878205|P11|Period 2|Lost to Follow-up|0
2566566|NCT01314872|8878206|P10|Period 2|Lost to Follow-up|0
2566567|NCT01314872|8878207|P9|Period 2|Lost to Follow-up|0
2566568|NCT01314872|8878208|P8|Period 2|Lost to Follow-up|0
2566569|NCT01314872|8878209|P7|Period 2|Lost to Follow-up|0
2566570|NCT01314872|8878210|P6|Period 2|Lost to Follow-up|0
2566571|NCT01314872|8878211|P5|Period 2|Lost to Follow-up|0
2566572|NCT01314872|8878212|P4|Period 2|Lost to Follow-up|0
2566573|NCT01314872|8878213|P3|Period 2|Lost to Follow-up|0
2566574|NCT01314872|8878214|P2|Period 2|Lost to Follow-up|0
2566575|NCT01314872|8878215|P1|Period 2|Lost to Follow-up|0
2566576|NCT01314872|8878201|P15|Period 2|Withdrawal by Subject|4
2566577|NCT01314872|8878202|P14|Period 2|Withdrawal by Subject|12
2566578|NCT01314872|8878203|P13|Period 2|Withdrawal by Subject|17
2566579|NCT01314872|8878204|P12|Period 2|Withdrawal by Subject|14
2566580|NCT01314872|8878205|P11|Period 2|Withdrawal by Subject|0
2566581|NCT01314872|8878206|P10|Period 2|Withdrawal by Subject|0
2566582|NCT01314872|8878207|P9|Period 2|Withdrawal by Subject|0
2566583|NCT01314872|8878208|P8|Period 2|Withdrawal by Subject|0
2566584|NCT01314872|8878209|P7|Period 2|Withdrawal by Subject|0
2566585|NCT01314872|8878210|P6|Period 2|Withdrawal by Subject|0
2566586|NCT01314872|8878211|P5|Period 2|Withdrawal by Subject|0
2566587|NCT01314872|8878212|P4|Period 2|Withdrawal by Subject|0
2566588|NCT01314872|8878213|P3|Period 2|Withdrawal by Subject|0
2566589|NCT01314872|8878214|P2|Period 2|Withdrawal by Subject|0
2566590|NCT01314872|8878215|P1|Period 2|Withdrawal by Subject|0
2566591|NCT01314872|8878201|P15|Period 2|Adverse event, non-fatal|9
2566592|NCT01314872|8878202|P14|Period 2|Adverse event, non-fatal|24
2566593|NCT01314872|8878203|P13|Period 2|Adverse event, non-fatal|16
2566594|NCT01314872|8878204|P12|Period 2|Adverse event, non-fatal|13
2566595|NCT01314872|8878205|P11|Period 2|Adverse event, non-fatal|0
2566596|NCT01314872|8878206|P10|Period 2|Adverse event, non-fatal|0
2566597|NCT01314872|8878207|P9|Period 2|Adverse event, non-fatal|0
2566598|NCT01314872|8878208|P8|Period 2|Adverse event, non-fatal|0
2566599|NCT01314872|8878209|P7|Period 2|Adverse event, non-fatal|0
2566600|NCT01314872|8878210|P6|Period 2|Adverse event, non-fatal|0
2566601|NCT01314872|8878211|P5|Period 2|Adverse event, non-fatal|0
2566602|NCT01314872|8878212|P4|Period 2|Adverse event, non-fatal|0
2566603|NCT01314872|8878213|P3|Period 2|Adverse event, non-fatal|0
2566604|NCT01314872|8878214|P2|Period 2|Adverse event, non-fatal|0
2566605|NCT01314872|8878215|P1|Period 2|Adverse event, non-fatal|0
2566606|NCT01314872|8878201|P15|Period 2|Study terminated by Sponsor|0
2566607|NCT01314872|8878202|P14|Period 2|Study terminated by Sponsor|3
2566608|NCT01314872|8878203|P13|Period 2|Study terminated by Sponsor|2
2566609|NCT01314872|8878204|P12|Period 2|Study terminated by Sponsor|2
2566610|NCT01314872|8878205|P11|Period 2|Study terminated by Sponsor|0
2566611|NCT01314872|8878206|P10|Period 2|Study terminated by Sponsor|0
2566612|NCT01314872|8878207|P9|Period 2|Study terminated by Sponsor|0
2566613|NCT01314872|8878208|P8|Period 2|Study terminated by Sponsor|0
2566614|NCT01314872|8878209|P7|Period 2|Study terminated by Sponsor|0
2566615|NCT01314872|8878210|P6|Period 2|Study terminated by Sponsor|0
2566616|NCT01314872|8878211|P5|Period 2|Study terminated by Sponsor|0
2566617|NCT01314872|8878212|P4|Period 2|Study terminated by Sponsor|0
2566618|NCT01314872|8878213|P3|Period 2|Study terminated by Sponsor|0
2566619|NCT01314872|8878214|P2|Period 2|Study terminated by Sponsor|0
2566620|NCT01314872|8878215|P1|Period 2|Study terminated by Sponsor|0
2566621|NCT01314872|8878201|P15|Period 2|Pregnancy|1
2566622|NCT01314872|8878202|P14|Period 2|Pregnancy|0
2566623|NCT01314872|8878203|P13|Period 2|Pregnancy|0
2566624|NCT01314872|8878204|P12|Period 2|Pregnancy|0
2566625|NCT01314872|8878205|P11|Period 2|Pregnancy|0
2566626|NCT01314872|8878206|P10|Period 2|Pregnancy|0
2566627|NCT01314872|8878207|P9|Period 2|Pregnancy|0
2566628|NCT01314872|8878208|P8|Period 2|Pregnancy|0
2566629|NCT01314872|8878209|P7|Period 2|Pregnancy|0
2566630|NCT01314872|8878210|P6|Period 2|Pregnancy|0
2566631|NCT01314872|8878211|P5|Period 2|Pregnancy|0
2566632|NCT01314872|8878212|P4|Period 2|Pregnancy|0
2566633|NCT01314872|8878213|P3|Period 2|Pregnancy|0
2566634|NCT01314872|8878214|P2|Period 2|Pregnancy|0
2566635|NCT01314872|8878215|P1|Period 2|Pregnancy|0
2566636|NCT01314872|8878201|P15|Period 2|Lack of Efficacy|2
2566637|NCT01314872|8878202|P14|Period 2|Lack of Efficacy|9
2566638|NCT01314872|8878203|P13|Period 2|Lack of Efficacy|12
2566639|NCT01314872|8878204|P12|Period 2|Lack of Efficacy|7
2566640|NCT01314872|8878205|P11|Period 2|Lack of Efficacy|0
2566641|NCT01314872|8878206|P10|Period 2|Lack of Efficacy|0
2566642|NCT01314872|8878207|P9|Period 2|Lack of Efficacy|0
2566643|NCT01314872|8878208|P8|Period 2|Lack of Efficacy|0
2566644|NCT01314872|8878209|P7|Period 2|Lack of Efficacy|0
2566645|NCT01314872|8878210|P6|Period 2|Lack of Efficacy|0
2566646|NCT01314872|8878211|P5|Period 2|Lack of Efficacy|0
2566647|NCT01314872|8878212|P4|Period 2|Lack of Efficacy|0
2566648|NCT01314872|8878213|P3|Period 2|Lack of Efficacy|0
2566649|NCT01314872|8878214|P2|Period 2|Lack of Efficacy|0
2566650|NCT01314872|8878215|P1|Period 2|Lack of Efficacy|0
2566651|NCT01314872|8878201|P15|Period 2|Non-compliance with study drug|2
2566652|NCT01314872|8878202|P14|Period 2|Non-compliance with study drug|1
2566653|NCT01314872|8878203|P13|Period 2|Non-compliance with study drug|3
2566654|NCT01314872|8878204|P12|Period 2|Non-compliance with study drug|3
2566655|NCT01314872|8878205|P11|Period 2|Non-compliance with study drug|0
2566656|NCT01314872|8878206|P10|Period 2|Non-compliance with study drug|0
2566657|NCT01314872|8878207|P9|Period 2|Non-compliance with study drug|0
2566658|NCT01314872|8878208|P8|Period 2|Non-compliance with study drug|0
2566659|NCT01314872|8878209|P7|Period 2|Non-compliance with study drug|0
2566660|NCT01314872|8878210|P6|Period 2|Non-compliance with study drug|0
2566661|NCT01314872|8878211|P5|Period 2|Non-compliance with study drug|0
2566662|NCT01314872|8878212|P4|Period 2|Non-compliance with study drug|0
2566663|NCT01314872|8878213|P3|Period 2|Non-compliance with study drug|0
2566664|NCT01314872|8878214|P2|Period 2|Non-compliance with study drug|0
2566665|NCT01314872|8878215|P1|Period 2|Non-compliance with study drug|0
2566666|NCT01314872|8878201|P15|Period 2|Protocol Violation|0
2566667|NCT01314872|8878202|P14|Period 2|Protocol Violation|2
2566668|NCT01314872|8878203|P13|Period 2|Protocol Violation|3
2566669|NCT01314872|8878204|P12|Period 2|Protocol Violation|3
2566670|NCT01314872|8878205|P11|Period 2|Protocol Violation|0
2566671|NCT01314872|8878206|P10|Period 2|Protocol Violation|0
2566672|NCT01314872|8878207|P9|Period 2|Protocol Violation|0
2566673|NCT01314872|8878208|P8|Period 2|Protocol Violation|0
2566674|NCT01314872|8878209|P7|Period 2|Protocol Violation|0
2566675|NCT01314872|8878210|P6|Period 2|Protocol Violation|0
2566676|NCT01314872|8878211|P5|Period 2|Protocol Violation|0
2566677|NCT01314872|8878212|P4|Period 2|Protocol Violation|0
2566678|NCT01314872|8878213|P3|Period 2|Protocol Violation|0
2566679|NCT01314872|8878214|P2|Period 2|Protocol Violation|0
2566680|NCT01314872|8878215|P1|Period 2|Protocol Violation|0
2566681|NCT01314872|8878201|P15|Treatment Period 1|Lost to Follow-up|0
2566682|NCT01314872|8878202|P14|Treatment Period 1|Lost to Follow-up|0
2566683|NCT01314872|8878203|P13|Treatment Period 1|Lost to Follow-up|0
2566684|NCT01314872|8878204|P12|Treatment Period 1|Lost to Follow-up|0
2566685|NCT01314872|8878205|P11|Treatment Period 1|Lost to Follow-up|0
2566686|NCT01314872|8878206|P10|Treatment Period 1|Lost to Follow-up|0
2566687|NCT01314872|8878207|P9|Treatment Period 1|Lost to Follow-up|1
2566688|NCT01314872|8878208|P8|Treatment Period 1|Lost to Follow-up|1
2566689|NCT01314872|8878209|P7|Treatment Period 1|Lost to Follow-up|1
2566690|NCT01314872|8878210|P6|Treatment Period 1|Lost to Follow-up|1
2566691|NCT01314872|8878211|P5|Treatment Period 1|Lost to Follow-up|1
2566692|NCT01314872|8878212|P4|Treatment Period 1|Lost to Follow-up|2
2566693|NCT01314872|8878213|P3|Treatment Period 1|Lost to Follow-up|2
2566694|NCT01314872|8878214|P2|Treatment Period 1|Lost to Follow-up|1
2566695|NCT01314872|8878215|P1|Treatment Period 1|Lost to Follow-up|0
2566696|NCT01314872|8878201|P15|Treatment Period 1|Withdrawal by Subject|0
2566697|NCT01314872|8878202|P14|Treatment Period 1|Withdrawal by Subject|0
2566698|NCT01314872|8878203|P13|Treatment Period 1|Withdrawal by Subject|0
2566699|NCT01314872|8878204|P12|Treatment Period 1|Withdrawal by Subject|0
2566700|NCT01314872|8878205|P11|Treatment Period 1|Withdrawal by Subject|1
2566701|NCT01314872|8878206|P10|Treatment Period 1|Withdrawal by Subject|2
2566702|NCT01314872|8878207|P9|Treatment Period 1|Withdrawal by Subject|2
2566703|NCT01314872|8878208|P8|Treatment Period 1|Withdrawal by Subject|2
2566704|NCT01314872|8878209|P7|Treatment Period 1|Withdrawal by Subject|3
2566705|NCT01314872|8878210|P6|Treatment Period 1|Withdrawal by Subject|1
2566706|NCT01314872|8878211|P5|Treatment Period 1|Withdrawal by Subject|3
2566707|NCT01314872|8878212|P4|Treatment Period 1|Withdrawal by Subject|2
2566708|NCT01314872|8878213|P3|Treatment Period 1|Withdrawal by Subject|0
2566709|NCT01314872|8878214|P2|Treatment Period 1|Withdrawal by Subject|1
2566710|NCT01314872|8878215|P1|Treatment Period 1|Withdrawal by Subject|3
2566711|NCT01314872|8878201|P15|Treatment Period 1|Adverse event, non-fatal|0
2566712|NCT01314872|8878202|P14|Treatment Period 1|Adverse event, non-fatal|0
2566713|NCT01314872|8878203|P13|Treatment Period 1|Adverse event, non-fatal|0
2566714|NCT01314872|8878204|P12|Treatment Period 1|Adverse event, non-fatal|0
2566715|NCT01314872|8878205|P11|Treatment Period 1|Adverse event, non-fatal|1
2566716|NCT01314872|8878206|P10|Treatment Period 1|Adverse event, non-fatal|0
2566717|NCT01314872|8878207|P9|Treatment Period 1|Adverse event, non-fatal|3
2566718|NCT01314872|8878208|P8|Treatment Period 1|Adverse event, non-fatal|2
2566719|NCT01314872|8878209|P7|Treatment Period 1|Adverse event, non-fatal|4
2566720|NCT01314872|8878210|P6|Treatment Period 1|Adverse event, non-fatal|4
2566721|NCT01314872|8878211|P5|Treatment Period 1|Adverse event, non-fatal|2
2566722|NCT01314872|8878212|P4|Treatment Period 1|Adverse event, non-fatal|2
2566723|NCT01314872|8878213|P3|Treatment Period 1|Adverse event, non-fatal|3
2566724|NCT01314872|8878214|P2|Treatment Period 1|Adverse event, non-fatal|2
2566725|NCT01314872|8878215|P1|Treatment Period 1|Adverse event, non-fatal|4
2566726|NCT01314872|8878201|P15|Treatment Period 1|Lack of Efficacy|0
2566727|NCT01314872|8878202|P14|Treatment Period 1|Lack of Efficacy|0
2566728|NCT01314872|8878203|P13|Treatment Period 1|Lack of Efficacy|0
2566729|NCT01314872|8878204|P12|Treatment Period 1|Lack of Efficacy|0
2566730|NCT01314872|8878205|P11|Treatment Period 1|Lack of Efficacy|0
2566731|NCT01314872|8878206|P10|Treatment Period 1|Lack of Efficacy|0
2566732|NCT01314872|8878207|P9|Treatment Period 1|Lack of Efficacy|0
2566733|NCT01314872|8878208|P8|Treatment Period 1|Lack of Efficacy|2
2566734|NCT01314872|8878209|P7|Treatment Period 1|Lack of Efficacy|0
2566735|NCT01314872|8878210|P6|Treatment Period 1|Lack of Efficacy|1
2566736|NCT01314872|8878211|P5|Treatment Period 1|Lack of Efficacy|0
2566737|NCT01314872|8878212|P4|Treatment Period 1|Lack of Efficacy|0
2566738|NCT01314872|8878213|P3|Treatment Period 1|Lack of Efficacy|0
2566739|NCT01314872|8878214|P2|Treatment Period 1|Lack of Efficacy|0
2566740|NCT01314872|8878215|P1|Treatment Period 1|Lack of Efficacy|1
2566741|NCT01314872|8878201|P15|Treatment Period 1|Physician Decision|0
2566742|NCT01314872|8878202|P14|Treatment Period 1|Physician Decision|0
2566743|NCT01314872|8878203|P13|Treatment Period 1|Physician Decision|0
2566744|NCT01314872|8878204|P12|Treatment Period 1|Physician Decision|0
2566745|NCT01314872|8878205|P11|Treatment Period 1|Physician Decision|0
2566746|NCT01314872|8878206|P10|Treatment Period 1|Physician Decision|1
2566747|NCT01314872|8878207|P9|Treatment Period 1|Physician Decision|0
2566748|NCT01314872|8878208|P8|Treatment Period 1|Physician Decision|0
2566749|NCT01314872|8878209|P7|Treatment Period 1|Physician Decision|0
2566750|NCT01314872|8878210|P6|Treatment Period 1|Physician Decision|0
2566751|NCT01314872|8878211|P5|Treatment Period 1|Physician Decision|0
2566752|NCT01314872|8878212|P4|Treatment Period 1|Physician Decision|1
2566753|NCT01314872|8878213|P3|Treatment Period 1|Physician Decision|0
2566754|NCT01314872|8878214|P2|Treatment Period 1|Physician Decision|1
2566755|NCT01314872|8878215|P1|Treatment Period 1|Physician Decision|0
2566756|NCT01314872|8878201|P15|Treatment Period 1|Protocol Violation|0
2566757|NCT01314872|8878202|P14|Treatment Period 1|Protocol Violation|0
2566758|NCT01314872|8878203|P13|Treatment Period 1|Protocol Violation|0
2566759|NCT01314872|8878204|P12|Treatment Period 1|Protocol Violation|0
2566760|NCT01314872|8878205|P11|Treatment Period 1|Protocol Violation|1
2566761|NCT01314872|8878206|P10|Treatment Period 1|Protocol Violation|1
2566762|NCT01314872|8878207|P9|Treatment Period 1|Protocol Violation|0
2566763|NCT01314872|8878208|P8|Treatment Period 1|Protocol Violation|0
2566764|NCT01314872|8878209|P7|Treatment Period 1|Protocol Violation|0
2566765|NCT01314872|8878210|P6|Treatment Period 1|Protocol Violation|0
2566766|NCT01314872|8878211|P5|Treatment Period 1|Protocol Violation|1
2566767|NCT01314872|8878212|P4|Treatment Period 1|Protocol Violation|0
2566768|NCT01314872|8878213|P3|Treatment Period 1|Protocol Violation|1
2566769|NCT01314872|8878214|P2|Treatment Period 1|Protocol Violation|1
2566770|NCT01314872|8878215|P1|Treatment Period 1|Protocol Violation|2
2566771|NCT01314716|8878319|P2|Open-Label Phase|Physician Decision|4
2566772|NCT01314716|8878320|P1|Open-Label Phase|Physician Decision|5
2566773|NCT01314716|8878319|P2|Open-Label Phase|Withdrawal by Subject|2
2566774|NCT01314716|8878320|P1|Open-Label Phase|Withdrawal by Subject|1
2566775|NCT01314716|8878319|P2|Open-Label Phase|Adverse Event|6
2566776|NCT01314716|8878320|P1|Open-Label Phase|Adverse Event|4
2566777|NCT01314716|8878319|P2|Double-Blind Phase|Physician Decision|1
2566778|NCT01314716|8878320|P1|Double-Blind Phase|Physician Decision|0
2566779|NCT01314716|8878319|P2|Double-Blind Phase|Sponsor request|2
2566780|NCT01314716|8878320|P1|Double-Blind Phase|Sponsor request|1
2566781|NCT01314716|8878319|P2|Double-Blind Phase|Lost to Follow-up|1
2566782|NCT01314716|8878320|P1|Double-Blind Phase|Lost to Follow-up|0
2566783|NCT01314716|8878319|P2|Double-Blind Phase|Withdrawal by Subject|6
2566784|NCT01314716|8878320|P1|Double-Blind Phase|Withdrawal by Subject|5
2566785|NCT01314716|8878319|P2|Double-Blind Phase|Adverse Event|4
2566786|NCT01314716|8878320|P1|Double-Blind Phase|Adverse Event|10
2566787|NCT01314716|8878319|P2|Double-Blind Phase|Randomized but not treated|1
2566788|NCT01314716|8878320|P1|Double-Blind Phase|Randomized but not treated|1
2566789|NCT01314703|8878332|P1|Overall Study|screen failure and closed enrollment|8
2566790|NCT01314443|8878341|P4|Overall Study|Protocol Violation|1
2566791|NCT01314443|8878342|P3|Overall Study|Protocol Violation|1
2566792|NCT01314443|8878343|P2|Overall Study|Protocol Violation|2
2566793|NCT01314443|8878344|P1|Overall Study|Protocol Violation|2
2566794|NCT01314443|8878341|P4|Overall Study|Withdrawal by Subject|1
2566795|NCT01314443|8878342|P3|Overall Study|Withdrawal by Subject|1
2566796|NCT01314443|8878343|P2|Overall Study|Withdrawal by Subject|1
2566797|NCT01314443|8878344|P1|Overall Study|Withdrawal by Subject|2
2566798|NCT01314261|8878414|P4|Overall Study|Virologic Failure|1
2566799|NCT01314261|8878415|P3|Overall Study|Virologic Failure|0
2566800|NCT01314261|8878416|P2|Overall Study|Virologic Failure|1
2566801|NCT01314261|8878417|P1|Overall Study|Virologic Failure|0
2566802|NCT01314261|8878414|P4|Overall Study|Lost to Follow-up|2
2566803|NCT01314261|8878415|P3|Overall Study|Lost to Follow-up|2
2566804|NCT01314261|8878416|P2|Overall Study|Lost to Follow-up|0
2566805|NCT01314261|8878417|P1|Overall Study|Lost to Follow-up|1
2566806|NCT01314261|8878414|P4|Overall Study|Withdrawal by Subject|0
2566807|NCT01314261|8878415|P3|Overall Study|Withdrawal by Subject|1
2566808|NCT01314261|8878416|P2|Overall Study|Withdrawal by Subject|3
2566809|NCT01314261|8878417|P1|Overall Study|Withdrawal by Subject|0
2566810|NCT01314261|8878414|P4|Overall Study|Adverse Event|0
2566811|NCT01314261|8878415|P3|Overall Study|Adverse Event|0
2566812|NCT01314261|8878416|P2|Overall Study|Adverse Event|0
2566813|NCT01314261|8878417|P1|Overall Study|Adverse Event|1
2566814|NCT01314118|8878468|P1|Overall Study|Ongoing|62
2566815|NCT01314118|8878468|P1|Overall Study|Other|2
2566816|NCT01314118|8878468|P1|Overall Study|Withdrawal by Subject|11
2566817|NCT01314118|8878468|P1|Overall Study|Protocol Violation|5
2566818|NCT01314118|8878468|P1|Overall Study|Death|4
2566819|NCT01314118|8878468|P1|Overall Study|Physician Decision|11
2566820|NCT01314118|8878468|P1|Overall Study|Progressive disease|27
2566821|NCT01314118|8878468|P1|Overall Study|Adverse Event|9
2566822|NCT01314105|8878477|P2|Overall Study|Other Adverse Event|1
2566823|NCT01314105|8878478|P1|Overall Study|Other Adverse Event|1
2566824|NCT01314105|8878477|P2|Overall Study|Refused to continue taking medication|1
2566825|NCT01314105|8878478|P1|Overall Study|Refused to continue taking medication|0
2566826|NCT01314105|8878477|P2|Overall Study|Progressive Disease|10
2566827|NCT01314105|8878478|P1|Overall Study|Progressive Disease|6
2566828|NCT01313923|8878596|P1|Overall Study|Physician Decision|3
2566829|NCT01313884|8878612|P1|Overall Study|Per insurance pvdr, pt can't be on cl tr|1
2566830|NCT01313858|8878620|P3|Overall Study|Lost to Follow-up|47
2566831|NCT01313858|8878621|P2|Overall Study|Lost to Follow-up|51
2566832|NCT01313858|8878622|P1|Overall Study|Lost to Follow-up|35
2566833|NCT01313858|8878620|P3|Overall Study|Premature Treatment Termination|191
2566834|NCT01313858|8878621|P2|Overall Study|Premature Treatment Termination|219
2566835|NCT01313858|8878622|P1|Overall Study|Premature Treatment Termination|251
2566836|NCT01313780|8878645|P2|Overall Study|missing data|3
2566837|NCT01313780|8878646|P1|Overall Study|missing data|3
2566838|NCT01313780|8878645|P2|Overall Study|Protocol Violation|4
2566839|NCT01313780|8878646|P1|Overall Study|Protocol Violation|10
2566840|NCT01313780|8878645|P2|Overall Study|Withdrawal by Subject|8
2566841|NCT01313780|8878646|P1|Overall Study|Withdrawal by Subject|2
2566842|NCT01313780|8878645|P2|Overall Study|Adverse Event|11
2566843|NCT01313780|8878646|P1|Overall Study|Adverse Event|6
2566844|NCT01313780|8878645|P2|Overall Study|Lack of Efficacy|2
2566845|NCT01313780|8878646|P1|Overall Study|Lack of Efficacy|4
2566846|NCT01313767|8878656|P2|Overall Study|Protocol Violation|1
2566847|NCT01313767|8878657|P1|Overall Study|Protocol Violation|3
2566848|NCT01313767|8878656|P2|Overall Study|Withdrawal by Subject|1
2566849|NCT01313767|8878657|P1|Overall Study|Withdrawal by Subject|2
2566850|NCT01313767|8878656|P2|Overall Study|Lost to Follow-up|0
2566851|NCT01313767|8878657|P1|Overall Study|Lost to Follow-up|1
2566852|NCT01313767|8878656|P2|Overall Study|Adverse Event|0
2566853|NCT01313767|8878657|P1|Overall Study|Adverse Event|1
2566854|NCT01313728|8878699|P1|Informed Consent to Baseline|Withdrawal by Subject|1
2566855|NCT01313689|8878719|P5|24-Week Randomization 2|Physician Decision|4
2566856|NCT01313689|8878720|P4|24-Week Randomization 2|Physician Decision|0
2566857|NCT01313689|8878721|P3|24-Week Randomization 2|Physician Decision|0
2566858|NCT01313689|8878722|P2|24-Week Randomization 2|Physician Decision|0
2566859|NCT01313689|8878723|P1|24-Week Randomization 2|Physician Decision|0
2566860|NCT01313689|8878719|P5|24-Week Randomization 2|Withdrawal by Subject|3
2566861|NCT01313689|8878720|P4|24-Week Randomization 2|Withdrawal by Subject|1
2566862|NCT01313689|8878721|P3|24-Week Randomization 2|Withdrawal by Subject|1
2566863|NCT01313689|8878722|P2|24-Week Randomization 2|Withdrawal by Subject|0
2566864|NCT01313689|8878723|P1|24-Week Randomization 2|Withdrawal by Subject|0
2566865|NCT01313689|8878719|P5|24-Week Randomization 2|Adverse Event|8
2566866|NCT01313689|8878720|P4|24-Week Randomization 2|Adverse Event|0
2566867|NCT01313689|8878721|P3|24-Week Randomization 2|Adverse Event|2
2566868|NCT01313689|8878722|P2|24-Week Randomization 2|Adverse Event|0
2566869|NCT01313689|8878723|P1|24-Week Randomization 2|Adverse Event|0
2566870|NCT01313689|8878719|P5|24-Week Randomization 1|Withdrawal by Subject|0
2566871|NCT01313689|8878720|P4|24-Week Randomization 1|Withdrawal by Subject|0
2566872|NCT01313689|8878721|P3|24-Week Randomization 1|Withdrawal by Subject|0
2566873|NCT01313689|8878722|P2|24-Week Randomization 1|Withdrawal by Subject|0
2566874|NCT01313689|8878723|P1|24-Week Randomization 1|Withdrawal by Subject|5
2566875|NCT01313689|8878719|P5|24-Week Randomization 1|Physician Decision|0
2566876|NCT01313689|8878720|P4|24-Week Randomization 1|Physician Decision|0
2566877|NCT01313689|8878721|P3|24-Week Randomization 1|Physician Decision|0
2566878|NCT01313689|8878722|P2|24-Week Randomization 1|Physician Decision|5
2566879|NCT01313689|8878723|P1|24-Week Randomization 1|Physician Decision|4
2566880|NCT01313689|8878719|P5|24-Week Randomization 1|Adverse Event|0
2566881|NCT01313689|8878720|P4|24-Week Randomization 1|Adverse Event|0
2566882|NCT01313689|8878721|P3|24-Week Randomization 1|Adverse Event|0
2566883|NCT01313689|8878722|P2|24-Week Randomization 1|Adverse Event|5
2566884|NCT01313689|8878723|P1|24-Week Randomization 1|Adverse Event|10
2566885|NCT01313676|8878802|P4|Overall Study|Missing|0
2566886|NCT01313676|8878803|P3|Overall Study|Missing|1
2566887|NCT01313676|8878804|P2|Overall Study|Missing|1
2566888|NCT01313676|8878805|P1|Overall Study|Missing|1
2566889|NCT01313676|8878802|P4|Overall Study|Investigator Site Closed|10
2566890|NCT01313676|8878803|P3|Overall Study|Investigator Site Closed|15
2566891|NCT01313676|8878804|P2|Overall Study|Investigator Site Closed|11
2566892|NCT01313676|8878805|P1|Overall Study|Investigator Site Closed|12
2566893|NCT01313676|8878802|P4|Overall Study|Sponsor Terminated Study Treatment|1
2566894|NCT01313676|8878803|P3|Overall Study|Sponsor Terminated Study Treatment|0
2566895|NCT01313676|8878804|P2|Overall Study|Sponsor Terminated Study Treatment|1
2566896|NCT01313676|8878805|P1|Overall Study|Sponsor Terminated Study Treatment|1
2566897|NCT01313676|8878802|P4|Overall Study|Decision by Participant or Proxy|492
2566898|NCT01313676|8878803|P3|Overall Study|Decision by Participant or Proxy|515
2566899|NCT01313676|8878804|P2|Overall Study|Decision by Participant or Proxy|527
2566900|NCT01313676|8878805|P1|Overall Study|Decision by Participant or Proxy|643
2566901|NCT01313676|8878802|P4|Overall Study|Physician Decision|48
2566902|NCT01313676|8878803|P3|Overall Study|Physician Decision|62
2566903|NCT01313676|8878804|P2|Overall Study|Physician Decision|64
2566904|NCT01313676|8878805|P1|Overall Study|Physician Decision|53
2566905|NCT01313676|8878802|P4|Overall Study|Lost to Follow-up|0
2566906|NCT01313676|8878803|P3|Overall Study|Lost to Follow-up|1
2566907|NCT01313676|8878804|P2|Overall Study|Lost to Follow-up|0
2566908|NCT01313676|8878805|P1|Overall Study|Lost to Follow-up|0
2566909|NCT01313676|8878802|P4|Overall Study|Study Closed/terminated|9
2566910|NCT01313676|8878803|P3|Overall Study|Study Closed/terminated|9
2566911|NCT01313676|8878804|P2|Overall Study|Study Closed/terminated|6
2566912|NCT01313676|8878805|P1|Overall Study|Study Closed/terminated|7
2566913|NCT01313676|8878802|P4|Overall Study|Met Protocol-Defined Stopping Critera|11
2566914|NCT01313676|8878803|P3|Overall Study|Met Protocol-Defined Stopping Critera|2
2566915|NCT01313676|8878804|P2|Overall Study|Met Protocol-Defined Stopping Critera|4
2566916|NCT01313676|8878805|P1|Overall Study|Met Protocol-Defined Stopping Critera|3
2566917|NCT01313676|8878802|P4|Overall Study|Protocol Violation|44
2566918|NCT01313676|8878803|P3|Overall Study|Protocol Violation|46
2566919|NCT01313676|8878804|P2|Overall Study|Protocol Violation|44
2566920|NCT01313676|8878805|P1|Overall Study|Protocol Violation|37
2566921|NCT01313676|8878802|P4|Overall Study|Lack of Efficacy|46
2566922|NCT01313676|8878803|P3|Overall Study|Lack of Efficacy|65
2566923|NCT01313676|8878804|P2|Overall Study|Lack of Efficacy|90
2566924|NCT01313676|8878805|P1|Overall Study|Lack of Efficacy|98
2566925|NCT01313676|8878802|P4|Overall Study|Adverse Event|333
2566926|NCT01313676|8878803|P3|Overall Study|Adverse Event|372
2566927|NCT01313676|8878804|P2|Overall Study|Adverse Event|365
2566928|NCT01313676|8878805|P1|Overall Study|Adverse Event|395
2566929|NCT01313663|8878825|P2|Overall Study|Withdrawal by Subject|1
2566930|NCT01313663|8878826|P1|Overall Study|Withdrawal by Subject|2
2566931|NCT01313663|8878825|P2|Overall Study|Physician Decision|2
2566932|NCT01313663|8878826|P1|Overall Study|Physician Decision|0
2566933|NCT01313663|8878825|P2|Overall Study|Lost to Follow-up|1
2566934|NCT01313663|8878826|P1|Overall Study|Lost to Follow-up|0
2566935|NCT01313663|8878825|P2|Overall Study|Study Closed/Terminated|4
2566936|NCT01313663|8878826|P1|Overall Study|Study Closed/Terminated|2
2566937|NCT01313650|8878864|P4|Overall Study|Met Protocol-defined Stopping Criteria|15
2566938|NCT01313650|8878865|P3|Overall Study|Met Protocol-defined Stopping Criteria|24
2566939|NCT01313650|8878866|P2|Overall Study|Met Protocol-defined Stopping Criteria|13
2566940|NCT01313650|8878867|P1|Overall Study|Met Protocol-defined Stopping Criteria|9
2566941|NCT01313650|8878864|P4|Overall Study|Protocol Violation|6
2566942|NCT01313650|8878865|P3|Overall Study|Protocol Violation|5
2566943|NCT01313650|8878866|P2|Overall Study|Protocol Violation|7
2566944|NCT01313650|8878867|P1|Overall Study|Protocol Violation|4
2566945|NCT01313650|8878864|P4|Overall Study|Withdrawal by Subject|15
2566946|NCT01313650|8878865|P3|Overall Study|Withdrawal by Subject|15
2566947|NCT01313650|8878866|P2|Overall Study|Withdrawal by Subject|20
2566948|NCT01313650|8878867|P1|Overall Study|Withdrawal by Subject|16
2566949|NCT01313650|8878864|P4|Overall Study|Lost to Follow-up|2
2566950|NCT01313650|8878865|P3|Overall Study|Lost to Follow-up|3
2566951|NCT01313650|8878866|P2|Overall Study|Lost to Follow-up|0
2566952|NCT01313650|8878867|P1|Overall Study|Lost to Follow-up|1
2566953|NCT01313650|8878864|P4|Overall Study|Lack of Efficacy|20
2566954|NCT01313650|8878865|P3|Overall Study|Lack of Efficacy|32
2566955|NCT01313650|8878866|P2|Overall Study|Lack of Efficacy|20
2566956|NCT01313650|8878867|P1|Overall Study|Lack of Efficacy|37
2566957|NCT01313650|8878864|P4|Overall Study|Adverse Event|23
2566958|NCT01313650|8878865|P3|Overall Study|Adverse Event|24
2566959|NCT01313650|8878866|P2|Overall Study|Adverse Event|34
2566960|NCT01313650|8878867|P1|Overall Study|Adverse Event|9
2566961|NCT01313637|8878893|P4|Overall Study|Withdrawal by Subject|15
2566962|NCT01313637|8878894|P3|Overall Study|Withdrawal by Subject|18
2566963|NCT01313637|8878895|P2|Overall Study|Withdrawal by Subject|13
2566964|NCT01313637|8878896|P1|Overall Study|Withdrawal by Subject|11
2566965|NCT01313637|8878893|P4|Overall Study|Lost to Follow-up|3
2566966|NCT01313637|8878894|P3|Overall Study|Lost to Follow-up|1
2566967|NCT01313637|8878895|P2|Overall Study|Lost to Follow-up|2
2566968|NCT01313637|8878896|P1|Overall Study|Lost to Follow-up|0
2566969|NCT01313637|8878893|P4|Overall Study|Met Protocol- Defined Stopping Criteria|13
2566970|NCT01313637|8878894|P3|Overall Study|Met Protocol- Defined Stopping Criteria|14
2566971|NCT01313637|8878895|P2|Overall Study|Met Protocol- Defined Stopping Criteria|15
2566972|NCT01313637|8878896|P1|Overall Study|Met Protocol- Defined Stopping Criteria|16
2566973|NCT01313637|8878893|P4|Overall Study|Protocol Violation|5
2566974|NCT01313637|8878894|P3|Overall Study|Protocol Violation|11
2566975|NCT01313637|8878895|P2|Overall Study|Protocol Violation|3
2566976|NCT01313637|8878896|P1|Overall Study|Protocol Violation|4
2566977|NCT01313637|8878893|P4|Overall Study|Lack of Efficacy|24
2566978|NCT01313637|8878894|P3|Overall Study|Lack of Efficacy|37
2566979|NCT01313637|8878895|P2|Overall Study|Lack of Efficacy|38
2566980|NCT01313637|8878896|P1|Overall Study|Lack of Efficacy|44
2566981|NCT01313637|8878893|P4|Overall Study|Adverse Event|18
2566982|NCT01313637|8878894|P3|Overall Study|Adverse Event|25
2566983|NCT01313637|8878895|P2|Overall Study|Adverse Event|24
2566984|NCT01313637|8878896|P1|Overall Study|Adverse Event|17
2566985|NCT01313624|8878920|P2|Open-Label Phase|Lost to Follow-up|1
2566986|NCT01313624|8878921|P1|Open-Label Phase|Lost to Follow-up|1
2566987|NCT01313624|8878920|P2|Open-Label Phase|Withdrawal by Subject|2
2566988|NCT01313624|8878921|P1|Open-Label Phase|Withdrawal by Subject|2
2566989|NCT01313624|8878920|P2|Open-Label Phase|Adverse Event|10
2566990|NCT01313624|8878921|P1|Open-Label Phase|Adverse Event|1
2566991|NCT01313624|8878920|P2|Double-Blind Phase|Lack of Efficacy|0
2566992|NCT01313624|8878921|P1|Double-Blind Phase|Lack of Efficacy|1
2566993|NCT01313624|8878920|P2|Double-Blind Phase|Physician Decision|0
2566994|NCT01313624|8878921|P1|Double-Blind Phase|Physician Decision|1
2566995|NCT01313624|8878920|P2|Double-Blind Phase|Lost to Follow-up|2
2566996|NCT01313624|8878921|P1|Double-Blind Phase|Lost to Follow-up|0
2566997|NCT01313624|8878920|P2|Double-Blind Phase|Withdrawal by Subject|4
2566998|NCT01313624|8878921|P1|Double-Blind Phase|Withdrawal by Subject|9
2566999|NCT01313624|8878920|P2|Double-Blind Phase|Adverse Event|4
2567000|NCT01313624|8878921|P1|Double-Blind Phase|Adverse Event|27
2567001|NCT01313559|8878935|P2|Overall Study|Rising PSA|0
2567002|NCT01313559|8878936|P1|Overall Study|Rising PSA|2
2567003|NCT01313559|8878935|P2|Overall Study|Disease progression|0
2567004|NCT01313559|8878936|P1|Overall Study|Disease progression|1
2567005|NCT01313559|8878935|P2|Overall Study|Withdrawal by Subject|2
2567006|NCT01313559|8878936|P1|Overall Study|Withdrawal by Subject|1
2567007|NCT01313312|8879037|P1|Overall Study|Did Not Receive Treatment with Dysport®|4
2567008|NCT01313312|8879037|P1|Overall Study|Subject Withdrawn Early in Error|4
2567009|NCT01313312|8879037|P1|Overall Study|Observational Phase|1
2567010|NCT01313312|8879037|P1|Overall Study|Investigator Decision|1
2567011|NCT01313312|8879037|P1|Overall Study|Lack of Efficacy|3
2567012|NCT01313312|8879037|P1|Overall Study|Withdrawal by Subject|18
2567013|NCT01313312|8879037|P1|Overall Study|Adverse Event|5
2567014|NCT01313299|8879084|P3|Overall Study|Lack of subject compliance|1
2567015|NCT01313299|8879085|P2|Overall Study|Lack of subject compliance|0
2567016|NCT01313299|8879086|P1|Overall Study|Lack of subject compliance|0
2567017|NCT01313299|8879084|P3|Overall Study|Family reason and moved out of state|0
2567018|NCT01313299|8879085|P2|Overall Study|Family reason and moved out of state|2
2567019|NCT01313299|8879086|P1|Overall Study|Family reason and moved out of state|0
2567020|NCT01313299|8879084|P3|Overall Study|Withdrawal by Subject|2
2567021|NCT01313299|8879085|P2|Overall Study|Withdrawal by Subject|0
2567022|NCT01313299|8879086|P1|Overall Study|Withdrawal by Subject|1
2567023|NCT01313299|8879084|P3|Overall Study|Protocol Violation|0
2567024|NCT01313299|8879085|P2|Overall Study|Protocol Violation|0
2567025|NCT01313299|8879086|P1|Overall Study|Protocol Violation|2
2567026|NCT01313299|8879084|P3|Overall Study|Lost to Follow-up|0
2567027|NCT01313299|8879085|P2|Overall Study|Lost to Follow-up|0
2567028|NCT01313299|8879086|P1|Overall Study|Lost to Follow-up|1
2567029|NCT01313299|8879084|P3|Overall Study|Adverse Event|1
2567030|NCT01313299|8879085|P2|Overall Study|Adverse Event|1
2567031|NCT01313299|8879086|P1|Overall Study|Adverse Event|3
2567032|NCT01313286|8879100|P2|Period 1|Withdrawal by Subject|0
2567033|NCT01313286|8879101|P1|Period 1|Withdrawal by Subject|2
2567034|NCT01313273|8879111|P2|Overall Study|Screening Chromogranin A-in normal range|1
2567035|NCT01313273|8879112|P1|Overall Study|Screening Chromogranin A-in normal range|0
2567036|NCT01313273|8879111|P2|Overall Study|Withdrawal by Subject|0
2567037|NCT01313273|8879112|P1|Overall Study|Withdrawal by Subject|1
2567038|NCT01313273|8879111|P2|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0
2567039|NCT01313273|8879112|P1|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1
2567040|NCT01313221|8879127|P3|Overall Study|Pregnancy|2
2567041|NCT01313221|8879128|P2|Overall Study|Pregnancy|0
2567042|NCT01313221|8879129|P1|Overall Study|Pregnancy|0
2567043|NCT01313221|8879127|P3|Overall Study|Physician Decision|2
2567044|NCT01313221|8879128|P2|Overall Study|Physician Decision|0
2567045|NCT01313221|8879129|P1|Overall Study|Physician Decision|0
2567046|NCT01313221|8879127|P3|Overall Study|Disease progression|2
2567047|NCT01313221|8879128|P2|Overall Study|Disease progression|0
2567048|NCT01313221|8879129|P1|Overall Study|Disease progression|0
2567049|NCT01313221|8879127|P3|Overall Study|Adverse Event|7
2567050|NCT01313221|8879128|P2|Overall Study|Adverse Event|0
2567051|NCT01313221|8879129|P1|Overall Study|Adverse Event|0
2567052|NCT01313221|8879127|P3|Overall Study|Other|0
2567053|NCT01313221|8879128|P2|Overall Study|Other|0
2567054|NCT01313221|8879129|P1|Overall Study|Other|1
2567055|NCT01313221|8879127|P3|Overall Study|Lost to Follow-up|1
2567056|NCT01313221|8879128|P2|Overall Study|Lost to Follow-up|3
2567057|NCT01313221|8879129|P1|Overall Study|Lost to Follow-up|6
2567058|NCT01313221|8879127|P3|Overall Study|Requirement for alternative therapy|1
2567059|NCT01313221|8879128|P2|Overall Study|Requirement for alternative therapy|1
2567060|NCT01313221|8879129|P1|Overall Study|Requirement for alternative therapy|0
2567061|NCT01313221|8879127|P3|Overall Study|Withdrawal by Subject|5
2567062|NCT01313221|8879128|P2|Overall Study|Withdrawal by Subject|3
2567063|NCT01313221|8879129|P1|Overall Study|Withdrawal by Subject|2
2567064|NCT01313221|8879127|P3|Overall Study|Non-compliance|2
2567065|NCT01313221|8879128|P2|Overall Study|Non-compliance|0
2567066|NCT01313221|8879129|P1|Overall Study|Non-compliance|3
2567067|NCT01313221|8879127|P3|Overall Study|Protocol Violation|1
2567068|NCT01313221|8879128|P2|Overall Study|Protocol Violation|1
2567069|NCT01313221|8879129|P1|Overall Study|Protocol Violation|0
2567070|NCT01313208|8879181|P2|Open-label Phase (Weeks 13 - 24)|Other|0
2567071|NCT01313208|8879182|P1|Open-label Phase (Weeks 13 - 24)|Other|2
2567072|NCT01313208|8879181|P2|Open-label Phase (Weeks 13 - 24)|Adverse Event|0
2567073|NCT01313208|8879182|P1|Open-label Phase (Weeks 13 - 24)|Adverse Event|1
2567074|NCT01313208|8879181|P2|Open-label Phase (Weeks 13 - 24)|Noncompliance|2
2567075|NCT01313208|8879182|P1|Open-label Phase (Weeks 13 - 24)|Noncompliance|0
2567076|NCT01313208|8879181|P2|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1
2567077|NCT01313208|8879182|P1|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3
2567078|NCT01313208|8879181|P2|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0
2567079|NCT01313208|8879182|P1|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1
2567080|NCT01313208|8879181|P2|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0
2567081|NCT01313208|8879182|P1|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1
2567082|NCT01313208|8879181|P2|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1
2567083|NCT01313208|8879182|P1|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0
2567084|NCT01313208|8879181|P2|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2
2567085|NCT01313208|8879182|P1|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1
2567086|NCT01313208|8879181|P2|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2
2567087|NCT01313208|8879182|P1|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3
2567088|NCT01313182|8879272|P2|Overall Study|Protocol Violation|92
2567089|NCT01313182|8879273|P1|Overall Study|Protocol Violation|66
2567090|NCT01313117|8879285|P1|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
2567091|NCT01313117|8879285|P1|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
2567092|NCT01313078|8879292|P1|Overall Study|Withdrawal by Subject|1
2567093|NCT01313078|8879292|P1|Overall Study|Discontinued study drug|1
2567094|NCT01313078|8879292|P1|Overall Study|Death|1
2567095|NCT01313039|8879297|P1|Overall Study|Adverse Event|1
2567096|NCT01313039|8879297|P1|Overall Study|Physician Decision|1
2567097|NCT01312961|8879303|P2|Overall Study|Other than specified above|3
2567098|NCT01312961|8879304|P1|Overall Study|Other than specified above|2
2567099|NCT01312961|8879303|P2|Overall Study|Poor compliance to protocol|0
2567100|NCT01312961|8879304|P1|Overall Study|Poor compliance to protocol|1
2567101|NCT01312961|8879303|P2|Overall Study|Lack of Efficacy|1
2567102|NCT01312961|8879304|P1|Overall Study|Lack of Efficacy|11
2567103|NCT01312961|8879303|P2|Overall Study|Adverse Event|3
2567104|NCT01312961|8879304|P1|Overall Study|Adverse Event|3
2567105|NCT01312909|8879340|P3|Overall Study|Entrance criteria not met|2
2567106|NCT01312909|8879341|P2|Overall Study|Entrance criteria not met|0
2567107|NCT01312909|8879342|P1|Overall Study|Entrance criteria not met|0
2567108|NCT01312909|8879340|P3|Overall Study|Insufficient clinical response|1
2567109|NCT01312909|8879341|P2|Overall Study|Insufficient clinical response|0
2567110|NCT01312909|8879342|P1|Overall Study|Insufficient clinical response|0
2567111|NCT01312909|8879340|P3|Overall Study|Lost to Follow-up|20
2567112|NCT01312909|8879341|P2|Overall Study|Lost to Follow-up|17
2567113|NCT01312909|8879342|P1|Overall Study|Lost to Follow-up|21
2567114|NCT01312909|8879340|P3|Overall Study|Withdrawal by Subject|7
2567115|NCT01312909|8879341|P2|Overall Study|Withdrawal by Subject|10
2567116|NCT01312909|8879342|P1|Overall Study|Withdrawal by Subject|8
2567117|NCT01312909|8879340|P3|Overall Study|Other|11
2567118|NCT01312909|8879341|P2|Overall Study|Other|6
2567119|NCT01312909|8879342|P1|Overall Study|Other|9
2567120|NCT01312909|8879340|P3|Overall Study|Protocol Violation|2
2567121|NCT01312909|8879341|P2|Overall Study|Protocol Violation|0
2567122|NCT01312909|8879342|P1|Overall Study|Protocol Violation|2
2567123|NCT01312909|8879340|P3|Overall Study|Adverse Event|3
2567124|NCT01312909|8879341|P2|Overall Study|Adverse Event|0
2567125|NCT01312909|8879342|P1|Overall Study|Adverse Event|1
2567126|NCT01312909|8879340|P3|Overall Study|Randomized but not treated|1
2567127|NCT01312909|8879341|P2|Overall Study|Randomized but not treated|3
2567128|NCT01312909|8879342|P1|Overall Study|Randomized but not treated|1
2567129|NCT01312779|8879429|P1|Overall Study|Not Implanted with Device|27
2567130|NCT01312779|8879429|P1|Overall Study|Death|3
2567131|NCT01312779|8879429|P1|Overall Study|Withdrawal by Subject|2
2567132|NCT01312467|8879512|P1|Overall Study|Ineligible|4
2567133|NCT01312467|8879512|P1|Overall Study|Another medical condition|1
2567134|NCT01312467|8879512|P1|Overall Study|Deported to country of origin|1
2567135|NCT01312467|8879512|P1|Overall Study|Withdrawal by Subject|2
2567136|NCT01312467|8879512|P1|Overall Study|Lost to Follow-up|1
2567137|NCT01312467|8879512|P1|Overall Study|Adverse Event|4
2567138|NCT01312428|8879521|P2|Overall Study|Study Termination|4
2567139|NCT01312428|8879522|P1|Overall Study|Study Termination|3
2567140|NCT01312129|8879592|P2|Second Intervention (24 Hours)|Lost to Follow-up|1
2567141|NCT01312129|8879593|P1|Second Intervention (24 Hours)|Lost to Follow-up|0
2567142|NCT01311661|8879678|P1|Overall Study|Withdrawal by Subject|2
2567143|NCT01311661|8879678|P1|Overall Study|Protocol Violation|3
2567144|NCT01311661|8879678|P1|Overall Study|Adverse Event|2
2567145|NCT01311557|8879822|P2|Overall Study|Withdrawal by Subject|2
2567146|NCT01311557|8879823|P1|Overall Study|Withdrawal by Subject|1
2567147|NCT01311557|8879822|P2|Overall Study|Lost to Follow-up|1
2567148|NCT01311557|8879823|P1|Overall Study|Lost to Follow-up|0
2567149|NCT01311557|8879822|P2|Overall Study|Protocol Violation|2
2567150|NCT01311557|8879823|P1|Overall Study|Protocol Violation|4
2567151|NCT01311557|8879822|P2|Overall Study|Serious adverse event|1
2567152|NCT01311557|8879823|P1|Overall Study|Serious adverse event|0
2567153|NCT01311505|8879839|P2|First Intervention Period|Protocol Violation|1
2567154|NCT01311505|8879840|P1|First Intervention Period|Protocol Violation|0
2567155|NCT01311024|8879896|P2|Overall Study|Protocol Violation|22
2567156|NCT01311024|8879897|P1|Overall Study|Protocol Violation|35
2567157|NCT01310868|8879903|P1|Overall Study|Do not have histologically confirmed GBM|13
2567158|NCT01310803|8879920|P2|Overall Study|Subject terminated by Sponsor|0
2567159|NCT01310803|8879921|P1|Overall Study|Subject terminated by Sponsor|1
2567160|NCT01310777|8879932|P3|Overall Study|Other|2
2567161|NCT01310777|8879933|P2|Overall Study|Other|1
2567162|NCT01310777|8879934|P1|Overall Study|Other|4
2567163|NCT01310777|8879932|P3|Overall Study|Inadequate Control of IOP|10
2567164|NCT01310777|8879933|P2|Overall Study|Inadequate Control of IOP|7
2567165|NCT01310777|8879934|P1|Overall Study|Inadequate Control of IOP|5
2567166|NCT01310777|8879932|P3|Overall Study|Patient's Decision Unrelated to AE|2
2567167|NCT01310777|8879933|P2|Overall Study|Patient's Decision Unrelated to AE|1
2567168|NCT01310777|8879934|P1|Overall Study|Patient's Decision Unrelated to AE|1
2567169|NCT01310777|8879932|P3|Overall Study|Lost to Follow-up|1
2567170|NCT01310777|8879933|P2|Overall Study|Lost to Follow-up|4
2567171|NCT01310777|8879934|P1|Overall Study|Lost to Follow-up|0
2567172|NCT01310777|8879932|P3|Overall Study|Adverse Event|15
2567173|NCT01310777|8879933|P2|Overall Study|Adverse Event|1
2567174|NCT01310777|8879934|P1|Overall Study|Adverse Event|23
2567175|NCT01310699|8879944|P2|Overall Study|Patients did not complete tandem.|6
2567176|NCT01310699|8879945|P1|Overall Study|Patients did not complete tandem.|4
2567177|NCT01310413|8879972|P7|From Day U0 to Day U385|Lost to Follow-up|2
2567178|NCT01310413|8879973|P6|From Day U0 to Day U385|Lost to Follow-up|0
2567179|NCT01310413|8879974|P5|From Day U0 to Day U385|Lost to Follow-up|0
2567180|NCT01310413|8879975|P4|From Day U0 to Day U385|Lost to Follow-up|0
2567181|NCT01310413|8879976|P3|From Day U0 to Day U385|Lost to Follow-up|0
2567182|NCT01310413|8879977|P2|From Day U0 to Day U385|Lost to Follow-up|0
2567183|NCT01310413|8879978|P1|From Day U0 to Day U385|Lost to Follow-up|0
2567184|NCT01310413|8879972|P7|From Day U0 to Day U385|Withdrawal by Subject|1
2567185|NCT01310413|8879973|P6|From Day U0 to Day U385|Withdrawal by Subject|0
2567186|NCT01310413|8879974|P5|From Day U0 to Day U385|Withdrawal by Subject|0
2567187|NCT01310413|8879975|P4|From Day U0 to Day U385|Withdrawal by Subject|0
2567188|NCT01310413|8879976|P3|From Day U0 to Day U385|Withdrawal by Subject|0
2567189|NCT01310413|8879977|P2|From Day U0 to Day U385|Withdrawal by Subject|0
2567190|NCT01310413|8879978|P1|From Day U0 to Day U385|Withdrawal by Subject|0
2567191|NCT01310413|8879972|P7|Day 0 to Day 385|Other|0
2567192|NCT01310413|8879973|P6|Day 0 to Day 385|Other|0
2567193|NCT01310413|8879974|P5|Day 0 to Day 385|Other|0
2567194|NCT01310413|8879975|P4|Day 0 to Day 385|Other|0
2567195|NCT01310413|8879976|P3|Day 0 to Day 385|Other|3
2567196|NCT01310413|8879977|P2|Day 0 to Day 385|Other|0
2567197|NCT01310413|8879978|P1|Day 0 to Day 385|Other|1
2567198|NCT01310413|8879972|P7|Day 0 to Day 385|Migrated/moved from study area|0
2567199|NCT01310413|8879973|P6|Day 0 to Day 385|Migrated/moved from study area|0
2567200|NCT01310413|8879974|P5|Day 0 to Day 385|Migrated/moved from study area|1
2567201|NCT01310413|8879975|P4|Day 0 to Day 385|Migrated/moved from study area|1
2567202|NCT01310413|8879976|P3|Day 0 to Day 385|Migrated/moved from study area|1
2567203|NCT01310413|8879977|P2|Day 0 to Day 385|Migrated/moved from study area|3
2567204|NCT01310413|8879978|P1|Day 0 to Day 385|Migrated/moved from study area|3
2567205|NCT01310413|8879972|P7|Day 0 to Day 385|Lost to Follow-up|0
2567206|NCT01310413|8879973|P6|Day 0 to Day 385|Lost to Follow-up|2
2567207|NCT01310413|8879974|P5|Day 0 to Day 385|Lost to Follow-up|1
2567208|NCT01310413|8879975|P4|Day 0 to Day 385|Lost to Follow-up|5
2567209|NCT01310413|8879976|P3|Day 0 to Day 385|Lost to Follow-up|3
2567210|NCT01310413|8879977|P2|Day 0 to Day 385|Lost to Follow-up|3
2567211|NCT01310413|8879978|P1|Day 0 to Day 385|Lost to Follow-up|18
2567212|NCT01310413|8879972|P7|Day 0 to Day 385|Withdrawal by Subject|0
2567213|NCT01310413|8879973|P6|Day 0 to Day 385|Withdrawal by Subject|1
2567214|NCT01310413|8879974|P5|Day 0 to Day 385|Withdrawal by Subject|1
2567215|NCT01310413|8879975|P4|Day 0 to Day 385|Withdrawal by Subject|2
2567216|NCT01310413|8879976|P3|Day 0 to Day 385|Withdrawal by Subject|0
2567217|NCT01310413|8879977|P2|Day 0 to Day 385|Withdrawal by Subject|2
2567218|NCT01310413|8879978|P1|Day 0 to Day 385|Withdrawal by Subject|5
2567219|NCT01310127|8880160|P2|Overall Study|advanced psc cataract outlier|0
2567220|NCT01310127|8880161|P1|Overall Study|advanced psc cataract outlier|1
2567221|NCT01310127|8880160|P2|Overall Study|Protocol Violation|1
2567222|NCT01310127|8880161|P1|Overall Study|Protocol Violation|1
2567223|NCT01310075|8880175|P2|Overall Study|Withdrawal by Subject|1
2567224|NCT01310075|8880176|P1|Overall Study|Withdrawal by Subject|1
2567225|NCT01310075|8880175|P2|Overall Study|Protocol Violation|2
2567226|NCT01310075|8880176|P1|Overall Study|Protocol Violation|2
2567227|NCT01310075|8880175|P2|Overall Study|Physician Decision|7
2567228|NCT01310075|8880176|P1|Overall Study|Physician Decision|10
2567229|NCT01310075|8880175|P2|Overall Study|Lost to Follow-up|0
2567230|NCT01310075|8880176|P1|Overall Study|Lost to Follow-up|1
2567231|NCT01310036|8880182|P1|Overall Study|Adverse event or intercurrent illness|12
2567232|NCT01310036|8880182|P1|Overall Study|Death|1
2567233|NCT01310036|8880182|P1|Overall Study|Progression of Disease|164
2567234|NCT01310036|8880182|P1|Overall Study|Refused Treatment/Did not Cooperate|4
2567235|NCT01310036|8880182|P1|Overall Study|Withdrew Consent|11
2567236|NCT01310036|8880182|P1|Overall Study|Administrative/other|10
2567237|NCT01309997|8880195|P2|Overall Study|Withdrawal by Subject|1
2567238|NCT01309997|8880196|P1|Overall Study|Withdrawal by Subject|1
2567239|NCT01309997|8880195|P2|Overall Study|Lack of Efficacy|2
2567240|NCT01309997|8880196|P1|Overall Study|Lack of Efficacy|2
2567241|NCT01309997|8880195|P2|Overall Study|Death|3
2567242|NCT01309997|8880196|P1|Overall Study|Death|1
2567243|NCT01309997|8880195|P2|Overall Study|Adverse Event|0
2567244|NCT01309997|8880196|P1|Overall Study|Adverse Event|1
2567245|NCT01309919|8880220|P2|Overall Study|Did not receive a postpartum IUD|48
2567246|NCT01309919|8880221|P1|Overall Study|Did not receive a postpartum IUD|17
2567247|NCT01309893|8880233|P2|Week 2 - Crossover Intervention|Missed crossover visit|1
2567248|NCT01309893|8880234|P1|Week 2 - Crossover Intervention|Missed crossover visit|0
2567249|NCT01309893|8880233|P2|Week 2 - Crossover Intervention|Lost to Follow-up|0
2567250|NCT01309893|8880234|P1|Week 2 - Crossover Intervention|Lost to Follow-up|1
2567251|NCT01309841|8880258|P3|Overall Study|Severe non-compliance with protocol|2
2567252|NCT01309841|8880259|P2|Overall Study|Severe non-compliance with protocol|5
2567253|NCT01309841|8880260|P1|Overall Study|Severe non-compliance with protocol|0
2567254|NCT01309841|8880258|P3|Overall Study|Did Not Receive Treatment|1
2567255|NCT01309841|8880259|P2|Overall Study|Did Not Receive Treatment|0
2567256|NCT01309841|8880260|P1|Overall Study|Did Not Receive Treatment|2
2567257|NCT01309841|8880258|P3|Overall Study|Withdrawal by Subject|13
2567258|NCT01309841|8880259|P2|Overall Study|Withdrawal by Subject|6
2567259|NCT01309841|8880260|P1|Overall Study|Withdrawal by Subject|17
2567260|NCT01309841|8880258|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
2567261|NCT01309841|8880259|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
2567262|NCT01309841|8880260|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
2567263|NCT01309841|8880258|P3|Overall Study|Death|0
2567264|NCT01309841|8880259|P2|Overall Study|Death|0
2567265|NCT01309841|8880260|P1|Overall Study|Death|1
2567266|NCT01309841|8880258|P3|Overall Study|Adverse Event|11
2567267|NCT01309841|8880259|P2|Overall Study|Adverse Event|22
2567268|NCT01309841|8880260|P1|Overall Study|Adverse Event|9
2567269|NCT01309841|8880258|P3|Overall Study|Lack of Efficacy|2
2567270|NCT01309841|8880259|P2|Overall Study|Lack of Efficacy|0
2567271|NCT01309841|8880260|P1|Overall Study|Lack of Efficacy|0
2567272|NCT01309841|8880258|P3|Overall Study|Study-Specific Withdrawal Criteria|2
2567273|NCT01309841|8880259|P2|Overall Study|Study-Specific Withdrawal Criteria|1
2567274|NCT01309841|8880260|P1|Overall Study|Study-Specific Withdrawal Criteria|3
2567275|NCT01309841|8880258|P3|Overall Study|Lost to Follow-up|4
2567276|NCT01309841|8880259|P2|Overall Study|Lost to Follow-up|6
2567277|NCT01309841|8880260|P1|Overall Study|Lost to Follow-up|7
2567278|NCT01309841|8880258|P3|Overall Study|Other|1
2567279|NCT01309841|8880259|P2|Overall Study|Other|1
2567280|NCT01309841|8880260|P1|Overall Study|Other|0
2567281|NCT01309828|8880300|P2|Overall Study|Other|0
2567282|NCT01309828|8880301|P1|Overall Study|Other|1
2567283|NCT01309828|8880300|P2|Overall Study|Major Protocol Deviation|1
2567284|NCT01309828|8880301|P1|Overall Study|Major Protocol Deviation|0
2567285|NCT01309828|8880300|P2|Overall Study|Voluntary Withdrawal|4
2567286|NCT01309828|8880301|P1|Overall Study|Voluntary Withdrawal|5
2567287|NCT01309828|8880300|P2|Overall Study|Adverse Event|11
2567288|NCT01309828|8880301|P1|Overall Study|Adverse Event|10
2567289|NCT01309737|8880335|P5|Week 16 to 52|Other|0
2567290|NCT01309737|8880336|P4|Week 16 to 52|Other|2
2567291|NCT01309737|8880337|P3|Week 16 to 52|Other|0
2567292|NCT01309737|8880338|P2|Week 16 to 52|Other|12
2567293|NCT01309737|8880339|P1|Week 16 to 52|Other|10
2567294|NCT01309737|8880335|P5|Week 16 to 52|Withdrawal by Subject|2
2567295|NCT01309737|8880336|P4|Week 16 to 52|Withdrawal by Subject|0
2567296|NCT01309737|8880337|P3|Week 16 to 52|Withdrawal by Subject|0
2567297|NCT01309737|8880338|P2|Week 16 to 52|Withdrawal by Subject|6
2567298|NCT01309737|8880339|P1|Week 16 to 52|Withdrawal by Subject|5
2567299|NCT01309737|8880335|P5|Week 16 to 52|Lost to Follow-up|4
2567300|NCT01309737|8880336|P4|Week 16 to 52|Lost to Follow-up|1
2567301|NCT01309737|8880337|P3|Week 16 to 52|Lost to Follow-up|0
2567302|NCT01309737|8880338|P2|Week 16 to 52|Lost to Follow-up|2
2567303|NCT01309737|8880339|P1|Week 16 to 52|Lost to Follow-up|4
2567304|NCT01309737|8880335|P5|Week 16 to 52|Lack of Efficacy|21
2567305|NCT01309737|8880336|P4|Week 16 to 52|Lack of Efficacy|25
2567306|NCT01309737|8880337|P3|Week 16 to 52|Lack of Efficacy|0
2567307|NCT01309737|8880338|P2|Week 16 to 52|Lack of Efficacy|76
2567308|NCT01309737|8880339|P1|Week 16 to 52|Lack of Efficacy|107
2567309|NCT01309737|8880335|P5|Week 16 to 52|Adverse Event|5
2567310|NCT01309737|8880336|P4|Week 16 to 52|Adverse Event|6
2567311|NCT01309737|8880337|P3|Week 16 to 52|Adverse Event|0
2567312|NCT01309737|8880338|P2|Week 16 to 52|Adverse Event|7
2567313|NCT01309737|8880339|P1|Week 16 to 52|Adverse Event|7
2567314|NCT01309737|8880335|P5|Week 16 to 52|Death|1
2567315|NCT01309737|8880336|P4|Week 16 to 52|Death|0
2567316|NCT01309737|8880337|P3|Week 16 to 52|Death|0
2567317|NCT01309737|8880338|P2|Week 16 to 52|Death|0
2567318|NCT01309737|8880339|P1|Week 16 to 52|Death|0
2567319|NCT01309737|8880335|P5|Week 0 to 16|Randomized, but not treated|0
2567320|NCT01309737|8880336|P4|Week 0 to 16|Randomized, but not treated|0
2567321|NCT01309737|8880337|P3|Week 0 to 16|Randomized, but not treated|0
2567322|NCT01309737|8880338|P2|Week 0 to 16|Randomized, but not treated|0
2567323|NCT01309737|8880339|P1|Week 0 to 16|Randomized, but not treated|1
2567324|NCT01309737|8880335|P5|Week 0 to 16|Other|0
2567325|NCT01309737|8880336|P4|Week 0 to 16|Other|0
2567326|NCT01309737|8880337|P3|Week 0 to 16|Other|4
2567327|NCT01309737|8880338|P2|Week 0 to 16|Other|14
2567328|NCT01309737|8880339|P1|Week 0 to 16|Other|10
2567329|NCT01309737|8880335|P5|Week 0 to 16|Withdrawal by Subject|0
2567330|NCT01309737|8880336|P4|Week 0 to 16|Withdrawal by Subject|0
2567331|NCT01309737|8880337|P3|Week 0 to 16|Withdrawal by Subject|7
2567332|NCT01309737|8880338|P2|Week 0 to 16|Withdrawal by Subject|6
2567333|NCT01309737|8880339|P1|Week 0 to 16|Withdrawal by Subject|7
2567334|NCT01309737|8880335|P5|Week 0 to 16|Lost to Follow-up|0
2567335|NCT01309737|8880336|P4|Week 0 to 16|Lost to Follow-up|0
2567336|NCT01309737|8880337|P3|Week 0 to 16|Lost to Follow-up|3
2567337|NCT01309737|8880338|P2|Week 0 to 16|Lost to Follow-up|8
2567338|NCT01309737|8880339|P1|Week 0 to 16|Lost to Follow-up|7
2567339|NCT01309737|8880335|P5|Week 0 to 16|Lack of Efficacy|0
2567340|NCT01309737|8880336|P4|Week 0 to 16|Lack of Efficacy|0
2567341|NCT01309737|8880337|P3|Week 0 to 16|Lack of Efficacy|24
2567342|NCT01309737|8880338|P2|Week 0 to 16|Lack of Efficacy|2
2567343|NCT01309737|8880339|P1|Week 0 to 16|Lack of Efficacy|15
2567344|NCT01309737|8880335|P5|Week 0 to 16|Adverse Event|0
2567345|NCT01309737|8880336|P4|Week 0 to 16|Adverse Event|0
2567346|NCT01309737|8880337|P3|Week 0 to 16|Adverse Event|5
2567347|NCT01309737|8880338|P2|Week 0 to 16|Adverse Event|10
2567348|NCT01309737|8880339|P1|Week 0 to 16|Adverse Event|11
2567349|NCT01309737|8880335|P5|Week 0 to 16|Death|0
2567350|NCT01309737|8880336|P4|Week 0 to 16|Death|0
2567351|NCT01309737|8880337|P3|Week 0 to 16|Death|1
2567352|NCT01309737|8880338|P2|Week 0 to 16|Death|0
2567353|NCT01309737|8880339|P1|Week 0 to 16|Death|1
2567354|NCT01309672|8880534|P1|Overall Study|Withdrawal by Subject|3
2567355|NCT01309672|8880534|P1|Overall Study|Adverse Event|5
2567356|NCT01309672|8880534|P1|Overall Study|Other|9
2567357|NCT01309672|8880534|P1|Overall Study|Lack of Efficacy|20
2567358|NCT01309659|8880544|P2|Overall Study|Protocol Violation|1
2567359|NCT01309659|8880545|P1|Overall Study|Protocol Violation|0
2567360|NCT01309386|8880650|P2|Overall Study|Adverse Event|8
2567361|NCT01309386|8880651|P1|Overall Study|Adverse Event|5
2567362|NCT01309386|8880650|P2|Overall Study|Lack of Efficacy|1
2567363|NCT01309386|8880651|P1|Overall Study|Lack of Efficacy|3
2567364|NCT01309386|8880650|P2|Overall Study|Physician Decision|1
2567365|NCT01309386|8880651|P1|Overall Study|Physician Decision|1
2567366|NCT01309386|8880650|P2|Overall Study|Progressive disease|11
2567367|NCT01309386|8880651|P1|Overall Study|Progressive disease|9
2567368|NCT01309386|8880650|P2|Overall Study|Withdrawal by Subject|0
2567369|NCT01309386|8880651|P1|Overall Study|Withdrawal by Subject|2
2567370|NCT01309386|8880650|P2|Overall Study|Other|0
2567371|NCT01309386|8880651|P1|Overall Study|Other|2
2567372|NCT01309308|8880699|P2|Overall Study|Lost to Follow-up|4
2567373|NCT01309308|8880700|P1|Overall Study|Lost to Follow-up|6
2567374|NCT01309282|8880708|P1|Overall Study|Lost to Follow-up|1
2567375|NCT01309269|8880725|P1|Overall Study|Enrolled but not Treated|107
2567376|NCT01309269|8880725|P1|Overall Study|Study Completion Data Not Recorded|95
2567377|NCT01309269|8880725|P1|Overall Study|Other|1
2567378|NCT01309269|8880725|P1|Overall Study|Other|256
2567379|NCT01309269|8880725|P1|Overall Study|Administrative Problems|141
2567380|NCT01309269|8880725|P1|Overall Study|Kidney Transplant|25
2567381|NCT01309269|8880725|P1|Overall Study|Other Erythropoiesis-stimulating Agents|119
2567382|NCT01309269|8880725|P1|Overall Study|Lack of Acceptance|15
2567383|NCT01309269|8880725|P1|Overall Study|Withdrawal by Subject|25
2567384|NCT01309269|8880725|P1|Overall Study|Adverse Event|56
2567385|NCT01309243|8880733|P2|Extension Phase|Lost to Follow-up|0
2567386|NCT01309243|8880734|P1|Extension Phase|Lost to Follow-up|6
2567387|NCT01309243|8880733|P2|Randomized Phase Through Week 96|Protocol Violation|1
2567388|NCT01309243|8880734|P1|Randomized Phase Through Week 96|Protocol Violation|1
2567389|NCT01309243|8880733|P2|Randomized Phase Through Week 96|Subject Non-Compliance|7
2567390|NCT01309243|8880734|P1|Randomized Phase Through Week 96|Subject Non-Compliance|9
2567391|NCT01309243|8880733|P2|Randomized Phase Through Week 96|Lost to Follow-up|22
2567392|NCT01309243|8880734|P1|Randomized Phase Through Week 96|Lost to Follow-up|23
2567393|NCT01309243|8880733|P2|Randomized Phase Through Week 96|Withdrew Consent|18
2567394|NCT01309243|8880734|P1|Randomized Phase Through Week 96|Withdrew Consent|12
2567395|NCT01309243|8880733|P2|Randomized Phase Through Week 96|Investigators Discretion|6
2567396|NCT01309243|8880734|P1|Randomized Phase Through Week 96|Investigators Discretion|3
2567397|NCT01309243|8880733|P2|Randomized Phase Through Week 96|Lack of Efficacy|4
2567398|NCT01309243|8880734|P1|Randomized Phase Through Week 96|Lack of Efficacy|16
2567399|NCT01309243|8880733|P2|Randomized Phase Through Week 96|Pregnancy|0
2567400|NCT01309243|8880734|P1|Randomized Phase Through Week 96|Pregnancy|2
2567401|NCT01309243|8880733|P2|Randomized Phase Through Week 96|Death|1
2567402|NCT01309243|8880734|P1|Randomized Phase Through Week 96|Death|0
2567403|NCT01309243|8880733|P2|Randomized Phase Through Week 96|Adverse Event|43
2567404|NCT01309243|8880734|P1|Randomized Phase Through Week 96|Adverse Event|12
2567405|NCT01309243|8880733|P2|Randomized Phase Through Week 96|Randomized but not treated|7
2567406|NCT01309243|8880734|P1|Randomized Phase Through Week 96|Randomized but not treated|6
2567407|NCT01309204|8880760|P2|Overall Study|Other|1
2567408|NCT01309204|8880761|P1|Overall Study|Other|4
2567409|NCT01309204|8880760|P2|Overall Study|Inadequate control of IOP|4
2567410|NCT01309204|8880761|P1|Overall Study|Inadequate control of IOP|4
2567411|NCT01309204|8880760|P2|Overall Study|Subject's decision unrelated to an AE|10
2567412|NCT01309204|8880761|P1|Overall Study|Subject's decision unrelated to an AE|9
2567413|NCT01309204|8880760|P2|Overall Study|Lost to Follow-up|2
2567414|NCT01309204|8880761|P1|Overall Study|Lost to Follow-up|2
2567415|NCT01309204|8880760|P2|Overall Study|Adverse Event|58
2567416|NCT01309204|8880761|P1|Overall Study|Adverse Event|48
2567417|NCT01309165|8880769|P2|Overall Study|Admitted to hospital for second stroke|0
2567418|NCT01309165|8880770|P1|Overall Study|Admitted to hospital for second stroke|1
2567419|NCT01309165|8880769|P2|Overall Study|No transportation|1
2567420|NCT01309165|8880770|P1|Overall Study|No transportation|0
2567421|NCT01309165|8880769|P2|Overall Study|Left country|1
2567422|NCT01309165|8880770|P1|Overall Study|Left country|0
2567423|NCT01309165|8880769|P2|Overall Study|Return to work|2
2567424|NCT01309165|8880770|P1|Overall Study|Return to work|1
2567425|NCT01309165|8880769|P2|Overall Study|Lost to Follow-up|3
2567426|NCT01309165|8880770|P1|Overall Study|Lost to Follow-up|4
2567427|NCT01309100|8880782|P1|Overall Study|Positive Slit lamp finding|1
2567428|NCT01309100|8880782|P1|Overall Study|Protocol Violation|1
2567429|NCT01308853|8880800|P1|Overall Study|Insertion of permanent implants|1
2567430|NCT01308853|8880800|P1|Overall Study|Lost to Follow-up|2
2567431|NCT01308853|8880800|P1|Overall Study|Adverse Event|1
2567432|NCT01308788|8880835|P2|2-year Treatment|medication change by treating physician|11
2567433|NCT01308788|8880836|P1|2-year Treatment|medication change by treating physician|4
2567434|NCT01308762|8880871|P3|Overall Study|Protocol Violation|0
2567435|NCT01308762|8880872|P2|Overall Study|Protocol Violation|1
2567436|NCT01308762|8880873|P1|Overall Study|Protocol Violation|0
2567437|NCT01308749|8880886|P2|Period 2: Open Label Treatment|Lost to Follow-up|1
2567438|NCT01308749|8880887|P1|Period 2: Open Label Treatment|Lost to Follow-up|0
2567439|NCT01308749|8880886|P2|Period 2: Open Label Treatment|Adverse Event|1
2567440|NCT01308749|8880887|P1|Period 2: Open Label Treatment|Adverse Event|0
2567441|NCT01308749|8880886|P2|Period 1: Double Blind Treatment|Adverse Event|0
2567442|NCT01308749|8880887|P1|Period 1: Double Blind Treatment|Adverse Event|1
2567443|NCT01308736|8880917|P2|Overall Study|Did not attend a single session|5
2567444|NCT01308736|8880918|P1|Overall Study|Did not attend a single session|6
2567445|NCT01308580|8880941|P2|Overall Study|Lost to Follow-up|7
2567446|NCT01308580|8880942|P1|Overall Study|Lost to Follow-up|12
2567447|NCT01308567|8880985|P3|Overall Study|Lost to Follow-up|4
2567448|NCT01308567|8880986|P2|Overall Study|Lost to Follow-up|4
2567449|NCT01308567|8880987|P1|Overall Study|Lost to Follow-up|2
2567450|NCT01308476|8881027|P2|Overall Study|Other|0
2567451|NCT01308476|8881028|P1|Overall Study|Other|1
2567452|NCT01308476|8881027|P2|Overall Study|Lost to Follow-up|2
2567453|NCT01308476|8881028|P1|Overall Study|Lost to Follow-up|2
2567454|NCT01308463|8881048|P1|Overall Study|Revision|2
2567455|NCT01308463|8881048|P1|Overall Study|Death|4
2567456|NCT01308463|8881048|P1|Overall Study|Study Discontinued|23
2567457|NCT01308424|8881061|P3|Randomization|Physician Decision|1
2567458|NCT01308424|8881062|P2|Randomization|Physician Decision|1
2567459|NCT01308424|8881063|P1|Randomization|Physician Decision|0
2567460|NCT01308424|8881061|P3|Randomization|Lost to Follow-up|0
2567461|NCT01308424|8881062|P2|Randomization|Lost to Follow-up|1
2567462|NCT01308424|8881063|P1|Randomization|Lost to Follow-up|0
2567463|NCT01308424|8881061|P3|Randomization|Adverse Event|1
2567464|NCT01308424|8881062|P2|Randomization|Adverse Event|1
2567465|NCT01308424|8881063|P1|Randomization|Adverse Event|0
2567466|NCT01308424|8881061|P3|Baseline Eligibility|Screen Failures|0
2567467|NCT01308424|8881062|P2|Baseline Eligibility|Screen Failures|0
2567468|NCT01308424|8881063|P1|Baseline Eligibility|Screen Failures|71
2567469|NCT01308008|8881103|P2|4 Weeks|Illness, disinterest, time|2
2567470|NCT01308008|8881104|P1|4 Weeks|Illness, disinterest, time|9
2567471|NCT01307891|8881127|P2|Overall Study|Progressive Disease|1
2567472|NCT01307891|8881128|P1|Overall Study|Progressive Disease|3
2567473|NCT01307787|8881140|P2|Overall Study|Withdrawal by Subject|0
2567474|NCT01307787|8881141|P1|Overall Study|Withdrawal by Subject|2
2567475|NCT01307579|8881210|P2|Overall Study|Ineligible|4
2567476|NCT01307579|8881211|P1|Overall Study|Ineligible|3
2567477|NCT01307579|8881210|P2|Overall Study|Refractory or relapsed AML|23
2567478|NCT01307579|8881211|P1|Overall Study|Refractory or relapsed AML|38
2567479|NCT01307579|8881210|P2|Overall Study|Begin conditioning for HSCT|44
2567480|NCT01307579|8881211|P1|Overall Study|Begin conditioning for HSCT|42
2567481|NCT01307579|8881210|P2|Overall Study|Institutional diagnosis of IFD|36
2567482|NCT01307579|8881211|P1|Overall Study|Institutional diagnosis of IFD|21
2567483|NCT01307579|8881210|P2|Overall Study|Withdrawal by Subject|3
2567484|NCT01307579|8881211|P1|Overall Study|Withdrawal by Subject|7
2567485|NCT01307579|8881210|P2|Overall Study|Physician Decision|29
2567486|NCT01307579|8881211|P1|Overall Study|Physician Decision|26
2567487|NCT01307579|8881210|P2|Overall Study|Death|6
2567488|NCT01307579|8881211|P1|Overall Study|Death|3
2567489|NCT01307501|8881223|P1|Overall Study|Starting Hospice|1
2567490|NCT01307501|8881223|P1|Overall Study|Lost to Follow-up|1
2567491|NCT01307501|8881223|P1|Overall Study|Death|20
2567492|NCT01307501|8881223|P1|Overall Study|Treatment Failure|1
2567493|NCT01307449|8881253|P4|Overall Study|Adverse Event|0
2567494|NCT01307449|8881254|P3|Overall Study|Adverse Event|0
2567495|NCT01307449|8881255|P2|Overall Study|Adverse Event|0
2567496|NCT01307449|8881256|P1|Overall Study|Adverse Event|1
2567497|NCT01307423|8881289|P9|Long-term Safety Phase (Year 5)|Miscellaneous|1
2567498|NCT01307423|8881290|P8|Long-term Safety Phase (Year 5)|Miscellaneous|1
2567499|NCT01307423|8881291|P7|Long-term Safety Phase (Year 5)|Miscellaneous|0
2567500|NCT01307423|8881292|P6|Long-term Safety Phase (Year 5)|Miscellaneous|0
2567501|NCT01307423|8881293|P5|Long-term Safety Phase (Year 5)|Miscellaneous|0
2567502|NCT01307423|8881294|P4|Long-term Safety Phase (Year 5)|Miscellaneous|0
2567503|NCT01307423|8881295|P3|Long-term Safety Phase (Year 5)|Miscellaneous|2
2567504|NCT01307423|8881296|P2|Long-term Safety Phase (Year 5)|Miscellaneous|0
2567505|NCT01307423|8881297|P1|Long-term Safety Phase (Year 5)|Miscellaneous|0
2567506|NCT01307423|8881289|P9|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
2567507|NCT01307423|8881290|P8|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
2567508|NCT01307423|8881291|P7|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
2567509|NCT01307423|8881292|P6|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
2567510|NCT01307423|8881293|P5|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
2567511|NCT01307423|8881294|P4|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
2567512|NCT01307423|8881295|P3|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
2567513|NCT01307423|8881296|P2|Long-term Safety Phase (Year 5)|Lost to Follow-up|1
2567514|NCT01307423|8881297|P1|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
2567515|NCT01307423|8881289|P9|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
2567516|NCT01307423|8881290|P8|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2567517|NCT01307423|8881291|P7|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2567518|NCT01307423|8881292|P6|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2567519|NCT01307423|8881293|P5|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2567520|NCT01307423|8881294|P4|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2567521|NCT01307423|8881295|P3|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
2567522|NCT01307423|8881296|P2|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6
2567523|NCT01307423|8881297|P1|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2567524|NCT01307423|8881289|P9|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2567525|NCT01307423|8881290|P8|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2567526|NCT01307423|8881291|P7|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2567527|NCT01307423|8881292|P6|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2567528|NCT01307423|8881293|P5|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2567529|NCT01307423|8881294|P4|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2567530|NCT01307423|8881295|P3|Long-term Safety Phase (Year 5)|Lack of Efficacy|1
2567531|NCT01307423|8881296|P2|Long-term Safety Phase (Year 5)|Lack of Efficacy|2
2567532|NCT01307423|8881297|P1|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2567533|NCT01307423|8881289|P9|Long-term Safety Phase (Year 5)|Adverse Event|1
2567534|NCT01307423|8881290|P8|Long-term Safety Phase (Year 5)|Adverse Event|0
2567535|NCT01307423|8881291|P7|Long-term Safety Phase (Year 5)|Adverse Event|0
2567536|NCT01307423|8881292|P6|Long-term Safety Phase (Year 5)|Adverse Event|0
2567537|NCT01307423|8881293|P5|Long-term Safety Phase (Year 5)|Adverse Event|0
2567538|NCT01307423|8881294|P4|Long-term Safety Phase (Year 5)|Adverse Event|0
2567539|NCT01307423|8881295|P3|Long-term Safety Phase (Year 5)|Adverse Event|1
2567540|NCT01307423|8881296|P2|Long-term Safety Phase (Year 5)|Adverse Event|1
2567541|NCT01307423|8881297|P1|Long-term Safety Phase (Year 5)|Adverse Event|0
2567542|NCT01307423|8881289|P9|Long-term Safety Phase (Year 4)|Miscellaneous|0
2567543|NCT01307423|8881290|P8|Long-term Safety Phase (Year 4)|Miscellaneous|1
2567544|NCT01307423|8881291|P7|Long-term Safety Phase (Year 4)|Miscellaneous|0
2567545|NCT01307423|8881292|P6|Long-term Safety Phase (Year 4)|Miscellaneous|0
2567546|NCT01307423|8881293|P5|Long-term Safety Phase (Year 4)|Miscellaneous|0
2567547|NCT01307423|8881294|P4|Long-term Safety Phase (Year 4)|Miscellaneous|0
2567548|NCT01307423|8881295|P3|Long-term Safety Phase (Year 4)|Miscellaneous|0
2567549|NCT01307423|8881296|P2|Long-term Safety Phase (Year 4)|Miscellaneous|0
2567550|NCT01307423|8881297|P1|Long-term Safety Phase (Year 4)|Miscellaneous|0
2567551|NCT01307423|8881289|P9|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2567552|NCT01307423|8881290|P8|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2567553|NCT01307423|8881291|P7|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2567554|NCT01307423|8881292|P6|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2567555|NCT01307423|8881293|P5|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2567556|NCT01307423|8881294|P4|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2567557|NCT01307423|8881295|P3|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
2567558|NCT01307423|8881296|P2|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2567559|NCT01307423|8881297|P1|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2567560|NCT01307423|8881289|P9|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
2567561|NCT01307423|8881290|P8|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1
2567562|NCT01307423|8881291|P7|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2567563|NCT01307423|8881292|P6|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2567564|NCT01307423|8881293|P5|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2567565|NCT01307423|8881294|P4|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2567566|NCT01307423|8881295|P3|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
2567567|NCT01307423|8881296|P2|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5
2567568|NCT01307423|8881297|P1|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2567569|NCT01307423|8881289|P9|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
2567570|NCT01307423|8881290|P8|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2567571|NCT01307423|8881291|P7|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2567572|NCT01307423|8881292|P6|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2567573|NCT01307423|8881293|P5|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2567574|NCT01307423|8881294|P4|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2567575|NCT01307423|8881295|P3|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2567576|NCT01307423|8881296|P2|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
2567577|NCT01307423|8881297|P1|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2567578|NCT01307423|8881289|P9|Long-term Safety Phase (Year 4)|Adverse Event|0
2567579|NCT01307423|8881290|P8|Long-term Safety Phase (Year 4)|Adverse Event|0
2567580|NCT01307423|8881291|P7|Long-term Safety Phase (Year 4)|Adverse Event|0
2567581|NCT01307423|8881292|P6|Long-term Safety Phase (Year 4)|Adverse Event|0
2567582|NCT01307423|8881293|P5|Long-term Safety Phase (Year 4)|Adverse Event|0
2567583|NCT01307423|8881294|P4|Long-term Safety Phase (Year 4)|Adverse Event|0
2567584|NCT01307423|8881295|P3|Long-term Safety Phase (Year 4)|Adverse Event|0
2567585|NCT01307423|8881296|P2|Long-term Safety Phase (Year 4)|Adverse Event|2
2567586|NCT01307423|8881297|P1|Long-term Safety Phase (Year 4)|Adverse Event|0
2567587|NCT01307423|8881289|P9|Long-term Safety Phase (Year 3)|Miscellaneous|0
2567588|NCT01307423|8881290|P8|Long-term Safety Phase (Year 3)|Miscellaneous|1
2567589|NCT01307423|8881291|P7|Long-term Safety Phase (Year 3)|Miscellaneous|0
2567590|NCT01307423|8881292|P6|Long-term Safety Phase (Year 3)|Miscellaneous|0
2567591|NCT01307423|8881293|P5|Long-term Safety Phase (Year 3)|Miscellaneous|0
2567592|NCT01307423|8881294|P4|Long-term Safety Phase (Year 3)|Miscellaneous|0
2567593|NCT01307423|8881295|P3|Long-term Safety Phase (Year 3)|Miscellaneous|0
2567594|NCT01307423|8881296|P2|Long-term Safety Phase (Year 3)|Miscellaneous|1
2567595|NCT01307423|8881297|P1|Long-term Safety Phase (Year 3)|Miscellaneous|0
2567596|NCT01307423|8881289|P9|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
2567597|NCT01307423|8881290|P8|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
2567598|NCT01307423|8881291|P7|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2567599|NCT01307423|8881292|P6|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2567600|NCT01307423|8881293|P5|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2567906|NCT01307267|8881540|P22|Overall Study|Death|2
2567601|NCT01307423|8881294|P4|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2567602|NCT01307423|8881295|P3|Long-term Safety Phase (Year 3)|Lost to Follow-up|3
2567603|NCT01307423|8881296|P2|Long-term Safety Phase (Year 3)|Lost to Follow-up|2
2567604|NCT01307423|8881297|P1|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2567605|NCT01307423|8881289|P9|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
2567606|NCT01307423|8881290|P8|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
2567607|NCT01307423|8881291|P7|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
2567608|NCT01307423|8881292|P6|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
2567609|NCT01307423|8881293|P5|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
2567610|NCT01307423|8881294|P4|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
2567611|NCT01307423|8881295|P3|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8
2567612|NCT01307423|8881296|P2|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
2567613|NCT01307423|8881297|P1|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
2567614|NCT01307423|8881289|P9|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
2567615|NCT01307423|8881290|P8|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
2567616|NCT01307423|8881291|P7|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
2567617|NCT01307423|8881292|P6|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
2567618|NCT01307423|8881293|P5|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
2567619|NCT01307423|8881294|P4|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
2567620|NCT01307423|8881295|P3|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
2567621|NCT01307423|8881296|P2|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
2567622|NCT01307423|8881297|P1|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
2567623|NCT01307423|8881289|P9|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
2567624|NCT01307423|8881290|P8|Long-term Safety Phase (Year 3)|Lack of Efficacy|1
2567625|NCT01307423|8881291|P7|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
2567626|NCT01307423|8881292|P6|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
2567627|NCT01307423|8881293|P5|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
2567628|NCT01307423|8881294|P4|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
2567629|NCT01307423|8881295|P3|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
2567630|NCT01307423|8881296|P2|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
2567631|NCT01307423|8881297|P1|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
2567632|NCT01307423|8881289|P9|Long-term Safety Phase (Year 3)|Adverse Event|4
2567633|NCT01307423|8881290|P8|Long-term Safety Phase (Year 3)|Adverse Event|3
2567634|NCT01307423|8881291|P7|Long-term Safety Phase (Year 3)|Adverse Event|0
2567635|NCT01307423|8881292|P6|Long-term Safety Phase (Year 3)|Adverse Event|0
2567636|NCT01307423|8881293|P5|Long-term Safety Phase (Year 3)|Adverse Event|0
2567637|NCT01307423|8881294|P4|Long-term Safety Phase (Year 3)|Adverse Event|0
2567638|NCT01307423|8881295|P3|Long-term Safety Phase (Year 3)|Adverse Event|2
2567639|NCT01307423|8881296|P2|Long-term Safety Phase (Year 3)|Adverse Event|1
2567640|NCT01307423|8881297|P1|Long-term Safety Phase (Year 3)|Adverse Event|0
2567641|NCT01307423|8881289|P9|Long-term Safety Phase (Year 2)|Miscellaneous|1
2567642|NCT01307423|8881290|P8|Long-term Safety Phase (Year 2)|Miscellaneous|1
2567643|NCT01307423|8881291|P7|Long-term Safety Phase (Year 2)|Miscellaneous|0
2567644|NCT01307423|8881292|P6|Long-term Safety Phase (Year 2)|Miscellaneous|0
2567645|NCT01307423|8881293|P5|Long-term Safety Phase (Year 2)|Miscellaneous|0
2567646|NCT01307423|8881294|P4|Long-term Safety Phase (Year 2)|Miscellaneous|0
2567647|NCT01307423|8881295|P3|Long-term Safety Phase (Year 2)|Miscellaneous|0
2567648|NCT01307423|8881296|P2|Long-term Safety Phase (Year 2)|Miscellaneous|1
2567649|NCT01307423|8881297|P1|Long-term Safety Phase (Year 2)|Miscellaneous|0
2567650|NCT01307423|8881289|P9|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2
2567651|NCT01307423|8881290|P8|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
2567652|NCT01307423|8881291|P7|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
2567653|NCT01307423|8881292|P6|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
2567654|NCT01307423|8881293|P5|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
2567655|NCT01307423|8881294|P4|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
2567656|NCT01307423|8881295|P3|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12
2567657|NCT01307423|8881296|P2|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13
2567658|NCT01307423|8881297|P1|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
2567659|NCT01307423|8881289|P9|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
2567660|NCT01307423|8881290|P8|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
2567661|NCT01307423|8881291|P7|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
2567662|NCT01307423|8881292|P6|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
2567663|NCT01307423|8881293|P5|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
2567664|NCT01307423|8881294|P4|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
2567665|NCT01307423|8881295|P3|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1
2567666|NCT01307423|8881296|P2|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
2567667|NCT01307423|8881297|P1|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
2567668|NCT01307423|8881289|P9|Long-term Safety Phase (Year 2)|Lack of Efficacy|3
2567669|NCT01307423|8881290|P8|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
2567670|NCT01307423|8881291|P7|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
2567671|NCT01307423|8881292|P6|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
2567672|NCT01307423|8881293|P5|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
2567673|NCT01307423|8881294|P4|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
2567674|NCT01307423|8881295|P3|Long-term Safety Phase (Year 2)|Lack of Efficacy|5
2567675|NCT01307423|8881296|P2|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
2567676|NCT01307423|8881297|P1|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
2567677|NCT01307423|8881289|P9|Long-term Safety Phase (Year 2)|Adverse Event|1
2567678|NCT01307423|8881290|P8|Long-term Safety Phase (Year 2)|Adverse Event|1
2567679|NCT01307423|8881291|P7|Long-term Safety Phase (Year 2)|Adverse Event|0
2567680|NCT01307423|8881292|P6|Long-term Safety Phase (Year 2)|Adverse Event|0
2567681|NCT01307423|8881293|P5|Long-term Safety Phase (Year 2)|Adverse Event|0
2567682|NCT01307423|8881294|P4|Long-term Safety Phase (Year 2)|Adverse Event|0
2567683|NCT01307423|8881295|P3|Long-term Safety Phase (Year 2)|Adverse Event|7
2567684|NCT01307423|8881296|P2|Long-term Safety Phase (Year 2)|Adverse Event|2
2567685|NCT01307423|8881297|P1|Long-term Safety Phase (Year 2)|Adverse Event|0
2567686|NCT01307423|8881289|P9|Active Treatment Phase (Week 25-52)|Protocol Violation|0
2567687|NCT01307423|8881290|P8|Active Treatment Phase (Week 25-52)|Protocol Violation|0
2567688|NCT01307423|8881291|P7|Active Treatment Phase (Week 25-52)|Protocol Violation|0
2567689|NCT01307423|8881292|P6|Active Treatment Phase (Week 25-52)|Protocol Violation|1
2567690|NCT01307423|8881293|P5|Active Treatment Phase (Week 25-52)|Protocol Violation|0
2567691|NCT01307423|8881294|P4|Active Treatment Phase (Week 25-52)|Protocol Violation|0
2567692|NCT01307423|8881295|P3|Active Treatment Phase (Week 25-52)|Protocol Violation|0
2567693|NCT01307423|8881296|P2|Active Treatment Phase (Week 25-52)|Protocol Violation|0
2567694|NCT01307423|8881297|P1|Active Treatment Phase (Week 25-52)|Protocol Violation|0
2567695|NCT01307423|8881289|P9|Active Treatment Phase (Week 25-52)|Other|0
2567696|NCT01307423|8881290|P8|Active Treatment Phase (Week 25-52)|Other|0
2567697|NCT01307423|8881291|P7|Active Treatment Phase (Week 25-52)|Other|0
2567698|NCT01307423|8881292|P6|Active Treatment Phase (Week 25-52)|Other|0
2567699|NCT01307423|8881293|P5|Active Treatment Phase (Week 25-52)|Other|0
2567700|NCT01307423|8881294|P4|Active Treatment Phase (Week 25-52)|Other|1
2567701|NCT01307423|8881295|P3|Active Treatment Phase (Week 25-52)|Other|0
2567702|NCT01307423|8881296|P2|Active Treatment Phase (Week 25-52)|Other|0
2567703|NCT01307423|8881297|P1|Active Treatment Phase (Week 25-52)|Other|0
2567704|NCT01307423|8881289|P9|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
2567705|NCT01307423|8881290|P8|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
2567706|NCT01307423|8881291|P7|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
2567707|NCT01307423|8881292|P6|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
2567708|NCT01307423|8881293|P5|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
2567709|NCT01307423|8881294|P4|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2
2567710|NCT01307423|8881295|P3|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
2567711|NCT01307423|8881296|P2|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
2567712|NCT01307423|8881297|P1|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
2567713|NCT01307423|8881289|P9|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
2567714|NCT01307423|8881290|P8|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
2567715|NCT01307423|8881291|P7|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
2567716|NCT01307423|8881292|P6|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
2567717|NCT01307423|8881293|P5|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
2567718|NCT01307423|8881294|P4|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
2567719|NCT01307423|8881295|P3|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2
2567720|NCT01307423|8881296|P2|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11
2567721|NCT01307423|8881297|P1|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
2567722|NCT01307423|8881289|P9|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
2567723|NCT01307423|8881290|P8|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
2567724|NCT01307423|8881291|P7|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
2567725|NCT01307423|8881292|P6|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1
2567726|NCT01307423|8881293|P5|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
2567727|NCT01307423|8881294|P4|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
2567728|NCT01307423|8881295|P3|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
2567729|NCT01307423|8881296|P2|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
2567730|NCT01307423|8881297|P1|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
2567731|NCT01307423|8881289|P9|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
2567732|NCT01307423|8881290|P8|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
2567733|NCT01307423|8881291|P7|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
2567734|NCT01307423|8881292|P6|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
2567735|NCT01307423|8881293|P5|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1
2567736|NCT01307423|8881294|P4|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3
2567737|NCT01307423|8881295|P3|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
2567738|NCT01307423|8881296|P2|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
2567739|NCT01307423|8881297|P1|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
2567740|NCT01307423|8881289|P9|Active Treatment Phase (Week 25-52)|Adverse Event|0
2567741|NCT01307423|8881290|P8|Active Treatment Phase (Week 25-52)|Adverse Event|0
2567742|NCT01307423|8881291|P7|Active Treatment Phase (Week 25-52)|Adverse Event|0
2567743|NCT01307423|8881292|P6|Active Treatment Phase (Week 25-52)|Adverse Event|0
2567907|NCT01307267|8881541|P21|Overall Study|Death|1
2567744|NCT01307423|8881293|P5|Active Treatment Phase (Week 25-52)|Adverse Event|2
2567745|NCT01307423|8881294|P4|Active Treatment Phase (Week 25-52)|Adverse Event|2
2567746|NCT01307423|8881295|P3|Active Treatment Phase (Week 25-52)|Adverse Event|2
2567747|NCT01307423|8881296|P2|Active Treatment Phase (Week 25-52)|Adverse Event|3
2567748|NCT01307423|8881297|P1|Active Treatment Phase (Week 25-52)|Adverse Event|0
2567749|NCT01307423|8881289|P9|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
2567750|NCT01307423|8881290|P8|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
2567751|NCT01307423|8881291|P7|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
2567752|NCT01307423|8881292|P6|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
2567753|NCT01307423|8881293|P5|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
2567754|NCT01307423|8881294|P4|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
2567755|NCT01307423|8881295|P3|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
2567756|NCT01307423|8881296|P2|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
2567757|NCT01307423|8881297|P1|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
2567758|NCT01307423|8881289|P9|Placebo-controlled Phase (Week 0 - 24)|Other|0
2567759|NCT01307423|8881290|P8|Placebo-controlled Phase (Week 0 - 24)|Other|0
2567760|NCT01307423|8881291|P7|Placebo-controlled Phase (Week 0 - 24)|Other|0
2567761|NCT01307423|8881292|P6|Placebo-controlled Phase (Week 0 - 24)|Other|0
2567762|NCT01307423|8881293|P5|Placebo-controlled Phase (Week 0 - 24)|Other|0
2567763|NCT01307423|8881294|P4|Placebo-controlled Phase (Week 0 - 24)|Other|0
2567764|NCT01307423|8881295|P3|Placebo-controlled Phase (Week 0 - 24)|Other|0
2567765|NCT01307423|8881296|P2|Placebo-controlled Phase (Week 0 - 24)|Other|2
2567766|NCT01307423|8881297|P1|Placebo-controlled Phase (Week 0 - 24)|Other|1
2567767|NCT01307423|8881289|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2567768|NCT01307423|8881290|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2567769|NCT01307423|8881291|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2567770|NCT01307423|8881292|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2567771|NCT01307423|8881293|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2567772|NCT01307423|8881294|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2567773|NCT01307423|8881295|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2567774|NCT01307423|8881296|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2567775|NCT01307423|8881297|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
2567776|NCT01307423|8881289|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2567777|NCT01307423|8881290|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2567778|NCT01307423|8881291|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2567779|NCT01307423|8881292|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2567780|NCT01307423|8881293|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2567781|NCT01307423|8881294|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2567782|NCT01307423|8881295|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
2567783|NCT01307423|8881296|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
2567784|NCT01307423|8881297|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5
2567785|NCT01307423|8881289|P9|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2567786|NCT01307423|8881290|P8|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2567787|NCT01307423|8881291|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2567788|NCT01307423|8881292|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2567789|NCT01307423|8881293|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2567790|NCT01307423|8881294|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2567791|NCT01307423|8881295|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
2567792|NCT01307423|8881296|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2567793|NCT01307423|8881297|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2567794|NCT01307423|8881289|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2567795|NCT01307423|8881290|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2567796|NCT01307423|8881291|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2567797|NCT01307423|8881292|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2567798|NCT01307423|8881293|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2567799|NCT01307423|8881294|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2567800|NCT01307423|8881295|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10
2567801|NCT01307423|8881296|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
2567802|NCT01307423|8881297|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8
2567803|NCT01307423|8881289|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2567804|NCT01307423|8881290|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2567805|NCT01307423|8881291|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2567806|NCT01307423|8881292|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2567807|NCT01307423|8881293|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2567808|NCT01307423|8881294|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2567809|NCT01307423|8881295|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
2567810|NCT01307423|8881296|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
2567811|NCT01307423|8881297|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1
2567812|NCT01307423|8881289|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2567813|NCT01307423|8881290|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2567908|NCT01307267|8881542|P20|Overall Study|Death|8
2567814|NCT01307423|8881291|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2567815|NCT01307423|8881292|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2567816|NCT01307423|8881293|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2567817|NCT01307423|8881294|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2567818|NCT01307423|8881295|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6
2567819|NCT01307423|8881296|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
2567820|NCT01307423|8881297|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
2567821|NCT01307319|8881503|P3|Overall Study|Other|3
2567822|NCT01307319|8881504|P2|Overall Study|Other|4
2567823|NCT01307319|8881505|P1|Overall Study|Other|0
2567824|NCT01307319|8881503|P3|Overall Study|Withdrawal by Subject|2
2567825|NCT01307319|8881504|P2|Overall Study|Withdrawal by Subject|1
2567826|NCT01307319|8881505|P1|Overall Study|Withdrawal by Subject|0
2567827|NCT01307319|8881503|P3|Overall Study|Protocol Violation|0
2567828|NCT01307319|8881504|P2|Overall Study|Protocol Violation|1
2567829|NCT01307319|8881505|P1|Overall Study|Protocol Violation|1
2567830|NCT01307319|8881503|P3|Overall Study|Lost to Follow-up|1
2567831|NCT01307319|8881504|P2|Overall Study|Lost to Follow-up|0
2567832|NCT01307319|8881505|P1|Overall Study|Lost to Follow-up|1
2567833|NCT01307319|8881503|P3|Overall Study|Adverse Event|1
2567834|NCT01307319|8881504|P2|Overall Study|Adverse Event|2
2567835|NCT01307319|8881505|P1|Overall Study|Adverse Event|2
2567836|NCT01307267|8881539|P23|Overall Study|Other|2
2567837|NCT01307267|8881540|P22|Overall Study|Other|3
2567838|NCT01307267|8881541|P21|Overall Study|Other|2
2567839|NCT01307267|8881542|P20|Overall Study|Other|19
2567840|NCT01307267|8881543|P19|Overall Study|Other|0
2567841|NCT01307267|8881544|P18|Overall Study|Other|0
2567842|NCT01307267|8881545|P17|Overall Study|Other|0
2567843|NCT01307267|8881546|P16|Overall Study|Other|1
2567844|NCT01307267|8881547|P15|Overall Study|Other|2
2567845|NCT01307267|8881548|P14|Overall Study|Other|0
2567846|NCT01307267|8881549|P13|Overall Study|Other|1
2567847|NCT01307267|8881550|P12|Overall Study|Other|1
2567848|NCT01307267|8881551|P11|Overall Study|Other|1
2567849|NCT01307267|8881552|P10|Overall Study|Other|0
2567850|NCT01307267|8881553|P9|Overall Study|Other|3
2567851|NCT01307267|8881554|P8|Overall Study|Other|1
2567852|NCT01307267|8881555|P7|Overall Study|Other|0
2567853|NCT01307267|8881556|P6|Overall Study|Other|7
2567854|NCT01307267|8881557|P5|Overall Study|Other|0
2567855|NCT01307267|8881558|P4|Overall Study|Other|0
2567856|NCT01307267|8881559|P3|Overall Study|Other|0
2567857|NCT01307267|8881560|P2|Overall Study|Other|0
2567858|NCT01307267|8881561|P1|Overall Study|Other|0
2567859|NCT01307267|8881539|P23|Overall Study|Withdrawal by Subject|0
2567860|NCT01307267|8881540|P22|Overall Study|Withdrawal by Subject|0
2567861|NCT01307267|8881541|P21|Overall Study|Withdrawal by Subject|0
2567862|NCT01307267|8881542|P20|Overall Study|Withdrawal by Subject|3
2567863|NCT01307267|8881543|P19|Overall Study|Withdrawal by Subject|0
2567864|NCT01307267|8881544|P18|Overall Study|Withdrawal by Subject|0
2567865|NCT01307267|8881545|P17|Overall Study|Withdrawal by Subject|0
2567866|NCT01307267|8881546|P16|Overall Study|Withdrawal by Subject|0
2567867|NCT01307267|8881547|P15|Overall Study|Withdrawal by Subject|0
2567868|NCT01307267|8881548|P14|Overall Study|Withdrawal by Subject|0
2567869|NCT01307267|8881549|P13|Overall Study|Withdrawal by Subject|0
2567870|NCT01307267|8881550|P12|Overall Study|Withdrawal by Subject|1
2567871|NCT01307267|8881551|P11|Overall Study|Withdrawal by Subject|1
2567872|NCT01307267|8881552|P10|Overall Study|Withdrawal by Subject|1
2567873|NCT01307267|8881553|P9|Overall Study|Withdrawal by Subject|5
2567874|NCT01307267|8881554|P8|Overall Study|Withdrawal by Subject|1
2567875|NCT01307267|8881555|P7|Overall Study|Withdrawal by Subject|0
2567876|NCT01307267|8881556|P6|Overall Study|Withdrawal by Subject|1
2567877|NCT01307267|8881557|P5|Overall Study|Withdrawal by Subject|0
2567878|NCT01307267|8881558|P4|Overall Study|Withdrawal by Subject|0
2567879|NCT01307267|8881559|P3|Overall Study|Withdrawal by Subject|0
2567880|NCT01307267|8881560|P2|Overall Study|Withdrawal by Subject|0
2567881|NCT01307267|8881561|P1|Overall Study|Withdrawal by Subject|0
2567882|NCT01307267|8881539|P23|Overall Study|Lost to Follow-up|0
2567883|NCT01307267|8881540|P22|Overall Study|Lost to Follow-up|0
2567884|NCT01307267|8881541|P21|Overall Study|Lost to Follow-up|0
2567885|NCT01307267|8881542|P20|Overall Study|Lost to Follow-up|2
2567886|NCT01307267|8881543|P19|Overall Study|Lost to Follow-up|0
2567887|NCT01307267|8881544|P18|Overall Study|Lost to Follow-up|0
2567888|NCT01307267|8881545|P17|Overall Study|Lost to Follow-up|0
2567889|NCT01307267|8881546|P16|Overall Study|Lost to Follow-up|0
2567890|NCT01307267|8881547|P15|Overall Study|Lost to Follow-up|0
2567891|NCT01307267|8881548|P14|Overall Study|Lost to Follow-up|0
2567892|NCT01307267|8881549|P13|Overall Study|Lost to Follow-up|0
2567893|NCT01307267|8881550|P12|Overall Study|Lost to Follow-up|0
2567894|NCT01307267|8881551|P11|Overall Study|Lost to Follow-up|1
2567895|NCT01307267|8881552|P10|Overall Study|Lost to Follow-up|2
2567896|NCT01307267|8881553|P9|Overall Study|Lost to Follow-up|1
2567897|NCT01307267|8881554|P8|Overall Study|Lost to Follow-up|0
2567898|NCT01307267|8881555|P7|Overall Study|Lost to Follow-up|0
2567899|NCT01307267|8881556|P6|Overall Study|Lost to Follow-up|7
2567900|NCT01307267|8881557|P5|Overall Study|Lost to Follow-up|0
2567901|NCT01307267|8881558|P4|Overall Study|Lost to Follow-up|0
2567902|NCT01307267|8881559|P3|Overall Study|Lost to Follow-up|0
2567903|NCT01307267|8881560|P2|Overall Study|Lost to Follow-up|0
2567904|NCT01307267|8881561|P1|Overall Study|Lost to Follow-up|0
2567905|NCT01307267|8881539|P23|Overall Study|Death|2
2567909|NCT01307267|8881543|P19|Overall Study|Death|2
2567910|NCT01307267|8881544|P18|Overall Study|Death|1
2567911|NCT01307267|8881545|P17|Overall Study|Death|1
2567912|NCT01307267|8881546|P16|Overall Study|Death|0
2567913|NCT01307267|8881547|P15|Overall Study|Death|0
2567914|NCT01307267|8881548|P14|Overall Study|Death|0
2567915|NCT01307267|8881549|P13|Overall Study|Death|0
2567916|NCT01307267|8881550|P12|Overall Study|Death|9
2567917|NCT01307267|8881551|P11|Overall Study|Death|3
2567918|NCT01307267|8881552|P10|Overall Study|Death|2
2567919|NCT01307267|8881553|P9|Overall Study|Death|21
2567920|NCT01307267|8881554|P8|Overall Study|Death|2
2567921|NCT01307267|8881555|P7|Overall Study|Death|2
2567922|NCT01307267|8881556|P6|Overall Study|Death|26
2567923|NCT01307267|8881557|P5|Overall Study|Death|1
2567924|NCT01307267|8881558|P4|Overall Study|Death|3
2567925|NCT01307267|8881559|P3|Overall Study|Death|5
2567926|NCT01307267|8881560|P2|Overall Study|Death|3
2567927|NCT01307267|8881561|P1|Overall Study|Death|4
2567928|NCT01307111|8882152|P2|1-2 Week IUD Check up|IUD expulsion/removal|2
2567929|NCT01307111|8882153|P1|1-2 Week IUD Check up|IUD expulsion/removal|2
2567930|NCT01307111|8882152|P2|IUD Insertion|Lost to Follow-up|0
2567931|NCT01307111|8882153|P1|IUD Insertion|Lost to Follow-up|2
2567932|NCT01307046|8882176|P2|Overall Study|Blood Pressure Withdrawal Criteria Met|3
2567933|NCT01307046|8882177|P1|Overall Study|Blood Pressure Withdrawal Criteria Met|2
2567934|NCT01307046|8882176|P2|Overall Study|Serum Potassium Withdrawal Criteria Met|2
2567935|NCT01307046|8882177|P1|Overall Study|Serum Potassium Withdrawal Criteria Met|4
2567936|NCT01307046|8882176|P2|Overall Study|Withdrawal by Subject|1
2567937|NCT01307046|8882177|P1|Overall Study|Withdrawal by Subject|1
2567938|NCT01307046|8882176|P2|Overall Study|Physician Decision|0
2567939|NCT01307046|8882177|P1|Overall Study|Physician Decision|2
2567940|NCT01307046|8882176|P2|Overall Study|Lack of Efficacy|2
2567941|NCT01307046|8882177|P1|Overall Study|Lack of Efficacy|0
2567942|NCT01307046|8882176|P2|Overall Study|Adverse Event|3
2567943|NCT01307046|8882177|P1|Overall Study|Adverse Event|3
2567944|NCT01307033|8882189|P4|44-week Open-label Extension|Death|1
2567945|NCT01307033|8882190|P3|44-week Open-label Extension|Death|0
2567946|NCT01307033|8882191|P2|44-week Open-label Extension|Death|0
2567947|NCT01307033|8882192|P1|44-week Open-label Extension|Death|0
2567948|NCT01307033|8882189|P4|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7
2567949|NCT01307033|8882190|P3|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6
2567950|NCT01307033|8882191|P2|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
2567951|NCT01307033|8882192|P1|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
2567952|NCT01307033|8882189|P4|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2
2567953|NCT01307033|8882190|P3|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
2567954|NCT01307033|8882191|P2|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
2567955|NCT01307033|8882192|P1|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
2567956|NCT01307033|8882189|P4|44-week Open-label Extension|Physician Decision|0
2567957|NCT01307033|8882190|P3|44-week Open-label Extension|Physician Decision|1
2567958|NCT01307033|8882191|P2|44-week Open-label Extension|Physician Decision|0
2567959|NCT01307033|8882192|P1|44-week Open-label Extension|Physician Decision|0
2567960|NCT01307033|8882189|P4|44-week Open-label Extension|Withdrawal by Subject|1
2567961|NCT01307033|8882190|P3|44-week Open-label Extension|Withdrawal by Subject|2
2567962|NCT01307033|8882191|P2|44-week Open-label Extension|Withdrawal by Subject|0
2567963|NCT01307033|8882192|P1|44-week Open-label Extension|Withdrawal by Subject|0
2567964|NCT01307033|8882189|P4|44-week Open-label Extension|Adverse Event|1
2567965|NCT01307033|8882190|P3|44-week Open-label Extension|Adverse Event|2
2567966|NCT01307033|8882191|P2|44-week Open-label Extension|Adverse Event|0
2567967|NCT01307033|8882192|P1|44-week Open-label Extension|Adverse Event|0
2567968|NCT01307033|8882189|P4|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
2567969|NCT01307033|8882190|P3|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
2567970|NCT01307033|8882191|P2|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3
2567971|NCT01307033|8882192|P1|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6
2567972|NCT01307033|8882189|P4|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
2567973|NCT01307033|8882190|P3|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
2567974|NCT01307033|8882191|P2|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3
2567975|NCT01307033|8882192|P1|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
2567976|NCT01307033|8882189|P4|8-week Double-blind Period|Lack of Efficacy|0
2567977|NCT01307033|8882190|P3|8-week Double-blind Period|Lack of Efficacy|0
2567978|NCT01307033|8882191|P2|8-week Double-blind Period|Lack of Efficacy|0
2567979|NCT01307033|8882192|P1|8-week Double-blind Period|Lack of Efficacy|1
2567980|NCT01307033|8882189|P4|8-week Double-blind Period|Withdrawal by Subject|0
2567981|NCT01307033|8882190|P3|8-week Double-blind Period|Withdrawal by Subject|0
2567982|NCT01307033|8882191|P2|8-week Double-blind Period|Withdrawal by Subject|1
2567983|NCT01307033|8882192|P1|8-week Double-blind Period|Withdrawal by Subject|4
2567984|NCT01307033|8882189|P4|8-week Double-blind Period|Adverse Event|0
2567985|NCT01307033|8882190|P3|8-week Double-blind Period|Adverse Event|0
2567986|NCT01307033|8882191|P2|8-week Double-blind Period|Adverse Event|0
2567987|NCT01307033|8882192|P1|8-week Double-blind Period|Adverse Event|2
2567988|NCT01307020|8882214|P10|Overall Study|Electronic data capture failure|0
2567989|NCT01307020|8882215|P9|Overall Study|Electronic data capture failure|0
2567990|NCT01307020|8882216|P8|Overall Study|Electronic data capture failure|0
2567991|NCT01307020|8882217|P7|Overall Study|Electronic data capture failure|0
2567992|NCT01307020|8882218|P6|Overall Study|Electronic data capture failure|0
2567993|NCT01307020|8882219|P5|Overall Study|Electronic data capture failure|0
2567994|NCT01307020|8882220|P4|Overall Study|Electronic data capture failure|0
2567995|NCT01307020|8882221|P3|Overall Study|Electronic data capture failure|0
2567996|NCT01307020|8882222|P2|Overall Study|Electronic data capture failure|1
2567997|NCT01307020|8882223|P1|Overall Study|Electronic data capture failure|0
2567998|NCT01307020|8882214|P10|Overall Study|Lost to Follow-up|0
2567999|NCT01307020|8882215|P9|Overall Study|Lost to Follow-up|0
2568000|NCT01307020|8882216|P8|Overall Study|Lost to Follow-up|0
2568001|NCT01307020|8882217|P7|Overall Study|Lost to Follow-up|1
2568002|NCT01307020|8882218|P6|Overall Study|Lost to Follow-up|0
2568003|NCT01307020|8882219|P5|Overall Study|Lost to Follow-up|0
2568004|NCT01307020|8882220|P4|Overall Study|Lost to Follow-up|1
2568005|NCT01307020|8882221|P3|Overall Study|Lost to Follow-up|1
2568006|NCT01307020|8882222|P2|Overall Study|Lost to Follow-up|0
2568007|NCT01307020|8882223|P1|Overall Study|Lost to Follow-up|0
2568008|NCT01306968|8882278|P4|Overall Study|Withdrew over privacy concerns|1
2568009|NCT01306968|8882279|P3|Overall Study|Withdrew over privacy concerns|0
2568010|NCT01306968|8882280|P2|Overall Study|Withdrew over privacy concerns|0
2568011|NCT01306968|8882281|P1|Overall Study|Withdrew over privacy concerns|0
2568012|NCT01306968|8882278|P4|Overall Study|Withdrew - time commitment|2
2568013|NCT01306968|8882279|P3|Overall Study|Withdrew - time commitment|0
2568014|NCT01306968|8882280|P2|Overall Study|Withdrew - time commitment|0
2568015|NCT01306968|8882281|P1|Overall Study|Withdrew - time commitment|0
2568016|NCT01306968|8882278|P4|Overall Study|Relocated and left active duty|1
2568017|NCT01306968|8882279|P3|Overall Study|Relocated and left active duty|1
2568018|NCT01306968|8882280|P2|Overall Study|Relocated and left active duty|1
2568019|NCT01306968|8882281|P1|Overall Study|Relocated and left active duty|0
2568020|NCT01306968|8882278|P4|Overall Study|Physician Decision|0
2568021|NCT01306968|8882279|P3|Overall Study|Physician Decision|0
2568022|NCT01306968|8882280|P2|Overall Study|Physician Decision|1
2568023|NCT01306968|8882281|P1|Overall Study|Physician Decision|0
2568024|NCT01306968|8882278|P4|Overall Study|Lost to Follow-up|0
2568025|NCT01306968|8882279|P3|Overall Study|Lost to Follow-up|0
2568026|NCT01306968|8882280|P2|Overall Study|Lost to Follow-up|1
2568027|NCT01306968|8882281|P1|Overall Study|Lost to Follow-up|1
2568028|NCT01306942|8882306|P4|Phase II|Protocol Violation|1
2568029|NCT01306942|8882307|P3|Phase II|Protocol Violation|0
2568030|NCT01306942|8882308|P2|Phase II|Protocol Violation|0
2568031|NCT01306942|8882309|P1|Phase II|Protocol Violation|0
2568032|NCT01306942|8882306|P4|Phase II|Not finished treatment|1
2568033|NCT01306942|8882307|P3|Phase II|Not finished treatment|0
2568034|NCT01306942|8882308|P2|Phase II|Not finished treatment|0
2568035|NCT01306942|8882309|P1|Phase II|Not finished treatment|0
2568036|NCT01306942|8882306|P4|Phase II|Death|1
2568037|NCT01306942|8882307|P3|Phase II|Death|0
2568038|NCT01306942|8882308|P2|Phase II|Death|0
2568039|NCT01306942|8882309|P1|Phase II|Death|0
2568040|NCT01306942|8882306|P4|Phase II|Withdrawal by Subject|2
2568041|NCT01306942|8882307|P3|Phase II|Withdrawal by Subject|0
2568042|NCT01306942|8882308|P2|Phase II|Withdrawal by Subject|0
2568043|NCT01306942|8882309|P1|Phase II|Withdrawal by Subject|0
2568044|NCT01306942|8882306|P4|Phase II|Physician Decision|5
2568045|NCT01306942|8882307|P3|Phase II|Physician Decision|0
2568046|NCT01306942|8882308|P2|Phase II|Physician Decision|0
2568047|NCT01306942|8882309|P1|Phase II|Physician Decision|2
2568048|NCT01306942|8882306|P4|Phase II|Adverse Event|6
2568049|NCT01306942|8882307|P3|Phase II|Adverse Event|0
2568050|NCT01306942|8882308|P2|Phase II|Adverse Event|0
2568051|NCT01306942|8882309|P1|Phase II|Adverse Event|0
2568052|NCT01306942|8882306|P4|Phase I|Physician Decision|0
2568053|NCT01306942|8882307|P3|Phase I|Physician Decision|0
2568054|NCT01306942|8882308|P2|Phase I|Physician Decision|1
2568055|NCT01306942|8882309|P1|Phase I|Physician Decision|3
2568056|NCT01306942|8882306|P4|Phase I|Adverse Event|0
2568057|NCT01306942|8882307|P3|Phase I|Adverse Event|0
2568058|NCT01306942|8882308|P2|Phase I|Adverse Event|2
2568059|NCT01306942|8882309|P1|Phase I|Adverse Event|2
2568060|NCT01306890|8882341|P1|Overall Study|No discontinuation documentation|41
2568061|NCT01306890|8882341|P1|Overall Study|Study Termination|3
2568062|NCT01306890|8882341|P1|Overall Study|Unspecified reasons|104
2568063|NCT01306890|8882341|P1|Overall Study|Withdrawal by Subject|88
2568064|NCT01306890|8882341|P1|Overall Study|Lost to Follow-up|58
2568065|NCT01306890|8882341|P1|Overall Study|Death|1223
2568066|NCT01306890|8882341|P1|Overall Study|Adverse Event|2
2568067|NCT01306877|8882348|P2|Overall Study|Physician Decision|1
2568068|NCT01306877|8882349|P1|Overall Study|Physician Decision|0
2568069|NCT01306877|8882348|P2|Overall Study|Lost to Follow-up|3
2568070|NCT01306877|8882349|P1|Overall Study|Lost to Follow-up|3
2568071|NCT01306656|8882369|P2|Overall Study|Lost to Follow-up|0
2568072|NCT01306656|8882370|P1|Overall Study|Lost to Follow-up|1
2568073|NCT01306643|8882382|P1|Overall Study|Other: Change in Eligibility Status|1
2568074|NCT01306643|8882382|P1|Overall Study|Disease Progression|7
2568075|NCT01306643|8882382|P1|Overall Study|Adverse Event|5
2568076|NCT01306617|8882394|P3|Overall Study|Non-compliance|0
2568077|NCT01306617|8882395|P2|Overall Study|Non-compliance|1
2568078|NCT01306617|8882396|P1|Overall Study|Non-compliance|0
2568079|NCT01306617|8882394|P3|Overall Study|Virologic Failure|5
2568080|NCT01306617|8882395|P2|Overall Study|Virologic Failure|0
2568081|NCT01306617|8882396|P1|Overall Study|Virologic Failure|0
2568082|NCT01306617|8882394|P3|Overall Study|Adverse Event|0
2568083|NCT01306617|8882395|P2|Overall Study|Adverse Event|0
2568084|NCT01306617|8882396|P1|Overall Study|Adverse Event|1
2568085|NCT01306305|8882439|P2|Overall Study|Withdrew consent|0
2568086|NCT01306305|8882440|P1|Overall Study|Withdrew consent|1
2568087|NCT01306305|8882439|P2|Overall Study|Lost to Follow-up|0
2568088|NCT01306305|8882440|P1|Overall Study|Lost to Follow-up|1
2568089|NCT01306253|8882477|P2|Overall Study|Lost to Follow-up|1
2568090|NCT01306253|8882478|P1|Overall Study|Lost to Follow-up|1
2568091|NCT01306214|8882495|P3|Overall Study|Not treated|1
2568092|NCT01306214|8882496|P2|Overall Study|Not treated|1
2568093|NCT01306214|8882497|P1|Overall Study|Not treated|1
2568094|NCT01306214|8882495|P3|Overall Study|Withdrawal by Subject|16
2568095|NCT01306214|8882496|P2|Overall Study|Withdrawal by Subject|22
2568096|NCT01306214|8882497|P1|Overall Study|Withdrawal by Subject|24
2568097|NCT01306214|8882495|P3|Overall Study|Lost to Follow-up|4
2568098|NCT01306214|8882496|P2|Overall Study|Lost to Follow-up|5
2568099|NCT01306214|8882497|P1|Overall Study|Lost to Follow-up|3
2568100|NCT01306214|8882495|P3|Overall Study|Death|1
2568101|NCT01306214|8882496|P2|Overall Study|Death|0
2568102|NCT01306214|8882497|P1|Overall Study|Death|0
2568103|NCT01306201|8882514|P1|Overall Study|Files unreadable|3
2568104|NCT01306201|8882514|P1|Overall Study|Files could not be processed|3
2568105|NCT01306201|8882514|P1|Overall Study|Arrhythmia|4
2568106|NCT01306162|8882536|P4|Washout 1|Non-compliance to protocol|0
2568107|NCT01306162|8882537|P3|Washout 1|Non-compliance to protocol|0
2568108|NCT01306162|8882538|P2|Washout 1|Non-compliance to protocol|1
2568109|NCT01306162|8882539|P1|Washout 1|Non-compliance to protocol|0
2568110|NCT01306162|8882536|P4|Period 1|Adverse Event|1
2568111|NCT01306162|8882537|P3|Period 1|Adverse Event|0
2568112|NCT01306162|8882538|P2|Period 1|Adverse Event|0
2568113|NCT01306162|8882539|P1|Period 1|Adverse Event|0
2568114|NCT01306058|8882567|P1|Overall Study|Enrolled but did not get treatment|1
2568115|NCT01306058|8882567|P1|Overall Study|Death|1
2568116|NCT01306032|8882594|P6|Disease Progression/Crossover|other/symptomatic progression|0
2568117|NCT01306032|8882595|P5|Disease Progression/Crossover|other/symptomatic progression|0
2568118|NCT01306032|8882596|P4|Disease Progression/Crossover|other/symptomatic progression|2
2568119|NCT01306032|8882597|P3|Disease Progression/Crossover|other/symptomatic progression|0
2568120|NCT01306032|8882598|P2|Disease Progression/Crossover|other/symptomatic progression|2
2568121|NCT01306032|8882599|P1|Disease Progression/Crossover|other/symptomatic progression|0
2568122|NCT01306032|8882594|P6|Disease Progression/Crossover|Withdrawal by Subject|0
2568123|NCT01306032|8882595|P5|Disease Progression/Crossover|Withdrawal by Subject|0
2568124|NCT01306032|8882596|P4|Disease Progression/Crossover|Withdrawal by Subject|1
2568125|NCT01306032|8882597|P3|Disease Progression/Crossover|Withdrawal by Subject|0
2568126|NCT01306032|8882598|P2|Disease Progression/Crossover|Withdrawal by Subject|0
2568127|NCT01306032|8882599|P1|Disease Progression/Crossover|Withdrawal by Subject|0
2568128|NCT01306032|8882594|P6|First Intervention|Progressive disease|0
2568129|NCT01306032|8882595|P5|First Intervention|Progressive disease|2
2568130|NCT01306032|8882596|P4|First Intervention|Progressive disease|0
2568131|NCT01306032|8882597|P3|First Intervention|Progressive disease|0
2568132|NCT01306032|8882598|P2|First Intervention|Progressive disease|0
2568133|NCT01306032|8882599|P1|First Intervention|Progressive disease|0
2568134|NCT01306032|8882594|P6|First Intervention|Ineligible|1
2568135|NCT01306032|8882595|P5|First Intervention|Ineligible|0
2568136|NCT01306032|8882596|P4|First Intervention|Ineligible|0
2568137|NCT01306032|8882597|P3|First Intervention|Ineligible|0
2568138|NCT01306032|8882598|P2|First Intervention|Ineligible|0
2568139|NCT01306032|8882599|P1|First Intervention|Ineligible|0
2568140|NCT01306032|8882594|P6|First Intervention|Death|0
2568141|NCT01306032|8882595|P5|First Intervention|Death|0
2568142|NCT01306032|8882596|P4|First Intervention|Death|0
2568143|NCT01306032|8882597|P3|First Intervention|Death|1
2568144|NCT01306032|8882598|P2|First Intervention|Death|0
2568145|NCT01306032|8882599|P1|First Intervention|Death|0
2568146|NCT01306032|8882594|P6|First Intervention|Withdrawal by Subject|0
2568147|NCT01306032|8882595|P5|First Intervention|Withdrawal by Subject|0
2568148|NCT01306032|8882596|P4|First Intervention|Withdrawal by Subject|1
2568149|NCT01306032|8882597|P3|First Intervention|Withdrawal by Subject|0
2568150|NCT01306032|8882598|P2|First Intervention|Withdrawal by Subject|2
2568151|NCT01306032|8882599|P1|First Intervention|Withdrawal by Subject|0
2568152|NCT01306032|8882594|P6|First Intervention|Adverse Event|1
2568153|NCT01306032|8882595|P5|First Intervention|Adverse Event|0
2568154|NCT01306032|8882596|P4|First Intervention|Adverse Event|0
2568155|NCT01306032|8882597|P3|First Intervention|Adverse Event|1
2568156|NCT01306032|8882598|P2|First Intervention|Adverse Event|0
2568157|NCT01306032|8882599|P1|First Intervention|Adverse Event|1
2568158|NCT01305941|8882651|P1|Overall Study|Death|1
2568159|NCT01305941|8882651|P1|Overall Study|Withdrawal by Subject|1
2568160|NCT01305941|8882651|P1|Overall Study|Clinical decline|2
2568161|NCT01305941|8882651|P1|Overall Study|Adverse Event|6
2568162|NCT01305577|8882691|P3|Overall Study|Protocol Deviation|1
2568163|NCT01305577|8882692|P2|Overall Study|Protocol Deviation|1
2568164|NCT01305577|8882693|P1|Overall Study|Protocol Deviation|0
2568165|NCT01305577|8882691|P3|Overall Study|Lost to Follow-up|2
2568166|NCT01305577|8882692|P2|Overall Study|Lost to Follow-up|3
2568167|NCT01305577|8882693|P1|Overall Study|Lost to Follow-up|4
2568168|NCT01305577|8882691|P3|Overall Study|Withdrawal by Subject|6
2568169|NCT01305577|8882692|P2|Overall Study|Withdrawal by Subject|5
2568170|NCT01305577|8882693|P1|Overall Study|Withdrawal by Subject|7
2568171|NCT01305577|8882691|P3|Overall Study|Adverse Event|1
2568172|NCT01305577|8882692|P2|Overall Study|Adverse Event|2
2568173|NCT01305577|8882693|P1|Overall Study|Adverse Event|2
2568174|NCT01305564|8882722|P1|Overall Study|Physician Decision|3
2568175|NCT01305564|8882722|P1|Overall Study|Withdrawal by Subject|1
2568176|NCT01305564|8882722|P1|Overall Study|Lost to Follow-up|12
2568177|NCT01305564|8882722|P1|Overall Study|Death|21
2568178|NCT01305408|8882749|P2|Overall Study|Other|0
2568179|NCT01305408|8882750|P1|Overall Study|Other|1
2568180|NCT01305408|8882749|P2|Overall Study|Noncompliance with study procedures|1
2568181|NCT01305408|8882750|P1|Overall Study|Noncompliance with study procedures|0
2568182|NCT01305408|8882749|P2|Overall Study|Noncompliance with study medication|1
2568183|NCT01305408|8882750|P1|Overall Study|Noncompliance with study medication|0
2568184|NCT01305408|8882749|P2|Overall Study|Lost to Follow-up|3
2568185|NCT01305408|8882750|P1|Overall Study|Lost to Follow-up|5
2568186|NCT01305408|8882749|P2|Overall Study|Protocol Violation|6
2568187|NCT01305408|8882750|P1|Overall Study|Protocol Violation|4
2568188|NCT01305408|8882749|P2|Overall Study|Withdrawal by Subject|9
2568189|NCT01305408|8882750|P1|Overall Study|Withdrawal by Subject|9
2568190|NCT01305408|8882749|P2|Overall Study|Lack of Efficacy|4
2568191|NCT01305408|8882750|P1|Overall Study|Lack of Efficacy|3
2568192|NCT01305408|8882749|P2|Overall Study|Adverse Event|7
2568193|NCT01305408|8882750|P1|Overall Study|Adverse Event|10
2568194|NCT01305239|8882843|P1|Overall Study|Exemestane taken prior to inclusion only|1
2568195|NCT01305239|8882843|P1|Overall Study|Adverse Event|22
2568196|NCT01305200|8882873|P3|Overall Study|Death|0
2568197|NCT01305200|8882874|P2|Overall Study|Death|2
2568198|NCT01305200|8882875|P1|Overall Study|Death|0
2568199|NCT01305200|8882873|P3|Overall Study|Ineligible|1
2568200|NCT01305200|8882874|P2|Overall Study|Ineligible|2
2568201|NCT01305200|8882875|P1|Overall Study|Ineligible|1
2568202|NCT01305200|8882873|P3|Overall Study|Withdrawal by Subject|1
2568203|NCT01305200|8882874|P2|Overall Study|Withdrawal by Subject|21
2568204|NCT01305200|8882875|P1|Overall Study|Withdrawal by Subject|24
2568205|NCT01305200|8882873|P3|Overall Study|Physician Decision|1
2568206|NCT01305200|8882874|P2|Overall Study|Physician Decision|6
2568207|NCT01305200|8882875|P1|Overall Study|Physician Decision|4
2568208|NCT01305044|8882905|P2|Overall Study|Withdrawal by Subject|6
2568209|NCT01305044|8882906|P1|Overall Study|Withdrawal by Subject|3
2568210|NCT01304940|8882938|P2|Overall Study|not meet symptom severity requirement|0
2568211|NCT01304940|8882939|P1|Overall Study|not meet symptom severity requirement|3
2568212|NCT01304706|8882945|P1|Overall Study|Discontinued due to failed drug admin.|1
2568213|NCT01304706|8882945|P1|Overall Study|Lost to Follow-up|7
2568214|NCT01304706|8882945|P1|Overall Study|Withdrawal by Subject|3
2568215|NCT01304706|8882945|P1|Overall Study|Death|3
2568216|NCT01304706|8882945|P1|Overall Study|Lack of Efficacy|1
2568217|NCT01304706|8882945|P1|Overall Study|Adverse Event|2
2568218|NCT01304693|8882954|P5|Overall Study|Decision Unrelated to an Adverse Event|0
2568219|NCT01304693|8882955|P4|Overall Study|Decision Unrelated to an Adverse Event|1
2568220|NCT01304693|8882956|P3|Overall Study|Decision Unrelated to an Adverse Event|1
2568221|NCT01304693|8882957|P2|Overall Study|Decision Unrelated to an Adverse Event|0
2568222|NCT01304693|8882958|P1|Overall Study|Decision Unrelated to an Adverse Event|0
2568223|NCT01304693|8882954|P5|Overall Study|Adverse Event|1
2568224|NCT01304693|8882955|P4|Overall Study|Adverse Event|0
2568225|NCT01304693|8882956|P3|Overall Study|Adverse Event|0
2568226|NCT01304693|8882957|P2|Overall Study|Adverse Event|0
2568227|NCT01304693|8882958|P1|Overall Study|Adverse Event|0
2568228|NCT01304498|8883005|P2|Overall Study|Lost to Follow-up|1
2568229|NCT01304498|8883006|P1|Overall Study|Lost to Follow-up|2
2568230|NCT01304498|8883005|P2|Overall Study|Protocol Violation|0
2568231|NCT01304498|8883006|P1|Overall Study|Protocol Violation|1
2568232|NCT01304498|8883005|P2|Overall Study|Withdrawal by Subject|3
2568233|NCT01304498|8883006|P1|Overall Study|Withdrawal by Subject|2
2568234|NCT01304498|8883005|P2|Overall Study|Adverse Event|1
2568235|NCT01304498|8883006|P1|Overall Study|Adverse Event|1
2568236|NCT01304329|8883026|P6|Third Intervention (3 Days)|Adverse Event|0
2568237|NCT01304329|8883027|P5|Third Intervention (3 Days)|Adverse Event|0
2568238|NCT01304329|8883028|P4|Third Intervention (3 Days)|Adverse Event|0
2568239|NCT01304329|8883029|P3|Third Intervention (3 Days)|Adverse Event|0
2568240|NCT01304329|8883030|P2|Third Intervention (3 Days)|Adverse Event|1
2568241|NCT01304329|8883031|P1|Third Intervention (3 Days)|Adverse Event|0
2568242|NCT01304147|8883165|P2|Second Intervention (7days)|Withdrawal by Subject|1
2568243|NCT01304147|8883166|P1|Second Intervention (7days)|Withdrawal by Subject|1
2568244|NCT01303965|8883197|P2|Overall Study|Disease Progression|6
2568245|NCT01303965|8883198|P1|Overall Study|Disease Progression|1
2568246|NCT01303965|8883197|P2|Overall Study|Withdrawal by Subject|0
2568247|NCT01303965|8883198|P1|Overall Study|Withdrawal by Subject|1
2568248|NCT01303965|8883197|P2|Overall Study|Death|3
2568249|NCT01303965|8883198|P1|Overall Study|Death|0
2568250|NCT01303965|8883197|P2|Overall Study|Adverse Event|1
2568251|NCT01303965|8883198|P1|Overall Study|Adverse Event|1
2568252|NCT01303861|8883226|P4|Overall Study|Pregnancy|0
2568253|NCT01303861|8883227|P3|Overall Study|Pregnancy|0
2568254|NCT01303861|8883228|P2|Overall Study|Pregnancy|0
2568255|NCT01303861|8883229|P1|Overall Study|Pregnancy|1
2568256|NCT01303861|8883226|P4|Overall Study|Adverse Event|5
2568257|NCT01303861|8883227|P3|Overall Study|Adverse Event|0
2568258|NCT01303861|8883228|P2|Overall Study|Adverse Event|1
2568259|NCT01303861|8883229|P1|Overall Study|Adverse Event|4
2568260|NCT01303861|8883226|P4|Overall Study|Withdrawal by Subject|23
2568261|NCT01303861|8883227|P3|Overall Study|Withdrawal by Subject|8
2568262|NCT01303861|8883228|P2|Overall Study|Withdrawal by Subject|8
2568263|NCT01303861|8883229|P1|Overall Study|Withdrawal by Subject|16
2568264|NCT01303861|8883226|P4|Overall Study|Lack of Efficacy|0
2568265|NCT01303861|8883227|P3|Overall Study|Lack of Efficacy|1
2568266|NCT01303861|8883228|P2|Overall Study|Lack of Efficacy|2
2568267|NCT01303861|8883229|P1|Overall Study|Lack of Efficacy|3
2568268|NCT01303861|8883226|P4|Overall Study|Lost to Follow-up|31
2568269|NCT01303861|8883227|P3|Overall Study|Lost to Follow-up|27
2568270|NCT01303861|8883228|P2|Overall Study|Lost to Follow-up|14
2568271|NCT01303861|8883229|P1|Overall Study|Lost to Follow-up|34
2568272|NCT01303627|8883288|P2|Overall Study|the failure while performing URS|1
2568273|NCT01303627|8883289|P1|Overall Study|the failure while performing URS|0
2568274|NCT01303510|8883297|P2|Overall Study|Lost to Follow-up|0
2568275|NCT01303510|8883298|P1|Overall Study|Lost to Follow-up|1
2568276|NCT01303445|8883312|P2|Follow-up Period (14 Days)|Withdrawal by Subject|1
2568277|NCT01303445|8883313|P1|Follow-up Period (14 Days)|Withdrawal by Subject|0
2568278|NCT01303445|8883312|P2|Fourth Intervention (7 Days)|Withdrawal by Subject|0
2568279|NCT01303445|8883313|P1|Fourth Intervention (7 Days)|Withdrawal by Subject|1
2568280|NCT01303445|8883312|P2|Washout (14 Days)|Lost to Follow-up|2
2568281|NCT01303445|8883313|P1|Washout (14 Days)|Lost to Follow-up|0
2568282|NCT01303445|8883312|P2|Washout (14 Days)|Protocol Violation|0
2568283|NCT01303445|8883313|P1|Washout (14 Days)|Protocol Violation|1
2568284|NCT01303445|8883312|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
2568285|NCT01303445|8883313|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
2568286|NCT01303445|8883312|P2|Second Intervention (7 Days)|Adverse Event|2
2568287|NCT01303445|8883313|P1|Second Intervention (7 Days)|Adverse Event|0
2568288|NCT01303445|8883312|P2|First Intervention (7 Days)|Withdrawal by Subject|0
2568289|NCT01303445|8883313|P1|First Intervention (7 Days)|Withdrawal by Subject|1
2568290|NCT01303419|8883343|P1|Overall Study|Did not meet all I/E after screening|31
2568291|NCT01303419|8883343|P1|Overall Study|Did not complete both imaging methods|5
2568292|NCT01303419|8883343|P1|Overall Study|Discontinuation of study|60
2568293|NCT01303380|8883362|P1|Overall Study|Lack of compliance to study procedures|1
2568294|NCT01303159|8883421|P1|Overall Study|Study Termination|7
2568295|NCT01303159|8883421|P1|Overall Study|Death|16
2568296|NCT01302964|8883439|P2|Overall Study|Adverse Event|0
2568297|NCT01302964|8883440|P1|Overall Study|Adverse Event|1
2568298|NCT01302938|8883450|P2|Overall Study|Adverse Event|0
2568299|NCT01302938|8883451|P1|Overall Study|Adverse Event|1
2568300|NCT01302938|8883450|P2|Overall Study|Withdrawal by Subject|0
2568301|NCT01302938|8883451|P1|Overall Study|Withdrawal by Subject|1
2568302|NCT01302899|8883496|P2|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1
2568303|NCT01302899|8883497|P1|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0
2568304|NCT01302899|8883496|P2|Period 2 (Weeks 7 to 12)|Protocol Deviation|0
2568305|NCT01302899|8883497|P1|Period 2 (Weeks 7 to 12)|Protocol Deviation|1
2568306|NCT01302834|8883561|P2|Overall Study|HIV positive|3
2568307|NCT01302834|8883562|P1|Overall Study|HIV positive|1
2568308|NCT01302834|8883561|P2|Overall Study|Protocol Violation|23
2568309|NCT01302834|8883562|P1|Overall Study|Protocol Violation|17
2568310|NCT01302691|8883622|P2|Overall Study|Protocol Violation|0
2568311|NCT01302691|8883623|P1|Overall Study|Protocol Violation|1
2568312|NCT01302691|8883622|P2|Overall Study|Physician Decision|1
2568313|NCT01302691|8883623|P1|Overall Study|Physician Decision|0
2568314|NCT01302691|8883622|P2|Overall Study|Blood Pressure/Potassium Criteria Met|4
2568315|NCT01302691|8883623|P1|Overall Study|Blood Pressure/Potassium Criteria Met|6
2568316|NCT01302691|8883622|P2|Overall Study|Lost to Follow-up|0
2568317|NCT01302691|8883623|P1|Overall Study|Lost to Follow-up|1
2568318|NCT01302691|8883622|P2|Overall Study|Death|1
2568319|NCT01302691|8883623|P1|Overall Study|Death|0
2568320|NCT01302691|8883622|P2|Overall Study|Adverse Event|0
2568321|NCT01302691|8883623|P1|Overall Study|Adverse Event|2
2568322|NCT01302548|8883643|P2|Overall Study|Lost to Follow-up|1
2568323|NCT01302548|8883644|P1|Overall Study|Lost to Follow-up|2
2568324|NCT01302418|8883694|P1|Overall Study|Non-evaluable|9
2568325|NCT01302418|8883694|P1|Overall Study|Protocol Violation|9
2568326|NCT01302392|8883700|P2|Overall Study|Withdrawal by Subject|1
2568327|NCT01302392|8883701|P1|Overall Study|Withdrawal by Subject|6
2568328|NCT01302392|8883700|P2|Overall Study|Lost to Follow-up|0
2568329|NCT01302392|8883701|P1|Overall Study|Lost to Follow-up|1
2568330|NCT01302366|8883721|P1|Overall Study|patient choice or noncompliance|5
2568331|NCT01302119|8883729|P2|Overall Study|Non-specific|1
2568332|NCT01302119|8883730|P1|Overall Study|Non-specific|4
2568333|NCT01302119|8883729|P2|Overall Study|Non-compliance|2
2568334|NCT01302119|8883730|P1|Overall Study|Non-compliance|4
2568335|NCT01302119|8883729|P2|Overall Study|Adverse Event|1
2568336|NCT01302119|8883730|P1|Overall Study|Adverse Event|2
2568337|NCT01302119|8883729|P2|Overall Study|Lost to Follow-up|4
2568338|NCT01302119|8883730|P1|Overall Study|Lost to Follow-up|10
2568339|NCT01302119|8883729|P2|Overall Study|Withdrawal by Subject|20
2568340|NCT01302119|8883730|P1|Overall Study|Withdrawal by Subject|30
2568341|NCT01302067|8883745|P3|Overall Study|Adverse Event|45
2568342|NCT01302067|8883746|P2|Overall Study|Adverse Event|14
2568343|NCT01302067|8883747|P1|Overall Study|Adverse Event|27
2568344|NCT01302067|8883745|P3|Overall Study|Protocol Violation|8
2568345|NCT01302067|8883746|P2|Overall Study|Protocol Violation|0
2568346|NCT01302067|8883747|P1|Overall Study|Protocol Violation|11
2568347|NCT01302067|8883745|P3|Overall Study|Other|3
2568348|NCT01302067|8883746|P2|Overall Study|Other|1
2568349|NCT01302067|8883747|P1|Overall Study|Other|1
2568350|NCT01302067|8883745|P3|Overall Study|Withdrawal by Subject|10
2568351|NCT01302067|8883746|P2|Overall Study|Withdrawal by Subject|6
2568352|NCT01302067|8883747|P1|Overall Study|Withdrawal by Subject|13
2568353|NCT01302067|8883745|P3|Overall Study|Lost to Follow-up|15
2568354|NCT01302067|8883746|P2|Overall Study|Lost to Follow-up|4
2568355|NCT01302067|8883747|P1|Overall Study|Lost to Follow-up|9
2568356|NCT01302067|8883745|P3|Overall Study|Lack of Efficacy|2
2568357|NCT01302067|8883746|P2|Overall Study|Lack of Efficacy|4
2568358|NCT01302067|8883747|P1|Overall Study|Lack of Efficacy|8
2568359|NCT01302067|8883745|P3|Overall Study|Physician Decision|14
2568360|NCT01302067|8883746|P2|Overall Study|Physician Decision|5
2568361|NCT01302067|8883747|P1|Overall Study|Physician Decision|9
2568362|NCT01302067|8883745|P3|Overall Study|Death|1
2568363|NCT01302067|8883746|P2|Overall Study|Death|0
2568364|NCT01302067|8883747|P1|Overall Study|Death|0
2568365|NCT01302054|8883818|P3|Double-Blind Treatment Phase|Other|9
2568366|NCT01302054|8883819|P2|Double-Blind Treatment Phase|Other|4
2568367|NCT01302054|8883820|P1|Double-Blind Treatment Phase|Other|0
2568368|NCT01302054|8883818|P3|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2
2568369|NCT01302054|8883819|P2|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
2568370|NCT01302054|8883820|P1|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
2568371|NCT01302054|8883818|P3|Double-Blind Treatment Phase|Adverse Event|10
2568372|NCT01302054|8883819|P2|Double-Blind Treatment Phase|Adverse Event|10
2568373|NCT01302054|8883820|P1|Double-Blind Treatment Phase|Adverse Event|0
2568374|NCT01302054|8883818|P3|Double-Blind Treatment Phase|Protocol Violation|6
2568375|NCT01302054|8883819|P2|Double-Blind Treatment Phase|Protocol Violation|3
2568376|NCT01302054|8883820|P1|Double-Blind Treatment Phase|Protocol Violation|0
2568377|NCT01302054|8883818|P3|Double-Blind Treatment Phase|Withdrawal by Subject|14
2568378|NCT01302054|8883819|P2|Double-Blind Treatment Phase|Withdrawal by Subject|6
2568379|NCT01302054|8883820|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
2568380|NCT01302054|8883818|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
2568381|NCT01302054|8883819|P2|Double-Blind Treatment Phase|Lost to Follow-up|2
2568382|NCT01302054|8883820|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
2568383|NCT01302054|8883818|P3|Double-Blind Treatment Phase|Lack of Efficacy|4
2568384|NCT01302054|8883819|P2|Double-Blind Treatment Phase|Lack of Efficacy|2
2568385|NCT01302054|8883820|P1|Double-Blind Treatment Phase|Lack of Efficacy|0
2568386|NCT01302054|8883818|P3|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
2568387|NCT01302054|8883819|P2|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
2568388|NCT01302054|8883820|P1|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2
2568389|NCT01302054|8883818|P3|Tolterodine Open-Label Run-In Phase|Other|0
2568390|NCT01302054|8883819|P2|Tolterodine Open-Label Run-In Phase|Other|0
2568391|NCT01302054|8883820|P1|Tolterodine Open-Label Run-In Phase|Other|7
2568392|NCT01302054|8883818|P3|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
2568393|NCT01302054|8883819|P2|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
2568394|NCT01302054|8883820|P1|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314
2568395|NCT01302054|8883818|P3|Tolterodine Open-Label Run-In Phase|Adverse Event|0
2568396|NCT01302054|8883819|P2|Tolterodine Open-Label Run-In Phase|Adverse Event|0
2568397|NCT01302054|8883820|P1|Tolterodine Open-Label Run-In Phase|Adverse Event|13
2568398|NCT01302054|8883818|P3|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
2568399|NCT01302054|8883819|P2|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
2568400|NCT01302054|8883820|P1|Tolterodine Open-Label Run-In Phase|Protocol Violation|8
2568401|NCT01302054|8883818|P3|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
2568402|NCT01302054|8883819|P2|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
2568403|NCT01302054|8883820|P1|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16
2568404|NCT01302054|8883818|P3|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
2568405|NCT01302054|8883819|P2|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
2568406|NCT01302054|8883820|P1|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17
2568407|NCT01302054|8883818|P3|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
2568408|NCT01302054|8883819|P2|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
2568409|NCT01302054|8883820|P1|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4
2568410|NCT01302041|8883847|P1|Overall Study|Other-Miscellaneous Reason|2
2568411|NCT01302041|8883847|P1|Overall Study|Other-Transitioned to 9785-CL-0123|29
2568412|NCT01302041|8883847|P1|Overall Study|Withdrawal by Subject|4
2568413|NCT01302041|8883847|P1|Overall Study|Death|5
2568414|NCT01301950|8883889|P2|Overall Study|Surgery was cancelled by patient|1
2568415|NCT01301950|8883890|P1|Overall Study|Surgery was cancelled by patient|0
2568416|NCT01301833|8883908|P4|Overall Study|Personal matter|0
2568417|NCT01301833|8883909|P3|Overall Study|Personal matter|0
2568418|NCT01301833|8883910|P2|Overall Study|Personal matter|0
2568419|NCT01301833|8883911|P1|Overall Study|Personal matter|1
2568420|NCT01301833|8883908|P4|Overall Study|Withdrawal by Subject|2
2568421|NCT01301833|8883909|P3|Overall Study|Withdrawal by Subject|1
2568422|NCT01301833|8883910|P2|Overall Study|Withdrawal by Subject|1
2568423|NCT01301833|8883911|P1|Overall Study|Withdrawal by Subject|3
2568424|NCT01301833|8883908|P4|Overall Study|Physician Decision|0
2568425|NCT01301833|8883909|P3|Overall Study|Physician Decision|1
2568426|NCT01301833|8883910|P2|Overall Study|Physician Decision|1
2568427|NCT01301833|8883911|P1|Overall Study|Physician Decision|3
2568428|NCT01301833|8883908|P4|Overall Study|Lack of Efficacy|0
2568429|NCT01301833|8883909|P3|Overall Study|Lack of Efficacy|0
2568430|NCT01301833|8883910|P2|Overall Study|Lack of Efficacy|1
2568431|NCT01301833|8883911|P1|Overall Study|Lack of Efficacy|1
2568432|NCT01301833|8883908|P4|Overall Study|Adverse Event|5
2568433|NCT01301833|8883909|P3|Overall Study|Adverse Event|5
2568434|NCT01301833|8883910|P2|Overall Study|Adverse Event|5
2568435|NCT01301833|8883911|P1|Overall Study|Adverse Event|7
2568436|NCT01301729|8883949|P1|Overall Study|Violated Selection Criteria|1
2568437|NCT01301729|8883949|P1|Overall Study|Participant did not Return for Treatment|1
2568438|NCT01301729|8883949|P1|Overall Study|Withdrawal by Subject|2
2568439|NCT01301625|8883960|P1|Overall Study|Lost to Follow-up|1
2568440|NCT01301625|8883960|P1|Overall Study|Expected|8
2568441|NCT01301625|8883960|P1|Overall Study|Not Due|21
2568442|NCT01301625|8883960|P1|Overall Study|Death|5
2568443|NCT01301508|8884032|P2|Overall Study|Lost to Follow-up|1
2568444|NCT01301508|8884033|P1|Overall Study|Lost to Follow-up|0
2568445|NCT01301508|8884032|P2|Overall Study|Withdrawal by Subject|2
2568446|NCT01301508|8884033|P1|Overall Study|Withdrawal by Subject|1
2568447|NCT01301456|8884063|P12|Stage 2|Adverse Event|0
2568448|NCT01301456|8884064|P11|Stage 2|Adverse Event|1
2568449|NCT01301456|8884065|P10|Stage 2|Adverse Event|0
2568450|NCT01301456|8884066|P9|Stage 2|Adverse Event|0
2568451|NCT01301456|8884067|P8|Stage 2|Adverse Event|0
2568452|NCT01301456|8884068|P7|Stage 2|Adverse Event|0
2568453|NCT01301456|8884069|P6|Stage 2|Adverse Event|0
2568454|NCT01301456|8884070|P5|Stage 2|Adverse Event|0
2568455|NCT01301456|8884071|P4|Stage 2|Adverse Event|0
2568456|NCT01301456|8884072|P3|Stage 2|Adverse Event|0
2568457|NCT01301456|8884073|P2|Stage 2|Adverse Event|0
2568458|NCT01301456|8884074|P1|Stage 2|Adverse Event|0
2568459|NCT01301456|8884063|P12|Stage 1|Randomized but not treated|0
2568460|NCT01301456|8884064|P11|Stage 1|Randomized but not treated|0
2568461|NCT01301456|8884065|P10|Stage 1|Randomized but not treated|0
2568462|NCT01301456|8884066|P9|Stage 1|Randomized but not treated|0
2568463|NCT01301456|8884067|P8|Stage 1|Randomized but not treated|0
2568464|NCT01301456|8884068|P7|Stage 1|Randomized but not treated|1
2568465|NCT01301456|8884069|P6|Stage 1|Randomized but not treated|0
2568466|NCT01301456|8884070|P5|Stage 1|Randomized but not treated|0
2568467|NCT01301456|8884071|P4|Stage 1|Randomized but not treated|0
2568468|NCT01301456|8884072|P3|Stage 1|Randomized but not treated|0
2568469|NCT01301456|8884073|P2|Stage 1|Randomized but not treated|0
2568470|NCT01301456|8884074|P1|Stage 1|Randomized but not treated|0
2568471|NCT01301456|8884063|P12|Stage 1|Withdrawal by Subject|0
2568472|NCT01301456|8884064|P11|Stage 1|Withdrawal by Subject|0
2568473|NCT01301456|8884065|P10|Stage 1|Withdrawal by Subject|0
2568474|NCT01301456|8884066|P9|Stage 1|Withdrawal by Subject|0
2568475|NCT01301456|8884067|P8|Stage 1|Withdrawal by Subject|0
2568476|NCT01301456|8884068|P7|Stage 1|Withdrawal by Subject|0
2568477|NCT01301456|8884069|P6|Stage 1|Withdrawal by Subject|0
2568478|NCT01301456|8884070|P5|Stage 1|Withdrawal by Subject|1
2568479|NCT01301456|8884071|P4|Stage 1|Withdrawal by Subject|0
2568480|NCT01301456|8884072|P3|Stage 1|Withdrawal by Subject|1
2568481|NCT01301456|8884073|P2|Stage 1|Withdrawal by Subject|0
2568482|NCT01301456|8884074|P1|Stage 1|Withdrawal by Subject|0
2568483|NCT01301391|8884300|P1|Overall Study|Sponsor's decision|8
2568484|NCT01301391|8884300|P1|Overall Study|Physician Decision|2
2568485|NCT01301391|8884300|P1|Overall Study|Lost to Follow-up|3
2568486|NCT01301391|8884300|P1|Overall Study|Death|13
2568487|NCT01301274|8884312|P2|Overall Study|Physician Decision|1
2568488|NCT01301274|8884313|P1|Overall Study|Physician Decision|2
2568489|NCT01301092|8884328|P3|Overall Study|Lost to Follow-up|1
2568490|NCT01301092|8884329|P2|Overall Study|Lost to Follow-up|0
2568491|NCT01301092|8884330|P1|Overall Study|Lost to Follow-up|0
2568492|NCT01301079|8884347|P2|Overall Study|Lost to Follow-up|2
2568493|NCT01301079|8884348|P1|Overall Study|Lost to Follow-up|2
2568494|NCT01301066|8884426|P2|Overall Study|Other|0
2568495|NCT01301066|8884427|P1|Overall Study|Other|2
2568496|NCT01301066|8884426|P2|Overall Study|Physician Decision|1
2568497|NCT01301066|8884427|P1|Overall Study|Physician Decision|0
2568498|NCT01301066|8884426|P2|Overall Study|Sponsor Decision|1
2568499|NCT01301066|8884427|P1|Overall Study|Sponsor Decision|2
2568500|NCT01301066|8884426|P2|Overall Study|Adverse Event|6
2568501|NCT01301066|8884427|P1|Overall Study|Adverse Event|6
2568502|NCT01301066|8884426|P2|Overall Study|Withdrawal by Subject|9
2568503|NCT01301066|8884427|P1|Overall Study|Withdrawal by Subject|4
2568504|NCT01301066|8884426|P2|Overall Study|Protocol Violation|7
2568505|NCT01301066|8884427|P1|Overall Study|Protocol Violation|8
2568506|NCT01301066|8884426|P2|Overall Study|Lost to Follow-up|11
2568507|NCT01301066|8884427|P1|Overall Study|Lost to Follow-up|5
2568508|NCT01301027|8884435|P2|Overall Study|Volume Overload|0
2568509|NCT01301027|8884436|P1|Overall Study|Volume Overload|3
2568510|NCT01301027|8884435|P2|Overall Study|Transplant|2
2568511|NCT01301027|8884436|P1|Overall Study|Transplant|0
2568512|NCT01301027|8884435|P2|Overall Study|Fracture|3
2568513|NCT01301027|8884436|P1|Overall Study|Fracture|1
2568514|NCT01301027|8884435|P2|Overall Study|Adverse Event|2
2568515|NCT01301027|8884436|P1|Overall Study|Adverse Event|0
2568516|NCT01301027|8884435|P2|Overall Study|Withdrawal by Subject|3
2568517|NCT01301027|8884436|P1|Overall Study|Withdrawal by Subject|2
2568518|NCT01301027|8884435|P2|Overall Study|Physician Decision|0
2568519|NCT01301027|8884436|P1|Overall Study|Physician Decision|2
2568520|NCT01301001|8884448|P2|Second Intervention|Withdrawal by Subject|0
2568521|NCT01301001|8884449|P1|Second Intervention|Withdrawal by Subject|2
2568522|NCT01301001|8884448|P2|Second Intervention|Adverse Event|0
2568523|NCT01301001|8884449|P1|Second Intervention|Adverse Event|2
2568524|NCT01301001|8884448|P2|First Intervention|Protocol Violation|1
2568525|NCT01301001|8884449|P1|First Intervention|Protocol Violation|0
2568526|NCT01301001|8884448|P2|First Intervention|Adverse Event|0
2568527|NCT01301001|8884449|P1|First Intervention|Adverse Event|5
2568528|NCT01301001|8884448|P2|First Intervention|Withdrawal by Subject|4
2568529|NCT01301001|8884449|P1|First Intervention|Withdrawal by Subject|1
2568530|NCT01301001|8884448|P2|First Intervention|Lost to Follow-up|4
2568531|NCT01301001|8884449|P1|First Intervention|Lost to Follow-up|4
2568532|NCT01300923|8884472|P2|Overall Study|Physician Decision|2
2568533|NCT01300923|8884473|P1|Overall Study|Physician Decision|0
2568534|NCT01300819|8884486|P2|Overall Study|Follow up call was not done|0
2568535|NCT01300819|8884487|P1|Overall Study|Follow up call was not done|1
2568536|NCT01300819|8884486|P2|Overall Study|Safety follow up not done by mistake|1
2568537|NCT01300819|8884487|P1|Overall Study|Safety follow up not done by mistake|0
2568538|NCT01300819|8884486|P2|Overall Study|Administrative reason|1
2568539|NCT01300819|8884487|P1|Overall Study|Administrative reason|0
2568540|NCT01300819|8884486|P2|Overall Study|Refusal to down titrate study drug|1
2568541|NCT01300819|8884487|P1|Overall Study|Refusal to down titrate study drug|0
2568542|NCT01300819|8884486|P2|Overall Study|Patient was 1 month late for Visit 10|1
2568543|NCT01300819|8884487|P1|Overall Study|Patient was 1 month late for Visit 10|0
2568544|NCT01300819|8884486|P2|Overall Study|Withdrawal by Subject|12
2568545|NCT01300819|8884487|P1|Overall Study|Withdrawal by Subject|10
2568546|NCT01300819|8884486|P2|Overall Study|Lack of Efficacy|1
2568547|NCT01300819|8884487|P1|Overall Study|Lack of Efficacy|2
2568548|NCT01300819|8884486|P2|Overall Study|Adverse Event|27
2568549|NCT01300819|8884487|P1|Overall Study|Adverse Event|9
2568550|NCT01300767|8884515|P1|Overall Study|Unacceptable fit|1
2568551|NCT01300767|8884515|P1|Overall Study|Biomicroscopy|1
2568552|NCT01300767|8884515|P1|Overall Study|Discomfort|2
2568553|NCT01300741|8884543|P1|Overall Study|Discomfort|1
2568554|NCT01300741|8884543|P1|Overall Study|Lost to Follow-up|1
2568555|NCT01300741|8884543|P1|Overall Study|Lens deposits|1
2568556|NCT01300728|8884573|P2|Overall Study|Physician Decision|0
2568557|NCT01300728|8884574|P1|Overall Study|Physician Decision|1
2568558|NCT01300728|8884573|P2|Overall Study|Withdrawal by Subject|1
2568559|NCT01300728|8884574|P1|Overall Study|Withdrawal by Subject|1
2568560|NCT01300650|8884588|P1|Overall Study|Adverse Event|1
2568561|NCT01300572|8884604|P1|Overall Study|HAMA + post dosimetry|1
2568562|NCT01300546|8884628|P2|Overall Study|Adverse Event|1
2568563|NCT01300546|8884629|P1|Overall Study|Adverse Event|0
2568564|NCT01300546|8884628|P2|Overall Study|Lack of Efficacy|3
2568565|NCT01300546|8884629|P1|Overall Study|Lack of Efficacy|0
2568566|NCT01300546|8884628|P2|Overall Study|Lost to Follow-up|2
2568567|NCT01300546|8884629|P1|Overall Study|Lost to Follow-up|0
2568568|NCT01300546|8884628|P2|Overall Study|Withdrawal by Subject|0
2568569|NCT01300546|8884629|P1|Overall Study|Withdrawal by Subject|1
2568570|NCT01300455|8884659|P2|Washout|Withdrawal by Subject|0
2568571|NCT01300455|8884660|P1|Washout|Withdrawal by Subject|1
2568572|NCT01300351|8884680|P2|Overall Study|Withdrawal by Subject|10
2568573|NCT01300351|8884681|P1|Overall Study|Withdrawal by Subject|7
2568574|NCT01300351|8884680|P2|Overall Study|Adverse Event|4
2568575|NCT01300351|8884681|P1|Overall Study|Adverse Event|0
2568576|NCT01300351|8884680|P2|Overall Study|Lost to Follow-up|1
2568577|NCT01300351|8884681|P1|Overall Study|Lost to Follow-up|0
2568578|NCT01300351|8884680|P2|Overall Study|Ongoing treatment at data cut-off|23
2568579|NCT01300351|8884681|P1|Overall Study|Ongoing treatment at data cut-off|27
2568580|NCT01300351|8884680|P2|Overall Study|Did not receive treatment|0
2568581|NCT01300351|8884681|P1|Overall Study|Did not receive treatment|2
2568582|NCT01300338|8884697|P2|Overall Study|Lost to Follow-up|0
2568583|NCT01300338|8884698|P1|Overall Study|Lost to Follow-up|5
2568584|NCT01300286|8884706|P1|Overall Study|did not get dosed|1
2568585|NCT01300260|8884716|P2|Period 2 of Study: Second Intervention|Adverse Event|1
2568586|NCT01300260|8884717|P1|Period 2 of Study: Second Intervention|Adverse Event|0
2568587|NCT01300260|8884716|P2|Period 1 of Study: First Intervention|Withdrawal by Subject|0
2568588|NCT01300260|8884717|P1|Period 1 of Study: First Intervention|Withdrawal by Subject|1
2568589|NCT01300260|8884716|P2|Period 1 of Study: First Intervention|Adverse Event|1
2568590|NCT01300260|8884717|P1|Period 1 of Study: First Intervention|Adverse Event|0
2568591|NCT01300247|8884749|P2|Overall Study|Non-Compliance|1
2568592|NCT01300247|8884750|P1|Overall Study|Non-Compliance|0
2568593|NCT01300247|8884749|P2|Overall Study|Withdrawal by Subject|0
2568594|NCT01300247|8884750|P1|Overall Study|Withdrawal by Subject|1
2568595|NCT01300247|8884749|P2|Overall Study|Lost to Follow-up|0
2568596|NCT01300247|8884750|P1|Overall Study|Lost to Follow-up|2
2568597|NCT01300247|8884749|P2|Overall Study|Death|1
2568598|NCT01300247|8884750|P1|Overall Study|Death|1
2568599|NCT01300234|8884782|P2|Overall Study|Participant refused return to hospital|0
2568600|NCT01300234|8884783|P1|Overall Study|Participant refused return to hospital|1
2568601|NCT01300234|8884782|P2|Overall Study|Participant stopped medication|1
2568602|NCT01300234|8884783|P1|Overall Study|Participant stopped medication|1
2568603|NCT01300234|8884782|P2|Overall Study|Participant reached stopping critera|0
2568604|NCT01300234|8884783|P1|Overall Study|Participant reached stopping critera|2
2568605|NCT01300234|8884782|P2|Overall Study|Pregnancy|1
2568606|NCT01300234|8884783|P1|Overall Study|Pregnancy|2
2568607|NCT01300234|8884782|P2|Overall Study|Lost to Follow-up|12
2568608|NCT01300234|8884783|P1|Overall Study|Lost to Follow-up|14
2568609|NCT01300234|8884782|P2|Overall Study|Withdrawal by Subject|9
2568610|NCT01300234|8884783|P1|Overall Study|Withdrawal by Subject|5
2568611|NCT01300234|8884782|P2|Overall Study|Protocol Violation|3
2568612|NCT01300234|8884783|P1|Overall Study|Protocol Violation|2
2568613|NCT01300234|8884782|P2|Overall Study|Adverse Event|1
2568614|NCT01300234|8884783|P1|Overall Study|Adverse Event|1
2568615|NCT01300052|8884819|P2|Overall Study|Protocol Violation|1
2568616|NCT01300052|8884820|P1|Overall Study|Protocol Violation|1
2568617|NCT01300052|8884819|P2|Overall Study|Withdrawal by Subject|2
2568618|NCT01300052|8884820|P1|Overall Study|Withdrawal by Subject|2
2568619|NCT01300052|8884819|P2|Overall Study|Adverse Event|0
2568620|NCT01300052|8884820|P1|Overall Study|Adverse Event|3
2568621|NCT01299961|8884838|P1|Overall Study|Lost to Follow-up|1
2568622|NCT01299961|8884838|P1|Overall Study|Lack of Efficacy|2
2568623|NCT01299961|8884838|P1|Overall Study|Adverse Event|3
2568624|NCT01299909|8884847|P3|Overall Study|Lost to Follow-up|17
2568625|NCT01299909|8884848|P2|Overall Study|Lost to Follow-up|18
2568626|NCT01299909|8884849|P1|Overall Study|Lost to Follow-up|22
2568627|NCT01299896|8884864|P2|Overall Study|Lost to Follow-up|11
2568628|NCT01299896|8884865|P1|Overall Study|Lost to Follow-up|0
2568629|NCT01299896|8884864|P2|Overall Study|Withdrawal by Subject|7
2568630|NCT01299896|8884865|P1|Overall Study|Withdrawal by Subject|1
2568631|NCT01299805|8884873|P2|Overall Study|Adverse Event|0
2568632|NCT01299805|8884874|P1|Overall Study|Adverse Event|2
2568633|NCT01299766|8884904|P2|Overall Study|Withdrawal by Subject|19
2568634|NCT01299766|8884905|P1|Overall Study|Withdrawal by Subject|29
2568635|NCT01299766|8884904|P2|Overall Study|Death|4
2568636|NCT01299766|8884905|P1|Overall Study|Death|5
2568637|NCT01299727|8884916|P3|Overall Study|Completed the Treatment Period|3
2568638|NCT01299727|8884917|P2|Overall Study|Completed the Treatment Period|4
2568639|NCT01299727|8884918|P1|Overall Study|Completed the Treatment Period|3
2568640|NCT01299727|8884916|P3|Overall Study|Adverse Event|1
2568641|NCT01299727|8884917|P2|Overall Study|Adverse Event|0
2568642|NCT01299727|8884918|P1|Overall Study|Adverse Event|0
2568643|NCT01299727|8884916|P3|Overall Study|Withdrawal by Subject|0
2568644|NCT01299727|8884917|P2|Overall Study|Withdrawal by Subject|0
2568645|NCT01299727|8884918|P1|Overall Study|Withdrawal by Subject|1
2568646|NCT01299584|8885012|P1|Overall Study|Protocol Violation|9
2568647|NCT01299571|8885019|P1|Overall Study|Protocol Violation|107
2568648|NCT01299480|8885030|P5|Overall Study|Started, but not vaccinated|0
2568649|NCT01299480|8885031|P4|Overall Study|Started, but not vaccinated|1
2568650|NCT01299480|8885032|P3|Overall Study|Started, but not vaccinated|1
2568651|NCT01299480|8885033|P2|Overall Study|Started, but not vaccinated|0
2568652|NCT01299480|8885034|P1|Overall Study|Started, but not vaccinated|0
2568653|NCT01299480|8885030|P5|Overall Study|Other|3
2568654|NCT01299480|8885031|P4|Overall Study|Other|0
2568655|NCT01299480|8885032|P3|Overall Study|Other|3
2568656|NCT01299480|8885033|P2|Overall Study|Other|2
2568657|NCT01299480|8885034|P1|Overall Study|Other|3
2568658|NCT01299480|8885030|P5|Overall Study|Lost to Follow-up|2
2568659|NCT01299480|8885031|P4|Overall Study|Lost to Follow-up|1
2568660|NCT01299480|8885032|P3|Overall Study|Lost to Follow-up|2
2568661|NCT01299480|8885033|P2|Overall Study|Lost to Follow-up|1
2568662|NCT01299480|8885034|P1|Overall Study|Lost to Follow-up|3
2568663|NCT01299480|8885030|P5|Overall Study|Physician Decision|0
2568664|NCT01299480|8885031|P4|Overall Study|Physician Decision|2
2568665|NCT01299480|8885032|P3|Overall Study|Physician Decision|0
2568666|NCT01299480|8885033|P2|Overall Study|Physician Decision|1
2568667|NCT01299480|8885034|P1|Overall Study|Physician Decision|1
2568668|NCT01299480|8885030|P5|Overall Study|Withdrawal due to pregnancy|0
2568669|NCT01299480|8885031|P4|Overall Study|Withdrawal due to pregnancy|0
2568670|NCT01299480|8885032|P3|Overall Study|Withdrawal due to pregnancy|1
2568671|NCT01299480|8885033|P2|Overall Study|Withdrawal due to pregnancy|1
2568672|NCT01299480|8885034|P1|Overall Study|Withdrawal due to pregnancy|0
2568673|NCT01299480|8885030|P5|Overall Study|Adverse Event|0
2568674|NCT01299480|8885031|P4|Overall Study|Adverse Event|4
2568675|NCT01299480|8885032|P3|Overall Study|Adverse Event|5
2568676|NCT01299480|8885033|P2|Overall Study|Adverse Event|4
2568677|NCT01299480|8885034|P1|Overall Study|Adverse Event|6
2568678|NCT01299480|8885030|P5|Overall Study|Withdrawal by Subject|4
2568679|NCT01299480|8885031|P4|Overall Study|Withdrawal by Subject|3
2568680|NCT01299480|8885032|P3|Overall Study|Withdrawal by Subject|7
2568681|NCT01299480|8885033|P2|Overall Study|Withdrawal by Subject|4
2568682|NCT01299480|8885034|P1|Overall Study|Withdrawal by Subject|3
2568683|NCT01299480|8885030|P5|Overall Study|Protocol Violation|1
2568684|NCT01299480|8885031|P4|Overall Study|Protocol Violation|1
2568685|NCT01299480|8885032|P3|Overall Study|Protocol Violation|8
2568686|NCT01299480|8885033|P2|Overall Study|Protocol Violation|5
2568687|NCT01299480|8885034|P1|Overall Study|Protocol Violation|7
2568688|NCT01299480|8885030|P5|Overall Study|No longer willing to participate|10
2568689|NCT01299480|8885031|P4|Overall Study|No longer willing to participate|13
2568690|NCT01299480|8885032|P3|Overall Study|No longer willing to participate|14
2568691|NCT01299480|8885033|P2|Overall Study|No longer willing to participate|17
2568692|NCT01299480|8885034|P1|Overall Study|No longer willing to participate|19
2568693|NCT01299389|8885236|P4|Post-observational|Other|6
2568694|NCT01299389|8885237|P3|Post-observational|Other|12
2568695|NCT01299389|8885238|P2|Post-observational|Other|0
2568696|NCT01299389|8885239|P1|Post-observational|Other|0
2568697|NCT01299389|8885236|P4|Double-blind|fail to meet “study population” criteria|0
2568698|NCT01299389|8885237|P3|Double-blind|fail to meet “study population” criteria|0
2568699|NCT01299389|8885238|P2|Double-blind|fail to meet “study population” criteria|1
2568700|NCT01299389|8885239|P1|Double-blind|fail to meet “study population” criteria|0
2568701|NCT01299389|8885236|P4|Double-blind|Other|0
2568702|NCT01299389|8885237|P3|Double-blind|Other|0
2568703|NCT01299389|8885238|P2|Double-blind|Other|1
2568704|NCT01299389|8885239|P1|Double-blind|Other|1
2568705|NCT01299389|8885236|P4|Double-blind|Withdrawal by Subject|0
2568706|NCT01299389|8885237|P3|Double-blind|Withdrawal by Subject|0
2568707|NCT01299389|8885238|P2|Double-blind|Withdrawal by Subject|13
2568708|NCT01299389|8885239|P1|Double-blind|Withdrawal by Subject|16
2568709|NCT01299389|8885236|P4|Double-blind|Lost to Follow-up|0
2568710|NCT01299389|8885237|P3|Double-blind|Lost to Follow-up|0
2568711|NCT01299389|8885238|P2|Double-blind|Lost to Follow-up|1
2568712|NCT01299389|8885239|P1|Double-blind|Lost to Follow-up|2
2568713|NCT01299389|8885236|P4|Double-blind|Lack of Efficacy|0
2568714|NCT01299389|8885237|P3|Double-blind|Lack of Efficacy|0
2568715|NCT01299389|8885238|P2|Double-blind|Lack of Efficacy|21
2568716|NCT01299389|8885239|P1|Double-blind|Lack of Efficacy|45
2568717|NCT01299389|8885236|P4|Double-blind|Adverse Event|0
2568718|NCT01299389|8885237|P3|Double-blind|Adverse Event|0
2568719|NCT01299389|8885238|P2|Double-blind|Adverse Event|27
2568720|NCT01299389|8885239|P1|Double-blind|Adverse Event|45
2568721|NCT01299376|8885261|P2|Extension (Weeks 9 to 52)|Physician Decision|0
2568722|NCT01299376|8885262|P1|Extension (Weeks 9 to 52)|Physician Decision|1
2568723|NCT01299376|8885261|P2|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9
2568724|NCT01299376|8885262|P1|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4
2568725|NCT01299376|8885261|P2|Extension (Weeks 9 to 52)|Lost to Follow-up|2
2568726|NCT01299376|8885262|P1|Extension (Weeks 9 to 52)|Lost to Follow-up|1
2568727|NCT01299376|8885261|P2|Extension (Weeks 9 to 52)|Adverse Event|3
2568728|NCT01299376|8885262|P1|Extension (Weeks 9 to 52)|Adverse Event|2
2568729|NCT01299376|8885261|P2|Extension (Weeks 9 to 52)|Withdrawal by Subject|1
2568730|NCT01299376|8885262|P1|Extension (Weeks 9 to 52)|Withdrawal by Subject|2
2568731|NCT01299376|8885261|P2|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
2568732|NCT01299376|8885262|P1|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
2568733|NCT01299376|8885261|P2|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0
2568734|NCT01299376|8885262|P1|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1
2568735|NCT01299376|8885261|P2|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7
2568736|NCT01299376|8885262|P1|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4
2568737|NCT01299376|8885261|P2|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1
2568738|NCT01299376|8885262|P1|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0
2568739|NCT01299376|8885261|P2|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1
2568740|NCT01299376|8885262|P1|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0
2568741|NCT01299376|8885261|P2|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2
2568742|NCT01299376|8885262|P1|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1
2568743|NCT01299272|8885305|P4|Double-blind (DB) Randomized Period|Sponsor Decision|1
2568744|NCT01299272|8885306|P3|Double-blind (DB) Randomized Period|Sponsor Decision|1
2568745|NCT01299272|8885307|P2|Double-blind (DB) Randomized Period|Sponsor Decision|0
2568746|NCT01299272|8885308|P1|Double-blind (DB) Randomized Period|Sponsor Decision|0
2568747|NCT01299272|8885305|P4|Double-blind (DB) Randomized Period|Physician Decision|1
2568748|NCT01299272|8885306|P3|Double-blind (DB) Randomized Period|Physician Decision|2
2568749|NCT01299272|8885307|P2|Double-blind (DB) Randomized Period|Physician Decision|0
2568750|NCT01299272|8885308|P1|Double-blind (DB) Randomized Period|Physician Decision|0
2568751|NCT01299272|8885305|P4|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10
2568752|NCT01299272|8885306|P3|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4
2568753|NCT01299272|8885307|P2|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
2568754|NCT01299272|8885308|P1|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
2568755|NCT01299272|8885305|P4|Double-blind (DB) Randomized Period|Lost to Follow-up|5
2568756|NCT01299272|8885306|P3|Double-blind (DB) Randomized Period|Lost to Follow-up|5
2568757|NCT01299272|8885307|P2|Double-blind (DB) Randomized Period|Lost to Follow-up|0
2568758|NCT01299272|8885308|P1|Double-blind (DB) Randomized Period|Lost to Follow-up|0
2568759|NCT01299272|8885305|P4|Double-blind (DB) Randomized Period|Protocol Violation|7
2568760|NCT01299272|8885306|P3|Double-blind (DB) Randomized Period|Protocol Violation|8
2568761|NCT01299272|8885307|P2|Double-blind (DB) Randomized Period|Protocol Violation|0
2568762|NCT01299272|8885308|P1|Double-blind (DB) Randomized Period|Protocol Violation|0
2568763|NCT01299272|8885305|P4|Double-blind (DB) Randomized Period|Adverse Event|9
2568764|NCT01299272|8885306|P3|Double-blind (DB) Randomized Period|Adverse Event|8
2568765|NCT01299272|8885307|P2|Double-blind (DB) Randomized Period|Adverse Event|0
2568766|NCT01299272|8885308|P1|Double-blind (DB) Randomized Period|Adverse Event|0
2568767|NCT01299272|8885305|P4|Double-blind (DB) Randomized Period|Lack of Efficacy|10
2568768|NCT01299272|8885306|P3|Double-blind (DB) Randomized Period|Lack of Efficacy|20
2568769|NCT01299272|8885307|P2|Double-blind (DB) Randomized Period|Lack of Efficacy|0
2568770|NCT01299272|8885308|P1|Double-blind (DB) Randomized Period|Lack of Efficacy|0
2568771|NCT01299272|8885305|P4|Double-blind (DB) Randomized Period|Withdrawal by Subject|15
2568772|NCT01299272|8885306|P3|Double-blind (DB) Randomized Period|Withdrawal by Subject|22
2568773|NCT01299272|8885307|P2|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
2568774|NCT01299272|8885308|P1|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
2568775|NCT01299272|8885305|P4|Stabilization Open-label (OL) Period|Physician Decision|0
2568776|NCT01299272|8885306|P3|Stabilization Open-label (OL) Period|Physician Decision|0
2568777|NCT01299272|8885307|P2|Stabilization Open-label (OL) Period|Physician Decision|3
2568778|NCT01299272|8885308|P1|Stabilization Open-label (OL) Period|Physician Decision|0
2568779|NCT01299272|8885305|P4|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
2568780|NCT01299272|8885306|P3|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
2568781|NCT01299272|8885307|P2|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6
2568782|NCT01299272|8885308|P1|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
2568783|NCT01299272|8885305|P4|Stabilization Open-label (OL) Period|Lost to Follow-up|0
2568784|NCT01299272|8885306|P3|Stabilization Open-label (OL) Period|Lost to Follow-up|0
2568785|NCT01299272|8885307|P2|Stabilization Open-label (OL) Period|Lost to Follow-up|9
2568786|NCT01299272|8885308|P1|Stabilization Open-label (OL) Period|Lost to Follow-up|0
2568787|NCT01299272|8885305|P4|Stabilization Open-label (OL) Period|Lack of Efficacy|0
2568788|NCT01299272|8885306|P3|Stabilization Open-label (OL) Period|Lack of Efficacy|0
2568789|NCT01299272|8885307|P2|Stabilization Open-label (OL) Period|Lack of Efficacy|11
2568790|NCT01299272|8885308|P1|Stabilization Open-label (OL) Period|Lack of Efficacy|0
2568791|NCT01299272|8885305|P4|Stabilization Open-label (OL) Period|Sponsor Decision|0
2568792|NCT01299272|8885306|P3|Stabilization Open-label (OL) Period|Sponsor Decision|0
2568793|NCT01299272|8885307|P2|Stabilization Open-label (OL) Period|Sponsor Decision|12
2568794|NCT01299272|8885308|P1|Stabilization Open-label (OL) Period|Sponsor Decision|0
2568795|NCT01299272|8885305|P4|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
2568796|NCT01299272|8885306|P3|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
2568797|NCT01299272|8885307|P2|Stabilization Open-label (OL) Period|Withdrawal by Subject|42
2568798|NCT01299272|8885308|P1|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
2568799|NCT01299272|8885305|P4|Stabilization Open-label (OL) Period|Adverse Event|0
2568800|NCT01299272|8885306|P3|Stabilization Open-label (OL) Period|Adverse Event|0
2568801|NCT01299272|8885307|P2|Stabilization Open-label (OL) Period|Adverse Event|42
2568802|NCT01299272|8885308|P1|Stabilization Open-label (OL) Period|Adverse Event|0
2568803|NCT01299272|8885305|P4|Stabilization Open-label (OL) Period|Protocol Violation|0
2568804|NCT01299272|8885306|P3|Stabilization Open-label (OL) Period|Protocol Violation|0
2568805|NCT01299272|8885307|P2|Stabilization Open-label (OL) Period|Protocol Violation|44
2568806|NCT01299272|8885308|P1|Stabilization Open-label (OL) Period|Protocol Violation|0
2568807|NCT01299272|8885305|P4|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
2568808|NCT01299272|8885306|P3|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
2568809|NCT01299272|8885307|P2|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80
2568810|NCT01299272|8885308|P1|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
2568811|NCT01299272|8885305|P4|Acute Open-label (OL) Period|Physician Decision|0
2568812|NCT01299272|8885306|P3|Acute Open-label (OL) Period|Physician Decision|0
2568813|NCT01299272|8885307|P2|Acute Open-label (OL) Period|Physician Decision|0
2568814|NCT01299272|8885308|P1|Acute Open-label (OL) Period|Physician Decision|5
2568815|NCT01299272|8885305|P4|Acute Open-label (OL) Period|Lack of Efficacy|0
2568816|NCT01299272|8885306|P3|Acute Open-label (OL) Period|Lack of Efficacy|0
2568817|NCT01299272|8885307|P2|Acute Open-label (OL) Period|Lack of Efficacy|0
2568818|NCT01299272|8885308|P1|Acute Open-label (OL) Period|Lack of Efficacy|10
2568819|NCT01299272|8885305|P4|Acute Open-label (OL) Period|Sponsor Decision|0
2568820|NCT01299272|8885306|P3|Acute Open-label (OL) Period|Sponsor Decision|0
2568821|NCT01299272|8885307|P2|Acute Open-label (OL) Period|Sponsor Decision|0
2568822|NCT01299272|8885308|P1|Acute Open-label (OL) Period|Sponsor Decision|13
2568823|NCT01299272|8885305|P4|Acute Open-label (OL) Period|Lost to Follow-up|0
2568824|NCT01299272|8885306|P3|Acute Open-label (OL) Period|Lost to Follow-up|0
2568825|NCT01299272|8885307|P2|Acute Open-label (OL) Period|Lost to Follow-up|0
2568826|NCT01299272|8885308|P1|Acute Open-label (OL) Period|Lost to Follow-up|14
2568827|NCT01299272|8885305|P4|Acute Open-label (OL) Period|Protocol Violation|0
2568828|NCT01299272|8885306|P3|Acute Open-label (OL) Period|Protocol Violation|0
2568829|NCT01299272|8885307|P2|Acute Open-label (OL) Period|Protocol Violation|0
2568830|NCT01299272|8885308|P1|Acute Open-label (OL) Period|Protocol Violation|36
2568831|NCT01299272|8885305|P4|Acute Open-label (OL) Period|Withdrawal by Subject|0
2568832|NCT01299272|8885306|P3|Acute Open-label (OL) Period|Withdrawal by Subject|0
2568833|NCT01299272|8885307|P2|Acute Open-label (OL) Period|Withdrawal by Subject|0
2568834|NCT01299272|8885308|P1|Acute Open-label (OL) Period|Withdrawal by Subject|56
2568835|NCT01299272|8885305|P4|Acute Open-label (OL) Period|Adverse Event|0
2568836|NCT01299272|8885306|P3|Acute Open-label (OL) Period|Adverse Event|0
2568837|NCT01299272|8885307|P2|Acute Open-label (OL) Period|Adverse Event|0
2568838|NCT01299272|8885308|P1|Acute Open-label (OL) Period|Adverse Event|140
2568839|NCT01299272|8885305|P4|Acute Open-label (OL) Period|Remission Criteria Not Met|0
2568840|NCT01299272|8885306|P3|Acute Open-label (OL) Period|Remission Criteria Not Met|0
2568841|NCT01299272|8885307|P2|Acute Open-label (OL) Period|Remission Criteria Not Met|0
2568842|NCT01299272|8885308|P1|Acute Open-label (OL) Period|Remission Criteria Not Met|140
2568843|NCT01299116|8885363|P3|Overall Study|Lost to Follow-up|11
2568844|NCT01299116|8885364|P2|Overall Study|Lost to Follow-up|9
2568845|NCT01299116|8885365|P1|Overall Study|Lost to Follow-up|65
2568846|NCT01299038|8885410|P2|Overall Study|Withdrawal by Subject|0
2568847|NCT01299038|8885411|P1|Overall Study|Withdrawal by Subject|1
2568848|NCT01299025|8885419|P2|Overall Study|Lost to Follow-up|0
2568849|NCT01299025|8885420|P1|Overall Study|Lost to Follow-up|1
2568850|NCT01299025|8885419|P2|Overall Study|Withdrawal by Subject|1
2568851|NCT01299025|8885420|P1|Overall Study|Withdrawal by Subject|2
2568852|NCT01298778|8885445|P2|Overall Study|not meet inclusion/exclusion criteria|1
2568853|NCT01298778|8885446|P1|Overall Study|not meet inclusion/exclusion criteria|0
2568854|NCT01298778|8885445|P2|Overall Study|Protocol Violation|1
2568855|NCT01298778|8885446|P1|Overall Study|Protocol Violation|0
2568856|NCT01298778|8885445|P2|Overall Study|Withdrawal by Subject|1
2568857|NCT01298778|8885446|P1|Overall Study|Withdrawal by Subject|0
2568858|NCT01298778|8885445|P2|Overall Study|Incorrect use of VAS|0
2568859|NCT01298778|8885446|P1|Overall Study|Incorrect use of VAS|1
2568860|NCT01298778|8885445|P2|Overall Study|Lost to Follow-up|3
2568861|NCT01298778|8885446|P1|Overall Study|Lost to Follow-up|2
2568862|NCT01298765|8885466|P1|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46
2568863|NCT01298765|8885466|P1|Long-Term Treatment Period|Physician Decision|1
2568864|NCT01298765|8885466|P1|Long-Term Treatment Period|Withdrawal by Subject|19
2568865|NCT01298765|8885466|P1|Long-Term Treatment Period|Lost to Follow-up|8
2568866|NCT01298765|8885466|P1|Long-Term Treatment Period|Lack of Efficacy|6
2568867|NCT01298765|8885466|P1|Long-Term Treatment Period|Adverse Event|19
2568868|NCT01298765|8885466|P1|Titration Period|Other: Not Lack of Analgesic Effect|8
2568869|NCT01298765|8885466|P1|Titration Period|Withdrawal by Subject|10
2568870|NCT01298765|8885466|P1|Titration Period|Physician Decision|1
2568871|NCT01298765|8885466|P1|Titration Period|Lost to Follow-up|9
2568872|NCT01298765|8885466|P1|Titration Period|Lack of Efficacy|21
2568873|NCT01298765|8885466|P1|Titration Period|Death|1
2568874|NCT01298765|8885466|P1|Titration Period|Adverse Event|26
2568875|NCT01298700|8885476|P2|Overall Study|Did not Receive Study Drug|5
2568876|NCT01298700|8885477|P1|Overall Study|Did not Receive Study Drug|3
2568877|NCT01298700|8885476|P2|Overall Study|Other Miscellaneous Reasons|15
2568878|NCT01298700|8885477|P1|Overall Study|Other Miscellaneous Reasons|16
2568879|NCT01298700|8885476|P2|Overall Study|Protocol Violation|4
2568880|NCT01298700|8885477|P1|Overall Study|Protocol Violation|6
2568881|NCT01298700|8885476|P2|Overall Study|Withdrawal by Subject|9
2568882|NCT01298700|8885477|P1|Overall Study|Withdrawal by Subject|12
2568883|NCT01298700|8885476|P2|Overall Study|Lost to Follow-up|2
2568884|NCT01298700|8885477|P1|Overall Study|Lost to Follow-up|5
2568885|NCT01298700|8885476|P2|Overall Study|Lack of Efficacy|14
2568886|NCT01298700|8885477|P1|Overall Study|Lack of Efficacy|9
2568887|NCT01298700|8885476|P2|Overall Study|Adverse Event|51
2568888|NCT01298700|8885477|P1|Overall Study|Adverse Event|50
2568889|NCT01298661|8885488|P3|Overall Study|Withdrawal by Subject|2
2568890|NCT01298661|8885489|P2|Overall Study|Withdrawal by Subject|0
2568891|NCT01298661|8885490|P1|Overall Study|Withdrawal by Subject|2
2568892|NCT01298648|8885568|P1|Overall Study|Lost to Follow-up|21
2568893|NCT01298648|8885568|P1|Overall Study|Withdrawal by Subject|2
2568894|NCT01298596|8885579|P2|Overall Study|Referred for further management|15
2568895|NCT01298596|8885580|P1|Overall Study|Referred for further management|16
2568896|NCT01298596|8885579|P2|Overall Study|Lost to Follow-up|14
2568897|NCT01298596|8885580|P1|Overall Study|Lost to Follow-up|6
2568898|NCT01298596|8885579|P2|Overall Study|Death|3
2568899|NCT01298596|8885580|P1|Overall Study|Death|5
2568900|NCT01298596|8885579|P2|Overall Study|Withdrawal by Subject|1
2568901|NCT01298596|8885580|P1|Overall Study|Withdrawal by Subject|1
2568902|NCT01298570|8885590|P2|Overall Study|Ineligibility|1
2568903|NCT01298570|8885591|P1|Overall Study|Ineligibility|0
2568904|NCT01298570|8885590|P2|Overall Study|Death|1
2568905|NCT01298570|8885591|P1|Overall Study|Death|0
2568906|NCT01298570|8885590|P2|Overall Study|Symptomatic progression/deterioration|2
2568907|NCT01298570|8885591|P1|Overall Study|Symptomatic progression/deterioration|3
2568908|NCT01298570|8885590|P2|Overall Study|Surgery|1
2568909|NCT01298570|8885591|P1|Overall Study|Surgery|2
2568910|NCT01298570|8885590|P2|Overall Study|Other complicating disease|1
2568911|NCT01298570|8885591|P1|Overall Study|Other complicating disease|2
2568912|NCT01298570|8885590|P2|Overall Study|Physician Decision|2
2568913|NCT01298570|8885591|P1|Overall Study|Physician Decision|4
2568914|NCT01298570|8885590|P2|Overall Study|Treatment delay > 4 weeks|5
2568915|NCT01298570|8885591|P1|Overall Study|Treatment delay > 4 weeks|4
2568916|NCT01298570|8885590|P2|Overall Study|Withdrawal by Subject|6
2568917|NCT01298570|8885591|P1|Overall Study|Withdrawal by Subject|21
2568918|NCT01298570|8885590|P2|Overall Study|Adverse Event|2
2568919|NCT01298570|8885591|P1|Overall Study|Adverse Event|20
2568920|NCT01298570|8885590|P2|Overall Study|Disease progression, relapse during acti|40
2568921|NCT01298570|8885591|P1|Overall Study|Disease progression, relapse during acti|64
2568922|NCT01298531|8885618|P2|Overall Study|Other|1
2568923|NCT01298531|8885619|P1|Overall Study|Other|2
2568924|NCT01298531|8885618|P2|Overall Study|Does not meet entrance criteria|1
2568925|NCT01298531|8885619|P1|Overall Study|Does not meet entrance criteria|0
2568926|NCT01298531|8885618|P2|Overall Study|Adverse Event|3
2568927|NCT01298531|8885619|P1|Overall Study|Adverse Event|4
2568928|NCT01298531|8885618|P2|Overall Study|Protocol Violation|1
2568929|NCT01298531|8885619|P1|Overall Study|Protocol Violation|1
2568930|NCT01298531|8885618|P2|Overall Study|Lost to Follow-up|0
2568931|NCT01298531|8885619|P1|Overall Study|Lost to Follow-up|2
2568932|NCT01298531|8885618|P2|Overall Study|Lack of Efficacy|1
2568933|NCT01298531|8885619|P1|Overall Study|Lack of Efficacy|0
2568934|NCT01298518|8885748|P3|Overall Study|Withdrawal by Subject|1
2568935|NCT01298518|8885749|P2|Overall Study|Withdrawal by Subject|0
2568936|NCT01298518|8885750|P1|Overall Study|Withdrawal by Subject|0
2568937|NCT01298492|8885802|P1|Overall Study|Adverse Event(Not Related to Study Drug)|18
2568938|NCT01298492|8885802|P1|Overall Study|Adverse Event(Related to Study Drug)|8
2568939|NCT01298492|8885802|P1|Overall Study|Protocol Violation|2
2568940|NCT01298492|8885802|P1|Overall Study|Withdrawn Due to Pregnancy|1
2568941|NCT01298492|8885802|P1|Overall Study|Other (Unspecified)|7
2568942|NCT01298492|8885802|P1|Overall Study|Withdrawal by Subject|47
2568943|NCT01298492|8885802|P1|Overall Study|Lost to Follow-up|12
2568944|NCT01298492|8885802|P1|Overall Study|Insufficient Clinical Response|22
2568945|NCT01298492|8885802|P1|Overall Study|Death|2
2568946|NCT01298362|8885810|P2|Overall Study|Did not provide 12month BMD measurements|43
2568947|NCT01298362|8885811|P1|Overall Study|Did not provide 12month BMD measurements|38
2568948|NCT01298323|8885831|P2|Overall Study|Eligibility criteria not fulfilled|1
2568949|NCT01298323|8885832|P1|Overall Study|Eligibility criteria not fulfilled|0
2568950|NCT01298323|8885831|P2|Overall Study|Ongoing|55
2568951|NCT01298323|8885832|P1|Overall Study|Ongoing|55
2568952|NCT01298323|8885831|P2|Overall Study|Other|9
2568953|NCT01298323|8885832|P1|Overall Study|Other|10
2568954|NCT01298323|8885831|P2|Overall Study|Protocol Violation|0
2568955|NCT01298323|8885832|P1|Overall Study|Protocol Violation|1
2568956|NCT01298323|8885831|P2|Overall Study|Withdrawal by Subject|3
2568957|NCT01298323|8885832|P1|Overall Study|Withdrawal by Subject|6
2568958|NCT01298323|8885831|P2|Overall Study|Lost to Follow-up|0
2568959|NCT01298323|8885832|P1|Overall Study|Lost to Follow-up|1
2568960|NCT01298323|8885831|P2|Overall Study|Death|16
2568961|NCT01298323|8885832|P1|Overall Study|Death|11
2568962|NCT01298323|8885831|P2|Overall Study|Adverse Event|4
2568963|NCT01298323|8885832|P1|Overall Study|Adverse Event|2
2568964|NCT01298193|8885855|P1|Efficacy Phase (Second Cycle)|Death|1
2568965|NCT01298193|8885855|P1|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9
2568966|NCT01298193|8885855|P1|Observational Phase (First Cycle)|Received TC at a different dose|16
2568967|NCT01298193|8885855|P1|Observational Phase (First Cycle)|Withdrawal by Subject|2
2568968|NCT01298141|8885877|P1|Overall Study|Not treated|4
2568969|NCT01298141|8885877|P1|Overall Study|Death|6
2568970|NCT01298141|8885877|P1|Overall Study|Lost to Follow-up|1
2568971|NCT01298141|8885877|P1|Overall Study|Other|5
2568972|NCT01298141|8885877|P1|Overall Study|Termination of Study by the Investigator|5
2568973|NCT01298141|8885877|P1|Overall Study|Withdrawal by Subject|6
2568974|NCT01298141|8885877|P1|Overall Study|Refusal of Required Study Procedures|1
2568975|NCT01298141|8885877|P1|Overall Study|Adverse Event|3
2568976|NCT01297920|8885952|P3|Overall Study|Patient Did Not Meet Entrance Criteria|0
2568977|NCT01297920|8885953|P2|Overall Study|Patient Did Not Meet Entrance Criteria|0
2568978|NCT01297920|8885954|P1|Overall Study|Patient Did Not Meet Entrance Criteria|1
2568979|NCT01297920|8885952|P3|Overall Study|Inadequate Control of IOP|17
2568980|NCT01297920|8885953|P2|Overall Study|Inadequate Control of IOP|9
2568981|NCT01297920|8885954|P1|Overall Study|Inadequate Control of IOP|7
2568982|NCT01297920|8885952|P3|Overall Study|Protocol Violation|0
2568983|NCT01297920|8885953|P2|Overall Study|Protocol Violation|3
2568984|NCT01297920|8885954|P1|Overall Study|Protocol Violation|1
2568985|NCT01297920|8885952|P3|Overall Study|Noncompliance|0
2568986|NCT01297920|8885953|P2|Overall Study|Noncompliance|0
2568987|NCT01297920|8885954|P1|Overall Study|Noncompliance|1
2568988|NCT01297920|8885952|P3|Overall Study|Patient Decision Unrelated to AE|2
2568989|NCT01297920|8885953|P2|Overall Study|Patient Decision Unrelated to AE|5
2568990|NCT01297920|8885954|P1|Overall Study|Patient Decision Unrelated to AE|6
2568991|NCT01297920|8885952|P3|Overall Study|Adverse Event|38
2568992|NCT01297920|8885953|P2|Overall Study|Adverse Event|10
2568993|NCT01297920|8885954|P1|Overall Study|Adverse Event|42
2568994|NCT01297517|8885998|P3|Overall Study|Inadequate Control of IOP|2
2568995|NCT01297517|8885999|P2|Overall Study|Inadequate Control of IOP|1
2568996|NCT01297517|8886000|P1|Overall Study|Inadequate Control of IOP|1
2568997|NCT01297517|8885998|P3|Overall Study|Protocol Violation|1
2568998|NCT01297517|8885999|P2|Overall Study|Protocol Violation|1
2568999|NCT01297517|8886000|P1|Overall Study|Protocol Violation|1
2569000|NCT01297517|8885998|P3|Overall Study|Noncompliance|0
2569001|NCT01297517|8885999|P2|Overall Study|Noncompliance|0
2569002|NCT01297517|8886000|P1|Overall Study|Noncompliance|1
2569003|NCT01297517|8885998|P3|Overall Study|Patient Decision Unrelated to AE|7
2569004|NCT01297517|8885999|P2|Overall Study|Patient Decision Unrelated to AE|3
2569005|NCT01297517|8886000|P1|Overall Study|Patient Decision Unrelated to AE|2
2569006|NCT01297517|8885998|P3|Overall Study|Lost to Follow-up|1
2569007|NCT01297517|8885999|P2|Overall Study|Lost to Follow-up|0
2569008|NCT01297517|8886000|P1|Overall Study|Lost to Follow-up|1
2569009|NCT01297517|8885998|P3|Overall Study|Adverse Event|16
2569010|NCT01297517|8885999|P2|Overall Study|Adverse Event|7
2569011|NCT01297517|8886000|P1|Overall Study|Adverse Event|21
2569012|NCT01297504|8886008|P1|Overall Study|Protocol Violation|3
2569013|NCT01297504|8886008|P1|Overall Study|Site Closure|3
2569014|NCT01297504|8886008|P1|Overall Study|Withdrawal by Subject|9
2569015|NCT01297504|8886008|P1|Overall Study|Lost to Follow-up|43
2569016|NCT01297504|8886008|P1|Overall Study|Death|3
2569017|NCT01297504|8886008|P1|Overall Study|No Study Visits|4
2569018|NCT01297504|8886008|P1|Overall Study|Received Palivizumab in Previous Season|1
2569019|NCT01297504|8886008|P1|Overall Study|Invalid Consent|1
2569020|NCT01297491|8886022|P2|Overall Study|Death|1
2569021|NCT01297491|8886023|P1|Overall Study|Death|2
2569022|NCT01297491|8886022|P2|Overall Study|Patient/Guardian decision|4
2569023|NCT01297491|8886023|P1|Overall Study|Patient/Guardian decision|3
2569024|NCT01297491|8886022|P2|Overall Study|Progressive disease|20
2569025|NCT01297491|8886023|P1|Overall Study|Progressive disease|11
2569026|NCT01297491|8886022|P2|Overall Study|Physician Decision|2
2569027|NCT01297491|8886023|P1|Overall Study|Physician Decision|3
2569028|NCT01297491|8886022|P2|Overall Study|Adverse Event|6
2569029|NCT01297491|8886023|P1|Overall Study|Adverse Event|11
2569030|NCT01297465|8886041|P2|Overall Study|Intention to Freeze all Embryos|1
2569031|NCT01297465|8886042|P1|Overall Study|Intention to Freeze all Embryos|0
2569032|NCT01297465|8886041|P2|Overall Study|All Embryos Discarded|1
2569033|NCT01297465|8886042|P1|Overall Study|All Embryos Discarded|0
2569034|NCT01297465|8886041|P2|Overall Study|No Fertilization|4
2569035|NCT01297465|8886042|P1|Overall Study|No Fertilization|6
2569036|NCT01297465|8886041|P2|Overall Study|Poor oocyte quality|1
2569037|NCT01297465|8886042|P1|Overall Study|Poor oocyte quality|0
2569038|NCT01297465|8886041|P2|Overall Study|No Oocytes Retrieved|1
2569039|NCT01297465|8886042|P1|Overall Study|No Oocytes Retrieved|1
2569040|NCT01297465|8886041|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
2569041|NCT01297465|8886042|P1|Overall Study|Ovarian hyperstimulation syndrome risk|0
2569042|NCT01297465|8886041|P2|Overall Study|Lack of Ovarian Response|1
2569043|NCT01297465|8886042|P1|Overall Study|Lack of Ovarian Response|1
2569044|NCT01297322|8886095|P2|Overall Study|Protocol Violation|3
2569045|NCT01297322|8886096|P1|Overall Study|Protocol Violation|0
2569046|NCT01297322|8886095|P2|Overall Study|Withdrawal by Subject|1
2569047|NCT01297322|8886096|P1|Overall Study|Withdrawal by Subject|0
2569048|NCT01297322|8886095|P2|Overall Study|Lost to Follow-up|0
2569049|NCT01297322|8886096|P1|Overall Study|Lost to Follow-up|1
2569050|NCT01297309|8886115|P1|Overall Study|Participant not entering extensionperiod|1
2569051|NCT01297309|8886115|P1|Overall Study|Death|1
2569052|NCT01297309|8886115|P1|Overall Study|Investigator Decision|2
2569053|NCT01297309|8886115|P1|Overall Study|Adverse Event|1
2569054|NCT01297309|8886115|P1|Overall Study|Withdrawal by Subject|5
2569055|NCT01297309|8886115|P1|Overall Study|Screen failure|2
2569056|NCT01297309|8886115|P1|Overall Study|Eligibility failure|2
2569057|NCT01297270|8886140|P3|Overall Study|Not treated|0
2569058|NCT01297270|8886141|P2|Overall Study|Not treated|1
2569059|NCT01297270|8886142|P1|Overall Study|Not treated|0
2569060|NCT01297270|8886140|P3|Overall Study|Other reason not defined above|1
2569061|NCT01297270|8886141|P2|Overall Study|Other reason not defined above|3
2569062|NCT01297270|8886142|P1|Overall Study|Other reason not defined above|3
2569063|NCT01297270|8886140|P3|Overall Study|Withdrawal by Subject|7
2569064|NCT01297270|8886141|P2|Overall Study|Withdrawal by Subject|15
2569065|NCT01297270|8886142|P1|Overall Study|Withdrawal by Subject|7
2569066|NCT01297270|8886140|P3|Overall Study|Protocol Violation|0
2569067|NCT01297270|8886141|P2|Overall Study|Protocol Violation|2
2569068|NCT01297270|8886142|P1|Overall Study|Protocol Violation|0
2569069|NCT01297270|8886140|P3|Overall Study|Lost to Follow-up|1
2569070|NCT01297270|8886141|P2|Overall Study|Lost to Follow-up|2
2569071|NCT01297270|8886142|P1|Overall Study|Lost to Follow-up|1
2569072|NCT01297270|8886140|P3|Overall Study|Lack of Efficacy|15
2569073|NCT01297270|8886141|P2|Overall Study|Lack of Efficacy|17
2569074|NCT01297270|8886142|P1|Overall Study|Lack of Efficacy|15
2569075|NCT01297270|8886140|P3|Overall Study|Adverse Event|5
2569076|NCT01297270|8886141|P2|Overall Study|Adverse Event|32
2569077|NCT01297270|8886142|P1|Overall Study|Adverse Event|19
2569078|NCT01297062|8886191|P7|Overall Study|Subject Decision|2
2569079|NCT01297062|8886192|P6|Overall Study|Subject Decision|1
2569080|NCT01297062|8886193|P5|Overall Study|Subject Decision|1
2569081|NCT01297062|8886194|P4|Overall Study|Subject Decision|1
2569082|NCT01297062|8886195|P3|Overall Study|Subject Decision|0
2569083|NCT01297062|8886196|P2|Overall Study|Subject Decision|1
2569084|NCT01297062|8886197|P1|Overall Study|Subject Decision|1
2569085|NCT01297062|8886191|P7|Overall Study|Protocol Violation|0
2569086|NCT01297062|8886192|P6|Overall Study|Protocol Violation|0
2569087|NCT01297062|8886193|P5|Overall Study|Protocol Violation|1
2569088|NCT01297062|8886194|P4|Overall Study|Protocol Violation|0
2569089|NCT01297062|8886195|P3|Overall Study|Protocol Violation|0
2569090|NCT01297062|8886196|P2|Overall Study|Protocol Violation|0
2569091|NCT01297062|8886197|P1|Overall Study|Protocol Violation|0
2569092|NCT01297062|8886191|P7|Overall Study|Physician Decision|6
2569093|NCT01297062|8886192|P6|Overall Study|Physician Decision|0
2569094|NCT01297062|8886193|P5|Overall Study|Physician Decision|0
2569095|NCT01297062|8886194|P4|Overall Study|Physician Decision|0
2569096|NCT01297062|8886195|P3|Overall Study|Physician Decision|1
2569097|NCT01297062|8886196|P2|Overall Study|Physician Decision|0
2569098|NCT01297062|8886197|P1|Overall Study|Physician Decision|1
2569099|NCT01297062|8886191|P7|Overall Study|Adverse Event|0
2569100|NCT01297062|8886192|P6|Overall Study|Adverse Event|0
2569101|NCT01297062|8886193|P5|Overall Study|Adverse Event|0
2569102|NCT01297062|8886194|P4|Overall Study|Adverse Event|0
2569103|NCT01297062|8886195|P3|Overall Study|Adverse Event|1
2569104|NCT01297062|8886196|P2|Overall Study|Adverse Event|0
2569105|NCT01297062|8886197|P1|Overall Study|Adverse Event|2
2569106|NCT01296698|8886259|P2|Overall Study|Study Terminated by Sponsor|12
2569107|NCT01296698|8886260|P1|Overall Study|Study Terminated by Sponsor|209
2569108|NCT01296698|8886259|P2|Overall Study|Difficulty Contacting Subject|0
2569109|NCT01296698|8886260|P1|Overall Study|Difficulty Contacting Subject|2
2569110|NCT01296698|8886259|P2|Overall Study|Withdrawal by Subject|0
2569111|NCT01296698|8886260|P1|Overall Study|Withdrawal by Subject|12
2569112|NCT01296698|8886259|P2|Overall Study|Lost to Follow-up|1
2569113|NCT01296698|8886260|P1|Overall Study|Lost to Follow-up|19
2569114|NCT01296698|8886259|P2|Overall Study|Death|0
2569115|NCT01296698|8886260|P1|Overall Study|Death|1
2569116|NCT01296698|8886259|P2|Overall Study|Adverse Event|0
2569117|NCT01296698|8886260|P1|Overall Study|Adverse Event|1
2569118|NCT01296672|8886314|P2|Overall Study|Lost to Follow-up|18
2569119|NCT01296672|8886315|P1|Overall Study|Lost to Follow-up|73
2569120|NCT01296568|8886336|P1|Continued Access Phase|Disease Progression|1
2569121|NCT01296568|8886336|P1|Continued Access Phase|Withdrawal by Subject|1
2569122|NCT01296568|8886336|P1|Continued Access Phase|Lost to Follow-up|1
2569123|NCT01296412|8886352|P2|Overall Study|Withdrawal by Subject|13
2569124|NCT01296412|8886353|P1|Overall Study|Withdrawal by Subject|10
2569125|NCT01296412|8886352|P2|Overall Study|Pregnancy|1
2569126|NCT01296412|8886353|P1|Overall Study|Pregnancy|0
2569127|NCT01296412|8886352|P2|Overall Study|Physician Decision|3
2569128|NCT01296412|8886353|P1|Overall Study|Physician Decision|1
2569129|NCT01296412|8886352|P2|Overall Study|Other reason not specified|15
2569130|NCT01296412|8886353|P1|Overall Study|Other reason not specified|20
2569131|NCT01296412|8886352|P2|Overall Study|Non-compliance with study drug|2
2569132|NCT01296412|8886353|P1|Overall Study|Non-compliance with study drug|1
2569133|NCT01296412|8886352|P2|Overall Study|Lost to Follow-up|7
2569134|NCT01296412|8886353|P1|Overall Study|Lost to Follow-up|10
2569135|NCT01296412|8886352|P2|Overall Study|Lack of Efficacy|0
2569136|NCT01296412|8886353|P1|Overall Study|Lack of Efficacy|1
2569137|NCT01296412|8886352|P2|Overall Study|Adverse Event|29
2569138|NCT01296412|8886353|P1|Overall Study|Adverse Event|8
2569139|NCT01296347|8886376|P2|12 Month Follow up|Withdrawal by Subject|1
2569140|NCT01296347|8886377|P1|12 Month Follow up|Withdrawal by Subject|0
2569141|NCT01296347|8886376|P2|12 Month Follow up|Death|1
2569142|NCT01296347|8886377|P1|12 Month Follow up|Death|1
2569143|NCT01296347|8886376|P2|12 Month Follow up|Lost to Follow-up|1
2569144|NCT01296347|8886377|P1|12 Month Follow up|Lost to Follow-up|3
2569145|NCT01296347|8886376|P2|6 Month Follow up|Lost to Follow-up|1
2569146|NCT01296347|8886377|P1|6 Month Follow up|Lost to Follow-up|0
2569147|NCT01296347|8886376|P2|6 Month Follow up|Death|1
2569148|NCT01296347|8886377|P1|6 Month Follow up|Death|2
2569149|NCT01296347|8886376|P2|3 Month Follow up|Lost to Follow-up|1
2569150|NCT01296347|8886377|P1|3 Month Follow up|Lost to Follow-up|0
2569151|NCT01296347|8886376|P2|3 Month Follow up|Death|0
2569152|NCT01296347|8886377|P1|3 Month Follow up|Death|1
2569153|NCT01296347|8886376|P2|6 Week Follow up|Death|1
2569154|NCT01296347|8886377|P1|6 Week Follow up|Death|0
2569155|NCT01296347|8886376|P2|Allocation|not received infusion|0
2569156|NCT01296347|8886377|P1|Allocation|not received infusion|1
2569157|NCT01296347|8886376|P2|Allocation|Lack of Efficacy|2
2569158|NCT01296347|8886377|P1|Allocation|Lack of Efficacy|1
2569159|NCT01296347|8886376|P2|Allocation|Withdrawal by Subject|2
2569160|NCT01296347|8886377|P1|Allocation|Withdrawal by Subject|1
2569161|NCT01296152|8886402|P1|Overall Study|Unwilling to adhere to study requirement|1
2569162|NCT01296035|8886429|P1|Overall Study|Withdrawal by Subject|1
2569163|NCT01295905|8886436|P2|Overall Study|Met exclusion criteria|0
2569164|NCT01295905|8886437|P1|Overall Study|Met exclusion criteria|1
2569165|NCT01295905|8886436|P2|Overall Study|Did not meet inclusion criteria|0
2569166|NCT01295905|8886437|P1|Overall Study|Did not meet inclusion criteria|1
2569167|NCT01295827|8886481|P15|Overall Study|Other|0
2569168|NCT01295827|8886482|P14|Overall Study|Other|0
2569169|NCT01295827|8886483|P13|Overall Study|Other|0
2569170|NCT01295827|8886484|P12|Overall Study|Other|0
2569171|NCT01295827|8886485|P11|Overall Study|Other|2
2569172|NCT01295827|8886486|P10|Overall Study|Other|0
2569173|NCT01295827|8886487|P9|Overall Study|Other|1
2569174|NCT01295827|8886488|P8|Overall Study|Other|1
2569175|NCT01295827|8886489|P7|Overall Study|Other|1
2569176|NCT01295827|8886490|P6|Overall Study|Other|0
2569177|NCT01295827|8886491|P5|Overall Study|Other|0
2569178|NCT01295827|8886492|P4|Overall Study|Other|0
2569179|NCT01295827|8886493|P3|Overall Study|Other|0
2569180|NCT01295827|8886494|P2|Overall Study|Other|0
2569181|NCT01295827|8886495|P1|Overall Study|Other|0
2569182|NCT01295827|8886481|P15|Overall Study|Withdrawal by Subject|0
2569183|NCT01295827|8886482|P14|Overall Study|Withdrawal by Subject|0
2569184|NCT01295827|8886483|P13|Overall Study|Withdrawal by Subject|0
2569185|NCT01295827|8886484|P12|Overall Study|Withdrawal by Subject|13
2569186|NCT01295827|8886485|P11|Overall Study|Withdrawal by Subject|18
2569187|NCT01295827|8886486|P10|Overall Study|Withdrawal by Subject|2
2569188|NCT01295827|8886487|P9|Overall Study|Withdrawal by Subject|11
2569189|NCT01295827|8886488|P8|Overall Study|Withdrawal by Subject|35
2569190|NCT01295827|8886489|P7|Overall Study|Withdrawal by Subject|13
2569191|NCT01295827|8886490|P6|Overall Study|Withdrawal by Subject|1
2569192|NCT01295827|8886491|P5|Overall Study|Withdrawal by Subject|0
2569193|NCT01295827|8886492|P4|Overall Study|Withdrawal by Subject|0
2569194|NCT01295827|8886493|P3|Overall Study|Withdrawal by Subject|2
2569195|NCT01295827|8886494|P2|Overall Study|Withdrawal by Subject|0
2569196|NCT01295827|8886495|P1|Overall Study|Withdrawal by Subject|1
2569197|NCT01295827|8886481|P15|Overall Study|Screen Failure|0
2569198|NCT01295827|8886482|P14|Overall Study|Screen Failure|0
2569199|NCT01295827|8886483|P13|Overall Study|Screen Failure|0
2569200|NCT01295827|8886484|P12|Overall Study|Screen Failure|0
2569201|NCT01295827|8886485|P11|Overall Study|Screen Failure|1
2569202|NCT01295827|8886486|P10|Overall Study|Screen Failure|0
2569203|NCT01295827|8886487|P9|Overall Study|Screen Failure|2
2569204|NCT01295827|8886488|P8|Overall Study|Screen Failure|2
2569205|NCT01295827|8886489|P7|Overall Study|Screen Failure|2
2569206|NCT01295827|8886490|P6|Overall Study|Screen Failure|0
2569207|NCT01295827|8886491|P5|Overall Study|Screen Failure|0
2569208|NCT01295827|8886492|P4|Overall Study|Screen Failure|0
2569209|NCT01295827|8886493|P3|Overall Study|Screen Failure|0
2569210|NCT01295827|8886494|P2|Overall Study|Screen Failure|0
2569211|NCT01295827|8886495|P1|Overall Study|Screen Failure|0
2569212|NCT01295827|8886481|P15|Overall Study|Progressive Disease|0
2569213|NCT01295827|8886482|P14|Overall Study|Progressive Disease|0
2569214|NCT01295827|8886483|P13|Overall Study|Progressive Disease|0
2569215|NCT01295827|8886484|P12|Overall Study|Progressive Disease|136
2569216|NCT01295827|8886485|P11|Overall Study|Progressive Disease|175
2569217|NCT01295827|8886486|P10|Overall Study|Progressive Disease|40
2569218|NCT01295827|8886487|P9|Overall Study|Progressive Disease|85
2569219|NCT01295827|8886488|P8|Overall Study|Progressive Disease|144
2569220|NCT01295827|8886489|P7|Overall Study|Progressive Disease|87
2569221|NCT01295827|8886490|P6|Overall Study|Progressive Disease|1
2569222|NCT01295827|8886491|P5|Overall Study|Progressive Disease|0
2569223|NCT01295827|8886492|P4|Overall Study|Progressive Disease|2
2569224|NCT01295827|8886493|P3|Overall Study|Progressive Disease|5
2569225|NCT01295827|8886494|P2|Overall Study|Progressive Disease|1
2569226|NCT01295827|8886495|P1|Overall Study|Progressive Disease|2
2569227|NCT01295827|8886481|P15|Overall Study|Not Reported|0
2569228|NCT01295827|8886482|P14|Overall Study|Not Reported|0
2569229|NCT01295827|8886483|P13|Overall Study|Not Reported|0
2569230|NCT01295827|8886484|P12|Overall Study|Not Reported|13
2569231|NCT01295827|8886485|P11|Overall Study|Not Reported|23
2569232|NCT01295827|8886486|P10|Overall Study|Not Reported|2
2569233|NCT01295827|8886487|P9|Overall Study|Not Reported|41
2569234|NCT01295827|8886488|P8|Overall Study|Not Reported|58
2569235|NCT01295827|8886489|P7|Overall Study|Not Reported|24
2569236|NCT01295827|8886490|P6|Overall Study|Not Reported|0
2569237|NCT01295827|8886491|P5|Overall Study|Not Reported|0
2569238|NCT01295827|8886492|P4|Overall Study|Not Reported|1
2569239|NCT01295827|8886493|P3|Overall Study|Not Reported|0
2569240|NCT01295827|8886494|P2|Overall Study|Not Reported|0
2569241|NCT01295827|8886495|P1|Overall Study|Not Reported|0
2569242|NCT01295827|8886481|P15|Overall Study|Lost to Follow-up|0
2569243|NCT01295827|8886482|P14|Overall Study|Lost to Follow-up|0
2569244|NCT01295827|8886483|P13|Overall Study|Lost to Follow-up|0
2569245|NCT01295827|8886484|P12|Overall Study|Lost to Follow-up|3
2569246|NCT01295827|8886485|P11|Overall Study|Lost to Follow-up|7
2569247|NCT01295827|8886486|P10|Overall Study|Lost to Follow-up|4
2569248|NCT01295827|8886487|P9|Overall Study|Lost to Follow-up|7
2569249|NCT01295827|8886488|P8|Overall Study|Lost to Follow-up|8
2569250|NCT01295827|8886489|P7|Overall Study|Lost to Follow-up|4
2569251|NCT01295827|8886490|P6|Overall Study|Lost to Follow-up|0
2569252|NCT01295827|8886491|P5|Overall Study|Lost to Follow-up|1
2569253|NCT01295827|8886492|P4|Overall Study|Lost to Follow-up|0
2569254|NCT01295827|8886493|P3|Overall Study|Lost to Follow-up|3
2569255|NCT01295827|8886494|P2|Overall Study|Lost to Follow-up|0
2569256|NCT01295827|8886495|P1|Overall Study|Lost to Follow-up|0
2569257|NCT01295827|8886481|P15|Overall Study|Adverse Event|0
2569258|NCT01295827|8886482|P14|Overall Study|Adverse Event|0
2569259|NCT01295827|8886483|P13|Overall Study|Adverse Event|0
2569260|NCT01295827|8886484|P12|Overall Study|Adverse Event|21
2569261|NCT01295827|8886485|P11|Overall Study|Adverse Event|50
2569262|NCT01295827|8886486|P10|Overall Study|Adverse Event|7
2569263|NCT01295827|8886487|P9|Overall Study|Adverse Event|22
2569264|NCT01295827|8886488|P8|Overall Study|Adverse Event|49
2569265|NCT01295827|8886489|P7|Overall Study|Adverse Event|15
2569266|NCT01295827|8886490|P6|Overall Study|Adverse Event|4
2569267|NCT01295827|8886491|P5|Overall Study|Adverse Event|1
2569268|NCT01295827|8886492|P4|Overall Study|Adverse Event|1
2569269|NCT01295827|8886493|P3|Overall Study|Adverse Event|2
2569270|NCT01295827|8886494|P2|Overall Study|Adverse Event|2
2569271|NCT01295827|8886495|P1|Overall Study|Adverse Event|1
2569272|NCT01295814|8886868|P2|Overall Study|Withdrawal by Subject|0
2569273|NCT01295814|8886869|P1|Overall Study|Withdrawal by Subject|2
2569274|NCT01295814|8886868|P2|Overall Study|Lack of Efficacy|2
2569275|NCT01295814|8886869|P1|Overall Study|Lack of Efficacy|0
2569276|NCT01295671|8886949|P3|Overall Study|Withdrawal by Subject|0
2569277|NCT01295671|8886950|P2|Overall Study|Withdrawal by Subject|1
2569278|NCT01295671|8886951|P1|Overall Study|Withdrawal by Subject|3
2569279|NCT01295671|8886949|P3|Overall Study|Lost to Follow-up|3
2569280|NCT01295671|8886950|P2|Overall Study|Lost to Follow-up|6
2569281|NCT01295671|8886951|P1|Overall Study|Lost to Follow-up|4
2569282|NCT01295320|8886997|P1|Overall Study|Unable to travel|1
2569283|NCT01295320|8886997|P1|Overall Study|Subject was bedridden|1
2569284|NCT01295320|8886997|P1|Overall Study|Withdrawal by Subject|2
2569285|NCT01295320|8886997|P1|Overall Study|Lost to Follow-up|4
2569286|NCT01295320|8886997|P1|Overall Study|Adverse Event|2
2569287|NCT01295281|8887014|P2|First Intervention (7 Days)|Death|1
2569288|NCT01295281|8887015|P1|First Intervention (7 Days)|Death|0
2569289|NCT01295034|8887053|P2|Overall Study|Lost to Follow-up|5
2569290|NCT01295034|8887054|P1|Overall Study|Lost to Follow-up|5
2569291|NCT01294917|8887062|P1|Overall Study|Inconvenience|1
2569292|NCT01294917|8887062|P1|Overall Study|Relocation|5
2569293|NCT01294800|8887072|P4|Overall Study|Did Not Meet Protocol Eligibility|0
2569294|NCT01294800|8887073|P3|Overall Study|Did Not Meet Protocol Eligibility|1
2569295|NCT01294800|8887074|P2|Overall Study|Did Not Meet Protocol Eligibility|1
2569296|NCT01294800|8887075|P1|Overall Study|Did Not Meet Protocol Eligibility|2
2569297|NCT01294800|8887072|P4|Overall Study|Non-compliance With Protocol|0
2569298|NCT01294800|8887073|P3|Overall Study|Non-compliance With Protocol|1
2569299|NCT01294800|8887074|P2|Overall Study|Non-compliance With Protocol|1
2569300|NCT01294800|8887075|P1|Overall Study|Non-compliance With Protocol|0
2569301|NCT01294800|8887072|P4|Overall Study|Lost to Follow-up|0
2569302|NCT01294800|8887073|P3|Overall Study|Lost to Follow-up|1
2569303|NCT01294800|8887074|P2|Overall Study|Lost to Follow-up|0
2569304|NCT01294800|8887075|P1|Overall Study|Lost to Follow-up|0
2569305|NCT01294800|8887072|P4|Overall Study|Subject Withdrew Consent|11
2569306|NCT01294800|8887073|P3|Overall Study|Subject Withdrew Consent|2
2569307|NCT01294800|8887074|P2|Overall Study|Subject Withdrew Consent|2
2569308|NCT01294800|8887075|P1|Overall Study|Subject Withdrew Consent|2
2569309|NCT01294800|8887072|P4|Overall Study|Adverse Event|5
2569310|NCT01294800|8887073|P3|Overall Study|Adverse Event|12
2569311|NCT01294800|8887074|P2|Overall Study|Adverse Event|6
2569312|NCT01294800|8887075|P1|Overall Study|Adverse Event|7
2569313|NCT01294787|8887101|P6|Period 3|Adverse Event|0
2569314|NCT01294787|8887102|P5|Period 3|Adverse Event|1
2569315|NCT01294787|8887103|P4|Period 3|Adverse Event|0
2569316|NCT01294787|8887104|P3|Period 3|Adverse Event|0
2569317|NCT01294787|8887105|P2|Period 3|Adverse Event|0
2569318|NCT01294787|8887106|P1|Period 3|Adverse Event|0
2569319|NCT01294787|8887101|P6|Period 2|No longer needs study drug|0
2569320|NCT01294787|8887102|P5|Period 2|No longer needs study drug|0
2569321|NCT01294787|8887103|P4|Period 2|No longer needs study drug|1
2569322|NCT01294787|8887104|P3|Period 2|No longer needs study drug|0
2569323|NCT01294787|8887105|P2|Period 2|No longer needs study drug|0
2569324|NCT01294787|8887106|P1|Period 2|No longer needs study drug|0
2569325|NCT01294787|8887101|P6|Period 2|Adverse Event|0
2569326|NCT01294787|8887102|P5|Period 2|Adverse Event|0
2569327|NCT01294787|8887103|P4|Period 2|Adverse Event|1
2569328|NCT01294787|8887104|P3|Period 2|Adverse Event|0
2569329|NCT01294787|8887105|P2|Period 2|Adverse Event|3
2569330|NCT01294787|8887106|P1|Period 2|Adverse Event|0
2569331|NCT01294787|8887101|P6|Period 1|Administrative problem|1
2569332|NCT01294787|8887102|P5|Period 1|Administrative problem|0
2569333|NCT01294787|8887103|P4|Period 1|Administrative problem|0
2569334|NCT01294787|8887104|P3|Period 1|Administrative problem|1
2569335|NCT01294787|8887105|P2|Period 1|Administrative problem|0
2569336|NCT01294787|8887106|P1|Period 1|Administrative problem|0
2569337|NCT01294787|8887101|P6|Period 1|Withdrawal by Subject|1
2569338|NCT01294787|8887102|P5|Period 1|Withdrawal by Subject|1
2569339|NCT01294787|8887103|P4|Period 1|Withdrawal by Subject|1
2569340|NCT01294787|8887104|P3|Period 1|Withdrawal by Subject|0
2569341|NCT01294787|8887105|P2|Period 1|Withdrawal by Subject|0
2569342|NCT01294787|8887106|P1|Period 1|Withdrawal by Subject|0
2569343|NCT01294787|8887101|P6|Period 1|Adverse Event|0
2569344|NCT01294787|8887102|P5|Period 1|Adverse Event|1
2569345|NCT01294787|8887103|P4|Period 1|Adverse Event|0
2569346|NCT01294787|8887104|P3|Period 1|Adverse Event|0
2569347|NCT01294787|8887105|P2|Period 1|Adverse Event|0
2569348|NCT01294787|8887106|P1|Period 1|Adverse Event|0
2569349|NCT01294696|8887197|P1|Overall Study|Site closure|52
2569350|NCT01294696|8887197|P1|Overall Study|Missing BPI Response|7
2569351|NCT01294696|8887197|P1|Overall Study|Protocol Violation|8
2569352|NCT01294696|8887197|P1|Overall Study|Screening failures|7
2569353|NCT01294683|8887211|P2|Post Crossover (Period III)|Withdrawal by Subject|2
2569354|NCT01294683|8887212|P1|Post Crossover (Period III)|Withdrawal by Subject|3
2569355|NCT01294683|8887211|P2|Post Crossover (Period III)|Study Terminated by Sponsor|21
2569356|NCT01294683|8887212|P1|Post Crossover (Period III)|Study Terminated by Sponsor|23
2569357|NCT01294683|8887211|P2|Post Crossover (Period III)|Lost to Follow-up|3
2569358|NCT01294683|8887212|P1|Post Crossover (Period III)|Lost to Follow-up|1
2569359|NCT01294683|8887211|P2|Post Crossover (Period III)|Adverse Event|6
2569360|NCT01294683|8887212|P1|Post Crossover (Period III)|Adverse Event|6
2569361|NCT01294683|8887211|P2|Precrossover (Periods I/II)|Withdrawal by Subject|9
2569362|NCT01294683|8887212|P1|Precrossover (Periods I/II)|Withdrawal by Subject|11
2569363|NCT01294683|8887211|P2|Precrossover (Periods I/II)|Technical Problems|1
2569364|NCT01294683|8887212|P1|Precrossover (Periods I/II)|Technical Problems|0
2569365|NCT01294683|8887211|P2|Precrossover (Periods I/II)|Study Terminated by Sponsor|192
2569366|NCT01294683|8887212|P1|Precrossover (Periods I/II)|Study Terminated by Sponsor|187
2569367|NCT01294683|8887211|P2|Precrossover (Periods I/II)|Protocol Violation|5
2569368|NCT01294683|8887212|P1|Precrossover (Periods I/II)|Protocol Violation|5
2569369|NCT01294683|8887211|P2|Precrossover (Periods I/II)|Physician Decision|0
2569370|NCT01294683|8887212|P1|Precrossover (Periods I/II)|Physician Decision|1
2569371|NCT01294683|8887211|P2|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
2569372|NCT01294683|8887212|P1|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
2569373|NCT01294683|8887211|P2|Precrossover (Periods I/II)|Lost to Follow-up|6
2569374|NCT01294683|8887212|P1|Precrossover (Periods I/II)|Lost to Follow-up|3
2569375|NCT01294683|8887211|P2|Precrossover (Periods I/II)|Adverse Event|52
2569376|NCT01294683|8887212|P1|Precrossover (Periods I/II)|Adverse Event|49
2569377|NCT01294644|8887265|P3|Overall Study|Miscellaneous Reason|4
2569378|NCT01294644|8887266|P2|Overall Study|Miscellaneous Reason|1
2569379|NCT01294644|8887267|P1|Overall Study|Miscellaneous Reason|2
2569380|NCT01294644|8887265|P3|Overall Study|Lost to Follow-up|5
2569381|NCT01294644|8887266|P2|Overall Study|Lost to Follow-up|2
2569382|NCT01294644|8887267|P1|Overall Study|Lost to Follow-up|3
2569383|NCT01294644|8887265|P3|Overall Study|Withdrawal by Subject|4
2569384|NCT01294644|8887266|P2|Overall Study|Withdrawal by Subject|7
2569385|NCT01294644|8887267|P1|Overall Study|Withdrawal by Subject|3
2569386|NCT01294644|8887265|P3|Overall Study|Adverse Event|1
2569387|NCT01294644|8887266|P2|Overall Study|Adverse Event|0
2569388|NCT01294644|8887267|P1|Overall Study|Adverse Event|2
2569389|NCT01294592|8887298|P2|Overall Study|Withdrawal by Subject|28
2569390|NCT01294592|8887299|P1|Overall Study|Withdrawal by Subject|28
2569391|NCT01294592|8887298|P2|Overall Study|Physician Decision|11
2569392|NCT01294592|8887299|P1|Overall Study|Physician Decision|6
2569393|NCT01294592|8887298|P2|Overall Study|Lost to Follow-up|9
2569394|NCT01294592|8887299|P1|Overall Study|Lost to Follow-up|7
2569395|NCT01294592|8887298|P2|Overall Study|Protocol Violation|7
2569396|NCT01294592|8887299|P1|Overall Study|Protocol Violation|1
2569397|NCT01294592|8887298|P2|Overall Study|Lack of Efficacy|5
2569398|NCT01294592|8887299|P1|Overall Study|Lack of Efficacy|7
2569399|NCT01294592|8887298|P2|Overall Study|Adverse Event|13
2569400|NCT01294592|8887299|P1|Overall Study|Adverse Event|28
2569401|NCT01294579|8887327|P1|Overall Study|Withdrawal by Subject|5
2569402|NCT01294579|8887327|P1|Overall Study|Physician Decision|3
2569403|NCT01294579|8887327|P1|Overall Study|Lost to Follow-up|1
2569404|NCT01294579|8887327|P1|Overall Study|Study closed/terminated|3
2569405|NCT01294579|8887327|P1|Overall Study|Adverse Event|11
2569406|NCT01294579|8887327|P1|Overall Study|Disease progression|12
2569407|NCT01294553|8887337|P1|Overall Study|Protocol Violation|268
2569408|NCT01294553|8887337|P1|Overall Study|Duplicated Participants|1
2569409|NCT01294514|8887343|P1|Overall Study|Excluded due to Arrhythmia|1
2569410|NCT01294462|8887353|P2|Overall Study|Withdrawal by Subject|63
2569411|NCT01294462|8887354|P1|Overall Study|Withdrawal by Subject|65
2569412|NCT01294462|8887353|P2|Overall Study|Lost to Follow-up|0
2569413|NCT01294462|8887354|P1|Overall Study|Lost to Follow-up|1
2569414|NCT01294449|8887368|P2|Overall Study|Withdrawal by Subject|3
2569415|NCT01294449|8887369|P1|Overall Study|Withdrawal by Subject|1
2569416|NCT01294449|8887368|P2|Overall Study|Death|12
2569417|NCT01294449|8887369|P1|Overall Study|Death|11
2569418|NCT01294436|8887377|P2|Overall Study|poor/non-compliance|5
2569419|NCT01294436|8887378|P1|Overall Study|poor/non-compliance|2
2569420|NCT01294436|8887377|P2|Overall Study|subject no longer meets study criteria|20
2569421|NCT01294436|8887378|P1|Overall Study|subject no longer meets study criteria|5
2569422|NCT01294436|8887377|P2|Overall Study|Withdrawal by Subject|28
2569423|NCT01294436|8887378|P1|Overall Study|Withdrawal by Subject|11
2569424|NCT01294436|8887377|P2|Overall Study|Adverse Event|17
2569425|NCT01294436|8887378|P1|Overall Study|Adverse Event|10
2569426|NCT01294423|8887413|P3|Overall Study|poor/non-compliance|1
2569427|NCT01294423|8887414|P2|Overall Study|poor/non-compliance|0
2569428|NCT01294423|8887415|P1|Overall Study|poor/non-compliance|1
2569429|NCT01294423|8887413|P3|Overall Study|subject no longer meets study criteria|2
2569430|NCT01294423|8887414|P2|Overall Study|subject no longer meets study criteria|5
2569431|NCT01294423|8887415|P1|Overall Study|subject no longer meets study criteria|2
2569432|NCT01294423|8887413|P3|Overall Study|Withdrawal by Subject|2
2569433|NCT01294423|8887414|P2|Overall Study|Withdrawal by Subject|2
2569434|NCT01294423|8887415|P1|Overall Study|Withdrawal by Subject|1
2569435|NCT01294423|8887413|P3|Overall Study|Adverse Event|3
2569436|NCT01294423|8887414|P2|Overall Study|Adverse Event|2
2569437|NCT01294423|8887415|P1|Overall Study|Adverse Event|1
2569438|NCT01294397|8887429|P1|Overall Study|Administrative Decision|1
2569439|NCT01294397|8887429|P1|Overall Study|Withdrawal by Subject|1
2569440|NCT01294371|8887473|P1|Overall Study|Other|14
2569441|NCT01294371|8887473|P1|Overall Study|Administrative Reason|1
2569442|NCT01294371|8887473|P1|Overall Study|Lost to Follow-up|6
2569443|NCT01294371|8887473|P1|Overall Study|Withdrawal by Subject|12
2569444|NCT01294371|8887473|P1|Overall Study|Adverse Event|1
2569445|NCT01294358|8887481|P5|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1
2569446|NCT01294358|8887482|P4|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
2569447|NCT01294358|8887483|P3|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
2569448|NCT01294358|8887484|P2|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
2569449|NCT01294358|8887485|P1|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
2569450|NCT01294358|8887481|P5|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
2569451|NCT01294358|8887482|P4|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1
2569452|NCT01294358|8887483|P3|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
2569453|NCT01294358|8887484|P2|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
2569454|NCT01294358|8887485|P1|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
2569455|NCT01294358|8887481|P5|Cohort 3: 12/1/11-10/6/12|Disease progression|0
2569456|NCT01294358|8887482|P4|Cohort 3: 12/1/11-10/6/12|Disease progression|0
2569457|NCT01294358|8887483|P3|Cohort 3: 12/1/11-10/6/12|Disease progression|2
2569458|NCT01294358|8887484|P2|Cohort 3: 12/1/11-10/6/12|Disease progression|0
2569459|NCT01294358|8887485|P1|Cohort 3: 12/1/11-10/6/12|Disease progression|0
2569460|NCT01294358|8887481|P5|Cohort 2: 6/9/11-9/17/12|Disease progression|0
2569461|NCT01294358|8887482|P4|Cohort 2: 6/9/11-9/17/12|Disease progression|0
2569462|NCT01294358|8887483|P3|Cohort 2: 6/9/11-9/17/12|Disease progression|0
2569463|NCT01294358|8887484|P2|Cohort 2: 6/9/11-9/17/12|Disease progression|2
2569464|NCT01294358|8887485|P1|Cohort 2: 6/9/11-9/17/12|Disease progression|0
2569465|NCT01294150|8887613|P2|Overall Study|Physician Decision|2
2569466|NCT01294150|8887614|P1|Overall Study|Physician Decision|2
2569467|NCT01294046|8887643|P1|Overall Study|Stimulation response inadqequate|1
2569468|NCT01294046|8887643|P1|Overall Study|Eligibility criteria expanded|1
2569469|NCT01294046|8887643|P1|Overall Study|Infection and surgical explant|1
2569470|NCT01293968|8887658|P2|Overall Study|non-cooperation|3
2569471|NCT01293968|8887659|P1|Overall Study|non-cooperation|3
2569472|NCT01293695|8887679|P2|Overall Study|Lost to Follow-up|6
2569473|NCT01293695|8887680|P1|Overall Study|Lost to Follow-up|8
2569474|NCT01293695|8887679|P2|Overall Study|Withdrawal by Subject|1
2569475|NCT01293695|8887680|P1|Overall Study|Withdrawal by Subject|7
2569476|NCT01293539|8887699|P1|Overall Study|Physician Decision|1
2569477|NCT01293240|8887703|P1|Overall Study|Noncompliance|2
2569478|NCT01293123|8887720|P2|Overall Study|Lost to Follow-up|1
2569479|NCT01293123|8887721|P1|Overall Study|Lost to Follow-up|0
2569480|NCT01293084|8887735|P1|Overall Study|Withdrawal by Subject|2
2569481|NCT01293084|8887735|P1|Overall Study|Physician Decision|3
2569482|NCT01293032|8887747|P4|Treatment|Disease Progression, relapse|0
2569483|NCT01293032|8887748|P3|Treatment|Disease Progression, relapse|0
2569484|NCT01293032|8887749|P2|Treatment|Disease Progression, relapse|1
2569485|NCT01293032|8887750|P1|Treatment|Disease Progression, relapse|0
2569486|NCT01293032|8887747|P4|Treatment|Withdrawal by Subject|0
2569487|NCT01293032|8887748|P3|Treatment|Withdrawal by Subject|0
2569488|NCT01293032|8887749|P2|Treatment|Withdrawal by Subject|4
2569489|NCT01293032|8887750|P1|Treatment|Withdrawal by Subject|2
2569490|NCT01293032|8887747|P4|Treatment|Adverse Event|1
2569491|NCT01293032|8887748|P3|Treatment|Adverse Event|1
2569492|NCT01293032|8887749|P2|Treatment|Adverse Event|0
2569493|NCT01293032|8887750|P1|Treatment|Adverse Event|0
2569494|NCT01293032|8887747|P4|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
2569495|NCT01293032|8887748|P3|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5
2569496|NCT01293032|8887749|P2|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
2569497|NCT01293032|8887750|P1|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
2569498|NCT01293006|8887761|P4|Period 2|Lost to Follow-up|0
2569499|NCT01293006|8887762|P3|Period 2|Lost to Follow-up|0
2569500|NCT01293006|8887763|P2|Period 2|Lost to Follow-up|0
2569501|NCT01293006|8887764|P1|Period 2|Lost to Follow-up|1
2569502|NCT01292928|8887785|P1|Overall Study|Physician Decision|2
2569503|NCT01292928|8887785|P1|Overall Study|Lost to Follow-up|6
2569504|NCT01292928|8887785|P1|Overall Study|Withdrawal by Subject|8
2569505|NCT01292928|8887785|P1|Overall Study|Death|8
2569506|NCT01292876|8887802|P1|Overall Study|Physician Decision|4
2569507|NCT01292837|8887808|P1|Overall Study|Further treatment determined|1
2569508|NCT01292837|8887808|P1|Overall Study|Adverse Event|1
2569509|NCT01292603|8887845|P6|Overall Survival Status|Death|10
2569510|NCT01292603|8887846|P5|Overall Survival Status|Death|16
2569511|NCT01292603|8887847|P4|Overall Survival Status|Death|1
2569512|NCT01292603|8887848|P3|Overall Survival Status|Death|3
2569513|NCT01292603|8887849|P2|Overall Survival Status|Death|1
2569514|NCT01292603|8887850|P1|Overall Survival Status|Death|3
2569515|NCT01292603|8887845|P6|Part 2: Regular Follow-Up|Adverse Event|2
2569516|NCT01292603|8887846|P5|Part 2: Regular Follow-Up|Adverse Event|2
2569517|NCT01292603|8887847|P4|Part 2: Regular Follow-Up|Adverse Event|0
2569518|NCT01292603|8887848|P3|Part 2: Regular Follow-Up|Adverse Event|0
2569519|NCT01292603|8887849|P2|Part 2: Regular Follow-Up|Adverse Event|0
2569520|NCT01292603|8887850|P1|Part 2: Regular Follow-Up|Adverse Event|0
2569521|NCT01292603|8887845|P6|Part 2: Regular Follow-Up|Lost to Follow-up|1
2569522|NCT01292603|8887846|P5|Part 2: Regular Follow-Up|Lost to Follow-up|1
2569523|NCT01292603|8887847|P4|Part 2: Regular Follow-Up|Lost to Follow-up|0
2569524|NCT01292603|8887848|P3|Part 2: Regular Follow-Up|Lost to Follow-up|0
2569525|NCT01292603|8887849|P2|Part 2: Regular Follow-Up|Lost to Follow-up|0
2569526|NCT01292603|8887850|P1|Part 2: Regular Follow-Up|Lost to Follow-up|0
2569527|NCT01292603|8887845|P6|Part 2: Regular Follow-Up|Physician Decision|0
2569528|NCT01292603|8887846|P5|Part 2: Regular Follow-Up|Physician Decision|2
2569529|NCT01292603|8887847|P4|Part 2: Regular Follow-Up|Physician Decision|0
2569530|NCT01292603|8887848|P3|Part 2: Regular Follow-Up|Physician Decision|0
2569531|NCT01292603|8887849|P2|Part 2: Regular Follow-Up|Physician Decision|0
2569532|NCT01292603|8887850|P1|Part 2: Regular Follow-Up|Physician Decision|0
2569533|NCT01292603|8887845|P6|Part 2: Regular Follow-Up|Protocol Violation|0
2569534|NCT01292603|8887846|P5|Part 2: Regular Follow-Up|Protocol Violation|2
2569535|NCT01292603|8887847|P4|Part 2: Regular Follow-Up|Protocol Violation|0
2569536|NCT01292603|8887848|P3|Part 2: Regular Follow-Up|Protocol Violation|0
2569537|NCT01292603|8887849|P2|Part 2: Regular Follow-Up|Protocol Violation|0
2569538|NCT01292603|8887850|P1|Part 2: Regular Follow-Up|Protocol Violation|0
2569539|NCT01292603|8887845|P6|Part 2: Regular Follow-Up|Withdrawal by Subject|1
2569540|NCT01292603|8887846|P5|Part 2: Regular Follow-Up|Withdrawal by Subject|0
2569541|NCT01292603|8887847|P4|Part 2: Regular Follow-Up|Withdrawal by Subject|0
2569542|NCT01292603|8887848|P3|Part 2: Regular Follow-Up|Withdrawal by Subject|0
2569543|NCT01292603|8887849|P2|Part 2: Regular Follow-Up|Withdrawal by Subject|0
2569544|NCT01292603|8887850|P1|Part 2: Regular Follow-Up|Withdrawal by Subject|0
2569545|NCT01292603|8887845|P6|Part 2: Regular Follow-Up|Noncompliance|0
2569546|NCT01292603|8887846|P5|Part 2: Regular Follow-Up|Noncompliance|1
2569547|NCT01292603|8887847|P4|Part 2: Regular Follow-Up|Noncompliance|0
2569548|NCT01292603|8887848|P3|Part 2: Regular Follow-Up|Noncompliance|0
2569549|NCT01292603|8887849|P2|Part 2: Regular Follow-Up|Noncompliance|0
2569550|NCT01292603|8887850|P1|Part 2: Regular Follow-Up|Noncompliance|0
2569551|NCT01292603|8887845|P6|Part 2: Regular Follow-Up|Disease Progression|5
2569552|NCT01292603|8887846|P5|Part 2: Regular Follow-Up|Disease Progression|5
2569553|NCT01292603|8887847|P4|Part 2: Regular Follow-Up|Disease Progression|0
2569554|NCT01292603|8887848|P3|Part 2: Regular Follow-Up|Disease Progression|0
2569555|NCT01292603|8887849|P2|Part 2: Regular Follow-Up|Disease Progression|0
2569556|NCT01292603|8887850|P1|Part 2: Regular Follow-Up|Disease Progression|0
2569557|NCT01292603|8887845|P6|Part 2: Regular Follow-Up|Death|3
2569558|NCT01292603|8887846|P5|Part 2: Regular Follow-Up|Death|6
2569559|NCT01292603|8887847|P4|Part 2: Regular Follow-Up|Death|0
2569560|NCT01292603|8887848|P3|Part 2: Regular Follow-Up|Death|0
2569561|NCT01292603|8887849|P2|Part 2: Regular Follow-Up|Death|0
2569562|NCT01292603|8887850|P1|Part 2: Regular Follow-Up|Death|0
2569563|NCT01292603|8887845|P6|Part 2: Dose Confirmation Period|Withdrawal by Subject|2
2569564|NCT01292603|8887846|P5|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
2569565|NCT01292603|8887847|P4|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
2569566|NCT01292603|8887848|P3|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
2569567|NCT01292603|8887849|P2|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
2569568|NCT01292603|8887850|P1|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
2569569|NCT01292603|8887845|P6|Part 2: Dose Confirmation Period|Protocol Violation|3
2569570|NCT01292603|8887846|P5|Part 2: Dose Confirmation Period|Protocol Violation|5
2569571|NCT01292603|8887847|P4|Part 2: Dose Confirmation Period|Protocol Violation|0
2569572|NCT01292603|8887848|P3|Part 2: Dose Confirmation Period|Protocol Violation|0
2569573|NCT01292603|8887849|P2|Part 2: Dose Confirmation Period|Protocol Violation|0
2569574|NCT01292603|8887850|P1|Part 2: Dose Confirmation Period|Protocol Violation|0
2569575|NCT01292603|8887845|P6|Part 2: Dose Confirmation Period|Adverse Event|9
2569576|NCT01292603|8887846|P5|Part 2: Dose Confirmation Period|Adverse Event|7
2569577|NCT01292603|8887847|P4|Part 2: Dose Confirmation Period|Adverse Event|0
2569578|NCT01292603|8887848|P3|Part 2: Dose Confirmation Period|Adverse Event|0
2569579|NCT01292603|8887849|P2|Part 2: Dose Confirmation Period|Adverse Event|0
2569580|NCT01292603|8887850|P1|Part 2: Dose Confirmation Period|Adverse Event|0
2569581|NCT01292603|8887845|P6|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
2569582|NCT01292603|8887846|P5|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
2569583|NCT01292603|8887847|P4|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
2569584|NCT01292603|8887848|P3|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
2569585|NCT01292603|8887849|P2|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
2569586|NCT01292603|8887850|P1|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
2569587|NCT01292603|8887845|P6|Part 2: Dose Confirmation Period|Physician Decision|0
2569588|NCT01292603|8887846|P5|Part 2: Dose Confirmation Period|Physician Decision|2
2569589|NCT01292603|8887847|P4|Part 2: Dose Confirmation Period|Physician Decision|0
2569590|NCT01292603|8887848|P3|Part 2: Dose Confirmation Period|Physician Decision|0
2569591|NCT01292603|8887849|P2|Part 2: Dose Confirmation Period|Physician Decision|0
2569592|NCT01292603|8887850|P1|Part 2: Dose Confirmation Period|Physician Decision|0
2569593|NCT01292603|8887845|P6|Part 2: Dose Confirmation Period|Death|0
2569594|NCT01292603|8887846|P5|Part 2: Dose Confirmation Period|Death|1
2569595|NCT01292603|8887847|P4|Part 2: Dose Confirmation Period|Death|0
2569596|NCT01292603|8887848|P3|Part 2: Dose Confirmation Period|Death|0
2569597|NCT01292603|8887849|P2|Part 2: Dose Confirmation Period|Death|0
2569598|NCT01292603|8887850|P1|Part 2: Dose Confirmation Period|Death|0
2569599|NCT01292603|8887845|P6|Part 1: Regular Follow-Up Period|Disease Progression|0
2569600|NCT01292603|8887846|P5|Part 1: Regular Follow-Up Period|Disease Progression|0
2569601|NCT01292603|8887847|P4|Part 1: Regular Follow-Up Period|Disease Progression|0
2569602|NCT01292603|8887848|P3|Part 1: Regular Follow-Up Period|Disease Progression|3
2569603|NCT01292603|8887849|P2|Part 1: Regular Follow-Up Period|Disease Progression|6
2569604|NCT01292603|8887850|P1|Part 1: Regular Follow-Up Period|Disease Progression|3
2569605|NCT01292603|8887845|P6|Part 1: Regular Follow-Up Period|Death|0
2569606|NCT01292603|8887846|P5|Part 1: Regular Follow-Up Period|Death|0
2569607|NCT01292603|8887847|P4|Part 1: Regular Follow-Up Period|Death|1
2569608|NCT01292603|8887848|P3|Part 1: Regular Follow-Up Period|Death|3
2569609|NCT01292603|8887849|P2|Part 1: Regular Follow-Up Period|Death|1
2569610|NCT01292603|8887850|P1|Part 1: Regular Follow-Up Period|Death|3
2569611|NCT01292603|8887845|P6|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
2569612|NCT01292603|8887846|P5|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
2569613|NCT01292603|8887847|P4|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1
2569614|NCT01292603|8887848|P3|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
2569615|NCT01292603|8887849|P2|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
2569616|NCT01292603|8887850|P1|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
2569617|NCT01292603|8887845|P6|Part 1: Pilot Dose Selection Period|Protocol Violation|0
2569618|NCT01292603|8887846|P5|Part 1: Pilot Dose Selection Period|Protocol Violation|0
2569619|NCT01292603|8887847|P4|Part 1: Pilot Dose Selection Period|Protocol Violation|2
2569620|NCT01292603|8887848|P3|Part 1: Pilot Dose Selection Period|Protocol Violation|0
2569621|NCT01292603|8887849|P2|Part 1: Pilot Dose Selection Period|Protocol Violation|0
2569622|NCT01292603|8887850|P1|Part 1: Pilot Dose Selection Period|Protocol Violation|0
2569623|NCT01292603|8887845|P6|Part 1: Pilot Dose Selection Period|Death|0
2569624|NCT01292603|8887846|P5|Part 1: Pilot Dose Selection Period|Death|0
2569625|NCT01292603|8887847|P4|Part 1: Pilot Dose Selection Period|Death|1
2569626|NCT01292603|8887848|P3|Part 1: Pilot Dose Selection Period|Death|0
2569627|NCT01292603|8887849|P2|Part 1: Pilot Dose Selection Period|Death|0
2569628|NCT01292603|8887850|P1|Part 1: Pilot Dose Selection Period|Death|0
2569629|NCT01292603|8887845|P6|Part 1: Pilot Dose Selection Period|Adverse Event|0
2569630|NCT01292603|8887846|P5|Part 1: Pilot Dose Selection Period|Adverse Event|0
2569631|NCT01292603|8887847|P4|Part 1: Pilot Dose Selection Period|Adverse Event|4
2569632|NCT01292603|8887848|P3|Part 1: Pilot Dose Selection Period|Adverse Event|0
2569633|NCT01292603|8887849|P2|Part 1: Pilot Dose Selection Period|Adverse Event|0
2569634|NCT01292603|8887850|P1|Part 1: Pilot Dose Selection Period|Adverse Event|0
2569635|NCT01292486|8887903|P1|Overall Study|Physician Decision|1
2569636|NCT01292486|8887903|P1|Overall Study|Adverse Event|1
2569637|NCT01292486|8887903|P1|Overall Study|Did not meet screening criteria|2
2569638|NCT01292486|8887903|P1|Overall Study|Protocol Violation|2
2569639|NCT01292473|8887917|P4|Overall Study|Disease Progression|6
2569640|NCT01292473|8887918|P3|Overall Study|Disease Progression|3
2569641|NCT01292473|8887919|P2|Overall Study|Disease Progression|1
2569642|NCT01292473|8887920|P1|Overall Study|Disease Progression|0
2569643|NCT01292473|8887917|P4|Overall Study|Physician Decision|0
2569644|NCT01292473|8887918|P3|Overall Study|Physician Decision|0
2569645|NCT01292473|8887919|P2|Overall Study|Physician Decision|1
2569646|NCT01292473|8887920|P1|Overall Study|Physician Decision|0
2569647|NCT01292473|8887917|P4|Overall Study|Withdrawal by Subject|3
2569648|NCT01292473|8887918|P3|Overall Study|Withdrawal by Subject|3
2569649|NCT01292473|8887919|P2|Overall Study|Withdrawal by Subject|4
2569650|NCT01292473|8887920|P1|Overall Study|Withdrawal by Subject|3
2569651|NCT01292473|8887917|P4|Overall Study|Lost to Follow-up|2
2569652|NCT01292473|8887918|P3|Overall Study|Lost to Follow-up|2
2569653|NCT01292473|8887919|P2|Overall Study|Lost to Follow-up|1
2569654|NCT01292473|8887920|P1|Overall Study|Lost to Follow-up|1
2569655|NCT01292473|8887917|P4|Overall Study|Adverse Event|1
2569656|NCT01292473|8887918|P3|Overall Study|Adverse Event|1
2569657|NCT01292473|8887919|P2|Overall Study|Adverse Event|0
2569658|NCT01292473|8887920|P1|Overall Study|Adverse Event|1
2569659|NCT01292239|8887979|P2|Overall Study|Withdrawal by Subject|6
2569660|NCT01292239|8887980|P1|Overall Study|Withdrawal by Subject|3
2569661|NCT01292239|8887979|P2|Overall Study|Other|1
2569662|NCT01292239|8887980|P1|Overall Study|Other|1
2569663|NCT01292226|8888001|P1|Overall Study|Other|2
2569664|NCT01292226|8888001|P1|Overall Study|Withdrawal by Subject|1
2569665|NCT01292226|8888001|P1|Overall Study|Protocol Violation|3
2569666|NCT01292226|8888001|P1|Overall Study|Graft loss|1
2569667|NCT01292226|8888001|P1|Overall Study|Death|1
2569668|NCT01292226|8888001|P1|Overall Study|Adverse Event|5
2569669|NCT01292187|8888034|P2|Overall Study|All other reasons|3
2569670|NCT01292187|8888035|P1|Overall Study|All other reasons|1
2569671|NCT01292187|8888034|P2|Overall Study|Withdrawal by Subject|5
2569672|NCT01292187|8888035|P1|Overall Study|Withdrawal by Subject|6
2569673|NCT01292187|8888034|P2|Overall Study|Adverse Event|5
2569674|NCT01292187|8888035|P1|Overall Study|Adverse Event|10
2569675|NCT01292057|8888070|P2|Overall Study|Lost to Follow-up|1
2569676|NCT01292057|8888071|P1|Overall Study|Lost to Follow-up|1
2569677|NCT01292057|8888070|P2|Overall Study|Protocol Violation|1
2569678|NCT01292057|8888071|P1|Overall Study|Protocol Violation|1
2569679|NCT01291277|8888143|P2|Overall Study|Lost to Follow-up|1
2569680|NCT01291277|8888144|P1|Overall Study|Lost to Follow-up|3
2569681|NCT01291277|8888143|P2|Overall Study|Death|2
2569682|NCT01291277|8888144|P1|Overall Study|Death|2
2569683|NCT01291225|8888156|P2|Overall Study|Lost to Follow-up|39
2569684|NCT01291225|8888157|P1|Overall Study|Lost to Follow-up|85
2569685|NCT01291173|8888171|P4|Overall Study|Excluded therapy|0
2569686|NCT01291173|8888172|P3|Overall Study|Excluded therapy|1
2569687|NCT01291173|8888173|P2|Overall Study|Excluded therapy|0
2569688|NCT01291173|8888174|P1|Overall Study|Excluded therapy|0
2569689|NCT01291173|8888171|P4|Overall Study|Subject was unblinded|0
2569690|NCT01291173|8888172|P3|Overall Study|Subject was unblinded|1
2569691|NCT01291173|8888173|P2|Overall Study|Subject was unblinded|0
2569692|NCT01291173|8888174|P1|Overall Study|Subject was unblinded|0
2569693|NCT01291173|8888171|P4|Overall Study|Lack of compliance|1
2569694|NCT01291173|8888172|P3|Overall Study|Lack of compliance|0
2569695|NCT01291173|8888173|P2|Overall Study|Lack of compliance|0
2569696|NCT01291173|8888174|P1|Overall Study|Lack of compliance|0
2569697|NCT01291173|8888171|P4|Overall Study|Unable to meet visit schedule|0
2569698|NCT01291173|8888172|P3|Overall Study|Unable to meet visit schedule|1
2569699|NCT01291173|8888173|P2|Overall Study|Unable to meet visit schedule|0
2569700|NCT01291173|8888174|P1|Overall Study|Unable to meet visit schedule|0
2569701|NCT01291173|8888171|P4|Overall Study|Lost to Follow-up|2
2569702|NCT01291173|8888172|P3|Overall Study|Lost to Follow-up|3
2569703|NCT01291173|8888173|P2|Overall Study|Lost to Follow-up|6
2569704|NCT01291173|8888174|P1|Overall Study|Lost to Follow-up|4
2569705|NCT01291173|8888171|P4|Overall Study|Withdrawal by Subject|2
2569706|NCT01291173|8888172|P3|Overall Study|Withdrawal by Subject|4
2569707|NCT01291173|8888173|P2|Overall Study|Withdrawal by Subject|4
2569708|NCT01291173|8888174|P1|Overall Study|Withdrawal by Subject|6
2569709|NCT01291173|8888171|P4|Overall Study|Protocol Violation|5
2569710|NCT01291173|8888172|P3|Overall Study|Protocol Violation|2
2569711|NCT01291173|8888173|P2|Overall Study|Protocol Violation|2
2569712|NCT01291173|8888174|P1|Overall Study|Protocol Violation|7
2569713|NCT01291173|8888171|P4|Overall Study|Adverse Event|3
2569714|NCT01291173|8888172|P3|Overall Study|Adverse Event|1
2569715|NCT01291173|8888173|P2|Overall Study|Adverse Event|3
2569716|NCT01291173|8888174|P1|Overall Study|Adverse Event|0
2569717|NCT01291017|8888283|P1|Overall Study|Withdrawal by Subject|3
2569718|NCT01291017|8888283|P1|Overall Study|Lost to Follow-up|2
2569719|NCT01290887|8888316|P2|Overall Study|Other|6
2569720|NCT01290887|8888317|P1|Overall Study|Other|3
2569721|NCT01290887|8888316|P2|Overall Study|Sponsor closure of study|476
2569722|NCT01290887|8888317|P1|Overall Study|Sponsor closure of study|420
2569723|NCT01290887|8888316|P2|Overall Study|Non-compliance to study medications|0
2569724|NCT01290887|8888317|P1|Overall Study|Non-compliance to study medications|1
2569725|NCT01290887|8888316|P2|Overall Study|Non-compliance to study procedures|1
2569726|NCT01290887|8888317|P1|Overall Study|Non-compliance to study procedures|0
2569727|NCT01290887|8888316|P2|Overall Study|Lost to Follow-up|4
2569728|NCT01290887|8888317|P1|Overall Study|Lost to Follow-up|4
2569729|NCT01290887|8888316|P2|Overall Study|Protocol Violation|1
2569730|NCT01290887|8888317|P1|Overall Study|Protocol Violation|2
2569731|NCT01290887|8888316|P2|Overall Study|Withdrawal by Subject|32
2569732|NCT01290887|8888317|P1|Overall Study|Withdrawal by Subject|26
2569733|NCT01290887|8888316|P2|Overall Study|Lack of Efficacy|5
2569734|NCT01290887|8888317|P1|Overall Study|Lack of Efficacy|4
2569735|NCT01290887|8888316|P2|Overall Study|Adverse Event|11
2569736|NCT01290887|8888317|P1|Overall Study|Adverse Event|6
2569737|NCT01290822|8888378|P1|Overall Study|Physician Decision|10
2569738|NCT01290822|8888378|P1|Overall Study|Withdrawal by Subject|1
2569739|NCT01290796|8888387|P1|Overall Study|Withdrawal by Sponsor|1
2569740|NCT01290796|8888387|P1|Overall Study|Secondary Surgical Intervention|2
2569741|NCT01290796|8888387|P1|Overall Study|Physician Decision|2
2569742|NCT01290796|8888387|P1|Overall Study|Withdrawal by Subject|4
2569743|NCT01290796|8888387|P1|Overall Study|Lost to Follow-up|21
2569744|NCT01290757|8888403|P2|Overall Study|Other|1
2569745|NCT01290757|8888404|P1|Overall Study|Other|0
2569746|NCT01290757|8888403|P2|Overall Study|Protocol Violation|1
2569747|NCT01290757|8888404|P1|Overall Study|Protocol Violation|1
2569748|NCT01290757|8888403|P2|Overall Study|Adverse Event|0
2569749|NCT01290757|8888404|P1|Overall Study|Adverse Event|1
2569750|NCT01290731|8888420|P1|Overall Study|Withdrawal by Subject|1
2569751|NCT01290718|8888432|P1|Overall Study|Early termination of the study|4
2569752|NCT01290679|8888441|P2|Overall Study|Subject Entered Another Trial|5
2569753|NCT01290679|8888442|P1|Overall Study|Subject Entered Another Trial|0
2569754|NCT01290679|8888441|P2|Overall Study|Withdrawal by Subject|5
2569755|NCT01290679|8888442|P1|Overall Study|Withdrawal by Subject|6
2569756|NCT01290679|8888441|P2|Overall Study|Protocol Violation|1
2569757|NCT01290679|8888442|P1|Overall Study|Protocol Violation|0
2569758|NCT01290679|8888441|P2|Overall Study|Lost to Follow-up|10
2569759|NCT01290679|8888442|P1|Overall Study|Lost to Follow-up|8
2569760|NCT01290679|8888441|P2|Overall Study|Adverse Event|0
2569761|NCT01290679|8888442|P1|Overall Study|Adverse Event|2
2569762|NCT01290666|8888511|P1|Overall Study|Early Termination of Study|4
2569763|NCT01290666|8888511|P1|Overall Study|Withdrawal by Subject|23
2569764|NCT01290666|8888511|P1|Overall Study|Lost to Follow-up|11
2569765|NCT01290601|8888564|P4|Overall Study|Protocol Violation|0
2569766|NCT01290601|8888565|P3|Overall Study|Protocol Violation|0
2569767|NCT01290601|8888566|P2|Overall Study|Protocol Violation|0
2569768|NCT01290601|8888567|P1|Overall Study|Protocol Violation|1
2569769|NCT01290601|8888564|P4|Overall Study|Other|0
2569770|NCT01290601|8888565|P3|Overall Study|Other|0
2569771|NCT01290601|8888566|P2|Overall Study|Other|0
2569772|NCT01290601|8888567|P1|Overall Study|Other|1
2569773|NCT01290601|8888564|P4|Overall Study|Lost to Follow-up|0
2569774|NCT01290601|8888565|P3|Overall Study|Lost to Follow-up|0
2569775|NCT01290601|8888566|P2|Overall Study|Lost to Follow-up|2
2569776|NCT01290601|8888567|P1|Overall Study|Lost to Follow-up|7
2569777|NCT01290601|8888564|P4|Overall Study|Lack of Efficacy|0
2569778|NCT01290601|8888565|P3|Overall Study|Lack of Efficacy|0
2569779|NCT01290601|8888566|P2|Overall Study|Lack of Efficacy|1
2569780|NCT01290601|8888567|P1|Overall Study|Lack of Efficacy|2
2569781|NCT01290601|8888564|P4|Overall Study|Adverse Event|0
2569782|NCT01290601|8888565|P3|Overall Study|Adverse Event|0
2569783|NCT01290601|8888566|P2|Overall Study|Adverse Event|2
2569784|NCT01290601|8888567|P1|Overall Study|Adverse Event|0
2569785|NCT01290523|8888588|P1|Overall Study|Death|3
2569786|NCT01290341|8888627|P2|Overall Study|Negative baseline culture and others|11
2569787|NCT01290341|8888628|P1|Overall Study|Negative baseline culture and others|44
2569788|NCT01290341|8888627|P2|Overall Study|Withdrawal by Subject|5
2569789|NCT01290341|8888628|P1|Overall Study|Withdrawal by Subject|19
2569790|NCT01290341|8888627|P2|Overall Study|Lost to Follow-up|10
2569791|NCT01290341|8888628|P1|Overall Study|Lost to Follow-up|21
2569792|NCT01290341|8888627|P2|Overall Study|Adverse Event|0
2569793|NCT01290341|8888628|P1|Overall Study|Adverse Event|1
2569794|NCT01290341|8888627|P2|Overall Study|Protocol Violation|3
2569795|NCT01290341|8888628|P1|Overall Study|Protocol Violation|7
2569796|NCT01290315|8888640|P4|Overall Study|Withdrawal by Subject|0
2569797|NCT01290315|8888641|P3|Overall Study|Withdrawal by Subject|0
2569798|NCT01290315|8888642|P2|Overall Study|Withdrawal by Subject|1
2569799|NCT01290315|8888643|P1|Overall Study|Withdrawal by Subject|1
2569800|NCT01290315|8888640|P4|Overall Study|Lost to Follow-up|0
2569801|NCT01290315|8888641|P3|Overall Study|Lost to Follow-up|0
2569802|NCT01290315|8888642|P2|Overall Study|Lost to Follow-up|1
2569803|NCT01290315|8888643|P1|Overall Study|Lost to Follow-up|0
2569804|NCT01290315|8888640|P4|Overall Study|Selection criteria/compliance|2
2569805|NCT01290315|8888641|P3|Overall Study|Selection criteria/compliance|0
2569806|NCT01290315|8888642|P2|Overall Study|Selection criteria/compliance|1
2569807|NCT01290315|8888643|P1|Overall Study|Selection criteria/compliance|2
2569808|NCT01290315|8888640|P4|Overall Study|Adverse Event|3
2569809|NCT01290315|8888641|P3|Overall Study|Adverse Event|0
2569810|NCT01290315|8888642|P2|Overall Study|Adverse Event|0
2569811|NCT01290315|8888643|P1|Overall Study|Adverse Event|0
2569812|NCT01290263|8888665|P5|Overall Study|Participant Non-Compliance|1
2569813|NCT01290263|8888666|P4|Overall Study|Participant Non-Compliance|1
2569814|NCT01290263|8888667|P3|Overall Study|Participant Non-Compliance|0
2569815|NCT01290263|8888668|P2|Overall Study|Participant Non-Compliance|0
2569816|NCT01290263|8888669|P1|Overall Study|Participant Non-Compliance|0
2569817|NCT01290263|8888665|P5|Overall Study|Withdrawal by Subject|2
2569818|NCT01290263|8888666|P4|Overall Study|Withdrawal by Subject|1
2569819|NCT01290263|8888667|P3|Overall Study|Withdrawal by Subject|0
2569820|NCT01290263|8888668|P2|Overall Study|Withdrawal by Subject|1
2569821|NCT01290263|8888669|P1|Overall Study|Withdrawal by Subject|3
2569822|NCT01290263|8888665|P5|Overall Study|Lack of Efficacy|33
2569823|NCT01290263|8888666|P4|Overall Study|Lack of Efficacy|24
2569824|NCT01290263|8888667|P3|Overall Study|Lack of Efficacy|7
2569825|NCT01290263|8888668|P2|Overall Study|Lack of Efficacy|2
2569826|NCT01290263|8888669|P1|Overall Study|Lack of Efficacy|8
2569827|NCT01290263|8888665|P5|Overall Study|Adverse Event|1
2569828|NCT01290263|8888666|P4|Overall Study|Adverse Event|1
2569829|NCT01290263|8888667|P3|Overall Study|Adverse Event|0
2569830|NCT01290263|8888668|P2|Overall Study|Adverse Event|0
2569831|NCT01290263|8888669|P1|Overall Study|Adverse Event|0
2569832|NCT01290224|8888696|P1|Overall Study|Refused Further Treatment|4
2569833|NCT01290224|8888696|P1|Overall Study|Adverse Event|1
2569834|NCT01290094|8888707|P1|Overall Study|Lost to Follow-up|5
2569835|NCT01290094|8888707|P1|Overall Study|Withdrawal by Subject|1
2569836|NCT01290068|8888720|P2|Overall Study|Other|1
2569837|NCT01290068|8888721|P1|Overall Study|Other|3
2569838|NCT01290068|8888720|P2|Overall Study|Withdrawal by subject prior to implant|2
2569839|NCT01290068|8888721|P1|Overall Study|Withdrawal by subject prior to implant|0
2569840|NCT01290068|8888720|P2|Overall Study|Lost to Follow-up|0
2569841|NCT01290068|8888721|P1|Overall Study|Lost to Follow-up|3
2569842|NCT01290068|8888720|P2|Overall Study|Adverse Event|3
2569843|NCT01290068|8888721|P1|Overall Study|Adverse Event|1
2569844|NCT01290029|8888733|P1|Overall Study|Other|2
2569845|NCT01289990|8888759|P13|Overall Study|Not treated|0
2569846|NCT01289990|8888760|P12|Overall Study|Not treated|2
2569847|NCT01289990|8888761|P11|Overall Study|Not treated|1
2569848|NCT01289990|8888762|P10|Overall Study|Not treated|0
2569849|NCT01289990|8888763|P9|Overall Study|Not treated|1
2569850|NCT01289990|8888764|P8|Overall Study|Not treated|0
2569851|NCT01289990|8888765|P7|Overall Study|Not treated|1
2569852|NCT01289990|8888766|P6|Overall Study|Not treated|0
2569853|NCT01289990|8888767|P5|Overall Study|Not treated|0
2569854|NCT01289990|8888768|P4|Overall Study|Not treated|0
2569855|NCT01289990|8888769|P3|Overall Study|Not treated|0
2569856|NCT01289990|8888770|P2|Overall Study|Not treated|0
2569857|NCT01289990|8888771|P1|Overall Study|Not treated|0
2569858|NCT01289990|8888759|P13|Overall Study|did not continue in extension|56
2569859|NCT01289990|8888760|P12|Overall Study|did not continue in extension|34
2569860|NCT01289990|8888761|P11|Overall Study|did not continue in extension|45
2569861|NCT01289990|8888762|P10|Overall Study|did not continue in extension|48
2569862|NCT01289990|8888763|P9|Overall Study|did not continue in extension|44
2569863|NCT01289990|8888764|P8|Overall Study|did not continue in extension|36
2569864|NCT01289990|8888765|P7|Overall Study|did not continue in extension|54
2569865|NCT01289990|8888766|P6|Overall Study|did not continue in extension|50
2569866|NCT01289990|8888767|P5|Overall Study|did not continue in extension|48
2569867|NCT01289990|8888768|P4|Overall Study|did not continue in extension|51
2569868|NCT01289990|8888769|P3|Overall Study|did not continue in extension|51
2569869|NCT01289990|8888770|P2|Overall Study|did not continue in extension|45
2569870|NCT01289990|8888771|P1|Overall Study|did not continue in extension|41
2569871|NCT01289990|8888759|P13|Overall Study|discontinued in preceding trial|24
2569872|NCT01289990|8888760|P12|Overall Study|discontinued in preceding trial|17
2569873|NCT01289990|8888761|P11|Overall Study|discontinued in preceding trial|17
2569874|NCT01289990|8888762|P10|Overall Study|discontinued in preceding trial|21
2569875|NCT01289990|8888763|P9|Overall Study|discontinued in preceding trial|17
2569876|NCT01289990|8888764|P8|Overall Study|discontinued in preceding trial|8
2569877|NCT01289990|8888765|P7|Overall Study|discontinued in preceding trial|18
2569878|NCT01289990|8888766|P6|Overall Study|discontinued in preceding trial|12
2569879|NCT01289990|8888767|P5|Overall Study|discontinued in preceding trial|11
2569880|NCT01289990|8888768|P4|Overall Study|discontinued in preceding trial|17
2569881|NCT01289990|8888769|P3|Overall Study|discontinued in preceding trial|41
2569882|NCT01289990|8888770|P2|Overall Study|discontinued in preceding trial|20
2569883|NCT01289990|8888771|P1|Overall Study|discontinued in preceding trial|18
2569884|NCT01289990|8888759|P13|Overall Study|Withdrawal by Subject|16
2569885|NCT01289990|8888760|P12|Overall Study|Withdrawal by Subject|13
2569886|NCT01289990|8888761|P11|Overall Study|Withdrawal by Subject|11
2569887|NCT01289990|8888762|P10|Overall Study|Withdrawal by Subject|13
2569888|NCT01289990|8888763|P9|Overall Study|Withdrawal by Subject|12
2569889|NCT01289990|8888764|P8|Overall Study|Withdrawal by Subject|9
2569890|NCT01289990|8888765|P7|Overall Study|Withdrawal by Subject|13
2569891|NCT01289990|8888766|P6|Overall Study|Withdrawal by Subject|7
2569892|NCT01289990|8888767|P5|Overall Study|Withdrawal by Subject|8
2569893|NCT01289990|8888768|P4|Overall Study|Withdrawal by Subject|13
2569894|NCT01289990|8888769|P3|Overall Study|Withdrawal by Subject|12
2569895|NCT01289990|8888770|P2|Overall Study|Withdrawal by Subject|14
2569896|NCT01289990|8888771|P1|Overall Study|Withdrawal by Subject|15
2569897|NCT01289990|8888759|P13|Overall Study|Lost to Follow-up|2
2569898|NCT01289990|8888760|P12|Overall Study|Lost to Follow-up|1
2569899|NCT01289990|8888761|P11|Overall Study|Lost to Follow-up|2
2569900|NCT01289990|8888762|P10|Overall Study|Lost to Follow-up|4
2569901|NCT01289990|8888763|P9|Overall Study|Lost to Follow-up|1
2569902|NCT01289990|8888764|P8|Overall Study|Lost to Follow-up|2
2569903|NCT01289990|8888765|P7|Overall Study|Lost to Follow-up|2
2569904|NCT01289990|8888766|P6|Overall Study|Lost to Follow-up|4
2569905|NCT01289990|8888767|P5|Overall Study|Lost to Follow-up|3
2569906|NCT01289990|8888768|P4|Overall Study|Lost to Follow-up|5
2569907|NCT01289990|8888769|P3|Overall Study|Lost to Follow-up|5
2569908|NCT01289990|8888770|P2|Overall Study|Lost to Follow-up|2
2569909|NCT01289990|8888771|P1|Overall Study|Lost to Follow-up|3
2569910|NCT01289990|8888759|P13|Overall Study|Death|0
2569911|NCT01289990|8888760|P12|Overall Study|Death|1
2569912|NCT01289990|8888761|P11|Overall Study|Death|0
2569913|NCT01289990|8888762|P10|Overall Study|Death|0
2569914|NCT01289990|8888763|P9|Overall Study|Death|0
2569915|NCT01289990|8888764|P8|Overall Study|Death|0
2569916|NCT01289990|8888765|P7|Overall Study|Death|0
2569917|NCT01289990|8888766|P6|Overall Study|Death|1
2569918|NCT01289990|8888767|P5|Overall Study|Death|2
2569919|NCT01289990|8888768|P4|Overall Study|Death|1
2569920|NCT01289990|8888769|P3|Overall Study|Death|0
2569921|NCT01289990|8888770|P2|Overall Study|Death|0
2569922|NCT01289990|8888771|P1|Overall Study|Death|0
2569923|NCT01289847|8888988|P1|Overall Study|Patient could not comply with visits|1
2569924|NCT01289821|8888997|P1|Survival Follow-up Period|Clinical endpoint reached|16
2569925|NCT01289821|8888997|P1|Survival Follow-up Period|Lost to Follow-up|1
2569926|NCT01289821|8888997|P1|Survival Follow-up Period|Protocol Violation|1
2569927|NCT01289821|8888997|P1|Safety Follow-up Period|Unspecified reason|1
2569928|NCT01289821|8888997|P1|Safety Follow-up Period|Protocol Violation|3
2569929|NCT01289821|8888997|P1|Safety Follow-up Period|Withdrawal by Subject|1
2569930|NCT01289821|8888997|P1|Treatment Period|Therapeutic procedure required|1
2569931|NCT01289821|8888997|P1|Treatment Period|Clinical Progression|2
2569932|NCT01289821|8888997|P1|Treatment Period|Radiological Progression|43
2569933|NCT01289821|8888997|P1|Treatment Period|Adverse Event|4
2569934|NCT01289821|8888997|P1|Treatment Period|Physician Decision|3
2569935|NCT01289821|8888997|P1|Treatment Period|Withdrawal by Subject|1
2569936|NCT01289782|8889008|P2|Overall Study|Reason not specified|2
2569937|NCT01289782|8889009|P1|Overall Study|Reason not specified|1
2569938|NCT01289782|8889008|P2|Overall Study|Sponsor's Decision|0
2569939|NCT01289782|8889009|P1|Overall Study|Sponsor's Decision|1
2569940|NCT01289782|8889008|P2|Overall Study|Withdrawal by Subject|2
2569941|NCT01289782|8889009|P1|Overall Study|Withdrawal by Subject|8
2569942|NCT01289782|8889008|P2|Overall Study|Protocol Violation|1
2569943|NCT01289782|8889009|P1|Overall Study|Protocol Violation|1
2569944|NCT01289782|8889008|P2|Overall Study|Lost to Follow-up|7
2569945|NCT01289782|8889009|P1|Overall Study|Lost to Follow-up|14
2569946|NCT01289678|8889078|P1|Overall Study|Physician Decision|6
2569947|NCT01289639|8889085|P3|Overall Study|Lost to Follow-up|0
2569948|NCT01289639|8889086|P2|Overall Study|Lost to Follow-up|0
2569949|NCT01289639|8889087|P1|Overall Study|Lost to Follow-up|1
2569950|NCT01289574|8889113|P3|Overall Study|Subject wanted alternate treatment|0
2569951|NCT01289574|8889114|P2|Overall Study|Subject wanted alternate treatment|1
2569952|NCT01289574|8889115|P1|Overall Study|Subject wanted alternate treatment|0
2569953|NCT01289574|8889113|P3|Overall Study|Adverse Event|0
2569954|NCT01289574|8889114|P2|Overall Study|Adverse Event|1
2569955|NCT01289574|8889115|P1|Overall Study|Adverse Event|0
2569956|NCT01289574|8889113|P3|Overall Study|Withdrawal by Subject|1
2569957|NCT01289574|8889114|P2|Overall Study|Withdrawal by Subject|1
2569958|NCT01289574|8889115|P1|Overall Study|Withdrawal by Subject|1
2569959|NCT01289574|8889113|P3|Overall Study|Lost to Follow-up|1
2569960|NCT01289574|8889114|P2|Overall Study|Lost to Follow-up|0
2569961|NCT01289574|8889115|P1|Overall Study|Lost to Follow-up|2
2569962|NCT01289574|8889113|P3|Overall Study|Lack of Efficacy|1
2569963|NCT01289574|8889114|P2|Overall Study|Lack of Efficacy|0
2569964|NCT01289574|8889115|P1|Overall Study|Lack of Efficacy|4
2569965|NCT01289418|8889209|P1|Day 29 Survey|participants did not complete the survey|2185
2569966|NCT01289418|8889209|P1|Day 29 Survey|email address invalid|283
2569967|NCT01289418|8889209|P1|Day 8 Survey|participants did not complete the survey|1935
2569968|NCT01289418|8889209|P1|Day 8 Survey|email address invalid|283
2569969|NCT01289210|8889257|P1|Overall Study|Adverse Event|1
2569970|NCT01289119|8889267|P6|Overall Study|Other|0
2569971|NCT01289119|8889268|P5|Overall Study|Other|0
2569972|NCT01289119|8889269|P4|Overall Study|Other|0
2569973|NCT01289119|8889270|P3|Overall Study|Other|1
2569974|NCT01289119|8889271|P2|Overall Study|Other|0
2569975|NCT01289119|8889272|P1|Overall Study|Other|1
2569976|NCT01289119|8889267|P6|Overall Study|Lack of Efficacy|1
2569977|NCT01289119|8889268|P5|Overall Study|Lack of Efficacy|1
2569978|NCT01289119|8889269|P4|Overall Study|Lack of Efficacy|1
2569979|NCT01289119|8889270|P3|Overall Study|Lack of Efficacy|1
2569980|NCT01289119|8889271|P2|Overall Study|Lack of Efficacy|1
2569981|NCT01289119|8889272|P1|Overall Study|Lack of Efficacy|0
2569982|NCT01289119|8889267|P6|Overall Study|Pregnancy|0
2569983|NCT01289119|8889268|P5|Overall Study|Pregnancy|0
2569984|NCT01289119|8889269|P4|Overall Study|Pregnancy|0
2569985|NCT01289119|8889270|P3|Overall Study|Pregnancy|0
2569986|NCT01289119|8889271|P2|Overall Study|Pregnancy|1
2569987|NCT01289119|8889272|P1|Overall Study|Pregnancy|0
2569988|NCT01289119|8889267|P6|Overall Study|Withdrawal by Subject|1
2569989|NCT01289119|8889268|P5|Overall Study|Withdrawal by Subject|1
2569990|NCT01289119|8889269|P4|Overall Study|Withdrawal by Subject|3
2569991|NCT01289119|8889270|P3|Overall Study|Withdrawal by Subject|4
2569992|NCT01289119|8889271|P2|Overall Study|Withdrawal by Subject|2
2569993|NCT01289119|8889272|P1|Overall Study|Withdrawal by Subject|4
2569994|NCT01289119|8889267|P6|Overall Study|Lost to Follow-up|1
2569995|NCT01289119|8889268|P5|Overall Study|Lost to Follow-up|0
2569996|NCT01289119|8889269|P4|Overall Study|Lost to Follow-up|0
2569997|NCT01289119|8889270|P3|Overall Study|Lost to Follow-up|0
2569998|NCT01289119|8889271|P2|Overall Study|Lost to Follow-up|3
2569999|NCT01289119|8889272|P1|Overall Study|Lost to Follow-up|0
2570000|NCT01289119|8889267|P6|Overall Study|Major Protocol Deviation|1
2570001|NCT01289119|8889268|P5|Overall Study|Major Protocol Deviation|2
2570002|NCT01289119|8889269|P4|Overall Study|Major Protocol Deviation|0
2570003|NCT01289119|8889270|P3|Overall Study|Major Protocol Deviation|3
2570004|NCT01289119|8889271|P2|Overall Study|Major Protocol Deviation|1
2570005|NCT01289119|8889272|P1|Overall Study|Major Protocol Deviation|2
2570006|NCT01289119|8889267|P6|Overall Study|Adverse Event|0
2570007|NCT01289119|8889268|P5|Overall Study|Adverse Event|1
2570008|NCT01289119|8889269|P4|Overall Study|Adverse Event|2
2570009|NCT01289119|8889270|P3|Overall Study|Adverse Event|0
2570010|NCT01289119|8889271|P2|Overall Study|Adverse Event|1
2570011|NCT01289119|8889272|P1|Overall Study|Adverse Event|2
2570012|NCT01289041|8889393|P1|Overall Study|Death|1
2570013|NCT01289041|8889393|P1|Overall Study|Withdrawal by Subject|3
2570014|NCT01289041|8889393|P1|Overall Study|Progressive Disease|41
2570015|NCT01289041|8889393|P1|Overall Study|Physician Decision|1
2570016|NCT01289041|8889393|P1|Overall Study|Adverse Event|24
2570017|NCT01289028|8889405|P1|Overall Study|Missing reason for discon|1
2570018|NCT01289028|8889405|P1|Overall Study|Abnormal Lab Value|1
2570019|NCT01289028|8889405|P1|Overall Study|New Cancer Therapy|2
2570020|NCT01289028|8889405|P1|Overall Study|Lost to Follow-up|2
2570021|NCT01289028|8889405|P1|Overall Study|No longer required|2
2570022|NCT01289028|8889405|P1|Overall Study|Lack of Efficacy|2
2570023|NCT01289028|8889405|P1|Overall Study|Death|4
2570024|NCT01289028|8889405|P1|Overall Study|Withdrawal by Subject|6
2570025|NCT01289028|8889405|P1|Overall Study|Adverse Event|14
2570026|NCT01289028|8889405|P1|Overall Study|Progressive Disease|49
2570027|NCT01289015|8889419|P2|Overall Study|Negative baseline culture and others|20
2570028|NCT01289015|8889420|P1|Overall Study|Negative baseline culture and others|33
2570029|NCT01289015|8889419|P2|Overall Study|Disease progression|0
2570030|NCT01289015|8889420|P1|Overall Study|Disease progression|1
2570031|NCT01289015|8889419|P2|Overall Study|Withdrawal by Subject|8
2570032|NCT01289015|8889420|P1|Overall Study|Withdrawal by Subject|17
2570033|NCT01289015|8889419|P2|Overall Study|Lost to Follow-up|17
2570034|NCT01289015|8889420|P1|Overall Study|Lost to Follow-up|33
2570035|NCT01289015|8889419|P2|Overall Study|Adverse Event|0
2570036|NCT01289015|8889420|P1|Overall Study|Adverse Event|3
2570037|NCT01289015|8889419|P2|Overall Study|Protocol Violation|9
2570038|NCT01289015|8889420|P1|Overall Study|Protocol Violation|12
2570039|NCT01288989|8889433|P5|Overall Study|Withdrawal by Subject|3
2570040|NCT01288989|8889434|P4|Overall Study|Withdrawal by Subject|0
2570041|NCT01288989|8889435|P3|Overall Study|Withdrawal by Subject|0
2570042|NCT01288989|8889436|P2|Overall Study|Withdrawal by Subject|0
2570043|NCT01288989|8889437|P1|Overall Study|Withdrawal by Subject|0
2570044|NCT01288989|8889433|P5|Overall Study|Physician Decision|1
2570045|NCT01288989|8889434|P4|Overall Study|Physician Decision|0
2570046|NCT01288989|8889435|P3|Overall Study|Physician Decision|0
2570047|NCT01288989|8889436|P2|Overall Study|Physician Decision|0
2570048|NCT01288989|8889437|P1|Overall Study|Physician Decision|0
2570049|NCT01288989|8889433|P5|Overall Study|Adverse Event|2
2570050|NCT01288989|8889434|P4|Overall Study|Adverse Event|0
2570051|NCT01288989|8889435|P3|Overall Study|Adverse Event|0
2570052|NCT01288989|8889436|P2|Overall Study|Adverse Event|0
2570053|NCT01288989|8889437|P1|Overall Study|Adverse Event|0
2570054|NCT01288989|8889433|P5|Overall Study|Dose limiting toxicity|0
2570055|NCT01288989|8889434|P4|Overall Study|Dose limiting toxicity|0
2570056|NCT01288989|8889435|P3|Overall Study|Dose limiting toxicity|0
2570057|NCT01288989|8889436|P2|Overall Study|Dose limiting toxicity|0
2570058|NCT01288989|8889437|P1|Overall Study|Dose limiting toxicity|1
2570059|NCT01288989|8889433|P5|Overall Study|Death|0
2570060|NCT01288989|8889434|P4|Overall Study|Death|1
2570061|NCT01288989|8889435|P3|Overall Study|Death|0
2570062|NCT01288989|8889436|P2|Overall Study|Death|0
2570063|NCT01288989|8889437|P1|Overall Study|Death|0
2570064|NCT01288976|8889498|P3|Overall Study|Data unavailable|7
2570065|NCT01288976|8889499|P2|Overall Study|Data unavailable|9
2570066|NCT01288976|8889500|P1|Overall Study|Data unavailable|22
2570067|NCT01288976|8889498|P3|Overall Study|Death|4
2570068|NCT01288976|8889499|P2|Overall Study|Death|6
2570069|NCT01288976|8889500|P1|Overall Study|Death|98
2570070|NCT01288976|8889498|P3|Overall Study|Withdrawal by Subject|9
2570071|NCT01288976|8889499|P2|Overall Study|Withdrawal by Subject|12
2570072|NCT01288976|8889500|P1|Overall Study|Withdrawal by Subject|58
2570073|NCT01288911|8889529|P2|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5
2570074|NCT01288911|8889530|P1|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17
2570075|NCT01288911|8889529|P2|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0
2570076|NCT01288911|8889530|P1|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5
2570077|NCT01288911|8889529|P2|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0
2570078|NCT01288911|8889530|P1|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1
2570079|NCT01288911|8889529|P2|Open-label Period (All Enzalutamide)|Progressive disease|3
2570080|NCT01288911|8889530|P1|Open-label Period (All Enzalutamide)|Progressive disease|18
2570081|NCT01288911|8889529|P2|Open-label Period (All Enzalutamide)|Lost to Follow-up|0
2570082|NCT01288911|8889530|P1|Open-label Period (All Enzalutamide)|Lost to Follow-up|1
2570083|NCT01288911|8889529|P2|Open-label Period (All Enzalutamide)|Death|1
2570084|NCT01288911|8889530|P1|Open-label Period (All Enzalutamide)|Death|0
2570085|NCT01288911|8889529|P2|Double-blind Period|Randomized but never received study drug|2
2570086|NCT01288911|8889530|P1|Double-blind Period|Randomized but never received study drug|1
2570087|NCT01288911|8889529|P2|Double-blind Period|Miscellaneous Reason|42
2570088|NCT01288911|8889530|P1|Double-blind Period|Miscellaneous Reason|29
2570089|NCT01288911|8889529|P2|Double-blind Period|Withdrawal by Subject|26
2570090|NCT01288911|8889530|P1|Double-blind Period|Withdrawal by Subject|25
2570091|NCT01288911|8889529|P2|Double-blind Period|Protocol Violation|0
2570092|NCT01288911|8889530|P1|Double-blind Period|Protocol Violation|1
2570093|NCT01288911|8889529|P2|Double-blind Period|Progressive Disease|103
2570094|NCT01288911|8889530|P1|Double-blind Period|Progressive Disease|75
2570095|NCT01288911|8889529|P2|Double-blind Period|Lost to Follow-up|2
2570096|NCT01288911|8889530|P1|Double-blind Period|Lost to Follow-up|0
2570097|NCT01288911|8889529|P2|Double-blind Period|Death|7
2570098|NCT01288911|8889530|P1|Double-blind Period|Death|11
2570099|NCT01288729|8889640|P2|Overall Study|Withdrawal by Subject|0
2570100|NCT01288729|8889641|P1|Overall Study|Withdrawal by Subject|1
2570101|NCT01288612|8889650|P3|Overall Study|Unable to intubate|0
2570102|NCT01288612|8889651|P2|Overall Study|Unable to intubate|3
2570103|NCT01288612|8889652|P1|Overall Study|Unable to intubate|0
2570104|NCT01288612|8889650|P3|Overall Study|Declined|62
2570105|NCT01288612|8889651|P2|Overall Study|Declined|63
2570106|NCT01288612|8889652|P1|Overall Study|Declined|78
2570107|NCT01288612|8889650|P3|Overall Study|Unable to contact|20
2570108|NCT01288612|8889651|P2|Overall Study|Unable to contact|16
2570109|NCT01288612|8889652|P1|Overall Study|Unable to contact|11
2570110|NCT01288469|8889701|P3|Overall Study|Exclusion criteria finally met|0
2570111|NCT01288469|8889702|P2|Overall Study|Exclusion criteria finally met|0
2570112|NCT01288469|8889703|P1|Overall Study|Exclusion criteria finally met|1
2570113|NCT01288469|8889701|P3|Overall Study|Consent withdrawn by subject|1
2570114|NCT01288469|8889702|P2|Overall Study|Consent withdrawn by subject|1
2570115|NCT01288469|8889703|P1|Overall Study|Consent withdrawn by subject|1
2570116|NCT01288469|8889701|P3|Overall Study|Participant Moved|0
2570117|NCT01288469|8889702|P2|Overall Study|Participant Moved|0
2570118|NCT01288469|8889703|P1|Overall Study|Participant Moved|1
2570119|NCT01288469|8889701|P3|Overall Study|Poor compliance to protocol|0
2570120|NCT01288469|8889702|P2|Overall Study|Poor compliance to protocol|1
2570121|NCT01288469|8889703|P1|Overall Study|Poor compliance to protocol|0
2570122|NCT01288469|8889701|P3|Overall Study|Adverse Event|1
2570123|NCT01288469|8889702|P2|Overall Study|Adverse Event|1
2570124|NCT01288469|8889703|P1|Overall Study|Adverse Event|4
2570125|NCT01288443|8889735|P6|Overall Study|Other than above|0
2570126|NCT01288443|8889736|P5|Overall Study|Other than above|1
2570127|NCT01288443|8889737|P4|Overall Study|Other than above|2
2570128|NCT01288443|8889738|P3|Overall Study|Other than above|0
2570129|NCT01288443|8889739|P2|Overall Study|Other than above|0
2570130|NCT01288443|8889740|P1|Overall Study|Other than above|0
2570131|NCT01288443|8889735|P6|Overall Study|Study drug auto-injector administration|1
2570132|NCT01288443|8889736|P5|Overall Study|Study drug auto-injector administration|1
2570133|NCT01288443|8889737|P4|Overall Study|Study drug auto-injector administration|0
2570134|NCT01288443|8889738|P3|Overall Study|Study drug auto-injector administration|0
2570135|NCT01288443|8889739|P2|Overall Study|Study drug auto-injector administration|0
2570136|NCT01288443|8889740|P1|Overall Study|Study drug auto-injector administration|0
2570137|NCT01288443|8889735|P6|Overall Study|Lost to Follow-up|0
2570138|NCT01288443|8889736|P5|Overall Study|Lost to Follow-up|0
2570139|NCT01288443|8889737|P4|Overall Study|Lost to Follow-up|0
2570140|NCT01288443|8889738|P3|Overall Study|Lost to Follow-up|0
2570141|NCT01288443|8889739|P2|Overall Study|Lost to Follow-up|1
2570142|NCT01288443|8889740|P1|Overall Study|Lost to Follow-up|0
2570143|NCT01288443|8889735|P6|Overall Study|Consent withdrawn by Participant|1
2570144|NCT01288443|8889736|P5|Overall Study|Consent withdrawn by Participant|0
2570145|NCT01288443|8889737|P4|Overall Study|Consent withdrawn by Participant|0
2570146|NCT01288443|8889738|P3|Overall Study|Consent withdrawn by Participant|0
2570147|NCT01288443|8889739|P2|Overall Study|Consent withdrawn by Participant|0
2570148|NCT01288443|8889740|P1|Overall Study|Consent withdrawn by Participant|0
2570149|NCT01288443|8889735|P6|Overall Study|Participant Moved|1
2570150|NCT01288443|8889736|P5|Overall Study|Participant Moved|2
2570151|NCT01288443|8889737|P4|Overall Study|Participant Moved|1
2570152|NCT01288443|8889738|P3|Overall Study|Participant Moved|0
2570153|NCT01288443|8889739|P2|Overall Study|Participant Moved|0
2570154|NCT01288443|8889740|P1|Overall Study|Participant Moved|0
2570155|NCT01288443|8889735|P6|Overall Study|Poor compliance to protocol|1
2570156|NCT01288443|8889736|P5|Overall Study|Poor compliance to protocol|0
2570157|NCT01288443|8889737|P4|Overall Study|Poor compliance to protocol|0
2570158|NCT01288443|8889738|P3|Overall Study|Poor compliance to protocol|0
2570159|NCT01288443|8889739|P2|Overall Study|Poor compliance to protocol|0
2570160|NCT01288443|8889740|P1|Overall Study|Poor compliance to protocol|0
2570161|NCT01288443|8889735|P6|Overall Study|Adverse Event|1
2570162|NCT01288443|8889736|P5|Overall Study|Adverse Event|3
2570163|NCT01288443|8889737|P4|Overall Study|Adverse Event|1
2570164|NCT01288443|8889738|P3|Overall Study|Adverse Event|1
2570165|NCT01288443|8889739|P2|Overall Study|Adverse Event|0
2570166|NCT01288443|8889740|P1|Overall Study|Adverse Event|0
2570167|NCT01288287|8889790|P1|Overall Study|Unknown Status|7
2570168|NCT01288287|8889790|P1|Overall Study|Unknown Reason|1
2570169|NCT01288287|8889790|P1|Overall Study|Other Reason|13
2570170|NCT01288287|8889790|P1|Overall Study|Lack of Efficacy|13
2570171|NCT01288287|8889790|P1|Overall Study|Withdrawal by Subject|4
2570172|NCT01288287|8889790|P1|Overall Study|Lost to Follow-up|8
2570173|NCT01288209|8889805|P2|Overall Study|Other|0
2570174|NCT01288209|8889806|P1|Overall Study|Other|1
2570175|NCT01288209|8889805|P2|Overall Study|Withdrawal by Subject|3
2570176|NCT01288209|8889806|P1|Overall Study|Withdrawal by Subject|1
2570177|NCT01288079|8889836|P4|Overall Study|Other or Study Termination|8
2570178|NCT01288079|8889837|P3|Overall Study|Other or Study Termination|14
2570179|NCT01288079|8889838|P2|Overall Study|Other or Study Termination|15
2570180|NCT01288079|8889839|P1|Overall Study|Other or Study Termination|11
2570181|NCT01288079|8889836|P4|Overall Study|Lost to Follow-up|0
2570182|NCT01288079|8889837|P3|Overall Study|Lost to Follow-up|1
2570183|NCT01288079|8889838|P2|Overall Study|Lost to Follow-up|1
2570184|NCT01288079|8889839|P1|Overall Study|Lost to Follow-up|1
2570185|NCT01288079|8889836|P4|Overall Study|Study-Specific Withdrawal Criteria|0
2570186|NCT01288079|8889837|P3|Overall Study|Study-Specific Withdrawal Criteria|0
2570187|NCT01288079|8889838|P2|Overall Study|Study-Specific Withdrawal Criteria|1
2570188|NCT01288079|8889839|P1|Overall Study|Study-Specific Withdrawal Criteria|1
2570189|NCT01288079|8889836|P4|Overall Study|Lack of Efficacy|2
2570190|NCT01288079|8889837|P3|Overall Study|Lack of Efficacy|0
2570191|NCT01288079|8889838|P2|Overall Study|Lack of Efficacy|2
2570192|NCT01288079|8889839|P1|Overall Study|Lack of Efficacy|2
2570193|NCT01288079|8889836|P4|Overall Study|Condition under Investigation Worsened|1
2570194|NCT01288079|8889837|P3|Overall Study|Condition under Investigation Worsened|0
2570195|NCT01288079|8889838|P2|Overall Study|Condition under Investigation Worsened|0
2570196|NCT01288079|8889839|P1|Overall Study|Condition under Investigation Worsened|0
2570197|NCT01288079|8889836|P4|Overall Study|Severe Non-Compliance to Protocol|3
2570198|NCT01288079|8889837|P3|Overall Study|Severe Non-Compliance to Protocol|1
2570199|NCT01288079|8889838|P2|Overall Study|Severe Non-Compliance to Protocol|3
2570200|NCT01288079|8889839|P1|Overall Study|Severe Non-Compliance to Protocol|1
2570201|NCT01288079|8889836|P4|Overall Study|Adverse Event|3
2570202|NCT01288079|8889837|P3|Overall Study|Adverse Event|2
2570203|NCT01288079|8889838|P2|Overall Study|Adverse Event|1
2570204|NCT01288079|8889839|P1|Overall Study|Adverse Event|2
2570205|NCT01288079|8889836|P4|Overall Study|Withdrawal by Subject|0
2570206|NCT01288079|8889837|P3|Overall Study|Withdrawal by Subject|1
2570207|NCT01288079|8889838|P2|Overall Study|Withdrawal by Subject|4
2570208|NCT01288079|8889839|P1|Overall Study|Withdrawal by Subject|2
2570209|NCT01288053|8889849|P1|Overall Study|Death|1
2570210|NCT01287897|8889867|P4|Overall Study|Other|0
2570211|NCT01287897|8889868|P3|Overall Study|Other|1
2570212|NCT01287897|8889869|P2|Overall Study|Other|0
2570213|NCT01287897|8889870|P1|Overall Study|Other|1
2570214|NCT01287897|8889867|P4|Overall Study|Not meeting entrance criteria|0
2570215|NCT01287897|8889868|P3|Overall Study|Not meeting entrance criteria|0
2570216|NCT01287897|8889869|P2|Overall Study|Not meeting entrance criteria|1
2570217|NCT01287897|8889870|P1|Overall Study|Not meeting entrance criteria|1
2570218|NCT01287897|8889867|P4|Overall Study|Not consented properly|0
2570219|NCT01287897|8889868|P3|Overall Study|Not consented properly|0
2570220|NCT01287897|8889869|P2|Overall Study|Not consented properly|1
2570221|NCT01287897|8889870|P1|Overall Study|Not consented properly|0
2570222|NCT01287897|8889867|P4|Overall Study|Withdrawal by Subject|2
2570223|NCT01287897|8889868|P3|Overall Study|Withdrawal by Subject|3
2570224|NCT01287897|8889869|P2|Overall Study|Withdrawal by Subject|5
2570225|NCT01287897|8889870|P1|Overall Study|Withdrawal by Subject|1
2570226|NCT01287897|8889867|P4|Overall Study|Lost to Follow-up|0
2570227|NCT01287897|8889868|P3|Overall Study|Lost to Follow-up|2
2570228|NCT01287897|8889869|P2|Overall Study|Lost to Follow-up|0
2570229|NCT01287897|8889870|P1|Overall Study|Lost to Follow-up|0
2570230|NCT01287897|8889867|P4|Overall Study|Protocol Violation|1
2570231|NCT01287897|8889868|P3|Overall Study|Protocol Violation|0
2570232|NCT01287897|8889869|P2|Overall Study|Protocol Violation|1
2570233|NCT01287897|8889870|P1|Overall Study|Protocol Violation|1
2570234|NCT01287897|8889867|P4|Overall Study|Lack of Efficacy|0
2570235|NCT01287897|8889868|P3|Overall Study|Lack of Efficacy|0
2570236|NCT01287897|8889869|P2|Overall Study|Lack of Efficacy|0
2570237|NCT01287897|8889870|P1|Overall Study|Lack of Efficacy|2
2570238|NCT01287897|8889867|P4|Overall Study|Adverse Event|4
2570239|NCT01287897|8889868|P3|Overall Study|Adverse Event|6
2570240|NCT01287897|8889869|P2|Overall Study|Adverse Event|3
2570241|NCT01287897|8889870|P1|Overall Study|Adverse Event|5
2570242|NCT01287832|8889921|P2|Overall Study|Death|1
2570243|NCT01287832|8889922|P1|Overall Study|Death|0
2570244|NCT01287832|8889921|P2|Overall Study|Adverse Event|0
2570245|NCT01287832|8889922|P1|Overall Study|Adverse Event|1
2570246|NCT01287754|8889930|P2|Overall Study|Protocol Violation|3
2570247|NCT01287754|8889931|P1|Overall Study|Protocol Violation|0
2570248|NCT01287754|8889930|P2|Overall Study|Lost to Follow-up|6
2570249|NCT01287754|8889931|P1|Overall Study|Lost to Follow-up|1
2570250|NCT01287754|8889930|P2|Overall Study|Death|12
2570251|NCT01287754|8889931|P1|Overall Study|Death|2
2570252|NCT01287741|8889943|P2|Overall Study|Reason not specified|9
2570253|NCT01287741|8889944|P1|Overall Study|Reason not specified|23
2570254|NCT01287741|8889943|P2|Overall Study|Progressive disease|166
2570255|NCT01287741|8889944|P1|Overall Study|Progressive disease|190
2570256|NCT01287741|8889943|P2|Overall Study|Study terminated by Sponsor|315
2570257|NCT01287741|8889944|P1|Overall Study|Study terminated by Sponsor|307
2570258|NCT01287741|8889943|P2|Overall Study|Adverse Event|6
2570259|NCT01287741|8889944|P1|Overall Study|Adverse Event|4
2570260|NCT01287741|8889943|P2|Overall Study|Death|44
2570261|NCT01287741|8889944|P1|Overall Study|Death|32
2570262|NCT01287741|8889943|P2|Overall Study|Lost to Follow-up|8
2570263|NCT01287741|8889944|P1|Overall Study|Lost to Follow-up|10
2570264|NCT01287741|8889943|P2|Overall Study|Non-compliance|6
2570265|NCT01287741|8889944|P1|Overall Study|Non-compliance|8
2570266|NCT01287741|8889943|P2|Overall Study|Physician Decision|23
2570267|NCT01287741|8889944|P1|Overall Study|Physician Decision|15
2570268|NCT01287741|8889943|P2|Overall Study|Protocol Violation|0
2570269|NCT01287741|8889944|P1|Overall Study|Protocol Violation|2
2570270|NCT01287741|8889943|P2|Overall Study|Withdrawal by Subject|38
2570271|NCT01287741|8889944|P1|Overall Study|Withdrawal by Subject|35
2570272|NCT01287611|8889980|P2|Overall Study|Exclusion due to expanded Kerr incision|3
2570273|NCT01287611|8889981|P1|Overall Study|Exclusion due to expanded Kerr incision|4
2570274|NCT01287611|8889980|P2|Overall Study|Lost to Follow-up|16
2570275|NCT01287611|8889981|P1|Overall Study|Lost to Follow-up|29
2570276|NCT01287520|8889998|P9|Overall Study|Withdrawal by Subject|1
2570277|NCT01287520|8889999|P8|Overall Study|Withdrawal by Subject|0
2570278|NCT01287520|8890000|P7|Overall Study|Withdrawal by Subject|0
2570279|NCT01287520|8890001|P6|Overall Study|Withdrawal by Subject|1
2570280|NCT01287520|8890002|P5|Overall Study|Withdrawal by Subject|0
2570281|NCT01287520|8890003|P4|Overall Study|Withdrawal by Subject|0
2570282|NCT01287520|8890004|P3|Overall Study|Withdrawal by Subject|0
2570283|NCT01287520|8890005|P2|Overall Study|Withdrawal by Subject|0
2570284|NCT01287520|8890006|P1|Overall Study|Withdrawal by Subject|0
2570285|NCT01287520|8889998|P9|Overall Study|Progressive disease|4
2570286|NCT01287520|8889999|P8|Overall Study|Progressive disease|2
2570287|NCT01287520|8890000|P7|Overall Study|Progressive disease|2
2570288|NCT01287520|8890001|P6|Overall Study|Progressive disease|0
2570289|NCT01287520|8890002|P5|Overall Study|Progressive disease|1
2570290|NCT01287520|8890003|P4|Overall Study|Progressive disease|6
2570291|NCT01287520|8890004|P3|Overall Study|Progressive disease|1
2570292|NCT01287520|8890005|P2|Overall Study|Progressive disease|4
2570293|NCT01287520|8890006|P1|Overall Study|Progressive disease|0
2570294|NCT01287520|8889998|P9|Overall Study|Physician Decision|0
2570295|NCT01287520|8889999|P8|Overall Study|Physician Decision|1
2570296|NCT01287520|8890000|P7|Overall Study|Physician Decision|0
2570297|NCT01287520|8890001|P6|Overall Study|Physician Decision|1
2570298|NCT01287520|8890002|P5|Overall Study|Physician Decision|1
2570299|NCT01287520|8890003|P4|Overall Study|Physician Decision|0
2570300|NCT01287520|8890004|P3|Overall Study|Physician Decision|2
2570301|NCT01287520|8890005|P2|Overall Study|Physician Decision|1
2570302|NCT01287520|8890006|P1|Overall Study|Physician Decision|1
2570303|NCT01287520|8889998|P9|Overall Study|Adverse Event|0
2570304|NCT01287520|8889999|P8|Overall Study|Adverse Event|2
2570305|NCT01287520|8890000|P7|Overall Study|Adverse Event|0
2570306|NCT01287520|8890001|P6|Overall Study|Adverse Event|2
2570307|NCT01287520|8890002|P5|Overall Study|Adverse Event|1
2570308|NCT01287520|8890003|P4|Overall Study|Adverse Event|1
2570309|NCT01287520|8890004|P3|Overall Study|Adverse Event|2
2570310|NCT01287520|8890005|P2|Overall Study|Adverse Event|2
2570311|NCT01287520|8890006|P1|Overall Study|Adverse Event|2
2570312|NCT01287416|8890070|P2|6 Month Follow-up|Lost to Follow-up|2
2570313|NCT01287416|8890071|P1|6 Month Follow-up|Lost to Follow-up|3
2570314|NCT01287416|8890070|P2|Pre-post Training|Lost to Follow-up|1
2570315|NCT01287416|8890071|P1|Pre-post Training|Lost to Follow-up|5
2570316|NCT01287416|8890070|P2|Pre-post Training|Withdrawal by Subject|24
2570317|NCT01287416|8890071|P1|Pre-post Training|Withdrawal by Subject|17
2570318|NCT01287403|8890107|P1|1st Intervention (1 Day)|Adverse Event|1
2570319|NCT01287364|8890139|P2|Overall Study|Other Reason|2
2570320|NCT01287364|8890140|P1|Overall Study|Other Reason|4
2570321|NCT01287364|8890139|P2|Overall Study|Protocol Violation|5
2570322|NCT01287364|8890140|P1|Overall Study|Protocol Violation|5
2570323|NCT01287364|8890139|P2|Overall Study|Adverse Event|3
2570324|NCT01287364|8890140|P1|Overall Study|Adverse Event|0
2570325|NCT01287221|8890162|P2|Overall Study|Withdrawal by Subject|1
2570326|NCT01287221|8890163|P1|Overall Study|Withdrawal by Subject|0
2570327|NCT01287221|8890162|P2|Overall Study|Adverse Event|3
2570328|NCT01287221|8890163|P1|Overall Study|Adverse Event|3
2570329|NCT01287221|8890162|P2|Overall Study|Lack of Perceived Benefit|1
2570330|NCT01287221|8890163|P1|Overall Study|Lack of Perceived Benefit|1
2570331|NCT01287195|8890198|P1|Overall Study|Withdrawal by Subject|2
2570332|NCT01287117|8890213|P4|Overall Study|Disease Progression|5
2570333|NCT01287117|8890214|P3|Overall Study|Disease Progression|6
2570334|NCT01287117|8890215|P2|Overall Study|Disease Progression|5
2570335|NCT01287117|8890216|P1|Overall Study|Disease Progression|10
2570336|NCT01287117|8890213|P4|Overall Study|Patient/Legal Guardian's Decision|5
2570337|NCT01287117|8890214|P3|Overall Study|Patient/Legal Guardian's Decision|8
2570338|NCT01287117|8890215|P2|Overall Study|Patient/Legal Guardian's Decision|6
2570339|NCT01287117|8890216|P1|Overall Study|Patient/Legal Guardian's Decision|2
2570340|NCT01287117|8890213|P4|Overall Study|Physician Decision|1
2570341|NCT01287117|8890214|P3|Overall Study|Physician Decision|1
2570342|NCT01287117|8890215|P2|Overall Study|Physician Decision|1
2570343|NCT01287117|8890216|P1|Overall Study|Physician Decision|0
2570344|NCT01287117|8890213|P4|Overall Study|Lost to Follow-up|0
2570345|NCT01287117|8890214|P3|Overall Study|Lost to Follow-up|0
2570346|NCT01287117|8890215|P2|Overall Study|Lost to Follow-up|1
2570347|NCT01287117|8890216|P1|Overall Study|Lost to Follow-up|1
2570348|NCT01287117|8890213|P4|Overall Study|Adverse Event|1
2570349|NCT01287117|8890214|P3|Overall Study|Adverse Event|1
2570350|NCT01287117|8890215|P2|Overall Study|Adverse Event|1
2570351|NCT01287117|8890216|P1|Overall Study|Adverse Event|2
2570352|NCT01287104|8890266|P4|Overall Study|NK cells did not meet release criteria|0
2570353|NCT01287104|8890267|P3|Overall Study|NK cells did not meet release criteria|0
2570354|NCT01287104|8890268|P2|Overall Study|NK cells did not meet release criteria|1
2570355|NCT01287104|8890269|P1|Overall Study|NK cells did not meet release criteria|0
2570356|NCT01287104|8890266|P4|Overall Study|Low donor chimerism|0
2570357|NCT01287104|8890267|P3|Overall Study|Low donor chimerism|0
2570358|NCT01287104|8890268|P2|Overall Study|Low donor chimerism|1
2570359|NCT01287104|8890269|P1|Overall Study|Low donor chimerism|0
2570360|NCT01287104|8890266|P4|Overall Study|Developed GVHD or complications of BMT|0
2570361|NCT01287104|8890267|P3|Overall Study|Developed GVHD or complications of BMT|4
2570362|NCT01287104|8890268|P2|Overall Study|Developed GVHD or complications of BMT|1
2570363|NCT01287104|8890269|P1|Overall Study|Developed GVHD or complications of BMT|0
2570364|NCT01287104|8890266|P4|Overall Study|Donor anaphylaxis|1
2570365|NCT01287104|8890267|P3|Overall Study|Donor anaphylaxis|0
2570366|NCT01287104|8890268|P2|Overall Study|Donor anaphylaxis|1
2570367|NCT01287104|8890269|P1|Overall Study|Donor anaphylaxis|0
2570368|NCT01287104|8890266|P4|Overall Study|Patient developed progressive disease|2
2570369|NCT01287104|8890267|P3|Overall Study|Patient developed progressive disease|3
2570370|NCT01287104|8890268|P2|Overall Study|Patient developed progressive disease|1
2570371|NCT01287104|8890269|P1|Overall Study|Patient developed progressive disease|1
2570372|NCT01287065|8890302|P6|Treatment Period 1|Withdrawal by Subject|1
2570373|NCT01287065|8890303|P5|Treatment Period 1|Withdrawal by Subject|0
2570374|NCT01287065|8890304|P4|Treatment Period 1|Withdrawal by Subject|0
2570375|NCT01287065|8890305|P3|Treatment Period 1|Withdrawal by Subject|0
2570376|NCT01287065|8890306|P2|Treatment Period 1|Withdrawal by Subject|0
2570377|NCT01287065|8890307|P1|Treatment Period 1|Withdrawal by Subject|0
2570378|NCT01287065|8890302|P6|Treatment Period 1|Adverse Event|0
2570379|NCT01287065|8890303|P5|Treatment Period 1|Adverse Event|1
2570380|NCT01287065|8890304|P4|Treatment Period 1|Adverse Event|0
2570381|NCT01287065|8890305|P3|Treatment Period 1|Adverse Event|0
2570382|NCT01287065|8890306|P2|Treatment Period 1|Adverse Event|0
2570383|NCT01287065|8890307|P1|Treatment Period 1|Adverse Event|0
2570384|NCT01287039|8890326|P2|Overall Study|Lost to Follow-up|2
2570385|NCT01287039|8890327|P1|Overall Study|Lost to Follow-up|3
2570386|NCT01287039|8890326|P2|Overall Study|Withdrawal by Subject|11
2570387|NCT01287039|8890327|P1|Overall Study|Withdrawal by Subject|14
2570388|NCT01287039|8890326|P2|Overall Study|Adverse Event|4
2570389|NCT01287039|8890327|P1|Overall Study|Adverse Event|7
2570390|NCT01287039|8890326|P2|Overall Study|Change of residence|0
2570391|NCT01287039|8890327|P1|Overall Study|Change of residence|1
2570392|NCT01287039|8890326|P2|Overall Study|Death|0
2570393|NCT01287039|8890327|P1|Overall Study|Death|1
2570394|NCT01287039|8890326|P2|Overall Study|Problem with travel|1
2570395|NCT01287039|8890327|P1|Overall Study|Problem with travel|0
2570396|NCT01287039|8890326|P2|Overall Study|Noncompliance with study medication|1
2570397|NCT01287039|8890327|P1|Overall Study|Noncompliance with study medication|0
2570398|NCT01287039|8890326|P2|Overall Study|Excluded medication taken|0
2570399|NCT01287039|8890327|P1|Overall Study|Excluded medication taken|1
2570400|NCT01287039|8890326|P2|Overall Study|Protocol Violation|3
2570401|NCT01287039|8890327|P1|Overall Study|Protocol Violation|2
2570402|NCT01287039|8890326|P2|Overall Study|Elective surgery|1
2570403|NCT01287039|8890327|P1|Overall Study|Elective surgery|0
2570404|NCT01287039|8890326|P2|Overall Study|Change of location/residence|3
2570405|NCT01287039|8890327|P1|Overall Study|Change of location/residence|0
2570406|NCT01287039|8890326|P2|Overall Study|Noncompliance with study procedures|1
2570407|NCT01287039|8890327|P1|Overall Study|Noncompliance with study procedures|0
2570408|NCT01287013|8890360|P3|Overall Study|Non-evaluable|21
2570409|NCT01287013|8890361|P2|Overall Study|Non-evaluable|5
2570410|NCT01287013|8890362|P1|Overall Study|Non-evaluable|3
2570411|NCT01286987|8890392|P15|Part 2: Dose Expansion|Withdrawal by Subject|0
2570412|NCT01286987|8890393|P14|Part 2: Dose Expansion|Withdrawal by Subject|0
2570413|NCT01286987|8890394|P13|Part 2: Dose Expansion|Withdrawal by Subject|0
2570414|NCT01286987|8890395|P12|Part 2: Dose Expansion|Withdrawal by Subject|0
2570415|NCT01286987|8890396|P11|Part 2: Dose Expansion|Withdrawal by Subject|1
2570416|NCT01286987|8890397|P10|Part 2: Dose Expansion|Withdrawal by Subject|0
2570417|NCT01286987|8890398|P9|Part 2: Dose Expansion|Withdrawal by Subject|0
2570418|NCT01286987|8890399|P8|Part 2: Dose Expansion|Withdrawal by Subject|0
2570419|NCT01286987|8890400|P7|Part 2: Dose Expansion|Withdrawal by Subject|0
2570420|NCT01286987|8890401|P6|Part 2: Dose Expansion|Withdrawal by Subject|0
2570421|NCT01286987|8890402|P5|Part 2: Dose Expansion|Withdrawal by Subject|0
2570422|NCT01286987|8890403|P4|Part 2: Dose Expansion|Withdrawal by Subject|0
2570423|NCT01286987|8890404|P3|Part 2: Dose Expansion|Withdrawal by Subject|0
2570424|NCT01286987|8890405|P2|Part 2: Dose Expansion|Withdrawal by Subject|0
2570425|NCT01286987|8890406|P1|Part 2: Dose Expansion|Withdrawal by Subject|0
2570426|NCT01286987|8890392|P15|Part 2: Dose Expansion|Clinical Progression|0
2570427|NCT01286987|8890393|P14|Part 2: Dose Expansion|Clinical Progression|2
2570428|NCT01286987|8890394|P13|Part 2: Dose Expansion|Clinical Progression|0
2570429|NCT01286987|8890395|P12|Part 2: Dose Expansion|Clinical Progression|2
2570430|NCT01286987|8890396|P11|Part 2: Dose Expansion|Clinical Progression|2
2570431|NCT01286987|8890397|P10|Part 2: Dose Expansion|Clinical Progression|0
2570432|NCT01286987|8890398|P9|Part 2: Dose Expansion|Clinical Progression|0
2570433|NCT01286987|8890399|P8|Part 2: Dose Expansion|Clinical Progression|0
2570434|NCT01286987|8890400|P7|Part 2: Dose Expansion|Clinical Progression|0
2570435|NCT01286987|8890401|P6|Part 2: Dose Expansion|Clinical Progression|0
2570436|NCT01286987|8890402|P5|Part 2: Dose Expansion|Clinical Progression|0
2570437|NCT01286987|8890403|P4|Part 2: Dose Expansion|Clinical Progression|0
2570438|NCT01286987|8890404|P3|Part 2: Dose Expansion|Clinical Progression|0
2570439|NCT01286987|8890405|P2|Part 2: Dose Expansion|Clinical Progression|0
2570440|NCT01286987|8890406|P1|Part 2: Dose Expansion|Clinical Progression|0
2570441|NCT01286987|8890392|P15|Part 2: Dose Expansion|Progressive Disease|2
2570442|NCT01286987|8890393|P14|Part 2: Dose Expansion|Progressive Disease|19
2570443|NCT01286987|8890394|P13|Part 2: Dose Expansion|Progressive Disease|11
2570444|NCT01286987|8890395|P12|Part 2: Dose Expansion|Progressive Disease|7
2570445|NCT01286987|8890396|P11|Part 2: Dose Expansion|Progressive Disease|6
2570446|NCT01286987|8890397|P10|Part 2: Dose Expansion|Progressive Disease|11
2570447|NCT01286987|8890398|P9|Part 2: Dose Expansion|Progressive Disease|0
2570448|NCT01286987|8890399|P8|Part 2: Dose Expansion|Progressive Disease|0
2570449|NCT01286987|8890400|P7|Part 2: Dose Expansion|Progressive Disease|0
2570450|NCT01286987|8890401|P6|Part 2: Dose Expansion|Progressive Disease|0
2570451|NCT01286987|8890402|P5|Part 2: Dose Expansion|Progressive Disease|0
2570452|NCT01286987|8890403|P4|Part 2: Dose Expansion|Progressive Disease|0
2570453|NCT01286987|8890404|P3|Part 2: Dose Expansion|Progressive Disease|0
2570454|NCT01286987|8890405|P2|Part 2: Dose Expansion|Progressive Disease|0
2570455|NCT01286987|8890406|P1|Part 2: Dose Expansion|Progressive Disease|0
2570456|NCT01286987|8890392|P15|Part 2: Dose Expansion|Other|0
2570457|NCT01286987|8890393|P14|Part 2: Dose Expansion|Other|1
2570458|NCT01286987|8890394|P13|Part 2: Dose Expansion|Other|0
2570459|NCT01286987|8890395|P12|Part 2: Dose Expansion|Other|0
2570460|NCT01286987|8890396|P11|Part 2: Dose Expansion|Other|0
2570461|NCT01286987|8890397|P10|Part 2: Dose Expansion|Other|0
2570462|NCT01286987|8890398|P9|Part 2: Dose Expansion|Other|0
2570463|NCT01286987|8890399|P8|Part 2: Dose Expansion|Other|0
2570464|NCT01286987|8890400|P7|Part 2: Dose Expansion|Other|0
2570465|NCT01286987|8890401|P6|Part 2: Dose Expansion|Other|0
2570466|NCT01286987|8890402|P5|Part 2: Dose Expansion|Other|0
2570467|NCT01286987|8890403|P4|Part 2: Dose Expansion|Other|0
2570468|NCT01286987|8890404|P3|Part 2: Dose Expansion|Other|0
2570469|NCT01286987|8890405|P2|Part 2: Dose Expansion|Other|0
2570470|NCT01286987|8890406|P1|Part 2: Dose Expansion|Other|0
2570471|NCT01286987|8890392|P15|Part 2: Dose Expansion|Physician Decision|0
2570472|NCT01286987|8890393|P14|Part 2: Dose Expansion|Physician Decision|1
2570473|NCT01286987|8890394|P13|Part 2: Dose Expansion|Physician Decision|0
2570474|NCT01286987|8890395|P12|Part 2: Dose Expansion|Physician Decision|1
2570475|NCT01286987|8890396|P11|Part 2: Dose Expansion|Physician Decision|1
2570476|NCT01286987|8890397|P10|Part 2: Dose Expansion|Physician Decision|0
2570477|NCT01286987|8890398|P9|Part 2: Dose Expansion|Physician Decision|0
2570478|NCT01286987|8890399|P8|Part 2: Dose Expansion|Physician Decision|0
2570479|NCT01286987|8890400|P7|Part 2: Dose Expansion|Physician Decision|0
2570480|NCT01286987|8890401|P6|Part 2: Dose Expansion|Physician Decision|0
2570481|NCT01286987|8890402|P5|Part 2: Dose Expansion|Physician Decision|0
2570482|NCT01286987|8890403|P4|Part 2: Dose Expansion|Physician Decision|0
2570483|NCT01286987|8890404|P3|Part 2: Dose Expansion|Physician Decision|0
2570484|NCT01286987|8890405|P2|Part 2: Dose Expansion|Physician Decision|0
2570485|NCT01286987|8890406|P1|Part 2: Dose Expansion|Physician Decision|0
2570486|NCT01286987|8890392|P15|Part 2: Dose Expansion|Death|0
2570487|NCT01286987|8890393|P14|Part 2: Dose Expansion|Death|1
2570488|NCT01286987|8890394|P13|Part 2: Dose Expansion|Death|1
2570489|NCT01286987|8890395|P12|Part 2: Dose Expansion|Death|0
2570490|NCT01286987|8890396|P11|Part 2: Dose Expansion|Death|0
2570491|NCT01286987|8890397|P10|Part 2: Dose Expansion|Death|0
2570492|NCT01286987|8890398|P9|Part 2: Dose Expansion|Death|0
2570493|NCT01286987|8890399|P8|Part 2: Dose Expansion|Death|0
2570494|NCT01286987|8890400|P7|Part 2: Dose Expansion|Death|0
2570495|NCT01286987|8890401|P6|Part 2: Dose Expansion|Death|0
2570496|NCT01286987|8890402|P5|Part 2: Dose Expansion|Death|0
2570497|NCT01286987|8890403|P4|Part 2: Dose Expansion|Death|0
2570498|NCT01286987|8890404|P3|Part 2: Dose Expansion|Death|0
2570499|NCT01286987|8890405|P2|Part 2: Dose Expansion|Death|0
2570500|NCT01286987|8890406|P1|Part 2: Dose Expansion|Death|0
2570501|NCT01286987|8890392|P15|Part 1: Dose Escalation|Physician Decision|0
2570502|NCT01286987|8890393|P14|Part 1: Dose Escalation|Physician Decision|0
2570503|NCT01286987|8890394|P13|Part 1: Dose Escalation|Physician Decision|0
2570504|NCT01286987|8890395|P12|Part 1: Dose Escalation|Physician Decision|0
2570505|NCT01286987|8890396|P11|Part 1: Dose Escalation|Physician Decision|0
2570506|NCT01286987|8890397|P10|Part 1: Dose Escalation|Physician Decision|0
2570507|NCT01286987|8890398|P9|Part 1: Dose Escalation|Physician Decision|0
2570508|NCT01286987|8890399|P8|Part 1: Dose Escalation|Physician Decision|0
2570509|NCT01286987|8890400|P7|Part 1: Dose Escalation|Physician Decision|0
2570510|NCT01286987|8890401|P6|Part 1: Dose Escalation|Physician Decision|0
2570511|NCT01286987|8890402|P5|Part 1: Dose Escalation|Physician Decision|1
2570512|NCT01286987|8890403|P4|Part 1: Dose Escalation|Physician Decision|0
2570513|NCT01286987|8890404|P3|Part 1: Dose Escalation|Physician Decision|0
2570514|NCT01286987|8890405|P2|Part 1: Dose Escalation|Physician Decision|0
2570515|NCT01286987|8890406|P1|Part 1: Dose Escalation|Physician Decision|0
2570516|NCT01286987|8890392|P15|Part 1: Dose Escalation|Progressive Disease|0
2570517|NCT01286987|8890393|P14|Part 1: Dose Escalation|Progressive Disease|0
2570518|NCT01286987|8890394|P13|Part 1: Dose Escalation|Progressive Disease|0
2570519|NCT01286987|8890395|P12|Part 1: Dose Escalation|Progressive Disease|0
2570520|NCT01286987|8890396|P11|Part 1: Dose Escalation|Progressive Disease|0
2570521|NCT01286987|8890397|P10|Part 1: Dose Escalation|Progressive Disease|0
2570522|NCT01286987|8890398|P9|Part 1: Dose Escalation|Progressive Disease|5
2570523|NCT01286987|8890399|P8|Part 1: Dose Escalation|Progressive Disease|3
2570524|NCT01286987|8890400|P7|Part 1: Dose Escalation|Progressive Disease|5
2570525|NCT01286987|8890401|P6|Part 1: Dose Escalation|Progressive Disease|5
2570526|NCT01286987|8890402|P5|Part 1: Dose Escalation|Progressive Disease|1
2570527|NCT01286987|8890403|P4|Part 1: Dose Escalation|Progressive Disease|2
2570528|NCT01286987|8890404|P3|Part 1: Dose Escalation|Progressive Disease|3
2570529|NCT01286987|8890405|P2|Part 1: Dose Escalation|Progressive Disease|2
2570530|NCT01286987|8890406|P1|Part 1: Dose Escalation|Progressive Disease|2
2570531|NCT01286987|8890392|P15|Part 1: Dose Escalation|Clinical Progression|0
2570532|NCT01286987|8890393|P14|Part 1: Dose Escalation|Clinical Progression|0
2570533|NCT01286987|8890394|P13|Part 1: Dose Escalation|Clinical Progression|0
2570534|NCT01286987|8890395|P12|Part 1: Dose Escalation|Clinical Progression|0
2570535|NCT01286987|8890396|P11|Part 1: Dose Escalation|Clinical Progression|0
2570536|NCT01286987|8890397|P10|Part 1: Dose Escalation|Clinical Progression|0
2570537|NCT01286987|8890398|P9|Part 1: Dose Escalation|Clinical Progression|1
2570538|NCT01286987|8890399|P8|Part 1: Dose Escalation|Clinical Progression|2
2570539|NCT01286987|8890400|P7|Part 1: Dose Escalation|Clinical Progression|0
2570540|NCT01286987|8890401|P6|Part 1: Dose Escalation|Clinical Progression|1
2570541|NCT01286987|8890402|P5|Part 1: Dose Escalation|Clinical Progression|1
2570542|NCT01286987|8890403|P4|Part 1: Dose Escalation|Clinical Progression|1
2570543|NCT01286987|8890404|P3|Part 1: Dose Escalation|Clinical Progression|0
2570544|NCT01286987|8890405|P2|Part 1: Dose Escalation|Clinical Progression|1
2570545|NCT01286987|8890406|P1|Part 1: Dose Escalation|Clinical Progression|1
2570546|NCT01286779|8890587|P1|Overall Study|Discontinued by sponsor|1
2570547|NCT01286779|8890587|P1|Overall Study|Participant moved to another country|1
2570548|NCT01286779|8890587|P1|Overall Study|Participant had scheduled surgery|1
2570549|NCT01286779|8890587|P1|Overall Study|Physician Decision|2
2570550|NCT01286779|8890587|P1|Overall Study|Protocol Violation|5
2570551|NCT01286779|8890587|P1|Overall Study|Withdrawal by Subject|9
2570552|NCT01286753|8890639|P2|Overall Study|Participant to Receive Radiotherapy|0
2570553|NCT01286753|8890640|P1|Overall Study|Participant to Receive Radiotherapy|1
2570554|NCT01286753|8890639|P2|Overall Study|Discontinued to Join Extension Study|4
2570555|NCT01286753|8890640|P1|Overall Study|Discontinued to Join Extension Study|6
2570556|NCT01286753|8890639|P2|Overall Study|Withdrawal of Consent|2
2570557|NCT01286753|8890640|P1|Overall Study|Withdrawal of Consent|0
2570558|NCT01286753|8890639|P2|Overall Study|Refused Treatment|0
2570559|NCT01286753|8890640|P1|Overall Study|Refused Treatment|1
2570560|NCT01286753|8890639|P2|Overall Study|Progression|13
2570561|NCT01286753|8890640|P1|Overall Study|Progression|11
2570562|NCT01286753|8890639|P2|Overall Study|Adverse Event|6
2570563|NCT01286753|8890640|P1|Overall Study|Adverse Event|7
2570564|NCT01286740|8890658|P1|Overall Study|Protocol Violation|1
2570565|NCT01286740|8890658|P1|Overall Study|Enrolled but not treated|1
2570566|NCT01286558|8890676|P2|Overall Study|Withdrawal by Subject|1
2570567|NCT01286558|8890677|P1|Overall Study|Withdrawal by Subject|0
2570568|NCT01286558|8890676|P2|Overall Study|Adverse Event|1
2570569|NCT01286558|8890677|P1|Overall Study|Adverse Event|1
2570570|NCT01286480|8890713|P2|Overall Study|Withdrawal by Subject|3
2570571|NCT01286480|8890714|P1|Overall Study|Withdrawal by Subject|5
2570572|NCT01286311|8890821|P2|Overall Study|Physician did not want outreach sent|0
2570573|NCT01286311|8890822|P1|Overall Study|Physician did not want outreach sent|14
2570574|NCT01286272|8890838|P2|Overall Study|Ineligible after beginning treatment|3
2570575|NCT01286272|8890839|P1|Overall Study|Ineligible after beginning treatment|1
2570576|NCT01286207|8890852|P3|Overall Study|Other|13
2570577|NCT01286207|8890853|P2|Overall Study|Other|47
2570578|NCT01286207|8890854|P1|Overall Study|Other|37
2570579|NCT01286207|8890852|P3|Overall Study|Lack of Response|8
2570580|NCT01286207|8890853|P2|Overall Study|Lack of Response|38
2570581|NCT01286207|8890854|P1|Overall Study|Lack of Response|92
2570582|NCT01286207|8890852|P3|Overall Study|Withdrawal by Subject|41
2570583|NCT01286207|8890853|P2|Overall Study|Withdrawal by Subject|79
2570584|NCT01286207|8890854|P1|Overall Study|Withdrawal by Subject|93
2570585|NCT01286207|8890852|P3|Overall Study|Lost to Follow-up|20
2570586|NCT01286207|8890853|P2|Overall Study|Lost to Follow-up|43
2570587|NCT01286207|8890854|P1|Overall Study|Lost to Follow-up|49
2570588|NCT01286207|8890852|P3|Overall Study|Adverse Event|8
2570589|NCT01286207|8890853|P2|Overall Study|Adverse Event|41
2570590|NCT01286207|8890854|P1|Overall Study|Adverse Event|27
2570591|NCT01286168|8890874|P1|Overall Study|Surgical Drains Fell Out at Home|2
2570592|NCT01286168|8890874|P1|Overall Study|Withdrawal by Subject|1
2570593|NCT01286129|8890888|P2|Overall Study|Could not comply with study requirements|4
2570594|NCT01286129|8890889|P1|Overall Study|Could not comply with study requirements|4
2570595|NCT01286129|8890888|P2|Overall Study|Withdrawal by Subject|1
2570596|NCT01286129|8890889|P1|Overall Study|Withdrawal by Subject|4
2570597|NCT01286077|8890899|P2|Overall Study|refill medication not received in time|0
2570598|NCT01286077|8890900|P1|Overall Study|refill medication not received in time|1
2570599|NCT01286077|8890899|P2|Overall Study|Progression of disease|1
2570600|NCT01286077|8890900|P1|Overall Study|Progression of disease|0
2570601|NCT01286077|8890899|P2|Overall Study|Patient's decision to stop treatment|0
2570602|NCT01286077|8890900|P1|Overall Study|Patient's decision to stop treatment|3
2570603|NCT01286077|8890899|P2|Overall Study|The subject starts with alternative MMY|3
2570604|NCT01286077|8890900|P1|Overall Study|The subject starts with alternative MMY|0
2570605|NCT01286077|8890899|P2|Overall Study|Non-compliance|0
2570606|NCT01286077|8890900|P1|Overall Study|Non-compliance|1
2570607|NCT01286077|8890899|P2|Overall Study|Intercurrent illness|0
2570608|NCT01286077|8890900|P1|Overall Study|Intercurrent illness|1
2570609|NCT01286077|8890899|P2|Overall Study|Withdrawal by Subject|2
2570610|NCT01286077|8890900|P1|Overall Study|Withdrawal by Subject|0
2570611|NCT01286077|8890899|P2|Overall Study|Protocol Violation|1
2570612|NCT01286077|8890900|P1|Overall Study|Protocol Violation|1
2570613|NCT01286077|8890899|P2|Overall Study|Death|0
2570614|NCT01286077|8890900|P1|Overall Study|Death|1
2570615|NCT01286077|8890899|P2|Overall Study|Adverse Event|0
2570616|NCT01286077|8890900|P1|Overall Study|Adverse Event|2
2570617|NCT01286012|8890936|P2|Overall Study|peritoneal dialysis, randomized in error|3
2570618|NCT01286012|8890937|P1|Overall Study|peritoneal dialysis, randomized in error|1
2570619|NCT01286012|8890936|P2|Overall Study|Physician Decision|0
2570620|NCT01286012|8890937|P1|Overall Study|Physician Decision|2
2570621|NCT01286012|8890936|P2|Overall Study|Withdrawal by Subject|4
2570622|NCT01286012|8890937|P1|Overall Study|Withdrawal by Subject|4
2570623|NCT01286012|8890936|P2|Overall Study|Protocol Violation|1
2570624|NCT01286012|8890937|P1|Overall Study|Protocol Violation|1
2570625|NCT01286012|8890936|P2|Overall Study|Death|3
2570626|NCT01286012|8890937|P1|Overall Study|Death|2
2570627|NCT01286012|8890936|P2|Overall Study|Adverse Event|3
2570628|NCT01286012|8890937|P1|Overall Study|Adverse Event|3
2570629|NCT01285960|8890951|P1|Overall Study|2 subjects received less 10 sonications|2
2570630|NCT01285960|8890951|P1|Overall Study|Lost to Follow-up|2
2570631|NCT01285960|8890951|P1|Overall Study|Withdrawal by Subject|2
2570632|NCT01285908|8890964|P3|Baseline Measurement|unable to tolerate procedure|0
2570633|NCT01285908|8890965|P2|Baseline Measurement|unable to tolerate procedure|0
2570634|NCT01285908|8890966|P1|Baseline Measurement|unable to tolerate procedure|1
2570635|NCT01285908|8890964|P3|Baseline Measurement|History of stroke, exclusion criteria|0
2570636|NCT01285908|8890965|P2|Baseline Measurement|History of stroke, exclusion criteria|0
2570637|NCT01285908|8890966|P1|Baseline Measurement|History of stroke, exclusion criteria|1
2570638|NCT01285908|8890964|P3|Baseline Measurement|unable to insert catheter|0
2570639|NCT01285908|8890965|P2|Baseline Measurement|unable to insert catheter|0
2570640|NCT01285908|8890966|P1|Baseline Measurement|unable to insert catheter|1
2570641|NCT01285609|8891060|P2|Treated With Blinded Therapy|Worsening of general condition|1
2570642|NCT01285609|8891061|P1|Treated With Blinded Therapy|Worsening of general condition|0
2570643|NCT01285609|8891060|P2|Treated With Blinded Therapy|PI decision to discontinue|1
2570644|NCT01285609|8891061|P1|Treated With Blinded Therapy|PI decision to discontinue|0
2570645|NCT01285609|8891060|P2|Treated With Blinded Therapy|Investigator's assessment|0
2570646|NCT01285609|8891061|P1|Treated With Blinded Therapy|Investigator's assessment|1
2570647|NCT01285609|8891060|P2|Treated With Blinded Therapy|Participant hospitalized|0
2570648|NCT01285609|8891061|P1|Treated With Blinded Therapy|Participant hospitalized|1
2570649|NCT01285609|8891060|P2|Treated With Blinded Therapy|Participant started radiotherapy|0
2570650|NCT01285609|8891061|P1|Treated With Blinded Therapy|Participant started radiotherapy|1
2570651|NCT01285609|8891060|P2|Treated With Blinded Therapy|Participant refused participation|0
2570652|NCT01285609|8891061|P1|Treated With Blinded Therapy|Participant refused participation|1
2570653|NCT01285609|8891060|P2|Treated With Blinded Therapy|Physician and Patient decision|3
2570654|NCT01285609|8891061|P1|Treated With Blinded Therapy|Physician and Patient decision|1
2570655|NCT01285609|8891060|P2|Treated With Blinded Therapy|Administrative Reason by Sponsor|3
2570656|NCT01285609|8891061|P1|Treated With Blinded Therapy|Administrative Reason by Sponsor|1
2570657|NCT01285609|8891060|P2|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0
2570658|NCT01285609|8891061|P1|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1
2570659|NCT01285609|8891060|P2|Treated With Blinded Therapy|Poor/Non-Compliance|2
2570660|NCT01285609|8891061|P1|Treated With Blinded Therapy|Poor/Non-Compliance|1
2570661|NCT01285609|8891060|P2|Treated With Blinded Therapy|Not Reported|2
2570662|NCT01285609|8891061|P1|Treated With Blinded Therapy|Not Reported|0
2570663|NCT01285609|8891060|P2|Treated With Blinded Therapy|Maximum Clinical Benefit|4
2570664|NCT01285609|8891061|P1|Treated With Blinded Therapy|Maximum Clinical Benefit|2
2570665|NCT01285609|8891060|P2|Treated With Blinded Therapy|Death|3
2570666|NCT01285609|8891061|P1|Treated With Blinded Therapy|Death|11
2570667|NCT01285609|8891060|P2|Treated With Blinded Therapy|Withdrawal by Subject|7
2570668|NCT01285609|8891061|P1|Treated With Blinded Therapy|Withdrawal by Subject|20
2570669|NCT01285609|8891060|P2|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14
2570670|NCT01285609|8891061|P1|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36
2570671|NCT01285609|8891060|P2|Treated With Blinded Therapy|Study Drug Toxicity|14
2570672|NCT01285609|8891061|P1|Treated With Blinded Therapy|Study Drug Toxicity|87
2570673|NCT01285609|8891060|P2|Treated With Blinded Therapy|Progressive Disease|305
2570674|NCT01285609|8891061|P1|Treated With Blinded Therapy|Progressive Disease|223
2570675|NCT01285609|8891060|P2|Randomized|Randomized but not Treated|4
2570676|NCT01285609|8891061|P1|Randomized|Randomized but not Treated|4
2570677|NCT01285609|8891060|P2|Randomized|Undisclosed Reasons|0
2570678|NCT01285609|8891061|P1|Randomized|Undisclosed Reasons|1
2570679|NCT01285609|8891060|P2|Randomized|Subject No Longer Met Study Criteria|1
2570680|NCT01285609|8891061|P1|Randomized|Subject No Longer Met Study Criteria|1
2570681|NCT01285609|8891060|P2|Randomized|Withdrawal by Subject|11
2570682|NCT01285609|8891061|P1|Randomized|Withdrawal by Subject|8
2570683|NCT01285609|8891060|P2|Randomized|Death|7
2570684|NCT01285609|8891061|P1|Randomized|Death|5
2570685|NCT01285609|8891060|P2|Randomized|Study Drug Toxicity|14
2570686|NCT01285609|8891061|P1|Randomized|Study Drug Toxicity|13
2570687|NCT01285609|8891060|P2|Randomized|Adverse Event Unrelated to Study Drug|18
2570688|NCT01285609|8891061|P1|Randomized|Adverse Event Unrelated to Study Drug|18
2570689|NCT01285609|8891060|P2|Randomized|Progressive Disease|61
2570690|NCT01285609|8891061|P1|Randomized|Progressive Disease|41
2570691|NCT01285518|8891079|P8|Overall Study|Lost to Follow-up|0
2570692|NCT01285518|8891080|P7|Overall Study|Lost to Follow-up|0
2570693|NCT01285518|8891081|P6|Overall Study|Lost to Follow-up|1
2570694|NCT01285518|8891082|P5|Overall Study|Lost to Follow-up|0
2570695|NCT01285518|8891083|P4|Overall Study|Lost to Follow-up|0
2570696|NCT01285518|8891084|P3|Overall Study|Lost to Follow-up|0
2570697|NCT01285518|8891085|P2|Overall Study|Lost to Follow-up|0
2570698|NCT01285518|8891086|P1|Overall Study|Lost to Follow-up|0
2570699|NCT01285492|8891346|P2|Overall Study|Death|0
2570700|NCT01285492|8891347|P1|Overall Study|Death|1
2570701|NCT01285492|8891346|P2|Overall Study|Withdrawal by Subject|1
2570702|NCT01285492|8891347|P1|Overall Study|Withdrawal by Subject|2
2570703|NCT01285492|8891346|P2|Overall Study|Protocol Violation|0
2570704|NCT01285492|8891347|P1|Overall Study|Protocol Violation|3
2570705|NCT01285492|8891346|P2|Overall Study|Adverse Event|0
2570706|NCT01285492|8891347|P1|Overall Study|Adverse Event|11
2570707|NCT01285401|8891379|P2|Overall Study|Prematurely withdrawn from the study|29
2570708|NCT01285401|8891380|P1|Overall Study|Prematurely withdrawn from the study|17
2570709|NCT01285349|8891421|P3|Overall Study|Lost to Follow-up|27
2570710|NCT01285349|8891422|P2|Overall Study|Lost to Follow-up|20
2570711|NCT01285349|8891423|P1|Overall Study|Lost to Follow-up|27
2570712|NCT01285323|8891436|P2|Overall Study|Other|3
2570713|NCT01285323|8891437|P1|Overall Study|Other|1
2570714|NCT01285323|8891436|P2|Overall Study|Lost to Follow-up|1
2570715|NCT01285323|8891437|P1|Overall Study|Lost to Follow-up|1
2570716|NCT01285323|8891436|P2|Overall Study|Non-compliance with study procedures|3
2570717|NCT01285323|8891437|P1|Overall Study|Non-compliance with study procedures|2
2570718|NCT01285323|8891436|P2|Overall Study|Protocol Violation|2
2570719|NCT01285323|8891437|P1|Overall Study|Protocol Violation|1
2570720|NCT01285323|8891436|P2|Overall Study|Withdrawal by Subject|11
2570721|NCT01285323|8891437|P1|Overall Study|Withdrawal by Subject|15
2570722|NCT01285323|8891436|P2|Overall Study|Lack of Efficacy|2
2570723|NCT01285323|8891437|P1|Overall Study|Lack of Efficacy|4
2570724|NCT01285323|8891436|P2|Overall Study|Adverse Event|8
2570725|NCT01285323|8891437|P1|Overall Study|Adverse Event|9
2570726|NCT01285310|8891472|P5|Active Treatment Phase: Weeks 25-52|Non-compliance|0
2570727|NCT01285310|8891473|P4|Active Treatment Phase: Weeks 25-52|Non-compliance|1
2570728|NCT01285310|8891474|P3|Active Treatment Phase: Weeks 25-52|Non-compliance|1
2570729|NCT01285310|8891475|P2|Active Treatment Phase: Weeks 25-52|Non-compliance|1
2570730|NCT01285310|8891476|P1|Active Treatment Phase: Weeks 25-52|Non-compliance|0
2570731|NCT01285310|8891472|P5|Active Treatment Phase: Weeks 25-52|Other|0
2570732|NCT01285310|8891473|P4|Active Treatment Phase: Weeks 25-52|Other|0
2570733|NCT01285310|8891474|P3|Active Treatment Phase: Weeks 25-52|Other|0
2570734|NCT01285310|8891475|P2|Active Treatment Phase: Weeks 25-52|Other|1
2570735|NCT01285310|8891476|P1|Active Treatment Phase: Weeks 25-52|Other|0
2570736|NCT01285310|8891472|P5|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15
2570737|NCT01285310|8891473|P4|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6
2570738|NCT01285310|8891474|P3|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19
2570739|NCT01285310|8891475|P2|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21
2570740|NCT01285310|8891476|P1|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0
2570741|NCT01285310|8891472|P5|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
2570742|NCT01285310|8891473|P4|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
2570743|NCT01285310|8891474|P3|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
2570744|NCT01285310|8891475|P2|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3
2570745|NCT01285310|8891476|P1|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
2570746|NCT01285310|8891472|P5|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
2570747|NCT01285310|8891473|P4|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1
2570748|NCT01285310|8891474|P3|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3
2570749|NCT01285310|8891475|P2|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4
2570750|NCT01285310|8891476|P1|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
2570751|NCT01285310|8891472|P5|Active Treatment Phase: Weeks 25-52|Adverse Event|2
2570752|NCT01285310|8891473|P4|Active Treatment Phase: Weeks 25-52|Adverse Event|0
2570753|NCT01285310|8891474|P3|Active Treatment Phase: Weeks 25-52|Adverse Event|3
2570754|NCT01285310|8891475|P2|Active Treatment Phase: Weeks 25-52|Adverse Event|2
2570755|NCT01285310|8891476|P1|Active Treatment Phase: Weeks 25-52|Adverse Event|0
2570756|NCT01285310|8891472|P5|Placebo Controlled Phase: Weeks 0-24|Other|0
2570757|NCT01285310|8891473|P4|Placebo Controlled Phase: Weeks 0-24|Other|0
2570758|NCT01285310|8891474|P3|Placebo Controlled Phase: Weeks 0-24|Other|1
2570759|NCT01285310|8891475|P2|Placebo Controlled Phase: Weeks 0-24|Other|0
2570760|NCT01285310|8891476|P1|Placebo Controlled Phase: Weeks 0-24|Other|1
2570761|NCT01285310|8891472|P5|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
2570762|NCT01285310|8891473|P4|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
2570763|NCT01285310|8891474|P3|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
2570764|NCT01285310|8891475|P2|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
2570765|NCT01285310|8891476|P1|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
2570766|NCT01285310|8891472|P5|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
2570767|NCT01285310|8891473|P4|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
2570768|NCT01285310|8891474|P3|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2
2570769|NCT01285310|8891475|P2|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
2570770|NCT01285310|8891476|P1|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
2570771|NCT01285310|8891472|P5|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
2570772|NCT01285310|8891473|P4|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
2570773|NCT01285310|8891474|P3|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2
2570774|NCT01285310|8891475|P2|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
2570775|NCT01285310|8891476|P1|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1
2570776|NCT01285310|8891472|P5|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
2570777|NCT01285310|8891473|P4|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
2570778|NCT01285310|8891474|P3|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3
2570779|NCT01285310|8891475|P2|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7
2570780|NCT01285310|8891476|P1|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1
2570781|NCT01285310|8891472|P5|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
2570782|NCT01285310|8891473|P4|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
2570783|NCT01285310|8891474|P3|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6
2570784|NCT01285310|8891475|P2|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4
2570785|NCT01285310|8891476|P1|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3
2570786|NCT01284959|8891741|P3|Overall Study|Adverse Event|1
2570787|NCT01284959|8891742|P2|Overall Study|Adverse Event|0
2570788|NCT01284959|8891743|P1|Overall Study|Adverse Event|0
2570789|NCT01284959|8891741|P3|Overall Study|Withdrawal by Subject|0
2570790|NCT01284959|8891742|P2|Overall Study|Withdrawal by Subject|0
2570791|NCT01284959|8891743|P1|Overall Study|Withdrawal by Subject|1
2570792|NCT01284634|8891773|P4|Overall Study|Adverse Event|1
2570793|NCT01284634|8891774|P3|Overall Study|Adverse Event|2
2570794|NCT01284634|8891775|P2|Overall Study|Adverse Event|0
2570795|NCT01284634|8891776|P1|Overall Study|Adverse Event|1
2570796|NCT01284621|8891806|P6|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
2570797|NCT01284621|8891807|P5|Washout Period 1 (7 Days)|Required unexpected medical treatment|1
2570798|NCT01284621|8891808|P4|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
2570799|NCT01284621|8891809|P3|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
2570800|NCT01284621|8891810|P2|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
2570801|NCT01284621|8891811|P1|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
2570802|NCT01284491|8891879|P1|Overall Study|Study termination|13
2570803|NCT01284361|8891889|P1|Overall Study|Lost to Follow-up|2
2570804|NCT01284361|8891889|P1|Overall Study|Adverse Event|1
2570805|NCT01284361|8891889|P1|Overall Study|Protocol Violation|5
2570806|NCT01284361|8891889|P1|Overall Study|Withdrawal by Subject|1
2570807|NCT01284140|8891985|P2|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1
2570808|NCT01284140|8891986|P1|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0
2570809|NCT01284140|8891985|P2|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
2570810|NCT01284140|8891986|P1|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
2570811|NCT01284127|8892000|P1|Overall Study|Physician Decision|1
2570812|NCT01284127|8892000|P1|Overall Study|Withdrawal by Subject|4
2570813|NCT01284127|8892000|P1|Overall Study|Adverse Event|2
2570814|NCT01284114|8892009|P1|Overall Study|dizziness|1
2570815|NCT01284114|8892009|P1|Overall Study|Symptomatic hypotension|1
2570816|NCT01284114|8892009|P1|Overall Study|From the results of ALLTITUDE study|1
2570817|NCT01284114|8892009|P1|Overall Study|viral infection|1
2570818|NCT01284062|8892021|P4|Overall Study|Site Closed|0
2570819|NCT01284062|8892022|P3|Overall Study|Site Closed|1
2570820|NCT01284062|8892023|P2|Overall Study|Site Closed|0
2570821|NCT01284062|8892024|P1|Overall Study|Site Closed|0
2570822|NCT01284062|8892021|P4|Overall Study|Other|1
2570823|NCT01284062|8892022|P3|Overall Study|Other|0
2570824|NCT01284062|8892023|P2|Overall Study|Other|0
2570825|NCT01284062|8892024|P1|Overall Study|Other|0
2570826|NCT01284062|8892021|P4|Overall Study|Withdrawal by Subject|5
2570827|NCT01284062|8892022|P3|Overall Study|Withdrawal by Subject|2
2570828|NCT01284062|8892023|P2|Overall Study|Withdrawal by Subject|1
2570829|NCT01284062|8892024|P1|Overall Study|Withdrawal by Subject|3
2570830|NCT01284062|8892021|P4|Overall Study|Protocol Violation|2
2570831|NCT01284062|8892022|P3|Overall Study|Protocol Violation|0
2570832|NCT01284062|8892023|P2|Overall Study|Protocol Violation|0
2570833|NCT01284062|8892024|P1|Overall Study|Protocol Violation|1
2570834|NCT01284062|8892021|P4|Overall Study|Medication error without adverse event|0
2570835|NCT01284062|8892022|P3|Overall Study|Medication error without adverse event|1
2570836|NCT01284062|8892023|P2|Overall Study|Medication error without adverse event|0
2570837|NCT01284062|8892024|P1|Overall Study|Medication error without adverse event|0
2570838|NCT01284062|8892021|P4|Overall Study|Lack of Efficacy|1
2570839|NCT01284062|8892022|P3|Overall Study|Lack of Efficacy|2
2570840|NCT01284062|8892023|P2|Overall Study|Lack of Efficacy|2
2570841|NCT01284062|8892024|P1|Overall Study|Lack of Efficacy|3
2570842|NCT01284062|8892021|P4|Overall Study|Adverse Event|5
2570843|NCT01284062|8892022|P3|Overall Study|Adverse Event|0
2570844|NCT01284062|8892023|P2|Overall Study|Adverse Event|5
2570845|NCT01284062|8892024|P1|Overall Study|Adverse Event|4
2570846|NCT01283971|8892098|P2|Overall Study|Administrative reasons|1
2570847|NCT01283971|8892099|P1|Overall Study|Administrative reasons|1
2570848|NCT01283971|8892098|P2|Overall Study|Failure to return|1
2570849|NCT01283971|8892099|P1|Overall Study|Failure to return|0
2570850|NCT01283971|8892098|P2|Overall Study|Refused treatment|1
2570851|NCT01283971|8892099|P1|Overall Study|Refused treatment|3
2570852|NCT01283971|8892098|P2|Overall Study|Protocol Violation|1
2570853|NCT01283971|8892099|P1|Overall Study|Protocol Violation|5
2570854|NCT01283971|8892098|P2|Overall Study|Insufficient therapeutic responses|3
2570855|NCT01283971|8892099|P1|Overall Study|Insufficient therapeutic responses|3
2570856|NCT01283971|8892098|P2|Overall Study|Adverse Event|5
2570857|NCT01283971|8892099|P1|Overall Study|Adverse Event|3
2570858|NCT01283581|8892146|P3|Overall Study|"Early termination"|1
2570859|NCT01283581|8892147|P2|Overall Study|"Early termination"|0
2570860|NCT01283581|8892148|P1|Overall Study|"Early termination"|0
2570861|NCT01283581|8892146|P3|Overall Study|Investigator unblinded|1
2570862|NCT01283581|8892147|P2|Overall Study|Investigator unblinded|0
2570863|NCT01283581|8892148|P1|Overall Study|Investigator unblinded|0
2570864|NCT01283581|8892146|P3|Overall Study|Noncompliance|0
2570865|NCT01283581|8892147|P2|Overall Study|Noncompliance|0
2570866|NCT01283581|8892148|P1|Overall Study|Noncompliance|1
2570867|NCT01283581|8892146|P3|Overall Study|Protocol Violation|2
2570868|NCT01283581|8892147|P2|Overall Study|Protocol Violation|1
2570869|NCT01283581|8892148|P1|Overall Study|Protocol Violation|0
2570870|NCT01283581|8892146|P3|Overall Study|Physician Decision|2
2570871|NCT01283581|8892147|P2|Overall Study|Physician Decision|1
2570872|NCT01283581|8892148|P1|Overall Study|Physician Decision|0
2570873|NCT01283581|8892146|P3|Overall Study|Adverse Event|4
2570874|NCT01283581|8892147|P2|Overall Study|Adverse Event|1
2570875|NCT01283581|8892148|P1|Overall Study|Adverse Event|1
2570876|NCT01283581|8892146|P3|Overall Study|Withdrawal by Subject|2
2570877|NCT01283581|8892147|P2|Overall Study|Withdrawal by Subject|5
2570878|NCT01283581|8892148|P1|Overall Study|Withdrawal by Subject|2
2570879|NCT01283581|8892146|P3|Overall Study|Lost to Follow-up|8
2570880|NCT01283581|8892147|P2|Overall Study|Lost to Follow-up|6
2570881|NCT01283581|8892148|P1|Overall Study|Lost to Follow-up|8
2570882|NCT01283542|8892218|P1|Extension Phase|Administrative problems|1
2570883|NCT01283542|8892218|P1|Extension Phase|Adverse Event|1
2570884|NCT01283542|8892218|P1|Extension Phase|Physician Decision|1
2570885|NCT01283542|8892218|P1|Main Phase|abnormal laboratory values|5
2570886|NCT01283542|8892218|P1|Main Phase|Uncontrolled diabetes mellitus|1
2570887|NCT01283542|8892218|P1|Main Phase|Acute or progressive vision loss|1
2570888|NCT01283516|8892283|P9|Overall Study|Lost to Follow-up|1
2570889|NCT01283516|8892284|P8|Overall Study|Lost to Follow-up|0
2570890|NCT01283516|8892285|P7|Overall Study|Lost to Follow-up|0
2570891|NCT01283516|8892286|P6|Overall Study|Lost to Follow-up|0
2570892|NCT01283516|8892287|P5|Overall Study|Lost to Follow-up|0
2570893|NCT01283516|8892288|P4|Overall Study|Lost to Follow-up|0
2570894|NCT01283516|8892289|P3|Overall Study|Lost to Follow-up|0
2570895|NCT01283516|8892290|P2|Overall Study|Lost to Follow-up|0
2570896|NCT01283516|8892291|P1|Overall Study|Lost to Follow-up|0
2570897|NCT01283516|8892283|P9|Overall Study|Administrative problems|39
2570898|NCT01283516|8892284|P8|Overall Study|Administrative problems|1
2570899|NCT01283516|8892285|P7|Overall Study|Administrative problems|1
2570900|NCT01283516|8892286|P6|Overall Study|Administrative problems|1
2570901|NCT01283516|8892287|P5|Overall Study|Administrative problems|0
2570902|NCT01283516|8892288|P4|Overall Study|Administrative problems|0
2570903|NCT01283516|8892289|P3|Overall Study|Administrative problems|0
2570904|NCT01283516|8892290|P2|Overall Study|Administrative problems|0
2570905|NCT01283516|8892291|P1|Overall Study|Administrative problems|0
2570906|NCT01283516|8892283|P9|Overall Study|Withdrawal by Subject|36
2570907|NCT01283516|8892284|P8|Overall Study|Withdrawal by Subject|0
2570908|NCT01283516|8892285|P7|Overall Study|Withdrawal by Subject|1
2570909|NCT01283516|8892286|P6|Overall Study|Withdrawal by Subject|0
2570910|NCT01283516|8892287|P5|Overall Study|Withdrawal by Subject|1
2570911|NCT01283516|8892288|P4|Overall Study|Withdrawal by Subject|0
2570912|NCT01283516|8892289|P3|Overall Study|Withdrawal by Subject|0
2570913|NCT01283516|8892290|P2|Overall Study|Withdrawal by Subject|0
2570914|NCT01283516|8892291|P1|Overall Study|Withdrawal by Subject|0
2570915|NCT01283516|8892283|P9|Overall Study|Disease Progression|139
2570916|NCT01283516|8892284|P8|Overall Study|Disease Progression|3
2570917|NCT01283516|8892285|P7|Overall Study|Disease Progression|6
2570918|NCT01283516|8892286|P6|Overall Study|Disease Progression|8
2570919|NCT01283516|8892287|P5|Overall Study|Disease Progression|13
2570920|NCT01283516|8892288|P4|Overall Study|Disease Progression|3
2570921|NCT01283516|8892289|P3|Overall Study|Disease Progression|3
2570922|NCT01283516|8892290|P2|Overall Study|Disease Progression|2
2570923|NCT01283516|8892291|P1|Overall Study|Disease Progression|2
2570924|NCT01283516|8892283|P9|Overall Study|Death|12
2570925|NCT01283516|8892284|P8|Overall Study|Death|1
2570926|NCT01283516|8892285|P7|Overall Study|Death|0
2570927|NCT01283516|8892286|P6|Overall Study|Death|1
2570928|NCT01283516|8892287|P5|Overall Study|Death|0
2570929|NCT01283516|8892288|P4|Overall Study|Death|0
2570930|NCT01283516|8892289|P3|Overall Study|Death|0
2570931|NCT01283516|8892290|P2|Overall Study|Death|0
2570932|NCT01283516|8892291|P1|Overall Study|Death|0
2570933|NCT01283516|8892283|P9|Overall Study|Adverse Event|28
2570934|NCT01283516|8892284|P8|Overall Study|Adverse Event|0
2570935|NCT01283516|8892285|P7|Overall Study|Adverse Event|2
2570936|NCT01283516|8892286|P6|Overall Study|Adverse Event|0
2570937|NCT01283516|8892287|P5|Overall Study|Adverse Event|0
2570938|NCT01283516|8892288|P4|Overall Study|Adverse Event|0
2570939|NCT01283516|8892289|P3|Overall Study|Adverse Event|0
2570940|NCT01283516|8892290|P2|Overall Study|Adverse Event|0
2570941|NCT01283516|8892291|P1|Overall Study|Adverse Event|0
2570942|NCT01283464|8892413|P2|Overall Study|Physician Decision|0
2570943|NCT01283464|8892414|P1|Overall Study|Physician Decision|1
2570944|NCT01283464|8892413|P2|Overall Study|Withdrawal by Subject|0
2570945|NCT01283464|8892414|P1|Overall Study|Withdrawal by Subject|1
2570946|NCT01283464|8892413|P2|Overall Study|Lost to Follow-up|1
2570947|NCT01283464|8892414|P1|Overall Study|Lost to Follow-up|0
2570948|NCT01283386|8892422|P2|Overall Study|Protocol Violation|1
2570949|NCT01283386|8892423|P1|Overall Study|Protocol Violation|0
2570950|NCT01283386|8892422|P2|Overall Study|Reason not specified|0
2570951|NCT01283386|8892423|P1|Overall Study|Reason not specified|1
2570952|NCT01283386|8892422|P2|Overall Study|Progression of underlying disease|7
2570953|NCT01283386|8892423|P1|Overall Study|Progression of underlying disease|2
2570954|NCT01283386|8892422|P2|Overall Study|Relapse of underlying disease|3
2570955|NCT01283386|8892423|P1|Overall Study|Relapse of underlying disease|1
2570956|NCT01283386|8892422|P2|Overall Study|Withdrawal by Subject|1
2570957|NCT01283386|8892423|P1|Overall Study|Withdrawal by Subject|2
2570958|NCT01283386|8892422|P2|Overall Study|Death|0
2570959|NCT01283386|8892423|P1|Overall Study|Death|2
2570960|NCT01283334|8892447|P1|Overall Study|Physician Decision|1
2570961|NCT01283334|8892447|P1|Overall Study|Adverse Event|4
2570962|NCT01283334|8892447|P1|Overall Study|Inability to Swallow Everolimus Pills|1
2570963|NCT01283334|8892447|P1|Overall Study|Withdrawal by Subject|1
2570964|NCT01283282|8892470|P2|First Intervention (6 Weeks)|Lost to Follow-up|0
2570965|NCT01283282|8892471|P1|First Intervention (6 Weeks)|Lost to Follow-up|1
2570966|NCT01283282|8892470|P2|First Intervention (6 Weeks)|Withdrawal by Subject|3
2570967|NCT01283282|8892471|P1|First Intervention (6 Weeks)|Withdrawal by Subject|2
2570968|NCT01283282|8892470|P2|First Intervention (6 Weeks)|Physician Decision|1
2570969|NCT01283282|8892471|P1|First Intervention (6 Weeks)|Physician Decision|0
2570970|NCT01283152|8892491|P2|Overall Study|Refused HESA|0
2570971|NCT01283152|8892492|P1|Overall Study|Refused HESA|1
2570972|NCT01283152|8892491|P2|Overall Study|Discharged prior to 24 hr assessment|0
2570973|NCT01283152|8892492|P1|Overall Study|Discharged prior to 24 hr assessment|1
2570974|NCT01283139|8892506|P4|Overall Study|Participant randomized in error|0
2570975|NCT01283139|8892507|P3|Overall Study|Participant randomized in error|1
2570976|NCT01283139|8892508|P2|Overall Study|Participant randomized in error|0
2570977|NCT01283139|8892509|P1|Overall Study|Participant randomized in error|0
2570978|NCT01283139|8892506|P4|Overall Study|Missed follow-up visit|2
2570979|NCT01283139|8892507|P3|Overall Study|Missed follow-up visit|2
2570980|NCT01283139|8892508|P2|Overall Study|Missed follow-up visit|1
2570981|NCT01283139|8892509|P1|Overall Study|Missed follow-up visit|0
2570982|NCT01283139|8892506|P4|Overall Study|Pregnancy|0
2570983|NCT01283139|8892507|P3|Overall Study|Pregnancy|1
2570984|NCT01283139|8892508|P2|Overall Study|Pregnancy|1
2570985|NCT01283139|8892509|P1|Overall Study|Pregnancy|0
2570986|NCT01283139|8892506|P4|Overall Study|Participant's refusal to continue|1
2570987|NCT01283139|8892507|P3|Overall Study|Participant's refusal to continue|1
2570988|NCT01283139|8892508|P2|Overall Study|Participant's refusal to continue|3
2570989|NCT01283139|8892509|P1|Overall Study|Participant's refusal to continue|0
2570990|NCT01283139|8892506|P4|Overall Study|Early termination due to AE/SAE|0
2570991|NCT01283139|8892507|P3|Overall Study|Early termination due to AE/SAE|0
2570992|NCT01283139|8892508|P2|Overall Study|Early termination due to AE/SAE|1
2570993|NCT01283139|8892509|P1|Overall Study|Early termination due to AE/SAE|1
2570994|NCT01283139|8892506|P4|Overall Study|Lack of Efficacy|1
2570995|NCT01283139|8892507|P3|Overall Study|Lack of Efficacy|2
2570996|NCT01283139|8892508|P2|Overall Study|Lack of Efficacy|2
2570997|NCT01283139|8892509|P1|Overall Study|Lack of Efficacy|1
2570998|NCT01283139|8892506|P4|Overall Study|Death|2
2570999|NCT01283139|8892507|P3|Overall Study|Death|2
2571000|NCT01283139|8892508|P2|Overall Study|Death|0
2571001|NCT01283139|8892509|P1|Overall Study|Death|2
2571002|NCT01283139|8892506|P4|Overall Study|Withdrawal by Subject|8
2571003|NCT01283139|8892507|P3|Overall Study|Withdrawal by Subject|6
2571004|NCT01283139|8892508|P2|Overall Study|Withdrawal by Subject|8
2571005|NCT01283139|8892509|P1|Overall Study|Withdrawal by Subject|8
2571006|NCT01283139|8892506|P4|Overall Study|Lost to Follow-up|1
2571007|NCT01283139|8892507|P3|Overall Study|Lost to Follow-up|3
2571008|NCT01283139|8892508|P2|Overall Study|Lost to Follow-up|2
2571009|NCT01283139|8892509|P1|Overall Study|Lost to Follow-up|5
2571010|NCT01283035|8892551|P1|Overall Study|Subject later found ineligible|1
2571011|NCT01282866|8892566|P1|Overall Study|Adverse Event|1
2571012|NCT01282814|8892574|P2|Washout of 7 Days|Withdrawal by Subject|0
2571013|NCT01282814|8892575|P1|Washout of 7 Days|Withdrawal by Subject|2
2571014|NCT01282814|8892574|P2|First Intervention|Emesis During Dosing Interval|3
2571015|NCT01282814|8892575|P1|First Intervention|Emesis During Dosing Interval|0
2571016|NCT01282801|8892587|P2|Second Intervention|Emesis During Critical Breakfast|1
2571017|NCT01282801|8892588|P1|Second Intervention|Emesis During Critical Breakfast|0
2571018|NCT01282476|8892612|P1|Overall Study|Death|11
2571019|NCT01282463|8892621|P3|Overall Study|Physician Decision|0
2571020|NCT01282463|8892622|P2|Overall Study|Physician Decision|0
2571021|NCT01282463|8892623|P1|Overall Study|Physician Decision|1
2571022|NCT01282463|8892621|P3|Overall Study|Protocol Violation|1
2571023|NCT01282463|8892622|P2|Overall Study|Protocol Violation|0
2571024|NCT01282463|8892623|P1|Overall Study|Protocol Violation|0
2571025|NCT01282463|8892621|P3|Overall Study|"Never Treated PD"|0
2571026|NCT01282463|8892622|P2|Overall Study|"Never Treated PD"|1
2571027|NCT01282463|8892623|P1|Overall Study|"Never Treated PD"|0
2571028|NCT01282463|8892621|P3|Overall Study|"Never Treated Death"|0
2571029|NCT01282463|8892622|P2|Overall Study|"Never Treated Death"|1
2571030|NCT01282463|8892623|P1|Overall Study|"Never Treated Death"|0
2571031|NCT01282463|8892621|P3|Overall Study|Withdrawal by Subject|3
2571032|NCT01282463|8892622|P2|Overall Study|Withdrawal by Subject|2
2571033|NCT01282463|8892623|P1|Overall Study|Withdrawal by Subject|6
2571034|NCT01282463|8892621|P3|Overall Study|Lost to Follow-up|0
2571035|NCT01282463|8892622|P2|Overall Study|Lost to Follow-up|0
2571036|NCT01282463|8892623|P1|Overall Study|Lost to Follow-up|1
2571037|NCT01282424|8892661|P1|Long-term Follow-up Period (5 Years)|Other (Unknown)|21
2571038|NCT01282424|8892661|P1|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1
2571039|NCT01282424|8892661|P1|Long-term Follow-up Period (5 Years)|Death|40
2571040|NCT01282424|8892661|P1|Long-term Follow-up Period (5 Years)|Withdrew Consent|2
2571041|NCT01282424|8892661|P1|Treatment Period (TP) (81 Months)|Other (Unknown)|3
2571042|NCT01282424|8892661|P1|Treatment Period (TP) (81 Months)|Investigator Request|7
2571043|NCT01282424|8892661|P1|Treatment Period (TP) (81 Months)|Withdrew Consent|6
2571044|NCT01282424|8892661|P1|Treatment Period (TP) (81 Months)|Adverse Event|30
2571045|NCT01282372|8892678|P1|Overall Study|Adverse Event|12
2571046|NCT01282372|8892678|P1|Overall Study|Refer Pre-Assignment Detail for Reason 2|1
2571047|NCT01282372|8892678|P1|Overall Study|Presence of AE, Regression of Symptoms|1
2571048|NCT01282372|8892678|P1|Overall Study|Presence of AE, Lack of Efficacy|1
2571049|NCT01282372|8892678|P1|Overall Study|Death|1
2571050|NCT01282372|8892678|P1|Overall Study|Refer Pre-Assignment Detail for Reason 1|4
2571051|NCT01282372|8892678|P1|Overall Study|Withdrawal by Subject|11
2571052|NCT01282372|8892678|P1|Overall Study|Lost to Follow-up|23
2571053|NCT01282372|8892678|P1|Overall Study|Lack of Efficacy / Exacerbation|25
2571054|NCT01282294|8892706|P1|Overall Study|Physician Decision|1
2571055|NCT01282294|8892706|P1|Overall Study|Patient non-compliance|2
2571056|NCT01282294|8892706|P1|Overall Study|Adverse Event|1
2571057|NCT01282294|8892706|P1|Overall Study|Screening failure|1
2571058|NCT01282294|8892706|P1|Overall Study|Lost to Follow-up|14
2571059|NCT01282229|8892735|P1|Overall Study|Protocol Violation|2
2571060|NCT01282216|8892767|P4|Overall Study|Death|0
2571061|NCT01282216|8892768|P3|Overall Study|Death|2
2571062|NCT01282216|8892769|P2|Overall Study|Death|0
2571063|NCT01282216|8892770|P1|Overall Study|Death|0
2571064|NCT01282216|8892767|P4|Overall Study|Relapse|6
2571065|NCT01282216|8892768|P3|Overall Study|Relapse|17
2571066|NCT01282216|8892769|P2|Overall Study|Relapse|0
2571067|NCT01282216|8892770|P1|Overall Study|Relapse|0
2571068|NCT01282216|8892767|P4|Overall Study|Physician Decision|0
2571069|NCT01282216|8892768|P3|Overall Study|Physician Decision|11
2571070|NCT01282216|8892769|P2|Overall Study|Physician Decision|0
2571071|NCT01282216|8892770|P1|Overall Study|Physician Decision|0
2571072|NCT01282216|8892767|P4|Overall Study|Graft failure|2
2571073|NCT01282216|8892768|P3|Overall Study|Graft failure|3
2571074|NCT01282216|8892769|P2|Overall Study|Graft failure|0
2571075|NCT01282216|8892770|P1|Overall Study|Graft failure|0
2571076|NCT01282203|8892780|P1|Overall Study|Adverse Event|1
2571077|NCT01282164|8892802|P2|Overall Study|Lack of hypoglycemia during ITT|0
2571078|NCT01282164|8892803|P1|Overall Study|Lack of hypoglycemia during ITT|1
2571079|NCT01281969|8892856|P3|Overall Study|not randomized, child consent not given|2
2571080|NCT01281969|8892857|P2|Overall Study|not randomized, child consent not given|0
2571081|NCT01281969|8892858|P1|Overall Study|not randomized, child consent not given|0
2571082|NCT01281969|8892856|P3|Overall Study|AE during LP prior to IVIG admin|3
2571083|NCT01281969|8892857|P2|Overall Study|AE during LP prior to IVIG admin|0
2571084|NCT01281969|8892858|P1|Overall Study|AE during LP prior to IVIG admin|1
2571085|NCT01281969|8892856|P3|Overall Study|not randomized didn't meet criteria|7
2571086|NCT01281969|8892857|P2|Overall Study|not randomized didn't meet criteria|0
2571087|NCT01281969|8892858|P1|Overall Study|not randomized didn't meet criteria|0
2571088|NCT01281956|8892870|P2|2nd Intervention (3 Months)|Withdrawal by Subject|0
2571089|NCT01281956|8892871|P1|2nd Intervention (3 Months)|Withdrawal by Subject|1
2571090|NCT01281917|8892902|P1|Overall Study|Withdrawal by Subject|1
2571091|NCT01281865|8892914|P2|Overall Study|Lack of Efficacy|0
2571092|NCT01281865|8892915|P1|Overall Study|Lack of Efficacy|1
2571093|NCT01281865|8892914|P2|Overall Study|Withdrawal by Subject|0
2571094|NCT01281865|8892915|P1|Overall Study|Withdrawal by Subject|1
2571095|NCT01281865|8892914|P2|Overall Study|Adverse Event|1
2571096|NCT01281865|8892915|P1|Overall Study|Adverse Event|1
2571097|NCT01281839|8892923|P2|Overall Study|Reason not specified|1
2571098|NCT01281839|8892924|P1|Overall Study|Reason not specified|0
2571099|NCT01281839|8892923|P2|Overall Study|Withdrawal by Subject|10
2571100|NCT01281839|8892924|P1|Overall Study|Withdrawal by Subject|4
2571101|NCT01281839|8892923|P2|Overall Study|Lost to Follow-up|3
2571102|NCT01281839|8892924|P1|Overall Study|Lost to Follow-up|6
2571103|NCT01281644|8892985|P1|Overall Study|Withdrawal by Subject|2
2571104|NCT01281644|8892985|P1|Overall Study|Lost to Follow-up|3
2571105|NCT01281306|8893026|P7|Overall Study|Randomized in error|0
2571106|NCT01281306|8893027|P6|Overall Study|Randomized in error|0
2571107|NCT01281306|8893028|P5|Overall Study|Randomized in error|0
2571108|NCT01281306|8893029|P4|Overall Study|Randomized in error|1
2571109|NCT01281306|8893030|P3|Overall Study|Randomized in error|0
2571110|NCT01281306|8893031|P2|Overall Study|Randomized in error|0
2571111|NCT01281306|8893032|P1|Overall Study|Randomized in error|1
2571112|NCT01281306|8893026|P7|Overall Study|Adverse Event|3
2571113|NCT01281306|8893027|P6|Overall Study|Adverse Event|3
2571114|NCT01281306|8893028|P5|Overall Study|Adverse Event|5
2571115|NCT01281306|8893029|P4|Overall Study|Adverse Event|3
2571116|NCT01281306|8893030|P3|Overall Study|Adverse Event|2
2571117|NCT01281306|8893031|P2|Overall Study|Adverse Event|2
2571118|NCT01281306|8893032|P1|Overall Study|Adverse Event|3
2571119|NCT01281306|8893026|P7|Overall Study|Death|0
2571120|NCT01281306|8893027|P6|Overall Study|Death|0
2571121|NCT01281306|8893028|P5|Overall Study|Death|0
2571122|NCT01281306|8893029|P4|Overall Study|Death|0
2571123|NCT01281306|8893030|P3|Overall Study|Death|0
2571124|NCT01281306|8893031|P2|Overall Study|Death|0
2571125|NCT01281306|8893032|P1|Overall Study|Death|1
2571126|NCT01281306|8893026|P7|Overall Study|Lost to Follow-up|1
2571127|NCT01281306|8893027|P6|Overall Study|Lost to Follow-up|0
2571128|NCT01281306|8893028|P5|Overall Study|Lost to Follow-up|0
2571129|NCT01281306|8893029|P4|Overall Study|Lost to Follow-up|2
2571130|NCT01281306|8893030|P3|Overall Study|Lost to Follow-up|0
2571131|NCT01281306|8893031|P2|Overall Study|Lost to Follow-up|0
2571132|NCT01281306|8893032|P1|Overall Study|Lost to Follow-up|1
2571133|NCT01281306|8893026|P7|Overall Study|Condition no longer requires study drug|1
2571134|NCT01281306|8893027|P6|Overall Study|Condition no longer requires study drug|1
2571135|NCT01281306|8893028|P5|Overall Study|Condition no longer requires study drug|0
2571136|NCT01281306|8893029|P4|Overall Study|Condition no longer requires study drug|0
2571137|NCT01281306|8893030|P3|Overall Study|Condition no longer requires study drug|0
2571138|NCT01281306|8893031|P2|Overall Study|Condition no longer requires study drug|0
2571139|NCT01281306|8893032|P1|Overall Study|Condition no longer requires study drug|1
2571140|NCT01281306|8893026|P7|Overall Study|Protocol deviation|0
2571141|NCT01281306|8893027|P6|Overall Study|Protocol deviation|0
2571142|NCT01281306|8893028|P5|Overall Study|Protocol deviation|1
2571143|NCT01281306|8893029|P4|Overall Study|Protocol deviation|1
2571144|NCT01281306|8893030|P3|Overall Study|Protocol deviation|1
2571145|NCT01281306|8893031|P2|Overall Study|Protocol deviation|1
2571146|NCT01281306|8893032|P1|Overall Study|Protocol deviation|0
2571147|NCT01281306|8893026|P7|Overall Study|Withdrawal by Subject|1
2571148|NCT01281306|8893027|P6|Overall Study|Withdrawal by Subject|3
2571149|NCT01281306|8893028|P5|Overall Study|Withdrawal by Subject|1
2571150|NCT01281306|8893029|P4|Overall Study|Withdrawal by Subject|4
2571151|NCT01281306|8893030|P3|Overall Study|Withdrawal by Subject|2
2571152|NCT01281306|8893031|P2|Overall Study|Withdrawal by Subject|0
2571153|NCT01281306|8893032|P1|Overall Study|Withdrawal by Subject|1
2571154|NCT01281306|8893026|P7|Overall Study|Lack of Efficacy|1
2571155|NCT01281306|8893027|P6|Overall Study|Lack of Efficacy|0
2571156|NCT01281306|8893028|P5|Overall Study|Lack of Efficacy|2
2571157|NCT01281306|8893029|P4|Overall Study|Lack of Efficacy|0
2571158|NCT01281306|8893030|P3|Overall Study|Lack of Efficacy|3
2571159|NCT01281306|8893031|P2|Overall Study|Lack of Efficacy|1
2571160|NCT01281306|8893032|P1|Overall Study|Lack of Efficacy|0
2571161|NCT01281202|8893148|P2|Overall Study|Incarceration|3
2571162|NCT01281202|8893149|P1|Overall Study|Incarceration|0
2571163|NCT01281202|8893148|P2|Overall Study|Lost to Follow-up|13
2571164|NCT01281202|8893149|P1|Overall Study|Lost to Follow-up|11
2571165|NCT01281202|8893148|P2|Overall Study|Administrative|8
2571166|NCT01281202|8893149|P1|Overall Study|Administrative|2
2571167|NCT01281202|8893148|P2|Overall Study|Protocol Violation|10
2571168|NCT01281202|8893149|P1|Overall Study|Protocol Violation|11
2571169|NCT01281202|8893148|P2|Overall Study|Withdrawal by Subject|2
2571170|NCT01281202|8893149|P1|Overall Study|Withdrawal by Subject|2
2571171|NCT01281202|8893148|P2|Overall Study|Adverse Event|0
2571172|NCT01281202|8893149|P1|Overall Study|Adverse Event|2
2571173|NCT01281124|8893157|P1|Overall Study|Death|1
2571174|NCT01280981|8893172|P1|Overall Study|Study site closure|1
2571175|NCT01280981|8893172|P1|Overall Study|Elective surgery|2
2571176|NCT01280981|8893172|P1|Overall Study|Withdrawal of consent|3
2571177|NCT01280981|8893172|P1|Overall Study|Non-compliance with protocol|3
2571178|NCT01280981|8893172|P1|Overall Study|Failed to return|45
2571179|NCT01280981|8893172|P1|Overall Study|Irregular or discontinued menses|3
2571180|NCT01280981|8893172|P1|Overall Study|Adverse Event|6
2571181|NCT01280981|8893172|P1|Overall Study|Lost to Follow-up|3
2571182|NCT01280981|8893172|P1|Overall Study|Lack of Efficacy|13
2571183|NCT01280981|8893172|P1|Overall Study|Protocol Violation|2
2571184|NCT01280981|8893172|P1|Overall Study|Withdrawal by Subject|11
2571185|NCT01280968|8893183|P2|Overall Study|Unable to Smoke in Supine Position|0
2571186|NCT01280968|8893184|P1|Overall Study|Unable to Smoke in Supine Position|1
2571187|NCT01280968|8893183|P2|Overall Study|Pre-existing Neurological Condition|0
2571188|NCT01280968|8893184|P1|Overall Study|Pre-existing Neurological Condition|1
2571189|NCT01280968|8893183|P2|Overall Study|Scheduling Conflicts|1
2571190|NCT01280968|8893184|P1|Overall Study|Scheduling Conflicts|1
2571191|NCT01280968|8893183|P2|Overall Study|Adverse Event|0
2571192|NCT01280968|8893184|P1|Overall Study|Adverse Event|1
2571193|NCT01280968|8893183|P2|Overall Study|Anxiety|0
2571194|NCT01280968|8893184|P1|Overall Study|Anxiety|2
2571195|NCT01280968|8893183|P2|Overall Study|Commuting Problems|0
2571196|NCT01280968|8893184|P1|Overall Study|Commuting Problems|2
2571197|NCT01280968|8893183|P2|Overall Study|Unable to Follow Experimental Protocol|0
2571198|NCT01280968|8893184|P1|Overall Study|Unable to Follow Experimental Protocol|2
2571199|NCT01280968|8893183|P2|Overall Study|Lost to Follow-up|2
2571200|NCT01280968|8893184|P1|Overall Study|Lost to Follow-up|8
2571201|NCT01280955|8893200|P1|Overall Study|Withdrawal by Subject|1
2571202|NCT01280955|8893200|P1|Overall Study|Death|2
2571203|NCT01280903|8893244|P2|Overall Study|Lost to Follow-up|16
2571204|NCT01280903|8893245|P1|Overall Study|Lost to Follow-up|23
2571205|NCT01280721|8893309|P1|Overall Study|No tolerability for the lowest dose|2
2571206|NCT01280721|8893309|P1|Overall Study|eGFR under the withdrawal criteria|7
2571207|NCT01280721|8893309|P1|Overall Study|Withdrawal by Subject|6
2571208|NCT01280721|8893309|P1|Overall Study|Physician Decision|3
2571209|NCT01280721|8893309|P1|Overall Study|Adverse Event|4
2571210|NCT01280656|8893373|P3|Overall Study|Other|7
2571211|NCT01280656|8893374|P2|Overall Study|Other|7
2571212|NCT01280656|8893375|P1|Overall Study|Other|1
2571213|NCT01280656|8893373|P3|Overall Study|Treatment shortening (RGT)|5
2571214|NCT01280656|8893374|P2|Overall Study|Treatment shortening (RGT)|4
2571215|NCT01280656|8893375|P1|Overall Study|Treatment shortening (RGT)|0
2571216|NCT01280656|8893373|P3|Overall Study|Lack of Efficacy|38
2571217|NCT01280656|8893374|P2|Overall Study|Lack of Efficacy|22
2571218|NCT01280656|8893375|P1|Overall Study|Lack of Efficacy|1
2571219|NCT01280656|8893373|P3|Overall Study|Adverse Event|13
2571220|NCT01280656|8893374|P2|Overall Study|Adverse Event|14
2571221|NCT01280656|8893375|P1|Overall Study|Adverse Event|1
2571222|NCT01280591|8893442|P4|Overall Study|Does not meet exclusion #27 criteria|1
2571223|NCT01280591|8893443|P3|Overall Study|Does not meet exclusion #27 criteria|0
2571224|NCT01280591|8893444|P2|Overall Study|Does not meet exclusion #27 criteria|0
2571225|NCT01280591|8893445|P1|Overall Study|Does not meet exclusion #27 criteria|0
2571226|NCT01280591|8893442|P4|Overall Study|Withdrawal by Subject|2
2571227|NCT01280591|8893443|P3|Overall Study|Withdrawal by Subject|0
2571228|NCT01280591|8893444|P2|Overall Study|Withdrawal by Subject|0
2571229|NCT01280591|8893445|P1|Overall Study|Withdrawal by Subject|0
2571230|NCT01280357|8893583|P1|Overall Study|IInsufficient data/No data supplied|12
2571231|NCT01280357|8893583|P1|Overall Study|Excluded no internal monitoring|14
2571232|NCT01280266|8893592|P2|First Intervention (Week 1-4)|Withdrawal by Subject|2
2571233|NCT01280266|8893593|P1|First Intervention (Week 1-4)|Withdrawal by Subject|0
2571234|NCT01280266|8893592|P2|First Intervention (Week 1-4)|Adverse Event|0
2571235|NCT01280266|8893593|P1|First Intervention (Week 1-4)|Adverse Event|1
2571236|NCT01279954|8893684|P2|Overall Study|Lack of Efficacy|4
2571237|NCT01279954|8893685|P1|Overall Study|Lack of Efficacy|3
2571238|NCT01279850|8893696|P1|Overall Study|No Visit After Treatment|34
2571239|NCT01279850|8893696|P1|Overall Study|No Drug Administration Information|7
2571240|NCT01279850|8893696|P1|Overall Study|Protocol Violation|50
2571241|NCT01279681|8893712|P2|Overall Study|Other Reason|2
2571242|NCT01279681|8893713|P1|Overall Study|Other Reason|0
2571243|NCT01279681|8893712|P2|Overall Study|Physician Decision|0
2571244|NCT01279681|8893713|P1|Overall Study|Physician Decision|1
2571245|NCT01279681|8893712|P2|Overall Study|Withdrawal Prior to Beginning Treatment|1
2571246|NCT01279681|8893713|P1|Overall Study|Withdrawal Prior to Beginning Treatment|0
2571247|NCT01279681|8893712|P2|Overall Study|Death|1
2571248|NCT01279681|8893713|P1|Overall Study|Death|0
2571249|NCT01279681|8893712|P2|Overall Study|Adverse Event|3
2571250|NCT01279681|8893713|P1|Overall Study|Adverse Event|2
2571251|NCT01279681|8893712|P2|Overall Study|Withdrawal by Subject|4
2571252|NCT01279681|8893713|P1|Overall Study|Withdrawal by Subject|3
2571253|NCT01279681|8893712|P2|Overall Study|Disease Progression|6
2571254|NCT01279681|8893713|P1|Overall Study|Disease Progression|9
2571255|NCT01279616|8893725|P1|Overall Study|no signs of sickle cell disease|2
2571256|NCT01279616|8893725|P1|Overall Study|donor could not be located|5
2571257|NCT01279486|8893738|P1|Overall Study|Lost to Follow-up|1
2571258|NCT01279447|8893744|P2|Overall Study|Lost to Follow-up|1
2571259|NCT01279447|8893745|P1|Overall Study|Lost to Follow-up|3
2571260|NCT01279343|8893753|P2|Overall Study|Did not receive treatment|6
2571261|NCT01279343|8893754|P1|Overall Study|Did not receive treatment|2
2571262|NCT01279200|8893799|P2|Overall Study|Adverse Event|0
2571263|NCT01279200|8893800|P1|Overall Study|Adverse Event|1
2571264|NCT01279200|8893799|P2|Overall Study|Lost to Follow-up|1
2571265|NCT01279200|8893800|P1|Overall Study|Lost to Follow-up|0
2571266|NCT01279200|8893799|P2|Overall Study|ultrasound screening failure|1
2571267|NCT01279200|8893800|P1|Overall Study|ultrasound screening failure|0
2571268|NCT01279200|8893799|P2|Overall Study|Inconvenience of ultrasound visit|1
2571269|NCT01279200|8893800|P1|Overall Study|Inconvenience of ultrasound visit|0
2571270|NCT01279200|8893799|P2|Overall Study|Patient withdrawal due to high cost|1
2571271|NCT01279200|8893800|P1|Overall Study|Patient withdrawal due to high cost|0
2571272|NCT01279200|8893799|P2|Overall Study|Withdrawal by Subject|3
2571273|NCT01279200|8893800|P1|Overall Study|Withdrawal by Subject|1
2571274|NCT01279070|8893838|P2|Overall Study|Acute exacerbation|1
2571275|NCT01279070|8893839|P1|Overall Study|Acute exacerbation|3
2571276|NCT01279070|8893838|P2|Overall Study|Withdrawal by Subject|3
2571277|NCT01279070|8893839|P1|Overall Study|Withdrawal by Subject|2
2571278|NCT01279044|8893858|P3|PHASE 2 - Randmonized Controlled Trial|Death|1
2571279|NCT01279044|8893859|P2|PHASE 2 - Randmonized Controlled Trial|Death|0
2571280|NCT01279044|8893860|P1|PHASE 2 - Randmonized Controlled Trial|Death|0
2571281|NCT01279044|8893858|P3|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
2571282|NCT01279044|8893859|P2|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8
2571283|NCT01279044|8893860|P1|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
2571284|NCT01279044|8893858|P3|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2
2571285|NCT01279044|8893859|P2|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3
2571286|NCT01279044|8893860|P1|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0
2571287|NCT01278862|8893936|P2|Overall Study|Lost to Follow-up|1
2571288|NCT01278862|8893937|P1|Overall Study|Lost to Follow-up|1
2571289|NCT01278797|8893945|P2|Period 1|Protocol Violation|0
2571290|NCT01278797|8893946|P1|Period 1|Protocol Violation|1
2571291|NCT01278797|8893945|P2|Period 1|Adverse Event|1
2571292|NCT01278797|8893946|P1|Period 1|Adverse Event|0
2571293|NCT01278745|8893958|P4|Overall Study|Moves,enrollment in mx studies, et al.|1
2571294|NCT01278745|8893959|P3|Overall Study|Moves,enrollment in mx studies, et al.|5
2571295|NCT01278745|8893960|P2|Overall Study|Moves,enrollment in mx studies, et al.|0
2571296|NCT01278745|8893961|P1|Overall Study|Moves,enrollment in mx studies, et al.|0
2571297|NCT01278745|8893958|P4|Overall Study|Ineligible|61
2571298|NCT01278745|8893959|P3|Overall Study|Ineligible|42
2571299|NCT01278745|8893960|P2|Overall Study|Ineligible|0
2571300|NCT01278745|8893961|P1|Overall Study|Ineligible|0
2571301|NCT01278745|8893958|P4|Overall Study|Sponsor Decision|6
2571302|NCT01278745|8893959|P3|Overall Study|Sponsor Decision|62
2571303|NCT01278745|8893960|P2|Overall Study|Sponsor Decision|0
2571304|NCT01278745|8893961|P1|Overall Study|Sponsor Decision|1
2571305|NCT01278745|8893958|P4|Overall Study|Withdrawal by Subject|1
2571306|NCT01278745|8893959|P3|Overall Study|Withdrawal by Subject|5
2571307|NCT01278745|8893960|P2|Overall Study|Withdrawal by Subject|1
2571308|NCT01278745|8893961|P1|Overall Study|Withdrawal by Subject|1
2571309|NCT01278745|8893958|P4|Overall Study|Physician Decision|9
2571310|NCT01278745|8893959|P3|Overall Study|Physician Decision|0
2571311|NCT01278745|8893960|P2|Overall Study|Physician Decision|0
2571312|NCT01278745|8893961|P1|Overall Study|Physician Decision|1
2571313|NCT01278745|8893958|P4|Overall Study|Death|0
2571314|NCT01278745|8893959|P3|Overall Study|Death|7
2571315|NCT01278745|8893960|P2|Overall Study|Death|5
2571316|NCT01278745|8893961|P1|Overall Study|Death|2
2571317|NCT01278615|8893993|P1|Overall Study|Withdrawal by Subject|2
2571318|NCT01278407|8894019|P5|Extension Phase|Other|3
2571319|NCT01278407|8894020|P4|Extension Phase|Other|1
2571320|NCT01278407|8894021|P3|Extension Phase|Other|0
2571321|NCT01278407|8894022|P2|Extension Phase|Other|0
2571322|NCT01278407|8894023|P1|Extension Phase|Other|0
2571323|NCT01278407|8894019|P5|Extension Phase|Participant's Choice|11
2571324|NCT01278407|8894020|P4|Extension Phase|Participant's Choice|4
2571325|NCT01278407|8894021|P3|Extension Phase|Participant's Choice|0
2571326|NCT01278407|8894022|P2|Extension Phase|Participant's Choice|0
2571327|NCT01278407|8894023|P1|Extension Phase|Participant's Choice|0
2571328|NCT01278407|8894019|P5|Extension Phase|Adverse Event|16
2571329|NCT01278407|8894020|P4|Extension Phase|Adverse Event|7
2571330|NCT01278407|8894021|P3|Extension Phase|Adverse Event|0
2571331|NCT01278407|8894022|P2|Extension Phase|Adverse Event|0
2571332|NCT01278407|8894023|P1|Extension Phase|Adverse Event|0
2571333|NCT01278407|8894019|P5|Confirmatory Phase|Other|0
2571334|NCT01278407|8894020|P4|Confirmatory Phase|Other|0
2571335|NCT01278407|8894021|P3|Confirmatory Phase|Other|2
2571336|NCT01278407|8894022|P2|Confirmatory Phase|Other|1
2571337|NCT01278407|8894023|P1|Confirmatory Phase|Other|1
2571338|NCT01278407|8894019|P5|Confirmatory Phase|Participant's Choice|0
2571339|NCT01278407|8894020|P4|Confirmatory Phase|Participant's Choice|0
2571340|NCT01278407|8894021|P3|Confirmatory Phase|Participant's Choice|3
2571341|NCT01278407|8894022|P2|Confirmatory Phase|Participant's Choice|5
2571342|NCT01278407|8894023|P1|Confirmatory Phase|Participant's Choice|3
2571343|NCT01278407|8894019|P5|Confirmatory Phase|Adverse Event|0
2571344|NCT01278407|8894020|P4|Confirmatory Phase|Adverse Event|0
2571345|NCT01278407|8894021|P3|Confirmatory Phase|Adverse Event|1
2571346|NCT01278407|8894022|P2|Confirmatory Phase|Adverse Event|10
2571347|NCT01278407|8894023|P1|Confirmatory Phase|Adverse Event|5
2571348|NCT01278394|8894036|P1|Overall Study|Lost to Follow-up|1
2571349|NCT01278342|8894049|P3|Overall Study|Other|0
2571350|NCT01278342|8894050|P2|Overall Study|Other|0
2571351|NCT01278342|8894051|P1|Overall Study|Other|1
2571352|NCT01278342|8894049|P3|Overall Study|Administrative problems|0
2571353|NCT01278342|8894050|P2|Overall Study|Administrative problems|0
2571354|NCT01278342|8894051|P1|Overall Study|Administrative problems|2
2571355|NCT01278342|8894049|P3|Overall Study|Lost to Follow-up|0
2571356|NCT01278342|8894050|P2|Overall Study|Lost to Follow-up|0
2571357|NCT01278342|8894051|P1|Overall Study|Lost to Follow-up|1
2571358|NCT01278342|8894049|P3|Overall Study|Physician Decision|0
2571359|NCT01278342|8894050|P2|Overall Study|Physician Decision|1
2571360|NCT01278342|8894051|P1|Overall Study|Physician Decision|0
2571361|NCT01278173|8894071|P1|Overall Study|Withdrawal by Subject|1
2571362|NCT01278173|8894071|P1|Overall Study|Protocol Violation|1
2571363|NCT01278173|8894071|P1|Overall Study|Administrative or other reason|4
2571364|NCT01278173|8894071|P1|Overall Study|Adverse Event|8
2571365|NCT01278173|8894071|P1|Overall Study|Lack of Efficacy|13
2571366|NCT01278160|8894078|P2|Overall Study|Unclassified|2
2571367|NCT01278160|8894079|P1|Overall Study|Unclassified|1
2571368|NCT01278160|8894078|P2|Overall Study|Withdrawal by Subject|2
2571369|NCT01278160|8894079|P1|Overall Study|Withdrawal by Subject|3
2571370|NCT01278160|8894078|P2|Overall Study|Lost to Follow-up|1
2571371|NCT01278160|8894079|P1|Overall Study|Lost to Follow-up|0
2571372|NCT01278160|8894078|P2|Overall Study|Adverse Event|1
2571373|NCT01278160|8894079|P1|Overall Study|Adverse Event|1
2571374|NCT01278030|8894095|P2|Overall Study|Withdrawal by Subject|4
2571375|NCT01278030|8894096|P1|Overall Study|Withdrawal by Subject|8
2571376|NCT01277887|8894104|P2|Post-Quit Treatment Phase|No longer interested in treatment|5
2571377|NCT01277887|8894105|P1|Post-Quit Treatment Phase|No longer interested in treatment|3
2571378|NCT01277887|8894104|P2|Pre-Quit Treatment Phase|Withdrawal by Subject|0
2571379|NCT01277887|8894105|P1|Pre-Quit Treatment Phase|Withdrawal by Subject|2
2571380|NCT01277887|8894104|P2|Pre-Quit Treatment Phase|No longer interested in treatment|0
2571381|NCT01277887|8894105|P1|Pre-Quit Treatment Phase|No longer interested in treatment|1
2571382|NCT01277861|8894117|P2|Overall Study|Physician Decision|2
2571383|NCT01277861|8894118|P1|Overall Study|Physician Decision|2
2571384|NCT01277822|8894130|P2|Overall Study|Participant moved|0
2571385|NCT01277822|8894131|P1|Overall Study|Participant moved|1
2571386|NCT01277822|8894130|P2|Overall Study|Contraindicated medication used|1
2571387|NCT01277822|8894131|P1|Overall Study|Contraindicated medication used|2
2571388|NCT01277822|8894130|P2|Overall Study|Lost to Follow-up|1
2571389|NCT01277822|8894131|P1|Overall Study|Lost to Follow-up|2
2571390|NCT01277822|8894130|P2|Overall Study|Protocol Violation|0
2571391|NCT01277822|8894131|P1|Overall Study|Protocol Violation|1
2571392|NCT01277822|8894130|P2|Overall Study|Physician Decision|1
2571393|NCT01277822|8894131|P1|Overall Study|Physician Decision|1
2571394|NCT01277822|8894130|P2|Overall Study|Withdrawal by Subject|7
2571395|NCT01277822|8894131|P1|Overall Study|Withdrawal by Subject|6
2571396|NCT01277822|8894130|P2|Overall Study|Adverse Event|1
2571397|NCT01277822|8894131|P1|Overall Study|Adverse Event|2
2571398|NCT01277757|8894167|P1|Overall Study|Withdrawal by Subject|1
2571399|NCT01277757|8894167|P1|Overall Study|Disease Progression|1
2571400|NCT01277744|8894174|P1|Overall Study|Physician Decision|2
2571401|NCT01277718|8894179|P2|Period 2 - Second Intervention|Physician Decision|2
2571402|NCT01277718|8894180|P1|Period 2 - Second Intervention|Physician Decision|0
2571403|NCT01277718|8894179|P2|Period 2 - Second Intervention|Protocol Violation|1
2571404|NCT01277718|8894180|P1|Period 2 - Second Intervention|Protocol Violation|0
2571405|NCT01277666|8894194|P3|Overall Study|Death|1
2571406|NCT01277666|8894195|P2|Overall Study|Death|0
2571407|NCT01277666|8894196|P1|Overall Study|Death|0
2571408|NCT01277666|8894194|P3|Overall Study|Withdrawal by Subject|6
2571409|NCT01277666|8894195|P2|Overall Study|Withdrawal by Subject|8
2571410|NCT01277666|8894196|P1|Overall Study|Withdrawal by Subject|7
2571411|NCT01277666|8894194|P3|Overall Study|Lost to Follow-up|2
2571412|NCT01277666|8894195|P2|Overall Study|Lost to Follow-up|1
2571413|NCT01277666|8894196|P1|Overall Study|Lost to Follow-up|1
2571414|NCT01277666|8894194|P3|Overall Study|Protocol Defined Stopping criteria|6
2571415|NCT01277666|8894195|P2|Overall Study|Protocol Defined Stopping criteria|2
2571416|NCT01277666|8894196|P1|Overall Study|Protocol Defined Stopping criteria|1
2571417|NCT01277666|8894194|P3|Overall Study|Protocol Violation|2
2571418|NCT01277666|8894195|P2|Overall Study|Protocol Violation|3
2571419|NCT01277666|8894196|P1|Overall Study|Protocol Violation|2
2571420|NCT01277666|8894194|P3|Overall Study|Lack of Efficacy|12
2571421|NCT01277666|8894195|P2|Overall Study|Lack of Efficacy|20
2571422|NCT01277666|8894196|P1|Overall Study|Lack of Efficacy|8
2571423|NCT01277666|8894194|P3|Overall Study|Adverse Event|20
2571424|NCT01277666|8894195|P2|Overall Study|Adverse Event|25
2571425|NCT01277666|8894196|P1|Overall Study|Adverse Event|26
2571426|NCT01277601|8894229|P4|Overall Study|Subject Terminated from Study by Sponsor|2
2571427|NCT01277601|8894230|P3|Overall Study|Subject Terminated from Study by Sponsor|0
2571428|NCT01277601|8894231|P2|Overall Study|Subject Terminated from Study by Sponsor|1
2571429|NCT01277601|8894232|P1|Overall Study|Subject Terminated from Study by Sponsor|0
2571430|NCT01277601|8894229|P4|Overall Study|Protocol Violation|0
2571431|NCT01277601|8894230|P3|Overall Study|Protocol Violation|5
2571432|NCT01277601|8894231|P2|Overall Study|Protocol Violation|2
2571433|NCT01277601|8894232|P1|Overall Study|Protocol Violation|0
2571434|NCT01277601|8894229|P4|Overall Study|Subject Never Dosed with Study Drug|1
2571435|NCT01277601|8894230|P3|Overall Study|Subject Never Dosed with Study Drug|3
2571436|NCT01277601|8894231|P2|Overall Study|Subject Never Dosed with Study Drug|2
2571437|NCT01277601|8894232|P1|Overall Study|Subject Never Dosed with Study Drug|1
2571438|NCT01277601|8894229|P4|Overall Study|Noncompliance with Study Drug|0
2571439|NCT01277601|8894230|P3|Overall Study|Noncompliance with Study Drug|2
2571440|NCT01277601|8894231|P2|Overall Study|Noncompliance with Study Drug|3
2571441|NCT01277601|8894232|P1|Overall Study|Noncompliance with Study Drug|1
2571442|NCT01277601|8894229|P4|Overall Study|Pregnancy|1
2571443|NCT01277601|8894230|P3|Overall Study|Pregnancy|4
2571444|NCT01277601|8894231|P2|Overall Study|Pregnancy|2
2571445|NCT01277601|8894232|P1|Overall Study|Pregnancy|2
2571446|NCT01277601|8894229|P4|Overall Study|Physician Decision|6
2571447|NCT01277601|8894230|P3|Overall Study|Physician Decision|1
2571448|NCT01277601|8894231|P2|Overall Study|Physician Decision|5
2571449|NCT01277601|8894232|P1|Overall Study|Physician Decision|3
2571450|NCT01277601|8894229|P4|Overall Study|Lost to Follow-up|2
2571451|NCT01277601|8894230|P3|Overall Study|Lost to Follow-up|4
2571452|NCT01277601|8894231|P2|Overall Study|Lost to Follow-up|9
2571453|NCT01277601|8894232|P1|Overall Study|Lost to Follow-up|7
2571454|NCT01277601|8894229|P4|Overall Study|Withdrawal by Subject|17
2571455|NCT01277601|8894230|P3|Overall Study|Withdrawal by Subject|8
2571456|NCT01277601|8894231|P2|Overall Study|Withdrawal by Subject|21
2571457|NCT01277601|8894232|P1|Overall Study|Withdrawal by Subject|18
2571458|NCT01277601|8894229|P4|Overall Study|Adverse Event|7
2571459|NCT01277601|8894230|P3|Overall Study|Adverse Event|0
2571460|NCT01277601|8894231|P2|Overall Study|Adverse Event|3
2571461|NCT01277601|8894232|P1|Overall Study|Adverse Event|5
2571462|NCT01277549|8894323|P2|Overall Study|Physician Decision|1
2571463|NCT01277549|8894324|P1|Overall Study|Physician Decision|2
2571464|NCT01277549|8894323|P2|Overall Study|Protocol Violation|1
2571465|NCT01277549|8894324|P1|Overall Study|Protocol Violation|10
2571466|NCT01277549|8894323|P2|Overall Study|Withdrawal by Subject|3
2571467|NCT01277549|8894324|P1|Overall Study|Withdrawal by Subject|1
2571468|NCT01277549|8894323|P2|Overall Study|Failed to meet eligibility criteria|9
2571469|NCT01277549|8894324|P1|Overall Study|Failed to meet eligibility criteria|13
2571470|NCT01277523|8894341|P3|Overall Study|Other Reason not Defined|0
2571471|NCT01277523|8894342|P2|Overall Study|Other Reason not Defined|1
2571472|NCT01277523|8894343|P1|Overall Study|Other Reason not Defined|0
2571473|NCT01277523|8894341|P3|Overall Study|Protocol Violation|0
2571474|NCT01277523|8894342|P2|Overall Study|Protocol Violation|0
2571475|NCT01277523|8894343|P1|Overall Study|Protocol Violation|2
2571476|NCT01277523|8894341|P3|Overall Study|Adverse Event|0
2571477|NCT01277523|8894342|P2|Overall Study|Adverse Event|0
2571478|NCT01277523|8894343|P1|Overall Study|Adverse Event|1
2571479|NCT01277510|8894395|P2|Open-label Phase|Never received investigational product|0
2571480|NCT01277510|8894396|P1|Open-label Phase|Never received investigational product|2
2571481|NCT01277510|8894395|P2|Open-label Phase|Protocol-specified criteria|0
2571482|NCT01277510|8894396|P1|Open-label Phase|Protocol-specified criteria|1
2571483|NCT01277510|8894395|P2|Open-label Phase|Administrative decision|3
2571484|NCT01277510|8894396|P1|Open-label Phase|Administrative decision|4
2571485|NCT01277510|8894395|P2|Double-blind Phase|Other|1
2571486|NCT01277510|8894396|P1|Double-blind Phase|Other|1
2571487|NCT01277510|8894395|P2|Double-blind Phase|Protocol-specified criteria|6
2571488|NCT01277510|8894396|P1|Double-blind Phase|Protocol-specified criteria|2
2571489|NCT01277510|8894395|P2|Double-blind Phase|Death|1
2571490|NCT01277510|8894396|P1|Double-blind Phase|Death|0
2571491|NCT01277510|8894395|P2|Double-blind Phase|Administrative decision|9
2571492|NCT01277510|8894396|P1|Double-blind Phase|Administrative decision|7
2571493|NCT01277510|8894395|P2|Double-blind Phase|Withdrawal by Subject|0
2571494|NCT01277510|8894396|P1|Double-blind Phase|Withdrawal by Subject|2
2571495|NCT01277510|8894395|P2|Double-blind Phase|Adverse Event|0
2571496|NCT01277510|8894396|P1|Double-blind Phase|Adverse Event|1
2571497|NCT01277510|8894395|P2|Double-blind Phase|Non-compliance|1
2571498|NCT01277510|8894396|P1|Double-blind Phase|Non-compliance|0
2571499|NCT01277302|8894430|P3|8-Month Alternate Dose Regimen Period|Relocation|1
2571500|NCT01277302|8894431|P2|8-Month Alternate Dose Regimen Period|Relocation|0
2571501|NCT01277302|8894432|P1|8-Month Alternate Dose Regimen Period|Relocation|1
2571502|NCT01277302|8894430|P3|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1
2571503|NCT01277302|8894431|P2|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2
2571504|NCT01277302|8894432|P1|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0
2571505|NCT01277302|8894430|P3|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1
2571506|NCT01277302|8894431|P2|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0
2571507|NCT01277302|8894432|P1|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3
2571508|NCT01277302|8894430|P3|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3
2571509|NCT01277302|8894431|P2|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
2571510|NCT01277302|8894432|P1|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
2571511|NCT01277302|8894430|P3|8-Month Alternate Dose Regimen Period|Death|0
2571512|NCT01277302|8894431|P2|8-Month Alternate Dose Regimen Period|Death|1
2571513|NCT01277302|8894432|P1|8-Month Alternate Dose Regimen Period|Death|0
2571514|NCT01277302|8894430|P3|7-Month Fixed Treatment Period|Subject Non-compliance|1
2571515|NCT01277302|8894431|P2|7-Month Fixed Treatment Period|Subject Non-compliance|0
2571516|NCT01277302|8894432|P1|7-Month Fixed Treatment Period|Subject Non-compliance|0
2571517|NCT01277302|8894430|P3|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1
2571518|NCT01277302|8894431|P2|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
2571519|NCT01277302|8894432|P1|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
2571520|NCT01277302|8894430|P3|7-Month Fixed Treatment Period|Lost to Follow-up|2
2571521|NCT01277302|8894431|P2|7-Month Fixed Treatment Period|Lost to Follow-up|0
2571522|NCT01277302|8894432|P1|7-Month Fixed Treatment Period|Lost to Follow-up|0
2571523|NCT01277302|8894430|P3|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8
2571524|NCT01277302|8894431|P2|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
2571525|NCT01277302|8894432|P1|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
2571526|NCT01277211|8894464|P2|Overall Study|Discontinued prior to treatment|13
2571527|NCT01277211|8894465|P1|Overall Study|Discontinued prior to treatment|24
2571528|NCT01277211|8894464|P2|Overall Study|Pregnancy wish|2
2571529|NCT01277211|8894465|P1|Overall Study|Pregnancy wish|0
2571530|NCT01277211|8894464|P2|Overall Study|Administrative|0
2571531|NCT01277211|8894465|P1|Overall Study|Administrative|3
2571532|NCT01277211|8894464|P2|Overall Study|Did not meet protocol eligibility|0
2571533|NCT01277211|8894465|P1|Overall Study|Did not meet protocol eligibility|1
2571534|NCT01277211|8894464|P2|Overall Study|Non-compliance with protocol|4
2571535|NCT01277211|8894465|P1|Overall Study|Non-compliance with protocol|13
2571536|NCT01277211|8894464|P2|Overall Study|Withdrew Consent|9
2571537|NCT01277211|8894465|P1|Overall Study|Withdrew Consent|9
2571538|NCT01277211|8894464|P2|Overall Study|Did not wish to continue|0
2571539|NCT01277211|8894465|P1|Overall Study|Did not wish to continue|17
2571540|NCT01277211|8894464|P2|Overall Study|Lost to Follow-up|9
2571541|NCT01277211|8894465|P1|Overall Study|Lost to Follow-up|14
2571542|NCT01277211|8894464|P2|Overall Study|Pregnancy|4
2571543|NCT01277211|8894465|P1|Overall Study|Pregnancy|9
2571544|NCT01277211|8894464|P2|Overall Study|Adverse Event|22
2571545|NCT01277211|8894465|P1|Overall Study|Adverse Event|60
2571546|NCT01277042|8894517|P2|Overall Study|Withdrawal by Subject|0
2571547|NCT01277042|8894518|P1|Overall Study|Withdrawal by Subject|2
2571548|NCT01277042|8894517|P2|Overall Study|Lost to Follow-up|2
2571549|NCT01277042|8894518|P1|Overall Study|Lost to Follow-up|2
2571550|NCT01277042|8894517|P2|Overall Study|Adverse Event|3
2571551|NCT01277042|8894518|P1|Overall Study|Adverse Event|4
2571552|NCT01276847|8894543|P3|Overall Study|Withdrawal by Subject|0
2571553|NCT01276847|8894544|P2|Overall Study|Withdrawal by Subject|0
2571554|NCT01276847|8894545|P1|Overall Study|Withdrawal by Subject|1
2571555|NCT01276821|8894555|P2|Overall Study|Protocol Violation|1
2571556|NCT01276821|8894556|P1|Overall Study|Protocol Violation|0
2571557|NCT01276756|8894576|P2|Overall Study|Adverse Event|2
2571558|NCT01276756|8894577|P1|Overall Study|Adverse Event|3
2571559|NCT01276756|8894576|P2|Overall Study|Lost to Follow-up|0
2571560|NCT01276756|8894577|P1|Overall Study|Lost to Follow-up|2
2571561|NCT01276639|8894622|P5|Week 16 to 52|Other|3
2571562|NCT01276639|8894623|P4|Week 16 to 52|Other|1
2571563|NCT01276639|8894624|P3|Week 16 to 52|Other|0
2571564|NCT01276639|8894625|P2|Week 16 to 52|Other|12
2571565|NCT01276639|8894626|P1|Week 16 to 52|Other|10
2571566|NCT01276639|8894622|P5|Week 16 to 52|Withdrawal by Subject|1
2571567|NCT01276639|8894623|P4|Week 16 to 52|Withdrawal by Subject|0
2571568|NCT01276639|8894624|P3|Week 16 to 52|Withdrawal by Subject|0
2571569|NCT01276639|8894625|P2|Week 16 to 52|Withdrawal by Subject|4
2571570|NCT01276639|8894626|P1|Week 16 to 52|Withdrawal by Subject|4
2571571|NCT01276639|8894622|P5|Week 16 to 52|Lost to Follow-up|1
2571572|NCT01276639|8894623|P4|Week 16 to 52|Lost to Follow-up|0
2571573|NCT01276639|8894624|P3|Week 16 to 52|Lost to Follow-up|0
2571574|NCT01276639|8894625|P2|Week 16 to 52|Lost to Follow-up|1
2571575|NCT01276639|8894626|P1|Week 16 to 52|Lost to Follow-up|3
2571576|NCT01276639|8894622|P5|Week 16 to 52|Lack of Efficacy|13
2571577|NCT01276639|8894623|P4|Week 16 to 52|Lack of Efficacy|14
2571578|NCT01276639|8894624|P3|Week 16 to 52|Lack of Efficacy|0
2571579|NCT01276639|8894625|P2|Week 16 to 52|Lack of Efficacy|71
2571580|NCT01276639|8894626|P1|Week 16 to 52|Lack of Efficacy|99
2571581|NCT01276639|8894622|P5|Week 16 to 52|Adverse Event|3
2571582|NCT01276639|8894623|P4|Week 16 to 52|Adverse Event|1
2571583|NCT01276639|8894624|P3|Week 16 to 52|Adverse Event|0
2571584|NCT01276639|8894625|P2|Week 16 to 52|Adverse Event|13
2571585|NCT01276639|8894626|P1|Week 16 to 52|Adverse Event|10
2571586|NCT01276639|8894622|P5|Week 16 to 52|Death|0
2571587|NCT01276639|8894623|P4|Week 16 to 52|Death|0
2571588|NCT01276639|8894624|P3|Week 16 to 52|Death|0
2571589|NCT01276639|8894625|P2|Week 16 to 52|Death|0
2571590|NCT01276639|8894626|P1|Week 16 to 52|Death|1
2571591|NCT01276639|8894622|P5|Week 0 to 16|Randomized, But Not Treated|0
2571592|NCT01276639|8894623|P4|Week 0 to 16|Randomized, But Not Treated|0
2571593|NCT01276639|8894624|P3|Week 0 to 16|Randomized, But Not Treated|0
2571594|NCT01276639|8894625|P2|Week 0 to 16|Randomized, But Not Treated|1
2571595|NCT01276639|8894626|P1|Week 0 to 16|Randomized, But Not Treated|0
2571596|NCT01276639|8894622|P5|Week 0 to 16|Other|0
2571597|NCT01276639|8894623|P4|Week 0 to 16|Other|0
2571598|NCT01276639|8894624|P3|Week 0 to 16|Other|2
2571599|NCT01276639|8894625|P2|Week 0 to 16|Other|7
2571600|NCT01276639|8894626|P1|Week 0 to 16|Other|7
2571601|NCT01276639|8894622|P5|Week 0 to 16|Withdrawal by Subject|0
2571602|NCT01276639|8894623|P4|Week 0 to 16|Withdrawal by Subject|0
2571603|NCT01276639|8894624|P3|Week 0 to 16|Withdrawal by Subject|4
2571604|NCT01276639|8894625|P2|Week 0 to 16|Withdrawal by Subject|5
2571605|NCT01276639|8894626|P1|Week 0 to 16|Withdrawal by Subject|8
2571606|NCT01276639|8894622|P5|Week 0 to 16|Lost to Follow-up|0
2571607|NCT01276639|8894623|P4|Week 0 to 16|Lost to Follow-up|0
2571608|NCT01276639|8894624|P3|Week 0 to 16|Lost to Follow-up|3
2571609|NCT01276639|8894625|P2|Week 0 to 16|Lost to Follow-up|5
2571610|NCT01276639|8894626|P1|Week 0 to 16|Lost to Follow-up|3
2571611|NCT01276639|8894622|P5|Week 0 to 16|Lack of Efficacy|0
2571612|NCT01276639|8894623|P4|Week 0 to 16|Lack of Efficacy|0
2571613|NCT01276639|8894624|P3|Week 0 to 16|Lack of Efficacy|25
2571614|NCT01276639|8894625|P2|Week 0 to 16|Lack of Efficacy|15
2571615|NCT01276639|8894626|P1|Week 0 to 16|Lack of Efficacy|20
2571616|NCT01276639|8894622|P5|Week 0 to 16|Adverse Event|0
2571617|NCT01276639|8894623|P4|Week 0 to 16|Adverse Event|0
2571618|NCT01276639|8894624|P3|Week 0 to 16|Adverse Event|11
2571619|NCT01276639|8894625|P2|Week 0 to 16|Adverse Event|8
2571620|NCT01276639|8894626|P1|Week 0 to 16|Adverse Event|11
2571621|NCT01276639|8894622|P5|Week 0 to 16|Death|0
2571622|NCT01276639|8894623|P4|Week 0 to 16|Death|0
2571623|NCT01276639|8894624|P3|Week 0 to 16|Death|0
2571624|NCT01276639|8894625|P2|Week 0 to 16|Death|0
2571625|NCT01276639|8894626|P1|Week 0 to 16|Death|1
2571626|NCT01276509|8894831|P4|Overall Study|Other|0
2571627|NCT01276509|8894832|P3|Overall Study|Other|0
2571628|NCT01276509|8894833|P2|Overall Study|Other|1
2571629|NCT01276509|8894834|P1|Overall Study|Other|0
2571630|NCT01276509|8894831|P4|Overall Study|Withdrawal by Subject|0
2571631|NCT01276509|8894832|P3|Overall Study|Withdrawal by Subject|0
2571632|NCT01276509|8894833|P2|Overall Study|Withdrawal by Subject|2
2571633|NCT01276509|8894834|P1|Overall Study|Withdrawal by Subject|1
2571634|NCT01276509|8894831|P4|Overall Study|Pregnancy|0
2571635|NCT01276509|8894832|P3|Overall Study|Pregnancy|0
2571636|NCT01276509|8894833|P2|Overall Study|Pregnancy|0
2571637|NCT01276509|8894834|P1|Overall Study|Pregnancy|1
2571638|NCT01276509|8894831|P4|Overall Study|Lack of Efficacy|2
2571639|NCT01276509|8894832|P3|Overall Study|Lack of Efficacy|1
2571640|NCT01276509|8894833|P2|Overall Study|Lack of Efficacy|1
2571641|NCT01276509|8894834|P1|Overall Study|Lack of Efficacy|2
2571642|NCT01276509|8894831|P4|Overall Study|Adverse Event|3
2571643|NCT01276509|8894832|P3|Overall Study|Adverse Event|4
2571644|NCT01276509|8894833|P2|Overall Study|Adverse Event|8
2571645|NCT01276509|8894834|P1|Overall Study|Adverse Event|9
2571646|NCT01276457|8894887|P2|Extension Study|Lack of Efficacy|1
2571647|NCT01276457|8894888|P1|Extension Study|Lack of Efficacy|3
2571648|NCT01276457|8894887|P2|Extension Study|Death|1
2571649|NCT01276457|8894888|P1|Extension Study|Death|0
2571650|NCT01276457|8894887|P2|Extension Study|Lost to Follow-up|0
2571651|NCT01276457|8894888|P1|Extension Study|Lost to Follow-up|3
2571652|NCT01276457|8894887|P2|Core Study|Lack of Efficacy|12
2571653|NCT01276457|8894888|P1|Core Study|Lack of Efficacy|3
2571654|NCT01276457|8894887|P2|Core Study|Death|2
2571655|NCT01276457|8894888|P1|Core Study|Death|2
2571656|NCT01276457|8894887|P2|Core Study|Administrative problems|1
2571657|NCT01276457|8894888|P1|Core Study|Administrative problems|1
2571658|NCT01276457|8894887|P2|Core Study|Lost to Follow-up|2
2571659|NCT01276457|8894888|P1|Core Study|Lost to Follow-up|1
2571660|NCT01276457|8894887|P2|Core Study|Adverse Event|3
2571661|NCT01276457|8894888|P1|Core Study|Adverse Event|6
2571662|NCT01276353|8894902|P2|Extension|Prohibited concomitant medications|1
2571663|NCT01276353|8894903|P1|Extension|Prohibited concomitant medications|0
2571664|NCT01276353|8894902|P2|Extension|Physician Decision|0
2571665|NCT01276353|8894903|P1|Extension|Physician Decision|1
2571666|NCT01276353|8894902|P2|Extension|Withdrawal of study drug 4 days in a row|1
2571667|NCT01276353|8894903|P1|Extension|Withdrawal of study drug 4 days in a row|3
2571668|NCT01276353|8894902|P2|Extension|Withdrawal by Subject|2
2571669|NCT01276353|8894903|P1|Extension|Withdrawal by Subject|1
2571670|NCT01276353|8894902|P2|Extension|Adverse Event|5
2571671|NCT01276353|8894903|P1|Extension|Adverse Event|2
2571672|NCT01276353|8894902|P2|Double-blind|Withdrawal by Subject|0
2571673|NCT01276353|8894903|P1|Double-blind|Withdrawal by Subject|1
2571674|NCT01276353|8894902|P2|Double-blind|Adverse Event|0
2571675|NCT01276353|8894903|P1|Double-blind|Adverse Event|2
2571676|NCT01276327|8894915|P2|Overall Study|Withdrawal by Subject|0
2571677|NCT01276327|8894916|P1|Overall Study|Withdrawal by Subject|1
2571678|NCT01276327|8894915|P2|Overall Study|Adverse Event|3
2571679|NCT01276327|8894916|P1|Overall Study|Adverse Event|1
2571680|NCT01276288|8894983|P4|Overall Study|not treated|0
2571681|NCT01276288|8894984|P3|Overall Study|not treated|0
2571682|NCT01276288|8894985|P2|Overall Study|not treated|0
2571683|NCT01276288|8894986|P1|Overall Study|not treated|1
2571684|NCT01276288|8894983|P4|Overall Study|Adverse Event|0
2571685|NCT01276288|8894984|P3|Overall Study|Adverse Event|0
2571686|NCT01276288|8894985|P2|Overall Study|Adverse Event|1
2571687|NCT01276288|8894986|P1|Overall Study|Adverse Event|1
2571688|NCT01276223|8895113|P3|Overall Study|Protocol Violation|0
2571689|NCT01276223|8895114|P2|Overall Study|Protocol Violation|0
2571690|NCT01276223|8895115|P1|Overall Study|Protocol Violation|1
2571691|NCT01276223|8895113|P3|Overall Study|Pt Decision Unrelated to Adverse Event|0
2571692|NCT01276223|8895114|P2|Overall Study|Pt Decision Unrelated to Adverse Event|0
2571693|NCT01276223|8895115|P1|Overall Study|Pt Decision Unrelated to Adverse Event|3
2571694|NCT01276223|8895113|P3|Overall Study|Other|1
2571695|NCT01276223|8895114|P2|Overall Study|Other|0
2571696|NCT01276223|8895115|P1|Overall Study|Other|0
2571697|NCT01276223|8895113|P3|Overall Study|Lost to Follow-up|1
2571698|NCT01276223|8895114|P2|Overall Study|Lost to Follow-up|0
2571699|NCT01276223|8895115|P1|Overall Study|Lost to Follow-up|0
2571700|NCT01276223|8895113|P3|Overall Study|Adverse Event|1
2571701|NCT01276223|8895114|P2|Overall Study|Adverse Event|4
2571702|NCT01276223|8895115|P1|Overall Study|Adverse Event|7
2571703|NCT01276106|8895156|P4|Overall Study|Insufficient therapeutic effects|0
2571704|NCT01276106|8895157|P3|Overall Study|Insufficient therapeutic effects|2
2571705|NCT01276106|8895158|P2|Overall Study|Insufficient therapeutic effects|0
2571706|NCT01276106|8895159|P1|Overall Study|Insufficient therapeutic effects|0
2571707|NCT01276106|8895156|P4|Overall Study|Protocol Violation|2
2571708|NCT01276106|8895157|P3|Overall Study|Protocol Violation|0
2571709|NCT01276106|8895158|P2|Overall Study|Protocol Violation|1
2571710|NCT01276106|8895159|P1|Overall Study|Protocol Violation|1
2571711|NCT01276106|8895156|P4|Overall Study|Physician Decision|1
2571712|NCT01276106|8895157|P3|Overall Study|Physician Decision|1
2571713|NCT01276106|8895158|P2|Overall Study|Physician Decision|0
2571714|NCT01276106|8895159|P1|Overall Study|Physician Decision|0
2571715|NCT01276106|8895156|P4|Overall Study|Lost to Follow-up|0
2571716|NCT01276106|8895157|P3|Overall Study|Lost to Follow-up|1
2571717|NCT01276106|8895158|P2|Overall Study|Lost to Follow-up|1
2571718|NCT01276106|8895159|P1|Overall Study|Lost to Follow-up|2
2571719|NCT01276106|8895156|P4|Overall Study|Lack of Efficacy|1
2571720|NCT01276106|8895157|P3|Overall Study|Lack of Efficacy|0
2571721|NCT01276106|8895158|P2|Overall Study|Lack of Efficacy|1
2571722|NCT01276106|8895159|P1|Overall Study|Lack of Efficacy|0
2571723|NCT01276106|8895156|P4|Overall Study|Withdrawal by Subject|6
2571724|NCT01276106|8895157|P3|Overall Study|Withdrawal by Subject|1
2571725|NCT01276106|8895158|P2|Overall Study|Withdrawal by Subject|3
2571726|NCT01276106|8895159|P1|Overall Study|Withdrawal by Subject|6
2571727|NCT01276106|8895156|P4|Overall Study|Adverse Event|3
2571728|NCT01276106|8895157|P3|Overall Study|Adverse Event|11
2571729|NCT01276106|8895158|P2|Overall Study|Adverse Event|3
2571730|NCT01276106|8895159|P1|Overall Study|Adverse Event|3
2571731|NCT01276054|8895171|P2|Overall Study|No one to oversee trial after P.I. left|2
2571732|NCT01276054|8895172|P1|Overall Study|No one to oversee trial after P.I. left|2
2571733|NCT01275833|8895180|P2|Overall Study|Study terminated|1
2571734|NCT01275833|8895181|P1|Overall Study|Study terminated|1
2571735|NCT01275755|8895189|P2|Run-out Placebo Period|Lost to Follow-up|0
2571736|NCT01275755|8895190|P1|Run-out Placebo Period|Lost to Follow-up|1
2571737|NCT01275755|8895189|P2|Double-blind Treatment Period|Withdrawal by Subject|0
2571738|NCT01275755|8895190|P1|Double-blind Treatment Period|Withdrawal by Subject|1
2571739|NCT01275755|8895189|P2|Double-blind Treatment Period|Lost to Follow-up|1
2571740|NCT01275755|8895190|P1|Double-blind Treatment Period|Lost to Follow-up|1
2571741|NCT01275755|8895189|P2|Double-blind Treatment Period|Adverse Event|2
2571742|NCT01275755|8895190|P1|Double-blind Treatment Period|Adverse Event|0
2571743|NCT01275625|8895204|P1|Overall Study|Other|1
2571744|NCT01275625|8895204|P1|Overall Study|Adverse Event|4
2571745|NCT01275625|8895204|P1|Overall Study|Protocol Violation|1
2571746|NCT01275625|8895204|P1|Overall Study|Withdrawal by Subject|3
2571747|NCT01275625|8895204|P1|Overall Study|Lost to Follow-up|1
2571748|NCT01275625|8895204|P1|Overall Study|Lack of Efficacy|2
2571749|NCT01275625|8895204|P1|Overall Study|Death|1
2571750|NCT01275430|8895222|P1|Overall Study|Inability to achieve maximum p-wave|1
2571751|NCT01275430|8895222|P1|Overall Study|Device Malfunction|1
2571752|NCT01275430|8895222|P1|Overall Study|No Contrast Injection|6
2571753|NCT01275430|8895222|P1|Overall Study|Adverse Event|1
2571754|NCT01275339|8895287|P4|Overall Study|Withdrawal by Subject|0
2571755|NCT01275339|8895288|P3|Overall Study|Withdrawal by Subject|1
2571756|NCT01275339|8895289|P2|Overall Study|Withdrawal by Subject|0
2571757|NCT01275339|8895290|P1|Overall Study|Withdrawal by Subject|0
2571758|NCT01275339|8895287|P4|Overall Study|Referred for surgery for AS symptoms|0
2571759|NCT01275339|8895288|P3|Overall Study|Referred for surgery for AS symptoms|0
2571760|NCT01275339|8895289|P2|Overall Study|Referred for surgery for AS symptoms|0
2571761|NCT01275339|8895290|P1|Overall Study|Referred for surgery for AS symptoms|1
2571762|NCT01275196|8895311|P2|Overall Study|Suboptimal response/treatment failure|6
2571763|NCT01275196|8895312|P1|Overall Study|Suboptimal response/treatment failure|5
2571764|NCT01275196|8895311|P2|Overall Study|Protocol Violation|0
2571765|NCT01275196|8895312|P1|Overall Study|Protocol Violation|1
2571766|NCT01275196|8895311|P2|Overall Study|Disease Progression|5
2571767|NCT01275196|8895312|P1|Overall Study|Disease Progression|6
2571768|NCT01275196|8895311|P2|Overall Study|Lost to Follow-up|0
2571769|NCT01275196|8895312|P1|Overall Study|Lost to Follow-up|1
2571770|NCT01275196|8895311|P2|Overall Study|Withdrawal by Subject|5
2571771|NCT01275196|8895312|P1|Overall Study|Withdrawal by Subject|4
2571772|NCT01275196|8895311|P2|Overall Study|Adverse Event|5
2571773|NCT01275196|8895312|P1|Overall Study|Adverse Event|3
2571774|NCT01275170|8895359|P8|Part 1: Period 1|Equipment malfunction before study drug|0
2571775|NCT01275170|8895360|P7|Part 1: Period 1|Equipment malfunction before study drug|0
2571776|NCT01275170|8895361|P6|Part 1: Period 1|Equipment malfunction before study drug|0
2571777|NCT01275170|8895362|P5|Part 1: Period 1|Equipment malfunction before study drug|0
2571778|NCT01275170|8895363|P4|Part 1: Period 1|Equipment malfunction before study drug|0
2571779|NCT01275170|8895364|P3|Part 1: Period 1|Equipment malfunction before study drug|0
2571780|NCT01275170|8895365|P2|Part 1: Period 1|Equipment malfunction before study drug|0
2571781|NCT01275170|8895366|P1|Part 1: Period 1|Equipment malfunction before study drug|1
2571782|NCT01275144|8895584|P2|Second Intervention (6 Days)|Withdrawal by Subject|0
2571783|NCT01275144|8895585|P1|Second Intervention (6 Days)|Withdrawal by Subject|1
2571784|NCT01275131|8895643|P4|Period 2 (Crossover)|Withdrawal by Subject|2
2571785|NCT01275131|8895644|P3|Period 2 (Crossover)|Withdrawal by Subject|1
2571786|NCT01275131|8895645|P2|Period 2 (Crossover)|Withdrawal by Subject|0
2571787|NCT01275131|8895646|P1|Period 2 (Crossover)|Withdrawal by Subject|1
2571788|NCT01275131|8895643|P4|Period 2 (Crossover)|Adverse Event|0
2571789|NCT01275131|8895644|P3|Period 2 (Crossover)|Adverse Event|0
2571790|NCT01275131|8895645|P2|Period 2 (Crossover)|Adverse Event|1
2571791|NCT01275131|8895646|P1|Period 2 (Crossover)|Adverse Event|0
2571792|NCT01275131|8895643|P4|Period 1|Physician Decision|0
2571793|NCT01275131|8895644|P3|Period 1|Physician Decision|0
2571794|NCT01275131|8895645|P2|Period 1|Physician Decision|0
2571795|NCT01275131|8895646|P1|Period 1|Physician Decision|1
2571796|NCT01275131|8895643|P4|Period 1|Withdrawal by Subject|2
2571797|NCT01275131|8895644|P3|Period 1|Withdrawal by Subject|3
2571798|NCT01275131|8895645|P2|Period 1|Withdrawal by Subject|0
2571799|NCT01275131|8895646|P1|Period 1|Withdrawal by Subject|1
2571800|NCT01275066|8895689|P3|Overall Study|Not Diagnosed w/ Disease|0
2571801|NCT01275066|8895690|P2|Overall Study|Not Diagnosed w/ Disease|0
2571802|NCT01275066|8895691|P1|Overall Study|Not Diagnosed w/ Disease|1
2571803|NCT01275066|8895689|P3|Overall Study|Withdrawal by Subject|1
2571804|NCT01275066|8895690|P2|Overall Study|Withdrawal by Subject|0
2571805|NCT01275066|8895691|P1|Overall Study|Withdrawal by Subject|0
2571806|NCT01274715|8895724|P1|Overall Study|After consent, met exclusion criteria.|1
2571807|NCT01274715|8895724|P1|Overall Study|After consent, met exclusion criteria.|1
2571808|NCT01274715|8895724|P1|Overall Study|After consent, met exclusion criteria.|1
2571809|NCT01274715|8895724|P1|Overall Study|Lost to Follow-up|1
2571810|NCT01274637|8895731|P2|Overall Study|Lost to Follow-up|1
2571811|NCT01274637|8895732|P1|Overall Study|Lost to Follow-up|0
2571812|NCT01274637|8895731|P2|Overall Study|Withdrawal by Subject|1
2571813|NCT01274637|8895732|P1|Overall Study|Withdrawal by Subject|0
2571814|NCT01274559|8895771|P2|Overall Study|Withdrawal by Subject|13
2571815|NCT01274559|8895772|P1|Overall Study|Withdrawal by Subject|25
2571816|NCT01274559|8895771|P2|Overall Study|Study Terminated by Sponsor|87
2571817|NCT01274559|8895772|P1|Overall Study|Study Terminated by Sponsor|79
2571818|NCT01274559|8895771|P2|Overall Study|Protocol Violation|23
2571819|NCT01274559|8895772|P1|Overall Study|Protocol Violation|28
2571820|NCT01274559|8895771|P2|Overall Study|Physician Decision|1
2571821|NCT01274559|8895772|P1|Overall Study|Physician Decision|2
2571822|NCT01274559|8895771|P2|Overall Study|Non-compliance with Study Drug|4
2571823|NCT01274559|8895772|P1|Overall Study|Non-compliance with Study Drug|2
2571824|NCT01274559|8895771|P2|Overall Study|Lost to Follow-up|3
2571825|NCT01274559|8895772|P1|Overall Study|Lost to Follow-up|3
2571826|NCT01274559|8895771|P2|Overall Study|Death|1
2571827|NCT01274559|8895772|P1|Overall Study|Death|1
2571828|NCT01274559|8895771|P2|Overall Study|Adverse Event|13
2571829|NCT01274559|8895772|P1|Overall Study|Adverse Event|57
2571830|NCT01274533|8895822|P1|Overall Study|Disease progression|2
2571831|NCT01274533|8895822|P1|Overall Study|Non-compliance|1
2571832|NCT01274533|8895822|P1|Overall Study|Withdrawal by Subject|1
2571833|NCT01274429|8895827|P1|Overall Study|Study closed do to lack of funding|5
2571834|NCT01274182|8895835|P3|Overall Study|Death|1
2571835|NCT01274182|8895836|P2|Overall Study|Death|0
2571836|NCT01274182|8895837|P1|Overall Study|Death|1
2571837|NCT01274182|8895835|P3|Overall Study|Protocol Violation|0
2571838|NCT01274182|8895836|P2|Overall Study|Protocol Violation|2
2571839|NCT01274182|8895837|P1|Overall Study|Protocol Violation|3
2571840|NCT01274182|8895835|P3|Overall Study|Lost to Follow-up|1
2571841|NCT01274182|8895836|P2|Overall Study|Lost to Follow-up|3
2571842|NCT01274182|8895837|P1|Overall Study|Lost to Follow-up|2
2571843|NCT01274182|8895835|P3|Overall Study|Withdrawal by Subject|3
2571844|NCT01274182|8895836|P2|Overall Study|Withdrawal by Subject|5
2571845|NCT01274182|8895837|P1|Overall Study|Withdrawal by Subject|5
2571846|NCT01274182|8895835|P3|Overall Study|Adverse Event|3
2571847|NCT01274182|8895836|P2|Overall Study|Adverse Event|5
2571848|NCT01274182|8895837|P1|Overall Study|Adverse Event|4
2571849|NCT01274182|8895835|P3|Overall Study|Unsatisfactory therapeutic effect|4
2571850|NCT01274182|8895836|P2|Overall Study|Unsatisfactory therapeutic effect|3
2571851|NCT01274182|8895837|P1|Overall Study|Unsatisfactory therapeutic effect|6
2571852|NCT01273883|8895878|P2|Second Intervention|Lack of Efficacy|0
2571853|NCT01273883|8895879|P1|Second Intervention|Lack of Efficacy|1
2571854|NCT01273883|8895878|P2|Second Intervention|Lost to Follow-up|1
2571855|NCT01273883|8895879|P1|Second Intervention|Lost to Follow-up|1
2571856|NCT01273883|8895878|P2|First Intervention|Adverse Event|1
2571857|NCT01273883|8895879|P1|First Intervention|Adverse Event|2
2571858|NCT01273818|8895905|P3|Overall Study|Physician Decision|9
2571859|NCT01273818|8895906|P2|Overall Study|Physician Decision|2
2571860|NCT01273818|8895907|P1|Overall Study|Physician Decision|13
2571861|NCT01273805|8895917|P2|Overall Study|Radiologic PD or Symptom Deterioration|10
2571862|NCT01273805|8895918|P1|Overall Study|Radiologic PD or Symptom Deterioration|10
2571863|NCT01273623|8895949|P1|Overall Study|did not meet IVUS criteria|29
2571864|NCT01273597|8895956|P1|Overall Study|Reason Not Reported|1
2571865|NCT01273597|8895956|P1|Overall Study|Underwent Kidney Transplantation|2
2571866|NCT01273597|8895956|P1|Overall Study|Adverse Event|5
2571867|NCT01273519|8895971|P3|Overall Study|Other|1
2571868|NCT01273519|8895972|P2|Overall Study|Other|1
2571869|NCT01273519|8895973|P1|Overall Study|Other|6
2571870|NCT01273519|8895971|P3|Overall Study|Lack of Efficacy|4
2571871|NCT01273519|8895972|P2|Overall Study|Lack of Efficacy|3
2571872|NCT01273519|8895973|P1|Overall Study|Lack of Efficacy|8
2571873|NCT01273519|8895971|P3|Overall Study|Lost to Follow-up|3
2571874|NCT01273519|8895972|P2|Overall Study|Lost to Follow-up|1
2571875|NCT01273519|8895973|P1|Overall Study|Lost to Follow-up|2
2571876|NCT01273519|8895971|P3|Overall Study|Adverse Event|0
2571877|NCT01273519|8895972|P2|Overall Study|Adverse Event|0
2571878|NCT01273519|8895973|P1|Overall Study|Adverse Event|3
2571879|NCT01273181|8896010|P4|Phase 2, Dose 2|Death during treatment|1
2571880|NCT01273181|8896011|P3|Phase 2, Dose 2|Death during treatment|0
2571881|NCT01273181|8896012|P2|Phase 2, Dose 2|Death during treatment|0
2571882|NCT01273181|8896013|P1|Phase 2, Dose 2|Death during treatment|0
2571883|NCT01273181|8896010|P4|Phase 2, Dose 1|Study termination|0
2571884|NCT01273181|8896011|P3|Phase 2, Dose 1|Study termination|1
2571885|NCT01273181|8896012|P2|Phase 2, Dose 1|Study termination|0
2571886|NCT01273181|8896013|P1|Phase 2, Dose 1|Study termination|0
2571887|NCT01273181|8896010|P4|Phase I, Dose 2|Death during treatment|0
2571888|NCT01273181|8896011|P3|Phase I, Dose 2|Death during treatment|0
2571889|NCT01273181|8896012|P2|Phase I, Dose 2|Death during treatment|1
2571890|NCT01273181|8896013|P1|Phase I, Dose 2|Death during treatment|0
2571891|NCT01273181|8896010|P4|Phase I, Dose 1|Study termination|0
2571892|NCT01273181|8896011|P3|Phase I, Dose 1|Study termination|0
2571893|NCT01273181|8896012|P2|Phase I, Dose 1|Study termination|0
2571894|NCT01273181|8896013|P1|Phase I, Dose 1|Study termination|1
2571895|NCT01273155|8896031|P7|Overall Study|Withdrew during C1/refused further trmt|0
2571896|NCT01273155|8896032|P6|Overall Study|Withdrew during C1/refused further trmt|1
2571897|NCT01273155|8896033|P5|Overall Study|Withdrew during C1/refused further trmt|1
2571898|NCT01273155|8896034|P4|Overall Study|Withdrew during C1/refused further trmt|0
2571899|NCT01273155|8896035|P3|Overall Study|Withdrew during C1/refused further trmt|1
2571900|NCT01273155|8896036|P2|Overall Study|Withdrew during C1/refused further trmt|0
2571901|NCT01273155|8896037|P1|Overall Study|Withdrew during C1/refused further trmt|0
2571902|NCT01273155|8896031|P7|Overall Study|Died during Cycle 1|2
2571903|NCT01273155|8896032|P6|Overall Study|Died during Cycle 1|2
2571904|NCT01273155|8896033|P5|Overall Study|Died during Cycle 1|0
2571905|NCT01273155|8896034|P4|Overall Study|Died during Cycle 1|1
2571906|NCT01273155|8896035|P3|Overall Study|Died during Cycle 1|1
2571907|NCT01273155|8896036|P2|Overall Study|Died during Cycle 1|0
2571908|NCT01273155|8896037|P1|Overall Study|Died during Cycle 1|0
2571909|NCT01273155|8896031|P7|Overall Study|Off study prior to C1/due to toxicity|1
2571910|NCT01273155|8896032|P6|Overall Study|Off study prior to C1/due to toxicity|0
2571911|NCT01273155|8896033|P5|Overall Study|Off study prior to C1/due to toxicity|0
2571912|NCT01273155|8896034|P4|Overall Study|Off study prior to C1/due to toxicity|0
2571913|NCT01273155|8896035|P3|Overall Study|Off study prior to C1/due to toxicity|2
2571914|NCT01273155|8896036|P2|Overall Study|Off study prior to C1/due to toxicity|0
2571915|NCT01273155|8896037|P1|Overall Study|Off study prior to C1/due to toxicity|0
2571916|NCT01273155|8896031|P7|Overall Study|Change in liver function/no longer eval.|0
2571917|NCT01273155|8896032|P6|Overall Study|Change in liver function/no longer eval.|0
2571918|NCT01273155|8896033|P5|Overall Study|Change in liver function/no longer eval.|1
2571919|NCT01273155|8896034|P4|Overall Study|Change in liver function/no longer eval.|0
2571920|NCT01273155|8896035|P3|Overall Study|Change in liver function/no longer eval.|0
2571921|NCT01273155|8896036|P2|Overall Study|Change in liver function/no longer eval.|1
2571922|NCT01273155|8896037|P1|Overall Study|Change in liver function/no longer eval.|0
2571923|NCT01273155|8896031|P7|Overall Study|Off study trmt prior to end of C1/PD|3
2571924|NCT01273155|8896032|P6|Overall Study|Off study trmt prior to end of C1/PD|2
2571925|NCT01273155|8896033|P5|Overall Study|Off study trmt prior to end of C1/PD|0
2571926|NCT01273155|8896034|P4|Overall Study|Off study trmt prior to end of C1/PD|0
2571927|NCT01273155|8896035|P3|Overall Study|Off study trmt prior to end of C1/PD|8
2571928|NCT01273155|8896036|P2|Overall Study|Off study trmt prior to end of C1/PD|3
2571929|NCT01273155|8896037|P1|Overall Study|Off study trmt prior to end of C1/PD|2
2571930|NCT01273064|8896114|P5|Overall Study|Physician Decision|1
2571931|NCT01273064|8896115|P4|Overall Study|Physician Decision|0
2571932|NCT01273064|8896116|P3|Overall Study|Physician Decision|0
2571933|NCT01273064|8896117|P2|Overall Study|Physician Decision|0
2571934|NCT01273064|8896118|P1|Overall Study|Physician Decision|0
2571935|NCT01273064|8896114|P5|Overall Study|Lost to Follow-up|0
2571936|NCT01273064|8896115|P4|Overall Study|Lost to Follow-up|0
2571937|NCT01273064|8896116|P3|Overall Study|Lost to Follow-up|0
2571938|NCT01273064|8896117|P2|Overall Study|Lost to Follow-up|0
2571939|NCT01273064|8896118|P1|Overall Study|Lost to Follow-up|1
2571940|NCT01273064|8896114|P5|Overall Study|Study Termination|8
2571941|NCT01273064|8896115|P4|Overall Study|Study Termination|16
2571942|NCT01273064|8896116|P3|Overall Study|Study Termination|26
2571943|NCT01273064|8896117|P2|Overall Study|Study Termination|27
2571944|NCT01273064|8896118|P1|Overall Study|Study Termination|13
2571945|NCT01273064|8896114|P5|Overall Study|Withdrawal by Subject|0
2571946|NCT01273064|8896115|P4|Overall Study|Withdrawal by Subject|2
2571947|NCT01273064|8896116|P3|Overall Study|Withdrawal by Subject|2
2571948|NCT01273064|8896117|P2|Overall Study|Withdrawal by Subject|2
2571949|NCT01273064|8896118|P1|Overall Study|Withdrawal by Subject|4
2571950|NCT01273064|8896114|P5|Overall Study|Adverse Event|1
2571951|NCT01273064|8896115|P4|Overall Study|Adverse Event|2
2571952|NCT01273064|8896116|P3|Overall Study|Adverse Event|3
2571953|NCT01273064|8896117|P2|Overall Study|Adverse Event|1
2571954|NCT01273064|8896118|P1|Overall Study|Adverse Event|5
2571955|NCT01273038|8896137|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
2571956|NCT01273038|8896138|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
2571957|NCT01273038|8896137|P2|Second Intervention (14 Days)|Adverse Event|1
2571958|NCT01273038|8896138|P1|Second Intervention (14 Days)|Adverse Event|0
2571959|NCT01272947|8896161|P2|Overall Study|Abnormal Laboratory Value|2
2571960|NCT01272947|8896162|P1|Overall Study|Abnormal Laboratory Value|2
2571961|NCT01272934|8896172|P2|Overall Study|Abnormal Laboratory Value|1
2571962|NCT01272934|8896173|P1|Overall Study|Abnormal Laboratory Value|0
2571963|NCT01272934|8896172|P2|Overall Study|Adverse Event|1
2571964|NCT01272934|8896173|P1|Overall Study|Adverse Event|0
2571965|NCT01272921|8896183|P2|Overall Study|Protocol Violation|1
2571966|NCT01272921|8896184|P1|Overall Study|Protocol Violation|2
2571967|NCT01272908|8896192|P1|Re-Treatment Period|Withdrawal by Subject|1
2571968|NCT01272908|8896192|P1|Re-Treatment Period|Lack of Efficacy|3
2571969|NCT01272908|8896192|P1|Re-Treatment Period|Adverse Event|2
2571970|NCT01272908|8896192|P1|Initial Treatment Period|Withdrawal by Subject|1
2571971|NCT01272908|8896192|P1|Initial Treatment Period|Protocol Violation|1
2571972|NCT01272908|8896192|P1|Initial Treatment Period|Lack of Efficacy|5
2571973|NCT01272908|8896192|P1|Initial Treatment Period|Adverse Event|1
2571974|NCT01272869|8896232|P2|Period 2 (14 Days)|Adverse Event|0
2571975|NCT01272869|8896233|P1|Period 2 (14 Days)|Adverse Event|1
2571976|NCT01272804|8896260|P6|Overall Study|Adverse Event|1
2571977|NCT01272804|8896261|P5|Overall Study|Adverse Event|2
2571978|NCT01272804|8896262|P4|Overall Study|Adverse Event|0
2571979|NCT01272804|8896263|P3|Overall Study|Adverse Event|0
2571980|NCT01272804|8896264|P2|Overall Study|Adverse Event|0
2571981|NCT01272804|8896265|P1|Overall Study|Adverse Event|1
2571982|NCT01272661|8896423|P3|Overall Study|lost to followup/case closed/ no birth|72
2571983|NCT01272661|8896424|P2|Overall Study|lost to followup/case closed/ no birth|209
2571984|NCT01272661|8896425|P1|Overall Study|lost to followup/case closed/ no birth|126
2571985|NCT01272635|8896450|P4|Overall Study|Lost to Follow-up|23
2571986|NCT01272635|8896451|P3|Overall Study|Lost to Follow-up|31
2571987|NCT01272635|8896452|P2|Overall Study|Lost to Follow-up|20
2571988|NCT01272635|8896453|P1|Overall Study|Lost to Follow-up|31
2571989|NCT01272232|8896537|P3|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0
2571990|NCT01272232|8896538|P2|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
2571991|NCT01272232|8896539|P1|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
2571992|NCT01272232|8896537|P3|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4
2571993|NCT01272232|8896538|P2|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7
2571994|NCT01272232|8896539|P1|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9
2571995|NCT01272232|8896537|P3|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
2571996|NCT01272232|8896538|P2|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0
2571997|NCT01272232|8896539|P1|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
2571998|NCT01272232|8896537|P3|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
2571999|NCT01272232|8896538|P2|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
2572000|NCT01272232|8896539|P1|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1
2572001|NCT01272232|8896537|P3|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0
2572002|NCT01272232|8896538|P2|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
2572003|NCT01272232|8896539|P1|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
2572004|NCT01272232|8896537|P3|Weeks 0-56|Unclassified|12
2572005|NCT01272232|8896538|P2|Weeks 0-56|Unclassified|7
2572006|NCT01272232|8896539|P1|Weeks 0-56|Unclassified|16
2572007|NCT01272232|8896537|P3|Weeks 0-56|Withdrawal criteria|37
2572008|NCT01272232|8896538|P2|Weeks 0-56|Withdrawal criteria|14
2572009|NCT01272232|8896539|P1|Weeks 0-56|Withdrawal criteria|32
2572010|NCT01272232|8896537|P3|Weeks 0-56|Protocol Violation|13
2572011|NCT01272232|8896538|P2|Weeks 0-56|Protocol Violation|8
2572012|NCT01272232|8896539|P1|Weeks 0-56|Protocol Violation|12
2572013|NCT01272232|8896537|P3|Weeks 0-56|Lack of Efficacy|3
2572014|NCT01272232|8896538|P2|Weeks 0-56|Lack of Efficacy|0
2572015|NCT01272232|8896539|P1|Weeks 0-56|Lack of Efficacy|0
2572016|NCT01272232|8896537|P3|Weeks 0-56|Adverse Event|7
2572017|NCT01272232|8896538|P2|Weeks 0-56|Adverse Event|18
2572018|NCT01272232|8896539|P1|Weeks 0-56|Adverse Event|39
2572019|NCT01272219|8896584|P6|Main + Extension Period: Week 0-172|Unclassified|51
2572020|NCT01272219|8896585|P5|Main + Extension Period: Week 0-172|Unclassified|61
2572021|NCT01272219|8896586|P4|Main + Extension Period: Week 0-172|Unclassified|0
2572022|NCT01272219|8896587|P3|Main + Extension Period: Week 0-172|Unclassified|0
2572023|NCT01272219|8896588|P2|Main + Extension Period: Week 0-172|Unclassified|0
2572024|NCT01272219|8896589|P1|Main + Extension Period: Week 0-172|Unclassified|0
2572025|NCT01272219|8896584|P6|Main + Extension Period: Week 0-172|Missing reason|0
2572026|NCT01272219|8896585|P5|Main + Extension Period: Week 0-172|Missing reason|1
2572027|NCT01272219|8896586|P4|Main + Extension Period: Week 0-172|Missing reason|0
2572028|NCT01272219|8896587|P3|Main + Extension Period: Week 0-172|Missing reason|0
2572029|NCT01272219|8896588|P2|Main + Extension Period: Week 0-172|Missing reason|0
2572030|NCT01272219|8896589|P1|Main + Extension Period: Week 0-172|Missing reason|0
2572031|NCT01272219|8896584|P6|Main + Extension Period: Week 0-172|Withdrawal criteria|256
2572032|NCT01272219|8896585|P5|Main + Extension Period: Week 0-172|Withdrawal criteria|364
2572033|NCT01272219|8896586|P4|Main + Extension Period: Week 0-172|Withdrawal criteria|0
2572034|NCT01272219|8896587|P3|Main + Extension Period: Week 0-172|Withdrawal criteria|0
2572035|NCT01272219|8896588|P2|Main + Extension Period: Week 0-172|Withdrawal criteria|0
2572036|NCT01272219|8896589|P1|Main + Extension Period: Week 0-172|Withdrawal criteria|0
2572037|NCT01272219|8896584|P6|Main + Extension Period: Week 0-172|Protocol Violation|36
2572038|NCT01272219|8896585|P5|Main + Extension Period: Week 0-172|Protocol Violation|76
2572039|NCT01272219|8896586|P4|Main + Extension Period: Week 0-172|Protocol Violation|0
2572040|NCT01272219|8896587|P3|Main + Extension Period: Week 0-172|Protocol Violation|0
2572041|NCT01272219|8896588|P2|Main + Extension Period: Week 0-172|Protocol Violation|0
2572042|NCT01272219|8896589|P1|Main + Extension Period: Week 0-172|Protocol Violation|0
2572043|NCT01272219|8896584|P6|Main + Extension Period: Week 0-172|Lack of Efficacy|36
2572044|NCT01272219|8896585|P5|Main + Extension Period: Week 0-172|Lack of Efficacy|29
2572045|NCT01272219|8896586|P4|Main + Extension Period: Week 0-172|Lack of Efficacy|0
2572046|NCT01272219|8896587|P3|Main + Extension Period: Week 0-172|Lack of Efficacy|0
2572047|NCT01272219|8896588|P2|Main + Extension Period: Week 0-172|Lack of Efficacy|0
2572048|NCT01272219|8896589|P1|Main + Extension Period: Week 0-172|Lack of Efficacy|0
2572049|NCT01272219|8896584|P6|Main + Extension Period: Week 0-172|Adverse Event|43
2572050|NCT01272219|8896585|P5|Main + Extension Period: Week 0-172|Adverse Event|191
2572051|NCT01272219|8896586|P4|Main + Extension Period: Week 0-172|Adverse Event|0
2572052|NCT01272219|8896587|P3|Main + Extension Period: Week 0-172|Adverse Event|0
2572053|NCT01272219|8896588|P2|Main + Extension Period: Week 0-172|Adverse Event|0
2572054|NCT01272219|8896589|P1|Main + Extension Period: Week 0-172|Adverse Event|0
2572055|NCT01272219|8896584|P6|Re-randomised Period: Week 56 to Week 68|Unclassified|0
2572056|NCT01272219|8896585|P5|Re-randomised Period: Week 56 to Week 68|Unclassified|0
2572057|NCT01272219|8896586|P4|Re-randomised Period: Week 56 to Week 68|Unclassified|2
2572058|NCT01272219|8896587|P3|Re-randomised Period: Week 56 to Week 68|Unclassified|2
2572059|NCT01272219|8896588|P2|Re-randomised Period: Week 56 to Week 68|Unclassified|1
2572060|NCT01272219|8896589|P1|Re-randomised Period: Week 56 to Week 68|Unclassified|0
2572061|NCT01272219|8896584|P6|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
2572062|NCT01272219|8896585|P5|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
2572063|NCT01272219|8896586|P4|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7
2572064|NCT01272219|8896587|P3|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4
2572065|NCT01272219|8896588|P2|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6
2572066|NCT01272219|8896589|P1|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
2572067|NCT01272219|8896584|P6|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
2572068|NCT01272219|8896585|P5|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
2572069|NCT01272219|8896586|P4|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3
2572070|NCT01272219|8896587|P3|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
2572071|NCT01272219|8896588|P2|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1
2572072|NCT01272219|8896589|P1|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
2572073|NCT01272219|8896584|P6|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
2572074|NCT01272219|8896585|P5|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
2572075|NCT01272219|8896586|P4|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1
2572076|NCT01272219|8896587|P3|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
2572077|NCT01272219|8896588|P2|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
2572078|NCT01272219|8896589|P1|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
2572079|NCT01272219|8896584|P6|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
2572080|NCT01272219|8896585|P5|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
2572081|NCT01272219|8896586|P4|Re-randomised Period: Week 56 to Week 68|Adverse Event|2
2572082|NCT01272219|8896587|P3|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
2572083|NCT01272219|8896588|P2|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
2572084|NCT01272219|8896589|P1|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
2572085|NCT01272219|8896584|P6|Main Period: Week 0 to Week 56|Unclassified|34
2572086|NCT01272219|8896585|P5|Main Period: Week 0 to Week 56|Unclassified|42
2572087|NCT01272219|8896586|P4|Main Period: Week 0 to Week 56|Unclassified|29
2572088|NCT01272219|8896587|P3|Main Period: Week 0 to Week 56|Unclassified|0
2572089|NCT01272219|8896588|P2|Main Period: Week 0 to Week 56|Unclassified|0
2572090|NCT01272219|8896589|P1|Main Period: Week 0 to Week 56|Unclassified|36
2572091|NCT01272219|8896584|P6|Main Period: Week 0 to Week 56|Withdrawal criteria|147
2572092|NCT01272219|8896585|P5|Main Period: Week 0 to Week 56|Withdrawal criteria|172
2572093|NCT01272219|8896586|P4|Main Period: Week 0 to Week 56|Withdrawal criteria|114
2572094|NCT01272219|8896587|P3|Main Period: Week 0 to Week 56|Withdrawal criteria|0
2572095|NCT01272219|8896588|P2|Main Period: Week 0 to Week 56|Withdrawal criteria|0
2572096|NCT01272219|8896589|P1|Main Period: Week 0 to Week 56|Withdrawal criteria|122
2572097|NCT01272219|8896584|P6|Main Period: Week 0 to Week 56|Protocol Violation|20
2572098|NCT01272219|8896585|P5|Main Period: Week 0 to Week 56|Protocol Violation|40
2572099|NCT01272219|8896586|P4|Main Period: Week 0 to Week 56|Protocol Violation|18
2572100|NCT01272219|8896587|P3|Main Period: Week 0 to Week 56|Protocol Violation|0
2572101|NCT01272219|8896588|P2|Main Period: Week 0 to Week 56|Protocol Violation|0
2572102|NCT01272219|8896589|P1|Main Period: Week 0 to Week 56|Protocol Violation|25
2572103|NCT01272219|8896584|P6|Main Period: Week 0 to Week 56|Lack of Efficacy|22
2572104|NCT01272219|8896585|P5|Main Period: Week 0 to Week 56|Lack of Efficacy|12
2572105|NCT01272219|8896586|P4|Main Period: Week 0 to Week 56|Lack of Efficacy|14
2572106|NCT01272219|8896587|P3|Main Period: Week 0 to Week 56|Lack of Efficacy|0
2572107|NCT01272219|8896588|P2|Main Period: Week 0 to Week 56|Lack of Efficacy|0
2572108|NCT01272219|8896589|P1|Main Period: Week 0 to Week 56|Lack of Efficacy|11
2572109|NCT01272219|8896584|P6|Main Period: Week 0 to Week 56|Adverse Event|29
2572110|NCT01272219|8896585|P5|Main Period: Week 0 to Week 56|Adverse Event|152
2572111|NCT01272219|8896586|P4|Main Period: Week 0 to Week 56|Adverse Event|16
2572112|NCT01272219|8896587|P3|Main Period: Week 0 to Week 56|Adverse Event|0
2572113|NCT01272219|8896588|P2|Main Period: Week 0 to Week 56|Adverse Event|0
2572114|NCT01272219|8896589|P1|Main Period: Week 0 to Week 56|Adverse Event|86
2572115|NCT01272193|8896623|P2|Overall Study|Unclassified|7
2572116|NCT01272193|8896624|P1|Overall Study|Unclassified|8
2572117|NCT01272193|8896623|P2|Overall Study|Withdrawal Criteria|1
2572118|NCT01272193|8896624|P1|Overall Study|Withdrawal Criteria|1
2572119|NCT01272193|8896623|P2|Overall Study|Lack of Efficacy|3
2572120|NCT01272193|8896624|P1|Overall Study|Lack of Efficacy|0
2572121|NCT01272193|8896623|P2|Overall Study|Adverse Event|1
2572122|NCT01272193|8896624|P1|Overall Study|Adverse Event|1
2572123|NCT01272180|8896644|P4|Overall Study|Protocol Violation|1
2572124|NCT01272180|8896645|P3|Overall Study|Protocol Violation|0
2572125|NCT01272180|8896646|P2|Overall Study|Protocol Violation|1
2572126|NCT01272180|8896647|P1|Overall Study|Protocol Violation|0
2572127|NCT01272180|8896644|P4|Overall Study|Inappropriate enrollment|1
2572128|NCT01272180|8896645|P3|Overall Study|Inappropriate enrollment|1
2572129|NCT01272180|8896646|P2|Overall Study|Inappropriate enrollment|0
2572130|NCT01272180|8896647|P1|Overall Study|Inappropriate enrollment|0
2572131|NCT01272180|8896644|P4|Overall Study|Lost to Follow-up|10
2572132|NCT01272180|8896645|P3|Overall Study|Lost to Follow-up|8
2572133|NCT01272180|8896646|P2|Overall Study|Lost to Follow-up|14
2572134|NCT01272180|8896647|P1|Overall Study|Lost to Follow-up|15
2572135|NCT01272180|8896644|P4|Overall Study|Withdrawal by Subject|2
2572136|NCT01272180|8896645|P3|Overall Study|Withdrawal by Subject|3
2572137|NCT01272180|8896646|P2|Overall Study|Withdrawal by Subject|6
2572138|NCT01272180|8896647|P1|Overall Study|Withdrawal by Subject|2
2572139|NCT01272180|8896644|P4|Overall Study|Adverse Event|0
2572140|NCT01272180|8896645|P3|Overall Study|Adverse Event|1
2572141|NCT01272180|8896646|P2|Overall Study|Adverse Event|0
2572142|NCT01272180|8896647|P1|Overall Study|Adverse Event|0
2572143|NCT01272011|8896696|P3|Overall Study|Withdrawal By Subject or Failed Screen|0
2572144|NCT01272011|8896697|P2|Overall Study|Withdrawal By Subject or Failed Screen|2
2572145|NCT01272011|8896698|P1|Overall Study|Withdrawal By Subject or Failed Screen|0
2572146|NCT01271933|8896734|P3|Double-Blind Phase|Participant request-personal reason|0
2572147|NCT01271933|8896735|P2|Double-Blind Phase|Participant request-personal reason|1
2572148|NCT01271933|8896736|P1|Double-Blind Phase|Participant request-personal reason|0
2572149|NCT01271933|8896734|P3|Double-Blind Phase|Adverse Event|0
2572150|NCT01271933|8896735|P2|Double-Blind Phase|Adverse Event|3
2572151|NCT01271933|8896736|P1|Double-Blind Phase|Adverse Event|0
2572152|NCT01271933|8896734|P3|Double-Blind Phase|Withdrawal by Subject|1
2572153|NCT01271933|8896735|P2|Double-Blind Phase|Withdrawal by Subject|6
2572154|NCT01271933|8896736|P1|Double-Blind Phase|Withdrawal by Subject|0
2572155|NCT01271933|8896734|P3|Double-Blind Phase|Lost to Follow-up|1
2572156|NCT01271933|8896735|P2|Double-Blind Phase|Lost to Follow-up|1
2572157|NCT01271933|8896736|P1|Double-Blind Phase|Lost to Follow-up|0
2572158|NCT01271933|8896734|P3|Double-Blind Phase|Lack of Efficacy|9
2572159|NCT01271933|8896735|P2|Double-Blind Phase|Lack of Efficacy|6
2572160|NCT01271933|8896736|P1|Double-Blind Phase|Lack of Efficacy|0
2572161|NCT01271933|8896734|P3|Double-Blind Phase|Randomized but not treated|1
2572162|NCT01271933|8896735|P2|Double-Blind Phase|Randomized but not treated|0
2572163|NCT01271933|8896736|P1|Double-Blind Phase|Randomized but not treated|0
2572164|NCT01271933|8896734|P3|Single-Blind Phase|(Participant request-personal reason)|0
2572165|NCT01271933|8896735|P2|Single-Blind Phase|(Participant request-personal reason)|0
2572166|NCT01271933|8896736|P1|Single-Blind Phase|(Participant request-personal reason)|1
2572167|NCT01271933|8896734|P3|Single-Blind Phase|(Protocol non-compliance)|0
2572168|NCT01271933|8896735|P2|Single-Blind Phase|(Protocol non-compliance)|0
2572169|NCT01271933|8896736|P1|Single-Blind Phase|(Protocol non-compliance)|2
2572170|NCT01271933|8896734|P3|Single-Blind Phase|(Failed to meet dosing requirement)|0
2572171|NCT01271933|8896735|P2|Single-Blind Phase|(Failed to meet dosing requirement)|0
2572172|NCT01271933|8896736|P1|Single-Blind Phase|(Failed to meet dosing requirement)|1
2572173|NCT01271933|8896734|P3|Single-Blind Phase|Adverse Event|0
2572174|NCT01271933|8896735|P2|Single-Blind Phase|Adverse Event|0
2572175|NCT01271933|8896736|P1|Single-Blind Phase|Adverse Event|52
2572176|NCT01271933|8896734|P3|Single-Blind Phase|Protocol Violation|0
2572177|NCT01271933|8896735|P2|Single-Blind Phase|Protocol Violation|0
2572178|NCT01271933|8896736|P1|Single-Blind Phase|Protocol Violation|3
2572179|NCT01271933|8896734|P3|Single-Blind Phase|Withdrawal by Subject|0
2572180|NCT01271933|8896735|P2|Single-Blind Phase|Withdrawal by Subject|0
2572181|NCT01271933|8896736|P1|Single-Blind Phase|Withdrawal by Subject|15
2572182|NCT01271933|8896734|P3|Single-Blind Phase|Lost to Follow-up|0
2572183|NCT01271933|8896735|P2|Single-Blind Phase|Lost to Follow-up|0
2572184|NCT01271933|8896736|P1|Single-Blind Phase|Lost to Follow-up|10
2572185|NCT01271933|8896734|P3|Single-Blind Phase|Lack of Efficacy|0
2572186|NCT01271933|8896735|P2|Single-Blind Phase|Lack of Efficacy|0
2572187|NCT01271933|8896736|P1|Single-Blind Phase|Lack of Efficacy|37
2572188|NCT01271803|8896879|P3|Overall Study|Lost to Follow-up|0
2572189|NCT01271803|8896880|P2|Overall Study|Lost to Follow-up|0
2572190|NCT01271803|8896881|P1|Overall Study|Lost to Follow-up|1
2572191|NCT01271803|8896879|P3|Overall Study|Withdrawal by Subject|0
2572192|NCT01271803|8896880|P2|Overall Study|Withdrawal by Subject|5
2572193|NCT01271803|8896881|P1|Overall Study|Withdrawal by Subject|1
2572194|NCT01271803|8896879|P3|Overall Study|Death|0
2572195|NCT01271803|8896880|P2|Overall Study|Death|34
2572196|NCT01271803|8896881|P1|Overall Study|Death|53
2572197|NCT01271803|8896879|P3|Overall Study|Progressive disease|2
2572198|NCT01271803|8896880|P2|Overall Study|Progressive disease|0
2572199|NCT01271803|8896881|P1|Overall Study|Progressive disease|0
2572200|NCT01271725|8897043|P2|Part B|Withdrawal by Subject|6
2572201|NCT01271725|8897044|P1|Part B|Withdrawal by Subject|0
2572202|NCT01271725|8897043|P2|Part B|Protocol Violation|1
2572203|NCT01271725|8897044|P1|Part B|Protocol Violation|0
2572204|NCT01271725|8897043|P2|Part B|Other Adverse Event|1
2572205|NCT01271725|8897044|P1|Part B|Other Adverse Event|0
2572206|NCT01271725|8897043|P2|Part B|Clinical signs/symptoms of progression|2
2572207|NCT01271725|8897044|P1|Part B|Clinical signs/symptoms of progression|0
2572208|NCT01271725|8897043|P2|Part B|Other than specified|2
2572209|NCT01271725|8897044|P1|Part B|Other than specified|0
2572210|NCT01271725|8897043|P2|Part A|Protocol Violation|0
2572211|NCT01271725|8897044|P1|Part A|Protocol Violation|1
2572212|NCT01271725|8897043|P2|Part A|Other than specified|0
2572213|NCT01271725|8897044|P1|Part A|Other than specified|3
2572214|NCT01271725|8897043|P2|Part A|Withdrawal by Subject|0
2572215|NCT01271725|8897044|P1|Part A|Withdrawal by Subject|12
2572216|NCT01271725|8897043|P2|Part A|Lost to Follow-up|0
2572217|NCT01271725|8897044|P1|Part A|Lost to Follow-up|1
2572218|NCT01271725|8897043|P2|Part A|Other Adverse Event|0
2572219|NCT01271725|8897044|P1|Part A|Other Adverse Event|8
2572220|NCT01271725|8897043|P2|Part A|Clinical signs/symptoms of progression|0
2572221|NCT01271725|8897044|P1|Part A|Clinical signs/symptoms of progression|2
2572222|NCT01271725|8897043|P2|Part A|Progressive disease according to RECIST|0
2572223|NCT01271725|8897044|P1|Part A|Progressive disease according to RECIST|8
2572224|NCT01271712|8897073|P2|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6
2572225|NCT01271712|8897074|P1|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15
2572226|NCT01271712|8897073|P2|Safety Follow-up|Progressive disease|0
2572227|NCT01271712|8897074|P1|Safety Follow-up|Progressive disease|1
2572228|NCT01271712|8897073|P2|Safety Follow-up|No follow-up|1
2572229|NCT01271712|8897074|P1|Safety Follow-up|No follow-up|1
2572230|NCT01271712|8897073|P2|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4
2572231|NCT01271712|8897074|P1|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3
2572232|NCT01271712|8897073|P2|Safety Follow-up|Protocol Violation|1
2572233|NCT01271712|8897074|P1|Safety Follow-up|Protocol Violation|1
2572234|NCT01271712|8897073|P2|Safety Follow-up|Withdrawal by Subject|2
2572235|NCT01271712|8897074|P1|Safety Follow-up|Withdrawal by Subject|4
2572236|NCT01271712|8897073|P2|Safety Follow-up|Death|7
2572237|NCT01271712|8897074|P1|Safety Follow-up|Death|11
2572238|NCT01271712|8897073|P2|Open Label Treatment|Switching to other therapy|1
2572239|NCT01271712|8897074|P1|Open Label Treatment|Switching to other therapy|2
2572240|NCT01271712|8897073|P2|Open Label Treatment|Protocol Violation|1
2572241|NCT01271712|8897074|P1|Open Label Treatment|Protocol Violation|0
2572242|NCT01271712|8897073|P2|Open Label Treatment|Non-compliance with study drug|0
2572243|NCT01271712|8897074|P1|Open Label Treatment|Non-compliance with study drug|1
2572244|NCT01271712|8897073|P2|Open Label Treatment|transferred to rollover study|0
2572245|NCT01271712|8897074|P1|Open Label Treatment|transferred to rollover study|1
2572246|NCT01271712|8897073|P2|Open Label Treatment|Progressive disease|32
2572247|NCT01271712|8897074|P1|Open Label Treatment|Progressive disease|59
2572248|NCT01271712|8897073|P2|Open Label Treatment|Adverse Event|8
2572249|NCT01271712|8897074|P1|Open Label Treatment|Adverse Event|14
2572250|NCT01271712|8897073|P2|Open Label Treatment|Physician Decision|0
2572251|NCT01271712|8897074|P1|Open Label Treatment|Physician Decision|2
2572252|NCT01271712|8897073|P2|Open Label Treatment|Withdrawal by Subject|11
2572253|NCT01271712|8897074|P1|Open Label Treatment|Withdrawal by Subject|6
2572254|NCT01271712|8897073|P2|Open Label Treatment|Death|5
2572255|NCT01271712|8897074|P1|Open Label Treatment|Death|6
2572256|NCT01271712|8897073|P2|Double Blind Treatment|receive no study drug|0
2572257|NCT01271712|8897074|P1|Double Blind Treatment|receive no study drug|1
2572258|NCT01271712|8897073|P2|Double Blind Treatment|Non compliance with study drug|0
2572259|NCT01271712|8897074|P1|Double Blind Treatment|Non compliance with study drug|2
2572260|NCT01271712|8897073|P2|Double Blind Treatment|Withdrawal by Subject|1
2572261|NCT01271712|8897074|P1|Double Blind Treatment|Withdrawal by Subject|4
2572262|NCT01271712|8897073|P2|Double Blind Treatment|Progressive disease|3
2572263|NCT01271712|8897074|P1|Double Blind Treatment|Progressive disease|23
2572264|NCT01271712|8897073|P2|Double Blind Treatment|Adverse Event|4
2572265|NCT01271712|8897074|P1|Double Blind Treatment|Adverse Event|9
2572266|NCT01271712|8897073|P2|Double Blind Treatment|Lack of Efficacy|0
2572267|NCT01271712|8897074|P1|Double Blind Treatment|Lack of Efficacy|1
2572268|NCT01271712|8897073|P2|Double Blind Treatment|Death|0
2572269|NCT01271712|8897074|P1|Double Blind Treatment|Death|2
2572270|NCT01271010|8897170|P1|Overall Study|Disease progression|27
2572271|NCT01271010|8897170|P1|Overall Study|Withdrawal by Subject|18
2572272|NCT01271010|8897170|P1|Overall Study|Progression and relapse of disease|1
2572273|NCT01271010|8897170|P1|Overall Study|Death|2
2572274|NCT01271010|8897170|P1|Overall Study|Protocol Violation|1
2572275|NCT01271010|8897170|P1|Overall Study|Start of new CLL therapy|1
2572276|NCT01271010|8897170|P1|Overall Study|Reason not specified|11
2572277|NCT01270971|8897185|P2|Overall Study|Non-specific|3
2572278|NCT01270971|8897186|P1|Overall Study|Non-specific|7
2572279|NCT01270971|8897185|P2|Overall Study|Non compliance|2
2572280|NCT01270971|8897186|P1|Overall Study|Non compliance|2
2572281|NCT01270971|8897185|P2|Overall Study|Adverse Event|2
2572282|NCT01270971|8897186|P1|Overall Study|Adverse Event|1
2572283|NCT01270971|8897185|P2|Overall Study|Lost to Follow-up|5
2572284|NCT01270971|8897186|P1|Overall Study|Lost to Follow-up|18
2572285|NCT01270971|8897185|P2|Overall Study|Withdrawal by Subject|11
2572286|NCT01270971|8897186|P1|Overall Study|Withdrawal by Subject|24
2572287|NCT01270958|8897198|P1|Overall Study|Did not meet inclusion criteria for age|2
2572288|NCT01270958|8897198|P1|Overall Study|Lost to Follow-up|2
2572289|NCT01270880|8897227|P1|Overall Study|Never rec'd treatment, but registered.|1
2572290|NCT01270841|8897257|P4|Overall Study|Enrolled in error|0
2572291|NCT01270841|8897258|P3|Overall Study|Enrolled in error|0
2572292|NCT01270841|8897259|P2|Overall Study|Enrolled in error|1
2572293|NCT01270841|8897260|P1|Overall Study|Enrolled in error|0
2572294|NCT01270841|8897257|P4|Overall Study|Protocol Violation|0
2572295|NCT01270841|8897258|P3|Overall Study|Protocol Violation|0
2572296|NCT01270841|8897259|P2|Overall Study|Protocol Violation|5
2572297|NCT01270841|8897260|P1|Overall Study|Protocol Violation|1
2572298|NCT01270841|8897257|P4|Overall Study|Did not qualify|5
2572299|NCT01270841|8897258|P3|Overall Study|Did not qualify|4
2572300|NCT01270841|8897259|P2|Overall Study|Did not qualify|3
2572301|NCT01270841|8897260|P1|Overall Study|Did not qualify|6
2572302|NCT01270841|8897257|P4|Overall Study|Physician Decision|0
2572303|NCT01270841|8897258|P3|Overall Study|Physician Decision|0
2572304|NCT01270841|8897259|P2|Overall Study|Physician Decision|1
2572305|NCT01270841|8897260|P1|Overall Study|Physician Decision|0
2572306|NCT01270841|8897257|P4|Overall Study|Lost to Follow-up|2
2572307|NCT01270841|8897258|P3|Overall Study|Lost to Follow-up|4
2572308|NCT01270841|8897259|P2|Overall Study|Lost to Follow-up|1
2572309|NCT01270841|8897260|P1|Overall Study|Lost to Follow-up|3
2572310|NCT01270841|8897257|P4|Overall Study|Withdrawal by Subject|3
2572311|NCT01270841|8897258|P3|Overall Study|Withdrawal by Subject|3
2572312|NCT01270841|8897259|P2|Overall Study|Withdrawal by Subject|2
2572313|NCT01270841|8897260|P1|Overall Study|Withdrawal by Subject|3
2572314|NCT01270841|8897257|P4|Overall Study|Adverse Event|3
2572315|NCT01270841|8897258|P3|Overall Study|Adverse Event|0
2572316|NCT01270841|8897259|P2|Overall Study|Adverse Event|1
2572317|NCT01270841|8897260|P1|Overall Study|Adverse Event|0
2572318|NCT01270828|8897284|P3|Double Blind Phase|Adverse event related to study drug|0
2572319|NCT01270828|8897285|P2|Double Blind Phase|Adverse event related to study drug|7
2572320|NCT01270828|8897286|P1|Double Blind Phase|Adverse event related to study drug|5
2572321|NCT01270828|8897284|P3|Double Blind Phase|Adverse event not related to study drug|0
2572322|NCT01270828|8897285|P2|Double Blind Phase|Adverse event not related to study drug|1
2572323|NCT01270828|8897286|P1|Double Blind Phase|Adverse event not related to study drug|1
2572324|NCT01270828|8897284|P3|Double Blind Phase|Lack of Efficacy|0
2572325|NCT01270828|8897285|P2|Double Blind Phase|Lack of Efficacy|11
2572326|NCT01270828|8897286|P1|Double Blind Phase|Lack of Efficacy|2
2572327|NCT01270828|8897284|P3|Double Blind Phase|Lost to Follow-up|0
2572328|NCT01270828|8897285|P2|Double Blind Phase|Lost to Follow-up|2
2572329|NCT01270828|8897286|P1|Double Blind Phase|Lost to Follow-up|1
2572330|NCT01270828|8897284|P3|Double Blind Phase|Withdrawal by Subject|0
2572331|NCT01270828|8897285|P2|Double Blind Phase|Withdrawal by Subject|15
2572332|NCT01270828|8897286|P1|Double Blind Phase|Withdrawal by Subject|6
2572333|NCT01270828|8897284|P3|Double Blind Phase|Reason Unspecified|0
2572334|NCT01270828|8897285|P2|Double Blind Phase|Reason Unspecified|4
2572335|NCT01270828|8897286|P1|Double Blind Phase|Reason Unspecified|7
2572336|NCT01270828|8897284|P3|Double Blind Phase|Protocol and GCP non-compliance|0
2572337|NCT01270828|8897285|P2|Double Blind Phase|Protocol and GCP non-compliance|3
2572338|NCT01270828|8897286|P1|Double Blind Phase|Protocol and GCP non-compliance|4
2572339|NCT01270828|8897284|P3|Double Blind Phase|Protocol Violation|0
2572340|NCT01270828|8897285|P2|Double Blind Phase|Protocol Violation|1
2572341|NCT01270828|8897286|P1|Double Blind Phase|Protocol Violation|0
2572342|NCT01270828|8897284|P3|Double Blind Phase|Death|0
2572343|NCT01270828|8897285|P2|Double Blind Phase|Death|1
2572344|NCT01270828|8897286|P1|Double Blind Phase|Death|0
2572345|NCT01270828|8897284|P3|Pregabalin CR SB|Protocol Violation|8
2572346|NCT01270828|8897285|P2|Pregabalin CR SB|Protocol Violation|0
2572347|NCT01270828|8897286|P1|Pregabalin CR SB|Protocol Violation|0
2572348|NCT01270828|8897284|P3|Pregabalin CR SB|Unrelated AE|8
2572349|NCT01270828|8897285|P2|Pregabalin CR SB|Unrelated AE|0
2572350|NCT01270828|8897286|P1|Pregabalin CR SB|Unrelated AE|0
2572351|NCT01270828|8897284|P3|Pregabalin CR SB|Lost to Follow-up|10
2572352|NCT01270828|8897285|P2|Pregabalin CR SB|Lost to Follow-up|0
2572353|NCT01270828|8897286|P1|Pregabalin CR SB|Lost to Follow-up|0
2572354|NCT01270828|8897284|P3|Pregabalin CR SB|Withdrawal by Subject|29
2572355|NCT01270828|8897285|P2|Pregabalin CR SB|Withdrawal by Subject|0
2572356|NCT01270828|8897286|P1|Pregabalin CR SB|Withdrawal by Subject|0
2572357|NCT01270828|8897284|P3|Pregabalin CR SB|Lack of Efficacy|32
2572358|NCT01270828|8897285|P2|Pregabalin CR SB|Lack of Efficacy|0
2572359|NCT01270828|8897286|P1|Pregabalin CR SB|Lack of Efficacy|0
2572360|NCT01270828|8897284|P3|Pregabalin CR SB|Related adverse event|46
2572361|NCT01270828|8897285|P2|Pregabalin CR SB|Related adverse event|0
2572362|NCT01270828|8897286|P1|Pregabalin CR SB|Related adverse event|0
2572363|NCT01270828|8897284|P3|Pregabalin CR SB|Enrolled but not treated|5
2572364|NCT01270828|8897285|P2|Pregabalin CR SB|Enrolled but not treated|0
2572365|NCT01270828|8897286|P1|Pregabalin CR SB|Enrolled but not treated|0
2572366|NCT01270828|8897284|P3|Pregabalin CR SB|Reason Unspecified|8
2572367|NCT01270828|8897285|P2|Pregabalin CR SB|Reason Unspecified|0
2572368|NCT01270828|8897286|P1|Pregabalin CR SB|Reason Unspecified|0
2572369|NCT01270802|8897328|P2|Overall Study|Lost to Follow-up|1
2572370|NCT01270802|8897329|P1|Overall Study|Lost to Follow-up|0
2572371|NCT01270802|8897328|P2|Overall Study|Adverse Event|0
2572372|NCT01270802|8897329|P1|Overall Study|Adverse Event|1
2572373|NCT01270802|8897328|P2|Overall Study|Withdrawal by Subject|0
2572374|NCT01270802|8897329|P1|Overall Study|Withdrawal by Subject|1
2572375|NCT01270620|8897476|P2|Overall Study|Withdrawal by Subject|3
2572376|NCT01270620|8897477|P1|Overall Study|Withdrawal by Subject|1
2572377|NCT01270503|8897572|P1|Overall Study|Lost to Follow-up|1
2572378|NCT01270464|8897580|P3|Overall Study|Other|3
2572379|NCT01270464|8897581|P2|Overall Study|Other|1
2572380|NCT01270464|8897582|P1|Overall Study|Other|1
2572381|NCT01270464|8897580|P3|Overall Study|Lost to Follow-up|1
2572382|NCT01270464|8897581|P2|Overall Study|Lost to Follow-up|3
2572383|NCT01270464|8897582|P1|Overall Study|Lost to Follow-up|2
2572384|NCT01270464|8897580|P3|Overall Study|Withdrawal by Subject|4
2572385|NCT01270464|8897581|P2|Overall Study|Withdrawal by Subject|1
2572386|NCT01270464|8897582|P1|Overall Study|Withdrawal by Subject|2
2572387|NCT01270464|8897580|P3|Overall Study|Adverse Event|7
2572388|NCT01270464|8897581|P2|Overall Study|Adverse Event|1
2572389|NCT01270464|8897582|P1|Overall Study|Adverse Event|9
2572390|NCT01270464|8897580|P3|Overall Study|Lack of Efficacy|1
2572391|NCT01270464|8897581|P2|Overall Study|Lack of Efficacy|3
2572392|NCT01270464|8897582|P1|Overall Study|Lack of Efficacy|2
2572393|NCT01270464|8897580|P3|Overall Study|Protocol Violation|2
2572394|NCT01270464|8897581|P2|Overall Study|Protocol Violation|3
2572395|NCT01270464|8897582|P1|Overall Study|Protocol Violation|4
2572396|NCT01270256|8897631|P2|Overall Study|Withdrawal by Subject|0
2572397|NCT01270256|8897632|P1|Overall Study|Withdrawal by Subject|1
2572398|NCT01270139|8897641|P3|Overall Study|Lost to Follow-up|2
2572399|NCT01270139|8897642|P2|Overall Study|Lost to Follow-up|9
2572400|NCT01270139|8897643|P1|Overall Study|Lost to Follow-up|10
2572401|NCT01270139|8897641|P3|Overall Study|Adverse Event|18
2572402|NCT01270139|8897642|P2|Overall Study|Adverse Event|17
2572403|NCT01270139|8897643|P1|Overall Study|Adverse Event|8
2572404|NCT01269918|8897712|P2|Overall Study|Did not receive study drug|3
2572405|NCT01269918|8897713|P1|Overall Study|Did not receive study drug|0
2572406|NCT01269346|8897788|P1|Extension Phase|Started a prohibited con med|1
2572407|NCT01269346|8897788|P1|Extension Phase|Clinical progression|1
2572408|NCT01269346|8897788|P1|Extension Phase|Physician decision or participant choice|9
2572409|NCT01269346|8897788|P1|Extension Phase|Disease progression|22
2572410|NCT01269346|8897788|P1|Extension Phase|Withdrawal by Subject|4
2572411|NCT01269346|8897788|P1|Extension Phase|Adverse Event|6
2572412|NCT01269346|8897788|P1|Treatment Phase|Other|2
2572413|NCT01269346|8897788|P1|Treatment Phase|Withdrawal by Subject|1
2572414|NCT01269346|8897788|P1|Treatment Phase|Adverse Event|3
2572415|NCT01269346|8897788|P1|Treatment Phase|Disease progression|3
2572416|NCT01269125|8897799|P3|Overall Study|Lost to Follow-up|0
2572417|NCT01269125|8897800|P2|Overall Study|Lost to Follow-up|0
2572418|NCT01269125|8897801|P1|Overall Study|Lost to Follow-up|4
2572419|NCT01269125|8897799|P3|Overall Study|Adverse Event|0
2572420|NCT01269125|8897800|P2|Overall Study|Adverse Event|5
2572421|NCT01269125|8897801|P1|Overall Study|Adverse Event|3
2572422|NCT01268891|8897860|P2|Overall Study|Administrative or other reason(s)|0
2572423|NCT01268891|8897861|P1|Overall Study|Administrative or other reason(s)|1
2572424|NCT01268891|8897860|P2|Overall Study|Withdrawal of Consent|1
2572425|NCT01268891|8897861|P1|Overall Study|Withdrawal of Consent|3
2572426|NCT01268891|8897860|P2|Overall Study|Lack of Efficacy|0
2572427|NCT01268891|8897861|P1|Overall Study|Lack of Efficacy|1
2572428|NCT01268891|8897860|P2|Overall Study|Adverse Event|7
2572429|NCT01268891|8897861|P1|Overall Study|Adverse Event|3
2572430|NCT01268566|8897887|P1|Overall Study|Death|30
2572431|NCT01268566|8897887|P1|Overall Study|Withdrawal by Subject|12
2572432|NCT01268566|8897887|P1|Overall Study|Lost to Follow-up|1
2572433|NCT01268514|8897914|P1|Overall Study|Withdrawal by Surgeon|5
2572434|NCT01268514|8897914|P1|Overall Study|Withdrawal by Subject|3
2572435|NCT01268514|8897914|P1|Overall Study|Lost to Follow-up|5
2572436|NCT01268514|8897914|P1|Overall Study|Death|8
2572437|NCT01268514|8897914|P1|Overall Study|Adverse Event|20
2572438|NCT01268501|8897923|P1|Overall Study|Handling Difficulties|2
2572439|NCT01268501|8897923|P1|Overall Study|Unacceptable Subjective Vision|3
2572440|NCT01268501|8897923|P1|Overall Study|Withdrawal by Subject|3
2572441|NCT01268501|8897923|P1|Overall Study|Lost to Follow-up|1
2572442|NCT01268488|8897927|P1|Overall Study|Physician Decision|2
2572443|NCT01268488|8897927|P1|Overall Study|Adverse Event|3
2572444|NCT01268306|8897934|P1|Overall Study|Lost to Follow-up|1
2572445|NCT01268293|8897938|P1|Overall Study|Subject choice|1
2572446|NCT01268293|8897938|P1|Overall Study|Adverse Event|1
2572447|NCT01268293|8897938|P1|Overall Study|Disease progression|7
2572448|NCT01268267|8897943|P1|Overall Study|Protocol Violation|1
2572449|NCT01268150|8897964|P1|Extension Phase|Other|6
2572450|NCT01268150|8897964|P1|Extension Phase|Disease progression|18
2572451|NCT01268150|8897964|P1|Extension Phase|Adverse Event|3
2572452|NCT01268150|8897964|P1|Treatment Phase|Other|4
2572453|NCT01268150|8897964|P1|Treatment Phase|Withdrawal by Subject|3
2572454|NCT01268150|8897964|P1|Treatment Phase|Adverse Event|3
2572455|NCT01268150|8897964|P1|Treatment Phase|Progression of disease|18
2572456|NCT01268098|8897983|P2|Overall Study|Adverse Event|0
2572457|NCT01268098|8897984|P1|Overall Study|Adverse Event|1
2572458|NCT01268046|8897996|P4|Overall Study|Lost to Follow-up|0
2572459|NCT01268046|8897997|P3|Overall Study|Lost to Follow-up|1
2572460|NCT01268046|8897998|P2|Overall Study|Lost to Follow-up|0
2572461|NCT01268046|8897999|P1|Overall Study|Lost to Follow-up|0
2572462|NCT01268046|8897996|P4|Overall Study|Withdrawal by Subject|1
2572463|NCT01268046|8897997|P3|Overall Study|Withdrawal by Subject|0
2572464|NCT01268046|8897998|P2|Overall Study|Withdrawal by Subject|0
2572465|NCT01268046|8897999|P1|Overall Study|Withdrawal by Subject|1
2572466|NCT01267994|8898009|P1|Overall Study|Adverse Event|2
2572467|NCT01267955|8898014|P1|Stage 2 (6 Months)|Protocol Violation|1
2572468|NCT01267955|8898014|P1|Stage 2 (6 Months)|Death|5
2572469|NCT01267955|8898014|P1|Stage 1 (6 Months)|Death|3
2572470|NCT01267825|8898051|P2|Overall Study|study terminated. no data collected.|0
2572471|NCT01267825|8898052|P1|Overall Study|study terminated. no data collected.|1
2572472|NCT01267266|8898127|P2|Lead-in Phase|Withdrawal by Subject|0
2572473|NCT01267266|8898128|P1|Lead-in Phase|Withdrawal by Subject|1
2572474|NCT01267266|8898127|P2|Lead-in Phase|Adverse Event|0
2572475|NCT01267266|8898128|P1|Lead-in Phase|Adverse Event|2
2572476|NCT01267266|8898127|P2|Lead-in Phase|Lack of Efficacy|0
2572477|NCT01267266|8898128|P1|Lead-in Phase|Lack of Efficacy|20
2572478|NCT01267266|8898127|P2|Enrollment Phase|Withdrawal by Subject|0
2572479|NCT01267266|8898128|P1|Enrollment Phase|Withdrawal by Subject|2
2572480|NCT01267253|8898141|P1|Overall Study|Inevaluable-never received study treatme|2
2572481|NCT01267253|8898141|P1|Overall Study|Ineligible - required test not done|1
2572482|NCT01267201|8898180|P6|Second Intervention Period|Withdrawal by Subject|0
2572483|NCT01267201|8898181|P5|Second Intervention Period|Withdrawal by Subject|0
2572484|NCT01267201|8898182|P4|Second Intervention Period|Withdrawal by Subject|0
2572485|NCT01267201|8898183|P3|Second Intervention Period|Withdrawal by Subject|0
2572486|NCT01267201|8898184|P2|Second Intervention Period|Withdrawal by Subject|1
2572487|NCT01267201|8898185|P1|Second Intervention Period|Withdrawal by Subject|0
2572488|NCT01267201|8898180|P6|First Intervention Period|Withdrawal by Subject|0
2572489|NCT01267201|8898181|P5|First Intervention Period|Withdrawal by Subject|0
2572490|NCT01267201|8898182|P4|First Intervention Period|Withdrawal by Subject|0
2572491|NCT01267201|8898183|P3|First Intervention Period|Withdrawal by Subject|0
2572492|NCT01267201|8898184|P2|First Intervention Period|Withdrawal by Subject|0
2572493|NCT01267201|8898185|P1|First Intervention Period|Withdrawal by Subject|1
2572494|NCT01267175|8898202|P1|Overall Study|Lost to Follow-up|1
2572495|NCT01267175|8898202|P1|Overall Study|Withdrawal by Subject|1
2572496|NCT01266993|8898274|P2|Booster Phase (Month 69)|Withdrawal by Subject|1
2572497|NCT01266993|8898275|P1|Booster Phase (Month 69)|Withdrawal by Subject|0
2572498|NCT01266993|8898274|P2|Booster Phase (Month 69)|Lost to Follow-up|1
2572499|NCT01266993|8898275|P1|Booster Phase (Month 69)|Lost to Follow-up|5
2572500|NCT01266967|8898345|P2|Overall Study|Withdrawal by Subject|3
2572501|NCT01266967|8898346|P1|Overall Study|Withdrawal by Subject|3
2572502|NCT01266967|8898345|P2|Overall Study|Physician Decision|1
2572503|NCT01266967|8898346|P1|Overall Study|Physician Decision|0
2572504|NCT01266967|8898345|P2|Overall Study|Lost to Follow-up|1
2572505|NCT01266967|8898346|P1|Overall Study|Lost to Follow-up|2
2572506|NCT01266967|8898345|P2|Overall Study|Study Closed/Terminated|17
2572507|NCT01266967|8898346|P1|Overall Study|Study Closed/Terminated|15
2572508|NCT01266967|8898345|P2|Overall Study|Death|61
2572509|NCT01266967|8898346|P1|Overall Study|Death|69
2572510|NCT01266876|8898398|P5|Overall Study|Adverse Event|0
2572511|NCT01266876|8898399|P4|Overall Study|Adverse Event|1
2572512|NCT01266876|8898400|P3|Overall Study|Adverse Event|0
2572513|NCT01266876|8898401|P2|Overall Study|Adverse Event|0
2572514|NCT01266876|8898402|P1|Overall Study|Adverse Event|0
2572515|NCT01266850|8898509|P5|Overall Study|Site Closure|0
2572516|NCT01266850|8898510|P4|Overall Study|Site Closure|1
2572517|NCT01266850|8898511|P3|Overall Study|Site Closure|1
2572518|NCT01266850|8898512|P2|Overall Study|Site Closure|1
2572519|NCT01266850|8898513|P1|Overall Study|Site Closure|0
2572520|NCT01266850|8898509|P5|Overall Study|Adverse Event|1
2572521|NCT01266850|8898510|P4|Overall Study|Adverse Event|0
2572522|NCT01266850|8898511|P3|Overall Study|Adverse Event|0
2572523|NCT01266850|8898512|P2|Overall Study|Adverse Event|0
2572524|NCT01266850|8898513|P1|Overall Study|Adverse Event|0
2572525|NCT01266850|8898509|P5|Overall Study|Protocol Violation|2
2572526|NCT01266850|8898510|P4|Overall Study|Protocol Violation|1
2572527|NCT01266850|8898511|P3|Overall Study|Protocol Violation|0
2572528|NCT01266850|8898512|P2|Overall Study|Protocol Violation|1
2572529|NCT01266850|8898513|P1|Overall Study|Protocol Violation|0
2572530|NCT01266850|8898509|P5|Overall Study|Physician Decision|3
2572531|NCT01266850|8898510|P4|Overall Study|Physician Decision|4
2572532|NCT01266850|8898511|P3|Overall Study|Physician Decision|4
2572533|NCT01266850|8898512|P2|Overall Study|Physician Decision|6
2572534|NCT01266850|8898513|P1|Overall Study|Physician Decision|3
2572535|NCT01266850|8898509|P5|Overall Study|Withdrawal by Subject|12
2572536|NCT01266850|8898510|P4|Overall Study|Withdrawal by Subject|9
2572537|NCT01266850|8898511|P3|Overall Study|Withdrawal by Subject|6
2572538|NCT01266850|8898512|P2|Overall Study|Withdrawal by Subject|9
2572539|NCT01266850|8898513|P1|Overall Study|Withdrawal by Subject|8
2572540|NCT01266850|8898509|P5|Overall Study|Lost to Follow-up|12
2572541|NCT01266850|8898510|P4|Overall Study|Lost to Follow-up|13
2572542|NCT01266850|8898511|P3|Overall Study|Lost to Follow-up|13
2572543|NCT01266850|8898512|P2|Overall Study|Lost to Follow-up|19
2572544|NCT01266850|8898513|P1|Overall Study|Lost to Follow-up|19
2572545|NCT01266824|8898567|P2|Overall Study|Study terminated prior to completion|3
2572546|NCT01266824|8898568|P1|Overall Study|Study terminated prior to completion|2
2572547|NCT01266603|8898580|P1|Overall Study|Failed screening; MAGE-A3 negative|26
2572548|NCT01266603|8898580|P1|Overall Study|Withdrawal by Subject|1
2572549|NCT01266603|8898580|P1|Overall Study|Lack of Efficacy|14
2572550|NCT01266603|8898580|P1|Overall Study|Adverse Event|1
2572551|NCT01266590|8898586|P1|Overall Study|Physician Decision|1
2572552|NCT01266590|8898586|P1|Overall Study|Withdrawal by Subject|1
2572553|NCT01266590|8898586|P1|Overall Study|Lost to Follow-up|1
2572554|NCT01266590|8898586|P1|Overall Study|Adverse Event|3
2572555|NCT01266317|8898606|P1|Overall Study|Withdrawal by Subject|2
2572556|NCT01266291|8898611|P1|Overall Study|Adverse Event|1
2572557|NCT01266265|8898618|P2|Overall Study|Clinical worsening|1
2572558|NCT01266265|8898619|P1|Overall Study|Clinical worsening|1
2572559|NCT01266265|8898618|P2|Overall Study|Site closed early|3
2572560|NCT01266265|8898619|P1|Overall Study|Site closed early|4
2572561|NCT01266265|8898618|P2|Overall Study|Lung transplant|5
2572562|NCT01266265|8898619|P1|Overall Study|Lung transplant|6
2572563|NCT01266265|8898618|P2|Overall Study|Non-compliance|5
2572564|NCT01266265|8898619|P1|Overall Study|Non-compliance|8
2572565|NCT01266265|8898618|P2|Overall Study|Enrolled in another clinical study|26
2572566|NCT01266265|8898619|P1|Overall Study|Enrolled in another clinical study|15
2572567|NCT01266265|8898618|P2|Overall Study|Stopped/changed PAH medication(s)|9
2572568|NCT01266265|8898619|P1|Overall Study|Stopped/changed PAH medication(s)|16
2572569|NCT01266265|8898618|P2|Overall Study|Transferred care to another provider|28
2572570|NCT01266265|8898619|P1|Overall Study|Transferred care to another provider|22
2572571|NCT01266265|8898618|P2|Overall Study|Respiratory-related adverse event|1
2572572|NCT01266265|8898619|P1|Overall Study|Respiratory-related adverse event|2
2572573|NCT01266265|8898618|P2|Overall Study|Withdrawal by Subject|11
2572574|NCT01266265|8898619|P1|Overall Study|Withdrawal by Subject|13
2572575|NCT01266265|8898618|P2|Overall Study|Lost to Follow-up|28
2572576|NCT01266265|8898619|P1|Overall Study|Lost to Follow-up|23
2572577|NCT01266265|8898618|P2|Overall Study|Death|73
2572578|NCT01266265|8898619|P1|Overall Study|Death|95
2572579|NCT01266161|8898627|P2|Overall Study|Vomited within 4 hours of dosing|0
2572580|NCT01266161|8898628|P1|Overall Study|Vomited within 4 hours of dosing|3
2572581|NCT01266161|8898627|P2|Overall Study|Lack of Efficacy|1
2572582|NCT01266161|8898628|P1|Overall Study|Lack of Efficacy|0
2572583|NCT01266161|8898627|P2|Overall Study|Ineligible|0
2572584|NCT01266161|8898628|P1|Overall Study|Ineligible|1
2572585|NCT01266148|8898660|P2|Overall Study|missing mGFR value + AE|0
2572586|NCT01266148|8898661|P1|Overall Study|missing mGFR value + AE|1
2572587|NCT01266148|8898660|P2|Overall Study|Death|3
2572588|NCT01266148|8898661|P1|Overall Study|Death|2
2572589|NCT01266148|8898660|P2|Overall Study|2 2R rejections|0
2572590|NCT01266148|8898661|P1|Overall Study|2 2R rejections|1
2572591|NCT01266148|8898660|P2|Overall Study|Ongoing rejection|0
2572592|NCT01266148|8898661|P1|Overall Study|Ongoing rejection|1
2572593|NCT01266148|8898660|P2|Overall Study|Adverse Event|0
2572594|NCT01266148|8898661|P1|Overall Study|Adverse Event|2
2572595|NCT01266122|8898689|P2|Overall Study|Lost to Follow-up|6
2572596|NCT01266122|8898690|P1|Overall Study|Lost to Follow-up|6
2572597|NCT01266070|8898698|P1|Overall Study|Protocol Violation|1
2572598|NCT01266070|8898698|P1|Overall Study|Adverse Event|3
2572599|NCT01266031|8898706|P3|Overall Study|Not treated|2
2572600|NCT01266031|8898707|P2|Overall Study|Not treated|3
2572601|NCT01266031|8898708|P1|Overall Study|Not treated|0
2572602|NCT01266018|8898735|P2|Overall Study|Progressive disease|1
2572603|NCT01266018|8898736|P1|Overall Study|Progressive disease|0
2572604|NCT01266018|8898735|P2|Overall Study|Physician Decision|0
2572605|NCT01266018|8898736|P1|Overall Study|Physician Decision|1
2572606|NCT01265992|8898747|P1|Overall Study|Did not receive treatment|1
2572607|NCT01265992|8898747|P1|Overall Study|Stopped treatment|3
2572608|NCT01265992|8898747|P1|Overall Study|Administrative reasons|2
2572609|NCT01265992|8898747|P1|Overall Study|Adverse Event|1
2572610|NCT01265992|8898747|P1|Overall Study|Withdrawal by Subject|1
2572611|NCT01265992|8898747|P1|Overall Study|Lost to Follow-up|1
2572612|NCT01265953|8898775|P2|Overall Study|Non compliance|3
2572613|NCT01265953|8898776|P1|Overall Study|Non compliance|5
2572614|NCT01265875|8898788|P1|Overall Study|Uncooperative/unreliable|1
2572615|NCT01265823|8898796|P1|Overall Study|Participant Request|1
2572616|NCT01265823|8898796|P1|Overall Study|Protocol Violation|1
2572617|NCT01265823|8898796|P1|Overall Study|Failure to Return|4
2572618|NCT01265823|8898796|P1|Overall Study|Unsatisfactory Response Efficacy|1
2572619|NCT01265797|8898825|P2|Open Label Month|Lost to Follow-up|1
2572620|NCT01265797|8898826|P1|Open Label Month|Lost to Follow-up|0
2572621|NCT01265797|8898825|P2|Blinded Month|Diary data incomplete|1
2572622|NCT01265797|8898826|P1|Blinded Month|Diary data incomplete|0
2572623|NCT01265797|8898825|P2|Blinded Month|Adverse Event|0
2572624|NCT01265797|8898826|P1|Blinded Month|Adverse Event|2
2572625|NCT01265797|8898825|P2|Blinded Month|Protocol Violation|1
2572626|NCT01265797|8898826|P1|Blinded Month|Protocol Violation|2
2572627|NCT01265797|8898825|P2|Blinded Month|Lost to Follow-up|0
2572628|NCT01265797|8898826|P1|Blinded Month|Lost to Follow-up|1
2572629|NCT01265797|8898825|P2|Blinded Month|Lack of Efficacy|0
2572630|NCT01265797|8898826|P1|Blinded Month|Lack of Efficacy|5
2572631|NCT01265797|8898825|P2|Run-in Month|1st seizure during run-in month|1
2572632|NCT01265797|8898826|P1|Run-in Month|1st seizure during run-in month|0
2572633|NCT01265797|8898825|P2|Run-in Month|Withdrawal by Subject|4
2572634|NCT01265797|8898826|P1|Run-in Month|Withdrawal by Subject|0
2572635|NCT01265784|8898857|P3|Overall Study|Incorrectly Randomized|1
2572636|NCT01265784|8898858|P2|Overall Study|Incorrectly Randomized|0
2572637|NCT01265784|8898859|P1|Overall Study|Incorrectly Randomized|0
2572638|NCT01265784|8898857|P3|Overall Study|Protocol Violation|0
2572639|NCT01265784|8898858|P2|Overall Study|Protocol Violation|0
2572640|NCT01265784|8898859|P1|Overall Study|Protocol Violation|2
2572641|NCT01265784|8898857|P3|Overall Study|Death|0
2572642|NCT01265784|8898858|P2|Overall Study|Death|0
2572643|NCT01265784|8898859|P1|Overall Study|Death|3
2572644|NCT01265784|8898857|P3|Overall Study|Adverse Event|0
2572645|NCT01265784|8898858|P2|Overall Study|Adverse Event|0
2572646|NCT01265784|8898859|P1|Overall Study|Adverse Event|1
2572647|NCT01265784|8898857|P3|Overall Study|Physician Decision|1
2572648|NCT01265784|8898858|P2|Overall Study|Physician Decision|0
2572649|NCT01265784|8898859|P1|Overall Study|Physician Decision|1
2572650|NCT01265784|8898857|P3|Overall Study|Withdrawal by Subject|0
2572651|NCT01265784|8898858|P2|Overall Study|Withdrawal by Subject|5
2572652|NCT01265784|8898859|P1|Overall Study|Withdrawal by Subject|0
2572653|NCT01265784|8898857|P3|Overall Study|Lost to Follow-up|2
2572654|NCT01265784|8898858|P2|Overall Study|Lost to Follow-up|3
2572655|NCT01265784|8898859|P1|Overall Study|Lost to Follow-up|5
2572656|NCT01265719|8898927|P2|Overall Study|Adverse Event|0
2572657|NCT01265719|8898928|P1|Overall Study|Adverse Event|2
2572658|NCT01265719|8898927|P2|Overall Study|Lost to Follow-up|7
2572659|NCT01265719|8898928|P1|Overall Study|Lost to Follow-up|2
2572660|NCT01265719|8898927|P2|Overall Study|Withdrawal by Subject|3
2572661|NCT01265719|8898928|P1|Overall Study|Withdrawal by Subject|8
2572662|NCT01265719|8898927|P2|Overall Study|Other reasons|0
2572663|NCT01265719|8898928|P1|Overall Study|Other reasons|2
2572664|NCT01265719|8898927|P2|Overall Study|Does not meet entrance criteria|3
2572665|NCT01265719|8898928|P1|Overall Study|Does not meet entrance criteria|0
2572666|NCT01265615|8898979|P4|Overall Study|Protocol Violation|3
2572667|NCT01265615|8898980|P3|Overall Study|Protocol Violation|4
2572668|NCT01265615|8898981|P2|Overall Study|Protocol Violation|2
2572669|NCT01265615|8898982|P1|Overall Study|Protocol Violation|2
2572670|NCT01265563|8899033|P5|Overall Study|Withdrawal by Subject|2
2572671|NCT01265563|8899034|P4|Overall Study|Withdrawal by Subject|0
2572672|NCT01265563|8899035|P3|Overall Study|Withdrawal by Subject|1
2572673|NCT01265563|8899036|P2|Overall Study|Withdrawal by Subject|1
2572674|NCT01265563|8899037|P1|Overall Study|Withdrawal by Subject|0
2572675|NCT01265550|8899063|P4|Pre Randomization|Functional heartburn|99
2572676|NCT01265550|8899064|P3|Pre Randomization|Functional heartburn|0
2572677|NCT01265550|8899065|P2|Pre Randomization|Functional heartburn|0
2572678|NCT01265550|8899066|P1|Pre Randomization|Functional heartburn|0
2572679|NCT01265550|8899063|P4|Pre Randomization|Non-GERD organic disorders|23
2572680|NCT01265550|8899064|P3|Pre Randomization|Non-GERD organic disorders|0
2572681|NCT01265550|8899065|P2|Pre Randomization|Non-GERD organic disorders|0
2572682|NCT01265550|8899066|P1|Pre Randomization|Non-GERD organic disorders|0
2572683|NCT01265550|8899063|P4|Pre Randomization|GERD, PPI-Responsive|42
2572684|NCT01265550|8899064|P3|Pre Randomization|GERD, PPI-Responsive|0
2572685|NCT01265550|8899065|P2|Pre Randomization|GERD, PPI-Responsive|0
2572686|NCT01265550|8899066|P1|Pre Randomization|GERD, PPI-Responsive|0
2572687|NCT01265550|8899063|P4|Pre Randomization|Technical Exclusions|54
2572688|NCT01265550|8899064|P3|Pre Randomization|Technical Exclusions|0
2572689|NCT01265550|8899065|P2|Pre Randomization|Technical Exclusions|0
2572690|NCT01265550|8899066|P1|Pre Randomization|Technical Exclusions|0
2572691|NCT01265550|8899063|P4|Pre Randomization|Withdrawal by Subject|70
2572692|NCT01265550|8899064|P3|Pre Randomization|Withdrawal by Subject|0
2572693|NCT01265550|8899065|P2|Pre Randomization|Withdrawal by Subject|0
2572694|NCT01265550|8899066|P1|Pre Randomization|Withdrawal by Subject|0
2572695|NCT01265537|8899158|P2|Overall Study|Physician Decision|1
2572696|NCT01265537|8899159|P1|Overall Study|Physician Decision|0
2572697|NCT01265537|8899158|P2|Overall Study|Adverse Event|1
2572698|NCT01265537|8899159|P1|Overall Study|Adverse Event|2
2572699|NCT01265511|8899210|P2|Overall Study|Met stopping rules|2
2572700|NCT01265511|8899211|P1|Overall Study|Met stopping rules|0
2572701|NCT01265511|8899210|P2|Overall Study|Lack of Efficacy|1
2572702|NCT01265511|8899211|P1|Overall Study|Lack of Efficacy|2
2572703|NCT01265498|8899225|P2|Overall Study|Protocol modified to eliminate wk72 bx|33
2572704|NCT01265498|8899226|P1|Overall Study|Protocol modified to eliminate wk72 bx|31
2572705|NCT01265420|8899362|P1|Overall Study|Lost to Follow-up|1
2572706|NCT01265394|8899366|P1|Overall Study|Subjects withdrawn|37
2572707|NCT01265056|8899373|P2|Follow up|Lost to Follow-up|3
2572708|NCT01265056|8899374|P1|Follow up|Lost to Follow-up|7
2572709|NCT01265056|8899373|P2|Initial Study Period|Withdrawal by Subject|1
2572710|NCT01265056|8899374|P1|Initial Study Period|Withdrawal by Subject|1
2572711|NCT01265056|8899373|P2|Initial Study Period|Withdrawal by Subject|1
2572712|NCT01265056|8899374|P1|Initial Study Period|Withdrawal by Subject|1
2572713|NCT01264939|8899405|P2|Overall Study|Disease Progression|11
2572714|NCT01264939|8899406|P1|Overall Study|Disease Progression|8
2572715|NCT01264939|8899405|P2|Overall Study|Patient/Guardian Decision|10
2572716|NCT01264939|8899406|P1|Overall Study|Patient/Guardian Decision|8
2572717|NCT01264939|8899405|P2|Overall Study|Physician Decision|1
2572718|NCT01264939|8899406|P1|Overall Study|Physician Decision|1
2572719|NCT01264939|8899405|P2|Overall Study|Lost to Follow-up|3
2572720|NCT01264939|8899406|P1|Overall Study|Lost to Follow-up|0
2572721|NCT01264939|8899405|P2|Overall Study|Adverse Event|3
2572722|NCT01264939|8899406|P1|Overall Study|Adverse Event|1
2572723|NCT01264887|8899432|P1|Overall Study|Other|2
2572724|NCT01264887|8899432|P1|Overall Study|Sponsor Decision Administrative Reasons|2
2572725|NCT01264887|8899432|P1|Overall Study|Withdrawal by Subject|6
2572726|NCT01264887|8899432|P1|Overall Study|Physician Decision|4
2572727|NCT01264887|8899432|P1|Overall Study|Lack of Efficacy|5
2572728|NCT01264887|8899432|P1|Overall Study|Death|7
2572729|NCT01264887|8899432|P1|Overall Study|Adverse Event|5
2572730|NCT01264835|8899443|P1|Overall Study|Lost to Follow-up|1
2572731|NCT01264770|8899453|P6|Overall Study|Adverse Event|1
2572732|NCT01264770|8899454|P5|Overall Study|Adverse Event|2
2572733|NCT01264770|8899455|P4|Overall Study|Adverse Event|0
2572734|NCT01264770|8899456|P3|Overall Study|Adverse Event|8
2572735|NCT01264770|8899457|P2|Overall Study|Adverse Event|7
2572736|NCT01264770|8899458|P1|Overall Study|Adverse Event|7
2572737|NCT01264770|8899453|P6|Overall Study|Lost to Follow-up|0
2572738|NCT01264770|8899454|P5|Overall Study|Lost to Follow-up|0
2572739|NCT01264770|8899455|P4|Overall Study|Lost to Follow-up|1
2572740|NCT01264770|8899456|P3|Overall Study|Lost to Follow-up|1
2572741|NCT01264770|8899457|P2|Overall Study|Lost to Follow-up|0
2572742|NCT01264770|8899458|P1|Overall Study|Lost to Follow-up|0
2572743|NCT01264770|8899453|P6|Overall Study|Dev. of study specific discont. criteria|1
2572744|NCT01264770|8899454|P5|Overall Study|Dev. of study specific discont. criteria|1
2572745|NCT01264770|8899455|P4|Overall Study|Dev. of study specific discont. criteria|0
2572746|NCT01264770|8899456|P3|Overall Study|Dev. of study specific discont. criteria|0
2572747|NCT01264770|8899457|P2|Overall Study|Dev. of study specific discont. criteria|0
2572748|NCT01264770|8899458|P1|Overall Study|Dev. of study specific discont. criteria|2
2572749|NCT01264770|8899453|P6|Overall Study|Lack of therapeutic response|0
2572750|NCT01264770|8899454|P5|Overall Study|Lack of therapeutic response|1
2572751|NCT01264770|8899455|P4|Overall Study|Lack of therapeutic response|1
2572752|NCT01264770|8899456|P3|Overall Study|Lack of therapeutic response|2
2572753|NCT01264770|8899457|P2|Overall Study|Lack of therapeutic response|0
2572754|NCT01264770|8899458|P1|Overall Study|Lack of therapeutic response|1
2572755|NCT01264770|8899453|P6|Overall Study|Severe non-compliance to protocol|0
2572756|NCT01264770|8899454|P5|Overall Study|Severe non-compliance to protocol|0
2572757|NCT01264770|8899455|P4|Overall Study|Severe non-compliance to protocol|1
2572758|NCT01264770|8899456|P3|Overall Study|Severe non-compliance to protocol|1
2572759|NCT01264770|8899457|P2|Overall Study|Severe non-compliance to protocol|0
2572760|NCT01264770|8899458|P1|Overall Study|Severe non-compliance to protocol|0
2572761|NCT01264770|8899453|P6|Overall Study|e.g., change in circumstances|4
2572762|NCT01264770|8899454|P5|Overall Study|e.g., change in circumstances|4
2572763|NCT01264770|8899455|P4|Overall Study|e.g., change in circumstances|3
2572764|NCT01264770|8899456|P3|Overall Study|e.g., change in circumstances|3
2572765|NCT01264770|8899457|P2|Overall Study|e.g., change in circumstances|3
2572766|NCT01264770|8899458|P1|Overall Study|e.g., change in circumstances|8
2572767|NCT01264770|8899453|P6|Overall Study|Not reported|0
2572768|NCT01264770|8899454|P5|Overall Study|Not reported|0
2572769|NCT01264770|8899455|P4|Overall Study|Not reported|0
2572770|NCT01264770|8899456|P3|Overall Study|Not reported|1
2572771|NCT01264770|8899457|P2|Overall Study|Not reported|0
2572772|NCT01264770|8899458|P1|Overall Study|Not reported|0
2572773|NCT01264718|8899544|P2|Overall Study|Loss of Medicaid/CHIP eligibility|26
2572774|NCT01264718|8899545|P1|Overall Study|Loss of Medicaid/CHIP eligibility|37
2572775|NCT01264718|8899544|P2|Overall Study|Withdrawal by Subject|15
2572776|NCT01264718|8899545|P1|Overall Study|Withdrawal by Subject|9
2572777|NCT01264718|8899544|P2|Overall Study|Lost to Follow-up|2
2572778|NCT01264718|8899545|P1|Overall Study|Lost to Follow-up|3
2572779|NCT01264679|8899557|P1|Overall Study|Withdrawal by Subject|1
2572780|NCT01264679|8899557|P1|Overall Study|Sponsor's Suspension of Dosing|2
2572781|NCT01264679|8899557|P1|Overall Study|Physician Decision|1
2572782|NCT01264679|8899557|P1|Overall Study|Participation in Another Clinical Trial|1
2572783|NCT01264419|8899591|P1|Overall Study|Lost to Follow-up|3
2572784|NCT01264380|8899596|P3|Period C|Adverse Event|1
2572785|NCT01264380|8899597|P2|Period C|Adverse Event|0
2572786|NCT01264380|8899598|P1|Period C|Adverse Event|0
2572787|NCT01264380|8899596|P3|Period C|Withdrawal by Subject|1
2572788|NCT01264380|8899597|P2|Period C|Withdrawal by Subject|0
2572789|NCT01264380|8899598|P1|Period C|Withdrawal by Subject|0
2572790|NCT01264380|8899596|P3|Period C|Follow-up for survival status|6
2572791|NCT01264380|8899597|P2|Period C|Follow-up for survival status|0
2572792|NCT01264380|8899598|P1|Period C|Follow-up for survival status|0
2572793|NCT01264380|8899596|P3|Period C|Death|2
2572794|NCT01264380|8899597|P2|Period C|Death|0
2572795|NCT01264380|8899598|P1|Period C|Death|0
2572796|NCT01264380|8899596|P3|Period C|Disease Progression|4
2572797|NCT01264380|8899597|P2|Period C|Disease Progression|0
2572798|NCT01264380|8899598|P1|Period C|Disease Progression|0
2572799|NCT01264081|8899619|P1|Started Treatment|Not complete cycle 1 due to death|1
2572800|NCT01264081|8899619|P1|Started Treatment|Withdrawal by Subject|1
2572801|NCT01264081|8899619|P1|Participants Screened|Screening failures|30
2572802|NCT01264016|8899624|P1|Overall Study|Felt faint at sight of blood|1
2572803|NCT01264016|8899624|P1|Overall Study|Withdrawal by Subject|1
2572804|NCT01263925|8899639|P2|Overall Study|Withdrawal/ Not specified|1
2572805|NCT01263925|8899640|P1|Overall Study|Withdrawal/ Not specified|0
2572806|NCT01263925|8899639|P2|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2
2572807|NCT01263925|8899640|P1|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1
2572808|NCT01263925|8899639|P2|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
2572809|NCT01263925|8899640|P1|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
2572810|NCT01263925|8899639|P2|Overall Study|AE/ Withdrawal|4
2572811|NCT01263925|8899640|P1|Overall Study|AE/ Withdrawal|1
2572812|NCT01263925|8899639|P2|Overall Study|AE/ Unsatisfactory Compliance|2
2572813|NCT01263925|8899640|P1|Overall Study|AE/ Unsatisfactory Compliance|2
2572814|NCT01263925|8899639|P2|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
2572815|NCT01263925|8899640|P1|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
2572816|NCT01263925|8899639|P2|Overall Study|Lost to Follow-up|1
2572817|NCT01263925|8899640|P1|Overall Study|Lost to Follow-up|3
2572818|NCT01263925|8899639|P2|Overall Study|Other|4
2572819|NCT01263925|8899640|P1|Overall Study|Other|4
2572820|NCT01263925|8899639|P2|Overall Study|Withdrawal by Subject|8
2572821|NCT01263925|8899640|P1|Overall Study|Withdrawal by Subject|6
2572822|NCT01263925|8899639|P2|Overall Study|Unsatisfactory Compliance of Subject|5
2572823|NCT01263925|8899640|P1|Overall Study|Unsatisfactory Compliance of Subject|8
2572824|NCT01263925|8899639|P2|Overall Study|Adverse Event|22
2572825|NCT01263925|8899640|P1|Overall Study|Adverse Event|23
2572826|NCT01263925|8899639|P2|Overall Study|Lack of Efficacy|1
2572827|NCT01263925|8899640|P1|Overall Study|Lack of Efficacy|0
2572828|NCT01263925|8899639|P2|Overall Study|Protocol Violation|0
2572829|NCT01263925|8899640|P1|Overall Study|Protocol Violation|1
2572830|NCT01263873|8899674|P2|Overall Study|One provider unable to complete numbers|1
2572831|NCT01263873|8899675|P1|Overall Study|One provider unable to complete numbers|1
2572832|NCT01263782|8899689|P4|Overall Study|Inevaluable|0
2572833|NCT01263782|8899690|P3|Overall Study|Inevaluable|1
2572834|NCT01263782|8899691|P2|Overall Study|Inevaluable|0
2572835|NCT01263782|8899692|P1|Overall Study|Inevaluable|0
2572836|NCT01263782|8899689|P4|Overall Study|Too early|0
2572837|NCT01263782|8899690|P3|Overall Study|Too early|1
2572838|NCT01263782|8899691|P2|Overall Study|Too early|0
2572839|NCT01263782|8899692|P1|Overall Study|Too early|0
2572840|NCT01263782|8899689|P4|Overall Study|Progressive disease|1
2572841|NCT01263782|8899690|P3|Overall Study|Progressive disease|0
2572842|NCT01263782|8899691|P2|Overall Study|Progressive disease|0
2572843|NCT01263782|8899692|P1|Overall Study|Progressive disease|0
2572844|NCT01263782|8899689|P4|Overall Study|Death|0
2572845|NCT01263782|8899690|P3|Overall Study|Death|1
2572846|NCT01263782|8899691|P2|Overall Study|Death|0
2572847|NCT01263782|8899692|P1|Overall Study|Death|0
2572848|NCT01263704|8899737|P1|Overall Study|Principal Investigator (PI) decision|1
2572849|NCT01263704|8899737|P1|Overall Study|Colon metastases|1
2572850|NCT01263704|8899737|P1|Overall Study|Lost to Follow-up|1
2572851|NCT01263704|8899737|P1|Overall Study|Eligibility criteria not fulfilled|1
2572852|NCT01263704|8899737|P1|Overall Study|Patient withdrew consent|2
2572853|NCT01263704|8899737|P1|Overall Study|Death|2
2572854|NCT01263704|8899737|P1|Overall Study|Adverse Event|3
2572855|NCT01263704|8899737|P1|Overall Study|Progressive disease|18
2572856|NCT01263691|8899752|P6|Overall Study|Adverse Event|0
2572857|NCT01263691|8899753|P5|Overall Study|Adverse Event|0
2572858|NCT01263691|8899754|P4|Overall Study|Adverse Event|0
2572859|NCT01263691|8899755|P3|Overall Study|Adverse Event|0
2572860|NCT01263691|8899756|P2|Overall Study|Adverse Event|0
2572861|NCT01263691|8899757|P1|Overall Study|Adverse Event|1
2572862|NCT01263691|8899752|P6|Overall Study|Withdrawal by Subject|0
2572863|NCT01263691|8899753|P5|Overall Study|Withdrawal by Subject|0
2572864|NCT01263691|8899754|P4|Overall Study|Withdrawal by Subject|0
2572865|NCT01263691|8899755|P3|Overall Study|Withdrawal by Subject|0
2572866|NCT01263691|8899756|P2|Overall Study|Withdrawal by Subject|0
2572867|NCT01263691|8899757|P1|Overall Study|Withdrawal by Subject|1
2572868|NCT01263691|8899752|P6|Overall Study|Lost to Follow-up|0
2572869|NCT01263691|8899753|P5|Overall Study|Lost to Follow-up|0
2572870|NCT01263691|8899754|P4|Overall Study|Lost to Follow-up|1
2572871|NCT01263691|8899755|P3|Overall Study|Lost to Follow-up|1
2572872|NCT01263691|8899756|P2|Overall Study|Lost to Follow-up|0
2572873|NCT01263691|8899757|P1|Overall Study|Lost to Follow-up|1
2572874|NCT01263665|8899867|P1|Overall Study|Surgical Bypass|2
2572875|NCT01263665|8899867|P1|Overall Study|Amputation above the ankle|1
2572876|NCT01263665|8899867|P1|Overall Study|Death|2
2572877|NCT01263665|8899867|P1|Overall Study|Lost to Follow-up|3
2572878|NCT01263665|8899867|P1|Overall Study|Withdrew Consent|1
2572879|NCT01263639|8899874|P2|Overall Study|Exclusion =Admission greater than 7 days|9
2572880|NCT01263639|8899875|P1|Overall Study|Exclusion =Admission greater than 7 days|7
2572881|NCT01263639|8899874|P2|Overall Study|Lost to Follow-up|70
2572882|NCT01263639|8899875|P1|Overall Study|Lost to Follow-up|66
2572883|NCT01263561|8899883|P2|Overall Study|Death|2
2572884|NCT01263561|8899884|P1|Overall Study|Death|1
2572885|NCT01263509|8899896|P4|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1
2572886|NCT01263509|8899897|P3|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
2572887|NCT01263509|8899898|P2|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
2572888|NCT01263509|8899899|P1|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
2572889|NCT01263509|8899896|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
2572890|NCT01263509|8899897|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
2572891|NCT01263509|8899898|P2|Entered - Long-Term Extension Study|Participant Unavailability|1
2572892|NCT01263509|8899899|P1|Entered - Long-Term Extension Study|Participant Unavailability|1
2572893|NCT01263509|8899896|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
2572894|NCT01263509|8899897|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
2572895|NCT01263509|8899898|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
2572896|NCT01263509|8899899|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
2572897|NCT01263509|8899896|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
2572898|NCT01263509|8899897|P3|Entered - Long-Term Extension Study|Lack of Efficacy|1
2572899|NCT01263509|8899898|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
2572900|NCT01263509|8899899|P1|Entered - Long-Term Extension Study|Lack of Efficacy|1
2572901|NCT01263509|8899896|P4|Entered - Long-Term Extension Study|Adverse Event|1
2572902|NCT01263509|8899897|P3|Entered - Long-Term Extension Study|Adverse Event|4
2572903|NCT01263509|8899898|P2|Entered - Long-Term Extension Study|Adverse Event|5
2572904|NCT01263509|8899899|P1|Entered - Long-Term Extension Study|Adverse Event|5
2572905|NCT01263496|8900028|P9|Entered - Long-Term Extension Study|Participant Unavailability|0
2572906|NCT01263496|8900029|P8|Entered - Long-Term Extension Study|Participant Unavailability|1
2572907|NCT01263496|8900030|P7|Entered - Long-Term Extension Study|Participant Unavailability|0
2572908|NCT01263496|8900031|P6|Entered - Long-Term Extension Study|Participant Unavailability|0
2572909|NCT01263496|8900032|P5|Entered - Long-Term Extension Study|Participant Unavailability|0
2572910|NCT01263496|8900033|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
2572911|NCT01263496|8900034|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
2572912|NCT01263496|8900035|P2|Entered - Long-Term Extension Study|Participant Unavailability|0
2572913|NCT01263496|8900036|P1|Entered - Long-Term Extension Study|Participant Unavailability|0
2572914|NCT01263496|8900028|P9|Entered - Long-Term Extension Study|Lack of Efficacy|1
2572915|NCT01263496|8900029|P8|Entered - Long-Term Extension Study|Lack of Efficacy|0
2572916|NCT01263496|8900030|P7|Entered - Long-Term Extension Study|Lack of Efficacy|0
2572917|NCT01263496|8900031|P6|Entered - Long-Term Extension Study|Lack of Efficacy|0
2572918|NCT01263496|8900032|P5|Entered - Long-Term Extension Study|Lack of Efficacy|5
2572919|NCT01263496|8900033|P4|Entered - Long-Term Extension Study|Lack of Efficacy|1
2572920|NCT01263496|8900034|P3|Entered - Long-Term Extension Study|Lack of Efficacy|4
2572921|NCT01263496|8900035|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
2572922|NCT01263496|8900036|P1|Entered - Long-Term Extension Study|Lack of Efficacy|8
2572923|NCT01263496|8900028|P9|Entered - Long-Term Extension Study|Withdrawal by Subject|1
2572924|NCT01263496|8900029|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|0
2572925|NCT01263496|8900030|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|1
2572926|NCT01263496|8900031|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|1
2572927|NCT01263496|8900032|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|4
2572928|NCT01263496|8900033|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|2
2572929|NCT01263496|8900034|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
2572930|NCT01263496|8900035|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
2572931|NCT01263496|8900036|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
2572932|NCT01263496|8900028|P9|Entered - Long-Term Extension Study|Lost to Follow-up|0
2572933|NCT01263496|8900029|P8|Entered - Long-Term Extension Study|Lost to Follow-up|0
2572934|NCT01263496|8900030|P7|Entered - Long-Term Extension Study|Lost to Follow-up|0
2572935|NCT01263496|8900031|P6|Entered - Long-Term Extension Study|Lost to Follow-up|0
2572936|NCT01263496|8900032|P5|Entered - Long-Term Extension Study|Lost to Follow-up|0
2572937|NCT01263496|8900033|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
2572938|NCT01263496|8900034|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
2572939|NCT01263496|8900035|P2|Entered - Long-Term Extension Study|Lost to Follow-up|2
2572940|NCT01263496|8900036|P1|Entered - Long-Term Extension Study|Lost to Follow-up|0
2572941|NCT01263496|8900028|P9|Entered - Long-Term Extension Study|Adverse Event|1
2572942|NCT01263496|8900029|P8|Entered - Long-Term Extension Study|Adverse Event|0
2572943|NCT01263496|8900030|P7|Entered - Long-Term Extension Study|Adverse Event|0
2572944|NCT01263496|8900031|P6|Entered - Long-Term Extension Study|Adverse Event|0
2572945|NCT01263496|8900032|P5|Entered - Long-Term Extension Study|Adverse Event|1
2572946|NCT01263496|8900033|P4|Entered - Long-Term Extension Study|Adverse Event|3
2572947|NCT01263496|8900034|P3|Entered - Long-Term Extension Study|Adverse Event|6
2572948|NCT01263496|8900035|P2|Entered - Long-Term Extension Study|Adverse Event|5
2572949|NCT01263496|8900036|P1|Entered - Long-Term Extension Study|Adverse Event|0
2572950|NCT01263496|8900028|P9|Enrolled - Long-Term Extension Study|Adverse Event|0
2572951|NCT01263496|8900029|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
2572952|NCT01263496|8900030|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
2572953|NCT01263496|8900031|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
2572954|NCT01263496|8900032|P5|Enrolled - Long-Term Extension Study|Adverse Event|2
2572955|NCT01263496|8900033|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
2572956|NCT01263496|8900034|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
2572957|NCT01263496|8900035|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
2572958|NCT01263496|8900036|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
2572959|NCT01263496|8900028|P9|Enrolled - Long-Term Extension Study|Protocol Violation|0
2572960|NCT01263496|8900029|P8|Enrolled - Long-Term Extension Study|Protocol Violation|0
2572961|NCT01263496|8900030|P7|Enrolled - Long-Term Extension Study|Protocol Violation|0
2572962|NCT01263496|8900031|P6|Enrolled - Long-Term Extension Study|Protocol Violation|0
2572963|NCT01263496|8900032|P5|Enrolled - Long-Term Extension Study|Protocol Violation|0
2572964|NCT01263496|8900033|P4|Enrolled - Long-Term Extension Study|Protocol Violation|0
2572965|NCT01263496|8900034|P3|Enrolled - Long-Term Extension Study|Protocol Violation|0
2572966|NCT01263496|8900035|P2|Enrolled - Long-Term Extension Study|Protocol Violation|0
2572967|NCT01263496|8900036|P1|Enrolled - Long-Term Extension Study|Protocol Violation|1
2572968|NCT01263483|8900331|P3|Overall Study|Participant Unavailability|1
2572969|NCT01263483|8900332|P2|Overall Study|Participant Unavailability|1
2572970|NCT01263483|8900333|P1|Overall Study|Participant Unavailability|0
2572971|NCT01263483|8900331|P3|Overall Study|Protocol Violation|1
2572972|NCT01263483|8900332|P2|Overall Study|Protocol Violation|1
2572973|NCT01263483|8900333|P1|Overall Study|Protocol Violation|0
2572974|NCT01263483|8900331|P3|Overall Study|Lack of Efficacy|0
2572975|NCT01263483|8900332|P2|Overall Study|Lack of Efficacy|0
2572976|NCT01263483|8900333|P1|Overall Study|Lack of Efficacy|2
2572977|NCT01263483|8900331|P3|Overall Study|Withdrawal by Subject|0
2572978|NCT01263483|8900332|P2|Overall Study|Withdrawal by Subject|0
2572979|NCT01263483|8900333|P1|Overall Study|Withdrawal by Subject|1
2572980|NCT01263483|8900331|P3|Overall Study|Adverse Event|3
2572981|NCT01263483|8900332|P2|Overall Study|Adverse Event|0
2572982|NCT01263483|8900333|P1|Overall Study|Adverse Event|4
2572983|NCT01263470|8900395|P6|Overall Study|Study Drug Non-compliance|0
2572984|NCT01263470|8900396|P5|Overall Study|Study Drug Non-compliance|1
2572985|NCT01263470|8900397|P4|Overall Study|Study Drug Non-compliance|0
2572986|NCT01263470|8900398|P3|Overall Study|Study Drug Non-compliance|0
2572987|NCT01263470|8900399|P2|Overall Study|Study Drug Non-compliance|0
2572988|NCT01263470|8900400|P1|Overall Study|Study Drug Non-compliance|0
2572989|NCT01263470|8900395|P6|Overall Study|Participant Unavailability|0
2572990|NCT01263470|8900396|P5|Overall Study|Participant Unavailability|0
2572991|NCT01263470|8900397|P4|Overall Study|Participant Unavailability|0
2572992|NCT01263470|8900398|P3|Overall Study|Participant Unavailability|0
2572993|NCT01263470|8900399|P2|Overall Study|Participant Unavailability|1
2572994|NCT01263470|8900400|P1|Overall Study|Participant Unavailability|0
2572995|NCT01263470|8900395|P6|Overall Study|Lack of Efficacy|0
2572996|NCT01263470|8900396|P5|Overall Study|Lack of Efficacy|0
2572997|NCT01263470|8900397|P4|Overall Study|Lack of Efficacy|0
2572998|NCT01263470|8900398|P3|Overall Study|Lack of Efficacy|2
2572999|NCT01263470|8900399|P2|Overall Study|Lack of Efficacy|0
2573000|NCT01263470|8900400|P1|Overall Study|Lack of Efficacy|0
2573001|NCT01263470|8900395|P6|Overall Study|Withdrawal by Subject|2
2573002|NCT01263470|8900396|P5|Overall Study|Withdrawal by Subject|0
2573003|NCT01263470|8900397|P4|Overall Study|Withdrawal by Subject|2
2573004|NCT01263470|8900398|P3|Overall Study|Withdrawal by Subject|1
2573005|NCT01263470|8900399|P2|Overall Study|Withdrawal by Subject|1
2573006|NCT01263470|8900400|P1|Overall Study|Withdrawal by Subject|0
2573007|NCT01263470|8900395|P6|Overall Study|Protocol Violation|1
2573008|NCT01263470|8900396|P5|Overall Study|Protocol Violation|0
2573009|NCT01263470|8900397|P4|Overall Study|Protocol Violation|0
2573010|NCT01263470|8900398|P3|Overall Study|Protocol Violation|0
2573011|NCT01263470|8900399|P2|Overall Study|Protocol Violation|1
2573012|NCT01263470|8900400|P1|Overall Study|Protocol Violation|0
2573013|NCT01263470|8900395|P6|Overall Study|Adverse Event|2
2573014|NCT01263470|8900396|P5|Overall Study|Adverse Event|2
2573015|NCT01263470|8900397|P4|Overall Study|Adverse Event|1
2573016|NCT01263470|8900398|P3|Overall Study|Adverse Event|1
2573017|NCT01263470|8900399|P2|Overall Study|Adverse Event|2
2573018|NCT01263470|8900400|P1|Overall Study|Adverse Event|2
2573019|NCT01263444|8900510|P1|Overall Study|Protocol Violation|1
2573020|NCT01263444|8900510|P1|Overall Study|Withdrawal by Subject|1
2573021|NCT01263444|8900510|P1|Overall Study|Adverse Event|8
2573022|NCT01263223|8900647|P2|7-day Follow-up|Lost to Follow-up|0
2573023|NCT01263223|8900648|P1|7-day Follow-up|Lost to Follow-up|1
2573024|NCT01263223|8900647|P2|7-day Follow-up|Withdrawal by Subject|1
2573025|NCT01263223|8900648|P1|7-day Follow-up|Withdrawal by Subject|0
2573026|NCT01263223|8900647|P2|Period 2|Withdrawal by Subject|1
2573027|NCT01263223|8900648|P1|Period 2|Withdrawal by Subject|0
2573028|NCT01263197|8900671|P6|Third Intervention (Period 3)|Adverse Event|0
2573029|NCT01263197|8900672|P5|Third Intervention (Period 3)|Adverse Event|0
2573030|NCT01263197|8900673|P4|Third Intervention (Period 3)|Adverse Event|0
2573031|NCT01263197|8900674|P3|Third Intervention (Period 3)|Adverse Event|0
2573032|NCT01263197|8900675|P2|Third Intervention (Period 3)|Adverse Event|1
2573033|NCT01263197|8900676|P1|Third Intervention (Period 3)|Adverse Event|0
2573034|NCT01263197|8900671|P6|Washout Period 2|Protocol Violation|0
2573035|NCT01263197|8900672|P5|Washout Period 2|Protocol Violation|0
2573036|NCT01263197|8900673|P4|Washout Period 2|Protocol Violation|1
2573037|NCT01263197|8900674|P3|Washout Period 2|Protocol Violation|0
2573038|NCT01263197|8900675|P2|Washout Period 2|Protocol Violation|0
2573039|NCT01263197|8900676|P1|Washout Period 2|Protocol Violation|0
2573040|NCT01263197|8900671|P6|Washout Period 2|Physician Decision|1
2573041|NCT01263197|8900672|P5|Washout Period 2|Physician Decision|0
2573042|NCT01263197|8900673|P4|Washout Period 2|Physician Decision|0
2573043|NCT01263197|8900674|P3|Washout Period 2|Physician Decision|0
2573044|NCT01263197|8900675|P2|Washout Period 2|Physician Decision|0
2573045|NCT01263197|8900676|P1|Washout Period 2|Physician Decision|0
2573046|NCT01263197|8900671|P6|Washout Period 1|Protocol Violation|0
2573047|NCT01263197|8900672|P5|Washout Period 1|Protocol Violation|1
2573048|NCT01263197|8900673|P4|Washout Period 1|Protocol Violation|0
2573049|NCT01263197|8900674|P3|Washout Period 1|Protocol Violation|0
2573050|NCT01263197|8900675|P2|Washout Period 1|Protocol Violation|0
2573051|NCT01263197|8900676|P1|Washout Period 1|Protocol Violation|0
2573052|NCT01263197|8900671|P6|First Intervention (Period 1)|Adverse Event|1
2573053|NCT01263197|8900672|P5|First Intervention (Period 1)|Adverse Event|0
2573054|NCT01263197|8900673|P4|First Intervention (Period 1)|Adverse Event|0
2573055|NCT01263197|8900674|P3|First Intervention (Period 1)|Adverse Event|0
2573056|NCT01263197|8900675|P2|First Intervention (Period 1)|Adverse Event|0
2573057|NCT01263197|8900676|P1|First Intervention (Period 1)|Adverse Event|0
2573058|NCT01263119|8900719|P1|Period 2|Adverse Event|2
2573059|NCT01263119|8900719|P1|Period 1|Protocol Violation|2
2573060|NCT01263106|8900740|P2|Washout (at Least 7 Days)|Lost to Follow-up|1
2573061|NCT01263106|8900741|P1|Washout (at Least 7 Days)|Lost to Follow-up|1
2573062|NCT01263093|8900756|P2|Period 2|Adverse Event|0
2573063|NCT01263093|8900757|P1|Period 2|Adverse Event|1
2573064|NCT01263093|8900756|P2|Washout|Physician Decision|0
2573065|NCT01263093|8900757|P1|Washout|Physician Decision|1
2573066|NCT01263054|8900774|P2|Overall Study|Other|1
2573067|NCT01263054|8900775|P1|Overall Study|Other|0
2573068|NCT01263054|8900774|P2|Overall Study|Qualification Violation|0
2573069|NCT01263054|8900775|P1|Overall Study|Qualification Violation|1
2573070|NCT01263054|8900774|P2|Overall Study|Withdrawal by Subject|3
2573071|NCT01263054|8900775|P1|Overall Study|Withdrawal by Subject|1
2573072|NCT01263054|8900774|P2|Overall Study|Lost to Follow-up|2
2573073|NCT01263054|8900775|P1|Overall Study|Lost to Follow-up|2
2573074|NCT01263054|8900774|P2|Overall Study|Death|0
2573075|NCT01263054|8900775|P1|Overall Study|Death|1
2573076|NCT01263028|8900793|P1|Overall Study|Study terminated due to low enrollment.|4
2573077|NCT01263028|8900793|P1|Overall Study|Adverse Event|1
2573078|NCT01263028|8900793|P1|Overall Study|Withdrawal by Subject|1
2573079|NCT01263015|8900803|P2|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7
2573080|NCT01263015|8900804|P1|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3
2573081|NCT01263015|8900803|P2|Open-label Phase: 48 Weeks Duration|Physician Decision|2
2573082|NCT01263015|8900804|P1|Open-label Phase: 48 Weeks Duration|Physician Decision|0
2573083|NCT01263015|8900803|P2|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
2573084|NCT01263015|8900804|P1|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
2573085|NCT01263015|8900803|P2|Open-label Phase: 48 Weeks Duration|Protocol Violation|2
2573086|NCT01263015|8900804|P1|Open-label Phase: 48 Weeks Duration|Protocol Violation|3
2573087|NCT01263015|8900803|P2|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2
2573088|NCT01263015|8900804|P1|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7
2573089|NCT01263015|8900803|P2|Open-label Phase: 48 Weeks Duration|Adverse Event|10
2573090|NCT01263015|8900804|P1|Open-label Phase: 48 Weeks Duration|Adverse Event|3
2573091|NCT01263015|8900803|P2|Double-blind Phase: 96 Weeks Duration|Physician Decision|2
2573092|NCT01263015|8900804|P1|Double-blind Phase: 96 Weeks Duration|Physician Decision|1
2573093|NCT01263015|8900803|P2|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15
2573094|NCT01263015|8900804|P1|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9
2573095|NCT01263015|8900803|P2|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18
2573096|NCT01263015|8900804|P1|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17
2573097|NCT01263015|8900803|P2|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12
2573098|NCT01263015|8900804|P1|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14
2573099|NCT01263015|8900803|P2|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14
2573100|NCT01263015|8900804|P1|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18
2573101|NCT01263015|8900803|P2|Double-blind Phase: 96 Weeks Duration|Adverse Event|48
2573102|NCT01263015|8900804|P1|Double-blind Phase: 96 Weeks Duration|Adverse Event|13
2573103|NCT01262989|8900830|P2|Period 2|Intercurrent disease|1
2573104|NCT01262989|8900831|P1|Period 2|Intercurrent disease|0
2573105|NCT01262989|8900830|P2|Period 1|Positive answer for exclusion criteria|1
2573106|NCT01262989|8900831|P1|Period 1|Positive answer for exclusion criteria|0
2573107|NCT01262989|8900830|P2|Period 1|Intercurrent disease|1
2573108|NCT01262989|8900831|P1|Period 1|Intercurrent disease|0
2573109|NCT01262989|8900830|P2|Period 1|Lost to Follow-up|1
2573110|NCT01262989|8900831|P1|Period 1|Lost to Follow-up|1
2573111|NCT01262976|8900847|P6|Up to Year 3|Other|0
2573112|NCT01262976|8900848|P5|Up to Year 3|Other|0
2573113|NCT01262976|8900849|P4|Up to Year 3|Other|0
2573114|NCT01262976|8900850|P3|Up to Year 3|Other|0
2573115|NCT01262976|8900851|P2|Up to Year 3|Other|0
2573116|NCT01262976|8900852|P1|Up to Year 3|Other|3
2573117|NCT01262976|8900847|P6|Up to Year 3|Subjects with unknown completion status|0
2573118|NCT01262976|8900848|P5|Up to Year 3|Subjects with unknown completion status|0
2573119|NCT01262976|8900849|P4|Up to Year 3|Subjects with unknown completion status|0
2573120|NCT01262976|8900850|P3|Up to Year 3|Subjects with unknown completion status|1
2573121|NCT01262976|8900851|P2|Up to Year 3|Subjects with unknown completion status|0
2573122|NCT01262976|8900852|P1|Up to Year 3|Subjects with unknown completion status|0
2573123|NCT01262976|8900847|P6|Up to Year 3|Lost to Follow-up|3
2573124|NCT01262976|8900848|P5|Up to Year 3|Lost to Follow-up|1
2573125|NCT01262976|8900849|P4|Up to Year 3|Lost to Follow-up|3
2573126|NCT01262976|8900850|P3|Up to Year 3|Lost to Follow-up|4
2573127|NCT01262976|8900851|P2|Up to Year 3|Lost to Follow-up|2
2573128|NCT01262976|8900852|P1|Up to Year 3|Lost to Follow-up|2
2573129|NCT01262976|8900847|P6|Up to Year 3|Migrated/moved from study area|1
2573130|NCT01262976|8900848|P5|Up to Year 3|Migrated/moved from study area|1
2573131|NCT01262976|8900849|P4|Up to Year 3|Migrated/moved from study area|2
2573132|NCT01262976|8900850|P3|Up to Year 3|Migrated/moved from study area|0
2573133|NCT01262976|8900851|P2|Up to Year 3|Migrated/moved from study area|0
2573134|NCT01262976|8900852|P1|Up to Year 3|Migrated/moved from study area|0
2573135|NCT01262976|8900847|P6|Up to Year 3|Withdrawal by Subject|0
2573136|NCT01262976|8900848|P5|Up to Year 3|Withdrawal by Subject|0
2573137|NCT01262976|8900849|P4|Up to Year 3|Withdrawal by Subject|0
2573138|NCT01262976|8900850|P3|Up to Year 3|Withdrawal by Subject|0
2573139|NCT01262976|8900851|P2|Up to Year 3|Withdrawal by Subject|0
2573140|NCT01262976|8900852|P1|Up to Year 3|Withdrawal by Subject|1
2573141|NCT01262976|8900847|P6|Up to Year 3|Serious Adverse Event|0
2573142|NCT01262976|8900848|P5|Up to Year 3|Serious Adverse Event|0
2573143|NCT01262976|8900849|P4|Up to Year 3|Serious Adverse Event|0
2573144|NCT01262976|8900850|P3|Up to Year 3|Serious Adverse Event|2
2573145|NCT01262976|8900851|P2|Up to Year 3|Serious Adverse Event|0
2573146|NCT01262976|8900852|P1|Up to Year 3|Serious Adverse Event|0
2573147|NCT01262976|8900847|P6|Up to Year 2|Other|0
2573148|NCT01262976|8900848|P5|Up to Year 2|Other|0
2573149|NCT01262976|8900849|P4|Up to Year 2|Other|0
2573150|NCT01262976|8900850|P3|Up to Year 2|Other|0
2573151|NCT01262976|8900851|P2|Up to Year 2|Other|0
2573152|NCT01262976|8900852|P1|Up to Year 2|Other|3
2573153|NCT01262976|8900847|P6|Up to Year 2|Subjects with unknown completion status|0
2573154|NCT01262976|8900848|P5|Up to Year 2|Subjects with unknown completion status|0
2573155|NCT01262976|8900849|P4|Up to Year 2|Subjects with unknown completion status|0
2573156|NCT01262976|8900850|P3|Up to Year 2|Subjects with unknown completion status|1
2573157|NCT01262976|8900851|P2|Up to Year 2|Subjects with unknown completion status|0
2573158|NCT01262976|8900852|P1|Up to Year 2|Subjects with unknown completion status|0
2573159|NCT01262976|8900847|P6|Up to Year 2|Lost to Follow-up|3
2573160|NCT01262976|8900848|P5|Up to Year 2|Lost to Follow-up|3
2573161|NCT01262976|8900849|P4|Up to Year 2|Lost to Follow-up|2
2573162|NCT01262976|8900850|P3|Up to Year 2|Lost to Follow-up|2
2573163|NCT01262976|8900851|P2|Up to Year 2|Lost to Follow-up|1
2573164|NCT01262976|8900852|P1|Up to Year 2|Lost to Follow-up|1
2573165|NCT01262976|8900847|P6|Up to Year 2|Migrated/moved from study area|2
2573166|NCT01262976|8900848|P5|Up to Year 2|Migrated/moved from study area|1
2573167|NCT01262976|8900849|P4|Up to Year 2|Migrated/moved from study area|2
2573168|NCT01262976|8900850|P3|Up to Year 2|Migrated/moved from study area|0
2573169|NCT01262976|8900851|P2|Up to Year 2|Migrated/moved from study area|0
2573170|NCT01262976|8900852|P1|Up to Year 2|Migrated/moved from study area|0
2573171|NCT01262976|8900847|P6|Up to Year 2|Withdrawal by Subject|0
2573172|NCT01262976|8900848|P5|Up to Year 2|Withdrawal by Subject|0
2573173|NCT01262976|8900849|P4|Up to Year 2|Withdrawal by Subject|0
2573174|NCT01262976|8900850|P3|Up to Year 2|Withdrawal by Subject|0
2573175|NCT01262976|8900851|P2|Up to Year 2|Withdrawal by Subject|0
2573176|NCT01262976|8900852|P1|Up to Year 2|Withdrawal by Subject|1
2573177|NCT01262976|8900847|P6|Up to Year 2|Serious Adverse Event|0
2573178|NCT01262976|8900848|P5|Up to Year 2|Serious Adverse Event|0
2573179|NCT01262976|8900849|P4|Up to Year 2|Serious Adverse Event|0
2573180|NCT01262976|8900850|P3|Up to Year 2|Serious Adverse Event|2
2573181|NCT01262976|8900851|P2|Up to Year 2|Serious Adverse Event|0
2573182|NCT01262976|8900852|P1|Up to Year 2|Serious Adverse Event|0
2573183|NCT01262976|8900847|P6|Up to Year 1|Subjects with unknown completion status|1
2573184|NCT01262976|8900848|P5|Up to Year 1|Subjects with unknown completion status|0
2573185|NCT01262976|8900849|P4|Up to Year 1|Subjects with unknown completion status|0
2573186|NCT01262976|8900850|P3|Up to Year 1|Subjects with unknown completion status|1
2573187|NCT01262976|8900851|P2|Up to Year 1|Subjects with unknown completion status|0
2573188|NCT01262976|8900852|P1|Up to Year 1|Subjects with unknown completion status|0
2573189|NCT01262976|8900847|P6|Up to Year 1|Other|1
2573190|NCT01262976|8900848|P5|Up to Year 1|Other|2
2573191|NCT01262976|8900849|P4|Up to Year 1|Other|0
2573192|NCT01262976|8900850|P3|Up to Year 1|Other|0
2573193|NCT01262976|8900851|P2|Up to Year 1|Other|1
2573194|NCT01262976|8900852|P1|Up to Year 1|Other|3
2573195|NCT01262976|8900847|P6|Up to Year 1|Lost to Follow-up|5
2573196|NCT01262976|8900848|P5|Up to Year 1|Lost to Follow-up|6
2573197|NCT01262976|8900849|P4|Up to Year 1|Lost to Follow-up|1
2573198|NCT01262976|8900850|P3|Up to Year 1|Lost to Follow-up|0
2573199|NCT01262976|8900851|P2|Up to Year 1|Lost to Follow-up|0
2573200|NCT01262976|8900852|P1|Up to Year 1|Lost to Follow-up|4
2573201|NCT01262976|8900847|P6|Up to Year 1|Migrated/moved from study area|2
2573202|NCT01262976|8900848|P5|Up to Year 1|Migrated/moved from study area|3
2573203|NCT01262976|8900849|P4|Up to Year 1|Migrated/moved from study area|3
2573204|NCT01262976|8900850|P3|Up to Year 1|Migrated/moved from study area|0
2573205|NCT01262976|8900851|P2|Up to Year 1|Migrated/moved from study area|0
2573206|NCT01262976|8900852|P1|Up to Year 1|Migrated/moved from study area|1
2573207|NCT01262976|8900847|P6|Up to Year 1|Withdrawal by Subject|0
2573208|NCT01262976|8900848|P5|Up to Year 1|Withdrawal by Subject|0
2573209|NCT01262976|8900849|P4|Up to Year 1|Withdrawal by Subject|0
2573210|NCT01262976|8900850|P3|Up to Year 1|Withdrawal by Subject|0
2573211|NCT01262976|8900851|P2|Up to Year 1|Withdrawal by Subject|0
2573212|NCT01262976|8900852|P1|Up to Year 1|Withdrawal by Subject|1
2573213|NCT01262976|8900847|P6|Up to Year 1|Serious Adverse Event|0
2573214|NCT01262976|8900848|P5|Up to Year 1|Serious Adverse Event|0
2573215|NCT01262976|8900849|P4|Up to Year 1|Serious Adverse Event|0
2573216|NCT01262976|8900850|P3|Up to Year 1|Serious Adverse Event|2
2573217|NCT01262976|8900851|P2|Up to Year 1|Serious Adverse Event|0
2573218|NCT01262976|8900852|P1|Up to Year 1|Serious Adverse Event|0
2573219|NCT01262976|8900847|P6|Up to Month 7|Other|0
2573220|NCT01262976|8900848|P5|Up to Month 7|Other|0
2573221|NCT01262976|8900849|P4|Up to Month 7|Other|0
2573222|NCT01262976|8900850|P3|Up to Month 7|Other|2
2573223|NCT01262976|8900851|P2|Up to Month 7|Other|0
2573224|NCT01262976|8900852|P1|Up to Month 7|Other|3
2573225|NCT01262976|8900847|P6|Up to Month 7|Lost to Follow-up|3
2573226|NCT01262976|8900848|P5|Up to Month 7|Lost to Follow-up|1
2573227|NCT01262976|8900849|P4|Up to Month 7|Lost to Follow-up|3
2573228|NCT01262976|8900850|P3|Up to Month 7|Lost to Follow-up|1
2573229|NCT01262976|8900851|P2|Up to Month 7|Lost to Follow-up|0
2573230|NCT01262976|8900852|P1|Up to Month 7|Lost to Follow-up|1
2573231|NCT01262976|8900847|P6|Up to Month 7|Migrated/moved from study area|1
2573232|NCT01262976|8900848|P5|Up to Month 7|Migrated/moved from study area|1
2573233|NCT01262976|8900849|P4|Up to Month 7|Migrated/moved from study area|3
2573234|NCT01262976|8900850|P3|Up to Month 7|Migrated/moved from study area|1
2573235|NCT01262976|8900851|P2|Up to Month 7|Migrated/moved from study area|0
2573236|NCT01262976|8900852|P1|Up to Month 7|Migrated/moved from study area|0
2573237|NCT01262976|8900847|P6|Up to Month 7|Withdrawal by Subject|0
2573238|NCT01262976|8900848|P5|Up to Month 7|Withdrawal by Subject|0
2573239|NCT01262976|8900849|P4|Up to Month 7|Withdrawal by Subject|0
2573240|NCT01262976|8900850|P3|Up to Month 7|Withdrawal by Subject|0
2573241|NCT01262976|8900851|P2|Up to Month 7|Withdrawal by Subject|0
2573242|NCT01262976|8900852|P1|Up to Month 7|Withdrawal by Subject|1
2573243|NCT01262976|8900847|P6|Up to Month 7|Serious Adverse Event|0
2573244|NCT01262976|8900848|P5|Up to Month 7|Serious Adverse Event|0
2573245|NCT01262976|8900849|P4|Up to Month 7|Serious Adverse Event|0
2573246|NCT01262976|8900850|P3|Up to Month 7|Serious Adverse Event|2
2573247|NCT01262976|8900851|P2|Up to Month 7|Serious Adverse Event|0
2573248|NCT01262976|8900852|P1|Up to Month 7|Serious Adverse Event|0
2573249|NCT01262976|8900847|P6|Up to Month 2|Other|2
2573250|NCT01262976|8900848|P5|Up to Month 2|Other|0
2573251|NCT01262976|8900849|P4|Up to Month 2|Other|1
2573252|NCT01262976|8900850|P3|Up to Month 2|Other|0
2573253|NCT01262976|8900851|P2|Up to Month 2|Other|0
2573254|NCT01262976|8900852|P1|Up to Month 2|Other|1
2573255|NCT01262976|8900847|P6|Up to Month 2|Lost to Follow-up|1
2573256|NCT01262976|8900848|P5|Up to Month 2|Lost to Follow-up|1
2573257|NCT01262976|8900849|P4|Up to Month 2|Lost to Follow-up|1
2573258|NCT01262976|8900850|P3|Up to Month 2|Lost to Follow-up|0
2573259|NCT01262976|8900851|P2|Up to Month 2|Lost to Follow-up|0
2573260|NCT01262976|8900852|P1|Up to Month 2|Lost to Follow-up|1
2573261|NCT01262976|8900847|P6|Up to Month 2|Migrated/moved from study area|1
2573262|NCT01262976|8900848|P5|Up to Month 2|Migrated/moved from study area|1
2573263|NCT01262976|8900849|P4|Up to Month 2|Migrated/moved from study area|0
2573264|NCT01262976|8900850|P3|Up to Month 2|Migrated/moved from study area|0
2573265|NCT01262976|8900851|P2|Up to Month 2|Migrated/moved from study area|1
2573266|NCT01262976|8900852|P1|Up to Month 2|Migrated/moved from study area|0
2573267|NCT01262976|8900847|P6|Up to Month 2|Withdrawal by Subject|0
2573268|NCT01262976|8900848|P5|Up to Month 2|Withdrawal by Subject|0
2573269|NCT01262976|8900849|P4|Up to Month 2|Withdrawal by Subject|0
2573270|NCT01262976|8900850|P3|Up to Month 2|Withdrawal by Subject|0
2573271|NCT01262976|8900851|P2|Up to Month 2|Withdrawal by Subject|0
2573272|NCT01262976|8900852|P1|Up to Month 2|Withdrawal by Subject|1
2573273|NCT01262976|8900847|P6|Up to Month 2|Serious Adverse Event|0
2573274|NCT01262976|8900848|P5|Up to Month 2|Serious Adverse Event|0
2573275|NCT01262976|8900849|P4|Up to Month 2|Serious Adverse Event|0
2573276|NCT01262976|8900850|P3|Up to Month 2|Serious Adverse Event|1
2573277|NCT01262976|8900851|P2|Up to Month 2|Serious Adverse Event|0
2573278|NCT01262976|8900852|P1|Up to Month 2|Serious Adverse Event|0
2573279|NCT01262898|8901008|P4|Overall Study|Withdrawal by Subject|0
2573280|NCT01262898|8901009|P3|Overall Study|Withdrawal by Subject|0
2573281|NCT01262898|8901010|P2|Overall Study|Withdrawal by Subject|1
2573282|NCT01262898|8901011|P1|Overall Study|Withdrawal by Subject|1
2573283|NCT01262898|8901008|P4|Overall Study|Lost to Follow-up|0
2573284|NCT01262898|8901009|P3|Overall Study|Lost to Follow-up|0
2573285|NCT01262898|8901010|P2|Overall Study|Lost to Follow-up|0
2573286|NCT01262898|8901011|P1|Overall Study|Lost to Follow-up|1
2573287|NCT01262898|8901008|P4|Overall Study|Protocol Violation|0
2573288|NCT01262898|8901009|P3|Overall Study|Protocol Violation|0
2573289|NCT01262898|8901010|P2|Overall Study|Protocol Violation|1
2573290|NCT01262898|8901011|P1|Overall Study|Protocol Violation|1
2573291|NCT01262872|8901139|P8|Step 2|Migrated/moved from study area|3
2573292|NCT01262872|8901140|P7|Step 2|Migrated/moved from study area|2
2573293|NCT01262872|8901141|P6|Step 2|Migrated/moved from study area|6
2573294|NCT01262872|8901142|P5|Step 2|Migrated/moved from study area|2
2573295|NCT01262872|8901143|P4|Step 2|Migrated/moved from study area|3
2573296|NCT01262872|8901144|P3|Step 2|Migrated/moved from study area|4
2573297|NCT01262872|8901145|P2|Step 2|Migrated/moved from study area|0
2573298|NCT01262872|8901146|P1|Step 2|Migrated/moved from study area|0
2573299|NCT01262872|8901139|P8|Step 2|Withdrawal by Subject|1
2573300|NCT01262872|8901140|P7|Step 2|Withdrawal by Subject|2
2573301|NCT01262872|8901141|P6|Step 2|Withdrawal by Subject|1
2573302|NCT01262872|8901142|P5|Step 2|Withdrawal by Subject|3
2573303|NCT01262872|8901143|P4|Step 2|Withdrawal by Subject|6
2573304|NCT01262872|8901144|P3|Step 2|Withdrawal by Subject|4
2573305|NCT01262872|8901145|P2|Step 2|Withdrawal by Subject|0
2573306|NCT01262872|8901146|P1|Step 2|Withdrawal by Subject|0
2573307|NCT01262872|8901139|P8|Step 2|Protocol Violation|1
2573308|NCT01262872|8901140|P7|Step 2|Protocol Violation|3
2573309|NCT01262872|8901141|P6|Step 2|Protocol Violation|0
2573310|NCT01262872|8901142|P5|Step 2|Protocol Violation|0
2573311|NCT01262872|8901143|P4|Step 2|Protocol Violation|0
2573312|NCT01262872|8901144|P3|Step 2|Protocol Violation|1
2573313|NCT01262872|8901145|P2|Step 2|Protocol Violation|0
2573314|NCT01262872|8901146|P1|Step 2|Protocol Violation|0
2573315|NCT01262872|8901139|P8|Step 2|Death|1
2573316|NCT01262872|8901140|P7|Step 2|Death|2
2573317|NCT01262872|8901141|P6|Step 2|Death|2
2573318|NCT01262872|8901142|P5|Step 2|Death|0
2573319|NCT01262872|8901143|P4|Step 2|Death|1
2573320|NCT01262872|8901144|P3|Step 2|Death|0
2573321|NCT01262872|8901145|P2|Step 2|Death|0
2573322|NCT01262872|8901146|P1|Step 2|Death|0
2573323|NCT01262820|8901420|P1|Overall Study|Drug held for 21+ days|1
2573324|NCT01262820|8901420|P1|Overall Study|Lack of Efficacy|9
2573325|NCT01262820|8901420|P1|Overall Study|Adverse Event|5
2573326|NCT01262677|8901434|P3|Overall Study|Adverse Event (AE) related to study drug|3
2573327|NCT01262677|8901435|P2|Overall Study|Adverse Event (AE) related to study drug|8
2573328|NCT01262677|8901436|P1|Overall Study|Adverse Event (AE) related to study drug|3
2573329|NCT01262677|8901434|P3|Overall Study|Protocol Violation|1
2573330|NCT01262677|8901435|P2|Overall Study|Protocol Violation|1
2573331|NCT01262677|8901436|P1|Overall Study|Protocol Violation|0
2573332|NCT01262677|8901434|P3|Overall Study|Reason not provided|3
2573333|NCT01262677|8901435|P2|Overall Study|Reason not provided|1
2573334|NCT01262677|8901436|P1|Overall Study|Reason not provided|2
2573335|NCT01262677|8901434|P3|Overall Study|No longer willing to participate|2
2573336|NCT01262677|8901435|P2|Overall Study|No longer willing to participate|3
2573337|NCT01262677|8901436|P1|Overall Study|No longer willing to participate|3
2573338|NCT01262677|8901434|P3|Overall Study|Lost to Follow-up|2
2573339|NCT01262677|8901435|P2|Overall Study|Lost to Follow-up|0
2573340|NCT01262677|8901436|P1|Overall Study|Lost to Follow-up|1
2573341|NCT01262677|8901434|P3|Overall Study|Insufficient clinical response|1
2573342|NCT01262677|8901435|P2|Overall Study|Insufficient clinical response|0
2573343|NCT01262677|8901436|P1|Overall Study|Insufficient clinical response|0
2573344|NCT01262677|8901434|P3|Overall Study|Does not meet entrance criteria|0
2573345|NCT01262677|8901435|P2|Overall Study|Does not meet entrance criteria|2
2573346|NCT01262677|8901436|P1|Overall Study|Does not meet entrance criteria|0
2573347|NCT01262651|8901527|P2|Overall Study|Met Withdrawal Criteria|0
2573348|NCT01262651|8901528|P1|Overall Study|Met Withdrawal Criteria|1
2573349|NCT01262651|8901527|P2|Overall Study|Withdrawal by Investigator|2
2573350|NCT01262651|8901528|P1|Overall Study|Withdrawal by Investigator|2
2573351|NCT01262651|8901527|P2|Overall Study|Withdrawal by Subject|11
2573352|NCT01262651|8901528|P1|Overall Study|Withdrawal by Subject|15
2573353|NCT01262651|8901527|P2|Overall Study|Adverse Event|35
2573354|NCT01262651|8901528|P1|Overall Study|Adverse Event|40
2573355|NCT01262573|8901569|P2|Overall Study|Withdrawal by Subject|1
2573356|NCT01262573|8901570|P1|Overall Study|Withdrawal by Subject|0
2573357|NCT01262560|8901581|P3|Overall Study|Protocol Violation|2
2573358|NCT01262560|8901582|P2|Overall Study|Protocol Violation|1
2573359|NCT01262560|8901583|P1|Overall Study|Protocol Violation|0
2573360|NCT01262456|8901632|P3|1-Month Open-Label Extension Period|Other Reason|0
2573361|NCT01262456|8901633|P2|1-Month Open-Label Extension Period|Other Reason|1
2573362|NCT01262456|8901634|P1|1-Month Open-Label Extension Period|Other Reason|0
2573363|NCT01262456|8901632|P3|1-Month Open-Label Extension Period|Protocol Violation|2
2573364|NCT01262456|8901633|P2|1-Month Open-Label Extension Period|Protocol Violation|0
2573365|NCT01262456|8901634|P1|1-Month Open-Label Extension Period|Protocol Violation|1
2573366|NCT01262456|8901632|P3|1-Month Open-Label Extension Period|Adverse Event|2
2573367|NCT01262456|8901633|P2|1-Month Open-Label Extension Period|Adverse Event|0
2573368|NCT01262456|8901634|P1|1-Month Open-Label Extension Period|Adverse Event|2
2573369|NCT01262456|8901632|P3|1-Month Open-Label Extension Period|Lost to Follow-up|0
2573370|NCT01262456|8901633|P2|1-Month Open-Label Extension Period|Lost to Follow-up|1
2573371|NCT01262456|8901634|P1|1-Month Open-Label Extension Period|Lost to Follow-up|0
2573372|NCT01262456|8901632|P3|1-Month Open-Label Extension Period|Withdrawal by Subject|1
2573373|NCT01262456|8901633|P2|1-Month Open-Label Extension Period|Withdrawal by Subject|1
2573374|NCT01262456|8901634|P1|1-Month Open-Label Extension Period|Withdrawal by Subject|1
2573375|NCT01262456|8901632|P3|3-Month Double-Blind Period|Protocol Violation|6
2573376|NCT01262456|8901633|P2|3-Month Double-Blind Period|Protocol Violation|6
2573377|NCT01262456|8901634|P1|3-Month Double-Blind Period|Protocol Violation|3
2573378|NCT01262456|8901632|P3|3-Month Double-Blind Period|Adverse Event|8
2573379|NCT01262456|8901633|P2|3-Month Double-Blind Period|Adverse Event|4
2573380|NCT01262456|8901634|P1|3-Month Double-Blind Period|Adverse Event|6
2573381|NCT01262456|8901632|P3|3-Month Double-Blind Period|Lost to Follow-up|3
2573382|NCT01262456|8901633|P2|3-Month Double-Blind Period|Lost to Follow-up|5
2573383|NCT01262456|8901634|P1|3-Month Double-Blind Period|Lost to Follow-up|4
2573384|NCT01262456|8901632|P3|3-Month Double-Blind Period|Withdrawal by Subject|9
2573385|NCT01262456|8901633|P2|3-Month Double-Blind Period|Withdrawal by Subject|8
2573386|NCT01262456|8901634|P1|3-Month Double-Blind Period|Withdrawal by Subject|6
2573387|NCT01262365|8901678|P3|Overall Study|Patient unavailable|1
2573388|NCT01262365|8901679|P2|Overall Study|Patient unavailable|0
2573389|NCT01262365|8901680|P1|Overall Study|Patient unavailable|0
2573390|NCT01262365|8901678|P3|Overall Study|Cannot tolerate the protocol|0
2573391|NCT01262365|8901679|P2|Overall Study|Cannot tolerate the protocol|1
2573392|NCT01262365|8901680|P1|Overall Study|Cannot tolerate the protocol|0
2573393|NCT01262365|8901678|P3|Overall Study|Toxicity related to study drug|0
2573394|NCT01262365|8901679|P2|Overall Study|Toxicity related to study drug|1
2573395|NCT01262365|8901680|P1|Overall Study|Toxicity related to study drug|0
2573396|NCT01262365|8901678|P3|Overall Study|Patient pregnant|1
2573397|NCT01262365|8901679|P2|Overall Study|Patient pregnant|0
2573398|NCT01262365|8901680|P1|Overall Study|Patient pregnant|1
2573399|NCT01262365|8901678|P3|Overall Study|Suspected pregnancy|0
2573400|NCT01262365|8901679|P2|Overall Study|Suspected pregnancy|0
2573401|NCT01262365|8901680|P1|Overall Study|Suspected pregnancy|1
2573402|NCT01262365|8901678|P3|Overall Study|Non-compliance|2
2573403|NCT01262365|8901679|P2|Overall Study|Non-compliance|0
2573404|NCT01262365|8901680|P1|Overall Study|Non-compliance|1
2573405|NCT01262365|8901678|P3|Overall Study|Randomization error|2
2573406|NCT01262365|8901679|P2|Overall Study|Randomization error|0
2573407|NCT01262365|8901680|P1|Overall Study|Randomization error|1
2573408|NCT01262365|8901678|P3|Overall Study|sponsor decision|0
2573409|NCT01262365|8901679|P2|Overall Study|sponsor decision|1
2573410|NCT01262365|8901680|P1|Overall Study|sponsor decision|1
2573411|NCT01262365|8901678|P3|Overall Study|Adverse Event|11
2573412|NCT01262365|8901679|P2|Overall Study|Adverse Event|16
2573413|NCT01262365|8901680|P1|Overall Study|Adverse Event|26
2573414|NCT01262365|8901678|P3|Overall Study|Death|1
2573415|NCT01262365|8901679|P2|Overall Study|Death|2
2573416|NCT01262365|8901680|P1|Overall Study|Death|1
2573417|NCT01262365|8901678|P3|Overall Study|Withdrawal by Subject|22
2573418|NCT01262365|8901679|P2|Overall Study|Withdrawal by Subject|22
2573419|NCT01262365|8901680|P1|Overall Study|Withdrawal by Subject|17
2573420|NCT01262365|8901678|P3|Overall Study|Lost to Follow-up|6
2573421|NCT01262365|8901679|P2|Overall Study|Lost to Follow-up|7
2573422|NCT01262365|8901680|P1|Overall Study|Lost to Follow-up|3
2573423|NCT01262365|8901678|P3|Overall Study|Protocol Violation|1
2573424|NCT01262365|8901679|P2|Overall Study|Protocol Violation|1
2573425|NCT01262365|8901680|P1|Overall Study|Protocol Violation|3
2573426|NCT01262365|8901678|P3|Overall Study|Lack of Efficacy|47
2573427|NCT01262365|8901679|P2|Overall Study|Lack of Efficacy|30
2573428|NCT01262365|8901680|P1|Overall Study|Lack of Efficacy|35
2573429|NCT01262352|8901705|P2|Washout|Extended Washout|1
2573430|NCT01262352|8901706|P1|Washout|Extended Washout|0
2573431|NCT01262352|8901705|P2|Washout|Adverse Event|1
2573432|NCT01262352|8901706|P1|Washout|Adverse Event|1
2573433|NCT01262352|8901705|P2|Period 1|Illness after randomization|0
2573434|NCT01262352|8901706|P1|Period 1|Illness after randomization|1
2573435|NCT01262287|8901724|P2|Overall Study|Lost to Follow-up|1
2573436|NCT01262287|8901725|P1|Overall Study|Lost to Follow-up|2
2573437|NCT01262092|8901786|P2|Gabapentin Taper|noncompliance - missed medications|0
2573438|NCT01262092|8901787|P1|Gabapentin Taper|noncompliance - missed medications|1
2573439|NCT01262092|8901786|P2|Buprenorphine Taper|noncompliance - missed medication|1
2573440|NCT01262092|8901787|P1|Buprenorphine Taper|noncompliance - missed medication|1
2573441|NCT01262092|8901786|P2|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0
2573442|NCT01262092|8901787|P1|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1
2573443|NCT01262092|8901786|P2|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1
2573444|NCT01262092|8901787|P1|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2
2573445|NCT01262027|8901793|P1|Overall Study|Protocol Violation|1
2573446|NCT01262027|8901793|P1|Overall Study|Withdrawal by Subject|3
2573447|NCT01262027|8901793|P1|Overall Study|Adverse Event|1
2573448|NCT01261975|8901798|P1|Overall Study|Surgical complication|1
2573449|NCT01261793|8901820|P3|Overall Study|Patient unable to start IV line|1
2573450|NCT01261793|8901821|P2|Overall Study|Patient unable to start IV line|0
2573451|NCT01261793|8901822|P1|Overall Study|Patient unable to start IV line|0
2573452|NCT01261793|8901820|P3|Overall Study|Randomization error|0
2573453|NCT01261793|8901821|P2|Overall Study|Randomization error|1
2573454|NCT01261793|8901822|P1|Overall Study|Randomization error|0
2573455|NCT01261793|8901820|P3|Overall Study|Patient withdrew after cardiology visit|0
2573456|NCT01261793|8901821|P2|Overall Study|Patient withdrew after cardiology visit|1
2573457|NCT01261793|8901822|P1|Overall Study|Patient withdrew after cardiology visit|0
2573458|NCT01261793|8901820|P3|Overall Study|Lack of efficacy & patient not available|0
2573459|NCT01261793|8901821|P2|Overall Study|Lack of efficacy & patient not available|1
2573460|NCT01261793|8901822|P1|Overall Study|Lack of efficacy & patient not available|0
2573461|NCT01261793|8901820|P3|Overall Study|Outside the study area|1
2573462|NCT01261793|8901821|P2|Overall Study|Outside the study area|2
2573463|NCT01261793|8901822|P1|Overall Study|Outside the study area|0
2573464|NCT01261793|8901820|P3|Overall Study|Patient pregnant|0
2573465|NCT01261793|8901821|P2|Overall Study|Patient pregnant|0
2573466|NCT01261793|8901822|P1|Overall Study|Patient pregnant|1
2573467|NCT01261793|8901820|P3|Overall Study|Patient non-compliance|1
2573468|NCT01261793|8901821|P2|Overall Study|Patient non-compliance|0
2573469|NCT01261793|8901822|P1|Overall Study|Patient non-compliance|1
2573470|NCT01261793|8901820|P3|Overall Study|Suspected pregnancy|0
2573471|NCT01261793|8901821|P2|Overall Study|Suspected pregnancy|1
2573472|NCT01261793|8901822|P1|Overall Study|Suspected pregnancy|1
2573473|NCT01261793|8901820|P3|Overall Study|Patient non-availability|1
2573474|NCT01261793|8901821|P2|Overall Study|Patient non-availability|1
2573475|NCT01261793|8901822|P1|Overall Study|Patient non-availability|1
2573476|NCT01261793|8901820|P3|Overall Study|Adverse Event|19
2573477|NCT01261793|8901821|P2|Overall Study|Adverse Event|24
2573478|NCT01261793|8901822|P1|Overall Study|Adverse Event|9
2573479|NCT01261793|8901820|P3|Overall Study|Death|0
2573480|NCT01261793|8901821|P2|Overall Study|Death|1
2573481|NCT01261793|8901822|P1|Overall Study|Death|3
2573482|NCT01261793|8901820|P3|Overall Study|Withdrawal by Subject|14
2573483|NCT01261793|8901821|P2|Overall Study|Withdrawal by Subject|14
2573484|NCT01261793|8901822|P1|Overall Study|Withdrawal by Subject|12
2573485|NCT01261793|8901820|P3|Overall Study|Lost to Follow-up|7
2573486|NCT01261793|8901821|P2|Overall Study|Lost to Follow-up|3
2573487|NCT01261793|8901822|P1|Overall Study|Lost to Follow-up|10
2573488|NCT01261793|8901820|P3|Overall Study|Protocol Violation|6
2573489|NCT01261793|8901821|P2|Overall Study|Protocol Violation|5
2573490|NCT01261793|8901822|P1|Overall Study|Protocol Violation|3
2573491|NCT01261793|8901820|P3|Overall Study|Lack of Efficacy|32
2573492|NCT01261793|8901821|P2|Overall Study|Lack of Efficacy|37
2573493|NCT01261793|8901822|P1|Overall Study|Lack of Efficacy|44
2573494|NCT01261780|8901847|P2|Overall Study|Event not related to subject|2
2573495|NCT01261780|8901848|P1|Overall Study|Event not related to subject|1
2573496|NCT01261780|8901847|P2|Overall Study|Withdrawal by Subject|0
2573497|NCT01261780|8901848|P1|Overall Study|Withdrawal by Subject|1
2573498|NCT01261624|8901858|P2|Week 13 to Week 24|Insufficient Response|1
2573499|NCT01261624|8901859|P1|Week 13 to Week 24|Insufficient Response|0
2573500|NCT01261624|8901858|P2|Week 0 to Week 12|Insufficient Response|2
2573501|NCT01261624|8901859|P1|Week 0 to Week 12|Insufficient Response|0
2573502|NCT01261624|8901858|P2|Week 0 to Week 12|Disease Progression|1
2573503|NCT01261624|8901859|P1|Week 0 to Week 12|Disease Progression|1
2573504|NCT01261611|8901879|P3|Treatment Cycle 5|Lost to Follow-up|0
2573505|NCT01261611|8901880|P2|Treatment Cycle 5|Lost to Follow-up|0
2573506|NCT01261611|8901881|P1|Treatment Cycle 5|Lost to Follow-up|1
2573507|NCT01261611|8901879|P3|Treatment Cycle 5|Adverse Event|0
2573508|NCT01261611|8901880|P2|Treatment Cycle 5|Adverse Event|0
2573509|NCT01261611|8901881|P1|Treatment Cycle 5|Adverse Event|1
2573510|NCT01261611|8901879|P3|Treatment Cycle 5|Withdrawal by Subject|0
2573511|NCT01261611|8901880|P2|Treatment Cycle 5|Withdrawal by Subject|0
2573512|NCT01261611|8901881|P1|Treatment Cycle 5|Withdrawal by Subject|1
2573513|NCT01261611|8901879|P3|Treatment Cycle 4|Not otherwise specified|0
2573514|NCT01261611|8901880|P2|Treatment Cycle 4|Not otherwise specified|0
2573515|NCT01261611|8901881|P1|Treatment Cycle 4|Not otherwise specified|3
2573516|NCT01261611|8901879|P3|Treatment Cycle 4|Lost to Follow-up|0
2573517|NCT01261611|8901880|P2|Treatment Cycle 4|Lost to Follow-up|0
2573518|NCT01261611|8901881|P1|Treatment Cycle 4|Lost to Follow-up|2
2573519|NCT01261611|8901879|P3|Treatment Cycle 4|Adverse Event|0
2573520|NCT01261611|8901880|P2|Treatment Cycle 4|Adverse Event|0
2573521|NCT01261611|8901881|P1|Treatment Cycle 4|Adverse Event|1
2573522|NCT01261611|8901879|P3|Treatment Cycle 4|Withdrawal by Subject|0
2573523|NCT01261611|8901880|P2|Treatment Cycle 4|Withdrawal by Subject|0
2573524|NCT01261611|8901881|P1|Treatment Cycle 4|Withdrawal by Subject|3
2573525|NCT01261611|8901879|P3|Treatment Cycle 4|Completed study|0
2573526|NCT01261611|8901880|P2|Treatment Cycle 4|Completed study|0
2573527|NCT01261611|8901881|P1|Treatment Cycle 4|Completed study|87
2573528|NCT01261611|8901879|P3|Treatment Cycle 3|Lost to Follow-up|0
2573529|NCT01261611|8901880|P2|Treatment Cycle 3|Lost to Follow-up|0
2573530|NCT01261611|8901881|P1|Treatment Cycle 3|Lost to Follow-up|1
2573531|NCT01261611|8901879|P3|Treatment Cycle 3|Adverse Event|0
2573532|NCT01261611|8901880|P2|Treatment Cycle 3|Adverse Event|0
2573533|NCT01261611|8901881|P1|Treatment Cycle 3|Adverse Event|1
2573534|NCT01261611|8901879|P3|Treatment Cycle 3|Withdrawal by Subject|0
2573535|NCT01261611|8901880|P2|Treatment Cycle 3|Withdrawal by Subject|0
2573536|NCT01261611|8901881|P1|Treatment Cycle 3|Withdrawal by Subject|4
2573537|NCT01261611|8901879|P3|Treatment Cycle 3|Completed study|0
2573538|NCT01261611|8901880|P2|Treatment Cycle 3|Completed study|0
2573539|NCT01261611|8901881|P1|Treatment Cycle 3|Completed study|24
2573540|NCT01261611|8901879|P3|Treatment Cycle 2|Not otherwise specified|0
2573541|NCT01261611|8901880|P2|Treatment Cycle 2|Not otherwise specified|0
2573542|NCT01261611|8901881|P1|Treatment Cycle 2|Not otherwise specified|2
2573543|NCT01261611|8901879|P3|Treatment Cycle 2|Protocol Violation|0
2573544|NCT01261611|8901880|P2|Treatment Cycle 2|Protocol Violation|0
2573545|NCT01261611|8901881|P1|Treatment Cycle 2|Protocol Violation|2
2573546|NCT01261611|8901879|P3|Treatment Cycle 2|Adverse Event|0
2573547|NCT01261611|8901880|P2|Treatment Cycle 2|Adverse Event|0
2573548|NCT01261611|8901881|P1|Treatment Cycle 2|Adverse Event|1
2573549|NCT01261611|8901879|P3|Treatment Cycle 2|Withdrawal by Subject|0
2573550|NCT01261611|8901880|P2|Treatment Cycle 2|Withdrawal by Subject|0
2573551|NCT01261611|8901881|P1|Treatment Cycle 2|Withdrawal by Subject|4
2573552|NCT01261611|8901879|P3|Treatment Cycle 2|Completed study|0
2573553|NCT01261611|8901880|P2|Treatment Cycle 2|Completed study|0
2573554|NCT01261611|8901881|P1|Treatment Cycle 2|Completed study|4
2573555|NCT01261611|8901879|P3|Treatment Cycle 1|Protocol Violation|2
2573556|NCT01261611|8901880|P2|Treatment Cycle 1|Protocol Violation|0
2573557|NCT01261611|8901881|P1|Treatment Cycle 1|Protocol Violation|0
2573558|NCT01261611|8901879|P3|Treatment Cycle 1|Adverse Event|0
2573559|NCT01261611|8901880|P2|Treatment Cycle 1|Adverse Event|1
2573560|NCT01261611|8901881|P1|Treatment Cycle 1|Adverse Event|0
2573561|NCT01261611|8901879|P3|Treatment Cycle 1|Lost to Follow-up|0
2573562|NCT01261611|8901880|P2|Treatment Cycle 1|Lost to Follow-up|0
2573563|NCT01261611|8901881|P1|Treatment Cycle 1|Lost to Follow-up|1
2573564|NCT01261611|8901879|P3|Treatment Cycle 1|Withdrawal by Subject|0
2573565|NCT01261611|8901880|P2|Treatment Cycle 1|Withdrawal by Subject|2
2573566|NCT01261611|8901881|P1|Treatment Cycle 1|Withdrawal by Subject|3
2573567|NCT01261390|8901945|P4|Overall Study|Lost to Follow-up|6
2573568|NCT01261390|8901946|P3|Overall Study|Lost to Follow-up|5
2573569|NCT01261390|8901947|P2|Overall Study|Lost to Follow-up|6
2573570|NCT01261390|8901948|P1|Overall Study|Lost to Follow-up|1
2573571|NCT01261390|8901945|P4|Overall Study|Loss of Interest in the Study|0
2573572|NCT01261390|8901946|P3|Overall Study|Loss of Interest in the Study|0
2573573|NCT01261390|8901947|P2|Overall Study|Loss of Interest in the Study|1
2573574|NCT01261390|8901948|P1|Overall Study|Loss of Interest in the Study|3
2573575|NCT01261390|8901945|P4|Overall Study|Relocation|0
2573576|NCT01261390|8901946|P3|Overall Study|Relocation|0
2573577|NCT01261390|8901947|P2|Overall Study|Relocation|1
2573578|NCT01261390|8901948|P1|Overall Study|Relocation|0
2573579|NCT01261390|8901945|P4|Overall Study|Dissatisfaction with Treatment|2
2573580|NCT01261390|8901946|P3|Overall Study|Dissatisfaction with Treatment|1
2573581|NCT01261390|8901947|P2|Overall Study|Dissatisfaction with Treatment|1
2573582|NCT01261390|8901948|P1|Overall Study|Dissatisfaction with Treatment|2
2573583|NCT01261390|8901945|P4|Overall Study|Significant Concurrent Illness|0
2573584|NCT01261390|8901946|P3|Overall Study|Significant Concurrent Illness|1
2573585|NCT01261390|8901947|P2|Overall Study|Significant Concurrent Illness|0
2573586|NCT01261390|8901948|P1|Overall Study|Significant Concurrent Illness|1
2573587|NCT01261325|8902113|P3|Overall Study|AE, serious fatal|2
2573588|NCT01261325|8902114|P2|Overall Study|AE, serious fatal|0
2573589|NCT01261325|8902115|P1|Overall Study|AE, serious fatal|0
2573590|NCT01261325|8902113|P3|Overall Study|Lost to Follow-up|3
2573591|NCT01261325|8902114|P2|Overall Study|Lost to Follow-up|1
2573592|NCT01261325|8902115|P1|Overall Study|Lost to Follow-up|0
2573593|NCT01261325|8902113|P3|Overall Study|Protocol Violation|1
2573594|NCT01261325|8902114|P2|Overall Study|Protocol Violation|3
2573595|NCT01261325|8902115|P1|Overall Study|Protocol Violation|0
2573596|NCT01261325|8902113|P3|Overall Study|Randomized in Error|1
2573597|NCT01261325|8902114|P2|Overall Study|Randomized in Error|0
2573598|NCT01261325|8902115|P1|Overall Study|Randomized in Error|0
2573599|NCT01261325|8902113|P3|Overall Study|Screen Failure|0
2573600|NCT01261325|8902114|P2|Overall Study|Screen Failure|0
2573601|NCT01261325|8902115|P1|Overall Study|Screen Failure|1
2573602|NCT01261325|8902113|P3|Overall Study|Erroneously Randomized|0
2573603|NCT01261325|8902114|P2|Overall Study|Erroneously Randomized|0
2573604|NCT01261325|8902115|P1|Overall Study|Erroneously Randomized|1
2573605|NCT01261325|8902113|P3|Overall Study|Patient Randomized by Mistake|0
2573606|NCT01261325|8902114|P2|Overall Study|Patient Randomized by Mistake|1
2573607|NCT01261325|8902115|P1|Overall Study|Patient Randomized by Mistake|0
2573608|NCT01261325|8902113|P3|Overall Study|Non Compliance|0
2573609|NCT01261325|8902114|P2|Overall Study|Non Compliance|0
2573610|NCT01261325|8902115|P1|Overall Study|Non Compliance|2
2573611|NCT01261325|8902113|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
2573612|NCT01261325|8902114|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
2573613|NCT01261325|8902115|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
2573614|NCT01261325|8902113|P3|Overall Study|AE, non-serious non-fatal|13
2573615|NCT01261325|8902114|P2|Overall Study|AE, non-serious non-fatal|15
2573616|NCT01261325|8902115|P1|Overall Study|AE, non-serious non-fatal|9
2573617|NCT01261325|8902113|P3|Overall Study|SAE, non-fatal|1
2573618|NCT01261325|8902114|P2|Overall Study|SAE, non-fatal|5
2573619|NCT01261325|8902115|P1|Overall Study|SAE, non-fatal|1
2573620|NCT01261325|8902113|P3|Overall Study|Withdrawal by Subject|4
2573621|NCT01261325|8902114|P2|Overall Study|Withdrawal by Subject|2
2573622|NCT01261325|8902115|P1|Overall Study|Withdrawal by Subject|2
2573623|NCT01261325|8902113|P3|Overall Study|Lack of Efficacy|0
2573624|NCT01261325|8902114|P2|Overall Study|Lack of Efficacy|1
2573625|NCT01261325|8902115|P1|Overall Study|Lack of Efficacy|1
2573626|NCT01261247|8902147|P1|Overall Study|Ineligible|2
2573627|NCT01261000|8902160|P1|Overall Study|Screen failure|1
2573628|NCT01260948|8902166|P2|Second Intervention|Emesis|1
2573629|NCT01260948|8902167|P1|Second Intervention|Emesis|0
2573630|NCT01260948|8902166|P2|Washout of 28 Days|Withdrawal by Subject|3
2573631|NCT01260948|8902167|P1|Washout of 28 Days|Withdrawal by Subject|1
2573632|NCT01260922|8902177|P2|Second Intervention|Emesis|2
2573633|NCT01260922|8902178|P1|Second Intervention|Emesis|0
2573634|NCT01260922|8902177|P2|Washout of 28 Days|Withdrawal by Subject|2
2573635|NCT01260922|8902178|P1|Washout of 28 Days|Withdrawal by Subject|4
2573636|NCT01260922|8902177|P2|First Intervention|Withdrawal by Subject|1
2573637|NCT01260922|8902178|P1|First Intervention|Withdrawal by Subject|0
2573638|NCT01260896|8902188|P2|First Intervention|Withdrawn Due to Emesis|0
2573639|NCT01260896|8902189|P1|First Intervention|Withdrawn Due to Emesis|2
2573640|NCT01260701|8902247|P1|Overall Study|Did not begin protocol therapy|1
2573641|NCT01260701|8902247|P1|Overall Study|Ineligible|4
2573642|NCT01260701|8902247|P1|Overall Study|Under review|1
2573643|NCT01260701|8902247|P1|Overall Study|Not protocol specified|3
2573644|NCT01260701|8902247|P1|Overall Study|Death|2
2573645|NCT01260701|8902247|P1|Overall Study|Progression|53
2573646|NCT01260701|8902247|P1|Overall Study|Withdrawal by Subject|2
2573647|NCT01260701|8902247|P1|Overall Study|Adverse Event|9
2573648|NCT01260584|8902328|P4|Period 2|Withdrawal by Subject|0
2573649|NCT01260584|8902329|P3|Period 2|Withdrawal by Subject|0
2573650|NCT01260584|8902330|P2|Period 2|Withdrawal by Subject|1
2573651|NCT01260584|8902331|P1|Period 2|Withdrawal by Subject|0
2573652|NCT01260584|8902328|P4|Period 2|Adverse Event|0
2573653|NCT01260584|8902329|P3|Period 2|Adverse Event|2
2573654|NCT01260584|8902330|P2|Period 2|Adverse Event|0
2573655|NCT01260584|8902331|P1|Period 2|Adverse Event|1
2573656|NCT01260584|8902328|P4|Period 2|Protocol Violation|1
2573657|NCT01260584|8902329|P3|Period 2|Protocol Violation|3
2573658|NCT01260584|8902330|P2|Period 2|Protocol Violation|2
2573659|NCT01260584|8902331|P1|Period 2|Protocol Violation|0
2573660|NCT01260584|8902328|P4|Period 1|Adverse Event|0
2573661|NCT01260584|8902329|P3|Period 1|Adverse Event|1
2573662|NCT01260584|8902330|P2|Period 1|Adverse Event|0
2573663|NCT01260584|8902331|P1|Period 1|Adverse Event|0
2573664|NCT01260584|8902328|P4|Period 1|Protocol Violation|1
2573665|NCT01260584|8902329|P3|Period 1|Protocol Violation|1
2573666|NCT01260584|8902330|P2|Period 1|Protocol Violation|0
2573667|NCT01260584|8902331|P1|Period 1|Protocol Violation|0
2573668|NCT01260467|8902374|P1|Overall Study|Withdrawal by Subject|2
2573669|NCT01260350|8902406|P22|Overall Study|Did Not Complete Follow-up 12 Visit|0
2573670|NCT01260350|8902407|P21|Overall Study|Did Not Complete Follow-up 12 Visit|0
2573671|NCT01260350|8902408|P20|Overall Study|Did Not Complete Follow-up 12 Visit|0
2573672|NCT01260350|8902409|P19|Overall Study|Did Not Complete Follow-up 12 Visit|0
2573673|NCT01260350|8902410|P18|Overall Study|Did Not Complete Follow-up 12 Visit|0
2573674|NCT01260350|8902411|P17|Overall Study|Did Not Complete Follow-up 12 Visit|0
2573675|NCT01260350|8902412|P16|Overall Study|Did Not Complete Follow-up 12 Visit|0
2573676|NCT01260350|8902413|P15|Overall Study|Did Not Complete Follow-up 12 Visit|0
2573677|NCT01260350|8902414|P14|Overall Study|Did Not Complete Follow-up 12 Visit|0
2573678|NCT01260350|8902415|P13|Overall Study|Did Not Complete Follow-up 12 Visit|0
2573679|NCT01260350|8902416|P12|Overall Study|Did Not Complete Follow-up 12 Visit|0
2573680|NCT01260350|8902417|P11|Overall Study|Did Not Complete Follow-up 12 Visit|0
2573681|NCT01260350|8902418|P10|Overall Study|Did Not Complete Follow-up 12 Visit|0
2573682|NCT01260350|8902419|P9|Overall Study|Did Not Complete Follow-up 12 Visit|1
2573683|NCT01260350|8902420|P8|Overall Study|Did Not Complete Follow-up 12 Visit|0
2573684|NCT01260350|8902421|P7|Overall Study|Did Not Complete Follow-up 12 Visit|0
2573685|NCT01260350|8902422|P6|Overall Study|Did Not Complete Follow-up 12 Visit|0
2573686|NCT01260350|8902423|P5|Overall Study|Did Not Complete Follow-up 12 Visit|0
2573687|NCT01260350|8902424|P4|Overall Study|Did Not Complete Follow-up 12 Visit|0
2573688|NCT01260350|8902425|P3|Overall Study|Did Not Complete Follow-up 12 Visit|0
2573689|NCT01260350|8902426|P2|Overall Study|Did Not Complete Follow-up 12 Visit|0
2573690|NCT01260350|8902427|P1|Overall Study|Did Not Complete Follow-up 12 Visit|0
2573691|NCT01260350|8902406|P22|Overall Study|Lack of Efficacy|0
2573692|NCT01260350|8902407|P21|Overall Study|Lack of Efficacy|3
2573693|NCT01260350|8902408|P20|Overall Study|Lack of Efficacy|0
2573694|NCT01260350|8902409|P19|Overall Study|Lack of Efficacy|0
2573695|NCT01260350|8902410|P18|Overall Study|Lack of Efficacy|1
2573696|NCT01260350|8902411|P17|Overall Study|Lack of Efficacy|0
2573697|NCT01260350|8902412|P16|Overall Study|Lack of Efficacy|0
2573698|NCT01260350|8902413|P15|Overall Study|Lack of Efficacy|0
2573699|NCT01260350|8902414|P14|Overall Study|Lack of Efficacy|0
2573700|NCT01260350|8902415|P13|Overall Study|Lack of Efficacy|0
2573701|NCT01260350|8902416|P12|Overall Study|Lack of Efficacy|0
2573702|NCT01260350|8902417|P11|Overall Study|Lack of Efficacy|0
2573703|NCT01260350|8902418|P10|Overall Study|Lack of Efficacy|0
2573704|NCT01260350|8902419|P9|Overall Study|Lack of Efficacy|0
2573705|NCT01260350|8902420|P8|Overall Study|Lack of Efficacy|0
2573706|NCT01260350|8902421|P7|Overall Study|Lack of Efficacy|0
2573707|NCT01260350|8902422|P6|Overall Study|Lack of Efficacy|0
2573708|NCT01260350|8902423|P5|Overall Study|Lack of Efficacy|0
2573709|NCT01260350|8902424|P4|Overall Study|Lack of Efficacy|0
2573710|NCT01260350|8902425|P3|Overall Study|Lack of Efficacy|0
2573711|NCT01260350|8902426|P2|Overall Study|Lack of Efficacy|0
2573712|NCT01260350|8902427|P1|Overall Study|Lack of Efficacy|0
2573713|NCT01260311|8902634|P1|Overall Study|Fesoterodine Started Before Enrollment|1
2573714|NCT01260311|8902634|P1|Overall Study|Medication Stopped|1
2573715|NCT01260311|8902634|P1|Overall Study|Gone to Province|2
2573716|NCT01260311|8902634|P1|Overall Study|Financial Constraints|77
2573717|NCT01260311|8902634|P1|Overall Study|Withdrawal by Subject|6
2573718|NCT01260311|8902634|P1|Overall Study|Lost to Follow-up|25
2573719|NCT01260311|8902634|P1|Overall Study|Lack of Efficacy|4
2573720|NCT01260311|8902634|P1|Overall Study|Adverse Event|11
2573721|NCT01260194|8902665|P1|Overall Study|Withdrawal of Consent|1
2573722|NCT01260181|8902677|P1|Overall Study|Decision of Investigator|1
2573723|NCT01260142|8902692|P6|Treatment Period 1|Withdrawal by Subject|1
2573724|NCT01260142|8902693|P5|Treatment Period 1|Withdrawal by Subject|0
2573725|NCT01260142|8902694|P4|Treatment Period 1|Withdrawal by Subject|0
2573726|NCT01260142|8902695|P3|Treatment Period 1|Withdrawal by Subject|0
2573727|NCT01260142|8902696|P2|Treatment Period 1|Withdrawal by Subject|0
2573728|NCT01260142|8902697|P1|Treatment Period 1|Withdrawal by Subject|0
2573729|NCT01260142|8902692|P6|Treatment Period 1|Unexplained elevated sys. BP|0
2573730|NCT01260142|8902693|P5|Treatment Period 1|Unexplained elevated sys. BP|1
2573731|NCT01260142|8902694|P4|Treatment Period 1|Unexplained elevated sys. BP|0
2573732|NCT01260142|8902695|P3|Treatment Period 1|Unexplained elevated sys. BP|0
2573733|NCT01260142|8902696|P2|Treatment Period 1|Unexplained elevated sys. BP|0
2573734|NCT01260142|8902697|P1|Treatment Period 1|Unexplained elevated sys. BP|0
2573735|NCT01260142|8902692|P6|Treatment Period 1|Study on hold|2
2573736|NCT01260142|8902693|P5|Treatment Period 1|Study on hold|1
2573737|NCT01260142|8902694|P4|Treatment Period 1|Study on hold|0
2573738|NCT01260142|8902695|P3|Treatment Period 1|Study on hold|0
2573739|NCT01260142|8902696|P2|Treatment Period 1|Study on hold|1
2573740|NCT01260142|8902697|P1|Treatment Period 1|Study on hold|1
2573741|NCT01259856|8902749|P2|Overall Study|Unknown/missing|2
2573742|NCT01259856|8902750|P1|Overall Study|Unknown/missing|2
2573743|NCT01259856|8902749|P2|Overall Study|Transfer to another study|1
2573744|NCT01259856|8902750|P1|Overall Study|Transfer to another study|0
2573745|NCT01259856|8902749|P2|Overall Study|Patient developed other disease|1
2573746|NCT01259856|8902750|P1|Overall Study|Patient developed other disease|0
2573747|NCT01259856|8902749|P2|Overall Study|Study closure by sponsor|41
2573748|NCT01259856|8902750|P1|Overall Study|Study closure by sponsor|40
2573749|NCT01259856|8902749|P2|Overall Study|Treatment never started|6
2573750|NCT01259856|8902750|P1|Overall Study|Treatment never started|0
2573751|NCT01259856|8902749|P2|Overall Study|Withdrawal by Subject|10
2573752|NCT01259856|8902750|P1|Overall Study|Withdrawal by Subject|9
2573753|NCT01259856|8902749|P2|Overall Study|Physician Decision|1
2573754|NCT01259856|8902750|P1|Overall Study|Physician Decision|2
2573755|NCT01259856|8902749|P2|Overall Study|Lost to Follow-up|1
2573756|NCT01259856|8902750|P1|Overall Study|Lost to Follow-up|1
2573757|NCT01259856|8902749|P2|Overall Study|Lack of Efficacy|1
2573758|NCT01259856|8902750|P1|Overall Study|Lack of Efficacy|3
2573759|NCT01259856|8902749|P2|Overall Study|Death|1
2573760|NCT01259856|8902750|P1|Overall Study|Death|0
2573761|NCT01259856|8902749|P2|Overall Study|Adverse Event|9
2573762|NCT01259856|8902750|P1|Overall Study|Adverse Event|12
2573763|NCT01259726|8902774|P4|Overall Study|Lost to Follow-up|3
2573764|NCT01259726|8902775|P3|Overall Study|Lost to Follow-up|1
2573765|NCT01259726|8902776|P2|Overall Study|Lost to Follow-up|1
2573766|NCT01259726|8902777|P1|Overall Study|Lost to Follow-up|1
2573767|NCT01259726|8902774|P4|Overall Study|Withdrawal by Subject|1
2573768|NCT01259726|8902775|P3|Overall Study|Withdrawal by Subject|2
2573769|NCT01259726|8902776|P2|Overall Study|Withdrawal by Subject|3
2573770|NCT01259726|8902777|P1|Overall Study|Withdrawal by Subject|1
2573771|NCT01259726|8902774|P4|Overall Study|Physician Decision|1
2573772|NCT01259726|8902775|P3|Overall Study|Physician Decision|1
2573773|NCT01259726|8902776|P2|Overall Study|Physician Decision|0
2573774|NCT01259726|8902777|P1|Overall Study|Physician Decision|2
2573775|NCT01259726|8902774|P4|Overall Study|Death|0
2573776|NCT01259726|8902775|P3|Overall Study|Death|0
2573777|NCT01259726|8902776|P2|Overall Study|Death|0
2573778|NCT01259726|8902777|P1|Overall Study|Death|1
2573779|NCT01259713|8902809|P2|Overall Study|Subject Withdrew Consent|7
2573780|NCT01259713|8902810|P1|Overall Study|Subject Withdrew Consent|12
2573781|NCT01259713|8902809|P2|Overall Study|Protocol Violation|4
2573782|NCT01259713|8902810|P1|Overall Study|Protocol Violation|5
2573783|NCT01259713|8902809|P2|Overall Study|Lack of Efficacy|0
2573784|NCT01259713|8902810|P1|Overall Study|Lack of Efficacy|2
2573785|NCT01259713|8902809|P2|Overall Study|Investigators Discretion|6
2573786|NCT01259713|8902810|P1|Overall Study|Investigators Discretion|14
2573787|NCT01259713|8902809|P2|Overall Study|Death Not Related to IFI|1
2573788|NCT01259713|8902810|P1|Overall Study|Death Not Related to IFI|8
2573789|NCT01259713|8902809|P2|Overall Study|Adverse Event|23
2573790|NCT01259713|8902810|P1|Overall Study|Adverse Event|54
2573791|NCT01259492|8902857|P4|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7
2573792|NCT01259492|8902858|P3|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3
2573793|NCT01259492|8902859|P2|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6
2573794|NCT01259492|8902860|P1|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5
2573795|NCT01259492|8902857|P4|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
2573796|NCT01259492|8902858|P3|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1
2573797|NCT01259492|8902859|P2|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
2573798|NCT01259492|8902860|P1|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
2573799|NCT01259492|8902857|P4|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
2573800|NCT01259492|8902858|P3|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6
2573801|NCT01259492|8902859|P2|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4
2573802|NCT01259492|8902860|P1|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
2573803|NCT01259492|8902857|P4|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3
2573804|NCT01259492|8902858|P3|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4
2573805|NCT01259492|8902859|P2|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6
2573806|NCT01259492|8902860|P1|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12
2573807|NCT01259492|8902857|P4|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
2573808|NCT01259492|8902858|P3|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
2573809|NCT01259492|8902859|P2|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
2573810|NCT01259492|8902860|P1|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1
2573811|NCT01259492|8902857|P4|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62
2573812|NCT01259492|8902858|P3|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29
2573813|NCT01259492|8902859|P2|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42
2573814|NCT01259492|8902860|P1|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28
2573815|NCT01259492|8902857|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
2573816|NCT01259492|8902858|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1
2573817|NCT01259492|8902859|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
2573818|NCT01259492|8902860|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
2573819|NCT01259492|8902857|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1
2573820|NCT01259492|8902858|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
2573821|NCT01259492|8902859|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
2573822|NCT01259492|8902860|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
2573823|NCT01259492|8902857|P4|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
2573824|NCT01259492|8902858|P3|Period 3 (Week 15 to End of Week 40)|Adverse Event|6
2573825|NCT01259492|8902859|P2|Period 3 (Week 15 to End of Week 40)|Adverse Event|11
2573826|NCT01259492|8902860|P1|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
2573827|NCT01259492|8902857|P4|Period 2 (Week 10 to Week 14)|Protocol Violation|0
2573828|NCT01259492|8902858|P3|Period 2 (Week 10 to Week 14)|Protocol Violation|1
2573829|NCT01259492|8902859|P2|Period 2 (Week 10 to Week 14)|Protocol Violation|2
2573830|NCT01259492|8902860|P1|Period 2 (Week 10 to Week 14)|Protocol Violation|0
2573831|NCT01259492|8902857|P4|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
2573832|NCT01259492|8902858|P3|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1
2573833|NCT01259492|8902859|P2|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
2573834|NCT01259492|8902860|P1|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
2573835|NCT01259492|8902857|P4|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4
2573836|NCT01259492|8902858|P3|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8
2573837|NCT01259492|8902859|P2|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2
2573838|NCT01259492|8902860|P1|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6
2573839|NCT01259492|8902857|P4|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
2573840|NCT01259492|8902858|P3|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
2573841|NCT01259492|8902859|P2|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
2573842|NCT01259492|8902860|P1|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
2573843|NCT01259492|8902857|P4|Period 2 (Week 10 to Week 14)|Adverse Event|8
2573844|NCT01259492|8902858|P3|Period 2 (Week 10 to Week 14)|Adverse Event|7
2573845|NCT01259492|8902859|P2|Period 2 (Week 10 to Week 14)|Adverse Event|4
2573846|NCT01259492|8902860|P1|Period 2 (Week 10 to Week 14)|Adverse Event|3
2573847|NCT01259492|8902857|P4|Period 1 (9 Weeks)|Protocol Violation|1
2573848|NCT01259492|8902858|P3|Period 1 (9 Weeks)|Protocol Violation|3
2573849|NCT01259492|8902859|P2|Period 1 (9 Weeks)|Protocol Violation|6
2573850|NCT01259492|8902860|P1|Period 1 (9 Weeks)|Protocol Violation|5
2573851|NCT01259492|8902857|P4|Period 1 (9 Weeks)|Administrative Problems|2
2573852|NCT01259492|8902858|P3|Period 1 (9 Weeks)|Administrative Problems|1
2573853|NCT01259492|8902859|P2|Period 1 (9 Weeks)|Administrative Problems|1
2573854|NCT01259492|8902860|P1|Period 1 (9 Weeks)|Administrative Problems|0
2573855|NCT01259492|8902857|P4|Period 1 (9 Weeks)|Lost to Follow-up|4
2573856|NCT01259492|8902858|P3|Period 1 (9 Weeks)|Lost to Follow-up|3
2573857|NCT01259492|8902859|P2|Period 1 (9 Weeks)|Lost to Follow-up|6
2573858|NCT01259492|8902860|P1|Period 1 (9 Weeks)|Lost to Follow-up|4
2573859|NCT01259492|8902857|P4|Period 1 (9 Weeks)|Withdrawal by Subject|7
2573860|NCT01259492|8902858|P3|Period 1 (9 Weeks)|Withdrawal by Subject|6
2573861|NCT01259492|8902859|P2|Period 1 (9 Weeks)|Withdrawal by Subject|8
2573862|NCT01259492|8902860|P1|Period 1 (9 Weeks)|Withdrawal by Subject|5
2573863|NCT01259492|8902857|P4|Period 1 (9 Weeks)|Lack of Efficacy|11
2573864|NCT01259492|8902858|P3|Period 1 (9 Weeks)|Lack of Efficacy|4
2573865|NCT01259492|8902859|P2|Period 1 (9 Weeks)|Lack of Efficacy|2
2573866|NCT01259492|8902860|P1|Period 1 (9 Weeks)|Lack of Efficacy|2
2573867|NCT01259492|8902857|P4|Period 1 (9 Weeks)|Adverse Event|3
2573868|NCT01259492|8902858|P3|Period 1 (9 Weeks)|Adverse Event|26
2573869|NCT01259492|8902859|P2|Period 1 (9 Weeks)|Adverse Event|18
2573870|NCT01259492|8902860|P1|Period 1 (9 Weeks)|Adverse Event|13
2573871|NCT01259466|8902909|P2|Overall Study|Withdrawal by Subject|9
2573872|NCT01259466|8902910|P1|Overall Study|Withdrawal by Subject|1
2573873|NCT01259401|8902948|P2|4-month Follow-up|Lost to Follow-up|1
2573874|NCT01259401|8902949|P1|4-month Follow-up|Lost to Follow-up|0
2573875|NCT01259401|8902948|P2|4-month Follow-up|Death|1
2573876|NCT01259401|8902949|P1|4-month Follow-up|Death|0
2573877|NCT01259388|8902959|P2|Overall Study|Physician Decision|0
2573878|NCT01259388|8902960|P1|Overall Study|Physician Decision|1
2573879|NCT01259388|8902959|P2|Overall Study|Withdrawal by Subject|1
2573880|NCT01259388|8902960|P1|Overall Study|Withdrawal by Subject|1
2573881|NCT01259388|8902959|P2|Overall Study|Adverse Event|0
2573882|NCT01259388|8902960|P1|Overall Study|Adverse Event|3
2573883|NCT01259375|8902970|P1|Overall Study|Adverse Event|1
2573884|NCT01259297|8902987|P8|Double Blind Randomized Period|Other reasons|1
2573885|NCT01259297|8902988|P7|Double Blind Randomized Period|Other reasons|3
2573886|NCT01259297|8902989|P6|Double Blind Randomized Period|Other reasons|2
2573887|NCT01259297|8902990|P5|Double Blind Randomized Period|Other reasons|1
2573888|NCT01259297|8902991|P4|Double Blind Randomized Period|Other reasons|0
2573889|NCT01259297|8902992|P3|Double Blind Randomized Period|Other reasons|0
2573890|NCT01259297|8902993|P2|Double Blind Randomized Period|Other reasons|1
2573891|NCT01259297|8902994|P1|Double Blind Randomized Period|Other reasons|0
2573892|NCT01259297|8902987|P8|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
2573893|NCT01259297|8902988|P7|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
2573894|NCT01259297|8902989|P6|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
2573895|NCT01259297|8902990|P5|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
2573896|NCT01259297|8902991|P4|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
2573897|NCT01259297|8902992|P3|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0
2573898|NCT01259297|8902993|P2|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
2573899|NCT01259297|8902994|P1|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
2573900|NCT01259297|8902987|P8|Double Blind Randomized Period|Death|1
2573901|NCT01259297|8902988|P7|Double Blind Randomized Period|Death|2
2573902|NCT01259297|8902989|P6|Double Blind Randomized Period|Death|5
2573903|NCT01259297|8902990|P5|Double Blind Randomized Period|Death|1
2573904|NCT01259297|8902991|P4|Double Blind Randomized Period|Death|2
2573905|NCT01259297|8902992|P3|Double Blind Randomized Period|Death|1
2573906|NCT01259297|8902993|P2|Double Blind Randomized Period|Death|1
2573907|NCT01259297|8902994|P1|Double Blind Randomized Period|Death|1
2573908|NCT01259284|8903025|P3|Overall Study|Study Termination|0
2573909|NCT01259284|8903026|P2|Overall Study|Study Termination|0
2573910|NCT01259284|8903027|P1|Overall Study|Study Termination|2
2573911|NCT01259245|8903037|P2|Overall Study|Death|2
2573912|NCT01259245|8903038|P1|Overall Study|Death|1
2573913|NCT01259245|8903037|P2|Overall Study|Withdrawal by Subject|24
2573914|NCT01259245|8903038|P1|Overall Study|Withdrawal by Subject|27
2573915|NCT01259115|8903062|P2|Period 2|Adverse Event|0
2573916|NCT01259115|8903063|P1|Period 2|Adverse Event|1
2573917|NCT01259115|8903062|P2|Period 1|Lost to Follow-up|1
2573918|NCT01259115|8903063|P1|Period 1|Lost to Follow-up|0
2573919|NCT01259115|8903062|P2|Period 1|Protocol Violation|0
2573920|NCT01259115|8903063|P1|Period 1|Protocol Violation|2
2573921|NCT01259115|8903062|P2|Period 1|Adverse Event|0
2573922|NCT01259115|8903063|P1|Period 1|Adverse Event|1
2573923|NCT01259102|8903099|P5|Overall Study|Other|1
2573924|NCT01259102|8903100|P4|Overall Study|Other|1
2573925|NCT01259102|8903101|P3|Overall Study|Other|1
2573926|NCT01259102|8903102|P2|Overall Study|Other|0
2573927|NCT01259102|8903103|P1|Overall Study|Other|0
2573928|NCT01259102|8903099|P5|Overall Study|Adverse Event|0
2573929|NCT01259102|8903100|P4|Overall Study|Adverse Event|1
2573930|NCT01259102|8903101|P3|Overall Study|Adverse Event|1
2573931|NCT01259102|8903102|P2|Overall Study|Adverse Event|0
2573932|NCT01259102|8903103|P1|Overall Study|Adverse Event|1
2573933|NCT01259089|8903160|P6|Survival Follow up for Two Years|stopped being followed as study closed|4
2573934|NCT01259089|8903161|P5|Survival Follow up for Two Years|stopped being followed as study closed|0
2573935|NCT01259089|8903162|P4|Survival Follow up for Two Years|stopped being followed as study closed|0
2573936|NCT01259089|8903163|P3|Survival Follow up for Two Years|stopped being followed as study closed|0
2573937|NCT01259089|8903164|P2|Survival Follow up for Two Years|stopped being followed as study closed|0
2573938|NCT01259089|8903165|P1|Survival Follow up for Two Years|stopped being followed as study closed|0
2573939|NCT01259089|8903160|P6|Survival Follow up for Two Years|Lost to Follow-up|2
2573940|NCT01259089|8903161|P5|Survival Follow up for Two Years|Lost to Follow-up|0
2573941|NCT01259089|8903162|P4|Survival Follow up for Two Years|Lost to Follow-up|0
2573942|NCT01259089|8903163|P3|Survival Follow up for Two Years|Lost to Follow-up|0
2573943|NCT01259089|8903164|P2|Survival Follow up for Two Years|Lost to Follow-up|0
2573944|NCT01259089|8903165|P1|Survival Follow up for Two Years|Lost to Follow-up|0
2573945|NCT01259089|8903160|P6|Survival Follow up for Two Years|Death|13
2573946|NCT01259089|8903161|P5|Survival Follow up for Two Years|Death|6
2573947|NCT01259089|8903162|P4|Survival Follow up for Two Years|Death|3
2573948|NCT01259089|8903163|P3|Survival Follow up for Two Years|Death|2
2573949|NCT01259089|8903164|P2|Survival Follow up for Two Years|Death|2
2573950|NCT01259089|8903165|P1|Survival Follow up for Two Years|Death|3
2573951|NCT01259089|8903160|P6|Continued Treatment After 8 Weeks|Progressive disease|0
2573952|NCT01259089|8903161|P5|Continued Treatment After 8 Weeks|Progressive disease|0
2573953|NCT01259089|8903162|P4|Continued Treatment After 8 Weeks|Progressive disease|1
2573954|NCT01259089|8903163|P3|Continued Treatment After 8 Weeks|Progressive disease|1
2573955|NCT01259089|8903164|P2|Continued Treatment After 8 Weeks|Progressive disease|1
2573956|NCT01259089|8903165|P1|Continued Treatment After 8 Weeks|Progressive disease|1
2573957|NCT01259089|8903160|P6|Continued Treatment After 8 Weeks|Adverse Event|1
2573958|NCT01259089|8903161|P5|Continued Treatment After 8 Weeks|Adverse Event|2
2573959|NCT01259089|8903162|P4|Continued Treatment After 8 Weeks|Adverse Event|0
2573960|NCT01259089|8903163|P3|Continued Treatment After 8 Weeks|Adverse Event|0
2573961|NCT01259089|8903164|P2|Continued Treatment After 8 Weeks|Adverse Event|0
2573962|NCT01259089|8903165|P1|Continued Treatment After 8 Weeks|Adverse Event|0
2573963|NCT01259089|8903160|P6|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
2573964|NCT01259089|8903161|P5|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
2573965|NCT01259089|8903162|P4|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
2573966|NCT01259089|8903163|P3|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
2573967|NCT01259089|8903164|P2|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
2573968|NCT01259089|8903165|P1|Continued Treatment After 8 Weeks|Withdrawal by Subject|1
2573969|NCT01259089|8903160|P6|Confirmed Response at 8 Weeks|Progressive disease|7
2573970|NCT01259089|8903161|P5|Confirmed Response at 8 Weeks|Progressive disease|3
2573971|NCT01259089|8903162|P4|Confirmed Response at 8 Weeks|Progressive disease|1
2573972|NCT01259089|8903163|P3|Confirmed Response at 8 Weeks|Progressive disease|1
2573973|NCT01259089|8903164|P2|Confirmed Response at 8 Weeks|Progressive disease|0
2573974|NCT01259089|8903165|P1|Confirmed Response at 8 Weeks|Progressive disease|0
2573975|NCT01259089|8903160|P6|Confirmed Response at 8 Weeks|Adverse Event|2
2573976|NCT01259089|8903161|P5|Confirmed Response at 8 Weeks|Adverse Event|1
2573977|NCT01259089|8903162|P4|Confirmed Response at 8 Weeks|Adverse Event|0
2573978|NCT01259089|8903163|P3|Confirmed Response at 8 Weeks|Adverse Event|0
2573979|NCT01259089|8903164|P2|Confirmed Response at 8 Weeks|Adverse Event|0
2573980|NCT01259089|8903165|P1|Confirmed Response at 8 Weeks|Adverse Event|0
2573981|NCT01259089|8903160|P6|Confirmed Response at 8 Weeks|Withdrawal by Subject|1
2573982|NCT01259089|8903161|P5|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
2573983|NCT01259089|8903162|P4|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
2573984|NCT01259089|8903163|P3|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
2573985|NCT01259089|8903164|P2|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
2573986|NCT01259089|8903165|P1|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
2573987|NCT01259089|8903160|P6|Reached First Response at 4 Weeks|Adverse Event|1
2573988|NCT01259089|8903161|P5|Reached First Response at 4 Weeks|Adverse Event|0
2573989|NCT01259089|8903162|P4|Reached First Response at 4 Weeks|Adverse Event|0
2573990|NCT01259089|8903163|P3|Reached First Response at 4 Weeks|Adverse Event|0
2573991|NCT01259089|8903164|P2|Reached First Response at 4 Weeks|Adverse Event|0
2573992|NCT01259089|8903165|P1|Reached First Response at 4 Weeks|Adverse Event|0
2573993|NCT01259089|8903160|P6|Reached First Response at 4 Weeks|Patient not treated on study|1
2573994|NCT01259089|8903161|P5|Reached First Response at 4 Weeks|Patient not treated on study|0
2573995|NCT01259089|8903162|P4|Reached First Response at 4 Weeks|Patient not treated on study|0
2573996|NCT01259089|8903163|P3|Reached First Response at 4 Weeks|Patient not treated on study|0
2573997|NCT01259089|8903164|P2|Reached First Response at 4 Weeks|Patient not treated on study|0
2573998|NCT01259089|8903165|P1|Reached First Response at 4 Weeks|Patient not treated on study|0
2573999|NCT01259024|8903193|P1|Overall Study|Physician Decision|1
2574000|NCT01258998|8903213|P1|Overall Study|Ineligible|1
2574001|NCT01258803|8903267|P6|Treatment Period 3 (1 Dose)|Protocol Violation|0
2574002|NCT01258803|8903268|P5|Treatment Period 3 (1 Dose)|Protocol Violation|0
2574003|NCT01258803|8903269|P4|Treatment Period 3 (1 Dose)|Protocol Violation|0
2574004|NCT01258803|8903270|P3|Treatment Period 3 (1 Dose)|Protocol Violation|1
2574005|NCT01258803|8903271|P2|Treatment Period 3 (1 Dose)|Protocol Violation|0
2574006|NCT01258803|8903272|P1|Treatment Period 3 (1 Dose)|Protocol Violation|0
2574007|NCT01258803|8903267|P6|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
2574008|NCT01258803|8903268|P5|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
2574009|NCT01258803|8903269|P4|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
2574010|NCT01258803|8903270|P3|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
2574011|NCT01258803|8903271|P2|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1
2574012|NCT01258803|8903272|P1|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
2574013|NCT01258803|8903267|P6|Treatment Period 2 (1 Dose)|Protocol Violation|1
2574014|NCT01258803|8903268|P5|Treatment Period 2 (1 Dose)|Protocol Violation|0
2574015|NCT01258803|8903269|P4|Treatment Period 2 (1 Dose)|Protocol Violation|0
2574016|NCT01258803|8903270|P3|Treatment Period 2 (1 Dose)|Protocol Violation|0
2574017|NCT01258803|8903271|P2|Treatment Period 2 (1 Dose)|Protocol Violation|1
2574018|NCT01258803|8903272|P1|Treatment Period 2 (1 Dose)|Protocol Violation|1
2574019|NCT01258738|8903309|P2|Open-label Period|Withdrawn due to pregnancy|1
2574020|NCT01258738|8903310|P1|Open-label Period|Withdrawn due to pregnancy|1
2574021|NCT01258738|8903309|P2|Open-label Period|Other Reasons|1
2574022|NCT01258738|8903310|P1|Open-label Period|Other Reasons|0
2574023|NCT01258738|8903309|P2|Open-label Period|Adverse Event|5
2574024|NCT01258738|8903310|P1|Open-label Period|Adverse Event|4
2574025|NCT01258738|8903309|P2|Open-label Period|Protocol Violation|2
2574026|NCT01258738|8903310|P1|Open-label Period|Protocol Violation|2
2574027|NCT01258738|8903309|P2|Open-label Period|Withdrawal by Subject|6
2574028|NCT01258738|8903310|P1|Open-label Period|Withdrawal by Subject|5
2574029|NCT01258738|8903309|P2|Open-label Period|Lost to Follow-up|2
2574030|NCT01258738|8903310|P1|Open-label Period|Lost to Follow-up|0
2574031|NCT01258738|8903309|P2|Open-label Period|Insufficient clinical response|3
2574032|NCT01258738|8903310|P1|Open-label Period|Insufficient clinical response|5
2574033|NCT01258738|8903309|P2|Open-label Period|Did not meet inclusion criteria|1
2574034|NCT01258738|8903310|P1|Open-label Period|Did not meet inclusion criteria|0
2574035|NCT01258738|8903309|P2|Double-blind Period|Adverse Event|1
2574036|NCT01258738|8903310|P1|Double-blind Period|Adverse Event|3
2574037|NCT01258738|8903309|P2|Double-blind Period|Protocol Violation|1
2574038|NCT01258738|8903310|P1|Double-blind Period|Protocol Violation|1
2574039|NCT01258738|8903309|P2|Double-blind Period|Withdrawal by Subject|2
2574040|NCT01258738|8903310|P1|Double-blind Period|Withdrawal by Subject|2
2574041|NCT01258738|8903309|P2|Double-blind Period|Did not meet inclusion criteria|3
2574042|NCT01258738|8903310|P1|Double-blind Period|Did not meet inclusion criteria|3
2574043|NCT01258660|8903448|P2|Overall Study|Invalid for primary analysis data set|6
2574044|NCT01258660|8903449|P1|Overall Study|Invalid for primary analysis data set|4
2574045|NCT01258660|8903448|P2|Overall Study|Protocol Violation|1
2574046|NCT01258660|8903449|P1|Overall Study|Protocol Violation|0
2574047|NCT01258660|8903448|P2|Overall Study|due to relocation|0
2574048|NCT01258660|8903449|P1|Overall Study|due to relocation|2
2574049|NCT01258660|8903448|P2|Overall Study|Withdrawal by Subject|0
2574050|NCT01258660|8903449|P1|Overall Study|Withdrawal by Subject|3
2574051|NCT01258660|8903448|P2|Overall Study|Adverse Event|4
2574052|NCT01258660|8903449|P1|Overall Study|Adverse Event|2
2574053|NCT01258608|8903468|P2|Overall Study|Withdrawal by Subject|5
2574054|NCT01258608|8903469|P1|Overall Study|Withdrawal by Subject|6
2574055|NCT01258608|8903468|P2|Overall Study|Adverse Event|10
2574056|NCT01258608|8903469|P1|Overall Study|Adverse Event|6
2574057|NCT01258608|8903468|P2|Overall Study|Lack of Efficacy|1
2574058|NCT01258608|8903469|P1|Overall Study|Lack of Efficacy|0
2574059|NCT01258608|8903468|P2|Overall Study|Lack of compliance|0
2574060|NCT01258608|8903469|P1|Overall Study|Lack of compliance|1
2574061|NCT01258608|8903468|P2|Overall Study|Lost to Follow-up|1
2574062|NCT01258608|8903469|P1|Overall Study|Lost to Follow-up|0
2574063|NCT01258608|8903468|P2|Overall Study|Physician Decision|1
2574064|NCT01258608|8903469|P1|Overall Study|Physician Decision|6
2574065|NCT01258608|8903468|P2|Overall Study|Sponsor decision|1
2574066|NCT01258608|8903469|P1|Overall Study|Sponsor decision|0
2574067|NCT01258608|8903468|P2|Overall Study|Clinical progression|0
2574068|NCT01258608|8903469|P1|Overall Study|Clinical progression|1
2574069|NCT01258608|8903468|P2|Overall Study|Metastatic Hepatocellular Carcinoma|0
2574070|NCT01258608|8903469|P1|Overall Study|Metastatic Hepatocellular Carcinoma|1
2574071|NCT01258595|8903517|P2|Overall Study|Withdrawal by Subject|1
2574072|NCT01258595|8903518|P1|Overall Study|Withdrawal by Subject|0
2574073|NCT01258595|8903517|P2|Overall Study|Lost to Follow-up|0
2574074|NCT01258595|8903518|P1|Overall Study|Lost to Follow-up|1
2574075|NCT01258348|8903615|P5|Overall Study|Withdrawal by Subject|0
2574076|NCT01258348|8903616|P4|Overall Study|Withdrawal by Subject|0
2574077|NCT01258348|8903617|P3|Overall Study|Withdrawal by Subject|0
2574078|NCT01258348|8903618|P2|Overall Study|Withdrawal by Subject|1
2574079|NCT01258348|8903619|P1|Overall Study|Withdrawal by Subject|0
2574080|NCT01258348|8903615|P5|Overall Study|Physician Decision|0
2574081|NCT01258348|8903616|P4|Overall Study|Physician Decision|2
2574082|NCT01258348|8903617|P3|Overall Study|Physician Decision|0
2574083|NCT01258348|8903618|P2|Overall Study|Physician Decision|0
2574084|NCT01258348|8903619|P1|Overall Study|Physician Decision|0
2574085|NCT01258348|8903615|P5|Overall Study|Progressive Disease|2
2574086|NCT01258348|8903616|P4|Overall Study|Progressive Disease|2
2574087|NCT01258348|8903617|P3|Overall Study|Progressive Disease|0
2574088|NCT01258348|8903618|P2|Overall Study|Progressive Disease|3
2574089|NCT01258348|8903619|P1|Overall Study|Progressive Disease|0
2574090|NCT01258348|8903615|P5|Overall Study|Adverse Event|4
2574091|NCT01258348|8903616|P4|Overall Study|Adverse Event|2
2574092|NCT01258348|8903617|P3|Overall Study|Adverse Event|3
2574093|NCT01258348|8903618|P2|Overall Study|Adverse Event|1
2574094|NCT01258348|8903619|P1|Overall Study|Adverse Event|1
2574095|NCT01258101|8903676|P4|Overall Study|Other reason|8
2574096|NCT01258101|8903677|P3|Overall Study|Other reason|1
2574097|NCT01258101|8903678|P2|Overall Study|Other reason|8
2574098|NCT01258101|8903679|P1|Overall Study|Other reason|7
2574099|NCT01258101|8903676|P4|Overall Study|PCR positive at week 24|1
2574100|NCT01258101|8903677|P3|Overall Study|PCR positive at week 24|0
2574101|NCT01258101|8903678|P2|Overall Study|PCR positive at week 24|0
2574102|NCT01258101|8903679|P1|Overall Study|PCR positive at week 24|0
2574103|NCT01258101|8903676|P4|Overall Study|Lost to Follow-up|6
2574104|NCT01258101|8903677|P3|Overall Study|Lost to Follow-up|0
2574105|NCT01258101|8903678|P2|Overall Study|Lost to Follow-up|5
2574106|NCT01258101|8903679|P1|Overall Study|Lost to Follow-up|5
2574107|NCT01258101|8903676|P4|Overall Study|Patient´s compliance|2
2574108|NCT01258101|8903677|P3|Overall Study|Patient´s compliance|1
2574109|NCT01258101|8903678|P2|Overall Study|Patient´s compliance|3
2574110|NCT01258101|8903679|P1|Overall Study|Patient´s compliance|4
2574111|NCT01258101|8903676|P4|Overall Study|Patient is not able to attend visits|6
2574112|NCT01258101|8903677|P3|Overall Study|Patient is not able to attend visits|7
2574113|NCT01258101|8903678|P2|Overall Study|Patient is not able to attend visits|9
2574114|NCT01258101|8903679|P1|Overall Study|Patient is not able to attend visits|8
2574115|NCT01258101|8903676|P4|Overall Study|Informed consent has been withdrawn|1
2574116|NCT01258101|8903677|P3|Overall Study|Informed consent has been withdrawn|1
2574117|NCT01258101|8903678|P2|Overall Study|Informed consent has been withdrawn|2
2574118|NCT01258101|8903679|P1|Overall Study|Informed consent has been withdrawn|2
2574119|NCT01258101|8903676|P4|Overall Study|Extra exclusion criterion amended|1
2574120|NCT01258101|8903677|P3|Overall Study|Extra exclusion criterion amended|1
2574121|NCT01258101|8903678|P2|Overall Study|Extra exclusion criterion amended|1
2574122|NCT01258101|8903679|P1|Overall Study|Extra exclusion criterion amended|2
2574123|NCT01258101|8903676|P4|Overall Study|Adverse Event|0
2574124|NCT01258101|8903677|P3|Overall Study|Adverse Event|0
2574125|NCT01258101|8903678|P2|Overall Study|Adverse Event|6
2574126|NCT01258101|8903679|P1|Overall Study|Adverse Event|5
2574127|NCT01257737|8903809|P2|Overall Study|Withdrew from study|1
2574128|NCT01257737|8903810|P1|Overall Study|Withdrew from study|0
2574129|NCT01257737|8903809|P2|Overall Study|Relocation out of the country|1
2574130|NCT01257737|8903810|P1|Overall Study|Relocation out of the country|0
2574131|NCT01257737|8903809|P2|Overall Study|Liver transplant|0
2574132|NCT01257737|8903810|P1|Overall Study|Liver transplant|1
2574133|NCT01257737|8903809|P2|Overall Study|Lost to Follow-up|2
2574134|NCT01257737|8903810|P1|Overall Study|Lost to Follow-up|1
2574135|NCT01257698|8903830|P2|Overall Study|Protocol Violation|0
2574136|NCT01257698|8903831|P1|Overall Study|Protocol Violation|4
2574137|NCT01257581|8903840|P3|Overall Study|Death|4
2574138|NCT01257581|8903841|P2|Overall Study|Death|2
2574139|NCT01257581|8903842|P1|Overall Study|Death|2
2574140|NCT01257581|8903840|P3|Overall Study|Early Termination|2
2574141|NCT01257581|8903841|P2|Overall Study|Early Termination|1
2574142|NCT01257581|8903842|P1|Overall Study|Early Termination|3
2574143|NCT01257568|8903880|P1|Overall Study|Component Revision|24
2574144|NCT01257568|8903880|P1|Overall Study|Terminated|1
2574145|NCT01257568|8903880|P1|Overall Study|Withdrawal by Subject|6
2574146|NCT01257568|8903880|P1|Overall Study|Lost to Follow-up|2
2574147|NCT01257542|8903894|P2|Overall Study|Withdrawal by Subject|2
2574148|NCT01257542|8903895|P1|Overall Study|Withdrawal by Subject|0
2574149|NCT01257542|8903894|P2|Overall Study|Protocol Violation|5
2574150|NCT01257542|8903895|P1|Overall Study|Protocol Violation|3
2574151|NCT01257503|8903915|P2|Overall Study|strep culture positive at enrollment|0
2574152|NCT01257503|8903916|P1|Overall Study|strep culture positive at enrollment|1
2574153|NCT01257503|8903915|P2|Overall Study|Over 5 years old at enrollment|1
2574154|NCT01257503|8903916|P1|Overall Study|Over 5 years old at enrollment|0
2574155|NCT01257503|8903915|P2|Overall Study|Lost to Follow-up|10
2574156|NCT01257503|8903916|P1|Overall Study|Lost to Follow-up|7
2574157|NCT01257425|8903945|P2|Overall Study|Death|0
2574158|NCT01257425|8903946|P1|Overall Study|Death|1
2574159|NCT01257425|8903945|P2|Overall Study|Withdrawal by Subject|1
2574160|NCT01257425|8903946|P1|Overall Study|Withdrawal by Subject|0
2574161|NCT01257425|8903945|P2|Overall Study|Protocol Violation|1
2574162|NCT01257425|8903946|P1|Overall Study|Protocol Violation|1
2574163|NCT01257425|8903945|P2|Overall Study|Adverse Event|1
2574164|NCT01257425|8903946|P1|Overall Study|Adverse Event|1
2574165|NCT01257425|8903945|P2|Overall Study|Lack of Efficacy|3
2574166|NCT01257425|8903946|P1|Overall Study|Lack of Efficacy|3
2574167|NCT01257230|8903988|P3|Overall Study|Other reason not defined above|3
2574168|NCT01257230|8903989|P2|Overall Study|Other reason not defined above|5
2574169|NCT01257230|8903990|P1|Overall Study|Other reason not defined above|1
2574170|NCT01257230|8903988|P3|Overall Study|Withdrawal by Subject|1
2574171|NCT01257230|8903989|P2|Overall Study|Withdrawal by Subject|4
2574172|NCT01257230|8903990|P1|Overall Study|Withdrawal by Subject|0
2574173|NCT01257230|8903988|P3|Overall Study|Protocol Violation|1
2574174|NCT01257230|8903989|P2|Overall Study|Protocol Violation|0
2574175|NCT01257230|8903990|P1|Overall Study|Protocol Violation|3
2574176|NCT01257230|8903988|P3|Overall Study|Lack of Efficacy|0
2574177|NCT01257230|8903989|P2|Overall Study|Lack of Efficacy|1
2574178|NCT01257230|8903990|P1|Overall Study|Lack of Efficacy|0
2574179|NCT01257230|8903988|P3|Overall Study|Adverse Event|0
2574180|NCT01257230|8903989|P2|Overall Study|Adverse Event|0
2574181|NCT01257230|8903990|P1|Overall Study|Adverse Event|2
2574182|NCT01257230|8903988|P3|Overall Study|Not Treated|1
2574183|NCT01257230|8903989|P2|Overall Study|Not Treated|0
2574184|NCT01257230|8903990|P1|Overall Study|Not Treated|0
2574185|NCT01257204|8904067|P3|Follow-up Period (up to Week 48)|Other|5
2574186|NCT01257204|8904068|P2|Follow-up Period (up to Week 48)|Other|0
2574187|NCT01257204|8904069|P1|Follow-up Period (up to Week 48)|Other|0
2574188|NCT01257204|8904067|P3|Follow-up Period (up to Week 48)|Lost to Follow-up|4
2574189|NCT01257204|8904068|P2|Follow-up Period (up to Week 48)|Lost to Follow-up|4
2574190|NCT01257204|8904069|P1|Follow-up Period (up to Week 48)|Lost to Follow-up|1
2574191|NCT01257204|8904067|P3|Follow-up Period (up to Week 48)|Withdrawal by Subject|1
2574192|NCT01257204|8904068|P2|Follow-up Period (up to Week 48)|Withdrawal by Subject|2
2574193|NCT01257204|8904069|P1|Follow-up Period (up to Week 48)|Withdrawal by Subject|0
2574194|NCT01257204|8904067|P3|Treatment Period (up to Week 24)|Participant's request to discontinue|2
2574195|NCT01257204|8904068|P2|Treatment Period (up to Week 24)|Participant's request to discontinue|2
2574196|NCT01257204|8904069|P1|Treatment Period (up to Week 24)|Participant's request to discontinue|1
2574197|NCT01257204|8904067|P3|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1
2574198|NCT01257204|8904068|P2|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
2574199|NCT01257204|8904069|P1|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
2574200|NCT01257204|8904067|P3|Treatment Period (up to Week 24)|Lost to Follow-up|0
2574201|NCT01257204|8904068|P2|Treatment Period (up to Week 24)|Lost to Follow-up|2
2574202|NCT01257204|8904069|P1|Treatment Period (up to Week 24)|Lost to Follow-up|0
2574203|NCT01257204|8904067|P3|Treatment Period (up to Week 24)|Withdrawal by Subject|1
2574204|NCT01257204|8904068|P2|Treatment Period (up to Week 24)|Withdrawal by Subject|0
2574205|NCT01257204|8904069|P1|Treatment Period (up to Week 24)|Withdrawal by Subject|1
2574206|NCT01257204|8904067|P3|Treatment Period (up to Week 24)|Adverse Event|2
2574207|NCT01257204|8904068|P2|Treatment Period (up to Week 24)|Adverse Event|1
2574208|NCT01257204|8904069|P1|Treatment Period (up to Week 24)|Adverse Event|3
2574209|NCT01257204|8904067|P3|Treatment Period (up to Week 24)|Lack of Efficacy|3
2574210|NCT01257204|8904068|P2|Treatment Period (up to Week 24)|Lack of Efficacy|1
2574211|NCT01257204|8904069|P1|Treatment Period (up to Week 24)|Lack of Efficacy|0
2574212|NCT01256879|8904164|P1|Overall Study|Withdrawal by Subject|1
2574213|NCT01256788|8904190|P3|Overall Study|Lost to Follow-up|3
2574214|NCT01256788|8904191|P2|Overall Study|Lost to Follow-up|8
2574215|NCT01256788|8904192|P1|Overall Study|Lost to Follow-up|5
2574216|NCT01256684|8904203|P3|Overall Study|Entry criteria not met/non-compliance|6
2574217|NCT01256684|8904204|P2|Overall Study|Entry criteria not met/non-compliance|7
2574218|NCT01256684|8904205|P1|Overall Study|Entry criteria not met/non-compliance|4
2574219|NCT01256684|8904203|P3|Overall Study|Lack of Efficacy|1
2574220|NCT01256684|8904204|P2|Overall Study|Lack of Efficacy|1
2574221|NCT01256684|8904205|P1|Overall Study|Lack of Efficacy|0
2574222|NCT01256684|8904203|P3|Overall Study|Physician Decision|0
2574223|NCT01256684|8904204|P2|Overall Study|Physician Decision|1
2574224|NCT01256684|8904205|P1|Overall Study|Physician Decision|0
2574225|NCT01256684|8904203|P3|Overall Study|Withdrawal by Subject|2
2574226|NCT01256684|8904204|P2|Overall Study|Withdrawal by Subject|0
2574227|NCT01256684|8904205|P1|Overall Study|Withdrawal by Subject|4
2574228|NCT01256684|8904203|P3|Overall Study|Adverse Event|2
2574229|NCT01256684|8904204|P2|Overall Study|Adverse Event|4
2574230|NCT01256684|8904205|P1|Overall Study|Adverse Event|1
2574231|NCT01256671|8904237|P1|Overall Study|Non-compliance/Sponsor Decision/Other|12
2574232|NCT01256671|8904237|P1|Overall Study|Lack of Efficacy|4
2574233|NCT01256671|8904237|P1|Overall Study|Physician Decision|3
2574234|NCT01256671|8904237|P1|Overall Study|Withdrawal by Subject|31
2574235|NCT01256671|8904237|P1|Overall Study|Lost to Follow-up|16
2574236|NCT01256671|8904237|P1|Overall Study|Adverse Event|29
2574237|NCT01256658|8904250|P2|Period 1|Death|44
2574238|NCT01256658|8904251|P1|Period 1|Death|48
2574239|NCT01256658|8904250|P2|Period 1|Withdrawal by Subject|43
2574240|NCT01256658|8904251|P1|Period 1|Withdrawal by Subject|35
2574241|NCT01256658|8904250|P2|Period 1|Lost to Follow-up|661
2574242|NCT01256658|8904251|P1|Period 1|Lost to Follow-up|837
2574243|NCT01256593|8904301|P1|Overall Study|No Visit After Treatment|186
2574244|NCT01256593|8904301|P1|Overall Study|No Drug Administration Information|2
2574245|NCT01256593|8904301|P1|Overall Study|Protocol Violation|26
2574246|NCT01256567|8904315|P1|Overall Study|Withdrawal by Subject|1
2574247|NCT01256502|8904325|P1|Overall Study|Protocol deviation|1
2574248|NCT01256502|8904325|P1|Overall Study|Personal reasons|5
2574249|NCT01256502|8904325|P1|Overall Study|Had scaffold removed|4
2574250|NCT01256476|8904337|P2|Overall Study|LDL-C elevation exceeding 250 mg/dL|1
2574251|NCT01256476|8904338|P1|Overall Study|LDL-C elevation exceeding 250 mg/dL|0
2574252|NCT01256476|8904337|P2|Overall Study|Subject non-compliance|1
2574253|NCT01256476|8904338|P1|Overall Study|Subject non-compliance|0
2574254|NCT01256476|8904337|P2|Overall Study|Physician Decision|1
2574255|NCT01256476|8904338|P1|Overall Study|Physician Decision|0
2574256|NCT01256476|8904337|P2|Overall Study|Persistent ALT or AST elevation|0
2574257|NCT01256476|8904338|P1|Overall Study|Persistent ALT or AST elevation|1
2574258|NCT01256476|8904337|P2|Overall Study|Lost to Follow-up|2
2574259|NCT01256476|8904338|P1|Overall Study|Lost to Follow-up|1
2574260|NCT01256476|8904337|P2|Overall Study|Withdrawal by Subject|1
2574261|NCT01256476|8904338|P1|Overall Study|Withdrawal by Subject|2
2574262|NCT01256476|8904337|P2|Overall Study|Adverse Event|1
2574263|NCT01256476|8904338|P1|Overall Study|Adverse Event|2
2574264|NCT01256450|8904346|P3|Double-blind Treatment|Other|12
2574265|NCT01256450|8904347|P2|Double-blind Treatment|Other|9
2574266|NCT01256450|8904348|P1|Double-blind Treatment|Other|0
2574267|NCT01256450|8904346|P3|Double-blind Treatment|Opioid withdrawal symptoms|1
2574268|NCT01256450|8904347|P2|Double-blind Treatment|Opioid withdrawal symptoms|0
2574269|NCT01256450|8904348|P1|Double-blind Treatment|Opioid withdrawal symptoms|0
2574270|NCT01256450|8904346|P3|Double-blind Treatment|Non-compliance|4
2574271|NCT01256450|8904347|P2|Double-blind Treatment|Non-compliance|5
2574272|NCT01256450|8904348|P1|Double-blind Treatment|Non-compliance|0
2574273|NCT01256450|8904346|P3|Double-blind Treatment|Lack of analgesic effect|6
2574274|NCT01256450|8904347|P2|Double-blind Treatment|Lack of analgesic effect|5
2574275|NCT01256450|8904348|P1|Double-blind Treatment|Lack of analgesic effect|0
2574276|NCT01256450|8904346|P3|Double-blind Treatment|Withdrawal by Subject|1
2574277|NCT01256450|8904347|P2|Double-blind Treatment|Withdrawal by Subject|0
2574278|NCT01256450|8904348|P1|Double-blind Treatment|Withdrawal by Subject|0
2574279|NCT01256450|8904346|P3|Double-blind Treatment|Lost to Follow-up|7
2574280|NCT01256450|8904347|P2|Double-blind Treatment|Lost to Follow-up|1
2574281|NCT01256450|8904348|P1|Double-blind Treatment|Lost to Follow-up|0
2574282|NCT01256450|8904346|P3|Double-blind Treatment|Adverse Event|6
2574283|NCT01256450|8904347|P2|Double-blind Treatment|Adverse Event|8
2574284|NCT01256450|8904348|P1|Double-blind Treatment|Adverse Event|0
2574285|NCT01256450|8904346|P3|Open-label Titration|Other|0
2574286|NCT01256450|8904347|P2|Open-label Titration|Other|0
2574287|NCT01256450|8904348|P1|Open-label Titration|Other|13
2574288|NCT01256450|8904346|P3|Open-label Titration|Screen failure|0
2574289|NCT01256450|8904347|P2|Open-label Titration|Screen failure|0
2574290|NCT01256450|8904348|P1|Open-label Titration|Screen failure|1
2574291|NCT01256450|8904346|P3|Open-label Titration|Non-compliance|0
2574292|NCT01256450|8904347|P2|Open-label Titration|Non-compliance|0
2574293|NCT01256450|8904348|P1|Open-label Titration|Non-compliance|9
2574294|NCT01256450|8904346|P3|Open-label Titration|Lack of analgesic effect|0
2574295|NCT01256450|8904347|P2|Open-label Titration|Lack of analgesic effect|0
2574296|NCT01256450|8904348|P1|Open-label Titration|Lack of analgesic effect|30
2574297|NCT01256450|8904346|P3|Open-label Titration|Lost to Follow-up|0
2574298|NCT01256450|8904347|P2|Open-label Titration|Lost to Follow-up|0
2574299|NCT01256450|8904348|P1|Open-label Titration|Lost to Follow-up|7
2574300|NCT01256450|8904346|P3|Open-label Titration|Adverse Event|0
2574301|NCT01256450|8904347|P2|Open-label Titration|Adverse Event|0
2574302|NCT01256450|8904348|P1|Open-label Titration|Adverse Event|39
2574303|NCT01256411|8904406|P6|Extension by Mono or Combination Therapy|Lack of Efficacy|1
2574304|NCT01256411|8904407|P5|Extension by Mono or Combination Therapy|Lack of Efficacy|1
2574305|NCT01256411|8904408|P4|Extension by Mono or Combination Therapy|Lack of Efficacy|0
2574306|NCT01256411|8904409|P3|Extension by Mono or Combination Therapy|Lack of Efficacy|0
2574307|NCT01256411|8904410|P2|Extension by Mono or Combination Therapy|Lack of Efficacy|0
2574308|NCT01256411|8904411|P1|Extension by Mono or Combination Therapy|Lack of Efficacy|0
2574309|NCT01256411|8904406|P6|Extension by Mono or Combination Therapy|Withdrawal by Subject|1
2574310|NCT01256411|8904407|P5|Extension by Mono or Combination Therapy|Withdrawal by Subject|7
2574311|NCT01256411|8904408|P4|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
2574312|NCT01256411|8904409|P3|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
2574313|NCT01256411|8904410|P2|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
2574314|NCT01256411|8904411|P1|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
2574315|NCT01256411|8904406|P6|Extension by Mono or Combination Therapy|Lost to Follow-up|0
2574316|NCT01256411|8904407|P5|Extension by Mono or Combination Therapy|Lost to Follow-up|3
2574317|NCT01256411|8904408|P4|Extension by Mono or Combination Therapy|Lost to Follow-up|0
2574318|NCT01256411|8904409|P3|Extension by Mono or Combination Therapy|Lost to Follow-up|0
2574319|NCT01256411|8904410|P2|Extension by Mono or Combination Therapy|Lost to Follow-up|0
2574320|NCT01256411|8904411|P1|Extension by Mono or Combination Therapy|Lost to Follow-up|0
2574321|NCT01256411|8904406|P6|Extension by Mono or Combination Therapy|Protocol deviation|1
2574322|NCT01256411|8904407|P5|Extension by Mono or Combination Therapy|Protocol deviation|0
2574323|NCT01256411|8904408|P4|Extension by Mono or Combination Therapy|Protocol deviation|0
2574324|NCT01256411|8904409|P3|Extension by Mono or Combination Therapy|Protocol deviation|0
2574325|NCT01256411|8904410|P2|Extension by Mono or Combination Therapy|Protocol deviation|0
2574326|NCT01256411|8904411|P1|Extension by Mono or Combination Therapy|Protocol deviation|0
2574327|NCT01256411|8904406|P6|Extension by Mono or Combination Therapy|Adverse Event|1
2574328|NCT01256411|8904407|P5|Extension by Mono or Combination Therapy|Adverse Event|6
2574329|NCT01256411|8904408|P4|Extension by Mono or Combination Therapy|Adverse Event|0
2574330|NCT01256411|8904409|P3|Extension by Mono or Combination Therapy|Adverse Event|0
2574331|NCT01256411|8904410|P2|Extension by Mono or Combination Therapy|Adverse Event|0
2574332|NCT01256411|8904411|P1|Extension by Mono or Combination Therapy|Adverse Event|0
2574333|NCT01256411|8904406|P6|Extension by Maximum Treatment|Adverse Event|0
2574334|NCT01256411|8904407|P5|Extension by Maximum Treatment|Adverse Event|0
2574335|NCT01256411|8904408|P4|Extension by Maximum Treatment|Adverse Event|0
2574336|NCT01256411|8904409|P3|Extension by Maximum Treatment|Adverse Event|1
2574337|NCT01256411|8904410|P2|Extension by Maximum Treatment|Adverse Event|2
2574338|NCT01256411|8904411|P1|Extension by Maximum Treatment|Adverse Event|4
2574339|NCT01256411|8904406|P6|Extension by Maximum Treatment|Lack of Efficacy|0
2574340|NCT01256411|8904407|P5|Extension by Maximum Treatment|Lack of Efficacy|0
2574341|NCT01256411|8904408|P4|Extension by Maximum Treatment|Lack of Efficacy|0
2574342|NCT01256411|8904409|P3|Extension by Maximum Treatment|Lack of Efficacy|1
2574343|NCT01256411|8904410|P2|Extension by Maximum Treatment|Lack of Efficacy|0
2574344|NCT01256411|8904411|P1|Extension by Maximum Treatment|Lack of Efficacy|1
2574345|NCT01256411|8904406|P6|Extension by Maximum Treatment|Withdrawal by Subject|0
2574346|NCT01256411|8904407|P5|Extension by Maximum Treatment|Withdrawal by Subject|0
2574347|NCT01256411|8904408|P4|Extension by Maximum Treatment|Withdrawal by Subject|0
2574348|NCT01256411|8904409|P3|Extension by Maximum Treatment|Withdrawal by Subject|1
2574349|NCT01256411|8904410|P2|Extension by Maximum Treatment|Withdrawal by Subject|6
2574350|NCT01256411|8904411|P1|Extension by Maximum Treatment|Withdrawal by Subject|1
2574351|NCT01256411|8904406|P6|Extension by Maximum Treatment|Lost to Follow-up|0
2574352|NCT01256411|8904407|P5|Extension by Maximum Treatment|Lost to Follow-up|0
2574353|NCT01256411|8904408|P4|Extension by Maximum Treatment|Lost to Follow-up|0
2574354|NCT01256411|8904409|P3|Extension by Maximum Treatment|Lost to Follow-up|0
2574355|NCT01256411|8904410|P2|Extension by Maximum Treatment|Lost to Follow-up|2
2574356|NCT01256411|8904411|P1|Extension by Maximum Treatment|Lost to Follow-up|1
2574357|NCT01256411|8904406|P6|Extension by Maximum Treatment|Protocol deviation|0
2574358|NCT01256411|8904407|P5|Extension by Maximum Treatment|Protocol deviation|0
2574359|NCT01256411|8904408|P4|Extension by Maximum Treatment|Protocol deviation|0
2574360|NCT01256411|8904409|P3|Extension by Maximum Treatment|Protocol deviation|1
2574361|NCT01256411|8904410|P2|Extension by Maximum Treatment|Protocol deviation|0
2574362|NCT01256411|8904411|P1|Extension by Maximum Treatment|Protocol deviation|0
2574363|NCT01256398|8904435|P1|Overall Study|Withdrawal by Subject|1
2574364|NCT01256385|8904441|P2|Overall Study|Withdrawal by Subject|2
2574365|NCT01256385|8904442|P1|Overall Study|Withdrawal by Subject|2
2574366|NCT01256385|8904441|P2|Overall Study|Physician Decision|1
2574367|NCT01256385|8904442|P1|Overall Study|Physician Decision|1
2574368|NCT01256294|8904462|P2|Overall Study|Protocol deviation|1
2574369|NCT01256294|8904463|P1|Overall Study|Protocol deviation|2
2574370|NCT01256294|8904462|P2|Overall Study|Withdrawal by Subject|1
2574371|NCT01256294|8904463|P1|Overall Study|Withdrawal by Subject|1
2574372|NCT01256294|8904462|P2|Overall Study|Adverse Event|0
2574373|NCT01256294|8904463|P1|Overall Study|Adverse Event|1
2574374|NCT01256190|8904485|P2|Overall Study|Lost to Follow-up|0
2574375|NCT01256190|8904486|P1|Overall Study|Lost to Follow-up|2
2574376|NCT01256177|8904502|P2|Overall Study|TG=593mg/dL, not fit to participate.|0
2574377|NCT01256177|8904503|P1|Overall Study|TG=593mg/dL, not fit to participate.|1
2574378|NCT01256177|8904502|P2|Overall Study|Lack of Efficacy|2
2574379|NCT01256177|8904503|P1|Overall Study|Lack of Efficacy|11
2574380|NCT01256177|8904502|P2|Overall Study|Condition under Investigation Worsened|0
2574381|NCT01256177|8904503|P1|Overall Study|Condition under Investigation Worsened|1
2574382|NCT01256177|8904502|P2|Overall Study|Severe Non-Compliance to Protocol|2
2574383|NCT01256177|8904503|P1|Overall Study|Severe Non-Compliance to Protocol|4
2574384|NCT01256177|8904502|P2|Overall Study|Adverse Event|9
2574385|NCT01256177|8904503|P1|Overall Study|Adverse Event|8
2574386|NCT01256177|8904502|P2|Overall Study|Lost to Follow-up|2
2574387|NCT01256177|8904503|P1|Overall Study|Lost to Follow-up|2
2574388|NCT01256177|8904502|P2|Overall Study|Withdrawal by Subject|22
2574389|NCT01256177|8904503|P1|Overall Study|Withdrawal by Subject|23
2574390|NCT01256060|8904559|P4|Overall Study|Lost to Follow-up|0
2574391|NCT01256060|8904560|P3|Overall Study|Lost to Follow-up|0
2574392|NCT01256060|8904561|P2|Overall Study|Lost to Follow-up|1
2574393|NCT01256060|8904562|P1|Overall Study|Lost to Follow-up|0
2574394|NCT01256008|8904581|P3|Overall Study|Withdrawal by Subject|10
2574395|NCT01256008|8904582|P2|Overall Study|Withdrawal by Subject|3
2574396|NCT01256008|8904583|P1|Overall Study|Withdrawal by Subject|2
2574397|NCT01256008|8904581|P3|Overall Study|Lost to Follow-up|11
2574398|NCT01256008|8904582|P2|Overall Study|Lost to Follow-up|4
2574399|NCT01256008|8904583|P1|Overall Study|Lost to Follow-up|6
2574400|NCT01255904|8904605|P2|Overall Study|Physician Decision|4
2574401|NCT01255904|8904606|P1|Overall Study|Physician Decision|1
2574402|NCT01255787|8904616|P4|Overall Study|Noncompliance with Study Drug|0
2574403|NCT01255787|8904617|P3|Overall Study|Noncompliance with Study Drug|0
2574404|NCT01255787|8904618|P2|Overall Study|Noncompliance with Study Drug|1
2574405|NCT01255787|8904619|P1|Overall Study|Noncompliance with Study Drug|3
2574406|NCT01255787|8904616|P4|Overall Study|Lack of Efficacy|2
2574407|NCT01255787|8904617|P3|Overall Study|Lack of Efficacy|2
2574408|NCT01255787|8904618|P2|Overall Study|Lack of Efficacy|2
2574409|NCT01255787|8904619|P1|Overall Study|Lack of Efficacy|2
2574410|NCT01255787|8904616|P4|Overall Study|Pregnancy|1
2574411|NCT01255787|8904617|P3|Overall Study|Pregnancy|0
2574412|NCT01255787|8904618|P2|Overall Study|Pregnancy|0
2574413|NCT01255787|8904619|P1|Overall Study|Pregnancy|0
2574414|NCT01255787|8904616|P4|Overall Study|Withdrawal of Consent|4
2574415|NCT01255787|8904617|P3|Overall Study|Withdrawal of Consent|3
2574416|NCT01255787|8904618|P2|Overall Study|Withdrawal of Consent|9
2574417|NCT01255787|8904619|P1|Overall Study|Withdrawal of Consent|3
2574418|NCT01255787|8904616|P4|Overall Study|Lost to Follow-up|2
2574419|NCT01255787|8904617|P3|Overall Study|Lost to Follow-up|4
2574420|NCT01255787|8904618|P2|Overall Study|Lost to Follow-up|2
2574421|NCT01255787|8904619|P1|Overall Study|Lost to Follow-up|1
2574422|NCT01255787|8904616|P4|Overall Study|Major Protocol Deviation|4
2574423|NCT01255787|8904617|P3|Overall Study|Major Protocol Deviation|0
2574424|NCT01255787|8904618|P2|Overall Study|Major Protocol Deviation|1
2574425|NCT01255787|8904619|P1|Overall Study|Major Protocol Deviation|1
2574426|NCT01255787|8904616|P4|Overall Study|Pretreatment Event or Adverse Event (AE)|9
2574427|NCT01255787|8904617|P3|Overall Study|Pretreatment Event or Adverse Event (AE)|9
2574428|NCT01255787|8904618|P2|Overall Study|Pretreatment Event or Adverse Event (AE)|2
2574429|NCT01255787|8904619|P1|Overall Study|Pretreatment Event or Adverse Event (AE)|6
2574430|NCT01255761|8904647|P2|Overall Study|Other Reasons|18
2574431|NCT01255761|8904648|P1|Overall Study|Other Reasons|37
2574432|NCT01255761|8904647|P2|Overall Study|Withdrawal by Subject|27
2574433|NCT01255761|8904648|P1|Overall Study|Withdrawal by Subject|11
2574434|NCT01255761|8904647|P2|Overall Study|Lost to Follow-up|8
2574435|NCT01255761|8904648|P1|Overall Study|Lost to Follow-up|10
2574436|NCT01255761|8904647|P2|Overall Study|Protocol Violation|5
2574437|NCT01255761|8904648|P1|Overall Study|Protocol Violation|9
2574438|NCT01255761|8904647|P2|Overall Study|Lack of Efficacy|74
2574439|NCT01255761|8904648|P1|Overall Study|Lack of Efficacy|86
2574440|NCT01255761|8904647|P2|Overall Study|Adverse Event|43
2574441|NCT01255761|8904648|P1|Overall Study|Adverse Event|29
2574442|NCT01255722|8904733|P3|Overall Study|beta-blocker contraindicated|0
2574443|NCT01255722|8904734|P2|Overall Study|beta-blocker contraindicated|0
2574444|NCT01255722|8904735|P1|Overall Study|beta-blocker contraindicated|2
2574445|NCT01255722|8904733|P3|Overall Study|asymptomatic patient|0
2574446|NCT01255722|8904734|P2|Overall Study|asymptomatic patient|0
2574447|NCT01255722|8904735|P1|Overall Study|asymptomatic patient|1
2574448|NCT01255722|8904733|P3|Overall Study|Adverse Event|1
2574449|NCT01255722|8904734|P2|Overall Study|Adverse Event|1
2574450|NCT01255722|8904735|P1|Overall Study|Adverse Event|0
2574451|NCT01255631|8904760|P2|Overall Study|poor enrollment, no data analyzed|6
2574452|NCT01255631|8904761|P1|Overall Study|poor enrollment, no data analyzed|9
2574453|NCT01255592|8904779|P2|Overall Study|Other|1
2574454|NCT01255592|8904780|P1|Overall Study|Other|0
2574455|NCT01255592|8904779|P2|Overall Study|Withdrawal by Subject|0
2574456|NCT01255592|8904780|P1|Overall Study|Withdrawal by Subject|1
2574457|NCT01255592|8904779|P2|Overall Study|Adverse Event|0
2574458|NCT01255592|8904780|P1|Overall Study|Adverse Event|5
2574459|NCT01255436|8904843|P2|Overall Study|Death, stroke, or MI|3
2574460|NCT01255436|8904844|P1|Overall Study|Death, stroke, or MI|4
2574461|NCT01255436|8904843|P2|Overall Study|Lost to Follow-up|191
2574462|NCT01255436|8904844|P1|Overall Study|Lost to Follow-up|178
2574463|NCT01255423|8904858|P2|Overall Study|Use of prohibited medications|1
2574464|NCT01255423|8904859|P1|Overall Study|Use of prohibited medications|0
2574465|NCT01255423|8904858|P2|Overall Study|Abnormal Laboratory value|2
2574466|NCT01255423|8904859|P1|Overall Study|Abnormal Laboratory value|3
2574467|NCT01255306|8904875|P2|Overall Study|Physician Decision|1
2574468|NCT01255306|8904876|P1|Overall Study|Physician Decision|1
2574469|NCT01255163|8904887|P2|Overall Study|AstraZeneca stopped support of the study|3
2574470|NCT01255163|8904888|P1|Overall Study|AstraZeneca stopped support of the study|1
2574471|NCT01255163|8904887|P2|Overall Study|Adverse Event|2
2574472|NCT01255163|8904888|P1|Overall Study|Adverse Event|0
2574473|NCT01255163|8904887|P2|Overall Study|Lost to Follow-up|0
2574474|NCT01255163|8904888|P1|Overall Study|Lost to Follow-up|2
2574475|NCT01255163|8904887|P2|Overall Study|Withdrawal by Subject|0
2574476|NCT01255163|8904888|P1|Overall Study|Withdrawal by Subject|1
2574477|NCT01254890|8904917|P2|Overall Study|Disease Progression|5
2574478|NCT01254890|8904918|P1|Overall Study|Disease Progression|0
2574479|NCT01254890|8904917|P2|Overall Study|Withdrawal by Subject|2
2574480|NCT01254890|8904918|P1|Overall Study|Withdrawal by Subject|1
2574481|NCT01254890|8904917|P2|Overall Study|Ineligible|3
2574482|NCT01254890|8904918|P1|Overall Study|Ineligible|0
2574483|NCT01254747|8904980|P4|Overall Study|Discomfort|0
2574484|NCT01254747|8904981|P3|Overall Study|Discomfort|0
2574485|NCT01254747|8904982|P2|Overall Study|Discomfort|4
2574486|NCT01254747|8904983|P1|Overall Study|Discomfort|0
2574487|NCT01254747|8904980|P4|Overall Study|Biomicroscopy|0
2574488|NCT01254747|8904981|P3|Overall Study|Biomicroscopy|1
2574489|NCT01254747|8904982|P2|Overall Study|Biomicroscopy|0
2574490|NCT01254747|8904983|P1|Overall Study|Biomicroscopy|0
2574491|NCT01254747|8904980|P4|Overall Study|Lost to Follow-up|0
2574492|NCT01254747|8904981|P3|Overall Study|Lost to Follow-up|1
2574493|NCT01254747|8904982|P2|Overall Study|Lost to Follow-up|0
2574494|NCT01254747|8904983|P1|Overall Study|Lost to Follow-up|0
2574495|NCT01254747|8904980|P4|Overall Study|Symptoms and problems|0
2574496|NCT01254747|8904981|P3|Overall Study|Symptoms and problems|1
2574497|NCT01254747|8904982|P2|Overall Study|Symptoms and problems|2
2574498|NCT01254747|8904983|P1|Overall Study|Symptoms and problems|0
2574499|NCT01254747|8904980|P4|Overall Study|Difficult removal handling|0
2574500|NCT01254747|8904981|P3|Overall Study|Difficult removal handling|1
2574501|NCT01254747|8904982|P2|Overall Study|Difficult removal handling|0
2574502|NCT01254747|8904983|P1|Overall Study|Difficult removal handling|0
2574503|NCT01254747|8904980|P4|Overall Study|Unacceptable subjective vision|2
2574504|NCT01254747|8904981|P3|Overall Study|Unacceptable subjective vision|0
2574505|NCT01254747|8904982|P2|Overall Study|Unacceptable subjective vision|0
2574506|NCT01254747|8904983|P1|Overall Study|Unacceptable subjective vision|0
2574507|NCT01254721|8905023|P2|Overall Study|Wrongly randomization|1
2574508|NCT01254721|8905024|P1|Overall Study|Wrongly randomization|0
2574509|NCT01254721|8905023|P2|Overall Study|Withdrawal by Subject|11
2574510|NCT01254721|8905024|P1|Overall Study|Withdrawal by Subject|8
2574511|NCT01254721|8905023|P2|Overall Study|Adverse Event|3
2574512|NCT01254721|8905024|P1|Overall Study|Adverse Event|2
2574513|NCT01254721|8905023|P2|Overall Study|technical problum|0
2574514|NCT01254721|8905024|P1|Overall Study|technical problum|1
2574515|NCT01254721|8905023|P2|Overall Study|Death|1
2574516|NCT01254721|8905024|P1|Overall Study|Death|0
2574517|NCT01254721|8905023|P2|Overall Study|Lack of Efficacy|2
2574518|NCT01254721|8905024|P1|Overall Study|Lack of Efficacy|4
2574519|NCT01254721|8905023|P2|Overall Study|Lost to Follow-up|4
2574520|NCT01254721|8905024|P1|Overall Study|Lost to Follow-up|0
2574521|NCT01254669|8905034|P2|Overall Study|called to clinic during intervention|1
2574522|NCT01254669|8905035|P1|Overall Study|called to clinic during intervention|1
2574523|NCT01254669|8905034|P2|Overall Study|time constraint|2
2574524|NCT01254669|8905035|P1|Overall Study|time constraint|2
2574525|NCT01254669|8905034|P2|Overall Study|Withdrawal by Subject|1
2574526|NCT01254669|8905035|P1|Overall Study|Withdrawal by Subject|0
2574527|NCT01254656|8905046|P3|Overall Study|Death|0
2574528|NCT01254656|8905047|P2|Overall Study|Death|1
2574529|NCT01254656|8905048|P1|Overall Study|Death|0
2574530|NCT01254656|8905046|P3|Overall Study|Adverse Event|0
2574531|NCT01254656|8905047|P2|Overall Study|Adverse Event|1
2574532|NCT01254656|8905048|P1|Overall Study|Adverse Event|1
2574533|NCT01254656|8905046|P3|Overall Study|Pregnancy|2
2574534|NCT01254656|8905047|P2|Overall Study|Pregnancy|0
2574535|NCT01254656|8905048|P1|Overall Study|Pregnancy|0
2574536|NCT01254656|8905046|P3|Overall Study|Withdrawal by Subject|1
2574537|NCT01254656|8905047|P2|Overall Study|Withdrawal by Subject|2
2574538|NCT01254656|8905048|P1|Overall Study|Withdrawal by Subject|2
2574539|NCT01254656|8905046|P3|Overall Study|Lost to Follow-up|2
2574540|NCT01254656|8905047|P2|Overall Study|Lost to Follow-up|0
2574541|NCT01254656|8905048|P1|Overall Study|Lost to Follow-up|1
2574542|NCT01254656|8905046|P3|Overall Study|Lack of Efficacy|0
2574543|NCT01254656|8905047|P2|Overall Study|Lack of Efficacy|0
2574544|NCT01254656|8905048|P1|Overall Study|Lack of Efficacy|3
2574545|NCT01254656|8905046|P3|Overall Study|Discontinued due to termination of study|13
2574546|NCT01254656|8905047|P2|Overall Study|Discontinued due to termination of study|39
2574547|NCT01254656|8905048|P1|Overall Study|Discontinued due to termination of study|40
2574548|NCT01254643|8905074|P1|Overall Study|Withdrawal by Subject|1
2574549|NCT01254630|8905086|P4|Overall Study|Status not recorded|0
2574550|NCT01254630|8905087|P3|Overall Study|Status not recorded|1
2574551|NCT01254630|8905088|P2|Overall Study|Status not recorded|0
2574552|NCT01254630|8905089|P1|Overall Study|Status not recorded|0
2574553|NCT01254630|8905086|P4|Overall Study|Study terminated by sponsor|1010
2574554|NCT01254630|8905087|P3|Overall Study|Study terminated by sponsor|0
2574555|NCT01254630|8905088|P2|Overall Study|Study terminated by sponsor|994
2574556|NCT01254630|8905089|P1|Overall Study|Study terminated by sponsor|0
2574557|NCT01254630|8905086|P4|Overall Study|Withdrawal by Subject|89
2574558|NCT01254630|8905087|P3|Overall Study|Withdrawal by Subject|188
2574559|NCT01254630|8905088|P2|Overall Study|Withdrawal by Subject|94
2574560|NCT01254630|8905089|P1|Overall Study|Withdrawal by Subject|201
2574561|NCT01254630|8905086|P4|Overall Study|Physician Decision|7
2574562|NCT01254630|8905087|P3|Overall Study|Physician Decision|16
2574563|NCT01254630|8905088|P2|Overall Study|Physician Decision|8
2574564|NCT01254630|8905089|P1|Overall Study|Physician Decision|24
2574565|NCT01254630|8905086|P4|Overall Study|Lost to Follow-up|32
2574566|NCT01254630|8905087|P3|Overall Study|Lost to Follow-up|89
2574567|NCT01254630|8905088|P2|Overall Study|Lost to Follow-up|26
2574568|NCT01254630|8905089|P1|Overall Study|Lost to Follow-up|80
2574569|NCT01254630|8905086|P4|Overall Study|Death|139
2574570|NCT01254630|8905087|P3|Overall Study|Death|478
2574571|NCT01254630|8905088|P2|Overall Study|Death|151
2574572|NCT01254630|8905089|P1|Overall Study|Death|461
2574573|NCT01254630|8905086|P4|Overall Study|Adverse Event|8
2574574|NCT01254630|8905087|P3|Overall Study|Adverse Event|40
2574575|NCT01254630|8905088|P2|Overall Study|Adverse Event|15
2574576|NCT01254630|8905089|P1|Overall Study|Adverse Event|36
2574577|NCT01254604|8905109|P2|Overall Study|Adverse Event|2
2574578|NCT01254604|8905110|P1|Overall Study|Adverse Event|3
2574579|NCT01254604|8905109|P2|Overall Study|Withdrawal by Subject|4
2574580|NCT01254604|8905110|P1|Overall Study|Withdrawal by Subject|2
2574581|NCT01254604|8905109|P2|Overall Study|Protocol Violation|2
2574582|NCT01254604|8905110|P1|Overall Study|Protocol Violation|2
2574583|NCT01254604|8905109|P2|Overall Study|Lost to Follow-up|1
2574584|NCT01254604|8905110|P1|Overall Study|Lost to Follow-up|1
2574585|NCT01254565|8905128|P6|Overall Study|Other|0
2574586|NCT01254565|8905129|P5|Overall Study|Other|0
2574587|NCT01254565|8905130|P4|Overall Study|Other|1
2574588|NCT01254565|8905131|P3|Overall Study|Other|0
2574589|NCT01254565|8905132|P2|Overall Study|Other|0
2574590|NCT01254565|8905133|P1|Overall Study|Other|0
2574591|NCT01254565|8905128|P6|Overall Study|Did not Receive Treatment|4
2574592|NCT01254565|8905129|P5|Overall Study|Did not Receive Treatment|3
2574593|NCT01254565|8905130|P4|Overall Study|Did not Receive Treatment|0
2574594|NCT01254565|8905131|P3|Overall Study|Did not Receive Treatment|0
2574595|NCT01254565|8905132|P2|Overall Study|Did not Receive Treatment|1
2574596|NCT01254565|8905133|P1|Overall Study|Did not Receive Treatment|1
2574597|NCT01254565|8905128|P6|Overall Study|Non-compliance to Study Procedures|0
2574598|NCT01254565|8905129|P5|Overall Study|Non-compliance to Study Procedures|1
2574599|NCT01254565|8905130|P4|Overall Study|Non-compliance to Study Procedures|0
2574600|NCT01254565|8905131|P3|Overall Study|Non-compliance to Study Procedures|0
2574601|NCT01254565|8905132|P2|Overall Study|Non-compliance to Study Procedures|0
2574602|NCT01254565|8905133|P1|Overall Study|Non-compliance to Study Procedures|0
2574603|NCT01254422|8905193|P2|Overall Study|Lost to Follow-up|0
2574604|NCT01254422|8905194|P1|Overall Study|Lost to Follow-up|1
2574605|NCT01254422|8905193|P2|Overall Study|Serious adverse event|1
2574606|NCT01254422|8905194|P1|Overall Study|Serious adverse event|0
2574607|NCT01254422|8905193|P2|Overall Study|Adverse Event|0
2574608|NCT01254422|8905194|P1|Overall Study|Adverse Event|1
2574609|NCT01254422|8905193|P2|Overall Study|Protocol Violation|0
2574610|NCT01254422|8905194|P1|Overall Study|Protocol Violation|1
2574611|NCT01254409|8905222|P4|Overall Study|Adverse Event|0
2574612|NCT01254409|8905223|P3|Overall Study|Adverse Event|0
2574613|NCT01254409|8905224|P2|Overall Study|Adverse Event|1
2574614|NCT01254409|8905225|P1|Overall Study|Adverse Event|0
2574615|NCT01254344|8905294|P2|Overall Study|Withdrawal by Subject|6
2574616|NCT01254344|8905295|P1|Overall Study|Withdrawal by Subject|3
2574617|NCT01254344|8905294|P2|Overall Study|Protocol Violation|4
2574618|NCT01254344|8905295|P1|Overall Study|Protocol Violation|1
2574619|NCT01254344|8905294|P2|Overall Study|Physician Decision|4
2574620|NCT01254344|8905295|P1|Overall Study|Physician Decision|7
2574621|NCT01254344|8905294|P2|Overall Study|Adverse Event|5
2574622|NCT01254344|8905295|P1|Overall Study|Adverse Event|2
2574623|NCT01254331|8905303|P1|Extension Phase|Lost to Follow-up|3
2574624|NCT01254331|8905303|P1|Extension Phase|Lack of Efficacy|1
2574625|NCT01254331|8905303|P1|Initial Phase|Pregnancy|1
2574626|NCT01254331|8905303|P1|Initial Phase|Withdrawal by Subject|1
2574627|NCT01254331|8905303|P1|Initial Phase|Adverse Event|3
2574628|NCT01254318|8905321|P1|Overall Study|Death|47
2574629|NCT01254318|8905321|P1|Overall Study|Lost to Follow-up|5
2574630|NCT01254305|8905330|P3|Overall Study|Other Reasons|2
2574631|NCT01254305|8905331|P2|Overall Study|Other Reasons|0
2574632|NCT01254305|8905332|P1|Overall Study|Other Reasons|0
2574633|NCT01254305|8905330|P3|Overall Study|Lost to Follow-up|5
2574634|NCT01254305|8905331|P2|Overall Study|Lost to Follow-up|6
2574635|NCT01254305|8905332|P1|Overall Study|Lost to Follow-up|10
2574636|NCT01254305|8905330|P3|Overall Study|Withdrawal by Subject|4
2574637|NCT01254305|8905331|P2|Overall Study|Withdrawal by Subject|2
2574638|NCT01254305|8905332|P1|Overall Study|Withdrawal by Subject|4
2574639|NCT01254305|8905330|P3|Overall Study|Protocol Violation|3
2574640|NCT01254305|8905331|P2|Overall Study|Protocol Violation|7
2574641|NCT01254305|8905332|P1|Overall Study|Protocol Violation|1
2574642|NCT01254305|8905330|P3|Overall Study|Lack of Efficacy|1
2574643|NCT01254305|8905331|P2|Overall Study|Lack of Efficacy|0
2574644|NCT01254305|8905332|P1|Overall Study|Lack of Efficacy|1
2574645|NCT01254305|8905330|P3|Overall Study|Adverse Event|2
2574646|NCT01254305|8905331|P2|Overall Study|Adverse Event|3
2574647|NCT01254305|8905332|P1|Overall Study|Adverse Event|6
2574648|NCT01254292|8905348|P2|LCS12 Extension Phase|Lost to Follow-up|0
2574649|NCT01254292|8905349|P1|LCS12 Extension Phase|Lost to Follow-up|1
2574650|NCT01254292|8905348|P2|LCS12 Extension Phase|Pregnancy|0
2574651|NCT01254292|8905349|P1|LCS12 Extension Phase|Pregnancy|2
2574652|NCT01254292|8905348|P2|LCS12 Extension Phase|Other unknown|0
2574653|NCT01254292|8905349|P1|LCS12 Extension Phase|Other unknown|4
2574654|NCT01254292|8905348|P2|LCS12 Extension Phase|Withdrawal by Subject|0
2574655|NCT01254292|8905349|P1|LCS12 Extension Phase|Withdrawal by Subject|7
2574656|NCT01254292|8905348|P2|LCS12 Extension Phase|Adverse Event|0
2574657|NCT01254292|8905349|P1|LCS12 Extension Phase|Adverse Event|9
2574658|NCT01254292|8905348|P2|LCS12 Extension Phase|Wish for pregnancy|0
2574659|NCT01254292|8905349|P1|LCS12 Extension Phase|Wish for pregnancy|14
2574660|NCT01254292|8905348|P2|Comparative Phase|Wish for pregnancy|6
2574661|NCT01254292|8905349|P1|Comparative Phase|Wish for pregnancy|4
2574662|NCT01254292|8905348|P2|Comparative Phase|Protocol Violation|2
2574663|NCT01254292|8905349|P1|Comparative Phase|Protocol Violation|1
2574664|NCT01254292|8905348|P2|Comparative Phase|Withdrawal by Subject|21
2574665|NCT01254292|8905349|P1|Comparative Phase|Withdrawal by Subject|20
2574666|NCT01254292|8905348|P2|Comparative Phase|Pregnancy|6
2574667|NCT01254292|8905349|P1|Comparative Phase|Pregnancy|2
2574668|NCT01254292|8905348|P2|Comparative Phase|Lost to Follow-up|21
2574669|NCT01254292|8905349|P1|Comparative Phase|Lost to Follow-up|3
2574670|NCT01254292|8905348|P2|Comparative Phase|Adverse Event|25
2574671|NCT01254292|8905349|P1|Comparative Phase|Adverse Event|25
2574672|NCT01254188|8905426|P1|Overall Study|per investigator discretion|20
2574673|NCT01254188|8905426|P1|Overall Study|Adverse Event|43
2574674|NCT01254188|8905426|P1|Overall Study|Withdrawal by Subject|7
2574675|NCT01254188|8905426|P1|Overall Study|Lost to Follow-up|5
2574676|NCT01254188|8905426|P1|Overall Study|Death|4
2574677|NCT01254188|8905426|P1|Overall Study|Pregnancy|2
2574678|NCT01254188|8905426|P1|Overall Study|Protocol Violation|6
2574679|NCT01254188|8905426|P1|Overall Study|Disease Progression|6
2574680|NCT01254045|8905437|P6|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
2574681|NCT01254045|8905438|P5|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
2574682|NCT01254045|8905439|P4|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
2574683|NCT01254045|8905440|P3|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
2574684|NCT01254045|8905441|P2|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
2574685|NCT01254045|8905442|P1|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1
2574686|NCT01254019|8905455|P2|Overall Study|Withdrawal by Subject|2
2574687|NCT01254019|8905456|P1|Overall Study|Withdrawal by Subject|0
2574688|NCT01254019|8905455|P2|Overall Study|Protocol Violation|0
2574689|NCT01254019|8905456|P1|Overall Study|Protocol Violation|1
2574690|NCT01254019|8905455|P2|Overall Study|Adverse Event|2
2574691|NCT01254019|8905456|P1|Overall Study|Adverse Event|0
2574692|NCT01253811|8905550|P1|Overall Study|Withdrawal criteria|1
2574693|NCT01253577|8905581|P1|Overall Study|Lost to Follow-up|3
2574694|NCT01253564|8905589|P1|Overall Study|Serious Adverse Event|1
2574695|NCT01253564|8905589|P1|Overall Study|Withdrawal by Subject|1
2574696|NCT01253564|8905589|P1|Overall Study|Disease Progression|22
2574697|NCT01253447|8905638|P1|Overall Study|Adverse Event|2
2574698|NCT01253421|8905648|P5|Drug+Scanning Visit|Physician Decision|1
2574699|NCT01253421|8905649|P4|Drug+Scanning Visit|Physician Decision|0
2574700|NCT01253421|8905650|P3|Drug+Scanning Visit|Physician Decision|0
2574701|NCT01253421|8905651|P2|Drug+Scanning Visit|Physician Decision|0
2574702|NCT01253421|8905652|P1|Drug+Scanning Visit|Physician Decision|0
2574703|NCT01253421|8905648|P5|Assessment and Scheduling|Physician Decision|0
2574704|NCT01253421|8905649|P4|Assessment and Scheduling|Physician Decision|0
2574705|NCT01253421|8905650|P3|Assessment and Scheduling|Physician Decision|0
2574706|NCT01253421|8905651|P2|Assessment and Scheduling|Physician Decision|0
2574707|NCT01253421|8905652|P1|Assessment and Scheduling|Physician Decision|1
2574708|NCT01253421|8905648|P5|Assessment and Scheduling|Withdrawal by Subject|0
2574709|NCT01253421|8905649|P4|Assessment and Scheduling|Withdrawal by Subject|0
2574710|NCT01253421|8905650|P3|Assessment and Scheduling|Withdrawal by Subject|0
2574711|NCT01253421|8905651|P2|Assessment and Scheduling|Withdrawal by Subject|0
2574712|NCT01253421|8905652|P1|Assessment and Scheduling|Withdrawal by Subject|7
2574713|NCT01253421|8905648|P5|Assessment and Scheduling|Lost to Follow-up|0
2574714|NCT01253421|8905649|P4|Assessment and Scheduling|Lost to Follow-up|0
2574715|NCT01253421|8905650|P3|Assessment and Scheduling|Lost to Follow-up|0
2574716|NCT01253421|8905651|P2|Assessment and Scheduling|Lost to Follow-up|0
2574717|NCT01253421|8905652|P1|Assessment and Scheduling|Lost to Follow-up|17
2574718|NCT01253421|8905648|P5|Assessment and Scheduling|Found to be Ineligible|0
2574719|NCT01253421|8905649|P4|Assessment and Scheduling|Found to be Ineligible|0
2574720|NCT01253421|8905650|P3|Assessment and Scheduling|Found to be Ineligible|0
2574721|NCT01253421|8905651|P2|Assessment and Scheduling|Found to be Ineligible|0
2574722|NCT01253421|8905652|P1|Assessment and Scheduling|Found to be Ineligible|74
2574723|NCT01253408|8905701|P3|Overall Study|Adverse Event|0
2574724|NCT01253408|8905702|P2|Overall Study|Adverse Event|1
2574725|NCT01253408|8905703|P1|Overall Study|Adverse Event|0
2574726|NCT01253369|8905726|P1|Overall Study|Not Evaluable|3
2574727|NCT01253369|8905726|P1|Overall Study|Progressive disease|23
2574728|NCT01253369|8905726|P1|Overall Study|Death|1
2574729|NCT01253369|8905726|P1|Overall Study|Withdrawal by Subject|2
2574730|NCT01253369|8905726|P1|Overall Study|Adverse Event|4
2574731|NCT01253317|8905756|P1|Overall Study|Adverse Event|2
2574732|NCT01253304|8905768|P4|Overall Study|Adverse Event|1
2574733|NCT01253304|8905769|P3|Overall Study|Adverse Event|0
2574734|NCT01253304|8905770|P2|Overall Study|Adverse Event|0
2574735|NCT01253304|8905771|P1|Overall Study|Adverse Event|0
2574736|NCT01253291|8905810|P5|Overall Study|Physician Decision|2
2574737|NCT01253291|8905811|P4|Overall Study|Physician Decision|0
2574738|NCT01253291|8905812|P3|Overall Study|Physician Decision|0
2574739|NCT01253291|8905813|P2|Overall Study|Physician Decision|0
2574740|NCT01253291|8905814|P1|Overall Study|Physician Decision|2
2574741|NCT01253291|8905810|P5|Overall Study|Lack of Efficacy|0
2574742|NCT01253291|8905811|P4|Overall Study|Lack of Efficacy|0
2574743|NCT01253291|8905812|P3|Overall Study|Lack of Efficacy|0
2574744|NCT01253291|8905813|P2|Overall Study|Lack of Efficacy|0
2574745|NCT01253291|8905814|P1|Overall Study|Lack of Efficacy|1
2574746|NCT01253291|8905810|P5|Overall Study|Adverse Event|0
2574747|NCT01253291|8905811|P4|Overall Study|Adverse Event|0
2574748|NCT01253291|8905812|P3|Overall Study|Adverse Event|0
2574749|NCT01253291|8905813|P2|Overall Study|Adverse Event|1
2574750|NCT01253291|8905814|P1|Overall Study|Adverse Event|0
2574751|NCT01253291|8905810|P5|Overall Study|Withdrawal by Subject|0
2574752|NCT01253291|8905811|P4|Overall Study|Withdrawal by Subject|0
2574753|NCT01253291|8905812|P3|Overall Study|Withdrawal by Subject|0
2574754|NCT01253291|8905813|P2|Overall Study|Withdrawal by Subject|1
2574755|NCT01253291|8905814|P1|Overall Study|Withdrawal by Subject|1
2574756|NCT01253265|8905838|P5|Overall Study|Withdrawal by Subject|1
2574757|NCT01253265|8905839|P4|Overall Study|Withdrawal by Subject|0
2574758|NCT01253265|8905840|P3|Overall Study|Withdrawal by Subject|0
2574759|NCT01253265|8905841|P2|Overall Study|Withdrawal by Subject|0
2574760|NCT01253265|8905842|P1|Overall Study|Withdrawal by Subject|0
2574761|NCT01253265|8905838|P5|Overall Study|Met Predefined Discontinuation Criteria|0
2574762|NCT01253265|8905839|P4|Overall Study|Met Predefined Discontinuation Criteria|0
2574763|NCT01253265|8905840|P3|Overall Study|Met Predefined Discontinuation Criteria|0
2574764|NCT01253265|8905841|P2|Overall Study|Met Predefined Discontinuation Criteria|0
2574765|NCT01253265|8905842|P1|Overall Study|Met Predefined Discontinuation Criteria|1
2574766|NCT01253226|8905891|P5|Overall Study|Withdrawal by Subject|0
2574767|NCT01253226|8905892|P4|Overall Study|Withdrawal by Subject|1
2574768|NCT01253226|8905893|P3|Overall Study|Withdrawal by Subject|0
2574769|NCT01253226|8905894|P2|Overall Study|Withdrawal by Subject|0
2574770|NCT01253226|8905895|P1|Overall Study|Withdrawal by Subject|0
2574771|NCT01253226|8905891|P5|Overall Study|Physician Decision|2
2574772|NCT01253226|8905892|P4|Overall Study|Physician Decision|0
2574773|NCT01253226|8905893|P3|Overall Study|Physician Decision|0
2574774|NCT01253226|8905894|P2|Overall Study|Physician Decision|0
2574775|NCT01253226|8905895|P1|Overall Study|Physician Decision|0
2574776|NCT01253226|8905891|P5|Overall Study|Death|0
2574777|NCT01253226|8905892|P4|Overall Study|Death|0
2574778|NCT01253226|8905893|P3|Overall Study|Death|0
2574779|NCT01253226|8905894|P2|Overall Study|Death|1
2574780|NCT01253226|8905895|P1|Overall Study|Death|0
2574781|NCT01253226|8905891|P5|Overall Study|Adverse Event|0
2574782|NCT01253226|8905892|P4|Overall Study|Adverse Event|0
2574783|NCT01253226|8905893|P3|Overall Study|Adverse Event|1
2574784|NCT01253226|8905894|P2|Overall Study|Adverse Event|0
2574785|NCT01253226|8905895|P1|Overall Study|Adverse Event|0
2574786|NCT01253200|8905955|P5|Overall Study|Attempts|0
2574787|NCT01253200|8905956|P4|Overall Study|Attempts|2
2574788|NCT01253200|8905957|P3|Overall Study|Attempts|1
2574789|NCT01253200|8905958|P2|Overall Study|Attempts|4
2574790|NCT01253200|8905959|P1|Overall Study|Attempts|6
2574791|NCT01253200|8905955|P5|Overall Study|intents|0
2574792|NCT01253200|8905956|P4|Overall Study|intents|3
2574793|NCT01253200|8905957|P3|Overall Study|intents|1
2574794|NCT01253200|8905958|P2|Overall Study|intents|10
2574795|NCT01253200|8905959|P1|Overall Study|intents|10
2574796|NCT01253200|8905955|P5|Overall Study|Protocol Violation|5
2574797|NCT01253200|8905956|P4|Overall Study|Protocol Violation|0
2574798|NCT01253200|8905957|P3|Overall Study|Protocol Violation|0
2574799|NCT01253200|8905958|P2|Overall Study|Protocol Violation|4
2574800|NCT01253200|8905959|P1|Overall Study|Protocol Violation|1
2574801|NCT01253200|8905955|P5|Overall Study|Withdrawal by Subject|0
2574802|NCT01253200|8905956|P4|Overall Study|Withdrawal by Subject|0
2574803|NCT01253200|8905957|P3|Overall Study|Withdrawal by Subject|0
2574804|NCT01253200|8905958|P2|Overall Study|Withdrawal by Subject|0
2574805|NCT01253200|8905959|P1|Overall Study|Withdrawal by Subject|2
2574806|NCT01253200|8905955|P5|Overall Study|Lost to Follow-up|0
2574807|NCT01253200|8905956|P4|Overall Study|Lost to Follow-up|0
2574808|NCT01253200|8905957|P3|Overall Study|Lost to Follow-up|0
2574809|NCT01253200|8905958|P2|Overall Study|Lost to Follow-up|1
2574810|NCT01253200|8905959|P1|Overall Study|Lost to Follow-up|1
2574811|NCT01253200|8905955|P5|Overall Study|Death|0
2574812|NCT01253200|8905956|P4|Overall Study|Death|0
2574813|NCT01253200|8905957|P3|Overall Study|Death|0
2574814|NCT01253200|8905958|P2|Overall Study|Death|0
2574815|NCT01253200|8905959|P1|Overall Study|Death|1
2574816|NCT01253187|8905974|P6|Period 3|non-compliance|0
2574817|NCT01253187|8905975|P5|Period 3|non-compliance|1
2574818|NCT01253187|8905976|P4|Period 3|non-compliance|0
2574819|NCT01253187|8905977|P3|Period 3|non-compliance|0
2574820|NCT01253187|8905978|P2|Period 3|non-compliance|0
2574821|NCT01253187|8905979|P1|Period 3|non-compliance|0
2574822|NCT01253187|8905974|P6|Period 3|difficulty with blood sampling|0
2574823|NCT01253187|8905975|P5|Period 3|difficulty with blood sampling|0
2574824|NCT01253187|8905976|P4|Period 3|difficulty with blood sampling|0
2574825|NCT01253187|8905977|P3|Period 3|difficulty with blood sampling|0
2574826|NCT01253187|8905978|P2|Period 3|difficulty with blood sampling|1
2574827|NCT01253187|8905979|P1|Period 3|difficulty with blood sampling|0
2574828|NCT01253187|8905974|P6|Period 3|Pregnancy|0
2574829|NCT01253187|8905975|P5|Period 3|Pregnancy|0
2574830|NCT01253187|8905976|P4|Period 3|Pregnancy|0
2574831|NCT01253187|8905977|P3|Period 3|Pregnancy|0
2574832|NCT01253187|8905978|P2|Period 3|Pregnancy|0
2574833|NCT01253187|8905979|P1|Period 3|Pregnancy|1
2574834|NCT01253187|8905974|P6|Period 2|Withdrawal by Subject|0
2574835|NCT01253187|8905975|P5|Period 2|Withdrawal by Subject|1
2574836|NCT01253187|8905976|P4|Period 2|Withdrawal by Subject|0
2574837|NCT01253187|8905977|P3|Period 2|Withdrawal by Subject|0
2574838|NCT01253187|8905978|P2|Period 2|Withdrawal by Subject|0
2574839|NCT01253187|8905979|P1|Period 2|Withdrawal by Subject|0
2574840|NCT01253174|8906008|P6|Period 3|Pregnancy|0
2574841|NCT01253174|8906009|P5|Period 3|Pregnancy|0
2574842|NCT01253174|8906010|P4|Period 3|Pregnancy|0
2574843|NCT01253174|8906011|P3|Period 3|Pregnancy|1
2574844|NCT01253174|8906012|P2|Period 3|Pregnancy|0
2574845|NCT01253174|8906013|P1|Period 3|Pregnancy|0
2574846|NCT01253174|8906008|P6|Period 3|Withdrawal by Subject|0
2574847|NCT01253174|8906009|P5|Period 3|Withdrawal by Subject|1
2574848|NCT01253174|8906010|P4|Period 3|Withdrawal by Subject|0
2574849|NCT01253174|8906011|P3|Period 3|Withdrawal by Subject|0
2574850|NCT01253174|8906012|P2|Period 3|Withdrawal by Subject|1
2574851|NCT01253174|8906013|P1|Period 3|Withdrawal by Subject|0
2574852|NCT01253174|8906008|P6|Period 2|Adverse Event|0
2574853|NCT01253174|8906009|P5|Period 2|Adverse Event|0
2574854|NCT01253174|8906010|P4|Period 2|Adverse Event|0
2574855|NCT01253174|8906011|P3|Period 2|Adverse Event|1
2574856|NCT01253174|8906012|P2|Period 2|Adverse Event|0
2574857|NCT01253174|8906013|P1|Period 2|Adverse Event|0
2574858|NCT01253174|8906008|P6|Period 1|Randomized but not treated|0
2574859|NCT01253174|8906009|P5|Period 1|Randomized but not treated|1
2574860|NCT01253174|8906010|P4|Period 1|Randomized but not treated|0
2574861|NCT01253174|8906011|P3|Period 1|Randomized but not treated|1
2574862|NCT01253174|8906012|P2|Period 1|Randomized but not treated|1
2574863|NCT01253174|8906013|P1|Period 1|Randomized but not treated|0
2574864|NCT01253135|8906048|P1|Amended Protocol|Non-compliance|1
2574865|NCT01253135|8906048|P1|Original Protocol|Protocol Amendment|15
2574866|NCT01253044|8906067|P2|Overall Study|Lost to Follow-up|29
2574867|NCT01253044|8906068|P1|Overall Study|Lost to Follow-up|38
2574868|NCT01253018|8906078|P2|Overall Study|Withdrawal by Subject|1
2574869|NCT01253018|8906079|P1|Overall Study|Withdrawal by Subject|1
2574870|NCT01253018|8906078|P2|Overall Study|Robot Repair Issues|0
2574871|NCT01253018|8906079|P1|Overall Study|Robot Repair Issues|2
2574872|NCT01253018|8906078|P2|Overall Study|Lost to Follow-up|1
2574873|NCT01253018|8906079|P1|Overall Study|Lost to Follow-up|1
2574874|NCT01252966|8906093|P2|Overall Study|Withdrawal by Subject|3
2574875|NCT01252966|8906094|P1|Overall Study|Withdrawal by Subject|7
2574876|NCT01252966|8906093|P2|Overall Study|Lost to Follow-up|10
2574877|NCT01252966|8906094|P1|Overall Study|Lost to Follow-up|16
2574878|NCT01252953|8906110|P2|Overall Study|Lost to Follow-up|21
2574879|NCT01252953|8906111|P1|Overall Study|Lost to Follow-up|22
2574880|NCT01252953|8906110|P2|Overall Study|Withdrawal by Subject|17
2574881|NCT01252953|8906111|P1|Overall Study|Withdrawal by Subject|16
2574882|NCT01252940|8906125|P2|Extension Phase|Withdrawal by Subject|1
2574883|NCT01252940|8906126|P1|Extension Phase|Withdrawal by Subject|1
2574884|NCT01252940|8906125|P2|Extension Phase|Subject Non-compliance|0
2574885|NCT01252940|8906126|P1|Extension Phase|Subject Non-compliance|1
2574886|NCT01252940|8906125|P2|Extension Phase|Physician Decision|1
2574887|NCT01252940|8906126|P1|Extension Phase|Physician Decision|0
2574888|NCT01252940|8906125|P2|Extension Phase|Lost to Follow-up|0
2574889|NCT01252940|8906126|P1|Extension Phase|Lost to Follow-up|5
2574890|NCT01252940|8906125|P2|Extension Phase|Lack of Efficacy|0
2574891|NCT01252940|8906126|P1|Extension Phase|Lack of Efficacy|1
2574892|NCT01252940|8906125|P2|Extension Phase|Adverse Event|1
2574893|NCT01252940|8906126|P1|Extension Phase|Adverse Event|2
2574894|NCT01252940|8906125|P2|Main Study Phase|Subject Non-compliance|1
2574895|NCT01252940|8906126|P1|Main Study Phase|Subject Non-compliance|1
2574896|NCT01252940|8906125|P2|Main Study Phase|Withdrawal by Subject|5
2574897|NCT01252940|8906126|P1|Main Study Phase|Withdrawal by Subject|6
2574898|NCT01252940|8906125|P2|Main Study Phase|Protocol Violation|2
2574899|NCT01252940|8906126|P1|Main Study Phase|Protocol Violation|4
2574900|NCT01252940|8906125|P2|Main Study Phase|Physician Decision|0
2574901|NCT01252940|8906126|P1|Main Study Phase|Physician Decision|1
2574902|NCT01252940|8906125|P2|Main Study Phase|Lost to Follow-up|1
2574903|NCT01252940|8906126|P1|Main Study Phase|Lost to Follow-up|6
2574904|NCT01252940|8906125|P2|Main Study Phase|Lack of Efficacy|0
2574905|NCT01252940|8906126|P1|Main Study Phase|Lack of Efficacy|1
2574906|NCT01252940|8906125|P2|Main Study Phase|Adverse Event|1
2574907|NCT01252940|8906126|P1|Main Study Phase|Adverse Event|3
2574908|NCT01252940|8906125|P2|Main Study Phase|Randomized but not treated|2
2574909|NCT01252940|8906126|P1|Main Study Phase|Randomized but not treated|4
2574910|NCT01252810|8906157|P2|Overall Study|Various reasons|0
2574911|NCT01252810|8906158|P1|Overall Study|Various reasons|8
2574912|NCT01252810|8906157|P2|Overall Study|Physician Decision|1
2574913|NCT01252810|8906158|P1|Overall Study|Physician Decision|2
2574914|NCT01252810|8906157|P2|Overall Study|Lost to Follow-up|1
2574915|NCT01252810|8906158|P1|Overall Study|Lost to Follow-up|0
2574916|NCT01252810|8906157|P2|Overall Study|Withdrawal by Subject|1
2574917|NCT01252810|8906158|P1|Overall Study|Withdrawal by Subject|4
2574918|NCT01252667|8906193|P6|Overall Study|Transplant aborted post-conditioning|1
2574919|NCT01252667|8906194|P5|Overall Study|Transplant aborted post-conditioning|0
2574920|NCT01252667|8906195|P4|Overall Study|Transplant aborted post-conditioning|0
2574921|NCT01252667|8906196|P3|Overall Study|Transplant aborted post-conditioning|0
2574922|NCT01252667|8906197|P2|Overall Study|Transplant aborted post-conditioning|0
2574923|NCT01252667|8906198|P1|Overall Study|Transplant aborted post-conditioning|0
2574924|NCT01252563|8906260|P1|Overall Study|No drug administration|6
2574925|NCT01252563|8906260|P1|Overall Study|No visit after first day of treatment|194
2574926|NCT01252563|8906260|P1|Overall Study|Lost to Follow-up|161
2574927|NCT01252563|8906260|P1|Overall Study|Centralized Registration Deviation|30
2574928|NCT01252563|8906260|P1|Overall Study|Contract Deviation|41
2574929|NCT01252355|8906300|P3|Overall Study|Other Than Above|7
2574930|NCT01252355|8906301|P2|Overall Study|Other Than Above|7
2574931|NCT01252355|8906302|P1|Overall Study|Other Than Above|8
2574932|NCT01252355|8906300|P3|Overall Study|Randomized but not Treated|0
2574933|NCT01252355|8906301|P2|Overall Study|Randomized but not Treated|0
2574934|NCT01252355|8906302|P1|Overall Study|Randomized but not Treated|2
2574935|NCT01252355|8906300|P3|Overall Study|Sponsor Early Termination of Study|146
2574936|NCT01252355|8906301|P2|Overall Study|Sponsor Early Termination of Study|149
2574937|NCT01252355|8906302|P1|Overall Study|Sponsor Early Termination of Study|149
2574938|NCT01252355|8906300|P3|Overall Study|Progressive Disease|0
2574939|NCT01252355|8906301|P2|Overall Study|Progressive Disease|0
2574940|NCT01252355|8906302|P1|Overall Study|Progressive Disease|2
2574941|NCT01252355|8906300|P3|Overall Study|Poor Compliance to Protocol|1
2574942|NCT01252355|8906301|P2|Overall Study|Poor Compliance to Protocol|1
2574943|NCT01252355|8906302|P1|Overall Study|Poor Compliance to Protocol|1
2574944|NCT01252355|8906300|P3|Overall Study|Lost to Follow-up|1
2574945|NCT01252355|8906301|P2|Overall Study|Lost to Follow-up|0
2574946|NCT01252355|8906302|P1|Overall Study|Lost to Follow-up|0
2574947|NCT01252355|8906300|P3|Overall Study|Lack of Efficacy|2
2574948|NCT01252355|8906301|P2|Overall Study|Lack of Efficacy|4
2574949|NCT01252355|8906302|P1|Overall Study|Lack of Efficacy|6
2574950|NCT01252355|8906300|P3|Overall Study|Adverse Event|22
2574951|NCT01252355|8906301|P2|Overall Study|Adverse Event|17
2574952|NCT01252355|8906302|P1|Overall Study|Adverse Event|9
2574953|NCT01252290|8906340|P1|Overall Study|Withdrawal by Subject|1
2574954|NCT01252251|8906356|P1|Overall Study|Withdrawal by Subject|1
2574955|NCT01252238|8906368|P3|Overall Study|Sponsor terminated study|4
2574956|NCT01252238|8906369|P2|Overall Study|Sponsor terminated study|4
2574957|NCT01252238|8906370|P1|Overall Study|Sponsor terminated study|4
2574958|NCT01252186|8906387|P3|Overall Study|Other - Miscellaneous Reasons|7
2574959|NCT01252186|8906388|P2|Overall Study|Other - Miscellaneous Reasons|5
2574960|NCT01252186|8906389|P1|Overall Study|Other - Miscellaneous Reasons|5
2574961|NCT01252186|8906387|P3|Overall Study|Lost to Follow-up|11
2574962|NCT01252186|8906388|P2|Overall Study|Lost to Follow-up|10
2574963|NCT01252186|8906389|P1|Overall Study|Lost to Follow-up|10
2574964|NCT01252186|8906387|P3|Overall Study|Sponsor Request|0
2574965|NCT01252186|8906388|P2|Overall Study|Sponsor Request|1
2574966|NCT01252186|8906389|P1|Overall Study|Sponsor Request|2
2574967|NCT01252186|8906387|P3|Overall Study|Pregnancy|0
2574968|NCT01252186|8906388|P2|Overall Study|Pregnancy|2
2574969|NCT01252186|8906389|P1|Overall Study|Pregnancy|2
2574970|NCT01252186|8906387|P3|Overall Study|Protocol Violation|1
2574971|NCT01252186|8906388|P2|Overall Study|Protocol Violation|0
2574972|NCT01252186|8906389|P1|Overall Study|Protocol Violation|0
2574973|NCT01252186|8906387|P3|Overall Study|Non-compliance|4
2574974|NCT01252186|8906388|P2|Overall Study|Non-compliance|3
2574975|NCT01252186|8906389|P1|Overall Study|Non-compliance|0
2574976|NCT01252186|8906387|P3|Overall Study|Physician Decision|1
2574977|NCT01252186|8906388|P2|Overall Study|Physician Decision|0
2574978|NCT01252186|8906389|P1|Overall Study|Physician Decision|0
2574979|NCT01252186|8906387|P3|Overall Study|Withdrawal by Subject|2
2574980|NCT01252186|8906388|P2|Overall Study|Withdrawal by Subject|5
2574981|NCT01252186|8906389|P1|Overall Study|Withdrawal by Subject|2
2574982|NCT01252186|8906387|P3|Overall Study|Adverse Event|8
2574983|NCT01252186|8906388|P2|Overall Study|Adverse Event|6
2574984|NCT01252186|8906389|P1|Overall Study|Adverse Event|9
2574985|NCT01252134|8906462|P6|Period 1, 8 Hours|Personal Reasons|0
2574986|NCT01252134|8906463|P5|Period 1, 8 Hours|Personal Reasons|0
2574987|NCT01252134|8906464|P4|Period 1, 8 Hours|Personal Reasons|0
2574988|NCT01252134|8906465|P3|Period 1, 8 Hours|Personal Reasons|1
2574989|NCT01252134|8906466|P2|Period 1, 8 Hours|Personal Reasons|1
2574990|NCT01252134|8906467|P1|Period 1, 8 Hours|Personal Reasons|0
2574991|NCT01252095|8906486|P2|Overall Study|Disease progression|0
2574992|NCT01252095|8906487|P1|Overall Study|Disease progression|1
2574993|NCT01251965|8906508|P3|Overall Study|Death|11
2574994|NCT01251965|8906509|P2|Overall Study|Death|0
2574995|NCT01251965|8906510|P1|Overall Study|Death|0
2574996|NCT01251965|8906508|P3|Overall Study|Participant/physician decision|0
2574997|NCT01251965|8906509|P2|Overall Study|Participant/physician decision|2
2574998|NCT01251965|8906510|P1|Overall Study|Participant/physician decision|1
2574999|NCT01251952|8906522|P1|Overall Study|Adverse Event|1
2575000|NCT01251861|8906528|P2|Overall Study|Potential interaction of drugs|1
2575001|NCT01251861|8906529|P1|Overall Study|Potential interaction of drugs|0
2575002|NCT01251861|8906528|P2|Overall Study|Never started therapy|1
2575003|NCT01251861|8906529|P1|Overall Study|Never started therapy|4
2575004|NCT01251861|8906528|P2|Overall Study|Other|0
2575005|NCT01251861|8906529|P1|Overall Study|Other|1
2575006|NCT01251861|8906528|P2|Overall Study|Continued treatment beyond 18 cycles|0
2575007|NCT01251861|8906529|P1|Overall Study|Continued treatment beyond 18 cycles|1
2575008|NCT01251861|8906528|P2|Overall Study|Physician Decision|0
2575009|NCT01251861|8906529|P1|Overall Study|Physician Decision|1
2575010|NCT01251861|8906528|P2|Overall Study|Other complicating disease|1
2575011|NCT01251861|8906529|P1|Overall Study|Other complicating disease|0
2575012|NCT01251861|8906528|P2|Overall Study|Alternative therapy|0
2575013|NCT01251861|8906529|P1|Overall Study|Alternative therapy|1
2575014|NCT01251861|8906528|P2|Overall Study|Withdrawal by Subject|2
2575015|NCT01251861|8906529|P1|Overall Study|Withdrawal by Subject|2
2575016|NCT01251861|8906528|P2|Overall Study|Adverse Event|17
2575017|NCT01251861|8906529|P1|Overall Study|Adverse Event|2
2575018|NCT01251861|8906528|P2|Overall Study|Disease progression|6
2575019|NCT01251861|8906529|P1|Overall Study|Disease progression|6
2575020|NCT01251770|8906557|P2|Overall Study|Protocol Violation|7
2575021|NCT01251770|8906558|P1|Overall Study|Protocol Violation|13
2575022|NCT01251744|8906602|P2|Overall Study|Lost to Follow-up|0
2575023|NCT01251744|8906603|P1|Overall Study|Lost to Follow-up|1
2575024|NCT01251653|8906661|P9|Overall Study|Other reason not mentioned above|0
2575025|NCT01251653|8906662|P8|Overall Study|Other reason not mentioned above|2
2575026|NCT01251653|8906663|P7|Overall Study|Other reason not mentioned above|0
2575027|NCT01251653|8906664|P6|Overall Study|Other reason not mentioned above|0
2575028|NCT01251653|8906665|P5|Overall Study|Other reason not mentioned above|0
2575029|NCT01251653|8906666|P4|Overall Study|Other reason not mentioned above|0
2575030|NCT01251653|8906667|P3|Overall Study|Other reason not mentioned above|0
2575031|NCT01251653|8906668|P2|Overall Study|Other reason not mentioned above|0
2575032|NCT01251653|8906669|P1|Overall Study|Other reason not mentioned above|0
2575033|NCT01251653|8906661|P9|Overall Study|Withdrawal by Subject|0
2575034|NCT01251653|8906662|P8|Overall Study|Withdrawal by Subject|1
2575035|NCT01251653|8906663|P7|Overall Study|Withdrawal by Subject|0
2575036|NCT01251653|8906664|P6|Overall Study|Withdrawal by Subject|1
2575037|NCT01251653|8906665|P5|Overall Study|Withdrawal by Subject|1
2575038|NCT01251653|8906666|P4|Overall Study|Withdrawal by Subject|0
2575039|NCT01251653|8906667|P3|Overall Study|Withdrawal by Subject|1
2575040|NCT01251653|8906668|P2|Overall Study|Withdrawal by Subject|0
2575041|NCT01251653|8906669|P1|Overall Study|Withdrawal by Subject|1
2575042|NCT01251653|8906661|P9|Overall Study|Adverse Event|1
2575043|NCT01251653|8906662|P8|Overall Study|Adverse Event|2
2575044|NCT01251653|8906663|P7|Overall Study|Adverse Event|2
2575045|NCT01251653|8906664|P6|Overall Study|Adverse Event|0
2575046|NCT01251653|8906665|P5|Overall Study|Adverse Event|1
2575047|NCT01251653|8906666|P4|Overall Study|Adverse Event|1
2575048|NCT01251653|8906667|P3|Overall Study|Adverse Event|2
2575049|NCT01251653|8906668|P2|Overall Study|Adverse Event|0
2575050|NCT01251653|8906669|P1|Overall Study|Adverse Event|1
2575051|NCT01251653|8906661|P9|Overall Study|Dose-limiting toxicity|0
2575052|NCT01251653|8906662|P8|Overall Study|Dose-limiting toxicity|0
2575053|NCT01251653|8906663|P7|Overall Study|Dose-limiting toxicity|2
2575054|NCT01251653|8906664|P6|Overall Study|Dose-limiting toxicity|0
2575055|NCT01251653|8906665|P5|Overall Study|Dose-limiting toxicity|0
2575056|NCT01251653|8906666|P4|Overall Study|Dose-limiting toxicity|1
2575057|NCT01251653|8906667|P3|Overall Study|Dose-limiting toxicity|1
2575058|NCT01251653|8906668|P2|Overall Study|Dose-limiting toxicity|1
2575059|NCT01251653|8906669|P1|Overall Study|Dose-limiting toxicity|0
2575060|NCT01251653|8906661|P9|Overall Study|Progressive Disease|5
2575061|NCT01251653|8906662|P8|Overall Study|Progressive Disease|7
2575062|NCT01251653|8906663|P7|Overall Study|Progressive Disease|14
2575063|NCT01251653|8906664|P6|Overall Study|Progressive Disease|17
2575064|NCT01251653|8906665|P5|Overall Study|Progressive Disease|0
2575065|NCT01251653|8906666|P4|Overall Study|Progressive Disease|4
2575066|NCT01251653|8906667|P3|Overall Study|Progressive Disease|16
2575067|NCT01251653|8906668|P2|Overall Study|Progressive Disease|7
2575068|NCT01251653|8906669|P1|Overall Study|Progressive Disease|1
2575069|NCT01251614|8906797|P3|Overall Study|Lost to Follow-up|0
2575070|NCT01251614|8906798|P2|Overall Study|Lost to Follow-up|1
2575071|NCT01251614|8906799|P1|Overall Study|Lost to Follow-up|0
2575072|NCT01251614|8906797|P3|Overall Study|Withdrawal by Subject|1
2575073|NCT01251614|8906798|P2|Overall Study|Withdrawal by Subject|2
2575074|NCT01251614|8906799|P1|Overall Study|Withdrawal by Subject|0
2575075|NCT01251614|8906797|P3|Overall Study|Loss of Disease Control|0
2575076|NCT01251614|8906798|P2|Overall Study|Loss of Disease Control|1
2575077|NCT01251614|8906799|P1|Overall Study|Loss of Disease Control|0
2575078|NCT01251614|8906797|P3|Overall Study|Pregnancy|2
2575079|NCT01251614|8906798|P2|Overall Study|Pregnancy|0
2575080|NCT01251614|8906799|P1|Overall Study|Pregnancy|0
2575081|NCT01251614|8906797|P3|Overall Study|Clearing of Psoriatic Lesions|0
2575082|NCT01251614|8906798|P2|Overall Study|Clearing of Psoriatic Lesions|0
2575083|NCT01251614|8906799|P1|Overall Study|Clearing of Psoriatic Lesions|1
2575084|NCT01251614|8906797|P3|Overall Study|Lack of Efficacy|4
2575085|NCT01251614|8906798|P2|Overall Study|Lack of Efficacy|9
2575086|NCT01251614|8906799|P1|Overall Study|Lack of Efficacy|1
2575087|NCT01251614|8906797|P3|Overall Study|Adverse Event|1
2575088|NCT01251614|8906798|P2|Overall Study|Adverse Event|0
2575089|NCT01251614|8906799|P1|Overall Study|Adverse Event|1
2575090|NCT01251380|8906997|P1|Overall Study|Lost to Follow-up|2
2575091|NCT01251380|8906997|P1|Overall Study|Adverse Event|1
2575092|NCT01251380|8906997|P1|Overall Study|Lack of Efficacy|1
2575093|NCT01251380|8906997|P1|Overall Study|Withdrawal by Subject|6
2575094|NCT01251380|8906997|P1|Overall Study|Other (Not otherwise specified)|12
2575095|NCT01251367|8907021|P1|Overall Study|End of Study Visit Performed in Error|1
2575096|NCT01251367|8907021|P1|Overall Study|Subject had Personal or Medical Issues|4
2575097|NCT01251367|8907021|P1|Overall Study|No Study Drug Available|1
2575098|NCT01251367|8907021|P1|Overall Study|Subject Required Alternative Treatment|7
2575099|NCT01251367|8907021|P1|Overall Study|Lost to Follow-up|5
2575100|NCT01251367|8907021|P1|Overall Study|Withdrawal by Subject|36
2575101|NCT01251367|8907021|P1|Overall Study|Adverse Event|19
2575102|NCT01251367|8907021|P1|Overall Study|Lack of Efficacy|2
2575103|NCT01251367|8907021|P1|Overall Study|Protocol Violation|1
2575104|NCT01251354|8907056|P1|Overall Study|Disease Progression|4
2575105|NCT01251354|8907056|P1|Overall Study|Investigator's Decision|1
2575106|NCT01251354|8907056|P1|Overall Study|Adverse Event|1
2575107|NCT01251276|8907099|P2|Overall Study|Lost to Follow-up|1
2575108|NCT01251276|8907100|P1|Overall Study|Lost to Follow-up|0
2575109|NCT01251276|8907099|P2|Overall Study|Protocol Violation|0
2575110|NCT01251276|8907100|P1|Overall Study|Protocol Violation|1
2575111|NCT01251146|8907118|P2|Overall Study|Lost to Follow-up|10
2575112|NCT01251146|8907119|P1|Overall Study|Lost to Follow-up|3
2575113|NCT01251120|8907141|P2|Overall Study|Lack of Efficacy|1
2575114|NCT01251120|8907142|P1|Overall Study|Lack of Efficacy|0
2575115|NCT01250925|8907222|P3|Overall Study|Adverse Event|1
2575116|NCT01250925|8907223|P2|Overall Study|Adverse Event|0
2575117|NCT01250925|8907224|P1|Overall Study|Adverse Event|0
2575118|NCT01250925|8907222|P3|Overall Study|Physician Decision|1
2575119|NCT01250925|8907223|P2|Overall Study|Physician Decision|2
2575120|NCT01250925|8907224|P1|Overall Study|Physician Decision|0
2575121|NCT01250925|8907222|P3|Overall Study|Protocol Violation|0
2575122|NCT01250925|8907223|P2|Overall Study|Protocol Violation|0
2575123|NCT01250925|8907224|P1|Overall Study|Protocol Violation|2
2575124|NCT01250925|8907222|P3|Overall Study|Withdrawal by Subject|0
2575125|NCT01250925|8907223|P2|Overall Study|Withdrawal by Subject|0
2575126|NCT01250925|8907224|P1|Overall Study|Withdrawal by Subject|2
2575127|NCT01250925|8907222|P3|Overall Study|Lost to Follow-up|0
2575128|NCT01250925|8907223|P2|Overall Study|Lost to Follow-up|1
2575129|NCT01250925|8907224|P1|Overall Study|Lost to Follow-up|1
2575130|NCT01250873|8907269|P1|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1
2575131|NCT01250873|8907269|P1|Period 1: LY2216684 (Days 1-3)|Adverse Event|2
2575132|NCT01250769|8907301|P4|Overall Study|Adverse Event|0
2575133|NCT01250769|8907302|P3|Overall Study|Adverse Event|1
2575134|NCT01250769|8907303|P2|Overall Study|Adverse Event|0
2575135|NCT01250769|8907304|P1|Overall Study|Adverse Event|0
2575136|NCT01250769|8907301|P4|Overall Study|Withdrawal by Subject|0
2575137|NCT01250769|8907302|P3|Overall Study|Withdrawal by Subject|1
2575138|NCT01250769|8907303|P2|Overall Study|Withdrawal by Subject|1
2575139|NCT01250769|8907304|P1|Overall Study|Withdrawal by Subject|0
2575140|NCT01250756|8907336|P2|After Toddler Dose|Adverse Event|1
2575141|NCT01250756|8907337|P1|After Toddler Dose|Adverse Event|0
2575142|NCT01250756|8907336|P2|Toddler Dose|Adverse Event|1
2575143|NCT01250756|8907337|P1|Toddler Dose|Adverse Event|0
2575144|NCT01250756|8907336|P2|After Infant Series|Other|1
2575145|NCT01250756|8907337|P1|After Infant Series|Other|2
2575146|NCT01250756|8907336|P2|After Infant Series|Withdrawal by Subject|1
2575147|NCT01250756|8907337|P1|After Infant Series|Withdrawal by Subject|4
2575148|NCT01250756|8907336|P2|After Infant Series|Adverse Event|2
2575149|NCT01250756|8907337|P1|After Infant Series|Adverse Event|5
2575150|NCT01250756|8907336|P2|Infant Series|Other|0
2575151|NCT01250756|8907337|P1|Infant Series|Other|22
2575152|NCT01250756|8907336|P2|Infant Series|Randomized, Not Vaccinated|2
2575153|NCT01250756|8907337|P1|Infant Series|Randomized, Not Vaccinated|2
2575154|NCT01250756|8907336|P2|Infant Series|Withdrawal by Subject|5
2575155|NCT01250756|8907337|P1|Infant Series|Withdrawal by Subject|4
2575156|NCT01250509|8907454|P2|Overall Study|Lost to Follow-up|2
2575157|NCT01250509|8907455|P1|Overall Study|Lost to Follow-up|5
2575158|NCT01250418|8907469|P2|Overall Study|monitor data failure|1
2575159|NCT01250418|8907470|P1|Overall Study|monitor data failure|1
2575160|NCT01250379|8907478|P2|Overall Study|Participant noncompliance|0
2575161|NCT01250379|8907479|P1|Overall Study|Participant noncompliance|2
2575162|NCT01250379|8907478|P2|Overall Study|Other|4
2575163|NCT01250379|8907479|P1|Overall Study|Other|0
2575164|NCT01250379|8907478|P2|Overall Study|Adverse Event|4
2575165|NCT01250379|8907479|P1|Overall Study|Adverse Event|5
2575166|NCT01250379|8907478|P2|Overall Study|Lost to Follow-up|6
2575167|NCT01250379|8907479|P1|Overall Study|Lost to Follow-up|9
2575168|NCT01250379|8907478|P2|Overall Study|Protocol Violation|8
2575169|NCT01250379|8907479|P1|Overall Study|Protocol Violation|2
2575170|NCT01250379|8907478|P2|Overall Study|Physician Decision|3
2575171|NCT01250379|8907479|P1|Overall Study|Physician Decision|11
2575172|NCT01250379|8907478|P2|Overall Study|Withdrawal by Subject|20
2575173|NCT01250379|8907479|P1|Overall Study|Withdrawal by Subject|32
2575174|NCT01250379|8907478|P2|Overall Study|Death|148
2575175|NCT01250379|8907479|P1|Overall Study|Death|141
2575176|NCT01250171|8907584|P3|Overall Study|Administrative reasons|0
2575177|NCT01250171|8907585|P2|Overall Study|Administrative reasons|0
2575178|NCT01250171|8907586|P1|Overall Study|Administrative reasons|1
2575179|NCT01250145|8907617|P2|Overall Study|Withdrawal by Subject|4
2575180|NCT01250145|8907618|P1|Overall Study|Withdrawal by Subject|0
2575181|NCT01250145|8907617|P2|Overall Study|Adverse Event|1
2575182|NCT01250145|8907618|P1|Overall Study|Adverse Event|2
2575183|NCT01250119|8907638|P2|Treatment Phase|Unknown reason|4
2575184|NCT01250119|8907639|P1|Treatment Phase|Unknown reason|0
2575185|NCT01250119|8907638|P2|Treatment Phase|Adverse Event|2
2575186|NCT01250119|8907639|P1|Treatment Phase|Adverse Event|0
2575187|NCT01250119|8907638|P2|Treatment Phase|Withdrawal by Subject|1
2575188|NCT01250119|8907639|P1|Treatment Phase|Withdrawal by Subject|0
2575189|NCT01250119|8907638|P2|Treatment Phase|Death|2
2575190|NCT01250119|8907639|P1|Treatment Phase|Death|0
2575191|NCT01250119|8907638|P2|Treatment Phase|Progressive Disease|32
2575192|NCT01250119|8907639|P1|Treatment Phase|Progressive Disease|0
2575193|NCT01250119|8907638|P2|Diagnostic Phase|Participants Not Tested|0
2575194|NCT01250119|8907639|P1|Diagnostic Phase|Participants Not Tested|44
2575195|NCT01250119|8907638|P2|Diagnostic Phase|Failed to Produce a Test Results|0
2575196|NCT01250119|8907639|P1|Diagnostic Phase|Failed to Produce a Test Results|69
2575197|NCT01250054|8907654|P2|Period 2, One Week of Wear|Unacceptable subjective vision|0
2575198|NCT01250054|8907655|P1|Period 2, One Week of Wear|Unacceptable subjective vision|1
2575199|NCT01250002|8907663|P2|Overall Study|Change to open surgical procedure|3
2575200|NCT01250002|8907664|P1|Overall Study|Change to open surgical procedure|4
2575201|NCT01249833|8907729|P2|Overall Study|Lost to Follow-up|1
2575202|NCT01249833|8907730|P1|Overall Study|Lost to Follow-up|0
2575203|NCT01249664|8907744|P2|Overall Study|Adverse Event|0
2575204|NCT01249664|8907745|P1|Overall Study|Adverse Event|1
2575205|NCT01249664|8907744|P2|Overall Study|Withdrawal by Subject|0
2575206|NCT01249664|8907745|P1|Overall Study|Withdrawal by Subject|5
2575207|NCT01249651|8907795|P1|Overall Study|Sponsor Decision|1
2575208|NCT01249651|8907795|P1|Overall Study|Protocol Violation|1
2575209|NCT01249651|8907795|P1|Overall Study|Adverse Event|1
2575210|NCT01249651|8907795|P1|Overall Study|Withdrawal by Subject|4
2575211|NCT01249417|8907824|P3|Treatment Phase - ITT Population|Lost to Follow-up|1
2575212|NCT01249417|8907825|P2|Treatment Phase - ITT Population|Lost to Follow-up|1
2575213|NCT01249417|8907826|P1|Treatment Phase - ITT Population|Lost to Follow-up|0
2575214|NCT01249417|8907824|P3|Treatment Phase - ITT Population|Withdrawal by Subject|1
2575215|NCT01249417|8907825|P2|Treatment Phase - ITT Population|Withdrawal by Subject|3
2575216|NCT01249417|8907826|P1|Treatment Phase - ITT Population|Withdrawal by Subject|1
2575217|NCT01249417|8907824|P3|Treatment Phase - ITT Population|Adverse Event|1
2575218|NCT01249417|8907825|P2|Treatment Phase - ITT Population|Adverse Event|0
2575219|NCT01249417|8907826|P1|Treatment Phase - ITT Population|Adverse Event|0
2575220|NCT01249417|8907824|P3|Treatment Phase - ITT Population|Other|1
2575221|NCT01249417|8907825|P2|Treatment Phase - ITT Population|Other|0
2575222|NCT01249417|8907826|P1|Treatment Phase - ITT Population|Other|0
2575223|NCT01249417|8907824|P3|Randomised Population|No MAS score at baseline and/or Week 4|2
2575224|NCT01249417|8907825|P2|Randomised Population|No MAS score at baseline and/or Week 4|1
2575225|NCT01249417|8907826|P1|Randomised Population|No MAS score at baseline and/or Week 4|1
2575226|NCT01249417|8907824|P3|Randomised Population|Study treatment not received|2
2575227|NCT01249417|8907825|P2|Randomised Population|Study treatment not received|0
2575228|NCT01249417|8907826|P1|Randomised Population|Study treatment not received|0
2575229|NCT01249404|8907843|P3|Overall Study|Non compliance to visit schedule|0
2575230|NCT01249404|8907844|P2|Overall Study|Non compliance to visit schedule|1
2575231|NCT01249404|8907845|P1|Overall Study|Non compliance to visit schedule|0
2575232|NCT01249404|8907843|P3|Overall Study|Botulinum toxin (BTX) in upper limb|1
2575233|NCT01249404|8907844|P2|Overall Study|Botulinum toxin (BTX) in upper limb|2
2575234|NCT01249404|8907845|P1|Overall Study|Botulinum toxin (BTX) in upper limb|1
2575235|NCT01249404|8907843|P3|Overall Study|Withdrawal by Subject|0
2575236|NCT01249404|8907844|P2|Overall Study|Withdrawal by Subject|2
2575237|NCT01249404|8907845|P1|Overall Study|Withdrawal by Subject|2
2575238|NCT01249404|8907843|P3|Overall Study|Adverse Event|2
2575239|NCT01249404|8907844|P2|Overall Study|Adverse Event|2
2575240|NCT01249404|8907845|P1|Overall Study|Adverse Event|2
2575241|NCT01249404|8907843|P3|Overall Study|No MAS Score at baseline and/or Week 4|2
2575242|NCT01249404|8907844|P2|Overall Study|No MAS Score at baseline and/or Week 4|0
2575243|NCT01249404|8907845|P1|Overall Study|No MAS Score at baseline and/or Week 4|2
2575244|NCT01249404|8907843|P3|Overall Study|Study treatment not received|2
2575245|NCT01249404|8907844|P2|Overall Study|Study treatment not received|1
2575246|NCT01249404|8907845|P1|Overall Study|Study treatment not received|0
2575247|NCT01249365|8907922|P1|Overall Study|Lost to Follow-up|1
2575248|NCT01249274|8907930|P2|Overall Study|Received inpatient substance treatment|2
2575249|NCT01249274|8907931|P1|Overall Study|Received inpatient substance treatment|1
2575250|NCT01249274|8907930|P2|Overall Study|Lost to Follow-up|4
2575251|NCT01249274|8907931|P1|Overall Study|Lost to Follow-up|3
2575252|NCT01249261|8907957|P2|Overall Study|Withdrawal by Subject|0
2575253|NCT01249261|8907958|P1|Overall Study|Withdrawal by Subject|1
2575254|NCT01249157|8907986|P1|Overall Study|Withdrawal by Subject|1
2575255|NCT01249131|8907990|P6|Washout Period of 10 Days|Adverse Event|0
2575256|NCT01249131|8907991|P5|Washout Period of 10 Days|Adverse Event|1
2575257|NCT01249131|8907992|P4|Washout Period of 10 Days|Adverse Event|0
2575258|NCT01249131|8907993|P3|Washout Period of 10 Days|Adverse Event|0
2575259|NCT01249131|8907994|P2|Washout Period of 10 Days|Adverse Event|0
2575260|NCT01249131|8907995|P1|Washout Period of 10 Days|Adverse Event|0
2575261|NCT01249118|8908015|P3|First Washout Period|Physician Decision|0
2575262|NCT01249118|8908016|P2|First Washout Period|Physician Decision|1
2575263|NCT01249118|8908017|P1|First Washout Period|Physician Decision|0
2575264|NCT01249092|8908051|P1|Overall Study|Unable to tolerate expected SE -nausea|1
2575265|NCT01249092|8908051|P1|Overall Study|Expected side effect of nausea/dyspepsia|1
2575266|NCT01248962|8908128|P2|Overall Study|Progression of Disease prior to 5 Cycles|13
2575267|NCT01248962|8908129|P1|Overall Study|Progression of Disease prior to 5 Cycles|12
2575268|NCT01248962|8908128|P2|Overall Study|Complete Response after 3 Cycles|1
2575269|NCT01248962|8908129|P1|Overall Study|Complete Response after 3 Cycles|0
2575270|NCT01248962|8908128|P2|Overall Study|Complete Response after 4 Cycles|0
2575271|NCT01248962|8908129|P1|Overall Study|Complete Response after 4 Cycles|1
2575272|NCT01248962|8908128|P2|Overall Study|Adverse Event|1
2575273|NCT01248962|8908129|P1|Overall Study|Adverse Event|2
2575274|NCT01248962|8908128|P2|Overall Study|Withdrawal by Subject|1
2575275|NCT01248962|8908129|P1|Overall Study|Withdrawal by Subject|1
2575276|NCT01248949|8908145|P5|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
2575277|NCT01248949|8908146|P4|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
2575278|NCT01248949|8908147|P3|Overall Study|Lesion In ThoracicSpine Requires Therapy|1
2575279|NCT01248949|8908148|P2|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
2575280|NCT01248949|8908149|P1|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
2575281|NCT01248949|8908145|P5|Overall Study|Pi Discretion Due To Hospitalisation|0
2575282|NCT01248949|8908146|P4|Overall Study|Pi Discretion Due To Hospitalisation|0
2575283|NCT01248949|8908147|P3|Overall Study|Pi Discretion Due To Hospitalisation|0
2575284|NCT01248949|8908148|P2|Overall Study|Pi Discretion Due To Hospitalisation|1
2575285|NCT01248949|8908149|P1|Overall Study|Pi Discretion Due To Hospitalisation|0
2575286|NCT01248949|8908145|P5|Overall Study|Pi Decision Due To Declining Status|0
2575287|NCT01248949|8908146|P4|Overall Study|Pi Decision Due To Declining Status|0
2575288|NCT01248949|8908147|P3|Overall Study|Pi Decision Due To Declining Status|1
2575289|NCT01248949|8908148|P2|Overall Study|Pi Decision Due To Declining Status|0
2575290|NCT01248949|8908149|P1|Overall Study|Pi Decision Due To Declining Status|0
2575291|NCT01248949|8908145|P5|Overall Study|Per Sponsor Request o Discontinue Drug|0
2575292|NCT01248949|8908146|P4|Overall Study|Per Sponsor Request o Discontinue Drug|0
2575293|NCT01248949|8908147|P3|Overall Study|Per Sponsor Request o Discontinue Drug|0
2575294|NCT01248949|8908148|P2|Overall Study|Per Sponsor Request o Discontinue Drug|0
2575295|NCT01248949|8908149|P1|Overall Study|Per Sponsor Request o Discontinue Drug|1
2575296|NCT01248949|8908145|P5|Overall Study|Participant Went To Hospice|0
2575297|NCT01248949|8908146|P4|Overall Study|Participant Went To Hospice|0
2575298|NCT01248949|8908147|P3|Overall Study|Participant Went To Hospice|1
2575299|NCT01248949|8908148|P2|Overall Study|Participant Went To Hospice|0
2575300|NCT01248949|8908149|P1|Overall Study|Participant Went To Hospice|0
2575301|NCT01248949|8908145|P5|Overall Study|Entered Hospice And Refused Follow Up|1
2575302|NCT01248949|8908146|P4|Overall Study|Entered Hospice And Refused Follow Up|0
2575303|NCT01248949|8908147|P3|Overall Study|Entered Hospice And Refused Follow Up|0
2575304|NCT01248949|8908148|P2|Overall Study|Entered Hospice And Refused Follow Up|0
2575305|NCT01248949|8908149|P1|Overall Study|Entered Hospice And Refused Follow Up|0
2575306|NCT01248949|8908145|P5|Overall Study|Palliative Radiation To Brain Metastases|0
2575307|NCT01248949|8908146|P4|Overall Study|Palliative Radiation To Brain Metastases|0
2575308|NCT01248949|8908147|P3|Overall Study|Palliative Radiation To Brain Metastases|0
2575309|NCT01248949|8908148|P2|Overall Study|Palliative Radiation To Brain Metastases|0
2575310|NCT01248949|8908149|P1|Overall Study|Palliative Radiation To Brain Metastases|1
2575311|NCT01248949|8908145|P5|Overall Study|Alternative Therapy.|0
2575312|NCT01248949|8908146|P4|Overall Study|Alternative Therapy.|0
2575313|NCT01248949|8908147|P3|Overall Study|Alternative Therapy.|0
2575314|NCT01248949|8908148|P2|Overall Study|Alternative Therapy.|0
2575315|NCT01248949|8908149|P1|Overall Study|Alternative Therapy.|1
2575316|NCT01248949|8908145|P5|Overall Study|Alternative Therapy|0
2575317|NCT01248949|8908146|P4|Overall Study|Alternative Therapy|0
2575318|NCT01248949|8908147|P3|Overall Study|Alternative Therapy|0
2575319|NCT01248949|8908148|P2|Overall Study|Alternative Therapy|0
2575320|NCT01248949|8908149|P1|Overall Study|Alternative Therapy|1
2575321|NCT01248949|8908145|P5|Overall Study|Death|2
2575322|NCT01248949|8908146|P4|Overall Study|Death|6
2575323|NCT01248949|8908147|P3|Overall Study|Death|21
2575324|NCT01248949|8908148|P2|Overall Study|Death|7
2575325|NCT01248949|8908149|P1|Overall Study|Death|22
2575326|NCT01248949|8908145|P5|Overall Study|Withdrawal by Subject|1
2575327|NCT01248949|8908146|P4|Overall Study|Withdrawal by Subject|3
2575328|NCT01248949|8908147|P3|Overall Study|Withdrawal by Subject|11
2575329|NCT01248949|8908148|P2|Overall Study|Withdrawal by Subject|3
2575330|NCT01248949|8908149|P1|Overall Study|Withdrawal by Subject|5
2575331|NCT01248949|8908145|P5|Overall Study|Lost to Follow-up|0
2575332|NCT01248949|8908146|P4|Overall Study|Lost to Follow-up|1
2575333|NCT01248949|8908147|P3|Overall Study|Lost to Follow-up|2
2575334|NCT01248949|8908148|P2|Overall Study|Lost to Follow-up|2
2575335|NCT01248949|8908149|P1|Overall Study|Lost to Follow-up|2
2575336|NCT01248936|8908261|P1|Overall Study|Other reason|3
2575337|NCT01248936|8908261|P1|Overall Study|Refused Treatment|1
2575338|NCT01248936|8908261|P1|Overall Study|Lost to Follow-up|7
2575339|NCT01248936|8908261|P1|Overall Study|Adverse Event|8
2575340|NCT01248936|8908261|P1|Overall Study|Withdrawal of Consent|20
2575341|NCT01248936|8908261|P1|Overall Study|Death|26
2575342|NCT01248936|8908261|P1|Overall Study|Progression of Disease|50
2575343|NCT01248936|8908261|P1|Overall Study|Sponsor Decision|259
2575344|NCT01248884|8908274|P3|Overall Study|Adverse Event|0
2575345|NCT01248884|8908275|P2|Overall Study|Adverse Event|0
2575346|NCT01248884|8908276|P1|Overall Study|Adverse Event|1
2575347|NCT01248884|8908274|P3|Overall Study|Withdrawal by Subject|1
2575348|NCT01248884|8908275|P2|Overall Study|Withdrawal by Subject|3
2575349|NCT01248884|8908276|P1|Overall Study|Withdrawal by Subject|1
2575350|NCT01248793|8908334|P2|Overall Study|Withdrawal by Subject|3
2575351|NCT01248793|8908335|P1|Overall Study|Withdrawal by Subject|3
2575352|NCT01248793|8908334|P2|Overall Study|Protocol Violation|1
2575353|NCT01248793|8908335|P1|Overall Study|Protocol Violation|0
2575354|NCT01248793|8908334|P2|Overall Study|Adverse Event|1
2575355|NCT01248793|8908335|P1|Overall Study|Adverse Event|1
2575356|NCT01248793|8908334|P2|Overall Study|Lost to Follow-up|1
2575357|NCT01248793|8908335|P1|Overall Study|Lost to Follow-up|0
2575358|NCT01248780|8908349|P2|Overall Study|Not treated|1
2575359|NCT01248780|8908350|P1|Overall Study|Not treated|0
2575360|NCT01248780|8908349|P2|Overall Study|Withdrawal by Subject|4
2575361|NCT01248780|8908350|P1|Overall Study|Withdrawal by Subject|4
2575362|NCT01248780|8908349|P2|Overall Study|Protocol Violation|1
2575363|NCT01248780|8908350|P1|Overall Study|Protocol Violation|1
2575364|NCT01248780|8908349|P2|Overall Study|Adverse Event|7
2575365|NCT01248780|8908350|P1|Overall Study|Adverse Event|2
2575366|NCT01248780|8908349|P2|Overall Study|Death|1
2575367|NCT01248780|8908350|P1|Overall Study|Death|0
2575368|NCT01248780|8908349|P2|Overall Study|Lost to Follow-up|1
2575369|NCT01248780|8908350|P1|Overall Study|Lost to Follow-up|0
2575370|NCT01248780|8908349|P2|Overall Study|Lack of Efficacy|0
2575371|NCT01248780|8908350|P1|Overall Study|Lack of Efficacy|2
2575372|NCT01248728|8908364|P2|Overall Study|Lack of Efficacy|0
2575373|NCT01248728|8908365|P1|Overall Study|Lack of Efficacy|1
2575374|NCT01248728|8908364|P2|Overall Study|Withdrawal by Subject|1
2575375|NCT01248728|8908365|P1|Overall Study|Withdrawal by Subject|2
2575376|NCT01248728|8908364|P2|Overall Study|Adverse Event|1
2575377|NCT01248728|8908365|P1|Overall Study|Adverse Event|1
2575378|NCT01248715|8908381|P2|Overall Study|Not influenza positive|510
2575379|NCT01248715|8908382|P1|Overall Study|Not influenza positive|501
2575380|NCT01248468|8908403|P3|Overall Study|Withdrawal by Subject|0
2575381|NCT01248468|8908404|P2|Overall Study|Withdrawal by Subject|2
2575382|NCT01248468|8908405|P1|Overall Study|Withdrawal by Subject|4
2575383|NCT01248468|8908403|P3|Overall Study|Pregnancy|0
2575384|NCT01248468|8908404|P2|Overall Study|Pregnancy|0
2575385|NCT01248468|8908405|P1|Overall Study|Pregnancy|1
2575386|NCT01248468|8908403|P3|Overall Study|Lost to Follow-up|4
2575387|NCT01248468|8908404|P2|Overall Study|Lost to Follow-up|12
2575388|NCT01248468|8908405|P1|Overall Study|Lost to Follow-up|9
2575389|NCT01248468|8908403|P3|Overall Study|Administrative problem|0
2575390|NCT01248468|8908404|P2|Overall Study|Administrative problem|0
2575391|NCT01248468|8908405|P1|Overall Study|Administrative problem|1
2575392|NCT01248455|8908422|P1|Overall Study|switched to alternate treatment|1
2575393|NCT01248364|8908467|P4|Overall Study|Adverse Event|0
2575394|NCT01248364|8908468|P3|Overall Study|Adverse Event|0
2575395|NCT01248364|8908469|P2|Overall Study|Adverse Event|1
2575396|NCT01248364|8908470|P1|Overall Study|Adverse Event|0
2575397|NCT01248130|8908533|P2|Overall Study|Ineligible|0
2575398|NCT01248130|8908534|P1|Overall Study|Ineligible|1
2575399|NCT01248130|8908533|P2|Overall Study|Protocol Violation|0
2575400|NCT01248130|8908534|P1|Overall Study|Protocol Violation|1
2575401|NCT01248065|8908544|P2|Overall Study|Other|5
2575402|NCT01248065|8908545|P1|Overall Study|Other|3
2575403|NCT01248065|8908544|P2|Overall Study|Third treatment failure event|1
2575404|NCT01248065|8908545|P1|Overall Study|Third treatment failure event|3
2575405|NCT01248065|8908544|P2|Overall Study|Adverse Event|0
2575406|NCT01248065|8908545|P1|Overall Study|Adverse Event|3
2575407|NCT01248065|8908544|P2|Overall Study|Withdrawal by Subject|11
2575408|NCT01248065|8908545|P1|Overall Study|Withdrawal by Subject|14
2575409|NCT01248065|8908544|P2|Overall Study|Lost to Follow-up|5
2575410|NCT01248065|8908545|P1|Overall Study|Lost to Follow-up|3
2575411|NCT01248013|8908555|P1|Overall Study|Withdrawal by Subject|14
2575412|NCT01247922|8908570|P1|Overall Study|Disease progression|4
2575413|NCT01247350|8908668|P5|Overall Study|Entry criteria not met|1
2575414|NCT01247350|8908669|P4|Overall Study|Entry criteria not met|0
2575415|NCT01247350|8908670|P3|Overall Study|Entry criteria not met|0
2575416|NCT01247350|8908671|P2|Overall Study|Entry criteria not met|0
2575417|NCT01247350|8908672|P1|Overall Study|Entry criteria not met|0
2575418|NCT01247350|8908668|P5|Overall Study|Withdrawal by Subject|0
2575419|NCT01247350|8908669|P4|Overall Study|Withdrawal by Subject|1
2575420|NCT01247350|8908670|P3|Overall Study|Withdrawal by Subject|0
2575421|NCT01247350|8908671|P2|Overall Study|Withdrawal by Subject|0
2575422|NCT01247350|8908672|P1|Overall Study|Withdrawal by Subject|0
2575423|NCT01247350|8908668|P5|Overall Study|Adverse Event|0
2575424|NCT01247350|8908669|P4|Overall Study|Adverse Event|0
2575425|NCT01247350|8908670|P3|Overall Study|Adverse Event|1
2575426|NCT01247350|8908671|P2|Overall Study|Adverse Event|0
2575427|NCT01247350|8908672|P1|Overall Study|Adverse Event|0
2575428|NCT01247324|8908730|P2|Overall Study|Lost to Follow-up|1
2575429|NCT01247324|8908731|P1|Overall Study|Lost to Follow-up|1
2575430|NCT01247324|8908730|P2|Overall Study|Adverse Event|13
2575431|NCT01247324|8908731|P1|Overall Study|Adverse Event|25
2575432|NCT01247324|8908730|P2|Overall Study|Consent withdrawn by participant|8
2575433|NCT01247324|8908731|P1|Overall Study|Consent withdrawn by participant|13
2575434|NCT01247324|8908730|P2|Overall Study|Reason not specified|8
2575435|NCT01247324|8908731|P1|Overall Study|Reason not specified|11
2575436|NCT01247324|8908730|P2|Overall Study|Protocol Violation|2
2575437|NCT01247324|8908731|P1|Overall Study|Protocol Violation|1
2575438|NCT01247324|8908730|P2|Overall Study|Pregnancy|3
2575439|NCT01247324|8908731|P1|Overall Study|Pregnancy|2
2575440|NCT01247324|8908730|P2|Overall Study|Non-compliance|0
2575441|NCT01247324|8908731|P1|Overall Study|Non-compliance|2
2575442|NCT01247324|8908730|P2|Overall Study|Lack of Efficacy|8
2575443|NCT01247324|8908731|P1|Overall Study|Lack of Efficacy|12
2575444|NCT01247324|8908730|P2|Overall Study|Non-compliance with study drug|0
2575445|NCT01247324|8908731|P1|Overall Study|Non-compliance with study drug|3
2575446|NCT01247324|8908730|P2|Overall Study|Physician Decision|1
2575447|NCT01247324|8908731|P1|Overall Study|Physician Decision|0
2575448|NCT01247324|8908730|P2|Overall Study|Death|0
2575449|NCT01247324|8908731|P1|Overall Study|Death|1
2575450|NCT01247090|8908824|P3|Overall Study|Withdrawal by Subject|0
2575451|NCT01247090|8908825|P2|Overall Study|Withdrawal by Subject|1
2575452|NCT01247090|8908826|P1|Overall Study|Withdrawal by Subject|0
2575453|NCT01247090|8908824|P3|Overall Study|Physician Decision|0
2575454|NCT01247090|8908825|P2|Overall Study|Physician Decision|0
2575455|NCT01247090|8908826|P1|Overall Study|Physician Decision|1
2575456|NCT01246999|8908855|P4|Overall Study|Withdrawal by Subject|2
2575457|NCT01246999|8908856|P3|Overall Study|Withdrawal by Subject|0
2575458|NCT01246999|8908857|P2|Overall Study|Withdrawal by Subject|0
2575459|NCT01246999|8908858|P1|Overall Study|Withdrawal by Subject|0
2575460|NCT01246999|8908855|P4|Overall Study|Lost to Follow-up|0
2575461|NCT01246999|8908856|P3|Overall Study|Lost to Follow-up|0
2575462|NCT01246999|8908857|P2|Overall Study|Lost to Follow-up|1
2575463|NCT01246999|8908858|P1|Overall Study|Lost to Follow-up|0
2575464|NCT01246973|8908893|P2|Overall Study|Withdrawal by Subject|13
2575465|NCT01246973|8908894|P1|Overall Study|Withdrawal by Subject|7
2575466|NCT01246973|8908893|P2|Overall Study|Adverse Event|9
2575467|NCT01246973|8908894|P1|Overall Study|Adverse Event|16
2575468|NCT01246973|8908893|P2|Overall Study|Other|25
2575469|NCT01246973|8908894|P1|Overall Study|Other|38
2575470|NCT01246960|8908904|P2|Overall Study|Withdrawal (by participant or physician)|3
2575471|NCT01246960|8908905|P1|Overall Study|Withdrawal (by participant or physician)|3
2575472|NCT01246960|8908904|P2|Overall Study|Lost to Follow-up|1
2575473|NCT01246960|8908905|P1|Overall Study|Lost to Follow-up|3
2575474|NCT01246206|8909017|P1|Overall Study|Patient did not receive study regiments.|1
2575475|NCT01246011|8909095|P3|Overall Study|Withdrawal by Subject|1
2575476|NCT01246011|8909096|P2|Overall Study|Withdrawal by Subject|0
2575477|NCT01246011|8909097|P1|Overall Study|Withdrawal by Subject|0
2575478|NCT01246011|8909095|P3|Overall Study|If needed warfarin clinically, withdrawn|3
2575479|NCT01246011|8909096|P2|Overall Study|If needed warfarin clinically, withdrawn|0
2575480|NCT01246011|8909097|P1|Overall Study|If needed warfarin clinically, withdrawn|0
2575481|NCT01245764|8909125|P4|Study Phase A|Lost to Follow-up|0
2575482|NCT01245764|8909126|P3|Study Phase A|Lost to Follow-up|5
2575483|NCT01245764|8909127|P2|Study Phase A|Lost to Follow-up|0
2575484|NCT01245764|8909128|P1|Study Phase A|Lost to Follow-up|0
2575485|NCT01245764|8909125|P4|Study Phase A|Protocol Violation|2
2575486|NCT01245764|8909126|P3|Study Phase A|Protocol Violation|2
2575487|NCT01245764|8909127|P2|Study Phase A|Protocol Violation|3
2575488|NCT01245764|8909128|P1|Study Phase A|Protocol Violation|6
2575489|NCT01245764|8909125|P4|Study Phase A|Other|1
2575490|NCT01245764|8909126|P3|Study Phase A|Other|3
2575491|NCT01245764|8909127|P2|Study Phase A|Other|2
2575492|NCT01245764|8909128|P1|Study Phase A|Other|3
2575493|NCT01245751|8909166|P4|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
2575494|NCT01245751|8909167|P3|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
2575495|NCT01245751|8909168|P2|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4
2575496|NCT01245751|8909169|P1|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
2575497|NCT01245751|8909166|P4|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2
2575498|NCT01245751|8909167|P3|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
2575499|NCT01245751|8909168|P2|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
2575500|NCT01245751|8909169|P1|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
2575501|NCT01245751|8909166|P4|Part 1: Day 1 to Week 52 (1 Year)|Death|0
2575502|NCT01245751|8909167|P3|Part 1: Day 1 to Week 52 (1 Year)|Death|0
2575503|NCT01245751|8909168|P2|Part 1: Day 1 to Week 52 (1 Year)|Death|1
2575504|NCT01245751|8909169|P1|Part 1: Day 1 to Week 52 (1 Year)|Death|2
2575505|NCT01245673|8909218|P1|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1
2575506|NCT01245387|8909286|P1|Overall Study|Missing discontinuation status|369
2575507|NCT01245387|8909286|P1|Overall Study|Other|131
2575508|NCT01245387|8909286|P1|Overall Study|Death|3
2575509|NCT01245387|8909286|P1|Overall Study|Adverse Event|9
2575510|NCT01245387|8909286|P1|Overall Study|Lack of Efficacy|195
2575511|NCT01245387|8909286|P1|Overall Study|Lost to Follow-up|106
2575512|NCT01245374|8909335|P1|Overall Study|Withdrawal by Subject|3
2575513|NCT01245374|8909335|P1|Overall Study|Protocol Violation|1
2575514|NCT01245283|8909358|P3|Overall Study|Lost to Follow-up|11
2575515|NCT01245283|8909359|P2|Overall Study|Lost to Follow-up|11
2575516|NCT01245283|8909360|P1|Overall Study|Lost to Follow-up|14
2575517|NCT01245140|8909405|P2|Overall Study|Refused Treatment/Did Not Coopera|1
2575518|NCT01245140|8909406|P1|Overall Study|Refused Treatment/Did Not Coopera|0
2575519|NCT01245140|8909405|P2|Overall Study|Withdrawal by Subject|1
2575520|NCT01245140|8909406|P1|Overall Study|Withdrawal by Subject|0
2575521|NCT01245140|8909405|P2|Overall Study|Protocol Violation|1
2575522|NCT01245140|8909406|P1|Overall Study|Protocol Violation|0
2575523|NCT01245140|8909405|P2|Overall Study|Lack of Efficacy|4
2575524|NCT01245140|8909406|P1|Overall Study|Lack of Efficacy|2
2575525|NCT01245140|8909405|P2|Overall Study|Adverse Event|3
2575526|NCT01245140|8909406|P1|Overall Study|Adverse Event|1
2575527|NCT01245101|8909462|P2|Period 3 (Treatment)|Withdrawal by Subject|0
2575528|NCT01245101|8909463|P1|Period 3 (Treatment)|Withdrawal by Subject|1
2575529|NCT01245101|8909462|P2|Period 2 (Washout)|Withdrawal by Subject|0
2575530|NCT01245101|8909463|P1|Period 2 (Washout)|Withdrawal by Subject|1
2575531|NCT01245101|8909462|P2|Period 1 (Treatment)|Withdrawal by Subject|0
2575532|NCT01245101|8909463|P1|Period 1 (Treatment)|Withdrawal by Subject|2
2575533|NCT01245062|8909473|P3|Cross-over Phase|Study closed/ terminated|11
2575534|NCT01245062|8909474|P2|Cross-over Phase|Study closed/ terminated|0
2575535|NCT01245062|8909475|P1|Cross-over Phase|Study closed/ terminated|0
2575536|NCT01245062|8909473|P3|Cross-over Phase|Withdrew Consent|4
2575537|NCT01245062|8909474|P2|Cross-over Phase|Withdrew Consent|0
2575538|NCT01245062|8909475|P1|Cross-over Phase|Withdrew Consent|0
2575539|NCT01245062|8909473|P3|Cross-over Phase|Physician Decision|1
2575540|NCT01245062|8909474|P2|Cross-over Phase|Physician Decision|0
2575541|NCT01245062|8909475|P1|Cross-over Phase|Physician Decision|0
2575542|NCT01245062|8909473|P3|Cross-over Phase|Lost to Follow-up|1
2575543|NCT01245062|8909474|P2|Cross-over Phase|Lost to Follow-up|0
2575544|NCT01245062|8909475|P1|Cross-over Phase|Lost to Follow-up|0
2575545|NCT01245062|8909473|P3|Randomization and Crossover Phase|Study closed/ terminated|0
2575546|NCT01245062|8909474|P2|Randomization and Crossover Phase|Study closed/ terminated|14
2575547|NCT01245062|8909475|P1|Randomization and Crossover Phase|Study closed/ terminated|23
2575548|NCT01245062|8909473|P3|Randomization and Crossover Phase|Withdrew Consent|0
2575549|NCT01245062|8909474|P2|Randomization and Crossover Phase|Withdrew Consent|11
2575550|NCT01245062|8909475|P1|Randomization and Crossover Phase|Withdrew Consent|12
2575551|NCT01245062|8909473|P3|Randomization and Crossover Phase|Physician Decision|0
2575552|NCT01245062|8909474|P2|Randomization and Crossover Phase|Physician Decision|4
2575553|NCT01245062|8909475|P1|Randomization and Crossover Phase|Physician Decision|2
2575554|NCT01245062|8909473|P3|Randomization and Crossover Phase|Lost to Follow-up|0
2575555|NCT01245062|8909474|P2|Randomization and Crossover Phase|Lost to Follow-up|2
2575556|NCT01245062|8909475|P1|Randomization and Crossover Phase|Lost to Follow-up|4
2575557|NCT01245049|8909513|P2|Overall Study|Lost to Follow-up|2
2575558|NCT01245049|8909514|P1|Overall Study|Lost to Follow-up|1
2575559|NCT01245049|8909513|P2|Overall Study|Withdrawal by Subject|1
2575560|NCT01245049|8909514|P1|Overall Study|Withdrawal by Subject|0
2575561|NCT01245049|8909513|P2|Overall Study|Migrated/moved from study area|1
2575562|NCT01245049|8909514|P1|Overall Study|Migrated/moved from study area|0
2575563|NCT01244984|8909567|P3|Overall Study|Withdrawal by Subject|2
2575564|NCT01244984|8909568|P2|Overall Study|Withdrawal by Subject|2
2575565|NCT01244984|8909569|P1|Overall Study|Withdrawal by Subject|1
2575566|NCT01244984|8909567|P3|Overall Study|Protocol Defined Stopping Criteria|0
2575567|NCT01244984|8909568|P2|Overall Study|Protocol Defined Stopping Criteria|1
2575568|NCT01244984|8909569|P1|Overall Study|Protocol Defined Stopping Criteria|1
2575569|NCT01244984|8909567|P3|Overall Study|Protocol Violation|0
2575570|NCT01244984|8909568|P2|Overall Study|Protocol Violation|0
2575571|NCT01244984|8909569|P1|Overall Study|Protocol Violation|1
2575572|NCT01244984|8909567|P3|Overall Study|Adverse Event|2
2575573|NCT01244984|8909568|P2|Overall Study|Adverse Event|11
2575574|NCT01244984|8909569|P1|Overall Study|Adverse Event|2
2575575|NCT01244906|8909643|P1|Overall Study|Progression of disease post treatment|6
2575576|NCT01244906|8909643|P1|Overall Study|Death|2
2575577|NCT01244893|8909652|P2|1-Week Follow Up|Lost to Follow-up|0
2575578|NCT01244893|8909653|P1|1-Week Follow Up|Lost to Follow-up|1
2575579|NCT01244893|8909652|P2|Baseline|Protocol Violation|1
2575580|NCT01244893|8909653|P1|Baseline|Protocol Violation|0
2575581|NCT01244828|8909665|P1|Overall Study|Other reason (not specified)|1
2575582|NCT01244828|8909665|P1|Overall Study|Lost to Follow-up|2
2575583|NCT01244828|8909665|P1|Overall Study|Lack of Efficacy|7
2575584|NCT01244828|8909665|P1|Overall Study|Withdrawal by Subject|31
2575585|NCT01244828|8909665|P1|Overall Study|Adverse Event|37
2575586|NCT01244815|8909681|P4|Overall Study|Did Not Meet Protocol Eligibility|0
2575587|NCT01244815|8909682|P3|Overall Study|Did Not Meet Protocol Eligibility|0
2575588|NCT01244815|8909683|P2|Overall Study|Did Not Meet Protocol Eligibility|1
2575589|NCT01244815|8909684|P1|Overall Study|Did Not Meet Protocol Eligibility|0
2575590|NCT01244815|8909681|P4|Overall Study|Protocol Violation|1
2575591|NCT01244815|8909682|P3|Overall Study|Protocol Violation|3
2575592|NCT01244815|8909683|P2|Overall Study|Protocol Violation|4
2575593|NCT01244815|8909684|P1|Overall Study|Protocol Violation|7
2575594|NCT01244815|8909681|P4|Overall Study|Withdrawal by Subject|3
2575595|NCT01244815|8909682|P3|Overall Study|Withdrawal by Subject|0
2575596|NCT01244815|8909683|P2|Overall Study|Withdrawal by Subject|2
2575597|NCT01244815|8909684|P1|Overall Study|Withdrawal by Subject|0
2575598|NCT01244815|8909681|P4|Overall Study|Lost to Follow-up|2
2575599|NCT01244815|8909682|P3|Overall Study|Lost to Follow-up|3
2575600|NCT01244815|8909683|P2|Overall Study|Lost to Follow-up|2
2575601|NCT01244815|8909684|P1|Overall Study|Lost to Follow-up|3
2575602|NCT01244815|8909681|P4|Overall Study|Treatment Failure|1
2575603|NCT01244815|8909682|P3|Overall Study|Treatment Failure|0
2575604|NCT01244815|8909683|P2|Overall Study|Treatment Failure|0
2575605|NCT01244815|8909684|P1|Overall Study|Treatment Failure|0
2575606|NCT01244815|8909681|P4|Overall Study|Adverse Event|5
2575607|NCT01244815|8909682|P3|Overall Study|Adverse Event|5
2575608|NCT01244815|8909683|P2|Overall Study|Adverse Event|7
2575609|NCT01244815|8909684|P1|Overall Study|Adverse Event|4
2575610|NCT01244815|8909681|P4|Overall Study|Not Treated|0
2575611|NCT01244815|8909682|P3|Overall Study|Not Treated|0
2575612|NCT01244815|8909683|P2|Overall Study|Not Treated|1
2575613|NCT01244815|8909684|P1|Overall Study|Not Treated|0
2575614|NCT01244620|8909771|P4|Overall Study|Study terminated|4
2575615|NCT01244620|8909772|P3|Overall Study|Study terminated|4
2575616|NCT01244620|8909773|P2|Overall Study|Study terminated|4
2575617|NCT01244620|8909774|P1|Overall Study|Study terminated|4
2575618|NCT01244516|8909833|P3|Period 2 (1-week to 2-week Visit)|Poor Comfort|1
2575619|NCT01244516|8909834|P2|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
2575620|NCT01244516|8909835|P1|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
2575621|NCT01244516|8909833|P3|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
2575622|NCT01244516|8909834|P2|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1
2575623|NCT01244516|8909835|P1|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
2575624|NCT01244516|8909833|P3|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
2575625|NCT01244516|8909834|P2|Period 2 (1-week to 2-week Visit)|Protocol Violation|0
2575626|NCT01244516|8909835|P1|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
2575627|NCT01244516|8909833|P3|Period 2 (1-week to 2-week Visit)|Adverse Event|0
2575628|NCT01244516|8909834|P2|Period 2 (1-week to 2-week Visit)|Adverse Event|0
2575629|NCT01244516|8909835|P1|Period 2 (1-week to 2-week Visit)|Adverse Event|2
2575630|NCT01244516|8909833|P3|Period 1 (Baseline to 1-week Visit)|Poor comfort|1
2575631|NCT01244516|8909834|P2|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
2575632|NCT01244516|8909835|P1|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
2575633|NCT01244516|8909833|P3|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
2575634|NCT01244516|8909834|P2|Period 1 (Baseline to 1-week Visit)|Poor Vision|1
2575635|NCT01244516|8909835|P1|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
2575636|NCT01244516|8909833|P3|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2
2575637|NCT01244516|8909834|P2|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5
2575638|NCT01244516|8909835|P1|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4
2575639|NCT01244490|8909856|P3|Overall Study|Other|1
2575640|NCT01244490|8909857|P2|Overall Study|Other|0
2575641|NCT01244490|8909858|P1|Overall Study|Other|0
2575642|NCT01244490|8909856|P3|Overall Study|Lost to Follow-up|3
2575643|NCT01244490|8909857|P2|Overall Study|Lost to Follow-up|6
2575644|NCT01244490|8909858|P1|Overall Study|Lost to Follow-up|0
2575645|NCT01244490|8909856|P3|Overall Study|Adverse Event|5
2575646|NCT01244490|8909857|P2|Overall Study|Adverse Event|9
2575647|NCT01244490|8909858|P1|Overall Study|Adverse Event|1
2575648|NCT01244490|8909856|P3|Overall Study|Withdrawal by Subject|9
2575649|NCT01244490|8909857|P2|Overall Study|Withdrawal by Subject|4
2575650|NCT01244490|8909858|P1|Overall Study|Withdrawal by Subject|4
2575651|NCT01244490|8909856|P3|Overall Study|Lack of Efficacy|5
2575652|NCT01244490|8909857|P2|Overall Study|Lack of Efficacy|5
2575653|NCT01244490|8909858|P1|Overall Study|Lack of Efficacy|14
2575654|NCT01244425|8909935|P2|Overall Study|Adverse Event|1
2575655|NCT01244425|8909936|P1|Overall Study|Adverse Event|1
2575656|NCT01244425|8909935|P2|Overall Study|Withdrawal by Subject|2
2575657|NCT01244425|8909936|P1|Overall Study|Withdrawal by Subject|2
2575658|NCT01244126|8909968|P3|Overall Study|Protocol Violation|9
2575659|NCT01244126|8909969|P2|Overall Study|Protocol Violation|3
2575660|NCT01244126|8909970|P1|Overall Study|Protocol Violation|3
2575661|NCT01244061|8909983|P2|Overall Study|Randomized but not treated|2
2575662|NCT01244061|8909984|P1|Overall Study|Randomized but not treated|2
2575663|NCT01244061|8909983|P2|Overall Study|Adverse Event|2
2575664|NCT01244061|8909984|P1|Overall Study|Adverse Event|5
2575665|NCT01244061|8909983|P2|Overall Study|Protocol Violation|1
2575666|NCT01244061|8909984|P1|Overall Study|Protocol Violation|1
2575667|NCT01244061|8909983|P2|Overall Study|Other|19
2575668|NCT01244061|8909984|P1|Overall Study|Other|8
2575669|NCT01244061|8909983|P2|Overall Study|Withdrawal by Subject|46
2575670|NCT01244061|8909984|P1|Overall Study|Withdrawal by Subject|29
2575671|NCT01244061|8909983|P2|Overall Study|Lost to Follow-up|30
2575672|NCT01244061|8909984|P1|Overall Study|Lost to Follow-up|34
2575673|NCT01244061|8909983|P2|Overall Study|Lack of Efficacy|3
2575674|NCT01244061|8909984|P1|Overall Study|Lack of Efficacy|1
2575675|NCT01244061|8909983|P2|Overall Study|Did not meet entrance criteria|0
2575676|NCT01244061|8909984|P1|Overall Study|Did not meet entrance criteria|1
2575677|NCT01244061|8909983|P2|Overall Study|Death|0
2575678|NCT01244061|8909984|P1|Overall Study|Death|1
2575679|NCT01244035|8909996|P6|Part 1: Period 3|Protocol Deviation|0
2575680|NCT01244035|8909997|P5|Part 1: Period 3|Protocol Deviation|0
2575681|NCT01244035|8909998|P4|Part 1: Period 3|Protocol Deviation|0
2575682|NCT01244035|8909999|P3|Part 1: Period 3|Protocol Deviation|0
2575683|NCT01244035|8910000|P2|Part 1: Period 3|Protocol Deviation|1
2575684|NCT01244035|8910001|P1|Part 1: Period 3|Protocol Deviation|0
2575685|NCT01244035|8909996|P6|Part 1: Period 3|Withdrawal by Subject|0
2575686|NCT01244035|8909997|P5|Part 1: Period 3|Withdrawal by Subject|1
2575687|NCT01244035|8909998|P4|Part 1: Period 3|Withdrawal by Subject|0
2575688|NCT01244035|8909999|P3|Part 1: Period 3|Withdrawal by Subject|0
2575689|NCT01244035|8910000|P2|Part 1: Period 3|Withdrawal by Subject|0
2575690|NCT01244035|8910001|P1|Part 1: Period 3|Withdrawal by Subject|0
2575691|NCT01244035|8909996|P6|Part 1: Period 3|Adverse Event|1
2575692|NCT01244035|8909997|P5|Part 1: Period 3|Adverse Event|0
2575693|NCT01244035|8909998|P4|Part 1: Period 3|Adverse Event|0
2575694|NCT01244035|8909999|P3|Part 1: Period 3|Adverse Event|0
2575695|NCT01244035|8910000|P2|Part 1: Period 3|Adverse Event|0
2575696|NCT01244035|8910001|P1|Part 1: Period 3|Adverse Event|0
2575697|NCT01244035|8909996|P6|Part 1: Period 2|Fulfilled Stopping Criteria|0
2575698|NCT01244035|8909997|P5|Part 1: Period 2|Fulfilled Stopping Criteria|0
2575699|NCT01244035|8909998|P4|Part 1: Period 2|Fulfilled Stopping Criteria|0
2575700|NCT01244035|8909999|P3|Part 1: Period 2|Fulfilled Stopping Criteria|1
2575701|NCT01244035|8910000|P2|Part 1: Period 2|Fulfilled Stopping Criteria|0
2575702|NCT01244035|8910001|P1|Part 1: Period 2|Fulfilled Stopping Criteria|0
2575703|NCT01244035|8909996|P6|Part 1: Period 1|Fulfilled Stopping Criteria|1
2575704|NCT01244035|8909997|P5|Part 1: Period 1|Fulfilled Stopping Criteria|1
2575705|NCT01244035|8909998|P4|Part 1: Period 1|Fulfilled Stopping Criteria|0
2575706|NCT01244035|8909999|P3|Part 1: Period 1|Fulfilled Stopping Criteria|2
2575707|NCT01244035|8910000|P2|Part 1: Period 1|Fulfilled Stopping Criteria|0
2575708|NCT01244035|8910001|P1|Part 1: Period 1|Fulfilled Stopping Criteria|1
2575709|NCT01244035|8909996|P6|Part 1: Period 1|Withdrawal by Subject|0
2575710|NCT01244035|8909997|P5|Part 1: Period 1|Withdrawal by Subject|0
2575711|NCT01244035|8909998|P4|Part 1: Period 1|Withdrawal by Subject|0
2575712|NCT01244035|8909999|P3|Part 1: Period 1|Withdrawal by Subject|0
2575713|NCT01244035|8910000|P2|Part 1: Period 1|Withdrawal by Subject|2
2575714|NCT01244035|8910001|P1|Part 1: Period 1|Withdrawal by Subject|0
2575715|NCT01244035|8909996|P6|Part 1: Period 1|Adverse Event|1
2575716|NCT01244035|8909997|P5|Part 1: Period 1|Adverse Event|0
2575717|NCT01244035|8909998|P4|Part 1: Period 1|Adverse Event|0
2575718|NCT01244035|8909999|P3|Part 1: Period 1|Adverse Event|0
2575719|NCT01244035|8910000|P2|Part 1: Period 1|Adverse Event|0
2575720|NCT01244035|8910001|P1|Part 1: Period 1|Adverse Event|0
2575721|NCT01243944|8910042|P2|Overall Study|Non-compliance with study treatment|0
2575722|NCT01243944|8910043|P1|Overall Study|Non-compliance with study treatment|1
2575723|NCT01243944|8910042|P2|Overall Study|Death|3
2575724|NCT01243944|8910043|P1|Overall Study|Death|2
2575725|NCT01243944|8910042|P2|Overall Study|Participant decision|15
2575726|NCT01243944|8910043|P1|Overall Study|Participant decision|10
2575727|NCT01243944|8910042|P2|Overall Study|Protocol deviation|1
2575728|NCT01243944|8910043|P1|Overall Study|Protocol deviation|1
2575729|NCT01243944|8910042|P2|Overall Study|Disease progression|11
2575730|NCT01243944|8910043|P1|Overall Study|Disease progression|12
2575731|NCT01243944|8910042|P2|Overall Study|Physician Decision|7
2575732|NCT01243944|8910043|P1|Overall Study|Physician Decision|2
2575733|NCT01243944|8910042|P2|Overall Study|Lost to Follow-up|1
2575734|NCT01243944|8910043|P1|Overall Study|Lost to Follow-up|2
2575735|NCT01243944|8910042|P2|Overall Study|Adverse Event|13
2575736|NCT01243944|8910043|P1|Overall Study|Adverse Event|15
2575737|NCT01243892|8910071|P2|Overall Study|Did not meet eligibility criteria|0
2575738|NCT01243892|8910072|P1|Overall Study|Did not meet eligibility criteria|2
2575739|NCT01243775|8910082|P1|Overall Study|Withdrawal by Subject|2
2575740|NCT01243762|8910096|P7|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
2575741|NCT01243762|8910097|P6|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
2575742|NCT01243762|8910098|P5|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
2575743|NCT01243762|8910099|P4|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
2575744|NCT01243762|8910100|P3|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
2575745|NCT01243762|8910101|P2|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
2575746|NCT01243762|8910102|P1|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
2575747|NCT01243762|8910096|P7|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
2575748|NCT01243762|8910097|P6|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
2575749|NCT01243762|8910098|P5|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
2575750|NCT01243762|8910099|P4|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
2575751|NCT01243762|8910100|P3|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
2575752|NCT01243762|8910101|P2|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
2575753|NCT01243762|8910102|P1|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
2575754|NCT01243762|8910096|P7|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
2575755|NCT01243762|8910097|P6|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
2575756|NCT01243762|8910098|P5|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2
2575757|NCT01243762|8910099|P4|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
2575758|NCT01243762|8910100|P3|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
2575759|NCT01243762|8910101|P2|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
2575760|NCT01243762|8910102|P1|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
2575761|NCT01243762|8910096|P7|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3
2575762|NCT01243762|8910097|P6|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
2575763|NCT01243762|8910098|P5|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
2575764|NCT01243762|8910099|P4|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
2575765|NCT01243762|8910100|P3|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
2575766|NCT01243762|8910101|P2|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1
2575767|NCT01243762|8910102|P1|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
2575768|NCT01243762|8910096|P7|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
2575769|NCT01243762|8910097|P6|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
2575770|NCT01243762|8910098|P5|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
2575771|NCT01243762|8910099|P4|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
2575772|NCT01243762|8910100|P3|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
2575773|NCT01243762|8910101|P2|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3
2575774|NCT01243762|8910102|P1|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
2575775|NCT01243762|8910096|P7|Part 1 (Dose Escalation/MTD)|Progressive Disease|0
2575776|NCT01243762|8910097|P6|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
2575777|NCT01243762|8910098|P5|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
2575778|NCT01243762|8910099|P4|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
2575779|NCT01243762|8910100|P3|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
2575780|NCT01243762|8910101|P2|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
2575781|NCT01243762|8910102|P1|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
2575782|NCT01243762|8910096|P7|Part 1 (Dose Escalation/MTD)|Physician Decision|0
2575783|NCT01243762|8910097|P6|Part 1 (Dose Escalation/MTD)|Physician Decision|0
2575784|NCT01243762|8910098|P5|Part 1 (Dose Escalation/MTD)|Physician Decision|0
2575785|NCT01243762|8910099|P4|Part 1 (Dose Escalation/MTD)|Physician Decision|1
2575786|NCT01243762|8910100|P3|Part 1 (Dose Escalation/MTD)|Physician Decision|0
2575787|NCT01243762|8910101|P2|Part 1 (Dose Escalation/MTD)|Physician Decision|1
2575788|NCT01243762|8910102|P1|Part 1 (Dose Escalation/MTD)|Physician Decision|0
2575789|NCT01243762|8910096|P7|Part 1 (Dose Escalation/MTD)|Adverse Event|0
2575790|NCT01243762|8910097|P6|Part 1 (Dose Escalation/MTD)|Adverse Event|1
2575791|NCT01243762|8910098|P5|Part 1 (Dose Escalation/MTD)|Adverse Event|1
2575792|NCT01243762|8910099|P4|Part 1 (Dose Escalation/MTD)|Adverse Event|0
2575793|NCT01243762|8910100|P3|Part 1 (Dose Escalation/MTD)|Adverse Event|0
2575794|NCT01243762|8910101|P2|Part 1 (Dose Escalation/MTD)|Adverse Event|2
2575795|NCT01243762|8910102|P1|Part 1 (Dose Escalation/MTD)|Adverse Event|0
2575796|NCT01243671|8910121|P1|Overall Study|Other|1
2575797|NCT01243671|8910121|P1|Overall Study|Anti-adalimumab antibody positive|1
2575798|NCT01243671|8910121|P1|Overall Study|Adverse Event|3
2575799|NCT01243424|8910200|P2|Discontinuation From Treatment|Other than listed above|211
2575800|NCT01243424|8910201|P1|Discontinuation From Treatment|Other than listed above|230
2575801|NCT01243424|8910200|P2|Discontinuation From Treatment|Withdrawal by Subject|328
2575802|NCT01243424|8910201|P1|Discontinuation From Treatment|Withdrawal by Subject|309
2575803|NCT01243424|8910200|P2|Discontinuation From Treatment|Lost to Follow-up|28
2575804|NCT01243424|8910201|P1|Discontinuation From Treatment|Lost to Follow-up|24
2575805|NCT01243424|8910200|P2|Discontinuation From Treatment|Protocol Violation|47
2575806|NCT01243424|8910201|P1|Discontinuation From Treatment|Protocol Violation|46
2575807|NCT01243424|8910200|P2|Discontinuation From Treatment|Lack of Efficacy|41
2575808|NCT01243424|8910201|P1|Discontinuation From Treatment|Lack of Efficacy|61
2575809|NCT01243424|8910200|P2|Discontinuation From Treatment|Adverse Event|523
2575810|NCT01243424|8910201|P1|Discontinuation From Treatment|Adverse Event|457
2575811|NCT01243424|8910200|P2|Discontinuation From Treatment|Not treated|4
2575812|NCT01243424|8910201|P1|Discontinuation From Treatment|Not treated|5
2575813|NCT01243424|8910200|P2|Discontinuation From Study (Treated Set)|Not treated|4
2575814|NCT01243424|8910201|P1|Discontinuation From Study (Treated Set)|Not treated|5
2575815|NCT01243424|8910200|P2|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P−MACE(StatusUnknown)|8
2575816|NCT01243424|8910201|P1|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P−MACE(StatusUnknown)|8
2575817|NCT01243424|8910200|P2|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P−MACE(StatusAlive)|35
2575818|NCT01243424|8910201|P1|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P−MACE(StatusAlive)|38
2575819|NCT01243424|8910200|P2|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1
2575820|NCT01243424|8910201|P1|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0
2575821|NCT01243424|8910200|P2|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22
2575822|NCT01243424|8910201|P1|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15
2575823|NCT01243424|8910200|P2|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12
2575824|NCT01243424|8910201|P1|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14
2575825|NCT01243424|8910200|P2|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37
2575826|NCT01243424|8910201|P1|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49
2575827|NCT01243411|8910243|P1|Overall Study|Other|8
2575828|NCT01243411|8910243|P1|Overall Study|Adverse Event|5
2575829|NCT01243411|8910243|P1|Overall Study|Lost to Follow-up|10
2575830|NCT01243411|8910243|P1|Overall Study|Withdrawal by Subject|18
2575831|NCT01243268|8910354|P1|Overall Study|Duplicate subject|2
2575832|NCT01243268|8910354|P1|Overall Study|Deviation with contract date|7
2575833|NCT01243268|8910354|P1|Overall Study|Protocol Violation|51
2575834|NCT01243268|8910354|P1|Overall Study|Lost to Follow-up|4
2575835|NCT01243242|8910364|P2|Overall Study|non compliance|0
2575836|NCT01243242|8910365|P1|Overall Study|non compliance|1
2575837|NCT01243242|8910364|P2|Overall Study|sponsor decision|1
2575838|NCT01243242|8910365|P1|Overall Study|sponsor decision|0
2575839|NCT01243242|8910364|P2|Overall Study|Physician Decision|1
2575840|NCT01243242|8910365|P1|Overall Study|Physician Decision|0
2575841|NCT01243242|8910364|P2|Overall Study|Withdrawal by Subject|1
2575842|NCT01243242|8910365|P1|Overall Study|Withdrawal by Subject|1
2575843|NCT01243242|8910364|P2|Overall Study|Adverse Event|1
2575844|NCT01243242|8910365|P1|Overall Study|Adverse Event|1
2575845|NCT01243177|8910379|P2|Overall Study|Other Reason|12
2575846|NCT01243177|8910380|P1|Overall Study|Other Reason|11
2575847|NCT01243177|8910379|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
2575848|NCT01243177|8910380|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
2575849|NCT01243177|8910379|P2|Overall Study|SAE, fatal + SAE, non-fatal|0
2575850|NCT01243177|8910380|P1|Overall Study|SAE, fatal + SAE, non-fatal|1
2575851|NCT01243177|8910379|P2|Overall Study|AE, non-serious non-fatal|58
2575852|NCT01243177|8910380|P1|Overall Study|AE, non-serious non-fatal|40
2575853|NCT01243177|8910379|P2|Overall Study|SAE, non-fatal|9
2575854|NCT01243177|8910380|P1|Overall Study|SAE, non-fatal|7
2575855|NCT01243177|8910379|P2|Overall Study|AE, serious fatal|1
2575856|NCT01243177|8910380|P1|Overall Study|AE, serious fatal|0
2575857|NCT01243177|8910379|P2|Overall Study|Withdrawal by Subject|38
2575858|NCT01243177|8910380|P1|Overall Study|Withdrawal by Subject|46
2575859|NCT01243177|8910379|P2|Overall Study|Lost to Follow-up|18
2575860|NCT01243177|8910380|P1|Overall Study|Lost to Follow-up|15
2575861|NCT01243177|8910379|P2|Overall Study|Protocol Violation|10
2575862|NCT01243177|8910380|P1|Overall Study|Protocol Violation|11
2575863|NCT01243177|8910379|P2|Overall Study|Lack of Efficacy|31
2575864|NCT01243177|8910380|P1|Overall Study|Lack of Efficacy|47
2575865|NCT01243151|8910401|P5|Overall Study|Randomized but not treated|0
2575866|NCT01243151|8910402|P4|Overall Study|Randomized but not treated|1
2575867|NCT01243151|8910403|P3|Overall Study|Randomized but not treated|0
2575868|NCT01243151|8910404|P2|Overall Study|Randomized but not treated|0
2575869|NCT01243151|8910405|P1|Overall Study|Randomized but not treated|0
2575870|NCT01243151|8910401|P5|Overall Study|Other|0
2575871|NCT01243151|8910402|P4|Overall Study|Other|1
2575872|NCT01243151|8910403|P3|Overall Study|Other|0
2575873|NCT01243151|8910404|P2|Overall Study|Other|0
2575874|NCT01243151|8910405|P1|Overall Study|Other|0
2575875|NCT01243151|8910401|P5|Overall Study|Protocol Violation|0
2575876|NCT01243151|8910402|P4|Overall Study|Protocol Violation|0
2575877|NCT01243151|8910403|P3|Overall Study|Protocol Violation|1
2575878|NCT01243151|8910404|P2|Overall Study|Protocol Violation|0
2575879|NCT01243151|8910405|P1|Overall Study|Protocol Violation|0
2575880|NCT01243151|8910401|P5|Overall Study|Adverse Event|0
2575881|NCT01243151|8910402|P4|Overall Study|Adverse Event|0
2575882|NCT01243151|8910403|P3|Overall Study|Adverse Event|0
2575883|NCT01243151|8910404|P2|Overall Study|Adverse Event|1
2575884|NCT01243151|8910405|P1|Overall Study|Adverse Event|0
2575885|NCT01242813|8910649|P1|Overall Study|Lost to Follow-up|2
2575886|NCT01242748|8910671|P2|Overall Study|Miscellaneous reasons|3
2575887|NCT01242748|8910672|P1|Overall Study|Miscellaneous reasons|8
2575888|NCT01242748|8910671|P2|Overall Study|Withdrawal by Subject|2
2575889|NCT01242748|8910672|P1|Overall Study|Withdrawal by Subject|10
2575890|NCT01242748|8910671|P2|Overall Study|Protocol Violation|0
2575891|NCT01242748|8910672|P1|Overall Study|Protocol Violation|1
2575892|NCT01242748|8910671|P2|Overall Study|Physician Decision|2
2575893|NCT01242748|8910672|P1|Overall Study|Physician Decision|3
2575894|NCT01242748|8910671|P2|Overall Study|Lost to Follow-up|2
2575895|NCT01242748|8910672|P1|Overall Study|Lost to Follow-up|6
2575896|NCT01242748|8910671|P2|Overall Study|Adverse Event|5
2575897|NCT01242748|8910672|P1|Overall Study|Adverse Event|10
2575898|NCT01242514|8910712|P3|Overall Study|Adverse Event|19
2575899|NCT01242514|8910713|P2|Overall Study|Adverse Event|18
2575900|NCT01242514|8910714|P1|Overall Study|Adverse Event|129
2575901|NCT01242514|8910712|P3|Overall Study|Lost to Follow-up|4
2575902|NCT01242514|8910713|P2|Overall Study|Lost to Follow-up|5
2575903|NCT01242514|8910714|P1|Overall Study|Lost to Follow-up|14
2575904|NCT01242514|8910712|P3|Overall Study|Dev. of study specific discont. criteria|5
2575905|NCT01242514|8910713|P2|Overall Study|Dev. of study specific discont. criteria|3
2575906|NCT01242514|8910714|P1|Overall Study|Dev. of study specific discont. criteria|21
2575907|NCT01242514|8910712|P3|Overall Study|Lack of therapeutic response|10
2575908|NCT01242514|8910713|P2|Overall Study|Lack of therapeutic response|16
2575909|NCT01242514|8910714|P1|Overall Study|Lack of therapeutic response|99
2575910|NCT01242514|8910712|P3|Overall Study|Severe non-compliance to protocol|1
2575911|NCT01242514|8910713|P2|Overall Study|Severe non-compliance to protocol|2
2575912|NCT01242514|8910714|P1|Overall Study|Severe non-compliance to protocol|5
2575913|NCT01242514|8910712|P3|Overall Study|Subject decision|2
2575914|NCT01242514|8910713|P2|Overall Study|Subject decision|8
2575915|NCT01242514|8910714|P1|Overall Study|Subject decision|33
2575916|NCT01242514|8910712|P3|Overall Study|e.g., project closure|171
2575917|NCT01242514|8910713|P2|Overall Study|e.g., project closure|305
2575918|NCT01242514|8910714|P1|Overall Study|e.g., project closure|1042
2575919|NCT01242371|8910733|P2|Overall Study|Protocol Violation|3
2575920|NCT01242371|8910734|P1|Overall Study|Protocol Violation|0
2575921|NCT01242371|8910733|P2|Overall Study|Withdrawal by Subject|2
2575922|NCT01242371|8910734|P1|Overall Study|Withdrawal by Subject|2
2575923|NCT01242176|8910740|P2|Washout Period of 7 Days|Non-compliant with protocol|0
2575924|NCT01242176|8910741|P1|Washout Period of 7 Days|Non-compliant with protocol|1
2575925|NCT01242176|8910740|P2|Washout Period of 7 Days|Adverse Event|2
2575926|NCT01242176|8910741|P1|Washout Period of 7 Days|Adverse Event|0
2575927|NCT01242111|8910751|P1|Overall Study|Did not consent to MOR-100 follow-up|1
2575928|NCT01242111|8910751|P1|Overall Study|Withdrawal by Subject|1
2575929|NCT01242111|8910751|P1|Overall Study|Adverse Event|1
2575930|NCT01242085|8910763|P3|Overall Study|medically unable to have surgery|0
2575931|NCT01242085|8910764|P2|Overall Study|medically unable to have surgery|5
2575932|NCT01242085|8910765|P1|Overall Study|medically unable to have surgery|4
2575933|NCT01242085|8910763|P3|Overall Study|Withdrawal by Subject|0
2575934|NCT01242085|8910764|P2|Overall Study|Withdrawal by Subject|2
2575935|NCT01242085|8910765|P1|Overall Study|Withdrawal by Subject|4
2575936|NCT01242020|8910775|P2|Overall Study|Failed screening|0
2575937|NCT01242020|8910776|P1|Overall Study|Failed screening|1
2575938|NCT01242020|8910775|P2|Overall Study|Withdrawal by Subject|0
2575939|NCT01242020|8910776|P1|Overall Study|Withdrawal by Subject|2
2575940|NCT01241760|8910806|P2|Overall Study|Other|1
2575941|NCT01241760|8910807|P1|Overall Study|Other|1
2575942|NCT01241760|8910806|P2|Overall Study|Switch To Commercially Available Medicat|4
2575943|NCT01241760|8910807|P1|Overall Study|Switch To Commercially Available Medicat|1
2575944|NCT01241760|8910806|P2|Overall Study|Withdrawal by Subject|13
2575945|NCT01241760|8910807|P1|Overall Study|Withdrawal by Subject|13
2575946|NCT01241760|8910806|P2|Overall Study|Lost to Follow-up|22
2575947|NCT01241760|8910807|P1|Overall Study|Lost to Follow-up|18
2575948|NCT01241760|8910806|P2|Overall Study|Adverse Event|0
2575949|NCT01241760|8910807|P1|Overall Study|Adverse Event|1
2575950|NCT01241604|8910826|P3|Screening Period|Screen Failure|0
2575951|NCT01241604|8910827|P2|Screening Period|Screen Failure|0
2575952|NCT01241604|8910828|P1|Screening Period|Screen Failure|3
2575953|NCT01241591|8910873|P4|Overall Study|Adverse Event|4
2575954|NCT01241591|8910874|P3|Overall Study|Adverse Event|12
2575955|NCT01241591|8910875|P2|Overall Study|Adverse Event|11
2575956|NCT01241591|8910876|P1|Overall Study|Adverse Event|3
2575957|NCT01241591|8910873|P4|Overall Study|Other|1
2575958|NCT01241591|8910874|P3|Overall Study|Other|0
2575959|NCT01241591|8910875|P2|Overall Study|Other|1
2575960|NCT01241591|8910876|P1|Overall Study|Other|0
2575961|NCT01241591|8910873|P4|Overall Study|Withdrawal by Subject|2
2575962|NCT01241591|8910874|P3|Overall Study|Withdrawal by Subject|2
2575963|NCT01241591|8910875|P2|Overall Study|Withdrawal by Subject|4
2575964|NCT01241591|8910876|P1|Overall Study|Withdrawal by Subject|6
2575965|NCT01241591|8910873|P4|Overall Study|Screen Failure|0
2575966|NCT01241591|8910874|P3|Overall Study|Screen Failure|1
2575967|NCT01241591|8910875|P2|Overall Study|Screen Failure|2
2575968|NCT01241591|8910876|P1|Overall Study|Screen Failure|3
2575969|NCT01241591|8910873|P4|Overall Study|Lost to Follow-up|2
2575970|NCT01241591|8910874|P3|Overall Study|Lost to Follow-up|2
2575971|NCT01241591|8910875|P2|Overall Study|Lost to Follow-up|2
2575972|NCT01241591|8910876|P1|Overall Study|Lost to Follow-up|1
2575973|NCT01241591|8910873|P4|Overall Study|Protocol Violation|0
2575974|NCT01241591|8910874|P3|Overall Study|Protocol Violation|3
2575975|NCT01241591|8910875|P2|Overall Study|Protocol Violation|2
2575976|NCT01241591|8910876|P1|Overall Study|Protocol Violation|5
2575977|NCT01241591|8910873|P4|Overall Study|Lack of Efficacy|3
2575978|NCT01241591|8910874|P3|Overall Study|Lack of Efficacy|2
2575979|NCT01241591|8910875|P2|Overall Study|Lack of Efficacy|2
2575980|NCT01241591|8910876|P1|Overall Study|Lack of Efficacy|5
2575981|NCT01241552|8911079|P4|Overall Study|Lost to Follow-up|16
2575982|NCT01241552|8911080|P3|Overall Study|Lost to Follow-up|15
2575983|NCT01241552|8911081|P2|Overall Study|Lost to Follow-up|11
2575984|NCT01241552|8911082|P1|Overall Study|Lost to Follow-up|2
2575985|NCT01241552|8911079|P4|Overall Study|Physician Decision|3
2575986|NCT01241552|8911080|P3|Overall Study|Physician Decision|2
2575987|NCT01241552|8911081|P2|Overall Study|Physician Decision|4
2575988|NCT01241552|8911082|P1|Overall Study|Physician Decision|2
2575989|NCT01241552|8911079|P4|Overall Study|Withdrawal by Subject|15
2575990|NCT01241552|8911080|P3|Overall Study|Withdrawal by Subject|14
2575991|NCT01241552|8911081|P2|Overall Study|Withdrawal by Subject|15
2575992|NCT01241552|8911082|P1|Overall Study|Withdrawal by Subject|7
2575993|NCT01241552|8911079|P4|Overall Study|Protocol Violation|1
2575994|NCT01241552|8911080|P3|Overall Study|Protocol Violation|6
2575995|NCT01241552|8911081|P2|Overall Study|Protocol Violation|2
2575996|NCT01241552|8911082|P1|Overall Study|Protocol Violation|0
2575997|NCT01241552|8911079|P4|Overall Study|Progressive Disease|2
2575998|NCT01241552|8911080|P3|Overall Study|Progressive Disease|1
2575999|NCT01241552|8911081|P2|Overall Study|Progressive Disease|0
2576000|NCT01241552|8911082|P1|Overall Study|Progressive Disease|0
2576001|NCT01241552|8911079|P4|Overall Study|Technical Problems|2
2576002|NCT01241552|8911080|P3|Overall Study|Technical Problems|2
2576003|NCT01241552|8911081|P2|Overall Study|Technical Problems|0
2576004|NCT01241552|8911082|P1|Overall Study|Technical Problems|2
2576005|NCT01241552|8911079|P4|Overall Study|Adverse Event|0
2576006|NCT01241552|8911080|P3|Overall Study|Adverse Event|0
2576007|NCT01241552|8911081|P2|Overall Study|Adverse Event|1
2576008|NCT01241552|8911082|P1|Overall Study|Adverse Event|1
2576009|NCT01241552|8911079|P4|Overall Study|Death|25
2576010|NCT01241552|8911080|P3|Overall Study|Death|20
2576011|NCT01241552|8911081|P2|Overall Study|Death|30
2576012|NCT01241552|8911082|P1|Overall Study|Death|26
2576013|NCT01241552|8911079|P4|Overall Study|Lack of Efficacy|0
2576014|NCT01241552|8911080|P3|Overall Study|Lack of Efficacy|0
2576015|NCT01241552|8911081|P2|Overall Study|Lack of Efficacy|0
2576016|NCT01241552|8911082|P1|Overall Study|Lack of Efficacy|1
2576017|NCT01241461|8911177|P2|Overall Study|Progressive Disease|6
2576018|NCT01241461|8911178|P1|Overall Study|Progressive Disease|3
2576019|NCT01241448|8911198|P4|Overall Study|Excluded due to data integrity issues|2
2576020|NCT01241448|8911199|P3|Overall Study|Excluded due to data integrity issues|2
2576021|NCT01241448|8911200|P2|Overall Study|Excluded due to data integrity issues|2
2576022|NCT01241448|8911201|P1|Overall Study|Excluded due to data integrity issues|3
2576023|NCT01241448|8911198|P4|Overall Study|Withdrawal by Subject|6
2576024|NCT01241448|8911199|P3|Overall Study|Withdrawal by Subject|3
2576025|NCT01241448|8911200|P2|Overall Study|Withdrawal by Subject|5
2576026|NCT01241448|8911201|P1|Overall Study|Withdrawal by Subject|4
2576027|NCT01241448|8911198|P4|Overall Study|Sponsor Decision|6
2576028|NCT01241448|8911199|P3|Overall Study|Sponsor Decision|12
2576029|NCT01241448|8911200|P2|Overall Study|Sponsor Decision|14
2576030|NCT01241448|8911201|P1|Overall Study|Sponsor Decision|17
2576031|NCT01241448|8911198|P4|Overall Study|Protocol Violation|6
2576032|NCT01241448|8911199|P3|Overall Study|Protocol Violation|3
2576033|NCT01241448|8911200|P2|Overall Study|Protocol Violation|5
2576034|NCT01241448|8911201|P1|Overall Study|Protocol Violation|10
2576035|NCT01241448|8911198|P4|Overall Study|Physician Decision|0
2576036|NCT01241448|8911199|P3|Overall Study|Physician Decision|0
2576037|NCT01241448|8911200|P2|Overall Study|Physician Decision|2
2576038|NCT01241448|8911201|P1|Overall Study|Physician Decision|0
2576039|NCT01241448|8911198|P4|Overall Study|Lost to Follow-up|1
2576040|NCT01241448|8911199|P3|Overall Study|Lost to Follow-up|1
2576041|NCT01241448|8911200|P2|Overall Study|Lost to Follow-up|1
2576042|NCT01241448|8911201|P1|Overall Study|Lost to Follow-up|2
2576043|NCT01241448|8911198|P4|Overall Study|Adverse Event|2
2576044|NCT01241448|8911199|P3|Overall Study|Adverse Event|2
2576045|NCT01241448|8911200|P2|Overall Study|Adverse Event|0
2576046|NCT01241448|8911201|P1|Overall Study|Adverse Event|1
2576047|NCT01241318|8911292|P2|Overall Study|Woman: Stillborn infant|146
2576048|NCT01241318|8911293|P1|Overall Study|Woman: Stillborn infant|129
2576049|NCT01241318|8911292|P2|Overall Study|Withdrew/LTF after delivery|38
2576050|NCT01241318|8911293|P1|Overall Study|Withdrew/LTF after delivery|60
2576051|NCT01241318|8911292|P2|Overall Study|Death|4
2576052|NCT01241318|8911293|P1|Overall Study|Death|2
2576053|NCT01241318|8911292|P2|Overall Study|Lost to Follow-up|455
2576054|NCT01241318|8911293|P1|Overall Study|Lost to Follow-up|740
2576055|NCT01241318|8911292|P2|Overall Study|Withdrawal by Subject|46
2576056|NCT01241318|8911293|P1|Overall Study|Withdrawal by Subject|175
2576057|NCT01241318|8911292|P2|Overall Study|Woman: miscarriage/abortion|38
2576058|NCT01241318|8911293|P1|Overall Study|Woman: miscarriage/abortion|46
2576059|NCT01241318|8911292|P2|Overall Study|Woman: false pregnancies|15
2576060|NCT01241318|8911293|P1|Overall Study|Woman: false pregnancies|27
2576061|NCT01241292|8911306|P2|Overall Study|Participant Discontinued Treatment|2
2576062|NCT01241292|8911307|P1|Overall Study|Participant Discontinued Treatment|0
2576063|NCT01241292|8911306|P2|Overall Study|Study Drug Toxicity|1
2576064|NCT01241292|8911307|P1|Overall Study|Study Drug Toxicity|0
2576065|NCT01241292|8911306|P2|Overall Study|Disease Progression|0
2576066|NCT01241292|8911307|P1|Overall Study|Disease Progression|2
2576067|NCT01241292|8911306|P2|Overall Study|Administrative Reason by Sponsor|0
2576068|NCT01241292|8911307|P1|Overall Study|Administrative Reason by Sponsor|1
2576069|NCT01241279|8911331|P2|Overall Study|Lost to Follow-up|1
2576070|NCT01241279|8911332|P1|Overall Study|Lost to Follow-up|0
2576071|NCT01241240|8911342|P2|Overall Study|Personal Reasons|1
2576072|NCT01241240|8911343|P1|Overall Study|Personal Reasons|1
2576073|NCT01241240|8911342|P2|Overall Study|Lost to Follow-up|4
2576074|NCT01241240|8911343|P1|Overall Study|Lost to Follow-up|2
2576075|NCT01241240|8911342|P2|Overall Study|Adverse Event|4
2576076|NCT01241240|8911343|P1|Overall Study|Adverse Event|5
2576077|NCT01240915|8911361|P9|Overall Study|Insufficient Clinical Response|3
2576078|NCT01240915|8911362|P8|Overall Study|Insufficient Clinical Response|0
2576079|NCT01240915|8911363|P7|Overall Study|Insufficient Clinical Response|6
2576080|NCT01240915|8911364|P6|Overall Study|Insufficient Clinical Response|3
2576081|NCT01240915|8911365|P5|Overall Study|Insufficient Clinical Response|1
2576082|NCT01240915|8911366|P4|Overall Study|Insufficient Clinical Response|0
2576083|NCT01240915|8911367|P3|Overall Study|Insufficient Clinical Response|0
2576084|NCT01240915|8911368|P2|Overall Study|Insufficient Clinical Response|0
2576085|NCT01240915|8911369|P1|Overall Study|Insufficient Clinical Response|0
2576086|NCT01240915|8911361|P9|Overall Study|Other|0
2576087|NCT01240915|8911362|P8|Overall Study|Other|0
2576088|NCT01240915|8911363|P7|Overall Study|Other|0
2576089|NCT01240915|8911364|P6|Overall Study|Other|0
2576090|NCT01240915|8911365|P5|Overall Study|Other|2
2576091|NCT01240915|8911366|P4|Overall Study|Other|0
2576092|NCT01240915|8911367|P3|Overall Study|Other|0
2576093|NCT01240915|8911368|P2|Overall Study|Other|0
2576094|NCT01240915|8911369|P1|Overall Study|Other|0
2576095|NCT01240915|8911361|P9|Overall Study|Withdrawal by Subject|3
2576096|NCT01240915|8911362|P8|Overall Study|Withdrawal by Subject|3
2576097|NCT01240915|8911363|P7|Overall Study|Withdrawal by Subject|2
2576098|NCT01240915|8911364|P6|Overall Study|Withdrawal by Subject|4
2576099|NCT01240915|8911365|P5|Overall Study|Withdrawal by Subject|0
2576100|NCT01240915|8911366|P4|Overall Study|Withdrawal by Subject|2
2576101|NCT01240915|8911367|P3|Overall Study|Withdrawal by Subject|0
2576102|NCT01240915|8911368|P2|Overall Study|Withdrawal by Subject|1
2576103|NCT01240915|8911369|P1|Overall Study|Withdrawal by Subject|2
2576104|NCT01240915|8911361|P9|Overall Study|Lost to Follow-up|1
2576105|NCT01240915|8911362|P8|Overall Study|Lost to Follow-up|1
2576106|NCT01240915|8911363|P7|Overall Study|Lost to Follow-up|0
2576107|NCT01240915|8911364|P6|Overall Study|Lost to Follow-up|1
2576108|NCT01240915|8911365|P5|Overall Study|Lost to Follow-up|1
2576109|NCT01240915|8911366|P4|Overall Study|Lost to Follow-up|0
2576110|NCT01240915|8911367|P3|Overall Study|Lost to Follow-up|0
2576111|NCT01240915|8911368|P2|Overall Study|Lost to Follow-up|0
2576112|NCT01240915|8911369|P1|Overall Study|Lost to Follow-up|0
2576113|NCT01240915|8911361|P9|Overall Study|Adverse Event|1
2576114|NCT01240915|8911362|P8|Overall Study|Adverse Event|0
2576115|NCT01240915|8911363|P7|Overall Study|Adverse Event|0
2576116|NCT01240915|8911364|P6|Overall Study|Adverse Event|2
2576117|NCT01240915|8911365|P5|Overall Study|Adverse Event|0
2576118|NCT01240915|8911366|P4|Overall Study|Adverse Event|1
2576119|NCT01240915|8911367|P3|Overall Study|Adverse Event|0
2576120|NCT01240915|8911368|P2|Overall Study|Adverse Event|0
2576121|NCT01240915|8911369|P1|Overall Study|Adverse Event|0
2576122|NCT01240863|8911643|P3|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
2576123|NCT01240863|8911644|P2|Double-blind Treatment Period (12 Weeks)|Physician Decision|1
2576124|NCT01240863|8911645|P1|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
2576125|NCT01240863|8911643|P3|Double-blind Treatment Period (12 Weeks)|Other|5
2576126|NCT01240863|8911644|P2|Double-blind Treatment Period (12 Weeks)|Other|1
2576127|NCT01240863|8911645|P1|Double-blind Treatment Period (12 Weeks)|Other|0
2576128|NCT01240863|8911643|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
2576129|NCT01240863|8911644|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
2576130|NCT01240863|8911645|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0
2576131|NCT01240863|8911643|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11
2576132|NCT01240863|8911644|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9
2576133|NCT01240863|8911645|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
2576134|NCT01240863|8911643|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14
2576135|NCT01240863|8911644|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
2576136|NCT01240863|8911645|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
2576137|NCT01240863|8911643|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5
2576138|NCT01240863|8911644|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3
2576139|NCT01240863|8911645|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
2576140|NCT01240863|8911643|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
2576141|NCT01240863|8911644|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
2576142|NCT01240863|8911645|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
2576143|NCT01240863|8911643|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|10
2576144|NCT01240863|8911644|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|4
2576145|NCT01240863|8911645|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
2576146|NCT01240863|8911643|P3|Open-label Titration Period|Other|0
2576147|NCT01240863|8911644|P2|Open-label Titration Period|Other|0
2576148|NCT01240863|8911645|P1|Open-label Titration Period|Other|7
2576149|NCT01240863|8911643|P3|Open-label Titration Period|Dropped out prior to dosing|0
2576150|NCT01240863|8911644|P2|Open-label Titration Period|Dropped out prior to dosing|0
2576151|NCT01240863|8911645|P1|Open-label Titration Period|Dropped out prior to dosing|2
2576152|NCT01240863|8911643|P3|Open-label Titration Period|Noncompliance to study procedures|0
2576153|NCT01240863|8911644|P2|Open-label Titration Period|Noncompliance to study procedures|0
2576154|NCT01240863|8911645|P1|Open-label Titration Period|Noncompliance to study procedures|3
2576155|NCT01240863|8911643|P3|Open-label Titration Period|Noncompliance to study drug admin|0
2576156|NCT01240863|8911644|P2|Open-label Titration Period|Noncompliance to study drug admin|0
2576157|NCT01240863|8911645|P1|Open-label Titration Period|Noncompliance to study drug admin|3
2576158|NCT01240863|8911643|P3|Open-label Titration Period|Protocol Violation|0
2576159|NCT01240863|8911644|P2|Open-label Titration Period|Protocol Violation|0
2576160|NCT01240863|8911645|P1|Open-label Titration Period|Protocol Violation|7
2576161|NCT01240863|8911643|P3|Open-label Titration Period|Withdrawal by Subject|0
2576162|NCT01240863|8911644|P2|Open-label Titration Period|Withdrawal by Subject|0
2576163|NCT01240863|8911645|P1|Open-label Titration Period|Withdrawal by Subject|9
2576164|NCT01240863|8911643|P3|Open-label Titration Period|Lack of Efficacy|0
2576165|NCT01240863|8911644|P2|Open-label Titration Period|Lack of Efficacy|0
2576166|NCT01240863|8911645|P1|Open-label Titration Period|Lack of Efficacy|19
2576167|NCT01240863|8911643|P3|Open-label Titration Period|Adverse Event|0
2576168|NCT01240863|8911644|P2|Open-label Titration Period|Adverse Event|0
2576169|NCT01240863|8911645|P1|Open-label Titration Period|Adverse Event|47
2576170|NCT01240811|8911707|P3|Overall Study|Withdrawal by Subject|1
2576171|NCT01240811|8911708|P2|Overall Study|Withdrawal by Subject|0
2576172|NCT01240811|8911709|P1|Overall Study|Withdrawal by Subject|0
2576173|NCT01240811|8911707|P3|Overall Study|Physician Decision|0
2576174|NCT01240811|8911708|P2|Overall Study|Physician Decision|1
2576175|NCT01240811|8911709|P1|Overall Study|Physician Decision|0
2576176|NCT01240785|8911725|P2|Overall Study|Protocol Violation|3
2576177|NCT01240785|8911726|P1|Overall Study|Protocol Violation|0
2576178|NCT01240785|8911725|P2|Overall Study|Lost to Follow-up|0
2576179|NCT01240785|8911726|P1|Overall Study|Lost to Follow-up|1
2576180|NCT01240746|8911757|P3|Overall Study|Withdrawal by Subject|59
2576181|NCT01240746|8911758|P2|Overall Study|Withdrawal by Subject|13
2576182|NCT01240746|8911759|P1|Overall Study|Withdrawal by Subject|10
2576183|NCT01240746|8911757|P3|Overall Study|Protocol Violation|72
2576184|NCT01240746|8911758|P2|Overall Study|Protocol Violation|15
2576185|NCT01240746|8911759|P1|Overall Study|Protocol Violation|24
2576186|NCT01240746|8911757|P3|Overall Study|Lost to Follow-up|102
2576187|NCT01240746|8911758|P2|Overall Study|Lost to Follow-up|20
2576188|NCT01240746|8911759|P1|Overall Study|Lost to Follow-up|23
2576189|NCT01240746|8911757|P3|Overall Study|Adverse Event|10
2576190|NCT01240746|8911758|P2|Overall Study|Adverse Event|0
2576191|NCT01240746|8911759|P1|Overall Study|Adverse Event|2
2576192|NCT01240590|8911814|P5|Phase II|Refused further treatment|1
2576193|NCT01240590|8911815|P4|Phase II|Refused further treatment|2
2576194|NCT01240590|8911816|P3|Phase II|Refused further treatment|0
2576195|NCT01240590|8911817|P2|Phase II|Refused further treatment|0
2576196|NCT01240590|8911818|P1|Phase II|Refused further treatment|0
2576197|NCT01240590|8911814|P5|Phase I|Refused further treatment|0
2576198|NCT01240590|8911815|P4|Phase I|Refused further treatment|0
2576199|NCT01240590|8911816|P3|Phase I|Refused further treatment|3
2576200|NCT01240590|8911817|P2|Phase I|Refused further treatment|0
2576201|NCT01240590|8911818|P1|Phase I|Refused further treatment|0
2576202|NCT01240551|8911846|P2|Overall Study|Lost to Follow-up|1
2576203|NCT01240551|8911847|P1|Overall Study|Lost to Follow-up|1
2576204|NCT01240551|8911846|P2|Overall Study|Refused further treatment|2
2576205|NCT01240551|8911847|P1|Overall Study|Refused further treatment|3
2576206|NCT01240382|8911857|P2|Overall Study|Fear of adverse events|1
2576207|NCT01240382|8911858|P1|Overall Study|Fear of adverse events|0
2576208|NCT01240382|8911857|P2|Overall Study|Lack of Efficacy|2
2576209|NCT01240382|8911858|P1|Overall Study|Lack of Efficacy|0
2576210|NCT01240382|8911857|P2|Overall Study|Adverse Event|1
2576211|NCT01240382|8911858|P1|Overall Study|Adverse Event|2
2576212|NCT01240356|8911868|P2|Overall Study|MRI contraindication|0
2576213|NCT01240356|8911869|P1|Overall Study|MRI contraindication|1
2576214|NCT01240356|8911868|P2|Overall Study|Withdrawal by Subject|0
2576215|NCT01240356|8911869|P1|Overall Study|Withdrawal by Subject|2
2576216|NCT01240200|8911892|P2|12-week Crossover Phase - Period 1|Withdrawal by Subject|1
2576217|NCT01240200|8911893|P1|12-week Crossover Phase - Period 1|Withdrawal by Subject|2
2576218|NCT01240135|8911911|P2|Period Two, 14 Days of Wear|Adverse Event|1
2576219|NCT01240135|8911912|P1|Period Two, 14 Days of Wear|Adverse Event|0
2576220|NCT01240135|8911911|P2|Period Two, 14 Days of Wear|Withdrawal by Subject|1
2576221|NCT01240135|8911912|P1|Period Two, 14 Days of Wear|Withdrawal by Subject|1
2576222|NCT01239992|8911929|P1|Overall Study|Withdrawal by Subject|2
2576223|NCT01239797|8911938|P2|Treated Participants|Poor/Non-compliance|1
2576224|NCT01239797|8911939|P1|Treated Participants|Poor/Non-compliance|0
2576225|NCT01239797|8911938|P2|Treated Participants|Subject No Longer Meets Study Criteria|1
2576226|NCT01239797|8911939|P1|Treated Participants|Subject No Longer Meets Study Criteria|1
2576227|NCT01239797|8911938|P2|Treated Participants|Death|1
2576228|NCT01239797|8911939|P1|Treated Participants|Death|1
2576229|NCT01239797|8911938|P2|Treated Participants|Non-specified|11
2576230|NCT01239797|8911939|P1|Treated Participants|Non-specified|1
2576231|NCT01239797|8911938|P2|Treated Participants|Withdrawal by Subject|23
2576232|NCT01239797|8911939|P1|Treated Participants|Withdrawal by Subject|27
2576233|NCT01239797|8911938|P2|Treated Participants|Adverse Event Unrelated to Study Drug|32
2576234|NCT01239797|8911939|P1|Treated Participants|Adverse Event Unrelated to Study Drug|22
2576235|NCT01239797|8911938|P2|Treated Participants|Study Drug Toxicity|44
2576236|NCT01239797|8911939|P1|Treated Participants|Study Drug Toxicity|30
2576237|NCT01239797|8911938|P2|Treated Participants|Disease Progression|161
2576238|NCT01239797|8911939|P1|Treated Participants|Disease Progression|153
2576239|NCT01239745|8911947|P1|Overall Study|Adverse Event|1
2576240|NCT01239745|8911947|P1|Overall Study|Study terminated by sponsor|45
2576241|NCT01239732|8911958|P1|Overall Study|Other|19
2576242|NCT01239732|8911958|P1|Overall Study|Treatment failure|2
2576243|NCT01239732|8911958|P1|Overall Study|Investigator's decision|4
2576244|NCT01239732|8911958|P1|Overall Study|Study termination by sponsor|2
2576245|NCT01239732|8911958|P1|Overall Study|Participant non compliance|5
2576246|NCT01239732|8911958|P1|Overall Study|Protocol Violation|3
2576247|NCT01239732|8911958|P1|Overall Study|Adverse Event|6
2576248|NCT01239732|8911958|P1|Overall Study|Withdrawal by Subject|87
2576249|NCT01239732|8911958|P1|Overall Study|Death|226
2576250|NCT01239732|8911958|P1|Overall Study|Termination of study per protocol|667
2576251|NCT01239680|8911971|P2|Overall Study|Withdrawal by Subject|0
2576252|NCT01239680|8911972|P1|Overall Study|Withdrawal by Subject|2
2576253|NCT01239472|8911997|P2|Overall Study|Lack of Efficacy|1
2576254|NCT01239472|8911998|P1|Overall Study|Lack of Efficacy|0
2576255|NCT01239472|8911997|P2|Overall Study|Adverse Event|1
2576256|NCT01239472|8911998|P1|Overall Study|Adverse Event|0
2576257|NCT01239472|8911997|P2|Overall Study|Withdrawal by Subject|1
2576258|NCT01239472|8911998|P1|Overall Study|Withdrawal by Subject|5
2576259|NCT01239394|8912006|P1|Overall Study|Adverse Event|1
2576260|NCT01239381|8912013|P1|Overall Study|Withdrawal by Subject|1
2576261|NCT01239381|8912013|P1|Overall Study|Protocol Violation|1
2576262|NCT01239368|8912033|P10|Overall Study|Death|0
2576263|NCT01239368|8912034|P9|Overall Study|Death|0
2576264|NCT01239368|8912035|P8|Overall Study|Death|0
2576265|NCT01239368|8912036|P7|Overall Study|Death|1
2576266|NCT01239368|8912037|P6|Overall Study|Death|0
2576267|NCT01239368|8912038|P5|Overall Study|Death|0
2576268|NCT01239368|8912039|P4|Overall Study|Death|0
2576269|NCT01239368|8912040|P3|Overall Study|Death|0
2576270|NCT01239368|8912041|P2|Overall Study|Death|0
2576271|NCT01239368|8912042|P1|Overall Study|Death|0
2576272|NCT01239368|8912033|P10|Overall Study|Refused further treatment|1
2576273|NCT01239368|8912034|P9|Overall Study|Refused further treatment|0
2576274|NCT01239368|8912035|P8|Overall Study|Refused further treatment|0
2576275|NCT01239368|8912036|P7|Overall Study|Refused further treatment|0
2576276|NCT01239368|8912037|P6|Overall Study|Refused further treatment|0
2576277|NCT01239368|8912038|P5|Overall Study|Refused further treatment|0
2576278|NCT01239368|8912039|P4|Overall Study|Refused further treatment|0
2576279|NCT01239368|8912040|P3|Overall Study|Refused further treatment|0
2576280|NCT01239368|8912041|P2|Overall Study|Refused further treatment|0
2576281|NCT01239368|8912042|P1|Overall Study|Refused further treatment|0
2576282|NCT01239368|8912033|P10|Overall Study|Disease progression on study|2
2576283|NCT01239368|8912034|P9|Overall Study|Disease progression on study|0
2576284|NCT01239368|8912035|P8|Overall Study|Disease progression on study|0
2576285|NCT01239368|8912036|P7|Overall Study|Disease progression on study|5
2576286|NCT01239368|8912037|P6|Overall Study|Disease progression on study|2
2576287|NCT01239368|8912038|P5|Overall Study|Disease progression on study|4
2576288|NCT01239368|8912039|P4|Overall Study|Disease progression on study|1
2576289|NCT01239368|8912040|P3|Overall Study|Disease progression on study|1
2576290|NCT01239368|8912041|P2|Overall Study|Disease progression on study|1
2576291|NCT01239368|8912042|P1|Overall Study|Disease progression on study|1
2576292|NCT01239368|8912033|P10|Overall Study|Principal investigator discretion|1
2576293|NCT01239368|8912034|P9|Overall Study|Principal investigator discretion|0
2576294|NCT01239368|8912035|P8|Overall Study|Principal investigator discretion|0
2576295|NCT01239368|8912036|P7|Overall Study|Principal investigator discretion|0
2576296|NCT01239368|8912037|P6|Overall Study|Principal investigator discretion|2
2576297|NCT01239368|8912038|P5|Overall Study|Principal investigator discretion|1
2576298|NCT01239368|8912039|P4|Overall Study|Principal investigator discretion|0
2576299|NCT01239368|8912040|P3|Overall Study|Principal investigator discretion|0
2576300|NCT01239368|8912041|P2|Overall Study|Principal investigator discretion|0
2576301|NCT01239368|8912042|P1|Overall Study|Principal investigator discretion|1
2576302|NCT01239342|8912094|P2|Overall Study|Reason Unknown|1
2576303|NCT01239342|8912095|P1|Overall Study|Reason Unknown|1
2576304|NCT01239342|8912094|P2|Overall Study|Withdrawal by Subject|5
2576305|NCT01239342|8912095|P1|Overall Study|Withdrawal by Subject|1
2576306|NCT01239342|8912094|P2|Overall Study|Adverse Event|0
2576307|NCT01239342|8912095|P1|Overall Study|Adverse Event|1
2576308|NCT01239316|8912111|P1|Overall Study|Adverse Event|1
2576309|NCT01239316|8912111|P1|Overall Study|Progression/Relapse|11
2576310|NCT01239121|8912126|P3|Overall Study|Withdrawal by Subject|0
2576311|NCT01239121|8912127|P2|Overall Study|Withdrawal by Subject|4
2576312|NCT01239121|8912128|P1|Overall Study|Withdrawal by Subject|2
2576313|NCT01239043|8912150|P2|Overall Study|Protocol Violation|1
2576314|NCT01239043|8912151|P1|Overall Study|Protocol Violation|2
2576315|NCT01238991|8912179|P10|Overall Study|Admission to a nursing home|0
2576316|NCT01238991|8912180|P9|Overall Study|Admission to a nursing home|0
2576317|NCT01238991|8912181|P8|Overall Study|Admission to a nursing home|0
2576318|NCT01238991|8912182|P7|Overall Study|Admission to a nursing home|0
2576319|NCT01238991|8912183|P6|Overall Study|Admission to a nursing home|0
2576320|NCT01238991|8912184|P5|Overall Study|Admission to a nursing home|0
2576321|NCT01238991|8912185|P4|Overall Study|Admission to a nursing home|0
2576322|NCT01238991|8912186|P3|Overall Study|Admission to a nursing home|1
2576323|NCT01238991|8912187|P2|Overall Study|Admission to a nursing home|0
2576324|NCT01238991|8912188|P1|Overall Study|Admission to a nursing home|1
2576325|NCT01238991|8912179|P10|Overall Study|Caregiver's request|0
2576326|NCT01238991|8912180|P9|Overall Study|Caregiver's request|1
2576327|NCT01238991|8912181|P8|Overall Study|Caregiver's request|0
2576328|NCT01238991|8912182|P7|Overall Study|Caregiver's request|0
2576329|NCT01238991|8912183|P6|Overall Study|Caregiver's request|0
2576330|NCT01238991|8912184|P5|Overall Study|Caregiver's request|0
2576331|NCT01238991|8912185|P4|Overall Study|Caregiver's request|0
2576332|NCT01238991|8912186|P3|Overall Study|Caregiver's request|0
2576333|NCT01238991|8912187|P2|Overall Study|Caregiver's request|0
2576334|NCT01238991|8912188|P1|Overall Study|Caregiver's request|0
2576335|NCT01238991|8912179|P10|Overall Study|Study Terminated by Sponsor|2
2576336|NCT01238991|8912180|P9|Overall Study|Study Terminated by Sponsor|2
2576337|NCT01238991|8912181|P8|Overall Study|Study Terminated by Sponsor|4
2576338|NCT01238991|8912182|P7|Overall Study|Study Terminated by Sponsor|7
2576339|NCT01238991|8912183|P6|Overall Study|Study Terminated by Sponsor|0
2576340|NCT01238991|8912184|P5|Overall Study|Study Terminated by Sponsor|1
2576341|NCT01238991|8912185|P4|Overall Study|Study Terminated by Sponsor|0
2576342|NCT01238991|8912186|P3|Overall Study|Study Terminated by Sponsor|0
2576343|NCT01238991|8912187|P2|Overall Study|Study Terminated by Sponsor|0
2576344|NCT01238991|8912188|P1|Overall Study|Study Terminated by Sponsor|0
2576345|NCT01238991|8912179|P10|Overall Study|Withdrawal by Subject|0
2576346|NCT01238991|8912180|P9|Overall Study|Withdrawal by Subject|0
2576347|NCT01238991|8912181|P8|Overall Study|Withdrawal by Subject|0
2576348|NCT01238991|8912182|P7|Overall Study|Withdrawal by Subject|0
2576349|NCT01238991|8912183|P6|Overall Study|Withdrawal by Subject|0
2576350|NCT01238991|8912184|P5|Overall Study|Withdrawal by Subject|0
2576351|NCT01238991|8912185|P4|Overall Study|Withdrawal by Subject|0
2576352|NCT01238991|8912186|P3|Overall Study|Withdrawal by Subject|1
2576353|NCT01238991|8912187|P2|Overall Study|Withdrawal by Subject|0
2576354|NCT01238991|8912188|P1|Overall Study|Withdrawal by Subject|0
2576355|NCT01238991|8912179|P10|Overall Study|Lack of Efficacy|0
2576356|NCT01238991|8912180|P9|Overall Study|Lack of Efficacy|1
2576357|NCT01238991|8912181|P8|Overall Study|Lack of Efficacy|0
2576358|NCT01238991|8912182|P7|Overall Study|Lack of Efficacy|0
2576359|NCT01238991|8912183|P6|Overall Study|Lack of Efficacy|0
2576360|NCT01238991|8912184|P5|Overall Study|Lack of Efficacy|0
2576361|NCT01238991|8912185|P4|Overall Study|Lack of Efficacy|0
2576362|NCT01238991|8912186|P3|Overall Study|Lack of Efficacy|1
2576363|NCT01238991|8912187|P2|Overall Study|Lack of Efficacy|0
2576364|NCT01238991|8912188|P1|Overall Study|Lack of Efficacy|0
2576365|NCT01238991|8912179|P10|Overall Study|Death|0
2576366|NCT01238991|8912180|P9|Overall Study|Death|0
2576367|NCT01238991|8912181|P8|Overall Study|Death|0
2576368|NCT01238991|8912182|P7|Overall Study|Death|0
2576369|NCT01238991|8912183|P6|Overall Study|Death|0
2576370|NCT01238991|8912184|P5|Overall Study|Death|0
2576371|NCT01238991|8912185|P4|Overall Study|Death|1
2576372|NCT01238991|8912186|P3|Overall Study|Death|0
2576373|NCT01238991|8912187|P2|Overall Study|Death|0
2576374|NCT01238991|8912188|P1|Overall Study|Death|0
2576375|NCT01238991|8912179|P10|Overall Study|Adverse Event|0
2576376|NCT01238991|8912180|P9|Overall Study|Adverse Event|0
2576377|NCT01238991|8912181|P8|Overall Study|Adverse Event|1
2576378|NCT01238991|8912182|P7|Overall Study|Adverse Event|1
2576379|NCT01238991|8912183|P6|Overall Study|Adverse Event|0
2576380|NCT01238991|8912184|P5|Overall Study|Adverse Event|1
2576381|NCT01238991|8912185|P4|Overall Study|Adverse Event|1
2576382|NCT01238991|8912186|P3|Overall Study|Adverse Event|3
2576383|NCT01238991|8912187|P2|Overall Study|Adverse Event|0
2576384|NCT01238991|8912188|P1|Overall Study|Adverse Event|1
2576385|NCT01238900|8912275|P1|<12 Months Post Stent Removal|persistent stricture after stenting|1
2576386|NCT01238900|8912275|P1|<12 Months Post Stent Removal|Lost to Follow-up|4
2576387|NCT01238861|8912289|P6|Overall Study|Withdrawal by Subject|9
2576388|NCT01238861|8912290|P5|Overall Study|Withdrawal by Subject|10
2576389|NCT01238861|8912291|P4|Overall Study|Withdrawal by Subject|8
2576390|NCT01238861|8912292|P3|Overall Study|Withdrawal by Subject|4
2576391|NCT01238861|8912293|P2|Overall Study|Withdrawal by Subject|5
2576392|NCT01238861|8912294|P1|Overall Study|Withdrawal by Subject|6
2576393|NCT01238861|8912289|P6|Overall Study|Adverse Event|0
2576394|NCT01238861|8912290|P5|Overall Study|Adverse Event|0
2576395|NCT01238861|8912291|P4|Overall Study|Adverse Event|0
2576396|NCT01238861|8912292|P3|Overall Study|Adverse Event|0
2576397|NCT01238861|8912293|P2|Overall Study|Adverse Event|1
2576398|NCT01238861|8912294|P1|Overall Study|Adverse Event|0
2576399|NCT01238861|8912289|P6|Overall Study|Lack of compliance|1
2576400|NCT01238861|8912290|P5|Overall Study|Lack of compliance|0
2576401|NCT01238861|8912291|P4|Overall Study|Lack of compliance|0
2576402|NCT01238861|8912292|P3|Overall Study|Lack of compliance|0
2576403|NCT01238861|8912293|P2|Overall Study|Lack of compliance|0
2576404|NCT01238861|8912294|P1|Overall Study|Lack of compliance|0
2576405|NCT01238861|8912289|P6|Overall Study|Serious adverse event|1
2576406|NCT01238861|8912290|P5|Overall Study|Serious adverse event|0
2576407|NCT01238861|8912291|P4|Overall Study|Serious adverse event|0
2576408|NCT01238861|8912292|P3|Overall Study|Serious adverse event|0
2576409|NCT01238861|8912293|P2|Overall Study|Serious adverse event|0
2576410|NCT01238861|8912294|P1|Overall Study|Serious adverse event|0
2576411|NCT01238861|8912289|P6|Overall Study|Unable to continue visits|1
2576412|NCT01238861|8912290|P5|Overall Study|Unable to continue visits|0
2576413|NCT01238861|8912291|P4|Overall Study|Unable to continue visits|1
2576414|NCT01238861|8912292|P3|Overall Study|Unable to continue visits|0
2576415|NCT01238861|8912293|P2|Overall Study|Unable to continue visits|0
2576416|NCT01238861|8912294|P1|Overall Study|Unable to continue visits|0
2576417|NCT01238861|8912289|P6|Overall Study|Personal problems|0
2576418|NCT01238861|8912290|P5|Overall Study|Personal problems|0
2576419|NCT01238861|8912291|P4|Overall Study|Personal problems|1
2576420|NCT01238861|8912292|P3|Overall Study|Personal problems|0
2576421|NCT01238861|8912293|P2|Overall Study|Personal problems|0
2576422|NCT01238861|8912294|P1|Overall Study|Personal problems|0
2576423|NCT01238861|8912289|P6|Overall Study|Strongyloides stercoralis antibodies +|0
2576424|NCT01238861|8912290|P5|Overall Study|Strongyloides stercoralis antibodies +|0
2576425|NCT01238861|8912291|P4|Overall Study|Strongyloides stercoralis antibodies +|1
2576426|NCT01238861|8912292|P3|Overall Study|Strongyloides stercoralis antibodies +|0
2576427|NCT01238861|8912293|P2|Overall Study|Strongyloides stercoralis antibodies +|0
2576428|NCT01238861|8912294|P1|Overall Study|Strongyloides stercoralis antibodies +|0
2576429|NCT01238861|8912289|P6|Overall Study|Subject moved out of state/area|0
2576430|NCT01238861|8912290|P5|Overall Study|Subject moved out of state/area|0
2576431|NCT01238861|8912291|P4|Overall Study|Subject moved out of state/area|1
2576432|NCT01238861|8912292|P3|Overall Study|Subject moved out of state/area|1
2576433|NCT01238861|8912293|P2|Overall Study|Subject moved out of state/area|0
2576434|NCT01238861|8912294|P1|Overall Study|Subject moved out of state/area|0
2576435|NCT01238861|8912289|P6|Overall Study|Subject traveled to Argentina by 1 year|0
2576436|NCT01238861|8912290|P5|Overall Study|Subject traveled to Argentina by 1 year|0
2576437|NCT01238861|8912291|P4|Overall Study|Subject traveled to Argentina by 1 year|0
2576438|NCT01238861|8912292|P3|Overall Study|Subject traveled to Argentina by 1 year|1
2576439|NCT01238861|8912293|P2|Overall Study|Subject traveled to Argentina by 1 year|0
2576440|NCT01238861|8912294|P1|Overall Study|Subject traveled to Argentina by 1 year|0
2576441|NCT01238861|8912289|P6|Overall Study|Incorrect enrollment/randomization|0
2576442|NCT01238861|8912290|P5|Overall Study|Incorrect enrollment/randomization|1
2576443|NCT01238861|8912291|P4|Overall Study|Incorrect enrollment/randomization|0
2576444|NCT01238861|8912292|P3|Overall Study|Incorrect enrollment/randomization|1
2576445|NCT01238861|8912293|P2|Overall Study|Incorrect enrollment/randomization|0
2576446|NCT01238861|8912294|P1|Overall Study|Incorrect enrollment/randomization|0
2576447|NCT01238861|8912289|P6|Overall Study|Did not meet entry ACQ-6 criteria|1
2576448|NCT01238861|8912290|P5|Overall Study|Did not meet entry ACQ-6 criteria|1
2576449|NCT01238861|8912291|P4|Overall Study|Did not meet entry ACQ-6 criteria|0
2576450|NCT01238861|8912292|P3|Overall Study|Did not meet entry ACQ-6 criteria|1
2576451|NCT01238861|8912293|P2|Overall Study|Did not meet entry ACQ-6 criteria|0
2576452|NCT01238861|8912294|P1|Overall Study|Did not meet entry ACQ-6 criteria|0
2576453|NCT01238861|8912289|P6|Overall Study|Unplanned surgery|0
2576454|NCT01238861|8912290|P5|Overall Study|Unplanned surgery|0
2576455|NCT01238861|8912291|P4|Overall Study|Unplanned surgery|0
2576456|NCT01238861|8912292|P3|Overall Study|Unplanned surgery|0
2576457|NCT01238861|8912293|P2|Overall Study|Unplanned surgery|0
2576458|NCT01238861|8912294|P1|Overall Study|Unplanned surgery|1
2576459|NCT01238861|8912289|P6|Overall Study|Lost to Follow-up|2
2576460|NCT01238861|8912290|P5|Overall Study|Lost to Follow-up|1
2576461|NCT01238861|8912291|P4|Overall Study|Lost to Follow-up|1
2576462|NCT01238861|8912292|P3|Overall Study|Lost to Follow-up|3
2576463|NCT01238861|8912293|P2|Overall Study|Lost to Follow-up|2
2576464|NCT01238861|8912294|P1|Overall Study|Lost to Follow-up|4
2576465|NCT01238848|8912374|P2|Overall Study|Physician Decision|5
2576466|NCT01238848|8912375|P1|Overall Study|Physician Decision|13
2576467|NCT01238822|8912383|P1|Overall Study|COULD NOT SWALLOW PILLS|3
2576468|NCT01238588|8912410|P1|Overall Study|Physician Decision|2
2576469|NCT01238588|8912410|P1|Overall Study|Withdrawal by Subject|1
2576470|NCT01238575|8912423|P2|Overall Study|Adverse Event|0
2576471|NCT01238575|8912424|P1|Overall Study|Adverse Event|2
2576472|NCT01238575|8912423|P2|Overall Study|Lack of Efficacy|4
2576473|NCT01238575|8912424|P1|Overall Study|Lack of Efficacy|2
2576474|NCT01238211|8912508|P1|Overall Study|Investigator/Patient Decision|3
2576475|NCT01238211|8912508|P1|Overall Study|Non-protocol treatment|4
2576476|NCT01238211|8912508|P1|Overall Study|Withdrawal by Subject|7
2576477|NCT01238211|8912508|P1|Overall Study|Relapse/Progression|2
2576478|NCT01238211|8912508|P1|Overall Study|Death|4
2576479|NCT01238211|8912508|P1|Overall Study|Adverse Event|7
2576480|NCT01238211|8912508|P1|Overall Study|Continues active treatment|31
2576481|NCT01238172|8912514|P2|Overall Study|Ineligible: based on Central Path Review|19
2576482|NCT01238172|8912515|P1|Overall Study|Ineligible: based on Central Path Review|9
2576483|NCT01238172|8912514|P2|Overall Study|Ineligible: based on Eligibility Review|5
2576484|NCT01238172|8912515|P1|Overall Study|Ineligible: based on Eligibility Review|2
2576485|NCT01237899|8912538|P11|Washout Period of at Least 7 Days|Adverse Event|0
2576486|NCT01237899|8912539|P10|Washout Period of at Least 7 Days|Adverse Event|0
2576487|NCT01237899|8912540|P9|Washout Period of at Least 7 Days|Adverse Event|0
2576488|NCT01237899|8912541|P8|Washout Period of at Least 7 Days|Adverse Event|0
2576489|NCT01237899|8912542|P7|Washout Period of at Least 7 Days|Adverse Event|0
2576490|NCT01237899|8912543|P6|Washout Period of at Least 7 Days|Adverse Event|0
2576491|NCT01237899|8912544|P5|Washout Period of at Least 7 Days|Adverse Event|0
2576492|NCT01237899|8912545|P4|Washout Period of at Least 7 Days|Adverse Event|0
2576493|NCT01237899|8912546|P3|Washout Period of at Least 7 Days|Adverse Event|1
2576494|NCT01237899|8912547|P2|Washout Period of at Least 7 Days|Adverse Event|0
2576495|NCT01237899|8912548|P1|Washout Period of at Least 7 Days|Adverse Event|0
2576496|NCT01237678|8912628|P3|Phase II|Randomized but were not treated|3
2576497|NCT01237678|8912629|P2|Phase II|Randomized but were not treated|4
2576498|NCT01237678|8912630|P1|Phase II|Randomized but were not treated|0
2576499|NCT01237678|8912628|P3|Phase II|Sponsor Decision/Study Closed|7
2576500|NCT01237678|8912629|P2|Phase II|Sponsor Decision/Study Closed|18
2576501|NCT01237678|8912630|P1|Phase II|Sponsor Decision/Study Closed|0
2576502|NCT01237678|8912628|P3|Phase II|Completed Cycles 4-6|21
2576503|NCT01237678|8912629|P2|Phase II|Completed Cycles 4-6|11
2576504|NCT01237678|8912630|P1|Phase II|Completed Cycles 4-6|0
2576505|NCT01237678|8912628|P3|Phase II|Withdrawal by Subject|5
2576506|NCT01237678|8912629|P2|Phase II|Withdrawal by Subject|1
2576507|NCT01237678|8912630|P1|Phase II|Withdrawal by Subject|0
2576508|NCT01237678|8912628|P3|Phase II|Lack of Efficacy|3
2576509|NCT01237678|8912629|P2|Phase II|Lack of Efficacy|25
2576510|NCT01237678|8912630|P1|Phase II|Lack of Efficacy|0
2576511|NCT01237678|8912628|P3|Phase II|Death|2
2576512|NCT01237678|8912629|P2|Phase II|Death|0
2576513|NCT01237678|8912630|P1|Phase II|Death|0
2576514|NCT01237678|8912628|P3|Phase II|Adverse Event|9
2576515|NCT01237678|8912629|P2|Phase II|Adverse Event|39
2576516|NCT01237678|8912630|P1|Phase II|Adverse Event|0
2576517|NCT01237678|8912628|P3|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
2576518|NCT01237678|8912629|P2|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
2576519|NCT01237678|8912630|P1|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1
2576520|NCT01237678|8912628|P3|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
2576521|NCT01237678|8912629|P2|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
2576522|NCT01237678|8912630|P1|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3
2576523|NCT01237678|8912628|P3|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
2576524|NCT01237678|8912629|P2|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
2576525|NCT01237678|8912630|P1|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24
2576526|NCT01237678|8912628|P3|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
2576527|NCT01237678|8912629|P2|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
2576528|NCT01237678|8912630|P1|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5
2576529|NCT01237587|8912675|P2|Taper Phase|Withdrawal by Subject|1
2576530|NCT01237587|8912676|P1|Taper Phase|Withdrawal by Subject|0
2576531|NCT01237587|8912675|P2|Taper Phase|Sponsor Decision|0
2576532|NCT01237587|8912676|P1|Taper Phase|Sponsor Decision|1
2576533|NCT01237587|8912675|P2|Taper Phase|Parent/Guardian Decision|2
2576534|NCT01237587|8912676|P1|Taper Phase|Parent/Guardian Decision|0
2576535|NCT01237587|8912675|P2|Taper Phase|Lack of Efficacy|5
2576536|NCT01237587|8912676|P1|Taper Phase|Lack of Efficacy|2
2576537|NCT01237587|8912675|P2|Taper Phase|Protocol Violation|0
2576538|NCT01237587|8912676|P1|Taper Phase|Protocol Violation|2
2576539|NCT01237587|8912675|P2|Taper Phase|Adverse Event|2
2576540|NCT01237587|8912676|P1|Taper Phase|Adverse Event|0
2576541|NCT01237587|8912675|P2|Open Label Treatment (Extension Phase)|Physician Decision|4
2576542|NCT01237587|8912676|P1|Open Label Treatment (Extension Phase)|Physician Decision|4
2576543|NCT01237587|8912675|P2|Open Label Treatment (Extension Phase)|Sponsor Decision|0
2576544|NCT01237587|8912676|P1|Open Label Treatment (Extension Phase)|Sponsor Decision|1
2576545|NCT01237587|8912675|P2|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5
2576546|NCT01237587|8912676|P1|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0
2576547|NCT01237587|8912675|P2|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4
2576548|NCT01237587|8912676|P1|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2
2576549|NCT01237587|8912675|P2|Open Label Treatment (Extension Phase)|Lack of Efficacy|4
2576550|NCT01237587|8912676|P1|Open Label Treatment (Extension Phase)|Lack of Efficacy|2
2576551|NCT01237587|8912675|P2|Open Label Treatment (Extension Phase)|Adverse Event|5
2576552|NCT01237587|8912676|P1|Open Label Treatment (Extension Phase)|Adverse Event|5
2576553|NCT01237587|8912675|P2|Open Label Treatment (Extension Phase)|Lost to Follow-up|3
2576554|NCT01237587|8912676|P1|Open Label Treatment (Extension Phase)|Lost to Follow-up|4
2576555|NCT01237587|8912675|P2|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4
2576556|NCT01237587|8912676|P1|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3
2576557|NCT01237587|8912675|P2|Double Blind Treatment (Acute Phase)|Protocol Violation|3
2576558|NCT01237587|8912676|P1|Double Blind Treatment (Acute Phase)|Protocol Violation|4
2576559|NCT01237587|8912675|P2|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4
2576560|NCT01237587|8912676|P1|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2
2576561|NCT01237587|8912675|P2|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3
2576562|NCT01237587|8912676|P1|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2
2576563|NCT01237587|8912675|P2|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3
2576564|NCT01237587|8912676|P1|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1
2576565|NCT01237587|8912675|P2|Double Blind Treatment (Acute Phase)|Adverse Event|1
2576566|NCT01237587|8912676|P1|Double Blind Treatment (Acute Phase)|Adverse Event|5
2576567|NCT01237340|8912728|P1|Overall Study|Early termination of the trial|36
2576568|NCT01237340|8912728|P1|Overall Study|Withdrawal by Subject|1
2576569|NCT01237340|8912728|P1|Overall Study|Adverse Event|3
2576570|NCT01237327|8912742|P2|Overall Study|Lost to Follow-up|0
2576571|NCT01237327|8912743|P1|Overall Study|Lost to Follow-up|3
2576572|NCT01237327|8912742|P2|Overall Study|Withdrawal by Subject|3
2576573|NCT01237327|8912743|P1|Overall Study|Withdrawal by Subject|1
2576574|NCT01237327|8912742|P2|Overall Study|Protocol Specific Withdrawal Criteria|0
2576575|NCT01237327|8912743|P1|Overall Study|Protocol Specific Withdrawal Criteria|1
2576576|NCT01237327|8912742|P2|Overall Study|Progression of Disease: Extension Study|13
2576577|NCT01237327|8912743|P1|Overall Study|Progression of Disease: Extension Study|15
2576578|NCT01237327|8912742|P2|Overall Study|Progression of Disease: Core Study|22
2576579|NCT01237327|8912743|P1|Overall Study|Progression of Disease: Core Study|18
2576580|NCT01237327|8912742|P2|Overall Study|Completed 26 weeks treatment:Core Study|2
2576581|NCT01237327|8912743|P1|Overall Study|Completed 26 weeks treatment:Core Study|3
2576582|NCT01237327|8912742|P2|Overall Study|Protocol Violation: Core Study|0
2576583|NCT01237327|8912743|P1|Overall Study|Protocol Violation: Core Study|1
2576584|NCT01237223|8912778|P6|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
2576585|NCT01237223|8912779|P5|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
2576586|NCT01237223|8912780|P4|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2
2576587|NCT01237223|8912781|P3|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
2576588|NCT01237223|8912782|P2|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
2576589|NCT01237223|8912783|P1|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0
2576590|NCT01237223|8912778|P6|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1
2576591|NCT01237223|8912779|P5|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
2576592|NCT01237223|8912780|P4|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
2576593|NCT01237223|8912781|P3|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
2576594|NCT01237223|8912782|P2|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
2576595|NCT01237223|8912783|P1|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
2576596|NCT01237223|8912778|P6|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
2576597|NCT01237223|8912779|P5|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
2576598|NCT01237223|8912780|P4|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0
2576599|NCT01237223|8912781|P3|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
2576600|NCT01237223|8912782|P2|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
2576601|NCT01237223|8912783|P1|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
2576602|NCT01237223|8912778|P6|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
2576603|NCT01237223|8912779|P5|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0
2576604|NCT01237223|8912780|P4|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
2576605|NCT01237223|8912781|P3|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7
2576606|NCT01237223|8912782|P2|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6
2576607|NCT01237223|8912783|P1|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20
2576608|NCT01237223|8912778|P6|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1
2576609|NCT01237223|8912779|P5|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
2576610|NCT01237223|8912780|P4|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
2576611|NCT01237223|8912781|P3|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3
2576612|NCT01237223|8912782|P2|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4
2576613|NCT01237223|8912783|P1|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12
2576614|NCT01237223|8912778|P6|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
2576615|NCT01237223|8912779|P5|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
2576616|NCT01237223|8912780|P4|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
2576617|NCT01237223|8912781|P3|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
2576618|NCT01237223|8912782|P2|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
2576619|NCT01237223|8912783|P1|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8
2576620|NCT01237223|8912778|P6|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
2576621|NCT01237223|8912779|P5|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
2576622|NCT01237223|8912780|P4|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
2576623|NCT01237223|8912781|P3|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
2576624|NCT01237223|8912782|P2|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
2576625|NCT01237223|8912783|P1|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28
2576626|NCT01237223|8912778|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
2576627|NCT01237223|8912779|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
2576628|NCT01237223|8912780|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
2576629|NCT01237223|8912781|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
2576630|NCT01237223|8912782|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
2576631|NCT01237223|8912783|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308
2576632|NCT01237223|8912778|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
2576633|NCT01237223|8912779|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
2576634|NCT01237223|8912780|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
2576635|NCT01237223|8912781|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
2576636|NCT01237223|8912782|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
2576637|NCT01237223|8912783|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25
2576714|NCT01236352|8913128|P7|Overall Study|Lack of response to drug|0
2576638|NCT01237223|8912778|P6|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
2576639|NCT01237223|8912779|P5|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
2576640|NCT01237223|8912780|P4|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
2576641|NCT01237223|8912781|P3|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
2576642|NCT01237223|8912782|P2|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
2576643|NCT01237223|8912783|P1|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29
2576644|NCT01237054|8912842|P1|Overall Study|imaging 10C0096|1
2576645|NCT01236755|8912911|P1|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3
2576646|NCT01236755|8912911|P1|Orthokeratology Wearing Phase|Withdrawal by Subject|5
2576647|NCT01236755|8912911|P1|Spectacles Wearing Phase|Lost to Follow-up|9
2576648|NCT01236755|8912911|P1|Spectacles Wearing Phase|Withdrawal by Subject|8
2576649|NCT01236534|8912934|P2|Overall Study|Adverse Event|0
2576650|NCT01236534|8912935|P1|Overall Study|Adverse Event|3
2576651|NCT01236365|8912953|P2|Overall Study|Dropped at Randomization due to high LFT|0
2576652|NCT01236365|8912954|P1|Overall Study|Dropped at Randomization due to high LFT|1
2576653|NCT01236365|8912953|P2|Overall Study|Moved Out of State|0
2576654|NCT01236365|8912954|P1|Overall Study|Moved Out of State|1
2576655|NCT01236365|8912953|P2|Overall Study|Lost to Follow-up|2
2576656|NCT01236365|8912954|P1|Overall Study|Lost to Follow-up|0
2576657|NCT01236339|8912978|P2|Overall Study|Termination of study by sponsor|13
2576658|NCT01236339|8912979|P1|Overall Study|Termination of study by sponsor|11
2576659|NCT01235793|8913008|P1|Overall Study|Death|6
2576660|NCT01236573|8913024|P11|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1
2576661|NCT01236573|8913025|P10|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
2576662|NCT01236573|8913026|P9|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
2576663|NCT01236573|8913027|P8|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
2576664|NCT01236573|8913028|P7|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
2576665|NCT01236573|8913029|P6|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
2576666|NCT01236573|8913030|P5|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
2576667|NCT01236573|8913031|P4|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
2576668|NCT01236573|8913032|P3|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
2576669|NCT01236573|8913033|P2|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
2576670|NCT01236573|8913034|P1|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
2576671|NCT01236573|8913024|P11|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
2576672|NCT01236573|8913025|P10|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
2576673|NCT01236573|8913026|P9|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1
2576674|NCT01236573|8913027|P8|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
2576675|NCT01236573|8913028|P7|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
2576676|NCT01236573|8913029|P6|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
2576677|NCT01236573|8913030|P5|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
2576678|NCT01236573|8913031|P4|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
2576679|NCT01236573|8913032|P3|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
2576680|NCT01236573|8913033|P2|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
2576681|NCT01236573|8913034|P1|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
2576682|NCT01236573|8913024|P11|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
2576683|NCT01236573|8913025|P10|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
2576684|NCT01236573|8913026|P9|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
2576685|NCT01236573|8913027|P8|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
2576686|NCT01236573|8913028|P7|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
2576687|NCT01236573|8913029|P6|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
2576688|NCT01236573|8913030|P5|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
2576689|NCT01236573|8913031|P4|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
2576690|NCT01236573|8913032|P3|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
2576691|NCT01236573|8913033|P2|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
2576692|NCT01236573|8913034|P1|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
2576693|NCT01236521|8913072|P2|Overall Study|Lost to Follow-up|7
2576694|NCT01236521|8913073|P1|Overall Study|Lost to Follow-up|7
2576695|NCT01236521|8913072|P2|Overall Study|Death|1
2576696|NCT01236521|8913073|P1|Overall Study|Death|2
2576697|NCT01236521|8913072|P2|Overall Study|Withdrawal by Subject|17
2576698|NCT01236521|8913073|P1|Overall Study|Withdrawal by Subject|12
2576699|NCT01236352|8913124|P11|Overall Study|Patient transferred to IST|6
2576700|NCT01236352|8913125|P10|Overall Study|Patient transferred to IST|2
2576701|NCT01236352|8913126|P9|Overall Study|Patient transferred to IST|0
2576702|NCT01236352|8913127|P8|Overall Study|Patient transferred to IST|0
2576703|NCT01236352|8913128|P7|Overall Study|Patient transferred to IST|0
2576704|NCT01236352|8913129|P6|Overall Study|Patient transferred to IST|0
2576705|NCT01236352|8913130|P5|Overall Study|Patient transferred to IST|0
2576706|NCT01236352|8913131|P4|Overall Study|Patient transferred to IST|0
2576707|NCT01236352|8913132|P3|Overall Study|Patient transferred to IST|0
2576708|NCT01236352|8913133|P2|Overall Study|Patient transferred to IST|0
2576709|NCT01236352|8913134|P1|Overall Study|Patient transferred to IST|0
2576710|NCT01236352|8913124|P11|Overall Study|Lack of response to drug|1
2576711|NCT01236352|8913125|P10|Overall Study|Lack of response to drug|1
2576712|NCT01236352|8913126|P9|Overall Study|Lack of response to drug|0
2576713|NCT01236352|8913127|P8|Overall Study|Lack of response to drug|0
2576715|NCT01236352|8913129|P6|Overall Study|Lack of response to drug|0
2576716|NCT01236352|8913130|P5|Overall Study|Lack of response to drug|0
2576717|NCT01236352|8913131|P4|Overall Study|Lack of response to drug|0
2576718|NCT01236352|8913132|P3|Overall Study|Lack of response to drug|0
2576719|NCT01236352|8913133|P2|Overall Study|Lack of response to drug|0
2576720|NCT01236352|8913134|P1|Overall Study|Lack of response to drug|0
2576721|NCT01236352|8913124|P11|Overall Study|Relapse of Splenomegaly and symptoms|1
2576722|NCT01236352|8913125|P10|Overall Study|Relapse of Splenomegaly and symptoms|0
2576723|NCT01236352|8913126|P9|Overall Study|Relapse of Splenomegaly and symptoms|0
2576724|NCT01236352|8913127|P8|Overall Study|Relapse of Splenomegaly and symptoms|0
2576725|NCT01236352|8913128|P7|Overall Study|Relapse of Splenomegaly and symptoms|0
2576726|NCT01236352|8913129|P6|Overall Study|Relapse of Splenomegaly and symptoms|0
2576727|NCT01236352|8913130|P5|Overall Study|Relapse of Splenomegaly and symptoms|0
2576728|NCT01236352|8913131|P4|Overall Study|Relapse of Splenomegaly and symptoms|0
2576729|NCT01236352|8913132|P3|Overall Study|Relapse of Splenomegaly and symptoms|0
2576730|NCT01236352|8913133|P2|Overall Study|Relapse of Splenomegaly and symptoms|0
2576731|NCT01236352|8913134|P1|Overall Study|Relapse of Splenomegaly and symptoms|0
2576732|NCT01236352|8913124|P11|Overall Study|Patient moving to allogeneic transplant|0
2576733|NCT01236352|8913125|P10|Overall Study|Patient moving to allogeneic transplant|0
2576734|NCT01236352|8913126|P9|Overall Study|Patient moving to allogeneic transplant|0
2576735|NCT01236352|8913127|P8|Overall Study|Patient moving to allogeneic transplant|0
2576736|NCT01236352|8913128|P7|Overall Study|Patient moving to allogeneic transplant|1
2576737|NCT01236352|8913129|P6|Overall Study|Patient moving to allogeneic transplant|0
2576738|NCT01236352|8913130|P5|Overall Study|Patient moving to allogeneic transplant|0
2576739|NCT01236352|8913131|P4|Overall Study|Patient moving to allogeneic transplant|0
2576740|NCT01236352|8913132|P3|Overall Study|Patient moving to allogeneic transplant|0
2576741|NCT01236352|8913133|P2|Overall Study|Patient moving to allogeneic transplant|0
2576742|NCT01236352|8913134|P1|Overall Study|Patient moving to allogeneic transplant|0
2576743|NCT01236352|8913124|P11|Overall Study|Subject to receive drug via EAP|0
2576744|NCT01236352|8913125|P10|Overall Study|Subject to receive drug via EAP|4
2576745|NCT01236352|8913126|P9|Overall Study|Subject to receive drug via EAP|0
2576746|NCT01236352|8913127|P8|Overall Study|Subject to receive drug via EAP|2
2576747|NCT01236352|8913128|P7|Overall Study|Subject to receive drug via EAP|0
2576748|NCT01236352|8913129|P6|Overall Study|Subject to receive drug via EAP|0
2576749|NCT01236352|8913130|P5|Overall Study|Subject to receive drug via EAP|0
2576750|NCT01236352|8913131|P4|Overall Study|Subject to receive drug via EAP|0
2576751|NCT01236352|8913132|P3|Overall Study|Subject to receive drug via EAP|1
2576752|NCT01236352|8913133|P2|Overall Study|Subject to receive drug via EAP|1
2576753|NCT01236352|8913134|P1|Overall Study|Subject to receive drug via EAP|1
2576754|NCT01236352|8913124|P11|Overall Study|Subject request to discontinue treatment|4
2576755|NCT01236352|8913125|P10|Overall Study|Subject request to discontinue treatment|1
2576756|NCT01236352|8913126|P9|Overall Study|Subject request to discontinue treatment|0
2576757|NCT01236352|8913127|P8|Overall Study|Subject request to discontinue treatment|0
2576758|NCT01236352|8913128|P7|Overall Study|Subject request to discontinue treatment|0
2576759|NCT01236352|8913129|P6|Overall Study|Subject request to discontinue treatment|1
2576760|NCT01236352|8913130|P5|Overall Study|Subject request to discontinue treatment|0
2576761|NCT01236352|8913131|P4|Overall Study|Subject request to discontinue treatment|1
2576762|NCT01236352|8913132|P3|Overall Study|Subject request to discontinue treatment|1
2576763|NCT01236352|8913133|P2|Overall Study|Subject request to discontinue treatment|0
2576764|NCT01236352|8913134|P1|Overall Study|Subject request to discontinue treatment|0
2576765|NCT01236352|8913124|P11|Overall Study|Maximum clinical benefit|2
2576766|NCT01236352|8913125|P10|Overall Study|Maximum clinical benefit|4
2576767|NCT01236352|8913126|P9|Overall Study|Maximum clinical benefit|1
2576768|NCT01236352|8913127|P8|Overall Study|Maximum clinical benefit|1
2576769|NCT01236352|8913128|P7|Overall Study|Maximum clinical benefit|3
2576770|NCT01236352|8913129|P6|Overall Study|Maximum clinical benefit|0
2576771|NCT01236352|8913130|P5|Overall Study|Maximum clinical benefit|2
2576772|NCT01236352|8913131|P4|Overall Study|Maximum clinical benefit|0
2576773|NCT01236352|8913132|P3|Overall Study|Maximum clinical benefit|1
2576774|NCT01236352|8913133|P2|Overall Study|Maximum clinical benefit|1
2576775|NCT01236352|8913134|P1|Overall Study|Maximum clinical benefit|1
2576776|NCT01236352|8913124|P11|Overall Study|Poor/Non-compliance|0
2576777|NCT01236352|8913125|P10|Overall Study|Poor/Non-compliance|0
2576778|NCT01236352|8913126|P9|Overall Study|Poor/Non-compliance|0
2576779|NCT01236352|8913127|P8|Overall Study|Poor/Non-compliance|0
2576780|NCT01236352|8913128|P7|Overall Study|Poor/Non-compliance|0
2576781|NCT01236352|8913129|P6|Overall Study|Poor/Non-compliance|0
2576782|NCT01236352|8913130|P5|Overall Study|Poor/Non-compliance|0
2576783|NCT01236352|8913131|P4|Overall Study|Poor/Non-compliance|0
2576784|NCT01236352|8913132|P3|Overall Study|Poor/Non-compliance|0
2576785|NCT01236352|8913133|P2|Overall Study|Poor/Non-compliance|0
2576786|NCT01236352|8913134|P1|Overall Study|Poor/Non-compliance|1
2576787|NCT01236352|8913124|P11|Overall Study|Disease progression|2
2576788|NCT01236352|8913125|P10|Overall Study|Disease progression|2
2576789|NCT01236352|8913126|P9|Overall Study|Disease progression|2
2576790|NCT01236352|8913127|P8|Overall Study|Disease progression|3
2576791|NCT01236352|8913128|P7|Overall Study|Disease progression|1
2576792|NCT01236352|8913129|P6|Overall Study|Disease progression|2
2576793|NCT01236352|8913130|P5|Overall Study|Disease progression|2
2576794|NCT01236352|8913131|P4|Overall Study|Disease progression|2
2576795|NCT01236352|8913132|P3|Overall Study|Disease progression|1
2576796|NCT01236352|8913133|P2|Overall Study|Disease progression|2
2576797|NCT01236352|8913134|P1|Overall Study|Disease progression|1
2576798|NCT01236352|8913124|P11|Overall Study|Study drug toxicity|2
2576799|NCT01236352|8913125|P10|Overall Study|Study drug toxicity|2
2576800|NCT01236352|8913126|P9|Overall Study|Study drug toxicity|0
2576801|NCT01236352|8913127|P8|Overall Study|Study drug toxicity|0
2576802|NCT01236352|8913128|P7|Overall Study|Study drug toxicity|1
2576803|NCT01236352|8913129|P6|Overall Study|Study drug toxicity|1
2576804|NCT01236352|8913130|P5|Overall Study|Study drug toxicity|0
2576805|NCT01236352|8913131|P4|Overall Study|Study drug toxicity|0
2576806|NCT01236352|8913132|P3|Overall Study|Study drug toxicity|0
2576807|NCT01236352|8913133|P2|Overall Study|Study drug toxicity|0
2576808|NCT01236352|8913134|P1|Overall Study|Study drug toxicity|0
2576809|NCT01236352|8913124|P11|Overall Study|Adverse Event|1
2576810|NCT01236352|8913125|P10|Overall Study|Adverse Event|4
2576811|NCT01236352|8913126|P9|Overall Study|Adverse Event|0
2576812|NCT01236352|8913127|P8|Overall Study|Adverse Event|0
2576813|NCT01236352|8913128|P7|Overall Study|Adverse Event|2
2576814|NCT01236352|8913129|P6|Overall Study|Adverse Event|0
2576815|NCT01236352|8913130|P5|Overall Study|Adverse Event|0
2576816|NCT01236352|8913131|P4|Overall Study|Adverse Event|0
2576817|NCT01236352|8913132|P3|Overall Study|Adverse Event|0
2576818|NCT01236352|8913133|P2|Overall Study|Adverse Event|0
2576819|NCT01236352|8913134|P1|Overall Study|Adverse Event|0
2576820|NCT01236352|8913124|P11|Overall Study|Withdrawal by Subject|1
2576821|NCT01236352|8913125|P10|Overall Study|Withdrawal by Subject|2
2576822|NCT01236352|8913126|P9|Overall Study|Withdrawal by Subject|0
2576823|NCT01236352|8913127|P8|Overall Study|Withdrawal by Subject|0
2576824|NCT01236352|8913128|P7|Overall Study|Withdrawal by Subject|0
2576825|NCT01236352|8913129|P6|Overall Study|Withdrawal by Subject|0
2576826|NCT01236352|8913130|P5|Overall Study|Withdrawal by Subject|0
2576827|NCT01236352|8913131|P4|Overall Study|Withdrawal by Subject|0
2576828|NCT01236352|8913132|P3|Overall Study|Withdrawal by Subject|0
2576829|NCT01236352|8913133|P2|Overall Study|Withdrawal by Subject|0
2576830|NCT01236352|8913134|P1|Overall Study|Withdrawal by Subject|0
2576831|NCT01236352|8913124|P11|Overall Study|Death|0
2576832|NCT01236352|8913125|P10|Overall Study|Death|0
2576833|NCT01236352|8913126|P9|Overall Study|Death|0
2576834|NCT01236352|8913127|P8|Overall Study|Death|1
2576835|NCT01236352|8913128|P7|Overall Study|Death|0
2576836|NCT01236352|8913129|P6|Overall Study|Death|0
2576837|NCT01236352|8913130|P5|Overall Study|Death|0
2576838|NCT01236352|8913131|P4|Overall Study|Death|0
2576839|NCT01236352|8913132|P3|Overall Study|Death|0
2576840|NCT01236352|8913133|P2|Overall Study|Death|0
2576841|NCT01236352|8913134|P1|Overall Study|Death|0
2576842|NCT01236118|8913352|P3|Overall Study|Withdrawal by Subject|1
2576843|NCT01236118|8913353|P2|Overall Study|Withdrawal by Subject|0
2576844|NCT01236118|8913354|P1|Overall Study|Withdrawal by Subject|0
2576845|NCT01236118|8913352|P3|Overall Study|Physician Decision|0
2576846|NCT01236118|8913353|P2|Overall Study|Physician Decision|1
2576847|NCT01236118|8913354|P1|Overall Study|Physician Decision|0
2576848|NCT01236118|8913352|P3|Overall Study|Adverse Event|2
2576849|NCT01236118|8913353|P2|Overall Study|Adverse Event|0
2576850|NCT01236118|8913354|P1|Overall Study|Adverse Event|2
2576851|NCT01236001|8913555|P2|Overall Study|Planned Visit After End of Study|1
2576852|NCT01236001|8913556|P1|Overall Study|Planned Visit After End of Study|0
2576853|NCT01236001|8913555|P2|Overall Study|Incompliance|0
2576854|NCT01236001|8913556|P1|Overall Study|Incompliance|1
2576855|NCT01236001|8913555|P2|Overall Study|Lost to Follow-up|1
2576856|NCT01236001|8913556|P1|Overall Study|Lost to Follow-up|6
2576857|NCT01236001|8913555|P2|Overall Study|Lack of Efficacy|6
2576858|NCT01236001|8913556|P1|Overall Study|Lack of Efficacy|6
2576859|NCT01236001|8913555|P2|Overall Study|Adverse Event|14
2576860|NCT01236001|8913556|P1|Overall Study|Adverse Event|5
2576861|NCT01235975|8913588|P2|Overall Study|Lost to Follow-up|3
2576862|NCT01235975|8913589|P1|Overall Study|Lost to Follow-up|7
2576863|NCT01235975|8913588|P2|Overall Study|Migrated/moved from study area|1
2576864|NCT01235975|8913589|P1|Overall Study|Migrated/moved from study area|2
2576865|NCT01235975|8913588|P2|Overall Study|Withdrawal by Subject|2
2576866|NCT01235975|8913589|P1|Overall Study|Withdrawal by Subject|8
2576867|NCT01235975|8913588|P2|Overall Study|Serious Adverse Event|1
2576868|NCT01235975|8913589|P1|Overall Study|Serious Adverse Event|0
2576869|NCT01235949|8913639|P18|Booster Phase|Lost to Follow-up|1
2576870|NCT01235949|8913640|P17|Booster Phase|Lost to Follow-up|0
2576871|NCT01235949|8913641|P16|Booster Phase|Lost to Follow-up|0
2576872|NCT01235949|8913642|P15|Booster Phase|Lost to Follow-up|0
2576873|NCT01235949|8913643|P14|Booster Phase|Lost to Follow-up|0
2576874|NCT01235949|8913644|P13|Booster Phase|Lost to Follow-up|0
2576875|NCT01235949|8913645|P12|Booster Phase|Lost to Follow-up|1
2576876|NCT01235949|8913646|P11|Booster Phase|Lost to Follow-up|1
2576877|NCT01235949|8913647|P10|Booster Phase|Lost to Follow-up|1
2576878|NCT01235949|8913648|P9|Booster Phase|Lost to Follow-up|1
2576879|NCT01235949|8913649|P8|Booster Phase|Lost to Follow-up|0
2576880|NCT01235949|8913650|P7|Booster Phase|Lost to Follow-up|0
2576881|NCT01235949|8913651|P6|Booster Phase|Lost to Follow-up|0
2576882|NCT01235949|8913652|P5|Booster Phase|Lost to Follow-up|0
2576883|NCT01235949|8913653|P4|Booster Phase|Lost to Follow-up|0
2576884|NCT01235949|8913654|P3|Booster Phase|Lost to Follow-up|0
2576885|NCT01235949|8913655|P2|Booster Phase|Lost to Follow-up|0
2576886|NCT01235949|8913656|P1|Booster Phase|Lost to Follow-up|0
2576887|NCT01235949|8913639|P18|Booster Phase|Withdrawal by Subject|0
2576888|NCT01235949|8913640|P17|Booster Phase|Withdrawal by Subject|0
2576889|NCT01235949|8913641|P16|Booster Phase|Withdrawal by Subject|0
2576890|NCT01235949|8913642|P15|Booster Phase|Withdrawal by Subject|2
2576891|NCT01235949|8913643|P14|Booster Phase|Withdrawal by Subject|0
2576892|NCT01235949|8913644|P13|Booster Phase|Withdrawal by Subject|2
2576893|NCT01235949|8913645|P12|Booster Phase|Withdrawal by Subject|1
2576894|NCT01235949|8913646|P11|Booster Phase|Withdrawal by Subject|1
2576895|NCT01235949|8913647|P10|Booster Phase|Withdrawal by Subject|0
2576896|NCT01235949|8913648|P9|Booster Phase|Withdrawal by Subject|1
2576897|NCT01235949|8913649|P8|Booster Phase|Withdrawal by Subject|1
2576898|NCT01235949|8913650|P7|Booster Phase|Withdrawal by Subject|0
2576899|NCT01235949|8913651|P6|Booster Phase|Withdrawal by Subject|0
2576900|NCT01235949|8913652|P5|Booster Phase|Withdrawal by Subject|0
2576901|NCT01235949|8913653|P4|Booster Phase|Withdrawal by Subject|0
2576902|NCT01235949|8913654|P3|Booster Phase|Withdrawal by Subject|0
2576903|NCT01235949|8913655|P2|Booster Phase|Withdrawal by Subject|0
2576904|NCT01235949|8913656|P1|Booster Phase|Withdrawal by Subject|0
2576905|NCT01235949|8913639|P18|Booster Phase|Adverse Event|0
2576906|NCT01235949|8913640|P17|Booster Phase|Adverse Event|0
2576907|NCT01235949|8913641|P16|Booster Phase|Adverse Event|1
2576908|NCT01235949|8913642|P15|Booster Phase|Adverse Event|0
2576909|NCT01235949|8913643|P14|Booster Phase|Adverse Event|0
2576910|NCT01235949|8913644|P13|Booster Phase|Adverse Event|0
2576911|NCT01235949|8913645|P12|Booster Phase|Adverse Event|0
2576912|NCT01235949|8913646|P11|Booster Phase|Adverse Event|0
2576913|NCT01235949|8913647|P10|Booster Phase|Adverse Event|0
2576914|NCT01235949|8913648|P9|Booster Phase|Adverse Event|0
2576915|NCT01235949|8913649|P8|Booster Phase|Adverse Event|0
2576916|NCT01235949|8913650|P7|Booster Phase|Adverse Event|0
2576917|NCT01235949|8913651|P6|Booster Phase|Adverse Event|0
2576918|NCT01235949|8913652|P5|Booster Phase|Adverse Event|0
2576919|NCT01235949|8913653|P4|Booster Phase|Adverse Event|0
2576920|NCT01235949|8913654|P3|Booster Phase|Adverse Event|0
2576921|NCT01235949|8913655|P2|Booster Phase|Adverse Event|0
2576922|NCT01235949|8913656|P1|Booster Phase|Adverse Event|0
2576923|NCT01235949|8913639|P18|Booster Phase|Migrated/moved from study area|1
2576924|NCT01235949|8913640|P17|Booster Phase|Migrated/moved from study area|0
2576925|NCT01235949|8913641|P16|Booster Phase|Migrated/moved from study area|0
2576926|NCT01235949|8913642|P15|Booster Phase|Migrated/moved from study area|0
2576927|NCT01235949|8913643|P14|Booster Phase|Migrated/moved from study area|0
2576928|NCT01235949|8913644|P13|Booster Phase|Migrated/moved from study area|1
2576929|NCT01235949|8913645|P12|Booster Phase|Migrated/moved from study area|1
2576930|NCT01235949|8913646|P11|Booster Phase|Migrated/moved from study area|0
2576931|NCT01235949|8913647|P10|Booster Phase|Migrated/moved from study area|0
2576932|NCT01235949|8913648|P9|Booster Phase|Migrated/moved from study area|0
2576933|NCT01235949|8913649|P8|Booster Phase|Migrated/moved from study area|0
2576934|NCT01235949|8913650|P7|Booster Phase|Migrated/moved from study area|0
2576935|NCT01235949|8913651|P6|Booster Phase|Migrated/moved from study area|0
2576936|NCT01235949|8913652|P5|Booster Phase|Migrated/moved from study area|0
2576937|NCT01235949|8913653|P4|Booster Phase|Migrated/moved from study area|0
2576938|NCT01235949|8913654|P3|Booster Phase|Migrated/moved from study area|0
2576939|NCT01235949|8913655|P2|Booster Phase|Migrated/moved from study area|0
2576940|NCT01235949|8913656|P1|Booster Phase|Migrated/moved from study area|0
2576941|NCT01235949|8913639|P18|Primary Phase|Lost to Follow-up|0
2576942|NCT01235949|8913640|P17|Primary Phase|Lost to Follow-up|0
2576943|NCT01235949|8913641|P16|Primary Phase|Lost to Follow-up|0
2576944|NCT01235949|8913642|P15|Primary Phase|Lost to Follow-up|0
2576945|NCT01235949|8913643|P14|Primary Phase|Lost to Follow-up|0
2576946|NCT01235949|8913644|P13|Primary Phase|Lost to Follow-up|0
2576947|NCT01235949|8913645|P12|Primary Phase|Lost to Follow-up|0
2576948|NCT01235949|8913646|P11|Primary Phase|Lost to Follow-up|0
2576949|NCT01235949|8913647|P10|Primary Phase|Lost to Follow-up|0
2576950|NCT01235949|8913648|P9|Primary Phase|Lost to Follow-up|0
2576951|NCT01235949|8913649|P8|Primary Phase|Lost to Follow-up|0
2576952|NCT01235949|8913650|P7|Primary Phase|Lost to Follow-up|0
2576953|NCT01235949|8913651|P6|Primary Phase|Lost to Follow-up|2
2576954|NCT01235949|8913652|P5|Primary Phase|Lost to Follow-up|0
2576955|NCT01235949|8913653|P4|Primary Phase|Lost to Follow-up|1
2576956|NCT01235949|8913654|P3|Primary Phase|Lost to Follow-up|1
2576957|NCT01235949|8913655|P2|Primary Phase|Lost to Follow-up|0
2576958|NCT01235949|8913656|P1|Primary Phase|Lost to Follow-up|0
2576959|NCT01235949|8913639|P18|Primary Phase|Withdrawal by Subject|0
2576960|NCT01235949|8913640|P17|Primary Phase|Withdrawal by Subject|0
2576961|NCT01235949|8913641|P16|Primary Phase|Withdrawal by Subject|0
2576962|NCT01235949|8913642|P15|Primary Phase|Withdrawal by Subject|0
2576963|NCT01235949|8913643|P14|Primary Phase|Withdrawal by Subject|0
2576964|NCT01235949|8913644|P13|Primary Phase|Withdrawal by Subject|0
2576965|NCT01235949|8913645|P12|Primary Phase|Withdrawal by Subject|0
2576966|NCT01235949|8913646|P11|Primary Phase|Withdrawal by Subject|0
2576967|NCT01235949|8913647|P10|Primary Phase|Withdrawal by Subject|0
2576968|NCT01235949|8913648|P9|Primary Phase|Withdrawal by Subject|0
2576969|NCT01235949|8913649|P8|Primary Phase|Withdrawal by Subject|0
2576970|NCT01235949|8913650|P7|Primary Phase|Withdrawal by Subject|0
2576971|NCT01235949|8913651|P6|Primary Phase|Withdrawal by Subject|3
2576972|NCT01235949|8913652|P5|Primary Phase|Withdrawal by Subject|0
2576973|NCT01235949|8913653|P4|Primary Phase|Withdrawal by Subject|0
2576974|NCT01235949|8913654|P3|Primary Phase|Withdrawal by Subject|2
2576975|NCT01235949|8913655|P2|Primary Phase|Withdrawal by Subject|2
2576976|NCT01235949|8913656|P1|Primary Phase|Withdrawal by Subject|3
2576977|NCT01235949|8913639|P18|Primary Phase|Adverse Event|0
2576978|NCT01235949|8913640|P17|Primary Phase|Adverse Event|0
2576979|NCT01235949|8913641|P16|Primary Phase|Adverse Event|0
2576980|NCT01235949|8913642|P15|Primary Phase|Adverse Event|0
2576981|NCT01235949|8913643|P14|Primary Phase|Adverse Event|0
2576982|NCT01235949|8913644|P13|Primary Phase|Adverse Event|0
2576983|NCT01235949|8913645|P12|Primary Phase|Adverse Event|0
2576984|NCT01235949|8913646|P11|Primary Phase|Adverse Event|0
2576985|NCT01235949|8913647|P10|Primary Phase|Adverse Event|0
2576986|NCT01235949|8913648|P9|Primary Phase|Adverse Event|0
2576987|NCT01235949|8913649|P8|Primary Phase|Adverse Event|0
2576988|NCT01235949|8913650|P7|Primary Phase|Adverse Event|0
2576989|NCT01235949|8913651|P6|Primary Phase|Adverse Event|0
2576990|NCT01235949|8913652|P5|Primary Phase|Adverse Event|0
2576991|NCT01235949|8913653|P4|Primary Phase|Adverse Event|1
2576992|NCT01235949|8913654|P3|Primary Phase|Adverse Event|0
2576993|NCT01235949|8913655|P2|Primary Phase|Adverse Event|0
2576994|NCT01235949|8913656|P1|Primary Phase|Adverse Event|0
2576995|NCT01235949|8913639|P18|Primary Phase|Migrated/moved from study area|0
2576996|NCT01235949|8913640|P17|Primary Phase|Migrated/moved from study area|0
2576997|NCT01235949|8913641|P16|Primary Phase|Migrated/moved from study area|0
2576998|NCT01235949|8913642|P15|Primary Phase|Migrated/moved from study area|0
2576999|NCT01235949|8913643|P14|Primary Phase|Migrated/moved from study area|0
2577000|NCT01235949|8913644|P13|Primary Phase|Migrated/moved from study area|0
2577001|NCT01235949|8913645|P12|Primary Phase|Migrated/moved from study area|0
2577002|NCT01235949|8913646|P11|Primary Phase|Migrated/moved from study area|0
2577003|NCT01235949|8913647|P10|Primary Phase|Migrated/moved from study area|0
2577004|NCT01235949|8913648|P9|Primary Phase|Migrated/moved from study area|0
2577005|NCT01235949|8913649|P8|Primary Phase|Migrated/moved from study area|0
2577006|NCT01235949|8913650|P7|Primary Phase|Migrated/moved from study area|0
2577007|NCT01235949|8913651|P6|Primary Phase|Migrated/moved from study area|2
2577008|NCT01235949|8913652|P5|Primary Phase|Migrated/moved from study area|1
2577009|NCT01235949|8913653|P4|Primary Phase|Migrated/moved from study area|0
2577010|NCT01235949|8913654|P3|Primary Phase|Migrated/moved from study area|0
2577011|NCT01235949|8913655|P2|Primary Phase|Migrated/moved from study area|1
2577012|NCT01235949|8913656|P1|Primary Phase|Migrated/moved from study area|1
2577013|NCT01235741|8913906|P3|Follow-Up Post Treatment up to Month 6|Other|0
2577014|NCT01235741|8913907|P2|Follow-Up Post Treatment up to Month 6|Other|1
2577015|NCT01235741|8913908|P1|Follow-Up Post Treatment up to Month 6|Other|0
2577016|NCT01235741|8913906|P3|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1
2577017|NCT01235741|8913907|P2|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5
2577018|NCT01235741|8913908|P1|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0
2577019|NCT01235741|8913906|P3|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6
2577020|NCT01235741|8913907|P2|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3
2577021|NCT01235741|8913908|P1|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0
2577022|NCT01235741|8913906|P3|Randomized to Treatment|Sponsor terminated study|34
2577023|NCT01235741|8913907|P2|Randomized to Treatment|Sponsor terminated study|35
2577024|NCT01235741|8913908|P1|Randomized to Treatment|Sponsor terminated study|0
2577025|NCT01235741|8913906|P3|Randomized to Treatment|Adverse Event|1
2577026|NCT01235741|8913907|P2|Randomized to Treatment|Adverse Event|1
2577027|NCT01235741|8913908|P1|Randomized to Treatment|Adverse Event|0
2577028|NCT01235741|8913906|P3|Randomized to Treatment|Withdrawal by Subject|1
2577029|NCT01235741|8913907|P2|Randomized to Treatment|Withdrawal by Subject|0
2577030|NCT01235741|8913908|P1|Randomized to Treatment|Withdrawal by Subject|0
2577031|NCT01235741|8913906|P3|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
2577032|NCT01235741|8913907|P2|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
2577033|NCT01235741|8913908|P1|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4
2577034|NCT01235741|8913906|P3|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
2577035|NCT01235741|8913907|P2|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
2577036|NCT01235741|8913908|P1|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5
2577037|NCT01235741|8913906|P3|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
2577038|NCT01235741|8913907|P2|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
2577039|NCT01235741|8913908|P1|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1
2577040|NCT01235741|8913906|P3|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
2577041|NCT01235741|8913907|P2|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
2577042|NCT01235741|8913908|P1|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1
2577043|NCT01235741|8913906|P3|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
2577044|NCT01235741|8913907|P2|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
2577045|NCT01235741|8913908|P1|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121
2577046|NCT01235741|8913906|P3|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
2577047|NCT01235741|8913907|P2|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
2577048|NCT01235741|8913908|P1|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9
2577049|NCT01235728|8913935|P8|Overall Study|Protocol Violation|0
2577050|NCT01235728|8913936|P7|Overall Study|Protocol Violation|0
2577051|NCT01235728|8913937|P6|Overall Study|Protocol Violation|0
2577052|NCT01235728|8913938|P5|Overall Study|Protocol Violation|0
2577053|NCT01235728|8913939|P4|Overall Study|Protocol Violation|1
2577054|NCT01235728|8913940|P3|Overall Study|Protocol Violation|0
2577055|NCT01235728|8913941|P2|Overall Study|Protocol Violation|0
2577056|NCT01235728|8913942|P1|Overall Study|Protocol Violation|0
2577057|NCT01235715|8913952|P2|Overall Study|Physician Decision|2
2577058|NCT01235715|8913953|P1|Overall Study|Physician Decision|0
2577059|NCT01235689|8913993|P2|Overall Study|Miscellaneous|5
2577060|NCT01235689|8913994|P1|Overall Study|Miscellaneous|1
2577061|NCT01235689|8913993|P2|Overall Study|Lost to Follow-up|2
2577062|NCT01235689|8913994|P1|Overall Study|Lost to Follow-up|1
2577063|NCT01235689|8913993|P2|Overall Study|Withdrawal by Subject|4
2577064|NCT01235689|8913994|P1|Overall Study|Withdrawal by Subject|3
2577065|NCT01235689|8913993|P2|Overall Study|Lack of Efficacy|5
2577066|NCT01235689|8913994|P1|Overall Study|Lack of Efficacy|12
2577067|NCT01235689|8913993|P2|Overall Study|Adverse Event|16
2577068|NCT01235689|8913994|P1|Overall Study|Adverse Event|12
2577069|NCT01235598|8914066|P2|Overall Study|Withdrawal by Subject|0
2577070|NCT01235598|8914067|P1|Overall Study|Withdrawal by Subject|1
2577071|NCT01235598|8914066|P2|Overall Study|Lack of Efficacy|1
2577072|NCT01235598|8914067|P1|Overall Study|Lack of Efficacy|0
2577073|NCT01235598|8914066|P2|Overall Study|Adverse Event|3
2577074|NCT01235598|8914067|P1|Overall Study|Adverse Event|0
2577075|NCT01235546|8914112|P2|Overall Study|Protocol Violation|1
2577076|NCT01235546|8914113|P1|Overall Study|Protocol Violation|1
2577077|NCT01235546|8914112|P2|Overall Study|Staff error, medication not administered|0
2577078|NCT01235546|8914113|P1|Overall Study|Staff error, medication not administered|1
2577079|NCT01235507|8914137|P1|Overall Study|Withdrawal by Subject|1
2577080|NCT01235507|8914137|P1|Overall Study|Adverse Event|1
2577081|NCT01235442|8914151|P2|Overall Study|Other unspecified|2
2577082|NCT01235442|8914152|P1|Overall Study|Other unspecified|1
2577083|NCT01235442|8914151|P2|Overall Study|Administrative decision|2
2577084|NCT01235442|8914152|P1|Overall Study|Administrative decision|1
2577085|NCT01235442|8914151|P2|Overall Study|Noncompliance|2
2577086|NCT01235442|8914152|P1|Overall Study|Noncompliance|1
2577087|NCT01235442|8914151|P2|Overall Study|Lack of Efficacy|3
2577088|NCT01235442|8914152|P1|Overall Study|Lack of Efficacy|1
2577089|NCT01235442|8914151|P2|Overall Study|Withdrawal by Subject|9
2577090|NCT01235442|8914152|P1|Overall Study|Withdrawal by Subject|15
2577091|NCT01235442|8914151|P2|Overall Study|Adverse Event|6
2577092|NCT01235442|8914152|P1|Overall Study|Adverse Event|4
2577093|NCT01235442|8914151|P2|Overall Study|Protocol Violation|3
2577094|NCT01235442|8914152|P1|Overall Study|Protocol Violation|3
2577095|NCT01235442|8914151|P2|Overall Study|Ineligibility determined|4
2577096|NCT01235442|8914152|P1|Overall Study|Ineligibility determined|5
2577097|NCT01235442|8914151|P2|Overall Study|Pregnancy|1
2577098|NCT01235442|8914152|P1|Overall Study|Pregnancy|1
2577099|NCT01235442|8914151|P2|Overall Study|Death|2
2577100|NCT01235442|8914152|P1|Overall Study|Death|0
2577101|NCT01235442|8914151|P2|Overall Study|Lost to Follow-up|10
2577102|NCT01235442|8914152|P1|Overall Study|Lost to Follow-up|12
2577103|NCT01235403|8914170|P1|Overall Study|Other reasons for premature termination|4
2577104|NCT01235403|8914170|P1|Overall Study|Lack of Efficacy|2
2577105|NCT01235403|8914170|P1|Overall Study|Withdrawal by Subject|4
2577106|NCT01235403|8914170|P1|Overall Study|Lost to Follow-up|2
2577107|NCT01235403|8914170|P1|Overall Study|Adverse Event|14
2577108|NCT01235351|8914187|P2|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4
2577109|NCT01235351|8914188|P1|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10
2577110|NCT01235338|8914200|P2|Overall Study|Prohibited meds|0
2577111|NCT01235338|8914201|P1|Overall Study|Prohibited meds|1
2577112|NCT01235338|8914200|P2|Overall Study|Positive drug screen|1
2577113|NCT01235338|8914201|P1|Overall Study|Positive drug screen|0
2577114|NCT01235338|8914200|P2|Overall Study|Exclusion criteria violations|1
2577115|NCT01235338|8914201|P1|Overall Study|Exclusion criteria violations|1
2577116|NCT01235338|8914200|P2|Overall Study|Withdrawal by Subject|0
2577117|NCT01235338|8914201|P1|Overall Study|Withdrawal by Subject|5
2577118|NCT01235338|8914200|P2|Overall Study|Protocol Violation|1
2577119|NCT01235338|8914201|P1|Overall Study|Protocol Violation|1
2577120|NCT01235338|8914200|P2|Overall Study|Adverse Event|2
2577121|NCT01235338|8914201|P1|Overall Study|Adverse Event|3
2577122|NCT01235234|8914246|P3|Overall Study|Adverse Event|1
2577123|NCT01235234|8914247|P2|Overall Study|Adverse Event|2
2577124|NCT01235234|8914248|P1|Overall Study|Adverse Event|2
2577125|NCT01234883|8914296|P2|Overall Study|Inclusion/exclusion failure|0
2577126|NCT01234883|8914297|P1|Overall Study|Inclusion/exclusion failure|1
2577127|NCT01234883|8914296|P2|Overall Study|Technical difficulties with IV infusion|1
2577128|NCT01234883|8914297|P1|Overall Study|Technical difficulties with IV infusion|0
2577129|NCT01234883|8914296|P2|Overall Study|Parent/guardian withdrew consent|2
2577130|NCT01234883|8914297|P1|Overall Study|Parent/guardian withdrew consent|1
2577131|NCT01234883|8914296|P2|Overall Study|Early treatment release|10
2577132|NCT01234883|8914297|P1|Overall Study|Early treatment release|8
2577133|NCT01234675|8914344|P2|First Intervention (6 Weeks)|Withdrawal by Subject|0
2577134|NCT01234675|8914345|P1|First Intervention (6 Weeks)|Withdrawal by Subject|1
2577135|NCT01234675|8914344|P2|First Intervention (6 Weeks)|Adverse Event|1
2577136|NCT01234675|8914345|P1|First Intervention (6 Weeks)|Adverse Event|0
2577137|NCT01234649|8914377|P2|Overall Study|Lack of Efficacy|3
2577138|NCT01234649|8914378|P1|Overall Study|Lack of Efficacy|0
2577139|NCT01234649|8914377|P2|Overall Study|Allergic reaction|0
2577140|NCT01234649|8914378|P1|Overall Study|Allergic reaction|1
2577141|NCT01234649|8914377|P2|Overall Study|intolerant to side effects|3
2577142|NCT01234649|8914378|P1|Overall Study|intolerant to side effects|4
2577143|NCT01234649|8914377|P2|Overall Study|Pregnancy|6
2577144|NCT01234649|8914378|P1|Overall Study|Pregnancy|6
2577145|NCT01234649|8914377|P2|Overall Study|Withdrawal by Subject|26
2577146|NCT01234649|8914378|P1|Overall Study|Withdrawal by Subject|32
2577147|NCT01234467|8914426|P1|Overall Study|Other complicating disease (stroke)|1
2577148|NCT01234467|8914426|P1|Overall Study|Physician Decision|1
2577149|NCT01234467|8914426|P1|Overall Study|Clinical deterioration|1
2577150|NCT01234467|8914426|P1|Overall Study|Disease Progression|2
2577151|NCT01234467|8914426|P1|Overall Study|Withdrawal by Subject|2
2577152|NCT01234467|8914426|P1|Overall Study|Death|2
2577153|NCT01234467|8914426|P1|Overall Study|Adverse Event|3
2577154|NCT01234402|8914438|P3|Overall Study|Never treated: Insurance Denied Xeloda|0
2577155|NCT01234402|8914439|P2|Overall Study|Never treated: Insurance Denied Xeloda|1
2577156|NCT01234402|8914440|P1|Overall Study|Never treated: Insurance Denied Xeloda|0
2577157|NCT01234402|8914438|P3|Overall Study|Never treated: Withdrawal By Subject|0
2577158|NCT01234402|8914439|P2|Overall Study|Never treated: Withdrawal By Subject|1
2577159|NCT01234402|8914440|P1|Overall Study|Never treated: Withdrawal By Subject|0
2577160|NCT01234402|8914438|P3|Overall Study|Never treated: Death|1
2577161|NCT01234402|8914439|P2|Overall Study|Never treated: Death|0
2577162|NCT01234402|8914440|P1|Overall Study|Never treated: Death|0
2577163|NCT01234402|8914438|P3|Overall Study|Withdrawal by Subject|4
2577164|NCT01234402|8914439|P2|Overall Study|Withdrawal by Subject|3
2577165|NCT01234402|8914440|P1|Overall Study|Withdrawal by Subject|1
2577166|NCT01234402|8914438|P3|Overall Study|Lost to Follow-up|3
2577167|NCT01234402|8914439|P2|Overall Study|Lost to Follow-up|1
2577168|NCT01234402|8914440|P1|Overall Study|Lost to Follow-up|0
2577169|NCT01234350|8914481|P2|Overall Study|Covers a diverse set of reasons|92
2577170|NCT01234350|8914482|P1|Overall Study|Covers a diverse set of reasons|234
2577171|NCT01234350|8914481|P2|Overall Study|Lost to Follow-up|47
2577172|NCT01234350|8914482|P1|Overall Study|Lost to Follow-up|115
2577173|NCT01234350|8914481|P2|Overall Study|Withdrawal by Subject|36
2577174|NCT01234350|8914482|P1|Overall Study|Withdrawal by Subject|61
2577175|NCT01234350|8914481|P2|Overall Study|Adverse Event|92
2577176|NCT01234350|8914482|P1|Overall Study|Adverse Event|277
2577177|NCT01234337|8914508|P2|Overall Study|Switch to commercial drug|1
2577178|NCT01234337|8914509|P1|Overall Study|Switch to commercial drug|0
2577179|NCT01234337|8914508|P2|Overall Study|Death|1
2577180|NCT01234337|8914509|P1|Overall Study|Death|0
2577181|NCT01234337|8914508|P2|Overall Study|Withdrawal by Subject|9
2577182|NCT01234337|8914509|P1|Overall Study|Withdrawal by Subject|11
2577183|NCT01234337|8914508|P2|Overall Study|Protocol Violation|3
2577184|NCT01234337|8914509|P1|Overall Study|Protocol Violation|2
2577185|NCT01234337|8914508|P2|Overall Study|Lost to Follow-up|1
2577186|NCT01234337|8914509|P1|Overall Study|Lost to Follow-up|0
2577187|NCT01234337|8914508|P2|Overall Study|Randomized but not treated|4
2577188|NCT01234337|8914509|P1|Overall Study|Randomized but not treated|6
2577189|NCT01234337|8914508|P2|Overall Study|Non-compliant with study medication|2
2577190|NCT01234337|8914509|P1|Overall Study|Non-compliant with study medication|3
2577191|NCT01234337|8914508|P2|Overall Study|Investi. decision not protocol driven|6
2577192|NCT01234337|8914509|P1|Overall Study|Investi. decision not protocol driven|5
2577193|NCT01234337|8914508|P2|Overall Study|Disease progression/recurrence/relapse|223
2577194|NCT01234337|8914509|P1|Overall Study|Disease progression/recurrence/relapse|181
2577195|NCT01234337|8914508|P2|Overall Study|Adverse Event|21
2577196|NCT01234337|8914509|P1|Overall Study|Adverse Event|58
2577197|NCT01233999|8914569|P1|Overall Study|Lost to Follow-up|1
2577198|NCT01233999|8914569|P1|Overall Study|Withdrawal by Subject|1
2577199|NCT01233869|8914588|P4|Extended Treatment Period (46 Months)|Adverse Event|1
2577200|NCT01233869|8914589|P3|Extended Treatment Period (46 Months)|Adverse Event|0
2577201|NCT01233869|8914590|P2|Extended Treatment Period (46 Months)|Adverse Event|0
2577202|NCT01233869|8914591|P1|Extended Treatment Period (46 Months)|Adverse Event|1
2577203|NCT01233869|8914588|P4|Extended Treatment Period (46 Months)|Other|3
2577204|NCT01233869|8914589|P3|Extended Treatment Period (46 Months)|Other|0
2577205|NCT01233869|8914590|P2|Extended Treatment Period (46 Months)|Other|0
2577206|NCT01233869|8914591|P1|Extended Treatment Period (46 Months)|Other|3
2577207|NCT01233869|8914588|P4|Extended Treatment Period (46 Months)|Withdrawal by Subject|11
2577208|NCT01233869|8914589|P3|Extended Treatment Period (46 Months)|Withdrawal by Subject|5
2577209|NCT01233869|8914590|P2|Extended Treatment Period (46 Months)|Withdrawal by Subject|3
2577210|NCT01233869|8914591|P1|Extended Treatment Period (46 Months)|Withdrawal by Subject|10
2577211|NCT01233869|8914588|P4|Extended Treatment Period (46 Months)|Lost to Follow-up|1
2577212|NCT01233869|8914589|P3|Extended Treatment Period (46 Months)|Lost to Follow-up|0
2577213|NCT01233869|8914590|P2|Extended Treatment Period (46 Months)|Lost to Follow-up|0
2577214|NCT01233869|8914591|P1|Extended Treatment Period (46 Months)|Lost to Follow-up|0
2577215|NCT01233869|8914588|P4|Initial Treatment Period (24 Months)|Not Related to Study Drug|19
2577216|NCT01233869|8914589|P3|Initial Treatment Period (24 Months)|Not Related to Study Drug|2
2577217|NCT01233869|8914590|P2|Initial Treatment Period (24 Months)|Not Related to Study Drug|11
2577218|NCT01233869|8914591|P1|Initial Treatment Period (24 Months)|Not Related to Study Drug|14
2577219|NCT01233869|8914588|P4|Initial Treatment Period (24 Months)|Adverse Event|3
2577220|NCT01233869|8914589|P3|Initial Treatment Period (24 Months)|Adverse Event|0
2577221|NCT01233869|8914590|P2|Initial Treatment Period (24 Months)|Adverse Event|17
2577222|NCT01233869|8914591|P1|Initial Treatment Period (24 Months)|Adverse Event|9
2577223|NCT01233869|8914588|P4|Initial Treatment Period (24 Months)|Death|0
2577224|NCT01233869|8914589|P3|Initial Treatment Period (24 Months)|Death|0
2577225|NCT01233869|8914590|P2|Initial Treatment Period (24 Months)|Death|0
2577226|NCT01233869|8914591|P1|Initial Treatment Period (24 Months)|Death|1
2577227|NCT01233817|8914677|P1|Overall Study|Withdrawal by Subject|2
2577228|NCT01233817|8914677|P1|Overall Study|Lost to Follow-up|1
2577229|NCT01233687|8914724|P1|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1
2577230|NCT01233687|8914724|P1|Phase II AMG 102 + Erlotinib|Physician Decision|2
2577231|NCT01233687|8914724|P1|Phase II AMG 102 + Erlotinib|Death|1
2577232|NCT01233609|8914734|P2|Overall Study|Withdrawal by Subject|0
2577233|NCT01233609|8914735|P1|Overall Study|Withdrawal by Subject|3
2577234|NCT01233609|8914734|P2|Overall Study|Adverse Event|1
2577235|NCT01233609|8914735|P1|Overall Study|Adverse Event|2
2577236|NCT01233609|8914734|P2|Overall Study|Lost to Follow-up|1
2577237|NCT01233609|8914735|P1|Overall Study|Lost to Follow-up|3
2577238|NCT01233609|8914734|P2|Overall Study|Death|0
2577239|NCT01233609|8914735|P1|Overall Study|Death|1
2577240|NCT01233284|8914759|P5|Period 4 (4 Weeks)|Lost to Follow-up|0
2577241|NCT01233284|8914760|P4|Period 4 (4 Weeks)|Lost to Follow-up|1
2577242|NCT01233284|8914761|P3|Period 4 (4 Weeks)|Lost to Follow-up|0
2577243|NCT01233284|8914762|P2|Period 4 (4 Weeks)|Lost to Follow-up|0
2577244|NCT01233284|8914763|P1|Period 4 (4 Weeks)|Lost to Follow-up|0
2577245|NCT01233284|8914759|P5|Period 4 (4 Weeks)|Adverse Event|0
2577246|NCT01233284|8914760|P4|Period 4 (4 Weeks)|Adverse Event|0
2577247|NCT01233284|8914761|P3|Period 4 (4 Weeks)|Adverse Event|0
2577248|NCT01233284|8914762|P2|Period 4 (4 Weeks)|Adverse Event|1
2577249|NCT01233284|8914763|P1|Period 4 (4 Weeks)|Adverse Event|0
2577250|NCT01233284|8914759|P5|Period 3 (4 Weeks)|Other|0
2577251|NCT01233284|8914760|P4|Period 3 (4 Weeks)|Other|1
2577252|NCT01233284|8914761|P3|Period 3 (4 Weeks)|Other|0
2577253|NCT01233284|8914762|P2|Period 3 (4 Weeks)|Other|0
2577254|NCT01233284|8914763|P1|Period 3 (4 Weeks)|Other|0
2577255|NCT01233284|8914759|P5|Period 3 (4 Weeks)|Withdrawal by Subject|0
2577256|NCT01233284|8914760|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
2577257|NCT01233284|8914761|P3|Period 3 (4 Weeks)|Withdrawal by Subject|1
2577258|NCT01233284|8914762|P2|Period 3 (4 Weeks)|Withdrawal by Subject|0
2577259|NCT01233284|8914763|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
2577260|NCT01233284|8914759|P5|Period 2 (4 Weeks)|Withdrawal by Subject|0
2577261|NCT01233284|8914760|P4|Period 2 (4 Weeks)|Withdrawal by Subject|0
2577262|NCT01233284|8914761|P3|Period 2 (4 Weeks)|Withdrawal by Subject|1
2577263|NCT01233284|8914762|P2|Period 2 (4 Weeks)|Withdrawal by Subject|0
2577264|NCT01233284|8914763|P1|Period 2 (4 Weeks)|Withdrawal by Subject|0
2577265|NCT01233284|8914759|P5|Period 1 (4 Weeks)|Other|0
2577266|NCT01233284|8914760|P4|Period 1 (4 Weeks)|Other|0
2577267|NCT01233284|8914761|P3|Period 1 (4 Weeks)|Other|1
2577268|NCT01233284|8914762|P2|Period 1 (4 Weeks)|Other|0
2577269|NCT01233284|8914763|P1|Period 1 (4 Weeks)|Other|0
2577270|NCT01233284|8914759|P5|Period 1 (4 Weeks)|Withdrawal by Subject|0
2577271|NCT01233284|8914760|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
2577272|NCT01233284|8914761|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
2577273|NCT01233284|8914762|P2|Period 1 (4 Weeks)|Withdrawal by Subject|1
2577274|NCT01233284|8914763|P1|Period 1 (4 Weeks)|Withdrawal by Subject|0
2577275|NCT01233284|8914759|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
2577276|NCT01233284|8914760|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
2577277|NCT01233284|8914761|P3|Period 1 (4 Weeks)|Lost to Follow-up|0
2577278|NCT01233284|8914762|P2|Period 1 (4 Weeks)|Lost to Follow-up|0
2577279|NCT01233284|8914763|P1|Period 1 (4 Weeks)|Lost to Follow-up|1
2577280|NCT01233258|8914844|P6|First Intervention (6 Months)|Non-compliance with study medication|0
2577281|NCT01233258|8914845|P5|First Intervention (6 Months)|Non-compliance with study medication|0
2577282|NCT01233258|8914846|P4|First Intervention (6 Months)|Non-compliance with study medication|0
2577283|NCT01233258|8914847|P3|First Intervention (6 Months)|Non-compliance with study medication|0
2577284|NCT01233258|8914848|P2|First Intervention (6 Months)|Non-compliance with study medication|0
2577285|NCT01233258|8914849|P1|First Intervention (6 Months)|Non-compliance with study medication|1
2577286|NCT01233258|8914844|P6|First Intervention (6 Months)|Protocol Violation|0
2577287|NCT01233258|8914845|P5|First Intervention (6 Months)|Protocol Violation|0
2577288|NCT01233258|8914846|P4|First Intervention (6 Months)|Protocol Violation|0
2577289|NCT01233258|8914847|P3|First Intervention (6 Months)|Protocol Violation|1
2577290|NCT01233258|8914848|P2|First Intervention (6 Months)|Protocol Violation|0
2577291|NCT01233258|8914849|P1|First Intervention (6 Months)|Protocol Violation|0
2577292|NCT01233258|8914844|P6|First Intervention (6 Months)|Withdrawal by Subject|1
2577293|NCT01233258|8914845|P5|First Intervention (6 Months)|Withdrawal by Subject|0
2577294|NCT01233258|8914846|P4|First Intervention (6 Months)|Withdrawal by Subject|1
2577295|NCT01233258|8914847|P3|First Intervention (6 Months)|Withdrawal by Subject|0
2577296|NCT01233258|8914848|P2|First Intervention (6 Months)|Withdrawal by Subject|0
2577297|NCT01233258|8914849|P1|First Intervention (6 Months)|Withdrawal by Subject|0
2577298|NCT01233232|8914869|P3|Overall Study|Voluntary Discontinuation by Subject|0
2577299|NCT01233232|8914870|P2|Overall Study|Voluntary Discontinuation by Subject|0
2577300|NCT01233232|8914871|P1|Overall Study|Voluntary Discontinuation by Subject|1
2577301|NCT01233076|8914924|P2|Period 2, One Week|Lost to Follow-up|0
2577302|NCT01233076|8914925|P1|Period 2, One Week|Lost to Follow-up|1
2577303|NCT01233050|8914933|P2|Overall Study|protocol deviation (inclusion/exclusion)|6
2577304|NCT01233050|8914934|P1|Overall Study|protocol deviation (inclusion/exclusion)|8
2577305|NCT01232894|8914986|P2|Overall Study|Physician Decision|1
2577306|NCT01232894|8914987|P1|Overall Study|Physician Decision|2
2577307|NCT01232894|8914986|P2|Overall Study|Withdrawal by Subject|5
2577308|NCT01232894|8914987|P1|Overall Study|Withdrawal by Subject|8
2577309|NCT01232894|8914986|P2|Overall Study|Protocol Violation|1
2577310|NCT01232894|8914987|P1|Overall Study|Protocol Violation|1
2577311|NCT01232894|8914986|P2|Overall Study|Death|0
2577312|NCT01232894|8914987|P1|Overall Study|Death|1
2577313|NCT01232894|8914986|P2|Overall Study|Lost to Follow-up|1
2577314|NCT01232894|8914987|P1|Overall Study|Lost to Follow-up|0
2577315|NCT01232868|8914995|P2|Overall Study|Lost to Follow-up|4
2577316|NCT01232868|8914996|P1|Overall Study|Lost to Follow-up|2
2577317|NCT01232790|8915010|P2|Second Crossover|Withdrawal by Subject|2
2577318|NCT01232790|8915011|P1|Second Crossover|Withdrawal by Subject|1
2577319|NCT01232790|8915010|P2|First Crossover|Withdrawal by Subject|0
2577320|NCT01232790|8915011|P1|First Crossover|Withdrawal by Subject|1
2577321|NCT01232790|8915010|P2|Initial Assessment|Withdrawal by Subject|1
2577322|NCT01232790|8915011|P1|Initial Assessment|Withdrawal by Subject|0
2577323|NCT01232790|8915010|P2|Randomization|Physician Decision|1
2577324|NCT01232790|8915011|P1|Randomization|Physician Decision|0
2577325|NCT01232790|8915010|P2|Randomization|Protocol Violation|1
2577326|NCT01232790|8915011|P1|Randomization|Protocol Violation|0
2577327|NCT01232790|8915010|P2|Randomization|Withdrawal by Subject|0
2577328|NCT01232790|8915011|P1|Randomization|Withdrawal by Subject|2
2577329|NCT01232738|8915065|P1|Overall Study|Adverse Event|5
2577330|NCT01232738|8915065|P1|Overall Study|Withdrawal by Subject|2
2577331|NCT01232738|8915065|P1|Overall Study|Lost to Follow-up|1
2577332|NCT01232738|8915065|P1|Overall Study|Physician Decision|2
2577333|NCT01232738|8915065|P1|Overall Study|Death|3
2577334|NCT01232569|8915081|P4|Double-blind Treatment Period|Death|0
2577335|NCT01232569|8915082|P3|Double-blind Treatment Period|Death|0
2577336|NCT01232569|8915083|P2|Double-blind Treatment Period|Death|0
2577337|NCT01232569|8915084|P1|Double-blind Treatment Period|Death|2
2577338|NCT01232569|8915081|P4|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
2577339|NCT01232569|8915082|P3|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
2577340|NCT01232569|8915083|P2|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3
2577341|NCT01232569|8915084|P1|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9
2577342|NCT01232569|8915081|P4|Double-blind Treatment Period|Physician Decision|0
2577343|NCT01232569|8915082|P3|Double-blind Treatment Period|Physician Decision|0
2577344|NCT01232569|8915083|P2|Double-blind Treatment Period|Physician Decision|0
2577345|NCT01232569|8915084|P1|Double-blind Treatment Period|Physician Decision|1
2577346|NCT01232569|8915081|P4|Double-blind Treatment Period|Lack of Efficacy|0
2577347|NCT01232569|8915082|P3|Double-blind Treatment Period|Lack of Efficacy|0
2577348|NCT01232569|8915083|P2|Double-blind Treatment Period|Lack of Efficacy|2
2577349|NCT01232569|8915084|P1|Double-blind Treatment Period|Lack of Efficacy|1
2577350|NCT01232569|8915081|P4|Double-blind Treatment Period|Lost to Follow-up|0
2577351|NCT01232569|8915082|P3|Double-blind Treatment Period|Lost to Follow-up|0
2577352|NCT01232569|8915083|P2|Double-blind Treatment Period|Lost to Follow-up|0
2577353|NCT01232569|8915084|P1|Double-blind Treatment Period|Lost to Follow-up|4
2577354|NCT01232569|8915081|P4|Double-blind Treatment Period|Escape|0
2577355|NCT01232569|8915082|P3|Double-blind Treatment Period|Escape|0
2577356|NCT01232569|8915083|P2|Double-blind Treatment Period|Escape|2
2577357|NCT01232569|8915084|P1|Double-blind Treatment Period|Escape|2
2577358|NCT01232569|8915081|P4|Double-blind Treatment Period|Withdrawal by Subject|0
2577359|NCT01232569|8915082|P3|Double-blind Treatment Period|Withdrawal by Subject|0
2577360|NCT01232569|8915083|P2|Double-blind Treatment Period|Withdrawal by Subject|2
2577361|NCT01232569|8915084|P1|Double-blind Treatment Period|Withdrawal by Subject|9
2577362|NCT01232556|8915127|P2|Overall Study|Other|4
2577363|NCT01232556|8915128|P1|Overall Study|Other|6
2577364|NCT01232556|8915127|P2|Overall Study|Terminated by Sponsor|51
2577365|NCT01232556|8915128|P1|Overall Study|Terminated by Sponsor|35
2577366|NCT01232556|8915127|P2|Overall Study|Lost to Follow-up|2
2577367|NCT01232556|8915128|P1|Overall Study|Lost to Follow-up|0
2577368|NCT01232556|8915127|P2|Overall Study|Death|97
2577369|NCT01232556|8915128|P1|Overall Study|Death|97
2577370|NCT01232556|8915127|P2|Overall Study|Withdrawal by Subject|17
2577371|NCT01232556|8915128|P1|Overall Study|Withdrawal by Subject|21
2577372|NCT01232491|8915187|P2|Overall Study|Other|18
2577373|NCT01232491|8915188|P1|Overall Study|Other|21
2577374|NCT01232491|8915187|P2|Overall Study|Withdrawal Criteria|21
2577375|NCT01232491|8915188|P1|Overall Study|Withdrawal Criteria|12
2577376|NCT01232491|8915187|P2|Overall Study|Protocol Violation|11
2577377|NCT01232491|8915188|P1|Overall Study|Protocol Violation|13
2577378|NCT01232491|8915187|P2|Overall Study|Lack of Efficacy|5
2577379|NCT01232491|8915188|P1|Overall Study|Lack of Efficacy|1
2577380|NCT01232491|8915187|P2|Overall Study|Adverse Event|8
2577381|NCT01232491|8915188|P1|Overall Study|Adverse Event|13
2577382|NCT01232452|8915217|P2|Overall Study|Protocol Violation|1
2577383|NCT01232452|8915218|P1|Overall Study|Protocol Violation|0
2577384|NCT01232452|8915217|P2|Overall Study|Sponsor Decision|1
2577385|NCT01232452|8915218|P1|Overall Study|Sponsor Decision|3
2577386|NCT01232452|8915217|P2|Overall Study|Protocol entry criterion not met|2
2577387|NCT01232452|8915218|P1|Overall Study|Protocol entry criterion not met|0
2577388|NCT01232452|8915217|P2|Overall Study|Physician Decision|12
2577389|NCT01232452|8915218|P1|Overall Study|Physician Decision|8
2577390|NCT01232452|8915217|P2|Overall Study|Withdrawal by Subject|8
2577391|NCT01232452|8915218|P1|Overall Study|Withdrawal by Subject|11
2577392|NCT01232452|8915217|P2|Overall Study|Adverse Event|15
2577393|NCT01232452|8915218|P1|Overall Study|Adverse Event|17
2577394|NCT01232296|8915244|P2|Overall Study|Death|6
2577395|NCT01232296|8915245|P1|Overall Study|Death|1
2577396|NCT01232296|8915244|P2|Overall Study|Subject/guardian decision|2
2577397|NCT01232296|8915245|P1|Overall Study|Subject/guardian decision|10
2577398|NCT01232296|8915244|P2|Overall Study|Technical problems|0
2577399|NCT01232296|8915245|P1|Overall Study|Technical problems|3
2577400|NCT01232296|8915244|P2|Overall Study|Study terminated by sponsor|1
2577401|NCT01232296|8915245|P1|Overall Study|Study terminated by sponsor|0
2577402|NCT01232296|8915244|P2|Overall Study|Progressive disease|61
2577403|NCT01232296|8915245|P1|Overall Study|Progressive disease|43
2577404|NCT01232296|8915244|P2|Overall Study|Physician Decision|1
2577405|NCT01232296|8915245|P1|Overall Study|Physician Decision|1
2577406|NCT01232296|8915244|P2|Overall Study|Adverse Event|12
2577407|NCT01232296|8915245|P1|Overall Study|Adverse Event|24
2577408|NCT01232283|8915262|P10|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3
2577409|NCT01232283|8915263|P9|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7
2577410|NCT01232283|8915264|P8|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
2577411|NCT01232283|8915265|P7|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
2577412|NCT01232283|8915266|P6|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
2577413|NCT01232283|8915267|P5|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
2577414|NCT01232283|8915268|P4|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
2577415|NCT01232283|8915269|P3|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
2577416|NCT01232283|8915270|P2|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
2577417|NCT01232283|8915271|P1|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
2577418|NCT01232283|8915262|P10|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
2577419|NCT01232283|8915263|P9|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1
2577420|NCT01232283|8915264|P8|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
2577421|NCT01232283|8915265|P7|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
2577422|NCT01232283|8915266|P6|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
2577423|NCT01232283|8915267|P5|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
2577424|NCT01232283|8915268|P4|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
2577425|NCT01232283|8915269|P3|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
2577426|NCT01232283|8915270|P2|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
2577427|NCT01232283|8915271|P1|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
2577428|NCT01232283|8915262|P10|Long-Term Extension Phase (Weeks 52-260)|Death|0
2577429|NCT01232283|8915263|P9|Long-Term Extension Phase (Weeks 52-260)|Death|1
2577430|NCT01232283|8915264|P8|Long-Term Extension Phase (Weeks 52-260)|Death|0
2577431|NCT01232283|8915265|P7|Long-Term Extension Phase (Weeks 52-260)|Death|0
2577432|NCT01232283|8915266|P6|Long-Term Extension Phase (Weeks 52-260)|Death|0
2577433|NCT01232283|8915267|P5|Long-Term Extension Phase (Weeks 52-260)|Death|0
2577434|NCT01232283|8915268|P4|Long-Term Extension Phase (Weeks 52-260)|Death|0
2577435|NCT01232283|8915269|P3|Long-Term Extension Phase (Weeks 52-260)|Death|0
2577436|NCT01232283|8915270|P2|Long-Term Extension Phase (Weeks 52-260)|Death|0
2577437|NCT01232283|8915271|P1|Long-Term Extension Phase (Weeks 52-260)|Death|0
2577438|NCT01232283|8915262|P10|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6
2577439|NCT01232283|8915263|P9|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9
2577440|NCT01232283|8915264|P8|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
2577441|NCT01232283|8915265|P7|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
2577442|NCT01232283|8915266|P6|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
2577443|NCT01232283|8915267|P5|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
2577444|NCT01232283|8915268|P4|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
2577445|NCT01232283|8915269|P3|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
2577446|NCT01232283|8915270|P2|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
2577447|NCT01232283|8915271|P1|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
2577448|NCT01232283|8915262|P10|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14
2577449|NCT01232283|8915263|P9|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30
2577450|NCT01232283|8915264|P8|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
2577451|NCT01232283|8915265|P7|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
2577452|NCT01232283|8915266|P6|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
2577453|NCT01232283|8915267|P5|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
2577454|NCT01232283|8915268|P4|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
2577455|NCT01232283|8915269|P3|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
2577456|NCT01232283|8915270|P2|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
2577457|NCT01232283|8915271|P1|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
2577458|NCT01232283|8915262|P10|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2
2577459|NCT01232283|8915263|P9|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3
2577460|NCT01232283|8915264|P8|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
2577461|NCT01232283|8915265|P7|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
2577462|NCT01232283|8915266|P6|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
2577463|NCT01232283|8915267|P5|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
2577464|NCT01232283|8915268|P4|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
2577465|NCT01232283|8915269|P3|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
2577466|NCT01232283|8915270|P2|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
2577467|NCT01232283|8915271|P1|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
2577468|NCT01232283|8915262|P10|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30
2577469|NCT01232283|8915263|P9|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46
2577470|NCT01232283|8915264|P8|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
2577471|NCT01232283|8915265|P7|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
2577472|NCT01232283|8915266|P6|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
2577473|NCT01232283|8915267|P5|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
2577474|NCT01232283|8915268|P4|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
2577475|NCT01232283|8915269|P3|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
2577476|NCT01232283|8915270|P2|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
2577477|NCT01232283|8915271|P1|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
2577478|NCT01232283|8915262|P10|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6
2577479|NCT01232283|8915263|P9|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11
2577480|NCT01232283|8915264|P8|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
2577481|NCT01232283|8915265|P7|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
2577482|NCT01232283|8915266|P6|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
2577483|NCT01232283|8915267|P5|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
2577484|NCT01232283|8915268|P4|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
2577485|NCT01232283|8915269|P3|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
2577486|NCT01232283|8915270|P2|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
2577487|NCT01232283|8915271|P1|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
2577488|NCT01232283|8915262|P10|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
2577489|NCT01232283|8915263|P9|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
2577490|NCT01232283|8915264|P8|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
2577491|NCT01232283|8915265|P7|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
2577492|NCT01232283|8915266|P6|Randomized Withdrawal Phase(Weeks 32-52)|Other|1
2577493|NCT01232283|8915267|P5|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
2577494|NCT01232283|8915268|P4|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
2577495|NCT01232283|8915269|P3|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
2577496|NCT01232283|8915270|P2|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
2577497|NCT01232283|8915271|P1|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
2577498|NCT01232283|8915262|P10|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
2577499|NCT01232283|8915263|P9|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
2577500|NCT01232283|8915264|P8|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1
2577501|NCT01232283|8915265|P7|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
2577502|NCT01232283|8915266|P6|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
2577503|NCT01232283|8915267|P5|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
2577504|NCT01232283|8915268|P4|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
2577505|NCT01232283|8915269|P3|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
2577506|NCT01232283|8915270|P2|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
2577507|NCT01232283|8915271|P1|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
2577508|NCT01232283|8915262|P10|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
2577509|NCT01232283|8915263|P9|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
2577510|NCT01232283|8915264|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
2577511|NCT01232283|8915265|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
2577512|NCT01232283|8915266|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
2577513|NCT01232283|8915267|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2
2577514|NCT01232283|8915268|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
2577515|NCT01232283|8915269|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
2577516|NCT01232283|8915270|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
2577517|NCT01232283|8915271|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
2577518|NCT01232283|8915262|P10|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
2577519|NCT01232283|8915263|P9|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
2577520|NCT01232283|8915264|P8|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
2577521|NCT01232283|8915265|P7|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
2577522|NCT01232283|8915266|P6|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
2577523|NCT01232283|8915267|P5|Randomized Withdrawal Phase(Weeks 32-52)|Death|1
2577524|NCT01232283|8915268|P4|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
2577525|NCT01232283|8915269|P3|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
2577526|NCT01232283|8915270|P2|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
2577527|NCT01232283|8915271|P1|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
2577528|NCT01232283|8915262|P10|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
2577529|NCT01232283|8915263|P9|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
2577530|NCT01232283|8915264|P8|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4
2577531|NCT01232283|8915265|P7|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
2577532|NCT01232283|8915266|P6|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
2577533|NCT01232283|8915267|P5|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
2577534|NCT01232283|8915268|P4|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
2577535|NCT01232283|8915269|P3|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
2577536|NCT01232283|8915270|P2|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
2577537|NCT01232283|8915271|P1|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
2577538|NCT01232283|8915262|P10|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
2577539|NCT01232283|8915263|P9|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
2577540|NCT01232283|8915264|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5
2577541|NCT01232283|8915265|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13
2577542|NCT01232283|8915266|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
2577543|NCT01232283|8915267|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4
2577544|NCT01232283|8915268|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
2577545|NCT01232283|8915269|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
2577546|NCT01232283|8915270|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
2577547|NCT01232283|8915271|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
2577548|NCT01232283|8915262|P10|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
2577549|NCT01232283|8915263|P9|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
2577550|NCT01232283|8915264|P8|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
2577551|NCT01232283|8915265|P7|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
2577552|NCT01232283|8915266|P6|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
2577553|NCT01232283|8915267|P5|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2
2577554|NCT01232283|8915268|P4|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
2577555|NCT01232283|8915269|P3|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
2577556|NCT01232283|8915270|P2|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
2577557|NCT01232283|8915271|P1|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
2577558|NCT01232283|8915262|P10|Maintenance Phase (Weeks16-32)|Other|0
2577559|NCT01232283|8915263|P9|Maintenance Phase (Weeks16-32)|Other|0
2577560|NCT01232283|8915264|P8|Maintenance Phase (Weeks16-32)|Other|0
2577561|NCT01232283|8915265|P7|Maintenance Phase (Weeks16-32)|Other|0
2577562|NCT01232283|8915266|P6|Maintenance Phase (Weeks16-32)|Other|0
2577563|NCT01232283|8915267|P5|Maintenance Phase (Weeks16-32)|Other|0
2577564|NCT01232283|8915268|P4|Maintenance Phase (Weeks16-32)|Other|0
2577565|NCT01232283|8915269|P3|Maintenance Phase (Weeks16-32)|Other|2
2577566|NCT01232283|8915270|P2|Maintenance Phase (Weeks16-32)|Other|0
2577567|NCT01232283|8915271|P1|Maintenance Phase (Weeks16-32)|Other|0
2577568|NCT01232283|8915262|P10|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
2577569|NCT01232283|8915263|P9|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
2577570|NCT01232283|8915264|P8|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
2577571|NCT01232283|8915265|P7|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
2577572|NCT01232283|8915266|P6|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
2577573|NCT01232283|8915267|P5|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
2577574|NCT01232283|8915268|P4|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2
2577575|NCT01232283|8915269|P3|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3
2577576|NCT01232283|8915270|P2|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
2577577|NCT01232283|8915271|P1|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
2577578|NCT01232283|8915262|P10|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
2577579|NCT01232283|8915263|P9|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
2577580|NCT01232283|8915264|P8|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
2577581|NCT01232283|8915265|P7|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
2577582|NCT01232283|8915266|P6|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
2577583|NCT01232283|8915267|P5|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
2577584|NCT01232283|8915268|P4|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1
2577585|NCT01232283|8915269|P3|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7
2577586|NCT01232283|8915270|P2|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
2577587|NCT01232283|8915271|P1|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
2577588|NCT01232283|8915262|P10|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
2577589|NCT01232283|8915263|P9|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
2577590|NCT01232283|8915264|P8|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
2577591|NCT01232283|8915265|P7|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
2577592|NCT01232283|8915266|P6|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
2577593|NCT01232283|8915267|P5|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
2577594|NCT01232283|8915268|P4|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
2577595|NCT01232283|8915269|P3|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1
2577596|NCT01232283|8915270|P2|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
2577597|NCT01232283|8915271|P1|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
2577598|NCT01232283|8915262|P10|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
2577599|NCT01232283|8915263|P9|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
2577600|NCT01232283|8915264|P8|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
2577601|NCT01232283|8915265|P7|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
2577602|NCT01232283|8915266|P6|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
2577760|NCT01231607|8915518|P5|Overall Study|Physician Decision|4
2577603|NCT01232283|8915267|P5|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
2577604|NCT01232283|8915268|P4|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3
2577605|NCT01232283|8915269|P3|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19
2577606|NCT01232283|8915270|P2|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
2577607|NCT01232283|8915271|P1|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
2577608|NCT01232283|8915262|P10|Maintenance Phase (Weeks16-32)|Adverse Event|0
2577609|NCT01232283|8915263|P9|Maintenance Phase (Weeks16-32)|Adverse Event|0
2577610|NCT01232283|8915264|P8|Maintenance Phase (Weeks16-32)|Adverse Event|0
2577611|NCT01232283|8915265|P7|Maintenance Phase (Weeks16-32)|Adverse Event|0
2577612|NCT01232283|8915266|P6|Maintenance Phase (Weeks16-32)|Adverse Event|0
2577613|NCT01232283|8915267|P5|Maintenance Phase (Weeks16-32)|Adverse Event|0
2577614|NCT01232283|8915268|P4|Maintenance Phase (Weeks16-32)|Adverse Event|2
2577615|NCT01232283|8915269|P3|Maintenance Phase (Weeks16-32)|Adverse Event|8
2577616|NCT01232283|8915270|P2|Maintenance Phase (Weeks16-32)|Adverse Event|0
2577617|NCT01232283|8915271|P1|Maintenance Phase (Weeks16-32)|Adverse Event|0
2577618|NCT01232283|8915262|P10|Placebo Controlled Phase (Weeks 0-16)|Other|0
2577619|NCT01232283|8915263|P9|Placebo Controlled Phase (Weeks 0-16)|Other|0
2577620|NCT01232283|8915264|P8|Placebo Controlled Phase (Weeks 0-16)|Other|0
2577621|NCT01232283|8915265|P7|Placebo Controlled Phase (Weeks 0-16)|Other|0
2577622|NCT01232283|8915266|P6|Placebo Controlled Phase (Weeks 0-16)|Other|0
2577623|NCT01232283|8915267|P5|Placebo Controlled Phase (Weeks 0-16)|Other|0
2577624|NCT01232283|8915268|P4|Placebo Controlled Phase (Weeks 0-16)|Other|0
2577625|NCT01232283|8915269|P3|Placebo Controlled Phase (Weeks 0-16)|Other|0
2577626|NCT01232283|8915270|P2|Placebo Controlled Phase (Weeks 0-16)|Other|1
2577627|NCT01232283|8915271|P1|Placebo Controlled Phase (Weeks 0-16)|Other|2
2577628|NCT01232283|8915262|P10|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
2577629|NCT01232283|8915263|P9|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
2577630|NCT01232283|8915264|P8|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
2577631|NCT01232283|8915265|P7|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
2577632|NCT01232283|8915266|P6|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
2577633|NCT01232283|8915267|P5|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
2577634|NCT01232283|8915268|P4|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
2577635|NCT01232283|8915269|P3|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
2577636|NCT01232283|8915270|P2|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2
2577637|NCT01232283|8915271|P1|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3
2577638|NCT01232283|8915262|P10|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
2577639|NCT01232283|8915263|P9|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
2577640|NCT01232283|8915264|P8|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
2577641|NCT01232283|8915265|P7|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
2577642|NCT01232283|8915266|P6|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
2577643|NCT01232283|8915267|P5|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
2577644|NCT01232283|8915268|P4|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
2577645|NCT01232283|8915269|P3|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
2577646|NCT01232283|8915270|P2|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
2577647|NCT01232283|8915271|P1|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
2577648|NCT01232283|8915262|P10|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2577649|NCT01232283|8915263|P9|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2577650|NCT01232283|8915264|P8|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2577651|NCT01232283|8915265|P7|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2577652|NCT01232283|8915266|P6|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2577653|NCT01232283|8915267|P5|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2577654|NCT01232283|8915268|P4|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2577655|NCT01232283|8915269|P3|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
2577656|NCT01232283|8915270|P2|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7
2577657|NCT01232283|8915271|P1|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9
2577658|NCT01232283|8915262|P10|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
2577659|NCT01232283|8915263|P9|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
2577660|NCT01232283|8915264|P8|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
2577661|NCT01232283|8915265|P7|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
2577662|NCT01232283|8915266|P6|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
2577663|NCT01232283|8915267|P5|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
2577664|NCT01232283|8915268|P4|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
2577665|NCT01232283|8915269|P3|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
2577666|NCT01232283|8915270|P2|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
2577667|NCT01232283|8915271|P1|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1
2577668|NCT01232283|8915262|P10|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2577669|NCT01232283|8915263|P9|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2577670|NCT01232283|8915264|P8|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2577671|NCT01232283|8915265|P7|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2577672|NCT01232283|8915266|P6|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2577673|NCT01232283|8915267|P5|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2577674|NCT01232283|8915268|P4|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2577675|NCT01232283|8915269|P3|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
2577676|NCT01232283|8915270|P2|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2
2577677|NCT01232283|8915271|P1|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3
2577678|NCT01232283|8915262|P10|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
2577679|NCT01232283|8915263|P9|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
2577680|NCT01232283|8915264|P8|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
2577681|NCT01232283|8915265|P7|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
2577682|NCT01232283|8915266|P6|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
2577683|NCT01232283|8915267|P5|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
2577684|NCT01232283|8915268|P4|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
2577685|NCT01232283|8915269|P3|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
2577686|NCT01232283|8915270|P2|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8
2577687|NCT01232283|8915271|P1|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12
2577688|NCT01232127|8915312|P3|Period 1: Days 1-10|Discontinued due to dosing error|0
2577689|NCT01232127|8915313|P2|Period 1: Days 1-10|Discontinued due to dosing error|0
2577690|NCT01232127|8915314|P1|Period 1: Days 1-10|Discontinued due to dosing error|1
2577691|NCT01231984|8915338|P4|Study Period 2|Did not continue to meet I/E Criteria|1
2577692|NCT01231984|8915339|P3|Study Period 2|Did not continue to meet I/E Criteria|0
2577693|NCT01231984|8915340|P2|Study Period 2|Did not continue to meet I/E Criteria|1
2577694|NCT01231984|8915341|P1|Study Period 2|Did not continue to meet I/E Criteria|1
2577695|NCT01231984|8915338|P4|Study Period 2|Lost to Follow-up|3
2577696|NCT01231984|8915339|P3|Study Period 2|Lost to Follow-up|0
2577697|NCT01231984|8915340|P2|Study Period 2|Lost to Follow-up|0
2577698|NCT01231984|8915341|P1|Study Period 2|Lost to Follow-up|1
2577699|NCT01231984|8915338|P4|Study Period 2|Withdrawal by Subject|0
2577700|NCT01231984|8915339|P3|Study Period 2|Withdrawal by Subject|0
2577701|NCT01231984|8915340|P2|Study Period 2|Withdrawal by Subject|1
2577702|NCT01231984|8915341|P1|Study Period 2|Withdrawal by Subject|1
2577703|NCT01231984|8915338|P4|Study Period 1|Other|1
2577704|NCT01231984|8915339|P3|Study Period 1|Other|0
2577705|NCT01231984|8915340|P2|Study Period 1|Other|0
2577706|NCT01231984|8915341|P1|Study Period 1|Other|0
2577707|NCT01231984|8915338|P4|Study Period 1|Adverse Event|0
2577708|NCT01231984|8915339|P3|Study Period 1|Adverse Event|0
2577709|NCT01231984|8915340|P2|Study Period 1|Adverse Event|0
2577710|NCT01231984|8915341|P1|Study Period 1|Adverse Event|1
2577711|NCT01231984|8915338|P4|Study Period 1|Protocol Violation|3
2577712|NCT01231984|8915339|P3|Study Period 1|Protocol Violation|2
2577713|NCT01231984|8915340|P2|Study Period 1|Protocol Violation|4
2577714|NCT01231984|8915341|P1|Study Period 1|Protocol Violation|3
2577715|NCT01231984|8915338|P4|Study Period 1|Non-compliance with study requirements|1
2577716|NCT01231984|8915339|P3|Study Period 1|Non-compliance with study requirements|2
2577717|NCT01231984|8915340|P2|Study Period 1|Non-compliance with study requirements|0
2577718|NCT01231984|8915341|P1|Study Period 1|Non-compliance with study requirements|5
2577719|NCT01231984|8915338|P4|Study Period 1|Screen Failure|1
2577720|NCT01231984|8915339|P3|Study Period 1|Screen Failure|0
2577721|NCT01231984|8915340|P2|Study Period 1|Screen Failure|0
2577722|NCT01231984|8915341|P1|Study Period 1|Screen Failure|0
2577723|NCT01231984|8915338|P4|Study Period 1|Did not continue to meet I/E Criteria|2
2577724|NCT01231984|8915339|P3|Study Period 1|Did not continue to meet I/E Criteria|2
2577725|NCT01231984|8915340|P2|Study Period 1|Did not continue to meet I/E Criteria|2
2577726|NCT01231984|8915341|P1|Study Period 1|Did not continue to meet I/E Criteria|2
2577727|NCT01231984|8915338|P4|Study Period 1|Lost to Follow-up|0
2577728|NCT01231984|8915339|P3|Study Period 1|Lost to Follow-up|1
2577729|NCT01231984|8915340|P2|Study Period 1|Lost to Follow-up|1
2577730|NCT01231984|8915341|P1|Study Period 1|Lost to Follow-up|1
2577731|NCT01231984|8915338|P4|Study Period 1|Withdrawal by Subject|1
2577732|NCT01231984|8915339|P3|Study Period 1|Withdrawal by Subject|0
2577733|NCT01231984|8915340|P2|Study Period 1|Withdrawal by Subject|0
2577734|NCT01231984|8915341|P1|Study Period 1|Withdrawal by Subject|0
2577735|NCT01231620|8915410|P3|Overall Study|Lost to Follow-up|9
2577736|NCT01231620|8915411|P2|Overall Study|Lost to Follow-up|4
2577737|NCT01231620|8915412|P1|Overall Study|Lost to Follow-up|3
2577738|NCT01231620|8915410|P3|Overall Study|Withdrawal by Subject|8
2577739|NCT01231620|8915411|P2|Overall Study|Withdrawal by Subject|6
2577740|NCT01231620|8915412|P1|Overall Study|Withdrawal by Subject|6
2577741|NCT01231620|8915410|P3|Overall Study|Adverse Event|1
2577742|NCT01231620|8915411|P2|Overall Study|Adverse Event|2
2577743|NCT01231620|8915412|P1|Overall Study|Adverse Event|2
2577744|NCT01231620|8915410|P3|Overall Study|Death|11
2577745|NCT01231620|8915411|P2|Overall Study|Death|14
2577746|NCT01231620|8915412|P1|Overall Study|Death|12
2577747|NCT01231620|8915410|P3|Overall Study|Physician Decision|10
2577748|NCT01231620|8915411|P2|Overall Study|Physician Decision|5
2577749|NCT01231620|8915412|P1|Overall Study|Physician Decision|3
2577750|NCT01231607|8915518|P5|Overall Study|Withdrawal by Subject|9
2577751|NCT01231607|8915519|P4|Overall Study|Withdrawal by Subject|17
2577752|NCT01231607|8915520|P3|Overall Study|Withdrawal by Subject|14
2577753|NCT01231607|8915521|P2|Overall Study|Withdrawal by Subject|9
2577754|NCT01231607|8915522|P1|Overall Study|Withdrawal by Subject|9
2577755|NCT01231607|8915518|P5|Overall Study|Protocol Violation|2
2577756|NCT01231607|8915519|P4|Overall Study|Protocol Violation|2
2577757|NCT01231607|8915520|P3|Overall Study|Protocol Violation|0
2577758|NCT01231607|8915521|P2|Overall Study|Protocol Violation|2
2577759|NCT01231607|8915522|P1|Overall Study|Protocol Violation|3
2577761|NCT01231607|8915519|P4|Overall Study|Physician Decision|5
2577762|NCT01231607|8915520|P3|Overall Study|Physician Decision|3
2577763|NCT01231607|8915521|P2|Overall Study|Physician Decision|4
2577764|NCT01231607|8915522|P1|Overall Study|Physician Decision|4
2577765|NCT01231607|8915518|P5|Overall Study|Lost to Follow-up|4
2577766|NCT01231607|8915519|P4|Overall Study|Lost to Follow-up|10
2577767|NCT01231607|8915520|P3|Overall Study|Lost to Follow-up|10
2577768|NCT01231607|8915521|P2|Overall Study|Lost to Follow-up|11
2577769|NCT01231607|8915522|P1|Overall Study|Lost to Follow-up|13
2577770|NCT01231607|8915518|P5|Overall Study|Adverse Event|5
2577771|NCT01231607|8915519|P4|Overall Study|Adverse Event|4
2577772|NCT01231607|8915520|P3|Overall Study|Adverse Event|4
2577773|NCT01231607|8915521|P2|Overall Study|Adverse Event|8
2577774|NCT01231607|8915522|P1|Overall Study|Adverse Event|0
2577775|NCT01231581|8915614|P2|Overall Study|Ongoing|0
2577776|NCT01231581|8915615|P1|Overall Study|Ongoing|1
2577777|NCT01231581|8915614|P2|Overall Study|Death|64
2577778|NCT01231581|8915615|P1|Overall Study|Death|65
2577779|NCT01231581|8915614|P2|Overall Study|Study Closed/Terminated|5
2577780|NCT01231581|8915615|P1|Overall Study|Study Closed/Terminated|6
2577781|NCT01231581|8915614|P2|Overall Study|Withdrawal by Subject|9
2577782|NCT01231581|8915615|P1|Overall Study|Withdrawal by Subject|6
2577783|NCT01231581|8915614|P2|Overall Study|Lost to Follow-up|2
2577784|NCT01231581|8915615|P1|Overall Study|Lost to Follow-up|2
2577785|NCT01231555|8915636|P3|Overall Study|Withdrawal by Subject|0
2577786|NCT01231555|8915637|P2|Overall Study|Withdrawal by Subject|2
2577787|NCT01231555|8915638|P1|Overall Study|Withdrawal by Subject|0
2577788|NCT01231555|8915636|P3|Overall Study|Study terminated|8
2577789|NCT01231555|8915637|P2|Overall Study|Study terminated|5
2577790|NCT01231555|8915638|P1|Overall Study|Study terminated|8
2577791|NCT01231516|8915669|P2|Open-label Phase|Ongoing at the time of analysis|23
2577792|NCT01231516|8915670|P1|Open-label Phase|Ongoing at the time of analysis|282
2577793|NCT01231516|8915669|P2|Open-label Phase|Withdrawal by Subject|0
2577794|NCT01231516|8915670|P1|Open-label Phase|Withdrawal by Subject|1
2577795|NCT01231516|8915669|P2|Open-label Phase|Lost to Follow-up|0
2577796|NCT01231516|8915670|P1|Open-label Phase|Lost to Follow-up|3
2577797|NCT01231516|8915669|P2|Open-label Phase|Protocol Violation|0
2577798|NCT01231516|8915670|P1|Open-label Phase|Protocol Violation|2
2577799|NCT01231516|8915669|P2|Open-label Phase|Lack of Efficacy|3
2577800|NCT01231516|8915670|P1|Open-label Phase|Lack of Efficacy|7
2577801|NCT01231516|8915669|P2|48 Week Double-blind Phase|Site Closed|1
2577802|NCT01231516|8915670|P1|48 Week Double-blind Phase|Site Closed|3
2577803|NCT01231516|8915669|P2|48 Week Double-blind Phase|Withdrawal by Subject|5
2577804|NCT01231516|8915670|P1|48 Week Double-blind Phase|Withdrawal by Subject|11
2577805|NCT01231516|8915669|P2|48 Week Double-blind Phase|Physician Decision|1
2577806|NCT01231516|8915670|P1|48 Week Double-blind Phase|Physician Decision|1
2577807|NCT01231516|8915669|P2|48 Week Double-blind Phase|Lost to Follow-up|10
2577808|NCT01231516|8915670|P1|48 Week Double-blind Phase|Lost to Follow-up|5
2577809|NCT01231516|8915669|P2|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|3
2577810|NCT01231516|8915670|P1|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|5
2577811|NCT01231516|8915669|P2|48 Week Double-blind Phase|Protocol Violation|6
2577812|NCT01231516|8915670|P1|48 Week Double-blind Phase|Protocol Violation|9
2577813|NCT01231516|8915669|P2|48 Week Double-blind Phase|Lack of Efficacy|42
2577814|NCT01231516|8915670|P1|48 Week Double-blind Phase|Lack of Efficacy|20
2577815|NCT01231516|8915669|P2|48 Week Double-blind Phase|Adverse Event|11
2577816|NCT01231516|8915670|P1|48 Week Double-blind Phase|Adverse Event|4
2577817|NCT01231503|8915700|P8|Overall Study|Protocol Violation|0
2577818|NCT01231503|8915701|P7|Overall Study|Protocol Violation|0
2577819|NCT01231503|8915702|P6|Overall Study|Protocol Violation|0
2577820|NCT01231503|8915703|P5|Overall Study|Protocol Violation|0
2577821|NCT01231503|8915704|P4|Overall Study|Protocol Violation|1
2577822|NCT01231503|8915705|P3|Overall Study|Protocol Violation|0
2577823|NCT01231503|8915706|P2|Overall Study|Protocol Violation|0
2577824|NCT01231503|8915707|P1|Overall Study|Protocol Violation|0
2577825|NCT01231503|8915700|P8|Overall Study|Lost to Follow-up|6
2577826|NCT01231503|8915701|P7|Overall Study|Lost to Follow-up|6
2577827|NCT01231503|8915702|P6|Overall Study|Lost to Follow-up|9
2577828|NCT01231503|8915703|P5|Overall Study|Lost to Follow-up|7
2577829|NCT01231503|8915704|P4|Overall Study|Lost to Follow-up|5
2577830|NCT01231503|8915705|P3|Overall Study|Lost to Follow-up|8
2577831|NCT01231503|8915706|P2|Overall Study|Lost to Follow-up|10
2577832|NCT01231503|8915707|P1|Overall Study|Lost to Follow-up|8
2577833|NCT01231503|8915700|P8|Overall Study|Withdrawal by Subject|2
2577834|NCT01231503|8915701|P7|Overall Study|Withdrawal by Subject|1
2577835|NCT01231503|8915702|P6|Overall Study|Withdrawal by Subject|5
2577836|NCT01231503|8915703|P5|Overall Study|Withdrawal by Subject|3
2577837|NCT01231503|8915704|P4|Overall Study|Withdrawal by Subject|1
2577838|NCT01231503|8915705|P3|Overall Study|Withdrawal by Subject|3
2577839|NCT01231503|8915706|P2|Overall Study|Withdrawal by Subject|3
2577840|NCT01231503|8915707|P1|Overall Study|Withdrawal by Subject|6
2577841|NCT01231503|8915700|P8|Overall Study|Adverse event, serious fatal|0
2577842|NCT01231503|8915701|P7|Overall Study|Adverse event, serious fatal|0
2577843|NCT01231503|8915702|P6|Overall Study|Adverse event, serious fatal|1
2577844|NCT01231503|8915703|P5|Overall Study|Adverse event, serious fatal|0
2577845|NCT01231503|8915704|P4|Overall Study|Adverse event, serious fatal|1
2577846|NCT01231503|8915705|P3|Overall Study|Adverse event, serious fatal|1
2577847|NCT01231503|8915706|P2|Overall Study|Adverse event, serious fatal|0
2577848|NCT01231503|8915707|P1|Overall Study|Adverse event, serious fatal|0
2577849|NCT01231503|8915700|P8|Overall Study|Adverse Event|0
2577850|NCT01231503|8915701|P7|Overall Study|Adverse Event|0
2577851|NCT01231503|8915702|P6|Overall Study|Adverse Event|1
2577852|NCT01231503|8915703|P5|Overall Study|Adverse Event|0
2577853|NCT01231503|8915704|P4|Overall Study|Adverse Event|0
2577854|NCT01231503|8915705|P3|Overall Study|Adverse Event|0
2577855|NCT01231503|8915706|P2|Overall Study|Adverse Event|0
2577856|NCT01231503|8915707|P1|Overall Study|Adverse Event|0
2577857|NCT01231464|8915947|P2|Overall Study|Withdrawal by Subject|2
2577858|NCT01231464|8915948|P1|Overall Study|Withdrawal by Subject|3
2577859|NCT01231464|8915947|P2|Overall Study|Lost to Follow-up|2
2577860|NCT01231464|8915948|P1|Overall Study|Lost to Follow-up|1
2577861|NCT01231464|8915947|P2|Overall Study|Protocol Violation|2
2577862|NCT01231464|8915948|P1|Overall Study|Protocol Violation|1
2577863|NCT01231464|8915947|P2|Overall Study|Adverse Event|1
2577864|NCT01231464|8915948|P1|Overall Study|Adverse Event|0
2577865|NCT01231373|8915997|P4|Overall Study|Withdrew Consent|0
2577866|NCT01231373|8915998|P3|Overall Study|Withdrew Consent|0
2577867|NCT01231373|8915999|P2|Overall Study|Withdrew Consent|0
2577868|NCT01231373|8916000|P1|Overall Study|Withdrew Consent|1
2577869|NCT01231373|8915997|P4|Overall Study|Lost to Follow-up|1
2577870|NCT01231373|8915998|P3|Overall Study|Lost to Follow-up|0
2577871|NCT01231373|8915999|P2|Overall Study|Lost to Follow-up|0
2577872|NCT01231373|8916000|P1|Overall Study|Lost to Follow-up|0
2577873|NCT01231373|8915997|P4|Overall Study|Withdrew consent prior to randomization|0
2577874|NCT01231373|8915998|P3|Overall Study|Withdrew consent prior to randomization|0
2577875|NCT01231373|8915999|P2|Overall Study|Withdrew consent prior to randomization|1
2577876|NCT01231373|8916000|P1|Overall Study|Withdrew consent prior to randomization|2
2577877|NCT01231321|8916039|P1|Overall Study|Lack of Efficacy|2
2577878|NCT01231321|8916039|P1|Overall Study|Adverse Event|3
2577879|NCT01230892|8916087|P2|Overall Study|Lost to Follow-up|0
2577880|NCT01230892|8916088|P1|Overall Study|Lost to Follow-up|2
2577881|NCT01230892|8916087|P2|Overall Study|Withdrawal by Subject|1
2577882|NCT01230892|8916088|P1|Overall Study|Withdrawal by Subject|1
2577883|NCT01230827|8916098|P4|Overall Study|Study terminated by Sponsor|63
2577884|NCT01230827|8916099|P3|Overall Study|Study terminated by Sponsor|56
2577885|NCT01230827|8916100|P2|Overall Study|Study terminated by Sponsor|2
2577886|NCT01230827|8916101|P1|Overall Study|Study terminated by Sponsor|0
2577887|NCT01230827|8916098|P4|Overall Study|Recovery|0
2577888|NCT01230827|8916099|P3|Overall Study|Recovery|0
2577889|NCT01230827|8916100|P2|Overall Study|Recovery|6
2577890|NCT01230827|8916101|P1|Overall Study|Recovery|0
2577891|NCT01230827|8916098|P4|Overall Study|Adverse Event|7
2577892|NCT01230827|8916099|P3|Overall Study|Adverse Event|3
2577893|NCT01230827|8916100|P2|Overall Study|Adverse Event|2
2577894|NCT01230827|8916101|P1|Overall Study|Adverse Event|4
2577895|NCT01230827|8916098|P4|Overall Study|Lack of Efficacy|3
2577896|NCT01230827|8916099|P3|Overall Study|Lack of Efficacy|2
2577897|NCT01230827|8916100|P2|Overall Study|Lack of Efficacy|1
2577898|NCT01230827|8916101|P1|Overall Study|Lack of Efficacy|14
2577899|NCT01230827|8916098|P4|Overall Study|Withdrawal by Subject|2
2577900|NCT01230827|8916099|P3|Overall Study|Withdrawal by Subject|3
2577901|NCT01230827|8916100|P2|Overall Study|Withdrawal by Subject|0
2577902|NCT01230827|8916101|P1|Overall Study|Withdrawal by Subject|1
2577903|NCT01230827|8916098|P4|Overall Study|Lost to Follow-up|3
2577904|NCT01230827|8916099|P3|Overall Study|Lost to Follow-up|1
2577905|NCT01230827|8916100|P2|Overall Study|Lost to Follow-up|0
2577906|NCT01230827|8916101|P1|Overall Study|Lost to Follow-up|0
2577907|NCT01230814|8916117|P2|Overall Study|Discontinued (not due to adverse event)|1
2577908|NCT01230814|8916118|P1|Overall Study|Discontinued (not due to adverse event)|2
2577909|NCT01230814|8916117|P2|Overall Study|Lost to Follow-up|3
2577910|NCT01230814|8916118|P1|Overall Study|Lost to Follow-up|11
2577911|NCT01230788|8916168|P1|Overall Study|Prescribed exclusion drug|1
2577912|NCT01230749|8916180|P4|Overall Study|Fasting glucose more than 270 mg/dL|1
2577913|NCT01230749|8916181|P3|Overall Study|Fasting glucose more than 270 mg/dL|1
2577914|NCT01230749|8916182|P2|Overall Study|Fasting glucose more than 270 mg/dL|1
2577915|NCT01230749|8916183|P1|Overall Study|Fasting glucose more than 270 mg/dL|0
2577916|NCT01230749|8916180|P4|Overall Study|Withdrawal by Subject|0
2577917|NCT01230749|8916181|P3|Overall Study|Withdrawal by Subject|0
2577918|NCT01230749|8916182|P2|Overall Study|Withdrawal by Subject|1
2577919|NCT01230749|8916183|P1|Overall Study|Withdrawal by Subject|0
2577920|NCT01230749|8916180|P4|Overall Study|Physician Decision|0
2577921|NCT01230749|8916181|P3|Overall Study|Physician Decision|1
2577922|NCT01230749|8916182|P2|Overall Study|Physician Decision|0
2577923|NCT01230749|8916183|P1|Overall Study|Physician Decision|0
2577924|NCT01230749|8916180|P4|Overall Study|Adverse Event|1
2577925|NCT01230749|8916181|P3|Overall Study|Adverse Event|0
2577926|NCT01230749|8916182|P2|Overall Study|Adverse Event|0
2577927|NCT01230749|8916183|P1|Overall Study|Adverse Event|0
2577928|NCT01230710|8916218|P1|Overall Study|Withdrawal of Consent|1
2577929|NCT01230710|8916218|P1|Overall Study|Death|4
2577930|NCT01230710|8916218|P1|Overall Study|Lost to Follow-up|3
2577931|NCT01230710|8916218|P1|Overall Study|Disease Progression|41
2577932|NCT01230554|8916242|P1|Overall Study|Inability to maintain visit schedule|1
2577933|NCT01230554|8916242|P1|Overall Study|Lost to Follow-up|2
2577934|NCT01230489|8916265|P1|Overall Study|Treatment modality changed|1
2577935|NCT01230489|8916265|P1|Overall Study|Adverse Event|2
2577936|NCT01230489|8916265|P1|Overall Study|Death|2
2577937|NCT01230307|8916300|P2|Overall Study|LVAD Placement|2
2577938|NCT01230307|8916301|P1|Overall Study|LVAD Placement|0
2577939|NCT01230060|8916321|P1|Overall Study|Withdrawal by Subject|1
2577940|NCT01229735|8916394|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
2577941|NCT01229735|8916395|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
2577942|NCT01229735|8916394|P2|Overall Study|AE, non-serious non-fatal|17
2577943|NCT01229735|8916395|P1|Overall Study|AE, non-serious non-fatal|13
2577944|NCT01229735|8916394|P2|Overall Study|SAE, non-fatal|4
2577945|NCT01229735|8916395|P1|Overall Study|SAE, non-fatal|0
2577946|NCT01229735|8916394|P2|Overall Study|Other Reason|10
2577947|NCT01229735|8916395|P1|Overall Study|Other Reason|13
2577948|NCT01229735|8916394|P2|Overall Study|Withdrawal by Subject|17
2577949|NCT01229735|8916395|P1|Overall Study|Withdrawal by Subject|18
2577950|NCT01229735|8916394|P2|Overall Study|Lost to Follow-up|2
2577951|NCT01229735|8916395|P1|Overall Study|Lost to Follow-up|0
2577952|NCT01229735|8916394|P2|Overall Study|Protocol Violation|8
2577953|NCT01229735|8916395|P1|Overall Study|Protocol Violation|13
2577954|NCT01229735|8916394|P2|Overall Study|Lack of Efficacy|8
2577955|NCT01229735|8916395|P1|Overall Study|Lack of Efficacy|8
2577956|NCT01229449|8916452|P5|Overall Study|Physician Decision|0
2577957|NCT01229449|8916453|P4|Overall Study|Physician Decision|0
2577958|NCT01229449|8916454|P3|Overall Study|Physician Decision|1
2577959|NCT01229449|8916455|P2|Overall Study|Physician Decision|0
2577960|NCT01229449|8916456|P1|Overall Study|Physician Decision|0
2577961|NCT01229449|8916452|P5|Overall Study|Lost to Follow-up|0
2577962|NCT01229449|8916453|P4|Overall Study|Lost to Follow-up|0
2577963|NCT01229449|8916454|P3|Overall Study|Lost to Follow-up|1
2577964|NCT01229449|8916455|P2|Overall Study|Lost to Follow-up|1
2577965|NCT01229449|8916456|P1|Overall Study|Lost to Follow-up|1
2577966|NCT01229449|8916452|P5|Overall Study|Withdrawal by Subject|1
2577967|NCT01229449|8916453|P4|Overall Study|Withdrawal by Subject|1
2577968|NCT01229449|8916454|P3|Overall Study|Withdrawal by Subject|0
2577969|NCT01229449|8916455|P2|Overall Study|Withdrawal by Subject|3
2577970|NCT01229449|8916456|P1|Overall Study|Withdrawal by Subject|0
2577971|NCT01229436|8916513|P1|Overall Study|Lost to Follow-up|3
2577972|NCT01229436|8916513|P1|Overall Study|Withdrawal by Subject|2
2577973|NCT01229397|8916575|P2|Overall Study|Migrated/moved from study area|0
2577974|NCT01229397|8916576|P1|Overall Study|Migrated/moved from study area|1
2577975|NCT01229397|8916575|P2|Overall Study|Lost to Follow-up|6
2577976|NCT01229397|8916576|P1|Overall Study|Lost to Follow-up|7
2577977|NCT01229397|8916575|P2|Overall Study|Withdrawal by Subject|3
2577978|NCT01229397|8916576|P1|Overall Study|Withdrawal by Subject|3
2577979|NCT01229371|8916594|P4|Overall Study|Withdrawal by Subject|0
2577980|NCT01229371|8916595|P3|Overall Study|Withdrawal by Subject|0
2577981|NCT01229371|8916596|P2|Overall Study|Withdrawal by Subject|1
2577982|NCT01229371|8916597|P1|Overall Study|Withdrawal by Subject|0
2577983|NCT01229267|8916624|P5|Overall Study|Lost to Follow-up|22
2577984|NCT01229267|8916625|P4|Overall Study|Lost to Follow-up|3
2577985|NCT01229267|8916626|P3|Overall Study|Lost to Follow-up|8
2577986|NCT01229267|8916627|P2|Overall Study|Lost to Follow-up|5
2577987|NCT01229267|8916628|P1|Overall Study|Lost to Follow-up|6
2577988|NCT01229267|8916624|P5|Overall Study|Physician Decision|25
2577989|NCT01229267|8916625|P4|Overall Study|Physician Decision|3
2577990|NCT01229267|8916626|P3|Overall Study|Physician Decision|8
2577991|NCT01229267|8916627|P2|Overall Study|Physician Decision|11
2577992|NCT01229267|8916628|P1|Overall Study|Physician Decision|8
2577993|NCT01229267|8916624|P5|Overall Study|Progressive disease|1
2577994|NCT01229267|8916625|P4|Overall Study|Progressive disease|0
2577995|NCT01229267|8916626|P3|Overall Study|Progressive disease|0
2577996|NCT01229267|8916627|P2|Overall Study|Progressive disease|0
2577997|NCT01229267|8916628|P1|Overall Study|Progressive disease|0
2577998|NCT01229267|8916624|P5|Overall Study|Protocol Violation|0
2577999|NCT01229267|8916625|P4|Overall Study|Protocol Violation|0
2578000|NCT01229267|8916626|P3|Overall Study|Protocol Violation|0
2578001|NCT01229267|8916627|P2|Overall Study|Protocol Violation|1
2578002|NCT01229267|8916628|P1|Overall Study|Protocol Violation|0
2578003|NCT01229267|8916624|P5|Overall Study|Withdrawal by Subject|59
2578004|NCT01229267|8916625|P4|Overall Study|Withdrawal by Subject|14
2578005|NCT01229267|8916626|P3|Overall Study|Withdrawal by Subject|32
2578006|NCT01229267|8916627|P2|Overall Study|Withdrawal by Subject|22
2578007|NCT01229267|8916628|P1|Overall Study|Withdrawal by Subject|23
2578008|NCT01229267|8916624|P5|Overall Study|Death|103
2578009|NCT01229267|8916625|P4|Overall Study|Death|13
2578010|NCT01229267|8916626|P3|Overall Study|Death|35
2578011|NCT01229267|8916627|P2|Overall Study|Death|37
2578012|NCT01229267|8916628|P1|Overall Study|Death|40
2578013|NCT01229267|8916624|P5|Overall Study|Adverse Event|10
2578014|NCT01229267|8916625|P4|Overall Study|Adverse Event|2
2578015|NCT01229267|8916626|P3|Overall Study|Adverse Event|3
2578016|NCT01229267|8916627|P2|Overall Study|Adverse Event|6
2578017|NCT01229267|8916628|P1|Overall Study|Adverse Event|4
2578018|NCT01229254|8916647|P3|Overall Study|Non-compliance with Study Drug|1
2578019|NCT01229254|8916648|P2|Overall Study|Non-compliance with Study Drug|1
2578020|NCT01229254|8916649|P1|Overall Study|Non-compliance with Study Drug|0
2578021|NCT01229254|8916647|P3|Overall Study|Withdrawal by Subject|1
2578022|NCT01229254|8916648|P2|Overall Study|Withdrawal by Subject|0
2578023|NCT01229254|8916649|P1|Overall Study|Withdrawal by Subject|1
2578024|NCT01229254|8916647|P3|Overall Study|Protocol Violation|5
2578025|NCT01229254|8916648|P2|Overall Study|Protocol Violation|6
2578026|NCT01229254|8916649|P1|Overall Study|Protocol Violation|4
2578027|NCT01229254|8916647|P3|Overall Study|Physician Decision|0
2578028|NCT01229254|8916648|P2|Overall Study|Physician Decision|3
2578029|NCT01229254|8916649|P1|Overall Study|Physician Decision|0
2578030|NCT01229254|8916647|P3|Overall Study|Lost to Follow-up|1
2578031|NCT01229254|8916648|P2|Overall Study|Lost to Follow-up|0
2578032|NCT01229254|8916649|P1|Overall Study|Lost to Follow-up|3
2578033|NCT01229254|8916647|P3|Overall Study|Adverse Event|3
2578034|NCT01229254|8916648|P2|Overall Study|Adverse Event|5
2578035|NCT01229254|8916649|P1|Overall Study|Adverse Event|4
2578036|NCT01229254|8916647|P3|Overall Study|Not Continuing Into Safety Extension|1
2578037|NCT01229254|8916648|P2|Overall Study|Not Continuing Into Safety Extension|1
2578038|NCT01229254|8916649|P1|Overall Study|Not Continuing Into Safety Extension|3
2578039|NCT01229176|8916687|P8|Overall Study|Lost to Follow-up|2
2578040|NCT01229176|8916688|P7|Overall Study|Lost to Follow-up|0
2578041|NCT01229176|8916689|P6|Overall Study|Lost to Follow-up|1
2578042|NCT01229176|8916690|P5|Overall Study|Lost to Follow-up|1
2578043|NCT01229176|8916691|P4|Overall Study|Lost to Follow-up|0
2578044|NCT01229176|8916692|P3|Overall Study|Lost to Follow-up|0
2578045|NCT01229176|8916693|P2|Overall Study|Lost to Follow-up|3
2578046|NCT01229176|8916694|P1|Overall Study|Lost to Follow-up|0
2578047|NCT01229176|8916687|P8|Overall Study|Withdrawal by Subject|1
2578048|NCT01229176|8916688|P7|Overall Study|Withdrawal by Subject|0
2578049|NCT01229176|8916689|P6|Overall Study|Withdrawal by Subject|1
2578050|NCT01229176|8916690|P5|Overall Study|Withdrawal by Subject|1
2578051|NCT01229176|8916691|P4|Overall Study|Withdrawal by Subject|1
2578052|NCT01229176|8916692|P3|Overall Study|Withdrawal by Subject|0
2578053|NCT01229176|8916693|P2|Overall Study|Withdrawal by Subject|0
2578054|NCT01229176|8916694|P1|Overall Study|Withdrawal by Subject|0
2578055|NCT01229150|8916748|P4|Overall Study|Toxicity|0
2578056|NCT01229150|8916749|P3|Overall Study|Toxicity|0
2578057|NCT01229150|8916750|P2|Overall Study|Toxicity|2
2578058|NCT01229150|8916751|P1|Overall Study|Toxicity|2
2578059|NCT01229111|8916808|P1|Overall Study|Death|1
2578060|NCT01228747|8916857|P2|Overall Study|Other Reason|5
2578061|NCT01228747|8916858|P1|Overall Study|Other Reason|2
2578062|NCT01228747|8916857|P2|Overall Study|Withdrawal by Subject|1
2578063|NCT01228747|8916858|P1|Overall Study|Withdrawal by Subject|5
2578064|NCT01228747|8916857|P2|Overall Study|Lost to Follow-up|3
2578065|NCT01228747|8916858|P1|Overall Study|Lost to Follow-up|4
2578066|NCT01228747|8916857|P2|Overall Study|Protocol Violation|5
2578067|NCT01228747|8916858|P1|Overall Study|Protocol Violation|6
2578068|NCT01228747|8916857|P2|Overall Study|Lack of Efficacy|27
2578069|NCT01228747|8916858|P1|Overall Study|Lack of Efficacy|40
2578070|NCT01228747|8916857|P2|Overall Study|Adverse Event|4
2578071|NCT01228747|8916858|P1|Overall Study|Adverse Event|8
2578072|NCT01228734|8916874|P2|Overall Study|Randomized, but not treated|4
2578073|NCT01228734|8916875|P1|Overall Study|Randomized, but not treated|0
2578074|NCT01228591|8916889|P2|Baseline|Lack of Efficacy|2
2578075|NCT01228591|8916890|P1|Baseline|Lack of Efficacy|1
2578076|NCT01228318|8916919|P2|Overall Study|Incarcerated|0
2578077|NCT01228318|8916920|P1|Overall Study|Incarcerated|1
2578078|NCT01228318|8916919|P2|Overall Study|Moved|2
2578079|NCT01228318|8916920|P1|Overall Study|Moved|0
2578080|NCT01228318|8916919|P2|Overall Study|Unable to contact|5
2578081|NCT01228318|8916920|P1|Overall Study|Unable to contact|2
2578082|NCT01228318|8916919|P2|Overall Study|Clinic no show to receive intervention|0
2578083|NCT01228318|8916920|P1|Overall Study|Clinic no show to receive intervention|1
2578084|NCT01228175|8916936|P2|Overall Study|Physician Decision|1
2578085|NCT01228175|8916937|P1|Overall Study|Physician Decision|1
2578086|NCT01228175|8916936|P2|Overall Study|Withdrawal by Subject|2
2578087|NCT01228175|8916937|P1|Overall Study|Withdrawal by Subject|1
2578088|NCT01228175|8916936|P2|Overall Study|Lost to Follow-up|50
2578089|NCT01228175|8916937|P1|Overall Study|Lost to Follow-up|64
2578090|NCT01228071|8916979|P1|Overall Study|Withdrawal by Subject|1
2578091|NCT01228071|8916979|P1|Overall Study|Protocol Violation|1
2578092|NCT01228019|8916985|P1|Overall Study|Violation of Entry Criterion|9
2578093|NCT01228019|8916985|P1|Overall Study|Triglyceride Entry Criteria Not Met|152
2578094|NCT01228019|8916985|P1|Overall Study|Missing pre-treatment data|72
2578095|NCT01228019|8916985|P1|Overall Study|Duplicate enrollment|1
2578096|NCT01228019|8916985|P1|Overall Study|Dose Violation|70
2578097|NCT01227967|8917051|P2|Overall Study|Taking Additional Antiviral Drug|0
2578098|NCT01227967|8917052|P1|Overall Study|Taking Additional Antiviral Drug|1
2578099|NCT01227967|8917051|P2|Overall Study|Never Started Treatment|4
2578100|NCT01227967|8917052|P1|Overall Study|Never Started Treatment|0
2578101|NCT01227967|8917051|P2|Overall Study|Physician Decision|1
2578102|NCT01227967|8917052|P1|Overall Study|Physician Decision|0
2578103|NCT01227967|8917051|P2|Overall Study|Withdrawal by Subject|3
2578104|NCT01227967|8917052|P1|Overall Study|Withdrawal by Subject|4
2578105|NCT01227967|8917051|P2|Overall Study|Lost to Follow-up|3
2578106|NCT01227967|8917052|P1|Overall Study|Lost to Follow-up|8
2578107|NCT01227967|8917051|P2|Overall Study|Death|1
2578108|NCT01227967|8917052|P1|Overall Study|Death|0
2578109|NCT01227967|8917051|P2|Overall Study|Protocol Violation|1
2578110|NCT01227967|8917052|P1|Overall Study|Protocol Violation|3
2578111|NCT01227954|8917086|P1|Overall Study|No protocol treatment|7
2578112|NCT01227954|8917086|P1|Overall Study|Protocol Violation|6
2578113|NCT01227928|8917100|P2|Overall Study|Death|12
2578114|NCT01227928|8917101|P1|Overall Study|Death|14
2578115|NCT01227928|8917100|P2|Overall Study|Withdrawal by Subject|3
2578116|NCT01227928|8917101|P1|Overall Study|Withdrawal by Subject|4
2578117|NCT01227928|8917100|P2|Overall Study|Lost to Follow-up|2
2578118|NCT01227928|8917101|P1|Overall Study|Lost to Follow-up|4
2578119|NCT01227902|8917139|P4|Overall Study|Withdrawal by Subject|3
2578120|NCT01227902|8917140|P3|Overall Study|Withdrawal by Subject|4
2578121|NCT01227902|8917141|P2|Overall Study|Withdrawal by Subject|2
2578122|NCT01227902|8917142|P1|Overall Study|Withdrawal by Subject|4
2578123|NCT01227902|8917139|P4|Overall Study|Physician Decision|0
2578124|NCT01227902|8917140|P3|Overall Study|Physician Decision|1
2578125|NCT01227902|8917141|P2|Overall Study|Physician Decision|1
2578126|NCT01227902|8917142|P1|Overall Study|Physician Decision|0
2578127|NCT01227902|8917139|P4|Overall Study|Lost to Follow-up|2
2578128|NCT01227902|8917140|P3|Overall Study|Lost to Follow-up|1
2578129|NCT01227902|8917141|P2|Overall Study|Lost to Follow-up|0
2578130|NCT01227902|8917142|P1|Overall Study|Lost to Follow-up|0
2578131|NCT01227902|8917139|P4|Overall Study|Protocol Violation|0
2578132|NCT01227902|8917140|P3|Overall Study|Protocol Violation|0
2578133|NCT01227902|8917141|P2|Overall Study|Protocol Violation|0
2578134|NCT01227902|8917142|P1|Overall Study|Protocol Violation|1
2578135|NCT01227902|8917139|P4|Overall Study|Lack of Efficacy|1
2578136|NCT01227902|8917140|P3|Overall Study|Lack of Efficacy|2
2578137|NCT01227902|8917141|P2|Overall Study|Lack of Efficacy|2
2578138|NCT01227902|8917142|P1|Overall Study|Lack of Efficacy|1
2578139|NCT01227902|8917139|P4|Overall Study|Adverse Event|4
2578140|NCT01227902|8917140|P3|Overall Study|Adverse Event|11
2578141|NCT01227902|8917141|P2|Overall Study|Adverse Event|8
2578142|NCT01227902|8917142|P1|Overall Study|Adverse Event|12
2578143|NCT01227889|8917235|P2|Crossover Phase|Withdrawal by Subject|1
2578144|NCT01227889|8917236|P1|Crossover Phase|Withdrawal by Subject|0
2578145|NCT01227889|8917235|P2|Crossover Phase|Study Terminated By Sponsor|1
2578146|NCT01227889|8917236|P1|Crossover Phase|Study Terminated By Sponsor|0
2578147|NCT01227889|8917235|P2|Crossover Phase|Progressive Disease|31
2578148|NCT01227889|8917236|P1|Crossover Phase|Progressive Disease|0
2578149|NCT01227889|8917235|P2|Crossover Phase|Physician Decision|3
2578150|NCT01227889|8917236|P1|Crossover Phase|Physician Decision|0
2578151|NCT01227889|8917235|P2|Crossover Phase|Adverse Event|1
2578152|NCT01227889|8917236|P1|Crossover Phase|Adverse Event|0
2578153|NCT01227889|8917235|P2|Randomized Phase (RP)|Withdrawal by Subject|3
2578154|NCT01227889|8917236|P1|Randomized Phase (RP)|Withdrawal by Subject|15
2578155|NCT01227889|8917235|P2|Randomized Phase (RP)|Missing|3
2578156|NCT01227889|8917236|P1|Randomized Phase (RP)|Missing|1
2578157|NCT01227889|8917235|P2|Randomized Phase (RP)|Study terminated by sponsor|0
2578158|NCT01227889|8917236|P1|Randomized Phase (RP)|Study terminated by sponsor|10
2578159|NCT01227889|8917235|P2|Randomized Phase (RP)|Progressive Disease|52
2578160|NCT01227889|8917236|P1|Randomized Phase (RP)|Progressive Disease|135
2578161|NCT01227889|8917235|P2|Randomized Phase (RP)|Physician Decision|5
2578162|NCT01227889|8917236|P1|Randomized Phase (RP)|Physician Decision|13
2578163|NCT01227889|8917235|P2|Randomized Phase (RP)|Adverse Event|0
2578164|NCT01227889|8917236|P1|Randomized Phase (RP)|Adverse Event|13
2578165|NCT01227824|8917263|P3|Open-label Phase: Median of 1267 Days|Physician Decision|3
2578166|NCT01227824|8917264|P2|Open-label Phase: Median of 1267 Days|Physician Decision|0
2578167|NCT01227824|8917265|P1|Open-label Phase: Median of 1267 Days|Physician Decision|0
2578168|NCT01227824|8917263|P3|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8
2578169|NCT01227824|8917264|P2|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
2578170|NCT01227824|8917265|P1|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
2578171|NCT01227824|8917263|P3|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15
2578172|NCT01227824|8917264|P2|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
2578173|NCT01227824|8917265|P1|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
2578174|NCT01227824|8917263|P3|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4
2578175|NCT01227824|8917264|P2|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
2578176|NCT01227824|8917265|P1|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
2578177|NCT01227824|8917263|P3|Open-label Phase: Median of 1267 Days|Protocol Violation|5
2578178|NCT01227824|8917264|P2|Open-label Phase: Median of 1267 Days|Protocol Violation|0
2578179|NCT01227824|8917265|P1|Open-label Phase: Median of 1267 Days|Protocol Violation|0
2578180|NCT01227824|8917263|P3|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5
2578181|NCT01227824|8917264|P2|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
2578182|NCT01227824|8917265|P1|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
2578183|NCT01227824|8917263|P3|Open-label Phase: Median of 1267 Days|Adverse Event|4
2578184|NCT01227824|8917264|P2|Open-label Phase: Median of 1267 Days|Adverse Event|0
2578185|NCT01227824|8917265|P1|Open-label Phase: Median of 1267 Days|Adverse Event|0
2578186|NCT01227824|8917263|P3|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
2578187|NCT01227824|8917264|P2|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
2578188|NCT01227824|8917265|P1|Double-blind Phase: 96 Weeks Duration|Physician Decision|3
2578189|NCT01227824|8917263|P3|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0
2578190|NCT01227824|8917264|P2|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14
2578191|NCT01227824|8917265|P1|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18
2578192|NCT01227824|8917263|P3|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0
2578193|NCT01227824|8917264|P2|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10
2578194|NCT01227824|8917265|P1|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22
2578195|NCT01227824|8917263|P3|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0
2578196|NCT01227824|8917264|P2|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4
2578197|NCT01227824|8917265|P1|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6
2578198|NCT01227824|8917263|P3|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0
2578199|NCT01227824|8917264|P2|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3
2578200|NCT01227824|8917265|P1|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6
2578201|NCT01227824|8917263|P3|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0
2578202|NCT01227824|8917264|P2|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16
2578203|NCT01227824|8917265|P1|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18
2578204|NCT01227824|8917263|P3|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0
2578205|NCT01227824|8917264|P2|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25
2578206|NCT01227824|8917265|P1|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22
2578207|NCT01227824|8917263|P3|Double-blind Phase: 96 Weeks Duration|Adverse Event|0
2578208|NCT01227824|8917264|P2|Double-blind Phase: 96 Weeks Duration|Adverse Event|7
2578209|NCT01227824|8917265|P1|Double-blind Phase: 96 Weeks Duration|Adverse Event|12
2578210|NCT01227707|8917360|P1|Overall Study|Death|1
2578211|NCT01227707|8917360|P1|Overall Study|Medical decision|6
2578212|NCT01227707|8917360|P1|Overall Study|Patient non-compliance|3
2578213|NCT01227707|8917360|P1|Overall Study|Withdrawal by Subject|1
2578214|NCT01227707|8917360|P1|Overall Study|Progression of disease|3
2578215|NCT01227707|8917360|P1|Overall Study|Adverse Event|10
2578216|NCT01227668|8917387|P2|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1
2578217|NCT01227668|8917388|P1|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0
2578218|NCT01227668|8917387|P2|Phase 2 (Randomization Phase)|Lack of Efficacy|23
2578219|NCT01227668|8917388|P1|Phase 2 (Randomization Phase)|Lack of Efficacy|13
2578220|NCT01227668|8917387|P2|Phase 2 (Randomization Phase)|Lost to Follow-up|0
2578221|NCT01227668|8917388|P1|Phase 2 (Randomization Phase)|Lost to Follow-up|1
2578222|NCT01227668|8917387|P2|Phase 2 (Randomization Phase)|Withdrawal by Subject|0
2578223|NCT01227668|8917388|P1|Phase 2 (Randomization Phase)|Withdrawal by Subject|5
2578224|NCT01227668|8917387|P2|Phase 2 (Randomization Phase)|Adverse Event|1
2578225|NCT01227668|8917388|P1|Phase 2 (Randomization Phase)|Adverse Event|0
2578226|NCT01227668|8917387|P2|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0
2578227|NCT01227668|8917388|P1|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2
2578228|NCT01227668|8917387|P2|Phase 1 (Stabilization Phase)|Lack of Efficacy|0
2578229|NCT01227668|8917388|P1|Phase 1 (Stabilization Phase)|Lack of Efficacy|25
2578230|NCT01227668|8917387|P2|Phase 1 (Stabilization Phase)|No longer meets study criteria|0
2578231|NCT01227668|8917388|P1|Phase 1 (Stabilization Phase)|No longer meets study criteria|7
2578232|NCT01227668|8917387|P2|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0
2578233|NCT01227668|8917388|P1|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11
2578234|NCT01227668|8917387|P2|Phase 1 (Stabilization Phase)|Lost to Follow-up|0
2578235|NCT01227668|8917388|P1|Phase 1 (Stabilization Phase)|Lost to Follow-up|8
2578236|NCT01227668|8917387|P2|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0
2578237|NCT01227668|8917388|P1|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7
2578238|NCT01227668|8917387|P2|Phase 1 (Stabilization Phase)|Adverse Event|0
2578239|NCT01227668|8917388|P1|Phase 1 (Stabilization Phase)|Adverse Event|12
2578240|NCT01227629|8917434|P10|Overall Study|Other|1
2578241|NCT01227629|8917435|P9|Overall Study|Other|2
2578242|NCT01227629|8917436|P8|Overall Study|Other|0
2578243|NCT01227629|8917437|P7|Overall Study|Other|0
2578244|NCT01227629|8917438|P6|Overall Study|Other|0
2578245|NCT01227629|8917439|P5|Overall Study|Other|0
2578246|NCT01227629|8917440|P4|Overall Study|Other|1
2578247|NCT01227629|8917441|P3|Overall Study|Other|0
2578248|NCT01227629|8917442|P2|Overall Study|Other|0
2578249|NCT01227629|8917443|P1|Overall Study|Other|0
2578250|NCT01227629|8917434|P10|Overall Study|Withdrawal by Subject|1
2578251|NCT01227629|8917435|P9|Overall Study|Withdrawal by Subject|0
2578252|NCT01227629|8917436|P8|Overall Study|Withdrawal by Subject|0
2578253|NCT01227629|8917437|P7|Overall Study|Withdrawal by Subject|2
2578254|NCT01227629|8917438|P6|Overall Study|Withdrawal by Subject|0
2578255|NCT01227629|8917439|P5|Overall Study|Withdrawal by Subject|0
2578256|NCT01227629|8917440|P4|Overall Study|Withdrawal by Subject|0
2578257|NCT01227629|8917441|P3|Overall Study|Withdrawal by Subject|0
2578258|NCT01227629|8917442|P2|Overall Study|Withdrawal by Subject|0
2578259|NCT01227629|8917443|P1|Overall Study|Withdrawal by Subject|0
2578260|NCT01227629|8917434|P10|Overall Study|Lost to Follow-up|0
2578261|NCT01227629|8917435|P9|Overall Study|Lost to Follow-up|0
2578262|NCT01227629|8917436|P8|Overall Study|Lost to Follow-up|0
2578263|NCT01227629|8917437|P7|Overall Study|Lost to Follow-up|0
2578264|NCT01227629|8917438|P6|Overall Study|Lost to Follow-up|0
2578265|NCT01227629|8917439|P5|Overall Study|Lost to Follow-up|1
2578266|NCT01227629|8917440|P4|Overall Study|Lost to Follow-up|0
2578267|NCT01227629|8917441|P3|Overall Study|Lost to Follow-up|0
2578268|NCT01227629|8917442|P2|Overall Study|Lost to Follow-up|0
2578269|NCT01227629|8917443|P1|Overall Study|Lost to Follow-up|0
2578270|NCT01227629|8917434|P10|Overall Study|Protocol Violation|0
2578271|NCT01227629|8917435|P9|Overall Study|Protocol Violation|0
2578272|NCT01227629|8917436|P8|Overall Study|Protocol Violation|0
2578273|NCT01227629|8917437|P7|Overall Study|Protocol Violation|0
2578274|NCT01227629|8917438|P6|Overall Study|Protocol Violation|0
2578275|NCT01227629|8917439|P5|Overall Study|Protocol Violation|0
2578276|NCT01227629|8917440|P4|Overall Study|Protocol Violation|1
2578277|NCT01227629|8917441|P3|Overall Study|Protocol Violation|0
2578278|NCT01227629|8917442|P2|Overall Study|Protocol Violation|0
2578279|NCT01227629|8917443|P1|Overall Study|Protocol Violation|0
2578280|NCT01227629|8917434|P10|Overall Study|Adverse Event|0
2578281|NCT01227629|8917435|P9|Overall Study|Adverse Event|4
2578282|NCT01227629|8917436|P8|Overall Study|Adverse Event|6
2578283|NCT01227629|8917437|P7|Overall Study|Adverse Event|6
2578284|NCT01227629|8917438|P6|Overall Study|Adverse Event|1
2578285|NCT01227629|8917439|P5|Overall Study|Adverse Event|1
2578286|NCT01227629|8917440|P4|Overall Study|Adverse Event|6
2578287|NCT01227629|8917441|P3|Overall Study|Adverse Event|1
2578288|NCT01227629|8917442|P2|Overall Study|Adverse Event|2
2578289|NCT01227629|8917443|P1|Overall Study|Adverse Event|2
2578290|NCT01227577|8917692|P1|Overall Study|Adverse Event|17
2578291|NCT01227577|8917692|P1|Overall Study|Lack of Efficacy|5
2578292|NCT01227577|8917692|P1|Overall Study|Withdrawal by Subject|4
2578293|NCT01227577|8917692|P1|Overall Study|Lost to Follow-up|1
2578294|NCT01227577|8917692|P1|Overall Study|Administrative problems|2
2578295|NCT01227577|8917692|P1|Overall Study|Death|3
2578296|NCT01227577|8917692|P1|Overall Study|Protocol deviation|3
2578297|NCT01227564|8917707|P3|Overall Study|Participant moved to another town|1
2578298|NCT01227564|8917708|P2|Overall Study|Participant moved to another town|0
2578299|NCT01227564|8917709|P1|Overall Study|Participant moved to another town|0
2578300|NCT01227564|8917707|P3|Overall Study|No Longer Willing to Participate|5
2578301|NCT01227564|8917708|P2|Overall Study|No Longer Willing to Participate|2
2578302|NCT01227564|8917709|P1|Overall Study|No Longer Willing to Participate|4
2578303|NCT01227512|8917847|P2|Overall Study|Participant met withdrawal criteria|1
2578304|NCT01227512|8917848|P1|Overall Study|Participant met withdrawal criteria|0
2578305|NCT01227512|8917847|P2|Overall Study|Withdrawal by Subject|0
2578306|NCT01227512|8917848|P1|Overall Study|Withdrawal by Subject|3
2578307|NCT01227512|8917847|P2|Overall Study|Adverse Event|3
2578308|NCT01227512|8917848|P1|Overall Study|Adverse Event|4
2578309|NCT01227512|8917847|P2|Overall Study|Physician Decision|6
2578310|NCT01227512|8917848|P1|Overall Study|Physician Decision|6
2578311|NCT01227421|8917882|P3|Overall Study|Randomized in error|0
2578312|NCT01227421|8917883|P2|Overall Study|Randomized in error|1
2578313|NCT01227421|8917884|P1|Overall Study|Randomized in error|1
2578314|NCT01227421|8917882|P3|Overall Study|Protocol Violation|2
2578315|NCT01227421|8917883|P2|Overall Study|Protocol Violation|1
2578316|NCT01227421|8917884|P1|Overall Study|Protocol Violation|1
2578317|NCT01227421|8917882|P3|Overall Study|Withdrawal by Subject|1
2578318|NCT01227421|8917883|P2|Overall Study|Withdrawal by Subject|2
2578319|NCT01227421|8917884|P1|Overall Study|Withdrawal by Subject|1
2578320|NCT01227421|8917882|P3|Overall Study|Adverse Event|2
2578321|NCT01227421|8917883|P2|Overall Study|Adverse Event|7
2578322|NCT01227421|8917884|P1|Overall Study|Adverse Event|2
2578323|NCT01227421|8917882|P3|Overall Study|Lost to Follow-up|5
2578324|NCT01227421|8917883|P2|Overall Study|Lost to Follow-up|7
2578325|NCT01227421|8917884|P1|Overall Study|Lost to Follow-up|6
2578326|NCT01227395|8917936|P2|Overall Study|Protocol Violation|1
2578327|NCT01227395|8917937|P1|Overall Study|Protocol Violation|0
2578328|NCT01227278|8917977|P2|Overall Study|Other|2
2578329|NCT01227278|8917978|P1|Overall Study|Other|1
2578330|NCT01227278|8917977|P2|Overall Study|Death|2
2578331|NCT01227278|8917978|P1|Overall Study|Death|0
2578332|NCT01227278|8917977|P2|Overall Study|Withdrawal by Subject|4
2578333|NCT01227278|8917978|P1|Overall Study|Withdrawal by Subject|4
2578334|NCT01227265|8918005|P3|Overall Study|Adverse Event|5
2578335|NCT01227265|8918006|P2|Overall Study|Adverse Event|10
2578336|NCT01227265|8918007|P1|Overall Study|Adverse Event|6
2578337|NCT01227265|8918005|P3|Overall Study|Lost to Follow-up|3
2578338|NCT01227265|8918006|P2|Overall Study|Lost to Follow-up|0
2578339|NCT01227265|8918007|P1|Overall Study|Lost to Follow-up|2
2578340|NCT01227265|8918005|P3|Overall Study|Withdrawal by Subject|3
2578341|NCT01227265|8918006|P2|Overall Study|Withdrawal by Subject|7
2578342|NCT01227265|8918007|P1|Overall Study|Withdrawal by Subject|7
2578343|NCT01227265|8918005|P3|Overall Study|Protocol Violation|0
2578344|NCT01227265|8918006|P2|Overall Study|Protocol Violation|1
2578345|NCT01227265|8918007|P1|Overall Study|Protocol Violation|2
2578346|NCT01227265|8918005|P3|Overall Study|Did Not Meet Protocol Eligibility|1
2578347|NCT01227265|8918006|P2|Overall Study|Did Not Meet Protocol Eligibility|0
2578348|NCT01227265|8918007|P1|Overall Study|Did Not Meet Protocol Eligibility|0
2578349|NCT01227265|8918005|P3|Overall Study|Administrative|2
2578350|NCT01227265|8918006|P2|Overall Study|Administrative|0
2578351|NCT01227265|8918007|P1|Overall Study|Administrative|1
2578352|NCT01227265|8918005|P3|Overall Study|Did Not Receive Treatment|0
2578353|NCT01227265|8918006|P2|Overall Study|Did Not Receive Treatment|2
2578354|NCT01227265|8918007|P1|Overall Study|Did Not Receive Treatment|1
2578355|NCT01227252|8918037|P4|Overall Study|Withdrawal by Subject|0
2578356|NCT01227252|8918038|P3|Overall Study|Withdrawal by Subject|0
2578357|NCT01227252|8918039|P2|Overall Study|Withdrawal by Subject|1
2578358|NCT01227252|8918040|P1|Overall Study|Withdrawal by Subject|0
2578359|NCT01227252|8918037|P4|Overall Study|Lost to Follow-up|0
2578360|NCT01227252|8918038|P3|Overall Study|Lost to Follow-up|0
2578361|NCT01227252|8918039|P2|Overall Study|Lost to Follow-up|1
2578362|NCT01227252|8918040|P1|Overall Study|Lost to Follow-up|0
2578363|NCT01227252|8918037|P4|Overall Study|Sponsor Decision|0
2578364|NCT01227252|8918038|P3|Overall Study|Sponsor Decision|0
2578365|NCT01227252|8918039|P2|Overall Study|Sponsor Decision|1
2578366|NCT01227252|8918040|P1|Overall Study|Sponsor Decision|0
2578367|NCT01227044|8918082|P2|Overall Study|Discontinued Intervention|2
2578368|NCT01227044|8918083|P1|Overall Study|Discontinued Intervention|1
2578369|NCT01227044|8918082|P2|Overall Study|Lost to Follow-up|7
2578370|NCT01227044|8918083|P1|Overall Study|Lost to Follow-up|5
2578371|NCT01227018|8918091|P1|Overall Study|Withdrew after beginning treatment|4
2578372|NCT01227018|8918091|P1|Overall Study|Toxicity|2
2578373|NCT01227018|8918091|P1|Overall Study|Disease progression|9
2578374|NCT01226745|8918127|P6|Overall Study|Other|1
2578375|NCT01226745|8918128|P5|Overall Study|Other|3
2578376|NCT01226745|8918129|P4|Overall Study|Other|4
2578377|NCT01226745|8918130|P3|Overall Study|Other|8
2578378|NCT01226745|8918131|P2|Overall Study|Other|7
2578379|NCT01226745|8918132|P1|Overall Study|Other|6
2578380|NCT01226745|8918127|P6|Overall Study|Death|1
2578381|NCT01226745|8918128|P5|Overall Study|Death|0
2578382|NCT01226745|8918129|P4|Overall Study|Death|0
2578383|NCT01226745|8918130|P3|Overall Study|Death|0
2578384|NCT01226745|8918131|P2|Overall Study|Death|0
2578385|NCT01226745|8918132|P1|Overall Study|Death|1
2578386|NCT01226745|8918127|P6|Overall Study|Lost to Follow-up|2
2578387|NCT01226745|8918128|P5|Overall Study|Lost to Follow-up|1
2578388|NCT01226745|8918129|P4|Overall Study|Lost to Follow-up|1
2578389|NCT01226745|8918130|P3|Overall Study|Lost to Follow-up|6
2578390|NCT01226745|8918131|P2|Overall Study|Lost to Follow-up|6
2578391|NCT01226745|8918132|P1|Overall Study|Lost to Follow-up|2
2578392|NCT01226745|8918127|P6|Overall Study|Did not complete schedule of assessments|1
2578393|NCT01226745|8918128|P5|Overall Study|Did not complete schedule of assessments|0
2578394|NCT01226745|8918129|P4|Overall Study|Did not complete schedule of assessments|0
2578395|NCT01226745|8918130|P3|Overall Study|Did not complete schedule of assessments|6
2578396|NCT01226745|8918131|P2|Overall Study|Did not complete schedule of assessments|3
2578397|NCT01226745|8918132|P1|Overall Study|Did not complete schedule of assessments|8
2578398|NCT01226511|8918328|P2|Taper Period|Parent/Caregiver Decision|1
2578399|NCT01226511|8918329|P1|Taper Period|Parent/Caregiver Decision|1
2578400|NCT01226511|8918328|P2|Taper Period|Protocol Violation|0
2578401|NCT01226511|8918329|P1|Taper Period|Protocol Violation|1
2578402|NCT01226511|8918328|P2|Taper Period|Lost to Follow-up|2
2578403|NCT01226511|8918329|P1|Taper Period|Lost to Follow-up|2
2578404|NCT01226511|8918328|P2|Taper Period|Adverse Event|0
2578405|NCT01226511|8918329|P1|Taper Period|Adverse Event|1
2578406|NCT01226511|8918328|P2|Extension Treatment Period|Sponsor Decision|1
2578407|NCT01226511|8918329|P1|Extension Treatment Period|Sponsor Decision|1
2578408|NCT01226511|8918328|P2|Extension Treatment Period|Parent/Caregiver Decision|8
2578409|NCT01226511|8918329|P1|Extension Treatment Period|Parent/Caregiver Decision|8
2578410|NCT01226511|8918328|P2|Extension Treatment Period|Withdrawal by Subject|3
2578411|NCT01226511|8918329|P1|Extension Treatment Period|Withdrawal by Subject|1
2578412|NCT01226511|8918328|P2|Extension Treatment Period|Protocol Violation|2
2578413|NCT01226511|8918329|P1|Extension Treatment Period|Protocol Violation|2
2578414|NCT01226511|8918328|P2|Extension Treatment Period|Lost to Follow-up|3
2578415|NCT01226511|8918329|P1|Extension Treatment Period|Lost to Follow-up|4
2578416|NCT01226511|8918328|P2|Extension Treatment Period|Lack of Efficacy|2
2578417|NCT01226511|8918329|P1|Extension Treatment Period|Lack of Efficacy|3
2578418|NCT01226511|8918328|P2|Extension Treatment Period|Adverse Event|8
2578419|NCT01226511|8918329|P1|Extension Treatment Period|Adverse Event|8
2578420|NCT01226511|8918328|P2|Acute Treatment Period|Withdrawal by Subject|6
2578421|NCT01226511|8918329|P1|Acute Treatment Period|Withdrawal by Subject|10
2578422|NCT01226511|8918328|P2|Acute Treatment Period|Protocol Violation|5
2578423|NCT01226511|8918329|P1|Acute Treatment Period|Protocol Violation|5
2578424|NCT01226511|8918328|P2|Acute Treatment Period|Parent/caregiver decision|7
2578425|NCT01226511|8918329|P1|Acute Treatment Period|Parent/caregiver decision|5
2578426|NCT01226511|8918328|P2|Acute Treatment Period|Lost to Follow-up|6
2578427|NCT01226511|8918329|P1|Acute Treatment Period|Lost to Follow-up|3
2578428|NCT01226511|8918328|P2|Acute Treatment Period|Lack of Efficacy|1
2578429|NCT01226511|8918329|P1|Acute Treatment Period|Lack of Efficacy|2
2578430|NCT01226511|8918328|P2|Acute Treatment Period|Adverse Event|6
2578431|NCT01226511|8918329|P1|Acute Treatment Period|Adverse Event|7
2578432|NCT01226459|8918429|P2|Overall Study|Pregnancy|0
2578433|NCT01226459|8918430|P1|Overall Study|Pregnancy|1
2578434|NCT01226459|8918429|P2|Overall Study|Lost to Follow-up|8
2578435|NCT01226459|8918430|P1|Overall Study|Lost to Follow-up|4
2578436|NCT01226459|8918429|P2|Overall Study|Withdrawal by Subject|13
2578437|NCT01226459|8918430|P1|Overall Study|Withdrawal by Subject|10
2578438|NCT01226459|8918429|P2|Overall Study|Protocol Violation|3
2578439|NCT01226459|8918430|P1|Overall Study|Protocol Violation|4
2578440|NCT01226459|8918429|P2|Overall Study|Adverse Event|8
2578441|NCT01226459|8918430|P1|Overall Study|Adverse Event|2
2578442|NCT01226121|8918448|P3|Overall Study|Lost to Follow-up|1
2578443|NCT01226121|8918449|P2|Overall Study|Lost to Follow-up|0
2578444|NCT01226121|8918450|P1|Overall Study|Lost to Follow-up|2
2578445|NCT01226095|8918461|P1|Overall Study|Poor compliance|1
2578446|NCT01226043|8918486|P4|30-week Observational Phase|Physician Decision|2
2578447|NCT01226043|8918487|P3|30-week Observational Phase|Physician Decision|2
2578448|NCT01226043|8918488|P2|30-week Observational Phase|Physician Decision|0
2578449|NCT01226043|8918489|P1|30-week Observational Phase|Physician Decision|0
2578450|NCT01226043|8918486|P4|30-week Observational Phase|Withdrawal by Subject|7
2578451|NCT01226043|8918487|P3|30-week Observational Phase|Withdrawal by Subject|1
2578452|NCT01226043|8918488|P2|30-week Observational Phase|Withdrawal by Subject|0
2578453|NCT01226043|8918489|P1|30-week Observational Phase|Withdrawal by Subject|0
2578454|NCT01226043|8918486|P4|30-week Observational Phase|Lost to Follow-up|2
2578455|NCT01226043|8918487|P3|30-week Observational Phase|Lost to Follow-up|2
2578456|NCT01226043|8918488|P2|30-week Observational Phase|Lost to Follow-up|0
2578457|NCT01226043|8918489|P1|30-week Observational Phase|Lost to Follow-up|0
2578458|NCT01226043|8918486|P4|30-week Observational Phase|Protocol Violation|1
2578459|NCT01226043|8918487|P3|30-week Observational Phase|Protocol Violation|0
2578460|NCT01226043|8918488|P2|30-week Observational Phase|Protocol Violation|0
2578461|NCT01226043|8918489|P1|30-week Observational Phase|Protocol Violation|0
2578462|NCT01226043|8918486|P4|30-week Observational Phase|Adverse Event|1
2578463|NCT01226043|8918487|P3|30-week Observational Phase|Adverse Event|1
2578464|NCT01226043|8918488|P2|30-week Observational Phase|Adverse Event|0
2578465|NCT01226043|8918489|P1|30-week Observational Phase|Adverse Event|0
2578466|NCT01226043|8918486|P4|6-week Re-randomization Phase|completed in error|1
2578467|NCT01226043|8918487|P3|6-week Re-randomization Phase|completed in error|0
2578468|NCT01226043|8918488|P2|6-week Re-randomization Phase|completed in error|0
2578469|NCT01226043|8918489|P1|6-week Re-randomization Phase|completed in error|0
2578470|NCT01226043|8918486|P4|6-week Re-randomization Phase|Physician Decision|2
2578471|NCT01226043|8918487|P3|6-week Re-randomization Phase|Physician Decision|3
2578472|NCT01226043|8918488|P2|6-week Re-randomization Phase|Physician Decision|0
2578473|NCT01226043|8918489|P1|6-week Re-randomization Phase|Physician Decision|0
2578474|NCT01226043|8918486|P4|6-week Re-randomization Phase|Withdrawal by Subject|3
2578475|NCT01226043|8918487|P3|6-week Re-randomization Phase|Withdrawal by Subject|1
2578476|NCT01226043|8918488|P2|6-week Re-randomization Phase|Withdrawal by Subject|0
2578477|NCT01226043|8918489|P1|6-week Re-randomization Phase|Withdrawal by Subject|0
2578478|NCT01226043|8918486|P4|6-week Re-randomization Phase|Lost to Follow-up|3
2578479|NCT01226043|8918487|P3|6-week Re-randomization Phase|Lost to Follow-up|1
2578480|NCT01226043|8918488|P2|6-week Re-randomization Phase|Lost to Follow-up|0
2578481|NCT01226043|8918489|P1|6-week Re-randomization Phase|Lost to Follow-up|0
2578482|NCT01226043|8918486|P4|6-week Re-randomization Phase|Protocol Violation|1
2578483|NCT01226043|8918487|P3|6-week Re-randomization Phase|Protocol Violation|1
2578484|NCT01226043|8918488|P2|6-week Re-randomization Phase|Protocol Violation|0
2578485|NCT01226043|8918489|P1|6-week Re-randomization Phase|Protocol Violation|0
2578486|NCT01226043|8918486|P4|6-week Re-randomization Phase|Adverse Event|1
2578487|NCT01226043|8918487|P3|6-week Re-randomization Phase|Adverse Event|1
2578488|NCT01226043|8918488|P2|6-week Re-randomization Phase|Adverse Event|0
2578489|NCT01226043|8918489|P1|6-week Re-randomization Phase|Adverse Event|0
2578490|NCT01226043|8918486|P4|4-week Crossover Phase - Period 2|Physician Decision|0
2578491|NCT01226043|8918487|P3|4-week Crossover Phase - Period 2|Physician Decision|0
2578492|NCT01226043|8918488|P2|4-week Crossover Phase - Period 2|Physician Decision|5
2578493|NCT01226043|8918489|P1|4-week Crossover Phase - Period 2|Physician Decision|4
2578494|NCT01226043|8918486|P4|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
2578495|NCT01226043|8918487|P3|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
2578496|NCT01226043|8918488|P2|4-week Crossover Phase - Period 2|Withdrawal by Subject|1
2578497|NCT01226043|8918489|P1|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
2578498|NCT01226043|8918486|P4|4-week Crossover Phase - Period 1|Physician Decision|0
2578499|NCT01226043|8918487|P3|4-week Crossover Phase - Period 1|Physician Decision|0
2578500|NCT01226043|8918488|P2|4-week Crossover Phase - Period 1|Physician Decision|6
2578501|NCT01226043|8918489|P1|4-week Crossover Phase - Period 1|Physician Decision|0
2578502|NCT01226043|8918486|P4|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
2578503|NCT01226043|8918487|P3|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
2578504|NCT01226043|8918488|P2|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
2578505|NCT01226043|8918489|P1|4-week Crossover Phase - Period 1|Withdrawal by Subject|2
2578506|NCT01226043|8918486|P4|4-week Crossover Phase - Period 1|Lost to Follow-up|0
2578507|NCT01226043|8918487|P3|4-week Crossover Phase - Period 1|Lost to Follow-up|0
2578508|NCT01226043|8918488|P2|4-week Crossover Phase - Period 1|Lost to Follow-up|1
2578509|NCT01226043|8918489|P1|4-week Crossover Phase - Period 1|Lost to Follow-up|0
2578510|NCT01226043|8918486|P4|4-week Crossover Phase - Period 1|Protocol Violation|0
2578511|NCT01226043|8918487|P3|4-week Crossover Phase - Period 1|Protocol Violation|0
2578512|NCT01226043|8918488|P2|4-week Crossover Phase - Period 1|Protocol Violation|2
2578513|NCT01226043|8918489|P1|4-week Crossover Phase - Period 1|Protocol Violation|1
2578514|NCT01225991|8918527|P1|Overall Study|Withdrawal by Subject|6
2578515|NCT01225952|8918538|P3|Overall Study|Surgical complications|0
2578516|NCT01225952|8918539|P2|Overall Study|Surgical complications|0
2578517|NCT01225952|8918540|P1|Overall Study|Surgical complications|1
2578518|NCT01225952|8918538|P3|Overall Study|Withdrawal by Subject|5
2578519|NCT01225952|8918539|P2|Overall Study|Withdrawal by Subject|4
2578520|NCT01225952|8918540|P1|Overall Study|Withdrawal by Subject|4
2578521|NCT01225952|8918538|P3|Overall Study|Study Eye Explanted|1
2578522|NCT01225952|8918539|P2|Overall Study|Study Eye Explanted|0
2578523|NCT01225952|8918540|P1|Overall Study|Study Eye Explanted|0
2578524|NCT01225952|8918538|P3|Overall Study|Lost to Follow-up|0
2578525|NCT01225952|8918539|P2|Overall Study|Lost to Follow-up|0
2578526|NCT01225952|8918540|P1|Overall Study|Lost to Follow-up|1
2578527|NCT01225887|8918632|P1|Overall Study|Ineligible:inadequate pathology|2
2578528|NCT01225887|8918632|P1|Overall Study|Ineligible;improper pre-protocol therapy|1
2578529|NCT01225887|8918632|P1|Overall Study|Ineligible:required test not done|2
2578530|NCT01225835|8918642|P2|Overall Study|Other|1
2578531|NCT01225835|8918643|P1|Overall Study|Other|1
2578532|NCT01225835|8918642|P2|Overall Study|Adverse Event|1
2578533|NCT01225835|8918643|P1|Overall Study|Adverse Event|2
2578534|NCT01225835|8918642|P2|Overall Study|Did not meet hCG criterion|0
2578535|NCT01225835|8918643|P1|Overall Study|Did not meet hCG criterion|2
2578536|NCT01225835|8918642|P2|Overall Study|Completed protocol|1
2578537|NCT01225835|8918643|P1|Overall Study|Completed protocol|2
2578538|NCT01225822|8918691|P5|Overall Study|Other|7
2578539|NCT01225822|8918692|P4|Overall Study|Other|10
2578540|NCT01225822|8918693|P3|Overall Study|Other|7
2578541|NCT01225822|8918694|P2|Overall Study|Other|10
2578542|NCT01225822|8918695|P1|Overall Study|Other|13
2578543|NCT01225822|8918691|P5|Overall Study|Withdrawal by Subject|6
2578544|NCT01225822|8918692|P4|Overall Study|Withdrawal by Subject|11
2578545|NCT01225822|8918693|P3|Overall Study|Withdrawal by Subject|7
2578546|NCT01225822|8918694|P2|Overall Study|Withdrawal by Subject|7
2578547|NCT01225822|8918695|P1|Overall Study|Withdrawal by Subject|6
2578548|NCT01225822|8918691|P5|Overall Study|Lost to Follow-up|0
2578549|NCT01225822|8918692|P4|Overall Study|Lost to Follow-up|1
2578550|NCT01225822|8918693|P3|Overall Study|Lost to Follow-up|0
2578551|NCT01225822|8918694|P2|Overall Study|Lost to Follow-up|0
2578552|NCT01225822|8918695|P1|Overall Study|Lost to Follow-up|0
2578553|NCT01225822|8918691|P5|Overall Study|Protocol Violation|4
2578554|NCT01225822|8918692|P4|Overall Study|Protocol Violation|7
2578555|NCT01225822|8918693|P3|Overall Study|Protocol Violation|6
2578556|NCT01225822|8918694|P2|Overall Study|Protocol Violation|8
2578557|NCT01225822|8918695|P1|Overall Study|Protocol Violation|6
2578558|NCT01225822|8918691|P5|Overall Study|Adverse Event|14
2578559|NCT01225822|8918692|P4|Overall Study|Adverse Event|23
2578560|NCT01225822|8918693|P3|Overall Study|Adverse Event|18
2578561|NCT01225822|8918694|P2|Overall Study|Adverse Event|31
2578562|NCT01225822|8918695|P1|Overall Study|Adverse Event|13
2578563|NCT01225731|8918762|P13|Part 3|Withdrawal by Subject|4
2578564|NCT01225731|8918763|P12|Part 3|Withdrawal by Subject|6
2578565|NCT01225731|8918764|P11|Part 3|Withdrawal by Subject|4
2578566|NCT01225731|8918765|P10|Part 3|Withdrawal by Subject|0
2578567|NCT01225731|8918766|P9|Part 3|Withdrawal by Subject|0
2578568|NCT01225731|8918767|P8|Part 3|Withdrawal by Subject|0
2578569|NCT01225731|8918768|P7|Part 3|Withdrawal by Subject|0
2578570|NCT01225731|8918769|P6|Part 3|Withdrawal by Subject|0
2578571|NCT01225731|8918770|P5|Part 3|Withdrawal by Subject|0
2578572|NCT01225731|8918771|P4|Part 3|Withdrawal by Subject|0
2578573|NCT01225731|8918772|P3|Part 3|Withdrawal by Subject|0
2578574|NCT01225731|8918773|P2|Part 3|Withdrawal by Subject|0
2578575|NCT01225731|8918774|P1|Part 3|Withdrawal by Subject|0
2578576|NCT01225731|8918762|P13|Part 3|Physician Decision|2
2578577|NCT01225731|8918763|P12|Part 3|Physician Decision|1
2578578|NCT01225731|8918764|P11|Part 3|Physician Decision|0
2578579|NCT01225731|8918765|P10|Part 3|Physician Decision|0
2578580|NCT01225731|8918766|P9|Part 3|Physician Decision|0
2578581|NCT01225731|8918767|P8|Part 3|Physician Decision|0
2578582|NCT01225731|8918768|P7|Part 3|Physician Decision|0
2578583|NCT01225731|8918769|P6|Part 3|Physician Decision|0
2578584|NCT01225731|8918770|P5|Part 3|Physician Decision|0
2578585|NCT01225731|8918771|P4|Part 3|Physician Decision|0
2578586|NCT01225731|8918772|P3|Part 3|Physician Decision|0
2578587|NCT01225731|8918773|P2|Part 3|Physician Decision|0
2578588|NCT01225731|8918774|P1|Part 3|Physician Decision|0
2578589|NCT01225731|8918762|P13|Part 3|Lost to Follow-up|1
2578590|NCT01225731|8918763|P12|Part 3|Lost to Follow-up|2
2578591|NCT01225731|8918764|P11|Part 3|Lost to Follow-up|1
2578592|NCT01225731|8918765|P10|Part 3|Lost to Follow-up|0
2578593|NCT01225731|8918766|P9|Part 3|Lost to Follow-up|0
2578594|NCT01225731|8918767|P8|Part 3|Lost to Follow-up|0
2578595|NCT01225731|8918768|P7|Part 3|Lost to Follow-up|0
2578596|NCT01225731|8918769|P6|Part 3|Lost to Follow-up|0
2578597|NCT01225731|8918770|P5|Part 3|Lost to Follow-up|0
2578598|NCT01225731|8918771|P4|Part 3|Lost to Follow-up|0
2578599|NCT01225731|8918772|P3|Part 3|Lost to Follow-up|0
2578600|NCT01225731|8918773|P2|Part 3|Lost to Follow-up|0
2578601|NCT01225731|8918774|P1|Part 3|Lost to Follow-up|0
2578602|NCT01225731|8918762|P13|Part 3|Adverse Event|0
2578603|NCT01225731|8918763|P12|Part 3|Adverse Event|1
2578604|NCT01225731|8918764|P11|Part 3|Adverse Event|1
2578605|NCT01225731|8918765|P10|Part 3|Adverse Event|0
2578606|NCT01225731|8918766|P9|Part 3|Adverse Event|0
2578607|NCT01225731|8918767|P8|Part 3|Adverse Event|0
2578608|NCT01225731|8918768|P7|Part 3|Adverse Event|0
2578609|NCT01225731|8918769|P6|Part 3|Adverse Event|0
2578610|NCT01225731|8918770|P5|Part 3|Adverse Event|0
2578611|NCT01225731|8918771|P4|Part 3|Adverse Event|0
2578612|NCT01225731|8918772|P3|Part 3|Adverse Event|0
2578613|NCT01225731|8918773|P2|Part 3|Adverse Event|0
2578614|NCT01225731|8918774|P1|Part 3|Adverse Event|0
2578615|NCT01225731|8918762|P13|Part 2|Withdrawal by Subject|0
2578616|NCT01225731|8918763|P12|Part 2|Withdrawal by Subject|0
2578617|NCT01225731|8918764|P11|Part 2|Withdrawal by Subject|0
2578618|NCT01225731|8918765|P10|Part 2|Withdrawal by Subject|0
2578619|NCT01225731|8918766|P9|Part 2|Withdrawal by Subject|1
2578620|NCT01225731|8918767|P8|Part 2|Withdrawal by Subject|4
2578621|NCT01225731|8918768|P7|Part 2|Withdrawal by Subject|3
2578622|NCT01225731|8918769|P6|Part 2|Withdrawal by Subject|1
2578623|NCT01225731|8918770|P5|Part 2|Withdrawal by Subject|0
2578624|NCT01225731|8918771|P4|Part 2|Withdrawal by Subject|0
2578625|NCT01225731|8918772|P3|Part 2|Withdrawal by Subject|0
2578626|NCT01225731|8918773|P2|Part 2|Withdrawal by Subject|0
2578627|NCT01225731|8918774|P1|Part 2|Withdrawal by Subject|0
2578628|NCT01225731|8918762|P13|Part 2|Physician Decision|0
2578629|NCT01225731|8918763|P12|Part 2|Physician Decision|0
2578630|NCT01225731|8918764|P11|Part 2|Physician Decision|0
2578631|NCT01225731|8918765|P10|Part 2|Physician Decision|0
2578632|NCT01225731|8918766|P9|Part 2|Physician Decision|2
2578633|NCT01225731|8918767|P8|Part 2|Physician Decision|2
2578634|NCT01225731|8918768|P7|Part 2|Physician Decision|0
2578635|NCT01225731|8918769|P6|Part 2|Physician Decision|0
2578636|NCT01225731|8918770|P5|Part 2|Physician Decision|0
2578637|NCT01225731|8918771|P4|Part 2|Physician Decision|0
2578638|NCT01225731|8918772|P3|Part 2|Physician Decision|0
2578639|NCT01225731|8918773|P2|Part 2|Physician Decision|0
2578640|NCT01225731|8918774|P1|Part 2|Physician Decision|0
2578641|NCT01225731|8918762|P13|Part 2|Lost to Follow-up|0
2578642|NCT01225731|8918763|P12|Part 2|Lost to Follow-up|0
2578643|NCT01225731|8918764|P11|Part 2|Lost to Follow-up|0
2578644|NCT01225731|8918765|P10|Part 2|Lost to Follow-up|0
2578645|NCT01225731|8918766|P9|Part 2|Lost to Follow-up|1
2578646|NCT01225731|8918767|P8|Part 2|Lost to Follow-up|3
2578647|NCT01225731|8918768|P7|Part 2|Lost to Follow-up|0
2578648|NCT01225731|8918769|P6|Part 2|Lost to Follow-up|0
2578649|NCT01225731|8918770|P5|Part 2|Lost to Follow-up|0
2578650|NCT01225731|8918771|P4|Part 2|Lost to Follow-up|0
2578651|NCT01225731|8918772|P3|Part 2|Lost to Follow-up|0
2578652|NCT01225731|8918773|P2|Part 2|Lost to Follow-up|0
2578653|NCT01225731|8918774|P1|Part 2|Lost to Follow-up|0
2578654|NCT01225731|8918762|P13|Part 2|Pregnancy|0
2578655|NCT01225731|8918763|P12|Part 2|Pregnancy|0
2578656|NCT01225731|8918764|P11|Part 2|Pregnancy|0
2578657|NCT01225731|8918765|P10|Part 2|Pregnancy|0
2578658|NCT01225731|8918766|P9|Part 2|Pregnancy|1
2578659|NCT01225731|8918767|P8|Part 2|Pregnancy|0
2578660|NCT01225731|8918768|P7|Part 2|Pregnancy|1
2578661|NCT01225731|8918769|P6|Part 2|Pregnancy|0
2578662|NCT01225731|8918770|P5|Part 2|Pregnancy|0
2578663|NCT01225731|8918771|P4|Part 2|Pregnancy|0
2578664|NCT01225731|8918772|P3|Part 2|Pregnancy|0
2578665|NCT01225731|8918773|P2|Part 2|Pregnancy|0
2578666|NCT01225731|8918774|P1|Part 2|Pregnancy|0
2578667|NCT01225731|8918762|P13|Part 2|Lack of Efficacy|0
2578668|NCT01225731|8918763|P12|Part 2|Lack of Efficacy|0
2578669|NCT01225731|8918764|P11|Part 2|Lack of Efficacy|0
2578670|NCT01225731|8918765|P10|Part 2|Lack of Efficacy|0
2578671|NCT01225731|8918766|P9|Part 2|Lack of Efficacy|3
2578672|NCT01225731|8918767|P8|Part 2|Lack of Efficacy|12
2578673|NCT01225731|8918768|P7|Part 2|Lack of Efficacy|0
2578674|NCT01225731|8918769|P6|Part 2|Lack of Efficacy|1
2578675|NCT01225731|8918770|P5|Part 2|Lack of Efficacy|0
2578676|NCT01225731|8918771|P4|Part 2|Lack of Efficacy|0
2578677|NCT01225731|8918772|P3|Part 2|Lack of Efficacy|0
2578678|NCT01225731|8918773|P2|Part 2|Lack of Efficacy|0
2578679|NCT01225731|8918774|P1|Part 2|Lack of Efficacy|0
2578680|NCT01225731|8918762|P13|Part 2|Adverse Event|0
2578681|NCT01225731|8918763|P12|Part 2|Adverse Event|0
2578682|NCT01225731|8918764|P11|Part 2|Adverse Event|0
2578683|NCT01225731|8918765|P10|Part 2|Adverse Event|0
2578684|NCT01225731|8918766|P9|Part 2|Adverse Event|2
2578685|NCT01225731|8918767|P8|Part 2|Adverse Event|4
2578686|NCT01225731|8918768|P7|Part 2|Adverse Event|4
2578687|NCT01225731|8918769|P6|Part 2|Adverse Event|0
2578688|NCT01225731|8918770|P5|Part 2|Adverse Event|0
2578689|NCT01225731|8918771|P4|Part 2|Adverse Event|0
2578690|NCT01225731|8918772|P3|Part 2|Adverse Event|0
2578691|NCT01225731|8918773|P2|Part 2|Adverse Event|0
2578692|NCT01225731|8918774|P1|Part 2|Adverse Event|0
2578693|NCT01225731|8918762|P13|Part 2|Protocol Violation|0
2578694|NCT01225731|8918763|P12|Part 2|Protocol Violation|0
2578695|NCT01225731|8918764|P11|Part 2|Protocol Violation|0
2578696|NCT01225731|8918765|P10|Part 2|Protocol Violation|0
2578697|NCT01225731|8918766|P9|Part 2|Protocol Violation|1
2578698|NCT01225731|8918767|P8|Part 2|Protocol Violation|0
2578699|NCT01225731|8918768|P7|Part 2|Protocol Violation|0
2578700|NCT01225731|8918769|P6|Part 2|Protocol Violation|1
2578701|NCT01225731|8918770|P5|Part 2|Protocol Violation|0
2578702|NCT01225731|8918771|P4|Part 2|Protocol Violation|0
2578703|NCT01225731|8918772|P3|Part 2|Protocol Violation|0
2578704|NCT01225731|8918773|P2|Part 2|Protocol Violation|0
2578705|NCT01225731|8918774|P1|Part 2|Protocol Violation|0
2578706|NCT01225731|8918762|P13|Part 1|Protocol Violation|0
2578707|NCT01225731|8918763|P12|Part 1|Protocol Violation|0
2578708|NCT01225731|8918764|P11|Part 1|Protocol Violation|0
2578709|NCT01225731|8918765|P10|Part 1|Protocol Violation|0
2578710|NCT01225731|8918766|P9|Part 1|Protocol Violation|0
2578711|NCT01225731|8918767|P8|Part 1|Protocol Violation|0
2578712|NCT01225731|8918768|P7|Part 1|Protocol Violation|0
2578713|NCT01225731|8918769|P6|Part 1|Protocol Violation|0
2578714|NCT01225731|8918770|P5|Part 1|Protocol Violation|0
2578715|NCT01225731|8918771|P4|Part 1|Protocol Violation|1
2578716|NCT01225731|8918772|P3|Part 1|Protocol Violation|0
2578717|NCT01225731|8918773|P2|Part 1|Protocol Violation|0
2578718|NCT01225731|8918774|P1|Part 1|Protocol Violation|0
2578719|NCT01225731|8918762|P13|Part 1|Withdrawal by Subject|0
2578720|NCT01225731|8918763|P12|Part 1|Withdrawal by Subject|0
2578721|NCT01225731|8918764|P11|Part 1|Withdrawal by Subject|0
2578722|NCT01225731|8918765|P10|Part 1|Withdrawal by Subject|0
2578723|NCT01225731|8918766|P9|Part 1|Withdrawal by Subject|0
2578724|NCT01225731|8918767|P8|Part 1|Withdrawal by Subject|0
2578725|NCT01225731|8918768|P7|Part 1|Withdrawal by Subject|0
2578726|NCT01225731|8918769|P6|Part 1|Withdrawal by Subject|0
2578727|NCT01225731|8918770|P5|Part 1|Withdrawal by Subject|4
2578728|NCT01225731|8918771|P4|Part 1|Withdrawal by Subject|0
2578729|NCT01225731|8918772|P3|Part 1|Withdrawal by Subject|0
2578730|NCT01225731|8918773|P2|Part 1|Withdrawal by Subject|3
2578731|NCT01225731|8918774|P1|Part 1|Withdrawal by Subject|0
2578732|NCT01225731|8918762|P13|Part 1|Adverse Event|0
2578733|NCT01225731|8918763|P12|Part 1|Adverse Event|0
2578734|NCT01225731|8918764|P11|Part 1|Adverse Event|0
2578735|NCT01225731|8918765|P10|Part 1|Adverse Event|0
2578736|NCT01225731|8918766|P9|Part 1|Adverse Event|0
2578737|NCT01225731|8918767|P8|Part 1|Adverse Event|0
2578738|NCT01225731|8918768|P7|Part 1|Adverse Event|0
2578739|NCT01225731|8918769|P6|Part 1|Adverse Event|0
2578740|NCT01225731|8918770|P5|Part 1|Adverse Event|1
2578741|NCT01225731|8918771|P4|Part 1|Adverse Event|1
2578742|NCT01225731|8918772|P3|Part 1|Adverse Event|1
2578743|NCT01225731|8918773|P2|Part 1|Adverse Event|2
2578744|NCT01225731|8918774|P1|Part 1|Adverse Event|1
2578745|NCT01225731|8918762|P13|Part 1|Did not meet eligibility criteria|0
2578746|NCT01225731|8918763|P12|Part 1|Did not meet eligibility criteria|0
2578747|NCT01225731|8918764|P11|Part 1|Did not meet eligibility criteria|0
2578748|NCT01225731|8918765|P10|Part 1|Did not meet eligibility criteria|0
2578749|NCT01225731|8918766|P9|Part 1|Did not meet eligibility criteria|0
2578750|NCT01225731|8918767|P8|Part 1|Did not meet eligibility criteria|0
2578751|NCT01225731|8918768|P7|Part 1|Did not meet eligibility criteria|0
2578752|NCT01225731|8918769|P6|Part 1|Did not meet eligibility criteria|0
2578753|NCT01225731|8918770|P5|Part 1|Did not meet eligibility criteria|1
2578754|NCT01225731|8918771|P4|Part 1|Did not meet eligibility criteria|0
2578755|NCT01225731|8918772|P3|Part 1|Did not meet eligibility criteria|0
2578756|NCT01225731|8918773|P2|Part 1|Did not meet eligibility criteria|0
2578757|NCT01225731|8918774|P1|Part 1|Did not meet eligibility criteria|1
2578758|NCT01225562|8918869|P3|Overall Study|Lost to Follow-up|1
2578759|NCT01225562|8918870|P2|Overall Study|Lost to Follow-up|6
2578760|NCT01225562|8918871|P1|Overall Study|Lost to Follow-up|3
2578761|NCT01225562|8918869|P3|Overall Study|Withdrawal by Subject|52
2578762|NCT01225562|8918870|P2|Overall Study|Withdrawal by Subject|50
2578763|NCT01225562|8918871|P1|Overall Study|Withdrawal by Subject|52
2578764|NCT01225549|8918888|P10|Period 6 - Washout|Disallowed medication|0
2578765|NCT01225549|8918889|P9|Period 6 - Washout|Disallowed medication|0
2578766|NCT01225549|8918890|P8|Period 6 - Washout|Disallowed medication|0
2578767|NCT01225549|8918891|P7|Period 6 - Washout|Disallowed medication|0
2578768|NCT01225549|8918892|P6|Period 6 - Washout|Disallowed medication|0
2578769|NCT01225549|8918893|P5|Period 6 - Washout|Disallowed medication|0
2578770|NCT01225549|8918894|P4|Period 6 - Washout|Disallowed medication|1
2578771|NCT01225549|8918895|P3|Period 6 - Washout|Disallowed medication|0
2578772|NCT01225549|8918896|P2|Period 6 - Washout|Disallowed medication|0
2578773|NCT01225549|8918897|P1|Period 6 - Washout|Disallowed medication|0
2578774|NCT01225549|8918888|P10|Period 4 - Washout|Disallowed medication|0
2578775|NCT01225549|8918889|P9|Period 4 - Washout|Disallowed medication|0
2578776|NCT01225549|8918890|P8|Period 4 - Washout|Disallowed medication|0
2578777|NCT01225549|8918891|P7|Period 4 - Washout|Disallowed medication|0
2578778|NCT01225549|8918892|P6|Period 4 - Washout|Disallowed medication|0
2578779|NCT01225549|8918893|P5|Period 4 - Washout|Disallowed medication|0
2578780|NCT01225549|8918894|P4|Period 4 - Washout|Disallowed medication|0
2578781|NCT01225549|8918895|P3|Period 4 - Washout|Disallowed medication|0
2578782|NCT01225549|8918896|P2|Period 4 - Washout|Disallowed medication|1
2578783|NCT01225549|8918897|P1|Period 4 - Washout|Disallowed medication|0
2578784|NCT01225211|8918980|P10|Overall Study|Other|1
2578785|NCT01225211|8918981|P9|Overall Study|Other|0
2578786|NCT01225211|8918982|P8|Overall Study|Other|0
2578787|NCT01225211|8918983|P7|Overall Study|Other|0
2578788|NCT01225211|8918984|P6|Overall Study|Other|0
2578789|NCT01225211|8918985|P5|Overall Study|Other|0
2578790|NCT01225211|8918986|P4|Overall Study|Other|0
2578791|NCT01225211|8918987|P3|Overall Study|Other|0
2578792|NCT01225211|8918988|P2|Overall Study|Other|0
2578793|NCT01225211|8918989|P1|Overall Study|Other|0
2578794|NCT01225211|8918980|P10|Overall Study|Withdrawal by Subject|3
2578795|NCT01225211|8918981|P9|Overall Study|Withdrawal by Subject|1
2578796|NCT01225211|8918982|P8|Overall Study|Withdrawal by Subject|0
2578797|NCT01225211|8918983|P7|Overall Study|Withdrawal by Subject|1
2578798|NCT01225211|8918984|P6|Overall Study|Withdrawal by Subject|0
2578799|NCT01225211|8918985|P5|Overall Study|Withdrawal by Subject|0
2578800|NCT01225211|8918986|P4|Overall Study|Withdrawal by Subject|0
2578801|NCT01225211|8918987|P3|Overall Study|Withdrawal by Subject|0
2578802|NCT01225211|8918988|P2|Overall Study|Withdrawal by Subject|0
2578803|NCT01225211|8918989|P1|Overall Study|Withdrawal by Subject|0
2578804|NCT01225211|8918980|P10|Overall Study|Adverse Event|1
2578805|NCT01225211|8918981|P9|Overall Study|Adverse Event|0
2578806|NCT01225211|8918982|P8|Overall Study|Adverse Event|0
2578807|NCT01225211|8918983|P7|Overall Study|Adverse Event|0
2578808|NCT01225211|8918984|P6|Overall Study|Adverse Event|0
2578809|NCT01225211|8918985|P5|Overall Study|Adverse Event|0
2578810|NCT01225211|8918986|P4|Overall Study|Adverse Event|0
2578811|NCT01225211|8918987|P3|Overall Study|Adverse Event|1
2578812|NCT01225211|8918988|P2|Overall Study|Adverse Event|0
2578813|NCT01225211|8918989|P1|Overall Study|Adverse Event|0
2578814|NCT01225172|8919092|P2|Overall Study|Withdrawal by Subject|0
2578815|NCT01225172|8919093|P1|Overall Study|Withdrawal by Subject|1
2578816|NCT01225172|8919092|P2|Overall Study|Subject no longer meets study criteria|0
2578817|NCT01225172|8919093|P1|Overall Study|Subject no longer meets study criteria|1
2578818|NCT01225172|8919092|P2|Overall Study|Subject request to discontinue treatment|1
2578819|NCT01225172|8919093|P1|Overall Study|Subject request to discontinue treatment|3
2578820|NCT01225172|8919092|P2|Overall Study|Subject decision to stop|0
2578821|NCT01225172|8919093|P1|Overall Study|Subject decision to stop|1
2578822|NCT01225159|8919115|P2|Overall Study|Change operation|0
2578823|NCT01225159|8919116|P1|Overall Study|Change operation|1
2578824|NCT01225146|8919126|P2|Overall Study|Sponsor discontinued making 2mg drug|2
2578825|NCT01225146|8919127|P1|Overall Study|Sponsor discontinued making 2mg drug|0
2578826|NCT01224925|8919195|P2|Overall Study|Lost to Follow-up|2
2578827|NCT01224925|8919196|P1|Overall Study|Lost to Follow-up|3
2578828|NCT01224821|8919204|P1|Long-Term Follow-Up|Completion of 10 Year Follow-up|9
2578829|NCT01224821|8919204|P1|Long-Term Follow-Up|Death|2
2578830|NCT01224821|8919204|P1|Dosimetric and Therapeutic Treatment|Started Other Treatment|1
2578831|NCT01224821|8919204|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1
2578832|NCT01224821|8919204|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
2578833|NCT01224821|8919204|P1|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3
2578834|NCT01224821|8919204|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|38
2578835|NCT01224821|8919204|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
2578836|NCT01224782|8919223|P1|Overall Study|Transplantation|1
2578837|NCT01224782|8919223|P1|Overall Study|Deterioration|1
2578838|NCT01224782|8919223|P1|Overall Study|Financial Reasons|1
2578839|NCT01224782|8919223|P1|Overall Study|Change of Treatment|1
2578840|NCT01224782|8919223|P1|Overall Study|Start of Dialysis|3
2578841|NCT01224782|8919223|P1|Overall Study|Other|4
2578842|NCT01224782|8919223|P1|Overall Study|Noncompliance|10
2578843|NCT01224782|8919223|P1|Overall Study|Adverse Reaction|11
2578844|NCT01224782|8919223|P1|Overall Study|Adverse Event|12
2578845|NCT01224782|8919223|P1|Overall Study|Improvement|13
2578846|NCT01224782|8919223|P1|Overall Study|Death|14
2578847|NCT01224782|8919223|P1|Overall Study|Withdrawal by Subject|16
2578848|NCT01224782|8919223|P1|Overall Study|Lost to Follow-up|177
2578849|NCT01224639|8919249|P8|Overall Study|Adverse Event|1
2578850|NCT01224639|8919250|P7|Overall Study|Adverse Event|0
2578851|NCT01224639|8919251|P6|Overall Study|Adverse Event|0
2578852|NCT01224639|8919252|P5|Overall Study|Adverse Event|0
2578853|NCT01224639|8919253|P4|Overall Study|Adverse Event|0
2578854|NCT01224639|8919254|P3|Overall Study|Adverse Event|0
2578855|NCT01224639|8919255|P2|Overall Study|Adverse Event|0
2578856|NCT01224639|8919256|P1|Overall Study|Adverse Event|0
2578857|NCT01224639|8919249|P8|Overall Study|Withdrawal by Subject|1
2578858|NCT01224639|8919250|P7|Overall Study|Withdrawal by Subject|1
2578859|NCT01224639|8919251|P6|Overall Study|Withdrawal by Subject|0
2578860|NCT01224639|8919252|P5|Overall Study|Withdrawal by Subject|2
2578861|NCT01224639|8919253|P4|Overall Study|Withdrawal by Subject|0
2578862|NCT01224639|8919254|P3|Overall Study|Withdrawal by Subject|0
2578863|NCT01224639|8919255|P2|Overall Study|Withdrawal by Subject|0
2578864|NCT01224639|8919256|P1|Overall Study|Withdrawal by Subject|0
2578865|NCT01224431|8919374|P2|Overall Study|no video record|1
2578866|NCT01224431|8919375|P1|Overall Study|no video record|0
2578867|NCT01224431|8919374|P2|Overall Study|not randomized|4
2578868|NCT01224431|8919375|P1|Overall Study|not randomized|0
2578869|NCT01224171|8919396|P2|Overall Study|Lost to Follow-up|3
2578870|NCT01224171|8919397|P1|Overall Study|Lost to Follow-up|0
2578871|NCT01224171|8919396|P2|Overall Study|Withdrawal of Consent|4
2578872|NCT01224171|8919397|P1|Overall Study|Withdrawal of Consent|2
2578873|NCT01224171|8919396|P2|Overall Study|Lack of Efficacy|1
2578874|NCT01224171|8919397|P1|Overall Study|Lack of Efficacy|5
2578875|NCT01224171|8919396|P2|Overall Study|Protocol Violation|1
2578876|NCT01224171|8919397|P1|Overall Study|Protocol Violation|0
2578877|NCT01224171|8919396|P2|Overall Study|Adverse Event|4
2578878|NCT01224171|8919397|P1|Overall Study|Adverse Event|8
2578879|NCT01224158|8919419|P2|Overall Study|Withdrawal by Subject|0
2578880|NCT01224158|8919420|P1|Overall Study|Withdrawal by Subject|1
2578881|NCT01223937|8919456|P2|Overall Study|Other|1
2578882|NCT01223937|8919457|P1|Overall Study|Other|4
2578883|NCT01223937|8919456|P2|Overall Study|Protocol Violation|7
2578884|NCT01223937|8919457|P1|Overall Study|Protocol Violation|8
2578885|NCT01223937|8919456|P2|Overall Study|Adverse Event|4
2578886|NCT01223937|8919457|P1|Overall Study|Adverse Event|1
2578887|NCT01223937|8919456|P2|Overall Study|Lost to Follow-up|4
2578888|NCT01223937|8919457|P1|Overall Study|Lost to Follow-up|1
2578889|NCT01223937|8919456|P2|Overall Study|Withdrawal by Subject|2
2578890|NCT01223937|8919457|P1|Overall Study|Withdrawal by Subject|3
2578891|NCT01223404|8919503|P6|Third Intervention (1 Day)|Non-compliance (slept)|0
2578892|NCT01223404|8919504|P5|Third Intervention (1 Day)|Non-compliance (slept)|0
2578893|NCT01223404|8919505|P4|Third Intervention (1 Day)|Non-compliance (slept)|1
2578894|NCT01223404|8919506|P3|Third Intervention (1 Day)|Non-compliance (slept)|0
2578895|NCT01223404|8919507|P2|Third Intervention (1 Day)|Non-compliance (slept)|0
2578896|NCT01223404|8919508|P1|Third Intervention (1 Day)|Non-compliance (slept)|0
2578897|NCT01223404|8919503|P6|Second Intervention (1 Day)|Adverse Event|0
2578898|NCT01223404|8919504|P5|Second Intervention (1 Day)|Adverse Event|0
2578899|NCT01223404|8919505|P4|Second Intervention (1 Day)|Adverse Event|0
2578900|NCT01223404|8919506|P3|Second Intervention (1 Day)|Adverse Event|0
2578901|NCT01223404|8919507|P2|Second Intervention (1 Day)|Adverse Event|0
2578902|NCT01223404|8919508|P1|Second Intervention (1 Day)|Adverse Event|1
2578903|NCT01223404|8919503|P6|First Intervention (1 Day)|Adverse Event|0
2578904|NCT01223404|8919504|P5|First Intervention (1 Day)|Adverse Event|0
2578905|NCT01223404|8919505|P4|First Intervention (1 Day)|Adverse Event|1
2578906|NCT01223404|8919506|P3|First Intervention (1 Day)|Adverse Event|0
2578907|NCT01223404|8919507|P2|First Intervention (1 Day)|Adverse Event|0
2578908|NCT01223404|8919508|P1|First Intervention (1 Day)|Adverse Event|0
2578909|NCT01223365|8919572|P1|Open-label Treatment Period|Physician Decision|2
2578910|NCT01223365|8919572|P1|Open-label Treatment Period|Starting physical therapy|1
2578911|NCT01223365|8919572|P1|Open-label Treatment Period|"Out of window"|1
2578912|NCT01223365|8919572|P1|Open-label Treatment Period|Negative urine drug screen when on treat|1
2578913|NCT01223365|8919572|P1|Open-label Treatment Period|Moved out of area|2
2578914|NCT01223365|8919572|P1|Open-label Treatment Period|Noncompliance with study procedures|6
2578915|NCT01223365|8919572|P1|Open-label Treatment Period|Noncompliance with study drug admin|7
2578916|NCT01223365|8919572|P1|Open-label Treatment Period|Lost to Follow-up|7
2578917|NCT01223365|8919572|P1|Open-label Treatment Period|Protocol Violation|15
2578918|NCT01223365|8919572|P1|Open-label Treatment Period|Withdrawal by Subject|19
2578919|NCT01223365|8919572|P1|Open-label Treatment Period|Lack of Efficacy|2
2578920|NCT01223365|8919572|P1|Open-label Treatment Period|Adverse Event|39
2578921|NCT01223365|8919572|P1|Open-label Titration Period|Starting physical therapy|1
2578922|NCT01223365|8919572|P1|Open-label Titration Period|Noncompliance with study procedures|2
2578923|NCT01223365|8919572|P1|Open-label Titration Period|Noncompliance with study drug admin|1
2578924|NCT01223365|8919572|P1|Open-label Titration Period|Lost to Follow-up|2
2578925|NCT01223365|8919572|P1|Open-label Titration Period|Protocol Violation|1
2578926|NCT01223365|8919572|P1|Open-label Titration Period|Withdrawal by Subject|5
2578927|NCT01223365|8919572|P1|Open-label Titration Period|Lack of Efficacy|3
2578928|NCT01223365|8919572|P1|Open-label Titration Period|Adverse Event|23
2578929|NCT01223365|8919572|P1|Open-label Titration Period|Enrolled but not treated|1
2578930|NCT01223235|8919636|P1|Overall Study|Withdrawal by Subject|1
2578931|NCT01223196|8919644|P2|Overall Study|Withdrawal by Subject|0
2578932|NCT01223196|8919645|P1|Overall Study|Withdrawal by Subject|1
2578933|NCT01223196|8919644|P2|Overall Study|Physician Decision|0
2578934|NCT01223196|8919645|P1|Overall Study|Physician Decision|1
2578935|NCT01223196|8919644|P2|Overall Study|Lost to Follow-up|0
2578936|NCT01223196|8919645|P1|Overall Study|Lost to Follow-up|2
2578937|NCT01223183|8919657|P2|Washout Period (5-24 Days)|Physician Decision|0
2578938|NCT01223183|8919658|P1|Washout Period (5-24 Days)|Physician Decision|1
2578939|NCT01223183|8919657|P2|Washout Period (5-24 Days)|Lost to Follow-up|0
2578940|NCT01223183|8919658|P1|Washout Period (5-24 Days)|Lost to Follow-up|1
2578941|NCT01223183|8919657|P2|Imaging Day 1|Physician Decision|1
2578942|NCT01223183|8919658|P1|Imaging Day 1|Physician Decision|0
2578943|NCT01223027|8919668|P2|Overall Study|Study terminated by sponsor|8
2578944|NCT01223027|8919669|P1|Overall Study|Study terminated by sponsor|2
2578945|NCT01223027|8919668|P2|Overall Study|New therapy for study indication|8
2578946|NCT01223027|8919669|P1|Overall Study|New therapy for study indication|17
2578947|NCT01223027|8919668|P2|Overall Study|Subject/guardian decicion|16
2578948|NCT01223027|8919669|P1|Overall Study|Subject/guardian decicion|18
2578949|NCT01223027|8919668|P2|Overall Study|Protocol Violation|1
2578950|NCT01223027|8919669|P1|Overall Study|Protocol Violation|2
2578951|NCT01223027|8919668|P2|Overall Study|Progressive Disease|183
2578952|NCT01223027|8919669|P1|Overall Study|Progressive Disease|167
2578953|NCT01223027|8919668|P2|Overall Study|Physician Decision|8
2578954|NCT01223027|8919669|P1|Overall Study|Physician Decision|4
2578955|NCT01223027|8919668|P2|Overall Study|Lost to Follow-up|1
2578956|NCT01223027|8919669|P1|Overall Study|Lost to Follow-up|2
2578957|NCT01223027|8919668|P2|Overall Study|Death|42
2578958|NCT01223027|8919669|P1|Overall Study|Death|42
2578959|NCT01223027|8919668|P2|Overall Study|Adverse Event|10
2578960|NCT01223027|8919669|P1|Overall Study|Adverse Event|20
2578961|NCT01222715|8919731|P2|Overall Study|Surgery or radiation therapy in 1st 6 wk|0
2578962|NCT01222715|8919732|P1|Overall Study|Surgery or radiation therapy in 1st 6 wk|1
2578963|NCT01222715|8919731|P2|Overall Study|Ineligible|1
2578964|NCT01222715|8919732|P1|Overall Study|Ineligible|0
2578965|NCT01222715|8919731|P2|Overall Study|Pt cannot receive treatment for >9 wks|1
2578966|NCT01222715|8919732|P1|Overall Study|Pt cannot receive treatment for >9 wks|1
2578967|NCT01222715|8919731|P2|Overall Study|Refusal of further protocol therapy|4
2578968|NCT01222715|8919732|P1|Overall Study|Refusal of further protocol therapy|0
2578969|NCT01222715|8919731|P2|Overall Study|Physician Decision|2
2578970|NCT01222715|8919732|P1|Overall Study|Physician Decision|12
2578971|NCT01222715|8919731|P2|Overall Study|Lack of Efficacy|14
2578972|NCT01222715|8919732|P1|Overall Study|Lack of Efficacy|22
2578973|NCT01222715|8919731|P2|Overall Study|Death|1
2578974|NCT01222715|8919732|P1|Overall Study|Death|0
2578975|NCT01222715|8919731|P2|Overall Study|Adverse Event|4
2578976|NCT01222715|8919732|P1|Overall Study|Adverse Event|0
2578977|NCT01222533|8919771|P1|Overall Study|Other|4
2578978|NCT01222533|8919771|P1|Overall Study|Withdrawal by Subject|5
2578979|NCT01222533|8919771|P1|Overall Study|Adverse Event|5
2578980|NCT01222520|8919910|P2|Double-blind Period|Study medication stolen|0
2578981|NCT01222520|8919911|P1|Double-blind Period|Study medication stolen|1
2578982|NCT01222520|8919910|P2|Double-blind Period|Lack of Efficacy|1
2578983|NCT01222520|8919911|P1|Double-blind Period|Lack of Efficacy|0
2578984|NCT01222520|8919910|P2|Double-blind Period|Adverse Event|1
2578985|NCT01222520|8919911|P1|Double-blind Period|Adverse Event|0
2578986|NCT01222520|8919910|P2|Open-label run-in Period|Number of patients fulfilled|3
2578987|NCT01222520|8919911|P1|Open-label run-in Period|Number of patients fulfilled|0
2578988|NCT01222520|8919910|P2|Open-label run-in Period|Blood pressure criteria not met|18
2578989|NCT01222520|8919911|P1|Open-label run-in Period|Blood pressure criteria not met|0
2578990|NCT01222520|8919910|P2|Open-label run-in Period|Withdrawal by Subject|2
2578991|NCT01222520|8919911|P1|Open-label run-in Period|Withdrawal by Subject|0
2578992|NCT01222507|8919929|P1|Overall Study|Withdrawal by Subject|1
2578993|NCT01222507|8919929|P1|Overall Study|Physician Decision|1
2578994|NCT01222416|8919957|P2|Overall Study|Death|0
2578995|NCT01222416|8919958|P1|Overall Study|Death|1
2578996|NCT01222416|8919957|P2|Overall Study|missed view/scan|0
2578997|NCT01222416|8919958|P1|Overall Study|missed view/scan|1
2578998|NCT01222416|8919957|P2|Overall Study|scheduling|0
2578999|NCT01222416|8919958|P1|Overall Study|scheduling|6
2579000|NCT01222416|8919957|P2|Overall Study|Withdrawal by Subject|0
2579001|NCT01222416|8919958|P1|Overall Study|Withdrawal by Subject|5
2579002|NCT01222416|8919957|P2|Overall Study|Adverse Event|0
2579003|NCT01222416|8919958|P1|Overall Study|Adverse Event|4
2579004|NCT01222416|8919957|P2|Overall Study|ineligible;metastasis|0
2579005|NCT01222416|8919958|P1|Overall Study|ineligible;metastasis|3
2579006|NCT01222403|8919968|P2|Overall Study|Inappropriate enrollment|2
2579007|NCT01222403|8919969|P1|Overall Study|Inappropriate enrollment|0
2579008|NCT01222247|8920013|P2|Overall Study|Lost to Follow-up|2
2579009|NCT01222247|8920014|P1|Overall Study|Lost to Follow-up|2
2579010|NCT01222104|8920150|P1|Overall Study|Death|10
2579011|NCT01222104|8920150|P1|Overall Study|Lost to Follow-up|37
2579012|NCT01222078|8920173|P1|Overall Study|Early termination of the study|1
2579013|NCT01221948|8920207|P1|Overall Study|Protocol Violation|4
2579014|NCT01221948|8920207|P1|Overall Study|Death|1
2579015|NCT01221948|8920207|P1|Overall Study|not disclosed|2
2579016|NCT01221948|8920207|P1|Overall Study|Withdrawal by Subject|2
2579017|NCT01221948|8920207|P1|Overall Study|Physician Decision|5
2579018|NCT01221753|8920226|P1|Overall Study|Adverse Event|1
2579019|NCT01221727|8920233|P2|Overall Study|Withdrawal by Subject|1
2579020|NCT01221727|8920234|P1|Overall Study|Withdrawal by Subject|1
2579021|NCT01221727|8920233|P2|Overall Study|Physician Decision|0
2579022|NCT01221727|8920234|P1|Overall Study|Physician Decision|2
2579023|NCT01221623|8920255|P2|Overall Study|Other|2
2579024|NCT01221623|8920256|P1|Overall Study|Other|5
2579025|NCT01221623|8920255|P2|Overall Study|Death|0
2579026|NCT01221623|8920256|P1|Overall Study|Death|1
2579027|NCT01221623|8920255|P2|Overall Study|Adverse Event|3
2579028|NCT01221623|8920256|P1|Overall Study|Adverse Event|6
2579029|NCT01221623|8920255|P2|Overall Study|Lost to Follow-up|1
2579030|NCT01221623|8920256|P1|Overall Study|Lost to Follow-up|7
2579031|NCT01221623|8920255|P2|Overall Study|Withdrawal by Subject|8
2579032|NCT01221623|8920256|P1|Overall Study|Withdrawal by Subject|19
2579033|NCT01221597|8920280|P2|Overall Study|Death|0
2579034|NCT01221597|8920281|P1|Overall Study|Death|2
2579035|NCT01221597|8920280|P2|Overall Study|Other|4
2579036|NCT01221597|8920281|P1|Overall Study|Other|3
2579037|NCT01221597|8920280|P2|Overall Study|Protocol Violation|0
2579038|NCT01221597|8920281|P1|Overall Study|Protocol Violation|1
2579039|NCT01221597|8920280|P2|Overall Study|Lost to Follow-up|5
2579040|NCT01221597|8920281|P1|Overall Study|Lost to Follow-up|6
2579041|NCT01221597|8920280|P2|Overall Study|Withdrawal by Subject|6
2579042|NCT01221597|8920281|P1|Overall Study|Withdrawal by Subject|20
2579043|NCT01221597|8920280|P2|Overall Study|Adverse Event|1
2579044|NCT01221597|8920281|P1|Overall Study|Adverse Event|4
2579045|NCT01221363|8920338|P2|Overall Study|Withdrawal by Subject|5
2579046|NCT01221363|8920339|P1|Overall Study|Withdrawal by Subject|11
2579047|NCT01221363|8920338|P2|Overall Study|Pregnancy|0
2579048|NCT01221363|8920339|P1|Overall Study|Pregnancy|1
2579049|NCT01221350|8920349|P2|Overall Study|Withdrawal by Subject|2
2579050|NCT01221350|8920350|P1|Overall Study|Withdrawal by Subject|4
2579051|NCT01221350|8920349|P2|Overall Study|Exclusion criteria, asthma exacerbation|1
2579052|NCT01221350|8920350|P1|Overall Study|Exclusion criteria, asthma exacerbation|0
2579053|NCT01221350|8920349|P2|Overall Study|Discontinued intervention (GERD)|0
2579054|NCT01221350|8920350|P1|Overall Study|Discontinued intervention (GERD)|1
2579055|NCT01221285|8920409|P1|Overall Study|Withdrawal by Subject|1
2579056|NCT01221272|8920418|P2|Period 2|Adverse Event|2
2579057|NCT01221272|8920419|P1|Period 2|Adverse Event|0
2579058|NCT01221272|8920418|P2|Period 1|Significant Dosing Noncompliance|1
2579059|NCT01221272|8920419|P1|Period 1|Significant Dosing Noncompliance|0
2579060|NCT01221272|8920418|P2|Period 1|Consent Withdrawal|1
2579061|NCT01221272|8920419|P1|Period 1|Consent Withdrawal|0
2579062|NCT01221272|8920418|P2|Period 1|Adverse Event|0
2579063|NCT01221272|8920419|P1|Period 1|Adverse Event|2
2579064|NCT01221233|8920436|P2|Overall Study|Withdrawal by Subject|1
2579065|NCT01221233|8920437|P1|Overall Study|Withdrawal by Subject|3
2579066|NCT01221181|8920443|P1|Overall Study|Lost to Follow-up|1
2579067|NCT01221090|8920451|P4|Overall Study|Withdrawal by Subject|2
2579068|NCT01221090|8920452|P3|Overall Study|Withdrawal by Subject|27
2579069|NCT01221090|8920453|P2|Overall Study|Withdrawal by Subject|22
2579070|NCT01221090|8920454|P1|Overall Study|Withdrawal by Subject|0
2579071|NCT01221090|8920451|P4|Overall Study|Non-Compliant or Unable to Contact|20
2579072|NCT01221090|8920452|P3|Overall Study|Non-Compliant or Unable to Contact|15
2579073|NCT01221090|8920453|P2|Overall Study|Non-Compliant or Unable to Contact|12
2579074|NCT01221090|8920454|P1|Overall Study|Non-Compliant or Unable to Contact|15
2579075|NCT01220999|8920485|P5|Overall Study|Progressive disease|0
2579076|NCT01220999|8920486|P4|Overall Study|Progressive disease|0
2579077|NCT01220999|8920487|P3|Overall Study|Progressive disease|1
2579078|NCT01220999|8920488|P2|Overall Study|Progressive disease|0
2579079|NCT01220999|8920489|P1|Overall Study|Progressive disease|0
2579080|NCT01220609|8920610|P1|Overall Study|Ineligible-Never treated|1
2579081|NCT01220609|8920610|P1|Overall Study|Ineligible- Wrong cell type|1
2579082|NCT01220609|8920610|P1|Overall Study|Ineligible-Wrong primary cancer site|1
2579083|NCT01220557|8920624|P2|Overall Study|attended less than 6 lessons|2
2579084|NCT01220557|8920625|P1|Overall Study|attended less than 6 lessons|1
2579085|NCT01220557|8920624|P2|Overall Study|Lost to Follow-up|3
2579086|NCT01220557|8920625|P1|Overall Study|Lost to Follow-up|5
2579087|NCT01220414|8920658|P4|Overall Study|Withdrawal by Subject|1
2579088|NCT01220414|8920659|P3|Overall Study|Withdrawal by Subject|0
2579089|NCT01220414|8920660|P2|Overall Study|Withdrawal by Subject|0
2579090|NCT01220414|8920661|P1|Overall Study|Withdrawal by Subject|1
2579091|NCT01220401|8920668|P1|Overall Study|Protocol Violation|1
2579092|NCT01220401|8920668|P1|Overall Study|Withdrawal by Subject|2
2579093|NCT01220297|8920677|P1|Overall Study|Lost to Follow-up|1
2579094|NCT01220297|8920677|P1|Overall Study|Death|2
2579095|NCT01220180|8920694|P1|Overall Study|Randomized but not treated|1
2579096|NCT01220180|8920694|P1|Overall Study|Death|1
2579097|NCT01220180|8920694|P1|Overall Study|Lack of Efficacy|22
2579098|NCT01220180|8920694|P1|Overall Study|Adverse Event|35
2579099|NCT01220180|8920694|P1|Overall Study|Other|72
2579100|NCT01220180|8920694|P1|Overall Study|Lost to Follow-up|76
2579101|NCT01220128|8920724|P7|Overall Study|Consent withdrawn by subject|0
2579102|NCT01220128|8920725|P6|Overall Study|Consent withdrawn by subject|0
2579103|NCT01220128|8920726|P5|Overall Study|Consent withdrawn by subject|0
2579104|NCT01220128|8920727|P4|Overall Study|Consent withdrawn by subject|0
2579105|NCT01220128|8920728|P3|Overall Study|Consent withdrawn by subject|0
2579106|NCT01220128|8920729|P2|Overall Study|Consent withdrawn by subject|0
2579107|NCT01220128|8920730|P1|Overall Study|Consent withdrawn by subject|1
2579108|NCT01220128|8920724|P7|Overall Study|Other|0
2579109|NCT01220128|8920725|P6|Overall Study|Other|0
2579110|NCT01220128|8920726|P5|Overall Study|Other|0
2579111|NCT01220128|8920727|P4|Overall Study|Other|0
2579112|NCT01220128|8920728|P3|Overall Study|Other|1
2579113|NCT01220128|8920729|P2|Overall Study|Other|0
2579114|NCT01220128|8920730|P1|Overall Study|Other|0
2579115|NCT01220128|8920724|P7|Overall Study|Adverse event, non-fatal|3
2579116|NCT01220128|8920725|P6|Overall Study|Adverse event, non-fatal|0
2579117|NCT01220128|8920726|P5|Overall Study|Adverse event, non-fatal|0
2579118|NCT01220128|8920727|P4|Overall Study|Adverse event, non-fatal|0
2579119|NCT01220128|8920728|P3|Overall Study|Adverse event, non-fatal|0
2579120|NCT01220128|8920729|P2|Overall Study|Adverse event, non-fatal|0
2579121|NCT01220128|8920730|P1|Overall Study|Adverse event, non-fatal|1
2579122|NCT01220128|8920724|P7|Overall Study|Adverse event, serious fatal|1
2579123|NCT01220128|8920725|P6|Overall Study|Adverse event, serious fatal|0
2579124|NCT01220128|8920726|P5|Overall Study|Adverse event, serious fatal|0
2579125|NCT01220128|8920727|P4|Overall Study|Adverse event, serious fatal|0
2579126|NCT01220128|8920728|P3|Overall Study|Adverse event, serious fatal|0
2579127|NCT01220128|8920729|P2|Overall Study|Adverse event, serious fatal|0
2579128|NCT01220128|8920730|P1|Overall Study|Adverse event, serious fatal|2
2579129|NCT01220128|8920724|P7|Overall Study|Sponsor study termination|1
2579130|NCT01220128|8920725|P6|Overall Study|Sponsor study termination|0
2579131|NCT01220128|8920726|P5|Overall Study|Sponsor study termination|0
2579132|NCT01220128|8920727|P4|Overall Study|Sponsor study termination|0
2579133|NCT01220128|8920728|P3|Overall Study|Sponsor study termination|0
2579134|NCT01220128|8920729|P2|Overall Study|Sponsor study termination|1
2579135|NCT01220128|8920730|P1|Overall Study|Sponsor study termination|0
2579136|NCT01220128|8920724|P7|Overall Study|Progressive disease|0
2579137|NCT01220128|8920725|P6|Overall Study|Progressive disease|0
2579138|NCT01220128|8920726|P5|Overall Study|Progressive disease|0
2579139|NCT01220128|8920727|P4|Overall Study|Progressive disease|0
2579140|NCT01220128|8920728|P3|Overall Study|Progressive disease|2
2579141|NCT01220128|8920729|P2|Overall Study|Progressive disease|0
2579142|NCT01220128|8920730|P1|Overall Study|Progressive disease|0
2579143|NCT01219985|8920935|P1|Overall Study|Physician Decision|20
2579144|NCT01219959|8920943|P2|Overall Study|Other|0
2579145|NCT01219959|8920944|P1|Overall Study|Other|1
2579146|NCT01219959|8920943|P2|Overall Study|Renal Transplantation|3
2579147|NCT01219959|8920944|P1|Overall Study|Renal Transplantation|0
2579148|NCT01219959|8920943|P2|Overall Study|Withdrawal by Subject|2
2579149|NCT01219959|8920944|P1|Overall Study|Withdrawal by Subject|0
2579150|NCT01219959|8920943|P2|Overall Study|Physician Decision|4
2579151|NCT01219959|8920944|P1|Overall Study|Physician Decision|0
2579152|NCT01219959|8920943|P2|Overall Study|Adverse Event|14
2579153|NCT01219959|8920944|P1|Overall Study|Adverse Event|6
2579154|NCT01219933|8920992|P1|Overall Study|Lack of Efficacy|1
2579155|NCT01219933|8920992|P1|Overall Study|Protocol Violation|8
2579156|NCT01219933|8920992|P1|Overall Study|Withdrawal by Subject|5
2579157|NCT01219933|8920992|P1|Overall Study|GC free|1
2579158|NCT01219933|8920992|P1|Overall Study|Lost to Follow-up|3
2579159|NCT01219933|8920992|P1|Overall Study|No LDA maintained|7
2579160|NCT01219933|8920992|P1|Overall Study|No LDA reached|5
2579161|NCT01219933|8920992|P1|Overall Study|Adverse Event|8
2579162|NCT01218867|8921202|P11|Overall Study|Death during treatment|0
2579163|NCT01218867|8921203|P10|Overall Study|Death during treatment|0
2579164|NCT01218867|8921204|P9|Overall Study|Death during treatment|0
2579165|NCT01218867|8921205|P8|Overall Study|Death during treatment|0
2579166|NCT01218867|8921206|P7|Overall Study|Death during treatment|1
2579167|NCT01218867|8921207|P6|Overall Study|Death during treatment|0
2579168|NCT01218867|8921208|P5|Overall Study|Death during treatment|0
2579169|NCT01218867|8921209|P4|Overall Study|Death during treatment|0
2579170|NCT01218867|8921210|P3|Overall Study|Death during treatment|0
2579171|NCT01218867|8921211|P2|Overall Study|Death during treatment|0
2579172|NCT01218867|8921212|P1|Overall Study|Death during treatment|0
2579173|NCT01218802|8921260|P2|Overall Study|Incarcerated|0
2579174|NCT01218802|8921261|P1|Overall Study|Incarcerated|2
2579175|NCT01218802|8921260|P2|Overall Study|Adverse Event|2
2579176|NCT01218802|8921261|P1|Overall Study|Adverse Event|0
2579177|NCT01218802|8921260|P2|Overall Study|Withdrawal by Subject|10
2579178|NCT01218802|8921261|P1|Overall Study|Withdrawal by Subject|3
2579179|NCT01218802|8921260|P2|Overall Study|Lost to Follow-up|6
2579180|NCT01218802|8921261|P1|Overall Study|Lost to Follow-up|5
2579181|NCT01218659|8921271|P3|12-Month OLE|Declined to participate in the OLE|4
2579182|NCT01218659|8921272|P2|12-Month OLE|Declined to participate in the OLE|0
2579183|NCT01218659|8921273|P1|12-Month OLE|Declined to participate in the OLE|0
2579184|NCT01218659|8921271|P3|12-Month OLE|Lack of Efficacy|1
2579185|NCT01218659|8921272|P2|12-Month OLE|Lack of Efficacy|0
2579186|NCT01218659|8921273|P1|12-Month OLE|Lack of Efficacy|0
2579187|NCT01218659|8921271|P3|12-Month OLE|Pregnancy|1
2579188|NCT01218659|8921272|P2|12-Month OLE|Pregnancy|0
2579189|NCT01218659|8921273|P1|12-Month OLE|Pregnancy|0
2579190|NCT01218659|8921271|P3|12-Month OLE|Lost to Follow-up|1
2579191|NCT01218659|8921272|P2|12-Month OLE|Lost to Follow-up|0
2579192|NCT01218659|8921273|P1|12-Month OLE|Lost to Follow-up|0
2579193|NCT01218659|8921271|P3|12-Month OLE|Physician Decision|1
2579194|NCT01218659|8921272|P2|12-Month OLE|Physician Decision|0
2579195|NCT01218659|8921273|P1|12-Month OLE|Physician Decision|0
2579196|NCT01218659|8921271|P3|12-Month OLE|Withdrawal by Subject|2
2579197|NCT01218659|8921272|P2|12-Month OLE|Withdrawal by Subject|0
2579198|NCT01218659|8921273|P1|12-Month OLE|Withdrawal by Subject|0
2579199|NCT01218659|8921271|P3|18-Month Randomized Period|Did not receive study drug|0
2579200|NCT01218659|8921272|P2|18-Month Randomized Period|Did not receive study drug|3
2579201|NCT01218659|8921273|P1|18-Month Randomized Period|Did not receive study drug|0
2579202|NCT01218659|8921271|P3|18-Month Randomized Period|Withdrawal by Subject|0
2579203|NCT01218659|8921272|P2|18-Month Randomized Period|Withdrawal by Subject|3
2579204|NCT01218659|8921273|P1|18-Month Randomized Period|Withdrawal by Subject|2
2579205|NCT01218646|8921288|P4|Overall Study|Protocol Violation|1
2579206|NCT01218646|8921289|P3|Overall Study|Protocol Violation|1
2579207|NCT01218646|8921290|P2|Overall Study|Protocol Violation|0
2579208|NCT01218646|8921291|P1|Overall Study|Protocol Violation|0
2579209|NCT01218646|8921288|P4|Overall Study|Lost to Follow-up|0
2579210|NCT01218646|8921289|P3|Overall Study|Lost to Follow-up|0
2579211|NCT01218646|8921290|P2|Overall Study|Lost to Follow-up|0
2579212|NCT01218646|8921291|P1|Overall Study|Lost to Follow-up|1
2579213|NCT01218646|8921288|P4|Overall Study|Adverse Event|0
2579214|NCT01218646|8921289|P3|Overall Study|Adverse Event|1
2579215|NCT01218646|8921290|P2|Overall Study|Adverse Event|0
2579216|NCT01218646|8921291|P1|Overall Study|Adverse Event|0
2579217|NCT01218594|8921329|P1|Overall Study|Physician Decision|6
2579218|NCT01218594|8921329|P1|Overall Study|Adverse Event|2
2579219|NCT01218594|8921329|P1|Overall Study|Withdrawal by Subject|3
2579220|NCT01218594|8921329|P1|Overall Study|Death|1
2579221|NCT01218477|8921337|P4|Overall Study|Maximum clinical benefit|0
2579222|NCT01218477|8921338|P3|Overall Study|Maximum clinical benefit|0
2579223|NCT01218477|8921339|P2|Overall Study|Maximum clinical benefit|2
2579224|NCT01218477|8921340|P1|Overall Study|Maximum clinical benefit|0
2579225|NCT01218477|8921337|P4|Overall Study|Administrative reason by sponsor|0
2579226|NCT01218477|8921338|P3|Overall Study|Administrative reason by sponsor|1
2579227|NCT01218477|8921339|P2|Overall Study|Administrative reason by sponsor|0
2579228|NCT01218477|8921340|P1|Overall Study|Administrative reason by sponsor|0
2579229|NCT01218477|8921337|P4|Overall Study|Prepared for cell transplantation|0
2579230|NCT01218477|8921338|P3|Overall Study|Prepared for cell transplantation|1
2579231|NCT01218477|8921339|P2|Overall Study|Prepared for cell transplantation|1
2579232|NCT01218477|8921340|P1|Overall Study|Prepared for cell transplantation|0
2579233|NCT01218477|8921337|P4|Overall Study|Withdrawal by Subject|0
2579234|NCT01218477|8921338|P3|Overall Study|Withdrawal by Subject|1
2579235|NCT01218477|8921339|P2|Overall Study|Withdrawal by Subject|0
2579236|NCT01218477|8921340|P1|Overall Study|Withdrawal by Subject|0
2579237|NCT01218477|8921337|P4|Overall Study|No longer meets study criteria|0
2579238|NCT01218477|8921338|P3|Overall Study|No longer meets study criteria|0
2579239|NCT01218477|8921339|P2|Overall Study|No longer meets study criteria|0
2579240|NCT01218477|8921340|P1|Overall Study|No longer meets study criteria|1
2579241|NCT01218477|8921337|P4|Overall Study|Study drug toxicity|0
2579242|NCT01218477|8921338|P3|Overall Study|Study drug toxicity|5
2579243|NCT01218477|8921339|P2|Overall Study|Study drug toxicity|2
2579244|NCT01218477|8921340|P1|Overall Study|Study drug toxicity|0
2579245|NCT01218477|8921337|P4|Overall Study|Disease progression|2
2579246|NCT01218477|8921338|P3|Overall Study|Disease progression|6
2579247|NCT01218477|8921339|P2|Overall Study|Disease progression|3
2579248|NCT01218477|8921340|P1|Overall Study|Disease progression|2
2579249|NCT01218438|8921357|P1|Epoch 4|Withdrawal by Subject|2
2579250|NCT01218438|8921357|P1|Epoch 4|Physician Decision|1
2579251|NCT01218438|8921357|P1|Epoch 3|Adverse Event|1
2579252|NCT01218438|8921357|P1|Epoch 3|Withdrawal by Subject|3
2579253|NCT01218438|8921357|P1|Epoch 1|Adverse Event|1
2579254|NCT01218438|8921357|P1|Epoch 1|Physician Decision|2
2579255|NCT01218308|8921523|P2|Overall Study|Other|21
2579256|NCT01218308|8921524|P1|Overall Study|Other|14
2579257|NCT01218308|8921523|P2|Overall Study|Lost to Follow-up|31
2579258|NCT01218308|8921524|P1|Overall Study|Lost to Follow-up|27
2579259|NCT01218308|8921523|P2|Overall Study|Withdrawal by Subject|64
2579260|NCT01218308|8921524|P1|Overall Study|Withdrawal by Subject|61
2579261|NCT01218308|8921523|P2|Overall Study|Protocol Violation|2
2579262|NCT01218308|8921524|P1|Overall Study|Protocol Violation|0
2579263|NCT01218308|8921523|P2|Overall Study|Adverse Event|2
2579264|NCT01218308|8921524|P1|Overall Study|Adverse Event|1
2579265|NCT01218243|8921568|P2|Overall Study|Protocol Violation|10
2579266|NCT01218243|8921569|P1|Overall Study|Protocol Violation|5
2579267|NCT01218243|8921568|P2|Overall Study|Lost to Follow-up|3
2579268|NCT01218243|8921569|P1|Overall Study|Lost to Follow-up|3
2579269|NCT01218243|8921568|P2|Overall Study|Lack of Efficacy|1
2579270|NCT01218243|8921569|P1|Overall Study|Lack of Efficacy|1
2579271|NCT01218204|8921585|P4|Part B Pooled Treatment Arm|Protocol Violation|1
2579272|NCT01218204|8921586|P3|Part B Pooled Treatment Arm|Protocol Violation|0
2579273|NCT01218204|8921587|P2|Part B Pooled Treatment Arm|Protocol Violation|0
2579274|NCT01218204|8921588|P1|Part B Pooled Treatment Arm|Protocol Violation|0
2579275|NCT01218204|8921585|P4|Part B Pooled Treatment Arm|Adverse Event|2
2579276|NCT01218204|8921586|P3|Part B Pooled Treatment Arm|Adverse Event|0
2579277|NCT01218204|8921587|P2|Part B Pooled Treatment Arm|Adverse Event|0
2579278|NCT01218204|8921588|P1|Part B Pooled Treatment Arm|Adverse Event|0
2579279|NCT01218204|8921585|P4|Part B Run-in|Withdrawal by Subject|0
2579280|NCT01218204|8921586|P3|Part B Run-in|Withdrawal by Subject|3
2579281|NCT01218204|8921587|P2|Part B Run-in|Withdrawal by Subject|0
2579282|NCT01218204|8921588|P1|Part B Run-in|Withdrawal by Subject|0
2579283|NCT01218204|8921585|P4|Part B Run-in|Protocol Violation|0
2579284|NCT01218204|8921586|P3|Part B Run-in|Protocol Violation|2
2579285|NCT01218204|8921587|P2|Part B Run-in|Protocol Violation|0
2579286|NCT01218204|8921588|P1|Part B Run-in|Protocol Violation|0
2579287|NCT01218204|8921585|P4|Part B Run-in|Adverse Event|0
2579288|NCT01218204|8921586|P3|Part B Run-in|Adverse Event|1
2579289|NCT01218204|8921587|P2|Part B Run-in|Adverse Event|0
2579290|NCT01218204|8921588|P1|Part B Run-in|Adverse Event|0
2579291|NCT01218204|8921585|P4|Part B Washout|Did not meet continuation criteria|0
2579292|NCT01218204|8921586|P3|Part B Washout|Did not meet continuation criteria|0
2579293|NCT01218204|8921587|P2|Part B Washout|Did not meet continuation criteria|112
2579294|NCT01218204|8921588|P1|Part B Washout|Did not meet continuation criteria|0
2579295|NCT01218204|8921585|P4|Part B Washout|Reached defined stopping criteria|0
2579296|NCT01218204|8921586|P3|Part B Washout|Reached defined stopping criteria|0
2579297|NCT01218204|8921587|P2|Part B Washout|Reached defined stopping criteria|2
2579298|NCT01218204|8921588|P1|Part B Washout|Reached defined stopping criteria|0
2579299|NCT01218204|8921585|P4|Part B Washout|Withdrawal by Subject|0
2579300|NCT01218204|8921586|P3|Part B Washout|Withdrawal by Subject|0
2579301|NCT01218204|8921587|P2|Part B Washout|Withdrawal by Subject|14
2579302|NCT01218204|8921588|P1|Part B Washout|Withdrawal by Subject|0
2579303|NCT01218204|8921585|P4|Part B Washout|Physician Decision|0
2579304|NCT01218204|8921586|P3|Part B Washout|Physician Decision|0
2579305|NCT01218204|8921587|P2|Part B Washout|Physician Decision|14
2579306|NCT01218204|8921588|P1|Part B Washout|Physician Decision|0
2579307|NCT01218204|8921585|P4|Part B Washout|Lost to Follow-up|0
2579308|NCT01218204|8921586|P3|Part B Washout|Lost to Follow-up|0
2579309|NCT01218204|8921587|P2|Part B Washout|Lost to Follow-up|2
2579310|NCT01218204|8921588|P1|Part B Washout|Lost to Follow-up|0
2579311|NCT01218204|8921585|P4|Part B Washout|Adverse Event|0
2579312|NCT01218204|8921586|P3|Part B Washout|Adverse Event|0
2579313|NCT01218204|8921587|P2|Part B Washout|Adverse Event|1
2579314|NCT01218204|8921588|P1|Part B Washout|Adverse Event|0
2579315|NCT01218126|8921852|P4|Overall Study|Withdrawal by Subject|6
2579316|NCT01218126|8921853|P3|Overall Study|Withdrawal by Subject|4
2579317|NCT01218126|8921854|P2|Overall Study|Withdrawal by Subject|5
2579318|NCT01218126|8921855|P1|Overall Study|Withdrawal by Subject|2
2579319|NCT01218126|8921852|P4|Overall Study|Physician Decision|2
2579320|NCT01218126|8921853|P3|Overall Study|Physician Decision|4
2579321|NCT01218126|8921854|P2|Overall Study|Physician Decision|2
2579322|NCT01218126|8921855|P1|Overall Study|Physician Decision|1
2579323|NCT01218126|8921852|P4|Overall Study|Lost to Follow-up|2
2579324|NCT01218126|8921853|P3|Overall Study|Lost to Follow-up|0
2579325|NCT01218126|8921854|P2|Overall Study|Lost to Follow-up|0
2579326|NCT01218126|8921855|P1|Overall Study|Lost to Follow-up|0
2579327|NCT01218126|8921852|P4|Overall Study|Protocol-defined stopping criteria|0
2579328|NCT01218126|8921853|P3|Overall Study|Protocol-defined stopping criteria|0
2579329|NCT01218126|8921854|P2|Overall Study|Protocol-defined stopping criteria|1
2579330|NCT01218126|8921855|P1|Overall Study|Protocol-defined stopping criteria|1
2579331|NCT01218126|8921852|P4|Overall Study|Protocol Violation|3
2579332|NCT01218126|8921853|P3|Overall Study|Protocol Violation|2
2579333|NCT01218126|8921854|P2|Overall Study|Protocol Violation|2
2579334|NCT01218126|8921855|P1|Overall Study|Protocol Violation|5
2579335|NCT01218126|8921852|P4|Overall Study|Lack of Efficacy|6
2579336|NCT01218126|8921853|P3|Overall Study|Lack of Efficacy|2
2579337|NCT01218126|8921854|P2|Overall Study|Lack of Efficacy|2
2579338|NCT01218126|8921855|P1|Overall Study|Lack of Efficacy|7
2579339|NCT01218126|8921852|P4|Overall Study|Adverse Event|16
2579340|NCT01218126|8921853|P3|Overall Study|Adverse Event|12
2579341|NCT01218126|8921854|P2|Overall Study|Adverse Event|10
2579342|NCT01218126|8921855|P1|Overall Study|Adverse Event|8
2579343|NCT01218113|8921896|P3|Overall Study|Protocol Deviation Eligibility Criteria|1
2579344|NCT01218113|8921897|P2|Overall Study|Protocol Deviation Eligibility Criteria|0
2579345|NCT01218113|8921898|P1|Overall Study|Protocol Deviation Eligibility Criteria|0
2579346|NCT01218113|8921896|P3|Overall Study|Lost to Follow-up|4
2579347|NCT01218113|8921897|P2|Overall Study|Lost to Follow-up|1
2579348|NCT01218113|8921898|P1|Overall Study|Lost to Follow-up|4
2579349|NCT01218113|8921896|P3|Overall Study|Withdrawal by Subject|1
2579350|NCT01218113|8921897|P2|Overall Study|Withdrawal by Subject|0
2579351|NCT01218113|8921898|P1|Overall Study|Withdrawal by Subject|1
2579352|NCT01218100|8922079|P4|Overall Study|Other Reason|4
2579353|NCT01218100|8922080|P3|Overall Study|Other Reason|6
2579354|NCT01218100|8922081|P2|Overall Study|Other Reason|2
2579355|NCT01218100|8922082|P1|Overall Study|Other Reason|2
2579356|NCT01218100|8922079|P4|Overall Study|Lost to Follow-up|1
2579357|NCT01218100|8922080|P3|Overall Study|Lost to Follow-up|2
2579358|NCT01218100|8922081|P2|Overall Study|Lost to Follow-up|8
2579359|NCT01218100|8922082|P1|Overall Study|Lost to Follow-up|3
2579360|NCT01218100|8922079|P4|Overall Study|Withdrawal by Subject|7
2579361|NCT01218100|8922080|P3|Overall Study|Withdrawal by Subject|6
2579362|NCT01218100|8922081|P2|Overall Study|Withdrawal by Subject|2
2579363|NCT01218100|8922082|P1|Overall Study|Withdrawal by Subject|5
2579364|NCT01218100|8922079|P4|Overall Study|Protocol Violation|1
2579365|NCT01218100|8922080|P3|Overall Study|Protocol Violation|1
2579366|NCT01218100|8922081|P2|Overall Study|Protocol Violation|0
2579367|NCT01218100|8922082|P1|Overall Study|Protocol Violation|0
2579368|NCT01218100|8922079|P4|Overall Study|Lack of Efficacy|12
2579369|NCT01218100|8922080|P3|Overall Study|Lack of Efficacy|5
2579370|NCT01218100|8922081|P2|Overall Study|Lack of Efficacy|6
2579371|NCT01218100|8922082|P1|Overall Study|Lack of Efficacy|9
2579372|NCT01218100|8922079|P4|Overall Study|Adverse Event|7
2579373|NCT01218100|8922080|P3|Overall Study|Adverse Event|6
2579374|NCT01218100|8922081|P2|Overall Study|Adverse Event|6
2579375|NCT01218100|8922082|P1|Overall Study|Adverse Event|4
2579376|NCT01218100|8922079|P4|Overall Study|Did not meet InclusionExclusion criteria|2
2579377|NCT01218100|8922080|P3|Overall Study|Did not meet InclusionExclusion criteria|1
2579378|NCT01218100|8922081|P2|Overall Study|Did not meet InclusionExclusion criteria|1
2579379|NCT01218100|8922082|P1|Overall Study|Did not meet InclusionExclusion criteria|1
2579380|NCT01218087|8922098|P2|Overall Study|Transferred|5
2579381|NCT01218087|8922099|P1|Overall Study|Transferred|8
2579382|NCT01218087|8922098|P2|Overall Study|Withdrawal by Subject|0
2579383|NCT01218087|8922099|P1|Overall Study|Withdrawal by Subject|5
2579384|NCT01218087|8922098|P2|Overall Study|Death|1
2579385|NCT01218087|8922099|P1|Overall Study|Death|2
2579386|NCT01218009|8922121|P2|Overall Study|Sponsor terminated study|163
2579387|NCT01218009|8922122|P1|Overall Study|Sponsor terminated study|161
2579388|NCT01218009|8922121|P2|Overall Study|Withdrawal by Subject|1
2579389|NCT01218009|8922122|P1|Overall Study|Withdrawal by Subject|3
2579390|NCT01218009|8922121|P2|Overall Study|Protocol Violation|1
2579391|NCT01218009|8922122|P1|Overall Study|Protocol Violation|2
2579392|NCT01217957|8922145|P5|Phase 2|Withdrawal by Patient|1
2579393|NCT01217957|8922146|P4|Phase 2|Withdrawal by Patient|0
2579394|NCT01217957|8922147|P3|Phase 2|Withdrawal by Patient|0
2579395|NCT01217957|8922148|P2|Phase 2|Withdrawal by Patient|0
2579396|NCT01217957|8922149|P1|Phase 2|Withdrawal by Patient|0
2579397|NCT01217957|8922145|P5|Phase 1|Withdrawal by Patient|0
2579398|NCT01217957|8922146|P4|Phase 1|Withdrawal by Patient|1
2579399|NCT01217957|8922147|P3|Phase 1|Withdrawal by Patient|1
2579400|NCT01217957|8922148|P2|Phase 1|Withdrawal by Patient|0
2579401|NCT01217957|8922149|P1|Phase 1|Withdrawal by Patient|1
2579402|NCT01217944|8922208|P3|Overall Study|Lack of Efficacy|0
2579403|NCT01217944|8922209|P2|Overall Study|Lack of Efficacy|0
2579404|NCT01217944|8922210|P1|Overall Study|Lack of Efficacy|1
2579405|NCT01217944|8922208|P3|Overall Study|Withdrawal by Subject|0
2579406|NCT01217944|8922209|P2|Overall Study|Withdrawal by Subject|2
2579407|NCT01217944|8922210|P1|Overall Study|Withdrawal by Subject|1
2579408|NCT01217944|8922208|P3|Overall Study|Lost to Follow-up|0
2579409|NCT01217944|8922209|P2|Overall Study|Lost to Follow-up|1
2579410|NCT01217944|8922210|P1|Overall Study|Lost to Follow-up|3
2579411|NCT01217944|8922208|P3|Overall Study|Protocol Violation|0
2579412|NCT01217944|8922209|P2|Overall Study|Protocol Violation|1
2579413|NCT01217944|8922210|P1|Overall Study|Protocol Violation|1
2579414|NCT01217892|8922253|P4|Overall Study|Poor/Non-Compliance|0
2579415|NCT01217892|8922254|P3|Overall Study|Poor/Non-Compliance|1
2579416|NCT01217892|8922255|P2|Overall Study|Poor/Non-Compliance|0
2579417|NCT01217892|8922256|P1|Overall Study|Poor/Non-Compliance|0
2579418|NCT01217892|8922253|P4|Overall Study|Incorrect enrollment|0
2579419|NCT01217892|8922254|P3|Overall Study|Incorrect enrollment|1
2579420|NCT01217892|8922255|P2|Overall Study|Incorrect enrollment|1
2579421|NCT01217892|8922256|P1|Overall Study|Incorrect enrollment|0
2579422|NCT01217892|8922253|P4|Overall Study|Subject no longer meets study criteria|8
2579423|NCT01217892|8922254|P3|Overall Study|Subject no longer meets study criteria|4
2579424|NCT01217892|8922255|P2|Overall Study|Subject no longer meets study criteria|2
2579425|NCT01217892|8922256|P1|Overall Study|Subject no longer meets study criteria|5
2579426|NCT01217892|8922253|P4|Overall Study|Lab value|0
2579427|NCT01217892|8922254|P3|Overall Study|Lab value|1
2579428|NCT01217892|8922255|P2|Overall Study|Lab value|0
2579429|NCT01217892|8922256|P1|Overall Study|Lab value|1
2579430|NCT01217892|8922253|P4|Overall Study|Withdrawal by Subject|0
2579431|NCT01217892|8922254|P3|Overall Study|Withdrawal by Subject|1
2579432|NCT01217892|8922255|P2|Overall Study|Withdrawal by Subject|2
2579433|NCT01217892|8922256|P1|Overall Study|Withdrawal by Subject|0
2579434|NCT01217892|8922253|P4|Overall Study|Adverse Event|0
2579435|NCT01217892|8922254|P3|Overall Study|Adverse Event|1
2579436|NCT01217892|8922255|P2|Overall Study|Adverse Event|1
2579437|NCT01217892|8922256|P1|Overall Study|Adverse Event|1
2579438|NCT01217814|8922319|P3|Overall Study|Lack of Efficacy|1
2579439|NCT01217814|8922320|P2|Overall Study|Lack of Efficacy|0
2579440|NCT01217814|8922321|P1|Overall Study|Lack of Efficacy|0
2579441|NCT01217814|8922319|P3|Overall Study|Adverse Event|0
2579442|NCT01217814|8922320|P2|Overall Study|Adverse Event|1
2579443|NCT01217814|8922321|P1|Overall Study|Adverse Event|1
2579444|NCT01217801|8922347|P2|Period 1|Withdrawal by Subject|1
2579445|NCT01217801|8922348|P1|Period 1|Withdrawal by Subject|0
2579446|NCT01217801|8922347|P2|Period 1|Protocol Violation|1
2579447|NCT01217801|8922348|P1|Period 1|Protocol Violation|1
2579448|NCT01217606|8922377|P2|9-Month Masked Extension|Lack of Efficacy|0
2579449|NCT01217606|8922378|P1|9-Month Masked Extension|Lack of Efficacy|2
2579450|NCT01217606|8922377|P2|9-Month Masked Extension|Pregnancy|0
2579451|NCT01217606|8922378|P1|9-Month Masked Extension|Pregnancy|1
2579452|NCT01217606|8922377|P2|9-Month Masked Extension|Lost to Follow-up|0
2579453|NCT01217606|8922378|P1|9-Month Masked Extension|Lost to Follow-up|1
2579454|NCT01217606|8922377|P2|9-Month Masked Extension|Personal Reasons|1
2579455|NCT01217606|8922378|P1|9-Month Masked Extension|Personal Reasons|2
2579456|NCT01217606|8922377|P2|9-Month Masked Extension|Other Reasons|4
2579457|NCT01217606|8922378|P1|9-Month Masked Extension|Other Reasons|4
2579458|NCT01217606|8922377|P2|9-Month Masked Extension|Adverse Event|6
2579459|NCT01217606|8922378|P1|9-Month Masked Extension|Adverse Event|3
2579460|NCT01217606|8922377|P2|Initial Treatment Phase|Adverse Event|6
2579461|NCT01217606|8922378|P1|Initial Treatment Phase|Adverse Event|10
2579462|NCT01217606|8922377|P2|Initial Treatment Phase|Lack of Efficacy|0
2579463|NCT01217606|8922378|P1|Initial Treatment Phase|Lack of Efficacy|1
2579464|NCT01217606|8922377|P2|Initial Treatment Phase|Personal Reasons|2
2579465|NCT01217606|8922378|P1|Initial Treatment Phase|Personal Reasons|0
2579466|NCT01217606|8922377|P2|Initial Treatment Phase|Protocol Violation|2
2579467|NCT01217606|8922378|P1|Initial Treatment Phase|Protocol Violation|3
2579468|NCT01217606|8922377|P2|Initial Treatment Phase|Other Reasons|2
2579469|NCT01217606|8922378|P1|Initial Treatment Phase|Other Reasons|0
2579470|NCT01217476|8922409|P2|Overall Study|Other|0
2579471|NCT01217476|8922410|P1|Overall Study|Other|2
2579472|NCT01217476|8922409|P2|Overall Study|Protocol Deviation|0
2579473|NCT01217476|8922410|P1|Overall Study|Protocol Deviation|1
2579474|NCT01217476|8922409|P2|Overall Study|Surgery on the Target Limb|2
2579475|NCT01217476|8922410|P1|Overall Study|Surgery on the Target Limb|0
2579476|NCT01217476|8922409|P2|Overall Study|Withdrawal by Subject|3
2579477|NCT01217476|8922410|P1|Overall Study|Withdrawal by Subject|3
2579478|NCT01217476|8922409|P2|Overall Study|Physician Decision|1
2579479|NCT01217476|8922410|P1|Overall Study|Physician Decision|0
2579480|NCT01217476|8922409|P2|Overall Study|Adverse Event|1
2579481|NCT01217476|8922410|P1|Overall Study|Adverse Event|6
2579482|NCT01217463|8922420|P2|Overall Study|Other|1
2579483|NCT01217463|8922421|P1|Overall Study|Other|1
2579484|NCT01217463|8922420|P2|Overall Study|Patient Non-compliant|0
2579485|NCT01217463|8922421|P1|Overall Study|Patient Non-compliant|1
2579486|NCT01217463|8922420|P2|Overall Study|Surgery on the Target Limb|1
2579487|NCT01217463|8922421|P1|Overall Study|Surgery on the Target Limb|0
2579488|NCT01217463|8922420|P2|Overall Study|Withdrawal by Subject|0
2579489|NCT01217463|8922421|P1|Overall Study|Withdrawal by Subject|3
2579490|NCT01217463|8922420|P2|Overall Study|Physician Decision|1
2579491|NCT01217463|8922421|P1|Overall Study|Physician Decision|0
2579492|NCT01217463|8922420|P2|Overall Study|Adverse Event|5
2579493|NCT01217463|8922421|P1|Overall Study|Adverse Event|8
2579494|NCT01217437|8922431|P2|Overall Study|Ineligible|1
2579495|NCT01217437|8922432|P1|Overall Study|Ineligible|1
2579496|NCT01217437|8922431|P2|Overall Study|Withdrawal by Subject|2
2579497|NCT01217437|8922432|P1|Overall Study|Withdrawal by Subject|0
2579498|NCT01217437|8922431|P2|Overall Study|Physician Decision|5
2579499|NCT01217437|8922432|P1|Overall Study|Physician Decision|8
2579500|NCT01217437|8922431|P2|Overall Study|Lack of Efficacy|25
2579501|NCT01217437|8922432|P1|Overall Study|Lack of Efficacy|29
2579502|NCT01217437|8922431|P2|Overall Study|Death|0
2579503|NCT01217437|8922432|P1|Overall Study|Death|5
2579504|NCT01217437|8922431|P2|Overall Study|Adverse Event|8
2579505|NCT01217437|8922432|P1|Overall Study|Adverse Event|0
2579506|NCT01217385|8922453|P1|Overall Study|Normal Breast TOI not available|10
2579507|NCT01217385|8922453|P1|Overall Study|Central Path not Available|1
2579508|NCT01217385|8922453|P1|Overall Study|DOSI not performed/not eval|12
2579509|NCT01217385|8922453|P1|Overall Study|Withdrawal by Subject|3
2579510|NCT01217307|8922465|P2|Overall Study|Withdrawal by Subject|1
2579511|NCT01217307|8922466|P1|Overall Study|Withdrawal by Subject|0
2579512|NCT01217229|8922472|P1|Overall Study|Disease progression not confirmed|2
2579513|NCT01217229|8922472|P1|Overall Study|Protocol Violation|1
2579514|NCT01217229|8922472|P1|Overall Study|Disease progression, Cheson criteria|14
2579515|NCT01217229|8922472|P1|Overall Study|Disease progression, deterioration|2
2579516|NCT01217229|8922472|P1|Overall Study|Adverse Event|1
2579517|NCT01217112|8922484|P5|Overall Study|Physician Decision|1
2579518|NCT01217112|8922485|P4|Overall Study|Physician Decision|0
2579519|NCT01217112|8922486|P3|Overall Study|Physician Decision|0
2579520|NCT01217112|8922487|P2|Overall Study|Physician Decision|0
2579521|NCT01217112|8922488|P1|Overall Study|Physician Decision|0
2579522|NCT01217112|8922484|P5|Overall Study|Withdrawal by Subject|0
2579523|NCT01217112|8922485|P4|Overall Study|Withdrawal by Subject|0
2579524|NCT01217112|8922486|P3|Overall Study|Withdrawal by Subject|1
2579525|NCT01217112|8922487|P2|Overall Study|Withdrawal by Subject|0
2579526|NCT01217112|8922488|P1|Overall Study|Withdrawal by Subject|0
2579527|NCT01217112|8922484|P5|Overall Study|Adverse Event|0
2579528|NCT01217112|8922485|P4|Overall Study|Adverse Event|2
2579529|NCT01217112|8922486|P3|Overall Study|Adverse Event|0
2579530|NCT01217112|8922487|P2|Overall Study|Adverse Event|2
2579531|NCT01217112|8922488|P1|Overall Study|Adverse Event|0
2579532|NCT01217073|8922721|P8|Extension Period|Withdrawal by Subject|8
2579533|NCT01217073|8922722|P7|Extension Period|Withdrawal by Subject|30
2579534|NCT01217073|8922723|P6|Extension Period|Withdrawal by Subject|0
2579535|NCT01217073|8922724|P5|Extension Period|Withdrawal by Subject|0
2579536|NCT01217073|8922725|P4|Extension Period|Withdrawal by Subject|0
2579537|NCT01217073|8922726|P3|Extension Period|Withdrawal by Subject|0
2579538|NCT01217073|8922727|P2|Extension Period|Withdrawal by Subject|0
2579539|NCT01217073|8922728|P1|Extension Period|Withdrawal by Subject|0
2579540|NCT01217073|8922721|P8|Extension Period|Site discontinued study participation|2
2579541|NCT01217073|8922722|P7|Extension Period|Site discontinued study participation|7
2579542|NCT01217073|8922723|P6|Extension Period|Site discontinued study participation|0
2579543|NCT01217073|8922724|P5|Extension Period|Site discontinued study participation|0
2579544|NCT01217073|8922725|P4|Extension Period|Site discontinued study participation|0
2579545|NCT01217073|8922726|P3|Extension Period|Site discontinued study participation|0
2579546|NCT01217073|8922727|P2|Extension Period|Site discontinued study participation|0
2579547|NCT01217073|8922728|P1|Extension Period|Site discontinued study participation|0
2579548|NCT01217073|8922721|P8|Extension Period|Protocol Violation|1
2579549|NCT01217073|8922722|P7|Extension Period|Protocol Violation|2
2579550|NCT01217073|8922723|P6|Extension Period|Protocol Violation|0
2579551|NCT01217073|8922724|P5|Extension Period|Protocol Violation|0
2579552|NCT01217073|8922725|P4|Extension Period|Protocol Violation|0
2579553|NCT01217073|8922726|P3|Extension Period|Protocol Violation|0
2579554|NCT01217073|8922727|P2|Extension Period|Protocol Violation|0
2579555|NCT01217073|8922728|P1|Extension Period|Protocol Violation|0
2579556|NCT01217073|8922721|P8|Extension Period|Physician Decision|1
2579557|NCT01217073|8922722|P7|Extension Period|Physician Decision|4
2579558|NCT01217073|8922723|P6|Extension Period|Physician Decision|0
2579559|NCT01217073|8922724|P5|Extension Period|Physician Decision|0
2579560|NCT01217073|8922725|P4|Extension Period|Physician Decision|0
2579561|NCT01217073|8922726|P3|Extension Period|Physician Decision|0
2579562|NCT01217073|8922727|P2|Extension Period|Physician Decision|0
2579563|NCT01217073|8922728|P1|Extension Period|Physician Decision|0
2579564|NCT01217073|8922721|P8|Extension Period|Non-compliance with study drug|1
2579565|NCT01217073|8922722|P7|Extension Period|Non-compliance with study drug|0
2579566|NCT01217073|8922723|P6|Extension Period|Non-compliance with study drug|0
2579567|NCT01217073|8922724|P5|Extension Period|Non-compliance with study drug|0
2579568|NCT01217073|8922725|P4|Extension Period|Non-compliance with study drug|0
2579569|NCT01217073|8922726|P3|Extension Period|Non-compliance with study drug|0
2579570|NCT01217073|8922727|P2|Extension Period|Non-compliance with study drug|0
2579571|NCT01217073|8922728|P1|Extension Period|Non-compliance with study drug|0
2579572|NCT01217073|8922721|P8|Extension Period|Lost to Follow-up|1
2579573|NCT01217073|8922722|P7|Extension Period|Lost to Follow-up|9
2579574|NCT01217073|8922723|P6|Extension Period|Lost to Follow-up|0
2579575|NCT01217073|8922724|P5|Extension Period|Lost to Follow-up|0
2579576|NCT01217073|8922725|P4|Extension Period|Lost to Follow-up|0
2579577|NCT01217073|8922726|P3|Extension Period|Lost to Follow-up|0
2579578|NCT01217073|8922727|P2|Extension Period|Lost to Follow-up|0
2579579|NCT01217073|8922728|P1|Extension Period|Lost to Follow-up|0
2579580|NCT01217073|8922721|P8|Extension Period|Lack of Efficacy|0
2579581|NCT01217073|8922722|P7|Extension Period|Lack of Efficacy|3
2579582|NCT01217073|8922723|P6|Extension Period|Lack of Efficacy|0
2579583|NCT01217073|8922724|P5|Extension Period|Lack of Efficacy|0
2579584|NCT01217073|8922725|P4|Extension Period|Lack of Efficacy|0
2579585|NCT01217073|8922726|P3|Extension Period|Lack of Efficacy|0
2579586|NCT01217073|8922727|P2|Extension Period|Lack of Efficacy|0
2579587|NCT01217073|8922728|P1|Extension Period|Lack of Efficacy|0
2579588|NCT01217073|8922721|P8|Extension Period|Excluded medication|0
2579589|NCT01217073|8922722|P7|Extension Period|Excluded medication|2
2579590|NCT01217073|8922723|P6|Extension Period|Excluded medication|0
2579591|NCT01217073|8922724|P5|Extension Period|Excluded medication|0
2579592|NCT01217073|8922725|P4|Extension Period|Excluded medication|0
2579593|NCT01217073|8922726|P3|Extension Period|Excluded medication|0
2579594|NCT01217073|8922727|P2|Extension Period|Excluded medication|0
2579595|NCT01217073|8922728|P1|Extension Period|Excluded medication|0
2579596|NCT01217073|8922721|P8|Extension Period|Death|0
2579597|NCT01217073|8922722|P7|Extension Period|Death|1
2579598|NCT01217073|8922723|P6|Extension Period|Death|0
2579599|NCT01217073|8922724|P5|Extension Period|Death|0
2579600|NCT01217073|8922725|P4|Extension Period|Death|0
2579601|NCT01217073|8922726|P3|Extension Period|Death|0
2579602|NCT01217073|8922727|P2|Extension Period|Death|0
2579603|NCT01217073|8922728|P1|Extension Period|Death|0
2579604|NCT01217073|8922721|P8|Extension Period|Creatinine/eGFR|1
2579605|NCT01217073|8922722|P7|Extension Period|Creatinine/eGFR|11
2579606|NCT01217073|8922723|P6|Extension Period|Creatinine/eGFR|0
2579607|NCT01217073|8922724|P5|Extension Period|Creatinine/eGFR|0
2579608|NCT01217073|8922725|P4|Extension Period|Creatinine/eGFR|0
2579609|NCT01217073|8922726|P3|Extension Period|Creatinine/eGFR|0
2579610|NCT01217073|8922727|P2|Extension Period|Creatinine/eGFR|0
2579611|NCT01217073|8922728|P1|Extension Period|Creatinine/eGFR|0
2579612|NCT01217073|8922721|P8|Extension Period|Contraindication to study medication|0
2579613|NCT01217073|8922722|P7|Extension Period|Contraindication to study medication|1
2579614|NCT01217073|8922723|P6|Extension Period|Contraindication to study medication|0
2579615|NCT01217073|8922724|P5|Extension Period|Contraindication to study medication|0
2579616|NCT01217073|8922725|P4|Extension Period|Contraindication to study medication|0
2579617|NCT01217073|8922726|P3|Extension Period|Contraindication to study medication|0
2579618|NCT01217073|8922727|P2|Extension Period|Contraindication to study medication|0
2579619|NCT01217073|8922728|P1|Extension Period|Contraindication to study medication|0
2579620|NCT01217073|8922721|P8|Extension Period|ALT/AST|0
2579621|NCT01217073|8922722|P7|Extension Period|ALT/AST|2
2579622|NCT01217073|8922723|P6|Extension Period|ALT/AST|0
2579623|NCT01217073|8922724|P5|Extension Period|ALT/AST|0
2579624|NCT01217073|8922725|P4|Extension Period|ALT/AST|0
2579625|NCT01217073|8922726|P3|Extension Period|ALT/AST|0
2579626|NCT01217073|8922727|P2|Extension Period|ALT/AST|0
2579627|NCT01217073|8922728|P1|Extension Period|ALT/AST|0
2579628|NCT01217073|8922721|P8|Extension Period|Adverse Event|5
2579629|NCT01217073|8922722|P7|Extension Period|Adverse Event|19
2579630|NCT01217073|8922723|P6|Extension Period|Adverse Event|0
2579631|NCT01217073|8922724|P5|Extension Period|Adverse Event|0
2579632|NCT01217073|8922725|P4|Extension Period|Adverse Event|0
2579633|NCT01217073|8922726|P3|Extension Period|Adverse Event|0
2579634|NCT01217073|8922727|P2|Extension Period|Adverse Event|0
2579635|NCT01217073|8922728|P1|Extension Period|Adverse Event|0
2579636|NCT01217073|8922721|P8|Base Period|Withdrawal by Subject|0
2579637|NCT01217073|8922722|P7|Base Period|Withdrawal by Subject|0
2579638|NCT01217073|8922723|P6|Base Period|Withdrawal by Subject|5
2579639|NCT01217073|8922724|P5|Base Period|Withdrawal by Subject|5
2579640|NCT01217073|8922725|P4|Base Period|Withdrawal by Subject|1
2579641|NCT01217073|8922726|P3|Base Period|Withdrawal by Subject|5
2579642|NCT01217073|8922727|P2|Base Period|Withdrawal by Subject|5
2579643|NCT01217073|8922728|P1|Base Period|Withdrawal by Subject|4
2579644|NCT01217073|8922721|P8|Base Period|Protocol Violation|0
2579645|NCT01217073|8922722|P7|Base Period|Protocol Violation|0
2579646|NCT01217073|8922723|P6|Base Period|Protocol Violation|2
2579647|NCT01217073|8922724|P5|Base Period|Protocol Violation|1
2579648|NCT01217073|8922725|P4|Base Period|Protocol Violation|0
2579649|NCT01217073|8922726|P3|Base Period|Protocol Violation|0
2579650|NCT01217073|8922727|P2|Base Period|Protocol Violation|0
2579651|NCT01217073|8922728|P1|Base Period|Protocol Violation|1
2579652|NCT01217073|8922721|P8|Base Period|Physician Decision|0
2579653|NCT01217073|8922722|P7|Base Period|Physician Decision|0
2579654|NCT01217073|8922723|P6|Base Period|Physician Decision|0
2579655|NCT01217073|8922724|P5|Base Period|Physician Decision|1
2579656|NCT01217073|8922725|P4|Base Period|Physician Decision|0
2579657|NCT01217073|8922726|P3|Base Period|Physician Decision|0
2579658|NCT01217073|8922727|P2|Base Period|Physician Decision|0
2579659|NCT01217073|8922728|P1|Base Period|Physician Decision|0
2579660|NCT01217073|8922721|P8|Base Period|Lost to Follow-up|0
2579661|NCT01217073|8922722|P7|Base Period|Lost to Follow-up|0
2579662|NCT01217073|8922723|P6|Base Period|Lost to Follow-up|0
2579663|NCT01217073|8922724|P5|Base Period|Lost to Follow-up|3
2579664|NCT01217073|8922725|P4|Base Period|Lost to Follow-up|1
2579665|NCT01217073|8922726|P3|Base Period|Lost to Follow-up|1
2579666|NCT01217073|8922727|P2|Base Period|Lost to Follow-up|0
2579667|NCT01217073|8922728|P1|Base Period|Lost to Follow-up|0
2579668|NCT01217073|8922721|P8|Base Period|Lack of Efficacy|0
2579669|NCT01217073|8922722|P7|Base Period|Lack of Efficacy|0
2579670|NCT01217073|8922723|P6|Base Period|Lack of Efficacy|1
2579671|NCT01217073|8922724|P5|Base Period|Lack of Efficacy|0
2579672|NCT01217073|8922725|P4|Base Period|Lack of Efficacy|0
2579673|NCT01217073|8922726|P3|Base Period|Lack of Efficacy|0
2579674|NCT01217073|8922727|P2|Base Period|Lack of Efficacy|0
2579675|NCT01217073|8922728|P1|Base Period|Lack of Efficacy|0
2579676|NCT01217073|8922721|P8|Base Period|Excluded medication|0
2579677|NCT01217073|8922722|P7|Base Period|Excluded medication|0
2579678|NCT01217073|8922723|P6|Base Period|Excluded medication|0
2579679|NCT01217073|8922724|P5|Base Period|Excluded medication|1
2579680|NCT01217073|8922725|P4|Base Period|Excluded medication|0
2579681|NCT01217073|8922726|P3|Base Period|Excluded medication|0
2579682|NCT01217073|8922727|P2|Base Period|Excluded medication|0
2579683|NCT01217073|8922728|P1|Base Period|Excluded medication|0
2579684|NCT01217073|8922721|P8|Base Period|Alanine aminotransferase (ALT)/AST|0
2579685|NCT01217073|8922722|P7|Base Period|Alanine aminotransferase (ALT)/AST|0
2579686|NCT01217073|8922723|P6|Base Period|Alanine aminotransferase (ALT)/AST|0
2579687|NCT01217073|8922724|P5|Base Period|Alanine aminotransferase (ALT)/AST|0
2579688|NCT01217073|8922725|P4|Base Period|Alanine aminotransferase (ALT)/AST|0
2579689|NCT01217073|8922726|P3|Base Period|Alanine aminotransferase (ALT)/AST|0
2579690|NCT01217073|8922727|P2|Base Period|Alanine aminotransferase (ALT)/AST|0
2579691|NCT01217073|8922728|P1|Base Period|Alanine aminotransferase (ALT)/AST|1
2579692|NCT01217073|8922721|P8|Base Period|Adverse Event|0
2579693|NCT01217073|8922722|P7|Base Period|Adverse Event|0
2579694|NCT01217073|8922723|P6|Base Period|Adverse Event|1
2579695|NCT01217073|8922724|P5|Base Period|Adverse Event|4
2579696|NCT01217073|8922725|P4|Base Period|Adverse Event|0
2579697|NCT01217073|8922726|P3|Base Period|Adverse Event|1
2579698|NCT01217073|8922727|P2|Base Period|Adverse Event|0
2579699|NCT01217073|8922728|P1|Base Period|Adverse Event|1
2579700|NCT01216332|8922919|P2|Overall Study|Withdrawal by Subject|0
2579701|NCT01216332|8922920|P1|Overall Study|Withdrawal by Subject|4
2579702|NCT01216319|8922938|P1|Overall Study|Unanticipated chemo for breast cancer|2
2579703|NCT01216319|8922938|P1|Overall Study|Lost to Follow-up|2
2579704|NCT01216176|8922955|P3|Overall Study|Physician Decision|1
2579705|NCT01216176|8922956|P2|Overall Study|Physician Decision|0
2579706|NCT01216176|8922957|P1|Overall Study|Physician Decision|0
2579707|NCT01216176|8922955|P3|Overall Study|Adverse Event|0
2579708|NCT01216176|8922956|P2|Overall Study|Adverse Event|8
2579709|NCT01216176|8922957|P1|Overall Study|Adverse Event|0
2579710|NCT01216163|8922980|P3|Overall Study|Withdrawal by Subject|0
2579711|NCT01216163|8922981|P2|Overall Study|Withdrawal by Subject|1
2579712|NCT01216163|8922982|P1|Overall Study|Withdrawal by Subject|1
2579713|NCT01216072|8923034|P2|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3
2579714|NCT01216072|8923035|P1|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0
2579715|NCT01216072|8923034|P2|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1
2579716|NCT01216072|8923035|P1|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0
2579717|NCT01216072|8923034|P2|Open-Label Extension Period (3 Months)|Adverse Event|10
2579718|NCT01216072|8923035|P1|Open-Label Extension Period (3 Months)|Adverse Event|0
2579719|NCT01216072|8923034|P2|Open-Label Core Period ( 6 Months)|Protocol Deviation|4
2579720|NCT01216072|8923035|P1|Open-Label Core Period ( 6 Months)|Protocol Deviation|11
2579721|NCT01216072|8923034|P2|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0
2579722|NCT01216072|8923035|P1|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5
2579723|NCT01216072|8923034|P2|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22
2579724|NCT01216072|8923035|P1|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12
2579725|NCT01216072|8923034|P2|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4
2579726|NCT01216072|8923035|P1|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3
2579727|NCT01216072|8923034|P2|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0
2579728|NCT01216072|8923035|P1|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3
2579729|NCT01216072|8923034|P2|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0
2579730|NCT01216072|8923035|P1|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2
2579731|NCT01216072|8923034|P2|Open-Label Core Period ( 6 Months)|Adverse Event|4
2579732|NCT01216072|8923035|P1|Open-Label Core Period ( 6 Months)|Adverse Event|40
2579733|NCT01215981|8923063|P2|Overall Study|Withdrawal by Subject|0
2579734|NCT01215981|8923064|P1|Overall Study|Withdrawal by Subject|1
2579735|NCT01215981|8923063|P2|Overall Study|Protocol Violation|0
2579736|NCT01215981|8923064|P1|Overall Study|Protocol Violation|1
2579737|NCT01215981|8923063|P2|Overall Study|Physician Decision|1
2579738|NCT01215981|8923064|P1|Overall Study|Physician Decision|0
2579739|NCT01215968|8923074|P2|Overall Study|Not received study drug|1
2579740|NCT01215968|8923075|P1|Overall Study|Not received study drug|0
2579741|NCT01215968|8923074|P2|Overall Study|Protocol Violation|4
2579742|NCT01215968|8923075|P1|Overall Study|Protocol Violation|2
2579743|NCT01215968|8923074|P2|Overall Study|Adverse Event|2
2579744|NCT01215968|8923075|P1|Overall Study|Adverse Event|0
2579745|NCT01215955|8923095|P4|Overall Study|Quality Issues|2
2579746|NCT01215955|8923096|P3|Overall Study|Quality Issues|3
2579747|NCT01215955|8923097|P2|Overall Study|Quality Issues|0
2579748|NCT01215955|8923098|P1|Overall Study|Quality Issues|0
2579749|NCT01215955|8923095|P4|Overall Study|Withdrawal by Subject|9
2579750|NCT01215955|8923096|P3|Overall Study|Withdrawal by Subject|13
2579751|NCT01215955|8923097|P2|Overall Study|Withdrawal by Subject|15
2579752|NCT01215955|8923098|P1|Overall Study|Withdrawal by Subject|14
2579753|NCT01215955|8923095|P4|Overall Study|Sponsor Decision|1
2579754|NCT01215955|8923096|P3|Overall Study|Sponsor Decision|0
2579755|NCT01215955|8923097|P2|Overall Study|Sponsor Decision|2
2579756|NCT01215955|8923098|P1|Overall Study|Sponsor Decision|1
2579757|NCT01215955|8923095|P4|Overall Study|Protocol Violation|8
2579758|NCT01215955|8923096|P3|Overall Study|Protocol Violation|8
2579759|NCT01215955|8923097|P2|Overall Study|Protocol Violation|13
2579760|NCT01215955|8923098|P1|Overall Study|Protocol Violation|17
2579761|NCT01215955|8923095|P4|Overall Study|Physician Decision|11
2579762|NCT01215955|8923096|P3|Overall Study|Physician Decision|8
2579763|NCT01215955|8923097|P2|Overall Study|Physician Decision|10
2579764|NCT01215955|8923098|P1|Overall Study|Physician Decision|4
2579765|NCT01215955|8923095|P4|Overall Study|Lost to Follow-up|9
2579766|NCT01215955|8923096|P3|Overall Study|Lost to Follow-up|8
2579767|NCT01215955|8923097|P2|Overall Study|Lost to Follow-up|4
2579768|NCT01215955|8923098|P1|Overall Study|Lost to Follow-up|4
2579769|NCT01215955|8923095|P4|Overall Study|Lack of Efficacy|0
2579770|NCT01215955|8923096|P3|Overall Study|Lack of Efficacy|1
2579771|NCT01215955|8923097|P2|Overall Study|Lack of Efficacy|2
2579772|NCT01215955|8923098|P1|Overall Study|Lack of Efficacy|1
2579773|NCT01215955|8923095|P4|Overall Study|Entry Criteria Not Met|7
2579774|NCT01215955|8923096|P3|Overall Study|Entry Criteria Not Met|4
2579775|NCT01215955|8923097|P2|Overall Study|Entry Criteria Not Met|3
2579776|NCT01215955|8923098|P1|Overall Study|Entry Criteria Not Met|1
2579777|NCT01215955|8923095|P4|Overall Study|Death|3
2579778|NCT01215955|8923096|P3|Overall Study|Death|1
2579779|NCT01215955|8923097|P2|Overall Study|Death|0
2579780|NCT01215955|8923098|P1|Overall Study|Death|2
2579781|NCT01215955|8923095|P4|Overall Study|Adverse Event|3
2579782|NCT01215955|8923096|P3|Overall Study|Adverse Event|2
2579783|NCT01215955|8923097|P2|Overall Study|Adverse Event|4
2579784|NCT01215955|8923098|P1|Overall Study|Adverse Event|1
2579785|NCT01215942|8923166|P2|Post-Treatment Follow-Up Period|Sponsor Decision|61
2579786|NCT01215942|8923167|P1|Post-Treatment Follow-Up Period|Sponsor Decision|28
2579787|NCT01215942|8923166|P2|Post-Treatment Follow-Up Period|Physician Decision|2
2579788|NCT01215942|8923167|P1|Post-Treatment Follow-Up Period|Physician Decision|1
2579789|NCT01215942|8923166|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|69
2579790|NCT01215942|8923167|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|43
2579791|NCT01215942|8923166|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|13
2579792|NCT01215942|8923167|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|13
2579793|NCT01215942|8923166|P2|Post-Treatment Follow-Up Period|Death|1
2579794|NCT01215942|8923167|P1|Post-Treatment Follow-Up Period|Death|0
2579795|NCT01215942|8923166|P2|Treatment Period|Sponsor Decision|530
2579796|NCT01215942|8923167|P1|Treatment Period|Sponsor Decision|349
2579797|NCT01215942|8923166|P2|Treatment Period|Protocol Violation|1
2579798|NCT01215942|8923167|P1|Treatment Period|Protocol Violation|0
2579799|NCT01215942|8923166|P2|Treatment Period|Physician Decision|5
2579800|NCT01215942|8923167|P1|Treatment Period|Physician Decision|5
2579801|NCT01215942|8923166|P2|Treatment Period|Withdrawal by Subject|40
2579802|NCT01215942|8923167|P1|Treatment Period|Withdrawal by Subject|17
2579803|NCT01215942|8923166|P2|Treatment Period|Lost to Follow-up|4
2579804|NCT01215942|8923167|P1|Treatment Period|Lost to Follow-up|3
2579805|NCT01215942|8923166|P2|Treatment Period|Lack of Efficacy|62
2579806|NCT01215942|8923167|P1|Treatment Period|Lack of Efficacy|23
2579807|NCT01215942|8923166|P2|Treatment Period|Death|4
2579808|NCT01215942|8923167|P1|Treatment Period|Death|2
2579809|NCT01215942|8923166|P2|Treatment Period|Adverse Event|26
2579810|NCT01215942|8923167|P1|Treatment Period|Adverse Event|15
2579811|NCT01215916|8923300|P9|Overall Study|Physician Decision|0
2579812|NCT01215916|8923301|P8|Overall Study|Physician Decision|0
2579813|NCT01215916|8923302|P7|Overall Study|Physician Decision|0
2579814|NCT01215916|8923303|P6|Overall Study|Physician Decision|0
2579815|NCT01215916|8923304|P5|Overall Study|Physician Decision|0
2579816|NCT01215916|8923305|P4|Overall Study|Physician Decision|1
2579817|NCT01215916|8923306|P3|Overall Study|Physician Decision|1
2579818|NCT01215916|8923307|P2|Overall Study|Physician Decision|0
2579819|NCT01215916|8923308|P1|Overall Study|Physician Decision|0
2579820|NCT01215916|8923300|P9|Overall Study|Death|1
2579821|NCT01215916|8923301|P8|Overall Study|Death|0
2579822|NCT01215916|8923302|P7|Overall Study|Death|0
2579823|NCT01215916|8923303|P6|Overall Study|Death|0
2579824|NCT01215916|8923304|P5|Overall Study|Death|1
2579825|NCT01215916|8923305|P4|Overall Study|Death|0
2579826|NCT01215916|8923306|P3|Overall Study|Death|0
2579827|NCT01215916|8923307|P2|Overall Study|Death|1
2579828|NCT01215916|8923308|P1|Overall Study|Death|0
2579829|NCT01215916|8923300|P9|Overall Study|Withdrawal by Subject|0
2579830|NCT01215916|8923301|P8|Overall Study|Withdrawal by Subject|0
2579831|NCT01215916|8923302|P7|Overall Study|Withdrawal by Subject|1
2579832|NCT01215916|8923303|P6|Overall Study|Withdrawal by Subject|0
2579833|NCT01215916|8923304|P5|Overall Study|Withdrawal by Subject|0
2579834|NCT01215916|8923305|P4|Overall Study|Withdrawal by Subject|2
2579835|NCT01215916|8923306|P3|Overall Study|Withdrawal by Subject|1
2579836|NCT01215916|8923307|P2|Overall Study|Withdrawal by Subject|1
2579837|NCT01215916|8923308|P1|Overall Study|Withdrawal by Subject|0
2579838|NCT01215916|8923300|P9|Overall Study|Adverse Event|0
2579839|NCT01215916|8923301|P8|Overall Study|Adverse Event|0
2579840|NCT01215916|8923302|P7|Overall Study|Adverse Event|3
2579841|NCT01215916|8923303|P6|Overall Study|Adverse Event|0
2579842|NCT01215916|8923304|P5|Overall Study|Adverse Event|0
2579843|NCT01215916|8923305|P4|Overall Study|Adverse Event|1
2579844|NCT01215916|8923306|P3|Overall Study|Adverse Event|0
2579845|NCT01215916|8923307|P2|Overall Study|Adverse Event|1
2579846|NCT01215916|8923308|P1|Overall Study|Adverse Event|1
2579847|NCT01215916|8923300|P9|Overall Study|Progressive Disease|1
2579848|NCT01215916|8923301|P8|Overall Study|Progressive Disease|3
2579849|NCT01215916|8923302|P7|Overall Study|Progressive Disease|5
2579850|NCT01215916|8923303|P6|Overall Study|Progressive Disease|4
2579851|NCT01215916|8923304|P5|Overall Study|Progressive Disease|5
2579852|NCT01215916|8923305|P4|Overall Study|Progressive Disease|2
2579853|NCT01215916|8923306|P3|Overall Study|Progressive Disease|1
2579854|NCT01215916|8923307|P2|Overall Study|Progressive Disease|2
2579855|NCT01215916|8923308|P1|Overall Study|Progressive Disease|0
2579856|NCT01215851|8923342|P6|Follow up Period|Lost to Follow-up|1
2579857|NCT01215851|8923343|P5|Follow up Period|Lost to Follow-up|0
2579858|NCT01215851|8923344|P4|Follow up Period|Lost to Follow-up|0
2579859|NCT01215851|8923345|P3|Follow up Period|Lost to Follow-up|0
2579860|NCT01215851|8923346|P2|Follow up Period|Lost to Follow-up|0
2579861|NCT01215851|8923347|P1|Follow up Period|Lost to Follow-up|0
2579862|NCT01215851|8923342|P6|Treatment Period|Adverse Event|1
2579863|NCT01215851|8923343|P5|Treatment Period|Adverse Event|0
2579864|NCT01215851|8923344|P4|Treatment Period|Adverse Event|3
2579865|NCT01215851|8923345|P3|Treatment Period|Adverse Event|1
2579866|NCT01215851|8923346|P2|Treatment Period|Adverse Event|1
2579867|NCT01215851|8923347|P1|Treatment Period|Adverse Event|1
2579868|NCT01215734|8923406|P2|Overall Study|Death|1
2579869|NCT01215734|8923407|P1|Overall Study|Death|0
2579870|NCT01215721|8923415|P1|Overall Study|Adverse Event|2
2579871|NCT01215513|8923547|P1|Overall Study|Miscellaneous reasons (CS42A)|2
2579872|NCT01215513|8923547|P1|Overall Study|Withdrawal by subject (CS42A)|5
2579873|NCT01215513|8923547|P1|Overall Study|Physician decision (CS42A)|6
2579874|NCT01215513|8923547|P1|Overall Study|Adverse event (CS42A)|2
2579875|NCT01215513|8923547|P1|Overall Study|Not enrolled from CS42 to CS42A|21
2579876|NCT01215513|8923547|P1|Overall Study|Not completed CS42|9
2579877|NCT01215435|8923556|P2|Overall Study|Unclassified|5
2579878|NCT01215435|8923557|P1|Overall Study|Unclassified|5
2579879|NCT01215435|8923556|P2|Overall Study|Lost to Follow-up|0
2579880|NCT01215435|8923557|P1|Overall Study|Lost to Follow-up|3
2579881|NCT01215435|8923556|P2|Overall Study|Withdrawal Criteria|11
2579882|NCT01215435|8923557|P1|Overall Study|Withdrawal Criteria|8
2579883|NCT01215435|8923556|P2|Overall Study|Protocol Violation|0
2579884|NCT01215435|8923557|P1|Overall Study|Protocol Violation|2
2579885|NCT01215435|8923556|P2|Overall Study|Adverse Event|0
2579886|NCT01215435|8923557|P1|Overall Study|Adverse Event|1
2579887|NCT01215422|8923571|P4|Overall Study|Did not complete all intubations|0
2579888|NCT01215422|8923572|P3|Overall Study|Did not complete all intubations|0
2579889|NCT01215422|8923573|P2|Overall Study|Did not complete all intubations|0
2579890|NCT01215422|8923574|P1|Overall Study|Did not complete all intubations|7
2579891|NCT01215422|8923571|P4|Overall Study|Failed intubations|8
2579892|NCT01215422|8923572|P3|Overall Study|Failed intubations|3
2579893|NCT01215422|8923573|P2|Overall Study|Failed intubations|0
2579894|NCT01215422|8923574|P1|Overall Study|Failed intubations|0
2579895|NCT01215422|8923571|P4|Overall Study|Relocation|0
2579896|NCT01215422|8923572|P3|Overall Study|Relocation|0
2579897|NCT01215422|8923573|P2|Overall Study|Relocation|0
2579898|NCT01215422|8923574|P1|Overall Study|Relocation|1
2579899|NCT01215357|8923596|P1|Overall Study|Protocol Violation|9
2579900|NCT01215357|8923596|P1|Overall Study|Withdrawal by Subject|3
2579901|NCT01215253|8923722|P2|Overall Study|Other|12
2579902|NCT01215253|8923723|P1|Overall Study|Other|14
2579903|NCT01215253|8923722|P2|Overall Study|Lost to Follow-up|4
2579904|NCT01215253|8923723|P1|Overall Study|Lost to Follow-up|6
2579905|NCT01215253|8923722|P2|Overall Study|Physician Decision|12
2579906|NCT01215253|8923723|P1|Overall Study|Physician Decision|9
2579907|NCT01215253|8923722|P2|Overall Study|Withdrawal by Subject|35
2579908|NCT01215253|8923723|P1|Overall Study|Withdrawal by Subject|57
2579909|NCT01215227|8923776|P6|Overall Study|Randomized but not treated|1
2579910|NCT01215227|8923777|P5|Overall Study|Randomized but not treated|0
2579911|NCT01215227|8923778|P4|Overall Study|Randomized but not treated|1
2579912|NCT01215227|8923779|P3|Overall Study|Randomized but not treated|1
2579913|NCT01215227|8923780|P2|Overall Study|Randomized but not treated|0
2579914|NCT01215227|8923781|P1|Overall Study|Randomized but not treated|0
2579915|NCT01215227|8923776|P6|Overall Study|Missing Status|0
2579916|NCT01215227|8923777|P5|Overall Study|Missing Status|0
2579917|NCT01215227|8923778|P4|Overall Study|Missing Status|0
2579918|NCT01215227|8923779|P3|Overall Study|Missing Status|0
2579919|NCT01215227|8923780|P2|Overall Study|Missing Status|1
2579920|NCT01215227|8923781|P1|Overall Study|Missing Status|0
2579921|NCT01215227|8923776|P6|Overall Study|Administrative|40
2579922|NCT01215227|8923777|P5|Overall Study|Administrative|28
2579923|NCT01215227|8923778|P4|Overall Study|Administrative|24
2579924|NCT01215227|8923779|P3|Overall Study|Administrative|42
2579925|NCT01215227|8923780|P2|Overall Study|Administrative|73
2579926|NCT01215227|8923781|P1|Overall Study|Administrative|83
2579927|NCT01215227|8923776|P6|Overall Study|Non-Compliance With Protocol|0
2579928|NCT01215227|8923777|P5|Overall Study|Non-Compliance With Protocol|0
2579929|NCT01215227|8923778|P4|Overall Study|Non-Compliance With Protocol|0
2579930|NCT01215227|8923779|P3|Overall Study|Non-Compliance With Protocol|1
2579931|NCT01215227|8923780|P2|Overall Study|Non-Compliance With Protocol|6
2579932|NCT01215227|8923781|P1|Overall Study|Non-Compliance With Protocol|2
2579933|NCT01215227|8923776|P6|Overall Study|Subject Withdrew Consent|8
2579934|NCT01215227|8923777|P5|Overall Study|Subject Withdrew Consent|11
2579935|NCT01215227|8923778|P4|Overall Study|Subject Withdrew Consent|10
2579936|NCT01215227|8923779|P3|Overall Study|Subject Withdrew Consent|7
2579937|NCT01215227|8923780|P2|Overall Study|Subject Withdrew Consent|20
2579938|NCT01215227|8923781|P1|Overall Study|Subject Withdrew Consent|16
2579939|NCT01215227|8923776|P6|Overall Study|Lost to Follow-up|2
2579940|NCT01215227|8923777|P5|Overall Study|Lost to Follow-up|1
2579941|NCT01215227|8923778|P4|Overall Study|Lost to Follow-up|1
2579942|NCT01215227|8923779|P3|Overall Study|Lost to Follow-up|1
2579943|NCT01215227|8923780|P2|Overall Study|Lost to Follow-up|4
2579944|NCT01215227|8923781|P1|Overall Study|Lost to Follow-up|1
2579945|NCT01215227|8923776|P6|Overall Study|Treatment Failure|1
2579946|NCT01215227|8923777|P5|Overall Study|Treatment Failure|1
2579947|NCT01215227|8923778|P4|Overall Study|Treatment Failure|5
2579948|NCT01215227|8923779|P3|Overall Study|Treatment Failure|1
2579949|NCT01215227|8923780|P2|Overall Study|Treatment Failure|4
2579950|NCT01215227|8923781|P1|Overall Study|Treatment Failure|8
2579951|NCT01215227|8923776|P6|Overall Study|Adverse Event|6
2579952|NCT01215227|8923777|P5|Overall Study|Adverse Event|7
2579953|NCT01215227|8923778|P4|Overall Study|Adverse Event|8
2579954|NCT01215227|8923779|P3|Overall Study|Adverse Event|4
2579955|NCT01215227|8923780|P2|Overall Study|Adverse Event|11
2579956|NCT01215227|8923781|P1|Overall Study|Adverse Event|11
2579957|NCT01215188|8923828|P3|Overall Study|Withdrawal by Subject|31
2579958|NCT01215188|8923829|P2|Overall Study|Withdrawal by Subject|34
2579959|NCT01215188|8923830|P1|Overall Study|Withdrawal by Subject|32
2579960|NCT01215188|8923828|P3|Overall Study|Protocol Violation|1
2579961|NCT01215188|8923829|P2|Overall Study|Protocol Violation|1
2579962|NCT01215188|8923830|P1|Overall Study|Protocol Violation|1
2579963|NCT01215188|8923828|P3|Overall Study|Lack of Efficacy|1
2579964|NCT01215188|8923829|P2|Overall Study|Lack of Efficacy|0
2579965|NCT01215188|8923830|P1|Overall Study|Lack of Efficacy|0
2579966|NCT01215188|8923828|P3|Overall Study|Physician Decision|0
2579967|NCT01215188|8923829|P2|Overall Study|Physician Decision|1
2579968|NCT01215188|8923830|P1|Overall Study|Physician Decision|2
2579969|NCT01215188|8923828|P3|Overall Study|Adverse Event|3
2579970|NCT01215188|8923829|P2|Overall Study|Adverse Event|1
2579971|NCT01215188|8923830|P1|Overall Study|Adverse Event|1
2579972|NCT01215188|8923828|P3|Overall Study|Lost to Follow-up|16
2579973|NCT01215188|8923829|P2|Overall Study|Lost to Follow-up|22
2579974|NCT01215188|8923830|P1|Overall Study|Lost to Follow-up|22
2579975|NCT01215175|8923882|P5|Overall Study|Lost to Follow-up|0
2579976|NCT01215175|8923883|P4|Overall Study|Lost to Follow-up|1
2579977|NCT01215175|8923884|P3|Overall Study|Lost to Follow-up|0
2579978|NCT01215175|8923885|P2|Overall Study|Lost to Follow-up|1
2579979|NCT01215175|8923886|P1|Overall Study|Lost to Follow-up|0
2579980|NCT01215097|8924003|P2|Overall Study|patient's private reason|1
2579981|NCT01215097|8924004|P1|Overall Study|patient's private reason|1
2579982|NCT01215097|8924003|P2|Overall Study|patient's refusal to come|2
2579983|NCT01215097|8924004|P1|Overall Study|patient's refusal to come|2
2579984|NCT01215097|8924003|P2|Overall Study|Lack of Efficacy|3
2579985|NCT01215097|8924004|P1|Overall Study|Lack of Efficacy|0
2579986|NCT01215097|8924003|P2|Overall Study|Withdrawal by Subject|3
2579987|NCT01215097|8924004|P1|Overall Study|Withdrawal by Subject|6
2579988|NCT01215097|8924003|P2|Overall Study|Lost to Follow-up|0
2579989|NCT01215097|8924004|P1|Overall Study|Lost to Follow-up|2
2579990|NCT01215097|8924003|P2|Overall Study|Protocol Violation|2
2579991|NCT01215097|8924004|P1|Overall Study|Protocol Violation|0
2579992|NCT01215097|8924003|P2|Overall Study|Adverse Event|3
2579993|NCT01215097|8924004|P1|Overall Study|Adverse Event|1
2579994|NCT01215032|8924036|P1|Overall Study|Lack of Efficacy|17
2579995|NCT01215032|8924036|P1|Overall Study|Adverse Event|3
2579996|NCT01214915|8924061|P1|Overall Study|Lack of Efficacy|3
2579997|NCT01214915|8924061|P1|Overall Study|Adverse Event|8
2579998|NCT01214850|8924072|P3|Overall Study|Unable to classify|1
2579999|NCT01214850|8924073|P2|Overall Study|Unable to classify|1
2580000|NCT01214850|8924074|P1|Overall Study|Unable to classify|2
2580001|NCT01214850|8924072|P3|Overall Study|Administrative reason|0
2580002|NCT01214850|8924073|P2|Overall Study|Administrative reason|0
2580003|NCT01214850|8924074|P1|Overall Study|Administrative reason|1
2580004|NCT01214850|8924072|P3|Overall Study|Inappropriate enrollment|0
2580005|NCT01214850|8924073|P2|Overall Study|Inappropriate enrollment|1
2580006|NCT01214850|8924074|P1|Overall Study|Inappropriate enrollment|2
2580007|NCT01214850|8924072|P3|Overall Study|Adverse event or death|3
2580008|NCT01214850|8924073|P2|Overall Study|Adverse event or death|8
2580009|NCT01214850|8924074|P1|Overall Study|Adverse event or death|11
2580010|NCT01214850|8924072|P3|Overall Study|Protocol Violation|6
2580011|NCT01214850|8924073|P2|Overall Study|Protocol Violation|5
2580012|NCT01214850|8924074|P1|Overall Study|Protocol Violation|5
2580013|NCT01214850|8924072|P3|Overall Study|Lost to Follow-up|123
2580014|NCT01214850|8924073|P2|Overall Study|Lost to Follow-up|98
2580015|NCT01214850|8924074|P1|Overall Study|Lost to Follow-up|124
2580016|NCT01214850|8924072|P3|Overall Study|Withdrawal by Subject|28
2580017|NCT01214850|8924073|P2|Overall Study|Withdrawal by Subject|31
2580018|NCT01214850|8924074|P1|Overall Study|Withdrawal by Subject|38
2580019|NCT01214837|8924158|P3|Overall Study|Unable to Classify|0
2580020|NCT01214837|8924159|P2|Overall Study|Unable to Classify|3
2580021|NCT01214837|8924160|P1|Overall Study|Unable to Classify|1
2580022|NCT01214837|8924158|P3|Overall Study|Protocol Violation|5
2580023|NCT01214837|8924159|P2|Overall Study|Protocol Violation|1
2580024|NCT01214837|8924160|P1|Overall Study|Protocol Violation|3
2580025|NCT01214837|8924158|P3|Overall Study|Administrative Reason|4
2580026|NCT01214837|8924159|P2|Overall Study|Administrative Reason|6
2580027|NCT01214837|8924160|P1|Overall Study|Administrative Reason|2
2580028|NCT01214837|8924158|P3|Overall Study|Inappropriate Enrolment|2
2580029|NCT01214837|8924159|P2|Overall Study|Inappropriate Enrolment|1
2580030|NCT01214837|8924160|P1|Overall Study|Inappropriate Enrolment|0
2580031|NCT01214837|8924158|P3|Overall Study|Lost to Follow-up|21
2580032|NCT01214837|8924159|P2|Overall Study|Lost to Follow-up|15
2580033|NCT01214837|8924160|P1|Overall Study|Lost to Follow-up|20
2580034|NCT01214837|8924158|P3|Overall Study|Withdrawal by Subject|28
2580035|NCT01214837|8924159|P2|Overall Study|Withdrawal by Subject|36
2580036|NCT01214837|8924160|P1|Overall Study|Withdrawal by Subject|27
2580037|NCT01214837|8924158|P3|Overall Study|Adverse Event|1
2580038|NCT01214837|8924159|P2|Overall Study|Adverse Event|2
2580039|NCT01214837|8924160|P1|Overall Study|Adverse Event|1
2580040|NCT01214837|8924158|P3|Overall Study|Death|1
2580041|NCT01214837|8924159|P2|Overall Study|Death|0
2580042|NCT01214837|8924160|P1|Overall Study|Death|0
2580043|NCT01214720|8924216|P2|Overall Study|Lost to Follow-up|2
2580044|NCT01214720|8924217|P1|Overall Study|Lost to Follow-up|6
2580045|NCT01214720|8924216|P2|Overall Study|Alive and in follow-up|48
2580046|NCT01214720|8924217|P1|Overall Study|Alive and in follow-up|45
2580047|NCT01214720|8924216|P2|Overall Study|Alive and still on treatment|18
2580048|NCT01214720|8924217|P1|Overall Study|Alive and still on treatment|34
2580049|NCT01214668|8924240|P6|Overall Study|Withdrawal by Subject|0
2580050|NCT01214668|8924241|P5|Overall Study|Withdrawal by Subject|1
2580051|NCT01214668|8924242|P4|Overall Study|Withdrawal by Subject|0
2580052|NCT01214668|8924243|P3|Overall Study|Withdrawal by Subject|0
2580053|NCT01214668|8924244|P2|Overall Study|Withdrawal by Subject|0
2580054|NCT01214668|8924245|P1|Overall Study|Withdrawal by Subject|0
2580055|NCT01214668|8924240|P6|Overall Study|Progressive Disease|5
2580056|NCT01214668|8924241|P5|Overall Study|Progressive Disease|4
2580057|NCT01214668|8924242|P4|Overall Study|Progressive Disease|4
2580058|NCT01214668|8924243|P3|Overall Study|Progressive Disease|5
2580059|NCT01214668|8924244|P2|Overall Study|Progressive Disease|2
2580060|NCT01214668|8924245|P1|Overall Study|Progressive Disease|4
2580061|NCT01214668|8924240|P6|Overall Study|Death|0
2580062|NCT01214668|8924241|P5|Overall Study|Death|0
2580063|NCT01214668|8924242|P4|Overall Study|Death|0
2580064|NCT01214668|8924243|P3|Overall Study|Death|1
2580065|NCT01214668|8924244|P2|Overall Study|Death|0
2580066|NCT01214668|8924245|P1|Overall Study|Death|0
2580067|NCT01214668|8924240|P6|Overall Study|Adverse Event|1
2580068|NCT01214668|8924241|P5|Overall Study|Adverse Event|1
2580069|NCT01214668|8924242|P4|Overall Study|Adverse Event|2
2580070|NCT01214668|8924243|P3|Overall Study|Adverse Event|0
2580071|NCT01214668|8924244|P2|Overall Study|Adverse Event|1
2580072|NCT01214668|8924245|P1|Overall Study|Adverse Event|0
2580073|NCT01214655|8924282|P3|Part C|Physician Decision|1
2580074|NCT01214655|8924283|P2|Part C|Physician Decision|0
2580075|NCT01214655|8924284|P1|Part C|Physician Decision|0
2580076|NCT01214655|8924282|P3|Part C|Death|1
2580077|NCT01214655|8924283|P2|Part C|Death|0
2580078|NCT01214655|8924284|P1|Part C|Death|0
2580079|NCT01214655|8924282|P3|Part C|Progressive Disease|5
2580080|NCT01214655|8924283|P2|Part C|Progressive Disease|0
2580081|NCT01214655|8924284|P1|Part C|Progressive Disease|0
2580082|NCT01214655|8924282|P3|Part B|Withdrawal by Subject|0
2580083|NCT01214655|8924283|P2|Part B|Withdrawal by Subject|2
2580084|NCT01214655|8924284|P1|Part B|Withdrawal by Subject|0
2580085|NCT01214655|8924282|P3|Part B|Death|0
2580086|NCT01214655|8924283|P2|Part B|Death|1
2580087|NCT01214655|8924284|P1|Part B|Death|0
2580088|NCT01214655|8924282|P3|Part B|Progressive disease|0
2580089|NCT01214655|8924283|P2|Part B|Progressive disease|10
2580090|NCT01214655|8924284|P1|Part B|Progressive disease|0
2580091|NCT01214655|8924282|P3|Part A|Physician Decision|0
2580092|NCT01214655|8924283|P2|Part A|Physician Decision|0
2580093|NCT01214655|8924284|P1|Part A|Physician Decision|1
2580094|NCT01214655|8924282|P3|Part A|Progressive Disease|0
2580095|NCT01214655|8924283|P2|Part A|Progressive Disease|0
2580096|NCT01214655|8924284|P1|Part A|Progressive Disease|7
2580097|NCT01214642|8924357|P12|Overall Study|Physician Decision|2
2580098|NCT01214642|8924358|P11|Overall Study|Physician Decision|0
2580099|NCT01214642|8924359|P10|Overall Study|Physician Decision|0
2580100|NCT01214642|8924360|P9|Overall Study|Physician Decision|0
2580101|NCT01214642|8924361|P8|Overall Study|Physician Decision|0
2580102|NCT01214642|8924362|P7|Overall Study|Physician Decision|0
2580103|NCT01214642|8924363|P6|Overall Study|Physician Decision|0
2580104|NCT01214642|8924364|P5|Overall Study|Physician Decision|1
2580105|NCT01214642|8924365|P4|Overall Study|Physician Decision|1
2580106|NCT01214642|8924366|P3|Overall Study|Physician Decision|1
2580107|NCT01214642|8924367|P2|Overall Study|Physician Decision|0
2580108|NCT01214642|8924368|P1|Overall Study|Physician Decision|0
2580109|NCT01214642|8924357|P12|Overall Study|Withdrawal by Subject|0
2580110|NCT01214642|8924358|P11|Overall Study|Withdrawal by Subject|1
2580111|NCT01214642|8924359|P10|Overall Study|Withdrawal by Subject|1
2580112|NCT01214642|8924360|P9|Overall Study|Withdrawal by Subject|3
2580113|NCT01214642|8924361|P8|Overall Study|Withdrawal by Subject|0
2580114|NCT01214642|8924362|P7|Overall Study|Withdrawal by Subject|0
2580115|NCT01214642|8924363|P6|Overall Study|Withdrawal by Subject|0
2580116|NCT01214642|8924364|P5|Overall Study|Withdrawal by Subject|0
2580117|NCT01214642|8924365|P4|Overall Study|Withdrawal by Subject|0
2580118|NCT01214642|8924366|P3|Overall Study|Withdrawal by Subject|1
2580119|NCT01214642|8924367|P2|Overall Study|Withdrawal by Subject|0
2580120|NCT01214642|8924368|P1|Overall Study|Withdrawal by Subject|0
2580121|NCT01214642|8924357|P12|Overall Study|Death|0
2580122|NCT01214642|8924358|P11|Overall Study|Death|1
2580123|NCT01214642|8924359|P10|Overall Study|Death|0
2580124|NCT01214642|8924360|P9|Overall Study|Death|0
2580125|NCT01214642|8924361|P8|Overall Study|Death|0
2580126|NCT01214642|8924362|P7|Overall Study|Death|0
2580127|NCT01214642|8924363|P6|Overall Study|Death|0
2580128|NCT01214642|8924364|P5|Overall Study|Death|0
2580129|NCT01214642|8924365|P4|Overall Study|Death|0
2580130|NCT01214642|8924366|P3|Overall Study|Death|1
2580131|NCT01214642|8924367|P2|Overall Study|Death|0
2580132|NCT01214642|8924368|P1|Overall Study|Death|0
2580133|NCT01214642|8924357|P12|Overall Study|Adverse Event|0
2580134|NCT01214642|8924358|P11|Overall Study|Adverse Event|1
2580135|NCT01214642|8924359|P10|Overall Study|Adverse Event|1
2580136|NCT01214642|8924360|P9|Overall Study|Adverse Event|0
2580137|NCT01214642|8924361|P8|Overall Study|Adverse Event|0
2580138|NCT01214642|8924362|P7|Overall Study|Adverse Event|1
2580139|NCT01214642|8924363|P6|Overall Study|Adverse Event|0
2580140|NCT01214642|8924364|P5|Overall Study|Adverse Event|0
2580141|NCT01214642|8924365|P4|Overall Study|Adverse Event|0
2580142|NCT01214642|8924366|P3|Overall Study|Adverse Event|0
2580143|NCT01214642|8924367|P2|Overall Study|Adverse Event|1
2580144|NCT01214642|8924368|P1|Overall Study|Adverse Event|0
2580145|NCT01214642|8924357|P12|Overall Study|Progressive Disease|4
2580146|NCT01214642|8924358|P11|Overall Study|Progressive Disease|1
2580147|NCT01214642|8924359|P10|Overall Study|Progressive Disease|2
2580148|NCT01214642|8924360|P9|Overall Study|Progressive Disease|10
2580149|NCT01214642|8924361|P8|Overall Study|Progressive Disease|3
2580150|NCT01214642|8924362|P7|Overall Study|Progressive Disease|5
2580151|NCT01214642|8924363|P6|Overall Study|Progressive Disease|3
2580152|NCT01214642|8924364|P5|Overall Study|Progressive Disease|5
2580153|NCT01214642|8924365|P4|Overall Study|Progressive Disease|5
2580154|NCT01214642|8924366|P3|Overall Study|Progressive Disease|3
2580155|NCT01214642|8924367|P2|Overall Study|Progressive Disease|2
2580156|NCT01214642|8924368|P1|Overall Study|Progressive Disease|3
2580157|NCT01214629|8924448|P11|Overall Study|Withdrawal by Subject|0
2580158|NCT01214629|8924449|P10|Overall Study|Withdrawal by Subject|1
2580159|NCT01214629|8924450|P9|Overall Study|Withdrawal by Subject|0
2580160|NCT01214629|8924451|P8|Overall Study|Withdrawal by Subject|0
2580161|NCT01214629|8924452|P7|Overall Study|Withdrawal by Subject|0
2580162|NCT01214629|8924453|P6|Overall Study|Withdrawal by Subject|0
2580163|NCT01214629|8924454|P5|Overall Study|Withdrawal by Subject|0
2580164|NCT01214629|8924455|P4|Overall Study|Withdrawal by Subject|0
2580165|NCT01214629|8924456|P3|Overall Study|Withdrawal by Subject|0
2580166|NCT01214629|8924457|P2|Overall Study|Withdrawal by Subject|0
2580167|NCT01214629|8924458|P1|Overall Study|Withdrawal by Subject|0
2580168|NCT01214629|8924448|P11|Overall Study|Physician Decision|1
2580169|NCT01214629|8924449|P10|Overall Study|Physician Decision|0
2580170|NCT01214629|8924450|P9|Overall Study|Physician Decision|0
2580171|NCT01214629|8924451|P8|Overall Study|Physician Decision|0
2580172|NCT01214629|8924452|P7|Overall Study|Physician Decision|0
2580173|NCT01214629|8924453|P6|Overall Study|Physician Decision|0
2580174|NCT01214629|8924454|P5|Overall Study|Physician Decision|0
2580175|NCT01214629|8924455|P4|Overall Study|Physician Decision|0
2580176|NCT01214629|8924456|P3|Overall Study|Physician Decision|0
2580177|NCT01214629|8924457|P2|Overall Study|Physician Decision|0
2580178|NCT01214629|8924458|P1|Overall Study|Physician Decision|0
2580179|NCT01214629|8924448|P11|Overall Study|Adverse Event|0
2580180|NCT01214629|8924449|P10|Overall Study|Adverse Event|1
2580181|NCT01214629|8924450|P9|Overall Study|Adverse Event|0
2580182|NCT01214629|8924451|P8|Overall Study|Adverse Event|0
2580183|NCT01214629|8924452|P7|Overall Study|Adverse Event|0
2580184|NCT01214629|8924453|P6|Overall Study|Adverse Event|1
2580185|NCT01214629|8924454|P5|Overall Study|Adverse Event|0
2580186|NCT01214629|8924455|P4|Overall Study|Adverse Event|1
2580187|NCT01214629|8924456|P3|Overall Study|Adverse Event|0
2580188|NCT01214629|8924457|P2|Overall Study|Adverse Event|0
2580189|NCT01214629|8924458|P1|Overall Study|Adverse Event|0
2580190|NCT01214629|8924448|P11|Overall Study|Progressive Disease|1
2580191|NCT01214629|8924449|P10|Overall Study|Progressive Disease|5
2580192|NCT01214629|8924450|P9|Overall Study|Progressive Disease|1
2580193|NCT01214629|8924451|P8|Overall Study|Progressive Disease|1
2580194|NCT01214629|8924452|P7|Overall Study|Progressive Disease|1
2580195|NCT01214629|8924453|P6|Overall Study|Progressive Disease|3
2580196|NCT01214629|8924454|P5|Overall Study|Progressive Disease|2
2580197|NCT01214629|8924455|P4|Overall Study|Progressive Disease|1
2580198|NCT01214629|8924456|P3|Overall Study|Progressive Disease|0
2580199|NCT01214629|8924457|P2|Overall Study|Progressive Disease|1
2580200|NCT01214629|8924458|P1|Overall Study|Progressive Disease|1
2580201|NCT01214616|8924523|P4|Overall Study|Withdrawal by Subject|1
2580202|NCT01214616|8924524|P3|Overall Study|Withdrawal by Subject|0
2580203|NCT01214616|8924525|P2|Overall Study|Withdrawal by Subject|0
2580204|NCT01214616|8924526|P1|Overall Study|Withdrawal by Subject|1
2580205|NCT01214616|8924523|P4|Overall Study|Other adverse events|1
2580206|NCT01214616|8924524|P3|Overall Study|Other adverse events|1
2580207|NCT01214616|8924525|P2|Overall Study|Other adverse events|1
2580208|NCT01214616|8924526|P1|Overall Study|Other adverse events|0
2580209|NCT01214616|8924523|P4|Overall Study|Dose limiting toxicity|0
2580210|NCT01214616|8924524|P3|Overall Study|Dose limiting toxicity|0
2580211|NCT01214616|8924525|P2|Overall Study|Dose limiting toxicity|2
2580212|NCT01214616|8924526|P1|Overall Study|Dose limiting toxicity|0
2580213|NCT01214616|8924523|P4|Overall Study|Progressive disease|4
2580214|NCT01214616|8924524|P3|Overall Study|Progressive disease|2
2580215|NCT01214616|8924525|P2|Overall Study|Progressive disease|2
2580216|NCT01214616|8924526|P1|Overall Study|Progressive disease|2
2580217|NCT01214603|8924563|P3|Overall Study|Progressive Disease|3
2580218|NCT01214603|8924564|P2|Overall Study|Progressive Disease|1
2580219|NCT01214603|8924565|P1|Overall Study|Progressive Disease|4
2580220|NCT01214603|8924563|P3|Overall Study|Death|0
2580221|NCT01214603|8924564|P2|Overall Study|Death|0
2580222|NCT01214603|8924565|P1|Overall Study|Death|1
2580223|NCT01214603|8924563|P3|Overall Study|Adverse Event|1
2580224|NCT01214603|8924564|P2|Overall Study|Adverse Event|0
2580225|NCT01214603|8924565|P1|Overall Study|Adverse Event|0
2580226|NCT01214434|8924588|P2|Overall Study|Site error|0
2580227|NCT01214434|8924589|P1|Overall Study|Site error|1
2580228|NCT01214434|8924588|P2|Overall Study|Lost to Follow-up|2
2580229|NCT01214434|8924589|P1|Overall Study|Lost to Follow-up|2
2580230|NCT01214434|8924588|P2|Overall Study|Withdrawal by Subject|0
2580231|NCT01214434|8924589|P1|Overall Study|Withdrawal by Subject|1
2580232|NCT01214395|8924605|P1|Overall Study|All patients had infection|5
2580233|NCT01214252|8924623|P1|Overall Study|Not eligible per protocol|82
2580234|NCT01214239|8924631|P2|Overall Study|patient's private reason|1
2580235|NCT01214239|8924632|P1|Overall Study|patient's private reason|1
2580236|NCT01214239|8924631|P2|Overall Study|Lack of Efficacy|2
2580237|NCT01214239|8924632|P1|Overall Study|Lack of Efficacy|1
2580238|NCT01214239|8924631|P2|Overall Study|Withdrawal by Subject|9
2580239|NCT01214239|8924632|P1|Overall Study|Withdrawal by Subject|4
2580240|NCT01214239|8924631|P2|Overall Study|Lost to Follow-up|1
2580241|NCT01214239|8924632|P1|Overall Study|Lost to Follow-up|1
2580242|NCT01214239|8924631|P2|Overall Study|Protocol Violation|1
2580243|NCT01214239|8924632|P1|Overall Study|Protocol Violation|2
2580244|NCT01214239|8924631|P2|Overall Study|Adverse Event|4
2580245|NCT01214239|8924632|P1|Overall Study|Adverse Event|3
2580246|NCT01214200|8924664|P1|Overall Study|Withdrawal by Subject|2
2580247|NCT01214200|8924664|P1|Overall Study|Did not meet inclusion/exclusion|9
2580248|NCT01214187|8924678|P2|Overall Study|Withdrawal by Subject|3
2580249|NCT01214187|8924679|P1|Overall Study|Withdrawal by Subject|0
2580250|NCT01214187|8924678|P2|Overall Study|Death|1
2580251|NCT01214187|8924679|P1|Overall Study|Death|1
2580252|NCT01214187|8924678|P2|Overall Study|Adverse Event|2
2580253|NCT01214187|8924679|P1|Overall Study|Adverse Event|6
2580254|NCT01214174|8924696|P3|Overall Study|Withdrawal by Subject|1
2580255|NCT01214174|8924697|P2|Overall Study|Withdrawal by Subject|0
2580256|NCT01214174|8924698|P1|Overall Study|Withdrawal by Subject|0
2580257|NCT01214044|8924848|P1|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1
2580258|NCT01214044|8924848|P1|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3
2580259|NCT01214044|8924848|P1|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3
2580260|NCT01214044|8924848|P1|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4
2580261|NCT01214044|8924848|P1|Visit 1: Screening and Consent, Washout|Ineligible|3
2580262|NCT01214044|8924848|P1|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5
2580263|NCT01213966|8924862|P4|Overall Study|Protocol Violation|1
2580264|NCT01213966|8924863|P3|Overall Study|Protocol Violation|3
2580265|NCT01213966|8924864|P2|Overall Study|Protocol Violation|0
2580266|NCT01213966|8924865|P1|Overall Study|Protocol Violation|1
2580267|NCT01213836|8924877|P2|Period 1, First Intervention|Withdrawal by Subject|1
2580268|NCT01213836|8924878|P1|Period 1, First Intervention|Withdrawal by Subject|1
2580269|NCT01213836|8924877|P2|Period 1, First Intervention|Protocol Violation|1
2580270|NCT01213836|8924878|P1|Period 1, First Intervention|Protocol Violation|0
2580271|NCT01213836|8924877|P2|Period 1, First Intervention|Adverse Event|1
2580272|NCT01213836|8924878|P1|Period 1, First Intervention|Adverse Event|2
2580273|NCT01213472|8924963|P1|Overall Study|Physician Decision|1
2580274|NCT01213472|8924963|P1|Overall Study|Withdrawal by Subject|1
2580275|NCT01213472|8924963|P1|Overall Study|Recurrence/Progressive disease|25
2580276|NCT01213264|8925012|P3|Overall Study|Lost to Follow-up|6
2580277|NCT01213264|8925013|P2|Overall Study|Lost to Follow-up|2
2580278|NCT01213264|8925014|P1|Overall Study|Lost to Follow-up|1
2580279|NCT01213264|8925012|P3|Overall Study|Adverse Event|0
2580280|NCT01213264|8925013|P2|Overall Study|Adverse Event|0
2580281|NCT01213264|8925014|P1|Overall Study|Adverse Event|1
2580282|NCT01213251|8925034|P3|Overall Study|Missed 18-Month Follow-up|1
2580283|NCT01213251|8925035|P2|Overall Study|Missed 18-Month Follow-up|0
2580284|NCT01213251|8925036|P1|Overall Study|Missed 18-Month Follow-up|0
2580285|NCT01213251|8925034|P3|Overall Study|Protocol Violation|0
2580286|NCT01213251|8925035|P2|Overall Study|Protocol Violation|1
2580287|NCT01213251|8925036|P1|Overall Study|Protocol Violation|1
2580288|NCT01213251|8925034|P3|Overall Study|Exit|8
2580289|NCT01213251|8925035|P2|Overall Study|Exit|2
2580290|NCT01213251|8925036|P1|Overall Study|Exit|3
2580291|NCT01213251|8925034|P3|Overall Study|Death|2
2580292|NCT01213251|8925035|P2|Overall Study|Death|1
2580293|NCT01213251|8925036|P1|Overall Study|Death|2
2580294|NCT01213173|8925063|P2|Overall Study|Incorrect Enrollment|3
2580295|NCT01213173|8925064|P1|Overall Study|Incorrect Enrollment|1
2580296|NCT01213173|8925063|P2|Overall Study|Withdrawal by Subject|5
2580297|NCT01213173|8925064|P1|Overall Study|Withdrawal by Subject|5
2580298|NCT01213173|8925063|P2|Overall Study|Adverse Event|8
2580299|NCT01213173|8925064|P1|Overall Study|Adverse Event|4
2580300|NCT01213173|8925063|P2|Overall Study|Protocol Violation|0
2580301|NCT01213173|8925064|P1|Overall Study|Protocol Violation|2
2580302|NCT01213082|8925097|P3|Overall Study|Physician Decision|1
2580303|NCT01213082|8925098|P2|Overall Study|Physician Decision|0
2580304|NCT01213082|8925099|P1|Overall Study|Physician Decision|0
2580305|NCT01213082|8925097|P3|Overall Study|Lost to Follow-up|4
2580306|NCT01213082|8925098|P2|Overall Study|Lost to Follow-up|7
2580307|NCT01213082|8925099|P1|Overall Study|Lost to Follow-up|6
2580308|NCT01212991|8925141|P3|Open-label|Other|3
2580309|NCT01212991|8925142|P2|Open-label|Other|0
2580310|NCT01212991|8925143|P1|Open-label|Other|0
2580311|NCT01212991|8925141|P3|Open-label|Sponsor decision|53
2580312|NCT01212991|8925142|P2|Open-label|Sponsor decision|0
2580313|NCT01212991|8925143|P1|Open-label|Sponsor decision|0
2580314|NCT01212991|8925141|P3|Open-label|Withdrawal by Subject|7
2580315|NCT01212991|8925142|P2|Open-label|Withdrawal by Subject|0
2580316|NCT01212991|8925143|P1|Open-label|Withdrawal by Subject|0
2580317|NCT01212991|8925141|P3|Open-label|Lost to Follow-up|5
2580318|NCT01212991|8925142|P2|Open-label|Lost to Follow-up|0
2580319|NCT01212991|8925143|P1|Open-label|Lost to Follow-up|0
2580320|NCT01212991|8925141|P3|Open-label|Death|166
2580321|NCT01212991|8925142|P2|Open-label|Death|0
2580322|NCT01212991|8925143|P1|Open-label|Death|0
2580323|NCT01212991|8925141|P3|Double-blind|Sponsor decision|0
2580324|NCT01212991|8925142|P2|Double-blind|Sponsor decision|38
2580325|NCT01212991|8925143|P1|Double-blind|Sponsor decision|142
2580326|NCT01212991|8925141|P3|Double-blind|Other|0
2580327|NCT01212991|8925142|P2|Double-blind|Other|0
2580328|NCT01212991|8925143|P1|Double-blind|Other|7
2580329|NCT01212991|8925141|P3|Double-blind|Withdrawal by Subject|0
2580330|NCT01212991|8925142|P2|Double-blind|Withdrawal by Subject|19
2580331|NCT01212991|8925143|P1|Double-blind|Withdrawal by Subject|16
2580332|NCT01212991|8925141|P3|Double-blind|Death|0
2580333|NCT01212991|8925142|P2|Double-blind|Death|550
2580334|NCT01212991|8925143|P1|Double-blind|Death|699
2580335|NCT01212991|8925141|P3|Double-blind|Lost to Follow-up|0
2580336|NCT01212991|8925142|P2|Double-blind|Lost to Follow-up|4
2580337|NCT01212991|8925143|P1|Double-blind|Lost to Follow-up|8
2580338|NCT01212770|8925215|P9|Long-term Safety Phase (Year 5)|Death|0
2580339|NCT01212770|8925216|P8|Long-term Safety Phase (Year 5)|Death|1
2580340|NCT01212770|8925217|P7|Long-term Safety Phase (Year 5)|Death|0
2580341|NCT01212770|8925218|P6|Long-term Safety Phase (Year 5)|Death|0
2580342|NCT01212770|8925219|P5|Long-term Safety Phase (Year 5)|Death|0
2580343|NCT01212770|8925220|P4|Long-term Safety Phase (Year 5)|Death|0
2580344|NCT01212770|8925221|P3|Long-term Safety Phase (Year 5)|Death|0
2580345|NCT01212770|8925222|P2|Long-term Safety Phase (Year 5)|Death|0
2580346|NCT01212770|8925223|P1|Long-term Safety Phase (Year 5)|Death|0
2580347|NCT01212770|8925215|P9|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2580348|NCT01212770|8925216|P8|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
2580349|NCT01212770|8925217|P7|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2580350|NCT01212770|8925218|P6|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2580351|NCT01212770|8925219|P5|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2580352|NCT01212770|8925220|P4|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2580353|NCT01212770|8925221|P3|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
2580354|NCT01212770|8925222|P2|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
2580355|NCT01212770|8925223|P1|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
2580356|NCT01212770|8925215|P9|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2580357|NCT01212770|8925216|P8|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2580358|NCT01212770|8925217|P7|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2580359|NCT01212770|8925218|P6|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2580360|NCT01212770|8925219|P5|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2580361|NCT01212770|8925220|P4|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2580362|NCT01212770|8925221|P3|Long-term Safety Phase (Year 5)|Lack of Efficacy|4
2580363|NCT01212770|8925222|P2|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2580364|NCT01212770|8925223|P1|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
2580365|NCT01212770|8925215|P9|Long-term Safety Phase (Year 5)|Adverse Event|1
2580366|NCT01212770|8925216|P8|Long-term Safety Phase (Year 5)|Adverse Event|0
2580367|NCT01212770|8925217|P7|Long-term Safety Phase (Year 5)|Adverse Event|0
2580368|NCT01212770|8925218|P6|Long-term Safety Phase (Year 5)|Adverse Event|0
2580369|NCT01212770|8925219|P5|Long-term Safety Phase (Year 5)|Adverse Event|0
2580370|NCT01212770|8925220|P4|Long-term Safety Phase (Year 5)|Adverse Event|0
2580371|NCT01212770|8925221|P3|Long-term Safety Phase (Year 5)|Adverse Event|2
2580372|NCT01212770|8925222|P2|Long-term Safety Phase (Year 5)|Adverse Event|0
2580373|NCT01212770|8925223|P1|Long-term Safety Phase (Year 5)|Adverse Event|0
2580374|NCT01212770|8925215|P9|Long-term Safety Phase (Year 5)|Miscellaneous|0
2580375|NCT01212770|8925216|P8|Long-term Safety Phase (Year 5)|Miscellaneous|0
2580376|NCT01212770|8925217|P7|Long-term Safety Phase (Year 5)|Miscellaneous|0
2580377|NCT01212770|8925218|P6|Long-term Safety Phase (Year 5)|Miscellaneous|0
2580378|NCT01212770|8925219|P5|Long-term Safety Phase (Year 5)|Miscellaneous|0
2580379|NCT01212770|8925220|P4|Long-term Safety Phase (Year 5)|Miscellaneous|0
2580380|NCT01212770|8925221|P3|Long-term Safety Phase (Year 5)|Miscellaneous|3
2580381|NCT01212770|8925222|P2|Long-term Safety Phase (Year 5)|Miscellaneous|0
2580382|NCT01212770|8925223|P1|Long-term Safety Phase (Year 5)|Miscellaneous|0
2580383|NCT01212770|8925215|P9|Long-term Safety Phase (Year 5)|Missing|0
2580384|NCT01212770|8925216|P8|Long-term Safety Phase (Year 5)|Missing|0
2580385|NCT01212770|8925217|P7|Long-term Safety Phase (Year 5)|Missing|0
2580386|NCT01212770|8925218|P6|Long-term Safety Phase (Year 5)|Missing|0
2580387|NCT01212770|8925219|P5|Long-term Safety Phase (Year 5)|Missing|0
2580388|NCT01212770|8925220|P4|Long-term Safety Phase (Year 5)|Missing|0
2580389|NCT01212770|8925221|P3|Long-term Safety Phase (Year 5)|Missing|1
2580390|NCT01212770|8925222|P2|Long-term Safety Phase (Year 5)|Missing|0
2580391|NCT01212770|8925223|P1|Long-term Safety Phase (Year 5)|Missing|0
2580392|NCT01212770|8925215|P9|Long-term Safety Phase (Year 4)|Miscellaneous|1
2580393|NCT01212770|8925216|P8|Long-term Safety Phase (Year 4)|Miscellaneous|0
2580394|NCT01212770|8925217|P7|Long-term Safety Phase (Year 4)|Miscellaneous|0
2580395|NCT01212770|8925218|P6|Long-term Safety Phase (Year 4)|Miscellaneous|0
2580396|NCT01212770|8925219|P5|Long-term Safety Phase (Year 4)|Miscellaneous|0
2580397|NCT01212770|8925220|P4|Long-term Safety Phase (Year 4)|Miscellaneous|0
2580398|NCT01212770|8925221|P3|Long-term Safety Phase (Year 4)|Miscellaneous|0
2580399|NCT01212770|8925222|P2|Long-term Safety Phase (Year 4)|Miscellaneous|1
2580400|NCT01212770|8925223|P1|Long-term Safety Phase (Year 4)|Miscellaneous|0
2580401|NCT01212770|8925215|P9|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2580402|NCT01212770|8925216|P8|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2580403|NCT01212770|8925217|P7|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2580404|NCT01212770|8925218|P6|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2580405|NCT01212770|8925219|P5|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2580406|NCT01212770|8925220|P4|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2580407|NCT01212770|8925221|P3|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
2580408|NCT01212770|8925222|P2|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2580409|NCT01212770|8925223|P1|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
2580410|NCT01212770|8925215|P9|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2580411|NCT01212770|8925216|P8|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2580412|NCT01212770|8925217|P7|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2580413|NCT01212770|8925218|P6|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2580414|NCT01212770|8925219|P5|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2580415|NCT01212770|8925220|P4|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2580416|NCT01212770|8925221|P3|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3
2580417|NCT01212770|8925222|P2|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2
2580418|NCT01212770|8925223|P1|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
2580419|NCT01212770|8925215|P9|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
2580420|NCT01212770|8925216|P8|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
2580421|NCT01212770|8925217|P7|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
2580422|NCT01212770|8925218|P6|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
2580423|NCT01212770|8925219|P5|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
2580424|NCT01212770|8925220|P4|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
2580425|NCT01212770|8925221|P3|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
2580426|NCT01212770|8925222|P2|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
2580427|NCT01212770|8925223|P1|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
2580428|NCT01212770|8925215|P9|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2580429|NCT01212770|8925216|P8|Long-term Safety Phase (Year 4)|Lack of Efficacy|2
2580430|NCT01212770|8925217|P7|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2580431|NCT01212770|8925218|P6|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2580432|NCT01212770|8925219|P5|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2580433|NCT01212770|8925220|P4|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2580434|NCT01212770|8925221|P3|Long-term Safety Phase (Year 4)|Lack of Efficacy|5
2580435|NCT01212770|8925222|P2|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
2580436|NCT01212770|8925223|P1|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
2580437|NCT01212770|8925215|P9|Long-term Safety Phase (Year 4)|Adverse Event|1
2580438|NCT01212770|8925216|P8|Long-term Safety Phase (Year 4)|Adverse Event|0
2580439|NCT01212770|8925217|P7|Long-term Safety Phase (Year 4)|Adverse Event|0
2580440|NCT01212770|8925218|P6|Long-term Safety Phase (Year 4)|Adverse Event|0
2580441|NCT01212770|8925219|P5|Long-term Safety Phase (Year 4)|Adverse Event|0
2580442|NCT01212770|8925220|P4|Long-term Safety Phase (Year 4)|Adverse Event|0
2580443|NCT01212770|8925221|P3|Long-term Safety Phase (Year 4)|Adverse Event|1
2580444|NCT01212770|8925222|P2|Long-term Safety Phase (Year 4)|Adverse Event|1
2580445|NCT01212770|8925223|P1|Long-term Safety Phase (Year 4)|Adverse Event|0
2580446|NCT01212770|8925215|P9|Long-term Safety Phase (Year 3)|Miscellaneous|1
2580447|NCT01212770|8925216|P8|Long-term Safety Phase (Year 3)|Miscellaneous|1
2580448|NCT01212770|8925217|P7|Long-term Safety Phase (Year 3)|Miscellaneous|0
2580449|NCT01212770|8925218|P6|Long-term Safety Phase (Year 3)|Miscellaneous|0
2580450|NCT01212770|8925219|P5|Long-term Safety Phase (Year 3)|Miscellaneous|0
2580451|NCT01212770|8925220|P4|Long-term Safety Phase (Year 3)|Miscellaneous|0
2580452|NCT01212770|8925221|P3|Long-term Safety Phase (Year 3)|Miscellaneous|1
2580453|NCT01212770|8925222|P2|Long-term Safety Phase (Year 3)|Miscellaneous|2
2580454|NCT01212770|8925223|P1|Long-term Safety Phase (Year 3)|Miscellaneous|0
2580455|NCT01212770|8925215|P9|Long-term Safety Phase (Year 3)|Protocol Violation|0
2580456|NCT01212770|8925216|P8|Long-term Safety Phase (Year 3)|Protocol Violation|1
2580457|NCT01212770|8925217|P7|Long-term Safety Phase (Year 3)|Protocol Violation|0
2580458|NCT01212770|8925218|P6|Long-term Safety Phase (Year 3)|Protocol Violation|0
2580459|NCT01212770|8925219|P5|Long-term Safety Phase (Year 3)|Protocol Violation|0
2580460|NCT01212770|8925220|P4|Long-term Safety Phase (Year 3)|Protocol Violation|0
2580461|NCT01212770|8925221|P3|Long-term Safety Phase (Year 3)|Protocol Violation|0
2580462|NCT01212770|8925222|P2|Long-term Safety Phase (Year 3)|Protocol Violation|0
2580463|NCT01212770|8925223|P1|Long-term Safety Phase (Year 3)|Protocol Violation|0
2580464|NCT01212770|8925215|P9|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2580465|NCT01212770|8925216|P8|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2580466|NCT01212770|8925217|P7|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2580467|NCT01212770|8925218|P6|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2580468|NCT01212770|8925219|P5|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2580469|NCT01212770|8925220|P4|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2580470|NCT01212770|8925221|P3|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2580471|NCT01212770|8925222|P2|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
2580472|NCT01212770|8925223|P1|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
2580473|NCT01212770|8925215|P9|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
2580474|NCT01212770|8925216|P8|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
2580475|NCT01212770|8925217|P7|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
2580476|NCT01212770|8925218|P6|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
2580477|NCT01212770|8925219|P5|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
2580478|NCT01212770|8925220|P4|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
2580479|NCT01212770|8925221|P3|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
2580480|NCT01212770|8925222|P2|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3
2580481|NCT01212770|8925223|P1|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
2580482|NCT01212770|8925215|P9|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
2580483|NCT01212770|8925216|P8|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
2580484|NCT01212770|8925217|P7|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
2580485|NCT01212770|8925218|P6|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
2580486|NCT01212770|8925219|P5|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
2580487|NCT01212770|8925220|P4|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
2580488|NCT01212770|8925221|P3|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
2580489|NCT01212770|8925222|P2|Long-term Safety Phase (Year 3)|Lack of Efficacy|3
2580490|NCT01212770|8925223|P1|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
2580491|NCT01212770|8925215|P9|Long-term Safety Phase (Year 3)|Adverse Event|1
2580492|NCT01212770|8925216|P8|Long-term Safety Phase (Year 3)|Adverse Event|2
2580493|NCT01212770|8925217|P7|Long-term Safety Phase (Year 3)|Adverse Event|0
2580494|NCT01212770|8925218|P6|Long-term Safety Phase (Year 3)|Adverse Event|0
2580495|NCT01212770|8925219|P5|Long-term Safety Phase (Year 3)|Adverse Event|0
2580496|NCT01212770|8925220|P4|Long-term Safety Phase (Year 3)|Adverse Event|0
2580497|NCT01212770|8925221|P3|Long-term Safety Phase (Year 3)|Adverse Event|2
2580498|NCT01212770|8925222|P2|Long-term Safety Phase (Year 3)|Adverse Event|2
2580499|NCT01212770|8925223|P1|Long-term Safety Phase (Year 3)|Adverse Event|0
2580500|NCT01212770|8925215|P9|Long-term Safety Phase (Year 2)|Miscellaneous|1
2580501|NCT01212770|8925216|P8|Long-term Safety Phase (Year 2)|Miscellaneous|0
2580502|NCT01212770|8925217|P7|Long-term Safety Phase (Year 2)|Miscellaneous|0
2580503|NCT01212770|8925218|P6|Long-term Safety Phase (Year 2)|Miscellaneous|0
2580504|NCT01212770|8925219|P5|Long-term Safety Phase (Year 2)|Miscellaneous|0
2580505|NCT01212770|8925220|P4|Long-term Safety Phase (Year 2)|Miscellaneous|0
2580506|NCT01212770|8925221|P3|Long-term Safety Phase (Year 2)|Miscellaneous|1
2580507|NCT01212770|8925222|P2|Long-term Safety Phase (Year 2)|Miscellaneous|2
2580508|NCT01212770|8925223|P1|Long-term Safety Phase (Year 2)|Miscellaneous|0
2580509|NCT01212770|8925215|P9|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
2580510|NCT01212770|8925216|P8|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
2580511|NCT01212770|8925217|P7|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
2580512|NCT01212770|8925218|P6|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
2580513|NCT01212770|8925219|P5|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
2580514|NCT01212770|8925220|P4|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
2580515|NCT01212770|8925221|P3|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
2580516|NCT01212770|8925222|P2|Long-term Safety Phase (Year 2)|Lost to Follow-up|2
2580517|NCT01212770|8925223|P1|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
2580518|NCT01212770|8925215|P9|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
2580519|NCT01212770|8925216|P8|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
2580520|NCT01212770|8925217|P7|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
2580521|NCT01212770|8925218|P6|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
2580522|NCT01212770|8925219|P5|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
2580523|NCT01212770|8925220|P4|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
2580524|NCT01212770|8925221|P3|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
2580525|NCT01212770|8925222|P2|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9
2580526|NCT01212770|8925223|P1|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
2580527|NCT01212770|8925215|P9|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
2580528|NCT01212770|8925216|P8|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
2580529|NCT01212770|8925217|P7|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
2580530|NCT01212770|8925218|P6|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
2580531|NCT01212770|8925219|P5|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
2580532|NCT01212770|8925220|P4|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
2580533|NCT01212770|8925221|P3|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
2580534|NCT01212770|8925222|P2|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1
2580535|NCT01212770|8925223|P1|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
2580536|NCT01212770|8925215|P9|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
2580537|NCT01212770|8925216|P8|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
2580538|NCT01212770|8925217|P7|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
2580539|NCT01212770|8925218|P6|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
2580540|NCT01212770|8925219|P5|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
2580541|NCT01212770|8925220|P4|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
2580542|NCT01212770|8925221|P3|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
2580543|NCT01212770|8925222|P2|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
2580544|NCT01212770|8925223|P1|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
2580545|NCT01212770|8925215|P9|Long-term Safety Phase (Year 2)|Adverse Event|2
2580546|NCT01212770|8925216|P8|Long-term Safety Phase (Year 2)|Adverse Event|0
2580547|NCT01212770|8925217|P7|Long-term Safety Phase (Year 2)|Adverse Event|0
2580548|NCT01212770|8925218|P6|Long-term Safety Phase (Year 2)|Adverse Event|0
2580549|NCT01212770|8925219|P5|Long-term Safety Phase (Year 2)|Adverse Event|0
2580550|NCT01212770|8925220|P4|Long-term Safety Phase (Year 2)|Adverse Event|0
2580551|NCT01212770|8925221|P3|Long-term Safety Phase (Year 2)|Adverse Event|3
2580552|NCT01212770|8925222|P2|Long-term Safety Phase (Year 2)|Adverse Event|3
2580553|NCT01212770|8925223|P1|Long-term Safety Phase (Year 2)|Adverse Event|0
2580554|NCT01212770|8925215|P9|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
2580555|NCT01212770|8925216|P8|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
2580556|NCT01212770|8925217|P7|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
2580557|NCT01212770|8925218|P6|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
2580558|NCT01212770|8925219|P5|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
2580559|NCT01212770|8925220|P4|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
2580560|NCT01212770|8925221|P3|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
2580561|NCT01212770|8925222|P2|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
2580562|NCT01212770|8925223|P1|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
2580563|NCT01212770|8925215|P9|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
2580564|NCT01212770|8925216|P8|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
2580565|NCT01212770|8925217|P7|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
2580566|NCT01212770|8925218|P6|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
2580567|NCT01212770|8925219|P5|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
2580568|NCT01212770|8925220|P4|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1
2580569|NCT01212770|8925221|P3|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
2580570|NCT01212770|8925222|P2|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
2580571|NCT01212770|8925223|P1|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
2580572|NCT01212770|8925215|P9|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
2580573|NCT01212770|8925216|P8|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
2580574|NCT01212770|8925217|P7|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
2580575|NCT01212770|8925218|P6|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
2580576|NCT01212770|8925219|P5|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
2580577|NCT01212770|8925220|P4|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
2580578|NCT01212770|8925221|P3|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
2580579|NCT01212770|8925222|P2|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
2580580|NCT01212770|8925223|P1|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
2580581|NCT01212770|8925215|P9|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
2580582|NCT01212770|8925216|P8|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
2580583|NCT01212770|8925217|P7|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
2580584|NCT01212770|8925218|P6|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
2580585|NCT01212770|8925219|P5|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
2580586|NCT01212770|8925220|P4|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
2580587|NCT01212770|8925221|P3|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
2580588|NCT01212770|8925222|P2|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6
2580589|NCT01212770|8925223|P1|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
2580590|NCT01212770|8925215|P9|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
2580591|NCT01212770|8925216|P8|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
2580592|NCT01212770|8925217|P7|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
2580593|NCT01212770|8925218|P6|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2
2580594|NCT01212770|8925219|P5|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1
2580595|NCT01212770|8925220|P4|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4
2580596|NCT01212770|8925221|P3|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5
2580597|NCT01212770|8925222|P2|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7
2580598|NCT01212770|8925223|P1|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
2580599|NCT01212770|8925215|P9|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
2580600|NCT01212770|8925216|P8|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
2580601|NCT01212770|8925217|P7|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
2580602|NCT01212770|8925218|P6|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
2580603|NCT01212770|8925219|P5|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
2580604|NCT01212770|8925220|P4|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
2580605|NCT01212770|8925221|P3|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
2580606|NCT01212770|8925222|P2|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6
2580607|NCT01212770|8925223|P1|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
2580608|NCT01212770|8925215|P9|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
2580609|NCT01212770|8925216|P8|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
2580610|NCT01212770|8925217|P7|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
2580611|NCT01212770|8925218|P6|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
2580612|NCT01212770|8925219|P5|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
2580613|NCT01212770|8925220|P4|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
2580614|NCT01212770|8925221|P3|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2
2580615|NCT01212770|8925222|P2|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1
2580616|NCT01212770|8925223|P1|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3
2580617|NCT01212770|8925215|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2580618|NCT01212770|8925216|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2580619|NCT01212770|8925217|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2580620|NCT01212770|8925218|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2580621|NCT01212770|8925219|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2580622|NCT01212770|8925220|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2580623|NCT01212770|8925221|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
2580624|NCT01212770|8925222|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2580625|NCT01212770|8925223|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2580626|NCT01212770|8925215|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2580627|NCT01212770|8925216|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2580628|NCT01212770|8925217|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2580629|NCT01212770|8925218|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2580630|NCT01212770|8925219|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2580631|NCT01212770|8925220|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2580632|NCT01212770|8925221|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3
2580633|NCT01212770|8925222|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2580634|NCT01212770|8925223|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
2580635|NCT01212770|8925215|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2580636|NCT01212770|8925216|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2580637|NCT01212770|8925217|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2580638|NCT01212770|8925218|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2580639|NCT01212770|8925219|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2580640|NCT01212770|8925220|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2580641|NCT01212770|8925221|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
2580642|NCT01212770|8925222|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
2580643|NCT01212770|8925223|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
2580644|NCT01212770|8925215|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2580645|NCT01212770|8925216|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2580646|NCT01212770|8925217|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2580647|NCT01212770|8925218|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2580648|NCT01212770|8925219|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2580649|NCT01212770|8925220|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2580650|NCT01212770|8925221|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7
2580651|NCT01212770|8925222|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5
2580652|NCT01212770|8925223|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
2580653|NCT01212770|8925215|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2580654|NCT01212770|8925216|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2580655|NCT01212770|8925217|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2580656|NCT01212770|8925218|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2580657|NCT01212770|8925219|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2580658|NCT01212770|8925220|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2580659|NCT01212770|8925221|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8
2580660|NCT01212770|8925222|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
2580661|NCT01212770|8925223|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
2580662|NCT01212757|8925420|P9|Long-Term Safety Phase (Year 5)|Miscellaneous|0
2580663|NCT01212757|8925421|P8|Long-Term Safety Phase (Year 5)|Miscellaneous|0
2580664|NCT01212757|8925422|P7|Long-Term Safety Phase (Year 5)|Miscellaneous|0
2580665|NCT01212757|8925423|P6|Long-Term Safety Phase (Year 5)|Miscellaneous|0
2580666|NCT01212757|8925424|P5|Long-Term Safety Phase (Year 5)|Miscellaneous|0
2580667|NCT01212757|8925425|P4|Long-Term Safety Phase (Year 5)|Miscellaneous|0
2580668|NCT01212757|8925426|P3|Long-Term Safety Phase (Year 5)|Miscellaneous|1
2580669|NCT01212757|8925427|P2|Long-Term Safety Phase (Year 5)|Miscellaneous|1
2580670|NCT01212757|8925428|P1|Long-Term Safety Phase (Year 5)|Miscellaneous|0
2581042|NCT01211197|8926094|P4|Washout Period 2 (7 Days)|Adverse Event|0
2580671|NCT01212757|8925420|P9|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
2580672|NCT01212757|8925421|P8|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
2580673|NCT01212757|8925422|P7|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
2580674|NCT01212757|8925423|P6|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
2580675|NCT01212757|8925424|P5|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
2580676|NCT01212757|8925425|P4|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
2580677|NCT01212757|8925426|P3|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
2580678|NCT01212757|8925427|P2|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1
2580679|NCT01212757|8925428|P1|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
2580680|NCT01212757|8925420|P9|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
2580681|NCT01212757|8925421|P8|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
2580682|NCT01212757|8925422|P7|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
2580683|NCT01212757|8925423|P6|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
2580684|NCT01212757|8925424|P5|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
2580685|NCT01212757|8925425|P4|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
2580686|NCT01212757|8925426|P3|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
2580687|NCT01212757|8925427|P2|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
2580688|NCT01212757|8925428|P1|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
2580689|NCT01212757|8925420|P9|Long-Term Safety Phase (Year 5)|Adverse Event|0
2580690|NCT01212757|8925421|P8|Long-Term Safety Phase (Year 5)|Adverse Event|2
2580691|NCT01212757|8925422|P7|Long-Term Safety Phase (Year 5)|Adverse Event|0
2580692|NCT01212757|8925423|P6|Long-Term Safety Phase (Year 5)|Adverse Event|0
2580693|NCT01212757|8925424|P5|Long-Term Safety Phase (Year 5)|Adverse Event|0
2580694|NCT01212757|8925425|P4|Long-Term Safety Phase (Year 5)|Adverse Event|0
2580695|NCT01212757|8925426|P3|Long-Term Safety Phase (Year 5)|Adverse Event|2
2580696|NCT01212757|8925427|P2|Long-Term Safety Phase (Year 5)|Adverse Event|2
2580697|NCT01212757|8925428|P1|Long-Term Safety Phase (Year 5)|Adverse Event|0
2580698|NCT01212757|8925420|P9|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
2580699|NCT01212757|8925421|P8|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
2580700|NCT01212757|8925422|P7|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
2580701|NCT01212757|8925423|P6|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
2580702|NCT01212757|8925424|P5|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
2580703|NCT01212757|8925425|P4|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
2580704|NCT01212757|8925426|P3|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
2580705|NCT01212757|8925427|P2|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
2580706|NCT01212757|8925428|P1|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
2580707|NCT01212757|8925420|P9|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
2580708|NCT01212757|8925421|P8|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1
2580709|NCT01212757|8925422|P7|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
2580710|NCT01212757|8925423|P6|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
2580711|NCT01212757|8925424|P5|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
2580712|NCT01212757|8925425|P4|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
2580713|NCT01212757|8925426|P3|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
2580714|NCT01212757|8925427|P2|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
2580715|NCT01212757|8925428|P1|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
2580716|NCT01212757|8925420|P9|Long-Term Safety Phase (Year 4)|Death|1
2580717|NCT01212757|8925421|P8|Long-Term Safety Phase (Year 4)|Death|0
2580718|NCT01212757|8925422|P7|Long-Term Safety Phase (Year 4)|Death|0
2580719|NCT01212757|8925423|P6|Long-Term Safety Phase (Year 4)|Death|0
2580720|NCT01212757|8925424|P5|Long-Term Safety Phase (Year 4)|Death|0
2580721|NCT01212757|8925425|P4|Long-Term Safety Phase (Year 4)|Death|0
2580722|NCT01212757|8925426|P3|Long-Term Safety Phase (Year 4)|Death|1
2580723|NCT01212757|8925427|P2|Long-Term Safety Phase (Year 4)|Death|0
2580724|NCT01212757|8925428|P1|Long-Term Safety Phase (Year 4)|Death|0
2580725|NCT01212757|8925420|P9|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3
2580726|NCT01212757|8925421|P8|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1
2580727|NCT01212757|8925422|P7|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
2580728|NCT01212757|8925423|P6|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
2580729|NCT01212757|8925424|P5|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
2580730|NCT01212757|8925425|P4|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
2580731|NCT01212757|8925426|P3|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2
2580732|NCT01212757|8925427|P2|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4
2580733|NCT01212757|8925428|P1|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
2580734|NCT01212757|8925420|P9|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
2580735|NCT01212757|8925421|P8|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
2580736|NCT01212757|8925422|P7|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
2580737|NCT01212757|8925423|P6|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
2580738|NCT01212757|8925424|P5|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
2580739|NCT01212757|8925425|P4|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
2580740|NCT01212757|8925426|P3|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
2580741|NCT01212757|8925427|P2|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
2580742|NCT01212757|8925428|P1|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
2580743|NCT01212757|8925420|P9|Long-Term Safety Phase (Year 4)|Adverse Event|1
2580744|NCT01212757|8925421|P8|Long-Term Safety Phase (Year 4)|Adverse Event|1
2580745|NCT01212757|8925422|P7|Long-Term Safety Phase (Year 4)|Adverse Event|0
2580746|NCT01212757|8925423|P6|Long-Term Safety Phase (Year 4)|Adverse Event|0
2580747|NCT01212757|8925424|P5|Long-Term Safety Phase (Year 4)|Adverse Event|0
2580748|NCT01212757|8925425|P4|Long-Term Safety Phase (Year 4)|Adverse Event|0
2580749|NCT01212757|8925426|P3|Long-Term Safety Phase (Year 4)|Adverse Event|2
2580750|NCT01212757|8925427|P2|Long-Term Safety Phase (Year 4)|Adverse Event|1
2580751|NCT01212757|8925428|P1|Long-Term Safety Phase (Year 4)|Adverse Event|0
2580752|NCT01212757|8925420|P9|Long-Term Safety Phase (Year 4)|Miscellaneous|1
2580753|NCT01212757|8925421|P8|Long-Term Safety Phase (Year 4)|Miscellaneous|0
2580754|NCT01212757|8925422|P7|Long-Term Safety Phase (Year 4)|Miscellaneous|0
2580755|NCT01212757|8925423|P6|Long-Term Safety Phase (Year 4)|Miscellaneous|0
2580756|NCT01212757|8925424|P5|Long-Term Safety Phase (Year 4)|Miscellaneous|0
2580757|NCT01212757|8925425|P4|Long-Term Safety Phase (Year 4)|Miscellaneous|0
2580758|NCT01212757|8925426|P3|Long-Term Safety Phase (Year 4)|Miscellaneous|0
2580759|NCT01212757|8925427|P2|Long-Term Safety Phase (Year 4)|Miscellaneous|2
2580760|NCT01212757|8925428|P1|Long-Term Safety Phase (Year 4)|Miscellaneous|0
2580761|NCT01212757|8925420|P9|Long-Term Safety Phase (Year 3)|Miscellaneous|2
2580762|NCT01212757|8925421|P8|Long-Term Safety Phase (Year 3)|Miscellaneous|0
2580763|NCT01212757|8925422|P7|Long-Term Safety Phase (Year 3)|Miscellaneous|0
2580764|NCT01212757|8925423|P6|Long-Term Safety Phase (Year 3)|Miscellaneous|0
2580765|NCT01212757|8925424|P5|Long-Term Safety Phase (Year 3)|Miscellaneous|0
2580766|NCT01212757|8925425|P4|Long-Term Safety Phase (Year 3)|Miscellaneous|0
2580767|NCT01212757|8925426|P3|Long-Term Safety Phase (Year 3)|Miscellaneous|3
2580768|NCT01212757|8925427|P2|Long-Term Safety Phase (Year 3)|Miscellaneous|0
2580769|NCT01212757|8925428|P1|Long-Term Safety Phase (Year 3)|Miscellaneous|0
2580770|NCT01212757|8925420|P9|Long-Term Safety Phase (Year 3)|Protocol Violation|0
2580771|NCT01212757|8925421|P8|Long-Term Safety Phase (Year 3)|Protocol Violation|0
2580772|NCT01212757|8925422|P7|Long-Term Safety Phase (Year 3)|Protocol Violation|0
2580773|NCT01212757|8925423|P6|Long-Term Safety Phase (Year 3)|Protocol Violation|0
2580774|NCT01212757|8925424|P5|Long-Term Safety Phase (Year 3)|Protocol Violation|0
2580775|NCT01212757|8925425|P4|Long-Term Safety Phase (Year 3)|Protocol Violation|0
2580776|NCT01212757|8925426|P3|Long-Term Safety Phase (Year 3)|Protocol Violation|0
2580777|NCT01212757|8925427|P2|Long-Term Safety Phase (Year 3)|Protocol Violation|1
2580778|NCT01212757|8925428|P1|Long-Term Safety Phase (Year 3)|Protocol Violation|0
2580779|NCT01212757|8925420|P9|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1
2580780|NCT01212757|8925421|P8|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
2580781|NCT01212757|8925422|P7|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
2580782|NCT01212757|8925423|P6|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
2580783|NCT01212757|8925424|P5|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
2580784|NCT01212757|8925425|P4|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
2580785|NCT01212757|8925426|P3|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
2580786|NCT01212757|8925427|P2|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
2580787|NCT01212757|8925428|P1|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
2580788|NCT01212757|8925420|P9|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
2580789|NCT01212757|8925421|P8|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
2580790|NCT01212757|8925422|P7|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
2580791|NCT01212757|8925423|P6|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
2580792|NCT01212757|8925424|P5|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
2580793|NCT01212757|8925425|P4|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
2580794|NCT01212757|8925426|P3|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
2580795|NCT01212757|8925427|P2|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5
2580796|NCT01212757|8925428|P1|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
2580797|NCT01212757|8925420|P9|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
2580798|NCT01212757|8925421|P8|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
2580799|NCT01212757|8925422|P7|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
2580800|NCT01212757|8925423|P6|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
2580801|NCT01212757|8925424|P5|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
2580802|NCT01212757|8925425|P4|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
2580803|NCT01212757|8925426|P3|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1
2580804|NCT01212757|8925427|P2|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
2580805|NCT01212757|8925428|P1|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
2580806|NCT01212757|8925420|P9|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1
2580807|NCT01212757|8925421|P8|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3
2580808|NCT01212757|8925422|P7|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
2580809|NCT01212757|8925423|P6|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
2580810|NCT01212757|8925424|P5|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
2580811|NCT01212757|8925425|P4|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
2580812|NCT01212757|8925426|P3|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5
2580813|NCT01212757|8925427|P2|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8
2580814|NCT01212757|8925428|P1|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
2580815|NCT01212757|8925420|P9|Long-Term Safety Phase (Year 3)|Adverse Event|0
2580816|NCT01212757|8925421|P8|Long-Term Safety Phase (Year 3)|Adverse Event|2
2580817|NCT01212757|8925422|P7|Long-Term Safety Phase (Year 3)|Adverse Event|0
2580818|NCT01212757|8925423|P6|Long-Term Safety Phase (Year 3)|Adverse Event|0
2580819|NCT01212757|8925424|P5|Long-Term Safety Phase (Year 3)|Adverse Event|0
2580820|NCT01212757|8925425|P4|Long-Term Safety Phase (Year 3)|Adverse Event|0
2580821|NCT01212757|8925426|P3|Long-Term Safety Phase (Year 3)|Adverse Event|1
2580822|NCT01212757|8925427|P2|Long-Term Safety Phase (Year 3)|Adverse Event|4
2580823|NCT01212757|8925428|P1|Long-Term Safety Phase (Year 3)|Adverse Event|0
2580824|NCT01212757|8925420|P9|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
2580825|NCT01212757|8925421|P8|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
2580826|NCT01212757|8925422|P7|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
2580827|NCT01212757|8925423|P6|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
2580828|NCT01212757|8925424|P5|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
2580829|NCT01212757|8925425|P4|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
2580830|NCT01212757|8925426|P3|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2
2580831|NCT01212757|8925427|P2|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
2580832|NCT01212757|8925428|P1|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
2580833|NCT01212757|8925420|P9|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6
2580834|NCT01212757|8925421|P8|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4
2580835|NCT01212757|8925422|P7|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
2580836|NCT01212757|8925423|P6|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
2580837|NCT01212757|8925424|P5|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
2580838|NCT01212757|8925425|P4|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
2580839|NCT01212757|8925426|P3|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9
2580840|NCT01212757|8925427|P2|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7
2580841|NCT01212757|8925428|P1|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
2580842|NCT01212757|8925420|P9|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
2580843|NCT01212757|8925421|P8|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
2580844|NCT01212757|8925422|P7|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
2580845|NCT01212757|8925423|P6|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
2580846|NCT01212757|8925424|P5|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
2580847|NCT01212757|8925425|P4|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
2580848|NCT01212757|8925426|P3|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2
2580849|NCT01212757|8925427|P2|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
2580850|NCT01212757|8925428|P1|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
2580851|NCT01212757|8925420|P9|Long-Term Safety Phase (Year 2)|Adverse Event|2
2580852|NCT01212757|8925421|P8|Long-Term Safety Phase (Year 2)|Adverse Event|2
2580853|NCT01212757|8925422|P7|Long-Term Safety Phase (Year 2)|Adverse Event|0
2580854|NCT01212757|8925423|P6|Long-Term Safety Phase (Year 2)|Adverse Event|0
2580855|NCT01212757|8925424|P5|Long-Term Safety Phase (Year 2)|Adverse Event|0
2580856|NCT01212757|8925425|P4|Long-Term Safety Phase (Year 2)|Adverse Event|0
2580857|NCT01212757|8925426|P3|Long-Term Safety Phase (Year 2)|Adverse Event|1
2580858|NCT01212757|8925427|P2|Long-Term Safety Phase (Year 2)|Adverse Event|1
2580859|NCT01212757|8925428|P1|Long-Term Safety Phase (Year 2)|Adverse Event|0
2580860|NCT01212757|8925420|P9|Long-Term Safety Phase (Year 2)|Miscellaneous|1
2580861|NCT01212757|8925421|P8|Long-Term Safety Phase (Year 2)|Miscellaneous|0
2580862|NCT01212757|8925422|P7|Long-Term Safety Phase (Year 2)|Miscellaneous|0
2580863|NCT01212757|8925423|P6|Long-Term Safety Phase (Year 2)|Miscellaneous|0
2580864|NCT01212757|8925424|P5|Long-Term Safety Phase (Year 2)|Miscellaneous|0
2580865|NCT01212757|8925425|P4|Long-Term Safety Phase (Year 2)|Miscellaneous|0
2580866|NCT01212757|8925426|P3|Long-Term Safety Phase (Year 2)|Miscellaneous|0
2580867|NCT01212757|8925427|P2|Long-Term Safety Phase (Year 2)|Miscellaneous|0
2580868|NCT01212757|8925428|P1|Long-Term Safety Phase (Year 2)|Miscellaneous|0
2580869|NCT01212757|8925420|P9|Active Treatment Phase (Weeks 24 - 52)|Other|0
2580870|NCT01212757|8925421|P8|Active Treatment Phase (Weeks 24 - 52)|Other|0
2580871|NCT01212757|8925422|P7|Active Treatment Phase (Weeks 24 - 52)|Other|0
2580872|NCT01212757|8925423|P6|Active Treatment Phase (Weeks 24 - 52)|Other|0
2580873|NCT01212757|8925424|P5|Active Treatment Phase (Weeks 24 - 52)|Other|0
2580874|NCT01212757|8925425|P4|Active Treatment Phase (Weeks 24 - 52)|Other|0
2580875|NCT01212757|8925426|P3|Active Treatment Phase (Weeks 24 - 52)|Other|1
2580876|NCT01212757|8925427|P2|Active Treatment Phase (Weeks 24 - 52)|Other|1
2580877|NCT01212757|8925428|P1|Active Treatment Phase (Weeks 24 - 52)|Other|0
2580878|NCT01212757|8925420|P9|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
2580879|NCT01212757|8925421|P8|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
2580880|NCT01212757|8925422|P7|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
2580881|NCT01212757|8925423|P6|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
2580882|NCT01212757|8925424|P5|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
2580883|NCT01212757|8925425|P4|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
2580884|NCT01212757|8925426|P3|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
2580885|NCT01212757|8925427|P2|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
2580886|NCT01212757|8925428|P1|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
2580887|NCT01212757|8925420|P9|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
2580888|NCT01212757|8925421|P8|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
2580889|NCT01212757|8925422|P7|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
2580890|NCT01212757|8925423|P6|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
2580891|NCT01212757|8925424|P5|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1
2580892|NCT01212757|8925425|P4|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
2580893|NCT01212757|8925426|P3|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7
2580894|NCT01212757|8925427|P2|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
2580895|NCT01212757|8925428|P1|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
2580896|NCT01212757|8925420|P9|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
2580897|NCT01212757|8925421|P8|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
2580898|NCT01212757|8925422|P7|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
2580899|NCT01212757|8925423|P6|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
2580900|NCT01212757|8925424|P5|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
2580901|NCT01212757|8925425|P4|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
2580902|NCT01212757|8925426|P3|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2
2580903|NCT01212757|8925427|P2|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
2580904|NCT01212757|8925428|P1|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
2580905|NCT01212757|8925420|P9|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
2580906|NCT01212757|8925421|P8|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
2580907|NCT01212757|8925422|P7|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
2580908|NCT01212757|8925423|P6|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2
2580909|NCT01212757|8925424|P5|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
2580910|NCT01212757|8925425|P4|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4
2580911|NCT01212757|8925426|P3|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7
2580912|NCT01212757|8925427|P2|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5
2580913|NCT01212757|8925428|P1|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
2580914|NCT01212757|8925420|P9|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
2580915|NCT01212757|8925421|P8|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
2580916|NCT01212757|8925422|P7|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
2580917|NCT01212757|8925423|P6|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
2580918|NCT01212757|8925424|P5|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
2580919|NCT01212757|8925425|P4|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1
2580920|NCT01212757|8925426|P3|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3
2580921|NCT01212757|8925427|P2|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
2580922|NCT01212757|8925428|P1|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
2580923|NCT01212757|8925420|P9|Placebo-controlled Phase (Week 0 - 24)|Other|0
2580924|NCT01212757|8925421|P8|Placebo-controlled Phase (Week 0 - 24)|Other|0
2580925|NCT01212757|8925422|P7|Placebo-controlled Phase (Week 0 - 24)|Other|0
2580926|NCT01212757|8925423|P6|Placebo-controlled Phase (Week 0 - 24)|Other|0
2580927|NCT01212757|8925424|P5|Placebo-controlled Phase (Week 0 - 24)|Other|0
2580928|NCT01212757|8925425|P4|Placebo-controlled Phase (Week 0 - 24)|Other|0
2580929|NCT01212757|8925426|P3|Placebo-controlled Phase (Week 0 - 24)|Other|0
2580930|NCT01212757|8925427|P2|Placebo-controlled Phase (Week 0 - 24)|Other|2
2580931|NCT01212757|8925428|P1|Placebo-controlled Phase (Week 0 - 24)|Other|1
2580932|NCT01212757|8925420|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2580933|NCT01212757|8925421|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2580934|NCT01212757|8925422|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2580935|NCT01212757|8925423|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2580936|NCT01212757|8925424|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2580937|NCT01212757|8925425|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2580938|NCT01212757|8925426|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
2580939|NCT01212757|8925427|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
2580940|NCT01212757|8925428|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
2580941|NCT01212757|8925420|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2580942|NCT01212757|8925421|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2580943|NCT01212757|8925422|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2580944|NCT01212757|8925423|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2580945|NCT01212757|8925424|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2580946|NCT01212757|8925425|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
2580947|NCT01212757|8925426|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
2580948|NCT01212757|8925427|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
2580949|NCT01212757|8925428|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
2580950|NCT01212757|8925420|P9|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2580951|NCT01212757|8925421|P8|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2580952|NCT01212757|8925422|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2580953|NCT01212757|8925423|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2580954|NCT01212757|8925424|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2580955|NCT01212757|8925425|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2580956|NCT01212757|8925426|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
2580957|NCT01212757|8925427|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
2580958|NCT01212757|8925428|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3
2580959|NCT01212757|8925420|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2580960|NCT01212757|8925421|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2580961|NCT01212757|8925422|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2580962|NCT01212757|8925423|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2580963|NCT01212757|8925424|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2580964|NCT01212757|8925425|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
2580965|NCT01212757|8925426|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
2580966|NCT01212757|8925427|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9
2580967|NCT01212757|8925428|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7
2580968|NCT01212757|8925420|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2580969|NCT01212757|8925421|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2580970|NCT01212757|8925422|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2580971|NCT01212757|8925423|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2580972|NCT01212757|8925424|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2580973|NCT01212757|8925425|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
2580974|NCT01212757|8925426|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
2580975|NCT01212757|8925427|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
2580976|NCT01212757|8925428|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
2580977|NCT01212757|8925420|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2580978|NCT01212757|8925421|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2580979|NCT01212757|8925422|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2580980|NCT01212757|8925423|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2580981|NCT01212757|8925424|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2580982|NCT01212757|8925425|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
2580983|NCT01212757|8925426|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
2580984|NCT01212757|8925427|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
2580985|NCT01212757|8925428|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
2580986|NCT01212744|8925612|P1|Overall Study|Withdrawal by Subject|1
2580987|NCT01212588|8925631|P2|Overall Study|Protocol Violation|1
2580988|NCT01212588|8925632|P1|Overall Study|Protocol Violation|1
2580989|NCT01212588|8925631|P2|Overall Study|Physician Decision|1
2580990|NCT01212588|8925632|P1|Overall Study|Physician Decision|0
2580991|NCT01212185|8925717|P2|Overall Study|Protocol Violation|1
2580992|NCT01212185|8925718|P1|Overall Study|Protocol Violation|2
2580993|NCT01212159|8925737|P2|Overall Study|Withdrawal by Subject|12
2580994|NCT01212159|8925738|P1|Overall Study|Withdrawal by Subject|12
2580995|NCT01212094|8925837|P3|Years 2 & 3: Treatment Randomization|Adverse Event|1
2580996|NCT01212094|8925838|P2|Years 2 & 3: Treatment Randomization|Adverse Event|0
2580997|NCT01212094|8925839|P1|Years 2 & 3: Treatment Randomization|Adverse Event|0
2580998|NCT01212094|8925837|P3|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3
2580999|NCT01212094|8925838|P2|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
2581000|NCT01212094|8925839|P1|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
2581001|NCT01212094|8925837|P3|Years 2 & 3: Treatment Randomization|Study terminated|7
2581002|NCT01212094|8925838|P2|Years 2 & 3: Treatment Randomization|Study terminated|4
2581003|NCT01212094|8925839|P1|Years 2 & 3: Treatment Randomization|Study terminated|0
2581004|NCT01212094|8925837|P3|Year 1: Baseline Monitoring|Started on DMT|0
2581005|NCT01212094|8925838|P2|Year 1: Baseline Monitoring|Started on DMT|0
2581006|NCT01212094|8925839|P1|Year 1: Baseline Monitoring|Started on DMT|2
2581007|NCT01212094|8925837|P3|Year 1: Baseline Monitoring|Withdrawal by Subject|0
2581008|NCT01212094|8925838|P2|Year 1: Baseline Monitoring|Withdrawal by Subject|0
2581009|NCT01212094|8925839|P1|Year 1: Baseline Monitoring|Withdrawal by Subject|7
2581010|NCT01212094|8925837|P3|Year 1: Baseline Monitoring|Study terminated|0
2581011|NCT01212094|8925838|P2|Year 1: Baseline Monitoring|Study terminated|0
2581012|NCT01212094|8925839|P1|Year 1: Baseline Monitoring|Study terminated|7
2581013|NCT01211769|8925898|P4|Overall Study|Adverse Event|1
2581014|NCT01211769|8925899|P3|Overall Study|Adverse Event|1
2581015|NCT01211769|8925900|P2|Overall Study|Adverse Event|1
2581016|NCT01211769|8925901|P1|Overall Study|Adverse Event|0
2581017|NCT01211769|8925898|P4|Overall Study|Physician Decision|1
2581018|NCT01211769|8925899|P3|Overall Study|Physician Decision|2
2581019|NCT01211769|8925900|P2|Overall Study|Physician Decision|0
2581020|NCT01211769|8925901|P1|Overall Study|Physician Decision|2
2581021|NCT01211769|8925898|P4|Overall Study|Lost to Follow-up|9
2581022|NCT01211769|8925899|P3|Overall Study|Lost to Follow-up|5
2581023|NCT01211769|8925900|P2|Overall Study|Lost to Follow-up|9
2581024|NCT01211769|8925901|P1|Overall Study|Lost to Follow-up|7
2581025|NCT01211665|8925956|P2|Overall Study|Death|0
2581026|NCT01211665|8925957|P1|Overall Study|Death|1
2581027|NCT01211665|8925956|P2|Overall Study|Withdrawal by Subject|0
2581028|NCT01211665|8925957|P1|Overall Study|Withdrawal by Subject|1
2581029|NCT01211613|8925984|P3|Overall Study|Withdrawal by Subject|0
2581030|NCT01211613|8925985|P2|Overall Study|Withdrawal by Subject|0
2581031|NCT01211613|8925986|P1|Overall Study|Withdrawal by Subject|1
2581032|NCT01211613|8925984|P3|Overall Study|Lost to Follow-up|2
2581033|NCT01211613|8925985|P2|Overall Study|Lost to Follow-up|2
2581034|NCT01211613|8925986|P1|Overall Study|Lost to Follow-up|2
2581035|NCT01211535|8926032|P2|Overall Study|Adverse Event|1
2581036|NCT01211535|8926033|P1|Overall Study|Adverse Event|0
2581037|NCT01211522|8926042|P3|Overall Study|Withdrawal by Subject|5
2581038|NCT01211522|8926043|P2|Overall Study|Withdrawal by Subject|7
2581039|NCT01211522|8926044|P1|Overall Study|Withdrawal by Subject|3
2581040|NCT01211197|8926092|P6|Washout Period 2 (7 Days)|Adverse Event|0
2581041|NCT01211197|8926093|P5|Washout Period 2 (7 Days)|Adverse Event|0
2581043|NCT01211197|8926095|P3|Washout Period 2 (7 Days)|Adverse Event|0
2581044|NCT01211197|8926096|P2|Washout Period 2 (7 Days)|Adverse Event|0
2581045|NCT01211197|8926097|P1|Washout Period 2 (7 Days)|Adverse Event|1
2581046|NCT01211197|8926092|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2581047|NCT01211197|8926093|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2581048|NCT01211197|8926094|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2581049|NCT01211197|8926095|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|1
2581050|NCT01211197|8926096|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2581051|NCT01211197|8926097|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
2581052|NCT01211184|8926144|P3|Overall Study|Withdrawal by Subject|1
2581053|NCT01211184|8926145|P2|Overall Study|Withdrawal by Subject|2
2581054|NCT01211184|8926146|P1|Overall Study|Withdrawal by Subject|0
2581055|NCT01211145|8926161|P4|Overall Study|Patient decision|2
2581056|NCT01211145|8926162|P3|Overall Study|Patient decision|0
2581057|NCT01211145|8926163|P2|Overall Study|Patient decision|1
2581058|NCT01211145|8926164|P1|Overall Study|Patient decision|2
2581059|NCT01211145|8926161|P4|Overall Study|Eligibility criteria not fulfilled|15
2581060|NCT01211145|8926162|P3|Overall Study|Eligibility criteria not fulfilled|10
2581061|NCT01211145|8926163|P2|Overall Study|Eligibility criteria not fulfilled|12
2581062|NCT01211145|8926164|P1|Overall Study|Eligibility criteria not fulfilled|16
2581063|NCT01211145|8926161|P4|Overall Study|Severe noncompliance to protocol|0
2581064|NCT01211145|8926162|P3|Overall Study|Severe noncompliance to protocol|0
2581065|NCT01211145|8926163|P2|Overall Study|Severe noncompliance to protocol|0
2581066|NCT01211145|8926164|P1|Overall Study|Severe noncompliance to protocol|1
2581067|NCT01211145|8926161|P4|Overall Study|Study-specific withdrawal criteria|0
2581068|NCT01211145|8926162|P3|Overall Study|Study-specific withdrawal criteria|0
2581069|NCT01211145|8926163|P2|Overall Study|Study-specific withdrawal criteria|0
2581070|NCT01211145|8926164|P1|Overall Study|Study-specific withdrawal criteria|1
2581071|NCT01211145|8926161|P4|Overall Study|Lost to Follow-up|2
2581072|NCT01211145|8926162|P3|Overall Study|Lost to Follow-up|1
2581073|NCT01211145|8926163|P2|Overall Study|Lost to Follow-up|2
2581074|NCT01211145|8926164|P1|Overall Study|Lost to Follow-up|3
2581075|NCT01211145|8926161|P4|Overall Study|Reason not specified|1
2581076|NCT01211145|8926162|P3|Overall Study|Reason not specified|2
2581077|NCT01211145|8926163|P2|Overall Study|Reason not specified|2
2581078|NCT01211145|8926164|P1|Overall Study|Reason not specified|3
2581079|NCT01210807|8926218|P2|Overall Study|Not implanted bilaterally|1
2581080|NCT01210807|8926219|P1|Overall Study|Not implanted bilaterally|2
2581081|NCT01210807|8926218|P2|Overall Study|Lost to Follow-up|2
2581082|NCT01210807|8926219|P1|Overall Study|Lost to Follow-up|1
2581083|NCT01210690|8926234|P1|Overall Study|Patient could not take glucose|1
2581084|NCT01210690|8926234|P1|Overall Study|Patient refused to swallow|1
2581085|NCT01210690|8926234|P1|Overall Study|Withdrawal by Subject|1
2581086|NCT01210690|8926234|P1|Overall Study|Disease Remission|1
2581087|NCT01210690|8926234|P1|Overall Study|Lost to Follow-up|3
2581088|NCT01210690|8926234|P1|Overall Study|Lack of Efficacy|12
2581089|NCT01210690|8926234|P1|Overall Study|Adverse Event|7
2581090|NCT01210664|8926247|P4|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1
2581091|NCT01210664|8926248|P3|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
2581092|NCT01210664|8926249|P2|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
2581093|NCT01210664|8926250|P1|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
2581094|NCT01210664|8926247|P4|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
2581095|NCT01210664|8926248|P3|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1
2581096|NCT01210664|8926249|P2|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
2581097|NCT01210664|8926250|P1|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
2581098|NCT01210664|8926247|P4|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
2581099|NCT01210664|8926248|P3|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1
2581100|NCT01210664|8926249|P2|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
2581101|NCT01210664|8926250|P1|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
2581102|NCT01210651|8926278|P2|Overall Study|Injury outside study|0
2581103|NCT01210651|8926279|P1|Overall Study|Injury outside study|2
2581104|NCT01210651|8926278|P2|Overall Study|Withdrawal by Subject|1
2581105|NCT01210651|8926279|P1|Overall Study|Withdrawal by Subject|1
2581106|NCT01210651|8926278|P2|Overall Study|Withdrawn by PI for disruptive behavior|1
2581107|NCT01210651|8926279|P1|Overall Study|Withdrawn by PI for disruptive behavior|0
2581108|NCT01210651|8926278|P2|Overall Study|schedule conflicts|5
2581109|NCT01210651|8926279|P1|Overall Study|schedule conflicts|1
2581110|NCT01210651|8926278|P2|Overall Study|Lost to Follow-up|1
2581111|NCT01210651|8926279|P1|Overall Study|Lost to Follow-up|1
2581112|NCT01210495|8926399|P4|Overall Study|Other unspecified|0
2581113|NCT01210495|8926400|P3|Overall Study|Other unspecified|6
2581114|NCT01210495|8926401|P2|Overall Study|Other unspecified|0
2581115|NCT01210495|8926402|P1|Overall Study|Other unspecified|0
2581116|NCT01210495|8926399|P4|Overall Study|Lost to Follow-up|1
2581117|NCT01210495|8926400|P3|Overall Study|Lost to Follow-up|1
2581118|NCT01210495|8926401|P2|Overall Study|Lost to Follow-up|0
2581119|NCT01210495|8926402|P1|Overall Study|Lost to Follow-up|0
2581120|NCT01210495|8926399|P4|Overall Study|Study Terminated by Sponsor|11
2581121|NCT01210495|8926400|P3|Overall Study|Study Terminated by Sponsor|4
2581122|NCT01210495|8926401|P2|Overall Study|Study Terminated by Sponsor|0
2581123|NCT01210495|8926402|P1|Overall Study|Study Terminated by Sponsor|0
2581124|NCT01210495|8926399|P4|Overall Study|Death|54
2581125|NCT01210495|8926400|P3|Overall Study|Death|112
2581126|NCT01210495|8926401|P2|Overall Study|Death|7
2581127|NCT01210495|8926402|P1|Overall Study|Death|14
2581128|NCT01210495|8926399|P4|Overall Study|Participant Refused Further Follow-Up|2
2581129|NCT01210495|8926400|P3|Overall Study|Participant Refused Further Follow-Up|11
2581130|NCT01210495|8926401|P2|Overall Study|Participant Refused Further Follow-Up|0
2581131|NCT01210495|8926402|P1|Overall Study|Participant Refused Further Follow-Up|1
2581132|NCT01210443|8926464|P1|Overall Study|Study terminated by sponsor|2
2581133|NCT01210352|8926481|P9|Overall Study|Patient Discharged Early|0
2581134|NCT01210352|8926482|P8|Overall Study|Patient Discharged Early|0
2581135|NCT01210352|8926483|P7|Overall Study|Patient Discharged Early|0
2581136|NCT01210352|8926484|P6|Overall Study|Patient Discharged Early|0
2581137|NCT01210352|8926485|P5|Overall Study|Patient Discharged Early|0
2581138|NCT01210352|8926486|P4|Overall Study|Patient Discharged Early|0
2581139|NCT01210352|8926487|P3|Overall Study|Patient Discharged Early|1
2581140|NCT01210352|8926488|P2|Overall Study|Patient Discharged Early|0
2581141|NCT01210352|8926489|P1|Overall Study|Patient Discharged Early|0
2581142|NCT01210352|8926481|P9|Overall Study|Withdrawal by Subject|1
2581143|NCT01210352|8926482|P8|Overall Study|Withdrawal by Subject|0
2581144|NCT01210352|8926483|P7|Overall Study|Withdrawal by Subject|1
2581145|NCT01210352|8926484|P6|Overall Study|Withdrawal by Subject|0
2581146|NCT01210352|8926485|P5|Overall Study|Withdrawal by Subject|0
2581147|NCT01210352|8926486|P4|Overall Study|Withdrawal by Subject|0
2581148|NCT01210352|8926487|P3|Overall Study|Withdrawal by Subject|1
2581149|NCT01210352|8926488|P2|Overall Study|Withdrawal by Subject|0
2581150|NCT01210352|8926489|P1|Overall Study|Withdrawal by Subject|0
2581151|NCT01210352|8926481|P9|Overall Study|Physician Decision|2
2581152|NCT01210352|8926482|P8|Overall Study|Physician Decision|1
2581153|NCT01210352|8926483|P7|Overall Study|Physician Decision|0
2581154|NCT01210352|8926484|P6|Overall Study|Physician Decision|0
2581155|NCT01210352|8926485|P5|Overall Study|Physician Decision|0
2581156|NCT01210352|8926486|P4|Overall Study|Physician Decision|0
2581157|NCT01210352|8926487|P3|Overall Study|Physician Decision|0
2581158|NCT01210352|8926488|P2|Overall Study|Physician Decision|0
2581159|NCT01210352|8926489|P1|Overall Study|Physician Decision|0
2581160|NCT01210352|8926481|P9|Overall Study|Lack of Efficacy|0
2581161|NCT01210352|8926482|P8|Overall Study|Lack of Efficacy|0
2581162|NCT01210352|8926483|P7|Overall Study|Lack of Efficacy|1
2581163|NCT01210352|8926484|P6|Overall Study|Lack of Efficacy|0
2581164|NCT01210352|8926485|P5|Overall Study|Lack of Efficacy|0
2581165|NCT01210352|8926486|P4|Overall Study|Lack of Efficacy|0
2581166|NCT01210352|8926487|P3|Overall Study|Lack of Efficacy|0
2581167|NCT01210352|8926488|P2|Overall Study|Lack of Efficacy|0
2581168|NCT01210352|8926489|P1|Overall Study|Lack of Efficacy|0
2581169|NCT01210352|8926481|P9|Overall Study|Adverse Event|1
2581170|NCT01210352|8926482|P8|Overall Study|Adverse Event|2
2581171|NCT01210352|8926483|P7|Overall Study|Adverse Event|0
2581172|NCT01210352|8926484|P6|Overall Study|Adverse Event|0
2581173|NCT01210352|8926485|P5|Overall Study|Adverse Event|0
2581174|NCT01210352|8926486|P4|Overall Study|Adverse Event|0
2581175|NCT01210352|8926487|P3|Overall Study|Adverse Event|0
2581176|NCT01210352|8926488|P2|Overall Study|Adverse Event|0
2581177|NCT01210352|8926489|P1|Overall Study|Adverse Event|0
2581178|NCT01210222|8926680|P1|Overall Study|Never treated|1
2581179|NCT01210222|8926680|P1|Overall Study|Ineligible|2
2581180|NCT01210144|8926716|P2|Overall Study|No transfer|0
2581181|NCT01210144|8926717|P1|Overall Study|No transfer|1
2581182|NCT01210144|8926716|P2|Overall Study|No fertilization|0
2581183|NCT01210144|8926717|P1|Overall Study|No fertilization|1
2581184|NCT01210144|8926716|P2|Overall Study|Lack of ovarian response|0
2581185|NCT01210144|8926717|P1|Overall Study|Lack of ovarian response|1
2581186|NCT01210118|8926739|P2|Overall Study|Spontaneous abortion|3
2581187|NCT01210118|8926740|P1|Overall Study|Spontaneous abortion|1
2581188|NCT01210118|8926739|P2|Overall Study|Protocol Violation|1
2581189|NCT01210118|8926740|P1|Overall Study|Protocol Violation|1
2581190|NCT01210118|8926739|P2|Overall Study|Lost to Follow-up|1
2581191|NCT01210118|8926740|P1|Overall Study|Lost to Follow-up|1
2581192|NCT01210001|8926764|P3|Overall Study|Other reason not defined above|1
2581193|NCT01210001|8926765|P2|Overall Study|Other reason not defined above|2
2581194|NCT01210001|8926766|P1|Overall Study|Other reason not defined above|2
2581195|NCT01210001|8926764|P3|Overall Study|Patient refusal to continue,not due toAE|1
2581196|NCT01210001|8926765|P2|Overall Study|Patient refusal to continue,not due toAE|2
2581197|NCT01210001|8926766|P1|Overall Study|Patient refusal to continue,not due toAE|6
2581198|NCT01210001|8926764|P3|Overall Study|Lost to Follow-up|2
2581199|NCT01210001|8926765|P2|Overall Study|Lost to Follow-up|3
2581200|NCT01210001|8926766|P1|Overall Study|Lost to Follow-up|4
2581201|NCT01210001|8926764|P3|Overall Study|Non compliant with protocol|3
2581202|NCT01210001|8926765|P2|Overall Study|Non compliant with protocol|2
2581203|NCT01210001|8926766|P1|Overall Study|Non compliant with protocol|2
2581204|NCT01210001|8926764|P3|Overall Study|Adverse Event|5
2581205|NCT01210001|8926765|P2|Overall Study|Adverse Event|2
2581206|NCT01210001|8926766|P1|Overall Study|Adverse Event|4
2581207|NCT01210001|8926764|P3|Overall Study|Not treated|0
2581208|NCT01210001|8926765|P2|Overall Study|Not treated|0
2581209|NCT01210001|8926766|P1|Overall Study|Not treated|1
2581210|NCT01209949|8926786|P1|Overall Study|Lost to Follow-up|3
2581211|NCT01209832|8926792|P1|Period 2|Sponsor Decision|1
2581212|NCT01209832|8926792|P1|Period 1|Sponsor Decision and was not dosed|1
2581213|NCT01209780|8926811|P5|Overall Study|Inappropriate enrollment|1
2581214|NCT01209780|8926812|P4|Overall Study|Inappropriate enrollment|0
2581215|NCT01209780|8926813|P3|Overall Study|Inappropriate enrollment|0
2581216|NCT01209780|8926814|P2|Overall Study|Inappropriate enrollment|2
2581217|NCT01209780|8926815|P1|Overall Study|Inappropriate enrollment|0
2581218|NCT01209780|8926811|P5|Overall Study|Protocol Violation|0
2581219|NCT01209780|8926812|P4|Overall Study|Protocol Violation|0
2581220|NCT01209780|8926813|P3|Overall Study|Protocol Violation|0
2581221|NCT01209780|8926814|P2|Overall Study|Protocol Violation|1
2581222|NCT01209780|8926815|P1|Overall Study|Protocol Violation|0
2581223|NCT01209780|8926811|P5|Overall Study|Lost to Follow-up|4
2581224|NCT01209780|8926812|P4|Overall Study|Lost to Follow-up|9
2581225|NCT01209780|8926813|P3|Overall Study|Lost to Follow-up|3
2581226|NCT01209780|8926814|P2|Overall Study|Lost to Follow-up|12
2581227|NCT01209780|8926815|P1|Overall Study|Lost to Follow-up|17
2581228|NCT01209780|8926811|P5|Overall Study|Withdrawal by Subject|0
2581229|NCT01209780|8926812|P4|Overall Study|Withdrawal by Subject|1
2581230|NCT01209780|8926813|P3|Overall Study|Withdrawal by Subject|1
2581231|NCT01209780|8926814|P2|Overall Study|Withdrawal by Subject|2
2581232|NCT01209780|8926815|P1|Overall Study|Withdrawal by Subject|9
2581233|NCT01209780|8926811|P5|Overall Study|Adverse Event|0
2581234|NCT01209780|8926812|P4|Overall Study|Adverse Event|0
2581235|NCT01209780|8926813|P3|Overall Study|Adverse Event|0
2581236|NCT01209780|8926814|P2|Overall Study|Adverse Event|1
2581237|NCT01209780|8926815|P1|Overall Study|Adverse Event|0
2581238|NCT01209767|8926841|P1|Overall Study|Lost to Follow-up|3
2581239|NCT01209767|8926841|P1|Overall Study|Withdrawal by Subject|1
2581240|NCT01209689|8926910|P2|Overall Study|Sponsor's Decision to Stop the Study|17
2581241|NCT01209689|8926911|P1|Overall Study|Sponsor's Decision to Stop the Study|68
2581242|NCT01209689|8926910|P2|Overall Study|Failure to Return|0
2581243|NCT01209689|8926911|P1|Overall Study|Failure to Return|3
2581244|NCT01209689|8926910|P2|Overall Study|Violation of Selection Criteria at Entry|0
2581245|NCT01209689|8926911|P1|Overall Study|Violation of Selection Criteria at Entry|1
2581246|NCT01209689|8926910|P2|Overall Study|Adverse Event|0
2581247|NCT01209689|8926911|P1|Overall Study|Adverse Event|4
2581248|NCT01209689|8926910|P2|Overall Study|Refused Treatment|3
2581249|NCT01209689|8926911|P1|Overall Study|Refused Treatment|8
2581250|NCT01209689|8926910|P2|Overall Study|Insufficient Therapeutic Response|2
2581251|NCT01209689|8926911|P1|Overall Study|Insufficient Therapeutic Response|7
2581252|NCT01209624|8926917|P1|Overall Study|Other|4
2581253|NCT01209624|8926917|P1|Overall Study|Lost to Follow-up|290
2581254|NCT01209624|8926917|P1|Overall Study|Lack of Efficacy|17
2581255|NCT01209624|8926917|P1|Overall Study|Adverse Event|13
2581256|NCT01209624|8926917|P1|Overall Study|Death|2
2581257|NCT01209598|8926950|P2|Overall Study|Withdrawal by Subject|0
2581258|NCT01209598|8926951|P1|Overall Study|Withdrawal by Subject|1
2581259|NCT01209520|8926959|P1|Overall Study|Withdrawal by Subject|3
2581260|NCT01209286|8926972|P3|Overall Study|Other|0
2581261|NCT01209286|8926973|P2|Overall Study|Other|1
2581262|NCT01209286|8926974|P1|Overall Study|Other|0
2581263|NCT01209286|8926972|P3|Overall Study|Physician Decision|0
2581264|NCT01209286|8926973|P2|Overall Study|Physician Decision|2
2581265|NCT01209286|8926974|P1|Overall Study|Physician Decision|0
2581266|NCT01209286|8926972|P3|Overall Study|Remission Not Achieved in 2 Cycles|1
2581267|NCT01209286|8926973|P2|Overall Study|Remission Not Achieved in 2 Cycles|3
2581268|NCT01209286|8926974|P1|Overall Study|Remission Not Achieved in 2 Cycles|1
2581269|NCT01209286|8926972|P3|Overall Study|Hematological Relapse After Remission|1
2581270|NCT01209286|8926973|P2|Overall Study|Hematological Relapse After Remission|1
2581271|NCT01209286|8926974|P1|Overall Study|Hematological Relapse After Remission|0
2581272|NCT01209286|8926972|P3|Overall Study|Adverse Event|1
2581273|NCT01209286|8926973|P2|Overall Study|Adverse Event|3
2581274|NCT01209286|8926974|P1|Overall Study|Adverse Event|4
2581275|NCT01209143|8927083|P2|Overall Study|Disease progression|16
2581276|NCT01209143|8927084|P1|Overall Study|Disease progression|11
2581277|NCT01209143|8927083|P2|Overall Study|Withdrawal by Subject|1
2581278|NCT01209143|8927084|P1|Overall Study|Withdrawal by Subject|2
2581279|NCT01209143|8927083|P2|Overall Study|Lost to Follow-up|0
2581280|NCT01209143|8927084|P1|Overall Study|Lost to Follow-up|1
2581281|NCT01209143|8927083|P2|Overall Study|Physician Decision|1
2581282|NCT01209143|8927084|P1|Overall Study|Physician Decision|3
2581283|NCT01209143|8927083|P2|Overall Study|Death|1
2581284|NCT01209143|8927084|P1|Overall Study|Death|0
2581285|NCT01209143|8927083|P2|Overall Study|Adverse Event|1
2581286|NCT01209143|8927084|P1|Overall Study|Adverse Event|2
2581287|NCT01209078|8927094|P2|Overall Study|Withdrawal by Subject|1
2581288|NCT01209078|8927095|P1|Overall Study|Withdrawal by Subject|2
2581289|NCT01209078|8927094|P2|Overall Study|Physician Decision|2
2581290|NCT01209078|8927095|P1|Overall Study|Physician Decision|5
2581291|NCT01209078|8927094|P2|Overall Study|Lost to Follow-up|0
2581292|NCT01209078|8927095|P1|Overall Study|Lost to Follow-up|4
2581293|NCT01209078|8927094|P2|Overall Study|Adverse Event|0
2581294|NCT01209078|8927095|P1|Overall Study|Adverse Event|5
2581295|NCT01208961|8927170|P2|High-Fat Period III|Protocol Violation|0
2581296|NCT01208961|8927171|P1|High-Fat Period III|Protocol Violation|1
2581297|NCT01208870|8927193|P2|Overall Study|Lost to Follow-up|8
2581298|NCT01208870|8927194|P1|Overall Study|Lost to Follow-up|2
2581299|NCT01208415|8927210|P1|Overall Study|Still be eligible for follow-up|33
2581300|NCT01208415|8927210|P1|Overall Study|Device not placed|1
2581301|NCT01208415|8927210|P1|Overall Study|Withdrawal by Subject|3
2581302|NCT01208415|8927210|P1|Overall Study|Lost to Follow-up|2
2581303|NCT01208415|8927210|P1|Overall Study|Death|1
2581304|NCT01208402|8927216|P2|Overall Study|Withdrawal by Subject|0
2581305|NCT01208402|8927217|P1|Overall Study|Withdrawal by Subject|1
2581306|NCT01208337|8927233|P1|Overall Study|Death|3
2581307|NCT01208233|8927247|P6|Overall Study|Withdrawal by Subject|2
2581308|NCT01208233|8927248|P5|Overall Study|Withdrawal by Subject|4
2581309|NCT01208233|8927249|P4|Overall Study|Withdrawal by Subject|1
2581310|NCT01208233|8927250|P3|Overall Study|Withdrawal by Subject|1
2581311|NCT01208233|8927251|P2|Overall Study|Withdrawal by Subject|0
2581312|NCT01208233|8927252|P1|Overall Study|Withdrawal by Subject|1
2581313|NCT01208233|8927247|P6|Overall Study|Other|1
2581314|NCT01208233|8927248|P5|Overall Study|Other|0
2581315|NCT01208233|8927249|P4|Overall Study|Other|0
2581316|NCT01208233|8927250|P3|Overall Study|Other|0
2581317|NCT01208233|8927251|P2|Overall Study|Other|1
2581318|NCT01208233|8927252|P1|Overall Study|Other|2
2581319|NCT01208233|8927247|P6|Overall Study|Protocol Violation|0
2581320|NCT01208233|8927248|P5|Overall Study|Protocol Violation|3
2581321|NCT01208233|8927249|P4|Overall Study|Protocol Violation|0
2581322|NCT01208233|8927250|P3|Overall Study|Protocol Violation|0
2581323|NCT01208233|8927251|P2|Overall Study|Protocol Violation|0
2581324|NCT01208233|8927252|P1|Overall Study|Protocol Violation|0
2581325|NCT01208233|8927247|P6|Overall Study|Study terminated by sponsor|7
2581326|NCT01208233|8927248|P5|Overall Study|Study terminated by sponsor|10
2581327|NCT01208233|8927249|P4|Overall Study|Study terminated by sponsor|0
2581328|NCT01208233|8927250|P3|Overall Study|Study terminated by sponsor|0
2581329|NCT01208233|8927251|P2|Overall Study|Study terminated by sponsor|0
2581330|NCT01208233|8927252|P1|Overall Study|Study terminated by sponsor|0
2581331|NCT01208233|8927247|P6|Overall Study|Medication error without adverse event|1
2581332|NCT01208233|8927248|P5|Overall Study|Medication error without adverse event|0
2581333|NCT01208233|8927249|P4|Overall Study|Medication error without adverse event|0
2581334|NCT01208233|8927250|P3|Overall Study|Medication error without adverse event|0
2581335|NCT01208233|8927251|P2|Overall Study|Medication error without adverse event|0
2581336|NCT01208233|8927252|P1|Overall Study|Medication error without adverse event|0
2581337|NCT01208233|8927247|P6|Overall Study|Did not meet entrance criteria|0
2581338|NCT01208233|8927248|P5|Overall Study|Did not meet entrance criteria|1
2581339|NCT01208233|8927249|P4|Overall Study|Did not meet entrance criteria|0
2581340|NCT01208233|8927250|P3|Overall Study|Did not meet entrance criteria|1
2581341|NCT01208233|8927251|P2|Overall Study|Did not meet entrance criteria|1
2581342|NCT01208233|8927252|P1|Overall Study|Did not meet entrance criteria|2
2581343|NCT01208233|8927247|P6|Overall Study|Death|5
2581344|NCT01208233|8927248|P5|Overall Study|Death|3
2581345|NCT01208233|8927249|P4|Overall Study|Death|0
2581346|NCT01208233|8927250|P3|Overall Study|Death|0
2581347|NCT01208233|8927251|P2|Overall Study|Death|0
2581348|NCT01208233|8927252|P1|Overall Study|Death|0
2581349|NCT01208233|8927247|P6|Overall Study|Adverse Event|5
2581350|NCT01208233|8927248|P5|Overall Study|Adverse Event|3
2581351|NCT01208233|8927249|P4|Overall Study|Adverse Event|0
2581352|NCT01208233|8927250|P3|Overall Study|Adverse Event|2
2581353|NCT01208233|8927251|P2|Overall Study|Adverse Event|1
2581354|NCT01208233|8927252|P1|Overall Study|Adverse Event|0
2581355|NCT01208207|8927377|P7|Part II|Technical Problems|0
2581356|NCT01208207|8927378|P6|Part II|Technical Problems|1
2581357|NCT01208207|8927379|P5|Part II|Technical Problems|0
2581358|NCT01208207|8927380|P4|Part II|Technical Problems|1
2581359|NCT01208207|8927381|P3|Part II|Technical Problems|0
2581360|NCT01208207|8927382|P2|Part II|Technical Problems|0
2581361|NCT01208207|8927383|P1|Part II|Technical Problems|0
2581362|NCT01208207|8927377|P7|Part II|Protocol Violation|0
2581363|NCT01208207|8927378|P6|Part II|Protocol Violation|0
2581364|NCT01208207|8927379|P5|Part II|Protocol Violation|0
2581365|NCT01208207|8927380|P4|Part II|Protocol Violation|1
2581366|NCT01208207|8927381|P3|Part II|Protocol Violation|0
2581367|NCT01208207|8927382|P2|Part II|Protocol Violation|0
2581368|NCT01208207|8927383|P1|Part II|Protocol Violation|0
2581369|NCT01208207|8927377|P7|Part II|Physician Decision|0
2581370|NCT01208207|8927378|P6|Part II|Physician Decision|2
2581371|NCT01208207|8927379|P5|Part II|Physician Decision|0
2581372|NCT01208207|8927380|P4|Part II|Physician Decision|1
2581373|NCT01208207|8927381|P3|Part II|Physician Decision|0
2581374|NCT01208207|8927382|P2|Part II|Physician Decision|0
2581375|NCT01208207|8927383|P1|Part II|Physician Decision|0
2581376|NCT01208207|8927377|P7|Part II|Non-Compliance With Study Drug|0
2581377|NCT01208207|8927378|P6|Part II|Non-Compliance With Study Drug|1
2581378|NCT01208207|8927379|P5|Part II|Non-Compliance With Study Drug|1
2581379|NCT01208207|8927380|P4|Part II|Non-Compliance With Study Drug|4
2581380|NCT01208207|8927381|P3|Part II|Non-Compliance With Study Drug|0
2581381|NCT01208207|8927382|P2|Part II|Non-Compliance With Study Drug|0
2581382|NCT01208207|8927383|P1|Part II|Non-Compliance With Study Drug|0
2581383|NCT01208207|8927377|P7|Part II|Lost to Follow-up|1
2581384|NCT01208207|8927378|P6|Part II|Lost to Follow-up|2
2581385|NCT01208207|8927379|P5|Part II|Lost to Follow-up|0
2581386|NCT01208207|8927380|P4|Part II|Lost to Follow-up|4
2581387|NCT01208207|8927381|P3|Part II|Lost to Follow-up|0
2581388|NCT01208207|8927382|P2|Part II|Lost to Follow-up|0
2581389|NCT01208207|8927383|P1|Part II|Lost to Follow-up|0
2581390|NCT01208207|8927377|P7|Part II|Lack of Efficacy|3
2581391|NCT01208207|8927378|P6|Part II|Lack of Efficacy|3
2581392|NCT01208207|8927379|P5|Part II|Lack of Efficacy|4
2581393|NCT01208207|8927380|P4|Part II|Lack of Efficacy|6
2581394|NCT01208207|8927381|P3|Part II|Lack of Efficacy|0
2581395|NCT01208207|8927382|P2|Part II|Lack of Efficacy|0
2581396|NCT01208207|8927383|P1|Part II|Lack of Efficacy|0
2581397|NCT01208207|8927377|P7|Part II|Adverse Event|2
2581398|NCT01208207|8927378|P6|Part II|Adverse Event|4
2581399|NCT01208207|8927379|P5|Part II|Adverse Event|9
2581400|NCT01208207|8927380|P4|Part II|Adverse Event|5
2581401|NCT01208207|8927381|P3|Part II|Adverse Event|0
2581402|NCT01208207|8927382|P2|Part II|Adverse Event|0
2581403|NCT01208207|8927383|P1|Part II|Adverse Event|0
2581404|NCT01208207|8927377|P7|Part II|Withdrawal by Subject|5
2581405|NCT01208207|8927378|P6|Part II|Withdrawal by Subject|3
2581406|NCT01208207|8927379|P5|Part II|Withdrawal by Subject|9
2581407|NCT01208207|8927380|P4|Part II|Withdrawal by Subject|10
2581408|NCT01208207|8927381|P3|Part II|Withdrawal by Subject|0
2581409|NCT01208207|8927382|P2|Part II|Withdrawal by Subject|0
2581410|NCT01208207|8927383|P1|Part II|Withdrawal by Subject|0
2581411|NCT01208207|8927377|P7|Part I|Withdrawal by Subject|0
2581412|NCT01208207|8927378|P6|Part I|Withdrawal by Subject|0
2581413|NCT01208207|8927379|P5|Part I|Withdrawal by Subject|0
2581414|NCT01208207|8927380|P4|Part I|Withdrawal by Subject|0
2581415|NCT01208207|8927381|P3|Part I|Withdrawal by Subject|4
2581416|NCT01208207|8927382|P2|Part I|Withdrawal by Subject|4
2581417|NCT01208207|8927383|P1|Part I|Withdrawal by Subject|14
2581418|NCT01208207|8927377|P7|Part I|Protocol Violation|0
2581419|NCT01208207|8927378|P6|Part I|Protocol Violation|0
2581420|NCT01208207|8927379|P5|Part I|Protocol Violation|0
2581421|NCT01208207|8927380|P4|Part I|Protocol Violation|0
2581422|NCT01208207|8927381|P3|Part I|Protocol Violation|2
2581423|NCT01208207|8927382|P2|Part I|Protocol Violation|0
2581424|NCT01208207|8927383|P1|Part I|Protocol Violation|8
2581425|NCT01208207|8927377|P7|Part I|Progressive Disease|0
2581426|NCT01208207|8927378|P6|Part I|Progressive Disease|0
2581427|NCT01208207|8927379|P5|Part I|Progressive Disease|0
2581428|NCT01208207|8927380|P4|Part I|Progressive Disease|0
2581429|NCT01208207|8927381|P3|Part I|Progressive Disease|0
2581430|NCT01208207|8927382|P2|Part I|Progressive Disease|0
2581431|NCT01208207|8927383|P1|Part I|Progressive Disease|1
2581432|NCT01208207|8927377|P7|Part I|Physician Decision|0
2581433|NCT01208207|8927378|P6|Part I|Physician Decision|0
2581434|NCT01208207|8927379|P5|Part I|Physician Decision|0
2581435|NCT01208207|8927380|P4|Part I|Physician Decision|0
2581436|NCT01208207|8927381|P3|Part I|Physician Decision|0
2581437|NCT01208207|8927382|P2|Part I|Physician Decision|1
2581438|NCT01208207|8927383|P1|Part I|Physician Decision|0
2581439|NCT01208207|8927377|P7|Part I|Non-Compliance With Study Drug|0
2581440|NCT01208207|8927378|P6|Part I|Non-Compliance With Study Drug|0
2581441|NCT01208207|8927379|P5|Part I|Non-Compliance With Study Drug|0
2581442|NCT01208207|8927380|P4|Part I|Non-Compliance With Study Drug|0
2581443|NCT01208207|8927381|P3|Part I|Non-Compliance With Study Drug|1
2581444|NCT01208207|8927382|P2|Part I|Non-Compliance With Study Drug|0
2581445|NCT01208207|8927383|P1|Part I|Non-Compliance With Study Drug|1
2581446|NCT01208207|8927377|P7|Part I|Lost to Follow-up|0
2581447|NCT01208207|8927378|P6|Part I|Lost to Follow-up|0
2581448|NCT01208207|8927379|P5|Part I|Lost to Follow-up|0
2581449|NCT01208207|8927380|P4|Part I|Lost to Follow-up|0
2581450|NCT01208207|8927381|P3|Part I|Lost to Follow-up|0
2581451|NCT01208207|8927382|P2|Part I|Lost to Follow-up|1
2581452|NCT01208207|8927383|P1|Part I|Lost to Follow-up|6
2581453|NCT01208207|8927377|P7|Part I|Lack of Efficacy|0
2581454|NCT01208207|8927378|P6|Part I|Lack of Efficacy|0
2581455|NCT01208207|8927379|P5|Part I|Lack of Efficacy|0
2581456|NCT01208207|8927380|P4|Part I|Lack of Efficacy|0
2581457|NCT01208207|8927381|P3|Part I|Lack of Efficacy|2
2581458|NCT01208207|8927382|P2|Part I|Lack of Efficacy|3
2581459|NCT01208207|8927383|P1|Part I|Lack of Efficacy|21
2581460|NCT01208207|8927377|P7|Part I|Adverse Event|0
2581461|NCT01208207|8927378|P6|Part I|Adverse Event|0
2581462|NCT01208207|8927379|P5|Part I|Adverse Event|0
2581463|NCT01208207|8927380|P4|Part I|Adverse Event|0
2581464|NCT01208207|8927381|P3|Part I|Adverse Event|6
2581465|NCT01208207|8927382|P2|Part I|Adverse Event|2
2581466|NCT01208207|8927383|P1|Part I|Adverse Event|19
2581467|NCT01208181|8927410|P5|Part 2|Lack of Efficacy|0
2581468|NCT01208181|8927411|P4|Part 2|Lack of Efficacy|7
2581469|NCT01208181|8927412|P3|Part 2|Lack of Efficacy|5
2581470|NCT01208181|8927413|P2|Part 2|Lack of Efficacy|0
2581471|NCT01208181|8927414|P1|Part 2|Lack of Efficacy|0
2581472|NCT01208181|8927410|P5|Part 2|Lost to Follow-up|0
2581473|NCT01208181|8927411|P4|Part 2|Lost to Follow-up|2
2581474|NCT01208181|8927412|P3|Part 2|Lost to Follow-up|1
2581475|NCT01208181|8927413|P2|Part 2|Lost to Follow-up|0
2581476|NCT01208181|8927414|P1|Part 2|Lost to Follow-up|0
2581477|NCT01208181|8927410|P5|Part 2|Non-compliance with study drug|0
2581478|NCT01208181|8927411|P4|Part 2|Non-compliance with study drug|1
2581479|NCT01208181|8927412|P3|Part 2|Non-compliance with study drug|1
2581480|NCT01208181|8927413|P2|Part 2|Non-compliance with study drug|0
2581481|NCT01208181|8927414|P1|Part 2|Non-compliance with study drug|0
2581482|NCT01208181|8927410|P5|Part 2|Physician Decision|0
2581483|NCT01208181|8927411|P4|Part 2|Physician Decision|2
2581484|NCT01208181|8927412|P3|Part 2|Physician Decision|1
2581485|NCT01208181|8927413|P2|Part 2|Physician Decision|0
2581486|NCT01208181|8927414|P1|Part 2|Physician Decision|0
2581487|NCT01208181|8927410|P5|Part 2|Protocol Violation|0
2581488|NCT01208181|8927411|P4|Part 2|Protocol Violation|0
2581489|NCT01208181|8927412|P3|Part 2|Protocol Violation|1
2581490|NCT01208181|8927413|P2|Part 2|Protocol Violation|0
2581491|NCT01208181|8927414|P1|Part 2|Protocol Violation|0
2581492|NCT01208181|8927410|P5|Part 2|Withdrawal by Subject|0
2581493|NCT01208181|8927411|P4|Part 2|Withdrawal by Subject|1
2581494|NCT01208181|8927412|P3|Part 2|Withdrawal by Subject|1
2581495|NCT01208181|8927413|P2|Part 2|Withdrawal by Subject|0
2581496|NCT01208181|8927414|P1|Part 2|Withdrawal by Subject|0
2581497|NCT01208181|8927410|P5|Part 2|Adverse Event|0
2581498|NCT01208181|8927411|P4|Part 2|Adverse Event|7
2581499|NCT01208181|8927412|P3|Part 2|Adverse Event|6
2581500|NCT01208181|8927413|P2|Part 2|Adverse Event|0
2581501|NCT01208181|8927414|P1|Part 2|Adverse Event|0
2581502|NCT01208181|8927410|P5|Part 1|Adverse Event|4
2581503|NCT01208181|8927411|P4|Part 1|Adverse Event|0
2581504|NCT01208181|8927412|P3|Part 1|Adverse Event|0
2581505|NCT01208181|8927413|P2|Part 1|Adverse Event|24
2581506|NCT01208181|8927414|P1|Part 1|Adverse Event|26
2581507|NCT01208181|8927410|P5|Part 1|Lack of Efficacy|17
2581508|NCT01208181|8927411|P4|Part 1|Lack of Efficacy|0
2581509|NCT01208181|8927412|P3|Part 1|Lack of Efficacy|0
2581510|NCT01208181|8927413|P2|Part 1|Lack of Efficacy|12
2581511|NCT01208181|8927414|P1|Part 1|Lack of Efficacy|37
2581512|NCT01208181|8927410|P5|Part 1|Lost to Follow-up|1
2581513|NCT01208181|8927411|P4|Part 1|Lost to Follow-up|0
2581514|NCT01208181|8927412|P3|Part 1|Lost to Follow-up|0
2581515|NCT01208181|8927413|P2|Part 1|Lost to Follow-up|3
2581516|NCT01208181|8927414|P1|Part 1|Lost to Follow-up|5
2581517|NCT01208181|8927410|P5|Part 1|Non-compliance with study drug|0
2581518|NCT01208181|8927411|P4|Part 1|Non-compliance with study drug|0
2581519|NCT01208181|8927412|P3|Part 1|Non-compliance with study drug|0
2581520|NCT01208181|8927413|P2|Part 1|Non-compliance with study drug|1
2581521|NCT01208181|8927414|P1|Part 1|Non-compliance with study drug|1
2581522|NCT01208181|8927410|P5|Part 1|Physician Decision|0
2581523|NCT01208181|8927411|P4|Part 1|Physician Decision|0
2581524|NCT01208181|8927412|P3|Part 1|Physician Decision|0
2581525|NCT01208181|8927413|P2|Part 1|Physician Decision|0
2581526|NCT01208181|8927414|P1|Part 1|Physician Decision|4
2581527|NCT01208181|8927410|P5|Part 1|Protocol Violation|0
2581528|NCT01208181|8927411|P4|Part 1|Protocol Violation|0
2581529|NCT01208181|8927412|P3|Part 1|Protocol Violation|0
2581530|NCT01208181|8927413|P2|Part 1|Protocol Violation|5
2581531|NCT01208181|8927414|P1|Part 1|Protocol Violation|10
2581532|NCT01208181|8927410|P5|Part 1|Technical problem|0
2581533|NCT01208181|8927411|P4|Part 1|Technical problem|0
2581534|NCT01208181|8927412|P3|Part 1|Technical problem|0
2581535|NCT01208181|8927413|P2|Part 1|Technical problem|0
2581536|NCT01208181|8927414|P1|Part 1|Technical problem|5
2581537|NCT01208181|8927410|P5|Part 1|Withdrawal by Subject|0
2581538|NCT01208181|8927411|P4|Part 1|Withdrawal by Subject|0
2581539|NCT01208181|8927412|P3|Part 1|Withdrawal by Subject|0
2581540|NCT01208181|8927413|P2|Part 1|Withdrawal by Subject|10
2581541|NCT01208181|8927414|P1|Part 1|Withdrawal by Subject|11
2581542|NCT01208103|8927443|P1|Overall Study|Withdrawal by Subject|1
2581543|NCT01208103|8927443|P1|Overall Study|Adverse Event|1
2581544|NCT01208038|8927451|P1|Overall Study|Withdrawal by Subject|1
2581545|NCT01207687|8927507|P1|Overall Study|Withdrawal by Subject|1
2581546|NCT01207687|8927507|P1|Overall Study|Adverse Event|1
2581547|NCT01207596|8927545|P1|Overall Study|Withdrawal by Subject|1
2581548|NCT01207596|8927545|P1|Overall Study|Adverse Event|3
2581549|NCT01207596|8927545|P1|Overall Study|Lack of Efficacy|1
2581550|NCT01207596|8927545|P1|Overall Study|Physician Decision|4
2581551|NCT01207583|8927558|P3|Overall Study|Lost to Follow-up|0
2581552|NCT01207583|8927559|P2|Overall Study|Lost to Follow-up|2
2581553|NCT01207583|8927560|P1|Overall Study|Lost to Follow-up|0
2581554|NCT01207583|8927558|P3|Overall Study|Participant failed to return|0
2581555|NCT01207583|8927559|P2|Overall Study|Participant failed to return|0
2581556|NCT01207583|8927560|P1|Overall Study|Participant failed to return|1
2581557|NCT01207583|8927558|P3|Overall Study|Withdrawal by Subject|1
2581558|NCT01207583|8927559|P2|Overall Study|Withdrawal by Subject|3
2581559|NCT01207583|8927560|P1|Overall Study|Withdrawal by Subject|0
2581560|NCT01207492|8927613|P1|Overall Study|Toxicity|1
2581561|NCT01207492|8927613|P1|Overall Study|Progressive disease|3
2581562|NCT01207492|8927613|P1|Overall Study|Physician Decision|1
2581563|NCT01207492|8927613|P1|Overall Study|Withdrawal by Subject|9
2581564|NCT01207492|8927613|P1|Overall Study|Still on study|1
2581565|NCT01207453|8927628|P2|2nd Intervention|Lost to Follow-up|0
2581566|NCT01207453|8927629|P1|2nd Intervention|Lost to Follow-up|1
2581567|NCT01207453|8927628|P2|2nd Intervention|Adverse Event|2
2581568|NCT01207453|8927629|P1|2nd Intervention|Adverse Event|1
2581569|NCT01207453|8927628|P2|Washout|Lost to Follow-up|0
2581570|NCT01207453|8927629|P1|Washout|Lost to Follow-up|1
2581571|NCT01207453|8927628|P2|Washout|Adverse Event|0
2581572|NCT01207453|8927629|P1|Washout|Adverse Event|1
2581573|NCT01207453|8927628|P2|First Intervention|Adverse Event|1
2581574|NCT01207453|8927629|P1|First Intervention|Adverse Event|2
2581575|NCT01207440|8927655|P7|Overall Study|Reason Not Specified|0
2581576|NCT01207440|8927656|P6|Overall Study|Reason Not Specified|3
2581577|NCT01207440|8927657|P5|Overall Study|Reason Not Specified|4
2581578|NCT01207440|8927658|P4|Overall Study|Reason Not Specified|0
2581579|NCT01207440|8927659|P3|Overall Study|Reason Not Specified|7
2581580|NCT01207440|8927660|P2|Overall Study|Reason Not Specified|10
2581581|NCT01207440|8927661|P1|Overall Study|Reason Not Specified|10
2581582|NCT01207440|8927655|P7|Overall Study|Withdrawal by Subject|0
2581583|NCT01207440|8927656|P6|Overall Study|Withdrawal by Subject|2
2581584|NCT01207440|8927657|P5|Overall Study|Withdrawal by Subject|2
2581585|NCT01207440|8927658|P4|Overall Study|Withdrawal by Subject|3
2581586|NCT01207440|8927659|P3|Overall Study|Withdrawal by Subject|5
2581587|NCT01207440|8927660|P2|Overall Study|Withdrawal by Subject|4
2581588|NCT01207440|8927661|P1|Overall Study|Withdrawal by Subject|29
2581589|NCT01207440|8927655|P7|Overall Study|Site Terminated by Sponsor|2
2581590|NCT01207440|8927656|P6|Overall Study|Site Terminated by Sponsor|0
2581591|NCT01207440|8927657|P5|Overall Study|Site Terminated by Sponsor|3
2581592|NCT01207440|8927658|P4|Overall Study|Site Terminated by Sponsor|2
2581593|NCT01207440|8927659|P3|Overall Study|Site Terminated by Sponsor|12
2581594|NCT01207440|8927660|P2|Overall Study|Site Terminated by Sponsor|19
2581595|NCT01207440|8927661|P1|Overall Study|Site Terminated by Sponsor|69
2581596|NCT01207440|8927655|P7|Overall Study|Protocol Violation|0
2581597|NCT01207440|8927656|P6|Overall Study|Protocol Violation|0
2581598|NCT01207440|8927657|P5|Overall Study|Protocol Violation|0
2581599|NCT01207440|8927658|P4|Overall Study|Protocol Violation|0
2581600|NCT01207440|8927659|P3|Overall Study|Protocol Violation|0
2581601|NCT01207440|8927660|P2|Overall Study|Protocol Violation|0
2581602|NCT01207440|8927661|P1|Overall Study|Protocol Violation|2
2581603|NCT01207440|8927655|P7|Overall Study|Progressive Disease|0
2581604|NCT01207440|8927656|P6|Overall Study|Progressive Disease|27
2581605|NCT01207440|8927657|P5|Overall Study|Progressive Disease|23
2581606|NCT01207440|8927658|P4|Overall Study|Progressive Disease|7
2581607|NCT01207440|8927659|P3|Overall Study|Progressive Disease|19
2581608|NCT01207440|8927660|P2|Overall Study|Progressive Disease|10
2581609|NCT01207440|8927661|P1|Overall Study|Progressive Disease|19
2581610|NCT01207440|8927655|P7|Overall Study|Physician Decision|0
2581611|NCT01207440|8927656|P6|Overall Study|Physician Decision|0
2581612|NCT01207440|8927657|P5|Overall Study|Physician Decision|1
2581613|NCT01207440|8927658|P4|Overall Study|Physician Decision|0
2581614|NCT01207440|8927659|P3|Overall Study|Physician Decision|5
2581615|NCT01207440|8927660|P2|Overall Study|Physician Decision|5
2581616|NCT01207440|8927661|P1|Overall Study|Physician Decision|6
2581617|NCT01207440|8927655|P7|Overall Study|Non-compliance with Study Drug|0
2581618|NCT01207440|8927656|P6|Overall Study|Non-compliance with Study Drug|0
2581619|NCT01207440|8927657|P5|Overall Study|Non-compliance with Study Drug|0
2581620|NCT01207440|8927658|P4|Overall Study|Non-compliance with Study Drug|0
2581621|NCT01207440|8927659|P3|Overall Study|Non-compliance with Study Drug|1
2581622|NCT01207440|8927660|P2|Overall Study|Non-compliance with Study Drug|0
2581623|NCT01207440|8927661|P1|Overall Study|Non-compliance with Study Drug|3
2581624|NCT01207440|8927655|P7|Overall Study|Lost to Follow-up|0
2581625|NCT01207440|8927656|P6|Overall Study|Lost to Follow-up|0
2581626|NCT01207440|8927657|P5|Overall Study|Lost to Follow-up|0
2581627|NCT01207440|8927658|P4|Overall Study|Lost to Follow-up|1
2581628|NCT01207440|8927659|P3|Overall Study|Lost to Follow-up|2
2581629|NCT01207440|8927660|P2|Overall Study|Lost to Follow-up|0
2581630|NCT01207440|8927661|P1|Overall Study|Lost to Follow-up|0
2581631|NCT01207440|8927655|P7|Overall Study|Lack of Efficacy|0
2581632|NCT01207440|8927656|P6|Overall Study|Lack of Efficacy|3
2581633|NCT01207440|8927657|P5|Overall Study|Lack of Efficacy|2
2581634|NCT01207440|8927658|P4|Overall Study|Lack of Efficacy|1
2581635|NCT01207440|8927659|P3|Overall Study|Lack of Efficacy|5
2581636|NCT01207440|8927660|P2|Overall Study|Lack of Efficacy|2
2581637|NCT01207440|8927661|P1|Overall Study|Lack of Efficacy|13
2581638|NCT01207440|8927655|P7|Overall Study|Death|1
2581639|NCT01207440|8927656|P6|Overall Study|Death|5
2581640|NCT01207440|8927657|P5|Overall Study|Death|7
2581641|NCT01207440|8927658|P4|Overall Study|Death|2
2581642|NCT01207440|8927659|P3|Overall Study|Death|2
2581643|NCT01207440|8927660|P2|Overall Study|Death|3
2581644|NCT01207440|8927661|P1|Overall Study|Death|6
2581645|NCT01207440|8927655|P7|Overall Study|Adverse Event|2
2581646|NCT01207440|8927656|P6|Overall Study|Adverse Event|6
2581647|NCT01207440|8927657|P5|Overall Study|Adverse Event|6
2581648|NCT01207440|8927658|P4|Overall Study|Adverse Event|2
2581649|NCT01207440|8927659|P3|Overall Study|Adverse Event|7
2581650|NCT01207440|8927660|P2|Overall Study|Adverse Event|11
2581651|NCT01207440|8927661|P1|Overall Study|Adverse Event|46
2581652|NCT01207427|8927728|P3|Double-blind Treatment Period|Withdrawal by Subject|0
2581653|NCT01207427|8927729|P2|Double-blind Treatment Period|Withdrawal by Subject|0
2581654|NCT01207427|8927730|P1|Double-blind Treatment Period|Withdrawal by Subject|1
2581655|NCT01207427|8927728|P3|Double-blind Treatment Period|Protocol Violation|1
2581656|NCT01207427|8927729|P2|Double-blind Treatment Period|Protocol Violation|1
2581657|NCT01207427|8927730|P1|Double-blind Treatment Period|Protocol Violation|2
2581658|NCT01207427|8927728|P3|Double-blind Treatment Period|Lost to Follow-up|1
2581659|NCT01207427|8927729|P2|Double-blind Treatment Period|Lost to Follow-up|0
2581660|NCT01207427|8927730|P1|Double-blind Treatment Period|Lost to Follow-up|0
2581661|NCT01207427|8927728|P3|Double-blind Treatment Period|Adverse Event|0
2581662|NCT01207427|8927729|P2|Double-blind Treatment Period|Adverse Event|1
2581663|NCT01207427|8927730|P1|Double-blind Treatment Period|Adverse Event|0
2581664|NCT01207414|8927740|P2|Overall Study|Randomized in error|0
2581665|NCT01207414|8927741|P1|Overall Study|Randomized in error|1
2581666|NCT01207414|8927740|P2|Overall Study|Protocol deviation|9
2581667|NCT01207414|8927741|P1|Overall Study|Protocol deviation|12
2581668|NCT01207414|8927740|P2|Overall Study|Administrative problems|1
2581669|NCT01207414|8927741|P1|Overall Study|Administrative problems|1
2581670|NCT01207414|8927740|P2|Overall Study|Lost to Follow-up|17
2581671|NCT01207414|8927741|P1|Overall Study|Lost to Follow-up|15
2581672|NCT01207414|8927740|P2|Overall Study|Patient withdrew consent|11
2581673|NCT01207414|8927741|P1|Overall Study|Patient withdrew consent|14
2581674|NCT01207414|8927740|P2|Overall Study|Unsatisfactory therapeutic effect|4
2581675|NCT01207414|8927741|P1|Overall Study|Unsatisfactory therapeutic effect|5
2581676|NCT01207414|8927740|P2|Overall Study|Abnormal test procedure results|1
2581677|NCT01207414|8927741|P1|Overall Study|Abnormal test procedure results|0
2581678|NCT01207414|8927740|P2|Overall Study|Adverse Event|39
2581679|NCT01207414|8927741|P1|Overall Study|Adverse Event|25
2581680|NCT01207388|8927766|P1|Overall Study|Withdrawal by Subject|1
2581681|NCT01207388|8927766|P1|Overall Study|Death|67
2581682|NCT01207219|8927791|P3|Overall Study|Lost to Follow-up|6
2581683|NCT01207219|8927792|P2|Overall Study|Lost to Follow-up|8
2581684|NCT01207219|8927793|P1|Overall Study|Lost to Follow-up|6
2581685|NCT01207219|8927791|P3|Overall Study|changed diagnosis during study period|1
2581686|NCT01207219|8927792|P2|Overall Study|changed diagnosis during study period|3
2581687|NCT01207219|8927793|P1|Overall Study|changed diagnosis during study period|5
2581688|NCT01207102|8927813|P1|Overall Study|Withdrawal by Treating Physician|1
2581689|NCT01207102|8927813|P1|Overall Study|progression|2
2581690|NCT01207102|8927813|P1|Overall Study|Adverse Event|2
2581691|NCT01207102|8927813|P1|Overall Study|Withdrawal by Subject|5
2581692|NCT01206816|8927825|P7|Overall Study|other than stated above|1
2581693|NCT01206816|8927826|P6|Overall Study|other than stated above|0
2581694|NCT01206816|8927827|P5|Overall Study|other than stated above|0
2581695|NCT01206816|8927828|P4|Overall Study|other than stated above|0
2581696|NCT01206816|8927829|P3|Overall Study|other than stated above|1
2581697|NCT01206816|8927830|P2|Overall Study|other than stated above|0
2581698|NCT01206816|8927831|P1|Overall Study|other than stated above|0
2581699|NCT01206816|8927825|P7|Overall Study|Other AE|2
2581700|NCT01206816|8927826|P6|Overall Study|Other AE|3
2581701|NCT01206816|8927827|P5|Overall Study|Other AE|0
2581702|NCT01206816|8927828|P4|Overall Study|Other AE|0
2581703|NCT01206816|8927829|P3|Overall Study|Other AE|4
2581704|NCT01206816|8927830|P2|Overall Study|Other AE|0
2581705|NCT01206816|8927831|P1|Overall Study|Other AE|0
2581706|NCT01206816|8927825|P7|Overall Study|Progressive disease|3
2581707|NCT01206816|8927826|P6|Overall Study|Progressive disease|16
2581708|NCT01206816|8927827|P5|Overall Study|Progressive disease|3
2581709|NCT01206816|8927828|P4|Overall Study|Progressive disease|3
2581710|NCT01206816|8927829|P3|Overall Study|Progressive disease|13
2581711|NCT01206816|8927830|P2|Overall Study|Progressive disease|3
2581712|NCT01206816|8927831|P1|Overall Study|Progressive disease|3
2581713|NCT01206816|8927825|P7|Overall Study|Withdrawal by Subject|0
2581714|NCT01206816|8927826|P6|Overall Study|Withdrawal by Subject|0
2581715|NCT01206816|8927827|P5|Overall Study|Withdrawal by Subject|0
2581716|NCT01206816|8927828|P4|Overall Study|Withdrawal by Subject|0
2581717|NCT01206816|8927829|P3|Overall Study|Withdrawal by Subject|1
2581718|NCT01206816|8927830|P2|Overall Study|Withdrawal by Subject|0
2581719|NCT01206816|8927831|P1|Overall Study|Withdrawal by Subject|0
2581720|NCT01206816|8927825|P7|Overall Study|Protocol Violation|0
2581721|NCT01206816|8927826|P6|Overall Study|Protocol Violation|0
2581722|NCT01206816|8927827|P5|Overall Study|Protocol Violation|0
2581723|NCT01206816|8927828|P4|Overall Study|Protocol Violation|0
2581724|NCT01206816|8927829|P3|Overall Study|Protocol Violation|1
2581725|NCT01206816|8927830|P2|Overall Study|Protocol Violation|0
2581726|NCT01206816|8927831|P1|Overall Study|Protocol Violation|0
2581727|NCT01206777|8927877|P1|Overall Study|Adverse Event|1
2581728|NCT01206777|8927877|P1|Overall Study|Death|1
2581729|NCT01206764|8927883|P1|Overall Study|Protocol deviation|3
2581730|NCT01206764|8927883|P1|Overall Study|Disease progression|88
2581731|NCT01206764|8927883|P1|Overall Study|New cancer therapy|2
2581732|NCT01206764|8927883|P1|Overall Study|Death|11
2581733|NCT01206764|8927883|P1|Overall Study|Lost to Follow-up|6
2581734|NCT01206764|8927883|P1|Overall Study|Patient withdrew consent|5
2581735|NCT01206764|8927883|P1|Overall Study|Abnormal test procedure result|1
2581736|NCT01206764|8927883|P1|Overall Study|Abnormal laboratory value|2
2581737|NCT01206764|8927883|P1|Overall Study|Adverse Event|20
2581738|NCT01206582|8927941|P2|Overall Study|Discontinued intervention before week 8|2
2581739|NCT01206582|8927942|P1|Overall Study|Discontinued intervention before week 8|1
2581740|NCT01206582|8927941|P2|Overall Study|Withdrew prior to study|0
2581741|NCT01206582|8927942|P1|Overall Study|Withdrew prior to study|1
2581742|NCT01206517|8927974|P6|Overall Study|Withdrawal by Subject|0
2581743|NCT01206517|8927975|P5|Overall Study|Withdrawal by Subject|1
2581744|NCT01206517|8927976|P4|Overall Study|Withdrawal by Subject|0
2581745|NCT01206517|8927977|P3|Overall Study|Withdrawal by Subject|2
2581746|NCT01206517|8927978|P2|Overall Study|Withdrawal by Subject|0
2581747|NCT01206517|8927979|P1|Overall Study|Withdrawal by Subject|0
2581748|NCT01206439|8928059|P1|Overall Study|subject did not meet inclusion criteria|1
2581749|NCT01206322|8928082|P4|Overall Study|Adverse Event|1
2581750|NCT01206322|8928083|P3|Overall Study|Adverse Event|0
2581751|NCT01206322|8928084|P2|Overall Study|Adverse Event|0
2581752|NCT01206322|8928085|P1|Overall Study|Adverse Event|0
2581753|NCT01206140|8928101|P2|Overall Study|Deemed ineligible due to incorrect diag.|0
2581754|NCT01206140|8928102|P1|Overall Study|Deemed ineligible due to incorrect diag.|1
2581755|NCT01206101|8928114|P2|Overall Study|Unclassified|0
2581756|NCT01206101|8928115|P1|Overall Study|Unclassified|1
2581757|NCT01206101|8928114|P2|Overall Study|Physician Decision|1
2581758|NCT01206101|8928115|P1|Overall Study|Physician Decision|0
2581759|NCT01206101|8928114|P2|Overall Study|Adverse Event|0
2581760|NCT01206101|8928115|P1|Overall Study|Adverse Event|1
2581761|NCT01205776|8928156|P2|Overall Study|Withdrawal by Subject|34
2581762|NCT01205776|8928157|P1|Overall Study|Withdrawal by Subject|11
2581763|NCT01205776|8928156|P2|Overall Study|Lost to Follow-up|61
2581764|NCT01205776|8928157|P1|Overall Study|Lost to Follow-up|53
2581765|NCT01205685|8928345|P1|Overall Study|Withdrawal by Subject|1
2581766|NCT01205685|8928345|P1|Overall Study|Disease Progression|10
2581767|NCT01205581|8928365|P6|Overall Study|Withdrawal by Subject|0
2581768|NCT01205581|8928366|P5|Overall Study|Withdrawal by Subject|0
2581769|NCT01205581|8928367|P4|Overall Study|Withdrawal by Subject|0
2581770|NCT01205581|8928368|P3|Overall Study|Withdrawal by Subject|0
2581771|NCT01205581|8928369|P2|Overall Study|Withdrawal by Subject|0
2581772|NCT01205581|8928370|P1|Overall Study|Withdrawal by Subject|1
2581773|NCT01205529|8928440|P1|Overall Study|No longer met criteria|30
2581774|NCT01205529|8928440|P1|Overall Study|Unstable post op|15
2581775|NCT01205529|8928440|P1|Overall Study|Physician Decision|4
2581776|NCT01205529|8928440|P1|Overall Study|Withdrawal by Subject|2
2581777|NCT01205529|8928440|P1|Overall Study|Procedure Cancelled|4
2581778|NCT01205451|8928463|P2|Overall Study|Withdrawal by Subject|9
2581779|NCT01205451|8928464|P1|Overall Study|Withdrawal by Subject|5
2581780|NCT01205451|8928463|P2|Overall Study|Lost to Follow-up|1
2581781|NCT01205451|8928464|P1|Overall Study|Lost to Follow-up|1
2581782|NCT01205438|8928509|P3|Overall Study|Sponsor Decision|1
2581783|NCT01205438|8928510|P2|Overall Study|Sponsor Decision|1
2581784|NCT01205438|8928511|P1|Overall Study|Sponsor Decision|0
2581785|NCT01205438|8928509|P3|Overall Study|Protocol Violation|4
2581786|NCT01205438|8928510|P2|Overall Study|Protocol Violation|7
2581787|NCT01205438|8928511|P1|Overall Study|Protocol Violation|2
2581788|NCT01205438|8928509|P3|Overall Study|Physician Decision|2
2581789|NCT01205438|8928510|P2|Overall Study|Physician Decision|3
2581790|NCT01205438|8928511|P1|Overall Study|Physician Decision|0
2581791|NCT01205438|8928509|P3|Overall Study|Withdrawal by Subject|19
2581792|NCT01205438|8928510|P2|Overall Study|Withdrawal by Subject|25
2581793|NCT01205438|8928511|P1|Overall Study|Withdrawal by Subject|19
2581794|NCT01205438|8928509|P3|Overall Study|Lost to Follow-up|8
2581795|NCT01205438|8928510|P2|Overall Study|Lost to Follow-up|7
2581796|NCT01205438|8928511|P1|Overall Study|Lost to Follow-up|6
2581797|NCT01205438|8928509|P3|Overall Study|Lack of Efficacy|14
2581798|NCT01205438|8928510|P2|Overall Study|Lack of Efficacy|11
2581799|NCT01205438|8928511|P1|Overall Study|Lack of Efficacy|14
2581800|NCT01205438|8928509|P3|Overall Study|Entry Criteria Not Met|13
2581801|NCT01205438|8928510|P2|Overall Study|Entry Criteria Not Met|15
2581802|NCT01205438|8928511|P1|Overall Study|Entry Criteria Not Met|16
2581803|NCT01205438|8928509|P3|Overall Study|Death|3
2581804|NCT01205438|8928510|P2|Overall Study|Death|1
2581805|NCT01205438|8928511|P1|Overall Study|Death|1
2581806|NCT01205438|8928509|P3|Overall Study|Adverse Event|24
2581807|NCT01205438|8928510|P2|Overall Study|Adverse Event|17
2581808|NCT01205438|8928511|P1|Overall Study|Adverse Event|19
2581809|NCT01205269|8928567|P6|Period 4 - Washout|Eligibility criteria not fulfilled|0
2581810|NCT01205269|8928568|P5|Period 4 - Washout|Eligibility criteria not fulfilled|0
2581811|NCT01205269|8928569|P4|Period 4 - Washout|Eligibility criteria not fulfilled|1
2581812|NCT01205269|8928570|P3|Period 4 - Washout|Eligibility criteria not fulfilled|0
2581813|NCT01205269|8928571|P2|Period 4 - Washout|Eligibility criteria not fulfilled|0
2581814|NCT01205269|8928572|P1|Period 4 - Washout|Eligibility criteria not fulfilled|0
2581815|NCT01205230|8928612|P2|Overall Study|Physician Decision|0
2581816|NCT01205230|8928613|P1|Overall Study|Physician Decision|1
2581817|NCT01205230|8928612|P2|Overall Study|Adverse Event|0
2581818|NCT01205230|8928613|P1|Overall Study|Adverse Event|4
2581819|NCT01205165|8928656|P1|Overall Study|Lost to Follow-up|2
2581820|NCT01205152|8928669|P1|Overall Study|Death|1
2581821|NCT01205126|8928682|P2|Maintenance Phase|Withdrawal by Subject|11
2581822|NCT01205126|8928683|P1|Maintenance Phase|Withdrawal by Subject|8
2581823|NCT01205126|8928682|P2|Maintenance Phase|Lost to Follow-up|5
2581824|NCT01205126|8928683|P1|Maintenance Phase|Lost to Follow-up|5
2581825|NCT01205126|8928682|P2|Maintenance Phase|Other|8
2581826|NCT01205126|8928683|P1|Maintenance Phase|Other|11
2581827|NCT01205126|8928682|P2|Maintenance Phase|Prohibited drugs used|0
2581828|NCT01205126|8928683|P1|Maintenance Phase|Prohibited drugs used|1
2581829|NCT01205126|8928682|P2|Maintenance Phase|More than the maximum dosage required|5
2581830|NCT01205126|8928683|P1|Maintenance Phase|More than the maximum dosage required|5
2581831|NCT01205126|8928682|P2|Maintenance Phase|Death|4
2581832|NCT01205126|8928683|P1|Maintenance Phase|Death|4
2581833|NCT01205126|8928682|P2|Maintenance Phase|Adverse Event|7
2581834|NCT01205126|8928683|P1|Maintenance Phase|Adverse Event|3
2581835|NCT01205126|8928682|P2|Between Titration & Maintenance Phase|Other|4
2581836|NCT01205126|8928683|P1|Between Titration & Maintenance Phase|Other|0
2581837|NCT01205126|8928682|P2|Titration Phase|Other|6
2581838|NCT01205126|8928683|P1|Titration Phase|Other|8
2581839|NCT01205126|8928682|P2|Titration Phase|More than maximum dosage required|3
2581840|NCT01205126|8928683|P1|Titration Phase|More than maximum dosage required|2
2581841|NCT01205126|8928682|P2|Titration Phase|No stable titration dose|0
2581842|NCT01205126|8928683|P1|Titration Phase|No stable titration dose|1
2581843|NCT01205126|8928682|P2|Titration Phase|Lost to Follow-up|2
2581844|NCT01205126|8928683|P1|Titration Phase|Lost to Follow-up|2
2581845|NCT01205126|8928682|P2|Titration Phase|Withdrawal by Subject|5
2581846|NCT01205126|8928683|P1|Titration Phase|Withdrawal by Subject|5
2581847|NCT01205126|8928682|P2|Titration Phase|Adverse Event|3
2581848|NCT01205126|8928683|P1|Titration Phase|Adverse Event|5
2581849|NCT01205035|8928701|P2|Overall Study|Physician Decision|0
2581850|NCT01205035|8928702|P1|Overall Study|Physician Decision|1
2581851|NCT01205035|8928701|P2|Overall Study|Withdrawal by Subject|0
2581852|NCT01205035|8928702|P1|Overall Study|Withdrawal by Subject|1
2581853|NCT01204918|8928719|P3|Overall Study|Withdrawal by Subject|5
2581854|NCT01204918|8928720|P2|Overall Study|Withdrawal by Subject|10
2581855|NCT01204918|8928721|P1|Overall Study|Withdrawal by Subject|4
2581856|NCT01204775|8928764|P2|Overall Study|Withdrawal by Subject|0
2581857|NCT01204775|8928765|P1|Overall Study|Withdrawal by Subject|1
2581858|NCT01204775|8928764|P2|Overall Study|Poor/non-compliance|1
2581859|NCT01204775|8928765|P1|Overall Study|Poor/non-compliance|0
2581860|NCT01204710|8928790|P2|Optional Olaratumab Monotherapy|Withdrawal by Subject|1
2581861|NCT01204710|8928791|P1|Optional Olaratumab Monotherapy|Withdrawal by Subject|0
2581862|NCT01204710|8928790|P2|Optional Olaratumab Monotherapy|Physician Decision|1
2581863|NCT01204710|8928791|P1|Optional Olaratumab Monotherapy|Physician Decision|0
2581864|NCT01204710|8928790|P2|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1
2581865|NCT01204710|8928791|P1|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0
2581866|NCT01204710|8928790|P2|Randomization Treatment|Moved and Followed for Survival|1
2581867|NCT01204710|8928791|P1|Randomization Treatment|Moved and Followed for Survival|0
2581868|NCT01204710|8928790|P2|Randomization Treatment|Worsening of General condition|1
2581869|NCT01204710|8928791|P1|Randomization Treatment|Worsening of General condition|0
2581870|NCT01204710|8928790|P2|Randomization Treatment|Sponsor Decision|1
2581871|NCT01204710|8928791|P1|Randomization Treatment|Sponsor Decision|0
2581872|NCT01204710|8928790|P2|Randomization Treatment|Adverse Event|2
2581873|NCT01204710|8928791|P1|Randomization Treatment|Adverse Event|4
2581874|NCT01204710|8928790|P2|Randomization Treatment|Entry criteria not met|1
2581875|NCT01204710|8928791|P1|Randomization Treatment|Entry criteria not met|0
2581876|NCT01204710|8928790|P2|Randomization Treatment|Physician Decision|2
2581877|NCT01204710|8928791|P1|Randomization Treatment|Physician Decision|3
2581878|NCT01204710|8928790|P2|Randomization Treatment|Withdrawal by Subject|5
2581879|NCT01204710|8928791|P1|Randomization Treatment|Withdrawal by Subject|6
2581880|NCT01204710|8928790|P2|Randomization Treatment|Lost to Follow-up|0
2581881|NCT01204710|8928791|P1|Randomization Treatment|Lost to Follow-up|1
2581882|NCT01204697|8928827|P2|Overall Study|Randomized, but not treated|1
2581883|NCT01204697|8928828|P1|Overall Study|Randomized, but not treated|0
2581884|NCT01204697|8928827|P2|Overall Study|Withdrawal by Subject|4
2581885|NCT01204697|8928828|P1|Overall Study|Withdrawal by Subject|2
2581886|NCT01204697|8928827|P2|Overall Study|Lost to Follow-up|4
2581887|NCT01204697|8928828|P1|Overall Study|Lost to Follow-up|3
2581888|NCT01204697|8928827|P2|Overall Study|Death|27
2581889|NCT01204697|8928828|P1|Overall Study|Death|26
2581890|NCT01204671|8928849|P5|Overall Study|Physician Decision|0
2581891|NCT01204671|8928850|P4|Overall Study|Physician Decision|1
2581892|NCT01204671|8928851|P3|Overall Study|Physician Decision|0
2581893|NCT01204671|8928852|P2|Overall Study|Physician Decision|0
2581894|NCT01204671|8928853|P1|Overall Study|Physician Decision|0
2581895|NCT01204671|8928849|P5|Overall Study|Unknown Completion Status|0
2581896|NCT01204671|8928850|P4|Overall Study|Unknown Completion Status|0
2581897|NCT01204671|8928851|P3|Overall Study|Unknown Completion Status|0
2581898|NCT01204671|8928852|P2|Overall Study|Unknown Completion Status|1
2581899|NCT01204671|8928853|P1|Overall Study|Unknown Completion Status|1
2581900|NCT01204671|8928849|P5|Overall Study|Lost to Follow-up|0
2581901|NCT01204671|8928850|P4|Overall Study|Lost to Follow-up|4
2581902|NCT01204671|8928851|P3|Overall Study|Lost to Follow-up|6
2581903|NCT01204671|8928852|P2|Overall Study|Lost to Follow-up|8
2581904|NCT01204671|8928853|P1|Overall Study|Lost to Follow-up|7
2581905|NCT01204671|8928849|P5|Overall Study|Withdrawal by Subject|3
2581906|NCT01204671|8928850|P4|Overall Study|Withdrawal by Subject|5
2581907|NCT01204671|8928851|P3|Overall Study|Withdrawal by Subject|4
2581908|NCT01204671|8928852|P2|Overall Study|Withdrawal by Subject|3
2581909|NCT01204671|8928853|P1|Overall Study|Withdrawal by Subject|2
2581910|NCT01204671|8928849|P5|Overall Study|Adverse Event|1
2581911|NCT01204671|8928850|P4|Overall Study|Adverse Event|3
2581912|NCT01204671|8928851|P3|Overall Study|Adverse Event|3
2581913|NCT01204671|8928852|P2|Overall Study|Adverse Event|3
2581914|NCT01204671|8928853|P1|Overall Study|Adverse Event|4
2581915|NCT01204658|8928915|P4|Primary Phase|Adverse Event|0
2581916|NCT01204658|8928916|P3|Primary Phase|Adverse Event|1
2581917|NCT01204658|8928917|P2|Primary Phase|Adverse Event|0
2581918|NCT01204658|8928918|P1|Primary Phase|Adverse Event|0
2581919|NCT01204398|8929036|P1|Overall Study|Adverse Event|1
2581920|NCT01204294|8929053|P7|Overall Study|Other (house moving)|0
2581921|NCT01204294|8929054|P6|Overall Study|Other (house moving)|0
2581922|NCT01204294|8929055|P5|Overall Study|Other (house moving)|0
2581923|NCT01204294|8929056|P4|Overall Study|Other (house moving)|0
2581924|NCT01204294|8929057|P3|Overall Study|Other (house moving)|1
2581925|NCT01204294|8929058|P2|Overall Study|Other (house moving)|0
2581926|NCT01204294|8929059|P1|Overall Study|Other (house moving)|0
2581927|NCT01204294|8929053|P7|Overall Study|Lack of Efficacy|0
2581928|NCT01204294|8929054|P6|Overall Study|Lack of Efficacy|0
2581929|NCT01204294|8929055|P5|Overall Study|Lack of Efficacy|0
2581930|NCT01204294|8929056|P4|Overall Study|Lack of Efficacy|2
2581931|NCT01204294|8929057|P3|Overall Study|Lack of Efficacy|0
2581932|NCT01204294|8929058|P2|Overall Study|Lack of Efficacy|0
2581933|NCT01204294|8929059|P1|Overall Study|Lack of Efficacy|0
2581934|NCT01204294|8929053|P7|Overall Study|Withdrawal by Subject|2
2581935|NCT01204294|8929054|P6|Overall Study|Withdrawal by Subject|1
2581936|NCT01204294|8929055|P5|Overall Study|Withdrawal by Subject|1
2581937|NCT01204294|8929056|P4|Overall Study|Withdrawal by Subject|1
2581938|NCT01204294|8929057|P3|Overall Study|Withdrawal by Subject|2
2581939|NCT01204294|8929058|P2|Overall Study|Withdrawal by Subject|2
2581940|NCT01204294|8929059|P1|Overall Study|Withdrawal by Subject|0
2581941|NCT01204294|8929053|P7|Overall Study|Protocol Violation|0
2581942|NCT01204294|8929054|P6|Overall Study|Protocol Violation|0
2581943|NCT01204294|8929055|P5|Overall Study|Protocol Violation|0
2581944|NCT01204294|8929056|P4|Overall Study|Protocol Violation|1
2581945|NCT01204294|8929057|P3|Overall Study|Protocol Violation|2
2581946|NCT01204294|8929058|P2|Overall Study|Protocol Violation|0
2581947|NCT01204294|8929059|P1|Overall Study|Protocol Violation|1
2581948|NCT01204294|8929053|P7|Overall Study|Adverse Event|0
2581949|NCT01204294|8929054|P6|Overall Study|Adverse Event|4
2581950|NCT01204294|8929055|P5|Overall Study|Adverse Event|1
2581951|NCT01204294|8929056|P4|Overall Study|Adverse Event|7
2581952|NCT01204294|8929057|P3|Overall Study|Adverse Event|0
2581953|NCT01204294|8929058|P2|Overall Study|Adverse Event|6
2581954|NCT01204294|8929059|P1|Overall Study|Adverse Event|2
2581955|NCT01203956|8929093|P2|Second Two-week Period|Non-compliant: no evaluable results|6
2581956|NCT01203956|8929094|P1|Second Two-week Period|Non-compliant: no evaluable results|5
2581957|NCT01203930|8929103|P2|Overall Study|Adverse Event|5
2581958|NCT01203930|8929104|P1|Overall Study|Adverse Event|17
2581959|NCT01203930|8929103|P2|Overall Study|Poor tolerance of study drug|1
2581960|NCT01203930|8929104|P1|Overall Study|Poor tolerance of study drug|0
2581961|NCT01203930|8929103|P2|Overall Study|Study Terminated by Sponsor|12
2581962|NCT01203930|8929104|P1|Overall Study|Study Terminated by Sponsor|0
2581963|NCT01203930|8929103|P2|Overall Study|Investigator Request|8
2581964|NCT01203930|8929104|P1|Overall Study|Investigator Request|0
2581965|NCT01203930|8929103|P2|Overall Study|Withdrew Consent|10
2581966|NCT01203930|8929104|P1|Overall Study|Withdrew Consent|1
2581967|NCT01203930|8929103|P2|Overall Study|Death|1
2581968|NCT01203930|8929104|P1|Overall Study|Death|3
2581969|NCT01203930|8929103|P2|Overall Study|Disease Progression|4
2581970|NCT01203930|8929104|P1|Overall Study|Disease Progression|0
2581971|NCT01203917|8929126|P1|Overall Study|Due to EGFR M+I patient|1
2581972|NCT01203917|8929126|P1|Overall Study|Due to objective disease progression|1
2581973|NCT01203917|8929126|P1|Overall Study|Withdrawal by Subject|3
2581974|NCT01203917|8929126|P1|Overall Study|Lost to Follow-up|2
2581975|NCT01203917|8929126|P1|Overall Study|Death|29
2581976|NCT01203878|8929139|P3|Overall Study|Adverse Event|2
2581977|NCT01203878|8929140|P2|Overall Study|Adverse Event|0
2581978|NCT01203878|8929141|P1|Overall Study|Adverse Event|0
2581979|NCT01203878|8929139|P3|Overall Study|Withdrawal by Subject|1
2581980|NCT01203878|8929140|P2|Overall Study|Withdrawal by Subject|0
2581981|NCT01203878|8929141|P1|Overall Study|Withdrawal by Subject|0
2581982|NCT01203852|8929152|P1|Washout 2 Weeks|Physician Decision|46
2581983|NCT01203852|8929152|P1|Metoprolol 8 Weeks|Physician Decision|470
2581984|NCT01203787|8929170|P2|Overall Study|Adverse Event|15
2581985|NCT01203787|8929171|P1|Overall Study|Adverse Event|11
2581986|NCT01203787|8929170|P2|Overall Study|Lost to Follow-up|0
2581987|NCT01203787|8929171|P1|Overall Study|Lost to Follow-up|2
2581988|NCT01203787|8929170|P2|Overall Study|Withdrawal by Subject|2
2581989|NCT01203787|8929171|P1|Overall Study|Withdrawal by Subject|6
2581990|NCT01203787|8929170|P2|Overall Study|Death|10
2581991|NCT01203787|8929171|P1|Overall Study|Death|12
2581992|NCT01203098|8929242|P3|Overall Study|Withdrawal by Subject|3
2581993|NCT01203098|8929243|P2|Overall Study|Withdrawal by Subject|1
2581994|NCT01203098|8929244|P1|Overall Study|Withdrawal by Subject|1
2581995|NCT01203098|8929242|P3|Overall Study|Physician Decision|0
2581996|NCT01203098|8929243|P2|Overall Study|Physician Decision|2
2581997|NCT01203098|8929244|P1|Overall Study|Physician Decision|2
2581998|NCT01203098|8929242|P3|Overall Study|Lost to Follow-up|1
2581999|NCT01203098|8929243|P2|Overall Study|Lost to Follow-up|0
2582000|NCT01203098|8929244|P1|Overall Study|Lost to Follow-up|0
2582001|NCT01203098|8929242|P3|Overall Study|Adverse Event|7
2582002|NCT01203098|8929243|P2|Overall Study|Adverse Event|1
2582003|NCT01203098|8929244|P1|Overall Study|Adverse Event|3
2582004|NCT01203072|8929260|P5|Overall Study|Withdrawal by Subject|3
2582005|NCT01203072|8929261|P4|Overall Study|Withdrawal by Subject|2
2582006|NCT01203072|8929262|P3|Overall Study|Withdrawal by Subject|1
2582007|NCT01203072|8929263|P2|Overall Study|Withdrawal by Subject|2
2582008|NCT01203072|8929264|P1|Overall Study|Withdrawal by Subject|2
2582009|NCT01203072|8929260|P5|Overall Study|Protocol Violation|1
2582010|NCT01203072|8929261|P4|Overall Study|Protocol Violation|0
2582011|NCT01203072|8929262|P3|Overall Study|Protocol Violation|0
2582012|NCT01203072|8929263|P2|Overall Study|Protocol Violation|0
2582013|NCT01203072|8929264|P1|Overall Study|Protocol Violation|2
2582014|NCT01203072|8929260|P5|Overall Study|Lost to Follow-up|0
2582015|NCT01203072|8929261|P4|Overall Study|Lost to Follow-up|0
2582016|NCT01203072|8929262|P3|Overall Study|Lost to Follow-up|0
2582017|NCT01203072|8929263|P2|Overall Study|Lost to Follow-up|1
2582018|NCT01203072|8929264|P1|Overall Study|Lost to Follow-up|0
2582019|NCT01203072|8929260|P5|Overall Study|Lack of Efficacy|0
2582020|NCT01203072|8929261|P4|Overall Study|Lack of Efficacy|0
2582021|NCT01203072|8929262|P3|Overall Study|Lack of Efficacy|0
2582022|NCT01203072|8929263|P2|Overall Study|Lack of Efficacy|0
2582023|NCT01203072|8929264|P1|Overall Study|Lack of Efficacy|1
2582024|NCT01203072|8929260|P5|Overall Study|Adverse Event|2
2582025|NCT01203072|8929261|P4|Overall Study|Adverse Event|4
2582026|NCT01203072|8929262|P3|Overall Study|Adverse Event|2
2582027|NCT01203072|8929263|P2|Overall Study|Adverse Event|3
2582028|NCT01203072|8929264|P1|Overall Study|Adverse Event|5
2582029|NCT01202955|8929299|P2|Period 1: 10 Days|Withdrawal by Subject|2
2582030|NCT01202955|8929300|P1|Period 1: 10 Days|Withdrawal by Subject|0
2582031|NCT01202903|8929312|P2|Overall Study|Withdrawal by Subject|4
2582032|NCT01202903|8929313|P1|Overall Study|Withdrawal by Subject|4
2582033|NCT01202903|8929312|P2|Overall Study|Adverse Event|3
2582034|NCT01202903|8929313|P1|Overall Study|Adverse Event|3
2582035|NCT01202903|8929312|P2|Overall Study|Lack of Efficacy|3
2582036|NCT01202903|8929313|P1|Overall Study|Lack of Efficacy|1
2582037|NCT01202903|8929312|P2|Overall Study|Lost to Follow-up|1
2582038|NCT01202903|8929313|P1|Overall Study|Lost to Follow-up|1
2582039|NCT01202903|8929312|P2|Overall Study|Death|0
2582040|NCT01202903|8929313|P1|Overall Study|Death|1
2582041|NCT01202903|8929312|P2|Overall Study|Protocol Violation|1
2582042|NCT01202903|8929313|P1|Overall Study|Protocol Violation|0
2582043|NCT01202903|8929312|P2|Overall Study|Administrative Probelms|4
2582044|NCT01202903|8929313|P1|Overall Study|Administrative Probelms|1
2582045|NCT01202877|8929340|P3|Overall Study|Death|1
2582046|NCT01202877|8929341|P2|Overall Study|Death|0
2582047|NCT01202877|8929342|P1|Overall Study|Death|0
2582048|NCT01202877|8929340|P3|Overall Study|Withdrawal by Subject|1
2582049|NCT01202877|8929341|P2|Overall Study|Withdrawal by Subject|0
2582050|NCT01202877|8929342|P1|Overall Study|Withdrawal by Subject|0
2582051|NCT01202877|8929340|P3|Overall Study|Adverse Event|2
2582052|NCT01202877|8929341|P2|Overall Study|Adverse Event|0
2582053|NCT01202877|8929342|P1|Overall Study|Adverse Event|0
2582054|NCT01202877|8929340|P3|Overall Study|Disease Progression|2
2582055|NCT01202877|8929341|P2|Overall Study|Disease Progression|1
2582056|NCT01202877|8929342|P1|Overall Study|Disease Progression|0
2582057|NCT01202773|8929356|P3|Overall Study|Sponsor Decision|23
2582058|NCT01202773|8929357|P2|Overall Study|Sponsor Decision|20
2582059|NCT01202773|8929358|P1|Overall Study|Sponsor Decision|19
2582060|NCT01202773|8929356|P3|Overall Study|Protocol Violation|10
2582061|NCT01202773|8929357|P2|Overall Study|Protocol Violation|6
2582062|NCT01202773|8929358|P1|Overall Study|Protocol Violation|11
2582063|NCT01202773|8929356|P3|Overall Study|Physician Decision|0
2582064|NCT01202773|8929357|P2|Overall Study|Physician Decision|0
2582065|NCT01202773|8929358|P1|Overall Study|Physician Decision|2
2582066|NCT01202773|8929356|P3|Overall Study|Withdrawal by Subject|5
2582067|NCT01202773|8929357|P2|Overall Study|Withdrawal by Subject|6
2582068|NCT01202773|8929358|P1|Overall Study|Withdrawal by Subject|13
2582069|NCT01202773|8929356|P3|Overall Study|Lost to Follow-up|2
2582070|NCT01202773|8929357|P2|Overall Study|Lost to Follow-up|2
2582071|NCT01202773|8929358|P1|Overall Study|Lost to Follow-up|1
2582072|NCT01202773|8929356|P3|Overall Study|Entry Criteria Not Met|1
2582073|NCT01202773|8929357|P2|Overall Study|Entry Criteria Not Met|0
2582074|NCT01202773|8929358|P1|Overall Study|Entry Criteria Not Met|2
2582075|NCT01202773|8929356|P3|Overall Study|Lack of Efficacy|9
2582076|NCT01202773|8929357|P2|Overall Study|Lack of Efficacy|4
2582077|NCT01202773|8929358|P1|Overall Study|Lack of Efficacy|5
2582078|NCT01202773|8929356|P3|Overall Study|Adverse Event|5
2582079|NCT01202773|8929357|P2|Overall Study|Adverse Event|5
2582080|NCT01202773|8929358|P1|Overall Study|Adverse Event|4
2582081|NCT01202760|8929435|P3|Overall Study|Sponsor Decision|0
2582082|NCT01202760|8929436|P2|Overall Study|Sponsor Decision|4
2582083|NCT01202760|8929437|P1|Overall Study|Sponsor Decision|4
2582084|NCT01202760|8929435|P3|Overall Study|Protocol Violation|2
2582085|NCT01202760|8929436|P2|Overall Study|Protocol Violation|5
2582086|NCT01202760|8929437|P1|Overall Study|Protocol Violation|7
2582087|NCT01202760|8929435|P3|Overall Study|Physician Decision|0
2582088|NCT01202760|8929436|P2|Overall Study|Physician Decision|1
2582089|NCT01202760|8929437|P1|Overall Study|Physician Decision|0
2582090|NCT01202760|8929435|P3|Overall Study|Withdrawal by Subject|14
2582091|NCT01202760|8929436|P2|Overall Study|Withdrawal by Subject|18
2582092|NCT01202760|8929437|P1|Overall Study|Withdrawal by Subject|17
2582093|NCT01202760|8929435|P3|Overall Study|Parent / Caregiver Decision|0
2582094|NCT01202760|8929436|P2|Overall Study|Parent / Caregiver Decision|1
2582095|NCT01202760|8929437|P1|Overall Study|Parent / Caregiver Decision|0
2582096|NCT01202760|8929435|P3|Overall Study|Lost to Follow-up|1
2582097|NCT01202760|8929436|P2|Overall Study|Lost to Follow-up|2
2582098|NCT01202760|8929437|P1|Overall Study|Lost to Follow-up|0
2582099|NCT01202760|8929435|P3|Overall Study|Lack of Efficacy|7
2582100|NCT01202760|8929436|P2|Overall Study|Lack of Efficacy|8
2582101|NCT01202760|8929437|P1|Overall Study|Lack of Efficacy|6
2582102|NCT01202760|8929435|P3|Overall Study|Death|0
2582103|NCT01202760|8929436|P2|Overall Study|Death|1
2582104|NCT01202760|8929437|P1|Overall Study|Death|2
2582105|NCT01202760|8929435|P3|Overall Study|Adverse Event|10
2582106|NCT01202760|8929436|P2|Overall Study|Adverse Event|9
2582107|NCT01202760|8929437|P1|Overall Study|Adverse Event|11
2582108|NCT01202760|8929435|P3|Overall Study|Entry Criteria Not Met|1
2582109|NCT01202760|8929436|P2|Overall Study|Entry Criteria Not Met|3
2582110|NCT01202760|8929437|P1|Overall Study|Entry Criteria Not Met|0
2582111|NCT01202747|8929505|P1|Overall Study|Withdrawal by Subject|1
2582112|NCT01202591|8929558|P6|Overall Study|Objective Disease Progression|0
2582113|NCT01202591|8929559|P5|Overall Study|Objective Disease Progression|2
2582114|NCT01202591|8929560|P4|Overall Study|Objective Disease Progression|0
2582115|NCT01202591|8929561|P3|Overall Study|Objective Disease Progression|0
2582116|NCT01202591|8929562|P2|Overall Study|Objective Disease Progression|0
2582117|NCT01202591|8929563|P1|Overall Study|Objective Disease Progression|0
2582118|NCT01202591|8929558|P6|Overall Study|Withdrawal by Subject|1
2582119|NCT01202591|8929559|P5|Overall Study|Withdrawal by Subject|2
2582120|NCT01202591|8929560|P4|Overall Study|Withdrawal by Subject|0
2582121|NCT01202591|8929561|P3|Overall Study|Withdrawal by Subject|0
2582122|NCT01202591|8929562|P2|Overall Study|Withdrawal by Subject|0
2582123|NCT01202591|8929563|P1|Overall Study|Withdrawal by Subject|0
2582124|NCT01202591|8929558|P6|Overall Study|Other reason as per investigator|3
2582125|NCT01202591|8929559|P5|Overall Study|Other reason as per investigator|1
2582126|NCT01202591|8929560|P4|Overall Study|Other reason as per investigator|3
2582127|NCT01202591|8929561|P3|Overall Study|Other reason as per investigator|7
2582128|NCT01202591|8929562|P2|Overall Study|Other reason as per investigator|4
2582129|NCT01202591|8929563|P1|Overall Study|Other reason as per investigator|3
2582130|NCT01202591|8929558|P6|Overall Study|Adverse Event|0
2582131|NCT01202591|8929559|P5|Overall Study|Adverse Event|0
2582132|NCT01202591|8929560|P4|Overall Study|Adverse Event|4
2582133|NCT01202591|8929561|P3|Overall Study|Adverse Event|4
2582134|NCT01202591|8929562|P2|Overall Study|Adverse Event|1
2582135|NCT01202591|8929563|P1|Overall Study|Adverse Event|2
2582136|NCT01202409|8929607|P1|Overall Study|Ineligible - KRAS mutants|7
2582137|NCT01202409|8929607|P1|Overall Study|Adverse Event|1
2582138|NCT01202279|8929614|P2|Overall Study|study compliance|2
2582139|NCT01202279|8929615|P1|Overall Study|study compliance|5
2582140|NCT01202279|8929614|P2|Overall Study|Protocol Violation|1
2582141|NCT01202279|8929615|P1|Overall Study|Protocol Violation|1
2582142|NCT01202279|8929614|P2|Overall Study|Lost to Follow-up|7
2582143|NCT01202279|8929615|P1|Overall Study|Lost to Follow-up|10
2582144|NCT01202279|8929614|P2|Overall Study|Physician Decision|1
2582145|NCT01202279|8929615|P1|Overall Study|Physician Decision|0
2582146|NCT01202279|8929614|P2|Overall Study|Withdrawal by Subject|10
2582147|NCT01202279|8929615|P1|Overall Study|Withdrawal by Subject|13
2582148|NCT01202279|8929614|P2|Overall Study|Adverse Event|6
2582149|NCT01202279|8929615|P1|Overall Study|Adverse Event|8
2582150|NCT01202227|8929667|P1|Overall Study|Lack of Efficacy|1
2582151|NCT01202227|8929667|P1|Overall Study|Withdrawal by Subject|2
2582152|NCT01202227|8929667|P1|Overall Study|Adverse Event|16
2582153|NCT01202188|8929691|P5|Overall Study|Abnormal test procedure result (s)|0
2582154|NCT01202188|8929692|P4|Overall Study|Abnormal test procedure result (s)|0
2582155|NCT01202188|8929693|P3|Overall Study|Abnormal test procedure result (s)|2
2582156|NCT01202188|8929694|P2|Overall Study|Abnormal test procedure result (s)|0
2582157|NCT01202188|8929695|P1|Overall Study|Abnormal test procedure result (s)|0
2582158|NCT01202188|8929691|P5|Overall Study|Death|0
2582159|NCT01202188|8929692|P4|Overall Study|Death|1
2582160|NCT01202188|8929693|P3|Overall Study|Death|1
2582161|NCT01202188|8929694|P2|Overall Study|Death|1
2582162|NCT01202188|8929695|P1|Overall Study|Death|1
2582163|NCT01202188|8929691|P5|Overall Study|Lost to Follow-up|1
2582164|NCT01202188|8929692|P4|Overall Study|Lost to Follow-up|4
2582165|NCT01202188|8929693|P3|Overall Study|Lost to Follow-up|0
2582166|NCT01202188|8929694|P2|Overall Study|Lost to Follow-up|1
2582167|NCT01202188|8929695|P1|Overall Study|Lost to Follow-up|1
2582168|NCT01202188|8929691|P5|Overall Study|Unsatisfactory therapeutic effect|8
2582169|NCT01202188|8929692|P4|Overall Study|Unsatisfactory therapeutic effect|5
2582170|NCT01202188|8929693|P3|Overall Study|Unsatisfactory therapeutic effect|2
2582171|NCT01202188|8929694|P2|Overall Study|Unsatisfactory therapeutic effect|8
2582172|NCT01202188|8929695|P1|Overall Study|Unsatisfactory therapeutic effect|2
2582173|NCT01202188|8929691|P5|Overall Study|Administrative problems|2
2582174|NCT01202188|8929692|P4|Overall Study|Administrative problems|1
2582175|NCT01202188|8929693|P3|Overall Study|Administrative problems|1
2582176|NCT01202188|8929694|P2|Overall Study|Administrative problems|2
2582177|NCT01202188|8929695|P1|Overall Study|Administrative problems|3
2582178|NCT01202188|8929691|P5|Overall Study|Adverse Event|10
2582179|NCT01202188|8929692|P4|Overall Study|Adverse Event|10
2582180|NCT01202188|8929693|P3|Overall Study|Adverse Event|13
2582181|NCT01202188|8929694|P2|Overall Study|Adverse Event|23
2582182|NCT01202188|8929695|P1|Overall Study|Adverse Event|5
2582183|NCT01202188|8929691|P5|Overall Study|Subject withdrew consent|13
2582184|NCT01202188|8929692|P4|Overall Study|Subject withdrew consent|11
2582185|NCT01202188|8929693|P3|Overall Study|Subject withdrew consent|22
2582186|NCT01202188|8929694|P2|Overall Study|Subject withdrew consent|13
2582187|NCT01202188|8929695|P1|Overall Study|Subject withdrew consent|12
2582188|NCT01202188|8929691|P5|Overall Study|Protocol deviation|11
2582189|NCT01202188|8929692|P4|Overall Study|Protocol deviation|10
2582190|NCT01202188|8929693|P3|Overall Study|Protocol deviation|12
2582191|NCT01202188|8929694|P2|Overall Study|Protocol deviation|8
2582192|NCT01202188|8929695|P1|Overall Study|Protocol deviation|14
2582193|NCT01202175|8929803|P1|Overall Study|Adverse Event|2
2582194|NCT01202175|8929803|P1|Overall Study|Withdrawal by Subject|1
2582195|NCT01202175|8929803|P1|Overall Study|Lost to Follow-up|2
2582196|NCT01201967|8929871|P2|Overall Study|Lost to Follow-up|5
2582197|NCT01201967|8929872|P1|Overall Study|Lost to Follow-up|6
2582198|NCT01201915|8929897|P3|Overall Study|Target Lesion Progression|0
2582199|NCT01201915|8929898|P2|Overall Study|Target Lesion Progression|3
2582200|NCT01201915|8929899|P1|Overall Study|Target Lesion Progression|0
2582201|NCT01201915|8929897|P3|Overall Study|Subject Decision|5
2582202|NCT01201915|8929898|P2|Overall Study|Subject Decision|3
2582203|NCT01201915|8929899|P1|Overall Study|Subject Decision|3
2582204|NCT01201915|8929897|P3|Overall Study|Physician Decision|0
2582205|NCT01201915|8929898|P2|Overall Study|Physician Decision|0
2582206|NCT01201915|8929899|P1|Overall Study|Physician Decision|3
2582207|NCT01201915|8929897|P3|Overall Study|Lost to Follow-up|0
2582208|NCT01201915|8929898|P2|Overall Study|Lost to Follow-up|4
2582209|NCT01201915|8929899|P1|Overall Study|Lost to Follow-up|0
2582210|NCT01201915|8929897|P3|Overall Study|Adverse Event|1
2582211|NCT01201915|8929898|P2|Overall Study|Adverse Event|1
2582212|NCT01201915|8929899|P1|Overall Study|Adverse Event|2
2582213|NCT01201811|8929910|P1|Overall Study|Physician Decision|1
2582214|NCT01201811|8929910|P1|Overall Study|Treatment Failure|2
2582215|NCT01201811|8929910|P1|Overall Study|Death|4
2582216|NCT01201811|8929910|P1|Overall Study|Withdrawal by Subject|3
2582217|NCT01201811|8929910|P1|Overall Study|Disease progression|3
2582218|NCT01201811|8929910|P1|Overall Study|Adverse Event|6
2582219|NCT01201798|8929932|P2|Overall Study|Treatment Failure|8
2582220|NCT01201798|8929933|P1|Overall Study|Treatment Failure|1
2582221|NCT01201798|8929932|P2|Overall Study|Protocol Violation|1
2582222|NCT01201798|8929933|P1|Overall Study|Protocol Violation|1
2582223|NCT01201798|8929932|P2|Overall Study|Noncompliance|0
2582224|NCT01201798|8929933|P1|Overall Study|Noncompliance|1
2582225|NCT01201798|8929932|P2|Overall Study|Decision Unrelated to an Adverse Event|1
2582226|NCT01201798|8929933|P1|Overall Study|Decision Unrelated to an Adverse Event|1
2582227|NCT01201798|8929932|P2|Overall Study|Lost to Follow-up|5
2582228|NCT01201798|8929933|P1|Overall Study|Lost to Follow-up|3
2582229|NCT01201798|8929932|P2|Overall Study|Adverse Event|0
2582230|NCT01201798|8929933|P1|Overall Study|Adverse Event|2
2582231|NCT01201785|8929957|P1|Overall Study|Lost to Follow-up|16
2582232|NCT01201759|8929974|P2|Visit 4 Crossover|Lost to Follow-up|1
2582233|NCT01201759|8929975|P1|Visit 4 Crossover|Lost to Follow-up|0
2582234|NCT01201759|8929974|P2|Visit 3 - Washout|Lost to Follow-up|0
2582235|NCT01201759|8929975|P1|Visit 3 - Washout|Lost to Follow-up|1
2582236|NCT01201759|8929974|P2|Visit 3 - Washout|Adverse Event|3
2582237|NCT01201759|8929975|P1|Visit 3 - Washout|Adverse Event|0
2582238|NCT01201759|8929974|P2|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1
2582239|NCT01201759|8929975|P1|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2
2582240|NCT01201356|8930004|P1|Overall Study|Protocol Violation|12
2582241|NCT01201356|8930004|P1|Overall Study|Death|16
2582242|NCT01201356|8930004|P1|Overall Study|administrative problems|74
2582243|NCT01201356|8930004|P1|Overall Study|Lost to Follow-up|50
2582244|NCT01201356|8930004|P1|Overall Study|Withdrawal by Subject|144
2582245|NCT01201356|8930004|P1|Overall Study|Condition no longer requires study drug|12
2582246|NCT01201356|8930004|P1|Overall Study|Unsatisfactory therapeutic effect|112
2582247|NCT01201356|8930004|P1|Overall Study|Abnormal test procedure result(s)|3
2582248|NCT01201356|8930004|P1|Overall Study|Abnormal laboratory value(s)|51
2582249|NCT01201356|8930004|P1|Overall Study|Adverse Event|170
2582250|NCT01201343|8930018|P1|Overall Study|Randomized, not treated|3
2582251|NCT01201343|8930018|P1|Overall Study|Participant wrongly included in trial|1
2582252|NCT01201343|8930018|P1|Overall Study|Lack of Efficacy|2
2582253|NCT01201343|8930018|P1|Overall Study|Lost to Follow-up|2
2582254|NCT01201343|8930018|P1|Overall Study|Withdrawal by Subject|5
2582255|NCT01201343|8930018|P1|Overall Study|Adverse Event|6
2582256|NCT01201317|8930032|P3|Overall Study|Safety, possible history of tuberculosis|1
2582257|NCT01201317|8930033|P2|Overall Study|Safety, possible history of tuberculosis|0
2582258|NCT01201317|8930034|P1|Overall Study|Safety, possible history of tuberculosis|0
2582259|NCT01201317|8930032|P3|Overall Study|Lack of Efficacy|0
2582260|NCT01201317|8930033|P2|Overall Study|Lack of Efficacy|0
2582261|NCT01201317|8930034|P1|Overall Study|Lack of Efficacy|1
2582262|NCT01201317|8930032|P3|Overall Study|Decrease in renal function|0
2582263|NCT01201317|8930033|P2|Overall Study|Decrease in renal function|1
2582264|NCT01201317|8930034|P1|Overall Study|Decrease in renal function|0
2582265|NCT01201317|8930032|P3|Overall Study|Painful Diabetic Neuropathy worsening|0
2582266|NCT01201317|8930033|P2|Overall Study|Painful Diabetic Neuropathy worsening|1
2582267|NCT01201317|8930034|P1|Overall Study|Painful Diabetic Neuropathy worsening|0
2582268|NCT01201317|8930032|P3|Overall Study|Study-specific withdrawal criteria|1
2582269|NCT01201317|8930033|P2|Overall Study|Study-specific withdrawal criteria|0
2582270|NCT01201317|8930034|P1|Overall Study|Study-specific withdrawal criteria|0
2582271|NCT01201317|8930032|P3|Overall Study|Death|0
2582272|NCT01201317|8930033|P2|Overall Study|Death|1
2582273|NCT01201317|8930034|P1|Overall Study|Death|0
2582274|NCT01201317|8930032|P3|Overall Study|Protocol Violation|1
2582275|NCT01201317|8930033|P2|Overall Study|Protocol Violation|1
2582276|NCT01201317|8930034|P1|Overall Study|Protocol Violation|0
2582277|NCT01201317|8930032|P3|Overall Study|Screen failure|0
2582278|NCT01201317|8930033|P2|Overall Study|Screen failure|1
2582279|NCT01201317|8930034|P1|Overall Study|Screen failure|1
2582280|NCT01201317|8930032|P3|Overall Study|Adverse Event|2
2582281|NCT01201317|8930033|P2|Overall Study|Adverse Event|2
2582282|NCT01201317|8930034|P1|Overall Study|Adverse Event|2
2582283|NCT01201317|8930032|P3|Overall Study|Withdrawal by Subject|3
2582284|NCT01201317|8930033|P2|Overall Study|Withdrawal by Subject|0
2582285|NCT01201317|8930034|P1|Overall Study|Withdrawal by Subject|5
2582286|NCT01201265|8930054|P1|Overall Study|Disease Progression|4
2582287|NCT01201265|8930054|P1|Overall Study|Withdrawal by Subject|7
2582288|NCT01201265|8930054|P1|Overall Study|Lost to Follow-up|10
2582289|NCT01201265|8930054|P1|Overall Study|Insufficient Therapeutic Response|3
2582290|NCT01201265|8930054|P1|Overall Study|Death|14
2582291|NCT01200992|8930101|P2|Overall Study|Randomized but not treated|0
2582292|NCT01200992|8930102|P1|Overall Study|Randomized but not treated|2
2582293|NCT01200992|8930101|P2|Overall Study|Study terminated early|41
2582294|NCT01200992|8930102|P1|Overall Study|Study terminated early|35
2582295|NCT01200810|8930116|P2|Overall Study|Sponsor stopped making study drug|3
2582296|NCT01200810|8930117|P1|Overall Study|Sponsor stopped making study drug|3
2582297|NCT01200810|8930116|P2|Overall Study|Withdrawal by Subject|2
2582298|NCT01200810|8930117|P1|Overall Study|Withdrawal by Subject|1
2582299|NCT01200810|8930116|P2|Overall Study|Physician Decision|0
2582300|NCT01200810|8930117|P1|Overall Study|Physician Decision|1
2582301|NCT01200797|8930137|P1|Overall Study|Disease Progression|13
2582302|NCT01200797|8930137|P1|Overall Study|Adverse Event|4
2582303|NCT01200797|8930137|P1|Overall Study|symptomatic deterioration|2
2582304|NCT01200758|8930147|P4|Stage 2|Death|5
2582305|NCT01200758|8930148|P3|Stage 2|Death|3
2582306|NCT01200758|8930149|P2|Stage 2|Death|0
2582307|NCT01200758|8930150|P1|Stage 2|Death|0
2582308|NCT01200758|8930147|P4|Stage 2|Protocol Violation|4
2582309|NCT01200758|8930148|P3|Stage 2|Protocol Violation|1
2582310|NCT01200758|8930149|P2|Stage 2|Protocol Violation|0
2582311|NCT01200758|8930150|P1|Stage 2|Protocol Violation|0
2582312|NCT01200758|8930147|P4|Stage 2|Lost to Follow-up|1
2582313|NCT01200758|8930148|P3|Stage 2|Lost to Follow-up|3
2582314|NCT01200758|8930149|P2|Stage 2|Lost to Follow-up|0
2582315|NCT01200758|8930150|P1|Stage 2|Lost to Follow-up|0
2582316|NCT01200758|8930147|P4|Stage 2|Withdrawal by Subject|1
2582317|NCT01200758|8930148|P3|Stage 2|Withdrawal by Subject|4
2582318|NCT01200758|8930149|P2|Stage 2|Withdrawal by Subject|0
2582319|NCT01200758|8930150|P1|Stage 2|Withdrawal by Subject|0
2582320|NCT01200758|8930147|P4|Stage 2|Adverse Event|9
2582321|NCT01200758|8930148|P3|Stage 2|Adverse Event|5
2582322|NCT01200758|8930149|P2|Stage 2|Adverse Event|0
2582323|NCT01200758|8930150|P1|Stage 2|Adverse Event|0
2582324|NCT01200758|8930147|P4|Stage 2|Physician Decision|7
2582325|NCT01200758|8930148|P3|Stage 2|Physician Decision|5
2582326|NCT01200758|8930149|P2|Stage 2|Physician Decision|0
2582327|NCT01200758|8930150|P1|Stage 2|Physician Decision|0
2582328|NCT01200758|8930147|P4|Stage 2|Lack of Efficacy|2
2582329|NCT01200758|8930148|P3|Stage 2|Lack of Efficacy|4
2582330|NCT01200758|8930149|P2|Stage 2|Lack of Efficacy|0
2582331|NCT01200758|8930150|P1|Stage 2|Lack of Efficacy|0
2582332|NCT01200758|8930147|P4|Stage 2|Disease Progression|21
2582333|NCT01200758|8930148|P3|Stage 2|Disease Progression|16
2582334|NCT01200758|8930149|P2|Stage 2|Disease Progression|0
2582335|NCT01200758|8930150|P1|Stage 2|Disease Progression|0
2582336|NCT01200758|8930147|P4|Stage I|Disease Progression|0
2582337|NCT01200758|8930148|P3|Stage I|Disease Progression|0
2582338|NCT01200758|8930149|P2|Stage I|Disease Progression|7
2582339|NCT01200758|8930150|P1|Stage I|Disease Progression|9
2582340|NCT01200758|8930147|P4|Stage I|Withdrawal by Subject|0
2582341|NCT01200758|8930148|P3|Stage I|Withdrawal by Subject|0
2582342|NCT01200758|8930149|P2|Stage I|Withdrawal by Subject|2
2582343|NCT01200758|8930150|P1|Stage I|Withdrawal by Subject|1
2582344|NCT01200758|8930147|P4|Stage I|Adverse Event|0
2582345|NCT01200758|8930148|P3|Stage I|Adverse Event|0
2582346|NCT01200758|8930149|P2|Stage I|Adverse Event|5
2582347|NCT01200758|8930150|P1|Stage I|Adverse Event|5
2582348|NCT01200758|8930147|P4|Stage I|Lack of Efficacy|0
2582349|NCT01200758|8930148|P3|Stage I|Lack of Efficacy|0
2582350|NCT01200758|8930149|P2|Stage I|Lack of Efficacy|1
2582351|NCT01200758|8930150|P1|Stage I|Lack of Efficacy|2
2582352|NCT01200758|8930147|P4|Stage I|Physician Decision|0
2582353|NCT01200758|8930148|P3|Stage I|Physician Decision|0
2582354|NCT01200758|8930149|P2|Stage I|Physician Decision|1
2582355|NCT01200758|8930150|P1|Stage I|Physician Decision|1
2582356|NCT01200758|8930147|P4|Stage I|Death|0
2582357|NCT01200758|8930148|P3|Stage I|Death|0
2582358|NCT01200758|8930149|P2|Stage I|Death|1
2582359|NCT01200758|8930150|P1|Stage I|Death|0
2582360|NCT01200589|8930223|P2|Overall Study|Study terminated|172
2582361|NCT01200589|8930224|P1|Overall Study|Study terminated|170
2582362|NCT01200589|8930223|P2|Overall Study|Lost to Follow-up|4
2582363|NCT01200589|8930224|P1|Overall Study|Lost to Follow-up|5
2582364|NCT01200589|8930223|P2|Overall Study|Physician Decision|2
2582365|NCT01200589|8930224|P1|Overall Study|Physician Decision|2
2582366|NCT01200589|8930223|P2|Overall Study|Withdrawal by Subject|11
2582367|NCT01200589|8930224|P1|Overall Study|Withdrawal by Subject|13
2582368|NCT01200524|8930251|P3|Overall Study|Non availability of study nurse|1
2582369|NCT01200524|8930252|P2|Overall Study|Non availability of study nurse|0
2582370|NCT01200524|8930253|P1|Overall Study|Non availability of study nurse|0
2582371|NCT01200524|8930251|P3|Overall Study|Adverse Event|0
2582372|NCT01200524|8930252|P2|Overall Study|Adverse Event|0
2582373|NCT01200524|8930253|P1|Overall Study|Adverse Event|1
2582374|NCT01200524|8930251|P3|Overall Study|Withdrawal by Subject|3
2582375|NCT01200524|8930252|P2|Overall Study|Withdrawal by Subject|1
2582376|NCT01200524|8930253|P1|Overall Study|Withdrawal by Subject|1
2582377|NCT01200511|8930273|P1|Overall Study|Adverse Event|1
2582378|NCT01200511|8930273|P1|Overall Study|Withdrawal by Subject|1
2582379|NCT01200511|8930273|P1|Overall Study|Lost to Follow-up|3
2582380|NCT01200485|8930285|P3|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0
2582381|NCT01200485|8930286|P2|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0
2582382|NCT01200485|8930287|P1|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2
2582383|NCT01200485|8930285|P3|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0
2582384|NCT01200485|8930286|P2|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0
2582385|NCT01200485|8930287|P1|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1
2582386|NCT01200394|8930321|P2|Overall Study|Other|1
2582387|NCT01200394|8930322|P1|Overall Study|Other|0
2582388|NCT01200394|8930321|P2|Overall Study|Withdrawal by Subject|5
2582389|NCT01200394|8930322|P1|Overall Study|Withdrawal by Subject|0
2582390|NCT01200394|8930321|P2|Overall Study|Protocol Violation|3
2582391|NCT01200394|8930322|P1|Overall Study|Protocol Violation|0
2582392|NCT01200394|8930321|P2|Overall Study|Did Not Meet Entrance Criteria|4
2582393|NCT01200394|8930322|P1|Overall Study|Did Not Meet Entrance Criteria|1
2582394|NCT01200394|8930321|P2|Overall Study|Lost to Follow-up|1
2582395|NCT01200394|8930322|P1|Overall Study|Lost to Follow-up|0
2582396|NCT01200394|8930321|P2|Overall Study|Death|0
2582397|NCT01200394|8930322|P1|Overall Study|Death|1
2582398|NCT01200394|8930321|P2|Overall Study|Adverse Event|14
2582399|NCT01200394|8930322|P1|Overall Study|Adverse Event|0
2582400|NCT01200368|8930360|P3|Toddler Dose|Adverse Event|1
2582401|NCT01200368|8930361|P2|Toddler Dose|Adverse Event|3
2582402|NCT01200368|8930362|P1|Toddler Dose|Adverse Event|0
2582403|NCT01200368|8930360|P3|After Infant Series|Other|2
2582404|NCT01200368|8930361|P2|After Infant Series|Other|2
2582405|NCT01200368|8930362|P1|After Infant Series|Other|1
2582406|NCT01200368|8930360|P3|After Infant Series|Lost to Follow-up|0
2582407|NCT01200368|8930361|P2|After Infant Series|Lost to Follow-up|0
2582408|NCT01200368|8930362|P1|After Infant Series|Lost to Follow-up|1
2582409|NCT01200368|8930360|P3|After Infant Series|Withdrawal by Subject|4
2582410|NCT01200368|8930361|P2|After Infant Series|Withdrawal by Subject|8
2582411|NCT01200368|8930362|P1|After Infant Series|Withdrawal by Subject|10
2582412|NCT01200368|8930360|P3|After Infant Series|Adverse Event|3
2582413|NCT01200368|8930361|P2|After Infant Series|Adverse Event|6
2582414|NCT01200368|8930362|P1|After Infant Series|Adverse Event|6
2582415|NCT01200368|8930360|P3|Infant Series|Other|0
2582416|NCT01200368|8930361|P2|Infant Series|Other|0
2582417|NCT01200368|8930362|P1|Infant Series|Other|1
2582418|NCT01200368|8930360|P3|Infant Series|Randomized, not vaccinated|1
2582419|NCT01200368|8930361|P2|Infant Series|Randomized, not vaccinated|1
2582420|NCT01200368|8930362|P1|Infant Series|Randomized, not vaccinated|0
2582421|NCT01200368|8930360|P3|Infant Series|Did not meet entrance criteria|0
2582422|NCT01200368|8930361|P2|Infant Series|Did not meet entrance criteria|1
2582423|NCT01200368|8930362|P1|Infant Series|Did not meet entrance criteria|0
2582424|NCT01200368|8930360|P3|Infant Series|Withdrawal by Subject|2
2582425|NCT01200368|8930361|P2|Infant Series|Withdrawal by Subject|2
2582426|NCT01200368|8930362|P1|Infant Series|Withdrawal by Subject|0
2582427|NCT01200368|8930360|P3|Infant Series|Adverse Event|3
2582428|NCT01200368|8930361|P2|Infant Series|Adverse Event|2
2582429|NCT01200368|8930362|P1|Infant Series|Adverse Event|2
2582430|NCT01200355|8930428|P2|Overall Study|Death|2
2582431|NCT01200355|8930429|P1|Overall Study|Death|7
2582432|NCT01200342|8930443|P1|Overall Study|Disease Progression|1
2582433|NCT01200329|8930448|P1|Overall Study|Progressive disease|1
2582434|NCT01200329|8930448|P1|Overall Study|Lack of financial coverage|2
2582435|NCT01200290|8930453|P1|Post-Treatment Follow-Up Period|Death|2
2582436|NCT01200290|8930453|P1|Treatment Period|Adverse Event|1
2582437|NCT01200238|8930466|P2|Overall Study|Withdrawal by Subject|1
2582438|NCT01200238|8930467|P1|Overall Study|Withdrawal by Subject|0
2582439|NCT01200238|8930466|P2|Overall Study|Progressive Disease|8
2582440|NCT01200238|8930467|P1|Overall Study|Progressive Disease|5
2582441|NCT01200238|8930466|P2|Overall Study|Adverse Event|1
2582442|NCT01200238|8930467|P1|Overall Study|Adverse Event|2
2582443|NCT01200069|8930491|P2|Overall Study|Withdrawal by Subject|1
2582444|NCT01200069|8930492|P1|Overall Study|Withdrawal by Subject|0
2582445|NCT01199939|8930588|P1|Overall Study|Reached a virologic endpoint|4
2582446|NCT01199939|8930588|P1|Overall Study|Lost to Follow-up|2
2582447|NCT01199939|8930588|P1|Overall Study|Protocol Violation|3
2582448|NCT01199939|8930588|P1|Overall Study|Adverse Event|4
2582449|NCT01199861|8930620|P2|Overall Study|Adverse Event|0
2582450|NCT01199861|8930621|P1|Overall Study|Adverse Event|1
2582451|NCT01199861|8930620|P2|Overall Study|Administrative problems|0
2582452|NCT01199861|8930621|P1|Overall Study|Administrative problems|1
2582453|NCT01199822|8930642|P3|Overall Study|Investigator discontinued therapy|0
2582454|NCT01199822|8930643|P2|Overall Study|Investigator discontinued therapy|1
2582455|NCT01199822|8930644|P1|Overall Study|Investigator discontinued therapy|0
2582456|NCT01199731|8930693|P3|Overall Study|Withdrawal by Subject|0
2582457|NCT01199731|8930694|P2|Overall Study|Withdrawal by Subject|0
2582458|NCT01199731|8930695|P1|Overall Study|Withdrawal by Subject|2
2582459|NCT01199731|8930693|P3|Overall Study|Physician Decision|1
2582460|NCT01199731|8930694|P2|Overall Study|Physician Decision|1
2582461|NCT01199731|8930695|P1|Overall Study|Physician Decision|0
2582462|NCT01199731|8930693|P3|Overall Study|Lost to Follow-up|2
2582463|NCT01199731|8930694|P2|Overall Study|Lost to Follow-up|0
2582464|NCT01199731|8930695|P1|Overall Study|Lost to Follow-up|0
2582465|NCT01199731|8930693|P3|Overall Study|Study closed/terminated|7
2582466|NCT01199731|8930694|P2|Overall Study|Study closed/terminated|9
2582467|NCT01199731|8930695|P1|Overall Study|Study closed/terminated|7
2582468|NCT01199731|8930693|P3|Overall Study|Adverse Event|0
2582469|NCT01199731|8930694|P2|Overall Study|Adverse Event|1
2582470|NCT01199731|8930695|P1|Overall Study|Adverse Event|0
2582471|NCT01199705|8930733|P1|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1
2582472|NCT01199601|8930765|P2|Overall Study|Insecurity prevented staff interviewing.|9
2582473|NCT01199601|8930766|P1|Overall Study|Insecurity prevented staff interviewing.|7
2582474|NCT01199601|8930765|P2|Overall Study|Withdrawal by Subject|3
2582475|NCT01199601|8930766|P1|Overall Study|Withdrawal by Subject|15
2582476|NCT01199601|8930765|P2|Overall Study|Lost to Follow-up|66
2582477|NCT01199601|8930766|P1|Overall Study|Lost to Follow-up|47
2582478|NCT01199575|8930776|P1|Overall Study|Withdrawal by Subject|5
2582479|NCT01199471|8930781|P1|Overall Study|Physician Decision|1
2582480|NCT01199471|8930781|P1|Overall Study|Withdrawal by Subject|1
2582481|NCT01199471|8930781|P1|Overall Study|Protocol Violation|4
2582482|NCT01199263|8930792|P2|Overall Study|Never Treated|0
2582483|NCT01199263|8930793|P1|Overall Study|Never Treated|6
2582484|NCT01199263|8930792|P2|Overall Study|Ineligible|2
2582485|NCT01199263|8930793|P1|Overall Study|Ineligible|0
2582486|NCT01199042|8930830|P1|At Home (3 Months)|Lost to Follow-up|1
2582487|NCT01199042|8930830|P1|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2
2582488|NCT01199016|8930839|P1|Overall Study|Lost to Follow-up|25
2582489|NCT01199016|8930839|P1|Overall Study|Withdrawal by Subject|21
2582490|NCT01199016|8930839|P1|Overall Study|Other|13
2582491|NCT01199016|8930839|P1|Overall Study|Protocol Violation|9
2582492|NCT01199016|8930839|P1|Overall Study|Entrance criteria|5
2582493|NCT01199016|8930839|P1|Overall Study|No longer meets eligibility criteria|4
2582494|NCT01198977|8930848|P2|Overall Study|Lost to Follow-up|0
2582495|NCT01198977|8930849|P1|Overall Study|Lost to Follow-up|1
2582496|NCT01198873|8930861|P2|Overall Study|Other than above|2
2582497|NCT01198873|8930862|P1|Overall Study|Other than above|4
2582498|NCT01198873|8930861|P2|Overall Study|Study closure|23
2582499|NCT01198873|8930862|P1|Overall Study|Study closure|29
2582500|NCT01198873|8930861|P2|Overall Study|Adverse Event|7
2582501|NCT01198873|8930862|P1|Overall Study|Adverse Event|4
2582502|NCT01198795|8930876|P1|Overall Study|Other Reason|4
2582503|NCT01198795|8930876|P1|Overall Study|Protocol Violation|2
2582504|NCT01198795|8930876|P1|Overall Study|Lack of Efficacy|5
2582505|NCT01198795|8930876|P1|Overall Study|Adverse Event|9
2582506|NCT01198795|8930876|P1|Overall Study|Lost to Follow-up|15
2582507|NCT01198795|8930876|P1|Overall Study|Withdrawal by Subject|17
2582508|NCT01198795|8930876|P1|Overall Study|Did not meet InclusionExclusion criteria|30
2582509|NCT01198756|8930893|P4|Overall Study|Lost to Follow-up|18
2582510|NCT01198756|8930894|P3|Overall Study|Lost to Follow-up|23
2582511|NCT01198756|8930895|P2|Overall Study|Lost to Follow-up|36
2582512|NCT01198756|8930896|P1|Overall Study|Lost to Follow-up|29
2582513|NCT01198756|8930893|P4|Overall Study|Withdrawal by Subject|5
2582514|NCT01198756|8930894|P3|Overall Study|Withdrawal by Subject|7
2582515|NCT01198756|8930895|P2|Overall Study|Withdrawal by Subject|4
2582516|NCT01198756|8930896|P1|Overall Study|Withdrawal by Subject|9
2582517|NCT01198756|8930893|P4|Overall Study|Protocol Violation|2
2582518|NCT01198756|8930894|P3|Overall Study|Protocol Violation|0
2582519|NCT01198756|8930895|P2|Overall Study|Protocol Violation|0
2582520|NCT01198756|8930896|P1|Overall Study|Protocol Violation|0
2582521|NCT01198756|8930893|P4|Overall Study|Adverse Event|1
2582522|NCT01198756|8930894|P3|Overall Study|Adverse Event|0
2582523|NCT01198756|8930895|P2|Overall Study|Adverse Event|0
2582524|NCT01198756|8930896|P1|Overall Study|Adverse Event|0
2582525|NCT01198600|8931007|P4|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
2582526|NCT01198600|8931008|P3|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1
2582527|NCT01198600|8931009|P2|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
2582528|NCT01198600|8931010|P1|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
2582529|NCT01198600|8931007|P4|Phase 2: 56 Days of Wear|Relocation|0
2582530|NCT01198600|8931008|P3|Phase 2: 56 Days of Wear|Relocation|2
2582531|NCT01198600|8931009|P2|Phase 2: 56 Days of Wear|Relocation|0
2582532|NCT01198600|8931010|P1|Phase 2: 56 Days of Wear|Relocation|0
2582533|NCT01198600|8931007|P4|Phase 2: 56 Days of Wear|Inconvenience|0
2582534|NCT01198600|8931008|P3|Phase 2: 56 Days of Wear|Inconvenience|2
2582535|NCT01198600|8931009|P2|Phase 2: 56 Days of Wear|Inconvenience|0
2582536|NCT01198600|8931010|P1|Phase 2: 56 Days of Wear|Inconvenience|0
2582537|NCT01198600|8931007|P4|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
2582538|NCT01198600|8931008|P3|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
2582539|NCT01198600|8931009|P2|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1
2582540|NCT01198600|8931010|P1|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
2582541|NCT01198600|8931007|P4|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
2582542|NCT01198600|8931008|P3|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
2582543|NCT01198600|8931009|P2|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1
2582544|NCT01198600|8931010|P1|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
2582545|NCT01198600|8931007|P4|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
2582546|NCT01198600|8931008|P3|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
2582547|NCT01198600|8931009|P2|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
2582548|NCT01198600|8931010|P1|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1
2582549|NCT01198600|8931007|P4|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
2582550|NCT01198600|8931008|P3|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
2582551|NCT01198600|8931009|P2|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
2582552|NCT01198600|8931010|P1|Phase 1: Period One, 30 Days of Wear|Inconvenience|1
2582553|NCT01198587|8931036|P4|Overall Study|Lost to Follow-up|0
2582554|NCT01198587|8931037|P3|Overall Study|Lost to Follow-up|9
2582555|NCT01198587|8931038|P2|Overall Study|Lost to Follow-up|0
2582556|NCT01198587|8931039|P1|Overall Study|Lost to Follow-up|8
2582557|NCT01198574|8931061|P4|Overall Study|Resigned from schools|4
2582558|NCT01198574|8931062|P3|Overall Study|Resigned from schools|1
2582559|NCT01198574|8931063|P2|Overall Study|Resigned from schools|1
2582560|NCT01198574|8931064|P1|Overall Study|Resigned from schools|4
2582561|NCT01198548|8931082|P1|Overall Study|Administrative Decision|1
2582562|NCT01198548|8931082|P1|Overall Study|Disease Progression|9
2582563|NCT01198509|8931097|P6|Overall Study|Withdrawal by Subject|0
2582564|NCT01198509|8931098|P5|Overall Study|Withdrawal by Subject|0
2582565|NCT01198509|8931099|P4|Overall Study|Withdrawal by Subject|0
2582566|NCT01198509|8931100|P3|Overall Study|Withdrawal by Subject|0
2582567|NCT01198509|8931101|P2|Overall Study|Withdrawal by Subject|0
2582568|NCT01198509|8931102|P1|Overall Study|Withdrawal by Subject|1
2582569|NCT01198470|8931119|P1|Overall Study|Adverse Event|2
2582570|NCT01198275|8931185|P2|Overall Study|spontaneous return to sinus rhythm|2
2582571|NCT01198275|8931186|P1|Overall Study|spontaneous return to sinus rhythm|4
2582572|NCT01198275|8931185|P2|Overall Study|Adverse Event|3
2582573|NCT01198275|8931186|P1|Overall Study|Adverse Event|2
2582574|NCT01198145|8931209|P2|Overall Study|Withdrawal by Subject|1
2582575|NCT01198145|8931210|P1|Overall Study|Withdrawal by Subject|1
2582576|NCT01198132|8931232|P2|Overall Study|Protocol Violation|0
2582577|NCT01198132|8931233|P1|Overall Study|Protocol Violation|1
2582578|NCT01198132|8931232|P2|Overall Study|Adverse Event|1
2582579|NCT01198132|8931233|P1|Overall Study|Adverse Event|0
2582580|NCT01198132|8931232|P2|Overall Study|Abnormal/clinically significant biologic|1
2582581|NCT01198132|8931233|P1|Overall Study|Abnormal/clinically significant biologic|1
2582582|NCT01198132|8931232|P2|Overall Study|Sign/symptoms of underlying disease|1
2582583|NCT01198132|8931233|P1|Overall Study|Sign/symptoms of underlying disease|2
2582584|NCT01198132|8931232|P2|Overall Study|Lack of Efficacy|3
2582585|NCT01198132|8931233|P1|Overall Study|Lack of Efficacy|2
2582586|NCT01198132|8931232|P2|Overall Study|Other Unspecified|6
2582587|NCT01198132|8931233|P1|Overall Study|Other Unspecified|3
2582588|NCT01198132|8931232|P2|Overall Study|Physician Decision|4
2582589|NCT01198132|8931233|P1|Overall Study|Physician Decision|5
2582590|NCT01198132|8931232|P2|Overall Study|Withdrawal by Subject|5
2582591|NCT01198132|8931233|P1|Overall Study|Withdrawal by Subject|4
2582592|NCT01198002|8931260|P3|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75
2582593|NCT01198002|8931261|P2|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70
2582594|NCT01198002|8931262|P1|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62
2582595|NCT01198002|8931260|P3|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
2582596|NCT01198002|8931261|P2|Treatment Period 2 (Weeks 52-100)|Physician Decision|0
2582597|NCT01198002|8931262|P1|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
2582598|NCT01198002|8931260|P3|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
2582599|NCT01198002|8931261|P2|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2
2582600|NCT01198002|8931262|P1|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
2582601|NCT01198002|8931260|P3|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
2582602|NCT01198002|8931261|P2|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
2582603|NCT01198002|8931262|P1|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1
2582604|NCT01198002|8931260|P3|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
2582605|NCT01198002|8931261|P2|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
2582606|NCT01198002|8931262|P1|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3
2582607|NCT01198002|8931260|P3|Treatment Period 2 (Weeks 52-100)|Adverse Event|1
2582608|NCT01198002|8931261|P2|Treatment Period 2 (Weeks 52-100)|Adverse Event|0
2582609|NCT01198002|8931262|P1|Treatment Period 2 (Weeks 52-100)|Adverse Event|2
2582610|NCT01198002|8931260|P3|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224
2582611|NCT01198002|8931261|P2|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216
2582612|NCT01198002|8931262|P1|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213
2582613|NCT01198002|8931260|P3|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
2582614|NCT01198002|8931261|P2|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
2582615|NCT01198002|8931262|P1|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14
2582616|NCT01198002|8931260|P3|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
2582617|NCT01198002|8931261|P2|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
2582618|NCT01198002|8931262|P1|Treatment Period 1 (Weeks 0-52)|Physician Decision|1
2582702|NCT01197755|8931583|P2|Overall Study|Lack of therapeutic response|7
2582619|NCT01198002|8931260|P3|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12
2582620|NCT01198002|8931261|P2|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21
2582621|NCT01198002|8931262|P1|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16
2582622|NCT01198002|8931260|P3|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
2582623|NCT01198002|8931261|P2|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2
2582624|NCT01198002|8931262|P1|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
2582625|NCT01198002|8931260|P3|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
2582626|NCT01198002|8931261|P2|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
2582627|NCT01198002|8931262|P1|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1
2582628|NCT01198002|8931260|P3|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6
2582629|NCT01198002|8931261|P2|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9
2582630|NCT01198002|8931262|P1|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10
2582631|NCT01198002|8931260|P3|Treatment Period 1 (Weeks 0-52)|Death|1
2582632|NCT01198002|8931261|P2|Treatment Period 1 (Weeks 0-52)|Death|0
2582633|NCT01198002|8931262|P1|Treatment Period 1 (Weeks 0-52)|Death|2
2582634|NCT01198002|8931260|P3|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
2582635|NCT01198002|8931261|P2|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
2582636|NCT01198002|8931262|P1|Treatment Period 1 (Weeks 0-52)|Adverse Event|18
2582637|NCT01197911|8931377|P3|Overall Study|Adverse Event|1
2582638|NCT01197911|8931378|P2|Overall Study|Adverse Event|0
2582639|NCT01197911|8931379|P1|Overall Study|Adverse Event|0
2582640|NCT01197794|8931494|P7|Overall Study|Other|4
2582641|NCT01197794|8931495|P6|Overall Study|Other|2
2582642|NCT01197794|8931496|P5|Overall Study|Other|2
2582643|NCT01197794|8931497|P4|Overall Study|Other|0
2582644|NCT01197794|8931498|P3|Overall Study|Other|3
2582645|NCT01197794|8931499|P2|Overall Study|Other|1
2582646|NCT01197794|8931500|P1|Overall Study|Other|1
2582647|NCT01197794|8931494|P7|Overall Study|Lost to Follow-up|0
2582648|NCT01197794|8931495|P6|Overall Study|Lost to Follow-up|1
2582649|NCT01197794|8931496|P5|Overall Study|Lost to Follow-up|0
2582650|NCT01197794|8931497|P4|Overall Study|Lost to Follow-up|1
2582651|NCT01197794|8931498|P3|Overall Study|Lost to Follow-up|0
2582652|NCT01197794|8931499|P2|Overall Study|Lost to Follow-up|1
2582653|NCT01197794|8931500|P1|Overall Study|Lost to Follow-up|1
2582654|NCT01197794|8931494|P7|Overall Study|Withdrawal by Subject|6
2582655|NCT01197794|8931495|P6|Overall Study|Withdrawal by Subject|5
2582656|NCT01197794|8931496|P5|Overall Study|Withdrawal by Subject|1
2582657|NCT01197794|8931497|P4|Overall Study|Withdrawal by Subject|1
2582658|NCT01197794|8931498|P3|Overall Study|Withdrawal by Subject|4
2582659|NCT01197794|8931499|P2|Overall Study|Withdrawal by Subject|3
2582660|NCT01197794|8931500|P1|Overall Study|Withdrawal by Subject|3
2582661|NCT01197794|8931494|P7|Overall Study|Eligibility criteria not fulfilled|6
2582662|NCT01197794|8931495|P6|Overall Study|Eligibility criteria not fulfilled|9
2582663|NCT01197794|8931496|P5|Overall Study|Eligibility criteria not fulfilled|5
2582664|NCT01197794|8931497|P4|Overall Study|Eligibility criteria not fulfilled|5
2582665|NCT01197794|8931498|P3|Overall Study|Eligibility criteria not fulfilled|2
2582666|NCT01197794|8931499|P2|Overall Study|Eligibility criteria not fulfilled|8
2582667|NCT01197794|8931500|P1|Overall Study|Eligibility criteria not fulfilled|5
2582668|NCT01197794|8931494|P7|Overall Study|Development of study withdrawal criteria|1
2582669|NCT01197794|8931495|P6|Overall Study|Development of study withdrawal criteria|0
2582670|NCT01197794|8931496|P5|Overall Study|Development of study withdrawal criteria|0
2582671|NCT01197794|8931497|P4|Overall Study|Development of study withdrawal criteria|1
2582672|NCT01197794|8931498|P3|Overall Study|Development of study withdrawal criteria|0
2582673|NCT01197794|8931499|P2|Overall Study|Development of study withdrawal criteria|0
2582674|NCT01197794|8931500|P1|Overall Study|Development of study withdrawal criteria|3
2582675|NCT01197794|8931494|P7|Overall Study|Protocol Violation|1
2582676|NCT01197794|8931495|P6|Overall Study|Protocol Violation|0
2582677|NCT01197794|8931496|P5|Overall Study|Protocol Violation|2
2582678|NCT01197794|8931497|P4|Overall Study|Protocol Violation|0
2582679|NCT01197794|8931498|P3|Overall Study|Protocol Violation|0
2582680|NCT01197794|8931499|P2|Overall Study|Protocol Violation|0
2582681|NCT01197794|8931500|P1|Overall Study|Protocol Violation|0
2582682|NCT01197794|8931494|P7|Overall Study|Adverse Event|3
2582683|NCT01197794|8931495|P6|Overall Study|Adverse Event|2
2582684|NCT01197794|8931496|P5|Overall Study|Adverse Event|4
2582685|NCT01197794|8931497|P4|Overall Study|Adverse Event|4
2582686|NCT01197794|8931498|P3|Overall Study|Adverse Event|4
2582687|NCT01197794|8931499|P2|Overall Study|Adverse Event|2
2582688|NCT01197794|8931500|P1|Overall Study|Adverse Event|3
2582689|NCT01197755|8931582|P3|Overall Study|eg, change in circumstances|2
2582690|NCT01197755|8931583|P2|Overall Study|eg, change in circumstances|3
2582691|NCT01197755|8931584|P1|Overall Study|eg, change in circumstances|7
2582692|NCT01197755|8931582|P3|Overall Study|Lost to Follow-up|1
2582693|NCT01197755|8931583|P2|Overall Study|Lost to Follow-up|0
2582694|NCT01197755|8931584|P1|Overall Study|Lost to Follow-up|0
2582695|NCT01197755|8931582|P3|Overall Study|Withdrawal by Subject|0
2582696|NCT01197755|8931583|P2|Overall Study|Withdrawal by Subject|0
2582697|NCT01197755|8931584|P1|Overall Study|Withdrawal by Subject|1
2582698|NCT01197755|8931582|P3|Overall Study|Severe non-compliance to the protocol|2
2582699|NCT01197755|8931583|P2|Overall Study|Severe non-compliance to the protocol|1
2582700|NCT01197755|8931584|P1|Overall Study|Severe non-compliance to the protocol|2
2582701|NCT01197755|8931582|P3|Overall Study|Lack of therapeutic response|4
2582703|NCT01197755|8931584|P1|Overall Study|Lack of therapeutic response|0
2582704|NCT01197755|8931582|P3|Overall Study|Entered the long-term extension study|35
2582705|NCT01197755|8931583|P2|Overall Study|Entered the long-term extension study|21
2582706|NCT01197755|8931584|P1|Overall Study|Entered the long-term extension study|18
2582707|NCT01197755|8931582|P3|Overall Study|Study-specific discontinuation criteria|0
2582708|NCT01197755|8931583|P2|Overall Study|Study-specific discontinuation criteria|1
2582709|NCT01197755|8931584|P1|Overall Study|Study-specific discontinuation criteria|2
2582710|NCT01197755|8931582|P3|Overall Study|Adverse Event|10
2582711|NCT01197755|8931583|P2|Overall Study|Adverse Event|10
2582712|NCT01197755|8931584|P1|Overall Study|Adverse Event|8
2582713|NCT01197560|8931656|P2|Overall Study|Missing|1
2582714|NCT01197560|8931657|P1|Overall Study|Missing|0
2582715|NCT01197560|8931656|P2|Overall Study|Miscellaneous|3
2582716|NCT01197560|8931657|P1|Overall Study|Miscellaneous|4
2582717|NCT01197560|8931656|P2|Overall Study|Disease progression|35
2582718|NCT01197560|8931657|P1|Overall Study|Disease progression|40
2582719|NCT01197560|8931656|P2|Overall Study|Withdrawal by Subject|1
2582720|NCT01197560|8931657|P1|Overall Study|Withdrawal by Subject|1
2582721|NCT01197560|8931656|P2|Overall Study|Death|5
2582722|NCT01197560|8931657|P1|Overall Study|Death|3
2582723|NCT01197560|8931656|P2|Overall Study|Adverse Event|8
2582724|NCT01197560|8931657|P1|Overall Study|Adverse Event|6
2582725|NCT01197534|8931704|P3|Overall Study|Adverse Event|24
2582726|NCT01197534|8931705|P2|Overall Study|Adverse Event|36
2582727|NCT01197534|8931706|P1|Overall Study|Adverse Event|35
2582728|NCT01197534|8931704|P3|Overall Study|Lost to Follow-up|2
2582729|NCT01197534|8931705|P2|Overall Study|Lost to Follow-up|4
2582730|NCT01197534|8931706|P1|Overall Study|Lost to Follow-up|1
2582731|NCT01197534|8931704|P3|Overall Study|Dev. of study specific discont. criteria|2
2582732|NCT01197534|8931705|P2|Overall Study|Dev. of study specific discont. criteria|6
2582733|NCT01197534|8931706|P1|Overall Study|Dev. of study specific discont. criteria|13
2582734|NCT01197534|8931704|P3|Overall Study|Lack of therapeutic response|9
2582735|NCT01197534|8931705|P2|Overall Study|Lack of therapeutic response|4
2582736|NCT01197534|8931706|P1|Overall Study|Lack of therapeutic response|9
2582737|NCT01197534|8931704|P3|Overall Study|Severe non-compliance to protocol|1
2582738|NCT01197534|8931705|P2|Overall Study|Severe non-compliance to protocol|4
2582739|NCT01197534|8931706|P1|Overall Study|Severe non-compliance to protocol|3
2582740|NCT01197534|8931704|P3|Overall Study|Enrolment in long term extension|119
2582741|NCT01197534|8931705|P2|Overall Study|Enrolment in long term extension|66
2582742|NCT01197534|8931706|P1|Overall Study|Enrolment in long term extension|57
2582743|NCT01197534|8931704|P3|Overall Study|Not reported|16
2582744|NCT01197534|8931705|P2|Overall Study|Not reported|10
2582745|NCT01197534|8931706|P1|Overall Study|Not reported|16
2582746|NCT01197521|8931750|P3|Overall Study|Adverse Event|24
2582747|NCT01197521|8931751|P2|Overall Study|Adverse Event|28
2582748|NCT01197521|8931752|P1|Overall Study|Adverse Event|25
2582749|NCT01197521|8931750|P3|Overall Study|Lost to Follow-up|2
2582750|NCT01197521|8931751|P2|Overall Study|Lost to Follow-up|2
2582751|NCT01197521|8931752|P1|Overall Study|Lost to Follow-up|3
2582752|NCT01197521|8931750|P3|Overall Study|Dev. of study specific discont. criteria|2
2582753|NCT01197521|8931751|P2|Overall Study|Dev. of study specific discont. criteria|16
2582754|NCT01197521|8931752|P1|Overall Study|Dev. of study specific discont. criteria|6
2582755|NCT01197521|8931750|P3|Overall Study|Lack of therapeutic response|4
2582756|NCT01197521|8931751|P2|Overall Study|Lack of therapeutic response|3
2582757|NCT01197521|8931752|P1|Overall Study|Lack of therapeutic response|2
2582758|NCT01197521|8931750|P3|Overall Study|Severe non-compliance to protocol|3
2582759|NCT01197521|8931751|P2|Overall Study|Severe non-compliance to protocol|3
2582760|NCT01197521|8931752|P1|Overall Study|Severe non-compliance to protocol|1
2582761|NCT01197521|8931750|P3|Overall Study|Enrolment in long term extension|87
2582762|NCT01197521|8931751|P2|Overall Study|Enrolment in long term extension|36
2582763|NCT01197521|8931752|P1|Overall Study|Enrolment in long term extension|42
2582764|NCT01197521|8931750|P3|Overall Study|Not reported|21
2582765|NCT01197521|8931751|P2|Overall Study|Not reported|25
2582766|NCT01197521|8931752|P1|Overall Study|Not reported|24
2582767|NCT01197508|8931797|P4|Overall Study|Other|2
2582768|NCT01197508|8931798|P3|Overall Study|Other|2
2582769|NCT01197508|8931799|P2|Overall Study|Other|3
2582770|NCT01197508|8931800|P1|Overall Study|Other|2
2582771|NCT01197508|8931797|P4|Overall Study|Lost to Follow-up|0
2582772|NCT01197508|8931798|P3|Overall Study|Lost to Follow-up|2
2582773|NCT01197508|8931799|P2|Overall Study|Lost to Follow-up|1
2582774|NCT01197508|8931800|P1|Overall Study|Lost to Follow-up|1
2582775|NCT01197508|8931797|P4|Overall Study|Study-specific withdrawal criteria|2
2582776|NCT01197508|8931798|P3|Overall Study|Study-specific withdrawal criteria|1
2582777|NCT01197508|8931799|P2|Overall Study|Study-specific withdrawal criteria|0
2582778|NCT01197508|8931800|P1|Overall Study|Study-specific withdrawal criteria|0
2582779|NCT01197508|8931797|P4|Overall Study|Lack of Efficacy|1
2582780|NCT01197508|8931798|P3|Overall Study|Lack of Efficacy|2
2582781|NCT01197508|8931799|P2|Overall Study|Lack of Efficacy|2
2582782|NCT01197508|8931800|P1|Overall Study|Lack of Efficacy|1
2582783|NCT01197508|8931797|P4|Overall Study|Condition under investigation worsened|1
2582784|NCT01197508|8931798|P3|Overall Study|Condition under investigation worsened|1
2582785|NCT01197508|8931799|P2|Overall Study|Condition under investigation worsened|1
2582786|NCT01197508|8931800|P1|Overall Study|Condition under investigation worsened|1
2582787|NCT01197508|8931797|P4|Overall Study|Severe non-compliance to protocol|3
2582788|NCT01197508|8931798|P3|Overall Study|Severe non-compliance to protocol|1
2582789|NCT01197508|8931799|P2|Overall Study|Severe non-compliance to protocol|3
2582790|NCT01197508|8931800|P1|Overall Study|Severe non-compliance to protocol|0
2582791|NCT01197508|8931797|P4|Overall Study|Adverse Event|3
2582792|NCT01197508|8931798|P3|Overall Study|Adverse Event|23
2582793|NCT01197508|8931799|P2|Overall Study|Adverse Event|13
2582794|NCT01197508|8931800|P1|Overall Study|Adverse Event|10
2582795|NCT01197508|8931797|P4|Overall Study|Eligiblity criteria not fulfilled|0
2582796|NCT01197508|8931798|P3|Overall Study|Eligiblity criteria not fulfilled|2
2582797|NCT01197508|8931799|P2|Overall Study|Eligiblity criteria not fulfilled|0
2582798|NCT01197508|8931800|P1|Overall Study|Eligiblity criteria not fulfilled|0
2582799|NCT01197508|8931797|P4|Overall Study|Withdrawal by Subject|4
2582800|NCT01197508|8931798|P3|Overall Study|Withdrawal by Subject|15
2582801|NCT01197508|8931799|P2|Overall Study|Withdrawal by Subject|7
2582802|NCT01197508|8931800|P1|Overall Study|Withdrawal by Subject|8
2582803|NCT01197417|8931921|P2|Overall Study|No 25-hour magnesium level|2
2582804|NCT01197417|8931922|P1|Overall Study|No 25-hour magnesium level|0
2582805|NCT01197417|8931921|P2|Overall Study|Found to be ineligible|5
2582806|NCT01197417|8931922|P1|Overall Study|Found to be ineligible|2
2582807|NCT01197417|8931921|P2|Overall Study|Hypotension|2
2582808|NCT01197417|8931922|P1|Overall Study|Hypotension|1
2582809|NCT01197417|8931921|P2|Overall Study|Not consented in time to receive drug|1
2582810|NCT01197417|8931922|P1|Overall Study|Not consented in time to receive drug|0
2582811|NCT01197417|8931921|P2|Overall Study|Subject transferred to intensive care|1
2582812|NCT01197417|8931922|P1|Overall Study|Subject transferred to intensive care|0
2582813|NCT01197417|8931921|P2|Overall Study|Site miscommunication|1
2582814|NCT01197417|8931922|P1|Overall Study|Site miscommunication|0
2582815|NCT01197417|8931921|P2|Overall Study|Withdrawal by Subject|4
2582816|NCT01197417|8931922|P1|Overall Study|Withdrawal by Subject|2
2582817|NCT01197417|8931921|P2|Overall Study|Physician Decision|2
2582818|NCT01197417|8931922|P1|Overall Study|Physician Decision|3
2582819|NCT01197378|8931940|P1|Overall Study|Other|2
2582820|NCT01197378|8931940|P1|Overall Study|Physician Decision|1
2582821|NCT01197378|8931940|P1|Overall Study|Withdrawal by Subject|1
2582822|NCT01197378|8931940|P1|Overall Study|Adverse Event|3
2582823|NCT01197300|8931959|P2|Overall Study|Protocol Violation|1
2582824|NCT01197300|8931960|P1|Overall Study|Protocol Violation|0
2582825|NCT01197300|8931959|P2|Overall Study|Lost to Follow-up|1
2582826|NCT01197300|8931960|P1|Overall Study|Lost to Follow-up|0
2582827|NCT01196988|8931992|P4|Overall Study|Other|0
2582828|NCT01196988|8931993|P3|Overall Study|Other|0
2582829|NCT01196988|8931994|P2|Overall Study|Other|0
2582830|NCT01196988|8931995|P1|Overall Study|Other|2
2582831|NCT01196988|8931992|P4|Overall Study|Lost to Follow-up|1
2582832|NCT01196988|8931993|P3|Overall Study|Lost to Follow-up|21
2582833|NCT01196988|8931994|P2|Overall Study|Lost to Follow-up|29
2582834|NCT01196988|8931995|P1|Overall Study|Lost to Follow-up|16
2582835|NCT01196988|8931992|P4|Overall Study|Withdrawal by Subject|0
2582836|NCT01196988|8931993|P3|Overall Study|Withdrawal by Subject|4
2582837|NCT01196988|8931994|P2|Overall Study|Withdrawal by Subject|1
2582838|NCT01196988|8931995|P1|Overall Study|Withdrawal by Subject|5
2582839|NCT01196988|8931992|P4|Overall Study|Adverse Event|0
2582840|NCT01196988|8931993|P3|Overall Study|Adverse Event|0
2582841|NCT01196988|8931994|P2|Overall Study|Adverse Event|2
2582842|NCT01196988|8931995|P1|Overall Study|Adverse Event|1
2582843|NCT01196975|8932089|P5|Overall Study|Lost to Follow-up|11
2582844|NCT01196975|8932090|P4|Overall Study|Lost to Follow-up|5
2582845|NCT01196975|8932091|P3|Overall Study|Lost to Follow-up|5
2582846|NCT01196975|8932092|P2|Overall Study|Lost to Follow-up|6
2582847|NCT01196975|8932093|P1|Overall Study|Lost to Follow-up|11
2582848|NCT01196975|8932089|P5|Overall Study|Withdrawal by Subject|0
2582849|NCT01196975|8932090|P4|Overall Study|Withdrawal by Subject|1
2582850|NCT01196975|8932091|P3|Overall Study|Withdrawal by Subject|0
2582851|NCT01196975|8932092|P2|Overall Study|Withdrawal by Subject|1
2582852|NCT01196975|8932093|P1|Overall Study|Withdrawal by Subject|2
2582853|NCT01196975|8932089|P5|Overall Study|Adverse Event|2
2582854|NCT01196975|8932090|P4|Overall Study|Adverse Event|0
2582855|NCT01196975|8932091|P3|Overall Study|Adverse Event|0
2582856|NCT01196975|8932092|P2|Overall Study|Adverse Event|2
2582857|NCT01196975|8932093|P1|Overall Study|Adverse Event|2
2582858|NCT01196741|8932377|P2|Overall Study|Protocol Violation|1
2582859|NCT01196741|8932378|P1|Overall Study|Protocol Violation|2
2582860|NCT01196741|8932377|P2|Overall Study|Other|2
2582861|NCT01196741|8932378|P1|Overall Study|Other|3
2582862|NCT01196741|8932377|P2|Overall Study|Other reason|3
2582863|NCT01196741|8932378|P1|Overall Study|Other reason|3
2582864|NCT01196741|8932377|P2|Overall Study|Withdrawal by Subject|0
2582865|NCT01196741|8932378|P1|Overall Study|Withdrawal by Subject|3
2582866|NCT01196741|8932377|P2|Overall Study|Dose limiting Adverse Event|1
2582867|NCT01196741|8932378|P1|Overall Study|Dose limiting Adverse Event|2
2582868|NCT01196741|8932377|P2|Overall Study|Serious Adverse Event|1
2582869|NCT01196741|8932378|P1|Overall Study|Serious Adverse Event|3
2582870|NCT01196741|8932377|P2|Overall Study|Adverse Event|6
2582871|NCT01196741|8932378|P1|Overall Study|Adverse Event|10
2582872|NCT01196741|8932377|P2|Overall Study|Disease progression|14
2582873|NCT01196741|8932378|P1|Overall Study|Disease progression|34
2582874|NCT01196429|8932408|P2|Overall Study|Refused – Never Treated|0
2582875|NCT01196429|8932409|P1|Overall Study|Refused – Never Treated|1
2582876|NCT01196429|8932408|P2|Overall Study|Ineligible - wrong cell type|0
2582877|NCT01196429|8932409|P1|Overall Study|Ineligible - wrong cell type|1
2582878|NCT01196429|8932408|P2|Overall Study|Ineligible - inadequate pathology|0
2582879|NCT01196429|8932409|P1|Overall Study|Ineligible - inadequate pathology|1
2582880|NCT01196416|8932425|P1|Overall Study|Withdrawal by Subject|2
2582881|NCT01196104|8932483|P2|Overall Study|Various|1
2582882|NCT01196104|8932484|P1|Overall Study|Various|0
2582883|NCT01196104|8932483|P2|Overall Study|Withdrawal by Subject|3
2582884|NCT01196104|8932484|P1|Overall Study|Withdrawal by Subject|3
2582885|NCT01196104|8932483|P2|Overall Study|Physician Decision|1
2582886|NCT01196104|8932484|P1|Overall Study|Physician Decision|0
2582887|NCT01196104|8932483|P2|Overall Study|Lost to Follow-up|0
2582888|NCT01196104|8932484|P1|Overall Study|Lost to Follow-up|1
2582889|NCT01196091|8932527|P3|Overall Study|Randomized, No Study Drug Received|1
2582890|NCT01196091|8932528|P2|Overall Study|Randomized, No Study Drug Received|0
2582891|NCT01196091|8932529|P1|Overall Study|Randomized, No Study Drug Received|1
2582892|NCT01196091|8932527|P3|Overall Study|Excluded Site|8
2582893|NCT01196091|8932528|P2|Overall Study|Excluded Site|11
2582894|NCT01196091|8932529|P1|Overall Study|Excluded Site|5
2582895|NCT01196091|8932527|P3|Overall Study|Sponsor Decision|4
2582896|NCT01196091|8932528|P2|Overall Study|Sponsor Decision|5
2582897|NCT01196091|8932529|P1|Overall Study|Sponsor Decision|6
2582898|NCT01196091|8932527|P3|Overall Study|Protocol Violation|3
2582899|NCT01196091|8932528|P2|Overall Study|Protocol Violation|3
2582900|NCT01196091|8932529|P1|Overall Study|Protocol Violation|1
2582901|NCT01196091|8932527|P3|Overall Study|Physician Decision|4
2582902|NCT01196091|8932528|P2|Overall Study|Physician Decision|3
2582903|NCT01196091|8932529|P1|Overall Study|Physician Decision|3
2582904|NCT01196091|8932527|P3|Overall Study|Withdrawal by Subject|22
2582905|NCT01196091|8932528|P2|Overall Study|Withdrawal by Subject|19
2582906|NCT01196091|8932529|P1|Overall Study|Withdrawal by Subject|16
2582907|NCT01196091|8932527|P3|Overall Study|Parent/Caregiver Decision|1
2582908|NCT01196091|8932528|P2|Overall Study|Parent/Caregiver Decision|0
2582909|NCT01196091|8932529|P1|Overall Study|Parent/Caregiver Decision|0
2582910|NCT01196091|8932527|P3|Overall Study|Lost to Follow-up|6
2582911|NCT01196091|8932528|P2|Overall Study|Lost to Follow-up|5
2582912|NCT01196091|8932529|P1|Overall Study|Lost to Follow-up|5
2582913|NCT01196091|8932527|P3|Overall Study|Lack of Efficacy|17
2582914|NCT01196091|8932528|P2|Overall Study|Lack of Efficacy|12
2582915|NCT01196091|8932529|P1|Overall Study|Lack of Efficacy|15
2582916|NCT01196091|8932527|P3|Overall Study|Entry Criteria Not Met|10
2582917|NCT01196091|8932528|P2|Overall Study|Entry Criteria Not Met|11
2582918|NCT01196091|8932529|P1|Overall Study|Entry Criteria Not Met|11
2582919|NCT01196091|8932527|P3|Overall Study|Death|2
2582920|NCT01196091|8932528|P2|Overall Study|Death|2
2582921|NCT01196091|8932529|P1|Overall Study|Death|3
2582922|NCT01196091|8932527|P3|Overall Study|Adverse Event|26
2582923|NCT01196091|8932528|P2|Overall Study|Adverse Event|27
2582924|NCT01196091|8932529|P1|Overall Study|Adverse Event|22
2582925|NCT01196078|8932581|P2|Overall Study|Death|4
2582926|NCT01196078|8932582|P1|Overall Study|Death|6
2582927|NCT01196078|8932581|P2|Overall Study|Lost to Follow-up|0
2582928|NCT01196078|8932582|P1|Overall Study|Lost to Follow-up|1
2582929|NCT01196078|8932581|P2|Overall Study|Lack of Efficacy|23
2582930|NCT01196078|8932582|P1|Overall Study|Lack of Efficacy|17
2582931|NCT01196078|8932581|P2|Overall Study|Protocol Violation|1
2582932|NCT01196078|8932582|P1|Overall Study|Protocol Violation|2
2582933|NCT01196078|8932581|P2|Overall Study|Adverse Event|4
2582934|NCT01196078|8932582|P1|Overall Study|Adverse Event|4
2582935|NCT01196078|8932581|P2|Overall Study|Withdrawal by Subject|5
2582936|NCT01196078|8932582|P1|Overall Study|Withdrawal by Subject|3
2582937|NCT01196052|8932610|P1|Overall Study|Withdrawal by Subject|6
2582938|NCT01196052|8932610|P1|Overall Study|Reason not Specified|5
2582939|NCT01196052|8932610|P1|Overall Study|Noncompliance to Protocol Requirements|2
2582940|NCT01196052|8932610|P1|Overall Study|Lost to Follow-up|1
2582941|NCT01196052|8932610|P1|Overall Study|Adverse Event|9
2582942|NCT01196026|8932627|P6|Overall Study|Other|0
2582943|NCT01196026|8932628|P5|Overall Study|Other|0
2582944|NCT01196026|8932629|P4|Overall Study|Other|0
2582945|NCT01196026|8932630|P3|Overall Study|Other|0
2582946|NCT01196026|8932631|P2|Overall Study|Other|1
2582947|NCT01196026|8932632|P1|Overall Study|Other|0
2582948|NCT01196026|8932627|P6|Overall Study|Lost to Follow-up|0
2582949|NCT01196026|8932628|P5|Overall Study|Lost to Follow-up|1
2582950|NCT01196026|8932629|P4|Overall Study|Lost to Follow-up|0
2582951|NCT01196026|8932630|P3|Overall Study|Lost to Follow-up|0
2582952|NCT01196026|8932631|P2|Overall Study|Lost to Follow-up|3
2582953|NCT01196026|8932632|P1|Overall Study|Lost to Follow-up|0
2582954|NCT01196026|8932627|P6|Overall Study|Withdrawal by Subject|0
2582955|NCT01196026|8932628|P5|Overall Study|Withdrawal by Subject|0
2582956|NCT01196026|8932629|P4|Overall Study|Withdrawal by Subject|0
2582957|NCT01196026|8932630|P3|Overall Study|Withdrawal by Subject|0
2582958|NCT01196026|8932631|P2|Overall Study|Withdrawal by Subject|4
2582959|NCT01196026|8932632|P1|Overall Study|Withdrawal by Subject|1
2582960|NCT01195948|8932866|P3|Overall Study|Lost to Follow-up|2
2582961|NCT01195948|8932867|P2|Overall Study|Lost to Follow-up|1
2582962|NCT01195948|8932868|P1|Overall Study|Lost to Follow-up|0
2582963|NCT01195844|8932921|P1|Overall Study|Fecal sample not collected|40
2582964|NCT01195831|8932938|P2|Overall Study|Protocol Violation|2
2582965|NCT01195831|8932939|P1|Overall Study|Protocol Violation|0
2582966|NCT01195831|8932938|P2|Overall Study|Adverse Event|2
2582967|NCT01195831|8932939|P1|Overall Study|Adverse Event|4
2582968|NCT01195831|8932938|P2|Overall Study|Withdrawal by Subject|2
2582969|NCT01195831|8932939|P1|Overall Study|Withdrawal by Subject|2
2582970|NCT01195831|8932938|P2|Overall Study|Lost to Follow-up|4
2582971|NCT01195831|8932939|P1|Overall Study|Lost to Follow-up|2
2582972|NCT01195675|8933179|P1|Overall Study|Withdrawal by Subject|2
2582973|NCT01195675|8933179|P1|Overall Study|Adverse Event|1
2582974|NCT01195662|8933212|P3|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
2582975|NCT01195662|8933213|P2|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
2582976|NCT01195662|8933214|P1|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1
2582977|NCT01195662|8933212|P3|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1
2582978|NCT01195662|8933213|P2|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0
2582979|NCT01195662|8933214|P1|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2
2582980|NCT01195662|8933212|P3|Double Blind Treatment Period|Missing disposition information|1
2582981|NCT01195662|8933213|P2|Double Blind Treatment Period|Missing disposition information|1
2582982|NCT01195662|8933214|P1|Double Blind Treatment Period|Missing disposition information|0
2582983|NCT01195662|8933212|P3|Double Blind Treatment Period|Non-specified|0
2582984|NCT01195662|8933213|P2|Double Blind Treatment Period|Non-specified|0
2582985|NCT01195662|8933214|P1|Double Blind Treatment Period|Non-specified|3
2582986|NCT01195662|8933212|P3|Double Blind Treatment Period|Lack of Efficacy|0
2582987|NCT01195662|8933213|P2|Double Blind Treatment Period|Lack of Efficacy|0
2582988|NCT01195662|8933214|P1|Double Blind Treatment Period|Lack of Efficacy|2
2582989|NCT01195662|8933212|P3|Double Blind Treatment Period|No Longer Meets Criteria|2
2582990|NCT01195662|8933213|P2|Double Blind Treatment Period|No Longer Meets Criteria|5
2582991|NCT01195662|8933214|P1|Double Blind Treatment Period|No Longer Meets Criteria|1
2582992|NCT01195662|8933212|P3|Double Blind Treatment Period|Requested discontinue treatment|1
2582993|NCT01195662|8933213|P2|Double Blind Treatment Period|Requested discontinue treatment|0
2582994|NCT01195662|8933214|P1|Double Blind Treatment Period|Requested discontinue treatment|1
2582995|NCT01195662|8933212|P3|Double Blind Treatment Period|Administrative reason|1
2582996|NCT01195662|8933213|P2|Double Blind Treatment Period|Administrative reason|1
2582997|NCT01195662|8933214|P1|Double Blind Treatment Period|Administrative reason|2
2582998|NCT01195662|8933212|P3|Double Blind Treatment Period|Lost to Follow-up|3
2582999|NCT01195662|8933213|P2|Double Blind Treatment Period|Lost to Follow-up|2
2583000|NCT01195662|8933214|P1|Double Blind Treatment Period|Lost to Follow-up|3
2583001|NCT01195662|8933212|P3|Double Blind Treatment Period|Withdrawal by Subject|4
2583002|NCT01195662|8933213|P2|Double Blind Treatment Period|Withdrawal by Subject|4
2583003|NCT01195662|8933214|P1|Double Blind Treatment Period|Withdrawal by Subject|6
2583004|NCT01195662|8933212|P3|Double Blind Treatment Period|Adverse Event|2
2583005|NCT01195662|8933213|P2|Double Blind Treatment Period|Adverse Event|1
2583006|NCT01195662|8933214|P1|Double Blind Treatment Period|Adverse Event|4
2583007|NCT01195636|8933244|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|1
2583008|NCT01195636|8933245|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|0
2583009|NCT01195636|8933244|P2|Second Intervention (3 Weeks)|Adverse Event|1
2583010|NCT01195636|8933245|P1|Second Intervention (3 Weeks)|Adverse Event|1
2583011|NCT01195636|8933244|P2|Washout Period (2 Weeks)|Withdrawal by Subject|2
2583012|NCT01195636|8933245|P1|Washout Period (2 Weeks)|Withdrawal by Subject|1
2583013|NCT01195636|8933244|P2|Washout Period (2 Weeks)|Adverse Event|1
2583014|NCT01195636|8933245|P1|Washout Period (2 Weeks)|Adverse Event|1
2583015|NCT01195636|8933244|P2|First Intervention (3 Weeks)|Lost to Follow-up|0
2583016|NCT01195636|8933245|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
2583017|NCT01195636|8933244|P2|First Intervention (3 Weeks)|Withdrawal by Subject|0
2583018|NCT01195636|8933245|P1|First Intervention (3 Weeks)|Withdrawal by Subject|1
2583019|NCT01195636|8933244|P2|First Intervention (3 Weeks)|Protocol Violation|0
2583020|NCT01195636|8933245|P1|First Intervention (3 Weeks)|Protocol Violation|1
2583021|NCT01195636|8933244|P2|First Intervention (3 Weeks)|Adverse Event|3
2583022|NCT01195636|8933245|P1|First Intervention (3 Weeks)|Adverse Event|2
2583023|NCT01195623|8933271|P2|Overall Study|Lost to Follow-up|37
2583024|NCT01195623|8933272|P1|Overall Study|Lost to Follow-up|35
2583025|NCT01195545|8933301|P1|Overall Study|Protocol Violation|4
2583026|NCT01195415|8933313|P1|Overall Study|No repeat biopsy due to progression|2
2583027|NCT01195363|8933322|P2|Overall Study|incarceration|0
2583028|NCT01195363|8933323|P1|Overall Study|incarceration|1
2583029|NCT01195363|8933322|P2|Overall Study|Lack of Efficacy|4
2583030|NCT01195363|8933323|P1|Overall Study|Lack of Efficacy|0
2583031|NCT01195363|8933322|P2|Overall Study|Adverse Event|1
2583032|NCT01195363|8933323|P1|Overall Study|Adverse Event|3
2583033|NCT01195363|8933322|P2|Overall Study|Lost to Follow-up|4
2583034|NCT01195363|8933323|P1|Overall Study|Lost to Follow-up|7
2583035|NCT01195272|8933329|P1|Overall Study|Lack of Efficacy|3
2583036|NCT01195272|8933329|P1|Overall Study|Adverse Event|1
2583037|NCT01195103|8933358|P3|Overall Study|Withdrawal by Subject|0
2583038|NCT01195103|8933359|P2|Overall Study|Withdrawal by Subject|0
2583039|NCT01195103|8933360|P1|Overall Study|Withdrawal by Subject|1
2583040|NCT01195090|8933370|P2|Overall Study|Protocol Violation|4
2583041|NCT01195090|8933371|P1|Overall Study|Protocol Violation|3
2583042|NCT01195090|8933370|P2|Overall Study|Lost to Follow-up|2
2583043|NCT01195090|8933371|P1|Overall Study|Lost to Follow-up|2
2583044|NCT01195090|8933370|P2|Overall Study|Adverse Event|2
2583045|NCT01195090|8933371|P1|Overall Study|Adverse Event|1
2583046|NCT01194999|8933440|P1|Overall Study|Lost to Follow-up|17
2583047|NCT01194973|8933444|P1|26 Week Treatment Period|Pregnancy|1
2583048|NCT01194973|8933444|P1|26 Week Treatment Period|Lack of Efficacy|1
2583049|NCT01194973|8933444|P1|26 Week Treatment Period|Adverse Event|1
2583050|NCT01194973|8933444|P1|Screening Period|Screen Failure|3
2583051|NCT01194869|8933464|P1|Overall Study|Toxicity|2
2583052|NCT01194869|8933464|P1|Overall Study|Disease Progression|2
2583053|NCT01194830|8933495|P2|Overall Study|Other Reason|8
2583054|NCT01194830|8933496|P1|Overall Study|Other Reason|12
2583055|NCT01194830|8933495|P2|Overall Study|Non-compliance issues|4
2583056|NCT01194830|8933496|P1|Overall Study|Non-compliance issues|4
2583057|NCT01194830|8933495|P2|Overall Study|Lack of Efficacy|1
2583058|NCT01194830|8933496|P1|Overall Study|Lack of Efficacy|1
2583059|NCT01194830|8933495|P2|Overall Study|Withdrawal by Subject|1
2583060|NCT01194830|8933496|P1|Overall Study|Withdrawal by Subject|2
2583061|NCT01194830|8933495|P2|Overall Study|Lost to Follow-up|7
2583062|NCT01194830|8933496|P1|Overall Study|Lost to Follow-up|9
2583063|NCT01194830|8933495|P2|Overall Study|Protocol Violation|4
2583064|NCT01194830|8933496|P1|Overall Study|Protocol Violation|5
2583065|NCT01194830|8933495|P2|Overall Study|Adverse Event|2
2583066|NCT01194830|8933496|P1|Overall Study|Adverse Event|3
2583067|NCT01194804|8933518|P1|Overall Study|Withdrawal by Subject|1
2583068|NCT01194570|8933540|P2|Overall Study|Lost to Follow-up|4
2583069|NCT01194570|8933541|P1|Overall Study|Lost to Follow-up|1
2583070|NCT01194570|8933540|P2|Overall Study|Pregnancy|1
2583071|NCT01194570|8933541|P1|Overall Study|Pregnancy|1
2583072|NCT01194570|8933540|P2|Overall Study|Withdrawal by Subject|22
2583073|NCT01194570|8933541|P1|Overall Study|Withdrawal by Subject|21
2583074|NCT01194570|8933540|P2|Overall Study|Lack of Efficacy|21
2583075|NCT01194570|8933541|P1|Overall Study|Lack of Efficacy|27
2583076|NCT01194570|8933540|P2|Overall Study|Non-compliance|2
2583077|NCT01194570|8933541|P1|Overall Study|Non-compliance|2
2583078|NCT01194570|8933540|P2|Overall Study|Adverse Event|18
2583079|NCT01194570|8933541|P1|Overall Study|Adverse Event|12
2583080|NCT01194570|8933540|P2|Overall Study|Non-compliance with study drug|2
2583081|NCT01194570|8933541|P1|Overall Study|Non-compliance with study drug|2
2583082|NCT01194570|8933540|P2|Overall Study|Protocol Violation|2
2583083|NCT01194570|8933541|P1|Overall Study|Protocol Violation|0
2583084|NCT01194570|8933540|P2|Overall Study|Reason not specified|20
2583085|NCT01194570|8933541|P1|Overall Study|Reason not specified|13
2583086|NCT01194570|8933540|P2|Overall Study|Physician Decision|6
2583087|NCT01194570|8933541|P1|Overall Study|Physician Decision|2
2583088|NCT01194570|8933540|P2|Overall Study|Ongoing at CCOD|387
2583089|NCT01194570|8933541|P1|Overall Study|Ongoing at CCOD|162
2583090|NCT01194570|8933540|P2|Overall Study|Death|3
2583091|NCT01194570|8933541|P1|Overall Study|Death|1
2583092|NCT01194531|8933561|P2|Overall Study|Physician Decision|2
2583093|NCT01194531|8933562|P1|Overall Study|Physician Decision|0
2583094|NCT01194531|8933561|P2|Overall Study|Protocol Violation|1
2583095|NCT01194531|8933562|P1|Overall Study|Protocol Violation|4
2583096|NCT01194531|8933561|P2|Overall Study|Withdrawal by Subject|0
2583097|NCT01194531|8933562|P1|Overall Study|Withdrawal by Subject|1
2583098|NCT01194440|8933616|P1|6-months (2nd Dose)|Change in therapy|4
2583099|NCT01194440|8933616|P1|Baseline (First Dose)|Adverse Event|1
2583100|NCT01194440|8933616|P1|Baseline (First Dose)|Change in therapy|1
2583101|NCT01194440|8933616|P1|Baseline (First Dose)|Lack of Efficacy|1
2583102|NCT01194440|8933616|P1|Baseline (First Dose)|Reason not specified|4
2583103|NCT01194414|8933629|P4|72 Weeks Open Label Extension|Death|2
2583104|NCT01194414|8933630|P3|72 Weeks Open Label Extension|Death|0
2583105|NCT01194414|8933631|P2|72 Weeks Open Label Extension|Death|2
2583106|NCT01194414|8933632|P1|72 Weeks Open Label Extension|Death|1
2583107|NCT01194414|8933629|P4|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
2583108|NCT01194414|8933630|P3|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
2583109|NCT01194414|8933631|P2|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
2583110|NCT01194414|8933632|P1|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
2583111|NCT01194414|8933629|P4|72 Weeks Open Label Extension|Adverse Event|12
2583112|NCT01194414|8933630|P3|72 Weeks Open Label Extension|Adverse Event|2
2583113|NCT01194414|8933631|P2|72 Weeks Open Label Extension|Adverse Event|21
2583114|NCT01194414|8933632|P1|72 Weeks Open Label Extension|Adverse Event|35
2583115|NCT01194414|8933629|P4|72 Weeks Open Label Extension|Protocol Violation|1
2583116|NCT01194414|8933630|P3|72 Weeks Open Label Extension|Protocol Violation|0
2583117|NCT01194414|8933631|P2|72 Weeks Open Label Extension|Protocol Violation|0
2583118|NCT01194414|8933632|P1|72 Weeks Open Label Extension|Protocol Violation|0
2583119|NCT01194414|8933629|P4|72 Weeks Open Label Extension|Other|0
2583120|NCT01194414|8933630|P3|72 Weeks Open Label Extension|Other|0
2583121|NCT01194414|8933631|P2|72 Weeks Open Label Extension|Other|1
2583122|NCT01194414|8933632|P1|72 Weeks Open Label Extension|Other|2
2583123|NCT01194414|8933629|P4|72 Weeks Open Label Extension|Pregnancy|1
2583124|NCT01194414|8933630|P3|72 Weeks Open Label Extension|Pregnancy|1
2583125|NCT01194414|8933631|P2|72 Weeks Open Label Extension|Pregnancy|3
2583126|NCT01194414|8933632|P1|72 Weeks Open Label Extension|Pregnancy|1
2583127|NCT01194414|8933629|P4|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
2583128|NCT01194414|8933630|P3|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
2583129|NCT01194414|8933631|P2|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5
2583130|NCT01194414|8933632|P1|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3
2583131|NCT01194414|8933629|P4|72 Weeks Open Label Extension|Lost to Follow-up|1
2583132|NCT01194414|8933630|P3|72 Weeks Open Label Extension|Lost to Follow-up|2
2583133|NCT01194414|8933631|P2|72 Weeks Open Label Extension|Lost to Follow-up|3
2583134|NCT01194414|8933632|P1|72 Weeks Open Label Extension|Lost to Follow-up|4
2583135|NCT01194414|8933629|P4|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3
2583136|NCT01194414|8933630|P3|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2
2583137|NCT01194414|8933631|P2|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11
2583138|NCT01194414|8933632|P1|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9
2583139|NCT01194414|8933629|P4|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6
2583140|NCT01194414|8933630|P3|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1
2583141|NCT01194414|8933631|P2|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14
2583142|NCT01194414|8933632|P1|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20
2583143|NCT01194414|8933629|P4|72 Weeks Open Label Extension|Randomized but not Treated|0
2583144|NCT01194414|8933630|P3|72 Weeks Open Label Extension|Randomized but not Treated|0
2583145|NCT01194414|8933631|P2|72 Weeks Open Label Extension|Randomized but not Treated|5
2583146|NCT01194414|8933632|P1|72 Weeks Open Label Extension|Randomized but not Treated|3
2583147|NCT01194414|8933629|P4|24 Weeks Double Blind Period|Death|0
2583148|NCT01194414|8933630|P3|24 Weeks Double Blind Period|Death|0
2583149|NCT01194414|8933631|P2|24 Weeks Double Blind Period|Death|1
2583150|NCT01194414|8933632|P1|24 Weeks Double Blind Period|Death|0
2583151|NCT01194414|8933629|P4|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
2583152|NCT01194414|8933630|P3|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
2583153|NCT01194414|8933631|P2|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1
2583154|NCT01194414|8933632|P1|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2
2583155|NCT01194414|8933629|P4|24 Weeks Double Blind Period|Adverse Event|0
2583156|NCT01194414|8933630|P3|24 Weeks Double Blind Period|Adverse Event|0
2583157|NCT01194414|8933631|P2|24 Weeks Double Blind Period|Adverse Event|40
2583158|NCT01194414|8933632|P1|24 Weeks Double Blind Period|Adverse Event|28
2583159|NCT01194414|8933629|P4|24 Weeks Double Blind Period|Other|0
2583160|NCT01194414|8933630|P3|24 Weeks Double Blind Period|Other|0
2583161|NCT01194414|8933631|P2|24 Weeks Double Blind Period|Other|1
2583162|NCT01194414|8933632|P1|24 Weeks Double Blind Period|Other|0
2583163|NCT01194414|8933629|P4|24 Weeks Double Blind Period|Lost to Follow-up|0
2583164|NCT01194414|8933630|P3|24 Weeks Double Blind Period|Lost to Follow-up|0
2583165|NCT01194414|8933631|P2|24 Weeks Double Blind Period|Lost to Follow-up|1
2583166|NCT01194414|8933632|P1|24 Weeks Double Blind Period|Lost to Follow-up|2
2583167|NCT01194414|8933629|P4|24 Weeks Double Blind Period|Pregnancy|0
2583168|NCT01194414|8933630|P3|24 Weeks Double Blind Period|Pregnancy|0
2583169|NCT01194414|8933631|P2|24 Weeks Double Blind Period|Pregnancy|2
2583170|NCT01194414|8933632|P1|24 Weeks Double Blind Period|Pregnancy|2
2583171|NCT01194414|8933629|P4|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
2583172|NCT01194414|8933630|P3|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
2583173|NCT01194414|8933631|P2|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5
2583174|NCT01194414|8933632|P1|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
2583175|NCT01194414|8933629|P4|24 Weeks Double Blind Period|Protocol Violation|0
2583176|NCT01194414|8933630|P3|24 Weeks Double Blind Period|Protocol Violation|0
2583177|NCT01194414|8933631|P2|24 Weeks Double Blind Period|Protocol Violation|3
2583178|NCT01194414|8933632|P1|24 Weeks Double Blind Period|Protocol Violation|5
2583179|NCT01194414|8933629|P4|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
2583180|NCT01194414|8933630|P3|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
2583181|NCT01194414|8933631|P2|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5
2583182|NCT01194414|8933632|P1|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9
2583183|NCT01194414|8933629|P4|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
2583184|NCT01194414|8933630|P3|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
2583185|NCT01194414|8933631|P2|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8
2583186|NCT01194414|8933632|P1|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11
2583187|NCT01194258|8933703|P5|Period 2 (12 Weeks)|Withdrawal by Subject|0
2583188|NCT01194258|8933704|P4|Period 2 (12 Weeks)|Withdrawal by Subject|0
2583189|NCT01194258|8933705|P3|Period 2 (12 Weeks)|Withdrawal by Subject|1
2583190|NCT01194258|8933706|P2|Period 2 (12 Weeks)|Withdrawal by Subject|1
2583191|NCT01194258|8933707|P1|Period 2 (12 Weeks)|Withdrawal by Subject|0
2583192|NCT01194258|8933703|P5|Period 2 (12 Weeks)|Adverse Event|0
2583193|NCT01194258|8933704|P4|Period 2 (12 Weeks)|Adverse Event|0
2583194|NCT01194258|8933705|P3|Period 2 (12 Weeks)|Adverse Event|0
2583195|NCT01194258|8933706|P2|Period 2 (12 Weeks)|Adverse Event|1
2583196|NCT01194258|8933707|P1|Period 2 (12 Weeks)|Adverse Event|0
2583197|NCT01194258|8933703|P5|Period 2 (12 Weeks)|Lost to Follow-up|2
2583198|NCT01194258|8933704|P4|Period 2 (12 Weeks)|Lost to Follow-up|0
2583199|NCT01194258|8933705|P3|Period 2 (12 Weeks)|Lost to Follow-up|0
2583200|NCT01194258|8933706|P2|Period 2 (12 Weeks)|Lost to Follow-up|0
2583201|NCT01194258|8933707|P1|Period 2 (12 Weeks)|Lost to Follow-up|0
2583202|NCT01194258|8933703|P5|Period 1 (12 Weeks)|Death|1
2583203|NCT01194258|8933704|P4|Period 1 (12 Weeks)|Death|0
2583204|NCT01194258|8933705|P3|Period 1 (12 Weeks)|Death|0
2583205|NCT01194258|8933706|P2|Period 1 (12 Weeks)|Death|0
2583206|NCT01194258|8933707|P1|Period 1 (12 Weeks)|Death|0
2583207|NCT01194258|8933703|P5|Titration Period|Titration failure|0
2583208|NCT01194258|8933704|P4|Titration Period|Titration failure|0
2583209|NCT01194258|8933705|P3|Titration Period|Titration failure|0
2583210|NCT01194258|8933706|P2|Titration Period|Titration failure|0
2583211|NCT01194258|8933707|P1|Titration Period|Titration failure|3
2583212|NCT01194258|8933703|P5|Titration Period|Lost to Follow-up|0
2583213|NCT01194258|8933704|P4|Titration Period|Lost to Follow-up|0
2583214|NCT01194258|8933705|P3|Titration Period|Lost to Follow-up|0
2583215|NCT01194258|8933706|P2|Titration Period|Lost to Follow-up|0
2583216|NCT01194258|8933707|P1|Titration Period|Lost to Follow-up|2
2583217|NCT01194258|8933703|P5|Titration Period|Withdrawal by Subject|0
2583218|NCT01194258|8933704|P4|Titration Period|Withdrawal by Subject|0
2583219|NCT01194258|8933705|P3|Titration Period|Withdrawal by Subject|0
2583220|NCT01194258|8933706|P2|Titration Period|Withdrawal by Subject|0
2583221|NCT01194258|8933707|P1|Titration Period|Withdrawal by Subject|6
2583222|NCT01194245|8933731|P5|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
2583223|NCT01194245|8933732|P4|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
2583224|NCT01194245|8933733|P3|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
2583225|NCT01194245|8933734|P2|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
2583226|NCT01194245|8933735|P1|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
2583227|NCT01194245|8933731|P5|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
2583228|NCT01194245|8933732|P4|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
2583229|NCT01194245|8933733|P3|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
2583230|NCT01194245|8933734|P2|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
2583231|NCT01194245|8933735|P1|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
2583232|NCT01194245|8933731|P5|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
2583233|NCT01194245|8933732|P4|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
2583234|NCT01194245|8933733|P3|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
2583235|NCT01194245|8933734|P2|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
2583236|NCT01194245|8933735|P1|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7
2583237|NCT01194245|8933731|P5|Titration Period (4 to 6 Weeks)|Titration Failure|0
2583238|NCT01194245|8933732|P4|Titration Period (4 to 6 Weeks)|Titration Failure|0
2583239|NCT01194245|8933733|P3|Titration Period (4 to 6 Weeks)|Titration Failure|0
2583240|NCT01194245|8933734|P2|Titration Period (4 to 6 Weeks)|Titration Failure|0
2583241|NCT01194245|8933735|P1|Titration Period (4 to 6 Weeks)|Titration Failure|3
2583242|NCT01194245|8933731|P5|Titration Period (4 to 6 Weeks)|Physician Decision|0
2583243|NCT01194245|8933732|P4|Titration Period (4 to 6 Weeks)|Physician Decision|0
2583244|NCT01194245|8933733|P3|Titration Period (4 to 6 Weeks)|Physician Decision|0
2583245|NCT01194245|8933734|P2|Titration Period (4 to 6 Weeks)|Physician Decision|0
2583246|NCT01194245|8933735|P1|Titration Period (4 to 6 Weeks)|Physician Decision|3
2583247|NCT01194245|8933731|P5|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
2583248|NCT01194245|8933732|P4|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
2583249|NCT01194245|8933733|P3|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
2583250|NCT01194245|8933734|P2|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
2583251|NCT01194245|8933735|P1|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5
2583252|NCT01194219|8933756|P10|Long-Term Extension Weeks 52 to 260|Miscellaneous|2
2583253|NCT01194219|8933757|P9|Long-Term Extension Weeks 52 to 260|Miscellaneous|11
2583254|NCT01194219|8933758|P8|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
2583255|NCT01194219|8933759|P7|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
2583256|NCT01194219|8933760|P6|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
2583257|NCT01194219|8933761|P5|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
2583258|NCT01194219|8933762|P4|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
2583259|NCT01194219|8933763|P3|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
2583260|NCT01194219|8933764|P2|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
2583261|NCT01194219|8933765|P1|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
2583262|NCT01194219|8933756|P10|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
2583263|NCT01194219|8933757|P9|Long-Term Extension Weeks 52 to 260|Protocol Violation|3
2583264|NCT01194219|8933758|P8|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
2583265|NCT01194219|8933759|P7|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
2583266|NCT01194219|8933760|P6|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
2583267|NCT01194219|8933761|P5|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
2583268|NCT01194219|8933762|P4|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
2583269|NCT01194219|8933763|P3|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
2583270|NCT01194219|8933764|P2|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
2583271|NCT01194219|8933765|P1|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
2583272|NCT01194219|8933756|P10|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10
2583273|NCT01194219|8933757|P9|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24
2583274|NCT01194219|8933758|P8|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
2583275|NCT01194219|8933759|P7|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
2583276|NCT01194219|8933760|P6|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
2583277|NCT01194219|8933761|P5|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
2583278|NCT01194219|8933762|P4|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
2583279|NCT01194219|8933763|P3|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
2583280|NCT01194219|8933764|P2|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
2583281|NCT01194219|8933765|P1|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
2583282|NCT01194219|8933756|P10|Long-Term Extension Weeks 52 to 260|Death|1
2583283|NCT01194219|8933757|P9|Long-Term Extension Weeks 52 to 260|Death|1
2583284|NCT01194219|8933758|P8|Long-Term Extension Weeks 52 to 260|Death|0
2583285|NCT01194219|8933759|P7|Long-Term Extension Weeks 52 to 260|Death|0
2583286|NCT01194219|8933760|P6|Long-Term Extension Weeks 52 to 260|Death|0
2583287|NCT01194219|8933761|P5|Long-Term Extension Weeks 52 to 260|Death|0
2583288|NCT01194219|8933762|P4|Long-Term Extension Weeks 52 to 260|Death|0
2583289|NCT01194219|8933763|P3|Long-Term Extension Weeks 52 to 260|Death|0
2583290|NCT01194219|8933764|P2|Long-Term Extension Weeks 52 to 260|Death|0
2583291|NCT01194219|8933765|P1|Long-Term Extension Weeks 52 to 260|Death|0
2583292|NCT01194219|8933756|P10|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32
2583293|NCT01194219|8933757|P9|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66
2583294|NCT01194219|8933758|P8|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
2583295|NCT01194219|8933759|P7|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
2583296|NCT01194219|8933760|P6|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
2583297|NCT01194219|8933761|P5|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
2583298|NCT01194219|8933762|P4|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
2583299|NCT01194219|8933763|P3|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
2583300|NCT01194219|8933764|P2|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
2583301|NCT01194219|8933765|P1|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
2583302|NCT01194219|8933756|P10|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4
2583303|NCT01194219|8933757|P9|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9
2583304|NCT01194219|8933758|P8|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
2583305|NCT01194219|8933759|P7|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
2583306|NCT01194219|8933760|P6|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
2583307|NCT01194219|8933761|P5|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
2583308|NCT01194219|8933762|P4|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
2583309|NCT01194219|8933763|P3|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
2583310|NCT01194219|8933764|P2|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
2583311|NCT01194219|8933765|P1|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
2583312|NCT01194219|8933756|P10|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49
2583313|NCT01194219|8933757|P9|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81
2583314|NCT01194219|8933758|P8|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
2583315|NCT01194219|8933759|P7|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
2583316|NCT01194219|8933760|P6|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
2583317|NCT01194219|8933761|P5|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
2583318|NCT01194219|8933762|P4|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
2583319|NCT01194219|8933763|P3|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
2583320|NCT01194219|8933764|P2|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
2583321|NCT01194219|8933765|P1|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
2583322|NCT01194219|8933756|P10|Long-Term Extension Weeks 52 to 260|Adverse Event|14
2583323|NCT01194219|8933757|P9|Long-Term Extension Weeks 52 to 260|Adverse Event|25
2583324|NCT01194219|8933758|P8|Long-Term Extension Weeks 52 to 260|Adverse Event|0
2583325|NCT01194219|8933759|P7|Long-Term Extension Weeks 52 to 260|Adverse Event|0
2583326|NCT01194219|8933760|P6|Long-Term Extension Weeks 52 to 260|Adverse Event|0
2583327|NCT01194219|8933761|P5|Long-Term Extension Weeks 52 to 260|Adverse Event|0
2583328|NCT01194219|8933762|P4|Long-Term Extension Weeks 52 to 260|Adverse Event|0
2583329|NCT01194219|8933763|P3|Long-Term Extension Weeks 52 to 260|Adverse Event|0
2583330|NCT01194219|8933764|P2|Long-Term Extension Weeks 52 to 260|Adverse Event|0
2583331|NCT01194219|8933765|P1|Long-Term Extension Weeks 52 to 260|Adverse Event|0
2583332|NCT01194219|8933756|P10|Randomized Withdrawal Phase-Weeks 32-52|Other|0
2583333|NCT01194219|8933757|P9|Randomized Withdrawal Phase-Weeks 32-52|Other|0
2583334|NCT01194219|8933758|P8|Randomized Withdrawal Phase-Weeks 32-52|Other|0
2583335|NCT01194219|8933759|P7|Randomized Withdrawal Phase-Weeks 32-52|Other|1
2583336|NCT01194219|8933760|P6|Randomized Withdrawal Phase-Weeks 32-52|Other|0
2583337|NCT01194219|8933761|P5|Randomized Withdrawal Phase-Weeks 32-52|Other|0
2583338|NCT01194219|8933762|P4|Randomized Withdrawal Phase-Weeks 32-52|Other|0
2583339|NCT01194219|8933763|P3|Randomized Withdrawal Phase-Weeks 32-52|Other|0
2583340|NCT01194219|8933764|P2|Randomized Withdrawal Phase-Weeks 32-52|Other|0
2583341|NCT01194219|8933765|P1|Randomized Withdrawal Phase-Weeks 32-52|Other|0
2583342|NCT01194219|8933756|P10|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
2583343|NCT01194219|8933757|P9|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
2583344|NCT01194219|8933758|P8|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1
2583345|NCT01194219|8933759|P7|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
2583346|NCT01194219|8933760|P6|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
2583347|NCT01194219|8933761|P5|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
2583348|NCT01194219|8933762|P4|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
2583349|NCT01194219|8933763|P3|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
2583350|NCT01194219|8933764|P2|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
2583351|NCT01194219|8933765|P1|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
2583352|NCT01194219|8933756|P10|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
2583353|NCT01194219|8933757|P9|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
2583354|NCT01194219|8933758|P8|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
2583355|NCT01194219|8933759|P7|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5
2583356|NCT01194219|8933760|P6|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2
2583357|NCT01194219|8933761|P5|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1
2583358|NCT01194219|8933762|P4|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
2583359|NCT01194219|8933763|P3|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
2583360|NCT01194219|8933764|P2|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
2583361|NCT01194219|8933765|P1|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
2583362|NCT01194219|8933756|P10|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
2583363|NCT01194219|8933757|P9|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
2583364|NCT01194219|8933758|P8|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6
2583365|NCT01194219|8933759|P7|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12
2583366|NCT01194219|8933760|P6|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
2583367|NCT01194219|8933761|P5|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1
2583368|NCT01194219|8933762|P4|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
2583369|NCT01194219|8933763|P3|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
2583370|NCT01194219|8933764|P2|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
2583371|NCT01194219|8933765|P1|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
2583372|NCT01194219|8933756|P10|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
2583373|NCT01194219|8933757|P9|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
2583374|NCT01194219|8933758|P8|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
2583375|NCT01194219|8933759|P7|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2
2583376|NCT01194219|8933760|P6|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
2583377|NCT01194219|8933761|P5|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1
2583378|NCT01194219|8933762|P4|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
2583379|NCT01194219|8933763|P3|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
2583380|NCT01194219|8933764|P2|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
2583381|NCT01194219|8933765|P1|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
2583382|NCT01194219|8933756|P10|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
2583383|NCT01194219|8933757|P9|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
2583384|NCT01194219|8933758|P8|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33
2583385|NCT01194219|8933759|P7|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35
2583386|NCT01194219|8933760|P6|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
2583387|NCT01194219|8933761|P5|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
2583388|NCT01194219|8933762|P4|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
2583389|NCT01194219|8933763|P3|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
2583390|NCT01194219|8933764|P2|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
2583391|NCT01194219|8933765|P1|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
2583392|NCT01194219|8933756|P10|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
2583393|NCT01194219|8933757|P9|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
2583394|NCT01194219|8933758|P8|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5
2583395|NCT01194219|8933759|P7|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6
2583396|NCT01194219|8933760|P6|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1
2583397|NCT01194219|8933761|P5|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
2583398|NCT01194219|8933762|P4|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
2583399|NCT01194219|8933763|P3|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
2583400|NCT01194219|8933764|P2|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
2583401|NCT01194219|8933765|P1|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
2583402|NCT01194219|8933756|P10|Maintenance Phase Weeks16-32|Other|0
2583403|NCT01194219|8933757|P9|Maintenance Phase Weeks16-32|Other|0
2583404|NCT01194219|8933758|P8|Maintenance Phase Weeks16-32|Other|0
2583405|NCT01194219|8933759|P7|Maintenance Phase Weeks16-32|Other|0
2583406|NCT01194219|8933760|P6|Maintenance Phase Weeks16-32|Other|0
2583407|NCT01194219|8933761|P5|Maintenance Phase Weeks16-32|Other|0
2583408|NCT01194219|8933762|P4|Maintenance Phase Weeks16-32|Other|1
2583409|NCT01194219|8933763|P3|Maintenance Phase Weeks16-32|Other|2
2583410|NCT01194219|8933764|P2|Maintenance Phase Weeks16-32|Other|0
2583411|NCT01194219|8933765|P1|Maintenance Phase Weeks16-32|Other|0
2583412|NCT01194219|8933756|P10|Maintenance Phase Weeks16-32|Protocol Violation|0
2583413|NCT01194219|8933757|P9|Maintenance Phase Weeks16-32|Protocol Violation|0
2583414|NCT01194219|8933758|P8|Maintenance Phase Weeks16-32|Protocol Violation|0
2583415|NCT01194219|8933759|P7|Maintenance Phase Weeks16-32|Protocol Violation|0
2583416|NCT01194219|8933760|P6|Maintenance Phase Weeks16-32|Protocol Violation|0
2583417|NCT01194219|8933761|P5|Maintenance Phase Weeks16-32|Protocol Violation|0
2583418|NCT01194219|8933762|P4|Maintenance Phase Weeks16-32|Protocol Violation|1
2583419|NCT01194219|8933763|P3|Maintenance Phase Weeks16-32|Protocol Violation|0
2583420|NCT01194219|8933764|P2|Maintenance Phase Weeks16-32|Protocol Violation|0
2583421|NCT01194219|8933765|P1|Maintenance Phase Weeks16-32|Protocol Violation|0
2583422|NCT01194219|8933756|P10|Maintenance Phase Weeks16-32|Lost to Follow-up|0
2583423|NCT01194219|8933757|P9|Maintenance Phase Weeks16-32|Lost to Follow-up|0
2583424|NCT01194219|8933758|P8|Maintenance Phase Weeks16-32|Lost to Follow-up|0
2583425|NCT01194219|8933759|P7|Maintenance Phase Weeks16-32|Lost to Follow-up|0
2583426|NCT01194219|8933760|P6|Maintenance Phase Weeks16-32|Lost to Follow-up|0
2583427|NCT01194219|8933761|P5|Maintenance Phase Weeks16-32|Lost to Follow-up|0
2583428|NCT01194219|8933762|P4|Maintenance Phase Weeks16-32|Lost to Follow-up|0
2583429|NCT01194219|8933763|P3|Maintenance Phase Weeks16-32|Lost to Follow-up|9
2583430|NCT01194219|8933764|P2|Maintenance Phase Weeks16-32|Lost to Follow-up|0
2583431|NCT01194219|8933765|P1|Maintenance Phase Weeks16-32|Lost to Follow-up|0
2583432|NCT01194219|8933756|P10|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
2583433|NCT01194219|8933757|P9|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
2583434|NCT01194219|8933758|P8|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
2583435|NCT01194219|8933759|P7|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
2583436|NCT01194219|8933760|P6|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
2583437|NCT01194219|8933761|P5|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
2583438|NCT01194219|8933762|P4|Maintenance Phase Weeks16-32|Withdrawal by Subject|3
2583439|NCT01194219|8933763|P3|Maintenance Phase Weeks16-32|Withdrawal by Subject|12
2583440|NCT01194219|8933764|P2|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
2583441|NCT01194219|8933765|P1|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
2583442|NCT01194219|8933756|P10|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
2583443|NCT01194219|8933757|P9|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
2583444|NCT01194219|8933758|P8|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
2583445|NCT01194219|8933759|P7|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
2583446|NCT01194219|8933760|P6|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
2583447|NCT01194219|8933761|P5|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
2583448|NCT01194219|8933762|P4|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1
2583449|NCT01194219|8933763|P3|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2
2583450|NCT01194219|8933764|P2|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
2583451|NCT01194219|8933765|P1|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
2583452|NCT01194219|8933756|P10|Maintenance Phase Weeks16-32|Lack of Efficacy|0
2583453|NCT01194219|8933757|P9|Maintenance Phase Weeks16-32|Lack of Efficacy|0
2583454|NCT01194219|8933758|P8|Maintenance Phase Weeks16-32|Lack of Efficacy|0
2583455|NCT01194219|8933759|P7|Maintenance Phase Weeks16-32|Lack of Efficacy|0
2583456|NCT01194219|8933760|P6|Maintenance Phase Weeks16-32|Lack of Efficacy|0
2583457|NCT01194219|8933761|P5|Maintenance Phase Weeks16-32|Lack of Efficacy|0
2583458|NCT01194219|8933762|P4|Maintenance Phase Weeks16-32|Lack of Efficacy|15
2583459|NCT01194219|8933763|P3|Maintenance Phase Weeks16-32|Lack of Efficacy|37
2583460|NCT01194219|8933764|P2|Maintenance Phase Weeks16-32|Lack of Efficacy|0
2583461|NCT01194219|8933765|P1|Maintenance Phase Weeks16-32|Lack of Efficacy|0
2583462|NCT01194219|8933756|P10|Maintenance Phase Weeks16-32|Adverse Event|0
2583463|NCT01194219|8933757|P9|Maintenance Phase Weeks16-32|Adverse Event|0
2583464|NCT01194219|8933758|P8|Maintenance Phase Weeks16-32|Adverse Event|0
2583465|NCT01194219|8933759|P7|Maintenance Phase Weeks16-32|Adverse Event|0
2583466|NCT01194219|8933760|P6|Maintenance Phase Weeks16-32|Adverse Event|0
2583467|NCT01194219|8933761|P5|Maintenance Phase Weeks16-32|Adverse Event|0
2583468|NCT01194219|8933762|P4|Maintenance Phase Weeks16-32|Adverse Event|9
2583469|NCT01194219|8933763|P3|Maintenance Phase Weeks16-32|Adverse Event|8
2583470|NCT01194219|8933764|P2|Maintenance Phase Weeks16-32|Adverse Event|0
2583471|NCT01194219|8933765|P1|Maintenance Phase Weeks16-32|Adverse Event|0
2583472|NCT01194219|8933756|P10|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
2583473|NCT01194219|8933757|P9|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
2583474|NCT01194219|8933758|P8|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
2583475|NCT01194219|8933759|P7|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
2583476|NCT01194219|8933760|P6|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
2583477|NCT01194219|8933761|P5|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
2583478|NCT01194219|8933762|P4|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
2583479|NCT01194219|8933763|P3|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
2583480|NCT01194219|8933764|P2|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
2583481|NCT01194219|8933765|P1|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
2583482|NCT01194219|8933756|P10|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
2583483|NCT01194219|8933757|P9|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
2583484|NCT01194219|8933758|P8|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
2583485|NCT01194219|8933759|P7|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
2583486|NCT01194219|8933760|P6|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
2583487|NCT01194219|8933761|P5|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
2583488|NCT01194219|8933762|P4|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
2583489|NCT01194219|8933763|P3|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
2583490|NCT01194219|8933764|P2|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1
2583491|NCT01194219|8933765|P1|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7
2583492|NCT01194219|8933756|P10|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
2583493|NCT01194219|8933757|P9|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
2583494|NCT01194219|8933758|P8|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
2583495|NCT01194219|8933759|P7|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
2583496|NCT01194219|8933760|P6|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
2583497|NCT01194219|8933761|P5|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
2583498|NCT01194219|8933762|P4|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
2583499|NCT01194219|8933763|P3|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
2583500|NCT01194219|8933764|P2|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9
2583501|NCT01194219|8933765|P1|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7
2583502|NCT01194219|8933756|P10|Placebo-Controlled Phase Weeks 0-16|Death|0
2583503|NCT01194219|8933757|P9|Placebo-Controlled Phase Weeks 0-16|Death|0
2583504|NCT01194219|8933758|P8|Placebo-Controlled Phase Weeks 0-16|Death|0
2583505|NCT01194219|8933759|P7|Placebo-Controlled Phase Weeks 0-16|Death|0
2583506|NCT01194219|8933760|P6|Placebo-Controlled Phase Weeks 0-16|Death|0
2583507|NCT01194219|8933761|P5|Placebo-Controlled Phase Weeks 0-16|Death|0
2583508|NCT01194219|8933762|P4|Placebo-Controlled Phase Weeks 0-16|Death|0
2583509|NCT01194219|8933763|P3|Placebo-Controlled Phase Weeks 0-16|Death|0
2583510|NCT01194219|8933764|P2|Placebo-Controlled Phase Weeks 0-16|Death|1
2583511|NCT01194219|8933765|P1|Placebo-Controlled Phase Weeks 0-16|Death|0
2583512|NCT01194219|8933756|P10|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
2583513|NCT01194219|8933757|P9|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
2583514|NCT01194219|8933758|P8|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
2583515|NCT01194219|8933759|P7|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
2583516|NCT01194219|8933760|P6|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
2583517|NCT01194219|8933761|P5|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
2583518|NCT01194219|8933762|P4|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
2583519|NCT01194219|8933763|P3|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
2583520|NCT01194219|8933764|P2|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9
2583521|NCT01194219|8933765|P1|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12
2583522|NCT01194219|8933756|P10|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
2583523|NCT01194219|8933757|P9|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
2583524|NCT01194219|8933758|P8|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
2583525|NCT01194219|8933759|P7|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
2583526|NCT01194219|8933760|P6|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
2583527|NCT01194219|8933761|P5|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
2583528|NCT01194219|8933762|P4|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
2583529|NCT01194219|8933763|P3|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
2583530|NCT01194219|8933764|P2|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
2583531|NCT01194219|8933765|P1|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7
2583532|NCT01194219|8933756|P10|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
2583533|NCT01194219|8933757|P9|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
2583534|NCT01194219|8933758|P8|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
2583535|NCT01194219|8933759|P7|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
2583536|NCT01194219|8933760|P6|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
2583537|NCT01194219|8933761|P5|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
2583538|NCT01194219|8933762|P4|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
2583539|NCT01194219|8933763|P3|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
2583540|NCT01194219|8933764|P2|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7
2583541|NCT01194219|8933765|P1|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2
2583542|NCT01194219|8933756|P10|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
2583543|NCT01194219|8933757|P9|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
2583544|NCT01194219|8933758|P8|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
2583545|NCT01194219|8933759|P7|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
2583546|NCT01194219|8933760|P6|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
2583547|NCT01194219|8933761|P5|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
2583548|NCT01194219|8933762|P4|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
2583549|NCT01194219|8933763|P3|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
2583550|NCT01194219|8933764|P2|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5
2583551|NCT01194219|8933765|P1|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23
2583552|NCT01194154|8933799|P2|Overall Study|Did not receive study medication|4
2583553|NCT01194154|8933800|P1|Overall Study|Did not receive study medication|2
2583554|NCT01194154|8933799|P2|Overall Study|Other|0
2583555|NCT01194154|8933800|P1|Overall Study|Other|4
2583556|NCT01194154|8933799|P2|Overall Study|Treatment with prohibited medication|5
2583557|NCT01194154|8933800|P1|Overall Study|Treatment with prohibited medication|4
2583558|NCT01194154|8933799|P2|Overall Study|Skipping of CERA treatment at two visits|0
2583559|NCT01194154|8933800|P1|Overall Study|Skipping of CERA treatment at two visits|3
2583560|NCT01194154|8933799|P2|Overall Study|Hemoglobin increase|3
2583561|NCT01194154|8933800|P1|Overall Study|Hemoglobin increase|12
2583562|NCT01194154|8933799|P2|Overall Study|Hemoglobin decrease|1
2583563|NCT01194154|8933800|P1|Overall Study|Hemoglobin decrease|0
2583564|NCT01194154|8933799|P2|Overall Study|Blood pressure increase|3
2583565|NCT01194154|8933800|P1|Overall Study|Blood pressure increase|5
2583566|NCT01194154|8933799|P2|Overall Study|Withdrawal by Subject|6
2583567|NCT01194154|8933800|P1|Overall Study|Withdrawal by Subject|5
2583568|NCT01194154|8933799|P2|Overall Study|Protocol Violation|1
2583569|NCT01194154|8933800|P1|Overall Study|Protocol Violation|0
2583570|NCT01194154|8933799|P2|Overall Study|Lost to Follow-up|3
2583571|NCT01194154|8933800|P1|Overall Study|Lost to Follow-up|2
2583572|NCT01194154|8933799|P2|Overall Study|Adverse Event|7
2583573|NCT01194154|8933800|P1|Overall Study|Adverse Event|12
2583574|NCT01193920|8933841|P10|Overall Study|Unable to classify|0
2583575|NCT01193920|8933842|P9|Overall Study|Unable to classify|0
2583576|NCT01193920|8933843|P8|Overall Study|Unable to classify|1
2583577|NCT01193920|8933844|P7|Overall Study|Unable to classify|0
2583578|NCT01193920|8933845|P6|Overall Study|Unable to classify|0
2583579|NCT01193920|8933846|P5|Overall Study|Unable to classify|0
2583580|NCT01193920|8933847|P4|Overall Study|Unable to classify|1
2583581|NCT01193920|8933848|P3|Overall Study|Unable to classify|0
2583582|NCT01193920|8933849|P2|Overall Study|Unable to classify|0
2583583|NCT01193920|8933850|P1|Overall Study|Unable to classify|0
2583584|NCT01193920|8933841|P10|Overall Study|Death|4
2583585|NCT01193920|8933842|P9|Overall Study|Death|2
2583586|NCT01193920|8933843|P8|Overall Study|Death|3
2583587|NCT01193920|8933844|P7|Overall Study|Death|2
2583588|NCT01193920|8933845|P6|Overall Study|Death|0
2583589|NCT01193920|8933846|P5|Overall Study|Death|0
2583590|NCT01193920|8933847|P4|Overall Study|Death|1
2583591|NCT01193920|8933848|P3|Overall Study|Death|0
2583592|NCT01193920|8933849|P2|Overall Study|Death|0
2583593|NCT01193920|8933850|P1|Overall Study|Death|0
2583594|NCT01193920|8933841|P10|Overall Study|Protocol Violation|0
2583595|NCT01193920|8933842|P9|Overall Study|Protocol Violation|0
2583596|NCT01193920|8933843|P8|Overall Study|Protocol Violation|0
2583597|NCT01193920|8933844|P7|Overall Study|Protocol Violation|0
2583598|NCT01193920|8933845|P6|Overall Study|Protocol Violation|0
2583599|NCT01193920|8933846|P5|Overall Study|Protocol Violation|0
2583600|NCT01193920|8933847|P4|Overall Study|Protocol Violation|0
2583601|NCT01193920|8933848|P3|Overall Study|Protocol Violation|0
2583602|NCT01193920|8933849|P2|Overall Study|Protocol Violation|0
2583603|NCT01193920|8933850|P1|Overall Study|Protocol Violation|1
2583604|NCT01193920|8933841|P10|Overall Study|Lost to Follow-up|3
2583605|NCT01193920|8933842|P9|Overall Study|Lost to Follow-up|2
2583606|NCT01193920|8933843|P8|Overall Study|Lost to Follow-up|0
2583607|NCT01193920|8933844|P7|Overall Study|Lost to Follow-up|1
2583608|NCT01193920|8933845|P6|Overall Study|Lost to Follow-up|3
2583609|NCT01193920|8933846|P5|Overall Study|Lost to Follow-up|3
2583610|NCT01193920|8933847|P4|Overall Study|Lost to Follow-up|1
2583611|NCT01193920|8933848|P3|Overall Study|Lost to Follow-up|1
2583612|NCT01193920|8933849|P2|Overall Study|Lost to Follow-up|0
2583613|NCT01193920|8933850|P1|Overall Study|Lost to Follow-up|1
2583614|NCT01193920|8933841|P10|Overall Study|Withdrawal by Subject|0
2583615|NCT01193920|8933842|P9|Overall Study|Withdrawal by Subject|1
2583616|NCT01193920|8933843|P8|Overall Study|Withdrawal by Subject|0
2583617|NCT01193920|8933844|P7|Overall Study|Withdrawal by Subject|3
2583618|NCT01193920|8933845|P6|Overall Study|Withdrawal by Subject|1
2583619|NCT01193920|8933846|P5|Overall Study|Withdrawal by Subject|3
2583620|NCT01193920|8933847|P4|Overall Study|Withdrawal by Subject|1
2583621|NCT01193920|8933848|P3|Overall Study|Withdrawal by Subject|5
2583622|NCT01193920|8933849|P2|Overall Study|Withdrawal by Subject|0
2583623|NCT01193920|8933850|P1|Overall Study|Withdrawal by Subject|1
2583624|NCT01193842|8933946|P5|Phase II: Randomized Groups|Disease progression/relapse on treatment|3
2583625|NCT01193842|8933947|P4|Phase II: Randomized Groups|Disease progression/relapse on treatment|5
2583626|NCT01193842|8933948|P3|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
2583627|NCT01193842|8933949|P2|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
2583628|NCT01193842|8933950|P1|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
2583629|NCT01193842|8933946|P5|Phase II: Randomized Groups|Ineligible|1
2583630|NCT01193842|8933947|P4|Phase II: Randomized Groups|Ineligible|0
2583631|NCT01193842|8933948|P3|Phase II: Randomized Groups|Ineligible|0
2583632|NCT01193842|8933949|P2|Phase II: Randomized Groups|Ineligible|0
2583633|NCT01193842|8933950|P1|Phase II: Randomized Groups|Ineligible|0
2583634|NCT01193842|8933946|P5|Phase II: Randomized Groups|Withdrawal by Subject|2
2583635|NCT01193842|8933947|P4|Phase II: Randomized Groups|Withdrawal by Subject|1
2583636|NCT01193842|8933948|P3|Phase II: Randomized Groups|Withdrawal by Subject|0
2583637|NCT01193842|8933949|P2|Phase II: Randomized Groups|Withdrawal by Subject|0
2583638|NCT01193842|8933950|P1|Phase II: Randomized Groups|Withdrawal by Subject|0
2583639|NCT01193842|8933946|P5|Phase II: Randomized Groups|Adverse Event|3
2583640|NCT01193842|8933947|P4|Phase II: Randomized Groups|Adverse Event|5
2583641|NCT01193842|8933948|P3|Phase II: Randomized Groups|Adverse Event|0
2583642|NCT01193842|8933949|P2|Phase II: Randomized Groups|Adverse Event|0
2583643|NCT01193842|8933950|P1|Phase II: Randomized Groups|Adverse Event|0
2583644|NCT01193842|8933946|P5|Phase II: Randomized Groups|Death|1
2583645|NCT01193842|8933947|P4|Phase II: Randomized Groups|Death|1
2583646|NCT01193842|8933948|P3|Phase II: Randomized Groups|Death|0
2583647|NCT01193842|8933949|P2|Phase II: Randomized Groups|Death|0
2583648|NCT01193842|8933950|P1|Phase II: Randomized Groups|Death|0
2583649|NCT01193842|8933946|P5|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
2583650|NCT01193842|8933947|P4|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
2583651|NCT01193842|8933948|P3|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1
2583652|NCT01193842|8933949|P2|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
2583653|NCT01193842|8933950|P1|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
2583654|NCT01193842|8933946|P5|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
2583655|NCT01193842|8933947|P4|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
2583656|NCT01193842|8933948|P3|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
2583657|NCT01193842|8933949|P2|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
2583658|NCT01193842|8933950|P1|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1
2583659|NCT01193842|8933946|P5|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
2583660|NCT01193842|8933947|P4|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
2583661|NCT01193842|8933948|P3|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
2583662|NCT01193842|8933949|P2|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1
2583663|NCT01193842|8933950|P1|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
2583664|NCT01193686|8933985|P2|Overall Study|Removed by Investigators; unable to matc|0
2583665|NCT01193686|8933986|P1|Overall Study|Removed by Investigators; unable to matc|3
2583666|NCT01193686|8933985|P2|Overall Study|Withdrawal by Subject|1
2583667|NCT01193686|8933986|P1|Overall Study|Withdrawal by Subject|4
2583668|NCT01193660|8934003|P3|Overall Study|Physician Decision|1
2583669|NCT01193660|8934004|P2|Overall Study|Physician Decision|0
2583670|NCT01193660|8934005|P1|Overall Study|Physician Decision|1
2583671|NCT01193660|8934003|P3|Overall Study|Death|0
2583672|NCT01193660|8934004|P2|Overall Study|Death|0
2583673|NCT01193660|8934005|P1|Overall Study|Death|1
2583674|NCT01193660|8934003|P3|Overall Study|Withdrawal by Subject|1
2583675|NCT01193660|8934004|P2|Overall Study|Withdrawal by Subject|3
2583676|NCT01193660|8934005|P1|Overall Study|Withdrawal by Subject|2
2583677|NCT01193608|8934049|P6|Overall Study|Adverse Event|0
2583678|NCT01193608|8934050|P5|Overall Study|Adverse Event|1
2583679|NCT01193608|8934051|P4|Overall Study|Adverse Event|0
2583680|NCT01193608|8934052|P3|Overall Study|Adverse Event|0
2583681|NCT01193608|8934053|P2|Overall Study|Adverse Event|0
2583682|NCT01193608|8934054|P1|Overall Study|Adverse Event|0
2583683|NCT01193608|8934049|P6|Overall Study|Lost to Follow-up|2
2583684|NCT01193608|8934050|P5|Overall Study|Lost to Follow-up|1
2583685|NCT01193608|8934051|P4|Overall Study|Lost to Follow-up|0
2583686|NCT01193608|8934052|P3|Overall Study|Lost to Follow-up|0
2583687|NCT01193608|8934053|P2|Overall Study|Lost to Follow-up|0
2583688|NCT01193608|8934054|P1|Overall Study|Lost to Follow-up|0
2583689|NCT01193608|8934049|P6|Overall Study|Withdrawal by Subject|0
2583690|NCT01193608|8934050|P5|Overall Study|Withdrawal by Subject|3
2583691|NCT01193608|8934051|P4|Overall Study|Withdrawal by Subject|3
2583692|NCT01193608|8934052|P3|Overall Study|Withdrawal by Subject|2
2583693|NCT01193608|8934053|P2|Overall Study|Withdrawal by Subject|1
2583694|NCT01193608|8934054|P1|Overall Study|Withdrawal by Subject|0
2583695|NCT01193608|8934049|P6|Overall Study|Other|0
2583696|NCT01193608|8934050|P5|Overall Study|Other|0
2583697|NCT01193608|8934051|P4|Overall Study|Other|0
2583698|NCT01193608|8934052|P3|Overall Study|Other|0
2583699|NCT01193608|8934053|P2|Overall Study|Other|1
2583700|NCT01193608|8934054|P1|Overall Study|Other|0
2583701|NCT01193582|8934291|P4|12 Month Follow-up|Withdrawal by Subject|11
2583702|NCT01193582|8934292|P3|12 Month Follow-up|Withdrawal by Subject|3
2583703|NCT01193582|8934293|P2|12 Month Follow-up|Withdrawal by Subject|0
2583704|NCT01193582|8934294|P1|12 Month Follow-up|Withdrawal by Subject|6
2583705|NCT01193582|8934291|P4|12 Month Follow-up|Death|0
2583706|NCT01193582|8934292|P3|12 Month Follow-up|Death|1
2583707|NCT01193582|8934293|P2|12 Month Follow-up|Death|0
2583708|NCT01193582|8934294|P1|12 Month Follow-up|Death|0
2583709|NCT01193582|8934291|P4|Vaccination Series|Withdrawal by Subject|3
2583710|NCT01193582|8934292|P3|Vaccination Series|Withdrawal by Subject|8
2583711|NCT01193582|8934293|P2|Vaccination Series|Withdrawal by Subject|13
2583712|NCT01193582|8934294|P1|Vaccination Series|Withdrawal by Subject|11
2583713|NCT01193556|8934324|P2|Overall Study|Study termination|25
2583714|NCT01193556|8934325|P1|Overall Study|Study termination|26
2583715|NCT01193530|8934335|P2|Overall Study|Non-Compliance|1
2583716|NCT01193530|8934336|P1|Overall Study|Non-Compliance|0
2583717|NCT01193530|8934335|P2|Overall Study|Returned home - out of state|1
2583718|NCT01193530|8934336|P1|Overall Study|Returned home - out of state|0
2583719|NCT01193530|8934335|P2|Overall Study|Lost Light Box|1
2583720|NCT01193530|8934336|P1|Overall Study|Lost Light Box|0
2583721|NCT01193530|8934335|P2|Overall Study|Began Contraindicated Therapy|0
2583722|NCT01193530|8934336|P1|Overall Study|Began Contraindicated Therapy|1
2583723|NCT01193530|8934335|P2|Overall Study|Withdrawal by Subject|2
2583724|NCT01193530|8934336|P1|Overall Study|Withdrawal by Subject|2
2583725|NCT01193517|8934345|P3|Overall Study|Early Progression|0
2583726|NCT01193517|8934346|P2|Overall Study|Early Progression|0
2583727|NCT01193517|8934347|P1|Overall Study|Early Progression|1
2583728|NCT01193348|8934356|P1|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2
2583729|NCT01193348|8934356|P1|Extension Treatment Period|Physician Decision|1
2583730|NCT01193348|8934356|P1|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1
2583731|NCT01193348|8934356|P1|Treatment Period (26 Weeks)|Serious Adverse Event|1
2583732|NCT01193348|8934356|P1|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1
2583733|NCT01193348|8934356|P1|Screening Period|Screen Failure|5
2583734|NCT01193335|8934376|P2|2-Year Follow-up|No Longer Met Eligibility Criteria|2
2583735|NCT01193335|8934377|P1|2-Year Follow-up|No Longer Met Eligibility Criteria|2
2583736|NCT01193335|8934376|P2|2-Year Follow-up|No Longer Willing to Participate|6
2583737|NCT01193335|8934377|P1|2-Year Follow-up|No Longer Willing to Participate|5
2583738|NCT01193335|8934376|P2|1-Year Follow-up|Lost to Follow-up|0
2583739|NCT01193335|8934377|P1|1-Year Follow-up|Lost to Follow-up|4
2583740|NCT01193335|8934376|P2|1-Year Follow-up|No Longer Willing to Participate|9
2583741|NCT01193335|8934377|P1|1-Year Follow-up|No Longer Willing to Participate|7
2583742|NCT01193335|8934376|P2|After Infant Series|No Longer Met Eligibility Criteria|1
2583743|NCT01193335|8934377|P1|After Infant Series|No Longer Met Eligibility Criteria|0
2583744|NCT01193335|8934376|P2|After Infant Series|Lost to Follow-up|2
2583745|NCT01193335|8934377|P1|After Infant Series|Lost to Follow-up|1
2583746|NCT01193283|8934472|P1|Overall Study|Death|1
2583747|NCT01193257|8934478|P2|Overall Study|Unblinded due to futility|251
2583748|NCT01193257|8934479|P1|Overall Study|Unblinded due to futility|135
2583749|NCT01193257|8934478|P2|Overall Study|Lost to Follow-up|3
2583750|NCT01193257|8934479|P1|Overall Study|Lost to Follow-up|2
2583751|NCT01193257|8934478|P2|Overall Study|Withdrawal by Subject|86
2583752|NCT01193257|8934479|P1|Overall Study|Withdrawal by Subject|26
2583753|NCT01193257|8934478|P2|Overall Study|Study termination by sponsor|3
2583754|NCT01193257|8934479|P1|Overall Study|Study termination by sponsor|0
2583755|NCT01193257|8934478|P2|Overall Study|Death|391
2583756|NCT01193257|8934479|P1|Overall Study|Death|202
2583757|NCT01193244|8934529|P2|Overall Study|Lost to Follow-up|15
2583758|NCT01193244|8934530|P1|Overall Study|Lost to Follow-up|6
2583759|NCT01193244|8934529|P2|Overall Study|Other|278
2583760|NCT01193244|8934530|P1|Overall Study|Other|303
2583761|NCT01193244|8934529|P2|Overall Study|Withdrawal by Subject|97
2583762|NCT01193244|8934530|P1|Overall Study|Withdrawal by Subject|79
2583763|NCT01193218|8934585|P8|12-52 Weeks|Other reason than above|0
2583764|NCT01193218|8934586|P7|12-52 Weeks|Other reason than above|0
2583765|NCT01193218|8934587|P6|12-52 Weeks|Other reason than above|0
2583766|NCT01193218|8934588|P5|12-52 Weeks|Other reason than above|1
2583767|NCT01193218|8934589|P4|12-52 Weeks|Other reason than above|1
2583768|NCT01193218|8934590|P3|12-52 Weeks|Other reason than above|0
2583769|NCT01193218|8934591|P2|12-52 Weeks|Other reason than above|0
2583770|NCT01193218|8934592|P1|12-52 Weeks|Other reason than above|1
2583771|NCT01193218|8934585|P8|12-52 Weeks|Withdrawal by Subject|2
2583772|NCT01193218|8934586|P7|12-52 Weeks|Withdrawal by Subject|1
2583773|NCT01193218|8934587|P6|12-52 Weeks|Withdrawal by Subject|2
2583774|NCT01193218|8934588|P5|12-52 Weeks|Withdrawal by Subject|0
2583775|NCT01193218|8934589|P4|12-52 Weeks|Withdrawal by Subject|0
2583776|NCT01193218|8934590|P3|12-52 Weeks|Withdrawal by Subject|3
2583777|NCT01193218|8934591|P2|12-52 Weeks|Withdrawal by Subject|0
2583778|NCT01193218|8934592|P1|12-52 Weeks|Withdrawal by Subject|3
2583779|NCT01193218|8934585|P8|12-52 Weeks|Lack of Efficacy|0
2583780|NCT01193218|8934586|P7|12-52 Weeks|Lack of Efficacy|1
2583781|NCT01193218|8934587|P6|12-52 Weeks|Lack of Efficacy|0
2583782|NCT01193218|8934588|P5|12-52 Weeks|Lack of Efficacy|0
2583783|NCT01193218|8934589|P4|12-52 Weeks|Lack of Efficacy|0
2583784|NCT01193218|8934590|P3|12-52 Weeks|Lack of Efficacy|0
2583785|NCT01193218|8934591|P2|12-52 Weeks|Lack of Efficacy|0
2583786|NCT01193218|8934592|P1|12-52 Weeks|Lack of Efficacy|0
2583787|NCT01193218|8934585|P8|12-52 Weeks|Adverse Event|2
2583788|NCT01193218|8934586|P7|12-52 Weeks|Adverse Event|1
2583789|NCT01193218|8934587|P6|12-52 Weeks|Adverse Event|3
2583790|NCT01193218|8934588|P5|12-52 Weeks|Adverse Event|3
2583791|NCT01193218|8934589|P4|12-52 Weeks|Adverse Event|2
2583792|NCT01193218|8934590|P3|12-52 Weeks|Adverse Event|1
2583793|NCT01193218|8934591|P2|12-52 Weeks|Adverse Event|0
2583794|NCT01193218|8934592|P1|12-52 Weeks|Adverse Event|1
2583795|NCT01193218|8934585|P8|0-12 Weeks|Withdrawal by Subject|0
2583796|NCT01193218|8934586|P7|0-12 Weeks|Withdrawal by Subject|1
2583797|NCT01193218|8934587|P6|0-12 Weeks|Withdrawal by Subject|0
2583798|NCT01193218|8934588|P5|0-12 Weeks|Withdrawal by Subject|0
2583799|NCT01193218|8934589|P4|0-12 Weeks|Withdrawal by Subject|0
2583800|NCT01193218|8934590|P3|0-12 Weeks|Withdrawal by Subject|2
2583801|NCT01193218|8934591|P2|0-12 Weeks|Withdrawal by Subject|0
2583802|NCT01193218|8934592|P1|0-12 Weeks|Withdrawal by Subject|3
2583803|NCT01193218|8934585|P8|0-12 Weeks|Protocol Violation|0
2583804|NCT01193218|8934586|P7|0-12 Weeks|Protocol Violation|0
2583805|NCT01193218|8934587|P6|0-12 Weeks|Protocol Violation|1
2583806|NCT01193218|8934588|P5|0-12 Weeks|Protocol Violation|1
2583807|NCT01193218|8934589|P4|0-12 Weeks|Protocol Violation|0
2583808|NCT01193218|8934590|P3|0-12 Weeks|Protocol Violation|0
2583809|NCT01193218|8934591|P2|0-12 Weeks|Protocol Violation|0
2583810|NCT01193218|8934592|P1|0-12 Weeks|Protocol Violation|0
2583811|NCT01193218|8934585|P8|0-12 Weeks|Adverse Event|0
2583812|NCT01193218|8934586|P7|0-12 Weeks|Adverse Event|2
2583813|NCT01193218|8934587|P6|0-12 Weeks|Adverse Event|2
2583814|NCT01193218|8934588|P5|0-12 Weeks|Adverse Event|0
2583815|NCT01193218|8934589|P4|0-12 Weeks|Adverse Event|0
2583816|NCT01193218|8934590|P3|0-12 Weeks|Adverse Event|1
2583817|NCT01193218|8934591|P2|0-12 Weeks|Adverse Event|0
2583818|NCT01193218|8934592|P1|0-12 Weeks|Adverse Event|6
2583819|NCT01193153|8934623|P2|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3
2583820|NCT01193153|8934624|P1|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1
2583821|NCT01193153|8934623|P2|Double Blind Relapse Prevention Period|Experienced Relapse|57
2583822|NCT01193153|8934624|P1|Double Blind Relapse Prevention Period|Experienced Relapse|25
2583823|NCT01193153|8934623|P2|Double Blind Relapse Prevention Period|Withdrawal by Subject|30
2583824|NCT01193153|8934624|P1|Double Blind Relapse Prevention Period|Withdrawal by Subject|19
2583825|NCT01193153|8934623|P2|Double Blind Relapse Prevention Period|Pregnancy|0
2583826|NCT01193153|8934624|P1|Double Blind Relapse Prevention Period|Pregnancy|1
2583827|NCT01193153|8934623|P2|Double Blind Relapse Prevention Period|Lost to Follow-up|9
2583828|NCT01193153|8934624|P1|Double Blind Relapse Prevention Period|Lost to Follow-up|2
2583829|NCT01193153|8934623|P2|Double Blind Relapse Prevention Period|Death|0
2583830|NCT01193153|8934624|P1|Double Blind Relapse Prevention Period|Death|2
2583831|NCT01193153|8934623|P2|Double Blind Relapse Prevention Period|Adverse Event|3
2583832|NCT01193153|8934624|P1|Double Blind Relapse Prevention Period|Adverse Event|12
2583833|NCT01193153|8934623|P2|Double Blind Relapse Prevention Period|Other|3
2583834|NCT01193153|8934624|P1|Double Blind Relapse Prevention Period|Other|2
2583835|NCT01193153|8934623|P2|Open-label Stabilization Period|Other|0
2583836|NCT01193153|8934624|P1|Open-label Stabilization Period|Other|8
2583837|NCT01193153|8934623|P2|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0
2583838|NCT01193153|8934624|P1|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35
2583839|NCT01193153|8934623|P2|Open-label Stabilization Period|Withdrawal by Subject|0
2583840|NCT01193153|8934624|P1|Open-label Stabilization Period|Withdrawal by Subject|29
2583841|NCT01193153|8934623|P2|Open-label Stabilization Period|Lack of Efficacy|0
2583842|NCT01193153|8934624|P1|Open-label Stabilization Period|Lack of Efficacy|5
2583843|NCT01193153|8934623|P2|Open-label Stabilization Period|Lost to Follow-up|0
2583844|NCT01193153|8934624|P1|Open-label Stabilization Period|Lost to Follow-up|10
2583845|NCT01193153|8934623|P2|Open-label Stabilization Period|Death|0
2583846|NCT01193153|8934624|P1|Open-label Stabilization Period|Death|2
2583847|NCT01193153|8934623|P2|Open-label Stabilization Period|Adverse Event|0
2583848|NCT01193153|8934624|P1|Open-label Stabilization Period|Adverse Event|9
2583849|NCT01193153|8934623|P2|Open-label Lead in Period|Lack of Efficacy|0
2583850|NCT01193153|8934624|P1|Open-label Lead in Period|Lack of Efficacy|26
2583851|NCT01193153|8934623|P2|Open-label Lead in Period|Death|0
2583852|NCT01193153|8934624|P1|Open-label Lead in Period|Death|1
2583853|NCT01193153|8934623|P2|Open-label Lead in Period|Adverse Event|0
2583854|NCT01193153|8934624|P1|Open-label Lead in Period|Adverse Event|41
2583855|NCT01193153|8934623|P2|Open-label Lead in Period|Subject Failed Stabilization Criteria|0
2583856|NCT01193153|8934624|P1|Open-label Lead in Period|Subject Failed Stabilization Criteria|47
2583857|NCT01193153|8934623|P2|Open-label Lead in Period|Other|0
2583858|NCT01193153|8934624|P1|Open-label Lead in Period|Other|14
2583859|NCT01193153|8934623|P2|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0
2583860|NCT01193153|8934624|P1|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4
2583861|NCT01193153|8934623|P2|Open-label Lead in Period|Withdrawal by Subject|0
2583862|NCT01193153|8934624|P1|Open-label Lead in Period|Withdrawal by Subject|69
2583863|NCT01193153|8934623|P2|Open-label Lead in Period|Pregnancy|0
2583864|NCT01193153|8934624|P1|Open-label Lead in Period|Pregnancy|1
2583865|NCT01193153|8934623|P2|Open-label Lead in Period|Lost to Follow-up|0
2583866|NCT01193153|8934624|P1|Open-label Lead in Period|Lost to Follow-up|32
2583867|NCT01193127|8934659|P4|Treated|Withdrawal by Subject|1
2583868|NCT01193127|8934660|P3|Treated|Withdrawal by Subject|0
2583869|NCT01193127|8934661|P2|Treated|Withdrawal by Subject|0
2583870|NCT01193127|8934662|P1|Treated|Withdrawal by Subject|0
2583871|NCT01193127|8934659|P4|Randomized|Surgery Cancelled|1
2583872|NCT01193127|8934660|P3|Randomized|Surgery Cancelled|0
2583873|NCT01193127|8934661|P2|Randomized|Surgery Cancelled|0
2583874|NCT01193127|8934662|P1|Randomized|Surgery Cancelled|0
2583875|NCT01193101|8934987|P4|Overall Study|Abnormal test procedure results|0
2583876|NCT01193101|8934988|P3|Overall Study|Abnormal test procedure results|0
2583877|NCT01193101|8934989|P2|Overall Study|Abnormal test procedure results|1
2583878|NCT01193101|8934990|P1|Overall Study|Abnormal test procedure results|0
2583879|NCT01193101|8934987|P4|Overall Study|Administrative problems|0
2583880|NCT01193101|8934988|P3|Overall Study|Administrative problems|1
2583881|NCT01193101|8934989|P2|Overall Study|Administrative problems|0
2583882|NCT01193101|8934990|P1|Overall Study|Administrative problems|0
2583883|NCT01193101|8934987|P4|Overall Study|Withdrawal by Subject|1
2583884|NCT01193101|8934988|P3|Overall Study|Withdrawal by Subject|1
2583885|NCT01193101|8934989|P2|Overall Study|Withdrawal by Subject|4
2583886|NCT01193101|8934990|P1|Overall Study|Withdrawal by Subject|2
2583887|NCT01193101|8934987|P4|Overall Study|Lack of Efficacy|8
2583888|NCT01193101|8934988|P3|Overall Study|Lack of Efficacy|0
2583889|NCT01193101|8934989|P2|Overall Study|Lack of Efficacy|1
2583890|NCT01193101|8934990|P1|Overall Study|Lack of Efficacy|3
2583891|NCT01193101|8934987|P4|Overall Study|Adverse Event|3
2583892|NCT01193101|8934988|P3|Overall Study|Adverse Event|1
2583893|NCT01193101|8934989|P2|Overall Study|Adverse Event|1
2583894|NCT01193101|8934990|P1|Overall Study|Adverse Event|0
2583895|NCT01192776|8935111|P4|Overall Study|Lost to Follow-up|5
2583896|NCT01192776|8935112|P3|Overall Study|Lost to Follow-up|3
2583897|NCT01192776|8935113|P2|Overall Study|Lost to Follow-up|6
2583898|NCT01192776|8935114|P1|Overall Study|Lost to Follow-up|3
2583899|NCT01192776|8935111|P4|Overall Study|Death|15
2583900|NCT01192776|8935112|P3|Overall Study|Death|18
2583901|NCT01192776|8935113|P2|Overall Study|Death|15
2583902|NCT01192776|8935114|P1|Overall Study|Death|8
2583903|NCT01192516|8935192|P3|Overall Study|Unable to follow Actiwatch instructions|0
2583904|NCT01192516|8935193|P2|Overall Study|Unable to follow Actiwatch instructions|2
2583905|NCT01192516|8935194|P1|Overall Study|Unable to follow Actiwatch instructions|4
2583906|NCT01192516|8935192|P3|Overall Study|started new treatment|0
2583907|NCT01192516|8935193|P2|Overall Study|started new treatment|1
2583908|NCT01192516|8935194|P1|Overall Study|started new treatment|5
2583909|NCT01192516|8935192|P3|Overall Study|Withdrawal by Subject|1
2583910|NCT01192516|8935193|P2|Overall Study|Withdrawal by Subject|4
2583911|NCT01192516|8935194|P1|Overall Study|Withdrawal by Subject|4
2583912|NCT01192516|8935192|P3|Overall Study|Lost to Follow-up|7
2583913|NCT01192516|8935193|P2|Overall Study|Lost to Follow-up|10
2583914|NCT01192516|8935194|P1|Overall Study|Lost to Follow-up|7
2583915|NCT01192412|8935228|P2|Overall Study|Withdrawal by Subject|1
2583916|NCT01192412|8935229|P1|Overall Study|Withdrawal by Subject|2
2583917|NCT01192412|8935228|P2|Overall Study|Lost to Follow-up|1
2583918|NCT01192412|8935229|P1|Overall Study|Lost to Follow-up|2
2583919|NCT01192399|8935237|P1|Overall Study|Lack of Efficacy|2
2583920|NCT01192347|8935247|P1|Overall Study|Patient did not show up for visits|1
2583921|NCT01192347|8935247|P1|Overall Study|Patient not visiting hospital regularly|1
2583922|NCT01192347|8935247|P1|Overall Study|Patient seen in different hospital|1
2583923|NCT01192347|8935247|P1|Overall Study|Suspected serious adverse drug reaction|1
2583924|NCT01192347|8935247|P1|Overall Study|Adverse Event|1
2583925|NCT01192347|8935247|P1|Overall Study|Withdrawal by Subject|1
2583926|NCT01192347|8935247|P1|Overall Study|Lost to Follow-up|3
2583927|NCT01192347|8935247|P1|Overall Study|Death|3
2583928|NCT01192295|8935270|P2|Overall Study|Administrative|6
2583929|NCT01192295|8935271|P1|Overall Study|Administrative|4
2583930|NCT01192295|8935270|P2|Overall Study|Lack of Efficacy|5
2583931|NCT01192295|8935271|P1|Overall Study|Lack of Efficacy|0
2583932|NCT01192295|8935270|P2|Overall Study|Lost to Follow-up|1
2583933|NCT01192295|8935271|P1|Overall Study|Lost to Follow-up|0
2583934|NCT01192295|8935270|P2|Overall Study|Withdrawal by Subject|4
2583935|NCT01192295|8935271|P1|Overall Study|Withdrawal by Subject|3
2583936|NCT01192295|8935270|P2|Overall Study|Adverse Event|7
2583937|NCT01192295|8935271|P1|Overall Study|Adverse Event|3
2583938|NCT01192204|8935309|P2|Overall Study|could not keep recall appointments|0
2583939|NCT01192204|8935310|P1|Overall Study|could not keep recall appointments|1
2583940|NCT01192191|8935322|P2|Overall Study|Withdrawal by Subject|6
2583941|NCT01192191|8935323|P1|Overall Study|Withdrawal by Subject|1
2583942|NCT01192191|8935322|P2|Overall Study|Lost to Follow-up|1
2583943|NCT01192191|8935323|P1|Overall Study|Lost to Follow-up|0
2583944|NCT01192191|8935322|P2|Overall Study|Participants Reached Stopping Criteria|2
2583945|NCT01192191|8935323|P1|Overall Study|Participants Reached Stopping Criteria|3
2583946|NCT01192191|8935322|P2|Overall Study|Adverse Event|12
2583947|NCT01192191|8935323|P1|Overall Study|Adverse Event|7
2583948|NCT01192178|8935349|P2|Overall Study|Lack of Efficacy|2
2583949|NCT01192178|8935350|P1|Overall Study|Lack of Efficacy|1
2583950|NCT01192178|8935349|P2|Overall Study|Adverse Event|1
2583951|NCT01192178|8935350|P1|Overall Study|Adverse Event|2
2583952|NCT01192178|8935349|P2|Overall Study|Lost to Follow-up|3
2583953|NCT01192178|8935350|P1|Overall Study|Lost to Follow-up|3
2583954|NCT01192178|8935349|P2|Overall Study|Physician Decision|4
2583955|NCT01192178|8935350|P1|Overall Study|Physician Decision|2
2583956|NCT01192178|8935349|P2|Overall Study|Protocol Violation|3
2583957|NCT01192178|8935350|P1|Overall Study|Protocol Violation|10
2583958|NCT01192178|8935349|P2|Overall Study|Withdrawal by Subject|10
2583959|NCT01192178|8935350|P1|Overall Study|Withdrawal by Subject|6
2583960|NCT01192152|8935370|P2|Period 3|family emergency|0
2583961|NCT01192152|8935371|P1|Period 3|family emergency|1
2583962|NCT01192152|8935370|P2|Period 1|left prematurely (while on treatment B)|1
2583963|NCT01192152|8935371|P1|Period 1|left prematurely (while on treatment B)|0
2583964|NCT01192126|8935542|P2|First Intervention (1 Week)|Lost to Follow-up|1
2583965|NCT01192126|8935543|P1|First Intervention (1 Week)|Lost to Follow-up|1
2583966|NCT01192126|8935542|P2|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0
2583967|NCT01192126|8935543|P1|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1
2583968|NCT01192100|8935551|P6|Overall Study|Protocol Violation|0
2583969|NCT01192100|8935552|P5|Overall Study|Protocol Violation|0
2583970|NCT01192100|8935553|P4|Overall Study|Protocol Violation|1
2583971|NCT01192100|8935554|P3|Overall Study|Protocol Violation|0
2583972|NCT01192100|8935555|P2|Overall Study|Protocol Violation|0
2583973|NCT01192100|8935556|P1|Overall Study|Protocol Violation|0
2583974|NCT01192100|8935551|P6|Overall Study|Withdrawal by Subject|0
2583975|NCT01192100|8935552|P5|Overall Study|Withdrawal by Subject|1
2583976|NCT01192100|8935553|P4|Overall Study|Withdrawal by Subject|0
2583977|NCT01192100|8935554|P3|Overall Study|Withdrawal by Subject|0
2583978|NCT01192100|8935555|P2|Overall Study|Withdrawal by Subject|0
2583979|NCT01192100|8935556|P1|Overall Study|Withdrawal by Subject|0
2583980|NCT01192022|8935576|P5|Overall Study|Parents did not allow all follow up|0
2583981|NCT01192022|8935577|P4|Overall Study|Parents did not allow all follow up|1
2583982|NCT01192022|8935578|P3|Overall Study|Parents did not allow all follow up|0
2583983|NCT01192022|8935579|P2|Overall Study|Parents did not allow all follow up|0
2583984|NCT01192022|8935580|P1|Overall Study|Parents did not allow all follow up|0
2583985|NCT01192022|8935576|P5|Overall Study|Patient needed surgery|0
2583986|NCT01192022|8935577|P4|Overall Study|Patient needed surgery|0
2583987|NCT01192022|8935578|P3|Overall Study|Patient needed surgery|0
2583988|NCT01192022|8935579|P2|Overall Study|Patient needed surgery|1
2583989|NCT01192022|8935580|P1|Overall Study|Patient needed surgery|0
2583990|NCT01192022|8935576|P5|Overall Study|Patient too sick from chemotherapy|0
2583991|NCT01192022|8935577|P4|Overall Study|Patient too sick from chemotherapy|0
2583992|NCT01192022|8935578|P3|Overall Study|Patient too sick from chemotherapy|0
2583993|NCT01192022|8935579|P2|Overall Study|Patient too sick from chemotherapy|1
2583994|NCT01192022|8935580|P1|Overall Study|Patient too sick from chemotherapy|0
2583995|NCT01192022|8935576|P5|Overall Study|Physician withdrew-patient hardship|0
2583996|NCT01192022|8935577|P4|Overall Study|Physician withdrew-patient hardship|0
2583997|NCT01192022|8935578|P3|Overall Study|Physician withdrew-patient hardship|0
2583998|NCT01192022|8935579|P2|Overall Study|Physician withdrew-patient hardship|0
2583999|NCT01192022|8935580|P1|Overall Study|Physician withdrew-patient hardship|1
2584000|NCT01192022|8935576|P5|Overall Study|Fatal Adverse Event|1
2584001|NCT01192022|8935577|P4|Overall Study|Fatal Adverse Event|0
2584002|NCT01192022|8935578|P3|Overall Study|Fatal Adverse Event|0
2584003|NCT01192022|8935579|P2|Overall Study|Fatal Adverse Event|6
2584004|NCT01192022|8935580|P1|Overall Study|Fatal Adverse Event|4
2584005|NCT01192022|8935576|P5|Overall Study|Adverse Event|0
2584006|NCT01192022|8935577|P4|Overall Study|Adverse Event|0
2584007|NCT01192022|8935578|P3|Overall Study|Adverse Event|0
2584008|NCT01192022|8935579|P2|Overall Study|Adverse Event|0
2584009|NCT01192022|8935580|P1|Overall Study|Adverse Event|1
2584010|NCT01192022|8935576|P5|Overall Study|Lost to Follow-up|0
2584011|NCT01192022|8935577|P4|Overall Study|Lost to Follow-up|1
2584012|NCT01192022|8935578|P3|Overall Study|Lost to Follow-up|1
2584013|NCT01192022|8935579|P2|Overall Study|Lost to Follow-up|2
2584014|NCT01192022|8935580|P1|Overall Study|Lost to Follow-up|4
2584015|NCT01192022|8935576|P5|Overall Study|Withdrawal of Consent|0
2584016|NCT01192022|8935577|P4|Overall Study|Withdrawal of Consent|0
2584017|NCT01192022|8935578|P3|Overall Study|Withdrawal of Consent|0
2584018|NCT01192022|8935579|P2|Overall Study|Withdrawal of Consent|1
2584019|NCT01192022|8935580|P1|Overall Study|Withdrawal of Consent|3
2584020|NCT01191944|8935603|P2|Overall Study|Other|3
2584021|NCT01191944|8935604|P1|Overall Study|Other|1
2584022|NCT01191944|8935603|P2|Overall Study|Withdrawal by Subject|2
2584023|NCT01191944|8935604|P1|Overall Study|Withdrawal by Subject|4
2584024|NCT01191944|8935603|P2|Overall Study|Protocol Violation|2
2584025|NCT01191944|8935604|P1|Overall Study|Protocol Violation|1
2584026|NCT01191944|8935603|P2|Overall Study|Adverse Event|12
2584027|NCT01191944|8935604|P1|Overall Study|Adverse Event|11
2584028|NCT01191840|8935650|P2|Overall Study|Withdrawal by Subject|0
2584029|NCT01191840|8935651|P1|Overall Study|Withdrawal by Subject|2
2584030|NCT01191840|8935650|P2|Overall Study|lab error speciation - non Staph infecti|1
2584031|NCT01191840|8935651|P1|Overall Study|lab error speciation - non Staph infecti|0
2584032|NCT01191840|8935650|P2|Overall Study|IRB approval lapse|2
2584033|NCT01191840|8935651|P1|Overall Study|IRB approval lapse|0
2584034|NCT01191840|8935650|P2|Overall Study|ineligible at enrollment|0
2584035|NCT01191840|8935651|P1|Overall Study|ineligible at enrollment|1
2584036|NCT01191840|8935650|P2|Overall Study|Non Staph Infection|3
2584037|NCT01191840|8935651|P1|Overall Study|Non Staph Infection|4
2584038|NCT01191840|8935650|P2|Overall Study|Lost to Follow-up|6
2584039|NCT01191840|8935651|P1|Overall Study|Lost to Follow-up|4
2584040|NCT01191840|8935650|P2|Overall Study|Subject discontinued treatment|2
2584041|NCT01191840|8935651|P1|Overall Study|Subject discontinued treatment|1
2584042|NCT01191840|8935650|P2|Overall Study|withdrew consent|1
2584043|NCT01191840|8935651|P1|Overall Study|withdrew consent|2
2584044|NCT01191801|8935676|P2|Overall Study|Not Provided|27
2584045|NCT01191801|8935677|P1|Overall Study|Not Provided|45
2584046|NCT01191801|8935676|P2|Overall Study|Withdrawal by Subject|4
2584047|NCT01191801|8935677|P1|Overall Study|Withdrawal by Subject|1
2584048|NCT01191801|8935676|P2|Overall Study|Physician Decision|24
2584049|NCT01191801|8935677|P1|Overall Study|Physician Decision|47
2584050|NCT01191801|8935676|P2|Overall Study|Protocol Violation|4
2584051|NCT01191801|8935677|P1|Overall Study|Protocol Violation|2
2584052|NCT01191801|8935676|P2|Overall Study|Adverse Event|8
2584053|NCT01191801|8935677|P1|Overall Study|Adverse Event|9
2584054|NCT01191801|8935676|P2|Overall Study|Lack of Efficacy|258
2584055|NCT01191801|8935677|P1|Overall Study|Lack of Efficacy|176
2584056|NCT01191801|8935676|P2|Overall Study|Death|12
2584057|NCT01191801|8935677|P1|Overall Study|Death|36
2584058|NCT01191788|8935697|P2|Overall Study|Lost to Follow-up|22
2584059|NCT01191788|8935698|P1|Overall Study|Lost to Follow-up|21
2584060|NCT01191762|8935708|P2|Overall Study|Adverse Event|0
2584061|NCT01191762|8935709|P1|Overall Study|Adverse Event|1
2584062|NCT01191268|8935867|P3|Overall Study|Sponsor Decision|0
2584063|NCT01191268|8935868|P2|Overall Study|Sponsor Decision|2
2584064|NCT01191268|8935869|P1|Overall Study|Sponsor Decision|0
2584065|NCT01191268|8935867|P3|Overall Study|Protocol Violation|1
2584066|NCT01191268|8935868|P2|Overall Study|Protocol Violation|0
2584067|NCT01191268|8935869|P1|Overall Study|Protocol Violation|1
2584068|NCT01191268|8935867|P3|Overall Study|Death|3
2584069|NCT01191268|8935868|P2|Overall Study|Death|1
2584070|NCT01191268|8935869|P1|Overall Study|Death|0
2584071|NCT01191268|8935867|P3|Overall Study|Entry Criteria Not Met|1
2584072|NCT01191268|8935868|P2|Overall Study|Entry Criteria Not Met|1
2584073|NCT01191268|8935869|P1|Overall Study|Entry Criteria Not Met|3
2584074|NCT01191268|8935867|P3|Overall Study|Lost to Follow-up|9
2584075|NCT01191268|8935868|P2|Overall Study|Lost to Follow-up|5
2584076|NCT01191268|8935869|P1|Overall Study|Lost to Follow-up|8
2584077|NCT01191268|8935867|P3|Overall Study|Physician Decision|9
2584078|NCT01191268|8935868|P2|Overall Study|Physician Decision|8
2584079|NCT01191268|8935869|P1|Overall Study|Physician Decision|6
2584080|NCT01191268|8935867|P3|Overall Study|Adverse Event|8
2584081|NCT01191268|8935868|P2|Overall Study|Adverse Event|13
2584082|NCT01191268|8935869|P1|Overall Study|Adverse Event|21
2584083|NCT01191268|8935867|P3|Overall Study|Withdrawal by Subject|21
2584084|NCT01191268|8935868|P2|Overall Study|Withdrawal by Subject|25
2584085|NCT01191268|8935869|P1|Overall Study|Withdrawal by Subject|19
2584086|NCT01191190|8936010|P1|Overall Study|Withdrawal by Subject|1
2584087|NCT01191086|8936023|P1|Overall Study|Other|1
2584088|NCT01191086|8936023|P1|Overall Study|Discontinuation criterion met|1
2584089|NCT01191086|8936023|P1|Overall Study|Withdrawal by Subject|24
2584090|NCT01191086|8936023|P1|Overall Study|Physician Decision|2
2584091|NCT01191086|8936023|P1|Overall Study|Lost to Follow-up|4
2584092|NCT01191086|8936023|P1|Overall Study|Lack of Efficacy|10
2584093|NCT01191086|8936023|P1|Overall Study|Adverse Event|20
2584094|NCT01191008|8936027|P1|Overall Study|Lost to Follow-up|8
2584095|NCT01191008|8936027|P1|Overall Study|Protocol Violation|7
2584096|NCT01190891|8936035|P2|Overall Study|Withdrawal by Subject|0
2584097|NCT01190891|8936036|P1|Overall Study|Withdrawal by Subject|5
2584098|NCT01190891|8936035|P2|Overall Study|Protocol Violation|0
2584099|NCT01190891|8936036|P1|Overall Study|Protocol Violation|1
2584100|NCT01190865|8936061|P1|Overall Study|Non-compliance|2
2584101|NCT01190865|8936061|P1|Overall Study|Withdrawal by Subject|1
2584102|NCT01190839|8936068|P2|Overall Study|Randomized but not treated|4
2584103|NCT01190839|8936069|P1|Overall Study|Randomized but not treated|2
2584104|NCT01190839|8936068|P2|Overall Study|Undefined|31
2584105|NCT01190839|8936069|P1|Overall Study|Undefined|35
2584106|NCT01190839|8936068|P2|Overall Study|Trial stopped by Sponsor|68
2584107|NCT01190839|8936069|P1|Overall Study|Trial stopped by Sponsor|71
2584108|NCT01190839|8936068|P2|Overall Study|Death|0
2584109|NCT01190839|8936069|P1|Overall Study|Death|1
2584110|NCT01190839|8936068|P2|Overall Study|Lost to Follow-up|1
2584111|NCT01190839|8936069|P1|Overall Study|Lost to Follow-up|7
2584112|NCT01190839|8936068|P2|Overall Study|Protocol Violation|2
2584113|NCT01190839|8936069|P1|Overall Study|Protocol Violation|2
2584114|NCT01190839|8936068|P2|Overall Study|Adverse Event|41
2584115|NCT01190839|8936069|P1|Overall Study|Adverse Event|32
2584116|NCT01190813|8936083|P2|Overall Study|Adverse Event|1
2584117|NCT01190813|8936084|P1|Overall Study|Adverse Event|0
2584118|NCT01190813|8936083|P2|Overall Study|Refused study treatment after randomized|0
2584119|NCT01190813|8936084|P1|Overall Study|Refused study treatment after randomized|1
2584120|NCT01190813|8936083|P2|Overall Study|Withdrawal by Subject|1
2584121|NCT01190813|8936084|P1|Overall Study|Withdrawal by Subject|2
2584122|NCT01190813|8936083|P2|Overall Study|Lost to Follow-up|2
2584123|NCT01190813|8936084|P1|Overall Study|Lost to Follow-up|1
2584124|NCT01190514|8936205|P4|Third Intervention (Period 3)|Adverse Event|0
2584125|NCT01190514|8936206|P3|Third Intervention (Period 3)|Adverse Event|0
2584126|NCT01190514|8936207|P2|Third Intervention (Period 3)|Adverse Event|0
2584127|NCT01190514|8936208|P1|Third Intervention (Period 3)|Adverse Event|1
2584128|NCT01190514|8936205|P4|First Intervention (Period 1)|Adverse Event|0
2584129|NCT01190514|8936206|P3|First Intervention (Period 1)|Adverse Event|0
2584130|NCT01190514|8936207|P2|First Intervention (Period 1)|Adverse Event|0
2584131|NCT01190514|8936208|P1|First Intervention (Period 1)|Adverse Event|1
2584132|NCT01190449|8936253|P2|Overall Study|Ineligible|4
2584133|NCT01190449|8936254|P1|Overall Study|Ineligible|0
2584134|NCT01190436|8936262|P1|Overall Study|Other|4
2584135|NCT01190436|8936262|P1|Overall Study|Lost to Follow-up|35
2584136|NCT01190410|8936278|P2|Overall Study|PI discretion|2
2584137|NCT01190410|8936279|P1|Overall Study|PI discretion|0
2584138|NCT01190410|8936278|P2|Overall Study|Administrative decision|0
2584139|NCT01190410|8936279|P1|Overall Study|Administrative decision|1
2584140|NCT01190410|8936278|P2|Overall Study|Withdrawal by Subject|2
2584141|NCT01190410|8936279|P1|Overall Study|Withdrawal by Subject|0
2584142|NCT01190410|8936278|P2|Overall Study|Lack of Efficacy|2
2584143|NCT01190410|8936279|P1|Overall Study|Lack of Efficacy|0
2584144|NCT01190410|8936278|P2|Overall Study|Adverse Event|3
2584145|NCT01190410|8936279|P1|Overall Study|Adverse Event|0
2584146|NCT01190267|8936307|P2|Overall Study|Protocol Violation|1
2584147|NCT01190267|8936308|P1|Overall Study|Protocol Violation|8
2584148|NCT01190267|8936307|P2|Overall Study|Withdrawal by Subject|1
2584149|NCT01190267|8936308|P1|Overall Study|Withdrawal by Subject|13
2584150|NCT01190267|8936307|P2|Overall Study|Lost to Follow-up|0
2584151|NCT01190267|8936308|P1|Overall Study|Lost to Follow-up|2
2584152|NCT01190267|8936307|P2|Overall Study|Treatment Failure|2
2584153|NCT01190267|8936308|P1|Overall Study|Treatment Failure|8
2584154|NCT01190267|8936307|P2|Overall Study|Adverse Event|0
2584155|NCT01190267|8936308|P1|Overall Study|Adverse Event|10
2584156|NCT01190254|8936319|P3|Overall Study|Did not meet protocol eligibility|0
2584157|NCT01190254|8936320|P2|Overall Study|Did not meet protocol eligibility|0
2584158|NCT01190254|8936321|P1|Overall Study|Did not meet protocol eligibility|1
2584159|NCT01190254|8936319|P3|Overall Study|Protocol Violation|2
2584160|NCT01190254|8936320|P2|Overall Study|Protocol Violation|0
2584161|NCT01190254|8936321|P1|Overall Study|Protocol Violation|2
2584162|NCT01190254|8936319|P3|Overall Study|Withdrawal by Subject|7
2584163|NCT01190254|8936320|P2|Overall Study|Withdrawal by Subject|5
2584164|NCT01190254|8936321|P1|Overall Study|Withdrawal by Subject|4
2584165|NCT01190254|8936319|P3|Overall Study|Lost to Follow-up|0
2584166|NCT01190254|8936320|P2|Overall Study|Lost to Follow-up|2
2584167|NCT01190254|8936321|P1|Overall Study|Lost to Follow-up|4
2584168|NCT01190254|8936319|P3|Overall Study|Lack of Efficacy|5
2584169|NCT01190254|8936320|P2|Overall Study|Lack of Efficacy|4
2584170|NCT01190254|8936321|P1|Overall Study|Lack of Efficacy|7
2584171|NCT01190254|8936319|P3|Overall Study|Adverse Event|8
2584172|NCT01190254|8936320|P2|Overall Study|Adverse Event|6
2584173|NCT01190254|8936321|P1|Overall Study|Adverse Event|3
2584174|NCT01190228|8936386|P3|Overall Study|Withdrawal by Subject|0
2584175|NCT01190228|8936387|P2|Overall Study|Withdrawal by Subject|0
2584176|NCT01190228|8936388|P1|Overall Study|Withdrawal by Subject|1
2584177|NCT01190228|8936386|P3|Overall Study|Protocol Violation|0
2584178|NCT01190228|8936387|P2|Overall Study|Protocol Violation|0
2584179|NCT01190228|8936388|P1|Overall Study|Protocol Violation|4
2584180|NCT01190215|8936411|P2|Up to Month 6|Lost to Follow-up|0
2584181|NCT01190215|8936412|P1|Up to Month 6|Lost to Follow-up|2
2584182|NCT01190189|8936480|P1|Overall Study|Migrated/moved from study area|1
2584183|NCT01190189|8936480|P1|Overall Study|Withdrawal by Subject|1
2584184|NCT01190189|8936480|P1|Overall Study|Lost to Follow-up|4
2584185|NCT01190176|8936487|P1|Overall Study|Lost to Follow-up|1
2584186|NCT01190176|8936487|P1|Overall Study|Withdrawal by Subject|1
2584187|NCT01190150|8936508|P2|Washout|Difficulty in adherence|1
2584188|NCT01190150|8936509|P1|Washout|Difficulty in adherence|0
2584189|NCT01190150|8936508|P2|Washout|Withdrawal by Subject|1
2584190|NCT01190150|8936509|P1|Washout|Withdrawal by Subject|0
2584191|NCT01190150|8936508|P2|First Treatment|Withdrawal by Subject|0
2584192|NCT01190150|8936509|P1|First Treatment|Withdrawal by Subject|1
2584193|NCT01190124|8936536|P3|Overall Study|Lost to Follow-up|0
2584194|NCT01190124|8936537|P2|Overall Study|Lost to Follow-up|0
2584195|NCT01190124|8936538|P1|Overall Study|Lost to Follow-up|2
2584196|NCT01190124|8936536|P3|Overall Study|Therapeutic Failure|1
2584197|NCT01190124|8936537|P2|Overall Study|Therapeutic Failure|0
2584198|NCT01190124|8936538|P1|Overall Study|Therapeutic Failure|12
2584199|NCT01190124|8936536|P3|Overall Study|Death|0
2584200|NCT01190124|8936537|P2|Overall Study|Death|0
2584201|NCT01190124|8936538|P1|Overall Study|Death|3
2584202|NCT01190098|8936576|P2|Overall Study|Other|1
2584203|NCT01190098|8936577|P1|Overall Study|Other|0
2584204|NCT01190098|8936576|P2|Overall Study|Lack of transportation|0
2584205|NCT01190098|8936577|P1|Overall Study|Lack of transportation|1
2584206|NCT01190098|8936576|P2|Overall Study|Patient coomorbidity|1
2584207|NCT01190098|8936577|P1|Overall Study|Patient coomorbidity|0
2584208|NCT01190098|8936576|P2|Overall Study|Adverse Event|0
2584209|NCT01190098|8936577|P1|Overall Study|Adverse Event|2
2584210|NCT01190020|8936618|P2|Overall Study|Withdrawal by Subject|0
2584211|NCT01190020|8936619|P1|Overall Study|Withdrawal by Subject|3
2584212|NCT01190020|8936618|P2|Overall Study|Lost to Follow-up|0
2584213|NCT01190020|8936619|P1|Overall Study|Lost to Follow-up|2
2584214|NCT01190020|8936618|P2|Overall Study|Adverse Event|0
2584215|NCT01190020|8936619|P1|Overall Study|Adverse Event|2
2584216|NCT01190007|8936631|P1|Overall Study|Participant was arrested|1
2584217|NCT01190007|8936631|P1|Overall Study|Difficulty of visit for complications|1
2584218|NCT01190007|8936631|P1|Overall Study|Adverse Event|8
2584219|NCT01190007|8936631|P1|Overall Study|Withdrawal by Subject|4
2584220|NCT01189890|8936648|P2|Overall Study|Hyperglycemia Discontinuation Criteria|5
2584221|NCT01189890|8936649|P1|Overall Study|Hyperglycemia Discontinuation Criteria|5
2584222|NCT01189890|8936648|P2|Overall Study|Physician Decision|4
2584223|NCT01189890|8936649|P1|Overall Study|Physician Decision|5
2584224|NCT01189890|8936648|P2|Overall Study|Non Compliance|1
2584225|NCT01189890|8936649|P1|Overall Study|Non Compliance|0
2584226|NCT01189890|8936648|P2|Overall Study|Withdrawal by Subject|11
2584227|NCT01189890|8936649|P1|Overall Study|Withdrawal by Subject|15
2584228|NCT01189890|8936648|P2|Overall Study|Protocol Violation|5
2584229|NCT01189890|8936649|P1|Overall Study|Protocol Violation|1
2584230|NCT01189890|8936648|P2|Overall Study|Lost to Follow-up|7
2584231|NCT01189890|8936649|P1|Overall Study|Lost to Follow-up|1
2584232|NCT01189890|8936648|P2|Overall Study|Lack of Efficacy|2
2584233|NCT01189890|8936649|P1|Overall Study|Lack of Efficacy|7
2584234|NCT01189890|8936648|P2|Overall Study|Adverse Event|4
2584235|NCT01189890|8936649|P1|Overall Study|Adverse Event|3
2584236|NCT01189812|8936671|P2|Overall Study|Moved out of State|2
2584237|NCT01189812|8936672|P1|Overall Study|Moved out of State|1
2584238|NCT01189812|8936671|P2|Overall Study|Out of Window|3
2584239|NCT01189812|8936672|P1|Overall Study|Out of Window|4
2584240|NCT01189812|8936671|P2|Overall Study|Adverse Event|0
2584241|NCT01189812|8936672|P1|Overall Study|Adverse Event|1
2584242|NCT01189812|8936671|P2|Overall Study|Withdrawal by Subject|3
2584243|NCT01189812|8936672|P1|Overall Study|Withdrawal by Subject|2
2584244|NCT01189604|8936756|P7|Overall Study|Withdrawal by Subject|0
2584245|NCT01189604|8936757|P6|Overall Study|Withdrawal by Subject|0
2584246|NCT01189604|8936758|P5|Overall Study|Withdrawal by Subject|0
2584247|NCT01189604|8936759|P4|Overall Study|Withdrawal by Subject|0
2584248|NCT01189604|8936760|P3|Overall Study|Withdrawal by Subject|0
2584249|NCT01189604|8936761|P2|Overall Study|Withdrawal by Subject|0
2584250|NCT01189604|8936762|P1|Overall Study|Withdrawal by Subject|1
2584251|NCT01189604|8936756|P7|Overall Study|Adverse Event|1
2584252|NCT01189604|8936757|P6|Overall Study|Adverse Event|0
2584253|NCT01189604|8936758|P5|Overall Study|Adverse Event|2
2584254|NCT01189604|8936759|P4|Overall Study|Adverse Event|0
2584255|NCT01189604|8936760|P3|Overall Study|Adverse Event|0
2584256|NCT01189604|8936761|P2|Overall Study|Adverse Event|1
2584257|NCT01189604|8936762|P1|Overall Study|Adverse Event|0
2584258|NCT01189604|8936756|P7|Overall Study|Impossible to visit|0
2584259|NCT01189604|8936757|P6|Overall Study|Impossible to visit|1
2584260|NCT01189604|8936758|P5|Overall Study|Impossible to visit|0
2584261|NCT01189604|8936759|P4|Overall Study|Impossible to visit|0
2584262|NCT01189604|8936760|P3|Overall Study|Impossible to visit|0
2584263|NCT01189604|8936761|P2|Overall Study|Impossible to visit|0
2584264|NCT01189604|8936762|P1|Overall Study|Impossible to visit|0
2584265|NCT01189500|8936806|P1|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1
2584266|NCT01189500|8936806|P1|Period 1: TAMOX Alone|Adverse Event|1
2584267|NCT01189487|8936867|P1|Overall Study|Adverse Event|1
2584268|NCT01189487|8936867|P1|Overall Study|Lack of Efficacy|2
2584269|NCT01189461|8936875|P1|Overall Study|Other|8
2584270|NCT01189461|8936875|P1|Overall Study|Did not meet entrance criteria|3
2584271|NCT01189461|8936875|P1|Overall Study|Adverse Event|2
2584272|NCT01189461|8936875|P1|Overall Study|Protocol Violation|1
2584273|NCT01189461|8936875|P1|Overall Study|Withdrawal by Subject|6
2584274|NCT01189461|8936875|P1|Overall Study|Lost to Follow-up|1
2584275|NCT01189461|8936875|P1|Overall Study|Lack of Efficacy|13
2584276|NCT01189435|8936882|P1|Overall Study|Physician Decision|1
2584277|NCT01189435|8936882|P1|Overall Study|Withdrawal by Subject|1
2584278|NCT01189266|8936962|P3|Overall Study|No treatment|1
2584279|NCT01189266|8936963|P2|Overall Study|No treatment|0
2584280|NCT01189266|8936964|P1|Overall Study|No treatment|0
2584281|NCT01189266|8936962|P3|Overall Study|Patient refuses further therapy|7
2584282|NCT01189266|8936963|P2|Overall Study|Patient refuses further therapy|0
2584283|NCT01189266|8936964|P1|Overall Study|Patient refuses further therapy|1
2584284|NCT01189266|8936962|P3|Overall Study|Withdrawal by Subject|1
2584285|NCT01189266|8936963|P2|Overall Study|Withdrawal by Subject|0
2584286|NCT01189266|8936964|P1|Overall Study|Withdrawal by Subject|0
2584287|NCT01189266|8936962|P3|Overall Study|Protocol Violation|1
2584288|NCT01189266|8936963|P2|Overall Study|Protocol Violation|1
2584289|NCT01189266|8936964|P1|Overall Study|Protocol Violation|0
2584290|NCT01189266|8936962|P3|Overall Study|Physician Decision|1
2584291|NCT01189266|8936963|P2|Overall Study|Physician Decision|0
2584292|NCT01189266|8936964|P1|Overall Study|Physician Decision|0
2584293|NCT01189266|8936962|P3|Overall Study|Lack of Efficacy|44
2584294|NCT01189266|8936963|P2|Overall Study|Lack of Efficacy|5
2584295|NCT01189266|8936964|P1|Overall Study|Lack of Efficacy|4
2584296|NCT01189266|8936962|P3|Overall Study|Death|5
2584297|NCT01189266|8936963|P2|Overall Study|Death|0
2584298|NCT01189266|8936964|P1|Overall Study|Death|0
2584299|NCT01189266|8936962|P3|Overall Study|Adverse Event|5
2584300|NCT01189266|8936963|P2|Overall Study|Adverse Event|0
2584301|NCT01189266|8936964|P1|Overall Study|Adverse Event|1
2584302|NCT01189227|8937005|P2|Overall Study|Study terminated due to low accrual|3
2584303|NCT01189227|8937006|P1|Overall Study|Study terminated due to low accrual|6
2584304|NCT01189201|8937012|P1|Overall Study|Adverse Event|1
2584305|NCT01189032|8937115|P3|Overall Study|Protocol Violation|1
2584306|NCT01189032|8937116|P2|Overall Study|Protocol Violation|1
2584307|NCT01189032|8937117|P1|Overall Study|Protocol Violation|1
2584308|NCT01189032|8937115|P3|Overall Study|Withdrawal by Subject|1
2584309|NCT01189032|8937116|P2|Overall Study|Withdrawal by Subject|0
2584310|NCT01189032|8937117|P1|Overall Study|Withdrawal by Subject|1
2584311|NCT01189032|8937115|P3|Overall Study|Lack of Efficacy|0
2584312|NCT01189032|8937116|P2|Overall Study|Lack of Efficacy|3
2584313|NCT01189032|8937117|P1|Overall Study|Lack of Efficacy|2
2584314|NCT01189032|8937115|P3|Overall Study|Adverse Event|4
2584315|NCT01189032|8937116|P2|Overall Study|Adverse Event|3
2584316|NCT01189032|8937117|P1|Overall Study|Adverse Event|1
2584317|NCT01188967|8937127|P2|Overall Study|Lost to Follow-up|2
2584318|NCT01188967|8937128|P1|Overall Study|Lost to Follow-up|3
2584319|NCT01188967|8937127|P2|Overall Study|Physician Decision|1
2584320|NCT01188967|8937128|P1|Overall Study|Physician Decision|1
2584321|NCT01188967|8937127|P2|Overall Study|Withdrawal by Subject|1
2584322|NCT01188967|8937128|P1|Overall Study|Withdrawal by Subject|1
2584323|NCT01188811|8937181|P2|Overall Study|Adverse Event|0
2584324|NCT01188811|8937182|P1|Overall Study|Adverse Event|6
2584325|NCT01188811|8937181|P2|Overall Study|Withdrawal by Subject|2
2584326|NCT01188811|8937182|P1|Overall Study|Withdrawal by Subject|0
2584327|NCT01188798|8937194|P2|Overall Study|Protocol closure|1
2584328|NCT01188798|8937195|P1|Overall Study|Protocol closure|1
2584329|NCT01188798|8937194|P2|Overall Study|Required additional transplant|1
2584330|NCT01188798|8937195|P1|Overall Study|Required additional transplant|1
2584331|NCT01188798|8937194|P2|Overall Study|Death|1
2584332|NCT01188798|8937195|P1|Overall Study|Death|0
2584333|NCT01188772|8937207|P4|Overall Study|Withdrawal by Subject|0
2584334|NCT01188772|8937208|P3|Overall Study|Withdrawal by Subject|2
2584335|NCT01188772|8937209|P2|Overall Study|Withdrawal by Subject|0
2584336|NCT01188772|8937210|P1|Overall Study|Withdrawal by Subject|0
2584337|NCT01188772|8937207|P4|Overall Study|Virologic Failure|0
2584338|NCT01188772|8937208|P3|Overall Study|Virologic Failure|0
2584339|NCT01188772|8937209|P2|Overall Study|Virologic Failure|0
2584340|NCT01188772|8937210|P1|Overall Study|Virologic Failure|1
2584341|NCT01188772|8937207|P4|Overall Study|Treatment Failure|0
2584342|NCT01188772|8937208|P3|Overall Study|Treatment Failure|1
2584343|NCT01188772|8937209|P2|Overall Study|Treatment Failure|0
2584344|NCT01188772|8937210|P1|Overall Study|Treatment Failure|0
2584345|NCT01188772|8937207|P4|Overall Study|Terminated by Sponsor|0
2584346|NCT01188772|8937208|P3|Overall Study|Terminated by Sponsor|1
2584347|NCT01188772|8937209|P2|Overall Study|Terminated by Sponsor|0
2584348|NCT01188772|8937210|P1|Overall Study|Terminated by Sponsor|0
2584349|NCT01188772|8937207|P4|Overall Study|Physician Decision|0
2584350|NCT01188772|8937208|P3|Overall Study|Physician Decision|1
2584351|NCT01188772|8937209|P2|Overall Study|Physician Decision|0
2584352|NCT01188772|8937210|P1|Overall Study|Physician Decision|0
2584353|NCT01188772|8937207|P4|Overall Study|Non-responder|0
2584354|NCT01188772|8937208|P3|Overall Study|Non-responder|3
2584355|NCT01188772|8937209|P2|Overall Study|Non-responder|0
2584356|NCT01188772|8937210|P1|Overall Study|Non-responder|0
2584357|NCT01188772|8937207|P4|Overall Study|Lost to Follow-up|1
2584358|NCT01188772|8937208|P3|Overall Study|Lost to Follow-up|1
2584359|NCT01188772|8937209|P2|Overall Study|Lost to Follow-up|1
2584360|NCT01188772|8937210|P1|Overall Study|Lost to Follow-up|4
2584361|NCT01188772|8937207|P4|Overall Study|Adverse Event|0
2584362|NCT01188772|8937208|P3|Overall Study|Adverse Event|2
2584363|NCT01188772|8937209|P2|Overall Study|Adverse Event|1
2584364|NCT01188772|8937210|P1|Overall Study|Adverse Event|0
2584365|NCT01188772|8937207|P4|Overall Study|Randomized but Not Treated|0
2584366|NCT01188772|8937208|P3|Overall Study|Randomized but Not Treated|0
2584367|NCT01188772|8937209|P2|Overall Study|Randomized but Not Treated|1
2584368|NCT01188772|8937210|P1|Overall Study|Randomized but Not Treated|0
2584369|NCT01188681|8937282|P4|Overall Study|Withdrawal by Subject|1
2584370|NCT01188681|8937283|P3|Overall Study|Withdrawal by Subject|0
2584371|NCT01188681|8937284|P2|Overall Study|Withdrawal by Subject|0
2584372|NCT01188681|8937285|P1|Overall Study|Withdrawal by Subject|0
2584373|NCT01188681|8937282|P4|Overall Study|bladder cancer|0
2584374|NCT01188681|8937283|P3|Overall Study|bladder cancer|1
2584375|NCT01188681|8937284|P2|Overall Study|bladder cancer|0
2584376|NCT01188681|8937285|P1|Overall Study|bladder cancer|0
2584377|NCT01188668|8937299|P1|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1
2584378|NCT01188668|8937299|P1|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2
2584379|NCT01188668|8937299|P1|Period 1: ARIP Alone|Protocol Violation|2
2584380|NCT01188655|8937332|P1|Overall Study|Other|11
2584381|NCT01188655|8937332|P1|Overall Study|Lost to Follow-up|1
2584382|NCT01188655|8937332|P1|Overall Study|Lack of Efficacy|1
2584383|NCT01188564|8937376|P2|Double-blind Phase|randomized not treated|0
2584384|NCT01188564|8937377|P1|Double-blind Phase|randomized not treated|1
2584385|NCT01188551|8937389|P4|Overall Study|Pharmacy issues|0
2584386|NCT01188551|8937390|P3|Overall Study|Pharmacy issues|0
2584387|NCT01188551|8937391|P2|Overall Study|Pharmacy issues|0
2584388|NCT01188551|8937392|P1|Overall Study|Pharmacy issues|1
2584389|NCT01188538|8937408|P2|Overall Study|Lost to Follow-up|1
2584390|NCT01188538|8937409|P1|Overall Study|Lost to Follow-up|0
2584391|NCT01188343|8937505|P3|Overall Study|Withdrawal by Subject|0
2584392|NCT01188343|8937506|P2|Overall Study|Withdrawal by Subject|24
2584393|NCT01188343|8937507|P1|Overall Study|Withdrawal by Subject|1
2584394|NCT01188343|8937505|P3|Overall Study|Not vaccinated|1
2584395|NCT01188343|8937506|P2|Overall Study|Not vaccinated|2
2584396|NCT01188343|8937507|P1|Overall Study|Not vaccinated|0
2584397|NCT01188226|8937533|P1|Overall Study|Withdrawal by Subject|4
2584398|NCT01187953|8937579|P2|Overall Study|Withdrawal by Subject|3
2584399|NCT01187953|8937580|P1|Overall Study|Withdrawal by Subject|3
2584400|NCT01187953|8937579|P2|Overall Study|Lost to Follow-up|3
2584401|NCT01187953|8937580|P1|Overall Study|Lost to Follow-up|0
2584402|NCT01187953|8937579|P2|Overall Study|Adverse Event|2
2584403|NCT01187953|8937580|P1|Overall Study|Adverse Event|1
2584404|NCT01187953|8937579|P2|Overall Study|Death|13
2584405|NCT01187953|8937580|P1|Overall Study|Death|11
2584406|NCT01187901|8937594|P2|Overall Study|Pregnancy|2
2584407|NCT01187901|8937595|P1|Overall Study|Pregnancy|0
2584408|NCT01187901|8937594|P2|Overall Study|No Endpoint due to Early Study Halt|3
2584409|NCT01187901|8937595|P1|Overall Study|No Endpoint due to Early Study Halt|2
2584410|NCT01187901|8937594|P2|Overall Study|Adverse Event|0
2584411|NCT01187901|8937595|P1|Overall Study|Adverse Event|3
2584412|NCT01187901|8937594|P2|Overall Study|Suspected Allergic Reaction|1
2584413|NCT01187901|8937595|P1|Overall Study|Suspected Allergic Reaction|1
2584414|NCT01187901|8937594|P2|Overall Study|Unrelated Health Reasons|2
2584415|NCT01187901|8937595|P1|Overall Study|Unrelated Health Reasons|1
2584416|NCT01187901|8937594|P2|Overall Study|Lost to Follow-up|2
2584417|NCT01187901|8937595|P1|Overall Study|Lost to Follow-up|1
2584418|NCT01187901|8937594|P2|Overall Study|Protocol Violation|0
2584419|NCT01187901|8937595|P1|Overall Study|Protocol Violation|1
2584420|NCT01187550|8937636|P2|Overall Study|Randomized but not treated|0
2584421|NCT01187550|8937637|P1|Overall Study|Randomized but not treated|8
2584422|NCT01187550|8937636|P2|Overall Study|Other|0
2584423|NCT01187550|8937637|P1|Overall Study|Other|3
2584424|NCT01187550|8937636|P2|Overall Study|Protocol Violation|1
2584425|NCT01187550|8937637|P1|Overall Study|Protocol Violation|3
2584426|NCT01187446|8937793|P2|Overall Study|Patient started non-protocol therapy|1
2584427|NCT01187446|8937794|P1|Overall Study|Patient started non-protocol therapy|0
2584428|NCT01187433|8937810|P2|Overall Study|Withdrawal by Subject|2
2584429|NCT01187433|8937811|P1|Overall Study|Withdrawal by Subject|5
2584430|NCT01187433|8937810|P2|Overall Study|Protocol Violation|2
2584431|NCT01187433|8937811|P1|Overall Study|Protocol Violation|6
2584432|NCT01187407|8937841|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
2584433|NCT01187407|8937842|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
2584434|NCT01187407|8937843|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
2584435|NCT01187407|8937844|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
2584436|NCT01187407|8937845|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
2584437|NCT01187407|8937841|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22
2584438|NCT01187407|8937842|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11
2584439|NCT01187407|8937843|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
2584440|NCT01187407|8937844|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
2584441|NCT01187407|8937845|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
2584442|NCT01187407|8937841|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10
2584443|NCT01187407|8937842|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3
2584444|NCT01187407|8937843|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
2584445|NCT01187407|8937844|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6
2584446|NCT01187407|8937845|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
2584447|NCT01187407|8937841|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
2584448|NCT01187407|8937842|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
2584449|NCT01187407|8937843|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
2584450|NCT01187407|8937844|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
2584451|NCT01187407|8937845|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
2584452|NCT01187407|8937841|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
2584453|NCT01187407|8937842|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
2584454|NCT01187407|8937843|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
2584455|NCT01187407|8937844|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
2584456|NCT01187407|8937845|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
2584457|NCT01187407|8937841|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13
2584458|NCT01187407|8937842|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5
2584459|NCT01187407|8937843|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
2584460|NCT01187407|8937844|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3
2584461|NCT01187407|8937845|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
2584462|NCT01187407|8937841|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12
2584463|NCT01187407|8937842|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5
2584464|NCT01187407|8937843|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6
2584465|NCT01187407|8937844|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
2584466|NCT01187407|8937845|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
2584467|NCT01187407|8937841|P5|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2584468|NCT01187407|8937842|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2584469|NCT01187407|8937843|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2584470|NCT01187407|8937844|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2584471|NCT01187407|8937845|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4
2584472|NCT01187407|8937841|P5|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2584473|NCT01187407|8937842|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2584474|NCT01187407|8937843|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2584475|NCT01187407|8937844|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2584476|NCT01187407|8937845|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29
2584477|NCT01187407|8937841|P5|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2584478|NCT01187407|8937842|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2584479|NCT01187407|8937843|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2584480|NCT01187407|8937844|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2584481|NCT01187407|8937845|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13
2584482|NCT01187407|8937841|P5|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2584483|NCT01187407|8937842|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2584484|NCT01187407|8937843|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2584485|NCT01187407|8937844|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2584486|NCT01187407|8937845|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
2584487|NCT01187407|8937841|P5|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2584488|NCT01187407|8937842|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2584489|NCT01187407|8937843|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2584490|NCT01187407|8937844|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2584491|NCT01187407|8937845|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9
2584492|NCT01187407|8937841|P5|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2584493|NCT01187407|8937842|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2584494|NCT01187407|8937843|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2584495|NCT01187407|8937844|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2584496|NCT01187407|8937845|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4
2584497|NCT01187407|8937841|P5|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2584498|NCT01187407|8937842|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2584499|NCT01187407|8937843|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2584500|NCT01187407|8937844|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2584501|NCT01187407|8937845|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29
2584502|NCT01187043|8937958|P5|Overall Study|Unable to make scheduled visits|1
2584503|NCT01187043|8937959|P4|Overall Study|Unable to make scheduled visits|0
2584504|NCT01187043|8937960|P3|Overall Study|Unable to make scheduled visits|4
2584505|NCT01187043|8937961|P2|Overall Study|Unable to make scheduled visits|0
2584506|NCT01187043|8937962|P1|Overall Study|Unable to make scheduled visits|1
2584507|NCT01187043|8937958|P5|Overall Study|Adverse Event|1
2584508|NCT01187043|8937959|P4|Overall Study|Adverse Event|0
2584509|NCT01187043|8937960|P3|Overall Study|Adverse Event|0
2584510|NCT01187043|8937961|P2|Overall Study|Adverse Event|0
2584511|NCT01187043|8937962|P1|Overall Study|Adverse Event|0
2584512|NCT01186939|8937988|P1|Overall Study|Transformation to AML|1
2584513|NCT01186939|8937988|P1|Overall Study|Bone marrow transplant|1
2584514|NCT01186939|8937988|P1|Overall Study|Myocardial infarction|1
2584515|NCT01186939|8937988|P1|Overall Study|NCI CTC Grade 3 or 4 toxicity|1
2584516|NCT01186939|8937988|P1|Overall Study|Started additional treatment|1
2584517|NCT01186939|8937988|P1|Overall Study|Sponsor decision|4
2584518|NCT01186939|8937988|P1|Overall Study|Program closed|5
2584519|NCT01186939|8937988|P1|Overall Study|No longer receiving clinical benefit|17
2584520|NCT01186939|8937988|P1|Overall Study|Withdrawal by Subject|2
2584521|NCT01186939|8937988|P1|Overall Study|Death|7
2584522|NCT01186848|8937992|P1|Overall Study|Adverse Event|2
2584523|NCT01186848|8937992|P1|Overall Study|Withdrawal by Subject|2
2584524|NCT01186848|8937992|P1|Overall Study|Lost to Follow-up|4
2584525|NCT01186809|8937998|P1|Overall Study|Death|30
2584526|NCT01186796|8938004|P2|Overall Study|Protocol Violation|1
2584527|NCT01186796|8938005|P1|Overall Study|Protocol Violation|0
2584528|NCT01186796|8938004|P2|Overall Study|Withdrawal by Subject|1
2584529|NCT01186796|8938005|P1|Overall Study|Withdrawal by Subject|1
2584530|NCT01186796|8938004|P2|Overall Study|Adverse Event|0
2584531|NCT01186796|8938005|P1|Overall Study|Adverse Event|3
2584532|NCT01186770|8938023|P4|Overall Study|Other than specified|2
2584533|NCT01186770|8938024|P3|Overall Study|Other than specified|1
2584534|NCT01186770|8938025|P2|Overall Study|Other than specified|1
2584535|NCT01186770|8938026|P1|Overall Study|Other than specified|0
2584536|NCT01186770|8938023|P4|Overall Study|Insufficient response to treatment|7
2584537|NCT01186770|8938024|P3|Overall Study|Insufficient response to treatment|5
2584538|NCT01186770|8938025|P2|Overall Study|Insufficient response to treatment|8
2584539|NCT01186770|8938026|P1|Overall Study|Insufficient response to treatment|7
2584540|NCT01186770|8938023|P4|Overall Study|Lost to Follow-up|9
2584541|NCT01186770|8938024|P3|Overall Study|Lost to Follow-up|14
2584542|NCT01186770|8938025|P2|Overall Study|Lost to Follow-up|6
2584543|NCT01186770|8938026|P1|Overall Study|Lost to Follow-up|10
2584544|NCT01186770|8938023|P4|Overall Study|Withdrawal by Subject|17
2584545|NCT01186770|8938024|P3|Overall Study|Withdrawal by Subject|11
2584546|NCT01186770|8938025|P2|Overall Study|Withdrawal by Subject|13
2584547|NCT01186770|8938026|P1|Overall Study|Withdrawal by Subject|15
2584548|NCT01186770|8938023|P4|Overall Study|Adverse Event|9
2584549|NCT01186770|8938024|P3|Overall Study|Adverse Event|7
2584550|NCT01186770|8938025|P2|Overall Study|Adverse Event|9
2584551|NCT01186770|8938026|P1|Overall Study|Adverse Event|2
2584552|NCT01186770|8938023|P4|Overall Study|Protocol Violation|14
2584553|NCT01186770|8938024|P3|Overall Study|Protocol Violation|12
2584554|NCT01186770|8938025|P2|Overall Study|Protocol Violation|9
2584555|NCT01186770|8938026|P1|Overall Study|Protocol Violation|7
2584556|NCT01186770|8938023|P4|Overall Study|Ineligibility|0
2584557|NCT01186770|8938024|P3|Overall Study|Ineligibility|2
2584558|NCT01186770|8938025|P2|Overall Study|Ineligibility|0
2584559|NCT01186770|8938026|P1|Overall Study|Ineligibility|0
2584560|NCT01186744|8938050|P6|Overall Study|Death|0
2584561|NCT01186744|8938051|P5|Overall Study|Death|0
2584562|NCT01186744|8938052|P4|Overall Study|Death|0
2584563|NCT01186744|8938053|P3|Overall Study|Death|0
2584564|NCT01186744|8938054|P2|Overall Study|Death|0
2584565|NCT01186744|8938055|P1|Overall Study|Death|1
2584566|NCT01186744|8938050|P6|Overall Study|Adverse Event|4
2584567|NCT01186744|8938051|P5|Overall Study|Adverse Event|1
2584568|NCT01186744|8938052|P4|Overall Study|Adverse Event|0
2584569|NCT01186744|8938053|P3|Overall Study|Adverse Event|1
2584570|NCT01186744|8938054|P2|Overall Study|Adverse Event|14
2584571|NCT01186744|8938055|P1|Overall Study|Adverse Event|10
2584572|NCT01186744|8938050|P6|Overall Study|Other|5
2584573|NCT01186744|8938051|P5|Overall Study|Other|1
2584574|NCT01186744|8938052|P4|Overall Study|Other|2
2584575|NCT01186744|8938053|P3|Overall Study|Other|1
2584576|NCT01186744|8938054|P2|Overall Study|Other|10
2584577|NCT01186744|8938055|P1|Overall Study|Other|9
2584578|NCT01186744|8938050|P6|Overall Study|Study terminated by Sponsor|0
2584579|NCT01186744|8938051|P5|Overall Study|Study terminated by Sponsor|0
2584580|NCT01186744|8938052|P4|Overall Study|Study terminated by Sponsor|0
2584581|NCT01186744|8938053|P3|Overall Study|Study terminated by Sponsor|0
2584582|NCT01186744|8938054|P2|Overall Study|Study terminated by Sponsor|0
2584583|NCT01186744|8938055|P1|Overall Study|Study terminated by Sponsor|1
2584584|NCT01186744|8938050|P6|Overall Study|Withdrawal by Subject|6
2584585|NCT01186744|8938051|P5|Overall Study|Withdrawal by Subject|0
2584586|NCT01186744|8938052|P4|Overall Study|Withdrawal by Subject|5
2584587|NCT01186744|8938053|P3|Overall Study|Withdrawal by Subject|2
2584588|NCT01186744|8938054|P2|Overall Study|Withdrawal by Subject|10
2584589|NCT01186744|8938055|P1|Overall Study|Withdrawal by Subject|14
2584590|NCT01186744|8938050|P6|Overall Study|Screen failure|0
2584591|NCT01186744|8938051|P5|Overall Study|Screen failure|0
2584592|NCT01186744|8938052|P4|Overall Study|Screen failure|1
2584593|NCT01186744|8938053|P3|Overall Study|Screen failure|0
2584594|NCT01186744|8938054|P2|Overall Study|Screen failure|1
2584595|NCT01186744|8938055|P1|Overall Study|Screen failure|1
2584596|NCT01186744|8938050|P6|Overall Study|Lost to Follow-up|4
2584597|NCT01186744|8938051|P5|Overall Study|Lost to Follow-up|1
2584598|NCT01186744|8938052|P4|Overall Study|Lost to Follow-up|1
2584599|NCT01186744|8938053|P3|Overall Study|Lost to Follow-up|2
2584600|NCT01186744|8938054|P2|Overall Study|Lost to Follow-up|16
2584601|NCT01186744|8938055|P1|Overall Study|Lost to Follow-up|15
2584602|NCT01186744|8938050|P6|Overall Study|Protocol Violation|2
2584603|NCT01186744|8938051|P5|Overall Study|Protocol Violation|1
2584604|NCT01186744|8938052|P4|Overall Study|Protocol Violation|1
2584605|NCT01186744|8938053|P3|Overall Study|Protocol Violation|0
2584606|NCT01186744|8938054|P2|Overall Study|Protocol Violation|2
2584607|NCT01186744|8938055|P1|Overall Study|Protocol Violation|1
2584608|NCT01186744|8938050|P6|Overall Study|Lack of Efficacy|5
2584609|NCT01186744|8938051|P5|Overall Study|Lack of Efficacy|2
2584610|NCT01186744|8938052|P4|Overall Study|Lack of Efficacy|2
2584611|NCT01186744|8938053|P3|Overall Study|Lack of Efficacy|0
2584612|NCT01186744|8938054|P2|Overall Study|Lack of Efficacy|99
2584613|NCT01186744|8938055|P1|Overall Study|Lack of Efficacy|156
2584614|NCT01186692|8938475|P1|Overall Study|Adverse Event|2
2584615|NCT01186692|8938475|P1|Overall Study|Futher testing contraindicated implant|19
2584616|NCT01186692|8938475|P1|Overall Study|Not Catheterized|11
2584617|NCT01186458|8938502|P1|Overall Study|Adverse Event|1
2584618|NCT01186419|8938511|P2|Overall Study|Other|1
2584619|NCT01186419|8938512|P1|Overall Study|Other|1
2584620|NCT01186419|8938511|P2|Overall Study|Physician Decision|3
2584621|NCT01186419|8938512|P1|Overall Study|Physician Decision|0
2584622|NCT01186419|8938511|P2|Overall Study|Adverse Event|2
2584623|NCT01186419|8938512|P1|Overall Study|Adverse Event|1
2584624|NCT01186419|8938511|P2|Overall Study|Withdrawal by Subject|3
2584625|NCT01186419|8938512|P1|Overall Study|Withdrawal by Subject|5
2584626|NCT01186328|8938526|P3|Overall Study|Death|0
2584627|NCT01186328|8938527|P2|Overall Study|Death|0
2584628|NCT01186328|8938528|P1|Overall Study|Death|1
2584629|NCT01185964|8938558|P4|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2
2584630|NCT01185964|8938559|P3|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
2584631|NCT01185964|8938560|P2|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
2584632|NCT01185964|8938561|P1|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
2584633|NCT01185964|8938558|P4|Optional Olaratumab Monotherapy on Dox|Adverse Event|1
2584634|NCT01185964|8938559|P3|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
2584635|NCT01185964|8938560|P2|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
2584636|NCT01185964|8938561|P1|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
2584637|NCT01185964|8938558|P4|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2
2584638|NCT01185964|8938559|P3|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
2584639|NCT01185964|8938560|P2|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
2584640|NCT01185964|8938561|P1|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
2584641|NCT01185964|8938558|P4|Phase 1b and Phase 2|Off Treatment but alive and on study|0
2584642|NCT01185964|8938559|P3|Phase 1b and Phase 2|Off Treatment but alive and on study|1
2584643|NCT01185964|8938560|P2|Phase 1b and Phase 2|Off Treatment but alive and on study|1
2584644|NCT01185964|8938561|P1|Phase 1b and Phase 2|Off Treatment but alive and on study|0
2584645|NCT01185964|8938558|P4|Phase 1b and Phase 2|Adverse Event|0
2584646|NCT01185964|8938559|P3|Phase 1b and Phase 2|Adverse Event|2
2584647|NCT01185964|8938560|P2|Phase 1b and Phase 2|Adverse Event|0
2584648|NCT01185964|8938561|P1|Phase 1b and Phase 2|Adverse Event|1
2584649|NCT01185964|8938558|P4|Phase 1b and Phase 2|Participant was beyond maximum weight|0
2584650|NCT01185964|8938559|P3|Phase 1b and Phase 2|Participant was beyond maximum weight|1
2584651|NCT01185964|8938560|P2|Phase 1b and Phase 2|Participant was beyond maximum weight|0
2584652|NCT01185964|8938561|P1|Phase 1b and Phase 2|Participant was beyond maximum weight|0
2584653|NCT01185964|8938558|P4|Phase 1b and Phase 2|Other Therapy Started|0
2584654|NCT01185964|8938559|P3|Phase 1b and Phase 2|Other Therapy Started|3
2584655|NCT01185964|8938560|P2|Phase 1b and Phase 2|Other Therapy Started|3
2584656|NCT01185964|8938561|P1|Phase 1b and Phase 2|Other Therapy Started|0
2584657|NCT01185964|8938558|P4|Phase 1b and Phase 2|Withdrawal by Subject|0
2584658|NCT01185964|8938559|P3|Phase 1b and Phase 2|Withdrawal by Subject|2
2584659|NCT01185964|8938560|P2|Phase 1b and Phase 2|Withdrawal by Subject|6
2584660|NCT01185964|8938561|P1|Phase 1b and Phase 2|Withdrawal by Subject|1
2584661|NCT01185834|8938587|P1|Overall Study|Early exit - Site error|2
2584662|NCT01185834|8938587|P1|Overall Study|Time/Job Conflict|2
2584663|NCT01185834|8938587|P1|Overall Study|Biomicroscopy|4
2584664|NCT01185834|8938587|P1|Overall Study|Discomfort|4
2584665|NCT01185834|8938587|P1|Overall Study|Lost to Follow-up|2
2584666|NCT01185821|8938597|P5|Overall Study|Administrative problems|2
2584667|NCT01185821|8938598|P4|Overall Study|Administrative problems|1
2584668|NCT01185821|8938599|P3|Overall Study|Administrative problems|1
2584669|NCT01185821|8938600|P2|Overall Study|Administrative problems|0
2584670|NCT01185821|8938601|P1|Overall Study|Administrative problems|0
2584671|NCT01185821|8938597|P5|Overall Study|Lost to Follow-up|2
2584672|NCT01185821|8938598|P4|Overall Study|Lost to Follow-up|1
2584673|NCT01185821|8938599|P3|Overall Study|Lost to Follow-up|2
2584674|NCT01185821|8938600|P2|Overall Study|Lost to Follow-up|1
2584675|NCT01185821|8938601|P1|Overall Study|Lost to Follow-up|1
2584676|NCT01185821|8938597|P5|Overall Study|Withdrawal by Subject|3
2584677|NCT01185821|8938598|P4|Overall Study|Withdrawal by Subject|1
2584678|NCT01185821|8938599|P3|Overall Study|Withdrawal by Subject|2
2584679|NCT01185821|8938600|P2|Overall Study|Withdrawal by Subject|2
2584680|NCT01185821|8938601|P1|Overall Study|Withdrawal by Subject|3
2584681|NCT01185821|8938597|P5|Overall Study|Lack of Efficacy|9
2584682|NCT01185821|8938598|P4|Overall Study|Lack of Efficacy|0
2584683|NCT01185821|8938599|P3|Overall Study|Lack of Efficacy|3
2584684|NCT01185821|8938600|P2|Overall Study|Lack of Efficacy|0
2584685|NCT01185821|8938601|P1|Overall Study|Lack of Efficacy|0
2584686|NCT01185821|8938597|P5|Overall Study|Adverse Event|5
2584687|NCT01185821|8938598|P4|Overall Study|Adverse Event|2
2584688|NCT01185821|8938599|P3|Overall Study|Adverse Event|1
2584689|NCT01185821|8938600|P2|Overall Study|Adverse Event|3
2584690|NCT01185821|8938601|P1|Overall Study|Adverse Event|2
2584691|NCT01185821|8938597|P5|Overall Study|Condition no longer required study drug|1
2584692|NCT01185821|8938598|P4|Overall Study|Condition no longer required study drug|0
2584693|NCT01185821|8938599|P3|Overall Study|Condition no longer required study drug|0
2584694|NCT01185821|8938600|P2|Overall Study|Condition no longer required study drug|0
2584695|NCT01185821|8938601|P1|Overall Study|Condition no longer required study drug|0
2584696|NCT01185821|8938597|P5|Overall Study|Death|0
2584697|NCT01185821|8938598|P4|Overall Study|Death|0
2584698|NCT01185821|8938599|P3|Overall Study|Death|0
2584699|NCT01185821|8938600|P2|Overall Study|Death|1
2584700|NCT01185821|8938601|P1|Overall Study|Death|0
2584701|NCT01185821|8938597|P5|Overall Study|Abnormal test procedure result|1
2584702|NCT01185821|8938598|P4|Overall Study|Abnormal test procedure result|0
2584703|NCT01185821|8938599|P3|Overall Study|Abnormal test procedure result|0
2584704|NCT01185821|8938600|P2|Overall Study|Abnormal test procedure result|0
2584705|NCT01185821|8938601|P1|Overall Study|Abnormal test procedure result|0
2584706|NCT01185821|8938597|P5|Overall Study|Protocol Violation|1
2584707|NCT01185821|8938598|P4|Overall Study|Protocol Violation|1
2584708|NCT01185821|8938599|P3|Overall Study|Protocol Violation|0
2584709|NCT01185821|8938600|P2|Overall Study|Protocol Violation|0
2584710|NCT01185821|8938601|P1|Overall Study|Protocol Violation|0
2584711|NCT01185821|8938597|P5|Overall Study|Abnormal laboratory value(s)|0
2584712|NCT01185821|8938598|P4|Overall Study|Abnormal laboratory value(s)|0
2584713|NCT01185821|8938599|P3|Overall Study|Abnormal laboratory value(s)|1
2584714|NCT01185821|8938600|P2|Overall Study|Abnormal laboratory value(s)|2
2584715|NCT01185821|8938601|P1|Overall Study|Abnormal laboratory value(s)|1
2584716|NCT01185782|8938652|P2|Overall Study|Randomized but not treated|4
2584717|NCT01185782|8938653|P1|Overall Study|Randomized but not treated|0
2584718|NCT01185782|8938652|P2|Overall Study|Other|5
2584719|NCT01185782|8938653|P1|Overall Study|Other|2
2584720|NCT01185782|8938652|P2|Overall Study|Poor Response to Treatment|1
2584721|NCT01185782|8938653|P1|Overall Study|Poor Response to Treatment|3
2584722|NCT01185782|8938652|P2|Overall Study|Protocol Violation|0
2584723|NCT01185782|8938653|P1|Overall Study|Protocol Violation|1
2584724|NCT01185782|8938652|P2|Overall Study|Adverse Event|1
2584725|NCT01185782|8938653|P1|Overall Study|Adverse Event|0
2584726|NCT01185704|8938681|P2|Overall Study|Ectopic pregnancy|1
2584727|NCT01185704|8938682|P1|Overall Study|Ectopic pregnancy|0
2584728|NCT01185704|8938681|P2|Overall Study|Ovarian hyperstimulation syndrome risk|3
2584729|NCT01185704|8938682|P1|Overall Study|Ovarian hyperstimulation syndrome risk|5
2584730|NCT01185704|8938681|P2|Overall Study|Lack of ovarian response|1
2584731|NCT01185704|8938682|P1|Overall Study|Lack of ovarian response|5
2584732|NCT01185704|8938681|P2|Overall Study|Randomized but not treated|3
2584733|NCT01185704|8938682|P1|Overall Study|Randomized but not treated|3
2584734|NCT01185639|8938716|P1|Overall Study|Progressed and didn't receive therapy|2
2584735|NCT01185600|8938726|P2|Overall Study|Hold by DSMB|2
2584736|NCT01185600|8938727|P1|Overall Study|Hold by DSMB|1
2584737|NCT01185600|8938726|P2|Overall Study|Withdrawal by Subject|1
2584738|NCT01185600|8938727|P1|Overall Study|Withdrawal by Subject|1
2584739|NCT01185600|8938726|P2|Overall Study|Physician Decision|35
2584740|NCT01185600|8938727|P1|Overall Study|Physician Decision|29
2584741|NCT01185600|8938726|P2|Overall Study|Lost to Follow-up|5
2584742|NCT01185600|8938727|P1|Overall Study|Lost to Follow-up|0
2584743|NCT01185600|8938726|P2|Overall Study|Death|1
2584744|NCT01185600|8938727|P1|Overall Study|Death|0
2584745|NCT01185600|8938726|P2|Overall Study|Adverse Event|1
2584746|NCT01185600|8938727|P1|Overall Study|Adverse Event|1
2584747|NCT01185561|8938749|P2|Overall Study|Withdrawal by Subject|8
2584748|NCT01185561|8938750|P1|Overall Study|Withdrawal by Subject|2
2584749|NCT01185561|8938749|P2|Overall Study|Lost to Follow-up|4
2584750|NCT01185561|8938750|P1|Overall Study|Lost to Follow-up|0
2584751|NCT01185548|8938762|P1|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2
2584752|NCT01185522|8938775|P1|Overall Study|Other reasons|12
2584753|NCT01185522|8938775|P1|Overall Study|Poor tolerance|39
2584754|NCT01185522|8938775|P1|Overall Study|Withdrawal by Subject|10
2584755|NCT01185522|8938775|P1|Overall Study|Lost to Follow-up|19
2584756|NCT01185522|8938775|P1|Overall Study|Lack of Efficacy|28
2584757|NCT01185509|8938801|P2|Overall Study|Intercurrent Illness|1
2584758|NCT01185509|8938802|P1|Overall Study|Intercurrent Illness|0
2584759|NCT01185509|8938801|P2|Overall Study|Death|1
2584760|NCT01185509|8938802|P1|Overall Study|Death|0
2584761|NCT01185509|8938801|P2|Overall Study|Withdrawal by Subject|1
2584762|NCT01185509|8938802|P1|Overall Study|Withdrawal by Subject|0
2584763|NCT01185509|8938801|P2|Overall Study|Physician Decision|2
2584764|NCT01185509|8938802|P1|Overall Study|Physician Decision|2
2584765|NCT01185509|8938801|P2|Overall Study|Progression/Relapse|15
2584766|NCT01185509|8938802|P1|Overall Study|Progression/Relapse|9
2584767|NCT01185353|8938818|P10|Part D (Weeks 76 Through 128)|Adverse Event|0
2584768|NCT01185353|8938819|P9|Part D (Weeks 76 Through 128)|Adverse Event|2
2584769|NCT01185353|8938820|P8|Part D (Weeks 76 Through 128)|Adverse Event|1
2584770|NCT01185353|8938821|P7|Part D (Weeks 76 Through 128)|Adverse Event|0
2584771|NCT01185353|8938822|P6|Part D (Weeks 76 Through 128)|Adverse Event|0
2584772|NCT01185353|8938823|P5|Part D (Weeks 76 Through 128)|Adverse Event|0
2584773|NCT01185353|8938824|P4|Part D (Weeks 76 Through 128)|Adverse Event|0
2584774|NCT01185353|8938825|P3|Part D (Weeks 76 Through 128)|Adverse Event|0
2584775|NCT01185353|8938826|P2|Part D (Weeks 76 Through 128)|Adverse Event|0
2584776|NCT01185353|8938827|P1|Part D (Weeks 76 Through 128)|Adverse Event|0
2584777|NCT01185353|8938818|P10|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
2584778|NCT01185353|8938819|P9|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2
2584779|NCT01185353|8938820|P8|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
2584780|NCT01185353|8938821|P7|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
2584781|NCT01185353|8938822|P6|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
2584782|NCT01185353|8938823|P5|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
2584783|NCT01185353|8938824|P4|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
2584784|NCT01185353|8938825|P3|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
2584785|NCT01185353|8938826|P2|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
2584786|NCT01185353|8938827|P1|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
2584787|NCT01185353|8938818|P10|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
2584788|NCT01185353|8938819|P9|Part D (Weeks 76 Through 128)|Lost to Follow-up|3
2584789|NCT01185353|8938820|P8|Part D (Weeks 76 Through 128)|Lost to Follow-up|1
2584790|NCT01185353|8938821|P7|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
2584791|NCT01185353|8938822|P6|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
2584792|NCT01185353|8938823|P5|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
2584793|NCT01185353|8938824|P4|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
2584794|NCT01185353|8938825|P3|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
2584795|NCT01185353|8938826|P2|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
2584796|NCT01185353|8938827|P1|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
2584797|NCT01185353|8938818|P10|Part C (Weeks 24 Through 76)|Reason missing|0
2584798|NCT01185353|8938819|P9|Part C (Weeks 24 Through 76)|Reason missing|1
2584799|NCT01185353|8938820|P8|Part C (Weeks 24 Through 76)|Reason missing|0
2584800|NCT01185353|8938821|P7|Part C (Weeks 24 Through 76)|Reason missing|0
2584801|NCT01185353|8938822|P6|Part C (Weeks 24 Through 76)|Reason missing|0
2584802|NCT01185353|8938823|P5|Part C (Weeks 24 Through 76)|Reason missing|0
2584803|NCT01185353|8938824|P4|Part C (Weeks 24 Through 76)|Reason missing|0
2584804|NCT01185353|8938825|P3|Part C (Weeks 24 Through 76)|Reason missing|0
2584805|NCT01185353|8938826|P2|Part C (Weeks 24 Through 76)|Reason missing|0
2584806|NCT01185353|8938827|P1|Part C (Weeks 24 Through 76)|Reason missing|0
2584807|NCT01185353|8938818|P10|Part C (Weeks 24 Through 76)|Physician Decision|1
2584808|NCT01185353|8938819|P9|Part C (Weeks 24 Through 76)|Physician Decision|0
2584809|NCT01185353|8938820|P8|Part C (Weeks 24 Through 76)|Physician Decision|0
2584810|NCT01185353|8938821|P7|Part C (Weeks 24 Through 76)|Physician Decision|0
2584811|NCT01185353|8938822|P6|Part C (Weeks 24 Through 76)|Physician Decision|0
2584812|NCT01185353|8938823|P5|Part C (Weeks 24 Through 76)|Physician Decision|0
2584813|NCT01185353|8938824|P4|Part C (Weeks 24 Through 76)|Physician Decision|0
2584814|NCT01185353|8938825|P3|Part C (Weeks 24 Through 76)|Physician Decision|0
2584815|NCT01185353|8938826|P2|Part C (Weeks 24 Through 76)|Physician Decision|0
2584816|NCT01185353|8938827|P1|Part C (Weeks 24 Through 76)|Physician Decision|0
2584817|NCT01185353|8938818|P10|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1
2584818|NCT01185353|8938819|P9|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
2584819|NCT01185353|8938820|P8|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
2584820|NCT01185353|8938821|P7|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
2584821|NCT01185353|8938822|P6|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
2584822|NCT01185353|8938823|P5|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
2584823|NCT01185353|8938824|P4|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
2584824|NCT01185353|8938825|P3|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
2584825|NCT01185353|8938826|P2|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
2584826|NCT01185353|8938827|P1|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
2584827|NCT01185353|8938818|P10|Part C (Weeks 24 Through 76)|Death|1
2584828|NCT01185353|8938819|P9|Part C (Weeks 24 Through 76)|Death|0
2584829|NCT01185353|8938820|P8|Part C (Weeks 24 Through 76)|Death|0
2584830|NCT01185353|8938821|P7|Part C (Weeks 24 Through 76)|Death|0
2584831|NCT01185353|8938822|P6|Part C (Weeks 24 Through 76)|Death|0
2584832|NCT01185353|8938823|P5|Part C (Weeks 24 Through 76)|Death|0
2584833|NCT01185353|8938824|P4|Part C (Weeks 24 Through 76)|Death|0
2584834|NCT01185353|8938825|P3|Part C (Weeks 24 Through 76)|Death|0
2584835|NCT01185353|8938826|P2|Part C (Weeks 24 Through 76)|Death|0
2584836|NCT01185353|8938827|P1|Part C (Weeks 24 Through 76)|Death|0
2584837|NCT01185353|8938818|P10|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
2584838|NCT01185353|8938819|P9|Part C (Weeks 24 Through 76)|Lack of Efficacy|2
2584839|NCT01185353|8938820|P8|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
2584840|NCT01185353|8938821|P7|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
2584841|NCT01185353|8938822|P6|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
2584842|NCT01185353|8938823|P5|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
2584843|NCT01185353|8938824|P4|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
2584844|NCT01185353|8938825|P3|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
2584845|NCT01185353|8938826|P2|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
2584846|NCT01185353|8938827|P1|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
2584847|NCT01185353|8938818|P10|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
2584848|NCT01185353|8938819|P9|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
2584849|NCT01185353|8938820|P8|Part C (Weeks 24 Through 76)|Lost to Follow-up|2
2584850|NCT01185353|8938821|P7|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
2584851|NCT01185353|8938822|P6|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
2584852|NCT01185353|8938823|P5|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
2584853|NCT01185353|8938824|P4|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
2584854|NCT01185353|8938825|P3|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
2584855|NCT01185353|8938826|P2|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
2584856|NCT01185353|8938827|P1|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
2584857|NCT01185353|8938818|P10|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
2584858|NCT01185353|8938819|P9|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
2584859|NCT01185353|8938820|P8|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6
2584860|NCT01185353|8938821|P7|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
2584861|NCT01185353|8938822|P6|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
2584862|NCT01185353|8938823|P5|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
2584863|NCT01185353|8938824|P4|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
2584864|NCT01185353|8938825|P3|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
2584865|NCT01185353|8938826|P2|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
2584866|NCT01185353|8938827|P1|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
2584867|NCT01185353|8938818|P10|Part C (Weeks 24 Through 76)|Adverse Event|2
2584868|NCT01185353|8938819|P9|Part C (Weeks 24 Through 76)|Adverse Event|2
2584869|NCT01185353|8938820|P8|Part C (Weeks 24 Through 76)|Adverse Event|8
2584870|NCT01185353|8938821|P7|Part C (Weeks 24 Through 76)|Adverse Event|0
2584871|NCT01185353|8938822|P6|Part C (Weeks 24 Through 76)|Adverse Event|0
2584872|NCT01185353|8938823|P5|Part C (Weeks 24 Through 76)|Adverse Event|0
2584873|NCT01185353|8938824|P4|Part C (Weeks 24 Through 76)|Adverse Event|0
2584874|NCT01185353|8938825|P3|Part C (Weeks 24 Through 76)|Adverse Event|0
2584875|NCT01185353|8938826|P2|Part C (Weeks 24 Through 76)|Adverse Event|0
2584876|NCT01185353|8938827|P1|Part C (Weeks 24 Through 76)|Adverse Event|0
2584877|NCT01185353|8938818|P10|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
2584878|NCT01185353|8938819|P9|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
2584879|NCT01185353|8938820|P8|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
2584880|NCT01185353|8938821|P7|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1
2584881|NCT01185353|8938822|P6|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
2584882|NCT01185353|8938823|P5|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
2584883|NCT01185353|8938824|P4|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
2584884|NCT01185353|8938825|P3|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
2584885|NCT01185353|8938826|P2|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
2584886|NCT01185353|8938827|P1|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
2584887|NCT01185353|8938818|P10|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
2584888|NCT01185353|8938819|P9|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
2584889|NCT01185353|8938820|P8|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
2584890|NCT01185353|8938821|P7|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4
2584891|NCT01185353|8938822|P6|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3
2584892|NCT01185353|8938823|P5|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
2584893|NCT01185353|8938824|P4|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2
2584894|NCT01185353|8938825|P3|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1
2584895|NCT01185353|8938826|P2|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
2584896|NCT01185353|8938827|P1|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
2584897|NCT01185353|8938818|P10|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
2584898|NCT01185353|8938819|P9|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
2584899|NCT01185353|8938820|P8|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
2584900|NCT01185353|8938821|P7|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
2584901|NCT01185353|8938822|P6|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
2584902|NCT01185353|8938823|P5|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
2584903|NCT01185353|8938824|P4|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
2584904|NCT01185353|8938825|P3|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
2584905|NCT01185353|8938826|P2|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
2584906|NCT01185353|8938827|P1|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
2584907|NCT01185353|8938818|P10|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
2584908|NCT01185353|8938819|P9|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
2584909|NCT01185353|8938820|P8|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
2584910|NCT01185353|8938821|P7|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
2584911|NCT01185353|8938822|P6|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
2584912|NCT01185353|8938823|P5|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
2584913|NCT01185353|8938824|P4|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
2584914|NCT01185353|8938825|P3|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
2584915|NCT01185353|8938826|P2|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
2584916|NCT01185353|8938827|P1|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
2584917|NCT01185353|8938818|P10|Part B (Weeks 12 Through 24)|Adverse Event|0
2584918|NCT01185353|8938819|P9|Part B (Weeks 12 Through 24)|Adverse Event|0
2584919|NCT01185353|8938820|P8|Part B (Weeks 12 Through 24)|Adverse Event|0
2584920|NCT01185353|8938821|P7|Part B (Weeks 12 Through 24)|Adverse Event|0
2584921|NCT01185353|8938822|P6|Part B (Weeks 12 Through 24)|Adverse Event|1
2584922|NCT01185353|8938823|P5|Part B (Weeks 12 Through 24)|Adverse Event|0
2584923|NCT01185353|8938824|P4|Part B (Weeks 12 Through 24)|Adverse Event|0
2584924|NCT01185353|8938825|P3|Part B (Weeks 12 Through 24)|Adverse Event|1
2584925|NCT01185353|8938826|P2|Part B (Weeks 12 Through 24)|Adverse Event|0
2584926|NCT01185353|8938827|P1|Part B (Weeks 12 Through 24)|Adverse Event|0
2584927|NCT01185353|8938818|P10|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
2584928|NCT01185353|8938819|P9|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
2584929|NCT01185353|8938820|P8|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
2584930|NCT01185353|8938821|P7|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
2584931|NCT01185353|8938822|P6|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
2584932|NCT01185353|8938823|P5|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3
2584933|NCT01185353|8938824|P4|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
2584934|NCT01185353|8938825|P3|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
2584935|NCT01185353|8938826|P2|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
2584936|NCT01185353|8938827|P1|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2
2584937|NCT01185353|8938818|P10|Part A (Weeks 0 Through 12)|Protocol Violation|0
2584938|NCT01185353|8938819|P9|Part A (Weeks 0 Through 12)|Protocol Violation|0
2584939|NCT01185353|8938820|P8|Part A (Weeks 0 Through 12)|Protocol Violation|0
2584940|NCT01185353|8938821|P7|Part A (Weeks 0 Through 12)|Protocol Violation|0
2584941|NCT01185353|8938822|P6|Part A (Weeks 0 Through 12)|Protocol Violation|0
2584942|NCT01185353|8938823|P5|Part A (Weeks 0 Through 12)|Protocol Violation|1
2584943|NCT01185353|8938824|P4|Part A (Weeks 0 Through 12)|Protocol Violation|0
2584944|NCT01185353|8938825|P3|Part A (Weeks 0 Through 12)|Protocol Violation|0
2584945|NCT01185353|8938826|P2|Part A (Weeks 0 Through 12)|Protocol Violation|0
2584946|NCT01185353|8938827|P1|Part A (Weeks 0 Through 12)|Protocol Violation|0
2584947|NCT01185353|8938818|P10|Part A (Weeks 0 Through 12)|Physician Decision|0
2584948|NCT01185353|8938819|P9|Part A (Weeks 0 Through 12)|Physician Decision|0
2584949|NCT01185353|8938820|P8|Part A (Weeks 0 Through 12)|Physician Decision|0
2584950|NCT01185353|8938821|P7|Part A (Weeks 0 Through 12)|Physician Decision|0
2584951|NCT01185353|8938822|P6|Part A (Weeks 0 Through 12)|Physician Decision|0
2584952|NCT01185353|8938823|P5|Part A (Weeks 0 Through 12)|Physician Decision|2
2584953|NCT01185353|8938824|P4|Part A (Weeks 0 Through 12)|Physician Decision|0
2584954|NCT01185353|8938825|P3|Part A (Weeks 0 Through 12)|Physician Decision|1
2584955|NCT01185353|8938826|P2|Part A (Weeks 0 Through 12)|Physician Decision|0
2584956|NCT01185353|8938827|P1|Part A (Weeks 0 Through 12)|Physician Decision|0
2584957|NCT01185353|8938818|P10|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
2584958|NCT01185353|8938819|P9|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
2584959|NCT01185353|8938820|P8|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
2584960|NCT01185353|8938821|P7|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
2584961|NCT01185353|8938822|P6|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
2584962|NCT01185353|8938823|P5|Part A (Weeks 0 Through 12)|Lack of Efficacy|1
2584963|NCT01185353|8938824|P4|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
2584964|NCT01185353|8938825|P3|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
2584965|NCT01185353|8938826|P2|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
2584966|NCT01185353|8938827|P1|Part A (Weeks 0 Through 12)|Lack of Efficacy|2
2584967|NCT01185353|8938818|P10|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
2584968|NCT01185353|8938819|P9|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
2584969|NCT01185353|8938820|P8|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
2584970|NCT01185353|8938821|P7|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
2584971|NCT01185353|8938822|P6|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
2584972|NCT01185353|8938823|P5|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4
2584973|NCT01185353|8938824|P4|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
2584974|NCT01185353|8938825|P3|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
2584975|NCT01185353|8938826|P2|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
2584976|NCT01185353|8938827|P1|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
2584977|NCT01185353|8938818|P10|Part A (Weeks 0 Through 12)|Adverse Event|0
2584978|NCT01185353|8938819|P9|Part A (Weeks 0 Through 12)|Adverse Event|0
2584979|NCT01185353|8938820|P8|Part A (Weeks 0 Through 12)|Adverse Event|0
2584980|NCT01185353|8938821|P7|Part A (Weeks 0 Through 12)|Adverse Event|0
2584981|NCT01185353|8938822|P6|Part A (Weeks 0 Through 12)|Adverse Event|0
2584982|NCT01185353|8938823|P5|Part A (Weeks 0 Through 12)|Adverse Event|5
2584983|NCT01185353|8938824|P4|Part A (Weeks 0 Through 12)|Adverse Event|1
2584984|NCT01185353|8938825|P3|Part A (Weeks 0 Through 12)|Adverse Event|1
2584985|NCT01185353|8938826|P2|Part A (Weeks 0 Through 12)|Adverse Event|1
2584986|NCT01185353|8938827|P1|Part A (Weeks 0 Through 12)|Adverse Event|1
2584987|NCT01185340|8938988|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
2584988|NCT01185340|8938989|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3
2584989|NCT01185340|8938990|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
2584990|NCT01185340|8938991|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
2584991|NCT01185340|8938988|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
2584992|NCT01185340|8938989|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
2584993|NCT01185340|8938990|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
2584994|NCT01185340|8938991|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
2584995|NCT01185340|8938988|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
2584996|NCT01185340|8938989|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2
2584997|NCT01185340|8938990|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
2584998|NCT01185340|8938991|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
2584999|NCT01185340|8938988|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
2585000|NCT01185340|8938989|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
2585001|NCT01185340|8938990|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
2585002|NCT01185340|8938991|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
2585003|NCT01185340|8938988|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7
2585004|NCT01185340|8938989|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
2585005|NCT01185340|8938990|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4
2585006|NCT01185340|8938991|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
2585007|NCT01185340|8938988|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
2585008|NCT01185340|8938989|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7
2585009|NCT01185340|8938990|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
2585010|NCT01185340|8938991|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
2585011|NCT01185340|8938988|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
2585012|NCT01185340|8938989|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8
2585013|NCT01185340|8938990|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
2585014|NCT01185340|8938991|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
2585015|NCT01185340|8938988|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2585016|NCT01185340|8938989|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2585017|NCT01185340|8938990|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2585018|NCT01185340|8938991|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3
2585019|NCT01185340|8938988|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2585020|NCT01185340|8938989|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2585021|NCT01185340|8938990|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2585022|NCT01185340|8938991|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32
2585023|NCT01185340|8938988|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2585024|NCT01185340|8938989|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2585025|NCT01185340|8938990|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2585026|NCT01185340|8938991|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16
2585027|NCT01185340|8938988|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2585028|NCT01185340|8938989|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2585029|NCT01185340|8938990|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2585030|NCT01185340|8938991|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
2585031|NCT01185340|8938988|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2585032|NCT01185340|8938989|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2585033|NCT01185340|8938990|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2585034|NCT01185340|8938991|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5
2585035|NCT01185340|8938988|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2585036|NCT01185340|8938989|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2585037|NCT01185340|8938990|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2585038|NCT01185340|8938991|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6
2585039|NCT01185340|8938988|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2585040|NCT01185340|8938989|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2585041|NCT01185340|8938990|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2585042|NCT01185340|8938991|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24
2585043|NCT01185301|8939043|P4|Overall Study|Other Reason|2
2585044|NCT01185301|8939044|P3|Overall Study|Other Reason|2
2585045|NCT01185301|8939045|P2|Overall Study|Other Reason|2
2585046|NCT01185301|8939046|P1|Overall Study|Other Reason|3
2585047|NCT01185301|8939043|P4|Overall Study|Lost to Follow-up|1
2585048|NCT01185301|8939044|P3|Overall Study|Lost to Follow-up|0
2585049|NCT01185301|8939045|P2|Overall Study|Lost to Follow-up|0
2585050|NCT01185301|8939046|P1|Overall Study|Lost to Follow-up|2
2585051|NCT01185301|8939043|P4|Overall Study|Withdrawal by Subject|3
2585052|NCT01185301|8939044|P3|Overall Study|Withdrawal by Subject|2
2585053|NCT01185301|8939045|P2|Overall Study|Withdrawal by Subject|5
2585054|NCT01185301|8939046|P1|Overall Study|Withdrawal by Subject|7
2585055|NCT01185301|8939043|P4|Overall Study|Adverse Event|3
2585056|NCT01185301|8939044|P3|Overall Study|Adverse Event|2
2585057|NCT01185301|8939045|P2|Overall Study|Adverse Event|0
2585058|NCT01185301|8939046|P1|Overall Study|Adverse Event|3
2585059|NCT01185288|8939106|P2|Overall Study|Noncompliance|1
2585060|NCT01185288|8939107|P1|Overall Study|Noncompliance|0
2585061|NCT01185288|8939106|P2|Overall Study|Did not meet inclusion criteria|0
2585062|NCT01185288|8939107|P1|Overall Study|Did not meet inclusion criteria|1
2585063|NCT01185288|8939106|P2|Overall Study|Investigator discretion|0
2585064|NCT01185288|8939107|P1|Overall Study|Investigator discretion|1
2585065|NCT01185288|8939106|P2|Overall Study|Lack of Efficacy|0
2585066|NCT01185288|8939107|P1|Overall Study|Lack of Efficacy|2
2585067|NCT01185288|8939106|P2|Overall Study|Lost to Follow-up|5
2585068|NCT01185288|8939107|P1|Overall Study|Lost to Follow-up|2
2585069|NCT01185288|8939106|P2|Overall Study|Withdrawal by Subject|4
2585070|NCT01185288|8939107|P1|Overall Study|Withdrawal by Subject|6
2585071|NCT01185288|8939106|P2|Overall Study|Adverse Event|6
2585072|NCT01185288|8939107|P1|Overall Study|Adverse Event|7
2585073|NCT01185249|8939125|P1|Overall Study|Patients discharged or change in status|42
2585074|NCT01185080|8939133|P3|Overall Study|Personal reasons|1
2585075|NCT01185080|8939134|P2|Overall Study|Personal reasons|0
2585076|NCT01185080|8939135|P1|Overall Study|Personal reasons|0
2585077|NCT01185080|8939133|P3|Overall Study|Adverse Event|0
2585078|NCT01185080|8939134|P2|Overall Study|Adverse Event|1
2585079|NCT01185080|8939135|P1|Overall Study|Adverse Event|1
2585080|NCT01184989|8939187|P1|Overall Study|Withdrawal by Subject|1
2585081|NCT01184989|8939187|P1|Overall Study|Adverse Event|11
2585082|NCT01184872|8939207|P2|Overall Study|Protocol deviation|0
2585083|NCT01184872|8939208|P1|Overall Study|Protocol deviation|1
2585084|NCT01184872|8939207|P2|Overall Study|Administrative problems|1
2585085|NCT01184872|8939208|P1|Overall Study|Administrative problems|1
2585086|NCT01184872|8939207|P2|Overall Study|Lost to Follow-up|1
2585087|NCT01184872|8939208|P1|Overall Study|Lost to Follow-up|0
2585088|NCT01184872|8939207|P2|Overall Study|Withdrawal by Subject|0
2585089|NCT01184872|8939208|P1|Overall Study|Withdrawal by Subject|2
2585090|NCT01184872|8939207|P2|Overall Study|Unsatisfactory therapeutic effect|2
2585091|NCT01184872|8939208|P1|Overall Study|Unsatisfactory therapeutic effect|3
2585092|NCT01184872|8939207|P2|Overall Study|Adverse Event|4
2585093|NCT01184872|8939208|P1|Overall Study|Adverse Event|3
2585094|NCT01184859|8939227|P5|Period 2: Daily Dose for 28 Days|Adverse Event|0
2585095|NCT01184859|8939228|P4|Period 2: Daily Dose for 28 Days|Adverse Event|0
2585096|NCT01184859|8939229|P3|Period 2: Daily Dose for 28 Days|Adverse Event|0
2585097|NCT01184859|8939230|P2|Period 2: Daily Dose for 28 Days|Adverse Event|0
2585098|NCT01184859|8939231|P1|Period 2: Daily Dose for 28 Days|Adverse Event|1
2585099|NCT01184859|8939227|P5|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1
2585100|NCT01184859|8939228|P4|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
2585101|NCT01184859|8939229|P3|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
2585102|NCT01184859|8939230|P2|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
2585103|NCT01184859|8939231|P1|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
2585104|NCT01184859|8939227|P5|Period 1: Single Dose|Adverse Event|1
2585105|NCT01184859|8939228|P4|Period 1: Single Dose|Adverse Event|0
2585106|NCT01184859|8939229|P3|Period 1: Single Dose|Adverse Event|0
2585107|NCT01184859|8939230|P2|Period 1: Single Dose|Adverse Event|0
2585108|NCT01184859|8939231|P1|Period 1: Single Dose|Adverse Event|0
2585109|NCT01184859|8939227|P5|Period 1: Single Dose|Protocol Violation|0
2585110|NCT01184859|8939228|P4|Period 1: Single Dose|Protocol Violation|0
2585111|NCT01184859|8939229|P3|Period 1: Single Dose|Protocol Violation|0
2585112|NCT01184859|8939230|P2|Period 1: Single Dose|Protocol Violation|1
2585113|NCT01184859|8939231|P1|Period 1: Single Dose|Protocol Violation|0
2585114|NCT01184859|8939227|P5|Period 1: Single Dose|Insufficient urine production|0
2585115|NCT01184859|8939228|P4|Period 1: Single Dose|Insufficient urine production|0
2585116|NCT01184859|8939229|P3|Period 1: Single Dose|Insufficient urine production|0
2585117|NCT01184859|8939230|P2|Period 1: Single Dose|Insufficient urine production|1
2585118|NCT01184859|8939231|P1|Period 1: Single Dose|Insufficient urine production|0
2585119|NCT01184846|8939323|P1|Overall Study|Insufficient response|1
2585120|NCT01184846|8939323|P1|Overall Study|Adverse Event|2
2585121|NCT01184508|8939356|P2|Overall Study|Randomized, Not Treated|1
2585122|NCT01184508|8939357|P1|Overall Study|Randomized, Not Treated|0
2585123|NCT01184508|8939356|P2|Overall Study|Withdrawal by Subject|3
2585124|NCT01184508|8939357|P1|Overall Study|Withdrawal by Subject|1
2585125|NCT01184508|8939356|P2|Overall Study|Sponsor Decision|2
2585126|NCT01184508|8939357|P1|Overall Study|Sponsor Decision|5
2585127|NCT01184508|8939356|P2|Overall Study|Protocol Violation|1
2585128|NCT01184508|8939357|P1|Overall Study|Protocol Violation|3
2585129|NCT01184508|8939356|P2|Overall Study|Physician Decision|0
2585130|NCT01184508|8939357|P1|Overall Study|Physician Decision|1
2585131|NCT01184508|8939356|P2|Overall Study|Lost to Follow-up|1
2585132|NCT01184508|8939357|P1|Overall Study|Lost to Follow-up|1
2585133|NCT01184508|8939356|P2|Overall Study|Lack of Efficacy|1
2585134|NCT01184508|8939357|P1|Overall Study|Lack of Efficacy|1
2585135|NCT01184508|8939356|P2|Overall Study|Adverse Event|6
2585136|NCT01184508|8939357|P1|Overall Study|Adverse Event|4
2585137|NCT01184326|8939417|P3|Overall Study|Disease Progression|12
2585138|NCT01184326|8939418|P2|Overall Study|Disease Progression|3
2585139|NCT01184326|8939419|P1|Overall Study|Disease Progression|1
2585140|NCT01184326|8939417|P3|Overall Study|Physician Decision|0
2585141|NCT01184326|8939418|P2|Overall Study|Physician Decision|1
2585142|NCT01184326|8939419|P1|Overall Study|Physician Decision|1
2585143|NCT01184326|8939417|P3|Overall Study|Withdrawal by Subject|1
2585144|NCT01184326|8939418|P2|Overall Study|Withdrawal by Subject|0
2585145|NCT01184326|8939419|P1|Overall Study|Withdrawal by Subject|0
2585146|NCT01184326|8939417|P3|Overall Study|Death|1
2585147|NCT01184326|8939418|P2|Overall Study|Death|0
2585148|NCT01184326|8939419|P1|Overall Study|Death|0
2585149|NCT01184326|8939417|P3|Overall Study|Adverse Event|0
2585150|NCT01184326|8939418|P2|Overall Study|Adverse Event|2
2585151|NCT01184326|8939419|P1|Overall Study|Adverse Event|1
2585152|NCT01184118|8939433|P1|Overall Study|Withdrawal by Subject|5
2585153|NCT01184118|8939433|P1|Overall Study|Exclusionary medical condition|2
2585154|NCT01184118|8939433|P1|Overall Study|FEV1 <60% predicted|2
2585155|NCT01184118|8939433|P1|Overall Study|No physiologic confirmation of asthma|8
2585156|NCT01184118|8939433|P1|Overall Study|Only asthma step 1 - screen fail|1
2585157|NCT01184079|8939441|P2|Overall Study|Lost to Follow-up|2
2585158|NCT01184079|8939442|P1|Overall Study|Lost to Follow-up|14
2585159|NCT01184053|8939452|P1|Overall Study|progression while on treatment|3
2585160|NCT01183975|8939468|P1|Overall Study|Lost to Follow-up|73
2585161|NCT01183884|8939485|P1|Overall Study|Other|4
2585162|NCT01183884|8939485|P1|Overall Study|Not Treated|1
2585163|NCT01183884|8939485|P1|Overall Study|Other Complicating Disease|3
2585164|NCT01183884|8939485|P1|Overall Study|Withdrawal by Subject|1
2585165|NCT01183884|8939485|P1|Overall Study|Adverse Event|3
2585166|NCT01183884|8939485|P1|Overall Study|Progressive Disease|26
2585167|NCT01183858|8939493|P2|Overall Study|Lost to Follow-up|1
2585168|NCT01183858|8939494|P1|Overall Study|Lost to Follow-up|1
2585169|NCT01183858|8939493|P2|Overall Study|Death related to Progressive Disease|5
2585170|NCT01183858|8939494|P1|Overall Study|Death related to Progressive Disease|4
2585171|NCT01183858|8939493|P2|Overall Study|Progressive Disease|115
2585172|NCT01183858|8939494|P1|Overall Study|Progressive Disease|112
2585173|NCT01183858|8939493|P2|Overall Study|Administrative/Other|6
2585174|NCT01183858|8939494|P1|Overall Study|Administrative/Other|6
2585175|NCT01183858|8939493|P2|Overall Study|Protocol Violation|0
2585176|NCT01183858|8939494|P1|Overall Study|Protocol Violation|1
2585177|NCT01183858|8939493|P2|Overall Study|Discontinued Smoking|1
2585178|NCT01183858|8939494|P1|Overall Study|Discontinued Smoking|3
2585179|NCT01183858|8939493|P2|Overall Study|Withdrew Consent|4
2585180|NCT01183858|8939494|P1|Overall Study|Withdrew Consent|4
2585181|NCT01183858|8939493|P2|Overall Study|Refused Treatment|4
2585182|NCT01183858|8939494|P1|Overall Study|Refused Treatment|1
2585183|NCT01183858|8939493|P2|Overall Study|Insufficient Therapeutic Response|0
2585184|NCT01183858|8939494|P1|Overall Study|Insufficient Therapeutic Response|2
2585185|NCT01183858|8939493|P2|Overall Study|Investigator's Decision|3
2585186|NCT01183858|8939494|P1|Overall Study|Investigator's Decision|0
2585187|NCT01183858|8939493|P2|Overall Study|Adverse Event|11
2585188|NCT01183858|8939494|P1|Overall Study|Adverse Event|14
2585189|NCT01183858|8939493|P2|Overall Study|Death not related to Progressive Disease|6
2585190|NCT01183858|8939494|P1|Overall Study|Death not related to Progressive Disease|5
2585191|NCT01183780|8939516|P2|Overall Study|Lost to Follow-up|11
2585192|NCT01183780|8939517|P1|Overall Study|Lost to Follow-up|6
2585193|NCT01183780|8939516|P2|Overall Study|Withdrawal by Subject|14
2585194|NCT01183780|8939517|P1|Overall Study|Withdrawal by Subject|25
2585195|NCT01183468|8939650|P4|Overall Study|Withdrawal by Subject|0
2585196|NCT01183468|8939651|P3|Overall Study|Withdrawal by Subject|0
2585197|NCT01183468|8939652|P2|Overall Study|Withdrawal by Subject|1
2585198|NCT01183468|8939653|P1|Overall Study|Withdrawal by Subject|0
2585199|NCT01183468|8939650|P4|Overall Study|Physician Decision|0
2585200|NCT01183468|8939651|P3|Overall Study|Physician Decision|0
2585201|NCT01183468|8939652|P2|Overall Study|Physician Decision|0
2585202|NCT01183468|8939653|P1|Overall Study|Physician Decision|1
2585203|NCT01183468|8939650|P4|Overall Study|Lost to Follow-up|0
2585204|NCT01183468|8939651|P3|Overall Study|Lost to Follow-up|0
2585205|NCT01183468|8939652|P2|Overall Study|Lost to Follow-up|1
2585206|NCT01183468|8939653|P1|Overall Study|Lost to Follow-up|2
2585207|NCT01183390|8939675|P2|First Intervention|Adverse Event|1
2585208|NCT01183390|8939676|P1|First Intervention|Adverse Event|0
2585209|NCT01183260|8939709|P2|Overall Study|Death|0
2585210|NCT01183260|8939710|P1|Overall Study|Death|1
2585211|NCT01183260|8939709|P2|Overall Study|Revised within 30 days|1
2585212|NCT01183260|8939710|P1|Overall Study|Revised within 30 days|0
2585213|NCT01183260|8939709|P2|Overall Study|Withdrawal by Subject|1
2585214|NCT01183260|8939710|P1|Overall Study|Withdrawal by Subject|1
2585215|NCT01183260|8939709|P2|Overall Study|Intraop screen failure|0
2585216|NCT01183260|8939710|P1|Overall Study|Intraop screen failure|2
2585217|NCT01183234|8939720|P2|First Intervention|Adverse Event|0
2585218|NCT01183234|8939721|P1|First Intervention|Adverse Event|1
2585219|NCT01183143|8939813|P1|Overall Study|Subjects enrolled, but not treated|11
2585220|NCT01183143|8939813|P1|Overall Study|Subject Questionnaires not returned|5
2585221|NCT01183143|8939813|P1|Overall Study|Withdrawal by Subject|19
2585222|NCT01183143|8939813|P1|Overall Study|Protocol Violation|115
2585223|NCT01183104|8939829|P2|Overall Study|Did not receive study drug|9
2585224|NCT01183104|8939830|P1|Overall Study|Did not receive study drug|5
2585225|NCT01183104|8939829|P2|Overall Study|Nonparticipation in Extension Study|50
2585226|NCT01183104|8939830|P1|Overall Study|Nonparticipation in Extension Study|39
2585227|NCT01183104|8939829|P2|Overall Study|Withdrawal by Subject|11
2585228|NCT01183104|8939830|P1|Overall Study|Withdrawal by Subject|6
2585229|NCT01183104|8939829|P2|Overall Study|Physician Decision|8
2585230|NCT01183104|8939830|P1|Overall Study|Physician Decision|5
2585231|NCT01183104|8939829|P2|Overall Study|Lost to Follow-up|7
2585232|NCT01183104|8939830|P1|Overall Study|Lost to Follow-up|14
2585233|NCT01183104|8939829|P2|Overall Study|Death|1
2585234|NCT01183104|8939830|P1|Overall Study|Death|0
2585235|NCT01183104|8939829|P2|Overall Study|Adverse Event|6
2585236|NCT01183104|8939830|P1|Overall Study|Adverse Event|8
2585237|NCT01183065|8939846|P1|Overall Study|Patient no longer fits eligibility crite|1
2585238|NCT01183013|8939857|P7|Overall Study|Reasons other than stated above|13
2585239|NCT01183013|8939858|P6|Overall Study|Reasons other than stated above|15
2585240|NCT01183013|8939859|P5|Overall Study|Reasons other than stated above|12
2585241|NCT01183013|8939860|P4|Overall Study|Reasons other than stated above|12
2585242|NCT01183013|8939861|P3|Overall Study|Reasons other than stated above|17
2585243|NCT01183013|8939862|P2|Overall Study|Reasons other than stated above|11
2585244|NCT01183013|8939863|P1|Overall Study|Reasons other than stated above|15
2585245|NCT01183013|8939857|P7|Overall Study|Withdrawal by Subject|10
2585246|NCT01183013|8939858|P6|Overall Study|Withdrawal by Subject|9
2585247|NCT01183013|8939859|P5|Overall Study|Withdrawal by Subject|7
2585248|NCT01183013|8939860|P4|Overall Study|Withdrawal by Subject|8
2585249|NCT01183013|8939861|P3|Overall Study|Withdrawal by Subject|10
2585250|NCT01183013|8939862|P2|Overall Study|Withdrawal by Subject|13
2585251|NCT01183013|8939863|P1|Overall Study|Withdrawal by Subject|9
2585252|NCT01183013|8939857|P7|Overall Study|Lost to Follow-up|5
2585253|NCT01183013|8939858|P6|Overall Study|Lost to Follow-up|6
2585254|NCT01183013|8939859|P5|Overall Study|Lost to Follow-up|2
2585255|NCT01183013|8939860|P4|Overall Study|Lost to Follow-up|3
2585256|NCT01183013|8939861|P3|Overall Study|Lost to Follow-up|4
2585257|NCT01183013|8939862|P2|Overall Study|Lost to Follow-up|3
2585258|NCT01183013|8939863|P1|Overall Study|Lost to Follow-up|7
2585259|NCT01183013|8939857|P7|Overall Study|Protocol Violation|3
2585260|NCT01183013|8939858|P6|Overall Study|Protocol Violation|3
2585261|NCT01183013|8939859|P5|Overall Study|Protocol Violation|4
2585262|NCT01183013|8939860|P4|Overall Study|Protocol Violation|0
2585263|NCT01183013|8939861|P3|Overall Study|Protocol Violation|4
2585264|NCT01183013|8939862|P2|Overall Study|Protocol Violation|2
2585265|NCT01183013|8939863|P1|Overall Study|Protocol Violation|5
2585266|NCT01183013|8939857|P7|Overall Study|Lack of Efficacy|0
2585267|NCT01183013|8939858|P6|Overall Study|Lack of Efficacy|2
2585268|NCT01183013|8939859|P5|Overall Study|Lack of Efficacy|1
2585269|NCT01183013|8939860|P4|Overall Study|Lack of Efficacy|2
2585270|NCT01183013|8939861|P3|Overall Study|Lack of Efficacy|1
2585271|NCT01183013|8939862|P2|Overall Study|Lack of Efficacy|2
2585272|NCT01183013|8939863|P1|Overall Study|Lack of Efficacy|3
2585273|NCT01183013|8939857|P7|Overall Study|Adverse Event|6
2585274|NCT01183013|8939858|P6|Overall Study|Adverse Event|10
2585275|NCT01183013|8939859|P5|Overall Study|Adverse Event|10
2585276|NCT01183013|8939860|P4|Overall Study|Adverse Event|5
2585277|NCT01183013|8939861|P3|Overall Study|Adverse Event|5
2585278|NCT01183013|8939862|P2|Overall Study|Adverse Event|8
2585279|NCT01183013|8939863|P1|Overall Study|Adverse Event|6
2585280|NCT01182441|8940030|P2|Overall Study|Physician Decision|1
2585281|NCT01182441|8940031|P1|Overall Study|Physician Decision|1
2585282|NCT01182441|8940030|P2|Overall Study|Adverse Event|0
2585283|NCT01182441|8940031|P1|Overall Study|Adverse Event|2
2585284|NCT01182441|8940030|P2|Overall Study|Implant Not Attempted|0
2585285|NCT01182441|8940031|P1|Overall Study|Implant Not Attempted|4
2585286|NCT01182441|8940030|P2|Overall Study|Withdrawal by Subject|13
2585287|NCT01182441|8940031|P1|Overall Study|Withdrawal by Subject|6
2585288|NCT01182441|8940030|P2|Overall Study|Lost to Follow-up|8
2585289|NCT01182441|8940031|P1|Overall Study|Lost to Follow-up|5
2585290|NCT01182441|8940030|P2|Overall Study|Implant Attempt Unsuccessful|0
2585291|NCT01182441|8940031|P1|Overall Study|Implant Attempt Unsuccessful|13
2585292|NCT01182441|8940030|P2|Overall Study|Death|25
2585293|NCT01182441|8940031|P1|Overall Study|Death|37
2585294|NCT01182441|8940030|P2|Overall Study|Patient Still in Follow-up|72
2585295|NCT01182441|8940031|P1|Overall Study|Patient Still in Follow-up|152
2585296|NCT01182428|8940042|P2|Overall Study|Withdrawal by Subject|0
2585297|NCT01182428|8940043|P1|Overall Study|Withdrawal by Subject|1
2585298|NCT01182428|8940042|P2|Overall Study|Lost to Follow-up|1
2585299|NCT01182428|8940043|P1|Overall Study|Lost to Follow-up|9
2585300|NCT01182428|8940042|P2|Overall Study|Physician Decision|0
2585301|NCT01182428|8940043|P1|Overall Study|Physician Decision|1
2585302|NCT01182415|8940107|P1|Overall Study|Lost to Follow-up|1
2585303|NCT01182350|8940123|P5|Overall Study|Unevaluable for Biopsy|3
2585304|NCT01182350|8940124|P4|Overall Study|Unevaluable for Biopsy|0
2585305|NCT01182350|8940125|P3|Overall Study|Unevaluable for Biopsy|0
2585306|NCT01182350|8940126|P2|Overall Study|Unevaluable for Biopsy|0
2585307|NCT01182350|8940127|P1|Overall Study|Unevaluable for Biopsy|0
2585308|NCT01182350|8940123|P5|Overall Study|Travel Issue/Prefer Treatment at Home|0
2585309|NCT01182350|8940124|P4|Overall Study|Travel Issue/Prefer Treatment at Home|1
2585310|NCT01182350|8940125|P3|Overall Study|Travel Issue/Prefer Treatment at Home|1
2585311|NCT01182350|8940126|P2|Overall Study|Travel Issue/Prefer Treatment at Home|0
2585312|NCT01182350|8940127|P1|Overall Study|Travel Issue/Prefer Treatment at Home|2
2585313|NCT01182350|8940123|P5|Overall Study|Alternative Therapy|0
2585314|NCT01182350|8940124|P4|Overall Study|Alternative Therapy|0
2585315|NCT01182350|8940125|P3|Overall Study|Alternative Therapy|1
2585316|NCT01182350|8940126|P2|Overall Study|Alternative Therapy|0
2585317|NCT01182350|8940127|P1|Overall Study|Alternative Therapy|2
2585318|NCT01182350|8940123|P5|Overall Study|Withdrawal by Subject|0
2585319|NCT01182350|8940124|P4|Overall Study|Withdrawal by Subject|1
2585320|NCT01182350|8940125|P3|Overall Study|Withdrawal by Subject|0
2585321|NCT01182350|8940126|P2|Overall Study|Withdrawal by Subject|1
2585322|NCT01182350|8940127|P1|Overall Study|Withdrawal by Subject|3
2585323|NCT01182350|8940123|P5|Overall Study|Death|0
2585324|NCT01182350|8940124|P4|Overall Study|Death|0
2585325|NCT01182350|8940125|P3|Overall Study|Death|1
2585326|NCT01182350|8940126|P2|Overall Study|Death|1
2585327|NCT01182350|8940127|P1|Overall Study|Death|0
2585328|NCT01182350|8940123|P5|Overall Study|Disease Progression|0
2585329|NCT01182350|8940124|P4|Overall Study|Disease Progression|1
2585330|NCT01182350|8940125|P3|Overall Study|Disease Progression|0
2585331|NCT01182350|8940126|P2|Overall Study|Disease Progression|12
2585332|NCT01182350|8940127|P1|Overall Study|Disease Progression|15
2585333|NCT01182350|8940123|P5|Overall Study|Adverse Event|0
2585334|NCT01182350|8940124|P4|Overall Study|Adverse Event|0
2585335|NCT01182350|8940125|P3|Overall Study|Adverse Event|0
2585336|NCT01182350|8940126|P2|Overall Study|Adverse Event|0
2585337|NCT01182350|8940127|P1|Overall Study|Adverse Event|5
2585338|NCT01182337|8940149|P2|Overall Study|Lost to Follow-up|1
2585339|NCT01182337|8940150|P1|Overall Study|Lost to Follow-up|0
2585340|NCT01182337|8940149|P2|Overall Study|Withdrawal by Subject|1
2585341|NCT01182337|8940150|P1|Overall Study|Withdrawal by Subject|3
2585342|NCT01182298|8940168|P1|Overall Study|Withdrawal by Subject|2
2585343|NCT01182298|8940168|P1|Overall Study|Lack of Efficacy|4
2585344|NCT01182285|8940172|P3|Third Intervention Week 11-52|Other|2
2585345|NCT01182285|8940173|P2|Third Intervention Week 11-52|Other|0
2585346|NCT01182285|8940174|P1|Third Intervention Week 11-52|Other|0
2585347|NCT01182285|8940172|P3|Third Intervention Week 11-52|Disease Progression|6
2585348|NCT01182285|8940173|P2|Third Intervention Week 11-52|Disease Progression|0
2585349|NCT01182285|8940174|P1|Third Intervention Week 11-52|Disease Progression|0
2585350|NCT01182285|8940172|P3|First Intervention Week 1-10|Non-compliance|0
2585351|NCT01182285|8940173|P2|First Intervention Week 1-10|Non-compliance|0
2585352|NCT01182285|8940174|P1|First Intervention Week 1-10|Non-compliance|1
2585353|NCT01182285|8940172|P3|First Intervention Week 1-10|Adverse Event|0
2585354|NCT01182285|8940173|P2|First Intervention Week 1-10|Adverse Event|0
2585355|NCT01182285|8940174|P1|First Intervention Week 1-10|Adverse Event|1
2585356|NCT01182285|8940172|P3|First Intervention Week 1-10|Disease progression|0
2585357|NCT01182285|8940173|P2|First Intervention Week 1-10|Disease progression|0
2585358|NCT01182285|8940174|P1|First Intervention Week 1-10|Disease progression|1
2585359|NCT01182207|8940184|P2|Second Intervention|Emeses within 1 hour of dosing|0
2585360|NCT01182207|8940185|P1|Second Intervention|Emeses within 1 hour of dosing|1
2585361|NCT01182207|8940184|P2|First Intervention|Positive Hepatitis Results|1
2585362|NCT01182207|8940185|P1|First Intervention|Positive Hepatitis Results|0
2585363|NCT01182194|8940203|P2|Washout of 28 Days|Withdrawal by Subject|0
2585364|NCT01182194|8940204|P1|Washout of 28 Days|Withdrawal by Subject|1
2585365|NCT01182181|8940222|P2|Washout of 21 Days|Withdrawal by Subject|1
2585366|NCT01182181|8940223|P1|Washout of 21 Days|Withdrawal by Subject|0
2585367|NCT01182181|8940222|P2|First Intervention|Adverse Event|0
2585368|NCT01182181|8940223|P1|First Intervention|Adverse Event|1
2585369|NCT01181986|8940248|P3|Phase 2|Medical condition|0
2585370|NCT01181986|8940249|P2|Phase 2|Medical condition|1
2585371|NCT01181986|8940250|P1|Phase 2|Medical condition|0
2585372|NCT01181986|8940248|P3|Phase 2|Adverse Event|0
2585373|NCT01181986|8940249|P2|Phase 2|Adverse Event|3
2585374|NCT01181986|8940250|P1|Phase 2|Adverse Event|0
2585375|NCT01181986|8940248|P3|Phase 1|Protocol Violation|0
2585376|NCT01181986|8940249|P2|Phase 1|Protocol Violation|0
2585377|NCT01181986|8940250|P1|Phase 1|Protocol Violation|1
2585378|NCT01181986|8940248|P3|Phase 1|Adverse Event|1
2585379|NCT01181986|8940249|P2|Phase 1|Adverse Event|0
2585380|NCT01181986|8940250|P1|Phase 1|Adverse Event|0
2585381|NCT01181986|8940248|P3|Phase 1|Lost to Follow-up|1
2585382|NCT01181986|8940249|P2|Phase 1|Lost to Follow-up|1
2585383|NCT01181986|8940250|P1|Phase 1|Lost to Follow-up|0
2585384|NCT01181921|8940271|P1|Overall Study|Lost to Follow-up|1
2585385|NCT01181895|8940278|P3|Overall Study|Withdrawal by Subject|5
2585386|NCT01181895|8940279|P2|Overall Study|Withdrawal by Subject|0
2585387|NCT01181895|8940280|P1|Overall Study|Withdrawal by Subject|3
2585388|NCT01181895|8940278|P3|Overall Study|Investigator Discretion|1
2585389|NCT01181895|8940279|P2|Overall Study|Investigator Discretion|2
2585390|NCT01181895|8940280|P1|Overall Study|Investigator Discretion|1
2585391|NCT01181895|8940278|P3|Overall Study|Lost to Follow-up|2
2585392|NCT01181895|8940279|P2|Overall Study|Lost to Follow-up|1
2585393|NCT01181895|8940280|P1|Overall Study|Lost to Follow-up|0
2585394|NCT01181895|8940278|P3|Overall Study|Protocol Violation|0
2585395|NCT01181895|8940279|P2|Overall Study|Protocol Violation|1
2585396|NCT01181895|8940280|P1|Overall Study|Protocol Violation|2
2585397|NCT01181895|8940278|P3|Overall Study|Lack of Efficacy|9
2585398|NCT01181895|8940279|P2|Overall Study|Lack of Efficacy|9
2585399|NCT01181895|8940280|P1|Overall Study|Lack of Efficacy|8
2585400|NCT01181895|8940278|P3|Overall Study|Adverse Event|1
2585401|NCT01181895|8940279|P2|Overall Study|Adverse Event|1
2585402|NCT01181895|8940280|P1|Overall Study|Adverse Event|3
2585403|NCT01181778|8940338|P1|Overall Study|Physician Decision|48
2585404|NCT01181726|8940346|P2|First Intervention|Adverse Event|0
2585405|NCT01181726|8940347|P1|First Intervention|Adverse Event|1
2585406|NCT01181609|8940393|P1|Overall Study|Death|50
2585407|NCT01181609|8940393|P1|Overall Study|Lost to Follow-up|1
2585408|NCT01181609|8940393|P1|Overall Study|Withdrawal by Subject|1
2585409|NCT01181609|8940393|P1|Overall Study|Adverse Event|1
2585410|NCT01181531|8940411|P2|Overall Study|Adverse Event|1
2585411|NCT01181531|8940412|P1|Overall Study|Adverse Event|0
2585412|NCT01181531|8940411|P2|Overall Study|Death|12
2585413|NCT01181531|8940412|P1|Overall Study|Death|9
2585414|NCT01181531|8940411|P2|Overall Study|Protocol Violation|6
2585415|NCT01181531|8940412|P1|Overall Study|Protocol Violation|6
2585416|NCT01181531|8940411|P2|Overall Study|Withdrawal by Subject|7
2585417|NCT01181531|8940412|P1|Overall Study|Withdrawal by Subject|8
2585418|NCT01181531|8940411|P2|Overall Study|Pregnancy|1
2585419|NCT01181531|8940412|P1|Overall Study|Pregnancy|0
2585420|NCT01181531|8940411|P2|Overall Study|Protocol Specified Criteria|8
2585421|NCT01181531|8940412|P1|Overall Study|Protocol Specified Criteria|15
2585422|NCT01181531|8940411|P2|Overall Study|Ineligibility determined|2
2585423|NCT01181531|8940412|P1|Overall Study|Ineligibility determined|1
2585424|NCT01181531|8940411|P2|Overall Study|Noncompliance|2
2585425|NCT01181531|8940412|P1|Overall Study|Noncompliance|2
2585426|NCT01181531|8940411|P2|Overall Study|Physician Decision|1
2585427|NCT01181531|8940412|P1|Overall Study|Physician Decision|3
2585428|NCT01181531|8940411|P2|Overall Study|Partial consent by subject withdrawn|1
2585429|NCT01181531|8940412|P1|Overall Study|Partial consent by subject withdrawn|0
2585430|NCT01181531|8940411|P2|Overall Study|Other|12
2585431|NCT01181531|8940412|P1|Overall Study|Other|17
2585432|NCT01181271|8940554|P1|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1
2585433|NCT01181271|8940554|P1|Evaluation for Allogeneic Transplant|No suitable donor|2
2585434|NCT01181271|8940554|P1|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4
2585435|NCT01181271|8940554|P1|Evaluation for Allogeneic Transplant|Lack of Efficacy|6
2585436|NCT01181167|8940578|P2|Overall Study|Withdrawal by Subject|8
2585437|NCT01181167|8940579|P1|Overall Study|Withdrawal by Subject|6
2585438|NCT01181167|8940578|P2|Overall Study|Protocol Violation|0
2585439|NCT01181167|8940579|P1|Overall Study|Protocol Violation|3
2585440|NCT01181167|8940578|P2|Overall Study|Physician Decision|3
2585441|NCT01181167|8940579|P1|Overall Study|Physician Decision|2
2585442|NCT01181167|8940578|P2|Overall Study|Lost to Follow-up|0
2585443|NCT01181167|8940579|P1|Overall Study|Lost to Follow-up|1
2585444|NCT01181167|8940578|P2|Overall Study|Adverse Event|21
2585445|NCT01181167|8940579|P1|Overall Study|Adverse Event|11
2585446|NCT01181141|8940589|P2|Overall Study|Withdrawal by Subject|1
2585447|NCT01181141|8940590|P1|Overall Study|Withdrawal by Subject|3
2585448|NCT01181141|8940589|P2|Overall Study|Protocol Violation|1
2585449|NCT01181141|8940590|P1|Overall Study|Protocol Violation|3
2585450|NCT01181141|8940589|P2|Overall Study|Physician Decision|0
2585451|NCT01181141|8940590|P1|Overall Study|Physician Decision|2
2585452|NCT01181141|8940589|P2|Overall Study|Lost to Follow-up|1
2585453|NCT01181141|8940590|P1|Overall Study|Lost to Follow-up|1
2585454|NCT01181141|8940589|P2|Overall Study|Lack of Efficacy|0
2585455|NCT01181141|8940590|P1|Overall Study|Lack of Efficacy|1
2585456|NCT01181141|8940589|P2|Overall Study|Adverse Event|1
2585457|NCT01181141|8940590|P1|Overall Study|Adverse Event|2
2585458|NCT01181128|8940599|P3|Overall Study|Other|1
2585459|NCT01181128|8940600|P2|Overall Study|Other|1
2585460|NCT01181128|8940601|P1|Overall Study|Other|1
2585461|NCT01181128|8940599|P3|Overall Study|Adverse Event|0
2585462|NCT01181128|8940600|P2|Overall Study|Adverse Event|2
2585463|NCT01181128|8940601|P1|Overall Study|Adverse Event|0
2585464|NCT01181128|8940599|P3|Overall Study|Physician Decision|0
2585465|NCT01181128|8940600|P2|Overall Study|Physician Decision|0
2585466|NCT01181128|8940601|P1|Overall Study|Physician Decision|2
2585467|NCT01181128|8940599|P3|Overall Study|Death|0
2585468|NCT01181128|8940600|P2|Overall Study|Death|0
2585469|NCT01181128|8940601|P1|Overall Study|Death|1
2585470|NCT01181128|8940599|P3|Overall Study|Withdrawal by Subject|0
2585471|NCT01181128|8940600|P2|Overall Study|Withdrawal by Subject|2
2585472|NCT01181128|8940601|P1|Overall Study|Withdrawal by Subject|2
2585473|NCT01181102|8940689|P2|Overall Study|Withdrawal by Subject|12
2585474|NCT01181102|8940690|P1|Overall Study|Withdrawal by Subject|10
2585475|NCT01181102|8940689|P2|Overall Study|Protocol Violation|6
2585476|NCT01181102|8940690|P1|Overall Study|Protocol Violation|5
2585477|NCT01181102|8940689|P2|Overall Study|Physician Decision|1
2585478|NCT01181102|8940690|P1|Overall Study|Physician Decision|3
2585479|NCT01181102|8940689|P2|Overall Study|Lost to Follow-up|0
2585480|NCT01181102|8940690|P1|Overall Study|Lost to Follow-up|2
2585481|NCT01181102|8940689|P2|Overall Study|Lack of Efficacy|1
2585482|NCT01181102|8940690|P1|Overall Study|Lack of Efficacy|3
2585483|NCT01181102|8940689|P2|Overall Study|Adverse Event|26
2585484|NCT01181102|8940690|P1|Overall Study|Adverse Event|28
2585485|NCT01181011|8940734|P1|Overall Study|Lost to Follow-up|1
2585486|NCT01181011|8940734|P1|Overall Study|Adverse Event|2
2585487|NCT01180998|8940784|P3|Overall Study|Poor lens handling|2
2585488|NCT01180998|8940785|P2|Overall Study|Poor lens handling|0
2585489|NCT01180998|8940786|P1|Overall Study|Poor lens handling|0
2585490|NCT01180998|8940784|P3|Overall Study|Poor comfort|4
2585491|NCT01180998|8940785|P2|Overall Study|Poor comfort|0
2585492|NCT01180998|8940786|P1|Overall Study|Poor comfort|3
2585493|NCT01180998|8940784|P3|Overall Study|Withdrawal by Subject|1
2585494|NCT01180998|8940785|P2|Overall Study|Withdrawal by Subject|0
2585495|NCT01180998|8940786|P1|Overall Study|Withdrawal by Subject|0
2585496|NCT01180998|8940784|P3|Overall Study|Protocol Violation|0
2585497|NCT01180998|8940785|P2|Overall Study|Protocol Violation|2
2585498|NCT01180998|8940786|P1|Overall Study|Protocol Violation|1
2585499|NCT01180998|8940784|P3|Overall Study|Lost to Follow-up|1
2585500|NCT01180998|8940785|P2|Overall Study|Lost to Follow-up|0
2585501|NCT01180998|8940786|P1|Overall Study|Lost to Follow-up|0
2585502|NCT01180998|8940784|P3|Overall Study|Poor Vision|2
2585503|NCT01180998|8940785|P2|Overall Study|Poor Vision|2
2585504|NCT01180998|8940786|P1|Overall Study|Poor Vision|0
2585505|NCT01180985|8940800|P2|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0
2585506|NCT01180985|8940801|P1|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1
2585507|NCT01180790|8940840|P7|Overall Study|Severe coronary atherosclerosis (death)|0
2585508|NCT01180790|8940841|P6|Overall Study|Severe coronary atherosclerosis (death)|0
2585509|NCT01180790|8940842|P5|Overall Study|Severe coronary atherosclerosis (death)|0
2585510|NCT01180790|8940843|P4|Overall Study|Severe coronary atherosclerosis (death)|0
2585511|NCT01180790|8940844|P3|Overall Study|Severe coronary atherosclerosis (death)|1
2585512|NCT01180790|8940845|P2|Overall Study|Severe coronary atherosclerosis (death)|0
2585513|NCT01180790|8940846|P1|Overall Study|Severe coronary atherosclerosis (death)|0
2585514|NCT01180790|8940840|P7|Overall Study|compliance|0
2585515|NCT01180790|8940841|P6|Overall Study|compliance|0
2585516|NCT01180790|8940842|P5|Overall Study|compliance|0
2585517|NCT01180790|8940843|P4|Overall Study|compliance|0
2585518|NCT01180790|8940844|P3|Overall Study|compliance|0
2585519|NCT01180790|8940845|P2|Overall Study|compliance|1
2585520|NCT01180790|8940846|P1|Overall Study|compliance|0
2585521|NCT01180790|8940840|P7|Overall Study|Lack of Efficacy|0
2585522|NCT01180790|8940841|P6|Overall Study|Lack of Efficacy|3
2585523|NCT01180790|8940842|P5|Overall Study|Lack of Efficacy|1
2585524|NCT01180790|8940843|P4|Overall Study|Lack of Efficacy|6
2585525|NCT01180790|8940844|P3|Overall Study|Lack of Efficacy|5
2585526|NCT01180790|8940845|P2|Overall Study|Lack of Efficacy|2
2585527|NCT01180790|8940846|P1|Overall Study|Lack of Efficacy|1
2585528|NCT01180790|8940840|P7|Overall Study|Physician Decision|0
2585529|NCT01180790|8940841|P6|Overall Study|Physician Decision|0
2585530|NCT01180790|8940842|P5|Overall Study|Physician Decision|0
2585531|NCT01180790|8940843|P4|Overall Study|Physician Decision|1
2585532|NCT01180790|8940844|P3|Overall Study|Physician Decision|0
2585533|NCT01180790|8940845|P2|Overall Study|Physician Decision|0
2585534|NCT01180790|8940846|P1|Overall Study|Physician Decision|1
2585535|NCT01180790|8940840|P7|Overall Study|Lost to Follow-up|1
2585536|NCT01180790|8940841|P6|Overall Study|Lost to Follow-up|0
2585537|NCT01180790|8940842|P5|Overall Study|Lost to Follow-up|1
2585538|NCT01180790|8940843|P4|Overall Study|Lost to Follow-up|2
2585539|NCT01180790|8940844|P3|Overall Study|Lost to Follow-up|0
2585540|NCT01180790|8940845|P2|Overall Study|Lost to Follow-up|1
2585541|NCT01180790|8940846|P1|Overall Study|Lost to Follow-up|3
2585542|NCT01180790|8940840|P7|Overall Study|Withdrawal by Subject|0
2585543|NCT01180790|8940841|P6|Overall Study|Withdrawal by Subject|1
2585544|NCT01180790|8940842|P5|Overall Study|Withdrawal by Subject|2
2585545|NCT01180790|8940843|P4|Overall Study|Withdrawal by Subject|0
2585546|NCT01180790|8940844|P3|Overall Study|Withdrawal by Subject|5
2585547|NCT01180790|8940845|P2|Overall Study|Withdrawal by Subject|0
2585548|NCT01180790|8940846|P1|Overall Study|Withdrawal by Subject|3
2585549|NCT01180790|8940840|P7|Overall Study|Adverse Event|0
2585550|NCT01180790|8940841|P6|Overall Study|Adverse Event|3
2585551|NCT01180790|8940842|P5|Overall Study|Adverse Event|1
2585552|NCT01180790|8940843|P4|Overall Study|Adverse Event|0
2585553|NCT01180790|8940844|P3|Overall Study|Adverse Event|2
2585554|NCT01180790|8940845|P2|Overall Study|Adverse Event|1
2585555|NCT01180790|8940846|P1|Overall Study|Adverse Event|1
2585556|NCT01180777|8940911|P1|Overall Study|Adverse Event|1
2585557|NCT01180777|8940911|P1|Overall Study|Lost to Follow-up|1
2585558|NCT01180777|8940911|P1|Overall Study|Poor lens fit|4
2585559|NCT01180777|8940911|P1|Overall Study|Protocol Violation|6
2585560|NCT01180660|8940925|P2|Overall Study|Changed to open surgery|0
2585561|NCT01180660|8940926|P1|Overall Study|Changed to open surgery|1
2585562|NCT01180647|8940936|P2|Overall Study|Lost to Follow-up|6
2585563|NCT01180647|8940937|P1|Overall Study|Lost to Follow-up|5
2585564|NCT01180400|8940972|P2|Overall Study|Other|1
2585565|NCT01180400|8940973|P1|Overall Study|Other|0
2585566|NCT01180400|8940972|P2|Overall Study|Lost to Follow-up|3
2585567|NCT01180400|8940973|P1|Overall Study|Lost to Follow-up|2
2585568|NCT01180400|8940972|P2|Overall Study|Study-specific withdrawal criteria|2
2585569|NCT01180400|8940973|P1|Overall Study|Study-specific withdrawal criteria|1
2585570|NCT01180400|8940972|P2|Overall Study|Lack of Efficacy|0
2585571|NCT01180400|8940973|P1|Overall Study|Lack of Efficacy|2
2585572|NCT01180400|8940972|P2|Overall Study|Condition under investigation worsened|1
2585573|NCT01180400|8940973|P1|Overall Study|Condition under investigation worsened|2
2585574|NCT01180400|8940972|P2|Overall Study|Severe non-compliance to protocol|2
2585575|NCT01180400|8940973|P1|Overall Study|Severe non-compliance to protocol|1
2585576|NCT01180400|8940972|P2|Overall Study|Adverse Event|10
2585577|NCT01180400|8940973|P1|Overall Study|Adverse Event|12
2585578|NCT01180400|8940972|P2|Overall Study|Eligibility criteria not fulfilled|2
2585579|NCT01180400|8940973|P1|Overall Study|Eligibility criteria not fulfilled|0
2585580|NCT01180400|8940972|P2|Overall Study|Withdrawal by Subject|6
2585581|NCT01180400|8940973|P1|Overall Study|Withdrawal by Subject|5
2585582|NCT01180296|8941021|P2|Overall Study|Protocol Violation|2
2585583|NCT01180296|8941022|P1|Overall Study|Protocol Violation|1
2585584|NCT01180244|8941032|P2|Overall Study|Lost to Follow-up|0
2585585|NCT01180244|8941033|P1|Overall Study|Lost to Follow-up|1
2585586|NCT01180244|8941032|P2|Overall Study|Protocol Violation|0
2585587|NCT01180244|8941033|P1|Overall Study|Protocol Violation|1
2585588|NCT01180244|8941032|P2|Overall Study|Withdrawal by Subject|1
2585589|NCT01180244|8941033|P1|Overall Study|Withdrawal by Subject|0
2585590|NCT01180244|8941032|P2|Overall Study|Adverse Event|0
2585591|NCT01180244|8941033|P1|Overall Study|Adverse Event|1
2585592|NCT01180244|8941032|P2|Overall Study|Physician Decision|0
2585593|NCT01180244|8941033|P1|Overall Study|Physician Decision|3
2585594|NCT01180244|8941032|P2|Overall Study|Lack of Efficacy|7
2585595|NCT01180244|8941033|P1|Overall Study|Lack of Efficacy|0
2585596|NCT01180049|8941078|P2|Overall Study|Death|35
2585597|NCT01180049|8941079|P1|Overall Study|Death|36
2585598|NCT01180049|8941078|P2|Overall Study|Lost to Follow-up|6
2585599|NCT01180049|8941079|P1|Overall Study|Lost to Follow-up|8
2585600|NCT01180049|8941078|P2|Overall Study|Other|7
2585601|NCT01180049|8941079|P1|Overall Study|Other|9
2585602|NCT01179919|8941116|P1|Overall Study|Adverse Event|1
2585603|NCT01179919|8941116|P1|Overall Study|Protocol Violation|1
2585604|NCT01179737|8941125|P4|Extension|The study was terminated|0
2585605|NCT01179737|8941126|P3|Extension|The study was terminated|0
2585606|NCT01179737|8941127|P2|Extension|The study was terminated|0
2585607|NCT01179737|8941128|P1|Extension|The study was terminated|3
2585608|NCT01179737|8941125|P4|Cohort 1 & Cohort 2 Expansion|Death|0
2585609|NCT01179737|8941126|P3|Cohort 1 & Cohort 2 Expansion|Death|0
2585610|NCT01179737|8941127|P2|Cohort 1 & Cohort 2 Expansion|Death|0
2585611|NCT01179737|8941128|P1|Cohort 1 & Cohort 2 Expansion|Death|1
2585612|NCT01179737|8941125|P4|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
2585613|NCT01179737|8941126|P3|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
2585614|NCT01179737|8941127|P2|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1
2585615|NCT01179737|8941128|P1|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
2585616|NCT01179737|8941125|P4|Cohort 1 & Cohort 2|Death|0
2585617|NCT01179737|8941126|P3|Cohort 1 & Cohort 2|Death|1
2585618|NCT01179737|8941127|P2|Cohort 1 & Cohort 2|Death|0
2585619|NCT01179737|8941128|P1|Cohort 1 & Cohort 2|Death|0
2585620|NCT01179737|8941125|P4|Cohort 1 & Cohort 2|Administrative problems|4
2585621|NCT01179737|8941126|P3|Cohort 1 & Cohort 2|Administrative problems|2
2585622|NCT01179737|8941127|P2|Cohort 1 & Cohort 2|Administrative problems|0
2585623|NCT01179737|8941128|P1|Cohort 1 & Cohort 2|Administrative problems|0
2585624|NCT01179737|8941125|P4|Cohort 1 & Cohort 2|Withdrew consent|0
2585625|NCT01179737|8941126|P3|Cohort 1 & Cohort 2|Withdrew consent|0
2585626|NCT01179737|8941127|P2|Cohort 1 & Cohort 2|Withdrew consent|0
2585627|NCT01179737|8941128|P1|Cohort 1 & Cohort 2|Withdrew consent|2
2585628|NCT01179737|8941125|P4|Cohort 1 & Cohort 2|Adverse Event|0
2585629|NCT01179737|8941126|P3|Cohort 1 & Cohort 2|Adverse Event|1
2585630|NCT01179737|8941127|P2|Cohort 1 & Cohort 2|Adverse Event|1
2585631|NCT01179737|8941128|P1|Cohort 1 & Cohort 2|Adverse Event|3
2585632|NCT01179672|8941139|P2|Overall Study|Physician Decision|1
2585633|NCT01179672|8941140|P1|Overall Study|Physician Decision|1
2585634|NCT01179672|8941139|P2|Overall Study|Protocol Violation|2
2585635|NCT01179672|8941140|P1|Overall Study|Protocol Violation|2
2585636|NCT01179672|8941139|P2|Overall Study|Lost to Follow-up|1
2585637|NCT01179672|8941140|P1|Overall Study|Lost to Follow-up|0
2585638|NCT01179672|8941139|P2|Overall Study|Entry Criteria Not Met|2
2585639|NCT01179672|8941140|P1|Overall Study|Entry Criteria Not Met|0
2585640|NCT01179672|8941139|P2|Overall Study|Withdrawal by Subject|12
2585641|NCT01179672|8941140|P1|Overall Study|Withdrawal by Subject|10
2585642|NCT01179672|8941139|P2|Overall Study|Adverse Event|8
2585643|NCT01179672|8941140|P1|Overall Study|Adverse Event|17
2585644|NCT01179516|8941196|P3|Overall Study|Other|2
2585645|NCT01179516|8941197|P2|Overall Study|Other|0
2585646|NCT01179516|8941198|P1|Overall Study|Other|2
2585647|NCT01179516|8941196|P3|Overall Study|Lost to Follow-up|3
2585648|NCT01179516|8941197|P2|Overall Study|Lost to Follow-up|7
2585649|NCT01179516|8941198|P1|Overall Study|Lost to Follow-up|7
2585650|NCT01179516|8941196|P3|Overall Study|Withdrawal of Consent|10
2585651|NCT01179516|8941197|P2|Overall Study|Withdrawal of Consent|6
2585652|NCT01179516|8941198|P1|Overall Study|Withdrawal of Consent|2
2585653|NCT01179516|8941196|P3|Overall Study|Protocol Deviations|3
2585654|NCT01179516|8941197|P2|Overall Study|Protocol Deviations|3
2585655|NCT01179516|8941198|P1|Overall Study|Protocol Deviations|4
2585656|NCT01179516|8941196|P3|Overall Study|Noncompliance with Study Drug|1
2585657|NCT01179516|8941197|P2|Overall Study|Noncompliance with Study Drug|0
2585658|NCT01179516|8941198|P1|Overall Study|Noncompliance with Study Drug|2
2585659|NCT01179516|8941196|P3|Overall Study|Lack of Efficacy|0
2585660|NCT01179516|8941197|P2|Overall Study|Lack of Efficacy|2
2585661|NCT01179516|8941198|P1|Overall Study|Lack of Efficacy|4
2585662|NCT01179516|8941196|P3|Overall Study|Pretreatment Event or Adverse Event|12
2585663|NCT01179516|8941197|P2|Overall Study|Pretreatment Event or Adverse Event|8
2585664|NCT01179516|8941198|P1|Overall Study|Pretreatment Event or Adverse Event|6
2585665|NCT01179477|8941242|P1|Overall Study|Did not complete final visit|27
2585666|NCT01179477|8941242|P1|Overall Study|Non-death withdrawal|438
2585667|NCT01179477|8941242|P1|Overall Study|Unsuccessful implant|80
2585668|NCT01179477|8941242|P1|Overall Study|Death|542
2585669|NCT01179399|8941247|P1|Overall Study|Withdrawal by Subject|1
2585670|NCT01179399|8941247|P1|Overall Study|Lack of Efficacy|30
2585671|NCT01179399|8941247|P1|Overall Study|Adverse Event|1
2585672|NCT01179347|8941253|P2|Open-label Period (12 Weeks)|Other|4
2585673|NCT01179347|8941254|P1|Open-label Period (12 Weeks)|Other|7
2585674|NCT01179347|8941253|P2|Open-label Period (12 Weeks)|Protocol Violation|0
2585675|NCT01179347|8941254|P1|Open-label Period (12 Weeks)|Protocol Violation|1
2585676|NCT01179347|8941253|P2|Open-label Period (12 Weeks)|Withdrawal by Subject|1
2585677|NCT01179347|8941254|P1|Open-label Period (12 Weeks)|Withdrawal by Subject|1
2585678|NCT01179347|8941253|P2|Open-label Period (12 Weeks)|Lost to Follow-up|0
2585679|NCT01179347|8941254|P1|Open-label Period (12 Weeks)|Lost to Follow-up|1
2585680|NCT01179347|8941253|P2|Open-label Period (12 Weeks)|Lack of Efficacy|2
2585681|NCT01179347|8941254|P1|Open-label Period (12 Weeks)|Lack of Efficacy|0
2585682|NCT01179347|8941253|P2|Open-label Period (12 Weeks)|Adverse Event|9
2585683|NCT01179347|8941254|P1|Open-label Period (12 Weeks)|Adverse Event|5
2585684|NCT01179347|8941253|P2|Double-blind Period (12 Weeks)|Other|4
2585685|NCT01179347|8941254|P1|Double-blind Period (12 Weeks)|Other|2
2585686|NCT01179347|8941253|P2|Double-blind Period (12 Weeks)|Withdrawal by Subject|2
2585687|NCT01179347|8941254|P1|Double-blind Period (12 Weeks)|Withdrawal by Subject|1
2585688|NCT01179347|8941253|P2|Double-blind Period (12 Weeks)|Lost to Follow-up|2
2585689|NCT01179347|8941254|P1|Double-blind Period (12 Weeks)|Lost to Follow-up|1
2585690|NCT01179347|8941253|P2|Double-blind Period (12 Weeks)|Protocol Violation|0
2585691|NCT01179347|8941254|P1|Double-blind Period (12 Weeks)|Protocol Violation|2
2585692|NCT01179347|8941253|P2|Double-blind Period (12 Weeks)|Adverse Event|6
2585693|NCT01179347|8941254|P1|Double-blind Period (12 Weeks)|Adverse Event|2
2585694|NCT01179334|8941276|P2|Long-term Extension (LTE) Period|Adverse Event|4
2585695|NCT01179334|8941277|P1|Long-term Extension (LTE) Period|Adverse Event|2
2585696|NCT01179334|8941276|P2|Long-term Extension (LTE) Period|Death|0
2585697|NCT01179334|8941277|P1|Long-term Extension (LTE) Period|Death|3
2585698|NCT01179334|8941276|P2|Long-term Extension (LTE) Period|Study terminated by sponsor|2
2585699|NCT01179334|8941277|P1|Long-term Extension (LTE) Period|Study terminated by sponsor|6
2585700|NCT01179334|8941276|P2|Treatment Period|Adverse Event|0
2585701|NCT01179334|8941277|P1|Treatment Period|Adverse Event|1
2585702|NCT01179191|8941332|P1|Maintenance Phase (8 Weeks)|Other|66
2585703|NCT01179191|8941332|P1|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29
2585704|NCT01179191|8941332|P1|Maintenance Phase (8 Weeks)|Physician Decision|3
2585705|NCT01179191|8941332|P1|Maintenance Phase (8 Weeks)|Lost to Follow-up|9
2585706|NCT01179191|8941332|P1|Maintenance Phase (8 Weeks)|Adverse Event|10
2585707|NCT01179191|8941332|P1|Titration Phase (up to 6 Weeks)|Other|62
2585708|NCT01179191|8941332|P1|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13
2585709|NCT01179191|8941332|P1|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162
2585710|NCT01179191|8941332|P1|Titration Phase (up to 6 Weeks)|Physician Decision|30
2585711|NCT01179191|8941332|P1|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19
2585712|NCT01179191|8941332|P1|Titration Phase (up to 6 Weeks)|Adverse Event|47
2585713|NCT01179048|8941364|P2|Overall Study|Alive|142
2585714|NCT01179048|8941365|P1|Overall Study|Alive|127
2585715|NCT01179048|8941364|P2|Overall Study|Lost to Follow-up|9
2585716|NCT01179048|8941365|P1|Overall Study|Lost to Follow-up|8
2585717|NCT01179048|8941364|P2|Overall Study|Withdrawn - does not allow contact|8
2585718|NCT01179048|8941365|P1|Overall Study|Withdrawn - does not allow contact|4
2585719|NCT01178853|8941392|P2|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1
2585720|NCT01178853|8941393|P1|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0
2585721|NCT01178853|8941392|P2|Period 4 (Warfarin + Study Drug)|Adverse Event|2
2585722|NCT01178853|8941393|P1|Period 4 (Warfarin + Study Drug)|Adverse Event|0
2585723|NCT01178853|8941392|P2|Period 3 (Warfarin Titration)|Adverse Event|0
2585724|NCT01178853|8941393|P1|Period 3 (Warfarin Titration)|Adverse Event|1
2585725|NCT01178853|8941392|P2|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0
2585726|NCT01178853|8941393|P1|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1
2585727|NCT01178853|8941392|P2|Period 1 (Warfarin Titration)|INR Out of Range|2
2585728|NCT01178853|8941393|P1|Period 1 (Warfarin Titration)|INR Out of Range|1
2585729|NCT01178762|8941433|P1|Overall Study|Lost to Follow-up|15
2585730|NCT01178671|8941439|P2|Overall Study|Physician Decision|6
2585731|NCT01178671|8941440|P1|Overall Study|Physician Decision|4
2585732|NCT01178671|8941439|P2|Overall Study|Lost to Follow-up|1
2585733|NCT01178671|8941440|P1|Overall Study|Lost to Follow-up|3
2585734|NCT01178671|8941439|P2|Overall Study|Lack of Efficacy|1
2585735|NCT01178671|8941440|P1|Overall Study|Lack of Efficacy|0
2585736|NCT01178671|8941439|P2|Overall Study|Protocol Violation|1
2585737|NCT01178671|8941440|P1|Overall Study|Protocol Violation|1
2585738|NCT01178671|8941439|P2|Overall Study|Adverse Event|6
2585739|NCT01178671|8941440|P1|Overall Study|Adverse Event|4
2585740|NCT01178385|8941488|P2|Overall Study|Withdrawal by Subject|0
2585741|NCT01178385|8941489|P1|Overall Study|Withdrawal by Subject|2
2585742|NCT01178294|8941558|P1|Overall Study|Completion status could not be verified|1
2585743|NCT01178294|8941558|P1|Overall Study|Subject status is terminal|1
2585744|NCT01178294|8941558|P1|Overall Study|Development of inhibitors to OBI-1|1
2585745|NCT01178294|8941558|P1|Overall Study|Death|1
2585746|NCT01178294|8941558|P1|Overall Study|Lack of Efficacy|1
2585747|NCT01178294|8941558|P1|Overall Study|Lost to Follow-up|2
2585748|NCT01178294|8941558|P1|Overall Study|Adverse Event|4
2585749|NCT01178138|8941838|P1|Overall Study|Physician Decision|8
2585750|NCT01178138|8941838|P1|Overall Study|Withdrawal by Subject|7
2585751|NCT01178138|8941838|P1|Overall Study|Lost to Follow-up|8
2585752|NCT01178125|8941859|P1|Overall Study|Investigator Decision|5
2585753|NCT01178125|8941859|P1|Overall Study|Protocol Violation|17
2585754|NCT01178125|8941859|P1|Overall Study|Sponsor Decision|28
2585755|NCT01178125|8941859|P1|Overall Study|Other Reason|39
2585756|NCT01178125|8941859|P1|Overall Study|Pregnancy|55
2585757|NCT01178125|8941859|P1|Overall Study|Noncompliance|184
2585758|NCT01178125|8941859|P1|Overall Study|Withdrawal by Subject|209
2585759|NCT01178125|8941859|P1|Overall Study|Adverse Event|244
2585760|NCT01178125|8941859|P1|Overall Study|Lost to Follow-up|397
2585761|NCT01178099|8941890|P2|Overall Study|Physician Decision|1
2585762|NCT01178099|8941891|P1|Overall Study|Physician Decision|0
2585763|NCT01178086|8941931|P1|Overall Study|Excluded from EAS|20
2585764|NCT01178086|8941931|P1|Overall Study|Other unspecified|89
2585765|NCT01178086|8941931|P1|Overall Study|Death|59
2585766|NCT01178086|8941931|P1|Overall Study|Switch to other CLL therapy|113
2585767|NCT01178086|8941931|P1|Overall Study|Physician Decision|44
2585768|NCT01178086|8941931|P1|Overall Study|Participant refusal|7
2585769|NCT01178073|8941958|P3|Overall Study|Missing Completion Status|0
2585770|NCT01178073|8941959|P2|Overall Study|Missing Completion Status|0
2585771|NCT01178073|8941960|P1|Overall Study|Missing Completion Status|1
2585772|NCT01178073|8941958|P3|Overall Study|Withdrawal by Subject|8
2585773|NCT01178073|8941959|P2|Overall Study|Withdrawal by Subject|6
2585774|NCT01178073|8941960|P1|Overall Study|Withdrawal by Subject|10
2585775|NCT01178073|8941958|P3|Overall Study|Physician Decision|10
2585776|NCT01178073|8941959|P2|Overall Study|Physician Decision|10
2585777|NCT01178073|8941960|P1|Overall Study|Physician Decision|14
2585778|NCT01178073|8941958|P3|Overall Study|Lost to Follow-up|3
2585779|NCT01178073|8941959|P2|Overall Study|Lost to Follow-up|0
2585780|NCT01178073|8941960|P1|Overall Study|Lost to Follow-up|2
2585781|NCT01178073|8941958|P3|Overall Study|Protocol Violation|1
2585782|NCT01178073|8941959|P2|Overall Study|Protocol Violation|1
2585783|NCT01178073|8941960|P1|Overall Study|Protocol Violation|1
2585784|NCT01178073|8941958|P3|Overall Study|Adverse Event|24
2585785|NCT01178073|8941959|P2|Overall Study|Adverse Event|27
2585786|NCT01178073|8941960|P1|Overall Study|Adverse Event|34
2585787|NCT01177969|8941991|P2|Overall Study|Withdrawal by Subject|2
2585788|NCT01177969|8941992|P1|Overall Study|Withdrawal by Subject|1
2585789|NCT01177969|8941991|P2|Overall Study|Protocol Violation|1
2585790|NCT01177969|8941992|P1|Overall Study|Protocol Violation|2
2585791|NCT01177943|8942015|P2|First Intervention|Withdrawal by Subject|0
2585792|NCT01177943|8942016|P1|First Intervention|Withdrawal by Subject|2
2585793|NCT01177813|8942029|P5|Overall Study|Other reason not defined above|2
2585794|NCT01177813|8942030|P4|Overall Study|Other reason not defined above|3
2585795|NCT01177813|8942031|P3|Overall Study|Other reason not defined above|2
2585796|NCT01177813|8942032|P2|Overall Study|Other reason not defined above|2
2585797|NCT01177813|8942033|P1|Overall Study|Other reason not defined above|5
2585798|NCT01177813|8942029|P5|Overall Study|Withdrawal by Subject|3
2585799|NCT01177813|8942030|P4|Overall Study|Withdrawal by Subject|5
2585800|NCT01177813|8942031|P3|Overall Study|Withdrawal by Subject|6
2585801|NCT01177813|8942032|P2|Overall Study|Withdrawal by Subject|7
2585802|NCT01177813|8942033|P1|Overall Study|Withdrawal by Subject|12
2585803|NCT01177813|8942029|P5|Overall Study|Lost to Follow-up|0
2585804|NCT01177813|8942030|P4|Overall Study|Lost to Follow-up|3
2585805|NCT01177813|8942031|P3|Overall Study|Lost to Follow-up|6
2585806|NCT01177813|8942032|P2|Overall Study|Lost to Follow-up|5
2585807|NCT01177813|8942033|P1|Overall Study|Lost to Follow-up|12
2585808|NCT01177813|8942029|P5|Overall Study|Protocol Violation|1
2585809|NCT01177813|8942030|P4|Overall Study|Protocol Violation|0
2585810|NCT01177813|8942031|P3|Overall Study|Protocol Violation|2
2585811|NCT01177813|8942032|P2|Overall Study|Protocol Violation|2
2585812|NCT01177813|8942033|P1|Overall Study|Protocol Violation|3
2585813|NCT01177813|8942029|P5|Overall Study|Lack of Efficacy|0
2585814|NCT01177813|8942030|P4|Overall Study|Lack of Efficacy|0
2585815|NCT01177813|8942031|P3|Overall Study|Lack of Efficacy|0
2585816|NCT01177813|8942032|P2|Overall Study|Lack of Efficacy|0
2585817|NCT01177813|8942033|P1|Overall Study|Lack of Efficacy|1
2585818|NCT01177813|8942029|P5|Overall Study|Adverse Event|3
2585819|NCT01177813|8942030|P4|Overall Study|Adverse Event|6
2585820|NCT01177813|8942031|P3|Overall Study|Adverse Event|4
2585821|NCT01177813|8942032|P2|Overall Study|Adverse Event|2
2585822|NCT01177813|8942033|P1|Overall Study|Adverse Event|8
2585823|NCT01177800|8942062|P2|Overall Study|Withdrawal of informed consent|1
2585824|NCT01177800|8942063|P1|Overall Study|Withdrawal of informed consent|0
2585825|NCT01177800|8942062|P2|Overall Study|Physician Decision|0
2585826|NCT01177800|8942063|P1|Overall Study|Physician Decision|1
2585827|NCT01177800|8942062|P2|Overall Study|Protocol Violation|1
2585828|NCT01177800|8942063|P1|Overall Study|Protocol Violation|0
2585829|NCT01177800|8942062|P2|Overall Study|Adverse Event|3
2585830|NCT01177800|8942063|P1|Overall Study|Adverse Event|9
2585831|NCT01177722|8942085|P4|Overall Study|Withdrawal by Subject|6
2585832|NCT01177722|8942086|P3|Overall Study|Withdrawal by Subject|4
2585833|NCT01177722|8942087|P2|Overall Study|Withdrawal by Subject|6
2585834|NCT01177722|8942088|P1|Overall Study|Withdrawal by Subject|10
2585835|NCT01177722|8942085|P4|Overall Study|Lost to Follow-up|1
2585836|NCT01177722|8942086|P3|Overall Study|Lost to Follow-up|3
2585837|NCT01177722|8942087|P2|Overall Study|Lost to Follow-up|4
2585838|NCT01177722|8942088|P1|Overall Study|Lost to Follow-up|3
2585839|NCT01177722|8942085|P4|Overall Study|Protocol Violation|0
2585840|NCT01177722|8942086|P3|Overall Study|Protocol Violation|1
2585841|NCT01177722|8942087|P2|Overall Study|Protocol Violation|0
2585842|NCT01177722|8942088|P1|Overall Study|Protocol Violation|0
2585843|NCT01177722|8942085|P4|Overall Study|Serious Adverse Event|0
2585844|NCT01177722|8942086|P3|Overall Study|Serious Adverse Event|1
2585845|NCT01177722|8942087|P2|Overall Study|Serious Adverse Event|0
2585846|NCT01177722|8942088|P1|Overall Study|Serious Adverse Event|0
2585847|NCT01177670|8942120|P1|Overall Study|Withdrawal by Subject|4
2585848|NCT01177670|8942120|P1|Overall Study|Physician Decision|50
2585849|NCT01177670|8942120|P1|Overall Study|Study Terminated|115
2585850|NCT01177553|8942127|P2|Overall Study|babies not yet 6 months of age|0
2585851|NCT01177553|8942128|P1|Overall Study|babies not yet 6 months of age|1
2585852|NCT01177410|8942137|P3|Overall Study|Lost to Follow-up|0
2585853|NCT01177410|8942138|P2|Overall Study|Lost to Follow-up|1
2585854|NCT01177410|8942139|P1|Overall Study|Lost to Follow-up|0
2585855|NCT01177410|8942137|P3|Overall Study|Withdrawal by Subject|3
2585856|NCT01177410|8942138|P2|Overall Study|Withdrawal by Subject|4
2585857|NCT01177410|8942139|P1|Overall Study|Withdrawal by Subject|1
2585858|NCT01177410|8942137|P3|Overall Study|Adverse Event|2
2585859|NCT01177410|8942138|P2|Overall Study|Adverse Event|2
2585860|NCT01177410|8942139|P1|Overall Study|Adverse Event|0
2585861|NCT01177384|8942152|P2|Overall Study|Withdrawal by Subject|12
2585862|NCT01177384|8942153|P1|Overall Study|Withdrawal by Subject|5
2585863|NCT01177384|8942152|P2|Overall Study|Protocol Violation|2
2585864|NCT01177384|8942153|P1|Overall Study|Protocol Violation|0
2585865|NCT01177384|8942152|P2|Overall Study|Physician Decision|3
2585866|NCT01177384|8942153|P1|Overall Study|Physician Decision|0
2585867|NCT01177384|8942152|P2|Overall Study|Lost to Follow-up|4
2585868|NCT01177384|8942153|P1|Overall Study|Lost to Follow-up|3
2585869|NCT01177384|8942152|P2|Overall Study|Lack of Efficacy|1
2585870|NCT01177384|8942153|P1|Overall Study|Lack of Efficacy|0
2585871|NCT01177384|8942152|P2|Overall Study|Adverse Event|4
2585872|NCT01177384|8942153|P1|Overall Study|Adverse Event|6
2585873|NCT01177293|8942165|P2|Washout Period (of 14 Days)|Lost to Follow-up|1
2585874|NCT01177293|8942166|P1|Washout Period (of 14 Days)|Lost to Follow-up|0
2585875|NCT01177228|8942184|P4|Overall Study|Withdrawal by Subject|0
2585876|NCT01177228|8942185|P3|Overall Study|Withdrawal by Subject|0
2585877|NCT01177228|8942186|P2|Overall Study|Withdrawal by Subject|1
2585878|NCT01177228|8942187|P1|Overall Study|Withdrawal by Subject|0
2585879|NCT01177228|8942184|P4|Overall Study|Worsening disease activity|0
2585880|NCT01177228|8942185|P3|Overall Study|Worsening disease activity|0
2585881|NCT01177228|8942186|P2|Overall Study|Worsening disease activity|0
2585882|NCT01177228|8942187|P1|Overall Study|Worsening disease activity|1
2585883|NCT01177228|8942184|P4|Overall Study|Positive tuberculosis test|0
2585884|NCT01177228|8942185|P3|Overall Study|Positive tuberculosis test|0
2585885|NCT01177228|8942186|P2|Overall Study|Positive tuberculosis test|1
2585886|NCT01177228|8942187|P1|Overall Study|Positive tuberculosis test|0
2585887|NCT01177137|8942241|P3|Overall Study|Withdrawal by Subject|2
2585888|NCT01177137|8942242|P2|Overall Study|Withdrawal by Subject|10
2585889|NCT01177137|8942243|P1|Overall Study|Withdrawal by Subject|10
2585890|NCT01177059|8942327|P1|Overall Study|Lost to Follow-up|18
2585891|NCT01177059|8942327|P1|Overall Study|Withdrew consent|2
2585892|NCT01177059|8942327|P1|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30
2585893|NCT01177007|8942333|P1|Overall Study|Change in treatment modality|21
2585894|NCT01177007|8942333|P1|Overall Study|Required additional Y90 treatment|6
2585895|NCT01177007|8942333|P1|Overall Study|Entered hospice care|5
2585896|NCT01177007|8942333|P1|Overall Study|Death|4
2585897|NCT01177007|8942333|P1|Overall Study|Lost to Follow-up|2
2585898|NCT01176968|8942347|P2|Overall Study|Reason not defined|3
2585899|NCT01176968|8942348|P1|Overall Study|Reason not defined|5
2585900|NCT01176968|8942347|P2|Overall Study|Study terminated by sponsor|1
2585901|NCT01176968|8942348|P1|Overall Study|Study terminated by sponsor|0
2585902|NCT01176968|8942347|P2|Overall Study|Did Not Meet Entrance Criteria|0
2585903|NCT01176968|8942348|P1|Overall Study|Did Not Meet Entrance Criteria|1
2585904|NCT01176968|8942347|P2|Overall Study|Protocol Violation|1
2585905|NCT01176968|8942348|P1|Overall Study|Protocol Violation|2
2585906|NCT01176968|8942347|P2|Overall Study|Withdrawal by Subject|48
2585907|NCT01176968|8942348|P1|Overall Study|Withdrawal by Subject|48
2585908|NCT01176968|8942347|P2|Overall Study|Lost to Follow-up|14
2585909|NCT01176968|8942348|P1|Overall Study|Lost to Follow-up|16
2585910|NCT01176968|8942347|P2|Overall Study|Lack of Efficacy|1
2585911|NCT01176968|8942348|P1|Overall Study|Lack of Efficacy|0
2585912|NCT01176968|8942347|P2|Overall Study|Death|3
2585913|NCT01176968|8942348|P1|Overall Study|Death|2
2585914|NCT01176968|8942347|P2|Overall Study|Adverse Event|11
2585915|NCT01176968|8942348|P1|Overall Study|Adverse Event|10
2585916|NCT01176773|8942399|P1|Overall Study|Withdrew consent|1
2585917|NCT01176773|8942399|P1|Overall Study|Screen Failure|2
2585918|NCT01176565|8942423|P2|Overall Study|Not Analyzed (any other reason)|2
2585919|NCT01176565|8942424|P1|Overall Study|Not Analyzed (any other reason)|1
2585920|NCT01176565|8942423|P2|Overall Study|Withdrawal by Subject|1
2585921|NCT01176565|8942424|P1|Overall Study|Withdrawal by Subject|7
2585922|NCT01176565|8942423|P2|Overall Study|Lost to Follow-up|16
2585923|NCT01176565|8942424|P1|Overall Study|Lost to Follow-up|12
2585924|NCT01176513|8942442|P1|Overall Study|Withdrew subjects prior to dosing|3
2585925|NCT01176292|8942470|P2|Overall Study|Has not scheduled one-year visit yet|2
2585926|NCT01176292|8942471|P1|Overall Study|Has not scheduled one-year visit yet|2
2585927|NCT01176292|8942470|P2|Overall Study|Physician Decision|2
2585928|NCT01176292|8942471|P1|Overall Study|Physician Decision|0
2585929|NCT01176292|8942470|P2|Overall Study|Adverse Event|1
2585930|NCT01176292|8942471|P1|Overall Study|Adverse Event|1
2585931|NCT01176292|8942470|P2|Overall Study|Lost to Follow-up|4
2585932|NCT01176292|8942471|P1|Overall Study|Lost to Follow-up|2
2585933|NCT01176266|8942489|P1|Overall Study|Withdrawal by Subject|3
2585934|NCT01176266|8942489|P1|Overall Study|Death|6
2585935|NCT01176240|8942513|P2|Study 306B|withdrew prior to dosing|1
2585936|NCT01176240|8942514|P1|Study 306B|withdrew prior to dosing|2
2585937|NCT01176240|8942513|P2|Study 306B|Lost to Follow-up|1
2585938|NCT01176240|8942514|P1|Study 306B|Lost to Follow-up|0
2585939|NCT01176240|8942513|P2|Study 306B|Supine Hypertension|2
2585940|NCT01176240|8942514|P1|Study 306B|Supine Hypertension|1
2585941|NCT01176240|8942513|P2|Study 306B|Physician Decision|1
2585942|NCT01176240|8942514|P1|Study 306B|Physician Decision|2
2585943|NCT01176240|8942513|P2|Study 306B|Withdrawal by Subject|1
2585944|NCT01176240|8942514|P1|Study 306B|Withdrawal by Subject|4
2585945|NCT01176240|8942513|P2|Study 306B|Protocol Violation|3
2585946|NCT01176240|8942514|P1|Study 306B|Protocol Violation|2
2585947|NCT01176240|8942513|P2|Study 306B|Adverse Event|5
2585948|NCT01176240|8942514|P1|Study 306B|Adverse Event|10
2585949|NCT01176240|8942513|P2|Study 306B|Lack of Efficacy|3
2585950|NCT01176240|8942514|P1|Study 306B|Lack of Efficacy|5
2585951|NCT01176240|8942513|P2|Study 306A|Stop due to diverse problems|0
2585952|NCT01176240|8942514|P1|Study 306A|Stop due to diverse problems|1
2585953|NCT01176240|8942513|P2|Study 306A|Withdrawal by Subject|1
2585954|NCT01176240|8942514|P1|Study 306A|Withdrawal by Subject|0
2585955|NCT01176240|8942513|P2|Study 306A|Protocol Violation|1
2585956|NCT01176240|8942514|P1|Study 306A|Protocol Violation|0
2585957|NCT01176240|8942513|P2|Study 306A|Lack of Efficacy|1
2585958|NCT01176240|8942514|P1|Study 306A|Lack of Efficacy|2
2585959|NCT01176058|8942540|P2|Overall Study|Withdrawal by Subject|0
2585960|NCT01176058|8942541|P1|Overall Study|Withdrawal by Subject|1
2585961|NCT01176058|8942540|P2|Overall Study|Insufficient mycological response|1
2585962|NCT01176058|8942541|P1|Overall Study|Insufficient mycological response|0
2585963|NCT01176058|8942540|P2|Overall Study|Insufficient clinical response|2
2585964|NCT01176058|8942541|P1|Overall Study|Insufficient clinical response|2
2585965|NCT01176058|8942540|P2|Overall Study|Adverse Event|0
2585966|NCT01176058|8942541|P1|Overall Study|Adverse Event|1
2585967|NCT01176032|8942565|P2|Overall Study|Other|0
2585968|NCT01176032|8942566|P1|Overall Study|Other|1
2585969|NCT01176032|8942565|P2|Overall Study|Informed consent withdrawn|0
2585970|NCT01176032|8942566|P1|Overall Study|Informed consent withdrawn|3
2585971|NCT01176032|8942565|P2|Overall Study|Protocol Violation|0
2585972|NCT01176032|8942566|P1|Overall Study|Protocol Violation|1
2585973|NCT01176032|8942565|P2|Overall Study|Unsatisfactory therapeutic effect|1
2585974|NCT01176032|8942566|P1|Overall Study|Unsatisfactory therapeutic effect|0
2585975|NCT01176032|8942565|P2|Overall Study|Adverse Event|0
2585976|NCT01176032|8942566|P1|Overall Study|Adverse Event|1
2585977|NCT01175824|8942690|P2|Overall Study|Entry Criteria Not Met|4
2585978|NCT01175824|8942691|P1|Overall Study|Entry Criteria Not Met|6
2585979|NCT01175824|8942690|P2|Overall Study|Sponsor Decision|0
2585980|NCT01175824|8942691|P1|Overall Study|Sponsor Decision|1
2585981|NCT01175824|8942690|P2|Overall Study|Withdrawal by Subject|7
2585982|NCT01175824|8942691|P1|Overall Study|Withdrawal by Subject|3
2585983|NCT01175824|8942690|P2|Overall Study|Protocol Violation|5
2585984|NCT01175824|8942691|P1|Overall Study|Protocol Violation|2
2585985|NCT01175824|8942690|P2|Overall Study|Physician Decision|4
2585986|NCT01175824|8942691|P1|Overall Study|Physician Decision|0
2585987|NCT01175824|8942690|P2|Overall Study|Lost to Follow-up|1
2585988|NCT01175824|8942691|P1|Overall Study|Lost to Follow-up|0
2585989|NCT01175824|8942690|P2|Overall Study|Lack of Efficacy|0
2585990|NCT01175824|8942691|P1|Overall Study|Lack of Efficacy|2
2585991|NCT01175824|8942690|P2|Overall Study|Adverse Event|1
2585992|NCT01175824|8942691|P1|Overall Study|Adverse Event|2
2585993|NCT01175811|8942725|P2|Overall Study|Withdrawal by Subject|7
2585994|NCT01175811|8942726|P1|Overall Study|Withdrawal by Subject|6
2585995|NCT01175811|8942725|P2|Overall Study|Protocol Violation|2
2585996|NCT01175811|8942726|P1|Overall Study|Protocol Violation|1
2585997|NCT01175811|8942725|P2|Overall Study|Physician Decision|1
2585998|NCT01175811|8942726|P1|Overall Study|Physician Decision|1
2585999|NCT01175811|8942725|P2|Overall Study|Lost to Follow-up|2
2586000|NCT01175811|8942726|P1|Overall Study|Lost to Follow-up|3
2586001|NCT01175811|8942725|P2|Overall Study|Lack of Efficacy|0
2586002|NCT01175811|8942726|P1|Overall Study|Lack of Efficacy|1
2586003|NCT01175811|8942725|P2|Overall Study|Entry criteria not met|1
2586004|NCT01175811|8942726|P1|Overall Study|Entry criteria not met|3
2586005|NCT01175811|8942725|P2|Overall Study|Adverse Event|1
2586006|NCT01175811|8942726|P1|Overall Study|Adverse Event|1
2586007|NCT01175707|8942761|P2|Overall Study|Adverse Event|6
2586008|NCT01175707|8942762|P1|Overall Study|Adverse Event|4
2586009|NCT01175668|8942798|P2|Overall Study|Withdrawal by Subject|0
2586010|NCT01175668|8942799|P1|Overall Study|Withdrawal by Subject|2
2586011|NCT01175590|8942809|P2|Overall Study|Protocol Violation|1
2586012|NCT01175590|8942810|P1|Overall Study|Protocol Violation|0
2586013|NCT01175590|8942809|P2|Overall Study|Herpes Simplex Dermatitis|0
2586014|NCT01175590|8942810|P1|Overall Study|Herpes Simplex Dermatitis|1
2586015|NCT01175590|8942809|P2|Overall Study|Treated not as randomized|2
2586016|NCT01175590|8942810|P1|Overall Study|Treated not as randomized|3
2586017|NCT01175590|8942809|P2|Overall Study|Residual Bacterial Conjunctivitis|0
2586018|NCT01175590|8942810|P1|Overall Study|Residual Bacterial Conjunctivitis|1
2586019|NCT01175590|8942809|P2|Overall Study|Lack of Efficacy|1
2586020|NCT01175590|8942810|P1|Overall Study|Lack of Efficacy|1
2586021|NCT01175590|8942809|P2|Overall Study|Physician Decision|4
2586022|NCT01175590|8942810|P1|Overall Study|Physician Decision|1
2586023|NCT01175590|8942809|P2|Overall Study|Adverse Event|0
2586024|NCT01175590|8942810|P1|Overall Study|Adverse Event|4
2586025|NCT01175590|8942809|P2|Overall Study|Withdrawal by Subject|2
2586026|NCT01175590|8942810|P1|Overall Study|Withdrawal by Subject|0
2586027|NCT01175590|8942809|P2|Overall Study|Lost to Follow-up|0
2586028|NCT01175590|8942810|P1|Overall Study|Lost to Follow-up|1
2586029|NCT01175473|8942844|P2|Overall Study|Adverse Event|2
2586030|NCT01175473|8942845|P1|Overall Study|Adverse Event|2
2586031|NCT01175382|8942886|P3|Overall Study|Unable to tolerate study meds|1
2586032|NCT01175382|8942887|P2|Overall Study|Unable to tolerate study meds|1
2586033|NCT01175382|8942888|P1|Overall Study|Unable to tolerate study meds|0
2586034|NCT01175382|8942886|P3|Overall Study|Unwilling to follow protocol|0
2586035|NCT01175382|8942887|P2|Overall Study|Unwilling to follow protocol|1
2586036|NCT01175382|8942888|P1|Overall Study|Unwilling to follow protocol|0
2586037|NCT01175382|8942886|P3|Overall Study|Unable/unwilling to attend visits|2
2586038|NCT01175382|8942887|P2|Overall Study|Unable/unwilling to attend visits|1
2586039|NCT01175382|8942888|P1|Overall Study|Unable/unwilling to attend visits|3
2586040|NCT01175382|8942886|P3|Overall Study|No longer having problem|1
2586041|NCT01175382|8942887|P2|Overall Study|No longer having problem|0
2586042|NCT01175382|8942888|P1|Overall Study|No longer having problem|1
2586043|NCT01175382|8942886|P3|Overall Study|Withdrawal by Subject|1
2586044|NCT01175382|8942887|P2|Overall Study|Withdrawal by Subject|0
2586045|NCT01175382|8942888|P1|Overall Study|Withdrawal by Subject|0
2586046|NCT01175382|8942886|P3|Overall Study|Physician Decision|0
2586047|NCT01175382|8942887|P2|Overall Study|Physician Decision|1
2586048|NCT01175382|8942888|P1|Overall Study|Physician Decision|0
2586049|NCT01175382|8942886|P3|Overall Study|Lost to Follow-up|1
2586050|NCT01175382|8942887|P2|Overall Study|Lost to Follow-up|3
2586051|NCT01175382|8942888|P1|Overall Study|Lost to Follow-up|4
2586052|NCT01175356|8942974|P1|Overall Study|Initiation other tx prior to completion|9
2586053|NCT01175356|8942974|P1|Overall Study|Inadequate stem cell for transplant|1
2586054|NCT01175356|8942974|P1|Overall Study|On other COG study w/tumor tx intent|7
2586055|NCT01175356|8942974|P1|Overall Study|Pts MIBG non-avid after enrollment|2
2586056|NCT01175356|8942974|P1|Overall Study|Refusal by patient/parent/guardian|6
2586057|NCT01175356|8942974|P1|Overall Study|Treatment Slot Not Available|18
2586058|NCT01175356|8942974|P1|Overall Study|Ineligible|1
2586059|NCT01175356|8942974|P1|Overall Study|Physician Decision|23
2586060|NCT01175356|8942974|P1|Overall Study|Lost to Follow-up|1
2586061|NCT01175356|8942974|P1|Overall Study|Lack of Efficacy|12
2586062|NCT01175356|8942974|P1|Overall Study|Death|1
2586063|NCT01175213|8943014|P2|Safety Follow-up|Adverse Event|0
2586064|NCT01175213|8943015|P1|Safety Follow-up|Adverse Event|1
2586065|NCT01175213|8943014|P2|IGSC, 10%/rHuPH20|site elected to exit study|0
2586066|NCT01175213|8943015|P1|IGSC, 10%/rHuPH20|site elected to exit study|3
2586067|NCT01175213|8943014|P2|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0
2586068|NCT01175213|8943015|P1|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6
2586069|NCT01175213|8943014|P2|IGSC, 10%/rHuPH20|bone marrow transplant|0
2586070|NCT01175213|8943015|P1|IGSC, 10%/rHuPH20|bone marrow transplant|1
2586071|NCT01175213|8943014|P2|IGSC, 10%/rHuPH20|Death|0
2586072|NCT01175213|8943015|P1|IGSC, 10%/rHuPH20|Death|1
2586073|NCT01175213|8943014|P2|IGSC, 10%/rHuPH20|Withdrawal by Subject|0
2586074|NCT01175213|8943015|P1|IGSC, 10%/rHuPH20|Withdrawal by Subject|4
2586075|NCT01175135|8943072|P4|Overall Study|Randomized But Not Treated|0
2586076|NCT01175135|8943073|P3|Overall Study|Randomized But Not Treated|1
2586077|NCT01175135|8943074|P2|Overall Study|Randomized But Not Treated|0
2586078|NCT01175135|8943075|P1|Overall Study|Randomized But Not Treated|0
2586079|NCT01175135|8943072|P4|Overall Study|Other|0
2586080|NCT01175135|8943073|P3|Overall Study|Other|3
2586081|NCT01175135|8943074|P2|Overall Study|Other|1
2586082|NCT01175135|8943075|P1|Overall Study|Other|3
2586083|NCT01175135|8943072|P4|Overall Study|Withdrawal by Subject|5
2586084|NCT01175135|8943073|P3|Overall Study|Withdrawal by Subject|5
2586085|NCT01175135|8943074|P2|Overall Study|Withdrawal by Subject|8
2586086|NCT01175135|8943075|P1|Overall Study|Withdrawal by Subject|4
2586087|NCT01175135|8943072|P4|Overall Study|Protocol Violation|0
2586088|NCT01175135|8943073|P3|Overall Study|Protocol Violation|0
2586089|NCT01175135|8943074|P2|Overall Study|Protocol Violation|1
2586090|NCT01175135|8943075|P1|Overall Study|Protocol Violation|1
2586091|NCT01175135|8943072|P4|Overall Study|Lost to Follow-up|0
2586092|NCT01175135|8943073|P3|Overall Study|Lost to Follow-up|0
2586093|NCT01175135|8943074|P2|Overall Study|Lost to Follow-up|2
2586094|NCT01175135|8943075|P1|Overall Study|Lost to Follow-up|1
2586095|NCT01175135|8943072|P4|Overall Study|Lack of Efficacy|5
2586096|NCT01175135|8943073|P3|Overall Study|Lack of Efficacy|0
2586097|NCT01175135|8943074|P2|Overall Study|Lack of Efficacy|5
2586098|NCT01175135|8943075|P1|Overall Study|Lack of Efficacy|4
2586099|NCT01175135|8943072|P4|Overall Study|Death|0
2586100|NCT01175135|8943073|P3|Overall Study|Death|0
2586101|NCT01175135|8943074|P2|Overall Study|Death|0
2586102|NCT01175135|8943075|P1|Overall Study|Death|1
2586103|NCT01175135|8943072|P4|Overall Study|Adverse Event|4
2586104|NCT01175135|8943073|P3|Overall Study|Adverse Event|3
2586105|NCT01175135|8943074|P2|Overall Study|Adverse Event|5
2586106|NCT01175135|8943075|P1|Overall Study|Adverse Event|2
2586107|NCT01175083|8943163|P6|Booster Epoch|Withdrawal by Subject|0
2586108|NCT01175083|8943164|P5|Booster Epoch|Withdrawal by Subject|0
2586109|NCT01175083|8943165|P4|Booster Epoch|Withdrawal by Subject|1
2586110|NCT01175083|8943166|P3|Booster Epoch|Withdrawal by Subject|0
2586111|NCT01175083|8943167|P2|Booster Epoch|Withdrawal by Subject|0
2586112|NCT01175083|8943168|P1|Booster Epoch|Withdrawal by Subject|0
2586113|NCT01175083|8943163|P6|Booster Epoch|Death|0
2586114|NCT01175083|8943164|P5|Booster Epoch|Death|0
2586115|NCT01175083|8943165|P4|Booster Epoch|Death|0
2586116|NCT01175083|8943166|P3|Booster Epoch|Death|1
2586117|NCT01175083|8943167|P2|Booster Epoch|Death|0
2586118|NCT01175083|8943168|P1|Booster Epoch|Death|0
2586119|NCT01175083|8943163|P6|Primary Epoch|Lost to Follow-up|1
2586120|NCT01175083|8943164|P5|Primary Epoch|Lost to Follow-up|0
2586121|NCT01175083|8943165|P4|Primary Epoch|Lost to Follow-up|0
2586122|NCT01175083|8943166|P3|Primary Epoch|Lost to Follow-up|0
2586123|NCT01175083|8943167|P2|Primary Epoch|Lost to Follow-up|0
2586124|NCT01175083|8943168|P1|Primary Epoch|Lost to Follow-up|0
2586125|NCT01175083|8943163|P6|Primary Epoch|Withdrawal by Subject|2
2586126|NCT01175083|8943164|P5|Primary Epoch|Withdrawal by Subject|0
2586127|NCT01175083|8943165|P4|Primary Epoch|Withdrawal by Subject|0
2586128|NCT01175083|8943166|P3|Primary Epoch|Withdrawal by Subject|0
2586129|NCT01175083|8943167|P2|Primary Epoch|Withdrawal by Subject|0
2586130|NCT01175083|8943168|P1|Primary Epoch|Withdrawal by Subject|0
2586131|NCT01175018|8943260|P2|Overall Study|Adverse Event|1
2586132|NCT01175018|8943261|P1|Overall Study|Adverse Event|3
2586133|NCT01174563|8943348|P1|Overall Study|Sponsor's decision|1
2586134|NCT01174563|8943348|P1|Overall Study|Rash Adverse Event|1
2586135|NCT01174563|8943348|P1|Overall Study|Participant Withdrew Consent|3
2586136|NCT01174563|8943348|P1|Overall Study|Investigator's Discretion|5
2586137|NCT01174563|8943348|P1|Overall Study|Death|5
2586138|NCT01174563|8943348|P1|Overall Study|Progressive Disease|45
2586139|NCT01174550|8943356|P2|Overall Study|Withdrawal by Subject|289
2586140|NCT01174550|8943357|P1|Overall Study|Withdrawal by Subject|543
2586141|NCT01174550|8943356|P2|Overall Study|Lost to Follow-up|510
2586142|NCT01174550|8943357|P1|Overall Study|Lost to Follow-up|652
2586143|NCT01174550|8943356|P2|Overall Study|Death|74
2586144|NCT01174550|8943357|P1|Overall Study|Death|75
2586145|NCT01174459|8943385|P1|Overall Study|case report form (CRF) not collected|5
2586146|NCT01174446|8943390|P4|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
2586147|NCT01174446|8943391|P3|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
2586148|NCT01174446|8943392|P2|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1
2586149|NCT01174446|8943393|P1|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
2586150|NCT01174446|8943390|P4|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
2586151|NCT01174446|8943391|P3|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
2586152|NCT01174446|8943392|P2|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
2586153|NCT01174446|8943393|P1|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1
2586154|NCT01174446|8943390|P4|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
2586155|NCT01174446|8943391|P3|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1
2586156|NCT01174446|8943392|P2|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
2586157|NCT01174446|8943393|P1|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
2586158|NCT01174446|8943390|P4|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
2586159|NCT01174446|8943391|P3|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1
2586160|NCT01174446|8943392|P2|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
2586161|NCT01174446|8943393|P1|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
2586162|NCT01174368|8943580|P1|Overall Study|Withdrawal by Subject|1
2586163|NCT01174342|8943586|P1|Overall Study|Conversion to cesarean section|4
2586164|NCT01174264|8943593|P3|Steady-state Pharmacokinetics|Not evaluable|2
2586165|NCT01174264|8943594|P2|Steady-state Pharmacokinetics|Not evaluable|0
2586166|NCT01174264|8943595|P1|Steady-state Pharmacokinetics|Not evaluable|6
2586167|NCT01174264|8943593|P3|Single Dose Pharmacokinetics|Patient entered hospice care|1
2586168|NCT01174264|8943594|P2|Single Dose Pharmacokinetics|Patient entered hospice care|0
2586169|NCT01174264|8943595|P1|Single Dose Pharmacokinetics|Patient entered hospice care|0
2586170|NCT01174264|8943593|P3|Single Dose Pharmacokinetics|Early progressive disease|1
2586171|NCT01174264|8943594|P2|Single Dose Pharmacokinetics|Early progressive disease|0
2586172|NCT01174264|8943595|P1|Single Dose Pharmacokinetics|Early progressive disease|1
2586173|NCT01174238|8943627|P1|Overall Study|Lost to Follow-up|2
2586174|NCT01174186|8943638|P2|Overall Study|Withdrawal by Subject|2
2586175|NCT01174186|8943639|P1|Overall Study|Withdrawal by Subject|0
2586176|NCT01174186|8943638|P2|Overall Study|Lost to Follow-up|1
2586177|NCT01174186|8943639|P1|Overall Study|Lost to Follow-up|0
2586178|NCT01174173|8943646|P1|Overall Study|drug-drug interaction|1
2586179|NCT01174160|8943657|P2|Overall Study|Withdrawal by Subject|0
2586180|NCT01174160|8943658|P1|Overall Study|Withdrawal by Subject|1
2586181|NCT01174160|8943657|P2|Overall Study|Protocol Violation|6
2586182|NCT01174160|8943658|P1|Overall Study|Protocol Violation|4
2586183|NCT01174160|8943657|P2|Overall Study|Physician Decision|0
2586184|NCT01174160|8943658|P1|Overall Study|Physician Decision|1
2586185|NCT01174160|8943657|P2|Overall Study|Lost to Follow-up|0
2586186|NCT01174160|8943658|P1|Overall Study|Lost to Follow-up|1
2586187|NCT01174160|8943657|P2|Overall Study|Adverse Event|0
2586188|NCT01174160|8943658|P1|Overall Study|Adverse Event|1
2586189|NCT01174043|8943673|P1|Overall Study|Withdrawal by Subject|2
2586190|NCT01174043|8943673|P1|Overall Study|Death|1
2586191|NCT01174043|8943673|P1|Overall Study|Adverse Event|3
2586192|NCT01174043|8943673|P1|Overall Study|Disease progression|5
2586193|NCT01174004|8943712|P2|Overall Study|Physician Decision|0
2586194|NCT01174004|8943713|P1|Overall Study|Physician Decision|1
2586195|NCT01174004|8943712|P2|Overall Study|Protocol Violation|1
2586196|NCT01174004|8943713|P1|Overall Study|Protocol Violation|0
2586197|NCT01174004|8943712|P2|Overall Study|At Discretion of Sponsor|2
2586198|NCT01174004|8943713|P1|Overall Study|At Discretion of Sponsor|2
2586199|NCT01174004|8943712|P2|Overall Study|Withdrawal by Subject|3
2586200|NCT01174004|8943713|P1|Overall Study|Withdrawal by Subject|2
2586201|NCT01174004|8943712|P2|Overall Study|Adverse Event|10
2586202|NCT01174004|8943713|P1|Overall Study|Adverse Event|2
2586203|NCT01173718|8943744|P1|Overall Study|Abandonment of study graft|27
2586204|NCT01173718|8943744|P1|Overall Study|Death|17
2586205|NCT01173679|8943753|P1|Overall Study|Death|1
2586206|NCT01173653|8943761|P2|Overall Study|Pts unwilling to provide follow-up|41
2586207|NCT01173653|8943762|P1|Overall Study|Pts unwilling to provide follow-up|53
2586208|NCT01173601|8943772|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6
2586209|NCT01173601|8943773|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
2586210|NCT01173601|8943774|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
2586211|NCT01173601|8943775|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
2586212|NCT01173601|8943776|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
2586213|NCT01173601|8943772|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
2586214|NCT01173601|8943773|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5
2586215|NCT01173601|8943774|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7
2586216|NCT01173601|8943775|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
2586217|NCT01173601|8943776|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
2586218|NCT01173601|8943772|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
2586219|NCT01173601|8943773|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4
2586220|NCT01173601|8943774|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
2586221|NCT01173601|8943775|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1
2586222|NCT01173601|8943776|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
2586223|NCT01173601|8943772|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
2586224|NCT01173601|8943773|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
2586225|NCT01173601|8943774|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
2586226|NCT01173601|8943775|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
2586227|NCT01173601|8943776|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
2586228|NCT01173601|8943772|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
2586229|NCT01173601|8943773|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
2586230|NCT01173601|8943774|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
2586231|NCT01173601|8943775|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
2586232|NCT01173601|8943776|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
2586233|NCT01173601|8943772|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9
2586234|NCT01173601|8943773|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
2586235|NCT01173601|8943774|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6
2586236|NCT01173601|8943775|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10
2586237|NCT01173601|8943776|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
2586238|NCT01173601|8943772|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14
2586239|NCT01173601|8943773|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7
2586240|NCT01173601|8943774|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15
2586241|NCT01173601|8943775|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10
2586242|NCT01173601|8943776|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
2586243|NCT01173601|8943772|P5|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2586244|NCT01173601|8943773|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2586245|NCT01173601|8943774|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2586246|NCT01173601|8943775|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
2586247|NCT01173601|8943776|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6
2586248|NCT01173601|8943772|P5|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2586249|NCT01173601|8943773|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2586250|NCT01173601|8943774|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2586251|NCT01173601|8943775|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
2586252|NCT01173601|8943776|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25
2586253|NCT01173601|8943772|P5|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2586254|NCT01173601|8943773|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2586255|NCT01173601|8943774|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2586256|NCT01173601|8943775|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
2586257|NCT01173601|8943776|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15
2586258|NCT01173601|8943772|P5|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2586259|NCT01173601|8943773|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2586260|NCT01173601|8943774|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2586261|NCT01173601|8943775|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
2586262|NCT01173601|8943776|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3
2586263|NCT01173601|8943772|P5|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2586264|NCT01173601|8943773|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2586265|NCT01173601|8943774|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2586266|NCT01173601|8943775|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
2586267|NCT01173601|8943776|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7
2586268|NCT01173601|8943772|P5|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2586269|NCT01173601|8943773|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2586270|NCT01173601|8943774|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2586271|NCT01173601|8943775|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
2586272|NCT01173601|8943776|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9
2586273|NCT01173601|8943772|P5|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2586274|NCT01173601|8943773|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2586275|NCT01173601|8943774|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2586276|NCT01173601|8943775|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
2586277|NCT01173601|8943776|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23
2586278|NCT01173523|8943853|P2|Overall Study|Other|3
2586279|NCT01173523|8943854|P1|Overall Study|Other|2
2586280|NCT01173523|8943853|P2|Overall Study|Progressive Disease|8
2586281|NCT01173523|8943854|P1|Overall Study|Progressive Disease|10
2586282|NCT01173523|8943853|P2|Overall Study|Clinical Progression|1
2586283|NCT01173523|8943854|P1|Overall Study|Clinical Progression|1
2586284|NCT01173471|8943870|P4|Overall Study|Reason given as Other|0
2586285|NCT01173471|8943871|P3|Overall Study|Reason given as Other|1
2586286|NCT01173471|8943872|P2|Overall Study|Reason given as Other|0
2586287|NCT01173471|8943873|P1|Overall Study|Reason given as Other|0
2586288|NCT01173471|8943870|P4|Overall Study|Lost to Follow-up|0
2586289|NCT01173471|8943871|P3|Overall Study|Lost to Follow-up|1
2586290|NCT01173471|8943872|P2|Overall Study|Lost to Follow-up|0
2586291|NCT01173471|8943873|P1|Overall Study|Lost to Follow-up|0
2586292|NCT01173471|8943870|P4|Overall Study|Condition under investigation worsened|0
2586293|NCT01173471|8943871|P3|Overall Study|Condition under investigation worsened|0
2586294|NCT01173471|8943872|P2|Overall Study|Condition under investigation worsened|0
2586295|NCT01173471|8943873|P1|Overall Study|Condition under investigation worsened|2
2586296|NCT01173471|8943870|P4|Overall Study|Eligibility criteria not fulfilled|1
2586297|NCT01173471|8943871|P3|Overall Study|Eligibility criteria not fulfilled|1
2586298|NCT01173471|8943872|P2|Overall Study|Eligibility criteria not fulfilled|0
2586299|NCT01173471|8943873|P1|Overall Study|Eligibility criteria not fulfilled|0
2586300|NCT01173120|8944003|P1|Overall Study|Switch-Difficulty With Device|12
2586301|NCT01173120|8944003|P1|Overall Study|Switch-Participant Decision|12
2586302|NCT01173120|8944003|P1|Overall Study|Switch-Administrative Reason By Sponsor|33
2586303|NCT01173120|8944003|P1|Overall Study|Participant Decision|2
2586304|NCT01173120|8944003|P1|Overall Study|Lost to Follow-up|1
2586305|NCT01173120|8944003|P1|Overall Study|Lack of Efficacy|2
2586306|NCT01173055|8944021|P2|Period 2 - Day 64 to 112|Adverse Event|1
2586307|NCT01173055|8944022|P1|Period 2 - Day 64 to 112|Adverse Event|0
2586308|NCT01173055|8944021|P2|Period 1 - Day 1 to 49|Withdrawal by Subject|2
2586309|NCT01173055|8944022|P1|Period 1 - Day 1 to 49|Withdrawal by Subject|2
2586310|NCT01172938|8944073|P9|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1
2586311|NCT01172938|8944074|P8|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
2586312|NCT01172938|8944075|P7|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
2586313|NCT01172938|8944076|P6|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
2586314|NCT01172938|8944077|P5|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
2586315|NCT01172938|8944078|P4|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
2586316|NCT01172938|8944079|P3|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
2586317|NCT01172938|8944080|P2|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
2586318|NCT01172938|8944081|P1|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
2586319|NCT01172938|8944073|P9|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
2586320|NCT01172938|8944074|P8|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
2586321|NCT01172938|8944075|P7|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
2586322|NCT01172938|8944076|P6|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
2586323|NCT01172938|8944077|P5|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
2586324|NCT01172938|8944078|P4|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
2586325|NCT01172938|8944079|P3|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1
2586326|NCT01172938|8944080|P2|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
2586327|NCT01172938|8944081|P1|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
2586328|NCT01172938|8944073|P9|Active-Treatment Phase (Weeks 208-260)|Death|0
2586329|NCT01172938|8944074|P8|Active-Treatment Phase (Weeks 208-260)|Death|0
2586330|NCT01172938|8944075|P7|Active-Treatment Phase (Weeks 208-260)|Death|0
2586331|NCT01172938|8944076|P6|Active-Treatment Phase (Weeks 208-260)|Death|0
2586332|NCT01172938|8944077|P5|Active-Treatment Phase (Weeks 208-260)|Death|0
2586333|NCT01172938|8944078|P4|Active-Treatment Phase (Weeks 208-260)|Death|0
2586334|NCT01172938|8944079|P3|Active-Treatment Phase (Weeks 208-260)|Death|1
2586335|NCT01172938|8944080|P2|Active-Treatment Phase (Weeks 208-260)|Death|0
2586336|NCT01172938|8944081|P1|Active-Treatment Phase (Weeks 208-260)|Death|0
2586337|NCT01172938|8944073|P9|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
2586338|NCT01172938|8944074|P8|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1
2586339|NCT01172938|8944075|P7|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
2586340|NCT01172938|8944076|P6|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
2586341|NCT01172938|8944077|P5|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
2586342|NCT01172938|8944078|P4|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
2586343|NCT01172938|8944079|P3|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3
2586344|NCT01172938|8944080|P2|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2
2586345|NCT01172938|8944081|P1|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
2586346|NCT01172938|8944073|P9|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
2586347|NCT01172938|8944074|P8|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
2586348|NCT01172938|8944075|P7|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
2586349|NCT01172938|8944076|P6|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
2586350|NCT01172938|8944077|P5|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
2586351|NCT01172938|8944078|P4|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
2586352|NCT01172938|8944079|P3|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
2586353|NCT01172938|8944080|P2|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
2586354|NCT01172938|8944081|P1|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
2586355|NCT01172938|8944073|P9|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
2586356|NCT01172938|8944074|P8|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
2586357|NCT01172938|8944075|P7|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
2586358|NCT01172938|8944076|P6|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
2586359|NCT01172938|8944077|P5|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
2586360|NCT01172938|8944078|P4|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
2586361|NCT01172938|8944079|P3|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2
2586362|NCT01172938|8944080|P2|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
2586363|NCT01172938|8944081|P1|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
2586364|NCT01172938|8944073|P9|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
2586365|NCT01172938|8944074|P8|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
2586366|NCT01172938|8944075|P7|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
2586367|NCT01172938|8944076|P6|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
2586368|NCT01172938|8944077|P5|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
2586369|NCT01172938|8944078|P4|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
2586370|NCT01172938|8944079|P3|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
2586371|NCT01172938|8944080|P2|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
2586372|NCT01172938|8944081|P1|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
2586373|NCT01172938|8944073|P9|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
2586374|NCT01172938|8944074|P8|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1
2586375|NCT01172938|8944075|P7|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
2586376|NCT01172938|8944076|P6|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
2586377|NCT01172938|8944077|P5|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
2586378|NCT01172938|8944078|P4|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
2586379|NCT01172938|8944079|P3|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
2586380|NCT01172938|8944080|P2|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
2586381|NCT01172938|8944081|P1|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
2586382|NCT01172938|8944073|P9|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
2586383|NCT01172938|8944074|P8|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
2586384|NCT01172938|8944075|P7|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
2586385|NCT01172938|8944076|P6|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
2586386|NCT01172938|8944077|P5|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
2586387|NCT01172938|8944078|P4|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
2586388|NCT01172938|8944079|P3|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
2586389|NCT01172938|8944080|P2|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
2586390|NCT01172938|8944081|P1|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
2586391|NCT01172938|8944073|P9|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
2586392|NCT01172938|8944074|P8|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
2586393|NCT01172938|8944075|P7|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
2586394|NCT01172938|8944076|P6|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
2586395|NCT01172938|8944077|P5|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
2586396|NCT01172938|8944078|P4|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
2586397|NCT01172938|8944079|P3|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
2586398|NCT01172938|8944080|P2|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
2586399|NCT01172938|8944081|P1|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
2586400|NCT01172938|8944073|P9|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2
2586401|NCT01172938|8944074|P8|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3
2586402|NCT01172938|8944075|P7|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
2586403|NCT01172938|8944076|P6|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
2586404|NCT01172938|8944077|P5|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
2586405|NCT01172938|8944078|P4|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
2586406|NCT01172938|8944079|P3|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
2586407|NCT01172938|8944080|P2|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
2586408|NCT01172938|8944081|P1|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
2586409|NCT01172938|8944073|P9|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
2586410|NCT01172938|8944074|P8|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3
2586411|NCT01172938|8944075|P7|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
2586412|NCT01172938|8944076|P6|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
2586413|NCT01172938|8944077|P5|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
2586414|NCT01172938|8944078|P4|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
2586415|NCT01172938|8944079|P3|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1
2586416|NCT01172938|8944080|P2|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4
2586417|NCT01172938|8944081|P1|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
2586418|NCT01172938|8944073|P9|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
2586419|NCT01172938|8944074|P8|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
2586420|NCT01172938|8944075|P7|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
2586421|NCT01172938|8944076|P6|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
2586422|NCT01172938|8944077|P5|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
2586423|NCT01172938|8944078|P4|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
2586424|NCT01172938|8944079|P3|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2
2586425|NCT01172938|8944080|P2|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
2586426|NCT01172938|8944081|P1|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
2586427|NCT01172938|8944073|P9|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
2586428|NCT01172938|8944074|P8|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
2586429|NCT01172938|8944075|P7|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
2586430|NCT01172938|8944076|P6|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
2586431|NCT01172938|8944077|P5|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
2586432|NCT01172938|8944078|P4|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
2586433|NCT01172938|8944079|P3|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
2586434|NCT01172938|8944080|P2|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1
2586435|NCT01172938|8944081|P1|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
2586436|NCT01172938|8944073|P9|Active-Treatment Phase Weeks (104-156)|Death|0
2586437|NCT01172938|8944074|P8|Active-Treatment Phase Weeks (104-156)|Death|1
2586438|NCT01172938|8944075|P7|Active-Treatment Phase Weeks (104-156)|Death|0
2586439|NCT01172938|8944076|P6|Active-Treatment Phase Weeks (104-156)|Death|0
2586440|NCT01172938|8944077|P5|Active-Treatment Phase Weeks (104-156)|Death|0
2586441|NCT01172938|8944078|P4|Active-Treatment Phase Weeks (104-156)|Death|0
2586442|NCT01172938|8944079|P3|Active-Treatment Phase Weeks (104-156)|Death|0
2586443|NCT01172938|8944080|P2|Active-Treatment Phase Weeks (104-156)|Death|0
2586444|NCT01172938|8944081|P1|Active-Treatment Phase Weeks (104-156)|Death|0
2586445|NCT01172938|8944073|P9|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1
2586446|NCT01172938|8944074|P8|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2
2586447|NCT01172938|8944075|P7|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
2586448|NCT01172938|8944076|P6|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
2586449|NCT01172938|8944077|P5|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
2586450|NCT01172938|8944078|P4|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
2586451|NCT01172938|8944079|P3|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3
2586452|NCT01172938|8944080|P2|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6
2586453|NCT01172938|8944081|P1|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
2586454|NCT01172938|8944073|P9|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
2586455|NCT01172938|8944074|P8|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
2586456|NCT01172938|8944075|P7|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
2586457|NCT01172938|8944076|P6|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
2586458|NCT01172938|8944077|P5|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
2586459|NCT01172938|8944078|P4|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
2586460|NCT01172938|8944079|P3|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
2586461|NCT01172938|8944080|P2|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4
2586462|NCT01172938|8944081|P1|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
2586463|NCT01172938|8944073|P9|Active-Treatment Phase Weeks (104-156)|Adverse Event|1
2586464|NCT01172938|8944074|P8|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
2586465|NCT01172938|8944075|P7|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
2586466|NCT01172938|8944076|P6|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
2586467|NCT01172938|8944077|P5|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
2586468|NCT01172938|8944078|P4|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
2586469|NCT01172938|8944079|P3|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
2586470|NCT01172938|8944080|P2|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
2586471|NCT01172938|8944081|P1|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
2586472|NCT01172938|8944073|P9|Active-Treatment Phase (Weeks 52-104)|Missing|0
2586473|NCT01172938|8944074|P8|Active-Treatment Phase (Weeks 52-104)|Missing|0
2586474|NCT01172938|8944075|P7|Active-Treatment Phase (Weeks 52-104)|Missing|0
2586475|NCT01172938|8944076|P6|Active-Treatment Phase (Weeks 52-104)|Missing|0
2586476|NCT01172938|8944077|P5|Active-Treatment Phase (Weeks 52-104)|Missing|0
2586477|NCT01172938|8944078|P4|Active-Treatment Phase (Weeks 52-104)|Missing|0
2586478|NCT01172938|8944079|P3|Active-Treatment Phase (Weeks 52-104)|Missing|0
2586479|NCT01172938|8944080|P2|Active-Treatment Phase (Weeks 52-104)|Missing|1
2586480|NCT01172938|8944081|P1|Active-Treatment Phase (Weeks 52-104)|Missing|0
2586481|NCT01172938|8944073|P9|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1
2586482|NCT01172938|8944074|P8|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
2586483|NCT01172938|8944075|P7|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
2586484|NCT01172938|8944076|P6|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
2586485|NCT01172938|8944077|P5|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
2586486|NCT01172938|8944078|P4|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
2586487|NCT01172938|8944079|P3|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
2586488|NCT01172938|8944080|P2|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2
2586489|NCT01172938|8944081|P1|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
2586490|NCT01172938|8944073|P9|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
2586491|NCT01172938|8944074|P8|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3
2586492|NCT01172938|8944075|P7|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
2586493|NCT01172938|8944076|P6|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
2586494|NCT01172938|8944077|P5|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
2586495|NCT01172938|8944078|P4|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
2586496|NCT01172938|8944079|P3|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
2586497|NCT01172938|8944080|P2|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
2586498|NCT01172938|8944081|P1|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
2586499|NCT01172938|8944073|P9|Active-Treatment Phase (Weeks 52-104)|Death|0
2586500|NCT01172938|8944074|P8|Active-Treatment Phase (Weeks 52-104)|Death|0
2586501|NCT01172938|8944075|P7|Active-Treatment Phase (Weeks 52-104)|Death|0
2586502|NCT01172938|8944076|P6|Active-Treatment Phase (Weeks 52-104)|Death|0
2586503|NCT01172938|8944077|P5|Active-Treatment Phase (Weeks 52-104)|Death|0
2586504|NCT01172938|8944078|P4|Active-Treatment Phase (Weeks 52-104)|Death|0
2586505|NCT01172938|8944079|P3|Active-Treatment Phase (Weeks 52-104)|Death|1
2586506|NCT01172938|8944080|P2|Active-Treatment Phase (Weeks 52-104)|Death|0
2586507|NCT01172938|8944081|P1|Active-Treatment Phase (Weeks 52-104)|Death|0
2586508|NCT01172938|8944073|P9|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2
2586509|NCT01172938|8944074|P8|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5
2586510|NCT01172938|8944075|P7|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
2586511|NCT01172938|8944076|P6|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
2586512|NCT01172938|8944077|P5|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
2586513|NCT01172938|8944078|P4|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
2586514|NCT01172938|8944079|P3|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8
2586515|NCT01172938|8944080|P2|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10
2586516|NCT01172938|8944081|P1|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
2586517|NCT01172938|8944073|P9|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
2586518|NCT01172938|8944074|P8|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
2586519|NCT01172938|8944075|P7|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
2586520|NCT01172938|8944076|P6|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
2586521|NCT01172938|8944077|P5|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
2586522|NCT01172938|8944078|P4|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
2586523|NCT01172938|8944079|P3|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2
2586524|NCT01172938|8944080|P2|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
2586525|NCT01172938|8944081|P1|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
2586526|NCT01172938|8944073|P9|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
2586527|NCT01172938|8944074|P8|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4
2586528|NCT01172938|8944075|P7|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
2586529|NCT01172938|8944076|P6|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
2586530|NCT01172938|8944077|P5|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
2586531|NCT01172938|8944078|P4|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
2586532|NCT01172938|8944079|P3|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8
2586533|NCT01172938|8944080|P2|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7
2586534|NCT01172938|8944081|P1|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
2586535|NCT01172938|8944073|P9|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
2586536|NCT01172938|8944074|P8|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3
2586537|NCT01172938|8944075|P7|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
2586538|NCT01172938|8944076|P6|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
2586539|NCT01172938|8944077|P5|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
2586540|NCT01172938|8944078|P4|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
2586541|NCT01172938|8944079|P3|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
2586542|NCT01172938|8944080|P2|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2
2586543|NCT01172938|8944081|P1|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
2586544|NCT01172938|8944073|P9|Active Treatment Phase (Weeks 25-52)|Other|0
2586545|NCT01172938|8944074|P8|Active Treatment Phase (Weeks 25-52)|Other|0
2586546|NCT01172938|8944075|P7|Active Treatment Phase (Weeks 25-52)|Other|1
2586547|NCT01172938|8944076|P6|Active Treatment Phase (Weeks 25-52)|Other|1
2586548|NCT01172938|8944077|P5|Active Treatment Phase (Weeks 25-52)|Other|0
2586549|NCT01172938|8944078|P4|Active Treatment Phase (Weeks 25-52)|Other|0
2586550|NCT01172938|8944079|P3|Active Treatment Phase (Weeks 25-52)|Other|0
2586551|NCT01172938|8944080|P2|Active Treatment Phase (Weeks 25-52)|Other|0
2586552|NCT01172938|8944081|P1|Active Treatment Phase (Weeks 25-52)|Other|0
2586553|NCT01172938|8944073|P9|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
2586554|NCT01172938|8944074|P8|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
2586555|NCT01172938|8944075|P7|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
2586556|NCT01172938|8944076|P6|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
2586557|NCT01172938|8944077|P5|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
2586558|NCT01172938|8944078|P4|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
2586559|NCT01172938|8944079|P3|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
2586560|NCT01172938|8944080|P2|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
2586561|NCT01172938|8944081|P1|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
2586562|NCT01172938|8944073|P9|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
2586563|NCT01172938|8944074|P8|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
2586564|NCT01172938|8944075|P7|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
2586565|NCT01172938|8944076|P6|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9
2586566|NCT01172938|8944077|P5|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
2586567|NCT01172938|8944078|P4|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
2586568|NCT01172938|8944079|P3|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
2586569|NCT01172938|8944080|P2|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5
2586570|NCT01172938|8944081|P1|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
2586571|NCT01172938|8944073|P9|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
2586572|NCT01172938|8944074|P8|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
2586573|NCT01172938|8944075|P7|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
2586574|NCT01172938|8944076|P6|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
2586575|NCT01172938|8944077|P5|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
2586576|NCT01172938|8944078|P4|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
2586577|NCT01172938|8944079|P3|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1
2586578|NCT01172938|8944080|P2|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
2586579|NCT01172938|8944081|P1|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
2586580|NCT01172938|8944073|P9|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
2586581|NCT01172938|8944074|P8|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
2586582|NCT01172938|8944075|P7|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
2586583|NCT01172938|8944076|P6|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
2586584|NCT01172938|8944077|P5|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1
2586585|NCT01172938|8944078|P4|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
2586586|NCT01172938|8944079|P3|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7
2586587|NCT01172938|8944080|P2|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4
2586588|NCT01172938|8944081|P1|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
2586589|NCT01172938|8944073|P9|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
2586590|NCT01172938|8944074|P8|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
2586591|NCT01172938|8944075|P7|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
2586592|NCT01172938|8944076|P6|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
2586593|NCT01172938|8944077|P5|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
2586594|NCT01172938|8944078|P4|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
2586595|NCT01172938|8944079|P3|Active Treatment Phase (Weeks 25-52)|Adverse Event|5
2586596|NCT01172938|8944080|P2|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
2586597|NCT01172938|8944081|P1|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
2586598|NCT01172938|8944073|P9|Placebo-controlled Phase (Week 0-24)|Other|0
2586599|NCT01172938|8944074|P8|Placebo-controlled Phase (Week 0-24)|Other|0
2586600|NCT01172938|8944075|P7|Placebo-controlled Phase (Week 0-24)|Other|0
2586601|NCT01172938|8944076|P6|Placebo-controlled Phase (Week 0-24)|Other|0
2586602|NCT01172938|8944077|P5|Placebo-controlled Phase (Week 0-24)|Other|0
2586603|NCT01172938|8944078|P4|Placebo-controlled Phase (Week 0-24)|Other|0
2586604|NCT01172938|8944079|P3|Placebo-controlled Phase (Week 0-24)|Other|1
2586605|NCT01172938|8944080|P2|Placebo-controlled Phase (Week 0-24)|Other|2
2586606|NCT01172938|8944081|P1|Placebo-controlled Phase (Week 0-24)|Other|0
2586607|NCT01172938|8944073|P9|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2586608|NCT01172938|8944074|P8|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2586609|NCT01172938|8944075|P7|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2586610|NCT01172938|8944076|P6|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2586611|NCT01172938|8944077|P5|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2586612|NCT01172938|8944078|P4|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2586613|NCT01172938|8944079|P3|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2586614|NCT01172938|8944080|P2|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
2586615|NCT01172938|8944081|P1|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1
2586616|NCT01172938|8944073|P9|Placebo-controlled Phase (Week 0-24)|Death|0
2586617|NCT01172938|8944074|P8|Placebo-controlled Phase (Week 0-24)|Death|0
2586618|NCT01172938|8944075|P7|Placebo-controlled Phase (Week 0-24)|Death|0
2586619|NCT01172938|8944076|P6|Placebo-controlled Phase (Week 0-24)|Death|0
2586620|NCT01172938|8944077|P5|Placebo-controlled Phase (Week 0-24)|Death|0
2586621|NCT01172938|8944078|P4|Placebo-controlled Phase (Week 0-24)|Death|0
2586622|NCT01172938|8944079|P3|Placebo-controlled Phase (Week 0-24)|Death|0
2586623|NCT01172938|8944080|P2|Placebo-controlled Phase (Week 0-24)|Death|1
2586624|NCT01172938|8944081|P1|Placebo-controlled Phase (Week 0-24)|Death|0
2586625|NCT01172938|8944073|P9|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2586626|NCT01172938|8944074|P8|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2586627|NCT01172938|8944075|P7|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2586628|NCT01172938|8944076|P6|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2586629|NCT01172938|8944077|P5|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2586630|NCT01172938|8944078|P4|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
2586631|NCT01172938|8944079|P3|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
2586632|NCT01172938|8944080|P2|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
2586633|NCT01172938|8944081|P1|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2
2586634|NCT01172938|8944073|P9|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2586635|NCT01172938|8944074|P8|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2586636|NCT01172938|8944075|P7|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2586637|NCT01172938|8944076|P6|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2586638|NCT01172938|8944077|P5|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2586639|NCT01172938|8944078|P4|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2586640|NCT01172938|8944079|P3|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2
2586641|NCT01172938|8944080|P2|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
2586642|NCT01172938|8944081|P1|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
2586643|NCT01172938|8944073|P9|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2586644|NCT01172938|8944074|P8|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2586645|NCT01172938|8944075|P7|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2586646|NCT01172938|8944076|P6|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2586647|NCT01172938|8944077|P5|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2586648|NCT01172938|8944078|P4|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
2586649|NCT01172938|8944079|P3|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
2586650|NCT01172938|8944080|P2|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
2586651|NCT01172938|8944081|P1|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
2586652|NCT01172938|8944073|P9|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2586653|NCT01172938|8944074|P8|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2586654|NCT01172938|8944075|P7|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2586655|NCT01172938|8944076|P6|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2586656|NCT01172938|8944077|P5|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2586657|NCT01172938|8944078|P4|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
2586658|NCT01172938|8944079|P3|Placebo-controlled Phase (Week 0-24)|Adverse Event|10
2586659|NCT01172938|8944080|P2|Placebo-controlled Phase (Week 0-24)|Adverse Event|8
2586660|NCT01172938|8944081|P1|Placebo-controlled Phase (Week 0-24)|Adverse Event|11
2586661|NCT01172873|8944267|P2|Overall Study|Withdrawal by Subject|2
2586662|NCT01172873|8944268|P1|Overall Study|Withdrawal by Subject|3
2586663|NCT01172847|8944278|P1|Overall Study|Withdrawal by Subject|3
2586664|NCT01172821|8944307|P4|Overall Study|Other|3
2586665|NCT01172821|8944308|P3|Overall Study|Other|5
2586666|NCT01172821|8944309|P2|Overall Study|Other|4
2586667|NCT01172821|8944310|P1|Overall Study|Other|3
2586668|NCT01172821|8944307|P4|Overall Study|Withdrawal by Subject|3
2586669|NCT01172821|8944308|P3|Overall Study|Withdrawal by Subject|3
2586670|NCT01172821|8944309|P2|Overall Study|Withdrawal by Subject|3
2586671|NCT01172821|8944310|P1|Overall Study|Withdrawal by Subject|2
2586672|NCT01172821|8944307|P4|Overall Study|Lost to Follow-up|2
2586673|NCT01172821|8944308|P3|Overall Study|Lost to Follow-up|2
2586674|NCT01172821|8944309|P2|Overall Study|Lost to Follow-up|1
2586675|NCT01172821|8944310|P1|Overall Study|Lost to Follow-up|4
2586676|NCT01172821|8944307|P4|Overall Study|Protocol Violation|2
2586677|NCT01172821|8944308|P3|Overall Study|Protocol Violation|1
2586678|NCT01172821|8944309|P2|Overall Study|Protocol Violation|2
2586679|NCT01172821|8944310|P1|Overall Study|Protocol Violation|0
2586680|NCT01172821|8944307|P4|Overall Study|Adverse Event|7
2586681|NCT01172821|8944308|P3|Overall Study|Adverse Event|2
2586682|NCT01172821|8944309|P2|Overall Study|Adverse Event|2
2586683|NCT01172821|8944310|P1|Overall Study|Adverse Event|5
2586684|NCT01172808|8944400|P4|Overall Study|Other|7
2586685|NCT01172808|8944401|P3|Overall Study|Other|9
2586686|NCT01172808|8944402|P2|Overall Study|Other|5
2586687|NCT01172808|8944403|P1|Overall Study|Other|6
2586688|NCT01172808|8944400|P4|Overall Study|Withdrawal by Subject|2
2586689|NCT01172808|8944401|P3|Overall Study|Withdrawal by Subject|3
2586690|NCT01172808|8944402|P2|Overall Study|Withdrawal by Subject|1
2586691|NCT01172808|8944403|P1|Overall Study|Withdrawal by Subject|4
2586692|NCT01172808|8944400|P4|Overall Study|Lost to Follow-up|3
2586693|NCT01172808|8944401|P3|Overall Study|Lost to Follow-up|1
2586694|NCT01172808|8944402|P2|Overall Study|Lost to Follow-up|1
2586695|NCT01172808|8944403|P1|Overall Study|Lost to Follow-up|0
2586696|NCT01172808|8944400|P4|Overall Study|Protocol Violation|0
2586697|NCT01172808|8944401|P3|Overall Study|Protocol Violation|2
2586698|NCT01172808|8944402|P2|Overall Study|Protocol Violation|2
2586699|NCT01172808|8944403|P1|Overall Study|Protocol Violation|2
2586700|NCT01172808|8944400|P4|Overall Study|Lack of Efficacy|0
2586701|NCT01172808|8944401|P3|Overall Study|Lack of Efficacy|0
2586702|NCT01172808|8944402|P2|Overall Study|Lack of Efficacy|0
2586703|NCT01172808|8944403|P1|Overall Study|Lack of Efficacy|1
2586704|NCT01172808|8944400|P4|Overall Study|Adverse Event|3
2586705|NCT01172808|8944401|P3|Overall Study|Adverse Event|8
2586706|NCT01172808|8944402|P2|Overall Study|Adverse Event|4
2586707|NCT01172808|8944403|P1|Overall Study|Adverse Event|8
2586708|NCT01172639|8944494|P5|Overall Study|Withdrawal by Subject|0
2586709|NCT01172639|8944495|P4|Overall Study|Withdrawal by Subject|5
2586710|NCT01172639|8944496|P3|Overall Study|Withdrawal by Subject|5
2586711|NCT01172639|8944497|P2|Overall Study|Withdrawal by Subject|3
2586712|NCT01172639|8944498|P1|Overall Study|Withdrawal by Subject|3
2586713|NCT01172639|8944494|P5|Overall Study|Lost to Follow-up|6
2586714|NCT01172639|8944495|P4|Overall Study|Lost to Follow-up|6
2586715|NCT01172639|8944496|P3|Overall Study|Lost to Follow-up|11
2586716|NCT01172639|8944497|P2|Overall Study|Lost to Follow-up|7
2586717|NCT01172639|8944498|P1|Overall Study|Lost to Follow-up|9
2586718|NCT01172639|8944494|P5|Overall Study|Death|0
2586719|NCT01172639|8944495|P4|Overall Study|Death|0
2586720|NCT01172639|8944496|P3|Overall Study|Death|0
2586721|NCT01172639|8944497|P2|Overall Study|Death|1
2586722|NCT01172639|8944498|P1|Overall Study|Death|1
2586723|NCT01172535|8944573|P1|Overall Study|Unwilling to adhere to study requirement|1
2586724|NCT01172535|8944573|P1|Overall Study|Ineligible at study entry|1
2586725|NCT01172535|8944573|P1|Overall Study|Lost to Follow-up|1
2586726|NCT01172535|8944573|P1|Overall Study|Withdrawal by Subject|2
2586727|NCT01172535|8944573|P1|Overall Study|Death|3
2586728|NCT01172288|8944626|P2|Overall Study|Protocol Violation|1
2586729|NCT01172288|8944627|P1|Overall Study|Protocol Violation|0
2586730|NCT01172288|8944626|P2|Overall Study|Adverse Event|0
2586731|NCT01172288|8944627|P1|Overall Study|Adverse Event|1
2586732|NCT01172275|8944643|P2|Overall Study|Protocol Violation|0
2586733|NCT01172275|8944644|P1|Overall Study|Protocol Violation|1
2586734|NCT01172275|8944643|P2|Overall Study|Lost to Follow-up|0
2586735|NCT01172275|8944644|P1|Overall Study|Lost to Follow-up|1
2586736|NCT01171989|8944702|P3|Overall Study|Lost to Follow-up|1
2586737|NCT01171989|8944703|P2|Overall Study|Lost to Follow-up|0
2586738|NCT01171989|8944704|P1|Overall Study|Lost to Follow-up|0
2586739|NCT01171976|8944778|P3|Overall Study|Adverse Event|5
2586740|NCT01171976|8944779|P2|Overall Study|Adverse Event|2
2586741|NCT01171976|8944780|P1|Overall Study|Adverse Event|6
2586742|NCT01171976|8944778|P3|Overall Study|Abnormal test result|0
2586743|NCT01171976|8944779|P2|Overall Study|Abnormal test result|0
2586744|NCT01171976|8944780|P1|Overall Study|Abnormal test result|1
2586745|NCT01171976|8944778|P3|Overall Study|Withdrawal by Subject|6
2586746|NCT01171976|8944779|P2|Overall Study|Withdrawal by Subject|5
2586747|NCT01171976|8944780|P1|Overall Study|Withdrawal by Subject|1
2586748|NCT01171976|8944778|P3|Overall Study|Lost to Follow-up|2
2586749|NCT01171976|8944779|P2|Overall Study|Lost to Follow-up|0
2586750|NCT01171976|8944780|P1|Overall Study|Lost to Follow-up|4
2586751|NCT01171976|8944778|P3|Overall Study|Death|1
2586752|NCT01171976|8944779|P2|Overall Study|Death|4
2586753|NCT01171976|8944780|P1|Overall Study|Death|2
2586754|NCT01171976|8944778|P3|Overall Study|Protocol Violation|1
2586755|NCT01171976|8944779|P2|Overall Study|Protocol Violation|0
2586756|NCT01171976|8944780|P1|Overall Study|Protocol Violation|0
2586757|NCT01171963|8944817|P2|Overall Study|Withdrawal by Subject|129
2586758|NCT01171963|8944818|P1|Overall Study|Withdrawal by Subject|114
2586759|NCT01171963|8944817|P2|Overall Study|Other - diarrhoea|0
2586760|NCT01171963|8944818|P1|Overall Study|Other - diarrhoea|1
2586761|NCT01171963|8944817|P2|Overall Study|Lost to Follow-up|24
2586762|NCT01171963|8944818|P1|Overall Study|Lost to Follow-up|23
2586763|NCT01171963|8944817|P2|Overall Study|Adverse Event|15
2586764|NCT01171963|8944818|P1|Overall Study|Adverse Event|10
2586765|NCT01171898|8944887|P4|Overall Study|Other|2
2586766|NCT01171898|8944888|P3|Overall Study|Other|0
2586767|NCT01171898|8944889|P2|Overall Study|Other|5
2586768|NCT01171898|8944890|P1|Overall Study|Other|1
2586769|NCT01171898|8944887|P4|Overall Study|Ongoing|0
2586770|NCT01171898|8944888|P3|Overall Study|Ongoing|3
2586771|NCT01171898|8944889|P2|Overall Study|Ongoing|9
2586772|NCT01171898|8944890|P1|Overall Study|Ongoing|1
2586773|NCT01171898|8944887|P4|Overall Study|Terminated by Sponsor|0
2586774|NCT01171898|8944888|P3|Overall Study|Terminated by Sponsor|0
2586775|NCT01171898|8944889|P2|Overall Study|Terminated by Sponsor|0
2586776|NCT01171898|8944890|P1|Overall Study|Terminated by Sponsor|1
2586777|NCT01171898|8944887|P4|Overall Study|Withdrawal by Subject|3
2586778|NCT01171898|8944888|P3|Overall Study|Withdrawal by Subject|6
2586779|NCT01171898|8944889|P2|Overall Study|Withdrawal by Subject|4
2586780|NCT01171898|8944890|P1|Overall Study|Withdrawal by Subject|1
2586781|NCT01171898|8944887|P4|Overall Study|Lost to Follow-up|1
2586782|NCT01171898|8944888|P3|Overall Study|Lost to Follow-up|1
2586783|NCT01171898|8944889|P2|Overall Study|Lost to Follow-up|1
2586784|NCT01171898|8944890|P1|Overall Study|Lost to Follow-up|0
2586785|NCT01171898|8944887|P4|Overall Study|Death|0
2586786|NCT01171898|8944888|P3|Overall Study|Death|2
2586787|NCT01171898|8944889|P2|Overall Study|Death|0
2586788|NCT01171898|8944890|P1|Overall Study|Death|0
2586789|NCT01171820|8944914|P2|Overall Study|1-Year Missed Visit|1
2586790|NCT01171820|8944915|P1|Overall Study|1-Year Missed Visit|1
2586791|NCT01171820|8944914|P2|Overall Study|Physician Decision|1
2586792|NCT01171820|8944915|P1|Overall Study|Physician Decision|0
2586793|NCT01171820|8944914|P2|Overall Study|Withdrawal by Subject|0
2586794|NCT01171820|8944915|P1|Overall Study|Withdrawal by Subject|2
2586795|NCT01171820|8944914|P2|Overall Study|Lost to Follow-up|1
2586796|NCT01171820|8944915|P1|Overall Study|Lost to Follow-up|0
2586797|NCT01171820|8944914|P2|Overall Study|Death|3
2586798|NCT01171820|8944915|P1|Overall Study|Death|3
2586799|NCT01171677|8944993|P2|Overall Study|completed <70% IntenSati classes|0
2586800|NCT01171677|8944994|P1|Overall Study|completed <70% IntenSati classes|5
2586801|NCT01171677|8944993|P2|Overall Study|Adverse Event|0
2586802|NCT01171677|8944994|P1|Overall Study|Adverse Event|1
2586803|NCT01171677|8944993|P2|Overall Study|Withdrawal by Subject|3
2586804|NCT01171677|8944994|P1|Overall Study|Withdrawal by Subject|0
2586805|NCT01171625|8945026|P1|Overall Study|Consented but did not receive device|25
2586806|NCT01171625|8945026|P1|Overall Study|Other|1
2586807|NCT01171625|8945026|P1|Overall Study|Patient received valve-in-valve|3
2586808|NCT01171625|8945026|P1|Overall Study|Lost to Follow-up|5
2586809|NCT01171625|8945026|P1|Overall Study|Explanted|10
2586810|NCT01171625|8945026|P1|Overall Study|Withdrawal by Subject|31
2586811|NCT01171625|8945026|P1|Overall Study|Death|38
2586812|NCT01171625|8945026|P1|Overall Study|On-Protocol|67
2586813|NCT01171612|8945059|P1|Overall Study|Lost to Follow-up|51
2586814|NCT01171534|8945069|P2|Overall Study|screen failure|1
2586815|NCT01171534|8945070|P1|Overall Study|screen failure|0
2586816|NCT01171534|8945069|P2|Overall Study|Lost to Follow-up|2
2586817|NCT01171534|8945070|P1|Overall Study|Lost to Follow-up|0
2586818|NCT01171521|8945082|P1|Overall Study|screen failure|1
2586819|NCT01171521|8945082|P1|Overall Study|Lost to Follow-up|5
2586820|NCT01171183|8945089|P2|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0
2586821|NCT01171183|8945090|P1|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1
2586822|NCT01171183|8945089|P2|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3
2586823|NCT01171183|8945090|P1|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7
2586824|NCT01171183|8945089|P2|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
2586825|NCT01171183|8945090|P1|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
2586826|NCT01171183|8945089|P2|Residential Facility (Weeks 1-2)|BP outside of study parameters|3
2586827|NCT01171183|8945090|P1|Residential Facility (Weeks 1-2)|BP outside of study parameters|0
2586828|NCT01171183|8945089|P2|Residential Facility (Weeks 1-2)|Protocol Violation|1
2586829|NCT01171183|8945090|P1|Residential Facility (Weeks 1-2)|Protocol Violation|0
2586830|NCT01171183|8945089|P2|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
2586831|NCT01171183|8945090|P1|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
2586832|NCT01170962|8945111|P3|Follow up Period|Others|3
2586833|NCT01170962|8945112|P2|Follow up Period|Others|7
2586834|NCT01170962|8945113|P1|Follow up Period|Others|10
2586835|NCT01170962|8945111|P3|Follow up Period|Death|0
2586836|NCT01170962|8945112|P2|Follow up Period|Death|2
2586837|NCT01170962|8945113|P1|Follow up Period|Death|2
2586838|NCT01170962|8945111|P3|Follow up Period|Lost to Follow-up|1
2586839|NCT01170962|8945112|P2|Follow up Period|Lost to Follow-up|8
2586840|NCT01170962|8945113|P1|Follow up Period|Lost to Follow-up|13
2586841|NCT01170962|8945111|P3|Follow up Period|Withdrawal by Subject|2
2586842|NCT01170962|8945112|P2|Follow up Period|Withdrawal by Subject|10
2586843|NCT01170962|8945113|P1|Follow up Period|Withdrawal by Subject|14
2586844|NCT01170962|8945111|P3|Treatment Period|Completed 24 Week treatment period only|0
2586845|NCT01170962|8945112|P2|Treatment Period|Completed 24 Week treatment period only|2
2586846|NCT01170962|8945113|P1|Treatment Period|Completed 24 Week treatment period only|10
2586847|NCT01170962|8945111|P3|Treatment Period|Request to discontinue treatment|1
2586848|NCT01170962|8945112|P2|Treatment Period|Request to discontinue treatment|3
2586849|NCT01170962|8945113|P1|Treatment Period|Request to discontinue treatment|7
2586850|NCT01170962|8945111|P3|Treatment Period|Participant no longer meets criteria|0
2586851|NCT01170962|8945112|P2|Treatment Period|Participant no longer meets criteria|1
2586852|NCT01170962|8945113|P1|Treatment Period|Participant no longer meets criteria|0
2586853|NCT01170962|8945111|P3|Treatment Period|Lost to Follow-up|1
2586854|NCT01170962|8945112|P2|Treatment Period|Lost to Follow-up|1
2586855|NCT01170962|8945113|P1|Treatment Period|Lost to Follow-up|1
2586856|NCT01170962|8945111|P3|Treatment Period|Withdrawal by Subject|0
2586857|NCT01170962|8945112|P2|Treatment Period|Withdrawal by Subject|1
2586858|NCT01170962|8945113|P1|Treatment Period|Withdrawal by Subject|2
2586859|NCT01170962|8945111|P3|Treatment Period|Adverse Event|3
2586860|NCT01170962|8945112|P2|Treatment Period|Adverse Event|12
2586861|NCT01170962|8945113|P1|Treatment Period|Adverse Event|11
2586862|NCT01170962|8945111|P3|Treatment Period|Lack of Efficacy|7
2586863|NCT01170962|8945112|P2|Treatment Period|Lack of Efficacy|91
2586864|NCT01170962|8945113|P1|Treatment Period|Lack of Efficacy|96
2586865|NCT01170663|8945208|P2|Overall Study|Withdrawal of consent without follow-up|11
2586866|NCT01170663|8945209|P1|Overall Study|Withdrawal of consent without follow-up|11
2586867|NCT01170663|8945208|P2|Overall Study|Lost to Follow-up|9
2586868|NCT01170663|8945209|P1|Overall Study|Lost to Follow-up|3
2586869|NCT01170598|8945237|P1|Overall Study|Refused|1
2586870|NCT01170598|8945237|P1|Overall Study|Lost to Follow-up|1
2586871|NCT01170598|8945237|P1|Overall Study|Death|3
2586872|NCT01170598|8945237|P1|Overall Study|Withdrawal by Subject|1
2586873|NCT01170364|8945300|P2|Overall Study|Protocol Violation|1
2586874|NCT01170364|8945301|P1|Overall Study|Protocol Violation|4
2586875|NCT01170273|8945309|P2|Overall Study|Adverse Event|1
2586876|NCT01170273|8945310|P1|Overall Study|Adverse Event|0
2586877|NCT01170273|8945309|P2|Overall Study|Death|0
2586878|NCT01170273|8945310|P1|Overall Study|Death|1
2586879|NCT01170273|8945309|P2|Overall Study|Protocol Violation|0
2586880|NCT01170273|8945310|P1|Overall Study|Protocol Violation|1
2586881|NCT01170273|8945309|P2|Overall Study|Lost to Follow-up|8
2586882|NCT01170273|8945310|P1|Overall Study|Lost to Follow-up|6
2586883|NCT01170221|8945327|P2|Overall Study|Randomized but not treated|0
2586884|NCT01170221|8945328|P1|Overall Study|Randomized but not treated|1
2586885|NCT01170221|8945327|P2|Overall Study|Subject completed only screening and LFU|0
2586886|NCT01170221|8945328|P1|Overall Study|Subject completed only screening and LFU|1
2586887|NCT01170221|8945327|P2|Overall Study|Withdrawal by Subject|7
2586888|NCT01170221|8945328|P1|Overall Study|Withdrawal by Subject|9
2586889|NCT01170221|8945327|P2|Overall Study|Lost to Follow-up|21
2586890|NCT01170221|8945328|P1|Overall Study|Lost to Follow-up|22
2586891|NCT01170208|8945351|P3|Overall Study|Protocol Violation|1
2586892|NCT01170208|8945352|P2|Overall Study|Protocol Violation|0
2586893|NCT01170208|8945353|P1|Overall Study|Protocol Violation|1
2586894|NCT01170208|8945351|P3|Overall Study|Withdrawal by Subject|1
2586895|NCT01170208|8945352|P2|Overall Study|Withdrawal by Subject|0
2586896|NCT01170208|8945353|P1|Overall Study|Withdrawal by Subject|5
2586897|NCT01170091|8945381|P1|Overall Study|Treatment duration is less than 4 weeks|21
2586898|NCT01170091|8945381|P1|Overall Study|Missing efficacy evaluation|3
2586899|NCT01170065|8945391|P3|Overall Study|Ongoing after planned observation time|10
2586900|NCT01170065|8945392|P2|Overall Study|Ongoing after planned observation time|26
2586901|NCT01170065|8945393|P1|Overall Study|Ongoing after planned observation time|5
2586902|NCT01170065|8945391|P3|Overall Study|Reason other than specified|3
2586903|NCT01170065|8945392|P2|Overall Study|Reason other than specified|8
2586904|NCT01170065|8945393|P1|Overall Study|Reason other than specified|3
2586905|NCT01170065|8945391|P3|Overall Study|Consent withdrawn, not due to AE|2
2586906|NCT01170065|8945392|P2|Overall Study|Consent withdrawn, not due to AE|4
2586907|NCT01170065|8945393|P1|Overall Study|Consent withdrawn, not due to AE|2
2586908|NCT01170065|8945391|P3|Overall Study|Lost to Follow-up|1
2586909|NCT01170065|8945392|P2|Overall Study|Lost to Follow-up|4
2586910|NCT01170065|8945393|P1|Overall Study|Lost to Follow-up|1
2586911|NCT01170065|8945391|P3|Overall Study|Adverse Event|10
2586912|NCT01170065|8945392|P2|Overall Study|Adverse Event|50
2586913|NCT01170065|8945393|P1|Overall Study|Adverse Event|17
2586914|NCT01170039|8945424|P2|Overall Study|Lack of funding, drug not available|3
2586915|NCT01170039|8945425|P1|Overall Study|Lack of funding, drug not available|3
2586916|NCT01170039|8945424|P2|Overall Study|Withdrawal by Subject|3
2586917|NCT01170039|8945425|P1|Overall Study|Withdrawal by Subject|5
2586918|NCT01169987|8945437|P1|Overall Study|Other|4
2586919|NCT01169987|8945437|P1|Overall Study|Lost to Follow-up|24
2586920|NCT01169987|8945437|P1|Overall Study|Withdrawal by Subject|3
2586921|NCT01169779|8945503|P2|Overall Study|Familial and personal reasons|3
2586922|NCT01169779|8945504|P1|Overall Study|Familial and personal reasons|3
2586923|NCT01169779|8945503|P2|Overall Study|Withdrawal by Subject|2
2586924|NCT01169779|8945504|P1|Overall Study|Withdrawal by Subject|3
2586925|NCT01169779|8945503|P2|Overall Study|Protocol Violation|1
2586926|NCT01169779|8945504|P1|Overall Study|Protocol Violation|1
2586927|NCT01169779|8945503|P2|Overall Study|Lack of Efficacy|0
2586928|NCT01169779|8945504|P1|Overall Study|Lack of Efficacy|1
2586929|NCT01169779|8945503|P2|Overall Study|Adverse Event|11
2586930|NCT01169779|8945504|P1|Overall Study|Adverse Event|3
2586931|NCT01169701|8945539|P2|Overall Study|Sponsor decision|1
2586932|NCT01169701|8945540|P1|Overall Study|Sponsor decision|0
2586933|NCT01169701|8945539|P2|Overall Study|Serious adverse event|1
2586934|NCT01169701|8945540|P1|Overall Study|Serious adverse event|0
2586935|NCT01169701|8945539|P2|Overall Study|Administrative problems|1
2586936|NCT01169701|8945540|P1|Overall Study|Administrative problems|0
2586937|NCT01169701|8945539|P2|Overall Study|Death|1
2586938|NCT01169701|8945540|P1|Overall Study|Death|0
2586939|NCT01169701|8945539|P2|Overall Study|Exclusion criteria|0
2586940|NCT01169701|8945540|P1|Overall Study|Exclusion criteria|2
2586941|NCT01169701|8945539|P2|Overall Study|Adverse Event|2
2586942|NCT01169701|8945540|P1|Overall Study|Adverse Event|1
2586943|NCT01169701|8945539|P2|Overall Study|Withdrawal by Subject|3
2586944|NCT01169701|8945540|P1|Overall Study|Withdrawal by Subject|1
2586945|NCT01169701|8945539|P2|Overall Study|Lost to Follow-up|1
2586946|NCT01169701|8945540|P1|Overall Study|Lost to Follow-up|1
2586947|NCT01169675|8945577|P5|Overall Study|Other Reason Not Defined Above|1
2586948|NCT01169675|8945578|P4|Overall Study|Other Reason Not Defined Above|1
2586949|NCT01169675|8945579|P3|Overall Study|Other Reason Not Defined Above|0
2586950|NCT01169675|8945580|P2|Overall Study|Other Reason Not Defined Above|0
2586951|NCT01169675|8945581|P1|Overall Study|Other Reason Not Defined Above|0
2586952|NCT01169675|8945577|P5|Overall Study|Withdrawal by Subject|2
2586953|NCT01169675|8945578|P4|Overall Study|Withdrawal by Subject|1
2586954|NCT01169675|8945579|P3|Overall Study|Withdrawal by Subject|0
2586955|NCT01169675|8945580|P2|Overall Study|Withdrawal by Subject|0
2586956|NCT01169675|8945581|P1|Overall Study|Withdrawal by Subject|1
2586957|NCT01169675|8945577|P5|Overall Study|Adverse Event|0
2586958|NCT01169675|8945578|P4|Overall Study|Adverse Event|0
2586959|NCT01169675|8945579|P3|Overall Study|Adverse Event|2
2586960|NCT01169675|8945580|P2|Overall Study|Adverse Event|1
2586961|NCT01169675|8945581|P1|Overall Study|Adverse Event|5
2586962|NCT01169675|8945577|P5|Overall Study|Dose Limiting Toxicity (DLT)|2
2586963|NCT01169675|8945578|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
2586964|NCT01169675|8945579|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
2586965|NCT01169675|8945580|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
2586966|NCT01169675|8945581|P1|Overall Study|Dose Limiting Toxicity (DLT)|1
2586967|NCT01169675|8945577|P5|Overall Study|Progressive disease|1
2586968|NCT01169675|8945578|P4|Overall Study|Progressive disease|15
2586969|NCT01169675|8945579|P3|Overall Study|Progressive disease|5
2586970|NCT01169675|8945580|P2|Overall Study|Progressive disease|2
2586971|NCT01169675|8945581|P1|Overall Study|Progressive disease|13
2586972|NCT01169649|8945618|P1|Overall Study|Patient Not Treated|3
2586973|NCT01169558|8945630|P1|Overall Study|Partial response|2
2586974|NCT01169558|8945630|P1|Overall Study|Protocol Violation|2
2586975|NCT01169558|8945630|P1|Overall Study|Non-compliance|2
2586976|NCT01169558|8945630|P1|Overall Study|Need for Surgery|4
2586977|NCT01169558|8945630|P1|Overall Study|Lost to Follow-up|4
2586978|NCT01169558|8945630|P1|Overall Study|Stable Disease|4
2586979|NCT01169558|8945630|P1|Overall Study|Medical Decision|7
2586980|NCT01169558|8945630|P1|Overall Study|Withdrawal of Consent|8
2586981|NCT01169558|8945630|P1|Overall Study|Adverse Event|25
2586982|NCT01169558|8945630|P1|Overall Study|Disease progression|98
2586983|NCT01169493|8945655|P6|Period 3 (6 Months)|Physician Decision|0
2586984|NCT01169493|8945656|P5|Period 3 (6 Months)|Physician Decision|0
2586985|NCT01169493|8945657|P4|Period 3 (6 Months)|Physician Decision|0
2586986|NCT01169493|8945658|P3|Period 3 (6 Months)|Physician Decision|1
2586987|NCT01169493|8945659|P2|Period 3 (6 Months)|Physician Decision|1
2586988|NCT01169493|8945660|P1|Period 3 (6 Months)|Physician Decision|0
2586989|NCT01169493|8945655|P6|Period 3 (6 Months)|Adverse Event|0
2586990|NCT01169493|8945656|P5|Period 3 (6 Months)|Adverse Event|0
2586991|NCT01169493|8945657|P4|Period 3 (6 Months)|Adverse Event|0
2586992|NCT01169493|8945658|P3|Period 3 (6 Months)|Adverse Event|0
2586993|NCT01169493|8945659|P2|Period 3 (6 Months)|Adverse Event|1
2586994|NCT01169493|8945660|P1|Period 3 (6 Months)|Adverse Event|0
2586995|NCT01169493|8945655|P6|Period 1 (6 Months)|Withdrawal by Subject|3
2586996|NCT01169493|8945656|P5|Period 1 (6 Months)|Withdrawal by Subject|0
2586997|NCT01169493|8945657|P4|Period 1 (6 Months)|Withdrawal by Subject|0
2586998|NCT01169493|8945658|P3|Period 1 (6 Months)|Withdrawal by Subject|2
2586999|NCT01169493|8945659|P2|Period 1 (6 Months)|Withdrawal by Subject|1
2587000|NCT01169493|8945660|P1|Period 1 (6 Months)|Withdrawal by Subject|0
2587001|NCT01169350|8945706|P1|Overall Study|Lost to Follow-up|2
2587002|NCT01169350|8945706|P1|Overall Study|Physician Decision|3
2587003|NCT01169103|8945836|P2|Overall Study|Withdrawal by Subject|1
2587004|NCT01169103|8945837|P1|Overall Study|Withdrawal by Subject|3
2587005|NCT01169103|8945836|P2|Overall Study|Lost to Follow-up|3
2587006|NCT01169103|8945837|P1|Overall Study|Lost to Follow-up|3
2587007|NCT01169038|8945864|P1|Overall Study|Required antibiotic administration|1
2587008|NCT01169038|8945864|P1|Overall Study|Adverse Event|5
2587009|NCT01169038|8945864|P1|Overall Study|Death|1
2587010|NCT01168999|8945872|P4|Overall Study|Lost to Follow-up|0
2587011|NCT01168999|8945873|P3|Overall Study|Lost to Follow-up|0
2587012|NCT01168999|8945874|P2|Overall Study|Lost to Follow-up|1
2587013|NCT01168999|8945875|P1|Overall Study|Lost to Follow-up|2
2587014|NCT01168973|8945941|P2|Overall Study|Protocol Criterion Not Met and Deviation|9
2587015|NCT01168973|8945942|P1|Overall Study|Protocol Criterion Not Met and Deviation|7
2587016|NCT01168973|8945941|P2|Overall Study|Sponsor Decision|1
2587017|NCT01168973|8945942|P1|Overall Study|Sponsor Decision|2
2587018|NCT01168973|8945941|P2|Overall Study|Physician Decision|19
2587019|NCT01168973|8945942|P1|Overall Study|Physician Decision|37
2587020|NCT01168973|8945941|P2|Overall Study|Death|45
2587021|NCT01168973|8945942|P1|Overall Study|Death|42
2587022|NCT01168973|8945941|P2|Overall Study|Withdrawal by Subject|53
2587023|NCT01168973|8945942|P1|Overall Study|Withdrawal by Subject|90
2587024|NCT01168973|8945941|P2|Overall Study|Adverse Event|55
2587025|NCT01168973|8945942|P1|Overall Study|Adverse Event|94
2587026|NCT01168973|8945941|P2|Overall Study|Progressive Disease|429
2587027|NCT01168973|8945942|P1|Overall Study|Progressive Disease|341
2587028|NCT01168856|8946017|P2|Overall Study|Protocol Violation|6
2587029|NCT01168856|8946018|P1|Overall Study|Protocol Violation|4
2587030|NCT01168856|8946017|P2|Overall Study|Other|291
2587031|NCT01168856|8946018|P1|Overall Study|Other|1
2587032|NCT01168856|8946017|P2|Overall Study|Death|2
2587033|NCT01168856|8946018|P1|Overall Study|Death|0
2587034|NCT01168856|8946017|P2|Overall Study|Participant received anti-HCV treatment|0
2587035|NCT01168856|8946018|P1|Overall Study|Participant received anti-HCV treatment|1
2587036|NCT01168856|8946017|P2|Overall Study|Confirmed Quantifiable HCV RNA|1
2587037|NCT01168856|8946018|P1|Overall Study|Confirmed Quantifiable HCV RNA|0
2587038|NCT01168856|8946017|P2|Overall Study|Physician Decision|1
2587039|NCT01168856|8946018|P1|Overall Study|Physician Decision|2
2587040|NCT01168856|8946017|P2|Overall Study|Withdrawal by Subject|8
2587041|NCT01168856|8946018|P1|Overall Study|Withdrawal by Subject|6
2587042|NCT01168856|8946017|P2|Overall Study|Lost to Follow-up|34
2587043|NCT01168856|8946018|P1|Overall Study|Lost to Follow-up|4
2587044|NCT01168596|8946116|P2|Overall Study|Withdrawal by Subject|1
2587045|NCT01168596|8946117|P1|Overall Study|Withdrawal by Subject|3
2587046|NCT01168427|8946161|P1|Overall Study|Patient exited prior to implant|1
2587047|NCT01168401|8946177|P11|Overall Study|Withdrawal by Subject|0
2587048|NCT01168401|8946178|P10|Overall Study|Withdrawal by Subject|0
2587049|NCT01168401|8946179|P9|Overall Study|Withdrawal by Subject|0
2587050|NCT01168401|8946180|P8|Overall Study|Withdrawal by Subject|0
2587051|NCT01168401|8946181|P7|Overall Study|Withdrawal by Subject|0
2587052|NCT01168401|8946182|P6|Overall Study|Withdrawal by Subject|0
2587053|NCT01168401|8946183|P5|Overall Study|Withdrawal by Subject|0
2587054|NCT01168401|8946184|P4|Overall Study|Withdrawal by Subject|1
2587055|NCT01168401|8946185|P3|Overall Study|Withdrawal by Subject|0
2587056|NCT01168401|8946186|P2|Overall Study|Withdrawal by Subject|0
2587057|NCT01168401|8946187|P1|Overall Study|Withdrawal by Subject|0
2587058|NCT01168401|8946177|P11|Overall Study|Lost to Follow-up|0
2587059|NCT01168401|8946178|P10|Overall Study|Lost to Follow-up|0
2587060|NCT01168401|8946179|P9|Overall Study|Lost to Follow-up|0
2587061|NCT01168401|8946180|P8|Overall Study|Lost to Follow-up|0
2587062|NCT01168401|8946181|P7|Overall Study|Lost to Follow-up|0
2587063|NCT01168401|8946182|P6|Overall Study|Lost to Follow-up|0
2587064|NCT01168401|8946183|P5|Overall Study|Lost to Follow-up|0
2587065|NCT01168401|8946184|P4|Overall Study|Lost to Follow-up|1
2587066|NCT01168401|8946185|P3|Overall Study|Lost to Follow-up|2
2587067|NCT01168401|8946186|P2|Overall Study|Lost to Follow-up|1
2587068|NCT01168401|8946187|P1|Overall Study|Lost to Follow-up|1
2587069|NCT01168349|8946420|P1|Overall Study|Protocol Violation|76
2587070|NCT01168349|8946420|P1|Overall Study|Other|22
2587071|NCT01168349|8946420|P1|Overall Study|Kidney transplantation|3
2587072|NCT01168349|8946420|P1|Overall Study|Withdrawal by Subject|9
2587073|NCT01168349|8946420|P1|Overall Study|Lost to Follow-up|34
2587074|NCT01168349|8946420|P1|Overall Study|Death|157
2587075|NCT01168232|8946526|P1|Overall Study|Ineligible-Inadequate pathology|1
2587076|NCT01168232|8946526|P1|Overall Study|Ineligible- Wrong cell type|6
2587077|NCT01168232|8946526|P1|Overall Study|Ineligible-Second primary cancer site|1
2587078|NCT01168219|8946533|P1|Overall Study|ineligible due to CML|2
2587079|NCT01168219|8946533|P1|Overall Study|withdrew before transplant|1
2587080|NCT01168219|8946533|P1|Overall Study|off study before starting treatment|2
2587081|NCT01167907|8946556|P2|Overall Study|saphenous catheter dislodged before comp|1
2587082|NCT01167907|8946557|P1|Overall Study|saphenous catheter dislodged before comp|1
2587083|NCT01167907|8946556|P2|Overall Study|Protocol Violation|0
2587084|NCT01167907|8946557|P1|Overall Study|Protocol Violation|1
2587085|NCT01167881|8946575|P2|Overall Study|Other not defined above|55
2587086|NCT01167881|8946576|P1|Overall Study|Other not defined above|31
2587087|NCT01167881|8946575|P2|Overall Study|Not treated|0
2587088|NCT01167881|8946576|P1|Overall Study|Not treated|4
2587089|NCT01167881|8946575|P2|Overall Study|Patient refusal to cont., not due to AE|40
2587090|NCT01167881|8946576|P1|Overall Study|Patient refusal to cont., not due to AE|45
2587091|NCT01167881|8946575|P2|Overall Study|Lost to Follow-up|20
2587092|NCT01167881|8946576|P1|Overall Study|Lost to Follow-up|19
2587093|NCT01167881|8946575|P2|Overall Study|Non compliant with protocol|18
2587094|NCT01167881|8946576|P1|Overall Study|Non compliant with protocol|9
2587095|NCT01167881|8946575|P2|Overall Study|Lack of Efficacy|7
2587096|NCT01167881|8946576|P1|Overall Study|Lack of Efficacy|4
2587097|NCT01167881|8946575|P2|Overall Study|Adverse Event|51
2587098|NCT01167881|8946576|P1|Overall Study|Adverse Event|47
2587099|NCT01167634|8946630|P4|Overall Study|Withdrawal by Subject|0
2587100|NCT01167634|8946631|P3|Overall Study|Withdrawal by Subject|0
2587101|NCT01167634|8946632|P2|Overall Study|Withdrawal by Subject|1
2587102|NCT01167634|8946633|P1|Overall Study|Withdrawal by Subject|1
2587103|NCT01167634|8946630|P4|Overall Study|Lost to Follow-up|4
2587104|NCT01167634|8946631|P3|Overall Study|Lost to Follow-up|3
2587105|NCT01167634|8946632|P2|Overall Study|Lost to Follow-up|3
2587106|NCT01167634|8946633|P1|Overall Study|Lost to Follow-up|1
2587107|NCT01167582|8946654|P2|Overall Study|Lost to Follow-up|1
2587108|NCT01167582|8946655|P1|Overall Study|Lost to Follow-up|0
2587109|NCT01167426|8946695|P1|Overall Study|Sponsor Decision|1
2587110|NCT01167426|8946695|P1|Overall Study|Withdrawal by Subject|2
2587111|NCT01167426|8946695|P1|Overall Study|Protocol Violation|1
2587112|NCT01167426|8946695|P1|Overall Study|Lost to Follow-up|6
2587113|NCT01167257|8946703|P2|Overall Study|Withdrew consent|1
2587114|NCT01167257|8946704|P1|Overall Study|Withdrew consent|1
2587115|NCT01167257|8946703|P2|Overall Study|Lost to Follow-up|2
2587116|NCT01167257|8946704|P1|Overall Study|Lost to Follow-up|2
2587117|NCT01167192|8946726|P1|Overall Study|Insurance denial|1
2587118|NCT01167192|8946726|P1|Overall Study|Withdrawal by Subject|1
2587119|NCT01167192|8946726|P1|Overall Study|Death|1
2587120|NCT01167192|8946726|P1|Overall Study|Adverse Event|1
2587121|NCT01167179|8946743|P2|Overall Study|diverse|5
2587122|NCT01167179|8946744|P1|Overall Study|diverse|6
2587123|NCT01167179|8946743|P2|Overall Study|Withdrawal by Subject|2
2587124|NCT01167179|8946744|P1|Overall Study|Withdrawal by Subject|1
2587125|NCT01167179|8946743|P2|Overall Study|Death|10
2587126|NCT01167179|8946744|P1|Overall Study|Death|4
2587127|NCT01167179|8946743|P2|Overall Study|disease recurrence|4
2587128|NCT01167179|8946744|P1|Overall Study|disease recurrence|4
2587129|NCT01167153|8946754|P2|Overall Study|Subject initiation withdrawal, Other|8
2587130|NCT01167153|8946755|P1|Overall Study|Subject initiation withdrawal, Other|5
2587131|NCT01167153|8946754|P2|Overall Study|Withdrawal consent|1
2587132|NCT01167153|8946755|P1|Overall Study|Withdrawal consent|1
2587133|NCT01167153|8946754|P2|Overall Study|Investigator initiation withdrawal,Other|1
2587134|NCT01167153|8946755|P1|Overall Study|Investigator initiation withdrawal,Other|1
2587135|NCT01167153|8946754|P2|Overall Study|Non-compliance to concomitant medication|2
2587136|NCT01167153|8946755|P1|Overall Study|Non-compliance to concomitant medication|0
2587137|NCT01167153|8946754|P2|Overall Study|Lost to Follow-up|9
2587138|NCT01167153|8946755|P1|Overall Study|Lost to Follow-up|7
2587139|NCT01167153|8946754|P2|Overall Study|Hypotension|0
2587140|NCT01167153|8946755|P1|Overall Study|Hypotension|1
2587141|NCT01167153|8946754|P2|Overall Study|AE including clinical laboratory AE|8
2587142|NCT01167153|8946755|P1|Overall Study|AE including clinical laboratory AE|2
2587143|NCT01167153|8946754|P2|Overall Study|Non-effective therapy|4
2587144|NCT01167153|8946755|P1|Overall Study|Non-effective therapy|1
2587145|NCT01167140|8946773|P1|Overall Study|Withdrawal by Subject|1
2587146|NCT01167023|8946781|P3|Overall Study|Withdrawal by Subject|1
2587147|NCT01167023|8946782|P2|Overall Study|Withdrawal by Subject|0
2587148|NCT01167023|8946783|P1|Overall Study|Withdrawal by Subject|0
2587149|NCT01167023|8946781|P3|Overall Study|Sponsor Decision|0
2587150|NCT01167023|8946782|P2|Overall Study|Sponsor Decision|1
2587151|NCT01167023|8946783|P1|Overall Study|Sponsor Decision|0
2587152|NCT01167023|8946781|P3|Overall Study|Screen Failure|0
2587153|NCT01167023|8946782|P2|Overall Study|Screen Failure|1
2587154|NCT01167023|8946783|P1|Overall Study|Screen Failure|0
2587155|NCT01167023|8946781|P3|Overall Study|Lost to Follow-up|1
2587156|NCT01167023|8946782|P2|Overall Study|Lost to Follow-up|1
2587157|NCT01167023|8946783|P1|Overall Study|Lost to Follow-up|0
2587158|NCT01166958|8946823|P2|Overall Study|Withdrawal by Subject|0
2587159|NCT01166958|8946824|P1|Overall Study|Withdrawal by Subject|1
2587160|NCT01166945|8946840|P2|Day 30|Lost to Follow-up|3
2587161|NCT01166945|8946841|P1|Day 30|Lost to Follow-up|4
2587162|NCT01166945|8946840|P2|Day 15|NonCompliance/Lost to Follow Up|1
2587163|NCT01166945|8946841|P1|Day 15|NonCompliance/Lost to Follow Up|2
2587164|NCT01166945|8946840|P2|Day 10|NonCompliance/Lost to Follow Up|2
2587165|NCT01166945|8946841|P1|Day 10|NonCompliance/Lost to Follow Up|3
2587166|NCT01166945|8946840|P2|Randomized|diagnosed with Group A strep|4
2587167|NCT01166945|8946841|P1|Randomized|diagnosed with Group A strep|4
2587168|NCT01166763|8946849|P1|Overall Study|Withdrawal by Subject|3
2587169|NCT01166750|8946857|P2|Overall Study|Lost to Follow-up|0
2587170|NCT01166750|8946858|P1|Overall Study|Lost to Follow-up|1
2587171|NCT01166659|8946875|P1|Overall Study|Study Closed at Site|1
2587172|NCT01166659|8946875|P1|Overall Study|Lost to Follow-up|1
2587173|NCT01166659|8946875|P1|Overall Study|Death|1
2587174|NCT01166659|8946875|P1|Overall Study|Investigator Decision|2
2587175|NCT01166659|8946875|P1|Overall Study|Subject Decision|8
2587176|NCT01166646|8946884|P2|Overall Study|Adverse Event|0
2587177|NCT01166646|8946885|P1|Overall Study|Adverse Event|1
2587178|NCT01166646|8946884|P2|Overall Study|Protocol Violation|1
2587179|NCT01166646|8946885|P1|Overall Study|Protocol Violation|0
2587180|NCT01166568|8946904|P3|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1
2587181|NCT01166568|8946905|P2|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
2587182|NCT01166568|8946906|P1|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7
2587183|NCT01166568|8946904|P3|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0
2587184|NCT01166568|8946905|P2|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1
2587185|NCT01166568|8946906|P1|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7
2587186|NCT01166568|8946904|P3|Deferred Implantation- Randomized|Withdrawal by Subject|1
2587187|NCT01166568|8946905|P2|Deferred Implantation- Randomized|Withdrawal by Subject|0
2587188|NCT01166568|8946906|P1|Deferred Implantation- Randomized|Withdrawal by Subject|0
2587189|NCT01166438|8946919|P2|Off Treatment Follow-up Phase|Lack of Efficacy|52
2587190|NCT01166438|8946920|P1|Off Treatment Follow-up Phase|Lack of Efficacy|29
2587191|NCT01166438|8946919|P2|Off Treatment Follow-up Phase|Lost to Follow-up|2
2587192|NCT01166438|8946920|P1|Off Treatment Follow-up Phase|Lost to Follow-up|4
2587193|NCT01166438|8946919|P2|Off Treatment Follow-up Phase|Withdrawal by Subject|2
2587194|NCT01166438|8946920|P1|Off Treatment Follow-up Phase|Withdrawal by Subject|1
2587195|NCT01166438|8946919|P2|Double-blind Phase: 1st 6 Months|Not treated|1
2587196|NCT01166438|8946920|P1|Double-blind Phase: 1st 6 Months|Not treated|1
2587197|NCT01166438|8946919|P2|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4
2587198|NCT01166438|8946920|P1|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0
2587199|NCT01166438|8946919|P2|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4
2587200|NCT01166438|8946920|P1|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8
2587201|NCT01166282|8946969|P3|Open-label Period|Irregular Compliance|1
2587202|NCT01166282|8946970|P2|Open-label Period|Irregular Compliance|0
2587203|NCT01166282|8946971|P1|Open-label Period|Irregular Compliance|0
2587204|NCT01166282|8946969|P3|Open-label Period|Remission|4
2587205|NCT01166282|8946970|P2|Open-label Period|Remission|0
2587206|NCT01166282|8946971|P1|Open-label Period|Remission|0
2587207|NCT01166282|8946969|P3|Open-label Period|Lack of Efficacy|2
2587208|NCT01166282|8946970|P2|Open-label Period|Lack of Efficacy|0
2587209|NCT01166282|8946971|P1|Open-label Period|Lack of Efficacy|0
2587210|NCT01166282|8946969|P3|Open-label Period|Withdrawal by Subject|4
2587211|NCT01166282|8946970|P2|Open-label Period|Withdrawal by Subject|0
2587212|NCT01166282|8946971|P1|Open-label Period|Withdrawal by Subject|0
2587213|NCT01166282|8946969|P3|Open-label Period|Adverse Event|6
2587214|NCT01166282|8946970|P2|Open-label Period|Adverse Event|0
2587215|NCT01166282|8946971|P1|Open-label Period|Adverse Event|0
2587216|NCT01166178|8947010|P2|Overall Study|Study was terminated|8
2587217|NCT01166178|8947011|P1|Overall Study|Study was terminated|20
2587218|NCT01166178|8947010|P2|Overall Study|Withdrawal by Subject|0
2587219|NCT01166178|8947011|P1|Overall Study|Withdrawal by Subject|1
2587220|NCT01165996|8947050|P1|Overall Study|Physician Decision|1
2587221|NCT01165996|8947050|P1|Overall Study|Death|1
2587222|NCT01165684|8947121|P2|Overall Study|Unclassified|22
2587223|NCT01165684|8947122|P1|Overall Study|Unclassified|16
2587224|NCT01165684|8947121|P2|Overall Study|Withdrawal Criteria|13
2587225|NCT01165684|8947122|P1|Overall Study|Withdrawal Criteria|2
2587226|NCT01165684|8947121|P2|Overall Study|Protocol Violation|15
2587227|NCT01165684|8947122|P1|Overall Study|Protocol Violation|7
2587228|NCT01165684|8947121|P2|Overall Study|Lack of Efficacy|1
2587229|NCT01165684|8947122|P1|Overall Study|Lack of Efficacy|2
2587230|NCT01165684|8947121|P2|Overall Study|Adverse Event|1
2587231|NCT01165684|8947122|P1|Overall Study|Adverse Event|1
2587232|NCT01165554|8947156|P1|Overall Study|Withdrawal by Subject|23
2587233|NCT01165424|8947179|P1|Overall Study|Participant moved (relocated)|1
2587234|NCT01165424|8947179|P1|Overall Study|Did not meet entry criteria|1
2587235|NCT01165424|8947179|P1|Overall Study|Laboratory adverse experiences|1
2587236|NCT01165424|8947179|P1|Overall Study|Clinical adverse experiences|1
2587237|NCT01165320|8947186|P3|Overall Study|Reason unknown|0
2587238|NCT01165320|8947187|P2|Overall Study|Reason unknown|1
2587239|NCT01165320|8947188|P1|Overall Study|Reason unknown|0
2587240|NCT01165320|8947186|P3|Overall Study|Lack of Efficacy|0
2587241|NCT01165320|8947187|P2|Overall Study|Lack of Efficacy|2
2587242|NCT01165320|8947188|P1|Overall Study|Lack of Efficacy|0
2587243|NCT01165320|8947186|P3|Overall Study|Laboratory adverse experience|0
2587244|NCT01165320|8947187|P2|Overall Study|Laboratory adverse experience|0
2587245|NCT01165320|8947188|P1|Overall Study|Laboratory adverse experience|1
2587246|NCT01165320|8947186|P3|Overall Study|Clinical adverse experience|0
2587247|NCT01165320|8947187|P2|Overall Study|Clinical adverse experience|1
2587248|NCT01165320|8947188|P1|Overall Study|Clinical adverse experience|2
2587249|NCT01165307|8947198|P2|Overall Study|Subject not available for contact|0
2587250|NCT01165307|8947199|P1|Overall Study|Subject not available for contact|1
2587251|NCT01165307|8947198|P2|Overall Study|Withdrawal by Subject|0
2587252|NCT01165307|8947199|P1|Overall Study|Withdrawal by Subject|2
2587253|NCT01165307|8947198|P2|Overall Study|Lost to Follow-up|3
2587254|NCT01165307|8947199|P1|Overall Study|Lost to Follow-up|11
2587255|NCT01165281|8947229|P2|Overall Study|Other|0
2587256|NCT01165281|8947230|P1|Overall Study|Other|6
2587257|NCT01165281|8947229|P2|Overall Study|Progressive Disease|14
2587258|NCT01165281|8947230|P1|Overall Study|Progressive Disease|10
2587259|NCT01165281|8947229|P2|Overall Study|Noncompliance with Study Drug|4
2587260|NCT01165281|8947230|P1|Overall Study|Noncompliance with Study Drug|1
2587261|NCT01165281|8947229|P2|Overall Study|Withdrawal by Subject|7
2587262|NCT01165281|8947230|P1|Overall Study|Withdrawal by Subject|8
2587263|NCT01165281|8947229|P2|Overall Study|Protocol Violation|5
2587264|NCT01165281|8947230|P1|Overall Study|Protocol Violation|6
2587265|NCT01165281|8947229|P2|Overall Study|Physician Decision|1
2587266|NCT01165281|8947230|P1|Overall Study|Physician Decision|8
2587267|NCT01165281|8947229|P2|Overall Study|Lost to Follow-up|1
2587268|NCT01165281|8947230|P1|Overall Study|Lost to Follow-up|0
2587269|NCT01165281|8947229|P2|Overall Study|Lack of Efficacy|1
2587270|NCT01165281|8947230|P1|Overall Study|Lack of Efficacy|4
2587271|NCT01165281|8947229|P2|Overall Study|Death|4
2587272|NCT01165281|8947230|P1|Overall Study|Death|3
2587273|NCT01165281|8947229|P2|Overall Study|Adverse Event|14
2587274|NCT01165281|8947230|P1|Overall Study|Adverse Event|12
2587275|NCT01165242|8947251|P3|Overall Study|Lost to Follow-up|10
2587276|NCT01165242|8947252|P2|Overall Study|Lost to Follow-up|7
2587277|NCT01165242|8947253|P1|Overall Study|Lost to Follow-up|9
2587278|NCT01165242|8947251|P3|Overall Study|Extended Holiday|1
2587279|NCT01165242|8947252|P2|Overall Study|Extended Holiday|0
2587280|NCT01165242|8947253|P1|Overall Study|Extended Holiday|0
2587281|NCT01165242|8947251|P3|Overall Study|Withdrawal by Subject|2
2587282|NCT01165242|8947252|P2|Overall Study|Withdrawal by Subject|2
2587283|NCT01165242|8947253|P1|Overall Study|Withdrawal by Subject|0
2587284|NCT01165242|8947251|P3|Overall Study|Visit 2 Declined by Subject|1
2587285|NCT01165242|8947252|P2|Overall Study|Visit 2 Declined by Subject|0
2587286|NCT01165242|8947253|P1|Overall Study|Visit 2 Declined by Subject|0
2587287|NCT01165242|8947251|P3|Overall Study|Incarcerated Subjects|0
2587288|NCT01165242|8947252|P2|Overall Study|Incarcerated Subjects|1
2587289|NCT01165242|8947253|P1|Overall Study|Incarcerated Subjects|0
2587290|NCT01165242|8947251|P3|Overall Study|Unreachable Subjects|0
2587291|NCT01165242|8947252|P2|Overall Study|Unreachable Subjects|0
2587292|NCT01165242|8947253|P1|Overall Study|Unreachable Subjects|1
2587293|NCT01165229|8947287|P2|Overall Study|Unknown completion status|1
2587294|NCT01165229|8947288|P1|Overall Study|Unknown completion status|0
2587295|NCT01165229|8947287|P2|Overall Study|No reason from the subject|102
2587296|NCT01165229|8947288|P1|Overall Study|No reason from the subject|108
2587297|NCT01165229|8947287|P2|Overall Study|Suspected HZ Episode|2
2587298|NCT01165229|8947288|P1|Overall Study|Suspected HZ Episode|2
2587299|NCT01165229|8947287|P2|Overall Study|Lost to Follow-up|133
2587300|NCT01165229|8947288|P1|Overall Study|Lost to Follow-up|123
2587301|NCT01165229|8947287|P2|Overall Study|Migrated/moved from study area|46
2587302|NCT01165229|8947288|P1|Overall Study|Migrated/moved from study area|51
2587303|NCT01165229|8947287|P2|Overall Study|Withdrawal by Subject|396
2587304|NCT01165229|8947288|P1|Overall Study|Withdrawal by Subject|387
2587305|NCT01165229|8947287|P2|Overall Study|Protocol Violation|8
2587306|NCT01165229|8947288|P1|Overall Study|Protocol Violation|6
2587307|NCT01165229|8947287|P2|Overall Study|Non-Serious Adverse Event|15
2587308|NCT01165229|8947288|P1|Overall Study|Non-Serious Adverse Event|47
2587309|NCT01165229|8947287|P2|Overall Study|Serious Adverse Event|487
2587310|NCT01165229|8947288|P1|Overall Study|Serious Adverse Event|456
2587311|NCT01165216|8947422|P2|Overall Study|Disease progression|3
2587312|NCT01165216|8947423|P1|Overall Study|Disease progression|1
2587313|NCT01165216|8947422|P2|Overall Study|Withdrawal by Subject|1
2587314|NCT01165216|8947423|P1|Overall Study|Withdrawal by Subject|1
2587315|NCT01165216|8947422|P2|Overall Study|Adverse Event|3
2587316|NCT01165216|8947423|P1|Overall Study|Adverse Event|6
2587317|NCT01165203|8947445|P2|Extended Safety Follow-up Phase|Other-subjects business reasons|1
2587318|NCT01165203|8947446|P1|Extended Safety Follow-up Phase|Other-subjects business reasons|0
2587319|NCT01165203|8947445|P2|Extended Safety Follow-up Phase|Lost to Follow-up|0
2587320|NCT01165203|8947446|P1|Extended Safety Follow-up Phase|Lost to Follow-up|2
2587321|NCT01165203|8947445|P2|Extended Safety Follow-up Phase|Migrated/moved from study area|1
2587322|NCT01165203|8947446|P1|Extended Safety Follow-up Phase|Migrated/moved from study area|2
2587323|NCT01165203|8947445|P2|Extended Safety Follow-up Phase|Withdrawal by Subject|2
2587324|NCT01165203|8947446|P1|Extended Safety Follow-up Phase|Withdrawal by Subject|2
2587325|NCT01165203|8947445|P2|Extended Safety Follow-up Phase|Serious Adverse Event|0
2587326|NCT01165203|8947446|P1|Extended Safety Follow-up Phase|Serious Adverse Event|1
2587327|NCT01165203|8947445|P2|Active Phase|Lost to Follow-up|0
2587328|NCT01165203|8947446|P1|Active Phase|Lost to Follow-up|2
2587329|NCT01165203|8947445|P2|Active Phase|Migrated/moved from study area|1
2587330|NCT01165203|8947446|P1|Active Phase|Migrated/moved from study area|0
2587331|NCT01165203|8947445|P2|Active Phase|Withdrawal by Subject|1
2587332|NCT01165203|8947446|P1|Active Phase|Withdrawal by Subject|2
2587333|NCT01165203|8947445|P2|Active Phase|Serious Adverse Event|0
2587334|NCT01165203|8947446|P1|Active Phase|Serious Adverse Event|1
2587335|NCT01165177|8947536|P2|Overall Study|Migrated/ moved from study area|43
2587336|NCT01165177|8947537|P1|Overall Study|Migrated/ moved from study area|48
2587337|NCT01165177|8947536|P2|Overall Study|Lost to Follow-up|194
2587338|NCT01165177|8947537|P1|Overall Study|Lost to Follow-up|183
2587339|NCT01165177|8947536|P2|Overall Study|Suspected HZ episode|2
2587340|NCT01165177|8947537|P1|Overall Study|Suspected HZ episode|0
2587341|NCT01165177|8947536|P2|Overall Study|Other unspecified reasons|35
2587342|NCT01165177|8947537|P1|Overall Study|Other unspecified reasons|47
2587343|NCT01165177|8947536|P2|Overall Study|Non-serious adverse event|18
2587344|NCT01165177|8947537|P1|Overall Study|Non-serious adverse event|30
2587345|NCT01165177|8947536|P2|Overall Study|Protocol Violation|21
2587346|NCT01165177|8947537|P1|Overall Study|Protocol Violation|19
2587347|NCT01165177|8947536|P2|Overall Study|Withdrawal by Subject|354
2587348|NCT01165177|8947537|P1|Overall Study|Withdrawal by Subject|368
2587349|NCT01165177|8947536|P2|Overall Study|Serious Adverse Event|235
2587350|NCT01165177|8947537|P1|Overall Study|Serious Adverse Event|227
2587351|NCT01165138|8947666|P4|Overall Study|Withdrawal by Subject|3
2587352|NCT01165138|8947667|P3|Overall Study|Withdrawal by Subject|6
2587353|NCT01165138|8947668|P2|Overall Study|Withdrawal by Subject|6
2587354|NCT01165138|8947669|P1|Overall Study|Withdrawal by Subject|0
2587355|NCT01165138|8947666|P4|Overall Study|Physician Decision|6
2587356|NCT01165138|8947667|P3|Overall Study|Physician Decision|7
2587357|NCT01165138|8947668|P2|Overall Study|Physician Decision|6
2587358|NCT01165138|8947669|P1|Overall Study|Physician Decision|0
2587359|NCT01165138|8947666|P4|Overall Study|Lost to Follow-up|2
2587360|NCT01165138|8947667|P3|Overall Study|Lost to Follow-up|1
2587361|NCT01165138|8947668|P2|Overall Study|Lost to Follow-up|0
2587362|NCT01165138|8947669|P1|Overall Study|Lost to Follow-up|0
2587363|NCT01165138|8947666|P4|Overall Study|Protocol Violation|2
2587364|NCT01165138|8947667|P3|Overall Study|Protocol Violation|0
2587365|NCT01165138|8947668|P2|Overall Study|Protocol Violation|7
2587366|NCT01165138|8947669|P1|Overall Study|Protocol Violation|0
2587367|NCT01165138|8947666|P4|Overall Study|Lack of Efficacy|7
2587368|NCT01165138|8947667|P3|Overall Study|Lack of Efficacy|6
2587369|NCT01165138|8947668|P2|Overall Study|Lack of Efficacy|32
2587370|NCT01165138|8947669|P1|Overall Study|Lack of Efficacy|0
2587371|NCT01165138|8947666|P4|Overall Study|Adverse Event|2
2587372|NCT01165138|8947667|P3|Overall Study|Adverse Event|0
2587373|NCT01165138|8947668|P2|Overall Study|Adverse Event|1
2587374|NCT01165138|8947669|P1|Overall Study|Adverse Event|0
2587375|NCT01165021|8947739|P1|Overall Study|Death|1
2587376|NCT01164956|8947747|P3|Overall Study|Side Effects|1
2587377|NCT01164956|8947748|P2|Overall Study|Side Effects|0
2587378|NCT01164956|8947749|P1|Overall Study|Side Effects|1
2587379|NCT01164891|8947757|P1|Overall Study|Adverse Event|1
2587380|NCT01164891|8947757|P1|Overall Study|Disease Progression|5
2587381|NCT01164865|8947777|P2|Overall Study|Lost to Follow-up|1
2587382|NCT01164865|8947778|P1|Overall Study|Lost to Follow-up|2
2587383|NCT01164722|8947788|P2|Overall Study|enrolled on other study, concomitant med|3
2587384|NCT01164722|8947789|P1|Overall Study|enrolled on other study, concomitant med|1
2587385|NCT01164722|8947788|P2|Overall Study|met protocol criteria for non-treatment|1
2587386|NCT01164722|8947789|P1|Overall Study|met protocol criteria for non-treatment|11
2587387|NCT01164722|8947788|P2|Overall Study|Lost to Follow-up|6
2587388|NCT01164722|8947789|P1|Overall Study|Lost to Follow-up|3
2587389|NCT01164722|8947788|P2|Overall Study|Withdrawal by Subject|4
2587390|NCT01164722|8947789|P1|Overall Study|Withdrawal by Subject|3
2587391|NCT01164722|8947788|P2|Overall Study|Adverse Event|1
2587392|NCT01164722|8947789|P1|Overall Study|Adverse Event|0
2587393|NCT01164579|8947819|P3|Overall Study|Reason not specified|0
2587394|NCT01164579|8947820|P2|Overall Study|Reason not specified|0
2587395|NCT01164579|8947821|P1|Overall Study|Reason not specified|1
2587396|NCT01164579|8947819|P3|Overall Study|Adverse Event|5
2587397|NCT01164579|8947820|P2|Overall Study|Adverse Event|2
2587398|NCT01164579|8947821|P1|Overall Study|Adverse Event|4
2587399|NCT01164579|8947819|P3|Overall Study|Protocol Violation|2
2587400|NCT01164579|8947820|P2|Overall Study|Protocol Violation|1
2587401|NCT01164579|8947821|P1|Overall Study|Protocol Violation|0
2587402|NCT01164579|8947819|P3|Overall Study|Withdrawal by Subject|3
2587403|NCT01164579|8947820|P2|Overall Study|Withdrawal by Subject|5
2587404|NCT01164579|8947821|P1|Overall Study|Withdrawal by Subject|2
2587405|NCT01164579|8947819|P3|Overall Study|Lost to Follow-up|0
2587406|NCT01164579|8947820|P2|Overall Study|Lost to Follow-up|1
2587407|NCT01164579|8947821|P1|Overall Study|Lost to Follow-up|1
2587408|NCT01164579|8947819|P3|Overall Study|Lack of Efficacy|6
2587409|NCT01164579|8947820|P2|Overall Study|Lack of Efficacy|0
2587410|NCT01164579|8947821|P1|Overall Study|Lack of Efficacy|0
2587411|NCT01164501|8947901|P3|Overall Study|Other reason not defined above|4
2587412|NCT01164501|8947902|P2|Overall Study|Other reason not defined above|1
2587413|NCT01164501|8947903|P1|Overall Study|Other reason not defined above|9
2587414|NCT01164501|8947901|P3|Overall Study|Patient refusal to continue,not due toAE|8
2587415|NCT01164501|8947902|P2|Overall Study|Patient refusal to continue,not due toAE|4
2587416|NCT01164501|8947903|P1|Overall Study|Patient refusal to continue,not due toAE|10
2587417|NCT01164501|8947901|P3|Overall Study|Lost to Follow-up|3
2587418|NCT01164501|8947902|P2|Overall Study|Lost to Follow-up|0
2587419|NCT01164501|8947903|P1|Overall Study|Lost to Follow-up|3
2587420|NCT01164501|8947901|P3|Overall Study|Non compliant with protocol|4
2587421|NCT01164501|8947902|P2|Overall Study|Non compliant with protocol|1
2587422|NCT01164501|8947903|P1|Overall Study|Non compliant with protocol|1
2587423|NCT01164501|8947901|P3|Overall Study|Lack of Efficacy|1
2587424|NCT01164501|8947902|P2|Overall Study|Lack of Efficacy|0
2587425|NCT01164501|8947903|P1|Overall Study|Lack of Efficacy|0
2587426|NCT01164501|8947901|P3|Overall Study|Adverse Event|21
2587427|NCT01164501|8947902|P2|Overall Study|Adverse Event|4
2587428|NCT01164501|8947903|P1|Overall Study|Adverse Event|18
2587429|NCT01164501|8947901|P3|Overall Study|Not treated|1
2587430|NCT01164501|8947902|P2|Overall Study|Not treated|0
2587431|NCT01164501|8947903|P1|Overall Study|Not treated|2
2587432|NCT01164475|8947920|P2|Overall Study|Protocol Violation|0
2587433|NCT01164475|8947921|P1|Overall Study|Protocol Violation|1
2587434|NCT01164475|8947920|P2|Overall Study|Progressive disease|1
2587435|NCT01164475|8947921|P1|Overall Study|Progressive disease|0
2587436|NCT01164475|8947920|P2|Overall Study|Other|1
2587437|NCT01164475|8947921|P1|Overall Study|Other|0
2587438|NCT01164475|8947920|P2|Overall Study|Lack of Efficacy|0
2587439|NCT01164475|8947921|P1|Overall Study|Lack of Efficacy|1
2587440|NCT01164007|8947975|P1|Overall Study|Medical Decision|3
2587441|NCT01164007|8947975|P1|Overall Study|Withdrawal by Subject|1
2587442|NCT01164007|8947975|P1|Overall Study|Protocol Violation|1
2587443|NCT01164007|8947975|P1|Overall Study|Progression of Disease|30
2587444|NCT01164007|8947975|P1|Overall Study|Adverse Event|5
2587445|NCT01163916|8948001|P3|Overall Study|Other|16
2587446|NCT01163916|8948002|P2|Overall Study|Other|4
2587447|NCT01163916|8948003|P1|Overall Study|Other|24
2587448|NCT01163916|8948001|P3|Overall Study|Lack of Efficacy|1
2587449|NCT01163916|8948002|P2|Overall Study|Lack of Efficacy|0
2587450|NCT01163916|8948003|P1|Overall Study|Lack of Efficacy|2
2587451|NCT01163916|8948001|P3|Overall Study|Adverse Event|1
2587452|NCT01163916|8948002|P2|Overall Study|Adverse Event|0
2587453|NCT01163916|8948003|P1|Overall Study|Adverse Event|2
2587454|NCT01163916|8948001|P3|Overall Study|Withdrawal by Subject|2
2587455|NCT01163916|8948002|P2|Overall Study|Withdrawal by Subject|0
2587456|NCT01163916|8948003|P1|Overall Study|Withdrawal by Subject|2
2587457|NCT01163851|8948041|P2|Overall Study|Enrolled but not treated|0
2587458|NCT01163851|8948042|P1|Overall Study|Enrolled but not treated|1
2587459|NCT01163851|8948041|P2|Overall Study|Site Closure|1
2587460|NCT01163851|8948042|P1|Overall Study|Site Closure|0
2587461|NCT01163786|8948120|P1|Completed Follow up (Visit 9 and 10)|Other|1
2587462|NCT01163786|8948120|P1|Treatment With Bortezomib|Adverse Event|2
2587463|NCT01163786|8948120|P1|Treatment With Bortezomib|Withdrawal by Subject|1
2587464|NCT01163747|8948143|P2|Overall Study|Refused Treatment|4
2587465|NCT01163747|8948144|P1|Overall Study|Refused Treatment|6
2587466|NCT01163747|8948143|P2|Overall Study|Protocol Violation|1
2587467|NCT01163747|8948144|P1|Overall Study|Protocol Violation|0
2587468|NCT01163747|8948143|P2|Overall Study|Insufficient Therapeutic Response|1
2587469|NCT01163747|8948144|P1|Overall Study|Insufficient Therapeutic Response|0
2587470|NCT01163747|8948143|P2|Overall Study|Adverse Event|5
2587471|NCT01163747|8948144|P1|Overall Study|Adverse Event|0
2587472|NCT01163721|8948164|P2|Overall Study|Physician Decision|1
2587473|NCT01163721|8948165|P1|Overall Study|Physician Decision|0
2587474|NCT01163721|8948164|P2|Overall Study|Lost to Follow-up|1
2587475|NCT01163721|8948165|P1|Overall Study|Lost to Follow-up|0
2587476|NCT01163721|8948164|P2|Overall Study|Withdrawal by Subject|4
2587477|NCT01163721|8948165|P1|Overall Study|Withdrawal by Subject|3
2587478|NCT01163721|8948164|P2|Overall Study|Adverse Event|6
2587479|NCT01163721|8948165|P1|Overall Study|Adverse Event|5
2587480|NCT01163617|8948184|P8|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
2587481|NCT01163617|8948185|P7|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
2587482|NCT01163617|8948186|P6|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
2587483|NCT01163617|8948187|P5|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
2587484|NCT01163617|8948188|P4|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
2587485|NCT01163617|8948189|P3|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1
2587486|NCT01163617|8948190|P2|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
2587487|NCT01163617|8948191|P1|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
2587488|NCT01163617|8948184|P8|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
2587489|NCT01163617|8948185|P7|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
2587490|NCT01163617|8948186|P6|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
2587491|NCT01163617|8948187|P5|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
2587492|NCT01163617|8948188|P4|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
2587493|NCT01163617|8948189|P3|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
2587494|NCT01163617|8948190|P2|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1
2587495|NCT01163617|8948191|P1|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
2587496|NCT01163617|8948184|P8|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
2587497|NCT01163617|8948185|P7|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
2587498|NCT01163617|8948186|P6|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
2587499|NCT01163617|8948187|P5|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
2587500|NCT01163617|8948188|P4|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
2587501|NCT01163617|8948189|P3|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
2587502|NCT01163617|8948190|P2|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1
2587503|NCT01163617|8948191|P1|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
2587504|NCT01163474|8948220|P1|Overall Study|Lost to Follow-up|3
2587505|NCT01163474|8948220|P1|Overall Study|Tech barriers to videoteleconference vis|12
2587506|NCT01163474|8948220|P1|Overall Study|Withdrawal by Subject|1
2587507|NCT01163318|8948232|P1|Overall Study|Multiple Reasons Per Participant|224
2587508|NCT01163318|8948232|P1|Overall Study|Participants Without Case Report Form|7
2587509|NCT01163318|8948232|P1|Overall Study|History/comorbidity of malignant tumor|3
2587510|NCT01163318|8948232|P1|Overall Study|Did Not Continue Use of Adalimumab|26
2587511|NCT01163318|8948232|P1|Overall Study|Off-Label Use of Adalimumab|8
2587512|NCT01163292|8948241|P2|Overall Study|No further visits|7
2587513|NCT01163292|8948242|P1|Overall Study|No further visits|5
2587514|NCT01163292|8948241|P2|Overall Study|Economic reasons|0
2587515|NCT01163292|8948242|P1|Overall Study|Economic reasons|6
2587516|NCT01163292|8948241|P2|Overall Study|Refusal to receive adalimumab|0
2587517|NCT01163292|8948242|P1|Overall Study|Refusal to receive adalimumab|7
2587518|NCT01163292|8948241|P2|Overall Study|Sufficient response to adalimumab|0
2587519|NCT01163292|8948242|P1|Overall Study|Sufficient response to adalimumab|8
2587520|NCT01163292|8948241|P2|Overall Study|Initiation of biological therapy|15
2587521|NCT01163292|8948242|P1|Overall Study|Initiation of biological therapy|0
2587522|NCT01163292|8948241|P2|Overall Study|Adverse Event|0
2587523|NCT01163292|8948242|P1|Overall Study|Adverse Event|6
2587524|NCT01163292|8948241|P2|Overall Study|Lack of Efficacy|0
2587525|NCT01163292|8948242|P1|Overall Study|Lack of Efficacy|9
2587526|NCT01163279|8948258|P2|Overall Study|Withdrawal by Subject|0
2587527|NCT01163279|8948259|P1|Overall Study|Withdrawal by Subject|2
2587528|NCT01163266|8948288|P3|Overall Study|Other|2
2587529|NCT01163266|8948289|P2|Overall Study|Other|1
2587530|NCT01163266|8948290|P1|Overall Study|Other|1
2587531|NCT01163266|8948288|P3|Overall Study|Lost to Follow-up|10
2587532|NCT01163266|8948289|P2|Overall Study|Lost to Follow-up|7
2587533|NCT01163266|8948290|P1|Overall Study|Lost to Follow-up|7
2587534|NCT01163266|8948288|P3|Overall Study|Withdrawal of Consent|3
2587535|NCT01163266|8948289|P2|Overall Study|Withdrawal of Consent|7
2587536|NCT01163266|8948290|P1|Overall Study|Withdrawal of Consent|5
2587537|NCT01163266|8948288|P3|Overall Study|Protocol Deviations|5
2587538|NCT01163266|8948289|P2|Overall Study|Protocol Deviations|2
2587539|NCT01163266|8948290|P1|Overall Study|Protocol Deviations|2
2587540|NCT01163266|8948288|P3|Overall Study|Noncompliance with Study Drug|0
2587541|NCT01163266|8948289|P2|Overall Study|Noncompliance with Study Drug|2
2587542|NCT01163266|8948290|P1|Overall Study|Noncompliance with Study Drug|0
2587543|NCT01163266|8948288|P3|Overall Study|Lack of Efficacy|1
2587544|NCT01163266|8948289|P2|Overall Study|Lack of Efficacy|3
2587545|NCT01163266|8948290|P1|Overall Study|Lack of Efficacy|1
2587546|NCT01163266|8948288|P3|Overall Study|Pretreatment Event or Adverse Event|7
2587547|NCT01163266|8948289|P2|Overall Study|Pretreatment Event or Adverse Event|9
2587548|NCT01163266|8948290|P1|Overall Study|Pretreatment Event or Adverse Event|2
2587549|NCT01163253|8948315|P2|Overall Study|Other Unspecified|34
2587550|NCT01163253|8948316|P1|Overall Study|Other Unspecified|170
2587551|NCT01163253|8948315|P2|Overall Study|Ongoing|4
2587552|NCT01163253|8948316|P1|Overall Study|Ongoing|13
2587553|NCT01163253|8948315|P2|Overall Study|Death|5
2587554|NCT01163253|8948316|P1|Overall Study|Death|17
2587555|NCT01163253|8948315|P2|Overall Study|Adverse Event|78
2587556|NCT01163253|8948316|P1|Overall Study|Adverse Event|300
2587557|NCT01163253|8948315|P2|Overall Study|Insufficient Clinical Response|29
2587558|NCT01163253|8948316|P1|Overall Study|Insufficient Clinical Response|423
2587559|NCT01163253|8948315|P2|Overall Study|Lost to Follow-up|23
2587560|NCT01163253|8948316|P1|Overall Study|Lost to Follow-up|125
2587561|NCT01163253|8948315|P2|Overall Study|Medication Error|0
2587562|NCT01163253|8948316|P1|Overall Study|Medication Error|1
2587563|NCT01163253|8948315|P2|Overall Study|Withdrawal by Subject|50
2587564|NCT01163253|8948316|P1|Overall Study|Withdrawal by Subject|199
2587565|NCT01163253|8948315|P2|Overall Study|Protocol Violation|12
2587566|NCT01163253|8948316|P1|Overall Study|Protocol Violation|43
2587567|NCT01163253|8948315|P2|Overall Study|Study Terminated by Sponsor|349
2587568|NCT01163253|8948316|P1|Overall Study|Study Terminated by Sponsor|978
2587569|NCT01163253|8948315|P2|Overall Study|Withdrawn Due to Pregnancy|2
2587570|NCT01163253|8948316|P1|Overall Study|Withdrawn Due to Pregnancy|12
2587571|NCT01163149|8948504|P3|Extension Treatment Period|Noncompliance|1
2587572|NCT01163149|8948505|P2|Extension Treatment Period|Noncompliance|0
2587573|NCT01163149|8948506|P1|Extension Treatment Period|Noncompliance|0
2587574|NCT01163149|8948504|P3|Extension Treatment Period|Adverse Event|0
2587575|NCT01163149|8948505|P2|Extension Treatment Period|Adverse Event|1
2587576|NCT01163149|8948506|P1|Extension Treatment Period|Adverse Event|0
2587577|NCT01163149|8948504|P3|Extension Treatment Period|Withdrawal by Subject|1
2587578|NCT01163149|8948505|P2|Extension Treatment Period|Withdrawal by Subject|0
2587579|NCT01163149|8948506|P1|Extension Treatment Period|Withdrawal by Subject|2
2587580|NCT01163032|8948615|P3|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2
2587581|NCT01163032|8948616|P2|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
2587582|NCT01163032|8948617|P1|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
2587583|NCT01163032|8948615|P3|Open Label Extension Phase|Study Termination|7
2587584|NCT01163032|8948616|P2|Open Label Extension Phase|Study Termination|0
2587585|NCT01163032|8948617|P1|Open Label Extension Phase|Study Termination|0
2587586|NCT01163032|8948615|P3|Open Label Extension Phase|Protocol Violation|1
2587587|NCT01163032|8948616|P2|Open Label Extension Phase|Protocol Violation|0
2587588|NCT01163032|8948617|P1|Open Label Extension Phase|Protocol Violation|0
2587589|NCT01163032|8948615|P3|Open Label Extension Phase|Withdrawal by Subject|3
2587590|NCT01163032|8948616|P2|Open Label Extension Phase|Withdrawal by Subject|0
2587591|NCT01163032|8948617|P1|Open Label Extension Phase|Withdrawal by Subject|0
2587592|NCT01163032|8948615|P3|Open Label Extension Phase|Adverse Event|3
2587593|NCT01163032|8948616|P2|Open Label Extension Phase|Adverse Event|0
2587594|NCT01163032|8948617|P1|Open Label Extension Phase|Adverse Event|0
2587595|NCT01163032|8948615|P3|Randomization Phase|Unsatisfactory Therapeutic Effect|0
2587596|NCT01163032|8948616|P2|Randomization Phase|Unsatisfactory Therapeutic Effect|1
2587597|NCT01163032|8948617|P1|Randomization Phase|Unsatisfactory Therapeutic Effect|0
2587598|NCT01163032|8948615|P3|Randomization Phase|Various*|0
2587599|NCT01163032|8948616|P2|Randomization Phase|Various*|4
2587600|NCT01163032|8948617|P1|Randomization Phase|Various*|5
2587601|NCT01163032|8948615|P3|Randomization Phase|Protocol Violation|0
2587602|NCT01163032|8948616|P2|Randomization Phase|Protocol Violation|1
2587603|NCT01163032|8948617|P1|Randomization Phase|Protocol Violation|0
2587604|NCT01163032|8948615|P3|Randomization Phase|Adverse Event|0
2587605|NCT01163032|8948616|P2|Randomization Phase|Adverse Event|3
2587606|NCT01163032|8948617|P1|Randomization Phase|Adverse Event|3
2587607|NCT01163032|8948615|P3|Randomization Phase|Withdrawal by Subject|0
2587608|NCT01163032|8948616|P2|Randomization Phase|Withdrawal by Subject|3
2587609|NCT01163032|8948617|P1|Randomization Phase|Withdrawal by Subject|2
2587610|NCT01162863|8948650|P3|Overall Study|Adverse Event|0
2587611|NCT01162863|8948651|P2|Overall Study|Adverse Event|1
2587612|NCT01162863|8948652|P1|Overall Study|Adverse Event|0
2587613|NCT01162863|8948650|P3|Overall Study|Lack of Efficacy|0
2587614|NCT01162863|8948651|P2|Overall Study|Lack of Efficacy|0
2587615|NCT01162863|8948652|P1|Overall Study|Lack of Efficacy|1
2587616|NCT01162499|8948682|P2|Intervention 1 (4 Hours)|Unable to establish IV access|1
2587617|NCT01162499|8948683|P1|Intervention 1 (4 Hours)|Unable to establish IV access|0
2587618|NCT01162486|8948708|P5|Overall Study|Pregnancy|0
2587619|NCT01162486|8948709|P4|Overall Study|Pregnancy|1
2587620|NCT01162486|8948710|P3|Overall Study|Pregnancy|0
2587621|NCT01162486|8948711|P2|Overall Study|Pregnancy|0
2587622|NCT01162486|8948712|P1|Overall Study|Pregnancy|0
2587623|NCT01162486|8948708|P5|Overall Study|elevated LFTs|0
2587624|NCT01162486|8948709|P4|Overall Study|elevated LFTs|0
2587625|NCT01162486|8948710|P3|Overall Study|elevated LFTs|1
2587626|NCT01162486|8948711|P2|Overall Study|elevated LFTs|0
2587627|NCT01162486|8948712|P1|Overall Study|elevated LFTs|0
2587628|NCT01162486|8948708|P5|Overall Study|vomited Rifampin/ gagged with midazolam|0
2587629|NCT01162486|8948709|P4|Overall Study|vomited Rifampin/ gagged with midazolam|0
2587630|NCT01162486|8948710|P3|Overall Study|vomited Rifampin/ gagged with midazolam|0
2587631|NCT01162486|8948711|P2|Overall Study|vomited Rifampin/ gagged with midazolam|0
2587632|NCT01162486|8948712|P1|Overall Study|vomited Rifampin/ gagged with midazolam|1
2587633|NCT01162486|8948708|P5|Overall Study|low ANC|0
2587634|NCT01162486|8948709|P4|Overall Study|low ANC|0
2587635|NCT01162486|8948710|P3|Overall Study|low ANC|0
2587636|NCT01162486|8948711|P2|Overall Study|low ANC|0
2587637|NCT01162486|8948712|P1|Overall Study|low ANC|1
2587638|NCT01162473|8948745|P2|Overall Study|Withdrawal by Subject|4
2587639|NCT01162473|8948746|P1|Overall Study|Withdrawal by Subject|0
2587640|NCT01162473|8948745|P2|Overall Study|Adverse Event|1
2587641|NCT01162473|8948746|P1|Overall Study|Adverse Event|2
2587642|NCT01162421|8948754|P2|Overall Study|Other|3
2587643|NCT01162421|8948755|P1|Overall Study|Other|2
2587644|NCT01162421|8948754|P2|Overall Study|Lack of Efficacy|2
2587645|NCT01162421|8948755|P1|Overall Study|Lack of Efficacy|2
2587646|NCT01162421|8948754|P2|Overall Study|Lost to Follow-up|2
2587647|NCT01162421|8948755|P1|Overall Study|Lost to Follow-up|0
2587648|NCT01162421|8948754|P2|Overall Study|Adverse Event|5
2587649|NCT01162421|8948755|P1|Overall Study|Adverse Event|2
2587650|NCT01162421|8948754|P2|Overall Study|Did not receive study drug|1
2587651|NCT01162421|8948755|P1|Overall Study|Did not receive study drug|2
2587652|NCT01162343|8948838|P1|Overall Study|Refused psychiatrist assessment|12
2587653|NCT01162343|8948838|P1|Overall Study|Left ED prior to psychiatrist assessment|80
2587654|NCT01162304|8948853|P1|Overall Study|Beck scale to high|11
2587655|NCT01162135|8948867|P1|Overall Study|Ineligible|1
2587656|NCT01162135|8948867|P1|Overall Study|Severe back pain|1
2587657|NCT01162135|8948867|P1|Overall Study|Withdrawal by Subject|1
2587658|NCT01162122|8948873|P2|Overall Study|Missing primary reason|0
2587659|NCT01162122|8948874|P1|Overall Study|Missing primary reason|1
2587660|NCT01162122|8948873|P2|Overall Study|Unable to classify|7
2587661|NCT01162122|8948874|P1|Overall Study|Unable to classify|3
2587662|NCT01162122|8948873|P2|Overall Study|Administrative reason|1
2587663|NCT01162122|8948874|P1|Overall Study|Administrative reason|1
2587664|NCT01162122|8948873|P2|Overall Study|Inappropriate enrollment|4
2587665|NCT01162122|8948874|P1|Overall Study|Inappropriate enrollment|5
2587666|NCT01162122|8948873|P2|Overall Study|Protocol Violation|2
2587667|NCT01162122|8948874|P1|Overall Study|Protocol Violation|2
2587668|NCT01162122|8948873|P2|Overall Study|Death|46
2587669|NCT01162122|8948874|P1|Overall Study|Death|51
2587670|NCT01162122|8948873|P2|Overall Study|Adverse Event|2
2587671|NCT01162122|8948874|P1|Overall Study|Adverse Event|3
2587672|NCT01162122|8948873|P2|Overall Study|Lost to Follow-up|91
2587673|NCT01162122|8948874|P1|Overall Study|Lost to Follow-up|73
2587674|NCT01162122|8948873|P2|Overall Study|Withdrawal by Subject|43
2587675|NCT01162122|8948874|P1|Overall Study|Withdrawal by Subject|52
2587676|NCT01161628|8948980|P1|Overall Study|Lack of Efficacy|2
2587677|NCT01161628|8948980|P1|Overall Study|Death|6
2587678|NCT01161537|8949003|P1|Part B|Withdrawal by Subject|2
2587679|NCT01161524|8949021|P3|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4
2587680|NCT01161524|8949022|P2|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0
2587681|NCT01161524|8949023|P1|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0
2587682|NCT01161524|8949021|P3|Extension Phase (Approximately 83 Weeks)|Subject Choice|5
2587683|NCT01161524|8949022|P2|Extension Phase (Approximately 83 Weeks)|Subject Choice|0
2587684|NCT01161524|8949023|P1|Extension Phase (Approximately 83 Weeks)|Subject Choice|0
2587685|NCT01161524|8949021|P3|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1
2587686|NCT01161524|8949022|P2|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0
2587687|NCT01161524|8949023|P1|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0
2587688|NCT01161524|8949021|P3|Extension Phase (Approximately 83 Weeks)|Other|6
2587689|NCT01161524|8949022|P2|Extension Phase (Approximately 83 Weeks)|Other|0
2587690|NCT01161524|8949023|P1|Extension Phase (Approximately 83 Weeks)|Other|0
2587691|NCT01161524|8949021|P3|Extension Phase (Approximately 83 Weeks)|Adverse Event|8
2587692|NCT01161524|8949022|P2|Extension Phase (Approximately 83 Weeks)|Adverse Event|0
2587693|NCT01161524|8949023|P1|Extension Phase (Approximately 83 Weeks)|Adverse Event|0
2587694|NCT01161524|8949021|P3|Core Study (23 Weeks)|Subject Choice|0
2587695|NCT01161524|8949022|P2|Core Study (23 Weeks)|Subject Choice|2
2587696|NCT01161524|8949023|P1|Core Study (23 Weeks)|Subject Choice|3
2587697|NCT01161524|8949021|P3|Core Study (23 Weeks)|Lost to Follow-up|0
2587698|NCT01161524|8949022|P2|Core Study (23 Weeks)|Lost to Follow-up|2
2587699|NCT01161524|8949023|P1|Core Study (23 Weeks)|Lost to Follow-up|1
2587700|NCT01161524|8949021|P3|Core Study (23 Weeks)|Withdrawal of Consent|0
2587701|NCT01161524|8949022|P2|Core Study (23 Weeks)|Withdrawal of Consent|1
2587702|NCT01161524|8949023|P1|Core Study (23 Weeks)|Withdrawal of Consent|1
2587703|NCT01161524|8949021|P3|Core Study (23 Weeks)|Other|0
2587704|NCT01161524|8949022|P2|Core Study (23 Weeks)|Other|0
2587705|NCT01161524|8949023|P1|Core Study (23 Weeks)|Other|1
2587706|NCT01161524|8949021|P3|Core Study (23 Weeks)|Adverse Event|0
2587707|NCT01161524|8949022|P2|Core Study (23 Weeks)|Adverse Event|0
2587708|NCT01161524|8949023|P1|Core Study (23 Weeks)|Adverse Event|3
2587709|NCT01161498|8949062|P2|Overall Study|Disease Progression|1
2587710|NCT01161498|8949063|P1|Overall Study|Disease Progression|0
2587711|NCT01161472|8949087|P4|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
2587712|NCT01161472|8949088|P3|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
2587713|NCT01161472|8949089|P2|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
2587714|NCT01161472|8949090|P1|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1
2587715|NCT01161446|8949146|P2|Overall Study|Withdrawal by Subject|1
2587716|NCT01161446|8949147|P1|Overall Study|Withdrawal by Subject|0
2587717|NCT01161446|8949146|P2|Overall Study|Lost to Follow-up|14
2587718|NCT01161446|8949147|P1|Overall Study|Lost to Follow-up|18
2587719|NCT01161407|8949173|P2|Overall Study|Protocol Violation|1
2587720|NCT01161407|8949174|P1|Overall Study|Protocol Violation|3
2587721|NCT01161173|8949229|P1|Overall Study|Reasons Not Specified|23
2587722|NCT01161173|8949229|P1|Overall Study|End of Study|2
2587723|NCT01161173|8949229|P1|Overall Study|Death|194
2587724|NCT01161173|8949229|P1|Overall Study|Unacceptable Toxicity|21
2587725|NCT01161173|8949229|P1|Overall Study|Withdrawal of Consent|5
2587726|NCT01161173|8949229|P1|Overall Study|Progressive Disease|82
2587727|NCT01161173|8949229|P1|Overall Study|Lost to Follow-up|7
2587728|NCT01161173|8949229|P1|Overall Study|Protocol Violation|13
2587729|NCT01160822|8949356|P7|Overall Study|Protocol deviation|0
2587730|NCT01160822|8949357|P6|Overall Study|Protocol deviation|0
2587731|NCT01160822|8949358|P5|Overall Study|Protocol deviation|2
2587732|NCT01160822|8949359|P4|Overall Study|Protocol deviation|0
2587733|NCT01160822|8949360|P3|Overall Study|Protocol deviation|0
2587734|NCT01160822|8949361|P2|Overall Study|Protocol deviation|0
2587735|NCT01160822|8949362|P1|Overall Study|Protocol deviation|0
2587736|NCT01160822|8949356|P7|Overall Study|Administrative problems|0
2587737|NCT01160822|8949357|P6|Overall Study|Administrative problems|0
2587738|NCT01160822|8949358|P5|Overall Study|Administrative problems|1
2587739|NCT01160822|8949359|P4|Overall Study|Administrative problems|0
2587740|NCT01160822|8949360|P3|Overall Study|Administrative problems|0
2587741|NCT01160822|8949361|P2|Overall Study|Administrative problems|0
2587742|NCT01160822|8949362|P1|Overall Study|Administrative problems|0
2587743|NCT01160822|8949356|P7|Overall Study|Lost to Follow-up|0
2587744|NCT01160822|8949357|P6|Overall Study|Lost to Follow-up|0
2587745|NCT01160822|8949358|P5|Overall Study|Lost to Follow-up|1
2587746|NCT01160822|8949359|P4|Overall Study|Lost to Follow-up|0
2587747|NCT01160822|8949360|P3|Overall Study|Lost to Follow-up|0
2587748|NCT01160822|8949361|P2|Overall Study|Lost to Follow-up|0
2587749|NCT01160822|8949362|P1|Overall Study|Lost to Follow-up|0
2587750|NCT01160822|8949356|P7|Overall Study|Withdrawal by Subject|1
2587751|NCT01160822|8949357|P6|Overall Study|Withdrawal by Subject|0
2587752|NCT01160822|8949358|P5|Overall Study|Withdrawal by Subject|0
2587753|NCT01160822|8949359|P4|Overall Study|Withdrawal by Subject|0
2587754|NCT01160822|8949360|P3|Overall Study|Withdrawal by Subject|0
2587755|NCT01160822|8949361|P2|Overall Study|Withdrawal by Subject|0
2587756|NCT01160822|8949362|P1|Overall Study|Withdrawal by Subject|0
2587757|NCT01160822|8949356|P7|Overall Study|Unsatisfactory therapeutic effect|3
2587758|NCT01160822|8949357|P6|Overall Study|Unsatisfactory therapeutic effect|5
2587759|NCT01160822|8949358|P5|Overall Study|Unsatisfactory therapeutic effect|4
2587760|NCT01160822|8949359|P4|Overall Study|Unsatisfactory therapeutic effect|0
2587761|NCT01160822|8949360|P3|Overall Study|Unsatisfactory therapeutic effect|0
2587762|NCT01160822|8949361|P2|Overall Study|Unsatisfactory therapeutic effect|0
2587763|NCT01160822|8949362|P1|Overall Study|Unsatisfactory therapeutic effect|0
2587764|NCT01160822|8949356|P7|Overall Study|Adverse Event|5
2587765|NCT01160822|8949357|P6|Overall Study|Adverse Event|2
2587766|NCT01160822|8949358|P5|Overall Study|Adverse Event|1
2587767|NCT01160822|8949359|P4|Overall Study|Adverse Event|0
2587768|NCT01160822|8949360|P3|Overall Study|Adverse Event|0
2587769|NCT01160822|8949361|P2|Overall Study|Adverse Event|0
2587770|NCT01160822|8949362|P1|Overall Study|Adverse Event|0
2587771|NCT01160770|8949451|P1|Overall Study|Other Reasons|1
2587772|NCT01160770|8949451|P1|Overall Study|Lack of Efficacy|15
2587773|NCT01160770|8949451|P1|Overall Study|Death|9
2587774|NCT01160770|8949451|P1|Overall Study|Study termination or sponsor request|1
2587775|NCT01160770|8949451|P1|Overall Study|Lost to Follow-up|7
2587776|NCT01160770|8949451|P1|Overall Study|Physician Decision|1
2587777|NCT01160770|8949451|P1|Overall Study|Subject/parent/caregiver request|33
2587778|NCT01160770|8949451|P1|Overall Study|Protocol Violation|2
2587779|NCT01160770|8949451|P1|Overall Study|Adverse Event|10
2587780|NCT01160744|8949464|P4|Overall Study|Not meet inclusion/exclusion criteria|0
2587781|NCT01160744|8949465|P3|Overall Study|Not meet inclusion/exclusion criteria|1
2587782|NCT01160744|8949466|P2|Overall Study|Not meet inclusion/exclusion criteria|0
2587783|NCT01160744|8949467|P1|Overall Study|Not meet inclusion/exclusion criteria|0
2587784|NCT01160744|8949464|P4|Overall Study|Withdrawal by Subject|4
2587785|NCT01160744|8949465|P3|Overall Study|Withdrawal by Subject|6
2587786|NCT01160744|8949466|P2|Overall Study|Withdrawal by Subject|5
2587787|NCT01160744|8949467|P1|Overall Study|Withdrawal by Subject|11
2587788|NCT01160640|8949503|P2|Overall Study|Withdrawal by Subject|3
2587789|NCT01160640|8949504|P1|Overall Study|Withdrawal by Subject|0
2587790|NCT01160640|8949503|P2|Overall Study|Incarceration|0
2587791|NCT01160640|8949504|P1|Overall Study|Incarceration|1
2587792|NCT01160640|8949503|P2|Overall Study|Physician Decision|3
2587793|NCT01160640|8949504|P1|Overall Study|Physician Decision|3
2587794|NCT01160614|8949520|P2|Overall Study|Withdrawal by Subject|2
2587795|NCT01160614|8949521|P1|Overall Study|Withdrawal by Subject|0
2587796|NCT01160484|8949569|P1|Overall Study|inclusion/exclusion criteria failure|1
2587797|NCT01160484|8949569|P1|Overall Study|Withdrawal by Subject|2
2587798|NCT01160484|8949569|P1|Overall Study|Adverse Event|6
2587799|NCT01160484|8949569|P1|Overall Study|Lack of Efficacy|9
2587800|NCT01160354|8949622|P3|Overall Study|Death|1
2587801|NCT01160354|8949623|P2|Overall Study|Death|1
2587802|NCT01160354|8949624|P1|Overall Study|Death|0
2587803|NCT01160289|8949643|P6|Post-Randomization Period|Sponsor Decision|0
2587804|NCT01160289|8949644|P5|Post-Randomization Period|Sponsor Decision|0
2587805|NCT01160289|8949645|P4|Post-Randomization Period|Sponsor Decision|0
2587806|NCT01160289|8949646|P3|Post-Randomization Period|Sponsor Decision|0
2587807|NCT01160289|8949647|P2|Post-Randomization Period|Sponsor Decision|1
2587808|NCT01160289|8949648|P1|Post-Randomization Period|Sponsor Decision|0
2587809|NCT01160289|8949643|P6|Post-Randomization Period|Entry Criteria Not Met|0
2587810|NCT01160289|8949644|P5|Post-Randomization Period|Entry Criteria Not Met|0
2587811|NCT01160289|8949645|P4|Post-Randomization Period|Entry Criteria Not Met|2
2587812|NCT01160289|8949646|P3|Post-Randomization Period|Entry Criteria Not Met|2
2587813|NCT01160289|8949647|P2|Post-Randomization Period|Entry Criteria Not Met|2
2587814|NCT01160289|8949648|P1|Post-Randomization Period|Entry Criteria Not Met|0
2587815|NCT01160289|8949643|P6|Post-Randomization Period|Withdrawal by Subject|7
2587816|NCT01160289|8949644|P5|Post-Randomization Period|Withdrawal by Subject|5
2587817|NCT01160289|8949645|P4|Post-Randomization Period|Withdrawal by Subject|8
2587818|NCT01160289|8949646|P3|Post-Randomization Period|Withdrawal by Subject|13
2587819|NCT01160289|8949647|P2|Post-Randomization Period|Withdrawal by Subject|5
2587820|NCT01160289|8949648|P1|Post-Randomization Period|Withdrawal by Subject|0
2587821|NCT01160289|8949643|P6|Post-Randomization Period|Protocol Violation|3
2587822|NCT01160289|8949644|P5|Post-Randomization Period|Protocol Violation|1
2587823|NCT01160289|8949645|P4|Post-Randomization Period|Protocol Violation|0
2587824|NCT01160289|8949646|P3|Post-Randomization Period|Protocol Violation|2
2587825|NCT01160289|8949647|P2|Post-Randomization Period|Protocol Violation|4
2587826|NCT01160289|8949648|P1|Post-Randomization Period|Protocol Violation|0
2587827|NCT01160289|8949643|P6|Post-Randomization Period|Physician Decision|0
2587828|NCT01160289|8949644|P5|Post-Randomization Period|Physician Decision|0
2587829|NCT01160289|8949645|P4|Post-Randomization Period|Physician Decision|0
2587830|NCT01160289|8949646|P3|Post-Randomization Period|Physician Decision|1
2587831|NCT01160289|8949647|P2|Post-Randomization Period|Physician Decision|0
2587832|NCT01160289|8949648|P1|Post-Randomization Period|Physician Decision|0
2587833|NCT01160289|8949643|P6|Post-Randomization Period|Lost to Follow-up|4
2587834|NCT01160289|8949644|P5|Post-Randomization Period|Lost to Follow-up|3
2587835|NCT01160289|8949645|P4|Post-Randomization Period|Lost to Follow-up|5
2587836|NCT01160289|8949646|P3|Post-Randomization Period|Lost to Follow-up|2
2587837|NCT01160289|8949647|P2|Post-Randomization Period|Lost to Follow-up|3
2587838|NCT01160289|8949648|P1|Post-Randomization Period|Lost to Follow-up|0
2587839|NCT01160289|8949643|P6|Post-Randomization Period|Lack of Efficacy|0
2587840|NCT01160289|8949644|P5|Post-Randomization Period|Lack of Efficacy|0
2587841|NCT01160289|8949645|P4|Post-Randomization Period|Lack of Efficacy|3
2587842|NCT01160289|8949646|P3|Post-Randomization Period|Lack of Efficacy|0
2587843|NCT01160289|8949647|P2|Post-Randomization Period|Lack of Efficacy|1
2587844|NCT01160289|8949648|P1|Post-Randomization Period|Lack of Efficacy|0
2587845|NCT01160289|8949643|P6|Post-Randomization Period|Death|0
2587846|NCT01160289|8949644|P5|Post-Randomization Period|Death|0
2587847|NCT01160289|8949645|P4|Post-Randomization Period|Death|1
2587848|NCT01160289|8949646|P3|Post-Randomization Period|Death|0
2587849|NCT01160289|8949647|P2|Post-Randomization Period|Death|0
2587850|NCT01160289|8949648|P1|Post-Randomization Period|Death|0
2587851|NCT01160289|8949643|P6|Post-Randomization Period|Adverse Event|0
2587852|NCT01160289|8949644|P5|Post-Randomization Period|Adverse Event|0
2587853|NCT01160289|8949645|P4|Post-Randomization Period|Adverse Event|2
2587854|NCT01160289|8949646|P3|Post-Randomization Period|Adverse Event|4
2587855|NCT01160289|8949647|P2|Post-Randomization Period|Adverse Event|4
2587856|NCT01160289|8949648|P1|Post-Randomization Period|Adverse Event|0
2587857|NCT01160289|8949643|P6|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
2587858|NCT01160289|8949644|P5|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
2587859|NCT01160289|8949645|P4|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
2587860|NCT01160289|8949646|P3|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
2587861|NCT01160289|8949647|P2|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
2587862|NCT01160289|8949648|P1|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64
2587863|NCT01160289|8949643|P6|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
2587864|NCT01160289|8949644|P5|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
2587865|NCT01160289|8949645|P4|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
2587866|NCT01160289|8949646|P3|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
2587867|NCT01160289|8949647|P2|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
2587868|NCT01160289|8949648|P1|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67
2587869|NCT01160289|8949643|P6|Screening, Washout, and Lead-In Period|Protocol Violation|0
2587870|NCT01160289|8949644|P5|Screening, Washout, and Lead-In Period|Protocol Violation|0
2587871|NCT01160289|8949645|P4|Screening, Washout, and Lead-In Period|Protocol Violation|0
2587872|NCT01160289|8949646|P3|Screening, Washout, and Lead-In Period|Protocol Violation|0
2587873|NCT01160289|8949647|P2|Screening, Washout, and Lead-In Period|Protocol Violation|0
2587874|NCT01160289|8949648|P1|Screening, Washout, and Lead-In Period|Protocol Violation|1
2587875|NCT01160289|8949643|P6|Screening, Washout, and Lead-In Period|Physician Decision|0
2587876|NCT01160289|8949644|P5|Screening, Washout, and Lead-In Period|Physician Decision|0
2587877|NCT01160289|8949645|P4|Screening, Washout, and Lead-In Period|Physician Decision|0
2587878|NCT01160289|8949646|P3|Screening, Washout, and Lead-In Period|Physician Decision|0
2587879|NCT01160289|8949647|P2|Screening, Washout, and Lead-In Period|Physician Decision|0
2587880|NCT01160289|8949648|P1|Screening, Washout, and Lead-In Period|Physician Decision|26
2587881|NCT01160289|8949643|P6|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
2587882|NCT01160289|8949644|P5|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
2587883|NCT01160289|8949645|P4|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
2587884|NCT01160289|8949646|P3|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
2587885|NCT01160289|8949647|P2|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
2587886|NCT01160289|8949648|P1|Screening, Washout, and Lead-In Period|Lost to Follow-up|9
2587887|NCT01160289|8949643|P6|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
2587888|NCT01160289|8949644|P5|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
2587889|NCT01160289|8949645|P4|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
2587890|NCT01160289|8949646|P3|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
2587891|NCT01160289|8949647|P2|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
2587892|NCT01160289|8949648|P1|Screening, Washout, and Lead-In Period|Lack of Efficacy|1
2587893|NCT01160289|8949643|P6|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
2587894|NCT01160289|8949644|P5|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
2587895|NCT01160289|8949645|P4|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
2587896|NCT01160289|8949646|P3|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
2587897|NCT01160289|8949647|P2|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
2587898|NCT01160289|8949648|P1|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308
2587899|NCT01160289|8949643|P6|Screening, Washout, and Lead-In Period|Adverse Event|0
2587900|NCT01160289|8949644|P5|Screening, Washout, and Lead-In Period|Adverse Event|0
2587901|NCT01160289|8949645|P4|Screening, Washout, and Lead-In Period|Adverse Event|0
2587902|NCT01160289|8949646|P3|Screening, Washout, and Lead-In Period|Adverse Event|0
2587903|NCT01160289|8949647|P2|Screening, Washout, and Lead-In Period|Adverse Event|0
2587904|NCT01160289|8949648|P1|Screening, Washout, and Lead-In Period|Adverse Event|8
2587905|NCT01160211|8949737|P3|Overall Study|Lost to Follow-up|5
2587906|NCT01160211|8949738|P2|Overall Study|Lost to Follow-up|7
2587907|NCT01160211|8949739|P1|Overall Study|Lost to Follow-up|4
2587908|NCT01160211|8949737|P3|Overall Study|Physician Decision|0
2587909|NCT01160211|8949738|P2|Overall Study|Physician Decision|0
2587910|NCT01160211|8949739|P1|Overall Study|Physician Decision|2
2587911|NCT01160211|8949737|P3|Overall Study|Withdrawal by Subject|3
2587912|NCT01160211|8949738|P2|Overall Study|Withdrawal by Subject|5
2587913|NCT01160211|8949739|P1|Overall Study|Withdrawal by Subject|3
2587914|NCT01160211|8949737|P3|Overall Study|ongoing|79
2587915|NCT01160211|8949738|P2|Overall Study|ongoing|75
2587916|NCT01160211|8949739|P1|Overall Study|ongoing|90
2587917|NCT01160198|8949772|P3|Overall Study|Participant lost drug; withdrew consent|1
2587918|NCT01160198|8949773|P2|Overall Study|Participant lost drug; withdrew consent|0
2587919|NCT01160198|8949774|P1|Overall Study|Participant lost drug; withdrew consent|0
2587920|NCT01160198|8949772|P3|Overall Study|Lost to Follow-up|0
2587921|NCT01160198|8949773|P2|Overall Study|Lost to Follow-up|1
2587922|NCT01160198|8949774|P1|Overall Study|Lost to Follow-up|0
2587923|NCT01160198|8949772|P3|Overall Study|Adverse Event|0
2587924|NCT01160198|8949773|P2|Overall Study|Adverse Event|1
2587925|NCT01160198|8949774|P1|Overall Study|Adverse Event|0
2587926|NCT01160198|8949772|P3|Overall Study|Withdrawal by Subject|0
2587927|NCT01160198|8949773|P2|Overall Study|Withdrawal by Subject|1
2587928|NCT01160198|8949774|P1|Overall Study|Withdrawal by Subject|2
2587929|NCT01159938|8949796|P5|First Study Period|Protocol Violation (Microalbuminuria)|0
2587930|NCT01159938|8949797|P4|First Study Period|Protocol Violation (Microalbuminuria)|0
2587931|NCT01159938|8949798|P3|First Study Period|Protocol Violation (Microalbuminuria)|1
2587932|NCT01159938|8949799|P2|First Study Period|Protocol Violation (Microalbuminuria)|0
2587933|NCT01159938|8949800|P1|First Study Period|Protocol Violation (Microalbuminuria)|0
2587934|NCT01159912|8949863|P3|Overall Study|Withdrawal by Subject|3
2587935|NCT01159912|8949864|P2|Overall Study|Withdrawal by Subject|3
2587936|NCT01159912|8949865|P1|Overall Study|Withdrawal by Subject|10
2587937|NCT01159912|8949863|P3|Overall Study|Physician Decision|3
2587938|NCT01159912|8949864|P2|Overall Study|Physician Decision|0
2587939|NCT01159912|8949865|P1|Overall Study|Physician Decision|0
2587940|NCT01159912|8949863|P3|Overall Study|Lost to Follow-up|0
2587941|NCT01159912|8949864|P2|Overall Study|Lost to Follow-up|0
2587942|NCT01159912|8949865|P1|Overall Study|Lost to Follow-up|4
2587943|NCT01159912|8949863|P3|Overall Study|Protocol Violation|3
2587944|NCT01159912|8949864|P2|Overall Study|Protocol Violation|2
2587945|NCT01159912|8949865|P1|Overall Study|Protocol Violation|1
2587946|NCT01159912|8949863|P3|Overall Study|Lack of Efficacy|14
2587947|NCT01159912|8949864|P2|Overall Study|Lack of Efficacy|15
2587948|NCT01159912|8949865|P1|Overall Study|Lack of Efficacy|23
2587949|NCT01159912|8949863|P3|Overall Study|Adverse Event|3
2587950|NCT01159912|8949864|P2|Overall Study|Adverse Event|2
2587951|NCT01159912|8949865|P1|Overall Study|Adverse Event|2
2587952|NCT01159769|8949888|P1|Overall Study|Adverse Event|1
2587953|NCT01159691|8949908|P1|Overall Study|Disc. Neupro lack of efficacy & unknown|1
2587954|NCT01159691|8949908|P1|Overall Study|Disc. Neupro due to AE & unknown reasons|2
2587955|NCT01159691|8949908|P1|Overall Study|Disc. Neupro other & unknown reasons|7
2587956|NCT01159691|8949908|P1|Overall Study|Disc. Neupro other & lost to follow-up|2
2587957|NCT01159691|8949908|P1|Overall Study|Discontinued Neupro due to other reasons|1
2587958|NCT01159691|8949908|P1|Overall Study|Discontinued Neupro due to Adverse Event|6
2587959|NCT01159691|8949908|P1|Overall Study|Unknown reasons|1
2587960|NCT01159691|8949908|P1|Overall Study|Lost to Follow-up|2
2587961|NCT01159665|8949921|P6|Overall Study|Withdrawal by Subject|0
2587962|NCT01159665|8949922|P5|Overall Study|Withdrawal by Subject|0
2587963|NCT01159665|8949923|P4|Overall Study|Withdrawal by Subject|0
2587964|NCT01159665|8949924|P3|Overall Study|Withdrawal by Subject|0
2587965|NCT01159665|8949925|P2|Overall Study|Withdrawal by Subject|1
2587966|NCT01159665|8949926|P1|Overall Study|Withdrawal by Subject|0
2587967|NCT01159600|8949954|P8|Overall Study|Other reason not defined above|3
2587968|NCT01159600|8949955|P7|Overall Study|Other reason not defined above|3
2587969|NCT01159600|8949956|P6|Overall Study|Other reason not defined above|7
2587970|NCT01159600|8949957|P5|Overall Study|Other reason not defined above|5
2587971|NCT01159600|8949958|P4|Overall Study|Other reason not defined above|2
2587972|NCT01159600|8949959|P3|Overall Study|Other reason not defined above|4
2587973|NCT01159600|8949960|P2|Overall Study|Other reason not defined above|0
2587974|NCT01159600|8949961|P1|Overall Study|Other reason not defined above|3
2587975|NCT01159600|8949954|P8|Overall Study|Patient refusal to continue,not due toAE|5
2587976|NCT01159600|8949955|P7|Overall Study|Patient refusal to continue,not due toAE|2
2587977|NCT01159600|8949956|P6|Overall Study|Patient refusal to continue,not due toAE|4
2587978|NCT01159600|8949957|P5|Overall Study|Patient refusal to continue,not due toAE|4
2587979|NCT01159600|8949958|P4|Overall Study|Patient refusal to continue,not due toAE|5
2587980|NCT01159600|8949959|P3|Overall Study|Patient refusal to continue,not due toAE|4
2587981|NCT01159600|8949960|P2|Overall Study|Patient refusal to continue,not due toAE|2
2587982|NCT01159600|8949961|P1|Overall Study|Patient refusal to continue,not due toAE|7
2587983|NCT01159600|8949954|P8|Overall Study|Lost to Follow-up|2
2587984|NCT01159600|8949955|P7|Overall Study|Lost to Follow-up|3
2587985|NCT01159600|8949956|P6|Overall Study|Lost to Follow-up|0
2587986|NCT01159600|8949957|P5|Overall Study|Lost to Follow-up|3
2587987|NCT01159600|8949958|P4|Overall Study|Lost to Follow-up|3
2587988|NCT01159600|8949959|P3|Overall Study|Lost to Follow-up|4
2587989|NCT01159600|8949960|P2|Overall Study|Lost to Follow-up|3
2587990|NCT01159600|8949961|P1|Overall Study|Lost to Follow-up|2
2587991|NCT01159600|8949954|P8|Overall Study|Non compliant with protocol|0
2587992|NCT01159600|8949955|P7|Overall Study|Non compliant with protocol|2
2587993|NCT01159600|8949956|P6|Overall Study|Non compliant with protocol|0
2587994|NCT01159600|8949957|P5|Overall Study|Non compliant with protocol|2
2587995|NCT01159600|8949958|P4|Overall Study|Non compliant with protocol|0
2587996|NCT01159600|8949959|P3|Overall Study|Non compliant with protocol|0
2587997|NCT01159600|8949960|P2|Overall Study|Non compliant with protocol|1
2587998|NCT01159600|8949961|P1|Overall Study|Non compliant with protocol|2
2587999|NCT01159600|8949954|P8|Overall Study|Lack of Efficacy|1
2588000|NCT01159600|8949955|P7|Overall Study|Lack of Efficacy|0
2588001|NCT01159600|8949956|P6|Overall Study|Lack of Efficacy|0
2588002|NCT01159600|8949957|P5|Overall Study|Lack of Efficacy|2
2588003|NCT01159600|8949958|P4|Overall Study|Lack of Efficacy|0
2588004|NCT01159600|8949959|P3|Overall Study|Lack of Efficacy|0
2588005|NCT01159600|8949960|P2|Overall Study|Lack of Efficacy|0
2588006|NCT01159600|8949961|P1|Overall Study|Lack of Efficacy|0
2588007|NCT01159600|8949954|P8|Overall Study|Adverse Event|5
2588008|NCT01159600|8949955|P7|Overall Study|Adverse Event|7
2588009|NCT01159600|8949956|P6|Overall Study|Adverse Event|6
2588010|NCT01159600|8949957|P5|Overall Study|Adverse Event|8
2588011|NCT01159600|8949958|P4|Overall Study|Adverse Event|1
2588012|NCT01159600|8949959|P3|Overall Study|Adverse Event|5
2588013|NCT01159600|8949960|P2|Overall Study|Adverse Event|2
2588014|NCT01159600|8949961|P1|Overall Study|Adverse Event|7
2588015|NCT01159600|8949954|P8|Overall Study|Not treated|2
2588016|NCT01159600|8949955|P7|Overall Study|Not treated|2
2588017|NCT01159600|8949956|P6|Overall Study|Not treated|1
2588018|NCT01159600|8949957|P5|Overall Study|Not treated|0
2588019|NCT01159600|8949958|P4|Overall Study|Not treated|0
2588020|NCT01159600|8949959|P3|Overall Study|Not treated|1
2588021|NCT01159600|8949960|P2|Overall Study|Not treated|0
2588022|NCT01159600|8949961|P1|Overall Study|Not treated|0
2588023|NCT01159574|8950003|P1|Follow Up Phase|still being followed for overall surviva|18
2588024|NCT01159574|8950003|P1|Follow Up Phase|Lost to Follow-up|2
2588025|NCT01159574|8950003|P1|Treatment Phase|still on treatment|2
2588026|NCT01159574|8950003|P1|Treatment Phase|Withdrawal by Subject|7
2588027|NCT01159574|8950003|P1|Treatment Phase|Physician Decision|2
2588028|NCT01159574|8950003|P1|Treatment Phase|Death|6
2588029|NCT01159574|8950003|P1|Treatment Phase|Adverse Event|3
2588030|NCT01159574|8950003|P1|Treatment Phase|non-evaluable/not included in analysis|1
2588031|NCT01159431|8950024|P2|Overall Study|Lack of Efficacy|3
2588032|NCT01159431|8950025|P1|Overall Study|Lack of Efficacy|0
2588033|NCT01159431|8950024|P2|Overall Study|non-compliance|1
2588034|NCT01159431|8950025|P1|Overall Study|non-compliance|1
2588035|NCT01159431|8950024|P2|Overall Study|Adverse Event|2
2588036|NCT01159431|8950025|P1|Overall Study|Adverse Event|1
2588037|NCT01159171|8950078|P1|Overall Study|Death|1
2588038|NCT01159171|8950078|P1|Overall Study|Medical Decision|4
2588039|NCT01159171|8950078|P1|Overall Study|Need for Surgery|5
2588040|NCT01159171|8950078|P1|Overall Study|Protocol Violation|1
2588041|NCT01159171|8950078|P1|Overall Study|Progression of Disease|28
2588042|NCT01159171|8950078|P1|Overall Study|Adverse Event|11
2588043|NCT01158924|8950159|P2|Overall Study|Lost to Follow-up|1
2588044|NCT01158924|8950160|P1|Overall Study|Lost to Follow-up|0
2588045|NCT01158924|8950159|P2|Overall Study|Withdrawal by Subject|2
2588046|NCT01158924|8950160|P1|Overall Study|Withdrawal by Subject|1
2588047|NCT01158534|8950265|P1|Overall Study|Other|1
2588048|NCT01158534|8950265|P1|Overall Study|Death|1
2588049|NCT01158534|8950265|P1|Overall Study|Withdrawal by Subject|1
2588050|NCT01158404|8950290|P8|Overall Study|Progressive Disease|0
2588051|NCT01158404|8950291|P7|Overall Study|Progressive Disease|1
2588052|NCT01158404|8950292|P6|Overall Study|Progressive Disease|0
2588053|NCT01158404|8950293|P5|Overall Study|Progressive Disease|0
2588054|NCT01158404|8950294|P4|Overall Study|Progressive Disease|0
2588055|NCT01158404|8950295|P3|Overall Study|Progressive Disease|0
2588056|NCT01158404|8950296|P2|Overall Study|Progressive Disease|0
2588057|NCT01158404|8950297|P1|Overall Study|Progressive Disease|0
2588058|NCT01158404|8950290|P8|Overall Study|Physician Decision|1
2588059|NCT01158404|8950291|P7|Overall Study|Physician Decision|0
2588060|NCT01158404|8950292|P6|Overall Study|Physician Decision|0
2588061|NCT01158404|8950293|P5|Overall Study|Physician Decision|0
2588062|NCT01158404|8950294|P4|Overall Study|Physician Decision|0
2588063|NCT01158404|8950295|P3|Overall Study|Physician Decision|0
2588064|NCT01158404|8950296|P2|Overall Study|Physician Decision|0
2588065|NCT01158404|8950297|P1|Overall Study|Physician Decision|0
2588066|NCT01158404|8950290|P8|Overall Study|Withdrawal by Subject|1
2588067|NCT01158404|8950291|P7|Overall Study|Withdrawal by Subject|0
2588068|NCT01158404|8950292|P6|Overall Study|Withdrawal by Subject|1
2588069|NCT01158404|8950293|P5|Overall Study|Withdrawal by Subject|3
2588070|NCT01158404|8950294|P4|Overall Study|Withdrawal by Subject|0
2588071|NCT01158404|8950295|P3|Overall Study|Withdrawal by Subject|0
2588072|NCT01158404|8950296|P2|Overall Study|Withdrawal by Subject|1
2588073|NCT01158404|8950297|P1|Overall Study|Withdrawal by Subject|0
2588074|NCT01158378|8950339|P2|Overall Study|Withdrawal by Subject|0
2588075|NCT01158378|8950340|P1|Overall Study|Withdrawal by Subject|4
2588076|NCT01158378|8950339|P2|Overall Study|Lost to Follow-up|4
2588077|NCT01158378|8950340|P1|Overall Study|Lost to Follow-up|2
2588078|NCT01158378|8950339|P2|Overall Study|Death|5
2588079|NCT01158378|8950340|P1|Overall Study|Death|4
2588080|NCT01158261|8950352|P1|Overall Study|Withdrawal by Subject|1
2588081|NCT01158261|8950352|P1|Overall Study|Death|7
2588082|NCT01158261|8950352|P1|Overall Study|Lost to Follow-up|9
2588083|NCT01158222|8950356|P1|Overall Study|Not eligible for intermediate phase|17
2588084|NCT01158118|8950368|P2|Overall Study|Death|1
2588085|NCT01158118|8950369|P1|Overall Study|Death|0
2588086|NCT01158118|8950368|P2|Overall Study|Suffered stroke prior to transplant|1
2588087|NCT01158118|8950369|P1|Overall Study|Suffered stroke prior to transplant|0
2588088|NCT01158118|8950368|P2|Overall Study|Donor match was a screen failure|1
2588089|NCT01158118|8950369|P1|Overall Study|Donor match was a screen failure|0
2588090|NCT01158118|8950368|P2|Overall Study|Screen failure|0
2588091|NCT01158118|8950369|P1|Overall Study|Screen failure|1
2588092|NCT01157897|8950389|P4|Overall Study|Relocated|0
2588093|NCT01157897|8950390|P3|Overall Study|Relocated|0
2588094|NCT01157897|8950391|P2|Overall Study|Relocated|2
2588095|NCT01157897|8950392|P1|Overall Study|Relocated|0
2588096|NCT01157897|8950389|P4|Overall Study|Lost to Follow-up|1
2588097|NCT01157897|8950390|P3|Overall Study|Lost to Follow-up|0
2588098|NCT01157897|8950391|P2|Overall Study|Lost to Follow-up|0
2588099|NCT01157897|8950392|P1|Overall Study|Lost to Follow-up|2
2588100|NCT01157845|8950417|P1|Overall Study|Device malfunction|1
2588101|NCT01157845|8950417|P1|Overall Study|Study was ended|1
2588102|NCT01157845|8950417|P1|Overall Study|Protocol Violation|13
2588103|NCT01157845|8950417|P1|Overall Study|Physician Decision|3
2588104|NCT01157845|8950417|P1|Overall Study|Withdrawal by Subject|12
2588105|NCT01157845|8950417|P1|Overall Study|Lost to Follow-up|5
2588106|NCT01157676|8950424|P2|Surgery|underwent robotic cystectomy|0
2588107|NCT01157676|8950425|P1|Surgery|underwent robotic cystectomy|1
2588108|NCT01157676|8950424|P2|Surgery|converted to open procedure|5
2588109|NCT01157676|8950425|P1|Surgery|converted to open procedure|0
2588110|NCT01157676|8950424|P2|Surgery|underwent open cystectomy|4
2588111|NCT01157676|8950425|P1|Surgery|underwent open cystectomy|0
2588112|NCT01157676|8950424|P2|Randomization|Physician Decision|0
2588113|NCT01157676|8950425|P1|Randomization|Physician Decision|1
2588114|NCT01157676|8950424|P2|Randomization|Withdrawal by Subject|13
2588115|NCT01157676|8950425|P1|Randomization|Withdrawal by Subject|17
2588116|NCT01157676|8950424|P2|Randomization|unresectable|3
2588117|NCT01157676|8950425|P1|Randomization|unresectable|2
2588118|NCT01157676|8950424|P2|Randomization|Death|1
2588119|NCT01157676|8950425|P1|Randomization|Death|1
2588120|NCT01157377|8950500|P7|Overall Study|Other Miscellaneous Reasons|1
2588121|NCT01157377|8950501|P6|Overall Study|Other Miscellaneous Reasons|1
2588122|NCT01157377|8950502|P5|Overall Study|Other Miscellaneous Reasons|1
2588123|NCT01157377|8950503|P4|Overall Study|Other Miscellaneous Reasons|0
2588124|NCT01157377|8950504|P3|Overall Study|Other Miscellaneous Reasons|0
2588125|NCT01157377|8950505|P2|Overall Study|Other Miscellaneous Reasons|2
2588126|NCT01157377|8950506|P1|Overall Study|Other Miscellaneous Reasons|0
2588127|NCT01157377|8950500|P7|Overall Study|Lack of Efficacy|1
2588128|NCT01157377|8950501|P6|Overall Study|Lack of Efficacy|0
2588129|NCT01157377|8950502|P5|Overall Study|Lack of Efficacy|0
2588130|NCT01157377|8950503|P4|Overall Study|Lack of Efficacy|0
2588131|NCT01157377|8950504|P3|Overall Study|Lack of Efficacy|0
2588132|NCT01157377|8950505|P2|Overall Study|Lack of Efficacy|0
2588133|NCT01157377|8950506|P1|Overall Study|Lack of Efficacy|0
2588134|NCT01157377|8950500|P7|Overall Study|Protocol Violation|0
2588135|NCT01157377|8950501|P6|Overall Study|Protocol Violation|1
2588136|NCT01157377|8950502|P5|Overall Study|Protocol Violation|0
2588137|NCT01157377|8950503|P4|Overall Study|Protocol Violation|0
2588138|NCT01157377|8950504|P3|Overall Study|Protocol Violation|0
2588139|NCT01157377|8950505|P2|Overall Study|Protocol Violation|0
2588140|NCT01157377|8950506|P1|Overall Study|Protocol Violation|0
2588141|NCT01157377|8950500|P7|Overall Study|Personal Reasons|0
2588142|NCT01157377|8950501|P6|Overall Study|Personal Reasons|0
2588143|NCT01157377|8950502|P5|Overall Study|Personal Reasons|0
2588144|NCT01157377|8950503|P4|Overall Study|Personal Reasons|1
2588145|NCT01157377|8950504|P3|Overall Study|Personal Reasons|0
2588146|NCT01157377|8950505|P2|Overall Study|Personal Reasons|1
2588147|NCT01157377|8950506|P1|Overall Study|Personal Reasons|2
2588148|NCT01157377|8950500|P7|Overall Study|Lost to Follow-up|0
2588149|NCT01157377|8950501|P6|Overall Study|Lost to Follow-up|1
2588150|NCT01157377|8950502|P5|Overall Study|Lost to Follow-up|1
2588151|NCT01157377|8950503|P4|Overall Study|Lost to Follow-up|0
2588152|NCT01157377|8950504|P3|Overall Study|Lost to Follow-up|1
2588153|NCT01157377|8950505|P2|Overall Study|Lost to Follow-up|0
2588154|NCT01157377|8950506|P1|Overall Study|Lost to Follow-up|0
2588155|NCT01157364|8950528|P6|Overall Study|Adverse Event|0
2588156|NCT01157364|8950529|P5|Overall Study|Adverse Event|1
2588157|NCT01157364|8950530|P4|Overall Study|Adverse Event|0
2588158|NCT01157364|8950531|P3|Overall Study|Adverse Event|1
2588159|NCT01157364|8950532|P2|Overall Study|Adverse Event|1
2588160|NCT01157364|8950533|P1|Overall Study|Adverse Event|0
2588161|NCT01157364|8950528|P6|Overall Study|Lack of Efficacy|0
2588162|NCT01157364|8950529|P5|Overall Study|Lack of Efficacy|0
2588163|NCT01157364|8950530|P4|Overall Study|Lack of Efficacy|1
2588164|NCT01157364|8950531|P3|Overall Study|Lack of Efficacy|0
2588165|NCT01157364|8950532|P2|Overall Study|Lack of Efficacy|0
2588166|NCT01157364|8950533|P1|Overall Study|Lack of Efficacy|0
2588167|NCT01157364|8950528|P6|Overall Study|Lost to Follow-up|0
2588168|NCT01157364|8950529|P5|Overall Study|Lost to Follow-up|0
2588169|NCT01157364|8950530|P4|Overall Study|Lost to Follow-up|0
2588170|NCT01157364|8950531|P3|Overall Study|Lost to Follow-up|1
2588171|NCT01157364|8950532|P2|Overall Study|Lost to Follow-up|0
2588172|NCT01157364|8950533|P1|Overall Study|Lost to Follow-up|1
2588173|NCT01157364|8950528|P6|Overall Study|Personal Reasons|1
2588174|NCT01157364|8950529|P5|Overall Study|Personal Reasons|1
2588175|NCT01157364|8950530|P4|Overall Study|Personal Reasons|0
2588176|NCT01157364|8950531|P3|Overall Study|Personal Reasons|0
2588177|NCT01157364|8950532|P2|Overall Study|Personal Reasons|2
2588178|NCT01157364|8950533|P1|Overall Study|Personal Reasons|0
2588179|NCT01157364|8950528|P6|Overall Study|Other Reasons|0
2588180|NCT01157364|8950529|P5|Overall Study|Other Reasons|0
2588181|NCT01157364|8950530|P4|Overall Study|Other Reasons|1
2588182|NCT01157364|8950531|P3|Overall Study|Other Reasons|2
2588183|NCT01157364|8950532|P2|Overall Study|Other Reasons|1
2588184|NCT01157364|8950533|P1|Overall Study|Other Reasons|1
2588185|NCT01157351|8950567|P2|Overall Study|Randomized but not Treated|2
2588186|NCT01157351|8950568|P1|Overall Study|Randomized but not Treated|4
2588187|NCT01157351|8950567|P2|Overall Study|Noncompliance with Study Drug|3
2588188|NCT01157351|8950568|P1|Overall Study|Noncompliance with Study Drug|0
2588189|NCT01157351|8950567|P2|Overall Study|Other|36
2588190|NCT01157351|8950568|P1|Overall Study|Other|32
2588191|NCT01157351|8950567|P2|Overall Study|Protocol Violation|1
2588192|NCT01157351|8950568|P1|Overall Study|Protocol Violation|0
2588193|NCT01157351|8950567|P2|Overall Study|Physician Decision|4
2588194|NCT01157351|8950568|P1|Overall Study|Physician Decision|5
2588195|NCT01157351|8950567|P2|Overall Study|Withdrawal by Subject|27
2588196|NCT01157351|8950568|P1|Overall Study|Withdrawal by Subject|37
2588197|NCT01157351|8950567|P2|Overall Study|Lost to Follow-up|55
2588198|NCT01157351|8950568|P1|Overall Study|Lost to Follow-up|53
2588199|NCT01157351|8950567|P2|Overall Study|Death|0
2588200|NCT01157351|8950568|P1|Overall Study|Death|1
2588201|NCT01157351|8950567|P2|Overall Study|Adverse Event|4
2588202|NCT01157351|8950568|P1|Overall Study|Adverse Event|5
2588203|NCT01157234|8950586|P2|Overall Study|Withdrawal by Subject|0
2588204|NCT01157234|8950587|P1|Overall Study|Withdrawal by Subject|1
2588205|NCT01157182|8950619|P2|Washout of 28 Days|Adverse Event|0
2588206|NCT01157182|8950620|P1|Washout of 28 Days|Adverse Event|2
2588207|NCT01157169|8950668|P2|Second Intervention|Emesis Within 4 hrs of Administration|1
2588208|NCT01157169|8950669|P1|Second Intervention|Emesis Within 4 hrs of Administration|0
2588209|NCT01157169|8950668|P2|First Intervention|Emesis Within 4 hrs of Administration|2
2588210|NCT01157169|8950669|P1|First Intervention|Emesis Within 4 hrs of Administration|4
2588211|NCT01157117|8950688|P3|Overall Study|Unknown (Pending Final Form Submission)|13
2588212|NCT01157117|8950689|P2|Overall Study|Unknown (Pending Final Form Submission)|5
2588213|NCT01157117|8950690|P1|Overall Study|Unknown (Pending Final Form Submission)|4
2588214|NCT01157117|8950688|P3|Overall Study|Lost to Follow-up|1
2588215|NCT01157117|8950689|P2|Overall Study|Lost to Follow-up|0
2588216|NCT01157117|8950690|P1|Overall Study|Lost to Follow-up|0
2588217|NCT01157117|8950688|P3|Overall Study|Lack of Efficacy|0
2588218|NCT01157117|8950689|P2|Overall Study|Lack of Efficacy|1
2588219|NCT01157117|8950690|P1|Overall Study|Lack of Efficacy|1
2588220|NCT01157117|8950688|P3|Overall Study|Withdrawal by Subject|1
2588221|NCT01157117|8950689|P2|Overall Study|Withdrawal by Subject|1
2588222|NCT01157117|8950690|P1|Overall Study|Withdrawal by Subject|4
2588223|NCT01157117|8950688|P3|Overall Study|Dosing Symptoms|0
2588224|NCT01157117|8950689|P2|Overall Study|Dosing Symptoms|4
2588225|NCT01157117|8950690|P1|Overall Study|Dosing Symptoms|0
2588226|NCT01157078|8950731|P2|Overall Study|Other|4
2588227|NCT01157078|8950732|P1|Overall Study|Other|2
2588228|NCT01157078|8950731|P2|Overall Study|Lost to Follow-up|5
2588229|NCT01157078|8950732|P1|Overall Study|Lost to Follow-up|7
2588230|NCT01157078|8950731|P2|Overall Study|Study-specific withdrawal criteria|2
2588231|NCT01157078|8950732|P1|Overall Study|Study-specific withdrawal criteria|2
2588232|NCT01157078|8950731|P2|Overall Study|Lack of Efficacy|0
2588233|NCT01157078|8950732|P1|Overall Study|Lack of Efficacy|2
2588234|NCT01157078|8950731|P2|Overall Study|Condition under investigation worsened|1
2588235|NCT01157078|8950732|P1|Overall Study|Condition under investigation worsened|0
2588236|NCT01157078|8950731|P2|Overall Study|Severe non-compliance to protocol|4
2588237|NCT01157078|8950732|P1|Overall Study|Severe non-compliance to protocol|2
2588238|NCT01157078|8950731|P2|Overall Study|Adverse Event|6
2588239|NCT01157078|8950732|P1|Overall Study|Adverse Event|6
2588240|NCT01157078|8950731|P2|Overall Study|Eligibility criteria not fulfilled|0
2588241|NCT01157078|8950732|P1|Overall Study|Eligibility criteria not fulfilled|2
2588242|NCT01157078|8950731|P2|Overall Study|Withdrawal by Subject|14
2588243|NCT01157078|8950732|P1|Overall Study|Withdrawal by Subject|12
2588244|NCT01157065|8950782|P2|Overall Study|Death|1
2588245|NCT01157065|8950783|P1|Overall Study|Death|0
2588246|NCT01156844|8950804|P4|Overall Study|Protocol deviation|0
2588247|NCT01156844|8950805|P3|Overall Study|Protocol deviation|0
2588248|NCT01156844|8950806|P2|Overall Study|Protocol deviation|0
2588249|NCT01156844|8950807|P1|Overall Study|Protocol deviation|2
2588250|NCT01156844|8950804|P4|Overall Study|Administrative problems|1
2588251|NCT01156844|8950805|P3|Overall Study|Administrative problems|0
2588252|NCT01156844|8950806|P2|Overall Study|Administrative problems|1
2588253|NCT01156844|8950807|P1|Overall Study|Administrative problems|0
2588254|NCT01156844|8950804|P4|Overall Study|Lost to Follow-up|0
2588255|NCT01156844|8950805|P3|Overall Study|Lost to Follow-up|1
2588256|NCT01156844|8950806|P2|Overall Study|Lost to Follow-up|0
2588257|NCT01156844|8950807|P1|Overall Study|Lost to Follow-up|0
2588258|NCT01156844|8950804|P4|Overall Study|Withdrawal by Subject|2
2588259|NCT01156844|8950805|P3|Overall Study|Withdrawal by Subject|2
2588260|NCT01156844|8950806|P2|Overall Study|Withdrawal by Subject|0
2588261|NCT01156844|8950807|P1|Overall Study|Withdrawal by Subject|0
2588262|NCT01156844|8950804|P4|Overall Study|Abnormal test procedure result(s)|2
2588263|NCT01156844|8950805|P3|Overall Study|Abnormal test procedure result(s)|2
2588264|NCT01156844|8950806|P2|Overall Study|Abnormal test procedure result(s)|1
2588265|NCT01156844|8950807|P1|Overall Study|Abnormal test procedure result(s)|0
2588266|NCT01156844|8950804|P4|Overall Study|Adverse Event|1
2588267|NCT01156844|8950805|P3|Overall Study|Adverse Event|1
2588268|NCT01156844|8950806|P2|Overall Study|Adverse Event|0
2588269|NCT01156844|8950807|P1|Overall Study|Adverse Event|0
2588270|NCT01156792|8950841|P1|Overall Study|other Sponsor Decision (Protocol Amendme|11
2588271|NCT01156792|8950841|P1|Overall Study|Withdrawal by Subject|9
2588272|NCT01156792|8950841|P1|Overall Study|Physician Decision|3
2588273|NCT01156792|8950841|P1|Overall Study|Lost to Follow-up|3
2588274|NCT01156792|8950841|P1|Overall Study|Protocol Violation|6
2588275|NCT01156792|8950841|P1|Overall Study|Lack of Efficacy|36
2588276|NCT01156792|8950841|P1|Overall Study|Adverse Event|1
2588277|NCT01156714|8950909|P3|Overall Study|Withdrawal by Subject|3
2588278|NCT01156714|8950910|P2|Overall Study|Withdrawal by Subject|4
2588279|NCT01156714|8950911|P1|Overall Study|Withdrawal by Subject|9
2588280|NCT01156675|8950974|P3|Overall Study|No data|2
2588281|NCT01156675|8950975|P2|Overall Study|No data|22
2588282|NCT01156675|8950976|P1|Overall Study|No data|29
2588283|NCT01156675|8950974|P3|Overall Study|Death|0
2588284|NCT01156675|8950975|P2|Overall Study|Death|3
2588285|NCT01156675|8950976|P1|Overall Study|Death|5
2588286|NCT01156532|8951034|P1|Overall Study|Lost to Follow-up|1
2588287|NCT01156532|8951034|P1|Overall Study|Family Reasons|1
2588288|NCT01156480|8951046|P2|Overall Study|change in diagnosis|1
2588289|NCT01156480|8951047|P1|Overall Study|change in diagnosis|0
2588290|NCT01156376|8951076|P3|Overall Study|Withdrawal by Subject|3
2588291|NCT01156376|8951077|P2|Overall Study|Withdrawal by Subject|0
2588292|NCT01156376|8951078|P1|Overall Study|Withdrawal by Subject|0
2588293|NCT01156376|8951076|P3|Overall Study|Adverse Event|1
2588294|NCT01156376|8951077|P2|Overall Study|Adverse Event|0
2588295|NCT01156376|8951078|P1|Overall Study|Adverse Event|1
2588296|NCT01156363|8951299|P1|Overall Study|Other|6
2588297|NCT01156363|8951299|P1|Overall Study|Refused Treatment|4
2588298|NCT01156363|8951299|P1|Overall Study|Failure to Return|1
2588299|NCT01156363|8951299|P1|Overall Study|Insufficient Therapeutic Response|5
2588300|NCT01156363|8951299|P1|Overall Study|Adverse Event|6
2588301|NCT01156311|8951321|P4|6-month Add-on Therapy Period|Other|2
2588302|NCT01156311|8951322|P3|6-month Add-on Therapy Period|Other|1
2588303|NCT01156311|8951323|P2|6-month Add-on Therapy Period|Other|0
2588304|NCT01156311|8951324|P1|6-month Add-on Therapy Period|Other|0
2588305|NCT01156311|8951321|P4|6-month Add-on Therapy Period|Physician Decision|0
2588306|NCT01156311|8951322|P3|6-month Add-on Therapy Period|Physician Decision|1
2588307|NCT01156311|8951323|P2|6-month Add-on Therapy Period|Physician Decision|0
2588308|NCT01156311|8951324|P1|6-month Add-on Therapy Period|Physician Decision|0
2588309|NCT01156311|8951321|P4|6-month Add-on Therapy Period|Disease Activity|2
2588310|NCT01156311|8951322|P3|6-month Add-on Therapy Period|Disease Activity|1
2588311|NCT01156311|8951323|P2|6-month Add-on Therapy Period|Disease Activity|0
2588312|NCT01156311|8951324|P1|6-month Add-on Therapy Period|Disease Activity|0
2588313|NCT01156311|8951321|P4|6-month Add-on Therapy Period|Lost to Follow-up|0
2588314|NCT01156311|8951322|P3|6-month Add-on Therapy Period|Lost to Follow-up|2
2588315|NCT01156311|8951323|P2|6-month Add-on Therapy Period|Lost to Follow-up|0
2588316|NCT01156311|8951324|P1|6-month Add-on Therapy Period|Lost to Follow-up|0
2588317|NCT01156311|8951321|P4|6-month Add-on Therapy Period|Adverse Event|6
2588318|NCT01156311|8951322|P3|6-month Add-on Therapy Period|Adverse Event|7
2588319|NCT01156311|8951323|P2|6-month Add-on Therapy Period|Adverse Event|0
2588320|NCT01156311|8951324|P1|6-month Add-on Therapy Period|Adverse Event|0
2588321|NCT01156311|8951321|P4|2-Month Monotherapy Period|Other|0
2588322|NCT01156311|8951322|P3|2-Month Monotherapy Period|Other|0
2588323|NCT01156311|8951323|P2|2-Month Monotherapy Period|Other|0
2588324|NCT01156311|8951324|P1|2-Month Monotherapy Period|Other|1
2588325|NCT01156311|8951321|P4|2-Month Monotherapy Period|Physician Decision|0
2588326|NCT01156311|8951322|P3|2-Month Monotherapy Period|Physician Decision|0
2588327|NCT01156311|8951323|P2|2-Month Monotherapy Period|Physician Decision|1
2588328|NCT01156311|8951324|P1|2-Month Monotherapy Period|Physician Decision|0
2588329|NCT01156311|8951321|P4|2-Month Monotherapy Period|Withdrawal by Subject|0
2588330|NCT01156311|8951322|P3|2-Month Monotherapy Period|Withdrawal by Subject|0
2588331|NCT01156311|8951323|P2|2-Month Monotherapy Period|Withdrawal by Subject|1
2588332|NCT01156311|8951324|P1|2-Month Monotherapy Period|Withdrawal by Subject|1
2588333|NCT01156142|8951348|P2|Overall Study|Ineligible|1
2588334|NCT01156142|8951349|P1|Overall Study|Ineligible|0
2588335|NCT01156142|8951348|P2|Overall Study|Withdrawal by Subject|6
2588336|NCT01156142|8951349|P1|Overall Study|Withdrawal by Subject|8
2588337|NCT01156116|8951367|P2|Overall Study|CPAP intolerance|0
2588338|NCT01156116|8951368|P1|Overall Study|CPAP intolerance|2
2588339|NCT01156116|8951367|P2|Overall Study|Withdrawal by Subject|1
2588340|NCT01156116|8951368|P1|Overall Study|Withdrawal by Subject|3
2588341|NCT01156051|8951382|P2|Overall Study|patient not compliant with protocol|1
2588342|NCT01156051|8951383|P1|Overall Study|patient not compliant with protocol|0
2588343|NCT01156051|8951382|P2|Overall Study|Lost to Follow-up|0
2588344|NCT01156051|8951383|P1|Overall Study|Lost to Follow-up|1
2588345|NCT01156012|8951397|P2|Overall Study|Non respect of one of inclusion criteria|1
2588346|NCT01156012|8951398|P1|Overall Study|Non respect of one of inclusion criteria|2
2588347|NCT01156012|8951397|P2|Overall Study|use of commercial drug instead of study|1
2588348|NCT01156012|8951398|P1|Overall Study|use of commercial drug instead of study|0
2588349|NCT01156012|8951397|P2|Overall Study|Withdrawal by Subject|0
2588350|NCT01156012|8951398|P1|Overall Study|Withdrawal by Subject|1
2588351|NCT01156012|8951397|P2|Overall Study|Lost to Follow-up|0
2588352|NCT01156012|8951398|P1|Overall Study|Lost to Follow-up|1
2588353|NCT01156012|8951397|P2|Overall Study|Adverse Event|1
2588354|NCT01156012|8951398|P1|Overall Study|Adverse Event|3
2588355|NCT01155869|8951415|P2|Overall Study|Lost to Follow-up|1
2588356|NCT01155869|8951416|P1|Overall Study|Lost to Follow-up|3
2588357|NCT01155726|8951525|P4|Period 1, 3 Days (Masked)|Inconvenience|0
2588358|NCT01155726|8951526|P3|Period 1, 3 Days (Masked)|Inconvenience|2
2588359|NCT01155726|8951527|P2|Period 1, 3 Days (Masked)|Inconvenience|0
2588360|NCT01155726|8951528|P1|Period 1, 3 Days (Masked)|Inconvenience|1
2588361|NCT01155661|8951550|P1|Overall Study|Sponsor Decision|13
2588362|NCT01155661|8951550|P1|Overall Study|Withdrawal by Subject|73
2588363|NCT01155661|8951550|P1|Overall Study|Protocol Violation|35
2588364|NCT01155661|8951550|P1|Overall Study|Physician Decision|3
2588365|NCT01155661|8951550|P1|Overall Study|Lost to Follow-up|22
2588366|NCT01155661|8951550|P1|Overall Study|Lack of Efficacy|32
2588367|NCT01155661|8951550|P1|Overall Study|Death|1
2588368|NCT01155661|8951550|P1|Overall Study|Adverse Event|101
2588369|NCT01155570|8951576|P1|Overall Study|Other Reasons|23
2588370|NCT01155570|8951576|P1|Overall Study|Participant's Economic Reasons + Other|1
2588371|NCT01155570|8951576|P1|Overall Study|Adverse Event + Other Reasons|7
2588372|NCT01155570|8951576|P1|Overall Study|Adverse Event + Lack of Efficacy|2
2588373|NCT01155570|8951576|P1|Overall Study|No Hospital Visits|7
2588374|NCT01155570|8951576|P1|Overall Study|Participant's Economic Reasons|17
2588375|NCT01155570|8951576|P1|Overall Study|Lack of Efficacy|46
2588376|NCT01155570|8951576|P1|Overall Study|Adverse Event|39
2588377|NCT01155531|8951610|P4|Overall Study|Withdrawal by Subject|0
2588378|NCT01155531|8951611|P3|Overall Study|Withdrawal by Subject|1
2588379|NCT01155531|8951612|P2|Overall Study|Withdrawal by Subject|0
2588380|NCT01155531|8951613|P1|Overall Study|Withdrawal by Subject|1
2588381|NCT01155531|8951610|P4|Overall Study|Lost to Follow-up|1
2588382|NCT01155531|8951611|P3|Overall Study|Lost to Follow-up|0
2588383|NCT01155531|8951612|P2|Overall Study|Lost to Follow-up|0
2588384|NCT01155531|8951613|P1|Overall Study|Lost to Follow-up|0
2588385|NCT01155531|8951610|P4|Overall Study|Adverse Event|0
2588386|NCT01155531|8951611|P3|Overall Study|Adverse Event|1
2588387|NCT01155531|8951612|P2|Overall Study|Adverse Event|0
2588388|NCT01155531|8951613|P1|Overall Study|Adverse Event|0
2588389|NCT01155479|8951661|P5|Part II|Non-Compliance with Protocol|0
2588390|NCT01155479|8951662|P4|Part II|Non-Compliance with Protocol|2
2588391|NCT01155479|8951663|P3|Part II|Non-Compliance with Protocol|0
2588392|NCT01155479|8951664|P2|Part II|Non-Compliance with Protocol|1
2588393|NCT01155479|8951665|P1|Part II|Non-Compliance with Protocol|0
2588394|NCT01155479|8951661|P5|Part II|Treatment Failure|1
2588395|NCT01155479|8951662|P4|Part II|Treatment Failure|0
2588396|NCT01155479|8951663|P3|Part II|Treatment Failure|2
2588397|NCT01155479|8951664|P2|Part II|Treatment Failure|1
2588398|NCT01155479|8951665|P1|Part II|Treatment Failure|0
2588399|NCT01155479|8951661|P5|Part II|Lost to Follow-up|1
2588400|NCT01155479|8951662|P4|Part II|Lost to Follow-up|0
2588401|NCT01155479|8951663|P3|Part II|Lost to Follow-up|0
2588402|NCT01155479|8951664|P2|Part II|Lost to Follow-up|0
2588403|NCT01155479|8951665|P1|Part II|Lost to Follow-up|1
2588404|NCT01155479|8951661|P5|Part II|Withdrawal by Subject|3
2588405|NCT01155479|8951662|P4|Part II|Withdrawal by Subject|7
2588406|NCT01155479|8951663|P3|Part II|Withdrawal by Subject|12
2588407|NCT01155479|8951664|P2|Part II|Withdrawal by Subject|4
2588408|NCT01155479|8951665|P1|Part II|Withdrawal by Subject|8
2588409|NCT01155479|8951661|P5|Part II|Administrative|46
2588410|NCT01155479|8951662|P4|Part II|Administrative|38
2588411|NCT01155479|8951663|P3|Part II|Administrative|36
2588412|NCT01155479|8951664|P2|Part II|Administrative|49
2588413|NCT01155479|8951665|P1|Part II|Administrative|43
2588414|NCT01155479|8951661|P5|Part II|Adverse Event|4
2588415|NCT01155479|8951662|P4|Part II|Adverse Event|3
2588416|NCT01155479|8951663|P3|Part II|Adverse Event|8
2588417|NCT01155479|8951664|P2|Part II|Adverse Event|6
2588418|NCT01155479|8951665|P1|Part II|Adverse Event|7
2588419|NCT01155479|8951661|P5|Part I|Non-Compliance with Protocol|2
2588420|NCT01155479|8951662|P4|Part I|Non-Compliance with Protocol|3
2588421|NCT01155479|8951663|P3|Part I|Non-Compliance with Protocol|3
2588422|NCT01155479|8951664|P2|Part I|Non-Compliance with Protocol|1
2588423|NCT01155479|8951665|P1|Part I|Non-Compliance with Protocol|2
2588424|NCT01155479|8951661|P5|Part I|Did Not Receive Treatment|1
2588425|NCT01155479|8951662|P4|Part I|Did Not Receive Treatment|6
2588426|NCT01155479|8951663|P3|Part I|Did Not Receive Treatment|2
2588427|NCT01155479|8951664|P2|Part I|Did Not Receive Treatment|2
2588428|NCT01155479|8951665|P1|Part I|Did Not Receive Treatment|4
2588429|NCT01155479|8951661|P5|Part I|Treatment Failure|2
2588430|NCT01155479|8951662|P4|Part I|Treatment Failure|1
2588431|NCT01155479|8951663|P3|Part I|Treatment Failure|3
2588432|NCT01155479|8951664|P2|Part I|Treatment Failure|0
2588433|NCT01155479|8951665|P1|Part I|Treatment Failure|3
2588434|NCT01155479|8951661|P5|Part I|Lost to Follow-up|0
2588435|NCT01155479|8951662|P4|Part I|Lost to Follow-up|1
2588436|NCT01155479|8951663|P3|Part I|Lost to Follow-up|1
2588437|NCT01155479|8951664|P2|Part I|Lost to Follow-up|0
2588438|NCT01155479|8951665|P1|Part I|Lost to Follow-up|0
2588439|NCT01155479|8951661|P5|Part I|Withdrawal by Subject|9
2588440|NCT01155479|8951662|P4|Part I|Withdrawal by Subject|8
2588441|NCT01155479|8951663|P3|Part I|Withdrawal by Subject|8
2588442|NCT01155479|8951664|P2|Part I|Withdrawal by Subject|13
2588443|NCT01155479|8951665|P1|Part I|Withdrawal by Subject|11
2588444|NCT01155479|8951661|P5|Part I|Did Not Meet Protocol Eligibility|3
2588445|NCT01155479|8951662|P4|Part I|Did Not Meet Protocol Eligibility|1
2588446|NCT01155479|8951663|P3|Part I|Did Not Meet Protocol Eligibility|2
2588447|NCT01155479|8951664|P2|Part I|Did Not Meet Protocol Eligibility|1
2588448|NCT01155479|8951665|P1|Part I|Did Not Meet Protocol Eligibility|3
2588449|NCT01155479|8951661|P5|Part I|Administrative|0
2588450|NCT01155479|8951662|P4|Part I|Administrative|0
2588451|NCT01155479|8951663|P3|Part I|Administrative|2
2588452|NCT01155479|8951664|P2|Part I|Administrative|2
2588453|NCT01155479|8951665|P1|Part I|Administrative|2
2588454|NCT01155479|8951661|P5|Part I|Adverse Event|6
2588455|NCT01155479|8951662|P4|Part I|Adverse Event|7
2588456|NCT01155479|8951663|P3|Part I|Adverse Event|18
2588457|NCT01155479|8951664|P2|Part I|Adverse Event|8
2588458|NCT01155479|8951665|P1|Part I|Adverse Event|13
2588459|NCT01155466|8951717|P5|Overall Study|Randomized not treated|2
2588460|NCT01155466|8951718|P4|Overall Study|Randomized not treated|0
2588461|NCT01155466|8951719|P3|Overall Study|Randomized not treated|3
2588462|NCT01155466|8951720|P2|Overall Study|Randomized not treated|2
2588463|NCT01155466|8951721|P1|Overall Study|Randomized not treated|2
2588464|NCT01155466|8951717|P5|Overall Study|Administrative|0
2588465|NCT01155466|8951718|P4|Overall Study|Administrative|0
2588466|NCT01155466|8951719|P3|Overall Study|Administrative|0
2588467|NCT01155466|8951720|P2|Overall Study|Administrative|3
2588468|NCT01155466|8951721|P1|Overall Study|Administrative|0
2588469|NCT01155466|8951717|P5|Overall Study|Protocol Violation|1
2588470|NCT01155466|8951718|P4|Overall Study|Protocol Violation|0
2588471|NCT01155466|8951719|P3|Overall Study|Protocol Violation|2
2588472|NCT01155466|8951720|P2|Overall Study|Protocol Violation|0
2588473|NCT01155466|8951721|P1|Overall Study|Protocol Violation|0
2588474|NCT01155466|8951717|P5|Overall Study|Withdrawal by Subject|4
2588475|NCT01155466|8951718|P4|Overall Study|Withdrawal by Subject|4
2588476|NCT01155466|8951719|P3|Overall Study|Withdrawal by Subject|9
2588477|NCT01155466|8951720|P2|Overall Study|Withdrawal by Subject|5
2588478|NCT01155466|8951721|P1|Overall Study|Withdrawal by Subject|7
2588479|NCT01155466|8951717|P5|Overall Study|Lost to Follow-up|2
2588480|NCT01155466|8951718|P4|Overall Study|Lost to Follow-up|0
2588481|NCT01155466|8951719|P3|Overall Study|Lost to Follow-up|0
2588482|NCT01155466|8951720|P2|Overall Study|Lost to Follow-up|0
2588483|NCT01155466|8951721|P1|Overall Study|Lost to Follow-up|0
2588484|NCT01155466|8951717|P5|Overall Study|Adverse Event|18
2588485|NCT01155466|8951718|P4|Overall Study|Adverse Event|17
2588486|NCT01155466|8951719|P3|Overall Study|Adverse Event|6
2588487|NCT01155466|8951720|P2|Overall Study|Adverse Event|15
2588488|NCT01155466|8951721|P1|Overall Study|Adverse Event|13
2588489|NCT01155388|8951775|P2|Overall Study|Adverse Event|0
2588490|NCT01155388|8951776|P1|Overall Study|Adverse Event|1
2588491|NCT01155375|8951786|P2|Overall Study|Adverse Event|0
2588492|NCT01155375|8951787|P1|Overall Study|Adverse Event|1
2588493|NCT01155323|8951806|P2|Second Intervention|Lost to Follow-up|1
2588494|NCT01155323|8951807|P1|Second Intervention|Lost to Follow-up|1
2588495|NCT01155323|8951806|P2|First Intervention|exclusion criteria|1
2588496|NCT01155323|8951807|P1|First Intervention|exclusion criteria|1
2588497|NCT01155284|8951825|P2|Overall Study|Adverse Event|0
2588498|NCT01155284|8951826|P1|Overall Study|Adverse Event|1
2588499|NCT01155284|8951825|P2|Overall Study|Physician Decision|0
2588500|NCT01155284|8951826|P1|Overall Study|Physician Decision|1
2588501|NCT01155284|8951825|P2|Overall Study|Lost to Follow-up|2
2588502|NCT01155284|8951826|P1|Overall Study|Lost to Follow-up|1
2588503|NCT01155284|8951825|P2|Overall Study|Withdrawal by Subject|3
2588504|NCT01155284|8951826|P1|Overall Study|Withdrawal by Subject|4
2588505|NCT01155219|8951836|P2|Overall Study|non-medical reason|2
2588506|NCT01155219|8951837|P1|Overall Study|non-medical reason|1
2588507|NCT01155219|8951836|P2|Overall Study|Adverse Event|1
2588508|NCT01155219|8951837|P1|Overall Study|Adverse Event|3
2588509|NCT01155167|8951886|P2|Overall Study|Access site changed to femoral artery|0
2588510|NCT01155167|8951887|P1|Overall Study|Access site changed to femoral artery|1
2588511|NCT01155167|8951886|P2|Overall Study|Insufficient ultrasound data|0
2588512|NCT01155167|8951887|P1|Overall Study|Insufficient ultrasound data|2
2588513|NCT01155141|8951910|P1|Overall Study|Screen Failure|1
2588514|NCT01155141|8951910|P1|Overall Study|Withdrawal by Subject|1
2588515|NCT01155063|8951922|P1|Overall Study|Study terminated by sponsor|87
2588516|NCT01155063|8951922|P1|Overall Study|Withdrawal by Subject|1
2588517|NCT01155063|8951922|P1|Overall Study|Adverse Event|1
2588518|NCT01155024|8951932|P2|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2
2588519|NCT01155024|8951933|P1|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0
2588520|NCT01155024|8951932|P2|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2
2588521|NCT01155024|8951933|P1|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0
2588522|NCT01155024|8951932|P2|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2
2588523|NCT01155024|8951933|P1|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0
2588524|NCT01155011|8951943|P2|6 to 12 Months|Death|5
2588525|NCT01155011|8951944|P1|6 to 12 Months|Death|1
2588526|NCT01155011|8951943|P2|6 to 12 Months|Withdrawal by Subject|5
2588527|NCT01155011|8951944|P1|6 to 12 Months|Withdrawal by Subject|8
2588528|NCT01155011|8951943|P2|Baseline to 6 Months|Death|1
2588529|NCT01155011|8951944|P1|Baseline to 6 Months|Death|0
2588530|NCT01155011|8951943|P2|Baseline to 6 Months|investigator decision, moved|5
2588531|NCT01155011|8951944|P1|Baseline to 6 Months|investigator decision, moved|4
2588532|NCT01155011|8951943|P2|Baseline to 6 Months|Withdrawal by Subject|19
2588533|NCT01155011|8951944|P1|Baseline to 6 Months|Withdrawal by Subject|18
2588534|NCT01154816|8951985|P12|Overall Study|Adverse Event|0
2588535|NCT01154816|8951986|P11|Overall Study|Adverse Event|0
2588536|NCT01154816|8951987|P10|Overall Study|Adverse Event|0
2588537|NCT01154816|8951988|P9|Overall Study|Adverse Event|0
2588538|NCT01154816|8951989|P8|Overall Study|Adverse Event|1
2588539|NCT01154816|8951990|P7|Overall Study|Adverse Event|1
2588540|NCT01154816|8951991|P6|Overall Study|Adverse Event|0
2588541|NCT01154816|8951992|P5|Overall Study|Adverse Event|0
2588542|NCT01154816|8951993|P4|Overall Study|Adverse Event|0
2588543|NCT01154816|8951994|P3|Overall Study|Adverse Event|0
2588544|NCT01154816|8951995|P2|Overall Study|Adverse Event|2
2588545|NCT01154816|8951996|P1|Overall Study|Adverse Event|5
2588546|NCT01154816|8951985|P12|Overall Study|Physician Decision|1
2588547|NCT01154816|8951986|P11|Overall Study|Physician Decision|1
2588548|NCT01154816|8951987|P10|Overall Study|Physician Decision|1
2588549|NCT01154816|8951988|P9|Overall Study|Physician Decision|0
2588550|NCT01154816|8951989|P8|Overall Study|Physician Decision|0
2588551|NCT01154816|8951990|P7|Overall Study|Physician Decision|0
2588552|NCT01154816|8951991|P6|Overall Study|Physician Decision|0
2588553|NCT01154816|8951992|P5|Overall Study|Physician Decision|2
2588554|NCT01154816|8951993|P4|Overall Study|Physician Decision|0
2588555|NCT01154816|8951994|P3|Overall Study|Physician Decision|1
2588556|NCT01154816|8951995|P2|Overall Study|Physician Decision|0
2588557|NCT01154816|8951996|P1|Overall Study|Physician Decision|1
2588558|NCT01154816|8951985|P12|Overall Study|Progressive Disease|3
2588559|NCT01154816|8951986|P11|Overall Study|Progressive Disease|10
2588560|NCT01154816|8951987|P10|Overall Study|Progressive Disease|6
2588561|NCT01154816|8951988|P9|Overall Study|Progressive Disease|8
2588562|NCT01154816|8951989|P8|Overall Study|Progressive Disease|6
2588563|NCT01154816|8951990|P7|Overall Study|Progressive Disease|5
2588564|NCT01154816|8951991|P6|Overall Study|Progressive Disease|8
2588565|NCT01154816|8951992|P5|Overall Study|Progressive Disease|8
2588566|NCT01154816|8951993|P4|Overall Study|Progressive Disease|9
2588567|NCT01154816|8951994|P3|Overall Study|Progressive Disease|9
2588568|NCT01154816|8951995|P2|Overall Study|Progressive Disease|8
2588569|NCT01154816|8951996|P1|Overall Study|Progressive Disease|13
2588570|NCT01154816|8951985|P12|Overall Study|Withdrawal by Subject|0
2588571|NCT01154816|8951986|P11|Overall Study|Withdrawal by Subject|0
2588572|NCT01154816|8951987|P10|Overall Study|Withdrawal by Subject|3
2588573|NCT01154816|8951988|P9|Overall Study|Withdrawal by Subject|1
2588574|NCT01154816|8951989|P8|Overall Study|Withdrawal by Subject|0
2588575|NCT01154816|8951990|P7|Overall Study|Withdrawal by Subject|0
2588576|NCT01154816|8951991|P6|Overall Study|Withdrawal by Subject|0
2588577|NCT01154816|8951992|P5|Overall Study|Withdrawal by Subject|0
2588578|NCT01154816|8951993|P4|Overall Study|Withdrawal by Subject|1
2588579|NCT01154816|8951994|P3|Overall Study|Withdrawal by Subject|0
2588580|NCT01154816|8951995|P2|Overall Study|Withdrawal by Subject|0
2588581|NCT01154816|8951996|P1|Overall Study|Withdrawal by Subject|1
2588582|NCT01154673|8952073|P2|Overall Study|moved out of province|0
2588583|NCT01154673|8952074|P1|Overall Study|moved out of province|1
2588584|NCT01154673|8952073|P2|Overall Study|Lost to Follow-up|0
2588585|NCT01154673|8952074|P1|Overall Study|Lost to Follow-up|1
2588586|NCT01154452|8952129|P4|Phase II|Adverse Event|4
2588587|NCT01154452|8952130|P3|Phase II|Adverse Event|4
2588588|NCT01154452|8952131|P2|Phase II|Adverse Event|0
2588589|NCT01154452|8952132|P1|Phase II|Adverse Event|0
2588590|NCT01154452|8952129|P4|Phase II|Withdrawal by Subject|2
2588591|NCT01154452|8952130|P3|Phase II|Withdrawal by Subject|1
2588592|NCT01154452|8952131|P2|Phase II|Withdrawal by Subject|0
2588593|NCT01154452|8952132|P1|Phase II|Withdrawal by Subject|0
2588594|NCT01154452|8952129|P4|Phase Ib|Adverse Event|0
2588595|NCT01154452|8952130|P3|Phase Ib|Adverse Event|0
2588596|NCT01154452|8952131|P2|Phase Ib|Adverse Event|1
2588597|NCT01154452|8952132|P1|Phase Ib|Adverse Event|2
2588598|NCT01154452|8952129|P4|Phase Ib|Not Treated|0
2588599|NCT01154452|8952130|P3|Phase Ib|Not Treated|0
2588600|NCT01154452|8952131|P2|Phase Ib|Not Treated|0
2588601|NCT01154452|8952132|P1|Phase Ib|Not Treated|1
2588602|NCT01154296|8952164|P2|6-month Follow-up|Declined by Study Coordinator|4
2588603|NCT01154296|8952165|P1|6-month Follow-up|Declined by Study Coordinator|5
2588604|NCT01154296|8952164|P2|6-month Follow-up|Death|2
2588605|NCT01154296|8952165|P1|6-month Follow-up|Death|3
2588606|NCT01154296|8952164|P2|6-month Follow-up|Withdrew consent|15
2588607|NCT01154296|8952165|P1|6-month Follow-up|Withdrew consent|14
2588608|NCT01154296|8952164|P2|6-month Follow-up|Incarcerated|32
2588609|NCT01154296|8952165|P1|6-month Follow-up|Incarcerated|37
2588610|NCT01154296|8952164|P2|6-month Follow-up|Lost contact|275
2588611|NCT01154296|8952165|P1|6-month Follow-up|Lost contact|269
2588612|NCT01154296|8952164|P2|Randomization and Intervention|Left clinic early|0
2588613|NCT01154296|8952165|P1|Randomization and Intervention|Left clinic early|2
2588614|NCT01154296|8952164|P2|Randomization and Intervention|Left before test|1
2588615|NCT01154296|8952165|P1|Randomization and Intervention|Left before test|0
2588616|NCT01154296|8952164|P2|Randomization and Intervention|Did not return|0
2588617|NCT01154296|8952165|P1|Randomization and Intervention|Did not return|1
2588618|NCT01154296|8952164|P2|Randomization and Intervention|Declined by staff|0
2588619|NCT01154296|8952165|P1|Randomization and Intervention|Declined by staff|1
2588620|NCT01154296|8952164|P2|Randomization and Intervention|Decided to decline|1
2588621|NCT01154296|8952165|P1|Randomization and Intervention|Decided to decline|1
2588622|NCT01154283|8952183|P2|7-12 Weeks|Withdrawal by Subject|1
2588623|NCT01154283|8952184|P1|7-12 Weeks|Withdrawal by Subject|0
2588624|NCT01154283|8952183|P2|7-12 Weeks|Death|0
2588625|NCT01154283|8952184|P1|7-12 Weeks|Death|1
2588626|NCT01154283|8952183|P2|0-6 Weeks|Death|1
2588627|NCT01154283|8952184|P1|0-6 Weeks|Death|0
2588628|NCT01154283|8952183|P2|0-6 Weeks|Withdrawal by Subject|2
2588629|NCT01154283|8952184|P1|0-6 Weeks|Withdrawal by Subject|7
2588630|NCT01154231|8952196|P1|Overall Study|No Info. After 1st Day, No Drug Admin.|1
2588631|NCT01154231|8952196|P1|Overall Study|Safety Unassessable, No Drug Admin.|1
2588632|NCT01154218|8952202|P4|Fourth Intervention Period|Withdrawal by Subject|0
2588633|NCT01154218|8952203|P3|Fourth Intervention Period|Withdrawal by Subject|0
2588634|NCT01154218|8952204|P2|Fourth Intervention Period|Withdrawal by Subject|0
2588635|NCT01154218|8952205|P1|Fourth Intervention Period|Withdrawal by Subject|1
2588636|NCT01154218|8952202|P4|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
2588637|NCT01154218|8952203|P3|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
2588638|NCT01154218|8952204|P2|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
2588639|NCT01154218|8952205|P1|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
2588640|NCT01154218|8952202|P4|Third Intervention Period|Adverse Event|0
2588641|NCT01154218|8952203|P3|Third Intervention Period|Adverse Event|0
2588642|NCT01154218|8952204|P2|Third Intervention Period|Adverse Event|1
2588643|NCT01154218|8952205|P1|Third Intervention Period|Adverse Event|0
2588644|NCT01154166|8952279|P2|Overall Study|Poor Compliance|0
2588645|NCT01154166|8952280|P1|Overall Study|Poor Compliance|1
2588646|NCT01154166|8952279|P2|Overall Study|Disease Progression|0
2588647|NCT01154166|8952280|P1|Overall Study|Disease Progression|1
2588648|NCT01154166|8952279|P2|Overall Study|Lack of Efficacy|0
2588649|NCT01154166|8952280|P1|Overall Study|Lack of Efficacy|3
2588650|NCT01154166|8952279|P2|Overall Study|Withdrawal by Subject|1
2588651|NCT01154166|8952280|P1|Overall Study|Withdrawal by Subject|10
2588652|NCT01154166|8952279|P2|Overall Study|Protocol Violation|1
2588653|NCT01154166|8952280|P1|Overall Study|Protocol Violation|4
2588654|NCT01154166|8952279|P2|Overall Study|Lost to Follow-up|1
2588655|NCT01154166|8952280|P1|Overall Study|Lost to Follow-up|1
2588656|NCT01154166|8952279|P2|Overall Study|Adverse Event|9
2588657|NCT01154166|8952280|P1|Overall Study|Adverse Event|14
2588658|NCT01154153|8952312|P2|Overall Study|Withdrew consent|0
2588659|NCT01154153|8952313|P1|Overall Study|Withdrew consent|1
2588660|NCT01154153|8952312|P2|Overall Study|Unable to use labs|3
2588661|NCT01154153|8952313|P1|Overall Study|Unable to use labs|2
2588662|NCT01154153|8952312|P2|Overall Study|Poor compliance to protocol|0
2588663|NCT01154153|8952313|P1|Overall Study|Poor compliance to protocol|2
2588664|NCT01154140|8952331|P2|Overall Study|Randomized but not treated|2
2588665|NCT01154140|8952332|P1|Overall Study|Randomized but not treated|1
2588666|NCT01154140|8952331|P2|Overall Study|Other|1
2588667|NCT01154140|8952332|P1|Overall Study|Other|3
2588668|NCT01154140|8952331|P2|Overall Study|Withdrawal by Subject|13
2588669|NCT01154140|8952332|P1|Overall Study|Withdrawal by Subject|12
2588670|NCT01154140|8952331|P2|Overall Study|Lost to Follow-up|5
2588671|NCT01154140|8952332|P1|Overall Study|Lost to Follow-up|4
2588672|NCT01154140|8952331|P2|Overall Study|Death|81
2588673|NCT01154140|8952332|P1|Overall Study|Death|71
2588674|NCT01154127|8952385|P2|Period 2 (21 Days)|Protocol Deviation|1
2588675|NCT01154127|8952386|P1|Period 2 (21 Days)|Protocol Deviation|0
2588676|NCT01154127|8952385|P2|Washout (14 - 28 Days)|Abnormal Test Procedure|0
2588677|NCT01154127|8952386|P1|Washout (14 - 28 Days)|Abnormal Test Procedure|1
2588678|NCT01154127|8952385|P2|Washout (14 - 28 Days)|Adverse Event|0
2588679|NCT01154127|8952386|P1|Washout (14 - 28 Days)|Adverse Event|2
2588680|NCT01154127|8952385|P2|Period 1 (21 Days)|Withdrawal by Subject|2
2588681|NCT01154127|8952386|P1|Period 1 (21 Days)|Withdrawal by Subject|0
2588682|NCT01154127|8952385|P2|Period 1 (21 Days)|Adverse Event|4
2588683|NCT01154127|8952386|P1|Period 1 (21 Days)|Adverse Event|3
2588684|NCT01154101|8952413|P5|Overall Study|Withdrawal by Subject|1
2588685|NCT01154101|8952414|P4|Overall Study|Withdrawal by Subject|0
2588686|NCT01154101|8952415|P3|Overall Study|Withdrawal by Subject|2
2588687|NCT01154101|8952416|P2|Overall Study|Withdrawal by Subject|1
2588688|NCT01154101|8952417|P1|Overall Study|Withdrawal by Subject|0
2588689|NCT01154101|8952413|P5|Overall Study|Lost to Follow-up|0
2588690|NCT01154101|8952414|P4|Overall Study|Lost to Follow-up|1
2588691|NCT01154101|8952415|P3|Overall Study|Lost to Follow-up|0
2588692|NCT01154101|8952416|P2|Overall Study|Lost to Follow-up|1
2588693|NCT01154101|8952417|P1|Overall Study|Lost to Follow-up|0
2588694|NCT01154101|8952413|P5|Overall Study|Adverse Event|0
2588695|NCT01154101|8952414|P4|Overall Study|Adverse Event|1
2588696|NCT01154101|8952415|P3|Overall Study|Adverse Event|1
2588697|NCT01154101|8952416|P2|Overall Study|Adverse Event|2
2588698|NCT01154101|8952417|P1|Overall Study|Adverse Event|0
2588699|NCT01154088|8952472|P3|Overall Study|Lost to Follow-up|7
2588700|NCT01154088|8952473|P2|Overall Study|Lost to Follow-up|6
2588701|NCT01154088|8952474|P1|Overall Study|Lost to Follow-up|4
2588702|NCT01154036|8952514|P8|Phase II|Withdrawal by Subject|4
2588703|NCT01154036|8952515|P7|Phase II|Withdrawal by Subject|5
2588704|NCT01154036|8952516|P6|Phase II|Withdrawal by Subject|2
2588705|NCT01154036|8952517|P5|Phase II|Withdrawal by Subject|4
2588706|NCT01154036|8952518|P4|Phase II|Withdrawal by Subject|0
2588707|NCT01154036|8952519|P3|Phase II|Withdrawal by Subject|0
2588708|NCT01154036|8952520|P2|Phase II|Withdrawal by Subject|0
2588709|NCT01154036|8952521|P1|Phase II|Withdrawal by Subject|0
2588710|NCT01154036|8952514|P8|Phase II|Protocol Violation|0
2588711|NCT01154036|8952515|P7|Phase II|Protocol Violation|0
2588712|NCT01154036|8952516|P6|Phase II|Protocol Violation|2
2588713|NCT01154036|8952517|P5|Phase II|Protocol Violation|1
2588714|NCT01154036|8952518|P4|Phase II|Protocol Violation|0
2588715|NCT01154036|8952519|P3|Phase II|Protocol Violation|0
2588716|NCT01154036|8952520|P2|Phase II|Protocol Violation|0
2588717|NCT01154036|8952521|P1|Phase II|Protocol Violation|0
2588718|NCT01154036|8952514|P8|Phase II|Lost to Follow-up|1
2588719|NCT01154036|8952515|P7|Phase II|Lost to Follow-up|2
2588720|NCT01154036|8952516|P6|Phase II|Lost to Follow-up|0
2588721|NCT01154036|8952517|P5|Phase II|Lost to Follow-up|2
2588722|NCT01154036|8952518|P4|Phase II|Lost to Follow-up|1
2588723|NCT01154036|8952519|P3|Phase II|Lost to Follow-up|0
2588724|NCT01154036|8952520|P2|Phase II|Lost to Follow-up|0
2588725|NCT01154036|8952521|P1|Phase II|Lost to Follow-up|0
2588726|NCT01154036|8952514|P8|Phase II|Physician Decision|0
2588727|NCT01154036|8952515|P7|Phase II|Physician Decision|1
2588728|NCT01154036|8952516|P6|Phase II|Physician Decision|0
2588729|NCT01154036|8952517|P5|Phase II|Physician Decision|0
2588730|NCT01154036|8952518|P4|Phase II|Physician Decision|0
2588731|NCT01154036|8952519|P3|Phase II|Physician Decision|0
2588732|NCT01154036|8952520|P2|Phase II|Physician Decision|0
2588733|NCT01154036|8952521|P1|Phase II|Physician Decision|0
2588734|NCT01154036|8952514|P8|Phase II|Adverse Event|1
2588735|NCT01154036|8952515|P7|Phase II|Adverse Event|1
2588736|NCT01154036|8952516|P6|Phase II|Adverse Event|1
2588737|NCT01154036|8952517|P5|Phase II|Adverse Event|1
2588738|NCT01154036|8952518|P4|Phase II|Adverse Event|0
2588739|NCT01154036|8952519|P3|Phase II|Adverse Event|0
2588740|NCT01154036|8952520|P2|Phase II|Adverse Event|0
2588741|NCT01154036|8952521|P1|Phase II|Adverse Event|0
2588742|NCT01154036|8952514|P8|Phase I|Adverse Event|0
2588743|NCT01154036|8952515|P7|Phase I|Adverse Event|0
2588744|NCT01154036|8952516|P6|Phase I|Adverse Event|0
2588745|NCT01154036|8952517|P5|Phase I|Adverse Event|0
2588746|NCT01154036|8952518|P4|Phase I|Adverse Event|0
2588747|NCT01154036|8952519|P3|Phase I|Adverse Event|12
2588748|NCT01154036|8952520|P2|Phase I|Adverse Event|11
2588749|NCT01154036|8952521|P1|Phase I|Adverse Event|1
2588750|NCT01154036|8952514|P8|Phase I|Withdrawal by Subject|0
2588751|NCT01154036|8952515|P7|Phase I|Withdrawal by Subject|0
2588752|NCT01154036|8952516|P6|Phase I|Withdrawal by Subject|0
2588753|NCT01154036|8952517|P5|Phase I|Withdrawal by Subject|0
2588754|NCT01154036|8952518|P4|Phase I|Withdrawal by Subject|0
2588755|NCT01154036|8952519|P3|Phase I|Withdrawal by Subject|29
2588756|NCT01154036|8952520|P2|Phase I|Withdrawal by Subject|10
2588757|NCT01154036|8952521|P1|Phase I|Withdrawal by Subject|2
2588758|NCT01154036|8952514|P8|Phase I|Protocol Violation|0
2588759|NCT01154036|8952515|P7|Phase I|Protocol Violation|0
2588760|NCT01154036|8952516|P6|Phase I|Protocol Violation|0
2588761|NCT01154036|8952517|P5|Phase I|Protocol Violation|0
2588762|NCT01154036|8952518|P4|Phase I|Protocol Violation|0
2588763|NCT01154036|8952519|P3|Phase I|Protocol Violation|9
2588764|NCT01154036|8952520|P2|Phase I|Protocol Violation|3
2588765|NCT01154036|8952521|P1|Phase I|Protocol Violation|0
2588766|NCT01154036|8952514|P8|Phase I|Lost to Follow-up|0
2588767|NCT01154036|8952515|P7|Phase I|Lost to Follow-up|0
2588768|NCT01154036|8952516|P6|Phase I|Lost to Follow-up|0
2588769|NCT01154036|8952517|P5|Phase I|Lost to Follow-up|0
2588770|NCT01154036|8952518|P4|Phase I|Lost to Follow-up|0
2588771|NCT01154036|8952519|P3|Phase I|Lost to Follow-up|6
2588772|NCT01154036|8952520|P2|Phase I|Lost to Follow-up|3
2588773|NCT01154036|8952521|P1|Phase I|Lost to Follow-up|0
2588774|NCT01154036|8952514|P8|Phase I|Physician Decision|0
2588775|NCT01154036|8952515|P7|Phase I|Physician Decision|0
2588776|NCT01154036|8952516|P6|Phase I|Physician Decision|0
2588777|NCT01154036|8952517|P5|Phase I|Physician Decision|0
2588778|NCT01154036|8952518|P4|Phase I|Physician Decision|0
2588779|NCT01154036|8952519|P3|Phase I|Physician Decision|0
2588780|NCT01154036|8952520|P2|Phase I|Physician Decision|1
2588781|NCT01154036|8952521|P1|Phase I|Physician Decision|0
2588782|NCT01154010|8952645|P2|Overall Study|Lost to Follow-up|1
2588783|NCT01154010|8952646|P1|Overall Study|Lost to Follow-up|0
2588784|NCT01153984|8952652|P1|Overall Study|Adverse Event|1
2588785|NCT01153984|8952652|P1|Overall Study|Withdrawal by Subject|1
2588786|NCT01153971|8952663|P1|Follow-up (Months 17-40 of Study)|Disease progression|2
2588787|NCT01153971|8952663|P1|Follow-up (Months 17-40 of Study)|Protocol Violation|1
2588788|NCT01153971|8952663|P1|Follow-up (Months 17-40 of Study)|Adverse Event|1
2588789|NCT01153971|8952663|P1|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1
2588790|NCT01153971|8952663|P1|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2
2588791|NCT01153971|8952663|P1|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1
2588792|NCT01153971|8952663|P1|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2
2588793|NCT01153958|8952686|P2|Overall Study|Study Terminated|32
2588794|NCT01153958|8952687|P1|Overall Study|Study Terminated|36
2588795|NCT01153893|8952705|P2|Overall Study|Adverse Event|0
2588796|NCT01153893|8952706|P1|Overall Study|Adverse Event|1
2588797|NCT01153841|8952732|P2|Overall Study|Lost to Follow-up|0
2588798|NCT01153841|8952733|P1|Overall Study|Lost to Follow-up|2
2588799|NCT01153841|8952732|P2|Overall Study|Protocol Violation|0
2588800|NCT01153841|8952733|P1|Overall Study|Protocol Violation|2
2588801|NCT01153841|8952732|P2|Overall Study|Withdrawal by Subject|0
2588802|NCT01153841|8952733|P1|Overall Study|Withdrawal by Subject|1
2588803|NCT01153841|8952732|P2|Overall Study|Adverse Event|0
2588804|NCT01153841|8952733|P1|Overall Study|Adverse Event|1
2588805|NCT01153815|8952749|P2|Overall Study|Withdrawal by Subject|4
2588806|NCT01153815|8952750|P1|Overall Study|Withdrawal by Subject|6
2588807|NCT01153815|8952749|P2|Overall Study|Adverse Event|1
2588808|NCT01153815|8952750|P1|Overall Study|Adverse Event|3
2588809|NCT01153763|8952772|P1|Overall Study|Withdrawal by Subject|2
2588810|NCT01153763|8952772|P1|Overall Study|Physician Decision|2
2588811|NCT01153763|8952772|P1|Overall Study|Lost to Follow-up|1
2588812|NCT01153763|8952772|P1|Overall Study|Study Closed|16
2588813|NCT01153724|8952788|P1|Treatment Period 2|Other reason not defined above|1
2588814|NCT01153724|8952788|P1|Treatment Period 2|Adverse Event|1
2588815|NCT01153724|8952788|P1|Treatment Period 1|Withdrawal by Subject|1
2588816|NCT01153698|8952828|P1|Overall Study|Not treated with Pradaxa|5
2588817|NCT01153698|8952828|P1|Overall Study|Other|2
2588818|NCT01153698|8952828|P1|Overall Study|Switch to other anticoagulants|4
2588819|NCT01153698|8952828|P1|Overall Study|Withdrawal by Subject|2
2588820|NCT01153698|8952828|P1|Overall Study|Lost to Follow-up|4
2588821|NCT01153698|8952828|P1|Overall Study|Adverse Event|12
2588822|NCT01153633|8952879|P2|Overall Study|Therapeutic failure|3
2588823|NCT01153633|8952880|P1|Overall Study|Therapeutic failure|3
2588824|NCT01153633|8952879|P2|Overall Study|Protocol Violation|1
2588825|NCT01153633|8952880|P1|Overall Study|Protocol Violation|1
2588826|NCT01153516|8952917|P2|Overall Study|Both subjects refused surgery|0
2588827|NCT01153516|8952918|P1|Overall Study|Both subjects refused surgery|2
2588828|NCT01153425|8952943|P2|Overall Study|Withdrawal by Subject|3
2588829|NCT01153425|8952944|P1|Overall Study|Withdrawal by Subject|3
2588830|NCT01153347|8952956|P4|Overall Study|Death|0
2588831|NCT01153347|8952957|P3|Overall Study|Death|0
2588832|NCT01153347|8952958|P2|Overall Study|Death|0
2588833|NCT01153347|8952959|P1|Overall Study|Death|1
2588834|NCT01153347|8952956|P4|Overall Study|Other|0
2588835|NCT01153347|8952957|P3|Overall Study|Other|4
2588836|NCT01153347|8952958|P2|Overall Study|Other|5
2588837|NCT01153347|8952959|P1|Overall Study|Other|5
2588838|NCT01153347|8952956|P4|Overall Study|Lost to Follow-up|8
2588839|NCT01153347|8952957|P3|Overall Study|Lost to Follow-up|11
2588840|NCT01153347|8952958|P2|Overall Study|Lost to Follow-up|9
2588841|NCT01153347|8952959|P1|Overall Study|Lost to Follow-up|4
2588842|NCT01153347|8952956|P4|Overall Study|Study-specific withdrawal criteria|2
2588843|NCT01153347|8952957|P3|Overall Study|Study-specific withdrawal criteria|1
2588844|NCT01153347|8952958|P2|Overall Study|Study-specific withdrawal criteria|3
2588845|NCT01153347|8952959|P1|Overall Study|Study-specific withdrawal criteria|4
2588846|NCT01153347|8952956|P4|Overall Study|Lack of Efficacy|4
2588847|NCT01153347|8952957|P3|Overall Study|Lack of Efficacy|0
2588848|NCT01153347|8952958|P2|Overall Study|Lack of Efficacy|2
2588849|NCT01153347|8952959|P1|Overall Study|Lack of Efficacy|2
2588850|NCT01153347|8952956|P4|Overall Study|Condition under investigation worsened|0
2588851|NCT01153347|8952957|P3|Overall Study|Condition under investigation worsened|0
2588852|NCT01153347|8952958|P2|Overall Study|Condition under investigation worsened|1
2588853|NCT01153347|8952959|P1|Overall Study|Condition under investigation worsened|1
2588854|NCT01153347|8952956|P4|Overall Study|Severe non-compliance to protocol|3
2588855|NCT01153347|8952957|P3|Overall Study|Severe non-compliance to protocol|4
2588856|NCT01153347|8952958|P2|Overall Study|Severe non-compliance to protocol|7
2588857|NCT01153347|8952959|P1|Overall Study|Severe non-compliance to protocol|6
2588858|NCT01153347|8952956|P4|Overall Study|Adverse Event|7
2588859|NCT01153347|8952957|P3|Overall Study|Adverse Event|21
2588860|NCT01153347|8952958|P2|Overall Study|Adverse Event|9
2588861|NCT01153347|8952959|P1|Overall Study|Adverse Event|3
2588862|NCT01153347|8952956|P4|Overall Study|Eligibility criteria not fulfilled|1
2588863|NCT01153347|8952957|P3|Overall Study|Eligibility criteria not fulfilled|2
2588864|NCT01153347|8952958|P2|Overall Study|Eligibility criteria not fulfilled|1
2588865|NCT01153347|8952959|P1|Overall Study|Eligibility criteria not fulfilled|0
2588866|NCT01153347|8952956|P4|Overall Study|Withdrawal by Subject|7
2588867|NCT01153347|8952957|P3|Overall Study|Withdrawal by Subject|7
2588868|NCT01153347|8952958|P2|Overall Study|Withdrawal by Subject|7
2588869|NCT01153347|8952959|P1|Overall Study|Withdrawal by Subject|7
2588870|NCT01153321|8953059|P2|Overall Study|Adverse Event|1
2588871|NCT01153321|8953060|P1|Overall Study|Adverse Event|1
2588872|NCT01153321|8953059|P2|Overall Study|Withdrawal by Subject|1
2588873|NCT01153321|8953060|P1|Overall Study|Withdrawal by Subject|0
2588874|NCT01153321|8953059|P2|Overall Study|Development of study withdrawal criteria|1
2588875|NCT01153321|8953060|P1|Overall Study|Development of study withdrawal criteria|0
2588876|NCT01153269|8953172|P1|Overall Study|Antiretroviral therapy break|1
2588877|NCT01153269|8953172|P1|Overall Study|Withdrawal by Subject|1
2588878|NCT01153009|8953235|P4|Overall Study|Other|2
2588879|NCT01153009|8953236|P3|Overall Study|Other|3
2588880|NCT01153009|8953237|P2|Overall Study|Other|1
2588881|NCT01153009|8953238|P1|Overall Study|Other|1
2588882|NCT01153009|8953235|P4|Overall Study|Lost to Follow-up|15
2588883|NCT01153009|8953236|P3|Overall Study|Lost to Follow-up|11
2588884|NCT01153009|8953237|P2|Overall Study|Lost to Follow-up|8
2588885|NCT01153009|8953238|P1|Overall Study|Lost to Follow-up|8
2588886|NCT01153009|8953235|P4|Overall Study|Withdrawal of Consent|6
2588887|NCT01153009|8953236|P3|Overall Study|Withdrawal of Consent|4
2588888|NCT01153009|8953237|P2|Overall Study|Withdrawal of Consent|5
2588889|NCT01153009|8953238|P1|Overall Study|Withdrawal of Consent|5
2588890|NCT01153009|8953235|P4|Overall Study|Protocol Deviations|2
2588891|NCT01153009|8953236|P3|Overall Study|Protocol Deviations|3
2588892|NCT01153009|8953237|P2|Overall Study|Protocol Deviations|3
2588893|NCT01153009|8953238|P1|Overall Study|Protocol Deviations|4
2588894|NCT01153009|8953235|P4|Overall Study|Noncompliance with Study Medication|1
2588895|NCT01153009|8953236|P3|Overall Study|Noncompliance with Study Medication|4
2588896|NCT01153009|8953237|P2|Overall Study|Noncompliance with Study Medication|3
2588897|NCT01153009|8953238|P1|Overall Study|Noncompliance with Study Medication|1
2588898|NCT01153009|8953235|P4|Overall Study|Lack of Efficacy|1
2588899|NCT01153009|8953236|P3|Overall Study|Lack of Efficacy|2
2588900|NCT01153009|8953237|P2|Overall Study|Lack of Efficacy|0
2588901|NCT01153009|8953238|P1|Overall Study|Lack of Efficacy|9
2588902|NCT01153009|8953235|P4|Overall Study|Adverse Event|10
2588903|NCT01153009|8953236|P3|Overall Study|Adverse Event|14
2588904|NCT01153009|8953237|P2|Overall Study|Adverse Event|14
2588905|NCT01153009|8953238|P1|Overall Study|Adverse Event|4
2588906|NCT01152996|8953268|P1|Overall Study|Elevated liver enzymes|1
2588907|NCT01152996|8953268|P1|Overall Study|Protocol Violation|22
2588908|NCT01152996|8953268|P1|Overall Study|Other|36
2588909|NCT01152996|8953268|P1|Overall Study|Noncompliance|41
2588910|NCT01152996|8953268|P1|Overall Study|Lack of Efficacy|68
2588911|NCT01152996|8953268|P1|Overall Study|Lost to Follow-up|112
2588912|NCT01152996|8953268|P1|Overall Study|Adverse Event|115
2588913|NCT01152996|8953268|P1|Overall Study|Withdrawal by Subject|142
2588914|NCT01152814|8953281|P1|Overall Study|Lost to Follow-up|2
2588915|NCT01152788|8953290|P2|Overall Study|No treatment|1
2588916|NCT01152788|8953291|P1|Overall Study|No treatment|0
2588917|NCT01152788|8953290|P2|Overall Study|Withdrawal by Subject|3
2588918|NCT01152788|8953291|P1|Overall Study|Withdrawal by Subject|0
2588919|NCT01152580|8953328|P2|Overall Study|Withdrawal by Subject|1
2588920|NCT01152580|8953329|P1|Overall Study|Withdrawal by Subject|0
2588921|NCT01152554|8953351|P2|Overall Study|Death|1
2588922|NCT01152554|8953352|P1|Overall Study|Death|1
2588923|NCT01152554|8953351|P2|Overall Study|Other|8
2588924|NCT01152554|8953352|P1|Overall Study|Other|28
2588925|NCT01152554|8953351|P2|Overall Study|Lost to Follow-up|32
2588926|NCT01152554|8953352|P1|Overall Study|Lost to Follow-up|87
2588927|NCT01152554|8953351|P2|Overall Study|Study-specific withdrawal criteria|8
2588928|NCT01152554|8953352|P1|Overall Study|Study-specific withdrawal criteria|17
2588929|NCT01152554|8953351|P2|Overall Study|Lack of Efficacy|3
2588930|NCT01152554|8953352|P1|Overall Study|Lack of Efficacy|20
2588931|NCT01152554|8953351|P2|Overall Study|Condition under investigation worsened|2
2588932|NCT01152554|8953352|P1|Overall Study|Condition under investigation worsened|5
2588933|NCT01152554|8953351|P2|Overall Study|Severe non-compliance to protocol|14
2588934|NCT01152554|8953352|P1|Overall Study|Severe non-compliance to protocol|36
2588935|NCT01152554|8953351|P2|Overall Study|Adverse Event|14
2588936|NCT01152554|8953352|P1|Overall Study|Adverse Event|67
2588937|NCT01152554|8953351|P2|Overall Study|Eligiblity criteria not fulfilled|1
2588938|NCT01152554|8953352|P1|Overall Study|Eligiblity criteria not fulfilled|0
2588939|NCT01152554|8953351|P2|Overall Study|Withdrawal by Subject|28
2588940|NCT01152554|8953352|P1|Overall Study|Withdrawal by Subject|73
2588941|NCT01152450|8953391|P6|Period 1 (4 Weeks)|Lost to Follow-up|0
2588942|NCT01152450|8953392|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
2588943|NCT01152450|8953393|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
2588944|NCT01152450|8953394|P3|Period 1 (4 Weeks)|Lost to Follow-up|1
2588945|NCT01152450|8953395|P2|Period 1 (4 Weeks)|Lost to Follow-up|1
2588946|NCT01152450|8953396|P1|Period 1 (4 Weeks)|Lost to Follow-up|0
2588947|NCT01152450|8953391|P6|Period 1 (4 Weeks)|Protocol Violation|0
2588948|NCT01152450|8953392|P5|Period 1 (4 Weeks)|Protocol Violation|1
2588949|NCT01152450|8953393|P4|Period 1 (4 Weeks)|Protocol Violation|0
2588950|NCT01152450|8953394|P3|Period 1 (4 Weeks)|Protocol Violation|0
2588951|NCT01152450|8953395|P2|Period 1 (4 Weeks)|Protocol Violation|0
2588952|NCT01152450|8953396|P1|Period 1 (4 Weeks)|Protocol Violation|0
2588953|NCT01152450|8953391|P6|Period 1 (4 Weeks)|Adverse Event|1
2588954|NCT01152450|8953392|P5|Period 1 (4 Weeks)|Adverse Event|1
2588955|NCT01152450|8953393|P4|Period 1 (4 Weeks)|Adverse Event|0
2588956|NCT01152450|8953394|P3|Period 1 (4 Weeks)|Adverse Event|0
2588957|NCT01152450|8953395|P2|Period 1 (4 Weeks)|Adverse Event|0
2588958|NCT01152450|8953396|P1|Period 1 (4 Weeks)|Adverse Event|0
2588959|NCT01152437|8953467|P3|Overall Study|Refusal to continue taking trial medicat|2
2588960|NCT01152437|8953468|P2|Overall Study|Refusal to continue taking trial medicat|0
2588961|NCT01152437|8953469|P1|Overall Study|Refusal to continue taking trial medicat|1
2588962|NCT01152437|8953467|P3|Overall Study|Progressive disease|32
2588963|NCT01152437|8953468|P2|Overall Study|Progressive disease|13
2588964|NCT01152437|8953469|P1|Overall Study|Progressive disease|27
2588965|NCT01152437|8953467|P3|Overall Study|Not treated|2
2588966|NCT01152437|8953468|P2|Overall Study|Not treated|1
2588967|NCT01152437|8953469|P1|Overall Study|Not treated|0
2588968|NCT01152437|8953467|P3|Overall Study|Other Adverse Event|7
2588969|NCT01152437|8953468|P2|Overall Study|Other Adverse Event|1
2588970|NCT01152437|8953469|P1|Overall Study|Other Adverse Event|8
2588971|NCT01152385|8953489|P4|Overall Study|Other|3
2588972|NCT01152385|8953490|P3|Overall Study|Other|2
2588973|NCT01152385|8953491|P2|Overall Study|Other|3
2588974|NCT01152385|8953492|P1|Overall Study|Other|4
2588975|NCT01152385|8953489|P4|Overall Study|Study-specific withdrawal criteria|0
2588976|NCT01152385|8953490|P3|Overall Study|Study-specific withdrawal criteria|2
2588977|NCT01152385|8953491|P2|Overall Study|Study-specific withdrawal criteria|1
2588978|NCT01152385|8953492|P1|Overall Study|Study-specific withdrawal criteria|1
2588979|NCT01152385|8953489|P4|Overall Study|Adverse Event|0
2588980|NCT01152385|8953490|P3|Overall Study|Adverse Event|0
2588981|NCT01152385|8953491|P2|Overall Study|Adverse Event|1
2588982|NCT01152385|8953492|P1|Overall Study|Adverse Event|1
2588983|NCT01152385|8953489|P4|Overall Study|Protocol Violation|1
2588984|NCT01152385|8953490|P3|Overall Study|Protocol Violation|0
2588985|NCT01152385|8953491|P2|Overall Study|Protocol Violation|0
2588986|NCT01152385|8953492|P1|Overall Study|Protocol Violation|0
2588987|NCT01152385|8953489|P4|Overall Study|Withdrawal by Subject|1
2588988|NCT01152385|8953490|P3|Overall Study|Withdrawal by Subject|1
2588989|NCT01152385|8953491|P2|Overall Study|Withdrawal by Subject|1
2588990|NCT01152385|8953492|P1|Overall Study|Withdrawal by Subject|3
2588991|NCT01152190|8953563|P2|Overall Study|Withdrawal by Subject|3
2588992|NCT01152190|8953564|P1|Overall Study|Withdrawal by Subject|1
2588993|NCT01152190|8953563|P2|Overall Study|Protocol Violation|1
2588994|NCT01152190|8953564|P1|Overall Study|Protocol Violation|1
2588995|NCT01152190|8953563|P2|Overall Study|Death|0
2588996|NCT01152190|8953564|P1|Overall Study|Death|1
2588997|NCT01152190|8953563|P2|Overall Study|Adverse Event|4
2588998|NCT01152190|8953564|P1|Overall Study|Adverse Event|2
2588999|NCT01152021|8953587|P2|Overall Study|No access to study drug in Pharmacy|1
2589000|NCT01152021|8953588|P1|Overall Study|No access to study drug in Pharmacy|0
2589001|NCT01152021|8953587|P2|Overall Study|Physician Decision|1
2589002|NCT01152021|8953588|P1|Overall Study|Physician Decision|1
2589003|NCT01152021|8953587|P2|Overall Study|Study drug had expired|0
2589004|NCT01152021|8953588|P1|Overall Study|Study drug had expired|1
2589005|NCT01152021|8953587|P2|Overall Study|Adverse Event|4
2589006|NCT01152021|8953588|P1|Overall Study|Adverse Event|4
2589007|NCT01151618|8953632|P1|Overall Study|Withdrawal by Subject|7
2589008|NCT01151618|8953632|P1|Overall Study|Adverse Event|2
2589009|NCT01151579|8953640|P2|Overall Study|Not meet inclusion criteria|4
2589010|NCT01151579|8953641|P1|Overall Study|Not meet inclusion criteria|6
2589011|NCT01151579|8953640|P2|Overall Study|Withdrawal by Subject|2
2589012|NCT01151579|8953641|P1|Overall Study|Withdrawal by Subject|3
2589013|NCT01151579|8953640|P2|Overall Study|Physician Decision|1
2589014|NCT01151579|8953641|P1|Overall Study|Physician Decision|3
2589015|NCT01151540|8953655|P1|Overall Study|Withdrawal by Subject|7
2589016|NCT01151540|8953655|P1|Overall Study|Adverse event, non-fatal|4
2589017|NCT01151540|8953655|P1|Overall Study|Other|2
2589018|NCT01151423|8953704|P2|Overall Study|Participated in other clinical trial|0
2589019|NCT01151423|8953705|P1|Overall Study|Participated in other clinical trial|1
2589020|NCT01151423|8953704|P2|Overall Study|Diagnosed as non-TTP patient|1
2589021|NCT01151423|8953705|P1|Overall Study|Diagnosed as non-TTP patient|0
2589022|NCT01151423|8953704|P2|Overall Study|Lost to Follow-up|0
2589023|NCT01151423|8953705|P1|Overall Study|Lost to Follow-up|1
2589024|NCT01151423|8953704|P2|Overall Study|Withdrawal by Subject|3
2589025|NCT01151423|8953705|P1|Overall Study|Withdrawal by Subject|1
2589026|NCT01151423|8953704|P2|Overall Study|Adverse Event|0
2589027|NCT01151423|8953705|P1|Overall Study|Adverse Event|3
2589028|NCT01151423|8953704|P2|Overall Study|Death|1
2589029|NCT01151423|8953705|P1|Overall Study|Death|0
2589030|NCT01151423|8953704|P2|Overall Study|Pregnancy|1
2589031|NCT01151423|8953705|P1|Overall Study|Pregnancy|0
2589032|NCT01151423|8953704|P2|Overall Study|Physician Decision|1
2589033|NCT01151423|8953705|P1|Overall Study|Physician Decision|1
2589034|NCT01151423|8953704|P2|Overall Study|Protocol Violation|1
2589035|NCT01151423|8953705|P1|Overall Study|Protocol Violation|0
2589036|NCT01151423|8953704|P2|Overall Study|Study terminated by Sponsor|10
2589037|NCT01151423|8953705|P1|Overall Study|Study terminated by Sponsor|9
2589038|NCT01151410|8953753|P2|Overall Study|Abnormal laboratory value(s)|1
2589039|NCT01151410|8953754|P1|Overall Study|Abnormal laboratory value(s)|0
2589040|NCT01151410|8953753|P2|Overall Study|Unsatisfactory therapeutic effect|1
2589041|NCT01151410|8953754|P1|Overall Study|Unsatisfactory therapeutic effect|1
2589042|NCT01151410|8953753|P2|Overall Study|Administrative problems|1
2589043|NCT01151410|8953754|P1|Overall Study|Administrative problems|1
2589044|NCT01151410|8953753|P2|Overall Study|Protocol deviation|1
2589045|NCT01151410|8953754|P1|Overall Study|Protocol deviation|2
2589046|NCT01151410|8953753|P2|Overall Study|Adverse Event|2
2589047|NCT01151410|8953754|P1|Overall Study|Adverse Event|1
2589048|NCT01151410|8953753|P2|Overall Study|Lost to Follow-up|4
2589049|NCT01151410|8953754|P1|Overall Study|Lost to Follow-up|3
2589050|NCT01151410|8953753|P2|Overall Study|Withdrawal by Subject|5
2589051|NCT01151410|8953754|P1|Overall Study|Withdrawal by Subject|3
2589052|NCT01151345|8953798|P2|First Intervention Period|Protocol Violation|1
2589053|NCT01151345|8953799|P1|First Intervention Period|Protocol Violation|0
2589054|NCT01151280|8953813|P1|Overall Study|Lack of Efficacy|3
2589055|NCT01151280|8953813|P1|Overall Study|Adverse Event|1
2589056|NCT01151215|8953826|P3|Overall Study|Safety as judged by the investigator|1
2589057|NCT01151215|8953827|P2|Overall Study|Safety as judged by the investigator|0
2589058|NCT01151215|8953828|P1|Overall Study|Safety as judged by the investigator|0
2589059|NCT01151215|8953826|P3|Overall Study|Disease progression|1
2589060|NCT01151215|8953827|P2|Overall Study|Disease progression|1
2589061|NCT01151215|8953828|P1|Overall Study|Disease progression|0
2589062|NCT01151215|8953826|P3|Overall Study|Withdrawal by Subject|2
2589063|NCT01151215|8953827|P2|Overall Study|Withdrawal by Subject|1
2589064|NCT01151215|8953828|P1|Overall Study|Withdrawal by Subject|3
2589065|NCT01151215|8953826|P3|Overall Study|Lost to Follow-up|3
2589066|NCT01151215|8953827|P2|Overall Study|Lost to Follow-up|0
2589067|NCT01151215|8953828|P1|Overall Study|Lost to Follow-up|0
2589068|NCT01151215|8953826|P3|Overall Study|Death|11
2589069|NCT01151215|8953827|P2|Overall Study|Death|20
2589070|NCT01151215|8953828|P1|Overall Study|Death|16
2589071|NCT01151215|8953826|P3|Overall Study|Worsening of condition under study|1
2589072|NCT01151215|8953827|P2|Overall Study|Worsening of condition under study|1
2589073|NCT01151215|8953828|P1|Overall Study|Worsening of condition under study|1
2589074|NCT01151137|8953866|P2|Overall Study|Lost to Follow-up|1
2589075|NCT01151137|8953867|P1|Overall Study|Lost to Follow-up|1
2589076|NCT01151137|8953866|P2|Overall Study|Death|27
2589077|NCT01151137|8953867|P1|Overall Study|Death|15
2589078|NCT01151098|8953885|P1|Overall Study|Miscellaneous|13
2589079|NCT01151098|8953885|P1|Overall Study|Protocol Violation|1
2589080|NCT01151098|8953885|P1|Overall Study|Lack of Efficacy|15
2589081|NCT01151098|8953885|P1|Overall Study|Lost to Follow-up|6
2589082|NCT01151098|8953885|P1|Overall Study|Adverse Event|82
2589083|NCT01151085|8953889|P1|Overall Study|Protocol Violation|25
2589084|NCT01151085|8953889|P1|Overall Study|Lost to Follow-up|31
2589085|NCT01151020|8953920|P1|Overall Study|Still be eligible for follow-up|79
2589086|NCT01151020|8953920|P1|Overall Study|Patients did not receive the device|2
2589087|NCT01151020|8953920|P1|Overall Study|Withdrawal by Subject|12
2589088|NCT01151020|8953920|P1|Overall Study|Lost to Follow-up|1
2589089|NCT01151020|8953920|P1|Overall Study|Conversion to open repair|1
2589090|NCT01151020|8953920|P1|Overall Study|Death|15
2589091|NCT01150474|8953999|P2|Overall Study|Surgery Changed|0
2589092|NCT01150474|8954000|P1|Overall Study|Surgery Changed|1
2589093|NCT01150474|8953999|P2|Overall Study|Drug not administered|0
2589094|NCT01150474|8954000|P1|Overall Study|Drug not administered|1
2589095|NCT01150474|8953999|P2|Overall Study|Drug did not arrive in time|0
2589096|NCT01150474|8954000|P1|Overall Study|Drug did not arrive in time|1
2589097|NCT01150474|8953999|P2|Overall Study|Rectotomy|0
2589098|NCT01150474|8954000|P1|Overall Study|Rectotomy|1
2589099|NCT01150474|8953999|P2|Overall Study|Multiple Studies|1
2589100|NCT01150474|8954000|P1|Overall Study|Multiple Studies|0
2589101|NCT01150474|8953999|P2|Overall Study|Cancer found|0
2589102|NCT01150474|8954000|P1|Overall Study|Cancer found|1
2589103|NCT01150474|8953999|P2|Overall Study|Withdrawal by Subject|2
2589104|NCT01150474|8954000|P1|Overall Study|Withdrawal by Subject|5
2589105|NCT01150357|8954045|P3|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
2589106|NCT01150357|8954046|P2|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
2589107|NCT01150357|8954047|P1|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1
2589108|NCT01150357|8954045|P3|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
2589109|NCT01150357|8954046|P2|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
2589110|NCT01150357|8954047|P1|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2
2589111|NCT01150357|8954045|P3|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2
2589112|NCT01150357|8954046|P2|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
2589113|NCT01150357|8954047|P1|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
2589114|NCT01150357|8954045|P3|Dose Response Phase (Phase 1)|Withdrawal by Participants|1
2589115|NCT01150357|8954046|P2|Dose Response Phase (Phase 1)|Withdrawal by Participants|2
2589116|NCT01150357|8954047|P1|Dose Response Phase (Phase 1)|Withdrawal by Participants|0
2589117|NCT01150357|8954045|P3|Dose Response Phase (Phase 1)|Adverse Event|1
2589118|NCT01150357|8954046|P2|Dose Response Phase (Phase 1)|Adverse Event|0
2589119|NCT01150357|8954047|P1|Dose Response Phase (Phase 1)|Adverse Event|0
2589120|NCT01150357|8954045|P3|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
2589121|NCT01150357|8954046|P2|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
2589122|NCT01150357|8954047|P1|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1
2589123|NCT01150357|8954045|P3|Dose Response Phase (Phase 1)|Protocol Violation|1
2589124|NCT01150357|8954046|P2|Dose Response Phase (Phase 1)|Protocol Violation|1
2589125|NCT01150357|8954047|P1|Dose Response Phase (Phase 1)|Protocol Violation|0
2589126|NCT01150123|8954127|P18|Overall Study|Lost to Follow-up|0
2589127|NCT01150123|8954128|P17|Overall Study|Lost to Follow-up|0
2589128|NCT01150123|8954129|P16|Overall Study|Lost to Follow-up|0
2589129|NCT01150123|8954130|P15|Overall Study|Lost to Follow-up|0
2589130|NCT01150123|8954131|P14|Overall Study|Lost to Follow-up|0
2589131|NCT01150123|8954132|P13|Overall Study|Lost to Follow-up|2
2589132|NCT01150123|8954133|P12|Overall Study|Lost to Follow-up|1
2589133|NCT01150123|8954134|P11|Overall Study|Lost to Follow-up|1
2589134|NCT01150123|8954135|P10|Overall Study|Lost to Follow-up|1
2589135|NCT01150123|8954136|P9|Overall Study|Lost to Follow-up|3
2589136|NCT01150123|8954137|P8|Overall Study|Lost to Follow-up|0
2589137|NCT01150123|8954138|P7|Overall Study|Lost to Follow-up|0
2589138|NCT01150123|8954139|P6|Overall Study|Lost to Follow-up|5
2589139|NCT01150123|8954140|P5|Overall Study|Lost to Follow-up|2
2589140|NCT01150123|8954141|P4|Overall Study|Lost to Follow-up|2
2589141|NCT01150123|8954142|P3|Overall Study|Lost to Follow-up|2
2589142|NCT01150123|8954143|P2|Overall Study|Lost to Follow-up|1
2589143|NCT01150123|8954144|P1|Overall Study|Lost to Follow-up|2
2589144|NCT01150123|8954127|P18|Overall Study|Withdrawal by Subject|1
2589145|NCT01150123|8954128|P17|Overall Study|Withdrawal by Subject|0
2589146|NCT01150123|8954129|P16|Overall Study|Withdrawal by Subject|1
2589147|NCT01150123|8954130|P15|Overall Study|Withdrawal by Subject|0
2589148|NCT01150123|8954131|P14|Overall Study|Withdrawal by Subject|0
2589149|NCT01150123|8954132|P13|Overall Study|Withdrawal by Subject|1
2589150|NCT01150123|8954133|P12|Overall Study|Withdrawal by Subject|0
2589151|NCT01150123|8954134|P11|Overall Study|Withdrawal by Subject|1
2589152|NCT01150123|8954135|P10|Overall Study|Withdrawal by Subject|0
2589153|NCT01150123|8954136|P9|Overall Study|Withdrawal by Subject|2
2589154|NCT01150123|8954137|P8|Overall Study|Withdrawal by Subject|3
2589155|NCT01150123|8954138|P7|Overall Study|Withdrawal by Subject|0
2589156|NCT01150123|8954139|P6|Overall Study|Withdrawal by Subject|1
2589157|NCT01150123|8954140|P5|Overall Study|Withdrawal by Subject|1
2589158|NCT01150123|8954141|P4|Overall Study|Withdrawal by Subject|1
2589159|NCT01150123|8954142|P3|Overall Study|Withdrawal by Subject|2
2589160|NCT01150123|8954143|P2|Overall Study|Withdrawal by Subject|1
2589161|NCT01150123|8954144|P1|Overall Study|Withdrawal by Subject|1
2589162|NCT01150097|8954320|P3|Months 24 to 48 Post-transplantation|Death|0
2589163|NCT01150097|8954321|P2|Months 24 to 48 Post-transplantation|Death|0
2589164|NCT01150097|8954322|P1|Months 24 to 48 Post-transplantation|Death|2
2589165|NCT01150097|8954320|P3|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
2589166|NCT01150097|8954321|P2|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
2589167|NCT01150097|8954322|P1|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4
2589168|NCT01150097|8954320|P3|Months 24 to 48 Post-transplantation|Administrative problems|0
2589169|NCT01150097|8954321|P2|Months 24 to 48 Post-transplantation|Administrative problems|4
2589170|NCT01150097|8954322|P1|Months 24 to 48 Post-transplantation|Administrative problems|5
2589171|NCT01150097|8954320|P3|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
2589172|NCT01150097|8954321|P2|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0
2589173|NCT01150097|8954322|P1|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
2589174|NCT01150097|8954320|P3|Months 24 to 36 Post-transplantation|Lost to Follow-up|3
2589175|NCT01150097|8954321|P2|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
2589176|NCT01150097|8954322|P1|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
2589177|NCT01150097|8954320|P3|Months 24 to 36 Post-transplantation|Administrative problems|2
2589178|NCT01150097|8954321|P2|Months 24 to 36 Post-transplantation|Administrative problems|2
2589179|NCT01150097|8954322|P1|Months 24 to 36 Post-transplantation|Administrative problems|5
2589180|NCT01150097|8954320|P3|Months 24 to 36 Post-transplantation|Death|0
2589181|NCT01150097|8954321|P2|Months 24 to 36 Post-transplantation|Death|0
2589182|NCT01150097|8954322|P1|Months 24 to 36 Post-transplantation|Death|2
2589183|NCT01149863|8954366|P1|Overall Study|Missing data or Not receiveing studydrug|3
2589184|NCT01149655|8954443|P4|Period 3-DB Maintenance Phase|Relapse With AE|18
2589185|NCT01149655|8954444|P3|Period 3-DB Maintenance Phase|Relapse With AE|19
2589186|NCT01149655|8954445|P2|Period 3-DB Maintenance Phase|Relapse With AE|0
2589187|NCT01149655|8954446|P1|Period 3-DB Maintenance Phase|Relapse With AE|0
2589188|NCT01149655|8954443|P4|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
2589189|NCT01149655|8954444|P3|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
2589190|NCT01149655|8954445|P2|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
2589191|NCT01149655|8954446|P1|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
2589192|NCT01149655|8954443|P4|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
2589193|NCT01149655|8954444|P3|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
2589194|NCT01149655|8954445|P2|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
2589195|NCT01149655|8954446|P1|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
2589196|NCT01149655|8954443|P4|Period 3-DB Maintenance Phase|Physician Decision|0
2589197|NCT01149655|8954444|P3|Period 3-DB Maintenance Phase|Physician Decision|1
2589198|NCT01149655|8954445|P2|Period 3-DB Maintenance Phase|Physician Decision|0
2589199|NCT01149655|8954446|P1|Period 3-DB Maintenance Phase|Physician Decision|0
2589200|NCT01149655|8954443|P4|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19
2589201|NCT01149655|8954444|P3|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58
2589202|NCT01149655|8954445|P2|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
2589203|NCT01149655|8954446|P1|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
2589204|NCT01149655|8954443|P4|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
2589205|NCT01149655|8954444|P3|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
2589206|NCT01149655|8954445|P2|Period 2-Stabilization Phase|Adverse Event Without Relapse|6
2589207|NCT01149655|8954446|P1|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
2589208|NCT01149655|8954443|P4|Period 2-Stabilization Phase|Withdrawal by Subject|0
2589209|NCT01149655|8954444|P3|Period 2-Stabilization Phase|Withdrawal by Subject|0
2589210|NCT01149655|8954445|P2|Period 2-Stabilization Phase|Withdrawal by Subject|5
2589211|NCT01149655|8954446|P1|Period 2-Stabilization Phase|Withdrawal by Subject|0
2589212|NCT01149655|8954443|P4|Period 2-Stabilization Phase|Physician Decision|0
2589213|NCT01149655|8954444|P3|Period 2-Stabilization Phase|Physician Decision|0
2589214|NCT01149655|8954445|P2|Period 2-Stabilization Phase|Physician Decision|3
2589215|NCT01149655|8954446|P1|Period 2-Stabilization Phase|Physician Decision|0
2589216|NCT01149655|8954443|P4|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
2589217|NCT01149655|8954444|P3|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
2589218|NCT01149655|8954445|P2|Period 2-Stabilization Phase|Met Withdrawal Criteria|7
2589219|NCT01149655|8954446|P1|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
2589220|NCT01149655|8954443|P4|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
2589221|NCT01149655|8954444|P3|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
2589222|NCT01149655|8954445|P2|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16
2589223|NCT01149655|8954446|P1|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
2589224|NCT01149655|8954443|P4|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
2589225|NCT01149655|8954444|P3|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
2589226|NCT01149655|8954445|P2|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
2589227|NCT01149655|8954446|P1|Period 1 - Conversion Phase|Adverse Event Without Relapse|3
2589228|NCT01149655|8954443|P4|Period 1 - Conversion Phase|Withdrawal by Subject|0
2589229|NCT01149655|8954444|P3|Period 1 - Conversion Phase|Withdrawal by Subject|0
2589230|NCT01149655|8954445|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
2589231|NCT01149655|8954446|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
2589232|NCT01149655|8954443|P4|Period 1 - Conversion Phase|Physician Decision|0
2589233|NCT01149655|8954444|P3|Period 1 - Conversion Phase|Physician Decision|0
2589234|NCT01149655|8954445|P2|Period 1 - Conversion Phase|Physician Decision|0
2589235|NCT01149655|8954446|P1|Period 1 - Conversion Phase|Physician Decision|2
2589236|NCT01149655|8954443|P4|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
2589237|NCT01149655|8954444|P3|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
2589238|NCT01149655|8954445|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
2589239|NCT01149655|8954446|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
2589240|NCT01149655|8954443|P4|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
2589241|NCT01149655|8954444|P3|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
2589242|NCT01149655|8954445|P2|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
2589243|NCT01149655|8954446|P1|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4
2589244|NCT01149655|8954443|P4|Period 1 - Conversion Phase|Lost to Follow-up|0
2589245|NCT01149655|8954444|P3|Period 1 - Conversion Phase|Lost to Follow-up|0
2589246|NCT01149655|8954445|P2|Period 1 - Conversion Phase|Lost to Follow-up|0
2589247|NCT01149655|8954446|P1|Period 1 - Conversion Phase|Lost to Follow-up|1
2589248|NCT01149538|8954489|P2|Overall Study|Withdrawal by Subject|3
2589249|NCT01149538|8954490|P1|Overall Study|Withdrawal by Subject|5
2589250|NCT01149538|8954489|P2|Overall Study|Lost to Follow-up|1
2589251|NCT01149538|8954490|P1|Overall Study|Lost to Follow-up|0
2589252|NCT01149486|8954511|P2|First Intervention|Adverse Event|1
2589253|NCT01149486|8954512|P1|First Intervention|Adverse Event|0
2589254|NCT01149473|8954536|P2|Washout of 7 Days|Withdrawal by Subject|1
2589255|NCT01149473|8954537|P1|Washout of 7 Days|Withdrawal by Subject|1
2589256|NCT01149473|8954536|P2|First Intervention|Adverse Event|1
2589257|NCT01149473|8954537|P1|First Intervention|Adverse Event|1
2589258|NCT01149460|8954555|P2|Overall Study|Withdrawal by Subject|2
2589259|NCT01149460|8954556|P1|Overall Study|Withdrawal by Subject|0
2589260|NCT01149421|8954589|P3|Overall Study|Protocol Violation|6
2589261|NCT01149421|8954590|P2|Overall Study|Protocol Violation|2
2589262|NCT01149421|8954591|P1|Overall Study|Protocol Violation|2
2589263|NCT01149421|8954589|P3|Overall Study|Entry Criteria Not Met|2
2589264|NCT01149421|8954590|P2|Overall Study|Entry Criteria Not Met|1
2589265|NCT01149421|8954591|P1|Overall Study|Entry Criteria Not Met|1
2589266|NCT01149421|8954589|P3|Overall Study|Physician Decision|6
2589267|NCT01149421|8954590|P2|Overall Study|Physician Decision|3
2589268|NCT01149421|8954591|P1|Overall Study|Physician Decision|5
2589269|NCT01149421|8954589|P3|Overall Study|Lost to Follow-up|5
2589270|NCT01149421|8954590|P2|Overall Study|Lost to Follow-up|4
2589271|NCT01149421|8954591|P1|Overall Study|Lost to Follow-up|2
2589272|NCT01149421|8954589|P3|Overall Study|Sponsor Decision|1
2589273|NCT01149421|8954590|P2|Overall Study|Sponsor Decision|1
2589274|NCT01149421|8954591|P1|Overall Study|Sponsor Decision|0
2589275|NCT01149421|8954589|P3|Overall Study|Withdrawal by Subject|13
2589276|NCT01149421|8954590|P2|Overall Study|Withdrawal by Subject|12
2589277|NCT01149421|8954591|P1|Overall Study|Withdrawal by Subject|20
2589278|NCT01149421|8954589|P3|Overall Study|Adverse Event|11
2589279|NCT01149421|8954590|P2|Overall Study|Adverse Event|6
2589280|NCT01149421|8954591|P1|Overall Study|Adverse Event|22
2589281|NCT01149369|8954672|P2|Overall Study|Adverse Event|3
2589282|NCT01149369|8954673|P1|Overall Study|Adverse Event|6
2589283|NCT01149343|8954841|P4|Overall Study|Recurrence / Progressive disease|0
2589284|NCT01149343|8954842|P3|Overall Study|Recurrence / Progressive disease|1
2589285|NCT01149343|8954843|P2|Overall Study|Recurrence / Progressive disease|0
2589286|NCT01149343|8954844|P1|Overall Study|Recurrence / Progressive disease|0
2589287|NCT01149343|8954841|P4|Overall Study|Sponsor study termination|2
2589288|NCT01149343|8954842|P3|Overall Study|Sponsor study termination|0
2589289|NCT01149343|8954843|P2|Overall Study|Sponsor study termination|0
2589290|NCT01149343|8954844|P1|Overall Study|Sponsor study termination|0
2589291|NCT01149343|8954841|P4|Overall Study|Other|14
2589292|NCT01149343|8954842|P3|Overall Study|Other|2
2589293|NCT01149343|8954843|P2|Overall Study|Other|10
2589294|NCT01149343|8954844|P1|Overall Study|Other|8
2589295|NCT01149343|8954841|P4|Overall Study|Lost to Follow-up|1
2589296|NCT01149343|8954842|P3|Overall Study|Lost to Follow-up|0
2589297|NCT01149343|8954843|P2|Overall Study|Lost to Follow-up|0
2589298|NCT01149343|8954844|P1|Overall Study|Lost to Follow-up|1
2589299|NCT01149343|8954841|P4|Overall Study|Death|18
2589300|NCT01149343|8954842|P3|Overall Study|Death|18
2589301|NCT01149343|8954843|P2|Overall Study|Death|13
2589302|NCT01149343|8954844|P1|Overall Study|Death|10
2589303|NCT01149343|8954841|P4|Overall Study|Withdrawal by Subject|5
2589304|NCT01149343|8954842|P3|Overall Study|Withdrawal by Subject|1
2589305|NCT01149343|8954843|P2|Overall Study|Withdrawal by Subject|1
2589306|NCT01149343|8954844|P1|Overall Study|Withdrawal by Subject|1
2589307|NCT01149148|8954929|P2|Overall Study|Death|0
2589308|NCT01149148|8954930|P1|Overall Study|Death|1
2589309|NCT01149148|8954929|P2|Overall Study|Lost to Follow-up|2
2589310|NCT01149148|8954930|P1|Overall Study|Lost to Follow-up|1
2589311|NCT01149096|8954940|P2|Overall Study|Lost to Follow-up|1
2589312|NCT01149096|8954941|P1|Overall Study|Lost to Follow-up|0
2589313|NCT01149057|8954965|P1|Overall Study|Other|6
2589314|NCT01149057|8954965|P1|Overall Study|High Parathyroid Hormone Value|1
2589315|NCT01149057|8954965|P1|Overall Study|Lost to Follow-up|1
2589316|NCT01149057|8954965|P1|Overall Study|Participant Non-Compliance|2
2589317|NCT01149057|8954965|P1|Overall Study|B Cell Depletion|4
2589318|NCT01149057|8954965|P1|Overall Study|Positive Hepatitis B Core Antibody|5
2589319|NCT01149057|8954965|P1|Overall Study|Withdrawal by Subject|9
2589320|NCT01149057|8954965|P1|Overall Study|Adverse Event|13
2589321|NCT01149057|8954965|P1|Overall Study|Lack of Efficacy|16
2589322|NCT01148979|8954992|P2|Overall Study|Lost to Follow-up|1
2589323|NCT01148979|8954993|P1|Overall Study|Lost to Follow-up|0
2589324|NCT01148862|8955011|P2|Second Intervention|Withdrawal by Subject|2
2589325|NCT01148862|8955012|P1|Second Intervention|Withdrawal by Subject|0
2589326|NCT01148810|8955044|P2|Overall Study|Protocol Violation|0
2589327|NCT01148810|8955045|P1|Overall Study|Protocol Violation|1
2589328|NCT01148810|8955044|P2|Overall Study|Withdrawal by Subject|2
2589329|NCT01148810|8955045|P1|Overall Study|Withdrawal by Subject|0
2589330|NCT01148810|8955044|P2|Overall Study|Lack of Efficacy|1
2589331|NCT01148810|8955045|P1|Overall Study|Lack of Efficacy|0
2589332|NCT01148810|8955044|P2|Overall Study|Adverse Event|2
2589333|NCT01148810|8955045|P1|Overall Study|Adverse Event|0
2589334|NCT01148771|8955072|P2|Washout Period|Withdrawal by Subject|1
2589335|NCT01148771|8955073|P1|Washout Period|Withdrawal by Subject|0
2589336|NCT01148693|8955093|P2|Overall Study|Attempts for cannulation were failed|10
2589337|NCT01148693|8955094|P1|Overall Study|Attempts for cannulation were failed|13
2589338|NCT01148537|8955114|P3|Overall Study|Adverse Event|1
2589339|NCT01148537|8955115|P2|Overall Study|Adverse Event|0
2589340|NCT01148537|8955116|P1|Overall Study|Adverse Event|2
2589341|NCT01148537|8955114|P3|Overall Study|Withdrawal by Subject|2
2589342|NCT01148537|8955115|P2|Overall Study|Withdrawal by Subject|0
2589343|NCT01148537|8955116|P1|Overall Study|Withdrawal by Subject|1
2589344|NCT01148511|8955202|P3|Randomized|Other|1
2589345|NCT01148511|8955203|P2|Randomized|Other|1
2589346|NCT01148511|8955204|P1|Randomized|Other|0
2589347|NCT01148511|8955202|P3|Randomized|Consent withdrawal|3
2589348|NCT01148511|8955203|P2|Randomized|Consent withdrawal|5
2589349|NCT01148511|8955204|P1|Randomized|Consent withdrawal|0
2589350|NCT01148511|8955202|P3|Randomized|Lost to Follow-up|1
2589351|NCT01148511|8955203|P2|Randomized|Lost to Follow-up|1
2589352|NCT01148511|8955204|P1|Randomized|Lost to Follow-up|0
2589353|NCT01148511|8955202|P3|Randomized|Protocol Violation|1
2589354|NCT01148511|8955203|P2|Randomized|Protocol Violation|2
2589355|NCT01148511|8955204|P1|Randomized|Protocol Violation|0
2589356|NCT01148511|8955202|P3|Randomized|Adverse Event|0
2589357|NCT01148511|8955203|P2|Randomized|Adverse Event|1
2589358|NCT01148511|8955204|P1|Randomized|Adverse Event|0
2589359|NCT01148511|8955202|P3|Exposed to Study Drug|Lost to Follow-up|0
2589360|NCT01148511|8955203|P2|Exposed to Study Drug|Lost to Follow-up|0
2589361|NCT01148511|8955204|P1|Exposed to Study Drug|Lost to Follow-up|4
2589362|NCT01148511|8955202|P3|Exposed to Study Drug|Protocol Violation|0
2589363|NCT01148511|8955203|P2|Exposed to Study Drug|Protocol Violation|0
2589364|NCT01148511|8955204|P1|Exposed to Study Drug|Protocol Violation|2
2589365|NCT01148459|8955225|P2|Overall Study|Failure to comply with study procedures|1
2589366|NCT01148459|8955226|P1|Overall Study|Failure to comply with study procedures|0
2589367|NCT01148459|8955225|P2|Overall Study|Refusal|0
2589368|NCT01148459|8955226|P1|Overall Study|Refusal|1
2589369|NCT01148459|8955225|P2|Overall Study|Lost to Follow-up|0
2589370|NCT01148459|8955226|P1|Overall Study|Lost to Follow-up|2
2589371|NCT01148459|8955225|P2|Overall Study|Migrated/moved from study area|6
2589372|NCT01148459|8955226|P1|Overall Study|Migrated/moved from study area|3
2589373|NCT01148459|8955225|P2|Overall Study|Withdrawal by Subject|0
2589374|NCT01148459|8955226|P1|Overall Study|Withdrawal by Subject|1
2589375|NCT01148459|8955225|P2|Overall Study|Serious Adverse Event|4
2589376|NCT01148459|8955226|P1|Overall Study|Serious Adverse Event|5
2589377|NCT01148225|8955274|P1|Overall Study|Other|185
2589378|NCT01148017|8955325|P4|Overall Study|Unable to classify|0
2589379|NCT01148017|8955326|P3|Overall Study|Unable to classify|0
2589380|NCT01148017|8955327|P2|Overall Study|Unable to classify|1
2589381|NCT01148017|8955328|P1|Overall Study|Unable to classify|3
2589382|NCT01148017|8955325|P4|Overall Study|Administrative reason|0
2589383|NCT01148017|8955326|P3|Overall Study|Administrative reason|0
2589384|NCT01148017|8955327|P2|Overall Study|Administrative reason|9
2589385|NCT01148017|8955328|P1|Overall Study|Administrative reason|22
2589386|NCT01148017|8955325|P4|Overall Study|Inappropriate enrollment|0
2589387|NCT01148017|8955326|P3|Overall Study|Inappropriate enrollment|0
2589388|NCT01148017|8955327|P2|Overall Study|Inappropriate enrollment|0
2589389|NCT01148017|8955328|P1|Overall Study|Inappropriate enrollment|1
2589390|NCT01148017|8955325|P4|Overall Study|Lost to Follow-up|0
2589391|NCT01148017|8955326|P3|Overall Study|Lost to Follow-up|0
2589392|NCT01148017|8955327|P2|Overall Study|Lost to Follow-up|10
2589393|NCT01148017|8955328|P1|Overall Study|Lost to Follow-up|23
2589394|NCT01148017|8955325|P4|Overall Study|Withdrawal by Subject|0
2589395|NCT01148017|8955326|P3|Overall Study|Withdrawal by Subject|0
2589396|NCT01148017|8955327|P2|Overall Study|Withdrawal by Subject|14
2589397|NCT01148017|8955328|P1|Overall Study|Withdrawal by Subject|31
2589398|NCT01147926|8955367|P2|Overall Study|Colonoscopy result|1
2589399|NCT01147926|8955368|P1|Overall Study|Colonoscopy result|0
2589400|NCT01147926|8955367|P2|Overall Study|Went on holiday|1
2589401|NCT01147926|8955368|P1|Overall Study|Went on holiday|0
2589402|NCT01147926|8955367|P2|Overall Study|Too busy, no time for study|0
2589403|NCT01147926|8955368|P1|Overall Study|Too busy, no time for study|1
2589404|NCT01147926|8955367|P2|Overall Study|Lack of Efficacy|0
2589405|NCT01147926|8955368|P1|Overall Study|Lack of Efficacy|1
2589406|NCT01147926|8955367|P2|Overall Study|Sponsor's Decision|1
2589407|NCT01147926|8955368|P1|Overall Study|Sponsor's Decision|0
2589408|NCT01147926|8955367|P2|Overall Study|Lost to Follow-up|2
2589409|NCT01147926|8955368|P1|Overall Study|Lost to Follow-up|0
2589410|NCT01147926|8955367|P2|Overall Study|Selection criteria not met|1
2589411|NCT01147926|8955368|P1|Overall Study|Selection criteria not met|3
2589412|NCT01147926|8955367|P2|Overall Study|Principal investigator left hospital|3
2589413|NCT01147926|8955368|P1|Overall Study|Principal investigator left hospital|1
2589414|NCT01147926|8955367|P2|Overall Study|Subject Non-Compliant|4
2589415|NCT01147926|8955368|P1|Overall Study|Subject Non-Compliant|5
2589416|NCT01147926|8955367|P2|Overall Study|Adverse Event|6
2589417|NCT01147926|8955368|P1|Overall Study|Adverse Event|7
2589418|NCT01147926|8955367|P2|Overall Study|Subject Withdrew Consent|10
2589419|NCT01147926|8955368|P1|Overall Study|Subject Withdrew Consent|9
2589420|NCT01147900|8955403|P3|At Year 10|Lost to Follow-up|0
2589421|NCT01147900|8955404|P2|At Year 10|Lost to Follow-up|1
2589422|NCT01147900|8955405|P1|At Year 10|Lost to Follow-up|0
2589423|NCT01147874|8955464|P1|Overall Study|Withdrawal by Subject|24
2589424|NCT01147874|8955464|P1|Overall Study|Sponsor's Decision|2
2589425|NCT01147874|8955464|P1|Overall Study|Protocol Violation|5
2589426|NCT01147874|8955464|P1|Overall Study|Other|5
2589427|NCT01147874|8955464|P1|Overall Study|Lost to Follow-up|25
2589428|NCT01147874|8955464|P1|Overall Study|Investigator’s Request|1
2589429|NCT01147874|8955464|P1|Overall Study|Adverse Event|5
2589430|NCT01147848|8955472|P3|Randomized Phase|Withdrawal by Subject|9
2589431|NCT01147848|8955473|P2|Randomized Phase|Withdrawal by Subject|7
2589432|NCT01147848|8955474|P1|Randomized Phase|Withdrawal by Subject|0
2589433|NCT01147848|8955472|P3|Randomized Phase|Physician Decision|1
2589434|NCT01147848|8955473|P2|Randomized Phase|Physician Decision|0
2589435|NCT01147848|8955474|P1|Randomized Phase|Physician Decision|0
2589436|NCT01147848|8955472|P3|Randomized Phase|Lost to Follow-up|7
2589437|NCT01147848|8955473|P2|Randomized Phase|Lost to Follow-up|5
2589438|NCT01147848|8955474|P1|Randomized Phase|Lost to Follow-up|0
2589439|NCT01147848|8955472|P3|Randomized Phase|Protocol Violation|10
2589440|NCT01147848|8955473|P2|Randomized Phase|Protocol Violation|7
2589441|NCT01147848|8955474|P1|Randomized Phase|Protocol Violation|0
2589442|NCT01147848|8955472|P3|Randomized Phase|Lack of Efficacy|11
2589443|NCT01147848|8955473|P2|Randomized Phase|Lack of Efficacy|20
2589444|NCT01147848|8955474|P1|Randomized Phase|Lack of Efficacy|0
2589445|NCT01147848|8955472|P3|Randomized Phase|Adverse Event|8
2589446|NCT01147848|8955473|P2|Randomized Phase|Adverse Event|6
2589447|NCT01147848|8955474|P1|Randomized Phase|Adverse Event|0
2589448|NCT01147848|8955472|P3|Run-in Period|Run-in Failure|0
2589449|NCT01147848|8955473|P2|Run-in Period|Run-in Failure|0
2589450|NCT01147848|8955474|P1|Run-in Period|Run-in Failure|135
2589451|NCT01147848|8955472|P3|Run-in Period|Screen Failure|0
2589452|NCT01147848|8955473|P2|Run-in Period|Screen Failure|0
2589453|NCT01147848|8955474|P1|Run-in Period|Screen Failure|623
2589454|NCT01147822|8955506|P2|Overall Study|Not Completed/Ongoing|102
2589455|NCT01147822|8955507|P1|Overall Study|Not Completed/Ongoing|111
2589456|NCT01147822|8955506|P2|Overall Study|Withdrawal by Subject|13
2589457|NCT01147822|8955507|P1|Overall Study|Withdrawal by Subject|8
2589458|NCT01147822|8955506|P2|Overall Study|Physician Decision|2
2589459|NCT01147822|8955507|P1|Overall Study|Physician Decision|0
2589460|NCT01147822|8955506|P2|Overall Study|Lost to Follow-up|2
2589461|NCT01147822|8955507|P1|Overall Study|Lost to Follow-up|3
2589462|NCT01147822|8955506|P2|Overall Study|Protocol Violation|1
2589463|NCT01147822|8955507|P1|Overall Study|Protocol Violation|0
2589464|NCT01147822|8955506|P2|Overall Study|Death|59
2589465|NCT01147822|8955507|P1|Overall Study|Death|66
2589466|NCT01147809|8955527|P6|Phase II (168 Days)|Ongoing|0
2589467|NCT01147809|8955528|P5|Phase II (168 Days)|Ongoing|1
2589468|NCT01147809|8955529|P4|Phase II (168 Days)|Ongoing|0
2589469|NCT01147809|8955530|P3|Phase II (168 Days)|Ongoing|0
2589470|NCT01147809|8955531|P2|Phase II (168 Days)|Ongoing|0
2589471|NCT01147809|8955532|P1|Phase II (168 Days)|Ongoing|0
2589472|NCT01147809|8955527|P6|Phase II (168 Days)|Withdrawal by Subject|15
2589473|NCT01147809|8955528|P5|Phase II (168 Days)|Withdrawal by Subject|7
2589474|NCT01147809|8955529|P4|Phase II (168 Days)|Withdrawal by Subject|0
2589475|NCT01147809|8955530|P3|Phase II (168 Days)|Withdrawal by Subject|0
2589476|NCT01147809|8955531|P2|Phase II (168 Days)|Withdrawal by Subject|0
2589477|NCT01147809|8955532|P1|Phase II (168 Days)|Withdrawal by Subject|0
2589478|NCT01147809|8955527|P6|Phase II (168 Days)|Physician Decision|11
2589479|NCT01147809|8955528|P5|Phase II (168 Days)|Physician Decision|5
2589480|NCT01147809|8955529|P4|Phase II (168 Days)|Physician Decision|0
2589481|NCT01147809|8955530|P3|Phase II (168 Days)|Physician Decision|0
2589482|NCT01147809|8955531|P2|Phase II (168 Days)|Physician Decision|0
2589483|NCT01147809|8955532|P1|Phase II (168 Days)|Physician Decision|0
2589484|NCT01147809|8955527|P6|Phase II (168 Days)|Protocol Violation|1
2589485|NCT01147809|8955528|P5|Phase II (168 Days)|Protocol Violation|0
2589486|NCT01147809|8955529|P4|Phase II (168 Days)|Protocol Violation|0
2589487|NCT01147809|8955530|P3|Phase II (168 Days)|Protocol Violation|0
2589488|NCT01147809|8955531|P2|Phase II (168 Days)|Protocol Violation|0
2589489|NCT01147809|8955532|P1|Phase II (168 Days)|Protocol Violation|0
2589490|NCT01147809|8955527|P6|Phase II (168 Days)|Adverse Event|6
2589491|NCT01147809|8955528|P5|Phase II (168 Days)|Adverse Event|3
2589492|NCT01147809|8955529|P4|Phase II (168 Days)|Adverse Event|0
2589493|NCT01147809|8955530|P3|Phase II (168 Days)|Adverse Event|0
2589494|NCT01147809|8955531|P2|Phase II (168 Days)|Adverse Event|0
2589495|NCT01147809|8955532|P1|Phase II (168 Days)|Adverse Event|0
2589496|NCT01147809|8955527|P6|Phase I (168 Days)|Withdrawal by Subject|0
2589497|NCT01147809|8955528|P5|Phase I (168 Days)|Withdrawal by Subject|0
2589498|NCT01147809|8955529|P4|Phase I (168 Days)|Withdrawal by Subject|3
2589499|NCT01147809|8955530|P3|Phase I (168 Days)|Withdrawal by Subject|0
2589500|NCT01147809|8955531|P2|Phase I (168 Days)|Withdrawal by Subject|0
2589501|NCT01147809|8955532|P1|Phase I (168 Days)|Withdrawal by Subject|0
2589502|NCT01147809|8955527|P6|Phase I (168 Days)|Physician Decision|0
2589503|NCT01147809|8955528|P5|Phase I (168 Days)|Physician Decision|0
2589504|NCT01147809|8955529|P4|Phase I (168 Days)|Physician Decision|0
2589505|NCT01147809|8955530|P3|Phase I (168 Days)|Physician Decision|2
2589506|NCT01147809|8955531|P2|Phase I (168 Days)|Physician Decision|1
2589507|NCT01147809|8955532|P1|Phase I (168 Days)|Physician Decision|0
2589508|NCT01147809|8955527|P6|Phase I (168 Days)|Lost to Follow-up|0
2589509|NCT01147809|8955528|P5|Phase I (168 Days)|Lost to Follow-up|0
2589510|NCT01147809|8955529|P4|Phase I (168 Days)|Lost to Follow-up|1
2589511|NCT01147809|8955530|P3|Phase I (168 Days)|Lost to Follow-up|0
2589512|NCT01147809|8955531|P2|Phase I (168 Days)|Lost to Follow-up|0
2589513|NCT01147809|8955532|P1|Phase I (168 Days)|Lost to Follow-up|1
2589514|NCT01147809|8955527|P6|Phase I (168 Days)|Adverse Event|0
2589515|NCT01147809|8955528|P5|Phase I (168 Days)|Adverse Event|0
2589516|NCT01147809|8955529|P4|Phase I (168 Days)|Adverse Event|1
2589517|NCT01147809|8955530|P3|Phase I (168 Days)|Adverse Event|0
2589518|NCT01147809|8955531|P2|Phase I (168 Days)|Adverse Event|0
2589519|NCT01147809|8955532|P1|Phase I (168 Days)|Adverse Event|0
2589520|NCT01147744|8955653|P7|Overall Study|Met Protocol-defined Stopping Criteria|0
2589521|NCT01147744|8955654|P6|Overall Study|Met Protocol-defined Stopping Criteria|1
2589522|NCT01147744|8955655|P5|Overall Study|Met Protocol-defined Stopping Criteria|0
2589523|NCT01147744|8955656|P4|Overall Study|Met Protocol-defined Stopping Criteria|0
2589524|NCT01147744|8955657|P3|Overall Study|Met Protocol-defined Stopping Criteria|0
2589525|NCT01147744|8955658|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
2589526|NCT01147744|8955659|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
2589527|NCT01147744|8955653|P7|Overall Study|Sponsor decision to amend protocol|6
2589528|NCT01147744|8955654|P6|Overall Study|Sponsor decision to amend protocol|2
2589529|NCT01147744|8955655|P5|Overall Study|Sponsor decision to amend protocol|7
2589530|NCT01147744|8955656|P4|Overall Study|Sponsor decision to amend protocol|5
2589531|NCT01147744|8955657|P3|Overall Study|Sponsor decision to amend protocol|2
2589532|NCT01147744|8955658|P2|Overall Study|Sponsor decision to amend protocol|4
2589533|NCT01147744|8955659|P1|Overall Study|Sponsor decision to amend protocol|7
2589534|NCT01147744|8955653|P7|Overall Study|Lost to Follow-up|0
2589535|NCT01147744|8955654|P6|Overall Study|Lost to Follow-up|0
2589536|NCT01147744|8955655|P5|Overall Study|Lost to Follow-up|0
2589537|NCT01147744|8955656|P4|Overall Study|Lost to Follow-up|0
2589538|NCT01147744|8955657|P3|Overall Study|Lost to Follow-up|0
2589539|NCT01147744|8955658|P2|Overall Study|Lost to Follow-up|1
2589540|NCT01147744|8955659|P1|Overall Study|Lost to Follow-up|0
2589541|NCT01147744|8955653|P7|Overall Study|Withdrawal by Subject|2
2589542|NCT01147744|8955654|P6|Overall Study|Withdrawal by Subject|5
2589543|NCT01147744|8955655|P5|Overall Study|Withdrawal by Subject|2
2589544|NCT01147744|8955656|P4|Overall Study|Withdrawal by Subject|2
2589545|NCT01147744|8955657|P3|Overall Study|Withdrawal by Subject|2
2589546|NCT01147744|8955658|P2|Overall Study|Withdrawal by Subject|4
2589547|NCT01147744|8955659|P1|Overall Study|Withdrawal by Subject|8
2589548|NCT01147744|8955653|P7|Overall Study|Adverse Event|2
2589549|NCT01147744|8955654|P6|Overall Study|Adverse Event|1
2589550|NCT01147744|8955655|P5|Overall Study|Adverse Event|2
2589551|NCT01147744|8955656|P4|Overall Study|Adverse Event|0
2589552|NCT01147744|8955657|P3|Overall Study|Adverse Event|3
2589553|NCT01147744|8955658|P2|Overall Study|Adverse Event|2
2589554|NCT01147744|8955659|P1|Overall Study|Adverse Event|1
2589555|NCT01147744|8955653|P7|Overall Study|Lack of Efficacy|7
2589556|NCT01147744|8955654|P6|Overall Study|Lack of Efficacy|8
2589557|NCT01147744|8955655|P5|Overall Study|Lack of Efficacy|13
2589558|NCT01147744|8955656|P4|Overall Study|Lack of Efficacy|11
2589559|NCT01147744|8955657|P3|Overall Study|Lack of Efficacy|9
2589560|NCT01147744|8955658|P2|Overall Study|Lack of Efficacy|11
2589561|NCT01147744|8955659|P1|Overall Study|Lack of Efficacy|11
2589562|NCT01147744|8955653|P7|Overall Study|Physician Decision|1
2589563|NCT01147744|8955654|P6|Overall Study|Physician Decision|0
2589564|NCT01147744|8955655|P5|Overall Study|Physician Decision|0
2589565|NCT01147744|8955656|P4|Overall Study|Physician Decision|0
2589566|NCT01147744|8955657|P3|Overall Study|Physician Decision|1
2589567|NCT01147744|8955658|P2|Overall Study|Physician Decision|1
2589568|NCT01147744|8955659|P1|Overall Study|Physician Decision|0
2589569|NCT01147744|8955653|P7|Overall Study|Protocol Violation|1
2589570|NCT01147744|8955654|P6|Overall Study|Protocol Violation|3
2589571|NCT01147744|8955655|P5|Overall Study|Protocol Violation|1
2589572|NCT01147744|8955656|P4|Overall Study|Protocol Violation|0
2589573|NCT01147744|8955657|P3|Overall Study|Protocol Violation|1
2589574|NCT01147744|8955658|P2|Overall Study|Protocol Violation|0
2589575|NCT01147744|8955659|P1|Overall Study|Protocol Violation|1
2589576|NCT01147653|8955754|P2|Year 2|Withdrawal by Subject|3
2589577|NCT01147653|8955755|P1|Year 2|Withdrawal by Subject|2
2589578|NCT01147640|8955816|P2|Overall Study|Didn't meet eligibility criteria|0
2589579|NCT01147640|8955817|P1|Overall Study|Didn't meet eligibility criteria|1
2589580|NCT01147640|8955816|P2|Overall Study|Lost to Follow-up|1
2589581|NCT01147640|8955817|P1|Overall Study|Lost to Follow-up|0
2589582|NCT01147640|8955816|P2|Overall Study|Withdrawal by Subject|0
2589583|NCT01147640|8955817|P1|Overall Study|Withdrawal by Subject|1
2589584|NCT01147640|8955816|P2|Overall Study|Physician Decision|0
2589585|NCT01147640|8955817|P1|Overall Study|Physician Decision|1
2589586|NCT01147640|8955816|P2|Overall Study|Adverse Event|0
2589587|NCT01147640|8955817|P1|Overall Study|Adverse Event|2
2589588|NCT01147497|8955849|P2|Overall Study|failed insertion|0
2589589|NCT01147497|8955850|P1|Overall Study|failed insertion|2
2589590|NCT01147471|8955870|P2|6 Month Follow Up|Lost to Follow-up|2
2589591|NCT01147471|8955871|P1|6 Month Follow Up|Lost to Follow-up|4
2589592|NCT01147471|8955870|P2|3 Month Follow Up|Physician Decision|1
2589593|NCT01147471|8955871|P1|3 Month Follow Up|Physician Decision|0
2589594|NCT01147471|8955870|P2|3 Month Follow Up|Lost to Follow-up|1
2589595|NCT01147471|8955871|P1|3 Month Follow Up|Lost to Follow-up|1
2589596|NCT01147471|8955870|P2|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1
2589597|NCT01147471|8955871|P1|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0
2589598|NCT01147471|8955870|P2|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1
2589599|NCT01147471|8955871|P1|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0
2589600|NCT01147471|8955870|P2|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1
2589601|NCT01147471|8955871|P1|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0
2589602|NCT01147458|8955885|P4|Second Intervention|Other|0
2589603|NCT01147458|8955886|P3|Second Intervention|Other|1
2589604|NCT01147458|8955887|P2|Second Intervention|Other|0
2589605|NCT01147458|8955888|P1|Second Intervention|Other|0
2589606|NCT01147458|8955885|P4|Second Intervention|Adverse Event|1
2589607|NCT01147458|8955886|P3|Second Intervention|Adverse Event|1
2589608|NCT01147458|8955887|P2|Second Intervention|Adverse Event|0
2589609|NCT01147458|8955888|P1|Second Intervention|Adverse Event|2
2589610|NCT01147458|8955885|P4|Second Intervention|Withdrawal by Subject|0
2589611|NCT01147458|8955886|P3|Second Intervention|Withdrawal by Subject|0
2589612|NCT01147458|8955887|P2|Second Intervention|Withdrawal by Subject|1
2589613|NCT01147458|8955888|P1|Second Intervention|Withdrawal by Subject|0
2589614|NCT01147458|8955885|P4|Second Intervention|Protocol Violation|0
2589615|NCT01147458|8955886|P3|Second Intervention|Protocol Violation|1
2589616|NCT01147458|8955887|P2|Second Intervention|Protocol Violation|1
2589617|NCT01147458|8955888|P1|Second Intervention|Protocol Violation|0
2589618|NCT01147458|8955885|P4|Second Intervention|Study terminated by sponsor|3
2589619|NCT01147458|8955886|P3|Second Intervention|Study terminated by sponsor|5
2589620|NCT01147458|8955887|P2|Second Intervention|Study terminated by sponsor|5
2589621|NCT01147458|8955888|P1|Second Intervention|Study terminated by sponsor|7
2589622|NCT01147458|8955885|P4|First Intervention|Other|0
2589623|NCT01147458|8955886|P3|First Intervention|Other|0
2589624|NCT01147458|8955887|P2|First Intervention|Other|2
2589625|NCT01147458|8955888|P1|First Intervention|Other|1
2589626|NCT01147458|8955885|P4|First Intervention|Adverse Event|3
2589627|NCT01147458|8955886|P3|First Intervention|Adverse Event|2
2589628|NCT01147458|8955887|P2|First Intervention|Adverse Event|3
2589629|NCT01147458|8955888|P1|First Intervention|Adverse Event|0
2589630|NCT01147458|8955885|P4|First Intervention|Withdrawal by Subject|0
2589631|NCT01147458|8955886|P3|First Intervention|Withdrawal by Subject|1
2589632|NCT01147458|8955887|P2|First Intervention|Withdrawal by Subject|0
2589633|NCT01147458|8955888|P1|First Intervention|Withdrawal by Subject|3
2589634|NCT01147458|8955885|P4|First Intervention|Protocol Violation|3
2589635|NCT01147458|8955886|P3|First Intervention|Protocol Violation|2
2589636|NCT01147458|8955887|P2|First Intervention|Protocol Violation|3
2589637|NCT01147458|8955888|P1|First Intervention|Protocol Violation|2
2589638|NCT01147458|8955885|P4|First Intervention|Study terminated by sponsor|8
2589639|NCT01147458|8955886|P3|First Intervention|Study terminated by sponsor|7
2589640|NCT01147458|8955887|P2|First Intervention|Study terminated by sponsor|8
2589641|NCT01147458|8955888|P1|First Intervention|Study terminated by sponsor|8
2589642|NCT01147393|8955967|P1|Dose Level -1|Dose Limited Toxicity|1
2589643|NCT01147393|8955967|P1|Dose Level 1|Dose limiting Toxicity|2
2589644|NCT01147341|8955988|P2|Open Label Period|Subject moved|0
2589645|NCT01147341|8955989|P1|Open Label Period|Subject moved|1
2589646|NCT01147341|8955988|P2|Open Label Period|Lack of Efficacy|0
2589647|NCT01147341|8955989|P1|Open Label Period|Lack of Efficacy|3
2589648|NCT01147341|8955988|P2|Double Blind Period|Withdrawal by Subject|1
2589649|NCT01147341|8955989|P1|Double Blind Period|Withdrawal by Subject|0
2589650|NCT01147341|8955988|P2|Double Blind Period|Lack of Efficacy|1
2589651|NCT01147341|8955989|P1|Double Blind Period|Lack of Efficacy|1
2589652|NCT01147250|8956052|P2|Overall Study|Other than specified|1
2589653|NCT01147250|8956053|P1|Overall Study|Other than specified|0
2589654|NCT01147250|8956052|P2|Overall Study|Site termination by sponsor|5
2589655|NCT01147250|8956053|P1|Overall Study|Site termination by sponsor|13
2589656|NCT01147250|8956052|P2|Overall Study|Withdrawal by Subject|88
2589657|NCT01147250|8956053|P1|Overall Study|Withdrawal by Subject|83
2589658|NCT01147250|8956052|P2|Overall Study|Lost to Follow-up|11
2589659|NCT01147250|8956053|P1|Overall Study|Lost to Follow-up|14
2589660|NCT01147172|8956065|P1|Overall Study|Lost to Follow-up|2
2589661|NCT01147172|8956065|P1|Overall Study|Withdrawal by Subject|2
2589662|NCT01147068|8956083|P7|Subjects That Completed Safety Follow-up|Ineligible|0
2589663|NCT01147068|8956084|P6|Subjects That Completed Safety Follow-up|Ineligible|0
2589664|NCT01147068|8956085|P5|Subjects That Completed Safety Follow-up|Ineligible|0
2589665|NCT01147068|8956086|P4|Subjects That Completed Safety Follow-up|Ineligible|0
2589666|NCT01147068|8956087|P3|Subjects That Completed Safety Follow-up|Ineligible|0
2589667|NCT01147068|8956088|P2|Subjects That Completed Safety Follow-up|Ineligible|1
2589668|NCT01147068|8956089|P1|Subjects That Completed Safety Follow-up|Ineligible|0
2589669|NCT01147068|8956083|P7|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
2589670|NCT01147068|8956084|P6|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
2589671|NCT01147068|8956085|P5|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
2589672|NCT01147068|8956086|P4|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2
2589673|NCT01147068|8956087|P3|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
2589674|NCT01147068|8956088|P2|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
2589675|NCT01147068|8956089|P1|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
2589676|NCT01147068|8956083|P7|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
2589677|NCT01147068|8956084|P6|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
2589678|NCT01147068|8956085|P5|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
2589679|NCT01147068|8956086|P4|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
2589680|NCT01147068|8956087|P3|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
2589681|NCT01147068|8956088|P2|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
2589682|NCT01147068|8956089|P1|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
2589683|NCT01147068|8956083|P7|Subjects That Received 2nd Dose|Other|0
2589684|NCT01147068|8956084|P6|Subjects That Received 2nd Dose|Other|0
2589685|NCT01147068|8956085|P5|Subjects That Received 2nd Dose|Other|1
2589686|NCT01147068|8956086|P4|Subjects That Received 2nd Dose|Other|0
2589687|NCT01147068|8956087|P3|Subjects That Received 2nd Dose|Other|3
2589688|NCT01147068|8956088|P2|Subjects That Received 2nd Dose|Other|3
2589689|NCT01147068|8956089|P1|Subjects That Received 2nd Dose|Other|0
2589690|NCT01147068|8956083|P7|Subjects That Received 2nd Dose|Did not complete the study|0
2589691|NCT01147068|8956084|P6|Subjects That Received 2nd Dose|Did not complete the study|1
2589692|NCT01147068|8956085|P5|Subjects That Received 2nd Dose|Did not complete the study|0
2589693|NCT01147068|8956086|P4|Subjects That Received 2nd Dose|Did not complete the study|0
2589694|NCT01147068|8956087|P3|Subjects That Received 2nd Dose|Did not complete the study|0
2589695|NCT01147068|8956088|P2|Subjects That Received 2nd Dose|Did not complete the study|1
2589696|NCT01147068|8956089|P1|Subjects That Received 2nd Dose|Did not complete the study|0
2589697|NCT01147068|8956083|P7|Subjects That Received 2nd Dose|Ineligible|0
2589698|NCT01147068|8956084|P6|Subjects That Received 2nd Dose|Ineligible|0
2589699|NCT01147068|8956085|P5|Subjects That Received 2nd Dose|Ineligible|0
2589700|NCT01147068|8956086|P4|Subjects That Received 2nd Dose|Ineligible|0
2589701|NCT01147068|8956087|P3|Subjects That Received 2nd Dose|Ineligible|0
2589702|NCT01147068|8956088|P2|Subjects That Received 2nd Dose|Ineligible|1
2589703|NCT01147068|8956089|P1|Subjects That Received 2nd Dose|Ineligible|0
2589704|NCT01147068|8956083|P7|Subjects That Received 2nd Dose|Lost to Follow-up|0
2589705|NCT01147068|8956084|P6|Subjects That Received 2nd Dose|Lost to Follow-up|1
2589706|NCT01147068|8956085|P5|Subjects That Received 2nd Dose|Lost to Follow-up|0
2589707|NCT01147068|8956086|P4|Subjects That Received 2nd Dose|Lost to Follow-up|0
2589708|NCT01147068|8956087|P3|Subjects That Received 2nd Dose|Lost to Follow-up|0
2589709|NCT01147068|8956088|P2|Subjects That Received 2nd Dose|Lost to Follow-up|0
2589710|NCT01147068|8956089|P1|Subjects That Received 2nd Dose|Lost to Follow-up|1
2589711|NCT01147055|8956119|P2|First Intervention Period|Lost to Follow-up|0
2589712|NCT01147055|8956120|P1|First Intervention Period|Lost to Follow-up|1
2589713|NCT01146951|8956162|P2|Overall Study|Adverse Event|1
2589714|NCT01146951|8956163|P1|Overall Study|Adverse Event|4
2589715|NCT01146912|8956184|P8|Overall Study|Duplicate patient|0
2589716|NCT01146912|8956185|P7|Overall Study|Duplicate patient|0
2589717|NCT01146912|8956186|P6|Overall Study|Duplicate patient|0
2589718|NCT01146912|8956187|P5|Overall Study|Duplicate patient|0
2589719|NCT01146912|8956188|P4|Overall Study|Duplicate patient|0
2589720|NCT01146912|8956189|P3|Overall Study|Duplicate patient|1
2589721|NCT01146912|8956190|P2|Overall Study|Duplicate patient|0
2589722|NCT01146912|8956191|P1|Overall Study|Duplicate patient|0
2589723|NCT01146912|8956184|P8|Overall Study|< 14 weeks gestational age|0
2589724|NCT01146912|8956185|P7|Overall Study|< 14 weeks gestational age|0
2589725|NCT01146912|8956186|P6|Overall Study|< 14 weeks gestational age|0
2589726|NCT01146912|8956187|P5|Overall Study|< 14 weeks gestational age|0
2589727|NCT01146912|8956188|P4|Overall Study|< 14 weeks gestational age|2
2589728|NCT01146912|8956189|P3|Overall Study|< 14 weeks gestational age|3
2589729|NCT01146912|8956190|P2|Overall Study|< 14 weeks gestational age|0
2589730|NCT01146912|8956191|P1|Overall Study|< 14 weeks gestational age|0
2589731|NCT01146912|8956184|P8|Overall Study|Already received influenza vaccination|0
2589732|NCT01146912|8956185|P7|Overall Study|Already received influenza vaccination|56
2589733|NCT01146912|8956186|P6|Overall Study|Already received influenza vaccination|61
2589734|NCT01146912|8956187|P5|Overall Study|Already received influenza vaccination|41
2589735|NCT01146912|8956188|P4|Overall Study|Already received influenza vaccination|15
2589736|NCT01146912|8956189|P3|Overall Study|Already received influenza vaccination|13
2589737|NCT01146912|8956190|P2|Overall Study|Already received influenza vaccination|822
2589738|NCT01146912|8956191|P1|Overall Study|Already received influenza vaccination|817
2589739|NCT01146873|8956213|P2|Overall Study|Transfer out|6
2589740|NCT01146873|8956214|P1|Overall Study|Transfer out|0
2589741|NCT01146860|8956230|P2|Overall Study|Withdrawal by Subject|1
2589742|NCT01146860|8956231|P1|Overall Study|Withdrawal by Subject|0
2589743|NCT01146782|8956282|P1|Primary Endpoint Cohort|Physician Decision|1
2589744|NCT01146782|8956282|P1|Primary Endpoint Cohort|Withdrawal by Subject|5
2589745|NCT01146782|8956282|P1|Safety Cohort|TST <4 hrs|14
2589746|NCT01146782|8956282|P1|Safety Cohort|Control AHI <5|4
2589747|NCT01146782|8956282|P1|Safety Cohort|Withdrawal by Subject|4
2589748|NCT01146782|8956282|P1|Safety Cohort|Screen Failure|61
2589749|NCT01146782|8956282|P1|Screening Cohort|Withdrawal by Subject|29
2589750|NCT01146782|8956282|P1|Screening Cohort|Physician Decision|1
2589751|NCT01146782|8956282|P1|Screening Cohort|Lost to Follow-up|4
2589752|NCT01146782|8956282|P1|Screening Cohort|Screen Failure|187
2589753|NCT01146665|8956300|P2|Overall Study|Withdrawal by Subject|16
2589754|NCT01146665|8956301|P1|Overall Study|Withdrawal by Subject|10
2589755|NCT01146613|8956333|P2|Overall Study|Outpatient detox|0
2589756|NCT01146613|8956334|P1|Overall Study|Outpatient detox|1
2589757|NCT01146613|8956333|P2|Overall Study|schedule conflict|0
2589758|NCT01146613|8956334|P1|Overall Study|schedule conflict|1
2589759|NCT01146613|8956333|P2|Overall Study|Withdrawal by Subject|3
2589760|NCT01146613|8956334|P1|Overall Study|Withdrawal by Subject|0
2589761|NCT01146613|8956333|P2|Overall Study|Physician Decision|0
2589762|NCT01146613|8956334|P1|Overall Study|Physician Decision|1
2589763|NCT01146613|8956333|P2|Overall Study|Death|0
2589764|NCT01146613|8956334|P1|Overall Study|Death|1
2589765|NCT01146613|8956333|P2|Overall Study|Lack of Efficacy|1
2589766|NCT01146613|8956334|P1|Overall Study|Lack of Efficacy|0
2589767|NCT01146613|8956333|P2|Overall Study|Lost to Follow-up|8
2589768|NCT01146613|8956334|P1|Overall Study|Lost to Follow-up|3
2589769|NCT01146288|8956444|P2|First Intervention(1 Day)|Adverse Event|1
2589770|NCT01146288|8956445|P1|First Intervention(1 Day)|Adverse Event|0
2589771|NCT01146054|8956459|P1|Overall Study|Lost to Follow-up|1
2589772|NCT01146054|8956459|P1|Overall Study|Other illness precluded treatment|2
2589773|NCT01146054|8956459|P1|Overall Study|Rapid tumor progression|2
2589774|NCT01146054|8956459|P1|Overall Study|Did not meet dose constraints for SBRT|5
2589775|NCT01145898|8956469|P2|3-year Treatment|medication change by treating physician|16
2589776|NCT01145898|8956470|P1|3-year Treatment|medication change by treating physician|3
2589777|NCT01145885|8956501|P1|Overall Study|Progressive Disease|7
2589778|NCT01145755|8956536|P3|Overall Study|Positive urine ethanol|0
2589779|NCT01145755|8956537|P2|Overall Study|Positive urine ethanol|1
2589780|NCT01145755|8956538|P1|Overall Study|Positive urine ethanol|0
2589781|NCT01145755|8956536|P3|Overall Study|Withdrawal by Subject|1
2589782|NCT01145755|8956537|P2|Overall Study|Withdrawal by Subject|0
2589783|NCT01145755|8956538|P1|Overall Study|Withdrawal by Subject|0
2589784|NCT01145755|8956536|P3|Overall Study|Patient could not swollow medication|1
2589785|NCT01145755|8956537|P2|Overall Study|Patient could not swollow medication|0
2589786|NCT01145755|8956538|P1|Overall Study|Patient could not swollow medication|0
2589787|NCT01145755|8956536|P3|Overall Study|Lack of Efficacy|0
2589788|NCT01145755|8956537|P2|Overall Study|Lack of Efficacy|1
2589789|NCT01145755|8956538|P1|Overall Study|Lack of Efficacy|0
2589790|NCT01145755|8956536|P3|Overall Study|Study Closure|17
2589791|NCT01145755|8956537|P2|Overall Study|Study Closure|14
2589792|NCT01145755|8956538|P1|Overall Study|Study Closure|14
2589793|NCT01145755|8956536|P3|Overall Study|Protocol Violation|1
2589794|NCT01145755|8956537|P2|Overall Study|Protocol Violation|3
2589795|NCT01145755|8956538|P1|Overall Study|Protocol Violation|0
2589796|NCT01145755|8956536|P3|Overall Study|Lost to Follow-up|1
2589797|NCT01145755|8956537|P2|Overall Study|Lost to Follow-up|3
2589798|NCT01145755|8956538|P1|Overall Study|Lost to Follow-up|2
2589799|NCT01145755|8956536|P3|Overall Study|Withdrawal by Subject|2
2589800|NCT01145755|8956537|P2|Overall Study|Withdrawal by Subject|2
2589801|NCT01145755|8956538|P1|Overall Study|Withdrawal by Subject|2
2589802|NCT01145755|8956536|P3|Overall Study|Adverse Event|2
2589803|NCT01145755|8956537|P2|Overall Study|Adverse Event|4
2589804|NCT01145755|8956538|P1|Overall Study|Adverse Event|2
2589805|NCT01145625|8956565|P2|Overall Study|Pregnancy|1
2589806|NCT01145625|8956566|P1|Overall Study|Pregnancy|0
2589807|NCT01145625|8956565|P2|Overall Study|Withdrawal by Subject|16
2589808|NCT01145625|8956566|P1|Overall Study|Withdrawal by Subject|7
2589809|NCT01145625|8956565|P2|Overall Study|Protocol Violation|1
2589810|NCT01145625|8956566|P1|Overall Study|Protocol Violation|3
2589811|NCT01145625|8956565|P2|Overall Study|Adverse Event|4
2589812|NCT01145625|8956566|P1|Overall Study|Adverse Event|6
2589813|NCT01145625|8956565|P2|Overall Study|Lost to Follow-up|9
2589814|NCT01145625|8956566|P1|Overall Study|Lost to Follow-up|8
2589815|NCT01145560|8956579|P3|Overall Study|Withdrawal of therapy|1
2589816|NCT01145560|8956580|P2|Overall Study|Withdrawal of therapy|0
2589817|NCT01145560|8956581|P1|Overall Study|Withdrawal of therapy|0
2589818|NCT01145560|8956579|P3|Overall Study|False insurance information|0
2589819|NCT01145560|8956580|P2|Overall Study|False insurance information|1
2589820|NCT01145560|8956581|P1|Overall Study|False insurance information|0
2589821|NCT01145560|8956579|P3|Overall Study|Accidental unblinding of study treatment|0
2589822|NCT01145560|8956580|P2|Overall Study|Accidental unblinding of study treatment|1
2589823|NCT01145560|8956581|P1|Overall Study|Accidental unblinding of study treatment|0
2589824|NCT01145560|8956579|P3|Overall Study|No study drug by 24h after organ failure|0
2589825|NCT01145560|8956580|P2|Overall Study|No study drug by 24h after organ failure|0
2589826|NCT01145560|8956581|P1|Overall Study|No study drug by 24h after organ failure|1
2589827|NCT01145560|8956579|P3|Overall Study|Lost to Follow-up|1
2589828|NCT01145560|8956580|P2|Overall Study|Lost to Follow-up|1
2589829|NCT01145560|8956581|P1|Overall Study|Lost to Follow-up|1
2589830|NCT01145560|8956579|P3|Overall Study|Withdrawal by Subject|0
2589831|NCT01145560|8956580|P2|Overall Study|Withdrawal by Subject|1
2589832|NCT01145560|8956581|P1|Overall Study|Withdrawal by Subject|2
2589833|NCT01145508|8956607|P2|Overall Study|Never started treatment|1
2589834|NCT01145508|8956608|P1|Overall Study|Never started treatment|1
2589835|NCT01145508|8956607|P2|Overall Study|Physician Decision|1
2589836|NCT01145508|8956608|P1|Overall Study|Physician Decision|2
2589837|NCT01145508|8956607|P2|Overall Study|Death|0
2589838|NCT01145508|8956608|P1|Overall Study|Death|1
2589839|NCT01145508|8956607|P2|Overall Study|Adverse Event|0
2589840|NCT01145508|8956608|P1|Overall Study|Adverse Event|1
2589841|NCT01145495|8956614|P1|Overall Study|Disease progression after respone|1
2589842|NCT01145495|8956614|P1|Overall Study|Withdrawal by Subject|5
2589843|NCT01145495|8956614|P1|Overall Study|Adverse Event|6
2589844|NCT01145482|8956620|P2|First Intervention (1 Day)|Withdrawal by Subject|1
2589845|NCT01145482|8956621|P1|First Intervention (1 Day)|Withdrawal by Subject|0
2589846|NCT01145417|8956631|P2|Overall Study|Other|0
2589847|NCT01145417|8956632|P1|Overall Study|Other|1
2589848|NCT01145417|8956631|P2|Overall Study|Study terminated by sponsor|43
2589849|NCT01145417|8956632|P1|Overall Study|Study terminated by sponsor|35
2589850|NCT01145417|8956631|P2|Overall Study|Adverse Event|1
2589851|NCT01145417|8956632|P1|Overall Study|Adverse Event|0
2589852|NCT01145417|8956631|P2|Overall Study|Pregnancy|0
2589853|NCT01145417|8956632|P1|Overall Study|Pregnancy|1
2589854|NCT01145417|8956631|P2|Overall Study|Withdrawal by Subject|2
2589855|NCT01145417|8956632|P1|Overall Study|Withdrawal by Subject|1
2589856|NCT01145417|8956631|P2|Overall Study|Lost to Follow-up|1
2589857|NCT01145417|8956632|P1|Overall Study|Lost to Follow-up|2
2589858|NCT01145417|8956631|P2|Overall Study|Death|0
2589859|NCT01145417|8956632|P1|Overall Study|Death|1
2589860|NCT01145352|8956665|P1|Overall Study|Syringe formulation was used|1
2589861|NCT01145352|8956665|P1|Overall Study|Treated before marketing approval|4
2589862|NCT01145352|8956665|P1|Overall Study|Found to have been registered twice|6
2589863|NCT01145222|8956677|P4|Overall Study|Poor bowel preparation|1
2589864|NCT01145222|8956678|P3|Overall Study|Poor bowel preparation|0
2589865|NCT01145222|8956679|P2|Overall Study|Poor bowel preparation|0
2589866|NCT01145222|8956680|P1|Overall Study|Poor bowel preparation|0
2589867|NCT01145222|8956677|P4|Overall Study|Procedure not done (no anesthesiologist)|0
2589868|NCT01145222|8956678|P3|Overall Study|Procedure not done (no anesthesiologist)|1
2589869|NCT01145222|8956679|P2|Overall Study|Procedure not done (no anesthesiologist)|0
2589870|NCT01145222|8956680|P1|Overall Study|Procedure not done (no anesthesiologist)|0
2589871|NCT01145066|8956727|P3|Overall Study|Low platelet count|0
2589872|NCT01145066|8956728|P2|Overall Study|Low platelet count|1
2589873|NCT01145066|8956729|P1|Overall Study|Low platelet count|0
2589874|NCT01145066|8956727|P3|Overall Study|Abdominal discomfort|0
2589875|NCT01145066|8956728|P2|Overall Study|Abdominal discomfort|1
2589876|NCT01145066|8956729|P1|Overall Study|Abdominal discomfort|0
2589877|NCT01145066|8956727|P3|Overall Study|problems swallowing capsule|0
2589878|NCT01145066|8956728|P2|Overall Study|problems swallowing capsule|0
2589879|NCT01145066|8956729|P1|Overall Study|problems swallowing capsule|1
2589880|NCT01145066|8956727|P3|Overall Study|To start new med|0
2589881|NCT01145066|8956728|P2|Overall Study|To start new med|0
2589882|NCT01145066|8956729|P1|Overall Study|To start new med|1
2589883|NCT01145066|8956727|P3|Overall Study|Withdrawal by Subject|2
2589884|NCT01145066|8956728|P2|Overall Study|Withdrawal by Subject|0
2589885|NCT01145066|8956729|P1|Overall Study|Withdrawal by Subject|0
2589886|NCT01145066|8956727|P3|Overall Study|Non-related surgery|1
2589887|NCT01145066|8956728|P2|Overall Study|Non-related surgery|0
2589888|NCT01145066|8956729|P1|Overall Study|Non-related surgery|0
2589889|NCT01145066|8956727|P3|Overall Study|To resume NSAIDs|1
2589890|NCT01145066|8956728|P2|Overall Study|To resume NSAIDs|2
2589891|NCT01145066|8956729|P1|Overall Study|To resume NSAIDs|2
2589892|NCT01145053|8956797|P1|Overall Study|Other|18
2589893|NCT01145053|8956797|P1|Overall Study|Withdrawal by Subject|25
2589894|NCT01145053|8956797|P1|Overall Study|Lost to Follow-up|28
2589895|NCT01145053|8956797|P1|Overall Study|Adverse Event|22
2589896|NCT01144715|8956849|P2|Overall Study|Adverse Event|1
2589897|NCT01144715|8956850|P1|Overall Study|Adverse Event|0
2589898|NCT01144715|8956849|P2|Overall Study|Withdrawal by Subject|1
2589899|NCT01144715|8956850|P1|Overall Study|Withdrawal by Subject|2
2589900|NCT01144715|8956849|P2|Overall Study|Lost to Follow-up|1
2589901|NCT01144715|8956850|P1|Overall Study|Lost to Follow-up|2
2589902|NCT01144663|8956866|P4|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0
2589903|NCT01144663|8956867|P3|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5
2589904|NCT01144663|8956868|P2|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6
2589905|NCT01144663|8956869|P1|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4
2589906|NCT01144663|8956866|P4|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0
2589907|NCT01144663|8956867|P3|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1
2589908|NCT01144663|8956868|P2|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3
2589909|NCT01144663|8956869|P1|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1
2589910|NCT01144663|8956866|P4|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1
2589911|NCT01144663|8956867|P3|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1
2589912|NCT01144663|8956868|P2|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0
2589913|NCT01144663|8956869|P1|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0
2589914|NCT01144663|8956866|P4|Booster Vaccination Phase|Lost to Follow-up|0
2589915|NCT01144663|8956867|P3|Booster Vaccination Phase|Lost to Follow-up|3
2589916|NCT01144663|8956868|P2|Booster Vaccination Phase|Lost to Follow-up|1
2589917|NCT01144663|8956869|P1|Booster Vaccination Phase|Lost to Follow-up|2
2589918|NCT01144663|8956866|P4|Booster Vaccination Phase|Migrated/moved from study area|0
2589919|NCT01144663|8956867|P3|Booster Vaccination Phase|Migrated/moved from study area|1
2589920|NCT01144663|8956868|P2|Booster Vaccination Phase|Migrated/moved from study area|1
2589921|NCT01144663|8956869|P1|Booster Vaccination Phase|Migrated/moved from study area|1
2589922|NCT01144663|8956866|P4|Booster Vaccination Phase|Withdrawal by Subject|1
2589923|NCT01144663|8956867|P3|Booster Vaccination Phase|Withdrawal by Subject|1
2589924|NCT01144663|8956868|P2|Booster Vaccination Phase|Withdrawal by Subject|0
2589925|NCT01144663|8956869|P1|Booster Vaccination Phase|Withdrawal by Subject|0
2589926|NCT01144663|8956866|P4|Primary Vaccination Phase|Other|2
2589927|NCT01144663|8956867|P3|Primary Vaccination Phase|Other|0
2589928|NCT01144663|8956868|P2|Primary Vaccination Phase|Other|1
2589929|NCT01144663|8956869|P1|Primary Vaccination Phase|Other|0
2589930|NCT01144663|8956866|P4|Primary Vaccination Phase|Lost to Follow-up|2
2589931|NCT01144663|8956867|P3|Primary Vaccination Phase|Lost to Follow-up|1
2589932|NCT01144663|8956868|P2|Primary Vaccination Phase|Lost to Follow-up|0
2589933|NCT01144663|8956869|P1|Primary Vaccination Phase|Lost to Follow-up|2
2589934|NCT01144663|8956866|P4|Primary Vaccination Phase|Migrated/moved from study area|3
2589935|NCT01144663|8956867|P3|Primary Vaccination Phase|Migrated/moved from study area|2
2589936|NCT01144663|8956868|P2|Primary Vaccination Phase|Migrated/moved from study area|1
2589937|NCT01144663|8956869|P1|Primary Vaccination Phase|Migrated/moved from study area|4
2589938|NCT01144663|8956866|P4|Primary Vaccination Phase|Withdrawal by Subject|10
2589939|NCT01144663|8956867|P3|Primary Vaccination Phase|Withdrawal by Subject|3
2589940|NCT01144663|8956868|P2|Primary Vaccination Phase|Withdrawal by Subject|5
2589941|NCT01144663|8956869|P1|Primary Vaccination Phase|Withdrawal by Subject|9
2589942|NCT01144663|8956866|P4|Primary Vaccination Phase|Protocol Violation|0
2589943|NCT01144663|8956867|P3|Primary Vaccination Phase|Protocol Violation|1
2589944|NCT01144663|8956868|P2|Primary Vaccination Phase|Protocol Violation|0
2589945|NCT01144663|8956869|P1|Primary Vaccination Phase|Protocol Violation|2
2589946|NCT01144663|8956866|P4|Primary Vaccination Phase|Adverse Event|1
2589947|NCT01144663|8956867|P3|Primary Vaccination Phase|Adverse Event|0
2589948|NCT01144663|8956868|P2|Primary Vaccination Phase|Adverse Event|0
2589949|NCT01144663|8956869|P1|Primary Vaccination Phase|Adverse Event|1
2589950|NCT01144663|8956866|P4|Primary Vaccination Phase|Serious adverse event, fatal|0
2589951|NCT01144663|8956867|P3|Primary Vaccination Phase|Serious adverse event, fatal|1
2589952|NCT01144663|8956868|P2|Primary Vaccination Phase|Serious adverse event, fatal|0
2589953|NCT01144663|8956869|P1|Primary Vaccination Phase|Serious adverse event, fatal|2
2589954|NCT01144416|8957207|P2|Intervention Period|Other|5
2589955|NCT01144416|8957208|P1|Intervention Period|Other|7
2589956|NCT01144416|8957207|P2|Intervention Period|No/too few/bad quality embryos|3
2589957|NCT01144416|8957208|P1|Intervention Period|No/too few/bad quality embryos|3
2589958|NCT01144416|8957207|P2|Intervention Period|No or abnormal fertilization|10
2589959|NCT01144416|8957208|P1|Intervention Period|No or abnormal fertilization|25
2589960|NCT01144416|8957207|P2|Intervention Period|No/too few/bad oocytes|5
2589961|NCT01144416|8957208|P1|Intervention Period|No/too few/bad oocytes|7
2589962|NCT01144416|8957207|P2|Intervention Period|Too high ovarian response|2
2589963|NCT01144416|8957208|P1|Intervention Period|Too high ovarian response|4
2589964|NCT01144416|8957207|P2|Intervention Period|Risk of OHSS|1
2589965|NCT01144416|8957208|P1|Intervention Period|Risk of OHSS|0
2589966|NCT01144416|8957207|P2|Intervention Period|Insufficient ovarian response|17
2589967|NCT01144416|8957208|P1|Intervention Period|Insufficient ovarian response|11
2589968|NCT01144416|8957207|P2|Intervention Period|Adverse Event|6
2589969|NCT01144416|8957208|P1|Intervention Period|Adverse Event|5
2589970|NCT01144403|8957224|P1|Overall Study|Adverse Event|1
2589971|NCT01144403|8957224|P1|Overall Study|Death|1
2589972|NCT01144403|8957224|P1|Overall Study|Lost to Follow-up|3
2589973|NCT01144377|8957236|P5|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
2589974|NCT01144377|8957237|P4|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
2589975|NCT01144377|8957238|P3|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
2589976|NCT01144377|8957239|P2|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
2589977|NCT01144377|8957240|P1|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1
2589978|NCT01144377|8957236|P5|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1
2589979|NCT01144377|8957237|P4|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
2589980|NCT01144377|8957238|P3|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
2589981|NCT01144377|8957239|P2|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
2589982|NCT01144377|8957240|P1|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
2589983|NCT01144377|8957236|P5|Optional 40 Week Safety Follow-up Period|Adverse Event|1
2589984|NCT01144377|8957237|P4|Optional 40 Week Safety Follow-up Period|Adverse Event|0
2589985|NCT01144377|8957238|P3|Optional 40 Week Safety Follow-up Period|Adverse Event|0
2589986|NCT01144377|8957239|P2|Optional 40 Week Safety Follow-up Period|Adverse Event|1
2589987|NCT01144377|8957240|P1|Optional 40 Week Safety Follow-up Period|Adverse Event|0
2589988|NCT01144377|8957236|P5|52 Week Treatment Period|Sponsor Decision|1
2589989|NCT01144377|8957237|P4|52 Week Treatment Period|Sponsor Decision|0
2589990|NCT01144377|8957238|P3|52 Week Treatment Period|Sponsor Decision|0
2589991|NCT01144377|8957239|P2|52 Week Treatment Period|Sponsor Decision|0
2589992|NCT01144377|8957240|P1|52 Week Treatment Period|Sponsor Decision|0
2589993|NCT01144377|8957236|P5|52 Week Treatment Period|Withdrawal by Subject|0
2589994|NCT01144377|8957237|P4|52 Week Treatment Period|Withdrawal by Subject|1
2589995|NCT01144377|8957238|P3|52 Week Treatment Period|Withdrawal by Subject|1
2589996|NCT01144377|8957239|P2|52 Week Treatment Period|Withdrawal by Subject|1
2589997|NCT01144377|8957240|P1|52 Week Treatment Period|Withdrawal by Subject|4
2589998|NCT01144377|8957236|P5|52 Week Treatment Period|Lost to Follow-up|0
2589999|NCT01144377|8957237|P4|52 Week Treatment Period|Lost to Follow-up|0
2590000|NCT01144377|8957238|P3|52 Week Treatment Period|Lost to Follow-up|0
2590001|NCT01144377|8957239|P2|52 Week Treatment Period|Lost to Follow-up|0
2590002|NCT01144377|8957240|P1|52 Week Treatment Period|Lost to Follow-up|1
2590003|NCT01144377|8957236|P5|52 Week Treatment Period|Protocol Violation|1
2590004|NCT01144377|8957237|P4|52 Week Treatment Period|Protocol Violation|0
2590005|NCT01144377|8957238|P3|52 Week Treatment Period|Protocol Violation|0
2590006|NCT01144377|8957239|P2|52 Week Treatment Period|Protocol Violation|0
2590007|NCT01144377|8957240|P1|52 Week Treatment Period|Protocol Violation|0
2590008|NCT01144377|8957236|P5|52 Week Treatment Period|Entry Criteria Not Met|0
2590009|NCT01144377|8957237|P4|52 Week Treatment Period|Entry Criteria Not Met|1
2590010|NCT01144377|8957238|P3|52 Week Treatment Period|Entry Criteria Not Met|1
2590011|NCT01144377|8957239|P2|52 Week Treatment Period|Entry Criteria Not Met|0
2590012|NCT01144377|8957240|P1|52 Week Treatment Period|Entry Criteria Not Met|0
2590013|NCT01144377|8957236|P5|52 Week Treatment Period|Adverse Event|1
2590014|NCT01144377|8957237|P4|52 Week Treatment Period|Adverse Event|2
2590015|NCT01144377|8957238|P3|52 Week Treatment Period|Adverse Event|3
2590016|NCT01144377|8957239|P2|52 Week Treatment Period|Adverse Event|0
2590017|NCT01144377|8957240|P1|52 Week Treatment Period|Adverse Event|0
2590018|NCT01144364|8957289|P3|Follow-Up/Maintenance Phase|Physician Decision|1
2590019|NCT01144364|8957290|P2|Follow-Up/Maintenance Phase|Physician Decision|0
2590020|NCT01144364|8957291|P1|Follow-Up/Maintenance Phase|Physician Decision|0
2590021|NCT01144364|8957289|P3|Follow-Up/Maintenance Phase|Relapse|5
2590022|NCT01144364|8957290|P2|Follow-Up/Maintenance Phase|Relapse|5
2590023|NCT01144364|8957291|P1|Follow-Up/Maintenance Phase|Relapse|0
2590024|NCT01144364|8957289|P3|Follow-Up/Maintenance Phase|Lost to Follow-up|4
2590025|NCT01144364|8957290|P2|Follow-Up/Maintenance Phase|Lost to Follow-up|1
2590026|NCT01144364|8957291|P1|Follow-Up/Maintenance Phase|Lost to Follow-up|0
2590027|NCT01144364|8957289|P3|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
2590028|NCT01144364|8957290|P2|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
2590029|NCT01144364|8957291|P1|Follow-Up/Maintenance Phase|Withdrawal by Subject|0
2590030|NCT01144364|8957289|P3|Follow-Up/Maintenance Phase|Death|0
2590031|NCT01144364|8957290|P2|Follow-Up/Maintenance Phase|Death|2
2590032|NCT01144364|8957291|P1|Follow-Up/Maintenance Phase|Death|0
2590033|NCT01144364|8957289|P3|Follow-Up/Maintenance Phase|Adverse Event|1
2590034|NCT01144364|8957290|P2|Follow-Up/Maintenance Phase|Adverse Event|3
2590035|NCT01144364|8957291|P1|Follow-Up/Maintenance Phase|Adverse Event|0
2590036|NCT01144364|8957289|P3|Follow-Up/Maintenance Phase|Disease progression|29
2590037|NCT01144364|8957290|P2|Follow-Up/Maintenance Phase|Disease progression|23
2590038|NCT01144364|8957291|P1|Follow-Up/Maintenance Phase|Disease progression|0
2590039|NCT01144364|8957289|P3|Induction Phase|Protocol Violation|0
2590040|NCT01144364|8957290|P2|Induction Phase|Protocol Violation|0
2590041|NCT01144364|8957291|P1|Induction Phase|Protocol Violation|1
2590042|NCT01144364|8957289|P3|Induction Phase|Secondary neoplasia|0
2590043|NCT01144364|8957290|P2|Induction Phase|Secondary neoplasia|0
2590044|NCT01144364|8957291|P1|Induction Phase|Secondary neoplasia|1
2590045|NCT01144364|8957289|P3|Induction Phase|Stable disease|0
2590046|NCT01144364|8957290|P2|Induction Phase|Stable disease|0
2590047|NCT01144364|8957291|P1|Induction Phase|Stable disease|2
2590048|NCT01144364|8957289|P3|Induction Phase|Physician Decision|0
2590049|NCT01144364|8957290|P2|Induction Phase|Physician Decision|0
2590050|NCT01144364|8957291|P1|Induction Phase|Physician Decision|1
2590051|NCT01144364|8957289|P3|Induction Phase|Lost to Follow-up|0
2590052|NCT01144364|8957290|P2|Induction Phase|Lost to Follow-up|0
2590053|NCT01144364|8957291|P1|Induction Phase|Lost to Follow-up|2
2590054|NCT01144364|8957289|P3|Induction Phase|Withdrawal by Subject|0
2590055|NCT01144364|8957290|P2|Induction Phase|Withdrawal by Subject|0
2590056|NCT01144364|8957291|P1|Induction Phase|Withdrawal by Subject|1
2590057|NCT01144364|8957289|P3|Induction Phase|Death|0
2590058|NCT01144364|8957290|P2|Induction Phase|Death|0
2590059|NCT01144364|8957291|P1|Induction Phase|Death|1
2590060|NCT01144364|8957289|P3|Induction Phase|Adverse Event|0
2590061|NCT01144364|8957290|P2|Induction Phase|Adverse Event|0
2590062|NCT01144364|8957291|P1|Induction Phase|Adverse Event|9
2590063|NCT01144364|8957289|P3|Induction Phase|Disease progression|0
2590064|NCT01144364|8957290|P2|Induction Phase|Disease progression|0
2590065|NCT01144364|8957291|P1|Induction Phase|Disease progression|14
2590066|NCT01144299|8957340|P2|Overall Study|Withdrawal by Subject|0
2590067|NCT01144299|8957341|P1|Overall Study|Withdrawal by Subject|1
2590068|NCT01144299|8957340|P2|Overall Study|Lost to Follow-up|0
2590069|NCT01144299|8957341|P1|Overall Study|Lost to Follow-up|1
2590070|NCT01144182|8957386|P2|Overall Study|Lost to Follow-up|9
2590071|NCT01144182|8957387|P1|Overall Study|Lost to Follow-up|9
2590072|NCT01144182|8957386|P2|Overall Study|Withdrawal by Subject|6
2590073|NCT01144182|8957387|P1|Overall Study|Withdrawal by Subject|3
2590074|NCT01144182|8957386|P2|Overall Study|Death|6
2590075|NCT01144182|8957387|P1|Overall Study|Death|5
2590076|NCT01144052|8957447|P2|Overall Study|Withdrawal by Subject|1
2590077|NCT01144052|8957448|P1|Overall Study|Withdrawal by Subject|1
2590078|NCT01143896|8957479|P2|Overall Study|Death|3
2590079|NCT01143896|8957480|P1|Overall Study|Death|6
2590080|NCT01143896|8957479|P2|Overall Study|Withdrawal by Subject|5
2590081|NCT01143896|8957480|P1|Overall Study|Withdrawal by Subject|13
2590082|NCT01143896|8957479|P2|Overall Study|Lost to Follow-up|13
2590083|NCT01143896|8957480|P1|Overall Study|Lost to Follow-up|18
2590084|NCT01143896|8957479|P2|Overall Study|Did not complete Baseline Interview|4
2590085|NCT01143896|8957480|P1|Overall Study|Did not complete Baseline Interview|5
2590086|NCT01143714|8957592|P2|Overall Study|wound size increased|0
2590087|NCT01143714|8957593|P1|Overall Study|wound size increased|1
2590088|NCT01143714|8957592|P2|Overall Study|wound closed = deemed healed|0
2590089|NCT01143714|8957593|P1|Overall Study|wound closed = deemed healed|1
2590090|NCT01143714|8957592|P2|Overall Study|Subject non-compliance|1
2590091|NCT01143714|8957593|P1|Overall Study|Subject non-compliance|0
2590092|NCT01143714|8957592|P2|Overall Study|Withdrawal by Subject|0
2590093|NCT01143714|8957593|P1|Overall Study|Withdrawal by Subject|1
2590094|NCT01143714|8957592|P2|Overall Study|Adverse Event|2
2590095|NCT01143714|8957593|P1|Overall Study|Adverse Event|4
2590096|NCT01143402|8957698|P3|Overall Study|Not Treated|1
2590097|NCT01143402|8957699|P2|Overall Study|Not Treated|0
2590098|NCT01143402|8957700|P1|Overall Study|Not Treated|0
2590099|NCT01143402|8957698|P3|Overall Study|Rapid clinical decline|0
2590100|NCT01143402|8957699|P2|Overall Study|Rapid clinical decline|1
2590101|NCT01143402|8957700|P1|Overall Study|Rapid clinical decline|1
2590102|NCT01143389|8957711|P2|Overall Study|Lost to Follow-up|25
2590103|NCT01143389|8957712|P1|Overall Study|Lost to Follow-up|26
2590104|NCT01143337|8957726|P3|Overall Study|Other reason|5
2590105|NCT01143337|8957727|P2|Overall Study|Other reason|0
2590106|NCT01143337|8957728|P1|Overall Study|Other reason|0
2590107|NCT01143337|8957726|P3|Overall Study|Withdrawal by Subject|1
2590108|NCT01143337|8957727|P2|Overall Study|Withdrawal by Subject|0
2590109|NCT01143337|8957728|P1|Overall Study|Withdrawal by Subject|0
2590110|NCT01143337|8957726|P3|Overall Study|Protocol Violation|0
2590111|NCT01143337|8957727|P2|Overall Study|Protocol Violation|0
2590112|NCT01143337|8957728|P1|Overall Study|Protocol Violation|1
2590113|NCT01143337|8957726|P3|Overall Study|Lack of Efficacy|1
2590114|NCT01143337|8957727|P2|Overall Study|Lack of Efficacy|2
2590115|NCT01143337|8957728|P1|Overall Study|Lack of Efficacy|6
2590116|NCT01143337|8957726|P3|Overall Study|Adverse Event|5
2590117|NCT01143337|8957727|P2|Overall Study|Adverse Event|9
2590118|NCT01143337|8957728|P1|Overall Study|Adverse Event|3
2590119|NCT01143324|8957742|P1|Overall Study|Explant of the device|4
2590120|NCT01143324|8957742|P1|Overall Study|Withdrawal by Subject|4
2590121|NCT01143324|8957742|P1|Overall Study|Lost to Follow-up|11
2590122|NCT01143259|8957781|P2|Overall Study|Screen Failure|9
2590123|NCT01143259|8957782|P1|Overall Study|Screen Failure|7
2590124|NCT01143259|8957781|P2|Overall Study|Protocol Violation|9
2590125|NCT01143259|8957782|P1|Overall Study|Protocol Violation|13
2590126|NCT01143259|8957781|P2|Overall Study|Withdrawal by Subject|2
2590127|NCT01143259|8957782|P1|Overall Study|Withdrawal by Subject|3
2590128|NCT01143207|8957790|P1|Overall Study|Lost to Follow-up|2
2590129|NCT01143090|8957810|P1|Overall Study|Administrative|1
2590130|NCT01143090|8957810|P1|Overall Study|Failure to meet eligibility criteria|1
2590131|NCT01143090|8957810|P1|Overall Study|Non-compliance with study drug|1
2590132|NCT01143090|8957810|P1|Overall Study|Withdrawal by Subject|18
2590133|NCT01143090|8957810|P1|Overall Study|Protocol Violation|2
2590134|NCT01143090|8957810|P1|Overall Study|Lost to Follow-up|9
2590135|NCT01143090|8957810|P1|Overall Study|Adverse Event|17
2590136|NCT01143090|8957810|P1|Overall Study|Lack of Efficacy|2
2590137|NCT01143077|8957817|P3|Overall Study|Principal Investigator Decision|1
2590138|NCT01143077|8957818|P2|Overall Study|Principal Investigator Decision|0
2590139|NCT01143077|8957819|P1|Overall Study|Principal Investigator Decision|2
2590140|NCT01143077|8957817|P3|Overall Study|Administrative|0
2590141|NCT01143077|8957818|P2|Overall Study|Administrative|0
2590142|NCT01143077|8957819|P1|Overall Study|Administrative|1
2590143|NCT01143077|8957817|P3|Overall Study|Non-compliance with study drug|1
2590144|NCT01143077|8957818|P2|Overall Study|Non-compliance with study drug|1
2590145|NCT01143077|8957819|P1|Overall Study|Non-compliance with study drug|0
2590146|NCT01143077|8957817|P3|Overall Study|Withdrawal by Subject|3
2590147|NCT01143077|8957818|P2|Overall Study|Withdrawal by Subject|3
2590148|NCT01143077|8957819|P1|Overall Study|Withdrawal by Subject|4
2590149|NCT01143077|8957817|P3|Overall Study|Protocol Violation|0
2590150|NCT01143077|8957818|P2|Overall Study|Protocol Violation|0
2590151|NCT01143077|8957819|P1|Overall Study|Protocol Violation|2
2590152|NCT01143077|8957817|P3|Overall Study|Lost to Follow-up|4
2590153|NCT01143077|8957818|P2|Overall Study|Lost to Follow-up|3
2590154|NCT01143077|8957819|P1|Overall Study|Lost to Follow-up|2
2590155|NCT01143077|8957817|P3|Overall Study|Adverse Event|5
2590156|NCT01143077|8957818|P2|Overall Study|Adverse Event|6
2590157|NCT01143077|8957819|P1|Overall Study|Adverse Event|5
2590158|NCT01143077|8957817|P3|Overall Study|Lack of Efficacy|1
2590159|NCT01143077|8957818|P2|Overall Study|Lack of Efficacy|2
2590160|NCT01143077|8957819|P1|Overall Study|Lack of Efficacy|0
2590161|NCT01143051|8957836|P6|3-14 Day Washout|Withdrawal by Subject|1
2590162|NCT01143051|8957837|P5|3-14 Day Washout|Withdrawal by Subject|0
2590163|NCT01143051|8957838|P4|3-14 Day Washout|Withdrawal by Subject|0
2590164|NCT01143051|8957839|P3|3-14 Day Washout|Withdrawal by Subject|0
2590165|NCT01143051|8957840|P2|3-14 Day Washout|Withdrawal by Subject|0
2590166|NCT01143051|8957841|P1|3-14 Day Washout|Withdrawal by Subject|0
2590167|NCT01143051|8957836|P6|3-14 Day Washout|Withdrawal by Subject|0
2590168|NCT01143051|8957837|P5|3-14 Day Washout|Withdrawal by Subject|0
2590169|NCT01143051|8957838|P4|3-14 Day Washout|Withdrawal by Subject|0
2590170|NCT01143051|8957839|P3|3-14 Day Washout|Withdrawal by Subject|1
2590171|NCT01143051|8957840|P2|3-14 Day Washout|Withdrawal by Subject|0
2590172|NCT01143051|8957841|P1|3-14 Day Washout|Withdrawal by Subject|0
2590173|NCT01143038|8957890|P1|Overall Study|Death|1
2590174|NCT01143038|8957890|P1|Overall Study|Protocol Deviation|1
2590175|NCT01143038|8957890|P1|Overall Study|Lost to Follow-up|2
2590176|NCT01143038|8957890|P1|Overall Study|Adverse Event|3
2590177|NCT01143038|8957890|P1|Overall Study|Requirement for alternative therapy|5
2590178|NCT01143038|8957890|P1|Overall Study|Withdrawal by Subject|4
2590179|NCT01142908|8957904|P2|Overall Study|Withdrawal by Subject|0
2590180|NCT01142908|8957905|P1|Overall Study|Withdrawal by Subject|3
2590181|NCT01142908|8957904|P2|Overall Study|Excluded - did not meet criteria|5
2590182|NCT01142908|8957905|P1|Overall Study|Excluded - did not meet criteria|9
2590183|NCT01142908|8957904|P2|Overall Study|Death|4
2590184|NCT01142908|8957905|P1|Overall Study|Death|1
2590185|NCT01142908|8957904|P2|Overall Study|Lost to Follow-up|13
2590186|NCT01142908|8957905|P1|Overall Study|Lost to Follow-up|19
2590187|NCT01142791|8957951|P2|Overall Study|Received only 1 sonication|6
2590188|NCT01142791|8957952|P1|Overall Study|Received only 1 sonication|0
2590189|NCT01142791|8957951|P2|Overall Study|Withdrawal by Subject|0
2590190|NCT01142791|8957952|P1|Overall Study|Withdrawal by Subject|5
2590191|NCT01142791|8957951|P2|Overall Study|Lost to Follow-up|0
2590192|NCT01142791|8957952|P1|Overall Study|Lost to Follow-up|1
2590193|NCT01142791|8957951|P2|Overall Study|Alternative Treatment|0
2590194|NCT01142791|8957952|P1|Overall Study|Alternative Treatment|1
2590195|NCT01142726|8957959|P3|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
2590196|NCT01142726|8957960|P2|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1
2590197|NCT01142726|8957961|P1|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
2590198|NCT01142726|8957959|P3|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1
2590199|NCT01142726|8957960|P2|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
2590200|NCT01142726|8957961|P1|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
2590201|NCT01142726|8957959|P3|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
2590202|NCT01142726|8957960|P2|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
2590203|NCT01142726|8957961|P1|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
2590204|NCT01142726|8957959|P3|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1
2590205|NCT01142726|8957960|P2|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
2590206|NCT01142726|8957961|P1|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
2590207|NCT01142726|8957959|P3|Withdrawal Phase: Months 12 up to 24|non-specified|1
2590208|NCT01142726|8957960|P2|Withdrawal Phase: Months 12 up to 24|non-specified|1
2590209|NCT01142726|8957961|P1|Withdrawal Phase: Months 12 up to 24|non-specified|0
2590210|NCT01142726|8957959|P3|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53
2590211|NCT01142726|8957960|P2|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54
2590212|NCT01142726|8957961|P1|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65
2590213|NCT01142726|8957959|P3|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
2590214|NCT01142726|8957960|P2|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
2590215|NCT01142726|8957961|P1|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1
2590216|NCT01142726|8957959|P3|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
2590217|NCT01142726|8957960|P2|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
2590218|NCT01142726|8957961|P1|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2
2590219|NCT01142726|8957959|P3|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
2590220|NCT01142726|8957960|P2|Withdrawal Phase: Months 12 up to 24|Pregnancy|0
2590221|NCT01142726|8957961|P1|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
2590222|NCT01142726|8957959|P3|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2
2590306|NCT01142232|8958157|P4|Overall Study|Disease Progression|2
2590223|NCT01142726|8957960|P2|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
2590224|NCT01142726|8957961|P1|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
2590225|NCT01142726|8957959|P3|Withdrawal Phase: Months 12 up to 24|Adverse Event|1
2590226|NCT01142726|8957960|P2|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
2590227|NCT01142726|8957961|P1|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
2590228|NCT01142726|8957959|P3|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11
2590229|NCT01142726|8957960|P2|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6
2590230|NCT01142726|8957961|P1|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5
2590231|NCT01142726|8957959|P3|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
2590232|NCT01142726|8957960|P2|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
2590233|NCT01142726|8957961|P1|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1
2590234|NCT01142726|8957959|P3|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
2590235|NCT01142726|8957960|P2|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2
2590236|NCT01142726|8957961|P1|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
2590237|NCT01142726|8957959|P3|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3
2590238|NCT01142726|8957960|P2|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9
2590239|NCT01142726|8957961|P1|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4
2590240|NCT01142726|8957959|P3|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
2590241|NCT01142726|8957960|P2|Treatment Phase: Day 1 Through Month 12|Adverse Event|8
2590242|NCT01142726|8957961|P1|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
2590243|NCT01142661|8958024|P1|Overall Study|Physician Decision|1
2590244|NCT01142661|8958024|P1|Overall Study|Withdrawal by Subject|1
2590245|NCT01142661|8958024|P1|Overall Study|Adverse Event|2
2590246|NCT01142596|8958031|P2|Overall Study|Other reason (not specified)|4
2590247|NCT01142596|8958032|P1|Overall Study|Other reason (not specified)|5
2590248|NCT01142596|8958031|P2|Overall Study|Lost to Follow-up|3
2590249|NCT01142596|8958032|P1|Overall Study|Lost to Follow-up|2
2590250|NCT01142596|8958031|P2|Overall Study|Lack of Efficacy|9
2590251|NCT01142596|8958032|P1|Overall Study|Lack of Efficacy|5
2590252|NCT01142596|8958031|P2|Overall Study|Adverse Event|35
2590253|NCT01142596|8958032|P1|Overall Study|Adverse Event|8
2590254|NCT01142596|8958031|P2|Overall Study|Withdrawal by Subject|35
2590255|NCT01142596|8958032|P1|Overall Study|Withdrawal by Subject|9
2590256|NCT01142466|8958084|P2|Overall Study|Withdrawal by Subject|1
2590257|NCT01142466|8958085|P1|Overall Study|Withdrawal by Subject|1
2590258|NCT01142466|8958084|P2|Overall Study|Adverse Event|1
2590259|NCT01142466|8958085|P1|Overall Study|Adverse Event|2
2590260|NCT01142388|8958105|P2|Overall Study|Never started therapy|3
2590261|NCT01142388|8958106|P1|Overall Study|Never started therapy|7
2590262|NCT01142388|8958105|P2|Overall Study|Other|1
2590263|NCT01142388|8958106|P1|Overall Study|Other|1
2590264|NCT01142388|8958105|P2|Overall Study|Other complications|2
2590265|NCT01142388|8958106|P1|Overall Study|Other complications|0
2590266|NCT01142388|8958105|P2|Overall Study|Alternative therapy|0
2590267|NCT01142388|8958106|P1|Overall Study|Alternative therapy|1
2590268|NCT01142388|8958105|P2|Overall Study|Withdrawal by Subject|3
2590269|NCT01142388|8958106|P1|Overall Study|Withdrawal by Subject|5
2590270|NCT01142388|8958105|P2|Overall Study|Death|2
2590271|NCT01142388|8958106|P1|Overall Study|Death|3
2590272|NCT01142388|8958105|P2|Overall Study|Adverse Event|5
2590273|NCT01142388|8958106|P1|Overall Study|Adverse Event|9
2590274|NCT01142388|8958105|P2|Overall Study|Lack of Efficacy|31
2590275|NCT01142388|8958106|P1|Overall Study|Lack of Efficacy|21
2590276|NCT01142336|8958118|P2|Overall Study|Lost to Follow-up|1
2590277|NCT01142336|8958119|P1|Overall Study|Lost to Follow-up|0
2590278|NCT01142336|8958118|P2|Overall Study|Adverse Event|1
2590279|NCT01142336|8958119|P1|Overall Study|Adverse Event|1
2590280|NCT01142232|8958156|P5|Overall Study|Noncompliance|2
2590281|NCT01142232|8958157|P4|Overall Study|Noncompliance|0
2590282|NCT01142232|8958158|P3|Overall Study|Noncompliance|0
2590283|NCT01142232|8958159|P2|Overall Study|Noncompliance|0
2590284|NCT01142232|8958160|P1|Overall Study|Noncompliance|0
2590285|NCT01142232|8958156|P5|Overall Study|Off Trt for other complicating disease|1
2590286|NCT01142232|8958157|P4|Overall Study|Off Trt for other complicating disease|0
2590287|NCT01142232|8958158|P3|Overall Study|Off Trt for other complicating disease|0
2590288|NCT01142232|8958159|P2|Overall Study|Off Trt for other complicating disease|0
2590289|NCT01142232|8958160|P1|Overall Study|Off Trt for other complicating disease|0
2590290|NCT01142232|8958156|P5|Overall Study|Alternative Therapy|1
2590291|NCT01142232|8958157|P4|Overall Study|Alternative Therapy|0
2590292|NCT01142232|8958158|P3|Overall Study|Alternative Therapy|1
2590293|NCT01142232|8958159|P2|Overall Study|Alternative Therapy|1
2590294|NCT01142232|8958160|P1|Overall Study|Alternative Therapy|0
2590295|NCT01142232|8958156|P5|Overall Study|Physician Decision|10
2590296|NCT01142232|8958157|P4|Overall Study|Physician Decision|2
2590297|NCT01142232|8958158|P3|Overall Study|Physician Decision|0
2590298|NCT01142232|8958159|P2|Overall Study|Physician Decision|1
2590299|NCT01142232|8958160|P1|Overall Study|Physician Decision|0
2590300|NCT01142232|8958156|P5|Overall Study|Withdrawal by Subject|3
2590301|NCT01142232|8958157|P4|Overall Study|Withdrawal by Subject|1
2590302|NCT01142232|8958158|P3|Overall Study|Withdrawal by Subject|0
2590303|NCT01142232|8958159|P2|Overall Study|Withdrawal by Subject|0
2590304|NCT01142232|8958160|P1|Overall Study|Withdrawal by Subject|0
2590305|NCT01142232|8958156|P5|Overall Study|Disease Progression|12
2590307|NCT01142232|8958158|P3|Overall Study|Disease Progression|1
2590308|NCT01142232|8958159|P2|Overall Study|Disease Progression|0
2590309|NCT01142232|8958160|P1|Overall Study|Disease Progression|2
2590310|NCT01142232|8958156|P5|Overall Study|Death|1
2590311|NCT01142232|8958157|P4|Overall Study|Death|0
2590312|NCT01142232|8958158|P3|Overall Study|Death|0
2590313|NCT01142232|8958159|P2|Overall Study|Death|0
2590314|NCT01142232|8958160|P1|Overall Study|Death|0
2590315|NCT01142232|8958156|P5|Overall Study|Adverse Event|4
2590316|NCT01142232|8958157|P4|Overall Study|Adverse Event|0
2590317|NCT01142232|8958158|P3|Overall Study|Adverse Event|1
2590318|NCT01142232|8958159|P2|Overall Study|Adverse Event|2
2590319|NCT01142232|8958160|P1|Overall Study|Adverse Event|1
2590320|NCT01142193|8958175|P2|Overall Study|Other|2
2590321|NCT01142193|8958176|P1|Overall Study|Other|1
2590322|NCT01142193|8958175|P2|Overall Study|Protocol Discontinuation Criterion Met|0
2590323|NCT01142193|8958176|P1|Overall Study|Protocol Discontinuation Criterion Met|1
2590324|NCT01142193|8958175|P2|Overall Study|Withdrawal by Subject|3
2590325|NCT01142193|8958176|P1|Overall Study|Withdrawal by Subject|4
2590326|NCT01142193|8958175|P2|Overall Study|Physician Decision|1
2590327|NCT01142193|8958176|P1|Overall Study|Physician Decision|1
2590328|NCT01142193|8958175|P2|Overall Study|Lack of Efficacy|1
2590329|NCT01142193|8958176|P1|Overall Study|Lack of Efficacy|2
2590330|NCT01142193|8958175|P2|Overall Study|Adverse Event|4
2590331|NCT01142193|8958176|P1|Overall Study|Adverse Event|12
2590332|NCT01142128|8958204|P1|Overall Study|Withdrawal by Subject|2
2590333|NCT01142128|8958204|P1|Overall Study|Lost to Follow-up|1
2590334|NCT01142128|8958204|P1|Overall Study|Physician Decision|1
2590335|NCT01142115|8958214|P2|First Intervention|Adverse Event|0
2590336|NCT01142115|8958215|P1|First Intervention|Adverse Event|1
2590337|NCT01142115|8958214|P2|First Intervention|Lack of Efficacy|1
2590338|NCT01142115|8958215|P1|First Intervention|Lack of Efficacy|1
2590339|NCT01142089|8958232|P2|Overall Study|Patient required rescue medication|17
2590340|NCT01142089|8958233|P1|Overall Study|Patient required rescue medication|8
2590341|NCT01142089|8958232|P2|Overall Study|Noncompliance with study procedures|1
2590342|NCT01142089|8958233|P1|Overall Study|Noncompliance with study procedures|2
2590343|NCT01142089|8958232|P2|Overall Study|Use of prohibited medications|1
2590344|NCT01142089|8958233|P1|Overall Study|Use of prohibited medications|0
2590345|NCT01142089|8958232|P2|Overall Study|Withdrawal by Subject|2
2590346|NCT01142089|8958233|P1|Overall Study|Withdrawal by Subject|1
2590347|NCT01142089|8958232|P2|Overall Study|Physician Decision|0
2590348|NCT01142089|8958233|P1|Overall Study|Physician Decision|1
2590349|NCT01141712|8958264|P1|Overall Study|Disease progression|3
2590350|NCT01141660|8958285|P2|Overall Study|Physician Decision|12
2590351|NCT01141660|8958286|P1|Overall Study|Physician Decision|0
2590352|NCT01141283|8958354|P1|Overall Study|Lack of Efficacy|10
2590353|NCT01141283|8958354|P1|Overall Study|Administrative|4
2590354|NCT01141283|8958354|P1|Overall Study|Withdrawal by Subject|14
2590355|NCT01141283|8958354|P1|Overall Study|Lost to Follow-up|4
2590356|NCT01141283|8958354|P1|Overall Study|Adverse Event|56
2590357|NCT01141205|8958360|P2|Overall Study|Withdrawal by Subject|1
2590358|NCT01141205|8958361|P1|Overall Study|Withdrawal by Subject|1
2590359|NCT01141205|8958360|P2|Overall Study|Lost to Follow-up|0
2590360|NCT01141205|8958361|P1|Overall Study|Lost to Follow-up|1
2590361|NCT01141205|8958360|P2|Overall Study|Physician Decision|1
2590362|NCT01141205|8958361|P1|Overall Study|Physician Decision|1
2590363|NCT01140906|8958388|P4|Overall Study|Administrative or other reason|2
2590364|NCT01140906|8958389|P3|Overall Study|Administrative or other reason|3
2590365|NCT01140906|8958390|P2|Overall Study|Administrative or other reason|5
2590366|NCT01140906|8958391|P1|Overall Study|Administrative or other reason|0
2590367|NCT01140906|8958388|P4|Overall Study|Lost to Follow-up|2
2590368|NCT01140906|8958389|P3|Overall Study|Lost to Follow-up|0
2590369|NCT01140906|8958390|P2|Overall Study|Lost to Follow-up|1
2590370|NCT01140906|8958391|P1|Overall Study|Lost to Follow-up|1
2590371|NCT01140906|8958388|P4|Overall Study|Withdrawal of consent|2
2590372|NCT01140906|8958389|P3|Overall Study|Withdrawal of consent|2
2590373|NCT01140906|8958390|P2|Overall Study|Withdrawal of consent|6
2590374|NCT01140906|8958391|P1|Overall Study|Withdrawal of consent|6
2590375|NCT01140906|8958388|P4|Overall Study|Protocol Violation|1
2590376|NCT01140906|8958389|P3|Overall Study|Protocol Violation|2
2590377|NCT01140906|8958390|P2|Overall Study|Protocol Violation|3
2590378|NCT01140906|8958391|P1|Overall Study|Protocol Violation|5
2590379|NCT01140906|8958388|P4|Overall Study|Non-compliance|1
2590380|NCT01140906|8958389|P3|Overall Study|Non-compliance|0
2590381|NCT01140906|8958390|P2|Overall Study|Non-compliance|1
2590382|NCT01140906|8958391|P1|Overall Study|Non-compliance|0
2590383|NCT01140906|8958388|P4|Overall Study|Lack of Efficacy|1
2590384|NCT01140906|8958389|P3|Overall Study|Lack of Efficacy|2
2590385|NCT01140906|8958390|P2|Overall Study|Lack of Efficacy|8
2590386|NCT01140906|8958391|P1|Overall Study|Lack of Efficacy|6
2590387|NCT01140906|8958388|P4|Overall Study|Adverse Event|7
2590388|NCT01140906|8958389|P3|Overall Study|Adverse Event|17
2590389|NCT01140906|8958390|P2|Overall Study|Adverse Event|10
2590390|NCT01140906|8958391|P1|Overall Study|Adverse Event|7
2590391|NCT01140880|8958431|P2|Overall Study|Protocol Violation|30
2590392|NCT01140880|8958432|P1|Overall Study|Protocol Violation|0
2590393|NCT01140880|8958431|P2|Overall Study|Lost to Follow-up|10
2590394|NCT01140880|8958432|P1|Overall Study|Lost to Follow-up|8
2590395|NCT01140880|8958431|P2|Overall Study|Withdrawal by Subject|3
2590396|NCT01140880|8958432|P1|Overall Study|Withdrawal by Subject|6
2590397|NCT01140880|8958431|P2|Overall Study|Death|1
2590398|NCT01140880|8958432|P1|Overall Study|Death|0
2590399|NCT01140867|8958444|P1|Overall Study|Medication Noncompliance|2
2590400|NCT01140867|8958444|P1|Overall Study|Uncooperative patient|2
2590401|NCT01140867|8958444|P1|Overall Study|Protocol Violation|1
2590402|NCT01140867|8958444|P1|Overall Study|Withdrawal by Subject|1
2590403|NCT01140867|8958444|P1|Overall Study|Lost to Follow-up|2
2590404|NCT01140867|8958444|P1|Overall Study|Lack of Efficacy|3
2590405|NCT01140867|8958444|P1|Overall Study|Adverse Event|22
2590406|NCT01140646|8958484|P1|Overall Study|Refused Further Treatment|5
2590407|NCT01140646|8958484|P1|Overall Study|Adverse Event|4
2590408|NCT01140568|8958492|P1|Overall Study|Withdrawal by Subject|2
2590409|NCT01140568|8958492|P1|Overall Study|disease progression|34
2590410|NCT01140503|8958497|P1|Overall Study|Withdrawal by Subject|1
2590411|NCT01140477|8958505|P2|Overall Study|Subject explanted|1
2590412|NCT01140477|8958506|P1|Overall Study|Subject explanted|0
2590413|NCT01140477|8958505|P2|Overall Study|Death|1
2590414|NCT01140477|8958506|P1|Overall Study|Death|1
2590415|NCT01140477|8958505|P2|Overall Study|Surgical complication preventing implant|0
2590416|NCT01140477|8958506|P1|Overall Study|Surgical complication preventing implant|2
2590417|NCT01140477|8958505|P2|Overall Study|Withdrawal by Subject|4
2590418|NCT01140477|8958506|P1|Overall Study|Withdrawal by Subject|1
2590419|NCT01140477|8958505|P2|Overall Study|Lost to Follow-up|0
2590420|NCT01140477|8958506|P1|Overall Study|Lost to Follow-up|4
2590421|NCT01140347|8958521|P2|Overall Study|Withdrawal by Subject|8
2590422|NCT01140347|8958522|P1|Overall Study|Withdrawal by Subject|13
2590423|NCT01140347|8958521|P2|Overall Study|Lost to Follow-up|6
2590424|NCT01140347|8958522|P1|Overall Study|Lost to Follow-up|5
2590425|NCT01140061|8958575|P10|Extension|Laboratory Adverse Event|1
2590426|NCT01140061|8958576|P9|Extension|Laboratory Adverse Event|0
2590427|NCT01140061|8958577|P8|Extension|Laboratory Adverse Event|0
2590428|NCT01140061|8958578|P7|Extension|Laboratory Adverse Event|0
2590429|NCT01140061|8958579|P6|Extension|Laboratory Adverse Event|0
2590430|NCT01140061|8958580|P5|Extension|Laboratory Adverse Event|0
2590431|NCT01140061|8958581|P4|Extension|Laboratory Adverse Event|0
2590432|NCT01140061|8958582|P3|Extension|Laboratory Adverse Event|0
2590433|NCT01140061|8958583|P2|Extension|Laboratory Adverse Event|0
2590434|NCT01140061|8958584|P1|Extension|Laboratory Adverse Event|0
2590435|NCT01140061|8958575|P10|Part I|Adverse Event|0
2590436|NCT01140061|8958576|P9|Part I|Adverse Event|0
2590437|NCT01140061|8958577|P8|Part I|Adverse Event|0
2590438|NCT01140061|8958578|P7|Part I|Adverse Event|0
2590439|NCT01140061|8958579|P6|Part I|Adverse Event|0
2590440|NCT01140061|8958580|P5|Part I|Adverse Event|0
2590441|NCT01140061|8958581|P4|Part I|Adverse Event|0
2590442|NCT01140061|8958582|P3|Part I|Adverse Event|0
2590443|NCT01140061|8958583|P2|Part I|Adverse Event|0
2590444|NCT01140061|8958584|P1|Part I|Adverse Event|1
2590445|NCT01140048|8958611|P1|Overall Study|Lost to Follow-up|31
2590446|NCT01140048|8958611|P1|Overall Study|Withdrawal by Subject|13
2590447|NCT01140048|8958611|P1|Overall Study|Physician Decision|1
2590448|NCT01139775|8958651|P3|Overall Study|Physician Decision|2
2590449|NCT01139775|8958652|P2|Overall Study|Physician Decision|2
2590450|NCT01139775|8958653|P1|Overall Study|Physician Decision|0
2590451|NCT01139775|8958651|P3|Overall Study|Withdrawal by Subject|2
2590452|NCT01139775|8958652|P2|Overall Study|Withdrawal by Subject|0
2590453|NCT01139775|8958653|P1|Overall Study|Withdrawal by Subject|1
2590454|NCT01139775|8958651|P3|Overall Study|Protocol Violation|0
2590455|NCT01139775|8958652|P2|Overall Study|Protocol Violation|5
2590456|NCT01139775|8958653|P1|Overall Study|Protocol Violation|0
2590457|NCT01139775|8958651|P3|Overall Study|Adverse Event|2
2590458|NCT01139775|8958652|P2|Overall Study|Adverse Event|6
2590459|NCT01139775|8958653|P1|Overall Study|Adverse Event|0
2590460|NCT01139762|8958685|P3|Double-Blind Randomized Active Treatment|Lost to Follow-up|4
2590461|NCT01139762|8958686|P2|Double-Blind Randomized Active Treatment|Lost to Follow-up|3
2590462|NCT01139762|8958687|P1|Double-Blind Randomized Active Treatment|Lost to Follow-up|0
2590463|NCT01139762|8958685|P3|Double-Blind Randomized Active Treatment|Lack of Efficacy|5
2590464|NCT01139762|8958686|P2|Double-Blind Randomized Active Treatment|Lack of Efficacy|3
2590465|NCT01139762|8958687|P1|Double-Blind Randomized Active Treatment|Lack of Efficacy|0
2590466|NCT01139762|8958685|P3|Double-Blind Randomized Active Treatment|Sponsor Decision|6
2590467|NCT01139762|8958686|P2|Double-Blind Randomized Active Treatment|Sponsor Decision|5
2590468|NCT01139762|8958687|P1|Double-Blind Randomized Active Treatment|Sponsor Decision|0
2590469|NCT01139762|8958685|P3|Double-Blind Randomized Active Treatment|Physician Decision|0
2590470|NCT01139762|8958686|P2|Double-Blind Randomized Active Treatment|Physician Decision|2
2590471|NCT01139762|8958687|P1|Double-Blind Randomized Active Treatment|Physician Decision|0
2590472|NCT01139762|8958685|P3|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13
2590473|NCT01139762|8958686|P2|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6
2590474|NCT01139762|8958687|P1|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0
2590475|NCT01139762|8958685|P3|Double-Blind Randomized Active Treatment|Protocol Violation|8
2590476|NCT01139762|8958686|P2|Double-Blind Randomized Active Treatment|Protocol Violation|2
2590477|NCT01139762|8958687|P1|Double-Blind Randomized Active Treatment|Protocol Violation|0
2590478|NCT01139762|8958685|P3|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17
2590479|NCT01139762|8958686|P2|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14
2590562|NCT01139021|8958899|P6|Overall Study|Protocol Violation|0
2590480|NCT01139762|8958687|P1|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0
2590481|NCT01139762|8958685|P3|Double-Blind Randomized Active Treatment|Death|1
2590482|NCT01139762|8958686|P2|Double-Blind Randomized Active Treatment|Death|1
2590483|NCT01139762|8958687|P1|Double-Blind Randomized Active Treatment|Death|0
2590484|NCT01139762|8958685|P3|Double-Blind Randomized Active Treatment|Adverse Event|10
2590485|NCT01139762|8958686|P2|Double-Blind Randomized Active Treatment|Adverse Event|4
2590486|NCT01139762|8958687|P1|Double-Blind Randomized Active Treatment|Adverse Event|0
2590487|NCT01139762|8958685|P3|Washout and Placebo Lead-In Period|Lost to Follow-up|0
2590488|NCT01139762|8958686|P2|Washout and Placebo Lead-In Period|Lost to Follow-up|0
2590489|NCT01139762|8958687|P1|Washout and Placebo Lead-In Period|Lost to Follow-up|10
2590490|NCT01139762|8958685|P3|Washout and Placebo Lead-In Period|Sponsor Decision|0
2590491|NCT01139762|8958686|P2|Washout and Placebo Lead-In Period|Sponsor Decision|0
2590492|NCT01139762|8958687|P1|Washout and Placebo Lead-In Period|Sponsor Decision|10
2590493|NCT01139762|8958685|P3|Washout and Placebo Lead-In Period|Physician Decision|0
2590494|NCT01139762|8958686|P2|Washout and Placebo Lead-In Period|Physician Decision|0
2590495|NCT01139762|8958687|P1|Washout and Placebo Lead-In Period|Physician Decision|12
2590496|NCT01139762|8958685|P3|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
2590497|NCT01139762|8958686|P2|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
2590498|NCT01139762|8958687|P1|Washout and Placebo Lead-In Period|Withdrawal by Subject|83
2590499|NCT01139762|8958685|P3|Washout and Placebo Lead-In Period|Adverse Event|0
2590500|NCT01139762|8958686|P2|Washout and Placebo Lead-In Period|Adverse Event|0
2590501|NCT01139762|8958687|P1|Washout and Placebo Lead-In Period|Adverse Event|1
2590502|NCT01139762|8958685|P3|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
2590503|NCT01139762|8958686|P2|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
2590504|NCT01139762|8958687|P1|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258
2590505|NCT01139658|8958722|P2|Overall Study|Other|75
2590506|NCT01139658|8958723|P1|Overall Study|Other|28
2590507|NCT01139658|8958722|P2|Overall Study|No documentation of treatment|0
2590508|NCT01139658|8958723|P1|Overall Study|No documentation of treatment|1
2590509|NCT01139658|8958722|P2|Overall Study|Withdrawal by Subject|4
2590510|NCT01139658|8958723|P1|Overall Study|Withdrawal by Subject|2
2590511|NCT01139658|8958722|P2|Overall Study|Lack of Efficacy|7
2590512|NCT01139658|8958723|P1|Overall Study|Lack of Efficacy|15
2590513|NCT01139658|8958722|P2|Overall Study|Adverse Event|27
2590514|NCT01139658|8958723|P1|Overall Study|Adverse Event|10
2590515|NCT01139580|8958761|P2|Overall Study|Participant Randomization in Error|1
2590516|NCT01139580|8958762|P1|Overall Study|Participant Randomization in Error|0
2590517|NCT01139580|8958761|P2|Overall Study|Beginning Study Exclusion Treatment|1
2590518|NCT01139580|8958762|P1|Overall Study|Beginning Study Exclusion Treatment|0
2590519|NCT01139580|8958761|P2|Overall Study|Misrandomized|0
2590520|NCT01139580|8958762|P1|Overall Study|Misrandomized|1
2590521|NCT01139580|8958761|P2|Overall Study|Did Not Meet Exclusion Criteria|0
2590522|NCT01139580|8958762|P1|Overall Study|Did Not Meet Exclusion Criteria|1
2590523|NCT01139580|8958761|P2|Overall Study|Used Excluded Medicine After Enrollment|0
2590524|NCT01139580|8958762|P1|Overall Study|Used Excluded Medicine After Enrollment|1
2590525|NCT01139580|8958761|P2|Overall Study|Withdrawal by Subject|9
2590526|NCT01139580|8958762|P1|Overall Study|Withdrawal by Subject|6
2590527|NCT01139580|8958761|P2|Overall Study|Lack of Efficacy|2
2590528|NCT01139580|8958762|P1|Overall Study|Lack of Efficacy|0
2590529|NCT01139580|8958761|P2|Overall Study|Lost to Follow-up|1
2590530|NCT01139580|8958762|P1|Overall Study|Lost to Follow-up|9
2590531|NCT01139580|8958761|P2|Overall Study|Adverse Event|4
2590532|NCT01139580|8958762|P1|Overall Study|Adverse Event|5
2590533|NCT01139450|8958810|P3|Overall Study|Adverse Event|3
2590534|NCT01139450|8958811|P2|Overall Study|Adverse Event|2
2590535|NCT01139450|8958812|P1|Overall Study|Adverse Event|2
2590536|NCT01139450|8958810|P3|Overall Study|Administrative|1
2590537|NCT01139450|8958811|P2|Overall Study|Administrative|0
2590538|NCT01139450|8958812|P1|Overall Study|Administrative|0
2590539|NCT01139450|8958810|P3|Overall Study|Lost to Follow-up|11
2590540|NCT01139450|8958811|P2|Overall Study|Lost to Follow-up|7
2590541|NCT01139450|8958812|P1|Overall Study|Lost to Follow-up|9
2590542|NCT01139450|8958810|P3|Overall Study|Protocol Violation|2
2590543|NCT01139450|8958811|P2|Overall Study|Protocol Violation|5
2590544|NCT01139450|8958812|P1|Overall Study|Protocol Violation|6
2590545|NCT01139450|8958810|P3|Overall Study|Lack of Efficacy|8
2590546|NCT01139450|8958811|P2|Overall Study|Lack of Efficacy|1
2590547|NCT01139450|8958812|P1|Overall Study|Lack of Efficacy|3
2590548|NCT01139450|8958810|P3|Overall Study|Withdrawal by Subject|13
2590549|NCT01139450|8958811|P2|Overall Study|Withdrawal by Subject|10
2590550|NCT01139450|8958812|P1|Overall Study|Withdrawal by Subject|7
2590551|NCT01139164|8958864|P3|Overall Study|Withdrawn prior to study start|0
2590552|NCT01139164|8958865|P2|Overall Study|Withdrawn prior to study start|2
2590553|NCT01139164|8958866|P1|Overall Study|Withdrawn prior to study start|0
2590554|NCT01139125|8958880|P1|Overall Study|Withdrawal by Subject|1
2590555|NCT01139047|8958884|P1|Overall Study|Withdrawal by Subject|1
2590556|NCT01139021|8958899|P6|Overall Study|Withdrawal by Subject|0
2590557|NCT01139021|8958900|P5|Overall Study|Withdrawal by Subject|4
2590558|NCT01139021|8958901|P4|Overall Study|Withdrawal by Subject|1
2590559|NCT01139021|8958902|P3|Overall Study|Withdrawal by Subject|0
2590560|NCT01139021|8958903|P2|Overall Study|Withdrawal by Subject|0
2590561|NCT01139021|8958904|P1|Overall Study|Withdrawal by Subject|0
2590563|NCT01139021|8958900|P5|Overall Study|Protocol Violation|2
2590564|NCT01139021|8958901|P4|Overall Study|Protocol Violation|0
2590565|NCT01139021|8958902|P3|Overall Study|Protocol Violation|0
2590566|NCT01139021|8958903|P2|Overall Study|Protocol Violation|0
2590567|NCT01139021|8958904|P1|Overall Study|Protocol Violation|1
2590568|NCT01139021|8958899|P6|Overall Study|Lost to Follow-up|0
2590569|NCT01139021|8958900|P5|Overall Study|Lost to Follow-up|2
2590570|NCT01139021|8958901|P4|Overall Study|Lost to Follow-up|0
2590571|NCT01139021|8958902|P3|Overall Study|Lost to Follow-up|0
2590572|NCT01139021|8958903|P2|Overall Study|Lost to Follow-up|0
2590573|NCT01139021|8958904|P1|Overall Study|Lost to Follow-up|0
2590574|NCT01139021|8958899|P6|Overall Study|Adverse Event|0
2590575|NCT01139021|8958900|P5|Overall Study|Adverse Event|1
2590576|NCT01139021|8958901|P4|Overall Study|Adverse Event|0
2590577|NCT01139021|8958902|P3|Overall Study|Adverse Event|0
2590578|NCT01139021|8958903|P2|Overall Study|Adverse Event|0
2590579|NCT01139021|8958904|P1|Overall Study|Adverse Event|0
2590580|NCT01139008|8958940|P1|Overall Study|Non-compliant, lost product|1
2590581|NCT01139008|8958940|P1|Overall Study|Withdrawal by Subject|5
2590582|NCT01138826|8958987|P6|Washout Period I (of 16 Days)|Lost to Follow-up|0
2590583|NCT01138826|8958988|P5|Washout Period I (of 16 Days)|Lost to Follow-up|1
2590584|NCT01138826|8958989|P4|Washout Period I (of 16 Days)|Lost to Follow-up|0
2590585|NCT01138826|8958990|P3|Washout Period I (of 16 Days)|Lost to Follow-up|0
2590586|NCT01138826|8958991|P2|Washout Period I (of 16 Days)|Lost to Follow-up|1
2590587|NCT01138826|8958992|P1|Washout Period I (of 16 Days)|Lost to Follow-up|1
2590588|NCT01138657|8959029|P2|Overall Study|Miscellaneous Reasons|4
2590589|NCT01138657|8959030|P1|Overall Study|Miscellaneous Reasons|3
2590590|NCT01138657|8959029|P2|Overall Study|Lost to Follow-up|3
2590591|NCT01138657|8959030|P1|Overall Study|Lost to Follow-up|0
2590592|NCT01138657|8959029|P2|Overall Study|Lack of Efficacy|1
2590593|NCT01138657|8959030|P1|Overall Study|Lack of Efficacy|2
2590594|NCT01138657|8959029|P2|Overall Study|Adverse Event|10
2590595|NCT01138657|8959030|P1|Overall Study|Adverse Event|3
2590596|NCT01138501|8959093|P1|Overall Study|Withdrawal by Subject|3
2590597|NCT01138501|8959093|P1|Overall Study|Protocol Violation|2
2590598|NCT01138150|8959137|P2|Overall Study|Physician Decision|0
2590599|NCT01138150|8959138|P1|Overall Study|Physician Decision|1
2590600|NCT01138150|8959137|P2|Overall Study|blood unable to be processed|1
2590601|NCT01138150|8959138|P1|Overall Study|blood unable to be processed|0
2590602|NCT01138111|8959219|P1|Overall Study|Lost to Follow-up|2
2590603|NCT01138111|8959219|P1|Overall Study|Death|1
2590604|NCT01138111|8959219|P1|Overall Study|Adverse Event|1
2590605|NCT01138111|8959219|P1|Overall Study|Withdrawal by Subject|5
2590606|NCT01138046|8959273|P1|Overall Study|Withdrawal due to death|6
2590607|NCT01138007|8959293|P3|Overall Study|Withdrawal by Subject|15
2590608|NCT01138007|8959294|P2|Overall Study|Withdrawal by Subject|6
2590609|NCT01138007|8959295|P1|Overall Study|Withdrawal by Subject|5
2590610|NCT01138007|8959293|P3|Overall Study|Physician Decision|3
2590611|NCT01138007|8959294|P2|Overall Study|Physician Decision|5
2590612|NCT01138007|8959295|P1|Overall Study|Physician Decision|0
2590613|NCT01138007|8959293|P3|Overall Study|Lost to Follow-up|5
2590614|NCT01138007|8959294|P2|Overall Study|Lost to Follow-up|3
2590615|NCT01138007|8959295|P1|Overall Study|Lost to Follow-up|3
2590616|NCT01138007|8959293|P3|Overall Study|Protocol-Defined Stopping Criteria|8
2590617|NCT01138007|8959294|P2|Overall Study|Protocol-Defined Stopping Criteria|1
2590618|NCT01138007|8959295|P1|Overall Study|Protocol-Defined Stopping Criteria|6
2590619|NCT01138007|8959293|P3|Overall Study|Protocol Violation|2
2590620|NCT01138007|8959294|P2|Overall Study|Protocol Violation|3
2590621|NCT01138007|8959295|P1|Overall Study|Protocol Violation|2
2590622|NCT01138007|8959293|P3|Overall Study|Lack of Efficacy|6
2590623|NCT01138007|8959294|P2|Overall Study|Lack of Efficacy|0
2590624|NCT01138007|8959295|P1|Overall Study|Lack of Efficacy|2
2590625|NCT01138007|8959293|P3|Overall Study|Adverse Event|9
2590626|NCT01138007|8959294|P2|Overall Study|Adverse Event|12
2590627|NCT01138007|8959295|P1|Overall Study|Adverse Event|4
2590628|NCT01137812|8959402|P2|Overall Study|Other|27
2590629|NCT01137812|8959403|P1|Overall Study|Other|19
2590630|NCT01137812|8959402|P2|Overall Study|Patient met glycemic withdrawal criteria|85
2590631|NCT01137812|8959403|P1|Overall Study|Patient met glycemic withdrawal criteria|40
2590632|NCT01137812|8959402|P2|Overall Study|Death|0
2590633|NCT01137812|8959403|P1|Overall Study|Death|2
2590634|NCT01137812|8959402|P2|Overall Study|Withdrawal by Subject|13
2590635|NCT01137812|8959403|P1|Overall Study|Withdrawal by Subject|5
2590636|NCT01137812|8959402|P2|Overall Study|Protocol Violation|4
2590637|NCT01137812|8959403|P1|Overall Study|Protocol Violation|5
2590638|NCT01137812|8959402|P2|Overall Study|Physician Decision|17
2590639|NCT01137812|8959403|P1|Overall Study|Physician Decision|25
2590640|NCT01137812|8959402|P2|Overall Study|Lost to Follow-up|8
2590641|NCT01137812|8959403|P1|Overall Study|Lost to Follow-up|6
2590642|NCT01137812|8959402|P2|Overall Study|Adverse Event|14
2590643|NCT01137812|8959403|P1|Overall Study|Adverse Event|21
2590644|NCT01137786|8959423|P2|Overall Study|Withdrawal by Subject|1
2590645|NCT01137786|8959424|P1|Overall Study|Withdrawal by Subject|1
2590646|NCT01137786|8959423|P2|Overall Study|Lost to Follow-up|2
2590647|NCT01137786|8959424|P1|Overall Study|Lost to Follow-up|0
2590648|NCT01137773|8959434|P2|Overall Study|Lost to Follow-up|0
2590649|NCT01137773|8959435|P1|Overall Study|Lost to Follow-up|6
2590650|NCT01137773|8959434|P2|Overall Study|Death|3
2590651|NCT01137773|8959435|P1|Overall Study|Death|3
2590652|NCT01137682|8959446|P3|Overall Study|Did not receive treatment in extension|1
2590653|NCT01137682|8959447|P2|Overall Study|Did not receive treatment in extension|0
2590654|NCT01137682|8959448|P1|Overall Study|Did not receive treatment in extension|0
2590655|NCT01137682|8959446|P3|Overall Study|Did not enter extension|2
2590656|NCT01137682|8959447|P2|Overall Study|Did not enter extension|3
2590657|NCT01137682|8959448|P1|Overall Study|Did not enter extension|2
2590658|NCT01137682|8959446|P3|Overall Study|Protocol Violation-Extension|0
2590659|NCT01137682|8959447|P2|Overall Study|Protocol Violation-Extension|1
2590660|NCT01137682|8959448|P1|Overall Study|Protocol Violation-Extension|2
2590661|NCT01137682|8959446|P3|Overall Study|Death-Extension|0
2590662|NCT01137682|8959447|P2|Overall Study|Death-Extension|0
2590663|NCT01137682|8959448|P1|Overall Study|Death-Extension|2
2590664|NCT01137682|8959446|P3|Overall Study|Administrative problems-Extension|0
2590665|NCT01137682|8959447|P2|Overall Study|Administrative problems-Extension|2
2590666|NCT01137682|8959448|P1|Overall Study|Administrative problems-Extension|0
2590667|NCT01137682|8959446|P3|Overall Study|Lost to Follow Up-Extension|0
2590668|NCT01137682|8959447|P2|Overall Study|Lost to Follow Up-Extension|1
2590669|NCT01137682|8959448|P1|Overall Study|Lost to Follow Up-Extension|0
2590670|NCT01137682|8959446|P3|Overall Study|Withdrawal by Subject-Extension|8
2590671|NCT01137682|8959447|P2|Overall Study|Withdrawal by Subject-Extension|8
2590672|NCT01137682|8959448|P1|Overall Study|Withdrawal by Subject-Extension|6
2590673|NCT01137682|8959446|P3|Overall Study|Lack of Efficacy-Extension|13
2590674|NCT01137682|8959447|P2|Overall Study|Lack of Efficacy-Extension|9
2590675|NCT01137682|8959448|P1|Overall Study|Lack of Efficacy-Extension|15
2590676|NCT01137682|8959446|P3|Overall Study|Adverse Event-Extension|7
2590677|NCT01137682|8959447|P2|Overall Study|Adverse Event-Extension|8
2590678|NCT01137682|8959448|P1|Overall Study|Adverse Event-Extension|4
2590679|NCT01137682|8959446|P3|Overall Study|Protocol Violation-CORE|1
2590680|NCT01137682|8959447|P2|Overall Study|Protocol Violation-CORE|1
2590681|NCT01137682|8959448|P1|Overall Study|Protocol Violation-CORE|0
2590682|NCT01137682|8959446|P3|Overall Study|Administrative problems-CORE|0
2590683|NCT01137682|8959447|P2|Overall Study|Administrative problems-CORE|1
2590684|NCT01137682|8959448|P1|Overall Study|Administrative problems-CORE|2
2590685|NCT01137682|8959446|P3|Overall Study|Withdrawal by Subject-CORE|2
2590686|NCT01137682|8959447|P2|Overall Study|Withdrawal by Subject-CORE|2
2590687|NCT01137682|8959448|P1|Overall Study|Withdrawal by Subject-CORE|2
2590688|NCT01137682|8959446|P3|Overall Study|Adverse Event-CORE|0
2590689|NCT01137682|8959447|P2|Overall Study|Adverse Event-CORE|4
2590690|NCT01137682|8959448|P1|Overall Study|Adverse Event-CORE|2
2590691|NCT01137604|8959498|P4|Overall Study|Clinical Decline|1
2590692|NCT01137604|8959499|P3|Overall Study|Clinical Decline|1
2590693|NCT01137604|8959500|P2|Overall Study|Clinical Decline|0
2590694|NCT01137604|8959501|P1|Overall Study|Clinical Decline|0
2590695|NCT01137604|8959498|P4|Overall Study|Participant's Decision|0
2590696|NCT01137604|8959499|P3|Overall Study|Participant's Decision|0
2590697|NCT01137604|8959500|P2|Overall Study|Participant's Decision|0
2590698|NCT01137604|8959501|P1|Overall Study|Participant's Decision|1
2590699|NCT01137604|8959498|P4|Overall Study|Clinical Progression|0
2590700|NCT01137604|8959499|P3|Overall Study|Clinical Progression|1
2590701|NCT01137604|8959500|P2|Overall Study|Clinical Progression|2
2590702|NCT01137604|8959501|P1|Overall Study|Clinical Progression|0
2590703|NCT01137604|8959498|P4|Overall Study|Withdrawal by Subject|1
2590704|NCT01137604|8959499|P3|Overall Study|Withdrawal by Subject|2
2590705|NCT01137604|8959500|P2|Overall Study|Withdrawal by Subject|2
2590706|NCT01137604|8959501|P1|Overall Study|Withdrawal by Subject|0
2590707|NCT01137604|8959498|P4|Overall Study|Adverse Event|9
2590708|NCT01137604|8959499|P3|Overall Study|Adverse Event|9
2590709|NCT01137604|8959500|P2|Overall Study|Adverse Event|6
2590710|NCT01137604|8959501|P1|Overall Study|Adverse Event|1
2590711|NCT01137578|8959535|P3|Overall Study|Other|6
2590712|NCT01137578|8959536|P2|Overall Study|Other|2
2590713|NCT01137578|8959537|P1|Overall Study|Other|12
2590714|NCT01137578|8959535|P3|Overall Study|Withdrawal by Subject|0
2590715|NCT01137578|8959536|P2|Overall Study|Withdrawal by Subject|0
2590716|NCT01137578|8959537|P1|Overall Study|Withdrawal by Subject|1
2590717|NCT01137578|8959535|P3|Overall Study|Participant requested to Discontinue|0
2590718|NCT01137578|8959536|P2|Overall Study|Participant requested to Discontinue|0
2590719|NCT01137578|8959537|P1|Overall Study|Participant requested to Discontinue|3
2590720|NCT01137474|8959586|P4|Overall Study|Administrative reason by sponsor|0
2590721|NCT01137474|8959587|P3|Overall Study|Administrative reason by sponsor|0
2590722|NCT01137474|8959588|P2|Overall Study|Administrative reason by sponsor|1
2590723|NCT01137474|8959589|P1|Overall Study|Administrative reason by sponsor|0
2590724|NCT01137474|8959586|P4|Overall Study|Pregnancy|0
2590725|NCT01137474|8959587|P3|Overall Study|Pregnancy|0
2590726|NCT01137474|8959588|P2|Overall Study|Pregnancy|1
2590727|NCT01137474|8959589|P1|Overall Study|Pregnancy|0
2590728|NCT01137474|8959586|P4|Overall Study|Other|0
2590729|NCT01137474|8959587|P3|Overall Study|Other|0
2590730|NCT01137474|8959588|P2|Overall Study|Other|1
2590731|NCT01137474|8959589|P1|Overall Study|Other|3
2590732|NCT01137474|8959586|P4|Overall Study|Lack of Efficacy|2
2590733|NCT01137474|8959587|P3|Overall Study|Lack of Efficacy|0
2590734|NCT01137474|8959588|P2|Overall Study|Lack of Efficacy|0
2590735|NCT01137474|8959589|P1|Overall Study|Lack of Efficacy|0
2590736|NCT01137474|8959586|P4|Overall Study|Lost to Follow-up|2
2590737|NCT01137474|8959587|P3|Overall Study|Lost to Follow-up|0
2590738|NCT01137474|8959588|P2|Overall Study|Lost to Follow-up|1
2590739|NCT01137474|8959589|P1|Overall Study|Lost to Follow-up|5
2590740|NCT01137474|8959586|P4|Overall Study|No longer met study criteria|5
2590741|NCT01137474|8959587|P3|Overall Study|No longer met study criteria|0
2590742|NCT01137474|8959588|P2|Overall Study|No longer met study criteria|1
2590743|NCT01137474|8959589|P1|Overall Study|No longer met study criteria|6
2590744|NCT01137474|8959586|P4|Overall Study|Withdrawal by Subject|9
2590745|NCT01137474|8959587|P3|Overall Study|Withdrawal by Subject|6
2590746|NCT01137474|8959588|P2|Overall Study|Withdrawal by Subject|2
2590747|NCT01137474|8959589|P1|Overall Study|Withdrawal by Subject|7
2590748|NCT01137474|8959586|P4|Overall Study|Adverse Event|3
2590749|NCT01137474|8959587|P3|Overall Study|Adverse Event|1
2590750|NCT01137474|8959588|P2|Overall Study|Adverse Event|5
2590751|NCT01137474|8959589|P1|Overall Study|Adverse Event|3
2590752|NCT01137435|8959607|P1|Overall Study|Off label usage|4
2590753|NCT01137435|8959607|P1|Overall Study|Lost to Follow-up|24
2590754|NCT01137292|8959634|P1|Overall Study|Other|7
2590755|NCT01137292|8959634|P1|Overall Study|Lost to Follow-up|1
2590756|NCT01137292|8959634|P1|Overall Study|Lack of Efficacy|13
2590757|NCT01137292|8959634|P1|Overall Study|Adverse Event|3
2590758|NCT01137292|8959634|P1|Overall Study|Death|30
2590759|NCT01137110|8959643|P2|Overall Study|Protocol Violation|0
2590760|NCT01137110|8959644|P1|Overall Study|Protocol Violation|1
2590761|NCT01137071|8959650|P1|Overall Study|Wrongly Included|1
2590762|NCT01137071|8959650|P1|Overall Study|Withdrawal by Subject|2
2590763|NCT01137071|8959650|P1|Overall Study|Disease Progression|11
2590764|NCT01136967|8959806|P2|Overall Study|Diagnosis of Second Primary Cancer|1
2590765|NCT01136967|8959807|P1|Overall Study|Diagnosis of Second Primary Cancer|0
2590766|NCT01136967|8959806|P2|Overall Study|Increase in Lesion Size|2
2590767|NCT01136967|8959807|P1|Overall Study|Increase in Lesion Size|0
2590768|NCT01136967|8959806|P2|Overall Study|Investigator's Choice|1
2590769|NCT01136967|8959807|P1|Overall Study|Investigator's Choice|1
2590770|NCT01136967|8959806|P2|Overall Study|Non-compliance|0
2590771|NCT01136967|8959807|P1|Overall Study|Non-compliance|1
2590772|NCT01136967|8959806|P2|Overall Study|Radiation|0
2590773|NCT01136967|8959807|P1|Overall Study|Radiation|1
2590774|NCT01136967|8959806|P2|Overall Study|Clinical Progression|5
2590775|NCT01136967|8959807|P1|Overall Study|Clinical Progression|3
2590776|NCT01136967|8959806|P2|Overall Study|Withdrawal by Subject|2
2590777|NCT01136967|8959807|P1|Overall Study|Withdrawal by Subject|1
2590778|NCT01136967|8959806|P2|Overall Study|Lost to Follow-up|1
2590779|NCT01136967|8959807|P1|Overall Study|Lost to Follow-up|0
2590780|NCT01136967|8959806|P2|Overall Study|Participant Choice|3
2590781|NCT01136967|8959807|P1|Overall Study|Participant Choice|8
2590782|NCT01136967|8959806|P2|Overall Study|Adverse Event|12
2590783|NCT01136967|8959807|P1|Overall Study|Adverse Event|9
2590784|NCT01136954|8959829|P2|Overall Study|Other|3
2590785|NCT01136954|8959830|P1|Overall Study|Other|1
2590786|NCT01136954|8959829|P2|Overall Study|Physician Decision|1
2590787|NCT01136954|8959830|P1|Overall Study|Physician Decision|0
2590788|NCT01136954|8959829|P2|Overall Study|Lack of Efficacy|13
2590789|NCT01136954|8959830|P1|Overall Study|Lack of Efficacy|14
2590790|NCT01136954|8959829|P2|Overall Study|Withdrawal by Subject|2
2590791|NCT01136954|8959830|P1|Overall Study|Withdrawal by Subject|6
2590792|NCT01136954|8959829|P2|Overall Study|Adverse Event|2
2590793|NCT01136954|8959830|P1|Overall Study|Adverse Event|3
2590794|NCT01136915|8959844|P2|Overall Study|Exclusion criterion met|1
2590795|NCT01136915|8959845|P1|Overall Study|Exclusion criterion met|0
2590796|NCT01136915|8959844|P2|Overall Study|Lost to Follow-up|0
2590797|NCT01136915|8959845|P1|Overall Study|Lost to Follow-up|2
2590798|NCT01136876|8959855|P2|Overall Study|Physician Decision|5
2590799|NCT01136876|8959856|P1|Overall Study|Physician Decision|3
2590800|NCT01136876|8959855|P2|Overall Study|Lost to Follow-up|1
2590801|NCT01136876|8959856|P1|Overall Study|Lost to Follow-up|0
2590802|NCT01136785|8959885|P2|Overall Study|Protocol Violation|1
2590803|NCT01136785|8959886|P1|Overall Study|Protocol Violation|2
2590804|NCT01136772|8959901|P2|Overall Study|Did not follow up after first injection|2
2590805|NCT01136772|8959902|P1|Overall Study|Did not follow up after first injection|2
2590806|NCT01136772|8959901|P2|Overall Study|Did not receive injection|7
2590807|NCT01136772|8959902|P1|Overall Study|Did not receive injection|10
2590808|NCT01136772|8959901|P2|Overall Study|Withdrawal by Subject|36
2590809|NCT01136772|8959902|P1|Overall Study|Withdrawal by Subject|33
2590810|NCT01136772|8959901|P2|Overall Study|Administrative|12
2590811|NCT01136772|8959902|P1|Overall Study|Administrative|14
2590812|NCT01136772|8959901|P2|Overall Study|Lack of Efficacy|39
2590813|NCT01136772|8959902|P1|Overall Study|Lack of Efficacy|42
2590814|NCT01136772|8959901|P2|Overall Study|Adverse Event|14
2590815|NCT01136772|8959902|P1|Overall Study|Adverse Event|15
2590816|NCT01136746|8959912|P2|Overall Study|Death|0
2590817|NCT01136746|8959913|P1|Overall Study|Death|1
2590818|NCT01136746|8959912|P2|Overall Study|Protocol Violation|1
2590819|NCT01136746|8959913|P1|Overall Study|Protocol Violation|2
2590820|NCT01136746|8959912|P2|Overall Study|Lost to Follow-up|2
2590821|NCT01136746|8959913|P1|Overall Study|Lost to Follow-up|0
2590822|NCT01136733|8959980|P7|Phase 2|Other|6
2590823|NCT01136733|8959981|P6|Phase 2|Other|7
2590824|NCT01136733|8959982|P5|Phase 2|Other|6
2590825|NCT01136733|8959983|P4|Phase 2|Other|0
2590826|NCT01136733|8959984|P3|Phase 2|Other|0
2590827|NCT01136733|8959985|P2|Phase 2|Other|0
2590828|NCT01136733|8959986|P1|Phase 2|Other|0
2590829|NCT01136733|8959980|P7|Phase 2|Administrative-Withdrew Consent|0
2590830|NCT01136733|8959981|P6|Phase 2|Administrative-Withdrew Consent|0
2590831|NCT01136733|8959982|P5|Phase 2|Administrative-Withdrew Consent|1
2590832|NCT01136733|8959983|P4|Phase 2|Administrative-Withdrew Consent|0
2590833|NCT01136733|8959984|P3|Phase 2|Administrative-Withdrew Consent|0
2590834|NCT01136733|8959985|P2|Phase 2|Administrative-Withdrew Consent|0
2590835|NCT01136733|8959986|P1|Phase 2|Administrative-Withdrew Consent|0
2590836|NCT01136733|8959980|P7|Phase 2|Participant Choice|1
2590837|NCT01136733|8959981|P6|Phase 2|Participant Choice|0
2590838|NCT01136733|8959982|P5|Phase 2|Participant Choice|3
2590839|NCT01136733|8959983|P4|Phase 2|Participant Choice|0
2590840|NCT01136733|8959984|P3|Phase 2|Participant Choice|0
2590841|NCT01136733|8959985|P2|Phase 2|Participant Choice|0
2590842|NCT01136733|8959986|P1|Phase 2|Participant Choice|0
2590843|NCT01136733|8959980|P7|Phase 2|Adverse Event|5
2590844|NCT01136733|8959981|P6|Phase 2|Adverse Event|13
2590845|NCT01136733|8959982|P5|Phase 2|Adverse Event|11
2590846|NCT01136733|8959983|P4|Phase 2|Adverse Event|0
2590847|NCT01136733|8959984|P3|Phase 2|Adverse Event|0
2590848|NCT01136733|8959985|P2|Phase 2|Adverse Event|0
2590849|NCT01136733|8959986|P1|Phase 2|Adverse Event|0
2590850|NCT01136733|8959980|P7|Phase 2|Disease Progression|38
2590851|NCT01136733|8959981|P6|Phase 2|Disease Progression|32
2590852|NCT01136733|8959982|P5|Phase 2|Disease Progression|30
2590853|NCT01136733|8959983|P4|Phase 2|Disease Progression|0
2590854|NCT01136733|8959984|P3|Phase 2|Disease Progression|0
2590855|NCT01136733|8959985|P2|Phase 2|Disease Progression|0
2590856|NCT01136733|8959986|P1|Phase 2|Disease Progression|0
2590857|NCT01136733|8959980|P7|Phase 1b|Clinical Progression|0
2590858|NCT01136733|8959981|P6|Phase 1b|Clinical Progression|0
2590859|NCT01136733|8959982|P5|Phase 1b|Clinical Progression|0
2590860|NCT01136733|8959983|P4|Phase 1b|Clinical Progression|0
2590861|NCT01136733|8959984|P3|Phase 1b|Clinical Progression|0
2590862|NCT01136733|8959985|P2|Phase 1b|Clinical Progression|1
2590863|NCT01136733|8959986|P1|Phase 1b|Clinical Progression|1
2590864|NCT01136733|8959980|P7|Phase 1b|Administrative-Withdrew Consent|0
2590865|NCT01136733|8959981|P6|Phase 1b|Administrative-Withdrew Consent|0
2590866|NCT01136733|8959982|P5|Phase 1b|Administrative-Withdrew Consent|0
2590867|NCT01136733|8959983|P4|Phase 1b|Administrative-Withdrew Consent|0
2590868|NCT01136733|8959984|P3|Phase 1b|Administrative-Withdrew Consent|0
2590869|NCT01136733|8959985|P2|Phase 1b|Administrative-Withdrew Consent|1
2590870|NCT01136733|8959986|P1|Phase 1b|Administrative-Withdrew Consent|0
2590871|NCT01136733|8959980|P7|Phase 1b|Participant Choice|0
2590872|NCT01136733|8959981|P6|Phase 1b|Participant Choice|0
2590873|NCT01136733|8959982|P5|Phase 1b|Participant Choice|0
2590874|NCT01136733|8959983|P4|Phase 1b|Participant Choice|0
2590875|NCT01136733|8959984|P3|Phase 1b|Participant Choice|1
2590876|NCT01136733|8959985|P2|Phase 1b|Participant Choice|0
2590877|NCT01136733|8959986|P1|Phase 1b|Participant Choice|0
2590878|NCT01136733|8959980|P7|Phase 1b|Adverse Event|0
2590879|NCT01136733|8959981|P6|Phase 1b|Adverse Event|0
2590880|NCT01136733|8959982|P5|Phase 1b|Adverse Event|0
2590881|NCT01136733|8959983|P4|Phase 1b|Adverse Event|0
2590882|NCT01136733|8959984|P3|Phase 1b|Adverse Event|1
2590883|NCT01136733|8959985|P2|Phase 1b|Adverse Event|3
2590884|NCT01136733|8959986|P1|Phase 1b|Adverse Event|0
2590885|NCT01136655|8960069|P1|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1
2590886|NCT01136655|8960069|P1|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1
2590887|NCT01136655|8960069|P1|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1
2590888|NCT01136655|8960069|P1|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1
2590889|NCT01136408|8960102|P3|Overall Study|Protocol Violation|1
2590890|NCT01136408|8960103|P2|Overall Study|Protocol Violation|1
2590891|NCT01136408|8960104|P1|Overall Study|Protocol Violation|1
2590892|NCT01136408|8960102|P3|Overall Study|Adverse Event|4
2590893|NCT01136408|8960103|P2|Overall Study|Adverse Event|8
2590894|NCT01136408|8960104|P1|Overall Study|Adverse Event|4
2590895|NCT01136382|8960161|P2|Overall Study|Withdrawal by Subject|1
2590896|NCT01136382|8960162|P1|Overall Study|Withdrawal by Subject|4
2590897|NCT01136382|8960161|P2|Overall Study|Severe Non-Compliance to Protocol|2
2590898|NCT01136382|8960162|P1|Overall Study|Severe Non-Compliance to Protocol|0
2590899|NCT01136382|8960161|P2|Overall Study|Study-Specific Withdrawal Criteria|25
2590900|NCT01136382|8960162|P1|Overall Study|Study-Specific Withdrawal Criteria|48
2590901|NCT01136382|8960161|P2|Overall Study|Other|3
2590902|NCT01136382|8960162|P1|Overall Study|Other|8
2590903|NCT01136356|8960188|P2|Second 18-day Withdrawal|Withdrawal by Subject|1
2590904|NCT01136356|8960189|P1|Second 18-day Withdrawal|Withdrawal by Subject|0
2590905|NCT01136356|8960188|P2|First 18-day Withdrawal|Physician Decision|0
2590906|NCT01136356|8960189|P1|First 18-day Withdrawal|Physician Decision|1
2590907|NCT01136356|8960188|P2|First 18-day Withdrawal|Withdrawal by Subject|0
2590908|NCT01136356|8960189|P1|First 18-day Withdrawal|Withdrawal by Subject|3
2590909|NCT01136291|8960200|P2|Overall Study|Lost to Follow-up|1
2590910|NCT01136291|8960201|P1|Overall Study|Lost to Follow-up|1
2590911|NCT01136174|8960220|P4|Overall Study|Adverse Event|4
2590912|NCT01136174|8960221|P3|Overall Study|Adverse Event|0
2590913|NCT01136174|8960222|P2|Overall Study|Adverse Event|0
2590914|NCT01136174|8960223|P1|Overall Study|Adverse Event|0
2590915|NCT01135992|8960303|P1|Overall Study|Unclassified|7
2590916|NCT01135992|8960303|P1|Overall Study|Withdrawal criteria|10
2590917|NCT01135992|8960303|P1|Overall Study|Protocol Violation|2
2590918|NCT01135992|8960303|P1|Overall Study|Lack of Efficacy|1
2590919|NCT01135992|8960303|P1|Overall Study|Adverse Event|1
2590920|NCT01135914|8960315|P3|Overall Study|Adverse Event|2
2590921|NCT01135914|8960316|P2|Overall Study|Adverse Event|1
2590922|NCT01135914|8960317|P1|Overall Study|Adverse Event|0
2590923|NCT01135914|8960315|P3|Overall Study|Lack of Efficacy|10
2590924|NCT01135914|8960316|P2|Overall Study|Lack of Efficacy|1
2590925|NCT01135914|8960317|P1|Overall Study|Lack of Efficacy|2
2590926|NCT01135914|8960315|P3|Overall Study|Protocol Violation|3
2590927|NCT01135914|8960316|P2|Overall Study|Protocol Violation|0
2590928|NCT01135914|8960317|P1|Overall Study|Protocol Violation|0
2590929|NCT01135914|8960315|P3|Overall Study|Lost to Follow-up|1
2590930|NCT01135914|8960316|P2|Overall Study|Lost to Follow-up|0
2590931|NCT01135914|8960317|P1|Overall Study|Lost to Follow-up|1
2590932|NCT01135914|8960315|P3|Overall Study|Withdrawal by Subject|6
2590933|NCT01135914|8960316|P2|Overall Study|Withdrawal by Subject|3
2590934|NCT01135914|8960317|P1|Overall Study|Withdrawal by Subject|1
2590935|NCT01135524|8960350|P1|Overall Study|Lack of Efficacy|8
2590936|NCT01135524|8960350|P1|Overall Study|Administrative|151
2590937|NCT01135524|8960350|P1|Overall Study|Lost to Follow-up|3
2590938|NCT01135524|8960350|P1|Overall Study|Adverse Event|20
2590939|NCT01135524|8960350|P1|Overall Study|Withdrawal by Subject|14
2590940|NCT01135511|8960363|P9|Overall Study|Withdrawal by Subject|1
2590941|NCT01135511|8960364|P8|Overall Study|Withdrawal by Subject|0
2590942|NCT01135511|8960365|P7|Overall Study|Withdrawal by Subject|1
2590943|NCT01135511|8960366|P6|Overall Study|Withdrawal by Subject|0
2590944|NCT01135511|8960367|P5|Overall Study|Withdrawal by Subject|0
2590945|NCT01135511|8960368|P4|Overall Study|Withdrawal by Subject|0
2590946|NCT01135511|8960369|P3|Overall Study|Withdrawal by Subject|0
2590947|NCT01135511|8960370|P2|Overall Study|Withdrawal by Subject|0
2590948|NCT01135511|8960371|P1|Overall Study|Withdrawal by Subject|0
2590949|NCT01135511|8960363|P9|Overall Study|noncompliance with study drug taken|0
2590950|NCT01135511|8960364|P8|Overall Study|noncompliance with study drug taken|0
2590951|NCT01135511|8960365|P7|Overall Study|noncompliance with study drug taken|0
2590952|NCT01135511|8960366|P6|Overall Study|noncompliance with study drug taken|0
2590953|NCT01135511|8960367|P5|Overall Study|noncompliance with study drug taken|1
2590954|NCT01135511|8960368|P4|Overall Study|noncompliance with study drug taken|0
2590955|NCT01135511|8960369|P3|Overall Study|noncompliance with study drug taken|0
2590956|NCT01135511|8960370|P2|Overall Study|noncompliance with study drug taken|0
2590957|NCT01135511|8960371|P1|Overall Study|noncompliance with study drug taken|0
2590958|NCT01135511|8960363|P9|Overall Study|could not visit the clinic|0
2590959|NCT01135511|8960364|P8|Overall Study|could not visit the clinic|0
2590960|NCT01135511|8960365|P7|Overall Study|could not visit the clinic|0
2590961|NCT01135511|8960366|P6|Overall Study|could not visit the clinic|0
2590962|NCT01135511|8960367|P5|Overall Study|could not visit the clinic|0
2590963|NCT01135511|8960368|P4|Overall Study|could not visit the clinic|0
2590964|NCT01135511|8960369|P3|Overall Study|could not visit the clinic|2
2590965|NCT01135511|8960370|P2|Overall Study|could not visit the clinic|1
2590966|NCT01135511|8960371|P1|Overall Study|could not visit the clinic|0
2590967|NCT01135511|8960363|P9|Overall Study|Pregnancy|0
2590968|NCT01135511|8960364|P8|Overall Study|Pregnancy|0
2590969|NCT01135511|8960365|P7|Overall Study|Pregnancy|0
2590970|NCT01135511|8960366|P6|Overall Study|Pregnancy|0
2590971|NCT01135511|8960367|P5|Overall Study|Pregnancy|0
2590972|NCT01135511|8960368|P4|Overall Study|Pregnancy|1
2590973|NCT01135511|8960369|P3|Overall Study|Pregnancy|0
2590974|NCT01135511|8960370|P2|Overall Study|Pregnancy|0
2590975|NCT01135511|8960371|P1|Overall Study|Pregnancy|0
2590976|NCT01135511|8960363|P9|Overall Study|Protocol Violation|0
2590977|NCT01135511|8960364|P8|Overall Study|Protocol Violation|0
2590978|NCT01135511|8960365|P7|Overall Study|Protocol Violation|0
2590979|NCT01135511|8960366|P6|Overall Study|Protocol Violation|0
2590980|NCT01135511|8960367|P5|Overall Study|Protocol Violation|0
2590981|NCT01135511|8960368|P4|Overall Study|Protocol Violation|0
2590982|NCT01135511|8960369|P3|Overall Study|Protocol Violation|3
2590983|NCT01135511|8960370|P2|Overall Study|Protocol Violation|0
2590984|NCT01135511|8960371|P1|Overall Study|Protocol Violation|0
2590985|NCT01135511|8960363|P9|Overall Study|Lack of Efficacy|0
2590986|NCT01135511|8960364|P8|Overall Study|Lack of Efficacy|0
2590987|NCT01135511|8960365|P7|Overall Study|Lack of Efficacy|0
2590988|NCT01135511|8960366|P6|Overall Study|Lack of Efficacy|0
2590989|NCT01135511|8960367|P5|Overall Study|Lack of Efficacy|0
2590990|NCT01135511|8960368|P4|Overall Study|Lack of Efficacy|2
2590991|NCT01135511|8960369|P3|Overall Study|Lack of Efficacy|1
2590992|NCT01135511|8960370|P2|Overall Study|Lack of Efficacy|1
2590993|NCT01135511|8960371|P1|Overall Study|Lack of Efficacy|0
2590994|NCT01135511|8960363|P9|Overall Study|Adverse Event|0
2590995|NCT01135511|8960364|P8|Overall Study|Adverse Event|1
2590996|NCT01135511|8960365|P7|Overall Study|Adverse Event|0
2590997|NCT01135511|8960366|P6|Overall Study|Adverse Event|1
2590998|NCT01135511|8960367|P5|Overall Study|Adverse Event|0
2590999|NCT01135511|8960368|P4|Overall Study|Adverse Event|0
2591000|NCT01135511|8960369|P3|Overall Study|Adverse Event|2
2591001|NCT01135511|8960370|P2|Overall Study|Adverse Event|1
2591002|NCT01135511|8960371|P1|Overall Study|Adverse Event|0
2591003|NCT01135498|8960653|P1|Overall Study|Ongoing at time of analysis|2
2591004|NCT01135498|8960653|P1|Overall Study|Death|1
2591005|NCT01135498|8960653|P1|Overall Study|Withdrawal by Subject|4
2591006|NCT01135498|8960653|P1|Overall Study|Investigator judgement|25
2591007|NCT01135498|8960653|P1|Overall Study|Progressive disease|38
2591008|NCT01135498|8960653|P1|Overall Study|Adverse Event|20
2591009|NCT01135134|8960832|P2|Overall Study|Did not meet protocol eligibility|0
2591010|NCT01135134|8960833|P1|Overall Study|Did not meet protocol eligibility|1
2591011|NCT01135134|8960832|P2|Overall Study|Adverse Event|1
2591012|NCT01135134|8960833|P1|Overall Study|Adverse Event|1
2591013|NCT01135017|8960856|P2|Overall Study|Other than above|4
2591014|NCT01135017|8960857|P1|Overall Study|Other than above|3
2591015|NCT01135017|8960856|P2|Overall Study|Adverse Event|8
2591016|NCT01135017|8960857|P1|Overall Study|Adverse Event|3
2591017|NCT01134939|8960895|P8|Overall Study|Termination page not available|0
2591018|NCT01134939|8960896|P7|Overall Study|Termination page not available|7
2591019|NCT01134939|8960897|P6|Overall Study|Termination page not available|3
2591020|NCT01134939|8960898|P5|Overall Study|Termination page not available|0
2591021|NCT01134939|8960899|P4|Overall Study|Termination page not available|8
2591022|NCT01134939|8960900|P3|Overall Study|Termination page not available|5
2591023|NCT01134939|8960901|P2|Overall Study|Termination page not available|6
2591024|NCT01134939|8960902|P1|Overall Study|Termination page not available|4
2591025|NCT01134939|8960895|P8|Overall Study|Death|0
2591026|NCT01134939|8960896|P7|Overall Study|Death|0
2591027|NCT01134939|8960897|P6|Overall Study|Death|0
2591028|NCT01134939|8960898|P5|Overall Study|Death|0
2591029|NCT01134939|8960899|P4|Overall Study|Death|0
2591030|NCT01134939|8960900|P3|Overall Study|Death|0
2591031|NCT01134939|8960901|P2|Overall Study|Death|1
2591032|NCT01134939|8960902|P1|Overall Study|Death|0
2591033|NCT01134939|8960895|P8|Overall Study|Lost to Follow-up|0
2591034|NCT01134939|8960896|P7|Overall Study|Lost to Follow-up|0
2591035|NCT01134939|8960897|P6|Overall Study|Lost to Follow-up|1
2591036|NCT01134939|8960898|P5|Overall Study|Lost to Follow-up|2
2591037|NCT01134939|8960899|P4|Overall Study|Lost to Follow-up|1
2591038|NCT01134939|8960900|P3|Overall Study|Lost to Follow-up|0
2591039|NCT01134939|8960901|P2|Overall Study|Lost to Follow-up|3
2591040|NCT01134939|8960902|P1|Overall Study|Lost to Follow-up|2
2591041|NCT01134939|8960895|P8|Overall Study|Lack of Efficacy|0
2591042|NCT01134939|8960896|P7|Overall Study|Lack of Efficacy|1
2591043|NCT01134939|8960897|P6|Overall Study|Lack of Efficacy|0
2591044|NCT01134939|8960898|P5|Overall Study|Lack of Efficacy|3
2591045|NCT01134939|8960899|P4|Overall Study|Lack of Efficacy|0
2591046|NCT01134939|8960900|P3|Overall Study|Lack of Efficacy|1
2591047|NCT01134939|8960901|P2|Overall Study|Lack of Efficacy|5
2591048|NCT01134939|8960902|P1|Overall Study|Lack of Efficacy|2
2591049|NCT01134939|8960895|P8|Overall Study|Adverse Event|0
2591050|NCT01134939|8960896|P7|Overall Study|Adverse Event|1
2591051|NCT01134939|8960897|P6|Overall Study|Adverse Event|5
2591052|NCT01134939|8960898|P5|Overall Study|Adverse Event|5
2591053|NCT01134939|8960899|P4|Overall Study|Adverse Event|5
2591054|NCT01134939|8960900|P3|Overall Study|Adverse Event|4
2591055|NCT01134939|8960901|P2|Overall Study|Adverse Event|3
2591056|NCT01134939|8960902|P1|Overall Study|Adverse Event|9
2591057|NCT01134783|8961040|P2|Overall Study|Lost to Follow-up|20
2591058|NCT01134783|8961041|P1|Overall Study|Lost to Follow-up|5
2591059|NCT01134783|8961040|P2|Overall Study|Withdrawal by Subject|9
2591060|NCT01134783|8961041|P1|Overall Study|Withdrawal by Subject|15
2591061|NCT01134783|8961040|P2|Overall Study|Pregnancy|8
2591062|NCT01134783|8961041|P1|Overall Study|Pregnancy|16
2591063|NCT01134731|8961060|P3|Overall Study|Lost to Follow-up|3
2591064|NCT01134731|8961061|P2|Overall Study|Lost to Follow-up|4
2591065|NCT01134731|8961062|P1|Overall Study|Lost to Follow-up|5
2591066|NCT01134731|8961060|P3|Overall Study|Withdrawal by Subject|1
2591067|NCT01134731|8961061|P2|Overall Study|Withdrawal by Subject|3
2591068|NCT01134731|8961062|P1|Overall Study|Withdrawal by Subject|3
2591069|NCT01134731|8961060|P3|Overall Study|Lack of Efficacy|1
2591070|NCT01134731|8961061|P2|Overall Study|Lack of Efficacy|0
2591071|NCT01134731|8961062|P1|Overall Study|Lack of Efficacy|0
2591072|NCT01134731|8961060|P3|Overall Study|Physician Decision|2
2591073|NCT01134731|8961061|P2|Overall Study|Physician Decision|2
2591074|NCT01134731|8961062|P1|Overall Study|Physician Decision|2
2591075|NCT01134731|8961060|P3|Overall Study|Adverse Event|1
2591076|NCT01134731|8961061|P2|Overall Study|Adverse Event|2
2591077|NCT01134731|8961062|P1|Overall Study|Adverse Event|3
2591078|NCT01134705|8961075|P2|Overall Study|Other|6
2591079|NCT01134705|8961076|P1|Overall Study|Other|1
2591080|NCT01134705|8961075|P2|Overall Study|Protocol Violation|1
2591081|NCT01134705|8961076|P1|Overall Study|Protocol Violation|1
2591082|NCT01134705|8961075|P2|Overall Study|Lost to Follow-up|2
2591083|NCT01134705|8961076|P1|Overall Study|Lost to Follow-up|5
2591084|NCT01134705|8961075|P2|Overall Study|Pregnancy|0
2591085|NCT01134705|8961076|P1|Overall Study|Pregnancy|1
2591086|NCT01134705|8961075|P2|Overall Study|Withdrawal by Subject|6
2591087|NCT01134705|8961076|P1|Overall Study|Withdrawal by Subject|6
2591088|NCT01134705|8961075|P2|Overall Study|Adverse Event|7
2591089|NCT01134705|8961076|P1|Overall Study|Adverse Event|1
2591090|NCT01134627|8961088|P2|Overall Study|Other|14
2591091|NCT01134627|8961089|P1|Overall Study|Other|11
2591092|NCT01134627|8961088|P2|Overall Study|Planning to become pregnant/pregnancy|0
2591093|NCT01134627|8961089|P1|Overall Study|Planning to become pregnant/pregnancy|1
2591094|NCT01134627|8961088|P2|Overall Study|Withdrawal by Subject|3
2591095|NCT01134627|8961089|P1|Overall Study|Withdrawal by Subject|4
2591096|NCT01134627|8961088|P2|Overall Study|Lack of Efficacy|12
2591097|NCT01134627|8961089|P1|Overall Study|Lack of Efficacy|2
2591098|NCT01134627|8961088|P2|Overall Study|Protocol Violation|5
2591099|NCT01134627|8961089|P1|Overall Study|Protocol Violation|3
2591100|NCT01134627|8961088|P2|Overall Study|Lost to Follow-up|2
2591101|NCT01134627|8961089|P1|Overall Study|Lost to Follow-up|1
2591102|NCT01134627|8961088|P2|Overall Study|Adverse Event|31
2591103|NCT01134627|8961089|P1|Overall Study|Adverse Event|47
2591104|NCT01134614|8961119|P2|Overall Study|Patient in hospice care|1
2591105|NCT01134614|8961120|P1|Overall Study|Patient in hospice care|0
2591106|NCT01134614|8961119|P2|Overall Study|Symptomatic deterioration|1
2591107|NCT01134614|8961120|P1|Overall Study|Symptomatic deterioration|0
2591108|NCT01134614|8961119|P2|Overall Study|Pt received tx not allowed on study|1
2591109|NCT01134614|8961120|P1|Overall Study|Pt received tx not allowed on study|0
2591110|NCT01134614|8961119|P2|Overall Study|Never started treatment|1
2591111|NCT01134614|8961120|P1|Overall Study|Never started treatment|4
2591112|NCT01134614|8961119|P2|Overall Study|Physician's decision|1
2591113|NCT01134614|8961120|P1|Overall Study|Physician's decision|0
2591114|NCT01134614|8961119|P2|Overall Study|Complicating disease|1
2591115|NCT01134614|8961120|P1|Overall Study|Complicating disease|2
2591116|NCT01134614|8961119|P2|Overall Study|Alternative therapy|0
2591117|NCT01134614|8961120|P1|Overall Study|Alternative therapy|2
2591118|NCT01134614|8961119|P2|Overall Study|Withdrawal by Subject|2
2591119|NCT01134614|8961120|P1|Overall Study|Withdrawal by Subject|3
2591120|NCT01134614|8961119|P2|Overall Study|Death|8
2591121|NCT01134614|8961120|P1|Overall Study|Death|5
2591122|NCT01134614|8961119|P2|Overall Study|Adverse Event|39
2591123|NCT01134614|8961120|P1|Overall Study|Adverse Event|26
2591124|NCT01134614|8961119|P2|Overall Study|Progressive disease|54
2591125|NCT01134614|8961120|P1|Overall Study|Progressive disease|60
2591126|NCT01134614|8961119|P2|Overall Study|Still on treatment as of March 2013|13
2591127|NCT01134614|8961120|P1|Overall Study|Still on treatment as of March 2013|21
2591128|NCT01134562|8961148|P5|Overall Study|Adverse Event|0
2591129|NCT01134562|8961149|P4|Overall Study|Adverse Event|0
2591130|NCT01134562|8961150|P3|Overall Study|Adverse Event|0
2591131|NCT01134562|8961151|P2|Overall Study|Adverse Event|1
2591132|NCT01134562|8961152|P1|Overall Study|Adverse Event|0
2591133|NCT01134393|8961324|P1|Overall Study|Other|6
2591134|NCT01134393|8961324|P1|Overall Study|Withdrawal by Subject|11
2591135|NCT01134393|8961324|P1|Overall Study|Lost to Follow-up|3
2591136|NCT01134393|8961324|P1|Overall Study|Protocol Violation|12
2591137|NCT01134393|8961324|P1|Overall Study|Lack of Efficacy|2
2591138|NCT01134393|8961324|P1|Overall Study|Adverse Event|18
2591139|NCT01134315|8961445|P2|Overall Study|Other Reason|17
2591140|NCT01134315|8961446|P1|Overall Study|Other Reason|8
2591141|NCT01134315|8961445|P2|Overall Study|Adverse Event|2
2591142|NCT01134315|8961446|P1|Overall Study|Adverse Event|1
2591143|NCT01134263|8961484|P5|Overall Study|Enrolled, but not treated|0
2591144|NCT01134263|8961485|P4|Overall Study|Enrolled, but not treated|1
2591145|NCT01134263|8961486|P3|Overall Study|Enrolled, but not treated|0
2591146|NCT01134263|8961487|P2|Overall Study|Enrolled, but not treated|1
2591147|NCT01134263|8961488|P1|Overall Study|Enrolled, but not treated|1
2591148|NCT01134263|8961484|P5|Overall Study|Withdrawal by Subject|5
2591149|NCT01134263|8961485|P4|Overall Study|Withdrawal by Subject|7
2591150|NCT01134263|8961486|P3|Overall Study|Withdrawal by Subject|16
2591151|NCT01134263|8961487|P2|Overall Study|Withdrawal by Subject|6
2591152|NCT01134263|8961488|P1|Overall Study|Withdrawal by Subject|8
2591153|NCT01134263|8961484|P5|Overall Study|Lost to Follow-up|1
2591154|NCT01134263|8961485|P4|Overall Study|Lost to Follow-up|3
2591155|NCT01134263|8961486|P3|Overall Study|Lost to Follow-up|5
2591156|NCT01134263|8961487|P2|Overall Study|Lost to Follow-up|3
2591157|NCT01134263|8961488|P1|Overall Study|Lost to Follow-up|4
2591158|NCT01134263|8961484|P5|Overall Study|Protocol Violation|2
2591159|NCT01134263|8961485|P4|Overall Study|Protocol Violation|4
2591160|NCT01134263|8961486|P3|Overall Study|Protocol Violation|2
2591161|NCT01134263|8961487|P2|Overall Study|Protocol Violation|7
2591162|NCT01134263|8961488|P1|Overall Study|Protocol Violation|8
2591163|NCT01134263|8961484|P5|Overall Study|Other adverse event|0
2591164|NCT01134263|8961485|P4|Overall Study|Other adverse event|3
2591165|NCT01134263|8961486|P3|Overall Study|Other adverse event|5
2591166|NCT01134263|8961487|P2|Overall Study|Other adverse event|2
2591167|NCT01134263|8961488|P1|Overall Study|Other adverse event|1
2591168|NCT01134263|8961484|P5|Overall Study|Serious adverse event|1
2591169|NCT01134263|8961485|P4|Overall Study|Serious adverse event|1
2591170|NCT01134263|8961486|P3|Overall Study|Serious adverse event|1
2591171|NCT01134263|8961487|P2|Overall Study|Serious adverse event|1
2591172|NCT01134263|8961488|P1|Overall Study|Serious adverse event|2
2591173|NCT01134107|8961521|P2|Period 2-Second Treatment Intervention|Sponsor Decision|0
2591174|NCT01134107|8961522|P1|Period 2-Second Treatment Intervention|Sponsor Decision|1
2591175|NCT01134107|8961521|P2|Period 2-Second Treatment Intervention|Physician Decision|0
2591176|NCT01134107|8961522|P1|Period 2-Second Treatment Intervention|Physician Decision|1
2591177|NCT01134107|8961521|P2|Period 2-Second Treatment Intervention|Withdrawal by Subject|0
2591178|NCT01134107|8961522|P1|Period 2-Second Treatment Intervention|Withdrawal by Subject|2
2591179|NCT01134107|8961521|P2|Period 1-First Treatment Intervention|Physician Decision|0
2591180|NCT01134107|8961522|P1|Period 1-First Treatment Intervention|Physician Decision|1
2591181|NCT01134107|8961521|P2|Period 1-First Treatment Intervention|Withdrawal by Subject|4
2591182|NCT01134107|8961522|P1|Period 1-First Treatment Intervention|Withdrawal by Subject|3
2591183|NCT01134107|8961521|P2|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
2591184|NCT01134107|8961522|P1|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
2591185|NCT01134107|8961521|P2|Period 1-First Treatment Intervention|Adverse Event|0
2591186|NCT01134107|8961522|P1|Period 1-First Treatment Intervention|Adverse Event|1
2591187|NCT01134055|8961569|P7|Overall Study|Physician Decision|1
2591188|NCT01134055|8961570|P6|Overall Study|Physician Decision|0
2591189|NCT01134055|8961571|P5|Overall Study|Physician Decision|0
2591190|NCT01134055|8961572|P4|Overall Study|Physician Decision|0
2591191|NCT01134055|8961573|P3|Overall Study|Physician Decision|0
2591192|NCT01134055|8961574|P2|Overall Study|Physician Decision|0
2591193|NCT01134055|8961575|P1|Overall Study|Physician Decision|0
2591194|NCT01134055|8961569|P7|Overall Study|Protocol Violation|0
2591195|NCT01134055|8961570|P6|Overall Study|Protocol Violation|0
2591196|NCT01134055|8961571|P5|Overall Study|Protocol Violation|1
2591197|NCT01134055|8961572|P4|Overall Study|Protocol Violation|1
2591198|NCT01134055|8961573|P3|Overall Study|Protocol Violation|0
2591199|NCT01134055|8961574|P2|Overall Study|Protocol Violation|0
2591200|NCT01134055|8961575|P1|Overall Study|Protocol Violation|0
2591201|NCT01134055|8961569|P7|Overall Study|Withdrawal by Subject|8
2591202|NCT01134055|8961570|P6|Overall Study|Withdrawal by Subject|0
2591203|NCT01134055|8961571|P5|Overall Study|Withdrawal by Subject|0
2591204|NCT01134055|8961572|P4|Overall Study|Withdrawal by Subject|2
2591205|NCT01134055|8961573|P3|Overall Study|Withdrawal by Subject|1
2591206|NCT01134055|8961574|P2|Overall Study|Withdrawal by Subject|3
2591207|NCT01134055|8961575|P1|Overall Study|Withdrawal by Subject|3
2591208|NCT01134055|8961569|P7|Overall Study|Lost to Follow-up|0
2591209|NCT01134055|8961570|P6|Overall Study|Lost to Follow-up|0
2591210|NCT01134055|8961571|P5|Overall Study|Lost to Follow-up|0
2591211|NCT01134055|8961572|P4|Overall Study|Lost to Follow-up|1
2591212|NCT01134055|8961573|P3|Overall Study|Lost to Follow-up|0
2591213|NCT01134055|8961574|P2|Overall Study|Lost to Follow-up|1
2591214|NCT01134055|8961575|P1|Overall Study|Lost to Follow-up|0
2591215|NCT01134055|8961569|P7|Overall Study|Adverse Event|2
2591216|NCT01134055|8961570|P6|Overall Study|Adverse Event|7
2591217|NCT01134055|8961571|P5|Overall Study|Adverse Event|5
2591218|NCT01134055|8961572|P4|Overall Study|Adverse Event|2
2591219|NCT01134055|8961573|P3|Overall Study|Adverse Event|2
2591220|NCT01134055|8961574|P2|Overall Study|Adverse Event|2
2591221|NCT01134055|8961575|P1|Overall Study|Adverse Event|5
2591222|NCT01134042|8961709|P3|Overall Study|Withdrawal by Subject|7
2591223|NCT01134042|8961710|P2|Overall Study|Withdrawal by Subject|4
2591224|NCT01134042|8961711|P1|Overall Study|Withdrawal by Subject|13
2591225|NCT01134042|8961709|P3|Overall Study|Physician Decision|1
2591226|NCT01134042|8961710|P2|Overall Study|Physician Decision|8
2591227|NCT01134042|8961711|P1|Overall Study|Physician Decision|4
2591228|NCT01134042|8961709|P3|Overall Study|Lost to Follow-up|1
2591229|NCT01134042|8961710|P2|Overall Study|Lost to Follow-up|0
2591230|NCT01134042|8961711|P1|Overall Study|Lost to Follow-up|2
2591231|NCT01134042|8961709|P3|Overall Study|Protocol Violation|5
2591232|NCT01134042|8961710|P2|Overall Study|Protocol Violation|3
2591233|NCT01134042|8961711|P1|Overall Study|Protocol Violation|5
2591234|NCT01134042|8961709|P3|Overall Study|Lack of Efficacy|18
2591235|NCT01134042|8961710|P2|Overall Study|Lack of Efficacy|6
2591236|NCT01134042|8961711|P1|Overall Study|Lack of Efficacy|21
2591237|NCT01134042|8961709|P3|Overall Study|Adverse Event|2
2591238|NCT01134042|8961710|P2|Overall Study|Adverse Event|7
2591239|NCT01134042|8961711|P1|Overall Study|Adverse Event|3
2591240|NCT01133977|8961787|P5|Overall Study|Withdrawal by Subject|1
2591241|NCT01133977|8961788|P4|Overall Study|Withdrawal by Subject|5
2591242|NCT01133977|8961789|P3|Overall Study|Withdrawal by Subject|0
2591243|NCT01133977|8961790|P2|Overall Study|Withdrawal by Subject|0
2591244|NCT01133977|8961791|P1|Overall Study|Withdrawal by Subject|0
2591245|NCT01133977|8961787|P5|Overall Study|Lost to Follow-up|1
2591246|NCT01133977|8961788|P4|Overall Study|Lost to Follow-up|2
2591247|NCT01133977|8961789|P3|Overall Study|Lost to Follow-up|0
2591248|NCT01133977|8961790|P2|Overall Study|Lost to Follow-up|0
2591249|NCT01133977|8961791|P1|Overall Study|Lost to Follow-up|0
2591250|NCT01133977|8961787|P5|Overall Study|Started a New Line of Therapy|33
2591251|NCT01133977|8961788|P4|Overall Study|Started a New Line of Therapy|25
2591252|NCT01133977|8961789|P3|Overall Study|Started a New Line of Therapy|4
2591253|NCT01133977|8961790|P2|Overall Study|Started a New Line of Therapy|6
2591254|NCT01133977|8961791|P1|Overall Study|Started a New Line of Therapy|2
2591255|NCT01133977|8961787|P5|Overall Study|Death|3
2591256|NCT01133977|8961788|P4|Overall Study|Death|7
2591257|NCT01133977|8961789|P3|Overall Study|Death|1
2591258|NCT01133977|8961790|P2|Overall Study|Death|1
2591259|NCT01133977|8961791|P1|Overall Study|Death|1
2591260|NCT01133977|8961787|P5|Overall Study|Adverse Event|0
2591261|NCT01133977|8961788|P4|Overall Study|Adverse Event|0
2591262|NCT01133977|8961789|P3|Overall Study|Adverse Event|1
2591263|NCT01133977|8961790|P2|Overall Study|Adverse Event|0
2591264|NCT01133977|8961791|P1|Overall Study|Adverse Event|0
2591265|NCT01133847|8961818|P3|Follow-Up Phase|Lost to Follow-up|7
2591266|NCT01133847|8961819|P2|Follow-Up Phase|Lost to Follow-up|3
2591267|NCT01133847|8961820|P1|Follow-Up Phase|Lost to Follow-up|1
2591268|NCT01133847|8961818|P3|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3
2591269|NCT01133847|8961819|P2|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1
2591270|NCT01133847|8961820|P1|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5
2591271|NCT01133821|8961860|P2|Overall Study|Refused participation|3
2591272|NCT01133821|8961861|P1|Overall Study|Refused participation|1
2591273|NCT01133821|8961860|P2|Overall Study|Protocol Violation|1
2591274|NCT01133821|8961861|P1|Overall Study|Protocol Violation|0
2591275|NCT01133821|8961860|P2|Overall Study|preferred other treatment|1
2591276|NCT01133821|8961861|P1|Overall Study|preferred other treatment|1
2591277|NCT01133821|8961860|P2|Overall Study|Withdrawal by Subject|3
2591278|NCT01133821|8961861|P1|Overall Study|Withdrawal by Subject|8
2591279|NCT01133821|8961860|P2|Overall Study|Lost to Follow-up|11
2591280|NCT01133821|8961861|P1|Overall Study|Lost to Follow-up|8
2591281|NCT01133756|8961872|P3|Overall Study|Progression of Disease|1
2591282|NCT01133756|8961873|P2|Overall Study|Progression of Disease|0
2591283|NCT01133756|8961874|P1|Overall Study|Progression of Disease|0
2591284|NCT01133756|8961872|P3|Overall Study|Withdrawal by Subject|0
2591285|NCT01133756|8961873|P2|Overall Study|Withdrawal by Subject|1
2591286|NCT01133756|8961874|P1|Overall Study|Withdrawal by Subject|0
2591287|NCT01133756|8961872|P3|Overall Study|Investigator Decision|0
2591288|NCT01133756|8961873|P2|Overall Study|Investigator Decision|0
2591289|NCT01133756|8961874|P1|Overall Study|Investigator Decision|1
2591290|NCT01133756|8961872|P3|Overall Study|Adverse Event|1
2591291|NCT01133756|8961873|P2|Overall Study|Adverse Event|2
2591292|NCT01133756|8961874|P1|Overall Study|Adverse Event|1
2591293|NCT01133704|8961890|P2|Overall Study|Study Closure|0
2591294|NCT01133704|8961891|P1|Overall Study|Study Closure|1
2591295|NCT01133704|8961890|P2|Overall Study|Patient refused to continue|0
2591296|NCT01133704|8961891|P1|Overall Study|Patient refused to continue|4
2591297|NCT01133704|8961890|P2|Overall Study|Death|26
2591298|NCT01133704|8961891|P1|Overall Study|Death|44
2591299|NCT01133665|8961899|P1|Overall Study|Physician Decision|2
2591300|NCT01133626|8961959|P3|Overall Study|Other|0
2591301|NCT01133626|8961960|P2|Overall Study|Other|2
2591302|NCT01133626|8961961|P1|Overall Study|Other|0
2591303|NCT01133626|8961959|P3|Overall Study|Withdrawal by Subject|2
2591304|NCT01133626|8961960|P2|Overall Study|Withdrawal by Subject|2
2591305|NCT01133626|8961961|P1|Overall Study|Withdrawal by Subject|1
2591306|NCT01133626|8961959|P3|Overall Study|Adverse Event|0
2591307|NCT01133626|8961960|P2|Overall Study|Adverse Event|1
2591308|NCT01133626|8961961|P1|Overall Study|Adverse Event|0
2591309|NCT01133522|8961979|P10|Overall Study|Physician Decision|0
2591310|NCT01133522|8961980|P9|Overall Study|Physician Decision|0
2591311|NCT01133522|8961981|P8|Overall Study|Physician Decision|0
2591312|NCT01133522|8961982|P7|Overall Study|Physician Decision|0
2591313|NCT01133522|8961983|P6|Overall Study|Physician Decision|0
2591314|NCT01133522|8961984|P5|Overall Study|Physician Decision|1
2591315|NCT01133522|8961985|P4|Overall Study|Physician Decision|0
2591316|NCT01133522|8961986|P3|Overall Study|Physician Decision|0
2591317|NCT01133522|8961987|P2|Overall Study|Physician Decision|0
2591318|NCT01133522|8961988|P1|Overall Study|Physician Decision|0
2591319|NCT01133522|8961979|P10|Overall Study|Withdrawal by Subject|0
2591320|NCT01133522|8961980|P9|Overall Study|Withdrawal by Subject|0
2591321|NCT01133522|8961981|P8|Overall Study|Withdrawal by Subject|0
2591322|NCT01133522|8961982|P7|Overall Study|Withdrawal by Subject|0
2591323|NCT01133522|8961983|P6|Overall Study|Withdrawal by Subject|0
2591324|NCT01133522|8961984|P5|Overall Study|Withdrawal by Subject|0
2591325|NCT01133522|8961985|P4|Overall Study|Withdrawal by Subject|1
2591326|NCT01133522|8961986|P3|Overall Study|Withdrawal by Subject|0
2591327|NCT01133522|8961987|P2|Overall Study|Withdrawal by Subject|1
2591328|NCT01133522|8961988|P1|Overall Study|Withdrawal by Subject|0
2591329|NCT01133418|8962056|P2|Overall Study|Lost to Follow-up|6
2591330|NCT01133418|8962057|P1|Overall Study|Lost to Follow-up|5
2591331|NCT01133405|8962079|P10|Period 2|Physician Decision|0
2591332|NCT01133405|8962080|P9|Period 2|Physician Decision|0
2591333|NCT01133405|8962081|P8|Period 2|Physician Decision|0
2591334|NCT01133405|8962082|P7|Period 2|Physician Decision|0
2591335|NCT01133405|8962083|P6|Period 2|Physician Decision|1
2591336|NCT01133405|8962084|P5|Period 2|Physician Decision|0
2591337|NCT01133405|8962085|P4|Period 2|Physician Decision|0
2591338|NCT01133405|8962086|P3|Period 2|Physician Decision|0
2591339|NCT01133405|8962087|P2|Period 2|Physician Decision|0
2591340|NCT01133405|8962088|P1|Period 2|Physician Decision|0
2591341|NCT01133405|8962079|P10|Period 2|Entry Criteria Not Met|0
2591342|NCT01133405|8962080|P9|Period 2|Entry Criteria Not Met|0
2591343|NCT01133405|8962081|P8|Period 2|Entry Criteria Not Met|0
2591344|NCT01133405|8962082|P7|Period 2|Entry Criteria Not Met|0
2591345|NCT01133405|8962083|P6|Period 2|Entry Criteria Not Met|0
2591346|NCT01133405|8962084|P5|Period 2|Entry Criteria Not Met|0
2591347|NCT01133405|8962085|P4|Period 2|Entry Criteria Not Met|0
2591348|NCT01133405|8962086|P3|Period 2|Entry Criteria Not Met|0
2591349|NCT01133405|8962087|P2|Period 2|Entry Criteria Not Met|1
2591350|NCT01133405|8962088|P1|Period 2|Entry Criteria Not Met|0
2591351|NCT01133405|8962079|P10|Period 2|Withdrawal by Subject|0
2591352|NCT01133405|8962080|P9|Period 2|Withdrawal by Subject|0
2591353|NCT01133405|8962081|P8|Period 2|Withdrawal by Subject|0
2591354|NCT01133405|8962082|P7|Period 2|Withdrawal by Subject|0
2591355|NCT01133405|8962083|P6|Period 2|Withdrawal by Subject|1
2591356|NCT01133405|8962084|P5|Period 2|Withdrawal by Subject|0
2591357|NCT01133405|8962085|P4|Period 2|Withdrawal by Subject|1
2591358|NCT01133405|8962086|P3|Period 2|Withdrawal by Subject|0
2591359|NCT01133405|8962087|P2|Period 2|Withdrawal by Subject|0
2591360|NCT01133405|8962088|P1|Period 2|Withdrawal by Subject|0
2591361|NCT01133405|8962079|P10|Period 2|Adverse Event|0
2591362|NCT01133405|8962080|P9|Period 2|Adverse Event|0
2591363|NCT01133405|8962081|P8|Period 2|Adverse Event|0
2591364|NCT01133405|8962082|P7|Period 2|Adverse Event|0
2591365|NCT01133405|8962083|P6|Period 2|Adverse Event|0
2591366|NCT01133405|8962084|P5|Period 2|Adverse Event|0
2591367|NCT01133405|8962085|P4|Period 2|Adverse Event|0
2591368|NCT01133405|8962086|P3|Period 2|Adverse Event|1
2591369|NCT01133405|8962087|P2|Period 2|Adverse Event|0
2591370|NCT01133405|8962088|P1|Period 2|Adverse Event|0
2591371|NCT01133405|8962079|P10|Period 1|Received drug only in period 3|0
2591372|NCT01133405|8962080|P9|Period 1|Received drug only in period 3|0
2591373|NCT01133405|8962081|P8|Period 1|Received drug only in period 3|0
2591374|NCT01133405|8962082|P7|Period 1|Received drug only in period 3|0
2591375|NCT01133405|8962083|P6|Period 1|Received drug only in period 3|0
2591376|NCT01133405|8962084|P5|Period 1|Received drug only in period 3|0
2591377|NCT01133405|8962085|P4|Period 1|Received drug only in period 3|0
2591378|NCT01133405|8962086|P3|Period 1|Received drug only in period 3|1
2591379|NCT01133405|8962087|P2|Period 1|Received drug only in period 3|1
2591380|NCT01133405|8962088|P1|Period 1|Received drug only in period 3|0
2591381|NCT01133405|8962079|P10|Period 1|Received drug only in period 2|0
2591382|NCT01133405|8962080|P9|Period 1|Received drug only in period 2|0
2591383|NCT01133405|8962081|P8|Period 1|Received drug only in period 2|0
2591384|NCT01133405|8962082|P7|Period 1|Received drug only in period 2|0
2591385|NCT01133405|8962083|P6|Period 1|Received drug only in period 2|1
2591386|NCT01133405|8962084|P5|Period 1|Received drug only in period 2|0
2591387|NCT01133405|8962085|P4|Period 1|Received drug only in period 2|2
2591388|NCT01133405|8962086|P3|Period 1|Received drug only in period 2|0
2591389|NCT01133405|8962087|P2|Period 1|Received drug only in period 2|1
2591390|NCT01133405|8962088|P1|Period 1|Received drug only in period 2|0
2591391|NCT01133405|8962079|P10|Period 1|Discontinued after randomization|0
2591392|NCT01133405|8962080|P9|Period 1|Discontinued after randomization|0
2591393|NCT01133405|8962081|P8|Period 1|Discontinued after randomization|0
2591394|NCT01133405|8962082|P7|Period 1|Discontinued after randomization|1
2591395|NCT01133405|8962083|P6|Period 1|Discontinued after randomization|0
2591396|NCT01133405|8962084|P5|Period 1|Discontinued after randomization|0
2591397|NCT01133405|8962085|P4|Period 1|Discontinued after randomization|0
2591398|NCT01133405|8962086|P3|Period 1|Discontinued after randomization|0
2591399|NCT01133405|8962087|P2|Period 1|Discontinued after randomization|0
2591400|NCT01133405|8962088|P1|Period 1|Discontinued after randomization|1
2591401|NCT01133405|8962079|P10|Period 1|Physician Decision|0
2591402|NCT01133405|8962080|P9|Period 1|Physician Decision|0
2591403|NCT01133405|8962081|P8|Period 1|Physician Decision|0
2591404|NCT01133405|8962082|P7|Period 1|Physician Decision|0
2591405|NCT01133405|8962083|P6|Period 1|Physician Decision|0
2591406|NCT01133405|8962084|P5|Period 1|Physician Decision|0
2591407|NCT01133405|8962085|P4|Period 1|Physician Decision|1
2591408|NCT01133405|8962086|P3|Period 1|Physician Decision|0
2591409|NCT01133405|8962087|P2|Period 1|Physician Decision|0
2591410|NCT01133405|8962088|P1|Period 1|Physician Decision|0
2591411|NCT01133405|8962079|P10|Period 1|Withdrawal by Subject|0
2591412|NCT01133405|8962080|P9|Period 1|Withdrawal by Subject|0
2591413|NCT01133405|8962081|P8|Period 1|Withdrawal by Subject|0
2591414|NCT01133405|8962082|P7|Period 1|Withdrawal by Subject|0
2591415|NCT01133405|8962083|P6|Period 1|Withdrawal by Subject|1
2591416|NCT01133405|8962084|P5|Period 1|Withdrawal by Subject|0
2591417|NCT01133405|8962085|P4|Period 1|Withdrawal by Subject|1
2591418|NCT01133405|8962086|P3|Period 1|Withdrawal by Subject|0
2591419|NCT01133405|8962087|P2|Period 1|Withdrawal by Subject|1
2591420|NCT01133405|8962088|P1|Period 1|Withdrawal by Subject|0
2591421|NCT01133392|8962139|P2|Interval Between Dosing (4-7 Days)|Protocol Violation|1
2591422|NCT01133392|8962140|P1|Interval Between Dosing (4-7 Days)|Protocol Violation|0
2591423|NCT01133392|8962139|P2|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1
2591424|NCT01133392|8962140|P1|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0
2591425|NCT01133379|8962157|P3|Overall Study|Lost to Follow-up|1
2591426|NCT01133379|8962158|P2|Overall Study|Lost to Follow-up|1
2591427|NCT01133379|8962159|P1|Overall Study|Lost to Follow-up|1
2591428|NCT01133379|8962157|P3|Overall Study|Withdrawal by Subject|1
2591429|NCT01133379|8962158|P2|Overall Study|Withdrawal by Subject|1
2591430|NCT01133379|8962159|P1|Overall Study|Withdrawal by Subject|0
2591431|NCT01133288|8962212|P1|Intervention Allocation|study terminated|2
2591432|NCT01133288|8962212|P1|Eligibility Assessment|met exclusion criteria|5
2591433|NCT01133275|8962217|P1|Overall Study|Cerebrovascular accident (CVA)|1
2591434|NCT01133275|8962217|P1|Overall Study|Withdrawal by Subject|1
2591435|NCT01133171|8962225|P3|Overall Study|Withdrawal by Subject|0
2591436|NCT01133171|8962226|P2|Overall Study|Withdrawal by Subject|2
2591437|NCT01133171|8962227|P1|Overall Study|Withdrawal by Subject|1
2591438|NCT01133067|8962243|P1|Overall Study|Lost to Follow-up|3
2591439|NCT01133067|8962243|P1|Overall Study|Death|136
2591440|NCT01132820|8962303|P1|Overall Study|Inadequate data|1
2591441|NCT01132820|8962303|P1|Overall Study|Never treated|1
2591442|NCT01132820|8962303|P1|Overall Study|Ineligible:Inadequate pathology|1
2591443|NCT01132820|8962303|P1|Overall Study|Ineligible:Improper pre-protocol therapy|1
2591444|NCT01132820|8962303|P1|Overall Study|Ineligible: wrong cell type|1
2591445|NCT01132755|8962312|P1|Overall Study|Withdrawal by Subject|4
2591446|NCT01132755|8962312|P1|Overall Study|Protocol Violation|15
2591447|NCT01132755|8962312|P1|Overall Study|Procedure not done due to medical reason|23
2591448|NCT01132664|8962341|P5|BM Cohort|Withdrawal by Subject|1
2591449|NCT01132664|8962342|P4|BM Cohort|Withdrawal by Subject|0
2591450|NCT01132664|8962343|P3|BM Cohort|Withdrawal by Subject|0
2591451|NCT01132664|8962344|P2|BM Cohort|Withdrawal by Subject|0
2591452|NCT01132664|8962345|P1|BM Cohort|Withdrawal by Subject|0
2591453|NCT01132664|8962341|P5|BM Cohort|Adverse Event|1
2591454|NCT01132664|8962342|P4|BM Cohort|Adverse Event|0
2591455|NCT01132664|8962343|P3|BM Cohort|Adverse Event|0
2591456|NCT01132664|8962344|P2|BM Cohort|Adverse Event|0
2591457|NCT01132664|8962345|P1|BM Cohort|Adverse Event|0
2591458|NCT01132664|8962341|P5|BM Cohort|Disease progression|4
2591459|NCT01132664|8962342|P4|BM Cohort|Disease progression|3
2591460|NCT01132664|8962343|P3|BM Cohort|Disease progression|0
2591461|NCT01132664|8962344|P2|BM Cohort|Disease progression|0
2591462|NCT01132664|8962345|P1|BM Cohort|Disease progression|0
2591463|NCT01132664|8962341|P5|Phase ll|Disease progression|0
2591464|NCT01132664|8962342|P4|Phase ll|Disease progression|0
2591465|NCT01132664|8962343|P3|Phase ll|Disease progression|35
2591466|NCT01132664|8962344|P2|Phase ll|Disease progression|0
2591467|NCT01132664|8962345|P1|Phase ll|Disease progression|0
2591468|NCT01132664|8962341|P5|Phase ll|Withdrawal by Subject|0
2591469|NCT01132664|8962342|P4|Phase ll|Withdrawal by Subject|0
2591470|NCT01132664|8962343|P3|Phase ll|Withdrawal by Subject|3
2591471|NCT01132664|8962344|P2|Phase ll|Withdrawal by Subject|0
2591472|NCT01132664|8962345|P1|Phase ll|Withdrawal by Subject|0
2591473|NCT01132664|8962341|P5|Phase ll|Adverse Event|0
2591474|NCT01132664|8962342|P4|Phase ll|Adverse Event|0
2591475|NCT01132664|8962343|P3|Phase ll|Adverse Event|10
2591476|NCT01132664|8962344|P2|Phase ll|Adverse Event|0
2591477|NCT01132664|8962345|P1|Phase ll|Adverse Event|0
2591478|NCT01132664|8962341|P5|Phase ll|Death|0
2591479|NCT01132664|8962342|P4|Phase ll|Death|0
2591480|NCT01132664|8962343|P3|Phase ll|Death|2
2591481|NCT01132664|8962344|P2|Phase ll|Death|0
2591482|NCT01132664|8962345|P1|Phase ll|Death|0
2591483|NCT01132664|8962341|P5|Phase lb|Disease Progression|0
2591484|NCT01132664|8962342|P4|Phase lb|Disease Progression|0
2591485|NCT01132664|8962343|P3|Phase lb|Disease Progression|0
2591486|NCT01132664|8962344|P2|Phase lb|Disease Progression|9
2591487|NCT01132664|8962345|P1|Phase lb|Disease Progression|4
2591488|NCT01132664|8962341|P5|Phase lb|Withdrawal by Subject|0
2591489|NCT01132664|8962342|P4|Phase lb|Withdrawal by Subject|0
2591490|NCT01132664|8962343|P3|Phase lb|Withdrawal by Subject|0
2591491|NCT01132664|8962344|P2|Phase lb|Withdrawal by Subject|2
2591492|NCT01132664|8962345|P1|Phase lb|Withdrawal by Subject|1
2591493|NCT01132664|8962341|P5|Phase lb|Adverse Event|0
2591494|NCT01132664|8962342|P4|Phase lb|Adverse Event|0
2591495|NCT01132664|8962343|P3|Phase lb|Adverse Event|0
2591496|NCT01132664|8962344|P2|Phase lb|Adverse Event|1
2591497|NCT01132664|8962345|P1|Phase lb|Adverse Event|0
2591498|NCT01132651|8962379|P2|Overall Study|Lost to Follow-up|1
2591499|NCT01132651|8962380|P1|Overall Study|Lost to Follow-up|1
2591500|NCT01132612|8962391|P3|Overall Study|Lack of Efficacy|73
2591501|NCT01132612|8962392|P2|Overall Study|Lack of Efficacy|22
2591502|NCT01132612|8962393|P1|Overall Study|Lack of Efficacy|23
2591503|NCT01132612|8962391|P3|Overall Study|Administrative problems|52
2591504|NCT01132612|8962392|P2|Overall Study|Administrative problems|1
2591505|NCT01132612|8962393|P1|Overall Study|Administrative problems|5
2591506|NCT01132612|8962391|P3|Overall Study|Withdrawal by Subject|19
2591507|NCT01132612|8962392|P2|Overall Study|Withdrawal by Subject|8
2591508|NCT01132612|8962393|P1|Overall Study|Withdrawal by Subject|5
2591509|NCT01132612|8962391|P3|Overall Study|Adverse Event|15
2591510|NCT01132612|8962392|P2|Overall Study|Adverse Event|2
2591511|NCT01132612|8962393|P1|Overall Study|Adverse Event|5
2591512|NCT01132612|8962391|P3|Overall Study|Lost to Follow-up|7
2591513|NCT01132612|8962392|P2|Overall Study|Lost to Follow-up|2
2591514|NCT01132612|8962393|P1|Overall Study|Lost to Follow-up|2
2591515|NCT01132612|8962391|P3|Overall Study|Protocol deviation|3
2591516|NCT01132612|8962392|P2|Overall Study|Protocol deviation|0
2591517|NCT01132612|8962393|P1|Overall Study|Protocol deviation|0
2591518|NCT01132612|8962391|P3|Overall Study|Death|1
2591519|NCT01132612|8962392|P2|Overall Study|Death|0
2591520|NCT01132612|8962393|P1|Overall Study|Death|0
2591521|NCT01132547|8962409|P2|Overall Study|Death|0
2591522|NCT01132547|8962410|P1|Overall Study|Death|1
2591523|NCT01132547|8962409|P2|Overall Study|Withdrawal by Subject|1
2591524|NCT01132547|8962410|P1|Overall Study|Withdrawal by Subject|3
2591525|NCT01132495|8962480|P4|Overall Study|Various reasons|12
2591526|NCT01132495|8962481|P3|Overall Study|Various reasons|20
2591527|NCT01132495|8962482|P2|Overall Study|Various reasons|38
2591528|NCT01132495|8962483|P1|Overall Study|Various reasons|40
2591529|NCT01132482|8962496|P2|Overall Study|Adverse Event|0
2591530|NCT01132482|8962497|P1|Overall Study|Adverse Event|1
2591531|NCT01132326|8962520|P1|Overall Study|Subject Unable to Come To Visits|1
2591532|NCT01132326|8962520|P1|Overall Study|Death|5
2591533|NCT01132326|8962520|P1|Overall Study|Caregiver Withdrew Consent|1
2591534|NCT01132326|8962520|P1|Overall Study|Pregnancy|1
2591535|NCT01132326|8962520|P1|Overall Study|Declining Health|1
2591536|NCT01132326|8962520|P1|Overall Study|Study Termination|80
2591537|NCT01132326|8962520|P1|Overall Study|Physician Decision|10
2591538|NCT01132326|8962520|P1|Overall Study|Withdrawal by Subject|40
2591539|NCT01132326|8962520|P1|Overall Study|Lost to Follow-up|16
2591540|NCT01132326|8962520|P1|Overall Study|Protocol Violation|1
2591541|NCT01132326|8962520|P1|Overall Study|Adverse Event|37
2591542|NCT01132326|8962520|P1|Overall Study|Lack of Efficacy|25
2591543|NCT01132313|8962536|P12|Overall Study|Other reason not defined above|0
2591544|NCT01132313|8962537|P11|Overall Study|Other reason not defined above|0
2591545|NCT01132313|8962538|P10|Overall Study|Other reason not defined above|0
2591546|NCT01132313|8962539|P9|Overall Study|Other reason not defined above|0
2591547|NCT01132313|8962540|P8|Overall Study|Other reason not defined above|1
2591548|NCT01132313|8962541|P7|Overall Study|Other reason not defined above|0
2591549|NCT01132313|8962542|P6|Overall Study|Other reason not defined above|0
2591550|NCT01132313|8962543|P5|Overall Study|Other reason not defined above|0
2591551|NCT01132313|8962544|P4|Overall Study|Other reason not defined above|0
2591552|NCT01132313|8962545|P3|Overall Study|Other reason not defined above|0
2591553|NCT01132313|8962546|P2|Overall Study|Other reason not defined above|0
2591554|NCT01132313|8962547|P1|Overall Study|Other reason not defined above|0
2591555|NCT01132313|8962536|P12|Overall Study|Lack of antiviral response|0
2591556|NCT01132313|8962537|P11|Overall Study|Lack of antiviral response|1
2591557|NCT01132313|8962538|P10|Overall Study|Lack of antiviral response|0
2591558|NCT01132313|8962539|P9|Overall Study|Lack of antiviral response|0
2591559|NCT01132313|8962540|P8|Overall Study|Lack of antiviral response|0
2591560|NCT01132313|8962541|P7|Overall Study|Lack of antiviral response|21
2591561|NCT01132313|8962542|P6|Overall Study|Lack of antiviral response|18
2591562|NCT01132313|8962543|P5|Overall Study|Lack of antiviral response|18
2591563|NCT01132313|8962544|P4|Overall Study|Lack of antiviral response|18
2591564|NCT01132313|8962545|P3|Overall Study|Lack of antiviral response|12
2591565|NCT01132313|8962546|P2|Overall Study|Lack of antiviral response|0
2591566|NCT01132313|8962547|P1|Overall Study|Lack of antiviral response|0
2591567|NCT01132313|8962536|P12|Overall Study|Withdrawal by Subject|0
2591568|NCT01132313|8962537|P11|Overall Study|Withdrawal by Subject|0
2591569|NCT01132313|8962538|P10|Overall Study|Withdrawal by Subject|2
2591570|NCT01132313|8962539|P9|Overall Study|Withdrawal by Subject|0
2591571|NCT01132313|8962540|P8|Overall Study|Withdrawal by Subject|0
2591572|NCT01132313|8962541|P7|Overall Study|Withdrawal by Subject|1
2591573|NCT01132313|8962542|P6|Overall Study|Withdrawal by Subject|0
2591574|NCT01132313|8962543|P5|Overall Study|Withdrawal by Subject|6
2591575|NCT01132313|8962544|P4|Overall Study|Withdrawal by Subject|3
2591576|NCT01132313|8962545|P3|Overall Study|Withdrawal by Subject|3
2591577|NCT01132313|8962546|P2|Overall Study|Withdrawal by Subject|0
2591578|NCT01132313|8962547|P1|Overall Study|Withdrawal by Subject|0
2591579|NCT01132313|8962536|P12|Overall Study|Lost to Follow-up|0
2591580|NCT01132313|8962537|P11|Overall Study|Lost to Follow-up|0
2591581|NCT01132313|8962538|P10|Overall Study|Lost to Follow-up|0
2591582|NCT01132313|8962539|P9|Overall Study|Lost to Follow-up|0
2591583|NCT01132313|8962540|P8|Overall Study|Lost to Follow-up|1
2591584|NCT01132313|8962541|P7|Overall Study|Lost to Follow-up|0
2591585|NCT01132313|8962542|P6|Overall Study|Lost to Follow-up|0
2591586|NCT01132313|8962543|P5|Overall Study|Lost to Follow-up|0
2591587|NCT01132313|8962544|P4|Overall Study|Lost to Follow-up|0
2591588|NCT01132313|8962545|P3|Overall Study|Lost to Follow-up|1
2591589|NCT01132313|8962546|P2|Overall Study|Lost to Follow-up|0
2591590|NCT01132313|8962547|P1|Overall Study|Lost to Follow-up|0
2591591|NCT01132313|8962536|P12|Overall Study|Protocol Violation|0
2591592|NCT01132313|8962537|P11|Overall Study|Protocol Violation|0
2591593|NCT01132313|8962538|P10|Overall Study|Protocol Violation|0
2591594|NCT01132313|8962539|P9|Overall Study|Protocol Violation|0
2591595|NCT01132313|8962540|P8|Overall Study|Protocol Violation|0
2591596|NCT01132313|8962541|P7|Overall Study|Protocol Violation|0
2591597|NCT01132313|8962542|P6|Overall Study|Protocol Violation|0
2591598|NCT01132313|8962543|P5|Overall Study|Protocol Violation|0
2591599|NCT01132313|8962544|P4|Overall Study|Protocol Violation|1
2591600|NCT01132313|8962545|P3|Overall Study|Protocol Violation|0
2591601|NCT01132313|8962546|P2|Overall Study|Protocol Violation|0
2591602|NCT01132313|8962547|P1|Overall Study|Protocol Violation|0
2591603|NCT01132313|8962536|P12|Overall Study|Adverse Event|0
2591604|NCT01132313|8962537|P11|Overall Study|Adverse Event|0
2591605|NCT01132313|8962538|P10|Overall Study|Adverse Event|2
2591606|NCT01132313|8962539|P9|Overall Study|Adverse Event|7
2591607|NCT01132313|8962540|P8|Overall Study|Adverse Event|3
2591608|NCT01132313|8962541|P7|Overall Study|Adverse Event|5
2591609|NCT01132313|8962542|P6|Overall Study|Adverse Event|6
2591610|NCT01132313|8962543|P5|Overall Study|Adverse Event|19
2591611|NCT01132313|8962544|P4|Overall Study|Adverse Event|10
2591612|NCT01132313|8962545|P3|Overall Study|Adverse Event|4
2591613|NCT01132313|8962546|P2|Overall Study|Adverse Event|0
2591614|NCT01132313|8962547|P1|Overall Study|Adverse Event|0
2591615|NCT01132313|8962536|P12|Overall Study|Not treated|0
2591616|NCT01132313|8962537|P11|Overall Study|Not treated|0
2591617|NCT01132313|8962538|P10|Overall Study|Not treated|0
2591618|NCT01132313|8962539|P9|Overall Study|Not treated|0
2591619|NCT01132313|8962540|P8|Overall Study|Not treated|0
2591620|NCT01132313|8962541|P7|Overall Study|Not treated|3
2591621|NCT01132313|8962542|P6|Overall Study|Not treated|1
2591622|NCT01132313|8962543|P5|Overall Study|Not treated|2
2591623|NCT01132313|8962544|P4|Overall Study|Not treated|0
2591624|NCT01132313|8962545|P3|Overall Study|Not treated|0
2591625|NCT01132313|8962546|P2|Overall Study|Not treated|0
2591626|NCT01132313|8962547|P1|Overall Study|Not treated|2
2591627|NCT01132313|8962536|P12|Overall Study|Lack of Efficacy|0
2591628|NCT01132313|8962537|P11|Overall Study|Lack of Efficacy|0
2591629|NCT01132313|8962538|P10|Overall Study|Lack of Efficacy|16
2591630|NCT01132313|8962539|P9|Overall Study|Lack of Efficacy|14
2591631|NCT01132313|8962540|P8|Overall Study|Lack of Efficacy|3
2591632|NCT01132313|8962541|P7|Overall Study|Lack of Efficacy|0
2591633|NCT01132313|8962542|P6|Overall Study|Lack of Efficacy|0
2591634|NCT01132313|8962543|P5|Overall Study|Lack of Efficacy|0
2591635|NCT01132313|8962544|P4|Overall Study|Lack of Efficacy|0
2591636|NCT01132313|8962545|P3|Overall Study|Lack of Efficacy|0
2591637|NCT01132313|8962546|P2|Overall Study|Lack of Efficacy|0
2591638|NCT01132313|8962547|P1|Overall Study|Lack of Efficacy|1
2591639|NCT01132118|8962627|P2|Second Intervention (8 Weeks)|Adverse Event|1
2591640|NCT01132118|8962628|P1|Second Intervention (8 Weeks)|Adverse Event|0
2591641|NCT01132118|8962627|P2|First Intervention (8 Weeks)|Withdrawal by Subject|3
2591642|NCT01132118|8962628|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
2591643|NCT01132118|8962627|P2|First Intervention (8 Weeks)|Adverse Event|0
2591644|NCT01132118|8962628|P1|First Intervention (8 Weeks)|Adverse Event|1
2591645|NCT01131676|8962658|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2
2591646|NCT01131676|8962659|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
2591647|NCT01131676|8962660|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
2591648|NCT01131676|8962658|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5
2591649|NCT01131676|8962659|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6
2591650|NCT01131676|8962660|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7
2591651|NCT01131676|8962658|P3|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7
2591652|NCT01131676|8962659|P2|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9
2591653|NCT01131676|8962660|P1|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5
2591654|NCT01131676|8962658|P3|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19
2591655|NCT01131676|8962659|P2|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21
2591656|NCT01131676|8962660|P1|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20
2591657|NCT01131676|8962658|P3|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5
2591658|NCT01131676|8962659|P2|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6
2591659|NCT01131676|8962660|P1|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8
2591660|NCT01131676|8962658|P3|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25
2591661|NCT01131676|8962659|P2|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35
2591662|NCT01131676|8962660|P1|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23
2591663|NCT01131676|8962658|P3|Discontinuation From Treatment|Adverse Event|273
2591664|NCT01131676|8962659|P2|Discontinuation From Treatment|Adverse Event|267
2591665|NCT01131676|8962660|P1|Discontinuation From Treatment|Adverse Event|303
2591666|NCT01131676|8962658|P3|Discontinuation From Treatment|Other than those specified|125
2591667|NCT01131676|8962659|P2|Discontinuation From Treatment|Other than those specified|142
2591668|NCT01131676|8962660|P1|Discontinuation From Treatment|Other than those specified|162
2591669|NCT01131676|8962658|P3|Discontinuation From Treatment|Refusal to continue, not due to AE|122
2591670|NCT01131676|8962659|P2|Discontinuation From Treatment|Refusal to continue, not due to AE|118
2591671|NCT01131676|8962660|P1|Discontinuation From Treatment|Refusal to continue, not due to AE|172
2591672|NCT01131676|8962658|P3|Discontinuation From Treatment|Lost to Follow-up|6
2591673|NCT01131676|8962659|P2|Discontinuation From Treatment|Lost to Follow-up|9
2591674|NCT01131676|8962660|P1|Discontinuation From Treatment|Lost to Follow-up|15
2591675|NCT01131676|8962658|P3|Discontinuation From Treatment|Non compliant with protocol|12
2591676|NCT01131676|8962659|P2|Discontinuation From Treatment|Non compliant with protocol|15
2591677|NCT01131676|8962660|P1|Discontinuation From Treatment|Non compliant with protocol|15
2591678|NCT01131676|8962658|P3|Discontinuation From Treatment|Lack of Efficacy|0
2591679|NCT01131676|8962659|P2|Discontinuation From Treatment|Lack of Efficacy|1
2591680|NCT01131676|8962660|P1|Discontinuation From Treatment|Lack of Efficacy|11
2591681|NCT01131676|8962658|P3|Discontinuation From Treatment|Not treated|2
2591682|NCT01131676|8962659|P2|Discontinuation From Treatment|Not treated|2
2591683|NCT01131676|8962660|P1|Discontinuation From Treatment|Not treated|4
2591684|NCT01131676|8962658|P3|Discontinuation From Treatment|Study drug stopped, reason missing|4
2591685|NCT01131676|8962659|P2|Discontinuation From Treatment|Study drug stopped, reason missing|3
2591686|NCT01131676|8962660|P1|Discontinuation From Treatment|Study drug stopped, reason missing|5
2591687|NCT01131585|8962695|P2|Overall Study|Study termination|32
2591688|NCT01131585|8962696|P1|Overall Study|Study termination|78
2591689|NCT01131585|8962695|P2|Overall Study|Administrative problems|1
2591690|NCT01131585|8962696|P1|Overall Study|Administrative problems|1
2591691|NCT01131585|8962695|P2|Overall Study|Lost to Follow-up|1
2591692|NCT01131585|8962696|P1|Overall Study|Lost to Follow-up|0
2591693|NCT01131585|8962695|P2|Overall Study|Withdrawal by Subject|3
2591694|NCT01131585|8962696|P1|Overall Study|Withdrawal by Subject|3
2591695|NCT01131585|8962695|P2|Overall Study|Protocol Violation|1
2591696|NCT01131585|8962696|P1|Overall Study|Protocol Violation|2
2591697|NCT01131585|8962695|P2|Overall Study|Unsatisfactory therapeutic effect|3
2591698|NCT01131585|8962696|P1|Overall Study|Unsatisfactory therapeutic effect|0
2591699|NCT01131585|8962695|P2|Overall Study|Abnormal laboratory value|0
2591700|NCT01131585|8962696|P1|Overall Study|Abnormal laboratory value|1
2591701|NCT01131585|8962695|P2|Overall Study|Adverse Event|2
2591702|NCT01131585|8962696|P1|Overall Study|Adverse Event|0
2591703|NCT01131520|8962704|P2|Overall Study|Subject changed history after enrollment|1
2591704|NCT01131520|8962705|P1|Overall Study|Subject changed history after enrollment|0
2591705|NCT01131520|8962704|P2|Overall Study|Counselor not available|3
2591706|NCT01131520|8962705|P1|Overall Study|Counselor not available|0
2591707|NCT01131520|8962704|P2|Overall Study|Computer problem|0
2591708|NCT01131520|8962705|P1|Overall Study|Computer problem|1
2591709|NCT01131507|8962727|P1|Overall Study|Withdrawal by Subject|1
2591710|NCT01131507|8962727|P1|Overall Study|Lost to Follow-up|1
2591711|NCT01131507|8962727|P1|Overall Study|Adverse Event|1
2591712|NCT01131494|8962732|P1|Overall Study|Withdrawal by Subject|2
2591713|NCT01131455|8962742|P3|Overall Study|Death of PI|0
2591714|NCT01131455|8962743|P2|Overall Study|Death of PI|4
2591715|NCT01131455|8962744|P1|Overall Study|Death of PI|6
2591716|NCT01131312|8962755|P3|Overall Study|Lost to Follow-up|351
2591717|NCT01131312|8962756|P2|Overall Study|Lost to Follow-up|229
2591718|NCT01131312|8962757|P1|Overall Study|Lost to Follow-up|425
2591719|NCT01131299|8962768|P2|Overall Study|Withdrawal by Subject|7
2591720|NCT01131299|8962769|P1|Overall Study|Withdrawal by Subject|4
2591721|NCT01131260|8962782|P2|Overall Study|Ineligible|2
2591722|NCT01131260|8962783|P1|Overall Study|Ineligible|0
2591723|NCT01131260|8962782|P2|Overall Study|Staff error|1
2591724|NCT01131260|8962783|P1|Overall Study|Staff error|2
2591725|NCT01131260|8962782|P2|Overall Study|Technical problems|6
2591726|NCT01131260|8962783|P1|Overall Study|Technical problems|7
2591727|NCT01131260|8962782|P2|Overall Study|Physician Decision|24
2591728|NCT01131260|8962783|P1|Overall Study|Physician Decision|22
2591729|NCT01131260|8962782|P2|Overall Study|Declined to continue participation|13
2591730|NCT01131260|8962783|P1|Overall Study|Declined to continue participation|8
2591731|NCT01131260|8962782|P2|Overall Study|Randomization error|1
2591732|NCT01131260|8962783|P1|Overall Study|Randomization error|5
2591733|NCT01131182|8962831|P2|Overall Study|Other Reason|0
2591734|NCT01131182|8962832|P1|Overall Study|Other Reason|1
2591735|NCT01131182|8962831|P2|Overall Study|Lost to Follow-up|15
2591736|NCT01131182|8962832|P1|Overall Study|Lost to Follow-up|14
2591737|NCT01131182|8962831|P2|Overall Study|Withdrawal by Subject|1
2591738|NCT01131182|8962832|P1|Overall Study|Withdrawal by Subject|1
2591739|NCT01131130|8962840|P1|Period 3- Crossover|+ Slit lamp finding|1
2591740|NCT01131130|8962840|P1|Period 1 - Baseline|Pregnancy|1
2591741|NCT01131104|8962853|P1|Overall Study|No Information on Index Date of Onset|1
2591742|NCT01131104|8962853|P1|Overall Study|Information Not Available|5
2591743|NCT01131104|8962853|P1|Overall Study|Physician Decision|4
2591744|NCT01131104|8962853|P1|Overall Study|Withdrawal by Subject|3
2591745|NCT01131078|8962860|P3|Overall Study|Other|0
2591746|NCT01131078|8962861|P2|Overall Study|Other|1
2591747|NCT01131078|8962862|P1|Overall Study|Other|0
2591748|NCT01131078|8962860|P3|Overall Study|Death|2
2591749|NCT01131078|8962861|P2|Overall Study|Death|0
2591750|NCT01131078|8962862|P1|Overall Study|Death|4
2591751|NCT01131078|8962860|P3|Overall Study|Physician Decision|8
2591752|NCT01131078|8962861|P2|Overall Study|Physician Decision|6
2591753|NCT01131078|8962862|P1|Overall Study|Physician Decision|10
2591754|NCT01131078|8962860|P3|Overall Study|Non-compliance|0
2591755|NCT01131078|8962861|P2|Overall Study|Non-compliance|0
2591756|NCT01131078|8962862|P1|Overall Study|Non-compliance|3
2591757|NCT01131078|8962860|P3|Overall Study|Withdrawal by Subject|3
2591758|NCT01131078|8962861|P2|Overall Study|Withdrawal by Subject|4
2591759|NCT01131078|8962862|P1|Overall Study|Withdrawal by Subject|2
2591760|NCT01131078|8962860|P3|Overall Study|Lost to Follow-up|1
2591761|NCT01131078|8962861|P2|Overall Study|Lost to Follow-up|1
2591762|NCT01131078|8962862|P1|Overall Study|Lost to Follow-up|1
2591763|NCT01131078|8962860|P3|Overall Study|Protocol Violation|0
2591764|NCT01131078|8962861|P2|Overall Study|Protocol Violation|0
2591765|NCT01131078|8962862|P1|Overall Study|Protocol Violation|1
2591766|NCT01131078|8962860|P3|Overall Study|Progressive Disease|71
2591767|NCT01131078|8962861|P2|Overall Study|Progressive Disease|77
2591768|NCT01131078|8962862|P1|Overall Study|Progressive Disease|58
2591769|NCT01131078|8962860|P3|Overall Study|Adverse Event|17
2591770|NCT01131078|8962861|P2|Overall Study|Adverse Event|12
2591771|NCT01131078|8962862|P1|Overall Study|Adverse Event|22
2591772|NCT01130974|8962949|P2|Overall Study|Ineligibility criteria|2
2591773|NCT01130974|8962950|P1|Overall Study|Ineligibility criteria|5
2591774|NCT01130974|8962949|P2|Overall Study|Withdrawal by Subject|1
2591775|NCT01130974|8962950|P1|Overall Study|Withdrawal by Subject|0
2591776|NCT01130974|8962949|P2|Overall Study|Protocol Violation|10
2591777|NCT01130974|8962950|P1|Overall Study|Protocol Violation|10
2591778|NCT01130883|8962976|P1|Overall Study|Adverse Event|3
2591779|NCT01130883|8962976|P1|Overall Study|Reason Unknown|1
2591780|NCT01130883|8962976|P1|Overall Study|Patient Noncompliance|6
2591781|NCT01130831|8963033|P1|Overall Study|Information was missing|3
2591782|NCT01130831|8963033|P1|Overall Study|Death|4
2591783|NCT01130831|8963033|P1|Overall Study|Withdrawal by Subject|7
2591784|NCT01130597|8963072|P1|Overall Study|Protocol Violation|1
2591785|NCT01130597|8963072|P1|Overall Study|Death|1
2591786|NCT01130597|8963072|P1|Overall Study|Adverse Event|4
2591787|NCT01130597|8963072|P1|Overall Study|Protocol-specified (High K+)|1
2591788|NCT01130532|8963097|P4|Period IV (Weeks 13-16)|Withdrawal by Subject|3
2591789|NCT01130532|8963098|P3|Period IV (Weeks 13-16)|Withdrawal by Subject|0
2591790|NCT01130532|8963099|P2|Period IV (Weeks 13-16)|Withdrawal by Subject|0
2591791|NCT01130532|8963100|P1|Period IV (Weeks 13-16)|Withdrawal by Subject|0
2591792|NCT01130532|8963097|P4|Period IV (Weeks 13-16)|Lost to Follow-up|5
2591793|NCT01130532|8963098|P3|Period IV (Weeks 13-16)|Lost to Follow-up|0
2591794|NCT01130532|8963099|P2|Period IV (Weeks 13-16)|Lost to Follow-up|0
2591795|NCT01130532|8963100|P1|Period IV (Weeks 13-16)|Lost to Follow-up|0
2591796|NCT01130532|8963097|P4|Period IV (Weeks 13-16)|Entry Criteria Not Met|1
2591797|NCT01130532|8963098|P3|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
2591798|NCT01130532|8963099|P2|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
2591799|NCT01130532|8963100|P1|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
2591800|NCT01130532|8963097|P4|Period IV (Weeks 13-16)|Adverse Event|1
2591801|NCT01130532|8963098|P3|Period IV (Weeks 13-16)|Adverse Event|0
2591802|NCT01130532|8963099|P2|Period IV (Weeks 13-16)|Adverse Event|0
2591803|NCT01130532|8963100|P1|Period IV (Weeks 13-16)|Adverse Event|0
2591804|NCT01130532|8963097|P4|Period III (Weeks 0-12)|Withdrawal by Subject|0
2591805|NCT01130532|8963098|P3|Period III (Weeks 0-12)|Withdrawal by Subject|6
2591806|NCT01130532|8963099|P2|Period III (Weeks 0-12)|Withdrawal by Subject|7
2591807|NCT01130532|8963100|P1|Period III (Weeks 0-12)|Withdrawal by Subject|7
2591808|NCT01130532|8963097|P4|Period III (Weeks 0-12)|Sponsor Decision|0
2591809|NCT01130532|8963098|P3|Period III (Weeks 0-12)|Sponsor Decision|2
2591810|NCT01130532|8963099|P2|Period III (Weeks 0-12)|Sponsor Decision|4
2591811|NCT01130532|8963100|P1|Period III (Weeks 0-12)|Sponsor Decision|3
2591812|NCT01130532|8963097|P4|Period III (Weeks 0-12)|Protocol Violation|0
2591813|NCT01130532|8963098|P3|Period III (Weeks 0-12)|Protocol Violation|1
2591814|NCT01130532|8963099|P2|Period III (Weeks 0-12)|Protocol Violation|0
2591815|NCT01130532|8963100|P1|Period III (Weeks 0-12)|Protocol Violation|0
2591816|NCT01130532|8963097|P4|Period III (Weeks 0-12)|Lost to Follow-up|0
2591817|NCT01130532|8963098|P3|Period III (Weeks 0-12)|Lost to Follow-up|3
2591818|NCT01130532|8963099|P2|Period III (Weeks 0-12)|Lost to Follow-up|2
2591819|NCT01130532|8963100|P1|Period III (Weeks 0-12)|Lost to Follow-up|2
2591820|NCT01130532|8963097|P4|Period III (Weeks 0-12)|Lack of Efficacy|0
2591821|NCT01130532|8963098|P3|Period III (Weeks 0-12)|Lack of Efficacy|1
2591822|NCT01130532|8963099|P2|Period III (Weeks 0-12)|Lack of Efficacy|0
2591823|NCT01130532|8963100|P1|Period III (Weeks 0-12)|Lack of Efficacy|2
2591824|NCT01130532|8963097|P4|Period III (Weeks 0-12)|Entry Criteria Not Met|0
2591825|NCT01130532|8963098|P3|Period III (Weeks 0-12)|Entry Criteria Not Met|4
2591826|NCT01130532|8963099|P2|Period III (Weeks 0-12)|Entry Criteria Not Met|2
2591827|NCT01130532|8963100|P1|Period III (Weeks 0-12)|Entry Criteria Not Met|4
2591828|NCT01130532|8963097|P4|Period III (Weeks 0-12)|Adverse Event|0
2591829|NCT01130532|8963098|P3|Period III (Weeks 0-12)|Adverse Event|2
2591830|NCT01130532|8963099|P2|Period III (Weeks 0-12)|Adverse Event|3
2591831|NCT01130532|8963100|P1|Period III (Weeks 0-12)|Adverse Event|3
2591832|NCT01130493|8963145|P3|Part 2: OLE|Withdrawal by Subject|4
2591833|NCT01130493|8963146|P2|Part 2: OLE|Withdrawal by Subject|1
2591834|NCT01130493|8963147|P1|Part 2: OLE|Withdrawal by Subject|0
2591835|NCT01130493|8963145|P3|Part 2: OLE|Adverse Event|1
2591836|NCT01130493|8963146|P2|Part 2: OLE|Adverse Event|2
2591837|NCT01130493|8963147|P1|Part 2: OLE|Adverse Event|0
2591838|NCT01130493|8963145|P3|Part 1: Double-blind Treatment Period 2|Noncompliance|1
2591839|NCT01130493|8963146|P2|Part 1: Double-blind Treatment Period 2|Noncompliance|0
2591840|NCT01130493|8963147|P1|Part 1: Double-blind Treatment Period 2|Noncompliance|0
2591841|NCT01130493|8963145|P3|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1
2591842|NCT01130493|8963146|P2|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
2591843|NCT01130493|8963147|P1|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
2591844|NCT01130493|8963145|P3|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1
2591845|NCT01130493|8963146|P2|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
2591846|NCT01130493|8963147|P1|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
2591847|NCT01130493|8963145|P3|Part 1: Open-Label IPX066 Washout|Adverse Event|1
2591848|NCT01130493|8963146|P2|Part 1: Open-Label IPX066 Washout|Adverse Event|0
2591849|NCT01130493|8963147|P1|Part 1: Open-Label IPX066 Washout|Adverse Event|0
2591850|NCT01130493|8963145|P3|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
2591851|NCT01130493|8963146|P2|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1
2591852|NCT01130493|8963147|P1|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
2591853|NCT01130493|8963145|P3|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
2591854|NCT01130493|8963146|P2|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1
2591855|NCT01130493|8963147|P1|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
2591856|NCT01130493|8963145|P3|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
2591857|NCT01130493|8963146|P2|Part 1: Double-blind Treatment Period 1|Protocol Violation|1
2591858|NCT01130493|8963147|P1|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
2591859|NCT01130493|8963145|P3|Open-label Dose Conversion to IPX066|Diary imcomplete|0
2591860|NCT01130493|8963146|P2|Open-label Dose Conversion to IPX066|Diary imcomplete|0
2591861|NCT01130493|8963147|P1|Open-label Dose Conversion to IPX066|Diary imcomplete|1
2591862|NCT01130493|8963145|P3|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
2591863|NCT01130493|8963146|P2|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
2591864|NCT01130493|8963147|P1|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7
2591865|NCT01130493|8963145|P3|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
2591866|NCT01130493|8963146|P2|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
2591867|NCT01130493|8963147|P1|Open-label Dose Conversion to IPX066|Lack of Efficacy|7
2591868|NCT01130493|8963145|P3|Open-label Dose Conversion to IPX066|Protocol Violation|0
2591869|NCT01130493|8963146|P2|Open-label Dose Conversion to IPX066|Protocol Violation|0
2591870|NCT01130493|8963147|P1|Open-label Dose Conversion to IPX066|Protocol Violation|3
2591871|NCT01130493|8963145|P3|Open-label Dose Conversion to IPX066|Adverse Event|0
2591872|NCT01130493|8963146|P2|Open-label Dose Conversion to IPX066|Adverse Event|0
2591873|NCT01130493|8963147|P1|Open-label Dose Conversion to IPX066|Adverse Event|1
2591874|NCT01130337|8963164|P1|Overall Study|Surgical resection (R2)|1
2591875|NCT01130337|8963164|P1|Overall Study|Toxicity, AE/intercurrent disease|7
2591876|NCT01130337|8963164|P1|Overall Study|Disease progression|1
2591877|NCT01130337|8963164|P1|Overall Study|Death|1
2591878|NCT01130337|8963164|P1|Overall Study|Principal investigator decision|1
2591879|NCT01130337|8963164|P1|Overall Study|Withdrawal by Subject|3
2591880|NCT01130272|8963176|P5|Overall Study|Study arm discontinued|0
2591881|NCT01130272|8963177|P4|Overall Study|Study arm discontinued|0
2591882|NCT01130272|8963178|P3|Overall Study|Study arm discontinued|0
2591883|NCT01130272|8963179|P2|Overall Study|Study arm discontinued|0
2591884|NCT01130272|8963180|P1|Overall Study|Study arm discontinued|38
2591885|NCT01130272|8963176|P5|Overall Study|Sponsor decision|16
2591886|NCT01130272|8963177|P4|Overall Study|Sponsor decision|13
2591887|NCT01130272|8963178|P3|Overall Study|Sponsor decision|16
2591888|NCT01130272|8963179|P2|Overall Study|Sponsor decision|15
2591889|NCT01130272|8963180|P1|Overall Study|Sponsor decision|6
2591890|NCT01130272|8963176|P5|Overall Study|Physician Decision|2
2591891|NCT01130272|8963177|P4|Overall Study|Physician Decision|1
2591892|NCT01130272|8963178|P3|Overall Study|Physician Decision|0
2591893|NCT01130272|8963179|P2|Overall Study|Physician Decision|1
2591894|NCT01130272|8963180|P1|Overall Study|Physician Decision|1
2591895|NCT01130272|8963176|P5|Overall Study|Withdrawal by Subject|8
2591896|NCT01130272|8963177|P4|Overall Study|Withdrawal by Subject|9
2591897|NCT01130272|8963178|P3|Overall Study|Withdrawal by Subject|10
2591898|NCT01130272|8963179|P2|Overall Study|Withdrawal by Subject|11
2591899|NCT01130272|8963180|P1|Overall Study|Withdrawal by Subject|4
2591900|NCT01130272|8963176|P5|Overall Study|Lost to Follow-up|6
2591901|NCT01130272|8963177|P4|Overall Study|Lost to Follow-up|7
2591902|NCT01130272|8963178|P3|Overall Study|Lost to Follow-up|4
2591903|NCT01130272|8963179|P2|Overall Study|Lost to Follow-up|3
2591904|NCT01130272|8963180|P1|Overall Study|Lost to Follow-up|4
2591905|NCT01130272|8963176|P5|Overall Study|Protocol Violation|5
2591906|NCT01130272|8963177|P4|Overall Study|Protocol Violation|5
2591907|NCT01130272|8963178|P3|Overall Study|Protocol Violation|3
2591908|NCT01130272|8963179|P2|Overall Study|Protocol Violation|0
2591909|NCT01130272|8963180|P1|Overall Study|Protocol Violation|0
2591910|NCT01130272|8963176|P5|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
2591911|NCT01130272|8963177|P4|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1
2591912|NCT01130272|8963178|P3|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
2591913|NCT01130272|8963179|P2|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
2591914|NCT01130272|8963180|P1|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
2591915|NCT01130272|8963176|P5|Overall Study|Lack of efficacy- uncontrolled diarrhea|2
2591916|NCT01130272|8963177|P4|Overall Study|Lack of efficacy- uncontrolled diarrhea|0
2591917|NCT01130272|8963178|P3|Overall Study|Lack of efficacy- uncontrolled diarrhea|0
2591918|NCT01130272|8963179|P2|Overall Study|Lack of efficacy- uncontrolled diarrhea|1
2591919|NCT01130272|8963180|P1|Overall Study|Lack of efficacy- uncontrolled diarrhea|1
2591920|NCT01130272|8963176|P5|Overall Study|Rescue medications due to diarrhea|6
2591921|NCT01130272|8963177|P4|Overall Study|Rescue medications due to diarrhea|8
2591922|NCT01130272|8963178|P3|Overall Study|Rescue medications due to diarrhea|8
2591923|NCT01130272|8963179|P2|Overall Study|Rescue medications due to diarrhea|5
2591924|NCT01130272|8963180|P1|Overall Study|Rescue medications due to diarrhea|3
2591925|NCT01130272|8963176|P5|Overall Study|IVRS-confirmed constipation|0
2591926|NCT01130272|8963177|P4|Overall Study|IVRS-confirmed constipation|2
2591927|NCT01130272|8963178|P3|Overall Study|IVRS-confirmed constipation|1
2591928|NCT01130272|8963179|P2|Overall Study|IVRS-confirmed constipation|1
2591929|NCT01130272|8963180|P1|Overall Study|IVRS-confirmed constipation|0
2591930|NCT01130272|8963176|P5|Overall Study|Adverse Event|7
2591931|NCT01130272|8963177|P4|Overall Study|Adverse Event|22
2591932|NCT01130272|8963178|P3|Overall Study|Adverse Event|6
2591933|NCT01130272|8963179|P2|Overall Study|Adverse Event|5
2591934|NCT01130272|8963180|P1|Overall Study|Adverse Event|2
2591935|NCT01130168|8963217|P6|Period 1|Adverse Event|0
2591936|NCT01130168|8963218|P5|Period 1|Adverse Event|0
2591937|NCT01130168|8963219|P4|Period 1|Adverse Event|1
2591938|NCT01130168|8963220|P3|Period 1|Adverse Event|0
2591939|NCT01130168|8963221|P2|Period 1|Adverse Event|0
2591940|NCT01130168|8963222|P1|Period 1|Adverse Event|0
2591941|NCT01130168|8963217|P6|Period 1|Discontinued For Other Reason|0
2591942|NCT01130168|8963218|P5|Period 1|Discontinued For Other Reason|0
2591943|NCT01130168|8963219|P4|Period 1|Discontinued For Other Reason|1
2591944|NCT01130168|8963220|P3|Period 1|Discontinued For Other Reason|1
2591945|NCT01130168|8963221|P2|Period 1|Discontinued For Other Reason|0
2591946|NCT01130168|8963222|P1|Period 1|Discontinued For Other Reason|0
2591947|NCT01130168|8963217|P6|Period 1|Withdrawal by Subject|0
2591948|NCT01130168|8963218|P5|Period 1|Withdrawal by Subject|0
2591949|NCT01130168|8963219|P4|Period 1|Withdrawal by Subject|1
2591950|NCT01130168|8963220|P3|Period 1|Withdrawal by Subject|0
2591951|NCT01130168|8963221|P2|Period 1|Withdrawal by Subject|1
2591952|NCT01130168|8963222|P1|Period 1|Withdrawal by Subject|0
2591953|NCT01130103|8963259|P2|Maintenance Treatment|Withdrawal by Subject|0
2591954|NCT01130103|8963260|P1|Maintenance Treatment|Withdrawal by Subject|1
2591955|NCT01130103|8963259|P2|Maintenance Treatment|Lost to Follow-up|1
2591956|NCT01130103|8963260|P1|Maintenance Treatment|Lost to Follow-up|1
2591957|NCT01130103|8963259|P2|Maintenance Treatment|Lack of Efficacy|1
2591958|NCT01130103|8963260|P1|Maintenance Treatment|Lack of Efficacy|0
2591959|NCT01130103|8963259|P2|Randomized Treatment|Withdrawal by Subject|2
2591960|NCT01130103|8963260|P1|Randomized Treatment|Withdrawal by Subject|1
2591961|NCT01130103|8963259|P2|Randomized Treatment|Protocol Violation|2
2591962|NCT01130103|8963260|P1|Randomized Treatment|Protocol Violation|3
2591963|NCT01130103|8963259|P2|Randomized Treatment|Lost to Follow-up|0
2591964|NCT01130103|8963260|P1|Randomized Treatment|Lost to Follow-up|1
2591965|NCT01130103|8963259|P2|Randomized Treatment|Adverse Event|1
2591966|NCT01130103|8963260|P1|Randomized Treatment|Adverse Event|1
2591967|NCT01130051|8963274|P2|Washout Period of 14 Days|Protocol Violation|1
2591968|NCT01130051|8963275|P1|Washout Period of 14 Days|Protocol Violation|1
2591969|NCT01130051|8963274|P2|Washout Period of 14 Days|Withdrawal by Subject|1
2591970|NCT01130051|8963275|P1|Washout Period of 14 Days|Withdrawal by Subject|0
2591971|NCT01129960|8963289|P4|Overall Study|Pregnancy|0
2591972|NCT01129960|8963290|P3|Overall Study|Pregnancy|0
2591973|NCT01129960|8963291|P2|Overall Study|Pregnancy|0
2591974|NCT01129960|8963292|P1|Overall Study|Pregnancy|1
2591975|NCT01129960|8963289|P4|Overall Study|Physician Decision|0
2591976|NCT01129960|8963290|P3|Overall Study|Physician Decision|0
2591977|NCT01129960|8963291|P2|Overall Study|Physician Decision|0
2591978|NCT01129960|8963292|P1|Overall Study|Physician Decision|1
2591979|NCT01129960|8963289|P4|Overall Study|Discontinuation of the study by Sponsor|0
2591980|NCT01129960|8963290|P3|Overall Study|Discontinuation of the study by Sponsor|0
2591981|NCT01129960|8963291|P2|Overall Study|Discontinuation of the study by Sponsor|1
2591982|NCT01129960|8963292|P1|Overall Study|Discontinuation of the study by Sponsor|0
2591983|NCT01129960|8963289|P4|Overall Study|Lost to Follow-up|3
2591984|NCT01129960|8963290|P3|Overall Study|Lost to Follow-up|3
2591985|NCT01129960|8963291|P2|Overall Study|Lost to Follow-up|2
2591986|NCT01129960|8963292|P1|Overall Study|Lost to Follow-up|0
2591987|NCT01129960|8963289|P4|Overall Study|Protocol Violation|0
2591988|NCT01129960|8963290|P3|Overall Study|Protocol Violation|3
2591989|NCT01129960|8963291|P2|Overall Study|Protocol Violation|2
2591990|NCT01129960|8963292|P1|Overall Study|Protocol Violation|1
2591991|NCT01129960|8963289|P4|Overall Study|Adverse Event|7
2591992|NCT01129960|8963290|P3|Overall Study|Adverse Event|16
2591993|NCT01129960|8963291|P2|Overall Study|Adverse Event|16
2591994|NCT01129960|8963292|P1|Overall Study|Adverse Event|23
2591995|NCT01129960|8963289|P4|Overall Study|Lack of Efficacy|1
2591996|NCT01129960|8963290|P3|Overall Study|Lack of Efficacy|1
2591997|NCT01129960|8963291|P2|Overall Study|Lack of Efficacy|1
2591998|NCT01129960|8963292|P1|Overall Study|Lack of Efficacy|1
2591999|NCT01129960|8963289|P4|Overall Study|Withdrawal by Subject|2
2592000|NCT01129960|8963290|P3|Overall Study|Withdrawal by Subject|3
2592001|NCT01129960|8963291|P2|Overall Study|Withdrawal by Subject|0
2592002|NCT01129960|8963292|P1|Overall Study|Withdrawal by Subject|3
2592003|NCT01129921|8963304|P2|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1
2592004|NCT01129921|8963305|P1|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0
2592005|NCT01129921|8963304|P2|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4
2592006|NCT01129921|8963305|P1|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0
2592007|NCT01129921|8963304|P2|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1
2592008|NCT01129921|8963305|P1|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0
2592009|NCT01129921|8963304|P2|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1
2592010|NCT01129921|8963305|P1|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2
2592011|NCT01129882|8963315|P1|Overall Study|Withdrawal by Subject|160
2592012|NCT01129882|8963315|P1|Overall Study|Trial Termination by Sponsor|6
2592013|NCT01129882|8963315|P1|Overall Study|Withdrawal Criteria Met|19
2592014|NCT01129882|8963315|P1|Overall Study|Protocol Deviation|3
2592015|NCT01129882|8963315|P1|Overall Study|Physician Decision|27
2592016|NCT01129882|8963315|P1|Overall Study|Lost to Follow-up|13
2592017|NCT01129882|8963315|P1|Overall Study|Lack of Efficacy|5
2592018|NCT01129882|8963315|P1|Overall Study|Death|6
2592019|NCT01129882|8963315|P1|Overall Study|Adverse Event|39
2592020|NCT01129622|8963334|P1|Overall Study|Withdrawal by Subject|2
2592021|NCT01129583|8963345|P2|Overall Study|Ipsilateral Upper Extremity Injury|1
2592022|NCT01129583|8963346|P1|Overall Study|Ipsilateral Upper Extremity Injury|1
2592023|NCT01129583|8963345|P2|Overall Study|Lost to Follow-up|1
2592024|NCT01129583|8963346|P1|Overall Study|Lost to Follow-up|1
2592025|NCT01129583|8963345|P2|Overall Study|Death|0
2592026|NCT01129583|8963346|P1|Overall Study|Death|1
2592027|NCT01129557|8963359|P3|Overall Study|Novartis terminated study early|2
2592028|NCT01129557|8963360|P2|Overall Study|Novartis terminated study early|3
2592029|NCT01129557|8963361|P1|Overall Study|Novartis terminated study early|3
2592030|NCT01129557|8963359|P3|Overall Study|Adverse Event|2
2592031|NCT01129557|8963360|P2|Overall Study|Adverse Event|2
2592032|NCT01129557|8963361|P1|Overall Study|Adverse Event|1
2592033|NCT01129336|8963474|P2|Overall Study|Death|4
2592034|NCT01129336|8963475|P1|Overall Study|Death|0
2592035|NCT01129336|8963474|P2|Overall Study|Missing Study Completion Status|3
2592036|NCT01129336|8963475|P1|Overall Study|Missing Study Completion Status|2
2592037|NCT01129336|8963474|P2|Overall Study|Adverse Event|1
2592038|NCT01129336|8963475|P1|Overall Study|Adverse Event|0
2592039|NCT01129336|8963474|P2|Overall Study|Withdrawal by Subject|4
2592040|NCT01129336|8963475|P1|Overall Study|Withdrawal by Subject|7
2592041|NCT01129336|8963474|P2|Overall Study|Lost to Follow-up|0
2592042|NCT01129336|8963475|P1|Overall Study|Lost to Follow-up|1
2592043|NCT01129336|8963474|P2|Overall Study|Disease Progression|4
2592044|NCT01129336|8963475|P1|Overall Study|Disease Progression|1
2592045|NCT01129336|8963474|P2|Overall Study|Protocol Violation|0
2592046|NCT01129336|8963475|P1|Overall Study|Protocol Violation|1
2592047|NCT01129284|8963490|P3|Overall Study|Adverse Event|1
2592048|NCT01129284|8963491|P2|Overall Study|Adverse Event|0
2592049|NCT01129284|8963492|P1|Overall Study|Adverse Event|2
2592050|NCT01129128|8963540|P3|Overall Study|Physician Decision|0
2592051|NCT01129128|8963541|P2|Overall Study|Physician Decision|0
2592052|NCT01129128|8963542|P1|Overall Study|Physician Decision|1
2592053|NCT01129128|8963540|P3|Overall Study|Withdrawal by Subject|3
2592054|NCT01129128|8963541|P2|Overall Study|Withdrawal by Subject|1
2592055|NCT01129128|8963542|P1|Overall Study|Withdrawal by Subject|0
2592056|NCT01129128|8963540|P3|Overall Study|Protocol Violation|0
2592057|NCT01129128|8963541|P2|Overall Study|Protocol Violation|1
2592058|NCT01129128|8963542|P1|Overall Study|Protocol Violation|0
2592059|NCT01129128|8963540|P3|Overall Study|Lost to Follow-up|1
2592060|NCT01129128|8963541|P2|Overall Study|Lost to Follow-up|2
2592061|NCT01129128|8963542|P1|Overall Study|Lost to Follow-up|2
2592062|NCT01129115|8963566|P4|Overall Study|Protocol Violation|2
2592063|NCT01129115|8963567|P3|Overall Study|Protocol Violation|2
2592064|NCT01129115|8963568|P2|Overall Study|Protocol Violation|2
2592065|NCT01129115|8963569|P1|Overall Study|Protocol Violation|0
2592066|NCT01129115|8963566|P4|Overall Study|Withdrawal by Subject|4
2592067|NCT01129115|8963567|P3|Overall Study|Withdrawal by Subject|1
2592068|NCT01129115|8963568|P2|Overall Study|Withdrawal by Subject|3
2592069|NCT01129115|8963569|P1|Overall Study|Withdrawal by Subject|1
2592070|NCT01129115|8963566|P4|Overall Study|Adverse Event|3
2592071|NCT01129115|8963567|P3|Overall Study|Adverse Event|3
2592072|NCT01129115|8963568|P2|Overall Study|Adverse Event|2
2592073|NCT01129115|8963569|P1|Overall Study|Adverse Event|1
2592074|NCT01129102|8963606|P3|Overall Study|Lost to Follow-up|0
2592075|NCT01129102|8963607|P2|Overall Study|Lost to Follow-up|0
2592076|NCT01129102|8963608|P1|Overall Study|Lost to Follow-up|2
2592077|NCT01129102|8963606|P3|Overall Study|Adverse Event|1
2592078|NCT01129102|8963607|P2|Overall Study|Adverse Event|2
2592079|NCT01129102|8963608|P1|Overall Study|Adverse Event|2
2592080|NCT01129102|8963606|P3|Overall Study|Pregnancy|1
2592081|NCT01129102|8963607|P2|Overall Study|Pregnancy|0
2592082|NCT01129102|8963608|P1|Overall Study|Pregnancy|0
2592083|NCT01129102|8963606|P3|Overall Study|Protocol Violation|1
2592084|NCT01129102|8963607|P2|Overall Study|Protocol Violation|1
2592085|NCT01129102|8963608|P1|Overall Study|Protocol Violation|0
2592086|NCT01129102|8963606|P3|Overall Study|Withdrawal by Subject|3
2592087|NCT01129102|8963607|P2|Overall Study|Withdrawal by Subject|0
2592088|NCT01129102|8963608|P1|Overall Study|Withdrawal by Subject|2
2592089|NCT01129102|8963606|P3|Overall Study|No study drug treatment|1
2592090|NCT01129102|8963607|P2|Overall Study|No study drug treatment|3
2592091|NCT01129102|8963608|P1|Overall Study|No study drug treatment|2
2592092|NCT01129011|8963619|P2|Overall Study|misc|4
2592093|NCT01129011|8963620|P1|Overall Study|misc|7
2592094|NCT01129011|8963619|P2|Overall Study|Duodenal Ulcer|8
2592095|NCT01129011|8963620|P1|Overall Study|Duodenal Ulcer|2
2592096|NCT01129011|8963619|P2|Overall Study|Lost to Follow-up|7
2592097|NCT01129011|8963620|P1|Overall Study|Lost to Follow-up|6
2592098|NCT01129011|8963619|P2|Overall Study|Withdrawal by Subject|8
2592099|NCT01129011|8963620|P1|Overall Study|Withdrawal by Subject|24
2592100|NCT01129011|8963619|P2|Overall Study|Adverse Event|30
2592101|NCT01129011|8963620|P1|Overall Study|Adverse Event|20
2592102|NCT01128959|8963675|P1|Treatment Period|Withdrawal by Subject|1
2592103|NCT01128959|8963675|P1|Treatment Period|Adverse Event|3
2592104|NCT01128959|8963675|P1|Lead in Period|Adverse Event|3
2592105|NCT01128946|8963681|P4|Period III|Protocol Violation|0
2592106|NCT01128946|8963682|P3|Period III|Protocol Violation|0
2592107|NCT01128946|8963683|P2|Period III|Protocol Violation|0
2592108|NCT01128946|8963684|P1|Period III|Protocol Violation|1
2592109|NCT01128946|8963681|P4|Period II|Withdrawal by Subject|1
2592110|NCT01128946|8963682|P3|Period II|Withdrawal by Subject|0
2592111|NCT01128946|8963683|P2|Period II|Withdrawal by Subject|0
2592112|NCT01128946|8963684|P1|Period II|Withdrawal by Subject|0
2592113|NCT01128946|8963681|P4|Period II|Protocol Violation|0
2592114|NCT01128946|8963682|P3|Period II|Protocol Violation|0
2592115|NCT01128946|8963683|P2|Period II|Protocol Violation|1
2592116|NCT01128946|8963684|P1|Period II|Protocol Violation|0
2592117|NCT01128946|8963681|P4|Period I|Withdrawal by Subject|1
2592118|NCT01128946|8963682|P3|Period I|Withdrawal by Subject|1
2592119|NCT01128946|8963683|P2|Period I|Withdrawal by Subject|0
2592120|NCT01128946|8963684|P1|Period I|Withdrawal by Subject|0
2592121|NCT01128946|8963681|P4|Period I|Protocol Violation|0
2592122|NCT01128946|8963682|P3|Period I|Protocol Violation|0
2592123|NCT01128946|8963683|P2|Period I|Protocol Violation|1
2592124|NCT01128946|8963684|P1|Period I|Protocol Violation|0
2592125|NCT01128894|8963702|P2|Overall Study|Conflicting HbA1c Results at Screening|0
2592126|NCT01128894|8963703|P1|Overall Study|Conflicting HbA1c Results at Screening|1
2592127|NCT01128894|8963702|P2|Overall Study|Physician Decision|1
2592128|NCT01128894|8963703|P1|Overall Study|Physician Decision|2
2592129|NCT01128894|8963702|P2|Overall Study|Withdrawal by Subject|12
2592130|NCT01128894|8963703|P1|Overall Study|Withdrawal by Subject|10
2592131|NCT01128894|8963702|P2|Overall Study|Lost to Follow-up|8
2592132|NCT01128894|8963703|P1|Overall Study|Lost to Follow-up|8
2592133|NCT01128894|8963702|P2|Overall Study|Noncompliance|5
2592134|NCT01128894|8963703|P1|Overall Study|Noncompliance|4
2592135|NCT01128894|8963702|P2|Overall Study|Protocol Violation|1
2592136|NCT01128894|8963703|P1|Overall Study|Protocol Violation|2
2592137|NCT01128894|8963702|P2|Overall Study|Adverse Event|41
2592138|NCT01128894|8963703|P1|Overall Study|Adverse Event|31
2592139|NCT01128842|8963721|P1|Overall Study|Disease Progression|6
2592140|NCT01128842|8963721|P1|Overall Study|Adverse Event|1
2592141|NCT01128738|8963738|P2|Second TP|Withdrawal by Subject|2
2592142|NCT01128738|8963739|P1|Second TP|Withdrawal by Subject|0
2592143|NCT01128738|8963738|P2|Second TP|Lost to Follow-up|1
2592144|NCT01128738|8963739|P1|Second TP|Lost to Follow-up|0
2592145|NCT01128738|8963738|P2|First Treatment Phase (TP)|Withdrawal by Subject|1
2592146|NCT01128738|8963739|P1|First Treatment Phase (TP)|Withdrawal by Subject|3
2592147|NCT01128738|8963738|P2|First Treatment Phase (TP)|Lost to Follow-up|0
2592148|NCT01128738|8963739|P1|First Treatment Phase (TP)|Lost to Follow-up|1
2592149|NCT01128621|8963864|P2|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2
2592150|NCT01128621|8963865|P1|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0
2592151|NCT01128595|8963986|P4|Treatment Period 3|Withdrawal by Subject|0
2592152|NCT01128595|8963987|P3|Treatment Period 3|Withdrawal by Subject|0
2592153|NCT01128595|8963988|P2|Treatment Period 3|Withdrawal by Subject|1
2592154|NCT01128595|8963989|P1|Treatment Period 3|Withdrawal by Subject|0
2592155|NCT01128569|8964019|P6|Treatment Period 2|Withdrawal by Subject|0
2592156|NCT01128569|8964020|P5|Treatment Period 2|Withdrawal by Subject|0
2592157|NCT01128569|8964021|P4|Treatment Period 2|Withdrawal by Subject|0
2592158|NCT01128569|8964022|P3|Treatment Period 2|Withdrawal by Subject|0
2592159|NCT01128569|8964023|P2|Treatment Period 2|Withdrawal by Subject|1
2592160|NCT01128569|8964024|P1|Treatment Period 2|Withdrawal by Subject|0
2592161|NCT01128569|8964019|P6|Washout Period 1|Adverse Event|0
2592162|NCT01128569|8964020|P5|Washout Period 1|Adverse Event|0
2592163|NCT01128569|8964021|P4|Washout Period 1|Adverse Event|0
2592164|NCT01128569|8964022|P3|Washout Period 1|Adverse Event|1
2592165|NCT01128569|8964023|P2|Washout Period 1|Adverse Event|0
2592166|NCT01128569|8964024|P1|Washout Period 1|Adverse Event|0
2592167|NCT01128543|8964041|P1|Overall Study|Protocol Violation|1
2592168|NCT01128543|8964041|P1|Overall Study|Withdrawal by Subject|3
2592169|NCT01128413|8964067|P2|Overall Study|Pt made DNR|0
2592170|NCT01128413|8964068|P1|Overall Study|Pt made DNR|1
2592171|NCT01128413|8964067|P2|Overall Study|NICOM Monitor Problems|1
2592172|NCT01128413|8964068|P1|Overall Study|NICOM Monitor Problems|2
2592173|NCT01128413|8964067|P2|Overall Study|Withdrawal by Subject|0
2592174|NCT01128413|8964068|P1|Overall Study|Withdrawal by Subject|1
2592175|NCT01128400|8964077|P3|Overall Study|Excluded due to sinus problems|0
2592176|NCT01128400|8964078|P2|Overall Study|Excluded due to sinus problems|1
2592177|NCT01128400|8964079|P1|Overall Study|Excluded due to sinus problems|0
2592178|NCT01128400|8964077|P3|Overall Study|were not invited to participate on taste|15
2592179|NCT01128400|8964078|P2|Overall Study|were not invited to participate on taste|0
2592180|NCT01128400|8964079|P1|Overall Study|were not invited to participate on taste|0
2592181|NCT01128400|8964077|P3|Overall Study|Screening failure|0
2592182|NCT01128400|8964078|P2|Overall Study|Screening failure|0
2592183|NCT01128400|8964079|P1|Overall Study|Screening failure|1
2592184|NCT01128400|8964077|P3|Overall Study|Lost to Follow-up|1
2592185|NCT01128400|8964078|P2|Overall Study|Lost to Follow-up|0
2592186|NCT01128400|8964079|P1|Overall Study|Lost to Follow-up|1
2592187|NCT01128387|8964092|P2|Overall Study|Physician Decision|1
2592188|NCT01128387|8964093|P1|Overall Study|Physician Decision|0
2592189|NCT01128361|8964103|P2|Overall Study|Withdrawal by Subject|2
2592190|NCT01128361|8964104|P1|Overall Study|Withdrawal by Subject|5
2592191|NCT01128361|8964103|P2|Overall Study|Lost to Follow-up|1
2592192|NCT01128361|8964104|P1|Overall Study|Lost to Follow-up|0
2592193|NCT01128296|8964116|P6|Overall Study|Withdrawal by Subject|2
2592194|NCT01128296|8964117|P5|Overall Study|Withdrawal by Subject|0
2592195|NCT01128296|8964118|P4|Overall Study|Withdrawal by Subject|0
2592196|NCT01128296|8964119|P3|Overall Study|Withdrawal by Subject|0
2592197|NCT01128296|8964120|P2|Overall Study|Withdrawal by Subject|0
2592198|NCT01128296|8964121|P1|Overall Study|Withdrawal by Subject|0
2592199|NCT01128296|8964116|P6|Overall Study|Physician Decision|3
2592200|NCT01128296|8964117|P5|Overall Study|Physician Decision|0
2592201|NCT01128296|8964118|P4|Overall Study|Physician Decision|0
2592202|NCT01128296|8964119|P3|Overall Study|Physician Decision|0
2592203|NCT01128296|8964120|P2|Overall Study|Physician Decision|0
2592204|NCT01128296|8964121|P1|Overall Study|Physician Decision|0
2592205|NCT01128244|8964152|P1|Overall Study|Scheduling conflict|2
2592206|NCT01128244|8964152|P1|Overall Study|Adverse Event|1
2592207|NCT01128179|8964193|P2|Overall Study|Protocol Violation|0
2592208|NCT01128179|8964194|P1|Overall Study|Protocol Violation|1
2592209|NCT01128179|8964193|P2|Overall Study|Death|0
2592210|NCT01128179|8964194|P1|Overall Study|Death|1
2592211|NCT01128153|8964214|P2|Overall Study|Developed discontinuation criteria|1
2592212|NCT01128153|8964215|P1|Overall Study|Developed discontinuation criteria|1
2592213|NCT01128153|8964214|P2|Overall Study|Protocol Violation|0
2592214|NCT01128153|8964215|P1|Overall Study|Protocol Violation|2
2592215|NCT01128153|8964214|P2|Overall Study|Incorrect enrolment to study|1
2592216|NCT01128153|8964215|P1|Overall Study|Incorrect enrolment to study|2
2592217|NCT01128153|8964214|P2|Overall Study|Withdrawal by Subject|3
2592218|NCT01128153|8964215|P1|Overall Study|Withdrawal by Subject|2
2592219|NCT01128153|8964214|P2|Overall Study|Condition under investigation worsened|7
2592220|NCT01128153|8964215|P1|Overall Study|Condition under investigation worsened|8
2592221|NCT01128153|8964214|P2|Overall Study|Adverse Event|3
2592222|NCT01128153|8964215|P1|Overall Study|Adverse Event|1
2592223|NCT01128114|8964231|P1|Overall Study|Screening Failed|2
2592224|NCT01128114|8964231|P1|Overall Study|Treatment Withdrawn|6
2592225|NCT01127763|8964248|P1|Overall Study|Physician Decision|2
2592226|NCT01127763|8964248|P1|Overall Study|Withdrawal by Subject|1
2592227|NCT01127763|8964248|P1|Overall Study|Adverse Event|2
2592228|NCT01127646|8964293|P2|Overall Study|Protocol Violation|1
2592229|NCT01127646|8964294|P1|Overall Study|Protocol Violation|0
2592230|NCT01127646|8964293|P2|Overall Study|Entry Criteria Not Met|0
2592231|NCT01127646|8964294|P1|Overall Study|Entry Criteria Not Met|1
2592232|NCT01127633|8964328|P2|Overall Study|Not treated|0
2592233|NCT01127633|8964329|P1|Overall Study|Not treated|1
2592234|NCT01127633|8964328|P2|Overall Study|Abnormal Lab/ECG Result|1
2592235|NCT01127633|8964329|P1|Overall Study|Abnormal Lab/ECG Result|0
2592236|NCT01127633|8964328|P2|Overall Study|Protocol Violation|16
2592237|NCT01127633|8964329|P1|Overall Study|Protocol Violation|8
2592238|NCT01127633|8964328|P2|Overall Study|Sponsor Decision|195
2592239|NCT01127633|8964329|P1|Overall Study|Sponsor Decision|163
2592240|NCT01127633|8964328|P2|Overall Study|Withdrawal by Subject|72
2592241|NCT01127633|8964329|P1|Overall Study|Withdrawal by Subject|57
2592242|NCT01127633|8964328|P2|Overall Study|Physician Decision|45
2592243|NCT01127633|8964329|P1|Overall Study|Physician Decision|60
2592244|NCT01127633|8964328|P2|Overall Study|Parent/Caregiver Decision|228
2592245|NCT01127633|8964329|P1|Overall Study|Parent/Caregiver Decision|246
2592246|NCT01127633|8964328|P2|Overall Study|Lost to Follow-up|0
2592247|NCT01127633|8964329|P1|Overall Study|Lost to Follow-up|4
2592248|NCT01127633|8964328|P2|Overall Study|Death|43
2592249|NCT01127633|8964329|P1|Overall Study|Death|40
2592250|NCT01127633|8964328|P2|Overall Study|Adverse Event|73
2592251|NCT01127633|8964329|P1|Overall Study|Adverse Event|74
2592252|NCT01127607|8964361|P2|Phase II (Between Subjects)|Withdrawal by Subject|0
2592253|NCT01127607|8964362|P1|Phase II (Between Subjects)|Withdrawal by Subject|1
2592254|NCT01127607|8964361|P2|Phase II (Between Subjects)|Lost to Follow-up|2
2592255|NCT01127607|8964362|P1|Phase II (Between Subjects)|Lost to Follow-up|0
2592256|NCT01127256|8964539|P2|Overall Study|Protocol Violation|0
2592257|NCT01127256|8964540|P1|Overall Study|Protocol Violation|1
2592258|NCT01127256|8964539|P2|Overall Study|Withdrawal by Subject|9
2592259|NCT01127256|8964540|P1|Overall Study|Withdrawal by Subject|5
2592260|NCT01127256|8964539|P2|Overall Study|Lost to Follow-up|17
2592261|NCT01127256|8964540|P1|Overall Study|Lost to Follow-up|16
2592262|NCT01127256|8964539|P2|Overall Study|Lack of Efficacy|0
2592263|NCT01127256|8964540|P1|Overall Study|Lack of Efficacy|4
2592264|NCT01127256|8964539|P2|Overall Study|Adverse Event|13
2592265|NCT01127256|8964540|P1|Overall Study|Adverse Event|13
2592266|NCT01127165|8964552|P2|Overall Study|Protocol Violation|1
2592267|NCT01127165|8964553|P1|Overall Study|Protocol Violation|0
2592268|NCT01127165|8964552|P2|Overall Study|Withdrawal by Subject|3
2592269|NCT01127165|8964553|P1|Overall Study|Withdrawal by Subject|1
2592270|NCT01127165|8964552|P2|Overall Study|Lost to Follow-up|5
2592271|NCT01127165|8964553|P1|Overall Study|Lost to Follow-up|3
2592272|NCT01127165|8964552|P2|Overall Study|Lack of Efficacy|8
2592273|NCT01127165|8964553|P1|Overall Study|Lack of Efficacy|10
2592274|NCT01127165|8964552|P2|Overall Study|Adverse Event|2
2592275|NCT01127165|8964553|P1|Overall Study|Adverse Event|2
2592276|NCT01127139|8964565|P1|Overall Study|Reason not specified|1
2592277|NCT01127139|8964565|P1|Overall Study|Lack of Efficacy|4
2592278|NCT01127139|8964565|P1|Overall Study|Incompliance|12
2592279|NCT01127139|8964565|P1|Overall Study|Adverse Event|40
2592280|NCT01127061|8964593|P2|Overall Study|Physician Decision|3
2592281|NCT01127061|8964594|P1|Overall Study|Physician Decision|3
2592282|NCT01127061|8964593|P2|Overall Study|Lost to Follow-up|10
2592283|NCT01127061|8964594|P1|Overall Study|Lost to Follow-up|7
2592284|NCT01126879|8964631|P2|Overall Study|Physician Decision|0
2592285|NCT01126879|8964632|P1|Overall Study|Physician Decision|1
2592286|NCT01126879|8964631|P2|Overall Study|Adverse Event|1
2592287|NCT01126879|8964632|P1|Overall Study|Adverse Event|0
2592288|NCT01126879|8964631|P2|Overall Study|Withdrawal by Subject|0
2592289|NCT01126879|8964632|P1|Overall Study|Withdrawal by Subject|1
2592290|NCT01126879|8964631|P2|Overall Study|Progressive Disease|1
2592291|NCT01126879|8964632|P1|Overall Study|Progressive Disease|3
2592292|NCT01126619|8964679|P1|Overall Study|Non-compliance|1
2592293|NCT01126619|8964679|P1|Overall Study|Withdrawal by Subject|9
2592294|NCT01126619|8964679|P1|Overall Study|Serious adverse event|1
2592295|NCT01126619|8964679|P1|Overall Study|Investigator decision|4
2592296|NCT01126619|8964679|P1|Overall Study|Not eligible for the study|2
2592297|NCT01126580|8964707|P3|Overall Study|Treatment Non-compliance|3
2592298|NCT01126580|8964708|P2|Overall Study|Treatment Non-compliance|2
2592299|NCT01126580|8964709|P1|Overall Study|Treatment Non-compliance|0
2592300|NCT01126580|8964707|P3|Overall Study|Lost to Follow-up|9
2592301|NCT01126580|8964708|P2|Overall Study|Lost to Follow-up|13
2592302|NCT01126580|8964709|P1|Overall Study|Lost to Follow-up|15
2592303|NCT01126580|8964707|P3|Overall Study|Protocol Violation|2
2592304|NCT01126580|8964708|P2|Overall Study|Protocol Violation|1
2592305|NCT01126580|8964709|P1|Overall Study|Protocol Violation|0
2592306|NCT01126580|8964707|P3|Overall Study|Lack of Efficacy|4
2592307|NCT01126580|8964708|P2|Overall Study|Lack of Efficacy|3
2592308|NCT01126580|8964709|P1|Overall Study|Lack of Efficacy|2
2592309|NCT01126580|8964707|P3|Overall Study|Entry Criteria Not Met|2
2592310|NCT01126580|8964708|P2|Overall Study|Entry Criteria Not Met|1
2592311|NCT01126580|8964709|P1|Overall Study|Entry Criteria Not Met|1
2592312|NCT01126580|8964707|P3|Overall Study|Physician Decision|2
2592313|NCT01126580|8964708|P2|Overall Study|Physician Decision|1
2592314|NCT01126580|8964709|P1|Overall Study|Physician Decision|1
2592315|NCT01126580|8964707|P3|Overall Study|Sponsor Decision|7
2592316|NCT01126580|8964708|P2|Overall Study|Sponsor Decision|4
2592317|NCT01126580|8964709|P1|Overall Study|Sponsor Decision|5
2592318|NCT01126580|8964707|P3|Overall Study|Withdrawal by Subject|14
2592319|NCT01126580|8964708|P2|Overall Study|Withdrawal by Subject|19
2592320|NCT01126580|8964709|P1|Overall Study|Withdrawal by Subject|11
2592321|NCT01126580|8964707|P3|Overall Study|Adverse Event|12
2592322|NCT01126580|8964708|P2|Overall Study|Adverse Event|8
2592323|NCT01126580|8964709|P1|Overall Study|Adverse Event|14
2592324|NCT01126541|8964804|P3|Overall Study|Administrative reason or other|2
2592325|NCT01126541|8964805|P2|Overall Study|Administrative reason or other|1
2592326|NCT01126541|8964806|P1|Overall Study|Administrative reason or other|1
2592327|NCT01126541|8964804|P3|Overall Study|Protocol Violation|1
2592328|NCT01126541|8964805|P2|Overall Study|Protocol Violation|0
2592329|NCT01126541|8964806|P1|Overall Study|Protocol Violation|0
2592330|NCT01126541|8964804|P3|Overall Study|Withdrawal by Subject|6
2592331|NCT01126541|8964805|P2|Overall Study|Withdrawal by Subject|5
2592332|NCT01126541|8964806|P1|Overall Study|Withdrawal by Subject|2
2592333|NCT01126541|8964804|P3|Overall Study|Lost to Follow-up|2
2592334|NCT01126541|8964805|P2|Overall Study|Lost to Follow-up|2
2592335|NCT01126541|8964806|P1|Overall Study|Lost to Follow-up|1
2592336|NCT01126541|8964804|P3|Overall Study|Lack of Efficacy|11
2592337|NCT01126541|8964805|P2|Overall Study|Lack of Efficacy|1
2592338|NCT01126541|8964806|P1|Overall Study|Lack of Efficacy|6
2592339|NCT01126541|8964804|P3|Overall Study|Death|0
2592340|NCT01126541|8964805|P2|Overall Study|Death|1
2592341|NCT01126541|8964806|P1|Overall Study|Death|0
2592342|NCT01126541|8964804|P3|Overall Study|Adverse Event|4
2592343|NCT01126541|8964805|P2|Overall Study|Adverse Event|2
2592344|NCT01126541|8964806|P1|Overall Study|Adverse Event|0
2592345|NCT01126437|8964890|P3|Overall Study|Other reason not specified|178
2592346|NCT01126437|8964891|P2|Overall Study|Other reason not specified|176
2592347|NCT01126437|8964892|P1|Overall Study|Other reason not specified|210
2592348|NCT01126437|8964890|P3|Overall Study|Withdrawal by Subject|319
2592349|NCT01126437|8964891|P2|Overall Study|Withdrawal by Subject|335
2592350|NCT01126437|8964892|P1|Overall Study|Withdrawal by Subject|331
2592351|NCT01126437|8964890|P3|Overall Study|Lost to Follow-up|55
2592352|NCT01126437|8964891|P2|Overall Study|Lost to Follow-up|63
2592353|NCT01126437|8964892|P1|Overall Study|Lost to Follow-up|52
2592354|NCT01126437|8964890|P3|Overall Study|Protocol Violation|41
2592355|NCT01126437|8964891|P2|Overall Study|Protocol Violation|66
2592356|NCT01126437|8964892|P1|Overall Study|Protocol Violation|64
2592357|NCT01126437|8964890|P3|Overall Study|Lack of Efficacy|59
2592358|NCT01126437|8964891|P2|Overall Study|Lack of Efficacy|60
2592359|NCT01126437|8964892|P1|Overall Study|Lack of Efficacy|65
2592360|NCT01126437|8964890|P3|Overall Study|Adverse Event|635
2592361|NCT01126437|8964891|P2|Overall Study|Adverse Event|606
2592362|NCT01126437|8964892|P1|Overall Study|Adverse Event|602
2592363|NCT01126437|8964890|P3|Overall Study|Sites with data irregularities/fraud|7
2592364|NCT01126437|8964891|P2|Overall Study|Sites with data irregularities/fraud|6
2592365|NCT01126437|8964892|P1|Overall Study|Sites with data irregularities/fraud|6
2592366|NCT01126437|8964890|P3|Overall Study|Not treated|19
2592367|NCT01126437|8964891|P2|Overall Study|Not treated|18
2592368|NCT01126437|8964892|P1|Overall Study|Not treated|11
2592369|NCT01126424|8964930|P6|Overall Study|Withdrawal by Subject|0
2592370|NCT01126424|8964931|P5|Overall Study|Withdrawal by Subject|1
2592371|NCT01126424|8964932|P4|Overall Study|Withdrawal by Subject|3
2592372|NCT01126424|8964933|P3|Overall Study|Withdrawal by Subject|1
2592373|NCT01126424|8964934|P2|Overall Study|Withdrawal by Subject|0
2592374|NCT01126424|8964935|P1|Overall Study|Withdrawal by Subject|0
2592375|NCT01126424|8964930|P6|Overall Study|Adverse Event|0
2592376|NCT01126424|8964931|P5|Overall Study|Adverse Event|1
2592377|NCT01126424|8964932|P4|Overall Study|Adverse Event|0
2592378|NCT01126424|8964933|P3|Overall Study|Adverse Event|0
2592379|NCT01126424|8964934|P2|Overall Study|Adverse Event|0
2592380|NCT01126424|8964935|P1|Overall Study|Adverse Event|0
2592381|NCT01126359|8964958|P2|First Intervention (20-minutes)|Physician Decision|1
2592382|NCT01126359|8964959|P1|First Intervention (20-minutes)|Physician Decision|0
2592383|NCT01126268|8964971|P1|Overall Study|Adverse Event|1
2592384|NCT01126060|8965010|P2|Overall Study|Protocol Violation|2
2592385|NCT01126060|8965011|P1|Overall Study|Protocol Violation|0
2592386|NCT01125930|8965019|P2|Overall Study|Lost to Follow-up|2
2592387|NCT01125930|8965020|P1|Overall Study|Lost to Follow-up|0
2592388|NCT01125930|8965019|P2|Overall Study|Protocol Violation|1
2592389|NCT01125930|8965020|P1|Overall Study|Protocol Violation|0
2592390|NCT01125930|8965019|P2|Overall Study|Withdrawal by Subject|6
2592391|NCT01125930|8965020|P1|Overall Study|Withdrawal by Subject|1
2592392|NCT01125930|8965019|P2|Overall Study|Adverse Event|1
2592393|NCT01125930|8965020|P1|Overall Study|Adverse Event|0
2592394|NCT01125917|8965174|P1|Overall Study|Lack of Efficacy|19
2592395|NCT01125917|8965174|P1|Overall Study|Administrative|223
2592396|NCT01125917|8965174|P1|Overall Study|Withdrawal by Subject|31
2592397|NCT01125917|8965174|P1|Overall Study|Lost to Follow-up|23
2592398|NCT01125917|8965174|P1|Overall Study|Adverse Event|43
2592399|NCT01125813|8965178|P1|Overall Study|Screen Failures|4
2592400|NCT01125813|8965178|P1|Overall Study|Withdrawal by Subject|1
2592401|NCT01125813|8965178|P1|Overall Study|Death|1
2592402|NCT01125800|8965188|P5|Phase II|Disease progression|8
2592403|NCT01125800|8965189|P4|Phase II|Disease progression|1
2592404|NCT01125800|8965190|P3|Phase II|Disease progression|0
2592405|NCT01125800|8965191|P2|Phase II|Disease progression|0
2592406|NCT01125800|8965192|P1|Phase II|Disease progression|0
2592407|NCT01125800|8965188|P5|Phase II|Adverse Event|2
2592408|NCT01125800|8965189|P4|Phase II|Adverse Event|0
2592409|NCT01125800|8965190|P3|Phase II|Adverse Event|0
2592410|NCT01125800|8965191|P2|Phase II|Adverse Event|0
2592411|NCT01125800|8965192|P1|Phase II|Adverse Event|0
2592412|NCT01125800|8965188|P5|Phase II|Protocol Violation|1
2592413|NCT01125800|8965189|P4|Phase II|Protocol Violation|0
2592414|NCT01125800|8965190|P3|Phase II|Protocol Violation|0
2592415|NCT01125800|8965191|P2|Phase II|Protocol Violation|0
2592416|NCT01125800|8965192|P1|Phase II|Protocol Violation|0
2592417|NCT01125800|8965188|P5|Phase I|Disease progression|0
2592418|NCT01125800|8965189|P4|Phase I|Disease progression|3
2592419|NCT01125800|8965190|P3|Phase I|Disease progression|1
2592420|NCT01125800|8965191|P2|Phase I|Disease progression|4
2592421|NCT01125800|8965192|P1|Phase I|Disease progression|5
2592422|NCT01125800|8965188|P5|Phase I|Withdrawal by Subject|0
2592423|NCT01125800|8965189|P4|Phase I|Withdrawal by Subject|0
2592424|NCT01125800|8965190|P3|Phase I|Withdrawal by Subject|1
2592425|NCT01125800|8965191|P2|Phase I|Withdrawal by Subject|0
2592426|NCT01125800|8965192|P1|Phase I|Withdrawal by Subject|0
2592427|NCT01125800|8965188|P5|Phase I|Administrative problems|0
2592428|NCT01125800|8965189|P4|Phase I|Administrative problems|0
2592429|NCT01125800|8965190|P3|Phase I|Administrative problems|0
2592430|NCT01125800|8965191|P2|Phase I|Administrative problems|0
2592431|NCT01125800|8965192|P1|Phase I|Administrative problems|1
2592432|NCT01125800|8965188|P5|Phase I|Adverse Event|0
2592433|NCT01125800|8965189|P4|Phase I|Adverse Event|7
2592434|NCT01125800|8965190|P3|Phase I|Adverse Event|1
2592435|NCT01125800|8965191|P2|Phase I|Adverse Event|2
2592436|NCT01125800|8965192|P1|Phase I|Adverse Event|2
2592437|NCT01125800|8965188|P5|Phase I|Protocol Violation|0
2592438|NCT01125800|8965189|P4|Phase I|Protocol Violation|1
2592439|NCT01125800|8965190|P3|Phase I|Protocol Violation|1
2592440|NCT01125800|8965191|P2|Phase I|Protocol Violation|3
2592441|NCT01125800|8965192|P1|Phase I|Protocol Violation|0
2592442|NCT01125748|8965258|P2|Overall Study|Patient Decision to Withdraw|4
2592443|NCT01125748|8965259|P1|Overall Study|Patient Decision to Withdraw|2
2592444|NCT01125748|8965258|P2|Overall Study|Physician Decision|7
2592445|NCT01125748|8965259|P1|Overall Study|Physician Decision|8
2592446|NCT01125748|8965258|P2|Overall Study|Lost to Follow-up|1
2592447|NCT01125748|8965259|P1|Overall Study|Lost to Follow-up|0
2592448|NCT01125748|8965258|P2|Overall Study|Adverse Event|2
2592449|NCT01125748|8965259|P1|Overall Study|Adverse Event|0
2592450|NCT01125722|8965269|P2|Overall Study|Lost to Follow-up|0
2592451|NCT01125722|8965270|P1|Overall Study|Lost to Follow-up|1
2592452|NCT01125722|8965269|P2|Overall Study|Withdrawal by Subject|1
2592453|NCT01125722|8965270|P1|Overall Study|Withdrawal by Subject|2
2592454|NCT01125566|8965317|P3|Patients Who Switched From AV to TV|Other than listed above|4
2592455|NCT01125566|8965318|P2|Patients Who Switched From AV to TV|Other than listed above|0
2592456|NCT01125566|8965319|P1|Patients Who Switched From AV to TV|Other than listed above|0
2592457|NCT01125566|8965317|P3|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3
2592458|NCT01125566|8965318|P2|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0
2592459|NCT01125566|8965319|P1|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0
2592460|NCT01125566|8965317|P3|Patients Who Switched From AV to TV|Refused to continue taking medication|7
2592461|NCT01125566|8965318|P2|Patients Who Switched From AV to TV|Refused to continue taking medication|0
2592462|NCT01125566|8965319|P1|Patients Who Switched From AV to TV|Refused to continue taking medication|0
2592463|NCT01125566|8965317|P3|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59
2592464|NCT01125566|8965318|P2|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
2592465|NCT01125566|8965319|P1|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
2592466|NCT01125566|8965317|P3|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0
2592467|NCT01125566|8965318|P2|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1
2592468|NCT01125566|8965319|P1|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1
2592469|NCT01125566|8965317|P3|Patients Before the Switch (26Apr2013)|Other than listed above|0
2592548|NCT01124864|8965523|P1|Overall Study|Lost to Follow-up|1
2592470|NCT01125566|8965318|P2|Patients Before the Switch (26Apr2013)|Other than listed above|13
2592471|NCT01125566|8965319|P1|Patients Before the Switch (26Apr2013)|Other than listed above|25
2592472|NCT01125566|8965317|P3|Patients Before the Switch (26Apr2013)|Not treated|0
2592473|NCT01125566|8965318|P2|Patients Before the Switch (26Apr2013)|Not treated|0
2592474|NCT01125566|8965319|P1|Patients Before the Switch (26Apr2013)|Not treated|2
2592475|NCT01125566|8965317|P3|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0
2592476|NCT01125566|8965318|P2|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23
2592477|NCT01125566|8965319|P1|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24
2592478|NCT01125566|8965317|P3|Patients Before the Switch (26Apr2013)|Protocol Violation|0
2592479|NCT01125566|8965318|P2|Patients Before the Switch (26Apr2013)|Protocol Violation|2
2592480|NCT01125566|8965319|P1|Patients Before the Switch (26Apr2013)|Protocol Violation|0
2592481|NCT01125566|8965317|P3|Patients Before the Switch (26Apr2013)|Adverse Event|0
2592482|NCT01125566|8965318|P2|Patients Before the Switch (26Apr2013)|Adverse Event|5
2592483|NCT01125566|8965319|P1|Patients Before the Switch (26Apr2013)|Adverse Event|25
2592484|NCT01125566|8965317|P3|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0
2592485|NCT01125566|8965318|P2|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6
2592486|NCT01125566|8965319|P1|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6
2592487|NCT01125566|8965317|P3|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0
2592488|NCT01125566|8965318|P2|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119
2592489|NCT01125566|8965319|P1|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182
2592490|NCT01125514|8965332|P1|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1
2592491|NCT01125514|8965332|P1|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1
2592492|NCT01125514|8965332|P1|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2
2592493|NCT01125514|8965332|P1|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3
2592494|NCT01125514|8965332|P1|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1
2592495|NCT01125514|8965332|P1|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1
2592496|NCT01125189|8965432|P3|Follow up Period|Other reasons|5
2592497|NCT01125189|8965433|P2|Follow up Period|Other reasons|4
2592498|NCT01125189|8965434|P1|Follow up Period|Other reasons|4
2592499|NCT01125189|8965432|P3|Follow up Period|Lost to Follow-up|6
2592500|NCT01125189|8965433|P2|Follow up Period|Lost to Follow-up|9
2592501|NCT01125189|8965434|P1|Follow up Period|Lost to Follow-up|12
2592502|NCT01125189|8965432|P3|Follow up Period|Death|0
2592503|NCT01125189|8965433|P2|Follow up Period|Death|0
2592504|NCT01125189|8965434|P1|Follow up Period|Death|1
2592505|NCT01125189|8965432|P3|Follow up Period|Withdrawal by Subject|5
2592506|NCT01125189|8965433|P2|Follow up Period|Withdrawal by Subject|2
2592507|NCT01125189|8965434|P1|Follow up Period|Withdrawal by Subject|3
2592508|NCT01125189|8965432|P3|Treatment Period|Completed 24 week treatment period only|2
2592509|NCT01125189|8965433|P2|Treatment Period|Completed 24 week treatment period only|1
2592510|NCT01125189|8965434|P1|Treatment Period|Completed 24 week treatment period only|2
2592511|NCT01125189|8965432|P3|Treatment Period|Other reasons|0
2592512|NCT01125189|8965433|P2|Treatment Period|Other reasons|1
2592513|NCT01125189|8965434|P1|Treatment Period|Other reasons|1
2592514|NCT01125189|8965432|P3|Treatment Period|Participants requested to discontinue|4
2592515|NCT01125189|8965433|P2|Treatment Period|Participants requested to discontinue|3
2592516|NCT01125189|8965434|P1|Treatment Period|Participants requested to discontinue|1
2592517|NCT01125189|8965432|P3|Treatment Period|Poor compliance/noncompliance|0
2592518|NCT01125189|8965433|P2|Treatment Period|Poor compliance/noncompliance|1
2592519|NCT01125189|8965434|P1|Treatment Period|Poor compliance/noncompliance|0
2592520|NCT01125189|8965432|P3|Treatment Period|Lost to Follow-up|1
2592521|NCT01125189|8965433|P2|Treatment Period|Lost to Follow-up|2
2592522|NCT01125189|8965434|P1|Treatment Period|Lost to Follow-up|1
2592523|NCT01125189|8965432|P3|Treatment Period|Death|0
2592524|NCT01125189|8965433|P2|Treatment Period|Death|0
2592525|NCT01125189|8965434|P1|Treatment Period|Death|1
2592526|NCT01125189|8965432|P3|Treatment Period|Withdrawal by Subject|1
2592527|NCT01125189|8965433|P2|Treatment Period|Withdrawal by Subject|1
2592528|NCT01125189|8965434|P1|Treatment Period|Withdrawal by Subject|3
2592529|NCT01125189|8965432|P3|Treatment Period|Adverse Event|8
2592530|NCT01125189|8965433|P2|Treatment Period|Adverse Event|8
2592531|NCT01125189|8965434|P1|Treatment Period|Adverse Event|7
2592532|NCT01125189|8965432|P3|Treatment Period|Lack of Efficacy|25
2592533|NCT01125189|8965433|P2|Treatment Period|Lack of Efficacy|18
2592534|NCT01125189|8965434|P1|Treatment Period|Lack of Efficacy|15
2592535|NCT01124916|8965503|P2|Overall Study|Lost to Follow-up|2
2592536|NCT01124916|8965504|P1|Overall Study|Lost to Follow-up|3
2592537|NCT01124864|8965518|P6|Overall Study|Protocol Violation|0
2592538|NCT01124864|8965519|P5|Overall Study|Protocol Violation|1
2592539|NCT01124864|8965520|P4|Overall Study|Protocol Violation|0
2592540|NCT01124864|8965521|P3|Overall Study|Protocol Violation|0
2592541|NCT01124864|8965522|P2|Overall Study|Protocol Violation|0
2592542|NCT01124864|8965523|P1|Overall Study|Protocol Violation|1
2592543|NCT01124864|8965518|P6|Overall Study|Lost to Follow-up|0
2592544|NCT01124864|8965519|P5|Overall Study|Lost to Follow-up|0
2592545|NCT01124864|8965520|P4|Overall Study|Lost to Follow-up|1
2592546|NCT01124864|8965521|P3|Overall Study|Lost to Follow-up|0
2592547|NCT01124864|8965522|P2|Overall Study|Lost to Follow-up|1
2592549|NCT01124864|8965518|P6|Overall Study|Withdrawal by Subject|1
2592550|NCT01124864|8965519|P5|Overall Study|Withdrawal by Subject|2
2592551|NCT01124864|8965520|P4|Overall Study|Withdrawal by Subject|0
2592552|NCT01124864|8965521|P3|Overall Study|Withdrawal by Subject|4
2592553|NCT01124864|8965522|P2|Overall Study|Withdrawal by Subject|3
2592554|NCT01124864|8965523|P1|Overall Study|Withdrawal by Subject|2
2592555|NCT01124864|8965518|P6|Overall Study|Death|0
2592556|NCT01124864|8965519|P5|Overall Study|Death|1
2592557|NCT01124864|8965520|P4|Overall Study|Death|2
2592558|NCT01124864|8965521|P3|Overall Study|Death|6
2592559|NCT01124864|8965522|P2|Overall Study|Death|9
2592560|NCT01124864|8965523|P1|Overall Study|Death|6
2592561|NCT01124864|8965518|P6|Overall Study|Follow up phase competed as per protocol|2
2592562|NCT01124864|8965519|P5|Overall Study|Follow up phase competed as per protocol|26
2592563|NCT01124864|8965520|P4|Overall Study|Follow up phase competed as per protocol|18
2592564|NCT01124864|8965521|P3|Overall Study|Follow up phase competed as per protocol|24
2592565|NCT01124864|8965522|P2|Overall Study|Follow up phase competed as per protocol|22
2592566|NCT01124864|8965523|P1|Overall Study|Follow up phase competed as per protocol|18
2592567|NCT01124838|8965557|P2|Overall Study|Lost to Follow-up|0
2592568|NCT01124838|8965558|P1|Overall Study|Lost to Follow-up|2
2592569|NCT01124838|8965557|P2|Overall Study|Withdrawal by Subject|2
2592570|NCT01124838|8965558|P1|Overall Study|Withdrawal by Subject|3
2592571|NCT01124838|8965557|P2|Overall Study|Lack of Efficacy|0
2592572|NCT01124838|8965558|P1|Overall Study|Lack of Efficacy|2
2592573|NCT01124838|8965557|P2|Overall Study|Adverse Event|11
2592574|NCT01124838|8965558|P1|Overall Study|Adverse Event|7
2592575|NCT01124838|8965557|P2|Overall Study|Miscellaneous|2
2592576|NCT01124838|8965558|P1|Overall Study|Miscellaneous|4
2592577|NCT01124734|8965625|P1|Overall Study|Elected for alternative treatment|2
2592578|NCT01124734|8965625|P1|Overall Study|Withdrawal by Subject|1
2592579|NCT01124734|8965625|P1|Overall Study|Adverse Event|1
2592580|NCT01124734|8965625|P1|Overall Study|Disease progression|13
2592581|NCT01124643|8965636|P1|Overall Study|Death|1
2592582|NCT01124617|8965650|P2|Overall Study|Other|1
2592583|NCT01124617|8965651|P1|Overall Study|Other|2
2592584|NCT01124617|8965650|P2|Overall Study|Withdrawal by Subject|1
2592585|NCT01124617|8965651|P1|Overall Study|Withdrawal by Subject|9
2592586|NCT01124617|8965650|P2|Overall Study|Protocol Violation|1
2592587|NCT01124617|8965651|P1|Overall Study|Protocol Violation|1
2592588|NCT01124617|8965650|P2|Overall Study|Lack of Efficacy|1
2592589|NCT01124617|8965651|P1|Overall Study|Lack of Efficacy|2
2592590|NCT01124617|8965650|P2|Overall Study|Adverse Event|2
2592591|NCT01124617|8965651|P1|Overall Study|Adverse Event|5
2592592|NCT01124604|8965683|P2|Overall Study|Disease Progression|1
2592593|NCT01124604|8965684|P1|Overall Study|Disease Progression|0
2592594|NCT01124604|8965683|P2|Overall Study|Withdrawal by Subject|0
2592595|NCT01124604|8965684|P1|Overall Study|Withdrawal by Subject|4
2592596|NCT01124604|8965683|P2|Overall Study|Lack of Efficacy|0
2592597|NCT01124604|8965684|P1|Overall Study|Lack of Efficacy|1
2592598|NCT01124604|8965683|P2|Overall Study|Adverse Event|1
2592599|NCT01124604|8965684|P1|Overall Study|Adverse Event|10
2592600|NCT01124448|8965723|P2|Overall Study|Protocol Violation|0
2592601|NCT01124448|8965724|P1|Overall Study|Protocol Violation|2
2592602|NCT01124448|8965723|P2|Overall Study|Lost to Follow-up|3
2592603|NCT01124448|8965724|P1|Overall Study|Lost to Follow-up|0
2592604|NCT01124422|8965732|P3|4-Week Double-blind Treatment Phase|Lost to Follow-up|1
2592605|NCT01124422|8965733|P2|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
2592606|NCT01124422|8965734|P1|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
2592607|NCT01124422|8965732|P3|4-Week Double-blind Treatment Phase|Physician Decision|2
2592608|NCT01124422|8965733|P2|4-Week Double-blind Treatment Phase|Physician Decision|5
2592609|NCT01124422|8965734|P1|4-Week Double-blind Treatment Phase|Physician Decision|0
2592610|NCT01124422|8965732|P3|4-Week Double-blind Treatment Phase|Adverse Event|3
2592611|NCT01124422|8965733|P2|4-Week Double-blind Treatment Phase|Adverse Event|6
2592612|NCT01124422|8965734|P1|4-Week Double-blind Treatment Phase|Adverse Event|0
2592613|NCT01124422|8965732|P3|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3
2592614|NCT01124422|8965733|P2|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
2592615|NCT01124422|8965734|P1|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
2592616|NCT01124422|8965732|P3|4-Week Open-label Run-in Phase|Protocol Violation|0
2592617|NCT01124422|8965733|P2|4-Week Open-label Run-in Phase|Protocol Violation|0
2592618|NCT01124422|8965734|P1|4-Week Open-label Run-in Phase|Protocol Violation|5
2592619|NCT01124422|8965732|P3|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
2592620|NCT01124422|8965733|P2|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
2592621|NCT01124422|8965734|P1|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61
2592622|NCT01124422|8965732|P3|4-Week Open-label Run-in Phase|Lost to Follow-up|0
2592623|NCT01124422|8965733|P2|4-Week Open-label Run-in Phase|Lost to Follow-up|0
2592624|NCT01124422|8965734|P1|4-Week Open-label Run-in Phase|Lost to Follow-up|1
2592625|NCT01124422|8965732|P3|4-Week Open-label Run-in Phase|Physician Decision|0
2592626|NCT01124422|8965733|P2|4-Week Open-label Run-in Phase|Physician Decision|0
2592627|NCT01124422|8965734|P1|4-Week Open-label Run-in Phase|Physician Decision|4
2592628|NCT01124422|8965732|P3|4-Week Open-label Run-in Phase|Adverse Event|0
2592629|NCT01124422|8965733|P2|4-Week Open-label Run-in Phase|Adverse Event|0
2592630|NCT01124422|8965734|P1|4-Week Open-label Run-in Phase|Adverse Event|7
2592631|NCT01124422|8965732|P3|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
2592632|NCT01124422|8965733|P2|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
2592633|NCT01124422|8965734|P1|4-Week Open-label Run-in Phase|Withdrawal by Subject|5
2592634|NCT01124292|8965804|P3|Overall Study|piercing track closed|1
2592635|NCT01124292|8965805|P2|Overall Study|piercing track closed|2
2592636|NCT01124292|8965806|P1|Overall Study|piercing track closed|0
2592637|NCT01124292|8965804|P3|Overall Study|medical issue unrelated to the study|2
2592638|NCT01124292|8965805|P2|Overall Study|medical issue unrelated to the study|0
2592639|NCT01124292|8965806|P1|Overall Study|medical issue unrelated to the study|0
2592640|NCT01124292|8965804|P3|Overall Study|Withdrawal by Subject|2
2592641|NCT01124292|8965805|P2|Overall Study|Withdrawal by Subject|6
2592642|NCT01124292|8965806|P1|Overall Study|Withdrawal by Subject|0
2592643|NCT01124292|8965804|P3|Overall Study|Physician Decision|2
2592644|NCT01124292|8965805|P2|Overall Study|Physician Decision|3
2592645|NCT01124292|8965806|P1|Overall Study|Physician Decision|0
2592646|NCT01124292|8965804|P3|Overall Study|Lost to Follow-up|3
2592647|NCT01124292|8965805|P2|Overall Study|Lost to Follow-up|4
2592648|NCT01124292|8965806|P1|Overall Study|Lost to Follow-up|2
2592649|NCT01124175|8965877|P2|Washout of 7 Days|Withdrawal by Subject|2
2592650|NCT01124175|8965878|P1|Washout of 7 Days|Withdrawal by Subject|0
2592651|NCT01124162|8965896|P2|Washout of 7 Days|Withdrawal by Subject|0
2592652|NCT01124162|8965897|P1|Washout of 7 Days|Withdrawal by Subject|1
2592653|NCT01124162|8965896|P2|First Intervention|Adverse Event|0
2592654|NCT01124162|8965897|P1|First Intervention|Adverse Event|2
2592655|NCT01124149|8965913|P1|Maintenance Phase|Non-compliance|1
2592656|NCT01124149|8965913|P1|Maintenance Phase|Coordinator error|1
2592657|NCT01124149|8965913|P1|Maintenance Phase|Protocol Violation|5
2592658|NCT01124149|8965913|P1|Maintenance Phase|Withdrawal by Subject|10
2592659|NCT01124149|8965913|P1|Maintenance Phase|Lost to Follow-up|15
2592660|NCT01124149|8965913|P1|Maintenance Phase|Adverse Event|24
2592661|NCT01124149|8965913|P1|Maintenance Phase|Lack of Efficacy|40
2592662|NCT01124149|8965913|P1|Acute Phase|Sponsor decision|1
2592663|NCT01124149|8965913|P1|Acute Phase|Travelling to another country|1
2592664|NCT01124149|8965913|P1|Acute Phase|Low hemoglobin|1
2592665|NCT01124149|8965913|P1|Acute Phase|Non-compliance|1
2592666|NCT01124149|8965913|P1|Acute Phase|UC symptoms not ameliorated|1
2592667|NCT01124149|8965913|P1|Acute Phase|Sponsor request|1
2592668|NCT01124149|8965913|P1|Acute Phase|Prolonged antibiotic therapy|1
2592669|NCT01124149|8965913|P1|Acute Phase|Lost to Follow-up|2
2592670|NCT01124149|8965913|P1|Acute Phase|Protocol Violation|14
2592671|NCT01124149|8965913|P1|Acute Phase|Lack of Efficacy|17
2592672|NCT01124149|8965913|P1|Acute Phase|Adverse Event|21
2592673|NCT01124149|8965913|P1|Acute Phase|Withdrawal by Subject|22
2592674|NCT01124097|8965933|P4|Overall Study|Physician Decision|0
2592675|NCT01124097|8965934|P3|Overall Study|Physician Decision|0
2592676|NCT01124097|8965935|P2|Overall Study|Physician Decision|1
2592677|NCT01124097|8965936|P1|Overall Study|Physician Decision|2
2592678|NCT01124097|8965933|P4|Overall Study|Protocol Violation|1
2592679|NCT01124097|8965934|P3|Overall Study|Protocol Violation|2
2592680|NCT01124097|8965935|P2|Overall Study|Protocol Violation|0
2592681|NCT01124097|8965936|P1|Overall Study|Protocol Violation|2
2592682|NCT01124097|8965933|P4|Overall Study|Adverse Event|7
2592683|NCT01124097|8965934|P3|Overall Study|Adverse Event|15
2592684|NCT01124097|8965935|P2|Overall Study|Adverse Event|15
2592685|NCT01124097|8965936|P1|Overall Study|Adverse Event|24
2592686|NCT01124097|8965933|P4|Overall Study|Lack of Efficacy|3
2592687|NCT01124097|8965934|P3|Overall Study|Lack of Efficacy|1
2592688|NCT01124097|8965935|P2|Overall Study|Lack of Efficacy|3
2592689|NCT01124097|8965936|P1|Overall Study|Lack of Efficacy|2
2592690|NCT01124097|8965933|P4|Overall Study|Withdrawal by Subject|3
2592691|NCT01124097|8965934|P3|Overall Study|Withdrawal by Subject|2
2592692|NCT01124097|8965935|P2|Overall Study|Withdrawal by Subject|3
2592693|NCT01124097|8965936|P1|Overall Study|Withdrawal by Subject|4
2592694|NCT01124045|8965948|P2|Overall Study|Physician Decision|2
2592695|NCT01124045|8965949|P1|Overall Study|Physician Decision|0
2592696|NCT01124045|8965948|P2|Overall Study|Lost to Follow-up|1
2592697|NCT01124045|8965949|P1|Overall Study|Lost to Follow-up|0
2592698|NCT01124006|8965982|P3|Overall Study|Other|1
2592699|NCT01124006|8965983|P2|Overall Study|Other|0
2592700|NCT01124006|8965984|P1|Overall Study|Other|0
2592701|NCT01124006|8965982|P3|Overall Study|Lost to Follow-up|1
2592702|NCT01124006|8965983|P2|Overall Study|Lost to Follow-up|0
2592703|NCT01124006|8965984|P1|Overall Study|Lost to Follow-up|1
2592704|NCT01124006|8965982|P3|Overall Study|Withdrawal by Subject|0
2592705|NCT01124006|8965983|P2|Overall Study|Withdrawal by Subject|2
2592706|NCT01124006|8965984|P1|Overall Study|Withdrawal by Subject|2
2592707|NCT01123980|8966012|P2|Overall Study|Unclassified|7
2592708|NCT01123980|8966013|P1|Overall Study|Unclassified|6
2592709|NCT01123980|8966012|P2|Overall Study|Withdrawal by Subject|3
2592710|NCT01123980|8966013|P1|Overall Study|Withdrawal by Subject|5
2592711|NCT01123980|8966012|P2|Overall Study|Protocol Violation|6
2592712|NCT01123980|8966013|P1|Overall Study|Protocol Violation|6
2592713|NCT01123980|8966012|P2|Overall Study|Lost to Follow-up|6
2592714|NCT01123980|8966013|P1|Overall Study|Lost to Follow-up|0
2592715|NCT01123980|8966012|P2|Overall Study|Physician Decision|1
2592716|NCT01123980|8966013|P1|Overall Study|Physician Decision|0
2592717|NCT01123980|8966012|P2|Overall Study|Lack of Efficacy|0
2592718|NCT01123980|8966013|P1|Overall Study|Lack of Efficacy|1
2592719|NCT01123980|8966012|P2|Overall Study|Adverse Event|1
2592720|NCT01123980|8966013|P1|Overall Study|Adverse Event|1
2592721|NCT01123941|8966033|P2|Overall Study|Lost to Follow-up|1
2592722|NCT01123941|8966034|P1|Overall Study|Lost to Follow-up|2
2592723|NCT01123889|8966069|P2|Overall Study|Lost to Follow-up|1
2592724|NCT01123889|8966070|P1|Overall Study|Lost to Follow-up|3
2592725|NCT01123850|8966080|P1|Overall Study|Slow enrollment|45
2592726|NCT01123655|8966087|P3|Overall Study|began prohibitive drug|1
2592727|NCT01123655|8966088|P2|Overall Study|began prohibitive drug|0
2592728|NCT01123655|8966089|P1|Overall Study|began prohibitive drug|0
2592729|NCT01123655|8966087|P3|Overall Study|new illness|0
2592730|NCT01123655|8966088|P2|Overall Study|new illness|1
2592731|NCT01123655|8966089|P1|Overall Study|new illness|0
2592732|NCT01123655|8966087|P3|Overall Study|Medication for RA had to be changed|0
2592733|NCT01123655|8966088|P2|Overall Study|Medication for RA had to be changed|0
2592734|NCT01123655|8966089|P1|Overall Study|Medication for RA had to be changed|1
2592735|NCT01123642|8966161|P1|Overall Study|ineligible at baseline assessment|36
2592736|NCT01123642|8966161|P1|Overall Study|Withdrawal by Subject|9
2592737|NCT01123642|8966161|P1|Overall Study|Lost to Follow-up|23
2592738|NCT01123395|8966177|P2|Washout Period of 14 Days|Withdrawal by Subject|1
2592739|NCT01123395|8966178|P1|Washout Period of 14 Days|Withdrawal by Subject|0
2592740|NCT01123382|8966190|P2|Overall Study|Lost to Follow-up|2
2592741|NCT01123382|8966191|P1|Overall Study|Lost to Follow-up|1
2592742|NCT01123382|8966190|P2|Overall Study|Withdrawal by Subject|4
2592743|NCT01123382|8966191|P1|Overall Study|Withdrawal by Subject|1
2592744|NCT01123356|8966213|P1|Overall Study|Withdrawal by Subject|1
2592745|NCT01123356|8966213|P1|Overall Study|Lack of Efficacy|4
2592746|NCT01123356|8966213|P1|Overall Study|Adverse Event|2
2592747|NCT01123200|8966221|P1|Overall Study|Withdrawal by Subject|1
2592748|NCT01123161|8966228|P2|Overall Study|Withdrawal by Subject|0
2592749|NCT01123161|8966229|P1|Overall Study|Withdrawal by Subject|1
2592750|NCT01123161|8966228|P2|Overall Study|Lost to Follow-up|0
2592751|NCT01123161|8966229|P1|Overall Study|Lost to Follow-up|1
2592752|NCT01123148|8966247|P1|Overall Study|Didn't meet milestone criteria|1
2592753|NCT01123148|8966247|P1|Overall Study|Coughing caused unacceptable EEG quality|1
2592754|NCT01123083|8966253|P2|Overall Study|Participant/legal representative request|3
2592755|NCT01123083|8966254|P1|Overall Study|Participant/legal representative request|7
2592756|NCT01123083|8966253|P2|Overall Study|Withdrew for another reason not covered|1
2592757|NCT01123083|8966254|P1|Overall Study|Withdrew for another reason not covered|0
2592758|NCT01123083|8966253|P2|Overall Study|Adverse Event|0
2592759|NCT01123083|8966254|P1|Overall Study|Adverse Event|1
2592760|NCT01123083|8966253|P2|Overall Study|Lost to Follow-up|6
2592761|NCT01123083|8966254|P1|Overall Study|Lost to Follow-up|2
2592762|NCT01123083|8966253|P2|Overall Study|Administrative reasons|4
2592763|NCT01123083|8966254|P1|Overall Study|Administrative reasons|0
2592764|NCT01123083|8966253|P2|Overall Study|Investigator recommendation|1
2592765|NCT01123083|8966254|P1|Overall Study|Investigator recommendation|1
2592766|NCT01122927|8966278|P2|Period 2- Open-label Treatment Phase|Lack of Efficacy|7
2592767|NCT01122927|8966279|P1|Period 2- Open-label Treatment Phase|Lack of Efficacy|0
2592768|NCT01122927|8966278|P2|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65
2592769|NCT01122927|8966279|P1|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0
2592770|NCT01122927|8966278|P2|Period 2- Open-label Treatment Phase|Physician Decision|12
2592771|NCT01122927|8966279|P1|Period 2- Open-label Treatment Phase|Physician Decision|0
2592772|NCT01122927|8966278|P2|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9
2592773|NCT01122927|8966279|P1|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0
2592774|NCT01122927|8966278|P2|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165
2592775|NCT01122927|8966279|P1|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0
2592776|NCT01122927|8966278|P2|Period 2- Open-label Treatment Phase|Adverse Event|33
2592777|NCT01122927|8966279|P1|Period 2- Open-label Treatment Phase|Adverse Event|0
2592778|NCT01122927|8966278|P2|Period 2- Open-label Treatment Phase|Lost to Follow-up|21
2592779|NCT01122927|8966279|P1|Period 2- Open-label Treatment Phase|Lost to Follow-up|0
2592780|NCT01122927|8966278|P2|Period 1 - Conversion Phase|Protocol Deviation|0
2592781|NCT01122927|8966279|P1|Period 1 - Conversion Phase|Protocol Deviation|1
2592782|NCT01122927|8966278|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
2592783|NCT01122927|8966279|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
2592784|NCT01122927|8966278|P2|Period 1 - Conversion Phase|Physician Decision|0
2592785|NCT01122927|8966279|P1|Period 1 - Conversion Phase|Physician Decision|2
2592786|NCT01122927|8966278|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
2592787|NCT01122927|8966279|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
2592788|NCT01122927|8966278|P2|Period 1 - Conversion Phase|Adverse Event|0
2592789|NCT01122927|8966279|P1|Period 1 - Conversion Phase|Adverse Event|3
2592790|NCT01122862|8966331|P3|Period 2|Adverse Event|1
2592791|NCT01122862|8966332|P2|Period 2|Adverse Event|0
2592792|NCT01122862|8966333|P1|Period 2|Adverse Event|0
2592793|NCT01122862|8966331|P3|Period 1|Protocol Violation|0
2592794|NCT01122862|8966332|P2|Period 1|Protocol Violation|1
2592795|NCT01122862|8966333|P1|Period 1|Protocol Violation|0
2592796|NCT01122680|8966439|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
2592797|NCT01122680|8966440|P3|Period 3 (4 Weeks)|Withdrawal by Subject|0
2592798|NCT01122680|8966441|P2|Period 3 (4 Weeks)|Withdrawal by Subject|1
2592799|NCT01122680|8966442|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
2592800|NCT01122680|8966439|P4|Period 3 (4 Weeks)|Adverse Event|0
2592801|NCT01122680|8966440|P3|Period 3 (4 Weeks)|Adverse Event|0
2592802|NCT01122680|8966441|P2|Period 3 (4 Weeks)|Adverse Event|0
2592803|NCT01122680|8966442|P1|Period 3 (4 Weeks)|Adverse Event|1
2592804|NCT01122680|8966439|P4|Period 2 (4 Weeks)|Other|0
2592805|NCT01122680|8966440|P3|Period 2 (4 Weeks)|Other|0
2592806|NCT01122680|8966441|P2|Period 2 (4 Weeks)|Other|0
2592807|NCT01122680|8966442|P1|Period 2 (4 Weeks)|Other|1
2592808|NCT01122680|8966439|P4|Period 2 (4 Weeks)|Protocol Violation|1
2592809|NCT01122680|8966440|P3|Period 2 (4 Weeks)|Protocol Violation|0
2592810|NCT01122680|8966441|P2|Period 2 (4 Weeks)|Protocol Violation|0
2592811|NCT01122680|8966442|P1|Period 2 (4 Weeks)|Protocol Violation|0
2592812|NCT01122680|8966439|P4|Period 1 (4 Weeks)|Other|0
2592813|NCT01122680|8966440|P3|Period 1 (4 Weeks)|Other|0
2592814|NCT01122680|8966441|P2|Period 1 (4 Weeks)|Other|1
2592815|NCT01122680|8966442|P1|Period 1 (4 Weeks)|Other|1
2592816|NCT01122680|8966439|P4|Period 1 (4 Weeks)|Protocol Violation|0
2592817|NCT01122680|8966440|P3|Period 1 (4 Weeks)|Protocol Violation|0
2592818|NCT01122680|8966441|P2|Period 1 (4 Weeks)|Protocol Violation|0
2592819|NCT01122680|8966442|P1|Period 1 (4 Weeks)|Protocol Violation|1
2592820|NCT01122680|8966439|P4|Period 1 (4 Weeks)|Adverse Event|0
2592821|NCT01122680|8966440|P3|Period 1 (4 Weeks)|Adverse Event|0
2592822|NCT01122680|8966441|P2|Period 1 (4 Weeks)|Adverse Event|0
2592823|NCT01122680|8966442|P1|Period 1 (4 Weeks)|Adverse Event|1
2592824|NCT01122576|8966507|P3|Post-Cataract Surgery|Fellow Eye Explanted|1
2592825|NCT01122576|8966508|P2|Post-Cataract Surgery|Fellow Eye Explanted|0
2592826|NCT01122576|8966509|P1|Post-Cataract Surgery|Fellow Eye Explanted|0
2592827|NCT01122576|8966507|P3|Post-Cataract Surgery|Central Macular Edema|1
2592828|NCT01122576|8966508|P2|Post-Cataract Surgery|Central Macular Edema|0
2592829|NCT01122576|8966509|P1|Post-Cataract Surgery|Central Macular Edema|0
2592830|NCT01122576|8966507|P3|Pre-Cataract Surgery|Withdrawal by Subject|2
2592831|NCT01122576|8966508|P2|Pre-Cataract Surgery|Withdrawal by Subject|1
2592832|NCT01122576|8966509|P1|Pre-Cataract Surgery|Withdrawal by Subject|0
2592833|NCT01122394|8966690|P2|Overall Study|Adverse Event|1
2592834|NCT01122394|8966691|P1|Overall Study|Adverse Event|0
2592835|NCT01122394|8966690|P2|Overall Study|Lost to Follow-up|2
2592836|NCT01122394|8966691|P1|Overall Study|Lost to Follow-up|2
2592837|NCT01122394|8966690|P2|Overall Study|Withdrawal by Subject|1
2592838|NCT01122394|8966691|P1|Overall Study|Withdrawal by Subject|1
2592839|NCT01122381|8966707|P2|Overall Study|study terminated early|1
2592840|NCT01122381|8966708|P1|Overall Study|study terminated early|0
2592841|NCT01122264|8966717|P3|Overall Study|Lack of Efficacy|1
2592842|NCT01122264|8966718|P2|Overall Study|Lack of Efficacy|1
2592843|NCT01122264|8966719|P1|Overall Study|Lack of Efficacy|3
2592844|NCT01122264|8966717|P3|Overall Study|Physician Decision|1
2592845|NCT01122264|8966718|P2|Overall Study|Physician Decision|1
2592846|NCT01122264|8966719|P1|Overall Study|Physician Decision|3
2592847|NCT01122264|8966717|P3|Overall Study|Withdrawal by Subject|16
2592848|NCT01122264|8966718|P2|Overall Study|Withdrawal by Subject|6
2592849|NCT01122264|8966719|P1|Overall Study|Withdrawal by Subject|6
2592850|NCT01122264|8966717|P3|Overall Study|Protocol Violation|9
2592851|NCT01122264|8966718|P2|Overall Study|Protocol Violation|7
2592852|NCT01122264|8966719|P1|Overall Study|Protocol Violation|7
2592853|NCT01122264|8966717|P3|Overall Study|Entry Criteria Not Met|0
2592854|NCT01122264|8966718|P2|Overall Study|Entry Criteria Not Met|0
2592855|NCT01122264|8966719|P1|Overall Study|Entry Criteria Not Met|1
2592856|NCT01122264|8966717|P3|Overall Study|Lost to Follow-up|13
2592857|NCT01122264|8966718|P2|Overall Study|Lost to Follow-up|9
2592858|NCT01122264|8966719|P1|Overall Study|Lost to Follow-up|5
2592859|NCT01122264|8966717|P3|Overall Study|Death|0
2592860|NCT01122264|8966718|P2|Overall Study|Death|0
2592861|NCT01122264|8966719|P1|Overall Study|Death|1
2592862|NCT01122264|8966717|P3|Overall Study|Adverse Event|7
2592863|NCT01122264|8966718|P2|Overall Study|Adverse Event|5
2592864|NCT01122264|8966719|P1|Overall Study|Adverse Event|6
2592865|NCT01122173|8966829|P1|Overall Study|Left study for other reasons|3
2592866|NCT01122173|8966829|P1|Overall Study|Withdrawal by Subject|3
2592867|NCT01122173|8966829|P1|Overall Study|Lost to Follow-up|3
2592868|NCT01121991|8967052|P1|Overall Study|No Fertilization|1
2592869|NCT01121991|8967052|P1|Overall Study|No Oocytes Retrieved|3
2592870|NCT01121991|8967052|P1|Overall Study|Lack of Ovarian Response|2
2592871|NCT01121926|8967077|P2|Washout Period|Positive pregnancy test|1
2592872|NCT01121926|8967078|P1|Washout Period|Positive pregnancy test|0
2592873|NCT01121926|8967077|P2|Washout Period|Adverse Event|1
2592874|NCT01121926|8967078|P1|Washout Period|Adverse Event|0
2592875|NCT01121926|8967077|P2|First Intervention Period|Adverse Event|0
2592876|NCT01121926|8967078|P1|First Intervention Period|Adverse Event|1
2592877|NCT01121913|8967096|P4|Third Washout Period|Adverse Event|0
2592878|NCT01121913|8967097|P3|Third Washout Period|Adverse Event|0
2592879|NCT01121913|8967098|P2|Third Washout Period|Adverse Event|0
2592880|NCT01121913|8967099|P1|Third Washout Period|Adverse Event|1
2592881|NCT01121913|8967096|P4|Second Washout Period|Withdrawal by Subject|0
2592882|NCT01121913|8967097|P3|Second Washout Period|Withdrawal by Subject|1
2592883|NCT01121913|8967098|P2|Second Washout Period|Withdrawal by Subject|0
2592884|NCT01121913|8967099|P1|Second Washout Period|Withdrawal by Subject|0
2592885|NCT01121913|8967096|P4|Second Intervention Period|Adverse Event|0
2592886|NCT01121913|8967097|P3|Second Intervention Period|Adverse Event|1
2592887|NCT01121913|8967098|P2|Second Intervention Period|Adverse Event|0
2592888|NCT01121913|8967099|P1|Second Intervention Period|Adverse Event|0
2592889|NCT01121913|8967096|P4|First Washout Period|Withdrawal by Subject|0
2592890|NCT01121913|8967097|P3|First Washout Period|Withdrawal by Subject|0
2592891|NCT01121913|8967098|P2|First Washout Period|Withdrawal by Subject|0
2592892|NCT01121913|8967099|P1|First Washout Period|Withdrawal by Subject|1
2592893|NCT01121913|8967096|P4|First Intervention Period|Adverse Event|0
2592894|NCT01121913|8967097|P3|First Intervention Period|Adverse Event|1
2592895|NCT01121913|8967098|P2|First Intervention Period|Adverse Event|0
2592896|NCT01121913|8967099|P1|First Intervention Period|Adverse Event|0
2592897|NCT01121900|8967129|P2|Washout Period of 7 Days|Withdrawal by Subject|1
2592898|NCT01121900|8967130|P1|Washout Period of 7 Days|Withdrawal by Subject|0
2592899|NCT01121900|8967129|P2|First Intervention Period|Adverse Event|1
2592900|NCT01121900|8967130|P1|First Intervention Period|Adverse Event|1
2592901|NCT01121757|8967150|P2|Combination|Disease Progression|0
2592902|NCT01121757|8967151|P1|Combination|Disease Progression|2
2592903|NCT01121757|8967150|P2|Combination|Physician Decision|1
2592904|NCT01121757|8967151|P1|Combination|Physician Decision|0
2592905|NCT01121757|8967150|P2|First Drug|Disease Progression|2
2592906|NCT01121757|8967151|P1|First Drug|Disease Progression|0
2592907|NCT01121757|8967150|P2|First Drug|Death|0
2592908|NCT01121757|8967151|P1|First Drug|Death|1
2592909|NCT01121666|8967167|P2|Overall Study|Protocol Violation|10
2592910|NCT01121666|8967168|P1|Overall Study|Protocol Violation|29
2592911|NCT01121575|8967224|P6|Overall Study|Death|1
2592912|NCT01121575|8967225|P5|Overall Study|Death|7
2592913|NCT01121575|8967226|P4|Overall Study|Death|1
2592914|NCT01121575|8967227|P3|Overall Study|Death|0
2592915|NCT01121575|8967228|P2|Overall Study|Death|0
2592916|NCT01121575|8967229|P1|Overall Study|Death|6
2592917|NCT01121575|8967224|P6|Overall Study|Unspecified Reasons|10
2592918|NCT01121575|8967225|P5|Overall Study|Unspecified Reasons|13
2592919|NCT01121575|8967226|P4|Overall Study|Unspecified Reasons|5
2592920|NCT01121575|8967227|P3|Overall Study|Unspecified Reasons|7
2592921|NCT01121575|8967228|P2|Overall Study|Unspecified Reasons|6
2592922|NCT01121575|8967229|P1|Overall Study|Unspecified Reasons|8
2592923|NCT01121575|8967224|P6|Overall Study|Participant Refused Further Follow-Up|1
2592924|NCT01121575|8967225|P5|Overall Study|Participant Refused Further Follow-Up|5
2592925|NCT01121575|8967226|P4|Overall Study|Participant Refused Further Follow-Up|0
2592926|NCT01121575|8967227|P3|Overall Study|Participant Refused Further Follow-Up|0
2592927|NCT01121575|8967228|P2|Overall Study|Participant Refused Further Follow-Up|0
2592928|NCT01121575|8967229|P1|Overall Study|Participant Refused Further Follow-Up|0
2592929|NCT01121562|8967353|P1|Overall Study|Met study discontinuation criteria|1
2592930|NCT01121562|8967353|P1|Overall Study|Sponsor Decision|1
2592931|NCT01121562|8967353|P1|Overall Study|Adverse Event|1
2592932|NCT01121562|8967353|P1|Overall Study|Withdrawal by Subject|1
2592933|NCT01121562|8967353|P1|Overall Study|Objective progression or relapse|8
2592934|NCT01121549|8967362|P1|Overall Study|Other|58
2592935|NCT01121549|8967362|P1|Overall Study|Withdrawal by Subject|16
2592936|NCT01121549|8967362|P1|Overall Study|Protocol Violation|33
2592937|NCT01121549|8967362|P1|Overall Study|Pregnancy|1
2592938|NCT01121549|8967362|P1|Overall Study|Study terminated by sponsor|197
2592939|NCT01121549|8967362|P1|Overall Study|Did not meet entrance criteria|9
2592940|NCT01121549|8967362|P1|Overall Study|Lost to Follow-up|12
2592941|NCT01121549|8967362|P1|Overall Study|Lack of Efficacy|11
2592942|NCT01121549|8967362|P1|Overall Study|Adverse Event|10
2592943|NCT01121536|8967373|P1|Overall Study|Other|118
2592944|NCT01121536|8967373|P1|Overall Study|Lost to Follow-up|39
2592945|NCT01121536|8967373|P1|Overall Study|Noncompliance with study procedures|9
2592946|NCT01121536|8967373|P1|Overall Study|Noncompliance with study medication|12
2592947|NCT01121536|8967373|P1|Overall Study|Protocol Violation|20
2592948|NCT01121536|8967373|P1|Overall Study|Withdrawal by Subject|65
2592949|NCT01121536|8967373|P1|Overall Study|Lack of Efficacy|35
2592950|NCT01121536|8967373|P1|Overall Study|Adverse Event|63
2592951|NCT01121484|8967394|P2|Overall Study|Randomized, not treated|4
2592952|NCT01121484|8967395|P1|Overall Study|Randomized, not treated|1
2592953|NCT01121484|8967394|P2|Overall Study|Other|3
2592954|NCT01121484|8967395|P1|Overall Study|Other|3
2592955|NCT01121484|8967394|P2|Overall Study|Discontinuation of study by sponsor|1
2592956|NCT01121484|8967395|P1|Overall Study|Discontinuation of study by sponsor|0
2592957|NCT01121484|8967394|P2|Overall Study|Withdrawal by Subject|7
2592958|NCT01121484|8967395|P1|Overall Study|Withdrawal by Subject|8
2592959|NCT01121484|8967394|P2|Overall Study|Protocol Violation|0
2592960|NCT01121484|8967395|P1|Overall Study|Protocol Violation|1
2592961|NCT01121484|8967394|P2|Overall Study|Physician Decision|3
2592962|NCT01121484|8967395|P1|Overall Study|Physician Decision|0
2592963|NCT01121484|8967394|P2|Overall Study|Lost to Follow-up|9
2592964|NCT01121484|8967395|P1|Overall Study|Lost to Follow-up|5
2592965|NCT01121484|8967394|P2|Overall Study|Lack of Efficacy|11
2592966|NCT01121484|8967395|P1|Overall Study|Lack of Efficacy|3
2592967|NCT01121484|8967394|P2|Overall Study|Adverse Event|5
2592968|NCT01121484|8967395|P1|Overall Study|Adverse Event|12
2592969|NCT01121406|8967413|P2|Overall Study|Not treated|0
2592970|NCT01121406|8967414|P1|Overall Study|Not treated|1
2592971|NCT01121406|8967413|P2|Overall Study|Reason other than specified above|6
2592972|NCT01121406|8967414|P1|Overall Study|Reason other than specified above|2
2592973|NCT01121406|8967413|P2|Overall Study|Refused continuation of study med.|2
2592974|NCT01121406|8967414|P1|Overall Study|Refused continuation of study med.|1
2592975|NCT01121406|8967413|P2|Overall Study|Lost to Follow-up|1
2592976|NCT01121406|8967414|P1|Overall Study|Lost to Follow-up|0
2592977|NCT01121406|8967413|P2|Overall Study|Non−compliant with protocol|2
2592978|NCT01121406|8967414|P1|Overall Study|Non−compliant with protocol|0
2592979|NCT01121406|8967413|P2|Overall Study|Other AE|10
2592980|NCT01121406|8967414|P1|Overall Study|Other AE|3
2592981|NCT01121406|8967413|P2|Overall Study|Wors. or AE of underlying cancer disease|6
2592982|NCT01121406|8967414|P1|Overall Study|Wors. or AE of underlying cancer disease|4
2592983|NCT01121406|8967413|P2|Overall Study|Progressive disease RECIST|28
2592984|NCT01121406|8967414|P1|Overall Study|Progressive disease RECIST|44
2592985|NCT01121393|8967464|P2|Overall Study|Other than listed|0
2592986|NCT01121393|8967465|P1|Overall Study|Other than listed|6
2592987|NCT01121393|8967464|P2|Overall Study|Not treated|9
2592988|NCT01121393|8967465|P1|Overall Study|Not treated|3
2592989|NCT01121393|8967464|P2|Overall Study|Refused cont. medication|7
2592990|NCT01121393|8967465|P1|Overall Study|Refused cont. medication|7
2592991|NCT01121393|8967464|P2|Overall Study|Lost to Follow-up|0
2592992|NCT01121393|8967465|P1|Overall Study|Lost to Follow-up|1
2592993|NCT01121393|8967464|P2|Overall Study|Non-compliant with protocol|3
2592994|NCT01121393|8967465|P1|Overall Study|Non-compliant with protocol|0
2592995|NCT01121393|8967464|P2|Overall Study|Other Adverse events|45
2592996|NCT01121393|8967465|P1|Overall Study|Other Adverse events|24
2592997|NCT01121393|8967464|P2|Overall Study|Progressive disease|20
2592998|NCT01121393|8967465|P1|Overall Study|Progressive disease|201
2592999|NCT01121263|8967510|P2|Overall Study|Withdrawal by Subject|1
2593000|NCT01121263|8967511|P1|Overall Study|Withdrawal by Subject|0
2593001|NCT01121263|8967510|P2|Overall Study|Lost to Follow-up|12
2593002|NCT01121263|8967511|P1|Overall Study|Lost to Follow-up|22
2593003|NCT01121263|8967510|P2|Overall Study|Death|2
2593004|NCT01121263|8967511|P1|Overall Study|Death|3
2593005|NCT01121185|8967602|P2|Overall Study|Not transplanted|0
2593006|NCT01121185|8967603|P1|Overall Study|Not transplanted|1
2593007|NCT01121185|8967602|P2|Overall Study|Not infused|1
2593008|NCT01121185|8967603|P1|Overall Study|Not infused|0
2593009|NCT01121146|8967637|P2|Overall Study|Lost to Follow-up|16
2593010|NCT01121146|8967638|P1|Overall Study|Lost to Follow-up|7
2593011|NCT01121146|8967637|P2|Overall Study|Adverse Event|11
2593012|NCT01121146|8967638|P1|Overall Study|Adverse Event|2
2593013|NCT01121146|8967637|P2|Overall Study|Death|15
2593014|NCT01121146|8967638|P1|Overall Study|Death|17
2593015|NCT01120899|8967659|P1|Overall Study|Withdrawal by Subject|3
2593016|NCT01120782|8967687|P1|Overall Study|Test article shipping error|11
2593017|NCT01120756|8967693|P2|Overall Study|Withdrawal by Subject|1
2593018|NCT01120756|8967694|P1|Overall Study|Withdrawal by Subject|1
2593019|NCT01120717|8967704|P2|Overall Study|Abnormal Test Procedure Result(s)|0
2593020|NCT01120717|8967705|P1|Overall Study|Abnormal Test Procedure Result(s)|1
2593021|NCT01120717|8967704|P2|Overall Study|Death|1
2593022|NCT01120717|8967705|P1|Overall Study|Death|3
2593023|NCT01120717|8967704|P2|Overall Study|Lost to Follow-up|3
2593024|NCT01120717|8967705|P1|Overall Study|Lost to Follow-up|2
2593025|NCT01120717|8967704|P2|Overall Study|Unsatisfactory Therapeutic Effect|3
2593026|NCT01120717|8967705|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
2593027|NCT01120717|8967704|P2|Overall Study|Protocol Deviation|5
2593028|NCT01120717|8967705|P1|Overall Study|Protocol Deviation|2
2593029|NCT01120717|8967704|P2|Overall Study|Adverse Event|6
2593030|NCT01120717|8967705|P1|Overall Study|Adverse Event|10
2593031|NCT01120717|8967704|P2|Overall Study|Withdrawal by Subject|6
2593032|NCT01120717|8967705|P1|Overall Study|Withdrawal by Subject|11
2593033|NCT01120691|8967811|P3|Overall Study|Abnormal laboratory value(s)|4
2593034|NCT01120691|8967812|P2|Overall Study|Abnormal laboratory value(s)|3
2593035|NCT01120691|8967813|P1|Overall Study|Abnormal laboratory value(s)|1
2593036|NCT01120691|8967811|P3|Overall Study|Patient's inability to use the device|0
2593037|NCT01120691|8967812|P2|Overall Study|Patient's inability to use the device|1
2593038|NCT01120691|8967813|P1|Overall Study|Patient's inability to use the device|3
2593039|NCT01120691|8967811|P3|Overall Study|Abnormal test procedure result(s)|1
2593040|NCT01120691|8967812|P2|Overall Study|Abnormal test procedure result(s)|2
2593041|NCT01120691|8967813|P1|Overall Study|Abnormal test procedure result(s)|3
2593042|NCT01120691|8967811|P3|Overall Study|Lost to Follow-up|4
2593043|NCT01120691|8967812|P2|Overall Study|Lost to Follow-up|6
2593044|NCT01120691|8967813|P1|Overall Study|Lost to Follow-up|5
2593045|NCT01120691|8967811|P3|Overall Study|Protocol deviation|12
2593046|NCT01120691|8967812|P2|Overall Study|Protocol deviation|12
2593047|NCT01120691|8967813|P1|Overall Study|Protocol deviation|13
2593048|NCT01120691|8967811|P3|Overall Study|Administrative problems|9
2593049|NCT01120691|8967812|P2|Overall Study|Administrative problems|8
2593050|NCT01120691|8967813|P1|Overall Study|Administrative problems|15
2593051|NCT01120691|8967811|P3|Overall Study|Unsatisfactory therapeutic effect|38
2593052|NCT01120691|8967812|P2|Overall Study|Unsatisfactory therapeutic effect|32
2593053|NCT01120691|8967813|P1|Overall Study|Unsatisfactory therapeutic effect|18
2593054|NCT01120691|8967811|P3|Overall Study|Death|24
2593055|NCT01120691|8967812|P2|Overall Study|Death|22
2593056|NCT01120691|8967813|P1|Overall Study|Death|21
2593057|NCT01120691|8967811|P3|Overall Study|Subject withdrew consent|44
2593058|NCT01120691|8967812|P2|Overall Study|Subject withdrew consent|50
2593059|NCT01120691|8967813|P1|Overall Study|Subject withdrew consent|33
2593060|NCT01120691|8967811|P3|Overall Study|Adverse Event|47
2593061|NCT01120691|8967812|P2|Overall Study|Adverse Event|67
2593062|NCT01120691|8967813|P1|Overall Study|Adverse Event|59
2593063|NCT01120626|8967910|P2|Overall Study|Withdrawal by Subject|0
2593064|NCT01120626|8967911|P1|Overall Study|Withdrawal by Subject|1
2593065|NCT01120600|8967921|P2|Overall Study|Withdrawal by Subject|11
2593066|NCT01120600|8967922|P1|Overall Study|Withdrawal by Subject|10
2593067|NCT01120600|8967921|P2|Overall Study|Protocol Violation|4
2593068|NCT01120600|8967922|P1|Overall Study|Protocol Violation|0
2593069|NCT01120600|8967921|P2|Overall Study|Physician Decision|3
2593070|NCT01120600|8967922|P1|Overall Study|Physician Decision|1
2593071|NCT01120600|8967921|P2|Overall Study|Lost to Follow-up|3
2593072|NCT01120600|8967922|P1|Overall Study|Lost to Follow-up|1
2593073|NCT01120600|8967921|P2|Overall Study|Excessive Bone Loss|4
2593074|NCT01120600|8967922|P1|Overall Study|Excessive Bone Loss|0
2593075|NCT01120600|8967921|P2|Overall Study|Adverse Event|7
2593076|NCT01120600|8967922|P1|Overall Study|Adverse Event|7
2593077|NCT01120379|8967977|P1|Four Year Timepoint|Any other reason for early termination|217
2593078|NCT01120379|8967977|P1|Four Year Timepoint|Physician Decision|5
2593079|NCT01120379|8967977|P1|Four Year Timepoint|Death|131
2593080|NCT01120379|8967977|P1|Four Year Timepoint|Lost to Follow-up|10
2593081|NCT01120379|8967977|P1|Four Year Timepoint|Withdrawal by Subject|5
2593082|NCT01120379|8967977|P1|Three Year Timepoint|Any other reason for early termination|17
2593083|NCT01120379|8967977|P1|Three Year Timepoint|Physician Decision|9
2593084|NCT01120379|8967977|P1|Three Year Timepoint|Death|120
2593085|NCT01120379|8967977|P1|Three Year Timepoint|Lost to Follow-up|43
2593086|NCT01120379|8967977|P1|Three Year Timepoint|Withdrawal by Subject|25
2593087|NCT01120379|8967977|P1|Two Year Timepoint|Any other reason for early termination|4
2593088|NCT01120379|8967977|P1|Two Year Timepoint|Physician Decision|12
2593089|NCT01120379|8967977|P1|Two Year Timepoint|Death|123
2593090|NCT01120379|8967977|P1|Two Year Timepoint|Lost to Follow-up|87
2593091|NCT01120379|8967977|P1|Two Year Timepoint|Withdrawal by Subject|11
2593092|NCT01120379|8967977|P1|One Year Timepoint|Any other reason for early termination|5
2593093|NCT01120379|8967977|P1|One Year Timepoint|Physician Decision|9
2593094|NCT01120379|8967977|P1|One Year Timepoint|Death|108
2593095|NCT01120379|8967977|P1|One Year Timepoint|Lost to Follow-up|115
2593096|NCT01120379|8967977|P1|One Year Timepoint|Withdrawal by Subject|41
2593097|NCT01120275|8968013|P1|Overall Study|Not specific|1
2593098|NCT01120275|8968013|P1|Overall Study|Refusal|1
2593099|NCT01120275|8968013|P1|Overall Study|Withdrawal by Subject|1
2593100|NCT01120275|8968013|P1|Overall Study|Ineligible|3
2593101|NCT01120275|8968013|P1|Overall Study|Progression|27
2593102|NCT01120275|8968013|P1|Overall Study|Adverse Event|3
2593103|NCT01120210|8968080|P2|MAIN INFUSION|Withdrawal by Subject|1
2593104|NCT01120210|8968081|P1|MAIN INFUSION|Withdrawal by Subject|0
2593105|NCT01120210|8968080|P2|MAIN INFUSION|Adverse Event|0
2593106|NCT01120210|8968081|P1|MAIN INFUSION|Adverse Event|1
2593107|NCT01120184|8968131|P3|Overall Study|Death|169
2593108|NCT01120184|8968132|P2|Overall Study|Death|176
2593109|NCT01120184|8968133|P1|Overall Study|Death|170
2593110|NCT01120184|8968131|P3|Overall Study|Subject/ Guardian Decision to Withdraw|25
2593111|NCT01120184|8968132|P2|Overall Study|Subject/ Guardian Decision to Withdraw|29
2593112|NCT01120184|8968133|P1|Overall Study|Subject/ Guardian Decision to Withdraw|32
2593113|NCT01120184|8968131|P3|Overall Study|Sponsor Decision to Terminate Study|143
2593114|NCT01120184|8968132|P2|Overall Study|Sponsor Decision to Terminate Study|144
2593115|NCT01120184|8968133|P1|Overall Study|Sponsor Decision to Terminate Study|133
2593116|NCT01120184|8968131|P3|Overall Study|Reason not Specified|12
2593117|NCT01120184|8968132|P2|Overall Study|Reason not Specified|3
2593118|NCT01120184|8968133|P1|Overall Study|Reason not Specified|8
2593119|NCT01120184|8968131|P3|Overall Study|Physician Decision|3
2593120|NCT01120184|8968132|P2|Overall Study|Physician Decision|1
2593121|NCT01120184|8968133|P1|Overall Study|Physician Decision|9
2593122|NCT01120184|8968131|P3|Overall Study|Lost to Follow-up|11
2593123|NCT01120184|8968132|P2|Overall Study|Lost to Follow-up|13
2593124|NCT01120184|8968133|P1|Overall Study|Lost to Follow-up|13
2593125|NCT01120184|8968131|P3|Overall Study|Adverse Event|0
2593126|NCT01120184|8968132|P2|Overall Study|Adverse Event|1
2593127|NCT01120184|8968133|P1|Overall Study|Adverse Event|0
2593128|NCT01120093|8968255|P5|Treatment Period 5|Adverse Event|0
2593129|NCT01120093|8968256|P4|Treatment Period 5|Adverse Event|1
2593130|NCT01120093|8968257|P3|Treatment Period 5|Adverse Event|0
2593131|NCT01120093|8968258|P2|Treatment Period 5|Adverse Event|1
2593132|NCT01120093|8968259|P1|Treatment Period 5|Adverse Event|0
2593133|NCT01120093|8968255|P5|Treatment Period 4|Adverse Event|0
2593134|NCT01120093|8968256|P4|Treatment Period 4|Adverse Event|0
2593135|NCT01120093|8968257|P3|Treatment Period 4|Adverse Event|0
2593136|NCT01120093|8968258|P2|Treatment Period 4|Adverse Event|0
2593137|NCT01120093|8968259|P1|Treatment Period 4|Adverse Event|1
2593138|NCT01120093|8968255|P5|Treatment Period 3|Withdrawal by Subject|0
2593139|NCT01120093|8968256|P4|Treatment Period 3|Withdrawal by Subject|0
2593140|NCT01120093|8968257|P3|Treatment Period 3|Withdrawal by Subject|1
2593141|NCT01120093|8968258|P2|Treatment Period 3|Withdrawal by Subject|0
2593142|NCT01120093|8968259|P1|Treatment Period 3|Withdrawal by Subject|0
2593143|NCT01120093|8968255|P5|Treatment Period 3|Adverse Event|1
2593144|NCT01120093|8968256|P4|Treatment Period 3|Adverse Event|0
2593145|NCT01120093|8968257|P3|Treatment Period 3|Adverse Event|0
2593146|NCT01120093|8968258|P2|Treatment Period 3|Adverse Event|0
2593147|NCT01120093|8968259|P1|Treatment Period 3|Adverse Event|0
2593148|NCT01120093|8968255|P5|Treatment Period 3|Lack of Efficacy|0
2593149|NCT01120093|8968256|P4|Treatment Period 3|Lack of Efficacy|1
2593150|NCT01120093|8968257|P3|Treatment Period 3|Lack of Efficacy|0
2593151|NCT01120093|8968258|P2|Treatment Period 3|Lack of Efficacy|0
2593152|NCT01120093|8968259|P1|Treatment Period 3|Lack of Efficacy|0
2593153|NCT01120093|8968255|P5|Treatment Period 2|Withdrawal by Subject|1
2593154|NCT01120093|8968256|P4|Treatment Period 2|Withdrawal by Subject|0
2593155|NCT01120093|8968257|P3|Treatment Period 2|Withdrawal by Subject|0
2593156|NCT01120093|8968258|P2|Treatment Period 2|Withdrawal by Subject|0
2593157|NCT01120093|8968259|P1|Treatment Period 2|Withdrawal by Subject|0
2593158|NCT01120093|8968255|P5|Treatment Period 2|Adverse Event|0
2593159|NCT01120093|8968256|P4|Treatment Period 2|Adverse Event|1
2593160|NCT01120093|8968257|P3|Treatment Period 2|Adverse Event|0
2593161|NCT01120093|8968258|P2|Treatment Period 2|Adverse Event|0
2593162|NCT01120093|8968259|P1|Treatment Period 2|Adverse Event|0
2593163|NCT01120093|8968255|P5|Treatment Period 1|Withdrawal by Subject|0
2593164|NCT01120093|8968256|P4|Treatment Period 1|Withdrawal by Subject|0
2593165|NCT01120093|8968257|P3|Treatment Period 1|Withdrawal by Subject|0
2593166|NCT01120093|8968258|P2|Treatment Period 1|Withdrawal by Subject|1
2593167|NCT01120093|8968259|P1|Treatment Period 1|Withdrawal by Subject|0
2593168|NCT01120093|8968255|P5|Treatment Period 1|Adverse Event|1
2593169|NCT01120093|8968256|P4|Treatment Period 1|Adverse Event|0
2593170|NCT01120093|8968257|P3|Treatment Period 1|Adverse Event|1
2593171|NCT01120093|8968258|P2|Treatment Period 1|Adverse Event|0
2593172|NCT01120093|8968259|P1|Treatment Period 1|Adverse Event|0
2593173|NCT01120067|8968288|P2|Overall Study|fail to engage >3 sessions|0
2593174|NCT01120067|8968289|P1|Overall Study|fail to engage >3 sessions|2
2593175|NCT01120067|8968288|P2|Overall Study|Lost to Follow-up|1
2593176|NCT01120067|8968289|P1|Overall Study|Lost to Follow-up|3
2593177|NCT01120028|8968299|P4|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0
2593178|NCT01120028|8968300|P3|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0
2593179|NCT01120028|8968301|P2|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18
2593180|NCT01120028|8968302|P1|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14
2593181|NCT01120028|8968299|P4|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
2593182|NCT01120028|8968300|P3|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
2593183|NCT01120028|8968301|P2|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5
2593184|NCT01120028|8968302|P1|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
2593185|NCT01119963|8968326|P2|Overall Study|Lost to Follow-up|1
2593186|NCT01119963|8968327|P1|Overall Study|Lost to Follow-up|1
2593187|NCT01119950|8968337|P1|Overall Study|Death|1
2593188|NCT01119950|8968337|P1|Overall Study|Abnormal lab value|1
2593189|NCT01119950|8968337|P1|Overall Study|Administrative|2
2593190|NCT01119950|8968337|P1|Overall Study|Lost to Follow-up|4
2593191|NCT01119950|8968337|P1|Overall Study|Protocol Violation|5
2593192|NCT01119950|8968337|P1|Overall Study|Withdrawal by Subject|9
2593193|NCT01119950|8968337|P1|Overall Study|Adverse Event|25
2593194|NCT01119937|8968584|P2|Overall Study|Withdrawal by Subject|1
2593195|NCT01119937|8968585|P1|Overall Study|Withdrawal by Subject|2
2593196|NCT01119937|8968584|P2|Overall Study|Unsatisfactory therapeutic effect|0
2593197|NCT01119937|8968585|P1|Overall Study|Unsatisfactory therapeutic effect|3
2593198|NCT01119937|8968584|P2|Overall Study|Protocol deviation|1
2593199|NCT01119937|8968585|P1|Overall Study|Protocol deviation|3
2593200|NCT01119937|8968584|P2|Overall Study|Adverse Event|5
2593201|NCT01119937|8968585|P1|Overall Study|Adverse Event|11
2593202|NCT01119898|8968613|P2|Overall Study|Randomized in error did not participate|0
2593203|NCT01119898|8968614|P1|Overall Study|Randomized in error did not participate|1
2593204|NCT01119898|8968613|P2|Overall Study|Medical procedure|0
2593205|NCT01119898|8968614|P1|Overall Study|Medical procedure|1
2593206|NCT01119898|8968613|P2|Overall Study|Protocol Violation|1
2593207|NCT01119898|8968614|P1|Overall Study|Protocol Violation|1
2593208|NCT01119898|8968613|P2|Overall Study|Lack of Efficacy|2
2593209|NCT01119898|8968614|P1|Overall Study|Lack of Efficacy|0
2593210|NCT01119898|8968613|P2|Overall Study|Withdrawal by Subject|4
2593211|NCT01119898|8968614|P1|Overall Study|Withdrawal by Subject|1
2593212|NCT01119898|8968613|P2|Overall Study|Adverse Event|5
2593213|NCT01119898|8968614|P1|Overall Study|Adverse Event|4
2593214|NCT01119859|8968640|P2|Overall Study|Failure to return|0
2593215|NCT01119859|8968641|P1|Overall Study|Failure to return|3
2593216|NCT01119859|8968640|P2|Overall Study|Refused treatment|6
2593217|NCT01119859|8968641|P1|Overall Study|Refused treatment|3
2593218|NCT01119859|8968640|P2|Overall Study|Insufficient therapeutic response|14
2593219|NCT01119859|8968641|P1|Overall Study|Insufficient therapeutic response|7
2593220|NCT01119859|8968640|P2|Overall Study|Death|0
2593221|NCT01119859|8968641|P1|Overall Study|Death|2
2593222|NCT01119859|8968640|P2|Overall Study|Adverse Event|10
2593223|NCT01119859|8968641|P1|Overall Study|Adverse Event|9
2593224|NCT01119846|8968660|P3|Overall Study|Withdrawal by Subject|4
2593225|NCT01119846|8968661|P2|Overall Study|Withdrawal by Subject|0
2593226|NCT01119846|8968662|P1|Overall Study|Withdrawal by Subject|0
2593227|NCT01119846|8968660|P3|Overall Study|Protocol Violation|1
2593228|NCT01119846|8968661|P2|Overall Study|Protocol Violation|0
2593229|NCT01119846|8968662|P1|Overall Study|Protocol Violation|0
2593230|NCT01119846|8968660|P3|Overall Study|Physician Decision|0
2593231|NCT01119846|8968661|P2|Overall Study|Physician Decision|0
2593232|NCT01119846|8968662|P1|Overall Study|Physician Decision|1
2593233|NCT01119846|8968660|P3|Overall Study|Adverse Event|6
2593234|NCT01119846|8968661|P2|Overall Study|Adverse Event|0
2593235|NCT01119846|8968662|P1|Overall Study|Adverse Event|1
2593236|NCT01119768|8968876|P2|Treatment Period|Lack of Efficacy|25
2593237|NCT01119768|8968877|P1|Treatment Period|Lack of Efficacy|18
2593238|NCT01119703|8968933|P2|Overall Study|Adverse Event|1
2593239|NCT01119703|8968934|P1|Overall Study|Adverse Event|0
2593240|NCT01119625|8968948|P2|Overall Study|Other|1
2593241|NCT01119625|8968949|P1|Overall Study|Other|0
2593242|NCT01119625|8968948|P2|Overall Study|Withdrawal by Subject|1
2593243|NCT01119625|8968949|P1|Overall Study|Withdrawal by Subject|2
2593244|NCT01119625|8968948|P2|Overall Study|Lost to Follow-up|2
2593245|NCT01119625|8968949|P1|Overall Study|Lost to Follow-up|1
2593246|NCT01119508|8968989|P1|Overall Study|Died before tumor response evaluation|1
2593247|NCT01119508|8968989|P1|Overall Study|Withdrawal by Subject|2
2593248|NCT01119508|8968989|P1|Overall Study|Adverse Event|56
2593249|NCT01119443|8969069|P2|Crossover Period 1 (5 Days)|Adverse Event|1
2593250|NCT01119443|8969070|P1|Crossover Period 1 (5 Days)|Adverse Event|0
2593251|NCT01119287|8969113|P6|Overall Study|Patient Decision, not related to AE|0
2593252|NCT01119287|8969114|P5|Overall Study|Patient Decision, not related to AE|1
2593253|NCT01119287|8969115|P4|Overall Study|Patient Decision, not related to AE|2
2593254|NCT01119287|8969116|P3|Overall Study|Patient Decision, not related to AE|2
2593255|NCT01119287|8969117|P2|Overall Study|Patient Decision, not related to AE|0
2593256|NCT01119287|8969118|P1|Overall Study|Patient Decision, not related to AE|0
2593257|NCT01119248|8969131|P1|Overall Study|Physician Decision|5
2593258|NCT01119131|8969181|P3|Overall Study|Physician Decision|1
2593259|NCT01119131|8969182|P2|Overall Study|Physician Decision|0
2593260|NCT01119131|8969183|P1|Overall Study|Physician Decision|0
2593261|NCT01119131|8969181|P3|Overall Study|Non-Compliance|4
2593262|NCT01119131|8969182|P2|Overall Study|Non-Compliance|0
2593263|NCT01119131|8969183|P1|Overall Study|Non-Compliance|1
2593264|NCT01119131|8969181|P3|Overall Study|Adverse Event|1
2593265|NCT01119131|8969182|P2|Overall Study|Adverse Event|1
2593266|NCT01119131|8969183|P1|Overall Study|Adverse Event|1
2593267|NCT01119118|8969212|P1|Overall Study|Adverse Event|1
2593268|NCT01119001|8969224|P1|Overall Study|Withdrawal by Subject|2
2593269|NCT01118975|8969268|P2|Overall Study|Adverse Event|1
2593270|NCT01118975|8969269|P1|Overall Study|Adverse Event|0
2593271|NCT01118962|8969275|P1|Overall Study|Non-compliance with Medicinal Product|1
2593272|NCT01118962|8969275|P1|Overall Study|Pregnancy|1
2593273|NCT01118962|8969275|P1|Overall Study|Withdrawal by Subject|4
2593274|NCT01118962|8969275|P1|Overall Study|Protocol Violation|1
2593275|NCT01118962|8969275|P1|Overall Study|Lack of Efficacy|1
2593276|NCT01118962|8969275|P1|Overall Study|Adverse Event|2
2593277|NCT01118949|8969280|P1|Overall Study|Withdrawal by Subject|4
2593278|NCT01118949|8969280|P1|Overall Study|Adverse Event|5
2593279|NCT01118780|8969310|P2|Overall Study|Withdrawal by Subject|8
2593280|NCT01118780|8969311|P1|Overall Study|Withdrawal by Subject|13
2593281|NCT01118780|8969310|P2|Overall Study|Protocol Violation|6
2593282|NCT01118780|8969311|P1|Overall Study|Protocol Violation|3
2593283|NCT01118780|8969310|P2|Overall Study|Physician Decision|0
2593284|NCT01118780|8969311|P1|Overall Study|Physician Decision|2
2593285|NCT01118780|8969310|P2|Overall Study|Lack of Efficacy|6
2593286|NCT01118780|8969311|P1|Overall Study|Lack of Efficacy|2
2593287|NCT01118780|8969310|P2|Overall Study|Death|0
2593288|NCT01118780|8969311|P1|Overall Study|Death|1
2593289|NCT01118780|8969310|P2|Overall Study|Adverse Event|15
2593290|NCT01118780|8969311|P1|Overall Study|Adverse Event|15
2593291|NCT01118728|8969369|P1|Overall Study|Lost to Follow-up|4
2593292|NCT01118728|8969369|P1|Overall Study|Withdrawal by Subject|3
2593293|NCT01118728|8969369|P1|Overall Study|Sponsor's decision to discontinue study|172
2593294|NCT01118728|8969369|P1|Overall Study|Lack of Efficacy|27
2593295|NCT01118728|8969369|P1|Overall Study|Adverse Event|17
2593296|NCT01118663|8969376|P2|Overall Study|Withdrawal by Subject|1
2593297|NCT01118663|8969377|P1|Overall Study|Withdrawal by Subject|0
2593298|NCT01118663|8969376|P2|Overall Study|Adverse Event|1
2593299|NCT01118663|8969377|P1|Overall Study|Adverse Event|2
2593300|NCT01118455|8969400|P2|Baseline [Visits 1 & 2]|Adverse Event|0
2593301|NCT01118455|8969401|P1|Baseline [Visits 1 & 2]|Adverse Event|1
2593302|NCT01118377|8969429|P1|Overall Study|Failure to Return|3
2593303|NCT01118377|8969429|P1|Overall Study|Death|38
2593304|NCT01118377|8969429|P1|Overall Study|Did Not Receive Study Medication|1
2593305|NCT01118351|8969435|P1|Overall Study|Withdrawal by Subject|1
2593306|NCT01118351|8969435|P1|Overall Study|Adverse Event|3
2593307|NCT01118325|8969446|P3|Overall Study|Adverse Event|1
2593308|NCT01118325|8969447|P2|Overall Study|Adverse Event|0
2593309|NCT01118325|8969448|P1|Overall Study|Adverse Event|1
2593310|NCT01118312|8969494|P2|Overall Study|Withdrawal by Subject|3
2593311|NCT01118312|8969495|P1|Overall Study|Withdrawal by Subject|1
2593312|NCT01118312|8969494|P2|Overall Study|Lost to Follow-up|32
2593313|NCT01118312|8969495|P1|Overall Study|Lost to Follow-up|33
2593314|NCT01118299|8969505|P2|Overall Study|Enrollment Closure, Protocol Amendment|15
2593315|NCT01118299|8969506|P1|Overall Study|Enrollment Closure, Protocol Amendment|6
2593316|NCT01118299|8969505|P2|Overall Study|Lost to Follow-up|1
2593317|NCT01118299|8969506|P1|Overall Study|Lost to Follow-up|2
2593318|NCT01118299|8969505|P2|Overall Study|Withdrawal by Subject|8
2593319|NCT01118299|8969506|P1|Overall Study|Withdrawal by Subject|8
2593320|NCT01118299|8969505|P2|Overall Study|Death|5
2593321|NCT01118299|8969506|P1|Overall Study|Death|7
2593322|NCT01118143|8969703|P2|Overall Study|Withdrawal by Subject|5
2593323|NCT01118143|8969704|P1|Overall Study|Withdrawal by Subject|2
2593324|NCT01118117|8969714|P2|Overall Study|Missed 12 Month Visit|0
2593325|NCT01118117|8969715|P1|Overall Study|Missed 12 Month Visit|7
2593326|NCT01118117|8969714|P2|Overall Study|Lost to Follow-up|0
2593327|NCT01118117|8969715|P1|Overall Study|Lost to Follow-up|6
2593328|NCT01118117|8969714|P2|Overall Study|Death|0
2593329|NCT01118117|8969715|P1|Overall Study|Death|8
2593330|NCT01118052|8969747|P1|Overall Study|Never treated|2
2593331|NCT01117987|8969770|P2|Overall Study|Administrative problems|22
2593332|NCT01117987|8969771|P1|Overall Study|Administrative problems|25
2593333|NCT01117987|8969770|P2|Overall Study|Adverse Event|26
2593334|NCT01117987|8969771|P1|Overall Study|Adverse Event|19
2593335|NCT01117987|8969770|P2|Overall Study|Withdrawal by Subject|10
2593336|NCT01117987|8969771|P1|Overall Study|Withdrawal by Subject|5
2593337|NCT01117987|8969770|P2|Overall Study|Death|10
2593338|NCT01117987|8969771|P1|Overall Study|Death|5
2593339|NCT01117987|8969770|P2|Overall Study|Lack of Efficacy|4
2593340|NCT01117987|8969771|P1|Overall Study|Lack of Efficacy|3
2593341|NCT01117987|8969770|P2|Overall Study|Abnormal test procedure result|0
2593342|NCT01117987|8969771|P1|Overall Study|Abnormal test procedure result|2
2593343|NCT01117987|8969770|P2|Overall Study|Lost to Follow-up|1
2593344|NCT01117987|8969771|P1|Overall Study|Lost to Follow-up|1
2593345|NCT01117987|8969770|P2|Overall Study|Subject no longer requires study drug|0
2593346|NCT01117987|8969771|P1|Overall Study|Subject no longer requires study drug|1
2593347|NCT01117987|8969770|P2|Overall Study|Protocol deviation|1
2593348|NCT01117987|8969771|P1|Overall Study|Protocol deviation|0
2593349|NCT01117870|8969792|P2|Overall Study|Inability to place needle|0
2593350|NCT01117870|8969793|P1|Overall Study|Inability to place needle|1
2593351|NCT01117857|8969807|P1|Overall Study|Physician Decision|1
2593352|NCT01117857|8969807|P1|Overall Study|Withdrawal by Subject|4
2593353|NCT01117857|8969807|P1|Overall Study|Lost to Follow-up|4
2593354|NCT01117766|8969815|P2|Second Intervention|Withdrawal by Subject|1
2593355|NCT01117766|8969816|P1|Second Intervention|Withdrawal by Subject|0
2593356|NCT01117766|8969815|P2|Second Intervention|Adverse Event|2
2593357|NCT01117766|8969816|P1|Second Intervention|Adverse Event|0
2593358|NCT01117766|8969815|P2|Second Intervention|Other|2
2593359|NCT01117766|8969816|P1|Second Intervention|Other|1
2593360|NCT01117766|8969815|P2|Second Intervention|Lost to Follow-up|0
2593361|NCT01117766|8969816|P1|Second Intervention|Lost to Follow-up|1
2593362|NCT01117766|8969815|P2|Washout Period|Protocol Violation|2
2593363|NCT01117766|8969816|P1|Washout Period|Protocol Violation|0
2593364|NCT01117766|8969815|P2|First Intervention|Protocol Violation|0
2593365|NCT01117766|8969816|P1|First Intervention|Protocol Violation|1
2593366|NCT01117766|8969815|P2|First Intervention|Adverse Event|1
2593367|NCT01117766|8969816|P1|First Intervention|Adverse Event|0
2593368|NCT01117623|8969853|P8|Overall Study|Invest. text: completed all planned txs|0
2593369|NCT01117623|8969854|P7|Overall Study|Invest. text: completed all planned txs|0
2593370|NCT01117623|8969855|P6|Overall Study|Invest. text: completed all planned txs|1
2593371|NCT01117623|8969856|P5|Overall Study|Invest. text: completed all planned txs|0
2593372|NCT01117623|8969857|P4|Overall Study|Invest. text: completed all planned txs|0
2593373|NCT01117623|8969858|P3|Overall Study|Invest. text: completed all planned txs|0
2593374|NCT01117623|8969859|P2|Overall Study|Invest. text: completed all planned txs|0
2593375|NCT01117623|8969860|P1|Overall Study|Invest. text: completed all planned txs|0
2593376|NCT01117623|8969853|P8|Overall Study|Non-compliance with study medication|1
2593377|NCT01117623|8969854|P7|Overall Study|Non-compliance with study medication|0
2593378|NCT01117623|8969855|P6|Overall Study|Non-compliance with study medication|0
2593379|NCT01117623|8969856|P5|Overall Study|Non-compliance with study medication|0
2593380|NCT01117623|8969857|P4|Overall Study|Non-compliance with study medication|0
2593381|NCT01117623|8969858|P3|Overall Study|Non-compliance with study medication|0
2593382|NCT01117623|8969859|P2|Overall Study|Non-compliance with study medication|0
2593383|NCT01117623|8969860|P1|Overall Study|Non-compliance with study medication|0
2593384|NCT01117623|8969853|P8|Overall Study|Withdrawal by Subject|1
2593385|NCT01117623|8969854|P7|Overall Study|Withdrawal by Subject|1
2593386|NCT01117623|8969855|P6|Overall Study|Withdrawal by Subject|1
2593387|NCT01117623|8969856|P5|Overall Study|Withdrawal by Subject|0
2593388|NCT01117623|8969857|P4|Overall Study|Withdrawal by Subject|0
2593389|NCT01117623|8969858|P3|Overall Study|Withdrawal by Subject|2
2593390|NCT01117623|8969859|P2|Overall Study|Withdrawal by Subject|0
2593391|NCT01117623|8969860|P1|Overall Study|Withdrawal by Subject|0
2593392|NCT01117623|8969853|P8|Overall Study|Disease progression, recurrence, relapse|22
2593393|NCT01117623|8969854|P7|Overall Study|Disease progression, recurrence, relapse|5
2593394|NCT01117623|8969855|P6|Overall Study|Disease progression, recurrence, relapse|14
2593395|NCT01117623|8969856|P5|Overall Study|Disease progression, recurrence, relapse|8
2593396|NCT01117623|8969857|P4|Overall Study|Disease progression, recurrence, relapse|6
2593397|NCT01117623|8969858|P3|Overall Study|Disease progression, recurrence, relapse|5
2593398|NCT01117623|8969859|P2|Overall Study|Disease progression, recurrence, relapse|6
2593399|NCT01117623|8969860|P1|Overall Study|Disease progression, recurrence, relapse|3
2593400|NCT01117623|8969853|P8|Overall Study|Adverse Event|2
2593401|NCT01117623|8969854|P7|Overall Study|Adverse Event|0
2593402|NCT01117623|8969855|P6|Overall Study|Adverse Event|0
2593403|NCT01117623|8969856|P5|Overall Study|Adverse Event|2
2593404|NCT01117623|8969857|P4|Overall Study|Adverse Event|0
2593405|NCT01117623|8969858|P3|Overall Study|Adverse Event|4
2593406|NCT01117623|8969859|P2|Overall Study|Adverse Event|2
2593407|NCT01117623|8969860|P1|Overall Study|Adverse Event|0
2593408|NCT01117480|8970012|P1|Overall Study|Did Not Start Adalimumab Therapy|20
2593409|NCT01117480|8970012|P1|Overall Study|Protocol Violation|8
2593410|NCT01117454|8970020|P2|Overall Study|Pregnancy|1
2593411|NCT01117454|8970021|P1|Overall Study|Pregnancy|0
2593412|NCT01117428|8970033|P6|Overall Study|Progressive disease|17
2593413|NCT01117428|8970034|P5|Overall Study|Progressive disease|16
2593414|NCT01117428|8970035|P4|Overall Study|Progressive disease|12
2593415|NCT01117428|8970036|P3|Overall Study|Progressive disease|10
2593416|NCT01117428|8970037|P2|Overall Study|Progressive disease|27
2593417|NCT01117428|8970038|P1|Overall Study|Progressive disease|15
2593418|NCT01117428|8970033|P6|Overall Study|Withdrawal by Subject|0
2593419|NCT01117428|8970034|P5|Overall Study|Withdrawal by Subject|0
2593420|NCT01117428|8970035|P4|Overall Study|Withdrawal by Subject|0
2593421|NCT01117428|8970036|P3|Overall Study|Withdrawal by Subject|1
2593422|NCT01117428|8970037|P2|Overall Study|Withdrawal by Subject|0
2593423|NCT01117428|8970038|P1|Overall Study|Withdrawal by Subject|0
2593424|NCT01117428|8970033|P6|Overall Study|Physician Decision|0
2593425|NCT01117428|8970034|P5|Overall Study|Physician Decision|0
2593426|NCT01117428|8970035|P4|Overall Study|Physician Decision|0
2593427|NCT01117428|8970036|P3|Overall Study|Physician Decision|0
2593428|NCT01117428|8970037|P2|Overall Study|Physician Decision|1
2593429|NCT01117428|8970038|P1|Overall Study|Physician Decision|0
2593430|NCT01117428|8970033|P6|Overall Study|Death|1
2593431|NCT01117428|8970034|P5|Overall Study|Death|0
2593432|NCT01117428|8970035|P4|Overall Study|Death|0
2593433|NCT01117428|8970036|P3|Overall Study|Death|2
2593434|NCT01117428|8970037|P2|Overall Study|Death|1
2593435|NCT01117428|8970038|P1|Overall Study|Death|0
2593436|NCT01117428|8970033|P6|Overall Study|Adverse Event|2
2593437|NCT01117428|8970034|P5|Overall Study|Adverse Event|1
2593438|NCT01117428|8970035|P4|Overall Study|Adverse Event|0
2593439|NCT01117428|8970036|P3|Overall Study|Adverse Event|0
2593440|NCT01117428|8970037|P2|Overall Study|Adverse Event|0
2593441|NCT01117428|8970038|P1|Overall Study|Adverse Event|4
2593442|NCT01117428|8970033|P6|Overall Study|Lack of Efficacy|0
2593443|NCT01117428|8970034|P5|Overall Study|Lack of Efficacy|0
2593444|NCT01117428|8970035|P4|Overall Study|Lack of Efficacy|0
2593445|NCT01117428|8970036|P3|Overall Study|Lack of Efficacy|0
2593446|NCT01117428|8970037|P2|Overall Study|Lack of Efficacy|0
2593447|NCT01117428|8970038|P1|Overall Study|Lack of Efficacy|1
2593448|NCT01117350|8970072|P2|Extension Period|Prohibited medication|1
2593449|NCT01117350|8970073|P1|Extension Period|Prohibited medication|0
2593450|NCT01117350|8970072|P2|Extension Period|Inclusion criteria not respected|1
2593451|NCT01117350|8970073|P1|Extension Period|Inclusion criteria not respected|0
2593452|NCT01117350|8970072|P2|Extension Period|Lack of Efficacy|2
2593453|NCT01117350|8970073|P1|Extension Period|Lack of Efficacy|0
2593454|NCT01117350|8970072|P2|Extension Period|Withdrawal by Subject|3
2593455|NCT01117350|8970073|P1|Extension Period|Withdrawal by Subject|0
2593456|NCT01117350|8970072|P2|Extension Period|Lost to Follow-up|2
2593457|NCT01117350|8970073|P1|Extension Period|Lost to Follow-up|0
2593458|NCT01117350|8970072|P2|Extension Period|Protocol Violation|2
2593459|NCT01117350|8970073|P1|Extension Period|Protocol Violation|0
2593460|NCT01117350|8970072|P2|Extension Period|Adverse Event|2
2593461|NCT01117350|8970073|P1|Extension Period|Adverse Event|0
2593462|NCT01117350|8970072|P2|Extension Period|Not included in extension, not treated|50
2593463|NCT01117350|8970073|P1|Extension Period|Not included in extension, not treated|0
2593464|NCT01117350|8970072|P2|Comparative Period|Move to another city/country|1
2593465|NCT01117350|8970073|P1|Comparative Period|Move to another city/country|2
2593466|NCT01117350|8970072|P2|Comparative Period|Physician Decision|1
2593467|NCT01117350|8970073|P1|Comparative Period|Physician Decision|0
2593468|NCT01117350|8970072|P2|Comparative Period|Lack of Efficacy|0
2593469|NCT01117350|8970073|P1|Comparative Period|Lack of Efficacy|1
2593470|NCT01117350|8970072|P2|Comparative Period|Protocol Violation|12
2593471|NCT01117350|8970073|P1|Comparative Period|Protocol Violation|8
2593472|NCT01117350|8970072|P2|Comparative Period|Withdrawal by Subject|13
2593473|NCT01117350|8970073|P1|Comparative Period|Withdrawal by Subject|9
2593474|NCT01117350|8970072|P2|Comparative Period|Lost to Follow-up|7
2593475|NCT01117350|8970073|P1|Comparative Period|Lost to Follow-up|11
2593476|NCT01117350|8970072|P2|Comparative Period|Adverse Event|33
2593477|NCT01117350|8970073|P1|Comparative Period|Adverse Event|6
2593478|NCT01117350|8970072|P2|Comparative Period|Not Treated|8
2593479|NCT01117350|8970073|P1|Comparative Period|Not Treated|5
2593480|NCT01117337|8970105|P2|Overall Study|Lost to Follow-up|0
2593481|NCT01117337|8970106|P1|Overall Study|Lost to Follow-up|4
2593482|NCT01117181|8970127|P2|Overall Study|Withdrawal by Subject|2
2593483|NCT01117181|8970128|P1|Overall Study|Withdrawal by Subject|0
2593484|NCT01117181|8970127|P2|Overall Study|Lost to Follow-up|0
2593485|NCT01117181|8970128|P1|Overall Study|Lost to Follow-up|1
2593486|NCT01117051|8970161|P2|Overall Study|Convenience issue|0
2593487|NCT01117051|8970162|P1|Overall Study|Convenience issue|1
2593488|NCT01117051|8970161|P2|Overall Study|Randomized by mistake|1
2593489|NCT01117051|8970162|P1|Overall Study|Randomized by mistake|0
2593490|NCT01117051|8970161|P2|Overall Study|Surgical procedure|1
2593491|NCT01117051|8970162|P1|Overall Study|Surgical procedure|0
2593492|NCT01117051|8970161|P2|Overall Study|Sponsor's decision|1
2593493|NCT01117051|8970162|P1|Overall Study|Sponsor's decision|3
2593494|NCT01117051|8970161|P2|Overall Study|Did not meet in-/exclusion criteria|1
2593495|NCT01117051|8970162|P1|Overall Study|Did not meet in-/exclusion criteria|0
2593496|NCT01117051|8970161|P2|Overall Study|Lost to Follow-up|1
2593497|NCT01117051|8970162|P1|Overall Study|Lost to Follow-up|0
2593498|NCT01117051|8970161|P2|Overall Study|Adverse Event|3
2593499|NCT01117051|8970162|P1|Overall Study|Adverse Event|4
2593500|NCT01117051|8970161|P2|Overall Study|Withdrawal by Subject|3
2593501|NCT01117051|8970162|P1|Overall Study|Withdrawal by Subject|5
2593502|NCT01117012|8970172|P2|Overall Study|Undefined|3
2593503|NCT01117012|8970173|P1|Overall Study|Undefined|4
2593504|NCT01117012|8970172|P2|Overall Study|Withdrawal by Subject|0
2593505|NCT01117012|8970173|P1|Overall Study|Withdrawal by Subject|3
2593506|NCT01117012|8970172|P2|Overall Study|Death|1
2593507|NCT01117012|8970173|P1|Overall Study|Death|1
2593508|NCT01117012|8970172|P2|Overall Study|Adverse Event|1
2593509|NCT01117012|8970173|P1|Overall Study|Adverse Event|0
2593510|NCT01116882|8970347|P2|12-month|Withdrawal by Subject|8
2593511|NCT01116882|8970348|P1|12-month|Withdrawal by Subject|5
2593512|NCT01116882|8970347|P2|12-month|Other Reasons|49
2593513|NCT01116882|8970348|P1|12-month|Other Reasons|151
2593514|NCT01116882|8970347|P2|12-month|Lost to Follow-up|42
2593515|NCT01116882|8970348|P1|12-month|Lost to Follow-up|111
2593516|NCT01116882|8970347|P2|30-day|Other Reasons|6
2593517|NCT01116882|8970348|P1|30-day|Other Reasons|16
2593518|NCT01116882|8970347|P2|30-day|Withdrawal by Subject|4
2593519|NCT01116882|8970348|P1|30-day|Withdrawal by Subject|2
2593520|NCT01116882|8970347|P2|30-day|Lost to Follow-up|21
2593521|NCT01116882|8970348|P1|30-day|Lost to Follow-up|50
2593522|NCT01116687|8970386|P1|Overall Study|Withdrawal by Subject|4
2593523|NCT01116544|8970400|P2|Overall Study|Withdrawal by Subject|1
2593524|NCT01116544|8970401|P1|Overall Study|Withdrawal by Subject|1
2593525|NCT01116544|8970400|P2|Overall Study|Protocol Violation|0
2593526|NCT01116544|8970401|P1|Overall Study|Protocol Violation|1
2593527|NCT01116427|8970427|P2|Extension Phase|Not using appropriate birth control|0
2593528|NCT01116427|8970428|P1|Extension Phase|Not using appropriate birth control|1
2593529|NCT01116427|8970427|P2|Extension Phase|Withdrawal by Subject|1
2593530|NCT01116427|8970428|P1|Extension Phase|Withdrawal by Subject|5
2593531|NCT01116427|8970427|P2|Extension Phase|Lost to Follow-up|0
2593532|NCT01116427|8970428|P1|Extension Phase|Lost to Follow-up|2
2593533|NCT01116427|8970427|P2|Extension Phase|Adverse Event|1
2593534|NCT01116427|8970428|P1|Extension Phase|Adverse Event|1
2593535|NCT01116427|8970427|P2|Core Phase|Worsening Multiple Sclerosis|0
2593536|NCT01116427|8970428|P1|Core Phase|Worsening Multiple Sclerosis|1
2593537|NCT01116427|8970427|P2|Core Phase|Withdrawal by Subject|0
2593538|NCT01116427|8970428|P1|Core Phase|Withdrawal by Subject|3
2593539|NCT01116427|8970427|P2|Core Phase|Lost to Follow-up|0
2593540|NCT01116427|8970428|P1|Core Phase|Lost to Follow-up|1
2593541|NCT01116427|8970427|P2|Core Phase|Adverse Event|1
2593542|NCT01116427|8970428|P1|Core Phase|Adverse Event|0
2593543|NCT01116232|8970469|P1|Overall Study|Progressive diease|4
2593544|NCT01115998|8970583|P2|Overall Study|Lost to Follow-up|6
2593545|NCT01115998|8970584|P1|Overall Study|Lost to Follow-up|6
2593546|NCT01115933|8970594|P1|Overall Study|Did not receive XIENCE PRIME SV|1
2593547|NCT01115855|8970691|P2|Overall Study|Other|6
2593548|NCT01115855|8970692|P1|Overall Study|Other|8
2593549|NCT01115855|8970691|P2|Overall Study|Withdrawal by Subject|5
2593550|NCT01115855|8970692|P1|Overall Study|Withdrawal by Subject|5
2593551|NCT01115855|8970691|P2|Overall Study|Protocol Violation|1
2593552|NCT01115855|8970692|P1|Overall Study|Protocol Violation|0
2593553|NCT01115855|8970691|P2|Overall Study|Lab Abnormality|1
2593554|NCT01115855|8970692|P1|Overall Study|Lab Abnormality|1
2593555|NCT01115855|8970691|P2|Overall Study|Death|5
2593556|NCT01115855|8970692|P1|Overall Study|Death|6
2593557|NCT01115855|8970691|P2|Overall Study|Adverse Event|18
2593558|NCT01115855|8970692|P1|Overall Study|Adverse Event|16
2593559|NCT01115803|8970747|P7|Overall Study|Progressive Disease during Cycle1|1
2593560|NCT01115803|8970748|P6|Overall Study|Progressive Disease during Cycle1|0
2593561|NCT01115803|8970749|P5|Overall Study|Progressive Disease during Cycle1|0
2593562|NCT01115803|8970750|P4|Overall Study|Progressive Disease during Cycle1|0
2593563|NCT01115803|8970751|P3|Overall Study|Progressive Disease during Cycle1|0
2593564|NCT01115803|8970752|P2|Overall Study|Progressive Disease during Cycle1|0
2593565|NCT01115803|8970753|P1|Overall Study|Progressive Disease during Cycle1|0
2593566|NCT01115803|8970747|P7|Overall Study|Lost to Follow-up|0
2593567|NCT01115803|8970748|P6|Overall Study|Lost to Follow-up|0
2593568|NCT01115803|8970749|P5|Overall Study|Lost to Follow-up|0
2593569|NCT01115803|8970750|P4|Overall Study|Lost to Follow-up|0
2593570|NCT01115803|8970751|P3|Overall Study|Lost to Follow-up|1
2593571|NCT01115803|8970752|P2|Overall Study|Lost to Follow-up|0
2593572|NCT01115803|8970753|P1|Overall Study|Lost to Follow-up|0
2593573|NCT01115803|8970747|P7|Overall Study|Withdrawal by Subject|1
2593574|NCT01115803|8970748|P6|Overall Study|Withdrawal by Subject|0
2593575|NCT01115803|8970749|P5|Overall Study|Withdrawal by Subject|0
2593576|NCT01115803|8970750|P4|Overall Study|Withdrawal by Subject|0
2593577|NCT01115803|8970751|P3|Overall Study|Withdrawal by Subject|0
2593578|NCT01115803|8970752|P2|Overall Study|Withdrawal by Subject|0
2593579|NCT01115803|8970753|P1|Overall Study|Withdrawal by Subject|0
2593580|NCT01115738|8970816|P3|Overall Study|Withdrawal by Subject|9
2593581|NCT01115738|8970817|P2|Overall Study|Withdrawal by Subject|6
2593582|NCT01115738|8970818|P1|Overall Study|Withdrawal by Subject|6
2593583|NCT01115738|8970816|P3|Overall Study|Physician Decision|17
2593584|NCT01115738|8970817|P2|Overall Study|Physician Decision|15
2593585|NCT01115738|8970818|P1|Overall Study|Physician Decision|18
2593586|NCT01115738|8970816|P3|Overall Study|Lost to Follow-up|1
2593587|NCT01115738|8970817|P2|Overall Study|Lost to Follow-up|0
2593588|NCT01115738|8970818|P1|Overall Study|Lost to Follow-up|0
2593589|NCT01115738|8970816|P3|Overall Study|Death|0
2593590|NCT01115738|8970817|P2|Overall Study|Death|0
2593591|NCT01115738|8970818|P1|Overall Study|Death|1
2593592|NCT01115569|8971016|P2|Maintenance Phase|Administrative|1
2593593|NCT01115569|8971017|P1|Maintenance Phase|Administrative|0
2593594|NCT01115569|8971016|P2|Maintenance Phase|Non-Compliance with Study Drug|48
2593595|NCT01115569|8971017|P1|Maintenance Phase|Non-Compliance with Study Drug|0
2593596|NCT01115569|8971016|P2|Maintenance Phase|Withdrawal by Subject|27
2593597|NCT01115569|8971017|P1|Maintenance Phase|Withdrawal by Subject|0
2593598|NCT01115569|8971016|P2|Maintenance Phase|Protocol Violation|9
2593599|NCT01115569|8971017|P1|Maintenance Phase|Protocol Violation|0
2593600|NCT01115569|8971016|P2|Maintenance Phase|Physician Decision|3
2593601|NCT01115569|8971017|P1|Maintenance Phase|Physician Decision|0
2593602|NCT01115569|8971016|P2|Maintenance Phase|Lost to Follow-up|8
2593603|NCT01115569|8971017|P1|Maintenance Phase|Lost to Follow-up|0
2593604|NCT01115569|8971016|P2|Maintenance Phase|Adverse Event|43
2593605|NCT01115569|8971017|P1|Maintenance Phase|Adverse Event|0
2593606|NCT01115569|8971016|P2|Conversion/Titration Phase|Non-Compliance with Study Drug|0
2593607|NCT01115569|8971017|P1|Conversion/Titration Phase|Non-Compliance with Study Drug|53
2593608|NCT01115569|8971016|P2|Conversion/Titration Phase|Withdrawal by Subject|0
2593609|NCT01115569|8971017|P1|Conversion/Titration Phase|Withdrawal by Subject|26
2593610|NCT01115569|8971016|P2|Conversion/Titration Phase|Protocol Violation|0
2593611|NCT01115569|8971017|P1|Conversion/Titration Phase|Protocol Violation|68
2593612|NCT01115569|8971016|P2|Conversion/Titration Phase|Physician Decision|0
2593613|NCT01115569|8971017|P1|Conversion/Titration Phase|Physician Decision|5
2593614|NCT01115569|8971016|P2|Conversion/Titration Phase|Lost to Follow-up|0
2593615|NCT01115569|8971017|P1|Conversion/Titration Phase|Lost to Follow-up|3
2593616|NCT01115569|8971016|P2|Conversion/Titration Phase|Adverse Event|0
2593617|NCT01115569|8971017|P1|Conversion/Titration Phase|Adverse Event|59
2593618|NCT01115491|8971046|P1|Overall Study|Physician Decision|1
2593619|NCT01115491|8971046|P1|Overall Study|Withdrawal by Subject|1
2593620|NCT01115491|8971046|P1|Overall Study|Lost to Follow-up|3
2593621|NCT01115491|8971046|P1|Overall Study|Adverse Event|3
2593622|NCT01115491|8971046|P1|Overall Study|Death|22
2593623|NCT01114880|8971264|P2|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2
2593624|NCT01114880|8971265|P1|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0
2593625|NCT01114880|8971264|P2|Period 2 (Week 12 to Week 24)|Adverse Event|0
2593626|NCT01114880|8971265|P1|Period 2 (Week 12 to Week 24)|Adverse Event|3
2593627|NCT01114880|8971264|P2|Period 1 (Week 0 to Week 12)|Poor subject compliance|1
2593628|NCT01114880|8971265|P1|Period 1 (Week 0 to Week 12)|Poor subject compliance|0
2593629|NCT01114880|8971264|P2|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1
2593630|NCT01114880|8971265|P1|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0
2593631|NCT01114880|8971264|P2|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0
2593632|NCT01114880|8971265|P1|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1
2593633|NCT01114880|8971264|P2|Period 1 (Week 0 to Week 12)|Adverse Event|0
2593634|NCT01114880|8971265|P1|Period 1 (Week 0 to Week 12)|Adverse Event|4
2593635|NCT01114828|8971317|P2|Overall Study|Withdrawal by Subject|1
2593636|NCT01114828|8971318|P1|Overall Study|Withdrawal by Subject|0
2593637|NCT01114828|8971317|P2|Overall Study|Protocol Violation|0
2593638|NCT01114828|8971318|P1|Overall Study|Protocol Violation|2
2593639|NCT01114828|8971317|P2|Overall Study|Lack of Efficacy|2
2593640|NCT01114828|8971318|P1|Overall Study|Lack of Efficacy|0
2593641|NCT01114828|8971317|P2|Overall Study|Adverse Event|1
2593642|NCT01114828|8971318|P1|Overall Study|Adverse Event|1
2593643|NCT01114737|8971328|P2|Open-Label Treatment Period|Difficult Personal Events|0
2593644|NCT01114737|8971329|P1|Open-Label Treatment Period|Difficult Personal Events|1
2593645|NCT01114737|8971328|P2|Open-Label Treatment Period|Lost to Follow-up|1
2593646|NCT01114737|8971329|P1|Open-Label Treatment Period|Lost to Follow-up|3
2593647|NCT01114737|8971328|P2|Open-Label Treatment Period|Withdrawal by Subject|1
2593648|NCT01114737|8971329|P1|Open-Label Treatment Period|Withdrawal by Subject|1
2593649|NCT01114737|8971328|P2|Randomized Treatment Period|Pregnancy|0
2593650|NCT01114737|8971329|P1|Randomized Treatment Period|Pregnancy|1
2593651|NCT01114737|8971328|P2|Randomized Treatment Period|Lost to Follow-up|1
2593652|NCT01114737|8971329|P1|Randomized Treatment Period|Lost to Follow-up|1
2593653|NCT01114737|8971328|P2|Randomized Treatment Period|Withdrawal by Subject|0
2593654|NCT01114737|8971329|P1|Randomized Treatment Period|Withdrawal by Subject|1
2593655|NCT01114724|8971377|P1|Overall Study|Withdrawal by Subject|1
2593656|NCT01114724|8971377|P1|Overall Study|Lost to Follow-up|1
2593657|NCT01114724|8971377|P1|Overall Study|Death|8
2593658|NCT01114672|8971397|P2|Overall Study|transplanted|0
2593659|NCT01114672|8971398|P1|Overall Study|transplanted|1
2593660|NCT01114672|8971397|P2|Overall Study|Lost to Follow-up|0
2593661|NCT01114672|8971398|P1|Overall Study|Lost to Follow-up|1
2593662|NCT01114672|8971397|P2|Overall Study|Withdrawal by Subject|1
2593663|NCT01114672|8971398|P1|Overall Study|Withdrawal by Subject|2
2593664|NCT01114672|8971397|P2|Overall Study|Death|1
2593665|NCT01114672|8971398|P1|Overall Study|Death|0
2593666|NCT01114646|8971406|P2|Overall Study|Withdrawal by Subject|2
2593667|NCT01114646|8971407|P1|Overall Study|Withdrawal by Subject|3
2593668|NCT01114529|8971467|P3|Completed Study Phase at Month 24|Missing|0
2593669|NCT01114529|8971468|P2|Completed Study Phase at Month 24|Missing|0
2593670|NCT01114529|8971469|P1|Completed Study Phase at Month 24|Missing|2
2593671|NCT01114529|8971467|P3|Completed Study Phase at Month 24|Other|0
2593672|NCT01114529|8971468|P2|Completed Study Phase at Month 24|Other|0
2593673|NCT01114529|8971469|P1|Completed Study Phase at Month 24|Other|2
2593674|NCT01114529|8971467|P3|Completed Study Phase at Month 24|Death|4
2593675|NCT01114529|8971468|P2|Completed Study Phase at Month 24|Death|5
2593676|NCT01114529|8971469|P1|Completed Study Phase at Month 24|Death|8
2593677|NCT01114529|8971467|P3|Completed Study Phase at Month 24|Lost to Follow-up|7
2593678|NCT01114529|8971468|P2|Completed Study Phase at Month 24|Lost to Follow-up|5
2593679|NCT01114529|8971469|P1|Completed Study Phase at Month 24|Lost to Follow-up|10
2593680|NCT01114529|8971467|P3|Completed Study Phase at Month 24|Withdrawal by Subject|3
2593681|NCT01114529|8971468|P2|Completed Study Phase at Month 24|Withdrawal by Subject|6
2593682|NCT01114529|8971469|P1|Completed Study Phase at Month 24|Withdrawal by Subject|18
2593683|NCT01114529|8971467|P3|Completed Study Medication at Month 24|Missing|0
2593684|NCT01114529|8971468|P2|Completed Study Medication at Month 24|Missing|0
2593685|NCT01114529|8971469|P1|Completed Study Medication at Month 24|Missing|2
2593686|NCT01114529|8971467|P3|Completed Study Medication at Month 24|Protocol Violation|2
2593687|NCT01114529|8971468|P2|Completed Study Medication at Month 24|Protocol Violation|5
2593688|NCT01114529|8971469|P1|Completed Study Medication at Month 24|Protocol Violation|0
2593689|NCT01114529|8971467|P3|Completed Study Medication at Month 24|Graft loss|0
2593690|NCT01114529|8971468|P2|Completed Study Medication at Month 24|Graft loss|2
2593691|NCT01114529|8971469|P1|Completed Study Medication at Month 24|Graft loss|0
2593692|NCT01114529|8971467|P3|Completed Study Medication at Month 24|Death|2
2593693|NCT01114529|8971468|P2|Completed Study Medication at Month 24|Death|1
2593694|NCT01114529|8971469|P1|Completed Study Medication at Month 24|Death|2
2593695|NCT01114529|8971467|P3|Completed Study Medication at Month 24|Administrative problems|2
2593696|NCT01114529|8971468|P2|Completed Study Medication at Month 24|Administrative problems|1
2593697|NCT01114529|8971469|P1|Completed Study Medication at Month 24|Administrative problems|2
2593698|NCT01114529|8971467|P3|Completed Study Medication at Month 24|Lost to Follow-up|2
2593699|NCT01114529|8971468|P2|Completed Study Medication at Month 24|Lost to Follow-up|4
2593700|NCT01114529|8971469|P1|Completed Study Medication at Month 24|Lost to Follow-up|1
2593701|NCT01114529|8971467|P3|Completed Study Medication at Month 24|Withdrawal by Subject|2
2593702|NCT01114529|8971468|P2|Completed Study Medication at Month 24|Withdrawal by Subject|8
2593703|NCT01114529|8971469|P1|Completed Study Medication at Month 24|Withdrawal by Subject|18
2593704|NCT01114529|8971467|P3|Completed Study Medication at Month 24|Subject's no longer required drug|1
2593705|NCT01114529|8971468|P2|Completed Study Medication at Month 24|Subject's no longer required drug|1
2593706|NCT01114529|8971469|P1|Completed Study Medication at Month 24|Subject's no longer required drug|1
2593707|NCT01114529|8971467|P3|Completed Study Medication at Month 24|Lack of Efficacy|2
2593708|NCT01114529|8971468|P2|Completed Study Medication at Month 24|Lack of Efficacy|1
2593709|NCT01114529|8971469|P1|Completed Study Medication at Month 24|Lack of Efficacy|2
2593710|NCT01114529|8971467|P3|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1
2593711|NCT01114529|8971468|P2|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0
2593712|NCT01114529|8971469|P1|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3
2593713|NCT01114529|8971467|P3|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1
2593714|NCT01114529|8971468|P2|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0
2593715|NCT01114529|8971469|P1|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6
2593716|NCT01114529|8971467|P3|Completed Study Medication at Month 24|Adverse Event|17
2593717|NCT01114529|8971468|P2|Completed Study Medication at Month 24|Adverse Event|18
2593718|NCT01114529|8971469|P1|Completed Study Medication at Month 24|Adverse Event|87
2593719|NCT01114516|8971488|P2|Overall Study|Lost to Follow-up|1
2593720|NCT01114516|8971489|P1|Overall Study|Lost to Follow-up|2
2593721|NCT01114438|8971524|P1|Overall Study|Withdrawal by Subject|2
2593722|NCT01114438|8971524|P1|Overall Study|Physician Decision|1
2593723|NCT01114438|8971524|P1|Overall Study|concomitant medication|1
2593724|NCT01114438|8971524|P1|Overall Study|Adverse Event|10
2593725|NCT01114373|8971534|P2|Intervention 2 (4 Weeks)|Lost to Follow-up|1
2593726|NCT01114373|8971535|P1|Intervention 2 (4 Weeks)|Lost to Follow-up|0
2593727|NCT01114373|8971534|P2|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0
2593728|NCT01114373|8971535|P1|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1
2593729|NCT01114373|8971534|P2|Intervention 1 (4 Weeks)|Incarceration|0
2593730|NCT01114373|8971535|P1|Intervention 1 (4 Weeks)|Incarceration|1
2593731|NCT01114373|8971534|P2|Intervention 1 (4 Weeks)|Lost to Follow-up|0
2593732|NCT01114373|8971535|P1|Intervention 1 (4 Weeks)|Lost to Follow-up|1
2593733|NCT01114360|8971567|P2|Intervention 1 (4 Weeks)|Physician Decision|1
2593734|NCT01114360|8971568|P1|Intervention 1 (4 Weeks)|Physician Decision|0
2593735|NCT01114217|8971619|P2|Overall Study|Other-Withdrawal by Subject|1
2593736|NCT01114217|8971620|P1|Overall Study|Other-Withdrawal by Subject|1
2593737|NCT01114217|8971619|P2|Overall Study|Other-Lost to Follow-up|0
2593738|NCT01114217|8971620|P1|Overall Study|Other-Lost to Follow-up|1
2593739|NCT01114217|8971619|P2|Overall Study|Other-Site Stopped Communicating|0
2593740|NCT01114217|8971620|P1|Overall Study|Other-Site Stopped Communicating|2
2593741|NCT01114217|8971619|P2|Overall Study|Other-Study Withdrawn|1
2593742|NCT01114217|8971620|P1|Overall Study|Other-Study Withdrawn|1
2593743|NCT01114217|8971619|P2|Overall Study|Other-Study Termination|1
2593744|NCT01114217|8971620|P1|Overall Study|Other-Study Termination|0
2593745|NCT01114217|8971619|P2|Overall Study|Other-Sponsor Decision|12
2593746|NCT01114217|8971620|P1|Overall Study|Other-Sponsor Decision|10
2593747|NCT01114217|8971619|P2|Overall Study|Other-Physician Decision|1
2593748|NCT01114217|8971620|P1|Overall Study|Other-Physician Decision|1
2593749|NCT01114217|8971619|P2|Overall Study|Other-Non Compliance|0
2593750|NCT01114217|8971620|P1|Overall Study|Other-Non Compliance|2
2593751|NCT01114217|8971619|P2|Overall Study|Other-Lack of Efficacy|0
2593752|NCT01114217|8971620|P1|Overall Study|Other-Lack of Efficacy|1
2593753|NCT01114217|8971619|P2|Overall Study|Other-Protocol Violation|3
2593754|NCT01114217|8971620|P1|Overall Study|Other-Protocol Violation|1
2593755|NCT01114217|8971619|P2|Overall Study|Other-Pregnancy|4
2593756|NCT01114217|8971620|P1|Overall Study|Other-Pregnancy|2
2593757|NCT01114217|8971619|P2|Overall Study|Other-Procedure|1
2593758|NCT01114217|8971620|P1|Overall Study|Other-Procedure|1
2593759|NCT01114217|8971619|P2|Overall Study|Other-Early termination|10
2593760|NCT01114217|8971620|P1|Overall Study|Other-Early termination|6
2593761|NCT01114217|8971619|P2|Overall Study|Other-Clerical Error|0
2593762|NCT01114217|8971620|P1|Overall Study|Other-Clerical Error|3
2593763|NCT01114217|8971619|P2|Overall Study|Withdrawal by Subject|28
2593764|NCT01114217|8971620|P1|Overall Study|Withdrawal by Subject|21
2593765|NCT01114217|8971619|P2|Overall Study|Lost to Follow-up|33
2593766|NCT01114217|8971620|P1|Overall Study|Lost to Follow-up|17
2593767|NCT01114217|8971619|P2|Overall Study|Adverse Event|3
2593768|NCT01114217|8971620|P1|Overall Study|Adverse Event|5
2593769|NCT01114204|8971632|P2|Overall Study|Other-Protocol Violation|0
2593770|NCT01114204|8971633|P1|Overall Study|Other-Protocol Violation|1
2593771|NCT01114204|8971632|P2|Overall Study|Other-Participant request|0
2593772|NCT01114204|8971633|P1|Overall Study|Other-Participant request|2
2593773|NCT01114204|8971632|P2|Overall Study|Other-Medical monitor request|0
2593774|NCT01114204|8971633|P1|Overall Study|Other-Medical monitor request|1
2593775|NCT01114204|8971632|P2|Overall Study|Other-Personal reasons|0
2593776|NCT01114204|8971633|P1|Overall Study|Other-Personal reasons|2
2593777|NCT01114204|8971632|P2|Overall Study|Death|0
2593778|NCT01114204|8971633|P1|Overall Study|Death|1
2593779|NCT01114204|8971632|P2|Overall Study|Withdrawal by Subject|6
2593780|NCT01114204|8971633|P1|Overall Study|Withdrawal by Subject|10
2593781|NCT01114204|8971632|P2|Overall Study|Lost to Follow-up|0
2593782|NCT01114204|8971633|P1|Overall Study|Lost to Follow-up|1
2593783|NCT01114204|8971632|P2|Overall Study|Adverse Event|2
2593784|NCT01114204|8971633|P1|Overall Study|Adverse Event|3
2593785|NCT01114139|8971651|P2|Overall Study|Other-Withdrew prior to receiving dose|3
2593786|NCT01114139|8971652|P1|Overall Study|Other-Withdrew prior to receiving dose|1
2593787|NCT01114139|8971651|P2|Overall Study|Other-Physician changed treatment|0
2593788|NCT01114139|8971652|P1|Overall Study|Other-Physician changed treatment|1
2593789|NCT01114139|8971651|P2|Overall Study|Other-Participant went on hospice|1
2593790|NCT01114139|8971652|P1|Overall Study|Other-Participant went on hospice|0
2593791|NCT01114139|8971651|P2|Overall Study|Other-Participant falsified records|1
2593792|NCT01114139|8971652|P1|Overall Study|Other-Participant falsified records|0
2593793|NCT01114139|8971651|P2|Overall Study|Other-Out of window for study drug dose|0
2593794|NCT01114139|8971652|P1|Overall Study|Other-Out of window for study drug dose|1
2593795|NCT01114139|8971651|P2|Overall Study|Other-Protocol Violation|0
2593796|NCT01114139|8971652|P1|Overall Study|Other-Protocol Violation|1
2593797|NCT01114139|8971651|P2|Overall Study|Other-Missed 1 visit|0
2593798|NCT01114139|8971652|P1|Overall Study|Other-Missed 1 visit|1
2593799|NCT01114139|8971651|P2|Overall Study|Withdrawal by Subject|6
2593800|NCT01114139|8971652|P1|Overall Study|Withdrawal by Subject|17
2593801|NCT01114139|8971651|P2|Overall Study|Lost to Follow-up|3
2593802|NCT01114139|8971652|P1|Overall Study|Lost to Follow-up|15
2593803|NCT01114139|8971651|P2|Overall Study|Adverse Event|2
2593804|NCT01114139|8971652|P1|Overall Study|Adverse Event|3
2593805|NCT01113931|8971670|P2|Overall Study|Withdrawal by Subject|0
2593806|NCT01113931|8971671|P1|Overall Study|Withdrawal by Subject|3
2593807|NCT01113931|8971670|P2|Overall Study|Various|4
2593808|NCT01113931|8971671|P1|Overall Study|Various|2
2593809|NCT01113931|8971670|P2|Overall Study|Lost to Follow-up|9
2593810|NCT01113931|8971671|P1|Overall Study|Lost to Follow-up|12
2593811|NCT01113931|8971670|P2|Overall Study|Physician Decision|2
2593812|NCT01113931|8971671|P1|Overall Study|Physician Decision|0
2593813|NCT01113931|8971670|P2|Overall Study|Adverse Event|2
2593814|NCT01113931|8971671|P1|Overall Study|Adverse Event|2
2593815|NCT01113879|8971685|P2|Period 1: Block 1|Withdrawal by Subject|0
2593816|NCT01113879|8971686|P1|Period 1: Block 1|Withdrawal by Subject|2
2593817|NCT01113801|8971698|P4|Overall Study|Clinical Endpoint (ESRD)|5
2593818|NCT01113801|8971699|P3|Overall Study|Clinical Endpoint (ESRD)|2
2593819|NCT01113801|8971700|P2|Overall Study|Clinical Endpoint (ESRD)|4
2593820|NCT01113801|8971701|P1|Overall Study|Clinical Endpoint (ESRD)|7
2593821|NCT01113801|8971698|P4|Overall Study|Sponsor Decision|15
2593822|NCT01113801|8971699|P3|Overall Study|Sponsor Decision|20
2593823|NCT01113801|8971700|P2|Overall Study|Sponsor Decision|21
2593824|NCT01113801|8971701|P1|Overall Study|Sponsor Decision|15
2593825|NCT01113801|8971698|P4|Overall Study|Physician Decision|3
2593826|NCT01113801|8971699|P3|Overall Study|Physician Decision|3
2593827|NCT01113801|8971700|P2|Overall Study|Physician Decision|2
2593828|NCT01113801|8971701|P1|Overall Study|Physician Decision|2
2593829|NCT01113801|8971698|P4|Overall Study|Withdrawal by Subject|8
2593830|NCT01113801|8971699|P3|Overall Study|Withdrawal by Subject|7
2593831|NCT01113801|8971700|P2|Overall Study|Withdrawal by Subject|7
2593832|NCT01113801|8971701|P1|Overall Study|Withdrawal by Subject|9
2593833|NCT01113801|8971698|P4|Overall Study|Protocol Violation|0
2593834|NCT01113801|8971699|P3|Overall Study|Protocol Violation|0
2593835|NCT01113801|8971700|P2|Overall Study|Protocol Violation|1
2593836|NCT01113801|8971701|P1|Overall Study|Protocol Violation|0
2593837|NCT01113801|8971698|P4|Overall Study|Death|4
2593838|NCT01113801|8971699|P3|Overall Study|Death|3
2593839|NCT01113801|8971700|P2|Overall Study|Death|5
2593840|NCT01113801|8971701|P1|Overall Study|Death|4
2593841|NCT01113801|8971698|P4|Overall Study|Adverse Event|6
2593842|NCT01113801|8971699|P3|Overall Study|Adverse Event|2
2593843|NCT01113801|8971700|P2|Overall Study|Adverse Event|0
2593844|NCT01113801|8971701|P1|Overall Study|Adverse Event|4
2593845|NCT01113749|8971729|P2|Overall Study|Lost to Follow-up|2
2593846|NCT01113749|8971730|P1|Overall Study|Lost to Follow-up|1
2593847|NCT01113710|8971753|P1|Overall Study|Subject Did Not Receive Neupro|3
2593848|NCT01113710|8971753|P1|Overall Study|Compliance/Subject Withdrawal/AE|1
2593849|NCT01113710|8971753|P1|Overall Study|Lack of Patient's Compliance/Other|1
2593850|NCT01113710|8971753|P1|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1
2593851|NCT01113710|8971753|P1|Overall Study|Compliance/Efficacy/Subject Withdrawal|1
2593852|NCT01113710|8971753|P1|Overall Study|Compliance/Efficacy/AE/Other|1
2593853|NCT01113710|8971753|P1|Overall Study|Compliance/Efficacy/Adverse Event|1
2593854|NCT01113710|8971753|P1|Overall Study|Efficacy/Withdrawal by Subject/Other|1
2593855|NCT01113710|8971753|P1|Overall Study|Lost to Follow up/Withdrawal by Subject|2
2593856|NCT01113710|8971753|P1|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2
2593857|NCT01113710|8971753|P1|Overall Study|Efficacy/Subject Withdrawal/AE|2
2593858|NCT01113710|8971753|P1|Overall Study|Lack of Efficacy/Adverse Event|3
2593859|NCT01113710|8971753|P1|Overall Study|Patient Compliance/Withdrawal by Subject|4
2593860|NCT01113710|8971753|P1|Overall Study|Lack of Efficacy/Other|4
2593861|NCT01113710|8971753|P1|Overall Study|Patient's Compliance/Lost to Follow up|5
2593862|NCT01113710|8971753|P1|Overall Study|Adverse Event/Other|5
2593863|NCT01113710|8971753|P1|Overall Study|Other|7
2593864|NCT01113710|8971753|P1|Overall Study|Lack of Patient's Compliance|8
2593865|NCT01113710|8971753|P1|Overall Study|Withdrawal by Subject/Adverse Event|11
2593866|NCT01113710|8971753|P1|Overall Study|Lack of Efficacy/Withdrawal by Subject|13
2593867|NCT01113710|8971753|P1|Overall Study|Lost to Follow-up|20
2593868|NCT01113710|8971753|P1|Overall Study|Withdrawal by Subject|28
2593869|NCT01113710|8971753|P1|Overall Study|No Information Available|40
2593870|NCT01113710|8971753|P1|Overall Study|Lack of Efficacy|41
2593871|NCT01113710|8971753|P1|Overall Study|Adverse Event|64
2593872|NCT01113580|8971781|P2|Overall Study|Protocol Violation|0
2593873|NCT01113580|8971782|P1|Overall Study|Protocol Violation|1
2593874|NCT01113541|8971796|P1|Overall Study|Adverse Event|4
2593875|NCT01113541|8971796|P1|Overall Study|Study Terminated by Sponsor|7
2593876|NCT01113541|8971796|P1|Overall Study|Protocol Violation|1
2593877|NCT01113541|8971796|P1|Overall Study|Withdrawal by Subject|1
2593878|NCT01113463|8971829|P1|Overall Study|Physician Decision|5
2593879|NCT01112982|8971859|P1|Overall Study|exceeded weight limit to complete MRI|1
2593880|NCT01112982|8971859|P1|Overall Study|Withdrawal by Subject|1
2593881|NCT01112917|8971871|P2|Overall Study|Unable to Convert Filter|0
2593882|NCT01112917|8971872|P1|Overall Study|Unable to Convert Filter|3
2593883|NCT01112917|8971871|P2|Overall Study|Withdrawal by Subject|3
2593884|NCT01112917|8971872|P1|Overall Study|Withdrawal by Subject|1
2593885|NCT01112917|8971871|P2|Overall Study|Lost to Follow-up|1
2593886|NCT01112917|8971872|P1|Overall Study|Lost to Follow-up|1
2593887|NCT01112917|8971871|P2|Overall Study|Death|11
2593888|NCT01112917|8971872|P1|Overall Study|Death|2
2593889|NCT01112579|8971976|P2|Overall Study|Death|2
2593890|NCT01112579|8971977|P1|Overall Study|Death|0
2593891|NCT01112579|8971976|P2|Overall Study|Missed Visit|1
2593892|NCT01112579|8971977|P1|Overall Study|Missed Visit|1
2593893|NCT01112514|8971987|P1|Overall Study|Lost to Follow-up|1
2593894|NCT01112267|8972043|P2|Overall Study|Participants not receive any study drug|2
2593895|NCT01112267|8972044|P1|Overall Study|Participants not receive any study drug|1
2593896|NCT01112267|8972043|P2|Overall Study|Participants not compliant|2
2593897|NCT01112267|8972044|P1|Overall Study|Participants not compliant|1
2593898|NCT01112267|8972043|P2|Overall Study|Protocol Violation|3
2593899|NCT01112267|8972044|P1|Overall Study|Protocol Violation|5
2593900|NCT01112267|8972043|P2|Overall Study|Withdrawal by Subject|5
2593901|NCT01112267|8972044|P1|Overall Study|Withdrawal by Subject|3
2593902|NCT01112267|8972043|P2|Overall Study|Adverse Event|6
2593903|NCT01112267|8972044|P1|Overall Study|Adverse Event|24
2593904|NCT01112059|8972077|P2|Overall Study|Withdrawal by Subject|0
2593905|NCT01112059|8972078|P1|Overall Study|Withdrawal by Subject|1
2593906|NCT01111851|8972092|P2|Overall Study|All planned PET scans were not obtained.|0
2593907|NCT01111851|8972093|P1|Overall Study|All planned PET scans were not obtained.|2
2593908|NCT01111838|8972105|P1|Overall Study|Other Complicating Disease|1
2593909|NCT01111838|8972105|P1|Overall Study|Clinical deterioration|1
2593910|NCT01111838|8972105|P1|Overall Study|Not Treated|3
2593911|NCT01111838|8972105|P1|Overall Study|Patient Ineligible|2
2593912|NCT01111825|8972113|P4|Overall Study|Discontinuation by Sponsor|20
2593913|NCT01111825|8972114|P3|Overall Study|Discontinuation by Sponsor|0
2593914|NCT01111825|8972115|P2|Overall Study|Discontinuation by Sponsor|0
2593915|NCT01111825|8972116|P1|Overall Study|Discontinuation by Sponsor|0
2593916|NCT01111825|8972113|P4|Overall Study|Disease Progression|0
2593917|NCT01111825|8972114|P3|Overall Study|Disease Progression|0
2593918|NCT01111825|8972115|P2|Overall Study|Disease Progression|0
2593919|NCT01111825|8972116|P1|Overall Study|Disease Progression|1
2593920|NCT01111825|8972113|P4|Overall Study|Adverse Event|0
2593921|NCT01111825|8972114|P3|Overall Study|Adverse Event|4
2593922|NCT01111825|8972115|P2|Overall Study|Adverse Event|1
2593923|NCT01111825|8972116|P1|Overall Study|Adverse Event|2
2593924|NCT01111825|8972113|P4|Overall Study|Lost to Follow-up|1
2593925|NCT01111825|8972114|P3|Overall Study|Lost to Follow-up|3
2593926|NCT01111825|8972115|P2|Overall Study|Lost to Follow-up|0
2593927|NCT01111825|8972116|P1|Overall Study|Lost to Follow-up|0
2593928|NCT01111825|8972113|P4|Overall Study|Withdrawal by Subject|0
2593929|NCT01111825|8972114|P3|Overall Study|Withdrawal by Subject|1
2593930|NCT01111825|8972115|P2|Overall Study|Withdrawal by Subject|0
2593931|NCT01111825|8972116|P1|Overall Study|Withdrawal by Subject|0
2593932|NCT01111604|8972138|P3|Overall Study|Met Exclusion Criteria|0
2593933|NCT01111604|8972139|P2|Overall Study|Met Exclusion Criteria|0
2593934|NCT01111604|8972140|P1|Overall Study|Met Exclusion Criteria|2
2593935|NCT01111604|8972138|P3|Overall Study|Death|0
2593936|NCT01111604|8972139|P2|Overall Study|Death|0
2593937|NCT01111604|8972140|P1|Overall Study|Death|1
2593938|NCT01111604|8972138|P3|Overall Study|Withdrawal by Subject|0
2593939|NCT01111604|8972139|P2|Overall Study|Withdrawal by Subject|0
2593940|NCT01111604|8972140|P1|Overall Study|Withdrawal by Subject|2
2593941|NCT01111604|8972138|P3|Overall Study|Withdrew Consent|2
2593942|NCT01111604|8972139|P2|Overall Study|Withdrew Consent|0
2593943|NCT01111604|8972140|P1|Overall Study|Withdrew Consent|3
2593944|NCT01111604|8972138|P3|Overall Study|Lost to Follow-up|1
2593945|NCT01111604|8972139|P2|Overall Study|Lost to Follow-up|0
2593946|NCT01111604|8972140|P1|Overall Study|Lost to Follow-up|0
2593947|NCT01111526|8972178|P3|Overall Study|GVHD Disease Progression|2
2593948|NCT01111526|8972179|P2|Overall Study|GVHD Disease Progression|1
2593949|NCT01111526|8972180|P1|Overall Study|GVHD Disease Progression|0
2593950|NCT01111461|8972192|P1|Overall Study|Other|6
2593951|NCT01111461|8972192|P1|Overall Study|Withdrawal by Subject|1
2593952|NCT01111461|8972192|P1|Overall Study|Lost to Follow-up|1
2593953|NCT01111461|8972192|P1|Overall Study|Participant choice|11
2593954|NCT01111461|8972192|P1|Overall Study|Adverse Event|32
2593955|NCT01111292|8972372|P2|Treatment|Physician Decision|1
2593956|NCT01111292|8972373|P1|Treatment|Physician Decision|1
2593957|NCT01111240|8972379|P1|Overall Study|Other|312
2593958|NCT01111240|8972379|P1|Overall Study|Lack of Efficacy and Adverse Event|19
2593959|NCT01111240|8972379|P1|Overall Study|Lack of Efficacy|545
2593960|NCT01111240|8972379|P1|Overall Study|Adverse Event|190
2593961|NCT01111149|8972409|P3|Overall Study|Withdrawal by Subject|2
2593962|NCT01111149|8972410|P2|Overall Study|Withdrawal by Subject|0
2593963|NCT01111149|8972411|P1|Overall Study|Withdrawal by Subject|1
2593964|NCT01111149|8972409|P3|Overall Study|Protocol Violation|2
2593965|NCT01111149|8972410|P2|Overall Study|Protocol Violation|1
2593966|NCT01111149|8972411|P1|Overall Study|Protocol Violation|1
2593967|NCT01111123|8972487|P2|Maintenance Phase|Lost to Follow-up|2
2593968|NCT01111123|8972488|P1|Maintenance Phase|Lost to Follow-up|0
2593969|NCT01111123|8972487|P2|Open- Label Phase|Failed to be clear or almost cleared|0
2593970|NCT01111123|8972488|P1|Open- Label Phase|Failed to be clear or almost cleared|14
2593971|NCT01111019|8972534|P1|Overall Study|Other|1
2593972|NCT01111019|8972534|P1|Overall Study|Withdrew Prematurely|2
2593973|NCT01110915|8972566|P2|Overall Study|Withdrawal by Subject|1
2593974|NCT01110915|8972567|P1|Overall Study|Withdrawal by Subject|7
2593975|NCT01110915|8972566|P2|Overall Study|Lost to Follow-up|0
2593976|NCT01110915|8972567|P1|Overall Study|Lost to Follow-up|1
2593977|NCT01110915|8972566|P2|Overall Study|Death|1
2593978|NCT01110915|8972567|P1|Overall Study|Death|2
2593979|NCT01110707|8972584|P2|Overall Study|Protocol Violation|3
2593980|NCT01110707|8972585|P1|Overall Study|Protocol Violation|0
2593981|NCT01110408|8972673|P2|Overall Study|Protocol Violation|0
2593982|NCT01110408|8972674|P1|Overall Study|Protocol Violation|1
2593983|NCT01110382|8972694|P2|Overall Study|Protocol Violation|1
2593984|NCT01110382|8972695|P1|Overall Study|Protocol Violation|0
2593985|NCT01110382|8972694|P2|Overall Study|Withdrawal by Subject|1
2593986|NCT01110382|8972695|P1|Overall Study|Withdrawal by Subject|0
2593987|NCT01110330|8972716|P3|Overall Study|Other|1
2593988|NCT01110330|8972717|P2|Overall Study|Other|1
2593989|NCT01110330|8972718|P1|Overall Study|Other|1
2593990|NCT01110330|8972716|P3|Overall Study|Withdrawal by Subject|2
2593991|NCT01110330|8972717|P2|Overall Study|Withdrawal by Subject|6
2593992|NCT01110330|8972718|P1|Overall Study|Withdrawal by Subject|0
2593993|NCT01110330|8972716|P3|Overall Study|Protocol Violation|4
2593994|NCT01110330|8972717|P2|Overall Study|Protocol Violation|0
2593995|NCT01110330|8972718|P1|Overall Study|Protocol Violation|2
2593996|NCT01110330|8972716|P3|Overall Study|Physician Decision|0
2593997|NCT01110330|8972717|P2|Overall Study|Physician Decision|1
2593998|NCT01110330|8972718|P1|Overall Study|Physician Decision|0
2593999|NCT01110330|8972716|P3|Overall Study|Lost to Follow-up|15
2594000|NCT01110330|8972717|P2|Overall Study|Lost to Follow-up|10
2594001|NCT01110330|8972718|P1|Overall Study|Lost to Follow-up|9
2594002|NCT01110330|8972716|P3|Overall Study|Lack of Efficacy|1
2594003|NCT01110330|8972717|P2|Overall Study|Lack of Efficacy|1
2594004|NCT01110330|8972718|P1|Overall Study|Lack of Efficacy|3
2594005|NCT01110330|8972716|P3|Overall Study|Adverse Event|3
2594006|NCT01110330|8972717|P2|Overall Study|Adverse Event|4
2594007|NCT01110330|8972718|P1|Overall Study|Adverse Event|0
2594008|NCT01110239|8972746|P4|7.5 Min Ischemia|Withdrawal by Subject|0
2594009|NCT01110239|8972747|P3|7.5 Min Ischemia|Withdrawal by Subject|1
2594010|NCT01110239|8972748|P2|7.5 Min Ischemia|Withdrawal by Subject|0
2594011|NCT01110239|8972749|P1|7.5 Min Ischemia|Withdrawal by Subject|0
2594012|NCT01110239|8972746|P4|Sham Preconditioning|Withdrawal by Subject|0
2594013|NCT01110239|8972747|P3|Sham Preconditioning|Withdrawal by Subject|1
2594014|NCT01110239|8972748|P2|Sham Preconditioning|Withdrawal by Subject|0
2594015|NCT01110239|8972749|P1|Sham Preconditioning|Withdrawal by Subject|0
2594016|NCT01110200|8972765|P2|Overall Study|Lost to Follow-up|7
2594017|NCT01110200|8972766|P1|Overall Study|Lost to Follow-up|10
2594018|NCT01110200|8972765|P2|Overall Study|Physician Decision|17
2594019|NCT01110200|8972766|P1|Overall Study|Physician Decision|13
2594020|NCT01110200|8972765|P2|Overall Study|Protocol Violation|12
2594021|NCT01110200|8972766|P1|Overall Study|Protocol Violation|14
2594022|NCT01110200|8972765|P2|Overall Study|Lack of Efficacy|25
2594023|NCT01110200|8972766|P1|Overall Study|Lack of Efficacy|16
2594024|NCT01110200|8972765|P2|Overall Study|Withdrawal by Subject|32
2594025|NCT01110200|8972766|P1|Overall Study|Withdrawal by Subject|25
2594026|NCT01110200|8972765|P2|Overall Study|Adverse Event|28
2594027|NCT01110200|8972766|P1|Overall Study|Adverse Event|28
2594028|NCT01110005|8972802|P2|Overall Study|Withdrawal by Subject|1
2594029|NCT01110005|8972803|P1|Overall Study|Withdrawal by Subject|0
2594030|NCT01110005|8972802|P2|Overall Study|missing consent|2
2594031|NCT01110005|8972803|P1|Overall Study|missing consent|3
2594032|NCT01110005|8972802|P2|Overall Study|ineligible|2
2594033|NCT01110005|8972803|P1|Overall Study|ineligible|1
2594034|NCT01109992|8972815|P2|Overall Study|Movement during rest scan.|1
2594035|NCT01109992|8972816|P1|Overall Study|Movement during rest scan.|0
2594036|NCT01109992|8972815|P2|Overall Study|Withdrawal by Subject|1
2594037|NCT01109992|8972816|P1|Overall Study|Withdrawal by Subject|0
2594038|NCT01109979|8972830|P2|Overall Study|Withdrawal by Subject|1
2594039|NCT01109979|8972831|P1|Overall Study|Withdrawal by Subject|0
2594040|NCT01109979|8972830|P2|Overall Study|Physician Decision|0
2594041|NCT01109979|8972831|P1|Overall Study|Physician Decision|2
2594042|NCT01109849|8972839|P5|Adaptive Randomization: Weight Recovery|moved away|0
2594043|NCT01109849|8972840|P4|Adaptive Randomization: Weight Recovery|moved away|2
2594044|NCT01109849|8972841|P3|Adaptive Randomization: Weight Recovery|moved away|0
2594045|NCT01109849|8972842|P2|Adaptive Randomization: Weight Recovery|moved away|0
2594046|NCT01109849|8972843|P1|Adaptive Randomization: Weight Recovery|moved away|0
2594047|NCT01109849|8972839|P5|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
2594048|NCT01109849|8972840|P4|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
2594049|NCT01109849|8972841|P3|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
2594050|NCT01109849|8972842|P2|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
2594051|NCT01109849|8972843|P1|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
2594052|NCT01109849|8972839|P5|Initial Randomization: ADHD Treatment|move away|0
2594053|NCT01109849|8972840|P4|Initial Randomization: ADHD Treatment|move away|0
2594054|NCT01109849|8972841|P3|Initial Randomization: ADHD Treatment|move away|0
2594055|NCT01109849|8972842|P2|Initial Randomization: ADHD Treatment|move away|7
2594056|NCT01109849|8972843|P1|Initial Randomization: ADHD Treatment|move away|2
2594057|NCT01109849|8972839|P5|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
2594058|NCT01109849|8972840|P4|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
2594059|NCT01109849|8972841|P3|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
2594060|NCT01109849|8972842|P2|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7
2594061|NCT01109849|8972843|P1|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6
2594062|NCT01109849|8972839|P5|Initial Randomization: ADHD Treatment|Protocol Violation|0
2594063|NCT01109849|8972840|P4|Initial Randomization: ADHD Treatment|Protocol Violation|0
2594064|NCT01109849|8972841|P3|Initial Randomization: ADHD Treatment|Protocol Violation|0
2594065|NCT01109849|8972842|P2|Initial Randomization: ADHD Treatment|Protocol Violation|0
2594066|NCT01109849|8972843|P1|Initial Randomization: ADHD Treatment|Protocol Violation|1
2594067|NCT01109849|8972839|P5|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
2594068|NCT01109849|8972840|P4|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
2594069|NCT01109849|8972841|P3|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
2594070|NCT01109849|8972842|P2|Initial Randomization: ADHD Treatment|Lost to Follow-up|35
2594071|NCT01109849|8972843|P1|Initial Randomization: ADHD Treatment|Lost to Follow-up|9
2594072|NCT01109524|8972912|P1|Overall Study|Other|5
2594073|NCT01109524|8972912|P1|Overall Study|Participant requested to end treatment|4
2594074|NCT01109524|8972912|P1|Overall Study|No longer meets criteria|2
2594075|NCT01109524|8972912|P1|Overall Study|Death|2
2594076|NCT01109524|8972912|P1|Overall Study|Maximum clinical benefit|3
2594077|NCT01109524|8972912|P1|Overall Study|Withdrawal by Subject|2
2594078|NCT01109524|8972912|P1|Overall Study|Adverse Event|4
2594079|NCT01109524|8972912|P1|Overall Study|Study Drug toxicity|6
2594080|NCT01109524|8972912|P1|Overall Study|Disease Progression|29
2594081|NCT01109316|8972934|P6|Study Period 3|Withdrawal by Subject|0
2594082|NCT01109316|8972935|P5|Study Period 3|Withdrawal by Subject|1
2594083|NCT01109316|8972936|P4|Study Period 3|Withdrawal by Subject|0
2594084|NCT01109316|8972937|P3|Study Period 3|Withdrawal by Subject|0
2594085|NCT01109316|8972938|P2|Study Period 3|Withdrawal by Subject|0
2594086|NCT01109316|8972939|P1|Study Period 3|Withdrawal by Subject|1
2594087|NCT01109316|8972934|P6|Study Period 3|Lost to Follow-up|0
2594088|NCT01109316|8972935|P5|Study Period 3|Lost to Follow-up|1
2594089|NCT01109316|8972936|P4|Study Period 3|Lost to Follow-up|0
2594090|NCT01109316|8972937|P3|Study Period 3|Lost to Follow-up|0
2594091|NCT01109316|8972938|P2|Study Period 3|Lost to Follow-up|0
2594092|NCT01109316|8972939|P1|Study Period 3|Lost to Follow-up|0
2594093|NCT01109316|8972934|P6|Study Period 2|Withdrawal by Subject|1
2594094|NCT01109316|8972935|P5|Study Period 2|Withdrawal by Subject|0
2594095|NCT01109316|8972936|P4|Study Period 2|Withdrawal by Subject|0
2594096|NCT01109316|8972937|P3|Study Period 2|Withdrawal by Subject|1
2594097|NCT01109316|8972938|P2|Study Period 2|Withdrawal by Subject|0
2594098|NCT01109316|8972939|P1|Study Period 2|Withdrawal by Subject|0
2594099|NCT01109316|8972934|P6|Study Period 2|Protocol Violation|0
2594100|NCT01109316|8972935|P5|Study Period 2|Protocol Violation|0
2594101|NCT01109316|8972936|P4|Study Period 2|Protocol Violation|0
2594102|NCT01109316|8972937|P3|Study Period 2|Protocol Violation|0
2594103|NCT01109316|8972938|P2|Study Period 2|Protocol Violation|0
2594104|NCT01109316|8972939|P1|Study Period 2|Protocol Violation|1
2594105|NCT01109316|8972934|P6|Study Period 2|Physician Decision|0
2594106|NCT01109316|8972935|P5|Study Period 2|Physician Decision|0
2594107|NCT01109316|8972936|P4|Study Period 2|Physician Decision|1
2594108|NCT01109316|8972937|P3|Study Period 2|Physician Decision|0
2594109|NCT01109316|8972938|P2|Study Period 2|Physician Decision|0
2594110|NCT01109316|8972939|P1|Study Period 2|Physician Decision|0
2594111|NCT01109316|8972934|P6|Study Period 2|Entry Criteria Not Met|0
2594112|NCT01109316|8972935|P5|Study Period 2|Entry Criteria Not Met|0
2594113|NCT01109316|8972936|P4|Study Period 2|Entry Criteria Not Met|0
2594114|NCT01109316|8972937|P3|Study Period 2|Entry Criteria Not Met|0
2594115|NCT01109316|8972938|P2|Study Period 2|Entry Criteria Not Met|1
2594116|NCT01109316|8972939|P1|Study Period 2|Entry Criteria Not Met|0
2594117|NCT01109316|8972934|P6|Study Period 1|Sponsor Decision|2
2594118|NCT01109316|8972935|P5|Study Period 1|Sponsor Decision|0
2594119|NCT01109316|8972936|P4|Study Period 1|Sponsor Decision|0
2594120|NCT01109316|8972937|P3|Study Period 1|Sponsor Decision|0
2594121|NCT01109316|8972938|P2|Study Period 1|Sponsor Decision|0
2594122|NCT01109316|8972939|P1|Study Period 1|Sponsor Decision|0
2594123|NCT01109316|8972934|P6|Study Period 1|Withdrawal by Subject|0
2594124|NCT01109316|8972935|P5|Study Period 1|Withdrawal by Subject|2
2594125|NCT01109316|8972936|P4|Study Period 1|Withdrawal by Subject|0
2594126|NCT01109316|8972937|P3|Study Period 1|Withdrawal by Subject|1
2594127|NCT01109316|8972938|P2|Study Period 1|Withdrawal by Subject|0
2594128|NCT01109316|8972939|P1|Study Period 1|Withdrawal by Subject|0
2594129|NCT01109316|8972934|P6|Study Period 1|Lost to Follow-up|0
2594130|NCT01109316|8972935|P5|Study Period 1|Lost to Follow-up|0
2594131|NCT01109316|8972936|P4|Study Period 1|Lost to Follow-up|1
2594132|NCT01109316|8972937|P3|Study Period 1|Lost to Follow-up|1
2594133|NCT01109316|8972938|P2|Study Period 1|Lost to Follow-up|0
2594134|NCT01109316|8972939|P1|Study Period 1|Lost to Follow-up|0
2594135|NCT01109316|8972934|P6|Study Period 1|Adverse Event|0
2594136|NCT01109316|8972935|P5|Study Period 1|Adverse Event|0
2594137|NCT01109316|8972936|P4|Study Period 1|Adverse Event|0
2594138|NCT01109316|8972937|P3|Study Period 1|Adverse Event|1
2594139|NCT01109316|8972938|P2|Study Period 1|Adverse Event|0
2594140|NCT01109316|8972939|P1|Study Period 1|Adverse Event|0
2594141|NCT01109173|8972987|P4|Overall Study|Not Specifiied|14
2594142|NCT01109173|8972988|P3|Overall Study|Not Specifiied|9
2594143|NCT01109173|8972989|P2|Overall Study|Not Specifiied|4
2594144|NCT01109173|8972990|P1|Overall Study|Not Specifiied|5
2594145|NCT01109173|8972987|P4|Overall Study|Patient Did Not Use Study Medication|7
2594146|NCT01109173|8972988|P3|Overall Study|Patient Did Not Use Study Medication|11
2594147|NCT01109173|8972989|P2|Overall Study|Patient Did Not Use Study Medication|26
2594148|NCT01109173|8972990|P1|Overall Study|Patient Did Not Use Study Medication|34
2594149|NCT01109173|8972987|P4|Overall Study|Protocol Violation|2
2594150|NCT01109173|8972988|P3|Overall Study|Protocol Violation|1
2594151|NCT01109173|8972989|P2|Overall Study|Protocol Violation|5
2594152|NCT01109173|8972990|P1|Overall Study|Protocol Violation|4
2594153|NCT01109173|8972987|P4|Overall Study|Treatment Failure|64
2594154|NCT01109173|8972988|P3|Overall Study|Treatment Failure|69
2594155|NCT01109173|8972989|P2|Overall Study|Treatment Failure|32
2594156|NCT01109173|8972990|P1|Overall Study|Treatment Failure|25
2594157|NCT01109173|8972987|P4|Overall Study|Noncompliance|0
2594158|NCT01109173|8972988|P3|Overall Study|Noncompliance|0
2594159|NCT01109173|8972989|P2|Overall Study|Noncompliance|1
2594160|NCT01109173|8972990|P1|Overall Study|Noncompliance|0
2594161|NCT01109173|8972987|P4|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
2594162|NCT01109173|8972988|P3|Overall Study|Patient Decision Unrelated to Advrs Evnt|2
2594163|NCT01109173|8972989|P2|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
2594164|NCT01109173|8972990|P1|Overall Study|Patient Decision Unrelated to Advrs Evnt|5
2594165|NCT01109173|8972987|P4|Overall Study|Lost to Follow-up|0
2594166|NCT01109173|8972988|P3|Overall Study|Lost to Follow-up|0
2594167|NCT01109173|8972989|P2|Overall Study|Lost to Follow-up|1
2594168|NCT01109173|8972990|P1|Overall Study|Lost to Follow-up|0
2594169|NCT01109173|8972987|P4|Overall Study|Adverse Event|6
2594170|NCT01109173|8972988|P3|Overall Study|Adverse Event|9
2594171|NCT01109173|8972989|P2|Overall Study|Adverse Event|17
2594172|NCT01109173|8972990|P1|Overall Study|Adverse Event|15
2594173|NCT01108809|8973096|P1|Overall Study|Lost to Follow-up|1
2594174|NCT01108809|8973096|P1|Overall Study|Adverse Event|3
2594175|NCT01108796|8973113|P2|Overall Study|Lost to Follow-up|6
2594176|NCT01108796|8973114|P1|Overall Study|Lost to Follow-up|7
2594177|NCT01108796|8973113|P2|Overall Study|Adverse Event|1
2594178|NCT01108796|8973114|P1|Overall Study|Adverse Event|0
2594179|NCT01108731|8973157|P2|Overall Study|Adverse Event|3
2594180|NCT01108731|8973158|P1|Overall Study|Adverse Event|3
2594181|NCT01108731|8973157|P2|Overall Study|Withdrawal by Subject|1
2594182|NCT01108731|8973158|P1|Overall Study|Withdrawal by Subject|1
2594183|NCT01108718|8973170|P2|Received Second Intervention (2 Months)|Withdrawal by Subject|0
2594184|NCT01108718|8973171|P1|Received Second Intervention (2 Months)|Withdrawal by Subject|1
2594185|NCT01108523|8973176|P1|Overall Study|Protocol Violation|4
2594186|NCT01108510|8973183|P2|Overall Study|Death|1
2594187|NCT01108510|8973184|P1|Overall Study|Death|1
2594188|NCT01108510|8973183|P2|Overall Study|Pregnancy|3
2594189|NCT01108510|8973184|P1|Overall Study|Pregnancy|0
2594190|NCT01108510|8973183|P2|Overall Study|Lack of Efficacy|0
2594191|NCT01108510|8973184|P1|Overall Study|Lack of Efficacy|3
2594192|NCT01108510|8973183|P2|Overall Study|Participant Noncompliance|7
2594193|NCT01108510|8973184|P1|Overall Study|Participant Noncompliance|5
2594194|NCT01108510|8973183|P2|Overall Study|Investigator’s Discretion|10
2594195|NCT01108510|8973184|P1|Overall Study|Investigator’s Discretion|12
2594196|NCT01108510|8973183|P2|Overall Study|Withdrew Consent|15
2594197|NCT01108510|8973184|P1|Overall Study|Withdrew Consent|21
2594198|NCT01108510|8973183|P2|Overall Study|Lost to Follow-up|17
2594199|NCT01108510|8973184|P1|Overall Study|Lost to Follow-up|20
2594200|NCT01108510|8973183|P2|Overall Study|Adverse Event|19
2594201|NCT01108510|8973184|P1|Overall Study|Adverse Event|26
2594202|NCT01108510|8973183|P2|Overall Study|Joined Another Gilead-sponsored Study|195
2594203|NCT01108510|8973184|P1|Overall Study|Joined Another Gilead-sponsored Study|186
2594204|NCT01108510|8973183|P2|Overall Study|Randomized but Not Treated|1
2594205|NCT01108510|8973184|P1|Overall Study|Randomized but Not Treated|5
2594206|NCT01108458|8973204|P1|Overall Study|Withdrawal by Subject|1
2594207|NCT01108341|8973256|P1|Overall Study|Other|1
2594208|NCT01108341|8973256|P1|Overall Study|Lost to Follow-up|1
2594209|NCT01108341|8973256|P1|Overall Study|Withdrawal by Subject|1
2594210|NCT01108341|8973256|P1|Overall Study|Death|2
2594211|NCT01108263|8973263|P2|Overall Study|Adverse Event|1
2594212|NCT01108263|8973264|P1|Overall Study|Adverse Event|0
2594213|NCT01108237|8973274|P2|Overall Study|Did not meet criteria for analysis|0
2594214|NCT01108237|8973275|P1|Overall Study|Did not meet criteria for analysis|7
2594215|NCT01108237|8973274|P2|Overall Study|No alignment data|17
2594216|NCT01108237|8973275|P1|Overall Study|No alignment data|2
2594217|NCT01108185|8973281|P1|Overall Study|Lost to Follow-up|12
2594218|NCT01108185|8973281|P1|Overall Study|Non-compliance|15
2594219|NCT01108094|8973298|P4|Overall Study|Withdrawal by Subject|0
2594220|NCT01108094|8973299|P3|Overall Study|Withdrawal by Subject|0
2594221|NCT01108094|8973300|P2|Overall Study|Withdrawal by Subject|0
2594222|NCT01108094|8973301|P1|Overall Study|Withdrawal by Subject|1
2594223|NCT01108094|8973298|P4|Overall Study|Adverse Event|0
2594224|NCT01108094|8973299|P3|Overall Study|Adverse Event|0
2594225|NCT01108094|8973300|P2|Overall Study|Adverse Event|0
2594226|NCT01108094|8973301|P1|Overall Study|Adverse Event|2
2594227|NCT01108068|8973345|P2|Overall Study|5 not started, 1 stop due to side effect|0
2594228|NCT01108068|8973346|P1|Overall Study|5 not started, 1 stop due to side effect|6
2594229|NCT01108055|8973353|P1|Overall Study|Not evaluable- didn't complete treatment|4
2594230|NCT01108055|8973353|P1|Overall Study|Ineligible|11
2594231|NCT01107925|8973391|P6|Period 2|Withdrawal by Subject|1
2594232|NCT01107925|8973392|P5|Period 2|Withdrawal by Subject|0
2594233|NCT01107925|8973393|P4|Period 2|Withdrawal by Subject|0
2594234|NCT01107925|8973394|P3|Period 2|Withdrawal by Subject|0
2594235|NCT01107925|8973395|P2|Period 2|Withdrawal by Subject|1
2594236|NCT01107925|8973396|P1|Period 2|Withdrawal by Subject|0
2594237|NCT01107925|8973391|P6|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
2594238|NCT01107925|8973392|P5|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
2594239|NCT01107925|8973393|P4|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
2594240|NCT01107925|8973394|P3|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
2594241|NCT01107925|8973395|P2|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
2594242|NCT01107925|8973396|P1|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
2594243|NCT01107912|8973434|P6|Period 3|Withdrawal by Subject|0
2594244|NCT01107912|8973435|P5|Period 3|Withdrawal by Subject|0
2594245|NCT01107912|8973436|P4|Period 3|Withdrawal by Subject|1
2594246|NCT01107912|8973437|P3|Period 3|Withdrawal by Subject|0
2594247|NCT01107912|8973438|P2|Period 3|Withdrawal by Subject|0
2594248|NCT01107912|8973439|P1|Period 3|Withdrawal by Subject|0
2594249|NCT01107912|8973434|P6|Period 3|Adverse Event|0
2594250|NCT01107912|8973435|P5|Period 3|Adverse Event|0
2594251|NCT01107912|8973436|P4|Period 3|Adverse Event|0
2594252|NCT01107912|8973437|P3|Period 3|Adverse Event|1
2594253|NCT01107912|8973438|P2|Period 3|Adverse Event|1
2594254|NCT01107912|8973439|P1|Period 3|Adverse Event|0
2594255|NCT01107912|8973434|P6|Period 2|Physician Decision|0
2594256|NCT01107912|8973435|P5|Period 2|Physician Decision|0
2594257|NCT01107912|8973436|P4|Period 2|Physician Decision|0
2594258|NCT01107912|8973437|P3|Period 2|Physician Decision|1
2594259|NCT01107912|8973438|P2|Period 2|Physician Decision|0
2594260|NCT01107912|8973439|P1|Period 2|Physician Decision|0
2594261|NCT01107912|8973434|P6|Period 1|Withdrawal by Subject|0
2594262|NCT01107912|8973435|P5|Period 1|Withdrawal by Subject|0
2594263|NCT01107912|8973436|P4|Period 1|Withdrawal by Subject|0
2594264|NCT01107912|8973437|P3|Period 1|Withdrawal by Subject|0
2594265|NCT01107912|8973438|P2|Period 1|Withdrawal by Subject|0
2594266|NCT01107912|8973439|P1|Period 1|Withdrawal by Subject|1
2594267|NCT01107912|8973434|P6|Period 1|Physician Decision|0
2594268|NCT01107912|8973435|P5|Period 1|Physician Decision|1
2594269|NCT01107912|8973436|P4|Period 1|Physician Decision|0
2594270|NCT01107912|8973437|P3|Period 1|Physician Decision|0
2594271|NCT01107912|8973438|P2|Period 1|Physician Decision|0
2594272|NCT01107912|8973439|P1|Period 1|Physician Decision|0
2594273|NCT01107912|8973434|P6|Period 1|Adverse Event|0
2594274|NCT01107912|8973435|P5|Period 1|Adverse Event|2
2594275|NCT01107912|8973436|P4|Period 1|Adverse Event|0
2594276|NCT01107912|8973437|P3|Period 1|Adverse Event|0
2594277|NCT01107912|8973438|P2|Period 1|Adverse Event|0
2594278|NCT01107912|8973439|P1|Period 1|Adverse Event|0
2594279|NCT01107899|8973476|P3|Overall Study|Withdrawal by Subject|1
2594280|NCT01107899|8973477|P2|Overall Study|Withdrawal by Subject|0
2594281|NCT01107899|8973478|P1|Overall Study|Withdrawal by Subject|0
2594282|NCT01107899|8973476|P3|Overall Study|Physician Decision|3
2594283|NCT01107899|8973477|P2|Overall Study|Physician Decision|0
2594284|NCT01107899|8973478|P1|Overall Study|Physician Decision|5
2594285|NCT01107886|8973524|P2|Overall Study|Administrative withdrawal of consent|5
2594286|NCT01107886|8973525|P1|Overall Study|Administrative withdrawal of consent|7
2594287|NCT01107886|8973524|P2|Overall Study|Withdrawal by Subject|196
2594288|NCT01107886|8973525|P1|Overall Study|Withdrawal by Subject|180
2594289|NCT01107886|8973524|P2|Overall Study|Lost to Follow-up|13
2594290|NCT01107886|8973525|P1|Overall Study|Lost to Follow-up|15
2594291|NCT01107743|8973558|P1|Overall Study|Protocol Violation|46
2594292|NCT01107535|8973672|P1|Overall Study|Death|5
2594293|NCT01107457|8973685|P6|Part B and C|Clinical Relapse|4
2594294|NCT01107457|8973686|P5|Part B and C|Clinical Relapse|0
2594295|NCT01107457|8973687|P4|Part B and C|Clinical Relapse|0
2594296|NCT01107457|8973688|P3|Part B and C|Clinical Relapse|0
2594297|NCT01107457|8973689|P2|Part B and C|Clinical Relapse|0
2594298|NCT01107457|8973690|P1|Part B and C|Clinical Relapse|0
2594299|NCT01107457|8973685|P6|Part B and C|Withdrawal by Subject|16
2594300|NCT01107457|8973686|P5|Part B and C|Withdrawal by Subject|0
2594301|NCT01107457|8973687|P4|Part B and C|Withdrawal by Subject|0
2594302|NCT01107457|8973688|P3|Part B and C|Withdrawal by Subject|0
2594303|NCT01107457|8973689|P2|Part B and C|Withdrawal by Subject|0
2594304|NCT01107457|8973690|P1|Part B and C|Withdrawal by Subject|0
2594305|NCT01107457|8973685|P6|Part B and C|Sponsor Decision|66
2594306|NCT01107457|8973686|P5|Part B and C|Sponsor Decision|0
2594307|NCT01107457|8973687|P4|Part B and C|Sponsor Decision|0
2594308|NCT01107457|8973688|P3|Part B and C|Sponsor Decision|0
2594309|NCT01107457|8973689|P2|Part B and C|Sponsor Decision|0
2594310|NCT01107457|8973690|P1|Part B and C|Sponsor Decision|0
2594311|NCT01107457|8973685|P6|Part B and C|Protocol Violation|1
2594312|NCT01107457|8973686|P5|Part B and C|Protocol Violation|0
2594313|NCT01107457|8973687|P4|Part B and C|Protocol Violation|0
2594314|NCT01107457|8973688|P3|Part B and C|Protocol Violation|0
2594315|NCT01107457|8973689|P2|Part B and C|Protocol Violation|0
2594316|NCT01107457|8973690|P1|Part B and C|Protocol Violation|0
2594317|NCT01107457|8973685|P6|Part B and C|Lost to Follow-up|10
2594318|NCT01107457|8973686|P5|Part B and C|Lost to Follow-up|0
2594319|NCT01107457|8973687|P4|Part B and C|Lost to Follow-up|0
2594320|NCT01107457|8973688|P3|Part B and C|Lost to Follow-up|0
2594321|NCT01107457|8973689|P2|Part B and C|Lost to Follow-up|0
2594322|NCT01107457|8973690|P1|Part B and C|Lost to Follow-up|0
2594323|NCT01107457|8973685|P6|Part B and C|Lack of Efficacy|7
2594324|NCT01107457|8973686|P5|Part B and C|Lack of Efficacy|0
2594325|NCT01107457|8973687|P4|Part B and C|Lack of Efficacy|0
2594326|NCT01107457|8973688|P3|Part B and C|Lack of Efficacy|0
2594327|NCT01107457|8973689|P2|Part B and C|Lack of Efficacy|0
2594328|NCT01107457|8973690|P1|Part B and C|Lack of Efficacy|0
2594329|NCT01107457|8973685|P6|Part B and C|Physician Decision|3
2594330|NCT01107457|8973686|P5|Part B and C|Physician Decision|0
2594331|NCT01107457|8973687|P4|Part B and C|Physician Decision|0
2594332|NCT01107457|8973688|P3|Part B and C|Physician Decision|0
2594333|NCT01107457|8973689|P2|Part B and C|Physician Decision|0
2594334|NCT01107457|8973690|P1|Part B and C|Physician Decision|0
2594335|NCT01107457|8973685|P6|Part B and C|Inclusion/Exclusion Criteria Not Met|1
2594336|NCT01107457|8973686|P5|Part B and C|Inclusion/Exclusion Criteria Not Met|0
2594337|NCT01107457|8973687|P4|Part B and C|Inclusion/Exclusion Criteria Not Met|0
2594338|NCT01107457|8973688|P3|Part B and C|Inclusion/Exclusion Criteria Not Met|0
2594339|NCT01107457|8973689|P2|Part B and C|Inclusion/Exclusion Criteria Not Met|0
2594340|NCT01107457|8973690|P1|Part B and C|Inclusion/Exclusion Criteria Not Met|0
2594341|NCT01107457|8973685|P6|Part B and C|Adverse Event|12
2594342|NCT01107457|8973686|P5|Part B and C|Adverse Event|0
2594343|NCT01107457|8973687|P4|Part B and C|Adverse Event|0
2594344|NCT01107457|8973688|P3|Part B and C|Adverse Event|0
2594345|NCT01107457|8973689|P2|Part B and C|Adverse Event|0
2594346|NCT01107457|8973690|P1|Part B and C|Adverse Event|0
2594347|NCT01107457|8973685|P6|Part A|Protocol Violation|0
2594348|NCT01107457|8973686|P5|Part A|Protocol Violation|0
2594349|NCT01107457|8973687|P4|Part A|Protocol Violation|0
2594350|NCT01107457|8973688|P3|Part A|Protocol Violation|0
2594351|NCT01107457|8973689|P2|Part A|Protocol Violation|1
2594352|NCT01107457|8973690|P1|Part A|Protocol Violation|0
2594353|NCT01107457|8973685|P6|Part A|Lack of Efficacy|0
2594354|NCT01107457|8973686|P5|Part A|Lack of Efficacy|0
2594355|NCT01107457|8973687|P4|Part A|Lack of Efficacy|0
2594356|NCT01107457|8973688|P3|Part A|Lack of Efficacy|0
2594357|NCT01107457|8973689|P2|Part A|Lack of Efficacy|0
2594358|NCT01107457|8973690|P1|Part A|Lack of Efficacy|1
2594359|NCT01107457|8973685|P6|Part A|Lost to Follow-up|0
2594360|NCT01107457|8973686|P5|Part A|Lost to Follow-up|0
2594361|NCT01107457|8973687|P4|Part A|Lost to Follow-up|0
2594362|NCT01107457|8973688|P3|Part A|Lost to Follow-up|0
2594363|NCT01107457|8973689|P2|Part A|Lost to Follow-up|1
2594364|NCT01107457|8973690|P1|Part A|Lost to Follow-up|0
2594365|NCT01107457|8973685|P6|Part A|Withdrawal by Subject|0
2594366|NCT01107457|8973686|P5|Part A|Withdrawal by Subject|1
2594367|NCT01107457|8973687|P4|Part A|Withdrawal by Subject|3
2594368|NCT01107457|8973688|P3|Part A|Withdrawal by Subject|0
2594369|NCT01107457|8973689|P2|Part A|Withdrawal by Subject|3
2594370|NCT01107457|8973690|P1|Part A|Withdrawal by Subject|3
2594371|NCT01107457|8973685|P6|Part A|Adverse Event|0
2594372|NCT01107457|8973686|P5|Part A|Adverse Event|0
2594373|NCT01107457|8973687|P4|Part A|Adverse Event|0
2594374|NCT01107457|8973688|P3|Part A|Adverse Event|1
2594375|NCT01107457|8973689|P2|Part A|Adverse Event|2
2594376|NCT01107457|8973690|P1|Part A|Adverse Event|1
2594377|NCT01107444|8973818|P2|Overall Study|Protocol Entry Criteria Not Met|1
2594378|NCT01107444|8973819|P1|Overall Study|Protocol Entry Criteria Not Met|0
2594379|NCT01107444|8973818|P2|Overall Study|Withdrawal by Subject|12
2594380|NCT01107444|8973819|P1|Overall Study|Withdrawal by Subject|8
2594381|NCT01107418|8973853|P1|Overall Study|Entered Extension Study|1
2594382|NCT01107418|8973853|P1|Overall Study|Started Other Therapy|1
2594383|NCT01107418|8973853|P1|Overall Study|Study Closing|1
2594384|NCT01107418|8973853|P1|Overall Study|Withdrawal by Subject|1
2594385|NCT01107418|8973853|P1|Overall Study|Adverse Event|3
2594386|NCT01107418|8973853|P1|Overall Study|Disease Progression|45
2594387|NCT01107405|8973926|P5|Overall Study|Protocol Violation|0
2594388|NCT01107405|8973927|P4|Overall Study|Protocol Violation|1
2594389|NCT01107405|8973928|P3|Overall Study|Protocol Violation|1
2594390|NCT01107405|8973929|P2|Overall Study|Protocol Violation|0
2594391|NCT01107405|8973930|P1|Overall Study|Protocol Violation|0
2594392|NCT01107405|8973926|P5|Overall Study|Withdrawal by Subject|1
2594393|NCT01107405|8973927|P4|Overall Study|Withdrawal by Subject|2
2594394|NCT01107405|8973928|P3|Overall Study|Withdrawal by Subject|1
2594395|NCT01107405|8973929|P2|Overall Study|Withdrawal by Subject|0
2594396|NCT01107405|8973930|P1|Overall Study|Withdrawal by Subject|1
2594397|NCT01107405|8973926|P5|Overall Study|Adverse Event|2
2594398|NCT01107405|8973927|P4|Overall Study|Adverse Event|0
2594399|NCT01107405|8973928|P3|Overall Study|Adverse Event|0
2594400|NCT01107405|8973929|P2|Overall Study|Adverse Event|1
2594401|NCT01107405|8973930|P1|Overall Study|Adverse Event|1
2594402|NCT01107392|8973969|P2|Overall Study|Administrative decision|0
2594403|NCT01107392|8973970|P1|Overall Study|Administrative decision|1
2594404|NCT01107392|8973969|P2|Overall Study|Personal Reasons|3
2594405|NCT01107392|8973970|P1|Overall Study|Personal Reasons|2
2594406|NCT01107392|8973969|P2|Overall Study|Adverse Event|0
2594407|NCT01107392|8973970|P1|Overall Study|Adverse Event|2
2594408|NCT01107379|8973982|P1|Overall Study|Lost to Follow-up|3
2594409|NCT01107379|8973982|P1|Overall Study|Withdrawal by Subject|18
2594410|NCT01107353|8973993|P2|Overall Study|Positive Drug Screen|0
2594411|NCT01107353|8973994|P1|Overall Study|Positive Drug Screen|1
2594412|NCT01107197|8974002|P2|Overall Study|Withdrawal by Subject|5
2594413|NCT01107197|8974003|P1|Overall Study|Withdrawal by Subject|3
2594414|NCT01107197|8974002|P2|Overall Study|Lost to Follow-up|8
2594415|NCT01107197|8974003|P1|Overall Study|Lost to Follow-up|5
2594416|NCT01107197|8974002|P2|Overall Study|Death|10
2594417|NCT01107197|8974003|P1|Overall Study|Death|12
2594418|NCT01106976|8974038|P1|Overall Study|Lost to Follow-up|8
2594419|NCT01106911|8974052|P1|Overall Study|deemed ineligible after screening|3
2594420|NCT01106911|8974052|P1|Overall Study|Physician Decision|2
2594421|NCT01106898|8974056|P1|Overall Study|Adverse Event|6
2594422|NCT01106846|8974101|P2|Overall Study|Change in surgical procedure|1
2594423|NCT01106846|8974102|P1|Overall Study|Change in surgical procedure|0
2594424|NCT01106690|8974152|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
2594425|NCT01106690|8974153|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
2594426|NCT01106690|8974154|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
2594427|NCT01106690|8974152|P3|Extension Period: Week 26 to Week 52|Other|4
2594428|NCT01106690|8974153|P2|Extension Period: Week 26 to Week 52|Other|3
2594429|NCT01106690|8974154|P1|Extension Period: Week 26 to Week 52|Other|8
2594430|NCT01106690|8974152|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
2594431|NCT01106690|8974153|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
2594432|NCT01106690|8974154|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
2594433|NCT01106690|8974152|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
2594434|NCT01106690|8974153|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
2594435|NCT01106690|8974154|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
2594436|NCT01106690|8974152|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
2594437|NCT01106690|8974153|P2|Extension Period: Week 26 to Week 52|Physician Decision|2
2594438|NCT01106690|8974154|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
2594439|NCT01106690|8974152|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
2594440|NCT01106690|8974153|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
2594441|NCT01106690|8974154|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
2594442|NCT01106690|8974152|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
2594443|NCT01106690|8974153|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
2594444|NCT01106690|8974154|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
2594445|NCT01106690|8974152|P3|Core Period: Baseline to Week 26|Other|6
2594446|NCT01106690|8974153|P2|Core Period: Baseline to Week 26|Other|2
2594447|NCT01106690|8974154|P1|Core Period: Baseline to Week 26|Other|10
2594448|NCT01106690|8974152|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
2594449|NCT01106690|8974153|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
2594450|NCT01106690|8974154|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
2594451|NCT01106690|8974152|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
2594452|NCT01106690|8974153|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
2594453|NCT01106690|8974154|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
2594454|NCT01106690|8974152|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
2594455|NCT01106690|8974153|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
2594456|NCT01106690|8974154|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
2594457|NCT01106690|8974152|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
2594458|NCT01106690|8974153|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
2594459|NCT01106690|8974154|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0
2594460|NCT01106690|8974152|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|0
2594461|NCT01106690|8974153|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|1
2594462|NCT01106690|8974154|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
2594463|NCT01106690|8974152|P3|Core Period: Baseline to Week 26|Protocol Violation|0
2594464|NCT01106690|8974153|P2|Core Period: Baseline to Week 26|Protocol Violation|0
2594465|NCT01106690|8974154|P1|Core Period: Baseline to Week 26|Protocol Violation|1
2594466|NCT01106690|8974152|P3|Core Period: Baseline to Week 26|Lost to Follow-up|2
2594467|NCT01106690|8974153|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
2594468|NCT01106690|8974154|P1|Core Period: Baseline to Week 26|Lost to Follow-up|1
2594469|NCT01106690|8974152|P3|Core Period: Baseline to Week 26|Adverse Event|4
2594470|NCT01106690|8974153|P2|Core Period: Baseline to Week 26|Adverse Event|1
2594471|NCT01106690|8974154|P1|Core Period: Baseline to Week 26|Adverse Event|6
2594472|NCT01106677|8974190|P4|Extension Period: Week 26 to Week 52|Other|5
2594473|NCT01106677|8974191|P3|Extension Period: Week 26 to Week 52|Other|8
2594474|NCT01106677|8974192|P2|Extension Period: Week 26 to Week 52|Other|5
2594475|NCT01106677|8974193|P1|Extension Period: Week 26 to Week 52|Other|6
2594476|NCT01106677|8974190|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
2594477|NCT01106677|8974191|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
2594478|NCT01106677|8974192|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
2594479|NCT01106677|8974193|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
2594480|NCT01106677|8974190|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
2594481|NCT01106677|8974191|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3
2594482|NCT01106677|8974192|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
2594483|NCT01106677|8974193|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
2594484|NCT01106677|8974190|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
2594485|NCT01106677|8974191|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
2594486|NCT01106677|8974192|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3
2594487|NCT01106677|8974193|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
2594488|NCT01106677|8974190|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
2594489|NCT01106677|8974191|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
2594490|NCT01106677|8974192|P2|Extension Period: Week 26 to Week 52|Protocol Violation|0
2594491|NCT01106677|8974193|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
2594492|NCT01106677|8974190|P4|Extension Period: Week 26 to Week 52|Physician Decision|3
2594493|NCT01106677|8974191|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
2594494|NCT01106677|8974192|P2|Extension Period: Week 26 to Week 52|Physician Decision|3
2594495|NCT01106677|8974193|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
2594496|NCT01106677|8974190|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
2594497|NCT01106677|8974191|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
2594498|NCT01106677|8974192|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
2594499|NCT01106677|8974193|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
2594500|NCT01106677|8974190|P4|Extension Period: Week 26 to Week 52|Lack of Efficacy|4
2594501|NCT01106677|8974191|P3|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
2594502|NCT01106677|8974192|P2|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
2594503|NCT01106677|8974193|P1|Extension Period: Week 26 to Week 52|Lack of Efficacy|2
2594504|NCT01106677|8974190|P4|Extension Period: Week 26 to Week 52|Death|1
2594505|NCT01106677|8974191|P3|Extension Period: Week 26 to Week 52|Death|0
2594506|NCT01106677|8974192|P2|Extension Period: Week 26 to Week 52|Death|0
2594507|NCT01106677|8974193|P1|Extension Period: Week 26 to Week 52|Death|0
2594508|NCT01106677|8974190|P4|Extension Period: Week 26 to Week 52|Adverse Event|9
2594509|NCT01106677|8974191|P3|Extension Period: Week 26 to Week 52|Adverse Event|5
2594510|NCT01106677|8974192|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
2594511|NCT01106677|8974193|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
2594512|NCT01106677|8974190|P4|Core Period: Baseline to Week 26|Pregnancy|0
2594513|NCT01106677|8974191|P3|Core Period: Baseline to Week 26|Pregnancy|0
2594514|NCT01106677|8974192|P2|Core Period: Baseline to Week 26|Pregnancy|1
2594515|NCT01106677|8974193|P1|Core Period: Baseline to Week 26|Pregnancy|0
2594516|NCT01106677|8974190|P4|Core Period: Baseline to Week 26|Other|23
2594517|NCT01106677|8974191|P3|Core Period: Baseline to Week 26|Other|8
2594518|NCT01106677|8974192|P2|Core Period: Baseline to Week 26|Other|14
2594519|NCT01106677|8974193|P1|Core Period: Baseline to Week 26|Other|8
2594520|NCT01106677|8974190|P4|Core Period: Baseline to Week 26|Product quality complaint|0
2594521|NCT01106677|8974191|P3|Core Period: Baseline to Week 26|Product quality complaint|1
2594522|NCT01106677|8974192|P2|Core Period: Baseline to Week 26|Product quality complaint|1
2594523|NCT01106677|8974193|P1|Core Period: Baseline to Week 26|Product quality complaint|0
2594524|NCT01106677|8974190|P4|Core Period: Baseline to Week 26|Study terminated by sponsor|0
2594525|NCT01106677|8974191|P3|Core Period: Baseline to Week 26|Study terminated by sponsor|2
2594526|NCT01106677|8974192|P2|Core Period: Baseline to Week 26|Study terminated by sponsor|1
2594527|NCT01106677|8974193|P1|Core Period: Baseline to Week 26|Study terminated by sponsor|0
2594528|NCT01106677|8974190|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|0
2594529|NCT01106677|8974191|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
2594530|NCT01106677|8974192|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|3
2594531|NCT01106677|8974193|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
2594532|NCT01106677|8974190|P4|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
2594533|NCT01106677|8974191|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
2594534|NCT01106677|8974192|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
2594535|NCT01106677|8974193|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
2594536|NCT01106677|8974190|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|6
2594537|NCT01106677|8974191|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|15
2594538|NCT01106677|8974192|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
2594539|NCT01106677|8974193|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|5
2594540|NCT01106677|8974190|P4|Core Period: Baseline to Week 26|Protocol Violation|3
2594541|NCT01106677|8974191|P3|Core Period: Baseline to Week 26|Protocol Violation|0
2594542|NCT01106677|8974192|P2|Core Period: Baseline to Week 26|Protocol Violation|1
2594543|NCT01106677|8974193|P1|Core Period: Baseline to Week 26|Protocol Violation|0
2594544|NCT01106677|8974190|P4|Core Period: Baseline to Week 26|Physician Decision|1
2594545|NCT01106677|8974191|P3|Core Period: Baseline to Week 26|Physician Decision|3
2594546|NCT01106677|8974192|P2|Core Period: Baseline to Week 26|Physician Decision|1
2594547|NCT01106677|8974193|P1|Core Period: Baseline to Week 26|Physician Decision|2
2594548|NCT01106677|8974190|P4|Core Period: Baseline to Week 26|Lost to Follow-up|3
2594549|NCT01106677|8974191|P3|Core Period: Baseline to Week 26|Lost to Follow-up|6
2594550|NCT01106677|8974192|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
2594551|NCT01106677|8974193|P1|Core Period: Baseline to Week 26|Lost to Follow-up|3
2594552|NCT01106677|8974190|P4|Core Period: Baseline to Week 26|Lack of Efficacy|0
2594553|NCT01106677|8974191|P3|Core Period: Baseline to Week 26|Lack of Efficacy|0
2594554|NCT01106677|8974192|P2|Core Period: Baseline to Week 26|Lack of Efficacy|0
2594555|NCT01106677|8974193|P1|Core Period: Baseline to Week 26|Lack of Efficacy|1
2594556|NCT01106677|8974190|P4|Core Period: Baseline to Week 26|Death|0
2594557|NCT01106677|8974191|P3|Core Period: Baseline to Week 26|Death|1
2594558|NCT01106677|8974192|P2|Core Period: Baseline to Week 26|Death|0
2594559|NCT01106677|8974193|P1|Core Period: Baseline to Week 26|Death|0
2594560|NCT01106677|8974190|P4|Core Period: Baseline to Week 26|Adverse Event|8
2594561|NCT01106677|8974191|P3|Core Period: Baseline to Week 26|Adverse Event|6
2594562|NCT01106677|8974192|P2|Core Period: Baseline to Week 26|Adverse Event|18
2594563|NCT01106677|8974193|P1|Core Period: Baseline to Week 26|Adverse Event|7
2594564|NCT01106651|8974256|P3|Overall Study|Death|0
2594565|NCT01106651|8974257|P2|Overall Study|Death|3
2594566|NCT01106651|8974258|P1|Overall Study|Death|0
2594567|NCT01106651|8974256|P3|Overall Study|Other|21
2594568|NCT01106651|8974257|P2|Overall Study|Other|31
2594569|NCT01106651|8974258|P1|Overall Study|Other|34
2594570|NCT01106651|8974256|P3|Overall Study|Noncompliance with study drug|2
2594571|NCT01106651|8974257|P2|Overall Study|Noncompliance with study drug|0
2594572|NCT01106651|8974258|P1|Overall Study|Noncompliance with study drug|1
2594573|NCT01106651|8974256|P3|Overall Study|Withdrawal by Subject|4
2594574|NCT01106651|8974257|P2|Overall Study|Withdrawal by Subject|7
2594575|NCT01106651|8974258|P1|Overall Study|Withdrawal by Subject|14
2594576|NCT01106651|8974256|P3|Overall Study|Protocol Violation|1
2594577|NCT01106651|8974257|P2|Overall Study|Protocol Violation|2
2594578|NCT01106651|8974258|P1|Overall Study|Protocol Violation|1
2594579|NCT01106651|8974256|P3|Overall Study|Physician Decision|1
2594580|NCT01106651|8974257|P2|Overall Study|Physician Decision|3
2594581|NCT01106651|8974258|P1|Overall Study|Physician Decision|4
2594582|NCT01106651|8974256|P3|Overall Study|Lost to Follow-up|6
2594583|NCT01106651|8974257|P2|Overall Study|Lost to Follow-up|2
2594584|NCT01106651|8974258|P1|Overall Study|Lost to Follow-up|8
2594585|NCT01106651|8974256|P3|Overall Study|Adverse Event|23
2594586|NCT01106651|8974257|P2|Overall Study|Adverse Event|9
2594587|NCT01106651|8974258|P1|Overall Study|Adverse Event|17
2594588|NCT01106625|8974311|P3|Extension Period: Week 26 to Week 52|Other|4
2594589|NCT01106625|8974312|P2|Extension Period: Week 26 to Week 52|Other|5
2594590|NCT01106625|8974313|P1|Extension Period: Week 26 to Week 52|Other|5
2594591|NCT01106625|8974311|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
2594592|NCT01106625|8974312|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
2594593|NCT01106625|8974313|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
2594594|NCT01106625|8974311|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4
2594595|NCT01106625|8974312|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5
2594596|NCT01106625|8974313|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14
2594597|NCT01106625|8974311|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
2594598|NCT01106625|8974312|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
2594599|NCT01106625|8974313|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4
2594600|NCT01106625|8974311|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
2594601|NCT01106625|8974312|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
2594602|NCT01106625|8974313|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
2594603|NCT01106625|8974311|P3|Extension Period: Week 26 to Week 52|Physician Decision|1
2594604|NCT01106625|8974312|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
2594605|NCT01106625|8974313|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
2594606|NCT01106625|8974311|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
2594607|NCT01106625|8974312|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|3
2594608|NCT01106625|8974313|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
2594609|NCT01106625|8974311|P3|Extension Period: Week 26 to Week 52|Adverse Event|3
2594610|NCT01106625|8974312|P2|Extension Period: Week 26 to Week 52|Adverse Event|2
2594611|NCT01106625|8974313|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
2594612|NCT01106625|8974311|P3|Core Period: Baseline to Week 26|Other|4
2594613|NCT01106625|8974312|P2|Core Period: Baseline to Week 26|Other|7
2594614|NCT01106625|8974313|P1|Core Period: Baseline to Week 26|Other|8
2594615|NCT01106625|8974311|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
2594616|NCT01106625|8974312|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
2594617|NCT01106625|8974313|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
2594618|NCT01106625|8974311|P3|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
2594619|NCT01106625|8974312|P2|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
2594620|NCT01106625|8974313|P1|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0
2594621|NCT01106625|8974311|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
2594622|NCT01106625|8974312|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
2594623|NCT01106625|8974313|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|4
2594624|NCT01106625|8974311|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|7
2594625|NCT01106625|8974312|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|9
2594626|NCT01106625|8974313|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|6
2594627|NCT01106625|8974311|P3|Core Period: Baseline to Week 26|Protocol Violation|3
2594628|NCT01106625|8974312|P2|Core Period: Baseline to Week 26|Protocol Violation|1
2594629|NCT01106625|8974313|P1|Core Period: Baseline to Week 26|Protocol Violation|2
2594630|NCT01106625|8974311|P3|Core Period: Baseline to Week 26|Physician Decision|0
2594631|NCT01106625|8974312|P2|Core Period: Baseline to Week 26|Physician Decision|0
2594632|NCT01106625|8974313|P1|Core Period: Baseline to Week 26|Physician Decision|1
2594633|NCT01106625|8974311|P3|Core Period: Baseline to Week 26|Lost to Follow-up|4
2594634|NCT01106625|8974312|P2|Core Period: Baseline to Week 26|Lost to Follow-up|0
2594635|NCT01106625|8974313|P1|Core Period: Baseline to Week 26|Lost to Follow-up|5
2594636|NCT01106625|8974311|P3|Core Period: Baseline to Week 26|Adverse Event|8
2594637|NCT01106625|8974312|P2|Core Period: Baseline to Week 26|Adverse Event|8
2594638|NCT01106625|8974313|P1|Core Period: Baseline to Week 26|Adverse Event|6
2594639|NCT01106586|8974344|P2|Overall Study|Participant Transferred to Another Study|197
2594640|NCT01106586|8974345|P1|Overall Study|Participant Transferred to Another Study|212
2594641|NCT01106586|8974344|P2|Overall Study|Protocol Violation|0
2594642|NCT01106586|8974345|P1|Overall Study|Protocol Violation|1
2594643|NCT01106586|8974344|P2|Overall Study|Participant Noncompliance|10
2594644|NCT01106586|8974345|P1|Overall Study|Participant Noncompliance|12
2594645|NCT01106586|8974344|P2|Overall Study|Lost to Follow-up|20
2594646|NCT01106586|8974345|P1|Overall Study|Lost to Follow-up|24
2594647|NCT01106586|8974344|P2|Overall Study|Withdrew Consent|30
2594648|NCT01106586|8974345|P1|Overall Study|Withdrew Consent|18
2594649|NCT01106586|8974344|P2|Overall Study|Investigator's Discretion|8
2594650|NCT01106586|8974345|P1|Overall Study|Investigator's Discretion|5
2594651|NCT01106586|8974344|P2|Overall Study|Lack of Efficacy|0
2594652|NCT01106586|8974345|P1|Overall Study|Lack of Efficacy|1
2594653|NCT01106586|8974344|P2|Overall Study|Pregnancy|2
2594654|NCT01106586|8974345|P1|Overall Study|Pregnancy|2
2594655|NCT01106586|8974344|P2|Overall Study|Death|3
2594656|NCT01106586|8974345|P1|Overall Study|Death|1
2594657|NCT01106586|8974344|P2|Overall Study|Adverse Event|15
2594658|NCT01106586|8974345|P1|Overall Study|Adverse Event|9
2594659|NCT01106534|8974363|P1|Overall Study|Physician Decision|1
2594660|NCT01106534|8974363|P1|Overall Study|Death|16
2594661|NCT01106534|8974363|P1|Overall Study|Lost to Follow-up|2
2594662|NCT01106534|8974363|P1|Overall Study|Withdrawal by Subject|18
2594663|NCT01106430|8974395|P2|Overall Study|Withdrawal by Subject|4
2594664|NCT01106430|8974396|P1|Overall Study|Withdrawal by Subject|8
2594665|NCT01106430|8974395|P2|Overall Study|Protocol Violation|2
2594666|NCT01106430|8974396|P1|Overall Study|Protocol Violation|7
2594667|NCT01106430|8974395|P2|Overall Study|Previous Use Of Marijuana|0
2594668|NCT01106430|8974396|P1|Overall Study|Previous Use Of Marijuana|1
2594669|NCT01106430|8974395|P2|Overall Study|Hard Time Swallowing The Pills|0
2594670|NCT01106430|8974396|P1|Overall Study|Hard Time Swallowing The Pills|1
2594671|NCT01106430|8974395|P2|Overall Study|Noncompliance|1
2594672|NCT01106430|8974396|P1|Overall Study|Noncompliance|0
2594673|NCT01106430|8974395|P2|Overall Study|Refused To Take Medication|1
2594674|NCT01106430|8974396|P1|Overall Study|Refused To Take Medication|0
2594675|NCT01106430|8974395|P2|Overall Study|Moved Out Of State|1
2594676|NCT01106430|8974396|P1|Overall Study|Moved Out Of State|0
2594677|NCT01106430|8974395|P2|Overall Study|Early Termination Requested By Sponsor|0
2594678|NCT01106430|8974396|P1|Overall Study|Early Termination Requested By Sponsor|1
2594679|NCT01106430|8974395|P2|Overall Study|Lost to Follow-up|1
2594680|NCT01106430|8974396|P1|Overall Study|Lost to Follow-up|5
2594681|NCT01106430|8974395|P2|Overall Study|Lack of Efficacy|13
2594682|NCT01106430|8974396|P1|Overall Study|Lack of Efficacy|2
2594683|NCT01106430|8974395|P2|Overall Study|Adverse Event|10
2594684|NCT01106430|8974396|P1|Overall Study|Adverse Event|8
2594685|NCT01106404|8974418|P2|Period I (First 6 Weeks)|Lack of Efficacy|1
2594686|NCT01106404|8974419|P1|Period I (First 6 Weeks)|Lack of Efficacy|0
2594687|NCT01106404|8974418|P2|Period I (First 6 Weeks)|Lost to Follow-up|1
2594688|NCT01106404|8974419|P1|Period I (First 6 Weeks)|Lost to Follow-up|0
2594689|NCT01106404|8974418|P2|Period I (First 6 Weeks)|Physician Decision|0
2594690|NCT01106404|8974419|P1|Period I (First 6 Weeks)|Physician Decision|1
2594691|NCT01106404|8974418|P2|Period I (First 6 Weeks)|Adverse Event|0
2594692|NCT01106404|8974419|P1|Period I (First 6 Weeks)|Adverse Event|2
2594693|NCT01106352|8974442|P5|Overall Study|Home hospice since July 2013|0
2594694|NCT01106352|8974443|P4|Overall Study|Home hospice since July 2013|1
2594695|NCT01106352|8974444|P3|Overall Study|Home hospice since July 2013|0
2594696|NCT01106352|8974445|P2|Overall Study|Home hospice since July 2013|0
2594697|NCT01106352|8974446|P1|Overall Study|Home hospice since July 2013|0
2594698|NCT01106352|8974442|P5|Overall Study|Subject entered hospice|0
2594699|NCT01106352|8974443|P4|Overall Study|Subject entered hospice|1
2594700|NCT01106352|8974444|P3|Overall Study|Subject entered hospice|0
2594701|NCT01106352|8974445|P2|Overall Study|Subject entered hospice|0
2594702|NCT01106352|8974446|P1|Overall Study|Subject entered hospice|0
2594703|NCT01106352|8974442|P5|Overall Study|Went on hospice|0
2594704|NCT01106352|8974443|P4|Overall Study|Went on hospice|1
2594705|NCT01106352|8974444|P3|Overall Study|Went on hospice|0
2594706|NCT01106352|8974445|P2|Overall Study|Went on hospice|0
2594707|NCT01106352|8974446|P1|Overall Study|Went on hospice|0
2594708|NCT01106352|8974442|P5|Overall Study|Withdrawal by Subject|2
2594709|NCT01106352|8974443|P4|Overall Study|Withdrawal by Subject|3
2594710|NCT01106352|8974444|P3|Overall Study|Withdrawal by Subject|0
2594711|NCT01106352|8974445|P2|Overall Study|Withdrawal by Subject|0
2594712|NCT01106352|8974446|P1|Overall Study|Withdrawal by Subject|0
2594713|NCT01106352|8974442|P5|Overall Study|Disease progression|0
2594714|NCT01106352|8974443|P4|Overall Study|Disease progression|1
2594715|NCT01106352|8974444|P3|Overall Study|Disease progression|0
2594716|NCT01106352|8974445|P2|Overall Study|Disease progression|0
2594717|NCT01106352|8974446|P1|Overall Study|Disease progression|0
2594718|NCT01106352|8974442|P5|Overall Study|Death|1
2594719|NCT01106352|8974443|P4|Overall Study|Death|3
2594720|NCT01106352|8974444|P3|Overall Study|Death|1
2594721|NCT01106352|8974445|P2|Overall Study|Death|0
2594722|NCT01106352|8974446|P1|Overall Study|Death|0
2594723|NCT01106352|8974442|P5|Overall Study|Lost to Follow-up|1
2594724|NCT01106352|8974443|P4|Overall Study|Lost to Follow-up|0
2594725|NCT01106352|8974444|P3|Overall Study|Lost to Follow-up|0
2594726|NCT01106352|8974445|P2|Overall Study|Lost to Follow-up|0
2594727|NCT01106352|8974446|P1|Overall Study|Lost to Follow-up|0
2594728|NCT01106352|8974442|P5|Overall Study|Too ill to come in for the visit|0
2594729|NCT01106352|8974443|P4|Overall Study|Too ill to come in for the visit|0
2594730|NCT01106352|8974444|P3|Overall Study|Too ill to come in for the visit|1
2594731|NCT01106352|8974445|P2|Overall Study|Too ill to come in for the visit|0
2594732|NCT01106352|8974446|P1|Overall Study|Too ill to come in for the visit|0
2594733|NCT01106352|8974442|P5|Overall Study|Sponsor Decision|0
2594734|NCT01106352|8974443|P4|Overall Study|Sponsor Decision|0
2594735|NCT01106352|8974444|P3|Overall Study|Sponsor Decision|0
2594736|NCT01106352|8974445|P2|Overall Study|Sponsor Decision|0
2594737|NCT01106352|8974446|P1|Overall Study|Sponsor Decision|1
2594738|NCT01106352|8974442|P5|Overall Study|Subjects untreated|4
2594739|NCT01106352|8974443|P4|Overall Study|Subjects untreated|3
2594740|NCT01106352|8974444|P3|Overall Study|Subjects untreated|0
2594741|NCT01106352|8974445|P2|Overall Study|Subjects untreated|0
2594742|NCT01106352|8974446|P1|Overall Study|Subjects untreated|0
2594743|NCT01106287|8974542|P4|Overall Study|Adverse Event|0
2594744|NCT01106287|8974543|P3|Overall Study|Adverse Event|0
2594745|NCT01106287|8974544|P2|Overall Study|Adverse Event|0
2594746|NCT01106287|8974545|P1|Overall Study|Adverse Event|1
2594747|NCT01106248|8974565|P1|Overall Study|Administrative|2
2594748|NCT01106248|8974565|P1|Overall Study|Adverse Event|1
2594749|NCT01106157|8974573|P2|Overall Study|Withdrawal by Subject|0
2594750|NCT01106157|8974574|P1|Overall Study|Withdrawal by Subject|1
2594751|NCT01106092|8974602|P4|Overall Study|Withdrawal by Subject|1
2594752|NCT01106092|8974603|P3|Overall Study|Withdrawal by Subject|0
2594753|NCT01106092|8974604|P2|Overall Study|Withdrawal by Subject|0
2594754|NCT01106092|8974605|P1|Overall Study|Withdrawal by Subject|0
2594755|NCT01106027|8974688|P1|Overall Study|Lost graft early, discontinued|1
2594756|NCT01106014|8974694|P2|Overall Study|Lost to Follow-up|3
2594757|NCT01106014|8974695|P1|Overall Study|Lost to Follow-up|2
2594758|NCT01106014|8974694|P2|Overall Study|Administrative reason|6
2594759|NCT01106014|8974695|P1|Overall Study|Administrative reason|7
2594760|NCT01106014|8974694|P2|Overall Study|Withdrawal by Subject|37
2594761|NCT01106014|8974695|P1|Overall Study|Withdrawal by Subject|43
2594762|NCT01106014|8974694|P2|Overall Study|Adverse Event|42
2594763|NCT01106014|8974695|P1|Overall Study|Adverse Event|78
2594764|NCT01106014|8974694|P2|Overall Study|Morbidity or Mortality primary endpoint|242
2594765|NCT01106014|8974695|P1|Overall Study|Morbidity or Mortality primary endpoint|155
2594766|NCT01105975|8974715|P10|Overall Study|Abnormal Lab/Electrocardiogram Result|0
2594767|NCT01105975|8974716|P9|Overall Study|Abnormal Lab/Electrocardiogram Result|2
2594768|NCT01105975|8974717|P8|Overall Study|Abnormal Lab/Electrocardiogram Result|1
2594769|NCT01105975|8974718|P7|Overall Study|Abnormal Lab/Electrocardiogram Result|1
2594770|NCT01105975|8974719|P6|Overall Study|Abnormal Lab/Electrocardiogram Result|2
2594771|NCT01105975|8974720|P5|Overall Study|Abnormal Lab/Electrocardiogram Result|0
2594772|NCT01105975|8974721|P4|Overall Study|Abnormal Lab/Electrocardiogram Result|0
2594773|NCT01105975|8974722|P3|Overall Study|Abnormal Lab/Electrocardiogram Result|1
2594774|NCT01105975|8974723|P2|Overall Study|Abnormal Lab/Electrocardiogram Result|0
2594775|NCT01105975|8974724|P1|Overall Study|Abnormal Lab/Electrocardiogram Result|0
2594776|NCT01105975|8974715|P10|Overall Study|Protocol Violation|2
2594777|NCT01105975|8974716|P9|Overall Study|Protocol Violation|2
2594778|NCT01105975|8974717|P8|Overall Study|Protocol Violation|1
2594779|NCT01105975|8974718|P7|Overall Study|Protocol Violation|1
2594780|NCT01105975|8974719|P6|Overall Study|Protocol Violation|1
2594781|NCT01105975|8974720|P5|Overall Study|Protocol Violation|1
2594782|NCT01105975|8974721|P4|Overall Study|Protocol Violation|0
2594783|NCT01105975|8974722|P3|Overall Study|Protocol Violation|2
2594784|NCT01105975|8974723|P2|Overall Study|Protocol Violation|2
2594785|NCT01105975|8974724|P1|Overall Study|Protocol Violation|0
2594786|NCT01105975|8974715|P10|Overall Study|Physician Decision|0
2594787|NCT01105975|8974716|P9|Overall Study|Physician Decision|0
2594788|NCT01105975|8974717|P8|Overall Study|Physician Decision|0
2594789|NCT01105975|8974718|P7|Overall Study|Physician Decision|2
2594790|NCT01105975|8974719|P6|Overall Study|Physician Decision|0
2594791|NCT01105975|8974720|P5|Overall Study|Physician Decision|0
2594792|NCT01105975|8974721|P4|Overall Study|Physician Decision|0
2594793|NCT01105975|8974722|P3|Overall Study|Physician Decision|0
2594794|NCT01105975|8974723|P2|Overall Study|Physician Decision|0
2594795|NCT01105975|8974724|P1|Overall Study|Physician Decision|0
2594796|NCT01105975|8974715|P10|Overall Study|Lost to Follow-up|0
2594797|NCT01105975|8974716|P9|Overall Study|Lost to Follow-up|1
2594798|NCT01105975|8974717|P8|Overall Study|Lost to Follow-up|0
2594799|NCT01105975|8974718|P7|Overall Study|Lost to Follow-up|0
2594800|NCT01105975|8974719|P6|Overall Study|Lost to Follow-up|0
2594801|NCT01105975|8974720|P5|Overall Study|Lost to Follow-up|1
2594802|NCT01105975|8974721|P4|Overall Study|Lost to Follow-up|1
2594803|NCT01105975|8974722|P3|Overall Study|Lost to Follow-up|0
2594804|NCT01105975|8974723|P2|Overall Study|Lost to Follow-up|0
2594805|NCT01105975|8974724|P1|Overall Study|Lost to Follow-up|1
2594806|NCT01105975|8974715|P10|Overall Study|Withdrawal by Subject|3
2594807|NCT01105975|8974716|P9|Overall Study|Withdrawal by Subject|0
2594808|NCT01105975|8974717|P8|Overall Study|Withdrawal by Subject|1
2594809|NCT01105975|8974718|P7|Overall Study|Withdrawal by Subject|2
2594810|NCT01105975|8974719|P6|Overall Study|Withdrawal by Subject|1
2594811|NCT01105975|8974720|P5|Overall Study|Withdrawal by Subject|4
2594812|NCT01105975|8974721|P4|Overall Study|Withdrawal by Subject|0
2594813|NCT01105975|8974722|P3|Overall Study|Withdrawal by Subject|2
2594814|NCT01105975|8974723|P2|Overall Study|Withdrawal by Subject|2
2594815|NCT01105975|8974724|P1|Overall Study|Withdrawal by Subject|2
2594816|NCT01105975|8974715|P10|Overall Study|Adverse Event|4
2594817|NCT01105975|8974716|P9|Overall Study|Adverse Event|1
2594818|NCT01105975|8974717|P8|Overall Study|Adverse Event|4
2594819|NCT01105975|8974718|P7|Overall Study|Adverse Event|2
2594820|NCT01105975|8974719|P6|Overall Study|Adverse Event|1
2594821|NCT01105975|8974720|P5|Overall Study|Adverse Event|0
2594822|NCT01105975|8974721|P4|Overall Study|Adverse Event|1
2594823|NCT01105975|8974722|P3|Overall Study|Adverse Event|5
2594824|NCT01105975|8974723|P2|Overall Study|Adverse Event|1
2594825|NCT01105975|8974724|P1|Overall Study|Adverse Event|2
2594826|NCT01105936|8974872|P4|Period 3|Protocol Violation|0
2594827|NCT01105936|8974873|P3|Period 3|Protocol Violation|0
2594828|NCT01105936|8974874|P2|Period 3|Protocol Violation|2
2594829|NCT01105936|8974875|P1|Period 3|Protocol Violation|0
2594830|NCT01105936|8974872|P4|Period 2|Adverse Event|0
2594831|NCT01105936|8974873|P3|Period 2|Adverse Event|0
2594832|NCT01105936|8974874|P2|Period 2|Adverse Event|0
2594833|NCT01105936|8974875|P1|Period 2|Adverse Event|1
2594834|NCT01105936|8974872|P4|Period 1|Adverse Event|1
2594835|NCT01105936|8974873|P3|Period 1|Adverse Event|0
2594836|NCT01105936|8974874|P2|Period 1|Adverse Event|0
2594837|NCT01105936|8974875|P1|Period 1|Adverse Event|0
2594838|NCT01105767|8974904|P3|Overall Study|Lost to Follow-up|1184
2594839|NCT01105767|8974905|P2|Overall Study|Lost to Follow-up|1614
2594840|NCT01105767|8974906|P1|Overall Study|Lost to Follow-up|1160
2594841|NCT01105533|8974958|P9|Overall Study|Physician Decision|0
2594842|NCT01105533|8974959|P8|Overall Study|Physician Decision|1
2594843|NCT01105533|8974960|P7|Overall Study|Physician Decision|0
2594844|NCT01105533|8974961|P6|Overall Study|Physician Decision|0
2594845|NCT01105533|8974962|P5|Overall Study|Physician Decision|0
2594846|NCT01105533|8974963|P4|Overall Study|Physician Decision|0
2594847|NCT01105533|8974964|P3|Overall Study|Physician Decision|0
2594848|NCT01105533|8974965|P2|Overall Study|Physician Decision|0
2594849|NCT01105533|8974966|P1|Overall Study|Physician Decision|0
2594850|NCT01105533|8974958|P9|Overall Study|Other|2
2594851|NCT01105533|8974959|P8|Overall Study|Other|1
2594852|NCT01105533|8974960|P7|Overall Study|Other|3
2594853|NCT01105533|8974961|P6|Overall Study|Other|0
2594854|NCT01105533|8974962|P5|Overall Study|Other|1
2594855|NCT01105533|8974963|P4|Overall Study|Other|0
2594856|NCT01105533|8974964|P3|Overall Study|Other|0
2594857|NCT01105533|8974965|P2|Overall Study|Other|0
2594858|NCT01105533|8974966|P1|Overall Study|Other|0
2594859|NCT01105533|8974958|P9|Overall Study|Adverse Event|1
2594860|NCT01105533|8974959|P8|Overall Study|Adverse Event|0
2594861|NCT01105533|8974960|P7|Overall Study|Adverse Event|2
2594862|NCT01105533|8974961|P6|Overall Study|Adverse Event|2
2594863|NCT01105533|8974962|P5|Overall Study|Adverse Event|1
2594864|NCT01105533|8974963|P4|Overall Study|Adverse Event|0
2594865|NCT01105533|8974964|P3|Overall Study|Adverse Event|0
2594866|NCT01105533|8974965|P2|Overall Study|Adverse Event|0
2594867|NCT01105533|8974966|P1|Overall Study|Adverse Event|0
2594868|NCT01105533|8974958|P9|Overall Study|Lack of Efficacy|9
2594869|NCT01105533|8974959|P8|Overall Study|Lack of Efficacy|2
2594870|NCT01105533|8974960|P7|Overall Study|Lack of Efficacy|3
2594871|NCT01105533|8974961|P6|Overall Study|Lack of Efficacy|5
2594872|NCT01105533|8974962|P5|Overall Study|Lack of Efficacy|4
2594873|NCT01105533|8974963|P4|Overall Study|Lack of Efficacy|3
2594874|NCT01105533|8974964|P3|Overall Study|Lack of Efficacy|3
2594875|NCT01105533|8974965|P2|Overall Study|Lack of Efficacy|1
2594876|NCT01105533|8974966|P1|Overall Study|Lack of Efficacy|1
2594877|NCT01105533|8974958|P9|Overall Study|Death|0
2594878|NCT01105533|8974959|P8|Overall Study|Death|0
2594879|NCT01105533|8974960|P7|Overall Study|Death|0
2594880|NCT01105533|8974961|P6|Overall Study|Death|0
2594881|NCT01105533|8974962|P5|Overall Study|Death|1
2594882|NCT01105533|8974963|P4|Overall Study|Death|0
2594883|NCT01105533|8974964|P3|Overall Study|Death|0
2594884|NCT01105533|8974965|P2|Overall Study|Death|0
2594885|NCT01105533|8974966|P1|Overall Study|Death|0
2594886|NCT01105377|8975056|P2|Overall Study|Withdrawal by Subject|1
2594887|NCT01105377|8975057|P1|Overall Study|Withdrawal by Subject|0
2594888|NCT01105130|8975105|P3|Overall Study|Multiple Reasons|2
2594889|NCT01105130|8975106|P2|Overall Study|Multiple Reasons|0
2594890|NCT01105130|8975107|P1|Overall Study|Multiple Reasons|3
2594891|NCT01105130|8975105|P3|Overall Study|Toxicity|2
2594892|NCT01105130|8975106|P2|Overall Study|Toxicity|3
2594893|NCT01105130|8975107|P1|Overall Study|Toxicity|1
2594894|NCT01105130|8975105|P3|Overall Study|Never Started|4
2594895|NCT01105130|8975106|P2|Overall Study|Never Started|2
2594896|NCT01105130|8975107|P1|Overall Study|Never Started|2
2594897|NCT01105130|8975105|P3|Overall Study|Withdrawal by Subject|2
2594898|NCT01105130|8975106|P2|Overall Study|Withdrawal by Subject|6
2594899|NCT01105130|8975107|P1|Overall Study|Withdrawal by Subject|4
2594900|NCT01105091|8975137|P2|Overall Study|Death|0
2594901|NCT01105091|8975138|P1|Overall Study|Death|2
2594902|NCT01105065|8975162|P1|Overall Study|Technical Problems|1
2594903|NCT01105065|8975162|P1|Overall Study|Adverse Event|5
2594904|NCT01104870|8975171|P3|Overall Study|Withdrawal by Subject|1
2594905|NCT01104870|8975172|P2|Overall Study|Withdrawal by Subject|0
2594906|NCT01104870|8975173|P1|Overall Study|Withdrawal by Subject|0
2594907|NCT01104870|8975171|P3|Overall Study|Death|1
2594908|NCT01104870|8975172|P2|Overall Study|Death|0
2594909|NCT01104870|8975173|P1|Overall Study|Death|0
2594910|NCT01104870|8975171|P3|Overall Study|Adverse Event|0
2594911|NCT01104870|8975172|P2|Overall Study|Adverse Event|1
2594912|NCT01104870|8975173|P1|Overall Study|Adverse Event|1
2594913|NCT01104792|8975202|P1|Overall Study|Did Not Meet Eligibility Criteria|133
2594914|NCT01104792|8975202|P1|Overall Study|Reasons Not Specified|27
2594915|NCT01104792|8975202|P1|Overall Study|Lost to Follow-up|43
2594916|NCT01104792|8975202|P1|Overall Study|Withdrawal of Consent|179
2594917|NCT01104792|8975202|P1|Overall Study|Protocol Violation|45
2594918|NCT01104792|8975202|P1|Overall Study|Insufficient Therapeutic Response|22
2594919|NCT01104792|8975202|P1|Overall Study|Adverse Event|77
2594920|NCT01104779|8975210|P3|Overall Study|Withdrawal by Subject|32
2594921|NCT01104779|8975211|P2|Overall Study|Withdrawal by Subject|25
2594922|NCT01104779|8975212|P1|Overall Study|Withdrawal by Subject|16
2594923|NCT01104779|8975210|P3|Overall Study|Lost to Follow-up|1
2594924|NCT01104779|8975211|P2|Overall Study|Lost to Follow-up|0
2594925|NCT01104779|8975212|P1|Overall Study|Lost to Follow-up|2
2594926|NCT01104779|8975210|P3|Overall Study|Other reasons|0
2594927|NCT01104779|8975211|P2|Overall Study|Other reasons|1
2594928|NCT01104779|8975212|P1|Overall Study|Other reasons|0
2594929|NCT01104779|8975210|P3|Overall Study|Did not meet inc/exc criteria|1
2594930|NCT01104779|8975211|P2|Overall Study|Did not meet inc/exc criteria|1
2594931|NCT01104779|8975212|P1|Overall Study|Did not meet inc/exc criteria|1
2594932|NCT01104779|8975210|P3|Overall Study|Adverse Event|13
2594933|NCT01104779|8975211|P2|Overall Study|Adverse Event|14
2594934|NCT01104779|8975212|P1|Overall Study|Adverse Event|13
2594935|NCT01104779|8975210|P3|Overall Study|Lack of Efficacy|13
2594936|NCT01104779|8975211|P2|Overall Study|Lack of Efficacy|12
2594937|NCT01104779|8975212|P1|Overall Study|Lack of Efficacy|26
2594938|NCT01104779|8975210|P3|Overall Study|Protocol Violation|2
2594939|NCT01104779|8975211|P2|Overall Study|Protocol Violation|2
2594940|NCT01104779|8975212|P1|Overall Study|Protocol Violation|1
2594941|NCT01104766|8975227|P4|Overall Study|Lost to Follow-up|1
2594942|NCT01104766|8975228|P3|Overall Study|Lost to Follow-up|1
2594943|NCT01104766|8975229|P2|Overall Study|Lost to Follow-up|2
2594944|NCT01104766|8975230|P1|Overall Study|Lost to Follow-up|1
2594945|NCT01104766|8975227|P4|Overall Study|Withdrawal by Subject|15
2594946|NCT01104766|8975228|P3|Overall Study|Withdrawal by Subject|25
2594947|NCT01104766|8975229|P2|Overall Study|Withdrawal by Subject|19
2594948|NCT01104766|8975230|P1|Overall Study|Withdrawal by Subject|17
2594949|NCT01104766|8975227|P4|Overall Study|Protocol Violation|0
2594950|NCT01104766|8975228|P3|Overall Study|Protocol Violation|0
2594951|NCT01104766|8975229|P2|Overall Study|Protocol Violation|0
2594952|NCT01104766|8975230|P1|Overall Study|Protocol Violation|2
2594953|NCT01104766|8975227|P4|Overall Study|Lack of Efficacy|8
2594954|NCT01104766|8975228|P3|Overall Study|Lack of Efficacy|14
2594955|NCT01104766|8975229|P2|Overall Study|Lack of Efficacy|15
2594956|NCT01104766|8975230|P1|Overall Study|Lack of Efficacy|20
2594957|NCT01104766|8975227|P4|Overall Study|Adverse Event|14
2594958|NCT01104766|8975228|P3|Overall Study|Adverse Event|20
2594959|NCT01104766|8975229|P2|Overall Study|Adverse Event|15
2594960|NCT01104766|8975230|P1|Overall Study|Adverse Event|17
2594961|NCT01104766|8975227|P4|Overall Study|Did not meet inc/exc criteria|0
2594962|NCT01104766|8975228|P3|Overall Study|Did not meet inc/exc criteria|0
2594963|NCT01104766|8975229|P2|Overall Study|Did not meet inc/exc criteria|0
2594964|NCT01104766|8975230|P1|Overall Study|Did not meet inc/exc criteria|1
2594965|NCT01104701|8975248|P4|Overall Study|Physician Decision|0
2594966|NCT01104701|8975249|P3|Overall Study|Physician Decision|0
2594967|NCT01104701|8975250|P2|Overall Study|Physician Decision|2
2594968|NCT01104701|8975251|P1|Overall Study|Physician Decision|0
2594969|NCT01104701|8975248|P4|Overall Study|Adverse Event|1
2594970|NCT01104701|8975249|P3|Overall Study|Adverse Event|0
2594971|NCT01104701|8975250|P2|Overall Study|Adverse Event|0
2594972|NCT01104701|8975251|P1|Overall Study|Adverse Event|0
2594973|NCT01104701|8975248|P4|Overall Study|Withdrawal by Subject|1
2594974|NCT01104701|8975249|P3|Overall Study|Withdrawal by Subject|2
2594975|NCT01104701|8975250|P2|Overall Study|Withdrawal by Subject|1
2594976|NCT01104701|8975251|P1|Overall Study|Withdrawal by Subject|0
2594977|NCT01104662|8975313|P8|Overall Study|Randomized but not treated|0
2594978|NCT01104662|8975314|P7|Overall Study|Randomized but not treated|0
2594979|NCT01104662|8975315|P6|Overall Study|Randomized but not treated|1
2594980|NCT01104662|8975316|P5|Overall Study|Randomized but not treated|0
2594981|NCT01104662|8975317|P4|Overall Study|Randomized but not treated|0
2594982|NCT01104662|8975318|P3|Overall Study|Randomized but not treated|1
2594983|NCT01104662|8975319|P2|Overall Study|Randomized but not treated|4
2594984|NCT01104662|8975320|P1|Overall Study|Randomized but not treated|3
2594985|NCT01104662|8975313|P8|Overall Study|Reason not specified|0
2594986|NCT01104662|8975314|P7|Overall Study|Reason not specified|0
2594987|NCT01104662|8975315|P6|Overall Study|Reason not specified|1
2594988|NCT01104662|8975316|P5|Overall Study|Reason not specified|0
2594989|NCT01104662|8975317|P4|Overall Study|Reason not specified|0
2594990|NCT01104662|8975318|P3|Overall Study|Reason not specified|0
2594991|NCT01104662|8975319|P2|Overall Study|Reason not specified|3
2594992|NCT01104662|8975320|P1|Overall Study|Reason not specified|3
2594993|NCT01104662|8975313|P8|Overall Study|Participant left investigator’s care|0
2594994|NCT01104662|8975314|P7|Overall Study|Participant left investigator’s care|0
2594995|NCT01104662|8975315|P6|Overall Study|Participant left investigator’s care|0
2594996|NCT01104662|8975316|P5|Overall Study|Participant left investigator’s care|0
2594997|NCT01104662|8975317|P4|Overall Study|Participant left investigator’s care|0
2594998|NCT01104662|8975318|P3|Overall Study|Participant left investigator’s care|0
2594999|NCT01104662|8975319|P2|Overall Study|Participant left investigator’s care|1
2595000|NCT01104662|8975320|P1|Overall Study|Participant left investigator’s care|1
2595001|NCT01104662|8975313|P8|Overall Study|Clinical Failure|0
2595002|NCT01104662|8975314|P7|Overall Study|Clinical Failure|0
2595003|NCT01104662|8975315|P6|Overall Study|Clinical Failure|1
2595004|NCT01104662|8975316|P5|Overall Study|Clinical Failure|0
2595005|NCT01104662|8975317|P4|Overall Study|Clinical Failure|0
2595006|NCT01104662|8975318|P3|Overall Study|Clinical Failure|0
2595007|NCT01104662|8975319|P2|Overall Study|Clinical Failure|0
2595008|NCT01104662|8975320|P1|Overall Study|Clinical Failure|1
2595009|NCT01104662|8975313|P8|Overall Study|Adverse Event|0
2595010|NCT01104662|8975314|P7|Overall Study|Adverse Event|0
2595011|NCT01104662|8975315|P6|Overall Study|Adverse Event|1
2595012|NCT01104662|8975316|P5|Overall Study|Adverse Event|1
2595013|NCT01104662|8975317|P4|Overall Study|Adverse Event|1
2595014|NCT01104662|8975318|P3|Overall Study|Adverse Event|0
2595015|NCT01104662|8975319|P2|Overall Study|Adverse Event|2
2595016|NCT01104662|8975320|P1|Overall Study|Adverse Event|2
2595017|NCT01104636|8975346|P1|Overall Study|Ongoing|21
2595018|NCT01104636|8975346|P1|Overall Study|Adverse Event|40
2595019|NCT01104636|8975346|P1|Overall Study|Pregnancy|2
2595020|NCT01104636|8975346|P1|Overall Study|Study terminated by sponsor|1
2595021|NCT01104636|8975346|P1|Overall Study|Other|43
2595022|NCT01104636|8975346|P1|Overall Study|Withdrawal by Subject|4
2595023|NCT01104636|8975346|P1|Overall Study|Lost to Follow-up|24
2595024|NCT01104636|8975346|P1|Overall Study|Lack of Efficacy|43
2595025|NCT01104584|8975351|P1|Overall Study|Study prematurely discontinued|2
2595026|NCT01104584|8975351|P1|Overall Study|Study drug never administered|21
2595027|NCT01104558|8975421|P1|Overall Study|Missing of genetic analysis results|1
2595028|NCT01104558|8975421|P1|Overall Study|Missing of primary efficacy assessment|10
2595029|NCT01104558|8975421|P1|Overall Study|Protocol Violation|6
2595030|NCT01104545|8975465|P3|Overall Study|Adverse Event|2
2595031|NCT01104545|8975466|P2|Overall Study|Adverse Event|1
2595032|NCT01104545|8975467|P1|Overall Study|Adverse Event|0
2595033|NCT01104493|8975624|P2|Overall Study|Lost to Follow-up|2
2595034|NCT01104493|8975625|P1|Overall Study|Lost to Follow-up|0
2595035|NCT01104415|8975643|P2|Extension Period|Heart surgery/feeling miserable|1
2595036|NCT01104415|8975644|P1|Extension Period|Heart surgery/feeling miserable|0
2595037|NCT01104415|8975643|P2|Extension Period|Transition to Study LX1606.302|4
2595038|NCT01104415|8975644|P1|Extension Period|Transition to Study LX1606.302|0
2595039|NCT01104415|8975643|P2|Extension Period|Physician Decision|1
2595040|NCT01104415|8975644|P1|Extension Period|Physician Decision|0
2595041|NCT01104415|8975643|P2|Extension Period|Death|1
2595042|NCT01104415|8975644|P1|Extension Period|Death|0
2595043|NCT01104415|8975643|P2|Extension Period|Progressive disease|4
2595044|NCT01104415|8975644|P1|Extension Period|Progressive disease|0
2595045|NCT01104415|8975643|P2|Core Phase|Consent withdrawn by subjects|0
2595046|NCT01104415|8975644|P1|Core Phase|Consent withdrawn by subjects|1
2595047|NCT01104376|8975688|P1|Overall Study|Consented but excluded after labs|13
2595048|NCT01104376|8975688|P1|Overall Study|Withdrawal by Subject|15
2595049|NCT01104311|8975694|P2|Overall Study|Adverse Event|2
2595050|NCT01104311|8975695|P1|Overall Study|Adverse Event|1
2595051|NCT01104311|8975694|P2|Overall Study|low compliance|1
2595052|NCT01104311|8975695|P1|Overall Study|low compliance|1
2595053|NCT01104311|8975694|P2|Overall Study|Physician Decision|2
2595054|NCT01104311|8975695|P1|Overall Study|Physician Decision|2
2595055|NCT01104311|8975694|P2|Overall Study|Protocol Violation|1
2595056|NCT01104311|8975695|P1|Overall Study|Protocol Violation|0
2595057|NCT01104311|8975694|P2|Overall Study|Withdrawal by Subject|6
2595058|NCT01104311|8975695|P1|Overall Study|Withdrawal by Subject|6
2595059|NCT01104246|8975722|P1|Overall Study|did not meet inclusion criteria|4
2595060|NCT01104246|8975722|P1|Overall Study|Withdrawal by Subject|1
2595061|NCT01104155|8975737|P2|Overall Study|Other|4
2595062|NCT01104155|8975738|P1|Overall Study|Other|3
2595063|NCT01104155|8975737|P2|Overall Study|Withdrawal of consent|1
2595064|NCT01104155|8975738|P1|Overall Study|Withdrawal of consent|1
2595065|NCT01104155|8975737|P2|Overall Study|Participant choice|5
2595066|NCT01104155|8975738|P1|Overall Study|Participant choice|6
2595067|NCT01104155|8975737|P2|Overall Study|Adverse Event|8
2595068|NCT01104155|8975738|P1|Overall Study|Adverse Event|15
2595069|NCT01103960|8975781|P2|Overall Study|Other|0
2595070|NCT01103960|8975782|P1|Overall Study|Other|1
2595071|NCT01103960|8975781|P2|Overall Study|Withdrawal by Subject|1
2595072|NCT01103960|8975782|P1|Overall Study|Withdrawal by Subject|2
2595073|NCT01103960|8975781|P2|Overall Study|Adverse Event|1
2595074|NCT01103960|8975782|P1|Overall Study|Adverse Event|2
2595075|NCT01103778|8975817|P1|Overall Study|Screen failure|1
2595076|NCT01103778|8975817|P1|Overall Study|Proteinuria improved prior to enrollment|1
2595077|NCT01103778|8975817|P1|Overall Study|Lost to Follow-up|1
2595078|NCT01103713|8975824|P1|Overall Study|Other|1
2595079|NCT01103713|8975824|P1|Overall Study|Study terminated by sponsor|2
2595080|NCT01103713|8975824|P1|Overall Study|Withdrawal by Subject|8
2595081|NCT01103713|8975824|P1|Overall Study|Lost to Follow-up|2
2595082|NCT01103479|8975874|P3|Overall Study|Saw non-study physician|0
2595083|NCT01103479|8975875|P2|Overall Study|Saw non-study physician|0
2595084|NCT01103479|8975876|P1|Overall Study|Saw non-study physician|2
2595085|NCT01103479|8975874|P3|Overall Study|Active cancer|0
2595086|NCT01103479|8975875|P2|Overall Study|Active cancer|0
2595087|NCT01103479|8975876|P1|Overall Study|Active cancer|1
2595088|NCT01103479|8975874|P3|Overall Study|Family history of CRC|2
2595089|NCT01103479|8975875|P2|Overall Study|Family history of CRC|0
2595090|NCT01103479|8975876|P1|Overall Study|Family history of CRC|1
2595091|NCT01103479|8975874|P3|Overall Study|Up to date with CRC screening|12
2595092|NCT01103479|8975875|P2|Overall Study|Up to date with CRC screening|9
2595093|NCT01103479|8975876|P1|Overall Study|Up to date with CRC screening|1
2595094|NCT01103466|8975889|P3|Third Period (14 +/- 3 Days)|not satisfied with product|1
2595095|NCT01103466|8975890|P2|Third Period (14 +/- 3 Days)|not satisfied with product|0
2595096|NCT01103466|8975891|P1|Third Period (14 +/- 3 Days)|not satisfied with product|0
2595097|NCT01103466|8975889|P3|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
2595098|NCT01103466|8975890|P2|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
2595099|NCT01103466|8975891|P1|Third Period (14 +/- 3 Days)|Lack of Efficacy|1
2595100|NCT01103466|8975889|P3|Third Period (14 +/- 3 Days)|Adverse Event|0
2595101|NCT01103466|8975890|P2|Third Period (14 +/- 3 Days)|Adverse Event|0
2595102|NCT01103466|8975891|P1|Third Period (14 +/- 3 Days)|Adverse Event|1
2595103|NCT01103466|8975889|P3|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
2595104|NCT01103466|8975890|P2|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
2595105|NCT01103466|8975891|P1|Second Period (14 +/- 3 Days)|Lack of Efficacy|0
2595106|NCT01103466|8975889|P3|Second Period (14 +/- 3 Days)|Adverse Event|0
2595107|NCT01103466|8975890|P2|Second Period (14 +/- 3 Days)|Adverse Event|1
2595108|NCT01103466|8975891|P1|Second Period (14 +/- 3 Days)|Adverse Event|2
2595109|NCT01103466|8975889|P3|First Period (14 +/- 3 Days)|Protocol Violation|0
2595110|NCT01103466|8975890|P2|First Period (14 +/- 3 Days)|Protocol Violation|0
2595111|NCT01103466|8975891|P1|First Period (14 +/- 3 Days)|Protocol Violation|2
2595112|NCT01103362|8975981|P1|Overall Study|study terminated|596
2595113|NCT01103323|8975987|P2|Switched From Placebo to Regorafenib|Adverse Event|1
2595114|NCT01103323|8975988|P1|Switched From Placebo to Regorafenib|Adverse Event|0
2595115|NCT01103323|8975987|P2|Without/Before Drug Switch|Switch to Regorafenib|4
2595116|NCT01103323|8975988|P1|Without/Before Drug Switch|Switch to Regorafenib|0
2595117|NCT01103323|8975987|P2|Without/Before Drug Switch|did not receive study treatment|2
2595118|NCT01103323|8975988|P1|Without/Before Drug Switch|did not receive study treatment|5
2595119|NCT01103323|8975987|P2|Without/Before Drug Switch|Physician Decision|0
2595120|NCT01103323|8975988|P1|Without/Before Drug Switch|Physician Decision|2
2595121|NCT01103323|8975987|P2|Without/Before Drug Switch|Protocol Violation|0
2595122|NCT01103323|8975988|P1|Without/Before Drug Switch|Protocol Violation|2
2595123|NCT01103323|8975987|P2|Without/Before Drug Switch|Withdrawal by Subject|5
2595124|NCT01103323|8975988|P1|Without/Before Drug Switch|Withdrawal by Subject|17
2595125|NCT01103323|8975987|P2|Without/Before Drug Switch|Adverse Event|7
2595126|NCT01103323|8975988|P1|Without/Before Drug Switch|Adverse Event|50
2595127|NCT01103284|8976005|P2|Overall Study|Missing CRF entries for study completion|2
2595128|NCT01103284|8976006|P1|Overall Study|Missing CRF entries for study completion|0
2595129|NCT01103284|8976005|P2|Overall Study|Not described|1
2595130|NCT01103284|8976006|P1|Overall Study|Not described|2
2595131|NCT01103284|8976005|P2|Overall Study|Termination by the Sponsor|1
2595132|NCT01103284|8976006|P1|Overall Study|Termination by the Sponsor|0
2595133|NCT01103284|8976005|P2|Overall Study|Dermal Hypersensitivity|1
2595134|NCT01103284|8976006|P1|Overall Study|Dermal Hypersensitivity|0
2595135|NCT01103284|8976005|P2|Overall Study|Withdrawal by Subject|18
2595136|NCT01103284|8976006|P1|Overall Study|Withdrawal by Subject|14
2595137|NCT01103284|8976005|P2|Overall Study|Adverse Event|5
2595138|NCT01103284|8976006|P1|Overall Study|Adverse Event|0
2595139|NCT01103284|8976005|P2|Overall Study|Protocol Violation|5
2595140|NCT01103284|8976006|P1|Overall Study|Protocol Violation|12
2595141|NCT01103284|8976005|P2|Overall Study|Pregnancy|1
2595142|NCT01103284|8976006|P1|Overall Study|Pregnancy|3
2595143|NCT01103284|8976005|P2|Overall Study|Lost to Follow-up|10
2595144|NCT01103284|8976006|P1|Overall Study|Lost to Follow-up|9
2595145|NCT01103284|8976005|P2|Overall Study|Death|0
2595146|NCT01103284|8976006|P1|Overall Study|Death|2
2595147|NCT01103245|8976034|P4|Overall Study|Physician Decision|0
2595148|NCT01103245|8976035|P3|Overall Study|Physician Decision|0
2595149|NCT01103245|8976036|P2|Overall Study|Physician Decision|0
2595150|NCT01103245|8976037|P1|Overall Study|Physician Decision|1
2595151|NCT01103245|8976034|P4|Overall Study|Adverse Event|0
2595152|NCT01103245|8976035|P3|Overall Study|Adverse Event|1
2595153|NCT01103245|8976036|P2|Overall Study|Adverse Event|2
2595154|NCT01103245|8976037|P1|Overall Study|Adverse Event|0
2595155|NCT01103245|8976034|P4|Overall Study|Inadequate IV access|0
2595156|NCT01103245|8976035|P3|Overall Study|Inadequate IV access|0
2595157|NCT01103245|8976036|P2|Overall Study|Inadequate IV access|0
2595158|NCT01103245|8976037|P1|Overall Study|Inadequate IV access|1
2595159|NCT01103245|8976034|P4|Overall Study|Withdrawal by Subject|0
2595160|NCT01103245|8976035|P3|Overall Study|Withdrawal by Subject|3
2595161|NCT01103245|8976036|P2|Overall Study|Withdrawal by Subject|0
2595162|NCT01103245|8976037|P1|Overall Study|Withdrawal by Subject|1
2595163|NCT01103232|8976053|P2|Overall Study|Protocol Violation|1
2595164|NCT01103232|8976054|P1|Overall Study|Protocol Violation|0
2595165|NCT01103232|8976053|P2|Overall Study|Withdrawal by Subject|1
2595166|NCT01103232|8976054|P1|Overall Study|Withdrawal by Subject|1
2595167|NCT01103180|8976062|P2|Overall Study|Protocol Violation|1
2595168|NCT01103180|8976063|P1|Overall Study|Protocol Violation|0
2595169|NCT01103180|8976062|P2|Overall Study|Physician Decision|0
2595170|NCT01103180|8976063|P1|Overall Study|Physician Decision|1
2595171|NCT01103180|8976062|P2|Overall Study|Lost to Follow-up|7
2595172|NCT01103180|8976063|P1|Overall Study|Lost to Follow-up|13
2595173|NCT01103180|8976062|P2|Overall Study|Withdrawal by Subject|13
2595174|NCT01103180|8976063|P1|Overall Study|Withdrawal by Subject|8
2595175|NCT01103141|8976073|P2|Overall Study|Lost to Follow-up|1
2595176|NCT01103141|8976074|P1|Overall Study|Lost to Follow-up|2
2595177|NCT01103141|8976073|P2|Overall Study|Death|1
2595178|NCT01103141|8976074|P1|Overall Study|Death|0
2595179|NCT01103063|8976082|P2|Overall Study|Death|1
2595180|NCT01103063|8976083|P1|Overall Study|Death|3
2595181|NCT01103063|8976082|P2|Overall Study|Study terminated by Sponsor|342
2595182|NCT01103063|8976083|P1|Overall Study|Study terminated by Sponsor|326
2595183|NCT01103063|8976082|P2|Overall Study|Protocol Violation|0
2595184|NCT01103063|8976083|P1|Overall Study|Protocol Violation|1
2595185|NCT01103063|8976082|P2|Overall Study|Other|11
2595186|NCT01103063|8976083|P1|Overall Study|Other|16
2595187|NCT01103063|8976082|P2|Overall Study|Withdrawal by Subject|15
2595188|NCT01103063|8976083|P1|Overall Study|Withdrawal by Subject|60
2595189|NCT01103063|8976082|P2|Overall Study|Lost to Follow-up|51
2595190|NCT01103063|8976083|P1|Overall Study|Lost to Follow-up|68
2595191|NCT01103063|8976082|P2|Overall Study|Adverse Event|1
2595192|NCT01103063|8976083|P1|Overall Study|Adverse Event|3
2595193|NCT01102972|8976151|P2|Overall Study|Withdrawal by Subject|6
2595194|NCT01102972|8976152|P1|Overall Study|Withdrawal by Subject|6
2595195|NCT01102972|8976151|P2|Overall Study|Investigator Discretion|0
2595196|NCT01102972|8976152|P1|Overall Study|Investigator Discretion|2
2595197|NCT01102972|8976151|P2|Overall Study|Lost to Follow-up|5
2595198|NCT01102972|8976152|P1|Overall Study|Lost to Follow-up|10
2595199|NCT01102972|8976151|P2|Overall Study|Protocol Violation|0
2595200|NCT01102972|8976152|P1|Overall Study|Protocol Violation|1
2595201|NCT01102972|8976151|P2|Overall Study|Lack of Efficacy|1
2595202|NCT01102972|8976152|P1|Overall Study|Lack of Efficacy|2
2595203|NCT01102972|8976151|P2|Overall Study|Adverse Event|2
2595204|NCT01102972|8976152|P1|Overall Study|Adverse Event|8
2595205|NCT01102803|8976216|P2|Post to Follow-Up|Lost to Follow-up|3
2595206|NCT01102803|8976217|P1|Post to Follow-Up|Lost to Follow-up|1
2595207|NCT01102803|8976216|P2|Baseline to Post-Treatment|Lost to Follow-up|0
2595208|NCT01102803|8976217|P1|Baseline to Post-Treatment|Lost to Follow-up|3
2595209|NCT01102777|8976231|P2|Overall Study|Lost to Follow-up|10
2595210|NCT01102777|8976232|P1|Overall Study|Lost to Follow-up|7
2595211|NCT01102777|8976231|P2|Overall Study|Death|6
2595212|NCT01102777|8976232|P1|Overall Study|Death|2
2595213|NCT01102491|8976287|P2|Overall Study|Protocol Violation|12
2595214|NCT01102491|8976288|P1|Overall Study|Protocol Violation|11
2595215|NCT01102374|8976307|P2|Overall Study|Lost to Follow-up|6
2595216|NCT01102374|8976308|P1|Overall Study|Lost to Follow-up|7
2595217|NCT01102374|8976307|P2|Overall Study|Death|13
2595218|NCT01102374|8976308|P1|Overall Study|Death|9
2595219|NCT01102257|8976357|P2|Overall Study|Adverse Event|0
2595220|NCT01102257|8976358|P1|Overall Study|Adverse Event|1
2595221|NCT01102257|8976357|P2|Overall Study|Adverse Event|0
2595222|NCT01102257|8976358|P1|Overall Study|Adverse Event|1
2595223|NCT01102140|8976375|P2|Overall Study|Investigator terminated study|2
2595224|NCT01102140|8976376|P1|Overall Study|Investigator terminated study|2
2595225|NCT01102140|8976375|P2|Overall Study|Lost to Follow-up|0
2595226|NCT01102140|8976376|P1|Overall Study|Lost to Follow-up|1
2595227|NCT01101841|8976431|P2|Overall Study|Eligibility Criteria|2
2595228|NCT01101841|8976432|P1|Overall Study|Eligibility Criteria|1
2595229|NCT01101841|8976431|P2|Overall Study|Suicidality Tracking Scale|1
2595230|NCT01101841|8976432|P1|Overall Study|Suicidality Tracking Scale|3
2595231|NCT01101841|8976431|P2|Overall Study|Other|1
2595232|NCT01101841|8976432|P1|Overall Study|Other|0
2595233|NCT01101841|8976431|P2|Overall Study|Lack of Efficacy|2
2595234|NCT01101841|8976432|P1|Overall Study|Lack of Efficacy|0
2595235|NCT01101841|8976431|P2|Overall Study|Physician Decision|2
2595236|NCT01101841|8976432|P1|Overall Study|Physician Decision|0
2595237|NCT01101841|8976431|P2|Overall Study|Protocol Violation|1
2595238|NCT01101841|8976432|P1|Overall Study|Protocol Violation|1
2595239|NCT01101841|8976431|P2|Overall Study|Withdrawal by Subject|40
2595240|NCT01101841|8976432|P1|Overall Study|Withdrawal by Subject|21
2595241|NCT01101841|8976431|P2|Overall Study|Lost to Follow-up|3
2595242|NCT01101841|8976432|P1|Overall Study|Lost to Follow-up|9
2595243|NCT01101841|8976431|P2|Overall Study|Adverse Event|15
2595244|NCT01101841|8976432|P1|Overall Study|Adverse Event|15
2595245|NCT01101542|8976470|P1|Year 6 Surveillance Period|Withdrawal by Subject|4
2595246|NCT01101542|8976470|P1|Year 6 Surveillance Period|Pregnancy|1
2595247|NCT01101542|8976470|P1|Year 6 Surveillance Period|Lost to Follow-up|986
2595248|NCT01101542|8976470|P1|Year 5 Surveillance Period|Pregnancy|1
2595249|NCT01101542|8976470|P1|Year 5 Surveillance Period|Lost to Follow-up|140
2595250|NCT01101542|8976470|P1|Year 4 Surveillance Period|Other|287
2595251|NCT01101542|8976470|P1|Year 3 Surveillance Period|Withdrawal by Subject|4
2595252|NCT01101542|8976470|P1|Year 3 Surveillance Period|Lost to Follow-up|7
2595253|NCT01101477|8976486|P3|Overall Study|Protocol Violation|1
2595254|NCT01101477|8976487|P2|Overall Study|Protocol Violation|3
2595255|NCT01101477|8976488|P1|Overall Study|Protocol Violation|5
2595256|NCT01101321|8976509|P2|Period 1|Adverse Event|3
2595257|NCT01101321|8976510|P1|Period 1|Adverse Event|3
2595258|NCT01101321|8976509|P2|Period 1|Withdrawal by Subject|1
2595259|NCT01101321|8976510|P1|Period 1|Withdrawal by Subject|1
2595260|NCT01101308|8976520|P2|Period 1|Positive for cotinine|0
2595261|NCT01101308|8976521|P1|Period 1|Positive for cotinine|1
2595262|NCT01101308|8976520|P2|Period 1|Adverse Event|1
2595263|NCT01101308|8976521|P1|Period 1|Adverse Event|2
2595264|NCT01101191|8976532|P2|Period 1|Adverse Event|2
2595265|NCT01101191|8976533|P1|Period 1|Adverse Event|1
2595266|NCT01101191|8976532|P2|Period 1|Withdrawal by Subject|0
2595267|NCT01101191|8976533|P1|Period 1|Withdrawal by Subject|1
2595268|NCT01101178|8976544|P2|Period 2|Withdrawal by Subject|1
2595269|NCT01101178|8976545|P1|Period 2|Withdrawal by Subject|0
2595270|NCT01101178|8976544|P2|Period 1|Adverse Event|1
2595271|NCT01101178|8976545|P1|Period 1|Adverse Event|2
2595272|NCT01101178|8976544|P2|Period 1|Positive drug screen|1
2595273|NCT01101178|8976545|P1|Period 1|Positive drug screen|1
2595274|NCT01101178|8976544|P2|Period 1|Withdrawal by Subject|2
2595275|NCT01101178|8976545|P1|Period 1|Withdrawal by Subject|1
2595276|NCT01101165|8976556|P2|Period 2|Adverse Event|0
2595277|NCT01101165|8976557|P1|Period 2|Adverse Event|1
2595278|NCT01101165|8976556|P2|Period 2|Withdrawal by Subject|1
2595279|NCT01101165|8976557|P1|Period 2|Withdrawal by Subject|3
2595280|NCT01101165|8976556|P2|Period 1|Lost to Follow-up|0
2595281|NCT01101165|8976557|P1|Period 1|Lost to Follow-up|1
2595282|NCT01101165|8976556|P2|Period 1|Positive Drug Screen|1
2595283|NCT01101165|8976557|P1|Period 1|Positive Drug Screen|0
2595284|NCT01101165|8976556|P2|Period 1|Withdrawal by Subject|2
2595285|NCT01101165|8976557|P1|Period 1|Withdrawal by Subject|0
2595286|NCT01101165|8976556|P2|Period 1|Adverse Event|2
2595287|NCT01101165|8976557|P1|Period 1|Adverse Event|1
2595288|NCT01101061|8976578|P6|Overall Study|Adverse Event|0
2595289|NCT01101061|8976579|P5|Overall Study|Adverse Event|0
2595290|NCT01101061|8976580|P4|Overall Study|Adverse Event|0
2595291|NCT01101061|8976581|P3|Overall Study|Adverse Event|1
2595292|NCT01101061|8976582|P2|Overall Study|Adverse Event|0
2595293|NCT01101061|8976583|P1|Overall Study|Adverse Event|0
2595294|NCT01101035|8976663|P2|Overall Study|Reason not Specified|363
2595295|NCT01101035|8976664|P1|Overall Study|Reason not Specified|333
2595296|NCT01101035|8976663|P2|Overall Study|Voluntary Withdrawal|587
2595297|NCT01101035|8976664|P1|Overall Study|Voluntary Withdrawal|595
2595298|NCT01101035|8976663|P2|Overall Study|Lost to Follow-up|223
2595299|NCT01101035|8976664|P1|Overall Study|Lost to Follow-up|226
2595300|NCT01101035|8976663|P2|Overall Study|Major Protocol Deviation|46
2595301|NCT01101035|8976664|P1|Overall Study|Major Protocol Deviation|52
2595302|NCT01101035|8976663|P2|Overall Study|Adverse Event|172
2595303|NCT01101035|8976664|P1|Overall Study|Adverse Event|191
2595304|NCT01101022|8976684|P2|Overall Study|Vacation|1
2595305|NCT01101022|8976685|P1|Overall Study|Vacation|0
2595306|NCT01101022|8976684|P2|Overall Study|Work schedule|1
2595307|NCT01101022|8976685|P1|Overall Study|Work schedule|1
2595308|NCT01101022|8976684|P2|Overall Study|Non-compliance|0
2595309|NCT01101022|8976685|P1|Overall Study|Non-compliance|1
2595310|NCT01101022|8976684|P2|Overall Study|Sponsor decision|1
2595311|NCT01101022|8976685|P1|Overall Study|Sponsor decision|1
2595312|NCT01101022|8976684|P2|Overall Study|Lack of Efficacy|7
2595313|NCT01101022|8976685|P1|Overall Study|Lack of Efficacy|0
2595314|NCT01101022|8976684|P2|Overall Study|Lost to Follow-up|4
2595315|NCT01101022|8976685|P1|Overall Study|Lost to Follow-up|1
2595316|NCT01101022|8976684|P2|Overall Study|Withdrawal by Subject|8
2595317|NCT01101022|8976685|P1|Overall Study|Withdrawal by Subject|3
2595318|NCT01101022|8976684|P2|Overall Study|Protocol Violation|3
2595319|NCT01101022|8976685|P1|Overall Study|Protocol Violation|4
2595320|NCT01101022|8976684|P2|Overall Study|Adverse Event|2
2595321|NCT01101022|8976685|P1|Overall Study|Adverse Event|6
2595322|NCT01100944|8976719|P3|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
2595323|NCT01100944|8976720|P2|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2
2595324|NCT01100944|8976721|P1|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
2595325|NCT01100944|8976719|P3|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
2595326|NCT01100944|8976720|P2|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
2595327|NCT01100944|8976721|P1|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1
2595328|NCT01100944|8976719|P3|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
2595329|NCT01100944|8976720|P2|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
2595330|NCT01100944|8976721|P1|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1
2595331|NCT01100944|8976719|P3|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
2595332|NCT01100944|8976720|P2|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
2595333|NCT01100944|8976721|P1|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2
2595334|NCT01100853|8976779|P2|Overall Study|Withdrawal by Subject|4
2595335|NCT01100853|8976780|P1|Overall Study|Withdrawal by Subject|6
2595336|NCT01100853|8976779|P2|Overall Study|Received <4 study injections|13
2595337|NCT01100853|8976780|P1|Overall Study|Received <4 study injections|10
2595338|NCT01100853|8976779|P2|Overall Study|Lost to Follow-up|6
2595339|NCT01100853|8976780|P1|Overall Study|Lost to Follow-up|11
2595340|NCT01100658|8976826|P1|Overall Study|Withdrawal by Subject|1
2595341|NCT01100567|8976858|P2|Overall Study|Deemed ineligible after consent|1
2595342|NCT01100567|8976859|P1|Overall Study|Deemed ineligible after consent|0
2595343|NCT01100567|8976858|P2|Overall Study|Physician Decision|1
2595344|NCT01100567|8976859|P1|Overall Study|Physician Decision|0
2595345|NCT01100567|8976858|P2|Overall Study|Lost to Follow-up|2
2595346|NCT01100567|8976859|P1|Overall Study|Lost to Follow-up|1
2595347|NCT01100567|8976858|P2|Overall Study|Early Hospital Discharge|4
2595348|NCT01100567|8976859|P1|Overall Study|Early Hospital Discharge|6
2595349|NCT01100567|8976858|P2|Overall Study|Withdrawal by Subject|8
2595350|NCT01100567|8976859|P1|Overall Study|Withdrawal by Subject|5
2595351|NCT01100528|8976867|P1|Overall Study|Withdrawal by Subject|2
2595352|NCT01100528|8976867|P1|Overall Study|Death|1
2595353|NCT01100502|8976875|P2|Long-Term Follow-up|Continuing in long-term follow-up|129
2595354|NCT01100502|8976876|P1|Long-Term Follow-up|Continuing in long-term follow-up|122
2595355|NCT01100502|8976875|P2|Long-Term Follow-up|Lost to Follow-up|2
2595356|NCT01100502|8976876|P1|Long-Term Follow-up|Lost to Follow-up|5
2595357|NCT01100502|8976875|P2|Long-Term Follow-up|Withdrawal by Subject|8
2595358|NCT01100502|8976876|P1|Long-Term Follow-up|Withdrawal by Subject|10
2595359|NCT01100502|8976875|P2|Treatment Period|Progressive Disease|69
2595360|NCT01100502|8976876|P1|Treatment Period|Progressive Disease|24
2595361|NCT01100502|8976875|P2|Treatment Period|Withdrawal by Subject|4
2595362|NCT01100502|8976876|P1|Treatment Period|Withdrawal by Subject|9
2595363|NCT01100502|8976875|P2|Treatment Period|Adverse Event|10
2595364|NCT01100502|8976876|P1|Treatment Period|Adverse Event|54
2595365|NCT01100437|8976886|P3|Maintenance|Sponsor termination of study|1
2595366|NCT01100437|8976887|P2|Maintenance|Sponsor termination of study|0
2595367|NCT01100437|8976888|P1|Maintenance|Sponsor termination of study|0
2595368|NCT01100437|8976886|P3|Maintenance|Withdrawal by Subject|1
2595369|NCT01100437|8976887|P2|Maintenance|Withdrawal by Subject|0
2595370|NCT01100437|8976888|P1|Maintenance|Withdrawal by Subject|0
2595371|NCT01100437|8976886|P3|Titration/Stabilization|Sponsor canceled study|1
2595372|NCT01100437|8976887|P2|Titration/Stabilization|Sponsor canceled study|0
2595373|NCT01100437|8976888|P1|Titration/Stabilization|Sponsor canceled study|0
2595374|NCT01100437|8976886|P3|Titration/Stabilization|Non-compliance|1
2595375|NCT01100437|8976887|P2|Titration/Stabilization|Non-compliance|0
2595376|NCT01100437|8976888|P1|Titration/Stabilization|Non-compliance|0
2595377|NCT01100437|8976886|P3|Titration/Stabilization|Adverse Event|4
2595378|NCT01100437|8976887|P2|Titration/Stabilization|Adverse Event|0
2595379|NCT01100437|8976888|P1|Titration/Stabilization|Adverse Event|0
2595380|NCT01100320|8976925|P2|Period 2|Withdrawal by Subject|1
2595381|NCT01100320|8976926|P1|Period 2|Withdrawal by Subject|1
2595382|NCT01100320|8976925|P2|Period 1|Adverse Event|2
2595383|NCT01100320|8976926|P1|Period 1|Adverse Event|2
2595384|NCT01100320|8976925|P2|Period 1|Positive Drug Screen|1
2595385|NCT01100320|8976926|P1|Period 1|Positive Drug Screen|1
2595386|NCT01100320|8976925|P2|Period 1|Withdrawal by Subject|4
2595387|NCT01100320|8976926|P1|Period 1|Withdrawal by Subject|2
2595388|NCT01100307|8976938|P2|Open Phase (Week 24 up to Week 54)|Adverse Event|8
2595389|NCT01100307|8976939|P1|Open Phase (Week 24 up to Week 54)|Adverse Event|3
2595390|NCT01100307|8976938|P2|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3
2595391|NCT01100307|8976939|P1|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2
2595392|NCT01100307|8976938|P2|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2
2595393|NCT01100307|8976939|P1|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1
2595394|NCT01100307|8976938|P2|Double Masked Phase (Up to Week 24)|Adverse Event|2
2595395|NCT01100307|8976939|P1|Double Masked Phase (Up to Week 24)|Adverse Event|5
2595396|NCT01100307|8976938|P2|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1
2595397|NCT01100307|8976939|P1|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0
2595398|NCT01100307|8976938|P2|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
2595399|NCT01100307|8976939|P1|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
2595400|NCT01100086|8977008|P2|Period 1|Withdrawal by Subject|0
2595401|NCT01100086|8977009|P1|Period 1|Withdrawal by Subject|1
2595402|NCT01100073|8977019|P1|Overall Study|Missing|5
2595403|NCT01100073|8977019|P1|Overall Study|Other|8
2595404|NCT01100073|8977019|P1|Overall Study|Insufficient tolerability +patients wish|8
2595405|NCT01100073|8977019|P1|Overall Study|Lack of effect + patient's wish|2
2595406|NCT01100073|8977019|P1|Overall Study|Lost to Follow-up|39
2595407|NCT01100073|8977019|P1|Overall Study|Withdrawal by Subject|13
2595408|NCT01100073|8977019|P1|Overall Study|Insufficient Tolerability|21
2595409|NCT01100073|8977019|P1|Overall Study|Lack of Efficacy|4
2595410|NCT01100034|8977034|P1|Overall Study|Site closed due to non-responsiveness|1
2595411|NCT01100034|8977034|P1|Overall Study|Participants moved to another hospital|4
2595412|NCT01100034|8977034|P1|Overall Study|Participated in another clinical trial|1
2595413|NCT01100034|8977034|P1|Overall Study|Sponsor decision|21
2595414|NCT01100034|8977034|P1|Overall Study|Withdrawal by Subject|4
2595415|NCT01100034|8977034|P1|Overall Study|Withdrawal of parent/guardian consent|1
2595416|NCT01100034|8977034|P1|Overall Study|Lost to Follow-up|11
2595417|NCT01099917|8977072|P1|Overall Study|Not Treated|24
2595418|NCT01099917|8977072|P1|Overall Study|Adverse Event|3
2595419|NCT01099709|8977134|P2|Period 1|Adverse Event|0
2595420|NCT01099709|8977135|P1|Period 1|Adverse Event|1
2595421|NCT01099709|8977134|P2|Period 1|Positive cotinine test|1
2595422|NCT01099709|8977135|P1|Period 1|Positive cotinine test|0
2595423|NCT01099709|8977134|P2|Period 1|Withdrawal by Subject|1
2595424|NCT01099709|8977135|P1|Period 1|Withdrawal by Subject|0
2595425|NCT01099579|8977161|P3|Stage 2 (ATV Capsule)|Adverse Event|0
2595426|NCT01099579|8977162|P2|Stage 2 (ATV Capsule)|Adverse Event|1
2595427|NCT01099579|8977163|P1|Stage 2 (ATV Capsule)|Adverse Event|0
2595428|NCT01099579|8977161|P3|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1
2595429|NCT01099579|8977162|P2|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0
2595430|NCT01099579|8977163|P1|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2
2595431|NCT01099579|8977161|P3|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
2595432|NCT01099579|8977162|P2|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
2595433|NCT01099579|8977163|P1|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
2595434|NCT01099579|8977161|P3|Stage 2 (ATV Capsule)|Lack of Efficacy|2
2595435|NCT01099579|8977162|P2|Stage 2 (ATV Capsule)|Lack of Efficacy|0
2595436|NCT01099579|8977163|P1|Stage 2 (ATV Capsule)|Lack of Efficacy|0
2595437|NCT01099579|8977161|P3|Stage 2 (ATV Capsule)|Lost to Follow-up|1
2595438|NCT01099579|8977162|P2|Stage 2 (ATV Capsule)|Lost to Follow-up|1
2595439|NCT01099579|8977163|P1|Stage 2 (ATV Capsule)|Lost to Follow-up|1
2595440|NCT01099579|8977161|P3|Stage 2 (ATV Capsule)|No longer met study criteria|1
2595441|NCT01099579|8977162|P2|Stage 2 (ATV Capsule)|No longer met study criteria|2
2595442|NCT01099579|8977163|P1|Stage 2 (ATV Capsule)|No longer met study criteria|2
2595443|NCT01099579|8977161|P3|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
2595444|NCT01099579|8977162|P2|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2
2595445|NCT01099579|8977163|P1|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
2595446|NCT01099579|8977161|P3|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
2595447|NCT01099579|8977162|P2|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2
2595448|NCT01099579|8977163|P1|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
2595449|NCT01099579|8977161|P3|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1
2595450|NCT01099579|8977162|P2|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
2595451|NCT01099579|8977163|P1|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
2595452|NCT01099579|8977161|P3|Stage 1 (ATV Powder Formulation)|Adverse Event|0
2595453|NCT01099579|8977162|P2|Stage 1 (ATV Powder Formulation)|Adverse Event|1
2595454|NCT01099579|8977163|P1|Stage 1 (ATV Powder Formulation)|Adverse Event|4
2595455|NCT01099397|8977272|P1|Overall Study|Withdrawal by Subject|5
2595456|NCT01099397|8977272|P1|Overall Study|Protocol Violation|4
2595457|NCT01099397|8977272|P1|Overall Study|Lost to Follow-up|4
2595458|NCT01099267|8977299|P1|MDS-003 Study|Secondary Malign Disease|1
2595459|NCT01099267|8977299|P1|MDS-003 Study|Loss of Response|1
2595460|NCT01099267|8977299|P1|MDS-003 Study|Non-Compliance|2
2595461|NCT01099267|8977299|P1|MDS-003 Study|Investigator Decision|2
2595462|NCT01099267|8977299|P1|MDS-003 Study|Disease Progression|7
2595463|NCT01099267|8977299|P1|MDS-003 Study|Study Closed by Sponsor|2
2595464|NCT01099267|8977299|P1|MDS-003 Study|Death|11
2595465|NCT01099267|8977299|P1|MDS-003 Study|Lost to Follow-up|1
2595466|NCT01099267|8977299|P1|MDS-003 Study|Withdrawal by Subject|8
2595467|NCT01099267|8977299|P1|MDS-003 Study|Lack of Efficacy|52
2595468|NCT01099267|8977299|P1|MDS-003 Study|Adverse Event|37
2595469|NCT01099215|8977309|P2|Overall Study|Adverse Event|1
2595470|NCT01099215|8977310|P1|Overall Study|Adverse Event|0
2595471|NCT01099215|8977309|P2|Overall Study|Withdrawal by Subject|0
2595472|NCT01099215|8977310|P1|Overall Study|Withdrawal by Subject|1
2595473|NCT01098851|8977380|P2|Overall Study|Equipment failure|0
2595474|NCT01098851|8977381|P1|Overall Study|Equipment failure|1
2595475|NCT01098812|8977392|P3|Overall Study|Lost to Follow-up|0
2595476|NCT01098812|8977393|P2|Overall Study|Lost to Follow-up|1
2595477|NCT01098812|8977394|P1|Overall Study|Lost to Follow-up|0
2595478|NCT01098812|8977392|P3|Overall Study|Death|1
2595479|NCT01098812|8977393|P2|Overall Study|Death|0
2595480|NCT01098812|8977394|P1|Overall Study|Death|2
2595481|NCT01098539|8977470|P2|Overall Study|Physician Decision|3
2595482|NCT01098539|8977471|P1|Overall Study|Physician Decision|5
2595483|NCT01098539|8977470|P2|Overall Study|Withdrawal by Subject|26
2595484|NCT01098539|8977471|P1|Overall Study|Withdrawal by Subject|12
2595485|NCT01098539|8977470|P2|Overall Study|Lost to Follow-up|4
2595486|NCT01098539|8977471|P1|Overall Study|Lost to Follow-up|4
2595487|NCT01098539|8977470|P2|Overall Study|Noncompliance|5
2595488|NCT01098539|8977471|P1|Overall Study|Noncompliance|3
2595489|NCT01098539|8977470|P2|Overall Study|Protocol Violation|4
2595490|NCT01098539|8977471|P1|Overall Study|Protocol Violation|1
2595491|NCT01098539|8977470|P2|Overall Study|Adverse Event|26
2595492|NCT01098539|8977471|P1|Overall Study|Adverse Event|26
2595493|NCT01098487|8977522|P1|Overall Study|Physician Decision|1
2595494|NCT01098487|8977522|P1|Overall Study|Lost to Follow-up|3
2595495|NCT01098487|8977522|P1|Overall Study|Withdrawal by Subject|7
2595496|NCT01098487|8977522|P1|Overall Study|Lack of Efficacy|11
2595497|NCT01098487|8977522|P1|Overall Study|Adverse Event|22
2595498|NCT01098474|8977540|P6|Follow Up Phase|Lost to Follow-up|0
2595499|NCT01098474|8977541|P5|Follow Up Phase|Lost to Follow-up|1
2595500|NCT01098474|8977542|P4|Follow Up Phase|Lost to Follow-up|0
2595501|NCT01098474|8977543|P3|Follow Up Phase|Lost to Follow-up|0
2595502|NCT01098474|8977544|P2|Follow Up Phase|Lost to Follow-up|0
2595503|NCT01098474|8977545|P1|Follow Up Phase|Lost to Follow-up|0
2595504|NCT01098474|8977540|P6|Follow Up Phase|Withdrawal by Subject|1
2595505|NCT01098474|8977541|P5|Follow Up Phase|Withdrawal by Subject|0
2595506|NCT01098474|8977542|P4|Follow Up Phase|Withdrawal by Subject|2
2595507|NCT01098474|8977543|P3|Follow Up Phase|Withdrawal by Subject|0
2595508|NCT01098474|8977544|P2|Follow Up Phase|Withdrawal by Subject|0
2595509|NCT01098474|8977545|P1|Follow Up Phase|Withdrawal by Subject|0
2595510|NCT01098474|8977540|P6|Follow Up Phase|Other|4
2595511|NCT01098474|8977541|P5|Follow Up Phase|Other|0
2595512|NCT01098474|8977542|P4|Follow Up Phase|Other|0
2595513|NCT01098474|8977543|P3|Follow Up Phase|Other|0
2595514|NCT01098474|8977544|P2|Follow Up Phase|Other|0
2595515|NCT01098474|8977545|P1|Follow Up Phase|Other|0
2595516|NCT01098474|8977540|P6|Follow Up Phase|Travelled out of study area|0
2595517|NCT01098474|8977541|P5|Follow Up Phase|Travelled out of study area|1
2595518|NCT01098474|8977542|P4|Follow Up Phase|Travelled out of study area|0
2595519|NCT01098474|8977543|P3|Follow Up Phase|Travelled out of study area|0
2595520|NCT01098474|8977544|P2|Follow Up Phase|Travelled out of study area|0
2595521|NCT01098474|8977545|P1|Follow Up Phase|Travelled out of study area|0
2595522|NCT01098474|8977540|P6|Active Phase|Lost to Follow-up|0
2595523|NCT01098474|8977541|P5|Active Phase|Lost to Follow-up|0
2595524|NCT01098474|8977542|P4|Active Phase|Lost to Follow-up|0
2595525|NCT01098474|8977543|P3|Active Phase|Lost to Follow-up|0
2595526|NCT01098474|8977544|P2|Active Phase|Lost to Follow-up|0
2595527|NCT01098474|8977545|P1|Active Phase|Lost to Follow-up|1
2595528|NCT01098474|8977540|P6|Active Phase|Withdrawal by Subject|0
2595529|NCT01098474|8977541|P5|Active Phase|Withdrawal by Subject|0
2595530|NCT01098474|8977542|P4|Active Phase|Withdrawal by Subject|0
2595531|NCT01098474|8977543|P3|Active Phase|Withdrawal by Subject|2
2595532|NCT01098474|8977544|P2|Active Phase|Withdrawal by Subject|1
2595533|NCT01098474|8977545|P1|Active Phase|Withdrawal by Subject|1
2595534|NCT01098474|8977540|P6|Active Phase|Other|0
2595535|NCT01098474|8977541|P5|Active Phase|Other|0
2595536|NCT01098474|8977542|P4|Active Phase|Other|0
2595537|NCT01098474|8977543|P3|Active Phase|Other|3
2595538|NCT01098474|8977544|P2|Active Phase|Other|0
2595539|NCT01098474|8977545|P1|Active Phase|Other|0
2595540|NCT01098461|8977779|P4|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
2595541|NCT01098461|8977780|P3|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
2595542|NCT01098461|8977781|P2|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
2595543|NCT01098461|8977782|P1|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
2595544|NCT01098461|8977779|P4|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
2595545|NCT01098461|8977780|P3|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
2595546|NCT01098461|8977781|P2|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1
2595547|NCT01098461|8977782|P1|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
2595548|NCT01098461|8977779|P4|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
2595549|NCT01098461|8977780|P3|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
2595550|NCT01098461|8977781|P2|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1
2595551|NCT01098461|8977782|P1|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
2595552|NCT01098461|8977779|P4|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
2595553|NCT01098461|8977780|P3|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
2595554|NCT01098461|8977781|P2|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1
2595555|NCT01098461|8977782|P1|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
2595556|NCT01098461|8977779|P4|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
2595557|NCT01098461|8977780|P3|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
2595558|NCT01098461|8977781|P2|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2
2595559|NCT01098461|8977782|P1|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1
2595560|NCT01098461|8977779|P4|Treatment Period (TP) (16 Weeks)|Adverse Event|3
2595561|NCT01098461|8977780|P3|Treatment Period (TP) (16 Weeks)|Adverse Event|1
2595562|NCT01098461|8977781|P2|Treatment Period (TP) (16 Weeks)|Adverse Event|2
2595563|NCT01098461|8977782|P1|Treatment Period (TP) (16 Weeks)|Adverse Event|1
2595564|NCT01098461|8977779|P4|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
2595565|NCT01098461|8977780|P3|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
2595566|NCT01098461|8977781|P2|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2
2595567|NCT01098461|8977782|P1|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10
2595568|NCT01098305|8977842|P2|Overall Study|Lost to Follow-up|33
2595569|NCT01098305|8977843|P1|Overall Study|Lost to Follow-up|31
2595570|NCT01098266|8977853|P2|Overall Study|Withdrawal by Subject|5
2595571|NCT01098266|8977854|P1|Overall Study|Withdrawal by Subject|3
2595572|NCT01098266|8977853|P2|Overall Study|Death|2
2595573|NCT01098266|8977854|P1|Overall Study|Death|3
2595574|NCT01098266|8977853|P2|Overall Study|Physician Decision|0
2595575|NCT01098266|8977854|P1|Overall Study|Physician Decision|1
2595576|NCT01098240|8977883|P3|Double-Blind Phase|Adverse Event|3
2595577|NCT01098240|8977884|P2|Double-Blind Phase|Adverse Event|3
2595578|NCT01098240|8977885|P1|Double-Blind Phase|Adverse Event|0
2595579|NCT01098240|8977883|P3|Double-Blind Phase|Withdrawal by Subject|3
2595580|NCT01098240|8977884|P2|Double-Blind Phase|Withdrawal by Subject|1
2595581|NCT01098240|8977885|P1|Double-Blind Phase|Withdrawal by Subject|0
2595582|NCT01098240|8977883|P3|Double-Blind Phase|Insufficient Clinical Response|2
2595583|NCT01098240|8977884|P2|Double-Blind Phase|Insufficient Clinical Response|1
2595584|NCT01098240|8977885|P1|Double-Blind Phase|Insufficient Clinical Response|0
2595585|NCT01098240|8977883|P3|Double-Blind Phase|Did Not Meet Entrance Criteria|0
2595586|NCT01098240|8977884|P2|Double-Blind Phase|Did Not Meet Entrance Criteria|1
2595587|NCT01098240|8977885|P1|Double-Blind Phase|Did Not Meet Entrance Criteria|0
2595588|NCT01098240|8977883|P3|Double-Blind Phase|Other|2
2595589|NCT01098240|8977884|P2|Double-Blind Phase|Other|2
2595590|NCT01098240|8977885|P1|Double-Blind Phase|Other|0
2595591|NCT01098240|8977883|P3|Double-Blind Phase|Lost to Follow-up|0
2595592|NCT01098240|8977884|P2|Double-Blind Phase|Lost to Follow-up|2
2595593|NCT01098240|8977885|P1|Double-Blind Phase|Lost to Follow-up|0
2595594|NCT01098240|8977883|P3|Double-Blind Phase|Protocol Violation|4
2595595|NCT01098240|8977884|P2|Double-Blind Phase|Protocol Violation|2
2595596|NCT01098240|8977885|P1|Double-Blind Phase|Protocol Violation|0
2595597|NCT01098240|8977883|P3|Double-Blind Phase|Study Terminated by Sponsor|8
2595598|NCT01098240|8977884|P2|Double-Blind Phase|Study Terminated by Sponsor|5
2595599|NCT01098240|8977885|P1|Double-Blind Phase|Study Terminated by Sponsor|0
2595600|NCT01098240|8977883|P3|Open-Label Phase|Adverse Event|0
2595601|NCT01098240|8977884|P2|Open-Label Phase|Adverse Event|0
2595602|NCT01098240|8977885|P1|Open-Label Phase|Adverse Event|12
2595603|NCT01098240|8977883|P3|Open-Label Phase|Withdrawal by Subject|0
2595604|NCT01098240|8977884|P2|Open-Label Phase|Withdrawal by Subject|0
2595605|NCT01098240|8977885|P1|Open-Label Phase|Withdrawal by Subject|9
2595606|NCT01098240|8977883|P3|Open-Label Phase|Pregnancy|0
2595607|NCT01098240|8977884|P2|Open-Label Phase|Pregnancy|0
2595608|NCT01098240|8977885|P1|Open-Label Phase|Pregnancy|1
2595609|NCT01098240|8977883|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
2595610|NCT01098240|8977884|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
2595611|NCT01098240|8977885|P1|Open-Label Phase|Did Not Meet Entrance Criteria|50
2595612|NCT01098240|8977883|P3|Open-Label Phase|Other|0
2595613|NCT01098240|8977884|P2|Open-Label Phase|Other|0
2595614|NCT01098240|8977885|P1|Open-Label Phase|Other|19
2595615|NCT01098240|8977883|P3|Open-Label Phase|Lost to Follow-up|0
2595616|NCT01098240|8977884|P2|Open-Label Phase|Lost to Follow-up|0
2595617|NCT01098240|8977885|P1|Open-Label Phase|Lost to Follow-up|13
2595618|NCT01098240|8977883|P3|Open-Label Phase|Protocol Violation|0
2595619|NCT01098240|8977884|P2|Open-Label Phase|Protocol Violation|0
2595620|NCT01098240|8977885|P1|Open-Label Phase|Protocol Violation|4
2595621|NCT01098240|8977883|P3|Open-Label Phase|Study Terminated by Sponsor|0
2595622|NCT01098240|8977884|P2|Open-Label Phase|Study Terminated by Sponsor|0
2595623|NCT01098240|8977885|P1|Open-Label Phase|Study Terminated by Sponsor|27
2595624|NCT01098162|8977915|P1|Overall Study|Reason Unknown|26
2595625|NCT01098162|8977915|P1|Overall Study|Other Reason|1
2595626|NCT01098162|8977915|P1|Overall Study|Wish of Patient & Lost to Follow-up|1
2595627|NCT01098162|8977915|P1|Overall Study|AE & Lack of Efficacy & Wish of Patient|1
2595628|NCT01098162|8977915|P1|Overall Study|Adverse Event & Lost to Follow-up|2
2595629|NCT01098162|8977915|P1|Overall Study|Adverse Event & Wish of Patient|13
2595630|NCT01098162|8977915|P1|Overall Study|Adverse Event & Lack of Efficacy|6
2595631|NCT01098162|8977915|P1|Overall Study|Lack of Efficacy & Wish of Patient|5
2595632|NCT01098162|8977915|P1|Overall Study|Lost to Follow-up|9
2595633|NCT01098162|8977915|P1|Overall Study|Wish of Patient|7
2595634|NCT01098162|8977915|P1|Overall Study|Lack of Efficacy|4
2595635|NCT01098162|8977915|P1|Overall Study|Adverse Event|37
2595636|NCT01098110|8977927|P3|Overall Study|Untreated|0
2595637|NCT01098110|8977928|P2|Overall Study|Untreated|1
2595638|NCT01098110|8977929|P1|Overall Study|Untreated|1
2595639|NCT01098110|8977927|P3|Overall Study|Other|5
2595640|NCT01098110|8977928|P2|Overall Study|Other|7
2595641|NCT01098110|8977929|P1|Overall Study|Other|4
2595642|NCT01098110|8977927|P3|Overall Study|Lack of Efficacy|27
2595643|NCT01098110|8977928|P2|Overall Study|Lack of Efficacy|9
2595644|NCT01098110|8977929|P1|Overall Study|Lack of Efficacy|13
2595645|NCT01098110|8977927|P3|Overall Study|Adverse Event|43
2595646|NCT01098110|8977928|P2|Overall Study|Adverse Event|32
2595647|NCT01098110|8977929|P1|Overall Study|Adverse Event|30
2595648|NCT01098110|8977927|P3|Overall Study|Withdrawal by Subject|19
2595649|NCT01098110|8977928|P2|Overall Study|Withdrawal by Subject|24
2595650|NCT01098110|8977929|P1|Overall Study|Withdrawal by Subject|14
2595651|NCT01098097|8977970|P1|Overall Study|No reason reported|31
2595652|NCT01098097|8977970|P1|Overall Study|Status unknown|16
2595653|NCT01098097|8977970|P1|Overall Study|Lost to Follow-up|18
2595654|NCT01098097|8977970|P1|Overall Study|Adverse Event|17
2595655|NCT01098071|8977979|P1|Overall Study|Lost to Follow-up|13
2595656|NCT01098071|8977979|P1|Overall Study|Surgery (adenoidectomy)|2
2595657|NCT01098032|8977992|P2|Overall Study|Withdrawal by Subject|1
2595658|NCT01098032|8977993|P1|Overall Study|Withdrawal by Subject|1
2595659|NCT01097863|8978110|P3|Overall Study|Did not return for final visit|1
2595660|NCT01097863|8978111|P2|Overall Study|Did not return for final visit|0
2595661|NCT01097863|8978112|P1|Overall Study|Did not return for final visit|0
2595662|NCT01097863|8978110|P3|Overall Study|Discomfort|1
2595663|NCT01097863|8978111|P2|Overall Study|Discomfort|0
2595664|NCT01097863|8978112|P1|Overall Study|Discomfort|1
2595665|NCT01097707|8978136|P5|Overall Study|Reason unknown|1
2595666|NCT01097707|8978137|P4|Overall Study|Reason unknown|0
2595667|NCT01097707|8978138|P3|Overall Study|Reason unknown|0
2595668|NCT01097707|8978139|P2|Overall Study|Reason unknown|0
2595669|NCT01097707|8978140|P1|Overall Study|Reason unknown|0
2595670|NCT01097707|8978136|P5|Overall Study|Withdrawal by Subject|3
2595671|NCT01097707|8978137|P4|Overall Study|Withdrawal by Subject|4
2595672|NCT01097707|8978138|P3|Overall Study|Withdrawal by Subject|1
2595673|NCT01097707|8978139|P2|Overall Study|Withdrawal by Subject|6
2595674|NCT01097707|8978140|P1|Overall Study|Withdrawal by Subject|3
2595675|NCT01097707|8978136|P5|Overall Study|Sponsor Decision|36
2595676|NCT01097707|8978137|P4|Overall Study|Sponsor Decision|35
2595677|NCT01097707|8978138|P3|Overall Study|Sponsor Decision|34
2595678|NCT01097707|8978139|P2|Overall Study|Sponsor Decision|31
2595679|NCT01097707|8978140|P1|Overall Study|Sponsor Decision|31
2595680|NCT01097707|8978136|P5|Overall Study|Protocol Violation|2
2595681|NCT01097707|8978137|P4|Overall Study|Protocol Violation|2
2595682|NCT01097707|8978138|P3|Overall Study|Protocol Violation|3
2595683|NCT01097707|8978139|P2|Overall Study|Protocol Violation|2
2595684|NCT01097707|8978140|P1|Overall Study|Protocol Violation|2
2595685|NCT01097707|8978136|P5|Overall Study|Lost to Follow-up|3
2595686|NCT01097707|8978137|P4|Overall Study|Lost to Follow-up|0
2595687|NCT01097707|8978138|P3|Overall Study|Lost to Follow-up|2
2595688|NCT01097707|8978139|P2|Overall Study|Lost to Follow-up|1
2595689|NCT01097707|8978140|P1|Overall Study|Lost to Follow-up|1
2595690|NCT01097707|8978136|P5|Overall Study|Lack of Efficacy|0
2595691|NCT01097707|8978137|P4|Overall Study|Lack of Efficacy|1
2595692|NCT01097707|8978138|P3|Overall Study|Lack of Efficacy|0
2595693|NCT01097707|8978139|P2|Overall Study|Lack of Efficacy|0
2595694|NCT01097707|8978140|P1|Overall Study|Lack of Efficacy|1
2595695|NCT01097707|8978136|P5|Overall Study|Entry Criteria Not Met|1
2595696|NCT01097707|8978137|P4|Overall Study|Entry Criteria Not Met|0
2595697|NCT01097707|8978138|P3|Overall Study|Entry Criteria Not Met|1
2595698|NCT01097707|8978139|P2|Overall Study|Entry Criteria Not Met|1
2595699|NCT01097707|8978140|P1|Overall Study|Entry Criteria Not Met|2
2595700|NCT01097707|8978136|P5|Overall Study|Adverse Event|3
2595701|NCT01097707|8978137|P4|Overall Study|Adverse Event|1
2595702|NCT01097707|8978138|P3|Overall Study|Adverse Event|3
2595703|NCT01097707|8978139|P2|Overall Study|Adverse Event|2
2595704|NCT01097707|8978140|P1|Overall Study|Adverse Event|4
2595705|NCT01097707|8978136|P5|Overall Study|Abnormal Lab/Electrocardiogram Result|1
2595706|NCT01097707|8978137|P4|Overall Study|Abnormal Lab/Electrocardiogram Result|1
2595707|NCT01097707|8978138|P3|Overall Study|Abnormal Lab/Electrocardiogram Result|1
2595708|NCT01097707|8978139|P2|Overall Study|Abnormal Lab/Electrocardiogram Result|0
2595709|NCT01097707|8978140|P1|Overall Study|Abnormal Lab/Electrocardiogram Result|0
2595710|NCT01097694|8978189|P2|Overall Study|Withdrawal by Subject|1
2595711|NCT01097694|8978190|P1|Overall Study|Withdrawal by Subject|3
2595712|NCT01097694|8978189|P2|Overall Study|Lost to Follow-up|3
2595713|NCT01097694|8978190|P1|Overall Study|Lost to Follow-up|0
2595714|NCT01097694|8978189|P2|Overall Study|Adverse Event|0
2595715|NCT01097694|8978190|P1|Overall Study|Adverse Event|5
2595716|NCT01097668|8978252|P2|Overall Study|Lost to Follow-up|0
2595717|NCT01097668|8978253|P1|Overall Study|Lost to Follow-up|1
2595718|NCT01097668|8978252|P2|Overall Study|Withdrawal by Subject|2
2595719|NCT01097668|8978253|P1|Overall Study|Withdrawal by Subject|1
2595720|NCT01097655|8978263|P1|Overall Study|Did Not Meet Inclusion Criteria|8
2595721|NCT01097655|8978263|P1|Overall Study|Subject Documented Twice|1
2595722|NCT01097655|8978263|P1|Overall Study|Withdrawal by Subject|1
2595723|NCT01097629|8978273|P8|DB RO Phase|Lost to Follow-up|0
2595724|NCT01097629|8978274|P7|DB RO Phase|Lost to Follow-up|2
2595725|NCT01097629|8978275|P6|DB RO Phase|Lost to Follow-up|0
2595726|NCT01097629|8978276|P5|DB RO Phase|Lost to Follow-up|0
2595727|NCT01097629|8978277|P4|DB RO Phase|Lost to Follow-up|0
2595728|NCT01097629|8978278|P3|DB RO Phase|Lost to Follow-up|0
2595729|NCT01097629|8978279|P2|DB RO Phase|Lost to Follow-up|0
2595730|NCT01097629|8978280|P1|DB RO Phase|Lost to Follow-up|0
2595731|NCT01097629|8978273|P8|DB RO Phase|Protocol Violation|0
2595732|NCT01097629|8978274|P7|DB RO Phase|Protocol Violation|1
2595733|NCT01097629|8978275|P6|DB RO Phase|Protocol Violation|1
2595734|NCT01097629|8978276|P5|DB RO Phase|Protocol Violation|0
2595735|NCT01097629|8978277|P4|DB RO Phase|Protocol Violation|1
2595736|NCT01097629|8978278|P3|DB RO Phase|Protocol Violation|0
2595737|NCT01097629|8978279|P2|DB RO Phase|Protocol Violation|0
2595738|NCT01097629|8978280|P1|DB RO Phase|Protocol Violation|0
2595739|NCT01097629|8978273|P8|DB RO Phase|Withdrawal by Subject|1
2595740|NCT01097629|8978274|P7|DB RO Phase|Withdrawal by Subject|0
2595741|NCT01097629|8978275|P6|DB RO Phase|Withdrawal by Subject|0
2595742|NCT01097629|8978276|P5|DB RO Phase|Withdrawal by Subject|0
2595743|NCT01097629|8978277|P4|DB RO Phase|Withdrawal by Subject|0
2595744|NCT01097629|8978278|P3|DB RO Phase|Withdrawal by Subject|0
2595745|NCT01097629|8978279|P2|DB RO Phase|Withdrawal by Subject|0
2595746|NCT01097629|8978280|P1|DB RO Phase|Withdrawal by Subject|0
2595747|NCT01097629|8978273|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2595748|NCT01097629|8978274|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2595749|NCT01097629|8978275|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2595750|NCT01097629|8978276|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2595751|NCT01097629|8978277|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2595752|NCT01097629|8978278|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4
2595753|NCT01097629|8978279|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5
2595754|NCT01097629|8978280|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
2595755|NCT01097629|8978273|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2595756|NCT01097629|8978274|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2595757|NCT01097629|8978275|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2595758|NCT01097629|8978276|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2595759|NCT01097629|8978277|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2595760|NCT01097629|8978278|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2595761|NCT01097629|8978279|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1
2595762|NCT01097629|8978280|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2
2595763|NCT01097629|8978273|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
2595764|NCT01097629|8978274|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
2595765|NCT01097629|8978275|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
2595766|NCT01097629|8978276|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
2595767|NCT01097629|8978277|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
2595768|NCT01097629|8978278|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8
2595769|NCT01097629|8978279|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4
2595770|NCT01097629|8978280|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
2595771|NCT01097629|8978273|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2595772|NCT01097629|8978274|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2595773|NCT01097629|8978275|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2595774|NCT01097629|8978276|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2595775|NCT01097629|8978277|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2595776|NCT01097629|8978278|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
2595777|NCT01097629|8978279|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4
2595778|NCT01097629|8978280|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2
2595779|NCT01097629|8978273|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
2595780|NCT01097629|8978274|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
2595781|NCT01097629|8978275|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
2595782|NCT01097629|8978276|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
2595783|NCT01097629|8978277|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
2595784|NCT01097629|8978278|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8
2595785|NCT01097629|8978279|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4
2595786|NCT01097629|8978280|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
2595787|NCT01097629|8978273|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
2595788|NCT01097629|8978274|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
2595789|NCT01097629|8978275|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
2595790|NCT01097629|8978276|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
2595791|NCT01097629|8978277|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
2595792|NCT01097629|8978278|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19
2595793|NCT01097629|8978279|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9
2595794|NCT01097629|8978280|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
2595795|NCT01097629|8978273|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
2595796|NCT01097629|8978274|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
2595797|NCT01097629|8978275|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
2595798|NCT01097629|8978276|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
2595799|NCT01097629|8978277|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
2595800|NCT01097629|8978278|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17
2595801|NCT01097629|8978279|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19
2595802|NCT01097629|8978280|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10
2595803|NCT01097616|8978331|P8|DB RO Phase|Not Treated in RO|0
2595804|NCT01097616|8978332|P7|DB RO Phase|Not Treated in RO|0
2595805|NCT01097616|8978333|P6|DB RO Phase|Not Treated in RO|1
2595806|NCT01097616|8978334|P5|DB RO Phase|Not Treated in RO|0
2595807|NCT01097616|8978335|P4|DB RO Phase|Not Treated in RO|0
2595808|NCT01097616|8978336|P3|DB RO Phase|Not Treated in RO|0
2595809|NCT01097616|8978337|P2|DB RO Phase|Not Treated in RO|0
2595810|NCT01097616|8978338|P1|DB RO Phase|Not Treated in RO|0
2595811|NCT01097616|8978331|P8|DB RO Phase|Lost to Follow-up|1
2595812|NCT01097616|8978332|P7|DB RO Phase|Lost to Follow-up|0
2595813|NCT01097616|8978333|P6|DB RO Phase|Lost to Follow-up|0
2595814|NCT01097616|8978334|P5|DB RO Phase|Lost to Follow-up|1
2595815|NCT01097616|8978335|P4|DB RO Phase|Lost to Follow-up|1
2595816|NCT01097616|8978336|P3|DB RO Phase|Lost to Follow-up|0
2595817|NCT01097616|8978337|P2|DB RO Phase|Lost to Follow-up|0
2595818|NCT01097616|8978338|P1|DB RO Phase|Lost to Follow-up|0
2595819|NCT01097616|8978331|P8|DB RO Phase|Withdrawal by Subject|0
2595820|NCT01097616|8978332|P7|DB RO Phase|Withdrawal by Subject|0
2595821|NCT01097616|8978333|P6|DB RO Phase|Withdrawal by Subject|1
2595822|NCT01097616|8978334|P5|DB RO Phase|Withdrawal by Subject|0
2595823|NCT01097616|8978335|P4|DB RO Phase|Withdrawal by Subject|0
2595824|NCT01097616|8978336|P3|DB RO Phase|Withdrawal by Subject|0
2595825|NCT01097616|8978337|P2|DB RO Phase|Withdrawal by Subject|0
2595826|NCT01097616|8978338|P1|DB RO Phase|Withdrawal by Subject|0
2595827|NCT01097616|8978331|P8|DB RO Phase|Adverse Event|0
2595828|NCT01097616|8978332|P7|DB RO Phase|Adverse Event|1
2595829|NCT01097616|8978333|P6|DB RO Phase|Adverse Event|0
2595830|NCT01097616|8978334|P5|DB RO Phase|Adverse Event|0
2595831|NCT01097616|8978335|P4|DB RO Phase|Adverse Event|0
2595832|NCT01097616|8978336|P3|DB RO Phase|Adverse Event|0
2595833|NCT01097616|8978337|P2|DB RO Phase|Adverse Event|0
2595834|NCT01097616|8978338|P1|DB RO Phase|Adverse Event|0
2595835|NCT01097616|8978331|P8|Optional DB EXT Phase|Physician Decision|0
2595836|NCT01097616|8978332|P7|Optional DB EXT Phase|Physician Decision|0
2595837|NCT01097616|8978333|P6|Optional DB EXT Phase|Physician Decision|0
2595838|NCT01097616|8978334|P5|Optional DB EXT Phase|Physician Decision|0
2595839|NCT01097616|8978335|P4|Optional DB EXT Phase|Physician Decision|0
2595840|NCT01097616|8978336|P3|Optional DB EXT Phase|Physician Decision|0
2595841|NCT01097616|8978337|P2|Optional DB EXT Phase|Physician Decision|0
2595842|NCT01097616|8978338|P1|Optional DB EXT Phase|Physician Decision|1
2595843|NCT01097616|8978331|P8|Optional DB EXT Phase|Lack of Efficacy|0
2595844|NCT01097616|8978332|P7|Optional DB EXT Phase|Lack of Efficacy|0
2595845|NCT01097616|8978333|P6|Optional DB EXT Phase|Lack of Efficacy|0
2595846|NCT01097616|8978334|P5|Optional DB EXT Phase|Lack of Efficacy|0
2595847|NCT01097616|8978335|P4|Optional DB EXT Phase|Lack of Efficacy|0
2595848|NCT01097616|8978336|P3|Optional DB EXT Phase|Lack of Efficacy|1
2595849|NCT01097616|8978337|P2|Optional DB EXT Phase|Lack of Efficacy|1
2595850|NCT01097616|8978338|P1|Optional DB EXT Phase|Lack of Efficacy|1
2595851|NCT01097616|8978331|P8|Optional DB EXT Phase|Lost to Follow-up|0
2595852|NCT01097616|8978332|P7|Optional DB EXT Phase|Lost to Follow-up|0
2595853|NCT01097616|8978333|P6|Optional DB EXT Phase|Lost to Follow-up|0
2595854|NCT01097616|8978334|P5|Optional DB EXT Phase|Lost to Follow-up|0
2595855|NCT01097616|8978335|P4|Optional DB EXT Phase|Lost to Follow-up|0
2595856|NCT01097616|8978336|P3|Optional DB EXT Phase|Lost to Follow-up|1
2595857|NCT01097616|8978337|P2|Optional DB EXT Phase|Lost to Follow-up|5
2595858|NCT01097616|8978338|P1|Optional DB EXT Phase|Lost to Follow-up|1
2595859|NCT01097616|8978331|P8|Optional DB EXT Phase|Protocol Violation|0
2595860|NCT01097616|8978332|P7|Optional DB EXT Phase|Protocol Violation|0
2595861|NCT01097616|8978333|P6|Optional DB EXT Phase|Protocol Violation|0
2595862|NCT01097616|8978334|P5|Optional DB EXT Phase|Protocol Violation|0
2595863|NCT01097616|8978335|P4|Optional DB EXT Phase|Protocol Violation|0
2595864|NCT01097616|8978336|P3|Optional DB EXT Phase|Protocol Violation|3
2595865|NCT01097616|8978337|P2|Optional DB EXT Phase|Protocol Violation|2
2595866|NCT01097616|8978338|P1|Optional DB EXT Phase|Protocol Violation|0
2595867|NCT01097616|8978331|P8|Optional DB EXT Phase|Withdrawal by Subject|0
2595868|NCT01097616|8978332|P7|Optional DB EXT Phase|Withdrawal by Subject|0
2595869|NCT01097616|8978333|P6|Optional DB EXT Phase|Withdrawal by Subject|0
2595870|NCT01097616|8978334|P5|Optional DB EXT Phase|Withdrawal by Subject|0
2595871|NCT01097616|8978335|P4|Optional DB EXT Phase|Withdrawal by Subject|0
2595872|NCT01097616|8978336|P3|Optional DB EXT Phase|Withdrawal by Subject|3
2595873|NCT01097616|8978337|P2|Optional DB EXT Phase|Withdrawal by Subject|6
2595874|NCT01097616|8978338|P1|Optional DB EXT Phase|Withdrawal by Subject|12
2595875|NCT01097616|8978331|P8|Optional DB EXT Phase|Adverse Event|0
2595876|NCT01097616|8978332|P7|Optional DB EXT Phase|Adverse Event|0
2595877|NCT01097616|8978333|P6|Optional DB EXT Phase|Adverse Event|0
2595878|NCT01097616|8978334|P5|Optional DB EXT Phase|Adverse Event|0
2595879|NCT01097616|8978335|P4|Optional DB EXT Phase|Adverse Event|0
2595880|NCT01097616|8978336|P3|Optional DB EXT Phase|Adverse Event|2
2595881|NCT01097616|8978337|P2|Optional DB EXT Phase|Adverse Event|7
2595882|NCT01097616|8978338|P1|Optional DB EXT Phase|Adverse Event|0
2595883|NCT01097616|8978331|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2595884|NCT01097616|8978332|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2595885|NCT01097616|8978333|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2595886|NCT01097616|8978334|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2595887|NCT01097616|8978335|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2595888|NCT01097616|8978336|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
2595889|NCT01097616|8978337|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2595890|NCT01097616|8978338|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
2595891|NCT01097616|8978331|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2595892|NCT01097616|8978332|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2595893|NCT01097616|8978333|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2595894|NCT01097616|8978334|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2595895|NCT01097616|8978335|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2595896|NCT01097616|8978336|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
2595897|NCT01097616|8978337|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3
2595898|NCT01097616|8978338|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4
2595899|NCT01097616|8978331|P8|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
2595900|NCT01097616|8978332|P7|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
2595901|NCT01097616|8978333|P6|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
2595902|NCT01097616|8978334|P5|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
2595903|NCT01097616|8978335|P4|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
2595904|NCT01097616|8978336|P3|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
2595905|NCT01097616|8978337|P2|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
2595906|NCT01097616|8978338|P1|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
2595907|NCT01097616|8978331|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
2595908|NCT01097616|8978332|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
2595909|NCT01097616|8978333|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
2595910|NCT01097616|8978334|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
2595911|NCT01097616|8978335|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
2595912|NCT01097616|8978336|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9
2595913|NCT01097616|8978337|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
2595914|NCT01097616|8978338|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1
2595915|NCT01097616|8978331|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2595916|NCT01097616|8978332|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2595917|NCT01097616|8978333|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2595918|NCT01097616|8978334|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2595919|NCT01097616|8978335|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2595920|NCT01097616|8978336|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
2595921|NCT01097616|8978337|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
2595922|NCT01097616|8978338|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
2595923|NCT01097616|8978331|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
2595924|NCT01097616|8978332|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
2595925|NCT01097616|8978333|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
2595926|NCT01097616|8978334|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
2595927|NCT01097616|8978335|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
2595928|NCT01097616|8978336|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1
2595929|NCT01097616|8978337|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3
2595930|NCT01097616|8978338|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
2595931|NCT01097616|8978331|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
2595932|NCT01097616|8978332|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
2595933|NCT01097616|8978333|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
2595934|NCT01097616|8978334|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
2595935|NCT01097616|8978335|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
2595936|NCT01097616|8978336|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12
2595937|NCT01097616|8978337|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
2595938|NCT01097616|8978338|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6
2595939|NCT01097616|8978331|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
2595940|NCT01097616|8978332|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
2595941|NCT01097616|8978333|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
2595942|NCT01097616|8978334|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
2595943|NCT01097616|8978335|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
2595944|NCT01097616|8978336|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21
2595945|NCT01097616|8978337|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15
2595946|NCT01097616|8978338|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6
2595947|NCT01097421|8978413|P1|Overall Study|Withdrawal by Subject|3
2595948|NCT01097421|8978413|P1|Overall Study|Lost to Follow-up|1
2595949|NCT01097421|8978413|P1|Overall Study|Protocol Violation|2
2595950|NCT01097421|8978413|P1|Overall Study|Adverse Event|8
2595951|NCT01097330|8978432|P2|Overall Study|Study terminated early|5
2595952|NCT01097330|8978433|P1|Overall Study|Study terminated early|7
2595953|NCT01097057|8978450|P1|Overall Study|Physician Decision|3
2595954|NCT01097044|8978459|P2|Overall Study|Withdrawal by Sponsor|1
2595955|NCT01097044|8978460|P1|Overall Study|Withdrawal by Sponsor|0
2595956|NCT01097044|8978459|P2|Overall Study|Lost to Follow-up|0
2595957|NCT01097044|8978460|P1|Overall Study|Lost to Follow-up|1
2595958|NCT01097044|8978459|P2|Overall Study|Withdrawal by Subject|4
2595959|NCT01097044|8978460|P1|Overall Study|Withdrawal by Subject|4
2595960|NCT01097005|8978478|P1|Overall Study|Discontinuance by complication|50
2595961|NCT01097005|8978478|P1|Overall Study|Adverse Event|14
2595962|NCT01097005|8978478|P1|Overall Study|Deviation from exclusion criteria|37
2595963|NCT01097005|8978478|P1|Overall Study|No examination data available|244
2595964|NCT01097005|8978478|P1|Overall Study|Poor medication compliance|1
2595965|NCT01097005|8978478|P1|Overall Study|Subjects cannot visit the hospital|1
2595966|NCT01097005|8978478|P1|Overall Study|Case Report Form not collected|18
2595967|NCT01096849|8978524|P3|Overall Study|Lost to Follow-up|1
2595968|NCT01096849|8978525|P2|Overall Study|Lost to Follow-up|3
2595969|NCT01096849|8978526|P1|Overall Study|Lost to Follow-up|1
2595970|NCT01096849|8978524|P3|Overall Study|Administrative Reasons|2
2595971|NCT01096849|8978525|P2|Overall Study|Administrative Reasons|1
2595972|NCT01096849|8978526|P1|Overall Study|Administrative Reasons|0
2595973|NCT01096849|8978524|P3|Overall Study|Investigator or Medical Monitor Decision|0
2595974|NCT01096849|8978525|P2|Overall Study|Investigator or Medical Monitor Decision|1
2595975|NCT01096849|8978526|P1|Overall Study|Investigator or Medical Monitor Decision|0
2595976|NCT01096849|8978524|P3|Overall Study|Unacceptable/ Intolerable AE(s)|1
2595977|NCT01096849|8978525|P2|Overall Study|Unacceptable/ Intolerable AE(s)|1
2595978|NCT01096849|8978526|P1|Overall Study|Unacceptable/ Intolerable AE(s)|0
2595979|NCT01096849|8978524|P3|Overall Study|Lack of Efficacy|0
2595980|NCT01096849|8978525|P2|Overall Study|Lack of Efficacy|2
2595981|NCT01096849|8978526|P1|Overall Study|Lack of Efficacy|0
2595982|NCT01096849|8978524|P3|Overall Study|Consent Withdrawn|2
2595983|NCT01096849|8978525|P2|Overall Study|Consent Withdrawn|4
2595984|NCT01096849|8978526|P1|Overall Study|Consent Withdrawn|1
2595985|NCT01096784|8978602|P2|Overall Study|Other Unspecified|1
2595986|NCT01096784|8978603|P1|Overall Study|Other Unspecified|0
2595987|NCT01096784|8978602|P2|Overall Study|Administrative Decision|1
2595988|NCT01096784|8978603|P1|Overall Study|Administrative Decision|0
2595989|NCT01096784|8978602|P2|Overall Study|Protocol Deviation|2
2595990|NCT01096784|8978603|P1|Overall Study|Protocol Deviation|2
2595991|NCT01096784|8978602|P2|Overall Study|Adverse Event|9
2595992|NCT01096784|8978603|P1|Overall Study|Adverse Event|11
2595993|NCT01096784|8978602|P2|Overall Study|Withdrawal by Subject|1
2595994|NCT01096784|8978603|P1|Overall Study|Withdrawal by Subject|2
2595995|NCT01096667|8978708|P5|Overall Study|Not treated|0
2595996|NCT01096667|8978709|P4|Overall Study|Not treated|0
2595997|NCT01096667|8978710|P3|Overall Study|Not treated|0
2595998|NCT01096667|8978711|P2|Overall Study|Not treated|0
2595999|NCT01096667|8978712|P1|Overall Study|Not treated|1
2596000|NCT01096667|8978708|P5|Overall Study|Protocol Violation|0
2596001|NCT01096667|8978709|P4|Overall Study|Protocol Violation|1
2596002|NCT01096667|8978710|P3|Overall Study|Protocol Violation|0
2596003|NCT01096667|8978711|P2|Overall Study|Protocol Violation|0
2596004|NCT01096667|8978712|P1|Overall Study|Protocol Violation|0
2596005|NCT01096667|8978708|P5|Overall Study|Reason not available|0
2596006|NCT01096667|8978709|P4|Overall Study|Reason not available|1
2596007|NCT01096667|8978710|P3|Overall Study|Reason not available|1
2596008|NCT01096667|8978711|P2|Overall Study|Reason not available|1
2596009|NCT01096667|8978712|P1|Overall Study|Reason not available|0
2596010|NCT01096667|8978708|P5|Overall Study|Withdrawal by Subject|0
2596011|NCT01096667|8978709|P4|Overall Study|Withdrawal by Subject|1
2596012|NCT01096667|8978710|P3|Overall Study|Withdrawal by Subject|0
2596013|NCT01096667|8978711|P2|Overall Study|Withdrawal by Subject|0
2596014|NCT01096667|8978712|P1|Overall Study|Withdrawal by Subject|1
2596015|NCT01096667|8978708|P5|Overall Study|Lost to Follow-up|0
2596016|NCT01096667|8978709|P4|Overall Study|Lost to Follow-up|0
2596017|NCT01096667|8978710|P3|Overall Study|Lost to Follow-up|1
2596018|NCT01096667|8978711|P2|Overall Study|Lost to Follow-up|1
2596019|NCT01096667|8978712|P1|Overall Study|Lost to Follow-up|1
2596020|NCT01096589|8978854|P4|Overall Study|found treatment exhausting|1
2596021|NCT01096589|8978855|P3|Overall Study|found treatment exhausting|0
2596022|NCT01096589|8978856|P2|Overall Study|found treatment exhausting|0
2596023|NCT01096589|8978857|P1|Overall Study|found treatment exhausting|0
2596024|NCT01096589|8978854|P4|Overall Study|Compliance with protocol|0
2596025|NCT01096589|8978855|P3|Overall Study|Compliance with protocol|1
2596026|NCT01096589|8978856|P2|Overall Study|Compliance with protocol|0
2596027|NCT01096589|8978857|P1|Overall Study|Compliance with protocol|0
2596028|NCT01096589|8978854|P4|Overall Study|Withdrawal by Subject|1
2596029|NCT01096589|8978855|P3|Overall Study|Withdrawal by Subject|1
2596030|NCT01096589|8978856|P2|Overall Study|Withdrawal by Subject|1
2596031|NCT01096589|8978857|P1|Overall Study|Withdrawal by Subject|2
2596032|NCT01096589|8978854|P4|Overall Study|Adverse Event|1
2596033|NCT01096589|8978855|P3|Overall Study|Adverse Event|2
2596034|NCT01096589|8978856|P2|Overall Study|Adverse Event|1
2596035|NCT01096589|8978857|P1|Overall Study|Adverse Event|2
2596036|NCT01096550|8978873|P2|Overall Study|Lost to Follow-up|9
2596037|NCT01096550|8978874|P1|Overall Study|Lost to Follow-up|12
2596038|NCT01096550|8978873|P2|Overall Study|non-African American participant|6
2596039|NCT01096550|8978874|P1|Overall Study|non-African American participant|13
2596040|NCT01096550|8978873|P2|Overall Study|Withdrawal by Subject|1
2596041|NCT01096550|8978874|P1|Overall Study|Withdrawal by Subject|0
2596042|NCT01096550|8978873|P2|Overall Study|clinic readmission|1
2596043|NCT01096550|8978874|P1|Overall Study|clinic readmission|1
2596044|NCT01096550|8978873|P2|Overall Study|non-regular treatment track at clinic|1
2596045|NCT01096550|8978874|P1|Overall Study|non-regular treatment track at clinic|1
2596046|NCT01096550|8978873|P2|Overall Study|discontinued site|11
2596047|NCT01096550|8978874|P1|Overall Study|discontinued site|10
2596048|NCT01096446|8978882|P2|Overall Study|Protocol Violation|0
2596049|NCT01096446|8978883|P1|Overall Study|Protocol Violation|2
2596050|NCT01096446|8978882|P2|Overall Study|Death|0
2596051|NCT01096446|8978883|P1|Overall Study|Death|1
2596052|NCT01096342|8978888|P1|Overall Study|Protocol Violation|1
2596053|NCT01096316|8978896|P2|Overall Study|Lost to Follow-up|9
2596054|NCT01096316|8978897|P1|Overall Study|Lost to Follow-up|15
2596055|NCT01096186|8978907|P1|Overall Study|Noncompliance with study drug|1
2596056|NCT01096186|8978907|P1|Overall Study|Physician Decision|1
2596057|NCT01096186|8978907|P1|Overall Study|Withdrawal by Subject|22
2596058|NCT01096186|8978907|P1|Overall Study|Lost to Follow-up|2
2596059|NCT01096186|8978907|P1|Overall Study|Lack of Efficacy|4
2596060|NCT01096186|8978907|P1|Overall Study|Death|4
2596061|NCT01096186|8978907|P1|Overall Study|Adverse Event|16
2596062|NCT01096160|8978923|P10|Overall Study|Met stopping criteria per protocol|0
2596063|NCT01096160|8978924|P9|Overall Study|Met stopping criteria per protocol|2
2596064|NCT01096160|8978925|P8|Overall Study|Met stopping criteria per protocol|0
2596065|NCT01096160|8978926|P7|Overall Study|Met stopping criteria per protocol|2
2596066|NCT01096160|8978927|P6|Overall Study|Met stopping criteria per protocol|0
2596067|NCT01096160|8978928|P5|Overall Study|Met stopping criteria per protocol|1
2596068|NCT01096160|8978929|P4|Overall Study|Met stopping criteria per protocol|0
2596069|NCT01096160|8978930|P3|Overall Study|Met stopping criteria per protocol|0
2596070|NCT01096160|8978931|P2|Overall Study|Met stopping criteria per protocol|0
2596071|NCT01096160|8978932|P1|Overall Study|Met stopping criteria per protocol|0
2596072|NCT01096160|8978923|P10|Overall Study|Adverse Event|1
2596073|NCT01096160|8978924|P9|Overall Study|Adverse Event|0
2596074|NCT01096160|8978925|P8|Overall Study|Adverse Event|0
2596075|NCT01096160|8978926|P7|Overall Study|Adverse Event|0
2596076|NCT01096160|8978927|P6|Overall Study|Adverse Event|0
2596077|NCT01096160|8978928|P5|Overall Study|Adverse Event|0
2596078|NCT01096160|8978929|P4|Overall Study|Adverse Event|0
2596079|NCT01096160|8978930|P3|Overall Study|Adverse Event|1
2596080|NCT01096160|8978931|P2|Overall Study|Adverse Event|0
2596081|NCT01096160|8978932|P1|Overall Study|Adverse Event|0
2596082|NCT01096056|8978990|P2|Overall Study|Lost to Follow-up|1
2596083|NCT01096056|8978991|P1|Overall Study|Lost to Follow-up|0
2596084|NCT01096017|8979023|P2|Treatment Period 2|Eligibility criteria not fulfilled|1
2596085|NCT01096017|8979024|P1|Treatment Period 2|Eligibility criteria not fulfilled|1
2596086|NCT01095978|8979052|P1|Overall Study|Adverse Event|1
2596087|NCT01095978|8979052|P1|Overall Study|Did not take Klacid SR|2
2596088|NCT01095835|8979086|P3|Overall Study|Protocol Violation|0
2596089|NCT01095835|8979087|P2|Overall Study|Protocol Violation|2
2596090|NCT01095835|8979088|P1|Overall Study|Protocol Violation|1
2596091|NCT01095835|8979086|P3|Overall Study|Non study compliance|1
2596092|NCT01095835|8979087|P2|Overall Study|Non study compliance|0
2596093|NCT01095835|8979088|P1|Overall Study|Non study compliance|0
2596094|NCT01095835|8979086|P3|Overall Study|Withdrawal by Subject|0
2596095|NCT01095835|8979087|P2|Overall Study|Withdrawal by Subject|3
2596096|NCT01095835|8979088|P1|Overall Study|Withdrawal by Subject|1
2596097|NCT01095835|8979086|P3|Overall Study|Physician Decision|1
2596098|NCT01095835|8979087|P2|Overall Study|Physician Decision|0
2596099|NCT01095835|8979088|P1|Overall Study|Physician Decision|0
2596100|NCT01095835|8979086|P3|Overall Study|Lack of Efficacy|0
2596101|NCT01095835|8979087|P2|Overall Study|Lack of Efficacy|1
2596102|NCT01095835|8979088|P1|Overall Study|Lack of Efficacy|0
2596103|NCT01095835|8979086|P3|Overall Study|Adverse Event|6
2596104|NCT01095835|8979087|P2|Overall Study|Adverse Event|6
2596105|NCT01095835|8979088|P1|Overall Study|Adverse Event|8
2596106|NCT01095796|8979126|P2|Overall Study|Participant Transferred to Another Study|200
2596107|NCT01095796|8979127|P1|Overall Study|Participant Transferred to Another Study|215
2596108|NCT01095796|8979126|P2|Overall Study|Protocol Violation|0
2596109|NCT01095796|8979127|P1|Overall Study|Protocol Violation|1
2596110|NCT01095796|8979126|P2|Overall Study|Participant Noncompliance|10
2596111|NCT01095796|8979127|P1|Overall Study|Participant Noncompliance|5
2596112|NCT01095796|8979126|P2|Overall Study|Lost to Follow-up|29
2596113|NCT01095796|8979127|P1|Overall Study|Lost to Follow-up|27
2596114|NCT01095796|8979126|P2|Overall Study|Withdrew Consent|22
2596115|NCT01095796|8979127|P1|Overall Study|Withdrew Consent|16
2596116|NCT01095796|8979126|P2|Overall Study|Investigator's Discretion|2
2596117|NCT01095796|8979127|P1|Overall Study|Investigator's Discretion|7
2596118|NCT01095796|8979126|P2|Overall Study|Lack of Efficacy|3
2596119|NCT01095796|8979127|P1|Overall Study|Lack of Efficacy|5
2596120|NCT01095796|8979126|P2|Overall Study|Pregnancy|0
2596121|NCT01095796|8979127|P1|Overall Study|Pregnancy|2
2596122|NCT01095796|8979126|P2|Overall Study|Death|2
2596123|NCT01095796|8979127|P1|Overall Study|Death|3
2596124|NCT01095796|8979126|P2|Overall Study|Adverse Event|19
2596125|NCT01095796|8979127|P1|Overall Study|Adverse Event|9
2596126|NCT01095796|8979126|P2|Overall Study|Randomized but Not Treated|2
2596127|NCT01095796|8979127|P1|Overall Study|Randomized but Not Treated|5
2596128|NCT01095666|8979157|P3|Overall Study|Non-compliance, not met criteria etc.|2
2596129|NCT01095666|8979158|P2|Overall Study|Non-compliance, not met criteria etc.|2
2596130|NCT01095666|8979159|P1|Overall Study|Non-compliance, not met criteria etc.|7
2596131|NCT01095666|8979157|P3|Overall Study|Withdrawal by Subject|1
2596132|NCT01095666|8979158|P2|Overall Study|Withdrawal by Subject|6
2596133|NCT01095666|8979159|P1|Overall Study|Withdrawal by Subject|6
2596134|NCT01095666|8979157|P3|Overall Study|Lost to Follow-up|0
2596135|NCT01095666|8979158|P2|Overall Study|Lost to Follow-up|2
2596136|NCT01095666|8979159|P1|Overall Study|Lost to Follow-up|2
2596137|NCT01095666|8979157|P3|Overall Study|Adverse Event|3
2596138|NCT01095666|8979158|P2|Overall Study|Adverse Event|1
2596139|NCT01095666|8979159|P1|Overall Study|Adverse Event|2
2596140|NCT01095666|8979157|P3|Overall Study|Lack of Efficacy|1
2596141|NCT01095666|8979158|P2|Overall Study|Lack of Efficacy|0
2596142|NCT01095666|8979159|P1|Overall Study|Lack of Efficacy|0
2596143|NCT01095653|8979182|P3|Overall Study|non-compliance, not met criteria, etc.|5
2596144|NCT01095653|8979183|P2|Overall Study|non-compliance, not met criteria, etc.|6
2596145|NCT01095653|8979184|P1|Overall Study|non-compliance, not met criteria, etc.|10
2596146|NCT01095653|8979182|P3|Overall Study|Withdrawal by Subject|3
2596147|NCT01095653|8979183|P2|Overall Study|Withdrawal by Subject|5
2596148|NCT01095653|8979184|P1|Overall Study|Withdrawal by Subject|4
2596149|NCT01095653|8979182|P3|Overall Study|Lost to Follow-up|4
2596150|NCT01095653|8979183|P2|Overall Study|Lost to Follow-up|0
2596151|NCT01095653|8979184|P1|Overall Study|Lost to Follow-up|1
2596152|NCT01095653|8979182|P3|Overall Study|Adverse Event|4
2596153|NCT01095653|8979183|P2|Overall Study|Adverse Event|4
2596154|NCT01095653|8979184|P1|Overall Study|Adverse Event|1
2596155|NCT01095653|8979182|P3|Overall Study|Lack of Efficacy|0
2596156|NCT01095653|8979183|P2|Overall Study|Lack of Efficacy|0
2596157|NCT01095653|8979184|P1|Overall Study|Lack of Efficacy|3
2596158|NCT01095250|8979242|P4|Overall Study|Withdrawal by Subject|0
2596159|NCT01095250|8979243|P3|Overall Study|Withdrawal by Subject|1
2596160|NCT01095250|8979244|P2|Overall Study|Withdrawal by Subject|0
2596161|NCT01095250|8979245|P1|Overall Study|Withdrawal by Subject|0
2596162|NCT01095250|8979242|P4|Overall Study|administrative reasons|5
2596163|NCT01095250|8979243|P3|Overall Study|administrative reasons|7
2596164|NCT01095250|8979244|P2|Overall Study|administrative reasons|10
2596165|NCT01095250|8979245|P1|Overall Study|administrative reasons|8
2596166|NCT01095094|8979275|P1|Overall Study|Physician Decision|1
2596167|NCT01095094|8979275|P1|Overall Study|Death|1
2596168|NCT01095094|8979275|P1|Overall Study|Withdrawal by Subject|1
2596169|NCT01094886|8979297|P1|Overall Study|Withdrawal by Subject|5
2596170|NCT01094886|8979297|P1|Overall Study|Adverse Event|2
2596171|NCT01094808|8979307|P3|Overall Study|Withdrawal by Subject|0
2596172|NCT01094808|8979308|P2|Overall Study|Withdrawal by Subject|1
2596173|NCT01094808|8979309|P1|Overall Study|Withdrawal by Subject|1
2596174|NCT01094782|8979350|P6|Overall Study|Noncompliance With Study Schedule|0
2596175|NCT01094782|8979351|P5|Overall Study|Noncompliance With Study Schedule|0
2596176|NCT01094782|8979352|P4|Overall Study|Noncompliance With Study Schedule|1
2596177|NCT01094782|8979353|P3|Overall Study|Noncompliance With Study Schedule|0
2596178|NCT01094782|8979354|P2|Overall Study|Noncompliance With Study Schedule|0
2596179|NCT01094782|8979355|P1|Overall Study|Noncompliance With Study Schedule|0
2596180|NCT01094782|8979350|P6|Overall Study|Low Visual Analog Scale (VAS) Score|0
2596181|NCT01094782|8979351|P5|Overall Study|Low Visual Analog Scale (VAS) Score|1
2596182|NCT01094782|8979352|P4|Overall Study|Low Visual Analog Scale (VAS) Score|0
2596183|NCT01094782|8979353|P3|Overall Study|Low Visual Analog Scale (VAS) Score|0
2596184|NCT01094782|8979354|P2|Overall Study|Low Visual Analog Scale (VAS) Score|0
2596185|NCT01094782|8979355|P1|Overall Study|Low Visual Analog Scale (VAS) Score|0
2596186|NCT01094782|8979350|P6|Overall Study|Recent Interventional Injection|1
2596187|NCT01094782|8979351|P5|Overall Study|Recent Interventional Injection|0
2596188|NCT01094782|8979352|P4|Overall Study|Recent Interventional Injection|0
2596189|NCT01094782|8979353|P3|Overall Study|Recent Interventional Injection|0
2596190|NCT01094782|8979354|P2|Overall Study|Recent Interventional Injection|0
2596191|NCT01094782|8979355|P1|Overall Study|Recent Interventional Injection|0
2596192|NCT01094782|8979350|P6|Overall Study|Wrong Pain Condition|1
2596193|NCT01094782|8979351|P5|Overall Study|Wrong Pain Condition|1
2596194|NCT01094782|8979352|P4|Overall Study|Wrong Pain Condition|2
2596195|NCT01094782|8979353|P3|Overall Study|Wrong Pain Condition|0
2596196|NCT01094782|8979354|P2|Overall Study|Wrong Pain Condition|0
2596197|NCT01094782|8979355|P1|Overall Study|Wrong Pain Condition|0
2596198|NCT01094782|8979350|P6|Overall Study|Hypertension|0
2596199|NCT01094782|8979351|P5|Overall Study|Hypertension|0
2596200|NCT01094782|8979352|P4|Overall Study|Hypertension|0
2596201|NCT01094782|8979353|P3|Overall Study|Hypertension|1
2596202|NCT01094782|8979354|P2|Overall Study|Hypertension|0
2596203|NCT01094782|8979355|P1|Overall Study|Hypertension|0
2596204|NCT01094782|8979350|P6|Overall Study|Healthy Subject Had Pain|0
2596205|NCT01094782|8979351|P5|Overall Study|Healthy Subject Had Pain|0
2596206|NCT01094782|8979352|P4|Overall Study|Healthy Subject Had Pain|0
2596207|NCT01094782|8979353|P3|Overall Study|Healthy Subject Had Pain|0
2596208|NCT01094782|8979354|P2|Overall Study|Healthy Subject Had Pain|1
2596209|NCT01094782|8979355|P1|Overall Study|Healthy Subject Had Pain|0
2596210|NCT01094782|8979350|P6|Overall Study|Unable to Complete Questionnaires|0
2596211|NCT01094782|8979351|P5|Overall Study|Unable to Complete Questionnaires|0
2596212|NCT01094782|8979352|P4|Overall Study|Unable to Complete Questionnaires|0
2596213|NCT01094782|8979353|P3|Overall Study|Unable to Complete Questionnaires|0
2596214|NCT01094782|8979354|P2|Overall Study|Unable to Complete Questionnaires|1
2596215|NCT01094782|8979355|P1|Overall Study|Unable to Complete Questionnaires|0
2596216|NCT01094782|8979350|P6|Overall Study|Sensory Deficit at Site of QST|0
2596217|NCT01094782|8979351|P5|Overall Study|Sensory Deficit at Site of QST|0
2596218|NCT01094782|8979352|P4|Overall Study|Sensory Deficit at Site of QST|0
2596219|NCT01094782|8979353|P3|Overall Study|Sensory Deficit at Site of QST|0
2596220|NCT01094782|8979354|P2|Overall Study|Sensory Deficit at Site of QST|1
2596221|NCT01094782|8979355|P1|Overall Study|Sensory Deficit at Site of QST|0
2596222|NCT01094782|8979350|P6|Overall Study|Positive Drug Screen|2
2596223|NCT01094782|8979351|P5|Overall Study|Positive Drug Screen|3
2596224|NCT01094782|8979352|P4|Overall Study|Positive Drug Screen|1
2596225|NCT01094782|8979353|P3|Overall Study|Positive Drug Screen|1
2596226|NCT01094782|8979354|P2|Overall Study|Positive Drug Screen|2
2596227|NCT01094782|8979355|P1|Overall Study|Positive Drug Screen|2
2596228|NCT01094782|8979350|P6|Overall Study|Lost to Follow-up|4
2596229|NCT01094782|8979351|P5|Overall Study|Lost to Follow-up|1
2596230|NCT01094782|8979352|P4|Overall Study|Lost to Follow-up|2
2596231|NCT01094782|8979353|P3|Overall Study|Lost to Follow-up|0
2596232|NCT01094782|8979354|P2|Overall Study|Lost to Follow-up|0
2596233|NCT01094782|8979355|P1|Overall Study|Lost to Follow-up|1
2596234|NCT01094782|8979350|P6|Overall Study|Withdrawal by Subject|0
2596235|NCT01094782|8979351|P5|Overall Study|Withdrawal by Subject|5
2596236|NCT01094782|8979352|P4|Overall Study|Withdrawal by Subject|5
2596237|NCT01094782|8979353|P3|Overall Study|Withdrawal by Subject|1
2596238|NCT01094782|8979354|P2|Overall Study|Withdrawal by Subject|5
2596239|NCT01094782|8979355|P1|Overall Study|Withdrawal by Subject|5
2596240|NCT01094743|8979399|P1|Period 1|Unsatisfactory comfort at lens fitting|2
2596241|NCT01094730|8979416|P2|Period 2 (14 Days)|Unsatisfactory lens fitting|1
2596242|NCT01094730|8979417|P1|Period 2 (14 Days)|Unsatisfactory lens fitting|0
2596243|NCT01094730|8979416|P2|Period 2 (14 Days)|Adverse Event|1
2596244|NCT01094730|8979417|P1|Period 2 (14 Days)|Adverse Event|0
2596245|NCT01094730|8979416|P2|Period 2 (14 Days)|No time for the follow-up visit|0
2596246|NCT01094730|8979417|P1|Period 2 (14 Days)|No time for the follow-up visit|1
2596247|NCT01094730|8979416|P2|Period 2 (14 Days)|Protocol Violation|0
2596248|NCT01094730|8979417|P1|Period 2 (14 Days)|Protocol Violation|2
2596249|NCT01094730|8979416|P2|Period 1 (14 Days)|Unsatisfactory visual response|0
2596250|NCT01094730|8979417|P1|Period 1 (14 Days)|Unsatisfactory visual response|1
2596251|NCT01094730|8979416|P2|Period 1 (14 Days)|No time for the follow-up visit|0
2596252|NCT01094730|8979417|P1|Period 1 (14 Days)|No time for the follow-up visit|1
2596253|NCT01094730|8979416|P2|Period 1 (14 Days)|Withdrawal by Subject|1
2596254|NCT01094730|8979417|P1|Period 1 (14 Days)|Withdrawal by Subject|0
2596255|NCT01094730|8979416|P2|Period 1 (14 Days)|Lost to Follow-up|1
2596256|NCT01094730|8979417|P1|Period 1 (14 Days)|Lost to Follow-up|0
2596257|NCT01094301|8979553|P1|Implant Stage|No return of pain|4
2596258|NCT01094301|8979553|P1|Implant Stage|Withdrawal by Subject|2
2596259|NCT01094301|8979553|P1|Implant Stage|Protocol Violation|1
2596260|NCT01094301|8979553|P1|Implant Stage|Adverse Event|1
2596261|NCT01094301|8979553|P1|Trial Stage|Withdrawal by Subject|1
2596262|NCT01094288|8979583|P8|Overall Study|Ongoing Participants|0
2596263|NCT01094288|8979584|P7|Overall Study|Ongoing Participants|0
2596264|NCT01094288|8979585|P6|Overall Study|Ongoing Participants|0
2596265|NCT01094288|8979586|P5|Overall Study|Ongoing Participants|0
2596266|NCT01094288|8979587|P4|Overall Study|Ongoing Participants|0
2596267|NCT01094288|8979588|P3|Overall Study|Ongoing Participants|0
2596268|NCT01094288|8979589|P2|Overall Study|Ongoing Participants|3
2596269|NCT01094288|8979590|P1|Overall Study|Ongoing Participants|0
2596270|NCT01094288|8979583|P8|Overall Study|Reason not Specified|0
2596271|NCT01094288|8979584|P7|Overall Study|Reason not Specified|0
2596272|NCT01094288|8979585|P6|Overall Study|Reason not Specified|0
2596273|NCT01094288|8979586|P5|Overall Study|Reason not Specified|0
2596274|NCT01094288|8979587|P4|Overall Study|Reason not Specified|1
2596275|NCT01094288|8979588|P3|Overall Study|Reason not Specified|0
2596276|NCT01094288|8979589|P2|Overall Study|Reason not Specified|3
2596277|NCT01094288|8979590|P1|Overall Study|Reason not Specified|2
2596278|NCT01094288|8979583|P8|Overall Study|Initiation of Alternative Therapy|0
2596279|NCT01094288|8979584|P7|Overall Study|Initiation of Alternative Therapy|0
2596280|NCT01094288|8979585|P6|Overall Study|Initiation of Alternative Therapy|0
2596281|NCT01094288|8979586|P5|Overall Study|Initiation of Alternative Therapy|0
2596282|NCT01094288|8979587|P4|Overall Study|Initiation of Alternative Therapy|0
2596283|NCT01094288|8979588|P3|Overall Study|Initiation of Alternative Therapy|1
2596284|NCT01094288|8979589|P2|Overall Study|Initiation of Alternative Therapy|0
2596285|NCT01094288|8979590|P1|Overall Study|Initiation of Alternative Therapy|0
2596286|NCT01094288|8979583|P8|Overall Study|Withdrawal by Subject|2
2596287|NCT01094288|8979584|P7|Overall Study|Withdrawal by Subject|0
2596288|NCT01094288|8979585|P6|Overall Study|Withdrawal by Subject|0
2596289|NCT01094288|8979586|P5|Overall Study|Withdrawal by Subject|0
2596290|NCT01094288|8979587|P4|Overall Study|Withdrawal by Subject|0
2596291|NCT01094288|8979588|P3|Overall Study|Withdrawal by Subject|2
2596292|NCT01094288|8979589|P2|Overall Study|Withdrawal by Subject|1
2596293|NCT01094288|8979590|P1|Overall Study|Withdrawal by Subject|0
2596294|NCT01094288|8979583|P8|Overall Study|Adverse Event|0
2596295|NCT01094288|8979584|P7|Overall Study|Adverse Event|0
2596296|NCT01094288|8979585|P6|Overall Study|Adverse Event|0
2596297|NCT01094288|8979586|P5|Overall Study|Adverse Event|0
2596298|NCT01094288|8979587|P4|Overall Study|Adverse Event|1
2596299|NCT01094288|8979588|P3|Overall Study|Adverse Event|1
2596300|NCT01094288|8979589|P2|Overall Study|Adverse Event|3
2596301|NCT01094288|8979590|P1|Overall Study|Adverse Event|0
2596302|NCT01094184|8979702|P2|Overall Study|Death|11
2596303|NCT01094184|8979703|P1|Overall Study|Death|35
2596304|NCT01094171|8979937|P1|Overall Study|Other|1
2596305|NCT01094171|8979937|P1|Overall Study|Migration from the study area|3
2596306|NCT01094171|8979937|P1|Overall Study|Informed consent withdrawal|4
2596307|NCT01094171|8979937|P1|Overall Study|Lost to Follow-up|2
2596308|NCT01094119|8979946|P2|Overall Study|Lack of Efficacy|4
2596309|NCT01094119|8979947|P1|Overall Study|Lack of Efficacy|2
2596310|NCT01093885|8979959|P1|Overall Study|Lost to Follow-up|1
2596311|NCT01093885|8979959|P1|Overall Study|Adverse Event|4
2596312|NCT01093846|8979967|P3|Overall Study|Administrative Problems|15
2596313|NCT01093846|8979968|P2|Overall Study|Administrative Problems|17
2596314|NCT01093846|8979969|P1|Overall Study|Administrative Problems|18
2596315|NCT01093846|8979967|P3|Overall Study|Condition no longer required study drug|1
2596316|NCT01093846|8979968|P2|Overall Study|Condition no longer required study drug|1
2596317|NCT01093846|8979969|P1|Overall Study|Condition no longer required study drug|1
2596318|NCT01093846|8979967|P3|Overall Study|Lack of Efficacy|4
2596319|NCT01093846|8979968|P2|Overall Study|Lack of Efficacy|0
2596320|NCT01093846|8979969|P1|Overall Study|Lack of Efficacy|0
2596321|NCT01093846|8979967|P3|Overall Study|Adverse Event|1
2596322|NCT01093846|8979968|P2|Overall Study|Adverse Event|0
2596323|NCT01093846|8979969|P1|Overall Study|Adverse Event|0
2596324|NCT01093755|8979994|P2|Overall Study|Withdrawal by Subject|4
2596325|NCT01093755|8979995|P1|Overall Study|Withdrawal by Subject|3
2596326|NCT01093625|8980035|P2|1-Year Visit|Lost to Follow-up|3
2596327|NCT01093625|8980036|P1|1-Year Visit|Lost to Follow-up|5
2596328|NCT01093625|8980035|P2|6-Month Visit|Lost to Follow-up|2
2596329|NCT01093625|8980036|P1|6-Month Visit|Lost to Follow-up|2
2596330|NCT01093625|8980035|P2|6-Month Visit|Withdrawal by Subject|7
2596331|NCT01093625|8980036|P1|6-Month Visit|Withdrawal by Subject|6
2596332|NCT01093625|8980035|P2|3-Month Visit|Lost to Follow-up|0
2596333|NCT01093625|8980036|P1|3-Month Visit|Lost to Follow-up|2
2596334|NCT01093625|8980035|P2|1-Month Visit|Lost to Follow-up|0
2596335|NCT01093625|8980036|P1|1-Month Visit|Lost to Follow-up|2
2596336|NCT01093625|8980035|P2|2-Week Visit|Withdrawal by Subject|0
2596337|NCT01093625|8980036|P1|2-Week Visit|Withdrawal by Subject|1
2596338|NCT01093625|8980035|P2|Baseline and Dispensed|Withdrawal by Subject|0
2596339|NCT01093625|8980036|P1|Baseline and Dispensed|Withdrawal by Subject|2
2596340|NCT01093599|8980056|P2|Overall Study|Lost to Follow-up|46
2596341|NCT01093599|8980057|P1|Overall Study|Lost to Follow-up|32
2596342|NCT01093586|8980063|P1|Overall Study|Failed to engraft|3
2596343|NCT01093534|8980084|P3|Overall Study|Other|4
2596344|NCT01093534|8980085|P2|Overall Study|Other|3
2596345|NCT01093534|8980086|P1|Overall Study|Other|1
2596346|NCT01093534|8980084|P3|Overall Study|Withdrawal by Subject|2
2596347|NCT01093534|8980085|P2|Overall Study|Withdrawal by Subject|7
2596348|NCT01093534|8980086|P1|Overall Study|Withdrawal by Subject|5
2596349|NCT01093534|8980084|P3|Overall Study|Lack of Efficacy|1
2596350|NCT01093534|8980085|P2|Overall Study|Lack of Efficacy|1
2596351|NCT01093534|8980086|P1|Overall Study|Lack of Efficacy|2
2596352|NCT01093534|8980084|P3|Overall Study|Adverse Event|2
2596353|NCT01093534|8980085|P2|Overall Study|Adverse Event|5
2596354|NCT01093534|8980086|P1|Overall Study|Adverse Event|2
2596355|NCT01093222|8980234|P1|Overall Study|Not protocol specified|1
2596356|NCT01093222|8980234|P1|Overall Study|Death|2
2596357|NCT01093222|8980234|P1|Overall Study|Progression/relapse|24
2596358|NCT01093222|8980234|P1|Overall Study|Adverse Event|7
2596359|NCT01093222|8980234|P1|Overall Study|Ineligible|6
2596360|NCT01092832|8980310|P2|Overall Study|Other|0
2596361|NCT01092832|8980311|P1|Overall Study|Other|1
2596362|NCT01092780|8980323|P4|Washout Period 2|Adverse Event|0
2596363|NCT01092780|8980324|P3|Washout Period 2|Adverse Event|1
2596364|NCT01092780|8980325|P2|Washout Period 2|Adverse Event|1
2596365|NCT01092780|8980326|P1|Washout Period 2|Adverse Event|0
2596366|NCT01092780|8980323|P4|Washout Period 1|Noncompliance with nCPAP|0
2596367|NCT01092780|8980324|P3|Washout Period 1|Noncompliance with nCPAP|0
2596368|NCT01092780|8980325|P2|Washout Period 1|Noncompliance with nCPAP|0
2596369|NCT01092780|8980326|P1|Washout Period 1|Noncompliance with nCPAP|1
2596370|NCT01092780|8980323|P4|Washout Period 1|Adverse Event|0
2596371|NCT01092780|8980324|P3|Washout Period 1|Adverse Event|0
2596372|NCT01092780|8980325|P2|Washout Period 1|Adverse Event|1
2596373|NCT01092780|8980326|P1|Washout Period 1|Adverse Event|0
2596374|NCT01092728|8980362|P2|Overall Study|Prohibited Concomitant Medications|0
2596375|NCT01092728|8980363|P1|Overall Study|Prohibited Concomitant Medications|1
2596376|NCT01092728|8980362|P2|Overall Study|Disease Progression|13
2596377|NCT01092728|8980363|P1|Overall Study|Disease Progression|1
2596378|NCT01092728|8980362|P2|Overall Study|Adverse Event|1
2596379|NCT01092728|8980363|P1|Overall Study|Adverse Event|0
2596380|NCT01092728|8980362|P2|Overall Study|Withdrawal by Subject|0
2596381|NCT01092728|8980363|P1|Overall Study|Withdrawal by Subject|2
2596382|NCT01092702|8980371|P1|Overall Study|Lost to Follow-up|2
2596383|NCT01092702|8980371|P1|Overall Study|Withdrawal by Subject|7
2596384|NCT01092663|8980388|P2|Overall Study|Protocol Violation|1
2596385|NCT01092663|8980389|P1|Overall Study|Protocol Violation|0
2596386|NCT01092663|8980388|P2|Overall Study|Adverse Event|1
2596387|NCT01092663|8980389|P1|Overall Study|Adverse Event|1
2596388|NCT01092663|8980388|P2|Overall Study|High fasting triglyceride|0
2596389|NCT01092663|8980389|P1|Overall Study|High fasting triglyceride|2
2596390|NCT01092663|8980388|P2|Overall Study|Glucose >300mg/dL|0
2596391|NCT01092663|8980389|P1|Overall Study|Glucose >300mg/dL|1
2596392|NCT01092663|8980388|P2|Overall Study|Withdrawal by Subject|2
2596393|NCT01092663|8980389|P1|Overall Study|Withdrawal by Subject|3
2596394|NCT01092637|8980437|P2|Overall Study|Death|49
2596395|NCT01092637|8980438|P1|Overall Study|Death|47
2596396|NCT01092546|8980453|P1|Overall Study|Subjects withdrawn prior to dosing|4
2596397|NCT01092507|8980460|P2|Overall Study|Withdrawal by Subject|0
2596398|NCT01092507|8980461|P1|Overall Study|Withdrawal by Subject|2
2596399|NCT01092416|8980496|P1|12-Month Follow-up|Data collected after close of 1Y window|2
2596400|NCT01092416|8980496|P1|12-Month Follow-up|Missed 1-year follow-up|1
2596401|NCT01092416|8980496|P1|12-Month Follow-up|Withdrawal by Subject|2
2596402|NCT01092416|8980496|P1|12-Month Follow-up|Lost to Follow-up|4
2596403|NCT01092416|8980496|P1|12-Month Follow-up|Death|16
2596404|NCT01092416|8980496|P1|30-Day Follow-up|Data collected after close of 30D window|5
2596405|NCT01092416|8980496|P1|30-Day Follow-up|Missed 30-day follow-up|3
2596406|NCT01092416|8980496|P1|30-Day Follow-up|Death|2
2596407|NCT01092416|8980496|P1|Enrollment|Atherectomy device not inserted|3
2596408|NCT01091974|8980546|P4|Overall Study|side-effects|2
2596409|NCT01091974|8980547|P3|Overall Study|side-effects|0
2596410|NCT01091974|8980548|P2|Overall Study|side-effects|1
2596411|NCT01091974|8980549|P1|Overall Study|side-effects|1
2596412|NCT01091974|8980546|P4|Overall Study|Withdrawal by Subject|2
2596413|NCT01091974|8980547|P3|Overall Study|Withdrawal by Subject|2
2596414|NCT01091974|8980548|P2|Overall Study|Withdrawal by Subject|3
2596415|NCT01091974|8980549|P1|Overall Study|Withdrawal by Subject|1
2596416|NCT01091974|8980546|P4|Overall Study|resumed sleep medication|2
2596417|NCT01091974|8980547|P3|Overall Study|resumed sleep medication|1
2596418|NCT01091974|8980548|P2|Overall Study|resumed sleep medication|0
2596419|NCT01091974|8980549|P1|Overall Study|resumed sleep medication|0
2596420|NCT01091974|8980546|P4|Overall Study|Did not start intervention|1
2596421|NCT01091974|8980547|P3|Overall Study|Did not start intervention|3
2596422|NCT01091974|8980548|P2|Overall Study|Did not start intervention|1
2596423|NCT01091974|8980549|P1|Overall Study|Did not start intervention|3
2596424|NCT01091675|8980584|P1|Overall Study|Lack of Efficacy|27
2596425|NCT01091675|8980584|P1|Overall Study|Adverse Event|7
2596426|NCT01091662|8980590|P2|Overall Study|unable to swallow capsule|1
2596427|NCT01091662|8980591|P1|Overall Study|unable to swallow capsule|0
2596428|NCT01091662|8980590|P2|Overall Study|Protocol Violation|2
2596429|NCT01091662|8980591|P1|Overall Study|Protocol Violation|0
2596430|NCT01091662|8980590|P2|Overall Study|Pregnancy|1
2596431|NCT01091662|8980591|P1|Overall Study|Pregnancy|0
2596432|NCT01091662|8980590|P2|Overall Study|Lost to Follow-up|1
2596433|NCT01091662|8980591|P1|Overall Study|Lost to Follow-up|0
2596434|NCT01091662|8980590|P2|Overall Study|met exclusion criteria|0
2596435|NCT01091662|8980591|P1|Overall Study|met exclusion criteria|1
2596436|NCT01091662|8980590|P2|Overall Study|met exit criteria|13
2596437|NCT01091662|8980591|P1|Overall Study|met exit criteria|7
2596438|NCT01091662|8980590|P2|Overall Study|Withdrawal by Subject|6
2596439|NCT01091662|8980591|P1|Overall Study|Withdrawal by Subject|7
2596440|NCT01091662|8980590|P2|Overall Study|Physician Decision|1
2596441|NCT01091662|8980591|P1|Overall Study|Physician Decision|1
2596442|NCT01091662|8980590|P2|Overall Study|Adverse Event|9
2596443|NCT01091662|8980591|P1|Overall Study|Adverse Event|1
2596444|NCT01091519|8980629|P2|Overall Study|Randomized not treated|4
2596445|NCT01091519|8980630|P1|Overall Study|Randomized not treated|4
2596446|NCT01091519|8980629|P2|Overall Study|Other|8
2596447|NCT01091519|8980630|P1|Overall Study|Other|6
2596448|NCT01091519|8980629|P2|Overall Study|Withdrawal by Subject|2
2596449|NCT01091519|8980630|P1|Overall Study|Withdrawal by Subject|2
2596450|NCT01091519|8980629|P2|Overall Study|Lost to Follow-up|24
2596451|NCT01091519|8980630|P1|Overall Study|Lost to Follow-up|14
2596452|NCT01091519|8980629|P2|Overall Study|Lack of Efficacy|19
2596453|NCT01091519|8980630|P1|Overall Study|Lack of Efficacy|16
2596454|NCT01091519|8980629|P2|Overall Study|Death|0
2596455|NCT01091519|8980630|P1|Overall Study|Death|1
2596456|NCT01091519|8980629|P2|Overall Study|Adverse Event|16
2596457|NCT01091519|8980630|P1|Overall Study|Adverse Event|12
2596458|NCT01091454|8980642|P1|Overall Study|Ineligible|1
2596459|NCT01091428|8980655|P4|Phase 2|Physician Decision|0
2596460|NCT01091428|8980656|P3|Phase 2|Physician Decision|2
2596461|NCT01091428|8980657|P2|Phase 2|Physician Decision|0
2596462|NCT01091428|8980658|P1|Phase 2|Physician Decision|0
2596463|NCT01091428|8980655|P4|Phase 2|Reason not specified|3
2596464|NCT01091428|8980656|P3|Phase 2|Reason not specified|4
2596465|NCT01091428|8980657|P2|Phase 2|Reason not specified|0
2596466|NCT01091428|8980658|P1|Phase 2|Reason not specified|0
2596467|NCT01091428|8980655|P4|Phase 2|Unsatisfactory Therapeutic Response|1
2596468|NCT01091428|8980656|P3|Phase 2|Unsatisfactory Therapeutic Response|1
2596469|NCT01091428|8980657|P2|Phase 2|Unsatisfactory Therapeutic Response|0
2596470|NCT01091428|8980658|P1|Phase 2|Unsatisfactory Therapeutic Response|0
2596471|NCT01091428|8980655|P4|Phase 2|Withdrawal by Subject|8
2596472|NCT01091428|8980656|P3|Phase 2|Withdrawal by Subject|9
2596473|NCT01091428|8980657|P2|Phase 2|Withdrawal by Subject|0
2596474|NCT01091428|8980658|P1|Phase 2|Withdrawal by Subject|0
2596475|NCT01091428|8980655|P4|Phase 2|Adverse Event|5
2596476|NCT01091428|8980656|P3|Phase 2|Adverse Event|12
2596477|NCT01091428|8980657|P2|Phase 2|Adverse Event|0
2596478|NCT01091428|8980658|P1|Phase 2|Adverse Event|0
2596479|NCT01091428|8980655|P4|Phase 2|Symptomatic Deterioration|6
2596480|NCT01091428|8980656|P3|Phase 2|Symptomatic Deterioration|1
2596481|NCT01091428|8980657|P2|Phase 2|Symptomatic Deterioration|0
2596482|NCT01091428|8980658|P1|Phase 2|Symptomatic Deterioration|0
2596483|NCT01091428|8980655|P4|Phase 2|Progressive Disease|46
2596484|NCT01091428|8980656|P3|Phase 2|Progressive Disease|44
2596485|NCT01091428|8980657|P2|Phase 2|Progressive Disease|0
2596486|NCT01091428|8980658|P1|Phase 2|Progressive Disease|0
2596487|NCT01091428|8980655|P4|Phase 1|Single-Patient IND|0
2596488|NCT01091428|8980656|P3|Phase 1|Single-Patient IND|0
2596489|NCT01091428|8980657|P2|Phase 1|Single-Patient IND|0
2596490|NCT01091428|8980658|P1|Phase 1|Single-Patient IND|2
2596491|NCT01091428|8980655|P4|Phase 1|Reason not specified|0
2596492|NCT01091428|8980656|P3|Phase 1|Reason not specified|0
2596493|NCT01091428|8980657|P2|Phase 1|Reason not specified|1
2596494|NCT01091428|8980658|P1|Phase 1|Reason not specified|0
2596495|NCT01091428|8980655|P4|Phase 1|Withdrawal by Subject|0
2596496|NCT01091428|8980656|P3|Phase 1|Withdrawal by Subject|0
2596497|NCT01091428|8980657|P2|Phase 1|Withdrawal by Subject|0
2596498|NCT01091428|8980658|P1|Phase 1|Withdrawal by Subject|7
2596499|NCT01091428|8980655|P4|Phase 1|Adverse Event|0
2596500|NCT01091428|8980656|P3|Phase 1|Adverse Event|0
2596501|NCT01091428|8980657|P2|Phase 1|Adverse Event|0
2596502|NCT01091428|8980658|P1|Phase 1|Adverse Event|2
2596503|NCT01091428|8980655|P4|Phase 1|Symptomatic Deterioration|0
2596504|NCT01091428|8980656|P3|Phase 1|Symptomatic Deterioration|0
2596505|NCT01091428|8980657|P2|Phase 1|Symptomatic Deterioration|2
2596506|NCT01091428|8980658|P1|Phase 1|Symptomatic Deterioration|3
2596507|NCT01091428|8980655|P4|Phase 1|Progressive Disease|0
2596508|NCT01091428|8980656|P3|Phase 1|Progressive Disease|0
2596509|NCT01091428|8980657|P2|Phase 1|Progressive Disease|8
2596510|NCT01091428|8980658|P1|Phase 1|Progressive Disease|24
2596511|NCT01091363|8980761|P2|Overall Study|Lost to Follow-up|2
2596512|NCT01091363|8980762|P1|Overall Study|Lost to Follow-up|2
2596513|NCT01091363|8980761|P2|Overall Study|Withdrawal by Subject|15
2596514|NCT01091363|8980762|P1|Overall Study|Withdrawal by Subject|11
2596515|NCT01091259|8980772|P1|Overall Study|Lack of Efficacy|2
2596516|NCT01091259|8980772|P1|Overall Study|Adverse Event|3
2596517|NCT01091246|8980783|P3|Overall Study|Subject not dosed|1
2596518|NCT01091246|8980784|P2|Overall Study|Subject not dosed|0
2596519|NCT01091246|8980785|P1|Overall Study|Subject not dosed|2
2596520|NCT01091246|8980783|P3|Overall Study|Withdrawal by Subject|4
2596521|NCT01091246|8980784|P2|Overall Study|Withdrawal by Subject|5
2596522|NCT01091246|8980785|P1|Overall Study|Withdrawal by Subject|9
2596523|NCT01091246|8980783|P3|Overall Study|Adverse Event|1
2596524|NCT01091246|8980784|P2|Overall Study|Adverse Event|0
2596525|NCT01091246|8980785|P1|Overall Study|Adverse Event|1
2596526|NCT01091246|8980783|P3|Overall Study|Lost to Follow-up|7
2596527|NCT01091246|8980784|P2|Overall Study|Lost to Follow-up|11
2596528|NCT01091246|8980785|P1|Overall Study|Lost to Follow-up|23
2596529|NCT01091168|8980861|P2|Overall Study|Physician, patient's decision, other|37
2596530|NCT01091168|8980862|P1|Overall Study|Physician, patient's decision, other|27
2596531|NCT01091168|8980861|P2|Overall Study|Lost to Follow-up|1
2596532|NCT01091168|8980862|P1|Overall Study|Lost to Follow-up|0
2596533|NCT01091168|8980861|P2|Overall Study|Adverse Event|24
2596534|NCT01091168|8980862|P1|Overall Study|Adverse Event|21
2596535|NCT01091168|8980861|P2|Overall Study|Progressive disease|234
2596536|NCT01091168|8980862|P1|Overall Study|Progressive disease|250
2596537|NCT01091103|8980937|P1|Overall Study|Progressive Disease|3
2596538|NCT01091103|8980937|P1|Overall Study|Adverse Event|1
2596539|NCT01090973|8980957|P1|Overall Study|Disease progression|1
2596540|NCT01090765|8980973|P6|Overall Study|Vasovagal reaction with first infusion|0
2596541|NCT01090765|8980974|P5|Overall Study|Vasovagal reaction with first infusion|1
2596542|NCT01090765|8980975|P4|Overall Study|Vasovagal reaction with first infusion|0
2596543|NCT01090765|8980976|P3|Overall Study|Vasovagal reaction with first infusion|0
2596544|NCT01090765|8980977|P2|Overall Study|Vasovagal reaction with first infusion|0
2596545|NCT01090765|8980978|P1|Overall Study|Vasovagal reaction with first infusion|0
2596546|NCT01090765|8980973|P6|Overall Study|Developed a DVT, needed anticoagulation|0
2596547|NCT01090765|8980974|P5|Overall Study|Developed a DVT, needed anticoagulation|0
2596548|NCT01090765|8980975|P4|Overall Study|Developed a DVT, needed anticoagulation|1
2596549|NCT01090765|8980976|P3|Overall Study|Developed a DVT, needed anticoagulation|0
2596550|NCT01090765|8980977|P2|Overall Study|Developed a DVT, needed anticoagulation|0
2596551|NCT01090765|8980978|P1|Overall Study|Developed a DVT, needed anticoagulation|0
2596552|NCT01090765|8980973|P6|Overall Study|Patient withdrew consent|1
2596553|NCT01090765|8980974|P5|Overall Study|Patient withdrew consent|1
2596554|NCT01090765|8980975|P4|Overall Study|Patient withdrew consent|0
2596555|NCT01090765|8980976|P3|Overall Study|Patient withdrew consent|0
2596556|NCT01090765|8980977|P2|Overall Study|Patient withdrew consent|0
2596557|NCT01090765|8980978|P1|Overall Study|Patient withdrew consent|0
2596558|NCT01090739|8981024|P1|36 Month Follow-up|Visit still pending|17
2596559|NCT01090739|8981024|P1|36 Month Follow-up|Withdrawal by Subject|6
2596560|NCT01090739|8981024|P1|24 Month Follow-up|Death|1
2596561|NCT01090739|8981024|P1|24 Month Follow-up|Lost to Follow-up|1
2596562|NCT01090739|8981024|P1|24 Month Follow-up|Withdrawal by Subject|7
2596563|NCT01090739|8981024|P1|12 Month Follow-up|Death|1
2596564|NCT01090739|8981024|P1|12 Month Follow-up|Physician Decision|1
2596565|NCT01090739|8981024|P1|12 Month Follow-up|Lost to Follow-up|1
2596566|NCT01090739|8981024|P1|12 Month Follow-up|Withdrawal by Subject|2
2596567|NCT01090739|8981024|P1|Enrollment|Adverse Event|1
2596568|NCT01090739|8981024|P1|Enrollment|Study implant limit reached|2
2596569|NCT01090739|8981024|P1|Enrollment|Sponsor termination of site|4
2596570|NCT01090739|8981024|P1|Enrollment|Physician Decision|5
2596571|NCT01090739|8981024|P1|Enrollment|Lost to Follow-up|5
2596572|NCT01090739|8981024|P1|Enrollment|Protocol Violation|14
2596573|NCT01090739|8981024|P1|Enrollment|Withdrawal by Subject|24
2596574|NCT01090492|8981049|P8|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
2596575|NCT01090492|8981050|P7|Second Intervention Period (4 Weeks)|Lost to Follow-up|1
2596576|NCT01090492|8981051|P6|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
2596577|NCT01090492|8981052|P5|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
2596578|NCT01090492|8981053|P4|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
2596579|NCT01090492|8981054|P3|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
2596580|NCT01090492|8981055|P2|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
2596581|NCT01090492|8981056|P1|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
2596582|NCT01090492|8981049|P8|Second Intervention Period (4 Weeks)|Adverse Event|1
2596583|NCT01090492|8981050|P7|Second Intervention Period (4 Weeks)|Adverse Event|7
2596584|NCT01090492|8981051|P6|Second Intervention Period (4 Weeks)|Adverse Event|1
2596585|NCT01090492|8981052|P5|Second Intervention Period (4 Weeks)|Adverse Event|1
2596586|NCT01090492|8981053|P4|Second Intervention Period (4 Weeks)|Adverse Event|0
2596587|NCT01090492|8981054|P3|Second Intervention Period (4 Weeks)|Adverse Event|1
2596588|NCT01090492|8981055|P2|Second Intervention Period (4 Weeks)|Adverse Event|0
2596589|NCT01090492|8981056|P1|Second Intervention Period (4 Weeks)|Adverse Event|0
2596590|NCT01090492|8981049|P8|Second Intervention Period (4 Weeks)|Other|0
2596591|NCT01090492|8981050|P7|Second Intervention Period (4 Weeks)|Other|0
2596592|NCT01090492|8981051|P6|Second Intervention Period (4 Weeks)|Other|0
2596593|NCT01090492|8981052|P5|Second Intervention Period (4 Weeks)|Other|0
2596594|NCT01090492|8981053|P4|Second Intervention Period (4 Weeks)|Other|0
2596595|NCT01090492|8981054|P3|Second Intervention Period (4 Weeks)|Other|1
2596596|NCT01090492|8981055|P2|Second Intervention Period (4 Weeks)|Other|1
2596597|NCT01090492|8981056|P1|Second Intervention Period (4 Weeks)|Other|0
2596598|NCT01090492|8981049|P8|Second Intervention Period (4 Weeks)|Non-compliance|0
2596599|NCT01090492|8981050|P7|Second Intervention Period (4 Weeks)|Non-compliance|0
2596600|NCT01090492|8981051|P6|Second Intervention Period (4 Weeks)|Non-compliance|0
2596601|NCT01090492|8981052|P5|Second Intervention Period (4 Weeks)|Non-compliance|0
2596602|NCT01090492|8981053|P4|Second Intervention Period (4 Weeks)|Non-compliance|0
2596603|NCT01090492|8981054|P3|Second Intervention Period (4 Weeks)|Non-compliance|0
2596604|NCT01090492|8981055|P2|Second Intervention Period (4 Weeks)|Non-compliance|1
2596605|NCT01090492|8981056|P1|Second Intervention Period (4 Weeks)|Non-compliance|0
2596606|NCT01090492|8981049|P8|Second Intervention Period (4 Weeks)|Protocol Violation|1
2596607|NCT01090492|8981050|P7|Second Intervention Period (4 Weeks)|Protocol Violation|1
2596608|NCT01090492|8981051|P6|Second Intervention Period (4 Weeks)|Protocol Violation|0
2596609|NCT01090492|8981052|P5|Second Intervention Period (4 Weeks)|Protocol Violation|1
2596610|NCT01090492|8981053|P4|Second Intervention Period (4 Weeks)|Protocol Violation|0
2596611|NCT01090492|8981054|P3|Second Intervention Period (4 Weeks)|Protocol Violation|0
2596612|NCT01090492|8981055|P2|Second Intervention Period (4 Weeks)|Protocol Violation|0
2596613|NCT01090492|8981056|P1|Second Intervention Period (4 Weeks)|Protocol Violation|1
2596614|NCT01090492|8981049|P8|First Intervention Period (4 Weeks)|Adverse Event|5
2596615|NCT01090492|8981050|P7|First Intervention Period (4 Weeks)|Adverse Event|0
2596616|NCT01090492|8981051|P6|First Intervention Period (4 Weeks)|Adverse Event|2
2596617|NCT01090492|8981052|P5|First Intervention Period (4 Weeks)|Adverse Event|1
2596618|NCT01090492|8981053|P4|First Intervention Period (4 Weeks)|Adverse Event|3
2596619|NCT01090492|8981054|P3|First Intervention Period (4 Weeks)|Adverse Event|0
2596620|NCT01090492|8981055|P2|First Intervention Period (4 Weeks)|Adverse Event|2
2596621|NCT01090492|8981056|P1|First Intervention Period (4 Weeks)|Adverse Event|0
2596622|NCT01090492|8981049|P8|First Intervention Period (4 Weeks)|Pregnancy|0
2596623|NCT01090492|8981050|P7|First Intervention Period (4 Weeks)|Pregnancy|0
2596624|NCT01090492|8981051|P6|First Intervention Period (4 Weeks)|Pregnancy|0
2596625|NCT01090492|8981052|P5|First Intervention Period (4 Weeks)|Pregnancy|1
2596626|NCT01090492|8981053|P4|First Intervention Period (4 Weeks)|Pregnancy|0
2596627|NCT01090492|8981054|P3|First Intervention Period (4 Weeks)|Pregnancy|0
2596628|NCT01090492|8981055|P2|First Intervention Period (4 Weeks)|Pregnancy|0
2596629|NCT01090492|8981056|P1|First Intervention Period (4 Weeks)|Pregnancy|0
2596630|NCT01090492|8981049|P8|First Intervention Period (4 Weeks)|Other|0
2596631|NCT01090492|8981050|P7|First Intervention Period (4 Weeks)|Other|0
2596632|NCT01090492|8981051|P6|First Intervention Period (4 Weeks)|Other|0
2596633|NCT01090492|8981052|P5|First Intervention Period (4 Weeks)|Other|2
2596634|NCT01090492|8981053|P4|First Intervention Period (4 Weeks)|Other|1
2596635|NCT01090492|8981054|P3|First Intervention Period (4 Weeks)|Other|1
2596636|NCT01090492|8981055|P2|First Intervention Period (4 Weeks)|Other|0
2596637|NCT01090492|8981056|P1|First Intervention Period (4 Weeks)|Other|0
2596638|NCT01090492|8981049|P8|First Intervention Period (4 Weeks)|Lost to Follow-up|0
2596639|NCT01090492|8981050|P7|First Intervention Period (4 Weeks)|Lost to Follow-up|0
2596640|NCT01090492|8981051|P6|First Intervention Period (4 Weeks)|Lost to Follow-up|0
2596641|NCT01090492|8981052|P5|First Intervention Period (4 Weeks)|Lost to Follow-up|0
2596642|NCT01090492|8981053|P4|First Intervention Period (4 Weeks)|Lost to Follow-up|0
2596643|NCT01090492|8981054|P3|First Intervention Period (4 Weeks)|Lost to Follow-up|1
2596644|NCT01090492|8981055|P2|First Intervention Period (4 Weeks)|Lost to Follow-up|0
2596645|NCT01090492|8981056|P1|First Intervention Period (4 Weeks)|Lost to Follow-up|0
2596646|NCT01090492|8981049|P8|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1
2596647|NCT01090492|8981050|P7|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
2596648|NCT01090492|8981051|P6|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
2596649|NCT01090492|8981052|P5|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
2596650|NCT01090492|8981053|P4|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
2596651|NCT01090492|8981054|P3|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
2596652|NCT01090492|8981055|P2|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2
2596653|NCT01090492|8981056|P1|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
2596654|NCT01090492|8981049|P8|First Intervention Period (4 Weeks)|Protocol Violation|0
2596655|NCT01090492|8981050|P7|First Intervention Period (4 Weeks)|Protocol Violation|1
2596656|NCT01090492|8981051|P6|First Intervention Period (4 Weeks)|Protocol Violation|0
2596657|NCT01090492|8981052|P5|First Intervention Period (4 Weeks)|Protocol Violation|0
2596658|NCT01090492|8981053|P4|First Intervention Period (4 Weeks)|Protocol Violation|2
2596659|NCT01090492|8981054|P3|First Intervention Period (4 Weeks)|Protocol Violation|1
2596660|NCT01090492|8981055|P2|First Intervention Period (4 Weeks)|Protocol Violation|1
2596661|NCT01090492|8981056|P1|First Intervention Period (4 Weeks)|Protocol Violation|1
2596662|NCT01090453|8981124|P2|Overall Study|Eligibility Criteria|1
2596663|NCT01090453|8981125|P1|Overall Study|Eligibility Criteria|0
2596664|NCT01090453|8981124|P2|Overall Study|Other|4
2596665|NCT01090453|8981125|P1|Overall Study|Other|2
2596666|NCT01090453|8981124|P2|Overall Study|Protocol Violation|0
2596667|NCT01090453|8981125|P1|Overall Study|Protocol Violation|2
2596668|NCT01090453|8981124|P2|Overall Study|Non serious AEs|0
2596669|NCT01090453|8981125|P1|Overall Study|Non serious AEs|1
2596670|NCT01090453|8981124|P2|Overall Study|Lost to Follow-up|7
2596671|NCT01090453|8981125|P1|Overall Study|Lost to Follow-up|7
2596672|NCT01090453|8981124|P2|Overall Study|Withdrawal by Subject|2
2596673|NCT01090453|8981125|P1|Overall Study|Withdrawal by Subject|1
2596674|NCT01090427|8981176|P7|After Controlled Period|Adverse Event|0
2596675|NCT01090427|8981177|P6|After Controlled Period|Adverse Event|1
2596676|NCT01090427|8981178|P5|After Controlled Period|Adverse Event|0
2596677|NCT01090427|8981179|P4|After Controlled Period|Adverse Event|2
2596678|NCT01090427|8981180|P3|After Controlled Period|Adverse Event|0
2596679|NCT01090427|8981181|P2|After Controlled Period|Adverse Event|0
2596680|NCT01090427|8981182|P1|After Controlled Period|Adverse Event|0
2596681|NCT01090427|8981176|P7|After Controlled Period|Lack of Efficacy|2
2596682|NCT01090427|8981177|P6|After Controlled Period|Lack of Efficacy|3
2596683|NCT01090427|8981178|P5|After Controlled Period|Lack of Efficacy|0
2596684|NCT01090427|8981179|P4|After Controlled Period|Lack of Efficacy|0
2596685|NCT01090427|8981180|P3|After Controlled Period|Lack of Efficacy|0
2596686|NCT01090427|8981181|P2|After Controlled Period|Lack of Efficacy|0
2596687|NCT01090427|8981182|P1|After Controlled Period|Lack of Efficacy|0
2596688|NCT01090427|8981176|P7|After Controlled Period|Death|0
2596689|NCT01090427|8981177|P6|After Controlled Period|Death|1
2596690|NCT01090427|8981178|P5|After Controlled Period|Death|0
2596691|NCT01090427|8981179|P4|After Controlled Period|Death|0
2596692|NCT01090427|8981180|P3|After Controlled Period|Death|0
2596693|NCT01090427|8981181|P2|After Controlled Period|Death|0
2596694|NCT01090427|8981182|P1|After Controlled Period|Death|0
2596695|NCT01090414|8981219|P4|Study 101-99|Participant Request|0
2596696|NCT01090414|8981220|P3|Study 101-99|Participant Request|0
2596697|NCT01090414|8981221|P2|Study 101-99|Participant Request|1
2596698|NCT01090414|8981222|P1|Study 101-99|Participant Request|3
2596699|NCT01090414|8981219|P4|Study 101-99|Withdrew Consent|1
2596700|NCT01090414|8981220|P3|Study 101-99|Withdrew Consent|3
2596701|NCT01090414|8981221|P2|Study 101-99|Withdrew Consent|2
2596702|NCT01090414|8981222|P1|Study 101-99|Withdrew Consent|0
2596703|NCT01090414|8981219|P4|Study 101-99|Other (Unknown Reasons)|0
2596704|NCT01090414|8981220|P3|Study 101-99|Other (Unknown Reasons)|0
2596705|NCT01090414|8981221|P2|Study 101-99|Other (Unknown Reasons)|3
2596706|NCT01090414|8981222|P1|Study 101-99|Other (Unknown Reasons)|3
2596707|NCT01090414|8981219|P4|Study 101-99|Sponsor Discontinued Study|0
2596708|NCT01090414|8981220|P3|Study 101-99|Sponsor Discontinued Study|5
2596709|NCT01090414|8981221|P2|Study 101-99|Sponsor Discontinued Study|7
2596710|NCT01090414|8981222|P1|Study 101-99|Sponsor Discontinued Study|0
2596711|NCT01090414|8981219|P4|Study 101-99|Death|0
2596712|NCT01090414|8981220|P3|Study 101-99|Death|1
2596713|NCT01090414|8981221|P2|Study 101-99|Death|8
2596714|NCT01090414|8981222|P1|Study 101-99|Death|3
2596715|NCT01090414|8981219|P4|Study 101-99|Investigator Request|0
2596716|NCT01090414|8981220|P3|Study 101-99|Investigator Request|4
2596717|NCT01090414|8981221|P2|Study 101-99|Investigator Request|11
2596718|NCT01090414|8981222|P1|Study 101-99|Investigator Request|1
2596719|NCT01090414|8981219|P4|Study 101-99|Adverse Event|0
2596720|NCT01090414|8981220|P3|Study 101-99|Adverse Event|18
2596721|NCT01090414|8981221|P2|Study 101-99|Adverse Event|28
2596722|NCT01090414|8981222|P1|Study 101-99|Adverse Event|10
2596723|NCT01090414|8981219|P4|Study 101-99|Progressive Disease|4
2596724|NCT01090414|8981220|P3|Study 101-99|Progressive Disease|10
2596725|NCT01090414|8981221|P2|Study 101-99|Progressive Disease|48
2596726|NCT01090414|8981222|P1|Study 101-99|Progressive Disease|28
2596727|NCT01090323|8981289|P2|Overall Study|Stopped end of extension 1#|1
2596728|NCT01090323|8981290|P1|Overall Study|Stopped end of extension 1#|3
2596729|NCT01090323|8981289|P2|Overall Study|Stopped end of core|0
2596730|NCT01090323|8981290|P1|Overall Study|Stopped end of core|7
2596731|NCT01090323|8981289|P2|Overall Study|Death|2
2596732|NCT01090323|8981290|P1|Overall Study|Death|1
2596733|NCT01090323|8981289|P2|Overall Study|Administrative problems|4
2596734|NCT01090323|8981290|P1|Overall Study|Administrative problems|6
2596735|NCT01090323|8981289|P2|Overall Study|Lost to Follow-up|6
2596736|NCT01090323|8981290|P1|Overall Study|Lost to Follow-up|11
2596737|NCT01090323|8981289|P2|Overall Study|Withdrew consent|11
2596738|NCT01090323|8981290|P1|Overall Study|Withdrew consent|33
2596739|NCT01090323|8981289|P2|Overall Study|Protocol Violation|1
2596740|NCT01090323|8981290|P1|Overall Study|Protocol Violation|2
2596741|NCT01090323|8981289|P2|Overall Study|Condition no longer requires drug|4
2596742|NCT01090323|8981290|P1|Overall Study|Condition no longer requires drug|5
2596743|NCT01090323|8981289|P2|Overall Study|Unsatisfactory therapeutic effect|2
2596744|NCT01090323|8981290|P1|Overall Study|Unsatisfactory therapeutic effect|4
2596745|NCT01090323|8981289|P2|Overall Study|Abnormal Test Procedure Results|0
2596746|NCT01090323|8981290|P1|Overall Study|Abnormal Test Procedure Results|2
2596747|NCT01090323|8981289|P2|Overall Study|Abnormal Lab Values|1
2596748|NCT01090323|8981290|P1|Overall Study|Abnormal Lab Values|3
2596749|NCT01090323|8981289|P2|Overall Study|Adverse Event|2
2596750|NCT01090323|8981290|P1|Overall Study|Adverse Event|12
2596751|NCT01090310|8981302|P4|Extension Study|Subject withdrew consent|0
2596752|NCT01090310|8981303|P3|Extension Study|Subject withdrew consent|0
2596753|NCT01090310|8981304|P2|Extension Study|Subject withdrew consent|1
2596754|NCT01090310|8981305|P1|Extension Study|Subject withdrew consent|0
2596755|NCT01090310|8981302|P4|Extension Study|Unsatisfactory therapeutic effect|1
2596756|NCT01090310|8981303|P3|Extension Study|Unsatisfactory therapeutic effect|1
2596757|NCT01090310|8981304|P2|Extension Study|Unsatisfactory therapeutic effect|0
2596758|NCT01090310|8981305|P1|Extension Study|Unsatisfactory therapeutic effect|1
2596759|NCT01090310|8981302|P4|Extension Study|Adverse Event|1
2596760|NCT01090310|8981303|P3|Extension Study|Adverse Event|0
2596761|NCT01090310|8981304|P2|Extension Study|Adverse Event|0
2596762|NCT01090310|8981305|P1|Extension Study|Adverse Event|0
2596763|NCT01090310|8981302|P4|Extension Study|Aministrative problems|18
2596764|NCT01090310|8981303|P3|Extension Study|Aministrative problems|14
2596765|NCT01090310|8981304|P2|Extension Study|Aministrative problems|15
2596766|NCT01090310|8981305|P1|Extension Study|Aministrative problems|13
2596767|NCT01090310|8981302|P4|Core Study|Protocol deviation|1
2596768|NCT01090310|8981303|P3|Core Study|Protocol deviation|0
2596769|NCT01090310|8981304|P2|Core Study|Protocol deviation|0
2596770|NCT01090310|8981305|P1|Core Study|Protocol deviation|1
2596771|NCT01090310|8981302|P4|Core Study|Administrative reasons|4
2596772|NCT01090310|8981303|P3|Core Study|Administrative reasons|4
2596773|NCT01090310|8981304|P2|Core Study|Administrative reasons|6
2596774|NCT01090310|8981305|P1|Core Study|Administrative reasons|5
2596775|NCT01090310|8981302|P4|Core Study|Abnormal test procedure result|0
2596776|NCT01090310|8981303|P3|Core Study|Abnormal test procedure result|1
2596777|NCT01090310|8981304|P2|Core Study|Abnormal test procedure result|0
2596778|NCT01090310|8981305|P1|Core Study|Abnormal test procedure result|0
2596779|NCT01090310|8981302|P4|Core Study|Subject withdrew consent|1
2596780|NCT01090310|8981303|P3|Core Study|Subject withdrew consent|1
2596781|NCT01090310|8981304|P2|Core Study|Subject withdrew consent|3
2596782|NCT01090310|8981305|P1|Core Study|Subject withdrew consent|0
2596783|NCT01090310|8981302|P4|Core Study|Adverse Event|1
2596784|NCT01090310|8981303|P3|Core Study|Adverse Event|1
2596785|NCT01090310|8981304|P2|Core Study|Adverse Event|2
2596786|NCT01090310|8981305|P1|Core Study|Adverse Event|2
2596787|NCT01090102|8981344|P2|Second 12 Weeks|Withdrawal by Subject|1
2596788|NCT01090102|8981345|P1|Second 12 Weeks|Withdrawal by Subject|0
2596789|NCT01090102|8981344|P2|First 12 Weeks|Death|1
2596790|NCT01090102|8981345|P1|First 12 Weeks|Death|1
2596791|NCT01090102|8981344|P2|First 12 Weeks|Adverse Event|0
2596792|NCT01090102|8981345|P1|First 12 Weeks|Adverse Event|2
2596793|NCT01090102|8981344|P2|First 12 Weeks|Withdrawal by Subject|1
2596794|NCT01090102|8981345|P1|First 12 Weeks|Withdrawal by Subject|1
2596795|NCT01090076|8981355|P2|Overall Study|Withdrawal by Subject|1
2596796|NCT01090076|8981356|P1|Overall Study|Withdrawal by Subject|0
2596797|NCT01090076|8981355|P2|Overall Study|Death|1
2596798|NCT01090076|8981356|P1|Overall Study|Death|1
2596799|NCT01090063|8981366|P1|Treatment|Withdrawal by Subject|4
2596800|NCT01090063|8981366|P1|Screen|Screen Failed|4
2596801|NCT01090050|8981382|P2|Overall Study|Physician Decision|1
2596802|NCT01090050|8981383|P1|Overall Study|Physician Decision|0
2596803|NCT01090050|8981382|P2|Overall Study|Lack of Efficacy|5
2596804|NCT01090050|8981383|P1|Overall Study|Lack of Efficacy|1
2596805|NCT01090050|8981382|P2|Overall Study|Lost to Follow-up|1
2596806|NCT01090050|8981383|P1|Overall Study|Lost to Follow-up|0
2596807|NCT01090011|8981403|P1|Overall Study|Other reason not defined above|5
2596808|NCT01090011|8981403|P1|Overall Study|Refusal to start/continue medication|5
2596809|NCT01090011|8981403|P1|Overall Study|Protocol Violation|1
2596810|NCT01090011|8981403|P1|Overall Study|Adverse Event|32
2596811|NCT01090011|8981403|P1|Overall Study|Progressive disease|128
2596812|NCT01089647|8981496|P2|Overall Study|Adverse Event|1
2596813|NCT01089647|8981497|P1|Overall Study|Adverse Event|0
2596814|NCT01089647|8981496|P2|Overall Study|Withdrawal by Subject|1
2596815|NCT01089647|8981497|P1|Overall Study|Withdrawal by Subject|2
2596816|NCT01089647|8981496|P2|Overall Study|Lost to Follow-up|2
2596817|NCT01089647|8981497|P1|Overall Study|Lost to Follow-up|2
2596818|NCT01089608|8981505|P2|Overall Study|Lost to Follow-up|2
2596819|NCT01089608|8981506|P1|Overall Study|Lost to Follow-up|0
2596820|NCT01089608|8981505|P2|Overall Study|Adverse Event|4
2596821|NCT01089608|8981506|P1|Overall Study|Adverse Event|0
2596822|NCT01089582|8981523|P1|Overall Study|Withdrawal by Subject|1
2596823|NCT01089582|8981523|P1|Overall Study|Other|4
2596824|NCT01089582|8981523|P1|Overall Study|Lost to Follow-up|8
2596825|NCT01089582|8981523|P1|Overall Study|Adverse Event|15
2596826|NCT01089582|8981523|P1|Overall Study|Death|2
2596827|NCT01089556|8981566|P6|Study Period III (Weeks 9-16)|Withdrawal by Subject|2
2596828|NCT01089556|8981567|P5|Study Period III (Weeks 9-16)|Withdrawal by Subject|1
2596829|NCT01089556|8981568|P4|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
2596830|NCT01089556|8981569|P3|Study Period III (Weeks 9-16)|Withdrawal by Subject|3
2596831|NCT01089556|8981570|P2|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
2596832|NCT01089556|8981571|P1|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
2596833|NCT01089556|8981566|P6|Study Period III (Weeks 9-16)|Satisfactory Response|1
2596834|NCT01089556|8981567|P5|Study Period III (Weeks 9-16)|Satisfactory Response|4
2596835|NCT01089556|8981568|P4|Study Period III (Weeks 9-16)|Satisfactory Response|3
2596836|NCT01089556|8981569|P3|Study Period III (Weeks 9-16)|Satisfactory Response|4
2596837|NCT01089556|8981570|P2|Study Period III (Weeks 9-16)|Satisfactory Response|0
2596838|NCT01089556|8981571|P1|Study Period III (Weeks 9-16)|Satisfactory Response|0
2596839|NCT01089556|8981566|P6|Study Period III (Weeks 9-16)|Protocol Violation|0
2596840|NCT01089556|8981567|P5|Study Period III (Weeks 9-16)|Protocol Violation|1
2596841|NCT01089556|8981568|P4|Study Period III (Weeks 9-16)|Protocol Violation|1
2596842|NCT01089556|8981569|P3|Study Period III (Weeks 9-16)|Protocol Violation|1
2596843|NCT01089556|8981570|P2|Study Period III (Weeks 9-16)|Protocol Violation|0
2596844|NCT01089556|8981571|P1|Study Period III (Weeks 9-16)|Protocol Violation|0
2596845|NCT01089556|8981566|P6|Study Period III (Weeks 9-16)|Lost to Follow-up|0
2596846|NCT01089556|8981567|P5|Study Period III (Weeks 9-16)|Lost to Follow-up|0
2596847|NCT01089556|8981568|P4|Study Period III (Weeks 9-16)|Lost to Follow-up|0
2596848|NCT01089556|8981569|P3|Study Period III (Weeks 9-16)|Lost to Follow-up|1
2596849|NCT01089556|8981570|P2|Study Period III (Weeks 9-16)|Lost to Follow-up|0
2596850|NCT01089556|8981571|P1|Study Period III (Weeks 9-16)|Lost to Follow-up|0
2596851|NCT01089556|8981566|P6|Study Period III (Weeks 9-16)|Lack of Efficacy|0
2596852|NCT01089556|8981567|P5|Study Period III (Weeks 9-16)|Lack of Efficacy|1
2596853|NCT01089556|8981568|P4|Study Period III (Weeks 9-16)|Lack of Efficacy|2
2596854|NCT01089556|8981569|P3|Study Period III (Weeks 9-16)|Lack of Efficacy|0
2596855|NCT01089556|8981570|P2|Study Period III (Weeks 9-16)|Lack of Efficacy|0
2596856|NCT01089556|8981571|P1|Study Period III (Weeks 9-16)|Lack of Efficacy|0
2596857|NCT01089556|8981566|P6|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
2596858|NCT01089556|8981567|P5|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
2596859|NCT01089556|8981568|P4|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
2596860|NCT01089556|8981569|P3|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
2596861|NCT01089556|8981570|P2|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
2596862|NCT01089556|8981571|P1|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
2596863|NCT01089556|8981566|P6|Study Period III (Weeks 9-16)|Adverse Event|3
2596864|NCT01089556|8981567|P5|Study Period III (Weeks 9-16)|Adverse Event|4
2596865|NCT01089556|8981568|P4|Study Period III (Weeks 9-16)|Adverse Event|2
2596866|NCT01089556|8981569|P3|Study Period III (Weeks 9-16)|Adverse Event|4
2596867|NCT01089556|8981570|P2|Study Period III (Weeks 9-16)|Adverse Event|0
2596868|NCT01089556|8981571|P1|Study Period III (Weeks 9-16)|Adverse Event|0
2596869|NCT01089556|8981566|P6|Study Period II (Weeks 1-8)|Not received any study drug|0
2596870|NCT01089556|8981567|P5|Study Period II (Weeks 1-8)|Not received any study drug|0
2596871|NCT01089556|8981568|P4|Study Period II (Weeks 1-8)|Not received any study drug|0
2596872|NCT01089556|8981569|P3|Study Period II (Weeks 1-8)|Not received any study drug|0
2596873|NCT01089556|8981570|P2|Study Period II (Weeks 1-8)|Not received any study drug|4
2596874|NCT01089556|8981571|P1|Study Period II (Weeks 1-8)|Not received any study drug|3
2596875|NCT01089556|8981566|P6|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
2596876|NCT01089556|8981567|P5|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
2596877|NCT01089556|8981568|P4|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
2596878|NCT01089556|8981569|P3|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
2596879|NCT01089556|8981570|P2|Study Period II (Weeks 1-8)|Withdrawal by Subject|14
2596880|NCT01089556|8981571|P1|Study Period II (Weeks 1-8)|Withdrawal by Subject|12
2596881|NCT01089556|8981566|P6|Study Period II (Weeks 1-8)|Protocol Violation|0
2596882|NCT01089556|8981567|P5|Study Period II (Weeks 1-8)|Protocol Violation|0
2596883|NCT01089556|8981568|P4|Study Period II (Weeks 1-8)|Protocol Violation|0
2596884|NCT01089556|8981569|P3|Study Period II (Weeks 1-8)|Protocol Violation|0
2596885|NCT01089556|8981570|P2|Study Period II (Weeks 1-8)|Protocol Violation|4
2596886|NCT01089556|8981571|P1|Study Period II (Weeks 1-8)|Protocol Violation|4
2596887|NCT01089556|8981566|P6|Study Period II (Weeks 1-8)|Physician Decision|0
2596888|NCT01089556|8981567|P5|Study Period II (Weeks 1-8)|Physician Decision|0
2596889|NCT01089556|8981568|P4|Study Period II (Weeks 1-8)|Physician Decision|0
2596890|NCT01089556|8981569|P3|Study Period II (Weeks 1-8)|Physician Decision|0
2596891|NCT01089556|8981570|P2|Study Period II (Weeks 1-8)|Physician Decision|0
2596892|NCT01089556|8981571|P1|Study Period II (Weeks 1-8)|Physician Decision|4
2596893|NCT01089556|8981566|P6|Study Period II (Weeks 1-8)|Lost to Follow-up|0
2596894|NCT01089556|8981567|P5|Study Period II (Weeks 1-8)|Lost to Follow-up|0
2596895|NCT01089556|8981568|P4|Study Period II (Weeks 1-8)|Lost to Follow-up|0
2596896|NCT01089556|8981569|P3|Study Period II (Weeks 1-8)|Lost to Follow-up|0
2596897|NCT01089556|8981570|P2|Study Period II (Weeks 1-8)|Lost to Follow-up|3
2596898|NCT01089556|8981571|P1|Study Period II (Weeks 1-8)|Lost to Follow-up|0
2596899|NCT01089556|8981566|P6|Study Period II (Weeks 1-8)|Lack of Efficacy|0
2596900|NCT01089556|8981567|P5|Study Period II (Weeks 1-8)|Lack of Efficacy|0
2596901|NCT01089556|8981568|P4|Study Period II (Weeks 1-8)|Lack of Efficacy|0
2596902|NCT01089556|8981569|P3|Study Period II (Weeks 1-8)|Lack of Efficacy|0
2596903|NCT01089556|8981570|P2|Study Period II (Weeks 1-8)|Lack of Efficacy|2
2596904|NCT01089556|8981571|P1|Study Period II (Weeks 1-8)|Lack of Efficacy|1
2596905|NCT01089556|8981566|P6|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
2596906|NCT01089556|8981567|P5|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
2596907|NCT01089556|8981568|P4|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
2596908|NCT01089556|8981569|P3|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
2596909|NCT01089556|8981570|P2|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8
2596910|NCT01089556|8981571|P1|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12
2596911|NCT01089556|8981566|P6|Study Period II (Weeks 1-8)|Adverse Event|0
2596912|NCT01089556|8981567|P5|Study Period II (Weeks 1-8)|Adverse Event|0
2596913|NCT01089556|8981568|P4|Study Period II (Weeks 1-8)|Adverse Event|0
2596914|NCT01089556|8981569|P3|Study Period II (Weeks 1-8)|Adverse Event|0
2596915|NCT01089556|8981570|P2|Study Period II (Weeks 1-8)|Adverse Event|39
2596916|NCT01089556|8981571|P1|Study Period II (Weeks 1-8)|Adverse Event|35
2596917|NCT01089543|8981645|P4|Overall Study|Adverse Event|0
2596918|NCT01089543|8981646|P3|Overall Study|Adverse Event|0
2596919|NCT01089543|8981647|P2|Overall Study|Adverse Event|1
2596920|NCT01089543|8981648|P1|Overall Study|Adverse Event|0
2596921|NCT01089543|8981645|P4|Overall Study|Physician Decision|1
2596922|NCT01089543|8981646|P3|Overall Study|Physician Decision|0
2596923|NCT01089543|8981647|P2|Overall Study|Physician Decision|0
2596924|NCT01089543|8981648|P1|Overall Study|Physician Decision|1
2596925|NCT01089543|8981645|P4|Overall Study|Withdrawal by Subject|1
2596926|NCT01089543|8981646|P3|Overall Study|Withdrawal by Subject|3
2596927|NCT01089543|8981647|P2|Overall Study|Withdrawal by Subject|3
2596928|NCT01089543|8981648|P1|Overall Study|Withdrawal by Subject|2
2596929|NCT01089504|8981683|P2|Overall Study|Withdrawal by Subject|0
2596930|NCT01089504|8981684|P1|Overall Study|Withdrawal by Subject|2
2596931|NCT01089504|8981683|P2|Overall Study|Lost to Follow-up|1
2596932|NCT01089504|8981684|P1|Overall Study|Lost to Follow-up|1
2596933|NCT01089413|8981697|P1|Overall Study|Other|71
2596934|NCT01089413|8981697|P1|Overall Study|Metastasectomy|13
2596935|NCT01089413|8981697|P1|Overall Study|Death|10
2596936|NCT01089413|8981697|P1|Overall Study|Unacceptable Toxicity|12
2596937|NCT01089413|8981697|P1|Overall Study|Participant Withdrew Consent|1
2596938|NCT01089413|8981697|P1|Overall Study|Progressive Disease|93
2596939|NCT01089413|8981697|P1|Overall Study|Lost to Follow-up|1
2596940|NCT01089361|8981716|P2|Overall Study|Death|0
2596941|NCT01089361|8981717|P1|Overall Study|Death|1
2596942|NCT01089127|8981766|P6|Overall Study|Protocol deviation|0
2596943|NCT01089127|8981767|P5|Overall Study|Protocol deviation|1
2596944|NCT01089127|8981768|P4|Overall Study|Protocol deviation|0
2596945|NCT01089127|8981769|P3|Overall Study|Protocol deviation|0
2596946|NCT01089127|8981770|P2|Overall Study|Protocol deviation|1
2596947|NCT01089127|8981771|P1|Overall Study|Protocol deviation|0
2596948|NCT01089127|8981766|P6|Overall Study|Lost to Follow-up|0
2596949|NCT01089127|8981767|P5|Overall Study|Lost to Follow-up|1
2596950|NCT01089127|8981768|P4|Overall Study|Lost to Follow-up|0
2596951|NCT01089127|8981769|P3|Overall Study|Lost to Follow-up|0
2596952|NCT01089127|8981770|P2|Overall Study|Lost to Follow-up|1
2596953|NCT01089127|8981771|P1|Overall Study|Lost to Follow-up|1
2596954|NCT01089127|8981766|P6|Overall Study|Abnormal test procedure result(s)|0
2596955|NCT01089127|8981767|P5|Overall Study|Abnormal test procedure result(s)|0
2596956|NCT01089127|8981768|P4|Overall Study|Abnormal test procedure result(s)|0
2596957|NCT01089127|8981769|P3|Overall Study|Abnormal test procedure result(s)|0
2596958|NCT01089127|8981770|P2|Overall Study|Abnormal test procedure result(s)|1
2596959|NCT01089127|8981771|P1|Overall Study|Abnormal test procedure result(s)|2
2596960|NCT01089127|8981766|P6|Overall Study|Subject withdrew consent|2
2596961|NCT01089127|8981767|P5|Overall Study|Subject withdrew consent|0
2596962|NCT01089127|8981768|P4|Overall Study|Subject withdrew consent|1
2596963|NCT01089127|8981769|P3|Overall Study|Subject withdrew consent|1
2596964|NCT01089127|8981770|P2|Overall Study|Subject withdrew consent|1
2596965|NCT01089127|8981771|P1|Overall Study|Subject withdrew consent|0
2596966|NCT01089127|8981766|P6|Overall Study|Adverse Event|1
2596967|NCT01089127|8981767|P5|Overall Study|Adverse Event|0
2596968|NCT01089127|8981768|P4|Overall Study|Adverse Event|0
2596969|NCT01089127|8981769|P3|Overall Study|Adverse Event|1
2596970|NCT01089127|8981770|P2|Overall Study|Adverse Event|1
2596971|NCT01089127|8981771|P1|Overall Study|Adverse Event|5
2596972|NCT01089023|8981825|P1|Overall Study|Lack of Efficacy|1
2596973|NCT01089023|8981825|P1|Overall Study|Protocol Violation|1
2596974|NCT01089023|8981825|P1|Overall Study|Withdrawal by Subject|1
2596975|NCT01089023|8981825|P1|Overall Study|Adverse Event|1
2596976|NCT01089023|8981825|P1|Overall Study|Lost to Follow-up|3
2596977|NCT01088997|8981839|P2|Overall Study|Excluded prior to receiving drug|1
2596978|NCT01088997|8981840|P1|Overall Study|Excluded prior to receiving drug|1
2596979|NCT01088997|8981839|P2|Overall Study|Req. Extracorporeal membrane oxygenation|1
2596980|NCT01088997|8981840|P1|Overall Study|Req. Extracorporeal membrane oxygenation|1
2596981|NCT01088997|8981839|P2|Overall Study|Physician Decision|1
2596982|NCT01088997|8981840|P1|Overall Study|Physician Decision|1
2596983|NCT01088984|8981851|P2|Phase 2|Other|1
2596984|NCT01088984|8981852|P1|Phase 2|Other|0
2596985|NCT01088984|8981851|P2|Phase 2|DIsease Progression|25
2596986|NCT01088984|8981852|P1|Phase 2|DIsease Progression|0
2596987|NCT01088984|8981851|P2|Phase 2|Withdrawal by Subject|1
2596988|NCT01088984|8981852|P1|Phase 2|Withdrawal by Subject|0
2596989|NCT01088984|8981851|P2|Phase 2|Death|5
2596990|NCT01088984|8981852|P1|Phase 2|Death|0
2596991|NCT01088984|8981851|P2|Phase 1|Other|1
2596992|NCT01088984|8981852|P1|Phase 1|Other|1
2596993|NCT01088984|8981851|P2|Phase 1|Disease Progression|4
2596994|NCT01088984|8981852|P1|Phase 1|Disease Progression|2
2596995|NCT01088984|8981851|P2|Phase 1|Death|1
2596996|NCT01088984|8981852|P1|Phase 1|Death|2
2596997|NCT01088529|8981922|P2|Overall Study|Did not receive study treatment|1
2596998|NCT01088529|8981923|P1|Overall Study|Did not receive study treatment|0
2596999|NCT01088503|8981936|P3|Overall Study|Death|7
2597000|NCT01088503|8981937|P2|Overall Study|Death|358
2597001|NCT01088503|8981938|P1|Overall Study|Death|64
2597002|NCT01088503|8981936|P3|Overall Study|Withdrawal by Subject|10
2597003|NCT01088503|8981937|P2|Overall Study|Withdrawal by Subject|327
2597004|NCT01088503|8981938|P1|Overall Study|Withdrawal by Subject|118
2597005|NCT01088438|8982016|P2|Overall Study|Lost to Follow-up|30
2597006|NCT01088438|8982017|P1|Overall Study|Lost to Follow-up|18
2597007|NCT01088438|8982016|P2|Overall Study|Withdrawal by Subject|6
2597008|NCT01088438|8982017|P1|Overall Study|Withdrawal by Subject|11
2597009|NCT01088412|8982030|P3|Overall Study|Study Summary Not Completed|22
2597010|NCT01088412|8982031|P2|Overall Study|Study Summary Not Completed|64
2597011|NCT01088412|8982032|P1|Overall Study|Study Summary Not Completed|4360
2597012|NCT01088412|8982030|P3|Overall Study|Lost to Follow-up|11
2597013|NCT01088412|8982031|P2|Overall Study|Lost to Follow-up|130
2597014|NCT01088412|8982032|P1|Overall Study|Lost to Follow-up|3052
2597015|NCT01088412|8982030|P3|Overall Study|Third Party Required to Change Brand|0
2597016|NCT01088412|8982031|P2|Overall Study|Third Party Required to Change Brand|0
2597017|NCT01088412|8982032|P1|Overall Study|Third Party Required to Change Brand|487
2597018|NCT01088412|8982030|P3|Overall Study|Sponsor Decision|23
2597019|NCT01088412|8982031|P2|Overall Study|Sponsor Decision|79
2597020|NCT01088412|8982032|P1|Overall Study|Sponsor Decision|4467
2597021|NCT01088412|8982030|P3|Overall Study|Physician Decision|4
2597022|NCT01088412|8982031|P2|Overall Study|Physician Decision|8
2597023|NCT01088412|8982032|P1|Overall Study|Physician Decision|1041
2597024|NCT01088412|8982030|P3|Overall Study|Participant Moved|2
2597025|NCT01088412|8982031|P2|Overall Study|Participant Moved|21
2597026|NCT01088412|8982032|P1|Overall Study|Participant Moved|601
2597027|NCT01088412|8982030|P3|Overall Study|Received Another GH Product|0
2597028|NCT01088412|8982031|P2|Overall Study|Received Another GH Product|0
2597029|NCT01088412|8982032|P1|Overall Study|Received Another GH Product|79
2597030|NCT01088412|8982030|P3|Overall Study|Withdrawal by Subject|1
2597031|NCT01088412|8982031|P2|Overall Study|Withdrawal by Subject|25
2597032|NCT01088412|8982032|P1|Overall Study|Withdrawal by Subject|1761
2597033|NCT01088412|8982030|P3|Overall Study|Other Reason per Case Report Form|9
2597034|NCT01088412|8982031|P2|Overall Study|Other Reason per Case Report Form|103
2597035|NCT01088412|8982032|P1|Overall Study|Other Reason per Case Report Form|2089
2597036|NCT01088412|8982030|P3|Overall Study|Death|0
2597037|NCT01088412|8982031|P2|Overall Study|Death|6
2597038|NCT01088412|8982032|P1|Overall Study|Death|42
2597039|NCT01088412|8982030|P3|Overall Study|Adverse Event|0
2597040|NCT01088412|8982031|P2|Overall Study|Adverse Event|0
2597041|NCT01088412|8982032|P1|Overall Study|Adverse Event|38
2597042|NCT01088399|8982051|P3|Overall Study|Study summary visit not completed|80
2597043|NCT01088399|8982052|P2|Overall Study|Study summary visit not completed|283
2597044|NCT01088399|8982053|P1|Overall Study|Study summary visit not completed|2398
2597045|NCT01088399|8982051|P3|Overall Study|Enrollment criteria not met|70
2597046|NCT01088399|8982052|P2|Overall Study|Enrollment criteria not met|119
2597047|NCT01088399|8982053|P1|Overall Study|Enrollment criteria not met|48
2597048|NCT01088399|8982051|P3|Overall Study|Protocol Violation|0
2597049|NCT01088399|8982052|P2|Overall Study|Protocol Violation|1
2597050|NCT01088399|8982053|P1|Overall Study|Protocol Violation|10
2597051|NCT01088399|8982051|P3|Overall Study|Sponsor decision|7
2597052|NCT01088399|8982052|P2|Overall Study|Sponsor decision|298
2597053|NCT01088399|8982053|P1|Overall Study|Sponsor decision|1573
2597054|NCT01088399|8982051|P3|Overall Study|Change to or start of somatropin therapy|12
2597055|NCT01088399|8982052|P2|Overall Study|Change to or start of somatropin therapy|17
2597056|NCT01088399|8982053|P1|Overall Study|Change to or start of somatropin therapy|234
2597057|NCT01088399|8982051|P3|Overall Study|Withdrawal by Subject|33
2597058|NCT01088399|8982052|P2|Overall Study|Withdrawal by Subject|195
2597059|NCT01088399|8982053|P1|Overall Study|Withdrawal by Subject|544
2597060|NCT01088399|8982051|P3|Overall Study|Physician Decision|16
2597061|NCT01088399|8982052|P2|Overall Study|Physician Decision|88
2597062|NCT01088399|8982053|P1|Overall Study|Physician Decision|531
2597063|NCT01088399|8982051|P3|Overall Study|Lost to Follow-up|58
2597064|NCT01088399|8982052|P2|Overall Study|Lost to Follow-up|278
2597065|NCT01088399|8982053|P1|Overall Study|Lost to Follow-up|1070
2597066|NCT01088399|8982051|P3|Overall Study|Lack of Efficacy|5
2597067|NCT01088399|8982052|P2|Overall Study|Lack of Efficacy|7
2597068|NCT01088399|8982053|P1|Overall Study|Lack of Efficacy|298
2597069|NCT01088399|8982051|P3|Overall Study|Death|0
2597070|NCT01088399|8982052|P2|Overall Study|Death|45
2597071|NCT01088399|8982053|P1|Overall Study|Death|204
2597072|NCT01088399|8982051|P3|Overall Study|Adverse Event|0
2597073|NCT01088399|8982052|P2|Overall Study|Adverse Event|16
2597074|NCT01088399|8982053|P1|Overall Study|Adverse Event|211
2597075|NCT01088243|8982082|P2|Overall Study|Adverse Event|0
2597076|NCT01088243|8982083|P1|Overall Study|Adverse Event|1
2597077|NCT01087970|8982124|P1|Overall Study|Protocol Violation|2
2597078|NCT01087957|8982136|P2|Overall Study|Physician Decision|9
2597079|NCT01087957|8982137|P1|Overall Study|Physician Decision|5
2597080|NCT01087957|8982136|P2|Overall Study|Withdrawal by Subject|15
2597081|NCT01087957|8982137|P1|Overall Study|Withdrawal by Subject|18
2597082|NCT01087957|8982136|P2|Overall Study|Protocol Violation|25
2597083|NCT01087957|8982137|P1|Overall Study|Protocol Violation|13
2597084|NCT01087957|8982136|P2|Overall Study|Lost to Follow-up|4
2597085|NCT01087957|8982137|P1|Overall Study|Lost to Follow-up|3
2597086|NCT01087957|8982136|P2|Overall Study|Death|2
2597087|NCT01087957|8982137|P1|Overall Study|Death|2
2597088|NCT01087944|8982163|P2|Period 2 (Week 4-6)|Adverse Event|2
2597089|NCT01087944|8982164|P1|Period 2 (Week 4-6)|Adverse Event|0
2597090|NCT01087944|8982163|P2|Period 1 (Week 1-3)|Adverse Event|0
2597091|NCT01087944|8982164|P1|Period 1 (Week 1-3)|Adverse Event|1
2597092|NCT01087905|8982244|P8|Overall Study|Withdrawal by Subject|5
2597093|NCT01087905|8982245|P7|Overall Study|Withdrawal by Subject|3
2597094|NCT01087905|8982246|P6|Overall Study|Withdrawal by Subject|3
2597095|NCT01087905|8982247|P5|Overall Study|Withdrawal by Subject|4
2597096|NCT01087905|8982248|P4|Overall Study|Withdrawal by Subject|5
2597097|NCT01087905|8982249|P3|Overall Study|Withdrawal by Subject|4
2597098|NCT01087905|8982250|P2|Overall Study|Withdrawal by Subject|4
2597099|NCT01087905|8982251|P1|Overall Study|Withdrawal by Subject|5
2597100|NCT01087905|8982244|P8|Overall Study|Lost to Follow-up|24
2597101|NCT01087905|8982245|P7|Overall Study|Lost to Follow-up|20
2597102|NCT01087905|8982246|P6|Overall Study|Lost to Follow-up|25
2597103|NCT01087905|8982247|P5|Overall Study|Lost to Follow-up|27
2597104|NCT01087905|8982248|P4|Overall Study|Lost to Follow-up|31
2597105|NCT01087905|8982249|P3|Overall Study|Lost to Follow-up|18
2597106|NCT01087905|8982250|P2|Overall Study|Lost to Follow-up|28
2597107|NCT01087905|8982251|P1|Overall Study|Lost to Follow-up|24
2597108|NCT01087814|8982273|P2|Second Intervention (5 Days)|Physician Decision|0
2597109|NCT01087814|8982274|P1|Second Intervention (5 Days)|Physician Decision|1
2597110|NCT01087814|8982273|P2|First Intervention (5 Days)|Withdrawal by Subject|1
2597111|NCT01087814|8982274|P1|First Intervention (5 Days)|Withdrawal by Subject|3
2597112|NCT01087788|8982292|P3|Open-Label Period (OL-P)|Personal reasons|1
2597113|NCT01087788|8982293|P2|Open-Label Period (OL-P)|Personal reasons|0
2597114|NCT01087788|8982294|P1|Open-Label Period (OL-P)|Personal reasons|0
2597115|NCT01087788|8982292|P3|Open-Label Period (OL-P)|No participation in study extension|1
2597116|NCT01087788|8982293|P2|Open-Label Period (OL-P)|No participation in study extension|0
2597117|NCT01087788|8982294|P1|Open-Label Period (OL-P)|No participation in study extension|0
2597118|NCT01087788|8982292|P3|Open-Label Period (OL-P)|Principal investigator decision|2
2597119|NCT01087788|8982293|P2|Open-Label Period (OL-P)|Principal investigator decision|1
2597120|NCT01087788|8982294|P1|Open-Label Period (OL-P)|Principal investigator decision|0
2597121|NCT01087788|8982292|P3|Open-Label Period (OL-P)|Sponsor request|0
2597122|NCT01087788|8982293|P2|Open-Label Period (OL-P)|Sponsor request|0
2597123|NCT01087788|8982294|P1|Open-Label Period (OL-P)|Sponsor request|1
2597124|NCT01087788|8982292|P3|Open-Label Period (OL-P)|AE, non-serious unknown|0
2597125|NCT01087788|8982293|P2|Open-Label Period (OL-P)|AE, non-serious unknown|0
2597126|NCT01087788|8982294|P1|Open-Label Period (OL-P)|AE, non-serious unknown|1
2597127|NCT01087788|8982292|P3|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
2597128|NCT01087788|8982293|P2|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1
2597129|NCT01087788|8982294|P1|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
2597130|NCT01087788|8982292|P3|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
2597131|NCT01087788|8982293|P2|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
2597132|NCT01087788|8982294|P1|Open-Label Period (OL-P)|AE, non-serious non-fatal|6
2597133|NCT01087788|8982292|P3|Open-Label Period (OL-P)|AE, serious non-fatal|4
2597134|NCT01087788|8982293|P2|Open-Label Period (OL-P)|AE, serious non-fatal|3
2597135|NCT01087788|8982294|P1|Open-Label Period (OL-P)|AE, serious non-fatal|1
2597136|NCT01087788|8982292|P3|Open-Label Period (OL-P)|AE, serious fatal|1
2597137|NCT01087788|8982293|P2|Open-Label Period (OL-P)|AE, serious fatal|0
2597138|NCT01087788|8982294|P1|Open-Label Period (OL-P)|AE, serious fatal|2
2597139|NCT01087788|8982292|P3|Open-Label Period (OL-P)|Withdrawal by Subject|10
2597140|NCT01087788|8982293|P2|Open-Label Period (OL-P)|Withdrawal by Subject|8
2597141|NCT01087788|8982294|P1|Open-Label Period (OL-P)|Withdrawal by Subject|13
2597142|NCT01087788|8982292|P3|Open-Label Period (OL-P)|Lost to Follow-up|2
2597143|NCT01087788|8982293|P2|Open-Label Period (OL-P)|Lost to Follow-up|4
2597144|NCT01087788|8982294|P1|Open-Label Period (OL-P)|Lost to Follow-up|0
2597145|NCT01087788|8982292|P3|Open-Label Period (OL-P)|Protocol Violation|0
2597146|NCT01087788|8982293|P2|Open-Label Period (OL-P)|Protocol Violation|1
2597147|NCT01087788|8982294|P1|Open-Label Period (OL-P)|Protocol Violation|2
2597148|NCT01087788|8982292|P3|Open-Label Period (OL-P)|Lack of Efficacy|3
2597149|NCT01087788|8982293|P2|Open-Label Period (OL-P)|Lack of Efficacy|2
2597150|NCT01087788|8982294|P1|Open-Label Period (OL-P)|Lack of Efficacy|4
2597151|NCT01087788|8982292|P3|24-weeks Dose-blind Period|Patient moved|1
2597152|NCT01087788|8982293|P2|24-weeks Dose-blind Period|Patient moved|0
2597153|NCT01087788|8982294|P1|24-weeks Dose-blind Period|Patient moved|0
2597154|NCT01087788|8982292|P3|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
2597155|NCT01087788|8982293|P2|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
2597156|NCT01087788|8982294|P1|24-weeks Dose-blind Period|Sponsor decision following missed visits|1
2597157|NCT01087788|8982292|P3|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
2597158|NCT01087788|8982293|P2|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
2597159|NCT01087788|8982294|P1|24-weeks Dose-blind Period|AE, non-serious non-fatal|2
2597160|NCT01087788|8982292|P3|24-weeks Dose-blind Period|AE, serious non-fatal|2
2597161|NCT01087788|8982293|P2|24-weeks Dose-blind Period|AE, serious non-fatal|1
2597162|NCT01087788|8982294|P1|24-weeks Dose-blind Period|AE, serious non-fatal|2
2597163|NCT01087788|8982292|P3|24-weeks Dose-blind Period|AE, serious fatal|0
2597164|NCT01087788|8982293|P2|24-weeks Dose-blind Period|AE, serious fatal|1
2597165|NCT01087788|8982294|P1|24-weeks Dose-blind Period|AE, serious fatal|0
2597166|NCT01087788|8982292|P3|24-weeks Dose-blind Period|Withdrawal by Subject|0
2597167|NCT01087788|8982293|P2|24-weeks Dose-blind Period|Withdrawal by Subject|0
2597168|NCT01087788|8982294|P1|24-weeks Dose-blind Period|Withdrawal by Subject|1
2597169|NCT01087788|8982292|P3|24-weeks Dose-blind Period|Lost to Follow-up|1
2597170|NCT01087788|8982293|P2|24-weeks Dose-blind Period|Lost to Follow-up|0
2597171|NCT01087788|8982294|P1|24-weeks Dose-blind Period|Lost to Follow-up|1
2597172|NCT01087788|8982292|P3|24-weeks Dose-blind Period|Lack of Efficacy|1
2597173|NCT01087788|8982293|P2|24-weeks Dose-blind Period|Lack of Efficacy|2
2597174|NCT01087788|8982294|P1|24-weeks Dose-blind Period|Lack of Efficacy|0
2597175|NCT01087788|8982292|P3|24-weeks Double-blind Period|P cannot comply with scheduled visits|1
2597176|NCT01087788|8982293|P2|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
2597177|NCT01087788|8982294|P1|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
2597178|NCT01087788|8982292|P3|24-weeks Double-blind Period|Exclusion criteria were not met|0
2597179|NCT01087788|8982293|P2|24-weeks Double-blind Period|Exclusion criteria were not met|1
2597180|NCT01087788|8982294|P1|24-weeks Double-blind Period|Exclusion criteria were not met|0
2597181|NCT01087788|8982292|P3|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
2597182|NCT01087788|8982293|P2|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1
2597183|NCT01087788|8982294|P1|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
2597184|NCT01087788|8982292|P3|24-weeks Double-blind Period|Patient (P) does not want to attend|0
2597185|NCT01087788|8982293|P2|24-weeks Double-blind Period|Patient (P) does not want to attend|0
2597186|NCT01087788|8982294|P1|24-weeks Double-blind Period|Patient (P) does not want to attend|1
2597187|NCT01087788|8982292|P3|24-weeks Double-blind Period|AE, unknown type|1
2597188|NCT01087788|8982293|P2|24-weeks Double-blind Period|AE, unknown type|0
2597189|NCT01087788|8982294|P1|24-weeks Double-blind Period|AE, unknown type|0
2597190|NCT01087788|8982292|P3|24-weeks Double-blind Period|AE, non-serious non-fatal|2
2597191|NCT01087788|8982293|P2|24-weeks Double-blind Period|AE, non-serious non-fatal|1
2597192|NCT01087788|8982294|P1|24-weeks Double-blind Period|AE, non-serious non-fatal|2
2597193|NCT01087788|8982292|P3|24-weeks Double-blind Period|AE, serious non-fatal|3
2597194|NCT01087788|8982293|P2|24-weeks Double-blind Period|AE, serious non-fatal|2
2597195|NCT01087788|8982294|P1|24-weeks Double-blind Period|AE, serious non-fatal|0
2597196|NCT01087788|8982292|P3|24-weeks Double-blind Period|AE, serious fatal|1
2597197|NCT01087788|8982293|P2|24-weeks Double-blind Period|AE, serious fatal|1
2597198|NCT01087788|8982294|P1|24-weeks Double-blind Period|AE, serious fatal|0
2597199|NCT01087788|8982292|P3|24-weeks Double-blind Period|Withdrawal by Subject|5
2597200|NCT01087788|8982293|P2|24-weeks Double-blind Period|Withdrawal by Subject|2
2597201|NCT01087788|8982294|P1|24-weeks Double-blind Period|Withdrawal by Subject|7
2597202|NCT01087788|8982292|P3|24-weeks Double-blind Period|Lost to Follow-up|1
2597203|NCT01087788|8982293|P2|24-weeks Double-blind Period|Lost to Follow-up|1
2597204|NCT01087788|8982294|P1|24-weeks Double-blind Period|Lost to Follow-up|4
2597205|NCT01087788|8982292|P3|24-weeks Double-blind Period|Protocol Violation|0
2597206|NCT01087788|8982293|P2|24-weeks Double-blind Period|Protocol Violation|1
2597207|NCT01087788|8982294|P1|24-weeks Double-blind Period|Protocol Violation|0
2597208|NCT01087788|8982292|P3|24-weeks Double-blind Period|Lack of Efficacy|1
2597209|NCT01087788|8982293|P2|24-weeks Double-blind Period|Lack of Efficacy|0
2597210|NCT01087788|8982294|P1|24-weeks Double-blind Period|Lack of Efficacy|2
2597211|NCT01087775|8982321|P1|Overall Study|failed inclusion criteria|2
2597212|NCT01087762|8982329|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4
2597213|NCT01087762|8982330|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2
2597214|NCT01087762|8982331|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
2597215|NCT01087762|8982332|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
2597216|NCT01087762|8982333|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
2597217|NCT01087762|8982329|P5|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13
2597218|NCT01087762|8982330|P4|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16
2597219|NCT01087762|8982331|P3|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
2597220|NCT01087762|8982332|P2|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
2597221|NCT01087762|8982333|P1|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
2597222|NCT01087762|8982329|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4
2597223|NCT01087762|8982330|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7
2597224|NCT01087762|8982331|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
2597225|NCT01087762|8982332|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
2597226|NCT01087762|8982333|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
2597227|NCT01087762|8982329|P5|Open-Label Period (Weeks 48-204)|Other|4
2597228|NCT01087762|8982330|P4|Open-Label Period (Weeks 48-204)|Other|2
2597229|NCT01087762|8982331|P3|Open-Label Period (Weeks 48-204)|Other|0
2597230|NCT01087762|8982332|P2|Open-Label Period (Weeks 48-204)|Other|0
2597231|NCT01087762|8982333|P1|Open-Label Period (Weeks 48-204)|Other|0
2597232|NCT01087762|8982329|P5|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15
2597233|NCT01087762|8982330|P4|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22
2597234|NCT01087762|8982331|P3|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
2597235|NCT01087762|8982332|P2|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
2597236|NCT01087762|8982333|P1|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
2597237|NCT01087762|8982329|P5|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2
2597238|NCT01087762|8982330|P4|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5
2597239|NCT01087762|8982331|P3|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
2597240|NCT01087762|8982332|P2|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
2597241|NCT01087762|8982333|P1|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
2597242|NCT01087762|8982329|P5|Open-Label Period (Weeks 48-204)|Protocol Violation|1
2597243|NCT01087762|8982330|P4|Open-Label Period (Weeks 48-204)|Protocol Violation|1
2597244|NCT01087762|8982331|P3|Open-Label Period (Weeks 48-204)|Protocol Violation|0
2597245|NCT01087762|8982332|P2|Open-Label Period (Weeks 48-204)|Protocol Violation|0
2597246|NCT01087762|8982333|P1|Open-Label Period (Weeks 48-204)|Protocol Violation|0
2597247|NCT01087762|8982329|P5|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14
2597248|NCT01087762|8982330|P4|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4
2597249|NCT01087762|8982331|P3|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
2597250|NCT01087762|8982332|P2|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
2597251|NCT01087762|8982333|P1|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
2597252|NCT01087762|8982329|P5|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
2597253|NCT01087762|8982330|P4|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
2597254|NCT01087762|8982331|P3|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3
2597255|NCT01087762|8982332|P2|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
2597256|NCT01087762|8982333|P1|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
2597257|NCT01087762|8982329|P5|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
2597258|NCT01087762|8982330|P4|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
2597259|NCT01087762|8982331|P3|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
2597260|NCT01087762|8982332|P2|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2
2597261|NCT01087762|8982333|P1|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
2597262|NCT01087762|8982329|P5|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
2597263|NCT01087762|8982330|P4|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
2597264|NCT01087762|8982331|P3|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
2597265|NCT01087762|8982332|P2|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2
2597266|NCT01087762|8982333|P1|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
2597267|NCT01087762|8982329|P5|Double Blind Period (Weeks 0-24)|Protocol Violation|0
2597268|NCT01087762|8982330|P4|Double Blind Period (Weeks 0-24)|Protocol Violation|0
2597269|NCT01087762|8982331|P3|Double Blind Period (Weeks 0-24)|Protocol Violation|1
2597270|NCT01087762|8982332|P2|Double Blind Period (Weeks 0-24)|Protocol Violation|0
2597271|NCT01087762|8982333|P1|Double Blind Period (Weeks 0-24)|Protocol Violation|6
2597272|NCT01087762|8982329|P5|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
2597273|NCT01087762|8982330|P4|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
2597274|NCT01087762|8982331|P3|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3
2597275|NCT01087762|8982332|P2|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
2597276|NCT01087762|8982333|P1|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2
2597277|NCT01087736|8982381|P2|Overall Study|Withdrawal by Subject|1
2597278|NCT01087736|8982382|P1|Overall Study|Withdrawal by Subject|0
2597279|NCT01087736|8982381|P2|Overall Study|Death|1
2597280|NCT01087736|8982382|P1|Overall Study|Death|0
2597281|NCT01087736|8982381|P2|Overall Study|Lost to Follow-up|0
2597282|NCT01087736|8982382|P1|Overall Study|Lost to Follow-up|1
2597283|NCT01087723|8982392|P2|Overall Study|Reason Not Specified|2
2597284|NCT01087723|8982393|P1|Overall Study|Reason Not Specified|1
2597285|NCT01087723|8982392|P2|Overall Study|Lost to Follow-up|4
2597286|NCT01087723|8982393|P1|Overall Study|Lost to Follow-up|1
2597287|NCT01087723|8982392|P2|Overall Study|Physician Decision|0
2597288|NCT01087723|8982393|P1|Overall Study|Physician Decision|2
2597289|NCT01087723|8982392|P2|Overall Study|Withdrawal by Subject|13
2597290|NCT01087723|8982393|P1|Overall Study|Withdrawal by Subject|10
2597291|NCT01087723|8982392|P2|Overall Study|1 Year Visit Too Early (<335 days)|1
2597292|NCT01087723|8982393|P1|Overall Study|1 Year Visit Too Early (<335 days)|0
2597293|NCT01087528|8982434|P1|Overall Study|Incomplete CE procedure|6
2597294|NCT01087528|8982434|P1|Overall Study|Withdrawal by Subject|1
2597295|NCT01087502|8982440|P2|Up to Final Analysis (Week 52)|Other reason not described above|4
2597296|NCT01087502|8982441|P1|Up to Final Analysis (Week 52)|Other reason not described above|5
2597297|NCT01087502|8982440|P2|Up to Final Analysis (Week 52)|Study site excluded from analysis|5
2597298|NCT01087502|8982441|P1|Up to Final Analysis (Week 52)|Study site excluded from analysis|1
2597299|NCT01087502|8982440|P2|Up to Final Analysis (Week 52)|Withdrawal by Subject|2
2597300|NCT01087502|8982441|P1|Up to Final Analysis (Week 52)|Withdrawal by Subject|3
2597301|NCT01087502|8982440|P2|Up to Final Analysis (Week 52)|Lost to Follow-up|0
2597302|NCT01087502|8982441|P1|Up to Final Analysis (Week 52)|Lost to Follow-up|2
2597303|NCT01087502|8982440|P2|Up to Final Analysis (Week 52)|Protocol Violation|0
2597304|NCT01087502|8982441|P1|Up to Final Analysis (Week 52)|Protocol Violation|4
2597305|NCT01087502|8982440|P2|Up to Final Analysis (Week 52)|Lack of Efficacy|2
2597306|NCT01087502|8982441|P1|Up to Final Analysis (Week 52)|Lack of Efficacy|1
2597307|NCT01087502|8982440|P2|Up to Final Analysis (Week 52)|Adverse Event|10
2597308|NCT01087502|8982441|P1|Up to Final Analysis (Week 52)|Adverse Event|17
2597309|NCT01087502|8982440|P2|Up to Interim Analysis (Week 12)|Other reason not described above|2
2597310|NCT01087502|8982441|P1|Up to Interim Analysis (Week 12)|Other reason not described above|1
2597311|NCT01087502|8982440|P2|Up to Interim Analysis (Week 12)|Lack of Efficacy|0
2597312|NCT01087502|8982441|P1|Up to Interim Analysis (Week 12)|Lack of Efficacy|1
2597313|NCT01087502|8982440|P2|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
2597314|NCT01087502|8982441|P1|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
2597315|NCT01087502|8982440|P2|Up to Interim Analysis (Week 12)|Protocol Violation|1
2597316|NCT01087502|8982441|P1|Up to Interim Analysis (Week 12)|Protocol Violation|1
2597317|NCT01087502|8982440|P2|Up to Interim Analysis (Week 12)|Adverse Event|4
2597318|NCT01087502|8982441|P1|Up to Interim Analysis (Week 12)|Adverse Event|5
2597319|NCT01087489|8982460|P2|Overall Study|unable to survey by telephone|1
2597320|NCT01087489|8982461|P1|Overall Study|unable to survey by telephone|0
2597321|NCT01087489|8982460|P2|Overall Study|Death|1
2597322|NCT01087489|8982461|P1|Overall Study|Death|0
2597323|NCT01087489|8982460|P2|Overall Study|enrolled in another VA study|1
2597324|NCT01087489|8982461|P1|Overall Study|enrolled in another VA study|0
2597325|NCT01086969|8982474|P3|Overall Study|Withdrawal by Subject|0
2597326|NCT01086969|8982475|P2|Overall Study|Withdrawal by Subject|2
2597327|NCT01086969|8982476|P1|Overall Study|Withdrawal by Subject|1
2597328|NCT01086423|8982586|P3|Overall Study|Lost to Follow-up|1
2597329|NCT01086423|8982587|P2|Overall Study|Lost to Follow-up|0
2597330|NCT01086423|8982588|P1|Overall Study|Lost to Follow-up|0
2597331|NCT01086423|8982586|P3|Overall Study|Withdrawal by Subject|3
2597332|NCT01086423|8982587|P2|Overall Study|Withdrawal by Subject|1
2597333|NCT01086423|8982588|P1|Overall Study|Withdrawal by Subject|5
2597334|NCT01086423|8982586|P3|Overall Study|Adverse event, non-fatal|0
2597335|NCT01086423|8982587|P2|Overall Study|Adverse event, non-fatal|1
2597336|NCT01086423|8982588|P1|Overall Study|Adverse event, non-fatal|2
2597337|NCT01086423|8982586|P3|Overall Study|Adverse event, fatal|0
2597338|NCT01086423|8982587|P2|Overall Study|Adverse event, fatal|1
2597339|NCT01086423|8982588|P1|Overall Study|Adverse event, fatal|1
2597340|NCT01086423|8982586|P3|Overall Study|Migrated/moved from study area|4
2597341|NCT01086423|8982587|P2|Overall Study|Migrated/moved from study area|0
2597342|NCT01086423|8982588|P1|Overall Study|Migrated/moved from study area|2
2597343|NCT01086423|8982586|P3|Overall Study|Protocol Violation|1
2597344|NCT01086423|8982587|P2|Overall Study|Protocol Violation|0
2597345|NCT01086423|8982588|P1|Overall Study|Protocol Violation|0
2597346|NCT01086410|8982633|P4|Overall Study|Lost to Follow-up|0
2597347|NCT01086410|8982634|P3|Overall Study|Lost to Follow-up|1
2597348|NCT01086410|8982635|P2|Overall Study|Lost to Follow-up|0
2597349|NCT01086410|8982636|P1|Overall Study|Lost to Follow-up|0
2597350|NCT01086410|8982633|P4|Overall Study|Protocol Violation|0
2597351|NCT01086410|8982634|P3|Overall Study|Protocol Violation|0
2597352|NCT01086410|8982635|P2|Overall Study|Protocol Violation|1
2597353|NCT01086410|8982636|P1|Overall Study|Protocol Violation|1
2597354|NCT01086410|8982633|P4|Overall Study|Lack of Efficacy|0
2597355|NCT01086410|8982634|P3|Overall Study|Lack of Efficacy|0
2597356|NCT01086410|8982635|P2|Overall Study|Lack of Efficacy|1
2597357|NCT01086410|8982636|P1|Overall Study|Lack of Efficacy|1
2597358|NCT01086410|8982633|P4|Overall Study|Adverse Event|2
2597359|NCT01086410|8982634|P3|Overall Study|Adverse Event|0
2597360|NCT01086410|8982635|P2|Overall Study|Adverse Event|0
2597361|NCT01086410|8982636|P1|Overall Study|Adverse Event|1
2597362|NCT01086384|8982732|P3|Treatment Period|Received Treatment in Error|0
2597363|NCT01086384|8982733|P2|Treatment Period|Received Treatment in Error|1
2597364|NCT01086384|8982734|P1|Treatment Period|Received Treatment in Error|0
2597365|NCT01086384|8982732|P3|Treatment Period|Protocol-Defined Stopping Criteria|1
2597366|NCT01086384|8982733|P2|Treatment Period|Protocol-Defined Stopping Criteria|0
2597367|NCT01086384|8982734|P1|Treatment Period|Protocol-Defined Stopping Criteria|0
2597368|NCT01086384|8982732|P3|Treatment Period|Study Closed/Terminated|8
2597369|NCT01086384|8982733|P2|Treatment Period|Study Closed/Terminated|7
2597370|NCT01086384|8982734|P1|Treatment Period|Study Closed/Terminated|0
2597371|NCT01086384|8982732|P3|Treatment Period|Physician Decision|6
2597372|NCT01086384|8982733|P2|Treatment Period|Physician Decision|9
2597373|NCT01086384|8982734|P1|Treatment Period|Physician Decision|0
2597374|NCT01086384|8982732|P3|Treatment Period|Lost to Follow-up|9
2597375|NCT01086384|8982733|P2|Treatment Period|Lost to Follow-up|11
2597376|NCT01086384|8982734|P1|Treatment Period|Lost to Follow-up|0
2597377|NCT01086384|8982732|P3|Treatment Period|Adverse Event|15
2597378|NCT01086384|8982733|P2|Treatment Period|Adverse Event|19
2597379|NCT01086384|8982734|P1|Treatment Period|Adverse Event|0
2597380|NCT01086384|8982732|P3|Treatment Period|Lack of Efficacy|13
2597381|NCT01086384|8982733|P2|Treatment Period|Lack of Efficacy|22
2597382|NCT01086384|8982734|P1|Treatment Period|Lack of Efficacy|0
2597383|NCT01086384|8982732|P3|Treatment Period|Protocol Violation|17
2597384|NCT01086384|8982733|P2|Treatment Period|Protocol Violation|26
2597385|NCT01086384|8982734|P1|Treatment Period|Protocol Violation|0
2597386|NCT01086384|8982732|P3|Treatment Period|Withdrawal by Subject|55
2597387|NCT01086384|8982733|P2|Treatment Period|Withdrawal by Subject|53
2597388|NCT01086384|8982734|P1|Treatment Period|Withdrawal by Subject|0
2597389|NCT01086384|8982732|P3|2-week Run-in Period|Randomized in Error|0
2597390|NCT01086384|8982733|P2|2-week Run-in Period|Randomized in Error|0
2597391|NCT01086384|8982734|P1|2-week Run-in Period|Randomized in Error|1
2597392|NCT01086384|8982732|P3|2-week Run-in Period|Continuation Criteria Not Met|0
2597393|NCT01086384|8982733|P2|2-week Run-in Period|Continuation Criteria Not Met|0
2597394|NCT01086384|8982734|P1|2-week Run-in Period|Continuation Criteria Not Met|92
2597395|NCT01086384|8982732|P3|2-week Run-in Period|Study Closed/Terminated|0
2597396|NCT01086384|8982733|P2|2-week Run-in Period|Study Closed/Terminated|0
2597397|NCT01086384|8982734|P1|2-week Run-in Period|Study Closed/Terminated|42
2597398|NCT01086384|8982732|P3|2-week Run-in Period|Withdrawal by Subject|0
2597399|NCT01086384|8982733|P2|2-week Run-in Period|Withdrawal by Subject|0
2597400|NCT01086384|8982734|P1|2-week Run-in Period|Withdrawal by Subject|19
2597401|NCT01086384|8982732|P3|2-week Run-in Period|Physician Decision|0
2597402|NCT01086384|8982733|P2|2-week Run-in Period|Physician Decision|0
2597403|NCT01086384|8982734|P1|2-week Run-in Period|Physician Decision|6
2597404|NCT01086384|8982732|P3|2-week Run-in Period|Lost to Follow-up|0
2597405|NCT01086384|8982733|P2|2-week Run-in Period|Lost to Follow-up|0
2597406|NCT01086384|8982734|P1|2-week Run-in Period|Lost to Follow-up|1
2597407|NCT01086384|8982732|P3|2-week Run-in Period|Protocol Violation|0
2597408|NCT01086384|8982733|P2|2-week Run-in Period|Protocol Violation|0
2597409|NCT01086384|8982734|P1|2-week Run-in Period|Protocol Violation|1
2597410|NCT01086384|8982732|P3|2-week Run-in Period|Adverse Event|0
2597411|NCT01086384|8982733|P2|2-week Run-in Period|Adverse Event|0
2597412|NCT01086384|8982734|P1|2-week Run-in Period|Adverse Event|1
2597413|NCT01086358|8982744|P2|Second Intervention|Lost to Follow-up|4
2597414|NCT01086358|8982745|P1|Second Intervention|Lost to Follow-up|4
2597415|NCT01086358|8982744|P2|First Intervention|Withdrawal by Subject|1
2597416|NCT01086358|8982745|P1|First Intervention|Withdrawal by Subject|0
2597417|NCT01086358|8982744|P2|First Intervention|Lost to Follow-up|4
2597418|NCT01086358|8982745|P1|First Intervention|Lost to Follow-up|9
2597419|NCT01086215|8982815|P4|Overall Study|Lost to Follow-up|2
2597420|NCT01086215|8982816|P3|Overall Study|Lost to Follow-up|18
2597421|NCT01086215|8982817|P2|Overall Study|Lost to Follow-up|39
2597422|NCT01086215|8982818|P1|Overall Study|Lost to Follow-up|22
2597423|NCT01086215|8982815|P4|Overall Study|Death|1
2597424|NCT01086215|8982816|P3|Overall Study|Death|8
2597425|NCT01086215|8982817|P2|Overall Study|Death|8
2597426|NCT01086215|8982818|P1|Overall Study|Death|14
2597427|NCT01086033|8982836|P1|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1
2597428|NCT01086033|8982836|P1|Overall Study|AE and Other Reason|1
2597429|NCT01086033|8982836|P1|Overall Study|AE and Lost to Follow-up|1
2597430|NCT01086033|8982836|P1|Overall Study|Death|1
2597431|NCT01086033|8982836|P1|Overall Study|AE and Lack of Efficacy|4
2597432|NCT01086033|8982836|P1|Overall Study|Withdrew consent and Other Reason|4
2597433|NCT01086033|8982836|P1|Overall Study|Withdrew Consent and Lack of Efficacy|5
2597434|NCT01086033|8982836|P1|Overall Study|AE and Withdrew Consent|5
2597435|NCT01086033|8982836|P1|Overall Study|Other|13
2597436|NCT01086033|8982836|P1|Overall Study|Other|14
2597437|NCT01086033|8982836|P1|Overall Study|Withdrawal by Subject|41
2597438|NCT01086033|8982836|P1|Overall Study|Adverse Event|42
2597439|NCT01086033|8982836|P1|Overall Study|Lost to Follow-up|86
2597440|NCT01086033|8982836|P1|Overall Study|Lack of efficacy/Exacerbation of RA|86
2597441|NCT01085812|8982902|P2|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2
2597442|NCT01085812|8982903|P1|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0
2597443|NCT01085812|8982902|P2|Double-blind Intent-to-treat Population|Lost to Follow-up|17
2597444|NCT01085812|8982903|P1|Double-blind Intent-to-treat Population|Lost to Follow-up|4
2597445|NCT01085812|8982902|P2|Double-blind Intent-to-treat Population|Withdrawal by Subject|22
2597446|NCT01085812|8982903|P1|Double-blind Intent-to-treat Population|Withdrawal by Subject|11
2597447|NCT01085812|8982902|P2|Double-blind Intent-to-treat Population|Protocol Violation|7
2597448|NCT01085812|8982903|P1|Double-blind Intent-to-treat Population|Protocol Violation|2
2597449|NCT01085812|8982902|P2|Double-blind Intent-to-treat Population|Adverse Event|8
2597450|NCT01085812|8982903|P1|Double-blind Intent-to-treat Population|Adverse Event|3
2597451|NCT01085812|8982902|P2|Double-Blind Period|Other Reasons|2
2597452|NCT01085812|8982903|P1|Double-Blind Period|Other Reasons|0
2597453|NCT01085812|8982902|P2|Double-Blind Period|Lost to Follow-up|17
2597454|NCT01085812|8982903|P1|Double-Blind Period|Lost to Follow-up|5
2597455|NCT01085812|8982902|P2|Double-Blind Period|Withdrawal by Subject|24
2597456|NCT01085812|8982903|P1|Double-Blind Period|Withdrawal by Subject|11
2597457|NCT01085812|8982902|P2|Double-Blind Period|Protocol Violation|7
2597458|NCT01085812|8982903|P1|Double-Blind Period|Protocol Violation|2
2597459|NCT01085812|8982902|P2|Double-Blind Period|Adverse Event|8
2597460|NCT01085812|8982903|P1|Double-Blind Period|Adverse Event|3
2597461|NCT01085812|8982902|P2|Open-Label Period|Lost to Follow-up|42
2597462|NCT01085812|8982903|P1|Open-Label Period|Lost to Follow-up|0
2597463|NCT01085812|8982902|P2|Open-Label Period|Withdrawal by Subject|53
2597464|NCT01085812|8982903|P1|Open-Label Period|Withdrawal by Subject|0
2597465|NCT01085812|8982902|P2|Open-Label Period|Protocol Violation|39
2597466|NCT01085812|8982903|P1|Open-Label Period|Protocol Violation|0
2597467|NCT01085812|8982902|P2|Open-Label Period|Lack of Efficacy|26
2597468|NCT01085812|8982903|P1|Open-Label Period|Lack of Efficacy|0
2597469|NCT01085812|8982902|P2|Open-Label Period|Adverse Event|80
2597470|NCT01085812|8982903|P1|Open-Label Period|Adverse Event|0
2597471|NCT01085734|8982950|P2|Overall Study|Withdrawal by Subject|1
2597472|NCT01085734|8982951|P1|Overall Study|Withdrawal by Subject|0
2597473|NCT01085734|8982950|P2|Overall Study|Lost to Follow-up|1
2597474|NCT01085734|8982951|P1|Overall Study|Lost to Follow-up|0
2597475|NCT01085734|8982950|P2|Overall Study|Death|0
2597476|NCT01085734|8982951|P1|Overall Study|Death|1
2597477|NCT01085734|8982950|P2|Overall Study|Adverse Event|2
2597478|NCT01085734|8982951|P1|Overall Study|Adverse Event|0
2597479|NCT01085682|8982963|P2|Overall Study|Withdrawal by Subject|25
2597480|NCT01085682|8982964|P1|Overall Study|Withdrawal by Subject|25
2597481|NCT01085630|8982981|P2|Overall Study|Ineligible|0
2597482|NCT01085630|8982982|P1|Overall Study|Ineligible|3
2597483|NCT01085630|8982981|P2|Overall Study|Insufficient data|0
2597484|NCT01085630|8982982|P1|Overall Study|Insufficient data|1
2597485|NCT01085591|8982995|P3|Overall Study|Not Properly Consented|0
2597486|NCT01085591|8982996|P2|Overall Study|Not Properly Consented|0
2597487|NCT01085591|8982997|P1|Overall Study|Not Properly Consented|1
2597488|NCT01085591|8982995|P3|Overall Study|Other|0
2597489|NCT01085591|8982996|P2|Overall Study|Other|1
2597490|NCT01085591|8982997|P1|Overall Study|Other|0
2597491|NCT01085591|8982995|P3|Overall Study|Protocol Violation|1
2597492|NCT01085591|8982996|P2|Overall Study|Protocol Violation|1
2597493|NCT01085591|8982997|P1|Overall Study|Protocol Violation|1
2597494|NCT01085591|8982995|P3|Overall Study|Lost to Follow-up|1
2597495|NCT01085591|8982996|P2|Overall Study|Lost to Follow-up|1
2597496|NCT01085591|8982997|P1|Overall Study|Lost to Follow-up|0
2597497|NCT01085591|8982995|P3|Overall Study|Withdrawal by Subject|1
2597498|NCT01085591|8982996|P2|Overall Study|Withdrawal by Subject|2
2597499|NCT01085591|8982997|P1|Overall Study|Withdrawal by Subject|0
2597500|NCT01085591|8982995|P3|Overall Study|Physician Decision|1
2597501|NCT01085591|8982996|P2|Overall Study|Physician Decision|0
2597502|NCT01085591|8982997|P1|Overall Study|Physician Decision|1
2597503|NCT01085591|8982995|P3|Overall Study|Adverse Event|3
2597504|NCT01085591|8982996|P2|Overall Study|Adverse Event|1
2597505|NCT01085591|8982997|P1|Overall Study|Adverse Event|0
2597506|NCT01085357|8983048|P2|Overall Study|Lost to Follow-up|0
2597507|NCT01085357|8983049|P1|Overall Study|Lost to Follow-up|2
2597508|NCT01085357|8983048|P2|Overall Study|Death|1
2597509|NCT01085357|8983049|P1|Overall Study|Death|11
2597510|NCT01085357|8983048|P2|Overall Study|Investigator Decision|1
2597511|NCT01085357|8983049|P1|Overall Study|Investigator Decision|1
2597512|NCT01085357|8983048|P2|Overall Study|Subject Decision|3
2597513|NCT01085357|8983049|P1|Overall Study|Subject Decision|4
2597514|NCT01085357|8983048|P2|Overall Study|Adverse Event|1
2597515|NCT01085357|8983049|P1|Overall Study|Adverse Event|1
2597516|NCT01085214|8983122|P1|Overall Study|Alternate treatment required|1
2597517|NCT01085201|8983134|P5|Overall Study|Fond ineligible after consent|0
2597518|NCT01085201|8983135|P4|Overall Study|Fond ineligible after consent|0
2597519|NCT01085201|8983136|P3|Overall Study|Fond ineligible after consent|1
2597520|NCT01085201|8983137|P2|Overall Study|Fond ineligible after consent|1
2597521|NCT01085201|8983138|P1|Overall Study|Fond ineligible after consent|0
2597522|NCT01085201|8983134|P5|Overall Study|Unknown- no study drug|0
2597523|NCT01085201|8983135|P4|Overall Study|Unknown- no study drug|0
2597524|NCT01085201|8983136|P3|Overall Study|Unknown- no study drug|0
2597525|NCT01085201|8983137|P2|Overall Study|Unknown- no study drug|0
2597526|NCT01085201|8983138|P1|Overall Study|Unknown- no study drug|2
2597527|NCT01085201|8983134|P5|Overall Study|Scheduling conflict|0
2597528|NCT01085201|8983135|P4|Overall Study|Scheduling conflict|0
2597529|NCT01085201|8983136|P3|Overall Study|Scheduling conflict|1
2597530|NCT01085201|8983137|P2|Overall Study|Scheduling conflict|0
2597531|NCT01085201|8983138|P1|Overall Study|Scheduling conflict|1
2597532|NCT01085136|8983160|P3|Part B|Other reason not defined above|3
2597533|NCT01085136|8983161|P2|Part B|Other reason not defined above|6
2597534|NCT01085136|8983162|P1|Part B|Other reason not defined above|0
2597535|NCT01085136|8983160|P3|Part B|Not treated|8
2597536|NCT01085136|8983161|P2|Part B|Not treated|4
2597537|NCT01085136|8983162|P1|Part B|Not treated|0
2597538|NCT01085136|8983160|P3|Part B|Refusal to continue trial medication|7
2597539|NCT01085136|8983161|P2|Part B|Refusal to continue trial medication|12
2597540|NCT01085136|8983162|P1|Part B|Refusal to continue trial medication|0
2597541|NCT01085136|8983160|P3|Part B|Other AE|8
2597542|NCT01085136|8983161|P2|Part B|Other AE|29
2597543|NCT01085136|8983162|P1|Part B|Other AE|0
2597544|NCT01085136|8983160|P3|Part A|Other reason not defined above|0
2597545|NCT01085136|8983161|P2|Part A|Other reason not defined above|0
2597546|NCT01085136|8983162|P1|Part A|Other reason not defined above|30
2597547|NCT01085136|8983160|P3|Part A|Refusal to continue trial medication|0
2597548|NCT01085136|8983161|P2|Part A|Refusal to continue trial medication|0
2597549|NCT01085136|8983162|P1|Part A|Refusal to continue trial medication|64
2597550|NCT01085136|8983160|P3|Part A|Lost to Follow-up|0
2597551|NCT01085136|8983161|P2|Part A|Lost to Follow-up|0
2597552|NCT01085136|8983162|P1|Part A|Lost to Follow-up|3
2597553|NCT01085136|8983160|P3|Part A|Protocol Violation|0
2597554|NCT01085136|8983161|P2|Part A|Protocol Violation|0
2597555|NCT01085136|8983162|P1|Part A|Protocol Violation|3
2597556|NCT01085136|8983160|P3|Part A|Other Adverse event|0
2597557|NCT01085136|8983161|P2|Part A|Other Adverse event|0
2597558|NCT01085136|8983162|P1|Part A|Other Adverse event|223
2597559|NCT01085045|8983178|P1|Part B|Adverse Event|6
2597560|NCT01085045|8983178|P1|Part B|Lost to Follow-up|1
2597561|NCT01085045|8983178|P1|Part B|Protocol Specified Criteria|6
2597562|NCT01085045|8983178|P1|Part B|Withdrawal by Subject|2
2597563|NCT01085045|8983178|P1|Part A|Protocol Specified Criteria|7
2597564|NCT01085045|8983178|P1|Part A|Protocol Violation|1
2597565|NCT01085045|8983178|P1|Part A|Adverse Event|6
2597566|NCT01085045|8983178|P1|Part A|Withdrawal by Subject|4
2597567|NCT01084772|8983289|P2|2 Years|Study Termination|2
2597568|NCT01084772|8983290|P1|2 Years|Study Termination|3
2597569|NCT01084772|8983289|P2|2 Years|Lost to Follow-up|2
2597570|NCT01084772|8983290|P1|2 Years|Lost to Follow-up|5
2597571|NCT01084772|8983289|P2|2 Years|Withdrawal by Subject|0
2597572|NCT01084772|8983290|P1|2 Years|Withdrawal by Subject|1
2597573|NCT01084772|8983289|P2|1 Year|Study Termination|7
2597574|NCT01084772|8983290|P1|1 Year|Study Termination|0
2597575|NCT01084772|8983289|P2|1 Year|Lost to Follow-up|0
2597576|NCT01084772|8983290|P1|1 Year|Lost to Follow-up|3
2597577|NCT01084772|8983289|P2|1 Year|Withdrawal by Subject|1
2597578|NCT01084772|8983290|P1|1 Year|Withdrawal by Subject|0
2597579|NCT01084772|8983289|P2|3 Months|Study Termination|2
2597580|NCT01084772|8983290|P1|3 Months|Study Termination|2
2597581|NCT01084772|8983289|P2|3 Months|Death|0
2597582|NCT01084772|8983290|P1|3 Months|Death|1
2597583|NCT01084772|8983289|P2|Baseline|Withdrawal by Subject|6
2597584|NCT01084772|8983290|P1|Baseline|Withdrawal by Subject|7
2597585|NCT01084707|8983326|P1|Overall Study|Withdrawal by Subject|6
2597586|NCT01084694|8983362|P2|Overall Study|eligibility not maintained|7
2597587|NCT01084694|8983363|P1|Overall Study|eligibility not maintained|2
2597588|NCT01084694|8983362|P2|Overall Study|Death|12
2597589|NCT01084694|8983363|P1|Overall Study|Death|2
2597590|NCT01084694|8983362|P2|Overall Study|Withdrawal by Subject|1
2597591|NCT01084694|8983363|P1|Overall Study|Withdrawal by Subject|2
2597592|NCT01084668|8983379|P1|Overall Study|Non-compliance|1
2597593|NCT01084668|8983379|P1|Overall Study|Pregnancy|1
2597594|NCT01084668|8983379|P1|Overall Study|Withdrawal by Subject|2
2597595|NCT01084668|8983379|P1|Overall Study|Lack of Efficacy|5
2597596|NCT01084655|8983391|P3|Overall Study|Prostate-specificAntigen(PSA)progression|1
2597597|NCT01084655|8983392|P2|Overall Study|Prostate-specificAntigen(PSA)progression|0
2597598|NCT01084655|8983393|P1|Overall Study|Prostate-specificAntigen(PSA)progression|0
2597599|NCT01084655|8983391|P3|Overall Study|Symptomatic deterioration|2
2597600|NCT01084655|8983392|P2|Overall Study|Symptomatic deterioration|0
2597601|NCT01084655|8983393|P1|Overall Study|Symptomatic deterioration|0
2597602|NCT01084655|8983391|P3|Overall Study|Other|2
2597603|NCT01084655|8983392|P2|Overall Study|Other|3
2597604|NCT01084655|8983393|P1|Overall Study|Other|0
2597605|NCT01084655|8983391|P3|Overall Study|Adverse Event|2
2597606|NCT01084655|8983392|P2|Overall Study|Adverse Event|1
2597607|NCT01084655|8983393|P1|Overall Study|Adverse Event|2
2597608|NCT01084655|8983391|P3|Overall Study|Withdrawal by Subject|4
2597609|NCT01084655|8983392|P2|Overall Study|Withdrawal by Subject|0
2597610|NCT01084655|8983393|P1|Overall Study|Withdrawal by Subject|1
2597611|NCT01084655|8983391|P3|Overall Study|Radiographic disease progression|8
2597612|NCT01084655|8983392|P2|Overall Study|Radiographic disease progression|2
2597613|NCT01084655|8983393|P1|Overall Study|Radiographic disease progression|3
2597614|NCT01084603|8983428|P1|Washout Period 4|Adverse Event|1
2597615|NCT01084603|8983428|P1|Oral Nicotine 1|Withdrawal by Subject|1
2597616|NCT01084603|8983428|P1|Nicorette® Gum|Withdrawal by Subject|1
2597617|NCT01084603|8983428|P1|NiQuitinTM Lozenge|Withdrawal by Subject|1
2597618|NCT01084603|8983428|P1|Baseline|Withdrawal by Subject|2
2597619|NCT01084551|8983464|P3|Overall Study|Physician Decision|0
2597620|NCT01084551|8983465|P2|Overall Study|Physician Decision|0
2597621|NCT01084551|8983466|P1|Overall Study|Physician Decision|1
2597622|NCT01084551|8983464|P3|Overall Study|Lost to Follow-up|3
2597623|NCT01084551|8983465|P2|Overall Study|Lost to Follow-up|0
2597624|NCT01084551|8983466|P1|Overall Study|Lost to Follow-up|0
2597625|NCT01084551|8983464|P3|Overall Study|Protocol Violation|0
2597626|NCT01084551|8983465|P2|Overall Study|Protocol Violation|4
2597627|NCT01084551|8983466|P1|Overall Study|Protocol Violation|2
2597628|NCT01084551|8983464|P3|Overall Study|Withdrawal by Subject|0
2597629|NCT01084551|8983465|P2|Overall Study|Withdrawal by Subject|1
2597630|NCT01084551|8983466|P1|Overall Study|Withdrawal by Subject|2
2597631|NCT01084551|8983464|P3|Overall Study|Lack of Efficacy|1
2597632|NCT01084551|8983465|P2|Overall Study|Lack of Efficacy|0
2597633|NCT01084551|8983466|P1|Overall Study|Lack of Efficacy|2
2597634|NCT01084551|8983464|P3|Overall Study|Adverse Event|4
2597635|NCT01084551|8983465|P2|Overall Study|Adverse Event|9
2597636|NCT01084551|8983466|P1|Overall Study|Adverse Event|2
2597637|NCT01084538|8983504|P1|Overall Study|Reason unknown|8
2597638|NCT01084538|8983504|P1|Overall Study|Over-suppression of parathyroid gland|2
2597639|NCT01084538|8983504|P1|Overall Study|Change of residence|2
2597640|NCT01084538|8983504|P1|Overall Study|Nodular hyperplasia of parathyroid gland|2
2597641|NCT01084538|8983504|P1|Overall Study|Hyperphosphatemia|2
2597642|NCT01084538|8983504|P1|Overall Study|Patient noncompliance|2
2597643|NCT01084538|8983504|P1|Overall Study|Lack of effectiveness|2
2597644|NCT01084538|8983504|P1|Overall Study|Serious Adverse Event|3
2597645|NCT01084538|8983504|P1|Overall Study|Kidney transplant|6
2597646|NCT01084538|8983504|P1|Overall Study|Adverse Event|9
2597647|NCT01084538|8983504|P1|Overall Study|Drug not available|30
2597648|NCT01084252|8983638|P14|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2597649|NCT01084252|8983639|P13|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|1
2597650|NCT01084252|8983640|P12|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2597651|NCT01084252|8983641|P11|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2597652|NCT01084252|8983642|P10|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2597653|NCT01084252|8983643|P9|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2597654|NCT01084252|8983644|P8|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2597655|NCT01084252|8983645|P7|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2597656|NCT01084252|8983646|P6|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2597657|NCT01084252|8983647|P5|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2597658|NCT01084252|8983648|P4|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2597659|NCT01084252|8983649|P3|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2597660|NCT01084252|8983650|P2|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2597661|NCT01084252|8983651|P1|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
2597662|NCT01084252|8983638|P14|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|15
2597663|NCT01084252|8983639|P13|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|13
2597664|NCT01084252|8983640|P12|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2597665|NCT01084252|8983641|P11|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2597666|NCT01084252|8983642|P10|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2597667|NCT01084252|8983643|P9|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2597668|NCT01084252|8983644|P8|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2597669|NCT01084252|8983645|P7|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2597670|NCT01084252|8983646|P6|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2597671|NCT01084252|8983647|P5|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2597672|NCT01084252|8983648|P4|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2597673|NCT01084252|8983649|P3|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2597674|NCT01084252|8983650|P2|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2597675|NCT01084252|8983651|P1|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
2597676|NCT01084252|8983638|P14|Phase 2 Stage 2 (97 Weeks)|Other than specified above|2
2597677|NCT01084252|8983639|P13|Phase 2 Stage 2 (97 Weeks)|Other than specified above|12
2597678|NCT01084252|8983640|P12|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2597679|NCT01084252|8983641|P11|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2597680|NCT01084252|8983642|P10|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2597681|NCT01084252|8983643|P9|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2597682|NCT01084252|8983644|P8|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2597683|NCT01084252|8983645|P7|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2597684|NCT01084252|8983646|P6|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2597685|NCT01084252|8983647|P5|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2597686|NCT01084252|8983648|P4|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2597687|NCT01084252|8983649|P3|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2597688|NCT01084252|8983650|P2|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2597689|NCT01084252|8983651|P1|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
2597690|NCT01084252|8983638|P14|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2597691|NCT01084252|8983639|P13|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|1
2597692|NCT01084252|8983640|P12|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2597693|NCT01084252|8983641|P11|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2597694|NCT01084252|8983642|P10|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2597695|NCT01084252|8983643|P9|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2597696|NCT01084252|8983644|P8|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2597697|NCT01084252|8983645|P7|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2597698|NCT01084252|8983646|P6|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2597699|NCT01084252|8983647|P5|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2597700|NCT01084252|8983648|P4|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2597701|NCT01084252|8983649|P3|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2597702|NCT01084252|8983650|P2|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2597703|NCT01084252|8983651|P1|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
2597704|NCT01084252|8983638|P14|Phase 2 Stage 2 (97 Weeks)|Progressive disease|33
2597705|NCT01084252|8983639|P13|Phase 2 Stage 2 (97 Weeks)|Progressive disease|70
2597706|NCT01084252|8983640|P12|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2597707|NCT01084252|8983641|P11|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2597708|NCT01084252|8983642|P10|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2597709|NCT01084252|8983643|P9|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2597710|NCT01084252|8983644|P8|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2597711|NCT01084252|8983645|P7|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2597712|NCT01084252|8983646|P6|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2597713|NCT01084252|8983647|P5|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2597714|NCT01084252|8983648|P4|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2597715|NCT01084252|8983649|P3|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2597716|NCT01084252|8983650|P2|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2597717|NCT01084252|8983651|P1|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
2597718|NCT01084252|8983638|P14|Phase 2 Stage 2 (97 Weeks)|Adverse Event|5
2597719|NCT01084252|8983639|P13|Phase 2 Stage 2 (97 Weeks)|Adverse Event|13
2597720|NCT01084252|8983640|P12|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2597721|NCT01084252|8983641|P11|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2597722|NCT01084252|8983642|P10|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2597723|NCT01084252|8983643|P9|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2597724|NCT01084252|8983644|P8|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2597725|NCT01084252|8983645|P7|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2597726|NCT01084252|8983646|P6|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2597727|NCT01084252|8983647|P5|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2597728|NCT01084252|8983648|P4|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2597729|NCT01084252|8983649|P3|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2597730|NCT01084252|8983650|P2|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2597731|NCT01084252|8983651|P1|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
2597732|NCT01084252|8983638|P14|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
2597733|NCT01084252|8983639|P13|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
2597734|NCT01084252|8983640|P12|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2
2597735|NCT01084252|8983641|P11|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2
2597736|NCT01084252|8983642|P10|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|4
2597737|NCT01084252|8983643|P9|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|1
2597738|NCT01084252|8983644|P8|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
2597739|NCT01084252|8983645|P7|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
2597740|NCT01084252|8983646|P6|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
2597741|NCT01084252|8983647|P5|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
2597742|NCT01084252|8983648|P4|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
2597743|NCT01084252|8983649|P3|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
2597744|NCT01084252|8983650|P2|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
2597745|NCT01084252|8983651|P1|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
2597746|NCT01084252|8983638|P14|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2597747|NCT01084252|8983639|P13|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2597748|NCT01084252|8983640|P12|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|3
2597749|NCT01084252|8983641|P11|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|4
2597750|NCT01084252|8983642|P10|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2597751|NCT01084252|8983643|P9|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|2
2597752|NCT01084252|8983644|P8|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2597753|NCT01084252|8983645|P7|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2597754|NCT01084252|8983646|P6|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2597755|NCT01084252|8983647|P5|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2597756|NCT01084252|8983648|P4|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2597757|NCT01084252|8983649|P3|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2597758|NCT01084252|8983650|P2|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2597759|NCT01084252|8983651|P1|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
2597760|NCT01084252|8983638|P14|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
2597761|NCT01084252|8983639|P13|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
2597762|NCT01084252|8983640|P12|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|19
2597763|NCT01084252|8983641|P11|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|17
2597764|NCT01084252|8983642|P10|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|18
2597765|NCT01084252|8983643|P9|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|20
2597766|NCT01084252|8983644|P8|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
2597767|NCT01084252|8983645|P7|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
2597768|NCT01084252|8983646|P6|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
2597769|NCT01084252|8983647|P5|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
2597770|NCT01084252|8983648|P4|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
2597771|NCT01084252|8983649|P3|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
2597772|NCT01084252|8983650|P2|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
2597773|NCT01084252|8983651|P1|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
2597774|NCT01084252|8983638|P14|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2597775|NCT01084252|8983639|P13|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2597776|NCT01084252|8983640|P12|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|1
2597777|NCT01084252|8983641|P11|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2
2597778|NCT01084252|8983642|P10|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2
2597779|NCT01084252|8983643|P9|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2597780|NCT01084252|8983644|P8|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2597781|NCT01084252|8983645|P7|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2597782|NCT01084252|8983646|P6|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2597783|NCT01084252|8983647|P5|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2597784|NCT01084252|8983648|P4|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2597785|NCT01084252|8983649|P3|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2597786|NCT01084252|8983650|P2|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2597787|NCT01084252|8983651|P1|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
2597788|NCT01084252|8983638|P14|Phase 1 (120 Weeks)|Other than specified above|0
2597789|NCT01084252|8983639|P13|Phase 1 (120 Weeks)|Other than specified above|0
2597790|NCT01084252|8983640|P12|Phase 1 (120 Weeks)|Other than specified above|0
2597791|NCT01084252|8983641|P11|Phase 1 (120 Weeks)|Other than specified above|0
2597792|NCT01084252|8983642|P10|Phase 1 (120 Weeks)|Other than specified above|0
2597793|NCT01084252|8983643|P9|Phase 1 (120 Weeks)|Other than specified above|0
2597794|NCT01084252|8983644|P8|Phase 1 (120 Weeks)|Other than specified above|1
2597795|NCT01084252|8983645|P7|Phase 1 (120 Weeks)|Other than specified above|1
2597796|NCT01084252|8983646|P6|Phase 1 (120 Weeks)|Other than specified above|0
2597797|NCT01084252|8983647|P5|Phase 1 (120 Weeks)|Other than specified above|1
2597798|NCT01084252|8983648|P4|Phase 1 (120 Weeks)|Other than specified above|3
2597799|NCT01084252|8983649|P3|Phase 1 (120 Weeks)|Other than specified above|0
2597800|NCT01084252|8983650|P2|Phase 1 (120 Weeks)|Other than specified above|1
2597801|NCT01084252|8983651|P1|Phase 1 (120 Weeks)|Other than specified above|1
2597802|NCT01084252|8983638|P14|Phase 1 (120 Weeks)|Progressive disease|0
2597803|NCT01084252|8983639|P13|Phase 1 (120 Weeks)|Progressive disease|0
2597804|NCT01084252|8983640|P12|Phase 1 (120 Weeks)|Progressive disease|0
2597805|NCT01084252|8983641|P11|Phase 1 (120 Weeks)|Progressive disease|0
2597806|NCT01084252|8983642|P10|Phase 1 (120 Weeks)|Progressive disease|0
2597807|NCT01084252|8983643|P9|Phase 1 (120 Weeks)|Progressive disease|0
2597808|NCT01084252|8983644|P8|Phase 1 (120 Weeks)|Progressive disease|6
2597809|NCT01084252|8983645|P7|Phase 1 (120 Weeks)|Progressive disease|5
2597810|NCT01084252|8983646|P6|Phase 1 (120 Weeks)|Progressive disease|6
2597811|NCT01084252|8983647|P5|Phase 1 (120 Weeks)|Progressive disease|16
2597812|NCT01084252|8983648|P4|Phase 1 (120 Weeks)|Progressive disease|22
2597813|NCT01084252|8983649|P3|Phase 1 (120 Weeks)|Progressive disease|2
2597814|NCT01084252|8983650|P2|Phase 1 (120 Weeks)|Progressive disease|5
2597815|NCT01084252|8983651|P1|Phase 1 (120 Weeks)|Progressive disease|15
2597816|NCT01084252|8983638|P14|Phase 1 (120 Weeks)|Adverse Event|0
2597817|NCT01084252|8983639|P13|Phase 1 (120 Weeks)|Adverse Event|0
2597818|NCT01084252|8983640|P12|Phase 1 (120 Weeks)|Adverse Event|0
2597819|NCT01084252|8983641|P11|Phase 1 (120 Weeks)|Adverse Event|0
2597820|NCT01084252|8983642|P10|Phase 1 (120 Weeks)|Adverse Event|0
2597821|NCT01084252|8983643|P9|Phase 1 (120 Weeks)|Adverse Event|0
2597822|NCT01084252|8983644|P8|Phase 1 (120 Weeks)|Adverse Event|0
2597823|NCT01084252|8983645|P7|Phase 1 (120 Weeks)|Adverse Event|1
2597824|NCT01084252|8983646|P6|Phase 1 (120 Weeks)|Adverse Event|0
2597825|NCT01084252|8983647|P5|Phase 1 (120 Weeks)|Adverse Event|1
2597826|NCT01084252|8983648|P4|Phase 1 (120 Weeks)|Adverse Event|1
2597827|NCT01084252|8983649|P3|Phase 1 (120 Weeks)|Adverse Event|1
2597828|NCT01084252|8983650|P2|Phase 1 (120 Weeks)|Adverse Event|0
2597829|NCT01084252|8983651|P1|Phase 1 (120 Weeks)|Adverse Event|0
2597830|NCT01084239|8983835|P2|28-Day Follow-up|Lost to Follow-up|9
2597831|NCT01084239|8983836|P1|28-Day Follow-up|Lost to Follow-up|4
2597832|NCT01084174|8983854|P2|Overall Study|Participant noncompliance|1
2597833|NCT01084174|8983855|P1|Overall Study|Participant noncompliance|0
2597834|NCT01084174|8983854|P2|Overall Study|Anaphylaxis|1
2597835|NCT01084174|8983855|P1|Overall Study|Anaphylaxis|0
2597836|NCT01084174|8983854|P2|Overall Study|Eosinophilic esophagitis|1
2597837|NCT01084174|8983855|P1|Overall Study|Eosinophilic esophagitis|0
2597838|NCT01084174|8983854|P2|Overall Study|gastrointestinal symptoms|1
2597839|NCT01084174|8983855|P1|Overall Study|gastrointestinal symptoms|1
2597840|NCT01084135|8983888|P2|20 Week|Physician Decision|1
2597841|NCT01084135|8983889|P1|20 Week|Physician Decision|0
2597842|NCT01084083|8983899|P1|Overall Study|Never started assigned therapy|1
2597843|NCT01084083|8983899|P1|Overall Study|Other|2
2597844|NCT01084083|8983899|P1|Overall Study|Complicating disease|1
2597845|NCT01084083|8983899|P1|Overall Study|Withdrawal by Subject|2
2597846|NCT01084083|8983899|P1|Overall Study|Death|1
2597847|NCT01084083|8983899|P1|Overall Study|Adverse Event|5
2597848|NCT01084005|8983907|P2|Overall Study|Withdrawal by Subject|1
2597849|NCT01084005|8983908|P1|Overall Study|Withdrawal by Subject|1
2597850|NCT01084005|8983907|P2|Overall Study|Protocol Violation|7
2597851|NCT01084005|8983908|P1|Overall Study|Protocol Violation|3
2597852|NCT01084005|8983907|P2|Overall Study|Adverse Event|8
2597853|NCT01084005|8983908|P1|Overall Study|Adverse Event|1
2597854|NCT01083810|8983989|P3|Overall Study|Virologic failure|0
2597855|NCT01083810|8983990|P2|Overall Study|Virologic failure|8
2597856|NCT01083810|8983991|P1|Overall Study|Virologic failure|1
2597857|NCT01083810|8983989|P3|Overall Study|Therapy break|2
2597858|NCT01083810|8983990|P2|Overall Study|Therapy break|2
2597859|NCT01083810|8983991|P1|Overall Study|Therapy break|1
2597860|NCT01083810|8983989|P3|Overall Study|Participation in study|0
2597861|NCT01083810|8983990|P2|Overall Study|Participation in study|0
2597862|NCT01083810|8983991|P1|Overall Study|Participation in study|1
2597863|NCT01083810|8983989|P3|Overall Study|Co-morbidities|0
2597864|NCT01083810|8983990|P2|Overall Study|Co-morbidities|0
2597865|NCT01083810|8983991|P1|Overall Study|Co-morbidities|1
2597866|NCT01083810|8983989|P3|Overall Study|Death|3
2597867|NCT01083810|8983990|P2|Overall Study|Death|2
2597868|NCT01083810|8983991|P1|Overall Study|Death|2
2597869|NCT01083810|8983989|P3|Overall Study|Simplification|0
2597870|NCT01083810|8983990|P2|Overall Study|Simplification|1
2597871|NCT01083810|8983991|P1|Overall Study|Simplification|4
2597872|NCT01083810|8983989|P3|Overall Study|Non-compliance|2
2597873|NCT01083810|8983990|P2|Overall Study|Non-compliance|7
2597874|NCT01083810|8983991|P1|Overall Study|Non-compliance|4
2597875|NCT01083810|8983989|P3|Overall Study|Reason not reported|1
2597876|NCT01083810|8983990|P2|Overall Study|Reason not reported|1
2597877|NCT01083810|8983991|P1|Overall Study|Reason not reported|6
2597878|NCT01083810|8983989|P3|Overall Study|Withdrawal by Subject|4
2597879|NCT01083810|8983990|P2|Overall Study|Withdrawal by Subject|2
2597880|NCT01083810|8983991|P1|Overall Study|Withdrawal by Subject|7
2597881|NCT01083810|8983989|P3|Overall Study|Adverse Event|4
2597882|NCT01083810|8983990|P2|Overall Study|Adverse Event|11
2597883|NCT01083810|8983991|P1|Overall Study|Adverse Event|15
2597884|NCT01083810|8983989|P3|Overall Study|Lost to Follow-up|4
2597885|NCT01083810|8983990|P2|Overall Study|Lost to Follow-up|11
2597886|NCT01083810|8983991|P1|Overall Study|Lost to Follow-up|23
2597887|NCT01083771|8984012|P1|Overall Study|Withdrawal by Subject|3
2597888|NCT01083771|8984012|P1|Overall Study|non-compliant|2
2597889|NCT01083693|8984113|P3|Overall Study|Reason unknown|1
2597890|NCT01083693|8984114|P2|Overall Study|Reason unknown|0
2597891|NCT01083693|8984115|P1|Overall Study|Reason unknown|0
2597892|NCT01083693|8984113|P3|Overall Study|Withdrawal by Subject|2
2597893|NCT01083693|8984114|P2|Overall Study|Withdrawal by Subject|0
2597894|NCT01083693|8984115|P1|Overall Study|Withdrawal by Subject|3
2597895|NCT01083693|8984113|P3|Overall Study|Other medical condition/surgery|0
2597896|NCT01083693|8984114|P2|Overall Study|Other medical condition/surgery|1
2597897|NCT01083693|8984115|P1|Overall Study|Other medical condition/surgery|1
2597898|NCT01083693|8984113|P3|Overall Study|Complete remission|0
2597899|NCT01083693|8984114|P2|Overall Study|Complete remission|1
2597900|NCT01083693|8984115|P1|Overall Study|Complete remission|0
2597901|NCT01083693|8984113|P3|Overall Study|Patient Moved|0
2597902|NCT01083693|8984114|P2|Overall Study|Patient Moved|1
2597903|NCT01083693|8984115|P1|Overall Study|Patient Moved|0
2597904|NCT01083693|8984113|P3|Overall Study|Lack of effectiveness|2
2597905|NCT01083693|8984114|P2|Overall Study|Lack of effectiveness|2
2597906|NCT01083693|8984115|P1|Overall Study|Lack of effectiveness|13
2597907|NCT01083693|8984113|P3|Overall Study|Lost to Follow-up|2
2597908|NCT01083693|8984114|P2|Overall Study|Lost to Follow-up|0
2597909|NCT01083693|8984115|P1|Overall Study|Lost to Follow-up|2
2597910|NCT01083693|8984113|P3|Overall Study|Adverse Event|0
2597911|NCT01083693|8984114|P2|Overall Study|Adverse Event|1
2597912|NCT01083693|8984115|P1|Overall Study|Adverse Event|1
2597913|NCT01083680|8984150|P1|Overall Study|Withdrawal by Subject|1086
2597914|NCT01083680|8984150|P1|Overall Study|Lost to Follow-up|2758
2597915|NCT01083641|8984173|P1|Overall Study|Withdrawal by Subject|2
2597916|NCT01083602|8984193|P1|Overall Study|Lack of Efficacy|36
2597917|NCT01083602|8984193|P1|Overall Study|Withdrawal by Subject|5
2597918|NCT01083602|8984193|P1|Overall Study|Death|1
2597919|NCT01083602|8984193|P1|Overall Study|New Cancer Therapy|2
2597920|NCT01083602|8984193|P1|Overall Study|Adverse Event|11
2597921|NCT01083576|8984204|P2|Overall Study|Treatment Failure|1
2597922|NCT01083576|8984205|P1|Overall Study|Treatment Failure|6
2597923|NCT01083485|8984235|P2|Overall Study|Other|0
2597924|NCT01083485|8984236|P1|Overall Study|Other|1
2597925|NCT01083485|8984235|P2|Overall Study|Withdrawal by Subject|2
2597926|NCT01083485|8984236|P1|Overall Study|Withdrawal by Subject|5
2597927|NCT01083485|8984235|P2|Overall Study|Protocol Violation|0
2597928|NCT01083485|8984236|P1|Overall Study|Protocol Violation|1
2597929|NCT01083485|8984235|P2|Overall Study|Adverse Event|1
2597930|NCT01083485|8984236|P1|Overall Study|Adverse Event|0
2597931|NCT01083316|8984268|P1|Overall Study|Withdrawal by Subject|1
2597932|NCT01083316|8984268|P1|Overall Study|Adverse Event|2
2597933|NCT01083186|8984280|P1|Overall Study|Non-compliance to Study Treatment|1
2597934|NCT01083186|8984280|P1|Overall Study|Administrative Reasons|2
2597935|NCT01083186|8984280|P1|Overall Study|Hemodialysis Initiation|28
2597936|NCT01083186|8984280|P1|Overall Study|Lack of Efficacy|2
2597937|NCT01083186|8984280|P1|Overall Study|Adverse Event|3
2597938|NCT01083186|8984280|P1|Overall Study|Death|3
2597939|NCT01083186|8984280|P1|Overall Study|Consent Withdrawal|7
2597940|NCT01083186|8984280|P1|Overall Study|Lost to Follow-up|48
2597941|NCT01083173|8984321|P2|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46
2597942|NCT01083173|8984322|P1|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0
2597943|NCT01083173|8984321|P2|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136
2597944|NCT01083173|8984322|P1|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0
2597945|NCT01083173|8984321|P2|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195
2597946|NCT01083173|8984322|P1|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0
2597947|NCT01083173|8984321|P2|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101
2597948|NCT01083173|8984322|P1|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0
2597949|NCT01083173|8984321|P2|Long-term Surveillance: Safety Group|Violation of the dosage|1
2597950|NCT01083173|8984322|P1|Long-term Surveillance: Safety Group|Violation of the dosage|0
2597951|NCT01083173|8984321|P2|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
2597952|NCT01083173|8984322|P1|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
2597953|NCT01083173|8984321|P2|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0
2597954|NCT01083173|8984322|P1|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13
2597955|NCT01083173|8984321|P2|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0
2597956|NCT01083173|8984322|P1|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168
2597957|NCT01083173|8984321|P2|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0
2597958|NCT01083173|8984322|P1|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201
2597959|NCT01083173|8984321|P2|Main Surveillance: Safety Group|Violation of the use/dosage|0
2597960|NCT01083173|8984322|P1|Main Surveillance: Safety Group|Violation of the use/dosage|1
2597961|NCT01083173|8984321|P2|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
2597962|NCT01083173|8984322|P1|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
2597963|NCT01083160|8984340|P1|Overall Study|Adverse Event|1
2597964|NCT01083121|8984347|P1|Overall Study|Use of Humira outside the approved label|81
2597965|NCT01082965|8984357|P2|Overall Study|Other|1
2597966|NCT01082965|8984358|P1|Overall Study|Other|1
2597967|NCT01082965|8984357|P2|Overall Study|Protocol Violation|1
2597968|NCT01082965|8984358|P1|Overall Study|Protocol Violation|0
2597969|NCT01082874|8984395|P4|Overall Study|Withdrawal by Subject|3
2597970|NCT01082874|8984396|P3|Overall Study|Withdrawal by Subject|5
2597971|NCT01082874|8984397|P2|Overall Study|Withdrawal by Subject|2
2597972|NCT01082874|8984398|P1|Overall Study|Withdrawal by Subject|1
2597973|NCT01082874|8984395|P4|Overall Study|Lost to Follow-up|10
2597974|NCT01082874|8984396|P3|Overall Study|Lost to Follow-up|6
2597975|NCT01082874|8984397|P2|Overall Study|Lost to Follow-up|10
2597976|NCT01082874|8984398|P1|Overall Study|Lost to Follow-up|10
2597977|NCT01082640|8984411|P3|Overall Study|Other|3
2597978|NCT01082640|8984412|P2|Overall Study|Other|1
2597979|NCT01082640|8984413|P1|Overall Study|Other|2
2597980|NCT01082640|8984411|P3|Overall Study|Lost to Follow-up|0
2597981|NCT01082640|8984412|P2|Overall Study|Lost to Follow-up|3
2597982|NCT01082640|8984413|P1|Overall Study|Lost to Follow-up|0
2597983|NCT01082640|8984411|P3|Overall Study|Major protocol deviation|0
2597984|NCT01082640|8984412|P2|Overall Study|Major protocol deviation|3
2597985|NCT01082640|8984413|P1|Overall Study|Major protocol deviation|3
2597986|NCT01082640|8984411|P3|Overall Study|Withdrawal by Subject|2
2597987|NCT01082640|8984412|P2|Overall Study|Withdrawal by Subject|3
2597988|NCT01082640|8984413|P1|Overall Study|Withdrawal by Subject|3
2597989|NCT01082640|8984411|P3|Overall Study|Adverse Event|3
2597990|NCT01082640|8984412|P2|Overall Study|Adverse Event|5
2597991|NCT01082640|8984413|P1|Overall Study|Adverse Event|9
2597992|NCT01082614|8984435|P2|Overall Study|Physician Decision|0
2597993|NCT01082614|8984436|P1|Overall Study|Physician Decision|2
2597994|NCT01082614|8984435|P2|Overall Study|Equipment Malfunction|1
2597995|NCT01082614|8984436|P1|Overall Study|Equipment Malfunction|0
2597996|NCT01082614|8984435|P2|Overall Study|Adverse Event|4
2597997|NCT01082614|8984436|P1|Overall Study|Adverse Event|1
2597998|NCT01082367|8984507|P2|Follow-up (F-U) Period|Adverse Event|1
2597999|NCT01082367|8984508|P1|Follow-up (F-U) Period|Adverse Event|0
2598000|NCT01082367|8984507|P2|Follow-up (F-U) Period|Abnormal lab values|0
2598001|NCT01082367|8984508|P1|Follow-up (F-U) Period|Abnormal lab values|1
2598002|NCT01082367|8984507|P2|Follow-up (F-U) Period|Administrative problems|0
2598003|NCT01082367|8984508|P1|Follow-up (F-U) Period|Administrative problems|1
2598004|NCT01082367|8984507|P2|Double-blind Period|Adverse Event|1
2598005|NCT01082367|8984508|P1|Double-blind Period|Adverse Event|0
2598006|NCT01082367|8984507|P2|Double-blind Period|Lack of Efficacy|11
2598007|NCT01082367|8984508|P1|Double-blind Period|Lack of Efficacy|5
2598008|NCT01082367|8984507|P2|Double-blind Period|Administrative problems|1
2598009|NCT01082367|8984508|P1|Double-blind Period|Administrative problems|0
2598010|NCT01082328|8984522|P1|Overall Study|Adverse Event|1
2598011|NCT01082211|8984531|P1|Overall Study|No protocol treatment received|3
2598012|NCT01082211|8984531|P1|Overall Study|Protocol Violation|4
2598013|NCT01082081|8984558|P3|Overall Study|Other Reason|0
2598014|NCT01082081|8984559|P2|Overall Study|Other Reason|1
2598015|NCT01082081|8984560|P1|Overall Study|Other Reason|0
2598016|NCT01082081|8984558|P3|Overall Study|Withdrawal by Subject|1
2598017|NCT01082081|8984559|P2|Overall Study|Withdrawal by Subject|0
2598018|NCT01082081|8984560|P1|Overall Study|Withdrawal by Subject|0
2598019|NCT01082081|8984558|P3|Overall Study|Lost to Follow-up|1
2598020|NCT01082081|8984559|P2|Overall Study|Lost to Follow-up|0
2598021|NCT01082081|8984560|P1|Overall Study|Lost to Follow-up|0
2598022|NCT01081951|8984612|P2|Overall Study|Lost to Follow-up|1
2598023|NCT01081951|8984613|P1|Overall Study|Lost to Follow-up|0
2598024|NCT01081951|8984612|P2|Overall Study|Allocated treatment but did not take it|1
2598025|NCT01081951|8984613|P1|Overall Study|Allocated treatment but did not take it|0
2598026|NCT01081951|8984612|P2|Overall Study|Withdrawal by Subject|6
2598027|NCT01081951|8984613|P1|Overall Study|Withdrawal by Subject|2
2598028|NCT01081951|8984612|P2|Overall Study|Death|47
2598029|NCT01081951|8984613|P1|Overall Study|Death|54
2598030|NCT01081912|8984623|P3|Maintenance Treatment|Withdrawal by Medical Monitor|1
2598031|NCT01081912|8984624|P2|Maintenance Treatment|Withdrawal by Medical Monitor|0
2598032|NCT01081912|8984625|P1|Maintenance Treatment|Withdrawal by Medical Monitor|0
2598033|NCT01081912|8984623|P3|Maintenance Treatment|Non-Compliance|7
2598034|NCT01081912|8984624|P2|Maintenance Treatment|Non-Compliance|4
2598035|NCT01081912|8984625|P1|Maintenance Treatment|Non-Compliance|0
2598036|NCT01081912|8984623|P3|Maintenance Treatment|Withdrawal by Subject|5
2598037|NCT01081912|8984624|P2|Maintenance Treatment|Withdrawal by Subject|5
2598038|NCT01081912|8984625|P1|Maintenance Treatment|Withdrawal by Subject|0
2598039|NCT01081912|8984623|P3|Maintenance Treatment|Protocol Violation|2
2598040|NCT01081912|8984624|P2|Maintenance Treatment|Protocol Violation|1
2598041|NCT01081912|8984625|P1|Maintenance Treatment|Protocol Violation|0
2598042|NCT01081912|8984623|P3|Maintenance Treatment|Physician Decision|1
2598043|NCT01081912|8984624|P2|Maintenance Treatment|Physician Decision|0
2598044|NCT01081912|8984625|P1|Maintenance Treatment|Physician Decision|0
2598045|NCT01081912|8984623|P3|Maintenance Treatment|Lost to Follow-up|0
2598046|NCT01081912|8984624|P2|Maintenance Treatment|Lost to Follow-up|1
2598047|NCT01081912|8984625|P1|Maintenance Treatment|Lost to Follow-up|0
2598048|NCT01081912|8984623|P3|Maintenance Treatment|Lack of Efficacy|64
2598049|NCT01081912|8984624|P2|Maintenance Treatment|Lack of Efficacy|14
2598050|NCT01081912|8984625|P1|Maintenance Treatment|Lack of Efficacy|0
2598051|NCT01081912|8984623|P3|Maintenance Treatment|Adverse Event|12
2598052|NCT01081912|8984624|P2|Maintenance Treatment|Adverse Event|2
2598053|NCT01081912|8984625|P1|Maintenance Treatment|Adverse Event|0
2598054|NCT01081912|8984623|P3|Conversion/Titration|Non-Compliance|0
2598055|NCT01081912|8984624|P2|Conversion/Titration|Non-Compliance|0
2598056|NCT01081912|8984625|P1|Conversion/Titration|Non-Compliance|47
2598057|NCT01081912|8984623|P3|Conversion/Titration|Withdrawal by Subject|0
2598058|NCT01081912|8984624|P2|Conversion/Titration|Withdrawal by Subject|0
2598059|NCT01081912|8984625|P1|Conversion/Titration|Withdrawal by Subject|23
2598060|NCT01081912|8984623|P3|Conversion/Titration|Protocol Violation|0
2598061|NCT01081912|8984624|P2|Conversion/Titration|Protocol Violation|0
2598062|NCT01081912|8984625|P1|Conversion/Titration|Protocol Violation|67
2598063|NCT01081912|8984623|P3|Conversion/Titration|Physician Decision|0
2598064|NCT01081912|8984624|P2|Conversion/Titration|Physician Decision|0
2598065|NCT01081912|8984625|P1|Conversion/Titration|Physician Decision|2
2598066|NCT01081912|8984623|P3|Conversion/Titration|Lost to Follow-up|0
2598067|NCT01081912|8984624|P2|Conversion/Titration|Lost to Follow-up|0
2598068|NCT01081912|8984625|P1|Conversion/Titration|Lost to Follow-up|5
2598069|NCT01081912|8984623|P3|Conversion/Titration|Lack of Efficacy|0
2598070|NCT01081912|8984624|P2|Conversion/Titration|Lack of Efficacy|0
2598071|NCT01081912|8984625|P1|Conversion/Titration|Lack of Efficacy|17
2598072|NCT01081912|8984623|P3|Conversion/Titration|Adverse Event|0
2598073|NCT01081912|8984624|P2|Conversion/Titration|Adverse Event|0
2598074|NCT01081912|8984625|P1|Conversion/Titration|Adverse Event|47
2598075|NCT01081886|8984634|P2|Overall Study|Study termination|13
2598076|NCT01081886|8984635|P1|Overall Study|Study termination|11
2598077|NCT01081873|8984643|P1|Overall Study|Other|47
2598078|NCT01081873|8984643|P1|Overall Study|Progression of prostate cancer|13
2598079|NCT01081873|8984643|P1|Overall Study|Lost to Follow-up|142
2598080|NCT01081873|8984643|P1|Overall Study|Withdrawal by Subject|10
2598081|NCT01081873|8984643|P1|Overall Study|Death|86
2598082|NCT01081834|8984715|P5|Extension Period: Week 26 to Week 52|Physician Decision|0
2598083|NCT01081834|8984716|P4|Extension Period: Week 26 to Week 52|Physician Decision|0
2598084|NCT01081834|8984717|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
2598085|NCT01081834|8984718|P2|Extension Period: Week 26 to Week 52|Physician Decision|1
2598086|NCT01081834|8984719|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
2598087|NCT01081834|8984715|P5|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
2598088|NCT01081834|8984716|P4|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
2598089|NCT01081834|8984717|P3|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
2598090|NCT01081834|8984718|P2|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1
2598091|NCT01081834|8984719|P1|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7
2598092|NCT01081834|8984715|P5|Extension Period: Week 26 to Week 52|Other|0
2598093|NCT01081834|8984716|P4|Extension Period: Week 26 to Week 52|Other|0
2598094|NCT01081834|8984717|P3|Extension Period: Week 26 to Week 52|Other|4
2598095|NCT01081834|8984718|P2|Extension Period: Week 26 to Week 52|Other|5
2598096|NCT01081834|8984719|P1|Extension Period: Week 26 to Week 52|Other|4
2598097|NCT01081834|8984715|P5|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
2598098|NCT01081834|8984716|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
2598099|NCT01081834|8984717|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
2598100|NCT01081834|8984718|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
2598101|NCT01081834|8984719|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
2598102|NCT01081834|8984715|P5|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
2598103|NCT01081834|8984716|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
2598104|NCT01081834|8984717|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
2598105|NCT01081834|8984718|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
2598106|NCT01081834|8984719|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
2598107|NCT01081834|8984715|P5|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
2598108|NCT01081834|8984716|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
2598109|NCT01081834|8984717|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
2598110|NCT01081834|8984718|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
2598111|NCT01081834|8984719|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
2598112|NCT01081834|8984715|P5|Extension Period: Week 26 to Week 52|Protocol Violation|0
2598113|NCT01081834|8984716|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
2598114|NCT01081834|8984717|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
2598115|NCT01081834|8984718|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
2598116|NCT01081834|8984719|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
2598117|NCT01081834|8984715|P5|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
2598118|NCT01081834|8984716|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
2598119|NCT01081834|8984717|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
2598120|NCT01081834|8984718|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
2598121|NCT01081834|8984719|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
2598122|NCT01081834|8984715|P5|Extension Period: Week 26 to Week 52|Death|0
2598123|NCT01081834|8984716|P4|Extension Period: Week 26 to Week 52|Death|0
2598124|NCT01081834|8984717|P3|Extension Period: Week 26 to Week 52|Death|0
2598125|NCT01081834|8984718|P2|Extension Period: Week 26 to Week 52|Death|0
2598126|NCT01081834|8984719|P1|Extension Period: Week 26 to Week 52|Death|1
2598127|NCT01081834|8984715|P5|Extension Period: Week 26 to Week 52|Adverse Event|0
2598128|NCT01081834|8984716|P4|Extension Period: Week 26 to Week 52|Adverse Event|0
2598129|NCT01081834|8984717|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
2598130|NCT01081834|8984718|P2|Extension Period: Week 26 to Week 52|Adverse Event|0
2598131|NCT01081834|8984719|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
2598132|NCT01081834|8984715|P5|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
2598133|NCT01081834|8984716|P4|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
2598134|NCT01081834|8984717|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
2598135|NCT01081834|8984718|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
2598136|NCT01081834|8984719|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3
2598137|NCT01081834|8984715|P5|Core Period: Baseline to Week 26|Other|0
2598138|NCT01081834|8984716|P4|Core Period: Baseline to Week 26|Other|1
2598139|NCT01081834|8984717|P3|Core Period: Baseline to Week 26|Other|3
2598140|NCT01081834|8984718|P2|Core Period: Baseline to Week 26|Other|4
2598141|NCT01081834|8984719|P1|Core Period: Baseline to Week 26|Other|4
2598142|NCT01081834|8984715|P5|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
2598143|NCT01081834|8984716|P4|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
2598144|NCT01081834|8984717|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
2598145|NCT01081834|8984718|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
2598146|NCT01081834|8984719|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
2598147|NCT01081834|8984715|P5|Core Period: Baseline to Week 26|Noncompliance with study drug|0
2598148|NCT01081834|8984716|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|2
2598149|NCT01081834|8984717|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|2
2598150|NCT01081834|8984718|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|4
2598151|NCT01081834|8984719|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|3
2598152|NCT01081834|8984715|P5|Core Period: Baseline to Week 26|Withdrawal by Subject|1
2598153|NCT01081834|8984716|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|3
2598154|NCT01081834|8984717|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|9
2598155|NCT01081834|8984718|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
2598156|NCT01081834|8984719|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|15
2598157|NCT01081834|8984715|P5|Core Period: Baseline to Week 26|Protocol Violation|2
2598158|NCT01081834|8984716|P4|Core Period: Baseline to Week 26|Protocol Violation|0
2598159|NCT01081834|8984717|P3|Core Period: Baseline to Week 26|Protocol Violation|0
2598160|NCT01081834|8984718|P2|Core Period: Baseline to Week 26|Protocol Violation|4
2598161|NCT01081834|8984719|P1|Core Period: Baseline to Week 26|Protocol Violation|0
2598162|NCT01081834|8984715|P5|Core Period: Baseline to Week 26|Lost to Follow-up|0
2598163|NCT01081834|8984716|P4|Core Period: Baseline to Week 26|Lost to Follow-up|0
2598164|NCT01081834|8984717|P3|Core Period: Baseline to Week 26|Lost to Follow-up|5
2598249|NCT01081678|8984859|P3|Overall Study|Administrative Decision|0
2598165|NCT01081834|8984718|P2|Core Period: Baseline to Week 26|Lost to Follow-up|2
2598166|NCT01081834|8984719|P1|Core Period: Baseline to Week 26|Lost to Follow-up|2
2598167|NCT01081834|8984715|P5|Core Period: Baseline to Week 26|Death|0
2598168|NCT01081834|8984716|P4|Core Period: Baseline to Week 26|Death|0
2598169|NCT01081834|8984717|P3|Core Period: Baseline to Week 26|Death|0
2598170|NCT01081834|8984718|P2|Core Period: Baseline to Week 26|Death|0
2598171|NCT01081834|8984719|P1|Core Period: Baseline to Week 26|Death|1
2598172|NCT01081834|8984715|P5|Core Period: Baseline to Week 26|Adverse Event|1
2598173|NCT01081834|8984716|P4|Core Period: Baseline to Week 26|Adverse Event|1
2598174|NCT01081834|8984717|P3|Core Period: Baseline to Week 26|Adverse Event|3
2598175|NCT01081834|8984718|P2|Core Period: Baseline to Week 26|Adverse Event|5
2598176|NCT01081834|8984719|P1|Core Period: Baseline to Week 26|Adverse Event|2
2598177|NCT01081834|8984715|P5|Core Period: Baseline to Week 26|Pregnancy|0
2598178|NCT01081834|8984716|P4|Core Period: Baseline to Week 26|Pregnancy|0
2598179|NCT01081834|8984717|P3|Core Period: Baseline to Week 26|Pregnancy|0
2598180|NCT01081834|8984718|P2|Core Period: Baseline to Week 26|Pregnancy|0
2598181|NCT01081834|8984719|P1|Core Period: Baseline to Week 26|Pregnancy|1
2598182|NCT01081795|8984780|P3|Overall Study|Other|0
2598183|NCT01081795|8984781|P2|Overall Study|Other|2
2598184|NCT01081795|8984782|P1|Overall Study|Other|1
2598185|NCT01081795|8984780|P3|Overall Study|Using drug with restricted days of use|2
2598186|NCT01081795|8984781|P2|Overall Study|Using drug with restricted days of use|3
2598187|NCT01081795|8984782|P1|Overall Study|Using drug with restricted days of use|2
2598188|NCT01081795|8984780|P3|Overall Study|Use of a prohibited concomitant drug|1
2598189|NCT01081795|8984781|P2|Overall Study|Use of a prohibited concomitant drug|1
2598190|NCT01081795|8984782|P1|Overall Study|Use of a prohibited concomitant drug|1
2598191|NCT01081795|8984780|P3|Overall Study|Ineligible for participation|0
2598192|NCT01081795|8984781|P2|Overall Study|Ineligible for participation|0
2598193|NCT01081795|8984782|P1|Overall Study|Ineligible for participation|1
2598194|NCT01081795|8984780|P3|Overall Study|Revocation of informed consent|0
2598195|NCT01081795|8984781|P2|Overall Study|Revocation of informed consent|0
2598196|NCT01081795|8984782|P1|Overall Study|Revocation of informed consent|2
2598197|NCT01081795|8984780|P3|Overall Study|Subject’s schedule|2
2598198|NCT01081795|8984781|P2|Overall Study|Subject’s schedule|1
2598199|NCT01081795|8984782|P1|Overall Study|Subject’s schedule|1
2598200|NCT01081795|8984780|P3|Overall Study|Lack of Efficacy|19
2598201|NCT01081795|8984781|P2|Overall Study|Lack of Efficacy|5
2598202|NCT01081795|8984782|P1|Overall Study|Lack of Efficacy|7
2598203|NCT01081795|8984780|P3|Overall Study|Adverse Event|6
2598204|NCT01081795|8984781|P2|Overall Study|Adverse Event|23
2598205|NCT01081795|8984782|P1|Overall Study|Adverse Event|18
2598206|NCT01081769|8984819|P2|CORE Intent-To-Treat|Patient Moved|2
2598207|NCT01081769|8984820|P1|CORE Intent-To-Treat|Patient Moved|2
2598208|NCT01081769|8984819|P2|CORE Intent-To-Treat|Visit Schedule Issues|2
2598209|NCT01081769|8984820|P1|CORE Intent-To-Treat|Visit Schedule Issues|1
2598210|NCT01081769|8984819|P2|CORE Intent-To-Treat|Ineligibility|4
2598211|NCT01081769|8984820|P1|CORE Intent-To-Treat|Ineligibility|3
2598212|NCT01081769|8984819|P2|CORE Intent-To-Treat|Other|1
2598213|NCT01081769|8984820|P1|CORE Intent-To-Treat|Other|0
2598214|NCT01081769|8984819|P2|CORE Intent-To-Treat|Noncompliance With Study Drug|5
2598215|NCT01081769|8984820|P1|CORE Intent-To-Treat|Noncompliance With Study Drug|0
2598216|NCT01081769|8984819|P2|CORE Intent-To-Treat|Withdrawal by Subject|60
2598217|NCT01081769|8984820|P1|CORE Intent-To-Treat|Withdrawal by Subject|52
2598218|NCT01081769|8984819|P2|CORE Intent-To-Treat|Pregnancy|0
2598219|NCT01081769|8984820|P1|CORE Intent-To-Treat|Pregnancy|1
2598220|NCT01081769|8984819|P2|CORE Intent-To-Treat|Lost to Follow-up|5
2598221|NCT01081769|8984820|P1|CORE Intent-To-Treat|Lost to Follow-up|4
2598222|NCT01081769|8984819|P2|CORE Intent-To-Treat|Lack of Efficacy|6
2598223|NCT01081769|8984820|P1|CORE Intent-To-Treat|Lack of Efficacy|2
2598224|NCT01081769|8984819|P2|CORE Intent-To-Treat|Death|1
2598225|NCT01081769|8984820|P1|CORE Intent-To-Treat|Death|1
2598226|NCT01081769|8984819|P2|CORE Intent-To-Treat|Adverse Event|11
2598227|NCT01081769|8984820|P1|CORE Intent-To-Treat|Adverse Event|14
2598228|NCT01081769|8984819|P2|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0
2598229|NCT01081769|8984820|P1|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2
2598230|NCT01081769|8984819|P2|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7
2598231|NCT01081769|8984820|P1|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6
2598232|NCT01081769|8984819|P2|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
2598233|NCT01081769|8984820|P1|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
2598234|NCT01081769|8984819|P2|Whole Intent-to-Treat|Missing Responder Assessment|12
2598235|NCT01081769|8984820|P1|Whole Intent-to-Treat|Missing Responder Assessment|10
2598236|NCT01081678|8984858|P4|Overall Study|Other|0
2598237|NCT01081678|8984859|P3|Overall Study|Other|0
2598238|NCT01081678|8984860|P2|Overall Study|Other|1
2598239|NCT01081678|8984861|P1|Overall Study|Other|0
2598240|NCT01081678|8984858|P4|Overall Study|Death|6
2598241|NCT01081678|8984859|P3|Overall Study|Death|2
2598242|NCT01081678|8984860|P2|Overall Study|Death|2
2598243|NCT01081678|8984861|P1|Overall Study|Death|2
2598244|NCT01081678|8984858|P4|Overall Study|Lost to Follow-up|3
2598245|NCT01081678|8984859|P3|Overall Study|Lost to Follow-up|4
2598246|NCT01081678|8984860|P2|Overall Study|Lost to Follow-up|1
2598247|NCT01081678|8984861|P1|Overall Study|Lost to Follow-up|4
2598248|NCT01081678|8984858|P4|Overall Study|Administrative Decision|1
2598250|NCT01081678|8984860|P2|Overall Study|Administrative Decision|0
2598251|NCT01081678|8984861|P1|Overall Study|Administrative Decision|1
2598252|NCT01081678|8984858|P4|Overall Study|Withdrawal by Subject|14
2598253|NCT01081678|8984859|P3|Overall Study|Withdrawal by Subject|17
2598254|NCT01081678|8984860|P2|Overall Study|Withdrawal by Subject|7
2598255|NCT01081678|8984861|P1|Overall Study|Withdrawal by Subject|15
2598256|NCT01081678|8984858|P4|Overall Study|Adverse Event|2
2598257|NCT01081678|8984859|P3|Overall Study|Adverse Event|2
2598258|NCT01081678|8984860|P2|Overall Study|Adverse Event|1
2598259|NCT01081678|8984861|P1|Overall Study|Adverse Event|2
2598260|NCT01081678|8984858|P4|Overall Study|Noncompliance|2
2598261|NCT01081678|8984859|P3|Overall Study|Noncompliance|5
2598262|NCT01081678|8984860|P2|Overall Study|Noncompliance|4
2598263|NCT01081678|8984861|P1|Overall Study|Noncompliance|3
2598264|NCT01081678|8984858|P4|Overall Study|Ineligibility Determined|1
2598265|NCT01081678|8984859|P3|Overall Study|Ineligibility Determined|1
2598266|NCT01081678|8984860|P2|Overall Study|Ineligibility Determined|0
2598267|NCT01081678|8984861|P1|Overall Study|Ineligibility Determined|0
2598268|NCT01081665|8984891|P1|Overall Study|Lack of Efficacy|1
2598269|NCT01081665|8984891|P1|Overall Study|Adverse Event|1
2598270|NCT01081665|8984891|P1|Overall Study|Change in renal replacement therapy|2
2598271|NCT01081665|8984891|P1|Overall Study|Regulation of iPTH|5
2598272|NCT01081665|8984891|P1|Overall Study|Change of dialysis unit|10
2598273|NCT01081665|8984891|P1|Overall Study|Withdrawal by Subject|17
2598274|NCT01081665|8984891|P1|Overall Study|Lost to Follow-up|18
2598275|NCT01081665|8984891|P1|Overall Study|Death|41
2598276|NCT01081626|8984903|P2|Overall Study|Other|30
2598277|NCT01081626|8984904|P1|Overall Study|Other|33
2598278|NCT01081626|8984903|P2|Overall Study|Lost to Follow-up|1
2598279|NCT01081626|8984904|P1|Overall Study|Lost to Follow-up|0
2598280|NCT01081626|8984903|P2|Overall Study|Overstimulation|1
2598281|NCT01081626|8984904|P1|Overall Study|Overstimulation|0
2598282|NCT01081626|8984903|P2|Overall Study|Low antral follicle count|0
2598283|NCT01081626|8984904|P1|Overall Study|Low antral follicle count|1
2598284|NCT01081626|8984903|P2|Overall Study|Missing Estradiol|28
2598285|NCT01081626|8984904|P1|Overall Study|Missing Estradiol|25
2598286|NCT01081626|8984903|P2|Overall Study|Dosing error|1
2598287|NCT01081626|8984904|P1|Overall Study|Dosing error|1
2598288|NCT01081301|8984930|P1|Overall Study|Lost to Follow-up|4
2598289|NCT01081301|8984930|P1|Overall Study|Patient too ill|2
2598290|NCT01081301|8984930|P1|Overall Study|Too busy|5
2598291|NCT01081301|8984930|P1|Overall Study|Bereaved|3
2598292|NCT01081249|8985005|P2|Overall Study|Diagnosed with Bipolar Disorder|1
2598293|NCT01081249|8985006|P1|Overall Study|Diagnosed with Bipolar Disorder|0
2598294|NCT01081145|8985012|P2|Double-Blind Randomized-Withdrawal Phase|Other|3
2598295|NCT01081145|8985013|P1|Double-Blind Randomized-Withdrawal Phase|Other|4
2598296|NCT01081145|8985012|P2|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71
2598297|NCT01081145|8985013|P1|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47
2598298|NCT01081145|8985012|P2|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20
2598299|NCT01081145|8985013|P1|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13
2598300|NCT01081145|8985012|P2|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2
2598301|NCT01081145|8985013|P1|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3
2598302|NCT01081145|8985012|P2|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8
2598303|NCT01081145|8985013|P1|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10
2598304|NCT01081145|8985012|P2|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0
2598305|NCT01081145|8985013|P1|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1
2598306|NCT01081145|8985012|P2|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2
2598307|NCT01081145|8985013|P1|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3
2598308|NCT01081145|8985012|P2|Open-Label Phase|Protocol Violation|0
2598309|NCT01081145|8985013|P1|Open-Label Phase|Protocol Violation|4
2598310|NCT01081145|8985012|P2|Open-Label Phase|Lost to Follow-up|0
2598311|NCT01081145|8985013|P1|Open-Label Phase|Lost to Follow-up|11
2598312|NCT01081145|8985012|P2|Open-Label Phase|Other|0
2598313|NCT01081145|8985013|P1|Open-Label Phase|Other|12
2598314|NCT01081145|8985012|P2|Open-Label Phase|Withdrawal by Subject|0
2598315|NCT01081145|8985013|P1|Open-Label Phase|Withdrawal by Subject|41
2598316|NCT01081145|8985012|P2|Open-Label Phase|Adverse Event|0
2598317|NCT01081145|8985013|P1|Open-Label Phase|Adverse Event|42
2598318|NCT01081145|8985012|P2|Open-Label Phase|Response criteria not met|0
2598319|NCT01081145|8985013|P1|Open-Label Phase|Response criteria not met|46
2598320|NCT01081145|8985012|P2|Open-Label Phase|Lack of Efficacy|0
2598321|NCT01081145|8985013|P1|Open-Label Phase|Lack of Efficacy|56
2598322|NCT01081132|8985041|P2|Overall Study|Protocol Violation|1
2598323|NCT01081132|8985042|P1|Overall Study|Protocol Violation|3
2598324|NCT01081132|8985041|P2|Overall Study|Declined Taper Phase|1
2598325|NCT01081132|8985042|P1|Overall Study|Declined Taper Phase|0
2598326|NCT01081132|8985041|P2|Overall Study|Patient Did Not Complete Wk14 and 15|1
2598327|NCT01081132|8985042|P1|Overall Study|Patient Did Not Complete Wk14 and 15|0
2598328|NCT01081132|8985041|P2|Overall Study|Stopped Taking Meds|0
2598329|NCT01081132|8985042|P1|Overall Study|Stopped Taking Meds|2
2598330|NCT01081132|8985041|P2|Overall Study|Missed Visits|1
2598331|NCT01081132|8985042|P1|Overall Study|Missed Visits|1
2598332|NCT01081132|8985041|P2|Overall Study|Lack Of Compliance|1
2598333|NCT01081132|8985042|P1|Overall Study|Lack Of Compliance|0
2598334|NCT01081132|8985041|P2|Overall Study|Non Compliance|2
2598335|NCT01081132|8985042|P1|Overall Study|Non Compliance|4
2598336|NCT01081132|8985041|P2|Overall Study|Adverse Event|9
2598337|NCT01081132|8985042|P1|Overall Study|Adverse Event|3
2598338|NCT01081132|8985041|P2|Overall Study|Lost to Follow-up|11
2598339|NCT01081132|8985042|P1|Overall Study|Lost to Follow-up|4
2598340|NCT01081132|8985041|P2|Overall Study|Withdrawal by Subject|16
2598341|NCT01081132|8985042|P1|Overall Study|Withdrawal by Subject|13
2598342|NCT01081132|8985041|P2|Overall Study|Lack of Efficacy|9
2598343|NCT01081132|8985042|P1|Overall Study|Lack of Efficacy|25
2598344|NCT01080807|8985126|P2|Overall Study|Moved away without notifying center|0
2598345|NCT01080807|8985127|P1|Overall Study|Moved away without notifying center|1
2598346|NCT01080807|8985126|P2|Overall Study|Switched to first shift|0
2598347|NCT01080807|8985127|P1|Overall Study|Switched to first shift|1
2598348|NCT01080807|8985126|P2|Overall Study|Work schedule and travel|1
2598349|NCT01080807|8985127|P1|Overall Study|Work schedule and travel|0
2598350|NCT01080807|8985126|P2|Overall Study|Work schedule changing|1
2598351|NCT01080807|8985127|P1|Overall Study|Work schedule changing|1
2598352|NCT01080807|8985126|P2|Overall Study|Stopped working consistent night shifts|1
2598353|NCT01080807|8985127|P1|Overall Study|Stopped working consistent night shifts|0
2598354|NCT01080807|8985126|P2|Overall Study|Laid off or terminated from job|2
2598355|NCT01080807|8985127|P1|Overall Study|Laid off or terminated from job|1
2598356|NCT01080807|8985126|P2|Overall Study|Began working day shift|2
2598357|NCT01080807|8985127|P1|Overall Study|Began working day shift|0
2598358|NCT01080807|8985126|P2|Overall Study|Noncompliance to study procedures|1
2598359|NCT01080807|8985127|P1|Overall Study|Noncompliance to study procedures|1
2598360|NCT01080807|8985126|P2|Overall Study|Noncompliance with drug administration|1
2598361|NCT01080807|8985127|P1|Overall Study|Noncompliance with drug administration|1
2598362|NCT01080807|8985126|P2|Overall Study|Lost to Follow-up|4
2598363|NCT01080807|8985127|P1|Overall Study|Lost to Follow-up|6
2598364|NCT01080807|8985126|P2|Overall Study|Protocol Violation|6
2598365|NCT01080807|8985127|P1|Overall Study|Protocol Violation|7
2598366|NCT01080807|8985126|P2|Overall Study|Withdrawal by Subject|2
2598367|NCT01080807|8985127|P1|Overall Study|Withdrawal by Subject|7
2598368|NCT01080807|8985126|P2|Overall Study|Lack of Efficacy|1
2598369|NCT01080807|8985127|P1|Overall Study|Lack of Efficacy|0
2598370|NCT01080807|8985126|P2|Overall Study|Adverse Event|1
2598371|NCT01080807|8985127|P1|Overall Study|Adverse Event|9
2598372|NCT01080768|8985236|P2|Overall Study|Protocol Deviation|1
2598373|NCT01080768|8985237|P1|Overall Study|Protocol Deviation|2
2598374|NCT01080716|8985247|P4|Part 1|Physician Decision|0
2598375|NCT01080716|8985248|P3|Part 1|Physician Decision|0
2598376|NCT01080716|8985249|P2|Part 1|Physician Decision|0
2598377|NCT01080716|8985250|P1|Part 1|Physician Decision|1
2598378|NCT01080625|8985289|P3|Overall Study|Physician Decision|1
2598379|NCT01080625|8985290|P2|Overall Study|Physician Decision|2
2598380|NCT01080625|8985291|P1|Overall Study|Physician Decision|0
2598381|NCT01080391|8985301|P2|Overall Study|Randomized but not treated|4
2598382|NCT01080391|8985302|P1|Overall Study|Randomized but not treated|7
2598383|NCT01080326|8985320|P1|Overall Study|Surgeon decision|1
2598384|NCT01080326|8985320|P1|Overall Study|Patient deterioration prior to procedure|3
2598385|NCT01080300|8985326|P2|Overall Study|Reasons not specified|6
2598386|NCT01080300|8985327|P1|Overall Study|Reasons not specified|4
2598387|NCT01080300|8985326|P2|Overall Study|Withdrawal by Subject|28
2598388|NCT01080300|8985327|P1|Overall Study|Withdrawal by Subject|12
2598389|NCT01080300|8985326|P2|Overall Study|Death|1
2598390|NCT01080300|8985327|P1|Overall Study|Death|0
2598391|NCT01080300|8985326|P2|Overall Study|Lost to Follow-up|6
2598392|NCT01080300|8985327|P1|Overall Study|Lost to Follow-up|10
2598393|NCT01080300|8985326|P2|Overall Study|Protocol Violation|13
2598394|NCT01080300|8985327|P1|Overall Study|Protocol Violation|7
2598395|NCT01080300|8985326|P2|Overall Study|Lack of Efficacy|15
2598396|NCT01080300|8985327|P1|Overall Study|Lack of Efficacy|12
2598397|NCT01080300|8985326|P2|Overall Study|Adverse Event|35
2598398|NCT01080300|8985327|P1|Overall Study|Adverse Event|49
2598399|NCT01080131|8985412|P2|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5
2598400|NCT01080131|8985413|P1|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4
2598401|NCT01080131|8985412|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4
2598402|NCT01080131|8985413|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3
2598403|NCT01080131|8985412|P2|Extension Study 2 (25-72 Weeks)|Adverse Event|2
2598404|NCT01080131|8985413|P1|Extension Study 2 (25-72 Weeks)|Adverse Event|1
2598405|NCT01080131|8985412|P2|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0
2598406|NCT01080131|8985413|P1|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1
2598407|NCT01080131|8985412|P2|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3
2598408|NCT01080131|8985413|P1|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4
2598409|NCT01080131|8985412|P2|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1
2598410|NCT01080131|8985413|P1|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0
2598411|NCT01080131|8985412|P2|Extension Study 1 (12 -24 Weeks)|Adverse Event|0
2598412|NCT01080131|8985413|P1|Extension Study 1 (12 -24 Weeks)|Adverse Event|1
2598413|NCT01080131|8985412|P2|Core Study (0- 12 Weeks)|Protocol deviation|2
2598414|NCT01080131|8985413|P1|Core Study (0- 12 Weeks)|Protocol deviation|0
2598415|NCT01080131|8985412|P2|Core Study (0- 12 Weeks)|Death|0
2598416|NCT01080131|8985413|P1|Core Study (0- 12 Weeks)|Death|1
2598417|NCT01080131|8985412|P2|Core Study (0- 12 Weeks)|Administrative problems|1
2598418|NCT01080131|8985413|P1|Core Study (0- 12 Weeks)|Administrative problems|0
2598419|NCT01080131|8985412|P2|Core Study (0- 12 Weeks)|Lost to Follow-up|3
2598420|NCT01080131|8985413|P1|Core Study (0- 12 Weeks)|Lost to Follow-up|5
2598421|NCT01080131|8985412|P2|Core Study (0- 12 Weeks)|Patient withdrew consent|4
2598422|NCT01080131|8985413|P1|Core Study (0- 12 Weeks)|Patient withdrew consent|6
2598423|NCT01080131|8985412|P2|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
2598424|NCT01080131|8985413|P1|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
2598425|NCT01079988|8985508|P5|Overall Study|Other|1
2598426|NCT01079988|8985509|P4|Overall Study|Other|2
2598427|NCT01079988|8985510|P3|Overall Study|Other|0
2598428|NCT01079988|8985511|P2|Overall Study|Other|0
2598429|NCT01079988|8985512|P1|Overall Study|Other|0
2598430|NCT01079988|8985508|P5|Overall Study|Lack of Efficacy|0
2598431|NCT01079988|8985509|P4|Overall Study|Lack of Efficacy|0
2598432|NCT01079988|8985510|P3|Overall Study|Lack of Efficacy|0
2598433|NCT01079988|8985511|P2|Overall Study|Lack of Efficacy|0
2598434|NCT01079988|8985512|P1|Overall Study|Lack of Efficacy|1
2598435|NCT01079988|8985508|P5|Overall Study|Lost to Follow-up|0
2598436|NCT01079988|8985509|P4|Overall Study|Lost to Follow-up|1
2598437|NCT01079988|8985510|P3|Overall Study|Lost to Follow-up|0
2598438|NCT01079988|8985511|P2|Overall Study|Lost to Follow-up|0
2598439|NCT01079988|8985512|P1|Overall Study|Lost to Follow-up|0
2598440|NCT01079962|8985531|P2|Overall Study|Due to arrhythmia/bradycardia|1
2598441|NCT01079962|8985532|P1|Overall Study|Due to arrhythmia/bradycardia|1
2598442|NCT01079962|8985531|P2|Overall Study|Participant not returning for next visit|0
2598443|NCT01079962|8985532|P1|Overall Study|Participant not returning for next visit|1
2598444|NCT01079962|8985531|P2|Overall Study|Inclusion/exclusion criteria|3
2598445|NCT01079962|8985532|P1|Overall Study|Inclusion/exclusion criteria|1
2598446|NCT01079962|8985531|P2|Overall Study|No blood pressure (BP) control|0
2598447|NCT01079962|8985532|P1|Overall Study|No blood pressure (BP) control|3
2598448|NCT01079962|8985531|P2|Overall Study|Protocol Violation|2
2598449|NCT01079962|8985532|P1|Overall Study|Protocol Violation|2
2598450|NCT01079962|8985531|P2|Overall Study|Withdrawal by Subject|7
2598451|NCT01079962|8985532|P1|Overall Study|Withdrawal by Subject|5
2598452|NCT01079962|8985531|P2|Overall Study|Adverse Event|2
2598453|NCT01079962|8985532|P1|Overall Study|Adverse Event|2
2598454|NCT01079949|8985560|P2|Overall Study|Randomized but not treated|0
2598455|NCT01079949|8985561|P1|Overall Study|Randomized but not treated|1
2598456|NCT01079949|8985560|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
2598457|NCT01079949|8985561|P1|Overall Study|Withdrawal between OPU - embryo transfer|8
2598458|NCT01079949|8985560|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8
2598459|NCT01079949|8985561|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4
2598460|NCT01079949|8985560|P2|Overall Study|Withdrawal before r-hCG administration|3
2598461|NCT01079949|8985561|P1|Overall Study|Withdrawal before r-hCG administration|2
2598462|NCT01079936|8985607|P5|Phase II|Insurance Issue|1
2598463|NCT01079936|8985608|P4|Phase II|Insurance Issue|0
2598464|NCT01079936|8985609|P3|Phase II|Insurance Issue|0
2598465|NCT01079936|8985610|P2|Phase II|Insurance Issue|0
2598466|NCT01079936|8985611|P1|Phase II|Insurance Issue|0
2598467|NCT01079936|8985607|P5|Phase II|Adverse Event|0
2598468|NCT01079936|8985608|P4|Phase II|Adverse Event|0
2598469|NCT01079936|8985609|P3|Phase II|Adverse Event|1
2598470|NCT01079936|8985610|P2|Phase II|Adverse Event|0
2598471|NCT01079936|8985611|P1|Phase II|Adverse Event|0
2598472|NCT01079936|8985607|P5|Phase I: MTD|No Stem Cell Transplantation|0
2598473|NCT01079936|8985608|P4|Phase I: MTD|No Stem Cell Transplantation|0
2598474|NCT01079936|8985609|P3|Phase I: MTD|No Stem Cell Transplantation|0
2598475|NCT01079936|8985610|P2|Phase I: MTD|No Stem Cell Transplantation|0
2598476|NCT01079936|8985611|P1|Phase I: MTD|No Stem Cell Transplantation|2
2598477|NCT01079936|8985607|P5|Phase I: MTD|First Remission Status|0
2598478|NCT01079936|8985608|P4|Phase I: MTD|First Remission Status|0
2598479|NCT01079936|8985609|P3|Phase I: MTD|First Remission Status|0
2598480|NCT01079936|8985610|P2|Phase I: MTD|First Remission Status|0
2598481|NCT01079936|8985611|P1|Phase I: MTD|First Remission Status|2
2598482|NCT01079832|8985630|P1|Overall Study|Withdrawal by Subject|1
2598483|NCT01079806|8985640|P2|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6
2598484|NCT01079806|8985641|P1|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6
2598485|NCT01079806|8985640|P2|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1
2598486|NCT01079806|8985641|P1|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0
2598487|NCT01079806|8985640|P2|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8
2598488|NCT01079806|8985641|P1|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13
2598489|NCT01079806|8985640|P2|Day 1 to Week 96|Removal by Medical Monitor|1
2598490|NCT01079806|8985641|P1|Day 1 to Week 96|Removal by Medical Monitor|0
2598491|NCT01079806|8985640|P2|Day 1 to Week 96|Subject request to stop study treatment|0
2598492|NCT01079806|8985641|P1|Day 1 to Week 96|Subject request to stop study treatment|1
2598493|NCT01079806|8985640|P2|Day 1 to Week 96|Lost to Follow-up|0
2598494|NCT01079806|8985641|P1|Day 1 to Week 96|Lost to Follow-up|1
2598495|NCT01079806|8985640|P2|Day 1 to Week 96|Poor compliance or noncompliance|0
2598496|NCT01079806|8985641|P1|Day 1 to Week 96|Poor compliance or noncompliance|2
2598497|NCT01079806|8985640|P2|Day 1 to Week 96|Pregnancy|1
2598498|NCT01079806|8985641|P1|Day 1 to Week 96|Pregnancy|0
2598499|NCT01079806|8985640|P2|Day 1 to Week 96|Withdrawal by Subject|2
2598500|NCT01079806|8985641|P1|Day 1 to Week 96|Withdrawal by Subject|3
2598501|NCT01079806|8985640|P2|Day 1 to Week 96|Adverse Event|3
2598502|NCT01079806|8985641|P1|Day 1 to Week 96|Adverse Event|0
2598503|NCT01079741|8985676|P5|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3
2598504|NCT01079741|8985677|P4|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
2598505|NCT01079741|8985678|P3|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
2598506|NCT01079741|8985679|P2|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
2598507|NCT01079741|8985680|P1|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
2598508|NCT01079741|8985676|P5|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
2598509|NCT01079741|8985677|P4|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
2598510|NCT01079741|8985678|P3|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
2598511|NCT01079741|8985679|P2|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1
2598512|NCT01079741|8985680|P1|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
2598513|NCT01079234|8985728|P4|Extension: Week 27 to 52|Unclassified|7
2598514|NCT01079234|8985729|P3|Extension: Week 27 to 52|Unclassified|4
2598515|NCT01079234|8985730|P2|Extension: Week 27 to 52|Unclassified|0
2598516|NCT01079234|8985731|P1|Extension: Week 27 to 52|Unclassified|0
2598517|NCT01079234|8985728|P4|Extension: Week 27 to 52|Withdrawal criteria|2
2598518|NCT01079234|8985729|P3|Extension: Week 27 to 52|Withdrawal criteria|4
2598519|NCT01079234|8985730|P2|Extension: Week 27 to 52|Withdrawal criteria|0
2598520|NCT01079234|8985731|P1|Extension: Week 27 to 52|Withdrawal criteria|0
2598521|NCT01079234|8985728|P4|Extension: Week 27 to 52|Protocol Violation|5
2598522|NCT01079234|8985729|P3|Extension: Week 27 to 52|Protocol Violation|2
2598523|NCT01079234|8985730|P2|Extension: Week 27 to 52|Protocol Violation|0
2598524|NCT01079234|8985731|P1|Extension: Week 27 to 52|Protocol Violation|0
2598525|NCT01079234|8985728|P4|Extension: Week 27 to 52|Lack of Efficacy|2
2598526|NCT01079234|8985729|P3|Extension: Week 27 to 52|Lack of Efficacy|0
2598527|NCT01079234|8985730|P2|Extension: Week 27 to 52|Lack of Efficacy|0
2598528|NCT01079234|8985731|P1|Extension: Week 27 to 52|Lack of Efficacy|0
2598529|NCT01079234|8985728|P4|Extension: Week 27 to 52|Adverse Event|0
2598530|NCT01079234|8985729|P3|Extension: Week 27 to 52|Adverse Event|1
2598531|NCT01079234|8985730|P2|Extension: Week 27 to 52|Adverse Event|0
2598532|NCT01079234|8985731|P1|Extension: Week 27 to 52|Adverse Event|0
2598533|NCT01079234|8985728|P4|Main: Week 0 to 26|Unclassified|0
2598534|NCT01079234|8985729|P3|Main: Week 0 to 26|Unclassified|4
2598535|NCT01079234|8985730|P2|Main: Week 0 to 26|Unclassified|13
2598536|NCT01079234|8985731|P1|Main: Week 0 to 26|Unclassified|7
2598537|NCT01079234|8985728|P4|Main: Week 0 to 26|Withdrawal criteria|0
2598538|NCT01079234|8985729|P3|Main: Week 0 to 26|Withdrawal criteria|2
2598539|NCT01079234|8985730|P2|Main: Week 0 to 26|Withdrawal criteria|6
2598540|NCT01079234|8985731|P1|Main: Week 0 to 26|Withdrawal criteria|6
2598541|NCT01079234|8985728|P4|Main: Week 0 to 26|Protocol Violation|0
2598542|NCT01079234|8985729|P3|Main: Week 0 to 26|Protocol Violation|4
2598543|NCT01079234|8985730|P2|Main: Week 0 to 26|Protocol Violation|2
2598544|NCT01079234|8985731|P1|Main: Week 0 to 26|Protocol Violation|6
2598545|NCT01079234|8985728|P4|Main: Week 0 to 26|Lack of Efficacy|0
2598546|NCT01079234|8985729|P3|Main: Week 0 to 26|Lack of Efficacy|1
2598547|NCT01079234|8985730|P2|Main: Week 0 to 26|Lack of Efficacy|1
2598548|NCT01079234|8985731|P1|Main: Week 0 to 26|Lack of Efficacy|2
2598549|NCT01079234|8985728|P4|Main: Week 0 to 26|Adverse Event|0
2598550|NCT01079234|8985729|P3|Main: Week 0 to 26|Adverse Event|1
2598551|NCT01079234|8985730|P2|Main: Week 0 to 26|Adverse Event|4
2598552|NCT01079234|8985731|P1|Main: Week 0 to 26|Adverse Event|5
2598553|NCT01079195|8985749|P1|Overall Study|Non-compliance|2
2598554|NCT01079195|8985749|P1|Overall Study|No Follow-up Documentation Available|4
2598555|NCT01079195|8985749|P1|Overall Study|Improved Status of Participant|4
2598556|NCT01079195|8985749|P1|Overall Study|Physician Decision|4
2598557|NCT01079195|8985749|P1|Overall Study|Lack of Effectiveness|12
2598558|NCT01079195|8985749|P1|Overall Study|Financial Reasons|15
2598559|NCT01079195|8985749|P1|Overall Study|Withdrawal by Subject|18
2598560|NCT01079195|8985749|P1|Overall Study|Reason Unknown|39
2598561|NCT01079195|8985749|P1|Overall Study|Adverse Event|157
2598562|NCT01079195|8985749|P1|Overall Study|No Documentation Available|437
2598563|NCT01079195|8985749|P1|Overall Study|No Documentation of Tarka Therapy|739
2598564|NCT01079182|8985755|P1|Overall Study|Reasons not Evaluated|271
2598565|NCT01079182|8985755|P1|Overall Study|ADR and Lack of Effectiveness|39
2598566|NCT01079182|8985755|P1|Overall Study|Lack of Efficacy|514
2598567|NCT01079182|8985755|P1|Overall Study|Adverse Drug Reaction (ADR)|261
2598568|NCT01079182|8985755|P1|Overall Study|Lost to Follow-up|1634
2598569|NCT01079130|8985863|P6|Overall Study|Lost to Follow-up|0
2598570|NCT01079130|8985864|P5|Overall Study|Lost to Follow-up|1
2598571|NCT01079130|8985865|P4|Overall Study|Lost to Follow-up|0
2598572|NCT01079130|8985866|P3|Overall Study|Lost to Follow-up|0
2598573|NCT01079130|8985867|P2|Overall Study|Lost to Follow-up|0
2598574|NCT01079130|8985868|P1|Overall Study|Lost to Follow-up|0
2598575|NCT01079130|8985863|P6|Overall Study|Unsatisfactory therapeutic effect|0
2598576|NCT01079130|8985864|P5|Overall Study|Unsatisfactory therapeutic effect|0
2598577|NCT01079130|8985865|P4|Overall Study|Unsatisfactory therapeutic effect|2
2598578|NCT01079130|8985866|P3|Overall Study|Unsatisfactory therapeutic effect|0
2598579|NCT01079130|8985867|P2|Overall Study|Unsatisfactory therapeutic effect|0
2598580|NCT01079130|8985868|P1|Overall Study|Unsatisfactory therapeutic effect|0
2598581|NCT01079130|8985863|P6|Overall Study|Abnormal test procedure result(s)|0
2598582|NCT01079130|8985864|P5|Overall Study|Abnormal test procedure result(s)|1
2598583|NCT01079130|8985865|P4|Overall Study|Abnormal test procedure result(s)|0
2598584|NCT01079130|8985866|P3|Overall Study|Abnormal test procedure result(s)|0
2598585|NCT01079130|8985867|P2|Overall Study|Abnormal test procedure result(s)|0
2598586|NCT01079130|8985868|P1|Overall Study|Abnormal test procedure result(s)|0
2598587|NCT01079130|8985863|P6|Overall Study|Protocol deviation|0
2598588|NCT01079130|8985864|P5|Overall Study|Protocol deviation|0
2598589|NCT01079130|8985865|P4|Overall Study|Protocol deviation|2
2598590|NCT01079130|8985866|P3|Overall Study|Protocol deviation|1
2598591|NCT01079130|8985867|P2|Overall Study|Protocol deviation|2
2598592|NCT01079130|8985868|P1|Overall Study|Protocol deviation|0
2598593|NCT01079130|8985863|P6|Overall Study|Withdrawal by Subject|3
2598594|NCT01079130|8985864|P5|Overall Study|Withdrawal by Subject|1
2598595|NCT01079130|8985865|P4|Overall Study|Withdrawal by Subject|0
2598596|NCT01079130|8985866|P3|Overall Study|Withdrawal by Subject|0
2598597|NCT01079130|8985867|P2|Overall Study|Withdrawal by Subject|1
2598598|NCT01079130|8985868|P1|Overall Study|Withdrawal by Subject|0
2598599|NCT01079130|8985863|P6|Overall Study|Administrative problems|1
2598600|NCT01079130|8985864|P5|Overall Study|Administrative problems|0
2598601|NCT01079130|8985865|P4|Overall Study|Administrative problems|0
2598602|NCT01079130|8985866|P3|Overall Study|Administrative problems|0
2598603|NCT01079130|8985867|P2|Overall Study|Administrative problems|3
2598604|NCT01079130|8985868|P1|Overall Study|Administrative problems|1
2598605|NCT01079130|8985863|P6|Overall Study|Adverse Event|1
2598606|NCT01079130|8985864|P5|Overall Study|Adverse Event|5
2598607|NCT01079130|8985865|P4|Overall Study|Adverse Event|1
2598608|NCT01079130|8985866|P3|Overall Study|Adverse Event|0
2598609|NCT01079130|8985867|P2|Overall Study|Adverse Event|1
2598610|NCT01079130|8985868|P1|Overall Study|Adverse Event|1
2598611|NCT01078974|8985888|P1|Overall Study|Adverse Event|3
2598612|NCT01078922|8985893|P1|Overall Study|Adverse Event|1
2598613|NCT01078805|8985934|P1|Overall Study|Didn't take study drug|82
2598614|NCT01078805|8985934|P1|Overall Study|Other|173
2598615|NCT01078805|8985934|P1|Overall Study|Withdrawal by Subject|739
2598616|NCT01078805|8985934|P1|Overall Study|Sponsor decision|46
2598617|NCT01078805|8985934|P1|Overall Study|Serious adverse event|26
2598618|NCT01078805|8985934|P1|Overall Study|Physician Decision|169
2598619|NCT01078805|8985934|P1|Overall Study|Lost to Follow-up|676
2598620|NCT01078805|8985934|P1|Overall Study|Death|134
2598621|NCT01078805|8985934|P1|Overall Study|Clinically significant abnormal lab|5
2598622|NCT01078675|8985961|P2|Overall Study|Adverse Event|0
2598623|NCT01078675|8985962|P1|Overall Study|Adverse Event|3
2598624|NCT01078675|8985961|P2|Overall Study|Provided in CRF for specific reasons|3
2598625|NCT01078675|8985962|P1|Overall Study|Provided in CRF for specific reasons|2
2598626|NCT01078675|8985961|P2|Overall Study|Protocol Violation|0
2598627|NCT01078675|8985962|P1|Overall Study|Protocol Violation|56
2598628|NCT01078675|8985961|P2|Overall Study|Withdrawal by Subject|3
2598629|NCT01078675|8985962|P1|Overall Study|Withdrawal by Subject|7
2598630|NCT01078662|8985984|P5|Overall Study|Lost to Follow-up|0
2598631|NCT01078662|8985985|P4|Overall Study|Lost to Follow-up|0
2598632|NCT01078662|8985986|P3|Overall Study|Lost to Follow-up|0
2598633|NCT01078662|8985987|P2|Overall Study|Lost to Follow-up|0
2598634|NCT01078662|8985988|P1|Overall Study|Lost to Follow-up|1
2598635|NCT01078662|8985984|P5|Overall Study|Protocol Violation|0
2598636|NCT01078662|8985985|P4|Overall Study|Protocol Violation|0
2598637|NCT01078662|8985986|P3|Overall Study|Protocol Violation|0
2598638|NCT01078662|8985987|P2|Overall Study|Protocol Violation|1
2598639|NCT01078662|8985988|P1|Overall Study|Protocol Violation|0
2598640|NCT01078662|8985984|P5|Overall Study|Withdrawal by Subject|0
2598641|NCT01078662|8985985|P4|Overall Study|Withdrawal by Subject|0
2598642|NCT01078662|8985986|P3|Overall Study|Withdrawal by Subject|1
2598643|NCT01078662|8985987|P2|Overall Study|Withdrawal by Subject|11
2598644|NCT01078662|8985988|P1|Overall Study|Withdrawal by Subject|4
2598645|NCT01078662|8985984|P5|Overall Study|Patients reached data cut-off|3
2598646|NCT01078662|8985985|P4|Overall Study|Patients reached data cut-off|2
2598647|NCT01078662|8985986|P3|Overall Study|Patients reached data cut-off|2
2598648|NCT01078662|8985987|P2|Overall Study|Patients reached data cut-off|53
2598649|NCT01078662|8985988|P1|Overall Study|Patients reached data cut-off|12
2598650|NCT01078662|8985984|P5|Overall Study|Death|8
2598651|NCT01078662|8985985|P4|Overall Study|Death|5
2598652|NCT01078662|8985986|P3|Overall Study|Death|18
2598653|NCT01078662|8985987|P2|Overall Study|Death|103
2598654|NCT01078662|8985988|P1|Overall Study|Death|41
2598655|NCT01078623|8986027|P20|Treatment Period 4|Withdrawal by Subject|0
2598656|NCT01078623|8986028|P19|Treatment Period 4|Withdrawal by Subject|0
2598657|NCT01078623|8986029|P18|Treatment Period 4|Withdrawal by Subject|0
2598658|NCT01078623|8986030|P17|Treatment Period 4|Withdrawal by Subject|0
2598659|NCT01078623|8986031|P16|Treatment Period 4|Withdrawal by Subject|1
2598660|NCT01078623|8986032|P15|Treatment Period 4|Withdrawal by Subject|0
2598661|NCT01078623|8986033|P14|Treatment Period 4|Withdrawal by Subject|0
2598662|NCT01078623|8986034|P13|Treatment Period 4|Withdrawal by Subject|0
2598663|NCT01078623|8986035|P12|Treatment Period 4|Withdrawal by Subject|0
2598664|NCT01078623|8986036|P11|Treatment Period 4|Withdrawal by Subject|0
2598665|NCT01078623|8986037|P10|Treatment Period 4|Withdrawal by Subject|0
2598666|NCT01078623|8986038|P9|Treatment Period 4|Withdrawal by Subject|0
2598667|NCT01078623|8986039|P8|Treatment Period 4|Withdrawal by Subject|0
2598668|NCT01078623|8986040|P7|Treatment Period 4|Withdrawal by Subject|0
2598669|NCT01078623|8986041|P6|Treatment Period 4|Withdrawal by Subject|0
2598670|NCT01078623|8986042|P5|Treatment Period 4|Withdrawal by Subject|0
2598671|NCT01078623|8986043|P4|Treatment Period 4|Withdrawal by Subject|0
2598672|NCT01078623|8986044|P3|Treatment Period 4|Withdrawal by Subject|0
2598673|NCT01078623|8986045|P2|Treatment Period 4|Withdrawal by Subject|0
2598674|NCT01078623|8986046|P1|Treatment Period 4|Withdrawal by Subject|0
2598675|NCT01078623|8986027|P20|Treatment Period 4|Adverse Event|0
2598676|NCT01078623|8986028|P19|Treatment Period 4|Adverse Event|0
2598677|NCT01078623|8986029|P18|Treatment Period 4|Adverse Event|0
2598678|NCT01078623|8986030|P17|Treatment Period 4|Adverse Event|0
2598679|NCT01078623|8986031|P16|Treatment Period 4|Adverse Event|0
2598680|NCT01078623|8986032|P15|Treatment Period 4|Adverse Event|0
2598681|NCT01078623|8986033|P14|Treatment Period 4|Adverse Event|0
2598682|NCT01078623|8986034|P13|Treatment Period 4|Adverse Event|0
2598683|NCT01078623|8986035|P12|Treatment Period 4|Adverse Event|0
2598684|NCT01078623|8986036|P11|Treatment Period 4|Adverse Event|0
2598685|NCT01078623|8986037|P10|Treatment Period 4|Adverse Event|0
2598686|NCT01078623|8986038|P9|Treatment Period 4|Adverse Event|0
2598687|NCT01078623|8986039|P8|Treatment Period 4|Adverse Event|0
2598688|NCT01078623|8986040|P7|Treatment Period 4|Adverse Event|0
2598689|NCT01078623|8986041|P6|Treatment Period 4|Adverse Event|0
2598690|NCT01078623|8986042|P5|Treatment Period 4|Adverse Event|0
2598691|NCT01078623|8986043|P4|Treatment Period 4|Adverse Event|0
2598692|NCT01078623|8986044|P3|Treatment Period 4|Adverse Event|1
2598693|NCT01078623|8986045|P2|Treatment Period 4|Adverse Event|0
2598694|NCT01078623|8986046|P1|Treatment Period 4|Adverse Event|0
2598695|NCT01078623|8986027|P20|Treatment Period 3|Adverse Event|0
2598696|NCT01078623|8986028|P19|Treatment Period 3|Adverse Event|0
2598697|NCT01078623|8986029|P18|Treatment Period 3|Adverse Event|0
2598698|NCT01078623|8986030|P17|Treatment Period 3|Adverse Event|0
2598699|NCT01078623|8986031|P16|Treatment Period 3|Adverse Event|0
2598700|NCT01078623|8986032|P15|Treatment Period 3|Adverse Event|0
2598701|NCT01078623|8986033|P14|Treatment Period 3|Adverse Event|1
2598702|NCT01078623|8986034|P13|Treatment Period 3|Adverse Event|0
2598703|NCT01078623|8986035|P12|Treatment Period 3|Adverse Event|0
2598704|NCT01078623|8986036|P11|Treatment Period 3|Adverse Event|0
2598705|NCT01078623|8986037|P10|Treatment Period 3|Adverse Event|0
2598706|NCT01078623|8986038|P9|Treatment Period 3|Adverse Event|0
2598707|NCT01078623|8986039|P8|Treatment Period 3|Adverse Event|0
2598708|NCT01078623|8986040|P7|Treatment Period 3|Adverse Event|0
2598709|NCT01078623|8986041|P6|Treatment Period 3|Adverse Event|0
2598710|NCT01078623|8986042|P5|Treatment Period 3|Adverse Event|1
2598711|NCT01078623|8986043|P4|Treatment Period 3|Adverse Event|0
2598712|NCT01078623|8986044|P3|Treatment Period 3|Adverse Event|0
2598713|NCT01078623|8986045|P2|Treatment Period 3|Adverse Event|0
2598714|NCT01078623|8986046|P1|Treatment Period 3|Adverse Event|0
2598715|NCT01078623|8986027|P20|Treatment Period 2|Withdrawal by Subject|0
2598716|NCT01078623|8986028|P19|Treatment Period 2|Withdrawal by Subject|0
2598717|NCT01078623|8986029|P18|Treatment Period 2|Withdrawal by Subject|0
2598718|NCT01078623|8986030|P17|Treatment Period 2|Withdrawal by Subject|0
2598719|NCT01078623|8986031|P16|Treatment Period 2|Withdrawal by Subject|0
2598720|NCT01078623|8986032|P15|Treatment Period 2|Withdrawal by Subject|0
2598721|NCT01078623|8986033|P14|Treatment Period 2|Withdrawal by Subject|0
2598722|NCT01078623|8986034|P13|Treatment Period 2|Withdrawal by Subject|0
2598723|NCT01078623|8986035|P12|Treatment Period 2|Withdrawal by Subject|0
2598724|NCT01078623|8986036|P11|Treatment Period 2|Withdrawal by Subject|0
2598725|NCT01078623|8986037|P10|Treatment Period 2|Withdrawal by Subject|0
2598726|NCT01078623|8986038|P9|Treatment Period 2|Withdrawal by Subject|0
2598727|NCT01078623|8986039|P8|Treatment Period 2|Withdrawal by Subject|0
2598728|NCT01078623|8986040|P7|Treatment Period 2|Withdrawal by Subject|0
2598729|NCT01078623|8986041|P6|Treatment Period 2|Withdrawal by Subject|1
2598730|NCT01078623|8986042|P5|Treatment Period 2|Withdrawal by Subject|0
2598731|NCT01078623|8986043|P4|Treatment Period 2|Withdrawal by Subject|0
2598732|NCT01078623|8986044|P3|Treatment Period 2|Withdrawal by Subject|0
2598733|NCT01078623|8986045|P2|Treatment Period 2|Withdrawal by Subject|0
2598734|NCT01078623|8986046|P1|Treatment Period 2|Withdrawal by Subject|0
2598735|NCT01078623|8986027|P20|Treatment Period 2|Adverse Event|0
2598736|NCT01078623|8986028|P19|Treatment Period 2|Adverse Event|1
2598737|NCT01078623|8986029|P18|Treatment Period 2|Adverse Event|0
2598738|NCT01078623|8986030|P17|Treatment Period 2|Adverse Event|0
2598739|NCT01078623|8986031|P16|Treatment Period 2|Adverse Event|0
2598740|NCT01078623|8986032|P15|Treatment Period 2|Adverse Event|0
2598741|NCT01078623|8986033|P14|Treatment Period 2|Adverse Event|0
2598742|NCT01078623|8986034|P13|Treatment Period 2|Adverse Event|0
2598743|NCT01078623|8986035|P12|Treatment Period 2|Adverse Event|0
2598744|NCT01078623|8986036|P11|Treatment Period 2|Adverse Event|0
2598745|NCT01078623|8986037|P10|Treatment Period 2|Adverse Event|0
2598746|NCT01078623|8986038|P9|Treatment Period 2|Adverse Event|0
2598747|NCT01078623|8986039|P8|Treatment Period 2|Adverse Event|0
2598748|NCT01078623|8986040|P7|Treatment Period 2|Adverse Event|1
2598749|NCT01078623|8986041|P6|Treatment Period 2|Adverse Event|0
2598750|NCT01078623|8986042|P5|Treatment Period 2|Adverse Event|0
2598751|NCT01078623|8986043|P4|Treatment Period 2|Adverse Event|0
2598752|NCT01078623|8986044|P3|Treatment Period 2|Adverse Event|0
2598753|NCT01078623|8986045|P2|Treatment Period 2|Adverse Event|0
2598754|NCT01078623|8986046|P1|Treatment Period 2|Adverse Event|0
2598755|NCT01078623|8986027|P20|Treatment Period 1|Protocol Violation|0
2598756|NCT01078623|8986028|P19|Treatment Period 1|Protocol Violation|0
2598757|NCT01078623|8986029|P18|Treatment Period 1|Protocol Violation|0
2598758|NCT01078623|8986030|P17|Treatment Period 1|Protocol Violation|0
2598759|NCT01078623|8986031|P16|Treatment Period 1|Protocol Violation|0
2598760|NCT01078623|8986032|P15|Treatment Period 1|Protocol Violation|0
2598761|NCT01078623|8986033|P14|Treatment Period 1|Protocol Violation|0
2598762|NCT01078623|8986034|P13|Treatment Period 1|Protocol Violation|0
2598763|NCT01078623|8986035|P12|Treatment Period 1|Protocol Violation|0
2598764|NCT01078623|8986036|P11|Treatment Period 1|Protocol Violation|0
2598765|NCT01078623|8986037|P10|Treatment Period 1|Protocol Violation|0
2598766|NCT01078623|8986038|P9|Treatment Period 1|Protocol Violation|0
2598767|NCT01078623|8986039|P8|Treatment Period 1|Protocol Violation|0
2598768|NCT01078623|8986040|P7|Treatment Period 1|Protocol Violation|0
2598769|NCT01078623|8986041|P6|Treatment Period 1|Protocol Violation|1
2598770|NCT01078623|8986042|P5|Treatment Period 1|Protocol Violation|0
2598771|NCT01078623|8986043|P4|Treatment Period 1|Protocol Violation|0
2598772|NCT01078623|8986044|P3|Treatment Period 1|Protocol Violation|0
2598773|NCT01078623|8986045|P2|Treatment Period 1|Protocol Violation|0
2598774|NCT01078623|8986046|P1|Treatment Period 1|Protocol Violation|0
2598775|NCT01078623|8986027|P20|Treatment Period 1|Withdrawal by Subject|0
2598776|NCT01078623|8986028|P19|Treatment Period 1|Withdrawal by Subject|0
2598777|NCT01078623|8986029|P18|Treatment Period 1|Withdrawal by Subject|0
2598778|NCT01078623|8986030|P17|Treatment Period 1|Withdrawal by Subject|0
2598779|NCT01078623|8986031|P16|Treatment Period 1|Withdrawal by Subject|0
2598780|NCT01078623|8986032|P15|Treatment Period 1|Withdrawal by Subject|0
2598781|NCT01078623|8986033|P14|Treatment Period 1|Withdrawal by Subject|0
2598782|NCT01078623|8986034|P13|Treatment Period 1|Withdrawal by Subject|0
2598783|NCT01078623|8986035|P12|Treatment Period 1|Withdrawal by Subject|0
2598784|NCT01078623|8986036|P11|Treatment Period 1|Withdrawal by Subject|1
2598785|NCT01078623|8986037|P10|Treatment Period 1|Withdrawal by Subject|0
2598786|NCT01078623|8986038|P9|Treatment Period 1|Withdrawal by Subject|0
2598787|NCT01078623|8986039|P8|Treatment Period 1|Withdrawal by Subject|1
2598788|NCT01078623|8986040|P7|Treatment Period 1|Withdrawal by Subject|0
2598789|NCT01078623|8986041|P6|Treatment Period 1|Withdrawal by Subject|0
2598790|NCT01078623|8986042|P5|Treatment Period 1|Withdrawal by Subject|0
2598791|NCT01078623|8986043|P4|Treatment Period 1|Withdrawal by Subject|0
2598792|NCT01078623|8986044|P3|Treatment Period 1|Withdrawal by Subject|0
2598793|NCT01078623|8986045|P2|Treatment Period 1|Withdrawal by Subject|0
2598794|NCT01078623|8986046|P1|Treatment Period 1|Withdrawal by Subject|0
2598795|NCT01078623|8986027|P20|Treatment Period 1|Adverse Event|0
2598796|NCT01078623|8986028|P19|Treatment Period 1|Adverse Event|0
2598797|NCT01078623|8986029|P18|Treatment Period 1|Adverse Event|0
2598798|NCT01078623|8986030|P17|Treatment Period 1|Adverse Event|0
2598799|NCT01078623|8986031|P16|Treatment Period 1|Adverse Event|0
2598800|NCT01078623|8986032|P15|Treatment Period 1|Adverse Event|0
2598801|NCT01078623|8986033|P14|Treatment Period 1|Adverse Event|0
2598802|NCT01078623|8986034|P13|Treatment Period 1|Adverse Event|0
2598803|NCT01078623|8986035|P12|Treatment Period 1|Adverse Event|0
2598804|NCT01078623|8986036|P11|Treatment Period 1|Adverse Event|0
2598805|NCT01078623|8986037|P10|Treatment Period 1|Adverse Event|1
2598806|NCT01078623|8986038|P9|Treatment Period 1|Adverse Event|1
2598807|NCT01078623|8986039|P8|Treatment Period 1|Adverse Event|0
2598808|NCT01078623|8986040|P7|Treatment Period 1|Adverse Event|1
2598809|NCT01078623|8986041|P6|Treatment Period 1|Adverse Event|0
2598810|NCT01078623|8986042|P5|Treatment Period 1|Adverse Event|0
2598811|NCT01078623|8986043|P4|Treatment Period 1|Adverse Event|0
2598812|NCT01078623|8986044|P3|Treatment Period 1|Adverse Event|1
2598813|NCT01078623|8986045|P2|Treatment Period 1|Adverse Event|1
2598814|NCT01078623|8986046|P1|Treatment Period 1|Adverse Event|1
2598815|NCT01078584|8986068|P1|Overall Study|Multiple Reasons|2
2598816|NCT01078584|8986068|P1|Overall Study|Serious Adverse Event|27
2598817|NCT01078584|8986068|P1|Overall Study|Protocol Violation|75
2598818|NCT01078584|8986068|P1|Overall Study|Lack of Efficacy|98
2598819|NCT01078584|8986068|P1|Overall Study|Physician Discontinued Patient|12
2598820|NCT01078584|8986068|P1|Overall Study|Physician Switched Medication|26
2598821|NCT01078584|8986068|P1|Overall Study|Blood Pressure Controlled|49
2598822|NCT01078584|8986068|P1|Overall Study|Non-compliance|67
2598823|NCT01078584|8986068|P1|Overall Study|Physician Withdrew from Study|90
2598824|NCT01078584|8986068|P1|Overall Study|Withdrawal of Consent|244
2598825|NCT01078584|8986068|P1|Overall Study|Non-serious Adverse Event|577
2598826|NCT01078584|8986068|P1|Overall Study|Lost to Follow-up|670
2598827|NCT01078584|8986068|P1|Overall Study|Final Status Unknown|1073
2598828|NCT01078571|8986149|P1|Overall Study|Protocol Violation|2
2598829|NCT01078571|8986149|P1|Overall Study|Lost to Follow-up|8
2598830|NCT01078571|8986149|P1|Overall Study|Withdrawal by Subject|12
2598831|NCT01078571|8986149|P1|Overall Study|Reason not reported|21
2598832|NCT01078571|8986149|P1|Overall Study|Lack of effectiveness|36
2598833|NCT01078571|8986149|P1|Overall Study|Adverse Event|36
2598834|NCT01078545|8986200|P1|Overall Study|Participant moved to another physician|1
2598835|NCT01078545|8986200|P1|Overall Study|Death|3
2598836|NCT01078545|8986200|P1|Overall Study|Withdrawal by Subject|3
2598837|NCT01078545|8986200|P1|Overall Study|Physician Decision|6
2598838|NCT01078545|8986200|P1|Overall Study|Lost to Follow-up|13
2598839|NCT01078454|8986210|P2|Overall Study|Death|1
2598840|NCT01078454|8986211|P1|Overall Study|Death|0
2598841|NCT01078454|8986210|P2|Overall Study|Adverse Event|1
2598842|NCT01078454|8986211|P1|Overall Study|Adverse Event|1
2598843|NCT01078441|8986217|P1|Overall Study|Withdrawal by Subject|1
2598844|NCT01078389|8986257|P2|Overall Study|Other|2
2598845|NCT01078389|8986258|P1|Overall Study|Other|9
2598846|NCT01078389|8986257|P2|Overall Study|Voluntary Withdrawal|36
2598847|NCT01078389|8986258|P1|Overall Study|Voluntary Withdrawal|20
2598848|NCT01078389|8986257|P2|Overall Study|Lost to Follow-up|23
2598849|NCT01078389|8986258|P1|Overall Study|Lost to Follow-up|23
2598850|NCT01078389|8986257|P2|Overall Study|Major Protocol Deviation|0
2598851|NCT01078389|8986258|P1|Overall Study|Major Protocol Deviation|2
2598852|NCT01078389|8986257|P2|Overall Study|Adverse Event|6
2598853|NCT01078389|8986258|P1|Overall Study|Adverse Event|10
2598854|NCT01078298|8986419|P2|Overall Study|Other|32
2598855|NCT01078298|8986420|P1|Overall Study|Other|24
2598856|NCT01078298|8986419|P2|Overall Study|Did not meet entrance criteria|1
2598857|NCT01078298|8986420|P1|Overall Study|Did not meet entrance criteria|0
2598858|NCT01078298|8986419|P2|Overall Study|Death|0
2598859|NCT01078298|8986420|P1|Overall Study|Death|2
2598860|NCT01078298|8986419|P2|Overall Study|Adverse Event|5
2598861|NCT01078298|8986420|P1|Overall Study|Adverse Event|6
2598862|NCT01078298|8986419|P2|Overall Study|Protocol Violation|6
2598863|NCT01078298|8986420|P1|Overall Study|Protocol Violation|6
2598864|NCT01078298|8986419|P2|Overall Study|Withdrawal by Subject|33
2598865|NCT01078298|8986420|P1|Overall Study|Withdrawal by Subject|31
2598866|NCT01078298|8986419|P2|Overall Study|Lost to Follow-up|13
2598867|NCT01078298|8986420|P1|Overall Study|Lost to Follow-up|12
2598868|NCT01078168|8986530|P2|Overall Study|Physician Decision|1
2598869|NCT01078168|8986531|P1|Overall Study|Physician Decision|0
2598870|NCT01078155|8986537|P1|Overall Study|Lost to Follow-up|15
2598871|NCT01078155|8986537|P1|Overall Study|Participant's Decision|6
2598872|NCT01078155|8986537|P1|Overall Study|Lack of Efficacy|16
2598873|NCT01078155|8986537|P1|Overall Study|Adverse Event|7
2598874|NCT01078116|8986553|P1|Overall Study|Case report form not completed|3
2598875|NCT01078116|8986553|P1|Overall Study|Lack of effectiveness|15
2598876|NCT01078116|8986553|P1|Overall Study|Withdrawal by Subject|8
2598877|NCT01078116|8986553|P1|Overall Study|Adverse Event|5
2598878|NCT01078116|8986553|P1|Overall Study|Lost to Follow-up|17
2598879|NCT01078090|8986561|P1|Overall Study|Other|523
2598880|NCT01078090|8986561|P1|Overall Study|ADR and lack of efficacy|61
2598881|NCT01078090|8986561|P1|Overall Study|Lack of Efficacy|1193
2598882|NCT01078090|8986561|P1|Overall Study|Adverse drug reaction (ADR)|453
2598883|NCT01078090|8986561|P1|Overall Study|Lost to Follow-up|2363
2598884|NCT01077960|8986655|P1|Overall Study|Reason unspecified|1
2598885|NCT01077960|8986655|P1|Overall Study|Subject decision|1
2598886|NCT01077960|8986655|P1|Overall Study|Lost to Follow-up|5
2598887|NCT01077960|8986655|P1|Overall Study|Protocol Violation|3
2598888|NCT01077960|8986655|P1|Overall Study|Adverse Event|6
2598889|NCT01077804|8986905|P1|Overall Study|Other|18
2598890|NCT01077804|8986905|P1|Overall Study|Refused to continue|79
2598891|NCT01077804|8986905|P1|Overall Study|Unreachable|102
2598892|NCT01077739|8986914|P2|Overall Study|Other|2
2598893|NCT01077739|8986915|P1|Overall Study|Other|2
2598894|NCT01077739|8986914|P2|Overall Study|Unacceptable toxicity|2
2598895|NCT01077739|8986915|P1|Overall Study|Unacceptable toxicity|1
2598896|NCT01077739|8986914|P2|Overall Study|Death|3
2598897|NCT01077739|8986915|P1|Overall Study|Death|0
2598898|NCT01077739|8986914|P2|Overall Study|Withdrawal by Subject|0
2598899|NCT01077739|8986915|P1|Overall Study|Withdrawal by Subject|1
2598900|NCT01077739|8986914|P2|Overall Study|Premature withdrawal|3
2598901|NCT01077739|8986915|P1|Overall Study|Premature withdrawal|1
2598902|NCT01077713|8986929|P2|Overall Study|Other|2
2598903|NCT01077713|8986930|P1|Overall Study|Other|4
2598904|NCT01077713|8986929|P2|Overall Study|Adverse Event|1
2598905|NCT01077713|8986930|P1|Overall Study|Adverse Event|2
2598906|NCT01077713|8986929|P2|Overall Study|Lost to Follow-up|1
2598907|NCT01077713|8986930|P1|Overall Study|Lost to Follow-up|1
2598908|NCT01077713|8986929|P2|Overall Study|Death|29
2598909|NCT01077713|8986930|P1|Overall Study|Death|28
2598910|NCT01077713|8986929|P2|Overall Study|Progressive Disease (PD)|1
2598911|NCT01077713|8986930|P1|Overall Study|Progressive Disease (PD)|0
2598912|NCT01077713|8986929|P2|Overall Study|Withdrawal by Subject|2
2598913|NCT01077713|8986930|P1|Overall Study|Withdrawal by Subject|1
2598914|NCT01077622|8986954|P1|Overall Study|Withdrawal by Subject|1
2598915|NCT01077622|8986954|P1|Overall Study|Physician Decision|2
2598916|NCT01077544|8987074|P2|Overall Study|Disease Progression|1
2598917|NCT01077544|8987075|P1|Overall Study|Disease Progression|0
2598918|NCT01077544|8987074|P2|Overall Study|Adverse Event|1
2598919|NCT01077544|8987075|P1|Overall Study|Adverse Event|0
2598920|NCT01077544|8987074|P2|Overall Study|New Cancer Therapy|3
2598921|NCT01077544|8987075|P1|Overall Study|New Cancer Therapy|3
2598922|NCT01077518|8987103|P3|Optional Ofa Phase|Withdrawal by Subject|3
2598923|NCT01077518|8987104|P2|Optional Ofa Phase|Withdrawal by Subject|0
2598924|NCT01077518|8987105|P1|Optional Ofa Phase|Withdrawal by Subject|0
2598925|NCT01077518|8987103|P3|Optional Ofa Phase|Study Terminated by Sponsor|12
2598926|NCT01077518|8987104|P2|Optional Ofa Phase|Study Terminated by Sponsor|0
2598927|NCT01077518|8987105|P1|Optional Ofa Phase|Study Terminated by Sponsor|0
2598928|NCT01077518|8987103|P3|Optional Ofa Phase|Physician Decision|1
2598929|NCT01077518|8987104|P2|Optional Ofa Phase|Physician Decision|0
2598930|NCT01077518|8987105|P1|Optional Ofa Phase|Physician Decision|0
2598931|NCT01077518|8987103|P3|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0
2598932|NCT01077518|8987104|P2|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28
2598933|NCT01077518|8987105|P1|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32
2598934|NCT01077518|8987103|P3|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0
2598935|NCT01077518|8987104|P2|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22
2598936|NCT01077518|8987105|P1|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28
2598937|NCT01077518|8987103|P3|Treatment Phase - no Optional Ofa|Physician Decision|0
2598938|NCT01077518|8987104|P2|Treatment Phase - no Optional Ofa|Physician Decision|11
2598939|NCT01077518|8987105|P1|Treatment Phase - no Optional Ofa|Physician Decision|10
2598940|NCT01077518|8987103|P3|Treatment Phase - no Optional Ofa|Lost to Follow-up|0
2598941|NCT01077518|8987104|P2|Treatment Phase - no Optional Ofa|Lost to Follow-up|4
2598942|NCT01077518|8987105|P1|Treatment Phase - no Optional Ofa|Lost to Follow-up|8
2598943|NCT01077375|8987178|P2|Overall Study|Other Reason|1
2598944|NCT01077375|8987179|P1|Overall Study|Other Reason|0
2598945|NCT01077375|8987178|P2|Overall Study|Lost to Follow-up|5
2598946|NCT01077375|8987179|P1|Overall Study|Lost to Follow-up|2
2598947|NCT01077375|8987178|P2|Overall Study|Withdrawal by Subject|6
2598948|NCT01077375|8987179|P1|Overall Study|Withdrawal by Subject|0
2598949|NCT01077375|8987178|P2|Overall Study|Lack of Efficacy|8
2598950|NCT01077375|8987179|P1|Overall Study|Lack of Efficacy|6
2598951|NCT01077375|8987178|P2|Overall Study|Adverse Event|15
2598952|NCT01077375|8987179|P1|Overall Study|Adverse Event|2
2598953|NCT01077362|8987190|P3|Overall Study|Other|2
2598954|NCT01077362|8987191|P2|Overall Study|Other|1
2598955|NCT01077362|8987192|P1|Overall Study|Other|0
2598956|NCT01077362|8987190|P3|Overall Study|Withdrawal by Subject|5
2598957|NCT01077362|8987191|P2|Overall Study|Withdrawal by Subject|3
2598958|NCT01077362|8987192|P1|Overall Study|Withdrawal by Subject|5
2598959|NCT01077362|8987190|P3|Overall Study|Adverse Event|4
2598960|NCT01077362|8987191|P2|Overall Study|Adverse Event|7
2598961|NCT01077362|8987192|P1|Overall Study|Adverse Event|12
2598962|NCT01077362|8987190|P3|Overall Study|Lost to Follow-up|3
2598963|NCT01077362|8987191|P2|Overall Study|Lost to Follow-up|0
2598964|NCT01077362|8987192|P1|Overall Study|Lost to Follow-up|1
2598965|NCT01077362|8987190|P3|Overall Study|Lack of Efficacy|10
2598966|NCT01077362|8987191|P2|Overall Study|Lack of Efficacy|8
2598967|NCT01077362|8987192|P1|Overall Study|Lack of Efficacy|13
2598968|NCT01077323|8987228|P3|Overall Study|Baseline diagnosis of pancreatic disease|120
2598969|NCT01077323|8987229|P2|Overall Study|Baseline diagnosis of pancreatic disease|2080
2598970|NCT01077323|8987230|P1|Overall Study|Baseline diagnosis of pancreatic disease|152
2598971|NCT01077323|8987228|P3|Overall Study|Dispensing of drug in baseline period|256446
2598972|NCT01077323|8987229|P2|Overall Study|Dispensing of drug in baseline period|120229
2598973|NCT01077323|8987230|P1|Overall Study|Dispensing of drug in baseline period|0
2598974|NCT01077323|8987228|P3|Overall Study|<9 months enroll before drug dispensed|11655523
2598975|NCT01077323|8987229|P2|Overall Study|<9 months enroll before drug dispensed|263954
2598976|NCT01077323|8987230|P1|Overall Study|<9 months enroll before drug dispensed|11226
2598977|NCT01077284|8987273|P3|Overall Study|Other|1
2598978|NCT01077284|8987274|P2|Overall Study|Other|0
2598979|NCT01077284|8987275|P1|Overall Study|Other|0
2598980|NCT01077284|8987273|P3|Overall Study|Withdrawal by Subject|1
2598981|NCT01077284|8987274|P2|Overall Study|Withdrawal by Subject|3
2598982|NCT01077284|8987275|P1|Overall Study|Withdrawal by Subject|2
2598983|NCT01077284|8987273|P3|Overall Study|Lost to Follow-up|0
2598984|NCT01077284|8987274|P2|Overall Study|Lost to Follow-up|2
2598985|NCT01077284|8987275|P1|Overall Study|Lost to Follow-up|1
2598986|NCT01077284|8987273|P3|Overall Study|Adverse Event|1
2598987|NCT01077284|8987274|P2|Overall Study|Adverse Event|0
2598988|NCT01077284|8987275|P1|Overall Study|Adverse Event|2
2598989|NCT01077271|8987296|P1|Overall Study|Mother unconvinced of the necessity|1
2598990|NCT01077271|8987296|P1|Overall Study|End of RSV season nearly reached|1
2598991|NCT01077271|8987296|P1|Overall Study|Parents thought too many injections|2
2598992|NCT01077271|8987296|P1|Overall Study|Changed doctors|2
2598993|NCT01077271|8987296|P1|Overall Study|Quota used up (insurance reimb issue)|2
2598994|NCT01077271|8987296|P1|Overall Study|Noncompliance|2
2598995|NCT01077271|8987296|P1|Overall Study|Screen failure, did not take palivizumab|4
2598996|NCT01077271|8987296|P1|Overall Study|Parental desire|8
2598997|NCT01077258|8987334|P1|Overall Study|Other reasons|260
2598998|NCT01077258|8987334|P1|Overall Study|Clinical remission|37
2598999|NCT01077258|8987334|P1|Overall Study|Lack of Efficacy|663
2599000|NCT01077258|8987334|P1|Overall Study|Adverse drug reaction|218
2599001|NCT01077258|8987334|P1|Overall Study|Lost to Follow-up|1390
2599002|NCT01077193|8987370|P1|Overall Study|Study Terminated by Sponsor|40
2599003|NCT01077193|8987370|P1|Overall Study|Lack of Efficacy|1
2599004|NCT01077193|8987370|P1|Overall Study|Withdrawal by Subject|2
2599005|NCT01077193|8987370|P1|Overall Study|Lost to Follow-up|1
2599006|NCT01077154|8987376|P2|Overall Study|Protocol Deviation|0
2599007|NCT01077154|8987377|P1|Overall Study|Protocol Deviation|1
2599008|NCT01077154|8987376|P2|Overall Study|Administrative Decision|6
2599009|NCT01077154|8987377|P1|Overall Study|Administrative Decision|1
2599010|NCT01077154|8987376|P2|Overall Study|Adverse Event|9
2599011|NCT01077154|8987377|P1|Overall Study|Adverse Event|9
2599012|NCT01077154|8987376|P2|Overall Study|Other|11
2599013|NCT01077154|8987377|P1|Overall Study|Other|14
2599014|NCT01077154|8987376|P2|Overall Study|Ineligibility Determined|14
2599015|NCT01077154|8987377|P1|Overall Study|Ineligibility Determined|10
2599016|NCT01077154|8987376|P2|Overall Study|Disease Progression|20
2599017|NCT01077154|8987377|P1|Overall Study|Disease Progression|18
2599018|NCT01077154|8987376|P2|Overall Study|Noncompliance|20
2599019|NCT01077154|8987377|P1|Overall Study|Noncompliance|22
2599020|NCT01077154|8987376|P2|Overall Study|Lost to Follow-up|35
2599021|NCT01077154|8987377|P1|Overall Study|Lost to Follow-up|43
2599022|NCT01077154|8987376|P2|Overall Study|Death|214
2599023|NCT01077154|8987377|P1|Overall Study|Death|215
2599024|NCT01077154|8987376|P2|Overall Study|Withdrawal by Subject|385
2599025|NCT01077154|8987377|P1|Overall Study|Withdrawal by Subject|369
2599026|NCT01077154|8987376|P2|Overall Study|Protocol-specified Criteria: Study Ended|1514
2599027|NCT01077154|8987377|P1|Overall Study|Protocol-specified Criteria: Study Ended|1524
2599028|NCT01077128|8987391|P1|Overall Study|Other|54
2599029|NCT01077128|8987391|P1|Overall Study|Lack of efficacy/disease exacerbation|1
2599030|NCT01077128|8987391|P1|Overall Study|Adverse event and disease exacerbation|1
2599031|NCT01077128|8987391|P1|Overall Study|Adverse event and consent withdrawal|1
2599032|NCT01077128|8987391|P1|Overall Study|Disease exacerbation|1
2599033|NCT01077128|8987391|P1|Overall Study|Lack of Efficacy|1
2599034|NCT01077128|8987391|P1|Overall Study|Adverse Event|8
2599035|NCT01077076|8987449|P6|Third Intervention|Death in the participant's family|1
2599036|NCT01077076|8987450|P5|Third Intervention|Death in the participant's family|0
2599037|NCT01077076|8987451|P4|Third Intervention|Death in the participant's family|0
2599038|NCT01077076|8987452|P3|Third Intervention|Death in the participant's family|0
2599039|NCT01077076|8987453|P2|Third Intervention|Death in the participant's family|0
2599040|NCT01077076|8987454|P1|Third Intervention|Death in the participant's family|0
2599041|NCT01077076|8987449|P6|First Intervention|Withdrawal by Subject|0
2599042|NCT01077076|8987450|P5|First Intervention|Withdrawal by Subject|0
2599043|NCT01077076|8987451|P4|First Intervention|Withdrawal by Subject|0
2599044|NCT01077076|8987452|P3|First Intervention|Withdrawal by Subject|0
2599045|NCT01077076|8987453|P2|First Intervention|Withdrawal by Subject|0
2599046|NCT01077076|8987454|P1|First Intervention|Withdrawal by Subject|1
2599047|NCT01077063|8987464|P2|Overall Study|Withdrawal by Subject|2
2599048|NCT01077063|8987465|P1|Overall Study|Withdrawal by Subject|0
2599049|NCT01077063|8987464|P2|Overall Study|Death|1
2599050|NCT01077063|8987465|P1|Overall Study|Death|1
2599051|NCT01077063|8987464|P2|Overall Study|Adverse Event|0
2599052|NCT01077063|8987465|P1|Overall Study|Adverse Event|3
2599053|NCT01077050|8987471|P1|Overall Study|Screen failure|8
2599054|NCT01077050|8987471|P1|Overall Study|Subjects signed ICF could not be located|1
2599055|NCT01077024|8987477|P2|Overall Study|Other|4
2599056|NCT01077024|8987478|P1|Overall Study|Other|4
2599057|NCT01077024|8987477|P2|Overall Study|Incarcerated|8
2599058|NCT01077024|8987478|P1|Overall Study|Incarcerated|7
2599059|NCT01077024|8987477|P2|Overall Study|Withdrawal by Subject|2
2599060|NCT01077024|8987478|P1|Overall Study|Withdrawal by Subject|0
2599061|NCT01077024|8987477|P2|Overall Study|Lost to Follow-up|14
2599062|NCT01077024|8987478|P1|Overall Study|Lost to Follow-up|20
2599063|NCT01076959|8987517|P1|Overall Study|Other|119
2599064|NCT01076959|8987517|P1|Overall Study|Lost to Follow-up|241
2599065|NCT01076959|8987517|P1|Overall Study|Non-compliance|274
2599066|NCT01076959|8987517|P1|Overall Study|Lack of Efficacy|849
2599067|NCT01076959|8987517|P1|Overall Study|Adverse Event|767
2599068|NCT01076647|8987553|P2|Overall Study|Unclassified|12
2599069|NCT01076647|8987554|P1|Overall Study|Unclassified|12
2599070|NCT01076647|8987553|P2|Overall Study|Withdrawal criteria|2
2599071|NCT01076647|8987554|P1|Overall Study|Withdrawal criteria|2
2599072|NCT01076647|8987553|P2|Overall Study|Protocol Violation|9
2599073|NCT01076647|8987554|P1|Overall Study|Protocol Violation|7
2599074|NCT01076647|8987553|P2|Overall Study|Lack of Efficacy|1
2599075|NCT01076647|8987554|P1|Overall Study|Lack of Efficacy|0
2599076|NCT01076647|8987553|P2|Overall Study|Adverse Event|1
2599077|NCT01076647|8987554|P1|Overall Study|Adverse Event|4
2599078|NCT01076543|8987568|P6|Overall Study|Withdrawal by Subject|0
2599079|NCT01076543|8987569|P5|Overall Study|Withdrawal by Subject|0
2599080|NCT01076543|8987570|P4|Overall Study|Withdrawal by Subject|0
2599081|NCT01076543|8987571|P3|Overall Study|Withdrawal by Subject|0
2599082|NCT01076543|8987572|P2|Overall Study|Withdrawal by Subject|0
2599083|NCT01076543|8987573|P1|Overall Study|Withdrawal by Subject|2
2599084|NCT01076400|8987634|P3|Overall Study|Progressive Disease|0
2599085|NCT01076400|8987635|P2|Overall Study|Progressive Disease|0
2599086|NCT01076400|8987636|P1|Overall Study|Progressive Disease|5
2599087|NCT01076400|8987634|P3|Overall Study|Adverse Event|0
2599088|NCT01076400|8987635|P2|Overall Study|Adverse Event|0
2599089|NCT01076400|8987636|P1|Overall Study|Adverse Event|2
2599090|NCT01076361|8987642|P1|Overall Study|22 leads were excluded from analysis|21
2599091|NCT01076335|8987650|P1|Overall Study|Withdrawal without treatment|1
2599092|NCT01076335|8987650|P1|Overall Study|Withdrawal by Subject|3
2599093|NCT01076205|8987702|P1|Overall Study|Lost to Follow-up|3151
2599094|NCT01076205|8987702|P1|Overall Study|Unknown Reason|71
2599095|NCT01076205|8987702|P1|Overall Study|Other Reason|1075
2599096|NCT01076205|8987702|P1|Overall Study|Lack of Effectiveness|1423
2599097|NCT01076205|8987702|P1|Overall Study|Adverse Drug Reaction|299
2599098|NCT01076192|8987755|P1|Overall Study|Other|197
2599099|NCT01076179|8987770|P1|Overall Study|Withdrawal by Subject|1
2599100|NCT01076166|8987793|P1|Overall Study|Symptoms improved/resolved|6
2599101|NCT01076166|8987793|P1|Overall Study|Adverse Event|3
2599102|NCT01076153|8987800|P1|Overall Study|Adverse Event|1
2599103|NCT01076153|8987800|P1|Overall Study|Symptoms improved/resolved|10
2599104|NCT01076088|8987814|P6|Overall Study|Other protocol specified criteria|1
2599105|NCT01076088|8987815|P5|Overall Study|Other protocol specified criteria|0
2599106|NCT01076088|8987816|P4|Overall Study|Other protocol specified criteria|0
2599107|NCT01076088|8987817|P3|Overall Study|Other protocol specified criteria|0
2599108|NCT01076088|8987818|P2|Overall Study|Other protocol specified criteria|0
2599109|NCT01076088|8987819|P1|Overall Study|Other protocol specified criteria|0
2599110|NCT01076088|8987814|P6|Overall Study|Withdrawal by Subject|17
2599111|NCT01076088|8987815|P5|Overall Study|Withdrawal by Subject|11
2599112|NCT01076088|8987816|P4|Overall Study|Withdrawal by Subject|10
2599113|NCT01076088|8987817|P3|Overall Study|Withdrawal by Subject|14
2599114|NCT01076088|8987818|P2|Overall Study|Withdrawal by Subject|8
2599115|NCT01076088|8987819|P1|Overall Study|Withdrawal by Subject|8
2599116|NCT01076088|8987814|P6|Overall Study|Physician Decision|0
2599117|NCT01076088|8987815|P5|Overall Study|Physician Decision|1
2599118|NCT01076088|8987816|P4|Overall Study|Physician Decision|1
2599119|NCT01076088|8987817|P3|Overall Study|Physician Decision|0
2599120|NCT01076088|8987818|P2|Overall Study|Physician Decision|3
2599121|NCT01076088|8987819|P1|Overall Study|Physician Decision|1
2599122|NCT01076088|8987814|P6|Overall Study|Non-compliance with study drug|0
2599123|NCT01076088|8987815|P5|Overall Study|Non-compliance with study drug|0
2599124|NCT01076088|8987816|P4|Overall Study|Non-compliance with study drug|1
2599125|NCT01076088|8987817|P3|Overall Study|Non-compliance with study drug|0
2599126|NCT01076088|8987818|P2|Overall Study|Non-compliance with study drug|0
2599127|NCT01076088|8987819|P1|Overall Study|Non-compliance with study drug|0
2599128|NCT01076088|8987814|P6|Overall Study|Lost to Follow-up|2
2599129|NCT01076088|8987815|P5|Overall Study|Lost to Follow-up|1
2599130|NCT01076088|8987816|P4|Overall Study|Lost to Follow-up|1
2599131|NCT01076088|8987817|P3|Overall Study|Lost to Follow-up|0
2599132|NCT01076088|8987818|P2|Overall Study|Lost to Follow-up|1
2599133|NCT01076088|8987819|P1|Overall Study|Lost to Follow-up|1
2599134|NCT01076088|8987814|P6|Overall Study|Adverse Event|3
2599135|NCT01076088|8987815|P5|Overall Study|Adverse Event|3
2599136|NCT01076088|8987816|P4|Overall Study|Adverse Event|2
2599137|NCT01076088|8987817|P3|Overall Study|Adverse Event|3
2599138|NCT01076088|8987818|P2|Overall Study|Adverse Event|6
2599139|NCT01076088|8987819|P1|Overall Study|Adverse Event|1
2599140|NCT01076075|8987847|P2|Overall Study|Withdrawal by Subject|19
2599141|NCT01076075|8987848|P1|Overall Study|Withdrawal by Subject|8
2599142|NCT01076075|8987847|P2|Overall Study|Protocol Violation|1
2599143|NCT01076075|8987848|P1|Overall Study|Protocol Violation|0
2599144|NCT01076075|8987847|P2|Overall Study|other|9
2599145|NCT01076075|8987848|P1|Overall Study|other|19
2599146|NCT01076075|8987847|P2|Overall Study|Lost to Follow-up|5
2599147|NCT01076075|8987848|P1|Overall Study|Lost to Follow-up|6
2599148|NCT01076075|8987847|P2|Overall Study|Lack of Efficacy|4
2599149|NCT01076075|8987848|P1|Overall Study|Lack of Efficacy|5
2599150|NCT01076075|8987847|P2|Overall Study|Adverse Event|9
2599151|NCT01076075|8987848|P1|Overall Study|Adverse Event|3
2599152|NCT01076036|8987862|P1|Overall Study|Didn't meet inclusion/exclusion criteria|2
2599153|NCT01075984|8987872|P5|Follow-up Phase|Treatment failure|4
2599154|NCT01075984|8987873|P4|Follow-up Phase|Treatment failure|0
2599155|NCT01075984|8987874|P3|Follow-up Phase|Treatment failure|0
2599156|NCT01075984|8987875|P2|Follow-up Phase|Treatment failure|0
2599157|NCT01075984|8987876|P1|Follow-up Phase|Treatment failure|0
2599158|NCT01075984|8987872|P5|Follow-up Phase|Progression of disease|2
2599159|NCT01075984|8987873|P4|Follow-up Phase|Progression of disease|0
2599160|NCT01075984|8987874|P3|Follow-up Phase|Progression of disease|0
2599161|NCT01075984|8987875|P2|Follow-up Phase|Progression of disease|0
2599162|NCT01075984|8987876|P1|Follow-up Phase|Progression of disease|0
2599163|NCT01075984|8987872|P5|Follow-up Phase|Withdrawal by Subject|10
2599164|NCT01075984|8987873|P4|Follow-up Phase|Withdrawal by Subject|0
2599165|NCT01075984|8987874|P3|Follow-up Phase|Withdrawal by Subject|0
2599166|NCT01075984|8987875|P2|Follow-up Phase|Withdrawal by Subject|0
2599167|NCT01075984|8987876|P1|Follow-up Phase|Withdrawal by Subject|0
2599168|NCT01075984|8987872|P5|Follow-up Phase|Administrative|1
2599169|NCT01075984|8987873|P4|Follow-up Phase|Administrative|0
2599170|NCT01075984|8987874|P3|Follow-up Phase|Administrative|0
2599171|NCT01075984|8987875|P2|Follow-up Phase|Administrative|0
2599172|NCT01075984|8987876|P1|Follow-up Phase|Administrative|0
2599173|NCT01075984|8987872|P5|Follow-up Phase|Adverse Event|27
2599174|NCT01075984|8987873|P4|Follow-up Phase|Adverse Event|2
2599175|NCT01075984|8987874|P3|Follow-up Phase|Adverse Event|0
2599176|NCT01075984|8987875|P2|Follow-up Phase|Adverse Event|0
2599177|NCT01075984|8987876|P1|Follow-up Phase|Adverse Event|0
2599178|NCT01075984|8987872|P5|Follow-up Phase|Protocol Violation|3
2599179|NCT01075984|8987873|P4|Follow-up Phase|Protocol Violation|0
2599180|NCT01075984|8987874|P3|Follow-up Phase|Protocol Violation|1
2599181|NCT01075984|8987875|P2|Follow-up Phase|Protocol Violation|0
2599182|NCT01075984|8987876|P1|Follow-up Phase|Protocol Violation|0
2599183|NCT01075984|8987872|P5|Treatment Phase|Progression of disease|2
2599184|NCT01075984|8987873|P4|Treatment Phase|Progression of disease|0
2599185|NCT01075984|8987874|P3|Treatment Phase|Progression of disease|0
2599186|NCT01075984|8987875|P2|Treatment Phase|Progression of disease|0
2599187|NCT01075984|8987876|P1|Treatment Phase|Progression of disease|0
2599188|NCT01075984|8987872|P5|Treatment Phase|Treatment Failure|5
2599189|NCT01075984|8987873|P4|Treatment Phase|Treatment Failure|0
2599190|NCT01075984|8987874|P3|Treatment Phase|Treatment Failure|1
2599191|NCT01075984|8987875|P2|Treatment Phase|Treatment Failure|0
2599192|NCT01075984|8987876|P1|Treatment Phase|Treatment Failure|0
2599193|NCT01075984|8987872|P5|Treatment Phase|Withdrawal by Subject|15
2599194|NCT01075984|8987873|P4|Treatment Phase|Withdrawal by Subject|0
2599195|NCT01075984|8987874|P3|Treatment Phase|Withdrawal by Subject|2
2599196|NCT01075984|8987875|P2|Treatment Phase|Withdrawal by Subject|0
2599197|NCT01075984|8987876|P1|Treatment Phase|Withdrawal by Subject|0
2599198|NCT01075984|8987872|P5|Treatment Phase|Protocol Violation|3
2599199|NCT01075984|8987873|P4|Treatment Phase|Protocol Violation|0
2599200|NCT01075984|8987874|P3|Treatment Phase|Protocol Violation|1
2599201|NCT01075984|8987875|P2|Treatment Phase|Protocol Violation|0
2599202|NCT01075984|8987876|P1|Treatment Phase|Protocol Violation|0
2599203|NCT01075984|8987872|P5|Treatment Phase|Adverse Event|35
2599204|NCT01075984|8987873|P4|Treatment Phase|Adverse Event|7
2599205|NCT01075984|8987874|P3|Treatment Phase|Adverse Event|3
2599206|NCT01075984|8987875|P2|Treatment Phase|Adverse Event|1
2599207|NCT01075984|8987876|P1|Treatment Phase|Adverse Event|0
2599208|NCT01075958|8987934|P1|Overall Study|Blood sample could not be obtained|44
2599209|NCT01075815|8987950|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
2599210|NCT01075815|8987951|P1|Overall Study|Withdrawal between OPU - embryo transfer|3
2599211|NCT01075815|8987950|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
2599212|NCT01075815|8987951|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
2599213|NCT01075815|8987950|P2|Overall Study|Withdrawal before r-hCG administration|1
2599214|NCT01075815|8987951|P1|Overall Study|Withdrawal before r-hCG administration|6
2599215|NCT01075763|8987989|P2|Overall Study|Withdrawal by Subject|2
2599216|NCT01075763|8987990|P1|Overall Study|Withdrawal by Subject|2
2599217|NCT01075763|8987989|P2|Overall Study|Lack of Efficacy|1
2599218|NCT01075763|8987990|P1|Overall Study|Lack of Efficacy|0
2599219|NCT01075763|8987989|P2|Overall Study|Lost to Follow-up|1
2599220|NCT01075763|8987990|P1|Overall Study|Lost to Follow-up|2
2599221|NCT01075685|8988014|P2|Overall Study|Lost to Follow-up|220
2599222|NCT01075685|8988015|P1|Overall Study|Lost to Follow-up|563
2599223|NCT01075685|8988014|P2|Overall Study|Withdrawal by Subject|5
2599224|NCT01075685|8988015|P1|Overall Study|Withdrawal by Subject|20
2599225|NCT01075685|8988014|P2|Overall Study|Protocol Violation|1
2599226|NCT01075685|8988015|P1|Overall Study|Protocol Violation|9
2599227|NCT01075646|8988031|P4|Overall Study|Lost to Follow-up|2
2599228|NCT01075646|8988032|P3|Overall Study|Lost to Follow-up|1
2599229|NCT01075646|8988033|P2|Overall Study|Lost to Follow-up|3
2599230|NCT01075646|8988034|P1|Overall Study|Lost to Follow-up|4
2599231|NCT01075412|8988066|P2|Overall Study|Withdrawal by Subject|1
2599232|NCT01075412|8988067|P1|Overall Study|Withdrawal by Subject|0
2599233|NCT01075321|8988092|P4|Overall Study|Ineligible (miscalculated lab value)|1
2599234|NCT01075321|8988093|P3|Overall Study|Ineligible (miscalculated lab value)|0
2599235|NCT01075321|8988094|P2|Overall Study|Ineligible (miscalculated lab value)|0
2599236|NCT01075321|8988095|P1|Overall Study|Ineligible (miscalculated lab value)|0
2599237|NCT01075321|8988092|P4|Overall Study|Treatment Incomplete due to progression|0
2599238|NCT01075321|8988093|P3|Overall Study|Treatment Incomplete due to progression|0
2599239|NCT01075321|8988094|P2|Overall Study|Treatment Incomplete due to progression|0
2599240|NCT01075321|8988095|P1|Overall Study|Treatment Incomplete due to progression|1
2599241|NCT01075321|8988092|P4|Overall Study|Protocol Violation|0
2599242|NCT01075321|8988093|P3|Overall Study|Protocol Violation|1
2599243|NCT01075321|8988094|P2|Overall Study|Protocol Violation|0
2599244|NCT01075321|8988095|P1|Overall Study|Protocol Violation|0
2599245|NCT01075321|8988092|P4|Overall Study|Withdrawal by Subject|1
2599246|NCT01075321|8988093|P3|Overall Study|Withdrawal by Subject|1
2599247|NCT01075321|8988094|P2|Overall Study|Withdrawal by Subject|0
2599248|NCT01075321|8988095|P1|Overall Study|Withdrawal by Subject|0
2599249|NCT01075282|8988113|P3|Overall Study|Death|2
2599250|NCT01075282|8988114|P2|Overall Study|Death|1
2599251|NCT01075282|8988115|P1|Overall Study|Death|0
2599252|NCT01075282|8988113|P3|Overall Study|Protocol Violation|1
2599253|NCT01075282|8988114|P2|Overall Study|Protocol Violation|2
2599254|NCT01075282|8988115|P1|Overall Study|Protocol Violation|0
2599255|NCT01075282|8988113|P3|Overall Study|Treatment Non-compliance|2
2599256|NCT01075282|8988114|P2|Overall Study|Treatment Non-compliance|2
2599257|NCT01075282|8988115|P1|Overall Study|Treatment Non-compliance|1
2599258|NCT01075282|8988113|P3|Overall Study|Lack of Efficacy|0
2599259|NCT01075282|8988114|P2|Overall Study|Lack of Efficacy|1
2599260|NCT01075282|8988115|P1|Overall Study|Lack of Efficacy|1
2599261|NCT01075282|8988113|P3|Overall Study|Physician Decision|3
2599262|NCT01075282|8988114|P2|Overall Study|Physician Decision|3
2599263|NCT01075282|8988115|P1|Overall Study|Physician Decision|3
2599264|NCT01075282|8988113|P3|Overall Study|Lost to Follow-up|3
2599265|NCT01075282|8988114|P2|Overall Study|Lost to Follow-up|3
2599266|NCT01075282|8988115|P1|Overall Study|Lost to Follow-up|3
2599267|NCT01075282|8988113|P3|Overall Study|Entry Criteria Not Met|0
2599268|NCT01075282|8988114|P2|Overall Study|Entry Criteria Not Met|2
2599269|NCT01075282|8988115|P1|Overall Study|Entry Criteria Not Met|3
2599270|NCT01075282|8988113|P3|Overall Study|Adverse Event|5
2599271|NCT01075282|8988114|P2|Overall Study|Adverse Event|8
2599272|NCT01075282|8988115|P1|Overall Study|Adverse Event|9
2599273|NCT01075282|8988113|P3|Overall Study|Withdrawal by Subject|11
2599274|NCT01075282|8988114|P2|Overall Study|Withdrawal by Subject|7
2599275|NCT01075282|8988115|P1|Overall Study|Withdrawal by Subject|11
2599276|NCT01075256|8988198|P3|Overall Study|Withdrawal by Subject|0
2599277|NCT01075256|8988199|P2|Overall Study|Withdrawal by Subject|0
2599278|NCT01075256|8988200|P1|Overall Study|Withdrawal by Subject|1
2599279|NCT01075243|8988232|P3|Overall Study|Withdrawal by Subject|0
2599280|NCT01075243|8988233|P2|Overall Study|Withdrawal by Subject|1
2599281|NCT01075243|8988234|P1|Overall Study|Withdrawal by Subject|1
2599282|NCT01075243|8988232|P3|Overall Study|Lost to Follow-up|0
2599283|NCT01075243|8988233|P2|Overall Study|Lost to Follow-up|2
2599284|NCT01075243|8988234|P1|Overall Study|Lost to Follow-up|5
2599285|NCT01075217|8988286|P2|Overall Study|Physician Decision|0
2599286|NCT01075217|8988287|P1|Overall Study|Physician Decision|1
2599287|NCT01075217|8988286|P2|Overall Study|Adverse Event|1
2599288|NCT01075217|8988287|P1|Overall Study|Adverse Event|1
2599289|NCT01075191|8988320|P1|Overall Study|Unknown Reasons|1
2599290|NCT01075191|8988320|P1|Overall Study|Patient's Wish|2
2599291|NCT01075191|8988320|P1|Overall Study|Therapy Break|3
2599292|NCT01075191|8988320|P1|Overall Study|Noncompliance|3
2599293|NCT01075191|8988320|P1|Overall Study|Adverse Event|4
2599294|NCT01075191|8988320|P1|Overall Study|Co-morbidities|1
2599295|NCT01075191|8988320|P1|Overall Study|Intensification|3
2599296|NCT01075191|8988320|P1|Overall Study|Death|1
2599297|NCT01075178|8988331|P2|Subject Chart Review|matched partner excluded (reasons above)|3
2599298|NCT01075178|8988332|P1|Subject Chart Review|matched partner excluded (reasons above)|6
2599299|NCT01075178|8988331|P2|Subject Chart Review|no data collected due to site closure|4
2599300|NCT01075178|8988332|P1|Subject Chart Review|no data collected due to site closure|3
2599301|NCT01075178|8988331|P2|Subject Chart Review|died before chart review period|2
2599302|NCT01075178|8988332|P1|Subject Chart Review|died before chart review period|0
2599303|NCT01075178|8988331|P2|Subject Matching|eligible but not matched|403
2599304|NCT01075178|8988332|P1|Subject Matching|eligible but not matched|130
2599305|NCT01075152|8988346|P2|Overall Study|Withdrawal by Subject|0
2599306|NCT01075152|8988347|P1|Overall Study|Withdrawal by Subject|1
2599307|NCT01075100|8988373|P2|Overall Study|Other|1
2599308|NCT01075100|8988374|P1|Overall Study|Other|3
2599309|NCT01075100|8988373|P2|Overall Study|Disease Progression|29
2599310|NCT01075100|8988374|P1|Overall Study|Disease Progression|25
2599311|NCT01075100|8988373|P2|Overall Study|Investigator Request|1
2599312|NCT01075100|8988374|P1|Overall Study|Investigator Request|2
2599313|NCT01075100|8988373|P2|Overall Study|Patient Request|4
2599314|NCT01075100|8988374|P1|Overall Study|Patient Request|4
2599315|NCT01075100|8988373|P2|Overall Study|Adverse Event|18
2599316|NCT01075100|8988374|P1|Overall Study|Adverse Event|15
2599317|NCT01075074|8988404|P3|Overall Study|Surgeon changed to open incisional case|2
2599318|NCT01075074|8988405|P2|Overall Study|Surgeon changed to open incisional case|2
2599319|NCT01075074|8988406|P1|Overall Study|Surgeon changed to open incisional case|1
2599320|NCT01074944|8988423|P5|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3
2599321|NCT01074944|8988424|P4|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
2599322|NCT01074944|8988425|P3|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
2599323|NCT01074944|8988426|P2|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
2599324|NCT01074944|8988427|P1|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
2599325|NCT01074944|8988423|P5|Extended Treatment (up to 42 Months)|Pregnancy|2
2599326|NCT01074944|8988424|P4|Extended Treatment (up to 42 Months)|Pregnancy|0
2599327|NCT01074944|8988425|P3|Extended Treatment (up to 42 Months)|Pregnancy|0
2599328|NCT01074944|8988426|P2|Extended Treatment (up to 42 Months)|Pregnancy|0
2599329|NCT01074944|8988427|P1|Extended Treatment (up to 42 Months)|Pregnancy|0
2599330|NCT01074944|8988423|P5|Long Term Treatment|Withdrawal by Subject|0
2599331|NCT01074944|8988424|P4|Long Term Treatment|Withdrawal by Subject|2
2599332|NCT01074944|8988425|P3|Long Term Treatment|Withdrawal by Subject|0
2599333|NCT01074944|8988426|P2|Long Term Treatment|Withdrawal by Subject|0
2599334|NCT01074944|8988427|P1|Long Term Treatment|Withdrawal by Subject|0
2599335|NCT01074944|8988423|P5|Long Term Treatment|Entered in Period, But Not Treated|0
2599336|NCT01074944|8988424|P4|Long Term Treatment|Entered in Period, But Not Treated|1
2599337|NCT01074944|8988425|P3|Long Term Treatment|Entered in Period, But Not Treated|0
2599338|NCT01074944|8988426|P2|Long Term Treatment|Entered in Period, But Not Treated|0
2599339|NCT01074944|8988427|P1|Long Term Treatment|Entered in Period, But Not Treated|0
2599340|NCT01074944|8988423|P5|Long Term Treatment|Transitioned to Commercial Eliglustat|0
2599341|NCT01074944|8988424|P4|Long Term Treatment|Transitioned to Commercial Eliglustat|18
2599342|NCT01074944|8988425|P3|Long Term Treatment|Transitioned to Commercial Eliglustat|0
2599343|NCT01074944|8988426|P2|Long Term Treatment|Transitioned to Commercial Eliglustat|0
2599344|NCT01074944|8988427|P1|Long Term Treatment|Transitioned to Commercial Eliglustat|0
2599345|NCT01074944|8988423|P5|Long Term Treatment|Lost to Follow-up|0
2599346|NCT01074944|8988424|P4|Long Term Treatment|Lost to Follow-up|2
2599347|NCT01074944|8988425|P3|Long Term Treatment|Lost to Follow-up|0
2599348|NCT01074944|8988426|P2|Long Term Treatment|Lost to Follow-up|0
2599349|NCT01074944|8988427|P1|Long Term Treatment|Lost to Follow-up|0
2599350|NCT01074944|8988423|P5|Long Term Treatment|Adverse Event|0
2599351|NCT01074944|8988424|P4|Long Term Treatment|Adverse Event|3
2599352|NCT01074944|8988425|P3|Long Term Treatment|Adverse Event|0
2599353|NCT01074944|8988426|P2|Long Term Treatment|Adverse Event|0
2599354|NCT01074944|8988427|P1|Long Term Treatment|Adverse Event|0
2599355|NCT01074944|8988423|P5|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
2599356|NCT01074944|8988424|P4|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
2599357|NCT01074944|8988425|P3|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
2599358|NCT01074944|8988426|P2|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
2599359|NCT01074944|8988427|P1|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
2599360|NCT01074944|8988423|P5|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
2599361|NCT01074944|8988424|P4|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
2599362|NCT01074944|8988425|P3|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
2599363|NCT01074944|8988426|P2|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1
2599364|NCT01074944|8988427|P1|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
2599365|NCT01074944|8988423|P5|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
2599366|NCT01074944|8988424|P4|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
2599367|NCT01074944|8988425|P3|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
2599368|NCT01074944|8988426|P2|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
2599369|NCT01074944|8988427|P1|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
2599370|NCT01074944|8988423|P5|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
2599371|NCT01074944|8988424|P4|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
2599372|NCT01074944|8988425|P3|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1
2599373|NCT01074944|8988426|P2|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6
2599374|NCT01074944|8988427|P1|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
2599375|NCT01074944|8988423|P5|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
2599376|NCT01074944|8988424|P4|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
2599377|NCT01074944|8988425|P3|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3
2599378|NCT01074944|8988426|P2|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2
2599379|NCT01074944|8988427|P1|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
2599380|NCT01074944|8988423|P5|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
2599381|NCT01074944|8988424|P4|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
2599382|NCT01074944|8988425|P3|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
2599383|NCT01074944|8988426|P2|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
2599384|NCT01074944|8988427|P1|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6
2599385|NCT01074944|8988423|P5|Lead-in Period (up to 78 Weeks)|Pregnancy|0
2599386|NCT01074944|8988424|P4|Lead-in Period (up to 78 Weeks)|Pregnancy|0
2599387|NCT01074944|8988425|P3|Lead-in Period (up to 78 Weeks)|Pregnancy|0
2599388|NCT01074944|8988426|P2|Lead-in Period (up to 78 Weeks)|Pregnancy|0
2599389|NCT01074944|8988427|P1|Lead-in Period (up to 78 Weeks)|Pregnancy|4
2599390|NCT01074944|8988423|P5|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
2599391|NCT01074944|8988424|P4|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
2599392|NCT01074944|8988425|P3|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
2599393|NCT01074944|8988426|P2|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
2599394|NCT01074944|8988427|P1|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1
2599395|NCT01074944|8988423|P5|Lead-in Period (up to 78 Weeks)|Adverse Event|0
2599396|NCT01074944|8988424|P4|Lead-in Period (up to 78 Weeks)|Adverse Event|0
2599397|NCT01074944|8988425|P3|Lead-in Period (up to 78 Weeks)|Adverse Event|0
2599398|NCT01074944|8988426|P2|Lead-in Period (up to 78 Weeks)|Adverse Event|0
2599399|NCT01074944|8988427|P1|Lead-in Period (up to 78 Weeks)|Adverse Event|2
2599400|NCT01074931|8988481|P1|Overall Study|Death|5
2599401|NCT01074931|8988481|P1|Overall Study|Economic reasons|1
2599402|NCT01074658|8988493|P1|Overall Study|No implant attempted|19
2599403|NCT01074554|8988501|P2|Overall Study|Lost to Follow-up|1
2599404|NCT01074554|8988502|P1|Overall Study|Lost to Follow-up|0
2599405|NCT01074554|8988501|P2|Overall Study|Adverse Event|3
2599406|NCT01074554|8988502|P1|Overall Study|Adverse Event|3
2599407|NCT01074502|8988512|P1|Overall Study|Withdrawal by Subject|1
2599408|NCT01074450|8988536|P2|Second Intervention|Physician Decision|1
2599409|NCT01074450|8988537|P1|Second Intervention|Physician Decision|0
2599410|NCT01074450|8988536|P2|Second Intervention|Protocol Violation|0
2599411|NCT01074450|8988537|P1|Second Intervention|Protocol Violation|1
2599412|NCT01074450|8988536|P2|First Intervention|Emesis in Dosing Interval|2
2599413|NCT01074450|8988537|P1|First Intervention|Emesis in Dosing Interval|0
2599414|NCT01074307|8988566|P2|Overall Study|Protocol Violation|5
2599415|NCT01074307|8988567|P1|Overall Study|Protocol Violation|8
2599416|NCT01074307|8988566|P2|Overall Study|Exclusion criterion|1
2599417|NCT01074307|8988567|P1|Overall Study|Exclusion criterion|0
2599418|NCT01074307|8988566|P2|Overall Study|No primary endpoint evaluation|6
2599419|NCT01074307|8988567|P1|Overall Study|No primary endpoint evaluation|14
2599420|NCT01074268|8988589|P2|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2
2599421|NCT01074268|8988590|P1|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3
2599422|NCT01074268|8988589|P2|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
2599423|NCT01074268|8988590|P1|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
2599424|NCT01074268|8988589|P2|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2
2599425|NCT01074268|8988590|P1|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0
2599426|NCT01074268|8988589|P2|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
2599427|NCT01074268|8988590|P1|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
2599428|NCT01074268|8988589|P2|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5
2599429|NCT01074268|8988590|P1|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8
2599430|NCT01074268|8988589|P2|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3
2599431|NCT01074268|8988590|P1|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6
2599432|NCT01074268|8988589|P2|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4
2599433|NCT01074268|8988590|P1|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3
2599434|NCT01074268|8988589|P2|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2
2599435|NCT01074268|8988590|P1|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0
2599436|NCT01074268|8988589|P2|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1
2599437|NCT01074268|8988590|P1|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3
2599438|NCT01074255|8988616|P1|Overall Study|Did not receive EMEND|2
2599439|NCT01074242|8988620|P1|Overall Study|Duplicate Case Report Form|5
2599440|NCT01074242|8988620|P1|Overall Study|Violation of vaccine dose or dosage|351
2599441|NCT01074242|8988620|P1|Overall Study|Case report unclear|6
2599442|NCT01074242|8988620|P1|Overall Study|Lost to Follow-up|1
2599443|NCT01074242|8988620|P1|Overall Study|Case report before date of contract|40
2599444|NCT01074229|8988628|P3|Overall Study|Change to open surgical procedure|4
2599445|NCT01074229|8988629|P2|Overall Study|Change to open surgical procedure|3
2599446|NCT01074229|8988630|P1|Overall Study|Change to open surgical procedure|1
2599447|NCT01074229|8988628|P3|Overall Study|Lost to Follow-up|0
2599448|NCT01074229|8988629|P2|Overall Study|Lost to Follow-up|0
2599449|NCT01074229|8988630|P1|Overall Study|Lost to Follow-up|1
2599450|NCT01074216|8988641|P1|Overall Study|Not Treated|12
2599451|NCT01074216|8988641|P1|Overall Study|Physician Decision|1
2599452|NCT01074047|8988705|P2|Extension Phase|Death|0
2599453|NCT01074047|8988706|P1|Extension Phase|Death|5
2599454|NCT01074047|8988705|P2|Extension Phase|Withdrawal by Subject|0
2599455|NCT01074047|8988706|P1|Extension Phase|Withdrawal by Subject|2
2599456|NCT01074047|8988705|P2|Extension Phase|Disease Progression|0
2599457|NCT01074047|8988706|P1|Extension Phase|Disease Progression|9
2599458|NCT01074047|8988705|P2|Extension Phase|Adverse Event|0
2599459|NCT01074047|8988706|P1|Extension Phase|Adverse Event|5
2599460|NCT01074047|8988705|P2|Extension Phase|Physician Decision|0
2599461|NCT01074047|8988706|P1|Extension Phase|Physician Decision|1
2599462|NCT01074047|8988705|P2|Survival Follow-Up Phase|Alive at study closure|3
2599463|NCT01074047|8988706|P1|Survival Follow-Up Phase|Alive at study closure|1
2599464|NCT01074047|8988705|P2|Survival Follow-Up Phase|Death|124
2599465|NCT01074047|8988706|P1|Survival Follow-Up Phase|Death|116
2599466|NCT01074047|8988705|P2|Survival Follow-Up Phase|Lost to Follow-up|1
2599467|NCT01074047|8988706|P1|Survival Follow-Up Phase|Lost to Follow-up|2
2599468|NCT01074047|8988705|P2|Survival Follow-Up Phase|Withdrawal by Subject|8
2599469|NCT01074047|8988706|P1|Survival Follow-Up Phase|Withdrawal by Subject|5
2599470|NCT01074047|8988705|P2|Treatment Phase|Miscellaneous|39
2599471|NCT01074047|8988706|P1|Treatment Phase|Miscellaneous|32
2599472|NCT01074047|8988705|P2|Treatment Phase|Protocol Violation|1
2599473|NCT01074047|8988706|P1|Treatment Phase|Protocol Violation|0
2599474|NCT01074047|8988705|P2|Treatment Phase|Lost to Follow-up|1
2599475|NCT01074047|8988706|P1|Treatment Phase|Lost to Follow-up|0
2599476|NCT01074047|8988705|P2|Treatment Phase|Death|58
2599477|NCT01074047|8988706|P1|Treatment Phase|Death|53
2599478|NCT01074047|8988705|P2|Treatment Phase|Withdrawal by Subject|48
2599479|NCT01074047|8988706|P1|Treatment Phase|Withdrawal by Subject|27
2599480|NCT01074047|8988705|P2|Treatment Phase|Disease Progression|21
2599481|NCT01074047|8988706|P1|Treatment Phase|Disease Progression|16
2599482|NCT01074047|8988705|P2|Treatment Phase|Adverse Event|66
2599483|NCT01074047|8988706|P1|Treatment Phase|Adverse Event|89
2599484|NCT01074008|8988794|P9|Overall Study|Lost to Follow-up|4
2599485|NCT01074008|8988795|P8|Overall Study|Lost to Follow-up|0
2599486|NCT01074008|8988796|P7|Overall Study|Lost to Follow-up|1
2599487|NCT01074008|8988797|P6|Overall Study|Lost to Follow-up|0
2599488|NCT01074008|8988798|P5|Overall Study|Lost to Follow-up|1
2599489|NCT01074008|8988799|P4|Overall Study|Lost to Follow-up|1
2599490|NCT01074008|8988800|P3|Overall Study|Lost to Follow-up|1
2599491|NCT01074008|8988801|P2|Overall Study|Lost to Follow-up|1
2599492|NCT01074008|8988802|P1|Overall Study|Lost to Follow-up|0
2599493|NCT01074008|8988794|P9|Overall Study|Withdrawal by Subject|0
2599494|NCT01074008|8988795|P8|Overall Study|Withdrawal by Subject|0
2599495|NCT01074008|8988796|P7|Overall Study|Withdrawal by Subject|0
2599496|NCT01074008|8988797|P6|Overall Study|Withdrawal by Subject|0
2599497|NCT01074008|8988798|P5|Overall Study|Withdrawal by Subject|1
2599498|NCT01074008|8988799|P4|Overall Study|Withdrawal by Subject|0
2599499|NCT01074008|8988800|P3|Overall Study|Withdrawal by Subject|1
2599500|NCT01074008|8988801|P2|Overall Study|Withdrawal by Subject|1
2599501|NCT01074008|8988802|P1|Overall Study|Withdrawal by Subject|1
2599502|NCT01074008|8988794|P9|Overall Study|Adverse Event|0
2599503|NCT01074008|8988795|P8|Overall Study|Adverse Event|0
2599504|NCT01074008|8988796|P7|Overall Study|Adverse Event|0
2599505|NCT01074008|8988797|P6|Overall Study|Adverse Event|0
2599506|NCT01074008|8988798|P5|Overall Study|Adverse Event|0
2599507|NCT01074008|8988799|P4|Overall Study|Adverse Event|0
2599508|NCT01074008|8988800|P3|Overall Study|Adverse Event|0
2599509|NCT01074008|8988801|P2|Overall Study|Adverse Event|1
2599510|NCT01074008|8988802|P1|Overall Study|Adverse Event|0
2599511|NCT01073943|8988912|P2|Overall Study|Could not tolerate prep|0
2599512|NCT01073943|8988913|P1|Overall Study|Could not tolerate prep|1
2599513|NCT01073943|8988912|P2|Overall Study|Unable to return for follow-up|1
2599514|NCT01073943|8988913|P1|Overall Study|Unable to return for follow-up|0
2599515|NCT01073943|8988912|P2|Overall Study|Subject forgot|1
2599516|NCT01073943|8988913|P1|Overall Study|Subject forgot|0
2599517|NCT01073943|8988912|P2|Overall Study|Power outage; colonoscopy not done|0
2599518|NCT01073943|8988913|P1|Overall Study|Power outage; colonoscopy not done|1
2599519|NCT01073943|8988912|P2|Overall Study|Lost to Follow-up|2
2599520|NCT01073943|8988913|P1|Overall Study|Lost to Follow-up|0
2599521|NCT01073943|8988912|P2|Overall Study|Adverse Event|1
2599522|NCT01073943|8988913|P1|Overall Study|Adverse Event|1
2599523|NCT01073943|8988912|P2|Overall Study|Protocol Violation|1
2599524|NCT01073943|8988913|P1|Overall Study|Protocol Violation|2
2599525|NCT01073943|8988912|P2|Overall Study|Withdrawal by Subject|2
2599526|NCT01073943|8988913|P1|Overall Study|Withdrawal by Subject|8
2599527|NCT01073930|8988939|P2|Overall Study|Inadequate prep; unable to do procedure|1
2599528|NCT01073930|8988940|P1|Overall Study|Inadequate prep; unable to do procedure|0
2599529|NCT01073930|8988939|P2|Overall Study|Noncompliance with study drug|1
2599530|NCT01073930|8988940|P1|Overall Study|Noncompliance with study drug|0
2599531|NCT01073930|8988939|P2|Overall Study|Adverse Event|1
2599532|NCT01073930|8988940|P1|Overall Study|Adverse Event|0
2599533|NCT01073930|8988939|P2|Overall Study|Lost to Follow-up|1
2599534|NCT01073930|8988940|P1|Overall Study|Lost to Follow-up|0
2599535|NCT01073930|8988939|P2|Overall Study|Withdrawal by Subject|2
2599536|NCT01073930|8988940|P1|Overall Study|Withdrawal by Subject|3
2599537|NCT01073865|8988964|P2|Overall Study|Withdrawal by Subject|5
2599538|NCT01073865|8988965|P1|Overall Study|Withdrawal by Subject|5
2599539|NCT01073865|8988964|P2|Overall Study|Death|2
2599540|NCT01073865|8988965|P1|Overall Study|Death|3
2599541|NCT01073865|8988964|P2|Overall Study|Lost to Follow-up|1
2599542|NCT01073865|8988965|P1|Overall Study|Lost to Follow-up|1
2599543|NCT01073865|8988964|P2|Overall Study|Reasons other than below|31
2599544|NCT01073865|8988965|P1|Overall Study|Reasons other than below|19
2599545|NCT01073631|8988984|P1|Overall Study|Other|63
2599546|NCT01073631|8988984|P1|Overall Study|Adverse Event|24
2599547|NCT01073631|8988984|P1|Overall Study|Death|82
2599548|NCT01073618|8988989|P1|Overall Study|Other|80
2599549|NCT01073618|8988989|P1|Overall Study|Adverse Event|19
2599550|NCT01073618|8988989|P1|Overall Study|Death|208
2599551|NCT01073605|8988997|P3|Overall Study|Randomized But Not Treated|1
2599552|NCT01073605|8988998|P2|Overall Study|Randomized But Not Treated|1
2599553|NCT01073605|8988999|P1|Overall Study|Randomized But Not Treated|0
2599554|NCT01073605|8988997|P3|Overall Study|Withdrawal by Subject|22
2599555|NCT01073605|8988998|P2|Overall Study|Withdrawal by Subject|39
2599556|NCT01073605|8988999|P1|Overall Study|Withdrawal by Subject|31
2599557|NCT01073605|8988997|P3|Overall Study|Other|29
2599558|NCT01073605|8988998|P2|Overall Study|Other|21
2599559|NCT01073605|8988999|P1|Overall Study|Other|25
2599560|NCT01073605|8988997|P3|Overall Study|Lost to Follow-up|9
2599561|NCT01073605|8988998|P2|Overall Study|Lost to Follow-up|4
2599562|NCT01073605|8988999|P1|Overall Study|Lost to Follow-up|3
2599563|NCT01073605|8988997|P3|Overall Study|Adverse Event|0
2599564|NCT01073605|8988998|P2|Overall Study|Adverse Event|1
2599565|NCT01073605|8988999|P1|Overall Study|Adverse Event|2
2599566|NCT01073605|8988997|P3|Overall Study|Ongoing at Cutoff Date|0
2599567|NCT01073605|8988998|P2|Overall Study|Ongoing at Cutoff Date|1
2599568|NCT01073605|8988999|P1|Overall Study|Ongoing at Cutoff Date|1
2599569|NCT01073566|8989045|P2|Period 2 (6 Weeks)|Adverse Event|0
2599570|NCT01073566|8989046|P1|Period 2 (6 Weeks)|Adverse Event|1
2599571|NCT01073462|8989058|P1|Overall Study|Lost to Follow-up|7
2599572|NCT01073462|8989058|P1|Overall Study|Serious adverse event|2
2599573|NCT01073462|8989058|P1|Overall Study|Low parathyroid hormone levels|8
2599574|NCT01073462|8989058|P1|Overall Study|Kidney transplant|10
2599575|NCT01073462|8989058|P1|Overall Study|Death|14
2599576|NCT01073293|8989077|P2|Overall Study|Withdrawal by Subject|10
2599577|NCT01073293|8989078|P1|Overall Study|Withdrawal by Subject|5
2599578|NCT01073293|8989077|P2|Overall Study|Lost to Follow-up|1
2599579|NCT01073293|8989078|P1|Overall Study|Lost to Follow-up|0
2599580|NCT01073267|8989100|P1|Overall Study|Disease Progression|3
2599581|NCT01073163|8989104|P1|Overall Study|Early termination|1
2599582|NCT01073163|8989104|P1|Overall Study|Disease Progression|1
2599583|NCT01073163|8989104|P1|Overall Study|Adverse Event|1
2599584|NCT01072929|8989127|P3|Overall Study|Other|0
2599585|NCT01072929|8989128|P2|Overall Study|Other|3
2599586|NCT01072929|8989129|P1|Overall Study|Other|0
2599587|NCT01072929|8989127|P3|Overall Study|Noncompliance with study procedures|1
2599588|NCT01072929|8989128|P2|Overall Study|Noncompliance with study procedures|0
2599589|NCT01072929|8989129|P1|Overall Study|Noncompliance with study procedures|1
2599590|NCT01072929|8989127|P3|Overall Study|Noncompliance with study medication|0
2599591|NCT01072929|8989128|P2|Overall Study|Noncompliance with study medication|3
2599592|NCT01072929|8989129|P1|Overall Study|Noncompliance with study medication|0
2599593|NCT01072929|8989127|P3|Overall Study|Lost to Follow-up|1
2599594|NCT01072929|8989128|P2|Overall Study|Lost to Follow-up|4
2599595|NCT01072929|8989129|P1|Overall Study|Lost to Follow-up|8
2599596|NCT01072929|8989127|P3|Overall Study|Protocol Violation|2
2599597|NCT01072929|8989128|P2|Overall Study|Protocol Violation|11
2599598|NCT01072929|8989129|P1|Overall Study|Protocol Violation|13
2599599|NCT01072929|8989127|P3|Overall Study|Withdrawal by Subject|3
2599600|NCT01072929|8989128|P2|Overall Study|Withdrawal by Subject|15
2599601|NCT01072929|8989129|P1|Overall Study|Withdrawal by Subject|7
2599602|NCT01072929|8989127|P3|Overall Study|Lack of Efficacy|0
2599603|NCT01072929|8989128|P2|Overall Study|Lack of Efficacy|4
2599604|NCT01072929|8989129|P1|Overall Study|Lack of Efficacy|7
2599605|NCT01072929|8989127|P3|Overall Study|Adverse Event|2
2599606|NCT01072929|8989128|P2|Overall Study|Adverse Event|11
2599607|NCT01072929|8989129|P1|Overall Study|Adverse Event|8
2599608|NCT01072877|8989208|P5|Overall Study|Lost to Follow-up|0
2599609|NCT01072877|8989209|P4|Overall Study|Lost to Follow-up|2
2599610|NCT01072877|8989210|P3|Overall Study|Lost to Follow-up|0
2599611|NCT01072877|8989211|P2|Overall Study|Lost to Follow-up|1
2599612|NCT01072877|8989212|P1|Overall Study|Lost to Follow-up|1
2599613|NCT01072630|8989291|P3|Overall Study|Other|1
2599614|NCT01072630|8989292|P2|Overall Study|Other|2
2599615|NCT01072630|8989293|P1|Overall Study|Other|3
2599616|NCT01072630|8989291|P3|Overall Study|Noncompliance with study procedures|1
2599617|NCT01072630|8989292|P2|Overall Study|Noncompliance with study procedures|2
2599618|NCT01072630|8989293|P1|Overall Study|Noncompliance with study procedures|1
2599619|NCT01072630|8989291|P3|Overall Study|Noncompliance with study medication|1
2599620|NCT01072630|8989292|P2|Overall Study|Noncompliance with study medication|1
2599621|NCT01072630|8989293|P1|Overall Study|Noncompliance with study medication|1
2599622|NCT01072630|8989291|P3|Overall Study|Lost to Follow-up|1
2599623|NCT01072630|8989292|P2|Overall Study|Lost to Follow-up|11
2599624|NCT01072630|8989293|P1|Overall Study|Lost to Follow-up|11
2599625|NCT01072630|8989291|P3|Overall Study|Protocol Violation|4
2599626|NCT01072630|8989292|P2|Overall Study|Protocol Violation|8
2599627|NCT01072630|8989293|P1|Overall Study|Protocol Violation|10
2599628|NCT01072630|8989291|P3|Overall Study|Withdrawal by Subject|2
2599629|NCT01072630|8989292|P2|Overall Study|Withdrawal by Subject|7
2599630|NCT01072630|8989293|P1|Overall Study|Withdrawal by Subject|8
2599631|NCT01072630|8989291|P3|Overall Study|Lack of Efficacy|1
2599632|NCT01072630|8989292|P2|Overall Study|Lack of Efficacy|10
2599633|NCT01072630|8989293|P1|Overall Study|Lack of Efficacy|10
2599634|NCT01072630|8989291|P3|Overall Study|Adverse Event|2
2599635|NCT01072630|8989292|P2|Overall Study|Adverse Event|19
2599636|NCT01072630|8989293|P1|Overall Study|Adverse Event|11
2599637|NCT01072539|8989374|P1|Overall Study|Protocol Violation|2
2599638|NCT01072539|8989374|P1|Overall Study|Treated prior to the Site Initiation|1
2599639|NCT01072500|8989398|P2|Overall Study|Withdrawal by Subject|10
2599640|NCT01072500|8989399|P1|Overall Study|Withdrawal by Subject|17
2599641|NCT01072500|8989398|P2|Overall Study|Lost to Follow-up|2
2599642|NCT01072500|8989399|P1|Overall Study|Lost to Follow-up|5
2599643|NCT01072500|8989398|P2|Overall Study|Death|2
2599644|NCT01072500|8989399|P1|Overall Study|Death|2
2599645|NCT01072448|8989409|P2|Overall Study|Death|2
2599646|NCT01072448|8989410|P1|Overall Study|Death|0
2599647|NCT01072448|8989409|P2|Overall Study|Abnormal laboratory value(s)|1
2599648|NCT01072448|8989410|P1|Overall Study|Abnormal laboratory value(s)|0
2599649|NCT01072448|8989409|P2|Overall Study|Lost to Follow-up|1
2599650|NCT01072448|8989410|P1|Overall Study|Lost to Follow-up|1
2599651|NCT01072448|8989409|P2|Overall Study|Unsatisfactory therapeutic effect|3
2599652|NCT01072448|8989410|P1|Overall Study|Unsatisfactory therapeutic effect|1
2599653|NCT01072448|8989409|P2|Overall Study|Abnormal test procedure result(s)|0
2599654|NCT01072448|8989410|P1|Overall Study|Abnormal test procedure result(s)|1
2599655|NCT01072448|8989409|P2|Overall Study|Protocol deviation|4
2599656|NCT01072448|8989410|P1|Overall Study|Protocol deviation|3
2599657|NCT01072448|8989409|P2|Overall Study|Subject withdrew consent|9
2599658|NCT01072448|8989410|P1|Overall Study|Subject withdrew consent|4
2599659|NCT01072448|8989409|P2|Overall Study|Adverse Event|10
2599660|NCT01072448|8989410|P1|Overall Study|Adverse Event|9
2599661|NCT01072396|8989424|P2|Period Two|Lost to Follow-up|0
2599662|NCT01072396|8989425|P1|Period Two|Lost to Follow-up|1
2599663|NCT01072396|8989424|P2|Period Two|Adverse Event|3
2599664|NCT01072396|8989425|P1|Period Two|Adverse Event|0
2599665|NCT01072396|8989424|P2|Washout Period|Missing termination information|1
2599666|NCT01072396|8989425|P1|Washout Period|Missing termination information|0
2599667|NCT01072396|8989424|P2|Period One|Withdrawal by Subject|0
2599668|NCT01072396|8989425|P1|Period One|Withdrawal by Subject|2
2599669|NCT01072396|8989424|P2|Period One|Protocol Violation|1
2599670|NCT01072396|8989425|P1|Period One|Protocol Violation|2
2599671|NCT01072396|8989424|P2|Period One|Adverse Event|1
2599672|NCT01072396|8989425|P1|Period One|Adverse Event|1
2599673|NCT01072357|8989437|P2|Overall Study|Lost to Follow-up|1
2599674|NCT01072357|8989438|P1|Overall Study|Lost to Follow-up|0
2599675|NCT01072344|8989448|P2|Overall Study|Lost to Follow-up|4
2599676|NCT01072344|8989449|P1|Overall Study|Lost to Follow-up|3
2599677|NCT01072344|8989448|P2|Overall Study|Protocol Violation|2
2599678|NCT01072344|8989449|P1|Overall Study|Protocol Violation|1
2599679|NCT01072344|8989448|P2|Overall Study|Relasped-reached end point|12
2599680|NCT01072344|8989449|P1|Overall Study|Relasped-reached end point|7
2599681|NCT01072201|8989487|P2|Overall Study|Lost to Follow-up|1
2599682|NCT01072201|8989488|P1|Overall Study|Lost to Follow-up|0
2599683|NCT01072175|8989521|P13|Part D (HPMC Capsules)|Withdrawal by Subject|0
2599684|NCT01072175|8989522|P12|Part D (HPMC Capsules)|Withdrawal by Subject|3
2599685|NCT01072175|8989523|P11|Part D (HPMC Capsules)|Withdrawal by Subject|1
2599686|NCT01072175|8989524|P10|Part D (HPMC Capsules)|Withdrawal by Subject|0
2599687|NCT01072175|8989525|P9|Part D (HPMC Capsules)|Withdrawal by Subject|0
2599688|NCT01072175|8989526|P8|Part D (HPMC Capsules)|Withdrawal by Subject|0
2599689|NCT01072175|8989527|P7|Part D (HPMC Capsules)|Withdrawal by Subject|0
2599690|NCT01072175|8989528|P6|Part D (HPMC Capsules)|Withdrawal by Subject|0
2599691|NCT01072175|8989529|P5|Part D (HPMC Capsules)|Withdrawal by Subject|0
2599692|NCT01072175|8989530|P4|Part D (HPMC Capsules)|Withdrawal by Subject|0
2599693|NCT01072175|8989531|P3|Part D (HPMC Capsules)|Withdrawal by Subject|0
2599694|NCT01072175|8989532|P2|Part D (HPMC Capsules)|Withdrawal by Subject|0
2599695|NCT01072175|8989533|P1|Part D (HPMC Capsules)|Withdrawal by Subject|0
2599696|NCT01072175|8989521|P13|Part D (HPMC Capsules)|Study closed/terminated|9
2599697|NCT01072175|8989522|P12|Part D (HPMC Capsules)|Study closed/terminated|10
2599698|NCT01072175|8989523|P11|Part D (HPMC Capsules)|Study closed/terminated|1
2599699|NCT01072175|8989524|P10|Part D (HPMC Capsules)|Study closed/terminated|2
2599700|NCT01072175|8989525|P9|Part D (HPMC Capsules)|Study closed/terminated|0
2599701|NCT01072175|8989526|P8|Part D (HPMC Capsules)|Study closed/terminated|0
2599702|NCT01072175|8989527|P7|Part D (HPMC Capsules)|Study closed/terminated|0
2599703|NCT01072175|8989528|P6|Part D (HPMC Capsules)|Study closed/terminated|0
2599704|NCT01072175|8989529|P5|Part D (HPMC Capsules)|Study closed/terminated|0
2599705|NCT01072175|8989530|P4|Part D (HPMC Capsules)|Study closed/terminated|0
2599706|NCT01072175|8989531|P3|Part D (HPMC Capsules)|Study closed/terminated|0
2599707|NCT01072175|8989532|P2|Part D (HPMC Capsules)|Study closed/terminated|0
2599708|NCT01072175|8989533|P1|Part D (HPMC Capsules)|Study closed/terminated|0
2599709|NCT01072175|8989521|P13|Part D (HPMC Capsules)|Lost to Follow-up|3
2599710|NCT01072175|8989522|P12|Part D (HPMC Capsules)|Lost to Follow-up|1
2599711|NCT01072175|8989523|P11|Part D (HPMC Capsules)|Lost to Follow-up|1
2599712|NCT01072175|8989524|P10|Part D (HPMC Capsules)|Lost to Follow-up|0
2599713|NCT01072175|8989525|P9|Part D (HPMC Capsules)|Lost to Follow-up|0
2599714|NCT01072175|8989526|P8|Part D (HPMC Capsules)|Lost to Follow-up|0
2599715|NCT01072175|8989527|P7|Part D (HPMC Capsules)|Lost to Follow-up|0
2599716|NCT01072175|8989528|P6|Part D (HPMC Capsules)|Lost to Follow-up|0
2599717|NCT01072175|8989529|P5|Part D (HPMC Capsules)|Lost to Follow-up|0
2599718|NCT01072175|8989530|P4|Part D (HPMC Capsules)|Lost to Follow-up|0
2599719|NCT01072175|8989531|P3|Part D (HPMC Capsules)|Lost to Follow-up|0
2599720|NCT01072175|8989532|P2|Part D (HPMC Capsules)|Lost to Follow-up|0
2599721|NCT01072175|8989533|P1|Part D (HPMC Capsules)|Lost to Follow-up|0
2599722|NCT01072175|8989521|P13|Part D (HPMC Capsules)|Physician Decision|1
2599723|NCT01072175|8989522|P12|Part D (HPMC Capsules)|Physician Decision|1
2599724|NCT01072175|8989523|P11|Part D (HPMC Capsules)|Physician Decision|1
2599725|NCT01072175|8989524|P10|Part D (HPMC Capsules)|Physician Decision|0
2599726|NCT01072175|8989525|P9|Part D (HPMC Capsules)|Physician Decision|0
2599727|NCT01072175|8989526|P8|Part D (HPMC Capsules)|Physician Decision|0
2599728|NCT01072175|8989527|P7|Part D (HPMC Capsules)|Physician Decision|0
2599729|NCT01072175|8989528|P6|Part D (HPMC Capsules)|Physician Decision|0
2599730|NCT01072175|8989529|P5|Part D (HPMC Capsules)|Physician Decision|0
2599731|NCT01072175|8989530|P4|Part D (HPMC Capsules)|Physician Decision|0
2599732|NCT01072175|8989531|P3|Part D (HPMC Capsules)|Physician Decision|0
2599733|NCT01072175|8989532|P2|Part D (HPMC Capsules)|Physician Decision|0
2599734|NCT01072175|8989533|P1|Part D (HPMC Capsules)|Physician Decision|0
2599735|NCT01072175|8989521|P13|Part D (HPMC Capsules)|Death|26
2599736|NCT01072175|8989522|P12|Part D (HPMC Capsules)|Death|28
2599737|NCT01072175|8989523|P11|Part D (HPMC Capsules)|Death|12
2599738|NCT01072175|8989524|P10|Part D (HPMC Capsules)|Death|10
2599739|NCT01072175|8989525|P9|Part D (HPMC Capsules)|Death|0
2599740|NCT01072175|8989526|P8|Part D (HPMC Capsules)|Death|0
2599741|NCT01072175|8989527|P7|Part D (HPMC Capsules)|Death|0
2599742|NCT01072175|8989528|P6|Part D (HPMC Capsules)|Death|0
2599743|NCT01072175|8989529|P5|Part D (HPMC Capsules)|Death|0
2599744|NCT01072175|8989530|P4|Part D (HPMC Capsules)|Death|0
2599745|NCT01072175|8989531|P3|Part D (HPMC Capsules)|Death|0
2599746|NCT01072175|8989532|P2|Part D (HPMC Capsules)|Death|0
2599747|NCT01072175|8989533|P1|Part D (HPMC Capsules)|Death|0
2599748|NCT01072175|8989521|P13|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2599749|NCT01072175|8989522|P12|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2599750|NCT01072175|8989523|P11|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2599751|NCT01072175|8989524|P10|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2599752|NCT01072175|8989525|P9|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3
2599753|NCT01072175|8989526|P8|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2599754|NCT01072175|8989527|P7|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2599755|NCT01072175|8989528|P6|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2599756|NCT01072175|8989529|P5|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2599757|NCT01072175|8989530|P4|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2599758|NCT01072175|8989531|P3|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2599759|NCT01072175|8989532|P2|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2599760|NCT01072175|8989533|P1|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
2599761|NCT01072175|8989521|P13|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2599762|NCT01072175|8989522|P12|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2599763|NCT01072175|8989523|P11|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2599764|NCT01072175|8989524|P10|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2599765|NCT01072175|8989525|P9|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4
2599766|NCT01072175|8989526|P8|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2599767|NCT01072175|8989527|P7|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2599768|NCT01072175|8989528|P6|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2599769|NCT01072175|8989529|P5|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2599770|NCT01072175|8989530|P4|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2599771|NCT01072175|8989531|P3|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2599772|NCT01072175|8989532|P2|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2599773|NCT01072175|8989533|P1|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
2599774|NCT01072175|8989521|P13|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2599775|NCT01072175|8989522|P12|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2599776|NCT01072175|8989523|P11|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2599777|NCT01072175|8989524|P10|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2599778|NCT01072175|8989525|P9|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1
2599779|NCT01072175|8989526|P8|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2599780|NCT01072175|8989527|P7|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2599781|NCT01072175|8989528|P6|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2599782|NCT01072175|8989529|P5|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2599783|NCT01072175|8989530|P4|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2599784|NCT01072175|8989531|P3|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2599785|NCT01072175|8989532|P2|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2599786|NCT01072175|8989533|P1|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
2599787|NCT01072175|8989521|P13|Part C (Phase II: Crossover Phase [CP])|Death|0
2599788|NCT01072175|8989522|P12|Part C (Phase II: Crossover Phase [CP])|Death|0
2599789|NCT01072175|8989523|P11|Part C (Phase II: Crossover Phase [CP])|Death|0
2599790|NCT01072175|8989524|P10|Part C (Phase II: Crossover Phase [CP])|Death|0
2599791|NCT01072175|8989525|P9|Part C (Phase II: Crossover Phase [CP])|Death|37
2599792|NCT01072175|8989526|P8|Part C (Phase II: Crossover Phase [CP])|Death|0
2599793|NCT01072175|8989527|P7|Part C (Phase II: Crossover Phase [CP])|Death|0
2599794|NCT01072175|8989528|P6|Part C (Phase II: Crossover Phase [CP])|Death|0
2599795|NCT01072175|8989529|P5|Part C (Phase II: Crossover Phase [CP])|Death|0
2599796|NCT01072175|8989530|P4|Part C (Phase II: Crossover Phase [CP])|Death|0
2599797|NCT01072175|8989531|P3|Part C (Phase II: Crossover Phase [CP])|Death|0
2599798|NCT01072175|8989532|P2|Part C (Phase II: Crossover Phase [CP])|Death|0
2599799|NCT01072175|8989533|P1|Part C (Phase II: Crossover Phase [CP])|Death|0
2599800|NCT01072175|8989521|P13|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2599801|NCT01072175|8989522|P12|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2599802|NCT01072175|8989523|P11|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2599803|NCT01072175|8989524|P10|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2599804|NCT01072175|8989525|P9|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2599805|NCT01072175|8989526|P8|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2599806|NCT01072175|8989527|P7|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7
2599807|NCT01072175|8989528|P6|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3
2599808|NCT01072175|8989529|P5|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2599809|NCT01072175|8989530|P4|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2599810|NCT01072175|8989531|P3|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2599811|NCT01072175|8989532|P2|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2599812|NCT01072175|8989533|P1|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
2599813|NCT01072175|8989521|P13|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
2599814|NCT01072175|8989522|P12|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
2599815|NCT01072175|8989523|P11|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
2599816|NCT01072175|8989524|P10|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
2599817|NCT01072175|8989525|P9|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
2599818|NCT01072175|8989526|P8|Part C (Phase II: Randomized Phase)|Study closed/terminated|11
2599819|NCT01072175|8989527|P7|Part C (Phase II: Randomized Phase)|Study closed/terminated|9
2599820|NCT01072175|8989528|P6|Part C (Phase II: Randomized Phase)|Study closed/terminated|6
2599821|NCT01072175|8989529|P5|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
2599822|NCT01072175|8989530|P4|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
2599823|NCT01072175|8989531|P3|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
2599824|NCT01072175|8989532|P2|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
2599825|NCT01072175|8989533|P1|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
2599826|NCT01072175|8989521|P13|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2599827|NCT01072175|8989522|P12|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2599828|NCT01072175|8989523|P11|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2599829|NCT01072175|8989524|P10|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2599830|NCT01072175|8989525|P9|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2599831|NCT01072175|8989526|P8|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3
2599832|NCT01072175|8989527|P7|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3
2599833|NCT01072175|8989528|P6|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2599834|NCT01072175|8989529|P5|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2599835|NCT01072175|8989530|P4|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2599836|NCT01072175|8989531|P3|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2599837|NCT01072175|8989532|P2|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2599838|NCT01072175|8989533|P1|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
2599987|NCT01072149|8989742|P18|Washout Period 2 (14 Days)|Lack of Efficacy|0
2599839|NCT01072175|8989521|P13|Part C (Phase II: Randomized Phase)|Physician Decision|0
2599840|NCT01072175|8989522|P12|Part C (Phase II: Randomized Phase)|Physician Decision|0
2599841|NCT01072175|8989523|P11|Part C (Phase II: Randomized Phase)|Physician Decision|0
2599842|NCT01072175|8989524|P10|Part C (Phase II: Randomized Phase)|Physician Decision|0
2599843|NCT01072175|8989525|P9|Part C (Phase II: Randomized Phase)|Physician Decision|0
2599844|NCT01072175|8989526|P8|Part C (Phase II: Randomized Phase)|Physician Decision|1
2599845|NCT01072175|8989527|P7|Part C (Phase II: Randomized Phase)|Physician Decision|1
2599846|NCT01072175|8989528|P6|Part C (Phase II: Randomized Phase)|Physician Decision|1
2599847|NCT01072175|8989529|P5|Part C (Phase II: Randomized Phase)|Physician Decision|0
2599848|NCT01072175|8989530|P4|Part C (Phase II: Randomized Phase)|Physician Decision|0
2599849|NCT01072175|8989531|P3|Part C (Phase II: Randomized Phase)|Physician Decision|0
2599850|NCT01072175|8989532|P2|Part C (Phase II: Randomized Phase)|Physician Decision|0
2599851|NCT01072175|8989533|P1|Part C (Phase II: Randomized Phase)|Physician Decision|0
2599852|NCT01072175|8989521|P13|Part C (Phase II: Randomized Phase)|Death|0
2599853|NCT01072175|8989522|P12|Part C (Phase II: Randomized Phase)|Death|0
2599854|NCT01072175|8989523|P11|Part C (Phase II: Randomized Phase)|Death|0
2599855|NCT01072175|8989524|P10|Part C (Phase II: Randomized Phase)|Death|0
2599856|NCT01072175|8989525|P9|Part C (Phase II: Randomized Phase)|Death|0
2599857|NCT01072175|8989526|P8|Part C (Phase II: Randomized Phase)|Death|39
2599858|NCT01072175|8989527|P7|Part C (Phase II: Randomized Phase)|Death|34
2599859|NCT01072175|8989528|P6|Part C (Phase II: Randomized Phase)|Death|44
2599860|NCT01072175|8989529|P5|Part C (Phase II: Randomized Phase)|Death|0
2599861|NCT01072175|8989530|P4|Part C (Phase II: Randomized Phase)|Death|0
2599862|NCT01072175|8989531|P3|Part C (Phase II: Randomized Phase)|Death|0
2599863|NCT01072175|8989532|P2|Part C (Phase II: Randomized Phase)|Death|0
2599864|NCT01072175|8989533|P1|Part C (Phase II: Randomized Phase)|Death|0
2599865|NCT01072175|8989521|P13|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
2599866|NCT01072175|8989522|P12|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
2599867|NCT01072175|8989523|P11|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
2599868|NCT01072175|8989524|P10|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
2599869|NCT01072175|8989525|P9|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
2599870|NCT01072175|8989526|P8|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
2599871|NCT01072175|8989527|P7|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
2599872|NCT01072175|8989528|P6|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
2599873|NCT01072175|8989529|P5|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6
2599874|NCT01072175|8989530|P4|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3
2599875|NCT01072175|8989531|P3|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
2599876|NCT01072175|8989532|P2|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1
2599877|NCT01072175|8989533|P1|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
2599878|NCT01072175|8989521|P13|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
2599879|NCT01072175|8989522|P12|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
2599880|NCT01072175|8989523|P11|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
2599881|NCT01072175|8989524|P10|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
2599882|NCT01072175|8989525|P9|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
2599883|NCT01072175|8989526|P8|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
2599884|NCT01072175|8989527|P7|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
2599885|NCT01072175|8989528|P6|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
2599886|NCT01072175|8989529|P5|Part B (Dose Escalation and Expansion)|Study closed/terminated|10
2599887|NCT01072175|8989530|P4|Part B (Dose Escalation and Expansion)|Study closed/terminated|2
2599888|NCT01072175|8989531|P3|Part B (Dose Escalation and Expansion)|Study closed/terminated|3
2599889|NCT01072175|8989532|P2|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
2599890|NCT01072175|8989533|P1|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
2599891|NCT01072175|8989521|P13|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
2599892|NCT01072175|8989522|P12|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
2599893|NCT01072175|8989523|P11|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
2599894|NCT01072175|8989524|P10|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
2599895|NCT01072175|8989525|P9|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
2599896|NCT01072175|8989526|P8|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
2599897|NCT01072175|8989527|P7|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
2599898|NCT01072175|8989528|P6|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
2599899|NCT01072175|8989529|P5|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6
2599900|NCT01072175|8989530|P4|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1
2599901|NCT01072175|8989531|P3|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
2599902|NCT01072175|8989532|P2|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1
2599903|NCT01072175|8989533|P1|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
2599904|NCT01072175|8989521|P13|Part B (Dose Escalation and Expansion)|Physician Decision|0
2599905|NCT01072175|8989522|P12|Part B (Dose Escalation and Expansion)|Physician Decision|0
2599906|NCT01072175|8989523|P11|Part B (Dose Escalation and Expansion)|Physician Decision|0
2599907|NCT01072175|8989524|P10|Part B (Dose Escalation and Expansion)|Physician Decision|0
2599908|NCT01072175|8989525|P9|Part B (Dose Escalation and Expansion)|Physician Decision|0
2599909|NCT01072175|8989526|P8|Part B (Dose Escalation and Expansion)|Physician Decision|0
2599910|NCT01072175|8989527|P7|Part B (Dose Escalation and Expansion)|Physician Decision|0
2599911|NCT01072175|8989528|P6|Part B (Dose Escalation and Expansion)|Physician Decision|0
2599912|NCT01072175|8989529|P5|Part B (Dose Escalation and Expansion)|Physician Decision|4
2599913|NCT01072175|8989530|P4|Part B (Dose Escalation and Expansion)|Physician Decision|0
2599914|NCT01072175|8989531|P3|Part B (Dose Escalation and Expansion)|Physician Decision|2
2599915|NCT01072175|8989532|P2|Part B (Dose Escalation and Expansion)|Physician Decision|0
2599916|NCT01072175|8989533|P1|Part B (Dose Escalation and Expansion)|Physician Decision|0
2599917|NCT01072175|8989521|P13|Part B (Dose Escalation and Expansion)|Death|0
2599918|NCT01072175|8989522|P12|Part B (Dose Escalation and Expansion)|Death|0
2599919|NCT01072175|8989523|P11|Part B (Dose Escalation and Expansion)|Death|0
2599920|NCT01072175|8989524|P10|Part B (Dose Escalation and Expansion)|Death|0
2599921|NCT01072175|8989525|P9|Part B (Dose Escalation and Expansion)|Death|0
2599922|NCT01072175|8989526|P8|Part B (Dose Escalation and Expansion)|Death|0
2599923|NCT01072175|8989527|P7|Part B (Dose Escalation and Expansion)|Death|0
2599924|NCT01072175|8989528|P6|Part B (Dose Escalation and Expansion)|Death|0
2599925|NCT01072175|8989529|P5|Part B (Dose Escalation and Expansion)|Death|68
2599926|NCT01072175|8989530|P4|Part B (Dose Escalation and Expansion)|Death|21
2599927|NCT01072175|8989531|P3|Part B (Dose Escalation and Expansion)|Death|18
2599928|NCT01072175|8989532|P2|Part B (Dose Escalation and Expansion)|Death|4
2599929|NCT01072175|8989533|P1|Part B (Dose Escalation and Expansion)|Death|0
2599930|NCT01072175|8989521|P13|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2599931|NCT01072175|8989522|P12|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2599932|NCT01072175|8989523|P11|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2599933|NCT01072175|8989524|P10|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2599934|NCT01072175|8989525|P9|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2599935|NCT01072175|8989526|P8|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2599936|NCT01072175|8989527|P7|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2599937|NCT01072175|8989528|P6|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2599938|NCT01072175|8989529|P5|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2599939|NCT01072175|8989530|P4|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2599940|NCT01072175|8989531|P3|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2599941|NCT01072175|8989532|P2|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
2599942|NCT01072175|8989533|P1|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1
2599943|NCT01072175|8989521|P13|Part A (Drug-Drug Interaction)|Physician Decision|0
2599944|NCT01072175|8989522|P12|Part A (Drug-Drug Interaction)|Physician Decision|0
2599945|NCT01072175|8989523|P11|Part A (Drug-Drug Interaction)|Physician Decision|0
2599946|NCT01072175|8989524|P10|Part A (Drug-Drug Interaction)|Physician Decision|0
2599947|NCT01072175|8989525|P9|Part A (Drug-Drug Interaction)|Physician Decision|0
2599948|NCT01072175|8989526|P8|Part A (Drug-Drug Interaction)|Physician Decision|0
2599949|NCT01072175|8989527|P7|Part A (Drug-Drug Interaction)|Physician Decision|0
2599950|NCT01072175|8989528|P6|Part A (Drug-Drug Interaction)|Physician Decision|0
2599951|NCT01072175|8989529|P5|Part A (Drug-Drug Interaction)|Physician Decision|0
2599952|NCT01072175|8989530|P4|Part A (Drug-Drug Interaction)|Physician Decision|0
2599953|NCT01072175|8989531|P3|Part A (Drug-Drug Interaction)|Physician Decision|0
2599954|NCT01072175|8989532|P2|Part A (Drug-Drug Interaction)|Physician Decision|0
2599955|NCT01072175|8989533|P1|Part A (Drug-Drug Interaction)|Physician Decision|6
2599956|NCT01072175|8989521|P13|Part A (Drug-Drug Interaction)|Death|0
2599957|NCT01072175|8989522|P12|Part A (Drug-Drug Interaction)|Death|0
2599958|NCT01072175|8989523|P11|Part A (Drug-Drug Interaction)|Death|0
2599959|NCT01072175|8989524|P10|Part A (Drug-Drug Interaction)|Death|0
2599960|NCT01072175|8989525|P9|Part A (Drug-Drug Interaction)|Death|0
2599961|NCT01072175|8989526|P8|Part A (Drug-Drug Interaction)|Death|0
2599962|NCT01072175|8989527|P7|Part A (Drug-Drug Interaction)|Death|0
2599963|NCT01072175|8989528|P6|Part A (Drug-Drug Interaction)|Death|0
2599964|NCT01072175|8989529|P5|Part A (Drug-Drug Interaction)|Death|0
2599965|NCT01072175|8989530|P4|Part A (Drug-Drug Interaction)|Death|0
2599966|NCT01072175|8989531|P3|Part A (Drug-Drug Interaction)|Death|0
2599967|NCT01072175|8989532|P2|Part A (Drug-Drug Interaction)|Death|0
2599968|NCT01072175|8989533|P1|Part A (Drug-Drug Interaction)|Death|1
2599969|NCT01072149|8989742|P18|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2599970|NCT01072149|8989743|P17|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2599971|NCT01072149|8989744|P16|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2599972|NCT01072149|8989745|P15|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2599973|NCT01072149|8989746|P14|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
2599974|NCT01072149|8989747|P13|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2599975|NCT01072149|8989748|P12|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2599976|NCT01072149|8989749|P11|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2599977|NCT01072149|8989750|P10|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2599978|NCT01072149|8989751|P9|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2599979|NCT01072149|8989752|P8|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2599980|NCT01072149|8989753|P7|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2599981|NCT01072149|8989754|P6|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2599982|NCT01072149|8989755|P5|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2599983|NCT01072149|8989756|P4|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2599984|NCT01072149|8989757|P3|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
2599985|NCT01072149|8989758|P2|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2599986|NCT01072149|8989759|P1|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
2599988|NCT01072149|8989743|P17|Washout Period 2 (14 Days)|Lack of Efficacy|0
2599989|NCT01072149|8989744|P16|Washout Period 2 (14 Days)|Lack of Efficacy|0
2599990|NCT01072149|8989745|P15|Washout Period 2 (14 Days)|Lack of Efficacy|0
2599991|NCT01072149|8989746|P14|Washout Period 2 (14 Days)|Lack of Efficacy|0
2599992|NCT01072149|8989747|P13|Washout Period 2 (14 Days)|Lack of Efficacy|1
2599993|NCT01072149|8989748|P12|Washout Period 2 (14 Days)|Lack of Efficacy|0
2599994|NCT01072149|8989749|P11|Washout Period 2 (14 Days)|Lack of Efficacy|0
2599995|NCT01072149|8989750|P10|Washout Period 2 (14 Days)|Lack of Efficacy|0
2599996|NCT01072149|8989751|P9|Washout Period 2 (14 Days)|Lack of Efficacy|0
2599997|NCT01072149|8989752|P8|Washout Period 2 (14 Days)|Lack of Efficacy|0
2599998|NCT01072149|8989753|P7|Washout Period 2 (14 Days)|Lack of Efficacy|0
2599999|NCT01072149|8989754|P6|Washout Period 2 (14 Days)|Lack of Efficacy|0
2600000|NCT01072149|8989755|P5|Washout Period 2 (14 Days)|Lack of Efficacy|0
2600001|NCT01072149|8989756|P4|Washout Period 2 (14 Days)|Lack of Efficacy|0
2600002|NCT01072149|8989757|P3|Washout Period 2 (14 Days)|Lack of Efficacy|0
2600003|NCT01072149|8989758|P2|Washout Period 2 (14 Days)|Lack of Efficacy|0
2600004|NCT01072149|8989759|P1|Washout Period 2 (14 Days)|Lack of Efficacy|0
2600005|NCT01072149|8989742|P18|Washout Period 2 (14 Days)|Adverse Event|0
2600006|NCT01072149|8989743|P17|Washout Period 2 (14 Days)|Adverse Event|0
2600007|NCT01072149|8989744|P16|Washout Period 2 (14 Days)|Adverse Event|1
2600008|NCT01072149|8989745|P15|Washout Period 2 (14 Days)|Adverse Event|0
2600009|NCT01072149|8989746|P14|Washout Period 2 (14 Days)|Adverse Event|0
2600010|NCT01072149|8989747|P13|Washout Period 2 (14 Days)|Adverse Event|0
2600011|NCT01072149|8989748|P12|Washout Period 2 (14 Days)|Adverse Event|0
2600012|NCT01072149|8989749|P11|Washout Period 2 (14 Days)|Adverse Event|0
2600013|NCT01072149|8989750|P10|Washout Period 2 (14 Days)|Adverse Event|0
2600014|NCT01072149|8989751|P9|Washout Period 2 (14 Days)|Adverse Event|0
2600015|NCT01072149|8989752|P8|Washout Period 2 (14 Days)|Adverse Event|0
2600016|NCT01072149|8989753|P7|Washout Period 2 (14 Days)|Adverse Event|0
2600017|NCT01072149|8989754|P6|Washout Period 2 (14 Days)|Adverse Event|0
2600018|NCT01072149|8989755|P5|Washout Period 2 (14 Days)|Adverse Event|0
2600019|NCT01072149|8989756|P4|Washout Period 2 (14 Days)|Adverse Event|0
2600020|NCT01072149|8989757|P3|Washout Period 2 (14 Days)|Adverse Event|0
2600021|NCT01072149|8989758|P2|Washout Period 2 (14 Days)|Adverse Event|0
2600022|NCT01072149|8989759|P1|Washout Period 2 (14 Days)|Adverse Event|0
2600023|NCT01072149|8989742|P18|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2600024|NCT01072149|8989743|P17|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2600025|NCT01072149|8989744|P16|Washout Period 2 (14 Days)|Withdrawal by Subject|1
2600026|NCT01072149|8989745|P15|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2600027|NCT01072149|8989746|P14|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2600028|NCT01072149|8989747|P13|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2600029|NCT01072149|8989748|P12|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2600030|NCT01072149|8989749|P11|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2600031|NCT01072149|8989750|P10|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2600032|NCT01072149|8989751|P9|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2600033|NCT01072149|8989752|P8|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2600034|NCT01072149|8989753|P7|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2600035|NCT01072149|8989754|P6|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2600036|NCT01072149|8989755|P5|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2600037|NCT01072149|8989756|P4|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2600038|NCT01072149|8989757|P3|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2600039|NCT01072149|8989758|P2|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2600040|NCT01072149|8989759|P1|Washout Period 2 (14 Days)|Withdrawal by Subject|0
2600041|NCT01072149|8989742|P18|Washout Period 2 (14 Days)|Physician Decision|0
2600042|NCT01072149|8989743|P17|Washout Period 2 (14 Days)|Physician Decision|0
2600043|NCT01072149|8989744|P16|Washout Period 2 (14 Days)|Physician Decision|0
2600044|NCT01072149|8989745|P15|Washout Period 2 (14 Days)|Physician Decision|0
2600045|NCT01072149|8989746|P14|Washout Period 2 (14 Days)|Physician Decision|0
2600046|NCT01072149|8989747|P13|Washout Period 2 (14 Days)|Physician Decision|0
2600047|NCT01072149|8989748|P12|Washout Period 2 (14 Days)|Physician Decision|0
2600048|NCT01072149|8989749|P11|Washout Period 2 (14 Days)|Physician Decision|0
2600049|NCT01072149|8989750|P10|Washout Period 2 (14 Days)|Physician Decision|0
2600050|NCT01072149|8989751|P9|Washout Period 2 (14 Days)|Physician Decision|0
2600051|NCT01072149|8989752|P8|Washout Period 2 (14 Days)|Physician Decision|0
2600052|NCT01072149|8989753|P7|Washout Period 2 (14 Days)|Physician Decision|0
2600053|NCT01072149|8989754|P6|Washout Period 2 (14 Days)|Physician Decision|0
2600054|NCT01072149|8989755|P5|Washout Period 2 (14 Days)|Physician Decision|0
2600055|NCT01072149|8989756|P4|Washout Period 2 (14 Days)|Physician Decision|0
2600056|NCT01072149|8989757|P3|Washout Period 2 (14 Days)|Physician Decision|0
2600057|NCT01072149|8989758|P2|Washout Period 2 (14 Days)|Physician Decision|0
2600058|NCT01072149|8989759|P1|Washout Period 2 (14 Days)|Physician Decision|1
2600059|NCT01072149|8989742|P18|Treatment Period 2 (28 Days)|Physician Decision|0
2600060|NCT01072149|8989743|P17|Treatment Period 2 (28 Days)|Physician Decision|0
2600061|NCT01072149|8989744|P16|Treatment Period 2 (28 Days)|Physician Decision|0
2600062|NCT01072149|8989745|P15|Treatment Period 2 (28 Days)|Physician Decision|0
2600063|NCT01072149|8989746|P14|Treatment Period 2 (28 Days)|Physician Decision|0
2600064|NCT01072149|8989747|P13|Treatment Period 2 (28 Days)|Physician Decision|0
2600065|NCT01072149|8989748|P12|Treatment Period 2 (28 Days)|Physician Decision|0
2600066|NCT01072149|8989749|P11|Treatment Period 2 (28 Days)|Physician Decision|0
2600067|NCT01072149|8989750|P10|Treatment Period 2 (28 Days)|Physician Decision|0
2600068|NCT01072149|8989751|P9|Treatment Period 2 (28 Days)|Physician Decision|0
2600069|NCT01072149|8989752|P8|Treatment Period 2 (28 Days)|Physician Decision|1
2600070|NCT01072149|8989753|P7|Treatment Period 2 (28 Days)|Physician Decision|0
2600071|NCT01072149|8989754|P6|Treatment Period 2 (28 Days)|Physician Decision|0
2600072|NCT01072149|8989755|P5|Treatment Period 2 (28 Days)|Physician Decision|0
2600073|NCT01072149|8989756|P4|Treatment Period 2 (28 Days)|Physician Decision|0
2600074|NCT01072149|8989757|P3|Treatment Period 2 (28 Days)|Physician Decision|0
2600075|NCT01072149|8989758|P2|Treatment Period 2 (28 Days)|Physician Decision|0
2600076|NCT01072149|8989759|P1|Treatment Period 2 (28 Days)|Physician Decision|0
2600077|NCT01072149|8989742|P18|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2600078|NCT01072149|8989743|P17|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2600079|NCT01072149|8989744|P16|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2600080|NCT01072149|8989745|P15|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2600081|NCT01072149|8989746|P14|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2600082|NCT01072149|8989747|P13|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2600083|NCT01072149|8989748|P12|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2600084|NCT01072149|8989749|P11|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2600085|NCT01072149|8989750|P10|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2600086|NCT01072149|8989751|P9|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2600087|NCT01072149|8989752|P8|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2600088|NCT01072149|8989753|P7|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2600089|NCT01072149|8989754|P6|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2600090|NCT01072149|8989755|P5|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2600091|NCT01072149|8989756|P4|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2600092|NCT01072149|8989757|P3|Treatment Period 2 (28 Days)|Withdrawal by Subject|1
2600093|NCT01072149|8989758|P2|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2600094|NCT01072149|8989759|P1|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
2600095|NCT01072149|8989742|P18|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2600096|NCT01072149|8989743|P17|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2600097|NCT01072149|8989744|P16|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2600098|NCT01072149|8989745|P15|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2600099|NCT01072149|8989746|P14|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2600100|NCT01072149|8989747|P13|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2600101|NCT01072149|8989748|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2600102|NCT01072149|8989749|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2600103|NCT01072149|8989750|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2600104|NCT01072149|8989751|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2600105|NCT01072149|8989752|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2600106|NCT01072149|8989753|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2600107|NCT01072149|8989754|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2600108|NCT01072149|8989755|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2600109|NCT01072149|8989756|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2600110|NCT01072149|8989757|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2600111|NCT01072149|8989758|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|1
2600112|NCT01072149|8989759|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2600113|NCT01072149|8989742|P18|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2600114|NCT01072149|8989743|P17|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2600115|NCT01072149|8989744|P16|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2600116|NCT01072149|8989745|P15|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2600117|NCT01072149|8989746|P14|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2600118|NCT01072149|8989747|P13|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2600119|NCT01072149|8989748|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2600120|NCT01072149|8989749|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|1
2600121|NCT01072149|8989750|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2600122|NCT01072149|8989751|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2600123|NCT01072149|8989752|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2600124|NCT01072149|8989753|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2600125|NCT01072149|8989754|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2600126|NCT01072149|8989755|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2600127|NCT01072149|8989756|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2600128|NCT01072149|8989757|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2600129|NCT01072149|8989758|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2600130|NCT01072149|8989759|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2600131|NCT01072149|8989742|P18|Treatment Period 1 (28 Days)|Protocol Violation|1
2600132|NCT01072149|8989743|P17|Treatment Period 1 (28 Days)|Protocol Violation|0
2600133|NCT01072149|8989744|P16|Treatment Period 1 (28 Days)|Protocol Violation|0
2600134|NCT01072149|8989745|P15|Treatment Period 1 (28 Days)|Protocol Violation|0
2600135|NCT01072149|8989746|P14|Treatment Period 1 (28 Days)|Protocol Violation|0
2600136|NCT01072149|8989747|P13|Treatment Period 1 (28 Days)|Protocol Violation|0
2600137|NCT01072149|8989748|P12|Treatment Period 1 (28 Days)|Protocol Violation|0
2600138|NCT01072149|8989749|P11|Treatment Period 1 (28 Days)|Protocol Violation|0
2600139|NCT01072149|8989750|P10|Treatment Period 1 (28 Days)|Protocol Violation|0
2600140|NCT01072149|8989751|P9|Treatment Period 1 (28 Days)|Protocol Violation|0
2600141|NCT01072149|8989752|P8|Treatment Period 1 (28 Days)|Protocol Violation|0
2600142|NCT01072149|8989753|P7|Treatment Period 1 (28 Days)|Protocol Violation|0
2600143|NCT01072149|8989754|P6|Treatment Period 1 (28 Days)|Protocol Violation|0
2600144|NCT01072149|8989755|P5|Treatment Period 1 (28 Days)|Protocol Violation|0
2600145|NCT01072149|8989756|P4|Treatment Period 1 (28 Days)|Protocol Violation|0
2600146|NCT01072149|8989757|P3|Treatment Period 1 (28 Days)|Protocol Violation|0
2600147|NCT01072149|8989758|P2|Treatment Period 1 (28 Days)|Protocol Violation|0
2600148|NCT01072149|8989759|P1|Treatment Period 1 (28 Days)|Protocol Violation|0
2600149|NCT01072149|8989742|P18|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2600150|NCT01072149|8989743|P17|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2600151|NCT01072149|8989744|P16|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2600152|NCT01072149|8989745|P15|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2600153|NCT01072149|8989746|P14|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2600154|NCT01072149|8989747|P13|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2600155|NCT01072149|8989748|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2600156|NCT01072149|8989749|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2600157|NCT01072149|8989750|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2600158|NCT01072149|8989751|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2600159|NCT01072149|8989752|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2600160|NCT01072149|8989753|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2600161|NCT01072149|8989754|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2600162|NCT01072149|8989755|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2600163|NCT01072149|8989756|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2600164|NCT01072149|8989757|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
2600165|NCT01072149|8989758|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2600166|NCT01072149|8989759|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2600167|NCT01071954|8989848|P1|Overall Study|Protocol Specified Criteria|1
2600168|NCT01071954|8989848|P1|Overall Study|Administrative Decision|5
2600169|NCT01071954|8989848|P1|Overall Study|Requirement for Alternative Therapy|5
2600170|NCT01071954|8989848|P1|Overall Study|Withdrawal by Subject|11
2600171|NCT01071954|8989848|P1|Overall Study|Adverse Event|1
2600172|NCT01071954|8989848|P1|Overall Study|Noncompliance|4
2600173|NCT01071915|8989857|P1|Overall Study|Miscellaneous Reasons|2
2600174|NCT01071915|8989857|P1|Overall Study|Withdrawal by Subject|2
2600175|NCT01071915|8989857|P1|Overall Study|Physician Decision|2
2600176|NCT01071915|8989857|P1|Overall Study|Adverse Event|3
2600177|NCT01071798|8989867|P1|Subpopulation Who Received Two Cycles|Patient Requirement|7
2600178|NCT01071798|8989867|P1|Subpopulation Who Received Two Cycles|Lack of Tolerability|4
2600179|NCT01071798|8989867|P1|Subpopulation Who Received Two Cycles|Lack of Efficacy|3
2600180|NCT01071798|8989867|P1|Subpopulation Who Received Two Cycles|Remission|1
2600181|NCT01071798|8989867|P1|Participants Who Received One Cycle|Severe concomitant disease|2
2600182|NCT01071798|8989867|P1|Participants Who Received One Cycle|Change of therapy|6
2600183|NCT01071798|8989867|P1|Participants Who Received One Cycle|Death|5
2600184|NCT01071798|8989867|P1|Participants Who Received One Cycle|Patient requirement|20
2600185|NCT01071798|8989867|P1|Participants Who Received One Cycle|Lack of tolerability|14
2600186|NCT01071798|8989867|P1|Participants Who Received One Cycle|Lack of Efficacy|18
2600187|NCT01071512|8989897|P1|Overall Study|positive anti-JC virus antibody test|2
2600188|NCT01071512|8989897|P1|Overall Study|Development of antibodies to drug|2
2600189|NCT01071512|8989897|P1|Overall Study|Adverse Event|1
2600190|NCT01071395|8989907|P2|Overall Study|Adverse Event|1
2600191|NCT01071395|8989908|P1|Overall Study|Adverse Event|3
2600192|NCT01071395|8989907|P2|Overall Study|Withdrawal by Subject|1
2600193|NCT01071395|8989908|P1|Overall Study|Withdrawal by Subject|2
2600194|NCT01071317|8989927|P2|Overall Study|Lost to Follow-up|2
2600195|NCT01071317|8989928|P1|Overall Study|Lost to Follow-up|2
2600196|NCT01071278|8989940|P1|Overall Study|Completion Status Unknown|459
2600197|NCT01071278|8989940|P1|Overall Study|Premature Discontinuation|254
2600198|NCT01071252|8989951|P5|Overall Study|Death|1
2600199|NCT01071252|8989952|P4|Overall Study|Death|0
2600200|NCT01071252|8989953|P3|Overall Study|Death|0
2600201|NCT01071252|8989954|P2|Overall Study|Death|0
2600202|NCT01071252|8989955|P1|Overall Study|Death|0
2600203|NCT01071252|8989951|P5|Overall Study|Adverse Event|0
2600204|NCT01071252|8989952|P4|Overall Study|Adverse Event|1
2600205|NCT01071252|8989953|P3|Overall Study|Adverse Event|0
2600206|NCT01071252|8989954|P2|Overall Study|Adverse Event|1
2600207|NCT01071252|8989955|P1|Overall Study|Adverse Event|1
2600208|NCT01071252|8989951|P5|Overall Study|Lost to Follow-up|0
2600209|NCT01071252|8989952|P4|Overall Study|Lost to Follow-up|2
2600210|NCT01071252|8989953|P3|Overall Study|Lost to Follow-up|1
2600211|NCT01071252|8989954|P2|Overall Study|Lost to Follow-up|0
2600212|NCT01071252|8989955|P1|Overall Study|Lost to Follow-up|1
2600213|NCT01071252|8989951|P5|Overall Study|administrative problems|1
2600214|NCT01071252|8989952|P4|Overall Study|administrative problems|2
2600215|NCT01071252|8989953|P3|Overall Study|administrative problems|0
2600216|NCT01071252|8989954|P2|Overall Study|administrative problems|1
2600217|NCT01071252|8989955|P1|Overall Study|administrative problems|1
2600218|NCT01071252|8989951|P5|Overall Study|Withdrawal by Subject|3
2600219|NCT01071252|8989952|P4|Overall Study|Withdrawal by Subject|2
2600220|NCT01071252|8989953|P3|Overall Study|Withdrawal by Subject|1
2600221|NCT01071252|8989954|P2|Overall Study|Withdrawal by Subject|2
2600222|NCT01071252|8989955|P1|Overall Study|Withdrawal by Subject|8
2600223|NCT01071252|8989951|P5|Overall Study|unsatisfactory therapeutic effect|6
2600224|NCT01071252|8989952|P4|Overall Study|unsatisfactory therapeutic effect|0
2600225|NCT01071252|8989953|P3|Overall Study|unsatisfactory therapeutic effect|2
2600226|NCT01071252|8989954|P2|Overall Study|unsatisfactory therapeutic effect|6
2600227|NCT01071252|8989955|P1|Overall Study|unsatisfactory therapeutic effect|4
2600228|NCT01071200|8989983|P2|Overall Study|No viable embryos|1
2600229|NCT01071200|8989984|P1|Overall Study|No viable embryos|0
2600230|NCT01071200|8989983|P2|Overall Study|Ovarian Hyper Stimulation Syndrome|0
2600231|NCT01071200|8989984|P1|Overall Study|Ovarian Hyper Stimulation Syndrome|1
2600232|NCT01071200|8989983|P2|Overall Study|No oocytes retrieved|1
2600233|NCT01071200|8989984|P1|Overall Study|No oocytes retrieved|1
2600234|NCT01071200|8989983|P2|Overall Study|No fertilization|0
2600235|NCT01071200|8989984|P1|Overall Study|No fertilization|4
2600236|NCT01071200|8989983|P2|Overall Study|Lack of ovarian response|1
2600237|NCT01071200|8989984|P1|Overall Study|Lack of ovarian response|1
2600238|NCT01071096|8990016|P2|First Intervention (90 Days)|Lost to Follow-up|0
2600239|NCT01071096|8990017|P1|First Intervention (90 Days)|Lost to Follow-up|1
2600240|NCT01071083|8990041|P5|Overall Study|Subject Refused to Continue|0
2600241|NCT01071083|8990042|P4|Overall Study|Subject Refused to Continue|0
2600242|NCT01071083|8990043|P3|Overall Study|Subject Refused to Continue|0
2600243|NCT01071083|8990044|P2|Overall Study|Subject Refused to Continue|0
2600244|NCT01071083|8990045|P1|Overall Study|Subject Refused to Continue|1
2600245|NCT01071083|8990041|P5|Overall Study|Did Not Want Per Protocol Treatment|1
2600246|NCT01071083|8990042|P4|Overall Study|Did Not Want Per Protocol Treatment|0
2600247|NCT01071083|8990043|P3|Overall Study|Did Not Want Per Protocol Treatment|1
2600248|NCT01071083|8990044|P2|Overall Study|Did Not Want Per Protocol Treatment|0
2600249|NCT01071083|8990045|P1|Overall Study|Did Not Want Per Protocol Treatment|0
2600250|NCT01071083|8990041|P5|Overall Study|Did Not Meet Eligibility Criteria|1
2600251|NCT01071083|8990042|P4|Overall Study|Did Not Meet Eligibility Criteria|1
2600252|NCT01071083|8990043|P3|Overall Study|Did Not Meet Eligibility Criteria|1
2600253|NCT01071083|8990044|P2|Overall Study|Did Not Meet Eligibility Criteria|0
2600254|NCT01071083|8990045|P1|Overall Study|Did Not Meet Eligibility Criteria|0
2600255|NCT01071083|8990041|P5|Overall Study|Images Not Usable (Motion)|0
2600256|NCT01071083|8990042|P4|Overall Study|Images Not Usable (Motion)|0
2600257|NCT01071083|8990043|P3|Overall Study|Images Not Usable (Motion)|0
2600258|NCT01071083|8990044|P2|Overall Study|Images Not Usable (Motion)|1
2600259|NCT01071083|8990045|P1|Overall Study|Images Not Usable (Motion)|0
2600260|NCT01071083|8990041|P5|Overall Study|Subject Moved|0
2600261|NCT01071083|8990042|P4|Overall Study|Subject Moved|0
2600262|NCT01071083|8990043|P3|Overall Study|Subject Moved|0
2600263|NCT01071083|8990044|P2|Overall Study|Subject Moved|1
2600264|NCT01071083|8990045|P1|Overall Study|Subject Moved|0
2600265|NCT01071083|8990041|P5|Overall Study|Early Rescue|1
2600266|NCT01071083|8990042|P4|Overall Study|Early Rescue|0
2600267|NCT01071083|8990043|P3|Overall Study|Early Rescue|0
2600268|NCT01071083|8990044|P2|Overall Study|Early Rescue|0
2600269|NCT01071083|8990045|P1|Overall Study|Early Rescue|1
2600270|NCT01071083|8990041|P5|Overall Study|Physician Decision|1
2600271|NCT01071083|8990042|P4|Overall Study|Physician Decision|1
2600272|NCT01071083|8990043|P3|Overall Study|Physician Decision|0
2600273|NCT01071083|8990044|P2|Overall Study|Physician Decision|0
2600274|NCT01071083|8990045|P1|Overall Study|Physician Decision|1
2600275|NCT01071083|8990041|P5|Overall Study|Withdrawal by Subject|3
2600276|NCT01071083|8990042|P4|Overall Study|Withdrawal by Subject|0
2600277|NCT01071083|8990043|P3|Overall Study|Withdrawal by Subject|2
2600278|NCT01071083|8990044|P2|Overall Study|Withdrawal by Subject|0
2600279|NCT01071083|8990045|P1|Overall Study|Withdrawal by Subject|3
2600280|NCT01071083|8990041|P5|Overall Study|Adverse Event|1
2600281|NCT01071083|8990042|P4|Overall Study|Adverse Event|0
2600282|NCT01071083|8990043|P3|Overall Study|Adverse Event|1
2600283|NCT01071083|8990044|P2|Overall Study|Adverse Event|0
2600284|NCT01071083|8990045|P1|Overall Study|Adverse Event|1
2600285|NCT01071070|8990064|P2|Overall Study|Hypercalcemia|0
2600286|NCT01071070|8990065|P1|Overall Study|Hypercalcemia|1
2600287|NCT01071070|8990064|P2|Overall Study|Missed 3 consecutive doses of study drug|0
2600288|NCT01071070|8990065|P1|Overall Study|Missed 3 consecutive doses of study drug|2
2600289|NCT01071070|8990064|P2|Overall Study|Withdrawal by Subject|0
2600290|NCT01071070|8990065|P1|Overall Study|Withdrawal by Subject|1
2600291|NCT01071070|8990064|P2|Overall Study|Adverse Event|3
2600292|NCT01071070|8990065|P1|Overall Study|Adverse Event|0
2600293|NCT01070979|8990111|P3|Overall Study|No study drug taken|0
2600294|NCT01070979|8990112|P2|Overall Study|No study drug taken|1
2600295|NCT01070979|8990113|P1|Overall Study|No study drug taken|0
2600296|NCT01070979|8990111|P3|Overall Study|Withdrawal by Subject|1
2600297|NCT01070979|8990112|P2|Overall Study|Withdrawal by Subject|1
2600298|NCT01070979|8990113|P1|Overall Study|Withdrawal by Subject|3
2600299|NCT01070979|8990111|P3|Overall Study|Surgery, moving, personal, abn. labs|2
2600300|NCT01070979|8990112|P2|Overall Study|Surgery, moving, personal, abn. labs|4
2600301|NCT01070979|8990113|P1|Overall Study|Surgery, moving, personal, abn. labs|4
2600302|NCT01070979|8990111|P3|Overall Study|Protocol Violation|6
2600303|NCT01070979|8990112|P2|Overall Study|Protocol Violation|2
2600304|NCT01070979|8990113|P1|Overall Study|Protocol Violation|0
2600305|NCT01070979|8990111|P3|Overall Study|Lost to Follow-up|1
2600306|NCT01070979|8990112|P2|Overall Study|Lost to Follow-up|1
2600307|NCT01070979|8990113|P1|Overall Study|Lost to Follow-up|2
2600308|NCT01070979|8990111|P3|Overall Study|Adverse Event|3
2600309|NCT01070979|8990112|P2|Overall Study|Adverse Event|3
2600310|NCT01070979|8990113|P1|Overall Study|Adverse Event|2
2600311|NCT01070966|8990139|P1|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2
2600312|NCT01070966|8990139|P1|Participants for Efficacy Evaluation|No efficacy evaluation|19
2600313|NCT01070966|8990139|P1|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61
2600314|NCT01070966|8990139|P1|Participants for Safety Evaluation|TMT given before date of contract|3
2600315|NCT01070966|8990139|P1|Participants for Safety Evaluation|Violation inclusion criteria/off label|3
2600316|NCT01070966|8990139|P1|Participants for Safety Evaluation|Duplicate Participants|4
2600317|NCT01070966|8990139|P1|Participants for Safety Evaluation|Off-label use|9
2600318|NCT01070966|8990139|P1|Participants for Safety Evaluation|Violation of inclusion criteria|59
2600319|NCT01070953|8990150|P1|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2
2600320|NCT01070953|8990150|P1|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106
2600321|NCT01070953|8990150|P1|Participants for Efficacy Evaluation|No efficacy evaluation|119
2600322|NCT01070953|8990150|P1|Participants for Safety Evaluation|Duplicated participants & off-label use|1
2600323|NCT01070953|8990150|P1|Participants for Safety Evaluation|Violation of inclusions & off label use|1
2600324|NCT01070953|8990150|P1|Participants for Safety Evaluation|Uncontracted participants|4
2600325|NCT01070953|8990150|P1|Participants for Safety Evaluation|Treatment prior to date of contract|8
2600326|NCT01070953|8990150|P1|Participants for Safety Evaluation|Duplicated participants|22
2600327|NCT01070953|8990150|P1|Participants for Safety Evaluation|Off-label use|283
2600328|NCT01070953|8990150|P1|Participants for Safety Evaluation|Violation of inclusion criteria|612
2600329|NCT01070888|8990163|P2|Washout (14 Days)|Physician Decision|0
2600330|NCT01070888|8990164|P1|Washout (14 Days)|Physician Decision|1
2600331|NCT01070888|8990163|P2|First Intervention (14 Days)|Lost to Follow-up|1
2600332|NCT01070888|8990164|P1|First Intervention (14 Days)|Lost to Follow-up|0
2600333|NCT01070888|8990163|P2|First Intervention (14 Days)|Adverse Event|1
2600334|NCT01070888|8990164|P1|First Intervention (14 Days)|Adverse Event|0
2600335|NCT01070784|8990189|P2|Overall Study|Adverse Event|9
2600336|NCT01070784|8990190|P1|Overall Study|Adverse Event|14
2600337|NCT01070784|8990189|P2|Overall Study|Withdrawal by Subject|9
2600338|NCT01070784|8990190|P1|Overall Study|Withdrawal by Subject|6
2600339|NCT01070771|8990278|P1|Overall Study|Protocol Violation|1
2600340|NCT01070771|8990278|P1|Overall Study|Adverse Event|2
2600341|NCT01070550|8990298|P6|Overall Study|Withdrawal by Subject|0
2600342|NCT01070550|8990299|P5|Overall Study|Withdrawal by Subject|0
2600343|NCT01070550|8990300|P4|Overall Study|Withdrawal by Subject|0
2600344|NCT01070550|8990301|P3|Overall Study|Withdrawal by Subject|3
2600345|NCT01070550|8990302|P2|Overall Study|Withdrawal by Subject|0
2600346|NCT01070550|8990303|P1|Overall Study|Withdrawal by Subject|35
2600347|NCT01070550|8990298|P6|Overall Study|Other|0
2600348|NCT01070550|8990299|P5|Overall Study|Other|0
2600349|NCT01070550|8990300|P4|Overall Study|Other|1
2600350|NCT01070550|8990301|P3|Overall Study|Other|0
2600351|NCT01070550|8990302|P2|Overall Study|Other|0
2600352|NCT01070550|8990303|P1|Overall Study|Other|5
2600353|NCT01070550|8990298|P6|Overall Study|Treatment was stopped early|0
2600354|NCT01070550|8990299|P5|Overall Study|Treatment was stopped early|0
2600355|NCT01070550|8990300|P4|Overall Study|Treatment was stopped early|0
2600356|NCT01070550|8990301|P3|Overall Study|Treatment was stopped early|0
2600357|NCT01070550|8990302|P2|Overall Study|Treatment was stopped early|0
2600358|NCT01070550|8990303|P1|Overall Study|Treatment was stopped early|7
2600359|NCT01070550|8990298|P6|Overall Study|Treatment unavailable|0
2600360|NCT01070550|8990299|P5|Overall Study|Treatment unavailable|0
2600361|NCT01070550|8990300|P4|Overall Study|Treatment unavailable|0
2600362|NCT01070550|8990301|P3|Overall Study|Treatment unavailable|0
2600363|NCT01070550|8990302|P2|Overall Study|Treatment unavailable|0
2600364|NCT01070550|8990303|P1|Overall Study|Treatment unavailable|1
2600365|NCT01070550|8990298|P6|Overall Study|Treatment stopped|0
2600366|NCT01070550|8990299|P5|Overall Study|Treatment stopped|0
2600367|NCT01070550|8990300|P4|Overall Study|Treatment stopped|0
2600368|NCT01070550|8990301|P3|Overall Study|Treatment stopped|0
2600369|NCT01070550|8990302|P2|Overall Study|Treatment stopped|0
2600370|NCT01070550|8990303|P1|Overall Study|Treatment stopped|3
2600371|NCT01070550|8990298|P6|Overall Study|Treatment restarted|0
2600372|NCT01070550|8990299|P5|Overall Study|Treatment restarted|0
2600373|NCT01070550|8990300|P4|Overall Study|Treatment restarted|0
2600374|NCT01070550|8990301|P3|Overall Study|Treatment restarted|0
2600375|NCT01070550|8990302|P2|Overall Study|Treatment restarted|1
2600376|NCT01070550|8990303|P1|Overall Study|Treatment restarted|0
2600377|NCT01070550|8990298|P6|Overall Study|Treatment not started|0
2600378|NCT01070550|8990299|P5|Overall Study|Treatment not started|0
2600379|NCT01070550|8990300|P4|Overall Study|Treatment not started|0
2600380|NCT01070550|8990301|P3|Overall Study|Treatment not started|4
2600381|NCT01070550|8990302|P2|Overall Study|Treatment not started|2
2600382|NCT01070550|8990303|P1|Overall Study|Treatment not started|14
2600383|NCT01070550|8990298|P6|Overall Study|Treatment interrupted|0
2600384|NCT01070550|8990299|P5|Overall Study|Treatment interrupted|0
2600385|NCT01070550|8990300|P4|Overall Study|Treatment interrupted|1
2600386|NCT01070550|8990301|P3|Overall Study|Treatment interrupted|1
2600387|NCT01070550|8990302|P2|Overall Study|Treatment interrupted|0
2600388|NCT01070550|8990303|P1|Overall Study|Treatment interrupted|7
2600389|NCT01070550|8990298|P6|Overall Study|Treatment duration shortened|0
2600390|NCT01070550|8990299|P5|Overall Study|Treatment duration shortened|0
2600391|NCT01070550|8990300|P4|Overall Study|Treatment duration shortened|0
2600392|NCT01070550|8990301|P3|Overall Study|Treatment duration shortened|0
2600393|NCT01070550|8990302|P2|Overall Study|Treatment duration shortened|0
2600394|NCT01070550|8990303|P1|Overall Study|Treatment duration shortened|1
2600395|NCT01070550|8990298|P6|Overall Study|Sponsor decision|0
2600396|NCT01070550|8990299|P5|Overall Study|Sponsor decision|0
2600397|NCT01070550|8990300|P4|Overall Study|Sponsor decision|0
2600398|NCT01070550|8990301|P3|Overall Study|Sponsor decision|0
2600399|NCT01070550|8990302|P2|Overall Study|Sponsor decision|0
2600400|NCT01070550|8990303|P1|Overall Study|Sponsor decision|1
2600401|NCT01070550|8990298|P6|Overall Study|Screen failure|0
2600402|NCT01070550|8990299|P5|Overall Study|Screen failure|0
2600403|NCT01070550|8990300|P4|Overall Study|Screen failure|0
2600404|NCT01070550|8990301|P3|Overall Study|Screen failure|0
2600405|NCT01070550|8990302|P2|Overall Study|Screen failure|0
2600406|NCT01070550|8990303|P1|Overall Study|Screen failure|1
2600407|NCT01070550|8990298|P6|Overall Study|Result not available|0
2600408|NCT01070550|8990299|P5|Overall Study|Result not available|0
2600409|NCT01070550|8990300|P4|Overall Study|Result not available|0
2600410|NCT01070550|8990301|P3|Overall Study|Result not available|3
2600411|NCT01070550|8990302|P2|Overall Study|Result not available|1
2600412|NCT01070550|8990303|P1|Overall Study|Result not available|3
2600413|NCT01070550|8990298|P6|Overall Study|Relapse|0
2600414|NCT01070550|8990299|P5|Overall Study|Relapse|0
2600415|NCT01070550|8990300|P4|Overall Study|Relapse|4
2600416|NCT01070550|8990301|P3|Overall Study|Relapse|14
2600417|NCT01070550|8990302|P2|Overall Study|Relapse|5
2600418|NCT01070550|8990303|P1|Overall Study|Relapse|44
2600419|NCT01070550|8990298|P6|Overall Study|Protocol Violation|0
2600420|NCT01070550|8990299|P5|Overall Study|Protocol Violation|0
2600421|NCT01070550|8990300|P4|Overall Study|Protocol Violation|1
2600422|NCT01070550|8990301|P3|Overall Study|Protocol Violation|1
2600423|NCT01070550|8990302|P2|Overall Study|Protocol Violation|1
2600424|NCT01070550|8990303|P1|Overall Study|Protocol Violation|15
2600425|NCT01070550|8990298|P6|Overall Study|Not categorized|1
2600426|NCT01070550|8990299|P5|Overall Study|Not categorized|0
2600427|NCT01070550|8990300|P4|Overall Study|Not categorized|1
2600428|NCT01070550|8990301|P3|Overall Study|Not categorized|6
2600429|NCT01070550|8990302|P2|Overall Study|Not categorized|2
2600430|NCT01070550|8990303|P1|Overall Study|Not categorized|33
2600431|NCT01070550|8990298|P6|Overall Study|Non-responders|2
2600432|NCT01070550|8990299|P5|Overall Study|Non-responders|0
2600433|NCT01070550|8990300|P4|Overall Study|Non-responders|20
2600434|NCT01070550|8990301|P3|Overall Study|Non-responders|21
2600435|NCT01070550|8990302|P2|Overall Study|Non-responders|4
2600436|NCT01070550|8990303|P1|Overall Study|Non-responders|493
2600437|NCT01070550|8990298|P6|Overall Study|New treatment started|0
2600438|NCT01070550|8990299|P5|Overall Study|New treatment started|0
2600439|NCT01070550|8990300|P4|Overall Study|New treatment started|2
2600440|NCT01070550|8990301|P3|Overall Study|New treatment started|0
2600441|NCT01070550|8990302|P2|Overall Study|New treatment started|1
2600442|NCT01070550|8990303|P1|Overall Study|New treatment started|3
2600443|NCT01070550|8990298|P6|Overall Study|Miscellaneous|0
2600444|NCT01070550|8990299|P5|Overall Study|Miscellaneous|0
2600445|NCT01070550|8990300|P4|Overall Study|Miscellaneous|1
2600446|NCT01070550|8990301|P3|Overall Study|Miscellaneous|3
2600447|NCT01070550|8990302|P2|Overall Study|Miscellaneous|2
2600448|NCT01070550|8990303|P1|Overall Study|Miscellaneous|12
2600449|NCT01070550|8990298|P6|Overall Study|Lack of Efficacy|1
2600450|NCT01070550|8990299|P5|Overall Study|Lack of Efficacy|0
2600451|NCT01070550|8990300|P4|Overall Study|Lack of Efficacy|5
2600452|NCT01070550|8990301|P3|Overall Study|Lack of Efficacy|5
2600453|NCT01070550|8990302|P2|Overall Study|Lack of Efficacy|1
2600454|NCT01070550|8990303|P1|Overall Study|Lack of Efficacy|65
2600455|NCT01070550|8990298|P6|Overall Study|Lab test not done|1
2600456|NCT01070550|8990299|P5|Overall Study|Lab test not done|0
2600457|NCT01070550|8990300|P4|Overall Study|Lab test not done|1
2600458|NCT01070550|8990301|P3|Overall Study|Lab test not done|4
2600459|NCT01070550|8990302|P2|Overall Study|Lab test not done|3
2600460|NCT01070550|8990303|P1|Overall Study|Lab test not done|22
2600461|NCT01070550|8990298|P6|Overall Study|Incomplete treatment|0
2600462|NCT01070550|8990299|P5|Overall Study|Incomplete treatment|0
2600463|NCT01070550|8990300|P4|Overall Study|Incomplete treatment|0
2600464|NCT01070550|8990301|P3|Overall Study|Incomplete treatment|0
2600465|NCT01070550|8990302|P2|Overall Study|Incomplete treatment|0
2600466|NCT01070550|8990303|P1|Overall Study|Incomplete treatment|2
2600467|NCT01070550|8990298|P6|Overall Study|Failed to return|2
2600468|NCT01070550|8990299|P5|Overall Study|Failed to return|1
2600469|NCT01070550|8990300|P4|Overall Study|Failed to return|40
2600470|NCT01070550|8990301|P3|Overall Study|Failed to return|144
2600471|NCT01070550|8990302|P2|Overall Study|Failed to return|33
2600472|NCT01070550|8990303|P1|Overall Study|Failed to return|450
2600473|NCT01070550|8990298|P6|Overall Study|Early termination|0
2600474|NCT01070550|8990299|P5|Overall Study|Early termination|0
2600475|NCT01070550|8990300|P4|Overall Study|Early termination|0
2600476|NCT01070550|8990301|P3|Overall Study|Early termination|0
2600477|NCT01070550|8990302|P2|Overall Study|Early termination|0
2600478|NCT01070550|8990303|P1|Overall Study|Early termination|3
2600479|NCT01070550|8990298|P6|Overall Study|Not meeting inclusion/exclusion criteria|0
2600480|NCT01070550|8990299|P5|Overall Study|Not meeting inclusion/exclusion criteria|0
2600481|NCT01070550|8990300|P4|Overall Study|Not meeting inclusion/exclusion criteria|0
2600482|NCT01070550|8990301|P3|Overall Study|Not meeting inclusion/exclusion criteria|1
2600483|NCT01070550|8990302|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
2600484|NCT01070550|8990303|P1|Overall Study|Not meeting inclusion/exclusion criteria|2
2600485|NCT01070550|8990298|P6|Overall Study|Death|0
2600486|NCT01070550|8990299|P5|Overall Study|Death|0
2600487|NCT01070550|8990300|P4|Overall Study|Death|0
2600488|NCT01070550|8990301|P3|Overall Study|Death|3
2600489|NCT01070550|8990302|P2|Overall Study|Death|4
2600490|NCT01070550|8990303|P1|Overall Study|Death|20
2600491|NCT01070550|8990298|P6|Overall Study|Adverse Event|0
2600492|NCT01070550|8990299|P5|Overall Study|Adverse Event|0
2600493|NCT01070550|8990300|P4|Overall Study|Adverse Event|0
2600494|NCT01070550|8990301|P3|Overall Study|Adverse Event|3
2600495|NCT01070550|8990302|P2|Overall Study|Adverse Event|1
2600496|NCT01070550|8990303|P1|Overall Study|Adverse Event|43
2600497|NCT01070394|8990443|P1|Overall Study|Withdrawal by Subject|1
2600498|NCT01070394|8990443|P1|Overall Study|Adverse Event|6
2600499|NCT01070381|8990454|P2|Period 2, 1 Week of Wear|Unacceptable Vision|0
2600500|NCT01070381|8990455|P1|Period 2, 1 Week of Wear|Unacceptable Vision|1
2600501|NCT01070381|8990454|P2|Period 2, 1 Week of Wear|Handling|1
2600502|NCT01070381|8990455|P1|Period 2, 1 Week of Wear|Handling|0
2600503|NCT01070329|8990463|P2|Overall Study|Sponsor Decision|1
2600504|NCT01070329|8990464|P1|Overall Study|Sponsor Decision|0
2600505|NCT01070329|8990463|P2|Overall Study|Entry Criteria Not Met|0
2600506|NCT01070329|8990464|P1|Overall Study|Entry Criteria Not Met|1
2600507|NCT01070329|8990463|P2|Overall Study|Physician Decision|1
2600508|NCT01070329|8990464|P1|Overall Study|Physician Decision|2
2600509|NCT01070329|8990463|P2|Overall Study|Lack of Efficacy|6
2600510|NCT01070329|8990464|P1|Overall Study|Lack of Efficacy|2
2600511|NCT01070329|8990463|P2|Overall Study|Protocol Violation|8
2600512|NCT01070329|8990464|P1|Overall Study|Protocol Violation|3
2600513|NCT01070329|8990463|P2|Overall Study|Withdrawal by Subject|11
2600514|NCT01070329|8990464|P1|Overall Study|Withdrawal by Subject|9
2600515|NCT01070329|8990463|P2|Overall Study|Lost to Follow-up|12
2600516|NCT01070329|8990464|P1|Overall Study|Lost to Follow-up|22
2600517|NCT01070329|8990463|P2|Overall Study|Adverse Event|10
2600518|NCT01070329|8990464|P1|Overall Study|Adverse Event|13
2600519|NCT01070316|8990496|P1|Extension Phase|Withdrawal by Subject|1
2600520|NCT01070316|8990496|P1|Extension Phase|Lack of Efficacy|3
2600521|NCT01070303|8990503|P1|Overall Study|Other|18
2600522|NCT01070303|8990503|P1|Overall Study|Administrative Reason|1
2600523|NCT01070303|8990503|P1|Overall Study|Lack of Efficacy|2
2600524|NCT01070303|8990503|P1|Overall Study|Protocol Violation|0
2600525|NCT01070303|8990503|P1|Overall Study|Lost to Follow-up|9
2600526|NCT01070303|8990503|P1|Overall Study|Withdrawal by Subject|20
2600527|NCT01070303|8990503|P1|Overall Study|Adverse Event|39
2600528|NCT01070043|8990598|P3|Double-Blind Treatment|Adverse Event|2
2600529|NCT01070043|8990599|P2|Double-Blind Treatment|Adverse Event|0
2600530|NCT01070043|8990600|P1|Double-Blind Treatment|Adverse Event|0
2600531|NCT01070043|8990598|P3|Run-In Phase|Did not Meet Inclusion Criteria|0
2600532|NCT01070043|8990599|P2|Run-In Phase|Did not Meet Inclusion Criteria|0
2600533|NCT01070043|8990600|P1|Run-In Phase|Did not Meet Inclusion Criteria|18
2600534|NCT01069939|8990616|P2|Randomised and Included in the Analyses|Removal|0
2600535|NCT01069939|8990617|P1|Randomised and Included in the Analyses|Removal|1
2600536|NCT01069939|8990616|P2|Randomised and Included in the Analyses|Physician Decision|2
2600537|NCT01069939|8990617|P1|Randomised and Included in the Analyses|Physician Decision|0
2600538|NCT01069939|8990616|P2|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2
2600539|NCT01069939|8990617|P1|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4
2600540|NCT01069939|8990616|P2|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3
2600541|NCT01069939|8990617|P1|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4
2600542|NCT01069939|8990616|P2|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33
2600543|NCT01069939|8990617|P1|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7
2600544|NCT01069939|8990616|P2|Randomised and Included in the Analyses|Lack of Efficacy|1
2600545|NCT01069939|8990617|P1|Randomised and Included in the Analyses|Lack of Efficacy|0
2600546|NCT01069939|8990616|P2|Randomised and Included in the Analyses|Protocol Violation|1
2600547|NCT01069939|8990617|P1|Randomised and Included in the Analyses|Protocol Violation|0
2600548|NCT01069939|8990616|P2|Randomised and Included in the Analyses|Lost to Follow-up|1
2600549|NCT01069939|8990617|P1|Randomised and Included in the Analyses|Lost to Follow-up|1
2600550|NCT01069939|8990616|P2|Randomised and Included in the Analyses|Withdrawal by Subject|12
2600551|NCT01069939|8990617|P1|Randomised and Included in the Analyses|Withdrawal by Subject|15
2600552|NCT01069939|8990616|P2|Randomised and Included in the Analyses|Adverse Event|22
2600553|NCT01069939|8990617|P1|Randomised and Included in the Analyses|Adverse Event|17
2600554|NCT01069900|8990643|P2|Overall Study|Insufficient Therapeutic effect|0
2600555|NCT01069900|8990644|P1|Overall Study|Insufficient Therapeutic effect|1
2600556|NCT01069900|8990643|P2|Overall Study|Protocol Violation|1
2600557|NCT01069900|8990644|P1|Overall Study|Protocol Violation|4
2600558|NCT01069900|8990643|P2|Overall Study|Withdrawal by Subject|1
2600559|NCT01069900|8990644|P1|Overall Study|Withdrawal by Subject|6
2600560|NCT01069900|8990643|P2|Overall Study|Lost to Follow-up|1
2600561|NCT01069900|8990644|P1|Overall Study|Lost to Follow-up|7
2600562|NCT01069900|8990643|P2|Overall Study|Technical problems|1
2600563|NCT01069900|8990644|P1|Overall Study|Technical problems|0
2600564|NCT01069861|8990688|P1|Overall Study|Did not meet entrance criteria|1
2600565|NCT01069861|8990688|P1|Overall Study|Adverse Event|1
2600566|NCT01069861|8990688|P1|Overall Study|Death|1
2600567|NCT01069627|8990701|P1|Overall Study|Protocol Violation|1
2600568|NCT01069627|8990701|P1|Overall Study|Adverse Event|12
2600569|NCT01069627|8990701|P1|Overall Study|Disease progression|7
2600570|NCT01069523|8990751|P2|Overall Study|Withdrawal by Subject|7
2600571|NCT01069523|8990752|P1|Overall Study|Withdrawal by Subject|4
2600572|NCT01069484|8990775|P2|Overall Study|Illness mother or child|1
2600573|NCT01069484|8990776|P1|Overall Study|Illness mother or child|3
2600574|NCT01069484|8990775|P2|Overall Study|No specific reason|2
2600575|NCT01069484|8990776|P1|Overall Study|No specific reason|8
2600576|NCT01069484|8990775|P2|Overall Study|Death-in-near-family|0
2600577|NCT01069484|8990776|P1|Overall Study|Death-in-near-family|1
2600578|NCT01069419|8990784|P1|Overall Study|Missing termination information|13
2600579|NCT01069419|8990784|P1|Overall Study|Other Reason|43
2600580|NCT01069419|8990784|P1|Overall Study|Withdrawal by Subject|34
2600581|NCT01069419|8990784|P1|Overall Study|Remission of disease|11
2600582|NCT01069419|8990784|P1|Overall Study|Lost to Follow-up|49
2600583|NCT01069419|8990784|P1|Overall Study|Lack of Efficacy|332
2600584|NCT01069419|8990784|P1|Overall Study|Adverse Event|233
2600585|NCT01069341|8990813|P1|Overall Study|Lost to Follow-up|1
2600586|NCT01069289|8990855|P2|Overall Study|Due to deteriorating health condition|0
2600587|NCT01069289|8990856|P1|Overall Study|Due to deteriorating health condition|1
2600588|NCT01069289|8990855|P2|Overall Study|Severe non-compliance to protocol|2
2600589|NCT01069289|8990856|P1|Overall Study|Severe non-compliance to protocol|3
2600590|NCT01069289|8990855|P2|Overall Study|Eligibility criteria not fulfilled|0
2600591|NCT01069289|8990856|P1|Overall Study|Eligibility criteria not fulfilled|2
2600592|NCT01069289|8990855|P2|Overall Study|Adverse Event|28
2600593|NCT01069289|8990856|P1|Overall Study|Adverse Event|21
2600594|NCT01069289|8990855|P2|Overall Study|Withdrawal by Subject|26
2600595|NCT01069289|8990856|P1|Overall Study|Withdrawal by Subject|15
2600596|NCT01069172|8990905|P2|Overall Study|Withdrawal by Subject|0
2600597|NCT01069172|8990906|P1|Overall Study|Withdrawal by Subject|1
2600598|NCT01069120|8990916|P1|Overall Study|Study prematurely terminated|27
2600599|NCT01068912|8990953|P3|Overall Study|other underlying illness|3
2600600|NCT01068912|8990954|P2|Overall Study|other underlying illness|3
2600601|NCT01068912|8990955|P1|Overall Study|other underlying illness|0
2600602|NCT01068912|8990953|P3|Overall Study|aggravation influenza|1
2600603|NCT01068912|8990954|P2|Overall Study|aggravation influenza|1
2600604|NCT01068912|8990955|P1|Overall Study|aggravation influenza|1
2600605|NCT01068912|8990953|P3|Overall Study|Protocol Violation|0
2600606|NCT01068912|8990954|P2|Overall Study|Protocol Violation|2
2600607|NCT01068912|8990955|P1|Overall Study|Protocol Violation|0
2600608|NCT01068912|8990953|P3|Overall Study|Lost to Follow-up|3
2600609|NCT01068912|8990954|P2|Overall Study|Lost to Follow-up|7
2600610|NCT01068912|8990955|P1|Overall Study|Lost to Follow-up|3
2600611|NCT01068912|8990953|P3|Overall Study|Withdrawal by Subject|6
2600612|NCT01068912|8990954|P2|Overall Study|Withdrawal by Subject|6
2600613|NCT01068912|8990955|P1|Overall Study|Withdrawal by Subject|5
2600614|NCT01068912|8990953|P3|Overall Study|Adverse Event|2
2600615|NCT01068912|8990954|P2|Overall Study|Adverse Event|3
2600616|NCT01068912|8990955|P1|Overall Study|Adverse Event|2
2600617|NCT01068860|8990973|P10|Overall Study|Lost to Follow-up|0
2600618|NCT01068860|8990974|P9|Overall Study|Lost to Follow-up|0
2600619|NCT01068860|8990975|P8|Overall Study|Lost to Follow-up|0
2600620|NCT01068860|8990976|P7|Overall Study|Lost to Follow-up|0
2600621|NCT01068860|8990977|P6|Overall Study|Lost to Follow-up|0
2600622|NCT01068860|8990978|P5|Overall Study|Lost to Follow-up|0
2600623|NCT01068860|8990979|P4|Overall Study|Lost to Follow-up|0
2600624|NCT01068860|8990980|P3|Overall Study|Lost to Follow-up|0
2600625|NCT01068860|8990981|P2|Overall Study|Lost to Follow-up|1
2600626|NCT01068860|8990982|P1|Overall Study|Lost to Follow-up|0
2600627|NCT01068860|8990973|P10|Overall Study|Administrative problems; misrandomized|1
2600628|NCT01068860|8990974|P9|Overall Study|Administrative problems; misrandomized|0
2600629|NCT01068860|8990975|P8|Overall Study|Administrative problems; misrandomized|0
2600630|NCT01068860|8990976|P7|Overall Study|Administrative problems; misrandomized|0
2600631|NCT01068860|8990977|P6|Overall Study|Administrative problems; misrandomized|0
2600632|NCT01068860|8990978|P5|Overall Study|Administrative problems; misrandomized|0
2600633|NCT01068860|8990979|P4|Overall Study|Administrative problems; misrandomized|1
2600634|NCT01068860|8990980|P3|Overall Study|Administrative problems; misrandomized|0
2600635|NCT01068860|8990981|P2|Overall Study|Administrative problems; misrandomized|0
2600636|NCT01068860|8990982|P1|Overall Study|Administrative problems; misrandomized|0
2600637|NCT01068860|8990973|P10|Overall Study|Withdrawal by Subject|3
2600638|NCT01068860|8990974|P9|Overall Study|Withdrawal by Subject|0
2600639|NCT01068860|8990975|P8|Overall Study|Withdrawal by Subject|0
2600640|NCT01068860|8990976|P7|Overall Study|Withdrawal by Subject|0
2600641|NCT01068860|8990977|P6|Overall Study|Withdrawal by Subject|2
2600642|NCT01068860|8990978|P5|Overall Study|Withdrawal by Subject|0
2600643|NCT01068860|8990979|P4|Overall Study|Withdrawal by Subject|0
2600644|NCT01068860|8990980|P3|Overall Study|Withdrawal by Subject|0
2600645|NCT01068860|8990981|P2|Overall Study|Withdrawal by Subject|0
2600646|NCT01068860|8990982|P1|Overall Study|Withdrawal by Subject|0
2600647|NCT01068769|8991165|P1|Overall Study|Ineligible|1
2600648|NCT01068743|8991170|P4|Period 3|Adverse Event|0
2600649|NCT01068743|8991171|P3|Period 3|Adverse Event|0
2600650|NCT01068743|8991172|P2|Period 3|Adverse Event|1
2600651|NCT01068743|8991173|P1|Period 3|Adverse Event|0
2600652|NCT01068730|8991247|P4|Period 4|Family emergency|0
2600653|NCT01068730|8991248|P3|Period 4|Family emergency|0
2600654|NCT01068730|8991249|P2|Period 4|Family emergency|1
2600655|NCT01068730|8991250|P1|Period 4|Family emergency|0
2600656|NCT01068730|8991247|P4|Period 3|Personal reason|0
2600657|NCT01068730|8991248|P3|Period 3|Personal reason|0
2600658|NCT01068730|8991249|P2|Period 3|Personal reason|0
2600659|NCT01068730|8991250|P1|Period 3|Personal reason|1
2600660|NCT01068717|8991304|P4|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
2600661|NCT01068717|8991305|P3|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
2600662|NCT01068717|8991306|P2|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
2600663|NCT01068717|8991307|P1|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1
2600664|NCT01068678|8991363|P2|Overall Study|Unclassified|15
2600665|NCT01068678|8991364|P1|Overall Study|Unclassified|18
2600666|NCT01068678|8991363|P2|Overall Study|Withdrawal criteria|6
2600667|NCT01068678|8991364|P1|Overall Study|Withdrawal criteria|12
2600668|NCT01068678|8991363|P2|Overall Study|Protocol Violation|1
2600669|NCT01068678|8991364|P1|Overall Study|Protocol Violation|5
2600670|NCT01068678|8991363|P2|Overall Study|Lack of Efficacy|2
2600671|NCT01068678|8991364|P1|Overall Study|Lack of Efficacy|3
2600672|NCT01068665|8991374|P2|Overall Study|Other|12
2600673|NCT01068665|8991375|P1|Overall Study|Other|17
2600674|NCT01068665|8991374|P2|Overall Study|Withdrawal Criteria|9
2600675|NCT01068665|8991375|P1|Overall Study|Withdrawal Criteria|3
2600676|NCT01068665|8991374|P2|Overall Study|Protocol Violation|2
2600677|NCT01068665|8991375|P1|Overall Study|Protocol Violation|5
2600678|NCT01068665|8991374|P2|Overall Study|Lack of Efficacy|2
2600679|NCT01068665|8991375|P1|Overall Study|Lack of Efficacy|0
2600680|NCT01068665|8991374|P2|Overall Study|Adverse Event|4
2600681|NCT01068665|8991375|P1|Overall Study|Adverse Event|5
2600682|NCT01068652|8991385|P2|Overall Study|Unclassified|4
2600683|NCT01068652|8991386|P1|Overall Study|Unclassified|7
2600684|NCT01068652|8991385|P2|Overall Study|Patient was not eligible|0
2600685|NCT01068652|8991386|P1|Overall Study|Patient was not eligible|1
2600686|NCT01068652|8991385|P2|Overall Study|Withdrawal criteria|2
2600687|NCT01068652|8991386|P1|Overall Study|Withdrawal criteria|1
2600688|NCT01068652|8991385|P2|Overall Study|Protocol Violation|6
2600689|NCT01068652|8991386|P1|Overall Study|Protocol Violation|3
2600690|NCT01068652|8991385|P2|Overall Study|Lost to Follow-up|1
2600691|NCT01068652|8991386|P1|Overall Study|Lost to Follow-up|2
2600692|NCT01068652|8991385|P2|Overall Study|Lack of Efficacy|2
2600693|NCT01068652|8991386|P1|Overall Study|Lack of Efficacy|0
2600694|NCT01068652|8991385|P2|Overall Study|Adverse Event|0
2600695|NCT01068652|8991386|P1|Overall Study|Adverse Event|4
2600696|NCT01068626|8991426|P2|Overall Study|Withdrawal by Subject|2
2600697|NCT01068626|8991427|P1|Overall Study|Withdrawal by Subject|0
2600698|NCT01068626|8991426|P2|Overall Study|Adverse Event|0
2600699|NCT01068626|8991427|P1|Overall Study|Adverse Event|3
2600700|NCT01068600|8991445|P2|Overall Study|Administrative problems|1
2600701|NCT01068600|8991446|P1|Overall Study|Administrative problems|0
2600702|NCT01068600|8991445|P2|Overall Study|Unsatisfactory therapeutic effect|4
2600703|NCT01068600|8991446|P1|Overall Study|Unsatisfactory therapeutic effect|0
2600704|NCT01068600|8991445|P2|Overall Study|Protocol deviation|1
2600705|NCT01068600|8991446|P1|Overall Study|Protocol deviation|1
2600706|NCT01068600|8991445|P2|Overall Study|Lost to Follow-up|2
2600707|NCT01068600|8991446|P1|Overall Study|Lost to Follow-up|1
2600708|NCT01068600|8991445|P2|Overall Study|Abnormal laboratory value(s)|0
2600709|NCT01068600|8991446|P1|Overall Study|Abnormal laboratory value(s)|1
2600710|NCT01068600|8991445|P2|Overall Study|Adverse Event|3
2600711|NCT01068600|8991446|P1|Overall Study|Adverse Event|3
2600712|NCT01068600|8991445|P2|Overall Study|Withdrawal by Subject|6
2600713|NCT01068600|8991446|P1|Overall Study|Withdrawal by Subject|5
2600714|NCT01068509|8991468|P3|Overall Study|Reason Not Specified|0
2600715|NCT01068509|8991469|P2|Overall Study|Reason Not Specified|1
2600716|NCT01068509|8991470|P1|Overall Study|Reason Not Specified|0
2600717|NCT01068509|8991468|P3|Overall Study|Withdrew Consent|2
2600718|NCT01068509|8991469|P2|Overall Study|Withdrew Consent|1
2600719|NCT01068509|8991470|P1|Overall Study|Withdrew Consent|0
2600720|NCT01068509|8991468|P3|Overall Study|Lost to Follow-up|0
2600721|NCT01068509|8991469|P2|Overall Study|Lost to Follow-up|0
2600722|NCT01068509|8991470|P1|Overall Study|Lost to Follow-up|1
2600723|NCT01068509|8991468|P3|Overall Study|Disease Progression|18
2600724|NCT01068509|8991469|P2|Overall Study|Disease Progression|20
2600725|NCT01068509|8991470|P1|Overall Study|Disease Progression|5
2600726|NCT01068509|8991468|P3|Overall Study|Death|1
2600727|NCT01068509|8991469|P2|Overall Study|Death|0
2600728|NCT01068509|8991470|P1|Overall Study|Death|0
2600729|NCT01068418|8991483|P1|Overall Study|Physician Decision|12
2600730|NCT01068262|8991492|P4|Overall Study|Withdrawal by Subject|0
2600731|NCT01068262|8991493|P3|Overall Study|Withdrawal by Subject|0
2600732|NCT01068262|8991494|P2|Overall Study|Withdrawal by Subject|1
2600733|NCT01068262|8991495|P1|Overall Study|Withdrawal by Subject|0
2600734|NCT01068262|8991492|P4|Overall Study|Protocol Violation|0
2600735|NCT01068262|8991493|P3|Overall Study|Protocol Violation|0
2600736|NCT01068262|8991494|P2|Overall Study|Protocol Violation|0
2600737|NCT01068262|8991495|P1|Overall Study|Protocol Violation|1
2600738|NCT01068262|8991492|P4|Overall Study|Adverse Event|0
2600739|NCT01068262|8991493|P3|Overall Study|Adverse Event|1
2600740|NCT01068262|8991494|P2|Overall Study|Adverse Event|0
2600741|NCT01068262|8991495|P1|Overall Study|Adverse Event|2
2600742|NCT01068158|8991525|P2|Overall Study|Protocol Violation|2
2600743|NCT01068158|8991526|P1|Overall Study|Protocol Violation|0
2600744|NCT01068158|8991525|P2|Overall Study|Lost to Follow-up|0
2600745|NCT01068158|8991526|P1|Overall Study|Lost to Follow-up|7
2600746|NCT01068158|8991525|P2|Overall Study|Withdrawal by Subject|2
2600747|NCT01068158|8991526|P1|Overall Study|Withdrawal by Subject|1
2600748|NCT01067976|8991538|P1|Overall Study|Study prematurely discontinued|2
2600749|NCT01067976|8991538|P1|Overall Study|Study drug never administered|20
2600750|NCT01067846|8991599|P2|Overall Study|participation in other tx study|0
2600751|NCT01067846|8991600|P1|Overall Study|participation in other tx study|1
2600752|NCT01067846|8991599|P2|Overall Study|Withdrawal by Subject|0
2600753|NCT01067846|8991600|P1|Overall Study|Withdrawal by Subject|1
2600754|NCT01067846|8991599|P2|Overall Study|Lost to Follow-up|19
2600755|NCT01067846|8991600|P1|Overall Study|Lost to Follow-up|17
2600756|NCT01067521|8991670|P2|Open-Label Period|Lost to Follow-up|20
2600757|NCT01067521|8991671|P1|Open-Label Period|Lost to Follow-up|21
2600758|NCT01067521|8991670|P2|Open-Label Period|Teva requested subject to be withdrawn|2
2600759|NCT01067521|8991671|P1|Open-Label Period|Teva requested subject to be withdrawn|5
2600760|NCT01067521|8991670|P2|Open-Label Period|Pregnancy|8
2600761|NCT01067521|8991671|P1|Open-Label Period|Pregnancy|14
2600762|NCT01067521|8991670|P2|Open-Label Period|Protocol Violation|0
2600763|NCT01067521|8991671|P1|Open-Label Period|Protocol Violation|3
2600764|NCT01067521|8991670|P2|Open-Label Period|Non-compliance with study drug|0
2600765|NCT01067521|8991671|P1|Open-Label Period|Non-compliance with study drug|5
2600766|NCT01067521|8991670|P2|Open-Label Period|Physician Decision|11
2600767|NCT01067521|8991671|P1|Open-Label Period|Physician Decision|13
2600768|NCT01067521|8991670|P2|Open-Label Period|Withdrawal by Subject|88
2600769|NCT01067521|8991671|P1|Open-Label Period|Withdrawal by Subject|160
2600770|NCT01067521|8991670|P2|Open-Label Period|Adverse Event|28
2600771|NCT01067521|8991671|P1|Open-Label Period|Adverse Event|30
2600772|NCT01067521|8991670|P2|Open-Label Period|Death|1
2600773|NCT01067521|8991671|P1|Open-Label Period|Death|3
2600774|NCT01067521|8991670|P2|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1
2600775|NCT01067521|8991671|P1|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5
2600776|NCT01067521|8991670|P2|Double-Blind Placebo-Controlled Period|Pregnancy|4
2600777|NCT01067521|8991671|P1|Double-Blind Placebo-Controlled Period|Pregnancy|7
2600778|NCT01067521|8991670|P2|Double-Blind Placebo-Controlled Period|Protocol Violation|0
2600779|NCT01067521|8991671|P1|Double-Blind Placebo-Controlled Period|Protocol Violation|2
2600780|NCT01067521|8991670|P2|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0
2600781|NCT01067521|8991671|P1|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2
2600782|NCT01067521|8991670|P2|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1
2600783|NCT01067521|8991671|P1|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4
2600784|NCT01067521|8991670|P2|Double-Blind Placebo-Controlled Period|Physician Decision|1
2600785|NCT01067521|8991671|P1|Double-Blind Placebo-Controlled Period|Physician Decision|1
2600786|NCT01067521|8991670|P2|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17
2600787|NCT01067521|8991671|P1|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34
2600788|NCT01067521|8991670|P2|Double-Blind Placebo-Controlled Period|Adverse Event|6
2600789|NCT01067521|8991671|P1|Double-Blind Placebo-Controlled Period|Adverse Event|29
2600790|NCT01067521|8991670|P2|Double-Blind Placebo-Controlled Period|Death|1
2600791|NCT01067521|8991671|P1|Double-Blind Placebo-Controlled Period|Death|0
2600792|NCT01067508|8991697|P2|Overall Study|Withdrawal by Subject|1
2600793|NCT01067508|8991698|P1|Overall Study|Withdrawal by Subject|0
2600794|NCT01067508|8991697|P2|Overall Study|Physician Decision|1
2600795|NCT01067508|8991698|P1|Overall Study|Physician Decision|0
2600796|NCT01067469|8991706|P2|Overall Study|Disease Progression|1
2600797|NCT01067469|8991707|P1|Overall Study|Disease Progression|0
2600798|NCT01067469|8991706|P2|Overall Study|Withdrawal by Subject|1
2600799|NCT01067469|8991707|P1|Overall Study|Withdrawal by Subject|0
2600800|NCT01067352|8991739|P3|Overall Study|Physician Decision|0
2600801|NCT01067352|8991740|P2|Overall Study|Physician Decision|1
2600802|NCT01067352|8991741|P1|Overall Study|Physician Decision|0
2600803|NCT01067352|8991739|P3|Overall Study|Withdrawal by Subject|1
2600804|NCT01067352|8991740|P2|Overall Study|Withdrawal by Subject|2
2600805|NCT01067352|8991741|P1|Overall Study|Withdrawal by Subject|1
2600806|NCT01067339|8991757|P2|Overall Study|Withdrawal by Subject|5
2600807|NCT01067339|8991758|P1|Overall Study|Withdrawal by Subject|6
2600808|NCT01067326|8991768|P2|Overall Study|Early Study Termination|1
2600809|NCT01067326|8991769|P1|Overall Study|Early Study Termination|1
2600810|NCT01067326|8991768|P2|Overall Study|Withdrawal by Subject|0
2600811|NCT01067326|8991769|P1|Overall Study|Withdrawal by Subject|1
2600812|NCT01067326|8991768|P2|Overall Study|Adverse Event|2
2600813|NCT01067326|8991769|P1|Overall Study|Adverse Event|0
2600814|NCT01067144|8991783|P2|Follow-up|Death|1
2600815|NCT01067144|8991784|P1|Follow-up|Death|0
2600816|NCT01067144|8991783|P2|Follow-up|Surgery cancelled|1
2600817|NCT01067144|8991784|P1|Follow-up|Surgery cancelled|0
2600818|NCT01067144|8991783|P2|Follow-up|Withdrawal by Subject|14
2600819|NCT01067144|8991784|P1|Follow-up|Withdrawal by Subject|18
2600820|NCT01067144|8991783|P2|Follow-up|Censored owing to second surgery|28
2600821|NCT01067144|8991784|P1|Follow-up|Censored owing to second surgery|19
2600822|NCT01067144|8991783|P2|Follow-up|Lost to Follow-up|12
2600823|NCT01067144|8991784|P1|Follow-up|Lost to Follow-up|22
2600824|NCT01067144|8991783|P2|Treatment|Did not receive allocated intervention|7
2600825|NCT01067144|8991784|P1|Treatment|Did not receive allocated intervention|4
2600826|NCT01067105|8991800|P1|Overall Study|Other|31
2600827|NCT01067105|8991800|P1|Overall Study|Physician Decision|6
2600828|NCT01067105|8991800|P1|Overall Study|Lost to Follow-up|6
2600829|NCT01067105|8991800|P1|Overall Study|Withdrawal by Subject|36
2600830|NCT01067105|8991800|P1|Overall Study|Protocol Violation|48
2600831|NCT01067105|8991800|P1|Overall Study|Adverse Event|14
2600832|NCT01066936|8991817|P1|Overall Study|Withdrawal by Subject|4
2600833|NCT01066936|8991817|P1|Overall Study|Lost to Follow-up|3
2600834|NCT01066936|8991817|P1|Overall Study|Device revised/removed|1
2600835|NCT01066936|8991817|P1|Overall Study|Death|2
2600836|NCT01066923|8991853|P4|Overall Study|Withdrawal by Subject|8
2600837|NCT01066923|8991854|P3|Overall Study|Withdrawal by Subject|8
2600838|NCT01066923|8991855|P2|Overall Study|Withdrawal by Subject|3
2600839|NCT01066923|8991856|P1|Overall Study|Withdrawal by Subject|3
2600840|NCT01066897|8991880|P2|Overall Study|stopped study after developing the flu.|0
2600841|NCT01066897|8991881|P1|Overall Study|stopped study after developing the flu.|1
2600842|NCT01066897|8991880|P2|Overall Study|Withdrawal by Subject|0
2600843|NCT01066897|8991881|P1|Overall Study|Withdrawal by Subject|1
2600844|NCT01066871|8991895|P4|Overall Study|Other|2
2600845|NCT01066871|8991896|P3|Overall Study|Other|1
2600846|NCT01066871|8991897|P2|Overall Study|Other|2
2600847|NCT01066871|8991898|P1|Overall Study|Other|0
2600848|NCT01066871|8991895|P4|Overall Study|Withdrawal by Subject|0
2600849|NCT01066871|8991896|P3|Overall Study|Withdrawal by Subject|0
2600850|NCT01066871|8991897|P2|Overall Study|Withdrawal by Subject|1
2600851|NCT01066871|8991898|P1|Overall Study|Withdrawal by Subject|3
2600852|NCT01066871|8991895|P4|Overall Study|Lack of Efficacy|1
2600853|NCT01066871|8991896|P3|Overall Study|Lack of Efficacy|0
2600854|NCT01066871|8991897|P2|Overall Study|Lack of Efficacy|0
2600855|NCT01066871|8991898|P1|Overall Study|Lack of Efficacy|0
2600856|NCT01066871|8991895|P4|Overall Study|Protocol Violation|2
2600857|NCT01066871|8991896|P3|Overall Study|Protocol Violation|3
2600858|NCT01066871|8991897|P2|Overall Study|Protocol Violation|0
2600859|NCT01066871|8991898|P1|Overall Study|Protocol Violation|1
2600860|NCT01066871|8991895|P4|Overall Study|Lost to Follow-up|0
2600861|NCT01066871|8991896|P3|Overall Study|Lost to Follow-up|2
2600862|NCT01066871|8991897|P2|Overall Study|Lost to Follow-up|2
2600863|NCT01066871|8991898|P1|Overall Study|Lost to Follow-up|0
2600864|NCT01066819|8991962|P6|Overall Study|Other|0
2600865|NCT01066819|8991963|P5|Overall Study|Other|0
2600866|NCT01066819|8991964|P4|Overall Study|Other|0
2600867|NCT01066819|8991965|P3|Overall Study|Other|1
2600868|NCT01066819|8991966|P2|Overall Study|Other|1
2600869|NCT01066819|8991967|P1|Overall Study|Other|5
2600870|NCT01066819|8991962|P6|Overall Study|Treatment stopped|0
2600871|NCT01066819|8991963|P5|Overall Study|Treatment stopped|0
2600872|NCT01066819|8991964|P4|Overall Study|Treatment stopped|1
2600873|NCT01066819|8991965|P3|Overall Study|Treatment stopped|2
2600874|NCT01066819|8991966|P2|Overall Study|Treatment stopped|1
2600875|NCT01066819|8991967|P1|Overall Study|Treatment stopped|12
2600876|NCT01066819|8991962|P6|Overall Study|Treatment never started|2
2600877|NCT01066819|8991963|P5|Overall Study|Treatment never started|2
2600878|NCT01066819|8991964|P4|Overall Study|Treatment never started|3
2600879|NCT01066819|8991965|P3|Overall Study|Treatment never started|19
2600880|NCT01066819|8991966|P2|Overall Study|Treatment never started|19
2600881|NCT01066819|8991967|P1|Overall Study|Treatment never started|85
2600882|NCT01066819|8991962|P6|Overall Study|Spontaneous cure|0
2600883|NCT01066819|8991963|P5|Overall Study|Spontaneous cure|0
2600884|NCT01066819|8991964|P4|Overall Study|Spontaneous cure|0
2600885|NCT01066819|8991965|P3|Overall Study|Spontaneous cure|0
2600886|NCT01066819|8991966|P2|Overall Study|Spontaneous cure|0
2600887|NCT01066819|8991967|P1|Overall Study|Spontaneous cure|1
2600888|NCT01066819|8991962|P6|Overall Study|Screen failure|0
2600889|NCT01066819|8991963|P5|Overall Study|Screen failure|0
2600890|NCT01066819|8991964|P4|Overall Study|Screen failure|0
2600891|NCT01066819|8991965|P3|Overall Study|Screen failure|0
2600892|NCT01066819|8991966|P2|Overall Study|Screen failure|0
2600893|NCT01066819|8991967|P1|Overall Study|Screen failure|1
2600894|NCT01066819|8991962|P6|Overall Study|Results not available|0
2600895|NCT01066819|8991963|P5|Overall Study|Results not available|0
2600896|NCT01066819|8991964|P4|Overall Study|Results not available|0
2600897|NCT01066819|8991965|P3|Overall Study|Results not available|0
2600898|NCT01066819|8991966|P2|Overall Study|Results not available|0
2600899|NCT01066819|8991967|P1|Overall Study|Results not available|1
2600900|NCT01066819|8991962|P6|Overall Study|Relapse|0
2600901|NCT01066819|8991963|P5|Overall Study|Relapse|0
2600902|NCT01066819|8991964|P4|Overall Study|Relapse|0
2600903|NCT01066819|8991965|P3|Overall Study|Relapse|3
2600904|NCT01066819|8991966|P2|Overall Study|Relapse|4
2600905|NCT01066819|8991967|P1|Overall Study|Relapse|16
2600906|NCT01066819|8991962|P6|Overall Study|Not categorised|0
2600907|NCT01066819|8991963|P5|Overall Study|Not categorised|0
2600908|NCT01066819|8991964|P4|Overall Study|Not categorised|1
2600909|NCT01066819|8991965|P3|Overall Study|Not categorised|6
2600910|NCT01066819|8991966|P2|Overall Study|Not categorised|2
2600911|NCT01066819|8991967|P1|Overall Study|Not categorised|9
2600912|NCT01066819|8991962|P6|Overall Study|Non responders|1
2600913|NCT01066819|8991963|P5|Overall Study|Non responders|0
2600914|NCT01066819|8991964|P4|Overall Study|Non responders|2
2600915|NCT01066819|8991965|P3|Overall Study|Non responders|7
2600916|NCT01066819|8991966|P2|Overall Study|Non responders|2
2600917|NCT01066819|8991967|P1|Overall Study|Non responders|123
2600918|NCT01066819|8991962|P6|Overall Study|Miscellaneous|0
2600919|NCT01066819|8991963|P5|Overall Study|Miscellaneous|0
2600920|NCT01066819|8991964|P4|Overall Study|Miscellaneous|1
2600921|NCT01066819|8991965|P3|Overall Study|Miscellaneous|18
2600922|NCT01066819|8991966|P2|Overall Study|Miscellaneous|10
2600923|NCT01066819|8991967|P1|Overall Study|Miscellaneous|28
2600924|NCT01066819|8991962|P6|Overall Study|Lab test not done|0
2600925|NCT01066819|8991963|P5|Overall Study|Lab test not done|0
2600926|NCT01066819|8991964|P4|Overall Study|Lab test not done|1
2600927|NCT01066819|8991965|P3|Overall Study|Lab test not done|2
2600928|NCT01066819|8991966|P2|Overall Study|Lab test not done|0
2600929|NCT01066819|8991967|P1|Overall Study|Lab test not done|9
2600930|NCT01066819|8991962|P6|Overall Study|Failed to return|3
2600931|NCT01066819|8991963|P5|Overall Study|Failed to return|2
2600932|NCT01066819|8991964|P4|Overall Study|Failed to return|7
2600933|NCT01066819|8991965|P3|Overall Study|Failed to return|68
2600934|NCT01066819|8991966|P2|Overall Study|Failed to return|107
2600935|NCT01066819|8991967|P1|Overall Study|Failed to return|298
2600936|NCT01066819|8991962|P6|Overall Study|Early termination|0
2600937|NCT01066819|8991963|P5|Overall Study|Early termination|0
2600938|NCT01066819|8991964|P4|Overall Study|Early termination|0
2600939|NCT01066819|8991965|P3|Overall Study|Early termination|0
2600940|NCT01066819|8991966|P2|Overall Study|Early termination|0
2600941|NCT01066819|8991967|P1|Overall Study|Early termination|2
2600942|NCT01066819|8991962|P6|Overall Study|Not met inclusion/exclusion criteria|0
2600943|NCT01066819|8991963|P5|Overall Study|Not met inclusion/exclusion criteria|0
2600944|NCT01066819|8991964|P4|Overall Study|Not met inclusion/exclusion criteria|0
2600945|NCT01066819|8991965|P3|Overall Study|Not met inclusion/exclusion criteria|0
2600946|NCT01066819|8991966|P2|Overall Study|Not met inclusion/exclusion criteria|0
2600947|NCT01066819|8991967|P1|Overall Study|Not met inclusion/exclusion criteria|1
2600948|NCT01066819|8991962|P6|Overall Study|Administrative|0
2600949|NCT01066819|8991963|P5|Overall Study|Administrative|0
2600950|NCT01066819|8991964|P4|Overall Study|Administrative|0
2600951|NCT01066819|8991965|P3|Overall Study|Administrative|2
2600952|NCT01066819|8991966|P2|Overall Study|Administrative|4
2600953|NCT01066819|8991967|P1|Overall Study|Administrative|6
2600954|NCT01066819|8991962|P6|Overall Study|Withdrawal by Subject|0
2600955|NCT01066819|8991963|P5|Overall Study|Withdrawal by Subject|0
2600956|NCT01066819|8991964|P4|Overall Study|Withdrawal by Subject|0
2600957|NCT01066819|8991965|P3|Overall Study|Withdrawal by Subject|6
2600958|NCT01066819|8991966|P2|Overall Study|Withdrawal by Subject|11
2600959|NCT01066819|8991967|P1|Overall Study|Withdrawal by Subject|29
2600960|NCT01066819|8991962|P6|Overall Study|Protocol Violation|0
2600961|NCT01066819|8991963|P5|Overall Study|Protocol Violation|0
2600962|NCT01066819|8991964|P4|Overall Study|Protocol Violation|0
2600963|NCT01066819|8991965|P3|Overall Study|Protocol Violation|0
2600964|NCT01066819|8991966|P2|Overall Study|Protocol Violation|6
2600965|NCT01066819|8991967|P1|Overall Study|Protocol Violation|12
2600966|NCT01066819|8991962|P6|Overall Study|Physician Decision|0
2600967|NCT01066819|8991963|P5|Overall Study|Physician Decision|0
2600968|NCT01066819|8991964|P4|Overall Study|Physician Decision|0
2600969|NCT01066819|8991965|P3|Overall Study|Physician Decision|3
2600970|NCT01066819|8991966|P2|Overall Study|Physician Decision|2
2600971|NCT01066819|8991967|P1|Overall Study|Physician Decision|6
2600972|NCT01066819|8991962|P6|Overall Study|Lack of Efficacy|0
2600973|NCT01066819|8991963|P5|Overall Study|Lack of Efficacy|0
2600974|NCT01066819|8991964|P4|Overall Study|Lack of Efficacy|1
2600975|NCT01066819|8991965|P3|Overall Study|Lack of Efficacy|2
2600976|NCT01066819|8991966|P2|Overall Study|Lack of Efficacy|1
2600977|NCT01066819|8991967|P1|Overall Study|Lack of Efficacy|22
2600978|NCT01066819|8991962|P6|Overall Study|Death|0
2600979|NCT01066819|8991963|P5|Overall Study|Death|0
2600980|NCT01066819|8991964|P4|Overall Study|Death|0
2600981|NCT01066819|8991965|P3|Overall Study|Death|1
2600982|NCT01066819|8991966|P2|Overall Study|Death|0
2600983|NCT01066819|8991967|P1|Overall Study|Death|5
2600984|NCT01066819|8991962|P6|Overall Study|Adverse Event|0
2600985|NCT01066819|8991963|P5|Overall Study|Adverse Event|0
2600986|NCT01066819|8991964|P4|Overall Study|Adverse Event|0
2600987|NCT01066819|8991965|P3|Overall Study|Adverse Event|6
2600988|NCT01066819|8991966|P2|Overall Study|Adverse Event|1
2600989|NCT01066819|8991967|P1|Overall Study|Adverse Event|18
2600990|NCT01066793|8992108|P6|Overall Study|Treatment Stopped|0
2600991|NCT01066793|8992109|P5|Overall Study|Treatment Stopped|0
2600992|NCT01066793|8992110|P4|Overall Study|Treatment Stopped|1
2600993|NCT01066793|8992111|P3|Overall Study|Treatment Stopped|0
2600994|NCT01066793|8992112|P2|Overall Study|Treatment Stopped|1
2600995|NCT01066793|8992113|P1|Overall Study|Treatment Stopped|2
2600996|NCT01066793|8992108|P6|Overall Study|Treatment Never Started|0
2600997|NCT01066793|8992109|P5|Overall Study|Treatment Never Started|0
2600998|NCT01066793|8992110|P4|Overall Study|Treatment Never Started|1
2600999|NCT01066793|8992111|P3|Overall Study|Treatment Never Started|4
2601000|NCT01066793|8992112|P2|Overall Study|Treatment Never Started|5
2601001|NCT01066793|8992113|P1|Overall Study|Treatment Never Started|18
2601002|NCT01066793|8992108|P6|Overall Study|Treatment Interrupted|0
2601003|NCT01066793|8992109|P5|Overall Study|Treatment Interrupted|0
2601004|NCT01066793|8992110|P4|Overall Study|Treatment Interrupted|0
2601005|NCT01066793|8992111|P3|Overall Study|Treatment Interrupted|0
2601006|NCT01066793|8992112|P2|Overall Study|Treatment Interrupted|1
2601007|NCT01066793|8992113|P1|Overall Study|Treatment Interrupted|1
2601008|NCT01066793|8992108|P6|Overall Study|Result Not Available|0
2601009|NCT01066793|8992109|P5|Overall Study|Result Not Available|0
2601010|NCT01066793|8992110|P4|Overall Study|Result Not Available|0
2601011|NCT01066793|8992111|P3|Overall Study|Result Not Available|0
2601012|NCT01066793|8992112|P2|Overall Study|Result Not Available|0
2601013|NCT01066793|8992113|P1|Overall Study|Result Not Available|1
2601014|NCT01066793|8992108|P6|Overall Study|Relapse|0
2601015|NCT01066793|8992109|P5|Overall Study|Relapse|0
2601016|NCT01066793|8992110|P4|Overall Study|Relapse|3
2601017|NCT01066793|8992111|P3|Overall Study|Relapse|2
2601018|NCT01066793|8992112|P2|Overall Study|Relapse|8
2601019|NCT01066793|8992113|P1|Overall Study|Relapse|20
2601020|NCT01066793|8992108|P6|Overall Study|Other|0
2601021|NCT01066793|8992109|P5|Overall Study|Other|0
2601022|NCT01066793|8992110|P4|Overall Study|Other|2
2601023|NCT01066793|8992111|P3|Overall Study|Other|6
2601024|NCT01066793|8992112|P2|Overall Study|Other|5
2601025|NCT01066793|8992113|P1|Overall Study|Other|15
2601026|NCT01066793|8992108|P6|Overall Study|Non-responders|0
2601027|NCT01066793|8992109|P5|Overall Study|Non-responders|0
2601028|NCT01066793|8992110|P4|Overall Study|Non-responders|25
2601029|NCT01066793|8992111|P3|Overall Study|Non-responders|11
2601030|NCT01066793|8992112|P2|Overall Study|Non-responders|5
2601031|NCT01066793|8992113|P1|Overall Study|Non-responders|104
2601032|NCT01066793|8992108|P6|Overall Study|Miscellaneous|0
2601033|NCT01066793|8992109|P5|Overall Study|Miscellaneous|0
2601034|NCT01066793|8992110|P4|Overall Study|Miscellaneous|0
2601035|NCT01066793|8992111|P3|Overall Study|Miscellaneous|6
2601036|NCT01066793|8992112|P2|Overall Study|Miscellaneous|5
2601037|NCT01066793|8992113|P1|Overall Study|Miscellaneous|4
2601038|NCT01066793|8992108|P6|Overall Study|Lab test not done|0
2601039|NCT01066793|8992109|P5|Overall Study|Lab test not done|0
2601040|NCT01066793|8992110|P4|Overall Study|Lab test not done|1
2601041|NCT01066793|8992111|P3|Overall Study|Lab test not done|0
2601042|NCT01066793|8992112|P2|Overall Study|Lab test not done|0
2601043|NCT01066793|8992113|P1|Overall Study|Lab test not done|7
2601044|NCT01066793|8992108|P6|Overall Study|Early Termination|0
2601045|NCT01066793|8992109|P5|Overall Study|Early Termination|0
2601046|NCT01066793|8992110|P4|Overall Study|Early Termination|0
2601047|NCT01066793|8992111|P3|Overall Study|Early Termination|0
2601048|NCT01066793|8992112|P2|Overall Study|Early Termination|0
2601049|NCT01066793|8992113|P1|Overall Study|Early Termination|3
2601050|NCT01066793|8992108|P6|Overall Study|Withdrawal by Subject|0
2601051|NCT01066793|8992109|P5|Overall Study|Withdrawal by Subject|0
2601052|NCT01066793|8992110|P4|Overall Study|Withdrawal by Subject|0
2601053|NCT01066793|8992111|P3|Overall Study|Withdrawal by Subject|1
2601054|NCT01066793|8992112|P2|Overall Study|Withdrawal by Subject|4
2601055|NCT01066793|8992113|P1|Overall Study|Withdrawal by Subject|7
2601056|NCT01066793|8992108|P6|Overall Study|Protocol Violation|0
2601057|NCT01066793|8992109|P5|Overall Study|Protocol Violation|0
2601058|NCT01066793|8992110|P4|Overall Study|Protocol Violation|0
2601059|NCT01066793|8992111|P3|Overall Study|Protocol Violation|2
2601060|NCT01066793|8992112|P2|Overall Study|Protocol Violation|2
2601061|NCT01066793|8992113|P1|Overall Study|Protocol Violation|3
2601062|NCT01066793|8992108|P6|Overall Study|Physician Decision|0
2601063|NCT01066793|8992109|P5|Overall Study|Physician Decision|0
2601064|NCT01066793|8992110|P4|Overall Study|Physician Decision|0
2601065|NCT01066793|8992111|P3|Overall Study|Physician Decision|0
2601066|NCT01066793|8992112|P2|Overall Study|Physician Decision|0
2601067|NCT01066793|8992113|P1|Overall Study|Physician Decision|3
2601068|NCT01066793|8992108|P6|Overall Study|Lost to Follow-up|1
2601069|NCT01066793|8992109|P5|Overall Study|Lost to Follow-up|0
2601070|NCT01066793|8992110|P4|Overall Study|Lost to Follow-up|16
2601071|NCT01066793|8992111|P3|Overall Study|Lost to Follow-up|82
2601072|NCT01066793|8992112|P2|Overall Study|Lost to Follow-up|39
2601073|NCT01066793|8992113|P1|Overall Study|Lost to Follow-up|180
2601074|NCT01066793|8992108|P6|Overall Study|Lack of Efficacy|0
2601075|NCT01066793|8992109|P5|Overall Study|Lack of Efficacy|0
2601076|NCT01066793|8992110|P4|Overall Study|Lack of Efficacy|0
2601077|NCT01066793|8992111|P3|Overall Study|Lack of Efficacy|0
2601078|NCT01066793|8992112|P2|Overall Study|Lack of Efficacy|1
2601079|NCT01066793|8992113|P1|Overall Study|Lack of Efficacy|2
2601080|NCT01066793|8992108|P6|Overall Study|Death|0
2601081|NCT01066793|8992109|P5|Overall Study|Death|0
2601082|NCT01066793|8992110|P4|Overall Study|Death|0
2601083|NCT01066793|8992111|P3|Overall Study|Death|1
2601084|NCT01066793|8992112|P2|Overall Study|Death|1
2601085|NCT01066793|8992113|P1|Overall Study|Death|4
2601086|NCT01066780|8992253|P2|Overall Study|Withdrawn prior to ClearVoice exposure.|1
2601087|NCT01066780|8992254|P1|Overall Study|Withdrawn prior to ClearVoice exposure.|1
2601088|NCT01066585|8992273|P2|Overall Study|Withdrawal by Subject|3
2601089|NCT01066585|8992274|P1|Overall Study|Withdrawal by Subject|0
2601090|NCT01066585|8992273|P2|Overall Study|Protocol Violation|0
2601091|NCT01066585|8992274|P1|Overall Study|Protocol Violation|1
2601092|NCT01066546|8992286|P1|Overall Study|Study terminated by sponsor|5
2601093|NCT01066156|8992316|P1|Overall Study|Withdrawal by Subject|1
2601094|NCT01066156|8992316|P1|Overall Study|Lost to Follow-up|7
2601095|NCT01066156|8992316|P1|Overall Study|ineligible|2
2601096|NCT01066143|8992320|P1|Overall Study|ineligible for the study|8
2601097|NCT01066104|8992326|P2|Overall Study|Protocol Violation|0
2601098|NCT01066104|8992327|P1|Overall Study|Protocol Violation|1
2601099|NCT01066104|8992326|P2|Overall Study|Adverse Event|1
2601100|NCT01066104|8992327|P1|Overall Study|Adverse Event|1
2601101|NCT01066052|8992337|P2|Overall Study|Enrolled But Not Treated|0
2601102|NCT01066052|8992338|P1|Overall Study|Enrolled But Not Treated|3
2601103|NCT01066039|8992349|P1|Overall Study|Drug/Dose Adjustment Required|1
2601104|NCT01066039|8992349|P1|Overall Study|Failure to Control Blood Pressure|1
2601105|NCT01066039|8992349|P1|Overall Study|Volunteer Failed to Make the Next Visit|2
2601106|NCT01066039|8992349|P1|Overall Study|Additional Antihypertensive Required|4
2601107|NCT01066039|8992349|P1|Overall Study|Dropout due to Insulin Administration|1
2601108|NCT01066039|8992349|P1|Overall Study|Investigator’s Request|1
2601109|NCT01066039|8992349|P1|Overall Study|Inclusion/Exclusion Criteria Violation|9
2601110|NCT01066039|8992349|P1|Overall Study|Protocol Violation|2
2601111|NCT01066039|8992349|P1|Overall Study|Withdrawal by Subject|17
2601112|NCT01066039|8992349|P1|Overall Study|Adverse Event|6
2601113|NCT01066000|8992362|P1|Overall Study|Adverse Event|1
2601114|NCT01066000|8992362|P1|Overall Study|Withdrawal by Subject|1
2601115|NCT01066000|8992362|P1|Overall Study|Death|3
2601116|NCT01066000|8992362|P1|Overall Study|Protocol Violation|4
2601117|NCT01065844|8992373|P1|Overall Study|Adverse Event|5
2601118|NCT01065818|8992377|P1|Overall Study|Not a candidate for surgery|1
2601119|NCT01065818|8992377|P1|Overall Study|Withdrawal by Subject|1
2601120|NCT01065779|8992381|P1|Overall Study|Inclusion Criteria Violation|7
2601121|NCT01065779|8992381|P1|Overall Study|Failed to Follow-up|10
2601122|NCT01065779|8992381|P1|Overall Study|Not Administered With Study Drug|17
2601123|NCT01065779|8992381|P1|Overall Study|Non-enrollment Period Administration|10
2601124|NCT01065779|8992381|P1|Overall Study|Investigation Before Contract Date|37
2601125|NCT01065779|8992381|P1|Overall Study|Duplicate Investigation|1
2601126|NCT01065766|8992392|P1|Overall Study|Violated dosage/administration|25
2601127|NCT01065766|8992392|P1|Overall Study|Contraindication to administration|6
2601128|NCT01065766|8992392|P1|Overall Study|Assessed before the contracted date|1
2601129|NCT01065597|8992411|P1|Overall Study|Adverse Event|1
2601130|NCT01065454|8992458|P4|Follow up|study ongoing|41
2601131|NCT01065454|8992459|P3|Follow up|study ongoing|15
2601132|NCT01065454|8992460|P2|Follow up|study ongoing|22
2601133|NCT01065454|8992461|P1|Follow up|study ongoing|37
2601134|NCT01065454|8992458|P4|Follow up|Withdrawal by Subject|0
2601135|NCT01065454|8992459|P3|Follow up|Withdrawal by Subject|1
2601136|NCT01065454|8992460|P2|Follow up|Withdrawal by Subject|1
2601137|NCT01065454|8992461|P1|Follow up|Withdrawal by Subject|1
2601138|NCT01065454|8992458|P4|Follow up|Progressive disease|1
2601139|NCT01065454|8992459|P3|Follow up|Progressive disease|0
2601140|NCT01065454|8992460|P2|Follow up|Progressive disease|0
2601141|NCT01065454|8992461|P1|Follow up|Progressive disease|0
2601142|NCT01065454|8992458|P4|Follow up|Lost to Follow-up|1
2601143|NCT01065454|8992459|P3|Follow up|Lost to Follow-up|0
2601144|NCT01065454|8992460|P2|Follow up|Lost to Follow-up|0
2601145|NCT01065454|8992461|P1|Follow up|Lost to Follow-up|0
2601146|NCT01065454|8992458|P4|Follow up|Death|0
2601147|NCT01065454|8992459|P3|Follow up|Death|1
2601148|NCT01065454|8992460|P2|Follow up|Death|1
2601149|NCT01065454|8992461|P1|Follow up|Death|0
2601150|NCT01065454|8992458|P4|Follow up|Adverse Event|1
2601151|NCT01065454|8992459|P3|Follow up|Adverse Event|0
2601152|NCT01065454|8992460|P2|Follow up|Adverse Event|0
2601153|NCT01065454|8992461|P1|Follow up|Adverse Event|1
2601154|NCT01065454|8992458|P4|Treatment|Withdrawal by Subject|3
2601155|NCT01065454|8992459|P3|Treatment|Withdrawal by Subject|2
2601156|NCT01065454|8992460|P2|Treatment|Withdrawal by Subject|1
2601157|NCT01065454|8992461|P1|Treatment|Withdrawal by Subject|3
2601158|NCT01065454|8992458|P4|Treatment|Protocol Violation|0
2601159|NCT01065454|8992459|P3|Treatment|Protocol Violation|1
2601160|NCT01065454|8992460|P2|Treatment|Protocol Violation|0
2601161|NCT01065454|8992461|P1|Treatment|Protocol Violation|1
2601162|NCT01065454|8992458|P4|Treatment|Protocol Decision|2
2601163|NCT01065454|8992459|P3|Treatment|Protocol Decision|3
2601164|NCT01065454|8992460|P2|Treatment|Protocol Decision|0
2601165|NCT01065454|8992461|P1|Treatment|Protocol Decision|0
2601166|NCT01065454|8992458|P4|Treatment|Non-compliance|1
2601167|NCT01065454|8992459|P3|Treatment|Non-compliance|0
2601168|NCT01065454|8992460|P2|Treatment|Non-compliance|0
2601169|NCT01065454|8992461|P1|Treatment|Non-compliance|1
2601170|NCT01065454|8992458|P4|Treatment|Death|0
2601171|NCT01065454|8992459|P3|Treatment|Death|0
2601172|NCT01065454|8992460|P2|Treatment|Death|0
2601173|NCT01065454|8992461|P1|Treatment|Death|1
2601174|NCT01065454|8992458|P4|Treatment|Adverse Event|6
2601175|NCT01065454|8992459|P3|Treatment|Adverse Event|3
2601176|NCT01065454|8992460|P2|Treatment|Adverse Event|4
2601177|NCT01065454|8992461|P1|Treatment|Adverse Event|7
2601178|NCT01065350|8992584|P2|Overall Study|Received incorrect drug allocation|1
2601179|NCT01065350|8992585|P1|Overall Study|Received incorrect drug allocation|0
2601180|NCT01064947|8992646|P1|Overall Study|negative culture|41
2601181|NCT01064856|8992687|P4|Open-label (OL) Period|Other|7
2601182|NCT01064856|8992688|P3|Open-label (OL) Period|Other|7
2601183|NCT01064856|8992689|P2|Open-label (OL) Period|Other|0
2601184|NCT01064856|8992690|P1|Open-label (OL) Period|Other|0
2601185|NCT01064856|8992687|P4|Open-label (OL) Period|Lost to Follow-up|1
2601186|NCT01064856|8992688|P3|Open-label (OL) Period|Lost to Follow-up|2
2601187|NCT01064856|8992689|P2|Open-label (OL) Period|Lost to Follow-up|0
2601188|NCT01064856|8992690|P1|Open-label (OL) Period|Lost to Follow-up|0
2601189|NCT01064856|8992687|P4|Open-label (OL) Period|Consent withdrawn by participant|6
2601190|NCT01064856|8992688|P3|Open-label (OL) Period|Consent withdrawn by participant|5
2601191|NCT01064856|8992689|P2|Open-label (OL) Period|Consent withdrawn by participant|0
2601192|NCT01064856|8992690|P1|Open-label (OL) Period|Consent withdrawn by participant|0
2601193|NCT01064856|8992687|P4|Open-label (OL) Period|Adverse Event|6
2601194|NCT01064856|8992688|P3|Open-label (OL) Period|Adverse Event|12
2601195|NCT01064856|8992689|P2|Open-label (OL) Period|Adverse Event|0
2601196|NCT01064856|8992690|P1|Open-label (OL) Period|Adverse Event|0
2601197|NCT01064856|8992687|P4|Double-blind (DB) Period|Consent withdrawn by participant|0
2601198|NCT01064856|8992688|P3|Double-blind (DB) Period|Consent withdrawn by participant|0
2601199|NCT01064856|8992689|P2|Double-blind (DB) Period|Consent withdrawn by participant|0
2601200|NCT01064856|8992690|P1|Double-blind (DB) Period|Consent withdrawn by participant|1
2601201|NCT01064856|8992687|P4|Double-blind (DB) Period|Adverse Event|0
2601202|NCT01064856|8992688|P3|Double-blind (DB) Period|Adverse Event|0
2601203|NCT01064856|8992689|P2|Double-blind (DB) Period|Adverse Event|0
2601204|NCT01064856|8992690|P1|Double-blind (DB) Period|Adverse Event|1
2601205|NCT01064817|8992734|P2|Study Completion|Withdrawal by Subject|0
2601206|NCT01064817|8992735|P1|Study Completion|Withdrawal by Subject|1
2601207|NCT01064817|8992734|P2|Study Completion|Physician Decision|0
2601208|NCT01064817|8992735|P1|Study Completion|Physician Decision|1
2601209|NCT01064739|8992747|P1|Fixed Sodium Diet + Fava Beans|Adverse Event|1
2601210|NCT01064687|8992818|P4|Overall Study|Treatment Noncompliance|0
2601211|NCT01064687|8992819|P3|Overall Study|Treatment Noncompliance|1
2601212|NCT01064687|8992820|P2|Overall Study|Treatment Noncompliance|1
2601213|NCT01064687|8992821|P1|Overall Study|Treatment Noncompliance|1
2601214|NCT01064687|8992818|P4|Overall Study|Withdrawal by Subject|5
2601215|NCT01064687|8992819|P3|Overall Study|Withdrawal by Subject|12
2601216|NCT01064687|8992820|P2|Overall Study|Withdrawal by Subject|7
2601217|NCT01064687|8992821|P1|Overall Study|Withdrawal by Subject|9
2601218|NCT01064687|8992818|P4|Overall Study|Sponsor Decision|0
2601219|NCT01064687|8992819|P3|Overall Study|Sponsor Decision|3
2601220|NCT01064687|8992820|P2|Overall Study|Sponsor Decision|0
2601221|NCT01064687|8992821|P1|Overall Study|Sponsor Decision|0
2601222|NCT01064687|8992818|P4|Overall Study|Protocol Violation|1
2601223|NCT01064687|8992819|P3|Overall Study|Protocol Violation|0
2601224|NCT01064687|8992820|P2|Overall Study|Protocol Violation|1
2601225|NCT01064687|8992821|P1|Overall Study|Protocol Violation|1
2601226|NCT01064687|8992818|P4|Overall Study|Physician Decision|0
2601227|NCT01064687|8992819|P3|Overall Study|Physician Decision|0
2601228|NCT01064687|8992820|P2|Overall Study|Physician Decision|2
2601229|NCT01064687|8992821|P1|Overall Study|Physician Decision|2
2601230|NCT01064687|8992818|P4|Overall Study|Lost to Follow-up|5
2601231|NCT01064687|8992819|P3|Overall Study|Lost to Follow-up|13
2601232|NCT01064687|8992820|P2|Overall Study|Lost to Follow-up|10
2601233|NCT01064687|8992821|P1|Overall Study|Lost to Follow-up|7
2601234|NCT01064687|8992818|P4|Overall Study|Lack of Efficacy|3
2601235|NCT01064687|8992819|P3|Overall Study|Lack of Efficacy|2
2601236|NCT01064687|8992820|P2|Overall Study|Lack of Efficacy|0
2601237|NCT01064687|8992821|P1|Overall Study|Lack of Efficacy|1
2601238|NCT01064687|8992818|P4|Overall Study|Entry Criteria Not Met|0
2601239|NCT01064687|8992819|P3|Overall Study|Entry Criteria Not Met|0
2601240|NCT01064687|8992820|P2|Overall Study|Entry Criteria Not Met|0
2601241|NCT01064687|8992821|P1|Overall Study|Entry Criteria Not Met|3
2601242|NCT01064687|8992818|P4|Overall Study|Death|0
2601243|NCT01064687|8992819|P3|Overall Study|Death|0
2601244|NCT01064687|8992820|P2|Overall Study|Death|1
2601245|NCT01064687|8992821|P1|Overall Study|Death|1
2601246|NCT01064687|8992818|P4|Overall Study|Adverse Event|3
2601247|NCT01064687|8992819|P3|Overall Study|Adverse Event|10
2601248|NCT01064687|8992820|P2|Overall Study|Adverse Event|4
2601249|NCT01064687|8992821|P1|Overall Study|Adverse Event|9
2601250|NCT01064648|8993001|P4|Phase II|Under Review|0
2601251|NCT01064648|8993002|P3|Phase II|Under Review|2
2601252|NCT01064648|8993003|P2|Phase II|Under Review|0
2601253|NCT01064648|8993004|P1|Phase II|Under Review|0
2601254|NCT01064648|8993001|P4|Phase II|Non-protocol specified|3
2601255|NCT01064648|8993002|P3|Phase II|Non-protocol specified|5
2601256|NCT01064648|8993003|P2|Phase II|Non-protocol specified|0
2601257|NCT01064648|8993004|P1|Phase II|Non-protocol specified|0
2601258|NCT01064648|8993001|P4|Phase II|Progression|27
2601259|NCT01064648|8993002|P3|Phase II|Progression|21
2601260|NCT01064648|8993003|P2|Phase II|Progression|0
2601261|NCT01064648|8993004|P1|Phase II|Progression|0
2601262|NCT01064648|8993001|P4|Phase II|Withdrawal by Subject|5
2601263|NCT01064648|8993002|P3|Phase II|Withdrawal by Subject|2
2601264|NCT01064648|8993003|P2|Phase II|Withdrawal by Subject|0
2601265|NCT01064648|8993004|P1|Phase II|Withdrawal by Subject|0
2601266|NCT01064648|8993001|P4|Phase II|Death|5
2601267|NCT01064648|8993002|P3|Phase II|Death|4
2601268|NCT01064648|8993003|P2|Phase II|Death|0
2601269|NCT01064648|8993004|P1|Phase II|Death|0
2601270|NCT01064648|8993001|P4|Phase II|Adverse Event|8
2601271|NCT01064648|8993002|P3|Phase II|Adverse Event|15
2601272|NCT01064648|8993003|P2|Phase II|Adverse Event|0
2601273|NCT01064648|8993004|P1|Phase II|Adverse Event|0
2601274|NCT01064648|8993001|P4|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
2601275|NCT01064648|8993002|P3|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
2601276|NCT01064648|8993003|P2|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4
2601277|NCT01064648|8993004|P1|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
2601278|NCT01064648|8993001|P4|Phase I Cohort 2: Dose Level 2|Progression|0
2601279|NCT01064648|8993002|P3|Phase I Cohort 2: Dose Level 2|Progression|0
2601280|NCT01064648|8993003|P2|Phase I Cohort 2: Dose Level 2|Progression|5
2601281|NCT01064648|8993004|P1|Phase I Cohort 2: Dose Level 2|Progression|0
2601282|NCT01064648|8993001|P4|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
2601283|NCT01064648|8993002|P3|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
2601284|NCT01064648|8993003|P2|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1
2601285|NCT01064648|8993004|P1|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
2601286|NCT01064648|8993001|P4|Phase I Cohort 2: Dose Level 2|Adverse Event|0
2601287|NCT01064648|8993002|P3|Phase I Cohort 2: Dose Level 2|Adverse Event|0
2601288|NCT01064648|8993003|P2|Phase I Cohort 2: Dose Level 2|Adverse Event|3
2601289|NCT01064648|8993004|P1|Phase I Cohort 2: Dose Level 2|Adverse Event|0
2601290|NCT01064648|8993001|P4|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
2601291|NCT01064648|8993002|P3|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
2601292|NCT01064648|8993003|P2|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
2601293|NCT01064648|8993004|P1|Phase I Cohort1: Dose Level 1|Non-protocol specified|2
2601294|NCT01064648|8993001|P4|Phase I Cohort1: Dose Level 1|Progression|0
2601295|NCT01064648|8993002|P3|Phase I Cohort1: Dose Level 1|Progression|0
2601296|NCT01064648|8993003|P2|Phase I Cohort1: Dose Level 1|Progression|0
2601297|NCT01064648|8993004|P1|Phase I Cohort1: Dose Level 1|Progression|5
2601298|NCT01064622|8993030|P2|Randomized Phase II|Protocol Violation|1
2601299|NCT01064622|8993031|P1|Randomized Phase II|Protocol Violation|0
2601300|NCT01064622|8993030|P2|Randomized Phase II|Withdrawal by Subject|2
2601301|NCT01064622|8993031|P1|Randomized Phase II|Withdrawal by Subject|2
2601302|NCT01064531|8993054|P2|Overall Study|Death|1
2601303|NCT01064531|8993055|P1|Overall Study|Death|0
2601304|NCT01064531|8993054|P2|Overall Study|Revision due to dislocation|1
2601305|NCT01064531|8993055|P1|Overall Study|Revision due to dislocation|0
2601306|NCT01064531|8993054|P2|Overall Study|Revision due to femoral stem loosening|0
2601307|NCT01064531|8993055|P1|Overall Study|Revision due to femoral stem loosening|1
2601308|NCT01064531|8993054|P2|Overall Study|Withdrawal by Subject|2
2601309|NCT01064531|8993055|P1|Overall Study|Withdrawal by Subject|2
2601310|NCT01064531|8993054|P2|Overall Study|Physician Decision|1
2601311|NCT01064531|8993055|P1|Overall Study|Physician Decision|0
2601312|NCT01064531|8993054|P2|Overall Study|Lost to Follow-up|2
2601313|NCT01064531|8993055|P1|Overall Study|Lost to Follow-up|0
2601314|NCT01064414|8993102|P3|Extension Period: Week 26 to Week 52|Other|1
2601315|NCT01064414|8993103|P2|Extension Period: Week 26 to Week 52|Other|2
2601316|NCT01064414|8993104|P1|Extension Period: Week 26 to Week 52|Other|5
2601317|NCT01064414|8993102|P3|Extension Period: Week 26 to Week 52|Protocol Violation|1
2601318|NCT01064414|8993103|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
2601319|NCT01064414|8993104|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
2601320|NCT01064414|8993102|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
2601321|NCT01064414|8993103|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
2601322|NCT01064414|8993104|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
2601323|NCT01064414|8993102|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
2601324|NCT01064414|8993103|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
2601325|NCT01064414|8993104|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
2601326|NCT01064414|8993102|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
2601327|NCT01064414|8993103|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
2601328|NCT01064414|8993104|P1|Extension Period: Week 26 to Week 52|Physician Decision|1
2601329|NCT01064414|8993102|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
2601330|NCT01064414|8993103|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
2601331|NCT01064414|8993104|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
2601332|NCT01064414|8993102|P3|Extension Period: Week 26 to Week 52|Death|0
2601333|NCT01064414|8993103|P2|Extension Period: Week 26 to Week 52|Death|1
2601334|NCT01064414|8993104|P1|Extension Period: Week 26 to Week 52|Death|0
2601335|NCT01064414|8993102|P3|Extension Period: Week 26 to Week 52|Adverse Event|2
2601336|NCT01064414|8993103|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
2601337|NCT01064414|8993104|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
2601338|NCT01064414|8993102|P3|Core Period: Baseline to Week 26|Other|2
2601339|NCT01064414|8993103|P2|Core Period: Baseline to Week 26|Other|7
2601340|NCT01064414|8993104|P1|Core Period: Baseline to Week 26|Other|4
2601341|NCT01064414|8993102|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
2601342|NCT01064414|8993103|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
2601343|NCT01064414|8993104|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
2601344|NCT01064414|8993102|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|2
2601345|NCT01064414|8993103|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|2
2601346|NCT01064414|8993104|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
2601347|NCT01064414|8993102|P3|Core Period: Baseline to Week 26|Protocol Violation|1
2601348|NCT01064414|8993103|P2|Core Period: Baseline to Week 26|Protocol Violation|0
2601349|NCT01064414|8993104|P1|Core Period: Baseline to Week 26|Protocol Violation|1
2601350|NCT01064414|8993102|P3|Core Period: Baseline to Week 26|Death|0
2601351|NCT01064414|8993103|P2|Core Period: Baseline to Week 26|Death|1
2601352|NCT01064414|8993104|P1|Core Period: Baseline to Week 26|Death|0
2601353|NCT01064414|8993102|P3|Core Period: Baseline to Week 26|Adverse Event|2
2601354|NCT01064414|8993103|P2|Core Period: Baseline to Week 26|Adverse Event|4
2601355|NCT01064414|8993104|P1|Core Period: Baseline to Week 26|Adverse Event|4
2601356|NCT01064401|8993123|P2|Overall Study|Other|1
2601357|NCT01064401|8993124|P1|Overall Study|Other|2
2601358|NCT01064401|8993123|P2|Overall Study|Site Closure|5
2601359|NCT01064401|8993124|P1|Overall Study|Site Closure|4
2601360|NCT01064401|8993123|P2|Overall Study|Noncompliance|8
2601361|NCT01064401|8993124|P1|Overall Study|Noncompliance|7
2601362|NCT01064401|8993123|P2|Overall Study|Pregnancy|7
2601363|NCT01064401|8993124|P1|Overall Study|Pregnancy|4
2601364|NCT01064401|8993123|P2|Overall Study|Death|0
2601365|NCT01064401|8993124|P1|Overall Study|Death|4
2601366|NCT01064401|8993123|P2|Overall Study|Investigator Decision|6
2601367|NCT01064401|8993124|P1|Overall Study|Investigator Decision|4
2601368|NCT01064401|8993123|P2|Overall Study|Consent Withdrawn|80
2601369|NCT01064401|8993124|P1|Overall Study|Consent Withdrawn|98
2601370|NCT01064401|8993123|P2|Overall Study|Lost to Follow-up|9
2601371|NCT01064401|8993124|P1|Overall Study|Lost to Follow-up|12
2601372|NCT01064401|8993123|P2|Overall Study|Lack of Efficacy|23
2601373|NCT01064401|8993124|P1|Overall Study|Lack of Efficacy|46
2601374|NCT01064401|8993123|P2|Overall Study|Adverse Event|56
2601375|NCT01064401|8993124|P1|Overall Study|Adverse Event|47
2601376|NCT01064310|8993173|P3|Open Label Pazopinib|Physician Decision|20
2601377|NCT01064310|8993174|P2|Open Label Pazopinib|Physician Decision|0
2601378|NCT01064310|8993175|P1|Open Label Pazopinib|Physician Decision|0
2601379|NCT01064310|8993173|P3|Open Label Pazopinib|Lack of Efficacy|51
2601380|NCT01064310|8993174|P2|Open Label Pazopinib|Lack of Efficacy|0
2601381|NCT01064310|8993175|P1|Open Label Pazopinib|Lack of Efficacy|0
2601382|NCT01064310|8993173|P3|Open Label Pazopinib|Adverse Event|12
2601383|NCT01064310|8993174|P2|Open Label Pazopinib|Adverse Event|0
2601384|NCT01064310|8993175|P1|Open Label Pazopinib|Adverse Event|0
2601385|NCT01064310|8993173|P3|Open Label Pazopinib|Withdrawal by Subject|1
2601386|NCT01064310|8993174|P2|Open Label Pazopinib|Withdrawal by Subject|0
2601387|NCT01064310|8993175|P1|Open Label Pazopinib|Withdrawal by Subject|0
2601388|NCT01064310|8993173|P3|Period 2|Lack of Efficacy|0
2601389|NCT01064310|8993174|P2|Period 2|Lack of Efficacy|4
2601390|NCT01064310|8993175|P1|Period 2|Lack of Efficacy|1
2601391|NCT01064310|8993173|P3|Period 2|Entered Open-label Period|0
2601392|NCT01064310|8993174|P2|Period 2|Entered Open-label Period|0
2601393|NCT01064310|8993175|P1|Period 2|Entered Open-label Period|1
2601394|NCT01064310|8993173|P3|Period 2|Physician Decision|0
2601395|NCT01064310|8993174|P2|Period 2|Physician Decision|1
2601396|NCT01064310|8993175|P1|Period 2|Physician Decision|0
2601397|NCT01064310|8993173|P3|Period 2|Adverse Event|0
2601398|NCT01064310|8993174|P2|Period 2|Adverse Event|1
2601399|NCT01064310|8993175|P1|Period 2|Adverse Event|2
2601400|NCT01064310|8993173|P3|Period 1|Entered Open-label Period|0
2601401|NCT01064310|8993174|P2|Period 1|Entered Open-label Period|1
2601402|NCT01064310|8993175|P1|Period 1|Entered Open-label Period|1
2601403|NCT01064310|8993173|P3|Period 1|Lack of Efficacy|0
2601404|NCT01064310|8993174|P2|Period 1|Lack of Efficacy|5
2601405|NCT01064310|8993175|P1|Period 1|Lack of Efficacy|3
2601406|NCT01064310|8993173|P3|Period 1|Withdrawal by Subject|0
2601407|NCT01064310|8993174|P2|Period 1|Withdrawal by Subject|2
2601408|NCT01064310|8993175|P1|Period 1|Withdrawal by Subject|2
2601409|NCT01064310|8993173|P3|Period 1|Physician Decision|0
2601410|NCT01064310|8993174|P2|Period 1|Physician Decision|0
2601411|NCT01064310|8993175|P1|Period 1|Physician Decision|1
2601412|NCT01064310|8993173|P3|Period 1|Adverse Event|0
2601413|NCT01064310|8993174|P2|Period 1|Adverse Event|10
2601414|NCT01064310|8993175|P1|Period 1|Adverse Event|7
2601415|NCT01064297|8993205|P3|Overall Study|Lost to Follow-up|133
2601416|NCT01064297|8993206|P2|Overall Study|Lost to Follow-up|48
2601417|NCT01064297|8993207|P1|Overall Study|Lost to Follow-up|791
2601418|NCT01064167|8993276|P2|Overall Study|Protocol Violation|15
2601419|NCT01064167|8993277|P1|Overall Study|Protocol Violation|14
2601420|NCT01063972|8993292|P2|Overall Study|Incarcerated|1
2601421|NCT01063972|8993293|P1|Overall Study|Incarcerated|2
2601422|NCT01063972|8993292|P2|Overall Study|Death|11
2601423|NCT01063972|8993293|P1|Overall Study|Death|12
2601424|NCT01063881|8993343|P3|Overall Study|Reason for not completed not specified|0
2601425|NCT01063881|8993344|P2|Overall Study|Reason for not completed not specified|1
2601426|NCT01063881|8993345|P1|Overall Study|Reason for not completed not specified|5
2601427|NCT01063881|8993343|P3|Overall Study|Withdrawal by Subject|0
2601428|NCT01063881|8993344|P2|Overall Study|Withdrawal by Subject|1
2601429|NCT01063881|8993345|P1|Overall Study|Withdrawal by Subject|25
2601430|NCT01063881|8993343|P3|Overall Study|Lost to Follow-up|1
2601431|NCT01063881|8993344|P2|Overall Study|Lost to Follow-up|7
2601432|NCT01063881|8993345|P1|Overall Study|Lost to Follow-up|13
2601433|NCT01063881|8993343|P3|Overall Study|Adverse Event|0
2601434|NCT01063881|8993344|P2|Overall Study|Adverse Event|2
2601435|NCT01063881|8993345|P1|Overall Study|Adverse Event|12
2601436|NCT01063868|8993369|P2|Overall Study|Study Terminated By Sponsor|4
2601437|NCT01063868|8993370|P1|Overall Study|Study Terminated By Sponsor|23
2601438|NCT01063868|8993369|P2|Overall Study|Withdrawal by Subject|1
2601439|NCT01063868|8993370|P1|Overall Study|Withdrawal by Subject|3
2601440|NCT01063868|8993369|P2|Overall Study|Adverse Event|7
2601441|NCT01063868|8993370|P1|Overall Study|Adverse Event|9
2601442|NCT01063855|8993378|P2|Overall Study|Reason not specified|11
2601443|NCT01063855|8993379|P1|Overall Study|Reason not specified|13
2601444|NCT01063855|8993378|P2|Overall Study|Withdrawal by Subject|8
2601445|NCT01063855|8993379|P1|Overall Study|Withdrawal by Subject|11
2601446|NCT01063855|8993378|P2|Overall Study|Lack of Efficacy|1
2601447|NCT01063855|8993379|P1|Overall Study|Lack of Efficacy|0
2601448|NCT01063855|8993378|P2|Overall Study|Pregnancy|0
2601449|NCT01063855|8993379|P1|Overall Study|Pregnancy|1
2601450|NCT01063855|8993378|P2|Overall Study|Lost to Follow-up|4
2601451|NCT01063855|8993379|P1|Overall Study|Lost to Follow-up|8
2601452|NCT01063855|8993378|P2|Overall Study|Death|1
2601453|NCT01063855|8993379|P1|Overall Study|Death|0
2601454|NCT01063855|8993378|P2|Overall Study|Adverse Event|4
2601455|NCT01063855|8993379|P1|Overall Study|Adverse Event|4
2601456|NCT01063764|8993426|P1|2nd Period (Week 22 to the End of Study)|Protocol Violation|1
2601457|NCT01063764|8993426|P1|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7
2601458|NCT01063764|8993426|P1|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9
2601459|NCT01063764|8993426|P1|2nd Period (Week 22 to the End of Study)|Adverse Event|3
2601460|NCT01063764|8993426|P1|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1
2601461|NCT01063764|8993426|P1|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6
2601462|NCT01063764|8993426|P1|1st Period (From Week 8 to Week 22)|Adverse Event|4
2601463|NCT01063595|8993445|P2|First Intervention|Reason not Specified|1
2601464|NCT01063595|8993446|P1|First Intervention|Reason not Specified|0
2601465|NCT01063595|8993445|P2|First Intervention|Withdrawal by Subject|0
2601466|NCT01063595|8993446|P1|First Intervention|Withdrawal by Subject|1
2601467|NCT01063595|8993445|P2|First Intervention|Adverse Event|4
2601468|NCT01063595|8993446|P1|First Intervention|Adverse Event|1
2601469|NCT01063595|8993445|P2|Enrolled in Study and Randomized|Withdrawn by the Investigator|1
2601470|NCT01063595|8993446|P1|Enrolled in Study and Randomized|Withdrawn by the Investigator|0
2601471|NCT01063595|8993445|P2|Enrolled in Study and Randomized|Adverse Event|1
2601472|NCT01063595|8993446|P1|Enrolled in Study and Randomized|Adverse Event|0
2601473|NCT01063595|8993445|P2|Enrolled in Study and Randomized|Reason not Specified|0
2601474|NCT01063595|8993446|P1|Enrolled in Study and Randomized|Reason not Specified|1
2601475|NCT01063517|8993458|P2|Overall Study|Death|48
2601476|NCT01063517|8993459|P1|Overall Study|Death|33
2601477|NCT01063517|8993458|P2|Overall Study|Withdrawal by Subject|2
2601478|NCT01063517|8993459|P1|Overall Study|Withdrawal by Subject|1
2601479|NCT01063517|8993458|P2|Overall Study|Lost to Follow-up|3
2601480|NCT01063517|8993459|P1|Overall Study|Lost to Follow-up|4
2601481|NCT01063517|8993458|P2|Overall Study|Study reached data cut-off|7
2601482|NCT01063517|8993459|P1|Overall Study|Study reached data cut-off|19
2601483|NCT01063517|8993458|P2|Overall Study|Consent withdrawal|0
2601484|NCT01063517|8993459|P1|Overall Study|Consent withdrawal|1
2601485|NCT01063348|8993499|P2|Overall Study|Lost to Follow-up|10
2601486|NCT01063348|8993500|P1|Overall Study|Lost to Follow-up|3
2601487|NCT01063283|8993510|P3|Cycle 1|Technical failure in data collection|0
2601488|NCT01063283|8993511|P2|Cycle 1|Technical failure in data collection|0
2601489|NCT01063283|8993512|P1|Cycle 1|Technical failure in data collection|1
2601490|NCT01063283|8993510|P3|Cycle 1|Adverse Event|0
2601491|NCT01063283|8993511|P2|Cycle 1|Adverse Event|0
2601492|NCT01063283|8993512|P1|Cycle 1|Adverse Event|2
2601493|NCT01063153|8993526|P2|Overall Study|Physician Decision|4
2601494|NCT01063153|8993527|P1|Overall Study|Physician Decision|0
2601495|NCT01063153|8993526|P2|Overall Study|Withdrawal by Subject|1
2601496|NCT01063153|8993527|P1|Overall Study|Withdrawal by Subject|0
2601497|NCT01063153|8993526|P2|Overall Study|Lost to Follow-up|7
2601498|NCT01063153|8993527|P1|Overall Study|Lost to Follow-up|0
2601499|NCT01063153|8993526|P2|Overall Study|Found Ineligible During Screening|0
2601500|NCT01063153|8993527|P1|Overall Study|Found Ineligible During Screening|2
2601501|NCT01063062|8993558|P2|Overall Study|Miscellaneous reason|1
2601502|NCT01063062|8993559|P1|Overall Study|Miscellaneous reason|0
2601503|NCT01063062|8993558|P2|Overall Study|Lost to Follow-up|2
2601504|NCT01063062|8993559|P1|Overall Study|Lost to Follow-up|0
2601505|NCT01063062|8993558|P2|Overall Study|Investigator's request|0
2601506|NCT01063062|8993559|P1|Overall Study|Investigator's request|1
2601507|NCT01063062|8993558|P2|Overall Study|Protocol Violation|4
2601508|NCT01063062|8993559|P1|Overall Study|Protocol Violation|5
2601509|NCT01063062|8993558|P2|Overall Study|Adverse Event|4
2601510|NCT01063062|8993559|P1|Overall Study|Adverse Event|2
2601511|NCT01063062|8993558|P2|Overall Study|Patient withdrew consent|1
2601512|NCT01063062|8993559|P1|Overall Study|Patient withdrew consent|0
2601513|NCT01063036|8993613|P1|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32
2601514|NCT01063036|8993613|P1|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6
2601515|NCT01063036|8993613|P1|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1
2601516|NCT01063036|8993613|P1|Participants Treated With Study Drug|Pregnancy|1
2601517|NCT01063036|8993613|P1|Participants Treated With Study Drug|Lost to Follow-up|1
2601518|NCT01063036|8993613|P1|Participants Treated With Study Drug|Withdrawal by Subject|2
2601607|NCT01061736|8993916|P3|Overall Study|Lack of Efficacy|1
2601519|NCT01063036|8993613|P1|Participants Treated With Study Drug|Protocol Violation|1
2601520|NCT01063036|8993613|P1|Participants Treated With Study Drug|Adverse Event|1
2601521|NCT01062971|8993629|P2|Overall Study|Lost to Follow-up|4
2601522|NCT01062971|8993630|P1|Overall Study|Lost to Follow-up|3
2601523|NCT01062971|8993629|P2|Overall Study|Protocol Violation|3
2601524|NCT01062971|8993630|P1|Overall Study|Protocol Violation|1
2601525|NCT01062841|8993669|P2|Overall Study|Withdrawal by Study|0
2601526|NCT01062841|8993670|P1|Overall Study|Withdrawal by Study|3
2601527|NCT01062841|8993669|P2|Overall Study|Withdrawal by Subject|0
2601528|NCT01062841|8993670|P1|Overall Study|Withdrawal by Subject|2
2601529|NCT01062841|8993669|P2|Overall Study|Death|5
2601530|NCT01062841|8993670|P1|Overall Study|Death|3
2601531|NCT01062841|8993669|P2|Overall Study|Indwelling Device Removed|48
2601532|NCT01062841|8993670|P1|Overall Study|Indwelling Device Removed|41
2601533|NCT01062763|8993700|P2|Overall Study|Adverse Event|4
2601534|NCT01062763|8993701|P1|Overall Study|Adverse Event|3
2601535|NCT01062425|8993727|P2|Overall Study|Protocol Violation|6
2601536|NCT01062425|8993728|P1|Overall Study|Protocol Violation|3
2601537|NCT01062399|8993745|P5|Overall Study|Protocol Violation|4
2601538|NCT01062399|8993746|P4|Overall Study|Protocol Violation|6
2601539|NCT01062399|8993747|P3|Overall Study|Protocol Violation|0
2601540|NCT01062399|8993748|P2|Overall Study|Protocol Violation|1
2601541|NCT01062399|8993749|P1|Overall Study|Protocol Violation|0
2601542|NCT01062256|8993793|P3|Overall Study|Administrative|0
2601543|NCT01062256|8993794|P2|Overall Study|Administrative|2
2601544|NCT01062256|8993795|P1|Overall Study|Administrative|0
2601545|NCT01062256|8993793|P3|Overall Study|Ineligible|3
2601546|NCT01062256|8993794|P2|Overall Study|Ineligible|4
2601547|NCT01062256|8993795|P1|Overall Study|Ineligible|1
2601548|NCT01062256|8993793|P3|Overall Study|Withdrawal by Subject|1
2601549|NCT01062256|8993794|P2|Overall Study|Withdrawal by Subject|1
2601550|NCT01062256|8993795|P1|Overall Study|Withdrawal by Subject|1
2601551|NCT01062256|8993793|P3|Overall Study|Adverse Event|0
2601552|NCT01062256|8993794|P2|Overall Study|Adverse Event|0
2601553|NCT01062256|8993795|P1|Overall Study|Adverse Event|1
2601554|NCT01062113|8993829|P3|Overall Study|Withdrawal by Subject|0
2601555|NCT01062113|8993830|P2|Overall Study|Withdrawal by Subject|0
2601556|NCT01062113|8993831|P1|Overall Study|Withdrawal by Subject|1
2601557|NCT01062113|8993829|P3|Overall Study|Lack of Efficacy|31
2601558|NCT01062113|8993830|P2|Overall Study|Lack of Efficacy|22
2601559|NCT01062113|8993831|P1|Overall Study|Lack of Efficacy|38
2601560|NCT01062113|8993829|P3|Overall Study|Adverse Event|0
2601561|NCT01062113|8993830|P2|Overall Study|Adverse Event|0
2601562|NCT01062113|8993831|P1|Overall Study|Adverse Event|1
2601563|NCT01062061|8993849|P1|Overall Study|Failed to meet inclusion criteria|2
2601564|NCT01062061|8993849|P1|Overall Study|Outside chief indications|10
2601565|NCT01062061|8993849|P1|Overall Study|Investigated before study start|13
2601566|NCT01062061|8993849|P1|Overall Study|Enrolled more than once|2
2601567|NCT01061866|8993888|P1|Overall Study|Adverse Event|2
2601568|NCT01061775|8993892|P1|Overall Study|Lost to Follow-up|1
2601569|NCT01061775|8993892|P1|Overall Study|Physician Decision|2
2601570|NCT01061736|8993909|P10|Overall Study|Other than specified above|21
2601571|NCT01061736|8993910|P9|Overall Study|Other than specified above|15
2601572|NCT01061736|8993911|P8|Overall Study|Other than specified above|18
2601573|NCT01061736|8993912|P7|Overall Study|Other than specified above|0
2601574|NCT01061736|8993913|P6|Overall Study|Other than specified above|0
2601575|NCT01061736|8993914|P5|Overall Study|Other than specified above|1
2601576|NCT01061736|8993915|P4|Overall Study|Other than specified above|0
2601577|NCT01061736|8993916|P3|Overall Study|Other than specified above|2
2601578|NCT01061736|8993917|P2|Overall Study|Other than specified above|1
2601579|NCT01061736|8993918|P1|Overall Study|Other than specified above|0
2601580|NCT01061736|8993909|P10|Overall Study|Not treated|0
2601581|NCT01061736|8993910|P9|Overall Study|Not treated|1
2601582|NCT01061736|8993911|P8|Overall Study|Not treated|2
2601583|NCT01061736|8993912|P7|Overall Study|Not treated|0
2601584|NCT01061736|8993913|P6|Overall Study|Not treated|0
2601585|NCT01061736|8993914|P5|Overall Study|Not treated|1
2601586|NCT01061736|8993915|P4|Overall Study|Not treated|0
2601587|NCT01061736|8993916|P3|Overall Study|Not treated|0
2601588|NCT01061736|8993917|P2|Overall Study|Not treated|0
2601589|NCT01061736|8993918|P1|Overall Study|Not treated|0
2601590|NCT01061736|8993909|P10|Overall Study|Poor compliance to protocol|9
2601591|NCT01061736|8993910|P9|Overall Study|Poor compliance to protocol|5
2601592|NCT01061736|8993911|P8|Overall Study|Poor compliance to protocol|2
2601593|NCT01061736|8993912|P7|Overall Study|Poor compliance to protocol|0
2601594|NCT01061736|8993913|P6|Overall Study|Poor compliance to protocol|0
2601595|NCT01061736|8993914|P5|Overall Study|Poor compliance to protocol|0
2601596|NCT01061736|8993915|P4|Overall Study|Poor compliance to protocol|0
2601597|NCT01061736|8993916|P3|Overall Study|Poor compliance to protocol|0
2601598|NCT01061736|8993917|P2|Overall Study|Poor compliance to protocol|0
2601599|NCT01061736|8993918|P1|Overall Study|Poor compliance to protocol|0
2601600|NCT01061736|8993909|P10|Overall Study|Lack of Efficacy|10
2601601|NCT01061736|8993910|P9|Overall Study|Lack of Efficacy|9
2601602|NCT01061736|8993911|P8|Overall Study|Lack of Efficacy|9
2601603|NCT01061736|8993912|P7|Overall Study|Lack of Efficacy|1
2601604|NCT01061736|8993913|P6|Overall Study|Lack of Efficacy|2
2601605|NCT01061736|8993914|P5|Overall Study|Lack of Efficacy|1
2601606|NCT01061736|8993915|P4|Overall Study|Lack of Efficacy|1
2601608|NCT01061736|8993917|P2|Overall Study|Lack of Efficacy|2
2601609|NCT01061736|8993918|P1|Overall Study|Lack of Efficacy|0
2601610|NCT01061736|8993909|P10|Overall Study|Adverse Event|34
2601611|NCT01061736|8993910|P9|Overall Study|Adverse Event|67
2601612|NCT01061736|8993911|P8|Overall Study|Adverse Event|63
2601613|NCT01061736|8993912|P7|Overall Study|Adverse Event|4
2601614|NCT01061736|8993913|P6|Overall Study|Adverse Event|1
2601615|NCT01061736|8993914|P5|Overall Study|Adverse Event|4
2601616|NCT01061736|8993915|P4|Overall Study|Adverse Event|2
2601617|NCT01061736|8993916|P3|Overall Study|Adverse Event|3
2601618|NCT01061736|8993917|P2|Overall Study|Adverse Event|1
2601619|NCT01061736|8993918|P1|Overall Study|Adverse Event|13
2601620|NCT01061736|8993909|P10|Overall Study|Dose regimen not selected|0
2601621|NCT01061736|8993910|P9|Overall Study|Dose regimen not selected|0
2601622|NCT01061736|8993911|P8|Overall Study|Dose regimen not selected|0
2601623|NCT01061736|8993912|P7|Overall Study|Dose regimen not selected|79
2601624|NCT01061736|8993913|P6|Overall Study|Dose regimen not selected|0
2601625|NCT01061736|8993914|P5|Overall Study|Dose regimen not selected|0
2601626|NCT01061736|8993915|P4|Overall Study|Dose regimen not selected|0
2601627|NCT01061736|8993916|P3|Overall Study|Dose regimen not selected|0
2601628|NCT01061736|8993917|P2|Overall Study|Dose regimen not selected|0
2601629|NCT01061736|8993918|P1|Overall Study|Dose regimen not selected|0
2601630|NCT01061723|8993957|P6|Overall Study|Other than specified above|1
2601631|NCT01061723|8993958|P5|Overall Study|Other than specified above|0
2601632|NCT01061723|8993959|P4|Overall Study|Other than specified above|1
2601633|NCT01061723|8993960|P3|Overall Study|Other than specified above|1
2601634|NCT01061723|8993961|P2|Overall Study|Other than specified above|1
2601635|NCT01061723|8993962|P1|Overall Study|Other than specified above|2
2601636|NCT01061723|8993957|P6|Overall Study|Randomized but not treated|1
2601637|NCT01061723|8993958|P5|Overall Study|Randomized but not treated|0
2601638|NCT01061723|8993959|P4|Overall Study|Randomized but not treated|0
2601639|NCT01061723|8993960|P3|Overall Study|Randomized but not treated|0
2601640|NCT01061723|8993961|P2|Overall Study|Randomized but not treated|0
2601641|NCT01061723|8993962|P1|Overall Study|Randomized but not treated|0
2601642|NCT01061723|8993957|P6|Overall Study|Lack of Efficacy|1
2601643|NCT01061723|8993958|P5|Overall Study|Lack of Efficacy|1
2601644|NCT01061723|8993959|P4|Overall Study|Lack of Efficacy|2
2601645|NCT01061723|8993960|P3|Overall Study|Lack of Efficacy|4
2601646|NCT01061723|8993961|P2|Overall Study|Lack of Efficacy|3
2601647|NCT01061723|8993962|P1|Overall Study|Lack of Efficacy|2
2601648|NCT01061723|8993957|P6|Overall Study|Adverse Event|6
2601649|NCT01061723|8993958|P5|Overall Study|Adverse Event|2
2601650|NCT01061723|8993959|P4|Overall Study|Adverse Event|5
2601651|NCT01061723|8993960|P3|Overall Study|Adverse Event|5
2601652|NCT01061723|8993961|P2|Overall Study|Adverse Event|2
2601653|NCT01061723|8993962|P1|Overall Study|Adverse Event|0
2601654|NCT01061710|8994042|P1|Overall Study|Protocol Violation|14
2601655|NCT01061671|8994052|P2|Overall Study|Death|30
2601656|NCT01061671|8994053|P1|Overall Study|Death|28
2601657|NCT01061671|8994052|P2|Overall Study|Lost to Follow-up|5
2601658|NCT01061671|8994053|P1|Overall Study|Lost to Follow-up|3
2601659|NCT01061671|8994052|P2|Overall Study|Withdrawal by Subject|20
2601660|NCT01061671|8994053|P1|Overall Study|Withdrawal by Subject|16
2601661|NCT01061606|8994065|P1|Overall Study|alternative therapy|2
2601662|NCT01061606|8994065|P1|Overall Study|Disease Progression|4
2601663|NCT01061606|8994065|P1|Overall Study|Death|1
2601664|NCT01061606|8994065|P1|Overall Study|Adverse Event|1
2601665|NCT01061567|8994074|P1|Overall Study|Other reason than stated above|3
2601666|NCT01061567|8994074|P1|Overall Study|Withdrawal by Subject|11
2601667|NCT01061567|8994074|P1|Overall Study|Protocol Violation|1
2601668|NCT01061567|8994074|P1|Overall Study|Lost to Follow-up|24
2601669|NCT01061567|8994074|P1|Overall Study|Lack of Efficacy|3
2601670|NCT01061567|8994074|P1|Overall Study|Death|2
2601671|NCT01061567|8994074|P1|Overall Study|Adverse Event|32
2601672|NCT01061385|8994098|P2|Overall Study|subject decision not related to AE|1
2601673|NCT01061385|8994099|P1|Overall Study|subject decision not related to AE|0
2601674|NCT01061385|8994098|P2|Overall Study|Lost to Follow-up|0
2601675|NCT01061385|8994099|P1|Overall Study|Lost to Follow-up|1
2601676|NCT01061359|8994107|P1|Overall Study|Secondary neoplasm|11
2601677|NCT01061359|8994107|P1|Overall Study|Relapse|187
2601678|NCT01061359|8994107|P1|Overall Study|Lost to Follow-up|1072
2601679|NCT01061359|8994107|P1|Overall Study|Death|32
2601680|NCT01061333|8994113|P2|Period 4: 20-day Washout|Discontinued by Study Team|1
2601681|NCT01061333|8994114|P1|Period 4: 20-day Washout|Discontinued by Study Team|0
2601682|NCT01061177|8994152|P1|Overall Study|Death|4
2601683|NCT01061177|8994152|P1|Overall Study|Administratie problems|4
2601684|NCT01061177|8994152|P1|Overall Study|Abnormal test procedure results|4
2601685|NCT01061177|8994152|P1|Overall Study|Abnormal laboratory values|6
2601686|NCT01061177|8994152|P1|Overall Study|New cancer therapy|9
2601687|NCT01061177|8994152|P1|Overall Study|Lost to Follow-up|9
2601688|NCT01061177|8994152|P1|Overall Study|Protocol Violation|11
2601689|NCT01061177|8994152|P1|Overall Study|Disease progression|17
2601690|NCT01061177|8994152|P1|Overall Study|Withdrawal by Subject|27
2601691|NCT01061177|8994152|P1|Overall Study|Adverse Event|117
2601692|NCT01061151|8994175|P4|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3
2601693|NCT01061151|8994176|P3|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1
2601694|NCT01061151|8994177|P2|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8
2601770|NCT01060540|8994290|P2|Overall Study|Physician Decision|1
2601695|NCT01061151|8994178|P1|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5
2601696|NCT01061151|8994175|P4|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5
2601697|NCT01061151|8994176|P3|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15
2601698|NCT01061151|8994177|P2|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26
2601699|NCT01061151|8994178|P1|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28
2601700|NCT01061151|8994175|P4|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0
2601701|NCT01061151|8994176|P3|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2
2601702|NCT01061151|8994177|P2|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11
2601703|NCT01061151|8994178|P1|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12
2601704|NCT01061151|8994175|P4|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4
2601705|NCT01061151|8994176|P3|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25
2601706|NCT01061151|8994177|P2|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36
2601707|NCT01061151|8994178|P1|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49
2601708|NCT01061151|8994175|P4|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3
2601709|NCT01061151|8994176|P3|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31
2601710|NCT01061151|8994177|P2|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52
2601711|NCT01061151|8994178|P1|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54
2601712|NCT01061151|8994175|P4|Protocol Version 3.0: 10/2012-10/2014|Death|1
2601713|NCT01061151|8994176|P3|Protocol Version 3.0: 10/2012-10/2014|Death|1
2601714|NCT01061151|8994177|P2|Protocol Version 3.0: 10/2012-10/2014|Death|5
2601715|NCT01061151|8994178|P1|Protocol Version 3.0: 10/2012-10/2014|Death|3
2601716|NCT01061151|8994175|P4|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
2601717|NCT01061151|8994176|P3|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
2601718|NCT01061151|8994177|P2|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
2601719|NCT01061151|8994178|P1|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1
2601720|NCT01061151|8994175|P4|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4
2601721|NCT01061151|8994176|P3|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2
2601722|NCT01061151|8994177|P2|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
2601723|NCT01061151|8994178|P1|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
2601724|NCT01061151|8994175|P4|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0
2601725|NCT01061151|8994176|P3|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1
2601726|NCT01061151|8994177|P2|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5
2601727|NCT01061151|8994178|P1|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3
2601728|NCT01061151|8994175|P4|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5
2601729|NCT01061151|8994176|P3|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2
2601730|NCT01061151|8994177|P2|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61
2601731|NCT01061151|8994178|P1|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44
2601732|NCT01061151|8994175|P4|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0
2601733|NCT01061151|8994176|P3|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1
2601734|NCT01061151|8994177|P2|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19
2601735|NCT01061151|8994178|P1|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15
2601736|NCT01061151|8994175|P4|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10
2601737|NCT01061151|8994176|P3|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2
2601738|NCT01061151|8994177|P2|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65
2601739|NCT01061151|8994178|P1|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73
2601740|NCT01061151|8994175|P4|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10
2601741|NCT01061151|8994176|P3|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2
2601742|NCT01061151|8994177|P2|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82
2601743|NCT01061151|8994178|P1|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89
2601744|NCT01061151|8994175|P4|Protocol Version 2.0: 04/2011-09/2012|Death|2
2601745|NCT01061151|8994176|P3|Protocol Version 2.0: 04/2011-09/2012|Death|1
2601746|NCT01061151|8994177|P2|Protocol Version 2.0: 04/2011-09/2012|Death|9
2601747|NCT01061151|8994178|P1|Protocol Version 2.0: 04/2011-09/2012|Death|6
2601748|NCT01061151|8994175|P4|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1
2601749|NCT01061151|8994176|P3|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
2601750|NCT01061151|8994177|P2|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
2601751|NCT01061151|8994178|P1|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2
2601752|NCT01061008|8994237|P2|Overall Study|Adverse Event|1
2601753|NCT01061008|8994238|P1|Overall Study|Adverse Event|0
2601754|NCT01061008|8994237|P2|Overall Study|Unable to exercise following surgery|0
2601755|NCT01061008|8994238|P1|Overall Study|Unable to exercise following surgery|1
2601756|NCT01061008|8994237|P2|Overall Study|Withdrawal by Subject|3
2601757|NCT01061008|8994238|P1|Overall Study|Withdrawal by Subject|1
2601758|NCT01061008|8994237|P2|Overall Study|Death|0
2601759|NCT01061008|8994238|P1|Overall Study|Death|1
2601760|NCT01061008|8994237|P2|Overall Study|Badiocephalic fistula failed|2
2601761|NCT01061008|8994238|P1|Overall Study|Badiocephalic fistula failed|3
2601762|NCT01060670|8994246|P2|Run In|screen failure|238
2601763|NCT01060670|8994247|P1|Run In|screen failure|0
2601764|NCT01060553|8994282|P2|Overall Study|Lack of Efficacy|0
2601765|NCT01060553|8994283|P1|Overall Study|Lack of Efficacy|1
2601766|NCT01060553|8994282|P2|Overall Study|Withdrawal by Subject|5
2601767|NCT01060553|8994283|P1|Overall Study|Withdrawal by Subject|5
2601768|NCT01060553|8994282|P2|Overall Study|Lost to Follow-up|5
2601769|NCT01060553|8994283|P1|Overall Study|Lost to Follow-up|3
2601771|NCT01060540|8994291|P1|Overall Study|Physician Decision|0
2601772|NCT01060540|8994290|P2|Overall Study|Death|1
2601773|NCT01060540|8994291|P1|Overall Study|Death|2
2601774|NCT01060540|8994290|P2|Overall Study|Lost to Follow-up|43
2601775|NCT01060540|8994291|P1|Overall Study|Lost to Follow-up|52
2601776|NCT01060540|8994290|P2|Overall Study|Withdrawal by Subject|20
2601777|NCT01060540|8994291|P1|Overall Study|Withdrawal by Subject|10
2601778|NCT01060384|8994305|P5|Overall Study|Intercurrent illness|1
2601779|NCT01060384|8994306|P4|Overall Study|Intercurrent illness|0
2601780|NCT01060384|8994307|P3|Overall Study|Intercurrent illness|0
2601781|NCT01060384|8994308|P2|Overall Study|Intercurrent illness|0
2601782|NCT01060384|8994309|P1|Overall Study|Intercurrent illness|0
2601783|NCT01060384|8994305|P5|Overall Study|Death|1
2601784|NCT01060384|8994306|P4|Overall Study|Death|0
2601785|NCT01060384|8994307|P3|Overall Study|Death|0
2601786|NCT01060384|8994308|P2|Overall Study|Death|0
2601787|NCT01060384|8994309|P1|Overall Study|Death|0
2601788|NCT01060384|8994305|P5|Overall Study|Withdrawal by Subject|0
2601789|NCT01060384|8994306|P4|Overall Study|Withdrawal by Subject|0
2601790|NCT01060384|8994307|P3|Overall Study|Withdrawal by Subject|0
2601791|NCT01060384|8994308|P2|Overall Study|Withdrawal by Subject|1
2601792|NCT01060384|8994309|P1|Overall Study|Withdrawal by Subject|0
2601793|NCT01060150|8994328|P1|Overall Study|Enrolled, but not treated|2
2601794|NCT01060150|8994328|P1|Overall Study|Withdrawal by Subject|8
2601795|NCT01060150|8994328|P1|Overall Study|Protocol Violation|6
2601796|NCT01060150|8994328|P1|Overall Study|Lost to Follow-up|1
2601797|NCT01060150|8994328|P1|Overall Study|Adverse Event|6
2601798|NCT01060124|8994343|P1|Overall Study|Withdrawal by Subject|7
2601799|NCT01060124|8994343|P1|Overall Study|Adverse Event|14
2601800|NCT01060124|8994343|P1|Overall Study|Other|16
2601801|NCT01060111|8994354|P3|Overall Study|Other|4
2601802|NCT01060111|8994355|P2|Overall Study|Other|3
2601803|NCT01060111|8994356|P1|Overall Study|Other|2
2601804|NCT01060111|8994354|P3|Overall Study|Participants' non-cooperation|0
2601805|NCT01060111|8994355|P2|Overall Study|Participants' non-cooperation|0
2601806|NCT01060111|8994356|P1|Overall Study|Participants' non-cooperation|1
2601807|NCT01060111|8994354|P3|Overall Study|Adverse event and insufficient effect|0
2601808|NCT01060111|8994355|P2|Overall Study|Adverse event and insufficient effect|1
2601809|NCT01060111|8994356|P1|Overall Study|Adverse event and insufficient effect|0
2601810|NCT01060111|8994354|P3|Overall Study|Participants' non-cooperation|6
2601811|NCT01060111|8994355|P2|Overall Study|Participants' non-cooperation|6
2601812|NCT01060111|8994356|P1|Overall Study|Participants' non-cooperation|8
2601813|NCT01060111|8994354|P3|Overall Study|Participants' evasion for hospital visit|2
2601814|NCT01060111|8994355|P2|Overall Study|Participants' evasion for hospital visit|3
2601815|NCT01060111|8994356|P1|Overall Study|Participants' evasion for hospital visit|0
2601816|NCT01060111|8994354|P3|Overall Study|Inappropriate participant|5
2601817|NCT01060111|8994355|P2|Overall Study|Inappropriate participant|4
2601818|NCT01060111|8994356|P1|Overall Study|Inappropriate participant|5
2601819|NCT01060111|8994354|P3|Overall Study|Lack of Efficacy|0
2601820|NCT01060111|8994355|P2|Overall Study|Lack of Efficacy|1
2601821|NCT01060111|8994356|P1|Overall Study|Lack of Efficacy|2
2601822|NCT01060111|8994354|P3|Overall Study|Adverse Event|18
2601823|NCT01060111|8994355|P2|Overall Study|Adverse Event|5
2601824|NCT01060111|8994356|P1|Overall Study|Adverse Event|9
2601825|NCT01060072|8994388|P2|Overall Study|Excluded Medications|1
2601826|NCT01060072|8994389|P1|Overall Study|Excluded Medications|0
2601827|NCT01060072|8994388|P2|Overall Study|Acute cholecystitis|0
2601828|NCT01060072|8994389|P1|Overall Study|Acute cholecystitis|1
2601829|NCT01060072|8994388|P2|Overall Study|Protocol Violation|1
2601830|NCT01060072|8994389|P1|Overall Study|Protocol Violation|0
2601831|NCT01060072|8994388|P2|Overall Study|Physician Decision|2
2601832|NCT01060072|8994389|P1|Overall Study|Physician Decision|0
2601833|NCT01060072|8994388|P2|Overall Study|Adverse Event|1
2601834|NCT01060072|8994389|P1|Overall Study|Adverse Event|1
2601835|NCT01060059|8994405|P2|Overall Study|lack of compliance|2
2601836|NCT01060059|8994406|P1|Overall Study|lack of compliance|5
2601837|NCT01060059|8994405|P2|Overall Study|lack of glycemic control|1
2601838|NCT01060059|8994406|P1|Overall Study|lack of glycemic control|2
2601839|NCT01060059|8994405|P2|Overall Study|Withdrawal by Subject|23
2601840|NCT01060059|8994406|P1|Overall Study|Withdrawal by Subject|35
2601841|NCT01060059|8994405|P2|Overall Study|entry criteria not met|3
2601842|NCT01060059|8994406|P1|Overall Study|entry criteria not met|4
2601843|NCT01060059|8994405|P2|Overall Study|Lost to Follow-up|34
2601844|NCT01060059|8994406|P1|Overall Study|Lost to Follow-up|18
2601845|NCT01060059|8994405|P2|Overall Study|Death|3
2601846|NCT01060059|8994406|P1|Overall Study|Death|2
2601847|NCT01060059|8994405|P2|Overall Study|Adverse Event|1
2601848|NCT01060059|8994406|P1|Overall Study|Adverse Event|1
2601849|NCT01060007|8994464|P1|Overall Study|Inevaluable for response at surgery|3
2601850|NCT01060007|8994464|P1|Overall Study|Withdrawal by Subject|1
2601851|NCT01059903|8994532|P2|Period 1: First Intervention- 24 Hours|Adverse Event|1
2601852|NCT01059903|8994533|P1|Period 1: First Intervention- 24 Hours|Adverse Event|1
2601853|NCT01059864|8994576|P3|Double-Blind Treatment Phase|Adverse Event|3
2601854|NCT01059864|8994577|P2|Double-Blind Treatment Phase|Adverse Event|3
2601855|NCT01059864|8994578|P1|Double-Blind Treatment Phase|Adverse Event|0
2601856|NCT01059864|8994576|P3|Open-Label Run-In Phase|Protocol Violation|0
2601857|NCT01059864|8994577|P2|Open-Label Run-In Phase|Protocol Violation|0
2601858|NCT01059864|8994578|P1|Open-Label Run-In Phase|Protocol Violation|2
2601859|NCT01059864|8994576|P3|Open-Label Run-In Phase|Withdrawal by Subject|0
2601860|NCT01059864|8994577|P2|Open-Label Run-In Phase|Withdrawal by Subject|0
2601861|NCT01059864|8994578|P1|Open-Label Run-In Phase|Withdrawal by Subject|1
2601862|NCT01059864|8994576|P3|Open-Label Run-In Phase|Lost to Follow-up|0
2601863|NCT01059864|8994577|P2|Open-Label Run-In Phase|Lost to Follow-up|0
2601864|NCT01059864|8994578|P1|Open-Label Run-In Phase|Lost to Follow-up|2
2601865|NCT01059864|8994576|P3|Open-Label Run-In Phase|Lack of Efficacy|0
2601866|NCT01059864|8994577|P2|Open-Label Run-In Phase|Lack of Efficacy|0
2601867|NCT01059864|8994578|P1|Open-Label Run-In Phase|Lack of Efficacy|1
2601868|NCT01059864|8994576|P3|Open-Label Run-In Phase|Adverse Event|0
2601869|NCT01059864|8994577|P2|Open-Label Run-In Phase|Adverse Event|0
2601870|NCT01059864|8994578|P1|Open-Label Run-In Phase|Adverse Event|7
2601871|NCT01059825|8994652|P7|Treatment Period|Adverse event not related to study drug|0
2601872|NCT01059825|8994653|P6|Treatment Period|Adverse event not related to study drug|1
2601873|NCT01059825|8994654|P5|Treatment Period|Adverse event not related to study drug|1
2601874|NCT01059825|8994655|P4|Treatment Period|Adverse event not related to study drug|1
2601875|NCT01059825|8994656|P3|Treatment Period|Adverse event not related to study drug|2
2601876|NCT01059825|8994657|P2|Treatment Period|Adverse event not related to study drug|1
2601877|NCT01059825|8994658|P1|Treatment Period|Adverse event not related to study drug|0
2601878|NCT01059825|8994652|P7|Treatment Period|Insufficient clinical response|0
2601879|NCT01059825|8994653|P6|Treatment Period|Insufficient clinical response|0
2601880|NCT01059825|8994654|P5|Treatment Period|Insufficient clinical response|0
2601881|NCT01059825|8994655|P4|Treatment Period|Insufficient clinical response|0
2601882|NCT01059825|8994656|P3|Treatment Period|Insufficient clinical response|0
2601883|NCT01059825|8994657|P2|Treatment Period|Insufficient clinical response|0
2601884|NCT01059825|8994658|P1|Treatment Period|Insufficient clinical response|3
2601885|NCT01059825|8994652|P7|Treatment Period|Adverse event related to study drug|0
2601886|NCT01059825|8994653|P6|Treatment Period|Adverse event related to study drug|0
2601887|NCT01059825|8994654|P5|Treatment Period|Adverse event related to study drug|0
2601888|NCT01059825|8994655|P4|Treatment Period|Adverse event related to study drug|1
2601889|NCT01059825|8994656|P3|Treatment Period|Adverse event related to study drug|1
2601890|NCT01059825|8994657|P2|Treatment Period|Adverse event related to study drug|0
2601891|NCT01059825|8994658|P1|Treatment Period|Adverse event related to study drug|1
2601892|NCT01059825|8994652|P7|Treatment Period|Protocol Violation|0
2601893|NCT01059825|8994653|P6|Treatment Period|Protocol Violation|1
2601894|NCT01059825|8994654|P5|Treatment Period|Protocol Violation|1
2601895|NCT01059825|8994655|P4|Treatment Period|Protocol Violation|1
2601896|NCT01059825|8994656|P3|Treatment Period|Protocol Violation|1
2601897|NCT01059825|8994657|P2|Treatment Period|Protocol Violation|0
2601898|NCT01059825|8994658|P1|Treatment Period|Protocol Violation|0
2601899|NCT01059825|8994652|P7|Treatment Period|Other reason not specified|0
2601900|NCT01059825|8994653|P6|Treatment Period|Other reason not specified|0
2601901|NCT01059825|8994654|P5|Treatment Period|Other reason not specified|0
2601902|NCT01059825|8994655|P4|Treatment Period|Other reason not specified|2
2601903|NCT01059825|8994656|P3|Treatment Period|Other reason not specified|1
2601904|NCT01059825|8994657|P2|Treatment Period|Other reason not specified|2
2601905|NCT01059825|8994658|P1|Treatment Period|Other reason not specified|1
2601906|NCT01059825|8994652|P7|Treatment Period|Withdrawal by Subject|0
2601907|NCT01059825|8994653|P6|Treatment Period|Withdrawal by Subject|1
2601908|NCT01059825|8994654|P5|Treatment Period|Withdrawal by Subject|4
2601909|NCT01059825|8994655|P4|Treatment Period|Withdrawal by Subject|5
2601910|NCT01059825|8994656|P3|Treatment Period|Withdrawal by Subject|1
2601911|NCT01059825|8994657|P2|Treatment Period|Withdrawal by Subject|0
2601912|NCT01059825|8994658|P1|Treatment Period|Withdrawal by Subject|3
2601913|NCT01059825|8994652|P7|Treatment Period|Lost to Follow-up|0
2601914|NCT01059825|8994653|P6|Treatment Period|Lost to Follow-up|0
2601915|NCT01059825|8994654|P5|Treatment Period|Lost to Follow-up|2
2601916|NCT01059825|8994655|P4|Treatment Period|Lost to Follow-up|1
2601917|NCT01059825|8994656|P3|Treatment Period|Lost to Follow-up|0
2601918|NCT01059825|8994657|P2|Treatment Period|Lost to Follow-up|1
2601919|NCT01059825|8994658|P1|Treatment Period|Lost to Follow-up|2
2601920|NCT01059825|8994652|P7|Enrolled, Run-in Period|Protocol Violation|5
2601921|NCT01059825|8994653|P6|Enrolled, Run-in Period|Protocol Violation|0
2601922|NCT01059825|8994654|P5|Enrolled, Run-in Period|Protocol Violation|0
2601923|NCT01059825|8994655|P4|Enrolled, Run-in Period|Protocol Violation|0
2601924|NCT01059825|8994656|P3|Enrolled, Run-in Period|Protocol Violation|0
2601925|NCT01059825|8994657|P2|Enrolled, Run-in Period|Protocol Violation|0
2601926|NCT01059825|8994658|P1|Enrolled, Run-in Period|Protocol Violation|0
2601927|NCT01059825|8994652|P7|Enrolled, Run-in Period|Other reason not specified|7
2601928|NCT01059825|8994653|P6|Enrolled, Run-in Period|Other reason not specified|0
2601929|NCT01059825|8994654|P5|Enrolled, Run-in Period|Other reason not specified|0
2601930|NCT01059825|8994655|P4|Enrolled, Run-in Period|Other reason not specified|0
2601931|NCT01059825|8994656|P3|Enrolled, Run-in Period|Other reason not specified|0
2601932|NCT01059825|8994657|P2|Enrolled, Run-in Period|Other reason not specified|0
2601933|NCT01059825|8994658|P1|Enrolled, Run-in Period|Other reason not specified|0
2601934|NCT01059825|8994652|P7|Enrolled, Run-in Period|Withdrawal by Subject|13
2601935|NCT01059825|8994653|P6|Enrolled, Run-in Period|Withdrawal by Subject|0
2601936|NCT01059825|8994654|P5|Enrolled, Run-in Period|Withdrawal by Subject|0
2601937|NCT01059825|8994655|P4|Enrolled, Run-in Period|Withdrawal by Subject|0
2601938|NCT01059825|8994656|P3|Enrolled, Run-in Period|Withdrawal by Subject|0
2601939|NCT01059825|8994657|P2|Enrolled, Run-in Period|Withdrawal by Subject|0
2601940|NCT01059825|8994658|P1|Enrolled, Run-in Period|Withdrawal by Subject|0
2601941|NCT01059825|8994652|P7|Enrolled, Run-in Period|Lost to Follow-up|5
2601942|NCT01059825|8994653|P6|Enrolled, Run-in Period|Lost to Follow-up|0
2601943|NCT01059825|8994654|P5|Enrolled, Run-in Period|Lost to Follow-up|0
2601944|NCT01059825|8994655|P4|Enrolled, Run-in Period|Lost to Follow-up|0
2601945|NCT01059825|8994656|P3|Enrolled, Run-in Period|Lost to Follow-up|0
2601946|NCT01059825|8994657|P2|Enrolled, Run-in Period|Lost to Follow-up|0
2601947|NCT01059825|8994658|P1|Enrolled, Run-in Period|Lost to Follow-up|0
2601948|NCT01059825|8994652|P7|Enrolled, Run-in Period|Did not meet entrance criteria|14
2601949|NCT01059825|8994653|P6|Enrolled, Run-in Period|Did not meet entrance criteria|0
2601950|NCT01059825|8994654|P5|Enrolled, Run-in Period|Did not meet entrance criteria|0
2601951|NCT01059825|8994655|P4|Enrolled, Run-in Period|Did not meet entrance criteria|0
2601952|NCT01059825|8994656|P3|Enrolled, Run-in Period|Did not meet entrance criteria|0
2601953|NCT01059825|8994657|P2|Enrolled, Run-in Period|Did not meet entrance criteria|0
2601954|NCT01059825|8994658|P1|Enrolled, Run-in Period|Did not meet entrance criteria|0
2601955|NCT01059825|8994652|P7|Enrolled, Run-in Period|Adverse event not related to study drug|3
2601956|NCT01059825|8994653|P6|Enrolled, Run-in Period|Adverse event not related to study drug|0
2601957|NCT01059825|8994654|P5|Enrolled, Run-in Period|Adverse event not related to study drug|0
2601958|NCT01059825|8994655|P4|Enrolled, Run-in Period|Adverse event not related to study drug|0
2601959|NCT01059825|8994656|P3|Enrolled, Run-in Period|Adverse event not related to study drug|0
2601960|NCT01059825|8994657|P2|Enrolled, Run-in Period|Adverse event not related to study drug|0
2601961|NCT01059825|8994658|P1|Enrolled, Run-in Period|Adverse event not related to study drug|0
2601962|NCT01059812|8994845|P2|Overall Study|Unclassified|4
2601963|NCT01059812|8994846|P1|Overall Study|Unclassified|14
2601964|NCT01059812|8994845|P2|Overall Study|Withdrawal Criteria|4
2601965|NCT01059812|8994846|P1|Overall Study|Withdrawal Criteria|9
2601966|NCT01059812|8994845|P2|Overall Study|Protocol Violation|1
2601967|NCT01059812|8994846|P1|Overall Study|Protocol Violation|3
2601968|NCT01059812|8994845|P2|Overall Study|Lack of Efficacy|2
2601969|NCT01059812|8994846|P1|Overall Study|Lack of Efficacy|2
2601970|NCT01059812|8994845|P2|Overall Study|Adverse Event|5
2601971|NCT01059812|8994846|P1|Overall Study|Adverse Event|9
2601972|NCT01059799|8994862|P2|Overall Study|Other|3
2601973|NCT01059799|8994863|P1|Overall Study|Other|12
2601974|NCT01059799|8994862|P2|Overall Study|Withdrawal criteria|2
2601975|NCT01059799|8994863|P1|Overall Study|Withdrawal criteria|13
2601976|NCT01059799|8994862|P2|Overall Study|Protocol Violation|2
2601977|NCT01059799|8994863|P1|Overall Study|Protocol Violation|3
2601978|NCT01059799|8994862|P2|Overall Study|Lack of Efficacy|0
2601979|NCT01059799|8994863|P1|Overall Study|Lack of Efficacy|1
2601980|NCT01059799|8994862|P2|Overall Study|Adverse Event|3
2601981|NCT01059799|8994863|P1|Overall Study|Adverse Event|2
2601982|NCT01059773|8994877|P2|Overall Study|Other|3
2601983|NCT01059773|8994878|P1|Overall Study|Other|1
2601984|NCT01059773|8994877|P2|Overall Study|Ineligible follow TB screening criteria|1
2601985|NCT01059773|8994878|P1|Overall Study|Ineligible follow TB screening criteria|0
2601986|NCT01059773|8994877|P2|Overall Study|Malignancy including squamous cell skin|1
2601987|NCT01059773|8994878|P1|Overall Study|Malignancy including squamous cell skin|0
2601988|NCT01059773|8994877|P2|Overall Study|Death|1
2601989|NCT01059773|8994878|P1|Overall Study|Death|0
2601990|NCT01059773|8994877|P2|Overall Study|Lack of Efficacy|3
2601991|NCT01059773|8994878|P1|Overall Study|Lack of Efficacy|3
2601992|NCT01059773|8994877|P2|Overall Study|Physician Decision|4
2601993|NCT01059773|8994878|P1|Overall Study|Physician Decision|5
2601994|NCT01059773|8994877|P2|Overall Study|Protocol Violation|2
2601995|NCT01059773|8994878|P1|Overall Study|Protocol Violation|6
2601996|NCT01059773|8994877|P2|Overall Study|Pregnancy|1
2601997|NCT01059773|8994878|P1|Overall Study|Pregnancy|1
2601998|NCT01059773|8994877|P2|Overall Study|Lost to Follow-up|1
2601999|NCT01059773|8994878|P1|Overall Study|Lost to Follow-up|1
2602000|NCT01059773|8994877|P2|Overall Study|Withdrawal by Subject|5
2602001|NCT01059773|8994878|P1|Overall Study|Withdrawal by Subject|1
2602002|NCT01059773|8994877|P2|Overall Study|Adverse Event|2
2602003|NCT01059773|8994878|P1|Overall Study|Adverse Event|2
2602004|NCT01059643|8995034|P1|Overall Study|Physician Decision|1
2602005|NCT01059643|8995034|P1|Overall Study|Withdrawal by Subject|2
2602006|NCT01059643|8995034|P1|Overall Study|Adverse Event|3
2602007|NCT01059630|8995049|P2|Overall Study|Withdrawal by Subject|14
2602008|NCT01059630|8995050|P1|Overall Study|Withdrawal by Subject|21
2602009|NCT01059630|8995049|P2|Overall Study|Physician Decision|4
2602010|NCT01059630|8995050|P1|Overall Study|Physician Decision|2
2602011|NCT01059630|8995049|P2|Overall Study|Lost to Follow-up|1
2602012|NCT01059630|8995050|P1|Overall Study|Lost to Follow-up|4
2602013|NCT01059630|8995049|P2|Overall Study|Death|84
2602014|NCT01059630|8995050|P1|Overall Study|Death|100
2602015|NCT01059617|8995124|P4|Overall Study|Other|6
2602016|NCT01059617|8995125|P3|Overall Study|Other|8
2602017|NCT01059617|8995126|P2|Overall Study|Other|1
2602018|NCT01059617|8995127|P1|Overall Study|Other|7
2602019|NCT01059565|8995297|P2|24-Week Open-Label Phase|Pulmonologist/participant decision|1
2602020|NCT01059565|8995298|P1|24-Week Open-Label Phase|Pulmonologist/participant decision|0
2602021|NCT01059565|8995297|P2|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1
2602022|NCT01059565|8995298|P1|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0
2602023|NCT01059565|8995297|P2|24-Week Open-Label Phase|Subject noncompliance|0
2602024|NCT01059565|8995298|P1|24-Week Open-Label Phase|Subject noncompliance|1
2602025|NCT01059565|8995297|P2|24-Week Open-Label Phase|Withdrawal by Subject|0
2602026|NCT01059565|8995298|P1|24-Week Open-Label Phase|Withdrawal by Subject|1
2602027|NCT01059565|8995297|P2|24-Week Open-Label Phase|Worsening health (physician decision)|1
2602028|NCT01059565|8995298|P1|24-Week Open-Label Phase|Worsening health (physician decision)|1
2602029|NCT01059565|8995297|P2|24-Week Open-Label Phase|Adverse Event|0
2602030|NCT01059565|8995298|P1|24-Week Open-Label Phase|Adverse Event|2
2602031|NCT01059565|8995297|P2|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5
2602032|NCT01059565|8995298|P1|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1
2602033|NCT01059565|8995297|P2|24-Week Randomized Phase|Lost to Follow-up|1
2602034|NCT01059565|8995298|P1|24-Week Randomized Phase|Lost to Follow-up|0
2602035|NCT01059565|8995297|P2|24-Week Randomized Phase|Withdrawal by Subject|1
2602036|NCT01059565|8995298|P1|24-Week Randomized Phase|Withdrawal by Subject|3
2602037|NCT01059565|8995297|P2|24-Week Randomized Phase|Adverse Event|0
2602038|NCT01059565|8995298|P1|24-Week Randomized Phase|Adverse Event|5
2602039|NCT01059565|8995297|P2|24-Week Randomized Phase|Randomized but not treated|0
2602040|NCT01059565|8995298|P1|24-Week Randomized Phase|Randomized but not treated|1
2602041|NCT01059539|8995332|P1|Overall Study|Reason Not Specified|2
2602042|NCT01059539|8995332|P1|Overall Study|Lost to Follow-up|42
2602043|NCT01059539|8995332|P1|Overall Study|Withdrawal of Consent|80
2602044|NCT01059539|8995332|P1|Overall Study|Protocol Violation|55
2602045|NCT01059539|8995332|P1|Overall Study|Insufficient Therapeutic Response|26
2602046|NCT01059539|8995332|P1|Overall Study|Adverse Event|66
2602047|NCT01059526|8995339|P2|Overall Study|Patient found to be dermatographic|0
2602048|NCT01059526|8995340|P1|Overall Study|Patient found to be dermatographic|1
2602049|NCT01059526|8995339|P2|Overall Study|Lost to Follow-up|1
2602050|NCT01059526|8995340|P1|Overall Study|Lost to Follow-up|4
2602051|NCT01059526|8995339|P2|Overall Study|Withdrawal by Subject|1
2602052|NCT01059526|8995340|P1|Overall Study|Withdrawal by Subject|3
2602053|NCT01059526|8995339|P2|Overall Study|Protocol Violation|1
2602054|NCT01059526|8995340|P1|Overall Study|Protocol Violation|0
2602055|NCT01059526|8995339|P2|Overall Study|Adverse Event|2
2602056|NCT01059526|8995340|P1|Overall Study|Adverse Event|2
2602057|NCT01059526|8995339|P2|Overall Study|Patient enrolled but not treated|17
2602058|NCT01059526|8995340|P1|Overall Study|Patient enrolled but not treated|20
2602059|NCT01059344|8995686|P2|Overall Study|Other|6
2602060|NCT01059344|8995687|P1|Overall Study|Other|3
2602061|NCT01059344|8995686|P2|Overall Study|Lost to Follow-up|1
2602062|NCT01059344|8995687|P1|Overall Study|Lost to Follow-up|1
2602063|NCT01059344|8995686|P2|Overall Study|Withdrawal by Subject|9
2602064|NCT01059344|8995687|P1|Overall Study|Withdrawal by Subject|6
2602065|NCT01059344|8995686|P2|Overall Study|Adverse Event|30
2602066|NCT01059344|8995687|P1|Overall Study|Adverse Event|12
2602067|NCT01059175|8995711|P2|Overall Study|Lost to Follow-up|1
2602068|NCT01059175|8995712|P1|Overall Study|Lost to Follow-up|0
2602069|NCT01059175|8995711|P2|Overall Study|Adverse Event|2
2602070|NCT01059175|8995712|P1|Overall Study|Adverse Event|4
2602071|NCT01059175|8995711|P2|Overall Study|Death|17
2602072|NCT01059175|8995712|P1|Overall Study|Death|17
2602073|NCT01059071|8995734|P4|Overall Study|Physician Decision|1
2602074|NCT01059071|8995735|P3|Overall Study|Physician Decision|0
2602075|NCT01059071|8995736|P2|Overall Study|Physician Decision|0
2602076|NCT01059071|8995737|P1|Overall Study|Physician Decision|0
2602077|NCT01059071|8995734|P4|Overall Study|Withdrawal by Subject|2
2602078|NCT01059071|8995735|P3|Overall Study|Withdrawal by Subject|0
2602079|NCT01059071|8995736|P2|Overall Study|Withdrawal by Subject|0
2602080|NCT01059071|8995737|P1|Overall Study|Withdrawal by Subject|1
2602081|NCT01059071|8995734|P4|Overall Study|Lack of Efficacy|3
2602082|NCT01059071|8995735|P3|Overall Study|Lack of Efficacy|2
2602083|NCT01059071|8995736|P2|Overall Study|Lack of Efficacy|4
2602084|NCT01059071|8995737|P1|Overall Study|Lack of Efficacy|1
2602085|NCT01058863|8995764|P1|Overall Study|Randomized in error|1
2602086|NCT01058863|8995764|P1|Overall Study|Sponsor requested withdrawal|1
2602087|NCT01058863|8995764|P1|Overall Study|Withdrawal by Subject|1
2602088|NCT01058863|8995764|P1|Overall Study|Lost to Follow-up|1
2602089|NCT01058707|8995789|P7|Overall Study|Reason Not Specified|7
2602090|NCT01058707|8995790|P6|Overall Study|Reason Not Specified|1
2602091|NCT01058707|8995791|P5|Overall Study|Reason Not Specified|7
2602092|NCT01058707|8995792|P4|Overall Study|Reason Not Specified|0
2602093|NCT01058707|8995793|P3|Overall Study|Reason Not Specified|2
2602094|NCT01058707|8995794|P2|Overall Study|Reason Not Specified|3
2602095|NCT01058707|8995795|P1|Overall Study|Reason Not Specified|0
2602096|NCT01058707|8995789|P7|Overall Study|Lost to Follow-up|0
2602097|NCT01058707|8995790|P6|Overall Study|Lost to Follow-up|0
2602098|NCT01058707|8995791|P5|Overall Study|Lost to Follow-up|0
2602099|NCT01058707|8995792|P4|Overall Study|Lost to Follow-up|0
2602100|NCT01058707|8995793|P3|Overall Study|Lost to Follow-up|1
2602101|NCT01058707|8995794|P2|Overall Study|Lost to Follow-up|0
2602102|NCT01058707|8995795|P1|Overall Study|Lost to Follow-up|0
2602103|NCT01058707|8995789|P7|Overall Study|Subject Decision|6
2602104|NCT01058707|8995790|P6|Overall Study|Subject Decision|3
2602105|NCT01058707|8995791|P5|Overall Study|Subject Decision|2
2602106|NCT01058707|8995792|P4|Overall Study|Subject Decision|1
2602107|NCT01058707|8995793|P3|Overall Study|Subject Decision|3
2602108|NCT01058707|8995794|P2|Overall Study|Subject Decision|3
2602109|NCT01058707|8995795|P1|Overall Study|Subject Decision|5
2602110|NCT01058707|8995789|P7|Overall Study|Adverse Event|1
2602111|NCT01058707|8995790|P6|Overall Study|Adverse Event|3
2602112|NCT01058707|8995791|P5|Overall Study|Adverse Event|7
2602113|NCT01058707|8995792|P4|Overall Study|Adverse Event|6
2602114|NCT01058707|8995793|P3|Overall Study|Adverse Event|7
2602115|NCT01058707|8995794|P2|Overall Study|Adverse Event|4
2602116|NCT01058707|8995795|P1|Overall Study|Adverse Event|11
2602117|NCT01058707|8995789|P7|Overall Study|Disease Progression|12
2602118|NCT01058707|8995790|P6|Overall Study|Disease Progression|10
2602119|NCT01058707|8995791|P5|Overall Study|Disease Progression|23
2602120|NCT01058707|8995792|P4|Overall Study|Disease Progression|15
2602121|NCT01058707|8995793|P3|Overall Study|Disease Progression|20
2602122|NCT01058707|8995794|P2|Overall Study|Disease Progression|20
2602123|NCT01058707|8995795|P1|Overall Study|Disease Progression|15
2602124|NCT01058668|8995961|P3|Double-blind Treatment Phase|Other Unspecified|0
2602125|NCT01058668|8995962|P2|Double-blind Treatment Phase|Other Unspecified|1
2602126|NCT01058668|8995963|P1|Double-blind Treatment Phase|Other Unspecified|1
2602127|NCT01058668|8995961|P3|Double-blind Treatment Phase|Lost to Follow-up|1
2602128|NCT01058668|8995962|P2|Double-blind Treatment Phase|Lost to Follow-up|1
2602129|NCT01058668|8995963|P1|Double-blind Treatment Phase|Lost to Follow-up|0
2602130|NCT01058668|8995961|P3|Double-blind Treatment Phase|Withdrawal of Consent|17
2602131|NCT01058668|8995962|P2|Double-blind Treatment Phase|Withdrawal of Consent|18
2602132|NCT01058668|8995963|P1|Double-blind Treatment Phase|Withdrawal of Consent|14
2602133|NCT01058668|8995961|P3|Double-blind Treatment Phase|Protocol Violation|2
2602134|NCT01058668|8995962|P2|Double-blind Treatment Phase|Protocol Violation|1
2602135|NCT01058668|8995963|P1|Double-blind Treatment Phase|Protocol Violation|1
2602136|NCT01058668|8995961|P3|Double-blind Treatment Phase|Insufficient Therapeutic Response|5
2602137|NCT01058668|8995962|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|2
2602138|NCT01058668|8995963|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|15
2602139|NCT01058668|8995961|P3|Double-blind Treatment Phase|Adverse Event|25
2602140|NCT01058668|8995962|P2|Double-blind Treatment Phase|Adverse Event|15
2602141|NCT01058668|8995963|P1|Double-blind Treatment Phase|Adverse Event|8
2602142|NCT01058655|8995978|P4|Overall Study|Other|4
2602143|NCT01058655|8995979|P3|Overall Study|Other|0
2602144|NCT01058655|8995980|P2|Overall Study|Other|0
2602145|NCT01058655|8995981|P1|Overall Study|Other|0
2602146|NCT01058655|8995978|P4|Overall Study|Disease Progression|24
2602147|NCT01058655|8995979|P3|Overall Study|Disease Progression|4
2602148|NCT01058655|8995980|P2|Overall Study|Disease Progression|2
2602149|NCT01058655|8995981|P1|Overall Study|Disease Progression|1
2602150|NCT01058655|8995978|P4|Overall Study|Death|0
2602151|NCT01058655|8995979|P3|Overall Study|Death|1
2602152|NCT01058655|8995980|P2|Overall Study|Death|1
2602153|NCT01058655|8995981|P1|Overall Study|Death|0
2602154|NCT01058655|8995978|P4|Overall Study|Clinical Progression (non-RECIST)|7
2602155|NCT01058655|8995979|P3|Overall Study|Clinical Progression (non-RECIST)|0
2602156|NCT01058655|8995980|P2|Overall Study|Clinical Progression (non-RECIST)|0
2602157|NCT01058655|8995981|P1|Overall Study|Clinical Progression (non-RECIST)|1
2602158|NCT01058655|8995978|P4|Overall Study|Symptomatic Deterioration|1
2602159|NCT01058655|8995979|P3|Overall Study|Symptomatic Deterioration|0
2602160|NCT01058655|8995980|P2|Overall Study|Symptomatic Deterioration|0
2602161|NCT01058655|8995981|P1|Overall Study|Symptomatic Deterioration|0
2602162|NCT01058655|8995978|P4|Overall Study|Prolonged Treatment Delay|2
2602163|NCT01058655|8995979|P3|Overall Study|Prolonged Treatment Delay|0
2602164|NCT01058655|8995980|P2|Overall Study|Prolonged Treatment Delay|0
2602165|NCT01058655|8995981|P1|Overall Study|Prolonged Treatment Delay|0
2602166|NCT01058655|8995978|P4|Overall Study|Withdrawal by Subject|4
2602167|NCT01058655|8995979|P3|Overall Study|Withdrawal by Subject|3
2602168|NCT01058655|8995980|P2|Overall Study|Withdrawal by Subject|0
2602169|NCT01058655|8995981|P1|Overall Study|Withdrawal by Subject|1
2602170|NCT01058642|8995999|P4|Treatment Period 1|Lack of Compliance with Study Drug|0
2602171|NCT01058642|8996000|P3|Treatment Period 1|Lack of Compliance with Study Drug|0
2602172|NCT01058642|8996001|P2|Treatment Period 1|Lack of Compliance with Study Drug|0
2602173|NCT01058642|8996002|P1|Treatment Period 1|Lack of Compliance with Study Drug|1
2602174|NCT01058642|8995999|P4|Treatment Period 1|Protocol Violation|1
2602175|NCT01058642|8996000|P3|Treatment Period 1|Protocol Violation|0
2602176|NCT01058642|8996001|P2|Treatment Period 1|Protocol Violation|0
2602177|NCT01058642|8996002|P1|Treatment Period 1|Protocol Violation|0
2602178|NCT01058642|8995999|P4|Treatment Period 1|Lack of Efficacy|1
2602179|NCT01058642|8996000|P3|Treatment Period 1|Lack of Efficacy|0
2602180|NCT01058642|8996001|P2|Treatment Period 1|Lack of Efficacy|0
2602181|NCT01058642|8996002|P1|Treatment Period 1|Lack of Efficacy|0
2602182|NCT01058642|8995999|P4|Treatment Period 1|Withdrawal by Subject|0
2602183|NCT01058642|8996000|P3|Treatment Period 1|Withdrawal by Subject|0
2602184|NCT01058642|8996001|P2|Treatment Period 1|Withdrawal by Subject|0
2602185|NCT01058642|8996002|P1|Treatment Period 1|Withdrawal by Subject|1
2602186|NCT01058642|8995999|P4|Treatment Period 1|Physician Decision|0
2602187|NCT01058642|8996000|P3|Treatment Period 1|Physician Decision|1
2602188|NCT01058642|8996001|P2|Treatment Period 1|Physician Decision|0
2602189|NCT01058642|8996002|P1|Treatment Period 1|Physician Decision|0
2602190|NCT01058642|8995999|P4|Treatment Period 1|Adverse Event|0
2602191|NCT01058642|8996000|P3|Treatment Period 1|Adverse Event|1
2602192|NCT01058642|8996001|P2|Treatment Period 1|Adverse Event|1
2602193|NCT01058642|8996002|P1|Treatment Period 1|Adverse Event|0
2602194|NCT01058421|8996012|P2|6 Month Outcomes|Remained in Other Facility|3
2602195|NCT01058421|8996013|P1|6 Month Outcomes|Remained in Other Facility|1
2602196|NCT01058421|8996012|P2|6 Month Outcomes|Lost to Follow-up|21
2602197|NCT01058421|8996013|P1|6 Month Outcomes|Lost to Follow-up|16
2602198|NCT01058421|8996012|P2|6 Month Outcomes|Death|2
2602199|NCT01058421|8996013|P1|6 Month Outcomes|Death|2
2602200|NCT01058421|8996012|P2|3 Month Outcomes|Remained in Other Facility|8
2602201|NCT01058421|8996013|P1|3 Month Outcomes|Remained in Other Facility|5
2602202|NCT01058421|8996012|P2|3 Month Outcomes|Remained in Hospital|2
2602203|NCT01058421|8996013|P1|3 Month Outcomes|Remained in Hospital|0
2602204|NCT01058421|8996012|P2|3 Month Outcomes|Lost to Follow-up|11
2602205|NCT01058421|8996013|P1|3 Month Outcomes|Lost to Follow-up|12
2602206|NCT01058421|8996012|P2|3 Month Outcomes|Death|5
2602207|NCT01058421|8996013|P1|3 Month Outcomes|Death|3
2602208|NCT01058421|8996012|P2|1 Month Outcomes|Remained in Other Facility|17
2602209|NCT01058421|8996013|P1|1 Month Outcomes|Remained in Other Facility|16
2602210|NCT01058421|8996012|P2|1 Month Outcomes|Remained in Hospital|12
2602211|NCT01058421|8996013|P1|1 Month Outcomes|Remained in Hospital|5
2602212|NCT01058421|8996012|P2|1 Month Outcomes|Lost to Follow-up|7
2602213|NCT01058421|8996013|P1|1 Month Outcomes|Lost to Follow-up|8
2602214|NCT01058421|8996012|P2|1 Month Outcomes|Death|6
2602215|NCT01058421|8996013|P1|1 Month Outcomes|Death|10
2602216|NCT01058395|8996037|P2|Overall Study|Lost to Follow-up|0
2602217|NCT01058395|8996038|P1|Overall Study|Lost to Follow-up|1
2602218|NCT01058395|8996037|P2|Overall Study|Death|1
2602219|NCT01058395|8996038|P1|Overall Study|Death|2
2602220|NCT01058356|8996047|P1|Overall Study|Lost to Follow-up|4
2602221|NCT01058356|8996047|P1|Overall Study|Withdrawal by Subject|21
2602222|NCT01058356|8996047|P1|Overall Study|Administration of contraindicated drugs|12
2602223|NCT01058356|8996047|P1|Overall Study|Adverse Event|5
2602224|NCT01058304|8996054|P2|Overall Study|Developed exclusion criterion|12
2602225|NCT01058304|8996055|P1|Overall Study|Developed exclusion criterion|6
2602226|NCT01058304|8996054|P2|Overall Study|Lost to Follow-up|16
2602227|NCT01058304|8996055|P1|Overall Study|Lost to Follow-up|13
2602228|NCT01058304|8996054|P2|Overall Study|Withdrawal by Subject|5
2602229|NCT01058304|8996055|P1|Overall Study|Withdrawal by Subject|8
2602230|NCT01058265|8996065|P2|Overall Study|Lost to Follow-up|12
2602231|NCT01058265|8996066|P1|Overall Study|Lost to Follow-up|11
2602232|NCT01058096|8996085|P2|Double-blind Treatment Phase|Other Unspecified|0
2602233|NCT01058096|8996086|P1|Double-blind Treatment Phase|Other Unspecified|2
2602234|NCT01058096|8996085|P2|Double-blind Treatment Phase|Lost to Follow-up|1
2602235|NCT01058096|8996086|P1|Double-blind Treatment Phase|Lost to Follow-up|0
2602236|NCT01058096|8996085|P2|Double-blind Treatment Phase|Withdrawal of Consent|26
2602237|NCT01058096|8996086|P1|Double-blind Treatment Phase|Withdrawal of Consent|17
2602238|NCT01058096|8996085|P2|Double-blind Treatment Phase|Protocol Violation|1
2602239|NCT01058096|8996086|P1|Double-blind Treatment Phase|Protocol Violation|2
2602240|NCT01058096|8996085|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|7
2602241|NCT01058096|8996086|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|16
2602242|NCT01058096|8996085|P2|Double-blind Treatment Phase|Adverse Event|15
2602243|NCT01058096|8996086|P1|Double-blind Treatment Phase|Adverse Event|11
2602244|NCT01058005|8996102|P3|Overall Study|Reason Missing|1
2602245|NCT01058005|8996103|P2|Overall Study|Reason Missing|3
2602246|NCT01058005|8996104|P1|Overall Study|Reason Missing|5
2602247|NCT01058005|8996102|P3|Overall Study|Withdrawn Due to Study Termination|7
2602248|NCT01058005|8996103|P2|Overall Study|Withdrawn Due to Study Termination|13
2602249|NCT01058005|8996104|P1|Overall Study|Withdrawn Due to Study Termination|27
2602250|NCT01058005|8996102|P3|Overall Study|Withdrawal by Subject|11
2602251|NCT01058005|8996103|P2|Overall Study|Withdrawal by Subject|5
2602252|NCT01058005|8996104|P1|Overall Study|Withdrawal by Subject|4
2602253|NCT01058005|8996102|P3|Overall Study|Physician Decision|0
2602254|NCT01058005|8996103|P2|Overall Study|Physician Decision|2
2602255|NCT01058005|8996104|P1|Overall Study|Physician Decision|2
2602256|NCT01058005|8996102|P3|Overall Study|Adverse Event|1
2602257|NCT01058005|8996103|P2|Overall Study|Adverse Event|2
2602258|NCT01058005|8996104|P1|Overall Study|Adverse Event|0
2602259|NCT01057862|8996139|P2|Overall Study|Withdrawal by Subject|2
2602260|NCT01057862|8996140|P1|Overall Study|Withdrawal by Subject|1
2602261|NCT01057810|8996150|P2|Overall Study|Other|14
2602262|NCT01057810|8996151|P1|Overall Study|Other|7
2602263|NCT01057810|8996150|P2|Overall Study|No longer met study criteria|1
2602264|NCT01057810|8996151|P1|Overall Study|No longer met study criteria|0
2602265|NCT01057810|8996150|P2|Overall Study|Poor/non-compliance|1
2602266|NCT01057810|8996151|P1|Overall Study|Poor/non-compliance|0
2602267|NCT01057810|8996150|P2|Overall Study|Maximum clinical benefit|5
2602268|NCT01057810|8996151|P1|Overall Study|Maximum clinical benefit|5
2602269|NCT01057810|8996150|P2|Overall Study|Death|12
2602270|NCT01057810|8996151|P1|Overall Study|Death|2
2602271|NCT01057810|8996150|P2|Overall Study|Withdrawal by Subject|25
2602272|NCT01057810|8996151|P1|Overall Study|Withdrawal by Subject|10
2602273|NCT01057810|8996150|P2|Overall Study|Adverse event unrelated to study drug|29
2602274|NCT01057810|8996151|P1|Overall Study|Adverse event unrelated to study drug|13
2602275|NCT01057810|8996150|P2|Overall Study|Study drug toxicity|114
2602276|NCT01057810|8996151|P1|Overall Study|Study drug toxicity|5
2602277|NCT01057810|8996150|P2|Overall Study|Disease progression|197
2602278|NCT01057810|8996151|P1|Overall Study|Disease progression|156
2602279|NCT01057693|8996167|P3|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2
2602280|NCT01057693|8996168|P2|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
2602281|NCT01057693|8996169|P1|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
2602282|NCT01057693|8996167|P3|Double-Blind Phase (Week 7 to Week 19)|Other|0
2602283|NCT01057693|8996168|P2|Double-Blind Phase (Week 7 to Week 19)|Other|1
2602284|NCT01057693|8996169|P1|Double-Blind Phase (Week 7 to Week 19)|Other|0
2602285|NCT01057693|8996167|P3|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6
2602286|NCT01057693|8996168|P2|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8
2602287|NCT01057693|8996169|P1|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0
2602288|NCT01057693|8996167|P3|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4
2602289|NCT01057693|8996168|P2|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
2602290|NCT01057693|8996169|P1|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
2602291|NCT01057693|8996167|P3|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5
2602292|NCT01057693|8996168|P2|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2
2602293|NCT01057693|8996169|P1|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0
2602294|NCT01057693|8996167|P3|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8
2602295|NCT01057693|8996168|P2|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3
2602296|NCT01057693|8996169|P1|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0
2602297|NCT01057693|8996167|P3|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11
2602298|NCT01057693|8996168|P2|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8
2602299|NCT01057693|8996169|P1|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0
2602300|NCT01057693|8996167|P3|Between Single-Blind and Double-Blind|Other|0
2602301|NCT01057693|8996168|P2|Between Single-Blind and Double-Blind|Other|0
2602302|NCT01057693|8996169|P1|Between Single-Blind and Double-Blind|Other|6
2602303|NCT01057693|8996167|P3|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
2602304|NCT01057693|8996168|P2|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
2602305|NCT01057693|8996169|P1|Between Single-Blind and Double-Blind|Withdrawal by Subject|4
2602306|NCT01057693|8996167|P3|Between Single-Blind and Double-Blind|Protocol Violation|0
2602307|NCT01057693|8996168|P2|Between Single-Blind and Double-Blind|Protocol Violation|0
2602308|NCT01057693|8996169|P1|Between Single-Blind and Double-Blind|Protocol Violation|7
2602309|NCT01057693|8996167|P3|Between Single-Blind and Double-Blind|Lost to Follow-up|0
2602310|NCT01057693|8996168|P2|Between Single-Blind and Double-Blind|Lost to Follow-up|0
2602311|NCT01057693|8996169|P1|Between Single-Blind and Double-Blind|Lost to Follow-up|1
2602312|NCT01057693|8996167|P3|Between Single-Blind and Double-Blind|Lack of Efficacy|0
2602313|NCT01057693|8996168|P2|Between Single-Blind and Double-Blind|Lack of Efficacy|0
2602314|NCT01057693|8996169|P1|Between Single-Blind and Double-Blind|Lack of Efficacy|247
2602315|NCT01057693|8996167|P3|Between Single-Blind and Double-Blind|Adverse Event|0
2602316|NCT01057693|8996168|P2|Between Single-Blind and Double-Blind|Adverse Event|0
2602317|NCT01057693|8996169|P1|Between Single-Blind and Double-Blind|Adverse Event|5
2602318|NCT01057693|8996167|P3|Single-Blind Phase (Up to Week 6)|Other|0
2602319|NCT01057693|8996168|P2|Single-Blind Phase (Up to Week 6)|Other|0
2602320|NCT01057693|8996169|P1|Single-Blind Phase (Up to Week 6)|Other|2
2602321|NCT01057693|8996167|P3|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
2602322|NCT01057693|8996168|P2|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
2602323|NCT01057693|8996169|P1|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22
2602324|NCT01057693|8996167|P3|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
2602325|NCT01057693|8996168|P2|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
2602326|NCT01057693|8996169|P1|Single-Blind Phase (Up to Week 6)|Protocol Violation|9
2602327|NCT01057693|8996167|P3|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
2602328|NCT01057693|8996168|P2|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
2602329|NCT01057693|8996169|P1|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14
2602330|NCT01057693|8996167|P3|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
2602331|NCT01057693|8996168|P2|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
2602332|NCT01057693|8996169|P1|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7
2602333|NCT01057693|8996167|P3|Single-Blind Phase (Up to Week 6)|Adverse Event|0
2602334|NCT01057693|8996168|P2|Single-Blind Phase (Up to Week 6)|Adverse Event|0
2602335|NCT01057693|8996169|P1|Single-Blind Phase (Up to Week 6)|Adverse Event|45
2602336|NCT01057589|8996215|P1|Overall Study|Lost to Follow-up|1
2602337|NCT01057589|8996215|P1|Overall Study|Death|8
2602338|NCT01057589|8996215|P1|Overall Study|Sponsor Decision|1
2602339|NCT01057589|8996215|P1|Overall Study|Withdrawal by Subject|3
2602340|NCT01057589|8996215|P1|Overall Study|Physician Decision|8
2602341|NCT01057589|8996215|P1|Overall Study|Adverse Event|10
2602342|NCT01057589|8996215|P1|Overall Study|Disease Progression|35
2602343|NCT01057433|8996224|P1|Overall Study|Adverse Event|1
2602344|NCT01057394|8996228|P2|Overall Study|Not eligible|2
2602345|NCT01057394|8996229|P1|Overall Study|Not eligible|0
2602346|NCT01057251|8996239|P2|Overall Study|Other Reason|1
2602347|NCT01057251|8996240|P1|Overall Study|Other Reason|1
2602348|NCT01057251|8996239|P2|Overall Study|Lost to Follow-up|6
2602349|NCT01057251|8996240|P1|Overall Study|Lost to Follow-up|7
2602350|NCT01057251|8996239|P2|Overall Study|Withdrawal by Subject|5
2602351|NCT01057251|8996240|P1|Overall Study|Withdrawal by Subject|4
2602352|NCT01057251|8996239|P2|Overall Study|Protocol Violation|2
2602353|NCT01057251|8996240|P1|Overall Study|Protocol Violation|6
2602354|NCT01057251|8996239|P2|Overall Study|Lack of Efficacy|11
2602355|NCT01057251|8996240|P1|Overall Study|Lack of Efficacy|2
2602356|NCT01057251|8996239|P2|Overall Study|Adverse Event|2
2602357|NCT01057251|8996240|P1|Overall Study|Adverse Event|4
2602358|NCT01057251|8996239|P2|Overall Study|Did not meet InclusionExclusion criteria|2
2602359|NCT01057251|8996240|P1|Overall Study|Did not meet InclusionExclusion criteria|4
2602360|NCT01056822|8996318|P2|Overall Study|Lost to Follow-up|0
2602361|NCT01056822|8996319|P1|Overall Study|Lost to Follow-up|1
2602362|NCT01056822|8996318|P2|Overall Study|Withdrawal by Subject|1
2602363|NCT01056822|8996319|P1|Overall Study|Withdrawal by Subject|1
2602364|NCT01056822|8996318|P2|Overall Study|Protocol Violation|5
2602365|NCT01056822|8996319|P1|Overall Study|Protocol Violation|6
2602366|NCT01056822|8996318|P2|Overall Study|Adverse Event|1
2602367|NCT01056822|8996319|P1|Overall Study|Adverse Event|0
2602368|NCT01056718|8996368|P1|Overall Study|Ischemia on baseline stress test|1
2602369|NCT01056718|8996368|P1|Overall Study|Withdrawal by Subject|2
2602370|NCT01056653|8996401|P3|Overall Study|Lost to Follow-up|2
2602371|NCT01056653|8996402|P2|Overall Study|Lost to Follow-up|0
2602372|NCT01056653|8996403|P1|Overall Study|Lost to Follow-up|0
2602373|NCT01056640|8996419|P2|Overall Study|Death|4
2602374|NCT01056640|8996420|P1|Overall Study|Death|15
2602375|NCT01056640|8996419|P2|Overall Study|Withdrawal by Subject|8
2602376|NCT01056640|8996420|P1|Overall Study|Withdrawal by Subject|11
2602377|NCT01056536|8996435|P3|Overall Study|Lost to Follow-up|248
2602378|NCT01056536|8996436|P2|Overall Study|Lost to Follow-up|116
2602379|NCT01056536|8996437|P1|Overall Study|Lost to Follow-up|202
2602380|NCT01056523|8996448|P7|Overall Study|Death|1
2602381|NCT01056523|8996449|P6|Overall Study|Death|0
2602382|NCT01056523|8996450|P5|Overall Study|Death|0
2602383|NCT01056523|8996451|P4|Overall Study|Death|3
2602384|NCT01056523|8996452|P3|Overall Study|Death|2
2602385|NCT01056523|8996453|P2|Overall Study|Death|0
2602386|NCT01056523|8996454|P1|Overall Study|Death|1
2602387|NCT01056510|8996464|P2|Overall Study|Missing|1
2602388|NCT01056510|8996465|P1|Overall Study|Missing|0
2602389|NCT01056510|8996464|P2|Overall Study|Other|12
2602390|NCT01056510|8996465|P1|Overall Study|Other|10
2602391|NCT01056510|8996464|P2|Overall Study|Lost to Follow-up|6
2602392|NCT01056510|8996465|P1|Overall Study|Lost to Follow-up|5
2602393|NCT01056510|8996464|P2|Overall Study|Physician Decision|5
2602394|NCT01056510|8996465|P1|Overall Study|Physician Decision|4
2602395|NCT01056510|8996464|P2|Overall Study|Noncompliance|3
2602396|NCT01056510|8996465|P1|Overall Study|Noncompliance|1
2602397|NCT01056510|8996464|P2|Overall Study|Death|34
2602398|NCT01056510|8996465|P1|Overall Study|Death|29
2602399|NCT01056510|8996464|P2|Overall Study|Withdrawal by Subject|2
2602400|NCT01056510|8996465|P1|Overall Study|Withdrawal by Subject|4
2602401|NCT01056510|8996464|P2|Overall Study|Dropout Before Start of Treatment|1
2602402|NCT01056510|8996465|P1|Overall Study|Dropout Before Start of Treatment|1
2602403|NCT01056484|8996511|P2|Follow up - Non-randomized|Withdrawal by Subject|2
2602404|NCT01056484|8996512|P1|Follow up - Non-randomized|Withdrawal by Subject|0
2602405|NCT01056484|8996511|P2|Randomized Controlled Trial|Physician Decision|0
2602406|NCT01056484|8996512|P1|Randomized Controlled Trial|Physician Decision|1
2602407|NCT01056484|8996511|P2|Randomized Controlled Trial|Withdrawal by Subject|1
2602408|NCT01056484|8996512|P1|Randomized Controlled Trial|Withdrawal by Subject|6
2602409|NCT01056380|8996528|P2|Overall Study|Lost to Follow-up|3
2602410|NCT01056380|8996529|P1|Overall Study|Lost to Follow-up|2
2602411|NCT01056341|8996556|P5|Overall Study|Other reasons|5
2602412|NCT01056341|8996557|P4|Overall Study|Other reasons|9
2602413|NCT01056341|8996558|P3|Overall Study|Other reasons|8
2602414|NCT01056341|8996559|P2|Overall Study|Other reasons|4
2602415|NCT01056341|8996560|P1|Overall Study|Other reasons|4
2602416|NCT01056341|8996556|P5|Overall Study|Lack of Efficacy|9
2602417|NCT01056341|8996557|P4|Overall Study|Lack of Efficacy|25
2602418|NCT01056341|8996558|P3|Overall Study|Lack of Efficacy|7
2602419|NCT01056341|8996559|P2|Overall Study|Lack of Efficacy|30
2602420|NCT01056341|8996560|P1|Overall Study|Lack of Efficacy|32
2602421|NCT01056341|8996556|P5|Overall Study|Treatment Intolerance|0
2602422|NCT01056341|8996557|P4|Overall Study|Treatment Intolerance|2
2602423|NCT01056341|8996558|P3|Overall Study|Treatment Intolerance|0
2602424|NCT01056341|8996559|P2|Overall Study|Treatment Intolerance|2
2602425|NCT01056341|8996560|P1|Overall Study|Treatment Intolerance|0
2602426|NCT01056289|8996633|P4|Double-blind Phase|Physician Decision|0
2602427|NCT01056289|8996634|P3|Double-blind Phase|Physician Decision|1
2602428|NCT01056289|8996635|P2|Double-blind Phase|Physician Decision|0
2602429|NCT01056289|8996636|P1|Double-blind Phase|Physician Decision|0
2602430|NCT01056289|8996633|P4|Double-blind Phase|Discontinuation symptom|2
2602431|NCT01056289|8996634|P3|Double-blind Phase|Discontinuation symptom|2
2602432|NCT01056289|8996635|P2|Double-blind Phase|Discontinuation symptom|1
2602433|NCT01056289|8996636|P1|Double-blind Phase|Discontinuation symptom|0
2602434|NCT01056289|8996633|P4|Double-blind Phase|Withdrawal by Subject|2
2602435|NCT01056289|8996634|P3|Double-blind Phase|Withdrawal by Subject|4
2602436|NCT01056289|8996635|P2|Double-blind Phase|Withdrawal by Subject|0
2602437|NCT01056289|8996636|P1|Double-blind Phase|Withdrawal by Subject|0
2602438|NCT01056289|8996633|P4|Double-blind Phase|Protocol Violation|1
2602439|NCT01056289|8996634|P3|Double-blind Phase|Protocol Violation|1
2602440|NCT01056289|8996635|P2|Double-blind Phase|Protocol Violation|0
2602441|NCT01056289|8996636|P1|Double-blind Phase|Protocol Violation|0
2602442|NCT01056289|8996633|P4|Double-blind Phase|Other|2
2602443|NCT01056289|8996634|P3|Double-blind Phase|Other|1
2602444|NCT01056289|8996635|P2|Double-blind Phase|Other|0
2602445|NCT01056289|8996636|P1|Double-blind Phase|Other|0
2602446|NCT01056289|8996633|P4|Double-blind Phase|Lost to Follow-up|2
2602447|NCT01056289|8996634|P3|Double-blind Phase|Lost to Follow-up|2
2602448|NCT01056289|8996635|P2|Double-blind Phase|Lost to Follow-up|2
2602449|NCT01056289|8996636|P1|Double-blind Phase|Lost to Follow-up|0
2602450|NCT01056289|8996633|P4|Double-blind Phase|Adverse Event|1
2602451|NCT01056289|8996634|P3|Double-blind Phase|Adverse Event|2
2602452|NCT01056289|8996635|P2|Double-blind Phase|Adverse Event|1
2602453|NCT01056289|8996636|P1|Double-blind Phase|Adverse Event|0
2602454|NCT01056289|8996633|P4|Open-label Phase|Not randomized to Double-blind phase|0
2602455|NCT01056289|8996634|P3|Open-label Phase|Not randomized to Double-blind phase|0
2602456|NCT01056289|8996635|P2|Open-label Phase|Not randomized to Double-blind phase|0
2602457|NCT01056289|8996636|P1|Open-label Phase|Not randomized to Double-blind phase|1
2602458|NCT01056289|8996633|P4|Open-label Phase|Lack of Efficacy|0
2602459|NCT01056289|8996634|P3|Open-label Phase|Lack of Efficacy|0
2602460|NCT01056289|8996635|P2|Open-label Phase|Lack of Efficacy|0
2602461|NCT01056289|8996636|P1|Open-label Phase|Lack of Efficacy|18
2602462|NCT01056289|8996633|P4|Open-label Phase|Withdrawal by Subject|0
2602463|NCT01056289|8996634|P3|Open-label Phase|Withdrawal by Subject|0
2602464|NCT01056289|8996635|P2|Open-label Phase|Withdrawal by Subject|0
2602465|NCT01056289|8996636|P1|Open-label Phase|Withdrawal by Subject|26
2602466|NCT01056289|8996633|P4|Open-label Phase|Protocol Violation|0
2602467|NCT01056289|8996634|P3|Open-label Phase|Protocol Violation|0
2602468|NCT01056289|8996635|P2|Open-label Phase|Protocol Violation|0
2602469|NCT01056289|8996636|P1|Open-label Phase|Protocol Violation|6
2602470|NCT01056289|8996633|P4|Open-label Phase|Other|0
2602471|NCT01056289|8996634|P3|Open-label Phase|Other|0
2602472|NCT01056289|8996635|P2|Open-label Phase|Other|0
2602473|NCT01056289|8996636|P1|Open-label Phase|Other|9
2602474|NCT01056289|8996633|P4|Open-label Phase|Lost to Follow-up|0
2602475|NCT01056289|8996634|P3|Open-label Phase|Lost to Follow-up|0
2602476|NCT01056289|8996635|P2|Open-label Phase|Lost to Follow-up|0
2602477|NCT01056289|8996636|P1|Open-label Phase|Lost to Follow-up|30
2602478|NCT01056289|8996633|P4|Open-label Phase|Adverse Event|0
2602479|NCT01056289|8996634|P3|Open-label Phase|Adverse Event|0
2602480|NCT01056289|8996635|P2|Open-label Phase|Adverse Event|0
2602481|NCT01056289|8996636|P1|Open-label Phase|Adverse Event|29
2602482|NCT01056276|8996653|P2|Maintenance Therapy|Continuing maintenance therapy|14
2602483|NCT01056276|8996654|P1|Maintenance Therapy|Continuing maintenance therapy|0
2602484|NCT01056276|8996653|P2|Maintenance Therapy|Intercurrent Illness|1
2602485|NCT01056276|8996654|P1|Maintenance Therapy|Intercurrent Illness|0
2602486|NCT01056276|8996653|P2|Maintenance Therapy|Withdrawal by Subject|1
2602487|NCT01056276|8996654|P1|Maintenance Therapy|Withdrawal by Subject|0
2602488|NCT01056276|8996653|P2|Maintenance Therapy|Physician Decision|1
2602489|NCT01056276|8996654|P1|Maintenance Therapy|Physician Decision|0
2602490|NCT01056276|8996653|P2|Maintenance Therapy|Progressive Disease|9
2602491|NCT01056276|8996654|P1|Maintenance Therapy|Progressive Disease|0
2602492|NCT01056276|8996653|P2|Maintenance Therapy|Toxicity|2
2602493|NCT01056276|8996654|P1|Maintenance Therapy|Toxicity|0
2602494|NCT01056276|8996653|P2|Treatment Period-Cycles 1-8|Lost to Follow-up|0
2602495|NCT01056276|8996654|P1|Treatment Period-Cycles 1-8|Lost to Follow-up|1
2602496|NCT01056276|8996653|P2|Treatment Period-Cycles 1-8|Death|1
2602497|NCT01056276|8996654|P1|Treatment Period-Cycles 1-8|Death|3
2602498|NCT01056276|8996653|P2|Treatment Period-Cycles 1-8|Physician Decision|0
2602499|NCT01056276|8996654|P1|Treatment Period-Cycles 1-8|Physician Decision|3
2602500|NCT01056276|8996653|P2|Treatment Period-Cycles 1-8|Intercurrent Illness|2
2602501|NCT01056276|8996654|P1|Treatment Period-Cycles 1-8|Intercurrent Illness|1
2602502|NCT01056276|8996653|P2|Treatment Period-Cycles 1-8|Disease Progression|2
2602503|NCT01056276|8996654|P1|Treatment Period-Cycles 1-8|Disease Progression|2
2602504|NCT01056276|8996653|P2|Treatment Period-Cycles 1-8|Withdrawal by Subject|2
2602505|NCT01056276|8996654|P1|Treatment Period-Cycles 1-8|Withdrawal by Subject|1
2602506|NCT01056276|8996653|P2|Treatment Period-Cycles 1-8|Toxicity|1
2602507|NCT01056276|8996654|P1|Treatment Period-Cycles 1-8|Toxicity|2
2602508|NCT01056263|8996668|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|5
2602509|NCT01056263|8996668|P1|Overall Study|Objective progression or relapse|1
2602510|NCT01056263|8996668|P1|Overall Study|Neoplasm progression|1
2602511|NCT01056263|8996668|P1|Overall Study|Progressive disease|2
2602512|NCT01056263|8996668|P1|Overall Study|Lack of Efficacy|29
2602513|NCT01056263|8996668|P1|Overall Study|Withdrawal by Subject|1
2602514|NCT01056263|8996668|P1|Overall Study|Death|1
2602515|NCT01056263|8996668|P1|Overall Study|Adverse Event|12
2602516|NCT01056107|8996691|P4|Overall Study|Withdrawal by Subject|0
2602517|NCT01056107|8996692|P3|Overall Study|Withdrawal by Subject|3
2602518|NCT01056107|8996693|P2|Overall Study|Withdrawal by Subject|1
2602519|NCT01056107|8996694|P1|Overall Study|Withdrawal by Subject|0
2602520|NCT01055886|8996751|P2|Overall Study|Withdrawal by PI|1
2602521|NCT01055886|8996752|P1|Overall Study|Withdrawal by PI|0
2602522|NCT01055886|8996751|P2|Overall Study|Lost to Follow-up|1
2602523|NCT01055886|8996752|P1|Overall Study|Lost to Follow-up|1
2602524|NCT01055886|8996751|P2|Overall Study|Withdrawal by Subject|9
2602525|NCT01055886|8996752|P1|Overall Study|Withdrawal by Subject|4
2602526|NCT01055834|8996764|P2|Treatment Period I|Adverse Event|0
2602527|NCT01055834|8996765|P1|Treatment Period I|Adverse Event|1
2602528|NCT01055639|8996850|P2|Overall Study|Withdrawal by Subject|11
2602529|NCT01055639|8996851|P1|Overall Study|Withdrawal by Subject|8
2602530|NCT01055639|8996850|P2|Overall Study|Protocol Violation|5
2602531|NCT01055639|8996851|P1|Overall Study|Protocol Violation|5
2602532|NCT01055639|8996850|P2|Overall Study|Lost to Follow-up|11
2602533|NCT01055639|8996851|P1|Overall Study|Lost to Follow-up|8
2602534|NCT01055639|8996850|P2|Overall Study|Lack of Efficacy|1
2602535|NCT01055639|8996851|P1|Overall Study|Lack of Efficacy|0
2602536|NCT01055639|8996850|P2|Overall Study|Adverse Event|1
2602537|NCT01055639|8996851|P1|Overall Study|Adverse Event|0
2602538|NCT01055613|8996875|P2|Overall Study|Subject Disinterest|1
2602539|NCT01055613|8996876|P1|Overall Study|Subject Disinterest|1
2602540|NCT01055613|8996875|P2|Overall Study|Protocol Violation|1
2602541|NCT01055613|8996876|P1|Overall Study|Protocol Violation|1
2602542|NCT01055613|8996875|P2|Overall Study|Lost to Follow-up|1
2602543|NCT01055613|8996876|P1|Overall Study|Lost to Follow-up|1
2602544|NCT01055613|8996875|P2|Overall Study|Discomfort|1
2602545|NCT01055613|8996876|P1|Overall Study|Discomfort|2
2602546|NCT01055613|8996875|P2|Overall Study|Unacceptable lens fit|0
2602547|NCT01055613|8996876|P1|Overall Study|Unacceptable lens fit|1
2602548|NCT01055613|8996875|P2|Overall Study|No Longer Meets Eligibility Criteria|0
2602549|NCT01055613|8996876|P1|Overall Study|No Longer Meets Eligibility Criteria|3
2602550|NCT01055496|8996886|P2|Overall Study|Other - Unspecified|1
2602551|NCT01055496|8996887|P1|Overall Study|Other - Unspecified|0
2602552|NCT01055496|8996886|P2|Overall Study|Lost to Follow-up|2
2602553|NCT01055496|8996887|P1|Overall Study|Lost to Follow-up|0
2602554|NCT01055496|8996886|P2|Overall Study|Death|23
2602555|NCT01055496|8996887|P1|Overall Study|Death|13
2602556|NCT01055496|8996886|P2|Overall Study|Withdrawal by Subject|4
2602557|NCT01055496|8996887|P1|Overall Study|Withdrawal by Subject|2
2602558|NCT01055457|8996944|P10|Overall Study|Adverse Event|0
2602559|NCT01055457|8996945|P9|Overall Study|Adverse Event|0
2602560|NCT01055457|8996946|P8|Overall Study|Adverse Event|0
2602561|NCT01055457|8996947|P7|Overall Study|Adverse Event|0
2602562|NCT01055457|8996948|P6|Overall Study|Adverse Event|0
2602563|NCT01055457|8996949|P5|Overall Study|Adverse Event|0
2602564|NCT01055457|8996950|P4|Overall Study|Adverse Event|1
2602565|NCT01055457|8996951|P3|Overall Study|Adverse Event|0
2602566|NCT01055457|8996952|P2|Overall Study|Adverse Event|0
2602567|NCT01055457|8996953|P1|Overall Study|Adverse Event|0
2602568|NCT01055457|8996944|P10|Overall Study|Pregnancy|0
2602569|NCT01055457|8996945|P9|Overall Study|Pregnancy|0
2602570|NCT01055457|8996946|P8|Overall Study|Pregnancy|0
2602571|NCT01055457|8996947|P7|Overall Study|Pregnancy|0
2602572|NCT01055457|8996948|P6|Overall Study|Pregnancy|0
2602573|NCT01055457|8996949|P5|Overall Study|Pregnancy|0
2602574|NCT01055457|8996950|P4|Overall Study|Pregnancy|1
2602575|NCT01055457|8996951|P3|Overall Study|Pregnancy|0
2602576|NCT01055457|8996952|P2|Overall Study|Pregnancy|0
2602577|NCT01055457|8996953|P1|Overall Study|Pregnancy|0
2602578|NCT01055457|8996944|P10|Overall Study|Discomfort|0
2602579|NCT01055457|8996945|P9|Overall Study|Discomfort|0
2602580|NCT01055457|8996946|P8|Overall Study|Discomfort|0
2602581|NCT01055457|8996947|P7|Overall Study|Discomfort|0
2602582|NCT01055457|8996948|P6|Overall Study|Discomfort|0
2602583|NCT01055457|8996949|P5|Overall Study|Discomfort|1
2602584|NCT01055457|8996950|P4|Overall Study|Discomfort|0
2602585|NCT01055457|8996951|P3|Overall Study|Discomfort|0
2602586|NCT01055457|8996952|P2|Overall Study|Discomfort|0
2602587|NCT01055457|8996953|P1|Overall Study|Discomfort|0
2602588|NCT01055457|8996944|P10|Overall Study|Subject Ineligible|0
2602589|NCT01055457|8996945|P9|Overall Study|Subject Ineligible|0
2602590|NCT01055457|8996946|P8|Overall Study|Subject Ineligible|0
2602591|NCT01055457|8996947|P7|Overall Study|Subject Ineligible|0
2602592|NCT01055457|8996948|P6|Overall Study|Subject Ineligible|0
2602593|NCT01055457|8996949|P5|Overall Study|Subject Ineligible|1
2602594|NCT01055457|8996950|P4|Overall Study|Subject Ineligible|0
2602595|NCT01055457|8996951|P3|Overall Study|Subject Ineligible|1
2602596|NCT01055457|8996952|P2|Overall Study|Subject Ineligible|0
2602597|NCT01055457|8996953|P1|Overall Study|Subject Ineligible|1
2602598|NCT01055457|8996944|P10|Overall Study|Subject Disinterest|0
2602599|NCT01055457|8996945|P9|Overall Study|Subject Disinterest|0
2602600|NCT01055457|8996946|P8|Overall Study|Subject Disinterest|1
2602601|NCT01055457|8996947|P7|Overall Study|Subject Disinterest|0
2602602|NCT01055457|8996948|P6|Overall Study|Subject Disinterest|0
2602603|NCT01055457|8996949|P5|Overall Study|Subject Disinterest|0
2602604|NCT01055457|8996950|P4|Overall Study|Subject Disinterest|0
2602605|NCT01055457|8996951|P3|Overall Study|Subject Disinterest|0
2602606|NCT01055457|8996952|P2|Overall Study|Subject Disinterest|0
2602607|NCT01055457|8996953|P1|Overall Study|Subject Disinterest|0
2602608|NCT01055457|8996944|P10|Overall Study|Protocol Violation|1
2602609|NCT01055457|8996945|P9|Overall Study|Protocol Violation|0
2602610|NCT01055457|8996946|P8|Overall Study|Protocol Violation|0
2602611|NCT01055457|8996947|P7|Overall Study|Protocol Violation|1
2602612|NCT01055457|8996948|P6|Overall Study|Protocol Violation|2
2602613|NCT01055457|8996949|P5|Overall Study|Protocol Violation|1
2602614|NCT01055457|8996950|P4|Overall Study|Protocol Violation|1
2602615|NCT01055457|8996951|P3|Overall Study|Protocol Violation|1
2602616|NCT01055457|8996952|P2|Overall Study|Protocol Violation|0
2602617|NCT01055457|8996953|P1|Overall Study|Protocol Violation|0
2602618|NCT01055457|8996944|P10|Overall Study|Lost to Follow-up|0
2602619|NCT01055457|8996945|P9|Overall Study|Lost to Follow-up|0
2602620|NCT01055457|8996946|P8|Overall Study|Lost to Follow-up|0
2602621|NCT01055457|8996947|P7|Overall Study|Lost to Follow-up|0
2602622|NCT01055457|8996948|P6|Overall Study|Lost to Follow-up|1
2602623|NCT01055457|8996949|P5|Overall Study|Lost to Follow-up|0
2602624|NCT01055457|8996950|P4|Overall Study|Lost to Follow-up|0
2602625|NCT01055457|8996951|P3|Overall Study|Lost to Follow-up|0
2602626|NCT01055457|8996952|P2|Overall Study|Lost to Follow-up|1
2602627|NCT01055457|8996953|P1|Overall Study|Lost to Follow-up|0
2602628|NCT01055314|8996987|P2|Overall Study|No treatment|0
2602629|NCT01055314|8996988|P1|Overall Study|No treatment|1
2602630|NCT01055314|8996987|P2|Overall Study|Refusal of further protocol therapy|4
2602631|NCT01055314|8996988|P1|Overall Study|Refusal of further protocol therapy|10
2602632|NCT01055314|8996987|P2|Overall Study|Ineligible|5
2602633|NCT01055314|8996988|P1|Overall Study|Ineligible|3
2602634|NCT01055314|8996987|P2|Overall Study|Withdrawal by Subject|0
2602635|NCT01055314|8996988|P1|Overall Study|Withdrawal by Subject|1
2602636|NCT01055314|8996987|P2|Overall Study|Physician Decision|5
2602637|NCT01055314|8996988|P1|Overall Study|Physician Decision|10
2602638|NCT01055314|8996987|P2|Overall Study|Lack of Efficacy|19
2602639|NCT01055314|8996988|P1|Overall Study|Lack of Efficacy|11
2602640|NCT01055314|8996987|P2|Overall Study|Death|1
2602641|NCT01055314|8996988|P1|Overall Study|Death|2
2602642|NCT01055314|8996987|P2|Overall Study|Adverse Event|4
2602643|NCT01055314|8996988|P1|Overall Study|Adverse Event|7
2602644|NCT01055262|8997000|P1|Overall Study|Uncooperativeness|1
2602645|NCT01055262|8997000|P1|Overall Study|Protocol Violation|3
2602646|NCT01055262|8997000|P1|Overall Study|Adverse Event|5
2602647|NCT01055197|8997041|P2|Overall Study|Withdrawal by Subject|0
2602648|NCT01055197|8997042|P1|Overall Study|Withdrawal by Subject|2
2602649|NCT01055197|8997041|P2|Overall Study|Protocol Violation|2
2602650|NCT01055197|8997042|P1|Overall Study|Protocol Violation|7
2602651|NCT01055132|8997077|P2|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1
2602652|NCT01055132|8997078|P1|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0
2602653|NCT01055132|8997077|P2|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0
2602654|NCT01055132|8997078|P1|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1
2602655|NCT01055028|8997091|P2|Inter-treatment Period|Did not start Cycle 4|3
2602656|NCT01055028|8997092|P1|Inter-treatment Period|Did not start Cycle 4|0
2602657|NCT01055028|8997091|P2|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
2602658|NCT01055028|8997092|P1|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
2602659|NCT01055028|8997091|P2|Treatment Cycles 1 to 3|Adverse Event|1
2602660|NCT01055028|8997092|P1|Treatment Cycles 1 to 3|Adverse Event|0
2602661|NCT01055028|8997091|P2|Screening|Screen Failure|1
2602662|NCT01055028|8997092|P1|Screening|Screen Failure|1
2602663|NCT01054976|8997106|P1|Overall Study|Other|8
2602664|NCT01054976|8997106|P1|Overall Study|Withdrawal by Subject|4
2602665|NCT01054976|8997106|P1|Overall Study|Uncooperative participations to study|7
2602666|NCT01054976|8997106|P1|Overall Study|Adverse Event|16
2602667|NCT01054885|8997127|P7|24-week, Double-blind Treatment Period|Withdrawal by Subject|2
2602668|NCT01054885|8997128|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
2602669|NCT01054885|8997129|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
2602670|NCT01054885|8997130|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
2602671|NCT01054885|8997131|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
2602672|NCT01054885|8997132|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|8
2602673|NCT01054885|8997133|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
2602674|NCT01054885|8997127|P7|24-week, Double-blind Treatment Period|Physician Decision|1
2602675|NCT01054885|8997128|P6|24-week, Double-blind Treatment Period|Physician Decision|1
2602676|NCT01054885|8997129|P5|24-week, Double-blind Treatment Period|Physician Decision|3
2602677|NCT01054885|8997130|P4|24-week, Double-blind Treatment Period|Physician Decision|6
2602678|NCT01054885|8997131|P3|24-week, Double-blind Treatment Period|Physician Decision|1
2602679|NCT01054885|8997132|P2|24-week, Double-blind Treatment Period|Physician Decision|4
2602680|NCT01054885|8997133|P1|24-week, Double-blind Treatment Period|Physician Decision|0
2602681|NCT01054885|8997127|P7|24-week, Double-blind Treatment Period|Lost to Follow-up|1
2602682|NCT01054885|8997128|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|2
2602683|NCT01054885|8997129|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|0
2602684|NCT01054885|8997130|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
2602685|NCT01054885|8997131|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|2
2602686|NCT01054885|8997132|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
2602687|NCT01054885|8997133|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
2602688|NCT01054885|8997127|P7|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
2602689|NCT01054885|8997128|P6|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
2602690|NCT01054885|8997129|P5|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
2602691|NCT01054885|8997130|P4|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
2602692|NCT01054885|8997131|P3|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
2602693|NCT01054885|8997132|P2|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
2602694|NCT01054885|8997133|P1|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
2602695|NCT01054885|8997127|P7|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
2602696|NCT01054885|8997128|P6|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15
2602697|NCT01054885|8997129|P5|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
2602698|NCT01054885|8997130|P4|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
2602699|NCT01054885|8997131|P3|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
2602700|NCT01054885|8997132|P2|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
2602701|NCT01054885|8997133|P1|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0
2602702|NCT01054885|8997127|P7|24-week, Double-blind Treatment Period|Protocol Violation|4
2602703|NCT01054885|8997128|P6|24-week, Double-blind Treatment Period|Protocol Violation|8
2602704|NCT01054885|8997129|P5|24-week, Double-blind Treatment Period|Protocol Violation|3
2602705|NCT01054885|8997130|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
2602706|NCT01054885|8997131|P3|24-week, Double-blind Treatment Period|Protocol Violation|7
2602707|NCT01054885|8997132|P2|24-week, Double-blind Treatment Period|Protocol Violation|7
2602708|NCT01054885|8997133|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
2602709|NCT01054885|8997127|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
2602710|NCT01054885|8997128|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
2602711|NCT01054885|8997129|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11
2602712|NCT01054885|8997130|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5
2602713|NCT01054885|8997131|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2
2602714|NCT01054885|8997132|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
2602715|NCT01054885|8997133|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
2602716|NCT01054885|8997127|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
2602717|NCT01054885|8997128|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
2602718|NCT01054885|8997129|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
2602719|NCT01054885|8997130|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
2602720|NCT01054885|8997131|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
2602721|NCT01054885|8997132|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
2602722|NCT01054885|8997133|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
2602723|NCT01054885|8997127|P7|24-week, Double-blind Treatment Period|Adverse Event|19
2602724|NCT01054885|8997128|P6|24-week, Double-blind Treatment Period|Adverse Event|17
2602725|NCT01054885|8997129|P5|24-week, Double-blind Treatment Period|Adverse Event|15
2602726|NCT01054885|8997130|P4|24-week, Double-blind Treatment Period|Adverse Event|15
2602727|NCT01054885|8997131|P3|24-week, Double-blind Treatment Period|Adverse Event|12
2602728|NCT01054885|8997132|P2|24-week, Double-blind Treatment Period|Adverse Event|18
2602729|NCT01054885|8997133|P1|24-week, Double-blind Treatment Period|Adverse Event|0
2602730|NCT01054885|8997127|P7|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2602731|NCT01054885|8997128|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2602732|NCT01054885|8997129|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2602733|NCT01054885|8997130|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2602734|NCT01054885|8997131|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2602735|NCT01054885|8997132|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2602736|NCT01054885|8997133|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|68
2602737|NCT01054885|8997127|P7|2-week, Single-blind Run-In Period|Adverse Event|0
2602738|NCT01054885|8997128|P6|2-week, Single-blind Run-In Period|Adverse Event|0
2602739|NCT01054885|8997129|P5|2-week, Single-blind Run-In Period|Adverse Event|0
2602740|NCT01054885|8997130|P4|2-week, Single-blind Run-In Period|Adverse Event|0
2602741|NCT01054885|8997131|P3|2-week, Single-blind Run-In Period|Adverse Event|0
2602742|NCT01054885|8997132|P2|2-week, Single-blind Run-In Period|Adverse Event|0
2602743|NCT01054885|8997133|P1|2-week, Single-blind Run-In Period|Adverse Event|7
2602744|NCT01054885|8997127|P7|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2602745|NCT01054885|8997128|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2602746|NCT01054885|8997129|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2602747|NCT01054885|8997130|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2602748|NCT01054885|8997131|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2602749|NCT01054885|8997132|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2602750|NCT01054885|8997133|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
2602751|NCT01054885|8997127|P7|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2602752|NCT01054885|8997128|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2602753|NCT01054885|8997129|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2602754|NCT01054885|8997130|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2602755|NCT01054885|8997131|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2602756|NCT01054885|8997132|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2602757|NCT01054885|8997133|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|23
2602758|NCT01054885|8997127|P7|2-week, Single-blind Run-In Period|Physician Decision|0
2602759|NCT01054885|8997128|P6|2-week, Single-blind Run-In Period|Physician Decision|0
2602760|NCT01054885|8997129|P5|2-week, Single-blind Run-In Period|Physician Decision|0
2602761|NCT01054885|8997130|P4|2-week, Single-blind Run-In Period|Physician Decision|0
2602762|NCT01054885|8997131|P3|2-week, Single-blind Run-In Period|Physician Decision|0
2602763|NCT01054885|8997132|P2|2-week, Single-blind Run-In Period|Physician Decision|0
2602764|NCT01054885|8997133|P1|2-week, Single-blind Run-In Period|Physician Decision|6
2602765|NCT01054885|8997127|P7|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2602766|NCT01054885|8997128|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2602767|NCT01054885|8997129|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2602768|NCT01054885|8997130|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2602769|NCT01054885|8997131|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2602770|NCT01054885|8997132|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2602771|NCT01054885|8997133|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246
2602772|NCT01054846|8997173|P2|Overall Study|Lost to Follow-up|17
2602773|NCT01054846|8997174|P1|Overall Study|Lost to Follow-up|76
2602774|NCT01054820|8997181|P1|Overall Study|Withdrawal by Subject|2
2602775|NCT01054729|8997203|P4|Overall Study|Lack of Efficacy|1
2602776|NCT01054729|8997204|P3|Overall Study|Lack of Efficacy|0
2602777|NCT01054729|8997205|P2|Overall Study|Lack of Efficacy|0
2602778|NCT01054729|8997206|P1|Overall Study|Lack of Efficacy|0
2602779|NCT01054729|8997203|P4|Overall Study|Subject moved|0
2602780|NCT01054729|8997204|P3|Overall Study|Subject moved|1
2602781|NCT01054729|8997205|P2|Overall Study|Subject moved|0
2602782|NCT01054729|8997206|P1|Overall Study|Subject moved|0
2602783|NCT01054729|8997203|P4|Overall Study|Personal/Obligations|0
2602784|NCT01054729|8997204|P3|Overall Study|Personal/Obligations|0
2602785|NCT01054729|8997205|P2|Overall Study|Personal/Obligations|1
2602786|NCT01054729|8997206|P1|Overall Study|Personal/Obligations|0
2602787|NCT01054729|8997203|P4|Overall Study|PEG/RBV Non-responder|0
2602788|NCT01054729|8997204|P3|Overall Study|PEG/RBV Non-responder|1
2602789|NCT01054729|8997205|P2|Overall Study|PEG/RBV Non-responder|0
2602790|NCT01054729|8997206|P1|Overall Study|PEG/RBV Non-responder|1
2602791|NCT01054729|8997203|P4|Overall Study|Non-responder|1
2602792|NCT01054729|8997204|P3|Overall Study|Non-responder|1
2602793|NCT01054729|8997205|P2|Overall Study|Non-responder|0
2602794|NCT01054729|8997206|P1|Overall Study|Non-responder|1
2602795|NCT01054729|8997203|P4|Overall Study|Lost to Follow-up, Later Contacted Site|0
2602796|NCT01054729|8997204|P3|Overall Study|Lost to Follow-up, Later Contacted Site|0
2602797|NCT01054729|8997205|P2|Overall Study|Lost to Follow-up, Later Contacted Site|1
2602798|NCT01054729|8997206|P1|Overall Study|Lost to Follow-up, Later Contacted Site|0
2602799|NCT01054729|8997203|P4|Overall Study|Lost to Follow-up|0
2602800|NCT01054729|8997204|P3|Overall Study|Lost to Follow-up|0
2602801|NCT01054729|8997205|P2|Overall Study|Lost to Follow-up|1
2602802|NCT01054729|8997206|P1|Overall Study|Lost to Follow-up|0
2602803|NCT01054729|8997203|P4|Overall Study|Withdrawal by Subject|0
2602804|NCT01054729|8997204|P3|Overall Study|Withdrawal by Subject|1
2602805|NCT01054729|8997205|P2|Overall Study|Withdrawal by Subject|0
2602806|NCT01054729|8997206|P1|Overall Study|Withdrawal by Subject|1
2602807|NCT01054729|8997203|P4|Overall Study|Adverse Event|1
2602808|NCT01054729|8997204|P3|Overall Study|Adverse Event|2
2602809|NCT01054729|8997205|P2|Overall Study|Adverse Event|1
2602810|NCT01054729|8997206|P1|Overall Study|Adverse Event|1
2602811|NCT01054729|8997203|P4|Overall Study|Randomized but Not Treated|0
2602812|NCT01054729|8997204|P3|Overall Study|Randomized but Not Treated|0
2602813|NCT01054729|8997205|P2|Overall Study|Randomized but Not Treated|1
2602814|NCT01054729|8997206|P1|Overall Study|Randomized but Not Treated|0
2602815|NCT01054599|8997304|P2|Overall Study|Withdrawal by Subject|1
2602816|NCT01054599|8997305|P1|Overall Study|Withdrawal by Subject|0
2602817|NCT01054599|8997304|P2|Overall Study|Adverse Event|1
2602818|NCT01054599|8997305|P1|Overall Study|Adverse Event|0
2602819|NCT01054599|8997304|P2|Overall Study|Lost to Follow-up|2
2602820|NCT01054599|8997305|P1|Overall Study|Lost to Follow-up|0
2602821|NCT01054599|8997304|P2|Overall Study|Visual impairment, WTAR <80|1
2602822|NCT01054599|8997305|P1|Overall Study|Visual impairment, WTAR <80|0
2602823|NCT01054599|8997304|P2|Overall Study|Timing/scheduling difficulties|1
2602824|NCT01054599|8997305|P1|Overall Study|Timing/scheduling difficulties|1
2602825|NCT01054599|8997304|P2|Overall Study|Spells/seizure-like episodes|1
2602826|NCT01054599|8997305|P1|Overall Study|Spells/seizure-like episodes|1
2602827|NCT01054599|8997304|P2|Overall Study|Protocol Violation|0
2602828|NCT01054599|8997305|P1|Overall Study|Protocol Violation|1
2602829|NCT01054599|8997304|P2|Overall Study|Dizziness due to phenytoin toxicity|0
2602830|NCT01054599|8997305|P1|Overall Study|Dizziness due to phenytoin toxicity|1
2602831|NCT01054573|8997412|P4|Overall Study|Withdrawal by Subject|1
2602832|NCT01054573|8997413|P3|Overall Study|Withdrawal by Subject|2
2602833|NCT01054573|8997414|P2|Overall Study|Withdrawal by Subject|2
2602834|NCT01054573|8997415|P1|Overall Study|Withdrawal by Subject|0
2602835|NCT01054573|8997412|P4|Overall Study|Lost to Follow-up|0
2602836|NCT01054573|8997413|P3|Overall Study|Lost to Follow-up|0
2602837|NCT01054573|8997414|P2|Overall Study|Lost to Follow-up|2
2602838|NCT01054573|8997415|P1|Overall Study|Lost to Follow-up|0
2602839|NCT01054573|8997412|P4|Overall Study|Adverse Event|1
2602840|NCT01054573|8997413|P3|Overall Study|Adverse Event|1
2602841|NCT01054573|8997414|P2|Overall Study|Adverse Event|0
2602842|NCT01054573|8997415|P1|Overall Study|Adverse Event|1
2602843|NCT01054560|8997461|P2|Overall Study|Physician Decision|0
2602844|NCT01054560|8997462|P1|Overall Study|Physician Decision|1
2602845|NCT01054560|8997461|P2|Overall Study|Withdrawal by Subject|2
2602846|NCT01054560|8997462|P1|Overall Study|Withdrawal by Subject|0
2602847|NCT01054560|8997461|P2|Overall Study|Lost to Follow-up|5
2602848|NCT01054560|8997462|P1|Overall Study|Lost to Follow-up|2
2602849|NCT01054560|8997461|P2|Overall Study|Death|21
2602850|NCT01054560|8997462|P1|Overall Study|Death|10
2602851|NCT01054300|8997514|P4|Period 2|Withdrawal by Subject|0
2602852|NCT01054300|8997515|P3|Period 2|Withdrawal by Subject|1
2602853|NCT01054300|8997516|P2|Period 2|Withdrawal by Subject|0
2602854|NCT01054300|8997517|P1|Period 2|Withdrawal by Subject|0
2602855|NCT01054300|8997514|P4|Period 1|Adverse Event|0
2602856|NCT01054300|8997515|P3|Period 1|Adverse Event|0
2602857|NCT01054300|8997516|P2|Period 1|Adverse Event|0
2602858|NCT01054300|8997517|P1|Period 1|Adverse Event|1
2602859|NCT01054222|8997567|P1|Overall Study|Withdrawal by Subject|6
2602860|NCT01054222|8997567|P1|Overall Study|Lost to Follow-up|4
2602861|NCT01054222|8997567|P1|Overall Study|Lack of Efficacy|1
2602862|NCT01054170|8997608|P2|Overall Study|Adverse Event|4
2602863|NCT01054170|8997609|P1|Overall Study|Adverse Event|0
2602864|NCT01054170|8997608|P2|Overall Study|Withdrawal by Subject|2
2602865|NCT01054170|8997609|P1|Overall Study|Withdrawal by Subject|3
2602866|NCT01054170|8997608|P2|Overall Study|Protocol Violation|0
2602867|NCT01054170|8997609|P1|Overall Study|Protocol Violation|1
2602868|NCT01053988|8997674|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
2602869|NCT01053988|8997675|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|10
2602870|NCT01053988|8997676|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
2602871|NCT01053988|8997677|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
2602872|NCT01053988|8997678|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|11
2602873|NCT01053988|8997679|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
2602874|NCT01053988|8997674|P6|24-week, Double-blind Treatment Period|Physician Decision|4
2602875|NCT01053988|8997675|P5|24-week, Double-blind Treatment Period|Physician Decision|5
2602876|NCT01053988|8997676|P4|24-week, Double-blind Treatment Period|Physician Decision|5
2602877|NCT01053988|8997677|P3|24-week, Double-blind Treatment Period|Physician Decision|2
2602878|NCT01053988|8997678|P2|24-week, Double-blind Treatment Period|Physician Decision|5
2602879|NCT01053988|8997679|P1|24-week, Double-blind Treatment Period|Physician Decision|0
2602880|NCT01053988|8997674|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|3
2602881|NCT01053988|8997675|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
2602882|NCT01053988|8997676|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|2
2602883|NCT01053988|8997677|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
2602884|NCT01053988|8997678|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|4
2602885|NCT01053988|8997679|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
2602886|NCT01053988|8997674|P6|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
2602887|NCT01053988|8997675|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
2602888|NCT01053988|8997676|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8
2602889|NCT01053988|8997677|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5
2602890|NCT01053988|8997678|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
2602891|NCT01053988|8997679|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
2602892|NCT01053988|8997674|P6|24-week, Double-blind Treatment Period|Protocol Violation|4
2602893|NCT01053988|8997675|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
2602894|NCT01053988|8997676|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
2602895|NCT01053988|8997677|P3|24-week, Double-blind Treatment Period|Protocol Violation|4
2602896|NCT01053988|8997678|P2|24-week, Double-blind Treatment Period|Protocol Violation|3
2602897|NCT01053988|8997679|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
2602898|NCT01053988|8997674|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
2602899|NCT01053988|8997675|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9
2602900|NCT01053988|8997676|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
2602901|NCT01053988|8997677|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16
2602902|NCT01053988|8997678|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17
2602903|NCT01053988|8997679|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
2602904|NCT01053988|8997674|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
2602905|NCT01053988|8997675|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
2602906|NCT01053988|8997676|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
2602907|NCT01053988|8997677|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
2602908|NCT01053988|8997678|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
2602909|NCT01053988|8997679|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
2602910|NCT01053988|8997674|P6|24-week, Double-blind Treatment Period|Adverse Event|14
2602911|NCT01053988|8997675|P5|24-week, Double-blind Treatment Period|Adverse Event|17
2602912|NCT01053988|8997676|P4|24-week, Double-blind Treatment Period|Adverse Event|24
2602913|NCT01053988|8997677|P3|24-week, Double-blind Treatment Period|Adverse Event|23
2602914|NCT01053988|8997678|P2|24-week, Double-blind Treatment Period|Adverse Event|15
2602915|NCT01053988|8997679|P1|24-week, Double-blind Treatment Period|Adverse Event|0
2602916|NCT01053988|8997674|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2602917|NCT01053988|8997675|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2602918|NCT01053988|8997676|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2602919|NCT01053988|8997677|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2602920|NCT01053988|8997678|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
2602921|NCT01053988|8997679|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
2602922|NCT01053988|8997674|P6|2-week, Single-blind Run-In Period|Physician Decision|0
2602923|NCT01053988|8997675|P5|2-week, Single-blind Run-In Period|Physician Decision|0
2602924|NCT01053988|8997676|P4|2-week, Single-blind Run-In Period|Physician Decision|0
2602925|NCT01053988|8997677|P3|2-week, Single-blind Run-In Period|Physician Decision|0
2602926|NCT01053988|8997678|P2|2-week, Single-blind Run-In Period|Physician Decision|0
2602927|NCT01053988|8997679|P1|2-week, Single-blind Run-In Period|Physician Decision|5
2602928|NCT01053988|8997674|P6|2-week, Single-blind Run-In Period|Adverse Event|0
2602929|NCT01053988|8997675|P5|2-week, Single-blind Run-In Period|Adverse Event|0
2602930|NCT01053988|8997676|P4|2-week, Single-blind Run-In Period|Adverse Event|0
2602931|NCT01053988|8997677|P3|2-week, Single-blind Run-In Period|Adverse Event|0
2602932|NCT01053988|8997678|P2|2-week, Single-blind Run-In Period|Adverse Event|0
2602933|NCT01053988|8997679|P1|2-week, Single-blind Run-In Period|Adverse Event|6
2602934|NCT01053988|8997674|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2602935|NCT01053988|8997675|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2602936|NCT01053988|8997676|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2602937|NCT01053988|8997677|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2602938|NCT01053988|8997678|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
2602939|NCT01053988|8997679|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|30
2602940|NCT01053988|8997674|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2602941|NCT01053988|8997675|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2602942|NCT01053988|8997676|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2602943|NCT01053988|8997677|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2602944|NCT01053988|8997678|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
2602945|NCT01053988|8997679|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|98
2602946|NCT01053988|8997674|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2602947|NCT01053988|8997675|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2602948|NCT01053988|8997676|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2602949|NCT01053988|8997677|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2602950|NCT01053988|8997678|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
2602951|NCT01053988|8997679|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220
2602952|NCT01053962|8997716|P5|Treatment Period|Noncompliance with protocol|0
2602953|NCT01053962|8997717|P4|Treatment Period|Noncompliance with protocol|0
2602954|NCT01053962|8997718|P3|Treatment Period|Noncompliance with protocol|0
2602955|NCT01053962|8997719|P2|Treatment Period|Noncompliance with protocol|0
2602956|NCT01053962|8997720|P1|Treatment Period|Noncompliance with protocol|1
2602957|NCT01053962|8997716|P5|Treatment Period|Withdrawal by Subject|1
2602958|NCT01053962|8997717|P4|Treatment Period|Withdrawal by Subject|0
2602959|NCT01053962|8997718|P3|Treatment Period|Withdrawal by Subject|0
2602960|NCT01053962|8997719|P2|Treatment Period|Withdrawal by Subject|0
2602961|NCT01053962|8997720|P1|Treatment Period|Withdrawal by Subject|0
2602962|NCT01053962|8997716|P5|Treatment Period|Adverse Event|1
2602963|NCT01053962|8997717|P4|Treatment Period|Adverse Event|0
2602964|NCT01053962|8997718|P3|Treatment Period|Adverse Event|0
2602965|NCT01053962|8997719|P2|Treatment Period|Adverse Event|0
2602966|NCT01053962|8997720|P1|Treatment Period|Adverse Event|0
2602967|NCT01053962|8997716|P5|Treatment Period|Lack of Efficacy|1
2602968|NCT01053962|8997717|P4|Treatment Period|Lack of Efficacy|0
2602969|NCT01053962|8997718|P3|Treatment Period|Lack of Efficacy|0
2602970|NCT01053962|8997719|P2|Treatment Period|Lack of Efficacy|0
2602971|NCT01053962|8997720|P1|Treatment Period|Lack of Efficacy|0
2602972|NCT01053962|8997716|P5|Pretreatment Period|Abnormal Lab values Exl 16|0
2602973|NCT01053962|8997717|P4|Pretreatment Period|Abnormal Lab values Exl 16|1
2602974|NCT01053962|8997718|P3|Pretreatment Period|Abnormal Lab values Exl 16|0
2602975|NCT01053962|8997719|P2|Pretreatment Period|Abnormal Lab values Exl 16|0
2602976|NCT01053962|8997720|P1|Pretreatment Period|Abnormal Lab values Exl 16|0
2602977|NCT01053962|8997716|P5|Pretreatment Period|Failed Urine drug screen Day 1|0
2602978|NCT01053962|8997717|P4|Pretreatment Period|Failed Urine drug screen Day 1|0
2602979|NCT01053962|8997718|P3|Pretreatment Period|Failed Urine drug screen Day 1|0
2602980|NCT01053962|8997719|P2|Pretreatment Period|Failed Urine drug screen Day 1|1
2602981|NCT01053962|8997720|P1|Pretreatment Period|Failed Urine drug screen Day 1|0
2602982|NCT01053962|8997716|P5|Pretreatment Period|Venipuncture Failure|0
2602983|NCT01053962|8997717|P4|Pretreatment Period|Venipuncture Failure|0
2602984|NCT01053962|8997718|P3|Pretreatment Period|Venipuncture Failure|1
2602985|NCT01053962|8997719|P2|Pretreatment Period|Venipuncture Failure|0
2602986|NCT01053962|8997720|P1|Pretreatment Period|Venipuncture Failure|0
2602987|NCT01053962|8997716|P5|Pretreatment Period|Withdrew Consent (Patient/PI)|2
2602988|NCT01053962|8997717|P4|Pretreatment Period|Withdrew Consent (Patient/PI)|1
2602989|NCT01053962|8997718|P3|Pretreatment Period|Withdrew Consent (Patient/PI)|0
2602990|NCT01053962|8997719|P2|Pretreatment Period|Withdrew Consent (Patient/PI)|0
2602991|NCT01053962|8997720|P1|Pretreatment Period|Withdrew Consent (Patient/PI)|0
2602992|NCT01053741|8997771|P2|2nd Study Intervention|Physician Decision|1
2602993|NCT01053741|8997772|P1|2nd Study Intervention|Physician Decision|0
2602994|NCT01053663|8997781|P1|Overall Study|Negative Influenza Diagnosis|1
2602995|NCT01053663|8997781|P1|Overall Study|Transferred to Another Hospital|1
2602996|NCT01053663|8997781|P1|Overall Study|Poor IV Access|1
2602997|NCT01053663|8997781|P1|Overall Study|Lost to Follow-up|1
2602998|NCT01053663|8997781|P1|Overall Study|Death|2
2602999|NCT01053429|8997839|P1|Overall Study|Other|309
2603000|NCT01053429|8997839|P1|Overall Study|Adverse Event|64
2603001|NCT01053247|8997869|P3|Overall Study|Adverse Event|3
2603002|NCT01053247|8997870|P2|Overall Study|Adverse Event|9
2603003|NCT01053247|8997871|P1|Overall Study|Adverse Event|0
2603004|NCT01053247|8997869|P3|Overall Study|Lost to Follow-up|7
2603005|NCT01053247|8997870|P2|Overall Study|Lost to Follow-up|5
2603006|NCT01053247|8997871|P1|Overall Study|Lost to Follow-up|8
2603007|NCT01053247|8997869|P3|Overall Study|Protocol Violation|2
2603008|NCT01053247|8997870|P2|Overall Study|Protocol Violation|1
2603009|NCT01053247|8997871|P1|Overall Study|Protocol Violation|2
2603010|NCT01053247|8997869|P3|Overall Study|Lack of Efficacy|1
2603011|NCT01053247|8997870|P2|Overall Study|Lack of Efficacy|0
2603012|NCT01053247|8997871|P1|Overall Study|Lack of Efficacy|1
2603013|NCT01053247|8997869|P3|Overall Study|Withdrawal by Subject|15
2603014|NCT01053247|8997870|P2|Overall Study|Withdrawal by Subject|4
2603015|NCT01053247|8997871|P1|Overall Study|Withdrawal by Subject|9
2603016|NCT01053221|8997881|P2|Overall Study|The study was closed prematurely|9
2603017|NCT01053221|8997882|P1|Overall Study|The study was closed prematurely|5
2603018|NCT01052844|8997984|P2|Overall Study|Adverse Event|1
2603019|NCT01052844|8997985|P1|Overall Study|Adverse Event|0
2603020|NCT01052779|8998006|P2|Overall Study|Other-Missed Week 5 Visit|0
2603021|NCT01052779|8998007|P1|Overall Study|Other-Missed Week 5 Visit|2
2603022|NCT01052779|8998006|P2|Overall Study|Other-Surgery|2
2603023|NCT01052779|8998007|P1|Overall Study|Other-Surgery|0
2603024|NCT01052779|8998006|P2|Overall Study|Other-Protocol Violation|1
2603025|NCT01052779|8998007|P1|Overall Study|Other-Protocol Violation|1
2603026|NCT01052779|8998006|P2|Overall Study|Withdrawal by Subject|2
2603027|NCT01052779|8998007|P1|Overall Study|Withdrawal by Subject|1
2603028|NCT01052779|8998006|P2|Overall Study|Adverse Event|4
2603029|NCT01052779|8998007|P1|Overall Study|Adverse Event|1
2603030|NCT01052714|8998017|P3|Overall Study|Withdrawal by Subject|1
2603031|NCT01052714|8998018|P2|Overall Study|Withdrawal by Subject|12
2603032|NCT01052714|8998019|P1|Overall Study|Withdrawal by Subject|7
2603033|NCT01052714|8998017|P3|Overall Study|Physician Decision|1
2603034|NCT01052714|8998018|P2|Overall Study|Physician Decision|9
2603035|NCT01052714|8998019|P1|Overall Study|Physician Decision|9
2603036|NCT01052714|8998017|P3|Overall Study|Lost to Follow-up|0
2603037|NCT01052714|8998018|P2|Overall Study|Lost to Follow-up|3
2603038|NCT01052714|8998019|P1|Overall Study|Lost to Follow-up|2
2603039|NCT01052714|8998017|P3|Overall Study|Death|0
2603040|NCT01052714|8998018|P2|Overall Study|Death|2
2603041|NCT01052714|8998019|P1|Overall Study|Death|1
2603042|NCT01052714|8998017|P3|Overall Study|Adverse Event|0
2603043|NCT01052714|8998018|P2|Overall Study|Adverse Event|3
2603044|NCT01052714|8998019|P1|Overall Study|Adverse Event|6
2603045|NCT01052662|8998073|P3|Overall Study|Administrative|0
2603046|NCT01052662|8998074|P2|Overall Study|Administrative|3
2603047|NCT01052662|8998075|P1|Overall Study|Administrative|0
2603048|NCT01052662|8998073|P3|Overall Study|Legal Problem|0
2603049|NCT01052662|8998074|P2|Overall Study|Legal Problem|0
2603050|NCT01052662|8998075|P1|Overall Study|Legal Problem|2
2603051|NCT01052662|8998073|P3|Overall Study|Adverse Event|0
2603052|NCT01052662|8998074|P2|Overall Study|Adverse Event|1
2603053|NCT01052662|8998075|P1|Overall Study|Adverse Event|1
2603054|NCT01052662|8998073|P3|Overall Study|Pharmacy issue|3
2603055|NCT01052662|8998074|P2|Overall Study|Pharmacy issue|3
2603056|NCT01052662|8998075|P1|Overall Study|Pharmacy issue|1
2603057|NCT01052662|8998073|P3|Overall Study|Withdrawal by Subject|1
2603058|NCT01052662|8998074|P2|Overall Study|Withdrawal by Subject|2
2603059|NCT01052662|8998075|P1|Overall Study|Withdrawal by Subject|3
2603060|NCT01052662|8998073|P3|Overall Study|Lost to Follow-up|18
2603061|NCT01052662|8998074|P2|Overall Study|Lost to Follow-up|13
2603062|NCT01052662|8998075|P1|Overall Study|Lost to Follow-up|15
2603063|NCT01052480|8998116|P2|Overall Study|Death|5
2603064|NCT01052480|8998117|P1|Overall Study|Death|1
2603065|NCT01052480|8998116|P2|Overall Study|Physician Decision|2
2603066|NCT01052480|8998117|P1|Overall Study|Physician Decision|0
2603067|NCT01052480|8998116|P2|Overall Study|Withdrawal by Subject|7
2603068|NCT01052480|8998117|P1|Overall Study|Withdrawal by Subject|3
2603069|NCT01052480|8998116|P2|Overall Study|Protocol Violation|0
2603070|NCT01052480|8998117|P1|Overall Study|Protocol Violation|1
2603071|NCT01052480|8998116|P2|Overall Study|Lost to Follow-up|3
2603072|NCT01052480|8998117|P1|Overall Study|Lost to Follow-up|3
2603073|NCT01052428|8998167|P2|Overall Study|Withdrawal by Subject|1
2603074|NCT01052428|8998168|P1|Overall Study|Withdrawal by Subject|0
2603075|NCT01052428|8998167|P2|Overall Study|Death|0
2603076|NCT01052428|8998168|P1|Overall Study|Death|1
2603077|NCT01052272|8998190|P4|Overall Study|decline in health|0
2603078|NCT01052272|8998191|P3|Overall Study|decline in health|1
2603079|NCT01052272|8998192|P2|Overall Study|decline in health|0
2603080|NCT01052272|8998193|P1|Overall Study|decline in health|0
2603081|NCT01052272|8998190|P4|Overall Study|placed in long-term care|0
2603082|NCT01052272|8998191|P3|Overall Study|placed in long-term care|1
2603083|NCT01052272|8998192|P2|Overall Study|placed in long-term care|0
2603084|NCT01052272|8998193|P1|Overall Study|placed in long-term care|0
2603085|NCT01052272|8998190|P4|Overall Study|Withdrawal by Subject|2
2603086|NCT01052272|8998191|P3|Overall Study|Withdrawal by Subject|3
2603087|NCT01052272|8998192|P2|Overall Study|Withdrawal by Subject|2
2603088|NCT01052272|8998193|P1|Overall Study|Withdrawal by Subject|0
2603089|NCT01052272|8998190|P4|Overall Study|patient refuses follow-up|4
2603090|NCT01052272|8998191|P3|Overall Study|patient refuses follow-up|2
2603091|NCT01052272|8998192|P2|Overall Study|patient refuses follow-up|4
2603092|NCT01052272|8998193|P1|Overall Study|patient refuses follow-up|5
2603093|NCT01052272|8998190|P4|Overall Study|Physician Decision|0
2603094|NCT01052272|8998191|P3|Overall Study|Physician Decision|0
2603095|NCT01052272|8998192|P2|Overall Study|Physician Decision|1
2603096|NCT01052272|8998193|P1|Overall Study|Physician Decision|0
2603097|NCT01052272|8998190|P4|Overall Study|Death|1
2603098|NCT01052272|8998191|P3|Overall Study|Death|1
2603099|NCT01052272|8998192|P2|Overall Study|Death|0
2603100|NCT01052272|8998193|P1|Overall Study|Death|0
2603101|NCT01052116|8998238|P2|Overall Study|Spirometry not performed|4
2603102|NCT01052116|8998239|P1|Overall Study|Spirometry not performed|0
2603103|NCT01052116|8998238|P2|Overall Study|Withdrawal by Subject|6
2603104|NCT01052116|8998239|P1|Overall Study|Withdrawal by Subject|3
2603105|NCT01052116|8998238|P2|Overall Study|Lost to Follow-up|17
2603106|NCT01052116|8998239|P1|Overall Study|Lost to Follow-up|11
2603107|NCT01052077|8998247|P4|Phase A+|Withdrawal by Subject|7
2603108|NCT01052077|8998248|P3|Phase A+|Withdrawal by Subject|0
2603109|NCT01052077|8998249|P2|Phase A+|Withdrawal by Subject|0
2603110|NCT01052077|8998250|P1|Phase A+|Withdrawal by Subject|0
2603111|NCT01052077|8998247|P4|Phase A+|Met Withdrawal Criteria|2
2603112|NCT01052077|8998248|P3|Phase A+|Met Withdrawal Criteria|0
2603113|NCT01052077|8998249|P2|Phase A+|Met Withdrawal Criteria|0
2603114|NCT01052077|8998250|P1|Phase A+|Met Withdrawal Criteria|0
2603115|NCT01052077|8998247|P4|Phase A+|Adverse Event|4
2603116|NCT01052077|8998248|P3|Phase A+|Adverse Event|0
2603117|NCT01052077|8998249|P2|Phase A+|Adverse Event|0
2603118|NCT01052077|8998250|P1|Phase A+|Adverse Event|0
2603119|NCT01052077|8998247|P4|Phase A+|Lost to Follow-up|8
2603120|NCT01052077|8998248|P3|Phase A+|Lost to Follow-up|0
2603121|NCT01052077|8998249|P2|Phase A+|Lost to Follow-up|0
2603122|NCT01052077|8998250|P1|Phase A+|Lost to Follow-up|0
2603123|NCT01052077|8998247|P4|Phase B|Lack of Efficacy|0
2603124|NCT01052077|8998248|P3|Phase B|Lack of Efficacy|0
2603125|NCT01052077|8998249|P2|Phase B|Lack of Efficacy|1
2603126|NCT01052077|8998250|P1|Phase B|Lack of Efficacy|0
2603127|NCT01052077|8998247|P4|Phase B|Protocol Deviation|0
2603128|NCT01052077|8998248|P3|Phase B|Protocol Deviation|4
2603129|NCT01052077|8998249|P2|Phase B|Protocol Deviation|3
2603130|NCT01052077|8998250|P1|Phase B|Protocol Deviation|0
2603131|NCT01052077|8998247|P4|Phase B|Withdrawal by Subject|0
2603132|NCT01052077|8998248|P3|Phase B|Withdrawal by Subject|5
2603133|NCT01052077|8998249|P2|Phase B|Withdrawal by Subject|0
2603134|NCT01052077|8998250|P1|Phase B|Withdrawal by Subject|0
2603135|NCT01052077|8998247|P4|Phase B|Physician Decision|0
2603136|NCT01052077|8998248|P3|Phase B|Physician Decision|1
2603137|NCT01052077|8998249|P2|Phase B|Physician Decision|1
2603138|NCT01052077|8998250|P1|Phase B|Physician Decision|0
2603139|NCT01052077|8998247|P4|Phase B|Met Withdrawal Criteria|0
2603140|NCT01052077|8998248|P3|Phase B|Met Withdrawal Criteria|1
2603141|NCT01052077|8998249|P2|Phase B|Met Withdrawal Criteria|2
2603142|NCT01052077|8998250|P1|Phase B|Met Withdrawal Criteria|0
2603143|NCT01052077|8998247|P4|Phase B|Adverse Event|0
2603144|NCT01052077|8998248|P3|Phase B|Adverse Event|2
2603145|NCT01052077|8998249|P2|Phase B|Adverse Event|9
2603146|NCT01052077|8998250|P1|Phase B|Adverse Event|0
2603147|NCT01052077|8998247|P4|Phase B|Lost to Follow-up|0
2603148|NCT01052077|8998248|P3|Phase B|Lost to Follow-up|3
2603149|NCT01052077|8998249|P2|Phase B|Lost to Follow-up|2
2603150|NCT01052077|8998250|P1|Phase B|Lost to Follow-up|0
2603151|NCT01052077|8998247|P4|Phase A|Protocol Deviation|0
2603152|NCT01052077|8998248|P3|Phase A|Protocol Deviation|0
2603153|NCT01052077|8998249|P2|Phase A|Protocol Deviation|0
2603154|NCT01052077|8998250|P1|Phase A|Protocol Deviation|27
2603155|NCT01052077|8998247|P4|Phase A|Withdrawal by Subject|0
2603156|NCT01052077|8998248|P3|Phase A|Withdrawal by Subject|0
2603157|NCT01052077|8998249|P2|Phase A|Withdrawal by Subject|0
2603158|NCT01052077|8998250|P1|Phase A|Withdrawal by Subject|29
2603159|NCT01052077|8998247|P4|Phase A|Physician Decision|0
2603160|NCT01052077|8998248|P3|Phase A|Physician Decision|0
2603161|NCT01052077|8998249|P2|Phase A|Physician Decision|0
2603162|NCT01052077|8998250|P1|Phase A|Physician Decision|10
2603163|NCT01052077|8998247|P4|Phase A|Met Withdrawal Criteria|0
2603164|NCT01052077|8998248|P3|Phase A|Met Withdrawal Criteria|0
2603165|NCT01052077|8998249|P2|Phase A|Met Withdrawal Criteria|0
2603166|NCT01052077|8998250|P1|Phase A|Met Withdrawal Criteria|26
2603167|NCT01052077|8998247|P4|Phase A|Adverse Event|0
2603168|NCT01052077|8998248|P3|Phase A|Adverse Event|0
2603169|NCT01052077|8998249|P2|Phase A|Adverse Event|0
2603170|NCT01052077|8998250|P1|Phase A|Adverse Event|32
2603171|NCT01052077|8998247|P4|Phase A|Lost to Follow-up|0
2603172|NCT01052077|8998248|P3|Phase A|Lost to Follow-up|0
2603173|NCT01052077|8998249|P2|Phase A|Lost to Follow-up|0
2603174|NCT01052077|8998250|P1|Phase A|Lost to Follow-up|22
2603175|NCT01052038|8998277|P3|Overall Study|Protocol Violation|3
2603176|NCT01052038|8998278|P2|Overall Study|Protocol Violation|3
2603177|NCT01052038|8998279|P1|Overall Study|Protocol Violation|2
2603178|NCT01052038|8998277|P3|Overall Study|Lost to Follow-up|1
2603179|NCT01052038|8998278|P2|Overall Study|Lost to Follow-up|3
2603180|NCT01052038|8998279|P1|Overall Study|Lost to Follow-up|2
2603181|NCT01051986|8998301|P2|Overall Study|Protocol Violation|3
2603182|NCT01051986|8998302|P1|Overall Study|Protocol Violation|2
2603183|NCT01051986|8998301|P2|Overall Study|Withdrawal by Subject|1
2603184|NCT01051986|8998302|P1|Overall Study|Withdrawal by Subject|2
2603185|NCT01051986|8998301|P2|Overall Study|Death|0
2603186|NCT01051986|8998302|P1|Overall Study|Death|1
2603187|NCT01051921|8998316|P1|Overall Study|patient moved|1
2603188|NCT01051921|8998316|P1|Overall Study|virological failure|1
2603189|NCT01051921|8998316|P1|Overall Study|Lost to Follow-up|4
2603190|NCT01051921|8998316|P1|Overall Study|Withdrawal by Subject|7
2603191|NCT01051921|8998316|P1|Overall Study|Adverse Event|8
2603192|NCT01051921|8998316|P1|Overall Study|Physician Decision|9
2603193|NCT01051856|8998323|P2|Overall Study|Withdrawal by Subject|0
2603194|NCT01051856|8998324|P1|Overall Study|Withdrawal by Subject|1
2603195|NCT01051817|8998334|P2|Overall Study|Protocol Violation|1
2603196|NCT01051817|8998335|P1|Overall Study|Protocol Violation|0
2603197|NCT01051817|8998334|P2|Overall Study|Withdrawal by Subject|5
2603198|NCT01051817|8998335|P1|Overall Study|Withdrawal by Subject|3
2603199|NCT01051817|8998334|P2|Overall Study|Abnormal Test Proceedure reults|1
2603200|NCT01051817|8998335|P1|Overall Study|Abnormal Test Proceedure reults|0
2603201|NCT01051817|8998334|P2|Overall Study|Adverse Event|2
2603202|NCT01051817|8998335|P1|Overall Study|Adverse Event|0
2603203|NCT01051791|8998345|P1|Overall Study|Withdrawal by Subject|1
2603204|NCT01051791|8998345|P1|Overall Study|Failed screening|3
2603205|NCT01051739|8998363|P2|Overall Study|Withdrawal by Subject|10
2603206|NCT01051739|8998364|P1|Overall Study|Withdrawal by Subject|25
2603207|NCT01051739|8998363|P2|Overall Study|Death|3
2603208|NCT01051739|8998364|P1|Overall Study|Death|3
2603209|NCT01051557|8998388|P7|Overall Study|Adverse Event|4
2603210|NCT01051557|8998389|P6|Overall Study|Adverse Event|3
2603211|NCT01051557|8998390|P5|Overall Study|Adverse Event|1
2603212|NCT01051557|8998391|P4|Overall Study|Adverse Event|1
2603213|NCT01051557|8998392|P3|Overall Study|Adverse Event|0
2603214|NCT01051557|8998393|P2|Overall Study|Adverse Event|0
2603215|NCT01051557|8998394|P1|Overall Study|Adverse Event|0
2603216|NCT01051557|8998388|P7|Overall Study|Withdrawal by Subject|1
2603217|NCT01051557|8998389|P6|Overall Study|Withdrawal by Subject|0
2603218|NCT01051557|8998390|P5|Overall Study|Withdrawal by Subject|2
2603219|NCT01051557|8998391|P4|Overall Study|Withdrawal by Subject|0
2603220|NCT01051557|8998392|P3|Overall Study|Withdrawal by Subject|1
2603221|NCT01051557|8998393|P2|Overall Study|Withdrawal by Subject|0
2603222|NCT01051557|8998394|P1|Overall Study|Withdrawal by Subject|0
2603223|NCT01051557|8998388|P7|Overall Study|disease progression|1
2603224|NCT01051557|8998389|P6|Overall Study|disease progression|3
2603225|NCT01051557|8998390|P5|Overall Study|disease progression|4
2603226|NCT01051557|8998391|P4|Overall Study|disease progression|2
2603227|NCT01051557|8998392|P3|Overall Study|disease progression|5
2603228|NCT01051557|8998393|P2|Overall Study|disease progression|3
2603229|NCT01051557|8998394|P1|Overall Study|disease progression|3
2603230|NCT01051557|8998388|P7|Overall Study|Physician Decision|0
2603231|NCT01051557|8998389|P6|Overall Study|Physician Decision|0
2603232|NCT01051557|8998390|P5|Overall Study|Physician Decision|0
2603233|NCT01051557|8998391|P4|Overall Study|Physician Decision|0
2603234|NCT01051557|8998392|P3|Overall Study|Physician Decision|0
2603235|NCT01051557|8998393|P2|Overall Study|Physician Decision|0
2603236|NCT01051557|8998394|P1|Overall Study|Physician Decision|1
2603237|NCT01051466|8998425|P2|Overall Study|Physician Decision|0
2603238|NCT01051466|8998426|P1|Overall Study|Physician Decision|1
2603239|NCT01051466|8998425|P2|Overall Study|Entry Criteria Not Met|3
2603240|NCT01051466|8998426|P1|Overall Study|Entry Criteria Not Met|0
2603241|NCT01051466|8998425|P2|Overall Study|Withdrawal by Subject|1
2603242|NCT01051466|8998426|P1|Overall Study|Withdrawal by Subject|5
2603243|NCT01051466|8998425|P2|Overall Study|Lost to Follow-up|1
2603244|NCT01051466|8998426|P1|Overall Study|Lost to Follow-up|1
2603245|NCT01051466|8998425|P2|Overall Study|Adverse Event|0
2603246|NCT01051466|8998426|P1|Overall Study|Adverse Event|1
2603247|NCT01051349|8998471|P1|Overall Study|Reason not Specified|12
2603248|NCT01051349|8998471|P1|Overall Study|Subject non-compliance|7
2603249|NCT01051349|8998471|P1|Overall Study|Lost to Follow-up|6
2603250|NCT01051349|8998471|P1|Overall Study|Investigator Decision|6
2603251|NCT01051349|8998471|P1|Overall Study|Consent Withdrawn|54
2603252|NCT01051349|8998471|P1|Overall Study|Adverse Event|88
2603253|NCT01051323|8998500|P1|Overall Study|Missing|37
2603254|NCT01051323|8998500|P1|Overall Study|Other|148
2603255|NCT01051323|8998500|P1|Overall Study|Hospitalization|28
2603256|NCT01051323|8998500|P1|Overall Study|Death|129
2603257|NCT01051323|8998500|P1|Overall Study|Lost to Follow-up|31
2603258|NCT01051323|8998500|P1|Overall Study|Withdrawal by Subject|13
2603259|NCT01051323|8998500|P1|Overall Study|Dialysis dependency|22
2603260|NCT01051323|8998500|P1|Overall Study|Transplantation|28
2603261|NCT01051323|8998500|P1|Overall Study|Discontinuation of treatment|103
2603262|NCT01051063|8998529|P2|Overall Study|Lost to Follow-up|1
2603263|NCT01051063|8998530|P1|Overall Study|Lost to Follow-up|0
2603264|NCT01051063|8998529|P2|Overall Study|Other|0
2603265|NCT01051063|8998530|P1|Overall Study|Other|1
2603266|NCT01051063|8998529|P2|Overall Study|Moved from the study site area|0
2603267|NCT01051063|8998530|P1|Overall Study|Moved from the study site area|1
2603268|NCT01051063|8998529|P2|Overall Study|Termination of the study|0
2603269|NCT01051063|8998530|P1|Overall Study|Termination of the study|5
2603270|NCT01051063|8998529|P2|Overall Study|Withdrawal by Subject|1
2603271|NCT01051063|8998530|P1|Overall Study|Withdrawal by Subject|1
2603272|NCT01051063|8998529|P2|Overall Study|Death|2
2603273|NCT01051063|8998530|P1|Overall Study|Death|2
2603274|NCT01050998|8998550|P5|Overall Study|Data integrity issues|4
2603275|NCT01050998|8998551|P4|Overall Study|Data integrity issues|1
2603276|NCT01050998|8998552|P3|Overall Study|Data integrity issues|1
2603277|NCT01050998|8998553|P2|Overall Study|Data integrity issues|0
2603278|NCT01050998|8998554|P1|Overall Study|Data integrity issues|0
2603279|NCT01050998|8998550|P5|Overall Study|Other|5
2603280|NCT01050998|8998551|P4|Overall Study|Other|1
2603281|NCT01050998|8998552|P3|Overall Study|Other|1
2603282|NCT01050998|8998553|P2|Overall Study|Other|2
2603283|NCT01050998|8998554|P1|Overall Study|Other|3
2603284|NCT01050998|8998550|P5|Overall Study|Withdrawal by Subject|3
2603285|NCT01050998|8998551|P4|Overall Study|Withdrawal by Subject|1
2603286|NCT01050998|8998552|P3|Overall Study|Withdrawal by Subject|0
2603287|NCT01050998|8998553|P2|Overall Study|Withdrawal by Subject|0
2603288|NCT01050998|8998554|P1|Overall Study|Withdrawal by Subject|0
2603289|NCT01050998|8998550|P5|Overall Study|Adverse Event|2
2603290|NCT01050998|8998551|P4|Overall Study|Adverse Event|0
2603291|NCT01050998|8998552|P3|Overall Study|Adverse Event|1
2603292|NCT01050998|8998553|P2|Overall Study|Adverse Event|0
2603293|NCT01050998|8998554|P1|Overall Study|Adverse Event|1
2603294|NCT01050816|8998888|P1|Overall Study|patient's refusal|2
2603295|NCT01050816|8998888|P1|Overall Study|Lost to Follow-up|2
2603296|NCT01050790|8998894|P1|Overall Study|Adverse Event|1
2603297|NCT01050764|8998904|P1|Overall Study|Death after HSCT, before T-cell infusion|1
2603298|NCT01050764|8998904|P1|Overall Study|Donor mobilization failure, death|1
2603299|NCT01050764|8998904|P1|Overall Study|Death, before HSCT|1
2603300|NCT01050673|8998915|P2|Overall Study|Physician Decision|5
2603301|NCT01050673|8998916|P1|Overall Study|Physician Decision|4
2603302|NCT01050634|8998984|P1|Overall Study|Ongoing at Date of Cut-Off|5
2603303|NCT01050634|8998984|P1|Overall Study|Other|21
2603304|NCT01050634|8998984|P1|Overall Study|Lost to Follow-up|2
2603305|NCT01050634|8998984|P1|Overall Study|Adverse Event|42
2603306|NCT01050634|8998984|P1|Overall Study|Death|2
2603307|NCT01050634|8998984|P1|Overall Study|Enrolled, but Not Treated|56
2603308|NCT01050569|8999008|P3|Overall Study|Physician Decision|3
2603309|NCT01050569|8999009|P2|Overall Study|Physician Decision|3
2603310|NCT01050569|8999010|P1|Overall Study|Physician Decision|3
2603311|NCT01050569|8999008|P3|Overall Study|Adverse Event|0
2603312|NCT01050569|8999009|P2|Overall Study|Adverse Event|0
2603313|NCT01050569|8999010|P1|Overall Study|Adverse Event|1
2603314|NCT01050569|8999008|P3|Overall Study|Lack of Efficacy|3
2603315|NCT01050569|8999009|P2|Overall Study|Lack of Efficacy|4
2603316|NCT01050569|8999010|P1|Overall Study|Lack of Efficacy|5
2603317|NCT01050569|8999008|P3|Overall Study|Withdrawal by Subject|11
2603318|NCT01050569|8999009|P2|Overall Study|Withdrawal by Subject|3
2603319|NCT01050569|8999010|P1|Overall Study|Withdrawal by Subject|9
2603320|NCT01050569|8999008|P3|Overall Study|Lost to Follow-up|16
2603321|NCT01050569|8999009|P2|Overall Study|Lost to Follow-up|14
2603322|NCT01050569|8999010|P1|Overall Study|Lost to Follow-up|20
2603323|NCT01050543|8999029|P2|Overall Study|Administrative|1
2603324|NCT01050543|8999030|P1|Overall Study|Administrative|4
2603325|NCT01050543|8999029|P2|Overall Study|Protocol Violation|1
2603326|NCT01050543|8999030|P1|Overall Study|Protocol Violation|0
2603327|NCT01050543|8999029|P2|Overall Study|Withdrawal by Subject|2
2603328|NCT01050543|8999030|P1|Overall Study|Withdrawal by Subject|0
2603329|NCT01050530|8999038|P2|Overall Study|Protocol Violation|0
2603330|NCT01050530|8999039|P1|Overall Study|Protocol Violation|1
2603331|NCT01050530|8999038|P2|Overall Study|Withdrawal by Subject|3
2603332|NCT01050530|8999039|P1|Overall Study|Withdrawal by Subject|0
2603333|NCT01050530|8999038|P2|Overall Study|Lack of Efficacy|4
2603334|NCT01050530|8999039|P1|Overall Study|Lack of Efficacy|1
2603335|NCT01050530|8999038|P2|Overall Study|Adverse Event|3
2603336|NCT01050530|8999039|P1|Overall Study|Adverse Event|6
2603337|NCT01050257|8999050|P3|Overall Study|Death|1
2603338|NCT01050257|8999051|P2|Overall Study|Death|0
2603339|NCT01050257|8999052|P1|Overall Study|Death|0
2603340|NCT01050257|8999050|P3|Overall Study|Failure to return|0
2603341|NCT01050257|8999051|P2|Overall Study|Failure to return|2
2603342|NCT01050257|8999052|P1|Overall Study|Failure to return|0
2603343|NCT01050257|8999050|P3|Overall Study|Violation criteria|0
2603344|NCT01050257|8999051|P2|Overall Study|Violation criteria|1
2603345|NCT01050257|8999052|P1|Overall Study|Violation criteria|0
2603346|NCT01050257|8999050|P3|Overall Study|Refused treatment/ Did not Cooperate|0
2603347|NCT01050257|8999051|P2|Overall Study|Refused treatment/ Did not Cooperate|1
2603348|NCT01050257|8999052|P1|Overall Study|Refused treatment/ Did not Cooperate|1
2603349|NCT01050257|8999050|P3|Overall Study|No reason specified|2
2603350|NCT01050257|8999051|P2|Overall Study|No reason specified|0
2603351|NCT01050257|8999052|P1|Overall Study|No reason specified|0
2603352|NCT01050257|8999050|P3|Overall Study|Withdrawal by Subject|0
2603353|NCT01050257|8999051|P2|Overall Study|Withdrawal by Subject|3
2603354|NCT01050257|8999052|P1|Overall Study|Withdrawal by Subject|0
2603355|NCT01050257|8999050|P3|Overall Study|Admin/Other (did not switch to oral)|2
2603356|NCT01050257|8999051|P2|Overall Study|Admin/Other (did not switch to oral)|2
2603357|NCT01050257|8999052|P1|Overall Study|Admin/Other (did not switch to oral)|6
2603358|NCT01050257|8999050|P3|Overall Study|Adverse Event|2
2603359|NCT01050257|8999051|P2|Overall Study|Adverse Event|4
2603360|NCT01050257|8999052|P1|Overall Study|Adverse Event|4
2603361|NCT01050218|8999087|P1|Overall Study|Family emergency|1
2603362|NCT01050218|8999087|P1|Overall Study|Serious Adverse Event|1
2603363|NCT01050218|8999087|P1|Overall Study|Failed to return|7
2603364|NCT01050218|8999087|P1|Overall Study|Compliance|2
2603365|NCT01050218|8999087|P1|Overall Study|Discontinued by sponsor|18
2603366|NCT01050218|8999087|P1|Overall Study|Withdrawal by Subject|18
2603367|NCT01050218|8999087|P1|Overall Study|Protocol Violation|3
2603368|NCT01050218|8999087|P1|Overall Study|Lack of Efficacy|8
2603369|NCT01050218|8999087|P1|Overall Study|Adverse Event|37
2603370|NCT01050205|8999093|P2|Overall Study|Discontinued Intervention|0
2603371|NCT01050205|8999094|P1|Overall Study|Discontinued Intervention|2
2603372|NCT01050205|8999093|P2|Overall Study|Relocated from area|2
2603373|NCT01050205|8999094|P1|Overall Study|Relocated from area|1
2603374|NCT01050205|8999093|P2|Overall Study|Withdrawal by Subject|1
2603375|NCT01050205|8999094|P1|Overall Study|Withdrawal by Subject|1
2603376|NCT01050205|8999093|P2|Overall Study|Lost to Follow-up|1
2603377|NCT01050205|8999094|P1|Overall Study|Lost to Follow-up|7
2603378|NCT01050062|8999151|P2|Overall Study|Others|11
2603379|NCT01050062|8999152|P1|Overall Study|Others|17
2603380|NCT01050062|8999151|P2|Overall Study|Physician Decision|9
2603381|NCT01050062|8999152|P1|Overall Study|Physician Decision|74
2603382|NCT01050062|8999151|P2|Overall Study|Lack of Efficacy|35
2603383|NCT01050062|8999152|P1|Overall Study|Lack of Efficacy|22
2603384|NCT01050062|8999151|P2|Overall Study|Lost to Follow-up|35
2603385|NCT01050062|8999152|P1|Overall Study|Lost to Follow-up|83
2603386|NCT01050062|8999151|P2|Overall Study|Adverse Event|22
2603387|NCT01050062|8999152|P1|Overall Study|Adverse Event|75
2603388|NCT01049984|8999174|P2|Overall Study|Treatment failure|2
2603389|NCT01049984|8999175|P1|Overall Study|Treatment failure|0
2603390|NCT01049984|8999174|P2|Overall Study|Adverse Event|7
2603391|NCT01049984|8999175|P1|Overall Study|Adverse Event|13
2603392|NCT01049984|8999174|P2|Overall Study|Lost to Follow-up|1
2603393|NCT01049984|8999175|P1|Overall Study|Lost to Follow-up|2
2603394|NCT01049984|8999174|P2|Overall Study|Protocol Violation|4
2603395|NCT01049984|8999175|P1|Overall Study|Protocol Violation|3
2603396|NCT01049984|8999174|P2|Overall Study|Withdrawal by Subject|5
2603397|NCT01049984|8999175|P1|Overall Study|Withdrawal by Subject|1
2603398|NCT01049581|8999239|P2|Overall Study|Lost to Follow-up|1
2603399|NCT01049581|8999240|P1|Overall Study|Lost to Follow-up|2
2603400|NCT01049503|8999255|P6|Overall Study|Lost to Follow-up|8
2603401|NCT01049503|8999256|P5|Overall Study|Lost to Follow-up|27
2603402|NCT01049503|8999257|P4|Overall Study|Lost to Follow-up|26
2603403|NCT01049503|8999258|P3|Overall Study|Lost to Follow-up|24
2603404|NCT01049503|8999259|P2|Overall Study|Lost to Follow-up|12
2603405|NCT01049503|8999260|P1|Overall Study|Lost to Follow-up|11
2603406|NCT01049412|8999291|P2|Period II|Lost to Follow-up|0
2603407|NCT01049412|8999292|P1|Period II|Lost to Follow-up|1
2603408|NCT01049412|8999291|P2|Period II|Adverse Event|0
2603409|NCT01049412|8999292|P1|Period II|Adverse Event|1
2603410|NCT01049412|8999291|P2|Period II|Withdrawal by Subject|3
2603411|NCT01049412|8999292|P1|Period II|Withdrawal by Subject|2
2603412|NCT01049412|8999291|P2|Period I|Adverse Event|0
2603413|NCT01049412|8999292|P1|Period I|Adverse Event|1
2603414|NCT01049412|8999291|P2|Period I|Protocol Violation|2
2603415|NCT01049412|8999292|P1|Period I|Protocol Violation|1
2603416|NCT01049412|8999291|P2|Period I|Physician Decision|3
2603417|NCT01049412|8999292|P1|Period I|Physician Decision|0
2603418|NCT01049412|8999291|P2|Period I|Lost to Follow-up|2
2603419|NCT01049412|8999292|P1|Period I|Lost to Follow-up|2
2603420|NCT01049412|8999291|P2|Period I|Withdrawal by Subject|6
2603421|NCT01049412|8999292|P1|Period I|Withdrawal by Subject|4
2603422|NCT01049373|8999321|P2|Overall Study|Non-cooperation|1
2603423|NCT01049373|8999322|P1|Overall Study|Non-cooperation|0
2603424|NCT01049373|8999321|P2|Overall Study|Other|1
2603425|NCT01049373|8999322|P1|Overall Study|Other|1
2603426|NCT01049373|8999321|P2|Overall Study|no evaluable study values|21
2603427|NCT01049373|8999322|P1|Overall Study|no evaluable study values|9
2603428|NCT01049373|8999321|P2|Overall Study|Lost to Follow-up|4
2603429|NCT01049373|8999322|P1|Overall Study|Lost to Follow-up|9
2603430|NCT01049373|8999321|P2|Overall Study|Adverse Event|3
2603431|NCT01049373|8999322|P1|Overall Study|Adverse Event|3
2603432|NCT01049373|8999321|P2|Overall Study|Withdrawal by Subject|5
2603433|NCT01049373|8999322|P1|Overall Study|Withdrawal by Subject|8
2603434|NCT01049373|8999321|P2|Overall Study|Protocol Violation|9
2603435|NCT01049373|8999322|P1|Overall Study|Protocol Violation|9
2603436|NCT01049360|8999336|P20|Period 4|Withdrawal by Subject|0
2603437|NCT01049360|8999337|P19|Period 4|Withdrawal by Subject|0
2603438|NCT01049360|8999338|P18|Period 4|Withdrawal by Subject|0
2603439|NCT01049360|8999339|P17|Period 4|Withdrawal by Subject|0
2603440|NCT01049360|8999340|P16|Period 4|Withdrawal by Subject|0
2603441|NCT01049360|8999341|P15|Period 4|Withdrawal by Subject|0
2603442|NCT01049360|8999342|P14|Period 4|Withdrawal by Subject|0
2603443|NCT01049360|8999343|P13|Period 4|Withdrawal by Subject|0
2603444|NCT01049360|8999344|P12|Period 4|Withdrawal by Subject|0
2603445|NCT01049360|8999345|P11|Period 4|Withdrawal by Subject|0
2603446|NCT01049360|8999346|P10|Period 4|Withdrawal by Subject|0
2603447|NCT01049360|8999347|P9|Period 4|Withdrawal by Subject|0
2603448|NCT01049360|8999348|P8|Period 4|Withdrawal by Subject|0
2603449|NCT01049360|8999349|P7|Period 4|Withdrawal by Subject|0
2603450|NCT01049360|8999350|P6|Period 4|Withdrawal by Subject|0
2603451|NCT01049360|8999351|P5|Period 4|Withdrawal by Subject|0
2603452|NCT01049360|8999352|P4|Period 4|Withdrawal by Subject|1
2603453|NCT01049360|8999353|P3|Period 4|Withdrawal by Subject|0
2603454|NCT01049360|8999354|P2|Period 4|Withdrawal by Subject|0
2603455|NCT01049360|8999355|P1|Period 4|Withdrawal by Subject|0
2603456|NCT01049360|8999336|P20|Period 4|Protocol Violation|0
2603457|NCT01049360|8999337|P19|Period 4|Protocol Violation|0
2603458|NCT01049360|8999338|P18|Period 4|Protocol Violation|1
2603459|NCT01049360|8999339|P17|Period 4|Protocol Violation|0
2603460|NCT01049360|8999340|P16|Period 4|Protocol Violation|0
2603461|NCT01049360|8999341|P15|Period 4|Protocol Violation|0
2603462|NCT01049360|8999342|P14|Period 4|Protocol Violation|0
2603463|NCT01049360|8999343|P13|Period 4|Protocol Violation|0
2603464|NCT01049360|8999344|P12|Period 4|Protocol Violation|0
2603465|NCT01049360|8999345|P11|Period 4|Protocol Violation|0
2603466|NCT01049360|8999346|P10|Period 4|Protocol Violation|0
2603467|NCT01049360|8999347|P9|Period 4|Protocol Violation|0
2603468|NCT01049360|8999348|P8|Period 4|Protocol Violation|0
2603469|NCT01049360|8999349|P7|Period 4|Protocol Violation|0
2603470|NCT01049360|8999350|P6|Period 4|Protocol Violation|0
2603471|NCT01049360|8999351|P5|Period 4|Protocol Violation|0
2603472|NCT01049360|8999352|P4|Period 4|Protocol Violation|0
2603473|NCT01049360|8999353|P3|Period 4|Protocol Violation|0
2603474|NCT01049360|8999354|P2|Period 4|Protocol Violation|0
2603475|NCT01049360|8999355|P1|Period 4|Protocol Violation|0
2603476|NCT01049360|8999336|P20|Period 2|Lack of Efficacy|0
2603477|NCT01049360|8999337|P19|Period 2|Lack of Efficacy|0
2603478|NCT01049360|8999338|P18|Period 2|Lack of Efficacy|0
2603479|NCT01049360|8999339|P17|Period 2|Lack of Efficacy|0
2603480|NCT01049360|8999340|P16|Period 2|Lack of Efficacy|0
2603481|NCT01049360|8999341|P15|Period 2|Lack of Efficacy|0
2603482|NCT01049360|8999342|P14|Period 2|Lack of Efficacy|0
2603483|NCT01049360|8999343|P13|Period 2|Lack of Efficacy|0
2603484|NCT01049360|8999344|P12|Period 2|Lack of Efficacy|0
2603485|NCT01049360|8999345|P11|Period 2|Lack of Efficacy|0
2603486|NCT01049360|8999346|P10|Period 2|Lack of Efficacy|0
2603487|NCT01049360|8999347|P9|Period 2|Lack of Efficacy|0
2603488|NCT01049360|8999348|P8|Period 2|Lack of Efficacy|0
2603489|NCT01049360|8999349|P7|Period 2|Lack of Efficacy|0
2603490|NCT01049360|8999350|P6|Period 2|Lack of Efficacy|1
2603491|NCT01049360|8999351|P5|Period 2|Lack of Efficacy|0
2603492|NCT01049360|8999352|P4|Period 2|Lack of Efficacy|0
2603493|NCT01049360|8999353|P3|Period 2|Lack of Efficacy|0
2603494|NCT01049360|8999354|P2|Period 2|Lack of Efficacy|0
2603495|NCT01049360|8999355|P1|Period 2|Lack of Efficacy|0
2603496|NCT01049360|8999336|P20|Period 2|Withdrawal by Subject|1
2603497|NCT01049360|8999337|P19|Period 2|Withdrawal by Subject|0
2603498|NCT01049360|8999338|P18|Period 2|Withdrawal by Subject|0
2603499|NCT01049360|8999339|P17|Period 2|Withdrawal by Subject|0
2603500|NCT01049360|8999340|P16|Period 2|Withdrawal by Subject|0
2603501|NCT01049360|8999341|P15|Period 2|Withdrawal by Subject|1
2603502|NCT01049360|8999342|P14|Period 2|Withdrawal by Subject|0
2603503|NCT01049360|8999343|P13|Period 2|Withdrawal by Subject|0
2603504|NCT01049360|8999344|P12|Period 2|Withdrawal by Subject|0
2603505|NCT01049360|8999345|P11|Period 2|Withdrawal by Subject|0
2603506|NCT01049360|8999346|P10|Period 2|Withdrawal by Subject|0
2603507|NCT01049360|8999347|P9|Period 2|Withdrawal by Subject|0
2603508|NCT01049360|8999348|P8|Period 2|Withdrawal by Subject|0
2603509|NCT01049360|8999349|P7|Period 2|Withdrawal by Subject|0
2603510|NCT01049360|8999350|P6|Period 2|Withdrawal by Subject|0
2603511|NCT01049360|8999351|P5|Period 2|Withdrawal by Subject|0
2603512|NCT01049360|8999352|P4|Period 2|Withdrawal by Subject|1
2603513|NCT01049360|8999353|P3|Period 2|Withdrawal by Subject|0
2603514|NCT01049360|8999354|P2|Period 2|Withdrawal by Subject|0
2603515|NCT01049360|8999355|P1|Period 2|Withdrawal by Subject|0
2603516|NCT01049360|8999336|P20|Period 2|Adverse Event|1
2603517|NCT01049360|8999337|P19|Period 2|Adverse Event|0
2603518|NCT01049360|8999338|P18|Period 2|Adverse Event|0
2603519|NCT01049360|8999339|P17|Period 2|Adverse Event|0
2603520|NCT01049360|8999340|P16|Period 2|Adverse Event|0
2603521|NCT01049360|8999341|P15|Period 2|Adverse Event|0
2603522|NCT01049360|8999342|P14|Period 2|Adverse Event|0
2603523|NCT01049360|8999343|P13|Period 2|Adverse Event|0
2603524|NCT01049360|8999344|P12|Period 2|Adverse Event|0
2603525|NCT01049360|8999345|P11|Period 2|Adverse Event|0
2603526|NCT01049360|8999346|P10|Period 2|Adverse Event|0
2603527|NCT01049360|8999347|P9|Period 2|Adverse Event|1
2603528|NCT01049360|8999348|P8|Period 2|Adverse Event|0
2603529|NCT01049360|8999349|P7|Period 2|Adverse Event|0
2603530|NCT01049360|8999350|P6|Period 2|Adverse Event|0
2603531|NCT01049360|8999351|P5|Period 2|Adverse Event|0
2603532|NCT01049360|8999352|P4|Period 2|Adverse Event|0
2603533|NCT01049360|8999353|P3|Period 2|Adverse Event|0
2603534|NCT01049360|8999354|P2|Period 2|Adverse Event|1
2603535|NCT01049360|8999355|P1|Period 2|Adverse Event|0
2603536|NCT01049360|8999336|P20|Period 2|Protocol Violation|0
2603537|NCT01049360|8999337|P19|Period 2|Protocol Violation|0
2603538|NCT01049360|8999338|P18|Period 2|Protocol Violation|0
2603539|NCT01049360|8999339|P17|Period 2|Protocol Violation|0
2603540|NCT01049360|8999340|P16|Period 2|Protocol Violation|1
2603541|NCT01049360|8999341|P15|Period 2|Protocol Violation|1
2603542|NCT01049360|8999342|P14|Period 2|Protocol Violation|0
2603543|NCT01049360|8999343|P13|Period 2|Protocol Violation|0
2603544|NCT01049360|8999344|P12|Period 2|Protocol Violation|0
2603545|NCT01049360|8999345|P11|Period 2|Protocol Violation|0
2603546|NCT01049360|8999346|P10|Period 2|Protocol Violation|0
2603547|NCT01049360|8999347|P9|Period 2|Protocol Violation|0
2603548|NCT01049360|8999348|P8|Period 2|Protocol Violation|0
2603549|NCT01049360|8999349|P7|Period 2|Protocol Violation|0
2603550|NCT01049360|8999350|P6|Period 2|Protocol Violation|0
2603551|NCT01049360|8999351|P5|Period 2|Protocol Violation|0
2603552|NCT01049360|8999352|P4|Period 2|Protocol Violation|1
2603553|NCT01049360|8999353|P3|Period 2|Protocol Violation|0
2603554|NCT01049360|8999354|P2|Period 2|Protocol Violation|0
2603555|NCT01049360|8999355|P1|Period 2|Protocol Violation|0
2603556|NCT01049360|8999336|P20|Period 1|Withdrawal by Subject|0
2603557|NCT01049360|8999337|P19|Period 1|Withdrawal by Subject|0
2603558|NCT01049360|8999338|P18|Period 1|Withdrawal by Subject|0
2603559|NCT01049360|8999339|P17|Period 1|Withdrawal by Subject|0
2603560|NCT01049360|8999340|P16|Period 1|Withdrawal by Subject|0
2603561|NCT01049360|8999341|P15|Period 1|Withdrawal by Subject|0
2603562|NCT01049360|8999342|P14|Period 1|Withdrawal by Subject|0
2603563|NCT01049360|8999343|P13|Period 1|Withdrawal by Subject|1
2603564|NCT01049360|8999344|P12|Period 1|Withdrawal by Subject|0
2603565|NCT01049360|8999345|P11|Period 1|Withdrawal by Subject|1
2603566|NCT01049360|8999346|P10|Period 1|Withdrawal by Subject|0
2603567|NCT01049360|8999347|P9|Period 1|Withdrawal by Subject|1
2603568|NCT01049360|8999348|P8|Period 1|Withdrawal by Subject|0
2603569|NCT01049360|8999349|P7|Period 1|Withdrawal by Subject|0
2603570|NCT01049360|8999350|P6|Period 1|Withdrawal by Subject|0
2603571|NCT01049360|8999351|P5|Period 1|Withdrawal by Subject|0
2603572|NCT01049360|8999352|P4|Period 1|Withdrawal by Subject|0
2603573|NCT01049360|8999353|P3|Period 1|Withdrawal by Subject|0
2603574|NCT01049360|8999354|P2|Period 1|Withdrawal by Subject|0
2603575|NCT01049360|8999355|P1|Period 1|Withdrawal by Subject|0
2603576|NCT01049360|8999336|P20|Period 1|Did not meet inc/exc criteria|0
2603577|NCT01049360|8999337|P19|Period 1|Did not meet inc/exc criteria|0
2603578|NCT01049360|8999338|P18|Period 1|Did not meet inc/exc criteria|0
2603579|NCT01049360|8999339|P17|Period 1|Did not meet inc/exc criteria|0
2603580|NCT01049360|8999340|P16|Period 1|Did not meet inc/exc criteria|0
2603581|NCT01049360|8999341|P15|Period 1|Did not meet inc/exc criteria|0
2603582|NCT01049360|8999342|P14|Period 1|Did not meet inc/exc criteria|0
2603583|NCT01049360|8999343|P13|Period 1|Did not meet inc/exc criteria|0
2603584|NCT01049360|8999344|P12|Period 1|Did not meet inc/exc criteria|0
2603585|NCT01049360|8999345|P11|Period 1|Did not meet inc/exc criteria|0
2603586|NCT01049360|8999346|P10|Period 1|Did not meet inc/exc criteria|0
2603587|NCT01049360|8999347|P9|Period 1|Did not meet inc/exc criteria|1
2603588|NCT01049360|8999348|P8|Period 1|Did not meet inc/exc criteria|1
2603589|NCT01049360|8999349|P7|Period 1|Did not meet inc/exc criteria|0
2603590|NCT01049360|8999350|P6|Period 1|Did not meet inc/exc criteria|0
2603591|NCT01049360|8999351|P5|Period 1|Did not meet inc/exc criteria|0
2603592|NCT01049360|8999352|P4|Period 1|Did not meet inc/exc criteria|0
2603593|NCT01049360|8999353|P3|Period 1|Did not meet inc/exc criteria|0
2603594|NCT01049360|8999354|P2|Period 1|Did not meet inc/exc criteria|0
2603595|NCT01049360|8999355|P1|Period 1|Did not meet inc/exc criteria|0
2603596|NCT01049360|8999336|P20|Period 1|Adverse Event|0
2603597|NCT01049360|8999337|P19|Period 1|Adverse Event|1
2603598|NCT01049360|8999338|P18|Period 1|Adverse Event|0
2603599|NCT01049360|8999339|P17|Period 1|Adverse Event|1
2603600|NCT01049360|8999340|P16|Period 1|Adverse Event|0
2603601|NCT01049360|8999341|P15|Period 1|Adverse Event|0
2603602|NCT01049360|8999342|P14|Period 1|Adverse Event|1
2603603|NCT01049360|8999343|P13|Period 1|Adverse Event|1
2603604|NCT01049360|8999344|P12|Period 1|Adverse Event|0
2603605|NCT01049360|8999345|P11|Period 1|Adverse Event|0
2603606|NCT01049360|8999346|P10|Period 1|Adverse Event|0
2603607|NCT01049360|8999347|P9|Period 1|Adverse Event|0
2603608|NCT01049360|8999348|P8|Period 1|Adverse Event|1
2603609|NCT01049360|8999349|P7|Period 1|Adverse Event|0
2603610|NCT01049360|8999350|P6|Period 1|Adverse Event|0
2603611|NCT01049360|8999351|P5|Period 1|Adverse Event|0
2603612|NCT01049360|8999352|P4|Period 1|Adverse Event|1
2603613|NCT01049360|8999353|P3|Period 1|Adverse Event|0
2603614|NCT01049360|8999354|P2|Period 1|Adverse Event|1
2603615|NCT01049360|8999355|P1|Period 1|Adverse Event|0
2603616|NCT01049334|8999379|P2|Overall Study|Protocol Violation|1
2603617|NCT01049334|8999380|P1|Overall Study|Protocol Violation|0
2603618|NCT01049334|8999379|P2|Overall Study|Physician Decision|0
2603619|NCT01049334|8999380|P1|Overall Study|Physician Decision|2
2603620|NCT01049334|8999379|P2|Overall Study|Adverse Event|3
2603621|NCT01049334|8999380|P1|Overall Study|Adverse Event|2
2603622|NCT01049334|8999379|P2|Overall Study|Withdrawal by Subject|3
2603623|NCT01049334|8999380|P1|Overall Study|Withdrawal by Subject|5
2603624|NCT01049308|8999416|P1|Pill Counts|Withdrawal by Subject|83
2603625|NCT01049217|8999430|P2|Overall Study|Randomized but not Treated|2
2603626|NCT01049217|8999431|P1|Overall Study|Randomized but not Treated|0
2603627|NCT01049217|8999430|P2|Overall Study|Other|2
2603628|NCT01049217|8999431|P1|Overall Study|Other|1
2603629|NCT01049217|8999430|P2|Overall Study|Study Terminated by Sponsor|43
2603630|NCT01049217|8999431|P1|Overall Study|Study Terminated by Sponsor|43
2603631|NCT01049217|8999430|P2|Overall Study|Pregnancy|0
2603632|NCT01049217|8999431|P1|Overall Study|Pregnancy|1
2603633|NCT01049217|8999430|P2|Overall Study|Protocol Violation|3
2603634|NCT01049217|8999431|P1|Overall Study|Protocol Violation|1
2603635|NCT01049217|8999430|P2|Overall Study|Withdrawal by Subject|3
2603636|NCT01049217|8999431|P1|Overall Study|Withdrawal by Subject|4
2603637|NCT01049217|8999430|P2|Overall Study|Lost to Follow-up|8
2603638|NCT01049217|8999431|P1|Overall Study|Lost to Follow-up|3
2603639|NCT01049217|8999430|P2|Overall Study|Lack of Efficacy|1
2603640|NCT01049217|8999431|P1|Overall Study|Lack of Efficacy|1
2603641|NCT01049217|8999430|P2|Overall Study|Adverse Event|1
2603642|NCT01049217|8999431|P1|Overall Study|Adverse Event|2
2603643|NCT01049009|8999503|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|7
2603644|NCT01049009|8999504|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|8
2603645|NCT01049009|8999503|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3
2603646|NCT01049009|8999504|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
2603647|NCT01049009|8999503|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
2603648|NCT01049009|8999504|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
2603649|NCT01049009|8999503|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|2
2603650|NCT01049009|8999504|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
2603651|NCT01048944|8999516|P4|Overall Study|Protocol Violation|2
2603652|NCT01048944|8999517|P3|Overall Study|Protocol Violation|10
2603653|NCT01048944|8999518|P2|Overall Study|Protocol Violation|10
2603654|NCT01048944|8999519|P1|Overall Study|Protocol Violation|8
2603655|NCT01048866|8999551|P2|Overall Study|Other|1
2603656|NCT01048866|8999552|P1|Overall Study|Other|1
2603657|NCT01048866|8999551|P2|Overall Study|Lost to Follow-up|2
2603658|NCT01048866|8999552|P1|Overall Study|Lost to Follow-up|0
2603659|NCT01048866|8999551|P2|Overall Study|Withdrawal by Subject|2
2603660|NCT01048866|8999552|P1|Overall Study|Withdrawal by Subject|0
2603661|NCT01048866|8999551|P2|Overall Study|Physician Decision|0
2603662|NCT01048866|8999552|P1|Overall Study|Physician Decision|1
2603663|NCT01048866|8999551|P2|Overall Study|Protocol Violation|0
2603664|NCT01048866|8999552|P1|Overall Study|Protocol Violation|1
2603665|NCT01048866|8999551|P2|Overall Study|Adverse Event|0
2603666|NCT01048866|8999552|P1|Overall Study|Adverse Event|1
2603667|NCT01048788|8999597|P3|Overall Study|Withdrawal by Subject|0
2603668|NCT01048788|8999598|P2|Overall Study|Withdrawal by Subject|1
2603669|NCT01048788|8999599|P1|Overall Study|Withdrawal by Subject|0
2603670|NCT01048788|8999597|P3|Overall Study|Lack of Efficacy|1
2603671|NCT01048788|8999598|P2|Overall Study|Lack of Efficacy|0
2603672|NCT01048788|8999599|P1|Overall Study|Lack of Efficacy|0
2603673|NCT01048788|8999597|P3|Overall Study|Adverse Event|1
2603674|NCT01048788|8999598|P2|Overall Study|Adverse Event|1
2603675|NCT01048788|8999599|P1|Overall Study|Adverse Event|5
2603676|NCT01048671|8999621|P3|Overall Study|Protocol Violation|1
2603677|NCT01048671|8999622|P2|Overall Study|Protocol Violation|1
2603678|NCT01048671|8999623|P1|Overall Study|Protocol Violation|0
2603679|NCT01048541|8999703|P2|Overall Study|Withdrawal by Subject|0
2603680|NCT01048541|8999704|P1|Overall Study|Withdrawal by Subject|1
2603681|NCT01048502|8999714|P4|Overall Study|Physician Decision|1
2603682|NCT01048502|8999715|P3|Overall Study|Physician Decision|0
2603683|NCT01048502|8999716|P2|Overall Study|Physician Decision|3
2603684|NCT01048502|8999717|P1|Overall Study|Physician Decision|0
2603685|NCT01048502|8999714|P4|Overall Study|Withdrawal by Subject|3
2603686|NCT01048502|8999715|P3|Overall Study|Withdrawal by Subject|5
2603687|NCT01048502|8999716|P2|Overall Study|Withdrawal by Subject|4
2603688|NCT01048502|8999717|P1|Overall Study|Withdrawal by Subject|1
2603689|NCT01048502|8999714|P4|Overall Study|Adverse Event|0
2603690|NCT01048502|8999715|P3|Overall Study|Adverse Event|0
2603691|NCT01048502|8999716|P2|Overall Study|Adverse Event|0
2603692|NCT01048502|8999717|P1|Overall Study|Adverse Event|1
2603693|NCT01048502|8999714|P4|Overall Study|Lost to Follow-up|0
2603694|NCT01048502|8999715|P3|Overall Study|Lost to Follow-up|0
2603695|NCT01048502|8999716|P2|Overall Study|Lost to Follow-up|0
2603696|NCT01048502|8999717|P1|Overall Study|Lost to Follow-up|2
2603697|NCT01048333|8999753|P6|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
2603698|NCT01048333|8999754|P5|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
2603699|NCT01048333|8999755|P4|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
2603700|NCT01048333|8999756|P3|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
2603701|NCT01048333|8999757|P2|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1
2603702|NCT01048333|8999758|P1|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
2603703|NCT01048242|8999780|P2|Overall Study|See study flow chart|2
2603704|NCT01048242|8999781|P1|Overall Study|See study flow chart|4
2603705|NCT01048099|8999796|P1|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202
2603706|NCT01048099|8999796|P1|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57
2603707|NCT01047553|8999826|P2|Overall Study|PI's decision|1
2603708|NCT01047553|8999827|P1|Overall Study|PI's decision|0
2603709|NCT01047553|8999826|P2|Overall Study|Sever Non-Compliance to Protocol|0
2603710|NCT01047553|8999827|P1|Overall Study|Sever Non-Compliance to Protocol|1
2603711|NCT01047553|8999826|P2|Overall Study|Lost to Follow-up|0
2603712|NCT01047553|8999827|P1|Overall Study|Lost to Follow-up|1
2603713|NCT01047553|8999826|P2|Overall Study|Development of Study-Specific Withdrawal|1
2603714|NCT01047553|8999827|P1|Overall Study|Development of Study-Specific Withdrawal|1
2603715|NCT01047553|8999826|P2|Overall Study|Withdrawal by Subject|2
2603716|NCT01047553|8999827|P1|Overall Study|Withdrawal by Subject|4
2603717|NCT01047553|8999826|P2|Overall Study|Adverse Event|5
2603718|NCT01047553|8999827|P1|Overall Study|Adverse Event|10
2603719|NCT01047436|8999934|P2|Overall Study|Protocol Violation|0
2603720|NCT01047436|8999935|P1|Overall Study|Protocol Violation|1
2603721|NCT01047345|8999960|P3|Extension|Lost to Follow-up|5
2603722|NCT01047345|8999961|P2|Extension|Lost to Follow-up|0
2603723|NCT01047345|8999962|P1|Extension|Lost to Follow-up|0
2603724|NCT01047345|8999960|P3|Extension|Withdrawal by Subject|1
2603725|NCT01047345|8999961|P2|Extension|Withdrawal by Subject|0
2603726|NCT01047345|8999962|P1|Extension|Withdrawal by Subject|0
2603727|NCT01047345|8999960|P3|Base Study|Withdrawal by Subject|0
2603728|NCT01047345|8999961|P2|Base Study|Withdrawal by Subject|4
2603729|NCT01047345|8999962|P1|Base Study|Withdrawal by Subject|12
2603730|NCT01047345|8999960|P3|Base Study|Protocol Violation|0
2603731|NCT01047345|8999961|P2|Base Study|Protocol Violation|1
2603732|NCT01047345|8999962|P1|Base Study|Protocol Violation|3
2603733|NCT01047345|8999960|P3|Base Study|Lost to Follow-up|0
2603734|NCT01047345|8999961|P2|Base Study|Lost to Follow-up|1
2603735|NCT01047345|8999962|P1|Base Study|Lost to Follow-up|4
2603736|NCT01047345|8999960|P3|Base Study|Adverse Event|0
2603737|NCT01047345|8999961|P2|Base Study|Adverse Event|0
2603738|NCT01047345|8999962|P1|Base Study|Adverse Event|3
2603739|NCT01047332|8999984|P2|Overall Study|Lost to Follow-up|3
2603740|NCT01047332|8999985|P1|Overall Study|Lost to Follow-up|8
2603741|NCT01047332|8999984|P2|Overall Study|Died Unobstructed|41
2603742|NCT01047332|8999985|P1|Overall Study|Died Unobstructed|38
2603743|NCT01047332|8999984|P2|Overall Study|SEMS Obstruction|20
2603744|NCT01047332|8999985|P1|Overall Study|SEMS Obstruction|11
2603745|NCT01047319|9000000|P3|Overall Study|Study terminated by Sponsor|203
2603746|NCT01047319|9000001|P2|Overall Study|Study terminated by Sponsor|215
2603747|NCT01047319|9000002|P1|Overall Study|Study terminated by Sponsor|198
2603748|NCT01047319|9000000|P3|Overall Study|Withdrawal by Subject|87
2603749|NCT01047319|9000001|P2|Overall Study|Withdrawal by Subject|75
2603750|NCT01047319|9000002|P1|Overall Study|Withdrawal by Subject|77
2603751|NCT01047319|9000000|P3|Overall Study|Adverse Event|21
2603752|NCT01047319|9000001|P2|Overall Study|Adverse Event|27
2603753|NCT01047319|9000002|P1|Overall Study|Adverse Event|16
2603754|NCT01047319|9000000|P3|Overall Study|Lost to Follow-up|10
2603755|NCT01047319|9000001|P2|Overall Study|Lost to Follow-up|10
2603756|NCT01047319|9000002|P1|Overall Study|Lost to Follow-up|14
2603757|NCT01047319|9000000|P3|Overall Study|Physician Decision|10
2603758|NCT01047319|9000001|P2|Overall Study|Physician Decision|9
2603759|NCT01047319|9000002|P1|Overall Study|Physician Decision|12
2603760|NCT01047319|9000000|P3|Overall Study|Pregnancy|8
2603761|NCT01047319|9000001|P2|Overall Study|Pregnancy|8
2603762|NCT01047319|9000002|P1|Overall Study|Pregnancy|13
2603763|NCT01047319|9000000|P3|Overall Study|Death|5
2603764|NCT01047319|9000001|P2|Overall Study|Death|1
2603765|NCT01047319|9000002|P1|Overall Study|Death|5
2603766|NCT01047319|9000000|P3|Overall Study|Lack of Efficacy|3
2603767|NCT01047319|9000001|P2|Overall Study|Lack of Efficacy|3
2603768|NCT01047319|9000002|P1|Overall Study|Lack of Efficacy|4
2603769|NCT01047319|9000000|P3|Overall Study|Protocol Violation|4
2603770|NCT01047319|9000001|P2|Overall Study|Protocol Violation|2
2603771|NCT01047319|9000002|P1|Overall Study|Protocol Violation|3
2603772|NCT01047319|9000000|P3|Overall Study|Teva requested participant withdrawal|1
2603773|NCT01047319|9000001|P2|Overall Study|Teva requested participant withdrawal|0
2603774|NCT01047319|9000002|P1|Overall Study|Teva requested participant withdrawal|3
2603775|NCT01047306|9000024|P2|Overall Study|Lost to Follow-up|0
2603776|NCT01047306|9000025|P1|Overall Study|Lost to Follow-up|1
2603777|NCT01047306|9000024|P2|Overall Study|Withdrawal by Subject|0
2603778|NCT01047306|9000025|P1|Overall Study|Withdrawal by Subject|2
2603779|NCT01047293|9000099|P4|Overall Study|DLT criteria not fulfilled|0
2603780|NCT01047293|9000100|P3|Overall Study|DLT criteria not fulfilled|0
2603781|NCT01047293|9000101|P2|Overall Study|DLT criteria not fulfilled|1
2603782|NCT01047293|9000102|P1|Overall Study|DLT criteria not fulfilled|1
2603783|NCT01047007|9000133|P4|Overall Study|Progressive Disease|0
2603784|NCT01047007|9000134|P3|Overall Study|Progressive Disease|1
2603785|NCT01047007|9000135|P2|Overall Study|Progressive Disease|4
2603786|NCT01047007|9000136|P1|Overall Study|Progressive Disease|2
2603787|NCT01047007|9000133|P4|Overall Study|Adverse Event|0
2603788|NCT01047007|9000134|P3|Overall Study|Adverse Event|1
2603789|NCT01047007|9000135|P2|Overall Study|Adverse Event|2
2603790|NCT01047007|9000136|P1|Overall Study|Adverse Event|0
2603791|NCT01046903|9000147|P1|Overall Study|Other|5
2603792|NCT01046903|9000147|P1|Overall Study|Withdrawal by Subject|3
2603793|NCT01046903|9000147|P1|Overall Study|Adverse Event|4
2603794|NCT01046903|9000147|P1|Overall Study|Lost to Follow-up|16
2603795|NCT01046877|9000160|P1|Overall Study|Exited voluntarily after tube extrusion|11
2603796|NCT01046877|9000160|P1|Overall Study|Exited voluntarily before tube extrusion|7
2603797|NCT01046695|9000176|P2|Overall Study|TENS interfered with the cardiac monitor|1
2603798|NCT01046695|9000177|P1|Overall Study|TENS interfered with the cardiac monitor|0
2603799|NCT01046695|9000176|P2|Overall Study|Subject had a pacemaker|1
2603800|NCT01046695|9000177|P1|Overall Study|Subject had a pacemaker|0
2603801|NCT01046682|9000189|P2|Overall Study|Adverse Event|0
2603802|NCT01046682|9000190|P1|Overall Study|Adverse Event|2
2603803|NCT01046643|9000207|P4|First Period Treatment or Placebo|Withdrawal by Subject|0
2603804|NCT01046643|9000208|P3|First Period Treatment or Placebo|Withdrawal by Subject|0
2603805|NCT01046643|9000209|P2|First Period Treatment or Placebo|Withdrawal by Subject|1
2603806|NCT01046643|9000210|P1|First Period Treatment or Placebo|Withdrawal by Subject|0
2603807|NCT01046565|9000232|P1|Overall Study|Withdrawal by Subject|7
2603808|NCT01046565|9000232|P1|Overall Study|Adverse Event|2
2603809|NCT01046396|9000241|P1|Overall Study|Withdrawal by Subject|5
2603810|NCT01046253|9000252|P2|Second Intervention|Protocol Violation|1
2603811|NCT01046253|9000253|P1|Second Intervention|Protocol Violation|0
2603812|NCT01046253|9000252|P2|Second Intervention|Adverse Event|1
2603813|NCT01046253|9000253|P1|Second Intervention|Adverse Event|0
2603814|NCT01046136|9000265|P2|Overall Study|Lost to Follow-up|3
2603815|NCT01046136|9000266|P1|Overall Study|Lost to Follow-up|3
2603816|NCT01046136|9000265|P2|Overall Study|Physician Decision|1
2603817|NCT01046136|9000266|P1|Overall Study|Physician Decision|1
2603818|NCT01046136|9000265|P2|Overall Study|Withdrawal by Subject|4
2603819|NCT01046136|9000266|P1|Overall Study|Withdrawal by Subject|0
2603820|NCT01046110|9000278|P2|Overall Study|Unclassified|35
2603821|NCT01046110|9000279|P1|Overall Study|Unclassified|36
2603822|NCT01046110|9000278|P2|Overall Study|Withdrawal Criteria|5
2603823|NCT01046110|9000279|P1|Overall Study|Withdrawal Criteria|3
2603824|NCT01046110|9000278|P2|Overall Study|Protocol Violation|12
2603825|NCT01046110|9000279|P1|Overall Study|Protocol Violation|7
2603826|NCT01046110|9000278|P2|Overall Study|Lack of Efficacy|1
2603827|NCT01046110|9000279|P1|Overall Study|Lack of Efficacy|0
2603828|NCT01046110|9000278|P2|Overall Study|Adverse Event|2
2603829|NCT01046110|9000279|P1|Overall Study|Adverse Event|9
2603830|NCT01046084|9000289|P2|Third Washout of 7 Days|Withdrawal by Subject|0
2603831|NCT01046084|9000290|P1|Third Washout of 7 Days|Withdrawal by Subject|2
2603832|NCT01045993|9000304|P4|Overall Study|Treated-later found eligibility not met|0
2603833|NCT01045993|9000305|P3|Overall Study|Treated-later found eligibility not met|0
2603834|NCT01045993|9000306|P2|Overall Study|Treated-later found eligibility not met|1
2603835|NCT01045993|9000307|P1|Overall Study|Treated-later found eligibility not met|0
2603836|NCT01045967|9000383|P2|Second Intervention|Protocol Violation|1
2603837|NCT01045967|9000384|P1|Second Intervention|Protocol Violation|0
2603838|NCT01045798|9000396|P2|Overall Study|Received Systemic Antifungal Prestudy|1
2603839|NCT01045798|9000397|P1|Overall Study|Received Systemic Antifungal Prestudy|0
2603840|NCT01045798|9000396|P2|Overall Study|Changed to Other Antifungal Therapy|2
2603841|NCT01045798|9000397|P1|Overall Study|Changed to Other Antifungal Therapy|1
2603842|NCT01045798|9000396|P2|Overall Study|Invasive Fungal Infection at Baseline|1
2603843|NCT01045798|9000397|P1|Overall Study|Invasive Fungal Infection at Baseline|0
2603844|NCT01045798|9000396|P2|Overall Study|Changed to Open-Label Caspofungin|0
2603845|NCT01045798|9000397|P1|Overall Study|Changed to Open-Label Caspofungin|1
2603846|NCT01045707|9000405|P2|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5
2603847|NCT01045707|9000406|P1|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6
2603848|NCT01045707|9000405|P2|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1
2603849|NCT01045707|9000406|P1|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2
2603850|NCT01045707|9000405|P2|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3
2603851|NCT01045707|9000406|P1|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2
2603852|NCT01045707|9000405|P2|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
2603853|NCT01045707|9000406|P1|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
2603854|NCT01045707|9000405|P2|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11
2603855|NCT01045707|9000406|P1|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10
2603856|NCT01045707|9000405|P2|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11
2603857|NCT01045707|9000406|P1|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22
2603858|NCT01045707|9000405|P2|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5
2603859|NCT01045707|9000406|P1|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6
2603860|NCT01045707|9000405|P2|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2
2603861|NCT01045707|9000406|P1|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4
2603862|NCT01045707|9000405|P2|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3
2603863|NCT01045707|9000406|P1|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5
2603864|NCT01045694|9000422|P1|Overall Study|Withdrawal by Subject|2
2603865|NCT01045460|9000443|P2|Overall Study|Lack of Efficacy|0
2603866|NCT01045460|9000444|P1|Overall Study|Lack of Efficacy|3
2603867|NCT01045460|9000443|P2|Overall Study|Lost to Follow-up|1
2603868|NCT01045460|9000444|P1|Overall Study|Lost to Follow-up|0
2603869|NCT01045460|9000443|P2|Overall Study|Physician Decision|2
2603870|NCT01045460|9000444|P1|Overall Study|Physician Decision|3
2603871|NCT01045447|9000456|P2|Overall Study|Unclassified|13
2603872|NCT01045447|9000457|P1|Overall Study|Unclassified|17
2603873|NCT01045447|9000456|P2|Overall Study|Withdrawal Criteria|10
2603874|NCT01045447|9000457|P1|Overall Study|Withdrawal Criteria|10
2603875|NCT01045447|9000456|P2|Overall Study|Protocol Violation|3
2603876|NCT01045447|9000457|P1|Overall Study|Protocol Violation|6
2603877|NCT01045447|9000456|P2|Overall Study|Lack of Efficacy|1
2603878|NCT01045447|9000457|P1|Overall Study|Lack of Efficacy|3
2603879|NCT01045447|9000456|P2|Overall Study|Adverse Event|1
2603880|NCT01045447|9000457|P1|Overall Study|Adverse Event|0
2603881|NCT01045421|9000471|P11|Phase 2|Other|1
2603882|NCT01045421|9000472|P10|Phase 2|Other|0
2603883|NCT01045421|9000473|P9|Phase 2|Other|0
2603884|NCT01045421|9000474|P8|Phase 2|Other|3
2603885|NCT01045421|9000475|P7|Phase 2|Other|0
2603886|NCT01045421|9000476|P6|Phase 2|Other|0
2603887|NCT01045421|9000477|P5|Phase 2|Other|0
2603888|NCT01045421|9000478|P4|Phase 2|Other|0
2603889|NCT01045421|9000479|P3|Phase 2|Other|0
2603890|NCT01045421|9000480|P2|Phase 2|Other|0
2603891|NCT01045421|9000481|P1|Phase 2|Other|0
2603892|NCT01045421|9000471|P11|Phase 2|Death|0
2603893|NCT01045421|9000472|P10|Phase 2|Death|2
2603894|NCT01045421|9000473|P9|Phase 2|Death|1
2603895|NCT01045421|9000474|P8|Phase 2|Death|1
2603896|NCT01045421|9000475|P7|Phase 2|Death|0
2603897|NCT01045421|9000476|P6|Phase 2|Death|0
2603898|NCT01045421|9000477|P5|Phase 2|Death|0
2603899|NCT01045421|9000478|P4|Phase 2|Death|0
2603900|NCT01045421|9000479|P3|Phase 2|Death|0
2603901|NCT01045421|9000480|P2|Phase 2|Death|0
2603902|NCT01045421|9000481|P1|Phase 2|Death|0
2603903|NCT01045421|9000471|P11|Phase 2|Progressive Disease|1
2603904|NCT01045421|9000472|P10|Phase 2|Progressive Disease|1
2603905|NCT01045421|9000473|P9|Phase 2|Progressive Disease|1
2603906|NCT01045421|9000474|P8|Phase 2|Progressive Disease|1
2603907|NCT01045421|9000475|P7|Phase 2|Progressive Disease|0
2603908|NCT01045421|9000476|P6|Phase 2|Progressive Disease|0
2603909|NCT01045421|9000477|P5|Phase 2|Progressive Disease|0
2603910|NCT01045421|9000478|P4|Phase 2|Progressive Disease|0
2603911|NCT01045421|9000479|P3|Phase 2|Progressive Disease|0
2603912|NCT01045421|9000480|P2|Phase 2|Progressive Disease|0
2603913|NCT01045421|9000481|P1|Phase 2|Progressive Disease|0
2603914|NCT01045421|9000471|P11|Phase 1|Withdrawal by Subject|0
2603915|NCT01045421|9000472|P10|Phase 1|Withdrawal by Subject|0
2603916|NCT01045421|9000473|P9|Phase 1|Withdrawal by Subject|0
2603917|NCT01045421|9000474|P8|Phase 1|Withdrawal by Subject|0
2603918|NCT01045421|9000475|P7|Phase 1|Withdrawal by Subject|0
2603919|NCT01045421|9000476|P6|Phase 1|Withdrawal by Subject|0
2603920|NCT01045421|9000477|P5|Phase 1|Withdrawal by Subject|0
2603921|NCT01045421|9000478|P4|Phase 1|Withdrawal by Subject|1
2603922|NCT01045421|9000479|P3|Phase 1|Withdrawal by Subject|0
2603923|NCT01045421|9000480|P2|Phase 1|Withdrawal by Subject|0
2603924|NCT01045421|9000481|P1|Phase 1|Withdrawal by Subject|0
2603925|NCT01045421|9000471|P11|Phase 1|Progressive Disease|0
2603926|NCT01045421|9000472|P10|Phase 1|Progressive Disease|0
2603927|NCT01045421|9000473|P9|Phase 1|Progressive Disease|0
2603928|NCT01045421|9000474|P8|Phase 1|Progressive Disease|0
2603929|NCT01045421|9000475|P7|Phase 1|Progressive Disease|0
2603930|NCT01045421|9000476|P6|Phase 1|Progressive Disease|0
2603931|NCT01045421|9000477|P5|Phase 1|Progressive Disease|1
2603932|NCT01045421|9000478|P4|Phase 1|Progressive Disease|0
2603933|NCT01045421|9000479|P3|Phase 1|Progressive Disease|0
2603934|NCT01045421|9000480|P2|Phase 1|Progressive Disease|0
2603935|NCT01045421|9000481|P1|Phase 1|Progressive Disease|0
2603936|NCT01045161|9000575|P3|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6
2603937|NCT01045161|9000576|P2|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1
2603938|NCT01045161|9000577|P1|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5
2603939|NCT01045161|9000575|P3|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
2603940|NCT01045161|9000576|P2|Part B - 40 Additional Weeks Open Label|Protocol Violation|6
2603941|NCT01045161|9000577|P1|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
2603942|NCT01045161|9000575|P3|Part B - 40 Additional Weeks Open Label|Other Reason|1
2603943|NCT01045161|9000576|P2|Part B - 40 Additional Weeks Open Label|Other Reason|2
2603944|NCT01045161|9000577|P1|Part B - 40 Additional Weeks Open Label|Other Reason|4
2603945|NCT01045161|9000575|P3|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
2603946|NCT01045161|9000576|P2|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5
2603947|NCT01045161|9000577|P1|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
2603948|NCT01045161|9000575|P3|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
2603949|NCT01045161|9000576|P2|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
2603950|NCT01045161|9000577|P1|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3
2603951|NCT01045161|9000575|P3|Part B - 40 Additional Weeks Open Label|Adverse Event|7
2603952|NCT01045161|9000576|P2|Part B - 40 Additional Weeks Open Label|Adverse Event|10
2603953|NCT01045161|9000577|P1|Part B - 40 Additional Weeks Open Label|Adverse Event|10
2603954|NCT01045161|9000575|P3|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9
2603955|NCT01045161|9000576|P2|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7
2603956|NCT01045161|9000577|P1|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10
2603957|NCT01045161|9000575|P3|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2
2603958|NCT01045161|9000576|P2|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
2603959|NCT01045161|9000577|P1|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
2603960|NCT01045161|9000575|P3|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
2603961|NCT01045161|9000576|P2|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4
2603962|NCT01045161|9000577|P1|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
2603963|NCT01045161|9000575|P3|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
2603964|NCT01045161|9000576|P2|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
2603965|NCT01045161|9000577|P1|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
2603966|NCT01045161|9000575|P3|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6
2603967|NCT01045161|9000576|P2|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1
2603968|NCT01045161|9000577|P1|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4
2603969|NCT01045161|9000575|P3|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2
2603970|NCT01045161|9000576|P2|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3
2603971|NCT01045161|9000577|P1|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6
2603972|NCT01045161|9000575|P3|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8
2604063|NCT01043705|9001120|P1|Overall Study|Multiple Reasons|4
2603973|NCT01045161|9000576|P2|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3
2603974|NCT01045161|9000577|P1|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4
2603975|NCT01045161|9000575|P3|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6
2603976|NCT01045161|9000576|P2|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12
2603977|NCT01045161|9000577|P1|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8
2603978|NCT01045096|9000614|P3|Overall Study|Other|0
2603979|NCT01045096|9000615|P2|Overall Study|Other|0
2603980|NCT01045096|9000616|P1|Overall Study|Other|1
2603981|NCT01045096|9000614|P3|Overall Study|Withdrawal by Subject|0
2603982|NCT01045096|9000615|P2|Overall Study|Withdrawal by Subject|0
2603983|NCT01045096|9000616|P1|Overall Study|Withdrawal by Subject|2
2603984|NCT01044745|9000733|P1|Overall Study|Ineiligible|2
2603985|NCT01044732|9000742|P2|Overall Study|Technical error or malfunction|14
2603986|NCT01044732|9000743|P1|Overall Study|Technical error or malfunction|15
2603987|NCT01044732|9000742|P2|Overall Study|Inability to reach cecum|2
2603988|NCT01044732|9000743|P1|Overall Study|Inability to reach cecum|5
2603989|NCT01044732|9000742|P2|Overall Study|Inadequate bowel preparation|17
2603990|NCT01044732|9000743|P1|Overall Study|Inadequate bowel preparation|11
2603991|NCT01044732|9000742|P2|Overall Study|Withdrawal by Subject|1
2603992|NCT01044732|9000743|P1|Overall Study|Withdrawal by Subject|0
2603993|NCT01044732|9000742|P2|Overall Study|Protocol Violation|12
2603994|NCT01044732|9000743|P1|Overall Study|Protocol Violation|11
2603995|NCT01044732|9000742|P2|Overall Study|Physician Decision|3
2603996|NCT01044732|9000743|P1|Overall Study|Physician Decision|5
2603997|NCT01044732|9000742|P2|Overall Study|Lost to Follow-up|1
2603998|NCT01044732|9000743|P1|Overall Study|Lost to Follow-up|2
2603999|NCT01044498|9000932|P2|Overall Study|Other|0
2604000|NCT01044498|9000933|P1|Overall Study|Other|1
2604001|NCT01044498|9000932|P2|Overall Study|Adverse Event|1
2604002|NCT01044498|9000933|P1|Overall Study|Adverse Event|1
2604003|NCT01044498|9000932|P2|Overall Study|Withdrew consent|1
2604004|NCT01044498|9000933|P1|Overall Study|Withdrew consent|1
2604005|NCT01044459|9000959|P2|Overall Study|Lost to Follow-up|12
2604006|NCT01044459|9000960|P1|Overall Study|Lost to Follow-up|18
2604007|NCT01044459|9000959|P2|Overall Study|COPD exacerbation|8
2604008|NCT01044459|9000960|P1|Overall Study|COPD exacerbation|9
2604009|NCT01044459|9000959|P2|Overall Study|Other Reason|14
2604010|NCT01044459|9000960|P1|Overall Study|Other Reason|7
2604011|NCT01044459|9000959|P2|Overall Study|Protocol Violation|16
2604012|NCT01044459|9000960|P1|Overall Study|Protocol Violation|11
2604013|NCT01044459|9000959|P2|Overall Study|Lack of Efficacy|12
2604014|NCT01044459|9000960|P1|Overall Study|Lack of Efficacy|23
2604015|NCT01044459|9000959|P2|Overall Study|Adverse Event|20
2604016|NCT01044459|9000960|P1|Overall Study|Adverse Event|22
2604017|NCT01044459|9000959|P2|Overall Study|Terminated by Sponsor|21
2604018|NCT01044459|9000960|P1|Overall Study|Terminated by Sponsor|22
2604019|NCT01044459|9000959|P2|Overall Study|Withdrawal by Subject|28
2604020|NCT01044459|9000960|P1|Overall Study|Withdrawal by Subject|21
2604021|NCT01044433|9000968|P1|Overall Study|Withdrawal by Subject|3
2604022|NCT01044433|9000968|P1|Overall Study|Lost to Follow-up|3
2604023|NCT01044303|9000976|P1|Overall Study|Lost to Follow-up|2
2604024|NCT01044290|9000986|P3|Follow-Up 2|Withdrawal by Subject|1
2604025|NCT01044290|9000987|P2|Follow-Up 2|Withdrawal by Subject|1
2604026|NCT01044290|9000988|P1|Follow-Up 2|Withdrawal by Subject|0
2604027|NCT01044290|9000986|P3|Follow-Up 2|Death|1
2604028|NCT01044290|9000987|P2|Follow-Up 2|Death|1
2604029|NCT01044290|9000988|P1|Follow-Up 2|Death|0
2604030|NCT01044290|9000986|P3|Follow-up 1|Withdrawal by Subject|0
2604031|NCT01044290|9000987|P2|Follow-up 1|Withdrawal by Subject|2
2604032|NCT01044290|9000988|P1|Follow-up 1|Withdrawal by Subject|2
2604033|NCT01044290|9000986|P3|Follow-up 1|Death|1
2604034|NCT01044290|9000987|P2|Follow-up 1|Death|3
2604035|NCT01044290|9000988|P1|Follow-up 1|Death|3
2604036|NCT01043874|9001108|P1|Overall Study|Administrative Problems|1
2604037|NCT01043874|9001108|P1|Overall Study|Lack of Efficacy|1
2604038|NCT01043874|9001108|P1|Overall Study|Withdrawal by Subject|1
2604039|NCT01043874|9001108|P1|Overall Study|Adverse Event|3
2604040|NCT01043705|9001118|P3|Overall Study|Other|25
2604041|NCT01043705|9001119|P2|Overall Study|Other|19
2604042|NCT01043705|9001120|P1|Overall Study|Other|0
2604043|NCT01043705|9001118|P3|Overall Study|Screen Fail|0
2604044|NCT01043705|9001119|P2|Overall Study|Screen Fail|0
2604045|NCT01043705|9001120|P1|Overall Study|Screen Fail|21
2604046|NCT01043705|9001118|P3|Overall Study|Adverse Event|0
2604047|NCT01043705|9001119|P2|Overall Study|Adverse Event|2
2604048|NCT01043705|9001120|P1|Overall Study|Adverse Event|0
2604049|NCT01043705|9001118|P3|Overall Study|Subsequent Procedure|29
2604050|NCT01043705|9001119|P2|Overall Study|Subsequent Procedure|24
2604051|NCT01043705|9001120|P1|Overall Study|Subsequent Procedure|9
2604052|NCT01043705|9001118|P3|Overall Study|Site Closure|0
2604053|NCT01043705|9001119|P2|Overall Study|Site Closure|0
2604054|NCT01043705|9001120|P1|Overall Study|Site Closure|8
2604055|NCT01043705|9001118|P3|Overall Study|Withdrawal by Subject|0
2604056|NCT01043705|9001119|P2|Overall Study|Withdrawal by Subject|6
2604057|NCT01043705|9001120|P1|Overall Study|Withdrawal by Subject|8
2604058|NCT01043705|9001118|P3|Overall Study|Protocol Violation|0
2604059|NCT01043705|9001119|P2|Overall Study|Protocol Violation|1
2604060|NCT01043705|9001120|P1|Overall Study|Protocol Violation|2
2604061|NCT01043705|9001118|P3|Overall Study|Multiple Reasons|0
2604062|NCT01043705|9001119|P2|Overall Study|Multiple Reasons|7
2604064|NCT01043705|9001118|P3|Overall Study|Lost to Follow-up|0
2604065|NCT01043705|9001119|P2|Overall Study|Lost to Follow-up|12
2604066|NCT01043705|9001120|P1|Overall Study|Lost to Follow-up|27
2604067|NCT01043705|9001118|P3|Overall Study|Death|26
2604068|NCT01043705|9001119|P2|Overall Study|Death|60
2604069|NCT01043705|9001120|P1|Overall Study|Death|28
2604070|NCT01043185|9001209|P10|Period 6 - Third Washout Period|Protocol Violation|0
2604071|NCT01043185|9001210|P9|Period 6 - Third Washout Period|Protocol Violation|1
2604072|NCT01043185|9001211|P8|Period 6 - Third Washout Period|Protocol Violation|0
2604073|NCT01043185|9001212|P7|Period 6 - Third Washout Period|Protocol Violation|0
2604074|NCT01043185|9001213|P6|Period 6 - Third Washout Period|Protocol Violation|0
2604075|NCT01043185|9001214|P5|Period 6 - Third Washout Period|Protocol Violation|0
2604076|NCT01043185|9001215|P4|Period 6 - Third Washout Period|Protocol Violation|0
2604077|NCT01043185|9001216|P3|Period 6 - Third Washout Period|Protocol Violation|0
2604078|NCT01043185|9001217|P2|Period 6 - Third Washout Period|Protocol Violation|0
2604079|NCT01043185|9001218|P1|Period 6 - Third Washout Period|Protocol Violation|0
2604080|NCT01042977|9001294|P2|Overall Study|Various|0
2604081|NCT01042977|9001295|P1|Overall Study|Various|3
2604082|NCT01042977|9001294|P2|Overall Study|Administrative reason by sponsor|1
2604083|NCT01042977|9001295|P1|Overall Study|Administrative reason by sponsor|0
2604084|NCT01042977|9001294|P2|Overall Study|Safety|2
2604085|NCT01042977|9001295|P1|Overall Study|Safety|0
2604086|NCT01042977|9001294|P2|Overall Study|Incorrect enrollment|4
2604087|NCT01042977|9001295|P1|Overall Study|Incorrect enrollment|6
2604088|NCT01042977|9001294|P2|Overall Study|Subject no longer meets study criteria|13
2604089|NCT01042977|9001295|P1|Overall Study|Subject no longer meets study criteria|15
2604090|NCT01042977|9001294|P2|Overall Study|Poor/non-compliance|4
2604091|NCT01042977|9001295|P1|Overall Study|Poor/non-compliance|3
2604092|NCT01042977|9001294|P2|Overall Study|Lost to Follow-up|2
2604093|NCT01042977|9001295|P1|Overall Study|Lost to Follow-up|0
2604094|NCT01042977|9001294|P2|Overall Study|Withdrawal by Subject|16
2604095|NCT01042977|9001295|P1|Overall Study|Withdrawal by Subject|8
2604096|NCT01042977|9001294|P2|Overall Study|Death|1
2604097|NCT01042977|9001295|P1|Overall Study|Death|2
2604098|NCT01042977|9001294|P2|Overall Study|Adverse Event|12
2604099|NCT01042977|9001295|P1|Overall Study|Adverse Event|4
2604100|NCT01042938|9001315|P2|Overall Study|Ineligible: RTOG study conflict|0
2604101|NCT01042938|9001316|P1|Overall Study|Ineligible: RTOG study conflict|1
2604102|NCT01042938|9001315|P2|Overall Study|Protocol Violation|1
2604103|NCT01042938|9001316|P1|Overall Study|Protocol Violation|1
2604104|NCT01042938|9001315|P2|Overall Study|Withdrawal by Subject|1
2604105|NCT01042938|9001316|P1|Overall Study|Withdrawal by Subject|1
2604106|NCT01042678|9001335|P6|Overall Study|Physician Decision|0
2604107|NCT01042678|9001336|P5|Overall Study|Physician Decision|0
2604108|NCT01042678|9001337|P4|Overall Study|Physician Decision|0
2604109|NCT01042678|9001338|P3|Overall Study|Physician Decision|0
2604110|NCT01042678|9001339|P2|Overall Study|Physician Decision|0
2604111|NCT01042678|9001340|P1|Overall Study|Physician Decision|1
2604112|NCT01042600|9001378|P2|Overall Study|Ineligible|0
2604113|NCT01042600|9001379|P1|Overall Study|Ineligible|1
2604114|NCT01042535|9001399|P1|Overall Study|complications from other disease|2
2604115|NCT01042535|9001399|P1|Overall Study|disease progression during treatment|3
2604116|NCT01042535|9001399|P1|Overall Study|disease progression prior to treatment|3
2604117|NCT01042392|9001433|P4|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
2604118|NCT01042392|9001434|P3|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
2604119|NCT01042392|9001435|P2|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
2604120|NCT01042392|9001436|P1|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0
2604121|NCT01042392|9001433|P4|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
2604122|NCT01042392|9001434|P3|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2
2604123|NCT01042392|9001435|P2|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
2604124|NCT01042392|9001436|P1|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
2604125|NCT01042392|9001433|P4|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
2604126|NCT01042392|9001434|P3|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
2604127|NCT01042392|9001435|P2|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
2604128|NCT01042392|9001436|P1|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2
2604129|NCT01042392|9001433|P4|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
2604130|NCT01042392|9001434|P3|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1
2604131|NCT01042392|9001435|P2|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
2604132|NCT01042392|9001436|P1|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
2604133|NCT01042392|9001433|P4|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
2604134|NCT01042392|9001434|P3|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
2604135|NCT01042392|9001435|P2|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
2604136|NCT01042392|9001436|P1|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2
2604137|NCT01042392|9001433|P4|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
2604138|NCT01042392|9001434|P3|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1
2604139|NCT01042392|9001435|P2|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
2604140|NCT01042392|9001436|P1|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
2604141|NCT01042392|9001433|P4|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
2604142|NCT01042392|9001434|P3|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2
2604143|NCT01042392|9001435|P2|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
2604144|NCT01042392|9001436|P1|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1
2604145|NCT01042392|9001433|P4|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
2604146|NCT01042392|9001434|P3|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
2604147|NCT01042392|9001435|P2|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
2604148|NCT01042392|9001436|P1|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1
2604149|NCT01042392|9001433|P4|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
2604150|NCT01042392|9001434|P3|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5
2604151|NCT01042392|9001435|P2|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
2604152|NCT01042392|9001436|P1|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6
2604153|NCT01042236|9001484|P6|Treatment Period 3|Protocol Violation|0
2604154|NCT01042236|9001485|P5|Treatment Period 3|Protocol Violation|0
2604155|NCT01042236|9001486|P4|Treatment Period 3|Protocol Violation|1
2604156|NCT01042236|9001487|P3|Treatment Period 3|Protocol Violation|0
2604157|NCT01042236|9001488|P2|Treatment Period 3|Protocol Violation|0
2604158|NCT01042236|9001489|P1|Treatment Period 3|Protocol Violation|0
2604159|NCT01042236|9001484|P6|Treatment Period 3|Adverse Event|0
2604160|NCT01042236|9001485|P5|Treatment Period 3|Adverse Event|0
2604161|NCT01042236|9001486|P4|Treatment Period 3|Adverse Event|1
2604162|NCT01042236|9001487|P3|Treatment Period 3|Adverse Event|0
2604163|NCT01042236|9001488|P2|Treatment Period 3|Adverse Event|0
2604164|NCT01042236|9001489|P1|Treatment Period 3|Adverse Event|0
2604165|NCT01042236|9001484|P6|Treatment Period 1|Adverse Event|0
2604166|NCT01042236|9001485|P5|Treatment Period 1|Adverse Event|1
2604167|NCT01042236|9001486|P4|Treatment Period 1|Adverse Event|0
2604168|NCT01042236|9001487|P3|Treatment Period 1|Adverse Event|0
2604169|NCT01042236|9001488|P2|Treatment Period 1|Adverse Event|1
2604170|NCT01042236|9001489|P1|Treatment Period 1|Adverse Event|0
2604171|NCT01042158|9001526|P1|Overall Study|Physician Decision|1
2604172|NCT01042093|9001556|P4|Overall Study|Withdrawal by Subject|1
2604173|NCT01042093|9001557|P3|Overall Study|Withdrawal by Subject|0
2604174|NCT01042093|9001558|P2|Overall Study|Withdrawal by Subject|0
2604175|NCT01042093|9001559|P1|Overall Study|Withdrawal by Subject|0
2604176|NCT01042093|9001556|P4|Overall Study|Protocol Violation|3
2604177|NCT01042093|9001557|P3|Overall Study|Protocol Violation|2
2604178|NCT01042093|9001558|P2|Overall Study|Protocol Violation|2
2604179|NCT01042093|9001559|P1|Overall Study|Protocol Violation|2
2604180|NCT01041976|9001579|P2|Overall Study|Death|4
2604181|NCT01041976|9001580|P1|Overall Study|Death|0
2604182|NCT01041976|9001579|P2|Overall Study|Incarceration|0
2604183|NCT01041976|9001580|P1|Overall Study|Incarceration|2
2604184|NCT01041976|9001579|P2|Overall Study|Withdrawal by Subject|0
2604185|NCT01041976|9001580|P1|Overall Study|Withdrawal by Subject|3
2604186|NCT01041859|9001590|P3|Double-Blind Maintenance|Withdrawal by Subject|9
2604187|NCT01041859|9001591|P2|Double-Blind Maintenance|Withdrawal by Subject|8
2604188|NCT01041859|9001592|P1|Double-Blind Maintenance|Withdrawal by Subject|0
2604189|NCT01041859|9001590|P3|Double-Blind Maintenance|Noncompliance With Study Drug|6
2604190|NCT01041859|9001591|P2|Double-Blind Maintenance|Noncompliance With Study Drug|2
2604191|NCT01041859|9001592|P1|Double-Blind Maintenance|Noncompliance With Study Drug|0
2604192|NCT01041859|9001590|P3|Double-Blind Maintenance|Other|2
2604193|NCT01041859|9001591|P2|Double-Blind Maintenance|Other|6
2604194|NCT01041859|9001592|P1|Double-Blind Maintenance|Other|0
2604195|NCT01041859|9001590|P3|Double-Blind Maintenance|Protocol Violation|3
2604196|NCT01041859|9001591|P2|Double-Blind Maintenance|Protocol Violation|1
2604197|NCT01041859|9001592|P1|Double-Blind Maintenance|Protocol Violation|0
2604198|NCT01041859|9001590|P3|Double-Blind Maintenance|Physician Decision|1
2604199|NCT01041859|9001591|P2|Double-Blind Maintenance|Physician Decision|2
2604200|NCT01041859|9001592|P1|Double-Blind Maintenance|Physician Decision|0
2604201|NCT01041859|9001590|P3|Double-Blind Maintenance|Lost to Follow-up|0
2604202|NCT01041859|9001591|P2|Double-Blind Maintenance|Lost to Follow-up|1
2604203|NCT01041859|9001592|P1|Double-Blind Maintenance|Lost to Follow-up|0
2604204|NCT01041859|9001590|P3|Double-Blind Maintenance|Lack of Efficacy|11
2604205|NCT01041859|9001591|P2|Double-Blind Maintenance|Lack of Efficacy|3
2604206|NCT01041859|9001592|P1|Double-Blind Maintenance|Lack of Efficacy|0
2604207|NCT01041859|9001590|P3|Double-Blind Maintenance|Adverse Event|13
2604208|NCT01041859|9001591|P2|Double-Blind Maintenance|Adverse Event|23
2604209|NCT01041859|9001592|P1|Double-Blind Maintenance|Adverse Event|0
2604210|NCT01041859|9001590|P3|Open-Label Titration|Withdrawal by Subject|0
2604211|NCT01041859|9001591|P2|Open-Label Titration|Withdrawal by Subject|0
2604212|NCT01041859|9001592|P1|Open-Label Titration|Withdrawal by Subject|11
2604213|NCT01041859|9001590|P3|Open-Label Titration|Noncompliance With Study Drug|0
2604214|NCT01041859|9001591|P2|Open-Label Titration|Noncompliance With Study Drug|0
2604215|NCT01041859|9001592|P1|Open-Label Titration|Noncompliance With Study Drug|8
2604216|NCT01041859|9001590|P3|Open-Label Titration|Other|0
2604217|NCT01041859|9001591|P2|Open-Label Titration|Other|0
2604218|NCT01041859|9001592|P1|Open-Label Titration|Other|7
2604219|NCT01041859|9001590|P3|Open-Label Titration|Protocol Violation|0
2604220|NCT01041859|9001591|P2|Open-Label Titration|Protocol Violation|0
2604221|NCT01041859|9001592|P1|Open-Label Titration|Protocol Violation|1
2604222|NCT01041859|9001590|P3|Open-Label Titration|Physician Decision|0
2604223|NCT01041859|9001591|P2|Open-Label Titration|Physician Decision|0
2604224|NCT01041859|9001592|P1|Open-Label Titration|Physician Decision|1
2604225|NCT01041859|9001590|P3|Open-Label Titration|Lost to Follow-up|0
2604226|NCT01041859|9001591|P2|Open-Label Titration|Lost to Follow-up|0
2604227|NCT01041859|9001592|P1|Open-Label Titration|Lost to Follow-up|1
2604228|NCT01041859|9001590|P3|Open-Label Titration|Lack of Efficacy|0
2604229|NCT01041859|9001591|P2|Open-Label Titration|Lack of Efficacy|0
2604230|NCT01041859|9001592|P1|Open-Label Titration|Lack of Efficacy|3
2604231|NCT01041859|9001590|P3|Open-Label Titration|Adverse Event|0
2604232|NCT01041859|9001591|P2|Open-Label Titration|Adverse Event|0
2604233|NCT01041859|9001592|P1|Open-Label Titration|Adverse Event|69
2604234|NCT01041638|9001628|P1|Overall Study|Withdrawal by Subject|11
2604235|NCT01041638|9001628|P1|Overall Study|Physician Decision|4
2604236|NCT01041638|9001628|P1|Overall Study|Lack of Efficacy|7
2604237|NCT01041638|9001628|P1|Overall Study|Death|1
2604238|NCT01041638|9001628|P1|Overall Study|Adverse Event|4
2604239|NCT01041573|9001638|P4|Overall Study|positive to anti-HCV|0
2604240|NCT01041573|9001639|P3|Overall Study|positive to anti-HCV|0
2604241|NCT01041573|9001640|P2|Overall Study|positive to anti-HCV|0
2604242|NCT01041573|9001641|P1|Overall Study|positive to anti-HCV|1
2604243|NCT01041573|9001638|P4|Overall Study|further blood extraction|0
2604244|NCT01041573|9001639|P3|Overall Study|further blood extraction|0
2604245|NCT01041573|9001640|P2|Overall Study|further blood extraction|1
2604246|NCT01041573|9001641|P1|Overall Study|further blood extraction|0
2604247|NCT01041573|9001638|P4|Overall Study|relocation|1
2604248|NCT01041573|9001639|P3|Overall Study|relocation|3
2604249|NCT01041573|9001640|P2|Overall Study|relocation|4
2604250|NCT01041573|9001641|P1|Overall Study|relocation|1
2604251|NCT01041573|9001638|P4|Overall Study|Adverse Event|0
2604252|NCT01041573|9001639|P3|Overall Study|Adverse Event|0
2604253|NCT01041573|9001640|P2|Overall Study|Adverse Event|2
2604254|NCT01041573|9001641|P1|Overall Study|Adverse Event|0
2604255|NCT01041573|9001638|P4|Overall Study|Lost to Follow-up|1
2604256|NCT01041573|9001639|P3|Overall Study|Lost to Follow-up|2
2604257|NCT01041573|9001640|P2|Overall Study|Lost to Follow-up|1
2604258|NCT01041573|9001641|P1|Overall Study|Lost to Follow-up|0
2604259|NCT01041573|9001638|P4|Overall Study|Death|0
2604260|NCT01041573|9001639|P3|Overall Study|Death|0
2604261|NCT01041573|9001640|P2|Overall Study|Death|0
2604262|NCT01041573|9001641|P1|Overall Study|Death|1
2604263|NCT01041573|9001638|P4|Overall Study|Withdrawal by Subject|0
2604264|NCT01041573|9001639|P3|Overall Study|Withdrawal by Subject|2
2604265|NCT01041573|9001640|P2|Overall Study|Withdrawal by Subject|5
2604266|NCT01041573|9001641|P1|Overall Study|Withdrawal by Subject|2
2604267|NCT01041417|9001664|P2|Overall Study|Death|0
2604268|NCT01041417|9001665|P1|Overall Study|Death|1
2604269|NCT01041417|9001664|P2|Overall Study|Lost to Follow-up|1
2604270|NCT01041417|9001665|P1|Overall Study|Lost to Follow-up|1
2604271|NCT01041417|9001664|P2|Overall Study|Adverse Event|2
2604272|NCT01041417|9001665|P1|Overall Study|Adverse Event|5
2604273|NCT01041404|9001703|P2|Overall Study|Other|23
2604274|NCT01041404|9001704|P1|Overall Study|Other|11
2604275|NCT01041404|9001703|P2|Overall Study|Failure to Return|2
2604276|NCT01041404|9001704|P1|Overall Study|Failure to Return|1
2604277|NCT01041404|9001703|P2|Overall Study|Withdrawal by Subject|23
2604278|NCT01041404|9001704|P1|Overall Study|Withdrawal by Subject|29
2604279|NCT01041404|9001703|P2|Overall Study|Protocol Violation|0
2604280|NCT01041404|9001704|P1|Overall Study|Protocol Violation|4
2604281|NCT01041404|9001703|P2|Overall Study|Violation of Selection Criteria|1
2604282|NCT01041404|9001704|P1|Overall Study|Violation of Selection Criteria|0
2604283|NCT01041404|9001703|P2|Overall Study|Lack of Efficacy|210
2604284|NCT01041404|9001704|P1|Overall Study|Lack of Efficacy|200
2604285|NCT01041404|9001703|P2|Overall Study|Adverse Event|35
2604286|NCT01041404|9001704|P1|Overall Study|Adverse Event|45
2604287|NCT01041287|9001745|P2|Treatment Period 2 (3 Months)|Adverse Event|2
2604288|NCT01041287|9001746|P1|Treatment Period 2 (3 Months)|Adverse Event|0
2604289|NCT01041287|9001745|P2|Treatment Period 2 (3 Months)|Lost to Follow-up|3
2604290|NCT01041287|9001746|P1|Treatment Period 2 (3 Months)|Lost to Follow-up|3
2604291|NCT01040871|9001786|P2|Overall Study|Randomized and Not Treated|1
2604292|NCT01040871|9001787|P1|Overall Study|Randomized and Not Treated|2
2604293|NCT01040871|9001786|P2|Overall Study|drug supply issue|0
2604294|NCT01040871|9001787|P1|Overall Study|drug supply issue|1
2604295|NCT01040871|9001786|P2|Overall Study|Lack of Efficacy|1
2604296|NCT01040871|9001787|P1|Overall Study|Lack of Efficacy|1
2604297|NCT01040871|9001786|P2|Overall Study|Death|3
2604298|NCT01040871|9001787|P1|Overall Study|Death|1
2604299|NCT01040871|9001786|P2|Overall Study|Withdrawal by Subject|0
2604300|NCT01040871|9001787|P1|Overall Study|Withdrawal by Subject|2
2604301|NCT01040871|9001786|P2|Overall Study|Adverse Event|2
2604302|NCT01040871|9001787|P1|Overall Study|Adverse Event|6
2604303|NCT01040845|9001838|P2|Overall Study|Physician Decision|0
2604304|NCT01040845|9001839|P1|Overall Study|Physician Decision|1
2604305|NCT01040845|9001838|P2|Overall Study|Withdrawal by Subject|1
2604306|NCT01040845|9001839|P1|Overall Study|Withdrawal by Subject|1
2604307|NCT01040832|9001854|P2|Overall Study|Other|1
2604308|NCT01040832|9001855|P1|Overall Study|Other|2
2604309|NCT01040832|9001854|P2|Overall Study|Symptomatic deterioration|5
2604310|NCT01040832|9001855|P1|Overall Study|Symptomatic deterioration|2
2604311|NCT01040832|9001854|P2|Overall Study|Progressive disease|17
2604312|NCT01040832|9001855|P1|Overall Study|Progressive disease|32
2604313|NCT01040832|9001854|P2|Overall Study|Withdrawal by Subject|3
2604314|NCT01040832|9001855|P1|Overall Study|Withdrawal by Subject|2
2604315|NCT01040832|9001854|P2|Overall Study|Death|6
2604316|NCT01040832|9001855|P1|Overall Study|Death|4
2604317|NCT01040832|9001854|P2|Overall Study|Adverse Event|5
2604318|NCT01040832|9001855|P1|Overall Study|Adverse Event|4
2604319|NCT01040793|9001878|P6|Overall Study|Other reasons not listed above|0
2604320|NCT01040793|9001879|P5|Overall Study|Other reasons not listed above|1
2604321|NCT01040793|9001880|P4|Overall Study|Other reasons not listed above|0
2604322|NCT01040793|9001881|P3|Overall Study|Other reasons not listed above|1
2604323|NCT01040793|9001882|P2|Overall Study|Other reasons not listed above|0
2604324|NCT01040793|9001883|P1|Overall Study|Other reasons not listed above|0
2604325|NCT01040793|9001878|P6|Overall Study|Withdrawal by Subject|0
2604326|NCT01040793|9001879|P5|Overall Study|Withdrawal by Subject|0
2604327|NCT01040793|9001880|P4|Overall Study|Withdrawal by Subject|2
2604328|NCT01040793|9001881|P3|Overall Study|Withdrawal by Subject|0
2604329|NCT01040793|9001882|P2|Overall Study|Withdrawal by Subject|0
2604330|NCT01040793|9001883|P1|Overall Study|Withdrawal by Subject|0
2604331|NCT01040793|9001878|P6|Overall Study|Lost to Follow-up|0
2604332|NCT01040793|9001879|P5|Overall Study|Lost to Follow-up|0
2604333|NCT01040793|9001880|P4|Overall Study|Lost to Follow-up|0
2604334|NCT01040793|9001881|P3|Overall Study|Lost to Follow-up|1
2604335|NCT01040793|9001882|P2|Overall Study|Lost to Follow-up|1
2604336|NCT01040793|9001883|P1|Overall Study|Lost to Follow-up|0
2604337|NCT01040793|9001878|P6|Overall Study|Protocol Violation|0
2604338|NCT01040793|9001879|P5|Overall Study|Protocol Violation|1
2604339|NCT01040793|9001880|P4|Overall Study|Protocol Violation|0
2604340|NCT01040793|9001881|P3|Overall Study|Protocol Violation|1
2604341|NCT01040793|9001882|P2|Overall Study|Protocol Violation|1
2604342|NCT01040793|9001883|P1|Overall Study|Protocol Violation|1
2604343|NCT01040793|9001878|P6|Overall Study|Adverse Event|1
2604344|NCT01040793|9001879|P5|Overall Study|Adverse Event|2
2604345|NCT01040793|9001880|P4|Overall Study|Adverse Event|2
2604346|NCT01040793|9001881|P3|Overall Study|Adverse Event|0
2604347|NCT01040793|9001882|P2|Overall Study|Adverse Event|3
2604348|NCT01040793|9001883|P1|Overall Study|Adverse Event|5
2604349|NCT01040780|9001962|P2|Overall Study|Protocol Violation|3
2604350|NCT01040780|9001963|P1|Overall Study|Protocol Violation|1
2604351|NCT01040728|9001977|P4|Overall Study|Other reasons not listed above|0
2604352|NCT01040728|9001978|P3|Overall Study|Other reasons not listed above|0
2604353|NCT01040728|9001979|P2|Overall Study|Other reasons not listed above|1
2604354|NCT01040728|9001980|P1|Overall Study|Other reasons not listed above|0
2604355|NCT01040728|9001977|P4|Overall Study|Lack of Efficacy|1
2604356|NCT01040728|9001978|P3|Overall Study|Lack of Efficacy|0
2604357|NCT01040728|9001979|P2|Overall Study|Lack of Efficacy|1
2604358|NCT01040728|9001980|P1|Overall Study|Lack of Efficacy|0
2604359|NCT01040728|9001977|P4|Overall Study|Protocol Violation|1
2604360|NCT01040728|9001978|P3|Overall Study|Protocol Violation|0
2604361|NCT01040728|9001979|P2|Overall Study|Protocol Violation|0
2604362|NCT01040728|9001980|P1|Overall Study|Protocol Violation|0
2604363|NCT01040728|9001977|P4|Overall Study|Withdrawal by Subject|0
2604364|NCT01040728|9001978|P3|Overall Study|Withdrawal by Subject|1
2604365|NCT01040728|9001979|P2|Overall Study|Withdrawal by Subject|1
2604366|NCT01040728|9001980|P1|Overall Study|Withdrawal by Subject|0
2604367|NCT01040728|9001977|P4|Overall Study|Adverse Event|4
2604368|NCT01040728|9001978|P3|Overall Study|Adverse Event|0
2604369|NCT01040728|9001979|P2|Overall Study|Adverse Event|8
2604370|NCT01040728|9001980|P1|Overall Study|Adverse Event|4
2604371|NCT01040689|9002050|P4|Overall Study|Other reasons not listed above|0
2604372|NCT01040689|9002051|P3|Overall Study|Other reasons not listed above|0
2604373|NCT01040689|9002052|P2|Overall Study|Other reasons not listed above|1
2604374|NCT01040689|9002053|P1|Overall Study|Other reasons not listed above|0
2604375|NCT01040689|9002050|P4|Overall Study|Withdrawal by Subject|0
2604376|NCT01040689|9002051|P3|Overall Study|Withdrawal by Subject|1
2604377|NCT01040689|9002052|P2|Overall Study|Withdrawal by Subject|1
2604378|NCT01040689|9002053|P1|Overall Study|Withdrawal by Subject|2
2604379|NCT01040689|9002050|P4|Overall Study|Lost to Follow-up|0
2604380|NCT01040689|9002051|P3|Overall Study|Lost to Follow-up|0
2604381|NCT01040689|9002052|P2|Overall Study|Lost to Follow-up|0
2604382|NCT01040689|9002053|P1|Overall Study|Lost to Follow-up|1
2604383|NCT01040689|9002050|P4|Overall Study|Lack of Efficacy|0
2604384|NCT01040689|9002051|P3|Overall Study|Lack of Efficacy|1
2604385|NCT01040689|9002052|P2|Overall Study|Lack of Efficacy|0
2604386|NCT01040689|9002053|P1|Overall Study|Lack of Efficacy|0
2604387|NCT01040689|9002050|P4|Overall Study|Adverse Event|4
2604388|NCT01040689|9002051|P3|Overall Study|Adverse Event|2
2604389|NCT01040689|9002052|P2|Overall Study|Adverse Event|0
2604390|NCT01040689|9002053|P1|Overall Study|Adverse Event|0
2604391|NCT01040403|9002132|P1|Overall Study|Other reason not defined above|6
2604392|NCT01040403|9002132|P1|Overall Study|Not treated|1
2604393|NCT01040403|9002132|P1|Overall Study|Lost to Follow-up|1
2604394|NCT01040403|9002132|P1|Overall Study|Protocol Violation|2
2604395|NCT01040403|9002132|P1|Overall Study|Adverse Event|10
2604396|NCT01040351|9002320|P2|Overall Study|poor ovarian response|2
2604397|NCT01040351|9002321|P1|Overall Study|poor ovarian response|1
2604398|NCT01040260|9002331|P2|Overall Study|Lost to Follow-up|5
2604399|NCT01040260|9002332|P1|Overall Study|Lost to Follow-up|3
2604400|NCT01040260|9002331|P2|Overall Study|Withdrawal by Subject|6
2604401|NCT01040260|9002332|P1|Overall Study|Withdrawal by Subject|12
2604402|NCT01040169|9002359|P2|Overall Study|Lost to Follow-up|8
2604403|NCT01040169|9002360|P1|Overall Study|Lost to Follow-up|3
2604404|NCT01040130|9002368|P6|Overall Study|Other reasons not listed above|0
2604405|NCT01040130|9002369|P5|Overall Study|Other reasons not listed above|0
2604406|NCT01040130|9002370|P4|Overall Study|Other reasons not listed above|0
2604407|NCT01040130|9002371|P3|Overall Study|Other reasons not listed above|0
2604408|NCT01040130|9002372|P2|Overall Study|Other reasons not listed above|0
2604409|NCT01040130|9002373|P1|Overall Study|Other reasons not listed above|2
2604410|NCT01040130|9002368|P6|Overall Study|Withdrawal by Subject|1
2604411|NCT01040130|9002369|P5|Overall Study|Withdrawal by Subject|0
2604412|NCT01040130|9002370|P4|Overall Study|Withdrawal by Subject|0
2604413|NCT01040130|9002371|P3|Overall Study|Withdrawal by Subject|0
2604414|NCT01040130|9002372|P2|Overall Study|Withdrawal by Subject|2
2604415|NCT01040130|9002373|P1|Overall Study|Withdrawal by Subject|0
2604416|NCT01040130|9002368|P6|Overall Study|Protocol Violation|0
2604417|NCT01040130|9002369|P5|Overall Study|Protocol Violation|0
2604418|NCT01040130|9002370|P4|Overall Study|Protocol Violation|0
2604419|NCT01040130|9002371|P3|Overall Study|Protocol Violation|2
2604420|NCT01040130|9002372|P2|Overall Study|Protocol Violation|0
2604421|NCT01040130|9002373|P1|Overall Study|Protocol Violation|0
2604422|NCT01040130|9002368|P6|Overall Study|Adverse Event|3
2604423|NCT01040130|9002369|P5|Overall Study|Adverse Event|0
2604424|NCT01040130|9002370|P4|Overall Study|Adverse Event|5
2604425|NCT01040130|9002371|P3|Overall Study|Adverse Event|0
2604426|NCT01040130|9002372|P2|Overall Study|Adverse Event|1
2604427|NCT01040130|9002373|P1|Overall Study|Adverse Event|1
2604428|NCT01039688|9002466|P3|Overall Study|Death|0
2604429|NCT01039688|9002467|P2|Overall Study|Death|0
2604430|NCT01039688|9002468|P1|Overall Study|Death|2
2604431|NCT01039688|9002466|P3|Overall Study|Withdrawal by Subject|13
2604432|NCT01039688|9002467|P2|Overall Study|Withdrawal by Subject|27
2604433|NCT01039688|9002468|P1|Overall Study|Withdrawal by Subject|23
2604434|NCT01039688|9002466|P3|Overall Study|Other|12
2604435|NCT01039688|9002467|P2|Overall Study|Other|25
2604436|NCT01039688|9002468|P1|Overall Study|Other|13
2604437|NCT01039688|9002466|P3|Overall Study|Lost to Follow-up|5
2604438|NCT01039688|9002467|P2|Overall Study|Lost to Follow-up|9
2604439|NCT01039688|9002468|P1|Overall Study|Lost to Follow-up|11
2604440|NCT01039688|9002466|P3|Overall Study|Lack of Efficacy|26
2604441|NCT01039688|9002467|P2|Overall Study|Lack of Efficacy|11
2604442|NCT01039688|9002468|P1|Overall Study|Lack of Efficacy|20
2604443|NCT01039688|9002466|P3|Overall Study|Adverse Event|24
2604444|NCT01039688|9002467|P2|Overall Study|Adverse Event|39
2604445|NCT01039688|9002468|P1|Overall Study|Adverse Event|38
2604446|NCT01039675|9002739|P2|Overall Study|Physician Decision|1
2604447|NCT01039675|9002740|P1|Overall Study|Physician Decision|0
2604448|NCT01039675|9002739|P2|Overall Study|Lost to Follow-up|1
2604449|NCT01039675|9002740|P1|Overall Study|Lost to Follow-up|0
2604450|NCT01039675|9002739|P2|Overall Study|Withdrawal by Subject|1
2604451|NCT01039675|9002740|P1|Overall Study|Withdrawal by Subject|0
2604452|NCT01039675|9002739|P2|Overall Study|Lack of Efficacy|2
2604453|NCT01039675|9002740|P1|Overall Study|Lack of Efficacy|0
2604454|NCT01039675|9002739|P2|Overall Study|Adverse Event|2
2604455|NCT01039675|9002740|P1|Overall Study|Adverse Event|0
2604456|NCT01039584|9002753|P3|Overall Study|Positive for Chlamydia or gonorrhea|8
2604457|NCT01039584|9002754|P2|Overall Study|Positive for Chlamydia or gonorrhea|10
2604458|NCT01039584|9002755|P1|Overall Study|Positive for Chlamydia or gonorrhea|7
2604459|NCT01039584|9002753|P3|Overall Study|Pap smear with significant pathology|3
2604460|NCT01039584|9002754|P2|Overall Study|Pap smear with significant pathology|10
2604461|NCT01039584|9002755|P1|Overall Study|Pap smear with significant pathology|10
2604462|NCT01039584|9002753|P3|Overall Study|other|1
2604463|NCT01039584|9002754|P2|Overall Study|other|3
2604464|NCT01039584|9002755|P1|Overall Study|other|1
2604465|NCT01039584|9002753|P3|Overall Study|Lack of Efficacy|10
2604466|NCT01039584|9002754|P2|Overall Study|Lack of Efficacy|6
2604467|NCT01039584|9002755|P1|Overall Study|Lack of Efficacy|7
2604468|NCT01039584|9002753|P3|Overall Study|Negative Baseline culture for Candida|24
2604469|NCT01039584|9002754|P2|Overall Study|Negative Baseline culture for Candida|59
2604470|NCT01039584|9002755|P1|Overall Study|Negative Baseline culture for Candida|59
2604471|NCT01039584|9002753|P3|Overall Study|Lost to Follow-up|4
2604472|NCT01039584|9002754|P2|Overall Study|Lost to Follow-up|3
2604473|NCT01039584|9002755|P1|Overall Study|Lost to Follow-up|5
2604474|NCT01039584|9002753|P3|Overall Study|Protocol Violation|6
2604475|NCT01039584|9002754|P2|Overall Study|Protocol Violation|4
2604476|NCT01039584|9002755|P1|Overall Study|Protocol Violation|10
2604477|NCT01039584|9002753|P3|Overall Study|Withdrawal by Subject|1
2604478|NCT01039584|9002754|P2|Overall Study|Withdrawal by Subject|2
2604479|NCT01039584|9002755|P1|Overall Study|Withdrawal by Subject|4
2604480|NCT01039519|9002769|P1|Survival Follow-up|Sponsor decision|4
2604481|NCT01039519|9002769|P1|Survival Follow-up|Death|23
2604482|NCT01039519|9002769|P1|Treatment|Physician Decision|2
2604483|NCT01039519|9002769|P1|Treatment|Adverse Event|3
2604484|NCT01039519|9002769|P1|Treatment|Treatment failure|2
2604485|NCT01039519|9002769|P1|Treatment|Progressive disease|20
2604486|NCT01039428|9002805|P2|Overall Study|Withdrawal by Subject|0
2604487|NCT01039428|9002806|P1|Overall Study|Withdrawal by Subject|1
2604488|NCT01039428|9002805|P2|Overall Study|Protocol Violation|0
2604489|NCT01039428|9002806|P1|Overall Study|Protocol Violation|1
2604490|NCT01039376|9002830|P2|Overall Study|Study terminated by Sponsor|72
2604491|NCT01039376|9002831|P1|Overall Study|Study terminated by Sponsor|90
2604492|NCT01039376|9002830|P2|Overall Study|Withdrawal by Subject|32
2604493|NCT01039376|9002831|P1|Overall Study|Withdrawal by Subject|20
2604494|NCT01039376|9002830|P2|Overall Study|Physician Decision|10
2604495|NCT01039376|9002831|P1|Overall Study|Physician Decision|15
2604496|NCT01039376|9002830|P2|Overall Study|Lost to Follow-up|12
2604497|NCT01039376|9002831|P1|Overall Study|Lost to Follow-up|5
2604498|NCT01038921|9002900|P2|Overall Study|Physician Decision|0
2604499|NCT01038921|9002901|P1|Overall Study|Physician Decision|1
2604500|NCT01038921|9002900|P2|Overall Study|Withdrawal by Subject|0
2604501|NCT01038921|9002901|P1|Overall Study|Withdrawal by Subject|1
2604502|NCT01038869|9002907|P1|Overall Study|Lost to Follow-up|6
2604503|NCT01038869|9002907|P1|Overall Study|Withdrawal by Subject|1
2604504|NCT01038856|9002915|P1|Overall Study|Adverse Event|2
2604505|NCT01038752|9002924|P2|Overall Study|Lost to Follow-up|3
2604506|NCT01038752|9002925|P1|Overall Study|Lost to Follow-up|3
2604507|NCT01038752|9002924|P2|Overall Study|Tumor Progression|2
2604508|NCT01038752|9002925|P1|Overall Study|Tumor Progression|2
2604509|NCT01038713|9002948|P3|Overall Study|Autoimmune Pancreatitis|0
2604510|NCT01038713|9002949|P2|Overall Study|Autoimmune Pancreatitis|0
2604511|NCT01038713|9002950|P1|Overall Study|Autoimmune Pancreatitis|1
2604512|NCT01038713|9002948|P3|Overall Study|died from PEP|0
2604513|NCT01038713|9002949|P2|Overall Study|died from PEP|1
2604514|NCT01038713|9002950|P1|Overall Study|died from PEP|0
2604515|NCT01038713|9002948|P3|Overall Study|Neuroendocrine Tumor|0
2604516|NCT01038713|9002949|P2|Overall Study|Neuroendocrine Tumor|1
2604517|NCT01038713|9002950|P1|Overall Study|Neuroendocrine Tumor|0
2604518|NCT01038713|9002948|P3|Overall Study|Lost to Follow-up|0
2604519|NCT01038713|9002949|P2|Overall Study|Lost to Follow-up|0
2604520|NCT01038713|9002950|P1|Overall Study|Lost to Follow-up|3
2604521|NCT01038713|9002948|P3|Overall Study|Patient to hospice|1
2604522|NCT01038713|9002949|P2|Overall Study|Patient to hospice|1
2604523|NCT01038713|9002950|P1|Overall Study|Patient to hospice|1
2604524|NCT01038635|9002979|P9|Overall Study|Death|2
2604525|NCT01038635|9002980|P8|Overall Study|Death|1
2604526|NCT01038635|9002981|P7|Overall Study|Death|1
2604527|NCT01038635|9002982|P6|Overall Study|Death|0
2604528|NCT01038635|9002983|P5|Overall Study|Death|1
2604529|NCT01038635|9002984|P4|Overall Study|Death|0
2604530|NCT01038635|9002985|P3|Overall Study|Death|0
2604531|NCT01038635|9002986|P2|Overall Study|Death|0
2604532|NCT01038635|9002987|P1|Overall Study|Death|0
2604533|NCT01038635|9002979|P9|Overall Study|Disease Progression|0
2604534|NCT01038635|9002980|P8|Overall Study|Disease Progression|4
2604535|NCT01038635|9002981|P7|Overall Study|Disease Progression|1
2604536|NCT01038635|9002982|P6|Overall Study|Disease Progression|0
2604537|NCT01038635|9002983|P5|Overall Study|Disease Progression|0
2604538|NCT01038635|9002984|P4|Overall Study|Disease Progression|0
2604539|NCT01038635|9002985|P3|Overall Study|Disease Progression|0
2604540|NCT01038635|9002986|P2|Overall Study|Disease Progression|0
2604541|NCT01038635|9002987|P1|Overall Study|Disease Progression|2
2604542|NCT01038609|9003013|P5|Overall Study|Refusal of Blood Draws|0
2604543|NCT01038609|9003014|P4|Overall Study|Refusal of Blood Draws|0
2604544|NCT01038609|9003015|P3|Overall Study|Refusal of Blood Draws|0
2604545|NCT01038609|9003016|P2|Overall Study|Refusal of Blood Draws|1
2604546|NCT01038609|9003017|P1|Overall Study|Refusal of Blood Draws|0
2604547|NCT01038609|9003013|P5|Overall Study|Death in the Family|0
2604548|NCT01038609|9003014|P4|Overall Study|Death in the Family|0
2604549|NCT01038609|9003015|P3|Overall Study|Death in the Family|0
2604550|NCT01038609|9003016|P2|Overall Study|Death in the Family|0
2604551|NCT01038609|9003017|P1|Overall Study|Death in the Family|1
2604552|NCT01038609|9003013|P5|Overall Study|Dosing Error|1
2604553|NCT01038609|9003014|P4|Overall Study|Dosing Error|1
2604554|NCT01038609|9003015|P3|Overall Study|Dosing Error|0
2604555|NCT01038609|9003016|P2|Overall Study|Dosing Error|0
2604556|NCT01038609|9003017|P1|Overall Study|Dosing Error|0
2604557|NCT01038609|9003013|P5|Overall Study|Adverse Event|0
2604558|NCT01038609|9003014|P4|Overall Study|Adverse Event|0
2604559|NCT01038609|9003015|P3|Overall Study|Adverse Event|1
2604560|NCT01038609|9003016|P2|Overall Study|Adverse Event|0
2604561|NCT01038609|9003017|P1|Overall Study|Adverse Event|0
2604562|NCT01038323|9003136|P3|Overall Study|Withdrawal by Subject|4
2604563|NCT01038323|9003137|P2|Overall Study|Withdrawal by Subject|2
2604564|NCT01038323|9003138|P1|Overall Study|Withdrawal by Subject|3
2604565|NCT01038128|9003152|P1|Overall Study|Withdrawal by Subject|2
2604566|NCT01038128|9003152|P1|Overall Study|Lost to Follow-up|1
2604567|NCT01038128|9003152|P1|Overall Study|Lack of Efficacy|1
2604568|NCT01037244|9003316|P4|Overall Study|Various|1
2604569|NCT01037244|9003317|P3|Overall Study|Various|1
2604570|NCT01037244|9003318|P2|Overall Study|Various|2
2604571|NCT01037244|9003319|P1|Overall Study|Various|3
2604572|NCT01037244|9003316|P4|Overall Study|Partner Withdrew Consent|0
2604573|NCT01037244|9003317|P3|Overall Study|Partner Withdrew Consent|0
2604574|NCT01037244|9003318|P2|Overall Study|Partner Withdrew Consent|1
2604575|NCT01037244|9003319|P1|Overall Study|Partner Withdrew Consent|2
2604576|NCT01037244|9003316|P4|Overall Study|Withdrawal by Subject|5
2604577|NCT01037244|9003317|P3|Overall Study|Withdrawal by Subject|3
2604578|NCT01037244|9003318|P2|Overall Study|Withdrawal by Subject|5
2604579|NCT01037244|9003319|P1|Overall Study|Withdrawal by Subject|1
2604580|NCT01037244|9003316|P4|Overall Study|Lost to Follow-up|4
2604581|NCT01037244|9003317|P3|Overall Study|Lost to Follow-up|4
2604582|NCT01037244|9003318|P2|Overall Study|Lost to Follow-up|3
2604583|NCT01037244|9003319|P1|Overall Study|Lost to Follow-up|3
2604584|NCT01037244|9003316|P4|Overall Study|Lack of Efficacy|1
2604585|NCT01037244|9003317|P3|Overall Study|Lack of Efficacy|0
2604586|NCT01037244|9003318|P2|Overall Study|Lack of Efficacy|1
2604587|NCT01037244|9003319|P1|Overall Study|Lack of Efficacy|1
2604588|NCT01037244|9003316|P4|Overall Study|Adverse Event|3
2604589|NCT01037244|9003317|P3|Overall Study|Adverse Event|6
2604590|NCT01037244|9003318|P2|Overall Study|Adverse Event|2
2604591|NCT01037244|9003319|P1|Overall Study|Adverse Event|3
2604592|NCT01037218|9003381|P4|Overall Study|Various|1
2604593|NCT01037218|9003382|P3|Overall Study|Various|3
2604594|NCT01037218|9003383|P2|Overall Study|Various|2
2604595|NCT01037218|9003384|P1|Overall Study|Various|3
2604596|NCT01037218|9003381|P4|Overall Study|Protocol Violation|2
2604597|NCT01037218|9003382|P3|Overall Study|Protocol Violation|2
2604598|NCT01037218|9003383|P2|Overall Study|Protocol Violation|0
2604599|NCT01037218|9003384|P1|Overall Study|Protocol Violation|0
2604600|NCT01037218|9003381|P4|Overall Study|Partner Withdrew Consent|1
2604601|NCT01037218|9003382|P3|Overall Study|Partner Withdrew Consent|2
2604602|NCT01037218|9003383|P2|Overall Study|Partner Withdrew Consent|3
2604603|NCT01037218|9003384|P1|Overall Study|Partner Withdrew Consent|0
2604604|NCT01037218|9003381|P4|Overall Study|Withdrawal by Subject|4
2604605|NCT01037218|9003382|P3|Overall Study|Withdrawal by Subject|7
2604606|NCT01037218|9003383|P2|Overall Study|Withdrawal by Subject|7
2604607|NCT01037218|9003384|P1|Overall Study|Withdrawal by Subject|6
2604608|NCT01037218|9003381|P4|Overall Study|Lost to Follow-up|2
2604609|NCT01037218|9003382|P3|Overall Study|Lost to Follow-up|4
2604610|NCT01037218|9003383|P2|Overall Study|Lost to Follow-up|5
2604611|NCT01037218|9003384|P1|Overall Study|Lost to Follow-up|3
2604612|NCT01037218|9003381|P4|Overall Study|Lack of Efficacy|5
2604613|NCT01037218|9003382|P3|Overall Study|Lack of Efficacy|1
2604614|NCT01037218|9003383|P2|Overall Study|Lack of Efficacy|2
2604615|NCT01037218|9003384|P1|Overall Study|Lack of Efficacy|0
2604616|NCT01037218|9003381|P4|Overall Study|Adverse Event|1
2604617|NCT01037218|9003382|P3|Overall Study|Adverse Event|2
2604618|NCT01037218|9003383|P2|Overall Study|Adverse Event|2
2604619|NCT01037218|9003384|P1|Overall Study|Adverse Event|4
2604620|NCT01037127|9003455|P2|Overall Study|Study Closed Terminated|17
2604621|NCT01037127|9003456|P1|Overall Study|Study Closed Terminated|2
2604622|NCT01037127|9003455|P2|Overall Study|Physician Decision|0
2604623|NCT01037127|9003456|P1|Overall Study|Physician Decision|1
2604624|NCT01037127|9003455|P2|Overall Study|Lost to Follow-up|4
2604625|NCT01037127|9003456|P1|Overall Study|Lost to Follow-up|2
2604626|NCT01037114|9003488|P1|Year 20|Others|1
2604627|NCT01037088|9003501|P1|Overall Study|Withdrawal by Subject|3
2604628|NCT01036763|9003533|P1|Overall Study|Other reason (not specified)|40
2604629|NCT01036763|9003533|P1|Overall Study|Lost to Follow-up|28
2604630|NCT01036763|9003533|P1|Overall Study|Adverse Event|25
2604631|NCT01036724|9003545|P2|Overall Study|Protocol Violation|5
2604632|NCT01036724|9003546|P1|Overall Study|Protocol Violation|4
2604633|NCT01036724|9003545|P2|Overall Study|Lack of Efficacy|1
2604634|NCT01036724|9003546|P1|Overall Study|Lack of Efficacy|1
2604635|NCT01036724|9003545|P2|Overall Study|Adverse Event|2
2604636|NCT01036724|9003546|P1|Overall Study|Adverse Event|1
2604637|NCT01036529|9003556|P2|Overall Study|Sponsor study termination|12
2604638|NCT01036529|9003557|P1|Overall Study|Sponsor study termination|11
2604639|NCT01036529|9003556|P2|Overall Study|Withdrawal by Subject|1
2604640|NCT01036529|9003557|P1|Overall Study|Withdrawal by Subject|1
2604641|NCT01036529|9003556|P2|Overall Study|Physician Decision|0
2604642|NCT01036529|9003557|P1|Overall Study|Physician Decision|1
2604643|NCT01036529|9003556|P2|Overall Study|Lost to Follow-up|1
2604644|NCT01036529|9003557|P1|Overall Study|Lost to Follow-up|0
2604645|NCT01036529|9003556|P2|Overall Study|Adverse Event|1
2604646|NCT01036529|9003557|P1|Overall Study|Adverse Event|0
2604647|NCT01036438|9003584|P2|Overall Study|No effect of study treatment|1
2604648|NCT01036438|9003585|P1|Overall Study|No effect of study treatment|3
2604649|NCT01036438|9003584|P2|Overall Study|Death|1
2604650|NCT01036438|9003585|P1|Overall Study|Death|0
2604651|NCT01036438|9003584|P2|Overall Study|Adverse Event|8
2604652|NCT01036438|9003585|P1|Overall Study|Adverse Event|7
2604653|NCT01036321|9003593|P2|Overall Study|Adverse Event|1
2604654|NCT01036321|9003594|P1|Overall Study|Adverse Event|2
2604655|NCT01036321|9003593|P2|Overall Study|Withdrawal by Subject|2
2604656|NCT01036321|9003594|P1|Overall Study|Withdrawal by Subject|3
2604657|NCT01036321|9003593|P2|Overall Study|Ineligible after randomization|1
2604658|NCT01036321|9003594|P1|Overall Study|Ineligible after randomization|0
2604659|NCT01036165|9003618|P1|Overall Study|Problems finding proper area to inject|1
2604660|NCT01036165|9003618|P1|Overall Study|Device Related Issues|3
2604661|NCT01036165|9003618|P1|Overall Study|Withdrawal by Subject|3
2604662|NCT01036165|9003618|P1|Overall Study|Lost to Follow-up|2
2604663|NCT01036165|9003618|P1|Overall Study|Adverse Event|6
2604664|NCT01036022|9003629|P6|Overall Study|Withdrawal by Subject|0
2604665|NCT01036022|9003630|P5|Overall Study|Withdrawal by Subject|2
2604666|NCT01036022|9003631|P4|Overall Study|Withdrawal by Subject|1
2604667|NCT01036022|9003632|P3|Overall Study|Withdrawal by Subject|0
2604668|NCT01036022|9003633|P2|Overall Study|Withdrawal by Subject|0
2604669|NCT01036022|9003634|P1|Overall Study|Withdrawal by Subject|0
2604670|NCT01036022|9003629|P6|Overall Study|Physician Decision|0
2604671|NCT01036022|9003630|P5|Overall Study|Physician Decision|0
2604672|NCT01036022|9003631|P4|Overall Study|Physician Decision|0
2604673|NCT01036022|9003632|P3|Overall Study|Physician Decision|1
2604674|NCT01036022|9003633|P2|Overall Study|Physician Decision|0
2604675|NCT01036022|9003634|P1|Overall Study|Physician Decision|0
2604676|NCT01036022|9003629|P6|Overall Study|Lack of Efficacy|1
2604677|NCT01036022|9003630|P5|Overall Study|Lack of Efficacy|1
2604678|NCT01036022|9003631|P4|Overall Study|Lack of Efficacy|0
2604679|NCT01036022|9003632|P3|Overall Study|Lack of Efficacy|1
2604680|NCT01036022|9003633|P2|Overall Study|Lack of Efficacy|1
2604681|NCT01036022|9003634|P1|Overall Study|Lack of Efficacy|1
2604682|NCT01036022|9003629|P6|Overall Study|Adverse Event|2
2604683|NCT01036022|9003630|P5|Overall Study|Adverse Event|0
2604684|NCT01036022|9003631|P4|Overall Study|Adverse Event|1
2604685|NCT01036022|9003632|P3|Overall Study|Adverse Event|2
2604686|NCT01036022|9003633|P2|Overall Study|Adverse Event|3
2604687|NCT01036022|9003634|P1|Overall Study|Adverse Event|1
2604688|NCT01035905|9003770|P2|Overall Study|Lack of Efficacy|1
2604689|NCT01035905|9003771|P1|Overall Study|Lack of Efficacy|1
2604690|NCT01035606|9003944|P3|Overall Study|change in health, job demands,family|4
2604691|NCT01035606|9003945|P2|Overall Study|change in health, job demands,family|3
2604692|NCT01035606|9003946|P1|Overall Study|change in health, job demands,family|3
2604693|NCT01035463|9003962|P6|Overall Study|Other|2
2604694|NCT01035463|9003963|P5|Overall Study|Other|0
2604695|NCT01035463|9003964|P4|Overall Study|Other|1
2604696|NCT01035463|9003965|P3|Overall Study|Other|0
2604697|NCT01035463|9003966|P2|Overall Study|Other|0
2604698|NCT01035463|9003967|P1|Overall Study|Other|0
2604699|NCT01035463|9003962|P6|Overall Study|Other Malignancy|2
2604700|NCT01035463|9003963|P5|Overall Study|Other Malignancy|0
2604701|NCT01035463|9003964|P4|Overall Study|Other Malignancy|0
2604702|NCT01035463|9003965|P3|Overall Study|Other Malignancy|0
2604703|NCT01035463|9003966|P2|Overall Study|Other Malignancy|0
2604704|NCT01035463|9003967|P1|Overall Study|Other Malignancy|0
2604705|NCT01035463|9003962|P6|Overall Study|Disease progression|3
2604706|NCT01035463|9003963|P5|Overall Study|Disease progression|0
2604707|NCT01035463|9003964|P4|Overall Study|Disease progression|0
2604708|NCT01035463|9003965|P3|Overall Study|Disease progression|0
2604709|NCT01035463|9003966|P2|Overall Study|Disease progression|0
2604710|NCT01035463|9003967|P1|Overall Study|Disease progression|0
2604711|NCT01035463|9003962|P6|Overall Study|Withdrawal by Subject|4
2604712|NCT01035463|9003963|P5|Overall Study|Withdrawal by Subject|1
2604713|NCT01035463|9003964|P4|Overall Study|Withdrawal by Subject|0
2604714|NCT01035463|9003965|P3|Overall Study|Withdrawal by Subject|1
2604715|NCT01035463|9003966|P2|Overall Study|Withdrawal by Subject|2
2604716|NCT01035463|9003967|P1|Overall Study|Withdrawal by Subject|0
2604717|NCT01035463|9003962|P6|Overall Study|Adverse Event|7
2604718|NCT01035463|9003963|P5|Overall Study|Adverse Event|5
2604719|NCT01035463|9003964|P4|Overall Study|Adverse Event|1
2604720|NCT01035463|9003965|P3|Overall Study|Adverse Event|4
2604721|NCT01035463|9003966|P2|Overall Study|Adverse Event|0
2604722|NCT01035463|9003967|P1|Overall Study|Adverse Event|0
2604723|NCT01035255|9004004|P2|Overall Study|patient's request|13
2604724|NCT01035255|9004005|P1|Overall Study|patient's request|15
2604725|NCT01035255|9004004|P2|Overall Study|Lost to Follow-up|5
2604726|NCT01035255|9004005|P1|Overall Study|Lost to Follow-up|2
2604727|NCT01035255|9004004|P2|Overall Study|Death|844
2604728|NCT01035255|9004005|P1|Overall Study|Death|724
2604729|NCT01035229|9004023|P2|Overall Study|Disease Progression|152
2604730|NCT01035229|9004024|P1|Overall Study|Disease Progression|261
2604731|NCT01035229|9004023|P2|Overall Study|Sponsor's decision to end study|3
2604732|NCT01035229|9004024|P1|Overall Study|Sponsor's decision to end study|3
2604733|NCT01035229|9004023|P2|Overall Study|Protocol Violation|2
2604734|NCT01035229|9004024|P1|Overall Study|Protocol Violation|0
2604735|NCT01035229|9004023|P2|Overall Study|New cancer therapy|0
2604736|NCT01035229|9004024|P1|Overall Study|New cancer therapy|2
2604737|NCT01035229|9004023|P2|Overall Study|Death|5
2604738|NCT01035229|9004024|P1|Overall Study|Death|13
2604739|NCT01035229|9004023|P2|Overall Study|Administrative problems|1
2604740|NCT01035229|9004024|P1|Overall Study|Administrative problems|1
2604741|NCT01035229|9004023|P2|Overall Study|Lost to Follow-up|0
2604742|NCT01035229|9004024|P1|Overall Study|Lost to Follow-up|1
2604743|NCT01035229|9004023|P2|Overall Study|Withdrawal by Subject|7
2604744|NCT01035229|9004024|P1|Overall Study|Withdrawal by Subject|20
2604745|NCT01035229|9004023|P2|Overall Study|Adverse Event|14
2604746|NCT01035229|9004024|P1|Overall Study|Adverse Event|61
2604747|NCT01035138|9004054|P3|Overall Study|Lost to Follow-up|1
2604748|NCT01035138|9004055|P2|Overall Study|Lost to Follow-up|0
2604749|NCT01035138|9004056|P1|Overall Study|Lost to Follow-up|0
2604750|NCT01035138|9004054|P3|Overall Study|Sponsor Decision|42
2604751|NCT01035138|9004055|P2|Overall Study|Sponsor Decision|60
2604752|NCT01035138|9004056|P1|Overall Study|Sponsor Decision|66
2604753|NCT01035138|9004054|P3|Overall Study|Physician Decision|1
2604754|NCT01035138|9004055|P2|Overall Study|Physician Decision|0
2604755|NCT01035138|9004056|P1|Overall Study|Physician Decision|0
2604756|NCT01035138|9004054|P3|Overall Study|Withdrawal by Subject|0
2604757|NCT01035138|9004055|P2|Overall Study|Withdrawal by Subject|0
2604758|NCT01035138|9004056|P1|Overall Study|Withdrawal by Subject|1
2604759|NCT01035138|9004054|P3|Overall Study|Caregiver Decision|1
2604760|NCT01035138|9004055|P2|Overall Study|Caregiver Decision|0
2604761|NCT01035138|9004056|P1|Overall Study|Caregiver Decision|2
2604762|NCT01035138|9004054|P3|Overall Study|Adverse Event|2
2604763|NCT01035138|9004055|P2|Overall Study|Adverse Event|0
2604764|NCT01035138|9004056|P1|Overall Study|Adverse Event|4
2604765|NCT01035060|9004117|P2|Overall Study|Physician Decision|0
2604766|NCT01035060|9004118|P1|Overall Study|Physician Decision|2
2604767|NCT01035060|9004117|P2|Overall Study|Withdrawal by Subject|6
2604768|NCT01035060|9004118|P1|Overall Study|Withdrawal by Subject|8
2604769|NCT01035060|9004117|P2|Overall Study|Did not quality after 2nd screening|1
2604770|NCT01035060|9004118|P1|Overall Study|Did not quality after 2nd screening|14
2604771|NCT01035060|9004117|P2|Overall Study|Lost to Follow-up|7
2604772|NCT01035060|9004118|P1|Overall Study|Lost to Follow-up|0
2604773|NCT01034709|9004143|P2|Overall Study|Protocol Violation|16
2604774|NCT01034709|9004144|P1|Overall Study|Protocol Violation|9
2604775|NCT01034657|9004150|P3|Randomized Phase|Adverse Event|1
2604776|NCT01034657|9004151|P2|Randomized Phase|Adverse Event|2
2604777|NCT01034657|9004152|P1|Randomized Phase|Adverse Event|0
2604778|NCT01034657|9004150|P3|Randomized Phase|Abnormal laboratory value|0
2604779|NCT01034657|9004151|P2|Randomized Phase|Abnormal laboratory value|1
2604780|NCT01034657|9004152|P1|Randomized Phase|Abnormal laboratory value|0
2604781|NCT01034657|9004150|P3|Randomized Phase|Lack of Efficacy|0
2604782|NCT01034657|9004151|P2|Randomized Phase|Lack of Efficacy|1
2604783|NCT01034657|9004152|P1|Randomized Phase|Lack of Efficacy|5
2604784|NCT01034657|9004150|P3|Randomized Phase|Withdrawal by Subject|0
2604785|NCT01034657|9004151|P2|Randomized Phase|Withdrawal by Subject|2
2604786|NCT01034657|9004152|P1|Randomized Phase|Withdrawal by Subject|0
2604787|NCT01034657|9004150|P3|Core Phase|Protocol Violation|0
2604788|NCT01034657|9004151|P2|Core Phase|Protocol Violation|0
2604789|NCT01034657|9004152|P1|Core Phase|Protocol Violation|2
2604790|NCT01034657|9004150|P3|Core Phase|Adverse Event|0
2604791|NCT01034657|9004151|P2|Core Phase|Adverse Event|0
2604792|NCT01034657|9004152|P1|Core Phase|Adverse Event|8
2604793|NCT01034657|9004150|P3|Core Phase|Abnormal laboratory value|0
2604794|NCT01034657|9004151|P2|Core Phase|Abnormal laboratory value|0
2604795|NCT01034657|9004152|P1|Core Phase|Abnormal laboratory value|1
2604796|NCT01034657|9004150|P3|Core Phase|Lack of Efficacy|0
2604797|NCT01034657|9004151|P2|Core Phase|Lack of Efficacy|0
2604798|NCT01034657|9004152|P1|Core Phase|Lack of Efficacy|2
2604799|NCT01034657|9004150|P3|Core Phase|Withdrawal by Subject|0
2604800|NCT01034657|9004151|P2|Core Phase|Withdrawal by Subject|0
2604801|NCT01034657|9004152|P1|Core Phase|Withdrawal by Subject|1
2604802|NCT01034631|9004193|P3|Phase II|Determined Ineligible per protocol|0
2604803|NCT01034631|9004194|P2|Phase II|Determined Ineligible per protocol|1
2604804|NCT01034631|9004195|P1|Phase II|Determined Ineligible per protocol|0
2604805|NCT01034631|9004193|P3|Phase II|Not Evaluable per protocol|2
2604806|NCT01034631|9004194|P2|Phase II|Not Evaluable per protocol|0
2604807|NCT01034631|9004195|P1|Phase II|Not Evaluable per protocol|0
2604808|NCT01034631|9004193|P3|Phase I|Symptomatic Deterioration before Treatme|0
2604809|NCT01034631|9004194|P2|Phase I|Symptomatic Deterioration before Treatme|0
2604810|NCT01034631|9004195|P1|Phase I|Symptomatic Deterioration before Treatme|3
2604811|NCT01034540|9004262|P2|Overall Study|Adverse Event|1
2604812|NCT01034540|9004263|P1|Overall Study|Adverse Event|0
2604813|NCT01034462|9004282|P2|Overall Study|Other reasons|2
2604814|NCT01034462|9004283|P1|Overall Study|Other reasons|1
2604815|NCT01034462|9004282|P2|Overall Study|Lost to Follow-up|16
2604816|NCT01034462|9004283|P1|Overall Study|Lost to Follow-up|14
2604817|NCT01034462|9004282|P2|Overall Study|Withdrawal by Subject|8
2604818|NCT01034462|9004283|P1|Overall Study|Withdrawal by Subject|9
2604819|NCT01034462|9004282|P2|Overall Study|Protocol Violation|7
2604820|NCT01034462|9004283|P1|Overall Study|Protocol Violation|10
2604821|NCT01034462|9004282|P2|Overall Study|Lack of Efficacy|4
2604822|NCT01034462|9004283|P1|Overall Study|Lack of Efficacy|4
2604823|NCT01034462|9004282|P2|Overall Study|Adverse Event|17
2604824|NCT01034462|9004283|P1|Overall Study|Adverse Event|7
2604825|NCT01034397|9004293|P2|Overall Study|Other|1
2604826|NCT01034397|9004294|P1|Overall Study|Other|0
2604827|NCT01034397|9004293|P2|Overall Study|Adverse Event|0
2604828|NCT01034397|9004294|P1|Overall Study|Adverse Event|4
2604829|NCT01034397|9004293|P2|Overall Study|Lack of Efficacy|0
2604830|NCT01034397|9004294|P1|Overall Study|Lack of Efficacy|3
2604831|NCT01034397|9004293|P2|Overall Study|Lack of compliance|1
2604832|NCT01034397|9004294|P1|Overall Study|Lack of compliance|0
2604833|NCT01034358|9004443|P1|Overall Study|Protocol Violation|1
2604834|NCT01034358|9004443|P1|Overall Study|Withdrawal by Subject|1
2604835|NCT01034306|9004449|P2|Overall Study|Noncomplience|0
2604836|NCT01034306|9004450|P1|Overall Study|Noncomplience|1
2604837|NCT01034306|9004449|P2|Overall Study|hospitalized and decided to stop|0
2604838|NCT01034306|9004450|P1|Overall Study|hospitalized and decided to stop|1
2604839|NCT01034306|9004449|P2|Overall Study|Withdrawal by Subject|2
2604840|NCT01034306|9004450|P1|Overall Study|Withdrawal by Subject|2
2604841|NCT01034306|9004449|P2|Overall Study|Lost to Follow-up|1
2604842|NCT01034306|9004450|P1|Overall Study|Lost to Follow-up|0
2604843|NCT01034306|9004449|P2|Overall Study|Adverse Event|0
2604844|NCT01034306|9004450|P1|Overall Study|Adverse Event|1
2604845|NCT01034176|9004458|P2|Overall Study|Lost to Follow-up|1
2604846|NCT01034176|9004459|P1|Overall Study|Lost to Follow-up|0
2604847|NCT01034176|9004458|P2|Overall Study|Withdrawal by Subject|1
2604848|NCT01034176|9004459|P1|Overall Study|Withdrawal by Subject|0
2604849|NCT01034176|9004458|P2|Overall Study|Physician Decision|0
2604850|NCT01034176|9004459|P1|Overall Study|Physician Decision|2
2604851|NCT01034163|9004469|P2|Overall Study|Abnormal laboratory value|0
2604852|NCT01034163|9004470|P1|Overall Study|Abnormal laboratory value|1
2604853|NCT01034163|9004469|P2|Overall Study|Administrative problems|1
2604854|NCT01034163|9004470|P1|Overall Study|Administrative problems|0
2604855|NCT01034163|9004469|P2|Overall Study|Adverse Event|0
2604856|NCT01034163|9004470|P1|Overall Study|Adverse Event|6
2604857|NCT01034163|9004469|P2|Overall Study|Disease progression|4
2604858|NCT01034163|9004470|P1|Overall Study|Disease progression|3
2604859|NCT01034163|9004469|P2|Overall Study|Protocol deviation|0
2604860|NCT01034163|9004470|P1|Overall Study|Protocol deviation|1
2604861|NCT01034163|9004469|P2|Overall Study|Withdrawal by Subject|2
2604862|NCT01034163|9004470|P1|Overall Study|Withdrawal by Subject|8
2604863|NCT01034163|9004469|P2|Overall Study|Treatment completed as per protocol|7
2604864|NCT01034163|9004470|P1|Overall Study|Treatment completed as per protocol|8
2604865|NCT01034137|9004479|P3|Overall Study|Administrative or other|4
2604866|NCT01034137|9004480|P2|Overall Study|Administrative or other|3
2604867|NCT01034137|9004481|P1|Overall Study|Administrative or other|2
2604868|NCT01034137|9004479|P3|Overall Study|Refused treatment or did not cooperate|1
2604869|NCT01034137|9004480|P2|Overall Study|Refused treatment or did not cooperate|0
2604870|NCT01034137|9004481|P1|Overall Study|Refused treatment or did not cooperate|2
2604871|NCT01034137|9004479|P3|Overall Study|Protocol Violation|1
2604872|NCT01034137|9004480|P2|Overall Study|Protocol Violation|2
2604873|NCT01034137|9004481|P1|Overall Study|Protocol Violation|2
2604874|NCT01034137|9004479|P3|Overall Study|Lack of Efficacy|13
2604875|NCT01034137|9004480|P2|Overall Study|Lack of Efficacy|4
2604876|NCT01034137|9004481|P1|Overall Study|Lack of Efficacy|9
2604877|NCT01034137|9004479|P3|Overall Study|Withdrawal by Subject|3
2604878|NCT01034137|9004480|P2|Overall Study|Withdrawal by Subject|3
2604879|NCT01034137|9004481|P1|Overall Study|Withdrawal by Subject|4
2604880|NCT01034137|9004479|P3|Overall Study|Adverse Event|8
2604881|NCT01034137|9004480|P2|Overall Study|Adverse Event|10
2604882|NCT01034137|9004481|P1|Overall Study|Adverse Event|9
2604883|NCT01033942|9004620|P3|Overall Study|Enrolled in Extension Study|0
2604884|NCT01033942|9004621|P2|Overall Study|Enrolled in Extension Study|3
2604885|NCT01033942|9004622|P1|Overall Study|Enrolled in Extension Study|0
2604886|NCT01033942|9004620|P3|Overall Study|Lost to Follow-up|0
2604887|NCT01033942|9004621|P2|Overall Study|Lost to Follow-up|0
2604888|NCT01033942|9004622|P1|Overall Study|Lost to Follow-up|1
2604889|NCT01033942|9004620|P3|Overall Study|Withdrawal by Subject|1
2604890|NCT01033942|9004621|P2|Overall Study|Withdrawal by Subject|1
2604891|NCT01033942|9004622|P1|Overall Study|Withdrawal by Subject|1
2604892|NCT01033851|9004920|P2|Overall Study|Withdrawal by Subject|7
2604893|NCT01033851|9004921|P1|Overall Study|Withdrawal by Subject|3
2604894|NCT01033825|9004936|P7|Overall Study|Other|0
2604895|NCT01033825|9004937|P6|Overall Study|Other|0
2604896|NCT01033825|9004938|P5|Overall Study|Other|1
2604897|NCT01033825|9004939|P4|Overall Study|Other|0
2604898|NCT01033825|9004940|P3|Overall Study|Other|0
2604899|NCT01033825|9004941|P2|Overall Study|Other|0
2604900|NCT01033825|9004942|P1|Overall Study|Other|0
2604901|NCT01033825|9004936|P7|Overall Study|Protocol Violation|0
2604902|NCT01033825|9004937|P6|Overall Study|Protocol Violation|0
2604903|NCT01033825|9004938|P5|Overall Study|Protocol Violation|0
2604904|NCT01033825|9004939|P4|Overall Study|Protocol Violation|0
2604905|NCT01033825|9004940|P3|Overall Study|Protocol Violation|0
2604906|NCT01033825|9004941|P2|Overall Study|Protocol Violation|0
2604907|NCT01033825|9004942|P1|Overall Study|Protocol Violation|1
2604908|NCT01033825|9004936|P7|Overall Study|Adverse Event|0
2604909|NCT01033825|9004937|P6|Overall Study|Adverse Event|0
2604910|NCT01033825|9004938|P5|Overall Study|Adverse Event|0
2604911|NCT01033825|9004939|P4|Overall Study|Adverse Event|1
2604912|NCT01033825|9004940|P3|Overall Study|Adverse Event|0
2604913|NCT01033825|9004941|P2|Overall Study|Adverse Event|0
2604914|NCT01033825|9004942|P1|Overall Study|Adverse Event|0
2604915|NCT01033825|9004936|P7|Overall Study|Withdrawal by Subject|0
2604916|NCT01033825|9004937|P6|Overall Study|Withdrawal by Subject|0
2604917|NCT01033825|9004938|P5|Overall Study|Withdrawal by Subject|1
2604918|NCT01033825|9004939|P4|Overall Study|Withdrawal by Subject|1
2604919|NCT01033825|9004940|P3|Overall Study|Withdrawal by Subject|2
2604920|NCT01033825|9004941|P2|Overall Study|Withdrawal by Subject|3
2604921|NCT01033825|9004942|P1|Overall Study|Withdrawal by Subject|2
2604922|NCT01033747|9005163|P2|Overall Study|Stopped at end of Extension 1|0
2604923|NCT01033747|9005164|P1|Overall Study|Stopped at end of Extension 1|2
2604924|NCT01033747|9005163|P2|Overall Study|Stopped at end of prolongation visit 1|0
2604925|NCT01033747|9005164|P1|Overall Study|Stopped at end of prolongation visit 1|1
2604926|NCT01033747|9005163|P2|Overall Study|Withdrawal by Subject|6
2604927|NCT01033747|9005164|P1|Overall Study|Withdrawal by Subject|9
2604928|NCT01033747|9005163|P2|Overall Study|Protocol Violation|0
2604929|NCT01033747|9005164|P1|Overall Study|Protocol Violation|1
2604930|NCT01033747|9005163|P2|Overall Study|Unsatisfactory therapeutic effect|4
2604931|NCT01033747|9005164|P1|Overall Study|Unsatisfactory therapeutic effect|14
2604932|NCT01033747|9005163|P2|Overall Study|Abnormal test procedure|1
2604933|NCT01033747|9005164|P1|Overall Study|Abnormal test procedure|0
2604934|NCT01033747|9005163|P2|Overall Study|Abnormal Laboratory Value|0
2604935|NCT01033747|9005164|P1|Overall Study|Abnormal Laboratory Value|1
2604936|NCT01033747|9005163|P2|Overall Study|Adverse Event|4
2604937|NCT01033747|9005164|P1|Overall Study|Adverse Event|9
2604938|NCT01033734|9005172|P1|Overall Study|Withdrawal by Subject|1
2604939|NCT01033487|9005228|P10|Fourth Intervention Period|Adverse Event|0
2604940|NCT01033487|9005229|P9|Fourth Intervention Period|Adverse Event|1
2604941|NCT01033487|9005230|P8|Fourth Intervention Period|Adverse Event|0
2604942|NCT01033487|9005231|P7|Fourth Intervention Period|Adverse Event|0
2604943|NCT01033487|9005232|P6|Fourth Intervention Period|Adverse Event|0
2604944|NCT01033487|9005233|P5|Fourth Intervention Period|Adverse Event|0
2604945|NCT01033487|9005234|P4|Fourth Intervention Period|Adverse Event|0
2604946|NCT01033487|9005235|P3|Fourth Intervention Period|Adverse Event|0
2604947|NCT01033487|9005236|P2|Fourth Intervention Period|Adverse Event|0
2604948|NCT01033487|9005237|P1|Fourth Intervention Period|Adverse Event|0
2604949|NCT01033448|9005291|P1|Overall Study|Unknown disposition|1
2604950|NCT01033448|9005291|P1|Overall Study|Withdrew due to other reasons|3
2604951|NCT01033448|9005291|P1|Overall Study|Lost to Follow-up|3
2604952|NCT01033448|9005291|P1|Overall Study|Positive HCV-RNA at week 48|1
2604953|NCT01033448|9005291|P1|Overall Study|Withdrawal by Subject|4
2604954|NCT01033136|9005350|P2|Follow-Up (3 Month)|Lost to Follow-up|2
2604955|NCT01033136|9005351|P1|Follow-Up (3 Month)|Lost to Follow-up|2
2604956|NCT01033071|9005362|P3|Overall Study|Other|3
2604957|NCT01033071|9005363|P2|Overall Study|Other|4
2604958|NCT01033071|9005364|P1|Overall Study|Other|6
2604959|NCT01033071|9005362|P3|Overall Study|Lack of Efficacy|1
2604960|NCT01033071|9005363|P2|Overall Study|Lack of Efficacy|1
2604961|NCT01033071|9005364|P1|Overall Study|Lack of Efficacy|0
2604962|NCT01033071|9005362|P3|Overall Study|Withdrawal by Subject|11
2604963|NCT01033071|9005363|P2|Overall Study|Withdrawal by Subject|14
2604964|NCT01033071|9005364|P1|Overall Study|Withdrawal by Subject|17
2604965|NCT01033071|9005362|P3|Overall Study|Lost to Follow-up|5
2604966|NCT01033071|9005363|P2|Overall Study|Lost to Follow-up|5
2604967|NCT01033071|9005364|P1|Overall Study|Lost to Follow-up|4
2604968|NCT01033071|9005362|P3|Overall Study|Protocol Violation|1
2604969|NCT01033071|9005363|P2|Overall Study|Protocol Violation|2
2604970|NCT01033071|9005364|P1|Overall Study|Protocol Violation|0
2604971|NCT01033071|9005362|P3|Overall Study|Adverse Event|26
2604972|NCT01033071|9005363|P2|Overall Study|Adverse Event|51
2604973|NCT01033071|9005364|P1|Overall Study|Adverse Event|28
2604974|NCT01033019|9005435|P2|Overall Study|Withdrawal by Subject|0
2604975|NCT01033019|9005436|P1|Overall Study|Withdrawal by Subject|1
2604976|NCT01032915|9005474|P4|Overall Study|Protocol Violation|1
2604977|NCT01032915|9005475|P3|Overall Study|Protocol Violation|0
2604978|NCT01032915|9005476|P2|Overall Study|Protocol Violation|0
2604979|NCT01032915|9005477|P1|Overall Study|Protocol Violation|1
2604980|NCT01032915|9005474|P4|Overall Study|Administrative reasons|4
2604981|NCT01032915|9005475|P3|Overall Study|Administrative reasons|4
2604982|NCT01032915|9005476|P2|Overall Study|Administrative reasons|6
2604983|NCT01032915|9005477|P1|Overall Study|Administrative reasons|5
2604984|NCT01032915|9005474|P4|Overall Study|Withdrawal by Subject|1
2604985|NCT01032915|9005475|P3|Overall Study|Withdrawal by Subject|1
2604986|NCT01032915|9005476|P2|Overall Study|Withdrawal by Subject|3
2604987|NCT01032915|9005477|P1|Overall Study|Withdrawal by Subject|0
2604988|NCT01032915|9005474|P4|Overall Study|Abnormal test procedure result|0
2604989|NCT01032915|9005475|P3|Overall Study|Abnormal test procedure result|1
2604990|NCT01032915|9005476|P2|Overall Study|Abnormal test procedure result|0
2604991|NCT01032915|9005477|P1|Overall Study|Abnormal test procedure result|0
2604992|NCT01032915|9005474|P4|Overall Study|Adverse Event|1
2604993|NCT01032915|9005475|P3|Overall Study|Adverse Event|1
2604994|NCT01032915|9005476|P2|Overall Study|Adverse Event|2
2604995|NCT01032915|9005477|P1|Overall Study|Adverse Event|2
2604996|NCT01032889|9005502|P3|Overall Study|Miscellaneous Reasons|1
2604997|NCT01032889|9005503|P2|Overall Study|Miscellaneous Reasons|1
2604998|NCT01032889|9005504|P1|Overall Study|Miscellaneous Reasons|2
2604999|NCT01032889|9005502|P3|Overall Study|Lack of Submental Fat|1
2605000|NCT01032889|9005503|P2|Overall Study|Lack of Submental Fat|8
2605001|NCT01032889|9005504|P1|Overall Study|Lack of Submental Fat|2
2605002|NCT01032889|9005502|P3|Overall Study|Lost to Follow-up|0
2605003|NCT01032889|9005503|P2|Overall Study|Lost to Follow-up|1
2605004|NCT01032889|9005504|P1|Overall Study|Lost to Follow-up|1
2605005|NCT01032889|9005502|P3|Overall Study|Patient Request|0
2605006|NCT01032889|9005503|P2|Overall Study|Patient Request|1
2605007|NCT01032889|9005504|P1|Overall Study|Patient Request|0
2605008|NCT01032889|9005502|P3|Overall Study|Withdrawal of Consent|1
2605009|NCT01032889|9005503|P2|Overall Study|Withdrawal of Consent|2
2605010|NCT01032889|9005504|P1|Overall Study|Withdrawal of Consent|1
2605011|NCT01032889|9005502|P3|Overall Study|Adverse Event|0
2605012|NCT01032889|9005503|P2|Overall Study|Adverse Event|2
2605013|NCT01032889|9005504|P1|Overall Study|Adverse Event|2
2605014|NCT01032837|9005535|P4|Overall Study|Refused treatment|1
2605015|NCT01032837|9005536|P3|Overall Study|Refused treatment|0
2605016|NCT01032837|9005537|P2|Overall Study|Refused treatment|0
2605017|NCT01032837|9005538|P1|Overall Study|Refused treatment|0
2605018|NCT01032837|9005535|P4|Overall Study|Failed to return|0
2605019|NCT01032837|9005536|P3|Overall Study|Failed to return|1
2605020|NCT01032837|9005537|P2|Overall Study|Failed to return|0
2605021|NCT01032837|9005538|P1|Overall Study|Failed to return|0
2605022|NCT01032837|9005535|P4|Overall Study|Withdrew consent|1
2605023|NCT01032837|9005536|P3|Overall Study|Withdrew consent|0
2605024|NCT01032837|9005537|P2|Overall Study|Withdrew consent|2
2605025|NCT01032837|9005538|P1|Overall Study|Withdrew consent|0
2605026|NCT01032837|9005535|P4|Overall Study|Adverse event/internal illness|1
2605027|NCT01032837|9005536|P3|Overall Study|Adverse event/internal illness|0
2605028|NCT01032837|9005537|P2|Overall Study|Adverse event/internal illness|1
2605029|NCT01032837|9005538|P1|Overall Study|Adverse event/internal illness|0
2605030|NCT01032629|9005638|P3|Overall Study|Lost to Follow-up|37
2605031|NCT01032629|9005639|P2|Overall Study|Lost to Follow-up|47
2605032|NCT01032629|9005640|P1|Overall Study|Lost to Follow-up|74
2605033|NCT01032629|9005638|P3|Overall Study|Withdrawal by Subject|35
2605034|NCT01032629|9005639|P2|Overall Study|Withdrawal by Subject|36
2605035|NCT01032629|9005640|P1|Overall Study|Withdrawal by Subject|50
2605036|NCT01032629|9005638|P3|Overall Study|Closed Site|16
2605037|NCT01032629|9005639|P2|Overall Study|Closed Site|18
2605038|NCT01032629|9005640|P1|Overall Study|Closed Site|21
2605039|NCT01032382|9005752|P2|Overall Study|Index lesion relapse|3
2605040|NCT01032382|9005753|P1|Overall Study|Index lesion relapse|1
2605041|NCT01032382|9005752|P2|Overall Study|Treatment failure|1
2605042|NCT01032382|9005753|P1|Overall Study|Treatment failure|3
2605043|NCT01032382|9005752|P2|Overall Study|Disease dissemination|1
2605044|NCT01032382|9005753|P1|Overall Study|Disease dissemination|1
2605045|NCT01032291|9005841|P3|Proof of Concept|Never Received Study Drug|0
2605046|NCT01032291|9005842|P2|Proof of Concept|Never Received Study Drug|1
2605047|NCT01032291|9005843|P1|Proof of Concept|Never Received Study Drug|0
2605048|NCT01032291|9005841|P3|Proof of Concept|Lack of Efficacy|0
2605049|NCT01032291|9005842|P2|Proof of Concept|Lack of Efficacy|1
2605050|NCT01032291|9005843|P1|Proof of Concept|Lack of Efficacy|0
2605051|NCT01032291|9005841|P3|Proof of Concept|Death|2
2605052|NCT01032291|9005842|P2|Proof of Concept|Death|1
2605053|NCT01032291|9005843|P1|Proof of Concept|Death|0
2605054|NCT01032291|9005841|P3|Proof of Concept|Adverse Event|1
2605055|NCT01032291|9005842|P2|Proof of Concept|Adverse Event|5
2605056|NCT01032291|9005843|P1|Proof of Concept|Adverse Event|0
2605057|NCT01032291|9005841|P3|Safety Lead-in|Death|0
2605058|NCT01032291|9005842|P2|Safety Lead-in|Death|0
2605059|NCT01032291|9005843|P1|Safety Lead-in|Death|1
2605060|NCT01032291|9005841|P3|Safety Lead-in|Adverse Event|0
2605061|NCT01032291|9005842|P2|Safety Lead-in|Adverse Event|0
2605062|NCT01032291|9005843|P1|Safety Lead-in|Adverse Event|1
2605063|NCT01032239|9005890|P2|Overall Study|Protocol Violation|0
2605064|NCT01032239|9005891|P1|Overall Study|Protocol Violation|1
2605065|NCT01032239|9005890|P2|Overall Study|Death|0
2605066|NCT01032239|9005891|P1|Overall Study|Death|1
2605067|NCT01032239|9005890|P2|Overall Study|Withdrawal by Subject|3
2605068|NCT01032239|9005891|P1|Overall Study|Withdrawal by Subject|2
2605069|NCT01032239|9005890|P2|Overall Study|Lost to Follow-up|2
2605070|NCT01032239|9005891|P1|Overall Study|Lost to Follow-up|3
2605071|NCT01032200|9005921|P2|Overall Study|Multiple|1
2605072|NCT01032200|9005922|P1|Overall Study|Multiple|1
2605073|NCT01032200|9005921|P2|Overall Study|Progression|0
2605074|NCT01032200|9005922|P1|Overall Study|Progression|1
2605075|NCT01032200|9005921|P2|Overall Study|Toxicity|2
2605076|NCT01032200|9005922|P1|Overall Study|Toxicity|0
2605077|NCT01032200|9005921|P2|Overall Study|Withdrawal by Subject|3
2605078|NCT01032200|9005922|P1|Overall Study|Withdrawal by Subject|1
2605079|NCT01032200|9005921|P2|Overall Study|Death|1
2605080|NCT01032200|9005922|P1|Overall Study|Death|1
2605081|NCT01032174|9005938|P2|Overall Study|Adverse Event|1
2605082|NCT01032174|9005939|P1|Overall Study|Adverse Event|0
2605083|NCT01032070|9006179|P2|Overall Study|Withdrawal by Subject|2
2605084|NCT01032070|9006180|P1|Overall Study|Withdrawal by Subject|0
2605085|NCT01032070|9006179|P2|Overall Study|Medical or ethical reasons|2
2605086|NCT01032070|9006180|P1|Overall Study|Medical or ethical reasons|0
2605087|NCT01032070|9006179|P2|Overall Study|Disease progression|8
2605088|NCT01032070|9006180|P1|Overall Study|Disease progression|13
2605089|NCT01032044|9006209|P2|Overall Study|Lost to Follow-up|11
2605090|NCT01032044|9006210|P1|Overall Study|Lost to Follow-up|11
2605091|NCT01032044|9006209|P2|Overall Study|Adverse Event|1
2605092|NCT01032044|9006210|P1|Overall Study|Adverse Event|0
2605093|NCT01032044|9006209|P2|Overall Study|Protocol Violation|8
2605094|NCT01032044|9006210|P1|Overall Study|Protocol Violation|14
2605095|NCT01032018|9006218|P2|Overall Study|Death|1
2605096|NCT01032018|9006219|P1|Overall Study|Death|0
2605097|NCT01032018|9006218|P2|Overall Study|Lost to Follow-up|5
2605098|NCT01032018|9006219|P1|Overall Study|Lost to Follow-up|6
2605099|NCT01031979|9006229|P2|Overall Study|Lost to Follow-up|4
2605100|NCT01031979|9006230|P1|Overall Study|Lost to Follow-up|5
2605101|NCT01031836|9006263|P6|Stage II|Other|0
2605102|NCT01031836|9006264|P5|Stage II|Other|1
2605103|NCT01031836|9006265|P4|Stage II|Other|1
2605104|NCT01031836|9006266|P3|Stage II|Other|0
2605105|NCT01031836|9006267|P2|Stage II|Other|0
2605106|NCT01031836|9006268|P1|Stage II|Other|2
2605107|NCT01031836|9006263|P6|Stage II|Adverse Event|1
2605108|NCT01031836|9006264|P5|Stage II|Adverse Event|1
2605109|NCT01031836|9006265|P4|Stage II|Adverse Event|2
2605110|NCT01031836|9006266|P3|Stage II|Adverse Event|2
2605111|NCT01031836|9006267|P2|Stage II|Adverse Event|0
2605112|NCT01031836|9006268|P1|Stage II|Adverse Event|0
2605113|NCT01031836|9006263|P6|Stage I|Other|1
2605114|NCT01031836|9006264|P5|Stage I|Other|0
2605115|NCT01031836|9006265|P4|Stage I|Other|0
2605116|NCT01031836|9006266|P3|Stage I|Other|0
2605117|NCT01031836|9006267|P2|Stage I|Other|1
2605118|NCT01031836|9006268|P1|Stage I|Other|0
2605119|NCT01031836|9006263|P6|Stage I|Adverse Event|0
2605120|NCT01031836|9006264|P5|Stage I|Adverse Event|0
2605121|NCT01031836|9006265|P4|Stage I|Adverse Event|0
2605122|NCT01031836|9006266|P3|Stage I|Adverse Event|0
2605123|NCT01031836|9006267|P2|Stage I|Adverse Event|1
2605124|NCT01031836|9006268|P1|Stage I|Adverse Event|1
2605125|NCT01031706|9006329|P2|Overall Study|Withdrawal by Subject|1
2605126|NCT01031706|9006330|P1|Overall Study|Withdrawal by Subject|1
2605127|NCT01031706|9006329|P2|Overall Study|Adverse Event|0
2605128|NCT01031706|9006330|P1|Overall Study|Adverse Event|1
2605129|NCT01031680|9006340|P2|Overall Study|Various|2
2605130|NCT01031680|9006341|P1|Overall Study|Various|0
2605131|NCT01031680|9006340|P2|Overall Study|Administrative Reason by Sponsor|1
2605132|NCT01031680|9006341|P1|Overall Study|Administrative Reason by Sponsor|0
2605133|NCT01031680|9006340|P2|Overall Study|Incorrect Enrolment|2
2605134|NCT01031680|9006341|P1|Overall Study|Incorrect Enrolment|1
2605135|NCT01031680|9006340|P2|Overall Study|Safety|0
2605136|NCT01031680|9006341|P1|Overall Study|Safety|1
2605137|NCT01031680|9006340|P2|Overall Study|Poor/Non-compliance|6
2605138|NCT01031680|9006341|P1|Overall Study|Poor/Non-compliance|5
2605139|NCT01031680|9006340|P2|Overall Study|Subject No Longer Meets Study Criteria|17
2605140|NCT01031680|9006341|P1|Overall Study|Subject No Longer Meets Study Criteria|26
2605141|NCT01031680|9006340|P2|Overall Study|Death|1
2605142|NCT01031680|9006341|P1|Overall Study|Death|2
2605143|NCT01031680|9006340|P2|Overall Study|Withdrawal by Subject|16
2605144|NCT01031680|9006341|P1|Overall Study|Withdrawal by Subject|12
2605145|NCT01031680|9006340|P2|Overall Study|Lost to Follow-up|10
2605146|NCT01031680|9006341|P1|Overall Study|Lost to Follow-up|2
2605147|NCT01031680|9006340|P2|Overall Study|Adverse Event|3
2605148|NCT01031680|9006341|P1|Overall Study|Adverse Event|8
2605149|NCT01031628|9006361|P4|Overall Study|Study terminated early|0
2605150|NCT01031628|9006362|P3|Overall Study|Study terminated early|3
2605151|NCT01031628|9006363|P2|Overall Study|Study terminated early|1
2605152|NCT01031628|9006364|P1|Overall Study|Study terminated early|0
2605153|NCT01031537|9006389|P1|Overall Study|PI removal, no longer met eligibility|12
2605154|NCT01031537|9006389|P1|Overall Study|Withdrawal by Subject|5
2605155|NCT01031537|9006389|P1|Overall Study|moved, met exclusion criteria|10
2605156|NCT01031537|9006389|P1|Overall Study|retired from NIH, met exclusion criteria|1
2605157|NCT01031537|9006389|P1|Overall Study|Lack of Efficacy|1
2605158|NCT01031537|9006389|P1|Overall Study|medical reasons not related to study|3
2605159|NCT01031446|9006407|P1|Overall Study|Still on treatment|1
2605160|NCT01031446|9006407|P1|Overall Study|Withdrawal by Subject|3
2605161|NCT01031446|9006407|P1|Overall Study|Physician Decision|4
2605162|NCT01031446|9006407|P1|Overall Study|Adverse Event|9
2605163|NCT01031446|9006407|P1|Overall Study|Disease Progression|38
2605164|NCT01031381|9006421|P1|Overall Study|Withdrawal by Subject|6
2605165|NCT01031381|9006421|P1|Overall Study|Physician Decision|3
2605166|NCT01031069|9006450|P4|Overall Study|Other|0
2605167|NCT01031069|9006451|P3|Overall Study|Other|1
2605168|NCT01031069|9006452|P2|Overall Study|Other|0
2605169|NCT01031069|9006453|P1|Overall Study|Other|0
2605170|NCT01031069|9006450|P4|Overall Study|Lost to Follow-up|15
2605171|NCT01031069|9006451|P3|Overall Study|Lost to Follow-up|21
2605172|NCT01031069|9006452|P2|Overall Study|Lost to Follow-up|5
2605173|NCT01031069|9006453|P1|Overall Study|Lost to Follow-up|9
2605174|NCT01031069|9006450|P4|Overall Study|Migrated/moved from study area|1
2605175|NCT01031069|9006451|P3|Overall Study|Migrated/moved from study area|1
2605176|NCT01031069|9006452|P2|Overall Study|Migrated/moved from study area|2
2605177|NCT01031069|9006453|P1|Overall Study|Migrated/moved from study area|1
2605178|NCT01031069|9006450|P4|Overall Study|Withdrawal by Subject|18
2605179|NCT01031069|9006451|P3|Overall Study|Withdrawal by Subject|18
2605180|NCT01031069|9006452|P2|Overall Study|Withdrawal by Subject|3
2605181|NCT01031069|9006453|P1|Overall Study|Withdrawal by Subject|2
2605182|NCT01031069|9006450|P4|Overall Study|Serious Adverse Event|0
2605183|NCT01031069|9006451|P3|Overall Study|Serious Adverse Event|0
2605184|NCT01031069|9006452|P2|Overall Study|Serious Adverse Event|1
2605185|NCT01031069|9006453|P1|Overall Study|Serious Adverse Event|0
2605186|NCT01031004|9006555|P2|Overall Study|Lost to Follow-up|0
2605187|NCT01031004|9006556|P1|Overall Study|Lost to Follow-up|1
2605188|NCT01031004|9006555|P2|Overall Study|Protocol Violation|1
2605189|NCT01031004|9006556|P1|Overall Study|Protocol Violation|0
2605190|NCT01030965|9006600|P4|Overall Study|Withdrawal by Subject|2
2605191|NCT01030965|9006601|P3|Overall Study|Withdrawal by Subject|0
2605192|NCT01030965|9006602|P2|Overall Study|Withdrawal by Subject|1
2605193|NCT01030965|9006603|P1|Overall Study|Withdrawal by Subject|0
2605194|NCT01030965|9006600|P4|Overall Study|Protocol-defined Stopping Criteria|0
2605195|NCT01030965|9006601|P3|Overall Study|Protocol-defined Stopping Criteria|1
2605196|NCT01030965|9006602|P2|Overall Study|Protocol-defined Stopping Criteria|1
2605197|NCT01030965|9006603|P1|Overall Study|Protocol-defined Stopping Criteria|0
2605198|NCT01030965|9006600|P4|Overall Study|Adverse Event|1
2605199|NCT01030965|9006601|P3|Overall Study|Adverse Event|2
2605200|NCT01030965|9006602|P2|Overall Study|Adverse Event|1
2605201|NCT01030965|9006603|P1|Overall Study|Adverse Event|0
2605202|NCT01030965|9006600|P4|Overall Study|Protocol Violation|1
2605203|NCT01030965|9006601|P3|Overall Study|Protocol Violation|1
2605204|NCT01030965|9006602|P2|Overall Study|Protocol Violation|1
2605205|NCT01030965|9006603|P1|Overall Study|Protocol Violation|1
2605206|NCT01030965|9006600|P4|Overall Study|Lack of Efficacy|3
2605207|NCT01030965|9006601|P3|Overall Study|Lack of Efficacy|0
2605208|NCT01030965|9006602|P2|Overall Study|Lack of Efficacy|2
2605209|NCT01030965|9006603|P1|Overall Study|Lack of Efficacy|3
2605210|NCT01030952|9006623|P2|Overall Study|Unexplained|1
2605211|NCT01030952|9006624|P1|Overall Study|Unexplained|1
2605212|NCT01030952|9006623|P2|Overall Study|Lost to Follow-up|1
2605213|NCT01030952|9006624|P1|Overall Study|Lost to Follow-up|0
2605214|NCT01030952|9006623|P2|Overall Study|Informed consent withdrawal|0
2605215|NCT01030952|9006624|P1|Overall Study|Informed consent withdrawal|1
2605216|NCT01030952|9006623|P2|Overall Study|Protocol Violation|1
2605217|NCT01030952|9006624|P1|Overall Study|Protocol Violation|0
2605218|NCT01030822|9006661|P3|Overall Study|Lost to Follow-up|7
2605219|NCT01030822|9006662|P2|Overall Study|Lost to Follow-up|4
2605220|NCT01030822|9006663|P1|Overall Study|Lost to Follow-up|9
2605221|NCT01030822|9006661|P3|Overall Study|Withdrawal by Subject|16
2605222|NCT01030822|9006662|P2|Overall Study|Withdrawal by Subject|13
2605223|NCT01030822|9006663|P1|Overall Study|Withdrawal by Subject|16
2605224|NCT01030822|9006661|P3|Overall Study|Moved/migrated from study area|3
2605225|NCT01030822|9006662|P2|Overall Study|Moved/migrated from study area|7
2605226|NCT01030822|9006663|P1|Overall Study|Moved/migrated from study area|6
2605227|NCT01030718|9006738|P3|Study CA180-036 Only|Other Reasons|0
2605228|NCT01030718|9006739|P2|Study CA180-036 Only|Other Reasons|2
2605229|NCT01030718|9006740|P1|Study CA180-036 Only|Other Reasons|0
2605230|NCT01030718|9006738|P3|Study CA180-036 Only|Death|0
2605231|NCT01030718|9006739|P2|Study CA180-036 Only|Death|1
2605232|NCT01030718|9006740|P1|Study CA180-036 Only|Death|0
2605233|NCT01030718|9006738|P3|Study CA180-036 Only|Adverse Event|0
2605234|NCT01030718|9006739|P2|Study CA180-036 Only|Adverse Event|3
2605235|NCT01030718|9006740|P1|Study CA180-036 Only|Adverse Event|2
2605236|NCT01030718|9006738|P3|Study CA180-036 Only|insufficient effect|5
2605237|NCT01030718|9006739|P2|Study CA180-036 Only|insufficient effect|1
2605238|NCT01030718|9006740|P1|Study CA180-036 Only|insufficient effect|1
2605239|NCT01030718|9006738|P3|Studies CA180-031 and -036 Combined|other reasons|0
2605240|NCT01030718|9006739|P2|Studies CA180-031 and -036 Combined|other reasons|2
2605241|NCT01030718|9006740|P1|Studies CA180-031 and -036 Combined|other reasons|0
2605242|NCT01030718|9006738|P3|Studies CA180-031 and -036 Combined|Death|0
2605243|NCT01030718|9006739|P2|Studies CA180-031 and -036 Combined|Death|1
2605244|NCT01030718|9006740|P1|Studies CA180-031 and -036 Combined|Death|0
2605245|NCT01030718|9006738|P3|Studies CA180-031 and -036 Combined|Adverse Event|1
2605246|NCT01030718|9006739|P2|Studies CA180-031 and -036 Combined|Adverse Event|5
2605247|NCT01030718|9006740|P1|Studies CA180-031 and -036 Combined|Adverse Event|3
2605248|NCT01030718|9006738|P3|Studies CA180-031 and -036 Combined|Insufficient effect|11
2605249|NCT01030718|9006739|P2|Studies CA180-031 and -036 Combined|Insufficient effect|1
2605250|NCT01030718|9006740|P1|Studies CA180-031 and -036 Combined|Insufficient effect|1
2605251|NCT01030666|9006801|P2|Overall Study|Lost to Follow-up|2
2605252|NCT01030666|9006802|P1|Overall Study|Lost to Follow-up|3
2605253|NCT01030536|9006827|P5|Overall Study|Death|0
2605254|NCT01030536|9006828|P4|Overall Study|Death|0
2605255|NCT01030536|9006829|P3|Overall Study|Death|0
2605256|NCT01030536|9006830|P2|Overall Study|Death|1
2605257|NCT01030536|9006831|P1|Overall Study|Death|0
2605258|NCT01030536|9006827|P5|Overall Study|Progressive disease|0
2605259|NCT01030536|9006828|P4|Overall Study|Progressive disease|2
2605260|NCT01030536|9006829|P3|Overall Study|Progressive disease|3
2605261|NCT01030536|9006830|P2|Overall Study|Progressive disease|2
2605262|NCT01030536|9006831|P1|Overall Study|Progressive disease|6
2605263|NCT01030536|9006827|P5|Overall Study|Adverse Event|1
2605264|NCT01030536|9006828|P4|Overall Study|Adverse Event|0
2605265|NCT01030536|9006829|P3|Overall Study|Adverse Event|1
2605266|NCT01030536|9006830|P2|Overall Study|Adverse Event|3
2605267|NCT01030536|9006831|P1|Overall Study|Adverse Event|0
2605268|NCT01030536|9006827|P5|Overall Study|undefined|0
2605269|NCT01030536|9006828|P4|Overall Study|undefined|1
2605270|NCT01030536|9006829|P3|Overall Study|undefined|1
2605271|NCT01030536|9006830|P2|Overall Study|undefined|0
2605272|NCT01030536|9006831|P1|Overall Study|undefined|1
2605273|NCT01030536|9006827|P5|Overall Study|Withdrawal by Subject|0
2605274|NCT01030536|9006828|P4|Overall Study|Withdrawal by Subject|0
2605275|NCT01030536|9006829|P3|Overall Study|Withdrawal by Subject|1
2605276|NCT01030536|9006830|P2|Overall Study|Withdrawal by Subject|0
2605277|NCT01030536|9006831|P1|Overall Study|Withdrawal by Subject|0
2605278|NCT01030458|9006936|P2|Overall Study|Side effect of medication|1
2605279|NCT01030458|9006937|P1|Overall Study|Side effect of medication|1
2605280|NCT01030458|9006936|P2|Overall Study|Moved or changed job|13
2605281|NCT01030458|9006937|P1|Overall Study|Moved or changed job|6
2605282|NCT01030458|9006936|P2|Overall Study|Logistical reasons|5
2605283|NCT01030458|9006937|P1|Overall Study|Logistical reasons|9
2605284|NCT01030458|9006936|P2|Overall Study|Withdrawal by Subject|3
2605285|NCT01030458|9006937|P1|Overall Study|Withdrawal by Subject|2
2605286|NCT01030458|9006936|P2|Overall Study|Lost to Follow-up|10
2605287|NCT01030458|9006937|P1|Overall Study|Lost to Follow-up|9
2605288|NCT01030341|9006970|P1|Overall Study|Lost to Follow-up|2
2605289|NCT01030341|9006970|P1|Overall Study|Withdrawal by Subject|1
2605290|NCT01030133|9006993|P2|Overall Study|failed to experience pain at level 7/10|2
2605291|NCT01030133|9006994|P1|Overall Study|failed to experience pain at level 7/10|2
2605292|NCT01029925|9007006|P1|Completion of Cycle 2 (56 Days)|off study due to disease progression|1
2605293|NCT01029925|9007006|P1|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2
2605294|NCT01029925|9007006|P1|Completion of Cycle 1 (28 Days)|Death|2
2605295|NCT01029886|9007025|P2|Overall Study|Loss Glucose Control|1
2605296|NCT01029886|9007026|P1|Overall Study|Loss Glucose Control|7
2605297|NCT01029886|9007025|P2|Overall Study|Sponsor Decision|0
2605298|NCT01029886|9007026|P1|Overall Study|Sponsor Decision|1
2605299|NCT01029886|9007025|P2|Overall Study|Entry Criteria Not Met|5
2605300|NCT01029886|9007026|P1|Overall Study|Entry Criteria Not Met|13
2605301|NCT01029886|9007025|P2|Overall Study|Withdrawal by Subject|18
2605302|NCT01029886|9007026|P1|Overall Study|Withdrawal by Subject|8
2605303|NCT01029886|9007025|P2|Overall Study|Protocol Violation|5
2605304|NCT01029886|9007026|P1|Overall Study|Protocol Violation|17
2605305|NCT01029886|9007025|P2|Overall Study|Physician Decision|6
2605306|NCT01029886|9007026|P1|Overall Study|Physician Decision|2
2605307|NCT01029886|9007025|P2|Overall Study|Lost to Follow-up|0
2605308|NCT01029886|9007026|P1|Overall Study|Lost to Follow-up|1
2605309|NCT01029886|9007025|P2|Overall Study|Adverse Event|25
2605310|NCT01029886|9007026|P1|Overall Study|Adverse Event|12
2605311|NCT01029795|9007054|P2|Overall Study|Withdrawal by Subject|3
2605312|NCT01029795|9007055|P1|Overall Study|Withdrawal by Subject|1
2605313|NCT01029795|9007054|P2|Overall Study|Sponsor Decision|17
2605314|NCT01029795|9007055|P1|Overall Study|Sponsor Decision|11
2605315|NCT01029795|9007054|P2|Overall Study|Physician Decision|1
2605316|NCT01029795|9007055|P1|Overall Study|Physician Decision|2
2605317|NCT01029795|9007054|P2|Overall Study|Entry Criteria Not Met|1
2605318|NCT01029795|9007055|P1|Overall Study|Entry Criteria Not Met|2
2605319|NCT01029782|9007109|P2|Overall Study|Withdrawal by Subject|1
2605320|NCT01029782|9007110|P1|Overall Study|Withdrawal by Subject|0
2605321|NCT01029782|9007109|P2|Overall Study|Protocol Violation|2
2605322|NCT01029782|9007110|P1|Overall Study|Protocol Violation|0
2605323|NCT01029782|9007109|P2|Overall Study|Physician Decision|1
2605324|NCT01029782|9007110|P1|Overall Study|Physician Decision|0
2605325|NCT01029782|9007109|P2|Overall Study|Adverse Event|1
2605326|NCT01029782|9007110|P1|Overall Study|Adverse Event|0
2605327|NCT01029782|9007109|P2|Overall Study|Diagnosis changed|1
2605328|NCT01029782|9007110|P1|Overall Study|Diagnosis changed|1
2605329|NCT01029782|9007109|P2|Overall Study|Lost to Follow-up|2
2605330|NCT01029782|9007110|P1|Overall Study|Lost to Follow-up|2
2605331|NCT01029691|9007162|P3|Continued APAP to Delivery|Death|1
2605332|NCT01029691|9007163|P2|Continued APAP to Delivery|Death|0
2605333|NCT01029691|9007164|P1|Continued APAP to Delivery|Death|0
2605334|NCT01029652|9007189|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1
2605335|NCT01029652|9007190|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0
2605336|NCT01029652|9007189|P2|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1
2605337|NCT01029652|9007190|P1|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0
2605338|NCT01029652|9007189|P2|Extension Study 2 (25-72 Weeks)|Death|1
2605339|NCT01029652|9007190|P1|Extension Study 2 (25-72 Weeks)|Death|1
2605340|NCT01029652|9007189|P2|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1
2605341|NCT01029652|9007190|P1|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0
2605342|NCT01029652|9007189|P2|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0
2605343|NCT01029652|9007190|P1|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1
2605344|NCT01029652|9007189|P2|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3
2605345|NCT01029652|9007190|P1|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2
2605346|NCT01029652|9007189|P2|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1
2605347|NCT01029652|9007190|P1|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0
2605348|NCT01029652|9007189|P2|Core Study (0-12 Weeks)|Death|1
2605349|NCT01029652|9007190|P1|Core Study (0-12 Weeks)|Death|0
2605350|NCT01029652|9007189|P2|Core Study (0-12 Weeks)|Administrative problems|1
2605351|NCT01029652|9007190|P1|Core Study (0-12 Weeks)|Administrative problems|2
2605352|NCT01029652|9007189|P2|Core Study (0-12 Weeks)|Lost to Follow-up|1
2605353|NCT01029652|9007190|P1|Core Study (0-12 Weeks)|Lost to Follow-up|3
2605354|NCT01029652|9007189|P2|Core Study (0-12 Weeks)|Patient Withdrew Consent|3
2605355|NCT01029652|9007190|P1|Core Study (0-12 Weeks)|Patient Withdrew Consent|1
2605356|NCT01029652|9007189|P2|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4
2605357|NCT01029652|9007190|P1|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0
2605358|NCT01029535|9007268|P1|Overall Study|Death|1
2605359|NCT01029535|9007268|P1|Overall Study|Use of Another Treatment|1
2605360|NCT01029535|9007268|P1|Overall Study|Adverse Event|1
2605361|NCT01029535|9007268|P1|Overall Study|Participant Withdrew Consent|2
2605362|NCT01029535|9007268|P1|Overall Study|Protocol Violation|2
2605363|NCT01029535|9007268|P1|Overall Study|Lost to Follow-up|24
2605364|NCT01029405|9007297|P4|Overall Study|Other|1
2605365|NCT01029405|9007298|P3|Overall Study|Other|0
2605366|NCT01029405|9007299|P2|Overall Study|Other|1
2605367|NCT01029405|9007300|P1|Overall Study|Other|0
2605368|NCT01029405|9007297|P4|Overall Study|Lost to Follow-up|2
2605369|NCT01029405|9007298|P3|Overall Study|Lost to Follow-up|1
2605370|NCT01029405|9007299|P2|Overall Study|Lost to Follow-up|1
2605371|NCT01029405|9007300|P1|Overall Study|Lost to Follow-up|2
2605372|NCT01029405|9007297|P4|Overall Study|Adverse Event|1
2605373|NCT01029405|9007298|P3|Overall Study|Adverse Event|1
2605374|NCT01029405|9007299|P2|Overall Study|Adverse Event|0
2605375|NCT01029405|9007300|P1|Overall Study|Adverse Event|0
2605376|NCT01029405|9007297|P4|Overall Study|Protocol Violation|1
2605377|NCT01029405|9007298|P3|Overall Study|Protocol Violation|0
2605378|NCT01029405|9007299|P2|Overall Study|Protocol Violation|0
2605379|NCT01029405|9007300|P1|Overall Study|Protocol Violation|0
2605380|NCT01029405|9007297|P4|Overall Study|Withdrawal by Subject|0
2605381|NCT01029405|9007298|P3|Overall Study|Withdrawal by Subject|2
2605382|NCT01029405|9007299|P2|Overall Study|Withdrawal by Subject|1
2605383|NCT01029405|9007300|P1|Overall Study|Withdrawal by Subject|0
2605384|NCT01029392|9007312|P2|Overall Study|Physician Decision|0
2605385|NCT01029392|9007313|P1|Overall Study|Physician Decision|2
2605386|NCT01029392|9007312|P2|Overall Study|Withdrawal by Subject|11
2605387|NCT01029392|9007313|P1|Overall Study|Withdrawal by Subject|18
2605388|NCT01029366|9007323|P2|Overall Study|manufacturing failure|1
2605389|NCT01029366|9007324|P1|Overall Study|manufacturing failure|0
2605390|NCT01029366|9007323|P2|Overall Study|disease progression|0
2605391|NCT01029366|9007324|P1|Overall Study|disease progression|2
2605392|NCT01029366|9007323|P2|Overall Study|Death|1
2605393|NCT01029366|9007324|P1|Overall Study|Death|1
2605394|NCT01029366|9007323|P2|Overall Study|Withdrawal by Subject|0
2605395|NCT01029366|9007324|P1|Overall Study|Withdrawal by Subject|1
2605396|NCT01029340|9007336|P6|Extension Period|Physician Decision|1
2605397|NCT01029340|9007337|P5|Extension Period|Physician Decision|0
2605398|NCT01029340|9007338|P4|Extension Period|Physician Decision|0
2605399|NCT01029340|9007339|P3|Extension Period|Physician Decision|0
2605400|NCT01029340|9007340|P2|Extension Period|Physician Decision|0
2605401|NCT01029340|9007341|P1|Extension Period|Physician Decision|0
2605402|NCT01029340|9007336|P6|Extension Period|Withdrawal by Subject|1
2605403|NCT01029340|9007337|P5|Extension Period|Withdrawal by Subject|0
2605404|NCT01029340|9007338|P4|Extension Period|Withdrawal by Subject|0
2605405|NCT01029340|9007339|P3|Extension Period|Withdrawal by Subject|0
2605406|NCT01029340|9007340|P2|Extension Period|Withdrawal by Subject|0
2605407|NCT01029340|9007341|P1|Extension Period|Withdrawal by Subject|0
2605408|NCT01029340|9007336|P6|Extension Period|non-compliance|1
2605409|NCT01029340|9007337|P5|Extension Period|non-compliance|0
2605410|NCT01029340|9007338|P4|Extension Period|non-compliance|0
2605411|NCT01029340|9007339|P3|Extension Period|non-compliance|0
2605412|NCT01029340|9007340|P2|Extension Period|non-compliance|0
2605413|NCT01029340|9007341|P1|Extension Period|non-compliance|0
2605414|NCT01029340|9007336|P6|Extension Period|starting another study|8
2605415|NCT01029340|9007337|P5|Extension Period|starting another study|0
2605416|NCT01029340|9007338|P4|Extension Period|starting another study|0
2605417|NCT01029340|9007339|P3|Extension Period|starting another study|0
2605418|NCT01029340|9007340|P2|Extension Period|starting another study|0
2605419|NCT01029340|9007341|P1|Extension Period|starting another study|0
2605420|NCT01029340|9007336|P6|Extension Period|Adverse Event|1
2605421|NCT01029340|9007337|P5|Extension Period|Adverse Event|0
2605422|NCT01029340|9007338|P4|Extension Period|Adverse Event|0
2605423|NCT01029340|9007339|P3|Extension Period|Adverse Event|0
2605424|NCT01029340|9007340|P2|Extension Period|Adverse Event|0
2605425|NCT01029340|9007341|P1|Extension Period|Adverse Event|0
2605426|NCT01029340|9007336|P6|Part B Treatment Period|Protocol Violation|0
2605427|NCT01029340|9007337|P5|Part B Treatment Period|Protocol Violation|0
2605428|NCT01029340|9007338|P4|Part B Treatment Period|Protocol Violation|0
2605429|NCT01029340|9007339|P3|Part B Treatment Period|Protocol Violation|1
2605430|NCT01029340|9007340|P2|Part B Treatment Period|Protocol Violation|0
2605431|NCT01029340|9007341|P1|Part B Treatment Period|Protocol Violation|0
2605432|NCT01029340|9007336|P6|Part B Treatment Period|Withdrawal by Subject|0
2605433|NCT01029340|9007337|P5|Part B Treatment Period|Withdrawal by Subject|0
2605434|NCT01029340|9007338|P4|Part B Treatment Period|Withdrawal by Subject|0
2605435|NCT01029340|9007339|P3|Part B Treatment Period|Withdrawal by Subject|1
2605436|NCT01029340|9007340|P2|Part B Treatment Period|Withdrawal by Subject|0
2605437|NCT01029340|9007341|P1|Part B Treatment Period|Withdrawal by Subject|0
2605438|NCT01029262|9007372|P2|Overall Study|Death|3
2605439|NCT01029262|9007373|P1|Overall Study|Death|0
2605440|NCT01029262|9007372|P2|Overall Study|Miscellaneous|9
2605441|NCT01029262|9007373|P1|Overall Study|Miscellaneous|1
2605442|NCT01029262|9007372|P2|Overall Study|Protocol Violation|3
2605443|NCT01029262|9007373|P1|Overall Study|Protocol Violation|2
2605444|NCT01029262|9007372|P2|Overall Study|Withdrawal by Subject|17
2605445|NCT01029262|9007373|P1|Overall Study|Withdrawal by Subject|10
2605446|NCT01029262|9007372|P2|Overall Study|Lack of therapeutic effect|76
2605447|NCT01029262|9007373|P1|Overall Study|Lack of therapeutic effect|57
2605448|NCT01029262|9007372|P2|Overall Study|Adverse Event|52
2605449|NCT01029262|9007373|P1|Overall Study|Adverse Event|9
2605450|NCT01028651|9007542|P1|Overall Study|Adverse Event|1
2605451|NCT01028651|9007542|P1|Overall Study|Death|2
2605452|NCT01028560|9007565|P2|Overall Study|Withdrawal by Subject|12
2605453|NCT01028560|9007566|P1|Overall Study|Withdrawal by Subject|7
2605454|NCT01028560|9007565|P2|Overall Study|Lack of Efficacy|6
2605455|NCT01028560|9007566|P1|Overall Study|Lack of Efficacy|3
2605456|NCT01028391|9007580|P2|Overall Study|Needed excluded medication|1
2605457|NCT01028391|9007581|P1|Overall Study|Needed excluded medication|1
2605458|NCT01028391|9007580|P2|Overall Study|Withdrawal by Subject|3
2605459|NCT01028391|9007581|P1|Overall Study|Withdrawal by Subject|6
2605460|NCT01028391|9007580|P2|Overall Study|Physician Decision|1
2605461|NCT01028391|9007581|P1|Overall Study|Physician Decision|0
2605462|NCT01028391|9007580|P2|Overall Study|Lost to Follow-up|4
2605463|NCT01028391|9007581|P1|Overall Study|Lost to Follow-up|3
2605464|NCT01028391|9007580|P2|Overall Study|Lack of Efficacy|2
2605465|NCT01028391|9007581|P1|Overall Study|Lack of Efficacy|0
2605466|NCT01028391|9007580|P2|Overall Study|Adverse Event|0
2605467|NCT01028391|9007581|P1|Overall Study|Adverse Event|4
2605468|NCT01028378|9007589|P1|Overall Study|Adminstrative Reasons|4
2605469|NCT01028378|9007589|P1|Overall Study|Withdrawal by Subject|1
2605470|NCT01028378|9007589|P1|Overall Study|Lost to Follow-up|12
2605471|NCT01028352|9007601|P1|Overall Study|Withdrawal by Subject|1
2605472|NCT01028352|9007601|P1|Overall Study|Ineligible due to baseline average pain|5
2605473|NCT01028300|9007606|P1|Overall Study|Study Terminated|4
2605474|NCT01028222|9007615|P2|Overall Study|Adverse Event|0
2605475|NCT01028222|9007616|P1|Overall Study|Adverse Event|2
2605476|NCT01028222|9007615|P2|Overall Study|Crossover to nilotinib w/out progression|2
2605477|NCT01028222|9007616|P1|Overall Study|Crossover to nilotinib w/out progression|0
2605478|NCT01028222|9007615|P2|Overall Study|Withdrawal by Subject|0
2605479|NCT01028222|9007616|P1|Overall Study|Withdrawal by Subject|1
2605480|NCT01028222|9007615|P2|Overall Study|Lost to Follow-up|1
2605481|NCT01028222|9007616|P1|Overall Study|Lost to Follow-up|0
2605482|NCT01028222|9007615|P2|Overall Study|Administrative problems|1
2605483|NCT01028222|9007616|P1|Overall Study|Administrative problems|1
2605484|NCT01028222|9007615|P2|Overall Study|Disease progression|9
2605485|NCT01028222|9007616|P1|Overall Study|Disease progression|33
2605486|NCT01028222|9007615|P2|Overall Study|Protocol deviation|0
2605487|NCT01028222|9007616|P1|Overall Study|Protocol deviation|1
2605488|NCT01028053|9007658|P1|Overall Study|Various reasons|4
2605489|NCT01028053|9007658|P1|Overall Study|Terminated by Sponsor|1
2605490|NCT01028053|9007658|P1|Overall Study|Technical Problem|1
2605491|NCT01028053|9007658|P1|Overall Study|Physician Decision|2
2605492|NCT01028053|9007658|P1|Overall Study|Protocol Violation|1
2605493|NCT01028053|9007658|P1|Overall Study|Patient Request|11
2605494|NCT01028053|9007658|P1|Overall Study|Screen Failure|113
2605495|NCT01028027|9007666|P2|Overall Study|Lack of Efficacy|1
2605496|NCT01028027|9007667|P1|Overall Study|Lack of Efficacy|0
2605497|NCT01028027|9007666|P2|Overall Study|Protocol Violation|1
2605498|NCT01028027|9007667|P1|Overall Study|Protocol Violation|3
2605499|NCT01028027|9007666|P2|Overall Study|Adverse Event|7
2605500|NCT01028027|9007667|P1|Overall Study|Adverse Event|4
2605501|NCT01028027|9007666|P2|Overall Study|Withdrawal by Subject|3
2605502|NCT01028027|9007667|P1|Overall Study|Withdrawal by Subject|5
2605503|NCT01028027|9007666|P2|Overall Study|Lost to Follow-up|1
2605504|NCT01028027|9007667|P1|Overall Study|Lost to Follow-up|4
2605505|NCT01028014|9007689|P6|Overall Study|Lost to Follow-up|2
2605506|NCT01028014|9007690|P5|Overall Study|Lost to Follow-up|1
2605507|NCT01028014|9007691|P4|Overall Study|Lost to Follow-up|1
2605508|NCT01028014|9007692|P3|Overall Study|Lost to Follow-up|0
2605509|NCT01028014|9007693|P2|Overall Study|Lost to Follow-up|2
2605510|NCT01028014|9007694|P1|Overall Study|Lost to Follow-up|1
2605511|NCT01027897|9007735|P1|Overall Study|Withdrawal by Subject|1
2605512|NCT01027897|9007735|P1|Overall Study|Protocol Violation|1
2605513|NCT01027884|9007743|P2|Overall Study|Spinal fixation surgery|3
2605514|NCT01027884|9007744|P1|Overall Study|Spinal fixation surgery|0
2605515|NCT01027884|9007743|P2|Overall Study|Lost to Follow-up|1
2605516|NCT01027884|9007744|P1|Overall Study|Lost to Follow-up|0
2605517|NCT01027884|9007743|P2|Overall Study|Withdrawal by Subject|1
2605518|NCT01027884|9007744|P1|Overall Study|Withdrawal by Subject|0
2605519|NCT01027884|9007743|P2|Overall Study|Non-compliance|1
2605520|NCT01027884|9007744|P1|Overall Study|Non-compliance|1
2605521|NCT01027884|9007743|P2|Overall Study|Protocol Violation|0
2605522|NCT01027884|9007744|P1|Overall Study|Protocol Violation|1
2605523|NCT01027884|9007743|P2|Overall Study|Adverse Event|1
2605524|NCT01027884|9007744|P1|Overall Study|Adverse Event|2
2605525|NCT01027871|9007761|P3|Overall Study|Discontinued Prior to Treatment|1
2605526|NCT01027871|9007762|P2|Overall Study|Discontinued Prior to Treatment|0
2605527|NCT01027871|9007763|P1|Overall Study|Discontinued Prior to Treatment|0
2605528|NCT01027871|9007761|P3|Overall Study|Sponsor Decision|0
2605529|NCT01027871|9007762|P2|Overall Study|Sponsor Decision|2
2605530|NCT01027871|9007763|P1|Overall Study|Sponsor Decision|0
2605531|NCT01027871|9007761|P3|Overall Study|Adverse Event|2
2605532|NCT01027871|9007762|P2|Overall Study|Adverse Event|2
2605533|NCT01027871|9007763|P1|Overall Study|Adverse Event|0
2605534|NCT01027871|9007761|P3|Overall Study|Withdrawal by Subject|2
2605535|NCT01027871|9007762|P2|Overall Study|Withdrawal by Subject|2
2605536|NCT01027871|9007763|P1|Overall Study|Withdrawal by Subject|1
2605537|NCT01027871|9007761|P3|Overall Study|Protocol Violation|2
2605538|NCT01027871|9007762|P2|Overall Study|Protocol Violation|2
2605539|NCT01027871|9007763|P1|Overall Study|Protocol Violation|0
2605540|NCT01027871|9007761|P3|Overall Study|Physician Decision|0
2605541|NCT01027871|9007762|P2|Overall Study|Physician Decision|5
2605542|NCT01027871|9007763|P1|Overall Study|Physician Decision|1
2605543|NCT01027845|9007822|P4|Booster Vaccination Phase|Migrated/moved from study area|0
2605544|NCT01027845|9007823|P3|Booster Vaccination Phase|Migrated/moved from study area|0
2605545|NCT01027845|9007824|P2|Booster Vaccination Phase|Migrated/moved from study area|0
2605546|NCT01027845|9007825|P1|Booster Vaccination Phase|Migrated/moved from study area|1
2605547|NCT01027845|9007822|P4|Booster Vaccination Phase|Withdrawal by Subject|0
2605548|NCT01027845|9007823|P3|Booster Vaccination Phase|Withdrawal by Subject|0
2605549|NCT01027845|9007824|P2|Booster Vaccination Phase|Withdrawal by Subject|0
2605550|NCT01027845|9007825|P1|Booster Vaccination Phase|Withdrawal by Subject|1
2605551|NCT01027845|9007822|P4|Primary Vaccination Phase|Migrated/moved from study area|0
2605552|NCT01027845|9007823|P3|Primary Vaccination Phase|Migrated/moved from study area|0
2605553|NCT01027845|9007824|P2|Primary Vaccination Phase|Migrated/moved from study area|1
2605554|NCT01027845|9007825|P1|Primary Vaccination Phase|Migrated/moved from study area|0
2605555|NCT01027845|9007822|P4|Primary Vaccination Phase|Protocol Violation|0
2605556|NCT01027845|9007823|P3|Primary Vaccination Phase|Protocol Violation|0
2605557|NCT01027845|9007824|P2|Primary Vaccination Phase|Protocol Violation|0
2605558|NCT01027845|9007825|P1|Primary Vaccination Phase|Protocol Violation|1
2605559|NCT01027845|9007822|P4|Primary Vaccination Phase|Adverse Event|0
2605560|NCT01027845|9007823|P3|Primary Vaccination Phase|Adverse Event|0
2605561|NCT01027845|9007824|P2|Primary Vaccination Phase|Adverse Event|0
2605562|NCT01027845|9007825|P1|Primary Vaccination Phase|Adverse Event|1
2605563|NCT01027845|9007822|P4|Primary Vaccination Phase|Serious Adverse Event|0
2605564|NCT01027845|9007823|P3|Primary Vaccination Phase|Serious Adverse Event|0
2605565|NCT01027845|9007824|P2|Primary Vaccination Phase|Serious Adverse Event|0
2605566|NCT01027845|9007825|P1|Primary Vaccination Phase|Serious Adverse Event|2
2605567|NCT01027754|9007908|P2|Overall Study|Withdrawal by Subject|5
2605568|NCT01027754|9007909|P1|Overall Study|Withdrawal by Subject|0
2605569|NCT01027754|9007908|P2|Overall Study|withdrew/lost to follow-up after interve|3
2605570|NCT01027754|9007909|P1|Overall Study|withdrew/lost to follow-up after interve|2
2605571|NCT01027702|9007943|P7|Overall Study|Death|0
2605572|NCT01027702|9007944|P6|Overall Study|Death|0
2605573|NCT01027702|9007945|P5|Overall Study|Death|0
2605574|NCT01027702|9007946|P4|Overall Study|Death|0
2605575|NCT01027702|9007947|P3|Overall Study|Death|1
2605576|NCT01027702|9007948|P2|Overall Study|Death|0
2605577|NCT01027702|9007949|P1|Overall Study|Death|0
2605578|NCT01027702|9007943|P7|Overall Study|Received subsequent therapy|1
2605579|NCT01027702|9007944|P6|Overall Study|Received subsequent therapy|0
2605580|NCT01027702|9007945|P5|Overall Study|Received subsequent therapy|1
2605581|NCT01027702|9007946|P4|Overall Study|Received subsequent therapy|4
2605582|NCT01027702|9007947|P3|Overall Study|Received subsequent therapy|0
2605583|NCT01027702|9007948|P2|Overall Study|Received subsequent therapy|2
2605584|NCT01027702|9007949|P1|Overall Study|Received subsequent therapy|1
2605585|NCT01027650|9007975|P8|Overall Study|Lack of Efficacy|0
2605586|NCT01027650|9007976|P7|Overall Study|Lack of Efficacy|0
2605587|NCT01027650|9007977|P6|Overall Study|Lack of Efficacy|1
2605588|NCT01027650|9007978|P5|Overall Study|Lack of Efficacy|0
2605589|NCT01027650|9007979|P4|Overall Study|Lack of Efficacy|0
2605590|NCT01027650|9007980|P3|Overall Study|Lack of Efficacy|0
2605591|NCT01027650|9007981|P2|Overall Study|Lack of Efficacy|0
2605592|NCT01027650|9007982|P1|Overall Study|Lack of Efficacy|0
2605593|NCT01027650|9007975|P8|Overall Study|Lost to Follow-up|0
2605594|NCT01027650|9007976|P7|Overall Study|Lost to Follow-up|1
2605595|NCT01027650|9007977|P6|Overall Study|Lost to Follow-up|0
2605596|NCT01027650|9007978|P5|Overall Study|Lost to Follow-up|0
2605597|NCT01027650|9007979|P4|Overall Study|Lost to Follow-up|0
2605598|NCT01027650|9007980|P3|Overall Study|Lost to Follow-up|0
2605599|NCT01027650|9007981|P2|Overall Study|Lost to Follow-up|0
2605600|NCT01027650|9007982|P1|Overall Study|Lost to Follow-up|0
2605601|NCT01027650|9007975|P8|Overall Study|Personal Reasons|0
2605602|NCT01027650|9007976|P7|Overall Study|Personal Reasons|0
2605603|NCT01027650|9007977|P6|Overall Study|Personal Reasons|1
2605604|NCT01027650|9007978|P5|Overall Study|Personal Reasons|2
2605605|NCT01027650|9007979|P4|Overall Study|Personal Reasons|0
2605606|NCT01027650|9007980|P3|Overall Study|Personal Reasons|0
2605607|NCT01027650|9007981|P2|Overall Study|Personal Reasons|0
2605608|NCT01027650|9007982|P1|Overall Study|Personal Reasons|0
2605609|NCT01027416|9008060|P2|Overall Study|Physician Decision|4
2605610|NCT01027416|9008061|P1|Overall Study|Physician Decision|1
2605611|NCT01027416|9008060|P2|Overall Study|Withdrawal by Subject|1
2605612|NCT01027416|9008061|P1|Overall Study|Withdrawal by Subject|0
2605613|NCT01027364|9008073|P4|Overall Study|Withdrawal by Subject|0
2605614|NCT01027364|9008074|P3|Overall Study|Withdrawal by Subject|0
2605615|NCT01027364|9008075|P2|Overall Study|Withdrawal by Subject|2
2605616|NCT01027364|9008076|P1|Overall Study|Withdrawal by Subject|1
2605617|NCT01027364|9008073|P4|Overall Study|Protocol Violation|1
2605618|NCT01027364|9008074|P3|Overall Study|Protocol Violation|0
2605619|NCT01027364|9008075|P2|Overall Study|Protocol Violation|0
2605620|NCT01027364|9008076|P1|Overall Study|Protocol Violation|1
2605621|NCT01027364|9008073|P4|Overall Study|Lost to Follow-up|0
2605622|NCT01027364|9008074|P3|Overall Study|Lost to Follow-up|0
2605623|NCT01027364|9008075|P2|Overall Study|Lost to Follow-up|0
2605624|NCT01027364|9008076|P1|Overall Study|Lost to Follow-up|1
2605625|NCT01027364|9008073|P4|Overall Study|Adverse Event|0
2605626|NCT01027364|9008074|P3|Overall Study|Adverse Event|1
2605627|NCT01027364|9008075|P2|Overall Study|Adverse Event|0
2605628|NCT01027364|9008076|P1|Overall Study|Adverse Event|1
2605629|NCT01027351|9008171|P6|Overall Study|Protocol Violation|0
2605630|NCT01027351|9008172|P5|Overall Study|Protocol Violation|1
2605631|NCT01027351|9008173|P4|Overall Study|Protocol Violation|1
2605632|NCT01027351|9008174|P3|Overall Study|Protocol Violation|0
2605633|NCT01027351|9008175|P2|Overall Study|Protocol Violation|0
2605634|NCT01027351|9008176|P1|Overall Study|Protocol Violation|1
2605635|NCT01027351|9008171|P6|Overall Study|Inappropriate enrollment|0
2605636|NCT01027351|9008172|P5|Overall Study|Inappropriate enrollment|1
2605637|NCT01027351|9008173|P4|Overall Study|Inappropriate enrollment|0
2605638|NCT01027351|9008174|P3|Overall Study|Inappropriate enrollment|0
2605639|NCT01027351|9008175|P2|Overall Study|Inappropriate enrollment|0
2605640|NCT01027351|9008176|P1|Overall Study|Inappropriate enrollment|0
2605641|NCT01027351|9008171|P6|Overall Study|Lost to Follow-up|0
2605642|NCT01027351|9008172|P5|Overall Study|Lost to Follow-up|6
2605643|NCT01027351|9008173|P4|Overall Study|Lost to Follow-up|1
2605644|NCT01027351|9008174|P3|Overall Study|Lost to Follow-up|0
2605645|NCT01027351|9008175|P2|Overall Study|Lost to Follow-up|1
2605646|NCT01027351|9008176|P1|Overall Study|Lost to Follow-up|1
2605647|NCT01027351|9008171|P6|Overall Study|Withdrawal by Subject|5
2605648|NCT01027351|9008172|P5|Overall Study|Withdrawal by Subject|3
2605649|NCT01027351|9008173|P4|Overall Study|Withdrawal by Subject|0
2605650|NCT01027351|9008174|P3|Overall Study|Withdrawal by Subject|1
2605651|NCT01027351|9008175|P2|Overall Study|Withdrawal by Subject|0
2605652|NCT01027351|9008176|P1|Overall Study|Withdrawal by Subject|1
2605653|NCT01027286|9008260|P2|Overall Study|Lost to Follow-up|1
2605654|NCT01027286|9008261|P1|Overall Study|Lost to Follow-up|0
2605655|NCT01027286|9008260|P2|Overall Study|Unable to Obtain Required Blood Volume|0
2605656|NCT01027286|9008261|P1|Overall Study|Unable to Obtain Required Blood Volume|1
2605657|NCT01027273|9008281|P2|Overall Study|Death|2
2605658|NCT01027273|9008282|P1|Overall Study|Death|2
2605659|NCT01027273|9008281|P2|Overall Study|Lost to Follow-up|31
2605660|NCT01027273|9008282|P1|Overall Study|Lost to Follow-up|57
2605661|NCT01026974|9008329|P4|Overall Study|Inappropriate enrollment|0
2605662|NCT01026974|9008330|P3|Overall Study|Inappropriate enrollment|1
2605663|NCT01026974|9008331|P2|Overall Study|Inappropriate enrollment|0
2605664|NCT01026974|9008332|P1|Overall Study|Inappropriate enrollment|0
2605665|NCT01026974|9008329|P4|Overall Study|Adverse Event|1
2605666|NCT01026974|9008330|P3|Overall Study|Adverse Event|0
2605667|NCT01026974|9008331|P2|Overall Study|Adverse Event|0
2605668|NCT01026974|9008332|P1|Overall Study|Adverse Event|0
2605669|NCT01026974|9008329|P4|Overall Study|Lost to Follow-up|0
2605670|NCT01026974|9008330|P3|Overall Study|Lost to Follow-up|4
2605671|NCT01026974|9008331|P2|Overall Study|Lost to Follow-up|1
2605672|NCT01026974|9008332|P1|Overall Study|Lost to Follow-up|1
2605673|NCT01026974|9008329|P4|Overall Study|Withdrawal by Subject|2
2605674|NCT01026974|9008330|P3|Overall Study|Withdrawal by Subject|7
2605675|NCT01026974|9008331|P2|Overall Study|Withdrawal by Subject|1
2605676|NCT01026974|9008332|P1|Overall Study|Withdrawal by Subject|0
2605677|NCT01026948|9008389|P1|Overall Study|Physician Decision|8
2605678|NCT01026831|9008422|P2|Overall Study|Withdrawal by Subject|5
2605679|NCT01026831|9008423|P1|Overall Study|Withdrawal by Subject|7
2605680|NCT01026831|9008422|P2|Overall Study|Protocol Violation|2
2605681|NCT01026831|9008423|P1|Overall Study|Protocol Violation|0
2605682|NCT01026831|9008422|P2|Overall Study|Physician Decision|1
2605683|NCT01026831|9008423|P1|Overall Study|Physician Decision|1
2605684|NCT01026831|9008422|P2|Overall Study|Lost to Follow-up|0
2605685|NCT01026831|9008423|P1|Overall Study|Lost to Follow-up|2
2605686|NCT01026831|9008422|P2|Overall Study|Adverse Event|3
2605687|NCT01026831|9008423|P1|Overall Study|Adverse Event|4
2605688|NCT01026818|9008434|P4|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1
2605689|NCT01026818|9008435|P3|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
2605690|NCT01026818|9008436|P2|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2
2605691|NCT01026818|9008437|P1|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
2605692|NCT01026818|9008434|P4|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
2605693|NCT01026818|9008435|P3|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3
2605694|NCT01026818|9008436|P2|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
2605695|NCT01026818|9008437|P1|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0
2605696|NCT01026818|9008434|P4|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
2605697|NCT01026818|9008435|P3|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2
2605698|NCT01026818|9008436|P2|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
2605699|NCT01026818|9008437|P1|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0
2605700|NCT01026818|9008434|P4|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
2605701|NCT01026818|9008435|P3|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
2605702|NCT01026818|9008436|P2|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1
2605703|NCT01026818|9008437|P1|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
2605704|NCT01026818|9008434|P4|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
2605705|NCT01026818|9008435|P3|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
2605706|NCT01026818|9008436|P2|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2
2605707|NCT01026818|9008437|P1|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
2605708|NCT01026818|9008434|P4|Drug-Free Washout Period (Month 9-10.5)|Death|1
2605709|NCT01026818|9008435|P3|Drug-Free Washout Period (Month 9-10.5)|Death|0
2605710|NCT01026818|9008436|P2|Drug-Free Washout Period (Month 9-10.5)|Death|0
2605711|NCT01026818|9008437|P1|Drug-Free Washout Period (Month 9-10.5)|Death|0
2605712|NCT01026818|9008434|P4|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
2605713|NCT01026818|9008435|P3|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2
2605714|NCT01026818|9008436|P2|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1
2605715|NCT01026818|9008437|P1|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
2605716|NCT01026818|9008434|P4|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
2605717|NCT01026818|9008435|P3|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
2605718|NCT01026818|9008436|P2|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1
2605719|NCT01026818|9008437|P1|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
2605720|NCT01026818|9008434|P4|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
2605721|NCT01026818|9008435|P3|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
2605722|NCT01026818|9008436|P2|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
2605723|NCT01026818|9008437|P1|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
2605724|NCT01026818|9008434|P4|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2
2605725|NCT01026818|9008435|P3|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
2605726|NCT01026818|9008436|P2|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1
2605727|NCT01026818|9008437|P1|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
2605728|NCT01026818|9008434|P4|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
2605729|NCT01026818|9008435|P3|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
2605730|NCT01026818|9008436|P2|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1
2605731|NCT01026818|9008437|P1|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
2605732|NCT01026818|9008434|P4|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
2605733|NCT01026818|9008435|P3|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1
2605734|NCT01026818|9008436|P2|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
2605735|NCT01026818|9008437|P1|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0
2605736|NCT01026818|9008434|P4|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
2605737|NCT01026818|9008435|P3|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1
2605738|NCT01026818|9008436|P2|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
2605739|NCT01026818|9008437|P1|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0
2605740|NCT01026818|9008434|P4|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2
2605741|NCT01026818|9008435|P3|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1
2605742|NCT01026818|9008436|P2|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
2605743|NCT01026818|9008437|P1|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
2605744|NCT01026818|9008434|P4|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7
2605745|NCT01026818|9008435|P3|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9
2605746|NCT01026818|9008436|P2|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2
2605747|NCT01026818|9008437|P1|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0
2605748|NCT01026818|9008434|P4|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4
2605749|NCT01026818|9008435|P3|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
2605750|NCT01026818|9008436|P2|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3
2605751|NCT01026818|9008437|P1|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
2605752|NCT01026818|9008434|P4|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6
2605753|NCT01026818|9008435|P3|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2
2605754|NCT01026818|9008436|P2|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3
2605755|NCT01026818|9008437|P1|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0
2605756|NCT01026818|9008434|P4|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
2605757|NCT01026818|9008435|P3|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
2605758|NCT01026818|9008436|P2|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7
2605759|NCT01026818|9008437|P1|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0
2605760|NCT01026818|9008434|P4|DB Treatment Period (Month 0 - 9)|Adverse Event|4
2605761|NCT01026818|9008435|P3|DB Treatment Period (Month 0 - 9)|Adverse Event|6
2605762|NCT01026818|9008436|P2|DB Treatment Period (Month 0 - 9)|Adverse Event|10
2605763|NCT01026818|9008437|P1|DB Treatment Period (Month 0 - 9)|Adverse Event|0
2605764|NCT01026818|9008434|P4|Screening Period|Physician Decision|0
2605765|NCT01026818|9008435|P3|Screening Period|Physician Decision|0
2605766|NCT01026818|9008436|P2|Screening Period|Physician Decision|0
2605767|NCT01026818|9008437|P1|Screening Period|Physician Decision|1
2605768|NCT01026818|9008434|P4|Screening Period|Adverse Event|0
2605769|NCT01026818|9008435|P3|Screening Period|Adverse Event|0
2605770|NCT01026818|9008436|P2|Screening Period|Adverse Event|0
2605771|NCT01026818|9008437|P1|Screening Period|Adverse Event|2
2605772|NCT01026818|9008434|P4|Screening Period|Protocol Deviation|0
2605773|NCT01026818|9008435|P3|Screening Period|Protocol Deviation|0
2605774|NCT01026818|9008436|P2|Screening Period|Protocol Deviation|0
2605775|NCT01026818|9008437|P1|Screening Period|Protocol Deviation|3
2605776|NCT01026818|9008434|P4|Screening Period|Withdrawal by Subject|0
2605777|NCT01026818|9008435|P3|Screening Period|Withdrawal by Subject|0
2605778|NCT01026818|9008436|P2|Screening Period|Withdrawal by Subject|0
2605779|NCT01026818|9008437|P1|Screening Period|Withdrawal by Subject|49
2605780|NCT01026818|9008434|P4|Screening Period|Entry Criteria Not Met|0
2605781|NCT01026818|9008435|P3|Screening Period|Entry Criteria Not Met|0
2605782|NCT01026818|9008436|P2|Screening Period|Entry Criteria Not Met|0
2605783|NCT01026818|9008437|P1|Screening Period|Entry Criteria Not Met|105
2605784|NCT01026792|9008525|P1|Overall Study|Protocol Violation|1
2605785|NCT01026493|9008568|P8|Overall Study|Protocol Violation|1
2605786|NCT01026493|9008569|P7|Overall Study|Protocol Violation|4
2605787|NCT01026493|9008570|P6|Overall Study|Protocol Violation|3
2605788|NCT01026493|9008571|P5|Overall Study|Protocol Violation|2
2605789|NCT01026493|9008572|P4|Overall Study|Protocol Violation|0
2605790|NCT01026493|9008573|P3|Overall Study|Protocol Violation|0
2605791|NCT01026493|9008574|P2|Overall Study|Protocol Violation|1
2605792|NCT01026493|9008575|P1|Overall Study|Protocol Violation|0
2605793|NCT01026454|9008603|P2|Second Intervention|Pregnancy|1
2605794|NCT01026454|9008604|P1|Second Intervention|Pregnancy|1
2605795|NCT01026389|9008953|P2|Overall Study|change of treatment, patient moved|2
2605796|NCT01026389|9008954|P1|Overall Study|change of treatment, patient moved|4
2605797|NCT01026389|9008953|P2|Overall Study|Withdrawal by Subject|3
2605798|NCT01026389|9008954|P1|Overall Study|Withdrawal by Subject|1
2605799|NCT01026324|9008969|P3|Follow up/Survival|Withdrawal by Subject|0
2605800|NCT01026324|9008970|P2|Follow up/Survival|Withdrawal by Subject|0
2605801|NCT01026324|9008971|P1|Follow up/Survival|Withdrawal by Subject|1
2605802|NCT01026220|9008981|P3|Consolidation Maintenance|Withdrawal by Subject|6
2605803|NCT01026220|9008982|P2|Consolidation Maintenance|Withdrawal by Subject|2
2605804|NCT01026220|9008983|P1|Consolidation Maintenance|Withdrawal by Subject|0
2605805|NCT01026220|9008981|P3|Consolidation Maintenance|Physician Decision|7
2605806|NCT01026220|9008982|P2|Consolidation Maintenance|Physician Decision|2
2605807|NCT01026220|9008983|P1|Consolidation Maintenance|Physician Decision|0
2605808|NCT01026220|9008981|P3|Consolidation Maintenance|Lack of Efficacy|1
2605809|NCT01026220|9008982|P2|Consolidation Maintenance|Lack of Efficacy|1
2605810|NCT01026220|9008983|P1|Consolidation Maintenance|Lack of Efficacy|0
2605811|NCT01026220|9008981|P3|Consolidation Maintenance|Death|0
2605812|NCT01026220|9008982|P2|Consolidation Maintenance|Death|1
2605813|NCT01026220|9008983|P1|Consolidation Maintenance|Death|0
2605814|NCT01026220|9008981|P3|Induction|Ineligible|0
2605815|NCT01026220|9008982|P2|Induction|Ineligible|0
2605816|NCT01026220|9008983|P1|Induction|Ineligible|1
2605817|NCT01026220|9008981|P3|Induction|Withdrawal by Subject|0
2605818|NCT01026220|9008982|P2|Induction|Withdrawal by Subject|0
2605819|NCT01026220|9008983|P1|Induction|Withdrawal by Subject|9
2605820|NCT01026220|9008981|P3|Induction|Physician Decision|0
2605821|NCT01026220|9008982|P2|Induction|Physician Decision|0
2605822|NCT01026220|9008983|P1|Induction|Physician Decision|12
2605823|NCT01026220|9008981|P3|Induction|Lack of Efficacy|0
2605824|NCT01026220|9008982|P2|Induction|Lack of Efficacy|0
2605825|NCT01026220|9008983|P1|Induction|Lack of Efficacy|2
2605826|NCT01026220|9008981|P3|Induction|Death|0
2605827|NCT01026220|9008982|P2|Induction|Death|0
2605828|NCT01026220|9008983|P1|Induction|Death|1
2605829|NCT01026194|9009007|P2|Period 2：Open-label Period|Withdrawal by Subject|4
2605830|NCT01026194|9009008|P1|Period 2：Open-label Period|Withdrawal by Subject|0
2605831|NCT01026194|9009007|P2|Period 2：Open-label Period|Physician Decision|1
2605832|NCT01026194|9009008|P1|Period 2：Open-label Period|Physician Decision|3
2605833|NCT01026194|9009007|P2|Period 2：Open-label Period|Adverse Event|5
2605834|NCT01026194|9009008|P1|Period 2：Open-label Period|Adverse Event|4
2605835|NCT01026194|9009007|P2|Period 1：Double Blind Period|Physician Decision|4
2605836|NCT01026194|9009008|P1|Period 1：Double Blind Period|Physician Decision|0
2605837|NCT01026194|9009007|P2|Period 1：Double Blind Period|Lack of Efficacy|0
2605838|NCT01026194|9009008|P1|Period 1：Double Blind Period|Lack of Efficacy|1
2605839|NCT01026194|9009007|P2|Period 1：Double Blind Period|Adverse Event|1
2605840|NCT01026194|9009008|P1|Period 1：Double Blind Period|Adverse Event|2
2605841|NCT01026142|9009040|P2|Overall Study|Withdrew consent or lost to follow-up|29
2605842|NCT01026142|9009041|P1|Overall Study|Withdrew consent or lost to follow-up|36
2605843|NCT01026142|9009040|P2|Overall Study|Death|134
2605844|NCT01026142|9009041|P1|Overall Study|Death|136
2605845|NCT01026103|9009063|P1|Overall Study|did not receive study device bc of error|1
2605846|NCT01026103|9009063|P1|Overall Study|Physician Decision|1
2605847|NCT01026038|9009073|P3|Overall Study|Lost to Follow-up|0
2605848|NCT01026038|9009074|P2|Overall Study|Lost to Follow-up|1
2605849|NCT01026038|9009075|P1|Overall Study|Lost to Follow-up|1
2605850|NCT01025843|9009124|P10|Washout 4|Withdrawal by Subject|0
2605851|NCT01025843|9009125|P9|Washout 4|Withdrawal by Subject|0
2605852|NCT01025843|9009126|P8|Washout 4|Withdrawal by Subject|0
2605853|NCT01025843|9009127|P7|Washout 4|Withdrawal by Subject|0
2605854|NCT01025843|9009128|P6|Washout 4|Withdrawal by Subject|0
2605855|NCT01025843|9009129|P5|Washout 4|Withdrawal by Subject|0
2605856|NCT01025843|9009130|P4|Washout 4|Withdrawal by Subject|1
2605857|NCT01025843|9009131|P3|Washout 4|Withdrawal by Subject|1
2605858|NCT01025843|9009132|P2|Washout 4|Withdrawal by Subject|0
2605859|NCT01025843|9009133|P1|Washout 4|Withdrawal by Subject|0
2605860|NCT01025817|9009227|P2|Completed Study|Lost to Follow-up|1
2605861|NCT01025817|9009228|P1|Completed Study|Lost to Follow-up|0
2605862|NCT01025817|9009227|P2|Completed Study|Missing|0
2605863|NCT01025817|9009228|P1|Completed Study|Missing|2
2605864|NCT01025817|9009227|P2|Completed Study|Death|5
2605865|NCT01025817|9009228|P1|Completed Study|Death|6
2605866|NCT01025817|9009227|P2|Completed Study|Withdrawal by Subject|16
2605867|NCT01025817|9009228|P1|Completed Study|Withdrawal by Subject|8
2605868|NCT01025817|9009227|P2|Completed Study Medication|Lost to Follow-up|1
2605869|NCT01025817|9009228|P1|Completed Study Medication|Lost to Follow-up|0
2605870|NCT01025817|9009227|P2|Completed Study Medication|Subject no longer required study drug|1
2605871|NCT01025817|9009228|P1|Completed Study Medication|Subject no longer required study drug|0
2605872|NCT01025817|9009227|P2|Completed Study Medication|Abnormal lab values|2
2605873|NCT01025817|9009228|P1|Completed Study Medication|Abnormal lab values|0
2605874|NCT01025817|9009227|P2|Completed Study Medication|Death|2
2605875|NCT01025817|9009228|P1|Completed Study Medication|Death|2
2605876|NCT01025817|9009227|P2|Completed Study Medication|Graft loss|5
2605877|NCT01025817|9009228|P1|Completed Study Medication|Graft loss|2
2605878|NCT01025817|9009227|P2|Completed Study Medication|Abnormal test procedure|0
2605879|NCT01025817|9009228|P1|Completed Study Medication|Abnormal test procedure|4
2605880|NCT01025817|9009227|P2|Completed Study Medication|Unsatisfactory therapeutic effect|0
2605968|NCT01024244|9009756|P5|Overall Study|Sponsor Decision|10
2605881|NCT01025817|9009228|P1|Completed Study Medication|Unsatisfactory therapeutic effect|7
2605882|NCT01025817|9009227|P2|Completed Study Medication|Administrative problems|5
2605883|NCT01025817|9009228|P1|Completed Study Medication|Administrative problems|7
2605884|NCT01025817|9009227|P2|Completed Study Medication|Withdrawal by Subject|9
2605885|NCT01025817|9009228|P1|Completed Study Medication|Withdrawal by Subject|8
2605886|NCT01025817|9009227|P2|Completed Study Medication|Protocol Deviation|8
2605887|NCT01025817|9009228|P1|Completed Study Medication|Protocol Deviation|9
2605888|NCT01025817|9009227|P2|Completed Study Medication|Adverse Event|39
2605889|NCT01025817|9009228|P1|Completed Study Medication|Adverse Event|66
2605890|NCT01025752|9009394|P2|Overall Study|Physician Decision|3
2605891|NCT01025752|9009395|P1|Overall Study|Physician Decision|1
2605892|NCT01025752|9009394|P2|Overall Study|Lost to Follow-up|10
2605893|NCT01025752|9009395|P1|Overall Study|Lost to Follow-up|7
2605894|NCT01025635|9009415|P2|Overall Study|Reason not known|2
2605895|NCT01025635|9009416|P1|Overall Study|Reason not known|4
2605896|NCT01025635|9009415|P2|Overall Study|Lost to Follow-up|13
2605897|NCT01025635|9009416|P1|Overall Study|Lost to Follow-up|9
2605898|NCT01025635|9009415|P2|Overall Study|Lack of Efficacy|1
2605899|NCT01025635|9009416|P1|Overall Study|Lack of Efficacy|0
2605900|NCT01025635|9009415|P2|Overall Study|Protocol Violation|2
2605901|NCT01025635|9009416|P1|Overall Study|Protocol Violation|4
2605902|NCT01025635|9009415|P2|Overall Study|Withdrawal by Subject|7
2605903|NCT01025635|9009416|P1|Overall Study|Withdrawal by Subject|6
2605904|NCT01025336|9009444|P5|Overall Study|Protocol Violation|0
2605905|NCT01025336|9009445|P4|Overall Study|Protocol Violation|2
2605906|NCT01025336|9009446|P3|Overall Study|Protocol Violation|0
2605907|NCT01025336|9009447|P2|Overall Study|Protocol Violation|0
2605908|NCT01025336|9009448|P1|Overall Study|Protocol Violation|0
2605909|NCT01025284|9009503|P3|Overall Study|Withdrawal by Subject|0
2605910|NCT01025284|9009504|P2|Overall Study|Withdrawal by Subject|1
2605911|NCT01025284|9009505|P1|Overall Study|Withdrawal by Subject|0
2605912|NCT01025284|9009503|P3|Overall Study|Investigator Decision|0
2605913|NCT01025284|9009504|P2|Overall Study|Investigator Decision|1
2605914|NCT01025284|9009505|P1|Overall Study|Investigator Decision|0
2605915|NCT01025232|9009530|P2|Overall Study|Study drug no longer available|6
2605916|NCT01025232|9009531|P1|Overall Study|Study drug no longer available|3
2605917|NCT01025193|9009549|P1|Overall Study|Adverse Event|3
2605918|NCT01025193|9009549|P1|Overall Study|Protocol Violation|1
2605919|NCT01025154|9009559|P1|Overall Study|Withdrawal by Subject|1
2605920|NCT01025154|9009559|P1|Overall Study|Lost to Follow-up|1
2605921|NCT01025037|9009568|P1|Overall Study|Withdrawal by Subject|1
2605922|NCT01025037|9009568|P1|Overall Study|Lost to Follow-up|7
2605923|NCT01025037|9009568|P1|Overall Study|Adverse Event|3
2605924|NCT01024959|9009590|P1|Overall Study|missing results required for analysis|17
2605925|NCT01024959|9009590|P1|Overall Study|results not evaluable|12
2605926|NCT01024959|9009590|P1|Overall Study|ineligible|12
2605927|NCT01024946|9009599|P1|Overall Study|Adverse Event|1
2605928|NCT01024946|9009599|P1|Overall Study|Withdrawal by Subject|1
2605929|NCT01024946|9009599|P1|Overall Study|Screen Failure|3
2605930|NCT01024855|9009603|P1|Overall Study|Inclusion/exclusion criteria|1
2605931|NCT01024751|9009610|P2|Eligible Participants|Ineligible|1
2605932|NCT01024751|9009611|P1|Eligible Participants|Ineligible|0
2605933|NCT01024751|9009610|P2|Eligible Participants|Lost to Follow-up|1
2605934|NCT01024751|9009611|P1|Eligible Participants|Lost to Follow-up|0
2605935|NCT01024751|9009610|P2|Eligible Participants|Withdrawal by Subject|1
2605936|NCT01024751|9009611|P1|Eligible Participants|Withdrawal by Subject|0
2605937|NCT01024751|9009610|P2|Enrolled Participants|Ineligible at baseline|4
2605938|NCT01024751|9009611|P1|Enrolled Participants|Ineligible at baseline|3
2605939|NCT01024608|9009668|P2|Overall Study|Never received study treatment|0
2605940|NCT01024608|9009669|P1|Overall Study|Never received study treatment|2
2605941|NCT01024608|9009668|P2|Overall Study|Protocol Violation|3
2605942|NCT01024608|9009669|P1|Overall Study|Protocol Violation|0
2605943|NCT01024608|9009668|P2|Overall Study|Lost to Follow-up|1
2605944|NCT01024608|9009669|P1|Overall Study|Lost to Follow-up|0
2605945|NCT01024608|9009668|P2|Overall Study|Withdrawal by Subject|0
2605946|NCT01024608|9009669|P1|Overall Study|Withdrawal by Subject|1
2605947|NCT01024608|9009668|P2|Overall Study|Adverse Event|0
2605948|NCT01024608|9009669|P1|Overall Study|Adverse Event|1
2605949|NCT01024465|9009698|P1|Overall Study|Physician Decision|1
2605950|NCT01024465|9009698|P1|Overall Study|Adverse Event|2
2605951|NCT01024387|9009702|P1|Overall Study|Other|5
2605952|NCT01024387|9009702|P1|Overall Study|Adverse Event|3
2605953|NCT01024387|9009702|P1|Overall Study|Prolonged Treatment Delay|1
2605954|NCT01024387|9009702|P1|Overall Study|Death|2
2605955|NCT01024387|9009702|P1|Overall Study|Withdrawal by Subject|5
2605956|NCT01024387|9009702|P1|Overall Study|Physician Decision|5
2605957|NCT01024387|9009702|P1|Overall Study|Symptomatic Progression|10
2605958|NCT01024387|9009702|P1|Overall Study|Radiographic Progression|29
2605959|NCT01024309|9009723|P2|Overall Study|Withdrawal by Subject|4
2605960|NCT01024309|9009724|P1|Overall Study|Withdrawal by Subject|4
2605961|NCT01024309|9009723|P2|Overall Study|Physician Decision|0
2605962|NCT01024309|9009724|P1|Overall Study|Physician Decision|4
2605963|NCT01024244|9009756|P5|Overall Study|Withdrawal by Subject|0
2605964|NCT01024244|9009757|P4|Overall Study|Withdrawal by Subject|0
2605965|NCT01024244|9009758|P3|Overall Study|Withdrawal by Subject|0
2605966|NCT01024244|9009759|P2|Overall Study|Withdrawal by Subject|1
2605967|NCT01024244|9009760|P1|Overall Study|Withdrawal by Subject|0
2605969|NCT01024244|9009757|P4|Overall Study|Sponsor Decision|12
2605970|NCT01024244|9009758|P3|Overall Study|Sponsor Decision|14
2605971|NCT01024244|9009759|P2|Overall Study|Sponsor Decision|7
2605972|NCT01024244|9009760|P1|Overall Study|Sponsor Decision|14
2605973|NCT01024244|9009756|P5|Overall Study|Protocol Violation|2
2605974|NCT01024244|9009757|P4|Overall Study|Protocol Violation|0
2605975|NCT01024244|9009758|P3|Overall Study|Protocol Violation|0
2605976|NCT01024244|9009759|P2|Overall Study|Protocol Violation|0
2605977|NCT01024244|9009760|P1|Overall Study|Protocol Violation|1
2605978|NCT01024244|9009756|P5|Overall Study|Lack of Efficacy|0
2605979|NCT01024244|9009757|P4|Overall Study|Lack of Efficacy|0
2605980|NCT01024244|9009758|P3|Overall Study|Lack of Efficacy|0
2605981|NCT01024244|9009759|P2|Overall Study|Lack of Efficacy|0
2605982|NCT01024244|9009760|P1|Overall Study|Lack of Efficacy|1
2605983|NCT01024244|9009756|P5|Overall Study|Entry Criteria Not Met|0
2605984|NCT01024244|9009757|P4|Overall Study|Entry Criteria Not Met|0
2605985|NCT01024244|9009758|P3|Overall Study|Entry Criteria Not Met|0
2605986|NCT01024244|9009759|P2|Overall Study|Entry Criteria Not Met|1
2605987|NCT01024244|9009760|P1|Overall Study|Entry Criteria Not Met|0
2605988|NCT01024244|9009756|P5|Overall Study|Adverse Event|2
2605989|NCT01024244|9009757|P4|Overall Study|Adverse Event|1
2605990|NCT01024244|9009758|P3|Overall Study|Adverse Event|0
2605991|NCT01024244|9009759|P2|Overall Study|Adverse Event|2
2605992|NCT01024244|9009760|P1|Overall Study|Adverse Event|1
2605993|NCT01024036|9009874|P2|Follow-Up Period|Adverse Event|1
2605994|NCT01024036|9009875|P1|Follow-Up Period|Adverse Event|4
2605995|NCT01024036|9009874|P2|Follow-Up Period|Withdrawal by Subject|1
2605996|NCT01024036|9009875|P1|Follow-Up Period|Withdrawal by Subject|0
2605997|NCT01024036|9009874|P2|Follow-Up Period|Lost to Follow-up|1
2605998|NCT01024036|9009875|P1|Follow-Up Period|Lost to Follow-up|1
2605999|NCT01024036|9009874|P2|Unblinded Treatment|Lack of Efficacy|2
2606000|NCT01024036|9009875|P1|Unblinded Treatment|Lack of Efficacy|0
2606001|NCT01024036|9009874|P2|Unblinded Treatment|Adverse Event|1
2606002|NCT01024036|9009875|P1|Unblinded Treatment|Adverse Event|0
2606003|NCT01024036|9009874|P2|Blinded Treatment|Withdrawal by Subject|3
2606004|NCT01024036|9009875|P1|Blinded Treatment|Withdrawal by Subject|4
2606005|NCT01024036|9009874|P2|Blinded Treatment|Death|2
2606006|NCT01024036|9009875|P1|Blinded Treatment|Death|0
2606007|NCT01024036|9009874|P2|Blinded Treatment|Physician Decision|0
2606008|NCT01024036|9009875|P1|Blinded Treatment|Physician Decision|1
2606009|NCT01024036|9009874|P2|Blinded Treatment|Lack of Efficacy|14
2606010|NCT01024036|9009875|P1|Blinded Treatment|Lack of Efficacy|16
2606011|NCT01024036|9009874|P2|Blinded Treatment|Adverse Event|1
2606012|NCT01024036|9009875|P1|Blinded Treatment|Adverse Event|1
2606013|NCT01023958|9009922|P1|Overall Study|Refused to continue medication|1
2606014|NCT01023958|9009922|P1|Overall Study|Other adverse event|1
2606015|NCT01023958|9009922|P1|Overall Study|Progressive disease|48
2606016|NCT01023815|9009970|P4|Randomized Period (Day 90 to Month 12)|Graft Loss|0
2606017|NCT01023815|9009971|P3|Randomized Period (Day 90 to Month 12)|Graft Loss|0
2606018|NCT01023815|9009972|P2|Randomized Period (Day 90 to Month 12)|Graft Loss|1
2606019|NCT01023815|9009973|P1|Randomized Period (Day 90 to Month 12)|Graft Loss|0
2606020|NCT01023815|9009970|P4|Randomized Period (Day 90 to Month 12)|Administrative Problems|2
2606021|NCT01023815|9009971|P3|Randomized Period (Day 90 to Month 12)|Administrative Problems|6
2606022|NCT01023815|9009972|P2|Randomized Period (Day 90 to Month 12)|Administrative Problems|1
2606023|NCT01023815|9009973|P1|Randomized Period (Day 90 to Month 12)|Administrative Problems|0
2606024|NCT01023815|9009970|P4|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
2606025|NCT01023815|9009971|P3|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
2606026|NCT01023815|9009972|P2|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
2606027|NCT01023815|9009973|P1|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
2606028|NCT01023815|9009970|P4|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
2606029|NCT01023815|9009971|P3|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
2606030|NCT01023815|9009972|P2|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
2606031|NCT01023815|9009973|P1|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
2606032|NCT01023815|9009970|P4|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
2606033|NCT01023815|9009971|P3|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
2606034|NCT01023815|9009972|P2|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
2606035|NCT01023815|9009973|P1|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144
2606036|NCT01023789|9009992|P1|3 - Year Visit|Lost to Follow-up|13
2606037|NCT01023789|9009992|P1|3 - Year Visit|Withdrawal of consent|1
2606038|NCT01023789|9009992|P1|3 - Year Visit|Death|29
2606039|NCT01023672|9010078|P1|Overall Study|Death|1
2606040|NCT01023672|9010078|P1|Overall Study|Worsening disease|2
2606041|NCT01023659|9010085|P3|Overall Study|Lost to Follow-up|99
2606042|NCT01023659|9010086|P2|Overall Study|Lost to Follow-up|228
2606043|NCT01023659|9010087|P1|Overall Study|Lost to Follow-up|73
2606044|NCT01023581|9010114|P7|Overall Study|Other|0
2606045|NCT01023581|9010115|P6|Overall Study|Other|0
2606046|NCT01023581|9010116|P5|Overall Study|Other|1
2606047|NCT01023581|9010117|P4|Overall Study|Other|0
2606048|NCT01023581|9010118|P3|Overall Study|Other|1
2606049|NCT01023581|9010119|P2|Overall Study|Other|0
2606050|NCT01023581|9010120|P1|Overall Study|Other|1
2606051|NCT01023581|9010114|P7|Overall Study|Physician Decision|1
2606052|NCT01023581|9010115|P6|Overall Study|Physician Decision|1
2606053|NCT01023581|9010116|P5|Overall Study|Physician Decision|1
2606054|NCT01023581|9010117|P4|Overall Study|Physician Decision|1
2606055|NCT01023581|9010118|P3|Overall Study|Physician Decision|2
2606056|NCT01023581|9010119|P2|Overall Study|Physician Decision|0
2606057|NCT01023581|9010120|P1|Overall Study|Physician Decision|2
2606058|NCT01023581|9010114|P7|Overall Study|Lack of Efficacy|1
2606059|NCT01023581|9010115|P6|Overall Study|Lack of Efficacy|2
2606060|NCT01023581|9010116|P5|Overall Study|Lack of Efficacy|1
2606061|NCT01023581|9010117|P4|Overall Study|Lack of Efficacy|2
2606062|NCT01023581|9010118|P3|Overall Study|Lack of Efficacy|6
2606063|NCT01023581|9010119|P2|Overall Study|Lack of Efficacy|3
2606064|NCT01023581|9010120|P1|Overall Study|Lack of Efficacy|9
2606065|NCT01023581|9010114|P7|Overall Study|Pregnancy|0
2606066|NCT01023581|9010115|P6|Overall Study|Pregnancy|1
2606067|NCT01023581|9010116|P5|Overall Study|Pregnancy|0
2606068|NCT01023581|9010117|P4|Overall Study|Pregnancy|2
2606069|NCT01023581|9010118|P3|Overall Study|Pregnancy|0
2606070|NCT01023581|9010119|P2|Overall Study|Pregnancy|0
2606071|NCT01023581|9010120|P1|Overall Study|Pregnancy|0
2606072|NCT01023581|9010114|P7|Overall Study|Withdrawal by Subject|5
2606073|NCT01023581|9010115|P6|Overall Study|Withdrawal by Subject|8
2606074|NCT01023581|9010116|P5|Overall Study|Withdrawal by Subject|6
2606075|NCT01023581|9010117|P4|Overall Study|Withdrawal by Subject|10
2606076|NCT01023581|9010118|P3|Overall Study|Withdrawal by Subject|16
2606077|NCT01023581|9010119|P2|Overall Study|Withdrawal by Subject|8
2606078|NCT01023581|9010120|P1|Overall Study|Withdrawal by Subject|13
2606079|NCT01023581|9010114|P7|Overall Study|Lost to Follow-up|2
2606080|NCT01023581|9010115|P6|Overall Study|Lost to Follow-up|2
2606081|NCT01023581|9010116|P5|Overall Study|Lost to Follow-up|5
2606082|NCT01023581|9010117|P4|Overall Study|Lost to Follow-up|2
2606083|NCT01023581|9010118|P3|Overall Study|Lost to Follow-up|7
2606084|NCT01023581|9010119|P2|Overall Study|Lost to Follow-up|8
2606085|NCT01023581|9010120|P1|Overall Study|Lost to Follow-up|4
2606086|NCT01023581|9010114|P7|Overall Study|Major protocol deviation|0
2606087|NCT01023581|9010115|P6|Overall Study|Major protocol deviation|0
2606088|NCT01023581|9010116|P5|Overall Study|Major protocol deviation|0
2606089|NCT01023581|9010117|P4|Overall Study|Major protocol deviation|0
2606090|NCT01023581|9010118|P3|Overall Study|Major protocol deviation|3
2606091|NCT01023581|9010119|P2|Overall Study|Major protocol deviation|0
2606092|NCT01023581|9010120|P1|Overall Study|Major protocol deviation|2
2606093|NCT01023581|9010114|P7|Overall Study|Adverse Event|11
2606094|NCT01023581|9010115|P6|Overall Study|Adverse Event|5
2606095|NCT01023581|9010116|P5|Overall Study|Adverse Event|2
2606096|NCT01023581|9010117|P4|Overall Study|Adverse Event|3
2606097|NCT01023581|9010118|P3|Overall Study|Adverse Event|7
2606098|NCT01023581|9010119|P2|Overall Study|Adverse Event|4
2606099|NCT01023581|9010120|P1|Overall Study|Adverse Event|4
2606100|NCT01023516|9010177|P2|Overall Study|Incorrect enrolment|2
2606101|NCT01023516|9010178|P1|Overall Study|Incorrect enrolment|4
2606102|NCT01023516|9010177|P2|Overall Study|Study-specific criteria|2
2606103|NCT01023516|9010178|P1|Overall Study|Study-specific criteria|4
2606104|NCT01023516|9010177|P2|Overall Study|Safety reason|3
2606105|NCT01023516|9010178|P1|Overall Study|Safety reason|0
2606106|NCT01023516|9010177|P2|Overall Study|Adverse Event|6
2606107|NCT01023516|9010178|P1|Overall Study|Adverse Event|9
2606108|NCT01023516|9010177|P2|Overall Study|Voluntary discontinuation|5
2606109|NCT01023516|9010178|P1|Overall Study|Voluntary discontinuation|7
2606110|NCT01023308|9010260|P2|Overall Study|Withdrawal by Subject|18
2606111|NCT01023308|9010261|P1|Overall Study|Withdrawal by Subject|34
2606112|NCT01023308|9010260|P2|Overall Study|Lost to Follow-up|0
2606113|NCT01023308|9010261|P1|Overall Study|Lost to Follow-up|1
2606114|NCT01023308|9010260|P2|Overall Study|Untreated|5
2606115|NCT01023308|9010261|P1|Overall Study|Untreated|5
2606116|NCT01023308|9010260|P2|Overall Study|Protocol Violation|4
2606117|NCT01023308|9010261|P1|Overall Study|Protocol Violation|3
2606118|NCT01023308|9010260|P2|Overall Study|New Cancer therapy|7
2606119|NCT01023308|9010261|P1|Overall Study|New Cancer therapy|4
2606120|NCT01023308|9010260|P2|Overall Study|Disease progression|153
2606121|NCT01023308|9010261|P1|Overall Study|Disease progression|82
2606122|NCT01023308|9010260|P2|Overall Study|Death|17
2606123|NCT01023308|9010261|P1|Overall Study|Death|21
2606124|NCT01023308|9010260|P2|Overall Study|Adverse Event|66
2606125|NCT01023308|9010261|P1|Overall Study|Adverse Event|130
2606126|NCT01023308|9010260|P2|Overall Study|Administrative problems|1
2606127|NCT01023308|9010261|P1|Overall Study|Administrative problems|2
2606128|NCT01023308|9010260|P2|Overall Study|Abnormal test proceedure results|8
2606129|NCT01023308|9010261|P1|Overall Study|Abnormal test proceedure results|3
2606130|NCT01023269|9010287|P2|Overall Study|early termination of the study|0
2606131|NCT01023269|9010288|P1|Overall Study|early termination of the study|2
2606132|NCT01023256|9010296|P4|Overall Study|Withdrawal by Subject|2
2606133|NCT01023256|9010297|P3|Overall Study|Withdrawal by Subject|0
2606134|NCT01023256|9010298|P2|Overall Study|Withdrawal by Subject|0
2606135|NCT01023256|9010299|P1|Overall Study|Withdrawal by Subject|0
2606136|NCT01023256|9010296|P4|Overall Study|Adverse Event|1
2606137|NCT01023256|9010297|P3|Overall Study|Adverse Event|0
2606138|NCT01023256|9010298|P2|Overall Study|Adverse Event|0
2606139|NCT01023256|9010299|P1|Overall Study|Adverse Event|0
2606140|NCT01023256|9010296|P4|Overall Study|Other|2
2606141|NCT01023256|9010297|P3|Overall Study|Other|0
2606142|NCT01023256|9010298|P2|Overall Study|Other|0
2606143|NCT01023256|9010299|P1|Overall Study|Other|1
2606144|NCT01023256|9010296|P4|Overall Study|Randomized but not treated|0
2606145|NCT01023256|9010297|P3|Overall Study|Randomized but not treated|1
2606146|NCT01023256|9010298|P2|Overall Study|Randomized but not treated|0
2606147|NCT01023256|9010299|P1|Overall Study|Randomized but not treated|1
2606148|NCT01023256|9010296|P4|Overall Study|Protocol Violation|0
2606149|NCT01023256|9010297|P3|Overall Study|Protocol Violation|0
2606150|NCT01023256|9010298|P2|Overall Study|Protocol Violation|3
2606151|NCT01023256|9010299|P1|Overall Study|Protocol Violation|2
2606152|NCT01023217|9010341|P2|Overall Study|Withdrawal by Subject|0
2606153|NCT01023217|9010342|P1|Overall Study|Withdrawal by Subject|1
2606154|NCT01023061|9010380|P1|Overall Study|Withdrawal prior to treatment|2
2606155|NCT01023035|9010389|P3|Follow-up Period (up to Week 72)|Non-medical Reason|38
2606156|NCT01023035|9010390|P2|Follow-up Period (up to Week 72)|Non-medical Reason|28
2606157|NCT01023035|9010391|P1|Follow-up Period (up to Week 72)|Non-medical Reason|26
2606158|NCT01023035|9010389|P3|Follow-up Period (up to Week 72)|Adverse Event|1
2606159|NCT01023035|9010390|P2|Follow-up Period (up to Week 72)|Adverse Event|0
2606160|NCT01023035|9010391|P1|Follow-up Period (up to Week 72)|Adverse Event|2
2606161|NCT01023035|9010389|P3|Treatment Period|Treatment Failure|24
2606162|NCT01023035|9010390|P2|Treatment Period|Treatment Failure|31
2606163|NCT01023035|9010391|P1|Treatment Period|Treatment Failure|26
2606164|NCT01023035|9010389|P3|Treatment Period|Non-Medical Reasons|44
2606165|NCT01023035|9010390|P2|Treatment Period|Non-Medical Reasons|22
2606166|NCT01023035|9010391|P1|Treatment Period|Non-Medical Reasons|19
2606167|NCT01023035|9010389|P3|Treatment Period|Adverse Event|50
2606168|NCT01023035|9010390|P2|Treatment Period|Adverse Event|32
2606169|NCT01023035|9010391|P1|Treatment Period|Adverse Event|27
2606170|NCT01023022|9010401|P1|Overall Study|due to technical issues|2
2606171|NCT01023022|9010401|P1|Overall Study|Lost to Follow-up|7
2606172|NCT01023022|9010401|P1|Overall Study|Death|5
2606173|NCT01022996|9010407|P1|Overall Study|Protocol Violation|1
2606174|NCT01022996|9010407|P1|Overall Study|Disease Progression|32
2606175|NCT01022996|9010407|P1|Overall Study|Administrative problems|6
2606176|NCT01022996|9010407|P1|Overall Study|Lost to Follow-up|1
2606177|NCT01022996|9010407|P1|Overall Study|Withdrawal by Subject|3
2606178|NCT01022996|9010407|P1|Overall Study|Adverse Event|14
2606179|NCT01022853|9010421|P5|Overall Study|Other not stated above|0
2606180|NCT01022853|9010422|P4|Overall Study|Other not stated above|0
2606181|NCT01022853|9010423|P3|Overall Study|Other not stated above|1
2606182|NCT01022853|9010424|P2|Overall Study|Other not stated above|0
2606183|NCT01022853|9010425|P1|Overall Study|Other not stated above|1
2606184|NCT01022853|9010421|P5|Overall Study|Withdrawal by Subject|0
2606185|NCT01022853|9010422|P4|Overall Study|Withdrawal by Subject|1
2606186|NCT01022853|9010423|P3|Overall Study|Withdrawal by Subject|1
2606187|NCT01022853|9010424|P2|Overall Study|Withdrawal by Subject|1
2606188|NCT01022853|9010425|P1|Overall Study|Withdrawal by Subject|0
2606189|NCT01022853|9010421|P5|Overall Study|Dose-limiting toxicity|1
2606190|NCT01022853|9010422|P4|Overall Study|Dose-limiting toxicity|0
2606191|NCT01022853|9010423|P3|Overall Study|Dose-limiting toxicity|0
2606192|NCT01022853|9010424|P2|Overall Study|Dose-limiting toxicity|0
2606193|NCT01022853|9010425|P1|Overall Study|Dose-limiting toxicity|0
2606194|NCT01022853|9010421|P5|Overall Study|Progressive disease|1
2606195|NCT01022853|9010422|P4|Overall Study|Progressive disease|7
2606196|NCT01022853|9010423|P3|Overall Study|Progressive disease|11
2606197|NCT01022853|9010424|P2|Overall Study|Progressive disease|3
2606198|NCT01022853|9010425|P1|Overall Study|Progressive disease|2
2606199|NCT01022762|9010504|P2|Overall Study|Unclassified|20
2606200|NCT01022762|9010505|P1|Overall Study|Unclassified|12
2606201|NCT01022762|9010504|P2|Overall Study|Protocol Violation|6
2606202|NCT01022762|9010505|P1|Overall Study|Protocol Violation|7
2606203|NCT01022762|9010504|P2|Overall Study|Lack of Efficacy|1
2606204|NCT01022762|9010505|P1|Overall Study|Lack of Efficacy|0
2606205|NCT01022762|9010504|P2|Overall Study|Adverse Event|1
2606206|NCT01022762|9010505|P1|Overall Study|Adverse Event|3
2606207|NCT01022502|9010540|P1|Overall Study|Withdrawal by Subject|1
2606208|NCT01022502|9010540|P1|Overall Study|employment related reasons|1
2606209|NCT01022502|9010540|P1|Overall Study|Adverse Event|1
2606210|NCT01022424|9010554|P1|Overall Study|eGFR under the withdrawal criteria|2
2606211|NCT01022424|9010554|P1|Overall Study|Physician Decision|1
2606212|NCT01022424|9010554|P1|Overall Study|Adverse Event|1
2606213|NCT01022398|9010569|P2|Overall Study|Study terminated|2
2606214|NCT01022398|9010570|P1|Overall Study|Study terminated|2
2606215|NCT01022203|9010595|P2|Follow-Up Assessment|Lost to Follow-up|2
2606216|NCT01022203|9010596|P1|Follow-Up Assessment|Lost to Follow-up|2
2606217|NCT01022203|9010595|P2|Post Treatment Assessment|Adverse Event|2
2606218|NCT01022203|9010596|P1|Post Treatment Assessment|Adverse Event|0
2606219|NCT01022203|9010595|P2|Post Treatment Assessment|Physician Decision|0
2606220|NCT01022203|9010596|P1|Post Treatment Assessment|Physician Decision|2
2606221|NCT01022203|9010595|P2|Post Treatment Assessment|Withdrawal by Subject|12
2606222|NCT01022203|9010596|P1|Post Treatment Assessment|Withdrawal by Subject|12
2606223|NCT01022112|9010615|P5|Overall Study|Fasting plasma glucose level increased|7
2606224|NCT01022112|9010616|P4|Overall Study|Fasting plasma glucose level increased|0
2606225|NCT01022112|9010617|P3|Overall Study|Fasting plasma glucose level increased|0
2606226|NCT01022112|9010618|P2|Overall Study|Fasting plasma glucose level increased|0
2606227|NCT01022112|9010619|P1|Overall Study|Fasting plasma glucose level increased|1
2606228|NCT01022112|9010615|P5|Overall Study|Withdrawal by Subject|1
2606229|NCT01022112|9010616|P4|Overall Study|Withdrawal by Subject|2
2606230|NCT01022112|9010617|P3|Overall Study|Withdrawal by Subject|2
2606231|NCT01022112|9010618|P2|Overall Study|Withdrawal by Subject|1
2606232|NCT01022112|9010619|P1|Overall Study|Withdrawal by Subject|0
2606233|NCT01022112|9010615|P5|Overall Study|Physician Decision|1
2606234|NCT01022112|9010616|P4|Overall Study|Physician Decision|0
2606235|NCT01022112|9010617|P3|Overall Study|Physician Decision|1
2606236|NCT01022112|9010618|P2|Overall Study|Physician Decision|0
2606237|NCT01022112|9010619|P1|Overall Study|Physician Decision|0
2606238|NCT01022112|9010615|P5|Overall Study|Lack of Efficacy|1
2606239|NCT01022112|9010616|P4|Overall Study|Lack of Efficacy|0
2606240|NCT01022112|9010617|P3|Overall Study|Lack of Efficacy|0
2606241|NCT01022112|9010618|P2|Overall Study|Lack of Efficacy|0
2606242|NCT01022112|9010619|P1|Overall Study|Lack of Efficacy|1
2606243|NCT01022112|9010615|P5|Overall Study|Adverse Event|0
2606244|NCT01022112|9010616|P4|Overall Study|Adverse Event|1
2606245|NCT01022112|9010617|P3|Overall Study|Adverse Event|0
2606246|NCT01022112|9010618|P2|Overall Study|Adverse Event|2
2606247|NCT01022112|9010619|P1|Overall Study|Adverse Event|1
2606248|NCT01021878|9010668|P2|Overall Study|Transplantation|1
2606249|NCT01021878|9010669|P1|Overall Study|Transplantation|6
2606250|NCT01021878|9010668|P2|Overall Study|Adverse Event|5
2606251|NCT01021878|9010669|P1|Overall Study|Adverse Event|6
2606252|NCT01021878|9010668|P2|Overall Study|Death|1
2606253|NCT01021878|9010669|P1|Overall Study|Death|0
2606254|NCT01021878|9010668|P2|Overall Study|Lost to Follow-up|3
2606255|NCT01021878|9010669|P1|Overall Study|Lost to Follow-up|4
2606256|NCT01021852|9010691|P8|Treatment Period 2|Withdrawal by Subject|2
2606257|NCT01021852|9010692|P7|Treatment Period 2|Withdrawal by Subject|1
2606258|NCT01021852|9010693|P6|Treatment Period 2|Withdrawal by Subject|0
2606259|NCT01021852|9010694|P5|Treatment Period 2|Withdrawal by Subject|0
2606260|NCT01021852|9010695|P4|Treatment Period 2|Withdrawal by Subject|0
2606261|NCT01021852|9010696|P3|Treatment Period 2|Withdrawal by Subject|0
2606262|NCT01021852|9010697|P2|Treatment Period 2|Withdrawal by Subject|0
2606263|NCT01021852|9010698|P1|Treatment Period 2|Withdrawal by Subject|0
2606264|NCT01021852|9010691|P8|Treatment Period 2|Protocol Violation|0
2606265|NCT01021852|9010692|P7|Treatment Period 2|Protocol Violation|1
2606266|NCT01021852|9010693|P6|Treatment Period 2|Protocol Violation|0
2606267|NCT01021852|9010694|P5|Treatment Period 2|Protocol Violation|1
2606268|NCT01021852|9010695|P4|Treatment Period 2|Protocol Violation|0
2606269|NCT01021852|9010696|P3|Treatment Period 2|Protocol Violation|0
2606270|NCT01021852|9010697|P2|Treatment Period 2|Protocol Violation|0
2606271|NCT01021852|9010698|P1|Treatment Period 2|Protocol Violation|0
2606272|NCT01021852|9010691|P8|Treatment Period 2|Physician Decision|0
2606273|NCT01021852|9010692|P7|Treatment Period 2|Physician Decision|0
2606274|NCT01021852|9010693|P6|Treatment Period 2|Physician Decision|0
2606275|NCT01021852|9010694|P5|Treatment Period 2|Physician Decision|0
2606276|NCT01021852|9010695|P4|Treatment Period 2|Physician Decision|0
2606277|NCT01021852|9010696|P3|Treatment Period 2|Physician Decision|1
2606278|NCT01021852|9010697|P2|Treatment Period 2|Physician Decision|0
2606279|NCT01021852|9010698|P1|Treatment Period 2|Physician Decision|0
2606280|NCT01021852|9010691|P8|Treatment Period 2|Lack of Efficacy|0
2606281|NCT01021852|9010692|P7|Treatment Period 2|Lack of Efficacy|0
2606282|NCT01021852|9010693|P6|Treatment Period 2|Lack of Efficacy|1
2606283|NCT01021852|9010694|P5|Treatment Period 2|Lack of Efficacy|0
2606284|NCT01021852|9010695|P4|Treatment Period 2|Lack of Efficacy|0
2606285|NCT01021852|9010696|P3|Treatment Period 2|Lack of Efficacy|0
2606286|NCT01021852|9010697|P2|Treatment Period 2|Lack of Efficacy|0
2606287|NCT01021852|9010698|P1|Treatment Period 2|Lack of Efficacy|0
2606288|NCT01021852|9010691|P8|Treatment Period 2|Adverse Event|0
2606289|NCT01021852|9010692|P7|Treatment Period 2|Adverse Event|1
2606290|NCT01021852|9010693|P6|Treatment Period 2|Adverse Event|0
2606291|NCT01021852|9010694|P5|Treatment Period 2|Adverse Event|1
2606292|NCT01021852|9010695|P4|Treatment Period 2|Adverse Event|0
2606293|NCT01021852|9010696|P3|Treatment Period 2|Adverse Event|0
2606294|NCT01021852|9010697|P2|Treatment Period 2|Adverse Event|1
2606295|NCT01021852|9010698|P1|Treatment Period 2|Adverse Event|0
2606296|NCT01021852|9010691|P8|Washout Period-No Drug|Adverse Event|0
2606297|NCT01021852|9010692|P7|Washout Period-No Drug|Adverse Event|0
2606298|NCT01021852|9010693|P6|Washout Period-No Drug|Adverse Event|1
2606299|NCT01021852|9010694|P5|Washout Period-No Drug|Adverse Event|0
2606300|NCT01021852|9010695|P4|Washout Period-No Drug|Adverse Event|0
2606301|NCT01021852|9010696|P3|Washout Period-No Drug|Adverse Event|0
2606302|NCT01021852|9010697|P2|Washout Period-No Drug|Adverse Event|0
2606303|NCT01021852|9010698|P1|Washout Period-No Drug|Adverse Event|1
2606304|NCT01021852|9010691|P8|Washout Period-Placebo|Protocol Violation|0
2606305|NCT01021852|9010692|P7|Washout Period-Placebo|Protocol Violation|1
2606306|NCT01021852|9010693|P6|Washout Period-Placebo|Protocol Violation|0
2606307|NCT01021852|9010694|P5|Washout Period-Placebo|Protocol Violation|0
2606308|NCT01021852|9010695|P4|Washout Period-Placebo|Protocol Violation|0
2606309|NCT01021852|9010696|P3|Washout Period-Placebo|Protocol Violation|0
2606310|NCT01021852|9010697|P2|Washout Period-Placebo|Protocol Violation|0
2606311|NCT01021852|9010698|P1|Washout Period-Placebo|Protocol Violation|0
2606312|NCT01021852|9010691|P8|Washout Period-Placebo|Lost to Follow-up|0
2606313|NCT01021852|9010692|P7|Washout Period-Placebo|Lost to Follow-up|0
2606314|NCT01021852|9010693|P6|Washout Period-Placebo|Lost to Follow-up|0
2606315|NCT01021852|9010694|P5|Washout Period-Placebo|Lost to Follow-up|1
2606316|NCT01021852|9010695|P4|Washout Period-Placebo|Lost to Follow-up|0
2606317|NCT01021852|9010696|P3|Washout Period-Placebo|Lost to Follow-up|0
2606318|NCT01021852|9010697|P2|Washout Period-Placebo|Lost to Follow-up|0
2606319|NCT01021852|9010698|P1|Washout Period-Placebo|Lost to Follow-up|0
2606320|NCT01021852|9010691|P8|Washout Period-Placebo|Adverse Event|0
2606321|NCT01021852|9010692|P7|Washout Period-Placebo|Adverse Event|0
2606322|NCT01021852|9010693|P6|Washout Period-Placebo|Adverse Event|1
2606323|NCT01021852|9010694|P5|Washout Period-Placebo|Adverse Event|0
2606324|NCT01021852|9010695|P4|Washout Period-Placebo|Adverse Event|1
2606325|NCT01021852|9010696|P3|Washout Period-Placebo|Adverse Event|0
2606326|NCT01021852|9010697|P2|Washout Period-Placebo|Adverse Event|0
2606327|NCT01021852|9010698|P1|Washout Period-Placebo|Adverse Event|0
2606328|NCT01021852|9010691|P8|Treatment Period 1|Not Treated|0
2606329|NCT01021852|9010692|P7|Treatment Period 1|Not Treated|0
2606330|NCT01021852|9010693|P6|Treatment Period 1|Not Treated|0
2606331|NCT01021852|9010694|P5|Treatment Period 1|Not Treated|0
2606332|NCT01021852|9010695|P4|Treatment Period 1|Not Treated|2
2606333|NCT01021852|9010696|P3|Treatment Period 1|Not Treated|0
2606334|NCT01021852|9010697|P2|Treatment Period 1|Not Treated|0
2606335|NCT01021852|9010698|P1|Treatment Period 1|Not Treated|0
2606336|NCT01021852|9010691|P8|Treatment Period 1|Withdrawal by Subject|1
2606337|NCT01021852|9010692|P7|Treatment Period 1|Withdrawal by Subject|0
2606338|NCT01021852|9010693|P6|Treatment Period 1|Withdrawal by Subject|0
2606339|NCT01021852|9010694|P5|Treatment Period 1|Withdrawal by Subject|1
2606340|NCT01021852|9010695|P4|Treatment Period 1|Withdrawal by Subject|0
2606341|NCT01021852|9010696|P3|Treatment Period 1|Withdrawal by Subject|0
2606342|NCT01021852|9010697|P2|Treatment Period 1|Withdrawal by Subject|0
2606343|NCT01021852|9010698|P1|Treatment Period 1|Withdrawal by Subject|0
2606344|NCT01021852|9010691|P8|Treatment Period 1|Pregnancy|0
2606345|NCT01021852|9010692|P7|Treatment Period 1|Pregnancy|0
2606346|NCT01021852|9010693|P6|Treatment Period 1|Pregnancy|0
2606347|NCT01021852|9010694|P5|Treatment Period 1|Pregnancy|0
2606348|NCT01021852|9010695|P4|Treatment Period 1|Pregnancy|0
2606349|NCT01021852|9010696|P3|Treatment Period 1|Pregnancy|1
2606350|NCT01021852|9010697|P2|Treatment Period 1|Pregnancy|0
2606351|NCT01021852|9010698|P1|Treatment Period 1|Pregnancy|0
2606352|NCT01021852|9010691|P8|Treatment Period 1|Adverse Event|0
2606353|NCT01021852|9010692|P7|Treatment Period 1|Adverse Event|0
2606354|NCT01021852|9010693|P6|Treatment Period 1|Adverse Event|2
2606355|NCT01021852|9010694|P5|Treatment Period 1|Adverse Event|2
2606356|NCT01021852|9010695|P4|Treatment Period 1|Adverse Event|0
2606357|NCT01021852|9010696|P3|Treatment Period 1|Adverse Event|1
2606358|NCT01021852|9010697|P2|Treatment Period 1|Adverse Event|1
2606359|NCT01021852|9010698|P1|Treatment Period 1|Adverse Event|3
2606360|NCT01021813|9010734|P5|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
2606361|NCT01021813|9010735|P4|DB Randomized Discontinuation Phase|Withdrawal by Subject|1
2606362|NCT01021813|9010736|P3|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
2606363|NCT01021813|9010737|P2|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
2606364|NCT01021813|9010738|P1|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
2606365|NCT01021813|9010734|P5|DB Randomized Discontinuation Phase|Protocol Violation|0
2606366|NCT01021813|9010735|P4|DB Randomized Discontinuation Phase|Protocol Violation|0
2606367|NCT01021813|9010736|P3|DB Randomized Discontinuation Phase|Protocol Violation|1
2606368|NCT01021813|9010737|P2|DB Randomized Discontinuation Phase|Protocol Violation|0
2606369|NCT01021813|9010738|P1|DB Randomized Discontinuation Phase|Protocol Violation|0
2606370|NCT01021813|9010734|P5|DB Randomized Discontinuation Phase|Lost to Follow-up|1
2606371|NCT01021813|9010735|P4|DB Randomized Discontinuation Phase|Lost to Follow-up|0
2606372|NCT01021813|9010736|P3|DB Randomized Discontinuation Phase|Lost to Follow-up|0
2606373|NCT01021813|9010737|P2|DB Randomized Discontinuation Phase|Lost to Follow-up|0
2606374|NCT01021813|9010738|P1|DB Randomized Discontinuation Phase|Lost to Follow-up|0
2606375|NCT01021813|9010734|P5|DB Randomized Discontinuation Phase|Lack of Efficacy|0
2606376|NCT01021813|9010735|P4|DB Randomized Discontinuation Phase|Lack of Efficacy|1
2606377|NCT01021813|9010736|P3|DB Randomized Discontinuation Phase|Lack of Efficacy|0
2606378|NCT01021813|9010737|P2|DB Randomized Discontinuation Phase|Lack of Efficacy|0
2606379|NCT01021813|9010738|P1|DB Randomized Discontinuation Phase|Lack of Efficacy|0
2606380|NCT01021813|9010734|P5|DB Randomized Discontinuation Phase|Adverse Event|1
2606381|NCT01021813|9010735|P4|DB Randomized Discontinuation Phase|Adverse Event|3
2606382|NCT01021813|9010736|P3|DB Randomized Discontinuation Phase|Adverse Event|0
2606383|NCT01021813|9010737|P2|DB Randomized Discontinuation Phase|Adverse Event|0
2606384|NCT01021813|9010738|P1|DB Randomized Discontinuation Phase|Adverse Event|0
2606385|NCT01021813|9010734|P5|DB Treatment Phase|Withdrawal by Subject|0
2606386|NCT01021813|9010735|P4|DB Treatment Phase|Withdrawal by Subject|0
2606387|NCT01021813|9010736|P3|DB Treatment Phase|Withdrawal by Subject|0
2606388|NCT01021813|9010737|P2|DB Treatment Phase|Withdrawal by Subject|24
2606389|NCT01021813|9010738|P1|DB Treatment Phase|Withdrawal by Subject|60
2606390|NCT01021813|9010734|P5|DB Treatment Phase|Protocol Violation|0
2606391|NCT01021813|9010735|P4|DB Treatment Phase|Protocol Violation|0
2606392|NCT01021813|9010736|P3|DB Treatment Phase|Protocol Violation|0
2606393|NCT01021813|9010737|P2|DB Treatment Phase|Protocol Violation|3
2606394|NCT01021813|9010738|P1|DB Treatment Phase|Protocol Violation|4
2606395|NCT01021813|9010734|P5|DB Treatment Phase|Pregnancy|0
2606396|NCT01021813|9010735|P4|DB Treatment Phase|Pregnancy|0
2606397|NCT01021813|9010736|P3|DB Treatment Phase|Pregnancy|0
2606398|NCT01021813|9010737|P2|DB Treatment Phase|Pregnancy|0
2606399|NCT01021813|9010738|P1|DB Treatment Phase|Pregnancy|1
2606400|NCT01021813|9010734|P5|DB Treatment Phase|Physician Decision|0
2606401|NCT01021813|9010735|P4|DB Treatment Phase|Physician Decision|0
2606402|NCT01021813|9010736|P3|DB Treatment Phase|Physician Decision|0
2606403|NCT01021813|9010737|P2|DB Treatment Phase|Physician Decision|8
2606404|NCT01021813|9010738|P1|DB Treatment Phase|Physician Decision|17
2606405|NCT01021813|9010734|P5|DB Treatment Phase|Lost to Follow-up|0
2606406|NCT01021813|9010735|P4|DB Treatment Phase|Lost to Follow-up|0
2606407|NCT01021813|9010736|P3|DB Treatment Phase|Lost to Follow-up|0
2606408|NCT01021813|9010737|P2|DB Treatment Phase|Lost to Follow-up|12
2606409|NCT01021813|9010738|P1|DB Treatment Phase|Lost to Follow-up|14
2606410|NCT01021813|9010734|P5|DB Treatment Phase|Lack of Efficacy|0
2606411|NCT01021813|9010735|P4|DB Treatment Phase|Lack of Efficacy|0
2606412|NCT01021813|9010736|P3|DB Treatment Phase|Lack of Efficacy|0
2606413|NCT01021813|9010737|P2|DB Treatment Phase|Lack of Efficacy|28
2606414|NCT01021813|9010738|P1|DB Treatment Phase|Lack of Efficacy|44
2606415|NCT01021813|9010734|P5|DB Treatment Phase|Adverse Event|0
2606416|NCT01021813|9010735|P4|DB Treatment Phase|Adverse Event|0
2606417|NCT01021813|9010736|P3|DB Treatment Phase|Adverse Event|0
2606418|NCT01021813|9010737|P2|DB Treatment Phase|Adverse Event|22
2606419|NCT01021813|9010738|P1|DB Treatment Phase|Adverse Event|60
2606420|NCT01021748|9010799|P9|Overall Study|Not Treated|0
2606421|NCT01021748|9010800|P8|Overall Study|Not Treated|0
2606422|NCT01021748|9010801|P7|Overall Study|Not Treated|0
2606423|NCT01021748|9010802|P6|Overall Study|Not Treated|0
2606424|NCT01021748|9010803|P5|Overall Study|Not Treated|0
2606425|NCT01021748|9010804|P4|Overall Study|Not Treated|0
2606426|NCT01021748|9010805|P3|Overall Study|Not Treated|0
2606427|NCT01021748|9010806|P2|Overall Study|Not Treated|1
2606428|NCT01021748|9010807|P1|Overall Study|Not Treated|0
2606429|NCT01021748|9010799|P9|Overall Study|Withdrawal by Subject|1
2606430|NCT01021748|9010800|P8|Overall Study|Withdrawal by Subject|0
2606431|NCT01021748|9010801|P7|Overall Study|Withdrawal by Subject|1
2606432|NCT01021748|9010802|P6|Overall Study|Withdrawal by Subject|0
2606433|NCT01021748|9010803|P5|Overall Study|Withdrawal by Subject|0
2606434|NCT01021748|9010804|P4|Overall Study|Withdrawal by Subject|0
2606435|NCT01021748|9010805|P3|Overall Study|Withdrawal by Subject|0
2606436|NCT01021748|9010806|P2|Overall Study|Withdrawal by Subject|0
2606437|NCT01021748|9010807|P1|Overall Study|Withdrawal by Subject|0
2606438|NCT01021748|9010799|P9|Overall Study|Progressive Disease|6
2606439|NCT01021748|9010800|P8|Overall Study|Progressive Disease|5
2606440|NCT01021748|9010801|P7|Overall Study|Progressive Disease|0
2606441|NCT01021748|9010802|P6|Overall Study|Progressive Disease|3
2606442|NCT01021748|9010803|P5|Overall Study|Progressive Disease|7
2606443|NCT01021748|9010804|P4|Overall Study|Progressive Disease|6
2606444|NCT01021748|9010805|P3|Overall Study|Progressive Disease|4
2606445|NCT01021748|9010806|P2|Overall Study|Progressive Disease|3
2606446|NCT01021748|9010807|P1|Overall Study|Progressive Disease|3
2606447|NCT01021748|9010799|P9|Overall Study|Physician Decision|2
2606448|NCT01021748|9010800|P8|Overall Study|Physician Decision|1
2606449|NCT01021748|9010801|P7|Overall Study|Physician Decision|1
2606450|NCT01021748|9010802|P6|Overall Study|Physician Decision|0
2606451|NCT01021748|9010803|P5|Overall Study|Physician Decision|0
2606452|NCT01021748|9010804|P4|Overall Study|Physician Decision|1
2606453|NCT01021748|9010805|P3|Overall Study|Physician Decision|1
2606454|NCT01021748|9010806|P2|Overall Study|Physician Decision|0
2606455|NCT01021748|9010807|P1|Overall Study|Physician Decision|1
2606456|NCT01021748|9010799|P9|Overall Study|Adverse Event|7
2606457|NCT01021748|9010800|P8|Overall Study|Adverse Event|0
2606458|NCT01021748|9010801|P7|Overall Study|Adverse Event|1
2606459|NCT01021748|9010802|P6|Overall Study|Adverse Event|0
2606460|NCT01021748|9010803|P5|Overall Study|Adverse Event|2
2606461|NCT01021748|9010804|P4|Overall Study|Adverse Event|0
2606462|NCT01021748|9010805|P3|Overall Study|Adverse Event|2
2606463|NCT01021748|9010806|P2|Overall Study|Adverse Event|1
2606464|NCT01021748|9010807|P1|Overall Study|Adverse Event|2
2606465|NCT01021683|9010854|P1|Overall Study|Other|8
2606466|NCT01021683|9010854|P1|Overall Study|Recovery of neutrophil count|51
2606467|NCT01021683|9010854|P1|Overall Study|Lack of Efficacy|12
2606468|NCT01021553|9010880|P3|Overall Study|Withdrawal by Subject|0
2606469|NCT01021553|9010881|P2|Overall Study|Withdrawal by Subject|1
2606470|NCT01021553|9010882|P1|Overall Study|Withdrawal by Subject|1
2606471|NCT01021553|9010880|P3|Overall Study|Lost to Follow-up|1
2606472|NCT01021553|9010881|P2|Overall Study|Lost to Follow-up|0
2606473|NCT01021553|9010882|P1|Overall Study|Lost to Follow-up|0
2606474|NCT01021553|9010880|P3|Overall Study|Protocol Violation|2
2606475|NCT01021553|9010881|P2|Overall Study|Protocol Violation|2
2606476|NCT01021553|9010882|P1|Overall Study|Protocol Violation|0
2606477|NCT01021553|9010880|P3|Overall Study|Lack of Efficacy|0
2606478|NCT01021553|9010881|P2|Overall Study|Lack of Efficacy|2
2606479|NCT01021553|9010882|P1|Overall Study|Lack of Efficacy|2
2606480|NCT01021553|9010880|P3|Overall Study|Adverse Event|0
2606481|NCT01021553|9010881|P2|Overall Study|Adverse Event|0
2606482|NCT01021553|9010882|P1|Overall Study|Adverse Event|1
2606483|NCT01021423|9010936|P2|Overall Study|Study terminated|5
2606484|NCT01021423|9010937|P1|Overall Study|Study terminated|4
2606485|NCT01021332|9010953|P1|Overall Study|Miscellaneous|3
2606486|NCT01021332|9010953|P1|Overall Study|Protocol Violation|9
2606487|NCT01021332|9010953|P1|Overall Study|Lost to Follow-up|4
2606488|NCT01021332|9010953|P1|Overall Study|Withdrawal of Consent|23
2606489|NCT01021332|9010953|P1|Overall Study|Lack of Efficacy|19
2606490|NCT01021332|9010953|P1|Overall Study|Adverse Event|43
2606491|NCT01021332|9010953|P1|Overall Study|Not fulfilling incl./excl.criteria|5
2606492|NCT01021293|9011014|P2|Overall Study|Lost to Follow-up|1
2606493|NCT01021293|9011015|P1|Overall Study|Lost to Follow-up|1
2606494|NCT01021293|9011014|P2|Overall Study|Migrated/moved from study area|18
2606495|NCT01021293|9011015|P1|Overall Study|Migrated/moved from study area|6
2606496|NCT01021293|9011014|P2|Overall Study|Withdrawal by Subject|3
2606497|NCT01021293|9011015|P1|Overall Study|Withdrawal by Subject|1
2606498|NCT01021293|9011014|P2|Overall Study|Adverse Event|1
2606499|NCT01021293|9011015|P1|Overall Study|Adverse Event|2
2606500|NCT01021293|9011014|P2|Overall Study|Serious Adverse Event|1
2606501|NCT01021293|9011015|P1|Overall Study|Serious Adverse Event|2
2606502|NCT01021215|9011034|P2|Overall Study|Lost to Follow-up|0
2606503|NCT01021215|9011035|P1|Overall Study|Lost to Follow-up|3
2606504|NCT01021137|9011049|P4|Overall Study|Withdrawal by Subject|3
2606505|NCT01021137|9011050|P3|Overall Study|Withdrawal by Subject|0
2606506|NCT01021137|9011051|P2|Overall Study|Withdrawal by Subject|0
2606507|NCT01021137|9011052|P1|Overall Study|Withdrawal by Subject|1
2606508|NCT01021137|9011049|P4|Overall Study|Lost to Follow-up|6
2606509|NCT01021137|9011050|P3|Overall Study|Lost to Follow-up|2
2606510|NCT01021137|9011051|P2|Overall Study|Lost to Follow-up|4
2606511|NCT01021137|9011052|P1|Overall Study|Lost to Follow-up|9
2606512|NCT01021020|9011095|P1|14 Day Washout Period A|Physician Decision|1
2606513|NCT01021020|9011095|P1|Period I|Withdrawal by Subject|1
2606514|NCT01021020|9011095|P1|Period I|Protocol Violation|1
2606515|NCT01021007|9011111|P2|Overall Study|Adverse Event|3
2606516|NCT01021007|9011112|P1|Overall Study|Adverse Event|1
2606517|NCT01021007|9011111|P2|Overall Study|Lost to Follow-up|1
2606518|NCT01021007|9011112|P1|Overall Study|Lost to Follow-up|1
2606519|NCT01020981|9011124|P2|Overall Study|Participant declined to complete survey|0
2606520|NCT01020981|9011125|P1|Overall Study|Participant declined to complete survey|2
2606521|NCT01020981|9011124|P2|Overall Study|Survey returned undeliverable|32
2606522|NCT01020981|9011125|P1|Overall Study|Survey returned undeliverable|8
2606523|NCT01020981|9011124|P2|Overall Study|Did not return mailed survey|58
2606524|NCT01020981|9011125|P1|Overall Study|Did not return mailed survey|74
2606525|NCT01020877|9011146|P2|Second Intervention|Withdrawal by Subject|0
2606526|NCT01020877|9011147|P1|Second Intervention|Withdrawal by Subject|1
2606527|NCT01020838|9011157|P1|Overall Study|Most common: Study ended by sponsor|77
2606528|NCT01020838|9011157|P1|Overall Study|Lost to Follow-up|6
2606529|NCT01020838|9011157|P1|Overall Study|Withdrawal by Subject|9
2606530|NCT01020838|9011157|P1|Overall Study|Adverse Event|1
2606531|NCT01020838|9011157|P1|Overall Study|Death|90
2606532|NCT01020812|9011172|P1|Overall Study|Protocol Violation|1
2606533|NCT01020812|9011172|P1|Overall Study|Withdrawal by Subject|1
2606534|NCT01020812|9011172|P1|Overall Study|Physician Decision|1
2606535|NCT01020799|9011182|P3|Overall Study|Lost to Follow-up|2
2606536|NCT01020799|9011183|P2|Overall Study|Lost to Follow-up|4
2606537|NCT01020799|9011184|P1|Overall Study|Lost to Follow-up|6
2606538|NCT01020799|9011182|P3|Overall Study|Withdrawal by Subject|3
2606539|NCT01020799|9011183|P2|Overall Study|Withdrawal by Subject|2
2606540|NCT01020799|9011184|P1|Overall Study|Withdrawal by Subject|2
2606541|NCT01020799|9011182|P3|Overall Study|Protocol Violation|0
2606542|NCT01020799|9011183|P2|Overall Study|Protocol Violation|2
2606543|NCT01020799|9011184|P1|Overall Study|Protocol Violation|3
2606544|NCT01020799|9011182|P3|Overall Study|non-compliance; lack of efficacy; etc.|0
2606545|NCT01020799|9011183|P2|Overall Study|non-compliance; lack of efficacy; etc.|3
2606546|NCT01020799|9011184|P1|Overall Study|non-compliance; lack of efficacy; etc.|4
2606547|NCT01020799|9011182|P3|Overall Study|Adverse Event|2
2606548|NCT01020799|9011183|P2|Overall Study|Adverse Event|3
2606549|NCT01020799|9011184|P1|Overall Study|Adverse Event|4
2606550|NCT01020786|9011207|P1|Maintenance Period|Sponsor Decision|1
2606551|NCT01020786|9011207|P1|Maintenance Period|Withdrawal by Subject|8
2606552|NCT01020786|9011207|P1|Maintenance Period|Progressive Disease|43
2606553|NCT01020786|9011207|P1|Maintenance Period|Adverse Event|8
2606554|NCT01020786|9011207|P1|Induction Period|Withdrawal by Subject|3
2606555|NCT01020786|9011207|P1|Induction Period|Investigator Decision|3
2606556|NCT01020786|9011207|P1|Induction Period|Progressive Disease|31
2606557|NCT01020786|9011207|P1|Induction Period|Adverse Event|10
2606558|NCT01020786|9011207|P1|Induction Period|Entry Criteria Not Met|2
2606559|NCT01020773|9011221|P2|Overall Study|Withdrawal by Subject|3
2606560|NCT01020773|9011222|P1|Overall Study|Withdrawal by Subject|4
2606561|NCT01020747|9011228|P1|Overall Study|Withdrawal by Subject|1
2606562|NCT01020526|9011244|P1|Overall Study|Adverse Event|2
2606563|NCT01020526|9011244|P1|Overall Study|Lost to Follow-up|1
2606564|NCT01020526|9011244|P1|Overall Study|Insufficient clinical response|3
2606565|NCT01020526|9011244|P1|Overall Study|Other reasons|3
2606566|NCT01020526|9011244|P1|Overall Study|Withdrawal by Subject|5
2606567|NCT01020474|9011250|P2|Overall Study|Insufficient Clinical Response|3
2606568|NCT01020474|9011251|P1|Overall Study|Insufficient Clinical Response|0
2606569|NCT01020474|9011250|P2|Overall Study|Other Reasons|1
2606570|NCT01020474|9011251|P1|Overall Study|Other Reasons|1
2606571|NCT01020474|9011250|P2|Overall Study|Withdrawal by Subject|7
2606572|NCT01020474|9011251|P1|Overall Study|Withdrawal by Subject|5
2606573|NCT01020474|9011250|P2|Overall Study|Protocol Violation|2
2606574|NCT01020474|9011251|P1|Overall Study|Protocol Violation|0
2606575|NCT01020474|9011250|P2|Overall Study|Adverse Event|4
2606576|NCT01020474|9011251|P1|Overall Study|Adverse Event|4
2606577|NCT01020448|9011271|P1|Treatment|Lost to Follow-up|2
2606578|NCT01020448|9011271|P1|Treatment|Lack of Efficacy|8
2606579|NCT01020448|9011271|P1|Treatment|Disease Progression|2
2606580|NCT01020448|9011271|P1|Treatment|Consent Withdrawn|3
2606581|NCT01020448|9011271|P1|Treatment|Adverse Event|11
2606582|NCT01020448|9011271|P1|Pre-assignment|Does Not Meet Entry Criteria|2
2606583|NCT01020448|9011271|P1|Pre-assignment|Withdrawal by Subject|5
2606584|NCT01020448|9011271|P1|Pre-assignment|Adverse Event|6
2606585|NCT01020435|9011282|P2|Overall Study|Lost to Follow-up|1
2606586|NCT01020435|9011283|P1|Overall Study|Lost to Follow-up|0
2606587|NCT01020305|9011291|P1|Overall Study|Adverse Event|2
2606588|NCT01020123|9011302|P7|Extention Period|Lost to Follow-up|0
2606589|NCT01020123|9011303|P6|Extention Period|Lost to Follow-up|2
2606590|NCT01020123|9011304|P5|Extention Period|Lost to Follow-up|0
2606591|NCT01020123|9011305|P4|Extention Period|Lost to Follow-up|0
2606592|NCT01020123|9011306|P3|Extention Period|Lost to Follow-up|0
2606593|NCT01020123|9011307|P2|Extention Period|Lost to Follow-up|0
2606594|NCT01020123|9011308|P1|Extention Period|Lost to Follow-up|0
2606595|NCT01020123|9011302|P7|Extention Period|Protocol Violation|1
2606596|NCT01020123|9011303|P6|Extention Period|Protocol Violation|0
2606597|NCT01020123|9011304|P5|Extention Period|Protocol Violation|0
2606598|NCT01020123|9011305|P4|Extention Period|Protocol Violation|0
2606599|NCT01020123|9011306|P3|Extention Period|Protocol Violation|1
2606600|NCT01020123|9011307|P2|Extention Period|Protocol Violation|1
2606601|NCT01020123|9011308|P1|Extention Period|Protocol Violation|1
2606602|NCT01020123|9011302|P7|Extention Period|Adverse Event|0
2606603|NCT01020123|9011303|P6|Extention Period|Adverse Event|0
2606604|NCT01020123|9011304|P5|Extention Period|Adverse Event|0
2606605|NCT01020123|9011305|P4|Extention Period|Adverse Event|1
2606606|NCT01020123|9011306|P3|Extention Period|Adverse Event|0
2606607|NCT01020123|9011307|P2|Extention Period|Adverse Event|0
2606608|NCT01020123|9011308|P1|Extention Period|Adverse Event|0
2606609|NCT01020123|9011302|P7|Extention Period|Withdrawal by Subject|0
2606610|NCT01020123|9011303|P6|Extention Period|Withdrawal by Subject|0
2606611|NCT01020123|9011304|P5|Extention Period|Withdrawal by Subject|0
2606612|NCT01020123|9011305|P4|Extention Period|Withdrawal by Subject|0
2606613|NCT01020123|9011306|P3|Extention Period|Withdrawal by Subject|1
2606614|NCT01020123|9011307|P2|Extention Period|Withdrawal by Subject|1
2606615|NCT01020123|9011308|P1|Extention Period|Withdrawal by Subject|2
2606616|NCT01020123|9011302|P7|Main Period|Unclasified|6
2606617|NCT01020123|9011303|P6|Main Period|Unclasified|3
2606618|NCT01020123|9011304|P5|Main Period|Unclasified|1
2606619|NCT01020123|9011305|P4|Main Period|Unclasified|0
2606620|NCT01020123|9011306|P3|Main Period|Unclasified|1
2606621|NCT01020123|9011307|P2|Main Period|Unclasified|0
2606622|NCT01020123|9011308|P1|Main Period|Unclasified|2
2606623|NCT01020123|9011302|P7|Main Period|Lost to Follow-up|0
2606624|NCT01020123|9011303|P6|Main Period|Lost to Follow-up|0
2606625|NCT01020123|9011304|P5|Main Period|Lost to Follow-up|0
2606626|NCT01020123|9011305|P4|Main Period|Lost to Follow-up|0
2606627|NCT01020123|9011306|P3|Main Period|Lost to Follow-up|0
2606628|NCT01020123|9011307|P2|Main Period|Lost to Follow-up|2
2606629|NCT01020123|9011308|P1|Main Period|Lost to Follow-up|0
2606630|NCT01020123|9011302|P7|Main Period|Protocol Violation|2
2606631|NCT01020123|9011303|P6|Main Period|Protocol Violation|3
2606632|NCT01020123|9011304|P5|Main Period|Protocol Violation|2
2606633|NCT01020123|9011305|P4|Main Period|Protocol Violation|5
2606634|NCT01020123|9011306|P3|Main Period|Protocol Violation|2
2606635|NCT01020123|9011307|P2|Main Period|Protocol Violation|4
2606636|NCT01020123|9011308|P1|Main Period|Protocol Violation|4
2606637|NCT01020123|9011302|P7|Main Period|Adverse Event|1
2606638|NCT01020123|9011303|P6|Main Period|Adverse Event|2
2606639|NCT01020123|9011304|P5|Main Period|Adverse Event|1
2606640|NCT01020123|9011305|P4|Main Period|Adverse Event|1
2606641|NCT01020123|9011306|P3|Main Period|Adverse Event|2
2606642|NCT01020123|9011307|P2|Main Period|Adverse Event|2
2606643|NCT01020123|9011308|P1|Main Period|Adverse Event|5
2606644|NCT01020123|9011302|P7|Main Period|Eligibility Criteria not fullfilled|0
2606645|NCT01020123|9011303|P6|Main Period|Eligibility Criteria not fullfilled|0
2606646|NCT01020123|9011304|P5|Main Period|Eligibility Criteria not fullfilled|1
2606647|NCT01020123|9011305|P4|Main Period|Eligibility Criteria not fullfilled|0
2606648|NCT01020123|9011306|P3|Main Period|Eligibility Criteria not fullfilled|0
2606649|NCT01020123|9011307|P2|Main Period|Eligibility Criteria not fullfilled|1
2606650|NCT01020123|9011308|P1|Main Period|Eligibility Criteria not fullfilled|0
2606651|NCT01020123|9011302|P7|Main Period|Withdrawal by Subject|2
2606652|NCT01020123|9011303|P6|Main Period|Withdrawal by Subject|3
2606653|NCT01020123|9011304|P5|Main Period|Withdrawal by Subject|6
2606654|NCT01020123|9011305|P4|Main Period|Withdrawal by Subject|1
2606655|NCT01020123|9011306|P3|Main Period|Withdrawal by Subject|3
2606656|NCT01020123|9011307|P2|Main Period|Withdrawal by Subject|5
2606657|NCT01020123|9011308|P1|Main Period|Withdrawal by Subject|6
2606658|NCT01020019|9011503|P2|Overall Study|moving|2
2606659|NCT01020019|9011504|P1|Overall Study|moving|0
2606660|NCT01020019|9011503|P2|Overall Study|not interested in treatment|4
2606661|NCT01020019|9011504|P1|Overall Study|not interested in treatment|4
2606662|NCT01020019|9011503|P2|Overall Study|Adverse Event|5
2606663|NCT01020019|9011504|P1|Overall Study|Adverse Event|1
2606664|NCT01020019|9011503|P2|Overall Study|Lost to Follow-up|18
2606665|NCT01020019|9011504|P1|Overall Study|Lost to Follow-up|21
2606666|NCT01019980|9011525|P2|Overall Study|Drug not available.|0
2606667|NCT01019980|9011526|P1|Overall Study|Drug not available.|2
2606668|NCT01019694|9011589|P3|Overall Study|Other reason (not specified)|6
2606669|NCT01019694|9011590|P2|Overall Study|Other reason (not specified)|5
2606670|NCT01019694|9011591|P1|Overall Study|Other reason (not specified)|1
2606671|NCT01019694|9011589|P3|Overall Study|Not treated|3
2606672|NCT01019694|9011590|P2|Overall Study|Not treated|2
2606673|NCT01019694|9011591|P1|Overall Study|Not treated|0
2606674|NCT01019694|9011589|P3|Overall Study|Withdrawal by Subject|12
2606675|NCT01019694|9011590|P2|Overall Study|Withdrawal by Subject|6
2606676|NCT01019694|9011591|P1|Overall Study|Withdrawal by Subject|4
2606677|NCT01019694|9011589|P3|Overall Study|Lost to Follow-up|3
2606678|NCT01019694|9011590|P2|Overall Study|Lost to Follow-up|3
2606679|NCT01019694|9011591|P1|Overall Study|Lost to Follow-up|5
2606680|NCT01019694|9011589|P3|Overall Study|Protocol Violation|4
2606681|NCT01019694|9011590|P2|Overall Study|Protocol Violation|6
2606682|NCT01019694|9011591|P1|Overall Study|Protocol Violation|2
2606683|NCT01019694|9011589|P3|Overall Study|Adverse Event|19
2606684|NCT01019694|9011590|P2|Overall Study|Adverse Event|16
2606685|NCT01019694|9011591|P1|Overall Study|Adverse Event|12
2606686|NCT01019486|9011716|P3|Overall Study|Withdrawal by Subject|1
2606687|NCT01019486|9011717|P2|Overall Study|Withdrawal by Subject|1
2606688|NCT01019486|9011718|P1|Overall Study|Withdrawal by Subject|1
2606689|NCT01019369|9011732|P2|Overall Study|Withdrawal by Subject|1
2606690|NCT01019369|9011733|P1|Overall Study|Withdrawal by Subject|0
2606691|NCT01019369|9011732|P2|Overall Study|Lost to Follow-up|6
2606692|NCT01019369|9011733|P1|Overall Study|Lost to Follow-up|10
2606693|NCT01019317|9011749|P1|Overall Study|Not Eligible|4
2606694|NCT01019252|9011755|P2|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5
2606695|NCT01019252|9011756|P1|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0
2606696|NCT01019252|9011755|P2|Wait List Cross-over to CBT for ADHD|Time constraints|2
2606697|NCT01019252|9011756|P1|Wait List Cross-over to CBT for ADHD|Time constraints|0
2606698|NCT01019252|9011755|P2|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0
2606699|NCT01019252|9011756|P1|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1
2606700|NCT01019252|9011755|P2|Initial CBT for ADHD vs. Wait List|Time constraints|0
2606701|NCT01019252|9011756|P1|Initial CBT for ADHD vs. Wait List|Time constraints|2
2606702|NCT01019135|9011769|P3|Overall Study|Did not attend CR|6
2606703|NCT01019135|9011770|P2|Overall Study|Did not attend CR|13
2606704|NCT01019135|9011771|P1|Overall Study|Did not attend CR|8
2606705|NCT01019135|9011769|P3|Overall Study|Did not receive allocated intervention|25
2606706|NCT01019135|9011770|P2|Overall Study|Did not receive allocated intervention|6
2606707|NCT01019135|9011771|P1|Overall Study|Did not receive allocated intervention|12
2606708|NCT01018992|9011799|P2|Overall Study|Lost to Follow-up|1
2606709|NCT01018992|9011800|P1|Overall Study|Lost to Follow-up|5
2606710|NCT01018992|9011799|P2|Overall Study|Protocol Violation|4
2606711|NCT01018992|9011800|P1|Overall Study|Protocol Violation|0
2606712|NCT01018992|9011799|P2|Overall Study|Withdrawal by Subject|8
2606713|NCT01018992|9011800|P1|Overall Study|Withdrawal by Subject|3
2606714|NCT01018992|9011799|P2|Overall Study|Adverse Event|3
2606715|NCT01018992|9011800|P1|Overall Study|Adverse Event|8
2606716|NCT01018979|9011814|P2|Overall Study|Not received at least one dose|1
2606717|NCT01018979|9011815|P1|Overall Study|Not received at least one dose|0
2606718|NCT01018979|9011814|P2|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9
2606719|NCT01018979|9011815|P1|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3
2606720|NCT01018953|9011845|P1|Overall Study|Study termination by sponsor|5
2606721|NCT01018953|9011845|P1|Overall Study|Withdrawal by Subject|1
2606722|NCT01018953|9011845|P1|Overall Study|Adverse Event|2
2606723|NCT01018862|9011858|P3|Overall Study|administrative problems|4
2606724|NCT01018862|9011859|P2|Overall Study|administrative problems|4
2606725|NCT01018862|9011860|P1|Overall Study|administrative problems|5
2606726|NCT01018862|9011858|P3|Overall Study|Withdrawal by Subject|1
2606727|NCT01018862|9011859|P2|Overall Study|Withdrawal by Subject|2
2606728|NCT01018862|9011860|P1|Overall Study|Withdrawal by Subject|1
2606729|NCT01018862|9011858|P3|Overall Study|Protocol Violation|3
2606730|NCT01018862|9011859|P2|Overall Study|Protocol Violation|3
2606731|NCT01018862|9011860|P1|Overall Study|Protocol Violation|1
2606732|NCT01018862|9011858|P3|Overall Study|Lost to Follow-up|0
2606733|NCT01018862|9011859|P2|Overall Study|Lost to Follow-up|1
2606734|NCT01018862|9011860|P1|Overall Study|Lost to Follow-up|3
2606735|NCT01018862|9011858|P3|Overall Study|Lack of Efficacy|2
2606736|NCT01018862|9011859|P2|Overall Study|Lack of Efficacy|0
2606737|NCT01018862|9011860|P1|Overall Study|Lack of Efficacy|1
2606738|NCT01018862|9011858|P3|Overall Study|Adverse Event|6
2606739|NCT01018862|9011859|P2|Overall Study|Adverse Event|0
2606740|NCT01018862|9011860|P1|Overall Study|Adverse Event|2
2606741|NCT01018810|9011882|P5|Overall Study|Sponsor Decision|1
2606742|NCT01018810|9011883|P4|Overall Study|Sponsor Decision|1
2606743|NCT01018810|9011884|P3|Overall Study|Sponsor Decision|1
2606744|NCT01018810|9011885|P2|Overall Study|Sponsor Decision|0
2606745|NCT01018810|9011886|P1|Overall Study|Sponsor Decision|2
2606746|NCT01018810|9011882|P5|Overall Study|Withdrawal by Subject|0
2606747|NCT01018810|9011883|P4|Overall Study|Withdrawal by Subject|0
2606748|NCT01018810|9011884|P3|Overall Study|Withdrawal by Subject|0
2606749|NCT01018810|9011885|P2|Overall Study|Withdrawal by Subject|1
2606750|NCT01018810|9011886|P1|Overall Study|Withdrawal by Subject|0
2606751|NCT01018732|9011946|P3|Overall Study|Unable to Classify|1
2606752|NCT01018732|9011947|P2|Overall Study|Unable to Classify|0
2606753|NCT01018732|9011948|P1|Overall Study|Unable to Classify|0
2606754|NCT01018732|9011946|P3|Overall Study|Inappropriate Enrollment|0
2606755|NCT01018732|9011947|P2|Overall Study|Inappropriate Enrollment|1
2606756|NCT01018732|9011948|P1|Overall Study|Inappropriate Enrollment|0
2606757|NCT01018732|9011946|P3|Overall Study|Protocol Violation|0
2606758|NCT01018732|9011947|P2|Overall Study|Protocol Violation|1
2606759|NCT01018732|9011948|P1|Overall Study|Protocol Violation|1
2606760|NCT01018732|9011946|P3|Overall Study|Lost to Follow-up|3
2606761|NCT01018732|9011947|P2|Overall Study|Lost to Follow-up|0
2606762|NCT01018732|9011948|P1|Overall Study|Lost to Follow-up|0
2606763|NCT01018680|9011982|P2|Overall Study|Physician Decision|1
2606764|NCT01018680|9011983|P1|Overall Study|Physician Decision|3
2606765|NCT01018680|9011982|P2|Overall Study|Entry Criteria Not Met|4
2606766|NCT01018680|9011983|P1|Overall Study|Entry Criteria Not Met|1
2606767|NCT01018680|9011982|P2|Overall Study|Lost to Follow-up|3
2606768|NCT01018680|9011983|P1|Overall Study|Lost to Follow-up|5
2606769|NCT01018680|9011982|P2|Overall Study|Lack of Efficacy|2
2606770|NCT01018680|9011983|P1|Overall Study|Lack of Efficacy|8
2606771|NCT01018680|9011982|P2|Overall Study|Sponsor Decision|7
2606772|NCT01018680|9011983|P1|Overall Study|Sponsor Decision|6
2606773|NCT01018680|9011982|P2|Overall Study|Protocol Violation|8
2606774|NCT01018680|9011983|P1|Overall Study|Protocol Violation|5
2606775|NCT01018680|9011982|P2|Overall Study|Withdrawal by Subject|10
2606776|NCT01018680|9011983|P1|Overall Study|Withdrawal by Subject|10
2606777|NCT01018680|9011982|P2|Overall Study|Adverse Event|40
2606778|NCT01018680|9011983|P1|Overall Study|Adverse Event|23
2606779|NCT01020487|9012026|P3|Part 2 Open-label Period|Adverse Event|1
2606780|NCT01020487|9012027|P2|Part 2 Open-label Period|Adverse Event|4
2606781|NCT01020487|9012028|P1|Part 2 Open-label Period|Adverse Event|0
2606782|NCT01020487|9012026|P3|Part 2 Double-blind Treatment Period|Randomized in Error|1
2606783|NCT01020487|9012027|P2|Part 2 Double-blind Treatment Period|Randomized in Error|0
2606784|NCT01020487|9012028|P1|Part 2 Double-blind Treatment Period|Randomized in Error|0
2606785|NCT01020487|9012026|P3|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3
2606786|NCT01020487|9012027|P2|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
2606787|NCT01020487|9012028|P1|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
2606788|NCT01020487|9012026|P3|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1
2606789|NCT01020487|9012027|P2|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
2606790|NCT01020487|9012028|P1|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
2606791|NCT01020487|9012026|P3|Part 2 Double-blind Treatment Period|Adverse Event|1
2606792|NCT01020487|9012027|P2|Part 2 Double-blind Treatment Period|Adverse Event|2
2606793|NCT01020487|9012028|P1|Part 2 Double-blind Treatment Period|Adverse Event|0
2606794|NCT01018511|9012053|P4|Overall Study|Miscellaneous|0
2606795|NCT01018511|9012054|P3|Overall Study|Miscellaneous|0
2606796|NCT01018511|9012055|P2|Overall Study|Miscellaneous|2
2606797|NCT01018511|9012056|P1|Overall Study|Miscellaneous|0
2606798|NCT01018511|9012053|P4|Overall Study|Protocol Violation|9
2606799|NCT01018511|9012054|P3|Overall Study|Protocol Violation|7
2606800|NCT01018511|9012055|P2|Overall Study|Protocol Violation|8
2606801|NCT01018511|9012056|P1|Overall Study|Protocol Violation|5
2606802|NCT01018511|9012053|P4|Overall Study|Lost to Follow-up|0
2606803|NCT01018511|9012054|P3|Overall Study|Lost to Follow-up|1
2606804|NCT01018511|9012055|P2|Overall Study|Lost to Follow-up|0
2606805|NCT01018511|9012056|P1|Overall Study|Lost to Follow-up|0
2606806|NCT01018511|9012053|P4|Overall Study|Withdrawal by Subject|9
2606807|NCT01018511|9012054|P3|Overall Study|Withdrawal by Subject|11
2606808|NCT01018511|9012055|P2|Overall Study|Withdrawal by Subject|5
2606809|NCT01018511|9012056|P1|Overall Study|Withdrawal by Subject|6
2606810|NCT01018511|9012053|P4|Overall Study|Lack of Efficacy|2
2606811|NCT01018511|9012054|P3|Overall Study|Lack of Efficacy|1
2606812|NCT01018511|9012055|P2|Overall Study|Lack of Efficacy|1
2606813|NCT01018511|9012056|P1|Overall Study|Lack of Efficacy|4
2606814|NCT01018511|9012053|P4|Overall Study|Adverse Event|10
2606815|NCT01018511|9012054|P3|Overall Study|Adverse Event|13
2606816|NCT01018511|9012055|P2|Overall Study|Adverse Event|9
2606817|NCT01018511|9012056|P1|Overall Study|Adverse Event|5
2606818|NCT01018511|9012053|P4|Overall Study|Not fulfilling eligibility criteria|3
2606819|NCT01018511|9012054|P3|Overall Study|Not fulfilling eligibility criteria|7
2606820|NCT01018511|9012055|P2|Overall Study|Not fulfilling eligibility criteria|7
2606821|NCT01018511|9012056|P1|Overall Study|Not fulfilling eligibility criteria|6
2606822|NCT01018394|9012253|P2|Overall Study|Lost to Follow-up|3
2606823|NCT01018394|9012254|P1|Overall Study|Lost to Follow-up|4
2606824|NCT01018394|9012253|P2|Overall Study|Withdrawal by Subject|5
2606825|NCT01018394|9012254|P1|Overall Study|Withdrawal by Subject|5
2606826|NCT01018264|9012264|P2|Overall Study|Lost to Follow-up|1
2606827|NCT01018264|9012265|P1|Overall Study|Lost to Follow-up|0
2606828|NCT01018264|9012264|P2|Overall Study|Withdrawal by Subject|0
2606829|NCT01018264|9012265|P1|Overall Study|Withdrawal by Subject|1
2606830|NCT01018186|9012282|P4|52-week Double-blind Treatment Period|Withdrawal by Subject|9
2606831|NCT01018186|9012283|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|7
2606832|NCT01018186|9012284|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|10
2606833|NCT01018186|9012285|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
2606834|NCT01018186|9012282|P4|52-week Double-blind Treatment Period|Physician Decision|3
2606835|NCT01018186|9012283|P3|52-week Double-blind Treatment Period|Physician Decision|0
2606836|NCT01018186|9012284|P2|52-week Double-blind Treatment Period|Physician Decision|1
2606837|NCT01018186|9012285|P1|52-week Double-blind Treatment Period|Physician Decision|0
2606838|NCT01018186|9012282|P4|52-week Double-blind Treatment Period|Lost to Follow-up|4
2606839|NCT01018186|9012283|P3|52-week Double-blind Treatment Period|Lost to Follow-up|3
2606840|NCT01018186|9012284|P2|52-week Double-blind Treatment Period|Lost to Follow-up|1
2606841|NCT01018186|9012285|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
2606842|NCT01018186|9012282|P4|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
2606843|NCT01018186|9012283|P3|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16
2606844|NCT01018186|9012284|P2|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14
2606845|NCT01018186|9012285|P1|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
2606846|NCT01018186|9012282|P4|52-week Double-blind Treatment Period|Protocol Violation|2
2606847|NCT01018186|9012283|P3|52-week Double-blind Treatment Period|Protocol Violation|8
2606848|NCT01018186|9012284|P2|52-week Double-blind Treatment Period|Protocol Violation|8
2606849|NCT01018186|9012285|P1|52-week Double-blind Treatment Period|Protocol Violation|0
2606850|NCT01018186|9012282|P4|52-week Double-blind Treatment Period|Lack of Efficacy|1
2606851|NCT01018186|9012283|P3|52-week Double-blind Treatment Period|Lack of Efficacy|4
2606852|NCT01018186|9012284|P2|52-week Double-blind Treatment Period|Lack of Efficacy|1
2606853|NCT01018186|9012285|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
2606854|NCT01018186|9012282|P4|52-week Double-blind Treatment Period|Adverse Event|6
2606855|NCT01018186|9012283|P3|52-week Double-blind Treatment Period|Adverse Event|3
2606856|NCT01018186|9012284|P2|52-week Double-blind Treatment Period|Adverse Event|5
2606857|NCT01018186|9012285|P1|52-week Double-blind Treatment Period|Adverse Event|0
2606858|NCT01018186|9012282|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
2606859|NCT01018186|9012283|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
2606860|NCT01018186|9012284|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
2606861|NCT01018186|9012285|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|97
2606862|NCT01018186|9012282|P4|2-week Run-in Period|Withdrawal by Subject|0
2606863|NCT01018186|9012283|P3|2-week Run-in Period|Withdrawal by Subject|0
2606864|NCT01018186|9012284|P2|2-week Run-in Period|Withdrawal by Subject|0
2606865|NCT01018186|9012285|P1|2-week Run-in Period|Withdrawal by Subject|11
2606866|NCT01018186|9012282|P4|2-week Run-in Period|Physician Decision|0
2606867|NCT01018186|9012283|P3|2-week Run-in Period|Physician Decision|0
2606868|NCT01018186|9012284|P2|2-week Run-in Period|Physician Decision|0
2606869|NCT01018186|9012285|P1|2-week Run-in Period|Physician Decision|3
2606870|NCT01018186|9012282|P4|2-week Run-in Period|Lost to Follow-up|0
2606871|NCT01018186|9012283|P3|2-week Run-in Period|Lost to Follow-up|0
2606872|NCT01018186|9012284|P2|2-week Run-in Period|Lost to Follow-up|0
2606873|NCT01018186|9012285|P1|2-week Run-in Period|Lost to Follow-up|2
2606874|NCT01018186|9012282|P4|2-week Run-in Period|Protocol Violation|0
2606875|NCT01018186|9012283|P3|2-week Run-in Period|Protocol Violation|0
2606876|NCT01018186|9012284|P2|2-week Run-in Period|Protocol Violation|0
2606877|NCT01018186|9012285|P1|2-week Run-in Period|Protocol Violation|1
2606878|NCT01018030|9012486|P3|Overall Study|Did Not Receive Study Drug|0
2606879|NCT01018030|9012487|P2|Overall Study|Did Not Receive Study Drug|3
2606880|NCT01018030|9012488|P1|Overall Study|Did Not Receive Study Drug|1
2606881|NCT01018030|9012486|P3|Overall Study|Lack of Efficacy|0
2606882|NCT01018030|9012487|P2|Overall Study|Lack of Efficacy|0
2606883|NCT01018030|9012488|P1|Overall Study|Lack of Efficacy|1
2606884|NCT01018030|9012486|P3|Overall Study|Physician Decision|1
2606885|NCT01018030|9012487|P2|Overall Study|Physician Decision|0
2606886|NCT01018030|9012488|P1|Overall Study|Physician Decision|1
2606887|NCT01018030|9012486|P3|Overall Study|Protocol Violation|0
2606888|NCT01018030|9012487|P2|Overall Study|Protocol Violation|1
2606889|NCT01018030|9012488|P1|Overall Study|Protocol Violation|2
2606890|NCT01018030|9012486|P3|Overall Study|Lost to Follow-up|3
2606891|NCT01018030|9012487|P2|Overall Study|Lost to Follow-up|0
2606892|NCT01018030|9012488|P1|Overall Study|Lost to Follow-up|2
2606893|NCT01018030|9012486|P3|Overall Study|Withdrawal by Subject|4
2606894|NCT01018030|9012487|P2|Overall Study|Withdrawal by Subject|2
2606895|NCT01018030|9012488|P1|Overall Study|Withdrawal by Subject|2
2606896|NCT01018030|9012486|P3|Overall Study|Adverse Event|5
2606897|NCT01018030|9012487|P2|Overall Study|Adverse Event|5
2606898|NCT01018030|9012488|P1|Overall Study|Adverse Event|10
2606899|NCT01017952|9012539|P5|52-week, Double-blind Treatment Period|Physician Decision|7
2606900|NCT01017952|9012540|P4|52-week, Double-blind Treatment Period|Physician Decision|9
2606901|NCT01017952|9012541|P3|52-week, Double-blind Treatment Period|Physician Decision|8
2606902|NCT01017952|9012542|P2|52-week, Double-blind Treatment Period|Physician Decision|10
2606903|NCT01017952|9012543|P1|52-week, Double-blind Treatment Period|Physician Decision|0
2606904|NCT01017952|9012539|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|10
2606905|NCT01017952|9012540|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
2606906|NCT01017952|9012541|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|8
2606907|NCT01017952|9012542|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|6
2606908|NCT01017952|9012543|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
2606909|NCT01017952|9012539|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
2606910|NCT01017952|9012540|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
2606911|NCT01017952|9012541|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
2606912|NCT01017952|9012542|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
2606913|NCT01017952|9012543|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
2606914|NCT01017952|9012539|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
2606915|NCT01017952|9012540|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12
2606916|NCT01017952|9012541|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
2606917|NCT01017952|9012542|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
2606918|NCT01017952|9012543|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
2606919|NCT01017952|9012539|P5|52-week, Double-blind Treatment Period|Protocol Violation|8
2606920|NCT01017952|9012540|P4|52-week, Double-blind Treatment Period|Protocol Violation|9
2606921|NCT01017952|9012541|P3|52-week, Double-blind Treatment Period|Protocol Violation|11
2606922|NCT01017952|9012542|P2|52-week, Double-blind Treatment Period|Protocol Violation|7
2606923|NCT01017952|9012543|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
2606924|NCT01017952|9012539|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|14
2606925|NCT01017952|9012540|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|16
2606926|NCT01017952|9012541|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|14
2606927|NCT01017952|9012542|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|35
2606928|NCT01017952|9012543|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
2606929|NCT01017952|9012539|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
2606930|NCT01017952|9012540|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
2606931|NCT01017952|9012541|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
2606932|NCT01017952|9012542|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|30
2606933|NCT01017952|9012543|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
2606934|NCT01017952|9012539|P5|52-week, Double-blind Treatment Period|Adverse Event|30
2606935|NCT01017952|9012540|P4|52-week, Double-blind Treatment Period|Adverse Event|35
2606936|NCT01017952|9012541|P3|52-week, Double-blind Treatment Period|Adverse Event|32
2606937|NCT01017952|9012542|P2|52-week, Double-blind Treatment Period|Adverse Event|25
2606938|NCT01017952|9012543|P1|52-week, Double-blind Treatment Period|Adverse Event|0
2606939|NCT01017952|9012539|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
2606940|NCT01017952|9012540|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
2606941|NCT01017952|9012541|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
2606942|NCT01017952|9012542|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
2606943|NCT01017952|9012543|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|63
2606944|NCT01017952|9012539|P5|4-week, Open-label Run-In Period|Physician Decision|0
2606945|NCT01017952|9012540|P4|4-week, Open-label Run-In Period|Physician Decision|0
2606946|NCT01017952|9012541|P3|4-week, Open-label Run-In Period|Physician Decision|0
2606947|NCT01017952|9012542|P2|4-week, Open-label Run-In Period|Physician Decision|0
2606948|NCT01017952|9012543|P1|4-week, Open-label Run-In Period|Physician Decision|10
2606949|NCT01017952|9012539|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
2606950|NCT01017952|9012540|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
2606951|NCT01017952|9012541|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
2606952|NCT01017952|9012542|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
2606953|NCT01017952|9012543|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
2606954|NCT01017952|9012539|P5|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
2606955|NCT01017952|9012540|P4|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
2606956|NCT01017952|9012541|P3|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
2606957|NCT01017952|9012542|P2|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
2606958|NCT01017952|9012543|P1|4-week, Open-label Run-In Period|Study Closed/Tterminated|1
2606959|NCT01017952|9012539|P5|4-week, Open-label Run-In Period|Adverse Event|0
2606960|NCT01017952|9012540|P4|4-week, Open-label Run-In Period|Adverse Event|0
2606961|NCT01017952|9012541|P3|4-week, Open-label Run-In Period|Adverse Event|0
2606962|NCT01017952|9012542|P2|4-week, Open-label Run-In Period|Adverse Event|0
2606963|NCT01017952|9012543|P1|4-week, Open-label Run-In Period|Adverse Event|23
2606964|NCT01017952|9012539|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
2606965|NCT01017952|9012540|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
2606966|NCT01017952|9012541|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
2606967|NCT01017952|9012542|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
2606968|NCT01017952|9012543|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356
2606969|NCT01017874|9012567|P2|Overall Study|Physician Decision|3
2606970|NCT01017874|9012568|P1|Overall Study|Physician Decision|1
2606971|NCT01017874|9012567|P2|Overall Study|Lost to Follow-up|2
2606972|NCT01017874|9012568|P1|Overall Study|Lost to Follow-up|3
2606973|NCT01017874|9012567|P2|Overall Study|Sponsor decision|1
2606974|NCT01017874|9012568|P1|Overall Study|Sponsor decision|3
2606975|NCT01017874|9012567|P2|Overall Study|Withdrawal by Subject|20
2606976|NCT01017874|9012568|P1|Overall Study|Withdrawal by Subject|23
2606977|NCT01017731|9012586|P1|Overall Study|Adverse Event|1
2606978|NCT01017731|9012586|P1|Overall Study|Physician Decision|2
2606979|NCT01017731|9012586|P1|Overall Study|Withdrawal by Subject|3
2606980|NCT01017731|9012586|P1|Overall Study|Lost to Follow-up|2
2606981|NCT01017601|9012615|P2|Overall Study|Withdrawal by Subject|1
2606982|NCT01017601|9012616|P1|Overall Study|Withdrawal by Subject|0
2606983|NCT01017601|9012615|P2|Overall Study|Disease Progression|12
2606984|NCT01017601|9012616|P1|Overall Study|Disease Progression|12
2606985|NCT01017575|9012643|P5|Overall Study|Withdrawal by Subject|0
2606986|NCT01017575|9012644|P4|Overall Study|Withdrawal by Subject|0
2606987|NCT01017575|9012645|P3|Overall Study|Withdrawal by Subject|0
2606988|NCT01017575|9012646|P2|Overall Study|Withdrawal by Subject|0
2606989|NCT01017575|9012647|P1|Overall Study|Withdrawal by Subject|1
2606990|NCT01017575|9012643|P5|Overall Study|Adverse Event|2
2606991|NCT01017575|9012644|P4|Overall Study|Adverse Event|0
2606992|NCT01017575|9012645|P3|Overall Study|Adverse Event|0
2606993|NCT01017575|9012646|P2|Overall Study|Adverse Event|1
2606994|NCT01017575|9012647|P1|Overall Study|Adverse Event|0
2606995|NCT01017575|9012643|P5|Overall Study|Lack of Efficacy|1
2606996|NCT01017575|9012644|P4|Overall Study|Lack of Efficacy|1
2606997|NCT01017575|9012645|P3|Overall Study|Lack of Efficacy|0
2606998|NCT01017575|9012646|P2|Overall Study|Lack of Efficacy|1
2606999|NCT01017575|9012647|P1|Overall Study|Lack of Efficacy|0
2607000|NCT01017549|9012684|P1|One-year Follow-up|Withdrawal by Subject|5
2607001|NCT01017549|9012684|P1|One-year Follow-up|Lost to Follow-up|2
2607002|NCT01017549|9012684|P1|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1
2607003|NCT01017263|9012715|P1|Overall Study|not eligible|12
2607004|NCT01017146|9012796|P2|Overall Study|Change in Work Situation|0
2607005|NCT01017146|9012797|P1|Overall Study|Change in Work Situation|1
2607006|NCT01017146|9012796|P2|Overall Study|Did Not Meet Eligibility Criteria|2
2607007|NCT01017146|9012797|P1|Overall Study|Did Not Meet Eligibility Criteria|1
2607008|NCT01017146|9012796|P2|Overall Study|Took Excluded Medication|0
2607009|NCT01017146|9012797|P1|Overall Study|Took Excluded Medication|2
2607010|NCT01017146|9012796|P2|Overall Study|Protocol Violation|0
2607011|NCT01017146|9012797|P1|Overall Study|Protocol Violation|2
2607012|NCT01017146|9012796|P2|Overall Study|Pregnancy|1
2607013|NCT01017146|9012797|P1|Overall Study|Pregnancy|2
2607014|NCT01017146|9012796|P2|Overall Study|Relocation|4
2607015|NCT01017146|9012797|P1|Overall Study|Relocation|0
2607016|NCT01017146|9012796|P2|Overall Study|Withdrawal by Subject|16
2607017|NCT01017146|9012797|P1|Overall Study|Withdrawal by Subject|32
2607018|NCT01017146|9012796|P2|Overall Study|Noncompliance with Study Product|1
2607019|NCT01017146|9012797|P1|Overall Study|Noncompliance with Study Product|1
2607020|NCT01017146|9012796|P2|Overall Study|Lost to Follow-up|14
2607021|NCT01017146|9012797|P1|Overall Study|Lost to Follow-up|14
2607022|NCT01017146|9012796|P2|Overall Study|Adverse Event|1
2607023|NCT01017146|9012797|P1|Overall Study|Adverse Event|11
2607024|NCT01017120|9012835|P2|Overall Study|Parent Unable to Provide Transportation|0
2607025|NCT01017120|9012836|P1|Overall Study|Parent Unable to Provide Transportation|1
2607026|NCT01017120|9012835|P2|Overall Study|Protocol Violation|0
2607027|NCT01017120|9012836|P1|Overall Study|Protocol Violation|1
2607028|NCT01017120|9012835|P2|Overall Study|Relocated Out of Town|2
2607029|NCT01017120|9012836|P1|Overall Study|Relocated Out of Town|0
2607030|NCT01017120|9012835|P2|Overall Study|Did Not Meet Eligibility Criteria|0
2607031|NCT01017120|9012836|P1|Overall Study|Did Not Meet Eligibility Criteria|1
2607032|NCT01017120|9012835|P2|Overall Study|Pregnancy|1
2607033|NCT01017120|9012836|P1|Overall Study|Pregnancy|1
2607034|NCT01017120|9012835|P2|Overall Study|Withdrawal by Subject|21
2607035|NCT01017120|9012836|P1|Overall Study|Withdrawal by Subject|39
2607036|NCT01017120|9012835|P2|Overall Study|Lack of Efficacy|0
2607037|NCT01017120|9012836|P1|Overall Study|Lack of Efficacy|1
2607038|NCT01017120|9012835|P2|Overall Study|Lost to Follow-up|11
2607039|NCT01017120|9012836|P1|Overall Study|Lost to Follow-up|13
2607040|NCT01017120|9012835|P2|Overall Study|Adverse Event|0
2607041|NCT01017120|9012836|P1|Overall Study|Adverse Event|9
2607042|NCT01017029|9012897|P2|Overall Study|Death|1
2607043|NCT01017029|9012898|P1|Overall Study|Death|3
2607044|NCT01017029|9012897|P2|Overall Study|Administrative problem|1
2607045|NCT01017029|9012898|P1|Overall Study|Administrative problem|0
2607046|NCT01017029|9012897|P2|Overall Study|Lost to Follow-up|0
2607047|NCT01017029|9012898|P1|Overall Study|Lost to Follow-up|1
2607048|NCT01016977|9012926|P2|Overall Study|Withdrawal by Subject|2
2607049|NCT01016977|9012927|P1|Overall Study|Withdrawal by Subject|2
2607050|NCT01016977|9012926|P2|Overall Study|Lost to Follow-up|0
2607051|NCT01016977|9012927|P1|Overall Study|Lost to Follow-up|1
2607052|NCT01016964|9012963|P2|Overall Study|Lost to Follow-up|3
2607053|NCT01016964|9012964|P1|Overall Study|Lost to Follow-up|3
2607054|NCT01016912|9012980|P5|Follow-up Period|Other reason|0
2607055|NCT01016912|9012981|P4|Follow-up Period|Other reason|1
2607056|NCT01016912|9012982|P3|Follow-up Period|Other reason|1
2607057|NCT01016912|9012983|P2|Follow-up Period|Other reason|0
2607058|NCT01016912|9012984|P1|Follow-up Period|Other reason|0
2607059|NCT01016912|9012980|P5|End of Treatment Period|Completed double-blind period only|0
2607060|NCT01016912|9012981|P4|End of Treatment Period|Completed double-blind period only|0
2607061|NCT01016912|9012982|P3|End of Treatment Period|Completed double-blind period only|0
2607062|NCT01016912|9012983|P2|End of Treatment Period|Completed double-blind period only|1
2607063|NCT01016912|9012984|P1|End of Treatment Period|Completed double-blind period only|0
2607064|NCT01016912|9012980|P5|End of Treatment Period|Adverse Event|0
2607065|NCT01016912|9012981|P4|End of Treatment Period|Adverse Event|0
2607066|NCT01016912|9012982|P3|End of Treatment Period|Adverse Event|1
2607067|NCT01016912|9012983|P2|End of Treatment Period|Adverse Event|1
2607068|NCT01016912|9012984|P1|End of Treatment Period|Adverse Event|0
2607069|NCT01016912|9012980|P5|End of Treatment Period|Lack of Efficacy|4
2607070|NCT01016912|9012981|P4|End of Treatment Period|Lack of Efficacy|4
2607071|NCT01016912|9012982|P3|End of Treatment Period|Lack of Efficacy|0
2607072|NCT01016912|9012983|P2|End of Treatment Period|Lack of Efficacy|1
2607073|NCT01016912|9012984|P1|End of Treatment Period|Lack of Efficacy|0
2607074|NCT01016600|9013163|P4|Overall Study|Did not start treatment|0
2607075|NCT01016600|9013164|P3|Overall Study|Did not start treatment|0
2607076|NCT01016600|9013165|P2|Overall Study|Did not start treatment|0
2607077|NCT01016600|9013166|P1|Overall Study|Did not start treatment|1
2607078|NCT01016262|9013354|P6|Open-Label Phase|Withdrawal of Informed Consent|0
2607079|NCT01016262|9013355|P5|Open-Label Phase|Withdrawal of Informed Consent|1
2607080|NCT01016262|9013356|P4|Open-Label Phase|Withdrawal of Informed Consent|0
2607081|NCT01016262|9013357|P3|Open-Label Phase|Withdrawal of Informed Consent|0
2607082|NCT01016262|9013358|P2|Open-Label Phase|Withdrawal of Informed Consent|0
2607083|NCT01016262|9013359|P1|Open-Label Phase|Withdrawal of Informed Consent|0
2607084|NCT01016262|9013354|P6|Open-Label Phase|Lack of Efficacy|0
2607085|NCT01016262|9013355|P5|Open-Label Phase|Lack of Efficacy|0
2607086|NCT01016262|9013356|P4|Open-Label Phase|Lack of Efficacy|1
2607087|NCT01016262|9013357|P3|Open-Label Phase|Lack of Efficacy|0
2607088|NCT01016262|9013358|P2|Open-Label Phase|Lack of Efficacy|0
2607089|NCT01016262|9013359|P1|Open-Label Phase|Lack of Efficacy|0
2607090|NCT01016262|9013354|P6|Open-Label Phase|Lost to Follow-up|0
2607091|NCT01016262|9013355|P5|Open-Label Phase|Lost to Follow-up|1
2607092|NCT01016262|9013356|P4|Open-Label Phase|Lost to Follow-up|0
2607093|NCT01016262|9013357|P3|Open-Label Phase|Lost to Follow-up|0
2607094|NCT01016262|9013358|P2|Open-Label Phase|Lost to Follow-up|0
2607095|NCT01016262|9013359|P1|Open-Label Phase|Lost to Follow-up|0
2607096|NCT01016262|9013354|P6|Open-Label Phase|Adverse Event|0
2607097|NCT01016262|9013355|P5|Open-Label Phase|Adverse Event|0
2607098|NCT01016262|9013356|P4|Open-Label Phase|Adverse Event|1
2607099|NCT01016262|9013357|P3|Open-Label Phase|Adverse Event|0
2607100|NCT01016262|9013358|P2|Open-Label Phase|Adverse Event|0
2607101|NCT01016262|9013359|P1|Open-Label Phase|Adverse Event|0
2607102|NCT01016262|9013354|P6|Double-blind Phase|Withdrawal of Informed Consent|0
2607103|NCT01016262|9013355|P5|Double-blind Phase|Withdrawal of Informed Consent|0
2607104|NCT01016262|9013356|P4|Double-blind Phase|Withdrawal of Informed Consent|0
2607105|NCT01016262|9013357|P3|Double-blind Phase|Withdrawal of Informed Consent|1
2607106|NCT01016262|9013358|P2|Double-blind Phase|Withdrawal of Informed Consent|0
2607107|NCT01016262|9013359|P1|Double-blind Phase|Withdrawal of Informed Consent|0
2607108|NCT01016262|9013354|P6|Double-blind Phase|Disease Progression|0
2607109|NCT01016262|9013355|P5|Double-blind Phase|Disease Progression|0
2607110|NCT01016262|9013356|P4|Double-blind Phase|Disease Progression|0
2607111|NCT01016262|9013357|P3|Double-blind Phase|Disease Progression|2
2607112|NCT01016262|9013358|P2|Double-blind Phase|Disease Progression|1
2607113|NCT01016262|9013359|P1|Double-blind Phase|Disease Progression|0
2607114|NCT01016262|9013354|P6|Double-blind Phase|Lack of Efficacy|0
2607115|NCT01016262|9013355|P5|Double-blind Phase|Lack of Efficacy|0
2607116|NCT01016262|9013356|P4|Double-blind Phase|Lack of Efficacy|0
2607117|NCT01016262|9013357|P3|Double-blind Phase|Lack of Efficacy|5
2607118|NCT01016262|9013358|P2|Double-blind Phase|Lack of Efficacy|0
2607119|NCT01016262|9013359|P1|Double-blind Phase|Lack of Efficacy|1
2607120|NCT01016262|9013354|P6|Double-blind Phase|Adverse Event|0
2607121|NCT01016262|9013355|P5|Double-blind Phase|Adverse Event|0
2607122|NCT01016262|9013356|P4|Double-blind Phase|Adverse Event|0
2607123|NCT01016262|9013357|P3|Double-blind Phase|Adverse Event|1
2607124|NCT01016262|9013358|P2|Double-blind Phase|Adverse Event|0
2607125|NCT01016262|9013359|P1|Double-blind Phase|Adverse Event|0
2607126|NCT01016132|9013382|P1|Overall Study|Discomfort|1
2607127|NCT01016067|9013397|P2|Overall Study|Withdrew due to Relocation|1
2607128|NCT01016067|9013398|P1|Overall Study|Withdrew due to Relocation|0
2607129|NCT01016067|9013397|P2|Overall Study|Physician Decision|1
2607130|NCT01016067|9013398|P1|Overall Study|Physician Decision|1
2607131|NCT01016067|9013397|P2|Overall Study|Lost to Follow-up|2
2607132|NCT01016067|9013398|P1|Overall Study|Lost to Follow-up|1
2607133|NCT01016015|9013416|P1|Overall Study|Adverse Event|15
2607134|NCT01016015|9013416|P1|Overall Study|Withdrawal by Subject|1
2607135|NCT01016015|9013416|P1|Overall Study|Not Treated|3
2607136|NCT01015833|9013427|P2|Overall Study|Did not start treatment|0
2607137|NCT01015833|9013428|P1|Overall Study|Did not start treatment|1
2607138|NCT01015833|9013427|P2|Overall Study|Motor Vehicle Accidents|0
2607139|NCT01015833|9013428|P1|Overall Study|Motor Vehicle Accidents|1
2607140|NCT01015833|9013427|P2|Overall Study|Other|1
2607141|NCT01015833|9013428|P1|Overall Study|Other|5
2607142|NCT01015833|9013427|P2|Overall Study|Symptomatic deterioration|1
2607143|NCT01015833|9013428|P1|Overall Study|Symptomatic deterioration|0
2607144|NCT01015833|9013427|P2|Overall Study|Physician Decision|0
2607145|NCT01015833|9013428|P1|Overall Study|Physician Decision|2
2607146|NCT01015833|9013427|P2|Overall Study|Adverse Event|1
2607147|NCT01015833|9013428|P1|Overall Study|Adverse Event|0
2607148|NCT01015833|9013427|P2|Overall Study|Withdrawal by Subject|2
2607149|NCT01015833|9013428|P1|Overall Study|Withdrawal by Subject|3
2607150|NCT01015833|9013427|P2|Overall Study|Death|0
2607151|NCT01015833|9013428|P1|Overall Study|Death|1
2607152|NCT01015820|9013444|P2|Overall Study|Suboptimal measurements|0
2607153|NCT01015820|9013445|P1|Overall Study|Suboptimal measurements|1
2607154|NCT01015703|9013480|P5|Overall Study|Protocol Violation|0
2607155|NCT01015703|9013481|P4|Overall Study|Protocol Violation|0
2607156|NCT01015703|9013482|P3|Overall Study|Protocol Violation|0
2607157|NCT01015703|9013483|P2|Overall Study|Protocol Violation|0
2607158|NCT01015703|9013484|P1|Overall Study|Protocol Violation|1
2607159|NCT01015703|9013480|P5|Overall Study|Adverse Event|0
2607160|NCT01015703|9013481|P4|Overall Study|Adverse Event|0
2607161|NCT01015703|9013482|P3|Overall Study|Adverse Event|0
2607162|NCT01015703|9013483|P2|Overall Study|Adverse Event|0
2607163|NCT01015703|9013484|P1|Overall Study|Adverse Event|1
2607164|NCT01015703|9013480|P5|Overall Study|Withdrawal by Subject|0
2607165|NCT01015703|9013481|P4|Overall Study|Withdrawal by Subject|0
2607166|NCT01015703|9013482|P3|Overall Study|Withdrawal by Subject|0
2607167|NCT01015703|9013483|P2|Overall Study|Withdrawal by Subject|1
2607168|NCT01015703|9013484|P1|Overall Study|Withdrawal by Subject|0
2607169|NCT01015677|9013499|P3|Overall Study|Withdrawal by Subject|0
2607170|NCT01015677|9013500|P2|Overall Study|Withdrawal by Subject|1
2607171|NCT01015677|9013501|P1|Overall Study|Withdrawal by Subject|1
2607172|NCT01015677|9013499|P3|Overall Study|Protocol Violation|0
2607173|NCT01015677|9013500|P2|Overall Study|Protocol Violation|1
2607174|NCT01015677|9013501|P1|Overall Study|Protocol Violation|0
2607175|NCT01015677|9013499|P3|Overall Study|Lack of Efficacy|0
2607176|NCT01015677|9013500|P2|Overall Study|Lack of Efficacy|1
2607177|NCT01015677|9013501|P1|Overall Study|Lack of Efficacy|0
2607178|NCT01015677|9013499|P3|Overall Study|Adverse Event|0
2607179|NCT01015677|9013500|P2|Overall Study|Adverse Event|1
2607180|NCT01015677|9013501|P1|Overall Study|Adverse Event|0
2607181|NCT01015638|9013523|P2|Overall Study|Withdrawal by Subject|0
2607182|NCT01015638|9013524|P1|Overall Study|Withdrawal by Subject|1
2607183|NCT01015612|9013552|P1|Overall Study|Withdrawal by Subject|40
2607184|NCT01015612|9013552|P1|Overall Study|Death|113
2607185|NCT01015560|9013583|P1|Overall Study|Withdrawal by Subject|1
2607186|NCT01015560|9013583|P1|Overall Study|Not protocol specified|1
2607187|NCT01015560|9013583|P1|Overall Study|Adverse Event|1
2607188|NCT01015287|9013632|P2|Overall Study|Protocol Violation|1
2607189|NCT01015287|9013633|P1|Overall Study|Protocol Violation|1
2607190|NCT01015287|9013632|P2|Overall Study|Lost to Follow-up|1
2607191|NCT01015287|9013633|P1|Overall Study|Lost to Follow-up|2
2607192|NCT01015287|9013632|P2|Overall Study|Entry Criteria not Met|14
2607193|NCT01015287|9013633|P1|Overall Study|Entry Criteria not Met|11
2607194|NCT01015287|9013632|P2|Overall Study|Withdrawal by Subject|19
2607195|NCT01015287|9013633|P1|Overall Study|Withdrawal by Subject|14
2607196|NCT01015287|9013632|P2|Overall Study|Physician Decision|21
2607197|NCT01015287|9013633|P1|Overall Study|Physician Decision|19
2607198|NCT01015287|9013632|P2|Overall Study|Sponsor Decision|7
2607199|NCT01015287|9013633|P1|Overall Study|Sponsor Decision|3
2607200|NCT01015287|9013632|P2|Overall Study|Adverse Event|0
2607201|NCT01015287|9013633|P1|Overall Study|Adverse Event|1
2607202|NCT01015287|9013632|P2|Overall Study|Death|16
2607203|NCT01015287|9013633|P1|Overall Study|Death|21
2607204|NCT01015131|9013665|P1|Overall Study|Other Protocol Specified Criteria|4
2607205|NCT01015131|9013665|P1|Overall Study|Withdrawal by Subject|2
2607206|NCT01015131|9013665|P1|Overall Study|Protocol Violation|1
2607207|NCT01015131|9013665|P1|Overall Study|Physician Decision|1
2607208|NCT01015118|9013681|P2|Overall Study|Other than stated above|23
2607209|NCT01015118|9013682|P1|Overall Study|Other than stated above|42
2607210|NCT01015118|9013681|P2|Overall Study|Not treated|5
2607211|NCT01015118|9013682|P1|Overall Study|Not treated|9
2607212|NCT01015118|9013681|P2|Overall Study|Progressive disease|229
2607213|NCT01015118|9013682|P1|Overall Study|Progressive disease|364
2607214|NCT01015118|9013681|P2|Overall Study|Worsening or AE of underlying disease|4
2607215|NCT01015118|9013682|P1|Overall Study|Worsening or AE of underlying disease|5
2607216|NCT01015118|9013681|P2|Overall Study|Other Adverse Event (AE)|33
2607217|NCT01015118|9013682|P1|Overall Study|Other Adverse Event (AE)|141
2607218|NCT01015118|9013681|P2|Overall Study|Withdrawal by Subject|27
2607219|NCT01015118|9013682|P1|Overall Study|Withdrawal by Subject|103
2607220|NCT01015118|9013681|P2|Overall Study|Protocol Violation|6
2607221|NCT01015118|9013682|P1|Overall Study|Protocol Violation|5
2607222|NCT01014988|9013710|P6|Overall Study|Withdrawal by Subject|0
2607223|NCT01014988|9013711|P5|Overall Study|Withdrawal by Subject|0
2607224|NCT01014988|9013712|P4|Overall Study|Withdrawal by Subject|0
2607225|NCT01014988|9013713|P3|Overall Study|Withdrawal by Subject|0
2607226|NCT01014988|9013714|P2|Overall Study|Withdrawal by Subject|0
2607227|NCT01014988|9013715|P1|Overall Study|Withdrawal by Subject|1
2607228|NCT01014988|9013710|P6|Overall Study|Physician Decision|0
2607229|NCT01014988|9013711|P5|Overall Study|Physician Decision|0
2607230|NCT01014988|9013712|P4|Overall Study|Physician Decision|0
2607231|NCT01014988|9013713|P3|Overall Study|Physician Decision|0
2607232|NCT01014988|9013714|P2|Overall Study|Physician Decision|0
2607233|NCT01014988|9013715|P1|Overall Study|Physician Decision|1
2607234|NCT01014988|9013710|P6|Overall Study|Lost to Follow-up|0
2607235|NCT01014988|9013711|P5|Overall Study|Lost to Follow-up|0
2607236|NCT01014988|9013712|P4|Overall Study|Lost to Follow-up|0
2607237|NCT01014988|9013713|P3|Overall Study|Lost to Follow-up|1
2607238|NCT01014988|9013714|P2|Overall Study|Lost to Follow-up|0
2607239|NCT01014988|9013715|P1|Overall Study|Lost to Follow-up|1
2607240|NCT01014988|9013710|P6|Overall Study|Adverse Event|3
2607241|NCT01014988|9013711|P5|Overall Study|Adverse Event|1
2607242|NCT01014988|9013712|P4|Overall Study|Adverse Event|0
2607243|NCT01014988|9013713|P3|Overall Study|Adverse Event|1
2607244|NCT01014988|9013714|P2|Overall Study|Adverse Event|0
2607245|NCT01014988|9013715|P1|Overall Study|Adverse Event|20
2607246|NCT01014975|9013887|P3|Overall Study|Lost to Follow-up|1
2607247|NCT01014975|9013888|P2|Overall Study|Lost to Follow-up|0
2607248|NCT01014975|9013889|P1|Overall Study|Lost to Follow-up|0
2607249|NCT01014975|9013887|P3|Overall Study|Death|4
2607250|NCT01014975|9013888|P2|Overall Study|Death|3
2607251|NCT01014975|9013889|P1|Overall Study|Death|3
2607252|NCT01014975|9013887|P3|Overall Study|Withdrawal by Subject|1
2607253|NCT01014975|9013888|P2|Overall Study|Withdrawal by Subject|0
2607254|NCT01014975|9013889|P1|Overall Study|Withdrawal by Subject|1
2607255|NCT01014910|9014394|P2|Overall Study|Withdrawal by Subject|2
2607256|NCT01014910|9014395|P1|Overall Study|Withdrawal by Subject|0
2607257|NCT01014767|9014413|P4|Overall Study|PI left institution, data unavailable|1
2607258|NCT01014767|9014414|P3|Overall Study|PI left institution, data unavailable|4
2607259|NCT01014767|9014415|P2|Overall Study|PI left institution, data unavailable|1
2607260|NCT01014767|9014416|P1|Overall Study|PI left institution, data unavailable|12
2607261|NCT01014689|9014460|P2|Overall Study|Pregnancy|0
2607262|NCT01014689|9014461|P1|Overall Study|Pregnancy|1
2607263|NCT01014689|9014460|P2|Overall Study|Lost to Follow-up|7
2607264|NCT01014689|9014461|P1|Overall Study|Lost to Follow-up|3
2607265|NCT01014689|9014460|P2|Overall Study|Protocol Violation|1
2607266|NCT01014689|9014461|P1|Overall Study|Protocol Violation|1
2607267|NCT01014689|9014460|P2|Overall Study|Withdrawal by Subject|4
2607268|NCT01014689|9014461|P1|Overall Study|Withdrawal by Subject|5
2607269|NCT01014689|9014460|P2|Overall Study|Adverse Event|0
2607270|NCT01014689|9014461|P1|Overall Study|Adverse Event|3
2607271|NCT01014689|9014460|P2|Overall Study|Lack of Efficacy|1
2607272|NCT01014689|9014461|P1|Overall Study|Lack of Efficacy|0
2607273|NCT01014585|9014496|P4|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
2607274|NCT01014585|9014497|P3|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
2607275|NCT01014585|9014498|P2|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23
2607276|NCT01014585|9014499|P1|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18
2607277|NCT01014585|9014496|P4|Overall Study|Lost to Follow-up|2
2607278|NCT01014585|9014497|P3|Overall Study|Lost to Follow-up|0
2607279|NCT01014585|9014498|P2|Overall Study|Lost to Follow-up|0
2607280|NCT01014585|9014499|P1|Overall Study|Lost to Follow-up|0
2607281|NCT01014585|9014496|P4|Overall Study|Withdrawal by Subject|3
2607282|NCT01014585|9014497|P3|Overall Study|Withdrawal by Subject|1
2607283|NCT01014585|9014498|P2|Overall Study|Withdrawal by Subject|0
2607284|NCT01014585|9014499|P1|Overall Study|Withdrawal by Subject|2
2607285|NCT01014585|9014496|P4|Overall Study|Adverse Event|3
2607286|NCT01014585|9014497|P3|Overall Study|Adverse Event|0
2607287|NCT01014585|9014498|P2|Overall Study|Adverse Event|2
2607288|NCT01014585|9014499|P1|Overall Study|Adverse Event|0
2607289|NCT01014533|9014519|P2|Overall Study|unable to come to appointment|3
2607290|NCT01014533|9014520|P1|Overall Study|unable to come to appointment|0
2607291|NCT01014533|9014519|P2|Overall Study|Withdrawal by Subject|0
2607292|NCT01014533|9014520|P1|Overall Study|Withdrawal by Subject|2
2607293|NCT01014533|9014519|P2|Overall Study|Protocol Violation|2
2607294|NCT01014533|9014520|P1|Overall Study|Protocol Violation|3
2607295|NCT01014442|9014541|P2|Overall Study|Unspecified Reason|1
2607296|NCT01014442|9014542|P1|Overall Study|Unspecified Reason|1
2607297|NCT01014442|9014541|P2|Overall Study|Lack of Compliance|1
2607298|NCT01014442|9014542|P1|Overall Study|Lack of Compliance|0
2607299|NCT01014442|9014541|P2|Overall Study|Protocol Violation|5
2607300|NCT01014442|9014542|P1|Overall Study|Protocol Violation|2
2607301|NCT01014442|9014541|P2|Overall Study|Withdrawal by Subject|4
2607302|NCT01014442|9014542|P1|Overall Study|Withdrawal by Subject|4
2607303|NCT01014442|9014541|P2|Overall Study|Adverse Event|8
2607304|NCT01014442|9014542|P1|Overall Study|Adverse Event|0
2607305|NCT01014208|9014666|P2|Overall Study|Study Closed/terminated|83
2607306|NCT01014208|9014667|P1|Overall Study|Study Closed/terminated|78
2607307|NCT01014208|9014666|P2|Overall Study|Did Not Receive Study Drug|0
2607308|NCT01014208|9014667|P1|Overall Study|Did Not Receive Study Drug|2
2607309|NCT01014208|9014666|P2|Overall Study|Participant Withdrew Consent|12
2607310|NCT01014208|9014667|P1|Overall Study|Participant Withdrew Consent|12
2607311|NCT01014208|9014666|P2|Overall Study|Lost to Follow-up|5
2607312|NCT01014208|9014667|P1|Overall Study|Lost to Follow-up|2
2607313|NCT01014143|9014709|P3|Second Intervention|Lost to Follow-up|0
2607314|NCT01014143|9014710|P2|Second Intervention|Lost to Follow-up|0
2607315|NCT01014143|9014711|P1|Second Intervention|Lost to Follow-up|2
2607316|NCT01014013|9014806|P2|Overall Study|Inappropriate therapy duration, < 7 Days|1
2607317|NCT01014013|9014807|P1|Overall Study|Inappropriate therapy duration, < 7 Days|0
2607318|NCT01014013|9014806|P2|Overall Study|Appendectomy|0
2607319|NCT01014013|9014807|P1|Overall Study|Appendectomy|1
2607320|NCT01014013|9014806|P2|Overall Study|Another antibiotic therapy required|1
2607321|NCT01014013|9014807|P1|Overall Study|Another antibiotic therapy required|0
2607322|NCT01014013|9014806|P2|Overall Study|Physician Decision|1
2607323|NCT01014013|9014807|P1|Overall Study|Physician Decision|0
2607324|NCT01014013|9014806|P2|Overall Study|Pathogen resistant|4
2607325|NCT01014013|9014807|P1|Overall Study|Pathogen resistant|7
2607326|NCT01014013|9014806|P2|Overall Study|Negative urine culture|0
2607327|NCT01014013|9014807|P1|Overall Study|Negative urine culture|2
2607328|NCT01014013|9014806|P2|Overall Study|Pathogen culture = no growth|34
2607329|NCT01014013|9014807|P1|Overall Study|Pathogen culture = no growth|26
2607330|NCT01014013|9014806|P2|Overall Study|Clinical/microbiologic failure|2
2607331|NCT01014013|9014807|P1|Overall Study|Clinical/microbiologic failure|1
2607332|NCT01014013|9014806|P2|Overall Study|Withdrawal by Subject|4
2607333|NCT01014013|9014807|P1|Overall Study|Withdrawal by Subject|7
2607334|NCT01014013|9014806|P2|Overall Study|Protocol Violation|3
2607335|NCT01014013|9014807|P1|Overall Study|Protocol Violation|1
2607336|NCT01014013|9014806|P2|Overall Study|Laboratory adverse experience|1
2607337|NCT01014013|9014807|P1|Overall Study|Laboratory adverse experience|1
2607338|NCT01014013|9014806|P2|Overall Study|Clinical adverse experience|2
2607339|NCT01014013|9014807|P1|Overall Study|Clinical adverse experience|4
2607340|NCT01014013|9014806|P2|Overall Study|Inclusion/Exclusion criteria not met|3
2607341|NCT01014013|9014807|P1|Overall Study|Inclusion/Exclusion criteria not met|1
2607342|NCT01013961|9014819|P2|Overall Study|Physician Decision|1
2607343|NCT01013961|9014820|P1|Overall Study|Physician Decision|0
2607344|NCT01013961|9014819|P2|Overall Study|Withdrawal by Subject|0
2607345|NCT01013961|9014820|P1|Overall Study|Withdrawal by Subject|1
2607346|NCT01013961|9014819|P2|Overall Study|Adverse Event|2
2607347|NCT01013961|9014820|P1|Overall Study|Adverse Event|2
2607348|NCT01013883|9014838|P2|Overall Study|Lost to Follow-up|2
2607349|NCT01013883|9014839|P1|Overall Study|Lost to Follow-up|2
2607350|NCT01013870|9014851|P2|Overall Study|Lost to Follow-up|3
2607351|NCT01013870|9014852|P1|Overall Study|Lost to Follow-up|1
2607352|NCT01013792|9014901|P2|Overall Study|Lost to Follow-up|1
2607353|NCT01013792|9014902|P1|Overall Study|Lost to Follow-up|0
2607354|NCT01013792|9014901|P2|Overall Study|Adverse Event|3
2607355|NCT01013792|9014902|P1|Overall Study|Adverse Event|0
2607356|NCT01013792|9014901|P2|Overall Study|Study suspended|1
2607357|NCT01013792|9014902|P1|Overall Study|Study suspended|2
2607358|NCT01013753|9014908|P1|Overall Study|Other|2
2607359|NCT01013753|9014908|P1|Overall Study|Withdrawal by Subject|2
2607360|NCT01013753|9014908|P1|Overall Study|Lost to Follow-up|1
2607361|NCT01013753|9014908|P1|Overall Study|Protocol Violation|3
2607362|NCT01013753|9014908|P1|Overall Study|Adverse Event|8
2607363|NCT01013740|9015104|P2|Overall Study|Ongoing: Study records not completed|2
2607364|NCT01013740|9015105|P1|Overall Study|Ongoing: Study records not completed|0
2607365|NCT01013740|9015104|P2|Overall Study|Missing|1
2607366|NCT01013740|9015105|P1|Overall Study|Missing|2
2607367|NCT01013740|9015104|P2|Overall Study|study close / terminated : done in error|1
2607368|NCT01013740|9015105|P1|Overall Study|study close / terminated : done in error|2
2607369|NCT01013740|9015104|P2|Overall Study|Withdrawal by Subject|10
2607370|NCT01013740|9015105|P1|Overall Study|Withdrawal by Subject|2
2607371|NCT01013740|9015104|P2|Overall Study|Physician Decision|0
2607372|NCT01013740|9015105|P1|Overall Study|Physician Decision|2
2607373|NCT01013740|9015104|P2|Overall Study|Lost to Follow-up|5
2607374|NCT01013740|9015105|P1|Overall Study|Lost to Follow-up|3
2607375|NCT01013701|9015129|P1|Overall Study|study prematurely terminated|7
2607376|NCT01013597|9015136|P1|Overall Study|Withdrawal by Subject|1
2607377|NCT01013350|9015148|P2|Overall Study|Other|25
2607378|NCT01013350|9015149|P1|Overall Study|Other|1
2607379|NCT01013350|9015148|P2|Overall Study|Participant entered interventional study|8
2607380|NCT01013350|9015149|P1|Overall Study|Participant entered interventional study|0
2607381|NCT01013350|9015148|P2|Overall Study|Death|5
2607382|NCT01013350|9015149|P1|Overall Study|Death|3
2607383|NCT01013350|9015148|P2|Overall Study|Withdrawal by Subject|38
2607384|NCT01013350|9015149|P1|Overall Study|Withdrawal by Subject|15
2607385|NCT01013350|9015148|P2|Overall Study|Physician Decision|20
2607386|NCT01013350|9015149|P1|Overall Study|Physician Decision|4
2607387|NCT01013350|9015148|P2|Overall Study|Adverse Event|1
2607388|NCT01013350|9015149|P1|Overall Study|Adverse Event|0
2607389|NCT01013350|9015148|P2|Overall Study|Lost to Follow-up|95
2607390|NCT01013350|9015149|P1|Overall Study|Lost to Follow-up|15
2607391|NCT01013207|9015160|P1|CPAP Post Nexus (S9)|Lost to Follow-up|6
2607392|NCT01012999|9015178|P1|Overall Study|Protocol Violation|1
2607393|NCT01012973|9015184|P2|Overall Study|Withdrawal by Subject|6
2607394|NCT01012973|9015185|P1|Overall Study|Withdrawal by Subject|4
2607395|NCT01012973|9015184|P2|Overall Study|Protocol Violation|2
2607396|NCT01012973|9015185|P1|Overall Study|Protocol Violation|5
2607397|NCT01012973|9015184|P2|Overall Study|Increase in vis. acuity, never injected|1
2607398|NCT01012973|9015185|P1|Overall Study|Increase in vis. acuity, never injected|0
2607399|NCT01012973|9015184|P2|Overall Study|(Overseas travel - indefinite period)|0
2607400|NCT01012973|9015185|P1|Overall Study|(Overseas travel - indefinite period)|1
2607401|NCT01012973|9015184|P2|Overall Study|Lost to Follow-up|0
2607402|NCT01012973|9015185|P1|Overall Study|Lost to Follow-up|1
2607403|NCT01012973|9015184|P2|Overall Study|Lack of Efficacy|5
2607404|NCT01012973|9015185|P1|Overall Study|Lack of Efficacy|0
2607405|NCT01012973|9015184|P2|Overall Study|Adverse Event|5
2607406|NCT01012973|9015185|P1|Overall Study|Adverse Event|5
2607407|NCT01012947|9015210|P5|Overall Study|Lost to Follow-up|142
2607408|NCT01012947|9015211|P4|Overall Study|Lost to Follow-up|118
2607409|NCT01012947|9015212|P3|Overall Study|Lost to Follow-up|130
2607410|NCT01012947|9015213|P2|Overall Study|Lost to Follow-up|135
2607411|NCT01012947|9015214|P1|Overall Study|Lost to Follow-up|131
2607412|NCT01012765|9015235|P6|Treatment Period 2|Unsatisfactory therapeutic effect|0
2607413|NCT01012765|9015236|P5|Treatment Period 2|Unsatisfactory therapeutic effect|0
2607414|NCT01012765|9015237|P4|Treatment Period 2|Unsatisfactory therapeutic effect|0
2607415|NCT01012765|9015238|P3|Treatment Period 2|Unsatisfactory therapeutic effect|1
2607416|NCT01012765|9015239|P2|Treatment Period 2|Unsatisfactory therapeutic effect|1
2607417|NCT01012765|9015240|P1|Treatment Period 2|Unsatisfactory therapeutic effect|0
2607418|NCT01012765|9015235|P6|Treatment Period 2|Adverse Event|0
2607419|NCT01012765|9015236|P5|Treatment Period 2|Adverse Event|0
2607420|NCT01012765|9015237|P4|Treatment Period 2|Adverse Event|0
2607421|NCT01012765|9015238|P3|Treatment Period 2|Adverse Event|1
2607422|NCT01012765|9015239|P2|Treatment Period 2|Adverse Event|1
2607423|NCT01012765|9015240|P1|Treatment Period 2|Adverse Event|0
2607424|NCT01012765|9015235|P6|Treatment Period 2|Abnormal laboratory value(s)|1
2607425|NCT01012765|9015236|P5|Treatment Period 2|Abnormal laboratory value(s)|0
2607426|NCT01012765|9015237|P4|Treatment Period 2|Abnormal laboratory value(s)|0
2607427|NCT01012765|9015238|P3|Treatment Period 2|Abnormal laboratory value(s)|0
2607428|NCT01012765|9015239|P2|Treatment Period 2|Abnormal laboratory value(s)|0
2607429|NCT01012765|9015240|P1|Treatment Period 2|Abnormal laboratory value(s)|0
2607430|NCT01012765|9015235|P6|Treatment Period 2|Withdrawal by Subject|0
2607431|NCT01012765|9015236|P5|Treatment Period 2|Withdrawal by Subject|1
2607432|NCT01012765|9015237|P4|Treatment Period 2|Withdrawal by Subject|0
2607433|NCT01012765|9015238|P3|Treatment Period 2|Withdrawal by Subject|1
2607434|NCT01012765|9015239|P2|Treatment Period 2|Withdrawal by Subject|0
2607435|NCT01012765|9015240|P1|Treatment Period 2|Withdrawal by Subject|1
2607436|NCT01012765|9015235|P6|Treatment Period 1|Unsatisfactory therapeutic effect|0
2607437|NCT01012765|9015236|P5|Treatment Period 1|Unsatisfactory therapeutic effect|1
2607438|NCT01012765|9015237|P4|Treatment Period 1|Unsatisfactory therapeutic effect|0
2607439|NCT01012765|9015238|P3|Treatment Period 1|Unsatisfactory therapeutic effect|0
2607440|NCT01012765|9015239|P2|Treatment Period 1|Unsatisfactory therapeutic effect|0
2607441|NCT01012765|9015240|P1|Treatment Period 1|Unsatisfactory therapeutic effect|0
2607442|NCT01012765|9015235|P6|Treatment Period 1|Protocol Violation|0
2607443|NCT01012765|9015236|P5|Treatment Period 1|Protocol Violation|1
2607444|NCT01012765|9015237|P4|Treatment Period 1|Protocol Violation|2
2607445|NCT01012765|9015238|P3|Treatment Period 1|Protocol Violation|0
2607446|NCT01012765|9015239|P2|Treatment Period 1|Protocol Violation|0
2607447|NCT01012765|9015240|P1|Treatment Period 1|Protocol Violation|0
2607448|NCT01012765|9015235|P6|Treatment Period 1|Administrative problems|0
2607449|NCT01012765|9015236|P5|Treatment Period 1|Administrative problems|1
2607450|NCT01012765|9015237|P4|Treatment Period 1|Administrative problems|1
2607451|NCT01012765|9015238|P3|Treatment Period 1|Administrative problems|1
2607452|NCT01012765|9015239|P2|Treatment Period 1|Administrative problems|0
2607453|NCT01012765|9015240|P1|Treatment Period 1|Administrative problems|0
2607454|NCT01012765|9015235|P6|Treatment Period 1|Withdrawal by Subject|0
2607455|NCT01012765|9015236|P5|Treatment Period 1|Withdrawal by Subject|0
2607456|NCT01012765|9015237|P4|Treatment Period 1|Withdrawal by Subject|0
2607457|NCT01012765|9015238|P3|Treatment Period 1|Withdrawal by Subject|0
2607458|NCT01012765|9015239|P2|Treatment Period 1|Withdrawal by Subject|0
2607459|NCT01012765|9015240|P1|Treatment Period 1|Withdrawal by Subject|2
2607460|NCT01012765|9015235|P6|Treatment Period 1|Adverse Event|0
2607461|NCT01012765|9015236|P5|Treatment Period 1|Adverse Event|0
2607462|NCT01012765|9015237|P4|Treatment Period 1|Adverse Event|0
2607463|NCT01012765|9015238|P3|Treatment Period 1|Adverse Event|1
2607464|NCT01012765|9015239|P2|Treatment Period 1|Adverse Event|0
2607465|NCT01012765|9015240|P1|Treatment Period 1|Adverse Event|1
2607466|NCT01012739|9015269|P4|Treatment Period 2|Abnormal test procedure results|1
2607467|NCT01012739|9015270|P3|Treatment Period 2|Abnormal test procedure results|0
2607468|NCT01012739|9015271|P2|Treatment Period 2|Abnormal test procedure results|0
2607469|NCT01012739|9015272|P1|Treatment Period 2|Abnormal test procedure results|0
2607470|NCT01012739|9015269|P4|Treatment Period 1|Adverse Event|1
2607471|NCT01012739|9015270|P3|Treatment Period 1|Adverse Event|0
2607472|NCT01012739|9015271|P2|Treatment Period 1|Adverse Event|0
2607473|NCT01012739|9015272|P1|Treatment Period 1|Adverse Event|0
2607474|NCT01012713|9015300|P1|Overall Study|Lack of Efficacy|3
2607475|NCT01012622|9015326|P1|Overall Study|withdrawal of consent by a parent|2
2607476|NCT01012622|9015326|P1|Overall Study|screening failure|1
2607477|NCT01012622|9015326|P1|Overall Study|Other|1
2607478|NCT01012622|9015326|P1|Overall Study|non-compliance with the drug|9
2607479|NCT01012622|9015326|P1|Overall Study|Adverse Event|7
2607480|NCT01012622|9015326|P1|Overall Study|Lost to Follow-up|5
2607481|NCT01012622|9015326|P1|Overall Study|Withdrawal by Subject|6
2607482|NCT01012440|9015352|P1|Overall Study|Withdrawal by Subject|2
2607483|NCT01012414|9015356|P1|Overall Study|Trial was stopped before completed|7
2607484|NCT01012414|9015356|P1|Overall Study|Lost to Follow-up|1
2607485|NCT01012414|9015356|P1|Overall Study|Withdrawal by Subject|2
2607486|NCT01012323|9015397|P1|Overall Study|Investigator Judgment|1
2607487|NCT01012258|9015434|P1|Overall Study|Ongoing|29
2607488|NCT01012258|9015434|P1|Overall Study|Another Tumor Discovered|1
2607489|NCT01012258|9015434|P1|Overall Study|Another Anti-cancer Drug Received|1
2607490|NCT01012258|9015434|P1|Overall Study|Symptomatic Deterioration|1
2607491|NCT01012258|9015434|P1|Overall Study|Progressive Disease (PD)|18
2607492|NCT01012258|9015434|P1|Overall Study|Adverse Event|1
2607493|NCT01012258|9015434|P1|Overall Study|Lost to Follow-up|1
2607494|NCT01012258|9015434|P1|Overall Study|Death|14
2607495|NCT01012219|9015481|P1|Period 2|Withdrawal by Subject|1
2607496|NCT01012219|9015481|P1|Period 1|Withdrawal by Subject|1
2607497|NCT01012037|9015772|P3|Overall Study|Other reason (not specified)|1
2607498|NCT01012037|9015773|P2|Overall Study|Other reason (not specified)|1
2607499|NCT01012037|9015774|P1|Overall Study|Other reason (not specified)|1
2607500|NCT01012037|9015772|P3|Overall Study|Withdrawal by Subject|1
2607501|NCT01012037|9015773|P2|Overall Study|Withdrawal by Subject|4
2607502|NCT01012037|9015774|P1|Overall Study|Withdrawal by Subject|0
2607503|NCT01012037|9015772|P3|Overall Study|Protocol Violation|5
2607504|NCT01012037|9015773|P2|Overall Study|Protocol Violation|3
2607505|NCT01012037|9015774|P1|Overall Study|Protocol Violation|0
2607506|NCT01012037|9015772|P3|Overall Study|Adverse Event|3
2607507|NCT01012037|9015773|P2|Overall Study|Adverse Event|8
2607508|NCT01012037|9015774|P1|Overall Study|Adverse Event|0
2607509|NCT01011946|9015809|P1|Overall Study|No pathological lab value|1
2607510|NCT01011946|9015809|P1|Overall Study|Transferred to another hospital|2
2607511|NCT01011933|9015813|P1|Overall Study|Never treated|1
2607512|NCT01011933|9015813|P1|Overall Study|Inadequate pathology|1
2607513|NCT01011933|9015813|P1|Overall Study|Improper pre-protocol Rx|1
2607514|NCT01011933|9015813|P1|Overall Study|Wrong cell type|1
2607515|NCT01011907|9015830|P2|Overall Study|Adverse Event|4
2607516|NCT01011907|9015831|P1|Overall Study|Adverse Event|1
2607517|NCT01011907|9015830|P2|Overall Study|Withdrawal by Subject|11
2607518|NCT01011907|9015831|P1|Overall Study|Withdrawal by Subject|13
2607519|NCT01011868|9015848|P3|After Week 78 Follow-up|Other reason not defined above|16
2607520|NCT01011868|9015849|P2|After Week 78 Follow-up|Other reason not defined above|5
2607521|NCT01011868|9015850|P1|After Week 78 Follow-up|Other reason not defined above|5
2607522|NCT01011868|9015848|P3|After Week 78 Follow-up|Withdrawal by Subject|1
2607523|NCT01011868|9015849|P2|After Week 78 Follow-up|Withdrawal by Subject|8
2607524|NCT01011868|9015850|P1|After Week 78 Follow-up|Withdrawal by Subject|9
2607525|NCT01011868|9015848|P3|After Week 78 Follow-up|Lost to Follow-up|4
2607526|NCT01011868|9015849|P2|After Week 78 Follow-up|Lost to Follow-up|6
2607527|NCT01011868|9015850|P1|After Week 78 Follow-up|Lost to Follow-up|11
2607528|NCT01011868|9015848|P3|After Week 78 Follow-up|Protocol Violation|2
2607529|NCT01011868|9015849|P2|After Week 78 Follow-up|Protocol Violation|1
2607530|NCT01011868|9015850|P1|After Week 78 Follow-up|Protocol Violation|9
2607531|NCT01011868|9015848|P3|After Week 78 Follow-up|Lack of Efficacy|0
2607532|NCT01011868|9015849|P2|After Week 78 Follow-up|Lack of Efficacy|0
2607533|NCT01011868|9015850|P1|After Week 78 Follow-up|Lack of Efficacy|4
2607534|NCT01011868|9015848|P3|After Week 78 Follow-up|Adverse Event|21
2607535|NCT01011868|9015849|P2|After Week 78 Follow-up|Adverse Event|18
2607536|NCT01011868|9015850|P1|After Week 78 Follow-up|Adverse Event|14
2607537|NCT01011868|9015848|P3|After Week 18 Follow-up|Other reason not defined above|12
2607538|NCT01011868|9015849|P2|After Week 18 Follow-up|Other reason not defined above|3
2607539|NCT01011868|9015850|P1|After Week 18 Follow-up|Other reason not defined above|2
2607540|NCT01011868|9015848|P3|After Week 18 Follow-up|Withdrawal by Subject|0
2607541|NCT01011868|9015849|P2|After Week 18 Follow-up|Withdrawal by Subject|3
2607542|NCT01011868|9015850|P1|After Week 18 Follow-up|Withdrawal by Subject|6
2607543|NCT01011868|9015848|P3|After Week 18 Follow-up|Lost to Follow-up|0
2607544|NCT01011868|9015849|P2|After Week 18 Follow-up|Lost to Follow-up|3
2607545|NCT01011868|9015850|P1|After Week 18 Follow-up|Lost to Follow-up|5
2607546|NCT01011868|9015848|P3|After Week 18 Follow-up|Protocol Violation|1
2607547|NCT01011868|9015849|P2|After Week 18 Follow-up|Protocol Violation|1
2607548|NCT01011868|9015850|P1|After Week 18 Follow-up|Protocol Violation|1
2607549|NCT01011868|9015848|P3|After Week 18 Follow-up|Lack of Efficacy|0
2607550|NCT01011868|9015849|P2|After Week 18 Follow-up|Lack of Efficacy|0
2607551|NCT01011868|9015850|P1|After Week 18 Follow-up|Lack of Efficacy|1
2607552|NCT01011868|9015848|P3|After Week 18 Follow-up|Adverse Event|13
2607553|NCT01011868|9015849|P2|After Week 18 Follow-up|Adverse Event|6
2607554|NCT01011868|9015850|P1|After Week 18 Follow-up|Adverse Event|8
2607555|NCT01011738|9015912|P3|Overall Study|Unknown reasons|17
2607556|NCT01011738|9015913|P2|Overall Study|Unknown reasons|291
2607557|NCT01011738|9015914|P1|Overall Study|Unknown reasons|312
2607558|NCT01011738|9015912|P3|Overall Study|Death|0
2607559|NCT01011738|9015913|P2|Overall Study|Death|3
2607560|NCT01011738|9015914|P1|Overall Study|Death|12
2607561|NCT01011673|9015954|P2|24 Hour Follow-up|Lost to Follow-up|3
2607562|NCT01011673|9015955|P1|24 Hour Follow-up|Lost to Follow-up|3
2607563|NCT01011673|9015954|P2|Randomized|Secondary headache|1
2607564|NCT01011673|9015955|P1|Randomized|Secondary headache|2
2607565|NCT01011556|9015978|P4|Overall Study|Inclusion/exclusion criteria not met|5
2607566|NCT01011556|9015979|P3|Overall Study|Inclusion/exclusion criteria not met|3
2607567|NCT01011556|9015980|P2|Overall Study|Inclusion/exclusion criteria not met|1
2607568|NCT01011556|9015981|P1|Overall Study|Inclusion/exclusion criteria not met|2
2607569|NCT01011556|9015978|P4|Overall Study|Sponsor decision|2
2607570|NCT01011556|9015979|P3|Overall Study|Sponsor decision|1
2607571|NCT01011556|9015980|P2|Overall Study|Sponsor decision|1
2607572|NCT01011556|9015981|P1|Overall Study|Sponsor decision|0
2607573|NCT01011556|9015978|P4|Overall Study|Withdrawal by Subject|4
2607574|NCT01011556|9015979|P3|Overall Study|Withdrawal by Subject|4
2607575|NCT01011556|9015980|P2|Overall Study|Withdrawal by Subject|2
2607576|NCT01011556|9015981|P1|Overall Study|Withdrawal by Subject|1
2607577|NCT01011556|9015978|P4|Overall Study|Protocol Violation|0
2607578|NCT01011556|9015979|P3|Overall Study|Protocol Violation|0
2607579|NCT01011556|9015980|P2|Overall Study|Protocol Violation|1
2607580|NCT01011556|9015981|P1|Overall Study|Protocol Violation|0
2607581|NCT01011556|9015978|P4|Overall Study|Physician Decision|1
2607582|NCT01011556|9015979|P3|Overall Study|Physician Decision|0
2607583|NCT01011556|9015980|P2|Overall Study|Physician Decision|0
2607584|NCT01011556|9015981|P1|Overall Study|Physician Decision|1
2607585|NCT01011556|9015978|P4|Overall Study|Lost to Follow-up|0
2607586|NCT01011556|9015979|P3|Overall Study|Lost to Follow-up|0
2607587|NCT01011556|9015980|P2|Overall Study|Lost to Follow-up|0
2607588|NCT01011556|9015981|P1|Overall Study|Lost to Follow-up|1
2607589|NCT01011556|9015978|P4|Overall Study|Adverse Event|1
2607590|NCT01011556|9015979|P3|Overall Study|Adverse Event|2
2607591|NCT01011556|9015980|P2|Overall Study|Adverse Event|3
2607592|NCT01011556|9015981|P1|Overall Study|Adverse Event|1
2607593|NCT01011465|9016059|P8|Overall Study|Withdrawal by Subject|0
2607594|NCT01011465|9016060|P7|Overall Study|Withdrawal by Subject|1
2607595|NCT01011465|9016061|P6|Overall Study|Withdrawal by Subject|0
2607596|NCT01011465|9016062|P5|Overall Study|Withdrawal by Subject|1
2607597|NCT01011465|9016063|P4|Overall Study|Withdrawal by Subject|0
2607598|NCT01011465|9016064|P3|Overall Study|Withdrawal by Subject|0
2607599|NCT01011465|9016065|P2|Overall Study|Withdrawal by Subject|1
2607600|NCT01011465|9016066|P1|Overall Study|Withdrawal by Subject|2
2607601|NCT01011439|9016094|P1|Overall Study|Sponsor's decision|15
2607602|NCT01011439|9016094|P1|Overall Study|Withdrawal by Subject|1
2607603|NCT01011439|9016094|P1|Overall Study|Lost to Follow-up|4
2607604|NCT01011439|9016094|P1|Overall Study|Death|37
2607605|NCT01011387|9016131|P1|Overall Study|Protocol Violation|1
2607606|NCT01011387|9016131|P1|Overall Study|Adverse Event|2
2607607|NCT01011387|9016131|P1|Overall Study|Withdrawal by Subject|3
2607608|NCT01011335|9016139|P13|Overall Study|Adverse Event|1
2607609|NCT01011335|9016140|P12|Overall Study|Adverse Event|0
2607610|NCT01011335|9016141|P11|Overall Study|Adverse Event|4
2607611|NCT01011335|9016142|P10|Overall Study|Adverse Event|0
2607612|NCT01011335|9016143|P9|Overall Study|Adverse Event|0
2607613|NCT01011335|9016144|P8|Overall Study|Adverse Event|0
2607614|NCT01011335|9016145|P7|Overall Study|Adverse Event|0
2607615|NCT01011335|9016146|P6|Overall Study|Adverse Event|0
2607616|NCT01011335|9016147|P5|Overall Study|Adverse Event|0
2607617|NCT01011335|9016148|P4|Overall Study|Adverse Event|0
2607618|NCT01011335|9016149|P3|Overall Study|Adverse Event|0
2607619|NCT01011335|9016150|P2|Overall Study|Adverse Event|0
2607620|NCT01011335|9016151|P1|Overall Study|Adverse Event|0
2607621|NCT01011335|9016139|P13|Overall Study|Moved/deployed or no booster|0
2607622|NCT01011335|9016140|P12|Overall Study|Moved/deployed or no booster|0
2607623|NCT01011335|9016141|P11|Overall Study|Moved/deployed or no booster|2
2607624|NCT01011335|9016142|P10|Overall Study|Moved/deployed or no booster|0
2607625|NCT01011335|9016143|P9|Overall Study|Moved/deployed or no booster|1
2607626|NCT01011335|9016144|P8|Overall Study|Moved/deployed or no booster|0
2607627|NCT01011335|9016145|P7|Overall Study|Moved/deployed or no booster|1
2607628|NCT01011335|9016146|P6|Overall Study|Moved/deployed or no booster|0
2607629|NCT01011335|9016147|P5|Overall Study|Moved/deployed or no booster|0
2607630|NCT01011335|9016148|P4|Overall Study|Moved/deployed or no booster|1
2607631|NCT01011335|9016149|P3|Overall Study|Moved/deployed or no booster|0
2607632|NCT01011335|9016150|P2|Overall Study|Moved/deployed or no booster|0
2607633|NCT01011335|9016151|P1|Overall Study|Moved/deployed or no booster|1
2607634|NCT01011335|9016139|P13|Overall Study|Protocol Violation|0
2607635|NCT01011335|9016140|P12|Overall Study|Protocol Violation|0
2607636|NCT01011335|9016141|P11|Overall Study|Protocol Violation|0
2607637|NCT01011335|9016142|P10|Overall Study|Protocol Violation|0
2607638|NCT01011335|9016143|P9|Overall Study|Protocol Violation|0
2607639|NCT01011335|9016144|P8|Overall Study|Protocol Violation|0
2607640|NCT01011335|9016145|P7|Overall Study|Protocol Violation|0
2607641|NCT01011335|9016146|P6|Overall Study|Protocol Violation|0
2607642|NCT01011335|9016147|P5|Overall Study|Protocol Violation|0
2607643|NCT01011335|9016148|P4|Overall Study|Protocol Violation|0
2607644|NCT01011335|9016149|P3|Overall Study|Protocol Violation|0
2607645|NCT01011335|9016150|P2|Overall Study|Protocol Violation|1
2607646|NCT01011335|9016151|P1|Overall Study|Protocol Violation|0
2607647|NCT01011335|9016139|P13|Overall Study|Lost to Follow-up|2
2607648|NCT01011335|9016140|P12|Overall Study|Lost to Follow-up|1
2607649|NCT01011335|9016141|P11|Overall Study|Lost to Follow-up|0
2607650|NCT01011335|9016142|P10|Overall Study|Lost to Follow-up|0
2607651|NCT01011335|9016143|P9|Overall Study|Lost to Follow-up|1
2607652|NCT01011335|9016144|P8|Overall Study|Lost to Follow-up|2
2607653|NCT01011335|9016145|P7|Overall Study|Lost to Follow-up|2
2607654|NCT01011335|9016146|P6|Overall Study|Lost to Follow-up|1
2607655|NCT01011335|9016147|P5|Overall Study|Lost to Follow-up|1
2607656|NCT01011335|9016148|P4|Overall Study|Lost to Follow-up|1
2607657|NCT01011335|9016149|P3|Overall Study|Lost to Follow-up|1
2607658|NCT01011335|9016150|P2|Overall Study|Lost to Follow-up|0
2607659|NCT01011335|9016151|P1|Overall Study|Lost to Follow-up|0
2607660|NCT01011309|9016191|P3|Overall Study|Protocol Violation|3
2607661|NCT01011309|9016192|P2|Overall Study|Protocol Violation|1
2607662|NCT01011309|9016193|P1|Overall Study|Protocol Violation|0
2607663|NCT01011309|9016191|P3|Overall Study|Lack of Efficacy|0
2607664|NCT01011309|9016192|P2|Overall Study|Lack of Efficacy|1
2607665|NCT01011309|9016193|P1|Overall Study|Lack of Efficacy|0
2607666|NCT01011309|9016191|P3|Overall Study|Adverse Event|2
2607667|NCT01011309|9016192|P2|Overall Study|Adverse Event|1
2607668|NCT01011309|9016193|P1|Overall Study|Adverse Event|2
2607669|NCT01011283|9016209|P2|Overall Study|Other|2
2607670|NCT01011283|9016210|P1|Overall Study|Other|2
2607671|NCT01011283|9016209|P2|Overall Study|Terminated by Sponsor|5
2607672|NCT01011283|9016210|P1|Overall Study|Terminated by Sponsor|5
2607673|NCT01011283|9016209|P2|Overall Study|Progressive Disease|2
2607674|NCT01011283|9016210|P1|Overall Study|Progressive Disease|0
2607675|NCT01011283|9016209|P2|Overall Study|Adverse Event|2
2607676|NCT01011283|9016210|P1|Overall Study|Adverse Event|4
2607677|NCT01011153|9016259|P3|Overall Study|Less than 78 cases completed|9
2607678|NCT01011153|9016260|P2|Overall Study|Less than 78 cases completed|11
2607679|NCT01011153|9016261|P1|Overall Study|Less than 78 cases completed|8
2607680|NCT01011049|9016290|P4|Overall Study|Withdrawal by Subject|0
2607681|NCT01011049|9016291|P3|Overall Study|Withdrawal by Subject|1
2607682|NCT01011049|9016292|P2|Overall Study|Withdrawal by Subject|0
2607683|NCT01011049|9016293|P1|Overall Study|Withdrawal by Subject|0
2607684|NCT01011049|9016290|P4|Overall Study|Lost to Follow-up|0
2607685|NCT01011049|9016291|P3|Overall Study|Lost to Follow-up|1
2607686|NCT01011049|9016292|P2|Overall Study|Lost to Follow-up|2
2607687|NCT01011049|9016293|P1|Overall Study|Lost to Follow-up|1
2607688|NCT01011049|9016290|P4|Overall Study|Protocol Violation|0
2607689|NCT01011049|9016291|P3|Overall Study|Protocol Violation|2
2607690|NCT01011049|9016292|P2|Overall Study|Protocol Violation|0
2607691|NCT01011049|9016293|P1|Overall Study|Protocol Violation|0
2607692|NCT01010971|9016323|P3|Overall Study|Other|2
2607693|NCT01010971|9016324|P2|Overall Study|Other|0
2607694|NCT01010971|9016325|P1|Overall Study|Other|1
2607695|NCT01010971|9016323|P3|Overall Study|Lost to Follow-up|3
2607696|NCT01010971|9016324|P2|Overall Study|Lost to Follow-up|2
2607697|NCT01010971|9016325|P1|Overall Study|Lost to Follow-up|0
2607698|NCT01010971|9016323|P3|Overall Study|Withdrawal by Subject|5
2607699|NCT01010971|9016324|P2|Overall Study|Withdrawal by Subject|2
2607700|NCT01010971|9016325|P1|Overall Study|Withdrawal by Subject|0
2607701|NCT01010971|9016323|P3|Overall Study|Adverse Event|3
2607702|NCT01010971|9016324|P2|Overall Study|Adverse Event|4
2607703|NCT01010971|9016325|P1|Overall Study|Adverse Event|2
2607704|NCT01010867|9016453|P1|Overall Study|< 50% adherence to probiotic|1
2607705|NCT01010776|9016465|P1|Extension Phase|Other|3
2607706|NCT01010776|9016465|P1|In-Between Main Phase & Extension Phase|Extension phase was optional|15
2607707|NCT01010776|9016465|P1|Main Phase|Did not received study medication|5
2607708|NCT01010776|9016465|P1|Main Phase|Other|1
2607709|NCT01010776|9016465|P1|Main Phase|Inform consent withdrawal|1
2607710|NCT01010776|9016465|P1|Main Phase|Selection failure|2
2607711|NCT01010776|9016465|P1|Main Phase|Non-compliance to study medication|5
2607712|NCT01010776|9016465|P1|Main Phase|Lost to Follow-up|6
2607713|NCT01010776|9016465|P1|Main Phase|Adverse Event|7
2607714|NCT01010776|9016465|P1|Main Phase|Lack of Efficacy|8
2607715|NCT01010776|9016465|P1|Main Phase|Withdrawal by Subject|14
2607716|NCT01010750|9016522|P6|Second Intervention|Adverse Event|0
2607717|NCT01010750|9016523|P5|Second Intervention|Adverse Event|0
2607718|NCT01010750|9016524|P4|Second Intervention|Adverse Event|0
2607719|NCT01010750|9016525|P3|Second Intervention|Adverse Event|0
2607720|NCT01010750|9016526|P2|Second Intervention|Adverse Event|1
2607721|NCT01010750|9016527|P1|Second Intervention|Adverse Event|0
2607722|NCT01010633|9016552|P2|Overall Study|Investigator decision|1
2607723|NCT01010633|9016553|P1|Overall Study|Investigator decision|0
2607724|NCT01010633|9016552|P2|Overall Study|Withdrawal by Subject|1
2607725|NCT01010633|9016553|P1|Overall Study|Withdrawal by Subject|2
2607726|NCT01010633|9016552|P2|Overall Study|Protocol Violation|2
2607727|NCT01010633|9016553|P1|Overall Study|Protocol Violation|1
2607728|NCT01010633|9016552|P2|Overall Study|Adverse Event|1
2607729|NCT01010633|9016553|P1|Overall Study|Adverse Event|1
2607730|NCT01010503|9016580|P1|Overall Study|Death|1
2607731|NCT01010503|9016580|P1|Overall Study|Adverse Event|1
2607732|NCT01010230|9016639|P2|Overall Study|Lost to Follow-up|2
2607733|NCT01010230|9016640|P1|Overall Study|Lost to Follow-up|4
2607734|NCT01010230|9016639|P2|Overall Study|Withdrawal by Subject|5
2607735|NCT01010230|9016640|P1|Overall Study|Withdrawal by Subject|6
2607736|NCT01010217|9016675|P5|Overall Study|Physician Decision|3
2607737|NCT01010217|9016676|P4|Overall Study|Physician Decision|6
2607738|NCT01010217|9016677|P3|Overall Study|Physician Decision|0
2607739|NCT01010217|9016678|P2|Overall Study|Physician Decision|0
2607740|NCT01010217|9016679|P1|Overall Study|Physician Decision|0
2607741|NCT01010217|9016675|P5|Overall Study|Withdrawal by Subject|0
2607742|NCT01010217|9016676|P4|Overall Study|Withdrawal by Subject|0
2607743|NCT01010217|9016677|P3|Overall Study|Withdrawal by Subject|0
2607744|NCT01010217|9016678|P2|Overall Study|Withdrawal by Subject|0
2607745|NCT01010217|9016679|P1|Overall Study|Withdrawal by Subject|1
2607746|NCT01010217|9016675|P5|Overall Study|Lost to Follow-up|0
2607747|NCT01010217|9016676|P4|Overall Study|Lost to Follow-up|0
2607748|NCT01010217|9016677|P3|Overall Study|Lost to Follow-up|1
2607749|NCT01010217|9016678|P2|Overall Study|Lost to Follow-up|5
2607750|NCT01010217|9016679|P1|Overall Study|Lost to Follow-up|4
2607751|NCT01010204|9016718|P2|Overall Study|psychiatric hospitalization|1
2607752|NCT01010204|9016719|P1|Overall Study|psychiatric hospitalization|2
2607753|NCT01010204|9016718|P2|Overall Study|Withdrawal by Subject|3
2607754|NCT01010204|9016719|P1|Overall Study|Withdrawal by Subject|2
2607755|NCT01010204|9016718|P2|Overall Study|Adverse Event|3
2607756|NCT01010204|9016719|P1|Overall Study|Adverse Event|1
2607757|NCT01010204|9016718|P2|Overall Study|Lost to Follow-up|2
2607758|NCT01010204|9016719|P1|Overall Study|Lost to Follow-up|2
2607759|NCT01010126|9016735|P6|Overall Study|Withdrawal by Subject|0
2607760|NCT01010126|9016736|P5|Overall Study|Withdrawal by Subject|3
2607761|NCT01010126|9016737|P4|Overall Study|Withdrawal by Subject|0
2607762|NCT01010126|9016738|P3|Overall Study|Withdrawal by Subject|1
2607763|NCT01010126|9016739|P2|Overall Study|Withdrawal by Subject|0
2607764|NCT01010126|9016740|P1|Overall Study|Withdrawal by Subject|1
2607765|NCT01010061|9016792|P2|Overall Study|Did Not Receive Treatment|2
2607766|NCT01010061|9016793|P1|Overall Study|Did Not Receive Treatment|2
2607767|NCT01010061|9016792|P2|Overall Study|Violation of Selection Criteria|1
2607768|NCT01010061|9016793|P1|Overall Study|Violation of Selection Criteria|0
2607769|NCT01010061|9016792|P2|Overall Study|Insufficient Therapeutic Response|5
2607770|NCT01010061|9016793|P1|Overall Study|Insufficient Therapeutic Response|1
2607771|NCT01010061|9016792|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
2607772|NCT01010061|9016793|P1|Overall Study|Refused Treatment/Did Not Cooperate|2
2607773|NCT01010061|9016792|P2|Overall Study|Administrative/Other|1
2607774|NCT01010061|9016793|P1|Overall Study|Administrative/Other|0
2607775|NCT01010061|9016792|P2|Overall Study|Death|6
2607776|NCT01010061|9016793|P1|Overall Study|Death|3
2607777|NCT01010061|9016792|P2|Overall Study|Withdrew Consent|1
2607778|NCT01010061|9016793|P1|Overall Study|Withdrew Consent|5
2607779|NCT01010061|9016792|P2|Overall Study|Disease Progression|8
2607780|NCT01010061|9016793|P1|Overall Study|Disease Progression|2
2607781|NCT01010061|9016792|P2|Overall Study|Adverse Events or Intercurrent Illness|16
2607782|NCT01010061|9016793|P1|Overall Study|Adverse Events or Intercurrent Illness|33
2607783|NCT01009983|9016844|P1|Overall Study|necessary scans not completed|1
2607784|NCT01009840|9016857|P1|Overall Study|Subject Withdrew Consent to Participate|1
2607785|NCT01009840|9016857|P1|Overall Study|Subject was Withdrawn by Investigator|1
2607786|NCT01009840|9016857|P1|Overall Study|Subject Met Withdrawal Criteria|7
2607787|NCT01009840|9016857|P1|Overall Study|Adverse Event|4
2607788|NCT01009840|9016857|P1|Overall Study|Lost to Follow-up|1
2607789|NCT01009814|9016875|P5|Overall Study|No longer met study criteria|0
2607790|NCT01009814|9016876|P4|Overall Study|No longer met study criteria|0
2607791|NCT01009814|9016877|P3|Overall Study|No longer met study criteria|0
2607792|NCT01009814|9016878|P2|Overall Study|No longer met study criteria|1
2607793|NCT01009814|9016879|P1|Overall Study|No longer met study criteria|1
2607794|NCT01009645|9017003|P4|Overall Study|Lost to Follow-up|5
2607795|NCT01009645|9017004|P3|Overall Study|Lost to Follow-up|4
2607796|NCT01009645|9017005|P2|Overall Study|Lost to Follow-up|8
2607797|NCT01009645|9017006|P1|Overall Study|Lost to Follow-up|2
2607798|NCT01009580|9017043|P2|Overall Study|Unclassified|21
2607799|NCT01009580|9017044|P1|Overall Study|Unclassified|17
2607800|NCT01009580|9017043|P2|Overall Study|Withdrawal Criteria|6
2607801|NCT01009580|9017044|P1|Overall Study|Withdrawal Criteria|4
2607802|NCT01009580|9017043|P2|Overall Study|Protocol Violation|3
2607803|NCT01009580|9017044|P1|Overall Study|Protocol Violation|2
2607804|NCT01009580|9017043|P2|Overall Study|Lack of Efficacy|1
2607805|NCT01009580|9017044|P1|Overall Study|Lack of Efficacy|0
2607806|NCT01009580|9017043|P2|Overall Study|Adverse Event|4
2607807|NCT01009580|9017044|P1|Overall Study|Adverse Event|4
2607808|NCT01009554|9017058|P2|Overall Study|Noncompliant with Study Product|3
2607809|NCT01009554|9017059|P1|Overall Study|Noncompliant with Study Product|0
2607810|NCT01009554|9017058|P2|Overall Study|Withdrawal by Subject|3
2607811|NCT01009554|9017059|P1|Overall Study|Withdrawal by Subject|1
2607812|NCT01009554|9017058|P2|Overall Study|Adverse Event|1
2607813|NCT01009554|9017059|P1|Overall Study|Adverse Event|1
2607814|NCT01009515|9017191|P1|Overall Study|Withdrawal by Subject|3
2607815|NCT01009463|9017202|P5|52-week, Double-blind Treatment Period|Physician Decision|8
2607816|NCT01009463|9017203|P4|52-week, Double-blind Treatment Period|Physician Decision|6
2607817|NCT01009463|9017204|P3|52-week, Double-blind Treatment Period|Physician Decision|6
2607818|NCT01009463|9017205|P2|52-week, Double-blind Treatment Period|Physician Decision|4
2607819|NCT01009463|9017206|P1|52-week, Double-blind Treatment Period|Physician Decision|0
2607820|NCT01009463|9017202|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|5
2607821|NCT01009463|9017203|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
2607822|NCT01009463|9017204|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|7
2607823|NCT01009463|9017205|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|11
2607824|NCT01009463|9017206|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
2607825|NCT01009463|9017202|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
2607826|NCT01009463|9017203|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
2607827|NCT01009463|9017204|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
2607828|NCT01009463|9017205|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|2
2607829|NCT01009463|9017206|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
2607830|NCT01009463|9017202|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
2607831|NCT01009463|9017203|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
2607832|NCT01009463|9017204|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14
2607833|NCT01009463|9017205|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
2607834|NCT01009463|9017206|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
2607835|NCT01009463|9017202|P5|52-week, Double-blind Treatment Period|Protocol Violation|7
2607836|NCT01009463|9017203|P4|52-week, Double-blind Treatment Period|Protocol Violation|8
2607837|NCT01009463|9017204|P3|52-week, Double-blind Treatment Period|Protocol Violation|7
2607838|NCT01009463|9017205|P2|52-week, Double-blind Treatment Period|Protocol Violation|8
2607839|NCT01009463|9017206|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
2607840|NCT01009463|9017202|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|18
2607841|NCT01009463|9017203|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|11
2607842|NCT01009463|9017204|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|16
2607843|NCT01009463|9017205|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|24
2607844|NCT01009463|9017206|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
2607845|NCT01009463|9017202|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
2607846|NCT01009463|9017203|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|17
2607847|NCT01009463|9017204|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|18
2607848|NCT01009463|9017205|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|34
2607849|NCT01009463|9017206|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
2607850|NCT01009463|9017202|P5|52-week, Double-blind Treatment Period|Adverse Event|31
2607851|NCT01009463|9017203|P4|52-week, Double-blind Treatment Period|Adverse Event|29
2607852|NCT01009463|9017204|P3|52-week, Double-blind Treatment Period|Adverse Event|25
2607853|NCT01009463|9017205|P2|52-week, Double-blind Treatment Period|Adverse Event|22
2607854|NCT01009463|9017206|P1|52-week, Double-blind Treatment Period|Adverse Event|0
2607855|NCT01009463|9017202|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
2607856|NCT01009463|9017203|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
2607857|NCT01009463|9017204|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
2607858|NCT01009463|9017205|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
2607859|NCT01009463|9017206|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|50
2607860|NCT01009463|9017202|P5|4-week, Open-label Run-In Period|Physician Decision|0
2607861|NCT01009463|9017203|P4|4-week, Open-label Run-In Period|Physician Decision|0
2607862|NCT01009463|9017204|P3|4-week, Open-label Run-In Period|Physician Decision|0
2607863|NCT01009463|9017205|P2|4-week, Open-label Run-In Period|Physician Decision|0
2607864|NCT01009463|9017206|P1|4-week, Open-label Run-In Period|Physician Decision|10
2607865|NCT01009463|9017202|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
2607866|NCT01009463|9017203|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
2607867|NCT01009463|9017204|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
2607868|NCT01009463|9017205|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
2607869|NCT01009463|9017206|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
2607870|NCT01009463|9017202|P5|4-week, Open-label Run-In Period|Adverse Event|0
2607871|NCT01009463|9017203|P4|4-week, Open-label Run-In Period|Adverse Event|0
2607872|NCT01009463|9017204|P3|4-week, Open-label Run-In Period|Adverse Event|0
2607873|NCT01009463|9017205|P2|4-week, Open-label Run-In Period|Adverse Event|0
2607874|NCT01009463|9017206|P1|4-week, Open-label Run-In Period|Adverse Event|10
2607875|NCT01009463|9017202|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
2607876|NCT01009463|9017203|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
2607877|NCT01009463|9017204|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
2607878|NCT01009463|9017205|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
2607879|NCT01009463|9017206|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373
2607880|NCT01009346|9017228|P1|Overall Study|Adverse Event|4
2607881|NCT01009203|9017252|P1|Overall Study|Treatment-unrelated death|1
2607882|NCT01009203|9017252|P1|Overall Study|Adverse Event|5
2607883|NCT01009203|9017252|P1|Overall Study|Withdrawal by Subject|1
2607884|NCT01009099|9017292|P2|Overall Study|Death|1
2607885|NCT01009099|9017293|P1|Overall Study|Death|0
2607886|NCT01009099|9017292|P2|Overall Study|Withdrawal by Subject|1
2607887|NCT01009099|9017293|P1|Overall Study|Withdrawal by Subject|1
2607888|NCT01009099|9017292|P2|Overall Study|Physician Decision|2
2607889|NCT01009099|9017293|P1|Overall Study|Physician Decision|3
2607890|NCT01009099|9017292|P2|Overall Study|Lost to Follow-up|0
2607891|NCT01009099|9017293|P1|Overall Study|Lost to Follow-up|1
2607892|NCT01009086|9017302|P3|Overall Study|Other|1
2607893|NCT01009086|9017303|P2|Overall Study|Other|5
2607894|NCT01009086|9017304|P1|Overall Study|Other|3
2607895|NCT01009086|9017302|P3|Overall Study|Withdrawal by Subject|13
2607896|NCT01009086|9017303|P2|Overall Study|Withdrawal by Subject|11
2607897|NCT01009086|9017304|P1|Overall Study|Withdrawal by Subject|9
2607898|NCT01009086|9017302|P3|Overall Study|Adverse Event|8
2607899|NCT01009086|9017303|P2|Overall Study|Adverse Event|11
2607900|NCT01009086|9017304|P1|Overall Study|Adverse Event|12
2607901|NCT01009086|9017302|P3|Overall Study|Lost to Follow-up|3
2607902|NCT01009086|9017303|P2|Overall Study|Lost to Follow-up|5
2607903|NCT01009086|9017304|P1|Overall Study|Lost to Follow-up|4
2607904|NCT01009086|9017302|P3|Overall Study|Lack of Efficacy|9
2607905|NCT01009086|9017303|P2|Overall Study|Lack of Efficacy|15
2607906|NCT01009086|9017304|P1|Overall Study|Lack of Efficacy|16
2607907|NCT01009060|9017339|P2|Overall Study|Withdrawal by Subject|1
2607908|NCT01009060|9017340|P1|Overall Study|Withdrawal by Subject|1
2607909|NCT01009060|9017339|P2|Overall Study|Physician Decision|1
2607910|NCT01009060|9017340|P1|Overall Study|Physician Decision|1
2607911|NCT01009060|9017339|P2|Overall Study|Lost to Follow-up|0
2607912|NCT01009060|9017340|P1|Overall Study|Lost to Follow-up|1
2607913|NCT01009060|9017339|P2|Overall Study|Protocol Violation|1
2607914|NCT01009060|9017340|P1|Overall Study|Protocol Violation|0
2607915|NCT01009060|9017339|P2|Overall Study|Adverse Event|2
2607916|NCT01009060|9017340|P1|Overall Study|Adverse Event|1
2607917|NCT01009047|9017378|P2|Overall Study|Other|2
2607918|NCT01009047|9017379|P1|Overall Study|Other|3
2607919|NCT01009047|9017378|P2|Overall Study|Withdrawal by consent|11
2607920|NCT01009047|9017379|P1|Overall Study|Withdrawal by consent|16
2607921|NCT01009047|9017378|P2|Overall Study|Lack of Efficacy|11
2607922|NCT01009047|9017379|P1|Overall Study|Lack of Efficacy|4
2607923|NCT01009047|9017378|P2|Overall Study|Lost to Follow-up|2
2607924|NCT01009047|9017379|P1|Overall Study|Lost to Follow-up|0
2607925|NCT01009047|9017378|P2|Overall Study|Adverse Event|0
2607926|NCT01009047|9017379|P1|Overall Study|Adverse Event|5
2607927|NCT01009034|9017401|P1|Overall Study|Withdrawal by Subject|2
2607928|NCT01009034|9017401|P1|Overall Study|Lost to Follow-up|2
2607929|NCT01008995|9017409|P4|After Controlled Period|Other|0
2607930|NCT01008995|9017410|P3|After Controlled Period|Other|1
2607931|NCT01008995|9017411|P2|After Controlled Period|Other|0
2607932|NCT01008995|9017412|P1|After Controlled Period|Other|0
2607933|NCT01008995|9017409|P4|After Controlled Period|Adverse Event|1
2607934|NCT01008995|9017410|P3|After Controlled Period|Adverse Event|1
2607935|NCT01008995|9017411|P2|After Controlled Period|Adverse Event|0
2607936|NCT01008995|9017412|P1|After Controlled Period|Adverse Event|0
2607937|NCT01008995|9017409|P4|Controlled Period|Other|0
2607938|NCT01008995|9017410|P3|Controlled Period|Other|0
2607939|NCT01008995|9017411|P2|Controlled Period|Other|1
2607940|NCT01008995|9017412|P1|Controlled Period|Other|2
2607941|NCT01008995|9017409|P4|Controlled Period|Adverse Event|0
2607942|NCT01008995|9017410|P3|Controlled Period|Adverse Event|0
2607943|NCT01008995|9017411|P2|Controlled Period|Adverse Event|2
2607944|NCT01008995|9017412|P1|Controlled Period|Adverse Event|1
2607945|NCT01008943|9017429|P1|Overall Study|Withdrawal by Subject|1
2607946|NCT01008904|9017436|P1|Overall Study|unexpected unrelated surgery|1
2607947|NCT01008904|9017436|P1|Overall Study|Adverse Event|2
2607948|NCT01008904|9017436|P1|Overall Study|Lost to Follow-up|1
2607949|NCT01008748|9017441|P1|Overall Study|Other|1
2607950|NCT01008748|9017441|P1|Overall Study|Lost to Follow-up|80
2607951|NCT01008696|9017466|P2|Overall Study|Other|2
2607952|NCT01008696|9017467|P1|Overall Study|Other|0
2607953|NCT01008696|9017466|P2|Overall Study|Other|3
2607954|NCT01008696|9017467|P1|Overall Study|Other|2
2607955|NCT01008696|9017466|P2|Overall Study|Participants' non-cooperation|3
2607956|NCT01008696|9017467|P1|Overall Study|Participants' non-cooperation|2
2607957|NCT01008696|9017466|P2|Overall Study|Adverse Event|0
2607958|NCT01008696|9017467|P1|Overall Study|Adverse Event|1
2607959|NCT01008696|9017466|P2|Overall Study|Physician Decision|1
2607960|NCT01008696|9017467|P1|Overall Study|Physician Decision|5
2607961|NCT01008696|9017466|P2|Overall Study|Withdrawal by Subject|4
2607962|NCT01008696|9017467|P1|Overall Study|Withdrawal by Subject|2
2607963|NCT01008696|9017466|P2|Overall Study|Participant's evasion of hospital visit|4
2607964|NCT01008696|9017467|P1|Overall Study|Participant's evasion of hospital visit|5
2607965|NCT01008618|9017477|P3|Period 2 (Double-Blind Period)|Not appropriate for this study|1
2607966|NCT01008618|9017478|P2|Period 2 (Double-Blind Period)|Not appropriate for this study|0
2607967|NCT01008618|9017479|P1|Period 2 (Double-Blind Period)|Not appropriate for this study|0
2607968|NCT01008618|9017477|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29
2607969|NCT01008618|9017478|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21
2607970|NCT01008618|9017479|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
2607971|NCT01008618|9017477|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
2607972|NCT01008618|9017478|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
2607973|NCT01008618|9017479|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
2607974|NCT01008618|9017477|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3
2607975|NCT01008618|9017478|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
2607976|NCT01008618|9017479|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
2607977|NCT01008618|9017477|P3|Period 2 (Double-Blind Period)|Physician Decision|0
2607978|NCT01008618|9017478|P2|Period 2 (Double-Blind Period)|Physician Decision|1
2607979|NCT01008618|9017479|P1|Period 2 (Double-Blind Period)|Physician Decision|0
2607980|NCT01008618|9017477|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
2607981|NCT01008618|9017478|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|3
2607982|NCT01008618|9017479|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
2607983|NCT01008618|9017477|P3|Period 2 (Double-Blind Period)|Adverse Event|2
2607984|NCT01008618|9017478|P2|Period 2 (Double-Blind Period)|Adverse Event|11
2607985|NCT01008618|9017479|P1|Period 2 (Double-Blind Period)|Adverse Event|0
2607986|NCT01008618|9017477|P3|Period 1 (Titration Period)|Aggravated symptom|0
2607987|NCT01008618|9017478|P2|Period 1 (Titration Period)|Aggravated symptom|0
2607988|NCT01008618|9017479|P1|Period 1 (Titration Period)|Aggravated symptom|2
2607989|NCT01008618|9017477|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
2607990|NCT01008618|9017478|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
2607991|NCT01008618|9017479|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20
2607992|NCT01008618|9017477|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
2607993|NCT01008618|9017478|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
2607994|NCT01008618|9017479|P1|Period 1 (Titration Period)|Withdrawal by Subject|11
2607995|NCT01008618|9017477|P3|Period 1 (Titration Period)|Adverse Event|0
2607996|NCT01008618|9017478|P2|Period 1 (Titration Period)|Adverse Event|0
2607997|NCT01008618|9017479|P1|Period 1 (Titration Period)|Adverse Event|33
2607998|NCT01008618|9017477|P3|Period 1 (Titration Period)|Physician Decision|0
2607999|NCT01008618|9017478|P2|Period 1 (Titration Period)|Physician Decision|0
2608000|NCT01008618|9017479|P1|Period 1 (Titration Period)|Physician Decision|2
2608001|NCT01008553|9017528|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35
2608002|NCT01008553|9017529|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18
2608003|NCT01008553|9017530|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
2608004|NCT01008553|9017528|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
2608005|NCT01008553|9017529|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
2608006|NCT01008553|9017530|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
2608007|NCT01008553|9017528|P3|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3
2608008|NCT01008553|9017529|P2|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
2608009|NCT01008553|9017530|P1|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
2608010|NCT01008553|9017528|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4
2608011|NCT01008553|9017529|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1
2608012|NCT01008553|9017530|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
2608013|NCT01008553|9017528|P3|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
2608014|NCT01008553|9017529|P2|Period 2 (Double-Blind Period)|Impossible to perform required tests|1
2608015|NCT01008553|9017530|P1|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
2608016|NCT01008553|9017528|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
2608017|NCT01008553|9017529|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
2608018|NCT01008553|9017530|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
2608019|NCT01008553|9017528|P3|Period 2 (Double-Blind Period)|Adverse Event|4
2608020|NCT01008553|9017529|P2|Period 2 (Double-Blind Period)|Adverse Event|14
2608021|NCT01008553|9017530|P1|Period 2 (Double-Blind Period)|Adverse Event|0
2608022|NCT01008553|9017528|P3|Period 2 (Double-Blind Period)|Physician Decision|2
2608023|NCT01008553|9017529|P2|Period 2 (Double-Blind Period)|Physician Decision|1
2608024|NCT01008553|9017530|P1|Period 2 (Double-Blind Period)|Physician Decision|0
2608025|NCT01008553|9017528|P3|Period 1 (Titration Period)|Not appropriate for this study|0
2608026|NCT01008553|9017529|P2|Period 1 (Titration Period)|Not appropriate for this study|0
2608027|NCT01008553|9017530|P1|Period 1 (Titration Period)|Not appropriate for this study|1
2608028|NCT01008553|9017528|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
2608029|NCT01008553|9017529|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
2608030|NCT01008553|9017530|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50
2608031|NCT01008553|9017528|P3|Period 1 (Titration Period)|Determined to increase dosage|0
2608032|NCT01008553|9017529|P2|Period 1 (Titration Period)|Determined to increase dosage|0
2608033|NCT01008553|9017530|P1|Period 1 (Titration Period)|Determined to increase dosage|3
2608034|NCT01008553|9017528|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
2608035|NCT01008553|9017529|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
2608036|NCT01008553|9017530|P1|Period 1 (Titration Period)|Withdrawal by Subject|6
2608037|NCT01008553|9017528|P3|Period 1 (Titration Period)|Adverse Event|0
2608038|NCT01008553|9017529|P2|Period 1 (Titration Period)|Adverse Event|0
2608039|NCT01008553|9017530|P1|Period 1 (Titration Period)|Adverse Event|33
2608040|NCT01008553|9017528|P3|Period 1 (Titration Period)|Physician Decision|0
2608041|NCT01008553|9017529|P2|Period 1 (Titration Period)|Physician Decision|0
2608042|NCT01008553|9017530|P1|Period 1 (Titration Period)|Physician Decision|2
2608043|NCT01008475|9017562|P7|Overall Study|Ongoing treatment at data cut-off date|4
2608044|NCT01008475|9017563|P6|Overall Study|Ongoing treatment at data cut-off date|6
2608045|NCT01008475|9017564|P5|Overall Study|Ongoing treatment at data cut-off date|5
2608046|NCT01008475|9017565|P4|Overall Study|Ongoing treatment at data cut-off date|0
2608047|NCT01008475|9017566|P3|Overall Study|Ongoing treatment at data cut-off date|0
2608048|NCT01008475|9017567|P2|Overall Study|Ongoing treatment at data cut-off date|0
2608049|NCT01008475|9017568|P1|Overall Study|Ongoing treatment at data cut-off date|0
2608050|NCT01008449|9017608|P2|Overall Study|Lost to Follow-up|19
2608051|NCT01008449|9017609|P1|Overall Study|Lost to Follow-up|29
2608052|NCT01008423|9017631|P2|Overall Study|Other|1
2608053|NCT01008423|9017632|P1|Overall Study|Other|0
2608054|NCT01008423|9017631|P2|Overall Study|Personal Conflict|0
2608055|NCT01008423|9017632|P1|Overall Study|Personal Conflict|1
2608056|NCT01008423|9017631|P2|Overall Study|Disease Extent 70 centimeters (cm)|0
2608057|NCT01008423|9017632|P1|Overall Study|Disease Extent 70 centimeters (cm)|1
2608058|NCT01008423|9017631|P2|Overall Study|Lack of Efficacy|5
2608059|NCT01008423|9017632|P1|Overall Study|Lack of Efficacy|0
2608060|NCT01008423|9017631|P2|Overall Study|Low Cortisol|1
2608061|NCT01008423|9017632|P1|Overall Study|Low Cortisol|0
2608062|NCT01008423|9017631|P2|Overall Study|Lost to Follow-up|2
2608063|NCT01008423|9017632|P1|Overall Study|Lost to Follow-up|0
2608064|NCT01008423|9017631|P2|Overall Study|Withdrawal by Subject|7
2608065|NCT01008423|9017632|P1|Overall Study|Withdrawal by Subject|4
2608066|NCT01008423|9017631|P2|Overall Study|Adverse Event|6
2608067|NCT01008423|9017632|P1|Overall Study|Adverse Event|13
2608068|NCT01008410|9017658|P2|Overall Study|Met Exclusion Criterion|1
2608069|NCT01008410|9017659|P1|Overall Study|Met Exclusion Criterion|0
2608070|NCT01008410|9017658|P2|Overall Study|Lack of Efficacy|6
2608071|NCT01008410|9017659|P1|Overall Study|Lack of Efficacy|2
2608072|NCT01008410|9017658|P2|Overall Study|Low Cortisol|0
2608073|NCT01008410|9017659|P1|Overall Study|Low Cortisol|2
2608074|NCT01008410|9017658|P2|Overall Study|Noncompliance|0
2608075|NCT01008410|9017659|P1|Overall Study|Noncompliance|1
2608076|NCT01008410|9017658|P2|Overall Study|Lost to Follow-up|0
2608077|NCT01008410|9017659|P1|Overall Study|Lost to Follow-up|1
2608078|NCT01008410|9017658|P2|Overall Study|Withdrawal by Subject|2
2608079|NCT01008410|9017659|P1|Overall Study|Withdrawal by Subject|6
2608080|NCT01008410|9017658|P2|Overall Study|Adverse Event|7
2608081|NCT01008410|9017659|P1|Overall Study|Adverse Event|13
2608082|NCT01008150|9017713|P4|Overall Study|did not receive study drug|0
2608083|NCT01008150|9017714|P3|Overall Study|did not receive study drug|1
2608084|NCT01008150|9017715|P2|Overall Study|did not receive study drug|1
2608085|NCT01008150|9017716|P1|Overall Study|did not receive study drug|1
2608086|NCT01007916|9017764|P2|Period 2, 4 Weeks of Wear|Relocation|0
2608087|NCT01007916|9017765|P1|Period 2, 4 Weeks of Wear|Relocation|1
2608088|NCT01007916|9017764|P2|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0
2608089|NCT01007916|9017765|P1|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1
2608090|NCT01007942|9017773|P2|Overall Study|Patients untreated|3
2608091|NCT01007942|9017774|P1|Overall Study|Patients untreated|4
2608092|NCT01007942|9017773|P2|Overall Study|Death|2
2608093|NCT01007942|9017774|P1|Overall Study|Death|3
2608094|NCT01007942|9017773|P2|Overall Study|Administrative problems|0
2608095|NCT01007942|9017774|P1|Overall Study|Administrative problems|2
2608096|NCT01007942|9017773|P2|Overall Study|Lost to Follow-up|0
2608097|NCT01007942|9017774|P1|Overall Study|Lost to Follow-up|1
2608098|NCT01007942|9017773|P2|Overall Study|Withdrawal by Subject|14
2608099|NCT01007942|9017774|P1|Overall Study|Withdrawal by Subject|19
2608100|NCT01007942|9017773|P2|Overall Study|Protocol Violation|1
2608101|NCT01007942|9017774|P1|Overall Study|Protocol Violation|1
2608102|NCT01007942|9017773|P2|Overall Study|New cancer therapy|1
2608103|NCT01007942|9017774|P1|Overall Study|New cancer therapy|5
2608104|NCT01007942|9017773|P2|Overall Study|Disease progression|242
2608105|NCT01007942|9017774|P1|Overall Study|Disease progression|217
2608106|NCT01007942|9017773|P2|Overall Study|Abnormal test procedure|1
2608107|NCT01007942|9017774|P1|Overall Study|Abnormal test procedure|0
2608108|NCT01007942|9017773|P2|Overall Study|Adverse Event|14
2608109|NCT01007942|9017774|P1|Overall Study|Adverse Event|29
2608110|NCT01007838|9017800|P4|Overall Study|Started home haemodialysis|0
2608111|NCT01007838|9017801|P3|Overall Study|Started home haemodialysis|0
2608112|NCT01007838|9017802|P2|Overall Study|Started home haemodialysis|0
2608113|NCT01007838|9017803|P1|Overall Study|Started home haemodialysis|1
2608114|NCT01007838|9017800|P4|Overall Study|Physician Decision|0
2608115|NCT01007838|9017801|P3|Overall Study|Physician Decision|0
2608116|NCT01007838|9017802|P2|Overall Study|Physician Decision|0
2608117|NCT01007838|9017803|P1|Overall Study|Physician Decision|1
2608118|NCT01007838|9017800|P4|Overall Study|Withdrawal by Subject|0
2608119|NCT01007838|9017801|P3|Overall Study|Withdrawal by Subject|0
2608120|NCT01007838|9017802|P2|Overall Study|Withdrawal by Subject|0
2608121|NCT01007838|9017803|P1|Overall Study|Withdrawal by Subject|1
2608122|NCT01007812|9017813|P2|Period 1, One Week|Discomfort|0
2608123|NCT01007812|9017814|P1|Period 1, One Week|Discomfort|1
2608124|NCT01007812|9017813|P2|Period 1, One Week|Lost to Follow-up|1
2608125|NCT01007812|9017814|P1|Period 1, One Week|Lost to Follow-up|0
2608126|NCT01007552|9017864|P1|Overall Study|Withdrawal by Subject|1
2608127|NCT01007448|9017880|P2|Overall Study|Adverse Event|4
2608128|NCT01007448|9017881|P1|Overall Study|Adverse Event|1
2608129|NCT01007448|9017880|P2|Overall Study|Withdrawal by Subject|3
2608130|NCT01007448|9017881|P1|Overall Study|Withdrawal by Subject|2
2608131|NCT01007448|9017880|P2|Overall Study|Lack of Efficacy|0
2608132|NCT01007448|9017881|P1|Overall Study|Lack of Efficacy|2
2608133|NCT01007448|9017880|P2|Overall Study|Progressive Disease|2
2608134|NCT01007448|9017881|P1|Overall Study|Progressive Disease|1
2608135|NCT01007448|9017880|P2|Overall Study|Participant Given Prohibited Medication|0
2608136|NCT01007448|9017881|P1|Overall Study|Participant Given Prohibited Medication|1
2608137|NCT01007448|9017880|P2|Overall Study|Participant Leaving the Country|0
2608138|NCT01007448|9017881|P1|Overall Study|Participant Leaving the Country|1
2608139|NCT01007448|9017880|P2|Overall Study|Staph Skin Infection Flare|0
2608140|NCT01007448|9017881|P1|Overall Study|Staph Skin Infection Flare|1
2608141|NCT01007448|9017880|P2|Overall Study|Continuing Prohibited Systemic Drugs|0
2608142|NCT01007448|9017881|P1|Overall Study|Continuing Prohibited Systemic Drugs|1
2608143|NCT01007435|9017913|P4|Overall Study|Reason not Specified|1
2608144|NCT01007435|9017914|P3|Overall Study|Reason not Specified|2
2608145|NCT01007435|9017915|P2|Overall Study|Reason not Specified|1
2608146|NCT01007435|9017916|P1|Overall Study|Reason not Specified|1
2608147|NCT01007435|9017913|P4|Overall Study|Failure to Return|6
2608148|NCT01007435|9017914|P3|Overall Study|Failure to Return|3
2608149|NCT01007435|9017915|P2|Overall Study|Failure to Return|4
2608150|NCT01007435|9017916|P1|Overall Study|Failure to Return|5
2608151|NCT01007435|9017913|P4|Overall Study|Refused Treatment|8
2608152|NCT01007435|9017914|P3|Overall Study|Refused Treatment|5
2608153|NCT01007435|9017915|P2|Overall Study|Refused Treatment|13
2608154|NCT01007435|9017916|P1|Overall Study|Refused Treatment|13
2608155|NCT01007435|9017913|P4|Overall Study|Other Protocol Violation|0
2608156|NCT01007435|9017914|P3|Overall Study|Other Protocol Violation|1
2608157|NCT01007435|9017915|P2|Overall Study|Other Protocol Violation|0
2608158|NCT01007435|9017916|P1|Overall Study|Other Protocol Violation|2
2608159|NCT01007435|9017913|P4|Overall Study|Violation of Selection Criteria at Entry|0
2608160|NCT01007435|9017914|P3|Overall Study|Violation of Selection Criteria at Entry|2
2608161|NCT01007435|9017915|P2|Overall Study|Violation of Selection Criteria at Entry|5
2608162|NCT01007435|9017916|P1|Overall Study|Violation of Selection Criteria at Entry|3
2608163|NCT01007435|9017913|P4|Overall Study|Insufficient Therapeutic Response|9
2608164|NCT01007435|9017914|P3|Overall Study|Insufficient Therapeutic Response|2
2608165|NCT01007435|9017915|P2|Overall Study|Insufficient Therapeutic Response|7
2608166|NCT01007435|9017916|P1|Overall Study|Insufficient Therapeutic Response|21
2608167|NCT01007435|9017913|P4|Overall Study|Death|1
2608168|NCT01007435|9017914|P3|Overall Study|Death|2
2608169|NCT01007435|9017915|P2|Overall Study|Death|4
2608170|NCT01007435|9017916|P1|Overall Study|Death|2
2608171|NCT01007435|9017913|P4|Overall Study|Adverse Event|31
2608172|NCT01007435|9017914|P3|Overall Study|Adverse Event|47
2608173|NCT01007435|9017915|P2|Overall Study|Adverse Event|25
2608174|NCT01007435|9017916|P1|Overall Study|Adverse Event|16
2608175|NCT01007396|9017958|P1|Overall Study|Lost to Follow-up|47
2608176|NCT01007253|9017963|P4|Washout Period (2 Weeks) # 3|Physician Decision|0
2608177|NCT01007253|9017964|P3|Washout Period (2 Weeks) # 3|Physician Decision|0
2608178|NCT01007253|9017965|P2|Washout Period (2 Weeks) # 3|Physician Decision|0
2608179|NCT01007253|9017966|P1|Washout Period (2 Weeks) # 3|Physician Decision|1
2608180|NCT01007149|9017998|P2|Overall Study|Administrative problems|1
2608181|NCT01007149|9017999|P1|Overall Study|Administrative problems|0
2608182|NCT01007123|9018025|P4|Overall Study|Lost to Follow-up|0
2608183|NCT01007123|9018026|P3|Overall Study|Lost to Follow-up|0
2608184|NCT01007123|9018027|P2|Overall Study|Lost to Follow-up|1
2608185|NCT01007123|9018028|P1|Overall Study|Lost to Follow-up|0
2608186|NCT01007123|9018025|P4|Overall Study|Withdrawal by Subject|0
2608187|NCT01007123|9018026|P3|Overall Study|Withdrawal by Subject|1
2608188|NCT01007123|9018027|P2|Overall Study|Withdrawal by Subject|0
2608189|NCT01007123|9018028|P1|Overall Study|Withdrawal by Subject|1
2608190|NCT01007123|9018025|P4|Overall Study|Protocol Violation|1
2608191|NCT01007123|9018026|P3|Overall Study|Protocol Violation|2
2608192|NCT01007123|9018027|P2|Overall Study|Protocol Violation|1
2608193|NCT01007123|9018028|P1|Overall Study|Protocol Violation|1
2608194|NCT01007123|9018025|P4|Overall Study|Lack of Efficacy|4
2608195|NCT01007123|9018026|P3|Overall Study|Lack of Efficacy|1
2608196|NCT01007123|9018027|P2|Overall Study|Lack of Efficacy|0
2608197|NCT01007123|9018028|P1|Overall Study|Lack of Efficacy|1
2608198|NCT01007123|9018025|P4|Overall Study|Adverse Event|1
2608199|NCT01007123|9018026|P3|Overall Study|Adverse Event|7
2608200|NCT01007123|9018027|P2|Overall Study|Adverse Event|4
2608201|NCT01007123|9018028|P1|Overall Study|Adverse Event|3
2608202|NCT01007032|9018089|P4|Overall Study|Withdrawal by Subject|1
2608203|NCT01007032|9018090|P3|Overall Study|Withdrawal by Subject|0
2608204|NCT01007032|9018091|P2|Overall Study|Withdrawal by Subject|0
2608205|NCT01007032|9018092|P1|Overall Study|Withdrawal by Subject|0
2608206|NCT01007032|9018089|P4|Overall Study|On Study Treatment at Cut-off Date|0
2608207|NCT01007032|9018090|P3|Overall Study|On Study Treatment at Cut-off Date|1
2608208|NCT01007032|9018091|P2|Overall Study|On Study Treatment at Cut-off Date|1
2608209|NCT01007032|9018092|P1|Overall Study|On Study Treatment at Cut-off Date|0
2608210|NCT01006980|9018136|P2|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10
2608211|NCT01006980|9018137|P1|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0
2608212|NCT01006980|9018136|P2|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1
2608213|NCT01006980|9018137|P1|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0
2608214|NCT01006980|9018136|P2|Crossover: Dacarbazine to Vemurafenib|Progression|65
2608215|NCT01006980|9018137|P1|Crossover: Dacarbazine to Vemurafenib|Progression|0
2608216|NCT01006980|9018136|P2|Crossover: Dacarbazine to Vemurafenib|Death|4
2608217|NCT01006980|9018137|P1|Crossover: Dacarbazine to Vemurafenib|Death|0
2608218|NCT01006980|9018136|P2|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4
2608219|NCT01006980|9018137|P1|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0
2608220|NCT01006980|9018136|P2|Vemurafenib and Dacarbazine|Reason Not Specified|43
2608221|NCT01006980|9018137|P1|Vemurafenib and Dacarbazine|Reason Not Specified|26
2608222|NCT01006980|9018136|P2|Vemurafenib and Dacarbazine|Protocol Violation|3
2608223|NCT01006980|9018137|P1|Vemurafenib and Dacarbazine|Protocol Violation|2
2608224|NCT01006980|9018136|P2|Vemurafenib and Dacarbazine|Refuse Treatment|6
2608225|NCT01006980|9018137|P1|Vemurafenib and Dacarbazine|Refuse Treatment|9
2608226|NCT01006980|9018136|P2|Vemurafenib and Dacarbazine|Withdrawal of Consent|6
2608227|NCT01006980|9018137|P1|Vemurafenib and Dacarbazine|Withdrawal of Consent|4
2608228|NCT01006980|9018136|P2|Vemurafenib and Dacarbazine|Progression|218
2608229|NCT01006980|9018137|P1|Vemurafenib and Dacarbazine|Progression|257
2608230|NCT01006980|9018136|P2|Vemurafenib and Dacarbazine|Death|12
2608231|NCT01006980|9018137|P1|Vemurafenib and Dacarbazine|Death|13
2608232|NCT01006980|9018136|P2|Vemurafenib and Dacarbazine|Adverse Event|5
2608233|NCT01006980|9018137|P1|Vemurafenib and Dacarbazine|Adverse Event|25
2608234|NCT01006980|9018136|P2|Vemurafenib and Dacarbazine|Randomized but Not Treated|45
2608235|NCT01006980|9018137|P1|Vemurafenib and Dacarbazine|Randomized but Not Treated|1
2608236|NCT01006889|9018176|P1|Overall Study|Withdrawal by Subject|3
2608237|NCT01006707|9018187|P3|Study Session 1|Could not tolerate withdrawal in scanner|0
2608238|NCT01006707|9018188|P2|Study Session 1|Could not tolerate withdrawal in scanner|0
2608239|NCT01006707|9018189|P1|Study Session 1|Could not tolerate withdrawal in scanner|3
2608240|NCT01006707|9018187|P3|Study Session 1|Lost to Follow-up|0
2608241|NCT01006707|9018188|P2|Study Session 1|Lost to Follow-up|0
2608242|NCT01006707|9018189|P1|Study Session 1|Lost to Follow-up|2
2608243|NCT01006629|9018209|P1|Overall Study|Parent unable to perform site visit|4
2608244|NCT01006629|9018209|P1|Overall Study|Parent refused to continue participation|1
2608245|NCT01006629|9018209|P1|Overall Study|Adverse Event|1
2608246|NCT01006616|9018224|P4|Period 2 (18 Months)|Study Terminated|70
2608247|NCT01006616|9018225|P3|Period 2 (18 Months)|Study Terminated|44
2608248|NCT01006616|9018226|P2|Period 2 (18 Months)|Study Terminated|46
2608249|NCT01006616|9018227|P1|Period 2 (18 Months)|Study Terminated|63
2608250|NCT01006616|9018224|P4|Period 2 (18 Months)|Noncompliance With Protocol|1
2608251|NCT01006616|9018225|P3|Period 2 (18 Months)|Noncompliance With Protocol|0
2608252|NCT01006616|9018226|P2|Period 2 (18 Months)|Noncompliance With Protocol|1
2608253|NCT01006616|9018227|P1|Period 2 (18 Months)|Noncompliance With Protocol|0
2608254|NCT01006616|9018224|P4|Period 2 (18 Months)|Withdrawal by Subject|1
2608255|NCT01006616|9018225|P3|Period 2 (18 Months)|Withdrawal by Subject|0
2608256|NCT01006616|9018226|P2|Period 2 (18 Months)|Withdrawal by Subject|4
2608257|NCT01006616|9018227|P1|Period 2 (18 Months)|Withdrawal by Subject|1
2608258|NCT01006616|9018224|P4|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2
2608259|NCT01006616|9018225|P3|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1
2608260|NCT01006616|9018226|P2|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6
2608261|NCT01006616|9018227|P1|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0
2608262|NCT01006616|9018224|P4|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2
2608263|NCT01006616|9018225|P3|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
2608264|NCT01006616|9018226|P2|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0
2608265|NCT01006616|9018227|P1|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
2608266|NCT01006616|9018224|P4|Period 2 (18 Months)|Lost to Follow-up|0
2608267|NCT01006616|9018225|P3|Period 2 (18 Months)|Lost to Follow-up|0
2608268|NCT01006616|9018226|P2|Period 2 (18 Months)|Lost to Follow-up|0
2608269|NCT01006616|9018227|P1|Period 2 (18 Months)|Lost to Follow-up|2
2608270|NCT01006616|9018224|P4|Period 2 (18 Months)|Lack of Efficacy|2
2608271|NCT01006616|9018225|P3|Period 2 (18 Months)|Lack of Efficacy|1
2608272|NCT01006616|9018226|P2|Period 2 (18 Months)|Lack of Efficacy|0
2608273|NCT01006616|9018227|P1|Period 2 (18 Months)|Lack of Efficacy|0
2608274|NCT01006616|9018224|P4|Period 2 (18 Months)|Adverse Event|4
2608275|NCT01006616|9018225|P3|Period 2 (18 Months)|Adverse Event|6
2608276|NCT01006616|9018226|P2|Period 2 (18 Months)|Adverse Event|6
2608277|NCT01006616|9018227|P1|Period 2 (18 Months)|Adverse Event|6
2608278|NCT01006616|9018224|P4|Period 1 (6 Months)|Not Treated|1
2608279|NCT01006616|9018225|P3|Period 1 (6 Months)|Not Treated|1
2608280|NCT01006616|9018226|P2|Period 1 (6 Months)|Not Treated|0
2608281|NCT01006616|9018227|P1|Period 1 (6 Months)|Not Treated|0
2608282|NCT01006616|9018224|P4|Period 1 (6 Months)|Noncompliance With Protocol|3
2608283|NCT01006616|9018225|P3|Period 1 (6 Months)|Noncompliance With Protocol|2
2608284|NCT01006616|9018226|P2|Period 1 (6 Months)|Noncompliance With Protocol|2
2608285|NCT01006616|9018227|P1|Period 1 (6 Months)|Noncompliance With Protocol|0
2608286|NCT01006616|9018224|P4|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
2608287|NCT01006616|9018225|P3|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
2608288|NCT01006616|9018226|P2|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7
2608289|NCT01006616|9018227|P1|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
2608290|NCT01006616|9018224|P4|Period 1 (6 Months)|Withdrawal by Subject|0
2608291|NCT01006616|9018225|P3|Period 1 (6 Months)|Withdrawal by Subject|2
2608292|NCT01006616|9018226|P2|Period 1 (6 Months)|Withdrawal by Subject|2
2608293|NCT01006616|9018227|P1|Period 1 (6 Months)|Withdrawal by Subject|2
2608294|NCT01006616|9018224|P4|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2
2608295|NCT01006616|9018225|P3|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1
2608296|NCT01006616|9018226|P2|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3
2608297|NCT01006616|9018227|P1|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0
2608298|NCT01006616|9018224|P4|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3
2608299|NCT01006616|9018225|P3|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2
2608300|NCT01006616|9018226|P2|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5
2608301|NCT01006616|9018227|P1|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6
2608302|NCT01006616|9018224|P4|Period 1 (6 Months)|Lost to Follow-up|0
2608303|NCT01006616|9018225|P3|Period 1 (6 Months)|Lost to Follow-up|1
2608304|NCT01006616|9018226|P2|Period 1 (6 Months)|Lost to Follow-up|0
2608305|NCT01006616|9018227|P1|Period 1 (6 Months)|Lost to Follow-up|0
2608306|NCT01006616|9018224|P4|Period 1 (6 Months)|Lack of Efficacy|4
2608307|NCT01006616|9018225|P3|Period 1 (6 Months)|Lack of Efficacy|0
2608308|NCT01006616|9018226|P2|Period 1 (6 Months)|Lack of Efficacy|4
2608309|NCT01006616|9018227|P1|Period 1 (6 Months)|Lack of Efficacy|3
2608310|NCT01006616|9018224|P4|Period 1 (6 Months)|Adverse Event|9
2608311|NCT01006616|9018225|P3|Period 1 (6 Months)|Adverse Event|37
2608312|NCT01006616|9018226|P2|Period 1 (6 Months)|Adverse Event|31
2608313|NCT01006616|9018227|P1|Period 1 (6 Months)|Adverse Event|10
2608314|NCT01006603|9018363|P2|Overall Study|Other|7
2608315|NCT01006603|9018364|P1|Overall Study|Other|3
2608316|NCT01006603|9018363|P2|Overall Study|Study specific discontinuation criteria|34
2608317|NCT01006603|9018364|P1|Overall Study|Study specific discontinuation criteria|33
2608318|NCT01006603|9018363|P2|Overall Study|Death|1
2608319|NCT01006603|9018364|P1|Overall Study|Death|1
2608320|NCT01006603|9018363|P2|Overall Study|Adverse Event|7
2608321|NCT01006603|9018364|P1|Overall Study|Adverse Event|15
2608322|NCT01006603|9018363|P2|Overall Study|Incorrect enrolment|2
2608323|NCT01006603|9018364|P1|Overall Study|Incorrect enrolment|0
2608324|NCT01006603|9018363|P2|Overall Study|Protocol Violation|3
2608325|NCT01006603|9018364|P1|Overall Study|Protocol Violation|1
2608326|NCT01006603|9018363|P2|Overall Study|Safety reason|1
2608327|NCT01006603|9018364|P1|Overall Study|Safety reason|1
2608328|NCT01006603|9018363|P2|Overall Study|Lost to Follow-up|1
2608329|NCT01006603|9018364|P1|Overall Study|Lost to Follow-up|0
2608330|NCT01006603|9018363|P2|Overall Study|Withdrawal by Subject|19
2608331|NCT01006603|9018364|P1|Overall Study|Withdrawal by Subject|17
2608332|NCT01006590|9018384|P2|Overall Study|Other|2
2608333|NCT01006590|9018385|P1|Overall Study|Other|3
2608334|NCT01006590|9018384|P2|Overall Study|Study specific discontinuation criteria|23
2608335|NCT01006590|9018385|P1|Overall Study|Study specific discontinuation criteria|16
2608336|NCT01006590|9018384|P2|Overall Study|Withdrawal by Subject|2
2608337|NCT01006590|9018385|P1|Overall Study|Withdrawal by Subject|4
2608338|NCT01006590|9018384|P2|Overall Study|Protocol Violation|0
2608339|NCT01006590|9018385|P1|Overall Study|Protocol Violation|1
2608340|NCT01006590|9018384|P2|Overall Study|Lost to Follow-up|1
2608341|NCT01006590|9018385|P1|Overall Study|Lost to Follow-up|1
2608342|NCT01006590|9018384|P2|Overall Study|Death|1
2608343|NCT01006590|9018385|P1|Overall Study|Death|1
2608344|NCT01006590|9018384|P2|Overall Study|Adverse Event|3
2608345|NCT01006590|9018385|P1|Overall Study|Adverse Event|2
2608346|NCT01006356|9018424|P1|Overall Study|Other|23
2608347|NCT01006356|9018424|P1|Overall Study|Protocol Violation|3
2608348|NCT01006356|9018424|P1|Overall Study|Choice by participants|2
2608349|NCT01006356|9018424|P1|Overall Study|Withdrawal by Subject|1
2608350|NCT01006356|9018424|P1|Overall Study|Paticipants did not cooperate|6
2608351|NCT01006356|9018424|P1|Overall Study|Physician Decision|1
2608352|NCT01006356|9018424|P1|Overall Study|Adverse Event|6
2608353|NCT01006291|9018439|P3|Overall Study|Other|17
2608354|NCT01006291|9018440|P2|Overall Study|Other|14
2608355|NCT01006291|9018441|P1|Overall Study|Other|14
2608356|NCT01006291|9018439|P3|Overall Study|Withdrawal criteria|4
2608357|NCT01006291|9018440|P2|Overall Study|Withdrawal criteria|4
2608358|NCT01006291|9018441|P1|Overall Study|Withdrawal criteria|5
2608359|NCT01006291|9018439|P3|Overall Study|Protocol Violation|3
2608360|NCT01006291|9018440|P2|Overall Study|Protocol Violation|3
2608361|NCT01006291|9018441|P1|Overall Study|Protocol Violation|3
2608362|NCT01006291|9018439|P3|Overall Study|Lack of Efficacy|1
2608363|NCT01006291|9018440|P2|Overall Study|Lack of Efficacy|2
2608364|NCT01006291|9018441|P1|Overall Study|Lack of Efficacy|2
2608365|NCT01006291|9018439|P3|Overall Study|Adverse Event|2
2608366|NCT01006291|9018440|P2|Overall Study|Adverse Event|1
2608367|NCT01006291|9018441|P1|Overall Study|Adverse Event|2
2608368|NCT01006135|9018491|P1|Overall Study|Other|72
2608369|NCT01006135|9018491|P1|Overall Study|Lost to Follow-up|32
2608370|NCT01006135|9018491|P1|Overall Study|Protocol Violation|14
2608371|NCT01006135|9018491|P1|Overall Study|Adverse Event|22
2608372|NCT01006122|9018498|P2|Second Double-blind Intervention Period|Death|1
2608373|NCT01006122|9018499|P1|Second Double-blind Intervention Period|Death|0
2608374|NCT01006122|9018498|P2|Second Double-blind Intervention Period|Withdrawal by Subject|2
2608375|NCT01006122|9018499|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
2608376|NCT01006122|9018498|P2|Second Double-blind Intervention Period|Lost to Follow-up|3
2608377|NCT01006122|9018499|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
2608378|NCT01006122|9018498|P2|Second Double-blind Intervention Period|Protocol Violation|0
2608379|NCT01006122|9018499|P1|Second Double-blind Intervention Period|Protocol Violation|1
2608380|NCT01006122|9018498|P2|Second Double-blind Intervention Period|Adverse Event|1
2608381|NCT01006122|9018499|P1|Second Double-blind Intervention Period|Adverse Event|1
2608382|NCT01006122|9018498|P2|First Double-blind Intervention Period|Adverse Event|4
2608383|NCT01006122|9018499|P1|First Double-blind Intervention Period|Adverse Event|0
2608384|NCT01006122|9018498|P2|First Double-blind Intervention Period|Other|0
2608385|NCT01006122|9018499|P1|First Double-blind Intervention Period|Other|3
2608386|NCT01006122|9018498|P2|First Double-blind Intervention Period|Lack of Efficacy|1
2608387|NCT01006122|9018499|P1|First Double-blind Intervention Period|Lack of Efficacy|2
2608388|NCT01006122|9018498|P2|First Double-blind Intervention Period|Does not meet entrance criteria|0
2608389|NCT01006122|9018499|P1|First Double-blind Intervention Period|Does not meet entrance criteria|1
2608390|NCT01006122|9018498|P2|First Double-blind Intervention Period|Withdrawal by Subject|8
2608391|NCT01006122|9018499|P1|First Double-blind Intervention Period|Withdrawal by Subject|9
2608392|NCT01006122|9018498|P2|First Double-blind Intervention Period|Pregnancy|1
2608393|NCT01006122|9018499|P1|First Double-blind Intervention Period|Pregnancy|0
2608394|NCT01006122|9018498|P2|First Double-blind Intervention Period|Protocol Violation|1
2608395|NCT01006122|9018499|P1|First Double-blind Intervention Period|Protocol Violation|1
2608396|NCT01006122|9018498|P2|First Double-blind Intervention Period|Lost to Follow-up|2
2608397|NCT01006122|9018499|P1|First Double-blind Intervention Period|Lost to Follow-up|0
2608398|NCT01005966|9018550|P5|Treatment Period 4 (14 Days)|Other Reason|1
2608399|NCT01005966|9018551|P4|Treatment Period 4 (14 Days)|Other Reason|0
2608400|NCT01005966|9018552|P3|Treatment Period 4 (14 Days)|Other Reason|0
2608401|NCT01005966|9018553|P2|Treatment Period 4 (14 Days)|Other Reason|0
2608402|NCT01005966|9018554|P1|Treatment Period 4 (14 Days)|Other Reason|0
2608403|NCT01005966|9018550|P5|Treatment Period 4 (14 Days)|Protocol Violation|0
2608404|NCT01005966|9018551|P4|Treatment Period 4 (14 Days)|Protocol Violation|0
2608405|NCT01005966|9018552|P3|Treatment Period 4 (14 Days)|Protocol Violation|0
2608406|NCT01005966|9018553|P2|Treatment Period 4 (14 Days)|Protocol Violation|1
2608407|NCT01005966|9018554|P1|Treatment Period 4 (14 Days)|Protocol Violation|0
2608408|NCT01005966|9018550|P5|Treatment Period 3 (14 Days)|Protocol Violation|1
2608409|NCT01005966|9018551|P4|Treatment Period 3 (14 Days)|Protocol Violation|0
2608410|NCT01005966|9018552|P3|Treatment Period 3 (14 Days)|Protocol Violation|0
2608411|NCT01005966|9018553|P2|Treatment Period 3 (14 Days)|Protocol Violation|1
2608412|NCT01005966|9018554|P1|Treatment Period 3 (14 Days)|Protocol Violation|0
2608413|NCT01005966|9018550|P5|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
2608414|NCT01005966|9018551|P4|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
2608415|NCT01005966|9018552|P3|Treatment Period 2 (14 Days)|Withdrawal by Subject|1
2608416|NCT01005966|9018553|P2|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
2608417|NCT01005966|9018554|P1|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
2608418|NCT01005966|9018550|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
2608419|NCT01005966|9018551|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
2608420|NCT01005966|9018552|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
2608421|NCT01005966|9018553|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
2608422|NCT01005966|9018554|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
2608423|NCT01005966|9018550|P5|Treatment Period 2 (14 Days)|Adverse Event|0
2608424|NCT01005966|9018551|P4|Treatment Period 2 (14 Days)|Adverse Event|0
2608425|NCT01005966|9018552|P3|Treatment Period 2 (14 Days)|Adverse Event|1
2608426|NCT01005966|9018553|P2|Treatment Period 2 (14 Days)|Adverse Event|1
2608427|NCT01005966|9018554|P1|Treatment Period 2 (14 Days)|Adverse Event|0
2608428|NCT01005966|9018550|P5|Washout Period 1 (4 Days)|Withdrawal by Subject|0
2608429|NCT01005966|9018551|P4|Washout Period 1 (4 Days)|Withdrawal by Subject|1
2608430|NCT01005966|9018552|P3|Washout Period 1 (4 Days)|Withdrawal by Subject|0
2608431|NCT01005966|9018553|P2|Washout Period 1 (4 Days)|Withdrawal by Subject|0
2608432|NCT01005966|9018554|P1|Washout Period 1 (4 Days)|Withdrawal by Subject|0
2608433|NCT01005966|9018550|P5|Treatment Period 1 (14 Days)|Protocol Violation|0
2608434|NCT01005966|9018551|P4|Treatment Period 1 (14 Days)|Protocol Violation|0
2608435|NCT01005966|9018552|P3|Treatment Period 1 (14 Days)|Protocol Violation|1
2608436|NCT01005966|9018553|P2|Treatment Period 1 (14 Days)|Protocol Violation|0
2608437|NCT01005966|9018554|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
2608438|NCT01005966|9018550|P5|Treatment Period 1 (14 Days)|Adverse Event|0
2608439|NCT01005966|9018551|P4|Treatment Period 1 (14 Days)|Adverse Event|0
2608440|NCT01005966|9018552|P3|Treatment Period 1 (14 Days)|Adverse Event|0
2608441|NCT01005966|9018553|P2|Treatment Period 1 (14 Days)|Adverse Event|0
2608442|NCT01005966|9018554|P1|Treatment Period 1 (14 Days)|Adverse Event|1
2608443|NCT01005914|9018574|P1|Overall Study|Withdrawal by Subject|1
2608444|NCT01005914|9018574|P1|Overall Study|Lack of Efficacy|1
2608445|NCT01005914|9018574|P1|Overall Study|Death|4
2608446|NCT01005914|9018574|P1|Overall Study|Adverse Event|4
2608447|NCT01005901|9018580|P2|Overall Study|No longer requires study drug|1
2608448|NCT01005901|9018581|P1|Overall Study|No longer requires study drug|0
2608449|NCT01005901|9018580|P2|Overall Study|Patient's inability to use the device|1
2608450|NCT01005901|9018581|P1|Overall Study|Patient's inability to use the device|1
2608451|NCT01005901|9018580|P2|Overall Study|Lost to Follow-up|2
2608452|NCT01005901|9018581|P1|Overall Study|Lost to Follow-up|1
2608453|NCT01005901|9018580|P2|Overall Study|Death|3
2608454|NCT01005901|9018581|P1|Overall Study|Death|2
2608455|NCT01005901|9018580|P2|Overall Study|Protocol Violation|3
2608456|NCT01005901|9018581|P1|Overall Study|Protocol Violation|4
2608457|NCT01005901|9018580|P2|Overall Study|Unsatisfactory therapeutic effect|5
2608458|NCT01005901|9018581|P1|Overall Study|Unsatisfactory therapeutic effect|5
2608459|NCT01005901|9018580|P2|Overall Study|Administrative problems|13
2608460|NCT01005901|9018581|P1|Overall Study|Administrative problems|21
2608461|NCT01005901|9018580|P2|Overall Study|Adverse Event|16
2608462|NCT01005901|9018581|P1|Overall Study|Adverse Event|30
2608463|NCT01005901|9018580|P2|Overall Study|Withdrawal by Subject|14
2608464|NCT01005901|9018581|P1|Overall Study|Withdrawal by Subject|38
2608465|NCT01005875|9018644|P1|Overall Study|Death|3
2608466|NCT01005745|9018661|P1|Overall Study|Inappropriate antidiuretic hormone|1
2608467|NCT01005745|9018661|P1|Overall Study|Death prior to treatment|1
2608468|NCT01005745|9018661|P1|Overall Study|Disease progressed during TIL growth|3
2608469|NCT01005745|9018661|P1|Overall Study|No TIL growth|1
2608470|NCT01005732|9018666|P1|Overall Study|Death|1
2608471|NCT01005732|9018666|P1|Overall Study|Lost to Follow-up|10
2608472|NCT01005719|9018682|P6|Period 2|Adverse Event|1
2608473|NCT01005719|9018683|P5|Period 2|Adverse Event|1
2608474|NCT01005719|9018684|P4|Period 2|Adverse Event|0
2608475|NCT01005719|9018685|P3|Period 2|Adverse Event|0
2608476|NCT01005719|9018686|P2|Period 2|Adverse Event|0
2608477|NCT01005719|9018687|P1|Period 2|Adverse Event|0
2608478|NCT01005719|9018682|P6|Period 1|Delay in completing study procedures|1
2608479|NCT01005719|9018683|P5|Period 1|Delay in completing study procedures|0
2608480|NCT01005719|9018684|P4|Period 1|Delay in completing study procedures|0
2608481|NCT01005719|9018685|P3|Period 1|Delay in completing study procedures|0
2608482|NCT01005719|9018686|P2|Period 1|Delay in completing study procedures|0
2608483|NCT01005719|9018687|P1|Period 1|Delay in completing study procedures|0
2608484|NCT01005719|9018682|P6|Period 1|Adverse Event|0
2608485|NCT01005719|9018683|P5|Period 1|Adverse Event|0
2608486|NCT01005719|9018684|P4|Period 1|Adverse Event|1
2608487|NCT01005719|9018685|P3|Period 1|Adverse Event|0
2608488|NCT01005719|9018686|P2|Period 1|Adverse Event|0
2608489|NCT01005719|9018687|P1|Period 1|Adverse Event|0
2608490|NCT01005680|9018754|P2|Overall Study|Physician Decision|1
2608491|NCT01005680|9018755|P1|Overall Study|Physician Decision|1
2608492|NCT01005680|9018754|P2|Overall Study|Withdrawal by Subject|4
2608493|NCT01005680|9018755|P1|Overall Study|Withdrawal by Subject|1
2608494|NCT01005680|9018754|P2|Overall Study|Lost to Follow-up|6
2608495|NCT01005680|9018755|P1|Overall Study|Lost to Follow-up|4
2608496|NCT01005602|9018779|P2|Overall Study|Excluded due to unreliable clinical data|0
2608497|NCT01005602|9018780|P1|Overall Study|Excluded due to unreliable clinical data|1
2608498|NCT01005329|9018868|P1|Overall Study|Ineligible or received no protocol trt.|4
2608499|NCT01005316|9018881|P4|Overall Study|Retransplanted|0
2608500|NCT01005316|9018882|P3|Overall Study|Retransplanted|0
2608501|NCT01005316|9018883|P2|Overall Study|Retransplanted|1
2608502|NCT01005316|9018884|P1|Overall Study|Retransplanted|0
2608503|NCT01005316|9018881|P4|Overall Study|Transferred Care|3
2608504|NCT01005316|9018882|P3|Overall Study|Transferred Care|1
2608505|NCT01005316|9018883|P2|Overall Study|Transferred Care|0
2608506|NCT01005316|9018884|P1|Overall Study|Transferred Care|1
2608507|NCT01005316|9018881|P4|Overall Study|Delisted|0
2608508|NCT01005316|9018882|P3|Overall Study|Delisted|0
2608509|NCT01005316|9018883|P2|Overall Study|Delisted|0
2608510|NCT01005316|9018884|P1|Overall Study|Delisted|8
2608511|NCT01005316|9018881|P4|Overall Study|Consented to Another Study|0
2608512|NCT01005316|9018882|P3|Overall Study|Consented to Another Study|0
2608513|NCT01005316|9018883|P2|Overall Study|Consented to Another Study|0
2608514|NCT01005316|9018884|P1|Overall Study|Consented to Another Study|2
2608515|NCT01005316|9018881|P4|Overall Study|Withdrawal by Subject|2
2608516|NCT01005316|9018882|P3|Overall Study|Withdrawal by Subject|0
2608517|NCT01005316|9018883|P2|Overall Study|Withdrawal by Subject|1
2608518|NCT01005316|9018884|P1|Overall Study|Withdrawal by Subject|1
2608519|NCT01005316|9018881|P4|Overall Study|Sponsor Decision|0
2608520|NCT01005316|9018882|P3|Overall Study|Sponsor Decision|0
2608521|NCT01005316|9018883|P2|Overall Study|Sponsor Decision|3
2608522|NCT01005316|9018884|P1|Overall Study|Sponsor Decision|6
2608523|NCT01005316|9018881|P4|Overall Study|Physician Decision|0
2608524|NCT01005316|9018882|P3|Overall Study|Physician Decision|0
2608525|NCT01005316|9018883|P2|Overall Study|Physician Decision|0
2608526|NCT01005316|9018884|P1|Overall Study|Physician Decision|6
2608527|NCT01005316|9018881|P4|Overall Study|Lost to Follow-up|2
2608528|NCT01005316|9018882|P3|Overall Study|Lost to Follow-up|0
2608529|NCT01005316|9018883|P2|Overall Study|Lost to Follow-up|3
2608530|NCT01005316|9018884|P1|Overall Study|Lost to Follow-up|1
2608531|NCT01005316|9018881|P4|Overall Study|Study Termination|85
2608532|NCT01005316|9018882|P3|Overall Study|Study Termination|9
2608533|NCT01005316|9018883|P2|Overall Study|Study Termination|63
2608534|NCT01005316|9018884|P1|Overall Study|Study Termination|5
2608535|NCT01005316|9018881|P4|Overall Study|Death|15
2608536|NCT01005316|9018882|P3|Overall Study|Death|1
2608537|NCT01005316|9018883|P2|Overall Study|Death|5
2608538|NCT01005316|9018884|P1|Overall Study|Death|20
2608539|NCT01005316|9018881|P4|Overall Study|Adverse Event|1
2608540|NCT01005316|9018882|P3|Overall Study|Adverse Event|0
2608541|NCT01005316|9018883|P2|Overall Study|Adverse Event|0
2608542|NCT01005316|9018884|P1|Overall Study|Adverse Event|0
2608543|NCT01005251|9018951|P5|Overall Study|Lack of Efficacy|0
2608544|NCT01005251|9018952|P4|Overall Study|Lack of Efficacy|1
2608545|NCT01005251|9018953|P3|Overall Study|Lack of Efficacy|1
2608546|NCT01005251|9018954|P2|Overall Study|Lack of Efficacy|0
2608547|NCT01005251|9018955|P1|Overall Study|Lack of Efficacy|0
2608548|NCT01005251|9018951|P5|Overall Study|Randomized in error|0
2608549|NCT01005251|9018952|P4|Overall Study|Randomized in error|1
2608550|NCT01005251|9018953|P3|Overall Study|Randomized in error|1
2608551|NCT01005251|9018954|P2|Overall Study|Randomized in error|0
2608552|NCT01005251|9018955|P1|Overall Study|Randomized in error|0
2608553|NCT01005251|9018951|P5|Overall Study|Wrong drug dispensed|0
2608554|NCT01005251|9018952|P4|Overall Study|Wrong drug dispensed|0
2608555|NCT01005251|9018953|P3|Overall Study|Wrong drug dispensed|0
2608556|NCT01005251|9018954|P2|Overall Study|Wrong drug dispensed|1
2608557|NCT01005251|9018955|P1|Overall Study|Wrong drug dispensed|0
2608558|NCT01005251|9018951|P5|Overall Study|Patient moved|0
2608559|NCT01005251|9018952|P4|Overall Study|Patient moved|0
2608560|NCT01005251|9018953|P3|Overall Study|Patient moved|0
2608561|NCT01005251|9018954|P2|Overall Study|Patient moved|0
2608562|NCT01005251|9018955|P1|Overall Study|Patient moved|1
2608563|NCT01005251|9018951|P5|Overall Study|Physician Decision|2
2608564|NCT01005251|9018952|P4|Overall Study|Physician Decision|0
2608565|NCT01005251|9018953|P3|Overall Study|Physician Decision|0
2608566|NCT01005251|9018954|P2|Overall Study|Physician Decision|0
2608567|NCT01005251|9018955|P1|Overall Study|Physician Decision|0
2608568|NCT01005251|9018951|P5|Overall Study|Lost to Follow-up|0
2608569|NCT01005251|9018952|P4|Overall Study|Lost to Follow-up|0
2608570|NCT01005251|9018953|P3|Overall Study|Lost to Follow-up|2
2608571|NCT01005251|9018954|P2|Overall Study|Lost to Follow-up|4
2608572|NCT01005251|9018955|P1|Overall Study|Lost to Follow-up|1
2608573|NCT01005251|9018951|P5|Overall Study|Developed study-specific withdrawal crit|1
2608574|NCT01005251|9018952|P4|Overall Study|Developed study-specific withdrawal crit|0
2608575|NCT01005251|9018953|P3|Overall Study|Developed study-specific withdrawal crit|3
2608576|NCT01005251|9018954|P2|Overall Study|Developed study-specific withdrawal crit|0
2608577|NCT01005251|9018955|P1|Overall Study|Developed study-specific withdrawal crit|2
2608578|NCT01005251|9018951|P5|Overall Study|Protocol Violation|2
2608579|NCT01005251|9018952|P4|Overall Study|Protocol Violation|0
2608580|NCT01005251|9018953|P3|Overall Study|Protocol Violation|0
2608581|NCT01005251|9018954|P2|Overall Study|Protocol Violation|0
2608582|NCT01005251|9018955|P1|Overall Study|Protocol Violation|1
2608583|NCT01005251|9018951|P5|Overall Study|Adverse Event|4
2608584|NCT01005251|9018952|P4|Overall Study|Adverse Event|5
2608585|NCT01005251|9018953|P3|Overall Study|Adverse Event|8
2608586|NCT01005251|9018954|P2|Overall Study|Adverse Event|6
2608587|NCT01005251|9018955|P1|Overall Study|Adverse Event|2
2608588|NCT01005251|9018951|P5|Overall Study|Eligibility criteria not fulfilled|0
2608589|NCT01005251|9018952|P4|Overall Study|Eligibility criteria not fulfilled|1
2608590|NCT01005251|9018953|P3|Overall Study|Eligibility criteria not fulfilled|4
2608591|NCT01005251|9018954|P2|Overall Study|Eligibility criteria not fulfilled|0
2608592|NCT01005251|9018955|P1|Overall Study|Eligibility criteria not fulfilled|4
2608593|NCT01005251|9018951|P5|Overall Study|Withdrawal by Subject|9
2608594|NCT01005251|9018952|P4|Overall Study|Withdrawal by Subject|4
2608595|NCT01005251|9018953|P3|Overall Study|Withdrawal by Subject|3
2608596|NCT01005251|9018954|P2|Overall Study|Withdrawal by Subject|5
2608597|NCT01005251|9018955|P1|Overall Study|Withdrawal by Subject|2
2608598|NCT01004861|9019039|P13|Overall Study|Ongoing (as of 31 Jan 2018)|0
2608599|NCT01004861|9019040|P12|Overall Study|Ongoing (as of 31 Jan 2018)|0
2608600|NCT01004861|9019041|P11|Overall Study|Ongoing (as of 31 Jan 2018)|0
2608601|NCT01004861|9019042|P10|Overall Study|Ongoing (as of 31 Jan 2018)|0
2608602|NCT01004861|9019043|P9|Overall Study|Ongoing (as of 31 Jan 2018)|13
2608603|NCT01004861|9019044|P8|Overall Study|Ongoing (as of 31 Jan 2018)|0
2608604|NCT01004861|9019045|P7|Overall Study|Ongoing (as of 31 Jan 2018)|0
2608605|NCT01004861|9019046|P6|Overall Study|Ongoing (as of 31 Jan 2018)|0
2608606|NCT01004861|9019047|P5|Overall Study|Ongoing (as of 31 Jan 2018)|0
2608607|NCT01004861|9019048|P4|Overall Study|Ongoing (as of 31 Jan 2018)|0
2608608|NCT01004861|9019049|P3|Overall Study|Ongoing (as of 31 Jan 2018)|0
2608609|NCT01004861|9019050|P2|Overall Study|Ongoing (as of 31 Jan 2018)|0
2608610|NCT01004861|9019051|P1|Overall Study|Ongoing (as of 31 Jan 2018)|0
2608611|NCT01004861|9019039|P13|Overall Study|Other|3
2608612|NCT01004861|9019040|P12|Overall Study|Other|2
2608613|NCT01004861|9019041|P11|Overall Study|Other|1
2608614|NCT01004861|9019042|P10|Overall Study|Other|2
2608615|NCT01004861|9019043|P9|Overall Study|Other|1
2608616|NCT01004861|9019044|P8|Overall Study|Other|0
2608617|NCT01004861|9019045|P7|Overall Study|Other|0
2608618|NCT01004861|9019046|P6|Overall Study|Other|0
2608619|NCT01004861|9019047|P5|Overall Study|Other|0
2608620|NCT01004861|9019048|P4|Overall Study|Other|0
2608621|NCT01004861|9019049|P3|Overall Study|Other|0
2608622|NCT01004861|9019050|P2|Overall Study|Other|0
2608623|NCT01004861|9019051|P1|Overall Study|Other|0
2608624|NCT01004861|9019039|P13|Overall Study|Non-compliance|1
2608625|NCT01004861|9019040|P12|Overall Study|Non-compliance|0
2608626|NCT01004861|9019041|P11|Overall Study|Non-compliance|0
2608627|NCT01004861|9019042|P10|Overall Study|Non-compliance|0
2608628|NCT01004861|9019043|P9|Overall Study|Non-compliance|5
2608629|NCT01004861|9019044|P8|Overall Study|Non-compliance|0
2608630|NCT01004861|9019045|P7|Overall Study|Non-compliance|0
2608631|NCT01004861|9019046|P6|Overall Study|Non-compliance|0
2608632|NCT01004861|9019047|P5|Overall Study|Non-compliance|0
2608633|NCT01004861|9019048|P4|Overall Study|Non-compliance|0
2608634|NCT01004861|9019049|P3|Overall Study|Non-compliance|0
2608635|NCT01004861|9019050|P2|Overall Study|Non-compliance|0
2608636|NCT01004861|9019051|P1|Overall Study|Non-compliance|0
2608637|NCT01004861|9019039|P13|Overall Study|Lost to Follow-up|0
2608638|NCT01004861|9019040|P12|Overall Study|Lost to Follow-up|1
2608639|NCT01004861|9019041|P11|Overall Study|Lost to Follow-up|0
2608640|NCT01004861|9019042|P10|Overall Study|Lost to Follow-up|0
2608641|NCT01004861|9019043|P9|Overall Study|Lost to Follow-up|1
2608642|NCT01004861|9019044|P8|Overall Study|Lost to Follow-up|1
2608643|NCT01004861|9019045|P7|Overall Study|Lost to Follow-up|0
2608644|NCT01004861|9019046|P6|Overall Study|Lost to Follow-up|0
2608645|NCT01004861|9019047|P5|Overall Study|Lost to Follow-up|0
2608646|NCT01004861|9019048|P4|Overall Study|Lost to Follow-up|0
2608647|NCT01004861|9019049|P3|Overall Study|Lost to Follow-up|0
2608648|NCT01004861|9019050|P2|Overall Study|Lost to Follow-up|0
2608649|NCT01004861|9019051|P1|Overall Study|Lost to Follow-up|0
2608650|NCT01004861|9019039|P13|Overall Study|Withdrawal by Subject|3
2608651|NCT01004861|9019040|P12|Overall Study|Withdrawal by Subject|2
2608652|NCT01004861|9019041|P11|Overall Study|Withdrawal by Subject|1
2608653|NCT01004861|9019042|P10|Overall Study|Withdrawal by Subject|1
2608654|NCT01004861|9019043|P9|Overall Study|Withdrawal by Subject|2
2608655|NCT01004861|9019044|P8|Overall Study|Withdrawal by Subject|0
2608656|NCT01004861|9019045|P7|Overall Study|Withdrawal by Subject|1
2608657|NCT01004861|9019046|P6|Overall Study|Withdrawal by Subject|0
2608658|NCT01004861|9019047|P5|Overall Study|Withdrawal by Subject|1
2608659|NCT01004861|9019048|P4|Overall Study|Withdrawal by Subject|0
2608660|NCT01004861|9019049|P3|Overall Study|Withdrawal by Subject|0
2608661|NCT01004861|9019050|P2|Overall Study|Withdrawal by Subject|0
2608662|NCT01004861|9019051|P1|Overall Study|Withdrawal by Subject|0
2608663|NCT01004861|9019039|P13|Overall Study|Protocol Violation|0
2608664|NCT01004861|9019040|P12|Overall Study|Protocol Violation|0
2608665|NCT01004861|9019041|P11|Overall Study|Protocol Violation|0
2608666|NCT01004861|9019042|P10|Overall Study|Protocol Violation|0
2608667|NCT01004861|9019043|P9|Overall Study|Protocol Violation|0
2608668|NCT01004861|9019044|P8|Overall Study|Protocol Violation|0
2608669|NCT01004861|9019045|P7|Overall Study|Protocol Violation|0
2608670|NCT01004861|9019046|P6|Overall Study|Protocol Violation|0
2608671|NCT01004861|9019047|P5|Overall Study|Protocol Violation|1
2608672|NCT01004861|9019048|P4|Overall Study|Protocol Violation|0
2608673|NCT01004861|9019049|P3|Overall Study|Protocol Violation|0
2608674|NCT01004861|9019050|P2|Overall Study|Protocol Violation|0
2608675|NCT01004861|9019051|P1|Overall Study|Protocol Violation|0
2608676|NCT01004861|9019039|P13|Overall Study|Adverse Event|2
2608677|NCT01004861|9019040|P12|Overall Study|Adverse Event|0
2608678|NCT01004861|9019041|P11|Overall Study|Adverse Event|1
2608679|NCT01004861|9019042|P10|Overall Study|Adverse Event|1
2608680|NCT01004861|9019043|P9|Overall Study|Adverse Event|13
2608681|NCT01004861|9019044|P8|Overall Study|Adverse Event|1
2608682|NCT01004861|9019045|P7|Overall Study|Adverse Event|1
2608683|NCT01004861|9019046|P6|Overall Study|Adverse Event|2
2608684|NCT01004861|9019047|P5|Overall Study|Adverse Event|0
2608685|NCT01004861|9019048|P4|Overall Study|Adverse Event|1
2608686|NCT01004861|9019049|P3|Overall Study|Adverse Event|0
2608687|NCT01004861|9019050|P2|Overall Study|Adverse Event|0
2608688|NCT01004861|9019051|P1|Overall Study|Adverse Event|0
2608689|NCT01004861|9019039|P13|Overall Study|Physician Decision|3
2608690|NCT01004861|9019040|P12|Overall Study|Physician Decision|0
2608691|NCT01004861|9019041|P11|Overall Study|Physician Decision|0
2608692|NCT01004861|9019042|P10|Overall Study|Physician Decision|0
2608693|NCT01004861|9019043|P9|Overall Study|Physician Decision|0
2608694|NCT01004861|9019044|P8|Overall Study|Physician Decision|1
2608695|NCT01004861|9019045|P7|Overall Study|Physician Decision|0
2608696|NCT01004861|9019046|P6|Overall Study|Physician Decision|0
2608697|NCT01004861|9019047|P5|Overall Study|Physician Decision|1
2608698|NCT01004861|9019048|P4|Overall Study|Physician Decision|1
2608699|NCT01004861|9019049|P3|Overall Study|Physician Decision|1
2608700|NCT01004861|9019050|P2|Overall Study|Physician Decision|2
2608701|NCT01004861|9019051|P1|Overall Study|Physician Decision|0
2608702|NCT01004861|9019039|P13|Overall Study|Disease progression|8
2608703|NCT01004861|9019040|P12|Overall Study|Disease progression|3
2608704|NCT01004861|9019041|P11|Overall Study|Disease progression|6
2608705|NCT01004861|9019042|P10|Overall Study|Disease progression|7
2608706|NCT01004861|9019043|P9|Overall Study|Disease progression|4
2608707|NCT01004861|9019044|P8|Overall Study|Disease progression|1
2608708|NCT01004861|9019045|P7|Overall Study|Disease progression|5
2608709|NCT01004861|9019046|P6|Overall Study|Disease progression|4
2608710|NCT01004861|9019047|P5|Overall Study|Disease progression|4
2608711|NCT01004861|9019048|P4|Overall Study|Disease progression|4
2608712|NCT01004861|9019049|P3|Overall Study|Disease progression|5
2608713|NCT01004861|9019050|P2|Overall Study|Disease progression|4
2608714|NCT01004861|9019051|P1|Overall Study|Disease progression|3
2608715|NCT01004848|9019117|P2|Overall Study|Lost to Follow-up|45
2608716|NCT01004848|9019118|P1|Overall Study|Lost to Follow-up|55
2608717|NCT01004822|9019156|P8|Overall Study|Other|0
2608718|NCT01004822|9019157|P7|Overall Study|Other|0
2608719|NCT01004822|9019158|P6|Overall Study|Other|1
2608720|NCT01004822|9019159|P5|Overall Study|Other|0
2608721|NCT01004822|9019160|P4|Overall Study|Other|1
2608722|NCT01004822|9019161|P3|Overall Study|Other|4
2608723|NCT01004822|9019162|P2|Overall Study|Other|0
2608724|NCT01004822|9019163|P1|Overall Study|Other|0
2608725|NCT01004822|9019156|P8|Overall Study|Adverse Event|1
2608726|NCT01004822|9019157|P7|Overall Study|Adverse Event|1
2608727|NCT01004822|9019158|P6|Overall Study|Adverse Event|0
2608728|NCT01004822|9019159|P5|Overall Study|Adverse Event|0
2608729|NCT01004822|9019160|P4|Overall Study|Adverse Event|0
2608730|NCT01004822|9019161|P3|Overall Study|Adverse Event|0
2608731|NCT01004822|9019162|P2|Overall Study|Adverse Event|0
2608732|NCT01004822|9019163|P1|Overall Study|Adverse Event|0
2608733|NCT01004822|9019156|P8|Overall Study|No longer willing to continue|0
2608734|NCT01004822|9019157|P7|Overall Study|No longer willing to continue|1
2608735|NCT01004822|9019158|P6|Overall Study|No longer willing to continue|1
2608736|NCT01004822|9019159|P5|Overall Study|No longer willing to continue|2
2608737|NCT01004822|9019160|P4|Overall Study|No longer willing to continue|1
2608738|NCT01004822|9019161|P3|Overall Study|No longer willing to continue|0
2608739|NCT01004822|9019162|P2|Overall Study|No longer willing to continue|0
2608740|NCT01004822|9019163|P1|Overall Study|No longer willing to continue|0
2608741|NCT01004822|9019156|P8|Overall Study|Global deterioration of health status|0
2608742|NCT01004822|9019157|P7|Overall Study|Global deterioration of health status|1
2608743|NCT01004822|9019158|P6|Overall Study|Global deterioration of health status|0
2608744|NCT01004822|9019159|P5|Overall Study|Global deterioration of health status|0
2608745|NCT01004822|9019160|P4|Overall Study|Global deterioration of health status|1
2608746|NCT01004822|9019161|P3|Overall Study|Global deterioration of health status|0
2608747|NCT01004822|9019162|P2|Overall Study|Global deterioration of health status|0
2608748|NCT01004822|9019163|P1|Overall Study|Global deterioration of health status|0
2608749|NCT01004822|9019156|P8|Overall Study|Objective progression or relapse|4
2608750|NCT01004822|9019157|P7|Overall Study|Objective progression or relapse|1
2608751|NCT01004822|9019158|P6|Overall Study|Objective progression or relapse|2
2608752|NCT01004822|9019159|P5|Overall Study|Objective progression or relapse|2
2608753|NCT01004822|9019160|P4|Overall Study|Objective progression or relapse|1
2608754|NCT01004822|9019161|P3|Overall Study|Objective progression or relapse|0
2608755|NCT01004822|9019162|P2|Overall Study|Objective progression or relapse|3
2608756|NCT01004822|9019163|P1|Overall Study|Objective progression or relapse|3
2608757|NCT01004614|9019328|P4|Washout|Withdrawal by Subject|0
2608758|NCT01004614|9019329|P3|Washout|Withdrawal by Subject|0
2608759|NCT01004614|9019330|P2|Washout|Withdrawal by Subject|1
2608760|NCT01004614|9019331|P1|Washout|Withdrawal by Subject|0
2608761|NCT01004510|9019365|P1|Overall Study|Adverse Event|1
2608762|NCT01004432|9019369|P5|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10
2608763|NCT01004432|9019370|P4|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
2608764|NCT01004432|9019371|P3|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
2608765|NCT01004432|9019372|P2|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
2608766|NCT01004432|9019373|P1|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
2608767|NCT01004432|9019369|P5|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2
2608768|NCT01004432|9019370|P4|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
2608769|NCT01004432|9019371|P3|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
2608770|NCT01004432|9019372|P2|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
2608771|NCT01004432|9019373|P1|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
2608772|NCT01004432|9019369|P5|OL Study Extension (Week 52 - 76)|Protocol Violation|4
2608773|NCT01004432|9019370|P4|OL Study Extension (Week 52 - 76)|Protocol Violation|0
2608774|NCT01004432|9019371|P3|OL Study Extension (Week 52 - 76)|Protocol Violation|0
2608775|NCT01004432|9019372|P2|OL Study Extension (Week 52 - 76)|Protocol Violation|0
2608776|NCT01004432|9019373|P1|OL Study Extension (Week 52 - 76)|Protocol Violation|0
2608777|NCT01004432|9019369|P5|OL Study Extension (Week 52 - 76)|Adverse Event|2
2608778|NCT01004432|9019370|P4|OL Study Extension (Week 52 - 76)|Adverse Event|0
2608779|NCT01004432|9019371|P3|OL Study Extension (Week 52 - 76)|Adverse Event|0
2608780|NCT01004432|9019372|P2|OL Study Extension (Week 52 - 76)|Adverse Event|0
2608781|NCT01004432|9019373|P1|OL Study Extension (Week 52 - 76)|Adverse Event|0
2608782|NCT01004432|9019369|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
2608783|NCT01004432|9019370|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
2608784|NCT01004432|9019371|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1
2608785|NCT01004432|9019372|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
2608786|NCT01004432|9019373|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
2608787|NCT01004432|9019369|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
2608788|NCT01004432|9019370|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37
2608789|NCT01004432|9019371|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24
2608790|NCT01004432|9019372|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2
2608791|NCT01004432|9019373|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
2608792|NCT01004432|9019369|P5|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
2608793|NCT01004432|9019370|P4|OL/Double-Blind (DB) Period (Week 16-52)|Death|1
2608794|NCT01004432|9019371|P3|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
2608795|NCT01004432|9019372|P2|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
2608796|NCT01004432|9019373|P1|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
2608797|NCT01004432|9019369|P5|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
2608798|NCT01004432|9019370|P4|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7
2608799|NCT01004432|9019371|P3|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4
2608800|NCT01004432|9019372|P2|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1
2608801|NCT01004432|9019373|P1|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
2608802|NCT01004432|9019369|P5|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
2608803|NCT01004432|9019370|P4|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4
2608804|NCT01004432|9019371|P3|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
2608805|NCT01004432|9019372|P2|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
2608806|NCT01004432|9019373|P1|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
2608807|NCT01004432|9019369|P5|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
2608808|NCT01004432|9019370|P4|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6
2608809|NCT01004432|9019371|P3|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5
2608810|NCT01004432|9019372|P2|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1
2608811|NCT01004432|9019373|P1|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
2608812|NCT01004432|9019369|P5|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
2608813|NCT01004432|9019370|P4|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
2608814|NCT01004432|9019371|P3|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
2608815|NCT01004432|9019372|P2|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
2608816|NCT01004432|9019373|P1|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|2
2608817|NCT01004432|9019369|P5|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
2608818|NCT01004432|9019370|P4|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
2608819|NCT01004432|9019371|P3|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
2608820|NCT01004432|9019372|P2|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
2608821|NCT01004432|9019373|P1|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|15
2608822|NCT01004432|9019369|P5|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
2608823|NCT01004432|9019370|P4|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
2608824|NCT01004432|9019371|P3|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
2608825|NCT01004432|9019372|P2|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
2608826|NCT01004432|9019373|P1|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|17
2608827|NCT01004432|9019369|P5|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
2608828|NCT01004432|9019370|P4|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
2608829|NCT01004432|9019371|P3|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
2608830|NCT01004432|9019372|P2|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
2608831|NCT01004432|9019373|P1|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|29
2608832|NCT01004432|9019369|P5|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
2608833|NCT01004432|9019370|P4|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
2608834|NCT01004432|9019371|P3|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
2608835|NCT01004432|9019372|P2|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
2608836|NCT01004432|9019373|P1|Open-label (OL) Period (Week 0 – 16)|Adverse Event|20
2608837|NCT01004406|9019395|P2|Overall Study|Lost to Follow-up|0
2608838|NCT01004406|9019396|P1|Overall Study|Lost to Follow-up|1
2608839|NCT01004406|9019395|P2|Overall Study|Withdrawal by Subject|0
2608840|NCT01004406|9019396|P1|Overall Study|Withdrawal by Subject|2
2608841|NCT01004263|9019431|P1|Overall Study|Lack of Qualifying Event|2
2608842|NCT01004263|9019431|P1|Overall Study|Physician Decision|15
2608843|NCT01004263|9019431|P1|Overall Study|Pregnancy|2
2608844|NCT01004263|9019431|P1|Overall Study|Lack of Efficacy|13
2608845|NCT01004263|9019431|P1|Overall Study|Lost to Follow-up|64
2608846|NCT01004263|9019431|P1|Overall Study|Protocol Violation|10
2608847|NCT01004263|9019431|P1|Overall Study|Withdrawal by Subject|58
2608848|NCT01004263|9019431|P1|Overall Study|Adverse Event|15
2608849|NCT01004250|9019439|P1|Follow-Up (FU) Period|Lost to Follow-up|1
2608850|NCT01004250|9019439|P1|Maintenance Therapy Period|Physician Decision|4
2608851|NCT01004250|9019439|P1|Maintenance Therapy Period|Withdrawal by Subject|5
2608852|NCT01004250|9019439|P1|Maintenance Therapy Period|Protocol Violation|1
2608853|NCT01004250|9019439|P1|Maintenance Therapy Period|Lost to Follow-up|1
2608854|NCT01004250|9019439|P1|Maintenance Therapy Period|Adverse Event|15
2608855|NCT01004250|9019439|P1|Induction Therapy Period|Physician Decision|2
2608856|NCT01004250|9019439|P1|Induction Therapy Period|Withdrawal by Subject|2
2608857|NCT01004250|9019439|P1|Induction Therapy Period|Entry Criteria Not Met|1
2608858|NCT01004250|9019439|P1|Induction Therapy Period|Adverse Event|10
2608859|NCT01004185|9019451|P2|Overall Study|Withdrawal by Subject|1
2608860|NCT01004185|9019452|P1|Overall Study|Withdrawal by Subject|2
2608861|NCT01004185|9019451|P2|Overall Study|Sponsor Terminated Study|5
2608862|NCT01004185|9019452|P1|Overall Study|Sponsor Terminated Study|4
2608863|NCT01004185|9019451|P2|Overall Study|Lack of Efficacy|1
2608864|NCT01004185|9019452|P1|Overall Study|Lack of Efficacy|2
2608865|NCT01004185|9019451|P2|Overall Study|Lost to Follow-up|1
2608866|NCT01004185|9019452|P1|Overall Study|Lost to Follow-up|0
2608867|NCT01004185|9019451|P2|Overall Study|Adverse Event|1
2608868|NCT01004185|9019452|P1|Overall Study|Adverse Event|1
2608869|NCT01004172|9019460|P1|Overall Study|Symptomatic Deterioration|2
2608870|NCT01004172|9019460|P1|Overall Study|Physician Decision|1
2608871|NCT01004172|9019460|P1|Overall Study|Adverse Event|1
2608872|NCT01004172|9019460|P1|Overall Study|Progressive Disease in CNS and Non-CNS|2
2608873|NCT01004172|9019460|P1|Overall Study|Progressive Disease in Non-CNS Only|16
2608874|NCT01004172|9019460|P1|Overall Study|Progressive Disease in CNS Only|16
2608875|NCT01004159|9019468|P1|Overall Study|Disease Progression|18
2608876|NCT01004159|9019468|P1|Overall Study|Adverse Event|2
2608877|NCT01004146|9019475|P2|Overall Study|Withdrawal by Subject|5
2608878|NCT01004146|9019476|P1|Overall Study|Withdrawal by Subject|4
2608879|NCT01004003|9019570|P9|Overall Study|Other|0
2608880|NCT01004003|9019571|P8|Overall Study|Other|0
2608881|NCT01004003|9019572|P7|Overall Study|Other|0
2608882|NCT01004003|9019573|P6|Overall Study|Other|1
2608883|NCT01004003|9019574|P5|Overall Study|Other|0
2608884|NCT01004003|9019575|P4|Overall Study|Other|0
2608885|NCT01004003|9019576|P3|Overall Study|Other|0
2608886|NCT01004003|9019577|P2|Overall Study|Other|0
2608887|NCT01004003|9019578|P1|Overall Study|Other|0
2608888|NCT01004003|9019570|P9|Overall Study|Refused to continue taking trial med.|2
2608889|NCT01004003|9019571|P8|Overall Study|Refused to continue taking trial med.|0
2608890|NCT01004003|9019572|P7|Overall Study|Refused to continue taking trial med.|0
2608891|NCT01004003|9019573|P6|Overall Study|Refused to continue taking trial med.|0
2608892|NCT01004003|9019574|P5|Overall Study|Refused to continue taking trial med.|0
2608893|NCT01004003|9019575|P4|Overall Study|Refused to continue taking trial med.|0
2608894|NCT01004003|9019576|P3|Overall Study|Refused to continue taking trial med.|0
2608895|NCT01004003|9019577|P2|Overall Study|Refused to continue taking trial med.|0
2608896|NCT01004003|9019578|P1|Overall Study|Refused to continue taking trial med.|0
2608897|NCT01004003|9019570|P9|Overall Study|Adverse Event|6
2608898|NCT01004003|9019571|P8|Overall Study|Adverse Event|21
2608899|NCT01004003|9019572|P7|Overall Study|Adverse Event|7
2608900|NCT01004003|9019573|P6|Overall Study|Adverse Event|2
2608901|NCT01004003|9019574|P5|Overall Study|Adverse Event|2
2608902|NCT01004003|9019575|P4|Overall Study|Adverse Event|3
2608903|NCT01004003|9019576|P3|Overall Study|Adverse Event|3
2608904|NCT01004003|9019577|P2|Overall Study|Adverse Event|2
2608905|NCT01004003|9019578|P1|Overall Study|Adverse Event|4
2608906|NCT01004003|9019570|P9|Overall Study|Progressive disease|22
2608907|NCT01004003|9019571|P8|Overall Study|Progressive disease|39
2608908|NCT01004003|9019572|P7|Overall Study|Progressive disease|1
2608909|NCT01004003|9019573|P6|Overall Study|Progressive disease|1
2608910|NCT01004003|9019574|P5|Overall Study|Progressive disease|2
2608911|NCT01004003|9019575|P4|Overall Study|Progressive disease|0
2608912|NCT01004003|9019576|P3|Overall Study|Progressive disease|1
2608913|NCT01004003|9019577|P2|Overall Study|Progressive disease|1
2608914|NCT01004003|9019578|P1|Overall Study|Progressive disease|2
2608915|NCT01003990|9019609|P3|Overall Study|Subject Withdrew Consent|7
2608916|NCT01003990|9019610|P2|Overall Study|Subject Withdrew Consent|5
2608917|NCT01003990|9019611|P1|Overall Study|Subject Withdrew Consent|12
2608918|NCT01003990|9019609|P3|Overall Study|No Longer Met Study Criteria|0
2608919|NCT01003990|9019610|P2|Overall Study|No Longer Met Study Criteria|1
2608920|NCT01003990|9019611|P1|Overall Study|No Longer Met Study Criteria|4
2608921|NCT01003990|9019609|P3|Overall Study|Pregnancy|4
2608922|NCT01003990|9019610|P2|Overall Study|Pregnancy|2
2608923|NCT01003990|9019611|P1|Overall Study|Pregnancy|10
2608924|NCT01003990|9019609|P3|Overall Study|Poor/Non-compliance|2
2608925|NCT01003990|9019610|P2|Overall Study|Poor/Non-compliance|3
2608926|NCT01003990|9019611|P1|Overall Study|Poor/Non-compliance|4
2608927|NCT01003990|9019609|P3|Overall Study|Reasons Not Identified|8
2608928|NCT01003990|9019610|P2|Overall Study|Reasons Not Identified|13
2608929|NCT01003990|9019611|P1|Overall Study|Reasons Not Identified|14
2608930|NCT01003990|9019609|P3|Overall Study|Lost to Follow-up|7
2608931|NCT01003990|9019610|P2|Overall Study|Lost to Follow-up|12
2608932|NCT01003990|9019611|P1|Overall Study|Lost to Follow-up|30
2608933|NCT01003990|9019609|P3|Overall Study|Lack of Efficacy|3
2608934|NCT01003990|9019610|P2|Overall Study|Lack of Efficacy|2
2608935|NCT01003990|9019611|P1|Overall Study|Lack of Efficacy|10
2608936|NCT01003990|9019609|P3|Overall Study|Death|1
2608937|NCT01003990|9019610|P2|Overall Study|Death|8
2608938|NCT01003990|9019611|P1|Overall Study|Death|0
2608939|NCT01003990|9019609|P3|Overall Study|Adverse Event|11
2608940|NCT01003990|9019610|P2|Overall Study|Adverse Event|5
2608941|NCT01003990|9019611|P1|Overall Study|Adverse Event|8
2608942|NCT01003899|9019628|P1|Overall Study|Progressive disease|34
2608943|NCT01003899|9019628|P1|Overall Study|Not treated|1
2608944|NCT01003899|9019628|P1|Overall Study|Not entered|4
2608945|NCT01003899|9019628|P1|Overall Study|Other Adverse Event|8
2608946|NCT01003886|9019637|P1|Overall Study|Adverse Event|3
2608947|NCT01003886|9019637|P1|Overall Study|Other|14
2608948|NCT01003886|9019637|P1|Overall Study|Withdrawal by Subject|39
2608949|NCT01003886|9019637|P1|Overall Study|Lost to Follow-up|169
2608950|NCT01003886|9019637|P1|Overall Study|Lack of Efficacy|5
2608951|NCT01003639|9019648|P2|Overall Study|Physician Decision|0
2608952|NCT01003639|9019649|P1|Overall Study|Physician Decision|1
2608953|NCT01003639|9019648|P2|Overall Study|Protocol Violation|1
2608954|NCT01003639|9019649|P1|Overall Study|Protocol Violation|0
2608955|NCT01003639|9019648|P2|Overall Study|Adverse Event|1
2608956|NCT01003639|9019649|P1|Overall Study|Adverse Event|0
2608957|NCT01003639|9019648|P2|Overall Study|Lack of Efficacy|6
2608958|NCT01003639|9019649|P1|Overall Study|Lack of Efficacy|1
2608959|NCT01003639|9019648|P2|Overall Study|Withdrawal by Subject|5
2608960|NCT01003639|9019649|P1|Overall Study|Withdrawal by Subject|9
2608961|NCT01003639|9019648|P2|Overall Study|Lost to Follow-up|9
2608962|NCT01003639|9019649|P1|Overall Study|Lost to Follow-up|6
2608963|NCT01003249|9019705|P2|Second Intervention (4 Weeks)|Adverse Event|0
2608964|NCT01003249|9019706|P1|Second Intervention (4 Weeks)|Adverse Event|1
2608965|NCT01003249|9019705|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
2608966|NCT01003249|9019706|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|0
2608967|NCT01003249|9019705|P2|First Intervention (4 Weeks)|Non-Serious Event|1
2608968|NCT01003249|9019706|P1|First Intervention (4 Weeks)|Non-Serious Event|1
2608969|NCT01003249|9019705|P2|First Intervention (4 Weeks)|Withdrawal by Subject|1
2608970|NCT01003249|9019706|P1|First Intervention (4 Weeks)|Withdrawal by Subject|1
2608971|NCT01003210|9019724|P2|Overall Study|Lost to Follow-up|3
2608972|NCT01003210|9019725|P1|Overall Study|Lost to Follow-up|1
2608973|NCT01003184|9019737|P2|Overall Study|Physician Decision|0
2608974|NCT01003184|9019738|P1|Overall Study|Physician Decision|1
2608975|NCT01003184|9019737|P2|Overall Study|Withdrawal by Subject|6
2608976|NCT01003184|9019738|P1|Overall Study|Withdrawal by Subject|1
2608977|NCT01003184|9019737|P2|Overall Study|Protocol Violation|0
2608978|NCT01003184|9019738|P1|Overall Study|Protocol Violation|3
2608979|NCT01003184|9019737|P2|Overall Study|Loss of glucose control|1
2608980|NCT01003184|9019738|P1|Overall Study|Loss of glucose control|1
2608981|NCT01003184|9019737|P2|Overall Study|Lost to Follow-up|0
2608982|NCT01003184|9019738|P1|Overall Study|Lost to Follow-up|1
2608983|NCT01003184|9019737|P2|Overall Study|Adverse Event|5
2608984|NCT01003184|9019738|P1|Overall Study|Adverse Event|12
2608985|NCT01002989|9019821|P1|Overall Study|exclusion criteria, no consent|5
2608986|NCT01002742|9019836|P2|Overall Study|Determined to be ineligible|1
2608987|NCT01002742|9019837|P1|Overall Study|Determined to be ineligible|0
2608988|NCT01002573|9019873|P2|Overall Study|Subject did not receive at least 1 dose|7
2608989|NCT01002573|9019874|P1|Overall Study|Subject did not receive at least 1 dose|11
2608990|NCT01002547|9019895|P3|Overall Study|Adverse Event|0
2608991|NCT01002547|9019896|P2|Overall Study|Adverse Event|0
2608992|NCT01002547|9019897|P1|Overall Study|Adverse Event|1
2608993|NCT01002547|9019895|P3|Overall Study|Death|2
2608994|NCT01002547|9019896|P2|Overall Study|Death|2
2608995|NCT01002547|9019897|P1|Overall Study|Death|0
2608996|NCT01002547|9019895|P3|Overall Study|Physician Decision|0
2608997|NCT01002547|9019896|P2|Overall Study|Physician Decision|0
2608998|NCT01002547|9019897|P1|Overall Study|Physician Decision|1
2608999|NCT01002547|9019895|P3|Overall Study|Lost to Follow-up|1
2609000|NCT01002547|9019896|P2|Overall Study|Lost to Follow-up|1
2609001|NCT01002547|9019897|P1|Overall Study|Lost to Follow-up|2
2609002|NCT01002547|9019895|P3|Overall Study|Withdrawal by Subject|5
2609003|NCT01002547|9019896|P2|Overall Study|Withdrawal by Subject|0
2609004|NCT01002547|9019897|P1|Overall Study|Withdrawal by Subject|4
2609005|NCT01002482|9019955|P2|Overall Study|Included twice|0
2609006|NCT01002482|9019956|P1|Overall Study|Included twice|1
2609007|NCT01002482|9019955|P2|Overall Study|Withdrawal by Subject|21
2609008|NCT01002482|9019956|P1|Overall Study|Withdrawal by Subject|14
2609009|NCT01002339|9019990|P3|Overall Study|Randomized. Not transplanted|1
2609010|NCT01002339|9019991|P2|Overall Study|Randomized. Not transplanted|0
2609011|NCT01002339|9019992|P1|Overall Study|Randomized. Not transplanted|0
2609012|NCT01002339|9019990|P3|Overall Study|Lung cancer detected before transplant|1
2609013|NCT01002339|9019991|P2|Overall Study|Lung cancer detected before transplant|0
2609014|NCT01002339|9019992|P1|Overall Study|Lung cancer detected before transplant|0
2609015|NCT01002339|9019990|P3|Overall Study|Protocol Violation|2
2609016|NCT01002339|9019991|P2|Overall Study|Protocol Violation|0
2609017|NCT01002339|9019992|P1|Overall Study|Protocol Violation|0
2609018|NCT01002339|9019990|P3|Overall Study|Incorrect treatment assignment|1
2609019|NCT01002339|9019991|P2|Overall Study|Incorrect treatment assignment|0
2609020|NCT01002339|9019992|P1|Overall Study|Incorrect treatment assignment|0
2609021|NCT01002339|9019990|P3|Overall Study|Withdrawal by Subject|0
2609022|NCT01002339|9019991|P2|Overall Study|Withdrawal by Subject|1
2609023|NCT01002339|9019992|P1|Overall Study|Withdrawal by Subject|0
2609024|NCT01002105|9020068|P2|Overall Study|condition worsened|2
2609025|NCT01002105|9020069|P1|Overall Study|condition worsened|4
2609026|NCT01002105|9020068|P2|Overall Study|non compliance|3
2609027|NCT01002105|9020069|P1|Overall Study|non compliance|5
2609028|NCT01002105|9020068|P2|Overall Study|Lost to Follow-up|16
2609029|NCT01002105|9020069|P1|Overall Study|Lost to Follow-up|10
2609030|NCT01001988|9020085|P1|Overall Study|Lost to Follow-up|15
2609031|NCT01001988|9020085|P1|Overall Study|Withdrawal by Subject|18
2609032|NCT01001988|9020085|P1|Overall Study|Protocol Violation|84
2609033|NCT01001832|9020103|P2|Follow-up Period|Other|1
2609034|NCT01001832|9020104|P1|Follow-up Period|Other|2
2609035|NCT01001832|9020103|P2|Follow-up Period|Follow-up no longer required /protocol|20
2609036|NCT01001832|9020104|P1|Follow-up Period|Follow-up no longer required /protocol|15
2609037|NCT01001832|9020103|P2|Follow-up Period|Withdrawal by Subject|0
2609038|NCT01001832|9020104|P1|Follow-up Period|Withdrawal by Subject|1
2609039|NCT01001832|9020103|P2|Long-term Period|Other|2
2609040|NCT01001832|9020104|P1|Long-term Period|Other|1
2609041|NCT01001832|9020103|P2|Long-term Period|Lack of Efficacy|2
2609042|NCT01001832|9020104|P1|Long-term Period|Lack of Efficacy|0
2609043|NCT01001832|9020103|P2|Long-term Period|Withdrawal by Subject|0
2609044|NCT01001832|9020104|P1|Long-term Period|Withdrawal by Subject|1
2609045|NCT01001832|9020103|P2|Long-term Period|Adverse Event|1
2609046|NCT01001832|9020104|P1|Long-term Period|Adverse Event|2
2609047|NCT01001832|9020103|P2|Short-term Period|Adverse Event|3
2609048|NCT01001832|9020104|P1|Short-term Period|Adverse Event|2
2609049|NCT01001767|9020162|P2|Overall Study|Physician Decision|0
2609050|NCT01001767|9020163|P1|Overall Study|Physician Decision|1
2609051|NCT01001767|9020162|P2|Overall Study|Lost to Follow-up|0
2609052|NCT01001767|9020163|P1|Overall Study|Lost to Follow-up|1
2609053|NCT01001767|9020162|P2|Overall Study|Protocol Violation|0
2609054|NCT01001767|9020163|P1|Overall Study|Protocol Violation|1
2609055|NCT01001767|9020162|P2|Overall Study|no baseline study performed|0
2609056|NCT01001767|9020163|P1|Overall Study|no baseline study performed|1
2609057|NCT01001702|9020169|P1|Overall Study|Lack of Efficacy per Investigator|3
2609058|NCT01001702|9020169|P1|Overall Study|Withdrawal by Subject|19
2609059|NCT01001702|9020169|P1|Overall Study|Investigator withdrew Subject|10
2609060|NCT01001702|9020169|P1|Overall Study|Subject met Withdrawal Criteria|22
2609061|NCT01001702|9020169|P1|Overall Study|Sponsor Discontinued Study|4
2609062|NCT01001702|9020169|P1|Overall Study|Adverse Event|7
2609063|NCT01001702|9020169|P1|Overall Study|Lost to Follow-up|7
2609064|NCT01001598|9020180|P1|Overall Study|Adverse Event|1
2609065|NCT01001598|9020180|P1|Overall Study|Hematopoietic Stem Cell Transplant|1
2609066|NCT01001572|9020188|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
2609067|NCT01001572|9020189|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
2609068|NCT01001572|9020190|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
2609069|NCT01001572|9020188|P3|Double-Blind Treatment Phase|Protocol deviation|1
2609070|NCT01001572|9020189|P2|Double-Blind Treatment Phase|Protocol deviation|0
2609071|NCT01001572|9020190|P1|Double-Blind Treatment Phase|Protocol deviation|0
2609072|NCT01001572|9020188|P3|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1
2609073|NCT01001572|9020189|P2|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
2609074|NCT01001572|9020190|P1|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
2609075|NCT01001572|9020188|P3|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1
2609076|NCT01001572|9020189|P2|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
2609077|NCT01001572|9020190|P1|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
2609078|NCT01001572|9020188|P3|Double-Blind Treatment Phase|Withdrawal by Subject|13
2609079|NCT01001572|9020189|P2|Double-Blind Treatment Phase|Withdrawal by Subject|8
2609080|NCT01001572|9020190|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
2609081|NCT01001572|9020188|P3|Double-Blind Treatment Phase|Adverse Event|2
2609082|NCT01001572|9020189|P2|Double-Blind Treatment Phase|Adverse Event|2
2609083|NCT01001572|9020190|P1|Double-Blind Treatment Phase|Adverse Event|0
2609084|NCT01001572|9020188|P3|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
2609085|NCT01001572|9020189|P2|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
2609086|NCT01001572|9020190|P1|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45
2609087|NCT01001572|9020188|P3|Single-Blind Valsartan 160 mg|Administrative problems|0
2609088|NCT01001572|9020189|P2|Single-Blind Valsartan 160 mg|Administrative problems|0
2609089|NCT01001572|9020190|P1|Single-Blind Valsartan 160 mg|Administrative problems|82
2609090|NCT01001572|9020188|P3|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
2609091|NCT01001572|9020189|P2|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
2609092|NCT01001572|9020190|P1|Single-Blind Valsartan 160 mg|Lost to Follow-up|4
2609093|NCT01001572|9020188|P3|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
2609094|NCT01001572|9020189|P2|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
2609095|NCT01001572|9020190|P1|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1
2609096|NCT01001572|9020188|P3|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
2609097|NCT01001572|9020189|P2|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
2609098|NCT01001572|9020190|P1|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7
2609099|NCT01001572|9020188|P3|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
2609100|NCT01001572|9020189|P2|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
2609101|NCT01001572|9020190|P1|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96
2609102|NCT01001572|9020188|P3|Single-Blind Valsartan 160 mg|Adverse Event|0
2609103|NCT01001572|9020189|P2|Single-Blind Valsartan 160 mg|Adverse Event|0
2609104|NCT01001572|9020190|P1|Single-Blind Valsartan 160 mg|Adverse Event|11
2609105|NCT01001572|9020188|P3|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
2609106|NCT01001572|9020189|P2|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
2609107|NCT01001572|9020190|P1|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32
2609108|NCT01001520|9020228|P2|Medication Period 2|Withdrawal by Subject|3
2609109|NCT01001520|9020229|P1|Medication Period 2|Withdrawal by Subject|0
2609110|NCT01001520|9020228|P2|Washout Period|Withdrawal by Subject|1
2609111|NCT01001520|9020229|P1|Washout Period|Withdrawal by Subject|2
2609112|NCT01001520|9020228|P2|Medication Period 1|Ineligible: Claustrophobia in fMRI|0
2609113|NCT01001520|9020229|P1|Medication Period 1|Ineligible: Claustrophobia in fMRI|2
2609114|NCT01001520|9020228|P2|Medication Period 1|Ineligible: fMRI contraindicated metal|2
2609115|NCT01001520|9020229|P1|Medication Period 1|Ineligible: fMRI contraindicated metal|0
2609116|NCT01001520|9020228|P2|Medication Period 1|Ineligible: Positive Urine Drug Screen|3
2609117|NCT01001520|9020229|P1|Medication Period 1|Ineligible: Positive Urine Drug Screen|0
2609118|NCT01001520|9020228|P2|Medication Period 1|Withdrawal by Subject|2
2609119|NCT01001520|9020229|P1|Medication Period 1|Withdrawal by Subject|2
2609120|NCT01001494|9020256|P3|Overall Study|Other|3
2609121|NCT01001494|9020257|P2|Overall Study|Other|1
2609122|NCT01001494|9020258|P1|Overall Study|Other|0
2609123|NCT01001494|9020256|P3|Overall Study|Lack of Efficacy|8
2609124|NCT01001494|9020257|P2|Overall Study|Lack of Efficacy|0
2609125|NCT01001494|9020258|P1|Overall Study|Lack of Efficacy|2
2609126|NCT01001494|9020256|P3|Overall Study|COPD exacerbation|5
2609127|NCT01001494|9020257|P2|Overall Study|COPD exacerbation|4
2609128|NCT01001494|9020258|P1|Overall Study|COPD exacerbation|3
2609129|NCT01001494|9020256|P3|Overall Study|Withdrawal by Subject|17
2609130|NCT01001494|9020257|P2|Overall Study|Withdrawal by Subject|7
2609131|NCT01001494|9020258|P1|Overall Study|Withdrawal by Subject|9
2609132|NCT01001494|9020256|P3|Overall Study|Lost to Follow-up|1
2609133|NCT01001494|9020257|P2|Overall Study|Lost to Follow-up|0
2609134|NCT01001494|9020258|P1|Overall Study|Lost to Follow-up|2
2609135|NCT01001494|9020256|P3|Overall Study|Protocol Violation|1
2609136|NCT01001494|9020257|P2|Overall Study|Protocol Violation|1
2609137|NCT01001494|9020258|P1|Overall Study|Protocol Violation|0
2609138|NCT01001494|9020256|P3|Overall Study|Adverse Event|6
2609139|NCT01001494|9020257|P2|Overall Study|Adverse Event|4
2609140|NCT01001494|9020258|P1|Overall Study|Adverse Event|8
2609141|NCT01001429|9020343|P2|Overall Study|surgery cancelled|1
2609142|NCT01001429|9020344|P1|Overall Study|surgery cancelled|0
2609143|NCT01001390|9020383|P2|Overall Study|Failure to wear AFO device|0
2609144|NCT01001390|9020384|P1|Overall Study|Failure to wear AFO device|2
2609145|NCT01001377|9020392|P2|Overall Study|Death|384
2609146|NCT01001377|9020393|P1|Overall Study|Death|391
2609147|NCT01001377|9020392|P2|Overall Study|Lost to Follow-up|17
2609148|NCT01001377|9020393|P1|Overall Study|Lost to Follow-up|14
2609149|NCT01001377|9020392|P2|Overall Study|Withdrawal by Subject|20
2609150|NCT01001377|9020393|P1|Overall Study|Withdrawal by Subject|19
2609151|NCT01001377|9020392|P2|Overall Study|Ineligibility determined|0
2609152|NCT01001377|9020393|P1|Overall Study|Ineligibility determined|2
2609153|NCT01001325|9020423|P2|Overall Study|Protocol Violation|0
2609154|NCT01001325|9020424|P1|Overall Study|Protocol Violation|2
2609155|NCT01001325|9020423|P2|Overall Study|Lost to Follow-up|10
2609156|NCT01001325|9020424|P1|Overall Study|Lost to Follow-up|16
2609157|NCT01001299|9020430|P1|Overall Study|Withdrew Consent|1
2609158|NCT01001299|9020430|P1|Overall Study|Began Taking Commercially Available Drug|2
2609159|NCT01001299|9020430|P1|Overall Study|Death|1
2609160|NCT01001299|9020430|P1|Overall Study|Adverse event or Intercurrent Illness|1
2609161|NCT01001299|9020430|P1|Overall Study|Insufficient Therapeutic Response|20
2609162|NCT01001234|9020459|P5|Overall Study|Not Treated: Lack of Qualifying Event|0
2609163|NCT01001234|9020460|P4|Overall Study|Not Treated: Lack of Qualifying Event|0
2609164|NCT01001234|9020461|P3|Overall Study|Not Treated: Lack of Qualifying Event|0
2609165|NCT01001234|9020462|P2|Overall Study|Not Treated: Lack of Qualifying Event|13
2609166|NCT01001234|9020463|P1|Overall Study|Not Treated: Lack of Qualifying Event|248
2609167|NCT01001234|9020459|P5|Overall Study|Not Treated: Physician Decision|0
2609168|NCT01001234|9020460|P4|Overall Study|Not Treated: Physician Decision|0
2609169|NCT01001234|9020461|P3|Overall Study|Not Treated: Physician Decision|0
2609170|NCT01001234|9020462|P2|Overall Study|Not Treated: Physician Decision|4
2609171|NCT01001234|9020463|P1|Overall Study|Not Treated: Physician Decision|37
2609172|NCT01001234|9020459|P5|Overall Study|Not Treated: Pregnancy|0
2609173|NCT01001234|9020460|P4|Overall Study|Not Treated: Pregnancy|0
2609174|NCT01001234|9020461|P3|Overall Study|Not Treated: Pregnancy|0
2609175|NCT01001234|9020462|P2|Overall Study|Not Treated: Pregnancy|0
2609176|NCT01001234|9020463|P1|Overall Study|Not Treated: Pregnancy|3
2609177|NCT01001234|9020459|P5|Overall Study|Not Treated: Lost to Follow-up|0
2609178|NCT01001234|9020460|P4|Overall Study|Not Treated: Lost to Follow-up|5
2609179|NCT01001234|9020461|P3|Overall Study|Not Treated: Lost to Follow-up|7
2609180|NCT01001234|9020462|P2|Overall Study|Not Treated: Lost to Follow-up|4
2609181|NCT01001234|9020463|P1|Overall Study|Not Treated: Lost to Follow-up|53
2609182|NCT01001234|9020459|P5|Overall Study|Not Treated: Protocol Violation|0
2609183|NCT01001234|9020460|P4|Overall Study|Not Treated: Protocol Violation|0
2609184|NCT01001234|9020461|P3|Overall Study|Not Treated: Protocol Violation|0
2609185|NCT01001234|9020462|P2|Overall Study|Not Treated: Protocol Violation|0
2609186|NCT01001234|9020463|P1|Overall Study|Not Treated: Protocol Violation|3
2609187|NCT01001234|9020459|P5|Overall Study|Not Treated: Withdrawal by Subject|0
2609188|NCT01001234|9020460|P4|Overall Study|Not Treated: Withdrawal by Subject|0
2609189|NCT01001234|9020461|P3|Overall Study|Not Treated: Withdrawal by Subject|2
2609190|NCT01001234|9020462|P2|Overall Study|Not Treated: Withdrawal by Subject|2
2609191|NCT01001234|9020463|P1|Overall Study|Not Treated: Withdrawal by Subject|23
2609192|NCT01001234|9020459|P5|Overall Study|Not Treated: Adverse Event|0
2609193|NCT01001234|9020460|P4|Overall Study|Not Treated: Adverse Event|0
2609194|NCT01001234|9020461|P3|Overall Study|Not Treated: Adverse Event|0
2609195|NCT01001234|9020462|P2|Overall Study|Not Treated: Adverse Event|0
2609196|NCT01001234|9020463|P1|Overall Study|Not Treated: Adverse Event|1
2609197|NCT01001234|9020459|P5|Overall Study|Physician Decision|0
2609198|NCT01001234|9020460|P4|Overall Study|Physician Decision|0
2609199|NCT01001234|9020461|P3|Overall Study|Physician Decision|0
2609200|NCT01001234|9020462|P2|Overall Study|Physician Decision|0
2609201|NCT01001234|9020463|P1|Overall Study|Physician Decision|1
2609202|NCT01001234|9020459|P5|Overall Study|Lost to Follow-up|0
2609203|NCT01001234|9020460|P4|Overall Study|Lost to Follow-up|2
2609204|NCT01001234|9020461|P3|Overall Study|Lost to Follow-up|1
2609205|NCT01001234|9020462|P2|Overall Study|Lost to Follow-up|0
2609206|NCT01001234|9020463|P1|Overall Study|Lost to Follow-up|0
2609207|NCT01001234|9020459|P5|Overall Study|Protocol Violation|0
2609208|NCT01001234|9020460|P4|Overall Study|Protocol Violation|18
2609209|NCT01001234|9020461|P3|Overall Study|Protocol Violation|19
2609210|NCT01001234|9020462|P2|Overall Study|Protocol Violation|3
2609211|NCT01001234|9020463|P1|Overall Study|Protocol Violation|34
2609212|NCT01001234|9020459|P5|Overall Study|Withdrawal by Subject|0
2609213|NCT01001234|9020460|P4|Overall Study|Withdrawal by Subject|0
2609214|NCT01001234|9020461|P3|Overall Study|Withdrawal by Subject|3
2609215|NCT01001234|9020462|P2|Overall Study|Withdrawal by Subject|0
2609216|NCT01001234|9020463|P1|Overall Study|Withdrawal by Subject|2
2609217|NCT01001221|9020479|P5|Overall Study|Not treated; protocol exclusion|0
2609218|NCT01001221|9020480|P4|Overall Study|Not treated; protocol exclusion|0
2609219|NCT01001221|9020481|P3|Overall Study|Not treated; protocol exclusion|1
2609220|NCT01001221|9020482|P2|Overall Study|Not treated; protocol exclusion|0
2609221|NCT01001221|9020483|P1|Overall Study|Not treated; protocol exclusion|0
2609222|NCT01001221|9020479|P5|Overall Study|Other|0
2609223|NCT01001221|9020480|P4|Overall Study|Other|0
2609224|NCT01001221|9020481|P3|Overall Study|Other|0
2609225|NCT01001221|9020482|P2|Overall Study|Other|1
2609226|NCT01001221|9020483|P1|Overall Study|Other|1
2609227|NCT01001221|9020479|P5|Overall Study|Disease progression|0
2609228|NCT01001221|9020480|P4|Overall Study|Disease progression|4
2609229|NCT01001221|9020481|P3|Overall Study|Disease progression|2
2609230|NCT01001221|9020482|P2|Overall Study|Disease progression|2
2609231|NCT01001221|9020483|P1|Overall Study|Disease progression|3
2609232|NCT01001221|9020479|P5|Overall Study|Adverse Event|0
2609233|NCT01001221|9020480|P4|Overall Study|Adverse Event|2
2609234|NCT01001221|9020481|P3|Overall Study|Adverse Event|0
2609235|NCT01001221|9020482|P2|Overall Study|Adverse Event|2
2609236|NCT01001221|9020483|P1|Overall Study|Adverse Event|1
2609237|NCT01001208|9020658|P2|Overall Study|Other|2
2609238|NCT01001208|9020659|P1|Overall Study|Other|0
2609239|NCT01001208|9020658|P2|Overall Study|Disease Progression|3
2609240|NCT01001208|9020659|P1|Overall Study|Disease Progression|0
2609241|NCT01001208|9020658|P2|Overall Study|Noncompliance|7
2609242|NCT01001208|9020659|P1|Overall Study|Noncompliance|4
2609243|NCT01001208|9020658|P2|Overall Study|Ineligibility Determined|2
2609244|NCT01001208|9020659|P1|Overall Study|Ineligibility Determined|4
2609245|NCT01001208|9020658|P2|Overall Study|Withdrawal by Subject|5
2609246|NCT01001208|9020659|P1|Overall Study|Withdrawal by Subject|4
2609247|NCT01001208|9020658|P2|Overall Study|Physician Decision|0
2609248|NCT01001208|9020659|P1|Overall Study|Physician Decision|1
2609249|NCT01001208|9020658|P2|Overall Study|Lost to Follow-up|9
2609250|NCT01001208|9020659|P1|Overall Study|Lost to Follow-up|5
2609251|NCT01001208|9020658|P2|Overall Study|Adverse Event|5
2609252|NCT01001208|9020659|P1|Overall Study|Adverse Event|10
2609253|NCT01001169|9020702|P2|Overall Study|Withdrawal by Subject|1
2609254|NCT01001169|9020703|P1|Overall Study|Withdrawal by Subject|2
2609255|NCT01001104|9020811|P4|Overall Study|Withdrawal by Subject|2
2609256|NCT01001104|9020812|P3|Overall Study|Withdrawal by Subject|0
2609257|NCT01001104|9020813|P2|Overall Study|Withdrawal by Subject|0
2609258|NCT01001104|9020814|P1|Overall Study|Withdrawal by Subject|0
2609259|NCT01001104|9020811|P4|Overall Study|Entry Criteria Not Met|1
2609260|NCT01001104|9020812|P3|Overall Study|Entry Criteria Not Met|0
2609261|NCT01001104|9020813|P2|Overall Study|Entry Criteria Not Met|0
2609262|NCT01001104|9020814|P1|Overall Study|Entry Criteria Not Met|0
2609263|NCT01001104|9020811|P4|Overall Study|Lost to Follow-up|0
2609264|NCT01001104|9020812|P3|Overall Study|Lost to Follow-up|1
2609265|NCT01001104|9020813|P2|Overall Study|Lost to Follow-up|0
2609266|NCT01001104|9020814|P1|Overall Study|Lost to Follow-up|0
2609267|NCT01001104|9020811|P4|Overall Study|Adverse Event|0
2609268|NCT01001104|9020812|P3|Overall Study|Adverse Event|0
2609269|NCT01001104|9020813|P2|Overall Study|Adverse Event|1
2609270|NCT01001104|9020814|P1|Overall Study|Adverse Event|2
2609271|NCT01000974|9020905|P3|Booster Vaccination Phase|Other|4
2609272|NCT01000974|9020906|P2|Booster Vaccination Phase|Other|6
2609273|NCT01000974|9020907|P1|Booster Vaccination Phase|Other|24
2609274|NCT01000974|9020905|P3|Booster Vaccination Phase|Lost to Follow-up|7
2609275|NCT01000974|9020906|P2|Booster Vaccination Phase|Lost to Follow-up|5
2609276|NCT01000974|9020907|P1|Booster Vaccination Phase|Lost to Follow-up|40
2609277|NCT01000974|9020905|P3|Booster Vaccination Phase|Withdrawal by Subject|1
2609278|NCT01000974|9020906|P2|Booster Vaccination Phase|Withdrawal by Subject|1
2609279|NCT01000974|9020907|P1|Booster Vaccination Phase|Withdrawal by Subject|3
2609280|NCT01000974|9020905|P3|Booster Vaccination Phase|Protocol Violation|2
2609281|NCT01000974|9020906|P2|Booster Vaccination Phase|Protocol Violation|0
2609282|NCT01000974|9020907|P1|Booster Vaccination Phase|Protocol Violation|0
2609283|NCT01000974|9020905|P3|Primary Vaccination Phase|Other|12
2609284|NCT01000974|9020906|P2|Primary Vaccination Phase|Other|9
2609285|NCT01000974|9020907|P1|Primary Vaccination Phase|Other|4
2609286|NCT01000974|9020905|P3|Primary Vaccination Phase|Adverse Event|2
2609287|NCT01000974|9020906|P2|Primary Vaccination Phase|Adverse Event|2
2609288|NCT01000974|9020907|P1|Primary Vaccination Phase|Adverse Event|14
2609289|NCT01000974|9020905|P3|Primary Vaccination Phase|Protocol Violation|2
2609290|NCT01000974|9020906|P2|Primary Vaccination Phase|Protocol Violation|3
2609291|NCT01000974|9020907|P1|Primary Vaccination Phase|Protocol Violation|40
2609292|NCT01000974|9020905|P3|Primary Vaccination Phase|Lost to Follow-up|26
2609293|NCT01000974|9020906|P2|Primary Vaccination Phase|Lost to Follow-up|19
2609294|NCT01000974|9020907|P1|Primary Vaccination Phase|Lost to Follow-up|171
2609295|NCT01000974|9020905|P3|Primary Vaccination Phase|Withdrawal by Subject|21
2609296|NCT01000974|9020906|P2|Primary Vaccination Phase|Withdrawal by Subject|17
2609297|NCT01000974|9020907|P1|Primary Vaccination Phase|Withdrawal by Subject|109
2609298|NCT01000961|9021014|P2|First Intervention (3 Weeks)|Infection after pre-planned surgery|1
2609299|NCT01000961|9021015|P1|First Intervention (3 Weeks)|Infection after pre-planned surgery|0
2609300|NCT01000961|9021014|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
2609301|NCT01000961|9021015|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
2609302|NCT01000805|9021038|P2|Overall Study|Sponsor Decision|1
2609303|NCT01000805|9021039|P1|Overall Study|Sponsor Decision|0
2609304|NCT01000805|9021038|P2|Overall Study|Withdrawal by Subject|6
2609305|NCT01000805|9021039|P1|Overall Study|Withdrawal by Subject|16
2609306|NCT01000805|9021038|P2|Overall Study|Protocol Violation|8
2609307|NCT01000805|9021039|P1|Overall Study|Protocol Violation|12
2609308|NCT01000805|9021038|P2|Overall Study|Physician Decision|1
2609309|NCT01000805|9021039|P1|Overall Study|Physician Decision|0
2609310|NCT01000805|9021038|P2|Overall Study|Lost to Follow-up|21
2609311|NCT01000805|9021039|P1|Overall Study|Lost to Follow-up|16
2609312|NCT01000805|9021038|P2|Overall Study|Lack of Efficacy|16
2609313|NCT01000805|9021039|P1|Overall Study|Lack of Efficacy|5
2609314|NCT01000805|9021038|P2|Overall Study|Adverse Event|9
2609315|NCT01000805|9021039|P1|Overall Study|Adverse Event|21
2609316|NCT01000727|9021073|P2|Overall Study|Study closed/terminated|24
2609317|NCT01000727|9021074|P1|Overall Study|Study closed/terminated|23
2609318|NCT01000727|9021073|P2|Overall Study|Withdrawal by Subject|109
2609319|NCT01000727|9021074|P1|Overall Study|Withdrawal by Subject|111
2609320|NCT01000727|9021073|P2|Overall Study|Lost to Follow-up|43
2609321|NCT01000727|9021074|P1|Overall Study|Lost to Follow-up|41
2609322|NCT01000649|9021115|P4|Overall Study|Lost to Follow-up|2
2609323|NCT01000649|9021116|P3|Overall Study|Lost to Follow-up|0
2609324|NCT01000649|9021117|P2|Overall Study|Lost to Follow-up|2
2609325|NCT01000649|9021118|P1|Overall Study|Lost to Follow-up|0
2609326|NCT01000649|9021115|P4|Overall Study|Adverse Event|4
2609327|NCT01000649|9021116|P3|Overall Study|Adverse Event|2
2609328|NCT01000649|9021117|P2|Overall Study|Adverse Event|1
2609329|NCT01000649|9021118|P1|Overall Study|Adverse Event|5
2609330|NCT01000610|9021199|P1|Overall Study|Treatment failure|1
2609331|NCT01000610|9021199|P1|Overall Study|Lost to Follow-up|4
2609332|NCT01000610|9021199|P1|Overall Study|Adverse Event|1
2609333|NCT01000506|9021210|P4|Overall Study|Withdrawal by Subject|7
2609334|NCT01000506|9021211|P3|Overall Study|Withdrawal by Subject|2
2609335|NCT01000506|9021212|P2|Overall Study|Withdrawal by Subject|8
2609336|NCT01000506|9021213|P1|Overall Study|Withdrawal by Subject|11
2609337|NCT01000506|9021210|P4|Overall Study|Physician Decision|3
2609338|NCT01000506|9021211|P3|Overall Study|Physician Decision|3
2609339|NCT01000506|9021212|P2|Overall Study|Physician Decision|3
2609340|NCT01000506|9021213|P1|Overall Study|Physician Decision|1
2609341|NCT01000506|9021210|P4|Overall Study|Lost to Follow-up|0
2609342|NCT01000506|9021211|P3|Overall Study|Lost to Follow-up|4
2609343|NCT01000506|9021212|P2|Overall Study|Lost to Follow-up|1
2609344|NCT01000506|9021213|P1|Overall Study|Lost to Follow-up|1
2609345|NCT01000506|9021210|P4|Overall Study|Protocol Violation|0
2609346|NCT01000506|9021211|P3|Overall Study|Protocol Violation|0
2609347|NCT01000506|9021212|P2|Overall Study|Protocol Violation|1
2609348|NCT01000506|9021213|P1|Overall Study|Protocol Violation|1
2609349|NCT01000506|9021210|P4|Overall Study|Lack of Efficacy|4
2609350|NCT01000506|9021211|P3|Overall Study|Lack of Efficacy|4
2609351|NCT01000506|9021212|P2|Overall Study|Lack of Efficacy|6
2609352|NCT01000506|9021213|P1|Overall Study|Lack of Efficacy|8
2609353|NCT01000506|9021210|P4|Overall Study|Adverse Event|9
2609354|NCT01000506|9021211|P3|Overall Study|Adverse Event|8
2609355|NCT01000506|9021212|P2|Overall Study|Adverse Event|5
2609356|NCT01000506|9021213|P1|Overall Study|Adverse Event|6
2609357|NCT01000493|9021257|P2|Overall Study|Withdrawal by Subject|7
2609358|NCT01000493|9021258|P1|Overall Study|Withdrawal by Subject|3
2609359|NCT01000493|9021257|P2|Overall Study|Physician Decision|1
2609360|NCT01000493|9021258|P1|Overall Study|Physician Decision|1
2609361|NCT01000493|9021257|P2|Overall Study|Lost to Follow-up|9
2609362|NCT01000493|9021258|P1|Overall Study|Lost to Follow-up|5
2609363|NCT01000493|9021257|P2|Overall Study|Study closed/terminated|23
2609364|NCT01000493|9021258|P1|Overall Study|Study closed/terminated|25
2609365|NCT01000493|9021257|P2|Overall Study|Protocol Violation|8
2609366|NCT01000493|9021258|P1|Overall Study|Protocol Violation|1
2609367|NCT01000493|9021257|P2|Overall Study|Lack of Efficacy|1
2609368|NCT01000493|9021258|P1|Overall Study|Lack of Efficacy|1
2609369|NCT01000493|9021257|P2|Overall Study|Adverse Event|6
2609370|NCT01000493|9021258|P1|Overall Study|Adverse Event|3
2609371|NCT01000480|9021308|P1|Concurrent Therapy Phase|Physician Decision|1
2609372|NCT01000480|9021308|P1|Concurrent Therapy Phase|Withdrawal by Subject|3
2609373|NCT01000480|9021308|P1|Concurrent Therapy Phase|Protocol Violation|2
2609374|NCT01000480|9021308|P1|Concurrent Therapy Phase|Adverse Event|4
2609375|NCT01000480|9021308|P1|Induction Phase|Entry Criteria Not Met|3
2609376|NCT01000480|9021308|P1|Induction Phase|Physician Decision|1
2609377|NCT01000480|9021308|P1|Induction Phase|Lost to Follow-up|1
2609378|NCT01000480|9021308|P1|Induction Phase|Adverse Event|2
2609379|NCT01000376|9021316|P2|Cycle 1 Day 1|Progressive Disease|0
2609380|NCT01000376|9021317|P1|Cycle 1 Day 1|Progressive Disease|1
2609381|NCT01000376|9021316|P2|Cycle 1 Day 1|Adverse Event|0
2609382|NCT01000376|9021317|P1|Cycle 1 Day 1|Adverse Event|1
2609383|NCT01000337|9021327|P2|Overall Study|Lost to Follow-up|3
2609384|NCT01000337|9021328|P1|Overall Study|Lost to Follow-up|4
2609385|NCT01000311|9021346|P2|Overall Study|Administrative reason|15
2609386|NCT01000311|9021347|P1|Overall Study|Administrative reason|9
2609387|NCT01000311|9021346|P2|Overall Study|Inappropriate enrollment|0
2609388|NCT01000311|9021347|P1|Overall Study|Inappropriate enrollment|2
2609389|NCT01000311|9021346|P2|Overall Study|Protocol Violation|2
2609390|NCT01000311|9021347|P1|Overall Study|Protocol Violation|1
2609391|NCT01000311|9021346|P2|Overall Study|Lost to Follow-up|24
2609392|NCT01000311|9021347|P1|Overall Study|Lost to Follow-up|15
2609393|NCT01000311|9021346|P2|Overall Study|Withdrawal by Subject|24
2609394|NCT01000311|9021347|P1|Overall Study|Withdrawal by Subject|16
2609395|NCT01000311|9021346|P2|Overall Study|Adverse Event|5
2609396|NCT01000311|9021347|P1|Overall Study|Adverse Event|2
2609397|NCT01000155|9021397|P1|Overall Study|Adverse Event|1
2609398|NCT01000155|9021397|P1|Overall Study|Withdrawal by Subject|1
2609399|NCT01000064|9021403|P2|Overall Study|Withdrawal by Subject|1
2609400|NCT01000064|9021404|P1|Overall Study|Withdrawal by Subject|1
2609401|NCT01000051|9021427|P2|Overall Study|Serious noncompliance|0
2609402|NCT01000051|9021428|P1|Overall Study|Serious noncompliance|1
2609403|NCT01000051|9021427|P2|Overall Study|Disease Progression|0
2609404|NCT01000051|9021428|P1|Overall Study|Disease Progression|1
2609405|NCT01000051|9021427|P2|Overall Study|Withdrawal by Subject|1
2609406|NCT01000051|9021428|P1|Overall Study|Withdrawal by Subject|1
2609407|NCT01000025|9021436|P2|Overall Study|Intercurrent Illness|7
2609408|NCT01000025|9021437|P1|Overall Study|Intercurrent Illness|26
2609409|NCT01000025|9021436|P2|Overall Study|Lack of Efficacy|208
2609410|NCT01000025|9021437|P1|Overall Study|Lack of Efficacy|363
2609411|NCT01000025|9021436|P2|Overall Study|Death|13
2609412|NCT01000025|9021437|P1|Overall Study|Death|23
2609413|NCT01000025|9021436|P2|Overall Study|Withdrawal by Subject|8
2609414|NCT01000025|9021437|P1|Overall Study|Withdrawal by Subject|13
2609415|NCT01000025|9021436|P2|Overall Study|Adverse Event|2
2609416|NCT01000025|9021437|P1|Overall Study|Adverse Event|43
2609417|NCT00999921|9021455|P2|Overall Study|Lost to Follow-up|19
2609418|NCT00999921|9021456|P1|Overall Study|Lost to Follow-up|10
2609419|NCT00999908|9021466|P3|Treatment Period 2|Protocol Violation|0
2609420|NCT00999908|9021467|P2|Treatment Period 2|Protocol Violation|0
2609421|NCT00999908|9021468|P1|Treatment Period 2|Protocol Violation|1
2609422|NCT00999908|9021466|P3|Treatment Period 1|Subject withdrew consent|0
2609423|NCT00999908|9021467|P2|Treatment Period 1|Subject withdrew consent|0
2609424|NCT00999908|9021468|P1|Treatment Period 1|Subject withdrew consent|2
2609425|NCT00999804|9021497|P2|Overall Study|Ineligible|0
2609426|NCT00999804|9021498|P1|Overall Study|Ineligible|3
2609427|NCT00999804|9021497|P2|Overall Study|Death|0
2609428|NCT00999804|9021498|P1|Overall Study|Death|1
2609429|NCT00999804|9021497|P2|Overall Study|Withdrawal by Subject|0
2609430|NCT00999804|9021498|P1|Overall Study|Withdrawal by Subject|4
2609431|NCT00999804|9021497|P2|Overall Study|Adverse Event|3
2609432|NCT00999804|9021498|P1|Overall Study|Adverse Event|4
2609433|NCT00999804|9021497|P2|Overall Study|Lack of Efficacy|2
2609434|NCT00999804|9021498|P1|Overall Study|Lack of Efficacy|9
2609435|NCT00999713|9021512|P2|Overall Study|Physician Decision|0
2609436|NCT00999713|9021513|P1|Overall Study|Physician Decision|2
2609437|NCT00999687|9021527|P1|Second Intervention|Lack of Efficacy|1
2609438|NCT00999687|9021527|P1|Second Intervention|Withdrawal by Subject|2
2609439|NCT00999687|9021527|P1|First Intervention|Withdrawal by Subject|1
2609440|NCT00999661|9021534|P1|Overall Study|Not meeting eligibility criteria|9
2609441|NCT00999661|9021534|P1|Overall Study|Withdrawal by Subject|1
2609442|NCT00999661|9021534|P1|Overall Study|Adverse Event|1
2609443|NCT00999661|9021534|P1|Overall Study|Lost to Follow-up|59
2609444|NCT00999596|9021555|P1|Overall Study|Statistical population not required|101
2609445|NCT00999544|9021560|P1|Overall Study|Withdrawal by Subject|1
2609446|NCT00999466|9021596|P3|Main Part|Adverse Event|2
2609447|NCT00999466|9021597|P2|Main Part|Adverse Event|4
2609448|NCT00999466|9021598|P1|Main Part|Adverse Event|0
2609449|NCT00999466|9021596|P3|Main Part|Withdrawal by Subject|2
2609450|NCT00999466|9021597|P2|Main Part|Withdrawal by Subject|0
2609451|NCT00999466|9021598|P1|Main Part|Withdrawal by Subject|0
2609452|NCT00999167|9021875|P3|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
2609453|NCT00999167|9021876|P2|Part B: Randomized, Placebo Controlled|Physician stopped drug|1
2609454|NCT00999167|9021877|P1|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
2609455|NCT00999167|9021875|P3|Part B: Randomized, Placebo Controlled|Physician Decision|0
2609456|NCT00999167|9021876|P2|Part B: Randomized, Placebo Controlled|Physician Decision|1
2609457|NCT00999167|9021877|P1|Part B: Randomized, Placebo Controlled|Physician Decision|0
2609458|NCT00999167|9021875|P3|Part B: Randomized, Placebo Controlled|Noncompliance|0
2609459|NCT00999167|9021876|P2|Part B: Randomized, Placebo Controlled|Noncompliance|1
2609460|NCT00999167|9021877|P1|Part B: Randomized, Placebo Controlled|Noncompliance|0
2609461|NCT00999167|9021875|P3|Part B: Randomized, Placebo Controlled|Adverse Event|1
2609462|NCT00999167|9021876|P2|Part B: Randomized, Placebo Controlled|Adverse Event|6
2609463|NCT00999167|9021877|P1|Part B: Randomized, Placebo Controlled|Adverse Event|0
2609464|NCT00999167|9021875|P3|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4
2609465|NCT00999167|9021876|P2|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7
2609466|NCT00999167|9021877|P1|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0
2609467|NCT00999167|9021875|P3|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16
2609468|NCT00999167|9021876|P2|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19
2609469|NCT00999167|9021877|P1|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0
2609470|NCT00999167|9021875|P3|Part A: Open Label Safety run-in|Adverse Event|0
2609471|NCT00999167|9021876|P2|Part A: Open Label Safety run-in|Adverse Event|0
2609472|NCT00999167|9021877|P1|Part A: Open Label Safety run-in|Adverse Event|3
2609473|NCT00999167|9021875|P3|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
2609474|NCT00999167|9021876|P2|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
2609475|NCT00999167|9021877|P1|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4
2609476|NCT00998985|9022015|P14|Overall Study|Protocol Violation|0
2609477|NCT00998985|9022016|P13|Overall Study|Protocol Violation|0
2609478|NCT00998985|9022017|P12|Overall Study|Protocol Violation|0
2609479|NCT00998985|9022018|P11|Overall Study|Protocol Violation|0
2609480|NCT00998985|9022019|P10|Overall Study|Protocol Violation|0
2609481|NCT00998985|9022020|P9|Overall Study|Protocol Violation|0
2609482|NCT00998985|9022021|P8|Overall Study|Protocol Violation|0
2609483|NCT00998985|9022022|P7|Overall Study|Protocol Violation|0
2609484|NCT00998985|9022023|P6|Overall Study|Protocol Violation|1
2609485|NCT00998985|9022024|P5|Overall Study|Protocol Violation|0
2609486|NCT00998985|9022025|P4|Overall Study|Protocol Violation|0
2609487|NCT00998985|9022026|P3|Overall Study|Protocol Violation|0
2609488|NCT00998985|9022027|P2|Overall Study|Protocol Violation|0
2609489|NCT00998985|9022028|P1|Overall Study|Protocol Violation|0
2609490|NCT00998985|9022015|P14|Overall Study|Withdrawal by Subject|0
2609491|NCT00998985|9022016|P13|Overall Study|Withdrawal by Subject|0
2609492|NCT00998985|9022017|P12|Overall Study|Withdrawal by Subject|0
2609493|NCT00998985|9022018|P11|Overall Study|Withdrawal by Subject|0
2609494|NCT00998985|9022019|P10|Overall Study|Withdrawal by Subject|0
2609495|NCT00998985|9022020|P9|Overall Study|Withdrawal by Subject|1
2609496|NCT00998985|9022021|P8|Overall Study|Withdrawal by Subject|0
2609497|NCT00998985|9022022|P7|Overall Study|Withdrawal by Subject|0
2609498|NCT00998985|9022023|P6|Overall Study|Withdrawal by Subject|0
2609499|NCT00998985|9022024|P5|Overall Study|Withdrawal by Subject|0
2609500|NCT00998985|9022025|P4|Overall Study|Withdrawal by Subject|0
2609501|NCT00998985|9022026|P3|Overall Study|Withdrawal by Subject|0
2609502|NCT00998985|9022027|P2|Overall Study|Withdrawal by Subject|0
2609503|NCT00998985|9022028|P1|Overall Study|Withdrawal by Subject|0
2609504|NCT00998881|9022096|P2|Overall Study|Personal matter|0
2609505|NCT00998881|9022097|P1|Overall Study|Personal matter|1
2609506|NCT00998881|9022096|P2|Overall Study|Withdrawal by Subject|0
2609507|NCT00998881|9022097|P1|Overall Study|Withdrawal by Subject|1
2609508|NCT00998881|9022096|P2|Overall Study|Physician Decision|0
2609509|NCT00998881|9022097|P1|Overall Study|Physician Decision|3
2609510|NCT00998881|9022096|P2|Overall Study|Lack of Efficacy|0
2609511|NCT00998881|9022097|P1|Overall Study|Lack of Efficacy|1
2609512|NCT00998881|9022096|P2|Overall Study|Adverse Event|2
2609513|NCT00998881|9022097|P1|Overall Study|Adverse Event|2
2609514|NCT00998790|9022116|P1|Overall Study|Withdrawal by Subject|21
2609515|NCT00998764|9022126|P2|Overall Study|Recurrent Episode of vasogenic edema|0
2609516|NCT00998764|9022127|P1|Overall Study|Recurrent Episode of vasogenic edema|1
2609517|NCT00998764|9022126|P2|Overall Study|Other|4
2609518|NCT00998764|9022127|P1|Overall Study|Other|4
2609519|NCT00998764|9022126|P2|Overall Study|Loss of Caregiver|3
2609520|NCT00998764|9022127|P1|Overall Study|Loss of Caregiver|0
2609521|NCT00998764|9022126|P2|Overall Study|Lost to Follow-up|1
2609522|NCT00998764|9022127|P1|Overall Study|Lost to Follow-up|1
2609523|NCT00998764|9022126|P2|Overall Study|Failed to Return|1
2609524|NCT00998764|9022127|P1|Overall Study|Failed to Return|1
2609525|NCT00998764|9022126|P2|Overall Study|Protocol Violation|1
2609526|NCT00998764|9022127|P1|Overall Study|Protocol Violation|0
2609527|NCT00998764|9022126|P2|Overall Study|Discontinuation of Study by Sponsor|217
2609528|NCT00998764|9022127|P1|Overall Study|Discontinuation of Study by Sponsor|164
2609529|NCT00998764|9022126|P2|Overall Study|Death|1
2609530|NCT00998764|9022127|P1|Overall Study|Death|3
2609531|NCT00998764|9022126|P2|Overall Study|Physician Decision|3
2609532|NCT00998764|9022127|P1|Overall Study|Physician Decision|3
2609533|NCT00998764|9022126|P2|Overall Study|Withdrawal by Subject|25
2609534|NCT00998764|9022127|P1|Overall Study|Withdrawal by Subject|19
2609535|NCT00998764|9022126|P2|Overall Study|Adverse Event|12
2609536|NCT00998764|9022127|P1|Overall Study|Adverse Event|17
2609537|NCT00998764|9022126|P2|Overall Study|Lack of Efficacy|6
2609538|NCT00998764|9022127|P1|Overall Study|Lack of Efficacy|3
2609539|NCT00998738|9022149|P1|Overall Study|Uknown|1
2609540|NCT00998400|9022217|P2|Overall Study|Logistical problems|0
2609541|NCT00998400|9022218|P1|Overall Study|Logistical problems|1
2609542|NCT00998400|9022217|P2|Overall Study|Lack of interest/motivation|2
2609543|NCT00998400|9022218|P1|Overall Study|Lack of interest/motivation|1
2609544|NCT00998335|9022263|P2|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2
2609545|NCT00998335|9022264|P1|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0
2609546|NCT00998309|9022292|P1|Overall Study|Protocol Violation|4
2609547|NCT00998296|9022359|P11|Overall Study|Reason other than those specified above|0
2609548|NCT00998296|9022360|P10|Overall Study|Reason other than those specified above|1
2609549|NCT00998296|9022361|P9|Overall Study|Reason other than those specified above|0
2609550|NCT00998296|9022362|P8|Overall Study|Reason other than those specified above|0
2609551|NCT00998296|9022363|P7|Overall Study|Reason other than those specified above|0
2609552|NCT00998296|9022364|P6|Overall Study|Reason other than those specified above|0
2609553|NCT00998296|9022365|P5|Overall Study|Reason other than those specified above|0
2609554|NCT00998296|9022366|P4|Overall Study|Reason other than those specified above|0
2609555|NCT00998296|9022367|P3|Overall Study|Reason other than those specified above|0
2609556|NCT00998296|9022368|P2|Overall Study|Reason other than those specified above|0
2609557|NCT00998296|9022369|P1|Overall Study|Reason other than those specified above|0
2609558|NCT00998296|9022359|P11|Overall Study|Refused to continue taking trial med.|0
2609559|NCT00998296|9022360|P10|Overall Study|Refused to continue taking trial med.|2
2609560|NCT00998296|9022361|P9|Overall Study|Refused to continue taking trial med.|0
2609561|NCT00998296|9022362|P8|Overall Study|Refused to continue taking trial med.|0
2609562|NCT00998296|9022363|P7|Overall Study|Refused to continue taking trial med.|0
2609563|NCT00998296|9022364|P6|Overall Study|Refused to continue taking trial med.|0
2609564|NCT00998296|9022365|P5|Overall Study|Refused to continue taking trial med.|0
2609565|NCT00998296|9022366|P4|Overall Study|Refused to continue taking trial med.|0
2609566|NCT00998296|9022367|P3|Overall Study|Refused to continue taking trial med.|0
2609567|NCT00998296|9022368|P2|Overall Study|Refused to continue taking trial med.|0
2609568|NCT00998296|9022369|P1|Overall Study|Refused to continue taking trial med.|0
2609569|NCT00998296|9022359|P11|Overall Study|Other adverse event|2
2609570|NCT00998296|9022360|P10|Overall Study|Other adverse event|1
2609571|NCT00998296|9022361|P9|Overall Study|Other adverse event|0
2609572|NCT00998296|9022362|P8|Overall Study|Other adverse event|0
2609573|NCT00998296|9022363|P7|Overall Study|Other adverse event|0
2609574|NCT00998296|9022364|P6|Overall Study|Other adverse event|0
2609575|NCT00998296|9022365|P5|Overall Study|Other adverse event|1
2609576|NCT00998296|9022366|P4|Overall Study|Other adverse event|0
2609577|NCT00998296|9022367|P3|Overall Study|Other adverse event|0
2609578|NCT00998296|9022368|P2|Overall Study|Other adverse event|0
2609579|NCT00998296|9022369|P1|Overall Study|Other adverse event|0
2609580|NCT00998296|9022359|P11|Overall Study|Dose limiting or dose reducing toxicity|0
2609581|NCT00998296|9022360|P10|Overall Study|Dose limiting or dose reducing toxicity|0
2609582|NCT00998296|9022361|P9|Overall Study|Dose limiting or dose reducing toxicity|2
2609583|NCT00998296|9022362|P8|Overall Study|Dose limiting or dose reducing toxicity|2
2609584|NCT00998296|9022363|P7|Overall Study|Dose limiting or dose reducing toxicity|0
2609585|NCT00998296|9022364|P6|Overall Study|Dose limiting or dose reducing toxicity|0
2609586|NCT00998296|9022365|P5|Overall Study|Dose limiting or dose reducing toxicity|1
2609587|NCT00998296|9022366|P4|Overall Study|Dose limiting or dose reducing toxicity|0
2609588|NCT00998296|9022367|P3|Overall Study|Dose limiting or dose reducing toxicity|0
2609589|NCT00998296|9022368|P2|Overall Study|Dose limiting or dose reducing toxicity|0
2609590|NCT00998296|9022369|P1|Overall Study|Dose limiting or dose reducing toxicity|0
2609591|NCT00998296|9022359|P11|Overall Study|Progressive disease|5
2609592|NCT00998296|9022360|P10|Overall Study|Progressive disease|14
2609593|NCT00998296|9022361|P9|Overall Study|Progressive disease|0
2609594|NCT00998296|9022362|P8|Overall Study|Progressive disease|0
2609595|NCT00998296|9022363|P7|Overall Study|Progressive disease|1
2609596|NCT00998296|9022364|P6|Overall Study|Progressive disease|0
2609597|NCT00998296|9022365|P5|Overall Study|Progressive disease|0
2609598|NCT00998296|9022366|P4|Overall Study|Progressive disease|0
2609599|NCT00998296|9022367|P3|Overall Study|Progressive disease|0
2609600|NCT00998296|9022368|P2|Overall Study|Progressive disease|1
2609601|NCT00998296|9022369|P1|Overall Study|Progressive disease|0
2609602|NCT00997984|9022464|P3|Overall Study|Work schedule|2
2609603|NCT00997984|9022465|P2|Overall Study|Work schedule|0
2609604|NCT00997984|9022466|P1|Overall Study|Work schedule|0
2609605|NCT00997984|9022464|P3|Overall Study|Suicidal ideation|1
2609606|NCT00997984|9022465|P2|Overall Study|Suicidal ideation|0
2609607|NCT00997984|9022466|P1|Overall Study|Suicidal ideation|0
2609608|NCT00997984|9022464|P3|Overall Study|Wrong medication dispensed|0
2609609|NCT00997984|9022465|P2|Overall Study|Wrong medication dispensed|1
2609610|NCT00997984|9022466|P1|Overall Study|Wrong medication dispensed|0
2609611|NCT00997984|9022464|P3|Overall Study|non-compliance|3
2609612|NCT00997984|9022465|P2|Overall Study|non-compliance|2
2609613|NCT00997984|9022466|P1|Overall Study|non-compliance|0
2609614|NCT00997984|9022464|P3|Overall Study|Met exclusion criteria|0
2609615|NCT00997984|9022465|P2|Overall Study|Met exclusion criteria|0
2609616|NCT00997984|9022466|P1|Overall Study|Met exclusion criteria|1
2609617|NCT00997984|9022464|P3|Overall Study|Lack of Efficacy|3
2609618|NCT00997984|9022465|P2|Overall Study|Lack of Efficacy|6
2609619|NCT00997984|9022466|P1|Overall Study|Lack of Efficacy|20
2609620|NCT00997984|9022464|P3|Overall Study|Lost to Follow-up|4
2609621|NCT00997984|9022465|P2|Overall Study|Lost to Follow-up|5
2609622|NCT00997984|9022466|P1|Overall Study|Lost to Follow-up|8
2609623|NCT00997984|9022464|P3|Overall Study|Withdrawal by Subject|5
2609624|NCT00997984|9022465|P2|Overall Study|Withdrawal by Subject|9
2609625|NCT00997984|9022466|P1|Overall Study|Withdrawal by Subject|6
2609626|NCT00997984|9022464|P3|Overall Study|Protocol Violation|0
2609627|NCT00997984|9022465|P2|Overall Study|Protocol Violation|3
2609628|NCT00997984|9022466|P1|Overall Study|Protocol Violation|1
2609629|NCT00997984|9022464|P3|Overall Study|Adverse Event|8
2609630|NCT00997984|9022465|P2|Overall Study|Adverse Event|8
2609631|NCT00997984|9022466|P1|Overall Study|Adverse Event|1
2609632|NCT00997503|9022624|P1|Overall Study|Other reason|13
2609633|NCT00997503|9022624|P1|Overall Study|Missed 12-month follow-up|85
2609634|NCT00997503|9022624|P1|Overall Study|Physician Decision|10
2609635|NCT00997503|9022624|P1|Overall Study|Adverse Event|3
2609636|NCT00997503|9022624|P1|Overall Study|Lost to Follow-up|33
2609637|NCT00997503|9022624|P1|Overall Study|Withdrawal by Subject|76
2609638|NCT00997503|9022624|P1|Overall Study|Death|53
2609639|NCT00997438|9022667|P3|Overall Study|Exclusion criteria at visit 1|3
2609640|NCT00997438|9022668|P2|Overall Study|Exclusion criteria at visit 1|2
2609641|NCT00997438|9022669|P1|Overall Study|Exclusion criteria at visit 1|2
2609642|NCT00997438|9022667|P3|Overall Study|Withdrawal by Subject|0
2609643|NCT00997438|9022668|P2|Overall Study|Withdrawal by Subject|1
2609644|NCT00997438|9022669|P1|Overall Study|Withdrawal by Subject|1
2609645|NCT00997438|9022667|P3|Overall Study|Blood draw difficulty|1
2609646|NCT00997438|9022668|P2|Overall Study|Blood draw difficulty|0
2609647|NCT00997438|9022669|P1|Overall Study|Blood draw difficulty|2
2609648|NCT00997386|9022709|P1|Overall Study|Death|7
2609649|NCT00997373|9022718|P2|Overall Study|could not have hysterectomy|0
2609650|NCT00997373|9022719|P1|Overall Study|could not have hysterectomy|6
2609651|NCT00997373|9022718|P2|Overall Study|wrong tumor type|0
2609652|NCT00997373|9022719|P1|Overall Study|wrong tumor type|4
2609653|NCT00997373|9022718|P2|Overall Study|Withdrawal by Subject|0
2609654|NCT00997373|9022719|P1|Overall Study|Withdrawal by Subject|5
2609655|NCT00997334|9022725|P1|Overall Study|Ineligible|1
2609656|NCT00997334|9022725|P1|Overall Study|No lesion amenable|1
2609657|NCT00997334|9022725|P1|Overall Study|Urgent Palliative Care|2
2609658|NCT00997334|9022725|P1|Overall Study|Death|2
2609659|NCT00997334|9022725|P1|Overall Study|Withdrawal by Subject|3
2609660|NCT00997334|9022725|P1|Overall Study|Patient non-compliance|1
2609661|NCT00997334|9022725|P1|Overall Study|Adverse Event|3
2609662|NCT00997334|9022725|P1|Overall Study|still on therapy|12
2609663|NCT00997321|9022734|P2|Overall Study|did not undergo sedation after enrollmen|3
2609664|NCT00997321|9022735|P1|Overall Study|did not undergo sedation after enrollmen|0
2609665|NCT00997243|9022747|P1|Overall Study|Early termination of study by sponsor|7
2609666|NCT00997126|9022779|P2|Overall Study|Physician Decision|11
2609667|NCT00997126|9022780|P1|Overall Study|Physician Decision|7
2609668|NCT00997035|9022809|P2|3-month Follow-up Visit|Lost to Follow-up|6
2609669|NCT00997035|9022810|P1|3-month Follow-up Visit|Lost to Follow-up|12
2609670|NCT00997035|9022809|P2|3-week Followup Visit|Lost to Follow-up|6
2609671|NCT00997035|9022810|P1|3-week Followup Visit|Lost to Follow-up|9
2609672|NCT00996996|9022834|P1|Overall Study|Did Not Receive Study Medications|1
2609673|NCT00996996|9022834|P1|Overall Study|Death|5
2609674|NCT00996996|9022834|P1|Overall Study|Lost to Follow-up|9
2609675|NCT00996996|9022834|P1|Overall Study|Non-compliance|8
2609676|NCT00996996|9022834|P1|Overall Study|Progressive Disease|10
2609677|NCT00996944|9022868|P2|Long-term Treatment Period|Study Closed/Terminated|5
2609678|NCT00996944|9022869|P1|Long-term Treatment Period|Study Closed/Terminated|12
2609679|NCT00996944|9022868|P2|Double-blind Treatment Period|Withdrawal by Subject|1
2609680|NCT00996944|9022869|P1|Double-blind Treatment Period|Withdrawal by Subject|1
2609681|NCT00996944|9022868|P2|Double-blind Treatment Period|Study Closed/Terminated|5
2609682|NCT00996944|9022869|P1|Double-blind Treatment Period|Study Closed/Terminated|6
2609683|NCT00996944|9022868|P2|Double-blind Treatment Period|Protocol Violation|0
2609684|NCT00996944|9022869|P1|Double-blind Treatment Period|Protocol Violation|1
2609685|NCT00996944|9022868|P2|Double-blind Treatment Period|Adverse Event|1
2609686|NCT00996944|9022869|P1|Double-blind Treatment Period|Adverse Event|2
2609687|NCT00996918|9022921|P5|Overall Study|Other|0
2609688|NCT00996918|9022922|P4|Overall Study|Other|0
2609689|NCT00996918|9022923|P3|Overall Study|Other|0
2609690|NCT00996918|9022924|P2|Overall Study|Other|1
2609691|NCT00996918|9022925|P1|Overall Study|Other|3
2609692|NCT00996918|9022921|P5|Overall Study|Loss of Caregiver|0
2609693|NCT00996918|9022922|P4|Overall Study|Loss of Caregiver|0
2609694|NCT00996918|9022923|P3|Overall Study|Loss of Caregiver|0
2609695|NCT00996918|9022924|P2|Overall Study|Loss of Caregiver|1
2609696|NCT00996918|9022925|P1|Overall Study|Loss of Caregiver|0
2609697|NCT00996918|9022921|P5|Overall Study|Discontinuation of Study by Sponsor|2
2609698|NCT00996918|9022922|P4|Overall Study|Discontinuation of Study by Sponsor|45
2609699|NCT00996918|9022923|P3|Overall Study|Discontinuation of Study by Sponsor|30
2609700|NCT00996918|9022924|P2|Overall Study|Discontinuation of Study by Sponsor|54
2609701|NCT00996918|9022925|P1|Overall Study|Discontinuation of Study by Sponsor|31
2609702|NCT00996918|9022921|P5|Overall Study|Physician Decision|0
2609703|NCT00996918|9022922|P4|Overall Study|Physician Decision|0
2609704|NCT00996918|9022923|P3|Overall Study|Physician Decision|0
2609705|NCT00996918|9022924|P2|Overall Study|Physician Decision|0
2609706|NCT00996918|9022925|P1|Overall Study|Physician Decision|1
2609707|NCT00996918|9022921|P5|Overall Study|Withdrawal by Subject|2
2609708|NCT00996918|9022922|P4|Overall Study|Withdrawal by Subject|3
2609709|NCT00996918|9022923|P3|Overall Study|Withdrawal by Subject|3
2609710|NCT00996918|9022924|P2|Overall Study|Withdrawal by Subject|4
2609711|NCT00996918|9022925|P1|Overall Study|Withdrawal by Subject|1
2609712|NCT00996918|9022921|P5|Overall Study|Adverse Event|0
2609713|NCT00996918|9022922|P4|Overall Study|Adverse Event|6
2609714|NCT00996918|9022923|P3|Overall Study|Adverse Event|2
2609715|NCT00996918|9022924|P2|Overall Study|Adverse Event|5
2609716|NCT00996918|9022925|P1|Overall Study|Adverse Event|2
2609717|NCT00996918|9022921|P5|Overall Study|Lack of Efficacy|0
2609718|NCT00996918|9022922|P4|Overall Study|Lack of Efficacy|2
2609719|NCT00996918|9022923|P3|Overall Study|Lack of Efficacy|2
2609720|NCT00996918|9022924|P2|Overall Study|Lack of Efficacy|1
2609721|NCT00996918|9022925|P1|Overall Study|Lack of Efficacy|1
2609722|NCT00996892|9022969|P20|Expansion Stage 2A|Disease Progression|31
2609723|NCT00996892|9022970|P19|Expansion Stage 2A|Disease Progression|0
2609724|NCT00996892|9022971|P18|Expansion Stage 2A|Disease Progression|0
2609725|NCT00996892|9022972|P17|Expansion Stage 2A|Disease Progression|0
2609726|NCT00996892|9022973|P16|Expansion Stage 2A|Disease Progression|0
2609727|NCT00996892|9022974|P15|Expansion Stage 2A|Disease Progression|0
2609728|NCT00996892|9022975|P14|Expansion Stage 2A|Disease Progression|0
2609729|NCT00996892|9022976|P13|Expansion Stage 2A|Disease Progression|0
2609730|NCT00996892|9022977|P12|Expansion Stage 2A|Disease Progression|0
2609731|NCT00996892|9022978|P11|Expansion Stage 2A|Disease Progression|0
2609732|NCT00996892|9022979|P10|Expansion Stage 2A|Disease Progression|0
2609733|NCT00996892|9022980|P9|Expansion Stage 2A|Disease Progression|0
2609734|NCT00996892|9022981|P8|Expansion Stage 2A|Disease Progression|0
2609735|NCT00996892|9022982|P7|Expansion Stage 2A|Disease Progression|0
2609736|NCT00996892|9022983|P6|Expansion Stage 2A|Disease Progression|0
2609737|NCT00996892|9022984|P5|Expansion Stage 2A|Disease Progression|0
2609738|NCT00996892|9022985|P4|Expansion Stage 2A|Disease Progression|0
2609739|NCT00996892|9022986|P3|Expansion Stage 2A|Disease Progression|0
2609740|NCT00996892|9022987|P2|Expansion Stage 2A|Disease Progression|0
2609741|NCT00996892|9022988|P1|Expansion Stage 2A|Disease Progression|0
2609742|NCT00996892|9022969|P20|Expansion Stage 2A|Withdrawal by Subject|4
2609743|NCT00996892|9022970|P19|Expansion Stage 2A|Withdrawal by Subject|0
2609744|NCT00996892|9022971|P18|Expansion Stage 2A|Withdrawal by Subject|0
2609745|NCT00996892|9022972|P17|Expansion Stage 2A|Withdrawal by Subject|0
2609746|NCT00996892|9022973|P16|Expansion Stage 2A|Withdrawal by Subject|0
2609747|NCT00996892|9022974|P15|Expansion Stage 2A|Withdrawal by Subject|0
2609748|NCT00996892|9022975|P14|Expansion Stage 2A|Withdrawal by Subject|0
2609749|NCT00996892|9022976|P13|Expansion Stage 2A|Withdrawal by Subject|0
2609750|NCT00996892|9022977|P12|Expansion Stage 2A|Withdrawal by Subject|0
2609751|NCT00996892|9022978|P11|Expansion Stage 2A|Withdrawal by Subject|0
2609752|NCT00996892|9022979|P10|Expansion Stage 2A|Withdrawal by Subject|0
2609753|NCT00996892|9022980|P9|Expansion Stage 2A|Withdrawal by Subject|0
2609754|NCT00996892|9022981|P8|Expansion Stage 2A|Withdrawal by Subject|0
2609755|NCT00996892|9022982|P7|Expansion Stage 2A|Withdrawal by Subject|0
2609756|NCT00996892|9022983|P6|Expansion Stage 2A|Withdrawal by Subject|0
2609757|NCT00996892|9022984|P5|Expansion Stage 2A|Withdrawal by Subject|0
2609758|NCT00996892|9022985|P4|Expansion Stage 2A|Withdrawal by Subject|0
2609759|NCT00996892|9022986|P3|Expansion Stage 2A|Withdrawal by Subject|0
2609760|NCT00996892|9022987|P2|Expansion Stage 2A|Withdrawal by Subject|0
2609761|NCT00996892|9022988|P1|Expansion Stage 2A|Withdrawal by Subject|0
2609762|NCT00996892|9022969|P20|Expansion Stage 2A|Physician Decision|2
2609763|NCT00996892|9022970|P19|Expansion Stage 2A|Physician Decision|0
2609764|NCT00996892|9022971|P18|Expansion Stage 2A|Physician Decision|0
2609765|NCT00996892|9022972|P17|Expansion Stage 2A|Physician Decision|0
2609766|NCT00996892|9022973|P16|Expansion Stage 2A|Physician Decision|0
2609767|NCT00996892|9022974|P15|Expansion Stage 2A|Physician Decision|0
2609768|NCT00996892|9022975|P14|Expansion Stage 2A|Physician Decision|0
2609769|NCT00996892|9022976|P13|Expansion Stage 2A|Physician Decision|0
2609770|NCT00996892|9022977|P12|Expansion Stage 2A|Physician Decision|0
2609771|NCT00996892|9022978|P11|Expansion Stage 2A|Physician Decision|0
2609772|NCT00996892|9022979|P10|Expansion Stage 2A|Physician Decision|0
2609773|NCT00996892|9022980|P9|Expansion Stage 2A|Physician Decision|0
2609774|NCT00996892|9022981|P8|Expansion Stage 2A|Physician Decision|0
2609775|NCT00996892|9022982|P7|Expansion Stage 2A|Physician Decision|0
2609776|NCT00996892|9022983|P6|Expansion Stage 2A|Physician Decision|0
2609777|NCT00996892|9022984|P5|Expansion Stage 2A|Physician Decision|0
2609778|NCT00996892|9022985|P4|Expansion Stage 2A|Physician Decision|0
2609779|NCT00996892|9022986|P3|Expansion Stage 2A|Physician Decision|0
2609780|NCT00996892|9022987|P2|Expansion Stage 2A|Physician Decision|0
2609781|NCT00996892|9022988|P1|Expansion Stage 2A|Physician Decision|0
2609782|NCT00996892|9022969|P20|Expansion Stage 2A|Adverse Event|8
2609783|NCT00996892|9022970|P19|Expansion Stage 2A|Adverse Event|0
2609784|NCT00996892|9022971|P18|Expansion Stage 2A|Adverse Event|0
2609785|NCT00996892|9022972|P17|Expansion Stage 2A|Adverse Event|0
2609786|NCT00996892|9022973|P16|Expansion Stage 2A|Adverse Event|0
2609787|NCT00996892|9022974|P15|Expansion Stage 2A|Adverse Event|0
2609788|NCT00996892|9022975|P14|Expansion Stage 2A|Adverse Event|0
2609789|NCT00996892|9022976|P13|Expansion Stage 2A|Adverse Event|0
2609790|NCT00996892|9022977|P12|Expansion Stage 2A|Adverse Event|0
2609791|NCT00996892|9022978|P11|Expansion Stage 2A|Adverse Event|0
2609792|NCT00996892|9022979|P10|Expansion Stage 2A|Adverse Event|0
2609793|NCT00996892|9022980|P9|Expansion Stage 2A|Adverse Event|0
2609794|NCT00996892|9022981|P8|Expansion Stage 2A|Adverse Event|0
2609795|NCT00996892|9022982|P7|Expansion Stage 2A|Adverse Event|0
2609796|NCT00996892|9022983|P6|Expansion Stage 2A|Adverse Event|0
2609797|NCT00996892|9022984|P5|Expansion Stage 2A|Adverse Event|0
2609798|NCT00996892|9022985|P4|Expansion Stage 2A|Adverse Event|0
2609799|NCT00996892|9022986|P3|Expansion Stage 2A|Adverse Event|0
2609800|NCT00996892|9022987|P2|Expansion Stage 2A|Adverse Event|0
2609801|NCT00996892|9022988|P1|Expansion Stage 2A|Adverse Event|0
2609802|NCT00996892|9022969|P20|Expansion Stage 2|Disease Progression|0
2609803|NCT00996892|9022970|P19|Expansion Stage 2|Disease Progression|28
2609804|NCT00996892|9022971|P18|Expansion Stage 2|Disease Progression|0
2609805|NCT00996892|9022972|P17|Expansion Stage 2|Disease Progression|0
2609806|NCT00996892|9022973|P16|Expansion Stage 2|Disease Progression|0
2609807|NCT00996892|9022974|P15|Expansion Stage 2|Disease Progression|0
2609808|NCT00996892|9022975|P14|Expansion Stage 2|Disease Progression|0
2609809|NCT00996892|9022976|P13|Expansion Stage 2|Disease Progression|0
2609810|NCT00996892|9022977|P12|Expansion Stage 2|Disease Progression|0
2609811|NCT00996892|9022978|P11|Expansion Stage 2|Disease Progression|0
2609812|NCT00996892|9022979|P10|Expansion Stage 2|Disease Progression|0
2609813|NCT00996892|9022980|P9|Expansion Stage 2|Disease Progression|0
2609814|NCT00996892|9022981|P8|Expansion Stage 2|Disease Progression|0
2609815|NCT00996892|9022982|P7|Expansion Stage 2|Disease Progression|0
2609816|NCT00996892|9022983|P6|Expansion Stage 2|Disease Progression|0
2609817|NCT00996892|9022984|P5|Expansion Stage 2|Disease Progression|0
2609818|NCT00996892|9022985|P4|Expansion Stage 2|Disease Progression|0
2609819|NCT00996892|9022986|P3|Expansion Stage 2|Disease Progression|0
2609820|NCT00996892|9022987|P2|Expansion Stage 2|Disease Progression|0
2609821|NCT00996892|9022988|P1|Expansion Stage 2|Disease Progression|0
2609822|NCT00996892|9022969|P20|Expansion Stage 2|Withdrawal by Subject|0
2609823|NCT00996892|9022970|P19|Expansion Stage 2|Withdrawal by Subject|1
2609824|NCT00996892|9022971|P18|Expansion Stage 2|Withdrawal by Subject|0
2609825|NCT00996892|9022972|P17|Expansion Stage 2|Withdrawal by Subject|0
2609826|NCT00996892|9022973|P16|Expansion Stage 2|Withdrawal by Subject|0
2609827|NCT00996892|9022974|P15|Expansion Stage 2|Withdrawal by Subject|0
2609828|NCT00996892|9022975|P14|Expansion Stage 2|Withdrawal by Subject|0
2609829|NCT00996892|9022976|P13|Expansion Stage 2|Withdrawal by Subject|0
2609830|NCT00996892|9022977|P12|Expansion Stage 2|Withdrawal by Subject|0
2609831|NCT00996892|9022978|P11|Expansion Stage 2|Withdrawal by Subject|0
2609832|NCT00996892|9022979|P10|Expansion Stage 2|Withdrawal by Subject|0
2609833|NCT00996892|9022980|P9|Expansion Stage 2|Withdrawal by Subject|0
2609834|NCT00996892|9022981|P8|Expansion Stage 2|Withdrawal by Subject|0
2609835|NCT00996892|9022982|P7|Expansion Stage 2|Withdrawal by Subject|0
2609836|NCT00996892|9022983|P6|Expansion Stage 2|Withdrawal by Subject|0
2609837|NCT00996892|9022984|P5|Expansion Stage 2|Withdrawal by Subject|0
2609838|NCT00996892|9022985|P4|Expansion Stage 2|Withdrawal by Subject|0
2609839|NCT00996892|9022986|P3|Expansion Stage 2|Withdrawal by Subject|0
2609840|NCT00996892|9022987|P2|Expansion Stage 2|Withdrawal by Subject|0
2609841|NCT00996892|9022988|P1|Expansion Stage 2|Withdrawal by Subject|0
2609842|NCT00996892|9022969|P20|Expansion Stage 2|Physician Decision|0
2609843|NCT00996892|9022970|P19|Expansion Stage 2|Physician Decision|1
2609844|NCT00996892|9022971|P18|Expansion Stage 2|Physician Decision|0
2609845|NCT00996892|9022972|P17|Expansion Stage 2|Physician Decision|0
2609846|NCT00996892|9022973|P16|Expansion Stage 2|Physician Decision|0
2609847|NCT00996892|9022974|P15|Expansion Stage 2|Physician Decision|0
2609848|NCT00996892|9022975|P14|Expansion Stage 2|Physician Decision|0
2609849|NCT00996892|9022976|P13|Expansion Stage 2|Physician Decision|0
2609850|NCT00996892|9022977|P12|Expansion Stage 2|Physician Decision|0
2609851|NCT00996892|9022978|P11|Expansion Stage 2|Physician Decision|0
2609852|NCT00996892|9022979|P10|Expansion Stage 2|Physician Decision|0
2609853|NCT00996892|9022980|P9|Expansion Stage 2|Physician Decision|0
2609854|NCT00996892|9022981|P8|Expansion Stage 2|Physician Decision|0
2609855|NCT00996892|9022982|P7|Expansion Stage 2|Physician Decision|0
2609856|NCT00996892|9022983|P6|Expansion Stage 2|Physician Decision|0
2609857|NCT00996892|9022984|P5|Expansion Stage 2|Physician Decision|0
2609858|NCT00996892|9022985|P4|Expansion Stage 2|Physician Decision|0
2609859|NCT00996892|9022986|P3|Expansion Stage 2|Physician Decision|0
2609860|NCT00996892|9022987|P2|Expansion Stage 2|Physician Decision|0
2609861|NCT00996892|9022988|P1|Expansion Stage 2|Physician Decision|0
2609862|NCT00996892|9022969|P20|Expansion Stage 2|Death|0
2609863|NCT00996892|9022970|P19|Expansion Stage 2|Death|2
2609864|NCT00996892|9022971|P18|Expansion Stage 2|Death|0
2609865|NCT00996892|9022972|P17|Expansion Stage 2|Death|0
2609866|NCT00996892|9022973|P16|Expansion Stage 2|Death|0
2609867|NCT00996892|9022974|P15|Expansion Stage 2|Death|0
2609868|NCT00996892|9022975|P14|Expansion Stage 2|Death|0
2609869|NCT00996892|9022976|P13|Expansion Stage 2|Death|0
2609870|NCT00996892|9022977|P12|Expansion Stage 2|Death|0
2609871|NCT00996892|9022978|P11|Expansion Stage 2|Death|0
2609872|NCT00996892|9022979|P10|Expansion Stage 2|Death|0
2609873|NCT00996892|9022980|P9|Expansion Stage 2|Death|0
2609874|NCT00996892|9022981|P8|Expansion Stage 2|Death|0
2609875|NCT00996892|9022982|P7|Expansion Stage 2|Death|0
2609876|NCT00996892|9022983|P6|Expansion Stage 2|Death|0
2609877|NCT00996892|9022984|P5|Expansion Stage 2|Death|0
2609878|NCT00996892|9022985|P4|Expansion Stage 2|Death|0
2609879|NCT00996892|9022986|P3|Expansion Stage 2|Death|0
2609880|NCT00996892|9022987|P2|Expansion Stage 2|Death|0
2609881|NCT00996892|9022988|P1|Expansion Stage 2|Death|0
2609882|NCT00996892|9022969|P20|Expansion Stage 2|Adverse Event|0
2609883|NCT00996892|9022970|P19|Expansion Stage 2|Adverse Event|3
2609884|NCT00996892|9022971|P18|Expansion Stage 2|Adverse Event|0
2609885|NCT00996892|9022972|P17|Expansion Stage 2|Adverse Event|0
2609886|NCT00996892|9022973|P16|Expansion Stage 2|Adverse Event|0
2609887|NCT00996892|9022974|P15|Expansion Stage 2|Adverse Event|0
2609888|NCT00996892|9022975|P14|Expansion Stage 2|Adverse Event|0
2609889|NCT00996892|9022976|P13|Expansion Stage 2|Adverse Event|0
2609890|NCT00996892|9022977|P12|Expansion Stage 2|Adverse Event|0
2609891|NCT00996892|9022978|P11|Expansion Stage 2|Adverse Event|0
2609892|NCT00996892|9022979|P10|Expansion Stage 2|Adverse Event|0
2609893|NCT00996892|9022980|P9|Expansion Stage 2|Adverse Event|0
2609894|NCT00996892|9022981|P8|Expansion Stage 2|Adverse Event|0
2609895|NCT00996892|9022982|P7|Expansion Stage 2|Adverse Event|0
2609896|NCT00996892|9022983|P6|Expansion Stage 2|Adverse Event|0
2609897|NCT00996892|9022984|P5|Expansion Stage 2|Adverse Event|0
2609898|NCT00996892|9022985|P4|Expansion Stage 2|Adverse Event|0
2609899|NCT00996892|9022986|P3|Expansion Stage 2|Adverse Event|0
2609900|NCT00996892|9022987|P2|Expansion Stage 2|Adverse Event|0
2609901|NCT00996892|9022988|P1|Expansion Stage 2|Adverse Event|0
2609902|NCT00996892|9022969|P20|Dose-Escalation Stage 1B|Disease Progression|0
2609903|NCT00996892|9022970|P19|Dose-Escalation Stage 1B|Disease Progression|0
2609904|NCT00996892|9022971|P18|Dose-Escalation Stage 1B|Disease Progression|3
2609905|NCT00996892|9022972|P17|Dose-Escalation Stage 1B|Disease Progression|3
2609906|NCT00996892|9022973|P16|Dose-Escalation Stage 1B|Disease Progression|3
2609907|NCT00996892|9022974|P15|Dose-Escalation Stage 1B|Disease Progression|4
2609908|NCT00996892|9022975|P14|Dose-Escalation Stage 1B|Disease Progression|0
2609909|NCT00996892|9022976|P13|Dose-Escalation Stage 1B|Disease Progression|0
2609910|NCT00996892|9022977|P12|Dose-Escalation Stage 1B|Disease Progression|0
2609911|NCT00996892|9022978|P11|Dose-Escalation Stage 1B|Disease Progression|0
2609912|NCT00996892|9022979|P10|Dose-Escalation Stage 1B|Disease Progression|0
2609913|NCT00996892|9022980|P9|Dose-Escalation Stage 1B|Disease Progression|0
2609914|NCT00996892|9022981|P8|Dose-Escalation Stage 1B|Disease Progression|0
2609915|NCT00996892|9022982|P7|Dose-Escalation Stage 1B|Disease Progression|0
2609916|NCT00996892|9022983|P6|Dose-Escalation Stage 1B|Disease Progression|0
2609917|NCT00996892|9022984|P5|Dose-Escalation Stage 1B|Disease Progression|0
2609918|NCT00996892|9022985|P4|Dose-Escalation Stage 1B|Disease Progression|0
2609919|NCT00996892|9022986|P3|Dose-Escalation Stage 1B|Disease Progression|0
2609920|NCT00996892|9022987|P2|Dose-Escalation Stage 1B|Disease Progression|0
2609921|NCT00996892|9022988|P1|Dose-Escalation Stage 1B|Disease Progression|0
2609922|NCT00996892|9022969|P20|Dose-Escalation Stage 1B|Physician Decision|0
2609923|NCT00996892|9022970|P19|Dose-Escalation Stage 1B|Physician Decision|0
2609924|NCT00996892|9022971|P18|Dose-Escalation Stage 1B|Physician Decision|2
2609925|NCT00996892|9022972|P17|Dose-Escalation Stage 1B|Physician Decision|0
2609926|NCT00996892|9022973|P16|Dose-Escalation Stage 1B|Physician Decision|0
2609927|NCT00996892|9022974|P15|Dose-Escalation Stage 1B|Physician Decision|0
2609928|NCT00996892|9022975|P14|Dose-Escalation Stage 1B|Physician Decision|0
2609929|NCT00996892|9022976|P13|Dose-Escalation Stage 1B|Physician Decision|0
2609930|NCT00996892|9022977|P12|Dose-Escalation Stage 1B|Physician Decision|0
2609931|NCT00996892|9022978|P11|Dose-Escalation Stage 1B|Physician Decision|0
2609932|NCT00996892|9022979|P10|Dose-Escalation Stage 1B|Physician Decision|0
2609933|NCT00996892|9022980|P9|Dose-Escalation Stage 1B|Physician Decision|0
2609934|NCT00996892|9022981|P8|Dose-Escalation Stage 1B|Physician Decision|0
2609935|NCT00996892|9022982|P7|Dose-Escalation Stage 1B|Physician Decision|0
2609936|NCT00996892|9022983|P6|Dose-Escalation Stage 1B|Physician Decision|0
2609937|NCT00996892|9022984|P5|Dose-Escalation Stage 1B|Physician Decision|0
2609938|NCT00996892|9022985|P4|Dose-Escalation Stage 1B|Physician Decision|0
2609939|NCT00996892|9022986|P3|Dose-Escalation Stage 1B|Physician Decision|0
2609940|NCT00996892|9022987|P2|Dose-Escalation Stage 1B|Physician Decision|0
2609941|NCT00996892|9022988|P1|Dose-Escalation Stage 1B|Physician Decision|0
2609942|NCT00996892|9022969|P20|Dose-Escalation Stage 1A|Disease Progression|0
2609943|NCT00996892|9022970|P19|Dose-Escalation Stage 1A|Disease Progression|0
2609944|NCT00996892|9022971|P18|Dose-Escalation Stage 1A|Disease Progression|0
2609945|NCT00996892|9022972|P17|Dose-Escalation Stage 1A|Disease Progression|0
2609946|NCT00996892|9022973|P16|Dose-Escalation Stage 1A|Disease Progression|0
2609947|NCT00996892|9022974|P15|Dose-Escalation Stage 1A|Disease Progression|0
2609948|NCT00996892|9022975|P14|Dose-Escalation Stage 1A|Disease Progression|4
2609949|NCT00996892|9022976|P13|Dose-Escalation Stage 1A|Disease Progression|6
2609950|NCT00996892|9022977|P12|Dose-Escalation Stage 1A|Disease Progression|7
2609951|NCT00996892|9022978|P11|Dose-Escalation Stage 1A|Disease Progression|5
2609952|NCT00996892|9022979|P10|Dose-Escalation Stage 1A|Disease Progression|1
2609953|NCT00996892|9022980|P9|Dose-Escalation Stage 1A|Disease Progression|3
2609954|NCT00996892|9022981|P8|Dose-Escalation Stage 1A|Disease Progression|2
2609955|NCT00996892|9022982|P7|Dose-Escalation Stage 1A|Disease Progression|0
2609956|NCT00996892|9022983|P6|Dose-Escalation Stage 1A|Disease Progression|0
2609957|NCT00996892|9022984|P5|Dose-Escalation Stage 1A|Disease Progression|0
2609958|NCT00996892|9022985|P4|Dose-Escalation Stage 1A|Disease Progression|0
2609959|NCT00996892|9022986|P3|Dose-Escalation Stage 1A|Disease Progression|0
2609960|NCT00996892|9022987|P2|Dose-Escalation Stage 1A|Disease Progression|0
2609961|NCT00996892|9022988|P1|Dose-Escalation Stage 1A|Disease Progression|0
2609962|NCT00996892|9022969|P20|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2609963|NCT00996892|9022970|P19|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2609964|NCT00996892|9022971|P18|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2609965|NCT00996892|9022972|P17|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2609966|NCT00996892|9022973|P16|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2609967|NCT00996892|9022974|P15|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2609968|NCT00996892|9022975|P14|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2609969|NCT00996892|9022976|P13|Dose-Escalation Stage 1A|Withdrawal by Subject|1
2609970|NCT00996892|9022977|P12|Dose-Escalation Stage 1A|Withdrawal by Subject|1
2609971|NCT00996892|9022978|P11|Dose-Escalation Stage 1A|Withdrawal by Subject|1
2609972|NCT00996892|9022979|P10|Dose-Escalation Stage 1A|Withdrawal by Subject|1
2609973|NCT00996892|9022980|P9|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2609974|NCT00996892|9022981|P8|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2609975|NCT00996892|9022982|P7|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2609976|NCT00996892|9022983|P6|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2609977|NCT00996892|9022984|P5|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2609978|NCT00996892|9022985|P4|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2609979|NCT00996892|9022986|P3|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2609980|NCT00996892|9022987|P2|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2609981|NCT00996892|9022988|P1|Dose-Escalation Stage 1A|Withdrawal by Subject|0
2609982|NCT00996892|9022969|P20|Dose-Escalation Stage 1A|Physician Decision|0
2609983|NCT00996892|9022970|P19|Dose-Escalation Stage 1A|Physician Decision|0
2609984|NCT00996892|9022971|P18|Dose-Escalation Stage 1A|Physician Decision|0
2609985|NCT00996892|9022972|P17|Dose-Escalation Stage 1A|Physician Decision|0
2609986|NCT00996892|9022973|P16|Dose-Escalation Stage 1A|Physician Decision|0
2609987|NCT00996892|9022974|P15|Dose-Escalation Stage 1A|Physician Decision|0
2609988|NCT00996892|9022975|P14|Dose-Escalation Stage 1A|Physician Decision|0
2609989|NCT00996892|9022976|P13|Dose-Escalation Stage 1A|Physician Decision|0
2609990|NCT00996892|9022977|P12|Dose-Escalation Stage 1A|Physician Decision|0
2609991|NCT00996892|9022978|P11|Dose-Escalation Stage 1A|Physician Decision|0
2609992|NCT00996892|9022979|P10|Dose-Escalation Stage 1A|Physician Decision|0
2609993|NCT00996892|9022980|P9|Dose-Escalation Stage 1A|Physician Decision|0
2609994|NCT00996892|9022981|P8|Dose-Escalation Stage 1A|Physician Decision|1
2609995|NCT00996892|9022982|P7|Dose-Escalation Stage 1A|Physician Decision|0
2609996|NCT00996892|9022983|P6|Dose-Escalation Stage 1A|Physician Decision|0
2609997|NCT00996892|9022984|P5|Dose-Escalation Stage 1A|Physician Decision|0
2609998|NCT00996892|9022985|P4|Dose-Escalation Stage 1A|Physician Decision|0
2609999|NCT00996892|9022986|P3|Dose-Escalation Stage 1A|Physician Decision|0
2610000|NCT00996892|9022987|P2|Dose-Escalation Stage 1A|Physician Decision|0
2610001|NCT00996892|9022988|P1|Dose-Escalation Stage 1A|Physician Decision|0
2610002|NCT00996892|9022969|P20|Dose-Escalation Stage 1A|Death|0
2610003|NCT00996892|9022970|P19|Dose-Escalation Stage 1A|Death|0
2610004|NCT00996892|9022971|P18|Dose-Escalation Stage 1A|Death|0
2610005|NCT00996892|9022972|P17|Dose-Escalation Stage 1A|Death|0
2610006|NCT00996892|9022973|P16|Dose-Escalation Stage 1A|Death|0
2610007|NCT00996892|9022974|P15|Dose-Escalation Stage 1A|Death|0
2610008|NCT00996892|9022975|P14|Dose-Escalation Stage 1A|Death|0
2610009|NCT00996892|9022976|P13|Dose-Escalation Stage 1A|Death|1
2610010|NCT00996892|9022977|P12|Dose-Escalation Stage 1A|Death|1
2610011|NCT00996892|9022978|P11|Dose-Escalation Stage 1A|Death|0
2610012|NCT00996892|9022979|P10|Dose-Escalation Stage 1A|Death|2
2610013|NCT00996892|9022980|P9|Dose-Escalation Stage 1A|Death|0
2610014|NCT00996892|9022981|P8|Dose-Escalation Stage 1A|Death|0
2610015|NCT00996892|9022982|P7|Dose-Escalation Stage 1A|Death|0
2610016|NCT00996892|9022983|P6|Dose-Escalation Stage 1A|Death|0
2610017|NCT00996892|9022984|P5|Dose-Escalation Stage 1A|Death|0
2610018|NCT00996892|9022985|P4|Dose-Escalation Stage 1A|Death|0
2610019|NCT00996892|9022986|P3|Dose-Escalation Stage 1A|Death|0
2610020|NCT00996892|9022987|P2|Dose-Escalation Stage 1A|Death|0
2610021|NCT00996892|9022988|P1|Dose-Escalation Stage 1A|Death|0
2610022|NCT00996892|9022969|P20|Dose-Escalation Stage 1A|Adverse Event|0
2610023|NCT00996892|9022970|P19|Dose-Escalation Stage 1A|Adverse Event|0
2610024|NCT00996892|9022971|P18|Dose-Escalation Stage 1A|Adverse Event|0
2610025|NCT00996892|9022972|P17|Dose-Escalation Stage 1A|Adverse Event|0
2610026|NCT00996892|9022973|P16|Dose-Escalation Stage 1A|Adverse Event|0
2610027|NCT00996892|9022974|P15|Dose-Escalation Stage 1A|Adverse Event|0
2610028|NCT00996892|9022975|P14|Dose-Escalation Stage 1A|Adverse Event|1
2610029|NCT00996892|9022976|P13|Dose-Escalation Stage 1A|Adverse Event|0
2610030|NCT00996892|9022977|P12|Dose-Escalation Stage 1A|Adverse Event|0
2610031|NCT00996892|9022978|P11|Dose-Escalation Stage 1A|Adverse Event|1
2610032|NCT00996892|9022979|P10|Dose-Escalation Stage 1A|Adverse Event|0
2610033|NCT00996892|9022980|P9|Dose-Escalation Stage 1A|Adverse Event|0
2610034|NCT00996892|9022981|P8|Dose-Escalation Stage 1A|Adverse Event|0
2610035|NCT00996892|9022982|P7|Dose-Escalation Stage 1A|Adverse Event|0
2610036|NCT00996892|9022983|P6|Dose-Escalation Stage 1A|Adverse Event|0
2610037|NCT00996892|9022984|P5|Dose-Escalation Stage 1A|Adverse Event|0
2610038|NCT00996892|9022985|P4|Dose-Escalation Stage 1A|Adverse Event|0
2610039|NCT00996892|9022986|P3|Dose-Escalation Stage 1A|Adverse Event|0
2610040|NCT00996892|9022987|P2|Dose-Escalation Stage 1A|Adverse Event|0
2610041|NCT00996892|9022988|P1|Dose-Escalation Stage 1A|Adverse Event|0
2610042|NCT00996892|9022969|P20|Dose-Escalation Stage 1|Disease Progression|0
2610043|NCT00996892|9022970|P19|Dose-Escalation Stage 1|Disease Progression|0
2610044|NCT00996892|9022971|P18|Dose-Escalation Stage 1|Disease Progression|0
2610045|NCT00996892|9022972|P17|Dose-Escalation Stage 1|Disease Progression|0
2610046|NCT00996892|9022973|P16|Dose-Escalation Stage 1|Disease Progression|0
2610047|NCT00996892|9022974|P15|Dose-Escalation Stage 1|Disease Progression|0
2610048|NCT00996892|9022975|P14|Dose-Escalation Stage 1|Disease Progression|0
2610049|NCT00996892|9022976|P13|Dose-Escalation Stage 1|Disease Progression|0
2610050|NCT00996892|9022977|P12|Dose-Escalation Stage 1|Disease Progression|0
2610051|NCT00996892|9022978|P11|Dose-Escalation Stage 1|Disease Progression|0
2610052|NCT00996892|9022979|P10|Dose-Escalation Stage 1|Disease Progression|0
2610053|NCT00996892|9022980|P9|Dose-Escalation Stage 1|Disease Progression|0
2610054|NCT00996892|9022981|P8|Dose-Escalation Stage 1|Disease Progression|0
2610055|NCT00996892|9022982|P7|Dose-Escalation Stage 1|Disease Progression|0
2610056|NCT00996892|9022983|P6|Dose-Escalation Stage 1|Disease Progression|7
2610057|NCT00996892|9022984|P5|Dose-Escalation Stage 1|Disease Progression|10
2610058|NCT00996892|9022985|P4|Dose-Escalation Stage 1|Disease Progression|4
2610059|NCT00996892|9022986|P3|Dose-Escalation Stage 1|Disease Progression|3
2610060|NCT00996892|9022987|P2|Dose-Escalation Stage 1|Disease Progression|2
2610061|NCT00996892|9022988|P1|Dose-Escalation Stage 1|Disease Progression|2
2610062|NCT00996892|9022969|P20|Dose-Escalation Stage 1|Withdrawal by Subject|0
2610063|NCT00996892|9022970|P19|Dose-Escalation Stage 1|Withdrawal by Subject|0
2610064|NCT00996892|9022971|P18|Dose-Escalation Stage 1|Withdrawal by Subject|0
2610065|NCT00996892|9022972|P17|Dose-Escalation Stage 1|Withdrawal by Subject|0
2610066|NCT00996892|9022973|P16|Dose-Escalation Stage 1|Withdrawal by Subject|0
2610067|NCT00996892|9022974|P15|Dose-Escalation Stage 1|Withdrawal by Subject|0
2610068|NCT00996892|9022975|P14|Dose-Escalation Stage 1|Withdrawal by Subject|0
2610069|NCT00996892|9022976|P13|Dose-Escalation Stage 1|Withdrawal by Subject|0
2610070|NCT00996892|9022977|P12|Dose-Escalation Stage 1|Withdrawal by Subject|0
2610071|NCT00996892|9022978|P11|Dose-Escalation Stage 1|Withdrawal by Subject|0
2610072|NCT00996892|9022979|P10|Dose-Escalation Stage 1|Withdrawal by Subject|0
2610073|NCT00996892|9022980|P9|Dose-Escalation Stage 1|Withdrawal by Subject|0
2610074|NCT00996892|9022981|P8|Dose-Escalation Stage 1|Withdrawal by Subject|0
2610075|NCT00996892|9022982|P7|Dose-Escalation Stage 1|Withdrawal by Subject|1
2610076|NCT00996892|9022983|P6|Dose-Escalation Stage 1|Withdrawal by Subject|1
2610077|NCT00996892|9022984|P5|Dose-Escalation Stage 1|Withdrawal by Subject|1
2610078|NCT00996892|9022985|P4|Dose-Escalation Stage 1|Withdrawal by Subject|2
2610079|NCT00996892|9022986|P3|Dose-Escalation Stage 1|Withdrawal by Subject|0
2610080|NCT00996892|9022987|P2|Dose-Escalation Stage 1|Withdrawal by Subject|1
2610081|NCT00996892|9022988|P1|Dose-Escalation Stage 1|Withdrawal by Subject|0
2610082|NCT00996892|9022969|P20|Dose-Escalation Stage 1|Physician Decision|0
2610083|NCT00996892|9022970|P19|Dose-Escalation Stage 1|Physician Decision|0
2610084|NCT00996892|9022971|P18|Dose-Escalation Stage 1|Physician Decision|0
2610085|NCT00996892|9022972|P17|Dose-Escalation Stage 1|Physician Decision|0
2610086|NCT00996892|9022973|P16|Dose-Escalation Stage 1|Physician Decision|0
2610087|NCT00996892|9022974|P15|Dose-Escalation Stage 1|Physician Decision|0
2610088|NCT00996892|9022975|P14|Dose-Escalation Stage 1|Physician Decision|0
2610089|NCT00996892|9022976|P13|Dose-Escalation Stage 1|Physician Decision|0
2610090|NCT00996892|9022977|P12|Dose-Escalation Stage 1|Physician Decision|0
2610091|NCT00996892|9022978|P11|Dose-Escalation Stage 1|Physician Decision|0
2610092|NCT00996892|9022979|P10|Dose-Escalation Stage 1|Physician Decision|0
2610093|NCT00996892|9022980|P9|Dose-Escalation Stage 1|Physician Decision|0
2610094|NCT00996892|9022981|P8|Dose-Escalation Stage 1|Physician Decision|0
2610095|NCT00996892|9022982|P7|Dose-Escalation Stage 1|Physician Decision|2
2610096|NCT00996892|9022983|P6|Dose-Escalation Stage 1|Physician Decision|1
2610097|NCT00996892|9022984|P5|Dose-Escalation Stage 1|Physician Decision|0
2610098|NCT00996892|9022985|P4|Dose-Escalation Stage 1|Physician Decision|1
2610099|NCT00996892|9022986|P3|Dose-Escalation Stage 1|Physician Decision|0
2610100|NCT00996892|9022987|P2|Dose-Escalation Stage 1|Physician Decision|0
2610101|NCT00996892|9022988|P1|Dose-Escalation Stage 1|Physician Decision|1
2610102|NCT00996892|9022969|P20|Dose-Escalation Stage 1|Death|0
2610103|NCT00996892|9022970|P19|Dose-Escalation Stage 1|Death|0
2610104|NCT00996892|9022971|P18|Dose-Escalation Stage 1|Death|0
2610105|NCT00996892|9022972|P17|Dose-Escalation Stage 1|Death|0
2610106|NCT00996892|9022973|P16|Dose-Escalation Stage 1|Death|0
2610107|NCT00996892|9022974|P15|Dose-Escalation Stage 1|Death|0
2610108|NCT00996892|9022975|P14|Dose-Escalation Stage 1|Death|0
2610109|NCT00996892|9022976|P13|Dose-Escalation Stage 1|Death|0
2610110|NCT00996892|9022977|P12|Dose-Escalation Stage 1|Death|0
2610111|NCT00996892|9022978|P11|Dose-Escalation Stage 1|Death|0
2610112|NCT00996892|9022979|P10|Dose-Escalation Stage 1|Death|0
2610113|NCT00996892|9022980|P9|Dose-Escalation Stage 1|Death|0
2610114|NCT00996892|9022981|P8|Dose-Escalation Stage 1|Death|0
2610115|NCT00996892|9022982|P7|Dose-Escalation Stage 1|Death|0
2610116|NCT00996892|9022983|P6|Dose-Escalation Stage 1|Death|1
2610117|NCT00996892|9022984|P5|Dose-Escalation Stage 1|Death|0
2610118|NCT00996892|9022985|P4|Dose-Escalation Stage 1|Death|0
2610119|NCT00996892|9022986|P3|Dose-Escalation Stage 1|Death|0
2610120|NCT00996892|9022987|P2|Dose-Escalation Stage 1|Death|0
2610121|NCT00996892|9022988|P1|Dose-Escalation Stage 1|Death|1
2610122|NCT00996892|9022969|P20|Dose-Escalation Stage 1|Adverse Event|0
2610123|NCT00996892|9022970|P19|Dose-Escalation Stage 1|Adverse Event|0
2610124|NCT00996892|9022971|P18|Dose-Escalation Stage 1|Adverse Event|0
2610125|NCT00996892|9022972|P17|Dose-Escalation Stage 1|Adverse Event|0
2610126|NCT00996892|9022973|P16|Dose-Escalation Stage 1|Adverse Event|0
2610127|NCT00996892|9022974|P15|Dose-Escalation Stage 1|Adverse Event|0
2610128|NCT00996892|9022975|P14|Dose-Escalation Stage 1|Adverse Event|0
2610129|NCT00996892|9022976|P13|Dose-Escalation Stage 1|Adverse Event|0
2610130|NCT00996892|9022977|P12|Dose-Escalation Stage 1|Adverse Event|0
2610131|NCT00996892|9022978|P11|Dose-Escalation Stage 1|Adverse Event|0
2610132|NCT00996892|9022979|P10|Dose-Escalation Stage 1|Adverse Event|0
2610133|NCT00996892|9022980|P9|Dose-Escalation Stage 1|Adverse Event|0
2610134|NCT00996892|9022981|P8|Dose-Escalation Stage 1|Adverse Event|0
2610135|NCT00996892|9022982|P7|Dose-Escalation Stage 1|Adverse Event|1
2610136|NCT00996892|9022983|P6|Dose-Escalation Stage 1|Adverse Event|0
2610137|NCT00996892|9022984|P5|Dose-Escalation Stage 1|Adverse Event|0
2610138|NCT00996892|9022985|P4|Dose-Escalation Stage 1|Adverse Event|2
2610139|NCT00996892|9022986|P3|Dose-Escalation Stage 1|Adverse Event|0
2610140|NCT00996892|9022987|P2|Dose-Escalation Stage 1|Adverse Event|0
2610141|NCT00996892|9022988|P1|Dose-Escalation Stage 1|Adverse Event|0
2610142|NCT00996840|9023582|P5|Overall Study|Withdrawal by Subject|0
2610143|NCT00996840|9023583|P4|Overall Study|Withdrawal by Subject|0
2610144|NCT00996840|9023584|P3|Overall Study|Withdrawal by Subject|0
2610145|NCT00996840|9023585|P2|Overall Study|Withdrawal by Subject|1
2610146|NCT00996840|9023586|P1|Overall Study|Withdrawal by Subject|1
2610147|NCT00996840|9023582|P5|Overall Study|Physician Decision|2
2610148|NCT00996840|9023583|P4|Overall Study|Physician Decision|1
2610149|NCT00996840|9023584|P3|Overall Study|Physician Decision|1
2610150|NCT00996840|9023585|P2|Overall Study|Physician Decision|0
2610151|NCT00996840|9023586|P1|Overall Study|Physician Decision|0
2610152|NCT00996840|9023582|P5|Overall Study|Adverse Event|0
2610153|NCT00996840|9023583|P4|Overall Study|Adverse Event|0
2610154|NCT00996840|9023584|P3|Overall Study|Adverse Event|0
2610155|NCT00996840|9023585|P2|Overall Study|Adverse Event|1
2610156|NCT00996840|9023586|P1|Overall Study|Adverse Event|0
2610157|NCT00996801|9023736|P6|Overall Study|Withdrawal by Subject|9
2610158|NCT00996801|9023737|P5|Overall Study|Withdrawal by Subject|5
2610159|NCT00996801|9023738|P4|Overall Study|Withdrawal by Subject|5
2610160|NCT00996801|9023739|P3|Overall Study|Withdrawal by Subject|9
2610161|NCT00996801|9023740|P2|Overall Study|Withdrawal by Subject|6
2610162|NCT00996801|9023741|P1|Overall Study|Withdrawal by Subject|8
2610163|NCT00996801|9023736|P6|Overall Study|Study Terminated by Sponsor|0
2610164|NCT00996801|9023737|P5|Overall Study|Study Terminated by Sponsor|46
2610165|NCT00996801|9023738|P4|Overall Study|Study Terminated by Sponsor|0
2610166|NCT00996801|9023739|P3|Overall Study|Study Terminated by Sponsor|0
2610167|NCT00996801|9023740|P2|Overall Study|Study Terminated by Sponsor|1
2610168|NCT00996801|9023741|P1|Overall Study|Study Terminated by Sponsor|0
2610169|NCT00996801|9023736|P6|Overall Study|Protocol Violation|4
2610170|NCT00996801|9023737|P5|Overall Study|Protocol Violation|3
2610171|NCT00996801|9023738|P4|Overall Study|Protocol Violation|2
2610172|NCT00996801|9023739|P3|Overall Study|Protocol Violation|1
2610173|NCT00996801|9023740|P2|Overall Study|Protocol Violation|4
2610174|NCT00996801|9023741|P1|Overall Study|Protocol Violation|3
2610175|NCT00996801|9023736|P6|Overall Study|Progressive Disease|0
2610176|NCT00996801|9023737|P5|Overall Study|Progressive Disease|0
2610177|NCT00996801|9023738|P4|Overall Study|Progressive Disease|0
2610178|NCT00996801|9023739|P3|Overall Study|Progressive Disease|0
2610179|NCT00996801|9023740|P2|Overall Study|Progressive Disease|1
2610180|NCT00996801|9023741|P1|Overall Study|Progressive Disease|0
2610181|NCT00996801|9023736|P6|Overall Study|Physician Decision|0
2610182|NCT00996801|9023737|P5|Overall Study|Physician Decision|0
2610183|NCT00996801|9023738|P4|Overall Study|Physician Decision|1
2610184|NCT00996801|9023739|P3|Overall Study|Physician Decision|0
2610185|NCT00996801|9023740|P2|Overall Study|Physician Decision|0
2610186|NCT00996801|9023741|P1|Overall Study|Physician Decision|0
2610187|NCT00996801|9023736|P6|Overall Study|Lost to Follow-up|2
2610188|NCT00996801|9023737|P5|Overall Study|Lost to Follow-up|3
2610189|NCT00996801|9023738|P4|Overall Study|Lost to Follow-up|3
2610190|NCT00996801|9023739|P3|Overall Study|Lost to Follow-up|0
2610191|NCT00996801|9023740|P2|Overall Study|Lost to Follow-up|0
2610192|NCT00996801|9023741|P1|Overall Study|Lost to Follow-up|0
2610193|NCT00996801|9023736|P6|Overall Study|Lack of Efficacy|1
2610194|NCT00996801|9023737|P5|Overall Study|Lack of Efficacy|0
2610195|NCT00996801|9023738|P4|Overall Study|Lack of Efficacy|3
2610196|NCT00996801|9023739|P3|Overall Study|Lack of Efficacy|1
2610197|NCT00996801|9023740|P2|Overall Study|Lack of Efficacy|0
2610198|NCT00996801|9023741|P1|Overall Study|Lack of Efficacy|3
2610199|NCT00996801|9023736|P6|Overall Study|Adverse Event|3
2610200|NCT00996801|9023737|P5|Overall Study|Adverse Event|31
2610201|NCT00996801|9023738|P4|Overall Study|Adverse Event|17
2610202|NCT00996801|9023739|P3|Overall Study|Adverse Event|12
2610203|NCT00996801|9023740|P2|Overall Study|Adverse Event|4
2610204|NCT00996801|9023741|P1|Overall Study|Adverse Event|6
2610205|NCT00996736|9023853|P2|Overall Study|Visit not within 3-month window|3
2610206|NCT00996736|9023854|P1|Overall Study|Visit not within 3-month window|5
2610207|NCT00996736|9023853|P2|Overall Study|Lost to Follow-up|14
2610208|NCT00996736|9023854|P1|Overall Study|Lost to Follow-up|15
2610209|NCT00996736|9023853|P2|Overall Study|Death|1
2610210|NCT00996736|9023854|P1|Overall Study|Death|1
2610211|NCT00996658|9023874|P2|Overall Study|Other|7
2610212|NCT00996658|9023875|P1|Overall Study|Other|9
2610213|NCT00996658|9023874|P2|Overall Study|Non-compliance issues|3
2610214|NCT00996658|9023875|P1|Overall Study|Non-compliance issues|3
2610215|NCT00996658|9023874|P2|Overall Study|Lost to Follow-up|5
2610216|NCT00996658|9023875|P1|Overall Study|Lost to Follow-up|2
2610217|NCT00996658|9023874|P2|Overall Study|Protocol Violation|1
2610218|NCT00996658|9023875|P1|Overall Study|Protocol Violation|0
2610219|NCT00996658|9023874|P2|Overall Study|Adverse Event|5
2610220|NCT00996658|9023875|P1|Overall Study|Adverse Event|2
2610221|NCT00996632|9023903|P2|Overall Study|Physician Decision|0
2610222|NCT00996632|9023904|P1|Overall Study|Physician Decision|0
2610223|NCT00996606|9023912|P1|Overall Study|Withdrawal by Subject|3
2610224|NCT00996606|9023912|P1|Overall Study|Protocol Violation|1
2610225|NCT00996606|9023912|P1|Overall Study|Insufficient Therapeutic Response|2
2610226|NCT00996606|9023912|P1|Overall Study|Adverse Event or Intercurrent Illness|2
2610227|NCT00996593|9024006|P1|Long-Term Follow-Up|Site Closed|1
2610228|NCT00996593|9024006|P1|Long-Term Follow-Up|Withdrawal by Subject|2
2610229|NCT00996593|9024006|P1|Dosimetric and Therapeutic Treatment|Non-compliance|1
2610230|NCT00996593|9024006|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3
2610231|NCT00996593|9024006|P1|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6
2610232|NCT00996593|9024006|P1|Dosimetric and Therapeutic Treatment|Death|1
2610233|NCT00996593|9024006|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|22
2610234|NCT00996593|9024006|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3
2610235|NCT00996593|9024006|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7
2610236|NCT00996580|9024034|P1|Overall Study|Other|29
2610237|NCT00996580|9024034|P1|Overall Study|Withdrawal by Subject|217
2610238|NCT00996580|9024034|P1|Overall Study|Sponsor requested participant withdrawal|35
2610239|NCT00996580|9024034|P1|Overall Study|Protocol Violation|16
2610240|NCT00996580|9024034|P1|Overall Study|Pregnancy|68
2610241|NCT00996580|9024034|P1|Overall Study|Physician Decision|5
2610242|NCT00996580|9024034|P1|Overall Study|Noncompliance with the protocol|137
2610243|NCT00996580|9024034|P1|Overall Study|Lost to Follow-up|480
2610244|NCT00996580|9024034|P1|Overall Study|Adverse Event|466
2610245|NCT00996489|9024069|P1|Overall Study|Discontinued|116
2610246|NCT00996489|9024069|P1|Overall Study|Device failure|45
2610247|NCT00996476|9024089|P5|Overall Study|Adverse Event|1
2610248|NCT00996476|9024090|P4|Overall Study|Adverse Event|0
2610249|NCT00996476|9024091|P3|Overall Study|Adverse Event|0
2610250|NCT00996476|9024092|P2|Overall Study|Adverse Event|1
2610251|NCT00996476|9024093|P1|Overall Study|Adverse Event|0
2610252|NCT00996476|9024089|P5|Overall Study|Withdrawal by Subject|1
2610253|NCT00996476|9024090|P4|Overall Study|Withdrawal by Subject|0
2610254|NCT00996476|9024091|P3|Overall Study|Withdrawal by Subject|1
2610255|NCT00996476|9024092|P2|Overall Study|Withdrawal by Subject|2
2610256|NCT00996476|9024093|P1|Overall Study|Withdrawal by Subject|1
2610257|NCT00996437|9024161|P2|Overall Study|Missed|5
2610258|NCT00996437|9024162|P1|Overall Study|Missed|2
2610259|NCT00996437|9024161|P2|Overall Study|Dropped|2
2610260|NCT00996437|9024162|P1|Overall Study|Dropped|2
2610261|NCT00996437|9024161|P2|Overall Study|Death|0
2610262|NCT00996437|9024162|P1|Overall Study|Death|1
2610263|NCT00996333|9024207|P1|Overall Study|Other|5
2610264|NCT00996333|9024207|P1|Overall Study|Physician Decision|1
2610265|NCT00996333|9024207|P1|Overall Study|Adverse Event|1
2610266|NCT00996333|9024207|P1|Overall Study|Death|4
2610267|NCT00996333|9024207|P1|Overall Study|Withdrawal by Subject|1
2610268|NCT00996333|9024207|P1|Overall Study|Screen failure|1
2610269|NCT00996307|9024217|P4|Overall Study|Unable to classify|1
2610270|NCT00996307|9024218|P3|Overall Study|Unable to classify|2
2610271|NCT00996307|9024219|P2|Overall Study|Unable to classify|0
2610272|NCT00996307|9024220|P1|Overall Study|Unable to classify|4
2610273|NCT00996307|9024217|P4|Overall Study|Administrative reason|0
2610274|NCT00996307|9024218|P3|Overall Study|Administrative reason|0
2610275|NCT00996307|9024219|P2|Overall Study|Administrative reason|1
2610276|NCT00996307|9024220|P1|Overall Study|Administrative reason|0
2610277|NCT00996307|9024217|P4|Overall Study|Lost to Follow-up|15
2610278|NCT00996307|9024218|P3|Overall Study|Lost to Follow-up|7
2610279|NCT00996307|9024219|P2|Overall Study|Lost to Follow-up|13
2610280|NCT00996307|9024220|P1|Overall Study|Lost to Follow-up|13
2610281|NCT00996307|9024217|P4|Overall Study|Withdrawal by Subject|5
2610282|NCT00996307|9024218|P3|Overall Study|Withdrawal by Subject|5
2610283|NCT00996307|9024219|P2|Overall Study|Withdrawal by Subject|2
2610284|NCT00996307|9024220|P1|Overall Study|Withdrawal by Subject|3
2610285|NCT00996307|9024217|P4|Overall Study|Adverse Event|0
2610286|NCT00996307|9024218|P3|Overall Study|Adverse Event|0
2610287|NCT00996307|9024219|P2|Overall Study|Adverse Event|1
2610288|NCT00996307|9024220|P1|Overall Study|Adverse Event|0
2610289|NCT00996281|9024280|P2|Overall Study|Other|7
2610290|NCT00996281|9024281|P1|Overall Study|Other|5
2610291|NCT00996281|9024280|P2|Overall Study|Lack of Efficacy|2
2610292|NCT00996281|9024281|P1|Overall Study|Lack of Efficacy|0
2610293|NCT00996281|9024280|P2|Overall Study|Withdrawal by Subject|20
2610294|NCT00996281|9024281|P1|Overall Study|Withdrawal by Subject|31
2610295|NCT00996281|9024280|P2|Overall Study|Lost to Follow-up|16
2610296|NCT00996281|9024281|P1|Overall Study|Lost to Follow-up|14
2610297|NCT00996281|9024280|P2|Overall Study|Major Protocol Deviation|7
2610298|NCT00996281|9024281|P1|Overall Study|Major Protocol Deviation|6
2610299|NCT00996281|9024280|P2|Overall Study|Adverse Event|37
2610300|NCT00996281|9024281|P1|Overall Study|Adverse Event|75
2610301|NCT00996216|9024289|P1|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1
2610302|NCT00996216|9024289|P1|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3
2610303|NCT00996216|9024289|P1|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1
2610304|NCT00996203|9024305|P1|Overall Study|Protocol Violation|2
2610305|NCT00996203|9024305|P1|Overall Study|Lack of Efficacy|1
2610306|NCT00996203|9024305|P1|Overall Study|Lost to Follow-up|1
2610307|NCT00996203|9024305|P1|Overall Study|Adverse Event|3
2610308|NCT00996125|9024337|P2|Overall Study|Withdrawal by Subject|3
2610309|NCT00996125|9024338|P1|Overall Study|Withdrawal by Subject|4
2610310|NCT00996125|9024337|P2|Overall Study|Lost to Follow-up|6
2610311|NCT00996125|9024338|P1|Overall Study|Lost to Follow-up|1
2610312|NCT00996125|9024337|P2|Overall Study|Adverse Event|2
2610313|NCT00996125|9024338|P1|Overall Study|Adverse Event|0
2610314|NCT00996034|9024358|P1|Overall Study|withdrawn by PI|1
2610315|NCT00996034|9024358|P1|Overall Study|Lost to Follow-up|2
2610316|NCT00995930|9024364|P2|Overall Study|Adverse Event|14
2610317|NCT00995930|9024365|P1|Overall Study|Adverse Event|11
2610318|NCT00995930|9024364|P2|Overall Study|Withdrawal by Subject|4
2610319|NCT00995930|9024365|P1|Overall Study|Withdrawal by Subject|3
2610320|NCT00995930|9024364|P2|Overall Study|Lost to Follow-up|2
2610321|NCT00995930|9024365|P1|Overall Study|Lost to Follow-up|1
2610322|NCT00995930|9024364|P2|Overall Study|Administrative problems|2
2610323|NCT00995930|9024365|P1|Overall Study|Administrative problems|4
2610324|NCT00995930|9024364|P2|Overall Study|Death|1
2610325|NCT00995930|9024365|P1|Overall Study|Death|0
2610326|NCT00995930|9024364|P2|Overall Study|Protocol deviation|5
2610327|NCT00995930|9024365|P1|Overall Study|Protocol deviation|2
2610328|NCT00995865|9024416|P3|Overall Study|Lost to Follow-up|1
2610329|NCT00995865|9024417|P2|Overall Study|Lost to Follow-up|0
2610330|NCT00995865|9024418|P1|Overall Study|Lost to Follow-up|0
2610331|NCT00995865|9024416|P3|Overall Study|Protocol Violation|0
2610332|NCT00995865|9024417|P2|Overall Study|Protocol Violation|0
2610333|NCT00995865|9024418|P1|Overall Study|Protocol Violation|2
2610334|NCT00995774|9024440|P2|Training Period 2|Withdrawal by Subject|0
2610335|NCT00995774|9024441|P1|Training Period 2|Withdrawal by Subject|2
2610336|NCT00995709|9024475|P3|Overall Study|Protocol Violation|0
2610337|NCT00995709|9024476|P2|Overall Study|Protocol Violation|1
2610338|NCT00995709|9024477|P1|Overall Study|Protocol Violation|2
2610339|NCT00995709|9024475|P3|Overall Study|Death|0
2610340|NCT00995709|9024476|P2|Overall Study|Death|1
2610341|NCT00995709|9024477|P1|Overall Study|Death|0
2610342|NCT00995709|9024475|P3|Overall Study|Lost to Follow-up|0
2610343|NCT00995709|9024476|P2|Overall Study|Lost to Follow-up|0
2610344|NCT00995709|9024477|P1|Overall Study|Lost to Follow-up|1
2610345|NCT00995709|9024475|P3|Overall Study|Withdrawal by Subject|1
2610346|NCT00995709|9024476|P2|Overall Study|Withdrawal by Subject|4
2610347|NCT00995709|9024477|P1|Overall Study|Withdrawal by Subject|0
2610348|NCT00995709|9024475|P3|Overall Study|Lack of Efficacy|4
2610349|NCT00995709|9024476|P2|Overall Study|Lack of Efficacy|1
2610350|NCT00995709|9024477|P1|Overall Study|Lack of Efficacy|0
2610351|NCT00995709|9024475|P3|Overall Study|Adverse Event|0
2610352|NCT00995709|9024476|P2|Overall Study|Adverse Event|2
2610353|NCT00995709|9024477|P1|Overall Study|Adverse Event|4
2610354|NCT00995670|9024503|P3|Overall Study|Failed arterial cannulation|3
2610355|NCT00995670|9024504|P2|Overall Study|Failed arterial cannulation|0
2610356|NCT00995670|9024505|P1|Overall Study|Failed arterial cannulation|1
2610357|NCT00995566|9024513|P1|Overall Study|Early study termination|52
2610358|NCT00995566|9024513|P1|Overall Study|Adverse Event|2
2610359|NCT00995553|9024527|P2|Overall Study|Withdrawal by Subject|6
2610360|NCT00995553|9024528|P1|Overall Study|Withdrawal by Subject|2
2610361|NCT00995488|9024577|P1|Overall Study|Withdrawal by Subject|1
2610362|NCT00995436|9024611|P3|Overall Study|Withdrawal by Subject|0
2610363|NCT00995436|9024612|P2|Overall Study|Withdrawal by Subject|5
2610364|NCT00995436|9024613|P1|Overall Study|Withdrawal by Subject|2
2610365|NCT00995410|9024621|P1|Overall Study|Misc|28
2610366|NCT00995410|9024621|P1|Overall Study|Lost to Follow-up|2
2610367|NCT00995410|9024621|P1|Overall Study|Withdrawal by Subject|7
2610368|NCT00995410|9024621|P1|Overall Study|Adverse Event|51
2610369|NCT00995371|9024628|P2|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
2610370|NCT00995371|9024629|P1|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
2610371|NCT00995345|9024647|P5|Overall Study|all other reasons combined|3
2610372|NCT00995345|9024648|P4|Overall Study|all other reasons combined|1
2610373|NCT00995345|9024649|P3|Overall Study|all other reasons combined|2
2610374|NCT00995345|9024650|P2|Overall Study|all other reasons combined|2
2610375|NCT00995345|9024651|P1|Overall Study|all other reasons combined|2
2610376|NCT00995345|9024647|P5|Overall Study|Lost to Follow-up|0
2610377|NCT00995345|9024648|P4|Overall Study|Lost to Follow-up|1
2610378|NCT00995345|9024649|P3|Overall Study|Lost to Follow-up|2
2610379|NCT00995345|9024650|P2|Overall Study|Lost to Follow-up|2
2610380|NCT00995345|9024651|P1|Overall Study|Lost to Follow-up|2
2610381|NCT00995345|9024647|P5|Overall Study|Adverse Event|1
2610382|NCT00995345|9024648|P4|Overall Study|Adverse Event|0
2610383|NCT00995345|9024649|P3|Overall Study|Adverse Event|2
2610384|NCT00995345|9024650|P2|Overall Study|Adverse Event|1
2610385|NCT00995345|9024651|P1|Overall Study|Adverse Event|3
2610386|NCT00995345|9024647|P5|Overall Study|Withdrawal by Subject|1
2610387|NCT00995345|9024648|P4|Overall Study|Withdrawal by Subject|3
2610388|NCT00995345|9024649|P3|Overall Study|Withdrawal by Subject|1
2610389|NCT00995345|9024650|P2|Overall Study|Withdrawal by Subject|2
2610390|NCT00995345|9024651|P1|Overall Study|Withdrawal by Subject|4
2610391|NCT00995085|9024683|P1|Overall Study|Withdrawal by Subject|5
2610392|NCT00995020|9024700|P2|Overall Study|specimen fragmentation, thermal damage|2
2610393|NCT00995020|9024701|P1|Overall Study|specimen fragmentation, thermal damage|1
2610394|NCT00995020|9024700|P2|Overall Study|margin analysis not performed|5
2610395|NCT00995020|9024701|P1|Overall Study|margin analysis not performed|2
2610396|NCT00995007|9024711|P2|Overall Study|Toxicity|0
2610397|NCT00995007|9024712|P1|Overall Study|Toxicity|8
2610398|NCT00995007|9024711|P2|Overall Study|Refused further treatment|2
2610399|NCT00995007|9024712|P1|Overall Study|Refused further treatment|8
2610400|NCT00995007|9024711|P2|Overall Study|Withdrew consent|0
2610401|NCT00995007|9024712|P1|Overall Study|Withdrew consent|1
2610402|NCT00994682|9024775|P2|Pioglitazone Open Label|Physician Decision|1
2610403|NCT00994682|9024776|P1|Pioglitazone Open Label|Physician Decision|6
2610404|NCT00994682|9024775|P2|Pioglitazone Open Label|Lost to Follow-up|2
2610405|NCT00994682|9024776|P1|Pioglitazone Open Label|Lost to Follow-up|3
2610406|NCT00994682|9024775|P2|Pioglitazone Open Label|Withdrawal by Subject|4
2610407|NCT00994682|9024776|P1|Pioglitazone Open Label|Withdrawal by Subject|4
2610408|NCT00994682|9024775|P2|Double Bilnd|Adverse Event|0
2610409|NCT00994682|9024776|P1|Double Bilnd|Adverse Event|1
2610410|NCT00994682|9024775|P2|Double Bilnd|Lost to Follow-up|3
2610411|NCT00994682|9024776|P1|Double Bilnd|Lost to Follow-up|3
2610412|NCT00994682|9024775|P2|Double Bilnd|Withdrawal by Subject|6
2610413|NCT00994682|9024776|P1|Double Bilnd|Withdrawal by Subject|5
2610414|NCT00994643|9024820|P1|Overall Study|Withdrawal by Subject|1
2610415|NCT00994461|9024834|P3|Overall Study|Adverse Event|0
2610416|NCT00994461|9024835|P2|Overall Study|Adverse Event|1
2610417|NCT00994461|9024836|P1|Overall Study|Adverse Event|2
2610418|NCT00994448|9024864|P2|Overall Study|Physician Decision|0
2610419|NCT00994448|9024865|P1|Overall Study|Physician Decision|1
2610420|NCT00994448|9024864|P2|Overall Study|Withdrawal by Subject|1
2610421|NCT00994448|9024865|P1|Overall Study|Withdrawal by Subject|1
2610422|NCT00994448|9024864|P2|Overall Study|Lost to Follow-up|1
2610423|NCT00994448|9024865|P1|Overall Study|Lost to Follow-up|5
2610424|NCT00994448|9024864|P2|Overall Study|Adverse Event|0
2610425|NCT00994448|9024865|P1|Overall Study|Adverse Event|1
2610426|NCT00994422|9024873|P2|Overall Study|Lost to Follow-up|1
2610427|NCT00994422|9024874|P1|Overall Study|Lost to Follow-up|7
2610428|NCT00994279|9024899|P2|Overall Study|Multiple reasons|3
2610429|NCT00994279|9024900|P1|Overall Study|Multiple reasons|1
2610430|NCT00994279|9024899|P2|Overall Study|Toxicity|0
2610431|NCT00994279|9024900|P1|Overall Study|Toxicity|1
2610432|NCT00994279|9024899|P2|Overall Study|Withdrawal by Subject|2
2610433|NCT00994279|9024900|P1|Overall Study|Withdrawal by Subject|2
2610434|NCT00994240|9024910|P2|Overall Study|study termination|3
2610435|NCT00994240|9024911|P1|Overall Study|study termination|2
2610436|NCT00994240|9024910|P2|Overall Study|Withdrawal by Subject|0
2610437|NCT00994240|9024911|P1|Overall Study|Withdrawal by Subject|1
2610438|NCT00994240|9024910|P2|Overall Study|Lost to Follow-up|2
2610439|NCT00994240|9024911|P1|Overall Study|Lost to Follow-up|3
2610440|NCT00994214|9024921|P4|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
2610441|NCT00994214|9024922|P3|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
2610442|NCT00994214|9024923|P2|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3
2610443|NCT00994214|9024924|P1|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4
2610444|NCT00994214|9024921|P4|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1
2610445|NCT00994214|9024922|P3|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
2610446|NCT00994214|9024923|P2|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
2610447|NCT00994214|9024924|P1|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
2610448|NCT00994214|9024921|P4|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14
2610449|NCT00994214|9024922|P3|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
2610450|NCT00994214|9024923|P2|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12
2610451|NCT00994214|9024924|P1|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
2610452|NCT00994214|9024921|P4|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
2610453|NCT00994214|9024922|P3|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
2610454|NCT00994214|9024923|P2|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
2610455|NCT00994214|9024924|P1|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1
2610456|NCT00994214|9024921|P4|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1
2610457|NCT00994214|9024922|P3|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
2610458|NCT00994214|9024923|P2|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
2610459|NCT00994214|9024924|P1|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
2610460|NCT00994214|9024921|P4|ITT (Intention-to-Treat) - Part A|Adverse Event|0
2610461|NCT00994214|9024922|P3|ITT (Intention-to-Treat) - Part A|Adverse Event|0
2610462|NCT00994214|9024923|P2|ITT (Intention-to-Treat) - Part A|Adverse Event|1
2610463|NCT00994214|9024924|P1|ITT (Intention-to-Treat) - Part A|Adverse Event|0
2610464|NCT00994110|9025003|P2|Overall Study|Pt not eligible|5
2610465|NCT00994110|9025004|P1|Overall Study|Pt not eligible|10
2610466|NCT00994110|9025003|P2|Overall Study|Patient not resected|52
2610467|NCT00994110|9025004|P1|Overall Study|Patient not resected|41
2610468|NCT00994110|9025003|P2|Overall Study|Adverse Event|0
2610469|NCT00994110|9025004|P1|Overall Study|Adverse Event|1
2610470|NCT00994110|9025003|P2|Overall Study|Not Treated|8
2610471|NCT00994110|9025004|P1|Overall Study|Not Treated|4
2610472|NCT00994110|9025003|P2|Overall Study|Withdrawal by Subject|9
2610473|NCT00994110|9025004|P1|Overall Study|Withdrawal by Subject|9
2610474|NCT00993967|9025010|P1|Overall Study|Protocol Violation|2
2610475|NCT00993967|9025010|P1|Overall Study|Withdrawal by Subject|36
2610476|NCT00993967|9025010|P1|Overall Study|Lost to Follow-up|14
2610477|NCT00993967|9025010|P1|Overall Study|Death|1
2610478|NCT00993967|9025010|P1|Overall Study|Adverse Event|8
2610479|NCT00993954|9025017|P2|Overall Study|Protocol Violation|2
2610480|NCT00993954|9025018|P1|Overall Study|Protocol Violation|21
2610481|NCT00993928|9025031|P2|Overall Study|ineligible|0
2610482|NCT00993928|9025032|P1|Overall Study|ineligible|1
2610483|NCT00993928|9025031|P2|Overall Study|Withdrawal by Subject|7
2610484|NCT00993928|9025032|P1|Overall Study|Withdrawal by Subject|4
2610485|NCT00993915|9025046|P1|Overall Study|Ongoing|3
2610486|NCT00993915|9025046|P1|Overall Study|Other|1
2610487|NCT00993915|9025046|P1|Overall Study|Withdrawal by Subject|2
2610488|NCT00993915|9025046|P1|Overall Study|Insufficient clinical response|3
2610489|NCT00993668|9025072|P2|Open-Label Period|Lost to Follow-up|1
2610490|NCT00993668|9025073|P1|Open-Label Period|Lost to Follow-up|6
2610491|NCT00993668|9025072|P2|Open-Label Period|Withdrawal by Subject|3
2610492|NCT00993668|9025073|P1|Open-Label Period|Withdrawal by Subject|4
2610493|NCT00993668|9025072|P2|Open-Label Period|Lack of Efficacy|3
2610494|NCT00993668|9025073|P1|Open-Label Period|Lack of Efficacy|4
2610495|NCT00993668|9025072|P2|Open-Label Period|Adverse Event|8
2610496|NCT00993668|9025073|P1|Open-Label Period|Adverse Event|9
2610497|NCT00993668|9025072|P2|Single-Blind Period|Lost to Follow-up|1
2610498|NCT00993668|9025073|P1|Single-Blind Period|Lost to Follow-up|3
2610499|NCT00993668|9025072|P2|Single-Blind Period|Lack of Efficacy|1
2610500|NCT00993668|9025073|P1|Single-Blind Period|Lack of Efficacy|0
2610501|NCT00993668|9025072|P2|Single-Blind Period|Adverse Event|1
2610502|NCT00993668|9025073|P1|Single-Blind Period|Adverse Event|1
2610503|NCT00993616|9025117|P1|Overall Study|Never treated|1
2610504|NCT00993616|9025117|P1|Overall Study|No tumor at entry|1
2610505|NCT00993499|9025135|P6|Discontinued After Starting Course 3|Other adverse event|0
2610506|NCT00993499|9025136|P5|Discontinued After Starting Course 3|Other adverse event|0
2610507|NCT00993499|9025137|P4|Discontinued After Starting Course 3|Other adverse event|0
2610508|NCT00993499|9025138|P3|Discontinued After Starting Course 3|Other adverse event|1
2610509|NCT00993499|9025139|P2|Discontinued After Starting Course 3|Other adverse event|0
2610510|NCT00993499|9025140|P1|Discontinued After Starting Course 3|Other adverse event|1
2610511|NCT00993499|9025135|P6|Discontinued After Starting Course 3|DLT|0
2610512|NCT00993499|9025136|P5|Discontinued After Starting Course 3|DLT|0
2610513|NCT00993499|9025137|P4|Discontinued After Starting Course 3|DLT|1
2610514|NCT00993499|9025138|P3|Discontinued After Starting Course 3|DLT|2
2610515|NCT00993499|9025139|P2|Discontinued After Starting Course 3|DLT|0
2610516|NCT00993499|9025140|P1|Discontinued After Starting Course 3|DLT|1
2610517|NCT00993499|9025135|P6|Discontinued After Starting Course 3|Progressive Disease|3
2610518|NCT00993499|9025136|P5|Discontinued After Starting Course 3|Progressive Disease|3
2610519|NCT00993499|9025137|P4|Discontinued After Starting Course 3|Progressive Disease|1
2610520|NCT00993499|9025138|P3|Discontinued After Starting Course 3|Progressive Disease|3
2610521|NCT00993499|9025139|P2|Discontinued After Starting Course 3|Progressive Disease|4
2610522|NCT00993499|9025140|P1|Discontinued After Starting Course 3|Progressive Disease|6
2610523|NCT00993499|9025135|P6|Discontinued After Starting Course 3|Withdrawal by Subject|0
2610524|NCT00993499|9025136|P5|Discontinued After Starting Course 3|Withdrawal by Subject|0
2610525|NCT00993499|9025137|P4|Discontinued After Starting Course 3|Withdrawal by Subject|0
2610526|NCT00993499|9025138|P3|Discontinued After Starting Course 3|Withdrawal by Subject|0
2610527|NCT00993499|9025139|P2|Discontinued After Starting Course 3|Withdrawal by Subject|1
2610528|NCT00993499|9025140|P1|Discontinued After Starting Course 3|Withdrawal by Subject|0
2610529|NCT00993499|9025135|P6|Discontinued Before Starting Course 3|Non compliance with the protocol|0
2610530|NCT00993499|9025136|P5|Discontinued Before Starting Course 3|Non compliance with the protocol|0
2610531|NCT00993499|9025137|P4|Discontinued Before Starting Course 3|Non compliance with the protocol|0
2610532|NCT00993499|9025138|P3|Discontinued Before Starting Course 3|Non compliance with the protocol|2
2610533|NCT00993499|9025139|P2|Discontinued Before Starting Course 3|Non compliance with the protocol|0
2610534|NCT00993499|9025140|P1|Discontinued Before Starting Course 3|Non compliance with the protocol|0
2610535|NCT00993499|9025135|P6|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
2610536|NCT00993499|9025136|P5|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
2610537|NCT00993499|9025137|P4|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
2610538|NCT00993499|9025138|P3|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
2610539|NCT00993499|9025139|P2|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
2610540|NCT00993499|9025140|P1|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
2610541|NCT00993499|9025135|P6|Discontinued Before Starting Course 3|Withdrawal by Subject|0
2610542|NCT00993499|9025136|P5|Discontinued Before Starting Course 3|Withdrawal by Subject|0
2610543|NCT00993499|9025137|P4|Discontinued Before Starting Course 3|Withdrawal by Subject|0
2610544|NCT00993499|9025138|P3|Discontinued Before Starting Course 3|Withdrawal by Subject|0
2610545|NCT00993499|9025139|P2|Discontinued Before Starting Course 3|Withdrawal by Subject|2
2610546|NCT00993499|9025140|P1|Discontinued Before Starting Course 3|Withdrawal by Subject|2
2610547|NCT00993499|9025135|P6|Discontinued Before Starting Course 3|Progressive Disease|0
2610548|NCT00993499|9025136|P5|Discontinued Before Starting Course 3|Progressive Disease|0
2610549|NCT00993499|9025137|P4|Discontinued Before Starting Course 3|Progressive Disease|0
2610550|NCT00993499|9025138|P3|Discontinued Before Starting Course 3|Progressive Disease|0
2610551|NCT00993499|9025139|P2|Discontinued Before Starting Course 3|Progressive Disease|2
2610552|NCT00993499|9025140|P1|Discontinued Before Starting Course 3|Progressive Disease|2
2610553|NCT00993499|9025135|P6|Run-in Period (8 Days)|Progressive disease|0
2610554|NCT00993499|9025136|P5|Run-in Period (8 Days)|Progressive disease|0
2610555|NCT00993499|9025137|P4|Run-in Period (8 Days)|Progressive disease|0
2610556|NCT00993499|9025138|P3|Run-in Period (8 Days)|Progressive disease|1
2610557|NCT00993499|9025139|P2|Run-in Period (8 Days)|Progressive disease|1
2610558|NCT00993499|9025140|P1|Run-in Period (8 Days)|Progressive disease|0
2610559|NCT00993499|9025135|P6|Run-in Period (8 Days)|Consent withdrawn|0
2610560|NCT00993499|9025136|P5|Run-in Period (8 Days)|Consent withdrawn|0
2610561|NCT00993499|9025137|P4|Run-in Period (8 Days)|Consent withdrawn|0
2610562|NCT00993499|9025138|P3|Run-in Period (8 Days)|Consent withdrawn|0
2610563|NCT00993499|9025139|P2|Run-in Period (8 Days)|Consent withdrawn|1
2610564|NCT00993499|9025140|P1|Run-in Period (8 Days)|Consent withdrawn|0
2610565|NCT00993499|9025135|P6|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
2610566|NCT00993499|9025136|P5|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
2610567|NCT00993499|9025137|P4|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
2610568|NCT00993499|9025138|P3|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
2610569|NCT00993499|9025139|P2|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
2610570|NCT00993499|9025140|P1|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1
2610571|NCT00993499|9025135|P6|Run-in Period (8 Days)|Adverse Event|0
2610572|NCT00993499|9025136|P5|Run-in Period (8 Days)|Adverse Event|0
2610573|NCT00993499|9025137|P4|Run-in Period (8 Days)|Adverse Event|0
2610574|NCT00993499|9025138|P3|Run-in Period (8 Days)|Adverse Event|0
2610575|NCT00993499|9025139|P2|Run-in Period (8 Days)|Adverse Event|1
2610576|NCT00993499|9025140|P1|Run-in Period (8 Days)|Adverse Event|0
2610577|NCT00993473|9025222|P2|Overall Study|Family event|0
2610578|NCT00993473|9025223|P1|Overall Study|Family event|1
2610579|NCT00993473|9025222|P2|Overall Study|Technical problem with CGM device|1
2610580|NCT00993473|9025223|P1|Overall Study|Technical problem with CGM device|0
2610581|NCT00993473|9025222|P2|Overall Study|Withdrawal by Subject|5
2610582|NCT00993473|9025223|P1|Overall Study|Withdrawal by Subject|1
2610583|NCT00993473|9025222|P2|Overall Study|Lost to Follow-up|0
2610584|NCT00993473|9025223|P1|Overall Study|Lost to Follow-up|1
2610585|NCT00993473|9025222|P2|Overall Study|Protocol Violation|2
2610586|NCT00993473|9025223|P1|Overall Study|Protocol Violation|1
2610587|NCT00993473|9025222|P2|Overall Study|Adverse Event|2
2610588|NCT00993473|9025223|P1|Overall Study|Adverse Event|0
2610589|NCT00993447|9025261|P2|Overall Study|Adverse Event|0
2610590|NCT00993447|9025262|P1|Overall Study|Adverse Event|1
2610591|NCT00993447|9025261|P2|Overall Study|Lost to Follow-up|3
2610592|NCT00993447|9025262|P1|Overall Study|Lost to Follow-up|1
2610593|NCT00993447|9025261|P2|Overall Study|Protocol Violation|8
2610594|NCT00993447|9025262|P1|Overall Study|Protocol Violation|12
2610595|NCT00993447|9025261|P2|Overall Study|Withdrawal by Subject|8
2610596|NCT00993447|9025262|P1|Overall Study|Withdrawal by Subject|23
2610597|NCT00993421|9025299|P7|Overall Study|Protocol Violation|1
2610598|NCT00993421|9025300|P6|Overall Study|Protocol Violation|2
2610599|NCT00993421|9025301|P5|Overall Study|Protocol Violation|0
2610600|NCT00993421|9025302|P4|Overall Study|Protocol Violation|0
2610601|NCT00993421|9025303|P3|Overall Study|Protocol Violation|0
2610602|NCT00993421|9025304|P2|Overall Study|Protocol Violation|0
2610603|NCT00993421|9025305|P1|Overall Study|Protocol Violation|0
2610604|NCT00993421|9025299|P7|Overall Study|Physician Decision|1
2610605|NCT00993421|9025300|P6|Overall Study|Physician Decision|1
2610606|NCT00993421|9025301|P5|Overall Study|Physician Decision|0
2610607|NCT00993421|9025302|P4|Overall Study|Physician Decision|0
2610608|NCT00993421|9025303|P3|Overall Study|Physician Decision|0
2610609|NCT00993421|9025304|P2|Overall Study|Physician Decision|0
2610610|NCT00993421|9025305|P1|Overall Study|Physician Decision|0
2610611|NCT00993421|9025299|P7|Overall Study|Entry Criteria Exclusion|0
2610612|NCT00993421|9025300|P6|Overall Study|Entry Criteria Exclusion|1
2610613|NCT00993421|9025301|P5|Overall Study|Entry Criteria Exclusion|0
2610614|NCT00993421|9025302|P4|Overall Study|Entry Criteria Exclusion|3
2610615|NCT00993421|9025303|P3|Overall Study|Entry Criteria Exclusion|1
2610616|NCT00993421|9025304|P2|Overall Study|Entry Criteria Exclusion|0
2610617|NCT00993421|9025305|P1|Overall Study|Entry Criteria Exclusion|0
2610618|NCT00993421|9025299|P7|Overall Study|Death|1
2610619|NCT00993421|9025300|P6|Overall Study|Death|0
2610620|NCT00993421|9025301|P5|Overall Study|Death|0
2610621|NCT00993421|9025302|P4|Overall Study|Death|0
2610622|NCT00993421|9025303|P3|Overall Study|Death|0
2610623|NCT00993421|9025304|P2|Overall Study|Death|0
2610624|NCT00993421|9025305|P1|Overall Study|Death|0
2610625|NCT00993421|9025299|P7|Overall Study|Withdrawal by Subject|3
2610626|NCT00993421|9025300|P6|Overall Study|Withdrawal by Subject|5
2610627|NCT00993421|9025301|P5|Overall Study|Withdrawal by Subject|3
2610628|NCT00993421|9025302|P4|Overall Study|Withdrawal by Subject|3
2610629|NCT00993421|9025303|P3|Overall Study|Withdrawal by Subject|3
2610630|NCT00993421|9025304|P2|Overall Study|Withdrawal by Subject|2
2610631|NCT00993421|9025305|P1|Overall Study|Withdrawal by Subject|3
2610632|NCT00993421|9025299|P7|Overall Study|Lost to Follow-up|6
2610633|NCT00993421|9025300|P6|Overall Study|Lost to Follow-up|0
2610634|NCT00993421|9025301|P5|Overall Study|Lost to Follow-up|0
2610635|NCT00993421|9025302|P4|Overall Study|Lost to Follow-up|0
2610636|NCT00993421|9025303|P3|Overall Study|Lost to Follow-up|5
2610637|NCT00993421|9025304|P2|Overall Study|Lost to Follow-up|5
2610638|NCT00993421|9025305|P1|Overall Study|Lost to Follow-up|3
2610639|NCT00993421|9025299|P7|Overall Study|Sponsor Decision|29
2610640|NCT00993421|9025300|P6|Overall Study|Sponsor Decision|30
2610641|NCT00993421|9025301|P5|Overall Study|Sponsor Decision|38
2610642|NCT00993421|9025302|P4|Overall Study|Sponsor Decision|30
2610643|NCT00993421|9025303|P3|Overall Study|Sponsor Decision|28
2610644|NCT00993421|9025304|P2|Overall Study|Sponsor Decision|31
2610645|NCT00993421|9025305|P1|Overall Study|Sponsor Decision|36
2610646|NCT00993421|9025299|P7|Overall Study|Adverse Event|1
2610647|NCT00993421|9025300|P6|Overall Study|Adverse Event|7
2610648|NCT00993421|9025301|P5|Overall Study|Adverse Event|5
2610649|NCT00993421|9025302|P4|Overall Study|Adverse Event|9
2610650|NCT00993421|9025303|P3|Overall Study|Adverse Event|6
2610651|NCT00993421|9025304|P2|Overall Study|Adverse Event|7
2610652|NCT00993421|9025305|P1|Overall Study|Adverse Event|2
2610653|NCT00993317|9025456|P2|Overall Study|Early study termination at the site|0
2610654|NCT00993317|9025457|P1|Overall Study|Early study termination at the site|1
2610655|NCT00993317|9025456|P2|Overall Study|Investigator's opinion|1
2610656|NCT00993317|9025457|P1|Overall Study|Investigator's opinion|0
2610657|NCT00993317|9025456|P2|Overall Study|Withdrawal by Subject|2
2610658|NCT00993317|9025457|P1|Overall Study|Withdrawal by Subject|0
2610659|NCT00993317|9025456|P2|Overall Study|Lack of Efficacy|18
2610660|NCT00993317|9025457|P1|Overall Study|Lack of Efficacy|18
2610661|NCT00993317|9025456|P2|Overall Study|Adverse Event|4
2610662|NCT00993317|9025457|P1|Overall Study|Adverse Event|2
2610663|NCT00993291|9025475|P1|Overall Study|Withdrawal by Subject|1
2610664|NCT00993265|9025481|P2|Overall Study|Non-compliant with study medication|0
2610665|NCT00993265|9025482|P1|Overall Study|Non-compliant with study medication|1
2610666|NCT00993265|9025481|P2|Overall Study|Changed dose of concomitant drug|0
2610667|NCT00993265|9025482|P1|Overall Study|Changed dose of concomitant drug|2
2610668|NCT00993265|9025481|P2|Overall Study|Adverse Event|0
2610669|NCT00993265|9025482|P1|Overall Study|Adverse Event|1
2610670|NCT00993148|9025534|P1|Overall Study|never initiated treatment|1
2610671|NCT00993148|9025534|P1|Overall Study|Lost to Follow-up|2
2610672|NCT00993044|9025546|P1|Irinotecan 50 mg|Physician Decision|1
2610673|NCT00993031|9025553|P2|Overall Study|Lost to Follow-up|13
2610674|NCT00993031|9025554|P1|Overall Study|Lost to Follow-up|19
2610675|NCT00993031|9025553|P2|Overall Study|Withdrawal by Subject|3
2610676|NCT00993031|9025554|P1|Overall Study|Withdrawal by Subject|3
2610677|NCT00993031|9025553|P2|Overall Study|Physician Decision|2
2610678|NCT00993031|9025554|P1|Overall Study|Physician Decision|0
2610679|NCT00993031|9025553|P2|Overall Study|Death|1
2610680|NCT00993031|9025554|P1|Overall Study|Death|0
2610681|NCT00992992|9025586|P1|Overall Study|Sponsor Closed the Study|4
2610682|NCT00992992|9025586|P1|Overall Study|GlaxoSmithKline Closed the Study|2
2610683|NCT00992992|9025586|P1|Overall Study|Death|16
2610684|NCT00992992|9025586|P1|Overall Study|Lost to Follow-up|3
2610685|NCT00992836|9025617|P1|Overall Study|Protocol Violation|2
2610686|NCT00992836|9025617|P1|Overall Study|Withdrawal by Subject|2
2610687|NCT00992836|9025617|P1|Overall Study|Lost to Follow-up|1
2610688|NCT00992784|9025632|P3|Overall Study|Withdrawal by Subject|1
2610689|NCT00992784|9025633|P2|Overall Study|Withdrawal by Subject|1
2610690|NCT00992784|9025634|P1|Overall Study|Withdrawal by Subject|1
2610691|NCT00992784|9025632|P3|Overall Study|Adverse Event|0
2610692|NCT00992784|9025633|P2|Overall Study|Adverse Event|1
2610693|NCT00992784|9025634|P1|Overall Study|Adverse Event|2
2610694|NCT00992589|9025746|P4|Double-Blind Phase|Other|3
2610695|NCT00992589|9025747|P3|Double-Blind Phase|Other|6
2610696|NCT00992589|9025748|P2|Double-Blind Phase|Other|1
2610697|NCT00992589|9025749|P1|Double-Blind Phase|Other|0
2610698|NCT00992589|9025746|P4|Double-Blind Phase|Lost to Follow-up|2
2610699|NCT00992589|9025747|P3|Double-Blind Phase|Lost to Follow-up|0
2610700|NCT00992589|9025748|P2|Double-Blind Phase|Lost to Follow-up|0
2610701|NCT00992589|9025749|P1|Double-Blind Phase|Lost to Follow-up|0
2610702|NCT00992589|9025746|P4|Double-Blind Phase|Withdrawal by Subject|2
2610703|NCT00992589|9025747|P3|Double-Blind Phase|Withdrawal by Subject|5
2610704|NCT00992589|9025748|P2|Double-Blind Phase|Withdrawal by Subject|6
2610705|NCT00992589|9025749|P1|Double-Blind Phase|Withdrawal by Subject|0
2610706|NCT00992589|9025746|P4|Double-Blind Phase|Adverse Event|3
2610707|NCT00992589|9025747|P3|Double-Blind Phase|Adverse Event|2
2610708|NCT00992589|9025748|P2|Double-Blind Phase|Adverse Event|6
2610709|NCT00992589|9025749|P1|Double-Blind Phase|Adverse Event|0
2610710|NCT00992589|9025746|P4|Open-Label Phase|Other|0
2610711|NCT00992589|9025747|P3|Open-Label Phase|Other|0
2610712|NCT00992589|9025748|P2|Open-Label Phase|Other|0
2610713|NCT00992589|9025749|P1|Open-Label Phase|Other|45
2610714|NCT00992589|9025746|P4|Open-Label Phase|Physician Decision|0
2610715|NCT00992589|9025747|P3|Open-Label Phase|Physician Decision|0
2610716|NCT00992589|9025748|P2|Open-Label Phase|Physician Decision|0
2610717|NCT00992589|9025749|P1|Open-Label Phase|Physician Decision|4
2610718|NCT00992589|9025746|P4|Open-Label Phase|Protocol Violation|0
2610719|NCT00992589|9025747|P3|Open-Label Phase|Protocol Violation|0
2610720|NCT00992589|9025748|P2|Open-Label Phase|Protocol Violation|0
2610721|NCT00992589|9025749|P1|Open-Label Phase|Protocol Violation|3
2610722|NCT00992589|9025746|P4|Open-Label Phase|Lost to Follow-up|0
2610723|NCT00992589|9025747|P3|Open-Label Phase|Lost to Follow-up|0
2610724|NCT00992589|9025748|P2|Open-Label Phase|Lost to Follow-up|0
2610725|NCT00992589|9025749|P1|Open-Label Phase|Lost to Follow-up|1
2610726|NCT00992589|9025746|P4|Open-Label Phase|Withdrawal by Subject|0
2610727|NCT00992589|9025747|P3|Open-Label Phase|Withdrawal by Subject|0
2610728|NCT00992589|9025748|P2|Open-Label Phase|Withdrawal by Subject|0
2610729|NCT00992589|9025749|P1|Open-Label Phase|Withdrawal by Subject|20
2610730|NCT00992589|9025746|P4|Open-Label Phase|Adverse Event|0
2610731|NCT00992589|9025747|P3|Open-Label Phase|Adverse Event|0
2610732|NCT00992589|9025748|P2|Open-Label Phase|Adverse Event|0
2610733|NCT00992589|9025749|P1|Open-Label Phase|Adverse Event|4
2610734|NCT00992511|9025795|P4|Overall Study|Withdrawal by Subject|1
2610735|NCT00992511|9025796|P3|Overall Study|Withdrawal by Subject|1
2610736|NCT00992511|9025797|P2|Overall Study|Withdrawal by Subject|0
2610737|NCT00992511|9025798|P1|Overall Study|Withdrawal by Subject|0
2610738|NCT00992511|9025795|P4|Overall Study|Lost to Follow-up|2
2610739|NCT00992511|9025796|P3|Overall Study|Lost to Follow-up|0
2610740|NCT00992511|9025797|P2|Overall Study|Lost to Follow-up|0
2610741|NCT00992511|9025798|P1|Overall Study|Lost to Follow-up|1
2610742|NCT00992511|9025795|P4|Overall Study|Migrated/moved from study area|2
2610743|NCT00992511|9025796|P3|Overall Study|Migrated/moved from study area|1
2610744|NCT00992511|9025797|P2|Overall Study|Migrated/moved from study area|0
2610745|NCT00992511|9025798|P1|Overall Study|Migrated/moved from study area|1
2610746|NCT00992459|9025882|P2|Overall Study|Adverse Event|0
2610747|NCT00992459|9025883|P1|Overall Study|Adverse Event|1
2610748|NCT00992459|9025882|P2|Overall Study|Withdrawal by Subject|1
2610749|NCT00992459|9025883|P1|Overall Study|Withdrawal by Subject|0
2610750|NCT00992446|9025907|P1|Overall Study|Maintenance Therapy Screen Fail|5
2610751|NCT00992446|9025907|P1|Overall Study|Withdrawal by Subject|2
2610752|NCT00992446|9025907|P1|Overall Study|Disease Progression|1
2610753|NCT00992407|9025982|P2|Overall Study|Study medication not administered|13
2610754|NCT00992407|9025983|P1|Overall Study|Study medication not administered|17
2610755|NCT00992407|9025982|P2|Overall Study|Loss of follow-up & Adverse events|1
2610756|NCT00992407|9025983|P1|Overall Study|Loss of follow-up & Adverse events|2
2610757|NCT00992407|9025982|P2|Overall Study|Other|0
2610758|NCT00992407|9025983|P1|Overall Study|Other|2
2610759|NCT00992407|9025982|P2|Overall Study|protocol Violation & Adverse events|4
2610760|NCT00992407|9025983|P1|Overall Study|protocol Violation & Adverse events|2
2610761|NCT00992407|9025982|P2|Overall Study|Adverse Event|2
2610762|NCT00992407|9025983|P1|Overall Study|Adverse Event|3
2610763|NCT00992407|9025982|P2|Overall Study|Lost to Follow-up|3
2610764|NCT00992407|9025983|P1|Overall Study|Lost to Follow-up|3
2610765|NCT00992407|9025982|P2|Overall Study|Protocol Violation|1
2610766|NCT00992407|9025983|P1|Overall Study|Protocol Violation|2
2610767|NCT00992394|9026033|P2|Overall Study|Other event|0
2610768|NCT00992394|9026034|P1|Overall Study|Other event|1
2610769|NCT00992394|9026033|P2|Overall Study|Lost to Follow-up|0
2610770|NCT00992394|9026034|P1|Overall Study|Lost to Follow-up|2
2610771|NCT00992394|9026033|P2|Overall Study|Protocol Violation|4
2610772|NCT00992394|9026034|P1|Overall Study|Protocol Violation|2
2610773|NCT00992394|9026033|P2|Overall Study|Physician Decision|0
2610774|NCT00992394|9026034|P1|Overall Study|Physician Decision|1
2610775|NCT00992394|9026033|P2|Overall Study|Withdrawal by Subject|2
2610776|NCT00992394|9026034|P1|Overall Study|Withdrawal by Subject|8
2610777|NCT00992394|9026033|P2|Overall Study|Adverse Event|5
2610778|NCT00992394|9026034|P1|Overall Study|Adverse Event|4
2610779|NCT00992394|9026033|P2|Overall Study|Lack of Efficacy|3
2610780|NCT00992394|9026034|P1|Overall Study|Lack of Efficacy|6
2610781|NCT00992225|9026121|P1|Overall Study|Adverse Event|2
2610782|NCT00992225|9026121|P1|Overall Study|Entry Criteria Not Met|8
2610783|NCT00992186|9026131|P1|Overall Study|Refusal To Receive Study Agent|3
2610784|NCT00992186|9026131|P1|Overall Study|Progressive Disease|30
2610785|NCT00992186|9026131|P1|Overall Study|Adverse Event|9
2610786|NCT00992186|9026131|P1|Overall Study|Physician Decision|1
2610787|NCT00992186|9026131|P1|Overall Study|Protocol Violation|1
2610788|NCT00992186|9026131|P1|Overall Study|Withdrawal by Subject|2
2610789|NCT00992108|9026150|P2|Overall Study|Lost to Follow-up|1
2610790|NCT00992108|9026151|P1|Overall Study|Lost to Follow-up|0
2610791|NCT00992056|9026165|P2|Washout Period (2 Weeks)|Physician Decision|0
2610792|NCT00992056|9026166|P1|Washout Period (2 Weeks)|Physician Decision|1
2610793|NCT00992056|9026165|P2|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2
2610794|NCT00992056|9026166|P1|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1
2610795|NCT00992017|9026172|P1|Overall Study|Not adhere to study requirements|1
2610796|NCT00992017|9026172|P1|Overall Study|Unable to get to clinic|5
2610797|NCT00992017|9026172|P1|Overall Study|Withdrawal by Subject|2
2610798|NCT00992017|9026172|P1|Overall Study|Lost to Follow-up|2
2610799|NCT00991952|9026187|P2|Overall Study|Adverse Event|1
2610800|NCT00991952|9026188|P1|Overall Study|Adverse Event|0
2610801|NCT00991939|9026196|P2|Overall Study|Entire study terminated|1
2610802|NCT00991939|9026197|P1|Overall Study|Entire study terminated|4
2610803|NCT00991939|9026196|P2|Overall Study|Withdrawal by Subject|0
2610804|NCT00991939|9026197|P1|Overall Study|Withdrawal by Subject|1
2610805|NCT00991939|9026196|P2|Overall Study|Lost to Follow-up|1
2610806|NCT00991939|9026197|P1|Overall Study|Lost to Follow-up|0
2610807|NCT00991887|9026231|P2|Overall Study|Lost to Follow-up|1
2610808|NCT00991887|9026232|P1|Overall Study|Lost to Follow-up|2
2610809|NCT00991510|9026251|P2|Period III (Days 29-112)|Adverse Event|1
2610810|NCT00991510|9026252|P1|Period III (Days 29-112)|Adverse Event|1
2610811|NCT00991510|9026251|P2|Period I (Days 1-14)|Adverse Event|0
2610812|NCT00991510|9026252|P1|Period I (Days 1-14)|Adverse Event|1
2610813|NCT00991406|9026296|P1|Overall Study|One participant did not respond to FES.|1
2610814|NCT00991341|9026305|P2|Overall Study|Withdrawal by Subject|4
2610815|NCT00991341|9026306|P1|Overall Study|Withdrawal by Subject|3
2610816|NCT00991341|9026305|P2|Overall Study|Physician Decision|2
2610817|NCT00991341|9026306|P1|Overall Study|Physician Decision|1
2610818|NCT00991341|9026305|P2|Overall Study|no RBCs received 96hrs after randomized|155
2610819|NCT00991341|9026306|P1|Overall Study|no RBCs received 96hrs after randomized|186
2610820|NCT00991341|9026305|P2|Overall Study|Death|0
2610821|NCT00991341|9026306|P1|Overall Study|Death|3
2610822|NCT00991341|9026305|P2|Overall Study|no surgery w/in 30 days of randomization|18
2610823|NCT00991341|9026306|P1|Overall Study|no surgery w/in 30 days of randomization|11
2610824|NCT00991302|9026344|P2|Overall Study|Lost to Follow-up|12
2610825|NCT00991302|9026345|P1|Overall Study|Lost to Follow-up|14
2610826|NCT00991302|9026344|P2|Overall Study|Death|1
2610827|NCT00991302|9026345|P1|Overall Study|Death|0
2610828|NCT00991289|9026361|P1|Overall Study|Protocol Violation|2
2610829|NCT00991289|9026361|P1|Overall Study|Lost to Follow-up|4
2610830|NCT00991289|9026361|P1|Overall Study|Withdrawal by Subject|3
2610831|NCT00991289|9026361|P1|Overall Study|Physician Decision|2
2610832|NCT00991289|9026361|P1|Overall Study|Adverse Event|1
2610833|NCT00991276|9026381|P6|Third Intervention Period|Withdrawal by Subject|0
2610834|NCT00991276|9026382|P5|Third Intervention Period|Withdrawal by Subject|0
2610835|NCT00991276|9026383|P4|Third Intervention Period|Withdrawal by Subject|1
2610836|NCT00991276|9026384|P3|Third Intervention Period|Withdrawal by Subject|0
2610837|NCT00991276|9026385|P2|Third Intervention Period|Withdrawal by Subject|0
2610838|NCT00991276|9026386|P1|Third Intervention Period|Withdrawal by Subject|0
2610839|NCT00991276|9026381|P6|Third Intervention Period|Adverse Event|0
2610840|NCT00991276|9026382|P5|Third Intervention Period|Adverse Event|0
2610841|NCT00991276|9026383|P4|Third Intervention Period|Adverse Event|0
2610842|NCT00991276|9026384|P3|Third Intervention Period|Adverse Event|1
2610843|NCT00991276|9026385|P2|Third Intervention Period|Adverse Event|0
2610844|NCT00991276|9026386|P1|Third Intervention Period|Adverse Event|0
2610845|NCT00991276|9026381|P6|Third Intervention Period|Other|1
2610846|NCT00991276|9026382|P5|Third Intervention Period|Other|0
2610847|NCT00991276|9026383|P4|Third Intervention Period|Other|0
2610848|NCT00991276|9026384|P3|Third Intervention Period|Other|0
2610849|NCT00991276|9026385|P2|Third Intervention Period|Other|0
2610850|NCT00991276|9026386|P1|Third Intervention Period|Other|0
2610851|NCT00991276|9026381|P6|Third Intervention Period|Protocol Violation|0
2610852|NCT00991276|9026382|P5|Third Intervention Period|Protocol Violation|0
2610853|NCT00991276|9026383|P4|Third Intervention Period|Protocol Violation|0
2610854|NCT00991276|9026384|P3|Third Intervention Period|Protocol Violation|0
2610855|NCT00991276|9026385|P2|Third Intervention Period|Protocol Violation|0
2610856|NCT00991276|9026386|P1|Third Intervention Period|Protocol Violation|1
2610857|NCT00991276|9026381|P6|Second Intervention Period|Other|1
2610858|NCT00991276|9026382|P5|Second Intervention Period|Other|0
2610859|NCT00991276|9026383|P4|Second Intervention Period|Other|1
2610860|NCT00991276|9026384|P3|Second Intervention Period|Other|0
2610861|NCT00991276|9026385|P2|Second Intervention Period|Other|0
2610862|NCT00991276|9026386|P1|Second Intervention Period|Other|0
2610863|NCT00991276|9026381|P6|Second Intervention Period|Protocol Violation|0
2610864|NCT00991276|9026382|P5|Second Intervention Period|Protocol Violation|0
2610865|NCT00991276|9026383|P4|Second Intervention Period|Protocol Violation|0
2610866|NCT00991276|9026384|P3|Second Intervention Period|Protocol Violation|0
2610867|NCT00991276|9026385|P2|Second Intervention Period|Protocol Violation|0
2610868|NCT00991276|9026386|P1|Second Intervention Period|Protocol Violation|1
2610869|NCT00991276|9026381|P6|Second Intervention Period|Adverse Event|0
2610870|NCT00991276|9026382|P5|Second Intervention Period|Adverse Event|1
2610871|NCT00991276|9026383|P4|Second Intervention Period|Adverse Event|1
2610872|NCT00991276|9026384|P3|Second Intervention Period|Adverse Event|0
2610873|NCT00991276|9026385|P2|Second Intervention Period|Adverse Event|2
2610874|NCT00991276|9026386|P1|Second Intervention Period|Adverse Event|0
2610875|NCT00991276|9026381|P6|First Intervention Period|Lost to Follow-up|0
2610876|NCT00991276|9026382|P5|First Intervention Period|Lost to Follow-up|0
2610877|NCT00991276|9026383|P4|First Intervention Period|Lost to Follow-up|1
2610878|NCT00991276|9026384|P3|First Intervention Period|Lost to Follow-up|0
2610879|NCT00991276|9026385|P2|First Intervention Period|Lost to Follow-up|1
2610880|NCT00991276|9026386|P1|First Intervention Period|Lost to Follow-up|0
2610881|NCT00991276|9026381|P6|First Intervention Period|Withdrawal by Subject|1
2610882|NCT00991276|9026382|P5|First Intervention Period|Withdrawal by Subject|0
2610883|NCT00991276|9026383|P4|First Intervention Period|Withdrawal by Subject|1
2610884|NCT00991276|9026384|P3|First Intervention Period|Withdrawal by Subject|0
2610885|NCT00991276|9026385|P2|First Intervention Period|Withdrawal by Subject|1
2610886|NCT00991276|9026386|P1|First Intervention Period|Withdrawal by Subject|0
2610887|NCT00991276|9026381|P6|First Intervention Period|Other|0
2610888|NCT00991276|9026382|P5|First Intervention Period|Other|1
2610889|NCT00991276|9026383|P4|First Intervention Period|Other|1
2610890|NCT00991276|9026384|P3|First Intervention Period|Other|0
2610891|NCT00991276|9026385|P2|First Intervention Period|Other|0
2610892|NCT00991276|9026386|P1|First Intervention Period|Other|0
2610893|NCT00991276|9026381|P6|First Intervention Period|Insufficient clinical response|0
2610894|NCT00991276|9026382|P5|First Intervention Period|Insufficient clinical response|1
2610895|NCT00991276|9026383|P4|First Intervention Period|Insufficient clinical response|0
2610896|NCT00991276|9026384|P3|First Intervention Period|Insufficient clinical response|0
2610897|NCT00991276|9026385|P2|First Intervention Period|Insufficient clinical response|0
2610898|NCT00991276|9026386|P1|First Intervention Period|Insufficient clinical response|0
2610899|NCT00991276|9026381|P6|First Intervention Period|Protocol Violation|0
2610900|NCT00991276|9026382|P5|First Intervention Period|Protocol Violation|2
2610901|NCT00991276|9026383|P4|First Intervention Period|Protocol Violation|0
2610902|NCT00991276|9026384|P3|First Intervention Period|Protocol Violation|0
2610903|NCT00991276|9026385|P2|First Intervention Period|Protocol Violation|0
2610904|NCT00991276|9026386|P1|First Intervention Period|Protocol Violation|0
2610905|NCT00991276|9026381|P6|First Intervention Period|Adverse Event|0
2610906|NCT00991276|9026382|P5|First Intervention Period|Adverse Event|0
2610907|NCT00991276|9026383|P4|First Intervention Period|Adverse Event|1
2610908|NCT00991276|9026384|P3|First Intervention Period|Adverse Event|0
2610909|NCT00991276|9026385|P2|First Intervention Period|Adverse Event|1
2610910|NCT00991276|9026386|P1|First Intervention Period|Adverse Event|0
2610911|NCT00990821|9026601|P14|Overall Study|Withdrawal by Subject|1
2610912|NCT00990821|9026602|P13|Overall Study|Withdrawal by Subject|2
2610913|NCT00990821|9026603|P12|Overall Study|Withdrawal by Subject|5
2610914|NCT00990821|9026604|P11|Overall Study|Withdrawal by Subject|3
2610915|NCT00990821|9026605|P10|Overall Study|Withdrawal by Subject|1
2610916|NCT00990821|9026606|P9|Overall Study|Withdrawal by Subject|0
2610917|NCT00990821|9026607|P8|Overall Study|Withdrawal by Subject|0
2610918|NCT00990821|9026608|P7|Overall Study|Withdrawal by Subject|1
2610919|NCT00990821|9026609|P6|Overall Study|Withdrawal by Subject|3
2610920|NCT00990821|9026610|P5|Overall Study|Withdrawal by Subject|3
2610921|NCT00990821|9026611|P4|Overall Study|Withdrawal by Subject|0
2610922|NCT00990821|9026612|P3|Overall Study|Withdrawal by Subject|0
2610923|NCT00990821|9026613|P2|Overall Study|Withdrawal by Subject|2
2610924|NCT00990821|9026614|P1|Overall Study|Withdrawal by Subject|0
2610925|NCT00990704|9026651|P2|Overall Study|Physician Decision|1
2610926|NCT00990704|9026652|P1|Overall Study|Physician Decision|0
2610927|NCT00990704|9026651|P2|Overall Study|Adverse Event|1
2610928|NCT00990704|9026652|P1|Overall Study|Adverse Event|1
2610929|NCT00990665|9026672|P1|Overall Study|System Explant|3
2610930|NCT00990665|9026672|P1|Overall Study|Lost to Follow-up|1
2610931|NCT00990665|9026672|P1|Overall Study|Withdrawal by Subject|6
2610932|NCT00990665|9026672|P1|Overall Study|Heart Transplant|1
2610933|NCT00990665|9026672|P1|Overall Study|Death|29
2610934|NCT00990665|9026672|P1|Overall Study|Unsuccessful Implant|8
2610935|NCT00990652|9026679|P1|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1
2610936|NCT00990652|9026679|P1|Pre-surgical Bortezomib|Adverse Event|1
2610937|NCT00990340|9026713|P2|First 14-day Treatment|Protocol Violation|2
2610938|NCT00990340|9026714|P1|First 14-day Treatment|Protocol Violation|2
2610939|NCT00990340|9026713|P2|First 14-day Treatment|Lost to Follow-up|1
2610940|NCT00990340|9026714|P1|First 14-day Treatment|Lost to Follow-up|2
2610941|NCT00990340|9026713|P2|First 14-day Treatment|Not Compliant|1
2610942|NCT00990340|9026714|P1|First 14-day Treatment|Not Compliant|2
2610943|NCT00990314|9026728|P1|Overall Study|Lack of Efficacy|1
2610944|NCT00990314|9026728|P1|Overall Study|Physician Decision|3
2610945|NCT00990314|9026728|P1|Overall Study|Non-Compliance|1
2610946|NCT00990314|9026728|P1|Overall Study|Withdrawal by Subject|3
2610947|NCT00990314|9026728|P1|Overall Study|Adverse Event|2
2610948|NCT00990314|9026728|P1|Overall Study|Death|2
2610949|NCT00990249|9026770|P1|Overall Study|Not treated|2
2610950|NCT00990249|9026770|P1|Overall Study|Death|2
2610951|NCT00990249|9026770|P1|Overall Study|Non-Compliance|1
2610952|NCT00990249|9026770|P1|Overall Study|Disease Progression|8
2610953|NCT00990184|9026785|P1|Overall Study|Physician Decision|1
2610954|NCT00990106|9026793|P2|Overall Study|scheduling conflicts|2
2610955|NCT00990106|9026794|P1|Overall Study|scheduling conflicts|0
2610956|NCT00990106|9026793|P2|Overall Study|planned major surgery|1
2610957|NCT00990106|9026794|P1|Overall Study|planned major surgery|0
2610958|NCT00990106|9026793|P2|Overall Study|started exclusionary medication|1
2610959|NCT00990106|9026794|P1|Overall Study|started exclusionary medication|0
2610960|NCT00990106|9026793|P2|Overall Study|relocation/deployment|1
2610961|NCT00990106|9026794|P1|Overall Study|relocation/deployment|4
2610962|NCT00990106|9026793|P2|Overall Study|opted for open label prazosin|1
2610963|NCT00990106|9026794|P1|Overall Study|opted for open label prazosin|1
2610964|NCT00990106|9026793|P2|Overall Study|Withdrawal by Subject|1
2610965|NCT00990106|9026794|P1|Overall Study|Withdrawal by Subject|2
2610966|NCT00990106|9026793|P2|Overall Study|Lost to Follow-up|3
2610967|NCT00990106|9026794|P1|Overall Study|Lost to Follow-up|1
2610968|NCT00990106|9026793|P2|Overall Study|"too busy to continue"|2
2610969|NCT00990106|9026794|P1|Overall Study|"too busy to continue"|1
2610970|NCT00990093|9026804|P2|Test Period 2 (15-28 Days)|Other|1
2610971|NCT00990093|9026805|P1|Test Period 2 (15-28 Days)|Other|0
2610972|NCT00990093|9026804|P2|Test Period 2 (15-28 Days)|Lack of Efficacy|0
2610973|NCT00990093|9026805|P1|Test Period 2 (15-28 Days)|Lack of Efficacy|1
2610974|NCT00990093|9026804|P2|Test Period 2 (15-28 Days)|Adverse Event|0
2610975|NCT00990093|9026805|P1|Test Period 2 (15-28 Days)|Adverse Event|1
2610976|NCT00990093|9026804|P2|Test Period 1 (1-14 Days)|Lack of Efficacy|2
2610977|NCT00990093|9026805|P1|Test Period 1 (1-14 Days)|Lack of Efficacy|0
2610978|NCT00990093|9026804|P2|Test Period 1 (1-14 Days)|Other|0
2610979|NCT00990093|9026805|P1|Test Period 1 (1-14 Days)|Other|1
2610980|NCT00990093|9026804|P2|Test Period 1 (1-14 Days)|Withdrawal by Subject|0
2610981|NCT00990093|9026805|P1|Test Period 1 (1-14 Days)|Withdrawal by Subject|2
2610982|NCT00990093|9026804|P2|Test Period 1 (1-14 Days)|Adverse Event|0
2610983|NCT00990093|9026805|P1|Test Period 1 (1-14 Days)|Adverse Event|1
2610984|NCT00989950|9026858|P4|Randomized Phase|Adverse Event|0
2610985|NCT00989950|9026859|P3|Randomized Phase|Adverse Event|0
2610986|NCT00989950|9026860|P2|Randomized Phase|Adverse Event|1
2610987|NCT00989950|9026861|P1|Randomized Phase|Adverse Event|0
2610988|NCT00989950|9026858|P4|Randomized Phase|Protocol Violation|0
2610989|NCT00989950|9026859|P3|Randomized Phase|Protocol Violation|0
2610990|NCT00989950|9026860|P2|Randomized Phase|Protocol Violation|0
2610991|NCT00989950|9026861|P1|Randomized Phase|Protocol Violation|1
2610992|NCT00989833|9026893|P3|Overall Study|Incorrectly randomized|0
2610993|NCT00989833|9026894|P2|Overall Study|Incorrectly randomized|0
2610994|NCT00989833|9026895|P1|Overall Study|Incorrectly randomized|1
2610995|NCT00989833|9026893|P3|Overall Study|Withdrawal by Subject|1
2610996|NCT00989833|9026894|P2|Overall Study|Withdrawal by Subject|0
2610997|NCT00989833|9026895|P1|Overall Study|Withdrawal by Subject|0
2610998|NCT00989833|9026893|P3|Overall Study|Protocol Violation|1
2610999|NCT00989833|9026894|P2|Overall Study|Protocol Violation|2
2611000|NCT00989833|9026895|P1|Overall Study|Protocol Violation|1
2611001|NCT00989833|9026893|P3|Overall Study|Lost to Follow-up|0
2611002|NCT00989833|9026894|P2|Overall Study|Lost to Follow-up|1
2611003|NCT00989833|9026895|P1|Overall Study|Lost to Follow-up|0
2611004|NCT00989781|9026926|P2|Ovarian Response to hCG|Lost to Follow-up|2
2611005|NCT00989781|9026927|P1|Ovarian Response to hCG|Lost to Follow-up|3
2611006|NCT00989664|9026957|P1|Long-Term Follow-Up|Death|3
2611007|NCT00989664|9026957|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1
2611008|NCT00989664|9026957|P1|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7
2611009|NCT00989664|9026957|P1|Dosimetric and Therapeutic Treatment|Death|1
2611010|NCT00989664|9026957|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|49
2611011|NCT00989664|9026957|P1|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2
2611012|NCT00989664|9026957|P1|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1
2611013|NCT00989287|9027042|P2|Overall Study|Lost to Follow-up|1
2611014|NCT00989287|9027043|P1|Overall Study|Lost to Follow-up|0
2611015|NCT00989287|9027042|P2|Overall Study|Adverse Event|0
2611016|NCT00989287|9027043|P1|Overall Study|Adverse Event|1
2611017|NCT00989261|9027145|P2|Overall Study|Lost to Follow-up|0
2611018|NCT00989261|9027146|P1|Overall Study|Lost to Follow-up|3
2611019|NCT00989261|9027145|P2|Overall Study|Withdrawal by Subject|1
2611020|NCT00989261|9027146|P1|Overall Study|Withdrawal by Subject|0
2611021|NCT00989261|9027145|P2|Overall Study|Still in follow up|21
2611022|NCT00989261|9027146|P1|Overall Study|Still in follow up|12
2611023|NCT00989235|9027176|P2|Overall Study|Lost to Follow-up|1
2611024|NCT00989235|9027177|P1|Overall Study|Lost to Follow-up|0
2611025|NCT00989235|9027176|P2|Overall Study|Randomized by Mistake|2
2611026|NCT00989235|9027177|P1|Overall Study|Randomized by Mistake|0
2611027|NCT00989235|9027176|P2|Overall Study|Desire to Become Pregnant|0
2611028|NCT00989235|9027177|P1|Overall Study|Desire to Become Pregnant|1
2611029|NCT00989235|9027176|P2|Overall Study|Withdrawal of Consent|1
2611030|NCT00989235|9027177|P1|Overall Study|Withdrawal of Consent|1
2611031|NCT00989235|9027176|P2|Overall Study|Lack of Efficacy|0
2611032|NCT00989235|9027177|P1|Overall Study|Lack of Efficacy|1
2611033|NCT00989235|9027176|P2|Overall Study|Adverse Event|1
2611034|NCT00989235|9027177|P1|Overall Study|Adverse Event|0
2611035|NCT00989235|9027176|P2|Overall Study|Death|1
2611036|NCT00989235|9027177|P1|Overall Study|Death|0
2611037|NCT00989196|9027222|P2|Treatment Period|Lost to Follow-up|0
2611038|NCT00989196|9027223|P1|Treatment Period|Lost to Follow-up|1
2611039|NCT00989092|9027261|P2|Overall Study|Did not receive study drug|0
2611040|NCT00989092|9027262|P1|Overall Study|Did not receive study drug|2
2611041|NCT00989092|9027261|P2|Overall Study|Erythropoietin therapy initiated|0
2611042|NCT00989092|9027262|P1|Overall Study|Erythropoietin therapy initiated|2
2611043|NCT00989092|9027261|P2|Overall Study|Protocol deviation|0
2611044|NCT00989092|9027262|P1|Overall Study|Protocol deviation|2
2611045|NCT00989092|9027261|P2|Overall Study|Other|1
2611046|NCT00989092|9027262|P1|Overall Study|Other|3
2611047|NCT00989092|9027261|P2|Overall Study|Lost to Follow-up|2
2611048|NCT00989092|9027262|P1|Overall Study|Lost to Follow-up|6
2611049|NCT00989092|9027261|P2|Overall Study|Ineligibility determined|3
2611050|NCT00989092|9027262|P1|Overall Study|Ineligibility determined|3
2611051|NCT00989092|9027261|P2|Overall Study|Death|2
2611052|NCT00989092|9027262|P1|Overall Study|Death|14
2611053|NCT00989092|9027261|P2|Overall Study|Withdrawal by Subject|9
2611054|NCT00989092|9027262|P1|Overall Study|Withdrawal by Subject|17
2611055|NCT00989092|9027261|P2|Overall Study|Chemotherapy initiated|4
2611056|NCT00989092|9027262|P1|Overall Study|Chemotherapy initiated|12
2611057|NCT00989092|9027261|P2|Overall Study|Adverse Event|1
2611058|NCT00989092|9027262|P1|Overall Study|Adverse Event|20
2611059|NCT00989092|9027261|P2|Overall Study|Physician Decision|6
2611060|NCT00989092|9027262|P1|Overall Study|Physician Decision|9
2611061|NCT00988884|9027314|P2|Overall Study|Withdrawal by Subject|18
2611062|NCT00988884|9027315|P1|Overall Study|Withdrawal by Subject|15
2611063|NCT00988884|9027314|P2|Overall Study|Protocol Violation|1
2611064|NCT00988884|9027315|P1|Overall Study|Protocol Violation|0
2611065|NCT00988884|9027314|P2|Overall Study|Lost to Follow-up|16
2611066|NCT00988884|9027315|P1|Overall Study|Lost to Follow-up|20
2611067|NCT00988884|9027314|P2|Overall Study|Adverse Event|1
2611068|NCT00988884|9027315|P1|Overall Study|Adverse Event|0
2611069|NCT00988858|9027337|P1|Overall Study|Sponsor Decision|1
2611070|NCT00988858|9027337|P1|Overall Study|Physician Decision|1
2611071|NCT00988858|9027337|P1|Overall Study|Death|1
2611072|NCT00988858|9027337|P1|Overall Study|Adverse Event|7
2611073|NCT00988637|9027386|P2|Overall Study|non-compliance with study drug|1
2611074|NCT00988637|9027387|P1|Overall Study|non-compliance with study drug|0
2611075|NCT00988637|9027386|P2|Overall Study|Withdrawal by Subject|1
2611076|NCT00988637|9027387|P1|Overall Study|Withdrawal by Subject|1
2611077|NCT00988637|9027386|P2|Overall Study|Lost to Follow-up|1
2611078|NCT00988637|9027387|P1|Overall Study|Lost to Follow-up|2
2611079|NCT00988559|9027421|P4|Overall Study|Lost to Follow-up|0
2611080|NCT00988559|9027422|P3|Overall Study|Lost to Follow-up|1
2611081|NCT00988559|9027423|P2|Overall Study|Lost to Follow-up|0
2611082|NCT00988559|9027424|P1|Overall Study|Lost to Follow-up|0
2611083|NCT00988559|9027421|P4|Overall Study|Pregnancy|0
2611084|NCT00988559|9027422|P3|Overall Study|Pregnancy|1
2611085|NCT00988559|9027423|P2|Overall Study|Pregnancy|1
2611086|NCT00988559|9027424|P1|Overall Study|Pregnancy|0
2611087|NCT00988559|9027421|P4|Overall Study|Withdrawal by Subject|1
2611088|NCT00988559|9027422|P3|Overall Study|Withdrawal by Subject|0
2611089|NCT00988559|9027423|P2|Overall Study|Withdrawal by Subject|1
2611090|NCT00988559|9027424|P1|Overall Study|Withdrawal by Subject|1
2611091|NCT00988533|9027438|P1|Overall Study|Lost to Follow-up|3
2611092|NCT00988442|9027452|P2|Overall Study|Early Study Closure|25
2611093|NCT00988442|9027453|P1|Overall Study|Early Study Closure|29
2611094|NCT00988442|9027452|P2|Overall Study|Lost to Follow-up|1
2611095|NCT00988442|9027453|P1|Overall Study|Lost to Follow-up|0
2611096|NCT00988442|9027452|P2|Overall Study|Death|2
2611097|NCT00988442|9027453|P1|Overall Study|Death|1
2611098|NCT00988429|9027516|P3|Overall Study|other reasons|1
2611099|NCT00988429|9027517|P2|Overall Study|other reasons|8
2611100|NCT00988429|9027518|P1|Overall Study|other reasons|8
2611101|NCT00988429|9027516|P3|Overall Study|Administrative Reasons|1
2611102|NCT00988429|9027517|P2|Overall Study|Administrative Reasons|2
2611103|NCT00988429|9027518|P1|Overall Study|Administrative Reasons|1
2611104|NCT00988429|9027516|P3|Overall Study|Withdrawal by Subject|12
2611105|NCT00988429|9027517|P2|Overall Study|Withdrawal by Subject|7
2611106|NCT00988429|9027518|P1|Overall Study|Withdrawal by Subject|7
2611107|NCT00988429|9027516|P3|Overall Study|Protocol Violation|3
2611108|NCT00988429|9027517|P2|Overall Study|Protocol Violation|3
2611109|NCT00988429|9027518|P1|Overall Study|Protocol Violation|4
2611110|NCT00988429|9027516|P3|Overall Study|Pregnancy|0
2611111|NCT00988429|9027517|P2|Overall Study|Pregnancy|1
2611112|NCT00988429|9027518|P1|Overall Study|Pregnancy|2
2611113|NCT00988429|9027516|P3|Overall Study|Physician Decision|3
2611114|NCT00988429|9027517|P2|Overall Study|Physician Decision|0
2611115|NCT00988429|9027518|P1|Overall Study|Physician Decision|1
2611116|NCT00988429|9027516|P3|Overall Study|Non-Compliance with Study Drug|3
2611117|NCT00988429|9027517|P2|Overall Study|Non-Compliance with Study Drug|1
2611118|NCT00988429|9027518|P1|Overall Study|Non-Compliance with Study Drug|5
2611119|NCT00988429|9027516|P3|Overall Study|Lack of Efficacy|1
2611120|NCT00988429|9027517|P2|Overall Study|Lack of Efficacy|0
2611121|NCT00988429|9027518|P1|Overall Study|Lack of Efficacy|0
2611122|NCT00988429|9027516|P3|Overall Study|Adverse Event|45
2611123|NCT00988429|9027517|P2|Overall Study|Adverse Event|21
2611124|NCT00988429|9027518|P1|Overall Study|Adverse Event|9
2611125|NCT00988351|9027531|P2|Overall Study|not using CPAP|3
2611126|NCT00988351|9027532|P1|Overall Study|not using CPAP|5
2611127|NCT00988351|9027531|P2|Overall Study|Lost to Follow-up|9
2611128|NCT00988351|9027532|P1|Overall Study|Lost to Follow-up|6
2611129|NCT00988351|9027531|P2|Overall Study|Withdrawal by Subject|0
2611130|NCT00988351|9027532|P1|Overall Study|Withdrawal by Subject|8
2611131|NCT00988247|9027609|P2|Overall Study|Other|0
2611132|NCT00988247|9027610|P1|Overall Study|Other|3
2611133|NCT00988247|9027609|P2|Overall Study|Sponsor requested withdrawal|1
2611134|NCT00988247|9027610|P1|Overall Study|Sponsor requested withdrawal|3
2611135|NCT00988247|9027609|P2|Overall Study|Protocol Violation|5
2611136|NCT00988247|9027610|P1|Overall Study|Protocol Violation|4
2611137|NCT00988247|9027609|P2|Overall Study|Lost to Follow-up|2
2611138|NCT00988247|9027610|P1|Overall Study|Lost to Follow-up|11
2611139|NCT00988247|9027609|P2|Overall Study|Pregnancy|2
2611140|NCT00988247|9027610|P1|Overall Study|Pregnancy|1
2611141|NCT00988247|9027609|P2|Overall Study|Withdrawal by Subject|13
2611142|NCT00988247|9027610|P1|Overall Study|Withdrawal by Subject|44
2611143|NCT00988247|9027609|P2|Overall Study|Adverse Event|3
2611144|NCT00988247|9027610|P1|Overall Study|Adverse Event|17
2611145|NCT00988221|9027629|P4|Part III|Refused Treatment|0
2611146|NCT00988221|9027630|P3|Part III|Refused Treatment|1
2611147|NCT00988221|9027631|P2|Part III|Refused Treatment|0
2611148|NCT00988221|9027632|P1|Part III|Refused Treatment|0
2611149|NCT00988221|9027629|P4|Part III|Insufficient Therapeutic Response|0
2611150|NCT00988221|9027630|P3|Part III|Insufficient Therapeutic Response|1
2611151|NCT00988221|9027631|P2|Part III|Insufficient Therapeutic Response|1
2611152|NCT00988221|9027632|P1|Part III|Insufficient Therapeutic Response|0
2611153|NCT00988221|9027629|P4|Part III|Adverse Event|0
2611154|NCT00988221|9027630|P3|Part III|Adverse Event|1
2611155|NCT00988221|9027631|P2|Part III|Adverse Event|0
2611156|NCT00988221|9027632|P1|Part III|Adverse Event|1
2611157|NCT00988221|9027629|P4|Part II|Reason not Specified|0
2611158|NCT00988221|9027630|P3|Part II|Reason not Specified|1
2611159|NCT00988221|9027631|P2|Part II|Reason not Specified|0
2611160|NCT00988221|9027632|P1|Part II|Reason not Specified|0
2611161|NCT00988221|9027629|P4|Part II|Withdrawal by Subject|2
2611162|NCT00988221|9027630|P3|Part II|Withdrawal by Subject|2
2611163|NCT00988221|9027631|P2|Part II|Withdrawal by Subject|0
2611164|NCT00988221|9027632|P1|Part II|Withdrawal by Subject|0
2611165|NCT00988221|9027629|P4|Part II|Adverse Event|1
2611166|NCT00988221|9027630|P3|Part II|Adverse Event|0
2611167|NCT00988221|9027631|P2|Part II|Adverse Event|0
2611168|NCT00988221|9027632|P1|Part II|Adverse Event|1
2611169|NCT00988221|9027629|P4|Part I|Lost to Follow-up|0
2611170|NCT00988221|9027630|P3|Part I|Lost to Follow-up|0
2611171|NCT00988221|9027631|P2|Part I|Lost to Follow-up|1
2611172|NCT00988221|9027632|P1|Part I|Lost to Follow-up|0
2611173|NCT00988221|9027629|P4|Part I|Refused Treatment|0
2611174|NCT00988221|9027630|P3|Part I|Refused Treatment|1
2611175|NCT00988221|9027631|P2|Part I|Refused Treatment|2
2611176|NCT00988221|9027632|P1|Part I|Refused Treatment|0
2611177|NCT00988221|9027629|P4|Part I|Insufficient Therapeutic Response|0
2611178|NCT00988221|9027630|P3|Part I|Insufficient Therapeutic Response|5
2611179|NCT00988221|9027631|P2|Part I|Insufficient Therapeutic Response|6
2611180|NCT00988221|9027632|P1|Part I|Insufficient Therapeutic Response|4
2611181|NCT00988221|9027629|P4|Part I|Adverse Event|0
2611182|NCT00988221|9027630|P3|Part I|Adverse Event|2
2611183|NCT00988221|9027631|P2|Part I|Adverse Event|1
2611184|NCT00988221|9027632|P1|Part I|Adverse Event|0
2611185|NCT00988208|9027805|P2|Overall Study|Other|3
2611186|NCT00988208|9027806|P1|Overall Study|Other|8
2611187|NCT00988208|9027805|P2|Overall Study|Subject Decision/Investigator Discretion|32
2611188|NCT00988208|9027806|P1|Overall Study|Subject Decision/Investigator Discretion|32
2611189|NCT00988208|9027805|P2|Overall Study|Clinical Deterioration|14
2611190|NCT00988208|9027806|P1|Overall Study|Clinical Deterioration|7
2611191|NCT00988208|9027805|P2|Overall Study|Biochemical Progression|7
2611192|NCT00988208|9027806|P1|Overall Study|Biochemical Progression|21
2611193|NCT00988208|9027805|P2|Overall Study|Clinical Progression|16
2611194|NCT00988208|9027806|P1|Overall Study|Clinical Progression|17
2611195|NCT00988208|9027805|P2|Overall Study|Sponsor Decision|78
2611196|NCT00988208|9027806|P1|Overall Study|Sponsor Decision|102
2611197|NCT00988208|9027805|P2|Overall Study|Protocol Violation|2
2611198|NCT00988208|9027806|P1|Overall Study|Protocol Violation|9
2611199|NCT00988208|9027805|P2|Overall Study|Lost to Follow-up|3
2611200|NCT00988208|9027806|P1|Overall Study|Lost to Follow-up|2
2611201|NCT00988208|9027805|P2|Overall Study|Death|15
2611202|NCT00988208|9027806|P1|Overall Study|Death|9
2611203|NCT00988208|9027805|P2|Overall Study|Withdrawal by Subject|57
2611204|NCT00988208|9027806|P1|Overall Study|Withdrawal by Subject|50
2611205|NCT00988208|9027805|P2|Overall Study|Disease Progression|89
2611206|NCT00988208|9027806|P1|Overall Study|Disease Progression|103
2611207|NCT00988208|9027805|P2|Overall Study|Adverse Event|122
2611208|NCT00988208|9027806|P1|Overall Study|Adverse Event|71
2611209|NCT00988169|9027824|P1|Overall Study|Withdrawal by Subject|1
2611210|NCT00988117|9027876|P1|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2
2611211|NCT00988117|9027876|P1|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1
2611212|NCT00988091|9027885|P2|Open-label Period|Other|3
2611213|NCT00988091|9027886|P1|Open-label Period|Other|2
2611214|NCT00988091|9027885|P2|Open-label Period|Lost to Follow-up|5
2611215|NCT00988091|9027886|P1|Open-label Period|Lost to Follow-up|3
2611216|NCT00988091|9027885|P2|Open-label Period|Withdrawal by Subject|16
2611217|NCT00988091|9027886|P1|Open-label Period|Withdrawal by Subject|10
2611218|NCT00988091|9027885|P2|Open-label Period|Protocol Violation|1
2611219|NCT00988091|9027886|P1|Open-label Period|Protocol Violation|1
2611220|NCT00988091|9027885|P2|Open-label Period|Use of exclusionary medication|1
2611221|NCT00988091|9027886|P1|Open-label Period|Use of exclusionary medication|1
2611222|NCT00988091|9027885|P2|Open-label Period|Adverse Event|7
2611223|NCT00988091|9027886|P1|Open-label Period|Adverse Event|4
2611224|NCT00988091|9027885|P2|Double-blind Period|Use of exclusionary medication|3
2611225|NCT00988091|9027886|P1|Double-blind Period|Use of exclusionary medication|2
2611226|NCT00988091|9027885|P2|Double-blind Period|Adverse Event|9
2611227|NCT00988091|9027886|P1|Double-blind Period|Adverse Event|6
2611228|NCT00988091|9027885|P2|Double-blind Period|Other|8
2611229|NCT00988091|9027886|P1|Double-blind Period|Other|8
2611230|NCT00988091|9027885|P2|Double-blind Period|Lost to Follow-up|14
2611231|NCT00988091|9027886|P1|Double-blind Period|Lost to Follow-up|12
2611232|NCT00988091|9027885|P2|Double-blind Period|Withdrawal by Subject|13
2611233|NCT00988091|9027886|P1|Double-blind Period|Withdrawal by Subject|15
2611234|NCT00988065|9027908|P3|Overall Study|Noncompliance with protocol|9
2611235|NCT00988065|9027909|P2|Overall Study|Noncompliance with protocol|6
2611236|NCT00988065|9027910|P1|Overall Study|Noncompliance with protocol|5
2611237|NCT00988065|9027908|P3|Overall Study|Subject withdrew consent|2
2611238|NCT00988065|9027909|P2|Overall Study|Subject withdrew consent|5
2611239|NCT00988065|9027910|P1|Overall Study|Subject withdrew consent|3
2611240|NCT00988065|9027908|P3|Overall Study|Lost to Follow-up|2
2611241|NCT00988065|9027909|P2|Overall Study|Lost to Follow-up|2
2611242|NCT00988065|9027910|P1|Overall Study|Lost to Follow-up|1
2611243|NCT00988065|9027908|P3|Overall Study|Adverse Event|2
2611244|NCT00988065|9027909|P2|Overall Study|Adverse Event|10
2611245|NCT00988065|9027910|P1|Overall Study|Adverse Event|4
2611246|NCT00988052|9027932|P2|Overall Study|Study terminated by sponsor|236
2611247|NCT00988052|9027933|P1|Overall Study|Study terminated by sponsor|240
2611248|NCT00988052|9027932|P2|Overall Study|Withdrawal by Subject|91
2611249|NCT00988052|9027933|P1|Overall Study|Withdrawal by Subject|90
2611250|NCT00988052|9027932|P2|Overall Study|Adverse Event|28
2611251|NCT00988052|9027933|P1|Overall Study|Adverse Event|35
2611252|NCT00988052|9027932|P2|Overall Study|Physician Decision|28
2611253|NCT00988052|9027933|P1|Overall Study|Physician Decision|27
2611254|NCT00988052|9027932|P2|Overall Study|Lost to Follow-up|11
2611255|NCT00988052|9027933|P1|Overall Study|Lost to Follow-up|6
2611256|NCT00988052|9027932|P2|Overall Study|Lack of Efficacy|7
2611257|NCT00988052|9027933|P1|Overall Study|Lack of Efficacy|8
2611258|NCT00988052|9027932|P2|Overall Study|Pregnancy|6
2611259|NCT00988052|9027933|P1|Overall Study|Pregnancy|6
2611260|NCT00988052|9027932|P2|Overall Study|Protocol Violation|5
2611261|NCT00988052|9027933|P1|Overall Study|Protocol Violation|6
2611262|NCT00988052|9027932|P2|Overall Study|Death|3
2611263|NCT00988052|9027933|P1|Overall Study|Death|1
2611264|NCT00988052|9027932|P2|Overall Study|Teva requested subject withdrawal|1
2611265|NCT00988052|9027933|P1|Overall Study|Teva requested subject withdrawal|3
2611266|NCT00988052|9027932|P2|Overall Study|Missing|0
2611267|NCT00988052|9027933|P1|Overall Study|Missing|1
2611268|NCT00987935|9027977|P9|Overall Study|Reason other than those specified above|1
2611269|NCT00987935|9027978|P8|Overall Study|Reason other than those specified above|0
2611270|NCT00987935|9027979|P7|Overall Study|Reason other than those specified above|0
2611271|NCT00987935|9027980|P6|Overall Study|Reason other than those specified above|0
2611272|NCT00987935|9027981|P5|Overall Study|Reason other than those specified above|0
2611273|NCT00987935|9027982|P4|Overall Study|Reason other than those specified above|0
2611274|NCT00987935|9027983|P3|Overall Study|Reason other than those specified above|0
2611275|NCT00987935|9027984|P2|Overall Study|Reason other than those specified above|0
2611276|NCT00987935|9027985|P1|Overall Study|Reason other than those specified above|0
2611277|NCT00987935|9027977|P9|Overall Study|Refused to continue taking trial med.|2
2611278|NCT00987935|9027978|P8|Overall Study|Refused to continue taking trial med.|4
2611279|NCT00987935|9027979|P7|Overall Study|Refused to continue taking trial med.|4
2611280|NCT00987935|9027980|P6|Overall Study|Refused to continue taking trial med.|0
2611281|NCT00987935|9027981|P5|Overall Study|Refused to continue taking trial med.|1
2611282|NCT00987935|9027982|P4|Overall Study|Refused to continue taking trial med.|0
2611283|NCT00987935|9027983|P3|Overall Study|Refused to continue taking trial med.|0
2611284|NCT00987935|9027984|P2|Overall Study|Refused to continue taking trial med.|0
2611285|NCT00987935|9027985|P1|Overall Study|Refused to continue taking trial med.|1
2611286|NCT00987935|9027977|P9|Overall Study|Adverse Event|6
2611287|NCT00987935|9027978|P8|Overall Study|Adverse Event|10
2611288|NCT00987935|9027979|P7|Overall Study|Adverse Event|2
2611289|NCT00987935|9027980|P6|Overall Study|Adverse Event|0
2611290|NCT00987935|9027981|P5|Overall Study|Adverse Event|1
2611291|NCT00987935|9027982|P4|Overall Study|Adverse Event|1
2611292|NCT00987935|9027983|P3|Overall Study|Adverse Event|0
2611293|NCT00987935|9027984|P2|Overall Study|Adverse Event|1
2611294|NCT00987935|9027985|P1|Overall Study|Adverse Event|0
2611295|NCT00987935|9027977|P9|Overall Study|Progressive disease|23
2611296|NCT00987935|9027978|P8|Overall Study|Progressive disease|48
2611297|NCT00987935|9027979|P7|Overall Study|Progressive disease|9
2611298|NCT00987935|9027980|P6|Overall Study|Progressive disease|3
2611299|NCT00987935|9027981|P5|Overall Study|Progressive disease|5
2611300|NCT00987935|9027982|P4|Overall Study|Progressive disease|2
2611301|NCT00987935|9027983|P3|Overall Study|Progressive disease|3
2611302|NCT00987935|9027984|P2|Overall Study|Progressive disease|2
2611303|NCT00987935|9027985|P1|Overall Study|Progressive disease|3
2611304|NCT00987831|9028041|P3|Overall Study|Lost to Follow-up|0
2611305|NCT00987831|9028042|P2|Overall Study|Lost to Follow-up|3
2611306|NCT00987831|9028043|P1|Overall Study|Lost to Follow-up|0
2611307|NCT00987831|9028041|P3|Overall Study|Never flared in 12 months|0
2611308|NCT00987831|9028042|P2|Overall Study|Never flared in 12 months|0
2611309|NCT00987831|9028043|P1|Overall Study|Never flared in 12 months|1
2611310|NCT00987623|9028065|P2|Overall Study|Influenza|1
2611311|NCT00987623|9028066|P1|Overall Study|Influenza|0
2611312|NCT00987623|9028065|P2|Overall Study|Biomicroscopy|1
2611313|NCT00987623|9028066|P1|Overall Study|Biomicroscopy|0
2611314|NCT00987623|9028065|P2|Overall Study|Discomfort|0
2611315|NCT00987623|9028066|P1|Overall Study|Discomfort|1
2611316|NCT00987623|9028065|P2|Overall Study|Time/job conflict|0
2611317|NCT00987623|9028066|P1|Overall Study|Time/job conflict|2
2611318|NCT00987623|9028065|P2|Overall Study|Lost to Follow-up|1
2611319|NCT00987623|9028066|P1|Overall Study|Lost to Follow-up|2
2611320|NCT00987467|9028095|P1|Overall Study|Lost to Follow-up|2
2611321|NCT00987402|9028119|P2|Overall Study|Insufficient data entry|98
2611322|NCT00987402|9028120|P1|Overall Study|Insufficient data entry|86
2611323|NCT00987337|9028129|P3|Overall Study|Participant Relapsed|5
2611324|NCT00987337|9028130|P2|Overall Study|Participant Relapsed|20
2611325|NCT00987337|9028131|P1|Overall Study|Participant Relapsed|18
2611326|NCT00987337|9028129|P3|Overall Study|Protocol Violation|2
2611327|NCT00987337|9028130|P2|Overall Study|Protocol Violation|0
2611328|NCT00987337|9028131|P1|Overall Study|Protocol Violation|1
2611329|NCT00987337|9028129|P3|Overall Study|Other|5
2611330|NCT00987337|9028130|P2|Overall Study|Other|2
2611331|NCT00987337|9028131|P1|Overall Study|Other|0
2611332|NCT00987337|9028129|P3|Overall Study|Withdrawal by Subject|9
2611333|NCT00987337|9028130|P2|Overall Study|Withdrawal by Subject|9
2611334|NCT00987337|9028131|P1|Overall Study|Withdrawal by Subject|6
2611335|NCT00987337|9028129|P3|Overall Study|Lost to Follow-up|2
2611336|NCT00987337|9028130|P2|Overall Study|Lost to Follow-up|6
2611337|NCT00987337|9028131|P1|Overall Study|Lost to Follow-up|10
2611338|NCT00987337|9028129|P3|Overall Study|Virologic Breakthrough|8
2611339|NCT00987337|9028130|P2|Overall Study|Virologic Breakthrough|2
2611340|NCT00987337|9028131|P1|Overall Study|Virologic Breakthrough|2
2611341|NCT00987337|9028129|P3|Overall Study|Insufficient Virologic Response|12
2611342|NCT00987337|9028130|P2|Overall Study|Insufficient Virologic Response|7
2611343|NCT00987337|9028131|P1|Overall Study|Insufficient Virologic Response|10
2611344|NCT00987337|9028129|P3|Overall Study|Adverse Event|8
2611345|NCT00987337|9028130|P2|Overall Study|Adverse Event|9
2611346|NCT00987337|9028131|P1|Overall Study|Adverse Event|10
2611347|NCT00986986|9028186|P2|Overall Study|Lost to Follow-up|1
2611348|NCT00986986|9028187|P1|Overall Study|Lost to Follow-up|0
2611349|NCT00986973|9028197|P1|Overall Study|Withdrawn by study team|1
2611350|NCT00986921|9028223|P2|Overall Study|Physician Decision|0
2611351|NCT00986921|9028224|P1|Overall Study|Physician Decision|1
2611352|NCT00986674|9028260|P3|Overall Study|unknown/not specify|9
2611353|NCT00986674|9028261|P2|Overall Study|unknown/not specify|7
2611354|NCT00986674|9028262|P1|Overall Study|unknown/not specify|0
2611355|NCT00986674|9028260|P3|Overall Study|not start protocol therapy|1
2611356|NCT00986674|9028261|P2|Overall Study|not start protocol therapy|3
2611357|NCT00986674|9028262|P1|Overall Study|not start protocol therapy|4
2611358|NCT00986674|9028260|P3|Overall Study|alternative therapy|1
2611359|NCT00986674|9028261|P2|Overall Study|alternative therapy|0
2611360|NCT00986674|9028262|P1|Overall Study|alternative therapy|0
2611361|NCT00986674|9028260|P3|Overall Study|Withdrawal by Subject|1
2611362|NCT00986674|9028261|P2|Overall Study|Withdrawal by Subject|2
2611363|NCT00986674|9028262|P1|Overall Study|Withdrawal by Subject|6
2611364|NCT00986674|9028260|P3|Overall Study|Death|4
2611365|NCT00986674|9028261|P2|Overall Study|Death|0
2611366|NCT00986674|9028262|P1|Overall Study|Death|5
2611367|NCT00986674|9028260|P3|Overall Study|Adverse Event|9
2611368|NCT00986674|9028261|P2|Overall Study|Adverse Event|8
2611369|NCT00986674|9028262|P1|Overall Study|Adverse Event|4
2611370|NCT00986674|9028260|P3|Overall Study|Lack of Efficacy|23
2611371|NCT00986674|9028261|P2|Overall Study|Lack of Efficacy|25
2611372|NCT00986674|9028262|P1|Overall Study|Lack of Efficacy|28
2611373|NCT00986570|9028295|P1|Overall Study|Potential bias for objective assessment|1
2611374|NCT00986570|9028295|P1|Overall Study|Lost to Follow-up|6
2611375|NCT00986479|9028312|P2|Period 1|Administrative reasons|0
2611376|NCT00986479|9028313|P1|Period 1|Administrative reasons|1
2611377|NCT00986479|9028312|P2|Period 1|Improved mood|0
2611378|NCT00986479|9028313|P1|Period 1|Improved mood|1
2611379|NCT00986427|9028359|P2|Overall Study|Withdrawal by Subject|0
2611380|NCT00986427|9028360|P1|Overall Study|Withdrawal by Subject|1
2611381|NCT00986427|9028359|P2|Overall Study|Lack of Efficacy|0
2611382|NCT00986427|9028360|P1|Overall Study|Lack of Efficacy|1
2611383|NCT00986427|9028359|P2|Overall Study|Lost to Follow-up|0
2611384|NCT00986427|9028360|P1|Overall Study|Lost to Follow-up|2
2611385|NCT00986362|9028388|P2|Overall Study|Lost to Follow-up|1
2611386|NCT00986362|9028389|P1|Overall Study|Lost to Follow-up|0
2611387|NCT00986362|9028388|P2|Overall Study|Death|0
2611388|NCT00986362|9028389|P1|Overall Study|Death|2
2611389|NCT00986349|9028395|P1|Overall Study|device migration|1
2611390|NCT00986349|9028395|P1|Overall Study|Physician Decision|1
2611391|NCT00986349|9028395|P1|Overall Study|Adverse Event|2
2611392|NCT00986349|9028395|P1|Overall Study|Unsuccessful implant procedure|3
2611393|NCT00986258|9028419|P1|Maintenance Period|Withdrawal by Subject|2
2611394|NCT00986258|9028419|P1|Maintenance Period|Lack of Efficacy|2
2611395|NCT00986258|9028419|P1|Maintenance Period|Adverse Event|5
2611396|NCT00986258|9028419|P1|Titration and Optimal Dose Period|Other|1
2611397|NCT00986258|9028419|P1|Titration and Optimal Dose Period|Non-Compliance|1
2611398|NCT00986258|9028419|P1|Titration and Optimal Dose Period|Withdrawal by Subject|3
2611399|NCT00986258|9028419|P1|Titration and Optimal Dose Period|Lack of Efficacy|3
2611400|NCT00986258|9028419|P1|Titration and Optimal Dose Period|Adverse Event|15
2611401|NCT00986258|9028419|P1|Observation Period|Not eligible to be dosed|11
2611402|NCT00986245|9028447|P2|Second Intervention|Protocol Violation|1
2611403|NCT00986245|9028448|P1|Second Intervention|Protocol Violation|0
2611404|NCT00986245|9028447|P2|Second Intervention|Lost to Follow-up|0
2611405|NCT00986245|9028448|P1|Second Intervention|Lost to Follow-up|1
2611406|NCT00986245|9028447|P2|Second Intervention|Poor compliance|0
2611407|NCT00986245|9028448|P1|Second Intervention|Poor compliance|1
2611408|NCT00986245|9028447|P2|First Intervention|Out of indication|0
2611409|NCT00986245|9028448|P1|First Intervention|Out of indication|1
2611410|NCT00986245|9028447|P2|First Intervention|Protocol Violation|1
2611411|NCT00986245|9028448|P1|First Intervention|Protocol Violation|0
2611412|NCT00986245|9028447|P2|First Intervention|Withdrawal by Subject|1
2611413|NCT00986245|9028448|P1|First Intervention|Withdrawal by Subject|0
2611414|NCT00986245|9028447|P2|First Intervention|Lack of Efficacy|2
2611415|NCT00986245|9028448|P1|First Intervention|Lack of Efficacy|1
2611416|NCT00986245|9028447|P2|First Intervention|Poor compliance|4
2611417|NCT00986245|9028448|P1|First Intervention|Poor compliance|8
2611418|NCT00986232|9028485|P4|Overall Study|Incomplete safety follow-up|2
2611419|NCT00986232|9028486|P3|Overall Study|Incomplete safety follow-up|2
2611420|NCT00986232|9028487|P2|Overall Study|Incomplete safety follow-up|7
2611421|NCT00986232|9028488|P1|Overall Study|Incomplete safety follow-up|3
2611422|NCT00986232|9028485|P4|Overall Study|Missed one or more bleeds|7
2611423|NCT00986232|9028486|P3|Overall Study|Missed one or more bleeds|6
2611424|NCT00986232|9028487|P2|Overall Study|Missed one or more bleeds|10
2611425|NCT00986232|9028488|P1|Overall Study|Missed one or more bleeds|13
2611426|NCT00986232|9028485|P4|Overall Study|Withdrawal by Subject|3
2611427|NCT00986232|9028486|P3|Overall Study|Withdrawal by Subject|12
2611428|NCT00986232|9028487|P2|Overall Study|Withdrawal by Subject|16
2611429|NCT00986232|9028488|P1|Overall Study|Withdrawal by Subject|13
2611430|NCT00986232|9028485|P4|Overall Study|Protocol Violation|1
2611431|NCT00986232|9028486|P3|Overall Study|Protocol Violation|0
2611432|NCT00986232|9028487|P2|Overall Study|Protocol Violation|3
2611433|NCT00986232|9028488|P1|Overall Study|Protocol Violation|2
2611434|NCT00986232|9028485|P4|Overall Study|Lost to Follow-up|7
2611435|NCT00986232|9028486|P3|Overall Study|Lost to Follow-up|12
2611436|NCT00986232|9028487|P2|Overall Study|Lost to Follow-up|12
2611437|NCT00986232|9028488|P1|Overall Study|Lost to Follow-up|19
2611438|NCT00986232|9028485|P4|Overall Study|Adverse Event|0
2611439|NCT00986232|9028486|P3|Overall Study|Adverse Event|3
2611440|NCT00986232|9028487|P2|Overall Study|Adverse Event|2
2611441|NCT00986232|9028488|P1|Overall Study|Adverse Event|1
2611442|NCT00986180|9028562|P2|Overall Study|Miscellanies|11
2611443|NCT00986180|9028563|P1|Overall Study|Miscellanies|10
2611444|NCT00986180|9028562|P2|Overall Study|Withdrawal by Subject|9
2611445|NCT00986180|9028563|P1|Overall Study|Withdrawal by Subject|1
2611446|NCT00986180|9028562|P2|Overall Study|Protocol Violation|0
2611447|NCT00986180|9028563|P1|Overall Study|Protocol Violation|2
2611448|NCT00986180|9028562|P2|Overall Study|Physician Decision|3
2611449|NCT00986180|9028563|P1|Overall Study|Physician Decision|1
2611450|NCT00986180|9028562|P2|Overall Study|Lost to Follow-up|7
2611451|NCT00986180|9028563|P1|Overall Study|Lost to Follow-up|5
2611452|NCT00986180|9028562|P2|Overall Study|Lack of Efficacy|3
2611453|NCT00986180|9028563|P1|Overall Study|Lack of Efficacy|4
2611454|NCT00986180|9028562|P2|Overall Study|Adverse Event|23
2611455|NCT00986180|9028563|P1|Overall Study|Adverse Event|21
2611456|NCT00986154|9028641|P2|Overall Study|never received study drug|27
2611457|NCT00986154|9028642|P1|Overall Study|never received study drug|25
2611458|NCT00986154|9028641|P2|Overall Study|investigator/subject decide not continue|3
2611459|NCT00986154|9028642|P1|Overall Study|investigator/subject decide not continue|6
2611460|NCT00986154|9028641|P2|Overall Study|Withdrawal by Subject|33
2611461|NCT00986154|9028642|P1|Overall Study|Withdrawal by Subject|32
2611462|NCT00986154|9028641|P2|Overall Study|Lost to Follow-up|4
2611463|NCT00986154|9028642|P1|Overall Study|Lost to Follow-up|7
2611464|NCT00986154|9028641|P2|Overall Study|Death|127
2611465|NCT00986154|9028642|P1|Overall Study|Death|136
2611466|NCT00986102|9028656|P4|Overall Study|Withdrawal by Subject|0
2611467|NCT00986102|9028657|P3|Overall Study|Withdrawal by Subject|0
2611468|NCT00986102|9028658|P2|Overall Study|Withdrawal by Subject|1
2611469|NCT00986102|9028659|P1|Overall Study|Withdrawal by Subject|1
2611470|NCT00986102|9028656|P4|Overall Study|Lost to Follow-up|1
2611471|NCT00986102|9028657|P3|Overall Study|Lost to Follow-up|0
2611472|NCT00986102|9028658|P2|Overall Study|Lost to Follow-up|1
2611473|NCT00986102|9028659|P1|Overall Study|Lost to Follow-up|0
2611474|NCT00985985|9028709|P4|Overall Study|Other Reason|2
2611475|NCT00985985|9028710|P3|Overall Study|Other Reason|4
2611476|NCT00985985|9028711|P2|Overall Study|Other Reason|1
2611477|NCT00985985|9028712|P1|Overall Study|Other Reason|6
2611478|NCT00985985|9028709|P4|Overall Study|Withdrawal by Subject|2
2611479|NCT00985985|9028710|P3|Overall Study|Withdrawal by Subject|2
2611480|NCT00985985|9028711|P2|Overall Study|Withdrawal by Subject|2
2611481|NCT00985985|9028712|P1|Overall Study|Withdrawal by Subject|4
2611482|NCT00985985|9028709|P4|Overall Study|Lack of Efficacy|3
2611483|NCT00985985|9028710|P3|Overall Study|Lack of Efficacy|1
2611484|NCT00985985|9028711|P2|Overall Study|Lack of Efficacy|6
2611485|NCT00985985|9028712|P1|Overall Study|Lack of Efficacy|5
2611486|NCT00985985|9028709|P4|Overall Study|Protocol Violation|1
2611487|NCT00985985|9028710|P3|Overall Study|Protocol Violation|0
2611488|NCT00985985|9028711|P2|Overall Study|Protocol Violation|2
2611489|NCT00985985|9028712|P1|Overall Study|Protocol Violation|1
2611490|NCT00985985|9028709|P4|Overall Study|Lost to Follow-up|3
2611491|NCT00985985|9028710|P3|Overall Study|Lost to Follow-up|2
2611492|NCT00985985|9028711|P2|Overall Study|Lost to Follow-up|11
2611493|NCT00985985|9028712|P1|Overall Study|Lost to Follow-up|4
2611494|NCT00985985|9028709|P4|Overall Study|Adverse Event|2
2611495|NCT00985985|9028710|P3|Overall Study|Adverse Event|2
2611496|NCT00985985|9028711|P2|Overall Study|Adverse Event|2
2611497|NCT00985985|9028712|P1|Overall Study|Adverse Event|4
2611498|NCT00985959|9028753|P3|Overall Study|Other|11
2611499|NCT00985959|9028754|P2|Overall Study|Other|0
2611500|NCT00985959|9028755|P1|Overall Study|Other|0
2611501|NCT00985959|9028753|P3|Overall Study|Complete response observed over 2 cycles|4
2611502|NCT00985959|9028754|P2|Overall Study|Complete response observed over 2 cycles|1
2611503|NCT00985959|9028755|P1|Overall Study|Complete response observed over 2 cycles|0
2611504|NCT00985959|9028753|P3|Overall Study|Pneumonitis or pulmonary fibrosis|2
2611505|NCT00985959|9028754|P2|Overall Study|Pneumonitis or pulmonary fibrosis|0
2611506|NCT00985959|9028755|P1|Overall Study|Pneumonitis or pulmonary fibrosis|2
2611507|NCT00985959|9028753|P3|Overall Study|Unrecovered toxicity|7
2611508|NCT00985959|9028754|P2|Overall Study|Unrecovered toxicity|0
2611509|NCT00985959|9028755|P1|Overall Study|Unrecovered toxicity|0
2611510|NCT00985959|9028753|P3|Overall Study|Progressive disease|8
2611511|NCT00985959|9028754|P2|Overall Study|Progressive disease|2
2611512|NCT00985959|9028755|P1|Overall Study|Progressive disease|1
2611513|NCT00985959|9028753|P3|Overall Study|Withdrawal by Subject|8
2611514|NCT00985959|9028754|P2|Overall Study|Withdrawal by Subject|0
2611515|NCT00985959|9028755|P1|Overall Study|Withdrawal by Subject|0
2611516|NCT00985959|9028753|P3|Overall Study|Adverse Event|19
2611517|NCT00985959|9028754|P2|Overall Study|Adverse Event|0
2611518|NCT00985959|9028755|P1|Overall Study|Adverse Event|0
2611519|NCT00985946|9028778|P1|Overall Study|Withdrawal by Subject|1
2611520|NCT00985946|9028778|P1|Overall Study|Lost to Follow-up|6
2611521|NCT00985790|9028797|P2|Overall Study|Lost to Follow-up|7
2611522|NCT00985790|9028798|P1|Overall Study|Lost to Follow-up|6
2611523|NCT00985790|9028797|P2|Overall Study|Withdrawal by Subject|1
2611524|NCT00985790|9028798|P1|Overall Study|Withdrawal by Subject|1
2611525|NCT00985751|9028839|P5|Overall Study|Adverse Event|1
2611526|NCT00985751|9028840|P4|Overall Study|Adverse Event|0
2611527|NCT00985751|9028841|P3|Overall Study|Adverse Event|0
2611528|NCT00985751|9028842|P2|Overall Study|Adverse Event|0
2611529|NCT00985751|9028843|P1|Overall Study|Adverse Event|0
2611530|NCT00985738|9028906|P2|Overall Study|Study closed prematurely|8
2611531|NCT00985738|9028907|P1|Overall Study|Study closed prematurely|8
2611532|NCT00985725|9028915|P2|Overall Study|Out-of-window visits|1
2611533|NCT00985725|9028916|P1|Overall Study|Out-of-window visits|0
2611534|NCT00985725|9028915|P2|Overall Study|Non-compliance|2
2611535|NCT00985725|9028916|P1|Overall Study|Non-compliance|1
2611536|NCT00985725|9028915|P2|Overall Study|Lack of Efficacy|1
2611537|NCT00985725|9028916|P1|Overall Study|Lack of Efficacy|0
2611538|NCT00985725|9028915|P2|Overall Study|Lost to Follow-up|1
2611539|NCT00985725|9028916|P1|Overall Study|Lost to Follow-up|1
2611540|NCT00985725|9028915|P2|Overall Study|Withdrawal by Subject|4
2611541|NCT00985725|9028916|P1|Overall Study|Withdrawal by Subject|4
2611542|NCT00985725|9028915|P2|Overall Study|Protocol Violation|3
2611543|NCT00985725|9028916|P1|Overall Study|Protocol Violation|1
2611544|NCT00985725|9028915|P2|Overall Study|Adverse Event|1
2611545|NCT00985725|9028916|P1|Overall Study|Adverse Event|4
2611546|NCT00985712|9028952|P2|Overall Study|Sponsor decision|2
2611547|NCT00985712|9028953|P1|Overall Study|Sponsor decision|0
2611548|NCT00985712|9028952|P2|Overall Study|Withdrawal by Subject|1
2611549|NCT00985712|9028953|P1|Overall Study|Withdrawal by Subject|4
2611550|NCT00985712|9028952|P2|Overall Study|Protocol Violation|1
2611551|NCT00985712|9028953|P1|Overall Study|Protocol Violation|0
2611552|NCT00985712|9028952|P2|Overall Study|Lost to Follow-up|2
2611553|NCT00985712|9028953|P1|Overall Study|Lost to Follow-up|2
2611554|NCT00985712|9028952|P2|Overall Study|Adverse Event|1
2611555|NCT00985712|9028953|P1|Overall Study|Adverse Event|0
2611556|NCT00985686|9028971|P4|Overall Study|Lost to Follow-up|2
2611557|NCT00985686|9028972|P3|Overall Study|Lost to Follow-up|0
2611558|NCT00985686|9028973|P2|Overall Study|Lost to Follow-up|1
2611559|NCT00985686|9028974|P1|Overall Study|Lost to Follow-up|1
2611560|NCT00985673|9028988|P6|Overall Study|Other|0
2611561|NCT00985673|9028989|P5|Overall Study|Other|1
2611562|NCT00985673|9028990|P4|Overall Study|Other|0
2611563|NCT00985673|9028991|P3|Overall Study|Other|1
2611564|NCT00985673|9028992|P2|Overall Study|Other|0
2611565|NCT00985673|9028993|P1|Overall Study|Other|1
2611566|NCT00985673|9028988|P6|Overall Study|Withdrawal by Subject|3
2611567|NCT00985673|9028989|P5|Overall Study|Withdrawal by Subject|2
2611568|NCT00985673|9028990|P4|Overall Study|Withdrawal by Subject|2
2611569|NCT00985673|9028991|P3|Overall Study|Withdrawal by Subject|5
2611570|NCT00985673|9028992|P2|Overall Study|Withdrawal by Subject|4
2611571|NCT00985673|9028993|P1|Overall Study|Withdrawal by Subject|0
2611572|NCT00985673|9028988|P6|Overall Study|Lost to Follow-up|3
2611573|NCT00985673|9028989|P5|Overall Study|Lost to Follow-up|5
2611574|NCT00985673|9028990|P4|Overall Study|Lost to Follow-up|10
2611575|NCT00985673|9028991|P3|Overall Study|Lost to Follow-up|6
2611576|NCT00985673|9028992|P2|Overall Study|Lost to Follow-up|7
2611577|NCT00985673|9028993|P1|Overall Study|Lost to Follow-up|6
2611578|NCT00985504|9029276|P2|Optimization Period|Withdrawal by Subject|8
2611579|NCT00985504|9029277|P1|Optimization Period|Withdrawal by Subject|10
2611580|NCT00985504|9029276|P2|Optimization Period|Protocol Violation|1
2611581|NCT00985504|9029277|P1|Optimization Period|Protocol Violation|3
2611582|NCT00985504|9029276|P2|Optimization Period|Physician Decision|0
2611583|NCT00985504|9029277|P1|Optimization Period|Physician Decision|1
2611584|NCT00985504|9029276|P2|Optimization Period|Lost to Follow-up|1
2611585|NCT00985504|9029277|P1|Optimization Period|Lost to Follow-up|0
2611586|NCT00985504|9029276|P2|Optimization Period|Lack of Efficacy|3
2611587|NCT00985504|9029277|P1|Optimization Period|Lack of Efficacy|5
2611588|NCT00985504|9029276|P2|Optimization Period|Death|1
2611589|NCT00985504|9029277|P1|Optimization Period|Death|0
2611590|NCT00985504|9029276|P2|Optimization Period|Adverse Event|9
2611591|NCT00985504|9029277|P1|Optimization Period|Adverse Event|7
2611592|NCT00985504|9029276|P2|Acute Treatment Period|Withdrawal by Subject|5
2611593|NCT00985504|9029277|P1|Acute Treatment Period|Withdrawal by Subject|9
2611594|NCT00985504|9029276|P2|Acute Treatment Period|Sponsor Decision|1
2611595|NCT00985504|9029277|P1|Acute Treatment Period|Sponsor Decision|0
2611596|NCT00985504|9029276|P2|Acute Treatment Period|Protocol Violation|0
2611597|NCT00985504|9029277|P1|Acute Treatment Period|Protocol Violation|2
2611598|NCT00985504|9029276|P2|Acute Treatment Period|Entry Criteria Not Met|2
2611599|NCT00985504|9029277|P1|Acute Treatment Period|Entry Criteria Not Met|1
2611600|NCT00985504|9029276|P2|Acute Treatment Period|Adverse Event|4
2611601|NCT00985504|9029277|P1|Acute Treatment Period|Adverse Event|3
2611602|NCT00985491|9029303|P1|Overall Study|implant failure|3
2611603|NCT00985491|9029303|P1|Overall Study|Withdrawal by Subject|1
2611604|NCT00985491|9029303|P1|Overall Study|device migration|7
2611605|NCT00985491|9029303|P1|Overall Study|Adverse Event|8
2611606|NCT00985465|9029310|P2|Overall Study|Considered to be part of the other group|1
2611607|NCT00985465|9029311|P1|Overall Study|Considered to be part of the other group|0
2611608|NCT00985465|9029310|P2|Overall Study|Withdrawal by Subject|2
2611609|NCT00985465|9029311|P1|Overall Study|Withdrawal by Subject|1
2611610|NCT00985439|9029338|P4|Overall Study|Adverse Event|0
2611611|NCT00985439|9029339|P3|Overall Study|Adverse Event|1
2611612|NCT00985439|9029340|P2|Overall Study|Adverse Event|0
2611613|NCT00985439|9029341|P1|Overall Study|Adverse Event|0
2611614|NCT00985231|9029357|P2|Overall Study|Study related symptoms & complaints|2
2611615|NCT00985231|9029358|P1|Overall Study|Study related symptoms & complaints|0
2611616|NCT00985231|9029357|P2|Overall Study|Lost to Follow-up|1
2611617|NCT00985231|9029358|P1|Overall Study|Lost to Follow-up|0
2611618|NCT00985231|9029357|P2|Overall Study|Withdrawal by Subject|0
2611619|NCT00985231|9029358|P1|Overall Study|Withdrawal by Subject|1
2611620|NCT00985231|9029357|P2|Overall Study|Protocol Violation|0
2611621|NCT00985231|9029358|P1|Overall Study|Protocol Violation|1
2611622|NCT00985231|9029357|P2|Overall Study|ineligible|0
2611623|NCT00985231|9029358|P1|Overall Study|ineligible|1
2611624|NCT00985192|9029366|P1|Overall Study|Determined to be Ineligible During Trial|2
2611625|NCT00985192|9029366|P1|Overall Study|Disease Progression|1
2611626|NCT00985192|9029366|P1|Overall Study|Withdrawal by Subject|1
2611627|NCT00985166|9029378|P3|Overall Study|Other|1
2611628|NCT00985166|9029379|P2|Overall Study|Other|0
2611629|NCT00985166|9029380|P1|Overall Study|Other|1
2611630|NCT00985166|9029378|P3|Overall Study|Test not done|4
2611631|NCT00985166|9029379|P2|Overall Study|Test not done|0
2611632|NCT00985166|9029380|P1|Overall Study|Test not done|2
2611633|NCT00985166|9029378|P3|Overall Study|Withdrawal by Subject|0
2611634|NCT00985166|9029379|P2|Overall Study|Withdrawal by Subject|2
2611635|NCT00985166|9029380|P1|Overall Study|Withdrawal by Subject|3
2611636|NCT00985166|9029378|P3|Overall Study|Lost to Follow-up|2
2611637|NCT00985166|9029379|P2|Overall Study|Lost to Follow-up|2
2611638|NCT00985166|9029380|P1|Overall Study|Lost to Follow-up|3
2611639|NCT00985153|9029400|P4|Overall Study|Incomplete Safety Follow-up|4
2611640|NCT00985153|9029401|P3|Overall Study|Incomplete Safety Follow-up|4
2611641|NCT00985153|9029402|P2|Overall Study|Incomplete Safety Follow-up|5
2611642|NCT00985153|9029403|P1|Overall Study|Incomplete Safety Follow-up|3
2611643|NCT00985153|9029400|P4|Overall Study|Missed One or More Bleeds|10
2611644|NCT00985153|9029401|P3|Overall Study|Missed One or More Bleeds|8
2611645|NCT00985153|9029402|P2|Overall Study|Missed One or More Bleeds|7
2611646|NCT00985153|9029403|P1|Overall Study|Missed One or More Bleeds|7
2611647|NCT00985153|9029400|P4|Overall Study|Withdrawal by Subject|10
2611648|NCT00985153|9029401|P3|Overall Study|Withdrawal by Subject|11
2611649|NCT00985153|9029402|P2|Overall Study|Withdrawal by Subject|11
2611650|NCT00985153|9029403|P1|Overall Study|Withdrawal by Subject|6
2611651|NCT00985153|9029400|P4|Overall Study|Protocol Violation|3
2611652|NCT00985153|9029401|P3|Overall Study|Protocol Violation|4
2611653|NCT00985153|9029402|P2|Overall Study|Protocol Violation|2
2611654|NCT00985153|9029403|P1|Overall Study|Protocol Violation|3
2611655|NCT00985153|9029400|P4|Overall Study|Lost to Follow-up|20
2611656|NCT00985153|9029401|P3|Overall Study|Lost to Follow-up|17
2611657|NCT00985153|9029402|P2|Overall Study|Lost to Follow-up|19
2611658|NCT00985153|9029403|P1|Overall Study|Lost to Follow-up|16
2611659|NCT00985114|9029451|P2|Overall Study|Withdrawal by Subject|2
2611660|NCT00985114|9029452|P1|Overall Study|Withdrawal by Subject|0
2611661|NCT00985114|9029451|P2|Overall Study|Adverse Event|0
2611662|NCT00985114|9029452|P1|Overall Study|Adverse Event|1
2611663|NCT00985088|9029466|P8|Overall Study|Lost to Follow-up|2
2611664|NCT00985088|9029467|P7|Overall Study|Lost to Follow-up|3
2611665|NCT00985088|9029468|P6|Overall Study|Lost to Follow-up|5
2611666|NCT00985088|9029469|P5|Overall Study|Lost to Follow-up|6
2611667|NCT00985088|9029470|P4|Overall Study|Lost to Follow-up|6
2611668|NCT00985088|9029471|P3|Overall Study|Lost to Follow-up|2
2611669|NCT00985088|9029472|P2|Overall Study|Lost to Follow-up|1
2611670|NCT00985088|9029473|P1|Overall Study|Lost to Follow-up|6
2611671|NCT00985088|9029466|P8|Overall Study|Migrated/moved from study area|1
2611672|NCT00985088|9029467|P7|Overall Study|Migrated/moved from study area|0
2611673|NCT00985088|9029468|P6|Overall Study|Migrated/moved from study area|0
2611674|NCT00985088|9029469|P5|Overall Study|Migrated/moved from study area|0
2611675|NCT00985088|9029470|P4|Overall Study|Migrated/moved from study area|0
2611676|NCT00985088|9029471|P3|Overall Study|Migrated/moved from study area|1
2611677|NCT00985088|9029472|P2|Overall Study|Migrated/moved from study area|0
2611678|NCT00985088|9029473|P1|Overall Study|Migrated/moved from study area|0
2611679|NCT00985088|9029466|P8|Overall Study|Withdrawal by Subject|2
2611680|NCT00985088|9029467|P7|Overall Study|Withdrawal by Subject|1
2611681|NCT00985088|9029468|P6|Overall Study|Withdrawal by Subject|2
2611682|NCT00985088|9029469|P5|Overall Study|Withdrawal by Subject|3
2611683|NCT00985088|9029470|P4|Overall Study|Withdrawal by Subject|1
2611684|NCT00985088|9029471|P3|Overall Study|Withdrawal by Subject|0
2611685|NCT00985088|9029472|P2|Overall Study|Withdrawal by Subject|0
2611686|NCT00985088|9029473|P1|Overall Study|Withdrawal by Subject|4
2611687|NCT00985088|9029466|P8|Overall Study|Adverse Event|0
2611688|NCT00985088|9029467|P7|Overall Study|Adverse Event|0
2611689|NCT00985088|9029468|P6|Overall Study|Adverse Event|0
2611690|NCT00985088|9029469|P5|Overall Study|Adverse Event|0
2611691|NCT00985088|9029470|P4|Overall Study|Adverse Event|0
2611692|NCT00985088|9029471|P3|Overall Study|Adverse Event|1
2611693|NCT00985088|9029472|P2|Overall Study|Adverse Event|0
2611694|NCT00985088|9029473|P1|Overall Study|Adverse Event|0
2611695|NCT00985088|9029466|P8|Overall Study|Serious Adverse Event|1
2611696|NCT00985088|9029467|P7|Overall Study|Serious Adverse Event|0
2611697|NCT00985088|9029468|P6|Overall Study|Serious Adverse Event|0
2611698|NCT00985088|9029469|P5|Overall Study|Serious Adverse Event|0
2611699|NCT00985088|9029470|P4|Overall Study|Serious Adverse Event|0
2611700|NCT00985088|9029471|P3|Overall Study|Serious Adverse Event|0
2611701|NCT00985088|9029472|P2|Overall Study|Serious Adverse Event|1
2611702|NCT00985088|9029473|P1|Overall Study|Serious Adverse Event|1
2611703|NCT00984867|9029742|P2|Overall Study|lack of efficacy and subject compliance|0
2611704|NCT00984867|9029743|P1|Overall Study|lack of efficacy and subject compliance|1
2611705|NCT00984867|9029742|P2|Overall Study|site closing|0
2611706|NCT00984867|9029743|P1|Overall Study|site closing|1
2611707|NCT00984867|9029742|P2|Overall Study|Subject no longer meets study criteria|1
2611708|NCT00984867|9029743|P1|Overall Study|Subject no longer meets study criteria|1
2611709|NCT00984867|9029742|P2|Overall Study|Poor/non-compliance|1
2611710|NCT00984867|9029743|P1|Overall Study|Poor/non-compliance|0
2611711|NCT00984867|9029742|P2|Overall Study|Lost to Follow-up|4
2611712|NCT00984867|9029743|P1|Overall Study|Lost to Follow-up|3
2611713|NCT00984867|9029742|P2|Overall Study|Withdrawal by Subject|4
2611714|NCT00984867|9029743|P1|Overall Study|Withdrawal by Subject|13
2611715|NCT00984867|9029742|P2|Overall Study|Death|0
2611716|NCT00984867|9029743|P1|Overall Study|Death|1
2611717|NCT00984867|9029742|P2|Overall Study|Adverse Event|7
2611718|NCT00984867|9029743|P1|Overall Study|Adverse Event|3
2611719|NCT00984659|9029783|P4|6-week Double-blind Treatment Period|Withdrawal by Subject|1
2611720|NCT00984659|9029784|P3|6-week Double-blind Treatment Period|Withdrawal by Subject|7
2611721|NCT00984659|9029785|P2|6-week Double-blind Treatment Period|Withdrawal by Subject|1
2611722|NCT00984659|9029786|P1|6-week Double-blind Treatment Period|Withdrawal by Subject|0
2611723|NCT00984659|9029783|P4|6-week Double-blind Treatment Period|Study Closed/Terminated|0
2611724|NCT00984659|9029784|P3|6-week Double-blind Treatment Period|Study Closed/Terminated|1
2611725|NCT00984659|9029785|P2|6-week Double-blind Treatment Period|Study Closed/Terminated|0
2611726|NCT00984659|9029786|P1|6-week Double-blind Treatment Period|Study Closed/Terminated|0
2611727|NCT00984659|9029783|P4|6-week Double-blind Treatment Period|Protocol Violation|4
2611728|NCT00984659|9029784|P3|6-week Double-blind Treatment Period|Protocol Violation|0
2611729|NCT00984659|9029785|P2|6-week Double-blind Treatment Period|Protocol Violation|0
2611730|NCT00984659|9029786|P1|6-week Double-blind Treatment Period|Protocol Violation|0
2611731|NCT00984659|9029783|P4|6-week Double-blind Treatment Period|Lack of Efficacy|1
2611732|NCT00984659|9029784|P3|6-week Double-blind Treatment Period|Lack of Efficacy|0
2611733|NCT00984659|9029785|P2|6-week Double-blind Treatment Period|Lack of Efficacy|2
2611734|NCT00984659|9029786|P1|6-week Double-blind Treatment Period|Lack of Efficacy|0
2611735|NCT00984659|9029783|P4|6-week Double-blind Treatment Period|Adverse Event|7
2611736|NCT00984659|9029784|P3|6-week Double-blind Treatment Period|Adverse Event|3
2611737|NCT00984659|9029785|P2|6-week Double-blind Treatment Period|Adverse Event|3
2611738|NCT00984659|9029786|P1|6-week Double-blind Treatment Period|Adverse Event|0
2611739|NCT00984659|9029783|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
2611740|NCT00984659|9029784|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
2611741|NCT00984659|9029785|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
2611742|NCT00984659|9029786|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|14
2611743|NCT00984659|9029783|P4|2-week Run-in Period|Withdrawal by Subject|0
2611744|NCT00984659|9029784|P3|2-week Run-in Period|Withdrawal by Subject|0
2611745|NCT00984659|9029785|P2|2-week Run-in Period|Withdrawal by Subject|0
2611746|NCT00984659|9029786|P1|2-week Run-in Period|Withdrawal by Subject|10
2611747|NCT00984659|9029783|P4|2-week Run-in Period|Physician Decision|0
2611748|NCT00984659|9029784|P3|2-week Run-in Period|Physician Decision|0
2611749|NCT00984659|9029785|P2|2-week Run-in Period|Physician Decision|0
2611750|NCT00984659|9029786|P1|2-week Run-in Period|Physician Decision|10
2611751|NCT00984659|9029783|P4|2-week Run-in Period|Lost to Follow-up|0
2611752|NCT00984659|9029784|P3|2-week Run-in Period|Lost to Follow-up|0
2611753|NCT00984659|9029785|P2|2-week Run-in Period|Lost to Follow-up|0
2611754|NCT00984659|9029786|P1|2-week Run-in Period|Lost to Follow-up|3
2611755|NCT00984659|9029783|P4|2-week Run-in Period|Study Closed/Terminated|0
2611756|NCT00984659|9029784|P3|2-week Run-in Period|Study Closed/Terminated|0
2611757|NCT00984659|9029785|P2|2-week Run-in Period|Study Closed/Terminated|0
2611758|NCT00984659|9029786|P1|2-week Run-in Period|Study Closed/Terminated|2
2611759|NCT00984659|9029783|P4|2-week Run-in Period|Protocol Violation|0
2611760|NCT00984659|9029784|P3|2-week Run-in Period|Protocol Violation|0
2611761|NCT00984659|9029785|P2|2-week Run-in Period|Protocol Violation|0
2611762|NCT00984659|9029786|P1|2-week Run-in Period|Protocol Violation|5
2611763|NCT00984659|9029783|P4|2-week Run-in Period|Adverse Event|0
2611764|NCT00984659|9029784|P3|2-week Run-in Period|Adverse Event|0
2611765|NCT00984659|9029785|P2|2-week Run-in Period|Adverse Event|0
2611766|NCT00984659|9029786|P1|2-week Run-in Period|Adverse Event|8
2611767|NCT00984620|9029813|P2|Overall Study|reason other than listed above|4
2611768|NCT00984620|9029814|P1|Overall Study|reason other than listed above|0
2611769|NCT00984620|9029813|P2|Overall Study|Withdrawal by Subject|2
2611770|NCT00984620|9029814|P1|Overall Study|Withdrawal by Subject|0
2611771|NCT00984620|9029813|P2|Overall Study|Lost to Follow-up|1
2611772|NCT00984620|9029814|P1|Overall Study|Lost to Follow-up|1
2611773|NCT00984620|9029813|P2|Overall Study|Adverse Event|5
2611774|NCT00984620|9029814|P1|Overall Study|Adverse Event|5
2611775|NCT00984594|9029852|P2|Overall Study|Withdrawal by Subject|1
2611776|NCT00984594|9029853|P1|Overall Study|Withdrawal by Subject|0
2611777|NCT00984594|9029852|P2|Overall Study|Lost to Follow-up|0
2611778|NCT00984594|9029853|P1|Overall Study|Lost to Follow-up|1
2611779|NCT00984568|9029869|P2|Overall Study|Unknown Reason|3
2611780|NCT00984568|9029870|P1|Overall Study|Unknown Reason|1
2611781|NCT00984568|9029869|P2|Overall Study|Opportunistic Infection|0
2611782|NCT00984568|9029870|P1|Overall Study|Opportunistic Infection|1
2611783|NCT00984568|9029869|P2|Overall Study|Lost to Follow-up|1
2611784|NCT00984568|9029870|P1|Overall Study|Lost to Follow-up|0
2611785|NCT00984568|9029869|P2|Overall Study|Did Not Meet Randomization Criteria|0
2611786|NCT00984568|9029870|P1|Overall Study|Did Not Meet Randomization Criteria|1
2611787|NCT00984568|9029869|P2|Overall Study|Adverse Event|0
2611788|NCT00984568|9029870|P1|Overall Study|Adverse Event|2
2611789|NCT00984568|9029869|P2|Overall Study|Lack of Efficacy|0
2611790|NCT00984568|9029870|P1|Overall Study|Lack of Efficacy|2
2611791|NCT00984568|9029869|P2|Overall Study|Withdrawal by Subject|2
2611792|NCT00984568|9029870|P1|Overall Study|Withdrawal by Subject|1
2611793|NCT00984542|9029878|P1|Overall Study|clinical deterioration|2
2611794|NCT00984542|9029878|P1|Overall Study|Withdrawal by Subject|3
2611795|NCT00984542|9029878|P1|Overall Study|complicating disease|3
2611796|NCT00984542|9029878|P1|Overall Study|Death|7
2611797|NCT00984542|9029878|P1|Overall Study|toxicity|7
2611798|NCT00984542|9029878|P1|Overall Study|disease progression|19
2611799|NCT00984295|9029928|P3|Overall Study|Incomplete safety follow-up|3
2611800|NCT00984295|9029929|P2|Overall Study|Incomplete safety follow-up|2
2611801|NCT00984295|9029930|P1|Overall Study|Incomplete safety follow-up|11
2611802|NCT00984295|9029928|P3|Overall Study|Missed one or more blood samplings|2
2611803|NCT00984295|9029929|P2|Overall Study|Missed one or more blood samplings|7
2611804|NCT00984295|9029930|P1|Overall Study|Missed one or more blood samplings|3
2611805|NCT00984295|9029928|P3|Overall Study|CAE – discontinued test vaccine|3
2611806|NCT00984295|9029929|P2|Overall Study|CAE – discontinued test vaccine|1
2611807|NCT00984295|9029930|P1|Overall Study|CAE – discontinued test vaccine|0
2611808|NCT00984295|9029928|P3|Overall Study|Withdrawal by Subject|12
2611809|NCT00984295|9029929|P2|Overall Study|Withdrawal by Subject|9
2611810|NCT00984295|9029930|P1|Overall Study|Withdrawal by Subject|18
2611811|NCT00984295|9029928|P3|Overall Study|Protocol Violation|4
2611812|NCT00984295|9029929|P2|Overall Study|Protocol Violation|1
2611813|NCT00984295|9029930|P1|Overall Study|Protocol Violation|2
2611814|NCT00984295|9029928|P3|Overall Study|Lost to Follow-up|13
2611815|NCT00984295|9029929|P2|Overall Study|Lost to Follow-up|12
2611816|NCT00984295|9029930|P1|Overall Study|Lost to Follow-up|31
2611817|NCT00984282|9029997|P2|Long Term Follow-up|Disease prog., recurrence or relapse|1
2611818|NCT00984282|9029998|P1|Long Term Follow-up|Disease prog., recurrence or relapse|0
2611819|NCT00984282|9029997|P2|Long Term Follow-up|Switched to commercial drug|2
2611820|NCT00984282|9029998|P1|Long Term Follow-up|Switched to commercial drug|4
2611821|NCT00984282|9029997|P2|Long Term Follow-up|Transferred to treat. continuation study|3
2611822|NCT00984282|9029998|P1|Long Term Follow-up|Transferred to treat. continuation study|2
2611823|NCT00984282|9029997|P2|Long Term Follow-up|Protocol driven decision point|26
2611824|NCT00984282|9029998|P1|Long Term Follow-up|Protocol driven decision point|25
2611825|NCT00984282|9029997|P2|Long Term Follow-up|Lost to Follow-up|6
2611826|NCT00984282|9029998|P1|Long Term Follow-up|Lost to Follow-up|3
2611827|NCT00984282|9029997|P2|Long Term Follow-up|Death|68
2611828|NCT00984282|9029998|P1|Long Term Follow-up|Death|27
2611829|NCT00984282|9029997|P2|Long Term Follow-up|Withdrawal by Subject|14
2611830|NCT00984282|9029998|P1|Long Term Follow-up|Withdrawal by Subject|8
2611831|NCT00984282|9029997|P2|Open-label Treatment|Physician Decision|0
2611832|NCT00984282|9029998|P1|Open-label Treatment|Physician Decision|1
2611833|NCT00984282|9029997|P2|Open-label Treatment|Switched to commercial drug|7
2611834|NCT00984282|9029998|P1|Open-label Treatment|Switched to commercial drug|6
2611835|NCT00984282|9029997|P2|Open-label Treatment|Transferred to treat. continuation study|3
2611836|NCT00984282|9029998|P1|Open-label Treatment|Transferred to treat. continuation study|2
2611837|NCT00984282|9029997|P2|Open-label Treatment|Protocol driven decision point|1
2611838|NCT00984282|9029998|P1|Open-label Treatment|Protocol driven decision point|1
2611839|NCT00984282|9029997|P2|Open-label Treatment|Target lesion removed|1
2611840|NCT00984282|9029998|P1|Open-label Treatment|Target lesion removed|0
2611841|NCT00984282|9029997|P2|Open-label Treatment|Non-compliant with study medication|0
2611842|NCT00984282|9029998|P1|Open-label Treatment|Non-compliant with study medication|1
2611843|NCT00984282|9029997|P2|Open-label Treatment|Patient convenience|0
2611844|NCT00984282|9029998|P1|Open-label Treatment|Patient convenience|1
2611845|NCT00984282|9029997|P2|Open-label Treatment|Lost to Follow-up|1
2611846|NCT00984282|9029998|P1|Open-label Treatment|Lost to Follow-up|1
2611847|NCT00984282|9029997|P2|Open-label Treatment|Progression, recurrence or relapse|82
2611848|NCT00984282|9029998|P1|Open-label Treatment|Progression, recurrence or relapse|40
2611849|NCT00984282|9029997|P2|Open-label Treatment|Death|15
2611850|NCT00984282|9029998|P1|Open-label Treatment|Death|7
2611851|NCT00984282|9029997|P2|Open-label Treatment|Withdrawal by Subject|21
2611852|NCT00984282|9029998|P1|Open-label Treatment|Withdrawal by Subject|6
2611853|NCT00984282|9029997|P2|Open-label Treatment|Adverse Event|30
2611854|NCT00984282|9029998|P1|Open-label Treatment|Adverse Event|20
2611855|NCT00984282|9029997|P2|Double Blind Treatment|Transferred to treat. continuation study|1
2611856|NCT00984282|9029998|P1|Double Blind Treatment|Transferred to treat. continuation study|2
2611857|NCT00984282|9029997|P2|Double Blind Treatment|Radiological and clinical progression|1
2611858|NCT00984282|9029998|P1|Double Blind Treatment|Radiological and clinical progression|0
2611859|NCT00984282|9029997|P2|Double Blind Treatment|protocol driven decision point|1
2611860|NCT00984282|9029998|P1|Double Blind Treatment|protocol driven decision point|1
2611861|NCT00984282|9029997|P2|Double Blind Treatment|Switched to commercial drug|1
2611862|NCT00984282|9029998|P1|Double Blind Treatment|Switched to commercial drug|6
2611863|NCT00984282|9029997|P2|Double Blind Treatment|Not treated|1
2611864|NCT00984282|9029998|P1|Double Blind Treatment|Not treated|0
2611865|NCT00984282|9029997|P2|Double Blind Treatment|Death|4
2611866|NCT00984282|9029998|P1|Double Blind Treatment|Death|8
2611867|NCT00984282|9029997|P2|Double Blind Treatment|Lost to Follow-up|0
2611868|NCT00984282|9029998|P1|Double Blind Treatment|Lost to Follow-up|3
2611869|NCT00984282|9029997|P2|Double Blind Treatment|Withdrawal by Subject|18
2611870|NCT00984282|9029998|P1|Double Blind Treatment|Withdrawal by Subject|13
2611871|NCT00984282|9029997|P2|Double Blind Treatment|Progression by clinical judgment|0
2611872|NCT00984282|9029998|P1|Double Blind Treatment|Progression by clinical judgment|2
2611873|NCT00984282|9029997|P2|Double Blind Treatment|Noncompliance with study medication|0
2611874|NCT00984282|9029998|P1|Double Blind Treatment|Noncompliance with study medication|3
2611875|NCT00984282|9029997|P2|Double Blind Treatment|Physician Decision|2
2611876|NCT00984282|9029998|P1|Double Blind Treatment|Physician Decision|1
2611877|NCT00984282|9029997|P2|Double Blind Treatment|Progression, recurrence or relapse|3
2611878|NCT00984282|9029998|P1|Double Blind Treatment|Progression, recurrence or relapse|25
2611879|NCT00984282|9029997|P2|Double Blind Treatment|Adverse Event|6
2611880|NCT00984282|9029998|P1|Double Blind Treatment|Adverse Event|40
2611881|NCT00984256|9030021|P2|Overall Study|Withdrawal by Subject|1
2611882|NCT00984256|9030022|P1|Overall Study|Withdrawal by Subject|0
2611883|NCT00984204|9030042|P1|Overall Study|Lack of Efficacy|10
2611884|NCT00984204|9030042|P1|Overall Study|Lost to Follow-up|4
2611885|NCT00984204|9030042|P1|Overall Study|Death|1
2611886|NCT00984165|9030052|P4|Overall Study|removed with a pair recipient|1
2611887|NCT00984165|9030053|P3|Overall Study|removed with a pair recipient|0
2611888|NCT00984165|9030054|P2|Overall Study|removed with a pair recipient|0
2611889|NCT00984165|9030055|P1|Overall Study|removed with a pair recipient|0
2611890|NCT00984165|9030052|P4|Overall Study|P+/donor pair removed from protocol|1
2611891|NCT00984165|9030053|P3|Overall Study|P+/donor pair removed from protocol|0
2611892|NCT00984165|9030054|P2|Overall Study|P+/donor pair removed from protocol|0
2611893|NCT00984165|9030055|P1|Overall Study|P+/donor pair removed from protocol|0
2611894|NCT00984165|9030052|P4|Overall Study|New protocol|1
2611895|NCT00984165|9030053|P3|Overall Study|New protocol|0
2611896|NCT00984165|9030054|P2|Overall Study|New protocol|0
2611897|NCT00984165|9030055|P1|Overall Study|New protocol|0
2611898|NCT00984165|9030052|P4|Overall Study|Death of recipient|1
2611899|NCT00984165|9030053|P3|Overall Study|Death of recipient|0
2611900|NCT00984165|9030054|P2|Overall Study|Death of recipient|0
2611901|NCT00984165|9030055|P1|Overall Study|Death of recipient|0
2611902|NCT00984165|9030052|P4|Overall Study|Disease progression on study|0
2611903|NCT00984165|9030053|P3|Overall Study|Disease progression on study|0
2611904|NCT00984165|9030054|P2|Overall Study|Disease progression on study|1
2611905|NCT00984165|9030055|P1|Overall Study|Disease progression on study|5
2611906|NCT00984165|9030052|P4|Overall Study|Death on study|0
2611907|NCT00984165|9030053|P3|Overall Study|Death on study|0
2611908|NCT00984165|9030054|P2|Overall Study|Death on study|0
2611909|NCT00984165|9030055|P1|Overall Study|Death on study|2
2611910|NCT00984126|9030084|P4|Overall Study|Withdrawal criteria|9
2611911|NCT00984126|9030085|P3|Overall Study|Withdrawal criteria|3
2611912|NCT00984126|9030086|P2|Overall Study|Withdrawal criteria|1
2611913|NCT00984126|9030087|P1|Overall Study|Withdrawal criteria|0
2611914|NCT00984126|9030084|P4|Overall Study|Choose to join Pathfinder trial™ + other|46
2611915|NCT00984126|9030085|P3|Overall Study|Choose to join Pathfinder trial™ + other|3
2611916|NCT00984126|9030086|P2|Overall Study|Choose to join Pathfinder trial™ + other|7
2611917|NCT00984126|9030087|P1|Overall Study|Choose to join Pathfinder trial™ + other|7
2611918|NCT00984126|9030084|P4|Overall Study|Adverse Event|2
2611919|NCT00984126|9030085|P3|Overall Study|Adverse Event|0
2611920|NCT00984126|9030086|P2|Overall Study|Adverse Event|0
2611921|NCT00984126|9030087|P1|Overall Study|Adverse Event|0
2611922|NCT00984126|9030084|P4|Overall Study|Protocol Violation|2
2611923|NCT00984126|9030085|P3|Overall Study|Protocol Violation|1
2611924|NCT00984126|9030086|P2|Overall Study|Protocol Violation|0
2611925|NCT00984126|9030087|P1|Overall Study|Protocol Violation|0
2611926|NCT00984061|9030112|P1|Clarithromycin Alone|Protocol Violation|1
2611927|NCT00984022|9030125|P2|Overall Study|Lost to Follow-up|14
2611928|NCT00984022|9030126|P1|Overall Study|Lost to Follow-up|10
2611929|NCT00984009|9030136|P1|Grapefruit Juice Alone|missed serving of grapefruit juice|1
2611930|NCT00983957|9030169|P1|Overall Study|Personal Reasons|1
2611931|NCT00983957|9030169|P1|Overall Study|Adverse Event|1
2611932|NCT00983931|9030203|P1|14 Day Washout Period|Physician Decision|1
2611933|NCT00983918|9030217|P4|Overall Study|conversion to open cholecystectomy|2
2611934|NCT00983918|9030218|P3|Overall Study|conversion to open cholecystectomy|2
2611935|NCT00983918|9030219|P2|Overall Study|conversion to open cholecystectomy|2
2611936|NCT00983918|9030220|P1|Overall Study|conversion to open cholecystectomy|0
2611937|NCT00983905|9030230|P1|Colchicine Alone|Adverse Event|2
2611938|NCT00983905|9030230|P1|Theophylline Alone|Adverse Event|1
2611939|NCT00983892|9030243|P2|Overall Study|Withdrawal by Subject|12
2611940|NCT00983892|9030244|P1|Overall Study|Withdrawal by Subject|10
2611941|NCT00983853|9030256|P6|Overall Study|Unable to come to study follow-up visits|0
2611942|NCT00983853|9030257|P5|Overall Study|Unable to come to study follow-up visits|0
2611943|NCT00983853|9030258|P4|Overall Study|Unable to come to study follow-up visits|0
2611944|NCT00983853|9030259|P3|Overall Study|Unable to come to study follow-up visits|0
2611945|NCT00983853|9030260|P2|Overall Study|Unable to come to study follow-up visits|1
2611946|NCT00983853|9030261|P1|Overall Study|Unable to come to study follow-up visits|0
2611947|NCT00983853|9030256|P6|Overall Study|Withdrawal by Subject|0
2611948|NCT00983853|9030257|P5|Overall Study|Withdrawal by Subject|1
2611949|NCT00983853|9030258|P4|Overall Study|Withdrawal by Subject|0
2611950|NCT00983853|9030259|P3|Overall Study|Withdrawal by Subject|1
2611951|NCT00983853|9030260|P2|Overall Study|Withdrawal by Subject|0
2611952|NCT00983853|9030261|P1|Overall Study|Withdrawal by Subject|0
2611953|NCT00983853|9030256|P6|Overall Study|Lost to Follow-up|1
2611954|NCT00983853|9030257|P5|Overall Study|Lost to Follow-up|2
2611955|NCT00983853|9030258|P4|Overall Study|Lost to Follow-up|2
2611956|NCT00983853|9030259|P3|Overall Study|Lost to Follow-up|2
2611957|NCT00983853|9030260|P2|Overall Study|Lost to Follow-up|1
2611958|NCT00983853|9030261|P1|Overall Study|Lost to Follow-up|1
2611959|NCT00983827|9030289|P1|Overall Study|Withdrawal by Subject|1
2611960|NCT00983749|9030307|P2|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3
2611961|NCT00983749|9030308|P1|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1
2611962|NCT00983580|9030333|P2|Overall Study|Ineligible|0
2611963|NCT00983580|9030334|P1|Overall Study|Ineligible|3
2611964|NCT00983580|9030333|P2|Overall Study|Protocol Violation|1
2611965|NCT00983580|9030334|P1|Overall Study|Protocol Violation|1
2611966|NCT00983580|9030333|P2|Overall Study|Cancel Prior to treatment|3
2611967|NCT00983580|9030334|P1|Overall Study|Cancel Prior to treatment|1
2611968|NCT00983515|9030360|P1|Colchicine With Ritonavir|Lost to Follow-up|1
2611969|NCT00983515|9030360|P1|Ritonavir Alone|liver panel out of range|6
2611970|NCT00983476|9030387|P3|Overall Study|Did not receive intervention|0
2611971|NCT00983476|9030388|P2|Overall Study|Did not receive intervention|22
2611972|NCT00983476|9030389|P1|Overall Study|Did not receive intervention|17
2611973|NCT00983437|9030421|P1|Overall Study|Other Reason|26
2611974|NCT00983437|9030421|P1|Overall Study|Lost to Follow-up|2
2611975|NCT00983437|9030421|P1|Overall Study|Noncompliance to Study Procedures|1
2611976|NCT00983437|9030421|P1|Overall Study|Withdrawal by Subject|8
2611977|NCT00983437|9030421|P1|Overall Study|Lack of Efficacy|1
2611978|NCT00983437|9030421|P1|Overall Study|Adverse Event|9
2611979|NCT00983385|9030440|P1|Observation Period|Not Evaluable due to Non Compliance|12
2611980|NCT00983385|9030440|P1|Observation Period|Not eligible to be dosed|20
2611981|NCT00983372|9030485|P1|Diltiazem ER Alone|Adverse Event|1
2611982|NCT00983372|9030485|P1|Diltiazem ER Alone|missed diltiazem dose|2
2611983|NCT00983372|9030485|P1|14 Day Washout Period|Withdrawal by Subject|1
2611984|NCT00983294|9030512|P1|Colchicine With Azithromycin|Adverse Event|1
2611985|NCT00983294|9030512|P1|14 Day Washout Period|Withdrawal by Subject|2
2611986|NCT00983073|9030554|P1|Maintenance Period|Other Reason|7
2611987|NCT00983073|9030554|P1|Maintenance Period|Lack of Efficacy|2
2611988|NCT00983073|9030554|P1|Maintenance Period|Withdrawal by Subject|2
2611989|NCT00983073|9030554|P1|Maintenance Period|Adverse Event|5
2611990|NCT00983073|9030554|P1|Titration and Optimal Dose Period|Other reason|4
2611991|NCT00983073|9030554|P1|Titration and Optimal Dose Period|Non-Compliance|1
2611992|NCT00983073|9030554|P1|Titration and Optimal Dose Period|Lack of Efficacy|5
2611993|NCT00983073|9030554|P1|Titration and Optimal Dose Period|Withdrawal by Subject|11
2611994|NCT00983073|9030554|P1|Titration and Optimal Dose Period|Adverse Event|19
2611995|NCT00982878|9030580|P1|Overall Study|Physician Decision|1
2611996|NCT00982735|9030878|P1|Overall Study|Patient ineligible for trial|224
2611997|NCT00982735|9030878|P1|Overall Study|Lost to Follow-up|6
2611998|NCT00982657|9030888|P4|Overall Study|On going at date of cut-off|1
2611999|NCT00982657|9030889|P3|Overall Study|On going at date of cut-off|0
2612000|NCT00982657|9030890|P2|Overall Study|On going at date of cut-off|0
2612001|NCT00982657|9030891|P1|Overall Study|On going at date of cut-off|0
2612002|NCT00982657|9030888|P4|Overall Study|Other|4
2612003|NCT00982657|9030889|P3|Overall Study|Other|0
2612004|NCT00982657|9030890|P2|Overall Study|Other|0
2612005|NCT00982657|9030891|P1|Overall Study|Other|0
2612006|NCT00982657|9030888|P4|Overall Study|Withdrawal by Subject|3
2612007|NCT00982657|9030889|P3|Overall Study|Withdrawal by Subject|1
2612008|NCT00982657|9030890|P2|Overall Study|Withdrawal by Subject|0
2612009|NCT00982657|9030891|P1|Overall Study|Withdrawal by Subject|0
2612010|NCT00982657|9030888|P4|Overall Study|Death|1
2612011|NCT00982657|9030889|P3|Overall Study|Death|1
2612012|NCT00982657|9030890|P2|Overall Study|Death|0
2612013|NCT00982657|9030891|P1|Overall Study|Death|1
2612014|NCT00982644|9030932|P2|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7
2612015|NCT00982644|9030933|P1|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23
2612016|NCT00982644|9030932|P2|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3
2612017|NCT00982644|9030933|P1|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6
2612018|NCT00982644|9030932|P2|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4
2612019|NCT00982644|9030933|P1|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2
2612020|NCT00982644|9030932|P2|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1
2612021|NCT00982644|9030933|P1|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3
2612022|NCT00982644|9030932|P2|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5
2612023|NCT00982644|9030933|P1|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12
2612024|NCT00982644|9030932|P2|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30
2612025|NCT00982644|9030933|P1|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84
2612026|NCT00982644|9030932|P2|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5
2612027|NCT00982644|9030933|P1|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9
2612028|NCT00982644|9030932|P2|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18
2612029|NCT00982644|9030933|P1|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46
2612030|NCT00982644|9030932|P2|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2
2612031|NCT00982644|9030933|P1|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7
2612032|NCT00982644|9030932|P2|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5
2612033|NCT00982644|9030933|P1|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20
2612034|NCT00982488|9030988|P5|Overall Study|Withdrawal by Subject|0
2612035|NCT00982488|9030989|P4|Overall Study|Withdrawal by Subject|0
2612036|NCT00982488|9030990|P3|Overall Study|Withdrawal by Subject|1
2612037|NCT00982488|9030991|P2|Overall Study|Withdrawal by Subject|1
2612038|NCT00982488|9030992|P1|Overall Study|Withdrawal by Subject|5
2612039|NCT00982488|9030988|P5|Overall Study|Study drug toxicity|0
2612040|NCT00982488|9030989|P4|Overall Study|Study drug toxicity|0
2612041|NCT00982488|9030990|P3|Overall Study|Study drug toxicity|6
2612042|NCT00982488|9030991|P2|Overall Study|Study drug toxicity|1
2612043|NCT00982488|9030992|P1|Overall Study|Study drug toxicity|34
2612044|NCT00982488|9030988|P5|Overall Study|Stem cell transplant|0
2612045|NCT00982488|9030989|P4|Overall Study|Stem cell transplant|1
2612046|NCT00982488|9030990|P3|Overall Study|Stem cell transplant|0
2612047|NCT00982488|9030991|P2|Overall Study|Stem cell transplant|0
2612048|NCT00982488|9030992|P1|Overall Study|Stem cell transplant|2
2612049|NCT00982488|9030988|P5|Overall Study|Poor compliance/noncompliance|0
2612050|NCT00982488|9030989|P4|Overall Study|Poor compliance/noncompliance|0
2612051|NCT00982488|9030990|P3|Overall Study|Poor compliance/noncompliance|0
2612052|NCT00982488|9030991|P2|Overall Study|Poor compliance/noncompliance|1
2612053|NCT00982488|9030992|P1|Overall Study|Poor compliance/noncompliance|0
2612054|NCT00982488|9030988|P5|Overall Study|Other|0
2612055|NCT00982488|9030989|P4|Overall Study|Other|1
2612056|NCT00982488|9030990|P3|Overall Study|Other|3
2612057|NCT00982488|9030991|P2|Overall Study|Other|1
2612058|NCT00982488|9030992|P1|Overall Study|Other|15
2612059|NCT00982488|9030988|P5|Overall Study|Maximum clinical benefit|0
2612060|NCT00982488|9030989|P4|Overall Study|Maximum clinical benefit|0
2612061|NCT00982488|9030990|P3|Overall Study|Maximum clinical benefit|1
2612062|NCT00982488|9030991|P2|Overall Study|Maximum clinical benefit|1
2612063|NCT00982488|9030992|P1|Overall Study|Maximum clinical benefit|1
2612064|NCT00982488|9030988|P5|Overall Study|Lost to Follow-up|0
2612065|NCT00982488|9030989|P4|Overall Study|Lost to Follow-up|0
2612066|NCT00982488|9030990|P3|Overall Study|Lost to Follow-up|0
2612067|NCT00982488|9030991|P2|Overall Study|Lost to Follow-up|0
2612068|NCT00982488|9030992|P1|Overall Study|Lost to Follow-up|1
2612069|NCT00982488|9030988|P5|Overall Study|Disease progression|1
2612070|NCT00982488|9030989|P4|Overall Study|Disease progression|1
2612071|NCT00982488|9030990|P3|Overall Study|Disease progression|10
2612072|NCT00982488|9030991|P2|Overall Study|Disease progression|5
2612073|NCT00982488|9030992|P1|Overall Study|Disease progression|30
2612074|NCT00982488|9030988|P5|Overall Study|Death|0
2612075|NCT00982488|9030989|P4|Overall Study|Death|0
2612076|NCT00982488|9030990|P3|Overall Study|Death|2
2612077|NCT00982488|9030991|P2|Overall Study|Death|0
2612078|NCT00982488|9030992|P1|Overall Study|Death|11
2612079|NCT00982488|9030988|P5|Overall Study|Adverse event unrelated to study drug|0
2612080|NCT00982488|9030989|P4|Overall Study|Adverse event unrelated to study drug|0
2612081|NCT00982488|9030990|P3|Overall Study|Adverse event unrelated to study drug|0
2612082|NCT00982488|9030991|P2|Overall Study|Adverse event unrelated to study drug|1
2612083|NCT00982488|9030992|P1|Overall Study|Adverse event unrelated to study drug|5
2612084|NCT00982488|9030988|P5|Overall Study|Administrative reason by sponsor|0
2612085|NCT00982488|9030989|P4|Overall Study|Administrative reason by sponsor|0
2612086|NCT00982488|9030990|P3|Overall Study|Administrative reason by sponsor|11
2612087|NCT00982488|9030991|P2|Overall Study|Administrative reason by sponsor|3
2612088|NCT00982488|9030992|P1|Overall Study|Administrative reason by sponsor|81
2612089|NCT00982410|9031025|P2|12-month Follow-up Assessment|scheduled, no-show|0
2612090|NCT00982410|9031026|P1|12-month Follow-up Assessment|scheduled, no-show|1
2612091|NCT00982410|9031025|P2|12-month Follow-up Assessment|incarceration|1
2612092|NCT00982410|9031026|P1|12-month Follow-up Assessment|incarceration|2
2612093|NCT00982410|9031025|P2|12-month Follow-up Assessment|Withdrawal by Subject|1
2612094|NCT00982410|9031026|P1|12-month Follow-up Assessment|Withdrawal by Subject|0
2612095|NCT00982410|9031025|P2|12-month Follow-up Assessment|could not reach to schedule|5
2612096|NCT00982410|9031026|P1|12-month Follow-up Assessment|could not reach to schedule|6
2612097|NCT00982410|9031025|P2|12-month Follow-up Assessment|Death|2
2612098|NCT00982410|9031026|P1|12-month Follow-up Assessment|Death|0
2612099|NCT00982410|9031025|P2|6-month Follow-up Assessment|scheduled, no-show|1
2612100|NCT00982410|9031026|P1|6-month Follow-up Assessment|scheduled, no-show|0
2612101|NCT00982410|9031025|P2|6-month Follow-up Assessment|patent surgery|1
2612102|NCT00982410|9031026|P1|6-month Follow-up Assessment|patent surgery|0
2612103|NCT00982410|9031025|P2|6-month Follow-up Assessment|incarceration|2
2612104|NCT00982410|9031026|P1|6-month Follow-up Assessment|incarceration|0
2612105|NCT00982410|9031025|P2|6-month Follow-up Assessment|participant no transportation|0
2612106|NCT00982410|9031026|P1|6-month Follow-up Assessment|participant no transportation|1
2612107|NCT00982410|9031025|P2|6-month Follow-up Assessment|Could not reach to schedule|7
2612108|NCT00982410|9031026|P1|6-month Follow-up Assessment|Could not reach to schedule|5
2612109|NCT00982410|9031025|P2|3-month Follow-up Assessment|Withdrawal by Subject|2
2612110|NCT00982410|9031026|P1|3-month Follow-up Assessment|Withdrawal by Subject|0
2612111|NCT00982410|9031025|P2|3-month Follow-up Assessment|Scheduled, no-show|2
2612112|NCT00982410|9031026|P1|3-month Follow-up Assessment|Scheduled, no-show|1
2612113|NCT00982410|9031025|P2|3-month Follow-up Assessment|Could not reach to schedule|9
2612114|NCT00982410|9031026|P1|3-month Follow-up Assessment|Could not reach to schedule|8
2612115|NCT00982319|9031067|P2|Overall Study|Pregnancy|1
2612116|NCT00982319|9031068|P1|Overall Study|Pregnancy|0
2612117|NCT00982319|9031067|P2|Overall Study|Preop values out of acceptable range|1
2612118|NCT00982319|9031068|P1|Overall Study|Preop values out of acceptable range|1
2612119|NCT00982319|9031067|P2|Overall Study|Surgery date change|0
2612120|NCT00982319|9031068|P1|Overall Study|Surgery date change|1
2612121|NCT00982280|9031076|P1|Maintenance Period|Adverse Event|1
2612122|NCT00982280|9031076|P1|Titration and Optimal Dose Period|Withdrawal by Subject|1
2612123|NCT00982280|9031076|P1|Titration and Optimal Dose Period|Lack of Efficacy|2
2612124|NCT00982280|9031076|P1|Titration and Optimal Dose Period|Adverse Event|5
2612125|NCT00982280|9031076|P1|Observation Period|Not eligible to be dosed|19
2612126|NCT00982228|9031101|P2|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1
2612127|NCT00982228|9031102|P1|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11
2612128|NCT00982228|9031101|P2|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0
2612129|NCT00982228|9031102|P1|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5
2612130|NCT00982228|9031101|P2|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2
2612131|NCT00982228|9031102|P1|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1
2612132|NCT00982228|9031101|P2|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0
2612133|NCT00982228|9031102|P1|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1
2612134|NCT00982228|9031101|P2|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2
2612135|NCT00982228|9031102|P1|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3
2612136|NCT00982228|9031101|P2|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13
2612137|NCT00982228|9031102|P1|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28
2612138|NCT00982228|9031101|P2|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3
2612139|NCT00982228|9031102|P1|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15
2612140|NCT00982228|9031101|P2|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2
2612141|NCT00982228|9031102|P1|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11
2612142|NCT00982228|9031101|P2|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0
2612143|NCT00982228|9031102|P1|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2
2612144|NCT00982228|9031101|P2|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2
2612145|NCT00982228|9031102|P1|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12
2612146|NCT00982137|9031161|P4|Overall Study|Withdrawal by Subject|0
2612147|NCT00982137|9031162|P3|Overall Study|Withdrawal by Subject|0
2612148|NCT00982137|9031163|P2|Overall Study|Withdrawal by Subject|1
2612149|NCT00982137|9031164|P1|Overall Study|Withdrawal by Subject|0
2612150|NCT00982137|9031161|P4|Overall Study|Lost to Follow-up|1
2612151|NCT00982137|9031162|P3|Overall Study|Lost to Follow-up|0
2612152|NCT00982137|9031163|P2|Overall Study|Lost to Follow-up|0
2612153|NCT00982137|9031164|P1|Overall Study|Lost to Follow-up|0
2612154|NCT00982111|9031196|P2|Overall Study|Withdrawal by Subject|17
2612155|NCT00982111|9031197|P1|Overall Study|Withdrawal by Subject|16
2612156|NCT00982111|9031196|P2|Overall Study|On Study Treatment at Conclusion|0
2612157|NCT00982111|9031197|P1|Overall Study|On Study Treatment at Conclusion|7
2612158|NCT00982111|9031196|P2|Overall Study|New Anti-Cancer Therapy|5
2612159|NCT00982111|9031197|P1|Overall Study|New Anti-Cancer Therapy|5
2612160|NCT00982111|9031196|P2|Overall Study|Lost to Follow-up|6
2612161|NCT00982111|9031197|P1|Overall Study|Lost to Follow-up|9
2612162|NCT00982111|9031196|P2|Overall Study|Progressive Disease|37
2612163|NCT00982111|9031197|P1|Overall Study|Progressive Disease|37
2612164|NCT00982111|9031196|P2|Overall Study|Adverse Event|1
2612165|NCT00982111|9031197|P1|Overall Study|Adverse Event|1
2612166|NCT00982020|9031230|P2|Overall Study|Clinical Relapse|1
2612167|NCT00982020|9031231|P1|Overall Study|Clinical Relapse|0
2612168|NCT00982020|9031230|P2|Overall Study|Protocol Violation|2
2612169|NCT00982020|9031231|P1|Overall Study|Protocol Violation|0
2612170|NCT00982020|9031230|P2|Overall Study|Entry Criteria Not Met|1
2612171|NCT00982020|9031231|P1|Overall Study|Entry Criteria Not Met|2
2612172|NCT00982020|9031230|P2|Overall Study|Physician Decision|5
2612173|NCT00982020|9031231|P1|Overall Study|Physician Decision|2
2612174|NCT00982020|9031230|P2|Overall Study|Treatment Non-compliance|6
2612175|NCT00982020|9031231|P1|Overall Study|Treatment Non-compliance|3
2612176|NCT00982020|9031230|P2|Overall Study|Parent/Caregiver Decision|5
2612177|NCT00982020|9031231|P1|Overall Study|Parent/Caregiver Decision|5
2612178|NCT00982020|9031230|P2|Overall Study|Lack of Efficacy|4
2612179|NCT00982020|9031231|P1|Overall Study|Lack of Efficacy|10
2612180|NCT00982020|9031230|P2|Overall Study|Lost to Follow-up|11
2612181|NCT00982020|9031231|P1|Overall Study|Lost to Follow-up|5
2612182|NCT00982020|9031230|P2|Overall Study|Withdrawal by Subject|14
2612183|NCT00982020|9031231|P1|Overall Study|Withdrawal by Subject|11
2612184|NCT00982020|9031230|P2|Overall Study|Adverse Event|15
2612185|NCT00982020|9031231|P1|Overall Study|Adverse Event|19
2612186|NCT00981747|9031281|P1|Placebo Oral Tablet|Withdrawal by Subject|1
2612187|NCT00981747|9031281|P1|Losartan|Death|1
2612188|NCT00981747|9031281|P1|Losartan|Withdrawal by Subject|1
2612189|NCT00981578|9031347|P1|Overall Study|Withdrawal by Subject|2
2612190|NCT00981578|9031347|P1|Overall Study|Death|1
2612191|NCT00981526|9031355|P2|Overall Study|Physician Decision|4
2612192|NCT00981526|9031356|P1|Overall Study|Physician Decision|4
2612193|NCT00981526|9031355|P2|Overall Study|Withdrawal by Subject|2
2612194|NCT00981526|9031356|P1|Overall Study|Withdrawal by Subject|0
2612195|NCT00981461|9031374|P2|Overall Study|Lost to Follow-up|2
2612196|NCT00981461|9031375|P1|Overall Study|Lost to Follow-up|5
2612197|NCT00981409|9031399|P2|Overall Study|Prostate Cancer Treatment before Trial|0
2612198|NCT00981409|9031400|P1|Overall Study|Prostate Cancer Treatment before Trial|2
2612199|NCT00981409|9031399|P2|Overall Study|Protocol Violation|1
2612200|NCT00981409|9031400|P1|Overall Study|Protocol Violation|0
2612201|NCT00981409|9031399|P2|Overall Study|Adverse Event|0
2612202|NCT00981409|9031400|P1|Overall Study|Adverse Event|4
2612203|NCT00981292|9031439|P6|Day 3|Protocol Violation|1
2612204|NCT00981292|9031440|P5|Day 3|Protocol Violation|0
2612205|NCT00981292|9031441|P4|Day 3|Protocol Violation|0
2612206|NCT00981292|9031442|P3|Day 3|Protocol Violation|0
2612207|NCT00981292|9031443|P2|Day 3|Protocol Violation|0
2612208|NCT00981292|9031444|P1|Day 3|Protocol Violation|0
2612209|NCT00981292|9031439|P6|Day 2|Protocol Violation|0
2612210|NCT00981292|9031440|P5|Day 2|Protocol Violation|0
2612211|NCT00981292|9031441|P4|Day 2|Protocol Violation|0
2612212|NCT00981292|9031442|P3|Day 2|Protocol Violation|0
2612213|NCT00981292|9031443|P2|Day 2|Protocol Violation|0
2612214|NCT00981292|9031444|P1|Day 2|Protocol Violation|2
2612215|NCT00981292|9031439|P6|Day 1|Protocol Violation|2
2612216|NCT00981292|9031440|P5|Day 1|Protocol Violation|0
2612217|NCT00981292|9031441|P4|Day 1|Protocol Violation|0
2612218|NCT00981292|9031442|P3|Day 1|Protocol Violation|0
2612219|NCT00981292|9031443|P2|Day 1|Protocol Violation|0
2612220|NCT00981292|9031444|P1|Day 1|Protocol Violation|1
2612221|NCT00981175|9031528|P2|Booster Dose Vaccination|Lost to Follow-up|3
2612222|NCT00981175|9031529|P1|Booster Dose Vaccination|Lost to Follow-up|2
2612223|NCT00981175|9031528|P2|Primary Dose Vaccination|Lost to Follow-up|1
2612224|NCT00981175|9031529|P1|Primary Dose Vaccination|Lost to Follow-up|2
2612225|NCT00981175|9031528|P2|Primary Dose Vaccination|Protocol Violation|1
2612226|NCT00981175|9031529|P1|Primary Dose Vaccination|Protocol Violation|0
2612227|NCT00981175|9031528|P2|Primary Dose Vaccination|Adverse Event|0
2612228|NCT00981175|9031529|P1|Primary Dose Vaccination|Adverse Event|1
2612229|NCT00981149|9031554|P2|Overall Study|Withdrawal by Subject|1
2612230|NCT00981149|9031555|P1|Overall Study|Withdrawal by Subject|1
2612231|NCT00981149|9031554|P2|Overall Study|Lost to Follow-up|2
2612232|NCT00981149|9031555|P1|Overall Study|Lost to Follow-up|1
2612233|NCT00981084|9031565|P2|Post Intervention (Data Analysis)|imbalance in disease subtype|0
2612234|NCT00981084|9031566|P1|Post Intervention (Data Analysis)|imbalance in disease subtype|1
2612235|NCT00981084|9031565|P2|Post Intervention (Data Analysis)|poor effort|1
2612236|NCT00981084|9031566|P1|Post Intervention (Data Analysis)|poor effort|1
2612237|NCT00981058|9031582|P2|Overall Study|On study treatment at conclusion|0
2612238|NCT00981058|9031583|P1|Overall Study|On study treatment at conclusion|9
2612239|NCT00981058|9031582|P2|Overall Study|Withdrawal by Subject|23
2612240|NCT00981058|9031583|P1|Overall Study|Withdrawal by Subject|25
2612241|NCT00981058|9031582|P2|Overall Study|Randomization Error|2
2612242|NCT00981058|9031583|P1|Overall Study|Randomization Error|1
2612243|NCT00981058|9031582|P2|Overall Study|Radiologist Error|1
2612244|NCT00981058|9031583|P1|Overall Study|Radiologist Error|0
2612245|NCT00981058|9031582|P2|Overall Study|Noncompliance|0
2612246|NCT00981058|9031583|P1|Overall Study|Noncompliance|1
2612247|NCT00981058|9031582|P2|Overall Study|New Anticancer Therapy|6
2612248|NCT00981058|9031583|P1|Overall Study|New Anticancer Therapy|6
2612249|NCT00981058|9031582|P2|Overall Study|Lost to Follow-up|15
2612250|NCT00981058|9031583|P1|Overall Study|Lost to Follow-up|16
2612251|NCT00981058|9031582|P2|Overall Study|Progressive Disease|49
2612252|NCT00981058|9031583|P1|Overall Study|Progressive Disease|61
2612253|NCT00981058|9031582|P2|Overall Study|Adverse Event|1
2612254|NCT00981058|9031583|P1|Overall Study|Adverse Event|1
2612255|NCT00981019|9031614|P1|Overall Study|Hit the survey after closure|79
2612256|NCT00981019|9031614|P1|Overall Study|Inadvertent exclusion|239
2612257|NCT00981019|9031614|P1|Overall Study|Did not match target population|94
2612258|NCT00981019|9031614|P1|Overall Study|Did not respond|65
2612259|NCT00980980|9031621|P3|Overall Study|Withdrawal by Hospital|0
2612260|NCT00980980|9031622|P2|Overall Study|Withdrawal by Hospital|1
2612261|NCT00980980|9031623|P1|Overall Study|Withdrawal by Hospital|0
2612262|NCT00980798|9031654|P2|Overall Study|Other|1
2612263|NCT00980798|9031655|P1|Overall Study|Other|0
2612264|NCT00980798|9031654|P2|Overall Study|Withdrawal by Subject|11
2612265|NCT00980798|9031655|P1|Overall Study|Withdrawal by Subject|8
2612266|NCT00980798|9031654|P2|Overall Study|Physician Decision|1
2612267|NCT00980798|9031655|P1|Overall Study|Physician Decision|2
2612268|NCT00980798|9031654|P2|Overall Study|Lost to Follow-up|1
2612269|NCT00980798|9031655|P1|Overall Study|Lost to Follow-up|0
2612270|NCT00980798|9031654|P2|Overall Study|Lack of Efficacy|5
2612271|NCT00980798|9031655|P1|Overall Study|Lack of Efficacy|16
2612272|NCT00980798|9031654|P2|Overall Study|Adverse Event|36
2612273|NCT00980798|9031655|P1|Overall Study|Adverse Event|7
2612274|NCT00980655|9031696|P2|Overall Study|Other|1
2612275|NCT00980655|9031697|P1|Overall Study|Other|0
2612276|NCT00980655|9031696|P2|Overall Study|Parent/legal guardian request|0
2612277|NCT00980655|9031697|P1|Overall Study|Parent/legal guardian request|1
2612278|NCT00980655|9031696|P2|Overall Study|Lost to Follow-up|1
2612279|NCT00980655|9031697|P1|Overall Study|Lost to Follow-up|0
2612280|NCT00980655|9031696|P2|Overall Study|Withdrawal by Subject|4
2612281|NCT00980655|9031697|P1|Overall Study|Withdrawal by Subject|0
2612282|NCT00980655|9031696|P2|Overall Study|Protocol Violation|7
2612283|NCT00980655|9031697|P1|Overall Study|Protocol Violation|2
2612284|NCT00980655|9031696|P2|Overall Study|Death|7
2612285|NCT00980655|9031697|P1|Overall Study|Death|0
2612286|NCT00980655|9031696|P2|Overall Study|Adverse Event|31
2612287|NCT00980655|9031697|P1|Overall Study|Adverse Event|13
2612288|NCT00980343|9031780|P2|Overall Study|no tumor at surgery - treatment effect|3
2612289|NCT00980343|9031781|P1|Overall Study|no tumor at surgery - treatment effect|1
2612290|NCT00980330|9031805|P7|Overall Study|(not specified)|0
2612291|NCT00980330|9031806|P6|Overall Study|(not specified)|1
2612292|NCT00980330|9031807|P5|Overall Study|(not specified)|1
2612293|NCT00980330|9031808|P4|Overall Study|(not specified)|1
2612294|NCT00980330|9031809|P3|Overall Study|(not specified)|0
2612295|NCT00980330|9031810|P2|Overall Study|(not specified)|0
2612296|NCT00980330|9031811|P1|Overall Study|(not specified)|2
2612297|NCT00980330|9031805|P7|Overall Study|Withdrawal by Subject|5
2612298|NCT00980330|9031806|P6|Overall Study|Withdrawal by Subject|2
2612299|NCT00980330|9031807|P5|Overall Study|Withdrawal by Subject|3
2612300|NCT00980330|9031808|P4|Overall Study|Withdrawal by Subject|1
2612301|NCT00980330|9031809|P3|Overall Study|Withdrawal by Subject|4
2612302|NCT00980330|9031810|P2|Overall Study|Withdrawal by Subject|4
2612303|NCT00980330|9031811|P1|Overall Study|Withdrawal by Subject|2
2612304|NCT00980330|9031805|P7|Overall Study|Lost to Follow-up|2
2612305|NCT00980330|9031806|P6|Overall Study|Lost to Follow-up|1
2612306|NCT00980330|9031807|P5|Overall Study|Lost to Follow-up|1
2612307|NCT00980330|9031808|P4|Overall Study|Lost to Follow-up|2
2612308|NCT00980330|9031809|P3|Overall Study|Lost to Follow-up|4
2612309|NCT00980330|9031810|P2|Overall Study|Lost to Follow-up|1
2612310|NCT00980330|9031811|P1|Overall Study|Lost to Follow-up|1
2612311|NCT00980330|9031805|P7|Overall Study|Adverse Event|0
2612312|NCT00980330|9031806|P6|Overall Study|Adverse Event|0
2612313|NCT00980330|9031807|P5|Overall Study|Adverse Event|0
2612314|NCT00980330|9031808|P4|Overall Study|Adverse Event|1
2612315|NCT00980330|9031809|P3|Overall Study|Adverse Event|0
2612316|NCT00980330|9031810|P2|Overall Study|Adverse Event|0
2612317|NCT00980330|9031811|P1|Overall Study|Adverse Event|0
2612318|NCT00980200|9031926|P5|7-day Treatment Period 3|Lack of Efficacy|1
2612319|NCT00980200|9031927|P4|7-day Treatment Period 3|Lack of Efficacy|0
2612320|NCT00980200|9031928|P3|7-day Treatment Period 3|Lack of Efficacy|0
2612321|NCT00980200|9031929|P2|7-day Treatment Period 3|Lack of Efficacy|1
2612322|NCT00980200|9031930|P1|7-day Treatment Period 3|Lack of Efficacy|0
2612323|NCT00980200|9031926|P5|7-day Treatment Period 1|Withdrawal by Subject|0
2612324|NCT00980200|9031927|P4|7-day Treatment Period 1|Withdrawal by Subject|0
2612325|NCT00980200|9031928|P3|7-day Treatment Period 1|Withdrawal by Subject|0
2612326|NCT00980200|9031929|P2|7-day Treatment Period 1|Withdrawal by Subject|1
2612327|NCT00980200|9031930|P1|7-day Treatment Period 1|Withdrawal by Subject|0
2612328|NCT00980174|9031949|P2|Overall Study|Other|1
2612329|NCT00980174|9031950|P1|Overall Study|Other|0
2612330|NCT00980174|9031949|P2|Overall Study|Death|1
2612331|NCT00980174|9031950|P1|Overall Study|Death|1
2612332|NCT00980174|9031949|P2|Overall Study|Ineligibility determined|1
2612333|NCT00980174|9031950|P1|Overall Study|Ineligibility determined|2
2612334|NCT00980174|9031949|P2|Overall Study|Adverse Event|3
2612335|NCT00980174|9031950|P1|Overall Study|Adverse Event|0
2612336|NCT00980174|9031949|P2|Overall Study|Withdrawal by Subject|4
2612337|NCT00980174|9031950|P1|Overall Study|Withdrawal by Subject|1
2612338|NCT00980148|9031968|P2|Overall Study|Various other reasons|9
2612339|NCT00980148|9031969|P1|Overall Study|Various other reasons|8
2612340|NCT00980148|9031968|P2|Overall Study|Negative for chlamydia at enrollment|9
2612341|NCT00980148|9031969|P1|Overall Study|Negative for chlamydia at enrollment|12
2612342|NCT00980148|9031968|P2|Overall Study|Received other antichlamydia treatment|14
2612343|NCT00980148|9031969|P1|Overall Study|Received other antichlamydia treatment|20
2612344|NCT00980148|9031968|P2|Overall Study|Discharged from facility|96
2612345|NCT00980148|9031969|P1|Overall Study|Discharged from facility|89
2612346|NCT00980057|9031977|P2|Overall Study|Withdrawal by Subject|1
2612347|NCT00980057|9031978|P1|Overall Study|Withdrawal by Subject|1
2612348|NCT00980057|9031977|P2|Overall Study|Lost to Follow-up|0
2612349|NCT00980057|9031978|P1|Overall Study|Lost to Follow-up|1
2612350|NCT00980057|9031977|P2|Overall Study|Physician Decision|0
2612351|NCT00980057|9031978|P1|Overall Study|Physician Decision|4
2612352|NCT00980057|9031977|P2|Overall Study|Adverse Event|1
2612353|NCT00980057|9031978|P1|Overall Study|Adverse Event|0
2612354|NCT00980057|9031977|P2|Overall Study|Death|3
2612355|NCT00980057|9031978|P1|Overall Study|Death|13
2612356|NCT00980044|9032001|P3|Overall Study|Protocol Violation|2
2612357|NCT00980044|9032002|P2|Overall Study|Protocol Violation|0
2612358|NCT00980044|9032003|P1|Overall Study|Protocol Violation|0
2612359|NCT00980044|9032001|P3|Overall Study|Withdrawal by Subject|3
2612360|NCT00980044|9032002|P2|Overall Study|Withdrawal by Subject|7
2612361|NCT00980044|9032003|P1|Overall Study|Withdrawal by Subject|5
2612362|NCT00980005|9032022|P2|Overall Study|Other|3
2612363|NCT00980005|9032023|P1|Overall Study|Other|4
2612364|NCT00980005|9032022|P2|Overall Study|Lost to Follow-up|43
2612365|NCT00980005|9032023|P1|Overall Study|Lost to Follow-up|37
2612366|NCT00980005|9032022|P2|Overall Study|Withdrawal by Subject|17
2612367|NCT00980005|9032023|P1|Overall Study|Withdrawal by Subject|6
2612368|NCT00979992|9032063|P1|Overall Study|Refused – Never Treated|2
2612369|NCT00979992|9032063|P1|Overall Study|Ineligible - wrong cell type|2
2612370|NCT00979992|9032063|P1|Overall Study|Ineligible - inadequate pathology|1
2612371|NCT00979953|9032075|P4|Overall Study|Protocol Violation|2
2612372|NCT00979953|9032076|P3|Overall Study|Protocol Violation|2
2612373|NCT00979953|9032077|P2|Overall Study|Protocol Violation|0
2612374|NCT00979953|9032078|P1|Overall Study|Protocol Violation|1
2612375|NCT00979953|9032075|P4|Overall Study|Withdrawal by Subject|1
2612376|NCT00979953|9032076|P3|Overall Study|Withdrawal by Subject|2
2612377|NCT00979953|9032077|P2|Overall Study|Withdrawal by Subject|0
2612378|NCT00979953|9032078|P1|Overall Study|Withdrawal by Subject|0
2612379|NCT00979953|9032075|P4|Overall Study|Lost to Follow-up|0
2612380|NCT00979953|9032076|P3|Overall Study|Lost to Follow-up|1
2612381|NCT00979953|9032077|P2|Overall Study|Lost to Follow-up|1
2612382|NCT00979953|9032078|P1|Overall Study|Lost to Follow-up|1
2612383|NCT00979953|9032075|P4|Overall Study|Lack of Efficacy|0
2612384|NCT00979953|9032076|P3|Overall Study|Lack of Efficacy|0
2612385|NCT00979953|9032077|P2|Overall Study|Lack of Efficacy|2
2612386|NCT00979953|9032078|P1|Overall Study|Lack of Efficacy|1
2612387|NCT00979953|9032075|P4|Overall Study|Adverse Event|4
2612388|NCT00979953|9032076|P3|Overall Study|Adverse Event|17
2612389|NCT00979953|9032077|P2|Overall Study|Adverse Event|2
2612390|NCT00979953|9032078|P1|Overall Study|Adverse Event|5
2612391|NCT00979901|9032101|P4|Overall Study|Treatment Group Terminated by Sponsor|112
2612392|NCT00979901|9032102|P3|Overall Study|Treatment Group Terminated by Sponsor|0
2612393|NCT00979901|9032103|P2|Overall Study|Treatment Group Terminated by Sponsor|0
2612394|NCT00979901|9032104|P1|Overall Study|Treatment Group Terminated by Sponsor|0
2612395|NCT00979901|9032101|P4|Overall Study|Left Country|0
2612396|NCT00979901|9032102|P3|Overall Study|Left Country|1
2612397|NCT00979901|9032103|P2|Overall Study|Left Country|0
2612398|NCT00979901|9032104|P1|Overall Study|Left Country|0
2612399|NCT00979901|9032101|P4|Overall Study|Discontinued in Error|0
2612400|NCT00979901|9032102|P3|Overall Study|Discontinued in Error|0
2612401|NCT00979901|9032103|P2|Overall Study|Discontinued in Error|1
2612402|NCT00979901|9032104|P1|Overall Study|Discontinued in Error|0
2612403|NCT00979901|9032101|P4|Overall Study|elevated lab values pre-randomization|0
2612404|NCT00979901|9032102|P3|Overall Study|elevated lab values pre-randomization|0
2612405|NCT00979901|9032103|P2|Overall Study|elevated lab values pre-randomization|0
2612406|NCT00979901|9032104|P1|Overall Study|elevated lab values pre-randomization|1
2612407|NCT00979901|9032101|P4|Overall Study|vacation|0
2612408|NCT00979901|9032102|P3|Overall Study|vacation|0
2612409|NCT00979901|9032103|P2|Overall Study|vacation|0
2612410|NCT00979901|9032104|P1|Overall Study|vacation|1
2612411|NCT00979901|9032101|P4|Overall Study|out-of-state|0
2612412|NCT00979901|9032102|P3|Overall Study|out-of-state|0
2612413|NCT00979901|9032103|P2|Overall Study|out-of-state|0
2612414|NCT00979901|9032104|P1|Overall Study|out-of-state|1
2612415|NCT00979901|9032101|P4|Overall Study|Noncompliance|0
2612416|NCT00979901|9032102|P3|Overall Study|Noncompliance|0
2612417|NCT00979901|9032103|P2|Overall Study|Noncompliance|0
2612418|NCT00979901|9032104|P1|Overall Study|Noncompliance|1
2612419|NCT00979901|9032101|P4|Overall Study|Withdrawal by Subject|1
2612420|NCT00979901|9032102|P3|Overall Study|Withdrawal by Subject|1
2612421|NCT00979901|9032103|P2|Overall Study|Withdrawal by Subject|1
2612422|NCT00979901|9032104|P1|Overall Study|Withdrawal by Subject|2
2612423|NCT00979901|9032101|P4|Overall Study|Protocol Violation|1
2612424|NCT00979901|9032102|P3|Overall Study|Protocol Violation|7
2612425|NCT00979901|9032103|P2|Overall Study|Protocol Violation|2
2612426|NCT00979901|9032104|P1|Overall Study|Protocol Violation|2
2612427|NCT00979901|9032101|P4|Overall Study|Lost to Follow-up|0
2612428|NCT00979901|9032102|P3|Overall Study|Lost to Follow-up|2
2612429|NCT00979901|9032103|P2|Overall Study|Lost to Follow-up|1
2612430|NCT00979901|9032104|P1|Overall Study|Lost to Follow-up|1
2612431|NCT00979901|9032101|P4|Overall Study|Lack of Efficacy|0
2612432|NCT00979901|9032102|P3|Overall Study|Lack of Efficacy|9
2612433|NCT00979901|9032103|P2|Overall Study|Lack of Efficacy|4
2612434|NCT00979901|9032104|P1|Overall Study|Lack of Efficacy|8
2612435|NCT00979901|9032101|P4|Overall Study|Adverse Event|2
2612436|NCT00979901|9032102|P3|Overall Study|Adverse Event|9
2612437|NCT00979901|9032103|P2|Overall Study|Adverse Event|3
2612438|NCT00979901|9032104|P1|Overall Study|Adverse Event|1
2612439|NCT00979654|9032177|P1|Overall Study|Unfavorable Risk-Benefit Analysis|1
2612440|NCT00979654|9032177|P1|Overall Study|Serious Adverse Event|1
2612441|NCT00979654|9032177|P1|Overall Study|Patient Wanted to Pursue Other Treatment|1
2612442|NCT00979654|9032177|P1|Overall Study|Per Principal Investigator’s Discretion|1
2612443|NCT00979654|9032177|P1|Overall Study|Adverse Event of Diverticulitis|1
2612444|NCT00979654|9032177|P1|Overall Study|Adverse Event|1
2612445|NCT00979654|9032177|P1|Overall Study|Lack of Efficacy|6
2612446|NCT00979654|9032177|P1|Overall Study|Death|1
2612447|NCT00979654|9032177|P1|Overall Study|Withdrawal by Subject|22
2612448|NCT00979654|9032177|P1|Overall Study|Lost to Follow-up|1
2612449|NCT00979628|9032192|P3|Overall Study|transferred to ICU|1
2612450|NCT00979628|9032193|P2|Overall Study|transferred to ICU|2
2612451|NCT00979628|9032194|P1|Overall Study|transferred to ICU|1
2612452|NCT00979628|9032192|P3|Overall Study|received steroids|0
2612453|NCT00979628|9032193|P2|Overall Study|received steroids|1
2612454|NCT00979628|9032194|P1|Overall Study|received steroids|1
2612455|NCT00979628|9032192|P3|Overall Study|received regimen < 24 hours|5
2612456|NCT00979628|9032193|P2|Overall Study|received regimen < 24 hours|6
2612457|NCT00979628|9032194|P1|Overall Study|received regimen < 24 hours|7
2612458|NCT00979602|9032224|P2|Overall Study|Others|3
2612459|NCT00979602|9032225|P1|Overall Study|Others|3
2612460|NCT00979602|9032224|P2|Overall Study|Migrated/moved from study area|6
2612461|NCT00979602|9032225|P1|Overall Study|Migrated/moved from study area|3
2612462|NCT00979602|9032224|P2|Overall Study|Lost to Follow-up|96
2612463|NCT00979602|9032225|P1|Overall Study|Lost to Follow-up|100
2612464|NCT00979602|9032224|P2|Overall Study|Withdrawal by Subject|25
2612465|NCT00979602|9032225|P1|Overall Study|Withdrawal by Subject|31
2612466|NCT00979602|9032224|P2|Overall Study|Protocol Violation|0
2612467|NCT00979602|9032225|P1|Overall Study|Protocol Violation|3
2612468|NCT00979602|9032224|P2|Overall Study|Serious Adverse Event|3
2612469|NCT00979602|9032225|P1|Overall Study|Serious Adverse Event|5
2612470|NCT00979576|9032396|P3|Combination Followed by Monotherapy|Progressive Disease|1
2612471|NCT00979576|9032397|P2|Combination Followed by Monotherapy|Progressive Disease|2
2612472|NCT00979576|9032398|P1|Combination Followed by Monotherapy|Progressive Disease|0
2612473|NCT00979576|9032396|P3|Combination Treatment Phase|Adverse Event|2
2612474|NCT00979576|9032397|P2|Combination Treatment Phase|Adverse Event|2
2612475|NCT00979576|9032398|P1|Combination Treatment Phase|Adverse Event|0
2612476|NCT00979576|9032396|P3|Combination Treatment Phase|Dose limiting toxicity|2
2612477|NCT00979576|9032397|P2|Combination Treatment Phase|Dose limiting toxicity|3
2612478|NCT00979576|9032398|P1|Combination Treatment Phase|Dose limiting toxicity|0
2612479|NCT00979576|9032396|P3|Combination Treatment Phase|Progressive disease|5
2612480|NCT00979576|9032397|P2|Combination Treatment Phase|Progressive disease|1
2612481|NCT00979576|9032398|P1|Combination Treatment Phase|Progressive disease|3
2612482|NCT00979420|9032455|P4|Overall Study|Other reasons not related to Viramune|1
2612483|NCT00979420|9032456|P3|Overall Study|Other reasons not related to Viramune|0
2612484|NCT00979420|9032457|P2|Overall Study|Other reasons not related to Viramune|0
2612485|NCT00979420|9032458|P1|Overall Study|Other reasons not related to Viramune|3
2612486|NCT00979420|9032455|P4|Overall Study|Lack of Efficacy|1
2612487|NCT00979420|9032456|P3|Overall Study|Lack of Efficacy|1
2612488|NCT00979420|9032457|P2|Overall Study|Lack of Efficacy|0
2612489|NCT00979420|9032458|P1|Overall Study|Lack of Efficacy|3
2612490|NCT00979420|9032455|P4|Overall Study|Adverse Event|0
2612491|NCT00979420|9032456|P3|Overall Study|Adverse Event|0
2612492|NCT00979420|9032457|P2|Overall Study|Adverse Event|0
2612493|NCT00979420|9032458|P1|Overall Study|Adverse Event|1
2612494|NCT00979407|9032528|P2|Overall Study|Lost to Follow-up|3
2612495|NCT00979407|9032529|P1|Overall Study|Lost to Follow-up|3
2612496|NCT00979407|9032528|P2|Overall Study|Withdrawal by Subject|4
2612497|NCT00979407|9032529|P1|Overall Study|Withdrawal by Subject|3
2612498|NCT00979212|9032582|P2|Overall Study|No protocol therapy received|0
2612499|NCT00979212|9032583|P1|Overall Study|No protocol therapy received|1
2612500|NCT00979212|9032582|P2|Overall Study|Protocol Violation|8
2612501|NCT00979212|9032583|P1|Overall Study|Protocol Violation|1
2612502|NCT00979134|9032609|P3|Overall Study|Other|5
2612503|NCT00979134|9032610|P2|Overall Study|Other|1
2612504|NCT00979134|9032611|P1|Overall Study|Other|8
2612505|NCT00979134|9032609|P3|Overall Study|Death|26
2612506|NCT00979134|9032610|P2|Overall Study|Death|0
2612507|NCT00979134|9032611|P1|Overall Study|Death|4
2612508|NCT00979134|9032609|P3|Overall Study|Lost to Follow-up|0
2612509|NCT00979134|9032610|P2|Overall Study|Lost to Follow-up|2
2612510|NCT00979134|9032611|P1|Overall Study|Lost to Follow-up|2
2612511|NCT00979134|9032609|P3|Overall Study|Withdrawal by Subject|2
2612512|NCT00979134|9032610|P2|Overall Study|Withdrawal by Subject|1
2612513|NCT00979134|9032611|P1|Overall Study|Withdrawal by Subject|1
2612514|NCT00979134|9032609|P3|Overall Study|Adverse Event|2
2612515|NCT00979134|9032610|P2|Overall Study|Adverse Event|0
2612516|NCT00979134|9032611|P1|Overall Study|Adverse Event|0
2612517|NCT00979134|9032609|P3|Overall Study|Disease progression|5
2612518|NCT00979134|9032610|P2|Overall Study|Disease progression|2
2612519|NCT00979134|9032611|P1|Overall Study|Disease progression|18
2612520|NCT00978757|9032699|P2|Overall Study|Physician Decision|3
2612521|NCT00978757|9032700|P1|Overall Study|Physician Decision|1
2612522|NCT00978731|9032710|P4|Overall Study|No response|0
2612523|NCT00978731|9032711|P3|Overall Study|No response|0
2612524|NCT00978731|9032712|P2|Overall Study|No response|0
2612525|NCT00978731|9032713|P1|Overall Study|No response|1
2612526|NCT00978731|9032710|P4|Overall Study|Study closure|1
2612527|NCT00978731|9032711|P3|Overall Study|Study closure|1
2612528|NCT00978731|9032712|P2|Overall Study|Study closure|4
2612529|NCT00978731|9032713|P1|Overall Study|Study closure|3
2612530|NCT00978731|9032710|P4|Overall Study|Disease progression/relapse|2
2612531|NCT00978731|9032711|P3|Overall Study|Disease progression/relapse|2
2612532|NCT00978731|9032712|P2|Overall Study|Disease progression/relapse|4
2612533|NCT00978731|9032713|P1|Overall Study|Disease progression/relapse|5
2612534|NCT00978731|9032710|P4|Overall Study|Deterioration without progression|0
2612535|NCT00978731|9032711|P3|Overall Study|Deterioration without progression|0
2612536|NCT00978731|9032712|P2|Overall Study|Deterioration without progression|1
2612537|NCT00978731|9032713|P1|Overall Study|Deterioration without progression|0
2612538|NCT00978731|9032710|P4|Overall Study|Administrative reason|0
2612539|NCT00978731|9032711|P3|Overall Study|Administrative reason|1
2612540|NCT00978731|9032712|P2|Overall Study|Administrative reason|3
2612541|NCT00978731|9032713|P1|Overall Study|Administrative reason|3
2612542|NCT00978731|9032710|P4|Overall Study|Participant's request|0
2612543|NCT00978731|9032711|P3|Overall Study|Participant's request|0
2612544|NCT00978731|9032712|P2|Overall Study|Participant's request|0
2612545|NCT00978731|9032713|P1|Overall Study|Participant's request|1
2612546|NCT00978731|9032710|P4|Overall Study|Adverse Event|0
2612547|NCT00978731|9032711|P3|Overall Study|Adverse Event|0
2612548|NCT00978731|9032712|P2|Overall Study|Adverse Event|2
2612549|NCT00978731|9032713|P1|Overall Study|Adverse Event|5
2612550|NCT00978731|9032710|P4|Overall Study|Lost to Follow-up|1
2612551|NCT00978731|9032711|P3|Overall Study|Lost to Follow-up|0
2612552|NCT00978731|9032712|P2|Overall Study|Lost to Follow-up|0
2612553|NCT00978731|9032713|P1|Overall Study|Lost to Follow-up|0
2612554|NCT00978731|9032710|P4|Overall Study|Death|0
2612555|NCT00978731|9032711|P3|Overall Study|Death|1
2612556|NCT00978731|9032712|P2|Overall Study|Death|1
2612557|NCT00978731|9032713|P1|Overall Study|Death|4
2612558|NCT00978627|9032753|P2|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7
2612559|NCT00978627|9032754|P1|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12
2612560|NCT00978627|9032753|P2|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1
2612561|NCT00978627|9032754|P1|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2
2612562|NCT00978627|9032753|P2|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1
2612563|NCT00978627|9032754|P1|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4
2612564|NCT00978627|9032753|P2|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0
2612565|NCT00978627|9032754|P1|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3
2612566|NCT00978627|9032753|P2|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12
2612567|NCT00978627|9032754|P1|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25
2612568|NCT00978627|9032753|P2|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5
2612569|NCT00978627|9032754|P1|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7
2612570|NCT00978627|9032753|P2|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6
2612571|NCT00978627|9032754|P1|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8
2612572|NCT00978627|9032753|P2|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0
2612573|NCT00978627|9032754|P1|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2
2612574|NCT00978627|9032753|P2|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3
2612575|NCT00978627|9032754|P1|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4
2612576|NCT00978432|9032792|P3|Overall Study|Adverse Event|1
2612577|NCT00978432|9032793|P2|Overall Study|Adverse Event|0
2612578|NCT00978432|9032794|P1|Overall Study|Adverse Event|2
2612579|NCT00978432|9032792|P3|Overall Study|Lack of Efficacy|3
2612580|NCT00978432|9032793|P2|Overall Study|Lack of Efficacy|1
2612581|NCT00978432|9032794|P1|Overall Study|Lack of Efficacy|1
2612582|NCT00978432|9032792|P3|Overall Study|Withdrawal by Subject|1
2612583|NCT00978432|9032793|P2|Overall Study|Withdrawal by Subject|0
2612584|NCT00978432|9032794|P1|Overall Study|Withdrawal by Subject|0
2612585|NCT00978380|9032845|P1|Overall Study|Unclassified|8
2612586|NCT00978380|9032845|P1|Overall Study|Withdrawal criteria|9
2612587|NCT00978380|9032845|P1|Overall Study|Protocol Violation|2
2612588|NCT00978341|9032851|P2|Washout Period of 2 Weeks|Adverse Event|0
2612589|NCT00978341|9032852|P1|Washout Period of 2 Weeks|Adverse Event|1
2612590|NCT00978250|9032874|P4|Overall Study|Late determination of ineligibility|1
2612591|NCT00978250|9032875|P3|Overall Study|Late determination of ineligibility|0
2612592|NCT00978250|9032876|P2|Overall Study|Late determination of ineligibility|1
2612593|NCT00978250|9032877|P1|Overall Study|Late determination of ineligibility|0
2612594|NCT00978120|9032893|P4|Overall Study|Moved out of state|1
2612595|NCT00978120|9032894|P3|Overall Study|Moved out of state|0
2612596|NCT00978120|9032895|P2|Overall Study|Moved out of state|0
2612597|NCT00978120|9032896|P1|Overall Study|Moved out of state|0
2612598|NCT00978120|9032893|P4|Overall Study|Withdrawal by Subject|0
2612599|NCT00978120|9032894|P3|Overall Study|Withdrawal by Subject|0
2612600|NCT00978120|9032895|P2|Overall Study|Withdrawal by Subject|0
2612601|NCT00978120|9032896|P1|Overall Study|Withdrawal by Subject|2
2612602|NCT00978120|9032893|P4|Overall Study|Lost to Follow-up|0
2612603|NCT00978120|9032894|P3|Overall Study|Lost to Follow-up|3
2612604|NCT00978120|9032895|P2|Overall Study|Lost to Follow-up|0
2612605|NCT00978120|9032896|P1|Overall Study|Lost to Follow-up|0
2612606|NCT00978120|9032893|P4|Overall Study|Death|1
2612607|NCT00978120|9032894|P3|Overall Study|Death|0
2612608|NCT00978120|9032895|P2|Overall Study|Death|0
2612609|NCT00978120|9032896|P1|Overall Study|Death|0
2612610|NCT00978068|9032948|P2|Overall Study|Unable to Comply with Study|2
2612611|NCT00978068|9032949|P1|Overall Study|Unable to Comply with Study|0
2612612|NCT00978068|9032948|P2|Overall Study|Physician Decision|1
2612613|NCT00978068|9032949|P1|Overall Study|Physician Decision|0
2612614|NCT00978068|9032948|P2|Overall Study|Lost to Follow-up|2
2612615|NCT00978068|9032949|P1|Overall Study|Lost to Follow-up|1
2612616|NCT00978068|9032948|P2|Overall Study|Death|2
2612617|NCT00978068|9032949|P1|Overall Study|Death|1
2612618|NCT00978068|9032948|P2|Overall Study|Were Awaiting Initiation of ART|2
2612619|NCT00978068|9032949|P1|Overall Study|Were Awaiting Initiation of ART|2
2612620|NCT00978042|9032967|P2|Initial Treatment Period|Other Miscellaneous Reasons|0
2612621|NCT00978042|9032968|P1|Initial Treatment Period|Other Miscellaneous Reasons|13
2612622|NCT00978042|9032967|P2|Initial Treatment Period|Consent withdrawn|9
2612623|NCT00978042|9032968|P1|Initial Treatment Period|Consent withdrawn|22
2612624|NCT00978042|9032967|P2|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0
2612625|NCT00978042|9032968|P1|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2
2612626|NCT00978042|9032967|P2|Initial Treatment Period|Adverse Event|0
2612627|NCT00978042|9032968|P1|Initial Treatment Period|Adverse Event|2
2612628|NCT00978042|9032967|P2|Initial Treatment Period|Lost to Follow-up|3
2612629|NCT00978042|9032968|P1|Initial Treatment Period|Lost to Follow-up|21
2612630|NCT00978042|9032967|P2|Initial Treatment Period|Ineligibility|0
2612631|NCT00978042|9032968|P1|Initial Treatment Period|Ineligibility|1
2612632|NCT00978042|9032967|P2|Initial Treatment Period|Treated in Error|3
2612633|NCT00978042|9032968|P1|Initial Treatment Period|Treated in Error|0
2612634|NCT00978029|9032981|P3|Overall Study|Protocol Violation|0
2612635|NCT00978029|9032982|P2|Overall Study|Protocol Violation|1
2612636|NCT00978029|9032983|P1|Overall Study|Protocol Violation|0
2612637|NCT00978029|9032981|P3|Overall Study|Withdrawal by Subject|1
2612638|NCT00978029|9032982|P2|Overall Study|Withdrawal by Subject|0
2612639|NCT00978029|9032983|P1|Overall Study|Withdrawal by Subject|0
2612640|NCT00978029|9032981|P3|Overall Study|Adverse Event|5
2612641|NCT00978029|9032982|P2|Overall Study|Adverse Event|2
2612642|NCT00978029|9032983|P1|Overall Study|Adverse Event|1
2612643|NCT00977938|9033010|P4|Observation (30-33 mo. Post Procedure)|Other|0
2612644|NCT00977938|9033011|P3|Observation (30-33 mo. Post Procedure)|Other|0
2612645|NCT00977938|9033012|P2|Observation (30-33 mo. Post Procedure)|Other|4
2612646|NCT00977938|9033013|P1|Observation (30-33 mo. Post Procedure)|Other|8
2612647|NCT00977938|9033010|P4|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3
2612648|NCT00977938|9033011|P3|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10
2612649|NCT00977938|9033012|P2|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42
2612650|NCT00977938|9033013|P1|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34
2612651|NCT00977938|9033010|P4|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0
2612652|NCT00977938|9033011|P3|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2
2612653|NCT00977938|9033012|P2|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12
2612654|NCT00977938|9033013|P1|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9
2612655|NCT00977938|9033010|P4|Treatment (12-30 mo. Post Procedure)|Other|4
2612656|NCT00977938|9033011|P3|Treatment (12-30 mo. Post Procedure)|Other|3
2612657|NCT00977938|9033012|P2|Treatment (12-30 mo. Post Procedure)|Other|18
2612658|NCT00977938|9033013|P1|Treatment (12-30 mo. Post Procedure)|Other|17
2612659|NCT00977938|9033010|P4|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37
2612660|NCT00977938|9033011|P3|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30
2612661|NCT00977938|9033012|P2|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91
2612662|NCT00977938|9033013|P1|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88
2612663|NCT00977938|9033010|P4|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20
2612664|NCT00977938|9033011|P3|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13
2612665|NCT00977938|9033012|P2|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116
2612666|NCT00977938|9033013|P1|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132
2612667|NCT00977665|9033090|P2|Overall Study|Treatment failure|1
2612668|NCT00977665|9033091|P1|Overall Study|Treatment failure|0
2612669|NCT00977665|9033090|P2|Overall Study|Adverse Event|7
2612670|NCT00977665|9033091|P1|Overall Study|Adverse Event|14
2612671|NCT00977665|9033090|P2|Overall Study|Death|2
2612672|NCT00977665|9033091|P1|Overall Study|Death|3
2612673|NCT00977665|9033090|P2|Overall Study|Lost to Follow-up|0
2612674|NCT00977665|9033091|P1|Overall Study|Lost to Follow-up|1
2612675|NCT00977665|9033090|P2|Overall Study|Sponsor requested withdrawal|1
2612676|NCT00977665|9033091|P1|Overall Study|Sponsor requested withdrawal|0
2612677|NCT00977665|9033090|P2|Overall Study|Physician Decision|1
2612678|NCT00977665|9033091|P1|Overall Study|Physician Decision|2
2612679|NCT00977665|9033090|P2|Overall Study|Withdrawal by Subject|3
2612680|NCT00977665|9033091|P1|Overall Study|Withdrawal by Subject|1
2612681|NCT00977613|9033123|P1|Overall Study|Lost to Follow-up|16
2612682|NCT00977574|9033130|P3|Overall Study|Never Treated|4
2612683|NCT00977574|9033131|P2|Overall Study|Never Treated|2
2612684|NCT00977574|9033132|P1|Overall Study|Never Treated|4
2612685|NCT00977561|9033151|P2|Overall Study|Other|0
2612686|NCT00977561|9033152|P1|Overall Study|Other|2
2612687|NCT00977561|9033151|P2|Overall Study|Study terminated|2
2612688|NCT00977561|9033152|P1|Overall Study|Study terminated|0
2612689|NCT00977561|9033151|P2|Overall Study|Death|2
2612690|NCT00977561|9033152|P1|Overall Study|Death|3
2612691|NCT00977548|9033179|P1|Overall Study|Withdrawal by Subject|1
2612692|NCT00977548|9033179|P1|Overall Study|Adverse Event|8
2612693|NCT00977548|9033179|P1|Overall Study|Ineligible|4
2612694|NCT00977470|9033188|P2|Overall Study|Still on-study|0
2612695|NCT00977470|9033189|P1|Overall Study|Still on-study|2
2612696|NCT00977470|9033188|P2|Overall Study|prolonged recovery post-surgery|1
2612697|NCT00977470|9033189|P1|Overall Study|prolonged recovery post-surgery|0
2612698|NCT00977470|9033188|P2|Overall Study|clinical decline|1
2612699|NCT00977470|9033189|P1|Overall Study|clinical decline|0
2612700|NCT00977470|9033188|P2|Overall Study|Death|2
2612701|NCT00977470|9033189|P1|Overall Study|Death|0
2612702|NCT00977470|9033188|P2|Overall Study|Withdrawal by Subject|2
2612703|NCT00977470|9033189|P1|Overall Study|Withdrawal by Subject|0
2612704|NCT00977470|9033188|P2|Overall Study|Protocol Violation|0
2612705|NCT00977470|9033189|P1|Overall Study|Protocol Violation|1
2612706|NCT00977470|9033188|P2|Overall Study|Adverse Event|2
2612707|NCT00977470|9033189|P1|Overall Study|Adverse Event|1
2612708|NCT00977470|9033188|P2|Overall Study|Physician Decision|0
2612709|NCT00977470|9033189|P1|Overall Study|Physician Decision|2
2612710|NCT00977470|9033188|P2|Overall Study|Lack of Efficacy|30
2612711|NCT00977470|9033189|P1|Overall Study|Lack of Efficacy|32
2612712|NCT00977431|9033212|P5|Overall Study|Progressive disease|5
2612713|NCT00977431|9033213|P4|Overall Study|Progressive disease|3
2612714|NCT00977431|9033214|P3|Overall Study|Progressive disease|1
2612715|NCT00977431|9033215|P2|Overall Study|Progressive disease|6
2612716|NCT00977431|9033216|P1|Overall Study|Progressive disease|2
2612717|NCT00977431|9033212|P5|Overall Study|Dose-limiting toxicity (DLT)|0
2612718|NCT00977431|9033213|P4|Overall Study|Dose-limiting toxicity (DLT)|0
2612719|NCT00977431|9033214|P3|Overall Study|Dose-limiting toxicity (DLT)|1
2612720|NCT00977431|9033215|P2|Overall Study|Dose-limiting toxicity (DLT)|0
2612721|NCT00977431|9033216|P1|Overall Study|Dose-limiting toxicity (DLT)|1
2612722|NCT00977431|9033212|P5|Overall Study|Adverse Event|6
2612723|NCT00977431|9033213|P4|Overall Study|Adverse Event|0
2612724|NCT00977431|9033214|P3|Overall Study|Adverse Event|4
2612725|NCT00977431|9033215|P2|Overall Study|Adverse Event|0
2612726|NCT00977431|9033216|P1|Overall Study|Adverse Event|3
2612727|NCT00977431|9033212|P5|Overall Study|Protocol Violation|0
2612728|NCT00977431|9033213|P4|Overall Study|Protocol Violation|0
2612729|NCT00977431|9033214|P3|Overall Study|Protocol Violation|1
2612730|NCT00977431|9033215|P2|Overall Study|Protocol Violation|0
2612731|NCT00977431|9033216|P1|Overall Study|Protocol Violation|0
2612732|NCT00977431|9033212|P5|Overall Study|Other than listed|2
2612733|NCT00977431|9033213|P4|Overall Study|Other than listed|0
2612734|NCT00977431|9033214|P3|Overall Study|Other than listed|0
2612735|NCT00977431|9033215|P2|Overall Study|Other than listed|0
2612736|NCT00977431|9033216|P1|Overall Study|Other than listed|1
2612737|NCT00977379|9033249|P2|Overall Study|Randomization Error|1
2612738|NCT00977379|9033250|P1|Overall Study|Randomization Error|0
2612739|NCT00977379|9033249|P2|Overall Study|Participant Moving House|1
2612740|NCT00977379|9033250|P1|Overall Study|Participant Moving House|0
2612741|NCT00977379|9033249|P2|Overall Study|Premature Study Termination|0
2612742|NCT00977379|9033250|P1|Overall Study|Premature Study Termination|4
2612743|NCT00977379|9033249|P2|Overall Study|Death|9
2612744|NCT00977379|9033250|P1|Overall Study|Death|7
2612745|NCT00977379|9033249|P2|Overall Study|Withdrawal by Subject|1
2612746|NCT00977379|9033250|P1|Overall Study|Withdrawal by Subject|1
2612747|NCT00977314|9033286|P2|Overall Study|Physician Decision|0
2612748|NCT00977314|9033287|P1|Overall Study|Physician Decision|1
2612749|NCT00977314|9033286|P2|Overall Study|Withdrawal by Subject|0
2612750|NCT00977314|9033287|P1|Overall Study|Withdrawal by Subject|1
2612751|NCT00977197|9033295|P2|Overall Study|Nonadherence|1
2612752|NCT00977197|9033296|P1|Overall Study|Nonadherence|1
2612753|NCT00977197|9033295|P2|Overall Study|Lost to Follow-up|3
2612754|NCT00977197|9033296|P1|Overall Study|Lost to Follow-up|1
2612755|NCT00977197|9033295|P2|Overall Study|Lack of Efficacy|0
2612756|NCT00977197|9033296|P1|Overall Study|Lack of Efficacy|1
2612757|NCT00977197|9033295|P2|Overall Study|Adverse Event|1
2612758|NCT00977197|9033296|P1|Overall Study|Adverse Event|3
2612759|NCT00977197|9033295|P2|Overall Study|Withdrawal by Subject|4
2612760|NCT00977197|9033296|P1|Overall Study|Withdrawal by Subject|3
2612761|NCT00977106|9033359|P2|Overall Study|Other|0
2612762|NCT00977106|9033360|P1|Overall Study|Other|1
2612763|NCT00977106|9033359|P2|Overall Study|Protocol Violation|1
2612764|NCT00977106|9033360|P1|Overall Study|Protocol Violation|0
2612765|NCT00977106|9033359|P2|Overall Study|Lack of Efficacy|2
2612766|NCT00977106|9033360|P1|Overall Study|Lack of Efficacy|2
2612767|NCT00977106|9033359|P2|Overall Study|Withdrawal by Subject|2
2612768|NCT00977106|9033360|P1|Overall Study|Withdrawal by Subject|2
2612769|NCT00977106|9033359|P2|Overall Study|Adverse Event|6
2612770|NCT00977106|9033360|P1|Overall Study|Adverse Event|5
2612771|NCT00977080|9033452|P4|Overall Study|Travel for family reasons|0
2612772|NCT00977080|9033453|P3|Overall Study|Travel for family reasons|0
2612773|NCT00977080|9033454|P2|Overall Study|Travel for family reasons|0
2612774|NCT00977080|9033455|P1|Overall Study|Travel for family reasons|1
2612775|NCT00977080|9033452|P4|Overall Study|Required kidney transplantation|1
2612776|NCT00977080|9033453|P3|Overall Study|Required kidney transplantation|3
2612777|NCT00977080|9033454|P2|Overall Study|Required kidney transplantation|3
2612778|NCT00977080|9033455|P1|Overall Study|Required kidney transplantation|1
2612779|NCT00977080|9033452|P4|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1
2612780|NCT00977080|9033453|P3|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
2612781|NCT00977080|9033454|P2|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
2612782|NCT00977080|9033455|P1|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
2612783|NCT00977080|9033452|P4|Overall Study|Noncompliance|0
2612784|NCT00977080|9033453|P3|Overall Study|Noncompliance|1
2612785|NCT00977080|9033454|P2|Overall Study|Noncompliance|2
2612786|NCT00977080|9033455|P1|Overall Study|Noncompliance|0
2612787|NCT00977080|9033452|P4|Overall Study|Protocol Violation|3
2612788|NCT00977080|9033453|P3|Overall Study|Protocol Violation|4
2612789|NCT00977080|9033454|P2|Overall Study|Protocol Violation|3
2612790|NCT00977080|9033455|P1|Overall Study|Protocol Violation|7
2612791|NCT00977080|9033452|P4|Overall Study|Withdrawal by Subject|5
2612792|NCT00977080|9033453|P3|Overall Study|Withdrawal by Subject|1
2612793|NCT00977080|9033454|P2|Overall Study|Withdrawal by Subject|5
2612794|NCT00977080|9033455|P1|Overall Study|Withdrawal by Subject|1
2612795|NCT00977080|9033452|P4|Overall Study|Adverse Event|7
2612796|NCT00977080|9033453|P3|Overall Study|Adverse Event|7
2612797|NCT00977080|9033454|P2|Overall Study|Adverse Event|7
2612798|NCT00977080|9033455|P1|Overall Study|Adverse Event|2
2612799|NCT00976989|9033488|P3|Overall Study|Other|1
2612800|NCT00976989|9033489|P2|Overall Study|Other|0
2612801|NCT00976989|9033490|P1|Overall Study|Other|1
2612802|NCT00976989|9033488|P3|Overall Study|Recurrence of Disease|0
2612803|NCT00976989|9033489|P2|Overall Study|Recurrence of Disease|1
2612804|NCT00976989|9033490|P1|Overall Study|Recurrence of Disease|0
2612805|NCT00976989|9033488|P3|Overall Study|Failure to Return|0
2612806|NCT00976989|9033489|P2|Overall Study|Failure to Return|1
2612807|NCT00976989|9033490|P1|Overall Study|Failure to Return|2
2612808|NCT00976989|9033488|P3|Overall Study|Refused Treatment|5
2612809|NCT00976989|9033489|P2|Overall Study|Refused Treatment|3
2612810|NCT00976989|9033490|P1|Overall Study|Refused Treatment|4
2612811|NCT00976989|9033488|P3|Overall Study|Death|10
2612812|NCT00976989|9033489|P2|Overall Study|Death|7
2612813|NCT00976989|9033490|P1|Overall Study|Death|5
2612814|NCT00976989|9033488|P3|Overall Study|Violation of Selection Criteria at Entry|1
2612815|NCT00976989|9033489|P2|Overall Study|Violation of Selection Criteria at Entry|0
2612816|NCT00976989|9033490|P1|Overall Study|Violation of Selection Criteria at Entry|1
2612817|NCT00976950|9033531|P1|Overall Study|Events with no relationship to Aptivus|3
2612818|NCT00976950|9033531|P1|Overall Study|Adverse Event|3
2612819|NCT00976937|9033539|P2|Overall Study|Personal and Familial Reason|2
2612820|NCT00976937|9033540|P1|Overall Study|Personal and Familial Reason|2
2612821|NCT00976937|9033539|P2|Overall Study|Poor compliance to protocol|0
2612822|NCT00976937|9033540|P1|Overall Study|Poor compliance to protocol|3
2612823|NCT00976937|9033539|P2|Overall Study|Withdrawal by Subject|3
2612824|NCT00976937|9033540|P1|Overall Study|Withdrawal by Subject|5
2612825|NCT00976937|9033539|P2|Overall Study|Lost to Follow-up|1
2612826|NCT00976937|9033540|P1|Overall Study|Lost to Follow-up|2
2612827|NCT00976937|9033539|P2|Overall Study|Adverse Event|5
2612828|NCT00976937|9033540|P1|Overall Study|Adverse Event|4
2612829|NCT00976911|9033582|P2|Overall Study|In Follow-Up as of 25 Jan 2013|37
2612830|NCT00976911|9033583|P1|Overall Study|In Follow-Up as of 25 Jan 2013|30
2612831|NCT00976911|9033582|P2|Overall Study|Other|9
2612832|NCT00976911|9033583|P1|Overall Study|Other|8
2612833|NCT00976911|9033582|P2|Overall Study|Protocol Violation|0
2612834|NCT00976911|9033583|P1|Overall Study|Protocol Violation|2
2612835|NCT00976911|9033582|P2|Overall Study|Adverse Event|1
2612836|NCT00976911|9033583|P1|Overall Study|Adverse Event|0
2612837|NCT00976911|9033582|P2|Overall Study|Death|126
2612838|NCT00976911|9033583|P1|Overall Study|Death|138
2612839|NCT00976911|9033582|P2|Overall Study|Withdrawal by Subject|6
2612840|NCT00976911|9033583|P1|Overall Study|Withdrawal by Subject|4
2612841|NCT00976898|9033601|P1|Overall Study|Progressive Disease|1
2612842|NCT00976898|9033601|P1|Overall Study|Liver Transplant|1
2612843|NCT00976898|9033601|P1|Overall Study|Physician Decision|1
2612844|NCT00976898|9033601|P1|Overall Study|Adverse Event|1
2612845|NCT00976898|9033601|P1|Overall Study|Protocol Violation|1
2612846|NCT00976820|9033612|P4|Overall Study|Withdrawal by Subject|4
2612847|NCT00976820|9033613|P3|Overall Study|Withdrawal by Subject|1
2612848|NCT00976820|9033614|P2|Overall Study|Withdrawal by Subject|4
2612849|NCT00976820|9033615|P1|Overall Study|Withdrawal by Subject|2
2612850|NCT00976820|9033612|P4|Overall Study|Poor Compliance. Numerous Visits Booked|0
2612851|NCT00976820|9033613|P3|Overall Study|Poor Compliance. Numerous Visits Booked|1
2612852|NCT00976820|9033614|P2|Overall Study|Poor Compliance. Numerous Visits Booked|0
2612853|NCT00976820|9033615|P1|Overall Study|Poor Compliance. Numerous Visits Booked|1
2612854|NCT00976820|9033612|P4|Overall Study|Lost to Follow-up|3
2612855|NCT00976820|9033613|P3|Overall Study|Lost to Follow-up|2
2612856|NCT00976820|9033614|P2|Overall Study|Lost to Follow-up|16
2612857|NCT00976820|9033615|P1|Overall Study|Lost to Follow-up|5
2612858|NCT00976716|9033951|P1|Overall Study|Adverse Event|1
2612859|NCT00976703|9033969|P2|Overall Study|ineligible for study|2
2612860|NCT00976703|9033970|P1|Overall Study|ineligible for study|2
2612861|NCT00976703|9033969|P2|Overall Study|Physician Decision|1
2612862|NCT00976703|9033970|P1|Overall Study|Physician Decision|1
2612863|NCT00976677|9033984|P2|Overall Study|Unknown/Missing|0
2612864|NCT00976677|9033985|P1|Overall Study|Unknown/Missing|1
2612865|NCT00976677|9033984|P2|Overall Study|Trial unblinded|2
2612866|NCT00976677|9033985|P1|Overall Study|Trial unblinded|2
2612867|NCT00976677|9033984|P2|Overall Study|Disease progression|1
2612868|NCT00976677|9033985|P1|Overall Study|Disease progression|1
2612869|NCT00976677|9033984|P2|Overall Study|Withdrawal by Subject|2
2612870|NCT00976677|9033985|P1|Overall Study|Withdrawal by Subject|0
2612871|NCT00976677|9033984|P2|Overall Study|Adverse Event|0
2612872|NCT00976677|9033985|P1|Overall Study|Adverse Event|1
2612873|NCT00976573|9034193|P2|Overall Study|Cancel prior to receiving treatment|2
2612874|NCT00976573|9034194|P1|Overall Study|Cancel prior to receiving treatment|4
2612875|NCT00976573|9034193|P2|Overall Study|Ineligible|1
2612876|NCT00976573|9034194|P1|Overall Study|Ineligible|0
2612877|NCT00976560|9034208|P2|Overall Study|Withdrawal by Subject|3
2612878|NCT00976560|9034209|P1|Overall Study|Withdrawal by Subject|2
2612879|NCT00976560|9034208|P2|Overall Study|Physician Decision|0
2612880|NCT00976560|9034209|P1|Overall Study|Physician Decision|2
2612881|NCT00976560|9034208|P2|Overall Study|Lost to Follow-up|0
2612882|NCT00976560|9034209|P1|Overall Study|Lost to Follow-up|1
2612883|NCT00976560|9034208|P2|Overall Study|Protocol Violation|0
2612884|NCT00976560|9034209|P1|Overall Study|Protocol Violation|1
2612885|NCT00976560|9034208|P2|Overall Study|Lack of Efficacy|5
2612886|NCT00976560|9034209|P1|Overall Study|Lack of Efficacy|3
2612887|NCT00976560|9034208|P2|Overall Study|Adverse Event|5
2612888|NCT00976560|9034209|P1|Overall Study|Adverse Event|5
2612889|NCT00976508|9034278|P2|Overall Study|Terminated by the Sponsor|1
2612890|NCT00976508|9034279|P1|Overall Study|Terminated by the Sponsor|0
2612891|NCT00976508|9034278|P2|Overall Study|Subject Enrolled in Hospice|0
2612892|NCT00976508|9034279|P1|Overall Study|Subject Enrolled in Hospice|1
2612893|NCT00976508|9034278|P2|Overall Study|Disease Progression|4
2612894|NCT00976508|9034279|P1|Overall Study|Disease Progression|4
2612895|NCT00976508|9034278|P2|Overall Study|Withdrawal by Subject|0
2612896|NCT00976508|9034279|P1|Overall Study|Withdrawal by Subject|1
2612897|NCT00976508|9034278|P2|Overall Study|Lost to Follow-up|0
2612898|NCT00976508|9034279|P1|Overall Study|Lost to Follow-up|1
2612899|NCT00976508|9034278|P2|Overall Study|Death|1
2612900|NCT00976508|9034279|P1|Overall Study|Death|7
2612901|NCT00976495|9034312|P3|Overall Study|Withdrawal by Subject|0
2612902|NCT00976495|9034313|P2|Overall Study|Withdrawal by Subject|1
2612903|NCT00976495|9034314|P1|Overall Study|Withdrawal by Subject|0
2612904|NCT00976482|9034331|P1|Overall Study|Protocol Violation|5
2612905|NCT00976482|9034331|P1|Overall Study|Center terminated|1
2612906|NCT00976482|9034331|P1|Overall Study|Withdrawal by Subject|45
2612907|NCT00976482|9034331|P1|Overall Study|Death|208
2612908|NCT00976456|9034337|P2|Overall Study|screening failure, unknown|4
2612909|NCT00976456|9034338|P1|Overall Study|screening failure, unknown|11
2612910|NCT00976456|9034337|P2|Overall Study|Withdrawal by Subject|1
2612911|NCT00976456|9034338|P1|Overall Study|Withdrawal by Subject|3
2612912|NCT00976456|9034337|P2|Overall Study|Lack of Efficacy|2
2612913|NCT00976456|9034338|P1|Overall Study|Lack of Efficacy|5
2612914|NCT00976456|9034337|P2|Overall Study|Death|9
2612915|NCT00976456|9034338|P1|Overall Study|Death|7
2612916|NCT00976456|9034337|P2|Overall Study|Adverse Event|22
2612917|NCT00976456|9034338|P1|Overall Study|Adverse Event|17
2612918|NCT00976391|9034365|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
2612919|NCT00976391|9034366|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
2612920|NCT00976391|9034365|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|7
2612921|NCT00976391|9034366|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
2612922|NCT00976391|9034365|P2|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8
2612923|NCT00976391|9034366|P1|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6
2612924|NCT00976391|9034365|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
2612925|NCT00976391|9034366|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|14
2612926|NCT00976391|9034365|P2|Follow-up Period (8 Weeks)|Noncompliance|2
2612927|NCT00976391|9034366|P1|Follow-up Period (8 Weeks)|Noncompliance|2
2612928|NCT00976391|9034365|P2|Follow-up Period (8 Weeks)|Adverse Event|1
2612929|NCT00976391|9034366|P1|Follow-up Period (8 Weeks)|Adverse Event|3
2612930|NCT00976391|9034365|P2|Treatment Period (52 Weeks)|Pregnancy|0
2612931|NCT00976391|9034366|P1|Treatment Period (52 Weeks)|Pregnancy|1
2612932|NCT00976391|9034365|P2|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4
2612933|NCT00976391|9034366|P1|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0
2612934|NCT00976391|9034365|P2|Treatment Period (52 Weeks)|Physician Decision|1
2612935|NCT00976391|9034366|P1|Treatment Period (52 Weeks)|Physician Decision|1
2612936|NCT00976391|9034365|P2|Treatment Period (52 Weeks)|Withdrawal by Subject|19
2612937|NCT00976391|9034366|P1|Treatment Period (52 Weeks)|Withdrawal by Subject|9
2612938|NCT00976391|9034365|P2|Treatment Period (52 Weeks)|Lost to Follow-up|8
2612939|NCT00976391|9034366|P1|Treatment Period (52 Weeks)|Lost to Follow-up|10
2612940|NCT00976391|9034365|P2|Treatment Period (52 Weeks)|Noncompliance|4
2612941|NCT00976391|9034366|P1|Treatment Period (52 Weeks)|Noncompliance|4
2612942|NCT00976391|9034365|P2|Treatment Period (52 Weeks)|Protocol Violation|1
2612943|NCT00976391|9034366|P1|Treatment Period (52 Weeks)|Protocol Violation|1
2612944|NCT00976391|9034365|P2|Treatment Period (52 Weeks)|Adverse Event|2
2612945|NCT00976391|9034366|P1|Treatment Period (52 Weeks)|Adverse Event|16
2612946|NCT00976274|9034414|P2|Overall Study|Physician Decision|2
2612947|NCT00976274|9034415|P1|Overall Study|Physician Decision|1
2612948|NCT00976274|9034414|P2|Overall Study|Withdrawal by Subject|1
2612949|NCT00976274|9034415|P1|Overall Study|Withdrawal by Subject|1
2612950|NCT00976274|9034414|P2|Overall Study|Lost to Follow-up|5
2612951|NCT00976274|9034415|P1|Overall Study|Lost to Follow-up|5
2612952|NCT00976209|9034431|P2|Treatment Period 2|Lost to Follow-up|1
2612953|NCT00976209|9034432|P1|Treatment Period 2|Lost to Follow-up|0
2612954|NCT00976209|9034431|P2|Treatment Period 2|Withdrawal by Subject|1
2612955|NCT00976209|9034432|P1|Treatment Period 2|Withdrawal by Subject|0
2612956|NCT00976209|9034431|P2|Wash-out Period|Other|0
2612957|NCT00976209|9034432|P1|Wash-out Period|Other|1
2612958|NCT00976209|9034431|P2|Wash-out Period|Protocol Violation|0
2612959|NCT00976209|9034432|P1|Wash-out Period|Protocol Violation|1
2612960|NCT00976209|9034431|P2|Wash-out Period|Lost to Follow-up|0
2612961|NCT00976209|9034432|P1|Wash-out Period|Lost to Follow-up|1
2612962|NCT00976209|9034431|P2|Wash-out Period|Adverse Event|2
2612963|NCT00976209|9034432|P1|Wash-out Period|Adverse Event|1
2612964|NCT00976209|9034431|P2|Treatment Period 1|Other|1
2612965|NCT00976209|9034432|P1|Treatment Period 1|Other|0
2612966|NCT00976209|9034431|P2|Treatment Period 1|Lost to Follow-up|0
2612967|NCT00976209|9034432|P1|Treatment Period 1|Lost to Follow-up|2
2612968|NCT00976209|9034431|P2|Treatment Period 1|Protocol Violation|0
2612969|NCT00976209|9034432|P1|Treatment Period 1|Protocol Violation|1
2612970|NCT00976027|9034445|P2|Overall Study|Withdrawal by Subject|66
2612971|NCT00976027|9034446|P1|Overall Study|Withdrawal by Subject|107
2612972|NCT00976027|9034445|P2|Overall Study|Lost to Follow-up|103
2612973|NCT00976027|9034446|P1|Overall Study|Lost to Follow-up|208
2612974|NCT00976027|9034445|P2|Overall Study|Protocol Violation|27
2612975|NCT00976027|9034446|P1|Overall Study|Protocol Violation|60
2612976|NCT00976027|9034445|P2|Overall Study|Adverse Event|2
2612977|NCT00976027|9034446|P1|Overall Study|Adverse Event|0
2612978|NCT00976027|9034445|P2|Overall Study|Serious Adverse Event|17
2612979|NCT00976027|9034446|P1|Overall Study|Serious Adverse Event|36
2612980|NCT00975975|9034458|P1|Overall Study|Death|6
2612981|NCT00975923|9034466|P2|Overall Study|Withdrawal by Subject|1
2612982|NCT00975923|9034467|P1|Overall Study|Withdrawal by Subject|0
2612983|NCT00975884|9034477|P2|Overall Study|Other|3
2612984|NCT00975884|9034478|P1|Overall Study|Other|1
2612985|NCT00975884|9034477|P2|Overall Study|Withdrawal by Subject|9
2612986|NCT00975884|9034478|P1|Overall Study|Withdrawal by Subject|9
2612987|NCT00975884|9034477|P2|Overall Study|Lost to Follow-up|3
2612988|NCT00975884|9034478|P1|Overall Study|Lost to Follow-up|5
2612989|NCT00975884|9034477|P2|Overall Study|Adverse Event|0
2612990|NCT00975884|9034478|P1|Overall Study|Adverse Event|1
2612991|NCT00975806|9034635|P3|Overall Study|Physician decision and disease related|1
2612992|NCT00975806|9034636|P2|Overall Study|Physician decision and disease related|0
2612993|NCT00975806|9034637|P1|Overall Study|Physician decision and disease related|1
2612994|NCT00975806|9034635|P3|Overall Study|Death|0
2612995|NCT00975806|9034636|P2|Overall Study|Death|1
2612996|NCT00975806|9034637|P1|Overall Study|Death|0
2612997|NCT00975806|9034635|P3|Overall Study|Withdrawal by Subject|0
2612998|NCT00975806|9034636|P2|Overall Study|Withdrawal by Subject|0
2612999|NCT00975806|9034637|P1|Overall Study|Withdrawal by Subject|1
2613000|NCT00975806|9034635|P3|Overall Study|Disease Progression|1
2613001|NCT00975806|9034636|P2|Overall Study|Disease Progression|5
2613002|NCT00975806|9034637|P1|Overall Study|Disease Progression|1
2613003|NCT00975806|9034635|P3|Overall Study|Adverse Event|2
2613004|NCT00975806|9034636|P2|Overall Study|Adverse Event|1
2613005|NCT00975806|9034637|P1|Overall Study|Adverse Event|2
2613006|NCT00975780|9034661|P2|Follow Up|Discharged from Facility|12
2613007|NCT00975780|9034662|P1|Follow Up|Discharged from Facility|7
2613008|NCT00975780|9034661|P2|Follow Up|Facility Withdrawal|23
2613009|NCT00975780|9034662|P1|Follow Up|Facility Withdrawal|7
2613010|NCT00975780|9034661|P2|Follow Up|Death|122
2613011|NCT00975780|9034662|P1|Follow Up|Death|88
2613012|NCT00975715|9034672|P2|Maintenance Period|Adverse Event|1
2613013|NCT00975715|9034673|P1|Maintenance Period|Adverse Event|2
2613014|NCT00975715|9034672|P2|Titration Period|Protocol Violation|0
2613015|NCT00975715|9034673|P1|Titration Period|Protocol Violation|1
2613016|NCT00975715|9034672|P2|Titration Period|Adverse Event|0
2613017|NCT00975715|9034673|P1|Titration Period|Adverse Event|6
2613018|NCT00975689|9034689|P2|Overall Study|Physician Decision|0
2613019|NCT00975689|9034690|P1|Overall Study|Physician Decision|1
2613020|NCT00975689|9034689|P2|Overall Study|Withdrawal by Subject|0
2613021|NCT00975689|9034690|P1|Overall Study|Withdrawal by Subject|1
2613022|NCT00975689|9034689|P2|Overall Study|Adverse Event|3
2613023|NCT00975689|9034690|P1|Overall Study|Adverse Event|0
2613024|NCT00975611|9034759|P1|Overall Study|Physician Decision|1
2613025|NCT00975611|9034759|P1|Overall Study|Screen Fail|16
2613026|NCT00975585|9034765|P2|Overall Study|Lens issue|2
2613027|NCT00975585|9034766|P1|Overall Study|Lens issue|2
2613028|NCT00975585|9034765|P2|Overall Study|Withdrawal by Subject|1
2613029|NCT00975585|9034766|P1|Overall Study|Withdrawal by Subject|2
2613030|NCT00975585|9034765|P2|Overall Study|Lost to Follow-up|5
2613031|NCT00975585|9034766|P1|Overall Study|Lost to Follow-up|3
2613032|NCT00975585|9034765|P2|Overall Study|Adverse Event|4
2613033|NCT00975585|9034766|P1|Overall Study|Adverse Event|0
2613034|NCT00975507|9034786|P2|Overall Study|Withdrawal by Subject|3
2613035|NCT00975507|9034787|P1|Overall Study|Withdrawal by Subject|10
2613036|NCT00975507|9034786|P2|Overall Study|Protocol Violation|0
2613037|NCT00975507|9034787|P1|Overall Study|Protocol Violation|2
2613038|NCT00975507|9034786|P2|Overall Study|Lost to Follow-up|1
2613039|NCT00975507|9034787|P1|Overall Study|Lost to Follow-up|7
2613040|NCT00975507|9034786|P2|Overall Study|Adverse Event|0
2613041|NCT00975507|9034787|P1|Overall Study|Adverse Event|1
2613042|NCT00975481|9034807|P6|Fifth Intervention Period|Withdrawal by Subject|0
2613043|NCT00975481|9034808|P5|Fifth Intervention Period|Withdrawal by Subject|1
2613044|NCT00975481|9034809|P4|Fifth Intervention Period|Withdrawal by Subject|0
2613045|NCT00975481|9034810|P3|Fifth Intervention Period|Withdrawal by Subject|0
2613046|NCT00975481|9034811|P2|Fifth Intervention Period|Withdrawal by Subject|0
2613047|NCT00975481|9034812|P1|Fifth Intervention Period|Withdrawal by Subject|0
2613048|NCT00975481|9034807|P6|Fourth Intervention Period|Withdrawal by Subject|0
2613049|NCT00975481|9034808|P5|Fourth Intervention Period|Withdrawal by Subject|0
2613050|NCT00975481|9034809|P4|Fourth Intervention Period|Withdrawal by Subject|1
2613051|NCT00975481|9034810|P3|Fourth Intervention Period|Withdrawal by Subject|1
2613052|NCT00975481|9034811|P2|Fourth Intervention Period|Withdrawal by Subject|0
2613053|NCT00975481|9034812|P1|Fourth Intervention Period|Withdrawal by Subject|0
2613054|NCT00975481|9034807|P6|Second Intervention Period|Withdrawal by Subject|0
2613055|NCT00975481|9034808|P5|Second Intervention Period|Withdrawal by Subject|0
2613056|NCT00975481|9034809|P4|Second Intervention Period|Withdrawal by Subject|0
2613057|NCT00975481|9034810|P3|Second Intervention Period|Withdrawal by Subject|1
2613058|NCT00975481|9034811|P2|Second Intervention Period|Withdrawal by Subject|0
2613059|NCT00975481|9034812|P1|Second Intervention Period|Withdrawal by Subject|0
2613060|NCT00975481|9034807|P6|Second Intervention Period|Adverse Event|0
2613061|NCT00975481|9034808|P5|Second Intervention Period|Adverse Event|0
2613062|NCT00975481|9034809|P4|Second Intervention Period|Adverse Event|0
2613063|NCT00975481|9034810|P3|Second Intervention Period|Adverse Event|0
2613064|NCT00975481|9034811|P2|Second Intervention Period|Adverse Event|1
2613065|NCT00975481|9034812|P1|Second Intervention Period|Adverse Event|2
2613066|NCT00975416|9034912|P2|Overall Study|early discharge from tx|5
2613067|NCT00975416|9034913|P1|Overall Study|early discharge from tx|3
2613068|NCT00975286|9034922|P2|Overall Study|Sponsor Decision|2
2613069|NCT00975286|9034923|P1|Overall Study|Sponsor Decision|0
2613070|NCT00975286|9034922|P2|Overall Study|Poor Compliance to Protocol|2
2613071|NCT00975286|9034923|P1|Overall Study|Poor Compliance to Protocol|0
2613072|NCT00975286|9034922|P2|Overall Study|Familial and Personal Reasons|2
2613073|NCT00975286|9034923|P1|Overall Study|Familial and Personal Reasons|2
2613074|NCT00975286|9034922|P2|Overall Study|Withdrawal by Subject|2
2613075|NCT00975286|9034923|P1|Overall Study|Withdrawal by Subject|0
2613076|NCT00975286|9034922|P2|Overall Study|Protocol Violation|2
2613077|NCT00975286|9034923|P1|Overall Study|Protocol Violation|1
2613078|NCT00975286|9034922|P2|Overall Study|Adverse Event|19
2613079|NCT00975286|9034923|P1|Overall Study|Adverse Event|9
2613080|NCT00975221|9034955|P2|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0
2613081|NCT00975221|9034956|P1|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1
2613082|NCT00975221|9034955|P2|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
2613083|NCT00975221|9034956|P1|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
2613084|NCT00975221|9034955|P2|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1
2613085|NCT00975221|9034956|P1|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0
2613086|NCT00975221|9034955|P2|Titration Phase (Weeks 1-12)|Other|1
2613087|NCT00975221|9034956|P1|Titration Phase (Weeks 1-12)|Other|0
2613088|NCT00975221|9034955|P2|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0
2613089|NCT00975221|9034956|P1|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1
2613090|NCT00975221|9034955|P2|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3
2613091|NCT00975221|9034956|P1|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2
2613092|NCT00975195|9034972|P2|Overall Study|Not treated|2
2613093|NCT00975195|9034973|P1|Overall Study|Not treated|1
2613094|NCT00975195|9034972|P2|Overall Study|Other reason not defined above|33
2613095|NCT00975195|9034973|P1|Overall Study|Other reason not defined above|29
2613096|NCT00975195|9034972|P2|Overall Study|Withdrawal by Subject|61
2613097|NCT00975195|9034973|P1|Overall Study|Withdrawal by Subject|48
2613098|NCT00975195|9034972|P2|Overall Study|Lost to Follow-up|7
2613099|NCT00975195|9034973|P1|Overall Study|Lost to Follow-up|9
2613100|NCT00975195|9034972|P2|Overall Study|Protocol Violation|23
2613101|NCT00975195|9034973|P1|Overall Study|Protocol Violation|27
2613102|NCT00975195|9034972|P2|Overall Study|Lack of Efficacy|6
2613103|NCT00975195|9034973|P1|Overall Study|Lack of Efficacy|6
2613104|NCT00975195|9034972|P2|Overall Study|Adverse Event|101
2613105|NCT00975195|9034973|P1|Overall Study|Adverse Event|108
2613106|NCT00975156|9035033|P2|Overall Study|Protocol Violation|1
2613107|NCT00975156|9035034|P1|Overall Study|Protocol Violation|0
2613108|NCT00975143|9035046|P2|Overall Study|Details not available|4
2613109|NCT00975143|9035047|P1|Overall Study|Details not available|10
2613110|NCT00975143|9035046|P2|Overall Study|Physician Decision|2
2613111|NCT00975143|9035047|P1|Overall Study|Physician Decision|1
2613112|NCT00975143|9035046|P2|Overall Study|Non-compliance|8
2613113|NCT00975143|9035047|P1|Overall Study|Non-compliance|5
2613114|NCT00975143|9035046|P2|Overall Study|Lost to Follow-up|16
2613115|NCT00975143|9035047|P1|Overall Study|Lost to Follow-up|20
2613116|NCT00975143|9035046|P2|Overall Study|Withdrawal by Subject|15
2613117|NCT00975143|9035047|P1|Overall Study|Withdrawal by Subject|15
2613118|NCT00975143|9035046|P2|Overall Study|Adverse Event|15
2613119|NCT00975143|9035047|P1|Overall Study|Adverse Event|19
2613120|NCT00975130|9035057|P3|Study Part 2|Protocol Violation|1
2613121|NCT00975130|9035058|P2|Study Part 2|Protocol Violation|0
2613122|NCT00975130|9035059|P1|Study Part 2|Protocol Violation|0
2613123|NCT00975130|9035057|P3|Study Part 2|Administrative|0
2613124|NCT00975130|9035058|P2|Study Part 2|Administrative|1
2613125|NCT00975130|9035059|P1|Study Part 2|Administrative|0
2613126|NCT00975130|9035057|P3|Study Part 2|Did Not Meet Protocol Eligibility|1
2613127|NCT00975130|9035058|P2|Study Part 2|Did Not Meet Protocol Eligibility|4
2613128|NCT00975130|9035059|P1|Study Part 2|Did Not Meet Protocol Eligibility|0
2613129|NCT00975130|9035057|P3|Study Part 2|Withdrew Consent|2
2613130|NCT00975130|9035058|P2|Study Part 2|Withdrew Consent|6
2613131|NCT00975130|9035059|P1|Study Part 2|Withdrew Consent|0
2613132|NCT00975130|9035057|P3|Study Part 2|Withdrawal by Subject|5
2613133|NCT00975130|9035058|P2|Study Part 2|Withdrawal by Subject|13
2613134|NCT00975130|9035059|P1|Study Part 2|Withdrawal by Subject|0
2613135|NCT00975130|9035057|P3|Study Part 2|Lost to Follow-up|1
2613136|NCT00975130|9035058|P2|Study Part 2|Lost to Follow-up|0
2613137|NCT00975130|9035059|P1|Study Part 2|Lost to Follow-up|0
2613138|NCT00975130|9035057|P3|Study Part 2|Adverse Event|7
2613139|NCT00975130|9035058|P2|Study Part 2|Adverse Event|14
2613140|NCT00975130|9035059|P1|Study Part 2|Adverse Event|0
2613141|NCT00975130|9035057|P3|Study Part 1|Withdrew Consent|0
2613142|NCT00975130|9035058|P2|Study Part 1|Withdrew Consent|0
2613143|NCT00975130|9035059|P1|Study Part 1|Withdrew Consent|24
2613144|NCT00975130|9035057|P3|Study Part 1|Administrative|0
2613145|NCT00975130|9035058|P2|Study Part 1|Administrative|0
2613146|NCT00975130|9035059|P1|Study Part 1|Administrative|4
2613147|NCT00975130|9035057|P3|Study Part 1|Did Not Meet Protocol Eligibility|0
2613148|NCT00975130|9035058|P2|Study Part 1|Did Not Meet Protocol Eligibility|0
2613149|NCT00975130|9035059|P1|Study Part 1|Did Not Meet Protocol Eligibility|9
2613150|NCT00975130|9035057|P3|Study Part 1|Protocol Violation|0
2613151|NCT00975130|9035058|P2|Study Part 1|Protocol Violation|0
2613152|NCT00975130|9035059|P1|Study Part 1|Protocol Violation|13
2613153|NCT00975130|9035057|P3|Study Part 1|Withdrawal by Subject|0
2613154|NCT00975130|9035058|P2|Study Part 1|Withdrawal by Subject|0
2613155|NCT00975130|9035059|P1|Study Part 1|Withdrawal by Subject|61
2613156|NCT00975130|9035057|P3|Study Part 1|Lost to Follow-up|0
2613157|NCT00975130|9035058|P2|Study Part 1|Lost to Follow-up|0
2613158|NCT00975130|9035059|P1|Study Part 1|Lost to Follow-up|19
2613159|NCT00975130|9035057|P3|Study Part 1|Adverse Event|0
2613160|NCT00975130|9035058|P2|Study Part 1|Adverse Event|0
2613161|NCT00975130|9035059|P1|Study Part 1|Adverse Event|150
2613162|NCT00975000|9035243|P2|Overall Study|Non-compliance|1
2613163|NCT00975000|9035244|P1|Overall Study|Non-compliance|0
2613164|NCT00975000|9035243|P2|Overall Study|Protocol-specified Criteria|0
2613165|NCT00975000|9035244|P1|Overall Study|Protocol-specified Criteria|1
2613166|NCT00975000|9035243|P2|Overall Study|Lost to Follow-up|1
2613167|NCT00975000|9035244|P1|Overall Study|Lost to Follow-up|0
2613168|NCT00975000|9035243|P2|Overall Study|Withdrawal by Subject|2
2613169|NCT00975000|9035244|P1|Overall Study|Withdrawal by Subject|2
2613170|NCT00975000|9035243|P2|Overall Study|Adverse Event|1
2613171|NCT00975000|9035244|P1|Overall Study|Adverse Event|1
2613172|NCT00975000|9035243|P2|Overall Study|Other|0
2613173|NCT00975000|9035244|P1|Overall Study|Other|1
2613174|NCT00974974|9035268|P2|Maintenance - Double Blind Treatment|Various|0
2613175|NCT00974974|9035269|P1|Maintenance - Double Blind Treatment|Various|4
2613176|NCT00974974|9035268|P2|Maintenance - Double Blind Treatment|Withdrawal by Subject|2
2613177|NCT00974974|9035269|P1|Maintenance - Double Blind Treatment|Withdrawal by Subject|5
2613178|NCT00974974|9035268|P2|Maintenance - Double Blind Treatment|Lost to Follow-up|1
2613179|NCT00974974|9035269|P1|Maintenance - Double Blind Treatment|Lost to Follow-up|0
2613180|NCT00974974|9035268|P2|Maintenance - Double Blind Treatment|Lack of Efficacy|2
2613181|NCT00974974|9035269|P1|Maintenance - Double Blind Treatment|Lack of Efficacy|2
2613182|NCT00974974|9035268|P2|Maintenance - Double Blind Treatment|Noncompliance with study drug|1
2613183|NCT00974974|9035269|P1|Maintenance - Double Blind Treatment|Noncompliance with study drug|0
2613184|NCT00974974|9035268|P2|Maintenance - Double Blind Treatment|Protocol Violation|1
2613185|NCT00974974|9035269|P1|Maintenance - Double Blind Treatment|Protocol Violation|1
2613186|NCT00974974|9035268|P2|Maintenance - Double Blind Treatment|Adverse Event|3
2613187|NCT00974974|9035269|P1|Maintenance - Double Blind Treatment|Adverse Event|3
2613188|NCT00974974|9035268|P2|IPX066 Dose Conversion|Protocol Violation|0
2613189|NCT00974974|9035269|P1|IPX066 Dose Conversion|Protocol Violation|4
2613190|NCT00974974|9035268|P2|IPX066 Dose Conversion|Various|0
2613191|NCT00974974|9035269|P1|IPX066 Dose Conversion|Various|3
2613192|NCT00974974|9035268|P2|IPX066 Dose Conversion|Withdrawal by Subject|0
2613193|NCT00974974|9035269|P1|IPX066 Dose Conversion|Withdrawal by Subject|12
2613194|NCT00974974|9035268|P2|IPX066 Dose Conversion|Lack of Efficacy|0
2613195|NCT00974974|9035269|P1|IPX066 Dose Conversion|Lack of Efficacy|13
2613196|NCT00974974|9035268|P2|IPX066 Dose Conversion|Death|0
2613197|NCT00974974|9035269|P1|IPX066 Dose Conversion|Death|2
2613198|NCT00974974|9035268|P2|IPX066 Dose Conversion|Adverse Event|0
2613199|NCT00974974|9035269|P1|IPX066 Dose Conversion|Adverse Event|23
2613200|NCT00974974|9035268|P2|IR CD-LD Dose Adjustment|Various|9
2613201|NCT00974974|9035269|P1|IR CD-LD Dose Adjustment|Various|0
2613202|NCT00974974|9035268|P2|IR CD-LD Dose Adjustment|Withdrawal by Subject|7
2613203|NCT00974974|9035269|P1|IR CD-LD Dose Adjustment|Withdrawal by Subject|0
2613204|NCT00974974|9035268|P2|IR CD-LD Dose Adjustment|Noncompliance with study drug|1
2613205|NCT00974974|9035269|P1|IR CD-LD Dose Adjustment|Noncompliance with study drug|0
2613206|NCT00974974|9035268|P2|IR CD-LD Dose Adjustment|Protocol Violation|1
2613207|NCT00974974|9035269|P1|IR CD-LD Dose Adjustment|Protocol Violation|0
2613208|NCT00974974|9035268|P2|IR CD-LD Dose Adjustment|Adverse Event|3
2613209|NCT00974974|9035269|P1|IR CD-LD Dose Adjustment|Adverse Event|0
2613210|NCT00974922|9035279|P1|Overall Study|study terminated|24
2613211|NCT00974675|9035297|P4|Overall Study|Participant on holiday; unable to attend|1
2613212|NCT00974675|9035298|P3|Overall Study|Participant on holiday; unable to attend|0
2613213|NCT00974675|9035299|P2|Overall Study|Participant on holiday; unable to attend|0
2613214|NCT00974675|9035300|P1|Overall Study|Participant on holiday; unable to attend|0
2613215|NCT00974675|9035297|P4|Overall Study|Physician Decision|0
2613216|NCT00974675|9035298|P3|Overall Study|Physician Decision|1
2613217|NCT00974675|9035299|P2|Overall Study|Physician Decision|0
2613218|NCT00974675|9035300|P1|Overall Study|Physician Decision|0
2613219|NCT00974675|9035297|P4|Overall Study|Adverse Event|1
2613220|NCT00974675|9035298|P3|Overall Study|Adverse Event|1
2613221|NCT00974675|9035299|P2|Overall Study|Adverse Event|1
2613222|NCT00974675|9035300|P1|Overall Study|Adverse Event|2
2613223|NCT00974571|9035349|P3|Overall Study|Other|10
2613224|NCT00974571|9035350|P2|Overall Study|Other|0
2613225|NCT00974571|9035351|P1|Overall Study|Other|4
2613226|NCT00974571|9035349|P3|Overall Study|Patient Moved|1
2613227|NCT00974571|9035350|P2|Overall Study|Patient Moved|0
2613228|NCT00974571|9035351|P1|Overall Study|Patient Moved|1
2613229|NCT00974571|9035349|P3|Overall Study|Withdrawal by Subject|16
2613230|NCT00974571|9035350|P2|Overall Study|Withdrawal by Subject|5
2613231|NCT00974571|9035351|P1|Overall Study|Withdrawal by Subject|14
2613232|NCT00974571|9035349|P3|Overall Study|Protocol Violation|18
2613233|NCT00974571|9035350|P2|Overall Study|Protocol Violation|4
2613234|NCT00974571|9035351|P1|Overall Study|Protocol Violation|13
2613235|NCT00974571|9035349|P3|Overall Study|Lost to Follow-up|2
2613236|NCT00974571|9035350|P2|Overall Study|Lost to Follow-up|1
2613237|NCT00974571|9035351|P1|Overall Study|Lost to Follow-up|2
2613238|NCT00974571|9035349|P3|Overall Study|Lack of Efficacy|9
2613239|NCT00974571|9035350|P2|Overall Study|Lack of Efficacy|2
2613240|NCT00974571|9035351|P1|Overall Study|Lack of Efficacy|3
2613241|NCT00974571|9035349|P3|Overall Study|Adverse Event|27
2613242|NCT00974571|9035350|P2|Overall Study|Adverse Event|4
2613243|NCT00974571|9035351|P1|Overall Study|Adverse Event|31
2613244|NCT00974311|9035448|P2|OLE Phase (up to 77 Months)|Withdrawal by Subject|1
2613245|NCT00974311|9035449|P1|OLE Phase (up to 77 Months)|Withdrawal by Subject|2
2613246|NCT00974311|9035448|P2|OLE Phase (up to 77 Months)|Other|2
2613247|NCT00974311|9035449|P1|OLE Phase (up to 77 Months)|Other|15
2613248|NCT00974311|9035448|P2|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26
2613249|NCT00974311|9035449|P1|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78
2613250|NCT00974311|9035448|P2|OLE Phase (up to 77 Months)|Death|21
2613251|NCT00974311|9035449|P1|OLE Phase (up to 77 Months)|Death|14
2613252|NCT00974311|9035448|P2|DB Phase (up to 24 Months)|Other|0
2613253|NCT00974311|9035449|P1|DB Phase (up to 24 Months)|Other|1
2613254|NCT00974311|9035448|P2|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42
2613255|NCT00974311|9035449|P1|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108
2613256|NCT00974311|9035448|P2|DB Phase (up to 24 Months)|Withdrawal by Subject|7
2613257|NCT00974311|9035449|P1|DB Phase (up to 24 Months)|Withdrawal by Subject|16
2613258|NCT00974311|9035448|P2|DB Phase (up to 24 Months)|Death|298
2613259|NCT00974311|9035449|P1|DB Phase (up to 24 Months)|Death|561
2613260|NCT00974311|9035448|P2|DB Phase (up to 24 Months)|Lost to Follow-up|2
2613261|NCT00974311|9035449|P1|DB Phase (up to 24 Months)|Lost to Follow-up|5
2613262|NCT00974259|9035487|P2|Overall Study|Technically inadequate PbtO2 recordings|1
2613263|NCT00974259|9035488|P1|Overall Study|Technically inadequate PbtO2 recordings|2
2613264|NCT00974233|9035506|P1|Maintenance Lenalidomide|Adverse Event|8
2613265|NCT00974233|9035506|P1|Maintenance Lenalidomide|Lack of Efficacy|5
2613266|NCT00974233|9035506|P1|Induction Chemoimmunotherapy|Withdrawal by Subject|1
2613267|NCT00974233|9035506|P1|Induction Chemoimmunotherapy|Adverse Event|7
2613268|NCT00974233|9035506|P1|Induction Chemoimmunotherapy|Lack of Efficacy|5
2613269|NCT00974233|9035506|P1|Induction Chemoimmunotherapy|Death|2
2613270|NCT00974220|9035521|P2|Treatment Period 1|noncompliant subjects|1
2613271|NCT00974220|9035522|P1|Treatment Period 1|noncompliant subjects|0
2613272|NCT00974220|9035521|P2|Treatment Period 1|Adverse Event|1
2613273|NCT00974220|9035522|P1|Treatment Period 1|Adverse Event|2
2613274|NCT00974090|9035567|P2|Period 2: Open-label Period|Withdrawal by Subject|0
2613275|NCT00974090|9035568|P1|Period 2: Open-label Period|Withdrawal by Subject|1
2613276|NCT00974090|9035567|P2|Period 2: Open-label Period|Physician Decision|3
2613277|NCT00974090|9035568|P1|Period 2: Open-label Period|Physician Decision|0
2613278|NCT00974090|9035567|P2|Period 2: Open-label Period|Lack of Efficacy|1
2613279|NCT00974090|9035568|P1|Period 2: Open-label Period|Lack of Efficacy|3
2613280|NCT00974090|9035567|P2|Period 2: Open-label Period|Adverse Event|6
2613281|NCT00974090|9035568|P1|Period 2: Open-label Period|Adverse Event|4
2613282|NCT00974090|9035567|P2|Period 1: Double Blind Period|Physician Decision|0
2613283|NCT00974090|9035568|P1|Period 1: Double Blind Period|Physician Decision|1
2613284|NCT00974090|9035567|P2|Period 1: Double Blind Period|Adverse Event|1
2613285|NCT00974090|9035568|P1|Period 1: Double Blind Period|Adverse Event|2
2613286|NCT00973973|9035604|P2|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0
2613287|NCT00973973|9035605|P1|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1
2613288|NCT00973973|9035604|P2|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0
2613289|NCT00973973|9035605|P1|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1
2613290|NCT00973973|9035604|P2|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3
2613291|NCT00973973|9035605|P1|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1
2613292|NCT00973973|9035604|P2|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0
2613293|NCT00973973|9035605|P1|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1
2613294|NCT00973973|9035604|P2|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0
2613295|NCT00973973|9035605|P1|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1
2613296|NCT00973973|9035604|P2|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2
2613297|NCT00973973|9035605|P1|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1
2613298|NCT00973973|9035604|P2|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
2613299|NCT00973973|9035605|P1|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
2613300|NCT00973973|9035604|P2|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
2613301|NCT00973973|9035605|P1|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
2613302|NCT00973973|9035604|P2|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0
2613303|NCT00973973|9035605|P1|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1
2613304|NCT00973973|9035604|P2|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3
2613305|NCT00973973|9035605|P1|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1
2613306|NCT00973973|9035604|P2|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0
2613307|NCT00973973|9035605|P1|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1
2613308|NCT00973973|9035604|P2|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3
2613309|NCT00973973|9035605|P1|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1
2613310|NCT00973921|9035665|P1|Overall Study|IVUS results were not available|9
2613311|NCT00973765|9035682|P2|Overall Study|Lost to Follow-up|14
2613312|NCT00973765|9035683|P1|Overall Study|Lost to Follow-up|8
2613313|NCT00973700|9035705|P5|Overall Study|Unable to Classify|1
2613314|NCT00973700|9035706|P4|Overall Study|Unable to Classify|2
2613315|NCT00973700|9035707|P3|Overall Study|Unable to Classify|1
2613316|NCT00973700|9035708|P2|Overall Study|Unable to Classify|0
2613317|NCT00973700|9035709|P1|Overall Study|Unable to Classify|0
2613318|NCT00973700|9035705|P5|Overall Study|Inappropriate enrolment|0
2613319|NCT00973700|9035706|P4|Overall Study|Inappropriate enrolment|4
2613320|NCT00973700|9035707|P3|Overall Study|Inappropriate enrolment|0
2613321|NCT00973700|9035708|P2|Overall Study|Inappropriate enrolment|0
2613322|NCT00973700|9035709|P1|Overall Study|Inappropriate enrolment|0
2613323|NCT00973700|9035705|P5|Overall Study|Lost to Follow-up|5
2613324|NCT00973700|9035706|P4|Overall Study|Lost to Follow-up|8
2613325|NCT00973700|9035707|P3|Overall Study|Lost to Follow-up|1
2613326|NCT00973700|9035708|P2|Overall Study|Lost to Follow-up|0
2613327|NCT00973700|9035709|P1|Overall Study|Lost to Follow-up|5
2613328|NCT00973700|9035705|P5|Overall Study|Withdrawal by Subject|4
2613329|NCT00973700|9035706|P4|Overall Study|Withdrawal by Subject|4
2613330|NCT00973700|9035707|P3|Overall Study|Withdrawal by Subject|8
2613331|NCT00973700|9035708|P2|Overall Study|Withdrawal by Subject|2
2613332|NCT00973700|9035709|P1|Overall Study|Withdrawal by Subject|2
2613333|NCT00973674|9035758|P2|Overall Study|Protocol Violation|0
2613334|NCT00973674|9035759|P1|Overall Study|Protocol Violation|2
2613335|NCT00973622|9035773|P2|Overall Study|did not complete rTMS sessions|2
2613336|NCT00973622|9035774|P1|Overall Study|did not complete rTMS sessions|11
2613337|NCT00973622|9035773|P2|Overall Study|did not pass MRI screen|0
2613338|NCT00973622|9035774|P1|Overall Study|did not pass MRI screen|6
2613339|NCT00973622|9035773|P2|Overall Study|did not attend MRI|3
2613340|NCT00973622|9035774|P1|Overall Study|did not attend MRI|14
2613341|NCT00973479|9035782|P2|Overall Study|Other|7
2613342|NCT00973479|9035783|P1|Overall Study|Other|1
2613343|NCT00973479|9035782|P2|Overall Study|Protocol Violation|2
2613344|NCT00973479|9035783|P1|Overall Study|Protocol Violation|2
2613345|NCT00973479|9035782|P2|Overall Study|Adverse Event|32
2613346|NCT00973479|9035783|P1|Overall Study|Adverse Event|12
2613347|NCT00973479|9035782|P2|Overall Study|Lack of Efficacy|7
2613348|NCT00973479|9035783|P1|Overall Study|Lack of Efficacy|5
2613349|NCT00973479|9035782|P2|Overall Study|Withdrawal by Subject|16
2613350|NCT00973479|9035783|P1|Overall Study|Withdrawal by Subject|15
2613351|NCT00973479|9035782|P2|Overall Study|Death|2
2613352|NCT00973479|9035783|P1|Overall Study|Death|2
2613353|NCT00973479|9035782|P2|Overall Study|Lost to Follow-up|3
2613354|NCT00973479|9035783|P1|Overall Study|Lost to Follow-up|0
2613355|NCT00973362|9035801|P2|3-Year Follow-up|Lost to Follow-up|0
2613356|NCT00973362|9035802|P1|3-Year Follow-up|Lost to Follow-up|17
2613357|NCT00973362|9035801|P2|Baseline Evaluation|Inevaluable|223
2613358|NCT00973362|9035802|P1|Baseline Evaluation|Inevaluable|686
2613359|NCT00973362|9035801|P2|Baseline Evaluation|No colposcopy visit|0
2613360|NCT00973362|9035802|P1|Baseline Evaluation|No colposcopy visit|62
2613361|NCT00973362|9035801|P2|Baseline Evaluation|W/D, later determined to be ineligible|0
2613362|NCT00973362|9035802|P1|Baseline Evaluation|W/D, later determined to be ineligible|25
2613363|NCT00973349|9035827|P16|Overall Study|Unable to classify|0
2613364|NCT00973349|9035828|P15|Overall Study|Unable to classify|0
2613365|NCT00973349|9035829|P14|Overall Study|Unable to classify|0
2613366|NCT00973349|9035830|P13|Overall Study|Unable to classify|0
2613367|NCT00973349|9035831|P12|Overall Study|Unable to classify|0
2613368|NCT00973349|9035832|P11|Overall Study|Unable to classify|0
2613369|NCT00973349|9035833|P10|Overall Study|Unable to classify|1
2613370|NCT00973349|9035834|P9|Overall Study|Unable to classify|0
2613371|NCT00973349|9035835|P8|Overall Study|Unable to classify|0
2613372|NCT00973349|9035836|P7|Overall Study|Unable to classify|0
2613373|NCT00973349|9035837|P6|Overall Study|Unable to classify|1
2613374|NCT00973349|9035838|P5|Overall Study|Unable to classify|1
2613375|NCT00973349|9035839|P4|Overall Study|Unable to classify|0
2613376|NCT00973349|9035840|P3|Overall Study|Unable to classify|0
2613377|NCT00973349|9035841|P2|Overall Study|Unable to classify|0
2613378|NCT00973349|9035842|P1|Overall Study|Unable to classify|0
2613379|NCT00973349|9035827|P16|Overall Study|Protocol Violation|0
2613380|NCT00973349|9035828|P15|Overall Study|Protocol Violation|0
2613381|NCT00973349|9035829|P14|Overall Study|Protocol Violation|0
2613382|NCT00973349|9035830|P13|Overall Study|Protocol Violation|0
2613383|NCT00973349|9035831|P12|Overall Study|Protocol Violation|0
2613384|NCT00973349|9035832|P11|Overall Study|Protocol Violation|0
2613385|NCT00973349|9035833|P10|Overall Study|Protocol Violation|0
2613386|NCT00973349|9035834|P9|Overall Study|Protocol Violation|1
2613387|NCT00973349|9035835|P8|Overall Study|Protocol Violation|0
2613388|NCT00973349|9035836|P7|Overall Study|Protocol Violation|0
2613389|NCT00973349|9035837|P6|Overall Study|Protocol Violation|0
2613390|NCT00973349|9035838|P5|Overall Study|Protocol Violation|0
2613391|NCT00973349|9035839|P4|Overall Study|Protocol Violation|0
2613392|NCT00973349|9035840|P3|Overall Study|Protocol Violation|0
2613393|NCT00973349|9035841|P2|Overall Study|Protocol Violation|0
2613394|NCT00973349|9035842|P1|Overall Study|Protocol Violation|0
2613395|NCT00973349|9035827|P16|Overall Study|Inappropriate enrolment|1
2613396|NCT00973349|9035828|P15|Overall Study|Inappropriate enrolment|1
2613397|NCT00973349|9035829|P14|Overall Study|Inappropriate enrolment|0
2613398|NCT00973349|9035830|P13|Overall Study|Inappropriate enrolment|1
2613399|NCT00973349|9035831|P12|Overall Study|Inappropriate enrolment|0
2613400|NCT00973349|9035832|P11|Overall Study|Inappropriate enrolment|0
2613401|NCT00973349|9035833|P10|Overall Study|Inappropriate enrolment|2
2613402|NCT00973349|9035834|P9|Overall Study|Inappropriate enrolment|0
2613403|NCT00973349|9035835|P8|Overall Study|Inappropriate enrolment|0
2613404|NCT00973349|9035836|P7|Overall Study|Inappropriate enrolment|0
2613405|NCT00973349|9035837|P6|Overall Study|Inappropriate enrolment|0
2613406|NCT00973349|9035838|P5|Overall Study|Inappropriate enrolment|0
2613407|NCT00973349|9035839|P4|Overall Study|Inappropriate enrolment|0
2613408|NCT00973349|9035840|P3|Overall Study|Inappropriate enrolment|1
2613409|NCT00973349|9035841|P2|Overall Study|Inappropriate enrolment|0
2613410|NCT00973349|9035842|P1|Overall Study|Inappropriate enrolment|0
2613411|NCT00973349|9035827|P16|Overall Study|Lost to Follow-up|1
2613412|NCT00973349|9035828|P15|Overall Study|Lost to Follow-up|0
2613413|NCT00973349|9035829|P14|Overall Study|Lost to Follow-up|0
2613414|NCT00973349|9035830|P13|Overall Study|Lost to Follow-up|0
2613415|NCT00973349|9035831|P12|Overall Study|Lost to Follow-up|1
2613416|NCT00973349|9035832|P11|Overall Study|Lost to Follow-up|0
2613417|NCT00973349|9035833|P10|Overall Study|Lost to Follow-up|1
2613418|NCT00973349|9035834|P9|Overall Study|Lost to Follow-up|2
2613419|NCT00973349|9035835|P8|Overall Study|Lost to Follow-up|1
2613420|NCT00973349|9035836|P7|Overall Study|Lost to Follow-up|0
2613421|NCT00973349|9035837|P6|Overall Study|Lost to Follow-up|3
2613422|NCT00973349|9035838|P5|Overall Study|Lost to Follow-up|1
2613423|NCT00973349|9035839|P4|Overall Study|Lost to Follow-up|2
2613424|NCT00973349|9035840|P3|Overall Study|Lost to Follow-up|2
2613425|NCT00973349|9035841|P2|Overall Study|Lost to Follow-up|1
2613426|NCT00973349|9035842|P1|Overall Study|Lost to Follow-up|3
2613427|NCT00973349|9035827|P16|Overall Study|Withdrawal by Subject|0
2613428|NCT00973349|9035828|P15|Overall Study|Withdrawal by Subject|0
2613429|NCT00973349|9035829|P14|Overall Study|Withdrawal by Subject|0
2613430|NCT00973349|9035830|P13|Overall Study|Withdrawal by Subject|0
2613431|NCT00973349|9035831|P12|Overall Study|Withdrawal by Subject|1
2613432|NCT00973349|9035832|P11|Overall Study|Withdrawal by Subject|0
2613433|NCT00973349|9035833|P10|Overall Study|Withdrawal by Subject|2
2613434|NCT00973349|9035834|P9|Overall Study|Withdrawal by Subject|0
2613435|NCT00973349|9035835|P8|Overall Study|Withdrawal by Subject|2
2613436|NCT00973349|9035836|P7|Overall Study|Withdrawal by Subject|2
2613437|NCT00973349|9035837|P6|Overall Study|Withdrawal by Subject|0
2613438|NCT00973349|9035838|P5|Overall Study|Withdrawal by Subject|2
2613439|NCT00973349|9035839|P4|Overall Study|Withdrawal by Subject|3
2613440|NCT00973349|9035840|P3|Overall Study|Withdrawal by Subject|2
2613441|NCT00973349|9035841|P2|Overall Study|Withdrawal by Subject|2
2613442|NCT00973349|9035842|P1|Overall Study|Withdrawal by Subject|1
2613443|NCT00973349|9035827|P16|Overall Study|Adverse Event|0
2613444|NCT00973349|9035828|P15|Overall Study|Adverse Event|1
2613445|NCT00973349|9035829|P14|Overall Study|Adverse Event|0
2613446|NCT00973349|9035830|P13|Overall Study|Adverse Event|0
2613447|NCT00973349|9035831|P12|Overall Study|Adverse Event|0
2613448|NCT00973349|9035832|P11|Overall Study|Adverse Event|0
2613449|NCT00973349|9035833|P10|Overall Study|Adverse Event|0
2613450|NCT00973349|9035834|P9|Overall Study|Adverse Event|1
2613451|NCT00973349|9035835|P8|Overall Study|Adverse Event|0
2613452|NCT00973349|9035836|P7|Overall Study|Adverse Event|0
2613453|NCT00973349|9035837|P6|Overall Study|Adverse Event|0
2613454|NCT00973349|9035838|P5|Overall Study|Adverse Event|1
2613455|NCT00973349|9035839|P4|Overall Study|Adverse Event|0
2613456|NCT00973349|9035840|P3|Overall Study|Adverse Event|0
2613457|NCT00973349|9035841|P2|Overall Study|Adverse Event|0
2613458|NCT00973349|9035842|P1|Overall Study|Adverse Event|0
2613459|NCT00973102|9035942|P2|Overall Study|Prisoner|1
2613460|NCT00973102|9035943|P1|Overall Study|Prisoner|0
2613461|NCT00973102|9035942|P2|Overall Study|Protocol Violation|0
2613462|NCT00973102|9035943|P1|Overall Study|Protocol Violation|1
2613463|NCT00972816|9035974|P8|Overall Study|Unable to classify|0
2613464|NCT00972816|9035975|P7|Overall Study|Unable to classify|0
2613465|NCT00972816|9035976|P6|Overall Study|Unable to classify|0
2613466|NCT00972816|9035977|P5|Overall Study|Unable to classify|1
2613467|NCT00972816|9035978|P4|Overall Study|Unable to classify|0
2613468|NCT00972816|9035979|P3|Overall Study|Unable to classify|0
2613469|NCT00972816|9035980|P2|Overall Study|Unable to classify|0
2613470|NCT00972816|9035981|P1|Overall Study|Unable to classify|2
2613471|NCT00972816|9035974|P8|Overall Study|Inappropriate enrolment|0
2613472|NCT00972816|9035975|P7|Overall Study|Inappropriate enrolment|2
2613473|NCT00972816|9035976|P6|Overall Study|Inappropriate enrolment|0
2613474|NCT00972816|9035977|P5|Overall Study|Inappropriate enrolment|0
2613475|NCT00972816|9035978|P4|Overall Study|Inappropriate enrolment|0
2613476|NCT00972816|9035979|P3|Overall Study|Inappropriate enrolment|0
2613477|NCT00972816|9035980|P2|Overall Study|Inappropriate enrolment|0
2613478|NCT00972816|9035981|P1|Overall Study|Inappropriate enrolment|0
2613479|NCT00972816|9035974|P8|Overall Study|Lost to Follow-up|7
2613480|NCT00972816|9035975|P7|Overall Study|Lost to Follow-up|7
2613481|NCT00972816|9035976|P6|Overall Study|Lost to Follow-up|10
2613482|NCT00972816|9035977|P5|Overall Study|Lost to Follow-up|11
2613483|NCT00972816|9035978|P4|Overall Study|Lost to Follow-up|5
2613484|NCT00972816|9035979|P3|Overall Study|Lost to Follow-up|7
2613485|NCT00972816|9035980|P2|Overall Study|Lost to Follow-up|9
2613486|NCT00972816|9035981|P1|Overall Study|Lost to Follow-up|11
2613487|NCT00972816|9035974|P8|Overall Study|Withdrawal by Subject|2
2613488|NCT00972816|9035975|P7|Overall Study|Withdrawal by Subject|1
2613489|NCT00972816|9035976|P6|Overall Study|Withdrawal by Subject|1
2613490|NCT00972816|9035977|P5|Overall Study|Withdrawal by Subject|0
2613491|NCT00972816|9035978|P4|Overall Study|Withdrawal by Subject|3
2613492|NCT00972816|9035979|P3|Overall Study|Withdrawal by Subject|1
2613493|NCT00972816|9035980|P2|Overall Study|Withdrawal by Subject|2
2613494|NCT00972816|9035981|P1|Overall Study|Withdrawal by Subject|4
2613495|NCT00972816|9035974|P8|Overall Study|Adverse Event|0
2613496|NCT00972816|9035975|P7|Overall Study|Adverse Event|0
2613497|NCT00972816|9035976|P6|Overall Study|Adverse Event|0
2613498|NCT00972816|9035977|P5|Overall Study|Adverse Event|0
2613499|NCT00972816|9035978|P4|Overall Study|Adverse Event|0
2613500|NCT00972816|9035979|P3|Overall Study|Adverse Event|1
2613501|NCT00972816|9035980|P2|Overall Study|Adverse Event|0
2613502|NCT00972816|9035981|P1|Overall Study|Adverse Event|0
2613503|NCT00972777|9036065|P2|Overall Study|Missed visit|0
2613504|NCT00972777|9036066|P1|Overall Study|Missed visit|1
2613505|NCT00972777|9036065|P2|Overall Study|Screening Failure|1
2613506|NCT00972777|9036066|P1|Overall Study|Screening Failure|2
2613507|NCT00972777|9036065|P2|Overall Study|Protocol Violation|2
2613508|NCT00972777|9036066|P1|Overall Study|Protocol Violation|0
2613509|NCT00972777|9036065|P2|Overall Study|Physician Decision|0
2613510|NCT00972777|9036066|P1|Overall Study|Physician Decision|4
2613511|NCT00972777|9036065|P2|Overall Study|Withdrawal by Subject|5
2613512|NCT00972777|9036066|P1|Overall Study|Withdrawal by Subject|4
2613513|NCT00972777|9036065|P2|Overall Study|Lost to Follow-up|4
2613514|NCT00972777|9036066|P1|Overall Study|Lost to Follow-up|0
2613515|NCT00972777|9036065|P2|Overall Study|Adverse Event|2
2613516|NCT00972777|9036066|P1|Overall Study|Adverse Event|3
2613517|NCT00972738|9036081|P3|Overall Study|Other|1
2613518|NCT00972738|9036082|P2|Overall Study|Other|2
2613519|NCT00972738|9036083|P1|Overall Study|Other|1
2613520|NCT00972738|9036081|P3|Overall Study|Moved|1
2613521|NCT00972738|9036082|P2|Overall Study|Moved|0
2613522|NCT00972738|9036083|P1|Overall Study|Moved|0
2613523|NCT00972738|9036081|P3|Overall Study|Withdrawal by Subject|4
2613524|NCT00972738|9036082|P2|Overall Study|Withdrawal by Subject|1
2613525|NCT00972738|9036083|P1|Overall Study|Withdrawal by Subject|5
2613526|NCT00972738|9036081|P3|Overall Study|Lack of Efficacy|11
2613527|NCT00972738|9036082|P2|Overall Study|Lack of Efficacy|1
2613528|NCT00972738|9036083|P1|Overall Study|Lack of Efficacy|5
2613529|NCT00972738|9036081|P3|Overall Study|Lost to Follow-up|1
2613530|NCT00972738|9036082|P2|Overall Study|Lost to Follow-up|0
2613531|NCT00972738|9036083|P1|Overall Study|Lost to Follow-up|1
2613532|NCT00972738|9036081|P3|Overall Study|Protocol Violation|3
2613533|NCT00972738|9036082|P2|Overall Study|Protocol Violation|1
2613534|NCT00972738|9036083|P1|Overall Study|Protocol Violation|2
2613535|NCT00972738|9036081|P3|Overall Study|Adverse Event|8
2613536|NCT00972738|9036082|P2|Overall Study|Adverse Event|1
2613537|NCT00972738|9036083|P1|Overall Study|Adverse Event|7
2613538|NCT00972595|9036200|P2|Period 1|Adverse Event|0
2613539|NCT00972595|9036201|P1|Period 1|Adverse Event|1
2613540|NCT00972543|9036211|P2|Overall Study|Early study termination by sponsor|1
2613541|NCT00972543|9036212|P1|Overall Study|Early study termination by sponsor|4
2613542|NCT00972543|9036211|P2|Overall Study|Adverse Event|0
2613543|NCT00972543|9036212|P1|Overall Study|Adverse Event|1
2613544|NCT00972517|9036295|P6|Overall Study|Withdrawal by Subject|0
2613545|NCT00972517|9036296|P5|Overall Study|Withdrawal by Subject|1
2613546|NCT00972517|9036297|P4|Overall Study|Withdrawal by Subject|2
2613547|NCT00972517|9036298|P3|Overall Study|Withdrawal by Subject|0
2613548|NCT00972517|9036299|P2|Overall Study|Withdrawal by Subject|1
2613549|NCT00972517|9036300|P1|Overall Study|Withdrawal by Subject|0
2613550|NCT00972517|9036295|P6|Overall Study|Adverse Event|0
2613551|NCT00972517|9036296|P5|Overall Study|Adverse Event|0
2613552|NCT00972517|9036297|P4|Overall Study|Adverse Event|1
2613553|NCT00972517|9036298|P3|Overall Study|Adverse Event|0
2613554|NCT00972517|9036299|P2|Overall Study|Adverse Event|0
2613555|NCT00972517|9036300|P1|Overall Study|Adverse Event|0
2613556|NCT00972504|9036395|P1|Overall Study|Investigator discretion|1
2613557|NCT00972504|9036395|P1|Overall Study|Adverse Event|2
2613558|NCT00972478|9036427|P2|Overall Study|Not start protocol treatment|2
2613559|NCT00972478|9036428|P1|Overall Study|Not start protocol treatment|1
2613560|NCT00972478|9036427|P2|Overall Study|Ineligible|7
2613561|NCT00972478|9036428|P1|Overall Study|Ineligible|1
2613562|NCT00972478|9036427|P2|Overall Study|Not protocol specified|1
2613563|NCT00972478|9036428|P1|Overall Study|Not protocol specified|1
2613564|NCT00972478|9036427|P2|Overall Study|Death|2
2613565|NCT00972478|9036428|P1|Overall Study|Death|0
2613566|NCT00972478|9036427|P2|Overall Study|Progression/Relapse|2
2613567|NCT00972478|9036428|P1|Overall Study|Progression/Relapse|0
2613568|NCT00972478|9036427|P2|Overall Study|Withdrawal by Subject|8
2613569|NCT00972478|9036428|P1|Overall Study|Withdrawal by Subject|1
2613570|NCT00972478|9036427|P2|Overall Study|Adverse Event|16
2613571|NCT00972478|9036428|P1|Overall Study|Adverse Event|3
2613572|NCT00972322|9036473|P2|Overall Study|Consistently high glucose values|0
2613573|NCT00972322|9036474|P1|Overall Study|Consistently high glucose values|1
2613574|NCT00972322|9036473|P2|Overall Study|Lost to Follow-up|1
2613575|NCT00972322|9036474|P1|Overall Study|Lost to Follow-up|0
2613576|NCT00972322|9036473|P2|Overall Study|Positive drug screen|1
2613577|NCT00972322|9036474|P1|Overall Study|Positive drug screen|0
2613578|NCT00972322|9036473|P2|Overall Study|Adverse Event|1
2613579|NCT00972322|9036474|P1|Overall Study|Adverse Event|2
2613580|NCT00972283|9036486|P2|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5
2613581|NCT00972283|9036487|P1|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11
2613582|NCT00972283|9036486|P2|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2
2613583|NCT00972283|9036487|P1|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6
2613584|NCT00972283|9036486|P2|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0
2613585|NCT00972283|9036487|P1|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5
2613586|NCT00972283|9036486|P2|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
2613587|NCT00972283|9036487|P1|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
2613588|NCT00972283|9036486|P2|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0
2613589|NCT00972283|9036487|P1|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4
2613590|NCT00972283|9036486|P2|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17
2613591|NCT00972283|9036487|P1|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72
2613592|NCT00972283|9036486|P2|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2
2613593|NCT00972283|9036487|P1|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8
2613594|NCT00972283|9036486|P2|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12
2613595|NCT00972283|9036487|P1|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23
2613596|NCT00972283|9036486|P2|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0
2613597|NCT00972283|9036487|P1|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3
2613598|NCT00972283|9036486|P2|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9
2613599|NCT00972283|9036487|P1|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31
2613600|NCT00972244|9036514|P5|Overall Study|Various|2
2613601|NCT00972244|9036515|P4|Overall Study|Various|0
2613602|NCT00972244|9036516|P3|Overall Study|Various|0
2613603|NCT00972244|9036517|P2|Overall Study|Various|0
2613604|NCT00972244|9036518|P1|Overall Study|Various|0
2613605|NCT00972244|9036514|P5|Overall Study|Death|0
2613606|NCT00972244|9036515|P4|Overall Study|Death|0
2613607|NCT00972244|9036516|P3|Overall Study|Death|0
2613608|NCT00972244|9036517|P2|Overall Study|Death|0
2613609|NCT00972244|9036518|P1|Overall Study|Death|1
2613610|NCT00972244|9036514|P5|Overall Study|Safety|1
2613611|NCT00972244|9036515|P4|Overall Study|Safety|0
2613612|NCT00972244|9036516|P3|Overall Study|Safety|0
2613613|NCT00972244|9036517|P2|Overall Study|Safety|0
2613614|NCT00972244|9036518|P1|Overall Study|Safety|0
2613615|NCT00972244|9036514|P5|Overall Study|Withdrawal by Subject|1
2613616|NCT00972244|9036515|P4|Overall Study|Withdrawal by Subject|0
2613617|NCT00972244|9036516|P3|Overall Study|Withdrawal by Subject|1
2613618|NCT00972244|9036517|P2|Overall Study|Withdrawal by Subject|2
2613619|NCT00972244|9036518|P1|Overall Study|Withdrawal by Subject|1
2613620|NCT00972244|9036514|P5|Overall Study|Subject No Longer Meets Study Criteria|5
2613621|NCT00972244|9036515|P4|Overall Study|Subject No Longer Meets Study Criteria|0
2613622|NCT00972244|9036516|P3|Overall Study|Subject No Longer Meets Study Criteria|0
2613623|NCT00972244|9036517|P2|Overall Study|Subject No Longer Meets Study Criteria|2
2613624|NCT00972244|9036518|P1|Overall Study|Subject No Longer Meets Study Criteria|2
2613625|NCT00972244|9036514|P5|Overall Study|Adverse Event|0
2613626|NCT00972244|9036515|P4|Overall Study|Adverse Event|0
2613627|NCT00972244|9036516|P3|Overall Study|Adverse Event|1
2613628|NCT00972244|9036517|P2|Overall Study|Adverse Event|1
2613629|NCT00972244|9036518|P1|Overall Study|Adverse Event|0
2613630|NCT00972244|9036514|P5|Overall Study|Incorrect Enrolment|0
2613631|NCT00972244|9036515|P4|Overall Study|Incorrect Enrolment|0
2613632|NCT00972244|9036516|P3|Overall Study|Incorrect Enrolment|0
2613633|NCT00972244|9036517|P2|Overall Study|Incorrect Enrolment|0
2613634|NCT00972244|9036518|P1|Overall Study|Incorrect Enrolment|1
2613635|NCT00972153|9036550|P3|Overall Study|Equipment malfunction during case|0
2613636|NCT00972153|9036551|P2|Overall Study|Equipment malfunction during case|1
2613637|NCT00972153|9036552|P1|Overall Study|Equipment malfunction during case|0
2613638|NCT00972023|9036567|P1|Overall Study|Withdrawal by Subject|1
2613639|NCT00971997|9036574|P1|Overall Study|Physician Decision|7
2613640|NCT00971997|9036574|P1|Overall Study|Withdrawal by Subject|5
2613641|NCT00971997|9036574|P1|Overall Study|Protocol Violation|4
2613642|NCT00971997|9036574|P1|Overall Study|Death|1
2613643|NCT00971997|9036574|P1|Overall Study|Adverse Event|2
2613644|NCT00971932|9036592|P1|Overall Study|Ongoing|4
2613645|NCT00971932|9036592|P1|Overall Study|Investigator's decision|2
2613646|NCT00971932|9036592|P1|Overall Study|Withdrawal by Subject|1
2613647|NCT00971425|9036693|P2|Overall Study|Withdrawal by Subject|1
2613648|NCT00971425|9036694|P1|Overall Study|Withdrawal by Subject|0
2613649|NCT00971425|9036693|P2|Overall Study|Adverse Event|1
2613650|NCT00971425|9036694|P1|Overall Study|Adverse Event|1
2613651|NCT00971321|9036730|P2|Up to Month 11-12|Lost to Follow-up|0
2613652|NCT00971321|9036731|P1|Up to Month 11-12|Lost to Follow-up|1
2613653|NCT00971321|9036730|P2|Up to Month 11-12|Migrated/moved from study area|2
2613654|NCT00971321|9036731|P1|Up to Month 11-12|Migrated/moved from study area|2
2613655|NCT00971321|9036730|P2|Up to Month 11-12|Withdrawal by Subject|1
2613656|NCT00971321|9036731|P1|Up to Month 11-12|Withdrawal by Subject|2
2613657|NCT00971321|9036730|P2|Up to Month 7|Migrated/moved from study area|2
2613658|NCT00971321|9036731|P1|Up to Month 7|Migrated/moved from study area|3
2613659|NCT00971321|9036730|P2|Up to Month 7|Withdrawal by Subject|0
2613660|NCT00971321|9036731|P1|Up to Month 7|Withdrawal by Subject|1
2613661|NCT00971243|9036811|P5|Open-label Period|Other reason|2
2613662|NCT00971243|9036812|P4|Open-label Period|Other reason|0
2613663|NCT00971243|9036813|P3|Open-label Period|Other reason|0
2613664|NCT00971243|9036814|P2|Open-label Period|Other reason|0
2613665|NCT00971243|9036815|P1|Open-label Period|Other reason|0
2613666|NCT00971243|9036811|P5|Open-label Period|Withdrawal by Subject|1
2613667|NCT00971243|9036812|P4|Open-label Period|Withdrawal by Subject|2
2613668|NCT00971243|9036813|P3|Open-label Period|Withdrawal by Subject|0
2613669|NCT00971243|9036814|P2|Open-label Period|Withdrawal by Subject|0
2613670|NCT00971243|9036815|P1|Open-label Period|Withdrawal by Subject|1
2613671|NCT00971243|9036811|P5|Open-label Period|Protocol Violation|1
2613672|NCT00971243|9036812|P4|Open-label Period|Protocol Violation|0
2613673|NCT00971243|9036813|P3|Open-label Period|Protocol Violation|1
2613674|NCT00971243|9036814|P2|Open-label Period|Protocol Violation|1
2613675|NCT00971243|9036815|P1|Open-label Period|Protocol Violation|1
2613676|NCT00971243|9036811|P5|Open-label Period|Physician Decision|2
2613677|NCT00971243|9036812|P4|Open-label Period|Physician Decision|7
2613678|NCT00971243|9036813|P3|Open-label Period|Physician Decision|3
2613679|NCT00971243|9036814|P2|Open-label Period|Physician Decision|9
2613680|NCT00971243|9036815|P1|Open-label Period|Physician Decision|5
2613681|NCT00971243|9036811|P5|Open-label Period|Adverse Event|0
2613682|NCT00971243|9036812|P4|Open-label Period|Adverse Event|1
2613683|NCT00971243|9036813|P3|Open-label Period|Adverse Event|1
2613684|NCT00971243|9036814|P2|Open-label Period|Adverse Event|0
2613685|NCT00971243|9036815|P1|Open-label Period|Adverse Event|1
2613686|NCT00971243|9036811|P5|Double Blind Period|Other reasons|1
2613687|NCT00971243|9036812|P4|Double Blind Period|Other reasons|0
2613688|NCT00971243|9036813|P3|Double Blind Period|Other reasons|2
2613689|NCT00971243|9036814|P2|Double Blind Period|Other reasons|0
2613690|NCT00971243|9036815|P1|Double Blind Period|Other reasons|1
2613691|NCT00971243|9036811|P5|Double Blind Period|Withdrawal by Subject|4
2613692|NCT00971243|9036812|P4|Double Blind Period|Withdrawal by Subject|4
2613693|NCT00971243|9036813|P3|Double Blind Period|Withdrawal by Subject|4
2613694|NCT00971243|9036814|P2|Double Blind Period|Withdrawal by Subject|1
2613695|NCT00971243|9036815|P1|Double Blind Period|Withdrawal by Subject|4
2613696|NCT00971243|9036811|P5|Double Blind Period|Protocol Violation|2
2613697|NCT00971243|9036812|P4|Double Blind Period|Protocol Violation|2
2613698|NCT00971243|9036813|P3|Double Blind Period|Protocol Violation|3
2613699|NCT00971243|9036814|P2|Double Blind Period|Protocol Violation|0
2613700|NCT00971243|9036815|P1|Double Blind Period|Protocol Violation|2
2613701|NCT00971243|9036811|P5|Double Blind Period|Physician Decision|7
2613702|NCT00971243|9036812|P4|Double Blind Period|Physician Decision|6
2613703|NCT00971243|9036813|P3|Double Blind Period|Physician Decision|7
2613704|NCT00971243|9036814|P2|Double Blind Period|Physician Decision|6
2613705|NCT00971243|9036815|P1|Double Blind Period|Physician Decision|10
2613706|NCT00971243|9036811|P5|Double Blind Period|Lost to Follow-up|1
2613707|NCT00971243|9036812|P4|Double Blind Period|Lost to Follow-up|0
2613708|NCT00971243|9036813|P3|Double Blind Period|Lost to Follow-up|1
2613709|NCT00971243|9036814|P2|Double Blind Period|Lost to Follow-up|1
2613710|NCT00971243|9036815|P1|Double Blind Period|Lost to Follow-up|0
2613711|NCT00971243|9036811|P5|Double Blind Period|Adverse Event|3
2613712|NCT00971243|9036812|P4|Double Blind Period|Adverse Event|2
2613713|NCT00971243|9036813|P3|Double Blind Period|Adverse Event|2
2613714|NCT00971243|9036814|P2|Double Blind Period|Adverse Event|3
2613715|NCT00971243|9036815|P1|Double Blind Period|Adverse Event|2
2613716|NCT00971204|9036832|P1|Overall Study|Lost to Follow-up|10
2613717|NCT00971204|9036832|P1|Overall Study|Did not meet all criteria-not treated|14
2613718|NCT00971048|9036840|P4|Overall Study|Physician Decision|1
2613719|NCT00971048|9036841|P3|Overall Study|Physician Decision|0
2613720|NCT00971048|9036842|P2|Overall Study|Physician Decision|0
2613721|NCT00971048|9036843|P1|Overall Study|Physician Decision|0
2613722|NCT00971048|9036840|P4|Overall Study|Adverse Event|0
2613723|NCT00971048|9036841|P3|Overall Study|Adverse Event|1
2613724|NCT00971048|9036842|P2|Overall Study|Adverse Event|0
2613725|NCT00971048|9036843|P1|Overall Study|Adverse Event|0
2613726|NCT00971048|9036840|P4|Overall Study|Protocol Violation|1
2613727|NCT00971048|9036841|P3|Overall Study|Protocol Violation|0
2613728|NCT00971048|9036842|P2|Overall Study|Protocol Violation|2
2613729|NCT00971048|9036843|P1|Overall Study|Protocol Violation|1
2613730|NCT00970944|9036867|P2|Overall Study|Physician Decision|2
2613731|NCT00970944|9036868|P1|Overall Study|Physician Decision|0
2613732|NCT00970944|9036867|P2|Overall Study|Death|0
2613733|NCT00970944|9036868|P1|Overall Study|Death|1
2613734|NCT00970684|9036920|P1|Overall Study|Withdrawal by Subject|1
2613735|NCT00970684|9036920|P1|Overall Study|Adverse Event|4
2613736|NCT00970684|9036920|P1|Overall Study|Lack of Efficacy|5
2613737|NCT00970632|9036929|P3|Overall Study|Sponsor decision|1
2613738|NCT00970632|9036930|P2|Overall Study|Sponsor decision|0
2613739|NCT00970632|9036931|P1|Overall Study|Sponsor decision|1
2613740|NCT00970632|9036929|P3|Overall Study|Entry criteria not met|2
2613741|NCT00970632|9036930|P2|Overall Study|Entry criteria not met|2
2613742|NCT00970632|9036931|P1|Overall Study|Entry criteria not met|0
2613743|NCT00970632|9036929|P3|Overall Study|Withdrawal by Subject|4
2613744|NCT00970632|9036930|P2|Overall Study|Withdrawal by Subject|6
2613745|NCT00970632|9036931|P1|Overall Study|Withdrawal by Subject|7
2613746|NCT00970632|9036929|P3|Overall Study|Protocol Violation|8
2613747|NCT00970632|9036930|P2|Overall Study|Protocol Violation|5
2613748|NCT00970632|9036931|P1|Overall Study|Protocol Violation|8
2613749|NCT00970632|9036929|P3|Overall Study|Lost to Follow-up|2
2613750|NCT00970632|9036930|P2|Overall Study|Lost to Follow-up|0
2613751|NCT00970632|9036931|P1|Overall Study|Lost to Follow-up|3
2613752|NCT00970632|9036929|P3|Overall Study|Lack of Efficacy|0
2613753|NCT00970632|9036930|P2|Overall Study|Lack of Efficacy|0
2613754|NCT00970632|9036931|P1|Overall Study|Lack of Efficacy|3
2613755|NCT00970632|9036929|P3|Overall Study|Adverse Event|1
2613756|NCT00970632|9036930|P2|Overall Study|Adverse Event|2
2613757|NCT00970632|9036931|P1|Overall Study|Adverse Event|2
2613758|NCT00970502|9036996|P1|Overall Study|Withdrawal by Subject|1
2613759|NCT00970489|9037007|P2|Overall Study|Death/Withdrew/Criteria Violation|41
2613760|NCT00970489|9037008|P1|Overall Study|Death/Withdrew/Criteria Violation|54
2613761|NCT00970359|9037020|P1|Overall Study|Not Treated|4
2613762|NCT00970307|9037050|P3|Overall Study|Withdrawal by Subject|2
2613763|NCT00970307|9037051|P2|Overall Study|Withdrawal by Subject|3
2613764|NCT00970307|9037052|P1|Overall Study|Withdrawal by Subject|2
2613765|NCT00970307|9037050|P3|Overall Study|Serious Adverse Event|0
2613766|NCT00970307|9037051|P2|Overall Study|Serious Adverse Event|0
2613767|NCT00970307|9037052|P1|Overall Study|Serious Adverse Event|1
2613768|NCT00970294|9037126|P1|Overall Study|Withdrawal by Subject|1
2613769|NCT00970294|9037126|P1|Overall Study|Physician Decision|4
2613770|NCT00970281|9037134|P2|Overall Study|Physician Decision|1
2613771|NCT00970281|9037135|P1|Overall Study|Physician Decision|1
2613772|NCT00970281|9037134|P2|Overall Study|Withdrawal by Subject|1
2613773|NCT00970281|9037135|P1|Overall Study|Withdrawal by Subject|0
2613774|NCT00970281|9037134|P2|Overall Study|Lack of Efficacy|14
2613775|NCT00970281|9037135|P1|Overall Study|Lack of Efficacy|1
2613776|NCT00970268|9037153|P2|Overall Study|Inclusion/Exclusion Criteria|0
2613777|NCT00970268|9037154|P1|Overall Study|Inclusion/Exclusion Criteria|1
2613778|NCT00970268|9037153|P2|Overall Study|Lost to Follow-up|2
2613779|NCT00970268|9037154|P1|Overall Study|Lost to Follow-up|1
2613780|NCT00970268|9037153|P2|Overall Study|COPD Exacerbation|2
2613781|NCT00970268|9037154|P1|Overall Study|COPD Exacerbation|4
2613782|NCT00970268|9037153|P2|Overall Study|Other Reason|1
2613783|NCT00970268|9037154|P1|Overall Study|Other Reason|3
2613784|NCT00970268|9037153|P2|Overall Study|Protocol Violation|7
2613785|NCT00970268|9037154|P1|Overall Study|Protocol Violation|4
2613786|NCT00970268|9037153|P2|Overall Study|Lack of Efficacy|6
2613787|NCT00970268|9037154|P1|Overall Study|Lack of Efficacy|3
2613788|NCT00970268|9037153|P2|Overall Study|Adverse Event|12
2613789|NCT00970268|9037154|P1|Overall Study|Adverse Event|15
2613790|NCT00970268|9037153|P2|Overall Study|Withdrawal by Subject|19
2613791|NCT00970268|9037154|P1|Overall Study|Withdrawal by Subject|12
2613792|NCT00969761|9037217|P12|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
2613793|NCT00969761|9037218|P11|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
2613794|NCT00969761|9037219|P10|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
2613795|NCT00969761|9037220|P9|Treated in and Beyond Treat. Cycle 2|Other adverse events|2
2613796|NCT00969761|9037221|P8|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
2613797|NCT00969761|9037222|P7|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
2613798|NCT00969761|9037223|P6|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
2613799|NCT00969761|9037224|P5|Treated in and Beyond Treat. Cycle 2|Other adverse events|1
2613800|NCT00969761|9037225|P4|Treated in and Beyond Treat. Cycle 2|Other adverse events|2
2613801|NCT00969761|9037226|P3|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
2613802|NCT00969761|9037227|P2|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
2613803|NCT00969761|9037228|P1|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
2613804|NCT00969761|9037217|P12|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
2613805|NCT00969761|9037218|P11|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
2613806|NCT00969761|9037219|P10|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
2613807|NCT00969761|9037220|P9|Treated in and Beyond Treat. Cycle 2|Progressive disease|9
2613808|NCT00969761|9037221|P8|Treated in and Beyond Treat. Cycle 2|Progressive disease|6
2613809|NCT00969761|9037222|P7|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
2613810|NCT00969761|9037223|P6|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
2613811|NCT00969761|9037224|P5|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
2613812|NCT00969761|9037225|P4|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
2613813|NCT00969761|9037226|P3|Treated in and Beyond Treat. Cycle 2|Progressive disease|10
2613814|NCT00969761|9037227|P2|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
2613815|NCT00969761|9037228|P1|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
2613816|NCT00969761|9037217|P12|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2613817|NCT00969761|9037218|P11|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2613818|NCT00969761|9037219|P10|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2613819|NCT00969761|9037220|P9|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1
2613820|NCT00969761|9037221|P8|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2613821|NCT00969761|9037222|P7|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2613822|NCT00969761|9037223|P6|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2613823|NCT00969761|9037224|P5|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2613824|NCT00969761|9037225|P4|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2613825|NCT00969761|9037226|P3|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2613826|NCT00969761|9037227|P2|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2613827|NCT00969761|9037228|P1|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
2613828|NCT00969761|9037217|P12|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2613829|NCT00969761|9037218|P11|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2613830|NCT00969761|9037219|P10|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2613831|NCT00969761|9037220|P9|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2613832|NCT00969761|9037221|P8|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2613833|NCT00969761|9037222|P7|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2613834|NCT00969761|9037223|P6|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2613835|NCT00969761|9037224|P5|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2613836|NCT00969761|9037225|P4|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2613837|NCT00969761|9037226|P3|Discont. Before Start of Treat. Cycle 2|Other adverse events|1
2613838|NCT00969761|9037227|P2|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2613839|NCT00969761|9037228|P1|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
2613840|NCT00969761|9037217|P12|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2613841|NCT00969761|9037218|P11|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2613842|NCT00969761|9037219|P10|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2613843|NCT00969761|9037220|P9|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2613844|NCT00969761|9037221|P8|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2613927|NCT00969553|9037576|P4|Overall Study|Dose limiting Toxicity (DLT)|0
2613845|NCT00969761|9037222|P7|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2613846|NCT00969761|9037223|P6|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2613847|NCT00969761|9037224|P5|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2613848|NCT00969761|9037225|P4|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2613849|NCT00969761|9037226|P3|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1
2613850|NCT00969761|9037227|P2|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2613851|NCT00969761|9037228|P1|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
2613852|NCT00969761|9037217|P12|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
2613853|NCT00969761|9037218|P11|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
2613854|NCT00969761|9037219|P10|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
2613855|NCT00969761|9037220|P9|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
2613856|NCT00969761|9037221|P8|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
2613857|NCT00969761|9037222|P7|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
2613858|NCT00969761|9037223|P6|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
2613859|NCT00969761|9037224|P5|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
2613860|NCT00969761|9037225|P4|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
2613861|NCT00969761|9037226|P3|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
2613862|NCT00969761|9037227|P2|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
2613863|NCT00969761|9037228|P1|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
2613864|NCT00969709|9037534|P4|Overall Study|Other reasons|0
2613865|NCT00969709|9037535|P3|Overall Study|Other reasons|3
2613866|NCT00969709|9037536|P2|Overall Study|Other reasons|0
2613867|NCT00969709|9037537|P1|Overall Study|Other reasons|0
2613868|NCT00969709|9037534|P4|Overall Study|Lost to Follow-up|15
2613869|NCT00969709|9037535|P3|Overall Study|Lost to Follow-up|8
2613870|NCT00969709|9037536|P2|Overall Study|Lost to Follow-up|14
2613871|NCT00969709|9037537|P1|Overall Study|Lost to Follow-up|10
2613872|NCT00969709|9037534|P4|Overall Study|Withdrawal by Subject|23
2613873|NCT00969709|9037535|P3|Overall Study|Withdrawal by Subject|11
2613874|NCT00969709|9037536|P2|Overall Study|Withdrawal by Subject|12
2613875|NCT00969709|9037537|P1|Overall Study|Withdrawal by Subject|9
2613876|NCT00969709|9037534|P4|Overall Study|Protocol Violation|10
2613877|NCT00969709|9037535|P3|Overall Study|Protocol Violation|9
2613878|NCT00969709|9037536|P2|Overall Study|Protocol Violation|5
2613879|NCT00969709|9037537|P1|Overall Study|Protocol Violation|9
2613880|NCT00969709|9037534|P4|Overall Study|Lack of Efficacy|3
2613881|NCT00969709|9037535|P3|Overall Study|Lack of Efficacy|1
2613882|NCT00969709|9037536|P2|Overall Study|Lack of Efficacy|4
2613883|NCT00969709|9037537|P1|Overall Study|Lack of Efficacy|7
2613884|NCT00969709|9037534|P4|Overall Study|Adverse Event|12
2613885|NCT00969709|9037535|P3|Overall Study|Adverse Event|26
2613886|NCT00969709|9037536|P2|Overall Study|Adverse Event|13
2613887|NCT00969709|9037537|P1|Overall Study|Adverse Event|3
2613888|NCT00969618|9037551|P1|Overall Study|Withdrawal by Subject|27
2613889|NCT00969618|9037551|P1|Overall Study|Protocol Violation|9
2613890|NCT00969618|9037551|P1|Overall Study|Physician Decision|1
2613891|NCT00969618|9037551|P1|Overall Study|Lost to Follow-up|7
2613892|NCT00969618|9037551|P1|Overall Study|Lack of Efficacy|2
2613893|NCT00969618|9037551|P1|Overall Study|Entry Criteria Not Met|3
2613894|NCT00969618|9037551|P1|Overall Study|Adverse Event|29
2613895|NCT00969553|9037571|P9|Overall Study|Not specified above|0
2613896|NCT00969553|9037572|P8|Overall Study|Not specified above|1
2613897|NCT00969553|9037573|P7|Overall Study|Not specified above|1
2613898|NCT00969553|9037574|P6|Overall Study|Not specified above|0
2613899|NCT00969553|9037575|P5|Overall Study|Not specified above|0
2613900|NCT00969553|9037576|P4|Overall Study|Not specified above|4
2613901|NCT00969553|9037577|P3|Overall Study|Not specified above|0
2613902|NCT00969553|9037578|P2|Overall Study|Not specified above|0
2613903|NCT00969553|9037579|P1|Overall Study|Not specified above|0
2613904|NCT00969553|9037571|P9|Overall Study|Refused cont. medication|0
2613905|NCT00969553|9037572|P8|Overall Study|Refused cont. medication|1
2613906|NCT00969553|9037573|P7|Overall Study|Refused cont. medication|0
2613907|NCT00969553|9037574|P6|Overall Study|Refused cont. medication|0
2613908|NCT00969553|9037575|P5|Overall Study|Refused cont. medication|0
2613909|NCT00969553|9037576|P4|Overall Study|Refused cont. medication|2
2613910|NCT00969553|9037577|P3|Overall Study|Refused cont. medication|0
2613911|NCT00969553|9037578|P2|Overall Study|Refused cont. medication|1
2613912|NCT00969553|9037579|P1|Overall Study|Refused cont. medication|1
2613913|NCT00969553|9037571|P9|Overall Study|Other Adverse Event|0
2613914|NCT00969553|9037572|P8|Overall Study|Other Adverse Event|0
2613915|NCT00969553|9037573|P7|Overall Study|Other Adverse Event|1
2613916|NCT00969553|9037574|P6|Overall Study|Other Adverse Event|0
2613917|NCT00969553|9037575|P5|Overall Study|Other Adverse Event|0
2613918|NCT00969553|9037576|P4|Overall Study|Other Adverse Event|1
2613919|NCT00969553|9037577|P3|Overall Study|Other Adverse Event|0
2613920|NCT00969553|9037578|P2|Overall Study|Other Adverse Event|0
2613921|NCT00969553|9037579|P1|Overall Study|Other Adverse Event|0
2613922|NCT00969553|9037571|P9|Overall Study|Dose limiting Toxicity (DLT)|0
2613923|NCT00969553|9037572|P8|Overall Study|Dose limiting Toxicity (DLT)|0
2613924|NCT00969553|9037573|P7|Overall Study|Dose limiting Toxicity (DLT)|0
2613925|NCT00969553|9037574|P6|Overall Study|Dose limiting Toxicity (DLT)|0
2613926|NCT00969553|9037575|P5|Overall Study|Dose limiting Toxicity (DLT)|1
2613928|NCT00969553|9037577|P3|Overall Study|Dose limiting Toxicity (DLT)|0
2613929|NCT00969553|9037578|P2|Overall Study|Dose limiting Toxicity (DLT)|0
2613930|NCT00969553|9037579|P1|Overall Study|Dose limiting Toxicity (DLT)|0
2613931|NCT00969553|9037571|P9|Overall Study|Progressive disease (PD)|3
2613932|NCT00969553|9037572|P8|Overall Study|Progressive disease (PD)|12
2613933|NCT00969553|9037573|P7|Overall Study|Progressive disease (PD)|2
2613934|NCT00969553|9037574|P6|Overall Study|Progressive disease (PD)|4
2613935|NCT00969553|9037575|P5|Overall Study|Progressive disease (PD)|2
2613936|NCT00969553|9037576|P4|Overall Study|Progressive disease (PD)|9
2613937|NCT00969553|9037577|P3|Overall Study|Progressive disease (PD)|6
2613938|NCT00969553|9037578|P2|Overall Study|Progressive disease (PD)|2
2613939|NCT00969553|9037579|P1|Overall Study|Progressive disease (PD)|2
2613940|NCT00969540|9037722|P2|Overall Study|Lost to Follow-up|1
2613941|NCT00969540|9037723|P1|Overall Study|Lost to Follow-up|1
2613942|NCT00969436|9037748|P3|Overall Study|Lost to Follow-up|5
2613943|NCT00969436|9037749|P2|Overall Study|Lost to Follow-up|8
2613944|NCT00969436|9037750|P1|Overall Study|Lost to Follow-up|8
2613945|NCT00969436|9037748|P3|Overall Study|Withdrawal by Subject|2
2613946|NCT00969436|9037749|P2|Overall Study|Withdrawal by Subject|0
2613947|NCT00969436|9037750|P1|Overall Study|Withdrawal by Subject|3
2613948|NCT00969436|9037748|P3|Overall Study|Subject eliminated (other vaccine)|0
2613949|NCT00969436|9037749|P2|Overall Study|Subject eliminated (other vaccine)|0
2613950|NCT00969436|9037750|P1|Overall Study|Subject eliminated (other vaccine)|1
2613951|NCT00969436|9037748|P3|Overall Study|Parents personal problem|1
2613952|NCT00969436|9037749|P2|Overall Study|Parents personal problem|0
2613953|NCT00969436|9037750|P1|Overall Study|Parents personal problem|0
2613954|NCT00969436|9037748|P3|Overall Study|Father - serious health problem|1
2613955|NCT00969436|9037749|P2|Overall Study|Father - serious health problem|0
2613956|NCT00969436|9037750|P1|Overall Study|Father - serious health problem|0
2613957|NCT00969436|9037748|P3|Overall Study|Migrated/moved from study area|2
2613958|NCT00969436|9037749|P2|Overall Study|Migrated/moved from study area|10
2613959|NCT00969436|9037750|P1|Overall Study|Migrated/moved from study area|12
2613960|NCT00969436|9037748|P3|Overall Study|Protocol Violation|0
2613961|NCT00969436|9037749|P2|Overall Study|Protocol Violation|3
2613962|NCT00969436|9037750|P1|Overall Study|Protocol Violation|1
2613963|NCT00969332|9037782|P1|Overall Study|Withdrawal by Subject|3
2613964|NCT00969332|9037782|P1|Overall Study|Physician Decision|8
2613965|NCT00969280|9037798|P2|Overall Study|infection of influenza A(H1N1)|1
2613966|NCT00969280|9037799|P1|Overall Study|infection of influenza A(H1N1)|0
2613967|NCT00969280|9037798|P2|Overall Study|Withdrawal by Subject|1
2613968|NCT00969280|9037799|P1|Overall Study|Withdrawal by Subject|0
2613969|NCT00969280|9037798|P2|Overall Study|Protocol Violation|1
2613970|NCT00969280|9037799|P1|Overall Study|Protocol Violation|2
2613971|NCT00969228|9037807|P2|Overall Study|Porcine circovirus detection in vaccine|14
2613972|NCT00969228|9037808|P1|Overall Study|Porcine circovirus detection in vaccine|38
2613973|NCT00969228|9037807|P2|Overall Study|Withdrawal by Subject|0
2613974|NCT00969228|9037808|P1|Overall Study|Withdrawal by Subject|4
2613975|NCT00969228|9037807|P2|Overall Study|Adverse Event|0
2613976|NCT00969228|9037808|P1|Overall Study|Adverse Event|1
2613977|NCT00969150|9037826|P2|Overall Study|Other reasons|0
2613978|NCT00969150|9037827|P1|Overall Study|Other reasons|1
2613979|NCT00969150|9037826|P2|Overall Study|Lost to Follow-up|4
2613980|NCT00969150|9037827|P1|Overall Study|Lost to Follow-up|5
2613981|NCT00969150|9037826|P2|Overall Study|Withdrawal by Subject|9
2613982|NCT00969150|9037827|P1|Overall Study|Withdrawal by Subject|13
2613983|NCT00969150|9037826|P2|Overall Study|Protocol Violation|12
2613984|NCT00969150|9037827|P1|Overall Study|Protocol Violation|9
2613985|NCT00969150|9037826|P2|Overall Study|Lack of Efficacy|1
2613986|NCT00969150|9037827|P1|Overall Study|Lack of Efficacy|1
2613987|NCT00969150|9037826|P2|Overall Study|Adverse Event|14
2613988|NCT00969150|9037827|P1|Overall Study|Adverse Event|4
2613989|NCT00969124|9037835|P1|Overall Study|Technical error|1
2613990|NCT00969124|9037835|P1|Overall Study|Previously unrecognized disease|3
2613991|NCT00969124|9037835|P1|Overall Study|Inability to reach cecum|9
2613992|NCT00969124|9037835|P1|Overall Study|Inadequate bowel preparation|15
2613993|NCT00969124|9037835|P1|Overall Study|Protocol Violation|2
2613994|NCT00968981|9037844|P3|Overall Study|Withdrawal by Subject|3
2613995|NCT00968981|9037845|P2|Overall Study|Withdrawal by Subject|3
2613996|NCT00968981|9037846|P1|Overall Study|Withdrawal by Subject|1
2613997|NCT00968981|9037844|P3|Overall Study|Physician Decision|5
2613998|NCT00968981|9037845|P2|Overall Study|Physician Decision|3
2613999|NCT00968981|9037846|P1|Overall Study|Physician Decision|5
2614000|NCT00968981|9037844|P3|Overall Study|Lost to Follow-up|1
2614001|NCT00968981|9037845|P2|Overall Study|Lost to Follow-up|0
2614002|NCT00968981|9037846|P1|Overall Study|Lost to Follow-up|0
2614003|NCT00968981|9037844|P3|Overall Study|Disease Progression|13
2614004|NCT00968981|9037845|P2|Overall Study|Disease Progression|16
2614005|NCT00968981|9037846|P1|Overall Study|Disease Progression|14
2614006|NCT00968981|9037844|P3|Overall Study|Adverse Event|0
2614007|NCT00968981|9037845|P2|Overall Study|Adverse Event|0
2614008|NCT00968981|9037846|P1|Overall Study|Adverse Event|2
2614009|NCT00968968|9037884|P2|Overall Study|Lost to Follow-up|1
2614010|NCT00968968|9037885|P1|Overall Study|Lost to Follow-up|0
2614011|NCT00968968|9037884|P2|Overall Study|Physician Decision|2
2614012|NCT00968968|9037885|P1|Overall Study|Physician Decision|1
2614013|NCT00968968|9037884|P2|Overall Study|Withdrawal by Subject|0
2614014|NCT00968968|9037885|P1|Overall Study|Withdrawal by Subject|2
2614015|NCT00968968|9037884|P2|Overall Study|Protocol defined stopping criteria|1
2614016|NCT00968968|9037885|P1|Overall Study|Protocol defined stopping criteria|3
2614017|NCT00968968|9037884|P2|Overall Study|Study closed/terminated|10
2614018|NCT00968968|9037885|P1|Overall Study|Study closed/terminated|10
2614019|NCT00968864|9037931|P1|Overall Study|Protocol exception/ not evaluable|1
2614020|NCT00968812|9037959|P3|Overall Study|Other|40
2614021|NCT00968812|9037960|P2|Overall Study|Other|37
2614022|NCT00968812|9037961|P1|Overall Study|Other|25
2614023|NCT00968812|9037959|P3|Overall Study|Unable to take rescue therapy|17
2614024|NCT00968812|9037960|P2|Overall Study|Unable to take rescue therapy|12
2614025|NCT00968812|9037961|P1|Overall Study|Unable to take rescue therapy|12
2614026|NCT00968812|9037959|P3|Overall Study|Noncompliance with study drug|6
2614027|NCT00968812|9037960|P2|Overall Study|Noncompliance with study drug|1
2614028|NCT00968812|9037961|P1|Overall Study|Noncompliance with study drug|4
2614029|NCT00968812|9037959|P3|Overall Study|Creatinine or eGFR withdrawal criteria|7
2614030|NCT00968812|9037960|P2|Overall Study|Creatinine or eGFR withdrawal criteria|13
2614031|NCT00968812|9037961|P1|Overall Study|Creatinine or eGFR withdrawal criteria|9
2614032|NCT00968812|9037959|P3|Overall Study|Withdrawal by Subject|25
2614033|NCT00968812|9037960|P2|Overall Study|Withdrawal by Subject|23
2614034|NCT00968812|9037961|P1|Overall Study|Withdrawal by Subject|17
2614035|NCT00968812|9037959|P3|Overall Study|Protocol Violation|3
2614036|NCT00968812|9037960|P2|Overall Study|Protocol Violation|4
2614037|NCT00968812|9037961|P1|Overall Study|Protocol Violation|7
2614038|NCT00968812|9037959|P3|Overall Study|Physician Decision|9
2614039|NCT00968812|9037960|P2|Overall Study|Physician Decision|5
2614040|NCT00968812|9037961|P1|Overall Study|Physician Decision|8
2614041|NCT00968812|9037959|P3|Overall Study|Lost to Follow-up|11
2614042|NCT00968812|9037960|P2|Overall Study|Lost to Follow-up|12
2614043|NCT00968812|9037961|P1|Overall Study|Lost to Follow-up|17
2614044|NCT00968812|9037959|P3|Overall Study|Lack of Efficacy|16
2614045|NCT00968812|9037960|P2|Overall Study|Lack of Efficacy|7
2614046|NCT00968812|9037961|P1|Overall Study|Lack of Efficacy|9
2614047|NCT00968812|9037959|P3|Overall Study|Death|1
2614048|NCT00968812|9037960|P2|Overall Study|Death|2
2614049|NCT00968812|9037961|P1|Overall Study|Death|2
2614050|NCT00968812|9037959|P3|Overall Study|Adverse Event|33
2614051|NCT00968812|9037960|P2|Overall Study|Adverse Event|46
2614052|NCT00968812|9037961|P1|Overall Study|Adverse Event|30
2614053|NCT00968799|9037981|P1|Overall Study|Advanced disease, HIPEC not applicable|2
2614054|NCT00968708|9037991|P2|Overall Study|Other|34
2614055|NCT00968708|9037992|P1|Overall Study|Other|26
2614056|NCT00968708|9037991|P2|Overall Study|Investigator Discretion|1
2614057|NCT00968708|9037992|P1|Overall Study|Investigator Discretion|0
2614058|NCT00968708|9037991|P2|Overall Study|Voluntary Withdrawal|101
2614059|NCT00968708|9037992|P1|Overall Study|Voluntary Withdrawal|104
2614060|NCT00968708|9037991|P2|Overall Study|Lost to Follow-up|11
2614061|NCT00968708|9037992|P1|Overall Study|Lost to Follow-up|19
2614062|NCT00968708|9037991|P2|Overall Study|Major Protocol Deviation|1
2614063|NCT00968708|9037992|P1|Overall Study|Major Protocol Deviation|0
2614064|NCT00968708|9037991|P2|Overall Study|Adverse Event|150
2614065|NCT00968708|9037992|P1|Overall Study|Adverse Event|169
2614066|NCT00968669|9038004|P4|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1
2614067|NCT00968669|9038005|P3|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
2614068|NCT00968669|9038006|P2|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
2614069|NCT00968669|9038007|P1|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
2614070|NCT00968669|9038004|P4|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
2614071|NCT00968669|9038005|P3|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
2614072|NCT00968669|9038006|P2|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1
2614073|NCT00968669|9038007|P1|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
2614074|NCT00968669|9038004|P4|Overall Study|SUBJECT INCARCERATED|0
2614075|NCT00968669|9038005|P3|Overall Study|SUBJECT INCARCERATED|0
2614076|NCT00968669|9038006|P2|Overall Study|SUBJECT INCARCERATED|1
2614077|NCT00968669|9038007|P1|Overall Study|SUBJECT INCARCERATED|0
2614078|NCT00968669|9038004|P4|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
2614079|NCT00968669|9038005|P3|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
2614080|NCT00968669|9038006|P2|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1
2614081|NCT00968669|9038007|P1|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
2614082|NCT00968669|9038004|P4|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
2614083|NCT00968669|9038005|P3|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1
2614084|NCT00968669|9038006|P2|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
2614085|NCT00968669|9038007|P1|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
2614086|NCT00968669|9038004|P4|Overall Study|SPONSOR DECISION|0
2614087|NCT00968669|9038005|P3|Overall Study|SPONSOR DECISION|0
2614088|NCT00968669|9038006|P2|Overall Study|SPONSOR DECISION|1
2614089|NCT00968669|9038007|P1|Overall Study|SPONSOR DECISION|0
2614090|NCT00968669|9038004|P4|Overall Study|PATIENT WILL BE WORKING ABROAD|0
2614091|NCT00968669|9038005|P3|Overall Study|PATIENT WILL BE WORKING ABROAD|0
2614092|NCT00968669|9038006|P2|Overall Study|PATIENT WILL BE WORKING ABROAD|1
2614093|NCT00968669|9038007|P1|Overall Study|PATIENT WILL BE WORKING ABROAD|0
2614094|NCT00968669|9038004|P4|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
2614095|NCT00968669|9038005|P3|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
2614096|NCT00968669|9038006|P2|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1
2614097|NCT00968669|9038007|P1|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
2614098|NCT00968669|9038004|P4|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
2614099|NCT00968669|9038005|P3|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
2614100|NCT00968669|9038006|P2|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1
2614101|NCT00968669|9038007|P1|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
2614102|NCT00968669|9038004|P4|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
2614103|NCT00968669|9038005|P3|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
2614104|NCT00968669|9038006|P2|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1
2614105|NCT00968669|9038007|P1|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
2614106|NCT00968669|9038004|P4|Overall Study|INEGIBILITY TO PERFORM VISIT|0
2614107|NCT00968669|9038005|P3|Overall Study|INEGIBILITY TO PERFORM VISIT|0
2614108|NCT00968669|9038006|P2|Overall Study|INEGIBILITY TO PERFORM VISIT|0
2614109|NCT00968669|9038007|P1|Overall Study|INEGIBILITY TO PERFORM VISIT|1
2614110|NCT00968669|9038004|P4|Overall Study|ERROR IN HADS ADMINISTRATION|0
2614111|NCT00968669|9038005|P3|Overall Study|ERROR IN HADS ADMINISTRATION|1
2614112|NCT00968669|9038006|P2|Overall Study|ERROR IN HADS ADMINISTRATION|0
2614113|NCT00968669|9038007|P1|Overall Study|ERROR IN HADS ADMINISTRATION|0
2614114|NCT00968669|9038004|P4|Overall Study|EARLY WITHDRAWAL|0
2614115|NCT00968669|9038005|P3|Overall Study|EARLY WITHDRAWAL|0
2614116|NCT00968669|9038006|P2|Overall Study|EARLY WITHDRAWAL|1
2614117|NCT00968669|9038007|P1|Overall Study|EARLY WITHDRAWAL|0
2614118|NCT00968669|9038004|P4|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
2614119|NCT00968669|9038005|P3|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1
2614120|NCT00968669|9038006|P2|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
2614121|NCT00968669|9038007|P1|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
2614122|NCT00968669|9038004|P4|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
2614123|NCT00968669|9038005|P3|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
2614124|NCT00968669|9038006|P2|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
2614125|NCT00968669|9038007|P1|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1
2614126|NCT00968669|9038004|P4|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
2614127|NCT00968669|9038005|P3|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
2614128|NCT00968669|9038006|P2|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
2614129|NCT00968669|9038007|P1|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1
2614130|NCT00968669|9038004|P4|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1
2614131|NCT00968669|9038005|P3|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
2614132|NCT00968669|9038006|P2|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
2614133|NCT00968669|9038007|P1|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
2614134|NCT00968669|9038004|P4|Overall Study|AE|0
2614135|NCT00968669|9038005|P3|Overall Study|AE|0
2614136|NCT00968669|9038006|P2|Overall Study|AE|0
2614137|NCT00968669|9038007|P1|Overall Study|AE|1
2614138|NCT00968669|9038004|P4|Overall Study|Pregnancy|0
2614139|NCT00968669|9038005|P3|Overall Study|Pregnancy|2
2614140|NCT00968669|9038006|P2|Overall Study|Pregnancy|0
2614141|NCT00968669|9038007|P1|Overall Study|Pregnancy|0
2614142|NCT00968669|9038004|P4|Overall Study|Withdrawal by Subject|3
2614143|NCT00968669|9038005|P3|Overall Study|Withdrawal by Subject|5
2614144|NCT00968669|9038006|P2|Overall Study|Withdrawal by Subject|7
2614145|NCT00968669|9038007|P1|Overall Study|Withdrawal by Subject|9
2614146|NCT00968669|9038004|P4|Overall Study|Lost to Follow-up|4
2614147|NCT00968669|9038005|P3|Overall Study|Lost to Follow-up|1
2614148|NCT00968669|9038006|P2|Overall Study|Lost to Follow-up|2
2614149|NCT00968669|9038007|P1|Overall Study|Lost to Follow-up|5
2614150|NCT00968617|9038097|P1|Overall Study|Study terminated by sponsor|6
2614151|NCT00968539|9038111|P2|Overall Study|Lost to follow-up (incompl. vaccination)|0
2614152|NCT00968539|9038112|P1|Overall Study|Lost to follow-up (incompl. vaccination)|1
2614153|NCT00968526|9038172|P2|Overall Study|Migrated/moved from study area|0
2614154|NCT00968526|9038173|P1|Overall Study|Migrated/moved from study area|1
2614155|NCT00968526|9038172|P2|Overall Study|Adverse Event|0
2614156|NCT00968526|9038173|P1|Overall Study|Adverse Event|2
2614157|NCT00968253|9038275|P3|Overall Study|Adverse Event|1
2614158|NCT00968253|9038276|P2|Overall Study|Adverse Event|0
2614159|NCT00968253|9038277|P1|Overall Study|Adverse Event|0
2614160|NCT00968253|9038275|P3|Overall Study|Disease Progression|3
2614161|NCT00968253|9038276|P2|Overall Study|Disease Progression|3
2614162|NCT00968253|9038277|P1|Overall Study|Disease Progression|0
2614163|NCT00968253|9038275|P3|Overall Study|Withdrawal by Subject|1
2614164|NCT00968253|9038276|P2|Overall Study|Withdrawal by Subject|0
2614165|NCT00968253|9038277|P1|Overall Study|Withdrawal by Subject|0
2614166|NCT00968253|9038275|P3|Overall Study|Death|2
2614167|NCT00968253|9038276|P2|Overall Study|Death|0
2614168|NCT00968253|9038277|P1|Overall Study|Death|0
2614169|NCT00968201|9038298|P3|Extension Study - (Period III)|Study Terminated for Admin Reasons|185
2614170|NCT00968201|9038299|P2|Extension Study - (Period III)|Study Terminated for Admin Reasons|74
2614171|NCT00968201|9038300|P1|Extension Study - (Period III)|Study Terminated for Admin Reasons|0
2614172|NCT00968201|9038298|P3|Extension Study - (Period III)|Other|2
2614173|NCT00968201|9038299|P2|Extension Study - (Period III)|Other|0
2614174|NCT00968201|9038300|P1|Extension Study - (Period III)|Other|0
2614175|NCT00968201|9038298|P3|Extension Study - (Period III)|Noncompliance|3
2614176|NCT00968201|9038299|P2|Extension Study - (Period III)|Noncompliance|0
2614177|NCT00968201|9038300|P1|Extension Study - (Period III)|Noncompliance|0
2614178|NCT00968201|9038298|P3|Extension Study - (Period III)|Patient Relocated|1
2614179|NCT00968201|9038299|P2|Extension Study - (Period III)|Patient Relocated|1
2614180|NCT00968201|9038300|P1|Extension Study - (Period III)|Patient Relocated|0
2614181|NCT00968201|9038298|P3|Extension Study - (Period III)|Withdrawal by Subject|40
2614182|NCT00968201|9038299|P2|Extension Study - (Period III)|Withdrawal by Subject|20
2614183|NCT00968201|9038300|P1|Extension Study - (Period III)|Withdrawal by Subject|0
2614184|NCT00968201|9038298|P3|Extension Study - (Period III)|Protocol Violation|14
2614185|NCT00968201|9038299|P2|Extension Study - (Period III)|Protocol Violation|17
2614186|NCT00968201|9038300|P1|Extension Study - (Period III)|Protocol Violation|0
2614187|NCT00968201|9038298|P3|Extension Study - (Period III)|Lost to Follow-up|13
2614188|NCT00968201|9038299|P2|Extension Study - (Period III)|Lost to Follow-up|7
2614189|NCT00968201|9038300|P1|Extension Study - (Period III)|Lost to Follow-up|0
2614190|NCT00968201|9038298|P3|Extension Study - (Period III)|Adverse Event|22
2614191|NCT00968201|9038299|P2|Extension Study - (Period III)|Adverse Event|5
2614192|NCT00968201|9038300|P1|Extension Study - (Period III)|Adverse Event|0
2614193|NCT00968201|9038298|P3|Base Study - (Period II)|Site Error|1
2614194|NCT00968201|9038299|P2|Base Study - (Period II)|Site Error|0
2614195|NCT00968201|9038300|P1|Base Study - (Period II)|Site Error|0
2614196|NCT00968201|9038298|P3|Base Study - (Period II)|Withdrawal by Subject|8
2614197|NCT00968201|9038299|P2|Base Study - (Period II)|Withdrawal by Subject|0
2614198|NCT00968201|9038300|P1|Base Study - (Period II)|Withdrawal by Subject|4
2614199|NCT00968201|9038298|P3|Base Study - (Period II)|Protocol Violation|12
2614200|NCT00968201|9038299|P2|Base Study - (Period II)|Protocol Violation|0
2614201|NCT00968201|9038300|P1|Base Study - (Period II)|Protocol Violation|12
2614202|NCT00968201|9038298|P3|Base Study - (Period II)|Lost to Follow-up|7
2614203|NCT00968201|9038299|P2|Base Study - (Period II)|Lost to Follow-up|0
2614204|NCT00968201|9038300|P1|Base Study - (Period II)|Lost to Follow-up|2
2614205|NCT00968201|9038298|P3|Base Study - (Period II)|Lack of Efficacy|1
2614206|NCT00968201|9038299|P2|Base Study - (Period II)|Lack of Efficacy|0
2614207|NCT00968201|9038300|P1|Base Study - (Period II)|Lack of Efficacy|0
2614208|NCT00968201|9038298|P3|Base Study - (Period II)|Adverse Event|16
2614209|NCT00968201|9038299|P2|Base Study - (Period II)|Adverse Event|0
2614210|NCT00968201|9038300|P1|Base Study - (Period II)|Adverse Event|8
2614211|NCT00968149|9038361|P2|Overall Study|Withdrawal by Subject|0
2614212|NCT00968149|9038362|P1|Overall Study|Withdrawal by Subject|2
2614213|NCT00968149|9038361|P2|Overall Study|Protocol Violation|0
2614214|NCT00968149|9038362|P1|Overall Study|Protocol Violation|4
2614215|NCT00968149|9038361|P2|Overall Study|Lost to Follow-up|1
2614216|NCT00968149|9038362|P1|Overall Study|Lost to Follow-up|0
2614217|NCT00968149|9038361|P2|Overall Study|Lack of Efficacy|4
2614218|NCT00968149|9038362|P1|Overall Study|Lack of Efficacy|0
2614219|NCT00968149|9038361|P2|Overall Study|Adverse Event|1
2614220|NCT00968149|9038362|P1|Overall Study|Adverse Event|5
2614221|NCT00967798|9038430|P2|Overall Study|Lost to Follow-up|1
2614222|NCT00967798|9038431|P1|Overall Study|Lost to Follow-up|4
2614223|NCT00967798|9038430|P2|Overall Study|Withdrawal by Subject|2
2614224|NCT00967798|9038431|P1|Overall Study|Withdrawal by Subject|5
2614225|NCT00967694|9038445|P1|Overall Study|Withdrawal by Subject|6
2614226|NCT00967668|9038452|P3|Overall Study|Pregnancy|0
2614227|NCT00967668|9038453|P2|Overall Study|Pregnancy|0
2614228|NCT00967668|9038454|P1|Overall Study|Pregnancy|1
2614229|NCT00967668|9038452|P3|Overall Study|Refused 12-mo assessment|9
2614230|NCT00967668|9038453|P2|Overall Study|Refused 12-mo assessment|1
2614231|NCT00967668|9038454|P1|Overall Study|Refused 12-mo assessment|3
2614232|NCT00967668|9038452|P3|Overall Study|Lost to Follow-up|16
2614233|NCT00967668|9038453|P2|Overall Study|Lost to Follow-up|9
2614234|NCT00967668|9038454|P1|Overall Study|Lost to Follow-up|15
2614235|NCT00967668|9038452|P3|Overall Study|Lost to follow-up at 12-mo|26
2614236|NCT00967668|9038453|P2|Overall Study|Lost to follow-up at 12-mo|29
2614237|NCT00967668|9038454|P1|Overall Study|Lost to follow-up at 12-mo|27
2614238|NCT00967668|9038452|P3|Overall Study|Refused Year 2|4
2614239|NCT00967668|9038453|P2|Overall Study|Refused Year 2|6
2614240|NCT00967668|9038454|P1|Overall Study|Refused Year 2|11
2614241|NCT00967668|9038452|P3|Overall Study|Removed due to behavior|2
2614242|NCT00967668|9038453|P2|Overall Study|Removed due to behavior|1
2614243|NCT00967668|9038454|P1|Overall Study|Removed due to behavior|1
2614244|NCT00967668|9038452|P3|Overall Study|Death|4
2614245|NCT00967668|9038453|P2|Overall Study|Death|2
2614246|NCT00967668|9038454|P1|Overall Study|Death|0
2614247|NCT00967668|9038452|P3|Overall Study|Withdrawal by Subject|8
2614248|NCT00967668|9038453|P2|Overall Study|Withdrawal by Subject|8
2614249|NCT00967668|9038454|P1|Overall Study|Withdrawal by Subject|13
2614250|NCT00967330|9038519|P2|Overall Study|Severe protocol deviation|1
2614251|NCT00967330|9038520|P1|Overall Study|Severe protocol deviation|0
2614252|NCT00967330|9038519|P2|Overall Study|Death|51
2614253|NCT00967330|9038520|P1|Overall Study|Death|102
2614254|NCT00967330|9038519|P2|Overall Study|Lost to Follow-up|1
2614255|NCT00967330|9038520|P1|Overall Study|Lost to Follow-up|1
2614256|NCT00967330|9038519|P2|Overall Study|Withdrawal by Subject|0
2614257|NCT00967330|9038520|P1|Overall Study|Withdrawal by Subject|6
2614258|NCT00967330|9038519|P2|Overall Study|Regular|3
2614259|NCT00967330|9038520|P1|Overall Study|Regular|10
2614260|NCT00967330|9038519|P2|Overall Study|Protocol Violation|4
2614261|NCT00967330|9038520|P1|Overall Study|Protocol Violation|3
2614262|NCT00967226|9038550|P2|Overall Study|Physician Decision|1
2614263|NCT00967226|9038551|P1|Overall Study|Physician Decision|0
2614264|NCT00967226|9038550|P2|Overall Study|Protocol Violation|0
2614265|NCT00967226|9038551|P1|Overall Study|Protocol Violation|2
2614266|NCT00967226|9038550|P2|Overall Study|Adverse Event|5
2614267|NCT00967226|9038551|P1|Overall Study|Adverse Event|0
2614268|NCT00967018|9038585|P1|Overall Study|Miscellaneous Reasons|9
2614269|NCT00967018|9038585|P1|Overall Study|Withdrawal by Subject|1
2614270|NCT00967018|9038585|P1|Overall Study|Lost to Follow-up|2
2614271|NCT00967018|9038585|P1|Overall Study|Physician Decision|7
2614272|NCT00967018|9038585|P1|Overall Study|Adverse Event|2
2614273|NCT00967005|9038594|P2|Overall Study|Lost to Follow-up|10
2614274|NCT00967005|9038595|P1|Overall Study|Lost to Follow-up|7
2614275|NCT00966940|9038681|P2|Period 1, First 6 Weeks|Protocol Violation|0
2614276|NCT00966940|9038682|P1|Period 1, First 6 Weeks|Protocol Violation|1
2614277|NCT00966940|9038681|P2|Period 1, First 6 Weeks|Withdrawal by Subject|0
2614278|NCT00966940|9038682|P1|Period 1, First 6 Weeks|Withdrawal by Subject|2
2614279|NCT00966875|9038709|P9|Part B|Entry Criteria|1
2614280|NCT00966875|9038710|P8|Part B|Entry Criteria|0
2614281|NCT00966875|9038711|P7|Part B|Entry Criteria|1
2614282|NCT00966875|9038712|P6|Part B|Entry Criteria|0
2614283|NCT00966875|9038713|P5|Part B|Entry Criteria|0
2614284|NCT00966875|9038714|P4|Part B|Entry Criteria|0
2614285|NCT00966875|9038715|P3|Part B|Entry Criteria|0
2614286|NCT00966875|9038716|P2|Part B|Entry Criteria|0
2614287|NCT00966875|9038717|P1|Part B|Entry Criteria|0
2614288|NCT00966875|9038709|P9|Part B|Withdrawal by Subject|5
2614289|NCT00966875|9038710|P8|Part B|Withdrawal by Subject|5
2614290|NCT00966875|9038711|P7|Part B|Withdrawal by Subject|4
2614291|NCT00966875|9038712|P6|Part B|Withdrawal by Subject|1
2614292|NCT00966875|9038713|P5|Part B|Withdrawal by Subject|2
2614293|NCT00966875|9038714|P4|Part B|Withdrawal by Subject|1
2614294|NCT00966875|9038715|P3|Part B|Withdrawal by Subject|2
2614295|NCT00966875|9038716|P2|Part B|Withdrawal by Subject|1
2614296|NCT00966875|9038717|P1|Part B|Withdrawal by Subject|2
2614297|NCT00966875|9038709|P9|Part B|Sponsor Decision|1
2614298|NCT00966875|9038710|P8|Part B|Sponsor Decision|2
2614299|NCT00966875|9038711|P7|Part B|Sponsor Decision|0
2614300|NCT00966875|9038712|P6|Part B|Sponsor Decision|1
2614301|NCT00966875|9038713|P5|Part B|Sponsor Decision|0
2614302|NCT00966875|9038714|P4|Part B|Sponsor Decision|0
2614303|NCT00966875|9038715|P3|Part B|Sponsor Decision|0
2614304|NCT00966875|9038716|P2|Part B|Sponsor Decision|0
2614305|NCT00966875|9038717|P1|Part B|Sponsor Decision|1
2614306|NCT00966875|9038709|P9|Part B|Physician Decision|2
2614307|NCT00966875|9038710|P8|Part B|Physician Decision|0
2614308|NCT00966875|9038711|P7|Part B|Physician Decision|0
2614309|NCT00966875|9038712|P6|Part B|Physician Decision|1
2614310|NCT00966875|9038713|P5|Part B|Physician Decision|2
2614311|NCT00966875|9038714|P4|Part B|Physician Decision|0
2614312|NCT00966875|9038715|P3|Part B|Physician Decision|1
2614313|NCT00966875|9038716|P2|Part B|Physician Decision|0
2614314|NCT00966875|9038717|P1|Part B|Physician Decision|0
2614315|NCT00966875|9038709|P9|Part B|Lost to Follow-up|1
2614316|NCT00966875|9038710|P8|Part B|Lost to Follow-up|0
2614317|NCT00966875|9038711|P7|Part B|Lost to Follow-up|0
2614318|NCT00966875|9038712|P6|Part B|Lost to Follow-up|0
2614319|NCT00966875|9038713|P5|Part B|Lost to Follow-up|0
2614320|NCT00966875|9038714|P4|Part B|Lost to Follow-up|1
2614321|NCT00966875|9038715|P3|Part B|Lost to Follow-up|0
2614322|NCT00966875|9038716|P2|Part B|Lost to Follow-up|0
2614323|NCT00966875|9038717|P1|Part B|Lost to Follow-up|0
2614324|NCT00966875|9038709|P9|Part B|Lack of Efficacy|6
2614325|NCT00966875|9038710|P8|Part B|Lack of Efficacy|9
2614326|NCT00966875|9038711|P7|Part B|Lack of Efficacy|12
2614327|NCT00966875|9038712|P6|Part B|Lack of Efficacy|3
2614328|NCT00966875|9038713|P5|Part B|Lack of Efficacy|2
2614329|NCT00966875|9038714|P4|Part B|Lack of Efficacy|1
2614330|NCT00966875|9038715|P3|Part B|Lack of Efficacy|1
2614331|NCT00966875|9038716|P2|Part B|Lack of Efficacy|1
2614332|NCT00966875|9038717|P1|Part B|Lack of Efficacy|2
2614333|NCT00966875|9038709|P9|Part B|Death|0
2614334|NCT00966875|9038710|P8|Part B|Death|1
2614335|NCT00966875|9038711|P7|Part B|Death|0
2614336|NCT00966875|9038712|P6|Part B|Death|0
2614337|NCT00966875|9038713|P5|Part B|Death|0
2614338|NCT00966875|9038714|P4|Part B|Death|0
2614339|NCT00966875|9038715|P3|Part B|Death|1
2614340|NCT00966875|9038716|P2|Part B|Death|0
2614341|NCT00966875|9038717|P1|Part B|Death|0
2614342|NCT00966875|9038709|P9|Part B|Adverse Event|2
2614343|NCT00966875|9038710|P8|Part B|Adverse Event|2
2614344|NCT00966875|9038711|P7|Part B|Adverse Event|5
2614345|NCT00966875|9038712|P6|Part B|Adverse Event|0
2614346|NCT00966875|9038713|P5|Part B|Adverse Event|1
2614347|NCT00966875|9038714|P4|Part B|Adverse Event|0
2614348|NCT00966875|9038715|P3|Part B|Adverse Event|1
2614349|NCT00966875|9038716|P2|Part B|Adverse Event|1
2614350|NCT00966875|9038717|P1|Part B|Adverse Event|0
2614351|NCT00966875|9038709|P9|Part A|Protocol Violation|1
2614352|NCT00966875|9038710|P8|Part A|Protocol Violation|1
2614353|NCT00966875|9038711|P7|Part A|Protocol Violation|2
2614354|NCT00966875|9038712|P6|Part A|Protocol Violation|0
2614355|NCT00966875|9038713|P5|Part A|Protocol Violation|0
2614356|NCT00966875|9038714|P4|Part A|Protocol Violation|0
2614357|NCT00966875|9038715|P3|Part A|Protocol Violation|0
2614358|NCT00966875|9038716|P2|Part A|Protocol Violation|0
2614359|NCT00966875|9038717|P1|Part A|Protocol Violation|0
2614360|NCT00966875|9038709|P9|Part A|Withdrawal by Subject|1
2614361|NCT00966875|9038710|P8|Part A|Withdrawal by Subject|1
2614362|NCT00966875|9038711|P7|Part A|Withdrawal by Subject|5
2614363|NCT00966875|9038712|P6|Part A|Withdrawal by Subject|0
2614364|NCT00966875|9038713|P5|Part A|Withdrawal by Subject|3
2614365|NCT00966875|9038714|P4|Part A|Withdrawal by Subject|1
2614366|NCT00966875|9038715|P3|Part A|Withdrawal by Subject|1
2614367|NCT00966875|9038716|P2|Part A|Withdrawal by Subject|2
2614368|NCT00966875|9038717|P1|Part A|Withdrawal by Subject|2
2614369|NCT00966875|9038709|P9|Part A|Sponsor Decision|1
2614370|NCT00966875|9038710|P8|Part A|Sponsor Decision|2
2614371|NCT00966875|9038711|P7|Part A|Sponsor Decision|0
2614372|NCT00966875|9038712|P6|Part A|Sponsor Decision|0
2614373|NCT00966875|9038713|P5|Part A|Sponsor Decision|1
2614374|NCT00966875|9038714|P4|Part A|Sponsor Decision|0
2614375|NCT00966875|9038715|P3|Part A|Sponsor Decision|1
2614376|NCT00966875|9038716|P2|Part A|Sponsor Decision|0
2614377|NCT00966875|9038717|P1|Part A|Sponsor Decision|0
2614378|NCT00966875|9038709|P9|Part A|Physician Decision|2
2614379|NCT00966875|9038710|P8|Part A|Physician Decision|0
2614380|NCT00966875|9038711|P7|Part A|Physician Decision|1
2614381|NCT00966875|9038712|P6|Part A|Physician Decision|0
2614382|NCT00966875|9038713|P5|Part A|Physician Decision|1
2614383|NCT00966875|9038714|P4|Part A|Physician Decision|0
2614384|NCT00966875|9038715|P3|Part A|Physician Decision|0
2614385|NCT00966875|9038716|P2|Part A|Physician Decision|0
2614386|NCT00966875|9038717|P1|Part A|Physician Decision|0
2614387|NCT00966875|9038709|P9|Part A|Parent/Caregiver Decision|0
2614388|NCT00966875|9038710|P8|Part A|Parent/Caregiver Decision|0
2614389|NCT00966875|9038711|P7|Part A|Parent/Caregiver Decision|0
2614390|NCT00966875|9038712|P6|Part A|Parent/Caregiver Decision|0
2614391|NCT00966875|9038713|P5|Part A|Parent/Caregiver Decision|0
2614392|NCT00966875|9038714|P4|Part A|Parent/Caregiver Decision|1
2614393|NCT00966875|9038715|P3|Part A|Parent/Caregiver Decision|0
2614394|NCT00966875|9038716|P2|Part A|Parent/Caregiver Decision|0
2614395|NCT00966875|9038717|P1|Part A|Parent/Caregiver Decision|0
2614396|NCT00966875|9038709|P9|Part A|Lost to Follow-up|0
2614397|NCT00966875|9038710|P8|Part A|Lost to Follow-up|0
2614398|NCT00966875|9038711|P7|Part A|Lost to Follow-up|0
2614399|NCT00966875|9038712|P6|Part A|Lost to Follow-up|1
2614400|NCT00966875|9038713|P5|Part A|Lost to Follow-up|0
2614401|NCT00966875|9038714|P4|Part A|Lost to Follow-up|0
2614402|NCT00966875|9038715|P3|Part A|Lost to Follow-up|0
2614403|NCT00966875|9038716|P2|Part A|Lost to Follow-up|0
2614404|NCT00966875|9038717|P1|Part A|Lost to Follow-up|2
2614405|NCT00966875|9038709|P9|Part A|Lack of Efficacy|0
2614406|NCT00966875|9038710|P8|Part A|Lack of Efficacy|0
2614407|NCT00966875|9038711|P7|Part A|Lack of Efficacy|4
2614408|NCT00966875|9038712|P6|Part A|Lack of Efficacy|0
2614409|NCT00966875|9038713|P5|Part A|Lack of Efficacy|0
2614410|NCT00966875|9038714|P4|Part A|Lack of Efficacy|0
2614411|NCT00966875|9038715|P3|Part A|Lack of Efficacy|0
2614412|NCT00966875|9038716|P2|Part A|Lack of Efficacy|1
2614413|NCT00966875|9038717|P1|Part A|Lack of Efficacy|0
2614414|NCT00966875|9038709|P9|Part A|Entry Criteria|0
2614415|NCT00966875|9038710|P8|Part A|Entry Criteria|0
2614416|NCT00966875|9038711|P7|Part A|Entry Criteria|0
2614417|NCT00966875|9038712|P6|Part A|Entry Criteria|2
2614418|NCT00966875|9038713|P5|Part A|Entry Criteria|0
2614419|NCT00966875|9038714|P4|Part A|Entry Criteria|0
2614420|NCT00966875|9038715|P3|Part A|Entry Criteria|0
2614421|NCT00966875|9038716|P2|Part A|Entry Criteria|0
2614422|NCT00966875|9038717|P1|Part A|Entry Criteria|0
2614423|NCT00966875|9038709|P9|Part A|Adverse Event|3
2614424|NCT00966875|9038710|P8|Part A|Adverse Event|3
2614425|NCT00966875|9038711|P7|Part A|Adverse Event|0
2614426|NCT00966875|9038712|P6|Part A|Adverse Event|1
2614427|NCT00966875|9038713|P5|Part A|Adverse Event|0
2614428|NCT00966875|9038714|P4|Part A|Adverse Event|1
2614429|NCT00966875|9038715|P3|Part A|Adverse Event|0
2614430|NCT00966875|9038716|P2|Part A|Adverse Event|1
2614431|NCT00966875|9038717|P1|Part A|Adverse Event|2
2614432|NCT00966719|9039068|P2|Overall Study|Lost to Follow-up|11
2614433|NCT00966719|9039069|P1|Overall Study|Lost to Follow-up|6
2614434|NCT00966654|9039089|P1|Overall Study|Study was terminated,PI left institution|12
2614435|NCT00966355|9039163|P3|Overall Study|Lost to Follow-up|3
2614436|NCT00966355|9039164|P2|Overall Study|Lost to Follow-up|4
2614437|NCT00966355|9039165|P1|Overall Study|Lost to Follow-up|5
2614438|NCT00966355|9039163|P3|Overall Study|newly diagnosed advanced HCC|10
2614439|NCT00966355|9039164|P2|Overall Study|newly diagnosed advanced HCC|12
2614440|NCT00966355|9039165|P1|Overall Study|newly diagnosed advanced HCC|11
2614441|NCT00966355|9039163|P3|Overall Study|non-variceal bleeding on endoscopy|71
2614442|NCT00966355|9039164|P2|Overall Study|non-variceal bleeding on endoscopy|70
2614443|NCT00966355|9039165|P1|Overall Study|non-variceal bleeding on endoscopy|68
2614444|NCT00966277|9039178|P2|Overall Study|Treatment Plan Changed|1
2614445|NCT00966277|9039179|P1|Overall Study|Treatment Plan Changed|0
2614446|NCT00966277|9039178|P2|Overall Study|Ineligible|3
2614447|NCT00966277|9039179|P1|Overall Study|Ineligible|1
2614448|NCT00966277|9039178|P2|Overall Study|Withdrawal by Subject|0
2614449|NCT00966277|9039179|P1|Overall Study|Withdrawal by Subject|3
2614450|NCT00966264|9039187|P2|Overall Study|Lost to Follow-up|3
2614451|NCT00966264|9039188|P1|Overall Study|Lost to Follow-up|4
2614452|NCT00965848|9039234|P3|Overall Study|Other|1
2614453|NCT00965848|9039235|P2|Overall Study|Other|0
2614454|NCT00965848|9039236|P1|Overall Study|Other|5
2614455|NCT00965848|9039234|P3|Overall Study|Not Clinically Evaluable|1
2614456|NCT00965848|9039235|P2|Overall Study|Not Clinically Evaluable|1
2614457|NCT00965848|9039236|P1|Overall Study|Not Clinically Evaluable|7
2614458|NCT00965848|9039234|P3|Overall Study|Indeterminate Clinical Outcome|1
2614459|NCT00965848|9039235|P2|Overall Study|Indeterminate Clinical Outcome|0
2614460|NCT00965848|9039236|P1|Overall Study|Indeterminate Clinical Outcome|2
2614461|NCT00965848|9039234|P3|Overall Study|Withdrawal by Subject|0
2614462|NCT00965848|9039235|P2|Overall Study|Withdrawal by Subject|0
2614463|NCT00965848|9039236|P1|Overall Study|Withdrawal by Subject|1
2614464|NCT00965848|9039234|P3|Overall Study|Lost to Follow-up|1
2614465|NCT00965848|9039235|P2|Overall Study|Lost to Follow-up|0
2614466|NCT00965848|9039236|P1|Overall Study|Lost to Follow-up|0
2614467|NCT00965848|9039234|P3|Overall Study|Death|5
2614468|NCT00965848|9039235|P2|Overall Study|Death|1
2614469|NCT00965848|9039236|P1|Overall Study|Death|11
2614470|NCT00965848|9039234|P3|Overall Study|Protocol Violation|1
2614471|NCT00965848|9039235|P2|Overall Study|Protocol Violation|0
2614472|NCT00965848|9039236|P1|Overall Study|Protocol Violation|3
2614473|NCT00965757|9039255|P4|Extension Phase|Other|1
2614474|NCT00965757|9039256|P3|Extension Phase|Other|2
2614475|NCT00965757|9039257|P2|Extension Phase|Other|0
2614476|NCT00965757|9039258|P1|Extension Phase|Other|0
2614477|NCT00965757|9039255|P4|Extension Phase|Protocol Violation|1
2614478|NCT00965757|9039256|P3|Extension Phase|Protocol Violation|0
2614479|NCT00965757|9039257|P2|Extension Phase|Protocol Violation|0
2614480|NCT00965757|9039258|P1|Extension Phase|Protocol Violation|0
2614481|NCT00965757|9039255|P4|Extension Phase|Ineligible after Taking Study Drug|3
2614482|NCT00965757|9039256|P3|Extension Phase|Ineligible after Taking Study Drug|3
2614483|NCT00965757|9039257|P2|Extension Phase|Ineligible after Taking Study Drug|0
2614484|NCT00965757|9039258|P1|Extension Phase|Ineligible after Taking Study Drug|0
2614485|NCT00965757|9039255|P4|Extension Phase|Lost to Follow-up|1
2614486|NCT00965757|9039256|P3|Extension Phase|Lost to Follow-up|0
2614487|NCT00965757|9039257|P2|Extension Phase|Lost to Follow-up|0
2614488|NCT00965757|9039258|P1|Extension Phase|Lost to Follow-up|0
2614489|NCT00965757|9039255|P4|Extension Phase|Drug Refusal Due to Adverse Event|0
2614490|NCT00965757|9039256|P3|Extension Phase|Drug Refusal Due to Adverse Event|4
2614491|NCT00965757|9039257|P2|Extension Phase|Drug Refusal Due to Adverse Event|0
2614492|NCT00965757|9039258|P1|Extension Phase|Drug Refusal Due to Adverse Event|0
2614493|NCT00965757|9039255|P4|Extension Phase|Lack of Efficacy|12
2614494|NCT00965757|9039256|P3|Extension Phase|Lack of Efficacy|8
2614495|NCT00965757|9039257|P2|Extension Phase|Lack of Efficacy|0
2614496|NCT00965757|9039258|P1|Extension Phase|Lack of Efficacy|0
2614497|NCT00965757|9039255|P4|Extension Phase|Abnormal Laboratory Value|1
2614498|NCT00965757|9039256|P3|Extension Phase|Abnormal Laboratory Value|6
2614499|NCT00965757|9039257|P2|Extension Phase|Abnormal Laboratory Value|0
2614500|NCT00965757|9039258|P1|Extension Phase|Abnormal Laboratory Value|0
2614501|NCT00965757|9039255|P4|Extension Phase|Adverse drug reaction|3
2614502|NCT00965757|9039256|P3|Extension Phase|Adverse drug reaction|6
2614503|NCT00965757|9039257|P2|Extension Phase|Adverse drug reaction|0
2614504|NCT00965757|9039258|P1|Extension Phase|Adverse drug reaction|0
2614505|NCT00965757|9039255|P4|Extension Phase|Progression of concomitant disease|2
2614506|NCT00965757|9039256|P3|Extension Phase|Progression of concomitant disease|4
2614507|NCT00965757|9039257|P2|Extension Phase|Progression of concomitant disease|0
2614508|NCT00965757|9039258|P1|Extension Phase|Progression of concomitant disease|0
2614509|NCT00965757|9039255|P4|Double-blind Phase|Other|0
2614510|NCT00965757|9039256|P3|Double-blind Phase|Other|0
2614511|NCT00965757|9039257|P2|Double-blind Phase|Other|0
2614512|NCT00965757|9039258|P1|Double-blind Phase|Other|1
2614513|NCT00965757|9039255|P4|Double-blind Phase|Ineligible after Taking Study Drug|0
2614514|NCT00965757|9039256|P3|Double-blind Phase|Ineligible after Taking Study Drug|0
2614515|NCT00965757|9039257|P2|Double-blind Phase|Ineligible after Taking Study Drug|3
2614516|NCT00965757|9039258|P1|Double-blind Phase|Ineligible after Taking Study Drug|2
2614517|NCT00965757|9039255|P4|Double-blind Phase|Lost to Follow-up|0
2614518|NCT00965757|9039256|P3|Double-blind Phase|Lost to Follow-up|0
2614519|NCT00965757|9039257|P2|Double-blind Phase|Lost to Follow-up|1
2614520|NCT00965757|9039258|P1|Double-blind Phase|Lost to Follow-up|0
2614521|NCT00965757|9039255|P4|Double-blind Phase|Drug Refusal Due to Adverse Event|0
2614522|NCT00965757|9039256|P3|Double-blind Phase|Drug Refusal Due to Adverse Event|0
2614523|NCT00965757|9039257|P2|Double-blind Phase|Drug Refusal Due to Adverse Event|0
2614524|NCT00965757|9039258|P1|Double-blind Phase|Drug Refusal Due to Adverse Event|2
2614525|NCT00965757|9039255|P4|Double-blind Phase|Lack of Efficacy|0
2614526|NCT00965757|9039256|P3|Double-blind Phase|Lack of Efficacy|0
2614527|NCT00965757|9039257|P2|Double-blind Phase|Lack of Efficacy|11
2614528|NCT00965757|9039258|P1|Double-blind Phase|Lack of Efficacy|7
2614529|NCT00965757|9039255|P4|Double-blind Phase|Abnormal Laboratory Value|0
2614530|NCT00965757|9039256|P3|Double-blind Phase|Abnormal Laboratory Value|0
2614531|NCT00965757|9039257|P2|Double-blind Phase|Abnormal Laboratory Value|0
2614532|NCT00965757|9039258|P1|Double-blind Phase|Abnormal Laboratory Value|2
2614533|NCT00965757|9039255|P4|Double-blind Phase|Adverse drug reaction|0
2614534|NCT00965757|9039256|P3|Double-blind Phase|Adverse drug reaction|0
2614535|NCT00965757|9039257|P2|Double-blind Phase|Adverse drug reaction|1
2614536|NCT00965757|9039258|P1|Double-blind Phase|Adverse drug reaction|2
2614537|NCT00965757|9039255|P4|Double-blind Phase|Progression of concomitant disease|0
2614538|NCT00965757|9039256|P3|Double-blind Phase|Progression of concomitant disease|0
2614539|NCT00965757|9039257|P2|Double-blind Phase|Progression of concomitant disease|2
2614540|NCT00965757|9039258|P1|Double-blind Phase|Progression of concomitant disease|1
2614541|NCT00965731|9039292|P2|Overall Study|Other|15
2614542|NCT00965731|9039293|P1|Overall Study|Other|7
2614543|NCT00965731|9039292|P2|Overall Study|Withdrawal by Subject|1
2614544|NCT00965731|9039293|P1|Overall Study|Withdrawal by Subject|0
2614545|NCT00965731|9039292|P2|Overall Study|Death|4
2614546|NCT00965731|9039293|P1|Overall Study|Death|0
2614547|NCT00965718|9039357|P1|Overall Study|Withdrawal by Subject|4
2614548|NCT00965562|9039370|P3|Overall Study|Withdrawal by Subject|0
2614549|NCT00965562|9039371|P2|Overall Study|Withdrawal by Subject|2
2614550|NCT00965562|9039372|P1|Overall Study|Withdrawal by Subject|2
2614551|NCT00965562|9039370|P3|Overall Study|Lost to Follow-up|3
2614552|NCT00965562|9039371|P2|Overall Study|Lost to Follow-up|2
2614553|NCT00965562|9039372|P1|Overall Study|Lost to Follow-up|1
2614554|NCT00965523|9039410|P1|Study 224|Physician Decision|1
2614555|NCT00965523|9039410|P1|Study 224|Progressive Disease|5
2614556|NCT00965523|9039410|P1|Study 221|Physician Decision|3
2614557|NCT00965523|9039410|P1|Study 221|Progressive Disease|4
2614558|NCT00965497|9039415|P1|Overall Study|Physician Decision|1
2614559|NCT00965484|9039420|P1|Overall Study|Withdrawal by Subject|1
2614560|NCT00965484|9039420|P1|Overall Study|Protocol Violation|1
2614561|NCT00965458|9039429|P2|Overall Study|Withdrawal by Subject|1
2614562|NCT00965458|9039430|P1|Overall Study|Withdrawal by Subject|0
2614563|NCT00965458|9039429|P2|Overall Study|Lost to Follow-up|3
2614564|NCT00965458|9039430|P1|Overall Study|Lost to Follow-up|1
2614565|NCT00965458|9039429|P2|Overall Study|Adverse Event|0
2614566|NCT00965458|9039430|P1|Overall Study|Adverse Event|1
2614567|NCT00965419|9039446|P1|Follow-up Phase|Lack of Efficacy|28
2614568|NCT00965419|9039446|P1|Follow-up Phase|Parent/Caregiver Decision|9
2614569|NCT00965419|9039446|P1|Follow-up Phase|Physician Decision|4
2614570|NCT00965419|9039446|P1|Follow-up Phase|Withdrawal by Subject|8
2614571|NCT00965419|9039446|P1|Follow-up Phase|Protocol Violation|4
2614572|NCT00965419|9039446|P1|Follow-up Phase|Adverse Event|9
2614573|NCT00965419|9039446|P1|Open Label Treatment for Responders|Lost to Follow-up|46
2614574|NCT00965419|9039446|P1|Open Label Treatment for Responders|Lack of Efficacy|67
2614575|NCT00965419|9039446|P1|Open Label Treatment for Responders|Parent/Caregiver Decision|41
2614576|NCT00965419|9039446|P1|Open Label Treatment for Responders|Sponsor Decision|5
2614577|NCT00965419|9039446|P1|Open Label Treatment for Responders|Physician Decision|6
2614578|NCT00965419|9039446|P1|Open Label Treatment for Responders|Withdrawal by Subject|27
2614579|NCT00965419|9039446|P1|Open Label Treatment for Responders|Protocol Violation|21
2614580|NCT00965419|9039446|P1|Open Label Treatment for Responders|Entry Criteria Not Met|1
2614581|NCT00965419|9039446|P1|Open Label Treatment for Responders|Adverse Event|33
2614582|NCT00965341|9039492|P2|Overall Study|Transportation issues|3
2614583|NCT00965341|9039493|P1|Overall Study|Transportation issues|4
2614584|NCT00965341|9039492|P2|Overall Study|Lost to Follow-up|0
2614585|NCT00965341|9039493|P1|Overall Study|Lost to Follow-up|1
2614586|NCT00965341|9039492|P2|Overall Study|Withdrew consent|5
2614587|NCT00965341|9039493|P1|Overall Study|Withdrew consent|1
2614588|NCT00965263|9039503|P2|Overall Study|Protocol Violation|2
2614589|NCT00965263|9039504|P1|Overall Study|Protocol Violation|0
2614590|NCT00965263|9039503|P2|Overall Study|Family emergency|1
2614591|NCT00965263|9039504|P1|Overall Study|Family emergency|0
2614592|NCT00965263|9039503|P2|Overall Study|Physician Decision|0
2614593|NCT00965263|9039504|P1|Overall Study|Physician Decision|2
2614594|NCT00965185|9039564|P2|Overall Study|Withdrawal by Subject|1
2614595|NCT00965185|9039565|P1|Overall Study|Withdrawal by Subject|0
2614596|NCT00965185|9039564|P2|Overall Study|Lost to Follow-up|0
2614597|NCT00965185|9039565|P1|Overall Study|Lost to Follow-up|2
2614598|NCT00965146|9039585|P1|Overall Study|Overall Study Termination|145
2614599|NCT00965146|9039585|P1|Overall Study|Revision / Removal of Study Implant|6
2614600|NCT00965146|9039585|P1|Overall Study|Intercurrent illness|1
2614601|NCT00965146|9039585|P1|Overall Study|Unwilling to return|11
2614602|NCT00965146|9039585|P1|Overall Study|Unable to return|1
2614603|NCT00965146|9039585|P1|Overall Study|Withdrawal by Subject|17
2614604|NCT00965146|9039585|P1|Overall Study|Lost to Follow-up|22
2614605|NCT00965146|9039585|P1|Overall Study|Death|7
2614606|NCT00965094|9039592|P2|Overall Study|Lost to Follow-up|1
2614607|NCT00965094|9039593|P1|Overall Study|Lost to Follow-up|0
2614608|NCT00965094|9039592|P2|Overall Study|Adverse Event|0
2614609|NCT00965094|9039593|P1|Overall Study|Adverse Event|5
2614610|NCT00965081|9039609|P2|Overall Study|Switched to Rescue Arm|12
2614611|NCT00965081|9039610|P1|Overall Study|Switched to Rescue Arm|5
2614612|NCT00965081|9039609|P2|Overall Study|Withdrawal by Subject|7
2614613|NCT00965081|9039610|P1|Overall Study|Withdrawal by Subject|4
2614614|NCT00965081|9039609|P2|Overall Study|Sponsor Decision|0
2614615|NCT00965081|9039610|P1|Overall Study|Sponsor Decision|1
2614616|NCT00965081|9039609|P2|Overall Study|Protocol Violation|5
2614617|NCT00965081|9039610|P1|Overall Study|Protocol Violation|2
2614618|NCT00965081|9039609|P2|Overall Study|Physician Decision|0
2614619|NCT00965081|9039610|P1|Overall Study|Physician Decision|2
2614620|NCT00965081|9039609|P2|Overall Study|Lost to Follow-up|5
2614621|NCT00965081|9039610|P1|Overall Study|Lost to Follow-up|4
2614622|NCT00965081|9039609|P2|Overall Study|Lack of Efficacy|5
2614623|NCT00965081|9039610|P1|Overall Study|Lack of Efficacy|2
2614624|NCT00965081|9039609|P2|Overall Study|Adverse Event|9
2614625|NCT00965081|9039610|P1|Overall Study|Adverse Event|14
2614626|NCT00964886|9039642|P4|Overall Study|Protocol Violation|0
2614627|NCT00964886|9039643|P3|Overall Study|Protocol Violation|0
2614628|NCT00964886|9039644|P2|Overall Study|Protocol Violation|2
2614629|NCT00964886|9039645|P1|Overall Study|Protocol Violation|0
2614630|NCT00964886|9039642|P4|Overall Study|Adverse Event|2
2614631|NCT00964886|9039643|P3|Overall Study|Adverse Event|5
2614632|NCT00964886|9039644|P2|Overall Study|Adverse Event|1
2614633|NCT00964886|9039645|P1|Overall Study|Adverse Event|3
2614634|NCT00964886|9039642|P4|Overall Study|Withdrawal by Subject|3
2614635|NCT00964886|9039643|P3|Overall Study|Withdrawal by Subject|5
2614636|NCT00964886|9039644|P2|Overall Study|Withdrawal by Subject|2
2614637|NCT00964886|9039645|P1|Overall Study|Withdrawal by Subject|6
2614638|NCT00964886|9039642|P4|Overall Study|Lost to Follow-up|4
2614639|NCT00964886|9039643|P3|Overall Study|Lost to Follow-up|6
2614640|NCT00964886|9039644|P2|Overall Study|Lost to Follow-up|2
2614641|NCT00964886|9039645|P1|Overall Study|Lost to Follow-up|2
2614642|NCT00964860|9039661|P2|Overall Study|Withdrawal by Subject|1
2614643|NCT00964860|9039662|P1|Overall Study|Withdrawal by Subject|0
2614644|NCT00964795|9039670|P1|Overall Study|Other|23
2614645|NCT00964795|9039670|P1|Overall Study|Unwilling to sign ICF for amendment 4|3
2614646|NCT00964795|9039670|P1|Overall Study|Termination of Study by Sponsor|169
2614647|NCT00964795|9039670|P1|Overall Study|Lost to Follow-up|7
2614648|NCT00964795|9039670|P1|Overall Study|Death|14
2614649|NCT00964795|9039670|P1|Overall Study|Adverse Event|12
2614650|NCT00964795|9039670|P1|Overall Study|Withdrawal by Subject|79
2614651|NCT00964782|9039679|P2|Overall Study|Lost to Follow-up|0
2614652|NCT00964782|9039680|P1|Overall Study|Lost to Follow-up|1
2614653|NCT00964743|9039694|P1|Overall Study|Neither patient completed 8 weeks of tre|2
2614654|NCT00964678|9039702|P1|Overall Study|Physician Decision|4
2614655|NCT00964392|9039766|P2|Overall Study|Not completed|168
2614656|NCT00964392|9039767|P1|Overall Study|Not completed|44
2614657|NCT00964392|9039766|P2|Overall Study|Early Termination, non-study arrhythmia|6
2614658|NCT00964392|9039767|P1|Overall Study|Early Termination, non-study arrhythmia|1
2614659|NCT00964392|9039766|P2|Overall Study|Lost to Follow-up|10
2614660|NCT00964392|9039767|P1|Overall Study|Lost to Follow-up|4
2614661|NCT00964392|9039766|P2|Overall Study|Withdrawal by Subject|6
2614662|NCT00964392|9039767|P1|Overall Study|Withdrawal by Subject|4
2614663|NCT00964366|9039777|P2|Overall Study|Withdrawal by Subject|1
2614664|NCT00964366|9039778|P1|Overall Study|Withdrawal by Subject|0
2614665|NCT00964366|9039777|P2|Overall Study|Did not qualify at Day 1|0
2614666|NCT00964366|9039778|P1|Overall Study|Did not qualify at Day 1|1
2614667|NCT00964223|9039803|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
2614668|NCT00964158|9039871|P3|Overall Study|Withdrawal by Subject|6
2614669|NCT00964158|9039872|P2|Overall Study|Withdrawal by Subject|0
2614670|NCT00964158|9039873|P1|Overall Study|Withdrawal by Subject|0
2614671|NCT00964158|9039871|P3|Overall Study|Lost to Follow-up|2
2614672|NCT00964158|9039872|P2|Overall Study|Lost to Follow-up|1
2614673|NCT00964158|9039873|P1|Overall Study|Lost to Follow-up|0
2614674|NCT00964028|9039948|P2|Overall Study|Withdrawal by Subject|1
2614675|NCT00964028|9039949|P1|Overall Study|Withdrawal by Subject|0
2614676|NCT00963937|9039964|P3|Overall Study|Physician Decision|4
2614677|NCT00963937|9039965|P2|Overall Study|Physician Decision|10
2614678|NCT00963937|9039966|P1|Overall Study|Physician Decision|18
2614679|NCT00963937|9039964|P3|Overall Study|Protocol Violation|0
2614680|NCT00963937|9039965|P2|Overall Study|Protocol Violation|1
2614681|NCT00963937|9039966|P1|Overall Study|Protocol Violation|1
2614682|NCT00963924|9040004|P2|Overall Study|Lost to Follow-up|1
2614683|NCT00963924|9040005|P1|Overall Study|Lost to Follow-up|0
2614684|NCT00963924|9040004|P2|Overall Study|Changed antipsychotic|1
2614685|NCT00963924|9040005|P1|Overall Study|Changed antipsychotic|0
2614686|NCT00963924|9040004|P2|Overall Study|Withdrawal by Subject|1
2614687|NCT00963924|9040005|P1|Overall Study|Withdrawal by Subject|0
2614688|NCT00963924|9040004|P2|Overall Study|Adverse Event|0
2614689|NCT00963924|9040005|P1|Overall Study|Adverse Event|1
2614690|NCT00963820|9040079|P12|Expansion Phase|Unsatisfactory Therapeutic Response|1
2614691|NCT00963820|9040080|P11|Expansion Phase|Unsatisfactory Therapeutic Response|0
2614692|NCT00963820|9040081|P10|Expansion Phase|Unsatisfactory Therapeutic Response|0
2614693|NCT00963820|9040082|P9|Expansion Phase|Unsatisfactory Therapeutic Response|0
2614694|NCT00963820|9040083|P8|Expansion Phase|Unsatisfactory Therapeutic Response|0
2614695|NCT00963820|9040084|P7|Expansion Phase|Unsatisfactory Therapeutic Response|0
2614696|NCT00963820|9040085|P6|Expansion Phase|Unsatisfactory Therapeutic Response|0
2614697|NCT00963820|9040086|P5|Expansion Phase|Unsatisfactory Therapeutic Response|0
2614698|NCT00963820|9040087|P4|Expansion Phase|Unsatisfactory Therapeutic Response|0
2614699|NCT00963820|9040088|P3|Expansion Phase|Unsatisfactory Therapeutic Response|0
2614700|NCT00963820|9040089|P2|Expansion Phase|Unsatisfactory Therapeutic Response|0
2614701|NCT00963820|9040090|P1|Expansion Phase|Unsatisfactory Therapeutic Response|0
2614702|NCT00963820|9040079|P12|Expansion Phase|Withdrawal by Subject|1
2614703|NCT00963820|9040080|P11|Expansion Phase|Withdrawal by Subject|1
2614704|NCT00963820|9040081|P10|Expansion Phase|Withdrawal by Subject|0
2614705|NCT00963820|9040082|P9|Expansion Phase|Withdrawal by Subject|1
2614706|NCT00963820|9040083|P8|Expansion Phase|Withdrawal by Subject|0
2614707|NCT00963820|9040084|P7|Expansion Phase|Withdrawal by Subject|0
2614708|NCT00963820|9040085|P6|Expansion Phase|Withdrawal by Subject|0
2614709|NCT00963820|9040086|P5|Expansion Phase|Withdrawal by Subject|0
2614710|NCT00963820|9040087|P4|Expansion Phase|Withdrawal by Subject|0
2614711|NCT00963820|9040088|P3|Expansion Phase|Withdrawal by Subject|0
2614712|NCT00963820|9040089|P2|Expansion Phase|Withdrawal by Subject|0
2614713|NCT00963820|9040090|P1|Expansion Phase|Withdrawal by Subject|0
2614714|NCT00963820|9040079|P12|Expansion Phase|Adverse Event|0
2614715|NCT00963820|9040080|P11|Expansion Phase|Adverse Event|0
2614716|NCT00963820|9040081|P10|Expansion Phase|Adverse Event|3
2614717|NCT00963820|9040082|P9|Expansion Phase|Adverse Event|1
2614718|NCT00963820|9040083|P8|Expansion Phase|Adverse Event|0
2614719|NCT00963820|9040084|P7|Expansion Phase|Adverse Event|0
2614720|NCT00963820|9040085|P6|Expansion Phase|Adverse Event|0
2614721|NCT00963820|9040086|P5|Expansion Phase|Adverse Event|0
2614722|NCT00963820|9040087|P4|Expansion Phase|Adverse Event|0
2614723|NCT00963820|9040088|P3|Expansion Phase|Adverse Event|0
2614724|NCT00963820|9040089|P2|Expansion Phase|Adverse Event|0
2614725|NCT00963820|9040090|P1|Expansion Phase|Adverse Event|0
2614726|NCT00963820|9040079|P12|Expansion Phase|Progressive Disease|2
2614727|NCT00963820|9040080|P11|Expansion Phase|Progressive Disease|4
2614728|NCT00963820|9040081|P10|Expansion Phase|Progressive Disease|6
2614729|NCT00963820|9040082|P9|Expansion Phase|Progressive Disease|8
2614730|NCT00963820|9040083|P8|Expansion Phase|Progressive Disease|0
2614731|NCT00963820|9040084|P7|Expansion Phase|Progressive Disease|0
2614732|NCT00963820|9040085|P6|Expansion Phase|Progressive Disease|0
2614733|NCT00963820|9040086|P5|Expansion Phase|Progressive Disease|0
2614734|NCT00963820|9040087|P4|Expansion Phase|Progressive Disease|0
2614735|NCT00963820|9040088|P3|Expansion Phase|Progressive Disease|0
2614736|NCT00963820|9040089|P2|Expansion Phase|Progressive Disease|0
2614737|NCT00963820|9040090|P1|Expansion Phase|Progressive Disease|0
2614738|NCT00963820|9040079|P12|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2614739|NCT00963820|9040080|P11|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2614740|NCT00963820|9040081|P10|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2614741|NCT00963820|9040082|P9|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2614742|NCT00963820|9040083|P8|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2614743|NCT00963820|9040084|P7|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
2614744|NCT00963820|9040085|P6|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2614745|NCT00963820|9040086|P5|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2614746|NCT00963820|9040087|P4|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2614747|NCT00963820|9040088|P3|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2614748|NCT00963820|9040089|P2|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2614749|NCT00963820|9040090|P1|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
2614750|NCT00963820|9040079|P12|Dose Escalation Phase|Withdrawal by Subject|0
2614751|NCT00963820|9040080|P11|Dose Escalation Phase|Withdrawal by Subject|0
2614752|NCT00963820|9040081|P10|Dose Escalation Phase|Withdrawal by Subject|0
2614753|NCT00963820|9040082|P9|Dose Escalation Phase|Withdrawal by Subject|0
2614754|NCT00963820|9040083|P8|Dose Escalation Phase|Withdrawal by Subject|2
2614755|NCT00963820|9040084|P7|Dose Escalation Phase|Withdrawal by Subject|1
2614756|NCT00963820|9040085|P6|Dose Escalation Phase|Withdrawal by Subject|0
2614757|NCT00963820|9040086|P5|Dose Escalation Phase|Withdrawal by Subject|0
2614758|NCT00963820|9040087|P4|Dose Escalation Phase|Withdrawal by Subject|0
2614759|NCT00963820|9040088|P3|Dose Escalation Phase|Withdrawal by Subject|0
2614760|NCT00963820|9040089|P2|Dose Escalation Phase|Withdrawal by Subject|0
2614761|NCT00963820|9040090|P1|Dose Escalation Phase|Withdrawal by Subject|0
2614762|NCT00963820|9040079|P12|Dose Escalation Phase|Adverse Event|0
2614763|NCT00963820|9040080|P11|Dose Escalation Phase|Adverse Event|0
2614764|NCT00963820|9040081|P10|Dose Escalation Phase|Adverse Event|0
2614765|NCT00963820|9040082|P9|Dose Escalation Phase|Adverse Event|0
2614766|NCT00963820|9040083|P8|Dose Escalation Phase|Adverse Event|1
2614767|NCT00963820|9040084|P7|Dose Escalation Phase|Adverse Event|3
2614768|NCT00963820|9040085|P6|Dose Escalation Phase|Adverse Event|0
2614769|NCT00963820|9040086|P5|Dose Escalation Phase|Adverse Event|0
2614770|NCT00963820|9040087|P4|Dose Escalation Phase|Adverse Event|0
2614771|NCT00963820|9040088|P3|Dose Escalation Phase|Adverse Event|0
2614772|NCT00963820|9040089|P2|Dose Escalation Phase|Adverse Event|0
2614773|NCT00963820|9040090|P1|Dose Escalation Phase|Adverse Event|0
2614774|NCT00963820|9040079|P12|Dose Escalation Phase|Progressive Disease|0
2614775|NCT00963820|9040080|P11|Dose Escalation Phase|Progressive Disease|0
2614776|NCT00963820|9040081|P10|Dose Escalation Phase|Progressive Disease|0
2614777|NCT00963820|9040082|P9|Dose Escalation Phase|Progressive Disease|0
2614778|NCT00963820|9040083|P8|Dose Escalation Phase|Progressive Disease|2
2614779|NCT00963820|9040084|P7|Dose Escalation Phase|Progressive Disease|3
2614780|NCT00963820|9040085|P6|Dose Escalation Phase|Progressive Disease|3
2614781|NCT00963820|9040086|P5|Dose Escalation Phase|Progressive Disease|4
2614782|NCT00963820|9040087|P4|Dose Escalation Phase|Progressive Disease|3
2614783|NCT00963820|9040088|P3|Dose Escalation Phase|Progressive Disease|3
2614784|NCT00963820|9040089|P2|Dose Escalation Phase|Progressive Disease|3
2614785|NCT00963820|9040090|P1|Dose Escalation Phase|Progressive Disease|3
2614786|NCT00963807|9040226|P1|Overall Study|Disease progression|15
2614787|NCT00963807|9040226|P1|Overall Study|Reaction to study chemotherapy regimen|1
2614788|NCT00963807|9040226|P1|Overall Study|Physician Decision|2
2614789|NCT00963599|9040259|P4|Overall Study|Withdrawal by Subject|3
2614790|NCT00963599|9040260|P3|Overall Study|Withdrawal by Subject|3
2614791|NCT00963599|9040261|P2|Overall Study|Withdrawal by Subject|1
2614792|NCT00963599|9040262|P1|Overall Study|Withdrawal by Subject|2
2614793|NCT00963599|9040259|P4|Overall Study|Protocol Violation|4
2614794|NCT00963599|9040260|P3|Overall Study|Protocol Violation|3
2614795|NCT00963599|9040261|P2|Overall Study|Protocol Violation|2
2614796|NCT00963599|9040262|P1|Overall Study|Protocol Violation|2
2614797|NCT00963599|9040259|P4|Overall Study|Lost to Follow-up|1
2614798|NCT00963599|9040260|P3|Overall Study|Lost to Follow-up|1
2614799|NCT00963599|9040261|P2|Overall Study|Lost to Follow-up|1
2614800|NCT00963599|9040262|P1|Overall Study|Lost to Follow-up|0
2614801|NCT00963599|9040259|P4|Overall Study|Lack of Efficacy|4
2614802|NCT00963599|9040260|P3|Overall Study|Lack of Efficacy|1
2614803|NCT00963599|9040261|P2|Overall Study|Lack of Efficacy|2
2614804|NCT00963599|9040262|P1|Overall Study|Lack of Efficacy|0
2614805|NCT00963599|9040259|P4|Overall Study|Adverse Event|2
2614806|NCT00963599|9040260|P3|Overall Study|Adverse Event|1
2614807|NCT00963599|9040261|P2|Overall Study|Adverse Event|0
2614808|NCT00963599|9040262|P1|Overall Study|Adverse Event|2
2614809|NCT00963547|9040333|P7|Overall Study|Reason Unknown|0
2614810|NCT00963547|9040334|P6|Overall Study|Reason Unknown|0
2614811|NCT00963547|9040335|P5|Overall Study|Reason Unknown|0
2614812|NCT00963547|9040336|P4|Overall Study|Reason Unknown|0
2614813|NCT00963547|9040337|P3|Overall Study|Reason Unknown|0
2614814|NCT00963547|9040338|P2|Overall Study|Reason Unknown|1
2614815|NCT00963547|9040339|P1|Overall Study|Reason Unknown|0
2614816|NCT00963547|9040333|P7|Overall Study|Withdrawal by Subject|0
2614817|NCT00963547|9040334|P6|Overall Study|Withdrawal by Subject|0
2614818|NCT00963547|9040335|P5|Overall Study|Withdrawal by Subject|0
2614819|NCT00963547|9040336|P4|Overall Study|Withdrawal by Subject|0
2614820|NCT00963547|9040337|P3|Overall Study|Withdrawal by Subject|3
2614821|NCT00963547|9040338|P2|Overall Study|Withdrawal by Subject|0
2614822|NCT00963547|9040339|P1|Overall Study|Withdrawal by Subject|0
2614823|NCT00963547|9040333|P7|Overall Study|Progressive Disease|0
2614824|NCT00963547|9040334|P6|Overall Study|Progressive Disease|0
2614825|NCT00963547|9040335|P5|Overall Study|Progressive Disease|0
2614826|NCT00963547|9040336|P4|Overall Study|Progressive Disease|5
2614827|NCT00963547|9040337|P3|Overall Study|Progressive Disease|9
2614828|NCT00963547|9040338|P2|Overall Study|Progressive Disease|8
2614829|NCT00963547|9040339|P1|Overall Study|Progressive Disease|3
2614830|NCT00963547|9040333|P7|Overall Study|Physician Decision|0
2614831|NCT00963547|9040334|P6|Overall Study|Physician Decision|0
2614832|NCT00963547|9040335|P5|Overall Study|Physician Decision|0
2614833|NCT00963547|9040336|P4|Overall Study|Physician Decision|0
2614834|NCT00963547|9040337|P3|Overall Study|Physician Decision|0
2614835|NCT00963547|9040338|P2|Overall Study|Physician Decision|1
2614836|NCT00963547|9040339|P1|Overall Study|Physician Decision|1
2614837|NCT00963547|9040333|P7|Overall Study|Adverse Event|0
2614838|NCT00963547|9040334|P6|Overall Study|Adverse Event|0
2614839|NCT00963547|9040335|P5|Overall Study|Adverse Event|0
2614840|NCT00963547|9040336|P4|Overall Study|Adverse Event|1
2614841|NCT00963547|9040337|P3|Overall Study|Adverse Event|0
2614842|NCT00963547|9040338|P2|Overall Study|Adverse Event|1
2614843|NCT00963547|9040339|P1|Overall Study|Adverse Event|0
2614844|NCT00963469|9040386|P3|Overall Study|Site closed (local pollen Season ended)|3
2614845|NCT00963469|9040387|P2|Overall Study|Site closed (local pollen Season ended)|1
2614846|NCT00963469|9040388|P1|Overall Study|Site closed (local pollen Season ended)|4
2614847|NCT00963469|9040386|P3|Overall Study|Moved|0
2614848|NCT00963469|9040387|P2|Overall Study|Moved|0
2614849|NCT00963469|9040388|P1|Overall Study|Moved|1
2614850|NCT00963469|9040386|P3|Overall Study|Pre-randomization Adverse Event|0
2614851|NCT00963469|9040387|P2|Overall Study|Pre-randomization Adverse Event|2
2614852|NCT00963469|9040388|P1|Overall Study|Pre-randomization Adverse Event|1
2614853|NCT00963469|9040386|P3|Overall Study|Withdrawal by Subject|1
2614854|NCT00963469|9040387|P2|Overall Study|Withdrawal by Subject|1
2614855|NCT00963469|9040388|P1|Overall Study|Withdrawal by Subject|4
2614856|NCT00963469|9040386|P3|Overall Study|Protocol Violation|3
2614857|NCT00963469|9040387|P2|Overall Study|Protocol Violation|5
2614858|NCT00963469|9040388|P1|Overall Study|Protocol Violation|5
2614859|NCT00963469|9040386|P3|Overall Study|Lost to Follow-up|0
2614860|NCT00963469|9040387|P2|Overall Study|Lost to Follow-up|1
2614861|NCT00963469|9040388|P1|Overall Study|Lost to Follow-up|1
2614862|NCT00963469|9040386|P3|Overall Study|Lack of Efficacy|2
2614863|NCT00963469|9040387|P2|Overall Study|Lack of Efficacy|7
2614864|NCT00963469|9040388|P1|Overall Study|Lack of Efficacy|10
2614865|NCT00963469|9040386|P3|Overall Study|Adverse Event|1
2614866|NCT00963469|9040387|P2|Overall Study|Adverse Event|11
2614867|NCT00963469|9040388|P1|Overall Study|Adverse Event|15
2614868|NCT00963235|9040455|P1|Overall Study|Other|1
2614869|NCT00963235|9040455|P1|Overall Study|Physician Decision|2
2614870|NCT00963235|9040455|P1|Overall Study|Adverse Event|5
2614871|NCT00963235|9040455|P1|Overall Study|Protocol Violation|7
2614872|NCT00963235|9040455|P1|Overall Study|Failed to return|9
2614873|NCT00963235|9040455|P1|Overall Study|Lost to Follow-up|14
2614874|NCT00963235|9040455|P1|Overall Study|Withdrawal by Subject|22
2614875|NCT00962780|9040747|P2|Overall Study|Other|1
2614876|NCT00962780|9040748|P1|Overall Study|Other|0
2614877|NCT00962780|9040747|P2|Overall Study|Withdrawal by Subject|8
2614878|NCT00962780|9040748|P1|Overall Study|Withdrawal by Subject|1
2614879|NCT00962780|9040747|P2|Overall Study|Protocol Violation|4
2614880|NCT00962780|9040748|P1|Overall Study|Protocol Violation|9
2614881|NCT00962780|9040747|P2|Overall Study|Death|1
2614882|NCT00962780|9040748|P1|Overall Study|Death|0
2614883|NCT00962741|9040823|P1|Overall Study|drug ineffective+prohibited drug taken|1
2614884|NCT00962741|9040823|P1|Overall Study|Lack of Efficacy|1
2614885|NCT00962741|9040823|P1|Overall Study|Withdrawal by Subject|1
2614886|NCT00962741|9040823|P1|Overall Study|Lost to Follow-up|2
2614887|NCT00962741|9040823|P1|Overall Study|Failed to return|3
2614888|NCT00962650|9040914|P1|Overall Study|Transgastric DP was not completed|2
2614889|NCT00962585|9040933|P4|Overall Study|Withdrew Consent|0
2614890|NCT00962585|9040934|P3|Overall Study|Withdrew Consent|0
2614891|NCT00962585|9040935|P2|Overall Study|Withdrew Consent|0
2614892|NCT00962585|9040936|P1|Overall Study|Withdrew Consent|2
2614893|NCT00962585|9040933|P4|Overall Study|Withdrawal by Subject|0
2614894|NCT00962585|9040934|P3|Overall Study|Withdrawal by Subject|0
2614895|NCT00962585|9040935|P2|Overall Study|Withdrawal by Subject|0
2614896|NCT00962585|9040936|P1|Overall Study|Withdrawal by Subject|1
2614897|NCT00962585|9040933|P4|Overall Study|Protocol Violation|0
2614898|NCT00962585|9040934|P3|Overall Study|Protocol Violation|1
2614899|NCT00962585|9040935|P2|Overall Study|Protocol Violation|0
2614900|NCT00962585|9040936|P1|Overall Study|Protocol Violation|0
2614901|NCT00962585|9040933|P4|Overall Study|Lost to Follow-up|0
2614902|NCT00962585|9040934|P3|Overall Study|Lost to Follow-up|1
2614903|NCT00962585|9040935|P2|Overall Study|Lost to Follow-up|0
2614904|NCT00962585|9040936|P1|Overall Study|Lost to Follow-up|3
2614905|NCT00962585|9040933|P4|Overall Study|Adverse Event|0
2614906|NCT00962585|9040934|P3|Overall Study|Adverse Event|1
2614907|NCT00962585|9040935|P2|Overall Study|Adverse Event|2
2614908|NCT00962585|9040936|P1|Overall Study|Adverse Event|0
2614909|NCT00962390|9040998|P4|Overall Study|Withdrawal by Subject|0
2614910|NCT00962390|9040999|P3|Overall Study|Withdrawal by Subject|1
2614911|NCT00962390|9041000|P2|Overall Study|Withdrawal by Subject|1
2614912|NCT00962390|9041001|P1|Overall Study|Withdrawal by Subject|1
2614913|NCT00962390|9040998|P4|Overall Study|Protocol Violation|0
2614914|NCT00962390|9040999|P3|Overall Study|Protocol Violation|0
2614915|NCT00962390|9041000|P2|Overall Study|Protocol Violation|0
2614916|NCT00962390|9041001|P1|Overall Study|Protocol Violation|1
2614917|NCT00962390|9040998|P4|Overall Study|Lost to Follow-up|0
2614918|NCT00962390|9040999|P3|Overall Study|Lost to Follow-up|0
2614919|NCT00962390|9041000|P2|Overall Study|Lost to Follow-up|2
2614920|NCT00962390|9041001|P1|Overall Study|Lost to Follow-up|2
2614921|NCT00962390|9040998|P4|Overall Study|Adverse Event|1
2614922|NCT00962390|9040999|P3|Overall Study|Adverse Event|3
2614923|NCT00962390|9041000|P2|Overall Study|Adverse Event|0
2614924|NCT00962390|9041001|P1|Overall Study|Adverse Event|0
2614925|NCT00962247|9041063|P1|25% Reduction of Sedentary Activity|Withdrawal by Subject|1
2614926|NCT00962247|9041063|P1|25% Reduction of Sedentary Activity|Protocol Violation|4
2614927|NCT00962208|9041074|P2|Overall Study|Lost to Follow-up|9
2614928|NCT00962208|9041075|P1|Overall Study|Lost to Follow-up|0
2614929|NCT00962208|9041074|P2|Overall Study|Contraindicated to continue study|1
2614930|NCT00962208|9041075|P1|Overall Study|Contraindicated to continue study|5
2614931|NCT00962208|9041074|P2|Overall Study|Could not achieve good vision|0
2614932|NCT00962208|9041075|P1|Overall Study|Could not achieve good vision|9
2614933|NCT00962104|9041083|P2|Overall Study|Other|0
2614934|NCT00962104|9041084|P1|Overall Study|Other|2
2614935|NCT00962104|9041083|P2|Overall Study|Withdrawal by Subject|6
2614936|NCT00962104|9041084|P1|Overall Study|Withdrawal by Subject|10
2614937|NCT00962104|9041083|P2|Overall Study|Sponsor Decision|1
2614938|NCT00962104|9041084|P1|Overall Study|Sponsor Decision|0
2614939|NCT00962104|9041083|P2|Overall Study|Protocol Violation|8
2614940|NCT00962104|9041084|P1|Overall Study|Protocol Violation|6
2614941|NCT00962104|9041083|P2|Overall Study|Physician Decision|0
2614942|NCT00962104|9041084|P1|Overall Study|Physician Decision|1
2614943|NCT00962104|9041083|P2|Overall Study|Lost to Follow-up|4
2614944|NCT00962104|9041084|P1|Overall Study|Lost to Follow-up|10
2614945|NCT00962104|9041083|P2|Overall Study|Lack of Efficacy|1
2614946|NCT00962104|9041084|P1|Overall Study|Lack of Efficacy|0
2614947|NCT00962104|9041083|P2|Overall Study|Entry Criteria Not Met|2
2614948|NCT00962104|9041084|P1|Overall Study|Entry Criteria Not Met|1
2614949|NCT00962104|9041083|P2|Overall Study|Adverse Event|3
2614950|NCT00962104|9041084|P1|Overall Study|Adverse Event|10
2614951|NCT00962091|9041117|P7|Overall Study|Adverse Event|1
2614952|NCT00962091|9041118|P6|Overall Study|Adverse Event|0
2614953|NCT00962091|9041119|P5|Overall Study|Adverse Event|0
2614954|NCT00962091|9041120|P4|Overall Study|Adverse Event|0
2614955|NCT00962091|9041121|P3|Overall Study|Adverse Event|0
2614956|NCT00962091|9041122|P2|Overall Study|Adverse Event|0
2614957|NCT00962091|9041123|P1|Overall Study|Adverse Event|0
2614958|NCT00962091|9041117|P7|Overall Study|Withdrawal by Subject|0
2614959|NCT00962091|9041118|P6|Overall Study|Withdrawal by Subject|1
2614960|NCT00962091|9041119|P5|Overall Study|Withdrawal by Subject|0
2614961|NCT00962091|9041120|P4|Overall Study|Withdrawal by Subject|1
2614962|NCT00962091|9041121|P3|Overall Study|Withdrawal by Subject|1
2614963|NCT00962091|9041122|P2|Overall Study|Withdrawal by Subject|2
2614964|NCT00962091|9041123|P1|Overall Study|Withdrawal by Subject|1
2614965|NCT00962013|9041207|P1|Overall Study|No 5 year evaluation|6
2614966|NCT00962013|9041207|P1|Overall Study|Site Termination|24
2614967|NCT00962013|9041207|P1|Overall Study|Removal of study device|3
2614968|NCT00962013|9041207|P1|Overall Study|Withdrawal by Subject|8
2614969|NCT00962013|9041207|P1|Overall Study|Unable/Unwilling to return|6
2614970|NCT00962013|9041207|P1|Overall Study|Lost to Follow-up|12
2614971|NCT00962013|9041207|P1|Overall Study|Death|8
2614972|NCT00962013|9041207|P1|Overall Study|Did not have surgery|1
2614973|NCT00961896|9041230|P3|Overall Study|Abnormal laboratory value|1
2614974|NCT00961896|9041231|P2|Overall Study|Abnormal laboratory value|0
2614975|NCT00961896|9041232|P1|Overall Study|Abnormal laboratory value|0
2614976|NCT00961649|9041299|P4|Overall Study|Study terminated by sponsor|1
2614977|NCT00961649|9041300|P3|Overall Study|Study terminated by sponsor|4
2614978|NCT00961649|9041301|P2|Overall Study|Study terminated by sponsor|4
2614979|NCT00961649|9041302|P1|Overall Study|Study terminated by sponsor|4
2614980|NCT00961649|9041299|P4|Overall Study|Patient left to Mexico-family emergency|0
2614981|NCT00961649|9041300|P3|Overall Study|Patient left to Mexico-family emergency|0
2614982|NCT00961649|9041301|P2|Overall Study|Patient left to Mexico-family emergency|0
2614983|NCT00961649|9041302|P1|Overall Study|Patient left to Mexico-family emergency|1
2614984|NCT00961649|9041299|P4|Overall Study|Patient has travel plans during holidays|0
2614985|NCT00961649|9041300|P3|Overall Study|Patient has travel plans during holidays|1
2614986|NCT00961649|9041301|P2|Overall Study|Patient has travel plans during holidays|0
2614987|NCT00961649|9041302|P1|Overall Study|Patient has travel plans during holidays|0
2614988|NCT00961649|9041299|P4|Overall Study|Inadequate control of IOP|1
2614989|NCT00961649|9041300|P3|Overall Study|Inadequate control of IOP|0
2614990|NCT00961649|9041301|P2|Overall Study|Inadequate control of IOP|0
2614991|NCT00961649|9041302|P1|Overall Study|Inadequate control of IOP|0
2614992|NCT00961649|9041299|P4|Overall Study|Adverse Event|2
2614993|NCT00961649|9041300|P3|Overall Study|Adverse Event|0
2614994|NCT00961649|9041301|P2|Overall Study|Adverse Event|0
2614995|NCT00961649|9041302|P1|Overall Study|Adverse Event|4
2614996|NCT00961636|9041316|P3|Overall Study|Withdrawal by Subject|13
2614997|NCT00961636|9041317|P2|Overall Study|Withdrawal by Subject|22
2614998|NCT00961636|9041318|P1|Overall Study|Withdrawal by Subject|29
2614999|NCT00961636|9041316|P3|Overall Study|Protocol Violation|1
2615000|NCT00961636|9041317|P2|Overall Study|Protocol Violation|5
2615001|NCT00961636|9041318|P1|Overall Study|Protocol Violation|9
2615002|NCT00961636|9041316|P3|Overall Study|Physician Decision|1
2615003|NCT00961636|9041317|P2|Overall Study|Physician Decision|1
2615004|NCT00961636|9041318|P1|Overall Study|Physician Decision|3
2615005|NCT00961636|9041316|P3|Overall Study|Lost to Follow-up|1
2615006|NCT00961636|9041317|P2|Overall Study|Lost to Follow-up|3
2615007|NCT00961636|9041318|P1|Overall Study|Lost to Follow-up|2
2615008|NCT00961636|9041316|P3|Overall Study|Flushing Symptoms|3
2615009|NCT00961636|9041317|P2|Overall Study|Flushing Symptoms|46
2615010|NCT00961636|9041318|P1|Overall Study|Flushing Symptoms|29
2615011|NCT00961636|9041316|P3|Overall Study|Adverse Event|13
2615012|NCT00961636|9041317|P2|Overall Study|Adverse Event|54
2615013|NCT00961636|9041318|P1|Overall Study|Adverse Event|35
2615014|NCT00961571|9041329|P1|Overall Study|Physician Decision|39
2615015|NCT00961415|9041357|P3|Maintenance Treatment Phase|Other reason|3
2615016|NCT00961415|9041358|P2|Maintenance Treatment Phase|Other reason|1
2615017|NCT00961415|9041359|P1|Maintenance Treatment Phase|Other reason|0
2615018|NCT00961415|9041357|P3|Maintenance Treatment Phase|Withdrawal by Subject|8
2615019|NCT00961415|9041358|P2|Maintenance Treatment Phase|Withdrawal by Subject|3
2615020|NCT00961415|9041359|P1|Maintenance Treatment Phase|Withdrawal by Subject|0
2615021|NCT00961415|9041357|P3|Maintenance Treatment Phase|Investigators decision|0
2615022|NCT00961415|9041358|P2|Maintenance Treatment Phase|Investigators decision|2
2615023|NCT00961415|9041359|P1|Maintenance Treatment Phase|Investigators decision|0
2615024|NCT00961415|9041357|P3|Maintenance Treatment Phase|Death|34
2615025|NCT00961415|9041358|P2|Maintenance Treatment Phase|Death|42
2615026|NCT00961415|9041359|P1|Maintenance Treatment Phase|Death|0
2615027|NCT00961415|9041357|P3|Induction Treatment Phase|Other Reason|0
2615028|NCT00961415|9041358|P2|Induction Treatment Phase|Other Reason|0
2615029|NCT00961415|9041359|P1|Induction Treatment Phase|Other Reason|5
2615030|NCT00961415|9041357|P3|Induction Treatment Phase|Didn’t meet maintenance phase criteria|0
2615031|NCT00961415|9041358|P2|Induction Treatment Phase|Didn’t meet maintenance phase criteria|0
2615032|NCT00961415|9041359|P1|Induction Treatment Phase|Didn’t meet maintenance phase criteria|27
2615033|NCT00961415|9041357|P3|Induction Treatment Phase|Physician Decision|0
2615034|NCT00961415|9041358|P2|Induction Treatment Phase|Physician Decision|0
2615035|NCT00961415|9041359|P1|Induction Treatment Phase|Physician Decision|2
2615036|NCT00961415|9041357|P3|Induction Treatment Phase|Protocol Violation|0
2615037|NCT00961415|9041358|P2|Induction Treatment Phase|Protocol Violation|0
2615038|NCT00961415|9041359|P1|Induction Treatment Phase|Protocol Violation|1
2615039|NCT00961415|9041357|P3|Induction Treatment Phase|Death|0
2615040|NCT00961415|9041358|P2|Induction Treatment Phase|Death|0
2615041|NCT00961415|9041359|P1|Induction Treatment Phase|Death|77
2615042|NCT00961415|9041357|P3|Induction Treatment Phase|Withdrawal by Subject|0
2615043|NCT00961415|9041358|P2|Induction Treatment Phase|Withdrawal by Subject|0
2615044|NCT00961415|9041359|P1|Induction Treatment Phase|Withdrawal by Subject|11
2615045|NCT00961350|9041399|P2|Overall Study|Misc|21
2615046|NCT00961350|9041400|P1|Overall Study|Misc|16
2615047|NCT00961350|9041399|P2|Overall Study|Lost to Follow-up|3
2615048|NCT00961350|9041400|P1|Overall Study|Lost to Follow-up|3
2615049|NCT00961350|9041399|P2|Overall Study|Withdrawal by Subject|10
2615050|NCT00961350|9041400|P1|Overall Study|Withdrawal by Subject|10
2615051|NCT00961350|9041399|P2|Overall Study|Adverse Event|33
2615052|NCT00961350|9041400|P1|Overall Study|Adverse Event|18
2615053|NCT00961298|9041421|P1|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1
2615054|NCT00961298|9041421|P1|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2
2615055|NCT00961298|9041421|P1|Two Week Placebo Run in|Withdrawal by Subject|1
2615056|NCT00961259|9041428|P3|Washout Period of 7 Days|due to concomitant medication used|0
2615057|NCT00961259|9041429|P2|Washout Period of 7 Days|due to concomitant medication used|1
2615058|NCT00961259|9041430|P1|Washout Period of 7 Days|due to concomitant medication used|0
2615059|NCT00961220|9041458|P1|Overall Study|Complete Response prior to 12 courses|1
2615060|NCT00961220|9041458|P1|Overall Study|O6BG no longer supplied|1
2615061|NCT00961220|9041458|P1|Overall Study|No IV access for O6BG|1
2615062|NCT00961220|9041458|P1|Overall Study|Lack of Efficacy|1
2615063|NCT00961220|9041458|P1|Overall Study|Adverse Event|3
2615064|NCT00961181|9041474|P1|Overall Study|Lost to Follow-up|1
2615065|NCT00961181|9041474|P1|Overall Study|Withdrawal by Subject|2
2615066|NCT00961181|9041474|P1|Overall Study|Death|2
2615067|NCT00961116|9041487|P2|Washout Period of 7 Days|Protocol Violation|1
2615068|NCT00961116|9041488|P1|Washout Period of 7 Days|Protocol Violation|0
2615069|NCT00961116|9041487|P2|Washout Period of 7 Days|Withdrawal by Subject|1
2615070|NCT00961116|9041488|P1|Washout Period of 7 Days|Withdrawal by Subject|1
2615071|NCT00961116|9041487|P2|Washout Period of 7 Days|Adverse Event|1
2615072|NCT00961116|9041488|P1|Washout Period of 7 Days|Adverse Event|1
2615073|NCT00960999|9041515|P2|Overall Study|RT dose constraints not met|0
2615074|NCT00960999|9041516|P1|Overall Study|RT dose constraints not met|2
2615075|NCT00960999|9041515|P2|Overall Study|Protocol Violation|2
2615076|NCT00960999|9041516|P1|Overall Study|Protocol Violation|5
2615077|NCT00960999|9041515|P2|Overall Study|Withdrawal by Subject|0
2615078|NCT00960999|9041516|P1|Overall Study|Withdrawal by Subject|1
2615079|NCT00960986|9041548|P4|Period 3 (7-week Therapy Period)|Lack of Efficacy|0
2615080|NCT00960986|9041549|P3|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
2615081|NCT00960986|9041550|P2|Period 3 (7-week Therapy Period)|Lack of Efficacy|2
2615082|NCT00960986|9041551|P1|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
2615083|NCT00960986|9041548|P4|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
2615084|NCT00960986|9041549|P3|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4
2615085|NCT00960986|9041550|P2|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
2615086|NCT00960986|9041551|P1|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
2615087|NCT00960986|9041548|P4|Period 3 (7-week Therapy Period)|Protocol Violation|11
2615088|NCT00960986|9041549|P3|Period 3 (7-week Therapy Period)|Protocol Violation|3
2615089|NCT00960986|9041550|P2|Period 3 (7-week Therapy Period)|Protocol Violation|4
2615090|NCT00960986|9041551|P1|Period 3 (7-week Therapy Period)|Protocol Violation|10
2615091|NCT00960986|9041548|P4|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
2615092|NCT00960986|9041549|P3|Period 3 (7-week Therapy Period)|Lost to Follow-up|1
2615093|NCT00960986|9041550|P2|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
2615094|NCT00960986|9041551|P1|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
2615095|NCT00960986|9041548|P4|Period 3 (7-week Therapy Period)|Death|0
2615096|NCT00960986|9041549|P3|Period 3 (7-week Therapy Period)|Death|1
2615097|NCT00960986|9041550|P2|Period 3 (7-week Therapy Period)|Death|0
2615098|NCT00960986|9041551|P1|Period 3 (7-week Therapy Period)|Death|0
2615099|NCT00960986|9041548|P4|Period 3 (7-week Therapy Period)|Adverse Event|12
2615100|NCT00960986|9041549|P3|Period 3 (7-week Therapy Period)|Adverse Event|10
2615101|NCT00960986|9041550|P2|Period 3 (7-week Therapy Period)|Adverse Event|15
2615102|NCT00960986|9041551|P1|Period 3 (7-week Therapy Period)|Adverse Event|17
2615103|NCT00960986|9041548|P4|Period 1 (Screening and Washout)|Withdrawal by Subject|1
2615104|NCT00960986|9041549|P3|Period 1 (Screening and Washout)|Withdrawal by Subject|1
2615105|NCT00960986|9041550|P2|Period 1 (Screening and Washout)|Withdrawal by Subject|2
2615106|NCT00960986|9041551|P1|Period 1 (Screening and Washout)|Withdrawal by Subject|1
2615107|NCT00960986|9041548|P4|Period 1 (Screening and Washout)|Protocol Violation|0
2615108|NCT00960986|9041549|P3|Period 1 (Screening and Washout)|Protocol Violation|0
2615109|NCT00960986|9041550|P2|Period 1 (Screening and Washout)|Protocol Violation|0
2615110|NCT00960986|9041551|P1|Period 1 (Screening and Washout)|Protocol Violation|1
2615111|NCT00960986|9041548|P4|Period 1 (Screening and Washout)|Lost to Follow-up|1
2615112|NCT00960986|9041549|P3|Period 1 (Screening and Washout)|Lost to Follow-up|2
2615113|NCT00960986|9041550|P2|Period 1 (Screening and Washout)|Lost to Follow-up|0
2615114|NCT00960986|9041551|P1|Period 1 (Screening and Washout)|Lost to Follow-up|0
2615115|NCT00960986|9041548|P4|Period 1 (Screening and Washout)|Adverse Event|1
2615116|NCT00960986|9041549|P3|Period 1 (Screening and Washout)|Adverse Event|1
2615117|NCT00960986|9041550|P2|Period 1 (Screening and Washout)|Adverse Event|2
2615118|NCT00960986|9041551|P1|Period 1 (Screening and Washout)|Adverse Event|1
2615119|NCT00960934|9041627|P6|Overall Study|Study Terminated by Sponsor|49
2615120|NCT00960934|9041628|P5|Overall Study|Study Terminated by Sponsor|49
2615121|NCT00960934|9041629|P4|Overall Study|Study Terminated by Sponsor|50
2615122|NCT00960934|9041630|P3|Overall Study|Study Terminated by Sponsor|52
2615123|NCT00960934|9041631|P2|Overall Study|Study Terminated by Sponsor|46
2615124|NCT00960934|9041632|P1|Overall Study|Study Terminated by Sponsor|50
2615125|NCT00960934|9041627|P6|Overall Study|Withdrawal by Subject|7
2615126|NCT00960934|9041628|P5|Overall Study|Withdrawal by Subject|5
2615127|NCT00960934|9041629|P4|Overall Study|Withdrawal by Subject|5
2615128|NCT00960934|9041630|P3|Overall Study|Withdrawal by Subject|4
2615129|NCT00960934|9041631|P2|Overall Study|Withdrawal by Subject|6
2615130|NCT00960934|9041632|P1|Overall Study|Withdrawal by Subject|5
2615131|NCT00960934|9041627|P6|Overall Study|Protocol Violation|2
2615132|NCT00960934|9041628|P5|Overall Study|Protocol Violation|3
2615133|NCT00960934|9041629|P4|Overall Study|Protocol Violation|3
2615134|NCT00960934|9041630|P3|Overall Study|Protocol Violation|0
2615135|NCT00960934|9041631|P2|Overall Study|Protocol Violation|4
2615136|NCT00960934|9041632|P1|Overall Study|Protocol Violation|3
2615137|NCT00960934|9041627|P6|Overall Study|Progressive Disease|1
2615138|NCT00960934|9041628|P5|Overall Study|Progressive Disease|1
2615139|NCT00960934|9041629|P4|Overall Study|Progressive Disease|0
2615140|NCT00960934|9041630|P3|Overall Study|Progressive Disease|0
2615141|NCT00960934|9041631|P2|Overall Study|Progressive Disease|1
2615142|NCT00960934|9041632|P1|Overall Study|Progressive Disease|1
2615143|NCT00960934|9041627|P6|Overall Study|Physician Decision|0
2615144|NCT00960934|9041628|P5|Overall Study|Physician Decision|0
2615145|NCT00960934|9041629|P4|Overall Study|Physician Decision|0
2615146|NCT00960934|9041630|P3|Overall Study|Physician Decision|0
2615147|NCT00960934|9041631|P2|Overall Study|Physician Decision|1
2615148|NCT00960934|9041632|P1|Overall Study|Physician Decision|0
2615149|NCT00960934|9041627|P6|Overall Study|Other|2
2615150|NCT00960934|9041628|P5|Overall Study|Other|2
2615151|NCT00960934|9041629|P4|Overall Study|Other|4
2615152|NCT00960934|9041630|P3|Overall Study|Other|5
2615153|NCT00960934|9041631|P2|Overall Study|Other|1
2615154|NCT00960934|9041632|P1|Overall Study|Other|2
2615155|NCT00960934|9041627|P6|Overall Study|Lost to Follow-up|0
2615156|NCT00960934|9041628|P5|Overall Study|Lost to Follow-up|0
2615157|NCT00960934|9041629|P4|Overall Study|Lost to Follow-up|0
2615158|NCT00960934|9041630|P3|Overall Study|Lost to Follow-up|0
2615159|NCT00960934|9041631|P2|Overall Study|Lost to Follow-up|1
2615160|NCT00960934|9041632|P1|Overall Study|Lost to Follow-up|0
2615161|NCT00960934|9041627|P6|Overall Study|Lack of Efficacy|0
2615162|NCT00960934|9041628|P5|Overall Study|Lack of Efficacy|0
2615163|NCT00960934|9041629|P4|Overall Study|Lack of Efficacy|0
2615164|NCT00960934|9041630|P3|Overall Study|Lack of Efficacy|0
2615165|NCT00960934|9041631|P2|Overall Study|Lack of Efficacy|0
2615166|NCT00960934|9041632|P1|Overall Study|Lack of Efficacy|1
2615167|NCT00960934|9041627|P6|Overall Study|Adverse Event|3
2615168|NCT00960934|9041628|P5|Overall Study|Adverse Event|4
2615169|NCT00960934|9041629|P4|Overall Study|Adverse Event|2
2615170|NCT00960934|9041630|P3|Overall Study|Adverse Event|3
2615171|NCT00960934|9041631|P2|Overall Study|Adverse Event|3
2615172|NCT00960934|9041632|P1|Overall Study|Adverse Event|2
2615173|NCT00960869|9041744|P2|Overall Study|Misc|18
2615174|NCT00960869|9041745|P1|Overall Study|Misc|19
2615175|NCT00960869|9041744|P2|Overall Study|Lost to Follow-up|4
2615176|NCT00960869|9041745|P1|Overall Study|Lost to Follow-up|1
2615177|NCT00960869|9041744|P2|Overall Study|Withdrawal by Subject|14
2615178|NCT00960869|9041745|P1|Overall Study|Withdrawal by Subject|16
2615179|NCT00960869|9041744|P2|Overall Study|Adverse Event|26
2615180|NCT00960869|9041745|P1|Overall Study|Adverse Event|17
2615181|NCT00960856|9041759|P4|Washout Period of 7 Days|Adverse Event|0
2615182|NCT00960856|9041760|P3|Washout Period of 7 Days|Adverse Event|1
2615183|NCT00960856|9041761|P2|Washout Period of 7 Days|Adverse Event|0
2615184|NCT00960856|9041762|P1|Washout Period of 7 Days|Adverse Event|0
2615185|NCT00960856|9041759|P4|Washout Period of 7 Days|Withdrawal by Subject|0
2615186|NCT00960856|9041760|P3|Washout Period of 7 Days|Withdrawal by Subject|0
2615187|NCT00960856|9041761|P2|Washout Period of 7 Days|Withdrawal by Subject|2
2615188|NCT00960856|9041762|P1|Washout Period of 7 Days|Withdrawal by Subject|0
2615189|NCT00960843|9041782|P2|Overall Study|Repeated needle dislodgment|1
2615190|NCT00960843|9041783|P1|Overall Study|Repeated needle dislodgment|0
2615191|NCT00960843|9041782|P2|Overall Study|Protocol Violation|4
2615192|NCT00960843|9041783|P1|Overall Study|Protocol Violation|0
2615193|NCT00960843|9041782|P2|Overall Study|Lost to Follow-up|0
2615194|NCT00960843|9041783|P1|Overall Study|Lost to Follow-up|2
2615195|NCT00960687|9041804|P2|Washout Period of 7 Days|Withdrawal by Subject|1
2615196|NCT00960687|9041805|P1|Washout Period of 7 Days|Withdrawal by Subject|1
2615197|NCT00960687|9041804|P2|Washout Period of 7 Days|Adverse Event|2
2615198|NCT00960687|9041805|P1|Washout Period of 7 Days|Adverse Event|3
2615199|NCT00960661|9041817|P3|Interventional Phase|Lack of Efficacy|0
2615200|NCT00960661|9041818|P2|Interventional Phase|Lack of Efficacy|2
2615201|NCT00960661|9041819|P1|Interventional Phase|Lack of Efficacy|0
2615202|NCT00960661|9041817|P3|Interventional Phase|sponsor decision|0
2615203|NCT00960661|9041818|P2|Interventional Phase|sponsor decision|1
2615204|NCT00960661|9041819|P1|Interventional Phase|sponsor decision|0
2615205|NCT00960661|9041817|P3|Interventional Phase|Physician Decision|5
2615206|NCT00960661|9041818|P2|Interventional Phase|Physician Decision|3
2615207|NCT00960661|9041819|P1|Interventional Phase|Physician Decision|0
2615208|NCT00960661|9041817|P3|Interventional Phase|Withdrawal by Subject|29
2615209|NCT00960661|9041818|P2|Interventional Phase|Withdrawal by Subject|18
2615210|NCT00960661|9041819|P1|Interventional Phase|Withdrawal by Subject|0
2615211|NCT00960661|9041817|P3|Interventional Phase|Protocol Violation|2
2615212|NCT00960661|9041818|P2|Interventional Phase|Protocol Violation|7
2615213|NCT00960661|9041819|P1|Interventional Phase|Protocol Violation|0
2615214|NCT00960661|9041817|P3|Interventional Phase|entry criteria not met|0
2615215|NCT00960661|9041818|P2|Interventional Phase|entry criteria not met|3
2615216|NCT00960661|9041819|P1|Interventional Phase|entry criteria not met|0
2615217|NCT00960661|9041817|P3|Interventional Phase|Lost to Follow-up|2
2615218|NCT00960661|9041818|P2|Interventional Phase|Lost to Follow-up|0
2615219|NCT00960661|9041819|P1|Interventional Phase|Lost to Follow-up|0
2615220|NCT00960661|9041817|P3|Interventional Phase|Death|0
2615221|NCT00960661|9041818|P2|Interventional Phase|Death|1
2615222|NCT00960661|9041819|P1|Interventional Phase|Death|0
2615223|NCT00960661|9041817|P3|Interventional Phase|Adverse Event|8
2615224|NCT00960661|9041818|P2|Interventional Phase|Adverse Event|17
2615225|NCT00960661|9041819|P1|Interventional Phase|Adverse Event|0
2615226|NCT00960661|9041817|P3|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
2615227|NCT00960661|9041818|P2|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
2615228|NCT00960661|9041819|P1|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3
2615229|NCT00960661|9041817|P3|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
2615230|NCT00960661|9041818|P2|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
2615231|NCT00960661|9041819|P1|Basal Insulin Optimization Phase (BIO)|Physician Decision|8
2615232|NCT00960661|9041817|P3|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
2615233|NCT00960661|9041818|P2|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
2615234|NCT00960661|9041819|P1|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47
2615235|NCT00960661|9041817|P3|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
2615236|NCT00960661|9041818|P2|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
2615237|NCT00960661|9041819|P1|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331
2615238|NCT00960661|9041817|P3|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
2615239|NCT00960661|9041818|P2|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
2615240|NCT00960661|9041819|P1|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4
2615241|NCT00960661|9041817|P3|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
2615242|NCT00960661|9041818|P2|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
2615243|NCT00960661|9041819|P1|Basal Insulin Optimization Phase (BIO)|Adverse Event|6
2615244|NCT00960570|9041858|P1|1 Day Period Between Dosing|Withdrawal by Subject|1
2615245|NCT00960570|9041858|P1|1 Day Period Between Dosing|Adverse Event|2
2615246|NCT00960570|9041858|P1|21 Day Washout Period|Withdrawal by Subject|1
2615247|NCT00960570|9041858|P1|21 Day Washout Period|Adverse Event|1
2615248|NCT00960531|9041879|P10|Overall Study|Reason not Specified|1
2615249|NCT00960531|9041880|P9|Overall Study|Reason not Specified|8
2615250|NCT00960531|9041881|P8|Overall Study|Reason not Specified|0
2615251|NCT00960531|9041882|P7|Overall Study|Reason not Specified|16
2615252|NCT00960531|9041883|P6|Overall Study|Reason not Specified|0
2615253|NCT00960531|9041884|P5|Overall Study|Reason not Specified|2
2615254|NCT00960531|9041885|P4|Overall Study|Reason not Specified|1
2615255|NCT00960531|9041886|P3|Overall Study|Reason not Specified|13
2615256|NCT00960531|9041887|P2|Overall Study|Reason not Specified|1
2615257|NCT00960531|9041888|P1|Overall Study|Reason not Specified|2
2615258|NCT00960531|9041879|P10|Overall Study|Adverse Event (AE)|0
2615259|NCT00960531|9041880|P9|Overall Study|Adverse Event (AE)|2
2615260|NCT00960531|9041881|P8|Overall Study|Adverse Event (AE)|0
2615261|NCT00960531|9041882|P7|Overall Study|Adverse Event (AE)|2
2615262|NCT00960531|9041883|P6|Overall Study|Adverse Event (AE)|1
2615263|NCT00960531|9041884|P5|Overall Study|Adverse Event (AE)|0
2615264|NCT00960531|9041885|P4|Overall Study|Adverse Event (AE)|0
2615265|NCT00960531|9041886|P3|Overall Study|Adverse Event (AE)|0
2615266|NCT00960531|9041887|P2|Overall Study|Adverse Event (AE)|0
2615267|NCT00960531|9041888|P1|Overall Study|Adverse Event (AE)|2
2615268|NCT00960531|9041879|P10|Overall Study|Failed to Return|0
2615269|NCT00960531|9041880|P9|Overall Study|Failed to Return|0
2615270|NCT00960531|9041881|P8|Overall Study|Failed to Return|2
2615271|NCT00960531|9041882|P7|Overall Study|Failed to Return|0
2615272|NCT00960531|9041883|P6|Overall Study|Failed to Return|0
2615273|NCT00960531|9041884|P5|Overall Study|Failed to Return|0
2615274|NCT00960531|9041885|P4|Overall Study|Failed to Return|0
2615275|NCT00960531|9041886|P3|Overall Study|Failed to Return|0
2615276|NCT00960531|9041887|P2|Overall Study|Failed to Return|0
2615277|NCT00960531|9041888|P1|Overall Study|Failed to Return|2
2615278|NCT00960531|9041879|P10|Overall Study|Lost to Follow-up|0
2615279|NCT00960531|9041880|P9|Overall Study|Lost to Follow-up|0
2615280|NCT00960531|9041881|P8|Overall Study|Lost to Follow-up|0
2615281|NCT00960531|9041882|P7|Overall Study|Lost to Follow-up|1
2615282|NCT00960531|9041883|P6|Overall Study|Lost to Follow-up|0
2615283|NCT00960531|9041884|P5|Overall Study|Lost to Follow-up|0
2615284|NCT00960531|9041885|P4|Overall Study|Lost to Follow-up|0
2615285|NCT00960531|9041886|P3|Overall Study|Lost to Follow-up|1
2615286|NCT00960531|9041887|P2|Overall Study|Lost to Follow-up|0
2615287|NCT00960531|9041888|P1|Overall Study|Lost to Follow-up|0
2615288|NCT00960531|9041879|P10|Overall Study|Discontinuation of Study by Sponsor|0
2615289|NCT00960531|9041880|P9|Overall Study|Discontinuation of Study by Sponsor|0
2615290|NCT00960531|9041881|P8|Overall Study|Discontinuation of Study by Sponsor|1
2615291|NCT00960531|9041882|P7|Overall Study|Discontinuation of Study by Sponsor|0
2615292|NCT00960531|9041883|P6|Overall Study|Discontinuation of Study by Sponsor|0
2615293|NCT00960531|9041884|P5|Overall Study|Discontinuation of Study by Sponsor|0
2615294|NCT00960531|9041885|P4|Overall Study|Discontinuation of Study by Sponsor|0
2615295|NCT00960531|9041886|P3|Overall Study|Discontinuation of Study by Sponsor|0
2615296|NCT00960531|9041887|P2|Overall Study|Discontinuation of Study by Sponsor|0
2615297|NCT00960531|9041888|P1|Overall Study|Discontinuation of Study by Sponsor|0
2615298|NCT00960531|9041879|P10|Overall Study|Investigator Request|0
2615299|NCT00960531|9041880|P9|Overall Study|Investigator Request|0
2615300|NCT00960531|9041881|P8|Overall Study|Investigator Request|0
2615301|NCT00960531|9041882|P7|Overall Study|Investigator Request|0
2615302|NCT00960531|9041883|P6|Overall Study|Investigator Request|0
2615303|NCT00960531|9041884|P5|Overall Study|Investigator Request|0
2615304|NCT00960531|9041885|P4|Overall Study|Investigator Request|0
2615305|NCT00960531|9041886|P3|Overall Study|Investigator Request|1
2615306|NCT00960531|9041887|P2|Overall Study|Investigator Request|0
2615307|NCT00960531|9041888|P1|Overall Study|Investigator Request|0
2615308|NCT00960531|9041879|P10|Overall Study|Caregiver Request|0
2615309|NCT00960531|9041880|P9|Overall Study|Caregiver Request|3
2615310|NCT00960531|9041881|P8|Overall Study|Caregiver Request|1
2615311|NCT00960531|9041882|P7|Overall Study|Caregiver Request|3
2615312|NCT00960531|9041883|P6|Overall Study|Caregiver Request|2
2615313|NCT00960531|9041884|P5|Overall Study|Caregiver Request|0
2615314|NCT00960531|9041885|P4|Overall Study|Caregiver Request|5
2615315|NCT00960531|9041886|P3|Overall Study|Caregiver Request|6
2615316|NCT00960531|9041887|P2|Overall Study|Caregiver Request|0
2615317|NCT00960531|9041888|P1|Overall Study|Caregiver Request|2
2615318|NCT00960531|9041879|P10|Overall Study|Withdrawal by Subject|0
2615319|NCT00960531|9041880|P9|Overall Study|Withdrawal by Subject|1
2615320|NCT00960531|9041881|P8|Overall Study|Withdrawal by Subject|0
2615321|NCT00960531|9041882|P7|Overall Study|Withdrawal by Subject|2
2615322|NCT00960531|9041883|P6|Overall Study|Withdrawal by Subject|0
2615323|NCT00960531|9041884|P5|Overall Study|Withdrawal by Subject|0
2615324|NCT00960531|9041885|P4|Overall Study|Withdrawal by Subject|2
2615325|NCT00960531|9041886|P3|Overall Study|Withdrawal by Subject|5
2615326|NCT00960531|9041887|P2|Overall Study|Withdrawal by Subject|0
2615327|NCT00960531|9041888|P1|Overall Study|Withdrawal by Subject|1
2615328|NCT00960531|9041879|P10|Overall Study|Lack of Efficacy|0
2615329|NCT00960531|9041880|P9|Overall Study|Lack of Efficacy|0
2615330|NCT00960531|9041881|P8|Overall Study|Lack of Efficacy|0
2615331|NCT00960531|9041882|P7|Overall Study|Lack of Efficacy|0
2615332|NCT00960531|9041883|P6|Overall Study|Lack of Efficacy|0
2615333|NCT00960531|9041884|P5|Overall Study|Lack of Efficacy|0
2615334|NCT00960531|9041885|P4|Overall Study|Lack of Efficacy|0
2615335|NCT00960531|9041886|P3|Overall Study|Lack of Efficacy|0
2615336|NCT00960531|9041887|P2|Overall Study|Lack of Efficacy|0
2615337|NCT00960531|9041888|P1|Overall Study|Lack of Efficacy|1
2615338|NCT00960440|9041936|P4|Overall Study|Other|0
2615339|NCT00960440|9041937|P3|Overall Study|Other|1
2615340|NCT00960440|9041938|P2|Overall Study|Other|1
2615341|NCT00960440|9041939|P1|Overall Study|Other|1
2615342|NCT00960440|9041936|P4|Overall Study|Withdrawal by Subject|1
2615343|NCT00960440|9041937|P3|Overall Study|Withdrawal by Subject|2
2615344|NCT00960440|9041938|P2|Overall Study|Withdrawal by Subject|5
2615345|NCT00960440|9041939|P1|Overall Study|Withdrawal by Subject|9
2615346|NCT00960440|9041936|P4|Overall Study|Protocol Violation|4
2615347|NCT00960440|9041937|P3|Overall Study|Protocol Violation|3
2615348|NCT00960440|9041938|P2|Overall Study|Protocol Violation|8
2615349|NCT00960440|9041939|P1|Overall Study|Protocol Violation|2
2615350|NCT00960440|9041936|P4|Overall Study|Lack of Efficacy|8
2615351|NCT00960440|9041937|P3|Overall Study|Lack of Efficacy|3
2615352|NCT00960440|9041938|P2|Overall Study|Lack of Efficacy|5
2615353|NCT00960440|9041939|P1|Overall Study|Lack of Efficacy|2
2615354|NCT00960440|9041936|P4|Overall Study|Adverse Event|4
2615355|NCT00960440|9041937|P3|Overall Study|Adverse Event|4
2615356|NCT00960440|9041938|P2|Overall Study|Adverse Event|12
2615357|NCT00960440|9041939|P1|Overall Study|Adverse Event|12
2615358|NCT00960440|9041936|P4|Overall Study|Death|1
2615359|NCT00960440|9041937|P3|Overall Study|Death|0
2615360|NCT00960440|9041938|P2|Overall Study|Death|0
2615361|NCT00960440|9041939|P1|Overall Study|Death|0
2615362|NCT00960375|9042111|P2|Overall Study|Lost to Follow-up|22
2615363|NCT00960375|9042112|P1|Overall Study|Lost to Follow-up|20
2615364|NCT00960323|9042120|P1|Atorvastatin Alone|Withdrawal by Subject|1
2615365|NCT00960297|9042131|P1|Overall Study|Disease progression|1
2615366|NCT00960297|9042131|P1|Overall Study|Venous port infection|1
2615367|NCT00960297|9042131|P1|Overall Study|Physician Decision|1
2615368|NCT00960206|9042138|P3|Overall Study|Missing 10 year data|1
2615369|NCT00960206|9042139|P2|Overall Study|Missing 10 year data|1
2615370|NCT00960206|9042140|P1|Overall Study|Missing 10 year data|20
2615371|NCT00960206|9042138|P3|Overall Study|Revision of study component|2
2615372|NCT00960206|9042139|P2|Overall Study|Revision of study component|2
2615373|NCT00960206|9042140|P1|Overall Study|Revision of study component|2
2615374|NCT00960206|9042138|P3|Overall Study|Withdrawal by Subject|0
2615375|NCT00960206|9042139|P2|Overall Study|Withdrawal by Subject|4
2615376|NCT00960206|9042140|P1|Overall Study|Withdrawal by Subject|2
2615377|NCT00960206|9042138|P3|Overall Study|Lost to Follow-up|8
2615378|NCT00960206|9042139|P2|Overall Study|Lost to Follow-up|14
2615379|NCT00960206|9042140|P1|Overall Study|Lost to Follow-up|8
2615380|NCT00960206|9042138|P3|Overall Study|Unwilling/Unable to return|0
2615381|NCT00960206|9042139|P2|Overall Study|Unwilling/Unable to return|2
2615382|NCT00960206|9042140|P1|Overall Study|Unwilling/Unable to return|1
2615383|NCT00960206|9042138|P3|Overall Study|Death|1
2615384|NCT00960206|9042139|P2|Overall Study|Death|4
2615385|NCT00960206|9042140|P1|Overall Study|Death|7
2615386|NCT00960193|9042158|P1|14 Day Washout Period|Withdrawal by Subject|1
2615387|NCT00960154|9042171|P2|Overall Study|Study termination|25
2615388|NCT00960154|9042172|P1|Overall Study|Study termination|25
2615389|NCT00960141|9042183|P3|Overall Study|Withdrawal by Subject|1
2615390|NCT00960141|9042184|P2|Overall Study|Withdrawal by Subject|2
2615391|NCT00960141|9042185|P1|Overall Study|Withdrawal by Subject|1
2615392|NCT00960141|9042183|P3|Overall Study|Protocol Violation|2
2615393|NCT00960141|9042184|P2|Overall Study|Protocol Violation|3
2615394|NCT00960141|9042185|P1|Overall Study|Protocol Violation|1
2615395|NCT00960141|9042183|P3|Overall Study|Lost to Follow-up|0
2615396|NCT00960141|9042184|P2|Overall Study|Lost to Follow-up|0
2615397|NCT00960141|9042185|P1|Overall Study|Lost to Follow-up|1
2615398|NCT00960141|9042183|P3|Overall Study|Lack of Efficacy|2
2615399|NCT00960141|9042184|P2|Overall Study|Lack of Efficacy|4
2615400|NCT00960141|9042185|P1|Overall Study|Lack of Efficacy|3
2615401|NCT00960141|9042183|P3|Overall Study|Adverse Event|2
2615402|NCT00960141|9042184|P2|Overall Study|Adverse Event|8
2615403|NCT00960141|9042185|P1|Overall Study|Adverse Event|4
2615404|NCT00960115|9042210|P2|Overall Study|Ongoing treatment at data cut-off date|15
2615405|NCT00960115|9042211|P1|Overall Study|Ongoing treatment at data cut-off date|19
2615406|NCT00960076|9042225|P2|Overall Study|Did not attend the termination visit|1
2615407|NCT00960076|9042226|P1|Overall Study|Did not attend the termination visit|0
2615408|NCT00960076|9042225|P2|Overall Study|Hyperglycemia|5
2615409|NCT00960076|9042226|P1|Overall Study|Hyperglycemia|1
2615410|NCT00960076|9042225|P2|Overall Study|Severe non-compliance to protocol|2
2615411|NCT00960076|9042226|P1|Overall Study|Severe non-compliance to protocol|1
2615412|NCT00960076|9042225|P2|Overall Study|Lost to Follow-up|3
2615413|NCT00960076|9042226|P1|Overall Study|Lost to Follow-up|3
2615414|NCT00960076|9042225|P2|Overall Study|Withdrawal by Subject|2
2615415|NCT00960076|9042226|P1|Overall Study|Withdrawal by Subject|1
2615416|NCT00960076|9042225|P2|Overall Study|No longer met study criteria|5
2615417|NCT00960076|9042226|P1|Overall Study|No longer met study criteria|1
2615418|NCT00960076|9042225|P2|Overall Study|Adverse Event|7
2615419|NCT00960076|9042226|P1|Overall Study|Adverse Event|1
2615420|NCT00960063|9042241|P3|Overall Study|Progression of Disease|3
2615421|NCT00960063|9042242|P2|Overall Study|Progression of Disease|0
2615422|NCT00960063|9042243|P1|Overall Study|Progression of Disease|0
2615423|NCT00960063|9042241|P3|Overall Study|Adverse Event|0
2615424|NCT00960063|9042242|P2|Overall Study|Adverse Event|0
2615425|NCT00960063|9042243|P1|Overall Study|Adverse Event|1
2615426|NCT00960011|9042283|P2|Overall Study|Lost to Follow-up|2
2615427|NCT00960011|9042284|P1|Overall Study|Lost to Follow-up|6
2615428|NCT00960011|9042283|P2|Overall Study|Death|0
2615429|NCT00960011|9042284|P1|Overall Study|Death|5
2615430|NCT00959946|9042377|P8|Overall Study|Withdrawal by Subject|0
2615431|NCT00959946|9042378|P7|Overall Study|Withdrawal by Subject|0
2615432|NCT00959946|9042379|P6|Overall Study|Withdrawal by Subject|1
2615433|NCT00959946|9042380|P5|Overall Study|Withdrawal by Subject|0
2615434|NCT00959946|9042381|P4|Overall Study|Withdrawal by Subject|0
2615435|NCT00959946|9042382|P3|Overall Study|Withdrawal by Subject|0
2615436|NCT00959946|9042383|P2|Overall Study|Withdrawal by Subject|0
2615437|NCT00959946|9042384|P1|Overall Study|Withdrawal by Subject|0
2615438|NCT00959946|9042377|P8|Overall Study|Disease Progression|2
2615439|NCT00959946|9042378|P7|Overall Study|Disease Progression|2
2615440|NCT00959946|9042379|P6|Overall Study|Disease Progression|6
2615441|NCT00959946|9042380|P5|Overall Study|Disease Progression|4
2615442|NCT00959946|9042381|P4|Overall Study|Disease Progression|4
2615443|NCT00959946|9042382|P3|Overall Study|Disease Progression|2
2615444|NCT00959946|9042383|P2|Overall Study|Disease Progression|4
2615445|NCT00959946|9042384|P1|Overall Study|Disease Progression|2
2615446|NCT00959946|9042377|P8|Overall Study|Death|0
2615447|NCT00959946|9042378|P7|Overall Study|Death|0
2615448|NCT00959946|9042379|P6|Overall Study|Death|1
2615449|NCT00959946|9042380|P5|Overall Study|Death|0
2615450|NCT00959946|9042381|P4|Overall Study|Death|0
2615451|NCT00959946|9042382|P3|Overall Study|Death|0
2615452|NCT00959946|9042383|P2|Overall Study|Death|0
2615453|NCT00959946|9042384|P1|Overall Study|Death|0
2615454|NCT00959946|9042377|P8|Overall Study|Adverse Event|0
2615455|NCT00959946|9042378|P7|Overall Study|Adverse Event|0
2615456|NCT00959946|9042379|P6|Overall Study|Adverse Event|1
2615457|NCT00959946|9042380|P5|Overall Study|Adverse Event|0
2615458|NCT00959946|9042381|P4|Overall Study|Adverse Event|1
2615459|NCT00959946|9042382|P3|Overall Study|Adverse Event|2
2615460|NCT00959946|9042383|P2|Overall Study|Adverse Event|0
2615461|NCT00959946|9042384|P1|Overall Study|Adverse Event|0
2615462|NCT00959907|9042448|P2|Overall Study|Withdrawal by Subject|0
2615463|NCT00959907|9042449|P1|Overall Study|Withdrawal by Subject|2
2615464|NCT00959907|9042448|P2|Overall Study|Adverse Event|0
2615465|NCT00959907|9042449|P1|Overall Study|Adverse Event|1
2615466|NCT00959907|9042448|P2|Overall Study|Protocol Violation|1
2615467|NCT00959907|9042449|P1|Overall Study|Protocol Violation|0
2615468|NCT00959894|9042459|P1|Overall Study|Subject moved out of town|1
2615469|NCT00959894|9042459|P1|Overall Study|Need for contraindicated medication|1
2615470|NCT00959894|9042459|P1|Overall Study|Withdrawal by Subject|1
2615471|NCT00959894|9042459|P1|Overall Study|Adverse Event|3
2615472|NCT00959894|9042459|P1|Overall Study|Lost to Follow-up|10
2615473|NCT00959751|9042508|P2|Overall Study|No migraine headache without aura|7
2615474|NCT00959751|9042509|P1|Overall Study|No migraine headache without aura|7
2615475|NCT00959751|9042508|P2|Overall Study|Non-compliance to Study Procedures|1
2615476|NCT00959751|9042509|P1|Overall Study|Non-compliance to Study Procedures|0
2615477|NCT00959751|9042508|P2|Overall Study|Consent Withdrawn|1
2615478|NCT00959751|9042509|P1|Overall Study|Consent Withdrawn|0
2615479|NCT00959751|9042508|P2|Overall Study|Lost to Follow-up|3
2615480|NCT00959751|9042509|P1|Overall Study|Lost to Follow-up|2
2615481|NCT00959699|9042531|P2|Follow-up Period|Withdrawal by Subject|4
2615482|NCT00959699|9042532|P1|Follow-up Period|Withdrawal by Subject|3
2615483|NCT00959699|9042531|P2|Follow-up Period|Lost to Follow-up|2
2615484|NCT00959699|9042532|P1|Follow-up Period|Lost to Follow-up|3
2615485|NCT00959699|9042531|P2|Treatment Period|Futility/crossover to boceprevir|0
2615486|NCT00959699|9042532|P1|Treatment Period|Futility/crossover to boceprevir|4
2615487|NCT00959699|9042531|P2|Treatment Period|Did not receive treatment|1
2615488|NCT00959699|9042532|P1|Treatment Period|Did not receive treatment|0
2615489|NCT00959699|9042531|P2|Treatment Period|Non-Compliance with Protocol|1
2615490|NCT00959699|9042532|P1|Treatment Period|Non-Compliance with Protocol|0
2615491|NCT00959699|9042531|P2|Treatment Period|Withdrawal by Subject|3
2615492|NCT00959699|9042532|P1|Treatment Period|Withdrawal by Subject|1
2615493|NCT00959699|9042531|P2|Treatment Period|Lost to Follow-up|1
2615494|NCT00959699|9042532|P1|Treatment Period|Lost to Follow-up|0
2615495|NCT00959699|9042531|P2|Treatment Period|Lack of Efficacy|6
2615496|NCT00959699|9042532|P1|Treatment Period|Lack of Efficacy|15
2615497|NCT00959699|9042531|P2|Treatment Period|Adverse Event|13
2615498|NCT00959699|9042532|P1|Treatment Period|Adverse Event|3
2615499|NCT00959647|9042578|P1|Overall Study|Withdrawal by Subject|7
2615500|NCT00959647|9042578|P1|Overall Study|Study terminated by sponsor|4
2615501|NCT00959647|9042578|P1|Overall Study|Progressive disease|6
2615502|NCT00959647|9042578|P1|Overall Study|Adverse Event|2
2615503|NCT00959374|9042583|P1|Overall Study|Physician Decision|1
2615504|NCT00959374|9042583|P1|Overall Study|Implant Removed/Not Replaced|4
2615505|NCT00959374|9042583|P1|Overall Study|Protocol Violation|1
2615506|NCT00959374|9042583|P1|Overall Study|Death|1
2615507|NCT00959374|9042583|P1|Overall Study|Lost to Follow-up|14
2615508|NCT00959374|9042583|P1|Overall Study|Withdrawal by Subject|2
2615509|NCT00959192|9042597|P4|Overall Study|Caregiver Request|1
2615510|NCT00959192|9042598|P3|Overall Study|Caregiver Request|2
2615511|NCT00959192|9042599|P2|Overall Study|Caregiver Request|0
2615512|NCT00959192|9042600|P1|Overall Study|Caregiver Request|0
2615513|NCT00959192|9042597|P4|Overall Study|Investigator Request|0
2615514|NCT00959192|9042598|P3|Overall Study|Investigator Request|0
2615515|NCT00959192|9042599|P2|Overall Study|Investigator Request|0
2615516|NCT00959192|9042600|P1|Overall Study|Investigator Request|1
2615517|NCT00959192|9042597|P4|Overall Study|Adverse Event|0
2615518|NCT00959192|9042598|P3|Overall Study|Adverse Event|1
2615519|NCT00959192|9042599|P2|Overall Study|Adverse Event|1
2615520|NCT00959192|9042600|P1|Overall Study|Adverse Event|1
2615521|NCT00959049|9042659|P6|Overall Study|Withdrawal by Subject|0
2615522|NCT00959049|9042660|P5|Overall Study|Withdrawal by Subject|0
2615523|NCT00959049|9042661|P4|Overall Study|Withdrawal by Subject|0
2615524|NCT00959049|9042662|P3|Overall Study|Withdrawal by Subject|0
2615525|NCT00959049|9042663|P2|Overall Study|Withdrawal by Subject|2
2615526|NCT00959049|9042664|P1|Overall Study|Withdrawal by Subject|0
2615527|NCT00959049|9042659|P6|Overall Study|Contraindicated medication|0
2615528|NCT00959049|9042660|P5|Overall Study|Contraindicated medication|0
2615529|NCT00959049|9042661|P4|Overall Study|Contraindicated medication|1
2615530|NCT00959049|9042662|P3|Overall Study|Contraindicated medication|0
2615531|NCT00959049|9042663|P2|Overall Study|Contraindicated medication|0
2615532|NCT00959049|9042664|P1|Overall Study|Contraindicated medication|0
2615533|NCT00959049|9042659|P6|Overall Study|Lost to Follow-up|1
2615534|NCT00959049|9042660|P5|Overall Study|Lost to Follow-up|9
2615535|NCT00959049|9042661|P4|Overall Study|Lost to Follow-up|10
2615536|NCT00959049|9042662|P3|Overall Study|Lost to Follow-up|1
2615537|NCT00959049|9042663|P2|Overall Study|Lost to Follow-up|5
2615538|NCT00959049|9042664|P1|Overall Study|Lost to Follow-up|17
2615539|NCT00959049|9042659|P6|Overall Study|Adverse Event|0
2615540|NCT00959049|9042660|P5|Overall Study|Adverse Event|0
2615541|NCT00959049|9042661|P4|Overall Study|Adverse Event|0
2615542|NCT00959049|9042662|P3|Overall Study|Adverse Event|0
2615543|NCT00959049|9042663|P2|Overall Study|Adverse Event|0
2615544|NCT00959049|9042664|P1|Overall Study|Adverse Event|1
2615545|NCT00958893|9042729|P1|Overall Study|Study prematurely terminated|4
2615546|NCT00958880|9042735|P2|Overall Study|Lost to Follow-up|2
2615547|NCT00958880|9042736|P1|Overall Study|Lost to Follow-up|2
2615548|NCT00958841|9042744|P1|Overall Study|Discontinued prior to M*|28
2615549|NCT00958841|9042744|P1|Overall Study|Completed M6/did not enter extension|27
2615550|NCT00958841|9042744|P1|Overall Study|Unsatisfactory therapeutic effect|22
2615551|NCT00958841|9042744|P1|Overall Study|Withdrawal by Subject|1
2615552|NCT00958841|9042744|P1|Overall Study|New cancer therapy|5
2615553|NCT00958841|9042744|P1|Overall Study|Adverse Event|8
2615554|NCT00958841|9042744|P1|Overall Study|Administrative problems|1
2615555|NCT00958841|9042744|P1|Overall Study|Abnormal test procedure result(s)|3
2615556|NCT00958841|9042744|P1|Overall Study|Abnormal laboratory value(s)|1
2615557|NCT00958828|9042762|P2|Period 2, 1 Week of Wear|Unacceptable lens fit|1
2615558|NCT00958828|9042763|P1|Period 2, 1 Week of Wear|Unacceptable lens fit|0
2615559|NCT00958828|9042762|P2|Period 1, 1 Week of Wear|Randomization break|1
2615560|NCT00958828|9042763|P1|Period 1, 1 Week of Wear|Randomization break|0
2615561|NCT00958789|9042769|P1|Overall Study|Revision|7
2615562|NCT00958789|9042769|P1|Overall Study|Subject terminated|2
2615563|NCT00958789|9042769|P1|Overall Study|2 yr. Knee Society Score not calculable|1
2615564|NCT00958789|9042769|P1|Overall Study|No 2 yr. Knee Society Score data|4
2615565|NCT00958789|9042769|P1|Overall Study|Withdrawal by Subject|17
2615566|NCT00958789|9042769|P1|Overall Study|Lost to Follow-up|14
2615567|NCT00958789|9042769|P1|Overall Study|Death|5
2615568|NCT00958776|9042776|P2|Overall Study|Missing|1
2615569|NCT00958776|9042777|P1|Overall Study|Missing|1
2615570|NCT00958776|9042776|P2|Overall Study|Noncompliance; Protocol Deviations|3
2615571|NCT00958776|9042777|P1|Overall Study|Noncompliance; Protocol Deviations|2
2615572|NCT00958776|9042776|P2|Overall Study|Death|1
2615573|NCT00958776|9042777|P1|Overall Study|Death|2
2615574|NCT00958776|9042776|P2|Overall Study|Protocol Violation|1
2615575|NCT00958776|9042777|P1|Overall Study|Protocol Violation|1
2615576|NCT00958776|9042776|P2|Overall Study|Withdrawal by Subject|16
2615577|NCT00958776|9042777|P1|Overall Study|Withdrawal by Subject|7
2615578|NCT00958776|9042776|P2|Overall Study|Lost to Follow-up|6
2615579|NCT00958776|9042777|P1|Overall Study|Lost to Follow-up|2
2615580|NCT00958776|9042776|P2|Overall Study|Physician Decision|0
2615581|NCT00958776|9042777|P1|Overall Study|Physician Decision|1
2615582|NCT00958776|9042776|P2|Overall Study|Adverse Event|1
2615583|NCT00958776|9042777|P1|Overall Study|Adverse Event|0
2615584|NCT00958724|9042807|P1|Overall Study|Disease Progression|6
2615585|NCT00958711|9042819|P2|Overall Study|Adverse Event|2
2615586|NCT00958711|9042820|P1|Overall Study|Adverse Event|1
2615587|NCT00958711|9042819|P2|Overall Study|Death|2
2615588|NCT00958711|9042820|P1|Overall Study|Death|1
2615589|NCT00958711|9042819|P2|Overall Study|Other|5
2615590|NCT00958711|9042820|P1|Overall Study|Other|2
2615591|NCT00958711|9042819|P2|Overall Study|Lost to Follow-up|1
2615592|NCT00958711|9042820|P1|Overall Study|Lost to Follow-up|4
2615593|NCT00958711|9042819|P2|Overall Study|Physician Decision|7
2615594|NCT00958711|9042820|P1|Overall Study|Physician Decision|5
2615595|NCT00958711|9042819|P2|Overall Study|Withdrawal by Subject|4
2615596|NCT00958711|9042820|P1|Overall Study|Withdrawal by Subject|0
2615597|NCT00958568|9042865|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
2615598|NCT00958568|9042866|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1
2615599|NCT00958568|9042867|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
2615600|NCT00958568|9042868|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
2615601|NCT00958568|9042865|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
2615602|NCT00958568|9042866|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1
2615603|NCT00958568|9042867|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
2615604|NCT00958568|9042868|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
2615605|NCT00958568|9042865|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1
2615606|NCT00958568|9042866|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2
2615607|NCT00958568|9042867|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
2615608|NCT00958568|9042868|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
2615609|NCT00958568|9042865|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4
2615610|NCT00958568|9042866|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5
2615611|NCT00958568|9042867|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
2615612|NCT00958568|9042868|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
2615613|NCT00958568|9042865|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8
2615614|NCT00958568|9042866|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3
2615615|NCT00958568|9042867|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
2615616|NCT00958568|9042868|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
2615617|NCT00958568|9042865|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5
2615618|NCT00958568|9042866|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11
2615619|NCT00958568|9042867|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
2615620|NCT00958568|9042868|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
2615621|NCT00958568|9042865|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15
2615622|NCT00958568|9042866|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16
2615623|NCT00958568|9042867|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
2615624|NCT00958568|9042868|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
2615625|NCT00958568|9042865|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10
2615626|NCT00958568|9042866|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19
2615627|NCT00958568|9042867|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
2615628|NCT00958568|9042868|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
2615629|NCT00958568|9042865|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63
2615630|NCT00958568|9042866|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24
2615631|NCT00958568|9042867|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
2615632|NCT00958568|9042868|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
2615633|NCT00958568|9042865|P4|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
2615634|NCT00958568|9042866|P3|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
2615635|NCT00958568|9042867|P2|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1
2615636|NCT00958568|9042868|P1|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
2615637|NCT00958568|9042865|P4|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
2615638|NCT00958568|9042866|P3|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
2615639|NCT00958568|9042867|P2|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1
2615640|NCT00958568|9042868|P1|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
2615641|NCT00958568|9042865|P4|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
2615642|NCT00958568|9042866|P3|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
2615643|NCT00958568|9042867|P2|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4
2615644|NCT00958568|9042868|P1|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
2615645|NCT00958568|9042865|P4|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
2615646|NCT00958568|9042866|P3|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
2615647|NCT00958568|9042867|P2|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5
2615648|NCT00958568|9042868|P1|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
2615649|NCT00958568|9042865|P4|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
2615650|NCT00958568|9042866|P3|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
2615651|NCT00958568|9042867|P2|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6
2615652|NCT00958568|9042868|P1|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
2615653|NCT00958568|9042865|P4|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
2615654|NCT00958568|9042866|P3|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
2615655|NCT00958568|9042867|P2|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9
2615656|NCT00958568|9042868|P1|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
2615657|NCT00958568|9042865|P4|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
2615658|NCT00958568|9042866|P3|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
2615659|NCT00958568|9042867|P2|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24
2615660|NCT00958568|9042868|P1|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
2615661|NCT00958568|9042865|P4|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
2615662|NCT00958568|9042866|P3|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
2615663|NCT00958568|9042867|P2|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41
2615664|NCT00958568|9042868|P1|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
2615665|NCT00958568|9042865|P4|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
2615666|NCT00958568|9042866|P3|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
2615667|NCT00958568|9042867|P2|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28
2615668|NCT00958568|9042868|P1|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
2615669|NCT00958568|9042865|P4|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
2615670|NCT00958568|9042866|P3|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
2615671|NCT00958568|9042867|P2|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30
2615672|NCT00958568|9042868|P1|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
2615673|NCT00958568|9042865|P4|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
2615674|NCT00958568|9042866|P3|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
2615675|NCT00958568|9042867|P2|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62
2615676|NCT00958568|9042868|P1|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
2615677|NCT00958568|9042865|P4|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
2615678|NCT00958568|9042866|P3|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
2615679|NCT00958568|9042867|P2|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
2615680|NCT00958568|9042868|P1|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1
2615681|NCT00958568|9042865|P4|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
2615682|NCT00958568|9042866|P3|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
2615683|NCT00958568|9042867|P2|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
2615684|NCT00958568|9042868|P1|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8
2615685|NCT00958568|9042865|P4|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
2615686|NCT00958568|9042866|P3|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
2615687|NCT00958568|9042867|P2|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
2615688|NCT00958568|9042868|P1|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4
2615689|NCT00958568|9042865|P4|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
2615690|NCT00958568|9042866|P3|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
2615691|NCT00958568|9042867|P2|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
2615692|NCT00958568|9042868|P1|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13
2615693|NCT00958568|9042865|P4|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
2615694|NCT00958568|9042866|P3|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
2615695|NCT00958568|9042867|P2|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
2615696|NCT00958568|9042868|P1|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14
2615697|NCT00958568|9042865|P4|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
2615698|NCT00958568|9042866|P3|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
2615699|NCT00958568|9042867|P2|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
2615700|NCT00958568|9042868|P1|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39
2615701|NCT00958568|9042865|P4|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
2615702|NCT00958568|9042866|P3|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
2615703|NCT00958568|9042867|P2|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
2615704|NCT00958568|9042868|P1|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34
2615705|NCT00958568|9042865|P4|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
2615706|NCT00958568|9042866|P3|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
2615707|NCT00958568|9042867|P2|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
2615708|NCT00958568|9042868|P1|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44
2615709|NCT00958568|9042865|P4|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
2615710|NCT00958568|9042866|P3|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
2615711|NCT00958568|9042867|P2|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
2615712|NCT00958568|9042868|P1|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80
2615713|NCT00958438|9043105|P3|Overall Study|Other than specified above|2
2615714|NCT00958438|9043106|P2|Overall Study|Other than specified above|3
2615715|NCT00958438|9043107|P1|Overall Study|Other than specified above|2
2615716|NCT00958438|9043105|P3|Overall Study|Physician Decision|1
2615717|NCT00958438|9043106|P2|Overall Study|Physician Decision|0
2615718|NCT00958438|9043107|P1|Overall Study|Physician Decision|1
2615719|NCT00958438|9043105|P3|Overall Study|Adverse Event|0
2615720|NCT00958438|9043106|P2|Overall Study|Adverse Event|3
2615721|NCT00958438|9043107|P1|Overall Study|Adverse Event|0
2615722|NCT00958438|9043105|P3|Overall Study|Withdrawal by Subject|1
2615723|NCT00958438|9043106|P2|Overall Study|Withdrawal by Subject|2
2615724|NCT00958438|9043107|P1|Overall Study|Withdrawal by Subject|4
2615725|NCT00958438|9043105|P3|Overall Study|Protocol Violation|2
2615726|NCT00958438|9043106|P2|Overall Study|Protocol Violation|2
2615727|NCT00958438|9043107|P1|Overall Study|Protocol Violation|3
2615728|NCT00958412|9043130|P1|Overall Study|Study prematurely terminated|18
2615729|NCT00958360|9043136|P2|Overall Study|Lost to Follow-up|1
2615730|NCT00958360|9043137|P1|Overall Study|Lost to Follow-up|0
2615731|NCT00958360|9043136|P2|Overall Study|Physician Decision|1
2615732|NCT00958360|9043137|P1|Overall Study|Physician Decision|2
2615733|NCT00958360|9043136|P2|Overall Study|Death|7
2615734|NCT00958360|9043137|P1|Overall Study|Death|6
2615735|NCT00958360|9043136|P2|Overall Study|Withdrawal by Subject|1
2615736|NCT00958360|9043137|P1|Overall Study|Withdrawal by Subject|3
2615737|NCT00958347|9043151|P1|Overall Study|study termination|135
2615738|NCT00958347|9043151|P1|Overall Study|revision/removal|10
2615739|NCT00958347|9043151|P1|Overall Study|Lost to Follow-up|15
2615740|NCT00958347|9043151|P1|Overall Study|Withdrawal by Subject|23
2615741|NCT00958347|9043151|P1|Overall Study|Death|43
2615742|NCT00958256|9043195|P1|Overall Study|Adverse Event|3
2615743|NCT00958243|9043205|P6|Overall Study|Lost to Follow-up|5
2615744|NCT00958243|9043206|P5|Overall Study|Lost to Follow-up|8
2615745|NCT00958243|9043207|P4|Overall Study|Lost to Follow-up|2
2615746|NCT00958243|9043208|P3|Overall Study|Lost to Follow-up|11
2615747|NCT00958243|9043209|P2|Overall Study|Lost to Follow-up|5
2615748|NCT00958243|9043210|P1|Overall Study|Lost to Follow-up|2
2615749|NCT00958243|9043205|P6|Overall Study|Withdrawal by Subject|5
2615750|NCT00958243|9043206|P5|Overall Study|Withdrawal by Subject|1
2615751|NCT00958243|9043207|P4|Overall Study|Withdrawal by Subject|1
2615752|NCT00958243|9043208|P3|Overall Study|Withdrawal by Subject|3
2615753|NCT00958243|9043209|P2|Overall Study|Withdrawal by Subject|1
2615754|NCT00958243|9043210|P1|Overall Study|Withdrawal by Subject|0
2615755|NCT00958217|9043268|P2|Overall Study|Inpatient hospitalization|1
2615756|NCT00958217|9043269|P1|Overall Study|Inpatient hospitalization|0
2615757|NCT00958217|9043268|P2|Overall Study|Moved out of area|1
2615758|NCT00958217|9043269|P1|Overall Study|Moved out of area|1
2615759|NCT00958217|9043268|P2|Overall Study|Lost to Follow-up|19
2615760|NCT00958217|9043269|P1|Overall Study|Lost to Follow-up|17
2615761|NCT00958217|9043268|P2|Overall Study|Withdrawal by Subject|3
2615762|NCT00958217|9043269|P1|Overall Study|Withdrawal by Subject|4
2615763|NCT00958217|9043268|P2|Overall Study|Death|1
2615764|NCT00958217|9043269|P1|Overall Study|Death|2
2615765|NCT00958191|9043280|P1|Overall Study|No 5 yr x-rays|56
2615766|NCT00958191|9043280|P1|Overall Study|Site termination|11
2615767|NCT00958191|9043280|P1|Overall Study|Revision of study device|4
2615768|NCT00958191|9043280|P1|Overall Study|Unable/Unwilling to Return/Withdrawal|21
2615769|NCT00958191|9043280|P1|Overall Study|Inadequate 5 yr x-ray quality|10
2615770|NCT00958191|9043280|P1|Overall Study|Lost to Follow-up|5
2615771|NCT00958191|9043280|P1|Overall Study|Death|4
2615772|NCT00958165|9043295|P1|Overall Study|Not eligible|9
2615773|NCT00958165|9043295|P1|Overall Study|Lost to Follow-up|5
2615774|NCT00958126|9043307|P8|Overall Study|Other Reason|0
2615775|NCT00958126|9043308|P7|Overall Study|Other Reason|0
2615776|NCT00958126|9043309|P6|Overall Study|Other Reason|1
2615777|NCT00958126|9043310|P5|Overall Study|Other Reason|0
2615778|NCT00958126|9043311|P4|Overall Study|Other Reason|1
2615779|NCT00958126|9043312|P3|Overall Study|Other Reason|0
2615780|NCT00958126|9043313|P2|Overall Study|Other Reason|0
2615781|NCT00958126|9043314|P1|Overall Study|Other Reason|0
2615782|NCT00958126|9043307|P8|Overall Study|Sponsor/Investigator decision|0
2615783|NCT00958126|9043308|P7|Overall Study|Sponsor/Investigator decision|0
2615784|NCT00958126|9043309|P6|Overall Study|Sponsor/Investigator decision|0
2615785|NCT00958126|9043310|P5|Overall Study|Sponsor/Investigator decision|0
2615786|NCT00958126|9043311|P4|Overall Study|Sponsor/Investigator decision|1
2615787|NCT00958126|9043312|P3|Overall Study|Sponsor/Investigator decision|0
2615788|NCT00958126|9043313|P2|Overall Study|Sponsor/Investigator decision|0
2615789|NCT00958126|9043314|P1|Overall Study|Sponsor/Investigator decision|0
2615790|NCT00958126|9043307|P8|Overall Study|Lost to Follow-up|0
2615791|NCT00958126|9043308|P7|Overall Study|Lost to Follow-up|0
2615792|NCT00958126|9043309|P6|Overall Study|Lost to Follow-up|0
2615793|NCT00958126|9043310|P5|Overall Study|Lost to Follow-up|0
2615794|NCT00958126|9043311|P4|Overall Study|Lost to Follow-up|8
2615795|NCT00958126|9043312|P3|Overall Study|Lost to Follow-up|9
2615796|NCT00958126|9043313|P2|Overall Study|Lost to Follow-up|5
2615797|NCT00958126|9043314|P1|Overall Study|Lost to Follow-up|1
2615798|NCT00958126|9043307|P8|Overall Study|Moved away from study area|0
2615799|NCT00958126|9043308|P7|Overall Study|Moved away from study area|0
2615800|NCT00958126|9043309|P6|Overall Study|Moved away from study area|0
2615801|NCT00958126|9043310|P5|Overall Study|Moved away from study area|0
2615802|NCT00958126|9043311|P4|Overall Study|Moved away from study area|1
2615803|NCT00958126|9043312|P3|Overall Study|Moved away from study area|1
2615804|NCT00958126|9043313|P2|Overall Study|Moved away from study area|0
2615805|NCT00958126|9043314|P1|Overall Study|Moved away from study area|0
2615806|NCT00958126|9043307|P8|Overall Study|Withdrawal by Subject|0
2615807|NCT00958126|9043308|P7|Overall Study|Withdrawal by Subject|0
2615808|NCT00958126|9043309|P6|Overall Study|Withdrawal by Subject|0
2615809|NCT00958126|9043310|P5|Overall Study|Withdrawal by Subject|0
2615810|NCT00958126|9043311|P4|Overall Study|Withdrawal by Subject|0
2615811|NCT00958126|9043312|P3|Overall Study|Withdrawal by Subject|0
2615812|NCT00958126|9043313|P2|Overall Study|Withdrawal by Subject|2
2615813|NCT00958126|9043314|P1|Overall Study|Withdrawal by Subject|0
2615814|NCT00958126|9043307|P8|Overall Study|Serious Adverse Event|0
2615815|NCT00958126|9043308|P7|Overall Study|Serious Adverse Event|1
2615816|NCT00958126|9043309|P6|Overall Study|Serious Adverse Event|0
2615817|NCT00958126|9043310|P5|Overall Study|Serious Adverse Event|0
2615818|NCT00958126|9043311|P4|Overall Study|Serious Adverse Event|0
2615819|NCT00958126|9043312|P3|Overall Study|Serious Adverse Event|0
2615820|NCT00958126|9043313|P2|Overall Study|Serious Adverse Event|2
2615821|NCT00958126|9043314|P1|Overall Study|Serious Adverse Event|0
2615822|NCT00958074|9043386|P2|Overall Study|Withdrawal by Subject|1
2615823|NCT00958074|9043387|P1|Overall Study|Withdrawal by Subject|0
2615824|NCT00958009|9043410|P1|Overall Study|Subject found device difficult to use|1
2615825|NCT00958009|9043410|P1|Overall Study|Adverse Event|1
2615826|NCT00957996|9043417|P2|Overall Study|Noncompliance; Protocol Deviations|6
2615827|NCT00957996|9043418|P1|Overall Study|Noncompliance; Protocol Deviations|5
2615828|NCT00957996|9043417|P2|Overall Study|Missing|0
2615829|NCT00957996|9043418|P1|Overall Study|Missing|1
2615830|NCT00957996|9043417|P2|Overall Study|Influenza-related complication|1
2615831|NCT00957996|9043418|P1|Overall Study|Influenza-related complication|0
2615832|NCT00957996|9043417|P2|Overall Study|Physician Decision|1
2615833|NCT00957996|9043418|P1|Overall Study|Physician Decision|1
2615834|NCT00957996|9043417|P2|Overall Study|Adverse Event|1
2615835|NCT00957996|9043418|P1|Overall Study|Adverse Event|2
2615836|NCT00957996|9043417|P2|Overall Study|Withdrawal by Subject|2
2615837|NCT00957996|9043418|P1|Overall Study|Withdrawal by Subject|9
2615838|NCT00957996|9043417|P2|Overall Study|Lost to Follow-up|7
2615839|NCT00957996|9043418|P1|Overall Study|Lost to Follow-up|4
2615840|NCT00957996|9043417|P2|Overall Study|Death|10
2615841|NCT00957996|9043418|P1|Overall Study|Death|4
2615842|NCT00957944|9043450|P2|First Intervention- 24 Hours|Withdrawal by Subject|1
2615843|NCT00957944|9043451|P1|First Intervention- 24 Hours|Withdrawal by Subject|0
2615844|NCT00957931|9043485|P1|Overall Study|Death|4
2615845|NCT00957905|9043495|P2|Part B|Protocol Violation|1
2615846|NCT00957905|9043496|P1|Part B|Protocol Violation|0
2615847|NCT00957905|9043495|P2|Part B|Death|1
2615848|NCT00957905|9043496|P1|Part B|Death|0
2615849|NCT00957905|9043495|P2|Part B|Physician Decision|1
2615850|NCT00957905|9043496|P1|Part B|Physician Decision|0
2615851|NCT00957905|9043495|P2|Part B|Not Treated|1
2615852|NCT00957905|9043496|P1|Part B|Not Treated|0
2615853|NCT00957853|9043505|P3|Overall Study|Withdrawal by Subject|0
2615854|NCT00957853|9043506|P2|Overall Study|Withdrawal by Subject|0
2615855|NCT00957853|9043507|P1|Overall Study|Withdrawal by Subject|1
2615856|NCT00957801|9043531|P4|Overall Study|Withdrawal by Subject|1
2615857|NCT00957801|9043532|P3|Overall Study|Withdrawal by Subject|0
2615858|NCT00957801|9043533|P2|Overall Study|Withdrawal by Subject|0
2615859|NCT00957801|9043534|P1|Overall Study|Withdrawal by Subject|0
2615860|NCT00957723|9043700|P1|Overall Study|2yr ROM Data Not Evaluable|12
2615861|NCT00957723|9043700|P1|Overall Study|Intercurrent Illness|2
2615862|NCT00957723|9043700|P1|Overall Study|Investigative Site Terminated|61
2615863|NCT00957723|9043700|P1|Overall Study|Withdrawal by Subject|24
2615864|NCT00957723|9043700|P1|Overall Study|Lost to Follow-up|8
2615865|NCT00957723|9043700|P1|Overall Study|Revision/ Removal of Study Implant|3
2615866|NCT00957723|9043700|P1|Overall Study|Death|3
2615867|NCT00957658|9043789|P1|Overall Study|Protocol Violation|5
2615868|NCT00957658|9043789|P1|Overall Study|surgery cancelled|2
2615869|NCT00957658|9043789|P1|Overall Study|unwilling/unable to return|2
2615870|NCT00957658|9043789|P1|Overall Study|Site termination|10
2615871|NCT00957658|9043789|P1|Overall Study|Incomplete 2 yr data|28
2615872|NCT00957658|9043789|P1|Overall Study|Revision|1
2615873|NCT00957658|9043789|P1|Overall Study|Withdrawal by Subject|12
2615874|NCT00957658|9043789|P1|Overall Study|Lost to Follow-up|4
2615875|NCT00957658|9043789|P1|Overall Study|Death|1
2615876|NCT00957580|9043816|P3|Overall Study|Enrolled but not treated|0
2615877|NCT00957580|9043817|P2|Overall Study|Enrolled but not treated|1
2615878|NCT00957580|9043818|P1|Overall Study|Enrolled but not treated|0
2615879|NCT00957580|9043816|P3|Overall Study|Ongoing at data cut-off|0
2615880|NCT00957580|9043817|P2|Overall Study|Ongoing at data cut-off|1
2615881|NCT00957580|9043818|P1|Overall Study|Ongoing at data cut-off|0
2615882|NCT00957528|9043965|P3|Overall Study|Withdrawal by Subject|1
2615883|NCT00957528|9043966|P2|Overall Study|Withdrawal by Subject|0
2615884|NCT00957528|9043967|P1|Overall Study|Withdrawal by Subject|0
2615885|NCT00957528|9043965|P3|Overall Study|Protocol Violation|0
2615886|NCT00957528|9043966|P2|Overall Study|Protocol Violation|1
2615887|NCT00957528|9043967|P1|Overall Study|Protocol Violation|0
2615888|NCT00957424|9043990|P1|Overall Study|Withdrawal by Subject|1
2615889|NCT00957424|9043990|P1|Overall Study|Protocol Violation|3
2615890|NCT00957424|9043990|P1|Overall Study|Lost to Follow-up|19
2615891|NCT00957372|9044000|P4|PART II|Patient non-compliance|4
2615892|NCT00957372|9044001|P3|PART II|Patient non-compliance|0
2615893|NCT00957372|9044002|P2|PART II|Patient non-compliance|0
2615894|NCT00957372|9044003|P1|PART II|Patient non-compliance|0
2615895|NCT00957372|9044000|P4|PART II|Adverse Event|10
2615896|NCT00957372|9044001|P3|PART II|Adverse Event|0
2615897|NCT00957372|9044002|P2|PART II|Adverse Event|0
2615898|NCT00957372|9044003|P1|PART II|Adverse Event|0
2615899|NCT00957372|9044000|P4|PART II|Not Know|20
2615900|NCT00957372|9044001|P3|PART II|Not Know|0
2615901|NCT00957372|9044002|P2|PART II|Not Know|0
2615902|NCT00957372|9044003|P1|PART II|Not Know|0
2615903|NCT00957372|9044000|P4|PART II|Pregnancy|1
2615904|NCT00957372|9044001|P3|PART II|Pregnancy|0
2615905|NCT00957372|9044002|P2|PART II|Pregnancy|0
2615906|NCT00957372|9044003|P1|PART II|Pregnancy|0
2615907|NCT00957372|9044000|P4|PART II|Physician Decision|1
2615908|NCT00957372|9044001|P3|PART II|Physician Decision|0
2615909|NCT00957372|9044002|P2|PART II|Physician Decision|0
2615910|NCT00957372|9044003|P1|PART II|Physician Decision|0
2615911|NCT00957372|9044000|P4|PART II|Withdrawal by Subject|8
2615912|NCT00957372|9044001|P3|PART II|Withdrawal by Subject|0
2615913|NCT00957372|9044002|P2|PART II|Withdrawal by Subject|0
2615914|NCT00957372|9044003|P1|PART II|Withdrawal by Subject|0
2615915|NCT00957372|9044000|P4|PART I|Lost to Follow-up|0
2615916|NCT00957372|9044001|P3|PART I|Lost to Follow-up|1
2615917|NCT00957372|9044002|P2|PART I|Lost to Follow-up|0
2615918|NCT00957372|9044003|P1|PART I|Lost to Follow-up|0
2615919|NCT00957268|9044143|P5|Overall Study|Voluntary Withdrawal|0
2615920|NCT00957268|9044144|P4|Overall Study|Voluntary Withdrawal|0
2615921|NCT00957268|9044145|P3|Overall Study|Voluntary Withdrawal|1
2615922|NCT00957268|9044146|P2|Overall Study|Voluntary Withdrawal|0
2615923|NCT00957268|9044147|P1|Overall Study|Voluntary Withdrawal|0
2615924|NCT00957034|9044269|P3|Overall Study|Withdrawal by Subject|0
2615925|NCT00957034|9044270|P2|Overall Study|Withdrawal by Subject|2
2615926|NCT00957034|9044271|P1|Overall Study|Withdrawal by Subject|0
2615927|NCT00957034|9044269|P3|Overall Study|Sponsor Terminated Study|5
2615928|NCT00957034|9044270|P2|Overall Study|Sponsor Terminated Study|1
2615929|NCT00957034|9044271|P1|Overall Study|Sponsor Terminated Study|6
2615930|NCT00957034|9044269|P3|Overall Study|Adverse Event|1
2615931|NCT00957034|9044270|P2|Overall Study|Adverse Event|1
2615932|NCT00957034|9044271|P1|Overall Study|Adverse Event|0
2615933|NCT00957021|9044294|P1|Overall Study|Termination due to language issue|2
2615934|NCT00957021|9044294|P1|Overall Study|Surgery Cancelled|9
2615935|NCT00957021|9044294|P1|Overall Study|Site Termination by the 2 yr visit|16
2615936|NCT00957021|9044294|P1|Overall Study|Revised study component by 2 yr visit|8
2615937|NCT00957021|9044294|P1|Overall Study|No 2 yr ROM data|35
2615938|NCT00957021|9044294|P1|Overall Study|Withdrawal by Subject|34
2615939|NCT00957021|9044294|P1|Overall Study|Lost to Follow-up|8
2615940|NCT00957021|9044294|P1|Overall Study|Death|5
2615941|NCT00957008|9044307|P4|Overall Study|Relocated; Family conflict|3
2615942|NCT00957008|9044308|P3|Overall Study|Relocated; Family conflict|1
2615943|NCT00957008|9044309|P2|Overall Study|Relocated; Family conflict|1
2615944|NCT00957008|9044310|P1|Overall Study|Relocated; Family conflict|4
2615945|NCT00957008|9044307|P4|Overall Study|Physician Decision|1
2615946|NCT00957008|9044308|P3|Overall Study|Physician Decision|1
2615947|NCT00957008|9044309|P2|Overall Study|Physician Decision|0
2615948|NCT00957008|9044310|P1|Overall Study|Physician Decision|1
2615949|NCT00957008|9044307|P4|Overall Study|Lost to Follow-up|4
2615950|NCT00957008|9044308|P3|Overall Study|Lost to Follow-up|3
2615951|NCT00957008|9044309|P2|Overall Study|Lost to Follow-up|1
2615952|NCT00957008|9044310|P1|Overall Study|Lost to Follow-up|3
2615953|NCT00957008|9044307|P4|Overall Study|Withdrawal by Subject|16
2615954|NCT00957008|9044308|P3|Overall Study|Withdrawal by Subject|12
2615955|NCT00957008|9044309|P2|Overall Study|Withdrawal by Subject|10
2615956|NCT00957008|9044310|P1|Overall Study|Withdrawal by Subject|13
2615957|NCT00956943|9044338|P2|Overall Study|Lost to Follow-up|10
2615958|NCT00956943|9044339|P1|Overall Study|Lost to Follow-up|9
2615959|NCT00956839|9044363|P3|Overall Study|Lost to Follow-up|3
2615960|NCT00956839|9044364|P2|Overall Study|Lost to Follow-up|0
2615961|NCT00956839|9044365|P1|Overall Study|Lost to Follow-up|3
2615962|NCT00956813|9044378|P2|Flaxseed and Placebo|Ineligible|1
2615963|NCT00956813|9044379|P1|Flaxseed and Placebo|Ineligible|3
2615964|NCT00956813|9044378|P2|Flaxseed and Placebo|Withdrawal by Subject|4
2615965|NCT00956813|9044379|P1|Flaxseed and Placebo|Withdrawal by Subject|5
2615966|NCT00956592|9044431|P2|Overall Study|Protocol Violation|3
2615967|NCT00956592|9044432|P1|Overall Study|Protocol Violation|1
2615968|NCT00956293|9044467|P3|Follow-up Period|Follow-up period was terminated.|0
2615969|NCT00956293|9044468|P2|Follow-up Period|Follow-up period was terminated.|32
2615970|NCT00956293|9044469|P1|Follow-up Period|Follow-up period was terminated.|20
2615971|NCT00956293|9044467|P3|Main Period (Randomization)|Adverse Event|0
2615972|NCT00956293|9044468|P2|Main Period (Randomization)|Adverse Event|15
2615973|NCT00956293|9044469|P1|Main Period (Randomization)|Adverse Event|0
2615974|NCT00956293|9044467|P3|Main Period (Randomization)|Lack of Efficacy|0
2615975|NCT00956293|9044468|P2|Main Period (Randomization)|Lack of Efficacy|10
2615976|NCT00956293|9044469|P1|Main Period (Randomization)|Lack of Efficacy|1
2615977|NCT00956293|9044467|P3|Main Period (Randomization)|Abnormal laboratory value|0
2615978|NCT00956293|9044468|P2|Main Period (Randomization)|Abnormal laboratory value|2
2615979|NCT00956293|9044469|P1|Main Period (Randomization)|Abnormal laboratory value|0
2615980|NCT00956293|9044467|P3|Main Period (Pre-randomization)|Abnormal laboratory value|44
2615981|NCT00956293|9044468|P2|Main Period (Pre-randomization)|Abnormal laboratory value|0
2615982|NCT00956293|9044469|P1|Main Period (Pre-randomization)|Abnormal laboratory value|0
2615983|NCT00956293|9044467|P3|Main Period (Pre-randomization)|Adverse Event|36
2615984|NCT00956293|9044468|P2|Main Period (Pre-randomization)|Adverse Event|0
2615985|NCT00956293|9044469|P1|Main Period (Pre-randomization)|Adverse Event|0
2615986|NCT00956293|9044467|P3|Main Period (Pre-randomization)|Lack of Efficacy|20
2615987|NCT00956293|9044468|P2|Main Period (Pre-randomization)|Lack of Efficacy|0
2615988|NCT00956293|9044469|P1|Main Period (Pre-randomization)|Lack of Efficacy|0
2615989|NCT00956293|9044467|P3|Main Period (Pre-randomization)|Withdrawal by Subject|12
2615990|NCT00956293|9044468|P2|Main Period (Pre-randomization)|Withdrawal by Subject|0
2615991|NCT00956293|9044469|P1|Main Period (Pre-randomization)|Withdrawal by Subject|0
2615992|NCT00956293|9044467|P3|Main Period (Pre-randomization)|Graft loss|7
2615993|NCT00956293|9044468|P2|Main Period (Pre-randomization)|Graft loss|0
2615994|NCT00956293|9044469|P1|Main Period (Pre-randomization)|Graft loss|0
2615995|NCT00956293|9044467|P3|Main Period (Pre-randomization)|Administrative problems|6
2615996|NCT00956293|9044468|P2|Main Period (Pre-randomization)|Administrative problems|0
2615997|NCT00956293|9044469|P1|Main Period (Pre-randomization)|Administrative problems|0
2615998|NCT00956293|9044467|P3|Main Period (Pre-randomization)|Abnormal test procedure result|2
2615999|NCT00956293|9044468|P2|Main Period (Pre-randomization)|Abnormal test procedure result|0
2616000|NCT00956293|9044469|P1|Main Period (Pre-randomization)|Abnormal test procedure result|0
2616001|NCT00956293|9044467|P3|Main Period (Pre-randomization)|Protocol Violation|1
2616002|NCT00956293|9044468|P2|Main Period (Pre-randomization)|Protocol Violation|0
2616003|NCT00956293|9044469|P1|Main Period (Pre-randomization)|Protocol Violation|0
2616004|NCT00956293|9044467|P3|Main Period (Pre-randomization)|Death|1
2616005|NCT00956293|9044468|P2|Main Period (Pre-randomization)|Death|0
2616006|NCT00956293|9044469|P1|Main Period (Pre-randomization)|Death|0
2616007|NCT00956293|9044467|P3|Main Period (Pre-randomization)|Not specified (data missing)|1
2616008|NCT00956293|9044468|P2|Main Period (Pre-randomization)|Not specified (data missing)|0
2616009|NCT00956293|9044469|P1|Main Period (Pre-randomization)|Not specified (data missing)|0
2616010|NCT00955968|9044524|P2|Overall Study|Site closed|52
2616011|NCT00955968|9044525|P1|Overall Study|Site closed|55
2616012|NCT00955968|9044524|P2|Overall Study|Lost to Follow-up|39
2616013|NCT00955968|9044525|P1|Overall Study|Lost to Follow-up|45
2616014|NCT00955968|9044524|P2|Overall Study|Withdrawal by Subject|31
2616015|NCT00955968|9044525|P1|Overall Study|Withdrawal by Subject|35
2616016|NCT00955968|9044524|P2|Overall Study|Death|4
2616017|NCT00955968|9044525|P1|Overall Study|Death|2
2616018|NCT00955955|9044563|P3|Overall Study|Lost to Follow-up|0
2616019|NCT00955955|9044564|P2|Overall Study|Lost to Follow-up|0
2616020|NCT00955955|9044565|P1|Overall Study|Lost to Follow-up|2
2616021|NCT00955825|9044649|P2|Overall Study|Any other reason not above-mentioned|9
2616022|NCT00955825|9044650|P1|Overall Study|Any other reason not above-mentioned|7
2616023|NCT00955825|9044649|P2|Overall Study|Withdrawal by Subject|6
2616024|NCT00955825|9044650|P1|Overall Study|Withdrawal by Subject|4
2616025|NCT00955825|9044649|P2|Overall Study|Adverse Event|2
2616026|NCT00955825|9044650|P1|Overall Study|Adverse Event|15
2616027|NCT00955721|9044667|P2|Overall Study|Withdrawal by Subject|0
2616028|NCT00955721|9044668|P1|Overall Study|Withdrawal by Subject|1
2616029|NCT00955721|9044667|P2|Overall Study|Death|0
2616030|NCT00955721|9044668|P1|Overall Study|Death|1
2616031|NCT00955721|9044667|P2|Overall Study|Physician Decision|0
2616032|NCT00955721|9044668|P1|Overall Study|Physician Decision|1
2616033|NCT00955708|9044678|P1|Overall Study|Patient changed care provider/moved|91
2616034|NCT00955708|9044678|P1|Overall Study|Closure of study location|60
2616035|NCT00955708|9044678|P1|Overall Study|Patient Refused to participate further|116
2616036|NCT00955708|9044678|P1|Overall Study|Product removed from service|94
2616037|NCT00955708|9044678|P1|Overall Study|Registry Conclusion|186
2616038|NCT00955708|9044678|P1|Overall Study|Protocol Violation|134
2616039|NCT00955708|9044678|P1|Overall Study|Physician Decision|36
2616040|NCT00955708|9044678|P1|Overall Study|Lost to Follow-up|72
2616041|NCT00955708|9044678|P1|Overall Study|Death|269
2616042|NCT00955682|9044684|P2|Booster Period (Month 49)|Lost to Follow-up|1
2616043|NCT00955682|9044685|P1|Booster Period (Month 49)|Lost to Follow-up|1
2616044|NCT00955617|9044795|P2|Second MRA (Between Day 1 and Day 51)|conventional angiography|0
2616045|NCT00955617|9044796|P1|Second MRA (Between Day 1 and Day 51)|conventional angiography|1
2616046|NCT00955617|9044795|P2|Second MRA (Between Day 1 and Day 51)|technical incident|1
2616047|NCT00955617|9044796|P1|Second MRA (Between Day 1 and Day 51)|technical incident|0
2616048|NCT00955617|9044795|P2|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1
2616049|NCT00955617|9044796|P1|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0
2616050|NCT00955617|9044795|P2|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1
2616051|NCT00955617|9044796|P1|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2
2616052|NCT00955474|9044860|P2|Overall Study|Physician Decision|5
2616053|NCT00955474|9044861|P1|Overall Study|Physician Decision|7
2616054|NCT00955357|9044897|P2|Maintenance Phase|Non compliance to study procedures|0
2616055|NCT00955357|9044898|P1|Maintenance Phase|Non compliance to study procedures|1
2616056|NCT00955357|9044897|P2|Maintenance Phase|Patient moving out of area|1
2616057|NCT00955357|9044898|P1|Maintenance Phase|Patient moving out of area|0
2616058|NCT00955357|9044897|P2|Maintenance Phase|Withdrawal by Subject|4
2616059|NCT00955357|9044898|P1|Maintenance Phase|Withdrawal by Subject|4
2616060|NCT00955357|9044897|P2|Maintenance Phase|Lost to Follow-up|7
2616061|NCT00955357|9044898|P1|Maintenance Phase|Lost to Follow-up|2
2616062|NCT00955357|9044897|P2|Maintenance Phase|Protocol Violation|6
2616063|NCT00955357|9044898|P1|Maintenance Phase|Protocol Violation|2
2616064|NCT00955357|9044897|P2|Maintenance Phase|Lack of Efficacy|4
2616065|NCT00955357|9044898|P1|Maintenance Phase|Lack of Efficacy|0
2616066|NCT00955357|9044897|P2|Maintenance Phase|Adverse Event|23
2616067|NCT00955357|9044898|P1|Maintenance Phase|Adverse Event|3
2616068|NCT00955357|9044897|P2|Titration Phase|Non compliance to study procedures|1
2616069|NCT00955357|9044898|P1|Titration Phase|Non compliance to study procedures|0
2616070|NCT00955357|9044897|P2|Titration Phase|Study medication not tolerated|1
2616071|NCT00955357|9044898|P1|Titration Phase|Study medication not tolerated|0
2616072|NCT00955357|9044897|P2|Titration Phase|Prohibited Antiepileptic Drug change|1
2616073|NCT00955357|9044898|P1|Titration Phase|Prohibited Antiepileptic Drug change|0
2616074|NCT00955357|9044897|P2|Titration Phase|Withdrawal by Subject|5
2616075|NCT00955357|9044898|P1|Titration Phase|Withdrawal by Subject|3
2616076|NCT00955357|9044897|P2|Titration Phase|Lost to Follow-up|3
2616077|NCT00955357|9044898|P1|Titration Phase|Lost to Follow-up|1
2616078|NCT00955357|9044897|P2|Titration Phase|Protocol Violation|7
2616079|NCT00955357|9044898|P1|Titration Phase|Protocol Violation|3
2616080|NCT00955357|9044897|P2|Titration Phase|Lack of Efficacy|2
2616081|NCT00955357|9044898|P1|Titration Phase|Lack of Efficacy|0
2616082|NCT00955357|9044897|P2|Titration Phase|Adverse Event|46
2616083|NCT00955357|9044898|P1|Titration Phase|Adverse Event|9
2616084|NCT00955305|9044906|P2|Overall Study|Ineligible|7
2616085|NCT00955305|9044907|P1|Overall Study|Ineligible|5
2616086|NCT00955305|9044906|P2|Overall Study|Never started protocol treatment|5
2616087|NCT00955305|9044907|P1|Overall Study|Never started protocol treatment|5
2616088|NCT00955305|9044906|P2|Overall Study|No off-treatment reason submitted|0
2616089|NCT00955305|9044907|P1|Overall Study|No off-treatment reason submitted|1
2616090|NCT00955305|9044906|P2|Overall Study|Lost to Follow-up|1
2616091|NCT00955305|9044907|P1|Overall Study|Lost to Follow-up|0
2616092|NCT00955305|9044906|P2|Overall Study|Maximum response achieved|1
2616093|NCT00955305|9044907|P1|Overall Study|Maximum response achieved|0
2616094|NCT00955305|9044906|P2|Overall Study|Functional decline|0
2616095|NCT00955305|9044907|P1|Overall Study|Functional decline|2
2616096|NCT00955305|9044906|P2|Overall Study|Continued presence of residual disease|1
2616097|NCT00955305|9044907|P1|Overall Study|Continued presence of residual disease|0
2616098|NCT00955305|9044906|P2|Overall Study|Physician Decision|0
2616099|NCT00955305|9044907|P1|Overall Study|Physician Decision|1
2616100|NCT00955305|9044906|P2|Overall Study|Other complicating disease|4
2616101|NCT00955305|9044907|P1|Overall Study|Other complicating disease|2
2616102|NCT00955305|9044906|P2|Overall Study|Alternative therapy|0
2616103|NCT00955305|9044907|P1|Overall Study|Alternative therapy|4
2616104|NCT00955305|9044906|P2|Overall Study|Withdrawal by Subject|4
2616105|NCT00955305|9044907|P1|Overall Study|Withdrawal by Subject|5
2616106|NCT00955305|9044906|P2|Overall Study|Death|1
2616107|NCT00955305|9044907|P1|Overall Study|Death|2
2616108|NCT00955305|9044906|P2|Overall Study|Adverse Event|22
2616109|NCT00955305|9044907|P1|Overall Study|Adverse Event|22
2616110|NCT00955305|9044906|P2|Overall Study|Disease progression|41
2616111|NCT00955305|9044907|P1|Overall Study|Disease progression|39
2616112|NCT00955279|9044920|P3|Overall Study|Withdrawal by Subject|3
2616113|NCT00955279|9044921|P2|Overall Study|Withdrawal by Subject|0
2616114|NCT00955279|9044922|P1|Overall Study|Withdrawal by Subject|2
2616115|NCT00955279|9044920|P3|Overall Study|Lost to Follow-up|1
2616116|NCT00955279|9044921|P2|Overall Study|Lost to Follow-up|3
2616117|NCT00955279|9044922|P1|Overall Study|Lost to Follow-up|0
2616118|NCT00955279|9044920|P3|Overall Study|Death|1
2616119|NCT00955279|9044921|P2|Overall Study|Death|1
2616120|NCT00955279|9044922|P1|Overall Study|Death|1
2616121|NCT00955279|9044920|P3|Overall Study|Other|3
2616122|NCT00955279|9044921|P2|Overall Study|Other|0
2616123|NCT00955279|9044922|P1|Overall Study|Other|0
2616124|NCT00955110|9045130|P1|Treatment Phase|Withdrawn by physician pre-treatment|1
2616125|NCT00955110|9045130|P1|Treatment Phase|Non-compliance with study restrictions|1
2616126|NCT00955110|9045130|P1|Treatment Phase|Administrative reasons|2
2616127|NCT00955110|9045130|P1|Treatment Phase|Adverse Event|2
2616128|NCT00955110|9045130|P1|Qualification Phase|Did not meet eligibility criteria|24
2616129|NCT00954941|9045177|P2|Overall Study|Adverse Event|1
2616130|NCT00954941|9045178|P1|Overall Study|Adverse Event|0
2616131|NCT00954941|9045177|P2|Overall Study|Ineligible|2
2616132|NCT00954941|9045178|P1|Overall Study|Ineligible|2
2616133|NCT00954941|9045177|P2|Overall Study|Physician Decision|2
2616134|NCT00954941|9045178|P1|Overall Study|Physician Decision|2
2616135|NCT00954941|9045177|P2|Overall Study|Insurance Denial|2
2616136|NCT00954941|9045178|P1|Overall Study|Insurance Denial|2
2616137|NCT00954941|9045177|P2|Overall Study|Withdrawal by Subject|0
2616138|NCT00954941|9045178|P1|Overall Study|Withdrawal by Subject|1
2616139|NCT00954941|9045177|P2|Overall Study|Received treatment at home|0
2616140|NCT00954941|9045178|P1|Overall Study|Received treatment at home|1
2616141|NCT00954733|9045194|P1|Overall Study|blood gas machine did not work|1
2616142|NCT00954707|9045198|P1|Overall Study|Lost to Follow-up|33
2616143|NCT00954707|9045198|P1|Overall Study|Withdrawal by Subject|100
2616144|NCT00954707|9045198|P1|Overall Study|Death|34
2616145|NCT00954538|9045220|P6|Part III|Withdrawal by Subject|0
2616146|NCT00954538|9045221|P5|Part III|Withdrawal by Subject|1
2616147|NCT00954538|9045222|P4|Part III|Withdrawal by Subject|0
2616148|NCT00954538|9045223|P3|Part III|Withdrawal by Subject|0
2616149|NCT00954538|9045224|P2|Part III|Withdrawal by Subject|0
2616150|NCT00954538|9045225|P1|Part III|Withdrawal by Subject|0
2616151|NCT00954512|9045242|P6|Overall Study|Progression of Disease|1
2616152|NCT00954512|9045243|P5|Overall Study|Progression of Disease|1
2616153|NCT00954512|9045244|P4|Overall Study|Progression of Disease|1
2616154|NCT00954512|9045245|P3|Overall Study|Progression of Disease|0
2616155|NCT00954512|9045246|P2|Overall Study|Progression of Disease|1
2616156|NCT00954512|9045247|P1|Overall Study|Progression of Disease|2
2616157|NCT00954512|9045242|P6|Overall Study|Symptomatic Deterioration|0
2616158|NCT00954512|9045243|P5|Overall Study|Symptomatic Deterioration|2
2616159|NCT00954512|9045244|P4|Overall Study|Symptomatic Deterioration|0
2616160|NCT00954512|9045245|P3|Overall Study|Symptomatic Deterioration|0
2616161|NCT00954512|9045246|P2|Overall Study|Symptomatic Deterioration|1
2616162|NCT00954512|9045247|P1|Overall Study|Symptomatic Deterioration|0
2616163|NCT00954512|9045242|P6|Overall Study|Physician Decision|0
2616164|NCT00954512|9045243|P5|Overall Study|Physician Decision|0
2616165|NCT00954512|9045244|P4|Overall Study|Physician Decision|1
2616166|NCT00954512|9045245|P3|Overall Study|Physician Decision|0
2616167|NCT00954512|9045246|P2|Overall Study|Physician Decision|1
2616168|NCT00954512|9045247|P1|Overall Study|Physician Decision|0
2616169|NCT00954512|9045242|P6|Overall Study|Adverse Event|2
2616170|NCT00954512|9045243|P5|Overall Study|Adverse Event|1
2616171|NCT00954512|9045244|P4|Overall Study|Adverse Event|0
2616172|NCT00954512|9045245|P3|Overall Study|Adverse Event|0
2616173|NCT00954512|9045246|P2|Overall Study|Adverse Event|0
2616174|NCT00954512|9045247|P1|Overall Study|Adverse Event|0
2616175|NCT00954512|9045242|P6|Overall Study|Withdrawal by Subject|1
2616176|NCT00954512|9045243|P5|Overall Study|Withdrawal by Subject|0
2616177|NCT00954512|9045244|P4|Overall Study|Withdrawal by Subject|0
2616178|NCT00954512|9045245|P3|Overall Study|Withdrawal by Subject|0
2616179|NCT00954512|9045246|P2|Overall Study|Withdrawal by Subject|0
2616180|NCT00954512|9045247|P1|Overall Study|Withdrawal by Subject|0
2616181|NCT00954447|9045268|P2|Overall Study|Other|18
2616182|NCT00954447|9045269|P1|Overall Study|Other|21
2616183|NCT00954447|9045268|P2|Overall Study|Withdrawal by Subject|21
2616184|NCT00954447|9045269|P1|Overall Study|Withdrawal by Subject|26
2616185|NCT00954447|9045268|P2|Overall Study|Lost to Follow-up|14
2616186|NCT00954447|9045269|P1|Overall Study|Lost to Follow-up|8
2616187|NCT00954447|9045268|P2|Overall Study|Protocol Violation|7
2616188|NCT00954447|9045269|P1|Overall Study|Protocol Violation|5
2616189|NCT00954447|9045268|P2|Overall Study|Lack of Efficacy|3
2616190|NCT00954447|9045269|P1|Overall Study|Lack of Efficacy|17
2616191|NCT00954447|9045268|P2|Overall Study|Adverse Event|25
2616192|NCT00954447|9045269|P1|Overall Study|Adverse Event|33
2616193|NCT00954421|9045305|P1|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1
2616194|NCT00954421|9045305|P1|6 Months of DBS|Withdrawal by Subject|1
2616195|NCT00954421|9045305|P1|Screening|screen failures|3
2616196|NCT00954122|9045351|P1|Overall Study|Safety Reason|1
2616197|NCT00954122|9045351|P1|Overall Study|Adverse Event|1
2616198|NCT00954122|9045351|P1|Overall Study|Withdrawal by Subject|5
2616199|NCT00953927|9045368|P2|Overall Study|Other study discontinuation|1
2616200|NCT00953927|9045369|P1|Overall Study|Other study discontinuation|1
2616201|NCT00953927|9045368|P2|Overall Study|Death|4
2616202|NCT00953927|9045369|P1|Overall Study|Death|7
2616203|NCT00953927|9045368|P2|Overall Study|Withdrawal by Subject|25
2616204|NCT00953927|9045369|P1|Overall Study|Withdrawal by Subject|36
2616205|NCT00953927|9045368|P2|Overall Study|Lost to Follow-up|65
2616206|NCT00953927|9045369|P1|Overall Study|Lost to Follow-up|61
2616207|NCT00953745|9045424|P2|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0
2616208|NCT00953745|9045425|P1|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1
2616209|NCT00953745|9045424|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0
2616210|NCT00953745|9045425|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6
2616211|NCT00953745|9045424|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0
2616212|NCT00953745|9045425|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1
2616213|NCT00953745|9045424|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0
2616214|NCT00953745|9045425|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3
2616215|NCT00953745|9045424|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0
2616216|NCT00953745|9045425|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2
2616217|NCT00953745|9045424|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0
2616218|NCT00953745|9045425|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1
2616219|NCT00953706|9045458|P4|Part B (96-Week Open-Label Extension)|Other|2
2616220|NCT00953706|9045459|P3|Part B (96-Week Open-Label Extension)|Other|0
2616221|NCT00953706|9045460|P2|Part B (96-Week Open-Label Extension)|Other|0
2616222|NCT00953706|9045461|P1|Part B (96-Week Open-Label Extension)|Other|0
2616223|NCT00953706|9045458|P4|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2
2616224|NCT00953706|9045459|P3|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1
2616225|NCT00953706|9045460|P2|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
2616226|NCT00953706|9045461|P1|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
2616227|NCT00953706|9045458|P4|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25
2616228|NCT00953706|9045459|P3|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4
2616229|NCT00953706|9045460|P2|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
2616230|NCT00953706|9045461|P1|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
2616231|NCT00953706|9045458|P4|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1
2616232|NCT00953706|9045459|P3|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
2616233|NCT00953706|9045460|P2|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
2616234|NCT00953706|9045461|P1|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
2616235|NCT00953706|9045458|P4|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1
2616236|NCT00953706|9045459|P3|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
2616237|NCT00953706|9045460|P2|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
2616238|NCT00953706|9045461|P1|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
2616239|NCT00953706|9045458|P4|Part B (96-Week Open-Label Extension)|Adverse Event|2
2616240|NCT00953706|9045459|P3|Part B (96-Week Open-Label Extension)|Adverse Event|0
2616241|NCT00953706|9045460|P2|Part B (96-Week Open-Label Extension)|Adverse Event|0
2616242|NCT00953706|9045461|P1|Part B (96-Week Open-Label Extension)|Adverse Event|0
2616243|NCT00953706|9045458|P4|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
2616244|NCT00953706|9045459|P3|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
2616245|NCT00953706|9045460|P2|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1
2616246|NCT00953706|9045461|P1|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
2616247|NCT00953706|9045458|P4|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
2616248|NCT00953706|9045459|P3|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
2616249|NCT00953706|9045460|P2|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1
2616250|NCT00953706|9045461|P1|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
2616251|NCT00953706|9045458|P4|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
2616252|NCT00953706|9045459|P3|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
2616253|NCT00953706|9045460|P2|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2
2616254|NCT00953706|9045461|P1|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
2616255|NCT00953706|9045458|P4|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
2616256|NCT00953706|9045459|P3|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
2616257|NCT00953706|9045460|P2|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1
2616258|NCT00953706|9045461|P1|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
2616259|NCT00953706|9045458|P4|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
2616260|NCT00953706|9045459|P3|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
2616261|NCT00953706|9045460|P2|Part A (16-Week Double-Blind Treatment)|Adverse Event|3
2616262|NCT00953706|9045461|P1|Part A (16-Week Double-Blind Treatment)|Adverse Event|2
2616263|NCT00953680|9045493|P2|Period 1|Withdrawal by Subject|1
2616264|NCT00953680|9045494|P1|Period 1|Withdrawal by Subject|0
2616265|NCT00953667|9045506|P1|Overall Study|poor venous access,unable to draw blood|4
2616266|NCT00953667|9045506|P1|Overall Study|Adverse Event|10
2616267|NCT00953667|9045506|P1|Overall Study|Withdrawal by Subject|63
2616268|NCT00953667|9045506|P1|Overall Study|Physician Decision|35
2616269|NCT00953667|9045506|P1|Overall Study|Lost to Follow-up|11
2616270|NCT00953615|9045527|P1|Overall Study|Adverse Event|1
2616271|NCT00953576|9045536|P2|Overall Study|Ineligible after Consent|0
2616272|NCT00953576|9045537|P1|Overall Study|Ineligible after Consent|2
2616273|NCT00953576|9045536|P2|Overall Study|Adverse Event|1
2616274|NCT00953576|9045537|P1|Overall Study|Adverse Event|0
2616275|NCT00953524|9045552|P4|Overall Study|Withdrawal by Subject|0
2616276|NCT00953524|9045553|P3|Overall Study|Withdrawal by Subject|1
2616277|NCT00953524|9045554|P2|Overall Study|Withdrawal by Subject|4
2616278|NCT00953524|9045555|P1|Overall Study|Withdrawal by Subject|2
2616279|NCT00953524|9045552|P4|Overall Study|Lost to Follow-up|0
2616280|NCT00953524|9045553|P3|Overall Study|Lost to Follow-up|1
2616281|NCT00953524|9045554|P2|Overall Study|Lost to Follow-up|1
2616282|NCT00953524|9045555|P1|Overall Study|Lost to Follow-up|0
2616283|NCT00953524|9045552|P4|Overall Study|Protocol Violation|6
2616284|NCT00953524|9045553|P3|Overall Study|Protocol Violation|11
2616285|NCT00953524|9045554|P2|Overall Study|Protocol Violation|10
2616286|NCT00953524|9045555|P1|Overall Study|Protocol Violation|18
2616287|NCT00953524|9045552|P4|Overall Study|Adverse Event|2
2616288|NCT00953524|9045553|P3|Overall Study|Adverse Event|1
2616289|NCT00953524|9045554|P2|Overall Study|Adverse Event|0
2616290|NCT00953524|9045555|P1|Overall Study|Adverse Event|2
2616291|NCT00953407|9045598|P5|Overall Study|Lost to Follow-up|0
2616292|NCT00953407|9045599|P4|Overall Study|Lost to Follow-up|1
2616293|NCT00953407|9045600|P3|Overall Study|Lost to Follow-up|0
2616294|NCT00953407|9045601|P2|Overall Study|Lost to Follow-up|0
2616295|NCT00953407|9045602|P1|Overall Study|Lost to Follow-up|0
2616296|NCT00953407|9045598|P5|Overall Study|Failed inclusion criteria|1
2616297|NCT00953407|9045599|P4|Overall Study|Failed inclusion criteria|1
2616298|NCT00953407|9045600|P3|Overall Study|Failed inclusion criteria|1
2616299|NCT00953407|9045601|P2|Overall Study|Failed inclusion criteria|1
2616300|NCT00953407|9045602|P1|Overall Study|Failed inclusion criteria|1
2616301|NCT00953329|9045614|P1|Overall Study|Lack of Efficacy|1
2616302|NCT00953225|9045627|P2|Overall Study|Withdrawal by Subject|0
2616303|NCT00953225|9045628|P1|Overall Study|Withdrawal by Subject|2
2616304|NCT00953160|9045712|P1|Overall Study|Withdrawal by Subject|4
2616305|NCT00953160|9045712|P1|Overall Study|Lost to Follow-up|23
2616306|NCT00953147|9045721|P3|Overall Study|Other|13
2616307|NCT00953147|9045722|P2|Overall Study|Other|11
2616308|NCT00953147|9045723|P1|Overall Study|Other|4
2616309|NCT00953147|9045721|P3|Overall Study|Physician Decision|3
2616310|NCT00953147|9045722|P2|Overall Study|Physician Decision|7
2616311|NCT00953147|9045723|P1|Overall Study|Physician Decision|2
2616312|NCT00953147|9045721|P3|Overall Study|Lost to Follow-up|4
2616313|NCT00953147|9045722|P2|Overall Study|Lost to Follow-up|9
2616314|NCT00953147|9045723|P1|Overall Study|Lost to Follow-up|8
2616315|NCT00953147|9045721|P3|Overall Study|Withdrawal by Subject|12
2616316|NCT00953147|9045722|P2|Overall Study|Withdrawal by Subject|15
2616317|NCT00953147|9045723|P1|Overall Study|Withdrawal by Subject|13
2616318|NCT00953147|9045721|P3|Overall Study|Protocol Violation|4
2616319|NCT00953147|9045722|P2|Overall Study|Protocol Violation|8
2616320|NCT00953147|9045723|P1|Overall Study|Protocol Violation|2
2616321|NCT00953147|9045721|P3|Overall Study|Adverse Event|6
2616322|NCT00953147|9045722|P2|Overall Study|Adverse Event|16
2616323|NCT00953147|9045723|P1|Overall Study|Adverse Event|8
2616324|NCT00953056|9045801|P6|Overall Study|Serious Adverse Event|1
2616325|NCT00953056|9045802|P5|Overall Study|Serious Adverse Event|0
2616326|NCT00953056|9045803|P4|Overall Study|Serious Adverse Event|0
2616327|NCT00953056|9045804|P3|Overall Study|Serious Adverse Event|0
2616328|NCT00953056|9045805|P2|Overall Study|Serious Adverse Event|0
2616329|NCT00953056|9045806|P1|Overall Study|Serious Adverse Event|0
2616330|NCT00953056|9045801|P6|Overall Study|Withdrew Consent|3
2616331|NCT00953056|9045802|P5|Overall Study|Withdrew Consent|2
2616332|NCT00953056|9045803|P4|Overall Study|Withdrew Consent|0
2616333|NCT00953056|9045804|P3|Overall Study|Withdrew Consent|0
2616334|NCT00953056|9045805|P2|Overall Study|Withdrew Consent|0
2616335|NCT00953056|9045806|P1|Overall Study|Withdrew Consent|0
2616336|NCT00953043|9045830|P2|Overall Study|Physician Decision|2
2616337|NCT00953043|9045831|P1|Overall Study|Physician Decision|0
2616338|NCT00953043|9045830|P2|Overall Study|Withdrawal by Subject|0
2616339|NCT00953043|9045831|P1|Overall Study|Withdrawal by Subject|4
2616340|NCT00953017|9045855|P4|Overall Study|Brown stool prior to procedure|0
2616341|NCT00953017|9045856|P3|Overall Study|Brown stool prior to procedure|1
2616342|NCT00953017|9045857|P2|Overall Study|Brown stool prior to procedure|0
2616343|NCT00953017|9045858|P1|Overall Study|Brown stool prior to procedure|0
2616344|NCT00953017|9045855|P4|Overall Study|Procedure incomplete due to pain/looping|1
2616345|NCT00953017|9045856|P3|Overall Study|Procedure incomplete due to pain/looping|0
2616346|NCT00953017|9045857|P2|Overall Study|Procedure incomplete due to pain/looping|1
2616347|NCT00953017|9045858|P1|Overall Study|Procedure incomplete due to pain/looping|0
2616348|NCT00953017|9045855|P4|Overall Study|Incomplete data|0
2616349|NCT00953017|9045856|P3|Overall Study|Incomplete data|0
2616350|NCT00953017|9045857|P2|Overall Study|Incomplete data|1
2616351|NCT00953017|9045858|P1|Overall Study|Incomplete data|1
2616352|NCT00953017|9045855|P4|Overall Study|DId not show up for colonoscopy|4
2616353|NCT00953017|9045856|P3|Overall Study|DId not show up for colonoscopy|5
2616354|NCT00953017|9045857|P2|Overall Study|DId not show up for colonoscopy|4
2616355|NCT00953017|9045858|P1|Overall Study|DId not show up for colonoscopy|4
2616356|NCT00952848|9045880|P1|Overall Study|Withdrawal by Subject|4
2616357|NCT00952822|9045887|P4|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
2616358|NCT00952822|9045888|P3|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1
2616359|NCT00952822|9045889|P2|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
2616360|NCT00952822|9045890|P1|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
2616361|NCT00952822|9045887|P4|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
2616362|NCT00952822|9045888|P3|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
2616363|NCT00952822|9045889|P2|1st Pharmacokinetic Evaluation|Lost to Follow-up|1
2616364|NCT00952822|9045890|P1|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
2616365|NCT00952731|9045922|P2|Overall Study|Drug supply expired|0
2616366|NCT00952731|9045923|P1|Overall Study|Drug supply expired|1
2616367|NCT00952705|9045955|P3|Overall Study|Exclusion criteria not met pre dose|0
2616368|NCT00952705|9045956|P2|Overall Study|Exclusion criteria not met pre dose|1
2616369|NCT00952705|9045957|P1|Overall Study|Exclusion criteria not met pre dose|0
2616370|NCT00952705|9045955|P3|Overall Study|Incarcerated post dose|0
2616371|NCT00952705|9045956|P2|Overall Study|Incarcerated post dose|0
2616372|NCT00952705|9045957|P1|Overall Study|Incarcerated post dose|5
2616373|NCT00952705|9045955|P3|Overall Study|Death|0
2616374|NCT00952705|9045956|P2|Overall Study|Death|0
2616375|NCT00952705|9045957|P1|Overall Study|Death|2
2616376|NCT00952705|9045955|P3|Overall Study|Withdrawal by Subject|1
2616377|NCT00952705|9045956|P2|Overall Study|Withdrawal by Subject|1
2616378|NCT00952705|9045957|P1|Overall Study|Withdrawal by Subject|2
2616379|NCT00952705|9045955|P3|Overall Study|Lost to Follow-up|9
2616380|NCT00952705|9045956|P2|Overall Study|Lost to Follow-up|8
2616381|NCT00952705|9045957|P1|Overall Study|Lost to Follow-up|24
2616382|NCT00952614|9046044|P1|Overall Study|other reason|1
2616383|NCT00952614|9046044|P1|Overall Study|Lost to Follow-up|3
2616384|NCT00952614|9046044|P1|Overall Study|Death|3
2616385|NCT00952588|9046051|P2|Overall Study|Lack of Efficacy|2
2616386|NCT00952588|9046052|P1|Overall Study|Lack of Efficacy|2
2616387|NCT00952588|9046051|P2|Overall Study|Physician Decision|1
2616388|NCT00952588|9046052|P1|Overall Study|Physician Decision|0
2616389|NCT00952588|9046051|P2|Overall Study|Lost to Follow-up|0
2616390|NCT00952588|9046052|P1|Overall Study|Lost to Follow-up|2
2616391|NCT00952588|9046051|P2|Overall Study|Adverse Event|3
2616392|NCT00952588|9046052|P1|Overall Study|Adverse Event|2
2616393|NCT00952588|9046051|P2|Overall Study|Withdrawal by Subject|5
2616394|NCT00952588|9046052|P1|Overall Study|Withdrawal by Subject|2
2616395|NCT00952588|9046051|P2|Overall Study|Death|13
2616396|NCT00952588|9046052|P1|Overall Study|Death|28
2616397|NCT00952523|9046070|P1|Overall Study|Withdrawal by Subject|7
2616398|NCT00952484|9046079|P3|Overall Study|Withdrawal by Subject|0
2616399|NCT00952484|9046080|P2|Overall Study|Withdrawal by Subject|1
2616400|NCT00952484|9046081|P1|Overall Study|Withdrawal by Subject|0
2616401|NCT00952419|9046108|P3|Overall Study|Withdrawal by Subject|0
2616402|NCT00952419|9046109|P2|Overall Study|Withdrawal by Subject|3
2616403|NCT00952419|9046110|P1|Overall Study|Withdrawal by Subject|1
2616404|NCT00952419|9046108|P3|Overall Study|Protocol Violation|0
2616405|NCT00952419|9046109|P2|Overall Study|Protocol Violation|7
2616406|NCT00952419|9046110|P1|Overall Study|Protocol Violation|3
2616407|NCT00952419|9046108|P3|Overall Study|Adverse Event|0
2616408|NCT00952419|9046109|P2|Overall Study|Adverse Event|0
2616409|NCT00952419|9046110|P1|Overall Study|Adverse Event|2
2616410|NCT00952380|9046151|P5|Overall Study|Non-compliant to protocol|0
2616411|NCT00952380|9046152|P4|Overall Study|Non-compliant to protocol|1
2616412|NCT00952380|9046153|P3|Overall Study|Non-compliant to protocol|0
2616413|NCT00952380|9046154|P2|Overall Study|Non-compliant to protocol|0
2616414|NCT00952380|9046155|P1|Overall Study|Non-compliant to protocol|0
2616415|NCT00952380|9046151|P5|Overall Study|Physician Decision|0
2616416|NCT00952380|9046152|P4|Overall Study|Physician Decision|2
2616417|NCT00952380|9046153|P3|Overall Study|Physician Decision|1
2616418|NCT00952380|9046154|P2|Overall Study|Physician Decision|0
2616419|NCT00952380|9046155|P1|Overall Study|Physician Decision|0
2616420|NCT00952380|9046151|P5|Overall Study|Adverse Event|3
2616421|NCT00952380|9046152|P4|Overall Study|Adverse Event|0
2616422|NCT00952380|9046153|P3|Overall Study|Adverse Event|0
2616423|NCT00952380|9046154|P2|Overall Study|Adverse Event|1
2616424|NCT00952380|9046155|P1|Overall Study|Adverse Event|0
2616425|NCT00952380|9046151|P5|Overall Study|Withdrawal by Subject|2
2616426|NCT00952380|9046152|P4|Overall Study|Withdrawal by Subject|0
2616427|NCT00952380|9046153|P3|Overall Study|Withdrawal by Subject|1
2616428|NCT00952380|9046154|P2|Overall Study|Withdrawal by Subject|0
2616429|NCT00952380|9046155|P1|Overall Study|Withdrawal by Subject|0
2616430|NCT00952380|9046151|P5|Overall Study|Other|1
2616431|NCT00952380|9046152|P4|Overall Study|Other|0
2616432|NCT00952380|9046153|P3|Overall Study|Other|0
2616433|NCT00952380|9046154|P2|Overall Study|Other|0
2616434|NCT00952380|9046155|P1|Overall Study|Other|0
2616435|NCT00952367|9046256|P1|Overall Study|Protocol Violation|3
2616436|NCT00952367|9046256|P1|Overall Study|Noncoordination|1
2616437|NCT00952367|9046256|P1|Overall Study|Withdrawal by Subject|2
2616438|NCT00952341|9046271|P2|Cycle 2|Progressive Disease|1
2616439|NCT00952341|9046272|P1|Cycle 2|Progressive Disease|0
2616440|NCT00952341|9046271|P2|Cycle 2|Physician Decision|1
2616441|NCT00952341|9046272|P1|Cycle 2|Physician Decision|1
2616442|NCT00952341|9046271|P2|Cycle 2|Lost to Follow-up|9
2616443|NCT00952341|9046272|P1|Cycle 2|Lost to Follow-up|6
2616444|NCT00952341|9046271|P2|Cycle 2|Protocol Violation|0
2616445|NCT00952341|9046272|P1|Cycle 2|Protocol Violation|1
2616446|NCT00952341|9046271|P2|Cycle 2|Withdrawal by Subject|1
2616447|NCT00952341|9046272|P1|Cycle 2|Withdrawal by Subject|1
2616448|NCT00952341|9046271|P2|Cycle 1|Physician Decision|1
2616449|NCT00952341|9046272|P1|Cycle 1|Physician Decision|0
2616450|NCT00952341|9046271|P2|Cycle 1|Lost to Follow-up|2
2616451|NCT00952341|9046272|P1|Cycle 1|Lost to Follow-up|11
2616452|NCT00952341|9046271|P2|Cycle 1|Protocol Violation|1
2616453|NCT00952341|9046272|P1|Cycle 1|Protocol Violation|2
2616454|NCT00952341|9046271|P2|Cycle 1|Withdrawal by Subject|8
2616455|NCT00952341|9046272|P1|Cycle 1|Withdrawal by Subject|3
2616456|NCT00952341|9046271|P2|Cycle 1|Adverse Event|1
2616457|NCT00952341|9046272|P1|Cycle 1|Adverse Event|4
2616458|NCT00952289|9046334|P2|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7
2616459|NCT00952289|9046335|P1|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0
2616460|NCT00952289|9046334|P2|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2
2616461|NCT00952289|9046335|P1|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0
2616462|NCT00952289|9046334|P2|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11
2616463|NCT00952289|9046335|P1|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0
2616464|NCT00952289|9046334|P2|Patients Who Crossed Over to Ruxolitinib|Disease progression|15
2616465|NCT00952289|9046335|P1|Patients Who Crossed Over to Ruxolitinib|Disease progression|0
2616466|NCT00952289|9046334|P2|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19
2616467|NCT00952289|9046335|P1|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0
2616468|NCT00952289|9046334|P2|All Participants|Data lost during site relocation|1
2616469|NCT00952289|9046335|P1|All Participants|Data lost during site relocation|0
2616470|NCT00952289|9046334|P2|All Participants|Withdrawal by Subject|10
2616471|NCT00952289|9046335|P1|All Participants|Withdrawal by Subject|1
2616472|NCT00952289|9046334|P2|All Participants|Disease progression|12
2616473|NCT00952289|9046335|P1|All Participants|Disease progression|3
2616474|NCT00952289|9046334|P2|All Participants|Adverse Event|8
2616475|NCT00952289|9046335|P1|All Participants|Adverse Event|8
2616476|NCT00952289|9046334|P2|All Participants|Death|9
2616477|NCT00952289|9046335|P1|All Participants|Death|9
2616478|NCT00952276|9046364|P5|Overall Study|Withdrawal by Subject|0
2616479|NCT00952276|9046365|P4|Overall Study|Withdrawal by Subject|1
2616480|NCT00952276|9046366|P3|Overall Study|Withdrawal by Subject|0
2616481|NCT00952276|9046367|P2|Overall Study|Withdrawal by Subject|0
2616482|NCT00952276|9046368|P1|Overall Study|Withdrawal by Subject|1
2616483|NCT00952068|9046454|P1|Overall Study|Withdrawal by Subject|4
2616484|NCT00952068|9046454|P1|Overall Study|Adverse Event|3
2616485|NCT00951912|9046465|P3|Overall Study|Other: Stroke|0
2616486|NCT00951912|9046466|P2|Overall Study|Other: Stroke|1
2616487|NCT00951912|9046467|P1|Overall Study|Other: Stroke|0
2616488|NCT00951912|9046465|P3|Overall Study|Other: Colon cancer|0
2616489|NCT00951912|9046466|P2|Overall Study|Other: Colon cancer|0
2616490|NCT00951912|9046467|P1|Overall Study|Other: Colon cancer|1
2616491|NCT00951912|9046465|P3|Overall Study|Other:Depression|0
2616492|NCT00951912|9046466|P2|Overall Study|Other:Depression|0
2616493|NCT00951912|9046467|P1|Overall Study|Other:Depression|1
2616494|NCT00951912|9046465|P3|Overall Study|Withdrawal by Subject|0
2616495|NCT00951912|9046466|P2|Overall Study|Withdrawal by Subject|1
2616496|NCT00951912|9046467|P1|Overall Study|Withdrawal by Subject|1
2616497|NCT00951912|9046465|P3|Overall Study|Physician Decision|1
2616498|NCT00951912|9046466|P2|Overall Study|Physician Decision|0
2616499|NCT00951912|9046467|P1|Overall Study|Physician Decision|1
2616500|NCT00951912|9046465|P3|Overall Study|Lost to Follow-up|0
2616501|NCT00951912|9046466|P2|Overall Study|Lost to Follow-up|2
2616502|NCT00951912|9046467|P1|Overall Study|Lost to Follow-up|2
2616503|NCT00951912|9046465|P3|Overall Study|Adverse Event|1
2616504|NCT00951912|9046466|P2|Overall Study|Adverse Event|1
2616505|NCT00951912|9046467|P1|Overall Study|Adverse Event|0
2616506|NCT00951912|9046465|P3|Overall Study|Lack of Efficacy|0
2616507|NCT00951912|9046466|P2|Overall Study|Lack of Efficacy|0
2616508|NCT00951912|9046467|P1|Overall Study|Lack of Efficacy|1
2616509|NCT00951665|9046567|P6|Phase 2a|Disease Progression|5
2616510|NCT00951665|9046568|P5|Phase 2a|Disease Progression|6
2616511|NCT00951665|9046569|P4|Phase 2a|Disease Progression|0
2616512|NCT00951665|9046570|P3|Phase 2a|Disease Progression|0
2616513|NCT00951665|9046571|P2|Phase 2a|Disease Progression|0
2616514|NCT00951665|9046572|P1|Phase 2a|Disease Progression|0
2616515|NCT00951665|9046567|P6|Phase 2a|Withdrawal by Subject|0
2616516|NCT00951665|9046568|P5|Phase 2a|Withdrawal by Subject|2
2616517|NCT00951665|9046569|P4|Phase 2a|Withdrawal by Subject|0
2616518|NCT00951665|9046570|P3|Phase 2a|Withdrawal by Subject|0
2616519|NCT00951665|9046571|P2|Phase 2a|Withdrawal by Subject|0
2616520|NCT00951665|9046572|P1|Phase 2a|Withdrawal by Subject|0
2616521|NCT00951665|9046567|P6|Phase 2a|Physician Decision|1
2616522|NCT00951665|9046568|P5|Phase 2a|Physician Decision|0
2616523|NCT00951665|9046569|P4|Phase 2a|Physician Decision|0
2616524|NCT00951665|9046570|P3|Phase 2a|Physician Decision|0
2616525|NCT00951665|9046571|P2|Phase 2a|Physician Decision|0
2616526|NCT00951665|9046572|P1|Phase 2a|Physician Decision|0
2616527|NCT00951665|9046567|P6|Phase 2a|Lost to Follow-up|0
2616528|NCT00951665|9046568|P5|Phase 2a|Lost to Follow-up|1
2616529|NCT00951665|9046569|P4|Phase 2a|Lost to Follow-up|0
2616530|NCT00951665|9046570|P3|Phase 2a|Lost to Follow-up|0
2616531|NCT00951665|9046571|P2|Phase 2a|Lost to Follow-up|0
2616532|NCT00951665|9046572|P1|Phase 2a|Lost to Follow-up|0
2616533|NCT00951665|9046567|P6|Phase 2a|Death|1
2616534|NCT00951665|9046568|P5|Phase 2a|Death|1
2616535|NCT00951665|9046569|P4|Phase 2a|Death|0
2616536|NCT00951665|9046570|P3|Phase 2a|Death|0
2616537|NCT00951665|9046571|P2|Phase 2a|Death|0
2616538|NCT00951665|9046572|P1|Phase 2a|Death|0
2616539|NCT00951665|9046567|P6|Phase 2a|Adverse Event|0
2616540|NCT00951665|9046568|P5|Phase 2a|Adverse Event|2
2616541|NCT00951665|9046569|P4|Phase 2a|Adverse Event|0
2616542|NCT00951665|9046570|P3|Phase 2a|Adverse Event|0
2616543|NCT00951665|9046571|P2|Phase 2a|Adverse Event|0
2616544|NCT00951665|9046572|P1|Phase 2a|Adverse Event|0
2616545|NCT00951665|9046567|P6|Phase 1b|Protocol Violation|0
2616546|NCT00951665|9046568|P5|Phase 1b|Protocol Violation|0
2616547|NCT00951665|9046569|P4|Phase 1b|Protocol Violation|0
2616548|NCT00951665|9046570|P3|Phase 1b|Protocol Violation|0
2616549|NCT00951665|9046571|P2|Phase 1b|Protocol Violation|0
2616550|NCT00951665|9046572|P1|Phase 1b|Protocol Violation|2
2616551|NCT00951665|9046567|P6|Phase 1b|Disease Progression|0
2616552|NCT00951665|9046568|P5|Phase 1b|Disease Progression|0
2616553|NCT00951665|9046569|P4|Phase 1b|Disease Progression|0
2616554|NCT00951665|9046570|P3|Phase 1b|Disease Progression|14
2616555|NCT00951665|9046571|P2|Phase 1b|Disease Progression|2
2616556|NCT00951665|9046572|P1|Phase 1b|Disease Progression|13
2616557|NCT00951665|9046567|P6|Phase 1b|Withdrawal by Subject|0
2616558|NCT00951665|9046568|P5|Phase 1b|Withdrawal by Subject|0
2616559|NCT00951665|9046569|P4|Phase 1b|Withdrawal by Subject|0
2616560|NCT00951665|9046570|P3|Phase 1b|Withdrawal by Subject|0
2616561|NCT00951665|9046571|P2|Phase 1b|Withdrawal by Subject|1
2616562|NCT00951665|9046572|P1|Phase 1b|Withdrawal by Subject|0
2616563|NCT00951665|9046567|P6|Phase 1b|Physician Decision|0
2616564|NCT00951665|9046568|P5|Phase 1b|Physician Decision|0
2616565|NCT00951665|9046569|P4|Phase 1b|Physician Decision|0
2616566|NCT00951665|9046570|P3|Phase 1b|Physician Decision|1
2616567|NCT00951665|9046571|P2|Phase 1b|Physician Decision|0
2616568|NCT00951665|9046572|P1|Phase 1b|Physician Decision|4
2616569|NCT00951665|9046567|P6|Phase 1b|Death|0
2616570|NCT00951665|9046568|P5|Phase 1b|Death|0
2616571|NCT00951665|9046569|P4|Phase 1b|Death|0
2616572|NCT00951665|9046570|P3|Phase 1b|Death|2
2616573|NCT00951665|9046571|P2|Phase 1b|Death|0
2616574|NCT00951665|9046572|P1|Phase 1b|Death|1
2616575|NCT00951665|9046567|P6|Phase 1b|Adverse Event|0
2616576|NCT00951665|9046568|P5|Phase 1b|Adverse Event|0
2616577|NCT00951665|9046569|P4|Phase 1b|Adverse Event|1
2616578|NCT00951665|9046570|P3|Phase 1b|Adverse Event|0
2616579|NCT00951665|9046571|P2|Phase 1b|Adverse Event|1
2616580|NCT00951665|9046572|P1|Phase 1b|Adverse Event|2
2616581|NCT00951509|9046681|P1|Overall Study|Withdrawal by Subject|2
2616582|NCT00951496|9046692|P3|Overall Study|Did not initiate study treatment|13
2616583|NCT00951496|9046693|P2|Overall Study|Did not initiate study treatment|8
2616584|NCT00951496|9046694|P1|Overall Study|Did not initiate study treatment|10
2616585|NCT00951483|9046722|P2|Overall Study|Withdrawal by Subject|0
2616586|NCT00951483|9046723|P1|Overall Study|Withdrawal by Subject|15
2616587|NCT00951483|9046722|P2|Overall Study|Physician Decision|0
2616588|NCT00951483|9046723|P1|Overall Study|Physician Decision|4
2616589|NCT00951379|9046743|P2|Overall Study|Disease Progression|1
2616590|NCT00951379|9046744|P1|Overall Study|Disease Progression|0
2616591|NCT00951379|9046743|P2|Overall Study|Noncompliance|0
2616592|NCT00951379|9046744|P1|Overall Study|Noncompliance|1
2616593|NCT00951379|9046743|P2|Overall Study|Withdrawal by Subject|0
2616594|NCT00951379|9046744|P1|Overall Study|Withdrawal by Subject|1
2616595|NCT00951379|9046743|P2|Overall Study|Adverse Event|1
2616596|NCT00951379|9046744|P1|Overall Study|Adverse Event|4
2616597|NCT00951275|9046786|P1|Overall Study|Protocol Violation|1
2616598|NCT00951275|9046786|P1|Overall Study|Withdrawal by Subject|4
2616599|NCT00951275|9046786|P1|Overall Study|Adverse Event|7
2616600|NCT00951275|9046786|P1|Overall Study|Administrative Reason|1
2616601|NCT00951171|9046818|P2|Overall Study|Adverse Event|0
2616602|NCT00951171|9046819|P1|Overall Study|Adverse Event|2
2616603|NCT00951041|9046851|P2|Overall Study|Other|0
2616604|NCT00951041|9046852|P1|Overall Study|Other|3
2616605|NCT00951041|9046851|P2|Overall Study|Lost to Follow-up|0
2616606|NCT00951041|9046852|P1|Overall Study|Lost to Follow-up|1
2616607|NCT00951041|9046851|P2|Overall Study|Withdrawal by Subject|1
2616608|NCT00951041|9046852|P1|Overall Study|Withdrawal by Subject|1
2616609|NCT00951015|9046907|P5|Open-label Phase|Physician Decision|8
2616610|NCT00951015|9046908|P4|Open-label Phase|Physician Decision|0
2616611|NCT00951015|9046909|P3|Open-label Phase|Physician Decision|0
2616612|NCT00951015|9046910|P2|Open-label Phase|Physician Decision|0
2616613|NCT00951015|9046911|P1|Open-label Phase|Physician Decision|0
2616614|NCT00951015|9046907|P5|Open-label Phase|Withdrawal by Subject|14
2616615|NCT00951015|9046908|P4|Open-label Phase|Withdrawal by Subject|0
2616616|NCT00951015|9046909|P3|Open-label Phase|Withdrawal by Subject|0
2616617|NCT00951015|9046910|P2|Open-label Phase|Withdrawal by Subject|0
2616618|NCT00951015|9046911|P1|Open-label Phase|Withdrawal by Subject|0
2616619|NCT00951015|9046907|P5|Open-label Phase|Lost to Follow-up|12
2616620|NCT00951015|9046908|P4|Open-label Phase|Lost to Follow-up|0
2616621|NCT00951015|9046909|P3|Open-label Phase|Lost to Follow-up|0
2616622|NCT00951015|9046910|P2|Open-label Phase|Lost to Follow-up|0
2616623|NCT00951015|9046911|P1|Open-label Phase|Lost to Follow-up|0
2616624|NCT00951015|9046907|P5|Open-label Phase|Protocol Violation|12
2616625|NCT00951015|9046908|P4|Open-label Phase|Protocol Violation|0
2616626|NCT00951015|9046909|P3|Open-label Phase|Protocol Violation|0
2616627|NCT00951015|9046910|P2|Open-label Phase|Protocol Violation|0
2616628|NCT00951015|9046911|P1|Open-label Phase|Protocol Violation|0
2616629|NCT00951015|9046907|P5|Open-label Phase|Lack of Efficacy|1
2616630|NCT00951015|9046908|P4|Open-label Phase|Lack of Efficacy|0
2616631|NCT00951015|9046909|P3|Open-label Phase|Lack of Efficacy|0
2616632|NCT00951015|9046910|P2|Open-label Phase|Lack of Efficacy|0
2616633|NCT00951015|9046911|P1|Open-label Phase|Lack of Efficacy|0
2616634|NCT00951015|9046907|P5|Open-label Phase|Adverse Event|3
2616635|NCT00951015|9046908|P4|Open-label Phase|Adverse Event|0
2616636|NCT00951015|9046909|P3|Open-label Phase|Adverse Event|0
2616637|NCT00951015|9046910|P2|Open-label Phase|Adverse Event|0
2616638|NCT00951015|9046911|P1|Open-label Phase|Adverse Event|0
2616639|NCT00951015|9046907|P5|Randomization Phase 96 Week|Withdrawal by Subject|0
2616640|NCT00951015|9046908|P4|Randomization Phase 96 Week|Withdrawal by Subject|2
2616641|NCT00951015|9046909|P3|Randomization Phase 96 Week|Withdrawal by Subject|1
2616642|NCT00951015|9046910|P2|Randomization Phase 96 Week|Withdrawal by Subject|1
2616643|NCT00951015|9046911|P1|Randomization Phase 96 Week|Withdrawal by Subject|2
2616644|NCT00951015|9046907|P5|Randomization Phase 96 Week|Lost to Follow-up|0
2616645|NCT00951015|9046908|P4|Randomization Phase 96 Week|Lost to Follow-up|2
2616646|NCT00951015|9046909|P3|Randomization Phase 96 Week|Lost to Follow-up|1
2616647|NCT00951015|9046910|P2|Randomization Phase 96 Week|Lost to Follow-up|3
2616648|NCT00951015|9046911|P1|Randomization Phase 96 Week|Lost to Follow-up|0
2616649|NCT00951015|9046907|P5|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
2616650|NCT00951015|9046908|P4|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1
2616651|NCT00951015|9046909|P3|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
2616652|NCT00951015|9046910|P2|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
2616653|NCT00951015|9046911|P1|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
2616654|NCT00951015|9046907|P5|Randomization Phase 96 Week|Protocol Violation|0
2616655|NCT00951015|9046908|P4|Randomization Phase 96 Week|Protocol Violation|0
2616656|NCT00951015|9046909|P3|Randomization Phase 96 Week|Protocol Violation|1
2616657|NCT00951015|9046910|P2|Randomization Phase 96 Week|Protocol Violation|1
2616658|NCT00951015|9046911|P1|Randomization Phase 96 Week|Protocol Violation|1
2616659|NCT00951015|9046907|P5|Randomization Phase 96 Week|Lack of Efficacy|0
2616660|NCT00951015|9046908|P4|Randomization Phase 96 Week|Lack of Efficacy|0
2616661|NCT00951015|9046909|P3|Randomization Phase 96 Week|Lack of Efficacy|0
2616662|NCT00951015|9046910|P2|Randomization Phase 96 Week|Lack of Efficacy|1
2616663|NCT00951015|9046911|P1|Randomization Phase 96 Week|Lack of Efficacy|1
2616664|NCT00951015|9046907|P5|Randomization Phase 96 Week|Adverse Event|0
2616665|NCT00951015|9046908|P4|Randomization Phase 96 Week|Adverse Event|5
2616666|NCT00951015|9046909|P3|Randomization Phase 96 Week|Adverse Event|2
2616667|NCT00951015|9046910|P2|Randomization Phase 96 Week|Adverse Event|1
2616668|NCT00951015|9046911|P1|Randomization Phase 96 Week|Adverse Event|1
2616669|NCT00950963|9047008|P2|Overall Study|Lost to Follow-up|24
2616670|NCT00950963|9047009|P1|Overall Study|Lost to Follow-up|29
2616671|NCT00950950|9047025|P2|Overall Study|Withdrawal by Subject|1
2616672|NCT00950950|9047026|P1|Overall Study|Withdrawal by Subject|0
2616673|NCT00950950|9047025|P2|Overall Study|Adverse Event|0
2616674|NCT00950950|9047026|P1|Overall Study|Adverse Event|1
2616675|NCT00950911|9047108|P2|Overall Study|Poor performance status|1
2616676|NCT00950911|9047109|P1|Overall Study|Poor performance status|0
2616677|NCT00950911|9047108|P2|Overall Study|Noncompliance|0
2616678|NCT00950911|9047109|P1|Overall Study|Noncompliance|1
2616679|NCT00950911|9047108|P2|Overall Study|Ineligibility determined|0
2616680|NCT00950911|9047109|P1|Overall Study|Ineligibility determined|1
2616681|NCT00950911|9047108|P2|Overall Study|Administrative decision|1
2616682|NCT00950911|9047109|P1|Overall Study|Administrative decision|3
2616683|NCT00950911|9047108|P2|Overall Study|Consent withdrawn|3
2616684|NCT00950911|9047109|P1|Overall Study|Consent withdrawn|1
2616685|NCT00950911|9047108|P2|Overall Study|Disease progression|2
2616686|NCT00950911|9047109|P1|Overall Study|Disease progression|2
2616687|NCT00950911|9047108|P2|Overall Study|Death|6
2616688|NCT00950911|9047109|P1|Overall Study|Death|4
2616689|NCT00950911|9047108|P2|Overall Study|Adverse Event|2
2616690|NCT00950911|9047109|P1|Overall Study|Adverse Event|0
2616691|NCT00950872|9047115|P1|Overall Study|Did not have surgery|2
2616692|NCT00950872|9047115|P1|Overall Study|Withdrawal by Subject|1
2616693|NCT00950859|9047124|P2|Overall Study|Lost to Follow-up|3
2616694|NCT00950859|9047125|P1|Overall Study|Lost to Follow-up|0
2616695|NCT00950859|9047124|P2|Overall Study|Protocol Violation|1
2616696|NCT00950859|9047125|P1|Overall Study|Protocol Violation|1
2616697|NCT00950859|9047124|P2|Overall Study|Insufficient Viral Load Response|3
2616698|NCT00950859|9047125|P1|Overall Study|Insufficient Viral Load Response|12
2616699|NCT00950859|9047124|P2|Overall Study|Adverse Event|3
2616700|NCT00950859|9047125|P1|Overall Study|Adverse Event|3
2616701|NCT00950807|9047224|P10|Treatment Period 3|Adverse Event|0
2616702|NCT00950807|9047225|P9|Treatment Period 3|Adverse Event|0
2616703|NCT00950807|9047226|P8|Treatment Period 3|Adverse Event|0
2616704|NCT00950807|9047227|P7|Treatment Period 3|Adverse Event|1
2616705|NCT00950807|9047228|P6|Treatment Period 3|Adverse Event|0
2616706|NCT00950807|9047229|P5|Treatment Period 3|Adverse Event|0
2616707|NCT00950807|9047230|P4|Treatment Period 3|Adverse Event|0
2616708|NCT00950807|9047231|P3|Treatment Period 3|Adverse Event|0
2616709|NCT00950807|9047232|P2|Treatment Period 3|Adverse Event|0
2616710|NCT00950807|9047233|P1|Treatment Period 3|Adverse Event|0
2616711|NCT00950807|9047224|P10|Treatment Period 3|Protocol-defined Stopping Criteria|0
2616712|NCT00950807|9047225|P9|Treatment Period 3|Protocol-defined Stopping Criteria|0
2616713|NCT00950807|9047226|P8|Treatment Period 3|Protocol-defined Stopping Criteria|1
2616714|NCT00950807|9047227|P7|Treatment Period 3|Protocol-defined Stopping Criteria|0
2616715|NCT00950807|9047228|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
2616716|NCT00950807|9047229|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
2616717|NCT00950807|9047230|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
2616718|NCT00950807|9047231|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
2616719|NCT00950807|9047232|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
2616720|NCT00950807|9047233|P1|Treatment Period 3|Protocol-defined Stopping Criteria|1
2616721|NCT00950807|9047224|P10|Treatment Period 3|Withdrawal by Subject|1
2616722|NCT00950807|9047225|P9|Treatment Period 3|Withdrawal by Subject|0
2616723|NCT00950807|9047226|P8|Treatment Period 3|Withdrawal by Subject|0
2616724|NCT00950807|9047227|P7|Treatment Period 3|Withdrawal by Subject|0
2616725|NCT00950807|9047228|P6|Treatment Period 3|Withdrawal by Subject|0
2616726|NCT00950807|9047229|P5|Treatment Period 3|Withdrawal by Subject|0
2616727|NCT00950807|9047230|P4|Treatment Period 3|Withdrawal by Subject|0
2616728|NCT00950807|9047231|P3|Treatment Period 3|Withdrawal by Subject|0
2616729|NCT00950807|9047232|P2|Treatment Period 3|Withdrawal by Subject|0
2616730|NCT00950807|9047233|P1|Treatment Period 3|Withdrawal by Subject|0
2616731|NCT00950807|9047224|P10|Washout Period 2|Adverse Event|0
2616732|NCT00950807|9047225|P9|Washout Period 2|Adverse Event|0
2616733|NCT00950807|9047226|P8|Washout Period 2|Adverse Event|0
2616734|NCT00950807|9047227|P7|Washout Period 2|Adverse Event|0
2616735|NCT00950807|9047228|P6|Washout Period 2|Adverse Event|0
2616736|NCT00950807|9047229|P5|Washout Period 2|Adverse Event|0
2616737|NCT00950807|9047230|P4|Washout Period 2|Adverse Event|1
2616738|NCT00950807|9047231|P3|Washout Period 2|Adverse Event|0
2616739|NCT00950807|9047232|P2|Washout Period 2|Adverse Event|0
2616740|NCT00950807|9047233|P1|Washout Period 2|Adverse Event|3
2616741|NCT00950807|9047224|P10|Washout Period 2|Protocol-defined Stopping Criteria|0
2616742|NCT00950807|9047225|P9|Washout Period 2|Protocol-defined Stopping Criteria|0
2616743|NCT00950807|9047226|P8|Washout Period 2|Protocol-defined Stopping Criteria|1
2616744|NCT00950807|9047227|P7|Washout Period 2|Protocol-defined Stopping Criteria|1
2616745|NCT00950807|9047228|P6|Washout Period 2|Protocol-defined Stopping Criteria|0
2616828|NCT00950807|9047231|P3|Washout Period 1|Withdrawal by Subject|0
2616746|NCT00950807|9047229|P5|Washout Period 2|Protocol-defined Stopping Criteria|1
2616747|NCT00950807|9047230|P4|Washout Period 2|Protocol-defined Stopping Criteria|0
2616748|NCT00950807|9047231|P3|Washout Period 2|Protocol-defined Stopping Criteria|0
2616749|NCT00950807|9047232|P2|Washout Period 2|Protocol-defined Stopping Criteria|1
2616750|NCT00950807|9047233|P1|Washout Period 2|Protocol-defined Stopping Criteria|0
2616751|NCT00950807|9047224|P10|Washout Period 2|Lack of Efficacy|0
2616752|NCT00950807|9047225|P9|Washout Period 2|Lack of Efficacy|0
2616753|NCT00950807|9047226|P8|Washout Period 2|Lack of Efficacy|0
2616754|NCT00950807|9047227|P7|Washout Period 2|Lack of Efficacy|0
2616755|NCT00950807|9047228|P6|Washout Period 2|Lack of Efficacy|0
2616756|NCT00950807|9047229|P5|Washout Period 2|Lack of Efficacy|0
2616757|NCT00950807|9047230|P4|Washout Period 2|Lack of Efficacy|0
2616758|NCT00950807|9047231|P3|Washout Period 2|Lack of Efficacy|0
2616759|NCT00950807|9047232|P2|Washout Period 2|Lack of Efficacy|0
2616760|NCT00950807|9047233|P1|Washout Period 2|Lack of Efficacy|1
2616761|NCT00950807|9047224|P10|Treatment Period 2|Adverse Event|0
2616762|NCT00950807|9047225|P9|Treatment Period 2|Adverse Event|0
2616763|NCT00950807|9047226|P8|Treatment Period 2|Adverse Event|1
2616764|NCT00950807|9047227|P7|Treatment Period 2|Adverse Event|0
2616765|NCT00950807|9047228|P6|Treatment Period 2|Adverse Event|1
2616766|NCT00950807|9047229|P5|Treatment Period 2|Adverse Event|0
2616767|NCT00950807|9047230|P4|Treatment Period 2|Adverse Event|1
2616768|NCT00950807|9047231|P3|Treatment Period 2|Adverse Event|0
2616769|NCT00950807|9047232|P2|Treatment Period 2|Adverse Event|1
2616770|NCT00950807|9047233|P1|Treatment Period 2|Adverse Event|0
2616771|NCT00950807|9047224|P10|Treatment Period 2|Protocol-defined Stopping Criteria|0
2616772|NCT00950807|9047225|P9|Treatment Period 2|Protocol-defined Stopping Criteria|0
2616773|NCT00950807|9047226|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
2616774|NCT00950807|9047227|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
2616775|NCT00950807|9047228|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
2616776|NCT00950807|9047229|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
2616777|NCT00950807|9047230|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
2616778|NCT00950807|9047231|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
2616779|NCT00950807|9047232|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
2616780|NCT00950807|9047233|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
2616781|NCT00950807|9047224|P10|Treatment Period 2|Withdrawal by Subject|0
2616782|NCT00950807|9047225|P9|Treatment Period 2|Withdrawal by Subject|0
2616783|NCT00950807|9047226|P8|Treatment Period 2|Withdrawal by Subject|2
2616784|NCT00950807|9047227|P7|Treatment Period 2|Withdrawal by Subject|1
2616785|NCT00950807|9047228|P6|Treatment Period 2|Withdrawal by Subject|0
2616786|NCT00950807|9047229|P5|Treatment Period 2|Withdrawal by Subject|0
2616787|NCT00950807|9047230|P4|Treatment Period 2|Withdrawal by Subject|0
2616788|NCT00950807|9047231|P3|Treatment Period 2|Withdrawal by Subject|0
2616789|NCT00950807|9047232|P2|Treatment Period 2|Withdrawal by Subject|0
2616790|NCT00950807|9047233|P1|Treatment Period 2|Withdrawal by Subject|0
2616791|NCT00950807|9047224|P10|Treatment Period 2|Lack of Efficacy|0
2616792|NCT00950807|9047225|P9|Treatment Period 2|Lack of Efficacy|0
2616793|NCT00950807|9047226|P8|Treatment Period 2|Lack of Efficacy|0
2616794|NCT00950807|9047227|P7|Treatment Period 2|Lack of Efficacy|0
2616795|NCT00950807|9047228|P6|Treatment Period 2|Lack of Efficacy|0
2616796|NCT00950807|9047229|P5|Treatment Period 2|Lack of Efficacy|0
2616797|NCT00950807|9047230|P4|Treatment Period 2|Lack of Efficacy|0
2616798|NCT00950807|9047231|P3|Treatment Period 2|Lack of Efficacy|0
2616799|NCT00950807|9047232|P2|Treatment Period 2|Lack of Efficacy|0
2616800|NCT00950807|9047233|P1|Treatment Period 2|Lack of Efficacy|1
2616801|NCT00950807|9047224|P10|Washout Period 1|Adverse Event|0
2616802|NCT00950807|9047225|P9|Washout Period 1|Adverse Event|0
2616803|NCT00950807|9047226|P8|Washout Period 1|Adverse Event|0
2616804|NCT00950807|9047227|P7|Washout Period 1|Adverse Event|0
2616805|NCT00950807|9047228|P6|Washout Period 1|Adverse Event|0
2616806|NCT00950807|9047229|P5|Washout Period 1|Adverse Event|1
2616807|NCT00950807|9047230|P4|Washout Period 1|Adverse Event|1
2616808|NCT00950807|9047231|P3|Washout Period 1|Adverse Event|0
2616809|NCT00950807|9047232|P2|Washout Period 1|Adverse Event|0
2616810|NCT00950807|9047233|P1|Washout Period 1|Adverse Event|2
2616811|NCT00950807|9047224|P10|Washout Period 1|Protocol-defined Stopping Criteria|0
2616812|NCT00950807|9047225|P9|Washout Period 1|Protocol-defined Stopping Criteria|0
2616813|NCT00950807|9047226|P8|Washout Period 1|Protocol-defined Stopping Criteria|1
2616814|NCT00950807|9047227|P7|Washout Period 1|Protocol-defined Stopping Criteria|1
2616815|NCT00950807|9047228|P6|Washout Period 1|Protocol-defined Stopping Criteria|0
2616816|NCT00950807|9047229|P5|Washout Period 1|Protocol-defined Stopping Criteria|0
2616817|NCT00950807|9047230|P4|Washout Period 1|Protocol-defined Stopping Criteria|0
2616818|NCT00950807|9047231|P3|Washout Period 1|Protocol-defined Stopping Criteria|0
2616819|NCT00950807|9047232|P2|Washout Period 1|Protocol-defined Stopping Criteria|0
2616820|NCT00950807|9047233|P1|Washout Period 1|Protocol-defined Stopping Criteria|3
2616821|NCT00950807|9047224|P10|Washout Period 1|Withdrawal by Subject|0
2616822|NCT00950807|9047225|P9|Washout Period 1|Withdrawal by Subject|1
2616823|NCT00950807|9047226|P8|Washout Period 1|Withdrawal by Subject|0
2616824|NCT00950807|9047227|P7|Washout Period 1|Withdrawal by Subject|0
2616825|NCT00950807|9047228|P6|Washout Period 1|Withdrawal by Subject|0
2616826|NCT00950807|9047229|P5|Washout Period 1|Withdrawal by Subject|0
2616827|NCT00950807|9047230|P4|Washout Period 1|Withdrawal by Subject|0
2616829|NCT00950807|9047232|P2|Washout Period 1|Withdrawal by Subject|0
2616830|NCT00950807|9047233|P1|Washout Period 1|Withdrawal by Subject|0
2616831|NCT00950807|9047224|P10|Washout Period 1|Lack of Efficacy|0
2616832|NCT00950807|9047225|P9|Washout Period 1|Lack of Efficacy|0
2616833|NCT00950807|9047226|P8|Washout Period 1|Lack of Efficacy|0
2616834|NCT00950807|9047227|P7|Washout Period 1|Lack of Efficacy|1
2616835|NCT00950807|9047228|P6|Washout Period 1|Lack of Efficacy|0
2616836|NCT00950807|9047229|P5|Washout Period 1|Lack of Efficacy|0
2616837|NCT00950807|9047230|P4|Washout Period 1|Lack of Efficacy|0
2616838|NCT00950807|9047231|P3|Washout Period 1|Lack of Efficacy|0
2616839|NCT00950807|9047232|P2|Washout Period 1|Lack of Efficacy|0
2616840|NCT00950807|9047233|P1|Washout Period 1|Lack of Efficacy|0
2616841|NCT00950807|9047224|P10|Treatment Period 1|Adverse Event|0
2616842|NCT00950807|9047225|P9|Treatment Period 1|Adverse Event|0
2616843|NCT00950807|9047226|P8|Treatment Period 1|Adverse Event|0
2616844|NCT00950807|9047227|P7|Treatment Period 1|Adverse Event|0
2616845|NCT00950807|9047228|P6|Treatment Period 1|Adverse Event|1
2616846|NCT00950807|9047229|P5|Treatment Period 1|Adverse Event|0
2616847|NCT00950807|9047230|P4|Treatment Period 1|Adverse Event|0
2616848|NCT00950807|9047231|P3|Treatment Period 1|Adverse Event|0
2616849|NCT00950807|9047232|P2|Treatment Period 1|Adverse Event|0
2616850|NCT00950807|9047233|P1|Treatment Period 1|Adverse Event|0
2616851|NCT00950807|9047224|P10|Treatment Period 1|Withdrawal by Subject|0
2616852|NCT00950807|9047225|P9|Treatment Period 1|Withdrawal by Subject|1
2616853|NCT00950807|9047226|P8|Treatment Period 1|Withdrawal by Subject|0
2616854|NCT00950807|9047227|P7|Treatment Period 1|Withdrawal by Subject|0
2616855|NCT00950807|9047228|P6|Treatment Period 1|Withdrawal by Subject|0
2616856|NCT00950807|9047229|P5|Treatment Period 1|Withdrawal by Subject|1
2616857|NCT00950807|9047230|P4|Treatment Period 1|Withdrawal by Subject|0
2616858|NCT00950807|9047231|P3|Treatment Period 1|Withdrawal by Subject|0
2616859|NCT00950807|9047232|P2|Treatment Period 1|Withdrawal by Subject|0
2616860|NCT00950807|9047233|P1|Treatment Period 1|Withdrawal by Subject|1
2616861|NCT00950807|9047224|P10|Treatment Period 1|Lost to Follow-up|0
2616862|NCT00950807|9047225|P9|Treatment Period 1|Lost to Follow-up|0
2616863|NCT00950807|9047226|P8|Treatment Period 1|Lost to Follow-up|0
2616864|NCT00950807|9047227|P7|Treatment Period 1|Lost to Follow-up|0
2616865|NCT00950807|9047228|P6|Treatment Period 1|Lost to Follow-up|0
2616866|NCT00950807|9047229|P5|Treatment Period 1|Lost to Follow-up|0
2616867|NCT00950807|9047230|P4|Treatment Period 1|Lost to Follow-up|0
2616868|NCT00950807|9047231|P3|Treatment Period 1|Lost to Follow-up|1
2616869|NCT00950807|9047232|P2|Treatment Period 1|Lost to Follow-up|0
2616870|NCT00950807|9047233|P1|Treatment Period 1|Lost to Follow-up|0
2616871|NCT00950807|9047224|P10|Treatment Period 1|Protocol Violation|0
2616872|NCT00950807|9047225|P9|Treatment Period 1|Protocol Violation|0
2616873|NCT00950807|9047226|P8|Treatment Period 1|Protocol Violation|0
2616874|NCT00950807|9047227|P7|Treatment Period 1|Protocol Violation|0
2616875|NCT00950807|9047228|P6|Treatment Period 1|Protocol Violation|0
2616876|NCT00950807|9047229|P5|Treatment Period 1|Protocol Violation|0
2616877|NCT00950807|9047230|P4|Treatment Period 1|Protocol Violation|0
2616878|NCT00950807|9047231|P3|Treatment Period 1|Protocol Violation|0
2616879|NCT00950807|9047232|P2|Treatment Period 1|Protocol Violation|0
2616880|NCT00950807|9047233|P1|Treatment Period 1|Protocol Violation|1
2616881|NCT00950807|9047224|P10|Treatment Period 1|Lack of Efficacy|0
2616882|NCT00950807|9047225|P9|Treatment Period 1|Lack of Efficacy|0
2616883|NCT00950807|9047226|P8|Treatment Period 1|Lack of Efficacy|0
2616884|NCT00950807|9047227|P7|Treatment Period 1|Lack of Efficacy|0
2616885|NCT00950807|9047228|P6|Treatment Period 1|Lack of Efficacy|1
2616886|NCT00950807|9047229|P5|Treatment Period 1|Lack of Efficacy|0
2616887|NCT00950807|9047230|P4|Treatment Period 1|Lack of Efficacy|0
2616888|NCT00950807|9047231|P3|Treatment Period 1|Lack of Efficacy|0
2616889|NCT00950807|9047232|P2|Treatment Period 1|Lack of Efficacy|0
2616890|NCT00950807|9047233|P1|Treatment Period 1|Lack of Efficacy|1
2616891|NCT00950755|9047275|P1|Long-Term Follow-Up|Death|8
2616892|NCT00950755|9047275|P1|Long-Term Follow-Up|Lost to Follow-up|1
2616893|NCT00950755|9047275|P1|Dosimetric and Therapeutic Treatment|Investigator Discretion|1
2616894|NCT00950755|9047275|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6
2616895|NCT00950755|9047275|P1|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1
2616896|NCT00950755|9047275|P1|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1
2616897|NCT00950755|9047275|P1|Dosimetric and Therapeutic Treatment|Death|1
2616898|NCT00950755|9047275|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|27
2616899|NCT00950755|9047275|P1|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1
2616900|NCT00950755|9047275|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
2616901|NCT00950742|9047301|P2|Overall Study|Dose limiting toxicity|0
2616902|NCT00950742|9047302|P1|Overall Study|Dose limiting toxicity|6
2616903|NCT00950742|9047301|P2|Overall Study|Progressive Disease|2
2616904|NCT00950742|9047302|P1|Overall Study|Progressive Disease|6
2616905|NCT00950742|9047301|P2|Overall Study|Withdrawal by Subject|0
2616906|NCT00950742|9047302|P1|Overall Study|Withdrawal by Subject|3
2616907|NCT00950742|9047301|P2|Overall Study|Other Adverse Event|0
2616908|NCT00950742|9047302|P1|Overall Study|Other Adverse Event|1
2616909|NCT00950690|9047323|P1|Overall Study|Other|163
2616910|NCT00950690|9047323|P1|Overall Study|Lost to Follow-up|40
2616911|NCT00950690|9047323|P1|Overall Study|Lack of Efficacy|22
2616912|NCT00950690|9047323|P1|Overall Study|Adverse Event|15
2616913|NCT00950690|9047323|P1|Overall Study|Death|4
2616914|NCT00950664|9047330|P2|First Intervention|Withdrawal by Subject|2
2616915|NCT00950664|9047331|P1|First Intervention|Withdrawal by Subject|2
2616916|NCT00950664|9047330|P2|First Intervention|Lost to Follow-up|3
2616917|NCT00950664|9047331|P1|First Intervention|Lost to Follow-up|1
2616918|NCT00950651|9047351|P2|Overall Study|Withdrawal by Subject|9
2616919|NCT00950651|9047352|P1|Overall Study|Withdrawal by Subject|8
2616920|NCT00950651|9047351|P2|Overall Study|Protocol Violation|4
2616921|NCT00950651|9047352|P1|Overall Study|Protocol Violation|3
2616922|NCT00950651|9047351|P2|Overall Study|Lack of Efficacy|2
2616923|NCT00950651|9047352|P1|Overall Study|Lack of Efficacy|2
2616924|NCT00950651|9047351|P2|Overall Study|Death|0
2616925|NCT00950651|9047352|P1|Overall Study|Death|1
2616926|NCT00950651|9047351|P2|Overall Study|Adverse Event|20
2616927|NCT00950651|9047352|P1|Overall Study|Adverse Event|17
2616928|NCT00950599|9047445|P10|Follow-Up Period|Subject withdrew Consent|1
2616929|NCT00950599|9047446|P9|Follow-Up Period|Subject withdrew Consent|2
2616930|NCT00950599|9047447|P8|Follow-Up Period|Subject withdrew Consent|0
2616931|NCT00950599|9047448|P7|Follow-Up Period|Subject withdrew Consent|0
2616932|NCT00950599|9047449|P6|Follow-Up Period|Subject withdrew Consent|0
2616933|NCT00950599|9047450|P5|Follow-Up Period|Subject withdrew Consent|0
2616934|NCT00950599|9047451|P4|Follow-Up Period|Subject withdrew Consent|0
2616935|NCT00950599|9047452|P3|Follow-Up Period|Subject withdrew Consent|0
2616936|NCT00950599|9047453|P2|Follow-Up Period|Subject withdrew Consent|0
2616937|NCT00950599|9047454|P1|Follow-Up Period|Subject withdrew Consent|0
2616938|NCT00950599|9047445|P10|Follow-Up Period|Poor/Noncompliance|0
2616939|NCT00950599|9047446|P9|Follow-Up Period|Poor/Noncompliance|1
2616940|NCT00950599|9047447|P8|Follow-Up Period|Poor/Noncompliance|0
2616941|NCT00950599|9047448|P7|Follow-Up Period|Poor/Noncompliance|0
2616942|NCT00950599|9047449|P6|Follow-Up Period|Poor/Noncompliance|0
2616943|NCT00950599|9047450|P5|Follow-Up Period|Poor/Noncompliance|0
2616944|NCT00950599|9047451|P4|Follow-Up Period|Poor/Noncompliance|0
2616945|NCT00950599|9047452|P3|Follow-Up Period|Poor/Noncompliance|0
2616946|NCT00950599|9047453|P2|Follow-Up Period|Poor/Noncompliance|0
2616947|NCT00950599|9047454|P1|Follow-Up Period|Poor/Noncompliance|0
2616948|NCT00950599|9047445|P10|Follow-Up Period|Physician Decision|0
2616949|NCT00950599|9047446|P9|Follow-Up Period|Physician Decision|1
2616950|NCT00950599|9047447|P8|Follow-Up Period|Physician Decision|0
2616951|NCT00950599|9047448|P7|Follow-Up Period|Physician Decision|0
2616952|NCT00950599|9047449|P6|Follow-Up Period|Physician Decision|0
2616953|NCT00950599|9047450|P5|Follow-Up Period|Physician Decision|0
2616954|NCT00950599|9047451|P4|Follow-Up Period|Physician Decision|0
2616955|NCT00950599|9047452|P3|Follow-Up Period|Physician Decision|0
2616956|NCT00950599|9047453|P2|Follow-Up Period|Physician Decision|0
2616957|NCT00950599|9047454|P1|Follow-Up Period|Physician Decision|0
2616958|NCT00950599|9047445|P10|Follow-Up Period|Lost to Follow-up|1
2616959|NCT00950599|9047446|P9|Follow-Up Period|Lost to Follow-up|5
2616960|NCT00950599|9047447|P8|Follow-Up Period|Lost to Follow-up|0
2616961|NCT00950599|9047448|P7|Follow-Up Period|Lost to Follow-up|0
2616962|NCT00950599|9047449|P6|Follow-Up Period|Lost to Follow-up|0
2616963|NCT00950599|9047450|P5|Follow-Up Period|Lost to Follow-up|0
2616964|NCT00950599|9047451|P4|Follow-Up Period|Lost to Follow-up|0
2616965|NCT00950599|9047452|P3|Follow-Up Period|Lost to Follow-up|0
2616966|NCT00950599|9047453|P2|Follow-Up Period|Lost to Follow-up|0
2616967|NCT00950599|9047454|P1|Follow-Up Period|Lost to Follow-up|0
2616968|NCT00950599|9047445|P10|Follow-Up Period|Lack of Efficacy|0
2616969|NCT00950599|9047446|P9|Follow-Up Period|Lack of Efficacy|3
2616970|NCT00950599|9047447|P8|Follow-Up Period|Lack of Efficacy|0
2616971|NCT00950599|9047448|P7|Follow-Up Period|Lack of Efficacy|0
2616972|NCT00950599|9047449|P6|Follow-Up Period|Lack of Efficacy|0
2616973|NCT00950599|9047450|P5|Follow-Up Period|Lack of Efficacy|0
2616974|NCT00950599|9047451|P4|Follow-Up Period|Lack of Efficacy|0
2616975|NCT00950599|9047452|P3|Follow-Up Period|Lack of Efficacy|0
2616976|NCT00950599|9047453|P2|Follow-Up Period|Lack of Efficacy|0
2616977|NCT00950599|9047454|P1|Follow-Up Period|Lack of Efficacy|0
2616978|NCT00950599|9047445|P10|Follow-Up Period|Adverse Event|0
2616979|NCT00950599|9047446|P9|Follow-Up Period|Adverse Event|1
2616980|NCT00950599|9047447|P8|Follow-Up Period|Adverse Event|0
2616981|NCT00950599|9047448|P7|Follow-Up Period|Adverse Event|0
2616982|NCT00950599|9047449|P6|Follow-Up Period|Adverse Event|0
2616983|NCT00950599|9047450|P5|Follow-Up Period|Adverse Event|0
2616984|NCT00950599|9047451|P4|Follow-Up Period|Adverse Event|0
2616985|NCT00950599|9047452|P3|Follow-Up Period|Adverse Event|0
2616986|NCT00950599|9047453|P2|Follow-Up Period|Adverse Event|0
2616987|NCT00950599|9047454|P1|Follow-Up Period|Adverse Event|0
2616988|NCT00950599|9047445|P10|Double-Blind Treatment Period|Subject Withdrew consent|0
2616989|NCT00950599|9047446|P9|Double-Blind Treatment Period|Subject Withdrew consent|0
2616990|NCT00950599|9047447|P8|Double-Blind Treatment Period|Subject Withdrew consent|3
2616991|NCT00950599|9047448|P7|Double-Blind Treatment Period|Subject Withdrew consent|0
2616992|NCT00950599|9047449|P6|Double-Blind Treatment Period|Subject Withdrew consent|2
2616993|NCT00950599|9047450|P5|Double-Blind Treatment Period|Subject Withdrew consent|1
2616994|NCT00950599|9047451|P4|Double-Blind Treatment Period|Subject Withdrew consent|1
2616995|NCT00950599|9047452|P3|Double-Blind Treatment Period|Subject Withdrew consent|3
2616996|NCT00950599|9047453|P2|Double-Blind Treatment Period|Subject Withdrew consent|3
2616997|NCT00950599|9047454|P1|Double-Blind Treatment Period|Subject Withdrew consent|4
2616998|NCT00950599|9047445|P10|Double-Blind Treatment Period|Subject no longer meets study criteria|0
2616999|NCT00950599|9047446|P9|Double-Blind Treatment Period|Subject no longer meets study criteria|0
2617000|NCT00950599|9047447|P8|Double-Blind Treatment Period|Subject no longer meets study criteria|0
2617001|NCT00950599|9047448|P7|Double-Blind Treatment Period|Subject no longer meets study criteria|0
2617002|NCT00950599|9047449|P6|Double-Blind Treatment Period|Subject no longer meets study criteria|1
2617003|NCT00950599|9047450|P5|Double-Blind Treatment Period|Subject no longer meets study criteria|1
2617004|NCT00950599|9047451|P4|Double-Blind Treatment Period|Subject no longer meets study criteria|0
2617005|NCT00950599|9047452|P3|Double-Blind Treatment Period|Subject no longer meets study criteria|0
2617006|NCT00950599|9047453|P2|Double-Blind Treatment Period|Subject no longer meets study criteria|0
2617007|NCT00950599|9047454|P1|Double-Blind Treatment Period|Subject no longer meets study criteria|0
2617008|NCT00950599|9047445|P10|Double-Blind Treatment Period|Poor/Noncompliance|0
2617009|NCT00950599|9047446|P9|Double-Blind Treatment Period|Poor/Noncompliance|0
2617010|NCT00950599|9047447|P8|Double-Blind Treatment Period|Poor/Noncompliance|1
2617011|NCT00950599|9047448|P7|Double-Blind Treatment Period|Poor/Noncompliance|0
2617012|NCT00950599|9047449|P6|Double-Blind Treatment Period|Poor/Noncompliance|0
2617013|NCT00950599|9047450|P5|Double-Blind Treatment Period|Poor/Noncompliance|0
2617014|NCT00950599|9047451|P4|Double-Blind Treatment Period|Poor/Noncompliance|0
2617015|NCT00950599|9047452|P3|Double-Blind Treatment Period|Poor/Noncompliance|0
2617016|NCT00950599|9047453|P2|Double-Blind Treatment Period|Poor/Noncompliance|1
2617017|NCT00950599|9047454|P1|Double-Blind Treatment Period|Poor/Noncompliance|1
2617018|NCT00950599|9047445|P10|Double-Blind Treatment Period|Lost to Follow-up|0
2617019|NCT00950599|9047446|P9|Double-Blind Treatment Period|Lost to Follow-up|0
2617020|NCT00950599|9047447|P8|Double-Blind Treatment Period|Lost to Follow-up|1
2617021|NCT00950599|9047448|P7|Double-Blind Treatment Period|Lost to Follow-up|0
2617022|NCT00950599|9047449|P6|Double-Blind Treatment Period|Lost to Follow-up|2
2617023|NCT00950599|9047450|P5|Double-Blind Treatment Period|Lost to Follow-up|1
2617024|NCT00950599|9047451|P4|Double-Blind Treatment Period|Lost to Follow-up|1
2617025|NCT00950599|9047452|P3|Double-Blind Treatment Period|Lost to Follow-up|0
2617026|NCT00950599|9047453|P2|Double-Blind Treatment Period|Lost to Follow-up|0
2617027|NCT00950599|9047454|P1|Double-Blind Treatment Period|Lost to Follow-up|0
2617028|NCT00950599|9047445|P10|Double-Blind Treatment Period|Lack of Efficacy|0
2617029|NCT00950599|9047446|P9|Double-Blind Treatment Period|Lack of Efficacy|0
2617030|NCT00950599|9047447|P8|Double-Blind Treatment Period|Lack of Efficacy|1
2617031|NCT00950599|9047448|P7|Double-Blind Treatment Period|Lack of Efficacy|0
2617032|NCT00950599|9047449|P6|Double-Blind Treatment Period|Lack of Efficacy|6
2617033|NCT00950599|9047450|P5|Double-Blind Treatment Period|Lack of Efficacy|3
2617034|NCT00950599|9047451|P4|Double-Blind Treatment Period|Lack of Efficacy|7
2617035|NCT00950599|9047452|P3|Double-Blind Treatment Period|Lack of Efficacy|5
2617036|NCT00950599|9047453|P2|Double-Blind Treatment Period|Lack of Efficacy|5
2617037|NCT00950599|9047454|P1|Double-Blind Treatment Period|Lack of Efficacy|2
2617038|NCT00950599|9047445|P10|Double-Blind Treatment Period|Adverse Event|0
2617039|NCT00950599|9047446|P9|Double-Blind Treatment Period|Adverse Event|0
2617040|NCT00950599|9047447|P8|Double-Blind Treatment Period|Adverse Event|0
2617041|NCT00950599|9047448|P7|Double-Blind Treatment Period|Adverse Event|0
2617042|NCT00950599|9047449|P6|Double-Blind Treatment Period|Adverse Event|1
2617043|NCT00950599|9047450|P5|Double-Blind Treatment Period|Adverse Event|1
2617044|NCT00950599|9047451|P4|Double-Blind Treatment Period|Adverse Event|1
2617045|NCT00950599|9047452|P3|Double-Blind Treatment Period|Adverse Event|1
2617046|NCT00950599|9047453|P2|Double-Blind Treatment Period|Adverse Event|1
2617047|NCT00950599|9047454|P1|Double-Blind Treatment Period|Adverse Event|0
2617048|NCT00950599|9047445|P10|Double-Blind Treatment Period|Administrative reason by sponsor|0
2617049|NCT00950599|9047446|P9|Double-Blind Treatment Period|Administrative reason by sponsor|0
2617050|NCT00950599|9047447|P8|Double-Blind Treatment Period|Administrative reason by sponsor|0
2617051|NCT00950599|9047448|P7|Double-Blind Treatment Period|Administrative reason by sponsor|0
2617052|NCT00950599|9047449|P6|Double-Blind Treatment Period|Administrative reason by sponsor|0
2617053|NCT00950599|9047450|P5|Double-Blind Treatment Period|Administrative reason by sponsor|0
2617054|NCT00950599|9047451|P4|Double-Blind Treatment Period|Administrative reason by sponsor|1
2617055|NCT00950599|9047452|P3|Double-Blind Treatment Period|Administrative reason by sponsor|0
2617056|NCT00950599|9047453|P2|Double-Blind Treatment Period|Administrative reason by sponsor|0
2617057|NCT00950599|9047454|P1|Double-Blind Treatment Period|Administrative reason by sponsor|0
2617058|NCT00950300|9048027|P2|SFU Period|Withdrawal by Subject|8
2617059|NCT00950300|9048028|P1|SFU Period|Withdrawal by Subject|4
2617060|NCT00950300|9048027|P2|SFU Period|Lost to Follow-up|28
2617061|NCT00950300|9048028|P1|SFU Period|Lost to Follow-up|30
2617062|NCT00950300|9048027|P2|SFU Period|Death|42
2617063|NCT00950300|9048028|P1|SFU Period|Death|44
2617064|NCT00950300|9048027|P2|TFFU Period|Other|3
2617065|NCT00950300|9048028|P1|TFFU Period|Other|4
2617066|NCT00950300|9048027|P2|TFFU Period|Recurrence of Disease|72
2617067|NCT00950300|9048028|P1|TFFU Period|Recurrence of Disease|63
2617068|NCT00950300|9048027|P2|TFFU Period|Failure to Return|16
2617069|NCT00950300|9048028|P1|TFFU Period|Failure to Return|16
2617070|NCT00950300|9048027|P2|TFFU Period|Refused Treatment|11
2617071|NCT00950300|9048028|P1|TFFU Period|Refused Treatment|10
2617072|NCT00950300|9048027|P2|TFFU Period|Death|1
2617073|NCT00950300|9048028|P1|TFFU Period|Death|4
2617074|NCT00950300|9048027|P2|TFFU Period|Adverse Event or Intercurrent Illness|4
2617075|NCT00950300|9048028|P1|TFFU Period|Adverse Event or Intercurrent Illness|3
2617076|NCT00950300|9048027|P2|Neoadjuvant/Adjuvant Treatment Periods|Other|1
2617077|NCT00950300|9048028|P1|Neoadjuvant/Adjuvant Treatment Periods|Other|1
2617078|NCT00950300|9048027|P2|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5
2617079|NCT00950300|9048028|P1|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10
2617080|NCT00950300|9048027|P2|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11
2617081|NCT00950300|9048028|P1|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12
2617082|NCT00950300|9048027|P2|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1
2617083|NCT00950300|9048028|P1|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2
2617084|NCT00950300|9048027|P2|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5
2617085|NCT00950300|9048028|P1|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4
2617086|NCT00950300|9048027|P2|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0
2617087|NCT00950300|9048028|P1|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1
2617088|NCT00950300|9048027|P2|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1
2617089|NCT00950300|9048028|P1|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2
2617090|NCT00950300|9048027|P2|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0
2617091|NCT00950300|9048028|P1|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3
2617092|NCT00950300|9048027|P2|Neoadjuvant/Adjuvant Treatment Periods|Death|3
2617093|NCT00950300|9048028|P1|Neoadjuvant/Adjuvant Treatment Periods|Death|1
2617094|NCT00950300|9048027|P2|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15
2617095|NCT00950300|9048028|P1|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6
2617096|NCT00950248|9048077|P3|Year 2&3 Treatment Randomization|MRI contraindication|0
2617097|NCT00950248|9048078|P2|Year 2&3 Treatment Randomization|MRI contraindication|1
2617098|NCT00950248|9048079|P1|Year 2&3 Treatment Randomization|MRI contraindication|0
2617099|NCT00950248|9048077|P3|Year 2&3 Treatment Randomization|Death|1
2617100|NCT00950248|9048078|P2|Year 2&3 Treatment Randomization|Death|0
2617101|NCT00950248|9048079|P1|Year 2&3 Treatment Randomization|Death|0
2617102|NCT00950248|9048077|P3|Year 2&3 Treatment Randomization|Withdrawal by Subject|0
2617103|NCT00950248|9048078|P2|Year 2&3 Treatment Randomization|Withdrawal by Subject|3
2617104|NCT00950248|9048079|P1|Year 2&3 Treatment Randomization|Withdrawal by Subject|0
2617105|NCT00950248|9048077|P3|Year 2&3 Treatment Randomization|worsening of symptoms|4
2617106|NCT00950248|9048078|P2|Year 2&3 Treatment Randomization|worsening of symptoms|2
2617107|NCT00950248|9048079|P1|Year 2&3 Treatment Randomization|worsening of symptoms|0
2617108|NCT00950248|9048077|P3|Year 1: Baseline|worsening of symptoms|0
2617109|NCT00950248|9048078|P2|Year 1: Baseline|worsening of symptoms|0
2617110|NCT00950248|9048079|P1|Year 1: Baseline|worsening of symptoms|2
2617111|NCT00950248|9048077|P3|Year 1: Baseline|Withdrawal by Subject|0
2617112|NCT00950248|9048078|P2|Year 1: Baseline|Withdrawal by Subject|0
2617113|NCT00950248|9048079|P1|Year 1: Baseline|Withdrawal by Subject|6
2617114|NCT00950170|9048119|P1|Overall Study|Discontinuation of Study by Sponsor|1
2617115|NCT00950170|9048119|P1|Overall Study|Adverse Event|2
2617116|NCT00950170|9048119|P1|Overall Study|Parent/Legal Guardian Request|1
2617117|NCT00949988|9048170|P1|Overall Study|Withdrawal by Subject|3
2617118|NCT00949975|9048185|P4|Overall Study|Other|0
2617119|NCT00949975|9048186|P3|Overall Study|Other|0
2617120|NCT00949975|9048187|P2|Overall Study|Other|0
2617121|NCT00949975|9048188|P1|Overall Study|Other|1
2617122|NCT00949975|9048185|P4|Overall Study|Lost to Follow-up|3
2617123|NCT00949975|9048186|P3|Overall Study|Lost to Follow-up|1
2617124|NCT00949975|9048187|P2|Overall Study|Lost to Follow-up|0
2617125|NCT00949975|9048188|P1|Overall Study|Lost to Follow-up|1
2617126|NCT00949975|9048185|P4|Overall Study|Severe non-compliance|2
2617127|NCT00949975|9048186|P3|Overall Study|Severe non-compliance|0
2617128|NCT00949975|9048187|P2|Overall Study|Severe non-compliance|1
2617129|NCT00949975|9048188|P1|Overall Study|Severe non-compliance|3
2617130|NCT00949975|9048185|P4|Overall Study|Incorrect enrolment|7
2617131|NCT00949975|9048186|P3|Overall Study|Incorrect enrolment|4
2617132|NCT00949975|9048187|P2|Overall Study|Incorrect enrolment|10
2617133|NCT00949975|9048188|P1|Overall Study|Incorrect enrolment|5
2617134|NCT00949975|9048185|P4|Overall Study|Study-specific criteria|0
2617135|NCT00949975|9048186|P3|Overall Study|Study-specific criteria|1
2617136|NCT00949975|9048187|P2|Overall Study|Study-specific criteria|1
2617137|NCT00949975|9048188|P1|Overall Study|Study-specific criteria|0
2617138|NCT00949975|9048185|P4|Overall Study|Safety reason|0
2617139|NCT00949975|9048186|P3|Overall Study|Safety reason|0
2617140|NCT00949975|9048187|P2|Overall Study|Safety reason|1
2617141|NCT00949975|9048188|P1|Overall Study|Safety reason|0
2617142|NCT00949975|9048185|P4|Overall Study|Adverse Event|10
2617143|NCT00949975|9048186|P3|Overall Study|Adverse Event|10
2617144|NCT00949975|9048187|P2|Overall Study|Adverse Event|11
2617145|NCT00949975|9048188|P1|Overall Study|Adverse Event|11
2617146|NCT00949975|9048185|P4|Overall Study|Voluntary discontinuation|6
2617147|NCT00949975|9048186|P3|Overall Study|Voluntary discontinuation|3
2617148|NCT00949975|9048187|P2|Overall Study|Voluntary discontinuation|5
2617149|NCT00949975|9048188|P1|Overall Study|Voluntary discontinuation|6
2617150|NCT00949910|9048306|P1|Overall Study|No Data|9
2617151|NCT00949910|9048306|P1|Overall Study|Other|4
2617152|NCT00949910|9048306|P1|Overall Study|Physician/Participant Decision|7
2617153|NCT00949910|9048306|P1|Overall Study|Serious Adverse Event|6
2617154|NCT00949910|9048306|P1|Overall Study|Adverse Event|83
2617155|NCT00949910|9048306|P1|Overall Study|Prolonged Dosing Interruption|4
2617156|NCT00949910|9048306|P1|Overall Study|Non-Compliance|10
2617157|NCT00949910|9048306|P1|Overall Study|Logistical Reasons|13
2617158|NCT00949910|9048306|P1|Overall Study|Violation of Eligibility|23
2617159|NCT00949910|9048306|P1|Overall Study|Switched to Commercial Treatment|4
2617160|NCT00949910|9048306|P1|Overall Study|Switched to Compassionate/Other Use|174
2617161|NCT00949910|9048306|P1|Overall Study|Unspecified Progression/Deterioration|13
2617162|NCT00949910|9048306|P1|Overall Study|Death from Unknown Cause|5
2617163|NCT00949910|9048306|P1|Overall Study|Death Due to Toxicity|3
2617164|NCT00949910|9048306|P1|Overall Study|Death Due to Adverse Event|115
2617165|NCT00949910|9048306|P1|Overall Study|Death Due to Progression/Deterioration|4
2617166|NCT00949910|9048306|P1|Overall Study|Death Due to Malignant Disease|456
2617167|NCT00949910|9048306|P1|Overall Study|Participant Refusal|390
2617168|NCT00949910|9048306|P1|Overall Study|Study Drug-Related Adverse Event|315
2617169|NCT00949910|9048306|P1|Overall Study|Lost to Follow-up|100
2617170|NCT00949910|9048306|P1|Overall Study|Symptomatic Deterioration|1088
2617171|NCT00949910|9048306|P1|Overall Study|Progressive Disease|3750
2617172|NCT00949884|9048319|P3|Overall Study|Study terminated by sponsor|1
2617173|NCT00949884|9048320|P2|Overall Study|Study terminated by sponsor|0
2617174|NCT00949884|9048321|P1|Overall Study|Study terminated by sponsor|0
2617175|NCT00949884|9048319|P3|Overall Study|Lack of Efficacy|7
2617176|NCT00949884|9048320|P2|Overall Study|Lack of Efficacy|2
2617177|NCT00949884|9048321|P1|Overall Study|Lack of Efficacy|4
2617178|NCT00949884|9048319|P3|Overall Study|Withdrawal by Subject|16
2617179|NCT00949884|9048320|P2|Overall Study|Withdrawal by Subject|4
2617180|NCT00949884|9048321|P1|Overall Study|Withdrawal by Subject|13
2617181|NCT00949884|9048319|P3|Overall Study|Treatment non-compliance|8
2617182|NCT00949884|9048320|P2|Overall Study|Treatment non-compliance|0
2617183|NCT00949884|9048321|P1|Overall Study|Treatment non-compliance|5
2617184|NCT00949884|9048319|P3|Overall Study|Physician Decision|6
2617185|NCT00949884|9048320|P2|Overall Study|Physician Decision|0
2617186|NCT00949884|9048321|P1|Overall Study|Physician Decision|5
2617187|NCT00949884|9048319|P3|Overall Study|Lost to Follow-up|5
2617188|NCT00949884|9048320|P2|Overall Study|Lost to Follow-up|5
2617189|NCT00949884|9048321|P1|Overall Study|Lost to Follow-up|7
2617190|NCT00949884|9048319|P3|Overall Study|Did not meet inclusion/exclusion|3
2617191|NCT00949884|9048320|P2|Overall Study|Did not meet inclusion/exclusion|1
2617192|NCT00949884|9048321|P1|Overall Study|Did not meet inclusion/exclusion|2
2617193|NCT00949884|9048319|P3|Overall Study|Adverse Event|12
2617194|NCT00949884|9048320|P2|Overall Study|Adverse Event|3
2617195|NCT00949884|9048321|P1|Overall Study|Adverse Event|14
2617196|NCT00949715|9048376|P2|Overall Study|Missing 24 month LVEF measurement|0
2617197|NCT00949715|9048377|P1|Overall Study|Missing 24 month LVEF measurement|2
2617198|NCT00949715|9048376|P2|Overall Study|Lost to Follow-up|0
2617199|NCT00949715|9048377|P1|Overall Study|Lost to Follow-up|1
2617200|NCT00949715|9048376|P2|Overall Study|Physician Decision|0
2617201|NCT00949715|9048377|P1|Overall Study|Physician Decision|1
2617202|NCT00949702|9048388|P1|Overall Study|Withdrawal of consent|1
2617203|NCT00949702|9048388|P1|Overall Study|Disease progression|7
2617204|NCT00949702|9048388|P1|Overall Study|Death|40
2617205|NCT00949650|9048405|P2|Overall Study|Other not specified above|0
2617206|NCT00949650|9048406|P1|Overall Study|Other not specified above|5
2617207|NCT00949650|9048405|P2|Overall Study|Not treated|4
2617208|NCT00949650|9048406|P1|Overall Study|Not treated|1
2617209|NCT00949650|9048405|P2|Overall Study|Refusal to continue medication|11
2617210|NCT00949650|9048406|P1|Overall Study|Refusal to continue medication|7
2617211|NCT00949650|9048405|P2|Overall Study|Protocol Violation|4
2617212|NCT00949650|9048406|P1|Overall Study|Protocol Violation|1
2617213|NCT00949650|9048405|P2|Overall Study|Other Adverse Event (AE)|17
2617214|NCT00949650|9048406|P1|Overall Study|Other Adverse Event (AE)|28
2617215|NCT00949650|9048405|P2|Overall Study|Completed 6 courses of chemotherapy|60
2617216|NCT00949650|9048406|P1|Overall Study|Completed 6 courses of chemotherapy|0
2617217|NCT00949650|9048405|P2|Overall Study|Progressive disease|19
2617218|NCT00949650|9048406|P1|Overall Study|Progressive disease|188
2617219|NCT00949533|9048444|P2|Overall Study|Lost to Follow-up|1
2617220|NCT00949533|9048445|P1|Overall Study|Lost to Follow-up|0
2617221|NCT00949325|9048457|P3|Overall Study|Adverse Event|0
2617222|NCT00949325|9048458|P2|Overall Study|Adverse Event|2
2617223|NCT00949325|9048459|P1|Overall Study|Adverse Event|0
2617224|NCT00949117|9048483|P2|Overall Study|Adverse Event|1
2617225|NCT00949117|9048484|P1|Overall Study|Adverse Event|0
2617226|NCT00949117|9048483|P2|Overall Study|Protocol Violation|1
2617227|NCT00949117|9048484|P1|Overall Study|Protocol Violation|1
2617228|NCT00949117|9048483|P2|Overall Study|Lack of Efficacy|3
2617229|NCT00949117|9048484|P1|Overall Study|Lack of Efficacy|2
2617230|NCT00948974|9048525|P2|Overall Study|Lost to Follow-up|20
2617231|NCT00948974|9048526|P1|Overall Study|Lost to Follow-up|23
2617232|NCT00948922|9048544|P3|Overall Study|Not evaluable at time of analysis|0
2617233|NCT00948922|9048545|P2|Overall Study|Not evaluable at time of analysis|3
2617234|NCT00948922|9048546|P1|Overall Study|Not evaluable at time of analysis|0
2617235|NCT00948922|9048544|P3|Overall Study|Transplant eligibility issues|0
2617236|NCT00948922|9048545|P2|Overall Study|Transplant eligibility issues|3
2617237|NCT00948922|9048546|P1|Overall Study|Transplant eligibility issues|2
2617238|NCT00948922|9048544|P3|Overall Study|Insurance issues|0
2617239|NCT00948922|9048545|P2|Overall Study|Insurance issues|0
2617240|NCT00948922|9048546|P1|Overall Study|Insurance issues|1
2617241|NCT00948922|9048544|P3|Overall Study|Disease progression|0
2617242|NCT00948922|9048545|P2|Overall Study|Disease progression|1
2617243|NCT00948922|9048546|P1|Overall Study|Disease progression|0
2617244|NCT00948922|9048544|P3|Overall Study|Death|0
2617245|NCT00948922|9048545|P2|Overall Study|Death|0
2617246|NCT00948922|9048546|P1|Overall Study|Death|3
2617247|NCT00948922|9048544|P3|Overall Study|Withdrawal by Subject|1
2617248|NCT00948922|9048545|P2|Overall Study|Withdrawal by Subject|2
2617249|NCT00948922|9048546|P1|Overall Study|Withdrawal by Subject|0
2617250|NCT00948922|9048544|P3|Overall Study|Did not start study treatment|0
2617251|NCT00948922|9048545|P2|Overall Study|Did not start study treatment|5
2617252|NCT00948922|9048546|P1|Overall Study|Did not start study treatment|2
2617253|NCT00948896|9048569|P8|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
2617254|NCT00948896|9048570|P7|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
2617255|NCT00948896|9048571|P6|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
2617256|NCT00948896|9048572|P5|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
2617257|NCT00948896|9048573|P4|24 Months of Age to 36 Months of Age|Moved out of Study Area|1
2617258|NCT00948896|9048574|P3|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
2617259|NCT00948896|9048575|P2|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
2617260|NCT00948896|9048576|P1|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
2617261|NCT00948896|9048569|P8|24 Months of Age to 36 Months of Age|Protocol Violation|0
2617262|NCT00948896|9048570|P7|24 Months of Age to 36 Months of Age|Protocol Violation|0
2617263|NCT00948896|9048571|P6|24 Months of Age to 36 Months of Age|Protocol Violation|1
2617264|NCT00948896|9048572|P5|24 Months of Age to 36 Months of Age|Protocol Violation|0
2617265|NCT00948896|9048573|P4|24 Months of Age to 36 Months of Age|Protocol Violation|0
2617266|NCT00948896|9048574|P3|24 Months of Age to 36 Months of Age|Protocol Violation|1
2617267|NCT00948896|9048575|P2|24 Months of Age to 36 Months of Age|Protocol Violation|0
2617268|NCT00948896|9048576|P1|24 Months of Age to 36 Months of Age|Protocol Violation|0
2617269|NCT00948896|9048569|P8|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
2617270|NCT00948896|9048570|P7|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
2617271|NCT00948896|9048571|P6|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
2617272|NCT00948896|9048572|P5|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
2617273|NCT00948896|9048573|P4|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
2617274|NCT00948896|9048574|P3|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
2617275|NCT00948896|9048575|P2|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
2617276|NCT00948896|9048576|P1|24 Months of Age to 36 Months of Age|Lost to Follow-up|2
2617277|NCT00948896|9048569|P8|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
2617278|NCT00948896|9048570|P7|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
2617279|NCT00948896|9048571|P6|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
2617280|NCT00948896|9048572|P5|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
2617281|NCT00948896|9048573|P4|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
2617282|NCT00948896|9048574|P3|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
2617283|NCT00948896|9048575|P2|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
2617284|NCT00948896|9048576|P1|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
2617285|NCT00948896|9048569|P8|24 Months of Age to 36 Months of Age|Death|0
2617286|NCT00948896|9048570|P7|24 Months of Age to 36 Months of Age|Death|0
2617287|NCT00948896|9048571|P6|24 Months of Age to 36 Months of Age|Death|1
2617288|NCT00948896|9048572|P5|24 Months of Age to 36 Months of Age|Death|0
2617289|NCT00948896|9048573|P4|24 Months of Age to 36 Months of Age|Death|0
2617290|NCT00948896|9048574|P3|24 Months of Age to 36 Months of Age|Death|2
2617291|NCT00948896|9048575|P2|24 Months of Age to 36 Months of Age|Death|2
2617292|NCT00948896|9048576|P1|24 Months of Age to 36 Months of Age|Death|0
2617293|NCT00948896|9048569|P8|Randomization to 24 Months of Age|Moved out of Study Area|0
2617294|NCT00948896|9048570|P7|Randomization to 24 Months of Age|Moved out of Study Area|0
2617295|NCT00948896|9048571|P6|Randomization to 24 Months of Age|Moved out of Study Area|2
2617296|NCT00948896|9048572|P5|Randomization to 24 Months of Age|Moved out of Study Area|0
2617297|NCT00948896|9048573|P4|Randomization to 24 Months of Age|Moved out of Study Area|1
2617298|NCT00948896|9048574|P3|Randomization to 24 Months of Age|Moved out of Study Area|3
2617299|NCT00948896|9048575|P2|Randomization to 24 Months of Age|Moved out of Study Area|3
2617300|NCT00948896|9048576|P1|Randomization to 24 Months of Age|Moved out of Study Area|0
2617301|NCT00948896|9048569|P8|Randomization to 24 Months of Age|Protocol Violation|1
2617302|NCT00948896|9048570|P7|Randomization to 24 Months of Age|Protocol Violation|1
2617303|NCT00948896|9048571|P6|Randomization to 24 Months of Age|Protocol Violation|0
2617304|NCT00948896|9048572|P5|Randomization to 24 Months of Age|Protocol Violation|0
2617305|NCT00948896|9048573|P4|Randomization to 24 Months of Age|Protocol Violation|1
2617306|NCT00948896|9048574|P3|Randomization to 24 Months of Age|Protocol Violation|0
2617307|NCT00948896|9048575|P2|Randomization to 24 Months of Age|Protocol Violation|1
2617308|NCT00948896|9048576|P1|Randomization to 24 Months of Age|Protocol Violation|0
2617309|NCT00948896|9048569|P8|Randomization to 24 Months of Age|Lost to Follow-up|0
2617310|NCT00948896|9048570|P7|Randomization to 24 Months of Age|Lost to Follow-up|1
2617311|NCT00948896|9048571|P6|Randomization to 24 Months of Age|Lost to Follow-up|0
2617312|NCT00948896|9048572|P5|Randomization to 24 Months of Age|Lost to Follow-up|0
2617313|NCT00948896|9048573|P4|Randomization to 24 Months of Age|Lost to Follow-up|5
2617314|NCT00948896|9048574|P3|Randomization to 24 Months of Age|Lost to Follow-up|2
2617315|NCT00948896|9048575|P2|Randomization to 24 Months of Age|Lost to Follow-up|4
2617316|NCT00948896|9048576|P1|Randomization to 24 Months of Age|Lost to Follow-up|4
2617317|NCT00948896|9048569|P8|Randomization to 24 Months of Age|Withdrawal by Subject|0
2617318|NCT00948896|9048570|P7|Randomization to 24 Months of Age|Withdrawal by Subject|0
2617319|NCT00948896|9048571|P6|Randomization to 24 Months of Age|Withdrawal by Subject|1
2617320|NCT00948896|9048572|P5|Randomization to 24 Months of Age|Withdrawal by Subject|0
2617321|NCT00948896|9048573|P4|Randomization to 24 Months of Age|Withdrawal by Subject|4
2617322|NCT00948896|9048574|P3|Randomization to 24 Months of Age|Withdrawal by Subject|4
2617323|NCT00948896|9048575|P2|Randomization to 24 Months of Age|Withdrawal by Subject|5
2617324|NCT00948896|9048576|P1|Randomization to 24 Months of Age|Withdrawal by Subject|3
2617325|NCT00948896|9048569|P8|Randomization to 24 Months of Age|Death|1
2617326|NCT00948896|9048570|P7|Randomization to 24 Months of Age|Death|2
2617327|NCT00948896|9048571|P6|Randomization to 24 Months of Age|Death|1
2617328|NCT00948896|9048572|P5|Randomization to 24 Months of Age|Death|2
2617329|NCT00948896|9048573|P4|Randomization to 24 Months of Age|Death|0
2617330|NCT00948896|9048574|P3|Randomization to 24 Months of Age|Death|0
2617331|NCT00948896|9048575|P2|Randomization to 24 Months of Age|Death|0
2617332|NCT00948896|9048576|P1|Randomization to 24 Months of Age|Death|1
2617333|NCT00948857|9048612|P2|Overall Study|Lost to Follow-up|0
2617334|NCT00948857|9048613|P1|Overall Study|Lost to Follow-up|1
2617335|NCT00948818|9048621|P2|Overall Study|Other Reason|5
2617336|NCT00948818|9048622|P1|Overall Study|Other Reason|4
2617337|NCT00948818|9048621|P2|Overall Study|Lack of Efficacy|5
2617338|NCT00948818|9048622|P1|Overall Study|Lack of Efficacy|4
2617339|NCT00948818|9048621|P2|Overall Study|Lost to Follow-up|17
2617340|NCT00948818|9048622|P1|Overall Study|Lost to Follow-up|10
2617341|NCT00948818|9048621|P2|Overall Study|Withdrawal by Subject|25
2617342|NCT00948818|9048622|P1|Overall Study|Withdrawal by Subject|25
2617343|NCT00948818|9048621|P2|Overall Study|Protocol Violation|10
2617344|NCT00948818|9048622|P1|Overall Study|Protocol Violation|9
2617345|NCT00948818|9048621|P2|Overall Study|Adverse Event|32
2617346|NCT00948818|9048622|P1|Overall Study|Adverse Event|10
2617347|NCT00948766|9048669|P2|Extension Study|Death|0
2617348|NCT00948766|9048670|P1|Extension Study|Death|4
2617349|NCT00948766|9048669|P2|Extension Study|Administrative Problems|0
2617350|NCT00948766|9048670|P1|Extension Study|Administrative Problems|1
2617351|NCT00948766|9048669|P2|Extension Study|Lost to Follow-up|0
2617352|NCT00948766|9048670|P1|Extension Study|Lost to Follow-up|8
2617353|NCT00948766|9048669|P2|Extension Study|Patient Withdrew Consent|0
2617354|NCT00948766|9048670|P1|Extension Study|Patient Withdrew Consent|32
2617355|NCT00948766|9048669|P2|Extension Study|Study Drug No Longer Required|0
2617356|NCT00948766|9048670|P1|Extension Study|Study Drug No Longer Required|1
2617357|NCT00948766|9048669|P2|Extension Study|Unsatisfactory Therapeutic Effect|0
2617358|NCT00948766|9048670|P1|Extension Study|Unsatisfactory Therapeutic Effect|2
2617359|NCT00948766|9048669|P2|Extension Study|Adverse Event|0
2617360|NCT00948766|9048670|P1|Extension Study|Adverse Event|43
2617361|NCT00948766|9048669|P2|Core Study|Protocol Deviation|10
2617362|NCT00948766|9048670|P1|Core Study|Protocol Deviation|8
2617363|NCT00948766|9048669|P2|Core Study|Death|1
2617364|NCT00948766|9048670|P1|Core Study|Death|1
2617365|NCT00948766|9048669|P2|Core Study|Administrative Problems|2
2617366|NCT00948766|9048670|P1|Core Study|Administrative Problems|2
2617367|NCT00948766|9048669|P2|Core Study|Lost to Follow-up|2
2617368|NCT00948766|9048670|P1|Core Study|Lost to Follow-up|3
2617369|NCT00948766|9048669|P2|Core Study|Patient Withdrew Consent|46
2617370|NCT00948766|9048670|P1|Core Study|Patient Withdrew Consent|27
2617371|NCT00948766|9048669|P2|Core Study|Unsatisfactory Therapeutic Effect|14
2617372|NCT00948766|9048670|P1|Core Study|Unsatisfactory Therapeutic Effect|13
2617373|NCT00948766|9048669|P2|Core Study|Adverse Event|51
2617374|NCT00948766|9048670|P1|Core Study|Adverse Event|73
2617375|NCT00948688|9048686|P2|Period 2: 100 mg Vorinostat|Adverse Event|1
2617376|NCT00948688|9048687|P1|Period 2: 100 mg Vorinostat|Adverse Event|0
2617377|NCT00948688|9048686|P2|Period 1: 200 mg Vorinostat|Protocol Violation|0
2617378|NCT00948688|9048687|P1|Period 1: 200 mg Vorinostat|Protocol Violation|1
2617379|NCT00948688|9048686|P2|Period 1: 200 mg Vorinostat|Adverse Event|0
2617380|NCT00948688|9048687|P1|Period 1: 200 mg Vorinostat|Adverse Event|1
2617381|NCT00948675|9048701|P2|Overall Study|Treatment ongoing|4
2617382|NCT00948675|9048702|P1|Overall Study|Treatment ongoing|5
2617383|NCT00948675|9048701|P2|Overall Study|Lost to Follow-up|0
2617384|NCT00948675|9048702|P1|Overall Study|Lost to Follow-up|2
2617385|NCT00948506|9048729|P2|Overall Study|Withdrawal by Subject|1
2617386|NCT00948506|9048730|P1|Overall Study|Withdrawal by Subject|3
2617387|NCT00948441|9048741|P2|Overall Study|no longer meet inclusion criteria|4
2617388|NCT00948441|9048742|P1|Overall Study|no longer meet inclusion criteria|1
2617389|NCT00948389|9048755|P5|Overall Study|Both Progression and Toxicity|0
2617390|NCT00948389|9048756|P4|Overall Study|Both Progression and Toxicity|0
2617391|NCT00948389|9048757|P3|Overall Study|Both Progression and Toxicity|0
2617392|NCT00948389|9048758|P2|Overall Study|Both Progression and Toxicity|0
2617393|NCT00948389|9048759|P1|Overall Study|Both Progression and Toxicity|1
2617394|NCT00948389|9048755|P5|Overall Study|Thrombocytopenia, Grade 4|0
2617395|NCT00948389|9048756|P4|Overall Study|Thrombocytopenia, Grade 4|1
2617396|NCT00948389|9048757|P3|Overall Study|Thrombocytopenia, Grade 4|0
2617397|NCT00948389|9048758|P2|Overall Study|Thrombocytopenia, Grade 4|0
2617398|NCT00948389|9048759|P1|Overall Study|Thrombocytopenia, Grade 4|2
2617399|NCT00948389|9048755|P5|Overall Study|Disease Progression/Relapse/Death|1
2617400|NCT00948389|9048756|P4|Overall Study|Disease Progression/Relapse/Death|8
2617401|NCT00948389|9048757|P3|Overall Study|Disease Progression/Relapse/Death|7
2617402|NCT00948389|9048758|P2|Overall Study|Disease Progression/Relapse/Death|3
2617403|NCT00948389|9048759|P1|Overall Study|Disease Progression/Relapse/Death|3
2617404|NCT00948246|9048807|P1|Overall Study|Withdrawal by Subject|1
2617405|NCT00948246|9048807|P1|Overall Study|Death|1
2617406|NCT00948246|9048807|P1|Overall Study|Adverse Event|11
2617407|NCT00948246|9048807|P1|Overall Study|Lost to Follow-up|11
2617408|NCT00948155|9048816|P2|Washout 14 Days|Lost to Follow-up|2
2617409|NCT00948155|9048817|P1|Washout 14 Days|Lost to Follow-up|1
2617410|NCT00948155|9048816|P2|First Intervention 21 Days|Lost to Follow-up|2
2617411|NCT00948155|9048817|P1|First Intervention 21 Days|Lost to Follow-up|2
2617412|NCT00948064|9048864|P3|Phase II|Withdrawal by Subject|0
2617413|NCT00948064|9048865|P2|Phase II|Withdrawal by Subject|1
2617414|NCT00948064|9048866|P1|Phase II|Withdrawal by Subject|0
2617415|NCT00948064|9048864|P3|Phase II|Physician Decision|1
2617416|NCT00948064|9048865|P2|Phase II|Physician Decision|0
2617417|NCT00948064|9048866|P1|Phase II|Physician Decision|0
2617418|NCT00948064|9048864|P3|Phase I|No treatment received|0
2617419|NCT00948064|9048865|P2|Phase I|No treatment received|0
2617420|NCT00948064|9048866|P1|Phase I|No treatment received|1
2617421|NCT00947882|9048881|P4|Overall Study|Trial Terminated by Sponsor|70
2617422|NCT00947882|9048882|P3|Overall Study|Trial Terminated by Sponsor|62
2617423|NCT00947882|9048883|P2|Overall Study|Trial Terminated by Sponsor|61
2617424|NCT00947882|9048884|P1|Overall Study|Trial Terminated by Sponsor|62
2617425|NCT00947882|9048881|P4|Overall Study|Other/Unknown|6
2617426|NCT00947882|9048882|P3|Overall Study|Other/Unknown|3
2617427|NCT00947882|9048883|P2|Overall Study|Other/Unknown|13
2617428|NCT00947882|9048884|P1|Overall Study|Other/Unknown|10
2617429|NCT00947882|9048881|P4|Overall Study|Lost to Follow-up|0
2617430|NCT00947882|9048882|P3|Overall Study|Lost to Follow-up|1
2617431|NCT00947882|9048883|P2|Overall Study|Lost to Follow-up|2
2617432|NCT00947882|9048884|P1|Overall Study|Lost to Follow-up|0
2617433|NCT00947882|9048881|P4|Overall Study|Protocol Violation|0
2617434|NCT00947882|9048882|P3|Overall Study|Protocol Violation|1
2617435|NCT00947882|9048883|P2|Overall Study|Protocol Violation|0
2617436|NCT00947882|9048884|P1|Overall Study|Protocol Violation|0
2617437|NCT00947882|9048881|P4|Overall Study|Withdrawal by Subject|2
2617438|NCT00947882|9048882|P3|Overall Study|Withdrawal by Subject|8
2617439|NCT00947882|9048883|P2|Overall Study|Withdrawal by Subject|0
2617440|NCT00947882|9048884|P1|Overall Study|Withdrawal by Subject|2
2617441|NCT00947882|9048881|P4|Overall Study|Adverse Event|4
2617442|NCT00947882|9048882|P3|Overall Study|Adverse Event|4
2617443|NCT00947882|9048883|P2|Overall Study|Adverse Event|1
2617444|NCT00947882|9048884|P1|Overall Study|Adverse Event|0
2617445|NCT00947856|9048912|P2|Follow-up Period|Withdrawal by Subject|0
2617446|NCT00947856|9048913|P1|Follow-up Period|Withdrawal by Subject|1
2617447|NCT00947856|9048912|P2|Follow-up Period|Patient unavailable for site visits|0
2617448|NCT00947856|9048913|P1|Follow-up Period|Patient unavailable for site visits|1
2617449|NCT00947856|9048912|P2|Follow-up Period|Lost to Follow-up|0
2617450|NCT00947856|9048913|P1|Follow-up Period|Lost to Follow-up|7
2617451|NCT00947856|9048912|P2|Follow-up Period|Re-enrolled for Retreatment|3
2617452|NCT00947856|9048913|P1|Follow-up Period|Re-enrolled for Retreatment|2
2617453|NCT00947856|9048912|P2|Follow-up Period|Study Stopped by Sponsor|20
2617454|NCT00947856|9048913|P1|Follow-up Period|Study Stopped by Sponsor|40
2617455|NCT00947856|9048912|P2|Treatment Period|Withdrawal by Subject|1
2617456|NCT00947856|9048913|P1|Treatment Period|Withdrawal by Subject|12
2617457|NCT00947856|9048912|P2|Treatment Period|Study Stopped by Sponsor|4
2617458|NCT00947856|9048913|P1|Treatment Period|Study Stopped by Sponsor|4
2617459|NCT00947856|9048912|P2|Treatment Period|Physician Decision|6
2617460|NCT00947856|9048913|P1|Treatment Period|Physician Decision|14
2617461|NCT00947856|9048912|P2|Treatment Period|Adverse Event|9
2617462|NCT00947856|9048913|P1|Treatment Period|Adverse Event|15
2617463|NCT00947856|9048912|P2|Treatment Period|Progressive Disease|12
2617464|NCT00947856|9048913|P1|Treatment Period|Progressive Disease|33
2617465|NCT00947544|9049002|P2|Safety-Extension Period (12 Months)|Withdrawal by Subject|0
2617466|NCT00947544|9049003|P1|Safety-Extension Period (12 Months)|Withdrawal by Subject|1
2617467|NCT00947531|9049029|P2|Overall Study|Other|1
2617468|NCT00947531|9049030|P1|Overall Study|Other|1
2617469|NCT00947531|9049029|P2|Overall Study|Lack of Efficacy|0
2617470|NCT00947531|9049030|P1|Overall Study|Lack of Efficacy|1
2617471|NCT00947531|9049029|P2|Overall Study|Adverse Event|2
2617472|NCT00947531|9049030|P1|Overall Study|Adverse Event|2
2617473|NCT00947531|9049029|P2|Overall Study|Administrative Reason|1
2617474|NCT00947531|9049030|P1|Overall Study|Administrative Reason|0
2617475|NCT00947531|9049029|P2|Overall Study|Withdrawal by Subject|7
2617476|NCT00947531|9049030|P1|Overall Study|Withdrawal by Subject|10
2617477|NCT00947427|9049066|P2|Overall Study|Protocol Violation|1
2617478|NCT00947427|9049067|P1|Overall Study|Protocol Violation|0
2617479|NCT00947427|9049066|P2|Overall Study|Withdrawal by Subject|3
2617480|NCT00947427|9049067|P1|Overall Study|Withdrawal by Subject|1
2617481|NCT00947349|9049077|P4|Overall Study Standard of Care|Other|1
2617482|NCT00947349|9049078|P3|Overall Study Standard of Care|Other|0
2617483|NCT00947349|9049079|P2|Overall Study Standard of Care|Other|0
2617484|NCT00947349|9049080|P1|Overall Study Standard of Care|Other|0
2617485|NCT00947349|9049077|P4|Overall Study Standard of Care|Withdrawal by Subject|0
2617486|NCT00947349|9049078|P3|Overall Study Standard of Care|Withdrawal by Subject|1
2617487|NCT00947349|9049079|P2|Overall Study Standard of Care|Withdrawal by Subject|0
2617488|NCT00947349|9049080|P1|Overall Study Standard of Care|Withdrawal by Subject|0
2617489|NCT00947349|9049077|P4|Overall Study Standard of Care|Lack of Efficacy|1
2617490|NCT00947349|9049078|P3|Overall Study Standard of Care|Lack of Efficacy|1
2617491|NCT00947349|9049079|P2|Overall Study Standard of Care|Lack of Efficacy|0
2617492|NCT00947349|9049080|P1|Overall Study Standard of Care|Lack of Efficacy|0
2617493|NCT00947349|9049077|P4|Triple Treatment Combination Period|Adverse Event|0
2617494|NCT00947349|9049078|P3|Triple Treatment Combination Period|Adverse Event|0
2617495|NCT00947349|9049079|P2|Triple Treatment Combination Period|Adverse Event|1
2617496|NCT00947349|9049080|P1|Triple Treatment Combination Period|Adverse Event|0
2617497|NCT00947154|9049294|P1|Overall Study|Lost to Follow-up|1
2617498|NCT00947115|9049304|P3|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|8
2617499|NCT00947115|9049305|P2|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|12
2617500|NCT00947115|9049306|P1|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|11
2617501|NCT00947115|9049304|P3|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|4
2617502|NCT00947115|9049305|P2|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|3
2617503|NCT00947115|9049306|P1|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|1
2617504|NCT00947115|9049304|P3|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|0
2617505|NCT00947115|9049305|P2|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|0
2617506|NCT00947115|9049306|P1|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|2
2617507|NCT00947115|9049304|P3|Year 0 (Month 0) - Year 10 (Month 120)|Death|1
2617508|NCT00947115|9049305|P2|Year 0 (Month 0) - Year 10 (Month 120)|Death|1
2617509|NCT00947115|9049306|P1|Year 0 (Month 0) - Year 10 (Month 120)|Death|0
2617510|NCT00947115|9049304|P3|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|0
2617511|NCT00947115|9049305|P2|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|2
2617512|NCT00947115|9049306|P1|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|0
2617513|NCT00947115|9049304|P3|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|2
2617514|NCT00947115|9049305|P2|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|4
2617515|NCT00947115|9049306|P1|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|3
2617516|NCT00947011|9049368|P1|Overall Study|Study was terminated,PI left institution|12
2617517|NCT00946998|9049378|P2|Overall Study|Exited prior to first outcome assessment|3
2617518|NCT00946998|9049379|P1|Overall Study|Exited prior to first outcome assessment|5
2617519|NCT00946985|9049393|P1|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2
2617520|NCT00946985|9049393|P1|Stabilization Phase (25 Weeks)|Patient Moved Away|2
2617521|NCT00946985|9049393|P1|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1
2617522|NCT00946985|9049393|P1|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2
2617523|NCT00946985|9049393|P1|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139
2617524|NCT00946985|9049393|P1|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4
2617525|NCT00946985|9049393|P1|Stabilization Phase (25 Weeks)|Lost to Follow-up|5
2617526|NCT00946985|9049393|P1|Stabilization Phase (25 Weeks)|Lack of Efficacy|3
2617527|NCT00946985|9049393|P1|Stabilization Phase (25 Weeks)|Adverse Event|4
2617528|NCT00946920|9049399|P2|Overall Study|Miscellaneous reasons|3
2617529|NCT00946920|9049400|P1|Overall Study|Miscellaneous reasons|18
2617530|NCT00946920|9049399|P2|Overall Study|Protocol Violation|8
2617531|NCT00946920|9049400|P1|Overall Study|Protocol Violation|16
2617532|NCT00946920|9049399|P2|Overall Study|Adverse Event|14
2617533|NCT00946920|9049400|P1|Overall Study|Adverse Event|41
2617534|NCT00946920|9049399|P2|Overall Study|Physician Decision|2
2617535|NCT00946920|9049400|P1|Overall Study|Physician Decision|5
2617536|NCT00946920|9049399|P2|Overall Study|Lost to Follow-up|2
2617537|NCT00946920|9049400|P1|Overall Study|Lost to Follow-up|2
2617538|NCT00946920|9049399|P2|Overall Study|Withdrawal by Subject|15
2617539|NCT00946920|9049400|P1|Overall Study|Withdrawal by Subject|28
2617540|NCT00946881|9049415|P1|Retreatment|Withdrawal by Subject|1
2617541|NCT00946881|9049415|P1|First Treatment|Patient relocated to another state|1
2617542|NCT00946881|9049415|P1|First Treatment|Withdrawal by Subject|1
2617543|NCT00946712|9049446|P2|Overall Study|Ineligible|6
2617544|NCT00946712|9049447|P1|Overall Study|Ineligible|14
2617545|NCT00946712|9049446|P2|Overall Study|On Treatment|4
2617546|NCT00946712|9049447|P1|Overall Study|On Treatment|0
2617547|NCT00946712|9049446|P2|Overall Study|Other reasons|73
2617548|NCT00946712|9049447|P1|Overall Study|Other reasons|61
2617549|NCT00946712|9049446|P2|Overall Study|No treatment given|29
2617550|NCT00946712|9049447|P1|Overall Study|No treatment given|25
2617551|NCT00946712|9049446|P2|Overall Study|Death|22
2617552|NCT00946712|9049447|P1|Overall Study|Death|21
2617553|NCT00946712|9049446|P2|Overall Study|Disease progression|404
2617554|NCT00946712|9049447|P1|Overall Study|Disease progression|308
2617555|NCT00946712|9049446|P2|Overall Study|Adverse Event|124
2617556|NCT00946712|9049447|P1|Overall Study|Adverse Event|118
2617557|NCT00946530|9049465|P4|Overall Study|Physician Decision|1
2617558|NCT00946530|9049466|P3|Overall Study|Physician Decision|1
2617559|NCT00946530|9049467|P2|Overall Study|Physician Decision|1
2617560|NCT00946530|9049468|P1|Overall Study|Physician Decision|1
2617561|NCT00946530|9049465|P4|Overall Study|Withdrawal by Subject|3
2617562|NCT00946530|9049466|P3|Overall Study|Withdrawal by Subject|0
2617563|NCT00946530|9049467|P2|Overall Study|Withdrawal by Subject|3
2617564|NCT00946530|9049468|P1|Overall Study|Withdrawal by Subject|0
2617565|NCT00946322|9049500|P1|Post-treatment|participant failure to follow up|2
2617566|NCT00946322|9049500|P1|Pre-treatment|participant failure to follow up|1
2617567|NCT00946309|9049513|P2|Overall Study|Procedure cancelled/discontinued|3
2617568|NCT00946309|9049514|P1|Overall Study|Procedure cancelled/discontinued|0
2617569|NCT00946309|9049513|P2|Overall Study|Lost to Follow-up|1
2617570|NCT00946309|9049514|P1|Overall Study|Lost to Follow-up|0
2617571|NCT00946309|9049513|P2|Overall Study|Protocol Violation|0
2617572|NCT00946309|9049514|P1|Overall Study|Protocol Violation|1
2617573|NCT00946296|9049532|P2|Overall Study|Physician Decision|0
2617574|NCT00946296|9049533|P1|Overall Study|Physician Decision|3
2617575|NCT00946192|9049555|P3|Overall Study|Did not start medication|0
2617576|NCT00946192|9049556|P2|Overall Study|Did not start medication|0
2617577|NCT00946192|9049557|P1|Overall Study|Did not start medication|2
2617578|NCT00946192|9049555|P3|Overall Study|Withdrawal by Subject|3
2617579|NCT00946192|9049556|P2|Overall Study|Withdrawal by Subject|7
2617580|NCT00946192|9049557|P1|Overall Study|Withdrawal by Subject|10
2617581|NCT00946192|9049555|P3|Overall Study|Lost to Follow-up|9
2617582|NCT00946192|9049556|P2|Overall Study|Lost to Follow-up|11
2617583|NCT00946192|9049557|P1|Overall Study|Lost to Follow-up|6
2617584|NCT00946153|9049573|P5|Phase 2|14 days washout for recovery due to AE|4
2617585|NCT00946153|9049574|P4|Phase 2|14 days washout for recovery due to AE|0
2617586|NCT00946153|9049575|P3|Phase 2|14 days washout for recovery due to AE|0
2617587|NCT00946153|9049576|P2|Phase 2|14 days washout for recovery due to AE|0
2617588|NCT00946153|9049577|P1|Phase 2|14 days washout for recovery due to AE|0
2617589|NCT00946153|9049573|P5|Phase 2|Physician Decision|1
2617590|NCT00946153|9049574|P4|Phase 2|Physician Decision|0
2617591|NCT00946153|9049575|P3|Phase 2|Physician Decision|0
2617592|NCT00946153|9049576|P2|Phase 2|Physician Decision|0
2617593|NCT00946153|9049577|P1|Phase 2|Physician Decision|0
2617594|NCT00946153|9049573|P5|Phase 2|Need more reduction of dose|2
2617595|NCT00946153|9049574|P4|Phase 2|Need more reduction of dose|0
2617596|NCT00946153|9049575|P3|Phase 2|Need more reduction of dose|0
2617597|NCT00946153|9049576|P2|Phase 2|Need more reduction of dose|0
2617598|NCT00946153|9049577|P1|Phase 2|Need more reduction of dose|0
2617599|NCT00946153|9049573|P5|Phase 2|Adverse Event|6
2617600|NCT00946153|9049574|P4|Phase 2|Adverse Event|0
2617601|NCT00946153|9049575|P3|Phase 2|Adverse Event|0
2617602|NCT00946153|9049576|P2|Phase 2|Adverse Event|0
2617603|NCT00946153|9049577|P1|Phase 2|Adverse Event|0
2617604|NCT00946114|9049605|P2|Overall Study|Withdrawal by Subject|0
2617605|NCT00946114|9049606|P1|Overall Study|Withdrawal by Subject|2
2617606|NCT00946114|9049605|P2|Overall Study|Other|0
2617607|NCT00946114|9049606|P1|Overall Study|Other|1
2617608|NCT00946114|9049605|P2|Overall Study|Death|2
2617609|NCT00946114|9049606|P1|Overall Study|Death|5
2617610|NCT00946101|9049614|P2|Overall Study|Physician Decision|1
2617611|NCT00946101|9049615|P1|Overall Study|Physician Decision|0
2617612|NCT00946101|9049614|P2|Overall Study|Withdrawal of consent|0
2617613|NCT00946101|9049615|P1|Overall Study|Withdrawal of consent|2
2617614|NCT00946101|9049614|P2|Overall Study|Lost to Follow-up|1
2617615|NCT00946101|9049615|P1|Overall Study|Lost to Follow-up|2
2617616|NCT00946088|9049681|P2|Overall Study|Withdrawal by Subject|1
2617617|NCT00946088|9049682|P1|Overall Study|Withdrawal by Subject|0
2617618|NCT00945945|9049726|P2|Overall Study|Entry Criteria Not Met|1
2617619|NCT00945945|9049727|P1|Overall Study|Entry Criteria Not Met|0
2617620|NCT00945945|9049726|P2|Overall Study|Protocol Violation|2
2617621|NCT00945945|9049727|P1|Overall Study|Protocol Violation|4
2617622|NCT00945945|9049726|P2|Overall Study|Lack of Efficacy|2
2617623|NCT00945945|9049727|P1|Overall Study|Lack of Efficacy|6
2617624|NCT00945945|9049726|P2|Overall Study|Lost to Follow-up|5
2617625|NCT00945945|9049727|P1|Overall Study|Lost to Follow-up|4
2617626|NCT00945945|9049726|P2|Overall Study|Withdrawal by Subject|10
2617627|NCT00945945|9049727|P1|Overall Study|Withdrawal by Subject|7
2617628|NCT00945945|9049726|P2|Overall Study|Adverse Event|35
2617629|NCT00945945|9049727|P1|Overall Study|Adverse Event|15
2617630|NCT00945906|9049753|P1|Overall Study|Moved to another country|2
2617631|NCT00945906|9049753|P1|Overall Study|Unable to return for last visit|2
2617632|NCT00945906|9049753|P1|Overall Study|Did not want to return for last visit|2
2617633|NCT00945906|9049753|P1|Overall Study|Withdrawal by Subject|1
2617634|NCT00945893|9049764|P2|Overall Study|Withdrawal of consent|2
2617635|NCT00945893|9049765|P1|Overall Study|Withdrawal of consent|1
2617636|NCT00945893|9049764|P2|Overall Study|Lost to Follow-up|8
2617637|NCT00945893|9049765|P1|Overall Study|Lost to Follow-up|2
2617638|NCT00945815|9049842|P1|Overall Study|Did not begin protocol therapy|1
2617639|NCT00945815|9049842|P1|Overall Study|Ineligible|3
2617640|NCT00945815|9049842|P1|Overall Study|Not protocol specified|1
2617641|NCT00945815|9049842|P1|Overall Study|Death|3
2617642|NCT00945659|9049874|P3|Overall Study|Lost to Follow-up|17
2617643|NCT00945659|9049875|P2|Overall Study|Lost to Follow-up|20
2617644|NCT00945659|9049876|P1|Overall Study|Lost to Follow-up|7
2617645|NCT00945555|9049933|P1|Overall Study|Other|1
2617646|NCT00945555|9049933|P1|Overall Study|Death|18
2617647|NCT00945555|9049933|P1|Overall Study|Participant continued treatment at home|1
2617648|NCT00945555|9049933|P1|Overall Study|Withdrawal by Subject|2
2617649|NCT00945555|9049933|P1|Overall Study|Worsening condition, intensive care unit|1
2617650|NCT00945555|9049933|P1|Overall Study|Referred to another hospital|5
2617651|NCT00945477|9049944|P1|Overall Study|Withdrawal by Subject|1
2617652|NCT00945477|9049944|P1|Overall Study|Lack of Efficacy|2
2617653|NCT00945477|9049944|P1|Overall Study|Adverse Event|3
2617654|NCT00945321|9049960|P6|Period 4|Lost to Follow-up|1
2617655|NCT00945321|9049961|P5|Period 4|Lost to Follow-up|0
2617656|NCT00945321|9049962|P4|Period 4|Lost to Follow-up|0
2617657|NCT00945321|9049963|P3|Period 4|Lost to Follow-up|0
2617658|NCT00945321|9049964|P2|Period 4|Lost to Follow-up|0
2617659|NCT00945321|9049965|P1|Period 4|Lost to Follow-up|0
2617660|NCT00945321|9049960|P6|Period 1|Adverse Event|0
2617661|NCT00945321|9049961|P5|Period 1|Adverse Event|1
2617662|NCT00945321|9049962|P4|Period 1|Adverse Event|0
2617663|NCT00945321|9049963|P3|Period 1|Adverse Event|0
2617664|NCT00945321|9049964|P2|Period 1|Adverse Event|0
2617665|NCT00945321|9049965|P1|Period 1|Adverse Event|0
2617666|NCT00945243|9050098|P1|Overall Study|Study Terminated: Subjects Dispositioned|3
2617667|NCT00945009|9050192|P3|Overall Study|Refusal of further protocol|0
2617668|NCT00945009|9050193|P2|Overall Study|Refusal of further protocol|0
2617669|NCT00945009|9050194|P1|Overall Study|Refusal of further protocol|1
2617670|NCT00945009|9050192|P3|Overall Study|Inevaluable|0
2617671|NCT00945009|9050193|P2|Overall Study|Inevaluable|1
2617672|NCT00945009|9050194|P1|Overall Study|Inevaluable|0
2617673|NCT00945009|9050192|P3|Overall Study|Ineligible|0
2617674|NCT00945009|9050193|P2|Overall Study|Ineligible|1
2617675|NCT00945009|9050194|P1|Overall Study|Ineligible|6
2617676|NCT00945009|9050192|P3|Overall Study|Withdrawal by Subject|0
2617677|NCT00945009|9050193|P2|Overall Study|Withdrawal by Subject|0
2617678|NCT00945009|9050194|P1|Overall Study|Withdrawal by Subject|1
2617679|NCT00945009|9050192|P3|Overall Study|Protocol Violation|0
2617680|NCT00945009|9050193|P2|Overall Study|Protocol Violation|1
2617681|NCT00945009|9050194|P1|Overall Study|Protocol Violation|6
2617682|NCT00945009|9050192|P3|Overall Study|Physician Decision|3
2617683|NCT00945009|9050193|P2|Overall Study|Physician Decision|4
2617684|NCT00945009|9050194|P1|Overall Study|Physician Decision|21
2617685|NCT00945009|9050192|P3|Overall Study|Lack of Efficacy|0
2617686|NCT00945009|9050193|P2|Overall Study|Lack of Efficacy|0
2617687|NCT00945009|9050194|P1|Overall Study|Lack of Efficacy|10
2617688|NCT00944697|9050270|P2|Overall Study|Administrative|1
2617689|NCT00944697|9050271|P1|Overall Study|Administrative|1
2617690|NCT00944697|9050270|P2|Overall Study|Adverse Event|3
2617691|NCT00944697|9050271|P1|Overall Study|Adverse Event|0
2617692|NCT00944697|9050270|P2|Overall Study|Withdrawal by Subject|1
2617693|NCT00944697|9050271|P1|Overall Study|Withdrawal by Subject|1
2617694|NCT00944658|9050303|P2|Treatment 12 Weeks|Adverse Event|2
2617695|NCT00944658|9050304|P1|Treatment 12 Weeks|Adverse Event|0
2617696|NCT00944645|9050316|P2|Period 2|Withdrawal by Subject|6
2617697|NCT00944645|9050317|P1|Period 2|Withdrawal by Subject|7
2617698|NCT00944645|9050316|P2|Period 2|Lost to Follow-up|3
2617699|NCT00944645|9050317|P1|Period 2|Lost to Follow-up|0
2617700|NCT00944645|9050316|P2|Period 2|Adverse Event|0
2617701|NCT00944645|9050317|P1|Period 2|Adverse Event|1
2617702|NCT00944229|9050364|P1|Overall Study|Physician Decision|14
2617703|NCT00944229|9050364|P1|Overall Study|Withdrawal by Subject|11
2617704|NCT00944125|9050370|P2|6 Months to Study Completion|Withdrawal by Subject|2
2617705|NCT00944125|9050371|P1|6 Months to Study Completion|Withdrawal by Subject|0
2617706|NCT00944125|9050370|P2|3 to 6 Months|Withdrawal by Subject|2
2617707|NCT00944125|9050371|P1|3 to 6 Months|Withdrawal by Subject|0
2617708|NCT00944034|9050474|P12|Overall Study|Administrative reason|0
2617709|NCT00944034|9050475|P11|Overall Study|Administrative reason|0
2617710|NCT00944034|9050476|P10|Overall Study|Administrative reason|0
2617711|NCT00944034|9050477|P9|Overall Study|Administrative reason|0
2617712|NCT00944034|9050478|P8|Overall Study|Administrative reason|0
2617713|NCT00944034|9050479|P7|Overall Study|Administrative reason|1
2617714|NCT00944034|9050480|P6|Overall Study|Administrative reason|0
2617715|NCT00944034|9050481|P5|Overall Study|Administrative reason|0
2617716|NCT00944034|9050482|P4|Overall Study|Administrative reason|0
2617717|NCT00944034|9050483|P3|Overall Study|Administrative reason|0
2617718|NCT00944034|9050484|P2|Overall Study|Administrative reason|0
2617719|NCT00944034|9050485|P1|Overall Study|Administrative reason|0
2617720|NCT00944034|9050474|P12|Overall Study|Unable to classify|0
2617721|NCT00944034|9050475|P11|Overall Study|Unable to classify|0
2617722|NCT00944034|9050476|P10|Overall Study|Unable to classify|0
2617723|NCT00944034|9050477|P9|Overall Study|Unable to classify|0
2617724|NCT00944034|9050478|P8|Overall Study|Unable to classify|1
2617725|NCT00944034|9050479|P7|Overall Study|Unable to classify|1
2617726|NCT00944034|9050480|P6|Overall Study|Unable to classify|1
2617727|NCT00944034|9050481|P5|Overall Study|Unable to classify|0
2617728|NCT00944034|9050482|P4|Overall Study|Unable to classify|0
2617729|NCT00944034|9050483|P3|Overall Study|Unable to classify|0
2617730|NCT00944034|9050484|P2|Overall Study|Unable to classify|0
2617731|NCT00944034|9050485|P1|Overall Study|Unable to classify|0
2617732|NCT00944034|9050474|P12|Overall Study|Protocol Violation|0
2617733|NCT00944034|9050475|P11|Overall Study|Protocol Violation|0
2617734|NCT00944034|9050476|P10|Overall Study|Protocol Violation|4
2617735|NCT00944034|9050477|P9|Overall Study|Protocol Violation|1
2617736|NCT00944034|9050478|P8|Overall Study|Protocol Violation|1
2617737|NCT00944034|9050479|P7|Overall Study|Protocol Violation|0
2617738|NCT00944034|9050480|P6|Overall Study|Protocol Violation|3
2617739|NCT00944034|9050481|P5|Overall Study|Protocol Violation|2
2617740|NCT00944034|9050482|P4|Overall Study|Protocol Violation|1
2617741|NCT00944034|9050483|P3|Overall Study|Protocol Violation|0
2617742|NCT00944034|9050484|P2|Overall Study|Protocol Violation|0
2617743|NCT00944034|9050485|P1|Overall Study|Protocol Violation|2
2617744|NCT00944034|9050474|P12|Overall Study|Death|0
2617745|NCT00944034|9050475|P11|Overall Study|Death|0
2617746|NCT00944034|9050476|P10|Overall Study|Death|0
2617747|NCT00944034|9050477|P9|Overall Study|Death|0
2617748|NCT00944034|9050478|P8|Overall Study|Death|0
2617749|NCT00944034|9050479|P7|Overall Study|Death|0
2617750|NCT00944034|9050480|P6|Overall Study|Death|0
2617751|NCT00944034|9050481|P5|Overall Study|Death|0
2617752|NCT00944034|9050482|P4|Overall Study|Death|0
2617753|NCT00944034|9050483|P3|Overall Study|Death|1
2617754|NCT00944034|9050484|P2|Overall Study|Death|0
2617755|NCT00944034|9050485|P1|Overall Study|Death|0
2617756|NCT00944034|9050474|P12|Overall Study|Lost to Follow-up|0
2617757|NCT00944034|9050475|P11|Overall Study|Lost to Follow-up|1
2617758|NCT00944034|9050476|P10|Overall Study|Lost to Follow-up|1
2617759|NCT00944034|9050477|P9|Overall Study|Lost to Follow-up|5
2617760|NCT00944034|9050478|P8|Overall Study|Lost to Follow-up|1
2617761|NCT00944034|9050479|P7|Overall Study|Lost to Follow-up|0
2617762|NCT00944034|9050480|P6|Overall Study|Lost to Follow-up|7
2617763|NCT00944034|9050481|P5|Overall Study|Lost to Follow-up|5
2617764|NCT00944034|9050482|P4|Overall Study|Lost to Follow-up|0
2617765|NCT00944034|9050483|P3|Overall Study|Lost to Follow-up|2
2617766|NCT00944034|9050484|P2|Overall Study|Lost to Follow-up|4
2617767|NCT00944034|9050485|P1|Overall Study|Lost to Follow-up|0
2617768|NCT00944034|9050474|P12|Overall Study|Withdrawal by Subject|4
2617769|NCT00944034|9050475|P11|Overall Study|Withdrawal by Subject|0
2617770|NCT00944034|9050476|P10|Overall Study|Withdrawal by Subject|4
2617771|NCT00944034|9050477|P9|Overall Study|Withdrawal by Subject|3
2617772|NCT00944034|9050478|P8|Overall Study|Withdrawal by Subject|2
2617773|NCT00944034|9050479|P7|Overall Study|Withdrawal by Subject|2
2617774|NCT00944034|9050480|P6|Overall Study|Withdrawal by Subject|8
2617775|NCT00944034|9050481|P5|Overall Study|Withdrawal by Subject|5
2617776|NCT00944034|9050482|P4|Overall Study|Withdrawal by Subject|2
2617777|NCT00944034|9050483|P3|Overall Study|Withdrawal by Subject|6
2617778|NCT00944034|9050484|P2|Overall Study|Withdrawal by Subject|2
2617779|NCT00944034|9050485|P1|Overall Study|Withdrawal by Subject|3
2617780|NCT00944034|9050474|P12|Overall Study|Inappropriate enrollment|0
2617781|NCT00944034|9050475|P11|Overall Study|Inappropriate enrollment|0
2617782|NCT00944034|9050476|P10|Overall Study|Inappropriate enrollment|1
2617783|NCT00944034|9050477|P9|Overall Study|Inappropriate enrollment|1
2617784|NCT00944034|9050478|P8|Overall Study|Inappropriate enrollment|0
2617785|NCT00944034|9050479|P7|Overall Study|Inappropriate enrollment|0
2617786|NCT00944034|9050480|P6|Overall Study|Inappropriate enrollment|1
2617787|NCT00944034|9050481|P5|Overall Study|Inappropriate enrollment|2
2617788|NCT00944034|9050482|P4|Overall Study|Inappropriate enrollment|1
2617789|NCT00944034|9050483|P3|Overall Study|Inappropriate enrollment|0
2617790|NCT00944034|9050484|P2|Overall Study|Inappropriate enrollment|1
2617791|NCT00944034|9050485|P1|Overall Study|Inappropriate enrollment|0
2617792|NCT00943917|9050631|P15|Stage II Continuation|A1C elevation|0
2617793|NCT00943917|9050632|P14|Stage II Continuation|A1C elevation|1
2617794|NCT00943917|9050633|P13|Stage II Continuation|A1C elevation|0
2617795|NCT00943917|9050634|P12|Stage II Continuation|A1C elevation|0
2617796|NCT00943917|9050635|P11|Stage II Continuation|A1C elevation|0
2617797|NCT00943917|9050636|P10|Stage II Continuation|A1C elevation|0
2617798|NCT00943917|9050637|P9|Stage II Continuation|A1C elevation|0
2617799|NCT00943917|9050638|P8|Stage II Continuation|A1C elevation|0
2617800|NCT00943917|9050639|P7|Stage II Continuation|A1C elevation|0
2617801|NCT00943917|9050640|P6|Stage II Continuation|A1C elevation|0
2617802|NCT00943917|9050641|P5|Stage II Continuation|A1C elevation|0
2617803|NCT00943917|9050642|P4|Stage II Continuation|A1C elevation|0
2617804|NCT00943917|9050643|P3|Stage II Continuation|A1C elevation|0
2617805|NCT00943917|9050644|P2|Stage II Continuation|A1C elevation|0
2617806|NCT00943917|9050645|P1|Stage II Continuation|A1C elevation|0
2617807|NCT00943917|9050631|P15|Stage II Continuation|hypoglycemia|0
2617808|NCT00943917|9050632|P14|Stage II Continuation|hypoglycemia|0
2617809|NCT00943917|9050633|P13|Stage II Continuation|hypoglycemia|1
2617810|NCT00943917|9050634|P12|Stage II Continuation|hypoglycemia|0
2617811|NCT00943917|9050635|P11|Stage II Continuation|hypoglycemia|0
2617812|NCT00943917|9050636|P10|Stage II Continuation|hypoglycemia|0
2617813|NCT00943917|9050637|P9|Stage II Continuation|hypoglycemia|0
2617814|NCT00943917|9050638|P8|Stage II Continuation|hypoglycemia|0
2617815|NCT00943917|9050639|P7|Stage II Continuation|hypoglycemia|0
2617816|NCT00943917|9050640|P6|Stage II Continuation|hypoglycemia|0
2617817|NCT00943917|9050641|P5|Stage II Continuation|hypoglycemia|0
2617818|NCT00943917|9050642|P4|Stage II Continuation|hypoglycemia|0
2617819|NCT00943917|9050643|P3|Stage II Continuation|hypoglycemia|0
2617820|NCT00943917|9050644|P2|Stage II Continuation|hypoglycemia|0
2617821|NCT00943917|9050645|P1|Stage II Continuation|hypoglycemia|0
2617822|NCT00943917|9050631|P15|Stage II Continuation|Protocol Violation|0
2617823|NCT00943917|9050632|P14|Stage II Continuation|Protocol Violation|0
2617824|NCT00943917|9050633|P13|Stage II Continuation|Protocol Violation|0
2617825|NCT00943917|9050634|P12|Stage II Continuation|Protocol Violation|1
2617826|NCT00943917|9050635|P11|Stage II Continuation|Protocol Violation|0
2617827|NCT00943917|9050636|P10|Stage II Continuation|Protocol Violation|1
2617828|NCT00943917|9050637|P9|Stage II Continuation|Protocol Violation|0
2617829|NCT00943917|9050638|P8|Stage II Continuation|Protocol Violation|0
2617830|NCT00943917|9050639|P7|Stage II Continuation|Protocol Violation|0
2617831|NCT00943917|9050640|P6|Stage II Continuation|Protocol Violation|0
2617832|NCT00943917|9050641|P5|Stage II Continuation|Protocol Violation|0
2617833|NCT00943917|9050642|P4|Stage II Continuation|Protocol Violation|0
2617834|NCT00943917|9050643|P3|Stage II Continuation|Protocol Violation|0
2617835|NCT00943917|9050644|P2|Stage II Continuation|Protocol Violation|0
2617836|NCT00943917|9050645|P1|Stage II Continuation|Protocol Violation|0
2617837|NCT00943917|9050631|P15|Stage II Continuation|Withdrawal by Subject|3
2617838|NCT00943917|9050632|P14|Stage II Continuation|Withdrawal by Subject|1
2617839|NCT00943917|9050633|P13|Stage II Continuation|Withdrawal by Subject|0
2617840|NCT00943917|9050634|P12|Stage II Continuation|Withdrawal by Subject|0
2617841|NCT00943917|9050635|P11|Stage II Continuation|Withdrawal by Subject|0
2617842|NCT00943917|9050636|P10|Stage II Continuation|Withdrawal by Subject|0
2617843|NCT00943917|9050637|P9|Stage II Continuation|Withdrawal by Subject|0
2617844|NCT00943917|9050638|P8|Stage II Continuation|Withdrawal by Subject|0
2617845|NCT00943917|9050639|P7|Stage II Continuation|Withdrawal by Subject|0
2617846|NCT00943917|9050640|P6|Stage II Continuation|Withdrawal by Subject|0
2617847|NCT00943917|9050641|P5|Stage II Continuation|Withdrawal by Subject|0
2617848|NCT00943917|9050642|P4|Stage II Continuation|Withdrawal by Subject|0
2617849|NCT00943917|9050643|P3|Stage II Continuation|Withdrawal by Subject|0
2617850|NCT00943917|9050644|P2|Stage II Continuation|Withdrawal by Subject|0
2617851|NCT00943917|9050645|P1|Stage II Continuation|Withdrawal by Subject|0
2617852|NCT00943917|9050631|P15|Stage II Continuation|Adverse Event|1
2617853|NCT00943917|9050632|P14|Stage II Continuation|Adverse Event|1
2617854|NCT00943917|9050633|P13|Stage II Continuation|Adverse Event|2
2617855|NCT00943917|9050634|P12|Stage II Continuation|Adverse Event|1
2617856|NCT00943917|9050635|P11|Stage II Continuation|Adverse Event|0
2617857|NCT00943917|9050636|P10|Stage II Continuation|Adverse Event|0
2617858|NCT00943917|9050637|P9|Stage II Continuation|Adverse Event|0
2617859|NCT00943917|9050638|P8|Stage II Continuation|Adverse Event|0
2617860|NCT00943917|9050639|P7|Stage II Continuation|Adverse Event|0
2617861|NCT00943917|9050640|P6|Stage II Continuation|Adverse Event|0
2617862|NCT00943917|9050641|P5|Stage II Continuation|Adverse Event|0
2617863|NCT00943917|9050642|P4|Stage II Continuation|Adverse Event|0
2617864|NCT00943917|9050643|P3|Stage II Continuation|Adverse Event|0
2617865|NCT00943917|9050644|P2|Stage II Continuation|Adverse Event|0
2617866|NCT00943917|9050645|P1|Stage II Continuation|Adverse Event|0
2617867|NCT00943917|9050631|P15|Stage II|Pregnancy|0
2617868|NCT00943917|9050632|P14|Stage II|Pregnancy|0
2617869|NCT00943917|9050633|P13|Stage II|Pregnancy|0
2617870|NCT00943917|9050634|P12|Stage II|Pregnancy|0
2617871|NCT00943917|9050635|P11|Stage II|Pregnancy|0
2617872|NCT00943917|9050636|P10|Stage II|Pregnancy|0
2617873|NCT00943917|9050637|P9|Stage II|Pregnancy|0
2617874|NCT00943917|9050638|P8|Stage II|Pregnancy|0
2617875|NCT00943917|9050639|P7|Stage II|Pregnancy|0
2617876|NCT00943917|9050640|P6|Stage II|Pregnancy|1
2617877|NCT00943917|9050641|P5|Stage II|Pregnancy|0
2617878|NCT00943917|9050642|P4|Stage II|Pregnancy|0
2617879|NCT00943917|9050643|P3|Stage II|Pregnancy|0
2617880|NCT00943917|9050644|P2|Stage II|Pregnancy|0
2617881|NCT00943917|9050645|P1|Stage II|Pregnancy|0
2617882|NCT00943917|9050631|P15|Stage II|Withdrawal by Subject|0
2617883|NCT00943917|9050632|P14|Stage II|Withdrawal by Subject|0
2617884|NCT00943917|9050633|P13|Stage II|Withdrawal by Subject|0
2617885|NCT00943917|9050634|P12|Stage II|Withdrawal by Subject|0
2617886|NCT00943917|9050635|P11|Stage II|Withdrawal by Subject|0
2617887|NCT00943917|9050636|P10|Stage II|Withdrawal by Subject|0
2617888|NCT00943917|9050637|P9|Stage II|Withdrawal by Subject|0
2617889|NCT00943917|9050638|P8|Stage II|Withdrawal by Subject|0
2617890|NCT00943917|9050639|P7|Stage II|Withdrawal by Subject|0
2617891|NCT00943917|9050640|P6|Stage II|Withdrawal by Subject|1
2617892|NCT00943917|9050641|P5|Stage II|Withdrawal by Subject|0
2617893|NCT00943917|9050642|P4|Stage II|Withdrawal by Subject|0
2617894|NCT00943917|9050643|P3|Stage II|Withdrawal by Subject|0
2617895|NCT00943917|9050644|P2|Stage II|Withdrawal by Subject|0
2617896|NCT00943917|9050645|P1|Stage II|Withdrawal by Subject|0
2617897|NCT00943917|9050631|P15|Stage II|Adverse Event|0
2617898|NCT00943917|9050632|P14|Stage II|Adverse Event|0
2617899|NCT00943917|9050633|P13|Stage II|Adverse Event|0
2617900|NCT00943917|9050634|P12|Stage II|Adverse Event|0
2617901|NCT00943917|9050635|P11|Stage II|Adverse Event|0
2617902|NCT00943917|9050636|P10|Stage II|Adverse Event|0
2617903|NCT00943917|9050637|P9|Stage II|Adverse Event|1
2617904|NCT00943917|9050638|P8|Stage II|Adverse Event|0
2617905|NCT00943917|9050639|P7|Stage II|Adverse Event|3
2617906|NCT00943917|9050640|P6|Stage II|Adverse Event|1
2617907|NCT00943917|9050641|P5|Stage II|Adverse Event|0
2617908|NCT00943917|9050642|P4|Stage II|Adverse Event|0
2617909|NCT00943917|9050643|P3|Stage II|Adverse Event|0
2617910|NCT00943917|9050644|P2|Stage II|Adverse Event|0
2617911|NCT00943917|9050645|P1|Stage II|Adverse Event|0
2617912|NCT00943917|9050631|P15|Stage I|Withdrawal by Subject|0
2617913|NCT00943917|9050632|P14|Stage I|Withdrawal by Subject|0
2617914|NCT00943917|9050633|P13|Stage I|Withdrawal by Subject|0
2617915|NCT00943917|9050634|P12|Stage I|Withdrawal by Subject|0
2617916|NCT00943917|9050635|P11|Stage I|Withdrawal by Subject|0
2617917|NCT00943917|9050636|P10|Stage I|Withdrawal by Subject|0
2617918|NCT00943917|9050637|P9|Stage I|Withdrawal by Subject|0
2617919|NCT00943917|9050638|P8|Stage I|Withdrawal by Subject|0
2617920|NCT00943917|9050639|P7|Stage I|Withdrawal by Subject|0
2617921|NCT00943917|9050640|P6|Stage I|Withdrawal by Subject|0
2617922|NCT00943917|9050641|P5|Stage I|Withdrawal by Subject|0
2617923|NCT00943917|9050642|P4|Stage I|Withdrawal by Subject|0
2617924|NCT00943917|9050643|P3|Stage I|Withdrawal by Subject|2
2617925|NCT00943917|9050644|P2|Stage I|Withdrawal by Subject|1
2617926|NCT00943917|9050645|P1|Stage I|Withdrawal by Subject|2
2617927|NCT00943917|9050631|P15|Stage I|A1C elevation|0
2617928|NCT00943917|9050632|P14|Stage I|A1C elevation|0
2617929|NCT00943917|9050633|P13|Stage I|A1C elevation|0
2617930|NCT00943917|9050634|P12|Stage I|A1C elevation|0
2617931|NCT00943917|9050635|P11|Stage I|A1C elevation|0
2617932|NCT00943917|9050636|P10|Stage I|A1C elevation|0
2617933|NCT00943917|9050637|P9|Stage I|A1C elevation|0
2617934|NCT00943917|9050638|P8|Stage I|A1C elevation|0
2617935|NCT00943917|9050639|P7|Stage I|A1C elevation|0
2617936|NCT00943917|9050640|P6|Stage I|A1C elevation|0
2617937|NCT00943917|9050641|P5|Stage I|A1C elevation|0
2617938|NCT00943917|9050642|P4|Stage I|A1C elevation|0
2617939|NCT00943917|9050643|P3|Stage I|A1C elevation|0
2617940|NCT00943917|9050644|P2|Stage I|A1C elevation|0
2617941|NCT00943917|9050645|P1|Stage I|A1C elevation|1
2617942|NCT00943917|9050631|P15|Stage I|hyperglycemia|0
2617943|NCT00943917|9050632|P14|Stage I|hyperglycemia|0
2617944|NCT00943917|9050633|P13|Stage I|hyperglycemia|0
2617945|NCT00943917|9050634|P12|Stage I|hyperglycemia|0
2617946|NCT00943917|9050635|P11|Stage I|hyperglycemia|0
2617947|NCT00943917|9050636|P10|Stage I|hyperglycemia|0
2617948|NCT00943917|9050637|P9|Stage I|hyperglycemia|0
2617949|NCT00943917|9050638|P8|Stage I|hyperglycemia|0
2617950|NCT00943917|9050639|P7|Stage I|hyperglycemia|0
2617951|NCT00943917|9050640|P6|Stage I|hyperglycemia|0
2617952|NCT00943917|9050641|P5|Stage I|hyperglycemia|0
2617953|NCT00943917|9050642|P4|Stage I|hyperglycemia|0
2617954|NCT00943917|9050643|P3|Stage I|hyperglycemia|1
2617955|NCT00943917|9050644|P2|Stage I|hyperglycemia|0
2617956|NCT00943917|9050645|P1|Stage I|hyperglycemia|0
2617957|NCT00943917|9050631|P15|Stage I|Lost to Follow-up|0
2617958|NCT00943917|9050632|P14|Stage I|Lost to Follow-up|0
2617959|NCT00943917|9050633|P13|Stage I|Lost to Follow-up|0
2617960|NCT00943917|9050634|P12|Stage I|Lost to Follow-up|0
2617961|NCT00943917|9050635|P11|Stage I|Lost to Follow-up|0
2617962|NCT00943917|9050636|P10|Stage I|Lost to Follow-up|0
2617963|NCT00943917|9050637|P9|Stage I|Lost to Follow-up|0
2617964|NCT00943917|9050638|P8|Stage I|Lost to Follow-up|0
2617965|NCT00943917|9050639|P7|Stage I|Lost to Follow-up|0
2617966|NCT00943917|9050640|P6|Stage I|Lost to Follow-up|0
2617967|NCT00943917|9050641|P5|Stage I|Lost to Follow-up|0
2617968|NCT00943917|9050642|P4|Stage I|Lost to Follow-up|0
2617969|NCT00943917|9050643|P3|Stage I|Lost to Follow-up|1
2617970|NCT00943917|9050644|P2|Stage I|Lost to Follow-up|0
2617971|NCT00943917|9050645|P1|Stage I|Lost to Follow-up|0
2617972|NCT00943917|9050631|P15|Stage I|Adverse Event|0
2617973|NCT00943917|9050632|P14|Stage I|Adverse Event|0
2617974|NCT00943917|9050633|P13|Stage I|Adverse Event|0
2617975|NCT00943917|9050634|P12|Stage I|Adverse Event|0
2617976|NCT00943917|9050635|P11|Stage I|Adverse Event|0
2617977|NCT00943917|9050636|P10|Stage I|Adverse Event|0
2617978|NCT00943917|9050637|P9|Stage I|Adverse Event|0
2617979|NCT00943917|9050638|P8|Stage I|Adverse Event|0
2617980|NCT00943917|9050639|P7|Stage I|Adverse Event|0
2617981|NCT00943917|9050640|P6|Stage I|Adverse Event|0
2617982|NCT00943917|9050641|P5|Stage I|Adverse Event|0
2617983|NCT00943917|9050642|P4|Stage I|Adverse Event|0
2617984|NCT00943917|9050643|P3|Stage I|Adverse Event|2
2617985|NCT00943917|9050644|P2|Stage I|Adverse Event|2
2617986|NCT00943917|9050645|P1|Stage I|Adverse Event|1
2617987|NCT00943852|9050821|P10|Washout Period After Period 4 Treatment|Trial stopped early|0
2617988|NCT00943852|9050822|P9|Washout Period After Period 4 Treatment|Trial stopped early|0
2617989|NCT00943852|9050823|P8|Washout Period After Period 4 Treatment|Trial stopped early|0
2617990|NCT00943852|9050824|P7|Washout Period After Period 4 Treatment|Trial stopped early|1
2617991|NCT00943852|9050825|P6|Washout Period After Period 4 Treatment|Trial stopped early|0
2617992|NCT00943852|9050826|P5|Washout Period After Period 4 Treatment|Trial stopped early|0
2617993|NCT00943852|9050827|P4|Washout Period After Period 4 Treatment|Trial stopped early|1
2617994|NCT00943852|9050828|P3|Washout Period After Period 4 Treatment|Trial stopped early|1
2617995|NCT00943852|9050829|P2|Washout Period After Period 4 Treatment|Trial stopped early|0
2617996|NCT00943852|9050830|P1|Washout Period After Period 4 Treatment|Trial stopped early|1
2617997|NCT00943852|9050821|P10|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
2617998|NCT00943852|9050822|P9|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
2617999|NCT00943852|9050823|P8|Washout Period After Period 4 Treatment|Not taking medication per protocol|1
2618000|NCT00943852|9050824|P7|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
2618001|NCT00943852|9050825|P6|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
2618002|NCT00943852|9050826|P5|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
2618003|NCT00943852|9050827|P4|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
2618004|NCT00943852|9050828|P3|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
2618005|NCT00943852|9050829|P2|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
2618006|NCT00943852|9050830|P1|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
2618007|NCT00943852|9050821|P10|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
2618008|NCT00943852|9050822|P9|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
2618009|NCT00943852|9050823|P8|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
2618010|NCT00943852|9050824|P7|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1
2618011|NCT00943852|9050825|P6|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
2618012|NCT00943852|9050826|P5|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
2618013|NCT00943852|9050827|P4|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
2618014|NCT00943852|9050828|P3|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
2618015|NCT00943852|9050829|P2|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
2618016|NCT00943852|9050830|P1|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
2618017|NCT00943852|9050821|P10|Washout Period After Period 2 Treatment|Trial stopped early|0
2618018|NCT00943852|9050822|P9|Washout Period After Period 2 Treatment|Trial stopped early|0
2618019|NCT00943852|9050823|P8|Washout Period After Period 2 Treatment|Trial stopped early|0
2618020|NCT00943852|9050824|P7|Washout Period After Period 2 Treatment|Trial stopped early|0
2618021|NCT00943852|9050825|P6|Washout Period After Period 2 Treatment|Trial stopped early|1
2618022|NCT00943852|9050826|P5|Washout Period After Period 2 Treatment|Trial stopped early|0
2618023|NCT00943852|9050827|P4|Washout Period After Period 2 Treatment|Trial stopped early|0
2618024|NCT00943852|9050828|P3|Washout Period After Period 2 Treatment|Trial stopped early|0
2618025|NCT00943852|9050829|P2|Washout Period After Period 2 Treatment|Trial stopped early|0
2618026|NCT00943852|9050830|P1|Washout Period After Period 2 Treatment|Trial stopped early|0
2618027|NCT00943852|9050821|P10|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
2618028|NCT00943852|9050822|P9|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
2618029|NCT00943852|9050823|P8|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
2618030|NCT00943852|9050824|P7|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
2618031|NCT00943852|9050825|P6|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
2618032|NCT00943852|9050826|P5|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
2618033|NCT00943852|9050827|P4|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1
2618034|NCT00943852|9050828|P3|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
2618035|NCT00943852|9050829|P2|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
2618036|NCT00943852|9050830|P1|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
2618037|NCT00943826|9050843|P2|After Primary Overall Survival Analysis|Withdrew Consent|0
2618038|NCT00943826|9050844|P1|After Primary Overall Survival Analysis|Withdrew Consent|4
2618039|NCT00943826|9050843|P2|After Primary Overall Survival Analysis|Progression of Disease|4
2618040|NCT00943826|9050844|P1|After Primary Overall Survival Analysis|Progression of Disease|2
2618041|NCT00943826|9050843|P2|After Primary Overall Survival Analysis|Administrative reasons|16
2618042|NCT00943826|9050844|P1|After Primary Overall Survival Analysis|Administrative reasons|10
2618043|NCT00943826|9050843|P2|After Primary Overall Survival Analysis|Adverse Event|0
2618044|NCT00943826|9050844|P1|After Primary Overall Survival Analysis|Adverse Event|11
2618045|NCT00943826|9050843|P2|Monotherapy Phase|Failure to return|1
2618046|NCT00943826|9050844|P1|Monotherapy Phase|Failure to return|2
2618047|NCT00943826|9050843|P2|Monotherapy Phase|Withdrew Consent|3
2618048|NCT00943826|9050844|P1|Monotherapy Phase|Withdrew Consent|2
2618049|NCT00943826|9050843|P2|Monotherapy Phase|Refused treatment/ Did not cooperate|2
2618050|NCT00943826|9050844|P1|Monotherapy Phase|Refused treatment/ Did not cooperate|8
2618051|NCT00943826|9050843|P2|Monotherapy Phase|Administrative reasons|5
2618052|NCT00943826|9050844|P1|Monotherapy Phase|Administrative reasons|11
2618053|NCT00943826|9050843|P2|Monotherapy Phase|Adverse Event|5
2618054|NCT00943826|9050844|P1|Monotherapy Phase|Adverse Event|42
2618055|NCT00943826|9050843|P2|Maintenance Phase|Failure to return|1
2618056|NCT00943826|9050844|P1|Maintenance Phase|Failure to return|0
2618057|NCT00943826|9050843|P2|Maintenance Phase|Administrative reasons|1
2618058|NCT00943826|9050844|P1|Maintenance Phase|Administrative reasons|4
2618059|NCT00943826|9050843|P2|Maintenance Phase|Refused treatment/Did not cooperate|3
2618060|NCT00943826|9050844|P1|Maintenance Phase|Refused treatment/Did not cooperate|6
2618061|NCT00943826|9050843|P2|Maintenance Phase|Withdrew consent|4
2618062|NCT00943826|9050844|P1|Maintenance Phase|Withdrew consent|2
2618063|NCT00943826|9050843|P2|Maintenance Phase|Adverse Event|30
2618064|NCT00943826|9050844|P1|Maintenance Phase|Adverse Event|31
2618065|NCT00943826|9050843|P2|Concurrent Phase|Protocol Violation|0
2618066|NCT00943826|9050844|P1|Concurrent Phase|Protocol Violation|1
2618067|NCT00943826|9050843|P2|Concurrent Phase|Administrative reasons|1
2618068|NCT00943826|9050844|P1|Concurrent Phase|Administrative reasons|2
2618069|NCT00943826|9050843|P2|Concurrent Phase|Refused treatment/Did not cooperate|7
2618070|NCT00943826|9050844|P1|Concurrent Phase|Refused treatment/Did not cooperate|5
2618071|NCT00943826|9050843|P2|Concurrent Phase|Withdrew consent|7
2618072|NCT00943826|9050844|P1|Concurrent Phase|Withdrew consent|3
2618073|NCT00943826|9050843|P2|Concurrent Phase|Adverse Event|27
2618074|NCT00943826|9050844|P1|Concurrent Phase|Adverse Event|50
2618075|NCT00943787|9050862|P1|Overall Study|Withdrawal by Subject|3
2618076|NCT00943787|9050862|P1|Overall Study|Physician Decision|4
2618077|NCT00943761|9050869|P2|Overall Study|Withdrawal by Subject|1
2618078|NCT00943761|9050870|P1|Overall Study|Withdrawal by Subject|2
2618079|NCT00943761|9050869|P2|Overall Study|Lost to Follow-up|0
2618080|NCT00943761|9050870|P1|Overall Study|Lost to Follow-up|2
2618081|NCT00943735|9050882|P1|Overall Study|Other|3
2618082|NCT00943735|9050882|P1|Overall Study|Other|8
2618083|NCT00943735|9050882|P1|Overall Study|Death|1
2618084|NCT00943735|9050882|P1|Overall Study|Withdrawal by Subject|8
2618085|NCT00943735|9050882|P1|Overall Study|Adverse Event|12
2618086|NCT00943722|9050920|P5|Overall Study|Withdrawal by Subject|8
2618087|NCT00943722|9050921|P4|Overall Study|Withdrawal by Subject|13
2618088|NCT00943722|9050922|P3|Overall Study|Withdrawal by Subject|2
2618089|NCT00943722|9050923|P2|Overall Study|Withdrawal by Subject|13
2618090|NCT00943722|9050924|P1|Overall Study|Withdrawal by Subject|12
2618091|NCT00943722|9050920|P5|Overall Study|Protocol Violation|2
2618092|NCT00943722|9050921|P4|Overall Study|Protocol Violation|0
2618093|NCT00943722|9050922|P3|Overall Study|Protocol Violation|0
2618094|NCT00943722|9050923|P2|Overall Study|Protocol Violation|1
2618095|NCT00943722|9050924|P1|Overall Study|Protocol Violation|0
2618096|NCT00943722|9050920|P5|Overall Study|Pregnancy|0
2618097|NCT00943722|9050921|P4|Overall Study|Pregnancy|0
2618098|NCT00943722|9050922|P3|Overall Study|Pregnancy|1
2618099|NCT00943722|9050923|P2|Overall Study|Pregnancy|0
2618100|NCT00943722|9050924|P1|Overall Study|Pregnancy|0
2618101|NCT00943722|9050920|P5|Overall Study|Physician Decision|1
2618102|NCT00943722|9050921|P4|Overall Study|Physician Decision|0
2618103|NCT00943722|9050922|P3|Overall Study|Physician Decision|0
2618104|NCT00943722|9050923|P2|Overall Study|Physician Decision|0
2618105|NCT00943722|9050924|P1|Overall Study|Physician Decision|1
2618106|NCT00943722|9050920|P5|Overall Study|Lost to Follow-up|11
2618107|NCT00943722|9050921|P4|Overall Study|Lost to Follow-up|8
2618108|NCT00943722|9050922|P3|Overall Study|Lost to Follow-up|10
2618109|NCT00943722|9050923|P2|Overall Study|Lost to Follow-up|8
2618110|NCT00943722|9050924|P1|Overall Study|Lost to Follow-up|12
2618111|NCT00943722|9050920|P5|Overall Study|Adverse Event|0
2618112|NCT00943722|9050921|P4|Overall Study|Adverse Event|1
2618113|NCT00943722|9050922|P3|Overall Study|Adverse Event|0
2618114|NCT00943722|9050923|P2|Overall Study|Adverse Event|0
2618115|NCT00943722|9050924|P1|Overall Study|Adverse Event|0
2618116|NCT00943683|9050954|P2|Overall Study|Patient Moved|0
2618117|NCT00943683|9050955|P1|Overall Study|Patient Moved|1
2618118|NCT00943683|9050954|P2|Overall Study|Withdrawal by Subject|0
2618119|NCT00943683|9050955|P1|Overall Study|Withdrawal by Subject|1
2618120|NCT00943683|9050954|P2|Overall Study|Protocol Violation|2
2618121|NCT00943683|9050955|P1|Overall Study|Protocol Violation|1
2618122|NCT00943683|9050954|P2|Overall Study|Lost to Follow-up|1
2618123|NCT00943683|9050955|P1|Overall Study|Lost to Follow-up|1
2618124|NCT00943683|9050954|P2|Overall Study|Adverse Event|3
2618125|NCT00943683|9050955|P1|Overall Study|Adverse Event|3
2618126|NCT00943670|9050961|P1|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5
2618127|NCT00943670|9050961|P1|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2
2618128|NCT00943670|9050961|P1|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6
2618129|NCT00943670|9050961|P1|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4
2618130|NCT00943670|9050961|P1|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1
2618131|NCT00943670|9050961|P1|Single-agent Trastuzumab Emtansine|Early progressive disease|20
2618132|NCT00943670|9050961|P1|Single-agent Trastuzumab Emtansine|Adverse Event|2
2618133|NCT00943670|9050961|P1|Single-agent Trastuzumab Emtansine|Systemic progression|15
2618134|NCT00943670|9050961|P1|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3
2618135|NCT00943670|9050961|P1|Single-agent Trastuzumab Emtansine|Physician Decision|2
2618136|NCT00943605|9051050|P2|Overall Study|Study termination|30
2618137|NCT00943605|9051051|P1|Overall Study|Study termination|30
2618138|NCT00943592|9051061|P1|Overall Study|Death|3
2618139|NCT00943579|9051074|P2|Overall Study|Lack of Efficacy|2
2618140|NCT00943579|9051075|P1|Overall Study|Lack of Efficacy|2
2618141|NCT00943579|9051074|P2|Overall Study|Adverse Event|3
2618142|NCT00943579|9051075|P1|Overall Study|Adverse Event|4
2618143|NCT00943397|9051176|P2|Overall Study|Site terminated and other|56
2618144|NCT00943397|9051177|P1|Overall Study|Site terminated and other|12
2618145|NCT00943397|9051176|P2|Overall Study|Withdrawal by Subject|1
2618146|NCT00943397|9051177|P1|Overall Study|Withdrawal by Subject|1
2618147|NCT00943397|9051176|P2|Overall Study|Protocol Violation|5
2618148|NCT00943397|9051177|P1|Overall Study|Protocol Violation|2
2618149|NCT00943397|9051176|P2|Overall Study|Lost to Follow-up|4
2618150|NCT00943397|9051177|P1|Overall Study|Lost to Follow-up|0
2618151|NCT00943397|9051176|P2|Overall Study|Adverse Event|6
2618152|NCT00943397|9051177|P1|Overall Study|Adverse Event|0
2618153|NCT00943384|9051183|P1|Overall Study|Withdrawal by Subject|5
2618154|NCT00943384|9051183|P1|Overall Study|Lost to Follow-up|16
2618155|NCT00943384|9051183|P1|Overall Study|Treated off protocol-protocol violation|5
2618156|NCT00943384|9051183|P1|Overall Study|Dispositioned prior to treatment|23
2618157|NCT00943319|9051197|P1|Overall Study|Death|1
2618158|NCT00943306|9051203|P1|Overall Study|Sponsor decision due to non-compliance|1
2618159|NCT00943306|9051203|P1|Overall Study|Death|1
2618160|NCT00943306|9051203|P1|Overall Study|Physician Decision|1
2618161|NCT00943124|9051505|P2|Period 1|Personal Reasons|1
2618162|NCT00943124|9051506|P1|Period 1|Personal Reasons|0
2618163|NCT00943124|9051505|P2|Period 1|Did Not Follow Study Procedures|0
2618164|NCT00943124|9051506|P1|Period 1|Did Not Follow Study Procedures|1
2618165|NCT00943124|9051505|P2|Period 1|Withdrawal by Subject|1
2618166|NCT00943124|9051506|P1|Period 1|Withdrawal by Subject|1
2618167|NCT00943111|9051528|P3|5 Years Long-term Treatment Period|Other than specified above|2
2618168|NCT00943111|9051529|P2|5 Years Long-term Treatment Period|Other than specified above|0
2618169|NCT00943111|9051530|P1|5 Years Long-term Treatment Period|Other than specified above|0
2618170|NCT00943111|9051528|P3|5 Years Long-term Treatment Period|Lost to Follow-up|1
2618171|NCT00943111|9051529|P2|5 Years Long-term Treatment Period|Lost to Follow-up|0
2618172|NCT00943111|9051530|P1|5 Years Long-term Treatment Period|Lost to Follow-up|0
2618173|NCT00943111|9051528|P3|5 Years Long-term Treatment Period|Pregnancy|4
2618174|NCT00943111|9051529|P2|5 Years Long-term Treatment Period|Pregnancy|0
2618175|NCT00943111|9051530|P1|5 Years Long-term Treatment Period|Pregnancy|0
2618176|NCT00943111|9051528|P3|5 Years Long-term Treatment Period|Withdrawal by Subject|8
2618177|NCT00943111|9051529|P2|5 Years Long-term Treatment Period|Withdrawal by Subject|0
2618178|NCT00943111|9051530|P1|5 Years Long-term Treatment Period|Withdrawal by Subject|0
2618179|NCT00943111|9051528|P3|5 Years Long-term Treatment Period|Adverse Event|9
2618180|NCT00943111|9051529|P2|5 Years Long-term Treatment Period|Adverse Event|0
2618181|NCT00943111|9051530|P1|5 Years Long-term Treatment Period|Adverse Event|0
2618182|NCT00943111|9051528|P3|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51
2618183|NCT00943111|9051529|P2|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
2618184|NCT00943111|9051530|P1|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
2618185|NCT00943111|9051528|P3|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
2618186|NCT00943111|9051529|P2|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1
2618187|NCT00943111|9051530|P1|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
2618188|NCT00943111|9051528|P3|52-Weeks Primary Analysis Period|Adverse Event|0
2618189|NCT00943111|9051529|P2|52-Weeks Primary Analysis Period|Adverse Event|1
2618190|NCT00943111|9051530|P1|52-Weeks Primary Analysis Period|Adverse Event|2
2618191|NCT00943072|9051598|P2|Overall Study|Other|1
2618192|NCT00943072|9051599|P1|Overall Study|Other|1
2618193|NCT00943072|9051598|P2|Overall Study|Lack of Efficacy|4
2618194|NCT00943072|9051599|P1|Overall Study|Lack of Efficacy|0
2618195|NCT00943072|9051598|P2|Overall Study|Lost to Follow-up|2
2618196|NCT00943072|9051599|P1|Overall Study|Lost to Follow-up|1
2618197|NCT00943072|9051598|P2|Overall Study|Protocol Violation|1
2618198|NCT00943072|9051599|P1|Overall Study|Protocol Violation|0
2618199|NCT00943072|9051598|P2|Overall Study|Withdrawal by Subject|1
2618200|NCT00943072|9051599|P1|Overall Study|Withdrawal by Subject|3
2618201|NCT00943072|9051598|P2|Overall Study|Death|2
2618202|NCT00943072|9051599|P1|Overall Study|Death|0
2618203|NCT00943072|9051598|P2|Overall Study|Adverse Event|3
2618204|NCT00943072|9051599|P1|Overall Study|Adverse Event|0
2618205|NCT00942994|9051617|P2|Overall Study|Protocol deviation|2
2618206|NCT00942994|9051618|P1|Overall Study|Protocol deviation|1
2618207|NCT00942994|9051617|P2|Overall Study|Lost to Follow-up|4
2618208|NCT00942994|9051618|P1|Overall Study|Lost to Follow-up|1
2618209|NCT00942994|9051617|P2|Overall Study|Patient withdrew consent|8
2618210|NCT00942994|9051618|P1|Overall Study|Patient withdrew consent|5
2618211|NCT00942994|9051617|P2|Overall Study|Unsatisfactory therapeutic effect|1
2618212|NCT00942994|9051618|P1|Overall Study|Unsatisfactory therapeutic effect|1
2618213|NCT00942994|9051617|P2|Overall Study|Abnormal laboratory value(s)|0
2618214|NCT00942994|9051618|P1|Overall Study|Abnormal laboratory value(s)|1
2618215|NCT00942994|9051617|P2|Overall Study|Adverse Event|4
2618216|NCT00942994|9051618|P1|Overall Study|Adverse Event|7
2618217|NCT00942968|9051634|P1|Overall Study|Deep vein thrombosis (DVT)|2
2618218|NCT00942968|9051634|P1|Overall Study|Participant required pancreatic biopsy|1
2618219|NCT00942968|9051634|P1|Overall Study|Pulmonary embolism (PE)|1
2618220|NCT00942968|9051634|P1|Overall Study|Inferior vena cava filter placement|4
2618221|NCT00942968|9051634|P1|Overall Study|Progression of disease|12
2618222|NCT00942968|9051634|P1|Overall Study|Physician Decision|11
2618223|NCT00942968|9051634|P1|Overall Study|Sponsor request|5
2618224|NCT00942968|9051634|P1|Overall Study|Withdrawal by Subject|44
2618225|NCT00942968|9051634|P1|Overall Study|Lost to Follow-up|4
2618226|NCT00942968|9051634|P1|Overall Study|Protocol Violation|9
2618227|NCT00942968|9051634|P1|Overall Study|Death|76
2618228|NCT00942968|9051634|P1|Overall Study|Adverse Event|60
2618229|NCT00942734|9051712|P1|Overall Study|Physician Decision|1
2618230|NCT00942734|9051712|P1|Overall Study|Disease Progression|2
2618231|NCT00942734|9051712|P1|Overall Study|Protocol Violation|3
2618232|NCT00942734|9051712|P1|Overall Study|Adverse Event|2
2618233|NCT00942708|9051716|P1|Overall Study|Withdrawal by Subject|1
2618234|NCT00942604|9051724|P2|Overall Study|Patient relocation|1
2618235|NCT00942604|9051725|P1|Overall Study|Patient relocation|1
2618236|NCT00942604|9051724|P2|Overall Study|Withdrawal by Subject|1
2618237|NCT00942604|9051725|P1|Overall Study|Withdrawal by Subject|0
2618238|NCT00942604|9051724|P2|Overall Study|Adverse Event|1
2618239|NCT00942604|9051725|P1|Overall Study|Adverse Event|0
2618240|NCT00942604|9051724|P2|Overall Study|Protocol Violation|1
2618241|NCT00942604|9051725|P1|Overall Study|Protocol Violation|1
2618242|NCT00942422|9051833|P1|Overall Study|Progressive diease|1
2618243|NCT00942422|9051833|P1|Overall Study|Death|1
2618244|NCT00942422|9051833|P1|Overall Study|Withdrawal by Subject|1
2618245|NCT00942409|9051837|P1|Overall Study|study drug unavailable|2
2618246|NCT00942409|9051837|P1|Overall Study|Lack of Efficacy|1
2618247|NCT00942357|9051843|P2|Overall Study|Ineligible|40
2618248|NCT00942357|9051844|P1|Overall Study|Ineligible|37
2618249|NCT00942331|9051860|P2|Overall Study|Did not start treatment|22
2618250|NCT00942331|9051861|P1|Overall Study|Did not start treatment|15
2618251|NCT00942266|9051871|P2|Overall Study|medical deterioration (pneumonia)|1
2618252|NCT00942266|9051872|P1|Overall Study|medical deterioration (pneumonia)|0
2618253|NCT00942266|9051871|P2|Overall Study|Physician Decision|0
2618254|NCT00942266|9051872|P1|Overall Study|Physician Decision|2
2618255|NCT00942266|9051871|P2|Overall Study|Intercurrent illness|1
2618256|NCT00942266|9051872|P1|Overall Study|Intercurrent illness|0
2618257|NCT00942266|9051871|P2|Overall Study|Failure to thrive and pt withdrawal|1
2618258|NCT00942266|9051872|P1|Overall Study|Failure to thrive and pt withdrawal|0
2618259|NCT00942266|9051871|P2|Overall Study|Disease Progression|11
2618260|NCT00942266|9051872|P1|Overall Study|Disease Progression|38
2618261|NCT00942266|9051871|P2|Overall Study|Adverse Event|1
2618262|NCT00942266|9051872|P1|Overall Study|Adverse Event|2
2618263|NCT00942266|9051871|P2|Overall Study|Withdrawal by Subject|0
2618264|NCT00942266|9051872|P1|Overall Study|Withdrawal by Subject|1
2618265|NCT00942188|9051894|P4|Overall Study|Sponsor Decision|1
2618266|NCT00942188|9051895|P3|Overall Study|Sponsor Decision|0
2618267|NCT00942188|9051896|P2|Overall Study|Sponsor Decision|2
2618268|NCT00942188|9051897|P1|Overall Study|Sponsor Decision|0
2618269|NCT00942188|9051894|P4|Overall Study|Physician Decision|0
2618270|NCT00942188|9051895|P3|Overall Study|Physician Decision|1
2618271|NCT00942188|9051896|P2|Overall Study|Physician Decision|0
2618272|NCT00942188|9051897|P1|Overall Study|Physician Decision|0
2618273|NCT00942188|9051894|P4|Overall Study|Withdrawal by Subject|2
2618274|NCT00942188|9051895|P3|Overall Study|Withdrawal by Subject|4
2618275|NCT00942188|9051896|P2|Overall Study|Withdrawal by Subject|3
2618276|NCT00942188|9051897|P1|Overall Study|Withdrawal by Subject|1
2618277|NCT00942188|9051894|P4|Overall Study|Lost to Follow-up|0
2618278|NCT00942188|9051895|P3|Overall Study|Lost to Follow-up|2
2618279|NCT00942188|9051896|P2|Overall Study|Lost to Follow-up|1
2618280|NCT00942188|9051897|P1|Overall Study|Lost to Follow-up|2
2618281|NCT00942188|9051894|P4|Overall Study|Protocol Violation|0
2618282|NCT00942188|9051895|P3|Overall Study|Protocol Violation|0
2618283|NCT00942188|9051896|P2|Overall Study|Protocol Violation|1
2618284|NCT00942188|9051897|P1|Overall Study|Protocol Violation|1
2618285|NCT00942188|9051894|P4|Overall Study|Lack of Efficacy|1
2618286|NCT00942188|9051895|P3|Overall Study|Lack of Efficacy|0
2618287|NCT00942188|9051896|P2|Overall Study|Lack of Efficacy|0
2618288|NCT00942188|9051897|P1|Overall Study|Lack of Efficacy|0
2618289|NCT00942188|9051894|P4|Overall Study|Adverse Event|0
2618290|NCT00942188|9051895|P3|Overall Study|Adverse Event|2
2618291|NCT00942188|9051896|P2|Overall Study|Adverse Event|3
2618292|NCT00942188|9051897|P1|Overall Study|Adverse Event|0
2618293|NCT00942175|9051936|P4|Overall Study|Low Platelet Count|0
2618294|NCT00942175|9051937|P3|Overall Study|Low Platelet Count|0
2618295|NCT00942175|9051938|P2|Overall Study|Low Platelet Count|2
2618296|NCT00942175|9051939|P1|Overall Study|Low Platelet Count|0
2618297|NCT00942175|9051936|P4|Overall Study|Elevated Alanine Amino Transferase|1
2618298|NCT00942175|9051937|P3|Overall Study|Elevated Alanine Amino Transferase|0
2618299|NCT00942175|9051938|P2|Overall Study|Elevated Alanine Amino Transferase|0
2618300|NCT00942175|9051939|P1|Overall Study|Elevated Alanine Amino Transferase|0
2618301|NCT00942175|9051936|P4|Overall Study|Pregnancy|1
2618302|NCT00942175|9051937|P3|Overall Study|Pregnancy|0
2618303|NCT00942175|9051938|P2|Overall Study|Pregnancy|0
2618304|NCT00942175|9051939|P1|Overall Study|Pregnancy|0
2618305|NCT00942175|9051936|P4|Overall Study|Protocol Violation|0
2618306|NCT00942175|9051937|P3|Overall Study|Protocol Violation|2
2618307|NCT00942175|9051938|P2|Overall Study|Protocol Violation|1
2618308|NCT00942175|9051939|P1|Overall Study|Protocol Violation|0
2618309|NCT00942175|9051936|P4|Overall Study|Adverse Event|0
2618310|NCT00942175|9051937|P3|Overall Study|Adverse Event|0
2618311|NCT00942175|9051938|P2|Overall Study|Adverse Event|1
2618312|NCT00942175|9051939|P1|Overall Study|Adverse Event|2
2618313|NCT00942162|9051992|P3|Overall Study|Other|0
2618314|NCT00942162|9051993|P2|Overall Study|Other|2
2618315|NCT00942162|9051994|P1|Overall Study|Other|8
2618316|NCT00942162|9051992|P3|Overall Study|Withdrawal by Subject|0
2618317|NCT00942162|9051993|P2|Overall Study|Withdrawal by Subject|2
2618318|NCT00942162|9051994|P1|Overall Study|Withdrawal by Subject|4
2618319|NCT00942162|9051992|P3|Overall Study|Protocol Violation|0
2618320|NCT00942162|9051993|P2|Overall Study|Protocol Violation|0
2618321|NCT00942162|9051994|P1|Overall Study|Protocol Violation|1
2618322|NCT00942162|9051992|P3|Overall Study|Adverse Event|0
2618323|NCT00942162|9051993|P2|Overall Study|Adverse Event|0
2618324|NCT00942162|9051994|P1|Overall Study|Adverse Event|2
2618325|NCT00942162|9051992|P3|Overall Study|Disease progression|1
2618326|NCT00942162|9051993|P2|Overall Study|Disease progression|43
2618327|NCT00942162|9051994|P1|Overall Study|Disease progression|53
2618328|NCT00942084|9052063|P1|Overall Study|Death|2
2618329|NCT00941928|9052080|P1|Overall Study|Disease Progression|1
2618330|NCT00941928|9052080|P1|Overall Study|Withdrawal by Subject|1
2618331|NCT00941863|9052098|P5|Continued After PCD|Disease progression, recurrence, relapse|18
2618332|NCT00941863|9052099|P4|Continued After PCD|Disease progression, recurrence, relapse|0
2618333|NCT00941863|9052100|P3|Continued After PCD|Disease progression, recurrence, relapse|0
2618334|NCT00941863|9052101|P2|Continued After PCD|Disease progression, recurrence, relapse|0
2618335|NCT00941863|9052102|P1|Continued After PCD|Disease progression, recurrence, relapse|0
2618336|NCT00941863|9052098|P5|Continued After PCD|Withdrawal by Subject|1
2618337|NCT00941863|9052099|P4|Continued After PCD|Withdrawal by Subject|0
2618338|NCT00941863|9052100|P3|Continued After PCD|Withdrawal by Subject|0
2618339|NCT00941863|9052101|P2|Continued After PCD|Withdrawal by Subject|0
2618340|NCT00941863|9052102|P1|Continued After PCD|Withdrawal by Subject|0
2618341|NCT00941863|9052098|P5|Until Primary Completion Date (PCD)|Disease progression|73
2618342|NCT00941863|9052099|P4|Until Primary Completion Date (PCD)|Disease progression|14
2618343|NCT00941863|9052100|P3|Until Primary Completion Date (PCD)|Disease progression|8
2618344|NCT00941863|9052101|P2|Until Primary Completion Date (PCD)|Disease progression|1
2618345|NCT00941863|9052102|P1|Until Primary Completion Date (PCD)|Disease progression|6
2618346|NCT00941863|9052098|P5|Until Primary Completion Date (PCD)|Death|7
2618347|NCT00941863|9052099|P4|Until Primary Completion Date (PCD)|Death|2
2618348|NCT00941863|9052100|P3|Until Primary Completion Date (PCD)|Death|1
2618349|NCT00941863|9052101|P2|Until Primary Completion Date (PCD)|Death|0
2618350|NCT00941863|9052102|P1|Until Primary Completion Date (PCD)|Death|0
2618351|NCT00941863|9052098|P5|Until Primary Completion Date (PCD)|Withdrawal by Subject|8
2618352|NCT00941863|9052099|P4|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
2618353|NCT00941863|9052100|P3|Until Primary Completion Date (PCD)|Withdrawal by Subject|1
2618354|NCT00941863|9052101|P2|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
2618355|NCT00941863|9052102|P1|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
2618356|NCT00941863|9052098|P5|Until Primary Completion Date (PCD)|Physician Decision|1
2618357|NCT00941863|9052099|P4|Until Primary Completion Date (PCD)|Physician Decision|0
2618358|NCT00941863|9052100|P3|Until Primary Completion Date (PCD)|Physician Decision|0
2618359|NCT00941863|9052101|P2|Until Primary Completion Date (PCD)|Physician Decision|0
2618360|NCT00941863|9052102|P1|Until Primary Completion Date (PCD)|Physician Decision|0
2618361|NCT00941863|9052098|P5|Until Primary Completion Date (PCD)|Adverse Event|5
2618362|NCT00941863|9052099|P4|Until Primary Completion Date (PCD)|Adverse Event|1
2618363|NCT00941863|9052100|P3|Until Primary Completion Date (PCD)|Adverse Event|2
2618364|NCT00941863|9052101|P2|Until Primary Completion Date (PCD)|Adverse Event|2
2618365|NCT00941863|9052102|P1|Until Primary Completion Date (PCD)|Adverse Event|1
2618366|NCT00941798|9052129|P2|Overall Study|Death|1
2618367|NCT00941798|9052130|P1|Overall Study|Death|0
2618368|NCT00941798|9052129|P2|Overall Study|Abnormal laboratory values|2
2618369|NCT00941798|9052130|P1|Overall Study|Abnormal laboratory values|1
2618370|NCT00941798|9052129|P2|Overall Study|Abnormal test procedure results|1
2618371|NCT00941798|9052130|P1|Overall Study|Abnormal test procedure results|3
2618372|NCT00941798|9052129|P2|Overall Study|Patient's inability to use device|1
2618373|NCT00941798|9052130|P1|Overall Study|Patient's inability to use device|6
2618374|NCT00941798|9052129|P2|Overall Study|Lack of Efficacy|17
2618375|NCT00941798|9052130|P1|Overall Study|Lack of Efficacy|10
2618376|NCT00941798|9052129|P2|Overall Study|Administrative problems|23
2618377|NCT00941798|9052130|P1|Overall Study|Administrative problems|13
2618378|NCT00941798|9052129|P2|Overall Study|Protocol Violation|20
2618379|NCT00941798|9052130|P1|Overall Study|Protocol Violation|17
2618380|NCT00941798|9052129|P2|Overall Study|Lost to Follow-up|23
2618381|NCT00941798|9052130|P1|Overall Study|Lost to Follow-up|29
2618382|NCT00941798|9052129|P2|Overall Study|Adverse Event|23
2618383|NCT00941798|9052130|P1|Overall Study|Adverse Event|43
2618384|NCT00941798|9052129|P2|Overall Study|Withdrawal by Subject|74
2618385|NCT00941798|9052130|P1|Overall Study|Withdrawal by Subject|72
2618386|NCT00941733|9052160|P2|Overall Study|Protocol Violation|6
2618387|NCT00941733|9052161|P1|Overall Study|Protocol Violation|15
2618388|NCT00941733|9052160|P2|Overall Study|Lost to Follow-up|2
2618389|NCT00941733|9052161|P1|Overall Study|Lost to Follow-up|1
2618390|NCT00941733|9052160|P2|Overall Study|Adverse Event|4
2618391|NCT00941733|9052161|P1|Overall Study|Adverse Event|20
2618392|NCT00941733|9052160|P2|Overall Study|Withdrawal by Subject|6
2618393|NCT00941733|9052161|P1|Overall Study|Withdrawal by Subject|14
2618394|NCT00941733|9052160|P2|Overall Study|Death|10
2618395|NCT00941733|9052161|P1|Overall Study|Death|24
2618396|NCT00941720|9052201|P1|Overall Study|ineligible|2
2618397|NCT00941720|9052201|P1|Overall Study|Insurance denied participation|11
2618398|NCT00941720|9052201|P1|Overall Study|Withdrawal by Subject|1
2618399|NCT00941655|9052248|P2|Overall Study|non-compliant|1
2618400|NCT00941655|9052249|P1|Overall Study|non-compliant|0
2618401|NCT00941655|9052248|P2|Overall Study|withdrew consent|1
2618402|NCT00941655|9052249|P1|Overall Study|withdrew consent|0
2618403|NCT00941655|9052248|P2|Overall Study|refused further treatment|1
2618404|NCT00941655|9052249|P1|Overall Study|refused further treatment|0
2618405|NCT00941655|9052248|P2|Overall Study|progressed while on chemo|2
2618406|NCT00941655|9052249|P1|Overall Study|progressed while on chemo|0
2618407|NCT00941655|9052248|P2|Overall Study|not meet criteria for chemo foll surgery|0
2618408|NCT00941655|9052249|P1|Overall Study|not meet criteria for chemo foll surgery|4
2618409|NCT00941655|9052248|P2|Overall Study|received some chemo, 4 and 9 cycles|0
2618410|NCT00941655|9052249|P1|Overall Study|received some chemo, 4 and 9 cycles|1
2618411|NCT00941603|9052274|P6|Overall Study|Did not meet protocol eligibility|0
2618412|NCT00941603|9052275|P5|Overall Study|Did not meet protocol eligibility|0
2618413|NCT00941603|9052276|P4|Overall Study|Did not meet protocol eligibility|0
2618414|NCT00941603|9052277|P3|Overall Study|Did not meet protocol eligibility|0
2618415|NCT00941603|9052278|P2|Overall Study|Did not meet protocol eligibility|0
2618416|NCT00941603|9052279|P1|Overall Study|Did not meet protocol eligibility|1
2618417|NCT00941603|9052274|P6|Overall Study|Protocol Violation|0
2618418|NCT00941603|9052275|P5|Overall Study|Protocol Violation|0
2618419|NCT00941603|9052276|P4|Overall Study|Protocol Violation|0
2618420|NCT00941603|9052277|P3|Overall Study|Protocol Violation|0
2618421|NCT00941603|9052278|P2|Overall Study|Protocol Violation|1
2618422|NCT00941603|9052279|P1|Overall Study|Protocol Violation|0
2618423|NCT00941603|9052274|P6|Overall Study|Withdrawal by Subject|1
2618424|NCT00941603|9052275|P5|Overall Study|Withdrawal by Subject|0
2618425|NCT00941603|9052276|P4|Overall Study|Withdrawal by Subject|2
2618426|NCT00941603|9052277|P3|Overall Study|Withdrawal by Subject|0
2618427|NCT00941603|9052278|P2|Overall Study|Withdrawal by Subject|0
2618428|NCT00941603|9052279|P1|Overall Study|Withdrawal by Subject|0
2618429|NCT00941603|9052274|P6|Overall Study|Lost to Follow-up|2
2618430|NCT00941603|9052275|P5|Overall Study|Lost to Follow-up|0
2618431|NCT00941603|9052276|P4|Overall Study|Lost to Follow-up|1
2618432|NCT00941603|9052277|P3|Overall Study|Lost to Follow-up|0
2618433|NCT00941603|9052278|P2|Overall Study|Lost to Follow-up|0
2618434|NCT00941603|9052279|P1|Overall Study|Lost to Follow-up|0
2618435|NCT00941603|9052274|P6|Overall Study|Adverse Event|0
2618436|NCT00941603|9052275|P5|Overall Study|Adverse Event|4
2618437|NCT00941603|9052276|P4|Overall Study|Adverse Event|1
2618438|NCT00941603|9052277|P3|Overall Study|Adverse Event|5
2618439|NCT00941603|9052278|P2|Overall Study|Adverse Event|15
2618440|NCT00941603|9052279|P1|Overall Study|Adverse Event|10
2618441|NCT00941330|9052301|P2|Overall Study|Physician Decision|2
2618442|NCT00941330|9052302|P1|Overall Study|Physician Decision|0
2618443|NCT00941330|9052301|P2|Overall Study|Other|0
2618444|NCT00941330|9052302|P1|Overall Study|Other|1
2618445|NCT00941304|9052315|P5|Overall Study|Lost to Follow-up|0
2618446|NCT00941304|9052316|P4|Overall Study|Lost to Follow-up|0
2618447|NCT00941304|9052317|P3|Overall Study|Lost to Follow-up|0
2618448|NCT00941304|9052318|P2|Overall Study|Lost to Follow-up|0
2618449|NCT00941304|9052319|P1|Overall Study|Lost to Follow-up|1
2618450|NCT00941070|9052381|P1|Overall Study|Patient non-compliant|1
2618451|NCT00941031|9052401|P7|Maintenance Period|Lack of Efficacy|13
2618452|NCT00941031|9052402|P6|Maintenance Period|Lack of Efficacy|0
2618453|NCT00941031|9052403|P5|Maintenance Period|Lack of Efficacy|0
2618454|NCT00941031|9052404|P4|Maintenance Period|Lack of Efficacy|0
2618455|NCT00941031|9052405|P3|Maintenance Period|Lack of Efficacy|0
2618456|NCT00941031|9052406|P2|Maintenance Period|Lack of Efficacy|0
2618457|NCT00941031|9052407|P1|Maintenance Period|Lack of Efficacy|0
2618458|NCT00941031|9052401|P7|Maintenance Period|Lost to Follow-up|7
2618459|NCT00941031|9052402|P6|Maintenance Period|Lost to Follow-up|2
2618460|NCT00941031|9052403|P5|Maintenance Period|Lost to Follow-up|2
2618461|NCT00941031|9052404|P4|Maintenance Period|Lost to Follow-up|0
2618462|NCT00941031|9052405|P3|Maintenance Period|Lost to Follow-up|0
2618463|NCT00941031|9052406|P2|Maintenance Period|Lost to Follow-up|0
2618464|NCT00941031|9052407|P1|Maintenance Period|Lost to Follow-up|0
2618465|NCT00941031|9052401|P7|Maintenance Period|Adverse Event|8
2618466|NCT00941031|9052402|P6|Maintenance Period|Adverse Event|2
2618467|NCT00941031|9052403|P5|Maintenance Period|Adverse Event|0
2618468|NCT00941031|9052404|P4|Maintenance Period|Adverse Event|0
2618469|NCT00941031|9052405|P3|Maintenance Period|Adverse Event|0
2618470|NCT00941031|9052406|P2|Maintenance Period|Adverse Event|0
2618471|NCT00941031|9052407|P1|Maintenance Period|Adverse Event|0
2618472|NCT00941031|9052401|P7|Maintenance Period|Protocol Violation|1
2618473|NCT00941031|9052402|P6|Maintenance Period|Protocol Violation|0
2618474|NCT00941031|9052403|P5|Maintenance Period|Protocol Violation|0
2618475|NCT00941031|9052404|P4|Maintenance Period|Protocol Violation|0
2618476|NCT00941031|9052405|P3|Maintenance Period|Protocol Violation|0
2618477|NCT00941031|9052406|P2|Maintenance Period|Protocol Violation|0
2618478|NCT00941031|9052407|P1|Maintenance Period|Protocol Violation|0
2618479|NCT00941031|9052401|P7|Maintenance Period|Administrative Problems|1
2618480|NCT00941031|9052402|P6|Maintenance Period|Administrative Problems|0
2618481|NCT00941031|9052403|P5|Maintenance Period|Administrative Problems|1
2618482|NCT00941031|9052404|P4|Maintenance Period|Administrative Problems|0
2618483|NCT00941031|9052405|P3|Maintenance Period|Administrative Problems|0
2618484|NCT00941031|9052406|P2|Maintenance Period|Administrative Problems|0
2618485|NCT00941031|9052407|P1|Maintenance Period|Administrative Problems|0
2618486|NCT00941031|9052401|P7|Maintenance Period|Withdrawal by Subject|13
2618487|NCT00941031|9052402|P6|Maintenance Period|Withdrawal by Subject|2
2618488|NCT00941031|9052403|P5|Maintenance Period|Withdrawal by Subject|6
2618489|NCT00941031|9052404|P4|Maintenance Period|Withdrawal by Subject|0
2618490|NCT00941031|9052405|P3|Maintenance Period|Withdrawal by Subject|0
2618491|NCT00941031|9052406|P2|Maintenance Period|Withdrawal by Subject|0
2618492|NCT00941031|9052407|P1|Maintenance Period|Withdrawal by Subject|0
2618493|NCT00941031|9052401|P7|Induction Period|Adverse Event|0
2618494|NCT00941031|9052402|P6|Induction Period|Adverse Event|0
2618495|NCT00941031|9052403|P5|Induction Period|Adverse Event|0
2618496|NCT00941031|9052404|P4|Induction Period|Adverse Event|2
2618497|NCT00941031|9052405|P3|Induction Period|Adverse Event|3
2618498|NCT00941031|9052406|P2|Induction Period|Adverse Event|0
2618499|NCT00941031|9052407|P1|Induction Period|Adverse Event|1
2618500|NCT00941031|9052401|P7|Induction Period|Adminstative Problems|0
2618501|NCT00941031|9052402|P6|Induction Period|Adminstative Problems|0
2618502|NCT00941031|9052403|P5|Induction Period|Adminstative Problems|0
2618503|NCT00941031|9052404|P4|Induction Period|Adminstative Problems|0
2618504|NCT00941031|9052405|P3|Induction Period|Adminstative Problems|1
2618505|NCT00941031|9052406|P2|Induction Period|Adminstative Problems|1
2618506|NCT00941031|9052407|P1|Induction Period|Adminstative Problems|1
2618507|NCT00941031|9052401|P7|Induction Period|Withdrawal by Subject|0
2618508|NCT00941031|9052402|P6|Induction Period|Withdrawal by Subject|0
2618509|NCT00941031|9052403|P5|Induction Period|Withdrawal by Subject|0
2618510|NCT00941031|9052404|P4|Induction Period|Withdrawal by Subject|2
2618511|NCT00941031|9052405|P3|Induction Period|Withdrawal by Subject|2
2618512|NCT00941031|9052406|P2|Induction Period|Withdrawal by Subject|2
2618513|NCT00941031|9052407|P1|Induction Period|Withdrawal by Subject|1
2618514|NCT00941031|9052401|P7|Induction Period|Lack of Efficacy|0
2618515|NCT00941031|9052402|P6|Induction Period|Lack of Efficacy|0
2618516|NCT00941031|9052403|P5|Induction Period|Lack of Efficacy|0
2618517|NCT00941031|9052404|P4|Induction Period|Lack of Efficacy|5
2618518|NCT00941031|9052405|P3|Induction Period|Lack of Efficacy|0
2618519|NCT00941031|9052406|P2|Induction Period|Lack of Efficacy|1
2618520|NCT00941031|9052407|P1|Induction Period|Lack of Efficacy|2
2618521|NCT00940992|9052433|P3|Overall Study|Lost to Follow-up|1
2618522|NCT00940992|9052434|P2|Overall Study|Lost to Follow-up|1
2618523|NCT00940992|9052435|P1|Overall Study|Lost to Follow-up|0
2618524|NCT00940992|9052433|P3|Overall Study|subject request|0
2618525|NCT00940992|9052434|P2|Overall Study|subject request|1
2618526|NCT00940992|9052435|P1|Overall Study|subject request|2
2618527|NCT00940992|9052433|P3|Overall Study|Adverse Event|1
2618528|NCT00940992|9052434|P2|Overall Study|Adverse Event|0
2618529|NCT00940992|9052435|P1|Overall Study|Adverse Event|2
2618530|NCT00940888|9052464|P1|Overall Study|Lost to Follow-up|6
2618531|NCT00940888|9052464|P1|Overall Study|Withdrawn - Non-Death|364
2618532|NCT00940888|9052464|P1|Overall Study|Death|461
2618533|NCT00940888|9052464|P1|Overall Study|Unsuccessful Implant|4
2618534|NCT00940875|9052471|P2|Post-Study Treatment|Disease Progression|2
2618535|NCT00940875|9052472|P1|Post-Study Treatment|Disease Progression|0
2618536|NCT00940875|9052471|P2|Post-Study Treatment|Death|1
2618537|NCT00940875|9052472|P1|Post-Study Treatment|Death|0
2618538|NCT00940875|9052471|P2|Treatment Phase|Physician Decision|0
2618539|NCT00940875|9052472|P1|Treatment Phase|Physician Decision|1
2618540|NCT00940875|9052471|P2|Treatment Phase|Disease progression|11
2618541|NCT00940875|9052472|P1|Treatment Phase|Disease progression|9
2618542|NCT00940875|9052471|P2|Treatment Phase|Withdrawal by Subject|0
2618543|NCT00940875|9052472|P1|Treatment Phase|Withdrawal by Subject|3
2618544|NCT00940875|9052471|P2|Treatment Phase|Lack of Efficacy|0
2618545|NCT00940875|9052472|P1|Treatment Phase|Lack of Efficacy|1
2618546|NCT00940875|9052471|P2|Treatment Phase|Death|5
2618547|NCT00940875|9052472|P1|Treatment Phase|Death|3
2618548|NCT00940875|9052471|P2|Treatment Phase|Adverse Event|3
2618549|NCT00940875|9052472|P1|Treatment Phase|Adverse Event|9
2618550|NCT00940823|9052492|P2|Overall Study|Lost to Follow-up|20
2618551|NCT00940823|9052493|P1|Overall Study|Lost to Follow-up|27
2618552|NCT00940823|9052492|P2|Overall Study|Death|12
2618553|NCT00940823|9052493|P1|Overall Study|Death|8
2618554|NCT00940498|9052557|P8|Overall Study|Not treated due to disease related pain|0
2618555|NCT00940498|9052558|P7|Overall Study|Not treated due to disease related pain|0
2618556|NCT00940498|9052559|P6|Overall Study|Not treated due to disease related pain|0
2618557|NCT00940498|9052560|P5|Overall Study|Not treated due to disease related pain|1
2618558|NCT00940498|9052561|P4|Overall Study|Not treated due to disease related pain|0
2618559|NCT00940498|9052562|P3|Overall Study|Not treated due to disease related pain|0
2618560|NCT00940498|9052563|P2|Overall Study|Not treated due to disease related pain|0
2618561|NCT00940498|9052564|P1|Overall Study|Not treated due to disease related pain|0
2618562|NCT00940498|9052557|P8|Overall Study|Physician Decision|0
2618563|NCT00940498|9052558|P7|Overall Study|Physician Decision|0
2618564|NCT00940498|9052559|P6|Overall Study|Physician Decision|0
2618565|NCT00940498|9052560|P5|Overall Study|Physician Decision|2
2618566|NCT00940498|9052561|P4|Overall Study|Physician Decision|0
2618567|NCT00940498|9052562|P3|Overall Study|Physician Decision|0
2618568|NCT00940498|9052563|P2|Overall Study|Physician Decision|0
2618569|NCT00940498|9052564|P1|Overall Study|Physician Decision|0
2618570|NCT00940498|9052557|P8|Overall Study|Disease Progression|0
2618571|NCT00940498|9052558|P7|Overall Study|Disease Progression|0
2618572|NCT00940498|9052559|P6|Overall Study|Disease Progression|1
2618573|NCT00940498|9052560|P5|Overall Study|Disease Progression|0
2618574|NCT00940498|9052561|P4|Overall Study|Disease Progression|1
2618575|NCT00940498|9052562|P3|Overall Study|Disease Progression|1
2618576|NCT00940498|9052563|P2|Overall Study|Disease Progression|0
2618577|NCT00940498|9052564|P1|Overall Study|Disease Progression|0
2618578|NCT00940498|9052557|P8|Overall Study|Lost to Follow-up|1
2618579|NCT00940498|9052558|P7|Overall Study|Lost to Follow-up|0
2618580|NCT00940498|9052559|P6|Overall Study|Lost to Follow-up|0
2618581|NCT00940498|9052560|P5|Overall Study|Lost to Follow-up|1
2618582|NCT00940498|9052561|P4|Overall Study|Lost to Follow-up|0
2618583|NCT00940498|9052562|P3|Overall Study|Lost to Follow-up|2
2618584|NCT00940498|9052563|P2|Overall Study|Lost to Follow-up|1
2618585|NCT00940498|9052564|P1|Overall Study|Lost to Follow-up|1
2618586|NCT00940498|9052557|P8|Overall Study|Death|0
2618587|NCT00940498|9052558|P7|Overall Study|Death|1
2618588|NCT00940498|9052559|P6|Overall Study|Death|0
2618589|NCT00940498|9052560|P5|Overall Study|Death|5
2618590|NCT00940498|9052561|P4|Overall Study|Death|1
2618591|NCT00940498|9052562|P3|Overall Study|Death|0
2618592|NCT00940498|9052563|P2|Overall Study|Death|0
2618593|NCT00940498|9052564|P1|Overall Study|Death|2
2618594|NCT00940485|9052682|P2|Overall Study|Others|1
2618595|NCT00940485|9052683|P1|Overall Study|Others|1
2618596|NCT00940485|9052682|P2|Overall Study|Withdrawal by Subject|1
2618597|NCT00940485|9052683|P1|Overall Study|Withdrawal by Subject|1
2618598|NCT00940485|9052682|P2|Overall Study|Adverse Event|0
2618599|NCT00940485|9052683|P1|Overall Study|Adverse Event|8
2618600|NCT00940485|9052682|P2|Overall Study|Lost to Follow-up|3
2618601|NCT00940485|9052683|P1|Overall Study|Lost to Follow-up|2
2618602|NCT00940485|9052682|P2|Overall Study|HBeAb positive at Baseline|2
2618603|NCT00940485|9052683|P1|Overall Study|HBeAb positive at Baseline|3
2618604|NCT00940342|9052721|P3|Overall Study|Adverse Event|1
2618605|NCT00940342|9052722|P2|Overall Study|Adverse Event|2
2618606|NCT00940342|9052723|P1|Overall Study|Adverse Event|0
2618607|NCT00940316|9052734|P3|Treated After Cycle 5|Progressive disease|0
2618608|NCT00940316|9052735|P2|Treated After Cycle 5|Progressive disease|1
2618609|NCT00940316|9052736|P1|Treated After Cycle 5|Progressive disease|0
2618610|NCT00940316|9052734|P3|Treated After Cycle 5|Adverse Event|1
2618611|NCT00940316|9052735|P2|Treated After Cycle 5|Adverse Event|0
2618612|NCT00940316|9052736|P1|Treated After Cycle 5|Adverse Event|0
2618613|NCT00940316|9052734|P3|Moved on to be Treated Cycle 5|Adverse Event|0
2618614|NCT00940316|9052735|P2|Moved on to be Treated Cycle 5|Adverse Event|0
2618615|NCT00940316|9052736|P1|Moved on to be Treated Cycle 5|Adverse Event|2
2618616|NCT00940316|9052734|P3|Reached First Response at 8 Weeks|Progressive disease|0
2618617|NCT00940316|9052735|P2|Reached First Response at 8 Weeks|Progressive disease|3
2618618|NCT00940316|9052736|P1|Reached First Response at 8 Weeks|Progressive disease|1
2618619|NCT00940316|9052734|P3|Reached First Response at 8 Weeks|Adverse Event|0
2618620|NCT00940316|9052735|P2|Reached First Response at 8 Weeks|Adverse Event|1
2618621|NCT00940316|9052736|P1|Reached First Response at 8 Weeks|Adverse Event|2
2618622|NCT00940108|9052779|P4|Overall Study|Diagnosed with H1N1|1
2618623|NCT00940108|9052780|P3|Overall Study|Diagnosed with H1N1|0
2618624|NCT00940108|9052781|P2|Overall Study|Diagnosed with H1N1|0
2618625|NCT00940108|9052782|P1|Overall Study|Diagnosed with H1N1|0
2618626|NCT00940108|9052779|P4|Overall Study|Viral illness after Dose 1|0
2618627|NCT00940108|9052780|P3|Overall Study|Viral illness after Dose 1|0
2618628|NCT00940108|9052781|P2|Overall Study|Viral illness after Dose 1|1
2618629|NCT00940108|9052782|P1|Overall Study|Viral illness after Dose 1|0
2618630|NCT00940108|9052779|P4|Overall Study|Refused - pyrexia after Dose 1|0
2618631|NCT00940108|9052780|P3|Overall Study|Refused - pyrexia after Dose 1|0
2618632|NCT00940108|9052781|P2|Overall Study|Refused - pyrexia after Dose 1|1
2618633|NCT00940108|9052782|P1|Overall Study|Refused - pyrexia after Dose 1|0
2618634|NCT00940108|9052779|P4|Overall Study|Declined further vaccination|0
2618635|NCT00940108|9052780|P3|Overall Study|Declined further vaccination|3
2618636|NCT00940108|9052781|P2|Overall Study|Declined further vaccination|1
2618637|NCT00940108|9052782|P1|Overall Study|Declined further vaccination|0
2618638|NCT00940108|9052779|P4|Overall Study|Dose 2 contraindicated|1
2618639|NCT00940108|9052780|P3|Overall Study|Dose 2 contraindicated|0
2618640|NCT00940108|9052781|P2|Overall Study|Dose 2 contraindicated|1
2618641|NCT00940108|9052782|P1|Overall Study|Dose 2 contraindicated|1
2618642|NCT00940108|9052779|P4|Overall Study|Withdrew Consent|1
2618643|NCT00940108|9052780|P3|Overall Study|Withdrew Consent|0
2618644|NCT00940108|9052781|P2|Overall Study|Withdrew Consent|1
2618645|NCT00940108|9052782|P1|Overall Study|Withdrew Consent|2
2618646|NCT00940108|9052779|P4|Overall Study|Adverse Event|2
2618647|NCT00940108|9052780|P3|Overall Study|Adverse Event|0
2618648|NCT00940108|9052781|P2|Overall Study|Adverse Event|4
2618649|NCT00940108|9052782|P1|Overall Study|Adverse Event|2
2618650|NCT00940017|9052832|P1|Overall Study|Adverse Event|1
2618651|NCT00940017|9052832|P1|Overall Study|did not meet entrance criteria|3
2618652|NCT00939822|9052890|P2|Overall Study|Mental health issues|2
2618653|NCT00939822|9052891|P1|Overall Study|Mental health issues|0
2618654|NCT00939822|9052890|P2|Overall Study|withdrew from study due to busy schedule|1
2618655|NCT00939822|9052891|P1|Overall Study|withdrew from study due to busy schedule|1
2618656|NCT00939822|9052890|P2|Overall Study|Lost to Follow-up|0
2618657|NCT00939822|9052891|P1|Overall Study|Lost to Follow-up|1
2618658|NCT00939809|9052903|P1|Overall Study|Death|1
2618659|NCT00939809|9052903|P1|Overall Study|Adverse Event|2
2618660|NCT00939783|9052918|P1|Overall Study|Enrolled but not treated|1
2618661|NCT00939783|9052918|P1|Overall Study|Protocol Violation|3
2618662|NCT00939783|9052918|P1|Overall Study|Lost to Follow-up|8
2618663|NCT00939783|9052918|P1|Overall Study|Other|16
2618664|NCT00939783|9052918|P1|Overall Study|Withdrawal by Subject|78
2618665|NCT00939783|9052918|P1|Overall Study|Study Terminated by Sponsor|498
2618666|NCT00939783|9052918|P1|Overall Study|Adverse Event|39
2618667|NCT00939783|9052918|P1|Overall Study|Death|6
2618668|NCT00939692|9052959|P2|Period 2 - Second Intervent - 5 Days|Protocol Violation|1
2618669|NCT00939692|9052960|P1|Period 2 - Second Intervent - 5 Days|Protocol Violation|0
2618670|NCT00939692|9052959|P2|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0
2618671|NCT00939692|9052960|P1|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1
2618672|NCT00939640|9052975|P1|Overall Study|Physician Decision|1
2618673|NCT00939627|9052996|P3|Overall Study|No off-tx reason given|0
2618674|NCT00939627|9052997|P2|Overall Study|No off-tx reason given|2
2618675|NCT00939627|9052998|P1|Overall Study|No off-tx reason given|0
2618676|NCT00939627|9052996|P3|Overall Study|Not compliant|0
2618677|NCT00939627|9052997|P2|Overall Study|Not compliant|0
2618678|NCT00939627|9052998|P1|Overall Study|Not compliant|2
2618679|NCT00939627|9052996|P3|Overall Study|Other complicating disease|0
2618680|NCT00939627|9052997|P2|Overall Study|Other complicating disease|1
2618681|NCT00939627|9052998|P1|Overall Study|Other complicating disease|1
2618682|NCT00939627|9052996|P3|Overall Study|Withdrawal by Subject|0
2618683|NCT00939627|9052997|P2|Overall Study|Withdrawal by Subject|4
2618684|NCT00939627|9052998|P1|Overall Study|Withdrawal by Subject|2
2618685|NCT00939627|9052996|P3|Overall Study|Death|0
2618686|NCT00939627|9052997|P2|Overall Study|Death|2
2618687|NCT00939627|9052998|P1|Overall Study|Death|0
2618688|NCT00939627|9052996|P3|Overall Study|Adverse Event|0
2618689|NCT00939627|9052997|P2|Overall Study|Adverse Event|7
2618690|NCT00939627|9052998|P1|Overall Study|Adverse Event|6
2618691|NCT00939627|9052996|P3|Overall Study|Disease Progression|0
2618692|NCT00939627|9052997|P2|Overall Study|Disease Progression|12
2618693|NCT00939627|9052998|P1|Overall Study|Disease Progression|16
2618694|NCT00939523|9053038|P1|Overall Study|Physician Decision|2
2618695|NCT00939523|9053038|P1|Overall Study|Lack of Efficacy|1
2618696|NCT00939510|9053045|P1|Overall Study|Withdrawal by Subject|1
2618697|NCT00939484|9053054|P3|Overall Study|Progression/Relapse|3
2618698|NCT00939484|9053055|P2|Overall Study|Progression/Relapse|20
2618699|NCT00939484|9053056|P1|Overall Study|Progression/Relapse|8
2618700|NCT00939393|9053082|P2|Overall Study|Lost to Follow-up|0
2618701|NCT00939393|9053083|P1|Overall Study|Lost to Follow-up|3
2618702|NCT00939393|9053082|P2|Overall Study|Withdrawal by Subject|0
2618703|NCT00939393|9053083|P1|Overall Study|Withdrawal by Subject|1
2618704|NCT00939341|9053114|P1|Overall Study|Incorrect enrolment|8
2618705|NCT00939341|9053114|P1|Overall Study|Protocol Violation|6
2618706|NCT00939341|9053114|P1|Overall Study|Withdrawal by Subject|13
2618707|NCT00939341|9053114|P1|Overall Study|Lost to Follow-up|23
2618708|NCT00939341|9053114|P1|Overall Study|Pregnancy|1
2618709|NCT00939341|9053114|P1|Overall Study|Adverse Event|15
2618710|NCT00939185|9053201|P1|Overall Study|Randomized But Did Not Receive Treatment|10
2618711|NCT00939185|9053201|P1|Overall Study|Withdrawal by Subject|2
2618712|NCT00939185|9053201|P1|Overall Study|Other|3
2618713|NCT00939185|9053201|P1|Overall Study|Lost to Follow-up|6
2618714|NCT00939185|9053201|P1|Overall Study|Lack of Efficacy|1
2618715|NCT00939185|9053201|P1|Overall Study|Adverse Event|3
2618716|NCT00939107|9053239|P2|Overall Study|Lost to Follow-up|12
2618717|NCT00939107|9053240|P1|Overall Study|Lost to Follow-up|14
2618718|NCT00939094|9053254|P2|Overall Study|Abnormal ECG findings|0
2618719|NCT00939094|9053255|P1|Overall Study|Abnormal ECG findings|1
2618720|NCT00939094|9053254|P2|Overall Study|Study stopped by sponsor|2
2618721|NCT00939094|9053255|P1|Overall Study|Study stopped by sponsor|0
2618722|NCT00939094|9053254|P2|Overall Study|Severe non-compliance to protocol|1
2618723|NCT00939094|9053255|P1|Overall Study|Severe non-compliance to protocol|0
2618724|NCT00939094|9053254|P2|Overall Study|Eligibility criteria not fulfilled|0
2618725|NCT00939094|9053255|P1|Overall Study|Eligibility criteria not fulfilled|2
2618726|NCT00939094|9053254|P2|Overall Study|Lost to Follow-up|1
2618727|NCT00939094|9053255|P1|Overall Study|Lost to Follow-up|1
2618728|NCT00939094|9053254|P2|Overall Study|Withdrawal by Subject|6
2618729|NCT00939094|9053255|P1|Overall Study|Withdrawal by Subject|1
2618730|NCT00939094|9053254|P2|Overall Study|Adverse Event|0
2618731|NCT00939094|9053255|P1|Overall Study|Adverse Event|9
2618732|NCT00939055|9053277|P2|Overall Study|Discontinuation prior to procedure|0
2618733|NCT00939055|9053278|P1|Overall Study|Discontinuation prior to procedure|4
2618734|NCT00939029|9053288|P2|Overall Study|Adverse Event|1
2618735|NCT00939029|9053289|P1|Overall Study|Adverse Event|0
2618736|NCT00939029|9053288|P2|Overall Study|Lost to Follow-up|4
2618737|NCT00939029|9053289|P1|Overall Study|Lost to Follow-up|3
2618738|NCT00939029|9053288|P2|Overall Study|Withdrawal by Subject|7
2618739|NCT00939029|9053289|P1|Overall Study|Withdrawal by Subject|3
2618740|NCT00939003|9053301|P2|Open-label Treatment Period|Site Closure|4
2618741|NCT00939003|9053302|P1|Open-label Treatment Period|Site Closure|3
2618742|NCT00939003|9053301|P2|Open-label Treatment Period|Exclusion Criteria|0
2618743|NCT00939003|9053302|P1|Open-label Treatment Period|Exclusion Criteria|1
2618744|NCT00939003|9053301|P2|Open-label Treatment Period|Pregnancy|1
2618745|NCT00939003|9053302|P1|Open-label Treatment Period|Pregnancy|1
2618746|NCT00939003|9053301|P2|Open-label Treatment Period|Lack of Efficacy|9
2618747|NCT00939003|9053302|P1|Open-label Treatment Period|Lack of Efficacy|6
2618748|NCT00939003|9053301|P2|Open-label Treatment Period|Withdrawal by Subject|7
2618749|NCT00939003|9053302|P1|Open-label Treatment Period|Withdrawal by Subject|14
2618750|NCT00939003|9053301|P2|Open-label Treatment Period|Adverse Event|8
2618751|NCT00939003|9053302|P1|Open-label Treatment Period|Adverse Event|4
2618752|NCT00939003|9053301|P2|Double-blind Treatment Period|MRI Not Diagnostic|1
2618753|NCT00939003|9053302|P1|Double-blind Treatment Period|MRI Not Diagnostic|1
2618754|NCT00939003|9053301|P2|Double-blind Treatment Period|Pregnancy|1
2618755|NCT00939003|9053302|P1|Double-blind Treatment Period|Pregnancy|0
2618756|NCT00939003|9053301|P2|Double-blind Treatment Period|Lack of Efficacy|1
2618757|NCT00939003|9053302|P1|Double-blind Treatment Period|Lack of Efficacy|0
2618758|NCT00939003|9053301|P2|Double-blind Treatment Period|Adverse Event|1
2618759|NCT00939003|9053302|P1|Double-blind Treatment Period|Adverse Event|1
2618760|NCT00938964|9053339|P2|Overall Study|Found to Meet Exclusion Criteria|4
2618761|NCT00938964|9053340|P1|Overall Study|Found to Meet Exclusion Criteria|3
2618762|NCT00938964|9053339|P2|Overall Study|Withdrawal by Subject|18
2618763|NCT00938964|9053340|P1|Overall Study|Withdrawal by Subject|22
2618764|NCT00938964|9053339|P2|Overall Study|Lost to Follow-up|3
2618765|NCT00938964|9053340|P1|Overall Study|Lost to Follow-up|2
2618766|NCT00938964|9053339|P2|Overall Study|Death|3
2618767|NCT00938964|9053340|P1|Overall Study|Death|3
2618768|NCT00938886|9053404|P2|Overall Study|Lost to Follow-up|2
2618769|NCT00938886|9053405|P1|Overall Study|Lost to Follow-up|3
2618770|NCT00938886|9053404|P2|Overall Study|Withdrawal by Subject|7
2618771|NCT00938886|9053405|P1|Overall Study|Withdrawal by Subject|4
2618772|NCT00938886|9053404|P2|Overall Study|Death|1
2618773|NCT00938886|9053405|P1|Overall Study|Death|0
2618774|NCT00938860|9053415|P2|Overall Study|Protocol Violation|1
2618775|NCT00938860|9053416|P1|Overall Study|Protocol Violation|3
2618776|NCT00938860|9053415|P2|Overall Study|Death|1
2618777|NCT00938860|9053416|P1|Overall Study|Death|1
2618778|NCT00938860|9053415|P2|Overall Study|Administration problems|0
2618779|NCT00938860|9053416|P1|Overall Study|Administration problems|2
2618780|NCT00938860|9053415|P2|Overall Study|Lost to Follow-up|4
2618781|NCT00938860|9053416|P1|Overall Study|Lost to Follow-up|4
2618782|NCT00938860|9053415|P2|Overall Study|Withdrawal by Subject|8
2618783|NCT00938860|9053416|P1|Overall Study|Withdrawal by Subject|11
2618784|NCT00938860|9053415|P2|Overall Study|Abnormal laboratory values|2
2618785|NCT00938860|9053416|P1|Overall Study|Abnormal laboratory values|2
2618786|NCT00938860|9053415|P2|Overall Study|Adverse Event|1
2618787|NCT00938860|9053416|P1|Overall Study|Adverse Event|2
2618788|NCT00938717|9053449|P2|Overall Study|Other reason|2
2618789|NCT00938717|9053450|P1|Overall Study|Other reason|5
2618790|NCT00938717|9053449|P2|Overall Study|Lack of Efficacy|15
2618791|NCT00938717|9053450|P1|Overall Study|Lack of Efficacy|33
2618792|NCT00938717|9053449|P2|Overall Study|Lost to Follow-up|18
2618793|NCT00938717|9053450|P1|Overall Study|Lost to Follow-up|13
2618794|NCT00938717|9053449|P2|Overall Study|Withdrawal by Subject|24
2618795|NCT00938717|9053450|P1|Overall Study|Withdrawal by Subject|26
2618796|NCT00938717|9053449|P2|Overall Study|Protocol Violation|8
2618797|NCT00938717|9053450|P1|Overall Study|Protocol Violation|11
2618798|NCT00938717|9053449|P2|Overall Study|Adverse Event|41
2618799|NCT00938717|9053450|P1|Overall Study|Adverse Event|10
2618800|NCT00938639|9053501|P2|Overall Study|Participant noncompliance|0
2618801|NCT00938639|9053502|P1|Overall Study|Participant noncompliance|1
2618802|NCT00938639|9053501|P2|Overall Study|Family issues|1
2618803|NCT00938639|9053502|P1|Overall Study|Family issues|1
2618804|NCT00938639|9053501|P2|Overall Study|Lost to Follow-up|2
2618805|NCT00938639|9053502|P1|Overall Study|Lost to Follow-up|1
2618806|NCT00938639|9053501|P2|Overall Study|Moved away from study area|1
2618807|NCT00938639|9053502|P1|Overall Study|Moved away from study area|0
2618808|NCT00938470|9053585|P2|Overall Study|Other Reason|1
2618809|NCT00938470|9053586|P1|Overall Study|Other Reason|0
2618810|NCT00938470|9053585|P2|Overall Study|Death|2
2618811|NCT00938470|9053586|P1|Overall Study|Death|3
2618812|NCT00938470|9053585|P2|Overall Study|Alternate Treatment|0
2618813|NCT00938470|9053586|P1|Overall Study|Alternate Treatment|1
2618814|NCT00938470|9053585|P2|Overall Study|Disease Progression|0
2618815|NCT00938470|9053586|P1|Overall Study|Disease Progression|3
2618816|NCT00938431|9053616|P3|Overall Study|Reached maximum dose early|1
2618817|NCT00938431|9053617|P2|Overall Study|Reached maximum dose early|0
2618818|NCT00938431|9053618|P1|Overall Study|Reached maximum dose early|0
2618819|NCT00938431|9053616|P3|Overall Study|Dosing compliance issue|1
2618820|NCT00938431|9053617|P2|Overall Study|Dosing compliance issue|0
2618821|NCT00938431|9053618|P1|Overall Study|Dosing compliance issue|0
2618822|NCT00938431|9053616|P3|Overall Study|Did not up titrate to 12 mg kg/day|0
2618823|NCT00938431|9053617|P2|Overall Study|Did not up titrate to 12 mg kg/day|0
2618824|NCT00938431|9053618|P1|Overall Study|Did not up titrate to 12 mg kg/day|1
2618825|NCT00938431|9053616|P3|Overall Study|Lack of Efficacy|0
2618826|NCT00938431|9053617|P2|Overall Study|Lack of Efficacy|1
2618827|NCT00938431|9053618|P1|Overall Study|Lack of Efficacy|0
2618828|NCT00938431|9053616|P3|Overall Study|Adverse Event|6
2618829|NCT00938431|9053617|P2|Overall Study|Adverse Event|8
2618830|NCT00938431|9053618|P1|Overall Study|Adverse Event|5
2618831|NCT00938392|9053645|P2|Overall Study|Lost to Follow-up|2
2618832|NCT00938392|9053646|P1|Overall Study|Lost to Follow-up|2
2618833|NCT00938392|9053645|P2|Overall Study|Withdrawal by Subject|1
2618834|NCT00938392|9053646|P1|Overall Study|Withdrawal by Subject|0
2618835|NCT00938392|9053645|P2|Overall Study|Adverse Event|1
2618836|NCT00938392|9053646|P1|Overall Study|Adverse Event|0
2618837|NCT00938366|9053672|P2|Overall Study|Withdrawal by Subject|0
2618838|NCT00938366|9053673|P1|Overall Study|Withdrawal by Subject|1
2618839|NCT00938340|9053693|P1|Overall Study|Adverse Event|1
2618840|NCT00938340|9053693|P1|Overall Study|Protocol Violation|1
2618841|NCT00938340|9053693|P1|Overall Study|Withdrawal by Subject|3
2618842|NCT00938327|9053823|P1|Overall Study|Vaccine not received as out of stock|9
2618843|NCT00938327|9053823|P1|Overall Study|2nd dose received outside of the study|7
2618844|NCT00938327|9053823|P1|Overall Study|Lost to Follow-up|37
2618845|NCT00938327|9053823|P1|Overall Study|Withdrawal by Subject|4
2618846|NCT00938327|9053823|P1|Overall Study|Protocol Violation|1
2618847|NCT00938327|9053823|P1|Overall Study|Adverse Event|2
2618848|NCT00938041|9053891|P1|Overall Study|Adrenal Insufficiency|3
2618849|NCT00938041|9053891|P1|Overall Study|Death|12
2618850|NCT00938041|9053891|P1|Overall Study|Progressive Disease|5
2618851|NCT00938041|9053891|P1|Overall Study|Received Alternative Therapy|1
2618852|NCT00938041|9053891|P1|Overall Study|Lost to Follow-up|6
2618853|NCT00938015|9053900|P1|Overall Study|Reason not related to Etanercept|29
2618854|NCT00938015|9053900|P1|Overall Study|Non-responder|52
2618855|NCT00938015|9053900|P1|Overall Study|Adverse Event|32
2618856|NCT00938015|9053900|P1|Overall Study|Lost to Follow-up|32
2618857|NCT00938015|9053900|P1|Overall Study|Death|2
2618858|NCT00937950|9053916|P1|Overall Study|Other|18
2618859|NCT00937950|9053916|P1|Overall Study|Missing confirmed|4
2618860|NCT00937950|9053916|P1|Overall Study|Lost to Follow-up|144
2618861|NCT00937950|9053916|P1|Overall Study|Migrated/moved from study area|27
2618862|NCT00937950|9053916|P1|Overall Study|Withdrawal by Subject|23
2618863|NCT00937937|9053932|P1|Overall Study|Other|2
2618864|NCT00937937|9053932|P1|Overall Study|Death|1
2618865|NCT00937937|9053932|P1|Overall Study|Progression/relapse|61
2618866|NCT00937937|9053932|P1|Overall Study|Withdrawal by Subject|2
2618867|NCT00937937|9053932|P1|Overall Study|Adverse Event|6
2618868|NCT00937833|9053941|P2|Overall Study|Withdrawal by Subject|6
2618869|NCT00937833|9053942|P1|Overall Study|Withdrawal by Subject|4
2618870|NCT00937833|9053941|P2|Overall Study|Lost to Follow-up|8
2618871|NCT00937833|9053942|P1|Overall Study|Lost to Follow-up|10
2618872|NCT00937833|9053941|P2|Overall Study|Procedure delayed; enrollment closed|1
2618873|NCT00937833|9053942|P1|Overall Study|Procedure delayed; enrollment closed|0
2618874|NCT00937833|9053941|P2|Overall Study|Protocol Violation|2
2618875|NCT00937833|9053942|P1|Overall Study|Protocol Violation|1
2618876|NCT00937768|9053955|P2|Overall Study|No Further Funding|4
2618877|NCT00937768|9053956|P1|Overall Study|No Further Funding|4
2618878|NCT00937768|9053955|P2|Overall Study|Alternate Treatment|1
2618879|NCT00937768|9053956|P1|Overall Study|Alternate Treatment|0
2618880|NCT00937768|9053955|P2|Overall Study|Disease Progression|1
2618881|NCT00937768|9053956|P1|Overall Study|Disease Progression|1
2618882|NCT00937768|9053955|P2|Overall Study|Refused Further Treatment|2
2618883|NCT00937768|9053956|P1|Overall Study|Refused Further Treatment|3
2618884|NCT00937560|9053976|P1|Maintenance Treatment|According to protocol|1
2618885|NCT00937560|9053976|P1|Maintenance Treatment|Withdraw consent|5
2618886|NCT00937560|9053976|P1|Maintenance Treatment|Death|12
2618887|NCT00937560|9053976|P1|Initial Treatment|No end of study page|10
2618888|NCT00937560|9053976|P1|Initial Treatment|Lost to Follow-up|1
2618889|NCT00937560|9053976|P1|Initial Treatment|Adverse Event|1
2618890|NCT00937560|9053976|P1|Initial Treatment|Withdraw consent|3
2618891|NCT00937560|9053976|P1|Initial Treatment|Death|6
2618892|NCT00937547|9053987|P3|Overall Study|misdiagnosis|7
2618893|NCT00937547|9053988|P2|Overall Study|misdiagnosis|6
2618894|NCT00937547|9053989|P1|Overall Study|misdiagnosis|1
2618895|NCT00937521|9054026|P8|Booster Phase|Protocol Deviation|0
2618896|NCT00937521|9054027|P7|Booster Phase|Protocol Deviation|1
2618897|NCT00937521|9054028|P6|Booster Phase|Protocol Deviation|0
2618898|NCT00937521|9054029|P5|Booster Phase|Protocol Deviation|0
2618899|NCT00937521|9054030|P4|Booster Phase|Protocol Deviation|0
2618900|NCT00937521|9054031|P3|Booster Phase|Protocol Deviation|0
2618901|NCT00937521|9054032|P2|Booster Phase|Protocol Deviation|0
2618902|NCT00937521|9054033|P1|Booster Phase|Protocol Deviation|0
2618903|NCT00937521|9054026|P8|Booster Phase|Administrative Reason|0
2618904|NCT00937521|9054027|P7|Booster Phase|Administrative Reason|0
2618905|NCT00937521|9054028|P6|Booster Phase|Administrative Reason|1
2618906|NCT00937521|9054029|P5|Booster Phase|Administrative Reason|1
2618907|NCT00937521|9054030|P4|Booster Phase|Administrative Reason|0
2618908|NCT00937521|9054031|P3|Booster Phase|Administrative Reason|1
2618909|NCT00937521|9054032|P2|Booster Phase|Administrative Reason|0
2618910|NCT00937521|9054033|P1|Booster Phase|Administrative Reason|0
2618911|NCT00937521|9054026|P8|Booster Phase|Lost to Follow-up|0
2618912|NCT00937521|9054027|P7|Booster Phase|Lost to Follow-up|3
2618913|NCT00937521|9054028|P6|Booster Phase|Lost to Follow-up|4
2618914|NCT00937521|9054029|P5|Booster Phase|Lost to Follow-up|4
2618915|NCT00937521|9054030|P4|Booster Phase|Lost to Follow-up|2
2618916|NCT00937521|9054031|P3|Booster Phase|Lost to Follow-up|4
2618917|NCT00937521|9054032|P2|Booster Phase|Lost to Follow-up|2
2618918|NCT00937521|9054033|P1|Booster Phase|Lost to Follow-up|2
2618919|NCT00937521|9054026|P8|Booster Phase|Withdrawal by Subject|2
2618920|NCT00937521|9054027|P7|Booster Phase|Withdrawal by Subject|0
2618921|NCT00937521|9054028|P6|Booster Phase|Withdrawal by Subject|0
2618922|NCT00937521|9054029|P5|Booster Phase|Withdrawal by Subject|0
2618923|NCT00937521|9054030|P4|Booster Phase|Withdrawal by Subject|1
2618924|NCT00937521|9054031|P3|Booster Phase|Withdrawal by Subject|0
2618925|NCT00937521|9054032|P2|Booster Phase|Withdrawal by Subject|0
2618926|NCT00937521|9054033|P1|Booster Phase|Withdrawal by Subject|1
2618927|NCT00937521|9054026|P8|Booster Phase|Adverse Event|0
2618928|NCT00937521|9054027|P7|Booster Phase|Adverse Event|1
2618929|NCT00937521|9054028|P6|Booster Phase|Adverse Event|0
2618930|NCT00937521|9054029|P5|Booster Phase|Adverse Event|0
2618931|NCT00937521|9054030|P4|Booster Phase|Adverse Event|0
2618932|NCT00937521|9054031|P3|Booster Phase|Adverse Event|0
2618933|NCT00937521|9054032|P2|Booster Phase|Adverse Event|0
2618934|NCT00937521|9054033|P1|Booster Phase|Adverse Event|0
2618935|NCT00937521|9054026|P8|Overall Study - Prior to Booster Dose|Protocol Deviation|0
2618936|NCT00937521|9054027|P7|Overall Study - Prior to Booster Dose|Protocol Deviation|1
2618937|NCT00937521|9054028|P6|Overall Study - Prior to Booster Dose|Protocol Deviation|0
2618938|NCT00937521|9054029|P5|Overall Study - Prior to Booster Dose|Protocol Deviation|0
2618939|NCT00937521|9054030|P4|Overall Study - Prior to Booster Dose|Protocol Deviation|0
2618940|NCT00937521|9054031|P3|Overall Study - Prior to Booster Dose|Protocol Deviation|0
2618941|NCT00937521|9054032|P2|Overall Study - Prior to Booster Dose|Protocol Deviation|0
2618942|NCT00937521|9054033|P1|Overall Study - Prior to Booster Dose|Protocol Deviation|1
2618943|NCT00937521|9054026|P8|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
2618944|NCT00937521|9054027|P7|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
2618945|NCT00937521|9054028|P6|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
2618946|NCT00937521|9054029|P5|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2
2618947|NCT00937521|9054030|P4|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
2618948|NCT00937521|9054031|P3|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
2618949|NCT00937521|9054032|P2|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4
2618950|NCT00937521|9054033|P1|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
2618951|NCT00937521|9054026|P8|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
2618952|NCT00937521|9054027|P7|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
2618953|NCT00937521|9054028|P6|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
2618954|NCT00937521|9054029|P5|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
2618955|NCT00937521|9054030|P4|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
2618956|NCT00937521|9054031|P3|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
2618957|NCT00937521|9054032|P2|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
2618958|NCT00937521|9054033|P1|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
2618959|NCT00937521|9054026|P8|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
2618960|NCT00937521|9054027|P7|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
2618961|NCT00937521|9054028|P6|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
2618962|NCT00937521|9054029|P5|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
2618963|NCT00937521|9054030|P4|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
2618964|NCT00937521|9054031|P3|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3
2618965|NCT00937521|9054032|P2|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
2618966|NCT00937521|9054033|P1|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
2618967|NCT00937521|9054026|P8|Overall Study - Prior to Booster Dose|Adverse Event|0
2618968|NCT00937521|9054027|P7|Overall Study - Prior to Booster Dose|Adverse Event|1
2618969|NCT00937521|9054028|P6|Overall Study - Prior to Booster Dose|Adverse Event|0
2618970|NCT00937521|9054029|P5|Overall Study - Prior to Booster Dose|Adverse Event|0
2618971|NCT00937521|9054030|P4|Overall Study - Prior to Booster Dose|Adverse Event|0
2618972|NCT00937521|9054031|P3|Overall Study - Prior to Booster Dose|Adverse Event|2
2618973|NCT00937521|9054032|P2|Overall Study - Prior to Booster Dose|Adverse Event|0
2618974|NCT00937521|9054033|P1|Overall Study - Prior to Booster Dose|Adverse Event|0
2618975|NCT00937495|9054139|P1|Overall Study|Protocol Violation|2
2618976|NCT00937404|9054145|P1|Overall Study|Withdrawal by Subject|1
2618977|NCT00937404|9054145|P1|Overall Study|Protocol Violation|1
2618978|NCT00937391|9054154|P1|Stage 2|Withdrawal by Subject|1
2618979|NCT00937326|9054210|P5|Overall Study|Chest X-ray showed a suspicious shadow|0
2618980|NCT00937326|9054211|P4|Overall Study|Chest X-ray showed a suspicious shadow|0
2618981|NCT00937326|9054212|P3|Overall Study|Chest X-ray showed a suspicious shadow|1
2618982|NCT00937326|9054213|P2|Overall Study|Chest X-ray showed a suspicious shadow|0
2618983|NCT00937326|9054214|P1|Overall Study|Chest X-ray showed a suspicious shadow|0
2618984|NCT00937326|9054210|P5|Overall Study|Withdrawal by Subject|3
2618985|NCT00937326|9054211|P4|Overall Study|Withdrawal by Subject|4
2618986|NCT00937326|9054212|P3|Overall Study|Withdrawal by Subject|1
2618987|NCT00937326|9054213|P2|Overall Study|Withdrawal by Subject|4
2618988|NCT00937326|9054214|P1|Overall Study|Withdrawal by Subject|3
2618989|NCT00937326|9054210|P5|Overall Study|Death|0
2618990|NCT00937326|9054211|P4|Overall Study|Death|0
2618991|NCT00937326|9054212|P3|Overall Study|Death|1
2618992|NCT00937326|9054213|P2|Overall Study|Death|0
2618993|NCT00937326|9054214|P1|Overall Study|Death|0
2618994|NCT00937326|9054210|P5|Overall Study|Adverse Event|2
2618995|NCT00937326|9054211|P4|Overall Study|Adverse Event|1
2618996|NCT00937326|9054212|P3|Overall Study|Adverse Event|1
2618997|NCT00937326|9054213|P2|Overall Study|Adverse Event|3
2618998|NCT00937326|9054214|P1|Overall Study|Adverse Event|0
2618999|NCT00937157|9054463|P1|Overall Study|Lost to Follow-up|3
2619000|NCT00937157|9054463|P1|Overall Study|Pregnancy|1
2619001|NCT00937040|9054494|P2|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8
2619002|NCT00937040|9054495|P1|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5
2619003|NCT00937040|9054494|P2|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2
2619004|NCT00937040|9054495|P1|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3
2619005|NCT00937040|9054494|P2|Overall Study|Withdrawal by Subject|7
2619006|NCT00937040|9054495|P1|Overall Study|Withdrawal by Subject|13
2619007|NCT00937040|9054494|P2|Overall Study|Protocol Violation|0
2619008|NCT00937040|9054495|P1|Overall Study|Protocol Violation|3
2619009|NCT00937040|9054494|P2|Overall Study|Lost to Follow-up|12
2619010|NCT00937040|9054495|P1|Overall Study|Lost to Follow-up|12
2619011|NCT00937040|9054494|P2|Overall Study|Adverse Event|8
2619012|NCT00937040|9054495|P1|Overall Study|Adverse Event|5
2619013|NCT00936975|9054537|P1|Overall Study|Post-Tx scan uninterpretable|2
2619014|NCT00936975|9054537|P1|Overall Study|Disease progression|3
2619015|NCT00936975|9054537|P1|Overall Study|Withdrawal by Subject|1
2619016|NCT00936910|9054546|P1|Overall Study|Lack of Efficacy|3
2619017|NCT00936897|9054555|P2|Overall Study|Death|1
2619018|NCT00936897|9054556|P1|Overall Study|Death|0
2619019|NCT00936897|9054555|P2|Overall Study|Noncompliance|2
2619020|NCT00936897|9054556|P1|Overall Study|Noncompliance|0
2619021|NCT00936897|9054555|P2|Overall Study|Ineligibility Determined|3
2619022|NCT00936897|9054556|P1|Overall Study|Ineligibility Determined|0
2619023|NCT00936897|9054555|P2|Overall Study|Protocol Violation|1
2619024|NCT00936897|9054556|P1|Overall Study|Protocol Violation|1
2619025|NCT00936897|9054555|P2|Overall Study|Administrative Decision|2
2619026|NCT00936897|9054556|P1|Overall Study|Administrative Decision|1
2619027|NCT00936897|9054555|P2|Overall Study|Lost to Follow-up|10
2619028|NCT00936897|9054556|P1|Overall Study|Lost to Follow-up|1
2619029|NCT00936897|9054555|P2|Overall Study|Other|9
2619030|NCT00936897|9054556|P1|Overall Study|Other|3
2619031|NCT00936897|9054555|P2|Overall Study|Adverse Event|13
2619032|NCT00936897|9054556|P1|Overall Study|Adverse Event|4
2619033|NCT00936897|9054555|P2|Overall Study|Withdrawal by Subject|19
2619034|NCT00936897|9054556|P1|Overall Study|Withdrawal by Subject|9
2619035|NCT00936884|9054570|P3|Double-blind|Did not receive study drug|0
2619036|NCT00936884|9054571|P2|Double-blind|Did not receive study drug|1
2619037|NCT00936884|9054572|P1|Double-blind|Did not receive study drug|0
2619038|NCT00936884|9054570|P3|Double-blind|No post baseline diary entry|0
2619039|NCT00936884|9054571|P2|Double-blind|No post baseline diary entry|0
2619040|NCT00936884|9054572|P1|Double-blind|No post baseline diary entry|1
2619041|NCT00936884|9054570|P3|Double-blind|Physician Decision|0
2619042|NCT00936884|9054571|P2|Double-blind|Physician Decision|0
2619043|NCT00936884|9054572|P1|Double-blind|Physician Decision|1
2619044|NCT00936884|9054570|P3|Double-blind|Adverse Event|0
2619045|NCT00936884|9054571|P2|Double-blind|Adverse Event|0
2619046|NCT00936884|9054572|P1|Double-blind|Adverse Event|1
2619047|NCT00936884|9054570|P3|Double-blind|Lack of Efficacy|0
2619048|NCT00936884|9054571|P2|Double-blind|Lack of Efficacy|1
2619049|NCT00936884|9054572|P1|Double-blind|Lack of Efficacy|1
2619050|NCT00936884|9054570|P3|Double-blind|Death|0
2619051|NCT00936884|9054571|P2|Double-blind|Death|1
2619052|NCT00936884|9054572|P1|Double-blind|Death|2
2619053|NCT00936884|9054570|P3|Double-blind|Withdrawal by Subject|0
2619054|NCT00936884|9054571|P2|Double-blind|Withdrawal by Subject|4
2619055|NCT00936884|9054572|P1|Double-blind|Withdrawal by Subject|6
2619056|NCT00936715|9054588|P1|Overall Study|Safety or Tolerability Reasons|4
2619057|NCT00936715|9054588|P1|Overall Study|Protocol Violation|1
2619058|NCT00936715|9054588|P1|Overall Study|Investigators Discretion|1
2619059|NCT00936702|9054592|P1|Overall Study|Other|1
2619060|NCT00936702|9054592|P1|Overall Study|Alternative Treatment|1
2619061|NCT00936702|9054592|P1|Overall Study|Withdrawal by Subject|2
2619062|NCT00936702|9054592|P1|Overall Study|Adverse Event|8
2619063|NCT00936702|9054592|P1|Overall Study|Disease progression|34
2619064|NCT00936598|9054625|P2|Overall Study|Ineligible after consent|0
2619065|NCT00936598|9054626|P1|Overall Study|Ineligible after consent|1
2619066|NCT00936598|9054625|P2|Overall Study|Withdrawal by Subject|0
2619067|NCT00936598|9054626|P1|Overall Study|Withdrawal by Subject|1
2619068|NCT00936221|9054728|P2|Overall Study|Withdrawal by Subject|1
2619069|NCT00936221|9054729|P1|Overall Study|Withdrawal by Subject|1
2619070|NCT00936208|9054743|P2|Overall Study|Protocol Violation|22
2619071|NCT00936208|9054744|P1|Overall Study|Protocol Violation|37
2619072|NCT00936117|9054762|P1|Overall Study|Unable to continue oral medication|3
2619073|NCT00936117|9054762|P1|Overall Study|Adverse Event|7
2619074|NCT00936065|9054770|P3|Overall Study|Withdrawal by Subject|4
2619075|NCT00936065|9054771|P2|Overall Study|Withdrawal by Subject|2
2619076|NCT00936065|9054772|P1|Overall Study|Withdrawal by Subject|0
2619077|NCT00936065|9054770|P3|Overall Study|Protocol Violation|1
2619078|NCT00936065|9054771|P2|Overall Study|Protocol Violation|2
2619079|NCT00936065|9054772|P1|Overall Study|Protocol Violation|1
2619080|NCT00936065|9054770|P3|Overall Study|Lost to Follow-up|0
2619081|NCT00936065|9054771|P2|Overall Study|Lost to Follow-up|0
2619082|NCT00936065|9054772|P1|Overall Study|Lost to Follow-up|1
2619083|NCT00936065|9054770|P3|Overall Study|Lack of Efficacy|1
2619084|NCT00936065|9054771|P2|Overall Study|Lack of Efficacy|0
2619085|NCT00936065|9054772|P1|Overall Study|Lack of Efficacy|1
2619086|NCT00936065|9054770|P3|Overall Study|Adverse Event|1
2619087|NCT00936065|9054771|P2|Overall Study|Adverse Event|0
2619088|NCT00936065|9054772|P1|Overall Study|Adverse Event|1
2619089|NCT00935883|9054878|P2|Treatment Period|Withdrawal by Subject|2
2619090|NCT00935883|9054879|P1|Treatment Period|Withdrawal by Subject|0
2619091|NCT00935883|9054878|P2|Treatment Period|Physician Decision|0
2619092|NCT00935883|9054879|P1|Treatment Period|Physician Decision|1
2619093|NCT00935818|9054906|P2|Overall Study|Physician Decision|1
2619094|NCT00935818|9054907|P1|Overall Study|Physician Decision|0
2619095|NCT00935818|9054906|P2|Overall Study|Adverse Event|7
2619096|NCT00935818|9054907|P1|Overall Study|Adverse Event|6
2619097|NCT00935818|9054906|P2|Overall Study|Lost to Follow-up|42
2619098|NCT00935818|9054907|P1|Overall Study|Lost to Follow-up|40
2619099|NCT00935818|9054906|P2|Overall Study|Withdrawal by Subject|50
2619100|NCT00935818|9054907|P1|Overall Study|Withdrawal by Subject|45
2619101|NCT00935701|9054958|P1|Overall Study|Failure to Transition to Acupuncture|1
2619102|NCT00935584|9054975|P2|Overall Study|Provider dropped out of study|4
2619103|NCT00935584|9054976|P1|Overall Study|Provider dropped out of study|14
2619104|NCT00935584|9054975|P2|Overall Study|Patient changed provider|0
2619105|NCT00935584|9054976|P1|Overall Study|Patient changed provider|3
2619106|NCT00935584|9054975|P2|Overall Study|Relocated|0
2619107|NCT00935584|9054976|P1|Overall Study|Relocated|3
2619108|NCT00935584|9054975|P2|Overall Study|No show|0
2619109|NCT00935584|9054976|P1|Overall Study|No show|9
2619110|NCT00935584|9054975|P2|Overall Study|Lost to Follow-up|0
2619111|NCT00935584|9054976|P1|Overall Study|Lost to Follow-up|8
2619112|NCT00935584|9054975|P2|Overall Study|Death|0
2619113|NCT00935584|9054976|P1|Overall Study|Death|3
2619114|NCT00935584|9054975|P2|Overall Study|Withdrawal by Subject|0
2619115|NCT00935584|9054976|P1|Overall Study|Withdrawal by Subject|9
2619116|NCT00935532|9054988|P2|Overall Study|Loss Glucose Control|0
2619117|NCT00935532|9054989|P1|Overall Study|Loss Glucose Control|4
2619118|NCT00935532|9054988|P2|Overall Study|Sponsor Decision|1
2619119|NCT00935532|9054989|P1|Overall Study|Sponsor Decision|0
2619120|NCT00935532|9054988|P2|Overall Study|Subject Decision|1
2619121|NCT00935532|9054989|P1|Overall Study|Subject Decision|2
2619122|NCT00935532|9054988|P2|Overall Study|Protocol Violation|1
2619123|NCT00935532|9054989|P1|Overall Study|Protocol Violation|2
2619124|NCT00935532|9054988|P2|Overall Study|Physician Decision|2
2619125|NCT00935532|9054989|P1|Overall Study|Physician Decision|1
2619126|NCT00935532|9054988|P2|Overall Study|Lost to Follow-up|0
2619127|NCT00935532|9054989|P1|Overall Study|Lost to Follow-up|1
2619128|NCT00935532|9054988|P2|Overall Study|Death|0
2619129|NCT00935532|9054989|P1|Overall Study|Death|1
2619130|NCT00935532|9054988|P2|Overall Study|Adverse Event|6
2619131|NCT00935532|9054989|P1|Overall Study|Adverse Event|11
2619132|NCT00935493|9055018|P3|Overall Study|Treatment Discontinued|0
2619133|NCT00935493|9055019|P2|Overall Study|Treatment Discontinued|1
2619134|NCT00935493|9055020|P1|Overall Study|Treatment Discontinued|0
2619135|NCT00935493|9055018|P3|Overall Study|Lost to Follow-up|1
2619136|NCT00935493|9055019|P2|Overall Study|Lost to Follow-up|1
2619137|NCT00935493|9055020|P1|Overall Study|Lost to Follow-up|1
2619138|NCT00935272|9055069|P2|Overall Study|Protocol Violation|1
2619139|NCT00935272|9055070|P1|Overall Study|Protocol Violation|0
2619140|NCT00935272|9055069|P2|Overall Study|Physician Decision|0
2619141|NCT00935272|9055070|P1|Overall Study|Physician Decision|1
2619142|NCT00935272|9055069|P2|Overall Study|Withdrawal by Subject|2
2619143|NCT00935272|9055070|P1|Overall Study|Withdrawal by Subject|8
2619144|NCT00935272|9055069|P2|Overall Study|Lost to Follow-up|3
2619145|NCT00935272|9055070|P1|Overall Study|Lost to Follow-up|10
2619146|NCT00935259|9055079|P2|Period 1|Administrative (scheduling conflict)|1
2619147|NCT00935259|9055080|P1|Period 1|Administrative (scheduling conflict)|1
2619148|NCT00935220|9055094|P1|Overall Study|Other reason (not specified)|1
2619149|NCT00935220|9055094|P1|Overall Study|Adverse Event|1
2619150|NCT00934947|9055125|P2|Overall Study|Adverse Event|2
2619151|NCT00934947|9055126|P1|Overall Study|Adverse Event|0
2619152|NCT00934856|9055155|P6|Extension Part|Non-compliance with drug|1
2619153|NCT00934856|9055156|P5|Extension Part|Non-compliance with drug|0
2619154|NCT00934856|9055157|P4|Extension Part|Non-compliance with drug|0
2619155|NCT00934856|9055158|P3|Extension Part|Non-compliance with drug|0
2619156|NCT00934856|9055159|P2|Extension Part|Non-compliance with drug|0
2619157|NCT00934856|9055160|P1|Extension Part|Non-compliance with drug|0
2619158|NCT00934856|9055155|P6|Extension Part|Progressive disease|0
2619159|NCT00934856|9055156|P5|Extension Part|Progressive disease|0
2619160|NCT00934856|9055157|P4|Extension Part|Progressive disease|1
2619161|NCT00934856|9055158|P3|Extension Part|Progressive disease|0
2619162|NCT00934856|9055159|P2|Extension Part|Progressive disease|0
2619163|NCT00934856|9055160|P1|Extension Part|Progressive disease|0
2619164|NCT00934856|9055155|P6|Extension Part|Adverse Event|4
2619165|NCT00934856|9055156|P5|Extension Part|Adverse Event|4
2619166|NCT00934856|9055157|P4|Extension Part|Adverse Event|1
2619167|NCT00934856|9055158|P3|Extension Part|Adverse Event|0
2619168|NCT00934856|9055159|P2|Extension Part|Adverse Event|0
2619169|NCT00934856|9055160|P1|Extension Part|Adverse Event|0
2619170|NCT00934856|9055155|P6|Feasibility Part|Withdrawal by Subject|1
2619171|NCT00934856|9055156|P5|Feasibility Part|Withdrawal by Subject|0
2619172|NCT00934856|9055157|P4|Feasibility Part|Withdrawal by Subject|1
2619173|NCT00934856|9055158|P3|Feasibility Part|Withdrawal by Subject|0
2619174|NCT00934856|9055159|P2|Feasibility Part|Withdrawal by Subject|0
2619175|NCT00934856|9055160|P1|Feasibility Part|Withdrawal by Subject|0
2619176|NCT00934856|9055155|P6|Feasibility Part|Adverse Event|2
2619177|NCT00934856|9055156|P5|Feasibility Part|Adverse Event|0
2619178|NCT00934856|9055157|P4|Feasibility Part|Adverse Event|1
2619179|NCT00934856|9055158|P3|Feasibility Part|Adverse Event|0
2619180|NCT00934856|9055159|P2|Feasibility Part|Adverse Event|1
2619181|NCT00934856|9055160|P1|Feasibility Part|Adverse Event|1
2619182|NCT00934856|9055155|P6|Feasibility Part|Physician Decision|0
2619183|NCT00934856|9055156|P5|Feasibility Part|Physician Decision|0
2619184|NCT00934856|9055157|P4|Feasibility Part|Physician Decision|0
2619185|NCT00934856|9055158|P3|Feasibility Part|Physician Decision|1
2619186|NCT00934856|9055159|P2|Feasibility Part|Physician Decision|0
2619187|NCT00934856|9055160|P1|Feasibility Part|Physician Decision|0
2619188|NCT00934856|9055155|P6|Feasibility Part|Progressive disease|0
2619189|NCT00934856|9055156|P5|Feasibility Part|Progressive disease|0
2619190|NCT00934856|9055157|P4|Feasibility Part|Progressive disease|3
2619191|NCT00934856|9055158|P3|Feasibility Part|Progressive disease|2
2619192|NCT00934856|9055159|P2|Feasibility Part|Progressive disease|4
2619193|NCT00934856|9055160|P1|Feasibility Part|Progressive disease|4
2619194|NCT00934843|9055258|P2|Overall Study|Protocol Violation|1
2619195|NCT00934843|9055259|P1|Overall Study|Protocol Violation|0
2619196|NCT00934791|9055275|P2|Overall Study|Withdrawal by Subject|0
2619197|NCT00934791|9055276|P1|Overall Study|Withdrawal by Subject|1
2619198|NCT00934661|9055284|P2|Overall Study|Failure of Combined/Spinal Epidural|0
2619199|NCT00934661|9055285|P1|Overall Study|Failure of Combined/Spinal Epidural|1
2619200|NCT00934648|9055305|P1|Overall Study|Withdrawal by Subject|1
2619201|NCT00934648|9055305|P1|Overall Study|Failure to return|8
2619202|NCT00934622|9055349|P1|Overall Study|2nd Intraoperative exclusion criteria|1
2619203|NCT00934622|9055349|P1|Overall Study|Lost to Follow-up|7
2619204|NCT00934544|9055387|P3|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5
2619205|NCT00934544|9055388|P2|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0
2619206|NCT00934544|9055389|P1|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8
2619207|NCT00934544|9055387|P3|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0
2619208|NCT00934544|9055388|P2|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1
2619209|NCT00934544|9055389|P1|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0
2619210|NCT00934544|9055387|P3|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1
2619211|NCT00934544|9055388|P2|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0
2619212|NCT00934544|9055389|P1|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4
2619213|NCT00934544|9055387|P3|Overall Disposition at 5 Year Follow-up|Disease progression|7
2619214|NCT00934544|9055388|P2|Overall Disposition at 5 Year Follow-up|Disease progression|4
2619215|NCT00934544|9055389|P1|Overall Disposition at 5 Year Follow-up|Disease progression|32
2619216|NCT00934544|9055387|P3|Overall Disposition at 5 Year Follow-up|Protocol Violation|5
2619217|NCT00934544|9055388|P2|Overall Disposition at 5 Year Follow-up|Protocol Violation|0
2619218|NCT00934544|9055389|P1|Overall Disposition at 5 Year Follow-up|Protocol Violation|2
2619219|NCT00934544|9055387|P3|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0
2619220|NCT00934544|9055388|P2|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9
2619221|NCT00934544|9055389|P1|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10
2619222|NCT00934544|9055387|P3|Overall Disposition at 5 Year Follow-up|Adverse Event|10
2619223|NCT00934544|9055388|P2|Overall Disposition at 5 Year Follow-up|Adverse Event|5
2619224|NCT00934544|9055389|P1|Overall Disposition at 5 Year Follow-up|Adverse Event|35
2619225|NCT00934544|9055387|P3|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6
2619226|NCT00934544|9055388|P2|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9
2619227|NCT00934544|9055389|P1|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16
2619228|NCT00934544|9055387|P3|Primary Endpoint Analysis (Interim)|Entered extension phase|0
2619229|NCT00934544|9055388|P2|Primary Endpoint Analysis (Interim)|Entered extension phase|18
2619230|NCT00934544|9055389|P1|Primary Endpoint Analysis (Interim)|Entered extension phase|29
2619231|NCT00934544|9055387|P3|Primary Endpoint Analysis (Interim)|Other reasons|0
2619232|NCT00934544|9055388|P2|Primary Endpoint Analysis (Interim)|Other reasons|7
2619233|NCT00934544|9055389|P1|Primary Endpoint Analysis (Interim)|Other reasons|7
2619234|NCT00934544|9055387|P3|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0
2619235|NCT00934544|9055388|P2|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1
2619236|NCT00934544|9055389|P1|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0
2619237|NCT00934544|9055387|P3|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0
2619238|NCT00934544|9055388|P2|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0
2619239|NCT00934544|9055389|P1|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2
2619240|NCT00934544|9055387|P3|Primary Endpoint Analysis (Interim)|Disease Progression|0
2619241|NCT00934544|9055388|P2|Primary Endpoint Analysis (Interim)|Disease Progression|3
2619242|NCT00934544|9055389|P1|Primary Endpoint Analysis (Interim)|Disease Progression|1
2619243|NCT00934544|9055387|P3|Primary Endpoint Analysis (Interim)|Protocol Violation|0
2619244|NCT00934544|9055388|P2|Primary Endpoint Analysis (Interim)|Protocol Violation|0
2619245|NCT00934544|9055389|P1|Primary Endpoint Analysis (Interim)|Protocol Violation|2
2619246|NCT00934544|9055387|P3|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0
2619247|NCT00934544|9055388|P2|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9
2619248|NCT00934544|9055389|P1|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2
2619249|NCT00934544|9055387|P3|Primary Endpoint Analysis (Interim)|Adverse Event|0
2619250|NCT00934544|9055388|P2|Primary Endpoint Analysis (Interim)|Adverse Event|4
2619251|NCT00934544|9055389|P1|Primary Endpoint Analysis (Interim)|Adverse Event|12
2619252|NCT00934440|9055425|P1|Overall Study|Lost to Follow-up|1
2619253|NCT00934362|9055441|P2|Overall Study|Adverse Event|0
2619254|NCT00934362|9055442|P1|Overall Study|Adverse Event|1
2619255|NCT00934128|9055492|P2|Second Intervention (2 Hours)|Claustrophobia/anxiety|3
2619256|NCT00934128|9055493|P1|Second Intervention (2 Hours)|Claustrophobia/anxiety|0
2619257|NCT00934128|9055492|P2|Washout Period (1 Hour)|Dyspnea too low to continue|2
2619258|NCT00934128|9055493|P1|Washout Period (1 Hour)|Dyspnea too low to continue|4
2619259|NCT00934128|9055492|P2|Washout Period (1 Hour)|Too tired|0
2619260|NCT00934128|9055493|P1|Washout Period (1 Hour)|Too tired|1
2619261|NCT00934128|9055492|P2|Washout Period (1 Hour)|Pain|0
2619262|NCT00934128|9055493|P1|Washout Period (1 Hour)|Pain|1
2619263|NCT00934128|9055492|P2|Washout Period (1 Hour)|Patient preference|3
2619264|NCT00934128|9055493|P1|Washout Period (1 Hour)|Patient preference|1
2619265|NCT00934128|9055492|P2|First Intervention (2 Hours)|Treatment Delivery Order Switched|0
2619266|NCT00934128|9055493|P1|First Intervention (2 Hours)|Treatment Delivery Order Switched|1
2619267|NCT00934128|9055492|P2|First Intervention (2 Hours)|Adverse Event|1
2619268|NCT00934128|9055493|P1|First Intervention (2 Hours)|Adverse Event|4
2619269|NCT00934128|9055492|P2|First Intervention (2 Hours)|Withdrawal by Subject|1
2619270|NCT00934128|9055493|P1|First Intervention (2 Hours)|Withdrawal by Subject|0
2619271|NCT00934102|9055501|P3|Period 1, One Night of Wear|Personal Reasons|0
2619272|NCT00934102|9055502|P2|Period 1, One Night of Wear|Personal Reasons|0
2619273|NCT00934102|9055503|P1|Period 1, One Night of Wear|Personal Reasons|1
2619274|NCT00934050|9055517|P6|Enrolled After 15 Dec 2009|Withdrawal by Subject|2
2619275|NCT00934050|9055518|P5|Enrolled After 15 Dec 2009|Withdrawal by Subject|4
2619276|NCT00934050|9055519|P4|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
2619277|NCT00934050|9055520|P3|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
2619278|NCT00934050|9055521|P2|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
2619279|NCT00934050|9055522|P1|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
2619280|NCT00934050|9055517|P6|Enrolled After 15 Dec 2009|Lost to Follow-up|1
2619281|NCT00934050|9055518|P5|Enrolled After 15 Dec 2009|Lost to Follow-up|0
2619282|NCT00934050|9055519|P4|Enrolled After 15 Dec 2009|Lost to Follow-up|0
2619283|NCT00934050|9055520|P3|Enrolled After 15 Dec 2009|Lost to Follow-up|0
2619284|NCT00934050|9055521|P2|Enrolled After 15 Dec 2009|Lost to Follow-up|0
2619285|NCT00934050|9055522|P1|Enrolled After 15 Dec 2009|Lost to Follow-up|0
2619286|NCT00934050|9055517|P6|Enrolled After 15 Dec 2009|Death|1
2619287|NCT00934050|9055518|P5|Enrolled After 15 Dec 2009|Death|0
2619288|NCT00934050|9055519|P4|Enrolled After 15 Dec 2009|Death|0
2619289|NCT00934050|9055520|P3|Enrolled After 15 Dec 2009|Death|0
2619290|NCT00934050|9055521|P2|Enrolled After 15 Dec 2009|Death|0
2619291|NCT00934050|9055522|P1|Enrolled After 15 Dec 2009|Death|0
2619292|NCT00934050|9055517|P6|Enrolled After 15 Dec 2009|Adverse Event|0
2619293|NCT00934050|9055518|P5|Enrolled After 15 Dec 2009|Adverse Event|3
2619294|NCT00934050|9055519|P4|Enrolled After 15 Dec 2009|Adverse Event|0
2619295|NCT00934050|9055520|P3|Enrolled After 15 Dec 2009|Adverse Event|0
2619296|NCT00934050|9055521|P2|Enrolled After 15 Dec 2009|Adverse Event|0
2619297|NCT00934050|9055522|P1|Enrolled After 15 Dec 2009|Adverse Event|0
2619298|NCT00934050|9055517|P6|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
2619299|NCT00934050|9055518|P5|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
2619300|NCT00934050|9055519|P4|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
2619301|NCT00934050|9055520|P3|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1
2619302|NCT00934050|9055521|P2|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
2619303|NCT00934050|9055522|P1|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
2619304|NCT00934050|9055517|P6|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
2619305|NCT00934050|9055518|P5|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
2619306|NCT00934050|9055519|P4|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13
2619307|NCT00934050|9055520|P3|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
2619308|NCT00934050|9055521|P2|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12
2619309|NCT00934050|9055522|P1|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
2619310|NCT00934050|9055517|P6|Enrolled Prior to 15 Dec 2009|Adverse Event|0
2619311|NCT00934050|9055518|P5|Enrolled Prior to 15 Dec 2009|Adverse Event|0
2619312|NCT00934050|9055519|P4|Enrolled Prior to 15 Dec 2009|Adverse Event|1
2619313|NCT00934050|9055520|P3|Enrolled Prior to 15 Dec 2009|Adverse Event|0
2619314|NCT00934050|9055521|P2|Enrolled Prior to 15 Dec 2009|Adverse Event|0
2619315|NCT00934050|9055522|P1|Enrolled Prior to 15 Dec 2009|Adverse Event|1
2619316|NCT00933933|9055545|P3|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
2619317|NCT00933933|9055546|P2|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2
2619318|NCT00933933|9055547|P1|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
2619319|NCT00933933|9055545|P3|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
2619320|NCT00933933|9055546|P2|General Population From 16 to 89 Years|Did not meet criteria for analysis|20
2619321|NCT00933933|9055547|P1|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
2619322|NCT00933686|9055565|P2|Overall Study|Failure to show up at endpoint visits|2
2619323|NCT00933686|9055566|P1|Overall Study|Failure to show up at endpoint visits|0
2619324|NCT00933686|9055565|P2|Overall Study|Physician Decision|0
2619325|NCT00933686|9055566|P1|Overall Study|Physician Decision|1
2619326|NCT00933686|9055565|P2|Overall Study|Adverse Event|1
2619327|NCT00933686|9055566|P1|Overall Study|Adverse Event|1
2619328|NCT00933686|9055565|P2|Overall Study|Withdrawal by Subject|5
2619329|NCT00933686|9055566|P1|Overall Study|Withdrawal by Subject|6
2619330|NCT00933686|9055565|P2|Overall Study|Lost to Follow-up|2
2619331|NCT00933686|9055566|P1|Overall Study|Lost to Follow-up|2
2619332|NCT00933686|9055565|P2|Overall Study|Protocol Violation|1
2619333|NCT00933686|9055566|P1|Overall Study|Protocol Violation|0
2619334|NCT00933608|9055586|P2|Overall Study|Physician Decision|0
2619335|NCT00933608|9055587|P1|Overall Study|Physician Decision|1
2619336|NCT00933608|9055586|P2|Overall Study|Adverse Event|2
2619337|NCT00933608|9055587|P1|Overall Study|Adverse Event|4
2619338|NCT00933543|9055595|P2|Overall Study|Other|1
2619339|NCT00933543|9055596|P1|Overall Study|Other|1
2619340|NCT00933543|9055595|P2|Overall Study|Lack of Efficacy|3
2619341|NCT00933543|9055596|P1|Overall Study|Lack of Efficacy|0
2619342|NCT00933543|9055595|P2|Overall Study|Withdrawal by Subject|1
2619343|NCT00933543|9055596|P1|Overall Study|Withdrawal by Subject|0
2619344|NCT00933543|9055595|P2|Overall Study|Lost to Follow-up|1
2619345|NCT00933543|9055596|P1|Overall Study|Lost to Follow-up|0
2619346|NCT00933543|9055595|P2|Overall Study|Adverse Event|1
2619347|NCT00933543|9055596|P1|Overall Study|Adverse Event|2
2619348|NCT00933335|9055665|P2|Overall Study|Co-morbid Illness|0
2619349|NCT00933335|9055666|P1|Overall Study|Co-morbid Illness|1
2619350|NCT00933335|9055665|P2|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1
2619351|NCT00933335|9055666|P1|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0
2619352|NCT00933335|9055665|P2|Overall Study|Progressive Disease|11
2619353|NCT00933335|9055666|P1|Overall Study|Progressive Disease|0
2619354|NCT00933335|9055665|P2|Overall Study|Withdrawal by Subject|1
2619355|NCT00933335|9055666|P1|Overall Study|Withdrawal by Subject|0
2619356|NCT00933335|9055665|P2|Overall Study|Lost to Follow-up|3
2619357|NCT00933335|9055666|P1|Overall Study|Lost to Follow-up|1
2619358|NCT00933270|9055736|P1|Overall Study|Moved or would not return|10
2619359|NCT00933270|9055736|P1|Overall Study|Death|24
2619360|NCT00933270|9055736|P1|Overall Study|Missed Visit|2
2619361|NCT00933270|9055736|P1|Overall Study|Adverse Event|1
2619362|NCT00933270|9055736|P1|Overall Study|Lost to Follow-up|14
2619363|NCT00933270|9055736|P1|Overall Study|Insufficient Follow-up|10
2619364|NCT00933270|9055736|P1|Overall Study|Withdrawal by Subject|26
2619365|NCT00933244|9055830|P3|Overall Study|Withdrawal by Subject|3
2619366|NCT00933244|9055831|P2|Overall Study|Withdrawal by Subject|1
2619367|NCT00933244|9055832|P1|Overall Study|Withdrawal by Subject|5
2619368|NCT00933166|9055849|P1|Overall Study|Withdrawal by Subject|1
2619369|NCT00933166|9055849|P1|Overall Study|Unavailable|4
2619370|NCT00933166|9055849|P1|Overall Study|Lack of Efficacy|9
2619371|NCT00933166|9055849|P1|Overall Study|Lost to Follow-up|4
2619372|NCT00932893|9055855|P2|Overall Study|Other|144
2619373|NCT00932893|9055856|P1|Overall Study|Other|5
2619374|NCT00932893|9055855|P2|Overall Study|Withdrawal by Subject|2
2619375|NCT00932893|9055856|P1|Overall Study|Withdrawal by Subject|5
2619376|NCT00932893|9055855|P2|Overall Study|Lost to Follow-up|0
2619377|NCT00932893|9055856|P1|Overall Study|Lost to Follow-up|8
2619378|NCT00932893|9055855|P2|Overall Study|Death|24
2619379|NCT00932893|9055856|P1|Overall Study|Death|115
2619380|NCT00932698|9055904|P11|Part 2 (Dose Expansion)|Adverse Event|0
2619381|NCT00932698|9055905|P10|Part 2 (Dose Expansion)|Adverse Event|1
2619382|NCT00932698|9055906|P9|Part 2 (Dose Expansion)|Adverse Event|1
2619383|NCT00932698|9055907|P8|Part 2 (Dose Expansion)|Adverse Event|5
2619384|NCT00932698|9055908|P7|Part 2 (Dose Expansion)|Adverse Event|0
2619385|NCT00932698|9055909|P6|Part 2 (Dose Expansion)|Adverse Event|0
2619386|NCT00932698|9055910|P5|Part 2 (Dose Expansion)|Adverse Event|0
2619387|NCT00932698|9055911|P4|Part 2 (Dose Expansion)|Adverse Event|0
2619388|NCT00932698|9055912|P3|Part 2 (Dose Expansion)|Adverse Event|0
2619389|NCT00932698|9055913|P2|Part 2 (Dose Expansion)|Adverse Event|0
2619390|NCT00932698|9055914|P1|Part 2 (Dose Expansion)|Adverse Event|0
2619391|NCT00932698|9055904|P11|Part 2 (Dose Expansion)|Withdrawal by Subject|0
2619392|NCT00932698|9055905|P10|Part 2 (Dose Expansion)|Withdrawal by Subject|2
2619393|NCT00932698|9055906|P9|Part 2 (Dose Expansion)|Withdrawal by Subject|3
2619394|NCT00932698|9055907|P8|Part 2 (Dose Expansion)|Withdrawal by Subject|1
2619395|NCT00932698|9055908|P7|Part 2 (Dose Expansion)|Withdrawal by Subject|0
2619396|NCT00932698|9055909|P6|Part 2 (Dose Expansion)|Withdrawal by Subject|0
2619397|NCT00932698|9055910|P5|Part 2 (Dose Expansion)|Withdrawal by Subject|0
2619398|NCT00932698|9055911|P4|Part 2 (Dose Expansion)|Withdrawal by Subject|0
2619399|NCT00932698|9055912|P3|Part 2 (Dose Expansion)|Withdrawal by Subject|0
2619400|NCT00932698|9055913|P2|Part 2 (Dose Expansion)|Withdrawal by Subject|0
2619401|NCT00932698|9055914|P1|Part 2 (Dose Expansion)|Withdrawal by Subject|0
2619402|NCT00932698|9055904|P11|Part 2 (Dose Expansion)|Progressive Disease|2
2619403|NCT00932698|9055905|P10|Part 2 (Dose Expansion)|Progressive Disease|3
2619404|NCT00932698|9055906|P9|Part 2 (Dose Expansion)|Progressive Disease|8
2619405|NCT00932698|9055907|P8|Part 2 (Dose Expansion)|Progressive Disease|14
2619406|NCT00932698|9055908|P7|Part 2 (Dose Expansion)|Progressive Disease|0
2619407|NCT00932698|9055909|P6|Part 2 (Dose Expansion)|Progressive Disease|0
2619408|NCT00932698|9055910|P5|Part 2 (Dose Expansion)|Progressive Disease|0
2619409|NCT00932698|9055911|P4|Part 2 (Dose Expansion)|Progressive Disease|0
2619410|NCT00932698|9055912|P3|Part 2 (Dose Expansion)|Progressive Disease|0
2619411|NCT00932698|9055913|P2|Part 2 (Dose Expansion)|Progressive Disease|0
2619412|NCT00932698|9055914|P1|Part 2 (Dose Expansion)|Progressive Disease|0
2619413|NCT00932698|9055904|P11|Part 1 (Dose Escalation)|Other|0
2619414|NCT00932698|9055905|P10|Part 1 (Dose Escalation)|Other|0
2619415|NCT00932698|9055906|P9|Part 1 (Dose Escalation)|Other|0
2619416|NCT00932698|9055907|P8|Part 1 (Dose Escalation)|Other|0
2619417|NCT00932698|9055908|P7|Part 1 (Dose Escalation)|Other|1
2619418|NCT00932698|9055909|P6|Part 1 (Dose Escalation)|Other|0
2619419|NCT00932698|9055910|P5|Part 1 (Dose Escalation)|Other|0
2619420|NCT00932698|9055911|P4|Part 1 (Dose Escalation)|Other|0
2619421|NCT00932698|9055912|P3|Part 1 (Dose Escalation)|Other|1
2619422|NCT00932698|9055913|P2|Part 1 (Dose Escalation)|Other|0
2619423|NCT00932698|9055914|P1|Part 1 (Dose Escalation)|Other|0
2619424|NCT00932698|9055904|P11|Part 1 (Dose Escalation)|Adverse Event|0
2619425|NCT00932698|9055905|P10|Part 1 (Dose Escalation)|Adverse Event|0
2619426|NCT00932698|9055906|P9|Part 1 (Dose Escalation)|Adverse Event|0
2619427|NCT00932698|9055907|P8|Part 1 (Dose Escalation)|Adverse Event|0
2619428|NCT00932698|9055908|P7|Part 1 (Dose Escalation)|Adverse Event|0
2619429|NCT00932698|9055909|P6|Part 1 (Dose Escalation)|Adverse Event|1
2619430|NCT00932698|9055910|P5|Part 1 (Dose Escalation)|Adverse Event|0
2619431|NCT00932698|9055911|P4|Part 1 (Dose Escalation)|Adverse Event|0
2619432|NCT00932698|9055912|P3|Part 1 (Dose Escalation)|Adverse Event|0
2619433|NCT00932698|9055913|P2|Part 1 (Dose Escalation)|Adverse Event|0
2619434|NCT00932698|9055914|P1|Part 1 (Dose Escalation)|Adverse Event|0
2619435|NCT00932698|9055904|P11|Part 1 (Dose Escalation)|Withdrawal by Participant|0
2619436|NCT00932698|9055905|P10|Part 1 (Dose Escalation)|Withdrawal by Participant|0
2619437|NCT00932698|9055906|P9|Part 1 (Dose Escalation)|Withdrawal by Participant|0
2619438|NCT00932698|9055907|P8|Part 1 (Dose Escalation)|Withdrawal by Participant|0
2619439|NCT00932698|9055908|P7|Part 1 (Dose Escalation)|Withdrawal by Participant|1
2619440|NCT00932698|9055909|P6|Part 1 (Dose Escalation)|Withdrawal by Participant|1
2619441|NCT00932698|9055910|P5|Part 1 (Dose Escalation)|Withdrawal by Participant|0
2619442|NCT00932698|9055911|P4|Part 1 (Dose Escalation)|Withdrawal by Participant|1
2619443|NCT00932698|9055912|P3|Part 1 (Dose Escalation)|Withdrawal by Participant|0
2619444|NCT00932698|9055913|P2|Part 1 (Dose Escalation)|Withdrawal by Participant|1
2619445|NCT00932698|9055914|P1|Part 1 (Dose Escalation)|Withdrawal by Participant|0
2619446|NCT00932698|9055904|P11|Part 1 (Dose Escalation)|Progressive Disease|0
2619447|NCT00932698|9055905|P10|Part 1 (Dose Escalation)|Progressive Disease|0
2619448|NCT00932698|9055906|P9|Part 1 (Dose Escalation)|Progressive Disease|0
2619449|NCT00932698|9055907|P8|Part 1 (Dose Escalation)|Progressive Disease|0
2619450|NCT00932698|9055908|P7|Part 1 (Dose Escalation)|Progressive Disease|2
2619451|NCT00932698|9055909|P6|Part 1 (Dose Escalation)|Progressive Disease|5
2619452|NCT00932698|9055910|P5|Part 1 (Dose Escalation)|Progressive Disease|3
2619453|NCT00932698|9055911|P4|Part 1 (Dose Escalation)|Progressive Disease|2
2619454|NCT00932698|9055912|P3|Part 1 (Dose Escalation)|Progressive Disease|2
2619455|NCT00932698|9055913|P2|Part 1 (Dose Escalation)|Progressive Disease|2
2619456|NCT00932698|9055914|P1|Part 1 (Dose Escalation)|Progressive Disease|3
2619457|NCT00932646|9056088|P4|Overall Study|Withdrawal by Subject|0
2619458|NCT00932646|9056089|P3|Overall Study|Withdrawal by Subject|3
2619459|NCT00932646|9056090|P2|Overall Study|Withdrawal by Subject|1
2619460|NCT00932646|9056091|P1|Overall Study|Withdrawal by Subject|1
2619461|NCT00932646|9056088|P4|Overall Study|Lost to Follow-up|0
2619462|NCT00932646|9056089|P3|Overall Study|Lost to Follow-up|0
2619463|NCT00932646|9056090|P2|Overall Study|Lost to Follow-up|1
2619464|NCT00932646|9056091|P1|Overall Study|Lost to Follow-up|2
2619465|NCT00932646|9056088|P4|Overall Study|Adverse Event|1
2619466|NCT00932646|9056089|P3|Overall Study|Adverse Event|1
2619467|NCT00932646|9056090|P2|Overall Study|Adverse Event|1
2619468|NCT00932646|9056091|P1|Overall Study|Adverse Event|2
2619469|NCT00932451|9056178|P1|Overall Study|Other reasons|5
2619470|NCT00932451|9056178|P1|Overall Study|Death|726
2619471|NCT00932451|9056178|P1|Overall Study|Lost to Follow-up|22
2619472|NCT00932451|9056178|P1|Overall Study|Withdrawal by Subject|69
2619473|NCT00932425|9056202|P2|Overall Study|Withdrawal by Subject|1
2619474|NCT00932425|9056203|P1|Overall Study|Withdrawal by Subject|0
2619475|NCT00932425|9056202|P2|Overall Study|Lost to Follow-up|1
2619476|NCT00932425|9056203|P1|Overall Study|Lost to Follow-up|0
2619477|NCT00932373|9056236|P11|Overall Study|Lack of Efficacy|0
2619478|NCT00932373|9056237|P10|Overall Study|Lack of Efficacy|1
2619479|NCT00932373|9056238|P9|Overall Study|Lack of Efficacy|0
2619480|NCT00932373|9056239|P8|Overall Study|Lack of Efficacy|0
2619481|NCT00932373|9056240|P7|Overall Study|Lack of Efficacy|0
2619482|NCT00932373|9056241|P6|Overall Study|Lack of Efficacy|0
2619483|NCT00932373|9056242|P5|Overall Study|Lack of Efficacy|0
2619484|NCT00932373|9056243|P4|Overall Study|Lack of Efficacy|0
2619485|NCT00932373|9056244|P3|Overall Study|Lack of Efficacy|0
2619486|NCT00932373|9056245|P2|Overall Study|Lack of Efficacy|0
2619487|NCT00932373|9056246|P1|Overall Study|Lack of Efficacy|0
2619488|NCT00932373|9056236|P11|Overall Study|Clinical progression|0
2619489|NCT00932373|9056237|P10|Overall Study|Clinical progression|0
2619490|NCT00932373|9056238|P9|Overall Study|Clinical progression|0
2619491|NCT00932373|9056239|P8|Overall Study|Clinical progression|0
2619492|NCT00932373|9056240|P7|Overall Study|Clinical progression|1
2619493|NCT00932373|9056241|P6|Overall Study|Clinical progression|0
2619494|NCT00932373|9056242|P5|Overall Study|Clinical progression|0
2619495|NCT00932373|9056243|P4|Overall Study|Clinical progression|0
2619496|NCT00932373|9056244|P3|Overall Study|Clinical progression|0
2619497|NCT00932373|9056245|P2|Overall Study|Clinical progression|0
2619498|NCT00932373|9056246|P1|Overall Study|Clinical progression|0
2619499|NCT00932373|9056236|P11|Overall Study|Withdrawal by Subject|0
2619500|NCT00932373|9056237|P10|Overall Study|Withdrawal by Subject|0
2619501|NCT00932373|9056238|P9|Overall Study|Withdrawal by Subject|1
2619502|NCT00932373|9056239|P8|Overall Study|Withdrawal by Subject|0
2619503|NCT00932373|9056240|P7|Overall Study|Withdrawal by Subject|0
2619504|NCT00932373|9056241|P6|Overall Study|Withdrawal by Subject|0
2619505|NCT00932373|9056242|P5|Overall Study|Withdrawal by Subject|0
2619506|NCT00932373|9056243|P4|Overall Study|Withdrawal by Subject|0
2619507|NCT00932373|9056244|P3|Overall Study|Withdrawal by Subject|0
2619508|NCT00932373|9056245|P2|Overall Study|Withdrawal by Subject|0
2619509|NCT00932373|9056246|P1|Overall Study|Withdrawal by Subject|0
2619510|NCT00932373|9056236|P11|Overall Study|Dose limiting toxicity|0
2619511|NCT00932373|9056237|P10|Overall Study|Dose limiting toxicity|0
2619512|NCT00932373|9056238|P9|Overall Study|Dose limiting toxicity|0
2619513|NCT00932373|9056239|P8|Overall Study|Dose limiting toxicity|0
2619514|NCT00932373|9056240|P7|Overall Study|Dose limiting toxicity|0
2619515|NCT00932373|9056241|P6|Overall Study|Dose limiting toxicity|1
2619516|NCT00932373|9056242|P5|Overall Study|Dose limiting toxicity|0
2619517|NCT00932373|9056243|P4|Overall Study|Dose limiting toxicity|0
2619518|NCT00932373|9056244|P3|Overall Study|Dose limiting toxicity|0
2619519|NCT00932373|9056245|P2|Overall Study|Dose limiting toxicity|0
2619520|NCT00932373|9056246|P1|Overall Study|Dose limiting toxicity|0
2619521|NCT00932373|9056236|P11|Overall Study|Physician Decision|0
2619522|NCT00932373|9056237|P10|Overall Study|Physician Decision|1
2619523|NCT00932373|9056238|P9|Overall Study|Physician Decision|0
2619524|NCT00932373|9056239|P8|Overall Study|Physician Decision|0
2619525|NCT00932373|9056240|P7|Overall Study|Physician Decision|0
2619526|NCT00932373|9056241|P6|Overall Study|Physician Decision|0
2619527|NCT00932373|9056242|P5|Overall Study|Physician Decision|2
2619528|NCT00932373|9056243|P4|Overall Study|Physician Decision|0
2619529|NCT00932373|9056244|P3|Overall Study|Physician Decision|1
2619530|NCT00932373|9056245|P2|Overall Study|Physician Decision|0
2619531|NCT00932373|9056246|P1|Overall Study|Physician Decision|0
2619532|NCT00932373|9056236|P11|Overall Study|Adverse Event|1
2619533|NCT00932373|9056237|P10|Overall Study|Adverse Event|2
2619534|NCT00932373|9056238|P9|Overall Study|Adverse Event|0
2619535|NCT00932373|9056239|P8|Overall Study|Adverse Event|1
2619536|NCT00932373|9056240|P7|Overall Study|Adverse Event|0
2619537|NCT00932373|9056241|P6|Overall Study|Adverse Event|1
2619538|NCT00932373|9056242|P5|Overall Study|Adverse Event|2
2619539|NCT00932373|9056243|P4|Overall Study|Adverse Event|0
2619540|NCT00932373|9056244|P3|Overall Study|Adverse Event|0
2619541|NCT00932373|9056245|P2|Overall Study|Adverse Event|0
2619542|NCT00932373|9056246|P1|Overall Study|Adverse Event|0
2619543|NCT00932373|9056236|P11|Overall Study|Progressive disease|2
2619544|NCT00932373|9056237|P10|Overall Study|Progressive disease|9
2619545|NCT00932373|9056238|P9|Overall Study|Progressive disease|1
2619546|NCT00932373|9056239|P8|Overall Study|Progressive disease|2
2619547|NCT00932373|9056240|P7|Overall Study|Progressive disease|0
2619548|NCT00932373|9056241|P6|Overall Study|Progressive disease|1
2619549|NCT00932373|9056242|P5|Overall Study|Progressive disease|10
2619550|NCT00932373|9056243|P4|Overall Study|Progressive disease|0
2619551|NCT00932373|9056244|P3|Overall Study|Progressive disease|0
2619552|NCT00932373|9056245|P2|Overall Study|Progressive disease|1
2619553|NCT00932373|9056246|P1|Overall Study|Progressive disease|3
2619554|NCT00932360|9056346|P6|Washout (One Week)|Withdrawal by Subject|0
2619555|NCT00932360|9056347|P5|Washout (One Week)|Withdrawal by Subject|2
2619556|NCT00932360|9056348|P4|Washout (One Week)|Withdrawal by Subject|0
2619557|NCT00932360|9056349|P3|Washout (One Week)|Withdrawal by Subject|0
2619558|NCT00932360|9056350|P2|Washout (One Week)|Withdrawal by Subject|0
2619559|NCT00932360|9056351|P1|Washout (One Week)|Withdrawal by Subject|0
2619560|NCT00932165|9056408|P1|Overall Study|Lost to Follow-up|1
2619561|NCT00932126|9056432|P8|Overall Study|Other|2
2619562|NCT00932126|9056433|P7|Overall Study|Other|1
2619563|NCT00932126|9056434|P6|Overall Study|Other|0
2619564|NCT00932126|9056435|P5|Overall Study|Other|1
2619565|NCT00932126|9056436|P4|Overall Study|Other|0
2619566|NCT00932126|9056437|P3|Overall Study|Other|0
2619567|NCT00932126|9056438|P2|Overall Study|Other|0
2619568|NCT00932126|9056439|P1|Overall Study|Other|0
2619569|NCT00932126|9056432|P8|Overall Study|Objective progression or relapse|5
2619570|NCT00932126|9056433|P7|Overall Study|Objective progression or relapse|3
2619571|NCT00932126|9056434|P6|Overall Study|Objective progression or relapse|3
2619572|NCT00932126|9056435|P5|Overall Study|Objective progression or relapse|3
2619573|NCT00932126|9056436|P4|Overall Study|Objective progression or relapse|3
2619574|NCT00932126|9056437|P3|Overall Study|Objective progression or relapse|2
2619575|NCT00932126|9056438|P2|Overall Study|Objective progression or relapse|3
2619576|NCT00932126|9056439|P1|Overall Study|Objective progression or relapse|3
2619577|NCT00932126|9056432|P8|Overall Study|Withdrawal by Subject|1
2619578|NCT00932126|9056433|P7|Overall Study|Withdrawal by Subject|0
2619579|NCT00932126|9056434|P6|Overall Study|Withdrawal by Subject|0
2619580|NCT00932126|9056435|P5|Overall Study|Withdrawal by Subject|0
2619581|NCT00932126|9056436|P4|Overall Study|Withdrawal by Subject|0
2619582|NCT00932126|9056437|P3|Overall Study|Withdrawal by Subject|1
2619583|NCT00932126|9056438|P2|Overall Study|Withdrawal by Subject|0
2619584|NCT00932126|9056439|P1|Overall Study|Withdrawal by Subject|0
2619585|NCT00932126|9056432|P8|Overall Study|Protocol Violation|0
2619586|NCT00932126|9056433|P7|Overall Study|Protocol Violation|0
2619587|NCT00932126|9056434|P6|Overall Study|Protocol Violation|0
2619588|NCT00932126|9056435|P5|Overall Study|Protocol Violation|1
2619589|NCT00932126|9056436|P4|Overall Study|Protocol Violation|0
2619590|NCT00932126|9056437|P3|Overall Study|Protocol Violation|0
2619591|NCT00932126|9056438|P2|Overall Study|Protocol Violation|0
2619592|NCT00932126|9056439|P1|Overall Study|Protocol Violation|0
2619593|NCT00932126|9056432|P8|Overall Study|Adverse Event|2
2619594|NCT00932126|9056433|P7|Overall Study|Adverse Event|1
2619595|NCT00932126|9056434|P6|Overall Study|Adverse Event|0
2619596|NCT00932126|9056435|P5|Overall Study|Adverse Event|0
2619597|NCT00932126|9056436|P4|Overall Study|Adverse Event|0
2619598|NCT00932126|9056437|P3|Overall Study|Adverse Event|0
2619599|NCT00932126|9056438|P2|Overall Study|Adverse Event|0
2619600|NCT00932126|9056439|P1|Overall Study|Adverse Event|0
2619601|NCT00932113|9056477|P2|Overall Study|Lost to Follow-up|0
2619602|NCT00932113|9056478|P1|Overall Study|Lost to Follow-up|1
2619603|NCT00931918|9056530|P2|Overall Study|Did not receive study drug|2
2619604|NCT00931918|9056531|P1|Overall Study|Did not receive study drug|3
2619605|NCT00931918|9056530|P2|Overall Study|Other Reason not Specified|4
2619606|NCT00931918|9056531|P1|Overall Study|Other Reason not Specified|4
2619607|NCT00931918|9056530|P2|Overall Study|Withdrawal by Patient|4
2619608|NCT00931918|9056531|P1|Overall Study|Withdrawal by Patient|3
2619609|NCT00931918|9056530|P2|Overall Study|Symptomatic Deterioration|0
2619610|NCT00931918|9056531|P1|Overall Study|Symptomatic Deterioration|1
2619611|NCT00931918|9056530|P2|Overall Study|Progressive Disease|1
2619612|NCT00931918|9056531|P1|Overall Study|Progressive Disease|2
2619613|NCT00931918|9056530|P2|Overall Study|Adverse Event|6
2619614|NCT00931918|9056531|P1|Overall Study|Adverse Event|4
2619615|NCT00931801|9056583|P3|Overall Study|Confirmed Virologic Failure|3
2619616|NCT00931801|9056584|P2|Overall Study|Confirmed Virologic Failure|0
2619617|NCT00931801|9056585|P1|Overall Study|Confirmed Virologic Failure|0
2619618|NCT00931801|9056583|P3|Overall Study|Withdrawal by Subject|0
2619619|NCT00931801|9056584|P2|Overall Study|Withdrawal by Subject|0
2619620|NCT00931801|9056585|P1|Overall Study|Withdrawal by Subject|1
2619621|NCT00931801|9056583|P3|Overall Study|Lost to Follow-up|0
2619622|NCT00931801|9056584|P2|Overall Study|Lost to Follow-up|1
2619623|NCT00931801|9056585|P1|Overall Study|Lost to Follow-up|0
2619624|NCT00931801|9056583|P3|Overall Study|Adverse Event|1
2619625|NCT00931801|9056584|P2|Overall Study|Adverse Event|0
2619626|NCT00931801|9056585|P1|Overall Study|Adverse Event|0
2619627|NCT00931723|9056608|P2|Overall Study|Late hospital discharge|0
2619628|NCT00931723|9056609|P1|Overall Study|Late hospital discharge|1
2619629|NCT00931723|9056608|P2|Overall Study|Sponsor decision|0
2619630|NCT00931723|9056609|P1|Overall Study|Sponsor decision|1
2619631|NCT00931723|9056608|P2|Overall Study|Lack or insufficient theraputic response|5
2619632|NCT00931723|9056609|P1|Overall Study|Lack or insufficient theraputic response|2
2619633|NCT00931723|9056608|P2|Overall Study|Took prohibited concomitant medication|1
2619634|NCT00931723|9056609|P1|Overall Study|Took prohibited concomitant medication|0
2619635|NCT00931723|9056608|P2|Overall Study|Safety reasons|1
2619636|NCT00931723|9056609|P1|Overall Study|Safety reasons|0
2619637|NCT00931723|9056608|P2|Overall Study|Severe non-compliance to protocol|0
2619638|NCT00931723|9056609|P1|Overall Study|Severe non-compliance to protocol|2
2619639|NCT00931723|9056608|P2|Overall Study|Study-specific discontinuation criteria|1
2619640|NCT00931723|9056609|P1|Overall Study|Study-specific discontinuation criteria|1
2619641|NCT00931723|9056608|P2|Overall Study|Lost to Follow-up|2
2619642|NCT00931723|9056609|P1|Overall Study|Lost to Follow-up|1
2619643|NCT00931723|9056608|P2|Overall Study|Condition under investigation worsened|2
2619644|NCT00931723|9056609|P1|Overall Study|Condition under investigation worsened|1
2619645|NCT00931723|9056608|P2|Overall Study|Lithium found in blood|1
2619646|NCT00931723|9056609|P1|Overall Study|Lithium found in blood|0
2619647|NCT00931723|9056608|P2|Overall Study|Adverse Event|13
2619648|NCT00931723|9056609|P1|Overall Study|Adverse Event|6
2619649|NCT00931723|9056608|P2|Overall Study|Withdrawal by Subject|13
2619650|NCT00931723|9056609|P1|Overall Study|Withdrawal by Subject|11
2619651|NCT00931710|9056657|P2|Overall Study|Protocol deviation|2
2619652|NCT00931710|9056658|P1|Overall Study|Protocol deviation|1
2619653|NCT00931710|9056657|P2|Overall Study|Lost to Follow-up|5
2619654|NCT00931710|9056658|P1|Overall Study|Lost to Follow-up|6
2619655|NCT00931710|9056657|P2|Overall Study|Patient withdrew consent|9
2619656|NCT00931710|9056658|P1|Overall Study|Patient withdrew consent|4
2619657|NCT00931710|9056657|P2|Overall Study|Unsatisfactory therapeutic effects|12
2619658|NCT00931710|9056658|P1|Overall Study|Unsatisfactory therapeutic effects|5
2619659|NCT00931710|9056657|P2|Overall Study|Abnormal test procedure results|0
2619660|NCT00931710|9056658|P1|Overall Study|Abnormal test procedure results|2
2619661|NCT00931710|9056657|P2|Overall Study|Adverse Event|10
2619662|NCT00931710|9056658|P1|Overall Study|Adverse Event|16
2619663|NCT00931632|9056676|P2|Overall Study|Adverse Event|15
2619664|NCT00931632|9056677|P1|Overall Study|Adverse Event|19
2619665|NCT00931632|9056676|P2|Overall Study|Withdrawal by Subject|3
2619666|NCT00931632|9056677|P1|Overall Study|Withdrawal by Subject|2
2619667|NCT00931528|9056699|P2|Overall Study|Assessment outside of Time Frame|23
2619668|NCT00931528|9056700|P1|Overall Study|Assessment outside of Time Frame|22
2619669|NCT00931528|9056699|P2|Overall Study|Lost to Follow-up|13
2619670|NCT00931528|9056700|P1|Overall Study|Lost to Follow-up|6
2619671|NCT00931528|9056699|P2|Overall Study|Withdrawal by Subject|12
2619672|NCT00931528|9056700|P1|Overall Study|Withdrawal by Subject|4
2619673|NCT00931528|9056699|P2|Overall Study|Protocol Violation|12
2619674|NCT00931528|9056700|P1|Overall Study|Protocol Violation|9
2619675|NCT00931515|9056720|P2|Overall Study|Lost to Follow-up|5
2619676|NCT00931515|9056721|P1|Overall Study|Lost to Follow-up|2
2619677|NCT00931463|9056751|P2|Overall Study|Lost to Follow-up|1
2619678|NCT00931463|9056752|P1|Overall Study|Lost to Follow-up|4
2619679|NCT00931463|9056751|P2|Overall Study|Withdrawal by Subject|0
2619680|NCT00931463|9056752|P1|Overall Study|Withdrawal by Subject|5
2619681|NCT00931463|9056751|P2|Overall Study|Death|4
2619682|NCT00931463|9056752|P1|Overall Study|Death|8
2619683|NCT00931411|9056768|P2|After Crossover - 14 Days (up to Day 56)|Adverse Event|1
2619684|NCT00931411|9056769|P1|After Crossover - 14 Days (up to Day 56)|Adverse Event|0
2619685|NCT00931411|9056768|P2|First Intervention - 42 Days|Lost to Follow-up|0
2619686|NCT00931411|9056769|P1|First Intervention - 42 Days|Lost to Follow-up|2
2619687|NCT00931411|9056768|P2|First Intervention - 42 Days|Adverse Event|3
2619688|NCT00931411|9056769|P1|First Intervention - 42 Days|Adverse Event|2
2619689|NCT00931385|9056790|P4|Overall Study|Lost to Follow-up|1
2619690|NCT00931385|9056791|P3|Overall Study|Lost to Follow-up|0
2619691|NCT00931385|9056792|P2|Overall Study|Lost to Follow-up|0
2619692|NCT00931385|9056793|P1|Overall Study|Lost to Follow-up|0
2619693|NCT00931385|9056790|P4|Overall Study|Withdrawal by Subject|1
2619694|NCT00931385|9056791|P3|Overall Study|Withdrawal by Subject|0
2619695|NCT00931385|9056792|P2|Overall Study|Withdrawal by Subject|1
2619696|NCT00931385|9056793|P1|Overall Study|Withdrawal by Subject|0
2619697|NCT00931385|9056790|P4|Overall Study|Protocol Violation|0
2619698|NCT00931385|9056791|P3|Overall Study|Protocol Violation|1
2619699|NCT00931385|9056792|P2|Overall Study|Protocol Violation|0
2619700|NCT00931385|9056793|P1|Overall Study|Protocol Violation|0
2619701|NCT00931385|9056790|P4|Overall Study|Adverse Event|3
2619702|NCT00931385|9056791|P3|Overall Study|Adverse Event|0
2619703|NCT00931385|9056792|P2|Overall Study|Adverse Event|1
2619704|NCT00931385|9056793|P1|Overall Study|Adverse Event|2
2619705|NCT00931307|9056862|P1|Overall Study|Biomicroscopy|1
2619706|NCT00931307|9056862|P1|Overall Study|Lack of Efficacy|12
2619707|NCT00931268|9056866|P1|Overall Study|Lost to Follow-up|6
2619708|NCT00931255|9056878|P2|Overall Study|Follow up biopsy not done|3
2619709|NCT00931255|9056879|P1|Overall Study|Follow up biopsy not done|2
2619710|NCT00930982|9056916|P2|Overall Study|Withdrawal by Subject|1
2619711|NCT00930982|9056917|P1|Overall Study|Withdrawal by Subject|1
2619712|NCT00930982|9056916|P2|Overall Study|Protocol Violation|5
2619713|NCT00930982|9056917|P1|Overall Study|Protocol Violation|1
2619714|NCT00930982|9056916|P2|Overall Study|Adverse Event|23
2619715|NCT00930982|9056917|P1|Overall Study|Adverse Event|19
2619716|NCT00930969|9056951|P1|Overall Study|Withdrawal by Subject|19
2619717|NCT00930969|9056951|P1|Overall Study|Physician Decision|13
2619718|NCT00930969|9056951|P1|Overall Study|Lost to Follow-up|1
2619719|NCT00930969|9056951|P1|Overall Study|Death|5
2619720|NCT00930930|9056961|P2|Overall Study|patients not compliant|1
2619721|NCT00930930|9056962|P1|Overall Study|patients not compliant|1
2619722|NCT00930930|9056961|P2|Overall Study|excessive lapse btw txs, not eligible|1
2619723|NCT00930930|9056962|P1|Overall Study|excessive lapse btw txs, not eligible|0
2619724|NCT00930930|9056961|P2|Overall Study|Disease progression|3
2619725|NCT00930930|9056962|P1|Overall Study|Disease progression|2
2619726|NCT00930930|9056961|P2|Overall Study|Withdrawal by Subject|1
2619727|NCT00930930|9056962|P1|Overall Study|Withdrawal by Subject|3
2619728|NCT00930930|9056961|P2|Overall Study|Adverse Event|3
2619729|NCT00930930|9056962|P1|Overall Study|Adverse Event|13
2619730|NCT00930930|9056961|P2|Overall Study|Physician Decision|0
2619731|NCT00930930|9056962|P1|Overall Study|Physician Decision|1
2619732|NCT00930930|9056961|P2|Overall Study|Death|0
2619733|NCT00930930|9056962|P1|Overall Study|Death|1
2619734|NCT00930813|9056976|P2|Overall Study|Lost to Follow-up|4
2619735|NCT00930813|9056977|P1|Overall Study|Lost to Follow-up|2
2619736|NCT00930813|9056976|P2|Overall Study|Withdrawal by Subject|5
2619737|NCT00930813|9056977|P1|Overall Study|Withdrawal by Subject|2
2619738|NCT00930813|9056976|P2|Overall Study|Death|5
2619739|NCT00930813|9056977|P1|Overall Study|Death|4
2619740|NCT00930774|9056998|P4|Overall Study|Withdrawal by Subject|0
2619741|NCT00930774|9056999|P3|Overall Study|Withdrawal by Subject|2
2619742|NCT00930774|9057000|P2|Overall Study|Withdrawal by Subject|9
2619743|NCT00930774|9057001|P1|Overall Study|Withdrawal by Subject|1
2619744|NCT00930761|9057041|P2|Overall Study|less than 3 music therapy sessions|3
2619745|NCT00930761|9057042|P1|Overall Study|less than 3 music therapy sessions|0
2619746|NCT00930761|9057041|P2|Overall Study|3 newborns died; 1 mother quit the study|0
2619747|NCT00930761|9057042|P1|Overall Study|3 newborns died; 1 mother quit the study|4
2619748|NCT00930722|9057054|P1|Overall Study|Study terminated by sponsor|2
2619749|NCT00930722|9057054|P1|Overall Study|No longer willing to participate|9
2619750|NCT00930722|9057054|P1|Overall Study|Lost to Follow-up|16
2619751|NCT00930644|9057069|P1|Overall Study|Adverse Event|16
2619752|NCT00930644|9057069|P1|Overall Study|Death|1
2619753|NCT00930644|9057069|P1|Overall Study|Physician Decision|2
2619754|NCT00930644|9057069|P1|Overall Study|Withdrawal by Subject|4
2619755|NCT00930553|9057082|P1|Overall Study|Other than specified above|28
2619756|NCT00930553|9057082|P1|Overall Study|Study terminated by sponsor|24
2619757|NCT00930553|9057082|P1|Overall Study|Death|9
2619758|NCT00930553|9057082|P1|Overall Study|Lost to Follow-up|25
2619759|NCT00930553|9057082|P1|Overall Study|Withdrawal by Subject|88
2619760|NCT00930553|9057082|P1|Overall Study|Pregnancy|1
2619761|NCT00930553|9057082|P1|Overall Study|Protocol Violation|1
2619762|NCT00930553|9057082|P1|Overall Study|Physician Decision|39
2619763|NCT00930553|9057082|P1|Overall Study|Lack of Efficacy|7
2619764|NCT00930553|9057082|P1|Overall Study|Adverse Event|1
2619765|NCT00930176|9057159|P1|Overall Study|Death|1
2619766|NCT00930046|9057166|P2|Overall Study|Wound catheter malfunctioned|2
2619767|NCT00930046|9057167|P1|Overall Study|Wound catheter malfunctioned|1
2619768|NCT00929994|9057175|P1|Overall Study|employment|1
2619769|NCT00929994|9057175|P1|Overall Study|medical issue unrelated to intervention|4
2619770|NCT00929994|9057175|P1|Overall Study|Withdrawal by Subject|1
2619771|NCT00929864|9057194|P2|Overall Study|Non-specified|7
2619772|NCT00929864|9057195|P1|Overall Study|Non-specified|2
2619773|NCT00929864|9057194|P2|Overall Study|Administrative reason by Sponsor|1
2619774|NCT00929864|9057195|P1|Overall Study|Administrative reason by Sponsor|1
2619775|NCT00929864|9057194|P2|Overall Study|Pregnancy|3
2619776|NCT00929864|9057195|P1|Overall Study|Pregnancy|0
2619777|NCT00929864|9057194|P2|Overall Study|Poor or non-compliance|3
2619778|NCT00929864|9057195|P1|Overall Study|Poor or non-compliance|3
2619779|NCT00929864|9057194|P2|Overall Study|No longer met criteria|1
2619780|NCT00929864|9057195|P1|Overall Study|No longer met criteria|2
2619781|NCT00929864|9057194|P2|Overall Study|Withdrawal by Subject|9
2619782|NCT00929864|9057195|P1|Overall Study|Withdrawal by Subject|20
2619783|NCT00929864|9057194|P2|Overall Study|Lost to Follow-up|12
2619784|NCT00929864|9057195|P1|Overall Study|Lost to Follow-up|7
2619785|NCT00929864|9057194|P2|Overall Study|Lack of Efficacy|16
2619786|NCT00929864|9057195|P1|Overall Study|Lack of Efficacy|19
2619787|NCT00929864|9057194|P2|Overall Study|Adverse Event|30
2619788|NCT00929864|9057195|P1|Overall Study|Adverse Event|11
2619789|NCT00929864|9057194|P2|Overall Study|Death|1
2619790|NCT00929864|9057195|P1|Overall Study|Death|1
2619791|NCT00929734|9057251|P2|Overall Study|Withdrawal by Subject|2
2619792|NCT00929734|9057252|P1|Overall Study|Withdrawal by Subject|0
2619793|NCT00929734|9057251|P2|Overall Study|Lost to Follow-up|1
2619794|NCT00929734|9057252|P1|Overall Study|Lost to Follow-up|2
2619795|NCT00929708|9057269|P5|Overall Study|Lost to Follow-up|0
2619796|NCT00929708|9057270|P4|Overall Study|Lost to Follow-up|1
2619797|NCT00929708|9057271|P3|Overall Study|Lost to Follow-up|0
2619798|NCT00929708|9057272|P2|Overall Study|Lost to Follow-up|0
2619799|NCT00929708|9057273|P1|Overall Study|Lost to Follow-up|0
2619800|NCT00929708|9057269|P5|Overall Study|Physician Decision|1
2619801|NCT00929708|9057270|P4|Overall Study|Physician Decision|2
2619802|NCT00929708|9057271|P3|Overall Study|Physician Decision|2
2619803|NCT00929708|9057272|P2|Overall Study|Physician Decision|2
2619804|NCT00929708|9057273|P1|Overall Study|Physician Decision|0
2619805|NCT00929708|9057269|P5|Overall Study|Adverse Event|3
2619806|NCT00929708|9057270|P4|Overall Study|Adverse Event|0
2619807|NCT00929708|9057271|P3|Overall Study|Adverse Event|0
2619808|NCT00929708|9057272|P2|Overall Study|Adverse Event|0
2619809|NCT00929708|9057273|P1|Overall Study|Adverse Event|0
2619810|NCT00929708|9057269|P5|Overall Study|Withdrawal by Subject|1
2619811|NCT00929708|9057270|P4|Overall Study|Withdrawal by Subject|2
2619812|NCT00929708|9057271|P3|Overall Study|Withdrawal by Subject|0
2619813|NCT00929708|9057272|P2|Overall Study|Withdrawal by Subject|0
2619814|NCT00929708|9057273|P1|Overall Study|Withdrawal by Subject|2
2619815|NCT00929708|9057269|P5|Overall Study|Protocol Violation|1
2619816|NCT00929708|9057270|P4|Overall Study|Protocol Violation|1
2619817|NCT00929708|9057271|P3|Overall Study|Protocol Violation|1
2619818|NCT00929708|9057272|P2|Overall Study|Protocol Violation|1
2619819|NCT00929708|9057273|P1|Overall Study|Protocol Violation|2
2619820|NCT00929695|9057327|P2|Overall Study|incorrect stratification|0
2619821|NCT00929695|9057328|P1|Overall Study|incorrect stratification|2
2619822|NCT00929695|9057327|P2|Overall Study|discharge home|3
2619823|NCT00929695|9057328|P1|Overall Study|discharge home|4
2619824|NCT00929695|9057327|P2|Overall Study|Withdrawal by Subject|2
2619825|NCT00929695|9057328|P1|Overall Study|Withdrawal by Subject|0
2619826|NCT00929695|9057327|P2|Overall Study|Death|1
2619827|NCT00929695|9057328|P1|Overall Study|Death|2
2619828|NCT00929669|9057358|P1|Overall Study|elevated glucose levels|1
2619829|NCT00929656|9057365|P2|Overall Study|Lost to Follow-up|1
2619830|NCT00929656|9057366|P1|Overall Study|Lost to Follow-up|0
2619831|NCT00929643|9057380|P1|Overall Study|Protocol Violation|2
2619832|NCT00929526|9057402|P2|Overall Study|Other|6
2619833|NCT00929526|9057403|P1|Overall Study|Other|8
2619834|NCT00929526|9057402|P2|Overall Study|Lost to Follow-up|12
2619835|NCT00929526|9057403|P1|Overall Study|Lost to Follow-up|8
2619836|NCT00929526|9057402|P2|Overall Study|Withdrawal by Subject|11
2619837|NCT00929526|9057403|P1|Overall Study|Withdrawal by Subject|1
2619838|NCT00929240|9057557|P3|Maintenance Phase|Participant not treated|0
2619839|NCT00929240|9057558|P2|Maintenance Phase|Participant not treated|2
2619840|NCT00929240|9057559|P1|Maintenance Phase|Participant not treated|0
2619841|NCT00929240|9057557|P3|Maintenance Phase|Treatment ongoing at study closure|10
2619842|NCT00929240|9057558|P2|Maintenance Phase|Treatment ongoing at study closure|0
2619843|NCT00929240|9057559|P1|Maintenance Phase|Treatment ongoing at study closure|0
2619844|NCT00929240|9057557|P3|Maintenance Phase|Change of treatment|0
2619845|NCT00929240|9057558|P2|Maintenance Phase|Change of treatment|4
2619846|NCT00929240|9057559|P1|Maintenance Phase|Change of treatment|0
2619847|NCT00929240|9057557|P3|Maintenance Phase|Physician Decision|1
2619848|NCT00929240|9057558|P2|Maintenance Phase|Physician Decision|2
2619849|NCT00929240|9057559|P1|Maintenance Phase|Physician Decision|0
2619850|NCT00929240|9057557|P3|Maintenance Phase|Health authority/Study termination|2
2619851|NCT00929240|9057558|P2|Maintenance Phase|Health authority/Study termination|1
2619852|NCT00929240|9057559|P1|Maintenance Phase|Health authority/Study termination|0
2619853|NCT00929240|9057557|P3|Maintenance Phase|Protocol Violation|0
2619854|NCT00929240|9057558|P2|Maintenance Phase|Protocol Violation|1
2619855|NCT00929240|9057559|P1|Maintenance Phase|Protocol Violation|0
2619856|NCT00929240|9057557|P3|Maintenance Phase|Withdrawal by Subject|6
2619857|NCT00929240|9057558|P2|Maintenance Phase|Withdrawal by Subject|2
2619858|NCT00929240|9057559|P1|Maintenance Phase|Withdrawal by Subject|0
2619859|NCT00929240|9057557|P3|Maintenance Phase|Adverse Event|12
2619860|NCT00929240|9057558|P2|Maintenance Phase|Adverse Event|9
2619861|NCT00929240|9057559|P1|Maintenance Phase|Adverse Event|0
2619862|NCT00929240|9057557|P3|Maintenance Phase|Disease progression|60
2619863|NCT00929240|9057558|P2|Maintenance Phase|Disease progression|73
2619864|NCT00929240|9057559|P1|Maintenance Phase|Disease progression|0
2619865|NCT00929240|9057557|P3|Initial Treatment Phase|Physician Decision|0
2619866|NCT00929240|9057558|P2|Initial Treatment Phase|Physician Decision|0
2619867|NCT00929240|9057559|P1|Initial Treatment Phase|Physician Decision|4
2619868|NCT00929240|9057557|P3|Initial Treatment Phase|Health authority/Study termination|0
2619869|NCT00929240|9057558|P2|Initial Treatment Phase|Health authority/Study termination|0
2619870|NCT00929240|9057559|P1|Initial Treatment Phase|Health authority/Study termination|3
2619871|NCT00929240|9057557|P3|Initial Treatment Phase|Death|0
2619872|NCT00929240|9057558|P2|Initial Treatment Phase|Death|0
2619873|NCT00929240|9057559|P1|Initial Treatment Phase|Death|2
2619874|NCT00929240|9057557|P3|Initial Treatment Phase|Protocol Violation|0
2619875|NCT00929240|9057558|P2|Initial Treatment Phase|Protocol Violation|0
2619876|NCT00929240|9057559|P1|Initial Treatment Phase|Protocol Violation|5
2619877|NCT00929240|9057557|P3|Initial Treatment Phase|Withdrawal by Subject|0
2619878|NCT00929240|9057558|P2|Initial Treatment Phase|Withdrawal by Subject|0
2619879|NCT00929240|9057559|P1|Initial Treatment Phase|Withdrawal by Subject|13
2619880|NCT00929240|9057557|P3|Initial Treatment Phase|Disease progression|0
2619881|NCT00929240|9057558|P2|Initial Treatment Phase|Disease progression|0
2619882|NCT00929240|9057559|P1|Initial Treatment Phase|Disease progression|41
2619883|NCT00929240|9057557|P3|Initial Treatment Phase|Adverse Event|0
2619884|NCT00929240|9057558|P2|Initial Treatment Phase|Adverse Event|0
2619885|NCT00929240|9057559|P1|Initial Treatment Phase|Adverse Event|31
2619886|NCT00929201|9057586|P2|Period 1|Withdrawal by Subject|1
2619887|NCT00929201|9057587|P1|Period 1|Withdrawal by Subject|0
2619888|NCT00929162|9057597|P2|Overall Study|Other termination reason|6
2619889|NCT00929162|9057598|P1|Overall Study|Other termination reason|5
2619890|NCT00929162|9057597|P2|Overall Study|Protocol Violation|30
2619891|NCT00929162|9057598|P1|Overall Study|Protocol Violation|32
2619892|NCT00929162|9057597|P2|Overall Study|Withdrawal by Subject|1
2619893|NCT00929162|9057598|P1|Overall Study|Withdrawal by Subject|3
2619894|NCT00929162|9057597|P2|Overall Study|Adverse Event|5
2619895|NCT00929162|9057598|P1|Overall Study|Adverse Event|8
2619896|NCT00929110|9057611|P3|Overall Study|Patient inability to use the device|0
2619897|NCT00929110|9057612|P2|Overall Study|Patient inability to use the device|1
2619898|NCT00929110|9057613|P1|Overall Study|Patient inability to use the device|0
2619899|NCT00929110|9057611|P3|Overall Study|Abnormal test procedure result(s)|1
2619900|NCT00929110|9057612|P2|Overall Study|Abnormal test procedure result(s)|1
2619901|NCT00929110|9057613|P1|Overall Study|Abnormal test procedure result(s)|0
2619902|NCT00929110|9057611|P3|Overall Study|Abnormal laboratory value(s)|0
2619903|NCT00929110|9057612|P2|Overall Study|Abnormal laboratory value(s)|1
2619904|NCT00929110|9057613|P1|Overall Study|Abnormal laboratory value(s)|0
2619905|NCT00929110|9057611|P3|Overall Study|Death|2
2619906|NCT00929110|9057612|P2|Overall Study|Death|2
2619907|NCT00929110|9057613|P1|Overall Study|Death|2
2619908|NCT00929110|9057611|P3|Overall Study|Administrative problems|2
2619909|NCT00929110|9057612|P2|Overall Study|Administrative problems|1
2619910|NCT00929110|9057613|P1|Overall Study|Administrative problems|4
2619911|NCT00929110|9057611|P3|Overall Study|Protocol deviation|4
2619912|NCT00929110|9057612|P2|Overall Study|Protocol deviation|2
2619913|NCT00929110|9057613|P1|Overall Study|Protocol deviation|5
2619914|NCT00929110|9057611|P3|Overall Study|Lost to Follow-up|3
2619915|NCT00929110|9057612|P2|Overall Study|Lost to Follow-up|7
2619916|NCT00929110|9057613|P1|Overall Study|Lost to Follow-up|7
2619917|NCT00929110|9057611|P3|Overall Study|Unsatisfactory therapeutic effect|6
2619918|NCT00929110|9057612|P2|Overall Study|Unsatisfactory therapeutic effect|9
2619919|NCT00929110|9057613|P1|Overall Study|Unsatisfactory therapeutic effect|20
2619920|NCT00929110|9057611|P3|Overall Study|Subject withdrew consent|26
2619921|NCT00929110|9057612|P2|Overall Study|Subject withdrew consent|23
2619922|NCT00929110|9057613|P1|Overall Study|Subject withdrew consent|40
2619923|NCT00929110|9057611|P3|Overall Study|Adverse Event|18
2619924|NCT00929110|9057612|P2|Overall Study|Adverse Event|29
2619925|NCT00929110|9057613|P1|Overall Study|Adverse Event|40
2619926|NCT00928889|9057696|P2|Overall Study|Other|0
2619927|NCT00928889|9057697|P1|Overall Study|Other|1
2619928|NCT00928889|9057696|P2|Overall Study|Adverse Event|0
2619929|NCT00928889|9057697|P1|Overall Study|Adverse Event|1
2619930|NCT00928889|9057696|P2|Overall Study|Protocol Violation|1
2619931|NCT00928889|9057697|P1|Overall Study|Protocol Violation|0
2619932|NCT00928889|9057696|P2|Overall Study|Lost to Follow-up|1
2619933|NCT00928889|9057697|P1|Overall Study|Lost to Follow-up|3
2619934|NCT00928746|9057743|P1|Overall Study|Other|2
2619935|NCT00928746|9057743|P1|Overall Study|Withdrawal by Subject|1
2619936|NCT00928746|9057743|P1|Overall Study|Protocol Violation|1
2619937|NCT00928746|9057743|P1|Overall Study|Adverse Event|2
2619938|NCT00928707|9057793|P2|Overall Study|Protocol Violation|0
2619939|NCT00928707|9057794|P1|Overall Study|Protocol Violation|1
2619940|NCT00928668|9057815|P5|Overall Study|Other reasons not listed above|0
2619941|NCT00928668|9057816|P4|Overall Study|Other reasons not listed above|1
2619942|NCT00928668|9057817|P3|Overall Study|Other reasons not listed above|0
2619943|NCT00928668|9057818|P2|Overall Study|Other reasons not listed above|0
2619944|NCT00928668|9057819|P1|Overall Study|Other reasons not listed above|0
2619945|NCT00928668|9057815|P5|Overall Study|Withdrawal by Subject|0
2619946|NCT00928668|9057816|P4|Overall Study|Withdrawal by Subject|0
2619947|NCT00928668|9057817|P3|Overall Study|Withdrawal by Subject|1
2619948|NCT00928668|9057818|P2|Overall Study|Withdrawal by Subject|1
2619949|NCT00928668|9057819|P1|Overall Study|Withdrawal by Subject|0
2619950|NCT00928668|9057815|P5|Overall Study|Protocol Violation|1
2619951|NCT00928668|9057816|P4|Overall Study|Protocol Violation|0
2619952|NCT00928668|9057817|P3|Overall Study|Protocol Violation|0
2619953|NCT00928668|9057818|P2|Overall Study|Protocol Violation|0
2619954|NCT00928668|9057819|P1|Overall Study|Protocol Violation|0
2619955|NCT00928668|9057815|P5|Overall Study|Adverse Event|0
2619956|NCT00928668|9057816|P4|Overall Study|Adverse Event|0
2619957|NCT00928668|9057817|P3|Overall Study|Adverse Event|0
2619958|NCT00928668|9057818|P2|Overall Study|Adverse Event|0
2619959|NCT00928668|9057819|P1|Overall Study|Adverse Event|1
2619960|NCT00928512|9057875|P5|Overall Study|Administrative Problems|0
2619961|NCT00928512|9057876|P4|Overall Study|Administrative Problems|0
2619962|NCT00928512|9057877|P3|Overall Study|Administrative Problems|0
2619963|NCT00928512|9057878|P2|Overall Study|Administrative Problems|1
2619964|NCT00928512|9057879|P1|Overall Study|Administrative Problems|0
2619965|NCT00928512|9057875|P5|Overall Study|Lost to Follow-up|3
2619966|NCT00928512|9057876|P4|Overall Study|Lost to Follow-up|1
2619967|NCT00928512|9057877|P3|Overall Study|Lost to Follow-up|2
2619968|NCT00928512|9057878|P2|Overall Study|Lost to Follow-up|1
2619969|NCT00928512|9057879|P1|Overall Study|Lost to Follow-up|1
2619970|NCT00928512|9057875|P5|Overall Study|Withdrawal by Subject|0
2619971|NCT00928512|9057876|P4|Overall Study|Withdrawal by Subject|4
2619972|NCT00928512|9057877|P3|Overall Study|Withdrawal by Subject|3
2619973|NCT00928512|9057878|P2|Overall Study|Withdrawal by Subject|0
2619974|NCT00928512|9057879|P1|Overall Study|Withdrawal by Subject|3
2619975|NCT00928512|9057875|P5|Overall Study|Protocol Violation|3
2619976|NCT00928512|9057876|P4|Overall Study|Protocol Violation|1
2619977|NCT00928512|9057877|P3|Overall Study|Protocol Violation|0
2619978|NCT00928512|9057878|P2|Overall Study|Protocol Violation|1
2619979|NCT00928512|9057879|P1|Overall Study|Protocol Violation|0
2619980|NCT00928512|9057875|P5|Overall Study|Lack of Efficacy|3
2619981|NCT00928512|9057876|P4|Overall Study|Lack of Efficacy|7
2619982|NCT00928512|9057877|P3|Overall Study|Lack of Efficacy|4
2619983|NCT00928512|9057878|P2|Overall Study|Lack of Efficacy|0
2619984|NCT00928512|9057879|P1|Overall Study|Lack of Efficacy|2
2619985|NCT00928512|9057875|P5|Overall Study|Adverse Event|6
2619986|NCT00928512|9057876|P4|Overall Study|Adverse Event|8
2619987|NCT00928512|9057877|P3|Overall Study|Adverse Event|2
2619988|NCT00928512|9057878|P2|Overall Study|Adverse Event|3
2619989|NCT00928512|9057879|P1|Overall Study|Adverse Event|4
2619990|NCT00928486|9057980|P1|Overall Study|Withdrawal by Subject|1
2619991|NCT00928486|9057980|P1|Overall Study|Disease Progression|7
2619992|NCT00928486|9057980|P1|Overall Study|Adverse Event|2
2619993|NCT00928434|9057989|P3|Overall Study|Other (not meeting above criteria)|2
2619994|NCT00928434|9057990|P2|Overall Study|Other (not meeting above criteria)|1
2619995|NCT00928434|9057991|P1|Overall Study|Other (not meeting above criteria)|5
2619996|NCT00928434|9057989|P3|Overall Study|PSA failure (>2 ng/mL) on other visit|1
2619997|NCT00928434|9057990|P2|Overall Study|PSA failure (>2 ng/mL) on other visit|1
2619998|NCT00928434|9057991|P1|Overall Study|PSA failure (>2 ng/mL) on other visit|2
2619999|NCT00928434|9057989|P3|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7
2620000|NCT00928434|9057990|P2|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4
2620001|NCT00928434|9057991|P1|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10
2620002|NCT00928434|9057989|P3|Overall Study|Withdrawal by Subject|2
2620003|NCT00928434|9057990|P2|Overall Study|Withdrawal by Subject|3
2620004|NCT00928434|9057991|P1|Overall Study|Withdrawal by Subject|5
2620005|NCT00928434|9057989|P3|Overall Study|Lost to Follow-up|3
2620006|NCT00928434|9057990|P2|Overall Study|Lost to Follow-up|0
2620007|NCT00928434|9057991|P1|Overall Study|Lost to Follow-up|1
2620008|NCT00928434|9057989|P3|Overall Study|Physician Decision|3
2620009|NCT00928434|9057990|P2|Overall Study|Physician Decision|0
2620010|NCT00928434|9057991|P1|Overall Study|Physician Decision|2
2620011|NCT00928434|9057989|P3|Overall Study|Protocol Violation|8
2620012|NCT00928434|9057990|P2|Overall Study|Protocol Violation|0
2620013|NCT00928434|9057991|P1|Overall Study|Protocol Violation|5
2620014|NCT00928434|9057989|P3|Overall Study|Adverse Event|18
2620015|NCT00928434|9057990|P2|Overall Study|Adverse Event|5
2620016|NCT00928434|9057991|P1|Overall Study|Adverse Event|14
2620017|NCT00928408|9058067|P1|Overall Study|Lost to Follow-up|12
2620018|NCT00928408|9058067|P1|Overall Study|Death|5
2620019|NCT00928408|9058067|P1|Overall Study|Withdrawal by Subject|4
2620020|NCT00928408|9058067|P1|Overall Study|Other|2
2620021|NCT00928252|9058113|P1|Overall Study|Physician Decision|3
2620022|NCT00928187|9058173|P3|Overall Study|Protocol Violation|0
2620023|NCT00928187|9058174|P2|Overall Study|Protocol Violation|1
2620024|NCT00928187|9058175|P1|Overall Study|Protocol Violation|0
2620025|NCT00928187|9058173|P3|Overall Study|Withdrawal by Subject|1
2620026|NCT00928187|9058174|P2|Overall Study|Withdrawal by Subject|1
2620027|NCT00928187|9058175|P1|Overall Study|Withdrawal by Subject|0
2620028|NCT00928187|9058173|P3|Overall Study|Lost to Follow-up|1
2620029|NCT00928187|9058174|P2|Overall Study|Lost to Follow-up|2
2620030|NCT00928187|9058175|P1|Overall Study|Lost to Follow-up|1
2620031|NCT00928187|9058173|P3|Overall Study|Death|3
2620032|NCT00928187|9058174|P2|Overall Study|Death|2
2620033|NCT00928187|9058175|P1|Overall Study|Death|1
2620034|NCT00928070|9058345|P2|Overall Study|Other|5
2620035|NCT00928070|9058346|P1|Overall Study|Other|5
2620036|NCT00928070|9058345|P2|Overall Study|Randomized but not treated|2
2620037|NCT00928070|9058346|P1|Overall Study|Randomized but not treated|2
2620038|NCT00928070|9058345|P2|Overall Study|Protocol Violation|5
2620039|NCT00928070|9058346|P1|Overall Study|Protocol Violation|6
2620040|NCT00928070|9058345|P2|Overall Study|Did not meet entrance criteria|9
2620041|NCT00928070|9058346|P1|Overall Study|Did not meet entrance criteria|16
2620042|NCT00928070|9058345|P2|Overall Study|Lack of Efficacy|5
2620043|NCT00928070|9058346|P1|Overall Study|Lack of Efficacy|9
2620044|NCT00928070|9058345|P2|Overall Study|Adverse Event|26
2620045|NCT00928070|9058346|P1|Overall Study|Adverse Event|14
2620046|NCT00928070|9058345|P2|Overall Study|Withdrawal by Subject|3
2620047|NCT00928070|9058346|P1|Overall Study|Withdrawal by Subject|10
2620048|NCT00928070|9058345|P2|Overall Study|Lost to Follow-up|2
2620049|NCT00928070|9058346|P1|Overall Study|Lost to Follow-up|1
2620050|NCT00928057|9058404|P2|Overall Study|Protocol Violation|1
2620051|NCT00928057|9058405|P1|Overall Study|Protocol Violation|0
2620052|NCT00928057|9058404|P2|Overall Study|Lost to Follow-up|1
2620053|NCT00928057|9058405|P1|Overall Study|Lost to Follow-up|0
2620054|NCT00928057|9058404|P2|Overall Study|Withdrawal by Subject|0
2620055|NCT00928057|9058405|P1|Overall Study|Withdrawal by Subject|1
2620056|NCT00928057|9058404|P2|Overall Study|Adverse Event|2
2620057|NCT00928057|9058405|P1|Overall Study|Adverse Event|1
2620058|NCT00928018|9058430|P2|Overall Study|Withdrawal by Subject|0
2620059|NCT00928018|9058431|P1|Overall Study|Withdrawal by Subject|1
2620060|NCT00927953|9058461|P2|Overall Study|Death|1
2620061|NCT00927953|9058462|P1|Overall Study|Death|2
2620062|NCT00927940|9058476|P1|Overall Study|Death|1
2620063|NCT00927927|9058496|P15|Overall Study|Withdrawal by Subject|0
2620064|NCT00927927|9058497|P14|Overall Study|Withdrawal by Subject|0
2620065|NCT00927927|9058498|P13|Overall Study|Withdrawal by Subject|0
2620066|NCT00927927|9058499|P12|Overall Study|Withdrawal by Subject|2
2620067|NCT00927927|9058500|P11|Overall Study|Withdrawal by Subject|0
2620068|NCT00927927|9058501|P10|Overall Study|Withdrawal by Subject|0
2620069|NCT00927927|9058502|P9|Overall Study|Withdrawal by Subject|0
2620070|NCT00927927|9058503|P8|Overall Study|Withdrawal by Subject|2
2620071|NCT00927927|9058504|P7|Overall Study|Withdrawal by Subject|0
2620072|NCT00927927|9058505|P6|Overall Study|Withdrawal by Subject|0
2620073|NCT00927927|9058506|P5|Overall Study|Withdrawal by Subject|0
2620074|NCT00927927|9058507|P4|Overall Study|Withdrawal by Subject|0
2620075|NCT00927927|9058508|P3|Overall Study|Withdrawal by Subject|0
2620076|NCT00927927|9058509|P2|Overall Study|Withdrawal by Subject|0
2620077|NCT00927927|9058510|P1|Overall Study|Withdrawal by Subject|0
2620078|NCT00927901|9058557|P4|Treatment Period 4|Subject withdrew consent|0
2620079|NCT00927901|9058558|P3|Treatment Period 4|Subject withdrew consent|1
2620080|NCT00927901|9058559|P2|Treatment Period 4|Subject withdrew consent|0
2620081|NCT00927901|9058560|P1|Treatment Period 4|Subject withdrew consent|0
2620082|NCT00927901|9058557|P4|Treatment Period 4|Adverse Event|1
2620083|NCT00927901|9058558|P3|Treatment Period 4|Adverse Event|0
2620084|NCT00927901|9058559|P2|Treatment Period 4|Adverse Event|0
2620085|NCT00927901|9058560|P1|Treatment Period 4|Adverse Event|0
2620086|NCT00927901|9058557|P4|Treatment Period 1|Subject withdrew consent|0
2620087|NCT00927901|9058558|P3|Treatment Period 1|Subject withdrew consent|1
2620088|NCT00927901|9058559|P2|Treatment Period 1|Subject withdrew consent|0
2620089|NCT00927901|9058560|P1|Treatment Period 1|Subject withdrew consent|0
2620090|NCT00927862|9058601|P2|Overall Study|Missing data needed for endpt analyses|45
2620091|NCT00927862|9058602|P1|Overall Study|Missing data needed for endpt analyses|27
2620092|NCT00927823|9058637|P4|Continuous Dosing Period|Other|3
2620093|NCT00927823|9058638|P3|Continuous Dosing Period|Other|9
2620094|NCT00927823|9058639|P2|Continuous Dosing Period|Other|2
2620095|NCT00927823|9058640|P1|Continuous Dosing Period|Other|1
2620096|NCT00927823|9058637|P4|Continuous Dosing Period|Withdrawal by Subject|2
2620097|NCT00927823|9058638|P3|Continuous Dosing Period|Withdrawal by Subject|2
2620098|NCT00927823|9058639|P2|Continuous Dosing Period|Withdrawal by Subject|0
2620099|NCT00927823|9058640|P1|Continuous Dosing Period|Withdrawal by Subject|1
2620100|NCT00927823|9058637|P4|Continuous Dosing Period|Lost to Follow-up|0
2620101|NCT00927823|9058638|P3|Continuous Dosing Period|Lost to Follow-up|9
2620102|NCT00927823|9058639|P2|Continuous Dosing Period|Lost to Follow-up|1
2620103|NCT00927823|9058640|P1|Continuous Dosing Period|Lost to Follow-up|1
2620104|NCT00927823|9058637|P4|Continuous Dosing Period|Death|0
2620105|NCT00927823|9058638|P3|Continuous Dosing Period|Death|6
2620106|NCT00927823|9058639|P2|Continuous Dosing Period|Death|0
2620107|NCT00927823|9058640|P1|Continuous Dosing Period|Death|0
2620108|NCT00927784|9058706|P2|Overall Study|Withdrawal by Subject|0
2620109|NCT00927784|9058707|P1|Overall Study|Withdrawal by Subject|1
2620110|NCT00927784|9058706|P2|Overall Study|Death|0
2620111|NCT00927784|9058707|P1|Overall Study|Death|1
2620112|NCT00927758|9058737|P6|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
2620113|NCT00927758|9058738|P5|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
2620114|NCT00927758|9058739|P4|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
2620115|NCT00927758|9058740|P3|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
2620116|NCT00927758|9058741|P2|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
2620117|NCT00927758|9058742|P1|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
2620118|NCT00927758|9058737|P6|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
2620119|NCT00927758|9058738|P5|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
2620120|NCT00927758|9058739|P4|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
2620121|NCT00927758|9058740|P3|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
2620122|NCT00927758|9058741|P2|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
2620123|NCT00927758|9058742|P1|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
2620124|NCT00927589|9058750|P1|Overall Study|Non-compliance|1
2620125|NCT00927589|9058750|P1|Overall Study|Disease Progression|8
2620126|NCT00927589|9058750|P1|Overall Study|Adverse Event|2
2620127|NCT00927589|9058750|P1|Overall Study|Withdrawal by Subject|3
2620128|NCT00927589|9058750|P1|Overall Study|Physician Decision|1
2620129|NCT00927589|9058750|P1|Overall Study|Death|1
2620130|NCT00927563|9058780|P1|Overall Study|Withdrawal by Subject|1
2620131|NCT00927563|9058780|P1|Overall Study|Lost to Follow-up|1
2620132|NCT00927472|9058788|P2|Overall Study|Post treatment Assessment out of window|4
2620133|NCT00927472|9058789|P1|Overall Study|Post treatment Assessment out of window|0
2620134|NCT00927472|9058788|P2|Overall Study|Protocol Violation|1
2620135|NCT00927472|9058789|P1|Overall Study|Protocol Violation|0
2620136|NCT00927472|9058788|P2|Overall Study|Lost to Follow-up|6
2620137|NCT00927472|9058789|P1|Overall Study|Lost to Follow-up|1
2620138|NCT00927472|9058788|P2|Overall Study|Withdrawal by Subject|11
2620139|NCT00927472|9058789|P1|Overall Study|Withdrawal by Subject|10
2620140|NCT00927394|9058815|P2|Overall Study|Randomized in error|1
2620141|NCT00927394|9058816|P1|Overall Study|Randomized in error|0
2620142|NCT00927394|9058815|P2|Overall Study|Protocol deviation|13
2620143|NCT00927394|9058816|P1|Overall Study|Protocol deviation|16
2620144|NCT00927394|9058815|P2|Overall Study|Death|1
2620145|NCT00927394|9058816|P1|Overall Study|Death|1
2620146|NCT00927394|9058815|P2|Overall Study|Administrative Problem|0
2620147|NCT00927394|9058816|P1|Overall Study|Administrative Problem|1
2620148|NCT00927394|9058815|P2|Overall Study|Lost to Follow-up|14
2620149|NCT00927394|9058816|P1|Overall Study|Lost to Follow-up|8
2620150|NCT00927394|9058815|P2|Overall Study|Withdrawal by Subject|24
2620151|NCT00927394|9058816|P1|Overall Study|Withdrawal by Subject|20
2620152|NCT00927394|9058815|P2|Overall Study|Unsatisfactory therapeutic effect|23
2620153|NCT00927394|9058816|P1|Overall Study|Unsatisfactory therapeutic effect|17
2620154|NCT00927394|9058815|P2|Overall Study|Adverse Event|9
2620155|NCT00927394|9058816|P1|Overall Study|Adverse Event|14
2620156|NCT00927368|9058847|P3|Overall Study|cancellation of surgery|2
2620157|NCT00927368|9058848|P2|Overall Study|cancellation of surgery|1
2620158|NCT00927368|9058849|P1|Overall Study|cancellation of surgery|0
2620159|NCT00927368|9058847|P3|Overall Study|ineligible post randomization|1
2620160|NCT00927368|9058848|P2|Overall Study|ineligible post randomization|3
2620161|NCT00927368|9058849|P1|Overall Study|ineligible post randomization|0
2620162|NCT00927368|9058847|P3|Overall Study|equipment failure|0
2620163|NCT00927368|9058848|P2|Overall Study|equipment failure|0
2620164|NCT00927368|9058849|P1|Overall Study|equipment failure|1
2620165|NCT00927368|9058847|P3|Overall Study|Lost to Follow-up|0
2620166|NCT00927368|9058848|P2|Overall Study|Lost to Follow-up|0
2620167|NCT00927368|9058849|P1|Overall Study|Lost to Follow-up|4
2620168|NCT00927368|9058847|P3|Overall Study|enrollment in another study|2
2620169|NCT00927368|9058848|P2|Overall Study|enrollment in another study|1
2620170|NCT00927368|9058849|P1|Overall Study|enrollment in another study|1
2620171|NCT00927355|9058868|P2|Overall Study|Adverse Event|1
2620172|NCT00927355|9058869|P1|Overall Study|Adverse Event|1
2620173|NCT00927251|9058904|P1|Overall Study|Patients not implanted with 4296 lead|8
2620174|NCT00927186|9058910|P2|12 Months Primary Study|Withdrawal by Subject|1
2620175|NCT00927186|9058911|P1|12 Months Primary Study|Withdrawal by Subject|1
2620176|NCT00927186|9058910|P2|12 Months Primary Study|Protocol Violation|1
2620177|NCT00927186|9058911|P1|12 Months Primary Study|Protocol Violation|0
2620178|NCT00927186|9058910|P2|12 Months Primary Study|Lost to Follow-up|0
2620179|NCT00927186|9058911|P1|12 Months Primary Study|Lost to Follow-up|1
2620180|NCT00927186|9058910|P2|12 Months Primary Study|Adverse Event|2
2620181|NCT00927186|9058911|P1|12 Months Primary Study|Adverse Event|5
2620182|NCT00927095|9059041|P3|Overall Study|Physician Decision|1
2620183|NCT00927095|9059042|P2|Overall Study|Physician Decision|2
2620184|NCT00927095|9059043|P1|Overall Study|Physician Decision|1
2620185|NCT00927095|9059041|P3|Overall Study|Withdrawal by Subject|1
2620186|NCT00927095|9059042|P2|Overall Study|Withdrawal by Subject|1
2620187|NCT00927095|9059043|P1|Overall Study|Withdrawal by Subject|2
2620188|NCT00927095|9059041|P3|Overall Study|Adverse Event|0
2620189|NCT00927095|9059042|P2|Overall Study|Adverse Event|1
2620190|NCT00927095|9059043|P1|Overall Study|Adverse Event|3
2620191|NCT00927082|9059055|P4|Overall Study|Screen fail,Participant migrated,Unknown|1
2620192|NCT00927082|9059056|P3|Overall Study|Screen fail,Participant migrated,Unknown|2
2620193|NCT00927082|9059057|P2|Overall Study|Screen fail,Participant migrated,Unknown|0
2620194|NCT00927082|9059058|P1|Overall Study|Screen fail,Participant migrated,Unknown|0
2620195|NCT00927082|9059055|P4|Overall Study|Death|0
2620196|NCT00927082|9059056|P3|Overall Study|Death|1
2620197|NCT00927082|9059057|P2|Overall Study|Death|0
2620198|NCT00927082|9059058|P1|Overall Study|Death|0
2620199|NCT00927082|9059055|P4|Overall Study|Withdrawal by Subject|2
2620200|NCT00927082|9059056|P3|Overall Study|Withdrawal by Subject|7
2620201|NCT00927082|9059057|P2|Overall Study|Withdrawal by Subject|2
2620202|NCT00927082|9059058|P1|Overall Study|Withdrawal by Subject|3
2620203|NCT00927082|9059055|P4|Overall Study|Lost to Follow-up|16
2620204|NCT00927082|9059056|P3|Overall Study|Lost to Follow-up|12
2620205|NCT00927082|9059057|P2|Overall Study|Lost to Follow-up|8
2620206|NCT00927082|9059058|P1|Overall Study|Lost to Follow-up|9
2620207|NCT00927069|9059122|P4|Week 12 to Week 24|Had a vaccination, removed from study|0
2620208|NCT00927069|9059123|P3|Week 12 to Week 24|Had a vaccination, removed from study|0
2620209|NCT00927069|9059124|P2|Week 12 to Week 24|Had a vaccination, removed from study|0
2620210|NCT00927069|9059125|P1|Week 12 to Week 24|Had a vaccination, removed from study|1
2620211|NCT00927069|9059122|P4|Week 12 to Week 24|Withdrawal by Subject|0
2620212|NCT00927069|9059123|P3|Week 12 to Week 24|Withdrawal by Subject|0
2620213|NCT00927069|9059124|P2|Week 12 to Week 24|Withdrawal by Subject|0
2620214|NCT00927069|9059125|P1|Week 12 to Week 24|Withdrawal by Subject|1
2620215|NCT00927069|9059122|P4|Week 12 to Week 24|Lost to Follow-up|0
2620216|NCT00927069|9059123|P3|Week 12 to Week 24|Lost to Follow-up|1
2620217|NCT00927069|9059124|P2|Week 12 to Week 24|Lost to Follow-up|0
2620218|NCT00927069|9059125|P1|Week 12 to Week 24|Lost to Follow-up|0
2620219|NCT00927069|9059122|P4|Week 12 to Week 24|Lack of Efficacy|3
2620220|NCT00927069|9059123|P3|Week 12 to Week 24|Lack of Efficacy|2
2620221|NCT00927069|9059124|P2|Week 12 to Week 24|Lack of Efficacy|0
2620222|NCT00927069|9059125|P1|Week 12 to Week 24|Lack of Efficacy|0
2620223|NCT00927069|9059122|P4|Week 0 to Week 12|Worsening of psoriasis|0
2620224|NCT00927069|9059123|P3|Week 0 to Week 12|Worsening of psoriasis|0
2620225|NCT00927069|9059124|P2|Week 0 to Week 12|Worsening of psoriasis|1
2620226|NCT00927069|9059125|P1|Week 0 to Week 12|Worsening of psoriasis|1
2620227|NCT00926796|9059181|P2|Overall Study|Withdrawal by Subject|0
2620228|NCT00926796|9059182|P1|Overall Study|Withdrawal by Subject|1
2620229|NCT00926796|9059181|P2|Overall Study|Protocol Violation|11
2620230|NCT00926796|9059182|P1|Overall Study|Protocol Violation|15
2620231|NCT00926796|9059181|P2|Overall Study|Lost to Follow-up|13
2620232|NCT00926796|9059182|P1|Overall Study|Lost to Follow-up|22
2620233|NCT00926796|9059181|P2|Overall Study|Adverse Event|14
2620234|NCT00926796|9059182|P1|Overall Study|Adverse Event|7
2620235|NCT00926796|9059181|P2|Overall Study|Ineligible, but positive for gonorrhea|1
2620236|NCT00926796|9059182|P1|Overall Study|Ineligible, but positive for gonorrhea|1
2620237|NCT00926796|9059181|P2|Overall Study|Ineligible, negative for gonorrhea|60
2620238|NCT00926796|9059182|P1|Overall Study|Ineligible, negative for gonorrhea|57
2620239|NCT00926796|9059181|P2|Overall Study|Did not receive randomized treatment|7
2620240|NCT00926796|9059182|P1|Overall Study|Did not receive randomized treatment|4
2620241|NCT00926783|9059203|P2|Overall Study|Incomplete CFAE Procedures|3
2620242|NCT00926783|9059204|P1|Overall Study|Incomplete CFAE Procedures|3
2620243|NCT00926575|9059231|P2|Overall Study|Withdrawal by Subject|9
2620244|NCT00926575|9059232|P1|Overall Study|Withdrawal by Subject|8
2620245|NCT00926575|9059231|P2|Overall Study|Protocol Violation|0
2620246|NCT00926575|9059232|P1|Overall Study|Protocol Violation|1
2620247|NCT00926575|9059231|P2|Overall Study|Physician Decision|2
2620248|NCT00926575|9059232|P1|Overall Study|Physician Decision|1
2620249|NCT00926575|9059231|P2|Overall Study|Lost to Follow-up|1
2620250|NCT00926575|9059232|P1|Overall Study|Lost to Follow-up|1
2620251|NCT00926575|9059231|P2|Overall Study|Death|4
2620252|NCT00926575|9059232|P1|Overall Study|Death|4
2620253|NCT00926575|9059231|P2|Overall Study|Adverse Event|1
2620254|NCT00926575|9059232|P1|Overall Study|Adverse Event|1
2620255|NCT00926536|9059244|P2|Overall Study|Physician Decision|2
2620256|NCT00926536|9059245|P1|Overall Study|Physician Decision|1
2620257|NCT00926393|9059266|P2|Overall Study|Adverse Event|1
2620258|NCT00926393|9059267|P1|Overall Study|Adverse Event|1
2620259|NCT00926393|9059266|P2|Overall Study|Withdrawal by Subject|2
2620260|NCT00926393|9059267|P1|Overall Study|Withdrawal by Subject|1
2620261|NCT00926367|9059312|P2|Overall Study|Skin Irritation|2
2620262|NCT00926367|9059313|P1|Overall Study|Skin Irritation|1
2620263|NCT00926367|9059312|P2|Overall Study|Lost to Follow-up|0
2620264|NCT00926367|9059313|P1|Overall Study|Lost to Follow-up|1
2620265|NCT00926367|9059312|P2|Overall Study|Withdrawal by Subject|1
2620266|NCT00926367|9059313|P1|Overall Study|Withdrawal by Subject|0
2620267|NCT00926328|9059355|P2|Overall Study|Lost to Follow-up|14
2620268|NCT00926328|9059356|P1|Overall Study|Lost to Follow-up|12
2620269|NCT00926289|9059366|P2|Overall Study|Other|3
2620270|NCT00926289|9059367|P1|Overall Study|Other|1
2620271|NCT00926289|9059366|P2|Overall Study|Withdrawal by Subject|4
2620272|NCT00926289|9059367|P1|Overall Study|Withdrawal by Subject|4
2620273|NCT00926289|9059366|P2|Overall Study|Lost to Follow-up|6
2620274|NCT00926289|9059367|P1|Overall Study|Lost to Follow-up|3
2620275|NCT00926289|9059366|P2|Overall Study|Protocol Violation|12
2620276|NCT00926289|9059367|P1|Overall Study|Protocol Violation|8
2620277|NCT00926289|9059366|P2|Overall Study|Adverse Event|11
2620278|NCT00926289|9059367|P1|Overall Study|Adverse Event|9
2620279|NCT00926211|9059435|P1|Overall Study|Lost to Follow-up|1
2620280|NCT00926029|9059466|P3|Overall Study|Lost to Follow-up|1
2620281|NCT00926029|9059467|P2|Overall Study|Lost to Follow-up|1
2620282|NCT00926029|9059468|P1|Overall Study|Lost to Follow-up|2
2620283|NCT00926003|9059482|P3|Post-Training 3-month Follow-up|Lost to Follow-up|0
2620284|NCT00926003|9059483|P2|Post-Training 3-month Follow-up|Lost to Follow-up|0
2620285|NCT00926003|9059484|P1|Post-Training 3-month Follow-up|Lost to Follow-up|1
2620286|NCT00926003|9059482|P3|Post-Training Evaluation|Withdrawal by Subject|0
2620287|NCT00926003|9059483|P2|Post-Training Evaluation|Withdrawal by Subject|0
2620288|NCT00926003|9059484|P1|Post-Training Evaluation|Withdrawal by Subject|1
2620289|NCT00925990|9059497|P2|Overall Study|moved out of state, missed medication|2
2620290|NCT00925990|9059498|P1|Overall Study|moved out of state, missed medication|0
2620291|NCT00925990|9059497|P2|Overall Study|Physician Decision|1
2620292|NCT00925990|9059498|P1|Overall Study|Physician Decision|1
2620293|NCT00925990|9059497|P2|Overall Study|Lost to Follow-up|3
2620294|NCT00925990|9059498|P1|Overall Study|Lost to Follow-up|1
2620295|NCT00925990|9059497|P2|Overall Study|Withdrawal by Subject|2
2620296|NCT00925990|9059498|P1|Overall Study|Withdrawal by Subject|2
2620297|NCT00925990|9059497|P2|Overall Study|Adverse Event|3
2620298|NCT00925990|9059498|P1|Overall Study|Adverse Event|1
2620299|NCT00925899|9059533|P2|Part 1|Withdrawal by Subject|9
2620300|NCT00925899|9059534|P1|Part 1|Withdrawal by Subject|10
2620301|NCT00925899|9059533|P2|Part 1|Death|2
2620302|NCT00925899|9059534|P1|Part 1|Death|1
2620303|NCT00925769|9059562|P6|Overall Study|Adverse Event|0
2620304|NCT00925769|9059563|P5|Overall Study|Adverse Event|1
2620305|NCT00925769|9059564|P4|Overall Study|Adverse Event|0
2620306|NCT00925769|9059565|P3|Overall Study|Adverse Event|0
2620307|NCT00925769|9059566|P2|Overall Study|Adverse Event|0
2620308|NCT00925769|9059567|P1|Overall Study|Adverse Event|0
2620309|NCT00925769|9059562|P6|Overall Study|Participant is unable to swallow drug|0
2620310|NCT00925769|9059563|P5|Overall Study|Participant is unable to swallow drug|0
2620311|NCT00925769|9059564|P4|Overall Study|Participant is unable to swallow drug|1
2620312|NCT00925769|9059565|P3|Overall Study|Participant is unable to swallow drug|0
2620313|NCT00925769|9059566|P2|Overall Study|Participant is unable to swallow drug|0
2620314|NCT00925769|9059567|P1|Overall Study|Participant is unable to swallow drug|0
2620315|NCT00925769|9059562|P6|Overall Study|End of study visit not done|0
2620316|NCT00925769|9059563|P5|Overall Study|End of study visit not done|0
2620317|NCT00925769|9059564|P4|Overall Study|End of study visit not done|0
2620318|NCT00925769|9059565|P3|Overall Study|End of study visit not done|1
2620319|NCT00925769|9059566|P2|Overall Study|End of study visit not done|0
2620320|NCT00925769|9059567|P1|Overall Study|End of study visit not done|0
2620321|NCT00925769|9059562|P6|Overall Study|Missing documentation|0
2620322|NCT00925769|9059563|P5|Overall Study|Missing documentation|0
2620323|NCT00925769|9059564|P4|Overall Study|Missing documentation|0
2620324|NCT00925769|9059565|P3|Overall Study|Missing documentation|0
2620325|NCT00925769|9059566|P2|Overall Study|Missing documentation|1
2620326|NCT00925769|9059567|P1|Overall Study|Missing documentation|0
2620327|NCT00925769|9059562|P6|Overall Study|Physician Decision|0
2620328|NCT00925769|9059563|P5|Overall Study|Physician Decision|0
2620329|NCT00925769|9059564|P4|Overall Study|Physician Decision|0
2620330|NCT00925769|9059565|P3|Overall Study|Physician Decision|0
2620331|NCT00925769|9059566|P2|Overall Study|Physician Decision|0
2620332|NCT00925769|9059567|P1|Overall Study|Physician Decision|1
2620333|NCT00925769|9059562|P6|Overall Study|Death|0
2620334|NCT00925769|9059563|P5|Overall Study|Death|0
2620335|NCT00925769|9059564|P4|Overall Study|Death|0
2620336|NCT00925769|9059565|P3|Overall Study|Death|1
2620337|NCT00925769|9059566|P2|Overall Study|Death|0
2620338|NCT00925769|9059567|P1|Overall Study|Death|0
2620339|NCT00925769|9059562|P6|Overall Study|Disease progression|3
2620340|NCT00925769|9059563|P5|Overall Study|Disease progression|2
2620341|NCT00925769|9059564|P4|Overall Study|Disease progression|4
2620342|NCT00925769|9059565|P3|Overall Study|Disease progression|3
2620343|NCT00925769|9059566|P2|Overall Study|Disease progression|5
2620344|NCT00925769|9059567|P1|Overall Study|Disease progression|4
2620345|NCT00925769|9059562|P6|Overall Study|Major toxicity|0
2620346|NCT00925769|9059563|P5|Overall Study|Major toxicity|0
2620347|NCT00925769|9059564|P4|Overall Study|Major toxicity|1
2620348|NCT00925769|9059565|P3|Overall Study|Major toxicity|1
2620349|NCT00925769|9059566|P2|Overall Study|Major toxicity|0
2620350|NCT00925769|9059567|P1|Overall Study|Major toxicity|1
2620351|NCT00925704|9059635|P6|Third Intervention|Withdrew consent|1
2620352|NCT00925704|9059636|P5|Third Intervention|Withdrew consent|0
2620353|NCT00925704|9059637|P4|Third Intervention|Withdrew consent|0
2620354|NCT00925704|9059638|P3|Third Intervention|Withdrew consent|0
2620355|NCT00925704|9059639|P2|Third Intervention|Withdrew consent|0
2620356|NCT00925704|9059640|P1|Third Intervention|Withdrew consent|0
2620357|NCT00925704|9059635|P6|Second Intervention|Withdrawal by Subject|0
2620358|NCT00925704|9059636|P5|Second Intervention|Withdrawal by Subject|1
2620359|NCT00925704|9059637|P4|Second Intervention|Withdrawal by Subject|0
2620360|NCT00925704|9059638|P3|Second Intervention|Withdrawal by Subject|0
2620361|NCT00925704|9059639|P2|Second Intervention|Withdrawal by Subject|0
2620362|NCT00925704|9059640|P1|Second Intervention|Withdrawal by Subject|1
2620363|NCT00925704|9059635|P6|First Intervention|Withdrew consent|0
2620364|NCT00925704|9059636|P5|First Intervention|Withdrew consent|1
2620365|NCT00925704|9059637|P4|First Intervention|Withdrew consent|1
2620366|NCT00925704|9059638|P3|First Intervention|Withdrew consent|0
2620367|NCT00925704|9059639|P2|First Intervention|Withdrew consent|0
2620368|NCT00925704|9059640|P1|First Intervention|Withdrew consent|0
2620369|NCT00925600|9059653|P2|Overall Study|Adverse Event|2
2620370|NCT00925600|9059654|P1|Overall Study|Adverse Event|1
2620371|NCT00925600|9059653|P2|Overall Study|Other|1
2620372|NCT00925600|9059654|P1|Overall Study|Other|3
2620373|NCT00925600|9059653|P2|Overall Study|Requirement for Alternative Therapy|1
2620374|NCT00925600|9059654|P1|Overall Study|Requirement for Alternative Therapy|0
2620375|NCT00925600|9059653|P2|Overall Study|Protocol Deviation|1
2620376|NCT00925600|9059654|P1|Overall Study|Protocol Deviation|0
2620377|NCT00925600|9059653|P2|Overall Study|Ineligibility Determined|0
2620378|NCT00925600|9059654|P1|Overall Study|Ineligibility Determined|2
2620379|NCT00925600|9059653|P2|Overall Study|Noncompliance|0
2620380|NCT00925600|9059654|P1|Overall Study|Noncompliance|2
2620381|NCT00925600|9059653|P2|Overall Study|Administrative Decision|1
2620382|NCT00925600|9059654|P1|Overall Study|Administrative Decision|1
2620383|NCT00925600|9059653|P2|Overall Study|Disease Progression|3
2620384|NCT00925600|9059654|P1|Overall Study|Disease Progression|1
2620385|NCT00925600|9059653|P2|Overall Study|Lost to Follow-up|2
2620386|NCT00925600|9059654|P1|Overall Study|Lost to Follow-up|2
2620387|NCT00925600|9059653|P2|Overall Study|Death|3
2620388|NCT00925600|9059654|P1|Overall Study|Death|4
2620389|NCT00925600|9059653|P2|Overall Study|Withdrawal by Subject|14
2620390|NCT00925600|9059654|P1|Overall Study|Withdrawal by Subject|16
2620391|NCT00925587|9059676|P2|Overall Study|Lost to Follow-up|1
2620392|NCT00925587|9059677|P1|Overall Study|Lost to Follow-up|0
2620393|NCT00925587|9059676|P2|Overall Study|Adverse Event|2
2620394|NCT00925587|9059677|P1|Overall Study|Adverse Event|6
2620395|NCT00925587|9059676|P2|Overall Study|Death|5
2620396|NCT00925587|9059677|P1|Overall Study|Death|5
2620397|NCT00925587|9059676|P2|Overall Study|Withdrawal by Subject|6
2620398|NCT00925587|9059677|P1|Overall Study|Withdrawal by Subject|9
2620399|NCT00925587|9059676|P2|Overall Study|Protocol Violation|4
2620400|NCT00925587|9059677|P1|Overall Study|Protocol Violation|6
2620401|NCT00925587|9059676|P2|Overall Study|Physician Decision|1
2620402|NCT00925587|9059677|P1|Overall Study|Physician Decision|4
2620403|NCT00925587|9059676|P2|Overall Study|Protocol Specified Criteria|6
2620404|NCT00925587|9059677|P1|Overall Study|Protocol Specified Criteria|6
2620405|NCT00925548|9059791|P2|Overall Study|Discontinuation of trial by sponsor|5
2620406|NCT00925548|9059792|P1|Overall Study|Discontinuation of trial by sponsor|10
2620407|NCT00925522|9059818|P1|Overall Study|study closed -- business decision|20
2620408|NCT00925353|9059822|P1|Overall Study|Failed preliminary EKG or lab criteria.|3
2620409|NCT00925301|9059828|P4|12-Month Open-label Extension (Optional)|Lost to Follow-up|1
2620410|NCT00925301|9059829|P3|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
2620411|NCT00925301|9059830|P2|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
2620412|NCT00925301|9059831|P1|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
2620413|NCT00925301|9059828|P4|12-Month Open-label Extension (Optional)|Pregnancy|1
2620414|NCT00925301|9059829|P3|12-Month Open-label Extension (Optional)|Pregnancy|0
2620415|NCT00925301|9059830|P2|12-Month Open-label Extension (Optional)|Pregnancy|0
2620416|NCT00925301|9059831|P1|12-Month Open-label Extension (Optional)|Pregnancy|0
2620417|NCT00925301|9059828|P4|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1
2620418|NCT00925301|9059829|P3|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
2620419|NCT00925301|9059830|P2|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
2620420|NCT00925301|9059831|P1|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
2620421|NCT00925301|9059828|P4|6-Month Open-label (Stage 2)|Adverse Event|0
2620422|NCT00925301|9059829|P3|6-Month Open-label (Stage 2)|Adverse Event|2
2620423|NCT00925301|9059830|P2|6-Month Open-label (Stage 2)|Adverse Event|0
2620424|NCT00925301|9059831|P1|6-Month Open-label (Stage 2)|Adverse Event|0
2620425|NCT00925301|9059828|P4|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
2620426|NCT00925301|9059829|P3|6-Month Open-label (Stage 2)|Withdrawal by Subject|1
2620427|NCT00925301|9059830|P2|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
2620428|NCT00925301|9059831|P1|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
2620429|NCT00925301|9059828|P4|6-Month Double-blind (Stage 1)|Pregnancy|0
2620430|NCT00925301|9059829|P3|6-Month Double-blind (Stage 1)|Pregnancy|0
2620431|NCT00925301|9059830|P2|6-Month Double-blind (Stage 1)|Pregnancy|1
2620432|NCT00925301|9059831|P1|6-Month Double-blind (Stage 1)|Pregnancy|0
2620433|NCT00925301|9059828|P4|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
2620434|NCT00925301|9059829|P3|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
2620435|NCT00925301|9059830|P2|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2
2620436|NCT00925301|9059831|P1|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
2620437|NCT00925288|9059847|P2|Overall Study|Lost to Follow-up|7
2620438|NCT00925288|9059848|P1|Overall Study|Lost to Follow-up|9
2620439|NCT00925132|9059860|P5|Overall Study|Removed due to disease progression|4
2620440|NCT00925132|9059861|P4|Overall Study|Removed due to disease progression|0
2620441|NCT00925132|9059862|P3|Overall Study|Removed due to disease progression|0
2620442|NCT00925132|9059863|P2|Overall Study|Removed due to disease progression|0
2620443|NCT00925132|9059864|P1|Overall Study|Removed due to disease progression|0
2620444|NCT00925132|9059860|P5|Overall Study|Withdrawal by Subject|1
2620445|NCT00925132|9059861|P4|Overall Study|Withdrawal by Subject|0
2620446|NCT00925132|9059862|P3|Overall Study|Withdrawal by Subject|0
2620447|NCT00925132|9059863|P2|Overall Study|Withdrawal by Subject|0
2620448|NCT00925132|9059864|P1|Overall Study|Withdrawal by Subject|2
2620449|NCT00925015|9059959|P3|Overall Study|Withdrawal by Subject|1
2620450|NCT00925015|9059960|P2|Overall Study|Withdrawal by Subject|0
2620451|NCT00925015|9059961|P1|Overall Study|Withdrawal by Subject|0
2620452|NCT00925015|9059959|P3|Overall Study|Progressive Disease|4
2620453|NCT00925015|9059960|P2|Overall Study|Progressive Disease|3
2620454|NCT00925015|9059961|P1|Overall Study|Progressive Disease|7
2620455|NCT00925015|9059959|P3|Overall Study|Physician Decision|0
2620456|NCT00925015|9059960|P2|Overall Study|Physician Decision|1
2620457|NCT00925015|9059961|P1|Overall Study|Physician Decision|0
2620458|NCT00925015|9059959|P3|Overall Study|Adverse Event|1
2620459|NCT00925015|9059960|P2|Overall Study|Adverse Event|2
2620460|NCT00925015|9059961|P1|Overall Study|Adverse Event|1
2620461|NCT00924950|9060017|P1|Overall Study|Lost to Follow-up|2
2620462|NCT00924898|9060024|P1|Overall Study|Withdrawal by Subject|2
2620463|NCT00924781|9060061|P2|Overall Study|Study terminated by sponsor|10
2620464|NCT00924781|9060062|P1|Overall Study|Study terminated by sponsor|12
2620465|NCT00924729|9060096|P2|Overall Study|Protocol Violation|0
2620466|NCT00924729|9060097|P1|Overall Study|Protocol Violation|1
2620467|NCT00924729|9060096|P2|Overall Study|insufficient volume for analysis|0
2620468|NCT00924729|9060097|P1|Overall Study|insufficient volume for analysis|1
2620469|NCT00924651|9060107|P2|Overall Study|Incomplete Form|1
2620470|NCT00924651|9060108|P1|Overall Study|Incomplete Form|2
2620471|NCT00924651|9060107|P2|Overall Study|Changed Mind|1
2620472|NCT00924651|9060108|P1|Overall Study|Changed Mind|10
2620473|NCT00924651|9060107|P2|Overall Study|Medical|3
2620474|NCT00924651|9060108|P1|Overall Study|Medical|1
2620475|NCT00924651|9060107|P2|Overall Study|Noncompliant|4
2620476|NCT00924651|9060108|P1|Overall Study|Noncompliant|1
2620477|NCT00924651|9060107|P2|Overall Study|Overwhelmed|6
2620478|NCT00924651|9060108|P1|Overall Study|Overwhelmed|6
2620479|NCT00924651|9060107|P2|Overall Study|No Reason|7
2620480|NCT00924651|9060108|P1|Overall Study|No Reason|3
2620481|NCT00924651|9060107|P2|Overall Study|Chemo started too soon|3
2620482|NCT00924651|9060108|P1|Overall Study|Chemo started too soon|2
2620483|NCT00924638|9060116|P2|Overall Study|Physician Decision|3
2620484|NCT00924638|9060117|P1|Overall Study|Physician Decision|3
2620485|NCT00924638|9060116|P2|Overall Study|Withdrawal by Subject|7
2620486|NCT00924638|9060117|P1|Overall Study|Withdrawal by Subject|5
2620487|NCT00924638|9060116|P2|Overall Study|Lost to Follow-up|1
2620488|NCT00924638|9060117|P1|Overall Study|Lost to Follow-up|1
2620489|NCT00924638|9060116|P2|Overall Study|Death|2
2620490|NCT00924638|9060117|P1|Overall Study|Death|3
2620491|NCT00924560|9060139|P3|Overall Study|Miscellaneous Reasons|10
2620492|NCT00924560|9060140|P2|Overall Study|Miscellaneous Reasons|10
2620493|NCT00924560|9060141|P1|Overall Study|Miscellaneous Reasons|13
2620494|NCT00924560|9060139|P3|Overall Study|Lost to Follow-up|45
2620495|NCT00924560|9060140|P2|Overall Study|Lost to Follow-up|94
2620496|NCT00924560|9060141|P1|Overall Study|Lost to Follow-up|78
2620497|NCT00924560|9060139|P3|Overall Study|Pregnancy|1
2620498|NCT00924560|9060140|P2|Overall Study|Pregnancy|7
2620499|NCT00924560|9060141|P1|Overall Study|Pregnancy|5
2620500|NCT00924560|9060139|P3|Overall Study|Adverse Event|0
2620501|NCT00924560|9060140|P2|Overall Study|Adverse Event|33
2620502|NCT00924560|9060141|P1|Overall Study|Adverse Event|39
2620503|NCT00924560|9060139|P3|Overall Study|Withdrawal by Subject|18
2620504|NCT00924560|9060140|P2|Overall Study|Withdrawal by Subject|44
2620505|NCT00924560|9060141|P1|Overall Study|Withdrawal by Subject|50
2620506|NCT00924560|9060139|P3|Overall Study|Physician Decision|4
2620507|NCT00924560|9060140|P2|Overall Study|Physician Decision|3
2620508|NCT00924560|9060141|P1|Overall Study|Physician Decision|2
2620509|NCT00924560|9060139|P3|Overall Study|Non Compliance with the Protocol|4
2620510|NCT00924560|9060140|P2|Overall Study|Non Compliance with the Protocol|15
2620511|NCT00924560|9060141|P1|Overall Study|Non Compliance with the Protocol|20
2620512|NCT00924560|9060139|P3|Overall Study|Did Not Meet Protocol Requirements|1
2620513|NCT00924560|9060140|P2|Overall Study|Did Not Meet Protocol Requirements|2
2620514|NCT00924560|9060141|P1|Overall Study|Did Not Meet Protocol Requirements|4
2620515|NCT00924508|9060185|P1|Overall Study|Withdrawal by Subject|3
2620516|NCT00924469|9060199|P2|Overall Study|Lost to Follow-up|1
2620517|NCT00924469|9060200|P1|Overall Study|Lost to Follow-up|0
2620518|NCT00924469|9060199|P2|Overall Study|Withdrawal by Subject|1
2620519|NCT00924469|9060200|P1|Overall Study|Withdrawal by Subject|0
2620520|NCT00924469|9060199|P2|Overall Study|Adverse Event|0
2620521|NCT00924469|9060200|P1|Overall Study|Adverse Event|2
2620522|NCT00924443|9060222|P1|Overall Study|Protocol Violation|1
2620523|NCT00924443|9060222|P1|Overall Study|Physician Decision|2
2620524|NCT00924404|9060232|P2|Overall Study|Lost to Follow-up|4
2620525|NCT00924404|9060233|P1|Overall Study|Lost to Follow-up|6
2620526|NCT00924313|9060304|P1|Overall Study|not imaged due to failed tracer imaging|1
2620527|NCT00924287|9060316|P1|Overall Study|Death|1
2620528|NCT00924170|9060332|P2|Overall Study|Death|0
2620529|NCT00924170|9060333|P1|Overall Study|Death|1
2620530|NCT00924170|9060332|P2|Overall Study|Stopped due to neutralizing antibodies|0
2620531|NCT00924170|9060333|P1|Overall Study|Stopped due to neutralizing antibodies|3
2620532|NCT00924170|9060332|P2|Overall Study|Progressive disease|6
2620533|NCT00924170|9060333|P1|Overall Study|Progressive disease|3
2620534|NCT00924170|9060332|P2|Overall Study|Physician Decision|1
2620535|NCT00924170|9060333|P1|Overall Study|Physician Decision|0
2620536|NCT00924170|9060332|P2|Overall Study|Refused further treatment|1
2620537|NCT00924170|9060333|P1|Overall Study|Refused further treatment|0
2620538|NCT00923975|9060458|P1|Overall Study|Did not meet inclusion criteria|1
2620539|NCT00923936|9060477|P2|Overall Study|Continuing in follow up period|1
2620540|NCT00923936|9060478|P1|Overall Study|Continuing in follow up period|2
2620541|NCT00923936|9060477|P2|Overall Study|Lost to follow up|0
2620542|NCT00923936|9060478|P1|Overall Study|Lost to follow up|2
2620543|NCT00923936|9060477|P2|Overall Study|Adverse Event|1
2620544|NCT00923936|9060478|P1|Overall Study|Adverse Event|2
2620545|NCT00923936|9060477|P2|Overall Study|progressive disease on study|1
2620546|NCT00923936|9060478|P1|Overall Study|progressive disease on study|2
2620547|NCT00923845|9060507|P2|Induction Therapy|Poor performance status|2
2620548|NCT00923845|9060508|P1|Induction Therapy|Poor performance status|0
2620549|NCT00923364|9060543|P2|Overall Study|Did not go to transplant|0
2620550|NCT00923364|9060544|P1|Overall Study|Did not go to transplant|1
2620551|NCT00923364|9060543|P2|Overall Study|Death|0
2620552|NCT00923364|9060544|P1|Overall Study|Death|3
2620553|NCT00923351|9060556|P3|Overall Study|no apheresis/adequate tumor sample|12
2620554|NCT00923351|9060557|P2|Overall Study|no apheresis/adequate tumor sample|0
2620555|NCT00923351|9060558|P1|Overall Study|no apheresis/adequate tumor sample|0
2620556|NCT00923273|9060573|P5|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
2620557|NCT00923273|9060574|P4|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6
2620558|NCT00923273|9060575|P3|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
2620559|NCT00923273|9060576|P2|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
2620560|NCT00923273|9060577|P1|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
2620561|NCT00923273|9060573|P5|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
2620562|NCT00923273|9060574|P4|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1
2620563|NCT00923273|9060575|P3|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
2620564|NCT00923273|9060576|P2|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
2620565|NCT00923273|9060577|P1|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
2620566|NCT00923260|9060602|P2|Overall Study|Lost to Follow-up|1
2620567|NCT00923260|9060603|P1|Overall Study|Lost to Follow-up|1
2620568|NCT00923195|9060766|P2|Overall Study|Death|1
2620569|NCT00923195|9060767|P1|Overall Study|Death|0
2620570|NCT00923156|9060778|P3|Overall Study|Lack of Efficacy|1
2620571|NCT00923156|9060779|P2|Overall Study|Lack of Efficacy|0
2620572|NCT00923156|9060780|P1|Overall Study|Lack of Efficacy|0
2620573|NCT00923156|9060778|P3|Overall Study|Death|0
2620574|NCT00923156|9060779|P2|Overall Study|Death|1
2620575|NCT00923156|9060780|P1|Overall Study|Death|0
2620576|NCT00923156|9060778|P3|Overall Study|Withdrawal by Subject|0
2620577|NCT00923156|9060779|P2|Overall Study|Withdrawal by Subject|1
2620578|NCT00923156|9060780|P1|Overall Study|Withdrawal by Subject|0
2620579|NCT00923156|9060778|P3|Overall Study|Abnormal laboratory values|1
2620580|NCT00923156|9060779|P2|Overall Study|Abnormal laboratory values|0
2620581|NCT00923156|9060780|P1|Overall Study|Abnormal laboratory values|0
2620582|NCT00923156|9060778|P3|Overall Study|Adverse Event|1
2620583|NCT00923156|9060779|P2|Overall Study|Adverse Event|2
2620584|NCT00923156|9060780|P1|Overall Study|Adverse Event|0
2620585|NCT00923130|9060806|P1|Overall Study|Refused further treatment|2
2620586|NCT00923130|9060806|P1|Overall Study|Switched to alternative treatment|2
2620587|NCT00923130|9060806|P1|Overall Study|Discontinued treatment due to toxicities|3
2620588|NCT00923130|9060806|P1|Overall Study|Death|1
2620589|NCT00923130|9060806|P1|Overall Study|Stopped treatment due to progression|17
2620590|NCT00923091|9060841|P13|Period VI (Open-Label)|Other Reason|0
2620591|NCT00923091|9060842|P12|Period VI (Open-Label)|Other Reason|0
2620592|NCT00923091|9060843|P11|Period VI (Open-Label)|Other Reason|0
2620593|NCT00923091|9060844|P10|Period VI (Open-Label)|Other Reason|0
2620594|NCT00923091|9060845|P9|Period VI (Open-Label)|Other Reason|0
2620595|NCT00923091|9060846|P8|Period VI (Open-Label)|Other Reason|0
2620596|NCT00923091|9060847|P7|Period VI (Open-Label)|Other Reason|0
2620597|NCT00923091|9060848|P6|Period VI (Open-Label)|Other Reason|0
2620598|NCT00923091|9060849|P5|Period VI (Open-Label)|Other Reason|1
2620599|NCT00923091|9060850|P4|Period VI (Open-Label)|Other Reason|1
2620600|NCT00923091|9060851|P3|Period VI (Open-Label)|Other Reason|0
2620601|NCT00923091|9060852|P2|Period VI (Open-Label)|Other Reason|0
2620602|NCT00923091|9060853|P1|Period VI (Open-Label)|Other Reason|0
2620603|NCT00923091|9060841|P13|Period VI (Open-Label)|Lost to Follow-up|0
2620604|NCT00923091|9060842|P12|Period VI (Open-Label)|Lost to Follow-up|0
2620605|NCT00923091|9060843|P11|Period VI (Open-Label)|Lost to Follow-up|0
2620606|NCT00923091|9060844|P10|Period VI (Open-Label)|Lost to Follow-up|0
2620607|NCT00923091|9060845|P9|Period VI (Open-Label)|Lost to Follow-up|0
2620608|NCT00923091|9060846|P8|Period VI (Open-Label)|Lost to Follow-up|0
2620609|NCT00923091|9060847|P7|Period VI (Open-Label)|Lost to Follow-up|0
2620610|NCT00923091|9060848|P6|Period VI (Open-Label)|Lost to Follow-up|0
2620611|NCT00923091|9060849|P5|Period VI (Open-Label)|Lost to Follow-up|0
2620612|NCT00923091|9060850|P4|Period VI (Open-Label)|Lost to Follow-up|0
2620613|NCT00923091|9060851|P3|Period VI (Open-Label)|Lost to Follow-up|1
2620614|NCT00923091|9060852|P2|Period VI (Open-Label)|Lost to Follow-up|0
2620615|NCT00923091|9060853|P1|Period VI (Open-Label)|Lost to Follow-up|1
2620616|NCT00923091|9060841|P13|Period VI (Open-Label)|Protocol Violation|0
2620617|NCT00923091|9060842|P12|Period VI (Open-Label)|Protocol Violation|0
2620618|NCT00923091|9060843|P11|Period VI (Open-Label)|Protocol Violation|0
2620619|NCT00923091|9060844|P10|Period VI (Open-Label)|Protocol Violation|0
2620620|NCT00923091|9060845|P9|Period VI (Open-Label)|Protocol Violation|0
2620621|NCT00923091|9060846|P8|Period VI (Open-Label)|Protocol Violation|0
2620622|NCT00923091|9060847|P7|Period VI (Open-Label)|Protocol Violation|0
2620623|NCT00923091|9060848|P6|Period VI (Open-Label)|Protocol Violation|0
2620624|NCT00923091|9060849|P5|Period VI (Open-Label)|Protocol Violation|4
2620625|NCT00923091|9060850|P4|Period VI (Open-Label)|Protocol Violation|1
2620626|NCT00923091|9060851|P3|Period VI (Open-Label)|Protocol Violation|3
2620627|NCT00923091|9060852|P2|Period VI (Open-Label)|Protocol Violation|1
2620628|NCT00923091|9060853|P1|Period VI (Open-Label)|Protocol Violation|6
2620629|NCT00923091|9060841|P13|Period VI (Open-Label)|Withdrawal by Subject|0
2620630|NCT00923091|9060842|P12|Period VI (Open-Label)|Withdrawal by Subject|0
2620631|NCT00923091|9060843|P11|Period VI (Open-Label)|Withdrawal by Subject|0
2620632|NCT00923091|9060844|P10|Period VI (Open-Label)|Withdrawal by Subject|0
2620633|NCT00923091|9060845|P9|Period VI (Open-Label)|Withdrawal by Subject|0
2620634|NCT00923091|9060846|P8|Period VI (Open-Label)|Withdrawal by Subject|0
2620635|NCT00923091|9060847|P7|Period VI (Open-Label)|Withdrawal by Subject|0
2620636|NCT00923091|9060848|P6|Period VI (Open-Label)|Withdrawal by Subject|0
2620637|NCT00923091|9060849|P5|Period VI (Open-Label)|Withdrawal by Subject|1
2620638|NCT00923091|9060850|P4|Period VI (Open-Label)|Withdrawal by Subject|0
2620639|NCT00923091|9060851|P3|Period VI (Open-Label)|Withdrawal by Subject|5
2620640|NCT00923091|9060852|P2|Period VI (Open-Label)|Withdrawal by Subject|7
2620641|NCT00923091|9060853|P1|Period VI (Open-Label)|Withdrawal by Subject|15
2620642|NCT00923091|9060841|P13|Period VI (Open-Label)|Adverse Event|0
2620643|NCT00923091|9060842|P12|Period VI (Open-Label)|Adverse Event|0
2620644|NCT00923091|9060843|P11|Period VI (Open-Label)|Adverse Event|0
2620645|NCT00923091|9060844|P10|Period VI (Open-Label)|Adverse Event|0
2620646|NCT00923091|9060845|P9|Period VI (Open-Label)|Adverse Event|0
2620647|NCT00923091|9060846|P8|Period VI (Open-Label)|Adverse Event|0
2620648|NCT00923091|9060847|P7|Period VI (Open-Label)|Adverse Event|0
2620649|NCT00923091|9060848|P6|Period VI (Open-Label)|Adverse Event|0
2620650|NCT00923091|9060849|P5|Period VI (Open-Label)|Adverse Event|1
2620651|NCT00923091|9060850|P4|Period VI (Open-Label)|Adverse Event|1
2620652|NCT00923091|9060851|P3|Period VI (Open-Label)|Adverse Event|4
2620653|NCT00923091|9060852|P2|Period VI (Open-Label)|Adverse Event|0
2620654|NCT00923091|9060853|P1|Period VI (Open-Label)|Adverse Event|17
2620655|NCT00923091|9060841|P13|Period V (Double -Blind)|Lost to Follow-up|0
2620656|NCT00923091|9060842|P12|Period V (Double -Blind)|Lost to Follow-up|0
2620657|NCT00923091|9060843|P11|Period V (Double -Blind)|Lost to Follow-up|1
2620658|NCT00923091|9060844|P10|Period V (Double -Blind)|Lost to Follow-up|0
2620659|NCT00923091|9060845|P9|Period V (Double -Blind)|Lost to Follow-up|0
2620660|NCT00923091|9060846|P8|Period V (Double -Blind)|Lost to Follow-up|0
2620661|NCT00923091|9060847|P7|Period V (Double -Blind)|Lost to Follow-up|0
2620662|NCT00923091|9060848|P6|Period V (Double -Blind)|Lost to Follow-up|0
2620663|NCT00923091|9060849|P5|Period V (Double -Blind)|Lost to Follow-up|0
2620664|NCT00923091|9060850|P4|Period V (Double -Blind)|Lost to Follow-up|0
2620665|NCT00923091|9060851|P3|Period V (Double -Blind)|Lost to Follow-up|0
2620666|NCT00923091|9060852|P2|Period V (Double -Blind)|Lost to Follow-up|0
2620667|NCT00923091|9060853|P1|Period V (Double -Blind)|Lost to Follow-up|0
2620668|NCT00923091|9060841|P13|Period V (Double -Blind)|Protocol Violation|1
2620669|NCT00923091|9060842|P12|Period V (Double -Blind)|Protocol Violation|0
2620670|NCT00923091|9060843|P11|Period V (Double -Blind)|Protocol Violation|0
2620671|NCT00923091|9060844|P10|Period V (Double -Blind)|Protocol Violation|0
2620672|NCT00923091|9060845|P9|Period V (Double -Blind)|Protocol Violation|0
2620673|NCT00923091|9060846|P8|Period V (Double -Blind)|Protocol Violation|0
2620674|NCT00923091|9060847|P7|Period V (Double -Blind)|Protocol Violation|0
2620675|NCT00923091|9060848|P6|Period V (Double -Blind)|Protocol Violation|0
2620676|NCT00923091|9060849|P5|Period V (Double -Blind)|Protocol Violation|0
2620677|NCT00923091|9060850|P4|Period V (Double -Blind)|Protocol Violation|0
2620678|NCT00923091|9060851|P3|Period V (Double -Blind)|Protocol Violation|0
2620679|NCT00923091|9060852|P2|Period V (Double -Blind)|Protocol Violation|0
2620680|NCT00923091|9060853|P1|Period V (Double -Blind)|Protocol Violation|0
2620681|NCT00923091|9060841|P13|Period V (Double -Blind)|Withdrawal by Subject|1
2620682|NCT00923091|9060842|P12|Period V (Double -Blind)|Withdrawal by Subject|0
2620683|NCT00923091|9060843|P11|Period V (Double -Blind)|Withdrawal by Subject|0
2620684|NCT00923091|9060844|P10|Period V (Double -Blind)|Withdrawal by Subject|0
2620685|NCT00923091|9060845|P9|Period V (Double -Blind)|Withdrawal by Subject|1
2620686|NCT00923091|9060846|P8|Period V (Double -Blind)|Withdrawal by Subject|0
2620687|NCT00923091|9060847|P7|Period V (Double -Blind)|Withdrawal by Subject|0
2620688|NCT00923091|9060848|P6|Period V (Double -Blind)|Withdrawal by Subject|0
2620689|NCT00923091|9060849|P5|Period V (Double -Blind)|Withdrawal by Subject|0
2620690|NCT00923091|9060850|P4|Period V (Double -Blind)|Withdrawal by Subject|0
2620691|NCT00923091|9060851|P3|Period V (Double -Blind)|Withdrawal by Subject|0
2620692|NCT00923091|9060852|P2|Period V (Double -Blind)|Withdrawal by Subject|0
2620693|NCT00923091|9060853|P1|Period V (Double -Blind)|Withdrawal by Subject|0
2620694|NCT00923091|9060841|P13|Period IV (Double-Blind)|Protocol Violation|0
2620695|NCT00923091|9060842|P12|Period IV (Double-Blind)|Protocol Violation|0
2620696|NCT00923091|9060843|P11|Period IV (Double-Blind)|Protocol Violation|0
2620697|NCT00923091|9060844|P10|Period IV (Double-Blind)|Protocol Violation|0
2620698|NCT00923091|9060845|P9|Period IV (Double-Blind)|Protocol Violation|0
2620699|NCT00923091|9060846|P8|Period IV (Double-Blind)|Protocol Violation|0
2620700|NCT00923091|9060847|P7|Period IV (Double-Blind)|Protocol Violation|0
2620701|NCT00923091|9060848|P6|Period IV (Double-Blind)|Protocol Violation|0
2620702|NCT00923091|9060849|P5|Period IV (Double-Blind)|Protocol Violation|0
2620703|NCT00923091|9060850|P4|Period IV (Double-Blind)|Protocol Violation|0
2620704|NCT00923091|9060851|P3|Period IV (Double-Blind)|Protocol Violation|0
2620705|NCT00923091|9060852|P2|Period IV (Double-Blind)|Protocol Violation|1
2620706|NCT00923091|9060853|P1|Period IV (Double-Blind)|Protocol Violation|0
2620707|NCT00923091|9060841|P13|Period IV (Double-Blind)|Withdrawal by Subject|0
2620708|NCT00923091|9060842|P12|Period IV (Double-Blind)|Withdrawal by Subject|0
2620709|NCT00923091|9060843|P11|Period IV (Double-Blind)|Withdrawal by Subject|0
2620710|NCT00923091|9060844|P10|Period IV (Double-Blind)|Withdrawal by Subject|0
2620711|NCT00923091|9060845|P9|Period IV (Double-Blind)|Withdrawal by Subject|0
2620712|NCT00923091|9060846|P8|Period IV (Double-Blind)|Withdrawal by Subject|0
2620713|NCT00923091|9060847|P7|Period IV (Double-Blind)|Withdrawal by Subject|0
2620714|NCT00923091|9060848|P6|Period IV (Double-Blind)|Withdrawal by Subject|0
2620715|NCT00923091|9060849|P5|Period IV (Double-Blind)|Withdrawal by Subject|0
2620716|NCT00923091|9060850|P4|Period IV (Double-Blind)|Withdrawal by Subject|0
2620717|NCT00923091|9060851|P3|Period IV (Double-Blind)|Withdrawal by Subject|0
2620718|NCT00923091|9060852|P2|Period IV (Double-Blind)|Withdrawal by Subject|1
2620719|NCT00923091|9060853|P1|Period IV (Double-Blind)|Withdrawal by Subject|0
2620720|NCT00923091|9060841|P13|Period IV (Double-Blind)|Adverse Event|0
2620721|NCT00923091|9060842|P12|Period IV (Double-Blind)|Adverse Event|0
2620722|NCT00923091|9060843|P11|Period IV (Double-Blind)|Adverse Event|0
2620723|NCT00923091|9060844|P10|Period IV (Double-Blind)|Adverse Event|0
2620724|NCT00923091|9060845|P9|Period IV (Double-Blind)|Adverse Event|0
2620725|NCT00923091|9060846|P8|Period IV (Double-Blind)|Adverse Event|0
2620726|NCT00923091|9060847|P7|Period IV (Double-Blind)|Adverse Event|0
2620727|NCT00923091|9060848|P6|Period IV (Double-Blind)|Adverse Event|0
2620728|NCT00923091|9060849|P5|Period IV (Double-Blind)|Adverse Event|0
2620729|NCT00923091|9060850|P4|Period IV (Double-Blind)|Adverse Event|0
2620730|NCT00923091|9060851|P3|Period IV (Double-Blind)|Adverse Event|0
2620731|NCT00923091|9060852|P2|Period IV (Double-Blind)|Adverse Event|0
2620732|NCT00923091|9060853|P1|Period IV (Double-Blind)|Adverse Event|2
2620733|NCT00923091|9060841|P13|Period III (Single-Blind)|Lost to Follow-up|0
2620734|NCT00923091|9060842|P12|Period III (Single-Blind)|Lost to Follow-up|0
2620735|NCT00923091|9060843|P11|Period III (Single-Blind)|Lost to Follow-up|0
2620736|NCT00923091|9060844|P10|Period III (Single-Blind)|Lost to Follow-up|0
2620737|NCT00923091|9060845|P9|Period III (Single-Blind)|Lost to Follow-up|0
2620738|NCT00923091|9060846|P8|Period III (Single-Blind)|Lost to Follow-up|0
2620739|NCT00923091|9060847|P7|Period III (Single-Blind)|Lost to Follow-up|0
2620740|NCT00923091|9060848|P6|Period III (Single-Blind)|Lost to Follow-up|0
2620741|NCT00923091|9060849|P5|Period III (Single-Blind)|Lost to Follow-up|0
2620742|NCT00923091|9060850|P4|Period III (Single-Blind)|Lost to Follow-up|0
2620743|NCT00923091|9060851|P3|Period III (Single-Blind)|Lost to Follow-up|0
2620744|NCT00923091|9060852|P2|Period III (Single-Blind)|Lost to Follow-up|0
2620745|NCT00923091|9060853|P1|Period III (Single-Blind)|Lost to Follow-up|2
2620746|NCT00923091|9060841|P13|Period III (Single-Blind)|Protocol Violation|0
2620747|NCT00923091|9060842|P12|Period III (Single-Blind)|Protocol Violation|0
2620748|NCT00923091|9060843|P11|Period III (Single-Blind)|Protocol Violation|0
2620749|NCT00923091|9060844|P10|Period III (Single-Blind)|Protocol Violation|0
2620750|NCT00923091|9060845|P9|Period III (Single-Blind)|Protocol Violation|0
2620751|NCT00923091|9060846|P8|Period III (Single-Blind)|Protocol Violation|0
2620752|NCT00923091|9060847|P7|Period III (Single-Blind)|Protocol Violation|0
2620753|NCT00923091|9060848|P6|Period III (Single-Blind)|Protocol Violation|0
2620754|NCT00923091|9060849|P5|Period III (Single-Blind)|Protocol Violation|0
2620755|NCT00923091|9060850|P4|Period III (Single-Blind)|Protocol Violation|0
2620756|NCT00923091|9060851|P3|Period III (Single-Blind)|Protocol Violation|0
2620757|NCT00923091|9060852|P2|Period III (Single-Blind)|Protocol Violation|0
2620758|NCT00923091|9060853|P1|Period III (Single-Blind)|Protocol Violation|3
2620759|NCT00923091|9060841|P13|Period III (Single-Blind)|Withdrawal by Subject|0
2620760|NCT00923091|9060842|P12|Period III (Single-Blind)|Withdrawal by Subject|0
2620761|NCT00923091|9060843|P11|Period III (Single-Blind)|Withdrawal by Subject|0
2620762|NCT00923091|9060844|P10|Period III (Single-Blind)|Withdrawal by Subject|0
2620763|NCT00923091|9060845|P9|Period III (Single-Blind)|Withdrawal by Subject|0
2620764|NCT00923091|9060846|P8|Period III (Single-Blind)|Withdrawal by Subject|0
2620765|NCT00923091|9060847|P7|Period III (Single-Blind)|Withdrawal by Subject|0
2620766|NCT00923091|9060848|P6|Period III (Single-Blind)|Withdrawal by Subject|0
2620767|NCT00923091|9060849|P5|Period III (Single-Blind)|Withdrawal by Subject|0
2620768|NCT00923091|9060850|P4|Period III (Single-Blind)|Withdrawal by Subject|0
2620769|NCT00923091|9060851|P3|Period III (Single-Blind)|Withdrawal by Subject|0
2620770|NCT00923091|9060852|P2|Period III (Single-Blind)|Withdrawal by Subject|0
2620771|NCT00923091|9060853|P1|Period III (Single-Blind)|Withdrawal by Subject|10
2620772|NCT00923091|9060841|P13|Period III (Single-Blind)|Adverse Event|0
2620773|NCT00923091|9060842|P12|Period III (Single-Blind)|Adverse Event|0
2620774|NCT00923091|9060843|P11|Period III (Single-Blind)|Adverse Event|0
2620775|NCT00923091|9060844|P10|Period III (Single-Blind)|Adverse Event|0
2620776|NCT00923091|9060845|P9|Period III (Single-Blind)|Adverse Event|0
2620777|NCT00923091|9060846|P8|Period III (Single-Blind)|Adverse Event|0
2620778|NCT00923091|9060847|P7|Period III (Single-Blind)|Adverse Event|0
2620779|NCT00923091|9060848|P6|Period III (Single-Blind)|Adverse Event|0
2620780|NCT00923091|9060849|P5|Period III (Single-Blind)|Adverse Event|0
2620781|NCT00923091|9060850|P4|Period III (Single-Blind)|Adverse Event|0
2620782|NCT00923091|9060851|P3|Period III (Single-Blind)|Adverse Event|0
2620783|NCT00923091|9060852|P2|Period III (Single-Blind)|Adverse Event|0
2620784|NCT00923091|9060853|P1|Period III (Single-Blind)|Adverse Event|5
2620785|NCT00923091|9060841|P13|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
2620786|NCT00923091|9060842|P12|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
2620787|NCT00923091|9060843|P11|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
2620788|NCT00923091|9060844|P10|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
2620789|NCT00923091|9060845|P9|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
2620790|NCT00923091|9060846|P8|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
2620791|NCT00923091|9060847|P7|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
2620792|NCT00923091|9060848|P6|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
2620793|NCT00923091|9060849|P5|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
2620794|NCT00923091|9060850|P4|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
2620795|NCT00923091|9060851|P3|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
2620796|NCT00923091|9060852|P2|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
2620797|NCT00923091|9060853|P1|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
2620798|NCT00923091|9060841|P13|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
2620799|NCT00923091|9060842|P12|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
2620800|NCT00923091|9060843|P11|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
2620801|NCT00923091|9060844|P10|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
2620802|NCT00923091|9060845|P9|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
2620803|NCT00923091|9060846|P8|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
2620804|NCT00923091|9060847|P7|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
2620805|NCT00923091|9060848|P6|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1
2620806|NCT00923091|9060849|P5|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
2620807|NCT00923091|9060850|P4|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
2620808|NCT00923091|9060851|P3|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
2620809|NCT00923091|9060852|P2|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
2620810|NCT00923091|9060853|P1|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
2620811|NCT00923091|9060841|P13|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
2620812|NCT00923091|9060842|P12|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
2620813|NCT00923091|9060843|P11|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
2620814|NCT00923091|9060844|P10|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
2620815|NCT00923091|9060845|P9|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
2620816|NCT00923091|9060846|P8|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3
2620817|NCT00923091|9060847|P7|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
2620818|NCT00923091|9060848|P6|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2
2620819|NCT00923091|9060849|P5|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
2620820|NCT00923091|9060850|P4|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5
2620821|NCT00923091|9060851|P3|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
2620822|NCT00923091|9060852|P2|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
2620823|NCT00923091|9060853|P1|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
2620824|NCT00923091|9060841|P13|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
2620825|NCT00923091|9060842|P12|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
2620826|NCT00923091|9060843|P11|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
2620827|NCT00923091|9060844|P10|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
2620828|NCT00923091|9060845|P9|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
2620829|NCT00923091|9060846|P8|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
2620830|NCT00923091|9060847|P7|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
2620831|NCT00923091|9060848|P6|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
2620832|NCT00923091|9060849|P5|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7
2620833|NCT00923091|9060850|P4|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8
2620834|NCT00923091|9060851|P3|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
2620835|NCT00923091|9060852|P2|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
2620836|NCT00923091|9060853|P1|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4
2620837|NCT00923091|9060841|P13|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
2620838|NCT00923091|9060842|P12|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
2620839|NCT00923091|9060843|P11|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
2620840|NCT00923091|9060844|P10|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
2620841|NCT00923091|9060845|P9|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
2620842|NCT00923091|9060846|P8|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17
2620843|NCT00923091|9060847|P7|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9
2620844|NCT00923091|9060848|P6|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5
2620845|NCT00923091|9060849|P5|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10
2620846|NCT00923091|9060850|P4|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13
2620847|NCT00923091|9060851|P3|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7
2620848|NCT00923091|9060852|P2|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3
2620849|NCT00923091|9060853|P1|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11
2620850|NCT00923078|9060903|P3|First Intervention (Weeks 1-4)|No intervention per protocol|20
2620851|NCT00923078|9060904|P2|First Intervention (Weeks 1-4)|No intervention per protocol|0
2620852|NCT00923078|9060905|P1|First Intervention (Weeks 1-4)|No intervention per protocol|0
2620853|NCT00923078|9060903|P3|First Intervention (Weeks 1-4)|Withdrawal by Subject|0
2620854|NCT00923078|9060904|P2|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
2620855|NCT00923078|9060905|P1|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
2620856|NCT00922987|9060924|P1|Overall Study|Adverse Event|1
2620857|NCT00922987|9060924|P1|Overall Study|Protocol Violation|2
2620858|NCT00922987|9060924|P1|Overall Study|Insufficient clinical response|1
2620859|NCT00922974|9060939|P2|Phase III Component|Protocol Violation|6
2620860|NCT00922974|9060940|P1|Phase III Component|Protocol Violation|8
2620861|NCT00922974|9060939|P2|Phase II Component|Not evaluable for treatment review|0
2620862|NCT00922974|9060940|P1|Phase II Component|Not evaluable for treatment review|5
2620863|NCT00922974|9060939|P2|Phase II Component|Protocol Violation|0
2620864|NCT00922974|9060940|P1|Phase II Component|Protocol Violation|2
2620865|NCT00922935|9060955|P3|Overall Study|Lost to Follow-up|0
2620866|NCT00922935|9060956|P2|Overall Study|Lost to Follow-up|1
2620867|NCT00922935|9060957|P1|Overall Study|Lost to Follow-up|0
2620868|NCT00922935|9060955|P3|Overall Study|Physician Decision|0
2620869|NCT00922935|9060956|P2|Overall Study|Physician Decision|1
2620870|NCT00922935|9060957|P1|Overall Study|Physician Decision|1
2620871|NCT00922935|9060955|P3|Overall Study|Protocol Violation|0
2620872|NCT00922935|9060956|P2|Overall Study|Protocol Violation|3
2620873|NCT00922935|9060957|P1|Overall Study|Protocol Violation|0
2620874|NCT00922779|9060969|P1|Overall Study|Missing|1874
2620875|NCT00922779|9060969|P1|Overall Study|Other|27
2620876|NCT00922779|9060969|P1|Overall Study|Lost to Follow-up|44
2620877|NCT00922779|9060969|P1|Overall Study|Withdrawal by Subject|308
2620878|NCT00922779|9060969|P1|Overall Study|Pregnancy|7
2620879|NCT00922779|9060969|P1|Overall Study|Adverse Event|67
2620880|NCT00922766|9060976|P1|Overall Study|Adverse Event|1
2620881|NCT00922766|9060976|P1|Overall Study|Other|1
2620882|NCT00922766|9060976|P1|Overall Study|Withdrawal by Subject|2
2620883|NCT00922766|9060976|P1|Overall Study|Death|3
2620884|NCT00922636|9060994|P5|Overall Study|Lost to Follow-up|4
2620885|NCT00922636|9060995|P4|Overall Study|Lost to Follow-up|2
2620886|NCT00922636|9060996|P3|Overall Study|Lost to Follow-up|2
2620887|NCT00922636|9060997|P2|Overall Study|Lost to Follow-up|2
2620888|NCT00922636|9060998|P1|Overall Study|Lost to Follow-up|1
2620889|NCT00922636|9060994|P5|Overall Study|Parent/Caregiver Decision|2
2620890|NCT00922636|9060995|P4|Overall Study|Parent/Caregiver Decision|5
2620891|NCT00922636|9060996|P3|Overall Study|Parent/Caregiver Decision|3
2620892|NCT00922636|9060997|P2|Overall Study|Parent/Caregiver Decision|4
2620893|NCT00922636|9060998|P1|Overall Study|Parent/Caregiver Decision|2
2620894|NCT00922636|9060994|P5|Overall Study|Entry Criteria Not Met|0
2620895|NCT00922636|9060995|P4|Overall Study|Entry Criteria Not Met|1
2620896|NCT00922636|9060996|P3|Overall Study|Entry Criteria Not Met|1
2620897|NCT00922636|9060997|P2|Overall Study|Entry Criteria Not Met|0
2620898|NCT00922636|9060998|P1|Overall Study|Entry Criteria Not Met|0
2620899|NCT00922636|9060994|P5|Overall Study|Protocol Violation|0
2620900|NCT00922636|9060995|P4|Overall Study|Protocol Violation|2
2620901|NCT00922636|9060996|P3|Overall Study|Protocol Violation|2
2620902|NCT00922636|9060997|P2|Overall Study|Protocol Violation|0
2620903|NCT00922636|9060998|P1|Overall Study|Protocol Violation|0
2620904|NCT00922636|9060994|P5|Overall Study|Withdrawal by Subject|4
2620905|NCT00922636|9060995|P4|Overall Study|Withdrawal by Subject|2
2620906|NCT00922636|9060996|P3|Overall Study|Withdrawal by Subject|5
2620907|NCT00922636|9060997|P2|Overall Study|Withdrawal by Subject|0
2620908|NCT00922636|9060998|P1|Overall Study|Withdrawal by Subject|0
2620909|NCT00922636|9060994|P5|Overall Study|Sponsor Decision|0
2620910|NCT00922636|9060995|P4|Overall Study|Sponsor Decision|0
2620911|NCT00922636|9060996|P3|Overall Study|Sponsor Decision|2
2620912|NCT00922636|9060997|P2|Overall Study|Sponsor Decision|0
2620913|NCT00922636|9060998|P1|Overall Study|Sponsor Decision|0
2620914|NCT00922636|9060994|P5|Overall Study|Lack of Efficacy|4
2620915|NCT00922636|9060995|P4|Overall Study|Lack of Efficacy|2
2620916|NCT00922636|9060996|P3|Overall Study|Lack of Efficacy|3
2620917|NCT00922636|9060997|P2|Overall Study|Lack of Efficacy|7
2620918|NCT00922636|9060998|P1|Overall Study|Lack of Efficacy|1
2620919|NCT00922636|9060994|P5|Overall Study|Adverse Event|2
2620920|NCT00922636|9060995|P4|Overall Study|Adverse Event|3
2620921|NCT00922636|9060996|P3|Overall Study|Adverse Event|2
2620922|NCT00922636|9060997|P2|Overall Study|Adverse Event|3
2620923|NCT00922636|9060998|P1|Overall Study|Adverse Event|3
2620924|NCT00922623|9061145|P1|Overall Study|Lost to Follow-up|1
2620925|NCT00922623|9061145|P1|Overall Study|Other|4
2620926|NCT00922480|9061153|P2|Extension Study|Others|1
2620927|NCT00922480|9061154|P1|Extension Study|Others|0
2620928|NCT00922480|9061153|P2|Extension Study|Withdrawal by Subject|1
2620929|NCT00922480|9061154|P1|Extension Study|Withdrawal by Subject|1
2620930|NCT00922480|9061153|P2|Extension Study|Adverse Event|1
2620931|NCT00922480|9061154|P1|Extension Study|Adverse Event|1
2620932|NCT00922480|9061153|P2|Extension Study|Protocol Violation|0
2620933|NCT00922480|9061154|P1|Extension Study|Protocol Violation|3
2620934|NCT00922480|9061153|P2|Main Study|Physician Decision|1
2620935|NCT00922480|9061154|P1|Main Study|Physician Decision|0
2620936|NCT00922480|9061153|P2|Main Study|Lost to Follow-up|0
2620937|NCT00922480|9061154|P1|Main Study|Lost to Follow-up|5
2620938|NCT00922480|9061153|P2|Main Study|Withdrawal by Subject|15
2620939|NCT00922480|9061154|P1|Main Study|Withdrawal by Subject|20
2620940|NCT00922480|9061153|P2|Main Study|Lack of Efficacy|0
2620941|NCT00922480|9061154|P1|Main Study|Lack of Efficacy|3
2620942|NCT00922480|9061153|P2|Main Study|Adverse Event|7
2620943|NCT00922480|9061154|P1|Main Study|Adverse Event|6
2620944|NCT00922480|9061153|P2|Main Study|Protocol Violation|6
2620945|NCT00922480|9061154|P1|Main Study|Protocol Violation|3
2620946|NCT00922441|9061165|P3|Overall Study|Withdrawal by Subject|1
2620947|NCT00922441|9061166|P2|Overall Study|Withdrawal by Subject|0
2620948|NCT00922441|9061167|P1|Overall Study|Withdrawal by Subject|0
2620949|NCT00922441|9061165|P3|Overall Study|Protocol Violation|2
2620950|NCT00922441|9061166|P2|Overall Study|Protocol Violation|0
2620951|NCT00922441|9061167|P1|Overall Study|Protocol Violation|0
2620952|NCT00922428|9061175|P1|Overall Study|no medication use or questionable use|13
2620953|NCT00922428|9061175|P1|Overall Study|retrospective/extremely implausible data|2
2620954|NCT00922272|9061204|P2|Double-blind Phase|Positive urine drug screen|1
2620955|NCT00922272|9061205|P1|Double-blind Phase|Positive urine drug screen|1
2620956|NCT00922272|9061204|P2|Double-blind Phase|Noncompliance|1
2620957|NCT00922272|9061205|P1|Double-blind Phase|Noncompliance|1
2620958|NCT00922272|9061204|P2|Double-blind Phase|Withdrawal criteria met|1
2620959|NCT00922272|9061205|P1|Double-blind Phase|Withdrawal criteria met|1
2620960|NCT00922272|9061204|P2|Double-blind Phase|Lost to Follow-up|1
2620961|NCT00922272|9061205|P1|Double-blind Phase|Lost to Follow-up|2
2620962|NCT00922272|9061204|P2|Double-blind Phase|Withdrawal by Subject|1
2620963|NCT00922272|9061205|P1|Double-blind Phase|Withdrawal by Subject|1
2620964|NCT00922272|9061204|P2|Double-blind Phase|Adverse Event|1
2620965|NCT00922272|9061205|P1|Double-blind Phase|Adverse Event|1
2620966|NCT00922272|9061204|P2|Open-label Phase|Withdrawal criteria met|0
2620967|NCT00922272|9061205|P1|Open-label Phase|Withdrawal criteria met|5
2620968|NCT00922272|9061204|P2|Open-label Phase|Failure to meet randomization criteria|0
2620969|NCT00922272|9061205|P1|Open-label Phase|Failure to meet randomization criteria|1
2620970|NCT00922272|9061204|P2|Open-label Phase|Withdrawal by Subject|0
2620971|NCT00922272|9061205|P1|Open-label Phase|Withdrawal by Subject|11
2620972|NCT00922272|9061204|P2|Open-label Phase|Protocol Violation|0
2620973|NCT00922272|9061205|P1|Open-label Phase|Protocol Violation|1
2620974|NCT00922272|9061204|P2|Open-label Phase|Adverse Event|0
2620975|NCT00922272|9061205|P1|Open-label Phase|Adverse Event|5
2620976|NCT00922207|9061270|P3|Overall Study|Abnormality of Laboratory Test|1
2620977|NCT00922207|9061271|P2|Overall Study|Abnormality of Laboratory Test|1
2620978|NCT00922207|9061272|P1|Overall Study|Abnormality of Laboratory Test|0
2620979|NCT00922207|9061270|P3|Overall Study|Withdrew Consent|2
2620980|NCT00922207|9061271|P2|Overall Study|Withdrew Consent|5
2620981|NCT00922207|9061272|P1|Overall Study|Withdrew Consent|2
2620982|NCT00922207|9061270|P3|Overall Study|Refused Treatment/Did Not Cooperate|0
2620983|NCT00922207|9061271|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
2620984|NCT00922207|9061272|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
2620985|NCT00922207|9061270|P3|Overall Study|Violation of Selection Criteria at Entry|0
2620986|NCT00922207|9061271|P2|Overall Study|Violation of Selection Criteria at Entry|1
2620987|NCT00922207|9061272|P1|Overall Study|Violation of Selection Criteria at Entry|0
2620988|NCT00922207|9061270|P3|Overall Study|Insufficient Therapeutic Response|1
2620989|NCT00922207|9061271|P2|Overall Study|Insufficient Therapeutic Response|0
2620990|NCT00922207|9061272|P1|Overall Study|Insufficient Therapeutic Response|0
2620991|NCT00922207|9061270|P3|Overall Study|Adverse Event/Intercurrent Illness|0
2620992|NCT00922207|9061271|P2|Overall Study|Adverse Event/Intercurrent Illness|0
2620993|NCT00922207|9061272|P1|Overall Study|Adverse Event/Intercurrent Illness|3
2620994|NCT00922116|9061308|P1|Overall Study|Other|5
2620995|NCT00922116|9061308|P1|Overall Study|Withdrawal by Subject|4
2620996|NCT00922116|9061308|P1|Overall Study|Lost to Follow-up|1
2620997|NCT00922116|9061308|P1|Overall Study|Death|1
2620998|NCT00922116|9061308|P1|Overall Study|Adverse Event|4
2620999|NCT00921557|9061370|P3|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
2621000|NCT00921557|9061371|P2|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
2621001|NCT00921557|9061372|P1|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2
2621002|NCT00921557|9061370|P3|Weeks 96-144 (Off Study Treatment)|Site closure|0
2621003|NCT00921557|9061371|P2|Weeks 96-144 (Off Study Treatment)|Site closure|0
2621004|NCT00921557|9061372|P1|Weeks 96-144 (Off Study Treatment)|Site closure|1
2621005|NCT00921557|9061370|P3|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1
2621006|NCT00921557|9061371|P2|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
2621007|NCT00921557|9061372|P1|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
2621008|NCT00921557|9061370|P3|Weeks 48-96 (on Study Treatment)|Site Closure|0
2621009|NCT00921557|9061371|P2|Weeks 48-96 (on Study Treatment)|Site Closure|1
2621010|NCT00921557|9061372|P1|Weeks 48-96 (on Study Treatment)|Site Closure|0
2621011|NCT00921557|9061370|P3|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
2621012|NCT00921557|9061371|P2|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
2621013|NCT00921557|9061372|P1|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2
2621014|NCT00921024|9061474|P2|Overall Study|Withdrawal by Subject|3
2621015|NCT00921024|9061475|P1|Overall Study|Withdrawal by Subject|0
2621016|NCT00921024|9061474|P2|Overall Study|Received concomittant therapy|0
2621017|NCT00921024|9061475|P1|Overall Study|Received concomittant therapy|2
2621018|NCT00921024|9061474|P2|Overall Study|Lost to Follow-up|0
2621019|NCT00921024|9061475|P1|Overall Study|Lost to Follow-up|2
2621020|NCT00920907|9061485|P2|Maintenance Period|Adverse Event|1
2621021|NCT00920907|9061486|P1|Maintenance Period|Adverse Event|0
2621022|NCT00920907|9061485|P2|Maintenance Period|Withdrawal by Subject|0
2621023|NCT00920907|9061486|P1|Maintenance Period|Withdrawal by Subject|1
2621024|NCT00920907|9061485|P2|Maintenance Period|Death|1
2621025|NCT00920907|9061486|P1|Maintenance Period|Death|1
2621026|NCT00920907|9061485|P2|Maintenance Period|Study Drug Toxicity|2
2621027|NCT00920907|9061486|P1|Maintenance Period|Study Drug Toxicity|0
2621028|NCT00920907|9061485|P2|Maintenance Period|Administrative (study closure)|2
2621029|NCT00920907|9061486|P1|Maintenance Period|Administrative (study closure)|7
2621030|NCT00920907|9061485|P2|Maintenance Period|Disease Progression|7
2621031|NCT00920907|9061486|P1|Maintenance Period|Disease Progression|3
2621032|NCT00920907|9061485|P2|Induction Period|Withdrawal by Subject|1
2621033|NCT00920907|9061486|P1|Induction Period|Withdrawal by Subject|1
2621034|NCT00920907|9061485|P2|Induction Period|No longer meets study criteria|1
2621035|NCT00920907|9061486|P1|Induction Period|No longer meets study criteria|0
2621036|NCT00920907|9061485|P2|Induction Period|Study Drug Toxicity|6
2621037|NCT00920907|9061486|P1|Induction Period|Study Drug Toxicity|8
2621038|NCT00920907|9061485|P2|Induction Period|Disease Progression|11
2621039|NCT00920907|9061486|P1|Induction Period|Disease Progression|12
2621040|NCT00920907|9061485|P2|Induction Period|Death|1
2621041|NCT00920907|9061486|P1|Induction Period|Death|1
2621042|NCT00920907|9061485|P2|Induction Period|Adverse Event|2
2621043|NCT00920907|9061486|P1|Induction Period|Adverse Event|0
2621044|NCT00920855|9061527|P3|Overall Study|Response plateau; started maintenance|1
2621045|NCT00920855|9061528|P2|Overall Study|Response plateau; started maintenance|0
2621046|NCT00920855|9061529|P1|Overall Study|Response plateau; started maintenance|0
2621047|NCT00920855|9061527|P3|Overall Study|Noncompliance to study medication|1
2621048|NCT00920855|9061528|P2|Overall Study|Noncompliance to study medication|0
2621049|NCT00920855|9061529|P1|Overall Study|Noncompliance to study medication|0
2621050|NCT00920855|9061527|P3|Overall Study|Disease progression|10
2621051|NCT00920855|9061528|P2|Overall Study|Disease progression|1
2621052|NCT00920855|9061529|P1|Overall Study|Disease progression|2
2621053|NCT00920855|9061527|P3|Overall Study|Withdrawal by Subject|6
2621054|NCT00920855|9061528|P2|Overall Study|Withdrawal by Subject|1
2621055|NCT00920855|9061529|P1|Overall Study|Withdrawal by Subject|2
2621056|NCT00920855|9061527|P3|Overall Study|Adverse Event|4
2621057|NCT00920855|9061528|P2|Overall Study|Adverse Event|1
2621058|NCT00920855|9061529|P1|Overall Study|Adverse Event|1
2621059|NCT00920829|9061555|P4|Available for Analysis|Required more treatment|1
2621060|NCT00920829|9061556|P3|Available for Analysis|Required more treatment|0
2621061|NCT00920829|9061557|P2|Available for Analysis|Required more treatment|2
2621062|NCT00920829|9061558|P1|Available for Analysis|Required more treatment|0
2621063|NCT00920829|9061555|P4|Available for Analysis|Protocol Violation|0
2621064|NCT00920829|9061556|P3|Available for Analysis|Protocol Violation|1
2621065|NCT00920829|9061557|P2|Available for Analysis|Protocol Violation|0
2621066|NCT00920829|9061558|P1|Available for Analysis|Protocol Violation|0
2621067|NCT00920829|9061555|P4|Available for Analysis|Death|0
2621068|NCT00920829|9061556|P3|Available for Analysis|Death|0
2621069|NCT00920829|9061557|P2|Available for Analysis|Death|0
2621070|NCT00920829|9061558|P1|Available for Analysis|Death|1
2621071|NCT00920829|9061555|P4|Available for Analysis|Adverse Event|0
2621072|NCT00920829|9061556|P3|Available for Analysis|Adverse Event|1
2621073|NCT00920829|9061557|P2|Available for Analysis|Adverse Event|2
2621074|NCT00920829|9061558|P1|Available for Analysis|Adverse Event|1
2621075|NCT00920829|9061555|P4|Available for Analysis|Required Medical Treatment|0
2621076|NCT00920829|9061556|P3|Available for Analysis|Required Medical Treatment|2
2621077|NCT00920829|9061557|P2|Available for Analysis|Required Medical Treatment|1
2621078|NCT00920829|9061558|P1|Available for Analysis|Required Medical Treatment|0
2621079|NCT00920829|9061555|P4|Available for Analysis|Withdrawal by Subject|10
2621080|NCT00920829|9061556|P3|Available for Analysis|Withdrawal by Subject|6
2621081|NCT00920829|9061557|P2|Available for Analysis|Withdrawal by Subject|6
2621082|NCT00920829|9061558|P1|Available for Analysis|Withdrawal by Subject|6
2621083|NCT00920829|9061555|P4|Allocation|No post randomization data|2
2621084|NCT00920829|9061556|P3|Allocation|No post randomization data|0
2621085|NCT00920829|9061557|P2|Allocation|No post randomization data|1
2621086|NCT00920829|9061558|P1|Allocation|No post randomization data|3
2621087|NCT00920816|9061572|P4|Overall Study|Ongoing|36
2621088|NCT00920816|9061573|P3|Overall Study|Ongoing|70
2621089|NCT00920816|9061574|P2|Overall Study|Ongoing|56
2621090|NCT00920816|9061575|P1|Overall Study|Ongoing|106
2621091|NCT00920816|9061572|P4|Overall Study|Withdrawal by Subject|1
2621092|NCT00920816|9061573|P3|Overall Study|Withdrawal by Subject|1
2621093|NCT00920816|9061574|P2|Overall Study|Withdrawal by Subject|2
2621094|NCT00920816|9061575|P1|Overall Study|Withdrawal by Subject|7
2621095|NCT00920816|9061572|P4|Overall Study|Objective progression or relapse|0
2621096|NCT00920816|9061573|P3|Overall Study|Objective progression or relapse|2
2621097|NCT00920816|9061574|P2|Overall Study|Objective progression or relapse|0
2621098|NCT00920816|9061575|P1|Overall Study|Objective progression or relapse|0
2621099|NCT00920816|9061572|P4|Overall Study|Lost to Follow-up|4
2621100|NCT00920816|9061573|P3|Overall Study|Lost to Follow-up|3
2621101|NCT00920816|9061574|P2|Overall Study|Lost to Follow-up|2
2621102|NCT00920816|9061575|P1|Overall Study|Lost to Follow-up|1
2621103|NCT00920816|9061572|P4|Overall Study|Adverse Event|0
2621104|NCT00920816|9061573|P3|Overall Study|Adverse Event|1
2621105|NCT00920816|9061574|P2|Overall Study|Adverse Event|0
2621106|NCT00920816|9061575|P1|Overall Study|Adverse Event|1
2621107|NCT00920816|9061572|P4|Overall Study|Death|28
2621108|NCT00920816|9061573|P3|Overall Study|Death|58
2621109|NCT00920816|9061574|P2|Overall Study|Death|36
2621110|NCT00920816|9061575|P1|Overall Study|Death|77
2621111|NCT00920790|9061613|P1|Overall Study|aggravation of general condition|14
2621112|NCT00920699|9061625|P3|Overall Study|Lost to Follow-up|2
2621113|NCT00920699|9061626|P2|Overall Study|Lost to Follow-up|0
2621114|NCT00920699|9061627|P1|Overall Study|Lost to Follow-up|0
2621115|NCT00920699|9061625|P3|Overall Study|no longer met eligibility|0
2621116|NCT00920699|9061626|P2|Overall Study|no longer met eligibility|1
2621117|NCT00920699|9061627|P1|Overall Study|no longer met eligibility|0
2621118|NCT00920699|9061625|P3|Overall Study|Withdrawal by Subject|2
2621119|NCT00920699|9061626|P2|Overall Study|Withdrawal by Subject|0
2621120|NCT00920699|9061627|P1|Overall Study|Withdrawal by Subject|2
2621121|NCT00920686|9061644|P3|Overall Study|Study drug dosing criteria not met|12
2621122|NCT00920686|9061645|P2|Overall Study|Study drug dosing criteria not met|19
2621123|NCT00920686|9061646|P1|Overall Study|Study drug dosing criteria not met|17
2621124|NCT00920686|9061644|P3|Overall Study|Lost to Follow-up|1
2621125|NCT00920686|9061645|P2|Overall Study|Lost to Follow-up|3
2621126|NCT00920686|9061646|P1|Overall Study|Lost to Follow-up|2
2621127|NCT00920621|9061725|P4|Overall Study|Blood sample not collected|0
2621128|NCT00920621|9061726|P3|Overall Study|Blood sample not collected|0
2621129|NCT00920621|9061727|P2|Overall Study|Blood sample not collected|14
2621130|NCT00920621|9061728|P1|Overall Study|Blood sample not collected|22
2621131|NCT00920621|9061725|P4|Overall Study|Fetal/neonatal deaths|14
2621132|NCT00920621|9061726|P3|Overall Study|Fetal/neonatal deaths|16
2621133|NCT00920621|9061727|P2|Overall Study|Fetal/neonatal deaths|14
2621134|NCT00920621|9061728|P1|Overall Study|Fetal/neonatal deaths|16
2621135|NCT00920621|9061725|P4|Overall Study|Lost to Follow-up|21
2621136|NCT00920621|9061726|P3|Overall Study|Lost to Follow-up|19
2621137|NCT00920621|9061727|P2|Overall Study|Lost to Follow-up|17
2621138|NCT00920621|9061728|P1|Overall Study|Lost to Follow-up|16
2621139|NCT00920556|9061758|P1|Overall Study|Withdrawal by Subject|1
2621140|NCT00920556|9061758|P1|Overall Study|Physician Decision|7
2621141|NCT00920556|9061758|P1|Overall Study|Adverse Event|16
2621142|NCT00920426|9061807|P4|ITZ111451|Adverse Event|0
2621143|NCT00920426|9061808|P3|ITZ111451|Adverse Event|0
2621144|NCT00920426|9061809|P2|ITZ111451|Adverse Event|0
2621145|NCT00920426|9061810|P1|ITZ111451|Adverse Event|1
2621146|NCT00920218|9061930|P4|Overall Study|Other|0
2621147|NCT00920218|9061931|P3|Overall Study|Other|1
2621148|NCT00920218|9061932|P2|Overall Study|Other|0
2621149|NCT00920218|9061933|P1|Overall Study|Other|0
2621150|NCT00920218|9061930|P4|Overall Study|Transplant failed/malignancy recurrence|3
2621151|NCT00920218|9061931|P3|Overall Study|Transplant failed/malignancy recurrence|2
2621152|NCT00920218|9061932|P2|Overall Study|Transplant failed/malignancy recurrence|1
2621153|NCT00920218|9061933|P1|Overall Study|Transplant failed/malignancy recurrence|0
2621154|NCT00920218|9061930|P4|Overall Study|Lost to Follow-up|3
2621155|NCT00920218|9061931|P3|Overall Study|Lost to Follow-up|0
2621156|NCT00920218|9061932|P2|Overall Study|Lost to Follow-up|1
2621157|NCT00920218|9061933|P1|Overall Study|Lost to Follow-up|0
2621158|NCT00920218|9061930|P4|Overall Study|Migrated/moved from study area|0
2621159|NCT00920218|9061931|P3|Overall Study|Migrated/moved from study area|1
2621160|NCT00920218|9061932|P2|Overall Study|Migrated/moved from study area|0
2621161|NCT00920218|9061933|P1|Overall Study|Migrated/moved from study area|0
2621162|NCT00920218|9061930|P4|Overall Study|Withdrawal by Subject|0
2621163|NCT00920218|9061931|P3|Overall Study|Withdrawal by Subject|2
2621164|NCT00920218|9061932|P2|Overall Study|Withdrawal by Subject|3
2621165|NCT00920218|9061933|P1|Overall Study|Withdrawal by Subject|0
2621166|NCT00920218|9061930|P4|Overall Study|Serious Adverse Event|1
2621167|NCT00920218|9061931|P3|Overall Study|Serious Adverse Event|2
2621168|NCT00920218|9061932|P2|Overall Study|Serious Adverse Event|0
2621169|NCT00920218|9061933|P1|Overall Study|Serious Adverse Event|2
2621170|NCT00920140|9062036|P5|Phase 2|Withdrawal by Subject|1
2621171|NCT00920140|9062037|P4|Phase 2|Withdrawal by Subject|2
2621172|NCT00920140|9062038|P3|Phase 2|Withdrawal by Subject|4
2621173|NCT00920140|9062039|P2|Phase 2|Withdrawal by Subject|0
2621174|NCT00920140|9062040|P1|Phase 2|Withdrawal by Subject|0
2621175|NCT00920140|9062036|P5|Phase 2|Physician Decision|2
2621176|NCT00920140|9062037|P4|Phase 2|Physician Decision|3
2621177|NCT00920140|9062038|P3|Phase 2|Physician Decision|3
2621178|NCT00920140|9062039|P2|Phase 2|Physician Decision|0
2621179|NCT00920140|9062040|P1|Phase 2|Physician Decision|0
2621180|NCT00920140|9062036|P5|Phase 2|Lost to Follow-up|0
2621181|NCT00920140|9062037|P4|Phase 2|Lost to Follow-up|1
2621182|NCT00920140|9062038|P3|Phase 2|Lost to Follow-up|0
2621183|NCT00920140|9062039|P2|Phase 2|Lost to Follow-up|0
2621184|NCT00920140|9062040|P1|Phase 2|Lost to Follow-up|0
2621185|NCT00920140|9062036|P5|Phase 2|Lack of Efficacy|5
2621186|NCT00920140|9062037|P4|Phase 2|Lack of Efficacy|14
2621187|NCT00920140|9062038|P3|Phase 2|Lack of Efficacy|29
2621188|NCT00920140|9062039|P2|Phase 2|Lack of Efficacy|0
2621189|NCT00920140|9062040|P1|Phase 2|Lack of Efficacy|0
2621190|NCT00920140|9062036|P5|Phase 2|Adverse Event|3
2621191|NCT00920140|9062037|P4|Phase 2|Adverse Event|2
2621192|NCT00920140|9062038|P3|Phase 2|Adverse Event|14
2621193|NCT00920140|9062039|P2|Phase 2|Adverse Event|0
2621194|NCT00920140|9062040|P1|Phase 2|Adverse Event|0
2621195|NCT00920140|9062036|P5|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
2621196|NCT00920140|9062037|P4|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
2621197|NCT00920140|9062038|P3|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
2621198|NCT00920140|9062039|P2|Phase 1 (Dose Escalation)|Withdrawal by Subject|2
2621199|NCT00920140|9062040|P1|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
2621200|NCT00920140|9062036|P5|Phase 1 (Dose Escalation)|Lack of Efficacy|0
2621201|NCT00920140|9062037|P4|Phase 1 (Dose Escalation)|Lack of Efficacy|0
2621202|NCT00920140|9062038|P3|Phase 1 (Dose Escalation)|Lack of Efficacy|0
2621203|NCT00920140|9062039|P2|Phase 1 (Dose Escalation)|Lack of Efficacy|4
2621204|NCT00920140|9062040|P1|Phase 1 (Dose Escalation)|Lack of Efficacy|2
2621205|NCT00920140|9062036|P5|Phase 1 (Dose Escalation)|Adverse Event|0
2621206|NCT00920140|9062037|P4|Phase 1 (Dose Escalation)|Adverse Event|0
2621207|NCT00920140|9062038|P3|Phase 1 (Dose Escalation)|Adverse Event|0
2621208|NCT00920140|9062039|P2|Phase 1 (Dose Escalation)|Adverse Event|3
2621209|NCT00920140|9062040|P1|Phase 1 (Dose Escalation)|Adverse Event|3
2621210|NCT00919893|9062102|P2|Overall Study|Protocol Violation|9
2621211|NCT00919893|9062103|P1|Overall Study|Protocol Violation|19
2621212|NCT00919867|9062115|P6|First Intervention|Physician Decision|1
2621213|NCT00919867|9062116|P5|First Intervention|Physician Decision|0
2621214|NCT00919867|9062117|P4|First Intervention|Physician Decision|0
2621215|NCT00919867|9062118|P3|First Intervention|Physician Decision|0
2621216|NCT00919867|9062119|P2|First Intervention|Physician Decision|0
2621217|NCT00919867|9062120|P1|First Intervention|Physician Decision|0
2621218|NCT00919867|9062115|P6|First Intervention|Withdrawal by Subject|0
2621219|NCT00919867|9062116|P5|First Intervention|Withdrawal by Subject|0
2621220|NCT00919867|9062117|P4|First Intervention|Withdrawal by Subject|0
2621221|NCT00919867|9062118|P3|First Intervention|Withdrawal by Subject|1
2621222|NCT00919867|9062119|P2|First Intervention|Withdrawal by Subject|0
2621223|NCT00919867|9062120|P1|First Intervention|Withdrawal by Subject|0
2621224|NCT00919854|9062141|P1|Overall Study|Adverse Event|1
2621225|NCT00919711|9062179|P2|Overall Study|Noncompliance|0
2621226|NCT00919711|9062180|P1|Overall Study|Noncompliance|1
2621227|NCT00919711|9062179|P2|Overall Study|Death|0
2621228|NCT00919711|9062180|P1|Overall Study|Death|1
2621229|NCT00919711|9062179|P2|Overall Study|Lost to Follow-up|0
2621230|NCT00919711|9062180|P1|Overall Study|Lost to Follow-up|2
2621231|NCT00919711|9062179|P2|Overall Study|Administrative Decision|1
2621232|NCT00919711|9062180|P1|Overall Study|Administrative Decision|0
2621233|NCT00919711|9062179|P2|Overall Study|Other|2
2621234|NCT00919711|9062180|P1|Overall Study|Other|1
2621235|NCT00919711|9062179|P2|Overall Study|Adverse Event|3
2621236|NCT00919711|9062180|P1|Overall Study|Adverse Event|13
2621237|NCT00919711|9062179|P2|Overall Study|Withdrawal by Subject|7
2621238|NCT00919711|9062180|P1|Overall Study|Withdrawal by Subject|15
2621239|NCT00919633|9062196|P4|Overall Study|Viral rebound outside protocol timepoint|0
2621240|NCT00919633|9062197|P3|Overall Study|Viral rebound outside protocol timepoint|1
2621241|NCT00919633|9062198|P2|Overall Study|Viral rebound outside protocol timepoint|0
2621242|NCT00919633|9062199|P1|Overall Study|Viral rebound outside protocol timepoint|0
2621243|NCT00919633|9062196|P4|Overall Study|Request of withdrawal w/o future contact|0
2621244|NCT00919633|9062197|P3|Overall Study|Request of withdrawal w/o future contact|1
2621245|NCT00919633|9062198|P2|Overall Study|Request of withdrawal w/o future contact|0
2621246|NCT00919633|9062199|P1|Overall Study|Request of withdrawal w/o future contact|0
2621247|NCT00919633|9062196|P4|Overall Study|Physician Decision|1
2621248|NCT00919633|9062197|P3|Overall Study|Physician Decision|0
2621249|NCT00919633|9062198|P2|Overall Study|Physician Decision|0
2621250|NCT00919633|9062199|P1|Overall Study|Physician Decision|0
2621251|NCT00919633|9062196|P4|Overall Study|Protocol Violation|1
2621252|NCT00919633|9062197|P3|Overall Study|Protocol Violation|0
2621253|NCT00919633|9062198|P2|Overall Study|Protocol Violation|0
2621254|NCT00919633|9062199|P1|Overall Study|Protocol Violation|0
2621255|NCT00919633|9062196|P4|Overall Study|Withdraw consent post transition to SOC|1
2621256|NCT00919633|9062197|P3|Overall Study|Withdraw consent post transition to SOC|1
2621257|NCT00919633|9062198|P2|Overall Study|Withdraw consent post transition to SOC|0
2621258|NCT00919633|9062199|P1|Overall Study|Withdraw consent post transition to SOC|0
2621259|NCT00919633|9062196|P4|Overall Study|Lost to Follow-up|2
2621260|NCT00919633|9062197|P3|Overall Study|Lost to Follow-up|0
2621261|NCT00919633|9062198|P2|Overall Study|Lost to Follow-up|1
2621262|NCT00919633|9062199|P1|Overall Study|Lost to Follow-up|3
2621263|NCT00919633|9062196|P4|Overall Study|Withdrawal by Subject|3
2621264|NCT00919633|9062197|P3|Overall Study|Withdrawal by Subject|4
2621265|NCT00919633|9062198|P2|Overall Study|Withdrawal by Subject|2
2621266|NCT00919633|9062199|P1|Overall Study|Withdrawal by Subject|1
2621267|NCT00919633|9062196|P4|Overall Study|Lack of Efficacy|3
2621268|NCT00919633|9062197|P3|Overall Study|Lack of Efficacy|2
2621269|NCT00919633|9062198|P2|Overall Study|Lack of Efficacy|3
2621270|NCT00919633|9062199|P1|Overall Study|Lack of Efficacy|17
2621271|NCT00919633|9062196|P4|Overall Study|Death|0
2621272|NCT00919633|9062197|P3|Overall Study|Death|2
2621273|NCT00919633|9062198|P2|Overall Study|Death|0
2621274|NCT00919633|9062199|P1|Overall Study|Death|0
2621275|NCT00919633|9062196|P4|Overall Study|Adverse Event|10
2621276|NCT00919633|9062197|P3|Overall Study|Adverse Event|12
2621277|NCT00919633|9062198|P2|Overall Study|Adverse Event|9
2621278|NCT00919633|9062199|P1|Overall Study|Adverse Event|1
2621279|NCT00919061|9062297|P1|Overall Study|Withdrawal by Subject|1
2621280|NCT00919061|9062297|P1|Overall Study|Adverse Event|1
2621281|NCT00918957|9062310|P2|Overall Study|Withdrawal by Subject|0
2621282|NCT00918957|9062311|P1|Overall Study|Withdrawal by Subject|1
2621283|NCT00918957|9062310|P2|Overall Study|Adverse Event|0
2621284|NCT00918957|9062311|P1|Overall Study|Adverse Event|2
2621285|NCT00918879|9062344|P2|Overall Study|Severe non-compliance to protocol|1
2621286|NCT00918879|9062345|P1|Overall Study|Severe non-compliance to protocol|1
2621287|NCT00918879|9062344|P2|Overall Study|Lost to Follow-up|1
2621288|NCT00918879|9062345|P1|Overall Study|Lost to Follow-up|1
2621289|NCT00918879|9062344|P2|Overall Study|Withdrawal by Subject|4
2621290|NCT00918879|9062345|P1|Overall Study|Withdrawal by Subject|4
2621291|NCT00918749|9062377|P3|Overall Study|No Study Medication Taken|0
2621292|NCT00918749|9062378|P2|Overall Study|No Study Medication Taken|0
2621293|NCT00918749|9062379|P1|Overall Study|No Study Medication Taken|1
2621294|NCT00918749|9062377|P3|Overall Study|Withdrawal by Subject|5
2621295|NCT00918749|9062378|P2|Overall Study|Withdrawal by Subject|3
2621296|NCT00918749|9062379|P1|Overall Study|Withdrawal by Subject|5
2621297|NCT00918749|9062377|P3|Overall Study|Lost to Follow-up|1
2621298|NCT00918749|9062378|P2|Overall Study|Lost to Follow-up|0
2621299|NCT00918749|9062379|P1|Overall Study|Lost to Follow-up|0
2621300|NCT00918749|9062377|P3|Overall Study|Adverse Event|1
2621301|NCT00918749|9062378|P2|Overall Study|Adverse Event|0
2621302|NCT00918749|9062379|P1|Overall Study|Adverse Event|1
2621303|NCT00918736|9062411|P1|Overall Study|Withdrawal by Subject|4
2621304|NCT00918684|9062424|P1|Treatment Phase|Withdrawal by Subject|8
2621305|NCT00918684|9062424|P1|Treatment Phase|Protocol Violation|1
2621306|NCT00918684|9062424|P1|Treatment Phase|Physician Decision|8
2621307|NCT00918684|9062424|P1|Treatment Phase|Lost to Follow-up|2
2621308|NCT00918684|9062424|P1|Treatment Phase|Lack of Efficacy|6
2621309|NCT00918684|9062424|P1|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16
2621310|NCT00918645|9062435|P1|Overall Study|Withdrawal by Subject|1
2621311|NCT00918580|9062441|P1|After 6-month FU to 1-year FU|Failed to Return|2
2621312|NCT00918580|9062441|P1|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58
2621313|NCT00918580|9062441|P1|Up to 6-month Follow-up(FU)|Failed to Return|1
2621314|NCT00918580|9062441|P1|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2
2621315|NCT00918580|9062441|P1|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2
2621316|NCT00918580|9062441|P1|Up to 6-month Follow-up(FU)|Lost to Follow-up|5
2621317|NCT00918580|9062441|P1|Up to 6-month Follow-up(FU)|Adverse Event|1
2621318|NCT00918567|9062461|P2|Overall Study|Adverse Event|0
2621319|NCT00918567|9062462|P1|Overall Study|Adverse Event|1
2621320|NCT00918567|9062461|P2|Overall Study|Withdrawal by Subject|1
2621321|NCT00918567|9062462|P1|Overall Study|Withdrawal by Subject|1
2621322|NCT00918567|9062461|P2|Overall Study|Lack of Efficacy|1
2621323|NCT00918567|9062462|P1|Overall Study|Lack of Efficacy|3
2621324|NCT00918463|9062488|P1|Overall Study|Lack of Efficacy|1
2621325|NCT00918463|9062488|P1|Overall Study|Death|1
2621326|NCT00918385|9062496|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7
2621327|NCT00918385|9062497|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
2621328|NCT00918385|9062496|P2|Combination Nilutamide and Dasatinib|Complicating illness|0
2621329|NCT00918385|9062497|P1|Combination Nilutamide and Dasatinib|Complicating illness|1
2621330|NCT00918385|9062496|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0
2621331|NCT00918385|9062497|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
2621332|NCT00918385|9062496|P2|Combination Nilutamide and Dasatinib|Adverse Event|1
2621333|NCT00918385|9062497|P1|Combination Nilutamide and Dasatinib|Adverse Event|1
2621334|NCT00918385|9062496|P2|Monotherapy|Complicating illness|0
2621335|NCT00918385|9062497|P1|Monotherapy|Complicating illness|1
2621336|NCT00918385|9062496|P2|Monotherapy|Adverse Event|6
2621337|NCT00918385|9062497|P1|Monotherapy|Adverse Event|1
2621338|NCT00918346|9062506|P2|First Treatment Period (4 Weeks)|Lack of Efficacy|1
2621339|NCT00918346|9062507|P1|First Treatment Period (4 Weeks)|Lack of Efficacy|0
2621340|NCT00918333|9062523|P2|Overall Study|Withdrawal by Subject|1
2621341|NCT00918333|9062524|P1|Overall Study|Withdrawal by Subject|0
2621342|NCT00918333|9062523|P2|Overall Study|Ineligible|0
2621343|NCT00918333|9062524|P1|Overall Study|Ineligible|1
2621344|NCT00918333|9062523|P2|Overall Study|Inadequate amount of drugs provided|4
2621345|NCT00918333|9062524|P1|Overall Study|Inadequate amount of drugs provided|1
2621346|NCT00918333|9062523|P2|Overall Study|Drug not taken per protocol|0
2621347|NCT00918333|9062524|P1|Overall Study|Drug not taken per protocol|1
2621348|NCT00918281|9062544|P1|Overall Study|Physician Decision|29
2621349|NCT00918255|9062554|P3|Overall Study|Investigator discretion|0
2621350|NCT00918255|9062555|P2|Overall Study|Investigator discretion|0
2621351|NCT00918255|9062556|P1|Overall Study|Investigator discretion|1
2621352|NCT00918255|9062554|P3|Overall Study|Non-compliance|0
2621353|NCT00918255|9062555|P2|Overall Study|Non-compliance|0
2621354|NCT00918255|9062556|P1|Overall Study|Non-compliance|1
2621355|NCT00918255|9062554|P3|Overall Study|Exceeded allowed number of interventions|1
2621356|NCT00918255|9062555|P2|Overall Study|Exceeded allowed number of interventions|0
2621357|NCT00918255|9062556|P1|Overall Study|Exceeded allowed number of interventions|0
2621358|NCT00918255|9062554|P3|Overall Study|Lost to Follow-up|2
2621359|NCT00918255|9062555|P2|Overall Study|Lost to Follow-up|0
2621360|NCT00918255|9062556|P1|Overall Study|Lost to Follow-up|1
2621361|NCT00918255|9062554|P3|Overall Study|Lack of Efficacy|0
2621362|NCT00918255|9062555|P2|Overall Study|Lack of Efficacy|0
2621363|NCT00918255|9062556|P1|Overall Study|Lack of Efficacy|1
2621364|NCT00918255|9062554|P3|Overall Study|Withdrawal by Subject|2
2621365|NCT00918255|9062555|P2|Overall Study|Withdrawal by Subject|0
2621366|NCT00918255|9062556|P1|Overall Study|Withdrawal by Subject|1
2621367|NCT00918255|9062554|P3|Overall Study|Adverse Event|0
2621368|NCT00918255|9062555|P2|Overall Study|Adverse Event|0
2621369|NCT00918255|9062556|P1|Overall Study|Adverse Event|1
2621370|NCT00918203|9062589|P3|Treatment With or Without Olaratumab|Never Treated/Death|0
2621371|NCT00918203|9062590|P2|Treatment With or Without Olaratumab|Never Treated/Death|0
2621372|NCT00918203|9062591|P1|Treatment With or Without Olaratumab|Never Treated/Death|1
2621373|NCT00918203|9062589|P3|Treatment With or Without Olaratumab|Other Therapy Started|0
2621374|NCT00918203|9062590|P2|Treatment With or Without Olaratumab|Other Therapy Started|1
2621375|NCT00918203|9062591|P1|Treatment With or Without Olaratumab|Other Therapy Started|2
2621376|NCT00918203|9062589|P3|Treatment With or Without Olaratumab|Withdrawal by Subject|0
2621377|NCT00918203|9062590|P2|Treatment With or Without Olaratumab|Withdrawal by Subject|8
2621378|NCT00918203|9062591|P1|Treatment With or Without Olaratumab|Withdrawal by Subject|2
2621379|NCT00918203|9062589|P3|Treatment With or Without Olaratumab|Lost to Follow-up|0
2621380|NCT00918203|9062590|P2|Treatment With or Without Olaratumab|Lost to Follow-up|1
2621381|NCT00918203|9062591|P1|Treatment With or Without Olaratumab|Lost to Follow-up|1
2621382|NCT00918138|9062622|P2|Overall Study|Death|0
2621383|NCT00918138|9062623|P1|Overall Study|Death|1
2621384|NCT00918138|9062622|P2|Overall Study|Subject withdrew consent|1
2621385|NCT00918138|9062623|P1|Overall Study|Subject withdrew consent|1
2621386|NCT00917852|9062662|P1|Overall Study|Death|6
2621387|NCT00917644|9062680|P2|Period 2: Second Intervention|family emergency|0
2621388|NCT00917644|9062681|P1|Period 2: Second Intervention|family emergency|1
2621389|NCT00917644|9062680|P2|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0
2621390|NCT00917644|9062681|P1|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1
2621391|NCT00917644|9062680|P2|Period: Washout Period of > = 2 Weeks|Protocol Violation|0
2621392|NCT00917644|9062681|P1|Period: Washout Period of > = 2 Weeks|Protocol Violation|1
2621393|NCT00917579|9062695|P2|Washout >= 2 Weeks|Withdrawal by Subject|0
2621394|NCT00917579|9062696|P1|Washout >= 2 Weeks|Withdrawal by Subject|1
2621395|NCT00917579|9062695|P2|Washout >= 2 Weeks|Adverse Event|0
2621396|NCT00917579|9062696|P1|Washout >= 2 Weeks|Adverse Event|1
2621397|NCT00917553|9062712|P2|Overall Study|Lost to Follow-up|1
2621398|NCT00917553|9062713|P1|Overall Study|Lost to Follow-up|2
2621399|NCT00917501|9062729|P2|Overall Study|trouble swollowing capsules|1
2621400|NCT00917501|9062730|P1|Overall Study|trouble swollowing capsules|0
2621401|NCT00917501|9062729|P2|Overall Study|Lack of Efficacy|2
2621402|NCT00917501|9062730|P1|Overall Study|Lack of Efficacy|1
2621403|NCT00917501|9062729|P2|Overall Study|Withdrawal by Subject|1
2621404|NCT00917501|9062730|P1|Overall Study|Withdrawal by Subject|3
2621405|NCT00917501|9062729|P2|Overall Study|Lost to Follow-up|1
2621406|NCT00917501|9062730|P1|Overall Study|Lost to Follow-up|4
2621407|NCT00917462|9062736|P1|Overall Study|Clinical Deterioration|1
2621408|NCT00917384|9062746|P2|Overall Study|Withdrawal by Subject|2
2621409|NCT00917384|9062747|P1|Overall Study|Withdrawal by Subject|10
2621410|NCT00917384|9062746|P2|Overall Study|Lost to Follow-up|2
2621411|NCT00917384|9062747|P1|Overall Study|Lost to Follow-up|4
2621412|NCT00917267|9062771|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
2621413|NCT00917267|9062772|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
2621414|NCT00917267|9062771|P2|Overall Study|Sponsor Decision|5
2621415|NCT00917267|9062772|P1|Overall Study|Sponsor Decision|5
2621416|NCT00917267|9062771|P2|Overall Study|Entry Criteria Not Met|0
2621417|NCT00917267|9062772|P1|Overall Study|Entry Criteria Not Met|1
2621418|NCT00917267|9062771|P2|Overall Study|Lost to follow up|2
2621419|NCT00917267|9062772|P1|Overall Study|Lost to follow up|0
2621420|NCT00917267|9062771|P2|Overall Study|Withdrawal by Subject|12
2621421|NCT00917267|9062772|P1|Overall Study|Withdrawal by Subject|5
2621422|NCT00917267|9062771|P2|Overall Study|Protocol Violation|18
2621423|NCT00917267|9062772|P1|Overall Study|Protocol Violation|9
2621424|NCT00917267|9062771|P2|Overall Study|Physician Decision|4
2621425|NCT00917267|9062772|P1|Overall Study|Physician Decision|2
2621426|NCT00917267|9062771|P2|Overall Study|Adverse Event|36
2621427|NCT00917267|9062772|P1|Overall Study|Adverse Event|15
2621428|NCT00917124|9062800|P2|Overall Study|Protocol Violation|6
2621429|NCT00917124|9062801|P1|Overall Study|Protocol Violation|4
2621430|NCT00916929|9062811|P2|Overall Study|Device unable to process impedance data|7
2621431|NCT00916929|9062812|P1|Overall Study|Device unable to process impedance data|0
2621432|NCT00916929|9062811|P2|Overall Study|Moved to another state|1
2621433|NCT00916929|9062812|P1|Overall Study|Moved to another state|0
2621434|NCT00916929|9062811|P2|Overall Study|System explant|0
2621435|NCT00916929|9062812|P1|Overall Study|System explant|1
2621436|NCT00916929|9062811|P2|Overall Study|Transferred to hospice care|1
2621437|NCT00916929|9062812|P1|Overall Study|Transferred to hospice care|1
2621438|NCT00916929|9062811|P2|Overall Study|Left ventricular epicardial lead|2
2621439|NCT00916929|9062812|P1|Overall Study|Left ventricular epicardial lead|1
2621440|NCT00916929|9062811|P2|Overall Study|Withdrawal by Subject|5
2621441|NCT00916929|9062812|P1|Overall Study|Withdrawal by Subject|1
2621442|NCT00916929|9062811|P2|Overall Study|Death|10
2621443|NCT00916929|9062812|P1|Overall Study|Death|5
2621444|NCT00916929|9062811|P2|Overall Study|Lost to Follow-up|3
2621445|NCT00916929|9062812|P1|Overall Study|Lost to Follow-up|1
2621446|NCT00916721|9062822|P2|Overall Study|Protocol Violation|4
2621447|NCT00916721|9062823|P1|Overall Study|Protocol Violation|2
2621448|NCT00916721|9062822|P2|Overall Study|Withdrawal by Subject|2
2621449|NCT00916721|9062823|P1|Overall Study|Withdrawal by Subject|2
2621450|NCT00916721|9062822|P2|Overall Study|Adverse Event|3
2621451|NCT00916721|9062823|P1|Overall Study|Adverse Event|6
2621452|NCT00916721|9062822|P2|Overall Study|Lost to Follow-up|1
2621453|NCT00916721|9062823|P1|Overall Study|Lost to Follow-up|0
2621454|NCT00916617|9062846|P4|Overall Study|Other|2
2621455|NCT00916617|9062847|P3|Overall Study|Other|0
2621456|NCT00916617|9062848|P2|Overall Study|Other|0
2621457|NCT00916617|9062849|P1|Overall Study|Other|2
2621458|NCT00916617|9062846|P4|Overall Study|Lack of Efficacy|0
2621459|NCT00916617|9062847|P3|Overall Study|Lack of Efficacy|0
2621460|NCT00916617|9062848|P2|Overall Study|Lack of Efficacy|0
2621461|NCT00916617|9062849|P1|Overall Study|Lack of Efficacy|1
2621462|NCT00916617|9062846|P4|Overall Study|Lost to Follow-up|0
2621463|NCT00916617|9062847|P3|Overall Study|Lost to Follow-up|0
2621464|NCT00916617|9062848|P2|Overall Study|Lost to Follow-up|1
2621465|NCT00916617|9062849|P1|Overall Study|Lost to Follow-up|2
2621466|NCT00916617|9062846|P4|Overall Study|Discontinuation of Study by Sponsor|1
2621467|NCT00916617|9062847|P3|Overall Study|Discontinuation of Study by Sponsor|3
2621468|NCT00916617|9062848|P2|Overall Study|Discontinuation of Study by Sponsor|13
2621469|NCT00916617|9062849|P1|Overall Study|Discontinuation of Study by Sponsor|8
2621470|NCT00916617|9062846|P4|Overall Study|Physician Decision|0
2621471|NCT00916617|9062847|P3|Overall Study|Physician Decision|0
2621472|NCT00916617|9062848|P2|Overall Study|Physician Decision|1
2621473|NCT00916617|9062849|P1|Overall Study|Physician Decision|1
2621474|NCT00916617|9062846|P4|Overall Study|Caregiver Request|0
2621475|NCT00916617|9062847|P3|Overall Study|Caregiver Request|1
2621476|NCT00916617|9062848|P2|Overall Study|Caregiver Request|2
2621477|NCT00916617|9062849|P1|Overall Study|Caregiver Request|3
2621478|NCT00916617|9062846|P4|Overall Study|Withdrawal by Subject|1
2621479|NCT00916617|9062847|P3|Overall Study|Withdrawal by Subject|0
2621480|NCT00916617|9062848|P2|Overall Study|Withdrawal by Subject|2
2621481|NCT00916617|9062849|P1|Overall Study|Withdrawal by Subject|3
2621482|NCT00916617|9062846|P4|Overall Study|Adverse Event|3
2621483|NCT00916617|9062847|P3|Overall Study|Adverse Event|6
2621484|NCT00916617|9062848|P2|Overall Study|Adverse Event|2
2621485|NCT00916617|9062849|P1|Overall Study|Adverse Event|3
2621486|NCT00916578|9062863|P1|Overall Study|Insurance Denial|2
2621487|NCT00916578|9062863|P1|Overall Study|Withdrawal by Subject|3
2621488|NCT00916578|9062863|P1|Overall Study|Physician Decision|2
2621489|NCT00916383|9062892|P1|Overall Study|Protocol Violation|1
2621490|NCT00916383|9062892|P1|Overall Study|Death|1
2621491|NCT00916383|9062892|P1|Overall Study|Adverse Event|1
2621492|NCT00916370|9062920|P2|Overall Study|Physician Decision|1
2621493|NCT00916370|9062921|P1|Overall Study|Physician Decision|0
2621494|NCT00916370|9062920|P2|Overall Study|Withdrawal by Subject|0
2621495|NCT00916370|9062921|P1|Overall Study|Withdrawal by Subject|2
2621496|NCT00916370|9062920|P2|Overall Study|Death|1
2621497|NCT00916370|9062921|P1|Overall Study|Death|3
2621498|NCT00916357|9063095|P6|Period 2|Weight loss > 3 kilograms (kg)|0
2621499|NCT00916357|9063096|P5|Period 2|Weight loss > 3 kilograms (kg)|0
2621500|NCT00916357|9063097|P4|Period 2|Weight loss > 3 kilograms (kg)|1
2621501|NCT00916357|9063098|P3|Period 2|Weight loss > 3 kilograms (kg)|0
2621502|NCT00916357|9063099|P2|Period 2|Weight loss > 3 kilograms (kg)|0
2621503|NCT00916357|9063100|P1|Period 2|Weight loss > 3 kilograms (kg)|0
2621504|NCT00916357|9063095|P6|Period 1|Withdrawal by Subject|0
2621505|NCT00916357|9063096|P5|Period 1|Withdrawal by Subject|0
2621506|NCT00916357|9063097|P4|Period 1|Withdrawal by Subject|0
2621507|NCT00916357|9063098|P3|Period 1|Withdrawal by Subject|0
2621508|NCT00916357|9063099|P2|Period 1|Withdrawal by Subject|0
2621509|NCT00916357|9063100|P1|Period 1|Withdrawal by Subject|1
2621510|NCT00916344|9063138|P1|Overall Study|Drop-out|5
2621511|NCT00916344|9063138|P1|Overall Study|ICD upgrade|1
2621512|NCT00916344|9063138|P1|Overall Study|Death|2
2621513|NCT00916305|9063145|P2|Overall Study|Withdrawal by Subject|1
2621514|NCT00916305|9063146|P1|Overall Study|Withdrawal by Subject|0
2621515|NCT00916305|9063145|P2|Overall Study|Lost to Follow-up|27
2621516|NCT00916305|9063146|P1|Overall Study|Lost to Follow-up|21
2621517|NCT00916279|9063154|P1|Overall Study|Lost to Follow-up|2
2621518|NCT00916279|9063154|P1|Overall Study|Death|2
2621519|NCT00916149|9063165|P3|Overall Study|Unable to place scalp EEG leads|0
2621520|NCT00916149|9063166|P2|Overall Study|Unable to place scalp EEG leads|0
2621521|NCT00916149|9063167|P1|Overall Study|Unable to place scalp EEG leads|1
2621522|NCT00916149|9063165|P3|Overall Study|Lost to Follow-up|0
2621523|NCT00916149|9063166|P2|Overall Study|Lost to Follow-up|2
2621524|NCT00916149|9063167|P1|Overall Study|Lost to Follow-up|3
2621525|NCT00916058|9063254|P7|Phase 2|Screen Failure|3
2621526|NCT00916058|9063255|P6|Phase 2|Screen Failure|0
2621527|NCT00916058|9063256|P5|Phase 2|Screen Failure|0
2621528|NCT00916058|9063257|P4|Phase 2|Screen Failure|0
2621529|NCT00916058|9063258|P3|Phase 2|Screen Failure|0
2621530|NCT00916058|9063259|P2|Phase 2|Screen Failure|0
2621531|NCT00916058|9063260|P1|Phase 2|Screen Failure|0
2621532|NCT00916058|9063254|P7|Phase 1|Screen Failure|0
2621533|NCT00916058|9063255|P6|Phase 1|Screen Failure|1
2621534|NCT00916058|9063256|P5|Phase 1|Screen Failure|0
2621535|NCT00916058|9063257|P4|Phase 1|Screen Failure|0
2621536|NCT00916058|9063258|P3|Phase 1|Screen Failure|0
2621537|NCT00916058|9063259|P2|Phase 1|Screen Failure|0
2621538|NCT00916058|9063260|P1|Phase 1|Screen Failure|0
2621539|NCT00916006|9063323|P2|Overall Study|Protocol Violation|1
2621540|NCT00916006|9063324|P1|Overall Study|Protocol Violation|0
2621541|NCT00916006|9063323|P2|Overall Study|Withdrawal by Subject|5
2621542|NCT00916006|9063324|P1|Overall Study|Withdrawal by Subject|2
2621543|NCT00916006|9063323|P2|Overall Study|Adverse Event|1
2621544|NCT00916006|9063324|P1|Overall Study|Adverse Event|1
2621545|NCT00915876|9063376|P2|Overall Study|Adverse Event|1
2621546|NCT00915876|9063377|P1|Overall Study|Adverse Event|0
2621547|NCT00915772|9063413|P3|Overall Study|Any other reason|7
2621548|NCT00915772|9063414|P2|Overall Study|Any other reason|7
2621549|NCT00915772|9063415|P1|Overall Study|Any other reason|4
2621550|NCT00915772|9063413|P3|Overall Study|Refused to continue trial medication|4
2621551|NCT00915772|9063414|P2|Overall Study|Refused to continue trial medication|8
2621552|NCT00915772|9063415|P1|Overall Study|Refused to continue trial medication|6
2621553|NCT00915772|9063413|P3|Overall Study|Lack of Efficacy|3
2621554|NCT00915772|9063414|P2|Overall Study|Lack of Efficacy|15
2621555|NCT00915772|9063415|P1|Overall Study|Lack of Efficacy|9
2621556|NCT00915772|9063413|P3|Overall Study|Lost to Follow-up|2
2621557|NCT00915772|9063414|P2|Overall Study|Lost to Follow-up|2
2621558|NCT00915772|9063415|P1|Overall Study|Lost to Follow-up|1
2621559|NCT00915772|9063413|P3|Overall Study|Protocol Violation|2
2621560|NCT00915772|9063414|P2|Overall Study|Protocol Violation|1
2621561|NCT00915772|9063415|P1|Overall Study|Protocol Violation|4
2621562|NCT00915772|9063413|P3|Overall Study|Adverse Event|11
2621563|NCT00915772|9063414|P2|Overall Study|Adverse Event|13
2621564|NCT00915772|9063415|P1|Overall Study|Adverse Event|12
2621565|NCT00915551|9063514|P2|Overall Study|Withdrawal by Subject|1
2621566|NCT00915551|9063515|P1|Overall Study|Withdrawal by Subject|0
2621567|NCT00915525|9063525|P2|Overall Study|Patient Moved|9
2621568|NCT00915525|9063526|P1|Overall Study|Patient Moved|15
2621569|NCT00915525|9063525|P2|Overall Study|Non-Compliance|1
2621570|NCT00915525|9063526|P1|Overall Study|Non-Compliance|3
2621571|NCT00915525|9063525|P2|Overall Study|Study Burden|12
2621572|NCT00915525|9063526|P1|Overall Study|Study Burden|28
2621573|NCT00915525|9063525|P2|Overall Study|Retreat Request >Wk 144 (exclusionary)|5
2621574|NCT00915525|9063526|P1|Overall Study|Retreat Request >Wk 144 (exclusionary)|4
2621575|NCT00915525|9063525|P2|Overall Study|Site Closed|9
2621576|NCT00915525|9063526|P1|Overall Study|Site Closed|27
2621577|NCT00915525|9063525|P2|Overall Study|Other Reason|12
2621578|NCT00915525|9063526|P1|Overall Study|Other Reason|35
2621579|NCT00915525|9063525|P2|Overall Study|Missing|1
2621580|NCT00915525|9063526|P1|Overall Study|Missing|12
2621581|NCT00915525|9063525|P2|Overall Study|Adverse Event|13
2621582|NCT00915525|9063526|P1|Overall Study|Adverse Event|29
2621583|NCT00915525|9063525|P2|Overall Study|Lack of Efficacy|32
2621584|NCT00915525|9063526|P1|Overall Study|Lack of Efficacy|15
2621585|NCT00915525|9063525|P2|Overall Study|Pregnancy|0
2621586|NCT00915525|9063526|P1|Overall Study|Pregnancy|2
2621587|NCT00915525|9063525|P2|Overall Study|Lost to Follow-up|16
2621588|NCT00915525|9063526|P1|Overall Study|Lost to Follow-up|27
2621589|NCT00915525|9063525|P2|Overall Study|Withdrawal by Subject|21
2621590|NCT00915525|9063526|P1|Overall Study|Withdrawal by Subject|59
2621591|NCT00915525|9063525|P2|Overall Study|Protocol Violation|4
2621592|NCT00915525|9063526|P1|Overall Study|Protocol Violation|9
2621593|NCT00915473|9063640|P2|4-week Follow Up|Lost to Follow-up|5
2621594|NCT00915473|9063641|P1|4-week Follow Up|Lost to Follow-up|1
2621595|NCT00915473|9063640|P2|Screening|Withdrawal by Subject|0
2621596|NCT00915473|9063641|P1|Screening|Withdrawal by Subject|1
2621597|NCT00915356|9063658|P5|Overall Study|Withdrawal by Subject|0
2621598|NCT00915356|9063659|P4|Overall Study|Withdrawal by Subject|0
2621599|NCT00915356|9063660|P3|Overall Study|Withdrawal by Subject|0
2621600|NCT00915356|9063661|P2|Overall Study|Withdrawal by Subject|0
2621601|NCT00915356|9063662|P1|Overall Study|Withdrawal by Subject|1
2621602|NCT00915343|9063724|P3|Part B - Open Label Period|Did not attend the last visit|1
2621603|NCT00915343|9063725|P2|Part B - Open Label Period|Did not attend the last visit|0
2621604|NCT00915343|9063726|P1|Part B - Open Label Period|Did not attend the last visit|0
2621605|NCT00915343|9063724|P3|Part B - Open Label Period|Treatment switch|1
2621606|NCT00915343|9063725|P2|Part B - Open Label Period|Treatment switch|0
2621607|NCT00915343|9063726|P1|Part B - Open Label Period|Treatment switch|0
2621608|NCT00915278|9063811|P6|Overall Study|Admission to hospice|0
2621609|NCT00915278|9063812|P5|Overall Study|Admission to hospice|0
2621610|NCT00915278|9063813|P4|Overall Study|Admission to hospice|0
2621611|NCT00915278|9063814|P3|Overall Study|Admission to hospice|1
2621612|NCT00915278|9063815|P2|Overall Study|Admission to hospice|0
2621613|NCT00915278|9063816|P1|Overall Study|Admission to hospice|0
2621614|NCT00915278|9063811|P6|Overall Study|Infusion related AEs|2
2621615|NCT00915278|9063812|P5|Overall Study|Infusion related AEs|0
2621616|NCT00915278|9063813|P4|Overall Study|Infusion related AEs|0
2621617|NCT00915278|9063814|P3|Overall Study|Infusion related AEs|0
2621618|NCT00915278|9063815|P2|Overall Study|Infusion related AEs|0
2621619|NCT00915278|9063816|P1|Overall Study|Infusion related AEs|0
2621620|NCT00915278|9063811|P6|Overall Study|Progressive disease/clinical progression|2
2621621|NCT00915278|9063812|P5|Overall Study|Progressive disease/clinical progression|1
2621622|NCT00915278|9063813|P4|Overall Study|Progressive disease/clinical progression|3
2621623|NCT00915278|9063814|P3|Overall Study|Progressive disease/clinical progression|0
2621624|NCT00915278|9063815|P2|Overall Study|Progressive disease/clinical progression|0
2621625|NCT00915278|9063816|P1|Overall Study|Progressive disease/clinical progression|0
2621626|NCT00915278|9063811|P6|Overall Study|Adverse Event|0
2621627|NCT00915278|9063812|P5|Overall Study|Adverse Event|0
2621628|NCT00915278|9063813|P4|Overall Study|Adverse Event|0
2621629|NCT00915278|9063814|P3|Overall Study|Adverse Event|0
2621630|NCT00915278|9063815|P2|Overall Study|Adverse Event|1
2621631|NCT00915278|9063816|P1|Overall Study|Adverse Event|4
2621632|NCT00915278|9063811|P6|Overall Study|Withdrawal by Subject|4
2621633|NCT00915278|9063812|P5|Overall Study|Withdrawal by Subject|1
2621634|NCT00915278|9063813|P4|Overall Study|Withdrawal by Subject|0
2621635|NCT00915278|9063814|P3|Overall Study|Withdrawal by Subject|0
2621636|NCT00915278|9063815|P2|Overall Study|Withdrawal by Subject|1
2621637|NCT00915278|9063816|P1|Overall Study|Withdrawal by Subject|0
2621638|NCT00915278|9063811|P6|Overall Study|Lost to Follow-up|0
2621639|NCT00915278|9063812|P5|Overall Study|Lost to Follow-up|0
2621640|NCT00915278|9063813|P4|Overall Study|Lost to Follow-up|0
2621641|NCT00915278|9063814|P3|Overall Study|Lost to Follow-up|0
2621642|NCT00915278|9063815|P2|Overall Study|Lost to Follow-up|1
2621643|NCT00915278|9063816|P1|Overall Study|Lost to Follow-up|0
2621644|NCT00915278|9063811|P6|Overall Study|Death|0
2621645|NCT00915278|9063812|P5|Overall Study|Death|0
2621646|NCT00915278|9063813|P4|Overall Study|Death|0
2621647|NCT00915278|9063814|P3|Overall Study|Death|0
2621648|NCT00915278|9063815|P2|Overall Study|Death|0
2621649|NCT00915278|9063816|P1|Overall Study|Death|1
2621650|NCT00915018|9063977|P2|Overall Study|By Sponsor due to Protocol Amendment|105
2621651|NCT00915018|9063978|P1|Overall Study|By Sponsor due to Protocol Amendment|92
2621652|NCT00915018|9063977|P2|Overall Study|Withdrawal by Subject|27
2621653|NCT00915018|9063978|P1|Overall Study|Withdrawal by Subject|38
2621654|NCT00915018|9063977|P2|Overall Study|Lost to Follow-up|5
2621655|NCT00915018|9063978|P1|Overall Study|Lost to Follow-up|10
2621656|NCT00915018|9063977|P2|Overall Study|Death|70
2621657|NCT00915018|9063978|P1|Overall Study|Death|75
2621658|NCT00914966|9063992|P1|Step 2: 2000 Units|Withdrawal by Subject|1
2621659|NCT00914966|9063992|P1|Step 1: 1500 Units|Physician Decision|1
2621660|NCT00914966|9063992|P1|Step 1: 1500 Units|Withdrawal by Subject|1
2621661|NCT00914927|9064011|P7|Overall Study|Administrative/Other|0
2621662|NCT00914927|9064012|P6|Overall Study|Administrative/Other|0
2621663|NCT00914927|9064013|P5|Overall Study|Administrative/Other|1
2621664|NCT00914927|9064014|P4|Overall Study|Administrative/Other|0
2621665|NCT00914927|9064015|P3|Overall Study|Administrative/Other|0
2621666|NCT00914927|9064016|P2|Overall Study|Administrative/Other|1
2621667|NCT00914927|9064017|P1|Overall Study|Administrative/Other|2
2621668|NCT00914927|9064011|P7|Overall Study|Lost to Follow-up|0
2621669|NCT00914927|9064012|P6|Overall Study|Lost to Follow-up|0
2621670|NCT00914927|9064013|P5|Overall Study|Lost to Follow-up|0
2621671|NCT00914927|9064014|P4|Overall Study|Lost to Follow-up|1
2621672|NCT00914927|9064015|P3|Overall Study|Lost to Follow-up|0
2621673|NCT00914927|9064016|P2|Overall Study|Lost to Follow-up|0
2621674|NCT00914927|9064017|P1|Overall Study|Lost to Follow-up|0
2621675|NCT00914927|9064011|P7|Overall Study|Withdrawal by Subject|0
2621676|NCT00914927|9064012|P6|Overall Study|Withdrawal by Subject|0
2621677|NCT00914927|9064013|P5|Overall Study|Withdrawal by Subject|0
2621678|NCT00914927|9064014|P4|Overall Study|Withdrawal by Subject|1
2621679|NCT00914927|9064015|P3|Overall Study|Withdrawal by Subject|0
2621680|NCT00914927|9064016|P2|Overall Study|Withdrawal by Subject|1
2621681|NCT00914927|9064017|P1|Overall Study|Withdrawal by Subject|0
2621682|NCT00914927|9064011|P7|Overall Study|Adverse Event|0
2621683|NCT00914927|9064012|P6|Overall Study|Adverse Event|0
2621684|NCT00914927|9064013|P5|Overall Study|Adverse Event|1
2621685|NCT00914927|9064014|P4|Overall Study|Adverse Event|0
2621686|NCT00914927|9064015|P3|Overall Study|Adverse Event|0
2621687|NCT00914927|9064016|P2|Overall Study|Adverse Event|0
2621688|NCT00914927|9064017|P1|Overall Study|Adverse Event|0
2621689|NCT00914849|9064144|P2|Overall Study|Not eligible|1
2621690|NCT00914849|9064145|P1|Overall Study|Not eligible|0
2621691|NCT00914849|9064144|P2|Overall Study|Withdrawal by Subject|0
2621692|NCT00914849|9064145|P1|Overall Study|Withdrawal by Subject|1
2621693|NCT00914810|9064179|P2|Overall Study|Hospitalized and unable to follow up.|1
2621694|NCT00914810|9064180|P1|Overall Study|Hospitalized and unable to follow up.|0
2621695|NCT00914810|9064179|P2|Overall Study|Relocated out of state|0
2621696|NCT00914810|9064180|P1|Overall Study|Relocated out of state|1
2621697|NCT00914810|9064179|P2|Overall Study|Withdrawal by Subject|0
2621698|NCT00914810|9064180|P1|Overall Study|Withdrawal by Subject|1
2621699|NCT00914589|9064191|P3|Overall Study|Death|1
2621700|NCT00914589|9064192|P2|Overall Study|Death|1
2621701|NCT00914589|9064193|P1|Overall Study|Death|0
2621702|NCT00914589|9064191|P3|Overall Study|unclassified|7
2621703|NCT00914589|9064192|P2|Overall Study|unclassified|9
2621704|NCT00914589|9064193|P1|Overall Study|unclassified|16
2621705|NCT00914589|9064191|P3|Overall Study|Protocol Violation|3
2621706|NCT00914589|9064192|P2|Overall Study|Protocol Violation|6
2621707|NCT00914589|9064193|P1|Overall Study|Protocol Violation|8
2621708|NCT00914589|9064191|P3|Overall Study|Adverse Event|1
2621709|NCT00914589|9064192|P2|Overall Study|Adverse Event|0
2621710|NCT00914589|9064193|P1|Overall Study|Adverse Event|1
2621711|NCT00914459|9064219|P2|Overall Study|Parent/Legal guardian request|0
2621712|NCT00914459|9064220|P1|Overall Study|Parent/Legal guardian request|1
2621713|NCT00914459|9064219|P2|Overall Study|Protocol Violation|1
2621714|NCT00914459|9064220|P1|Overall Study|Protocol Violation|0
2621715|NCT00914316|9064250|P4|Phase 2|Withdrawal by Subject|0
2621716|NCT00914316|9064251|P3|Phase 2|Withdrawal by Subject|1
2621717|NCT00914316|9064252|P2|Phase 2|Withdrawal by Subject|0
2621718|NCT00914316|9064253|P1|Phase 2|Withdrawal by Subject|1
2621719|NCT00914316|9064250|P4|Phase 1|Adverse Event|0
2621720|NCT00914316|9064251|P3|Phase 1|Adverse Event|0
2621721|NCT00914316|9064252|P2|Phase 1|Adverse Event|0
2621722|NCT00914316|9064253|P1|Phase 1|Adverse Event|1
2621723|NCT00914316|9064250|P4|Phase 1|Withdrawal by Subject|0
2621724|NCT00914316|9064251|P3|Phase 1|Withdrawal by Subject|4
2621725|NCT00914316|9064252|P2|Phase 1|Withdrawal by Subject|2
2621726|NCT00914316|9064253|P1|Phase 1|Withdrawal by Subject|0
2621727|NCT00914316|9064250|P4|Phase 1|Physician Decision|2
2621728|NCT00914316|9064251|P3|Phase 1|Physician Decision|1
2621729|NCT00914316|9064252|P2|Phase 1|Physician Decision|0
2621730|NCT00914316|9064253|P1|Phase 1|Physician Decision|4
2621731|NCT00913978|9064325|P2|Overall Study|Surgeon choice|3
2621732|NCT00913978|9064326|P1|Overall Study|Surgeon choice|1
2621733|NCT00913835|9064343|P2|Lip Dox: Olaratumab Monotherapy|Other|3
2621734|NCT00913835|9064344|P1|Lip Dox: Olaratumab Monotherapy|Other|0
2621735|NCT00913835|9064343|P2|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
2621736|NCT00913835|9064344|P1|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
2621737|NCT00913835|9064343|P2|Olara+Lip Dox and Lip Dox Monotherapy|Other|3
2621738|NCT00913835|9064344|P1|Olara+Lip Dox and Lip Dox Monotherapy|Other|4
2621739|NCT00913835|9064343|P2|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0
2621740|NCT00913835|9064344|P1|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1
2621741|NCT00913835|9064343|P2|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3
2621742|NCT00913835|9064344|P1|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2
2621743|NCT00913770|9064383|P3|Overall Study|Refused|8
2621744|NCT00913770|9064384|P2|Overall Study|Refused|10
2621745|NCT00913770|9064385|P1|Overall Study|Refused|11
2621746|NCT00913770|9064383|P3|Overall Study|Unable to contact|13
2621747|NCT00913770|9064384|P2|Overall Study|Unable to contact|19
2621748|NCT00913770|9064385|P1|Overall Study|Unable to contact|24
2621749|NCT00913744|9064398|P2|Overall Study|Death|0
2621750|NCT00913744|9064399|P1|Overall Study|Death|1
2621751|NCT00913744|9064398|P2|Overall Study|Withdrawal by Subject|1
2621752|NCT00913744|9064399|P1|Overall Study|Withdrawal by Subject|2
2621753|NCT00913744|9064398|P2|Overall Study|Adverse Event|0
2621754|NCT00913744|9064399|P1|Overall Study|Adverse Event|2
2621755|NCT00913692|9064405|P1|Treatment Phase 1 (5 Months)|Physician Decision|1
2621756|NCT00913692|9064405|P1|Screening (4 Months)|Not eligible after screening phase.|6
2621757|NCT00913692|9064405|P1|Screening (4 Months)|Physician Decision|3
2621758|NCT00913523|9064499|P3|Overall Study|Inadequate Number of Tampons Used|3
2621759|NCT00913523|9064500|P2|Overall Study|Inadequate Number of Tampons Used|2
2621760|NCT00913523|9064501|P1|Overall Study|Inadequate Number of Tampons Used|7
2621761|NCT00913523|9064499|P3|Overall Study|Pregnancy|0
2621762|NCT00913523|9064500|P2|Overall Study|Pregnancy|3
2621763|NCT00913523|9064501|P1|Overall Study|Pregnancy|1
2621764|NCT00913523|9064499|P3|Overall Study|Protocol Violation|8
2621765|NCT00913523|9064500|P2|Overall Study|Protocol Violation|8
2621766|NCT00913523|9064501|P1|Overall Study|Protocol Violation|5
2621767|NCT00913523|9064499|P3|Overall Study|Adverse Event|0
2621768|NCT00913523|9064500|P2|Overall Study|Adverse Event|0
2621769|NCT00913523|9064501|P1|Overall Study|Adverse Event|1
2621770|NCT00913523|9064499|P3|Overall Study|Lost to Follow-up|1
2621771|NCT00913523|9064500|P2|Overall Study|Lost to Follow-up|1
2621772|NCT00913523|9064501|P1|Overall Study|Lost to Follow-up|1
2621773|NCT00913523|9064499|P3|Overall Study|Withdrawal by Subject|2
2621774|NCT00913523|9064500|P2|Overall Study|Withdrawal by Subject|2
2621775|NCT00913523|9064501|P1|Overall Study|Withdrawal by Subject|3
2621776|NCT00913458|9064533|P7|Phase 3|Unsatisfactory Response per Investigator|4
2621777|NCT00913458|9064534|P6|Phase 3|Unsatisfactory Response per Investigator|11
2621778|NCT00913458|9064535|P5|Phase 3|Unsatisfactory Response per Investigator|14
2621779|NCT00913458|9064536|P4|Phase 3|Unsatisfactory Response per Investigator|0
2621780|NCT00913458|9064537|P3|Phase 3|Unsatisfactory Response per Investigator|0
2621781|NCT00913458|9064538|P2|Phase 3|Unsatisfactory Response per Investigator|0
2621782|NCT00913458|9064539|P1|Phase 3|Unsatisfactory Response per Investigator|0
2621783|NCT00913458|9064533|P7|Phase 3|Withdrawal by Subject|0
2621784|NCT00913458|9064534|P6|Phase 3|Withdrawal by Subject|2
2621785|NCT00913458|9064535|P5|Phase 3|Withdrawal by Subject|1
2621786|NCT00913458|9064536|P4|Phase 3|Withdrawal by Subject|0
2621787|NCT00913458|9064537|P3|Phase 3|Withdrawal by Subject|0
2621788|NCT00913458|9064538|P2|Phase 3|Withdrawal by Subject|0
2621789|NCT00913458|9064539|P1|Phase 3|Withdrawal by Subject|0
2621790|NCT00913458|9064533|P7|Phase 3|Non-Responder|3
2621791|NCT00913458|9064534|P6|Phase 3|Non-Responder|1
2621792|NCT00913458|9064535|P5|Phase 3|Non-Responder|0
2621793|NCT00913458|9064536|P4|Phase 3|Non-Responder|0
2621794|NCT00913458|9064537|P3|Phase 3|Non-Responder|0
2621795|NCT00913458|9064538|P2|Phase 3|Non-Responder|0
2621796|NCT00913458|9064539|P1|Phase 3|Non-Responder|0
2621797|NCT00913458|9064533|P7|Phase 3|Lost to Follow-up|0
2621798|NCT00913458|9064534|P6|Phase 3|Lost to Follow-up|0
2621799|NCT00913458|9064535|P5|Phase 3|Lost to Follow-up|2
2621800|NCT00913458|9064536|P4|Phase 3|Lost to Follow-up|0
2621801|NCT00913458|9064537|P3|Phase 3|Lost to Follow-up|0
2621802|NCT00913458|9064538|P2|Phase 3|Lost to Follow-up|0
2621803|NCT00913458|9064539|P1|Phase 3|Lost to Follow-up|0
2621804|NCT00913458|9064533|P7|Phase 3|Adverse Event|1
2621805|NCT00913458|9064534|P6|Phase 3|Adverse Event|4
2621806|NCT00913458|9064535|P5|Phase 3|Adverse Event|5
2621807|NCT00913458|9064536|P4|Phase 3|Adverse Event|0
2621808|NCT00913458|9064537|P3|Phase 3|Adverse Event|0
2621809|NCT00913458|9064538|P2|Phase 3|Adverse Event|0
2621810|NCT00913458|9064539|P1|Phase 3|Adverse Event|0
2621811|NCT00913458|9064533|P7|Phase 2|Unsatisfactory Response per Investigator|0
2621812|NCT00913458|9064534|P6|Phase 2|Unsatisfactory Response per Investigator|0
2621813|NCT00913458|9064535|P5|Phase 2|Unsatisfactory Response per Investigator|0
2621814|NCT00913458|9064536|P4|Phase 2|Unsatisfactory Response per Investigator|17
2621815|NCT00913458|9064537|P3|Phase 2|Unsatisfactory Response per Investigator|11
2621816|NCT00913458|9064538|P2|Phase 2|Unsatisfactory Response per Investigator|0
2621817|NCT00913458|9064539|P1|Phase 2|Unsatisfactory Response per Investigator|0
2621818|NCT00913458|9064533|P7|Phase 2|Protocol Violation|0
2621819|NCT00913458|9064534|P6|Phase 2|Protocol Violation|0
2621820|NCT00913458|9064535|P5|Phase 2|Protocol Violation|0
2621821|NCT00913458|9064536|P4|Phase 2|Protocol Violation|0
2621822|NCT00913458|9064537|P3|Phase 2|Protocol Violation|0
2621823|NCT00913458|9064538|P2|Phase 2|Protocol Violation|2
2621824|NCT00913458|9064539|P1|Phase 2|Protocol Violation|0
2621825|NCT00913458|9064533|P7|Phase 2|Lost to Follow-up|0
2621826|NCT00913458|9064534|P6|Phase 2|Lost to Follow-up|0
2621827|NCT00913458|9064535|P5|Phase 2|Lost to Follow-up|0
2621828|NCT00913458|9064536|P4|Phase 2|Lost to Follow-up|1
2621829|NCT00913458|9064537|P3|Phase 2|Lost to Follow-up|0
2621830|NCT00913458|9064538|P2|Phase 2|Lost to Follow-up|0
2621831|NCT00913458|9064539|P1|Phase 2|Lost to Follow-up|0
2621832|NCT00913458|9064533|P7|Phase 2|Adverse Event|0
2621833|NCT00913458|9064534|P6|Phase 2|Adverse Event|0
2621834|NCT00913458|9064535|P5|Phase 2|Adverse Event|0
2621835|NCT00913458|9064536|P4|Phase 2|Adverse Event|1
2621836|NCT00913458|9064537|P3|Phase 2|Adverse Event|0
2621837|NCT00913458|9064538|P2|Phase 2|Adverse Event|3
2621838|NCT00913458|9064539|P1|Phase 2|Adverse Event|0
2621839|NCT00913458|9064533|P7|Phase 2|Subject Request|0
2621840|NCT00913458|9064534|P6|Phase 2|Subject Request|0
2621841|NCT00913458|9064535|P5|Phase 2|Subject Request|0
2621842|NCT00913458|9064536|P4|Phase 2|Subject Request|2
2621843|NCT00913458|9064537|P3|Phase 2|Subject Request|1
2621844|NCT00913458|9064538|P2|Phase 2|Subject Request|0
2621845|NCT00913458|9064539|P1|Phase 2|Subject Request|0
2621846|NCT00913458|9064533|P7|Phase 2|Non-Responder|0
2621847|NCT00913458|9064534|P6|Phase 2|Non-Responder|0
2621848|NCT00913458|9064535|P5|Phase 2|Non-Responder|0
2621849|NCT00913458|9064536|P4|Phase 2|Non-Responder|12
2621850|NCT00913458|9064537|P3|Phase 2|Non-Responder|7
2621851|NCT00913458|9064538|P2|Phase 2|Non-Responder|5
2621852|NCT00913458|9064539|P1|Phase 2|Non-Responder|0
2621853|NCT00913458|9064533|P7|Phase 1|Unsatisfactory Response per Investigator|0
2621854|NCT00913458|9064534|P6|Phase 1|Unsatisfactory Response per Investigator|0
2621855|NCT00913458|9064535|P5|Phase 1|Unsatisfactory Response per Investigator|0
2621856|NCT00913458|9064536|P4|Phase 1|Unsatisfactory Response per Investigator|0
2621857|NCT00913458|9064537|P3|Phase 1|Unsatisfactory Response per Investigator|0
2621858|NCT00913458|9064538|P2|Phase 1|Unsatisfactory Response per Investigator|0
2621859|NCT00913458|9064539|P1|Phase 1|Unsatisfactory Response per Investigator|7
2621860|NCT00913458|9064533|P7|Phase 1|Sponsor|0
2621861|NCT00913458|9064534|P6|Phase 1|Sponsor|0
2621862|NCT00913458|9064535|P5|Phase 1|Sponsor|0
2621863|NCT00913458|9064536|P4|Phase 1|Sponsor|0
2621864|NCT00913458|9064537|P3|Phase 1|Sponsor|0
2621865|NCT00913458|9064538|P2|Phase 1|Sponsor|0
2621866|NCT00913458|9064539|P1|Phase 1|Sponsor|2
2621867|NCT00913458|9064533|P7|Phase 1|Protocol Violation|0
2621868|NCT00913458|9064534|P6|Phase 1|Protocol Violation|0
2621869|NCT00913458|9064535|P5|Phase 1|Protocol Violation|0
2621870|NCT00913458|9064536|P4|Phase 1|Protocol Violation|0
2621871|NCT00913458|9064537|P3|Phase 1|Protocol Violation|0
2621872|NCT00913458|9064538|P2|Phase 1|Protocol Violation|0
2621873|NCT00913458|9064539|P1|Phase 1|Protocol Violation|10
2621874|NCT00913458|9064533|P7|Phase 1|Lost to Follow-up|0
2621875|NCT00913458|9064534|P6|Phase 1|Lost to Follow-up|0
2621876|NCT00913458|9064535|P5|Phase 1|Lost to Follow-up|0
2621877|NCT00913458|9064536|P4|Phase 1|Lost to Follow-up|0
2621878|NCT00913458|9064537|P3|Phase 1|Lost to Follow-up|0
2621879|NCT00913458|9064538|P2|Phase 1|Lost to Follow-up|0
2621880|NCT00913458|9064539|P1|Phase 1|Lost to Follow-up|2
2621881|NCT00913458|9064533|P7|Phase 1|Adverse Event|0
2621882|NCT00913458|9064534|P6|Phase 1|Adverse Event|0
2621883|NCT00913458|9064535|P5|Phase 1|Adverse Event|0
2621884|NCT00913458|9064536|P4|Phase 1|Adverse Event|0
2621885|NCT00913458|9064537|P3|Phase 1|Adverse Event|0
2621886|NCT00913458|9064538|P2|Phase 1|Adverse Event|0
2621887|NCT00913458|9064539|P1|Phase 1|Adverse Event|20
2621888|NCT00913458|9064533|P7|Phase 1|Subject Request|0
2621889|NCT00913458|9064534|P6|Phase 1|Subject Request|0
2621890|NCT00913458|9064535|P5|Phase 1|Subject Request|0
2621891|NCT00913458|9064536|P4|Phase 1|Subject Request|0
2621892|NCT00913458|9064537|P3|Phase 1|Subject Request|0
2621893|NCT00913458|9064538|P2|Phase 1|Subject Request|0
2621894|NCT00913458|9064539|P1|Phase 1|Subject Request|17
2621895|NCT00913458|9064533|P7|Phase 1|Non-Responder|0
2621896|NCT00913458|9064534|P6|Phase 1|Non-Responder|0
2621897|NCT00913458|9064535|P5|Phase 1|Non-Responder|0
2621898|NCT00913458|9064536|P4|Phase 1|Non-Responder|0
2621899|NCT00913458|9064537|P3|Phase 1|Non-Responder|0
2621900|NCT00913458|9064538|P2|Phase 1|Non-Responder|0
2621901|NCT00913458|9064539|P1|Phase 1|Non-Responder|54
2621902|NCT00913380|9064632|P2|Clinical Outcomes|Lost to Follow-up|6
2621903|NCT00913380|9064633|P1|Clinical Outcomes|Lost to Follow-up|6
2621904|NCT00912964|9064699|P3|Overall Study|Randomized but never received study drug|0
2621905|NCT00912964|9064700|P2|Overall Study|Randomized but never received study drug|1
2621906|NCT00912964|9064701|P1|Overall Study|Randomized but never received study drug|0
2621907|NCT00912964|9064699|P3|Overall Study|Violation of exclusion criterion|2
2621908|NCT00912964|9064700|P2|Overall Study|Violation of exclusion criterion|0
2621909|NCT00912964|9064701|P1|Overall Study|Violation of exclusion criterion|0
2621910|NCT00912964|9064699|P3|Overall Study|Non-compliance with study procedures|0
2621911|NCT00912964|9064700|P2|Overall Study|Non-compliance with study procedures|0
2621912|NCT00912964|9064701|P1|Overall Study|Non-compliance with study procedures|2
2621913|NCT00912964|9064699|P3|Overall Study|Medical History|0
2621914|NCT00912964|9064700|P2|Overall Study|Medical History|0
2621915|NCT00912964|9064701|P1|Overall Study|Medical History|1
2621916|NCT00912964|9064699|P3|Overall Study|Taking exclusionary medications|8
2621917|NCT00912964|9064700|P2|Overall Study|Taking exclusionary medications|4
2621918|NCT00912964|9064701|P1|Overall Study|Taking exclusionary medications|7
2621919|NCT00912964|9064699|P3|Overall Study|Protocol Violation|8
2621920|NCT00912964|9064700|P2|Overall Study|Protocol Violation|3
2621921|NCT00912964|9064701|P1|Overall Study|Protocol Violation|5
2621922|NCT00912964|9064699|P3|Overall Study|Lost to Follow-up|3
2621923|NCT00912964|9064700|P2|Overall Study|Lost to Follow-up|3
2621924|NCT00912964|9064701|P1|Overall Study|Lost to Follow-up|4
2621925|NCT00912964|9064699|P3|Overall Study|Withdrawal by Subject|18
2621926|NCT00912964|9064700|P2|Overall Study|Withdrawal by Subject|12
2621927|NCT00912964|9064701|P1|Overall Study|Withdrawal by Subject|20
2621928|NCT00912964|9064699|P3|Overall Study|Lack of Efficacy|3
2621929|NCT00912964|9064700|P2|Overall Study|Lack of Efficacy|4
2621930|NCT00912964|9064701|P1|Overall Study|Lack of Efficacy|11
2621931|NCT00912964|9064699|P3|Overall Study|Adverse Event|12
2621932|NCT00912964|9064700|P2|Overall Study|Adverse Event|18
2621933|NCT00912964|9064701|P1|Overall Study|Adverse Event|15
2621934|NCT00912964|9064699|P3|Overall Study|Eligibility criterion not met|0
2621935|NCT00912964|9064700|P2|Overall Study|Eligibility criterion not met|1
2621936|NCT00912964|9064701|P1|Overall Study|Eligibility criterion not met|1
2621937|NCT00912912|9064844|P1|Overall Study|Disease Progression|3
2621938|NCT00912912|9064844|P1|Overall Study|Withdrawal by Subject|1
2621939|NCT00912808|9064850|P2|Second Intervention (6 Weeks)|Withdrawal by Subject|0
2621940|NCT00912808|9064851|P1|Second Intervention (6 Weeks)|Withdrawal by Subject|1
2621941|NCT00912808|9064850|P2|Second Intervention (6 Weeks)|Adverse Event|1
2621942|NCT00912808|9064851|P1|Second Intervention (6 Weeks)|Adverse Event|0
2621943|NCT00912808|9064850|P2|Washout|Withdrawal by Subject|1
2621944|NCT00912808|9064851|P1|Washout|Withdrawal by Subject|0
2621945|NCT00912808|9064850|P2|First Intervention (6 Weeks)|Adverse Event|1
2621946|NCT00912808|9064851|P1|First Intervention (6 Weeks)|Adverse Event|2
2621947|NCT00912782|9064876|P2|Overall Study|Relocated before study completion|1
2621948|NCT00912782|9064877|P1|Overall Study|Relocated before study completion|0
2621949|NCT00912782|9064876|P2|Overall Study|Did not receive vascular access type|2
2621950|NCT00912782|9064877|P1|Overall Study|Did not receive vascular access type|1
2621951|NCT00912782|9064876|P2|Overall Study|Lost to Follow-up|1
2621952|NCT00912782|9064877|P1|Overall Study|Lost to Follow-up|0
2621953|NCT00912782|9064876|P2|Overall Study|Death|1
2621954|NCT00912782|9064877|P1|Overall Study|Death|2
2621955|NCT00912743|9064887|P2|Overall Study|End of treatment form was not collected|0
2621956|NCT00912743|9064888|P1|Overall Study|End of treatment form was not collected|1
2621957|NCT00912743|9064887|P2|Overall Study|Toxicity|1
2621958|NCT00912743|9064888|P1|Overall Study|Toxicity|0
2621959|NCT00912743|9064887|P2|Overall Study|Lack of Efficacy|18
2621960|NCT00912743|9064888|P1|Overall Study|Lack of Efficacy|9
2621961|NCT00912743|9064887|P2|Overall Study|Adverse Event|1
2621962|NCT00912743|9064888|P1|Overall Study|Adverse Event|3
2621963|NCT00912509|9064900|P2|Overall Study|Lack of Efficacy|3
2621964|NCT00912509|9064901|P1|Overall Study|Lack of Efficacy|4
2621965|NCT00912509|9064900|P2|Overall Study|Lost to Follow-up|0
2621966|NCT00912509|9064901|P1|Overall Study|Lost to Follow-up|1
2621967|NCT00912405|9064909|P1|Overall Study|Lost to Follow-up|5
2621968|NCT00912340|9064919|P3|Overall Study|Protocol revised to remove arm|4
2621969|NCT00912340|9064920|P2|Overall Study|Protocol revised to remove arm|0
2621970|NCT00912340|9064921|P1|Overall Study|Protocol revised to remove arm|0
2621971|NCT00912340|9064919|P3|Overall Study|Adverse Event|0
2621972|NCT00912340|9064920|P2|Overall Study|Adverse Event|4
2621973|NCT00912340|9064921|P1|Overall Study|Adverse Event|2
2621974|NCT00912288|9064959|P2|Overall Study|Other|0
2621975|NCT00912288|9064960|P1|Overall Study|Other|1
2621976|NCT00912288|9064959|P2|Overall Study|Study terminated by sponsor|35
2621977|NCT00912288|9064960|P1|Overall Study|Study terminated by sponsor|34
2621978|NCT00912288|9064959|P2|Overall Study|Withdrawal by Subject|3
2621979|NCT00912288|9064960|P1|Overall Study|Withdrawal by Subject|3
2621980|NCT00912288|9064959|P2|Overall Study|Protocol Violation|0
2621981|NCT00912288|9064960|P1|Overall Study|Protocol Violation|1
2621982|NCT00912288|9064959|P2|Overall Study|Lost to Follow-up|0
2621983|NCT00912288|9064960|P1|Overall Study|Lost to Follow-up|1
2621984|NCT00912288|9064959|P2|Overall Study|Adverse Event|1
2621985|NCT00912288|9064960|P1|Overall Study|Adverse Event|1
2621986|NCT00912288|9064959|P2|Overall Study|Death|1
2621987|NCT00912288|9064960|P1|Overall Study|Death|0
2621988|NCT00912223|9064982|P1|Overall Study|Transformed disease|1
2621989|NCT00912223|9064982|P1|Overall Study|Not transplanted|1
2621990|NCT00912223|9064982|P1|Overall Study|Withdrawal by Subject|1
2621991|NCT00912093|9065013|P5|The Controlled Phase|Lost to Follow-up|1
2621992|NCT00912093|9065014|P4|The Controlled Phase|Lost to Follow-up|0
2621993|NCT00912093|9065015|P3|The Controlled Phase|Lost to Follow-up|0
2621994|NCT00912093|9065016|P2|The Controlled Phase|Lost to Follow-up|0
2621995|NCT00912093|9065017|P1|The Controlled Phase|Lost to Follow-up|0
2621996|NCT00912093|9065013|P5|The Controlled Phase|Medical Condition|0
2621997|NCT00912093|9065014|P4|The Controlled Phase|Medical Condition|0
2621998|NCT00912093|9065015|P3|The Controlled Phase|Medical Condition|0
2621999|NCT00912093|9065016|P2|The Controlled Phase|Medical Condition|1
2622000|NCT00912093|9065017|P1|The Controlled Phase|Medical Condition|0
2622001|NCT00912093|9065013|P5|The Controlled Phase|Death|0
2622002|NCT00912093|9065014|P4|The Controlled Phase|Death|0
2622003|NCT00912093|9065015|P3|The Controlled Phase|Death|0
2622004|NCT00912093|9065016|P2|The Controlled Phase|Death|1
2622005|NCT00912093|9065017|P1|The Controlled Phase|Death|0
2622006|NCT00912028|9065036|P5|Overall Study|Withdrawal by Subject|0
2622007|NCT00912028|9065037|P4|Overall Study|Withdrawal by Subject|0
2622008|NCT00912028|9065038|P3|Overall Study|Withdrawal by Subject|0
2622009|NCT00912028|9065039|P2|Overall Study|Withdrawal by Subject|0
2622010|NCT00912028|9065040|P1|Overall Study|Withdrawal by Subject|3
2622011|NCT00912028|9065036|P5|Overall Study|Lost to Follow-up|3
2622012|NCT00912028|9065037|P4|Overall Study|Lost to Follow-up|1
2622013|NCT00912028|9065038|P3|Overall Study|Lost to Follow-up|0
2622014|NCT00912028|9065039|P2|Overall Study|Lost to Follow-up|3
2622015|NCT00912028|9065040|P1|Overall Study|Lost to Follow-up|2
2622016|NCT00912015|9065069|P4|Overall Study|Adverse Event|1
2622017|NCT00912015|9065070|P3|Overall Study|Adverse Event|0
2622018|NCT00912015|9065071|P2|Overall Study|Adverse Event|0
2622019|NCT00912015|9065072|P1|Overall Study|Adverse Event|6
2622020|NCT00912015|9065069|P4|Overall Study|Protocol Violation|1
2622021|NCT00912015|9065070|P3|Overall Study|Protocol Violation|0
2622022|NCT00912015|9065071|P2|Overall Study|Protocol Violation|0
2622023|NCT00912015|9065072|P1|Overall Study|Protocol Violation|1
2622024|NCT00912015|9065069|P4|Overall Study|Withdrawal by Subject|0
2622025|NCT00912015|9065070|P3|Overall Study|Withdrawal by Subject|3
2622026|NCT00912015|9065071|P2|Overall Study|Withdrawal by Subject|8
2622027|NCT00912015|9065072|P1|Overall Study|Withdrawal by Subject|8
2622028|NCT00912015|9065069|P4|Overall Study|Lack of Efficacy|0
2622029|NCT00912015|9065070|P3|Overall Study|Lack of Efficacy|0
2622030|NCT00912015|9065071|P2|Overall Study|Lack of Efficacy|0
2622031|NCT00912015|9065072|P1|Overall Study|Lack of Efficacy|1
2622032|NCT00911989|9065088|P1|Overall Study|Adverse Event|1
2622033|NCT00911937|9065094|P2|Overall Study|Other|5
2622034|NCT00911937|9065095|P1|Overall Study|Other|9
2622035|NCT00911937|9065094|P2|Overall Study|Randomized but not treated|13
2622036|NCT00911937|9065095|P1|Overall Study|Randomized but not treated|13
2622037|NCT00911937|9065094|P2|Overall Study|Protocol Violation|23
2622038|NCT00911937|9065095|P1|Overall Study|Protocol Violation|14
2622039|NCT00911937|9065094|P2|Overall Study|Did not meet inclusion criteria|11
2622040|NCT00911937|9065095|P1|Overall Study|Did not meet inclusion criteria|9
2622041|NCT00911937|9065094|P2|Overall Study|Lack of Efficacy|6
2622042|NCT00911937|9065095|P1|Overall Study|Lack of Efficacy|11
2622043|NCT00911937|9065094|P2|Overall Study|Adverse Event|25
2622044|NCT00911937|9065095|P1|Overall Study|Adverse Event|11
2622045|NCT00911937|9065094|P2|Overall Study|Withdrawn due to pregnancy|0
2622046|NCT00911937|9065095|P1|Overall Study|Withdrawn due to pregnancy|1
2622047|NCT00911937|9065094|P2|Overall Study|Withdrawal by Subject|7
2622048|NCT00911937|9065095|P1|Overall Study|Withdrawal by Subject|10
2622049|NCT00911937|9065094|P2|Overall Study|Lost to Follow-up|5
2622050|NCT00911937|9065095|P1|Overall Study|Lost to Follow-up|8
2622051|NCT00911937|9065094|P2|Overall Study|Death|0
2622052|NCT00911937|9065095|P1|Overall Study|Death|1
2622053|NCT00911859|9065162|P3|Follow-up Period|Study terminated by sponsor|27
2622054|NCT00911859|9065163|P2|Follow-up Period|Study terminated by sponsor|33
2622055|NCT00911859|9065164|P1|Follow-up Period|Study terminated by sponsor|5
2622056|NCT00911859|9065162|P3|Follow-up Period|Withdrawal by Subject|4
2622057|NCT00911859|9065163|P2|Follow-up Period|Withdrawal by Subject|4
2622058|NCT00911859|9065164|P1|Follow-up Period|Withdrawal by Subject|0
2622059|NCT00911859|9065162|P3|Follow-up Period|Lost to Follow-up|0
2622060|NCT00911859|9065163|P2|Follow-up Period|Lost to Follow-up|1
2622061|NCT00911859|9065164|P1|Follow-up Period|Lost to Follow-up|1
2622062|NCT00911859|9065162|P3|Follow-up Period|Death|10
2622063|NCT00911859|9065163|P2|Follow-up Period|Death|8
2622064|NCT00911859|9065164|P1|Follow-up Period|Death|5
2622065|NCT00911859|9065162|P3|Maintainance Period|Withdrawal by Subject|3
2622066|NCT00911859|9065163|P2|Maintainance Period|Withdrawal by Subject|0
2622067|NCT00911859|9065164|P1|Maintainance Period|Withdrawal by Subject|0
2622068|NCT00911859|9065162|P3|Maintainance Period|Physician Decision|9
2622069|NCT00911859|9065163|P2|Maintainance Period|Physician Decision|0
2622070|NCT00911859|9065164|P1|Maintainance Period|Physician Decision|0
2622071|NCT00911859|9065162|P3|Maintainance Period|Lack of Efficacy|9
2622072|NCT00911859|9065163|P2|Maintainance Period|Lack of Efficacy|0
2622073|NCT00911859|9065164|P1|Maintainance Period|Lack of Efficacy|0
2622074|NCT00911859|9065162|P3|Treatment Period|Did not receive study treatment|0
2622075|NCT00911859|9065163|P2|Treatment Period|Did not receive study treatment|1
2622076|NCT00911859|9065164|P1|Treatment Period|Did not receive study treatment|0
2622077|NCT00911859|9065162|P3|Treatment Period|Withdrawal by Subject|5
2622078|NCT00911859|9065163|P2|Treatment Period|Withdrawal by Subject|4
2622079|NCT00911859|9065164|P1|Treatment Period|Withdrawal by Subject|0
2622080|NCT00911859|9065162|P3|Treatment Period|Physician Decision|3
2622081|NCT00911859|9065163|P2|Treatment Period|Physician Decision|3
2622082|NCT00911859|9065164|P1|Treatment Period|Physician Decision|3
2622083|NCT00911859|9065162|P3|Treatment Period|Lack of Efficacy|5
2622084|NCT00911859|9065163|P2|Treatment Period|Lack of Efficacy|7
2622085|NCT00911859|9065164|P1|Treatment Period|Lack of Efficacy|1
2622086|NCT00911859|9065162|P3|Treatment Period|Death|5
2622087|NCT00911859|9065163|P2|Treatment Period|Death|3
2622088|NCT00911859|9065164|P1|Treatment Period|Death|1
2622089|NCT00911859|9065162|P3|Treatment Period|Adverse Event|7
2622090|NCT00911859|9065163|P2|Treatment Period|Adverse Event|3
2622091|NCT00911859|9065164|P1|Treatment Period|Adverse Event|3
2622092|NCT00911820|9065190|P2|Overall Study|Withdraw before Receive Treatment|2
2622093|NCT00911820|9065191|P1|Overall Study|Withdraw before Receive Treatment|0
2622094|NCT00911820|9065190|P2|Overall Study|Pathology Not Confirmed|0
2622095|NCT00911820|9065191|P1|Overall Study|Pathology Not Confirmed|1
2622096|NCT00911820|9065190|P2|Overall Study|Still on Therapy|2
2622097|NCT00911820|9065191|P1|Overall Study|Still on Therapy|2
2622098|NCT00911820|9065190|P2|Overall Study|Pursue Radiation|0
2622099|NCT00911820|9065191|P1|Overall Study|Pursue Radiation|1
2622100|NCT00911820|9065190|P2|Overall Study|Pursue surgery|1
2622101|NCT00911820|9065191|P1|Overall Study|Pursue surgery|1
2622102|NCT00911820|9065190|P2|Overall Study|Death|2
2622103|NCT00911820|9065191|P1|Overall Study|Death|1
2622104|NCT00911820|9065190|P2|Overall Study|Withdrawal by Subject|4
2622105|NCT00911820|9065191|P1|Overall Study|Withdrawal by Subject|3
2622106|NCT00911820|9065190|P2|Overall Study|Decline in Performance Status|2
2622107|NCT00911820|9065191|P1|Overall Study|Decline in Performance Status|4
2622108|NCT00911820|9065190|P2|Overall Study|Physician Decision|9
2622109|NCT00911820|9065191|P1|Overall Study|Physician Decision|5
2622110|NCT00911820|9065190|P2|Overall Study|Clinical Progression|5
2622111|NCT00911820|9065191|P1|Overall Study|Clinical Progression|7
2622112|NCT00911820|9065190|P2|Overall Study|Adverse Event|8
2622113|NCT00911820|9065191|P1|Overall Study|Adverse Event|8
2622114|NCT00911820|9065190|P2|Overall Study|RECIST progression|8
2622115|NCT00911820|9065191|P1|Overall Study|RECIST progression|12
2622116|NCT00911807|9065208|P3|Overall Study|Organizational reasons|1
2622117|NCT00911807|9065209|P2|Overall Study|Organizational reasons|3
2622118|NCT00911807|9065210|P1|Overall Study|Organizational reasons|1
2622119|NCT00911807|9065208|P3|Overall Study|Withdrawal by Subject|7
2622120|NCT00911807|9065209|P2|Overall Study|Withdrawal by Subject|10
2622121|NCT00911807|9065210|P1|Overall Study|Withdrawal by Subject|8
2622122|NCT00911807|9065208|P3|Overall Study|Protocol Violation|9
2622123|NCT00911807|9065209|P2|Overall Study|Protocol Violation|4
2622124|NCT00911807|9065210|P1|Overall Study|Protocol Violation|6
2622125|NCT00911807|9065208|P3|Overall Study|Death|1
2622126|NCT00911807|9065209|P2|Overall Study|Death|0
2622127|NCT00911807|9065210|P1|Overall Study|Death|0
2622128|NCT00911807|9065208|P3|Overall Study|Adverse Event|5
2622129|NCT00911807|9065209|P2|Overall Study|Adverse Event|1
2622130|NCT00911807|9065210|P1|Overall Study|Adverse Event|2
2622131|NCT00911768|9065220|P2|Overall Study|Withdrawal by Subject|0
2622132|NCT00911768|9065221|P1|Overall Study|Withdrawal by Subject|1
2622133|NCT00911768|9065220|P2|Overall Study|Protocol Violation|4
2622134|NCT00911768|9065221|P1|Overall Study|Protocol Violation|5
2622135|NCT00911625|9065250|P2|Overall Study|Lost to Follow-up|0
2622136|NCT00911625|9065251|P1|Overall Study|Lost to Follow-up|7
2622137|NCT00911547|9065280|P4|Overall Study|Withdrawal by Subject|8
2622138|NCT00911547|9065281|P3|Overall Study|Withdrawal by Subject|4
2622139|NCT00911547|9065282|P2|Overall Study|Withdrawal by Subject|10
2622140|NCT00911547|9065283|P1|Overall Study|Withdrawal by Subject|3
2622141|NCT00911547|9065280|P4|Overall Study|Protocol Violation|1
2622142|NCT00911547|9065281|P3|Overall Study|Protocol Violation|5
2622143|NCT00911547|9065282|P2|Overall Study|Protocol Violation|5
2622144|NCT00911547|9065283|P1|Overall Study|Protocol Violation|0
2622145|NCT00911547|9065280|P4|Overall Study|Lost to Follow-up|1
2622146|NCT00911547|9065281|P3|Overall Study|Lost to Follow-up|2
2622147|NCT00911547|9065282|P2|Overall Study|Lost to Follow-up|0
2622148|NCT00911547|9065283|P1|Overall Study|Lost to Follow-up|0
2622149|NCT00911547|9065280|P4|Overall Study|Adverse Event|6
2622150|NCT00911547|9065281|P3|Overall Study|Adverse Event|11
2622151|NCT00911547|9065282|P2|Overall Study|Adverse Event|27
2622152|NCT00911547|9065283|P1|Overall Study|Adverse Event|8
2622153|NCT00911534|9065311|P2|Overall Study|Other|2
2622154|NCT00911534|9065312|P1|Overall Study|Other|2
2622155|NCT00911534|9065311|P2|Overall Study|Withdrawal of consent|4
2622156|NCT00911534|9065312|P1|Overall Study|Withdrawal of consent|1
2622157|NCT00911534|9065311|P2|Overall Study|Lack of Efficacy|1
2622158|NCT00911534|9065312|P1|Overall Study|Lack of Efficacy|4
2622159|NCT00911534|9065311|P2|Overall Study|Withdrawal by Subject|1
2622160|NCT00911534|9065312|P1|Overall Study|Withdrawal by Subject|2
2622161|NCT00911534|9065311|P2|Overall Study|Lost to Follow-up|4
2622162|NCT00911534|9065312|P1|Overall Study|Lost to Follow-up|2
2622163|NCT00911534|9065311|P2|Overall Study|Adverse Event|4
2622164|NCT00911534|9065312|P1|Overall Study|Adverse Event|4
2622165|NCT00911508|9065326|P2|Overall Study|Withdrawal by Subject|112
2622166|NCT00911508|9065327|P1|Overall Study|Withdrawal by Subject|79
2622167|NCT00911508|9065326|P2|Overall Study|Lost to Follow-up|18
2622168|NCT00911508|9065327|P1|Overall Study|Lost to Follow-up|27
2622169|NCT00911300|9065402|P2|Overall Study|Randomized; No Study Medication Received|2
2622170|NCT00911300|9065403|P1|Overall Study|Randomized; No Study Medication Received|0
2622171|NCT00911300|9065402|P2|Overall Study|Treatment Stopped by Mistake|1
2622172|NCT00911300|9065403|P1|Overall Study|Treatment Stopped by Mistake|0
2622173|NCT00911300|9065402|P2|Overall Study|Physician Decision|1
2622174|NCT00911300|9065403|P1|Overall Study|Physician Decision|0
2622175|NCT00911300|9065402|P2|Overall Study|Underlying Disease (Myocarditis)|1
2622176|NCT00911300|9065403|P1|Overall Study|Underlying Disease (Myocarditis)|0
2622177|NCT00911300|9065402|P2|Overall Study|Participant Refused Hospital Consulation|1
2622178|NCT00911300|9065403|P1|Overall Study|Participant Refused Hospital Consulation|0
2622179|NCT00911300|9065402|P2|Overall Study|International Normalized Ratio Too High|1
2622180|NCT00911300|9065403|P1|Overall Study|International Normalized Ratio Too High|0
2622181|NCT00911300|9065402|P2|Overall Study|Investigator's Decision; New AF Episode|1
2622182|NCT00911300|9065403|P1|Overall Study|Investigator's Decision; New AF Episode|0
2622183|NCT00911300|9065402|P2|Overall Study|Participant Could Not Stay in Hospital|1
2622184|NCT00911300|9065403|P1|Overall Study|Participant Could Not Stay in Hospital|0
2622185|NCT00911300|9065402|P2|Overall Study|CV Unsuccessful; Phenprocoumon Received|0
2622186|NCT00911300|9065403|P1|Overall Study|CV Unsuccessful; Phenprocoumon Received|1
2622187|NCT00911300|9065402|P2|Overall Study|Nurse Unavailable in Participant's City|0
2622188|NCT00911300|9065403|P1|Overall Study|Nurse Unavailable in Participant's City|1
2622189|NCT00911300|9065402|P2|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
2622190|NCT00911300|9065403|P1|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
2622191|NCT00911300|9065402|P2|Overall Study|Recurrent Tachyarrhythmia|1
2622192|NCT00911300|9065403|P1|Overall Study|Recurrent Tachyarrhythmia|1
2622193|NCT00911300|9065402|P2|Overall Study|Received Commercial Treatment|0
2622194|NCT00911300|9065403|P1|Overall Study|Received Commercial Treatment|1
2622195|NCT00911300|9065402|P2|Overall Study|Atrial Fibrillation (AF) Recurrence|3
2622196|NCT00911300|9065403|P1|Overall Study|Atrial Fibrillation (AF) Recurrence|3
2622197|NCT00911300|9065402|P2|Overall Study|Coronary Angiography Performed|0
2622198|NCT00911300|9065403|P1|Overall Study|Coronary Angiography Performed|1
2622199|NCT00911300|9065402|P2|Overall Study|Consent Withdrawn|12
2622200|NCT00911300|9065403|P1|Overall Study|Consent Withdrawn|4
2622201|NCT00911300|9065402|P2|Overall Study|Protocol Violation|2
2622202|NCT00911300|9065403|P1|Overall Study|Protocol Violation|3
2622203|NCT00911300|9065402|P2|Overall Study|Adverse Event|6
2622204|NCT00911300|9065403|P1|Overall Study|Adverse Event|14
2622205|NCT00911300|9065402|P2|Overall Study|Thrombus Persistant in Second TEE|7
2622206|NCT00911300|9065403|P1|Overall Study|Thrombus Persistant in Second TEE|3
2622207|NCT00911300|9065402|P2|Overall Study|Death|0
2622208|NCT00911300|9065403|P1|Overall Study|Death|1
2622209|NCT00911300|9065402|P2|Overall Study|Primary Endpoint Component Occurred|2
2622210|NCT00911300|9065403|P1|Overall Study|Primary Endpoint Component Occurred|1
2622211|NCT00911170|9065440|P2|Long Term Follow-Up|Death|121
2622212|NCT00911170|9065441|P1|Long Term Follow-Up|Death|116
2622213|NCT00911170|9065440|P2|Long Term Follow-Up|Lost to Follow-up|7
2622214|NCT00911170|9065441|P1|Long Term Follow-Up|Lost to Follow-up|8
2622215|NCT00911170|9065440|P2|Long Term Follow-Up|Physician Decision|4
2622216|NCT00911170|9065441|P1|Long Term Follow-Up|Physician Decision|5
2622217|NCT00911170|9065440|P2|Long Term Follow-Up|Withdrawal by Subject|21
2622218|NCT00911170|9065441|P1|Long Term Follow-Up|Withdrawal by Subject|20
2622219|NCT00911170|9065440|P2|Long Term Follow-Up|Continuing in study|269
2622220|NCT00911170|9065441|P1|Long Term Follow-Up|Continuing in study|274
2622221|NCT00911170|9065440|P2|Treatment Period|Death|9
2622222|NCT00911170|9065441|P1|Treatment Period|Death|6
2622223|NCT00911170|9065440|P2|Treatment Period|Lost to Follow-up|1
2622224|NCT00911170|9065441|P1|Treatment Period|Lost to Follow-up|0
2622225|NCT00911170|9065440|P2|Treatment Period|Physician Decision|5
2622226|NCT00911170|9065441|P1|Treatment Period|Physician Decision|5
2622227|NCT00911170|9065440|P2|Treatment Period|Disease progression|2
2622228|NCT00911170|9065441|P1|Treatment Period|Disease progression|0
2622229|NCT00911170|9065440|P2|Treatment Period|Withdrawal by Subject|4
2622230|NCT00911170|9065441|P1|Treatment Period|Withdrawal by Subject|4
2622231|NCT00911170|9065440|P2|Treatment Period|Adverse Event|10
2622232|NCT00911170|9065441|P1|Treatment Period|Adverse Event|9
2622233|NCT00911170|9065440|P2|Treatment Period|Protocol deviation|2
2622234|NCT00911170|9065441|P1|Treatment Period|Protocol deviation|1
2622235|NCT00911170|9065440|P2|Treatment Period|Ineligibility determined|3
2622236|NCT00911170|9065441|P1|Treatment Period|Ineligibility determined|1
2622237|NCT00911170|9065440|P2|Treatment Period|Randomized in error|1
2622238|NCT00911170|9065441|P1|Treatment Period|Randomized in error|1
2622239|NCT00911157|9065465|P2|Overall Study|Need to treat for lung cancer|0
2622240|NCT00911157|9065466|P1|Overall Study|Need to treat for lung cancer|1
2622241|NCT00911157|9065465|P2|Overall Study|Need for prohibited drug (heparin)|0
2622242|NCT00911157|9065466|P1|Overall Study|Need for prohibited drug (heparin)|1
2622243|NCT00911157|9065465|P2|Overall Study|Withdrawal by Subject|1
2622244|NCT00911157|9065466|P1|Overall Study|Withdrawal by Subject|1
2622245|NCT00911157|9065465|P2|Overall Study|Adverse Event|1
2622246|NCT00911157|9065466|P1|Overall Study|Adverse Event|4
2622247|NCT00911144|9065482|P2|Overall Study|Withdrawal by Subject|5
2622248|NCT00911144|9065483|P1|Overall Study|Withdrawal by Subject|16
2622249|NCT00910988|9065537|P4|Overall Study|Lost to Follow-up|0
2622250|NCT00910988|9065538|P3|Overall Study|Lost to Follow-up|3
2622251|NCT00910988|9065539|P2|Overall Study|Lost to Follow-up|4
2622252|NCT00910988|9065540|P1|Overall Study|Lost to Follow-up|2
2622253|NCT00910962|9065585|P3|Overall Study|Reached defined stopping criteria|17
2622254|NCT00910962|9065586|P2|Overall Study|Reached defined stopping criteria|14
2622255|NCT00910962|9065587|P1|Overall Study|Reached defined stopping criteria|12
2622256|NCT00910962|9065585|P3|Overall Study|Withdrawal by Subject|32
2622257|NCT00910962|9065586|P2|Overall Study|Withdrawal by Subject|32
2622258|NCT00910962|9065587|P1|Overall Study|Withdrawal by Subject|25
2622259|NCT00910962|9065585|P3|Overall Study|Physician Decision|6
2622260|NCT00910962|9065586|P2|Overall Study|Physician Decision|6
2622261|NCT00910962|9065587|P1|Overall Study|Physician Decision|0
2622262|NCT00910962|9065585|P3|Overall Study|Lost to Follow-up|1
2622263|NCT00910962|9065586|P2|Overall Study|Lost to Follow-up|3
2622264|NCT00910962|9065587|P1|Overall Study|Lost to Follow-up|0
2622265|NCT00910962|9065585|P3|Overall Study|Protocol Violation|3
2622266|NCT00910962|9065586|P2|Overall Study|Protocol Violation|3
2622267|NCT00910962|9065587|P1|Overall Study|Protocol Violation|1
2622268|NCT00910962|9065585|P3|Overall Study|Adverse Event|17
2622269|NCT00910962|9065586|P2|Overall Study|Adverse Event|20
2622270|NCT00910962|9065587|P1|Overall Study|Adverse Event|5
2622271|NCT00910910|9065679|P2|Overall Study|Untreated before cycle 1|2
2622272|NCT00910910|9065680|P1|Overall Study|Untreated before cycle 1|1
2622273|NCT00910910|9065679|P2|Overall Study|Other|32
2622274|NCT00910910|9065680|P1|Overall Study|Other|114
2622275|NCT00910910|9065679|P2|Overall Study|Completed 13 cycles of treatment|118
2622276|NCT00910910|9065680|P1|Overall Study|Completed 13 cycles of treatment|0
2622277|NCT00910910|9065679|P2|Overall Study|Protocol Violation|2
2622278|NCT00910910|9065680|P1|Overall Study|Protocol Violation|2
2622279|NCT00910910|9065679|P2|Overall Study|Death|3
2622280|NCT00910910|9065680|P1|Overall Study|Death|9
2622281|NCT00910910|9065679|P2|Overall Study|Lost to Follow-up|2
2622282|NCT00910910|9065680|P1|Overall Study|Lost to Follow-up|2
2622283|NCT00910910|9065679|P2|Overall Study|Withdrawal by Subject|5
2622284|NCT00910910|9065680|P1|Overall Study|Withdrawal by Subject|7
2622285|NCT00910910|9065679|P2|Overall Study|PD with histologic change|2
2622286|NCT00910910|9065680|P1|Overall Study|PD with histologic change|0
2622287|NCT00910910|9065679|P2|Overall Study|PD without histologic change|23
2622288|NCT00910910|9065680|P1|Overall Study|PD without histologic change|27
2622289|NCT00910910|9065679|P2|Overall Study|Adverse Event|35
2622290|NCT00910910|9065680|P1|Overall Study|Adverse Event|63
2622291|NCT00910871|9065716|P1|Overall Study|Undefined|1
2622292|NCT00910871|9065716|P1|Overall Study|Subject didn’t meet eligibility criteria|5
2622293|NCT00910871|9065716|P1|Overall Study|Withdrawal by Subject|12
2622294|NCT00910871|9065716|P1|Overall Study|Protocol Violation|11
2622295|NCT00910871|9065716|P1|Overall Study|Lost to Follow-up|8
2622296|NCT00910871|9065716|P1|Overall Study|Death|12
2622297|NCT00910871|9065716|P1|Overall Study|Adverse Event|5
2622298|NCT00910858|9065724|P3|Combined Treatment Phase|Other|1
2622299|NCT00910858|9065725|P2|Combined Treatment Phase|Other|2
2622300|NCT00910858|9065726|P1|Combined Treatment Phase|Other|0
2622301|NCT00910858|9065724|P3|Combined Treatment Phase|Protocol Violation|0
2622302|NCT00910858|9065725|P2|Combined Treatment Phase|Protocol Violation|0
2622303|NCT00910858|9065726|P1|Combined Treatment Phase|Protocol Violation|1
2622304|NCT00910858|9065724|P3|Combined Treatment Phase|Withdrawal by Subject|0
2622305|NCT00910858|9065725|P2|Combined Treatment Phase|Withdrawal by Subject|2
2622306|NCT00910858|9065726|P1|Combined Treatment Phase|Withdrawal by Subject|0
2622307|NCT00910858|9065724|P3|Combined Treatment Phase|Lack of therapeutic effect|3
2622308|NCT00910858|9065725|P2|Combined Treatment Phase|Lack of therapeutic effect|6
2622309|NCT00910858|9065726|P1|Combined Treatment Phase|Lack of therapeutic effect|8
2622310|NCT00910858|9065724|P3|Monotherapy Phase|Other|2
2622311|NCT00910858|9065725|P2|Monotherapy Phase|Other|4
2622312|NCT00910858|9065726|P1|Monotherapy Phase|Other|3
2622313|NCT00910858|9065724|P3|Monotherapy Phase|Protocol Violation|0
2622314|NCT00910858|9065725|P2|Monotherapy Phase|Protocol Violation|0
2622315|NCT00910858|9065726|P1|Monotherapy Phase|Protocol Violation|1
2622316|NCT00910858|9065724|P3|Monotherapy Phase|Withdrawal by Subject|1
2622317|NCT00910858|9065725|P2|Monotherapy Phase|Withdrawal by Subject|3
2622318|NCT00910858|9065726|P1|Monotherapy Phase|Withdrawal by Subject|1
2622319|NCT00910858|9065724|P3|Monotherapy Phase|Lack of therapeutic effect|4
2622320|NCT00910858|9065725|P2|Monotherapy Phase|Lack of therapeutic effect|6
2622321|NCT00910858|9065726|P1|Monotherapy Phase|Lack of therapeutic effect|9
2622322|NCT00910858|9065724|P3|Monotherapy Phase|Adverse Event|0
2622323|NCT00910858|9065725|P2|Monotherapy Phase|Adverse Event|2
2622324|NCT00910858|9065726|P1|Monotherapy Phase|Adverse Event|3
2622325|NCT00910858|9065724|P3|Pharmacokinetic Phase|Adverse Event|0
2622326|NCT00910858|9065725|P2|Pharmacokinetic Phase|Adverse Event|0
2622327|NCT00910858|9065726|P1|Pharmacokinetic Phase|Adverse Event|1
2622328|NCT00910728|9065771|P9|Overall Study|Adverse Event|1
2622329|NCT00910728|9065772|P8|Overall Study|Adverse Event|1
2622330|NCT00910728|9065773|P7|Overall Study|Adverse Event|2
2622331|NCT00910728|9065774|P6|Overall Study|Adverse Event|0
2622332|NCT00910728|9065775|P5|Overall Study|Adverse Event|0
2622333|NCT00910728|9065776|P4|Overall Study|Adverse Event|1
2622334|NCT00910728|9065777|P3|Overall Study|Adverse Event|1
2622335|NCT00910728|9065778|P2|Overall Study|Adverse Event|0
2622336|NCT00910728|9065779|P1|Overall Study|Adverse Event|2
2622337|NCT00910728|9065771|P9|Overall Study|(not specified)|0
2622338|NCT00910728|9065772|P8|Overall Study|(not specified)|0
2622339|NCT00910728|9065773|P7|Overall Study|(not specified)|0
2622340|NCT00910728|9065774|P6|Overall Study|(not specified)|0
2622341|NCT00910728|9065775|P5|Overall Study|(not specified)|1
2622342|NCT00910728|9065776|P4|Overall Study|(not specified)|0
2622343|NCT00910728|9065777|P3|Overall Study|(not specified)|1
2622344|NCT00910728|9065778|P2|Overall Study|(not specified)|0
2622345|NCT00910728|9065779|P1|Overall Study|(not specified)|2
2622346|NCT00910728|9065771|P9|Overall Study|Withdrawal by Subject|0
2622347|NCT00910728|9065772|P8|Overall Study|Withdrawal by Subject|0
2622348|NCT00910728|9065773|P7|Overall Study|Withdrawal by Subject|2
2622349|NCT00910728|9065774|P6|Overall Study|Withdrawal by Subject|1
2622350|NCT00910728|9065775|P5|Overall Study|Withdrawal by Subject|3
2622351|NCT00910728|9065776|P4|Overall Study|Withdrawal by Subject|0
2622352|NCT00910728|9065777|P3|Overall Study|Withdrawal by Subject|0
2622353|NCT00910728|9065778|P2|Overall Study|Withdrawal by Subject|0
2622354|NCT00910728|9065779|P1|Overall Study|Withdrawal by Subject|0
2622355|NCT00910728|9065771|P9|Overall Study|Lack of Efficacy|2
2622356|NCT00910728|9065772|P8|Overall Study|Lack of Efficacy|2
2622357|NCT00910728|9065773|P7|Overall Study|Lack of Efficacy|2
2622358|NCT00910728|9065774|P6|Overall Study|Lack of Efficacy|0
2622359|NCT00910728|9065775|P5|Overall Study|Lack of Efficacy|1
2622360|NCT00910728|9065776|P4|Overall Study|Lack of Efficacy|2
2622361|NCT00910728|9065777|P3|Overall Study|Lack of Efficacy|1
2622362|NCT00910728|9065778|P2|Overall Study|Lack of Efficacy|3
2622363|NCT00910728|9065779|P1|Overall Study|Lack of Efficacy|2
2622364|NCT00910715|9065901|P3|Overall Study|Lost to Follow-up|0
2622365|NCT00910715|9065902|P2|Overall Study|Lost to Follow-up|26
2622366|NCT00910715|9065903|P1|Overall Study|Lost to Follow-up|22
2622367|NCT00910689|9065917|P4|Months 11- 16: Evaluation Period II|Physician Decision|0
2622368|NCT00910689|9065918|P3|Months 11- 16: Evaluation Period II|Physician Decision|1
2622369|NCT00910689|9065919|P2|Months 11- 16: Evaluation Period II|Physician Decision|2
2622370|NCT00910689|9065920|P1|Months 11- 16: Evaluation Period II|Physician Decision|0
2622371|NCT00910689|9065917|P4|Months 11- 16: Evaluation Period II|Perceived Improvement|1
2622372|NCT00910689|9065918|P3|Months 11- 16: Evaluation Period II|Perceived Improvement|0
2622373|NCT00910689|9065919|P2|Months 11- 16: Evaluation Period II|Perceived Improvement|0
2622374|NCT00910689|9065920|P1|Months 11- 16: Evaluation Period II|Perceived Improvement|0
2622375|NCT00910689|9065917|P4|Months 11- 16: Evaluation Period II|Time Demands|0
2622376|NCT00910689|9065918|P3|Months 11- 16: Evaluation Period II|Time Demands|0
2622377|NCT00910689|9065919|P2|Months 11- 16: Evaluation Period II|Time Demands|1
2622378|NCT00910689|9065920|P1|Months 11- 16: Evaluation Period II|Time Demands|2
2622379|NCT00910689|9065917|P4|Months 11- 16: Evaluation Period II|Lack of Efficacy|1
2622380|NCT00910689|9065918|P3|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
2622381|NCT00910689|9065919|P2|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
2622382|NCT00910689|9065920|P1|Months 11- 16: Evaluation Period II|Lack of Efficacy|2
2622383|NCT00910689|9065917|P4|Months 11- 16: Evaluation Period II|Pregnancy|0
2622384|NCT00910689|9065918|P3|Months 11- 16: Evaluation Period II|Pregnancy|0
2622385|NCT00910689|9065919|P2|Months 11- 16: Evaluation Period II|Pregnancy|0
2622386|NCT00910689|9065920|P1|Months 11- 16: Evaluation Period II|Pregnancy|1
2622387|NCT00910689|9065917|P4|Months 11- 16: Evaluation Period II|Adverse Event|2
2622388|NCT00910689|9065918|P3|Months 11- 16: Evaluation Period II|Adverse Event|2
2622389|NCT00910689|9065919|P2|Months 11- 16: Evaluation Period II|Adverse Event|4
2622390|NCT00910689|9065920|P1|Months 11- 16: Evaluation Period II|Adverse Event|2
2622391|NCT00910689|9065917|P4|Months 11- 16: Evaluation Period II|Lost to Follow-up|2
2622392|NCT00910689|9065918|P3|Months 11- 16: Evaluation Period II|Lost to Follow-up|1
2622393|NCT00910689|9065919|P2|Months 11- 16: Evaluation Period II|Lost to Follow-up|0
2622394|NCT00910689|9065920|P1|Months 11- 16: Evaluation Period II|Lost to Follow-up|3
2622395|NCT00910689|9065917|P4|Months 5 - 10: Evaluation Period I|Time Demands|1
2622396|NCT00910689|9065918|P3|Months 5 - 10: Evaluation Period I|Time Demands|1
2622397|NCT00910689|9065919|P2|Months 5 - 10: Evaluation Period I|Time Demands|0
2622398|NCT00910689|9065920|P1|Months 5 - 10: Evaluation Period I|Time Demands|0
2622399|NCT00910689|9065917|P4|Months 5 - 10: Evaluation Period I|Pregnancy|0
2622400|NCT00910689|9065918|P3|Months 5 - 10: Evaluation Period I|Pregnancy|2
2622401|NCT00910689|9065919|P2|Months 5 - 10: Evaluation Period I|Pregnancy|0
2622402|NCT00910689|9065920|P1|Months 5 - 10: Evaluation Period I|Pregnancy|0
2622403|NCT00910689|9065917|P4|Months 5 - 10: Evaluation Period I|Protocol Violation|0
2622404|NCT00910689|9065918|P3|Months 5 - 10: Evaluation Period I|Protocol Violation|0
2622405|NCT00910689|9065919|P2|Months 5 - 10: Evaluation Period I|Protocol Violation|1
2622406|NCT00910689|9065920|P1|Months 5 - 10: Evaluation Period I|Protocol Violation|1
2622407|NCT00910689|9065917|P4|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
2622408|NCT00910689|9065918|P3|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
2622409|NCT00910689|9065919|P2|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
2622410|NCT00910689|9065920|P1|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0
2622411|NCT00910689|9065917|P4|Months 5 - 10: Evaluation Period I|Adverse Event|4
2622412|NCT00910689|9065918|P3|Months 5 - 10: Evaluation Period I|Adverse Event|2
2622413|NCT00910689|9065919|P2|Months 5 - 10: Evaluation Period I|Adverse Event|0
2622414|NCT00910689|9065920|P1|Months 5 - 10: Evaluation Period I|Adverse Event|1
2622415|NCT00910689|9065917|P4|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
2622416|NCT00910689|9065918|P3|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
2622417|NCT00910689|9065919|P2|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5
2622418|NCT00910689|9065920|P1|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2
2622419|NCT00910689|9065917|P4|Month 2- 4: Treatment Period|Protocol Violation|0
2622420|NCT00910689|9065918|P3|Month 2- 4: Treatment Period|Protocol Violation|0
2622421|NCT00910689|9065919|P2|Month 2- 4: Treatment Period|Protocol Violation|0
2622422|NCT00910689|9065920|P1|Month 2- 4: Treatment Period|Protocol Violation|1
2622423|NCT00910689|9065917|P4|Month 2- 4: Treatment Period|Pregnancy|0
2622424|NCT00910689|9065918|P3|Month 2- 4: Treatment Period|Pregnancy|0
2622425|NCT00910689|9065919|P2|Month 2- 4: Treatment Period|Pregnancy|2
2622426|NCT00910689|9065920|P1|Month 2- 4: Treatment Period|Pregnancy|0
2622427|NCT00910689|9065917|P4|Month 2- 4: Treatment Period|Perceived Improvement|0
2622428|NCT00910689|9065918|P3|Month 2- 4: Treatment Period|Perceived Improvement|1
2622429|NCT00910689|9065919|P2|Month 2- 4: Treatment Period|Perceived Improvement|0
2622430|NCT00910689|9065920|P1|Month 2- 4: Treatment Period|Perceived Improvement|0
2622431|NCT00910689|9065917|P4|Month 2- 4: Treatment Period|Lack of Efficacy|0
2622432|NCT00910689|9065918|P3|Month 2- 4: Treatment Period|Lack of Efficacy|0
2622433|NCT00910689|9065919|P2|Month 2- 4: Treatment Period|Lack of Efficacy|1
2622434|NCT00910689|9065920|P1|Month 2- 4: Treatment Period|Lack of Efficacy|2
2622435|NCT00910689|9065917|P4|Month 2- 4: Treatment Period|Time Demands|8
2622436|NCT00910689|9065918|P3|Month 2- 4: Treatment Period|Time Demands|4
2622437|NCT00910689|9065919|P2|Month 2- 4: Treatment Period|Time Demands|0
2622438|NCT00910689|9065920|P1|Month 2- 4: Treatment Period|Time Demands|1
2622439|NCT00910689|9065917|P4|Month 2- 4: Treatment Period|Adverse Event|0
2622440|NCT00910689|9065918|P3|Month 2- 4: Treatment Period|Adverse Event|2
2622441|NCT00910689|9065919|P2|Month 2- 4: Treatment Period|Adverse Event|3
2622442|NCT00910689|9065920|P1|Month 2- 4: Treatment Period|Adverse Event|2
2622443|NCT00910689|9065917|P4|Month 2- 4: Treatment Period|Lost to Follow-up|3
2622444|NCT00910689|9065918|P3|Month 2- 4: Treatment Period|Lost to Follow-up|1
2622445|NCT00910689|9065919|P2|Month 2- 4: Treatment Period|Lost to Follow-up|4
2622446|NCT00910689|9065920|P1|Month 2- 4: Treatment Period|Lost to Follow-up|3
2622447|NCT00910689|9065917|P4|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10
2622448|NCT00910689|9065918|P3|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5
2622449|NCT00910689|9065919|P2|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1
2622450|NCT00910689|9065920|P1|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2
2622451|NCT00910663|9065952|P2|Period 1|Withdrawal by Subject|1
2622452|NCT00910663|9065953|P1|Period 1|Withdrawal by Subject|0
2622453|NCT00910624|9065967|P4|Follow-Up Phase|Administrative|0
2622454|NCT00910624|9065968|P3|Follow-Up Phase|Administrative|1
2622455|NCT00910624|9065969|P2|Follow-Up Phase|Administrative|1
2622456|NCT00910624|9065970|P1|Follow-Up Phase|Administrative|0
2622457|NCT00910624|9065967|P4|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
2622458|NCT00910624|9065968|P3|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
2622459|NCT00910624|9065969|P2|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
2622460|NCT00910624|9065970|P1|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1
2622461|NCT00910624|9065967|P4|Follow-Up Phase|Withdrawal by Subject|0
2622462|NCT00910624|9065968|P3|Follow-Up Phase|Withdrawal by Subject|0
2622463|NCT00910624|9065969|P2|Follow-Up Phase|Withdrawal by Subject|0
2622464|NCT00910624|9065970|P1|Follow-Up Phase|Withdrawal by Subject|1
2622465|NCT00910624|9065967|P4|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
2622466|NCT00910624|9065968|P3|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
2622467|NCT00910624|9065969|P2|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2
2622468|NCT00910624|9065970|P1|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1
2622469|NCT00910624|9065967|P4|Follow-Up Phase|Lost to Follow-up|0
2622470|NCT00910624|9065968|P3|Follow-Up Phase|Lost to Follow-up|2
2622471|NCT00910624|9065969|P2|Follow-Up Phase|Lost to Follow-up|1
2622472|NCT00910624|9065970|P1|Follow-Up Phase|Lost to Follow-up|3
2622473|NCT00910624|9065967|P4|Follow-Up Phase|Adverse Event|0
2622474|NCT00910624|9065968|P3|Follow-Up Phase|Adverse Event|1
2622475|NCT00910624|9065969|P2|Follow-Up Phase|Adverse Event|0
2622476|NCT00910624|9065970|P1|Follow-Up Phase|Adverse Event|0
2622477|NCT00910624|9065967|P4|Treatment Phase|Non-Compliance With Protocol|0
2622478|NCT00910624|9065968|P3|Treatment Phase|Non-Compliance With Protocol|1
2622479|NCT00910624|9065969|P2|Treatment Phase|Non-Compliance With Protocol|1
2622480|NCT00910624|9065970|P1|Treatment Phase|Non-Compliance With Protocol|0
2622481|NCT00910624|9065967|P4|Treatment Phase|Withdrawal by Subject|0
2622482|NCT00910624|9065968|P3|Treatment Phase|Withdrawal by Subject|0
2622483|NCT00910624|9065969|P2|Treatment Phase|Withdrawal by Subject|1
2622484|NCT00910624|9065970|P1|Treatment Phase|Withdrawal by Subject|2
2622485|NCT00910624|9065967|P4|Treatment Phase|Reasons Unrelated To Assigned Treatment|0
2622486|NCT00910624|9065968|P3|Treatment Phase|Reasons Unrelated To Assigned Treatment|1
2622487|NCT00910624|9065969|P2|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
2622488|NCT00910624|9065970|P1|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
2622489|NCT00910624|9065967|P4|Treatment Phase|Lost to Follow-up|0
2622490|NCT00910624|9065968|P3|Treatment Phase|Lost to Follow-up|1
2622491|NCT00910624|9065969|P2|Treatment Phase|Lost to Follow-up|0
2622492|NCT00910624|9065970|P1|Treatment Phase|Lost to Follow-up|0
2622493|NCT00910624|9065967|P4|Treatment Phase|Treatment Failure|0
2622494|NCT00910624|9065968|P3|Treatment Phase|Treatment Failure|0
2622495|NCT00910624|9065969|P2|Treatment Phase|Treatment Failure|10
2622496|NCT00910624|9065970|P1|Treatment Phase|Treatment Failure|23
2622497|NCT00910624|9065967|P4|Treatment Phase|Adverse Event|0
2622498|NCT00910624|9065968|P3|Treatment Phase|Adverse Event|6
2622499|NCT00910624|9065969|P2|Treatment Phase|Adverse Event|6
2622500|NCT00910624|9065970|P1|Treatment Phase|Adverse Event|2
2622501|NCT00910299|9065997|P2|Overall Study|Didn't receive any study drug|1
2622502|NCT00910299|9065998|P1|Overall Study|Didn't receive any study drug|2
2622503|NCT00910299|9065997|P2|Overall Study|Sponsor Decision|60
2622504|NCT00910299|9065998|P1|Overall Study|Sponsor Decision|58
2622505|NCT00910299|9065997|P2|Overall Study|Withdrawal by Subject|13
2622506|NCT00910299|9065998|P1|Overall Study|Withdrawal by Subject|16
2622507|NCT00910273|9066010|P2|Overall Study|Lost to Follow-up|1
2622508|NCT00910273|9066011|P1|Overall Study|Lost to Follow-up|1
2622509|NCT00910273|9066010|P2|Overall Study|Protocol Violation|0
2622510|NCT00910273|9066011|P1|Overall Study|Protocol Violation|1
2622511|NCT00910273|9066010|P2|Overall Study|Discontinuation of study by sponsor|2
2622512|NCT00910273|9066011|P1|Overall Study|Discontinuation of study by sponsor|8
2622513|NCT00910273|9066010|P2|Overall Study|Withdrawal by Subject|0
2622514|NCT00910273|9066011|P1|Overall Study|Withdrawal by Subject|1
2622515|NCT00910273|9066010|P2|Overall Study|Adverse Event|1
2622516|NCT00910273|9066011|P1|Overall Study|Adverse Event|1
2622517|NCT00910273|9066010|P2|Overall Study|Lack of Efficacy|9
2622518|NCT00910273|9066011|P1|Overall Study|Lack of Efficacy|6
2622519|NCT00910247|9066061|P1|Overall Study|Not collected|4
2622520|NCT00910247|9066061|P1|Overall Study|Withdrawal by Subject|25
2622521|NCT00910247|9066061|P1|Overall Study|Protocol Violation|10
2622522|NCT00910247|9066061|P1|Overall Study|Physician Decision|3
2622523|NCT00910247|9066061|P1|Overall Study|Lost to Follow-up|10
2622524|NCT00910247|9066061|P1|Overall Study|Death|2
2622525|NCT00910247|9066061|P1|Overall Study|Adverse Event|15
2622526|NCT00910091|9066111|P2|Treatment and Survival|Adverse Event|0
2622527|NCT00910091|9066112|P1|Treatment and Survival|Adverse Event|1
2622528|NCT00910091|9066111|P2|Treatment and Survival|Withdrawal by Subject|4
2622529|NCT00910091|9066112|P1|Treatment and Survival|Withdrawal by Subject|3
2622530|NCT00910091|9066111|P2|Pre-assignment|Withdrawal by Subject|2
2622531|NCT00910091|9066112|P1|Pre-assignment|Withdrawal by Subject|0
2622532|NCT00910039|9066140|P1|Overall Study|Physician Decision|1
2622533|NCT00910000|9066157|P6|Overall Study|Withdrawal by Subject|0
2622534|NCT00910000|9066158|P5|Overall Study|Withdrawal by Subject|1
2622535|NCT00910000|9066159|P4|Overall Study|Withdrawal by Subject|0
2622536|NCT00910000|9066160|P3|Overall Study|Withdrawal by Subject|1
2622537|NCT00910000|9066161|P2|Overall Study|Withdrawal by Subject|0
2622538|NCT00910000|9066162|P1|Overall Study|Withdrawal by Subject|0
2622539|NCT00910000|9066157|P6|Overall Study|Adverse Event|1
2622540|NCT00910000|9066158|P5|Overall Study|Adverse Event|0
2622541|NCT00910000|9066159|P4|Overall Study|Adverse Event|2
2622542|NCT00910000|9066160|P3|Overall Study|Adverse Event|2
2622543|NCT00910000|9066161|P2|Overall Study|Adverse Event|3
2622544|NCT00910000|9066162|P1|Overall Study|Adverse Event|0
2622545|NCT00909870|9066180|P2|Overall Study|Other|5
2622546|NCT00909870|9066181|P1|Overall Study|Other|1
2622547|NCT00909870|9066180|P2|Overall Study|Physician Decision|2
2622548|NCT00909870|9066181|P1|Overall Study|Physician Decision|0
2622549|NCT00909870|9066180|P2|Overall Study|Lost to Follow-up|3
2622550|NCT00909870|9066181|P1|Overall Study|Lost to Follow-up|3
2622551|NCT00909870|9066180|P2|Overall Study|Withdrawal by Subject|8
2622552|NCT00909870|9066181|P1|Overall Study|Withdrawal by Subject|5
2622553|NCT00909870|9066180|P2|Overall Study|Protocol Violation|2
2622554|NCT00909870|9066181|P1|Overall Study|Protocol Violation|1
2622555|NCT00909870|9066180|P2|Overall Study|Adverse Event|7
2622556|NCT00909870|9066181|P1|Overall Study|Adverse Event|13
2622557|NCT00909857|9066193|P2|Overall Study|Did not receive study medication|24
2622558|NCT00909857|9066194|P1|Overall Study|Did not receive study medication|19
2622559|NCT00909857|9066193|P2|Overall Study|Other|0
2622560|NCT00909857|9066194|P1|Overall Study|Other|1
2622561|NCT00909857|9066193|P2|Overall Study|Pregnancy|0
2622562|NCT00909857|9066194|P1|Overall Study|Pregnancy|1
2622563|NCT00909857|9066193|P2|Overall Study|Protocol Violation|1
2622564|NCT00909857|9066194|P1|Overall Study|Protocol Violation|2
2622565|NCT00909857|9066193|P2|Overall Study|Lost to Follow-up|5
2622566|NCT00909857|9066194|P1|Overall Study|Lost to Follow-up|2
2622567|NCT00909857|9066193|P2|Overall Study|Adverse Event|5
2622568|NCT00909857|9066194|P1|Overall Study|Adverse Event|5
2622569|NCT00909857|9066193|P2|Overall Study|Withdrawal by Subject|10
2622570|NCT00909857|9066194|P1|Overall Study|Withdrawal by Subject|6
2622571|NCT00909844|9066334|P1|Overall Study|Lost to Follow-up|2
2622572|NCT00909844|9066334|P1|Overall Study|Withdrawal by Subject|1
2622573|NCT00909844|9066334|P1|Overall Study|Adverse Event|1
2622574|NCT00909792|9066352|P2|Period 2|Lost to Follow-up|1
2622575|NCT00909792|9066353|P1|Period 2|Lost to Follow-up|0
2622576|NCT00909792|9066352|P2|Period 2|Biomicroscopy|0
2622577|NCT00909792|9066353|P1|Period 2|Biomicroscopy|1
2622578|NCT00909792|9066352|P2|Period 1|Did not meet inclusion criteria|1
2622579|NCT00909792|9066353|P1|Period 1|Did not meet inclusion criteria|0
2622580|NCT00909779|9066361|P2|Overall Study|Randomized in error|1
2622581|NCT00909779|9066362|P1|Overall Study|Randomized in error|1
2622582|NCT00909779|9066361|P2|Overall Study|Noncompliance|1
2622583|NCT00909779|9066362|P1|Overall Study|Noncompliance|1
2622584|NCT00909779|9066361|P2|Overall Study|Medical Monitor Decision|0
2622585|NCT00909779|9066362|P1|Overall Study|Medical Monitor Decision|1
2622586|NCT00909779|9066361|P2|Overall Study|Site Ceasing Operation|2
2622587|NCT00909779|9066362|P1|Overall Study|Site Ceasing Operation|2
2622588|NCT00909779|9066361|P2|Overall Study|Withdrawal by Subject|80
2622589|NCT00909779|9066362|P1|Overall Study|Withdrawal by Subject|116
2622590|NCT00909779|9066361|P2|Overall Study|Protocol Violation|5
2622591|NCT00909779|9066362|P1|Overall Study|Protocol Violation|2
2622592|NCT00909779|9066361|P2|Overall Study|Physician Decision|2
2622593|NCT00909779|9066362|P1|Overall Study|Physician Decision|8
2622594|NCT00909779|9066361|P2|Overall Study|Lost to Follow-up|15
2622595|NCT00909779|9066362|P1|Overall Study|Lost to Follow-up|19
2622596|NCT00909779|9066361|P2|Overall Study|Lack of Efficacy|4
2622597|NCT00909779|9066362|P1|Overall Study|Lack of Efficacy|7
2622598|NCT00909779|9066361|P2|Overall Study|Adverse Event|55
2622599|NCT00909779|9066362|P1|Overall Study|Adverse Event|53
2622600|NCT00909753|9066386|P2|Period: Second Intervention|Protocol Violation|0
2622601|NCT00909753|9066387|P1|Period: Second Intervention|Protocol Violation|1
2622602|NCT00909753|9066386|P2|Period: Washout of 28 Days|Protocol Violation|3
2622603|NCT00909753|9066387|P1|Period: Washout of 28 Days|Protocol Violation|2
2622604|NCT00909727|9066407|P2|Overall Study|Prohibited Medication|0
2622605|NCT00909727|9066408|P1|Overall Study|Prohibited Medication|1
2622606|NCT00909727|9066407|P2|Overall Study|Withdrawal of Consent|0
2622607|NCT00909727|9066408|P1|Overall Study|Withdrawal of Consent|1
2622608|NCT00909727|9066407|P2|Overall Study|Wrong Genotype|0
2622609|NCT00909727|9066408|P1|Overall Study|Wrong Genotype|1
2622610|NCT00909727|9066407|P2|Overall Study|Adverse Event|0
2622611|NCT00909727|9066408|P1|Overall Study|Adverse Event|1
2622612|NCT00909610|9066431|P2|Period: Second Intervention|Adverse Event|0
2622613|NCT00909610|9066432|P1|Period: Second Intervention|Adverse Event|1
2622614|NCT00909610|9066431|P2|Period: Washout of 28 Days|Withdrawal by Subject|6
2622615|NCT00909610|9066432|P1|Period: Washout of 28 Days|Withdrawal by Subject|3
2622616|NCT00909610|9066431|P2|Period: First Intervention|Adverse Event|1
2622617|NCT00909610|9066432|P1|Period: First Intervention|Adverse Event|0
2622618|NCT00909532|9066593|P2|Overall Study|Increased Lab Draws, Difficult Lab Stick|0
2622619|NCT00909532|9066594|P1|Overall Study|Increased Lab Draws, Difficult Lab Stick|1
2622620|NCT00909532|9066593|P2|Overall Study|Wrong Genotype|0
2622621|NCT00909532|9066594|P1|Overall Study|Wrong Genotype|1
2622622|NCT00909532|9066593|P2|Overall Study|Physician Decision|0
2622623|NCT00909532|9066594|P1|Overall Study|Physician Decision|1
2622624|NCT00909532|9066593|P2|Overall Study|Noncompliance with Study Requirements|2
2622625|NCT00909532|9066594|P1|Overall Study|Noncompliance with Study Requirements|0
2622626|NCT00909532|9066593|P2|Overall Study|Withdrawal of Consent|1
2622627|NCT00909532|9066594|P1|Overall Study|Withdrawal of Consent|1
2622628|NCT00909532|9066593|P2|Overall Study|Prohibited Medication|1
2622629|NCT00909532|9066594|P1|Overall Study|Prohibited Medication|2
2622630|NCT00909532|9066593|P2|Overall Study|Pregnancy|1
2622631|NCT00909532|9066594|P1|Overall Study|Pregnancy|0
2622632|NCT00909532|9066593|P2|Overall Study|Adverse Event|1
2622633|NCT00909532|9066594|P1|Overall Study|Adverse Event|4
2622634|NCT00909480|9066612|P2|Overall Study|Unclassified|19
2622635|NCT00909480|9066613|P1|Overall Study|Unclassified|18
2622636|NCT00909480|9066612|P2|Overall Study|Withdrawal criteria|11
2622637|NCT00909480|9066613|P1|Overall Study|Withdrawal criteria|9
2622638|NCT00909480|9066612|P2|Overall Study|Protocol Violation|8
2622639|NCT00909480|9066613|P1|Overall Study|Protocol Violation|6
2622640|NCT00909480|9066612|P2|Overall Study|Adverse Event|3
2622641|NCT00909480|9066613|P1|Overall Study|Adverse Event|5
2622642|NCT00909428|9066648|P3|Overall Study|Lost to Follow-up|9
2622643|NCT00909428|9066649|P2|Overall Study|Lost to Follow-up|10
2622644|NCT00909428|9066650|P1|Overall Study|Lost to Follow-up|13
2622645|NCT00909389|9066657|P1|Overall Study|No Information|103
2622646|NCT00909389|9066657|P1|Overall Study|Lost to Follow-up|4
2622647|NCT00909389|9066657|P1|Overall Study|Poor Compliance|16
2622648|NCT00909389|9066657|P1|Overall Study|Death|4
2622649|NCT00909389|9066657|P1|Overall Study|Adverse Event|6
2622650|NCT00909363|9066664|P3|Overall Study|Lack of Efficacy|0
2622651|NCT00909363|9066665|P2|Overall Study|Lack of Efficacy|0
2622652|NCT00909363|9066666|P1|Overall Study|Lack of Efficacy|1
2622653|NCT00909363|9066664|P3|Overall Study|Withdrawal by Subject|0
2622654|NCT00909363|9066665|P2|Overall Study|Withdrawal by Subject|0
2622655|NCT00909363|9066666|P1|Overall Study|Withdrawal by Subject|1
2622656|NCT00909181|9066713|P3|Overall Study|Lost to Follow-up|33
2622657|NCT00909181|9066714|P2|Overall Study|Lost to Follow-up|18
2622658|NCT00909181|9066715|P1|Overall Study|Lost to Follow-up|39
2622659|NCT00909038|9066745|P1|Overall Study|Non-evaluable Subjects|230
2622660|NCT00909038|9066745|P1|Overall Study|Protocol Violation|187
2622661|NCT00908960|9066757|P3|Overall Study|Presence VTE dx or Absent VTE eval|2
2622662|NCT00908960|9066758|P2|Overall Study|Presence VTE dx or Absent VTE eval|1
2622663|NCT00908960|9066759|P1|Overall Study|Presence VTE dx or Absent VTE eval|1
2622664|NCT00908895|9066803|P2|Overall Study|Adverse Event|1
2622665|NCT00908895|9066804|P1|Overall Study|Adverse Event|1
2622666|NCT00908895|9066803|P2|Overall Study|algodystrophy|2
2622667|NCT00908895|9066804|P1|Overall Study|algodystrophy|2
2622668|NCT00908895|9066803|P2|Overall Study|Lost to Follow-up|3
2622669|NCT00908895|9066804|P1|Overall Study|Lost to Follow-up|1
2622670|NCT00908596|9066905|P4|Overall Study|Withdrawal by Subject|1
2622671|NCT00908596|9066906|P3|Overall Study|Withdrawal by Subject|3
2622672|NCT00908596|9066907|P2|Overall Study|Withdrawal by Subject|1
2622673|NCT00908596|9066908|P1|Overall Study|Withdrawal by Subject|0
2622674|NCT00908596|9066905|P4|Overall Study|Protocol Violation|0
2622675|NCT00908596|9066906|P3|Overall Study|Protocol Violation|0
2622676|NCT00908596|9066907|P2|Overall Study|Protocol Violation|0
2622677|NCT00908596|9066908|P1|Overall Study|Protocol Violation|1
2622678|NCT00908596|9066905|P4|Overall Study|Death|32
2622679|NCT00908596|9066906|P3|Overall Study|Death|57
2622680|NCT00908596|9066907|P2|Overall Study|Death|5
2622681|NCT00908596|9066908|P1|Overall Study|Death|0
2622682|NCT00908596|9066905|P4|Overall Study|Lost to Follow-up|4
2622683|NCT00908596|9066906|P3|Overall Study|Lost to Follow-up|12
2622684|NCT00908596|9066907|P2|Overall Study|Lost to Follow-up|1
2622685|NCT00908596|9066908|P1|Overall Study|Lost to Follow-up|0
2622686|NCT00908596|9066905|P4|Overall Study|Other reasons|0
2622687|NCT00908596|9066906|P3|Overall Study|Other reasons|2
2622688|NCT00908596|9066907|P2|Overall Study|Other reasons|6
2622689|NCT00908596|9066908|P1|Overall Study|Other reasons|46
2622690|NCT00908583|9066938|P1|Phase 5|Adverse Event|3
2622691|NCT00908583|9066938|P1|Phase 4|Physician Decision|1
2622692|NCT00908583|9066938|P1|Phase 4|Adverse Event|1
2622693|NCT00908583|9066938|P1|Phase 3|Adverse Event|2
2622694|NCT00908583|9066938|P1|Phase 2|Adverse Event|1
2622695|NCT00908583|9066938|P1|Phase 2|Physician Decision|1
2622696|NCT00908583|9066938|P1|Phase 1|Adverse Event|4
2622697|NCT00908583|9066938|P1|Phase 1|Withdrawal by Subject|1
2622698|NCT00908544|9066958|P2|Overall Study|Unable to visit sutdy center|0
2622699|NCT00908544|9066959|P1|Overall Study|Unable to visit sutdy center|1
2622700|NCT00908544|9066958|P2|Overall Study|Relocation abroad|1
2622701|NCT00908544|9066959|P1|Overall Study|Relocation abroad|1
2622702|NCT00908544|9066958|P2|Overall Study|Pregnancy|0
2622703|NCT00908544|9066959|P1|Overall Study|Pregnancy|1
2622704|NCT00908544|9066958|P2|Overall Study|Lack of Efficacy|1
2622705|NCT00908544|9066959|P1|Overall Study|Lack of Efficacy|0
2622706|NCT00908544|9066958|P2|Overall Study|Withdrawal by Subject|4
2622707|NCT00908544|9066959|P1|Overall Study|Withdrawal by Subject|2
2622708|NCT00908375|9067018|P2|Overall Study|Lost to Follow-up|6
2622709|NCT00908375|9067019|P1|Overall Study|Lost to Follow-up|8
2622710|NCT00908375|9067018|P2|Overall Study|Withdrawal by Subject|4
2622711|NCT00908375|9067019|P1|Overall Study|Withdrawal by Subject|2
2622712|NCT00908349|9067029|P1|Overall Study|Various|6
2622713|NCT00908349|9067029|P1|Overall Study|Lost to Follow-up|5
2622714|NCT00908349|9067029|P1|Overall Study|Physician Decision|5
2622715|NCT00908349|9067029|P1|Overall Study|Withdrawal by Subject|9
2622716|NCT00908349|9067029|P1|Overall Study|Adverse Event|10
2622717|NCT00908310|9067033|P1|Overall Study|Other reasons|4
2622718|NCT00908310|9067033|P1|Overall Study|Screening failure|5
2622719|NCT00908310|9067033|P1|Overall Study|Lost to Follow-up|7
2622720|NCT00908310|9067033|P1|Overall Study|Withdrawal by Subject|7
2622721|NCT00908310|9067033|P1|Overall Study|Death|37
2622722|NCT00908232|9067037|P4|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
2622723|NCT00908232|9067038|P3|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
2622724|NCT00908232|9067039|P2|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
2622725|NCT00908232|9067040|P1|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1
2622726|NCT00908232|9067037|P4|Randomization (Cycle 5) to Cycle 8|Other|0
2622727|NCT00908232|9067038|P3|Randomization (Cycle 5) to Cycle 8|Other|0
2622728|NCT00908232|9067039|P2|Randomization (Cycle 5) to Cycle 8|Other|1
2622729|NCT00908232|9067040|P1|Randomization (Cycle 5) to Cycle 8|Other|3
2622730|NCT00908232|9067037|P4|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
2622731|NCT00908232|9067038|P3|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
2622732|NCT00908232|9067039|P2|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
2622733|NCT00908232|9067040|P1|Randomization (Cycle 5) to Cycle 8|Physician Decision|2
2622734|NCT00908232|9067037|P4|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
2622735|NCT00908232|9067038|P3|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
2622736|NCT00908232|9067039|P2|Randomization (Cycle 5) to Cycle 8|Adverse Event|2
2622737|NCT00908232|9067040|P1|Randomization (Cycle 5) to Cycle 8|Adverse Event|17
2622738|NCT00908232|9067037|P4|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
2622739|NCT00908232|9067038|P3|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1
2622740|NCT00908232|9067039|P2|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
2622741|NCT00908232|9067040|P1|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4
2622742|NCT00908232|9067037|P4|Randomization (Cycle 5) to Cycle 8|Death|0
2622743|NCT00908232|9067038|P3|Randomization (Cycle 5) to Cycle 8|Death|0
2622744|NCT00908232|9067039|P2|Randomization (Cycle 5) to Cycle 8|Death|0
2622745|NCT00908232|9067040|P1|Randomization (Cycle 5) to Cycle 8|Death|2
2622746|NCT00908232|9067037|P4|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
2622747|NCT00908232|9067038|P3|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
2622748|NCT00908232|9067039|P2|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
2622749|NCT00908232|9067040|P1|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5
2622750|NCT00908232|9067037|P4|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
2622751|NCT00908232|9067038|P3|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
2622752|NCT00908232|9067039|P2|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
2622753|NCT00908232|9067040|P1|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1
2622754|NCT00908232|9067037|P4|Cycle 1 to 4|Other|0
2622755|NCT00908232|9067038|P3|Cycle 1 to 4|Other|0
2622756|NCT00908232|9067039|P2|Cycle 1 to 4|Other|0
2622757|NCT00908232|9067040|P1|Cycle 1 to 4|Other|1
2622758|NCT00908232|9067037|P4|Cycle 1 to 4|Adverse Event|0
2622759|NCT00908232|9067038|P3|Cycle 1 to 4|Adverse Event|0
2622760|NCT00908232|9067039|P2|Cycle 1 to 4|Adverse Event|0
2622761|NCT00908232|9067040|P1|Cycle 1 to 4|Adverse Event|12
2622762|NCT00908232|9067037|P4|Cycle 1 to 4|Progressive Disease|0
2622763|NCT00908232|9067038|P3|Cycle 1 to 4|Progressive Disease|0
2622764|NCT00908232|9067039|P2|Cycle 1 to 4|Progressive Disease|0
2622765|NCT00908232|9067040|P1|Cycle 1 to 4|Progressive Disease|6
2622766|NCT00908232|9067037|P4|Cycle 1 to 4|Withdrawal by Subject|0
2622767|NCT00908232|9067038|P3|Cycle 1 to 4|Withdrawal by Subject|0
2622768|NCT00908232|9067039|P2|Cycle 1 to 4|Withdrawal by Subject|0
2622769|NCT00908232|9067040|P1|Cycle 1 to 4|Withdrawal by Subject|4
2622770|NCT00908232|9067037|P4|Cycle 1 to 4|Death|0
2622771|NCT00908232|9067038|P3|Cycle 1 to 4|Death|0
2622772|NCT00908232|9067039|P2|Cycle 1 to 4|Death|0
2622773|NCT00908232|9067040|P1|Cycle 1 to 4|Death|5
2622774|NCT00908141|9067058|P2|Overall Study|Withdrawal by Subject|1
2622775|NCT00908141|9067059|P1|Overall Study|Withdrawal by Subject|0
2622776|NCT00908115|9067076|P1|Overall Study|Other|14
2622777|NCT00908076|9067084|P2|Overall Study|Lack of Efficacy|1
2622778|NCT00908076|9067085|P1|Overall Study|Lack of Efficacy|1
2622779|NCT00908037|9067098|P12|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
2622780|NCT00908037|9067099|P11|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2
2622781|NCT00908037|9067100|P10|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
2622782|NCT00908037|9067101|P9|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
2622783|NCT00908037|9067102|P8|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
2622784|NCT00908037|9067103|P7|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
2622785|NCT00908037|9067104|P6|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
2622786|NCT00908037|9067105|P5|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
2622787|NCT00908037|9067106|P4|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
2622788|NCT00908037|9067107|P3|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
2622789|NCT00908037|9067108|P2|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
2622790|NCT00908037|9067109|P1|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
2622791|NCT00908037|9067098|P12|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
2622792|NCT00908037|9067099|P11|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
2622793|NCT00908037|9067100|P10|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1
2622794|NCT00908037|9067101|P9|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
2622795|NCT00908037|9067102|P8|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
2622796|NCT00908037|9067103|P7|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
2622797|NCT00908037|9067104|P6|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
2622798|NCT00908037|9067105|P5|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
2622799|NCT00908037|9067106|P4|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
2622800|NCT00908037|9067107|P3|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
2622801|NCT00908037|9067108|P2|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
2622802|NCT00908037|9067109|P1|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
2622803|NCT00908037|9067098|P12|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
2622804|NCT00908037|9067099|P11|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2
2622805|NCT00908037|9067100|P10|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
2622806|NCT00908037|9067101|P9|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
2622807|NCT00908037|9067102|P8|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
2622808|NCT00908037|9067103|P7|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
2622809|NCT00908037|9067104|P6|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
2622810|NCT00908037|9067105|P5|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
2622811|NCT00908037|9067106|P4|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
2622812|NCT00908037|9067107|P3|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
2622813|NCT00908037|9067108|P2|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
2622814|NCT00908037|9067109|P1|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
2622815|NCT00908037|9067098|P12|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
2622816|NCT00908037|9067099|P11|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
2622817|NCT00908037|9067100|P10|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1
2622818|NCT00908037|9067101|P9|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
2622819|NCT00908037|9067102|P8|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
2622820|NCT00908037|9067103|P7|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
2622821|NCT00908037|9067104|P6|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
2622822|NCT00908037|9067105|P5|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
2622823|NCT00908037|9067106|P4|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
2622824|NCT00908037|9067107|P3|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
2622825|NCT00908037|9067108|P2|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
2622826|NCT00908037|9067109|P1|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
2622827|NCT00908037|9067098|P12|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2
2622828|NCT00908037|9067099|P11|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
2622829|NCT00908037|9067100|P10|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1
2622830|NCT00908037|9067101|P9|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
2622831|NCT00908037|9067102|P8|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
2622832|NCT00908037|9067103|P7|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
2622833|NCT00908037|9067104|P6|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
2622834|NCT00908037|9067105|P5|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
2622835|NCT00908037|9067106|P4|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
2622836|NCT00908037|9067107|P3|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
2622837|NCT00908037|9067108|P2|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
2622838|NCT00908037|9067109|P1|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
2622839|NCT00908037|9067098|P12|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1
2622840|NCT00908037|9067099|P11|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
2622841|NCT00908037|9067100|P10|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
2622842|NCT00908037|9067101|P9|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
2622843|NCT00908037|9067102|P8|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
2622844|NCT00908037|9067103|P7|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
2622845|NCT00908037|9067104|P6|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
2622846|NCT00908037|9067105|P5|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
2622847|NCT00908037|9067106|P4|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
2622848|NCT00908037|9067107|P3|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
2622849|NCT00908037|9067108|P2|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
2622850|NCT00908037|9067109|P1|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
2622851|NCT00908037|9067098|P12|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
2622852|NCT00908037|9067099|P11|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
2622853|NCT00908037|9067100|P10|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
2622854|NCT00908037|9067101|P9|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
2622855|NCT00908037|9067102|P8|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
2622856|NCT00908037|9067103|P7|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
2622857|NCT00908037|9067104|P6|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
2622858|NCT00908037|9067105|P5|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
2622859|NCT00908037|9067106|P4|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
2622860|NCT00908037|9067107|P3|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
2622861|NCT00908037|9067108|P2|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
2622862|NCT00908037|9067109|P1|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
2622863|NCT00908037|9067098|P12|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
2622864|NCT00908037|9067099|P11|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
2622865|NCT00908037|9067100|P10|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
2622866|NCT00908037|9067101|P9|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4
2622867|NCT00908037|9067102|P8|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
2622868|NCT00908037|9067103|P7|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
2622869|NCT00908037|9067104|P6|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
2622870|NCT00908037|9067105|P5|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2
2622871|NCT00908037|9067106|P4|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
2622872|NCT00908037|9067107|P3|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
2622873|NCT00908037|9067108|P2|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
2622874|NCT00908037|9067109|P1|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
2622875|NCT00908037|9067098|P12|Part 2 (7 Week Randomized Period)|Protocol Violation|0
2622876|NCT00908037|9067099|P11|Part 2 (7 Week Randomized Period)|Protocol Violation|0
2622877|NCT00908037|9067100|P10|Part 2 (7 Week Randomized Period)|Protocol Violation|0
2622878|NCT00908037|9067101|P9|Part 2 (7 Week Randomized Period)|Protocol Violation|1
2622879|NCT00908037|9067102|P8|Part 2 (7 Week Randomized Period)|Protocol Violation|0
2622880|NCT00908037|9067103|P7|Part 2 (7 Week Randomized Period)|Protocol Violation|3
2622881|NCT00908037|9067104|P6|Part 2 (7 Week Randomized Period)|Protocol Violation|0
2622882|NCT00908037|9067105|P5|Part 2 (7 Week Randomized Period)|Protocol Violation|1
2622883|NCT00908037|9067106|P4|Part 2 (7 Week Randomized Period)|Protocol Violation|0
2622884|NCT00908037|9067107|P3|Part 2 (7 Week Randomized Period)|Protocol Violation|0
2622885|NCT00908037|9067108|P2|Part 2 (7 Week Randomized Period)|Protocol Violation|0
2622886|NCT00908037|9067109|P1|Part 2 (7 Week Randomized Period)|Protocol Violation|0
2622887|NCT00908011|9067258|P2|Overall Study|Withdrawal by Subject|2
2622888|NCT00908011|9067259|P1|Overall Study|Withdrawal by Subject|2
2622889|NCT00907881|9067276|P1|Overall Study|Missing discontinuation information|15
2622890|NCT00907881|9067276|P1|Overall Study|Protocol Violation|1
2622891|NCT00907881|9067276|P1|Overall Study|Withdrawal by Subject|5
2622892|NCT00907881|9067276|P1|Overall Study|Noncompliance|5
2622893|NCT00907881|9067276|P1|Overall Study|Lost to Follow-up|59
2622894|NCT00907803|9067286|P3|Overall Study|Protocol Violation|0
2622895|NCT00907803|9067287|P2|Overall Study|Protocol Violation|1
2622896|NCT00907803|9067288|P1|Overall Study|Protocol Violation|0
2622897|NCT00907803|9067286|P3|Overall Study|Lost to Follow-up|0
2622898|NCT00907803|9067287|P2|Overall Study|Lost to Follow-up|1
2622899|NCT00907803|9067288|P1|Overall Study|Lost to Follow-up|0
2622900|NCT00907803|9067286|P3|Overall Study|Withdrawal by Subject|0
2622901|NCT00907803|9067287|P2|Overall Study|Withdrawal by Subject|1
2622902|NCT00907803|9067288|P1|Overall Study|Withdrawal by Subject|0
2622903|NCT00907803|9067286|P3|Overall Study|Adverse Event|0
2622904|NCT00907803|9067287|P2|Overall Study|Adverse Event|0
2622905|NCT00907803|9067288|P1|Overall Study|Adverse Event|2
2622906|NCT00907803|9067286|P3|Overall Study|Withdrawal of consent - long commute|0
2622907|NCT00907803|9067287|P2|Overall Study|Withdrawal of consent - long commute|0
2622908|NCT00907803|9067288|P1|Overall Study|Withdrawal of consent - long commute|1
2622909|NCT00907777|9067319|P2|Overall Study|Withdrawal by Subject|1
2622910|NCT00907777|9067320|P1|Overall Study|Withdrawal by Subject|0
2622911|NCT00907738|9067347|P5|Overall Study|Disease progression|2
2622912|NCT00907738|9067348|P4|Overall Study|Disease progression|4
2622913|NCT00907738|9067349|P3|Overall Study|Disease progression|6
2622914|NCT00907738|9067350|P2|Overall Study|Disease progression|1
2622915|NCT00907738|9067351|P1|Overall Study|Disease progression|8
2622916|NCT00907738|9067347|P5|Overall Study|not specified or withdrew consent|0
2622917|NCT00907738|9067348|P4|Overall Study|not specified or withdrew consent|0
2622918|NCT00907738|9067349|P3|Overall Study|not specified or withdrew consent|0
2622919|NCT00907738|9067350|P2|Overall Study|not specified or withdrew consent|0
2622920|NCT00907738|9067351|P1|Overall Study|not specified or withdrew consent|3
2622921|NCT00907738|9067347|P5|Overall Study|Adverse Event|0
2622922|NCT00907738|9067348|P4|Overall Study|Adverse Event|0
2622923|NCT00907738|9067349|P3|Overall Study|Adverse Event|1
2622924|NCT00907738|9067350|P2|Overall Study|Adverse Event|0
2622925|NCT00907738|9067351|P1|Overall Study|Adverse Event|2
2622926|NCT00907621|9067369|P2|Overall Study|intercurrent febrile illness|1
2622927|NCT00907621|9067370|P1|Overall Study|intercurrent febrile illness|1
2622928|NCT00907621|9067369|P2|Overall Study|Lost to Follow-up|3
2622929|NCT00907621|9067370|P1|Overall Study|Lost to Follow-up|6
2622930|NCT00907517|9067383|P5|Overall Study|Symptomatic Deterioration|1
2622931|NCT00907517|9067384|P4|Overall Study|Symptomatic Deterioration|0
2622932|NCT00907517|9067385|P3|Overall Study|Symptomatic Deterioration|0
2622933|NCT00907517|9067386|P2|Overall Study|Symptomatic Deterioration|0
2622934|NCT00907517|9067387|P1|Overall Study|Symptomatic Deterioration|0
2622935|NCT00907517|9067383|P5|Overall Study|Progressive Disease|4
2622936|NCT00907517|9067384|P4|Overall Study|Progressive Disease|4
2622937|NCT00907517|9067385|P3|Overall Study|Progressive Disease|4
2622938|NCT00907517|9067386|P2|Overall Study|Progressive Disease|3
2622939|NCT00907517|9067387|P1|Overall Study|Progressive Disease|3
2622940|NCT00907478|9067412|P3|Overall Study|Other|1
2622941|NCT00907478|9067413|P2|Overall Study|Other|0
2622942|NCT00907478|9067414|P1|Overall Study|Other|3
2622943|NCT00907478|9067412|P3|Overall Study|Lost to Follow-up|0
2622944|NCT00907478|9067413|P2|Overall Study|Lost to Follow-up|0
2622945|NCT00907478|9067414|P1|Overall Study|Lost to Follow-up|1
2622946|NCT00907478|9067412|P3|Overall Study|Pregnancy|1
2622947|NCT00907478|9067413|P2|Overall Study|Pregnancy|1
2622948|NCT00907478|9067414|P1|Overall Study|Pregnancy|0
2622949|NCT00907478|9067412|P3|Overall Study|Protocol-specified criteria|3
2622950|NCT00907478|9067413|P2|Overall Study|Protocol-specified criteria|2
2622951|NCT00907478|9067414|P1|Overall Study|Protocol-specified criteria|5
2622952|NCT00907478|9067412|P3|Overall Study|Death|1
2622953|NCT00907478|9067413|P2|Overall Study|Death|2
2622954|NCT00907478|9067414|P1|Overall Study|Death|4
2622955|NCT00907478|9067412|P3|Overall Study|Physician Decision|3
2622956|NCT00907478|9067413|P2|Overall Study|Physician Decision|0
2622957|NCT00907478|9067414|P1|Overall Study|Physician Decision|2
2622958|NCT00907478|9067412|P3|Overall Study|Requirement for alternative therapy|3
2622959|NCT00907478|9067413|P2|Overall Study|Requirement for alternative therapy|2
2622960|NCT00907478|9067414|P1|Overall Study|Requirement for alternative therapy|1
2622961|NCT00907478|9067412|P3|Overall Study|Withdrawal by Subject|6
2622962|NCT00907478|9067413|P2|Overall Study|Withdrawal by Subject|9
2622963|NCT00907478|9067414|P1|Overall Study|Withdrawal by Subject|8
2622964|NCT00907478|9067412|P3|Overall Study|Adverse Event|2
2622965|NCT00907478|9067413|P2|Overall Study|Adverse Event|1
2622966|NCT00907478|9067414|P1|Overall Study|Adverse Event|3
2622967|NCT00907478|9067412|P3|Overall Study|Noncompliance|1
2622968|NCT00907478|9067413|P2|Overall Study|Noncompliance|0
2622969|NCT00907478|9067414|P1|Overall Study|Noncompliance|0
2622970|NCT00907478|9067412|P3|Overall Study|Ineligibility determined|1
2622971|NCT00907478|9067413|P2|Overall Study|Ineligibility determined|0
2622972|NCT00907478|9067414|P1|Overall Study|Ineligibility determined|0
2622973|NCT00907374|9067464|P2|Overall Study|Noncompliant w/study protocol at <3 mos|2
2622974|NCT00907374|9067465|P1|Overall Study|Noncompliant w/study protocol at <3 mos|2
2622975|NCT00907335|9067479|P2|Overall Study|Lost to Follow-up|0
2622976|NCT00907335|9067480|P1|Overall Study|Lost to Follow-up|2
2622977|NCT00907335|9067479|P2|Overall Study|Adverse Event|1
2622978|NCT00907335|9067480|P1|Overall Study|Adverse Event|4
2622979|NCT00907335|9067479|P2|Overall Study|Withdrawal by Subject|0
2622980|NCT00907335|9067480|P1|Overall Study|Withdrawal by Subject|2
2622981|NCT00907296|9067506|P10|Overall Study|Lost to Follow-up|4
2622982|NCT00907296|9067507|P9|Overall Study|Lost to Follow-up|0
2622983|NCT00907296|9067508|P8|Overall Study|Lost to Follow-up|2
2622984|NCT00907296|9067509|P7|Overall Study|Lost to Follow-up|2
2622985|NCT00907296|9067510|P6|Overall Study|Lost to Follow-up|3
2622986|NCT00907296|9067511|P5|Overall Study|Lost to Follow-up|0
2622987|NCT00907296|9067512|P4|Overall Study|Lost to Follow-up|2
2622988|NCT00907296|9067513|P3|Overall Study|Lost to Follow-up|0
2622989|NCT00907296|9067514|P2|Overall Study|Lost to Follow-up|1
2622990|NCT00907296|9067515|P1|Overall Study|Lost to Follow-up|9
2622991|NCT00907296|9067506|P10|Overall Study|Withdrawal by Subject|2
2622992|NCT00907296|9067507|P9|Overall Study|Withdrawal by Subject|4
2622993|NCT00907296|9067508|P8|Overall Study|Withdrawal by Subject|2
2622994|NCT00907296|9067509|P7|Overall Study|Withdrawal by Subject|3
2622995|NCT00907296|9067510|P6|Overall Study|Withdrawal by Subject|5
2622996|NCT00907296|9067511|P5|Overall Study|Withdrawal by Subject|1
2622997|NCT00907296|9067512|P4|Overall Study|Withdrawal by Subject|1
2622998|NCT00907296|9067513|P3|Overall Study|Withdrawal by Subject|1
2622999|NCT00907296|9067514|P2|Overall Study|Withdrawal by Subject|2
2623000|NCT00907296|9067515|P1|Overall Study|Withdrawal by Subject|7
2623001|NCT00907296|9067506|P10|Overall Study|Adverse Event|1
2623002|NCT00907296|9067507|P9|Overall Study|Adverse Event|0
2623003|NCT00907296|9067508|P8|Overall Study|Adverse Event|0
2623004|NCT00907296|9067509|P7|Overall Study|Adverse Event|1
2623005|NCT00907296|9067510|P6|Overall Study|Adverse Event|0
2623006|NCT00907296|9067511|P5|Overall Study|Adverse Event|0
2623007|NCT00907296|9067512|P4|Overall Study|Adverse Event|0
2623008|NCT00907296|9067513|P3|Overall Study|Adverse Event|0
2623009|NCT00907296|9067514|P2|Overall Study|Adverse Event|0
2623010|NCT00907296|9067515|P1|Overall Study|Adverse Event|2
2623011|NCT00907296|9067506|P10|Overall Study|Noncompliance|0
2623012|NCT00907296|9067507|P9|Overall Study|Noncompliance|0
2623013|NCT00907296|9067508|P8|Overall Study|Noncompliance|2
2623014|NCT00907296|9067509|P7|Overall Study|Noncompliance|0
2623015|NCT00907296|9067510|P6|Overall Study|Noncompliance|1
2623016|NCT00907296|9067511|P5|Overall Study|Noncompliance|0
2623017|NCT00907296|9067512|P4|Overall Study|Noncompliance|0
2623018|NCT00907296|9067513|P3|Overall Study|Noncompliance|1
2623019|NCT00907296|9067514|P2|Overall Study|Noncompliance|1
2623020|NCT00907296|9067515|P1|Overall Study|Noncompliance|1
2623021|NCT00907296|9067506|P10|Overall Study|Protocol Deviation|0
2623022|NCT00907296|9067507|P9|Overall Study|Protocol Deviation|0
2623023|NCT00907296|9067508|P8|Overall Study|Protocol Deviation|0
2623024|NCT00907296|9067509|P7|Overall Study|Protocol Deviation|0
2623025|NCT00907296|9067510|P6|Overall Study|Protocol Deviation|0
2623026|NCT00907296|9067511|P5|Overall Study|Protocol Deviation|0
2623027|NCT00907296|9067512|P4|Overall Study|Protocol Deviation|0
2623028|NCT00907296|9067513|P3|Overall Study|Protocol Deviation|0
2623029|NCT00907296|9067514|P2|Overall Study|Protocol Deviation|1
2623030|NCT00907296|9067515|P1|Overall Study|Protocol Deviation|0
2623031|NCT00907296|9067506|P10|Overall Study|Ineligibility Determined|0
2623032|NCT00907296|9067507|P9|Overall Study|Ineligibility Determined|0
2623033|NCT00907296|9067508|P8|Overall Study|Ineligibility Determined|1
2623034|NCT00907296|9067509|P7|Overall Study|Ineligibility Determined|0
2623035|NCT00907296|9067510|P6|Overall Study|Ineligibility Determined|0
2623036|NCT00907296|9067511|P5|Overall Study|Ineligibility Determined|0
2623037|NCT00907296|9067512|P4|Overall Study|Ineligibility Determined|1
2623038|NCT00907296|9067513|P3|Overall Study|Ineligibility Determined|0
2623039|NCT00907296|9067514|P2|Overall Study|Ineligibility Determined|0
2623040|NCT00907296|9067515|P1|Overall Study|Ineligibility Determined|1
2623041|NCT00907257|9067569|P2|Overall Study|Personal Reasons|1
2623042|NCT00907257|9067570|P1|Overall Study|Personal Reasons|6
2623043|NCT00907257|9067569|P2|Overall Study|Moved|0
2623044|NCT00907257|9067570|P1|Overall Study|Moved|1
2623045|NCT00907257|9067569|P2|Overall Study|Per IRB-Subject became vulnerable|0
2623046|NCT00907257|9067570|P1|Overall Study|Per IRB-Subject became vulnerable|1
2623047|NCT00907257|9067569|P2|Overall Study|Withdrawal by Subject|2
2623048|NCT00907257|9067570|P1|Overall Study|Withdrawal by Subject|1
2623049|NCT00907257|9067569|P2|Overall Study|Lost to Follow-up|3
2623050|NCT00907257|9067570|P1|Overall Study|Lost to Follow-up|3
2623051|NCT00907257|9067569|P2|Overall Study|Protocol Violation|2
2623052|NCT00907257|9067570|P1|Overall Study|Protocol Violation|1
2623053|NCT00907257|9067569|P2|Overall Study|Adverse Event|4
2623054|NCT00907257|9067570|P1|Overall Study|Adverse Event|0
2623055|NCT00907153|9067592|P2|Overall Study|Withdrawal by Subject|3
2623056|NCT00907153|9067593|P1|Overall Study|Withdrawal by Subject|1
2623057|NCT00907153|9067592|P2|Overall Study|Lost to Follow-up|1
2623058|NCT00907153|9067593|P1|Overall Study|Lost to Follow-up|1
2623059|NCT00906971|9067654|P2|Overall Study|Lost to Follow-up|1
2623060|NCT00906971|9067655|P1|Overall Study|Lost to Follow-up|0
2623061|NCT00906971|9067654|P2|Overall Study|Withdrawal by Subject|2
2623062|NCT00906971|9067655|P1|Overall Study|Withdrawal by Subject|8
2623063|NCT00906945|9067668|P6|Overall Study|Physician Decision|1
2623064|NCT00906945|9067669|P5|Overall Study|Physician Decision|0
2623065|NCT00906945|9067670|P4|Overall Study|Physician Decision|0
2623066|NCT00906945|9067671|P3|Overall Study|Physician Decision|0
2623067|NCT00906945|9067672|P2|Overall Study|Physician Decision|0
2623068|NCT00906945|9067673|P1|Overall Study|Physician Decision|0
2623069|NCT00906945|9067668|P6|Overall Study|Found to be not eligible|1
2623070|NCT00906945|9067669|P5|Overall Study|Found to be not eligible|1
2623071|NCT00906945|9067670|P4|Overall Study|Found to be not eligible|1
2623072|NCT00906945|9067671|P3|Overall Study|Found to be not eligible|0
2623073|NCT00906945|9067672|P2|Overall Study|Found to be not eligible|0
2623074|NCT00906945|9067673|P1|Overall Study|Found to be not eligible|0
2623075|NCT00906698|9067733|P6|Overall Study|incl. non compliance, lost to follow-up|0
2623076|NCT00906698|9067734|P5|Overall Study|incl. non compliance, lost to follow-up|0
2623077|NCT00906698|9067735|P4|Overall Study|incl. non compliance, lost to follow-up|0
2623078|NCT00906698|9067736|P3|Overall Study|incl. non compliance, lost to follow-up|0
2623079|NCT00906698|9067737|P2|Overall Study|incl. non compliance, lost to follow-up|1
2623080|NCT00906698|9067738|P1|Overall Study|incl. non compliance, lost to follow-up|0
2623081|NCT00906698|9067733|P6|Overall Study|Withdrawal by Subject|0
2623082|NCT00906698|9067734|P5|Overall Study|Withdrawal by Subject|1
2623083|NCT00906698|9067735|P4|Overall Study|Withdrawal by Subject|0
2623084|NCT00906698|9067736|P3|Overall Study|Withdrawal by Subject|0
2623085|NCT00906698|9067737|P2|Overall Study|Withdrawal by Subject|0
2623086|NCT00906698|9067738|P1|Overall Study|Withdrawal by Subject|0
2623087|NCT00906698|9067733|P6|Overall Study|Disease progression|4
2623088|NCT00906698|9067734|P5|Overall Study|Disease progression|12
2623089|NCT00906698|9067735|P4|Overall Study|Disease progression|4
2623090|NCT00906698|9067736|P3|Overall Study|Disease progression|4
2623091|NCT00906698|9067737|P2|Overall Study|Disease progression|12
2623092|NCT00906698|9067738|P1|Overall Study|Disease progression|3
2623093|NCT00906698|9067733|P6|Overall Study|Adverse Event|1
2623094|NCT00906698|9067734|P5|Overall Study|Adverse Event|4
2623095|NCT00906698|9067735|P4|Overall Study|Adverse Event|0
2623096|NCT00906698|9067736|P3|Overall Study|Adverse Event|2
2623097|NCT00906698|9067737|P2|Overall Study|Adverse Event|0
2623098|NCT00906698|9067738|P1|Overall Study|Adverse Event|0
2623099|NCT00906698|9067733|P6|Overall Study|Dose-limiting toxicity (DLT)|0
2623100|NCT00906698|9067734|P5|Overall Study|Dose-limiting toxicity (DLT)|1
2623101|NCT00906698|9067735|P4|Overall Study|Dose-limiting toxicity (DLT)|0
2623102|NCT00906698|9067736|P3|Overall Study|Dose-limiting toxicity (DLT)|0
2623103|NCT00906698|9067737|P2|Overall Study|Dose-limiting toxicity (DLT)|6
2623104|NCT00906698|9067738|P1|Overall Study|Dose-limiting toxicity (DLT)|0
2623105|NCT00906399|9067840|P7|Year 2|Other|0
2623106|NCT00906399|9067841|P6|Year 2|Other|1
2623107|NCT00906399|9067842|P5|Year 2|Other|3
2623108|NCT00906399|9067843|P4|Year 2|Other|2
2623109|NCT00906399|9067844|P3|Year 2|Other|0
2623110|NCT00906399|9067845|P2|Year 2|Other|0
2623111|NCT00906399|9067846|P1|Year 2|Other|0
2623112|NCT00906399|9067840|P7|Year 2|Death|3
2623113|NCT00906399|9067841|P6|Year 2|Death|0
2623114|NCT00906399|9067842|P5|Year 2|Death|0
2623115|NCT00906399|9067843|P4|Year 2|Death|1
2623116|NCT00906399|9067844|P3|Year 2|Death|0
2623117|NCT00906399|9067845|P2|Year 2|Death|0
2623118|NCT00906399|9067846|P1|Year 2|Death|0
2623119|NCT00906399|9067840|P7|Year 2|Physician Decision|3
2623120|NCT00906399|9067841|P6|Year 2|Physician Decision|6
2623121|NCT00906399|9067842|P5|Year 2|Physician Decision|2
2623122|NCT00906399|9067843|P4|Year 2|Physician Decision|0
2623123|NCT00906399|9067844|P3|Year 2|Physician Decision|0
2623124|NCT00906399|9067845|P2|Year 2|Physician Decision|0
2623125|NCT00906399|9067846|P1|Year 2|Physician Decision|0
2623126|NCT00906399|9067840|P7|Year 2|Withdrawal by Subject|13
2623127|NCT00906399|9067841|P6|Year 2|Withdrawal by Subject|27
2623128|NCT00906399|9067842|P5|Year 2|Withdrawal by Subject|18
2623129|NCT00906399|9067843|P4|Year 2|Withdrawal by Subject|17
2623130|NCT00906399|9067844|P3|Year 2|Withdrawal by Subject|0
2623131|NCT00906399|9067845|P2|Year 2|Withdrawal by Subject|0
2623132|NCT00906399|9067846|P1|Year 2|Withdrawal by Subject|0
2623133|NCT00906399|9067840|P7|Year 2|Lost to Follow-up|4
2623134|NCT00906399|9067841|P6|Year 2|Lost to Follow-up|2
2623135|NCT00906399|9067842|P5|Year 2|Lost to Follow-up|4
2623136|NCT00906399|9067843|P4|Year 2|Lost to Follow-up|1
2623137|NCT00906399|9067844|P3|Year 2|Lost to Follow-up|0
2623138|NCT00906399|9067845|P2|Year 2|Lost to Follow-up|0
2623139|NCT00906399|9067846|P1|Year 2|Lost to Follow-up|0
2623140|NCT00906399|9067840|P7|Year 2|Adverse Event|6
2623141|NCT00906399|9067841|P6|Year 2|Adverse Event|11
2623142|NCT00906399|9067842|P5|Year 2|Adverse Event|8
2623143|NCT00906399|9067843|P4|Year 2|Adverse Event|9
2623144|NCT00906399|9067844|P3|Year 2|Adverse Event|0
2623145|NCT00906399|9067845|P2|Year 2|Adverse Event|0
2623146|NCT00906399|9067846|P1|Year 2|Adverse Event|0
2623147|NCT00906399|9067840|P7|Year 1|Other|0
2623148|NCT00906399|9067841|P6|Year 1|Other|0
2623149|NCT00906399|9067842|P5|Year 1|Other|0
2623150|NCT00906399|9067843|P4|Year 1|Other|0
2623151|NCT00906399|9067844|P3|Year 1|Other|7
2623152|NCT00906399|9067845|P2|Year 1|Other|2
2623153|NCT00906399|9067846|P1|Year 1|Other|4
2623154|NCT00906399|9067840|P7|Year 1|Death|0
2623155|NCT00906399|9067841|P6|Year 1|Death|0
2623156|NCT00906399|9067842|P5|Year 1|Death|0
2623157|NCT00906399|9067843|P4|Year 1|Death|0
2623158|NCT00906399|9067844|P3|Year 1|Death|1
2623159|NCT00906399|9067845|P2|Year 1|Death|1
2623160|NCT00906399|9067846|P1|Year 1|Death|2
2623161|NCT00906399|9067840|P7|Year 1|Physician Decision|0
2623162|NCT00906399|9067841|P6|Year 1|Physician Decision|0
2623163|NCT00906399|9067842|P5|Year 1|Physician Decision|0
2623164|NCT00906399|9067843|P4|Year 1|Physician Decision|0
2623165|NCT00906399|9067844|P3|Year 1|Physician Decision|3
2623166|NCT00906399|9067845|P2|Year 1|Physician Decision|1
2623167|NCT00906399|9067846|P1|Year 1|Physician Decision|0
2623168|NCT00906399|9067840|P7|Year 1|Withdrawal by Subject|0
2623169|NCT00906399|9067841|P6|Year 1|Withdrawal by Subject|0
2623170|NCT00906399|9067842|P5|Year 1|Withdrawal by Subject|0
2623171|NCT00906399|9067843|P4|Year 1|Withdrawal by Subject|0
2623172|NCT00906399|9067844|P3|Year 1|Withdrawal by Subject|36
2623173|NCT00906399|9067845|P2|Year 1|Withdrawal by Subject|32
2623174|NCT00906399|9067846|P1|Year 1|Withdrawal by Subject|30
2623175|NCT00906399|9067840|P7|Year 1|Lost to Follow-up|0
2623176|NCT00906399|9067841|P6|Year 1|Lost to Follow-up|0
2623177|NCT00906399|9067842|P5|Year 1|Lost to Follow-up|0
2623178|NCT00906399|9067843|P4|Year 1|Lost to Follow-up|0
2623179|NCT00906399|9067844|P3|Year 1|Lost to Follow-up|2
2623180|NCT00906399|9067845|P2|Year 1|Lost to Follow-up|4
2623181|NCT00906399|9067846|P1|Year 1|Lost to Follow-up|4
2623182|NCT00906399|9067840|P7|Year 1|Adverse Event|0
2623183|NCT00906399|9067841|P6|Year 1|Adverse Event|0
2623184|NCT00906399|9067842|P5|Year 1|Adverse Event|0
2623185|NCT00906399|9067843|P4|Year 1|Adverse Event|0
2623186|NCT00906399|9067844|P3|Year 1|Adverse Event|24
2623187|NCT00906399|9067845|P2|Year 1|Adverse Event|22
2623188|NCT00906399|9067846|P1|Year 1|Adverse Event|4
2623189|NCT00906399|9067840|P7|Year 1|Randomized But Not Treated|0
2623190|NCT00906399|9067841|P6|Year 1|Randomized But Not Treated|0
2623191|NCT00906399|9067842|P5|Year 1|Randomized But Not Treated|0
2623192|NCT00906399|9067843|P4|Year 1|Randomized But Not Treated|0
2623193|NCT00906399|9067844|P3|Year 1|Randomized But Not Treated|3
2623194|NCT00906399|9067845|P2|Year 1|Randomized But Not Treated|1
2623195|NCT00906399|9067846|P1|Year 1|Randomized But Not Treated|0
2623196|NCT00906373|9067869|P2|Overall Study|Still on treatment at cutoff date|2
2623197|NCT00906373|9067870|P1|Overall Study|Still on treatment at cutoff date|0
2623198|NCT00906373|9067869|P2|Overall Study|Other|1
2623199|NCT00906373|9067870|P1|Overall Study|Other|0
2623200|NCT00906373|9067869|P2|Overall Study|Withdrawal by Subject|5
2623201|NCT00906373|9067870|P1|Overall Study|Withdrawal by Subject|0
2623202|NCT00906347|9067909|P2|Received Study Drug|Uterine tachysystole or hypertonus|0
2623203|NCT00906347|9067910|P1|Received Study Drug|Uterine tachysystole or hypertonus|8
2623204|NCT00906347|9067909|P2|Received Study Drug|Refused study drug|0
2623205|NCT00906347|9067910|P1|Received Study Drug|Refused study drug|1
2623206|NCT00906347|9067909|P2|Received Study Drug|Nonreassuring fetal heart rate|1
2623207|NCT00906347|9067910|P1|Received Study Drug|Nonreassuring fetal heart rate|13
2623208|NCT00906347|9067909|P2|Received Study Drug|8 cm prior to initiation of study drug|30
2623209|NCT00906347|9067910|P1|Received Study Drug|8 cm prior to initiation of study drug|18
2623210|NCT00906282|9067930|P1|Preoperative Chemotherapy|Toxicity|1
2623211|NCT00906282|9067930|P1|Preoperative Chemotherapy|Progressive disease|6
2623212|NCT00906282|9067930|P1|Preoperative Chemotherapy|Not surgical candidates, off study|10
2623213|NCT00906282|9067930|P1|Preoperative Chemotherapy|Withdrawal by Subject|2
2623214|NCT00906204|9067944|P2|Secondary Endpoints (Long-term Safety)|Death|1
2623215|NCT00906204|9067945|P1|Secondary Endpoints (Long-term Safety)|Death|0
2623216|NCT00906204|9067944|P2|Secondary Endpoints (Long-term Safety)|Adverse Event|2
2623217|NCT00906204|9067945|P1|Secondary Endpoints (Long-term Safety)|Adverse Event|2
2623218|NCT00906204|9067944|P2|Primary Endpoint (Early Safety)|Withdrawal by Subject|0
2623219|NCT00906204|9067945|P1|Primary Endpoint (Early Safety)|Withdrawal by Subject|1
2623220|NCT00906204|9067944|P2|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1
2623221|NCT00906204|9067945|P1|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0
2623222|NCT00906204|9067944|P2|Primary Endpoint (Early Safety)|Physician Decision|0
2623223|NCT00906204|9067945|P1|Primary Endpoint (Early Safety)|Physician Decision|1
2623224|NCT00906087|9067999|P1|Initial Washout|Physician Decision|1
2623225|NCT00906087|9067999|P1|Initial Washout|Withdrawal by Subject|1
2623226|NCT00906035|9068036|P3|Overall Study|Withdrawal by Subject|0
2623227|NCT00906035|9068037|P2|Overall Study|Withdrawal by Subject|3
2623228|NCT00906035|9068038|P1|Overall Study|Withdrawal by Subject|2
2623229|NCT00905840|9068052|P1|Overall Study|Adverse Event|1
2623230|NCT00905840|9068052|P1|Overall Study|Withdrawal by Subject|1
2623231|NCT00905840|9068052|P1|Overall Study|Death|3
2623232|NCT00905840|9068052|P1|Overall Study|Lost to Follow-up|11
2623233|NCT00905632|9068083|P7|Overall Study|Adverse Event|4
2623234|NCT00905632|9068084|P6|Overall Study|Adverse Event|1
2623235|NCT00905632|9068085|P5|Overall Study|Adverse Event|0
2623236|NCT00905632|9068086|P4|Overall Study|Adverse Event|0
2623237|NCT00905632|9068087|P3|Overall Study|Adverse Event|0
2623238|NCT00905632|9068088|P2|Overall Study|Adverse Event|0
2623239|NCT00905632|9068089|P1|Overall Study|Adverse Event|0
2623240|NCT00905606|9068227|P2|Washout|Withdrawal by Subject|0
2623241|NCT00905606|9068228|P1|Washout|Withdrawal by Subject|1
2623242|NCT00905606|9068227|P2|Period 1|Adverse Event|1
2623243|NCT00905606|9068228|P1|Period 1|Adverse Event|0
2623244|NCT00905567|9068253|P2|Washout|Withdrawal by Subject|1
2623245|NCT00905567|9068254|P1|Washout|Withdrawal by Subject|0
2623246|NCT00905489|9068286|P1|Optional Extension Phase (OEP)|Adverse Event|1
2623247|NCT00905489|9068286|P1|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3
2623248|NCT00905489|9068286|P1|Pharmaco-kinetic (PK) Phase|Protocol Violation|2
2623249|NCT00905437|9068335|P2|Overall Study|Other|6
2623250|NCT00905437|9068336|P1|Overall Study|Other|5
2623251|NCT00905437|9068335|P2|Overall Study|Withdrawal by Subject|1
2623252|NCT00905437|9068336|P1|Overall Study|Withdrawal by Subject|0
2623253|NCT00905437|9068335|P2|Overall Study|Lost to Follow-up|1
2623254|NCT00905437|9068336|P1|Overall Study|Lost to Follow-up|0
2623255|NCT00905437|9068335|P2|Overall Study|Adverse Event|2
2623256|NCT00905437|9068336|P1|Overall Study|Adverse Event|3
2623257|NCT00905424|9068356|P2|Overall Study|Non-adherence to visit schedule|1
2623258|NCT00905424|9068357|P1|Overall Study|Non-adherence to visit schedule|0
2623259|NCT00905424|9068356|P2|Overall Study|Positive urine drug screen|1
2623260|NCT00905424|9068357|P1|Overall Study|Positive urine drug screen|0
2623261|NCT00905424|9068356|P2|Overall Study|Sponsor decision|0
2623262|NCT00905424|9068357|P1|Overall Study|Sponsor decision|1
2623263|NCT00905424|9068356|P2|Overall Study|Non-compliance with study medication|0
2623264|NCT00905424|9068357|P1|Overall Study|Non-compliance with study medication|2
2623265|NCT00905424|9068356|P2|Overall Study|Adverse Event|2
2623266|NCT00905424|9068357|P1|Overall Study|Adverse Event|4
2623267|NCT00905424|9068356|P2|Overall Study|Withdrawal by Subject|2
2623268|NCT00905424|9068357|P1|Overall Study|Withdrawal by Subject|1
2623269|NCT00905424|9068356|P2|Overall Study|Lost to Follow-up|3
2623270|NCT00905424|9068357|P1|Overall Study|Lost to Follow-up|3
2623271|NCT00905359|9068399|P2|Overall Study|Withdrawal consent|6
2623272|NCT00905359|9068400|P1|Overall Study|Withdrawal consent|5
2623273|NCT00905359|9068399|P2|Overall Study|Death|0
2623274|NCT00905359|9068400|P1|Overall Study|Death|2
2623275|NCT00905359|9068399|P2|Overall Study|Lost to Follow-up|10
2623276|NCT00905359|9068400|P1|Overall Study|Lost to Follow-up|17
2623277|NCT00905346|9068436|P2|Period 1|Withdrawal by Subject|0
2623278|NCT00905346|9068437|P1|Period 1|Withdrawal by Subject|1
2623279|NCT00905307|9068451|P6|Overall Study|Lack of Efficacy|8
2623280|NCT00905307|9068452|P5|Overall Study|Lack of Efficacy|4
2623281|NCT00905307|9068453|P4|Overall Study|Lack of Efficacy|4
2623282|NCT00905307|9068454|P3|Overall Study|Lack of Efficacy|5
2623283|NCT00905307|9068455|P2|Overall Study|Lack of Efficacy|3
2623284|NCT00905307|9068456|P1|Overall Study|Lack of Efficacy|6
2623285|NCT00905307|9068451|P6|Overall Study|Protocol Violation|0
2623286|NCT00905307|9068452|P5|Overall Study|Protocol Violation|0
2623287|NCT00905307|9068453|P4|Overall Study|Protocol Violation|0
2623288|NCT00905307|9068454|P3|Overall Study|Protocol Violation|1
2623289|NCT00905307|9068455|P2|Overall Study|Protocol Violation|0
2623290|NCT00905307|9068456|P1|Overall Study|Protocol Violation|1
2623291|NCT00905307|9068451|P6|Overall Study|Withdrawal by Subject|13
2623292|NCT00905307|9068452|P5|Overall Study|Withdrawal by Subject|4
2623293|NCT00905307|9068453|P4|Overall Study|Withdrawal by Subject|11
2623294|NCT00905307|9068454|P3|Overall Study|Withdrawal by Subject|15
2623295|NCT00905307|9068455|P2|Overall Study|Withdrawal by Subject|13
2623296|NCT00905307|9068456|P1|Overall Study|Withdrawal by Subject|5
2623297|NCT00905307|9068451|P6|Overall Study|Adverse Event|5
2623298|NCT00905307|9068452|P5|Overall Study|Adverse Event|3
2623299|NCT00905307|9068453|P4|Overall Study|Adverse Event|11
2623300|NCT00905307|9068454|P3|Overall Study|Adverse Event|5
2623301|NCT00905307|9068455|P2|Overall Study|Adverse Event|4
2623302|NCT00905307|9068456|P1|Overall Study|Adverse Event|3
2623303|NCT00905307|9068451|P6|Overall Study|Lost to Follow-up|1
2623304|NCT00905307|9068452|P5|Overall Study|Lost to Follow-up|1
2623305|NCT00905307|9068453|P4|Overall Study|Lost to Follow-up|0
2623306|NCT00905307|9068454|P3|Overall Study|Lost to Follow-up|0
2623307|NCT00905307|9068455|P2|Overall Study|Lost to Follow-up|0
2623308|NCT00905307|9068456|P1|Overall Study|Lost to Follow-up|0
2623309|NCT00905307|9068451|P6|Overall Study|Switched to Open Label Rescue|15
2623310|NCT00905307|9068452|P5|Overall Study|Switched to Open Label Rescue|4
2623311|NCT00905307|9068453|P4|Overall Study|Switched to Open Label Rescue|11
2623312|NCT00905307|9068454|P3|Overall Study|Switched to Open Label Rescue|11
2623313|NCT00905307|9068455|P2|Overall Study|Switched to Open Label Rescue|17
2623314|NCT00905307|9068456|P1|Overall Study|Switched to Open Label Rescue|7
2623315|NCT00905255|9068551|P2|Overall Study|Familial and Personal Reasons|0
2623316|NCT00905255|9068552|P1|Overall Study|Familial and Personal Reasons|1
2623317|NCT00905255|9068551|P2|Overall Study|Withdrawal by Subject|4
2623318|NCT00905255|9068552|P1|Overall Study|Withdrawal by Subject|5
2623319|NCT00905255|9068551|P2|Overall Study|Adverse Event|5
2623320|NCT00905255|9068552|P1|Overall Study|Adverse Event|7
2623321|NCT00905164|9068570|P2|Period 1|Protocol Violation|1
2623322|NCT00905164|9068571|P1|Period 1|Protocol Violation|0
2623323|NCT00905034|9068618|P1|Overall Study|Withdrawal by Subject|1
2623324|NCT00905021|9068622|P1|Overall Study|Adverse Event|2
2623325|NCT00904982|9068640|P4|Overall Study|Withdrawal by Subject|0
2623326|NCT00904982|9068641|P3|Overall Study|Withdrawal by Subject|0
2623327|NCT00904982|9068642|P2|Overall Study|Withdrawal by Subject|0
2623328|NCT00904982|9068643|P1|Overall Study|Withdrawal by Subject|2
2623329|NCT00904969|9068653|P1|Overall Study|Case Aborted; Subject Exited|1
2623330|NCT00904969|9068653|P1|Overall Study|Additional Treatments|11
2623331|NCT00904969|9068653|P1|Overall Study|Withdrawal by Subject|3
2623332|NCT00904969|9068653|P1|Overall Study|Lost to Follow-up|4
2623333|NCT00904917|9068718|P4|Overall Study|Lost to Follow-up|2
2623334|NCT00904917|9068719|P3|Overall Study|Lost to Follow-up|2
2623335|NCT00904917|9068720|P2|Overall Study|Lost to Follow-up|2
2623336|NCT00904917|9068721|P1|Overall Study|Lost to Follow-up|2
2623337|NCT00904839|9068739|P3|Overall Study|Other than above|7
2623338|NCT00904839|9068740|P2|Overall Study|Other than above|9
2623339|NCT00904839|9068741|P1|Overall Study|Other than above|0
2623340|NCT00904839|9068739|P3|Overall Study|Not treated|1
2623341|NCT00904839|9068740|P2|Overall Study|Not treated|0
2623342|NCT00904839|9068741|P1|Overall Study|Not treated|1
2623343|NCT00904839|9068739|P3|Overall Study|Withdrawal by Subject|0
2623344|NCT00904839|9068740|P2|Overall Study|Withdrawal by Subject|2
2623345|NCT00904839|9068741|P1|Overall Study|Withdrawal by Subject|0
2623346|NCT00904839|9068739|P3|Overall Study|Lost to Follow-up|2
2623347|NCT00904839|9068740|P2|Overall Study|Lost to Follow-up|1
2623348|NCT00904839|9068741|P1|Overall Study|Lost to Follow-up|0
2623349|NCT00904839|9068739|P3|Overall Study|Protocol Violation|1
2623350|NCT00904839|9068740|P2|Overall Study|Protocol Violation|1
2623351|NCT00904839|9068741|P1|Overall Study|Protocol Violation|0
2623352|NCT00904839|9068739|P3|Overall Study|Adverse Event|4
2623353|NCT00904839|9068740|P2|Overall Study|Adverse Event|5
2623354|NCT00904839|9068741|P1|Overall Study|Adverse Event|0
2623355|NCT00904748|9068787|P6|Overall Study|Adverse Event|0
2623356|NCT00904748|9068788|P5|Overall Study|Adverse Event|1
2623357|NCT00904748|9068789|P4|Overall Study|Adverse Event|0
2623358|NCT00904748|9068790|P3|Overall Study|Adverse Event|0
2623359|NCT00904748|9068791|P2|Overall Study|Adverse Event|0
2623360|NCT00904748|9068792|P1|Overall Study|Adverse Event|0
2623361|NCT00904748|9068787|P6|Overall Study|Withdrawal by Subject|0
2623362|NCT00904748|9068788|P5|Overall Study|Withdrawal by Subject|0
2623363|NCT00904748|9068789|P4|Overall Study|Withdrawal by Subject|2
2623364|NCT00904748|9068790|P3|Overall Study|Withdrawal by Subject|1
2623365|NCT00904748|9068791|P2|Overall Study|Withdrawal by Subject|1
2623366|NCT00904748|9068792|P1|Overall Study|Withdrawal by Subject|1
2623367|NCT00904722|9068816|P1|Overall Study|Physician Decision|1
2623368|NCT00904670|9068821|P2|Open Label Phase|Lost to Follow-up|0
2623369|NCT00904670|9068822|P1|Open Label Phase|Lost to Follow-up|1
2623370|NCT00904670|9068821|P2|Open Label Phase|Lack of Efficacy|0
2623371|NCT00904670|9068822|P1|Open Label Phase|Lack of Efficacy|1
2623372|NCT00904670|9068821|P2|Open Label Phase|Adverse Event|0
2623373|NCT00904670|9068822|P1|Open Label Phase|Adverse Event|2
2623374|NCT00904670|9068821|P2|Open Label Phase|Withdrawal by Subject|0
2623375|NCT00904670|9068822|P1|Open Label Phase|Withdrawal by Subject|2
2623376|NCT00904371|9068892|P1|Overall Study|Continued with Tritace|1
2623377|NCT00904371|9068892|P1|Overall Study|Discontinued at target blood pressure|2
2623378|NCT00904371|9068892|P1|Overall Study|Lost to Follow-up|4
2623379|NCT00904371|9068892|P1|Overall Study|Adverse Event|2
2623380|NCT00904215|9068906|P1|Overall Study|Other|28
2623381|NCT00904215|9068906|P1|Overall Study|Withdrawal by Subject|9
2623382|NCT00904215|9068906|P1|Overall Study|Lost to Follow-up|63
2623383|NCT00904215|9068906|P1|Overall Study|Protocol Violation|10
2623384|NCT00904215|9068906|P1|Overall Study|Adverse Event|25
2623385|NCT00904150|9068920|P2|Saliva Samples (DNA)|Australian samples of different genotype|145
2623386|NCT00904150|9068921|P1|Saliva Samples (DNA)|Australian samples of different genotype|0
2623387|NCT00904150|9068920|P2|Saliva Samples (DNA)|saliva samples not suitable for assay|0
2623388|NCT00904150|9068921|P1|Saliva Samples (DNA)|saliva samples not suitable for assay|3
2623389|NCT00904033|9068943|P4|Overall Study|Unable to obtain final blood draw|2
2623390|NCT00904033|9068944|P3|Overall Study|Unable to obtain final blood draw|0
2623391|NCT00904033|9068945|P2|Overall Study|Unable to obtain final blood draw|0
2623392|NCT00904033|9068946|P1|Overall Study|Unable to obtain final blood draw|0
2623393|NCT00904033|9068943|P4|Overall Study|Physician Decision|0
2623394|NCT00904033|9068944|P3|Overall Study|Physician Decision|1
2623395|NCT00904033|9068945|P2|Overall Study|Physician Decision|0
2623396|NCT00904033|9068946|P1|Overall Study|Physician Decision|0
2623397|NCT00904033|9068943|P4|Overall Study|Withdrawal by Subject|0
2623398|NCT00904033|9068944|P3|Overall Study|Withdrawal by Subject|0
2623399|NCT00904033|9068945|P2|Overall Study|Withdrawal by Subject|1
2623400|NCT00904033|9068946|P1|Overall Study|Withdrawal by Subject|1
2623401|NCT00903968|9069011|P8|Overall Study|Lack of Efficacy|3
2623402|NCT00903968|9069012|P7|Overall Study|Lack of Efficacy|0
2623403|NCT00903968|9069013|P6|Overall Study|Lack of Efficacy|0
2623404|NCT00903968|9069014|P5|Overall Study|Lack of Efficacy|0
2623405|NCT00903968|9069015|P4|Overall Study|Lack of Efficacy|0
2623406|NCT00903968|9069016|P3|Overall Study|Lack of Efficacy|0
2623407|NCT00903968|9069017|P2|Overall Study|Lack of Efficacy|0
2623408|NCT00903968|9069018|P1|Overall Study|Lack of Efficacy|0
2623409|NCT00903968|9069011|P8|Overall Study|Progressive Disease|18
2623410|NCT00903968|9069012|P7|Overall Study|Progressive Disease|0
2623411|NCT00903968|9069013|P6|Overall Study|Progressive Disease|3
2623412|NCT00903968|9069014|P5|Overall Study|Progressive Disease|3
2623413|NCT00903968|9069015|P4|Overall Study|Progressive Disease|3
2623414|NCT00903968|9069016|P3|Overall Study|Progressive Disease|2
2623415|NCT00903968|9069017|P2|Overall Study|Progressive Disease|3
2623416|NCT00903968|9069018|P1|Overall Study|Progressive Disease|2
2623417|NCT00903968|9069011|P8|Overall Study|Physician Decision|0
2623418|NCT00903968|9069012|P7|Overall Study|Physician Decision|0
2623419|NCT00903968|9069013|P6|Overall Study|Physician Decision|1
2623420|NCT00903968|9069014|P5|Overall Study|Physician Decision|0
2623421|NCT00903968|9069015|P4|Overall Study|Physician Decision|0
2623422|NCT00903968|9069016|P3|Overall Study|Physician Decision|0
2623423|NCT00903968|9069017|P2|Overall Study|Physician Decision|0
2623424|NCT00903968|9069018|P1|Overall Study|Physician Decision|0
2623425|NCT00903968|9069011|P8|Overall Study|Non-Compliance|0
2623426|NCT00903968|9069012|P7|Overall Study|Non-Compliance|0
2623427|NCT00903968|9069013|P6|Overall Study|Non-Compliance|1
2623428|NCT00903968|9069014|P5|Overall Study|Non-Compliance|0
2623429|NCT00903968|9069015|P4|Overall Study|Non-Compliance|0
2623430|NCT00903968|9069016|P3|Overall Study|Non-Compliance|0
2623431|NCT00903968|9069017|P2|Overall Study|Non-Compliance|0
2623432|NCT00903968|9069018|P1|Overall Study|Non-Compliance|0
2623433|NCT00903968|9069011|P8|Overall Study|Withdrawal by Subject|4
2623434|NCT00903968|9069012|P7|Overall Study|Withdrawal by Subject|0
2623435|NCT00903968|9069013|P6|Overall Study|Withdrawal by Subject|1
2623436|NCT00903968|9069014|P5|Overall Study|Withdrawal by Subject|1
2623437|NCT00903968|9069015|P4|Overall Study|Withdrawal by Subject|0
2623438|NCT00903968|9069016|P3|Overall Study|Withdrawal by Subject|1
2623439|NCT00903968|9069017|P2|Overall Study|Withdrawal by Subject|0
2623440|NCT00903968|9069018|P1|Overall Study|Withdrawal by Subject|1
2623441|NCT00903968|9069011|P8|Overall Study|DLT|0
2623442|NCT00903968|9069012|P7|Overall Study|DLT|2
2623443|NCT00903968|9069013|P6|Overall Study|DLT|0
2623444|NCT00903968|9069014|P5|Overall Study|DLT|0
2623445|NCT00903968|9069015|P4|Overall Study|DLT|0
2623446|NCT00903968|9069016|P3|Overall Study|DLT|0
2623447|NCT00903968|9069017|P2|Overall Study|DLT|0
2623448|NCT00903968|9069018|P1|Overall Study|DLT|0
2623449|NCT00903968|9069011|P8|Overall Study|Adverse Event|8
2623450|NCT00903968|9069012|P7|Overall Study|Adverse Event|1
2623451|NCT00903968|9069013|P6|Overall Study|Adverse Event|0
2623452|NCT00903968|9069014|P5|Overall Study|Adverse Event|0
2623453|NCT00903968|9069015|P4|Overall Study|Adverse Event|0
2623454|NCT00903968|9069016|P3|Overall Study|Adverse Event|0
2623455|NCT00903968|9069017|P2|Overall Study|Adverse Event|0
2623456|NCT00903968|9069018|P1|Overall Study|Adverse Event|0
2623457|NCT00903929|9069048|P4|Overall Study|Adverse Event|1
2623458|NCT00903929|9069049|P3|Overall Study|Adverse Event|0
2623459|NCT00903929|9069050|P2|Overall Study|Adverse Event|0
2623460|NCT00903929|9069051|P1|Overall Study|Adverse Event|0
2623461|NCT00903929|9069048|P4|Overall Study|Withdrawal by Subject|2
2623462|NCT00903929|9069049|P3|Overall Study|Withdrawal by Subject|1
2623463|NCT00903929|9069050|P2|Overall Study|Withdrawal by Subject|0
2623464|NCT00903929|9069051|P1|Overall Study|Withdrawal by Subject|0
2623465|NCT00903877|9069057|P1|Overall Study|Participation put on hold|4
2623466|NCT00903877|9069057|P1|Overall Study|Lost to Follow-up|1
2623467|NCT00903877|9069057|P1|Overall Study|Adverse Event|2
2623468|NCT00903877|9069057|P1|Overall Study|Withdrawal by Subject|3
2623469|NCT00903877|9069057|P1|Overall Study|Did not meet study criteria|33
2623470|NCT00903786|9069061|P1|Overall Study|Reason other than lack of efficacy|4
2623471|NCT00903786|9069061|P1|Overall Study|Lack of Efficacy|5
2623472|NCT00903786|9069061|P1|Overall Study|Physician Decision|6
2623473|NCT00903760|9069071|P2|Overall Study|Off treatment for long period|1
2623474|NCT00903760|9069072|P1|Overall Study|Off treatment for long period|0
2623475|NCT00903760|9069071|P2|Overall Study|Withdrawal by Subject|2
2623476|NCT00903760|9069072|P1|Overall Study|Withdrawal by Subject|1
2623477|NCT00903760|9069071|P2|Overall Study|Lost to Follow-up|0
2623478|NCT00903760|9069072|P1|Overall Study|Lost to Follow-up|1
2623479|NCT00903760|9069071|P2|Overall Study|Death|1
2623480|NCT00903760|9069072|P1|Overall Study|Death|0
2623481|NCT00903760|9069071|P2|Overall Study|Physician Decision|2
2623482|NCT00903760|9069072|P1|Overall Study|Physician Decision|1
2623483|NCT00903760|9069071|P2|Overall Study|Stem Cell Transplant|4
2623484|NCT00903760|9069072|P1|Overall Study|Stem Cell Transplant|8
2623485|NCT00903760|9069071|P2|Overall Study|Disease Progression/Death|6
2623486|NCT00903760|9069072|P1|Overall Study|Disease Progression/Death|8
2623487|NCT00903695|9069082|P2|Overall Study|lung cancer|0
2623488|NCT00903695|9069083|P1|Overall Study|lung cancer|1
2623489|NCT00903695|9069082|P2|Overall Study|medical exclusion after 1st testing|0
2623490|NCT00903695|9069083|P1|Overall Study|medical exclusion after 1st testing|1
2623491|NCT00903682|9069105|P2|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0
2623492|NCT00903682|9069106|P1|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1
2623493|NCT00903682|9069105|P2|Overall Study|Patient Couldn't Come For The Visit Due|0
2623494|NCT00903682|9069106|P1|Overall Study|Patient Couldn't Come For The Visit Due|1
2623495|NCT00903682|9069105|P2|Overall Study|Subject Non-Compliant|0
2623496|NCT00903682|9069106|P1|Overall Study|Subject Non-Compliant|1
2623497|NCT00903682|9069105|P2|Overall Study|Subject Reached A Virologic Endpoint|1
2623498|NCT00903682|9069106|P1|Overall Study|Subject Reached A Virologic Endpoint|1
2623499|NCT00903682|9069105|P2|Overall Study|Pregnancy|1
2623500|NCT00903682|9069106|P1|Overall Study|Pregnancy|0
2623501|NCT00903682|9069105|P2|Overall Study|Withdrawal by Subject|0
2623502|NCT00903682|9069106|P1|Overall Study|Withdrawal by Subject|5
2623503|NCT00903682|9069105|P2|Overall Study|Lost to Follow-up|0
2623504|NCT00903682|9069106|P1|Overall Study|Lost to Follow-up|1
2623505|NCT00903682|9069105|P2|Overall Study|Adverse Event|13
2623506|NCT00903682|9069106|P1|Overall Study|Adverse Event|6
2623507|NCT00903630|9069127|P3|Phase 2|Adverse Event|1
2623508|NCT00903630|9069128|P2|Phase 2|Adverse Event|0
2623509|NCT00903630|9069129|P1|Phase 2|Adverse Event|0
2623510|NCT00903617|9069147|P4|Overall Study|Withdrawal by Subject|0
2623511|NCT00903617|9069148|P3|Overall Study|Withdrawal by Subject|3
2623512|NCT00903617|9069149|P2|Overall Study|Withdrawal by Subject|2
2623513|NCT00903617|9069150|P1|Overall Study|Withdrawal by Subject|1
2623514|NCT00903617|9069147|P4|Overall Study|Lost to Follow-up|1
2623515|NCT00903617|9069148|P3|Overall Study|Lost to Follow-up|1
2623516|NCT00903617|9069149|P2|Overall Study|Lost to Follow-up|0
2623517|NCT00903617|9069150|P1|Overall Study|Lost to Follow-up|2
2623518|NCT00903617|9069147|P4|Overall Study|Protocol-defined stopping criteria|0
2623519|NCT00903617|9069148|P3|Overall Study|Protocol-defined stopping criteria|0
2623520|NCT00903617|9069149|P2|Overall Study|Protocol-defined stopping criteria|2
2623521|NCT00903617|9069150|P1|Overall Study|Protocol-defined stopping criteria|0
2623522|NCT00903617|9069147|P4|Overall Study|Adverse Event|0
2623523|NCT00903617|9069148|P3|Overall Study|Adverse Event|1
2623524|NCT00903617|9069149|P2|Overall Study|Adverse Event|1
2623525|NCT00903617|9069150|P1|Overall Study|Adverse Event|0
2623526|NCT00903409|9069253|P2|Overall Study|Lost to Follow-up|6
2623527|NCT00903409|9069254|P1|Overall Study|Lost to Follow-up|2
2623528|NCT00903409|9069253|P2|Overall Study|Other|3
2623529|NCT00903409|9069254|P1|Overall Study|Other|2
2623530|NCT00903409|9069253|P2|Overall Study|Withdrawal by Subject|8
2623531|NCT00903409|9069254|P1|Overall Study|Withdrawal by Subject|8
2623532|NCT00903409|9069253|P2|Overall Study|Laboratory Abnormality|0
2623533|NCT00903409|9069254|P1|Overall Study|Laboratory Abnormality|2
2623534|NCT00903409|9069253|P2|Overall Study|Non-compliance with Protocol|1
2623535|NCT00903409|9069254|P1|Overall Study|Non-compliance with Protocol|1
2623536|NCT00903409|9069253|P2|Overall Study|Adverse Event|9
2623537|NCT00903409|9069254|P1|Overall Study|Adverse Event|11
2623538|NCT00903383|9069305|P4|Overall Study|Patient Decision|1
2623539|NCT00903383|9069306|P3|Overall Study|Patient Decision|0
2623540|NCT00903383|9069307|P2|Overall Study|Patient Decision|0
2623541|NCT00903383|9069308|P1|Overall Study|Patient Decision|0
2623542|NCT00903383|9069305|P4|Overall Study|Patient Decision - Lack of Efficacy|0
2623543|NCT00903383|9069306|P3|Overall Study|Patient Decision - Lack of Efficacy|0
2623544|NCT00903383|9069307|P2|Overall Study|Patient Decision - Lack of Efficacy|1
2623545|NCT00903383|9069308|P1|Overall Study|Patient Decision - Lack of Efficacy|0
2623546|NCT00903383|9069305|P4|Overall Study|Withdrawal by Subject|2
2623547|NCT00903383|9069306|P3|Overall Study|Withdrawal by Subject|0
2623548|NCT00903383|9069307|P2|Overall Study|Withdrawal by Subject|1
2623549|NCT00903383|9069308|P1|Overall Study|Withdrawal by Subject|4
2623550|NCT00903383|9069305|P4|Overall Study|Decision of Sponsor|0
2623551|NCT00903383|9069306|P3|Overall Study|Decision of Sponsor|0
2623552|NCT00903383|9069307|P2|Overall Study|Decision of Sponsor|0
2623553|NCT00903383|9069308|P1|Overall Study|Decision of Sponsor|1
2623554|NCT00903383|9069305|P4|Overall Study|Lost to Follow-up|1
2623555|NCT00903383|9069306|P3|Overall Study|Lost to Follow-up|0
2623556|NCT00903383|9069307|P2|Overall Study|Lost to Follow-up|0
2623557|NCT00903383|9069308|P1|Overall Study|Lost to Follow-up|0
2623558|NCT00903383|9069305|P4|Overall Study|Physician Decision|0
2623559|NCT00903383|9069306|P3|Overall Study|Physician Decision|0
2623560|NCT00903383|9069307|P2|Overall Study|Physician Decision|2
2623561|NCT00903383|9069308|P1|Overall Study|Physician Decision|1
2623562|NCT00903383|9069305|P4|Overall Study|Adverse Event|1
2623563|NCT00903383|9069306|P3|Overall Study|Adverse Event|3
2623564|NCT00903383|9069307|P2|Overall Study|Adverse Event|2
2623565|NCT00903383|9069308|P1|Overall Study|Adverse Event|1
2623566|NCT00903370|9069340|P2|Overall Study|Lost to Follow-up|8
2623567|NCT00903370|9069341|P1|Overall Study|Lost to Follow-up|6
2623568|NCT00903370|9069340|P2|Overall Study|Withdrawal by Subject|6
2623569|NCT00903370|9069341|P1|Overall Study|Withdrawal by Subject|9
2623570|NCT00903370|9069340|P2|Overall Study|Death|10
2623571|NCT00903370|9069341|P1|Overall Study|Death|13
2623572|NCT00903357|9069349|P2|Second Intervention|Lost to Follow-up|0
2623573|NCT00903357|9069350|P1|Second Intervention|Lost to Follow-up|1
2623574|NCT00903357|9069349|P2|Wash Out Period of 2 Weeks|Flu|1
2623575|NCT00903357|9069350|P1|Wash Out Period of 2 Weeks|Flu|0
2623576|NCT00903357|9069349|P2|First Intervention|Flu|1
2623577|NCT00903357|9069350|P1|First Intervention|Flu|0
2623578|NCT00903357|9069349|P2|First Intervention|Withdrawal by Subject|3
2623579|NCT00903357|9069350|P1|First Intervention|Withdrawal by Subject|5
2623580|NCT00903344|9069362|P2|Overall Study|Lost to Follow-up|0
2623581|NCT00903344|9069363|P1|Overall Study|Lost to Follow-up|3
2623582|NCT00903344|9069362|P2|Overall Study|Pregnancy|3
2623583|NCT00903344|9069363|P1|Overall Study|Pregnancy|2
2623584|NCT00903331|9069381|P2|Overall Study|Lung transplant|2
2623585|NCT00903331|9069382|P1|Overall Study|Lung transplant|0
2623586|NCT00903331|9069381|P2|Overall Study|Withdrawal of consent|8
2623587|NCT00903331|9069382|P1|Overall Study|Withdrawal of consent|1
2623588|NCT00903331|9069381|P2|Overall Study|Death|8
2623589|NCT00903331|9069382|P1|Overall Study|Death|4
2623590|NCT00903201|9069393|P3|Overall Study|Withdrawal by Subject|1
2623591|NCT00903201|9069394|P2|Overall Study|Withdrawal by Subject|0
2623592|NCT00903201|9069395|P1|Overall Study|Withdrawal by Subject|1
2623593|NCT00903201|9069393|P3|Overall Study|Physician Decision|1
2623594|NCT00903201|9069394|P2|Overall Study|Physician Decision|0
2623595|NCT00903201|9069395|P1|Overall Study|Physician Decision|1
2623596|NCT00903201|9069393|P3|Overall Study|Lost to Follow-up|0
2623597|NCT00903201|9069394|P2|Overall Study|Lost to Follow-up|1
2623598|NCT00903201|9069395|P1|Overall Study|Lost to Follow-up|0
2623599|NCT00903201|9069393|P3|Overall Study|Protocol Violation|0
2623600|NCT00903201|9069394|P2|Overall Study|Protocol Violation|1
2623601|NCT00903201|9069395|P1|Overall Study|Protocol Violation|2
2623602|NCT00903201|9069393|P3|Overall Study|Adverse Event|0
2623603|NCT00903201|9069394|P2|Overall Study|Adverse Event|4
2623604|NCT00903201|9069395|P1|Overall Study|Adverse Event|1
2623605|NCT00903175|9069453|P2|Period 2 - Second Line|Death|2
2623606|NCT00903175|9069454|P1|Period 2 - Second Line|Death|5
2623607|NCT00903175|9069453|P2|Period 2 - Second Line|Administrative problems|9
2623608|NCT00903175|9069454|P1|Period 2 - Second Line|Administrative problems|19
2623609|NCT00903175|9069453|P2|Period 2 - Second Line|Lost to Follow-up|0
2623610|NCT00903175|9069454|P1|Period 2 - Second Line|Lost to Follow-up|1
2623611|NCT00903175|9069453|P2|Period 2 - Second Line|Withdrawal by Subject|5
2623612|NCT00903175|9069454|P1|Period 2 - Second Line|Withdrawal by Subject|7
2623613|NCT00903175|9069453|P2|Period 2 - Second Line|Adverse Event|20
2623614|NCT00903175|9069454|P1|Period 2 - Second Line|Adverse Event|16
2623615|NCT00903175|9069453|P2|Period 2 - Second Line|Missing|0
2623616|NCT00903175|9069454|P1|Period 2 - Second Line|Missing|1
2623617|NCT00903175|9069453|P2|Period 1 - First Line|Death|10
2623618|NCT00903175|9069454|P1|Period 1 - First Line|Death|17
2623619|NCT00903175|9069453|P2|Period 1 - First Line|Administrative problems|13
2623620|NCT00903175|9069454|P1|Period 1 - First Line|Administrative problems|12
2623621|NCT00903175|9069453|P2|Period 1 - First Line|Withdrawal by Subject|12
2623622|NCT00903175|9069454|P1|Period 1 - First Line|Withdrawal by Subject|8
2623623|NCT00903175|9069453|P2|Period 1 - First Line|Protocol Violation|3
2623624|NCT00903175|9069454|P1|Period 1 - First Line|Protocol Violation|3
2623625|NCT00903175|9069453|P2|Period 1 - First Line|Abnormal test procedure result(s)|0
2623626|NCT00903175|9069454|P1|Period 1 - First Line|Abnormal test procedure result(s)|1
2623627|NCT00903175|9069453|P2|Period 1 - First Line|Abnormal lab value(s)|1
2623628|NCT00903175|9069454|P1|Period 1 - First Line|Abnormal lab value(s)|0
2623629|NCT00903175|9069453|P2|Period 1 - First Line|Adverse Event|50
2623630|NCT00903175|9069454|P1|Period 1 - First Line|Adverse Event|36
2623631|NCT00903032|9069492|P2|Overall Study|Lost to Follow-up|2
2623632|NCT00903032|9069493|P1|Overall Study|Lost to Follow-up|2
2623633|NCT00903032|9069492|P2|Overall Study|Withdrawal by Subject|3
2623634|NCT00903032|9069493|P1|Overall Study|Withdrawal by Subject|5
2623635|NCT00903006|9069503|P4|Overall Study|Progressive Disease|0
2623636|NCT00903006|9069504|P3|Overall Study|Progressive Disease|1
2623637|NCT00903006|9069505|P2|Overall Study|Progressive Disease|3
2623638|NCT00903006|9069506|P1|Overall Study|Progressive Disease|0
2623639|NCT00903006|9069503|P4|Overall Study|Withdrawal by Subject|0
2623640|NCT00903006|9069504|P3|Overall Study|Withdrawal by Subject|0
2623641|NCT00903006|9069505|P2|Overall Study|Withdrawal by Subject|0
2623642|NCT00903006|9069506|P1|Overall Study|Withdrawal by Subject|2
2623643|NCT00902850|9069518|P2|Overall Study|Physician Decision|2
2623644|NCT00902850|9069519|P1|Overall Study|Physician Decision|2
2623645|NCT00902746|9069525|P1|Overall Study|Physician Decision|2
2623646|NCT00902746|9069525|P1|Overall Study|Lost to Follow-up|3
2623647|NCT00902746|9069525|P1|Overall Study|Adverse Event|8
2623648|NCT00902746|9069525|P1|Overall Study|Withdrawal by Subject|16
2623649|NCT00902746|9069525|P1|Overall Study|Protocol Violation|7
2623650|NCT00902668|9069530|P1|Overall Study|Protocol stopped due to slow accrual.|3
2623651|NCT00902577|9069534|P1|Overall Study|FMISO production failure|2
2623652|NCT00902577|9069534|P1|Overall Study|Withdrawal by Subject|6
2623653|NCT00902564|9069563|P1|Overall Study|Withdrawal by Subject|2
2623654|NCT00902538|9069578|P6|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
2623655|NCT00902538|9069579|P5|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
2623656|NCT00902538|9069580|P4|4-Randomized Double-blind 2 Treatments|Protocol Violation|3
2623657|NCT00902538|9069581|P3|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
2623658|NCT00902538|9069582|P2|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
2623659|NCT00902538|9069583|P1|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
2623660|NCT00902538|9069578|P6|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
2623661|NCT00902538|9069579|P5|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1
2623662|NCT00902538|9069580|P4|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3
2623663|NCT00902538|9069581|P3|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
2623664|NCT00902538|9069582|P2|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
2623665|NCT00902538|9069583|P1|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
2623666|NCT00902538|9069578|P6|4-Randomized Double-blind 2 Treatments|Adverse Event|1
2623667|NCT00902538|9069579|P5|4-Randomized Double-blind 2 Treatments|Adverse Event|1
2623668|NCT00902538|9069580|P4|4-Randomized Double-blind 2 Treatments|Adverse Event|3
2623669|NCT00902538|9069581|P3|4-Randomized Double-blind 2 Treatments|Adverse Event|0
2623670|NCT00902538|9069582|P2|4-Randomized Double-blind 2 Treatments|Adverse Event|0
2623671|NCT00902538|9069583|P1|4-Randomized Double-blind 2 Treatments|Adverse Event|0
2623672|NCT00902538|9069578|P6|3-Single-blind, Single Treatment|Lost to Follow-up|0
2623673|NCT00902538|9069579|P5|3-Single-blind, Single Treatment|Lost to Follow-up|0
2623674|NCT00902538|9069580|P4|3-Single-blind, Single Treatment|Lost to Follow-up|0
2623675|NCT00902538|9069581|P3|3-Single-blind, Single Treatment|Lost to Follow-up|0
2623676|NCT00902538|9069582|P2|3-Single-blind, Single Treatment|Lost to Follow-up|1
2623677|NCT00902538|9069583|P1|3-Single-blind, Single Treatment|Lost to Follow-up|0
2623678|NCT00902538|9069578|P6|3-Single-blind, Single Treatment|Withdrawal by Subject|0
2623679|NCT00902538|9069579|P5|3-Single-blind, Single Treatment|Withdrawal by Subject|0
2623680|NCT00902538|9069580|P4|3-Single-blind, Single Treatment|Withdrawal by Subject|0
2623681|NCT00902538|9069581|P3|3-Single-blind, Single Treatment|Withdrawal by Subject|0
2623682|NCT00902538|9069582|P2|3-Single-blind, Single Treatment|Withdrawal by Subject|4
2623683|NCT00902538|9069583|P1|3-Single-blind, Single Treatment|Withdrawal by Subject|0
2623684|NCT00902538|9069578|P6|3-Single-blind, Single Treatment|Protocol Violation|0
2623685|NCT00902538|9069579|P5|3-Single-blind, Single Treatment|Protocol Violation|0
2623686|NCT00902538|9069580|P4|3-Single-blind, Single Treatment|Protocol Violation|0
2623687|NCT00902538|9069581|P3|3-Single-blind, Single Treatment|Protocol Violation|0
2623688|NCT00902538|9069582|P2|3-Single-blind, Single Treatment|Protocol Violation|5
2623689|NCT00902538|9069583|P1|3-Single-blind, Single Treatment|Protocol Violation|0
2623690|NCT00902538|9069578|P6|3-Single-blind, Single Treatment|Adverse Event|0
2623691|NCT00902538|9069579|P5|3-Single-blind, Single Treatment|Adverse Event|0
2623692|NCT00902538|9069580|P4|3-Single-blind, Single Treatment|Adverse Event|0
2623693|NCT00902538|9069581|P3|3-Single-blind, Single Treatment|Adverse Event|0
2623694|NCT00902538|9069582|P2|3-Single-blind, Single Treatment|Adverse Event|5
2623695|NCT00902538|9069583|P1|3-Single-blind, Single Treatment|Adverse Event|0
2623696|NCT00902538|9069578|P6|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
2623697|NCT00902538|9069579|P5|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
2623698|NCT00902538|9069580|P4|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
2623699|NCT00902538|9069581|P3|2-Randomized Double-blind 3 Treatments|Protocol Violation|2
2623700|NCT00902538|9069582|P2|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
2623701|NCT00902538|9069583|P1|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
2623702|NCT00902538|9069578|P6|2-Randomized Double-blind 3 Treatments|Other|0
2623703|NCT00902538|9069579|P5|2-Randomized Double-blind 3 Treatments|Other|0
2623704|NCT00902538|9069580|P4|2-Randomized Double-blind 3 Treatments|Other|0
2623705|NCT00902538|9069581|P3|2-Randomized Double-blind 3 Treatments|Other|0
2623706|NCT00902538|9069582|P2|2-Randomized Double-blind 3 Treatments|Other|1
2623707|NCT00902538|9069583|P1|2-Randomized Double-blind 3 Treatments|Other|2
2623708|NCT00902538|9069578|P6|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
2623709|NCT00902538|9069579|P5|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
2623710|NCT00902538|9069580|P4|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
2623711|NCT00902538|9069581|P3|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2
2623712|NCT00902538|9069582|P2|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
2623713|NCT00902538|9069583|P1|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1
2623714|NCT00902538|9069578|P6|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
2623715|NCT00902538|9069579|P5|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
2623716|NCT00902538|9069580|P4|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
2623717|NCT00902538|9069581|P3|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
2623718|NCT00902538|9069582|P2|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2
2623719|NCT00902538|9069583|P1|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
2623720|NCT00902538|9069578|P6|2-Randomized Double-blind 3 Treatments|Adverse Event|0
2623721|NCT00902538|9069579|P5|2-Randomized Double-blind 3 Treatments|Adverse Event|0
2623722|NCT00902538|9069580|P4|2-Randomized Double-blind 3 Treatments|Adverse Event|0
2623723|NCT00902538|9069581|P3|2-Randomized Double-blind 3 Treatments|Adverse Event|3
2623724|NCT00902538|9069582|P2|2-Randomized Double-blind 3 Treatments|Adverse Event|2
2623725|NCT00902538|9069583|P1|2-Randomized Double-blind 3 Treatments|Adverse Event|4
2623726|NCT00902538|9069578|P6|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
2623727|NCT00902538|9069579|P5|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
2623728|NCT00902538|9069580|P4|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
2623729|NCT00902538|9069581|P3|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
2623730|NCT00902538|9069582|P2|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
2623731|NCT00902538|9069583|P1|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4
2623732|NCT00902538|9069578|P6|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
2623733|NCT00902538|9069579|P5|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
2623734|NCT00902538|9069580|P4|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
2623735|NCT00902538|9069581|P3|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
2623736|NCT00902538|9069582|P2|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
2623737|NCT00902538|9069583|P1|1-Single-blind, Run-in, Single-Treatment|Other Reason|13
2623738|NCT00902538|9069578|P6|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
2623739|NCT00902538|9069579|P5|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
2623740|NCT00902538|9069580|P4|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
2623741|NCT00902538|9069581|P3|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
2623742|NCT00902538|9069582|P2|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
2623743|NCT00902538|9069583|P1|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22
2623744|NCT00902538|9069578|P6|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
2623745|NCT00902538|9069579|P5|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
2623746|NCT00902538|9069580|P4|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
2623747|NCT00902538|9069581|P3|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
2623748|NCT00902538|9069582|P2|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
2623749|NCT00902538|9069583|P1|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30
2623750|NCT00902538|9069578|P6|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
2623751|NCT00902538|9069579|P5|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
2623752|NCT00902538|9069580|P4|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
2623753|NCT00902538|9069581|P3|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
2623754|NCT00902538|9069582|P2|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
2623755|NCT00902538|9069583|P1|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49
2623756|NCT00902486|9069617|P6|Follow-up (After Week 24)|Lost to Follow-up|0
2623757|NCT00902486|9069618|P5|Follow-up (After Week 24)|Lost to Follow-up|0
2623758|NCT00902486|9069619|P4|Follow-up (After Week 24)|Lost to Follow-up|1
2623759|NCT00902486|9069620|P3|Follow-up (After Week 24)|Lost to Follow-up|0
2623760|NCT00902486|9069621|P2|Follow-up (After Week 24)|Lost to Follow-up|0
2623761|NCT00902486|9069622|P1|Follow-up (After Week 24)|Lost to Follow-up|0
2623762|NCT00902486|9069617|P6|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
2623763|NCT00902486|9069618|P5|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
2623764|NCT00902486|9069619|P4|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
2623765|NCT00902486|9069620|P3|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1
2623766|NCT00902486|9069621|P2|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
2623767|NCT00902486|9069622|P1|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
2623768|NCT00902486|9069617|P6|Extension Period (Weeks 12 Through 24)|Disease Progression|0
2623769|NCT00902486|9069618|P5|Extension Period (Weeks 12 Through 24)|Disease Progression|0
2623770|NCT00902486|9069619|P4|Extension Period (Weeks 12 Through 24)|Disease Progression|1
2623771|NCT00902486|9069620|P3|Extension Period (Weeks 12 Through 24)|Disease Progression|0
2623772|NCT00902486|9069621|P2|Extension Period (Weeks 12 Through 24)|Disease Progression|0
2623773|NCT00902486|9069622|P1|Extension Period (Weeks 12 Through 24)|Disease Progression|0
2623774|NCT00902486|9069617|P6|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1
2623775|NCT00902486|9069618|P5|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
2623776|NCT00902486|9069619|P4|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
2623777|NCT00902486|9069620|P3|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
2623778|NCT00902486|9069621|P2|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
2623779|NCT00902486|9069622|P1|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
2623780|NCT00902486|9069617|P6|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
2623781|NCT00902486|9069618|P5|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
2623782|NCT00902486|9069619|P4|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
2623783|NCT00902486|9069620|P3|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
2623784|NCT00902486|9069621|P2|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
2623785|NCT00902486|9069622|P1|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
2623786|NCT00902486|9069617|P6|Extension Period (Weeks 12 Through 24)|Adverse Event|2
2623787|NCT00902486|9069618|P5|Extension Period (Weeks 12 Through 24)|Adverse Event|1
2623788|NCT00902486|9069619|P4|Extension Period (Weeks 12 Through 24)|Adverse Event|0
2623789|NCT00902486|9069620|P3|Extension Period (Weeks 12 Through 24)|Adverse Event|0
2623790|NCT00902486|9069621|P2|Extension Period (Weeks 12 Through 24)|Adverse Event|0
2623791|NCT00902486|9069622|P1|Extension Period (Weeks 12 Through 24)|Adverse Event|0
2623792|NCT00902486|9069617|P6|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
2623793|NCT00902486|9069618|P5|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
2623794|NCT00902486|9069619|P4|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1
2623795|NCT00902486|9069620|P3|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
2623796|NCT00902486|9069621|P2|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
2623797|NCT00902486|9069622|P1|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
2623798|NCT00902486|9069617|P6|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
2623799|NCT00902486|9069618|P5|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
2623800|NCT00902486|9069619|P4|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1
2623801|NCT00902486|9069620|P3|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
2623802|NCT00902486|9069621|P2|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
2623803|NCT00902486|9069622|P1|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
2623804|NCT00902486|9069617|P6|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
2623805|NCT00902486|9069618|P5|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
2623806|NCT00902486|9069619|P4|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
2623807|NCT00902486|9069620|P3|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
2623808|NCT00902486|9069621|P2|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
2623809|NCT00902486|9069622|P1|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
2623810|NCT00902486|9069617|P6|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2
2623811|NCT00902486|9069618|P5|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
2623812|NCT00902486|9069619|P4|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
2623813|NCT00902486|9069620|P3|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
2623814|NCT00902486|9069621|P2|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
2623815|NCT00902486|9069622|P1|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1
2623816|NCT00902486|9069617|P6|Treatment Period (Weeks 0 Through 12)|Adverse Event|2
2623817|NCT00902486|9069618|P5|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
2623818|NCT00902486|9069619|P4|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
2623819|NCT00902486|9069620|P3|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
2623820|NCT00902486|9069621|P2|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
2623821|NCT00902486|9069622|P1|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
2623822|NCT00902330|9069760|P2|Overall Study|No post baseline data|0
2623823|NCT00902330|9069761|P1|Overall Study|No post baseline data|1
2623824|NCT00902330|9069760|P2|Overall Study|Adverse Event|0
2623825|NCT00902330|9069761|P1|Overall Study|Adverse Event|1
2623826|NCT00902330|9069760|P2|Overall Study|Too overwhelmed by treatment|5
2623827|NCT00902330|9069761|P1|Overall Study|Too overwhelmed by treatment|2
2623828|NCT00902304|9069798|P3|Overall Study|includes pregnancy|2
2623829|NCT00902304|9069799|P2|Overall Study|includes pregnancy|9
2623830|NCT00902304|9069800|P1|Overall Study|includes pregnancy|3
2623831|NCT00902304|9069798|P3|Overall Study|Withdrawal by Subject|43
2623832|NCT00902304|9069799|P2|Overall Study|Withdrawal by Subject|22
2623833|NCT00902304|9069800|P1|Overall Study|Withdrawal by Subject|32
2623834|NCT00902304|9069798|P3|Overall Study|Protocol Violation|20
2623835|NCT00902304|9069799|P2|Overall Study|Protocol Violation|18
2623836|NCT00902304|9069800|P1|Overall Study|Protocol Violation|9
2623837|NCT00902304|9069798|P3|Overall Study|Lost to Follow-up|7
2623838|NCT00902304|9069799|P2|Overall Study|Lost to Follow-up|7
2623839|NCT00902304|9069800|P1|Overall Study|Lost to Follow-up|7
2623840|NCT00902304|9069798|P3|Overall Study|Investigator discretion|13
2623841|NCT00902304|9069799|P2|Overall Study|Investigator discretion|5
2623842|NCT00902304|9069800|P1|Overall Study|Investigator discretion|3
2623843|NCT00902304|9069798|P3|Overall Study|Adverse Event|25
2623844|NCT00902304|9069799|P2|Overall Study|Adverse Event|10
2623845|NCT00902304|9069800|P1|Overall Study|Adverse Event|4
2623846|NCT00902278|9069850|P5|Overall Study|Lost to Follow-up|1
2623847|NCT00902278|9069851|P4|Overall Study|Lost to Follow-up|0
2623848|NCT00902278|9069852|P3|Overall Study|Lost to Follow-up|3
2623849|NCT00902278|9069853|P2|Overall Study|Lost to Follow-up|2
2623850|NCT00902278|9069854|P1|Overall Study|Lost to Follow-up|3
2623851|NCT00902278|9069850|P5|Overall Study|Physician Decision|1
2623852|NCT00902278|9069851|P4|Overall Study|Physician Decision|0
2623853|NCT00902278|9069852|P3|Overall Study|Physician Decision|2
2623854|NCT00902278|9069853|P2|Overall Study|Physician Decision|0
2623855|NCT00902278|9069854|P1|Overall Study|Physician Decision|1
2623856|NCT00902265|9069871|P1|Overall Study|Protocol Violation|1
2623857|NCT00902265|9069871|P1|Overall Study|Lack of Efficacy|2
2623858|NCT00902265|9069871|P1|Overall Study|Adverse Event|2
2623859|NCT00902265|9069871|P1|Overall Study|Lost to Follow-up Prior to First Visit|1
2623860|NCT00902174|9069895|P2|Overall Study|Administration problem|1
2623861|NCT00902174|9069896|P1|Overall Study|Administration problem|0
2623862|NCT00902174|9069895|P2|Overall Study|Protocol Violation|1
2623863|NCT00902174|9069896|P1|Overall Study|Protocol Violation|1
2623864|NCT00902174|9069895|P2|Overall Study|Abnormal labs|1
2623865|NCT00902174|9069896|P1|Overall Study|Abnormal labs|1
2623866|NCT00902174|9069895|P2|Overall Study|Withdrawal by Subject|1
2623867|NCT00902174|9069896|P1|Overall Study|Withdrawal by Subject|2
2623868|NCT00902174|9069895|P2|Overall Study|Death|2
2623869|NCT00902174|9069896|P1|Overall Study|Death|2
2623870|NCT00902174|9069895|P2|Overall Study|Lack of Efficacy|5
2623871|NCT00902174|9069896|P1|Overall Study|Lack of Efficacy|1
2623872|NCT00902174|9069895|P2|Overall Study|Adverse Event|7
2623873|NCT00902174|9069896|P1|Overall Study|Adverse Event|27
2623874|NCT00901927|9069971|P1|Overall Study|Withdrawal by Subject|2
2623875|NCT00901927|9069971|P1|Overall Study|Protocol Violation|3
2623876|NCT00901927|9069971|P1|Overall Study|Lack of Efficacy|1
2623877|NCT00901901|9069979|P2|Follow-up Period|Missing|80
2623878|NCT00901901|9069980|P1|Follow-up Period|Missing|94
2623879|NCT00901901|9069979|P2|Follow-up Period|Lost to Follow-up|8
2623880|NCT00901901|9069980|P1|Follow-up Period|Lost to Follow-up|12
2623881|NCT00901901|9069979|P2|Follow-up Period|Withdrawal by Subject|9
2623882|NCT00901901|9069980|P1|Follow-up Period|Withdrawal by Subject|6
2623883|NCT00901901|9069979|P2|Follow-up Period|Protocol driven decision point|36
2623884|NCT00901901|9069980|P1|Follow-up Period|Protocol driven decision point|47
2623885|NCT00901901|9069979|P2|Follow-up Period|Death|208
2623886|NCT00901901|9069980|P1|Follow-up Period|Death|181
2623887|NCT00901901|9069979|P2|Treatment Period|Transfer to treatment continuation study|2
2623888|NCT00901901|9069980|P1|Treatment Period|Transfer to treatment continuation study|5
2623889|NCT00901901|9069979|P2|Treatment Period|Switch to commercial drug|1
2623890|NCT00901901|9069980|P1|Treatment Period|Switch to commercial drug|1
2623891|NCT00901901|9069979|P2|Treatment Period|Protocol Violation|9
2623892|NCT00901901|9069980|P1|Treatment Period|Protocol Violation|5
2623893|NCT00901901|9069979|P2|Treatment Period|Study terminated by sponsor|0
2623894|NCT00901901|9069980|P1|Treatment Period|Study terminated by sponsor|2
2623895|NCT00901901|9069979|P2|Treatment Period|Protocol driven decision point|2
2623896|NCT00901901|9069980|P1|Treatment Period|Protocol driven decision point|0
2623897|NCT00901901|9069979|P2|Treatment Period|Never treated|3
2623898|NCT00901901|9069980|P1|Treatment Period|Never treated|0
2623899|NCT00901901|9069979|P2|Treatment Period|Missing|0
2623900|NCT00901901|9069980|P1|Treatment Period|Missing|1
2623901|NCT00901901|9069979|P2|Treatment Period|Noncompliance with study medication|1
2623902|NCT00901901|9069980|P1|Treatment Period|Noncompliance with study medication|4
2623903|NCT00901901|9069979|P2|Treatment Period|Lost to Follow-up|5
2623904|NCT00901901|9069980|P1|Treatment Period|Lost to Follow-up|3
2623905|NCT00901901|9069979|P2|Treatment Period|Physician Decision|2
2623906|NCT00901901|9069980|P1|Treatment Period|Physician Decision|2
2623907|NCT00901901|9069979|P2|Treatment Period|Withdrawal by Subject|24
2623908|NCT00901901|9069980|P1|Treatment Period|Withdrawal by Subject|26
2623909|NCT00901901|9069979|P2|Treatment Period|Adverse Event|128
2623910|NCT00901901|9069980|P1|Treatment Period|Adverse Event|120
2623911|NCT00901628|9070002|P2|Overall Study|peroneal nerve palsy|1
2623912|NCT00901628|9070003|P1|Overall Study|peroneal nerve palsy|0
2623913|NCT00901628|9070002|P2|Overall Study|disconnection of drain|1
2623914|NCT00901628|9070003|P1|Overall Study|disconnection of drain|0
2623915|NCT00901628|9070002|P2|Overall Study|disconnection of catheter|8
2623916|NCT00901628|9070003|P1|Overall Study|disconnection of catheter|4
2623917|NCT00901576|9070025|P6|Second Intervention|Physician Decision|0
2623918|NCT00901576|9070026|P5|Second Intervention|Physician Decision|0
2623919|NCT00901576|9070027|P4|Second Intervention|Physician Decision|0
2623920|NCT00901576|9070028|P3|Second Intervention|Physician Decision|0
2623921|NCT00901576|9070029|P2|Second Intervention|Physician Decision|0
2623922|NCT00901576|9070030|P1|Second Intervention|Physician Decision|1
2623923|NCT00901576|9070025|P6|Second Intervention|Withdrawal by Subject|1
2623924|NCT00901576|9070026|P5|Second Intervention|Withdrawal by Subject|0
2623925|NCT00901576|9070027|P4|Second Intervention|Withdrawal by Subject|1
2623926|NCT00901576|9070028|P3|Second Intervention|Withdrawal by Subject|0
2623927|NCT00901576|9070029|P2|Second Intervention|Withdrawal by Subject|0
2623928|NCT00901576|9070030|P1|Second Intervention|Withdrawal by Subject|0
2623929|NCT00901459|9070051|P1|Overall Study|Withdrawal by Subject|6
2623930|NCT00901342|9070062|P1|Overall Study|Withdrawal by Subject|9
2623931|NCT00901342|9070062|P1|Overall Study|Disease progression|1
2623932|NCT00901342|9070062|P1|Overall Study|Death|4
2623933|NCT00901342|9070062|P1|Overall Study|Adverse Event|1
2623934|NCT00901186|9070095|P2|Overall Study|Protocol deviations|4
2623935|NCT00901186|9070096|P1|Overall Study|Protocol deviations|5
2623936|NCT00901186|9070095|P2|Overall Study|Administration problems|1
2623937|NCT00901186|9070096|P1|Overall Study|Administration problems|0
2623938|NCT00901186|9070095|P2|Overall Study|Adverse Event|4
2623939|NCT00901186|9070096|P1|Overall Study|Adverse Event|2
2623940|NCT00901186|9070095|P2|Overall Study|Lost to Follow-up|0
2623941|NCT00901186|9070096|P1|Overall Study|Lost to Follow-up|2
2623942|NCT00901186|9070095|P2|Overall Study|Abnormal laboratory values|1
2623943|NCT00901186|9070096|P1|Overall Study|Abnormal laboratory values|0
2623944|NCT00901186|9070095|P2|Overall Study|Lack of Efficacy|1
2623945|NCT00901186|9070096|P1|Overall Study|Lack of Efficacy|0
2623946|NCT00900796|9070136|P1|Phase 2|Lost to Follow-up|5
2623947|NCT00900796|9070136|P1|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110
2623948|NCT00900796|9070136|P1|Phase 1|Missing information at Week 16|7
2623949|NCT00900796|9070136|P1|Phase 1|Lacked sufficient information|4
2623950|NCT00900757|9070146|P1|Overall Study|screen failure|19
2623951|NCT00900731|9070156|P2|Overall Study|Death|2
2623952|NCT00900731|9070157|P1|Overall Study|Death|0
2623953|NCT00900731|9070156|P2|Overall Study|Lack of Efficacy|3
2623954|NCT00900731|9070157|P1|Overall Study|Lack of Efficacy|1
2623955|NCT00900731|9070156|P2|Overall Study|Lost to Follow-up|3
2623956|NCT00900731|9070157|P1|Overall Study|Lost to Follow-up|2
2623957|NCT00900731|9070156|P2|Overall Study|Abnormal Laboratory Value(s)|4
2623958|NCT00900731|9070157|P1|Overall Study|Abnormal Laboratory Value(s)|2
2623959|NCT00900731|9070156|P2|Overall Study|Abnormal Test Procedure Result(s)|0
2623960|NCT00900731|9070157|P1|Overall Study|Abnormal Test Procedure Result(s)|3
2623961|NCT00900731|9070156|P2|Overall Study|Administrative Problems|4
2623962|NCT00900731|9070157|P1|Overall Study|Administrative Problems|5
2623963|NCT00900731|9070156|P2|Overall Study|Protocol Deviation|11
2623964|NCT00900731|9070157|P1|Overall Study|Protocol Deviation|8
2623965|NCT00900731|9070156|P2|Overall Study|Withdrawal by Subject|7
2623966|NCT00900731|9070157|P1|Overall Study|Withdrawal by Subject|8
2623967|NCT00900731|9070156|P2|Overall Study|Adverse Event|27
2623968|NCT00900731|9070157|P1|Overall Study|Adverse Event|31
2623969|NCT00900627|9070194|P6|Overall Study|Death|24
2623970|NCT00900627|9070195|P5|Overall Study|Death|28
2623971|NCT00900627|9070196|P4|Overall Study|Death|0
2623972|NCT00900627|9070197|P3|Overall Study|Death|0
2623973|NCT00900627|9070198|P2|Overall Study|Death|0
2623974|NCT00900627|9070199|P1|Overall Study|Death|0
2623975|NCT00900627|9070194|P6|Overall Study|Adverse Event|0
2623976|NCT00900627|9070195|P5|Overall Study|Adverse Event|0
2623977|NCT00900627|9070196|P4|Overall Study|Adverse Event|3
2623978|NCT00900627|9070197|P3|Overall Study|Adverse Event|0
2623979|NCT00900627|9070198|P2|Overall Study|Adverse Event|2
2623980|NCT00900627|9070199|P1|Overall Study|Adverse Event|1
2623981|NCT00900627|9070194|P6|Overall Study|Withdrawal by Subject|2
2623982|NCT00900627|9070195|P5|Overall Study|Withdrawal by Subject|1
2623983|NCT00900627|9070196|P4|Overall Study|Withdrawal by Subject|0
2623984|NCT00900627|9070197|P3|Overall Study|Withdrawal by Subject|1
2623985|NCT00900627|9070198|P2|Overall Study|Withdrawal by Subject|0
2623986|NCT00900627|9070199|P1|Overall Study|Withdrawal by Subject|1
2623987|NCT00900627|9070194|P6|Overall Study|Condition under investigation worsened|0
2623988|NCT00900627|9070195|P5|Overall Study|Condition under investigation worsened|0
2623989|NCT00900627|9070196|P4|Overall Study|Condition under investigation worsened|3
2623990|NCT00900627|9070197|P3|Overall Study|Condition under investigation worsened|5
2623991|NCT00900627|9070198|P2|Overall Study|Condition under investigation worsened|0
2623992|NCT00900627|9070199|P1|Overall Study|Condition under investigation worsened|4
2623993|NCT00900601|9070217|P1|Overall Study|Physician Decision|1
2623994|NCT00900159|9070236|P2|Second Intervention|disempanelled for inappropriate behavior|0
2623995|NCT00900159|9070237|P1|Second Intervention|disempanelled for inappropriate behavior|1
2623996|NCT00900146|9070256|P5|Intermediate: Period III|Administrative problems|163
2623997|NCT00900146|9070257|P4|Intermediate: Period III|Administrative problems|90
2623998|NCT00900146|9070258|P3|Intermediate: Period III|Administrative problems|84
2623999|NCT00900146|9070259|P2|Intermediate: Period III|Administrative problems|92
2624000|NCT00900146|9070260|P1|Intermediate: Period III|Administrative problems|85
2624001|NCT00900146|9070256|P5|Intermediate: Period III|Lost to Follow-up|1
2624002|NCT00900146|9070257|P4|Intermediate: Period III|Lost to Follow-up|0
2624003|NCT00900146|9070258|P3|Intermediate: Period III|Lost to Follow-up|0
2624004|NCT00900146|9070259|P2|Intermediate: Period III|Lost to Follow-up|0
2624005|NCT00900146|9070260|P1|Intermediate: Period III|Lost to Follow-up|2
2624006|NCT00900146|9070256|P5|Intermediate: Period III|Withdrawal by Subject|3
2624007|NCT00900146|9070257|P4|Intermediate: Period III|Withdrawal by Subject|0
2624008|NCT00900146|9070258|P3|Intermediate: Period III|Withdrawal by Subject|0
2624009|NCT00900146|9070259|P2|Intermediate: Period III|Withdrawal by Subject|1
2624010|NCT00900146|9070260|P1|Intermediate: Period III|Withdrawal by Subject|0
2624011|NCT00900146|9070256|P5|Dose Finding: Period II (4 Months)|Administrative problems|0
2624012|NCT00900146|9070257|P4|Dose Finding: Period II (4 Months)|Administrative problems|0
2624013|NCT00900146|9070258|P3|Dose Finding: Period II (4 Months)|Administrative problems|0
2624014|NCT00900146|9070259|P2|Dose Finding: Period II (4 Months)|Administrative problems|0
2624015|NCT00900146|9070260|P1|Dose Finding: Period II (4 Months)|Administrative problems|1
2624016|NCT00900146|9070256|P5|Dose Finding: Period II (4 Months)|Lost to Follow-up|3
2624017|NCT00900146|9070257|P4|Dose Finding: Period II (4 Months)|Lost to Follow-up|1
2624018|NCT00900146|9070258|P3|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
2624100|NCT00899379|9070608|P5|Overall Study|Abnormal Prestudy Labs|2
2624019|NCT00900146|9070259|P2|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
2624020|NCT00900146|9070260|P1|Dose Finding: Period II (4 Months)|Lost to Follow-up|2
2624021|NCT00900146|9070256|P5|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9
2624022|NCT00900146|9070257|P4|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1
2624023|NCT00900146|9070258|P3|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5
2624024|NCT00900146|9070259|P2|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
2624025|NCT00900146|9070260|P1|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
2624026|NCT00900029|9070377|P5|Overall Study|Death|0
2624027|NCT00900029|9070378|P4|Overall Study|Death|1
2624028|NCT00900029|9070379|P3|Overall Study|Death|0
2624029|NCT00900029|9070380|P2|Overall Study|Death|0
2624030|NCT00900029|9070381|P1|Overall Study|Death|1
2624031|NCT00900029|9070377|P5|Overall Study|Adverse Event|1
2624032|NCT00900029|9070378|P4|Overall Study|Adverse Event|1
2624033|NCT00900029|9070379|P3|Overall Study|Adverse Event|1
2624034|NCT00900029|9070380|P2|Overall Study|Adverse Event|0
2624035|NCT00900029|9070381|P1|Overall Study|Adverse Event|0
2624036|NCT00900029|9070377|P5|Overall Study|Withdrawal by Subject|1
2624037|NCT00900029|9070378|P4|Overall Study|Withdrawal by Subject|1
2624038|NCT00900029|9070379|P3|Overall Study|Withdrawal by Subject|1
2624039|NCT00900029|9070380|P2|Overall Study|Withdrawal by Subject|2
2624040|NCT00900029|9070381|P1|Overall Study|Withdrawal by Subject|2
2624041|NCT00900029|9070377|P5|Overall Study|Lost to Follow-up|4
2624042|NCT00900029|9070378|P4|Overall Study|Lost to Follow-up|4
2624043|NCT00900029|9070379|P3|Overall Study|Lost to Follow-up|1
2624044|NCT00900029|9070380|P2|Overall Study|Lost to Follow-up|2
2624045|NCT00900029|9070381|P1|Overall Study|Lost to Follow-up|0
2624046|NCT00899847|9070398|P1|Overall Study|Lack of suitable allogeneic donor|2
2624047|NCT00899678|9070429|P3|Maintenance Period (Weeks 8 to 62)|Other reason|2
2624048|NCT00899678|9070430|P2|Maintenance Period (Weeks 8 to 62)|Other reason|2
2624049|NCT00899678|9070431|P1|Maintenance Period (Weeks 8 to 62)|Other reason|0
2624050|NCT00899678|9070429|P3|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2
2624051|NCT00899678|9070430|P2|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1
2624052|NCT00899678|9070431|P1|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0
2624053|NCT00899678|9070429|P3|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
2624054|NCT00899678|9070430|P2|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
2624055|NCT00899678|9070431|P1|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0
2624056|NCT00899678|9070429|P3|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18
2624057|NCT00899678|9070430|P2|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11
2624058|NCT00899678|9070431|P1|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0
2624059|NCT00899678|9070429|P3|Maintenance Period (Weeks 8 to 62)|Adverse Event|5
2624060|NCT00899678|9070430|P2|Maintenance Period (Weeks 8 to 62)|Adverse Event|10
2624061|NCT00899678|9070431|P1|Maintenance Period (Weeks 8 to 62)|Adverse Event|0
2624062|NCT00899678|9070429|P3|Induction Period (Weeks 0 to 6)|Other reason|0
2624063|NCT00899678|9070430|P2|Induction Period (Weeks 0 to 6)|Other reason|0
2624064|NCT00899678|9070431|P1|Induction Period (Weeks 0 to 6)|Other reason|1
2624065|NCT00899678|9070429|P3|Induction Period (Weeks 0 to 6)|Protocol Violation|0
2624066|NCT00899678|9070430|P2|Induction Period (Weeks 0 to 6)|Protocol Violation|0
2624067|NCT00899678|9070431|P1|Induction Period (Weeks 0 to 6)|Protocol Violation|1
2624068|NCT00899678|9070429|P3|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
2624069|NCT00899678|9070430|P2|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
2624070|NCT00899678|9070431|P1|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17
2624071|NCT00899678|9070429|P3|Induction Period (Weeks 0 to 6)|Adverse Event|0
2624072|NCT00899678|9070430|P2|Induction Period (Weeks 0 to 6)|Adverse Event|0
2624073|NCT00899678|9070431|P1|Induction Period (Weeks 0 to 6)|Adverse Event|6
2624074|NCT00899548|9070481|P1|Overall Study|Physician Decision|3
2624075|NCT00899431|9070575|P3|Overall Study|Physician Decision|0
2624076|NCT00899431|9070576|P2|Overall Study|Physician Decision|0
2624077|NCT00899431|9070577|P1|Overall Study|Physician Decision|1
2624078|NCT00899392|9070590|P2|Overall Study|Subject didn't finish/partial pilot data|24
2624079|NCT00899392|9070591|P1|Overall Study|Subject didn't finish/partial pilot data|21
2624080|NCT00899379|9070608|P5|Overall Study|Inc/Exc Criteria Not Met|0
2624081|NCT00899379|9070609|P4|Overall Study|Inc/Exc Criteria Not Met|0
2624082|NCT00899379|9070610|P3|Overall Study|Inc/Exc Criteria Not Met|1
2624083|NCT00899379|9070611|P2|Overall Study|Inc/Exc Criteria Not Met|0
2624084|NCT00899379|9070612|P1|Overall Study|Inc/Exc Criteria Not Met|0
2624085|NCT00899379|9070608|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
2624086|NCT00899379|9070609|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
2624087|NCT00899379|9070610|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
2624088|NCT00899379|9070611|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
2624089|NCT00899379|9070612|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
2624090|NCT00899379|9070608|P5|Overall Study|No Attack Pretreatment|4
2624091|NCT00899379|9070609|P4|Overall Study|No Attack Pretreatment|6
2624092|NCT00899379|9070610|P3|Overall Study|No Attack Pretreatment|5
2624093|NCT00899379|9070611|P2|Overall Study|No Attack Pretreatment|5
2624094|NCT00899379|9070612|P1|Overall Study|No Attack Pretreatment|3
2624095|NCT00899379|9070608|P5|Overall Study|Abnormal Baseline ECG|0
2624096|NCT00899379|9070609|P4|Overall Study|Abnormal Baseline ECG|1
2624097|NCT00899379|9070610|P3|Overall Study|Abnormal Baseline ECG|1
2624098|NCT00899379|9070611|P2|Overall Study|Abnormal Baseline ECG|0
2624099|NCT00899379|9070612|P1|Overall Study|Abnormal Baseline ECG|0
2624101|NCT00899379|9070609|P4|Overall Study|Abnormal Prestudy Labs|0
2624102|NCT00899379|9070610|P3|Overall Study|Abnormal Prestudy Labs|0
2624103|NCT00899379|9070611|P2|Overall Study|Abnormal Prestudy Labs|0
2624104|NCT00899379|9070612|P1|Overall Study|Abnormal Prestudy Labs|0
2624105|NCT00899379|9070608|P5|Overall Study|Patient Uncooperative|0
2624106|NCT00899379|9070609|P4|Overall Study|Patient Uncooperative|1
2624107|NCT00899379|9070610|P3|Overall Study|Patient Uncooperative|0
2624108|NCT00899379|9070611|P2|Overall Study|Patient Uncooperative|0
2624109|NCT00899379|9070612|P1|Overall Study|Patient Uncooperative|0
2624110|NCT00899379|9070608|P5|Overall Study|Pregnancy|0
2624111|NCT00899379|9070609|P4|Overall Study|Pregnancy|0
2624112|NCT00899379|9070610|P3|Overall Study|Pregnancy|0
2624113|NCT00899379|9070611|P2|Overall Study|Pregnancy|0
2624114|NCT00899379|9070612|P1|Overall Study|Pregnancy|1
2624115|NCT00899379|9070608|P5|Overall Study|Withdrawal by Subject|2
2624116|NCT00899379|9070609|P4|Overall Study|Withdrawal by Subject|7
2624117|NCT00899379|9070610|P3|Overall Study|Withdrawal by Subject|4
2624118|NCT00899379|9070611|P2|Overall Study|Withdrawal by Subject|7
2624119|NCT00899379|9070612|P1|Overall Study|Withdrawal by Subject|4
2624120|NCT00899379|9070608|P5|Overall Study|Lost to Follow-up|5
2624121|NCT00899379|9070609|P4|Overall Study|Lost to Follow-up|2
2624122|NCT00899379|9070610|P3|Overall Study|Lost to Follow-up|0
2624123|NCT00899379|9070611|P2|Overall Study|Lost to Follow-up|1
2624124|NCT00899379|9070612|P1|Overall Study|Lost to Follow-up|3
2624125|NCT00899379|9070608|P5|Overall Study|Study Terminated|1
2624126|NCT00899379|9070609|P4|Overall Study|Study Terminated|3
2624127|NCT00899379|9070610|P3|Overall Study|Study Terminated|3
2624128|NCT00899379|9070611|P2|Overall Study|Study Terminated|0
2624129|NCT00899379|9070612|P1|Overall Study|Study Terminated|3
2624130|NCT00899379|9070608|P5|Overall Study|Not Completed/Entered Extn|3
2624131|NCT00899379|9070609|P4|Overall Study|Not Completed/Entered Extn|4
2624132|NCT00899379|9070610|P3|Overall Study|Not Completed/Entered Extn|6
2624133|NCT00899379|9070611|P2|Overall Study|Not Completed/Entered Extn|1
2624134|NCT00899379|9070612|P1|Overall Study|Not Completed/Entered Extn|5
2624135|NCT00899379|9070608|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
2624136|NCT00899379|9070609|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
2624137|NCT00899379|9070610|P3|Overall Study|No Longer Met Inc/Exc Criteria|1
2624138|NCT00899379|9070611|P2|Overall Study|No Longer Met Inc/Exc Criteria|1
2624139|NCT00899379|9070612|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
2624140|NCT00899379|9070608|P5|Overall Study|Abnormal Baseline ECG|0
2624141|NCT00899379|9070609|P4|Overall Study|Abnormal Baseline ECG|1
2624142|NCT00899379|9070610|P3|Overall Study|Abnormal Baseline ECG|0
2624143|NCT00899379|9070611|P2|Overall Study|Abnormal Baseline ECG|0
2624144|NCT00899379|9070612|P1|Overall Study|Abnormal Baseline ECG|0
2624145|NCT00899379|9070608|P5|Overall Study|Patient Uncooperative|2
2624146|NCT00899379|9070609|P4|Overall Study|Patient Uncooperative|1
2624147|NCT00899379|9070610|P3|Overall Study|Patient Uncooperative|0
2624148|NCT00899379|9070611|P2|Overall Study|Patient Uncooperative|1
2624149|NCT00899379|9070612|P1|Overall Study|Patient Uncooperative|0
2624150|NCT00899379|9070608|P5|Overall Study|Pregnancy|1
2624151|NCT00899379|9070609|P4|Overall Study|Pregnancy|0
2624152|NCT00899379|9070610|P3|Overall Study|Pregnancy|1
2624153|NCT00899379|9070611|P2|Overall Study|Pregnancy|0
2624154|NCT00899379|9070612|P1|Overall Study|Pregnancy|0
2624155|NCT00899379|9070608|P5|Overall Study|Withdrawal by Subject|6
2624156|NCT00899379|9070609|P4|Overall Study|Withdrawal by Subject|3
2624157|NCT00899379|9070610|P3|Overall Study|Withdrawal by Subject|2
2624158|NCT00899379|9070611|P2|Overall Study|Withdrawal by Subject|4
2624159|NCT00899379|9070612|P1|Overall Study|Withdrawal by Subject|2
2624160|NCT00899379|9070608|P5|Overall Study|Protocol Violation|0
2624161|NCT00899379|9070609|P4|Overall Study|Protocol Violation|1
2624162|NCT00899379|9070610|P3|Overall Study|Protocol Violation|1
2624163|NCT00899379|9070611|P2|Overall Study|Protocol Violation|0
2624164|NCT00899379|9070612|P1|Overall Study|Protocol Violation|0
2624165|NCT00899379|9070608|P5|Overall Study|Lost to Follow-up|2
2624166|NCT00899379|9070609|P4|Overall Study|Lost to Follow-up|6
2624167|NCT00899379|9070610|P3|Overall Study|Lost to Follow-up|0
2624168|NCT00899379|9070611|P2|Overall Study|Lost to Follow-up|3
2624169|NCT00899379|9070612|P1|Overall Study|Lost to Follow-up|9
2624170|NCT00899379|9070608|P5|Overall Study|Lack of Efficacy|1
2624171|NCT00899379|9070609|P4|Overall Study|Lack of Efficacy|0
2624172|NCT00899379|9070610|P3|Overall Study|Lack of Efficacy|3
2624173|NCT00899379|9070611|P2|Overall Study|Lack of Efficacy|4
2624174|NCT00899379|9070612|P1|Overall Study|Lack of Efficacy|0
2624175|NCT00899379|9070608|P5|Overall Study|Adverse Event|2
2624176|NCT00899379|9070609|P4|Overall Study|Adverse Event|1
2624177|NCT00899379|9070610|P3|Overall Study|Adverse Event|1
2624178|NCT00899379|9070611|P2|Overall Study|Adverse Event|2
2624179|NCT00899379|9070612|P1|Overall Study|Adverse Event|2
2624180|NCT00899353|9070624|P1|Overall Study|Withdrawal by Subject|2
2624181|NCT00899353|9070624|P1|Overall Study|Lost to Follow-up|1
2624182|NCT00899353|9070624|P1|Overall Study|Adverse Event|2
2624183|NCT00898807|9070660|P2|Overall Study|Death|1
2624184|NCT00898807|9070661|P1|Overall Study|Death|0
2624185|NCT00898807|9070660|P2|Overall Study|Lost to Follow-up|3
2624186|NCT00898807|9070661|P1|Overall Study|Lost to Follow-up|1
2624187|NCT00898807|9070660|P2|Overall Study|Family pressure to discontinue|2
2624188|NCT00898807|9070661|P1|Overall Study|Family pressure to discontinue|2
2624189|NCT00898807|9070660|P2|Overall Study|Withdrawal by Subject|3
2624190|NCT00898807|9070661|P1|Overall Study|Withdrawal by Subject|5
2624191|NCT00898677|9070677|P4|Overall Study|Not Treated: Other (Not Specified)|0
2624192|NCT00898677|9070678|P3|Overall Study|Not Treated: Other (Not Specified)|2
2624193|NCT00898677|9070679|P2|Overall Study|Not Treated: Other (Not Specified)|0
2624194|NCT00898677|9070680|P1|Overall Study|Not Treated: Other (Not Specified)|0
2624195|NCT00898677|9070677|P4|Overall Study|Not Treated: Lack of Migraine Attack|12
2624196|NCT00898677|9070678|P3|Overall Study|Not Treated: Lack of Migraine Attack|43
2624197|NCT00898677|9070679|P2|Overall Study|Not Treated: Lack of Migraine Attack|39
2624198|NCT00898677|9070680|P1|Overall Study|Not Treated: Lack of Migraine Attack|9
2624199|NCT00898677|9070677|P4|Overall Study|Not Treated: No Longer Met Inc Criteria|0
2624200|NCT00898677|9070678|P3|Overall Study|Not Treated: No Longer Met Inc Criteria|1
2624201|NCT00898677|9070679|P2|Overall Study|Not Treated: No Longer Met Inc Criteria|3
2624202|NCT00898677|9070680|P1|Overall Study|Not Treated: No Longer Met Inc Criteria|0
2624203|NCT00898677|9070677|P4|Overall Study|Not Treated: Abnormal Baseline ECG|0
2624204|NCT00898677|9070678|P3|Overall Study|Not Treated: Abnormal Baseline ECG|0
2624205|NCT00898677|9070679|P2|Overall Study|Not Treated: Abnormal Baseline ECG|0
2624206|NCT00898677|9070680|P1|Overall Study|Not Treated: Abnormal Baseline ECG|1
2624207|NCT00898677|9070677|P4|Overall Study|Not Treated: Abnormal Prestudy Labs|1
2624208|NCT00898677|9070678|P3|Overall Study|Not Treated: Abnormal Prestudy Labs|0
2624209|NCT00898677|9070679|P2|Overall Study|Not Treated: Abnormal Prestudy Labs|0
2624210|NCT00898677|9070680|P1|Overall Study|Not Treated: Abnormal Prestudy Labs|0
2624211|NCT00898677|9070677|P4|Overall Study|Not Treated: Patient uncooperative|0
2624212|NCT00898677|9070678|P3|Overall Study|Not Treated: Patient uncooperative|1
2624213|NCT00898677|9070679|P2|Overall Study|Not Treated: Patient uncooperative|3
2624214|NCT00898677|9070680|P1|Overall Study|Not Treated: Patient uncooperative|2
2624215|NCT00898677|9070677|P4|Overall Study|Not Treated: Withdraw by Subject|3
2624216|NCT00898677|9070678|P3|Overall Study|Not Treated: Withdraw by Subject|11
2624217|NCT00898677|9070679|P2|Overall Study|Not Treated: Withdraw by Subject|16
2624218|NCT00898677|9070680|P1|Overall Study|Not Treated: Withdraw by Subject|2
2624219|NCT00898677|9070677|P4|Overall Study|Not Treated: Protocol Violation|0
2624220|NCT00898677|9070678|P3|Overall Study|Not Treated: Protocol Violation|2
2624221|NCT00898677|9070679|P2|Overall Study|Not Treated: Protocol Violation|0
2624222|NCT00898677|9070680|P1|Overall Study|Not Treated: Protocol Violation|2
2624223|NCT00898677|9070677|P4|Overall Study|Not Treated: Pregnancy|0
2624224|NCT00898677|9070678|P3|Overall Study|Not Treated: Pregnancy|1
2624225|NCT00898677|9070679|P2|Overall Study|Not Treated: Pregnancy|0
2624226|NCT00898677|9070680|P1|Overall Study|Not Treated: Pregnancy|0
2624227|NCT00898677|9070677|P4|Overall Study|Not Treated: Lost to Follow-Up|2
2624228|NCT00898677|9070678|P3|Overall Study|Not Treated: Lost to Follow-Up|5
2624229|NCT00898677|9070679|P2|Overall Study|Not Treated: Lost to Follow-Up|5
2624230|NCT00898677|9070680|P1|Overall Study|Not Treated: Lost to Follow-Up|0
2624231|NCT00898677|9070677|P4|Overall Study|Not Treated: Adverse Event|0
2624232|NCT00898677|9070678|P3|Overall Study|Not Treated: Adverse Event|1
2624233|NCT00898677|9070679|P2|Overall Study|Not Treated: Adverse Event|2
2624234|NCT00898677|9070680|P1|Overall Study|Not Treated: Adverse Event|0
2624235|NCT00898677|9070677|P4|Overall Study|Withdrawal by Subject|1
2624236|NCT00898677|9070678|P3|Overall Study|Withdrawal by Subject|0
2624237|NCT00898677|9070679|P2|Overall Study|Withdrawal by Subject|0
2624238|NCT00898677|9070680|P1|Overall Study|Withdrawal by Subject|0
2624239|NCT00898677|9070677|P4|Overall Study|Protocol Violation|0
2624240|NCT00898677|9070678|P3|Overall Study|Protocol Violation|2
2624241|NCT00898677|9070679|P2|Overall Study|Protocol Violation|1
2624242|NCT00898677|9070680|P1|Overall Study|Protocol Violation|1
2624243|NCT00898677|9070677|P4|Overall Study|Lost to Follow-up|0
2624244|NCT00898677|9070678|P3|Overall Study|Lost to Follow-up|2
2624245|NCT00898677|9070679|P2|Overall Study|Lost to Follow-up|0
2624246|NCT00898677|9070680|P1|Overall Study|Lost to Follow-up|0
2624247|NCT00898677|9070677|P4|Overall Study|Adverse Event|0
2624248|NCT00898677|9070678|P3|Overall Study|Adverse Event|1
2624249|NCT00898677|9070679|P2|Overall Study|Adverse Event|0
2624250|NCT00898677|9070680|P1|Overall Study|Adverse Event|0
2624251|NCT00898443|9070718|P2|Overall Study|Withdrawal by Subject|0
2624252|NCT00898443|9070719|P1|Overall Study|Withdrawal by Subject|1
2624253|NCT00897949|9070734|P3|Overall Study|Did not take study drug|4
2624254|NCT00897949|9070735|P2|Overall Study|Did not take study drug|3
2624255|NCT00897949|9070736|P1|Overall Study|Did not take study drug|9
2624256|NCT00897949|9070734|P3|Overall Study|Lack of Migraine Attack|19
2624257|NCT00897949|9070735|P2|Overall Study|Lack of Migraine Attack|30
2624258|NCT00897949|9070736|P1|Overall Study|Lack of Migraine Attack|29
2624259|NCT00897949|9070734|P3|Overall Study|Need for Concom. Med.|1
2624260|NCT00897949|9070735|P2|Overall Study|Need for Concom. Med.|1
2624261|NCT00897949|9070736|P1|Overall Study|Need for Concom. Med.|0
2624262|NCT00897949|9070734|P3|Overall Study|Abnormal Baseline ECG|4
2624263|NCT00897949|9070735|P2|Overall Study|Abnormal Baseline ECG|2
2624264|NCT00897949|9070736|P1|Overall Study|Abnormal Baseline ECG|2
2624265|NCT00897949|9070734|P3|Overall Study|Abnormal Prestudy Labs|4
2624266|NCT00897949|9070735|P2|Overall Study|Abnormal Prestudy Labs|3
2624267|NCT00897949|9070736|P1|Overall Study|Abnormal Prestudy Labs|2
2624268|NCT00897949|9070734|P3|Overall Study|Withdrawal by Subject|17
2624269|NCT00897949|9070735|P2|Overall Study|Withdrawal by Subject|31
2624270|NCT00897949|9070736|P1|Overall Study|Withdrawal by Subject|24
2624271|NCT00897949|9070734|P3|Overall Study|Lost to Follow-up|17
2624272|NCT00897949|9070735|P2|Overall Study|Lost to Follow-up|23
2624273|NCT00897949|9070736|P1|Overall Study|Lost to Follow-up|30
2624274|NCT00897949|9070734|P3|Overall Study|Patient Uncoorperative|1
2624275|NCT00897949|9070735|P2|Overall Study|Patient Uncoorperative|2
2624276|NCT00897949|9070736|P1|Overall Study|Patient Uncoorperative|0
2624277|NCT00897949|9070734|P3|Overall Study|Withdrawal by Subject|0
2624278|NCT00897949|9070735|P2|Overall Study|Withdrawal by Subject|2
2624279|NCT00897949|9070736|P1|Overall Study|Withdrawal by Subject|1
2624280|NCT00897949|9070734|P3|Overall Study|Protocol Violation|1
2624281|NCT00897949|9070735|P2|Overall Study|Protocol Violation|3
2624282|NCT00897949|9070736|P1|Overall Study|Protocol Violation|6
2624283|NCT00897949|9070734|P3|Overall Study|Lost to Follow-up|1
2624284|NCT00897949|9070735|P2|Overall Study|Lost to Follow-up|2
2624285|NCT00897949|9070736|P1|Overall Study|Lost to Follow-up|0
2624286|NCT00897949|9070734|P3|Overall Study|Adverse Event|0
2624287|NCT00897949|9070735|P2|Overall Study|Adverse Event|1
2624288|NCT00897949|9070736|P1|Overall Study|Adverse Event|1
2624289|NCT00897715|9070770|P2|Overall Study|increased risk of infection|0
2624290|NCT00897715|9070771|P1|Overall Study|increased risk of infection|1
2624291|NCT00897715|9070770|P2|Overall Study|Physician Decision|0
2624292|NCT00897715|9070771|P1|Overall Study|Physician Decision|1
2624293|NCT00897715|9070770|P2|Overall Study|Lost to Follow-up|1
2624294|NCT00897715|9070771|P1|Overall Study|Lost to Follow-up|0
2624295|NCT00897390|9070796|P1|Overall Study|Did not Return for the Clinic Visit|2
2624296|NCT00897390|9070796|P1|Overall Study|Personal Reasons|1
2624297|NCT00897390|9070796|P1|Overall Study|No Longer Met Study Criteria|1
2624298|NCT00897390|9070796|P1|Overall Study|Adverse Event|2
2624299|NCT00897104|9070886|P3|Overall Study|Withdrawal by Subject|1
2624300|NCT00897104|9070887|P2|Overall Study|Withdrawal by Subject|0
2624301|NCT00897104|9070888|P1|Overall Study|Withdrawal by Subject|0
2624302|NCT00897104|9070886|P3|Overall Study|Protocol Violation|0
2624303|NCT00897104|9070887|P2|Overall Study|Protocol Violation|0
2624304|NCT00897104|9070888|P1|Overall Study|Protocol Violation|1
2624305|NCT00897104|9070886|P3|Overall Study|Other|0
2624306|NCT00897104|9070887|P2|Overall Study|Other|0
2624307|NCT00897104|9070888|P1|Overall Study|Other|3
2624308|NCT00897104|9070886|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
2624309|NCT00897104|9070887|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
2624310|NCT00897104|9070888|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
2624311|NCT00897104|9070886|P3|Overall Study|Lack of Migraine Attack|1
2624312|NCT00897104|9070887|P2|Overall Study|Lack of Migraine Attack|22
2624313|NCT00897104|9070888|P1|Overall Study|Lack of Migraine Attack|20
2624314|NCT00897104|9070886|P3|Overall Study|Need for Concom. Med.|1
2624315|NCT00897104|9070887|P2|Overall Study|Need for Concom. Med.|1
2624316|NCT00897104|9070888|P1|Overall Study|Need for Concom. Med.|0
2624317|NCT00897104|9070886|P3|Overall Study|Abnormal Baseline ECG|0
2624318|NCT00897104|9070887|P2|Overall Study|Abnormal Baseline ECG|2
2624319|NCT00897104|9070888|P1|Overall Study|Abnormal Baseline ECG|2
2624320|NCT00897104|9070886|P3|Overall Study|Abnormal Prestudy Labs|0
2624321|NCT00897104|9070887|P2|Overall Study|Abnormal Prestudy Labs|0
2624322|NCT00897104|9070888|P1|Overall Study|Abnormal Prestudy Labs|2
2624323|NCT00897104|9070886|P3|Overall Study|Withdrawal by Subject|3
2624324|NCT00897104|9070887|P2|Overall Study|Withdrawal by Subject|27
2624325|NCT00897104|9070888|P1|Overall Study|Withdrawal by Subject|23
2624326|NCT00897104|9070886|P3|Overall Study|Protocol Violation|0
2624327|NCT00897104|9070887|P2|Overall Study|Protocol Violation|1
2624328|NCT00897104|9070888|P1|Overall Study|Protocol Violation|0
2624329|NCT00897104|9070886|P3|Overall Study|Pregnancy|0
2624330|NCT00897104|9070887|P2|Overall Study|Pregnancy|1
2624331|NCT00897104|9070888|P1|Overall Study|Pregnancy|0
2624332|NCT00897104|9070886|P3|Overall Study|Lost to Follow-up|2
2624333|NCT00897104|9070887|P2|Overall Study|Lost to Follow-up|17
2624334|NCT00897104|9070888|P1|Overall Study|Lost to Follow-up|12
2624335|NCT00896649|9070923|P1|Overall Study|technical difficulties|2
2624336|NCT00896649|9070923|P1|Overall Study|missing documentation|1
2624337|NCT00896649|9070923|P1|Overall Study|Pregnancy|1
2624338|NCT00896649|9070923|P1|Overall Study|Physician Decision|1
2624339|NCT00896532|9070936|P23|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2624340|NCT00896532|9070937|P22|Months 48-72: Follow-on Phase|Withdrawal by Subject|1
2624341|NCT00896532|9070938|P21|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2624342|NCT00896532|9070939|P20|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2624343|NCT00896532|9070940|P19|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2624344|NCT00896532|9070941|P18|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2624345|NCT00896532|9070942|P17|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2624346|NCT00896532|9070943|P16|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2624347|NCT00896532|9070944|P15|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2624348|NCT00896532|9070945|P14|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2624349|NCT00896532|9070946|P13|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2624350|NCT00896532|9070947|P12|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2624351|NCT00896532|9070948|P11|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2624352|NCT00896532|9070949|P10|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2624353|NCT00896532|9070950|P9|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2624354|NCT00896532|9070951|P8|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2624355|NCT00896532|9070952|P7|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2624356|NCT00896532|9070953|P6|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2624357|NCT00896532|9070954|P5|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2624358|NCT00896532|9070955|P4|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2624359|NCT00896532|9070956|P3|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2624360|NCT00896532|9070957|P2|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2624361|NCT00896532|9070958|P1|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
2624362|NCT00896532|9070936|P23|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2624363|NCT00896532|9070937|P22|Months 48-72: Follow-on Phase|Ineligibility Determined|1
2624364|NCT00896532|9070938|P21|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2624365|NCT00896532|9070939|P20|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2624366|NCT00896532|9070940|P19|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2624367|NCT00896532|9070941|P18|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2624368|NCT00896532|9070942|P17|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2624369|NCT00896532|9070943|P16|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2624370|NCT00896532|9070944|P15|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2624371|NCT00896532|9070945|P14|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2624372|NCT00896532|9070946|P13|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2624373|NCT00896532|9070947|P12|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2624374|NCT00896532|9070948|P11|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2624375|NCT00896532|9070949|P10|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2624376|NCT00896532|9070950|P9|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2624377|NCT00896532|9070951|P8|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2624378|NCT00896532|9070952|P7|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2624379|NCT00896532|9070953|P6|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2624380|NCT00896532|9070954|P5|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2624381|NCT00896532|9070955|P4|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2624382|NCT00896532|9070956|P3|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2624383|NCT00896532|9070957|P2|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2624384|NCT00896532|9070958|P1|Months 48-72: Follow-on Phase|Ineligibility Determined|0
2624385|NCT00896532|9070936|P23|Months 48-72: Follow-on Phase|Death|0
2624386|NCT00896532|9070937|P22|Months 48-72: Follow-on Phase|Death|0
2624387|NCT00896532|9070938|P21|Months 48-72: Follow-on Phase|Death|0
2624388|NCT00896532|9070939|P20|Months 48-72: Follow-on Phase|Death|0
2624389|NCT00896532|9070940|P19|Months 48-72: Follow-on Phase|Death|1
2624390|NCT00896532|9070941|P18|Months 48-72: Follow-on Phase|Death|0
2624391|NCT00896532|9070942|P17|Months 48-72: Follow-on Phase|Death|0
2624392|NCT00896532|9070943|P16|Months 48-72: Follow-on Phase|Death|0
2624393|NCT00896532|9070944|P15|Months 48-72: Follow-on Phase|Death|0
2624394|NCT00896532|9070945|P14|Months 48-72: Follow-on Phase|Death|0
2624395|NCT00896532|9070946|P13|Months 48-72: Follow-on Phase|Death|0
2624396|NCT00896532|9070947|P12|Months 48-72: Follow-on Phase|Death|0
2624397|NCT00896532|9070948|P11|Months 48-72: Follow-on Phase|Death|0
2624398|NCT00896532|9070949|P10|Months 48-72: Follow-on Phase|Death|0
2624399|NCT00896532|9070950|P9|Months 48-72: Follow-on Phase|Death|0
2624400|NCT00896532|9070951|P8|Months 48-72: Follow-on Phase|Death|0
2624401|NCT00896532|9070952|P7|Months 48-72: Follow-on Phase|Death|0
2624402|NCT00896532|9070953|P6|Months 48-72: Follow-on Phase|Death|0
2624403|NCT00896532|9070954|P5|Months 48-72: Follow-on Phase|Death|0
2624404|NCT00896532|9070955|P4|Months 48-72: Follow-on Phase|Death|0
2624405|NCT00896532|9070956|P3|Months 48-72: Follow-on Phase|Death|0
2624406|NCT00896532|9070957|P2|Months 48-72: Follow-on Phase|Death|0
2624407|NCT00896532|9070958|P1|Months 48-72: Follow-on Phase|Death|0
2624408|NCT00896532|9070936|P23|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2624409|NCT00896532|9070937|P22|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2624410|NCT00896532|9070938|P21|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2624411|NCT00896532|9070939|P20|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2624412|NCT00896532|9070940|P19|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2624413|NCT00896532|9070941|P18|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2624414|NCT00896532|9070942|P17|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1
2624415|NCT00896532|9070943|P16|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2624416|NCT00896532|9070944|P15|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2624417|NCT00896532|9070945|P14|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2624418|NCT00896532|9070946|P13|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2624419|NCT00896532|9070947|P12|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2624420|NCT00896532|9070948|P11|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2624421|NCT00896532|9070949|P10|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2624422|NCT00896532|9070950|P9|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2624423|NCT00896532|9070951|P8|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2624424|NCT00896532|9070952|P7|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2624425|NCT00896532|9070953|P6|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2624426|NCT00896532|9070954|P5|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2624427|NCT00896532|9070955|P4|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2624428|NCT00896532|9070956|P3|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2624429|NCT00896532|9070957|P2|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2624430|NCT00896532|9070958|P1|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
2624431|NCT00896532|9070936|P23|Months 36-48: Romosozumab Retreatment|Other|0
2624432|NCT00896532|9070937|P22|Months 36-48: Romosozumab Retreatment|Other|0
2624433|NCT00896532|9070938|P21|Months 36-48: Romosozumab Retreatment|Other|0
2624434|NCT00896532|9070939|P20|Months 36-48: Romosozumab Retreatment|Other|0
2624435|NCT00896532|9070940|P19|Months 36-48: Romosozumab Retreatment|Other|0
2624436|NCT00896532|9070941|P18|Months 36-48: Romosozumab Retreatment|Other|1
2624437|NCT00896532|9070942|P17|Months 36-48: Romosozumab Retreatment|Other|0
2624438|NCT00896532|9070943|P16|Months 36-48: Romosozumab Retreatment|Other|0
2624439|NCT00896532|9070944|P15|Months 36-48: Romosozumab Retreatment|Other|0
2624440|NCT00896532|9070945|P14|Months 36-48: Romosozumab Retreatment|Other|0
2624441|NCT00896532|9070946|P13|Months 36-48: Romosozumab Retreatment|Other|0
2624442|NCT00896532|9070947|P12|Months 36-48: Romosozumab Retreatment|Other|0
2624443|NCT00896532|9070948|P11|Months 36-48: Romosozumab Retreatment|Other|0
2624444|NCT00896532|9070949|P10|Months 36-48: Romosozumab Retreatment|Other|0
2624445|NCT00896532|9070950|P9|Months 36-48: Romosozumab Retreatment|Other|0
2624446|NCT00896532|9070951|P8|Months 36-48: Romosozumab Retreatment|Other|0
2624447|NCT00896532|9070952|P7|Months 36-48: Romosozumab Retreatment|Other|0
2624448|NCT00896532|9070953|P6|Months 36-48: Romosozumab Retreatment|Other|0
2624449|NCT00896532|9070954|P5|Months 36-48: Romosozumab Retreatment|Other|0
2624450|NCT00896532|9070955|P4|Months 36-48: Romosozumab Retreatment|Other|0
2624451|NCT00896532|9070956|P3|Months 36-48: Romosozumab Retreatment|Other|0
2624452|NCT00896532|9070957|P2|Months 36-48: Romosozumab Retreatment|Other|0
2624453|NCT00896532|9070958|P1|Months 36-48: Romosozumab Retreatment|Other|0
2624454|NCT00896532|9070936|P23|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2624455|NCT00896532|9070937|P22|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2624456|NCT00896532|9070938|P21|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2624457|NCT00896532|9070939|P20|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2624458|NCT00896532|9070940|P19|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2624459|NCT00896532|9070941|P18|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2624460|NCT00896532|9070942|P17|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1
2624461|NCT00896532|9070943|P16|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2624462|NCT00896532|9070944|P15|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2624463|NCT00896532|9070945|P14|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2624464|NCT00896532|9070946|P13|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2624465|NCT00896532|9070947|P12|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2624466|NCT00896532|9070948|P11|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2624467|NCT00896532|9070949|P10|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2624468|NCT00896532|9070950|P9|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2624469|NCT00896532|9070951|P8|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2624470|NCT00896532|9070952|P7|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2624471|NCT00896532|9070953|P6|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2624472|NCT00896532|9070954|P5|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2624473|NCT00896532|9070955|P4|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2624474|NCT00896532|9070956|P3|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2624475|NCT00896532|9070957|P2|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2624476|NCT00896532|9070958|P1|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
2624477|NCT00896532|9070936|P23|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2624478|NCT00896532|9070937|P22|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2624479|NCT00896532|9070938|P21|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2624480|NCT00896532|9070939|P20|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2624481|NCT00896532|9070940|P19|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2624482|NCT00896532|9070941|P18|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2
2624483|NCT00896532|9070942|P17|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2
2624484|NCT00896532|9070943|P16|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1
2624485|NCT00896532|9070944|P15|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2624486|NCT00896532|9070945|P14|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2624487|NCT00896532|9070946|P13|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2624488|NCT00896532|9070947|P12|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2624489|NCT00896532|9070948|P11|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2624490|NCT00896532|9070949|P10|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2624491|NCT00896532|9070950|P9|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2624492|NCT00896532|9070951|P8|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2624493|NCT00896532|9070952|P7|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2624494|NCT00896532|9070953|P6|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2624495|NCT00896532|9070954|P5|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2624496|NCT00896532|9070955|P4|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2624497|NCT00896532|9070956|P3|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2624498|NCT00896532|9070957|P2|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2624499|NCT00896532|9070958|P1|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
2624500|NCT00896532|9070936|P23|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2624501|NCT00896532|9070937|P22|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2624502|NCT00896532|9070938|P21|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2624503|NCT00896532|9070939|P20|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2624504|NCT00896532|9070940|P19|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2624505|NCT00896532|9070941|P18|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2624506|NCT00896532|9070942|P17|Months 36-48: Romosozumab Retreatment|Adverse Event|3
2624507|NCT00896532|9070943|P16|Months 36-48: Romosozumab Retreatment|Adverse Event|1
2624508|NCT00896532|9070944|P15|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2624509|NCT00896532|9070945|P14|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2624510|NCT00896532|9070946|P13|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2624511|NCT00896532|9070947|P12|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2624512|NCT00896532|9070948|P11|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2624513|NCT00896532|9070949|P10|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2624514|NCT00896532|9070950|P9|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2624515|NCT00896532|9070951|P8|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2624516|NCT00896532|9070952|P7|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2624517|NCT00896532|9070953|P6|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2624518|NCT00896532|9070954|P5|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2624519|NCT00896532|9070955|P4|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2624520|NCT00896532|9070956|P3|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2624521|NCT00896532|9070957|P2|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2624522|NCT00896532|9070958|P1|Months 36-48: Romosozumab Retreatment|Adverse Event|0
2624523|NCT00896532|9070936|P23|Months 24-36: Denosumab Extension Phase|Other|0
2624524|NCT00896532|9070937|P22|Months 24-36: Denosumab Extension Phase|Other|0
2624525|NCT00896532|9070938|P21|Months 24-36: Denosumab Extension Phase|Other|0
2624526|NCT00896532|9070939|P20|Months 24-36: Denosumab Extension Phase|Other|0
2624527|NCT00896532|9070940|P19|Months 24-36: Denosumab Extension Phase|Other|0
2624528|NCT00896532|9070941|P18|Months 24-36: Denosumab Extension Phase|Other|0
2624529|NCT00896532|9070942|P17|Months 24-36: Denosumab Extension Phase|Other|0
2624530|NCT00896532|9070943|P16|Months 24-36: Denosumab Extension Phase|Other|0
2624531|NCT00896532|9070944|P15|Months 24-36: Denosumab Extension Phase|Other|0
2624532|NCT00896532|9070945|P14|Months 24-36: Denosumab Extension Phase|Other|1
2624533|NCT00896532|9070946|P13|Months 24-36: Denosumab Extension Phase|Other|2
2624534|NCT00896532|9070947|P12|Months 24-36: Denosumab Extension Phase|Other|2
2624535|NCT00896532|9070948|P11|Months 24-36: Denosumab Extension Phase|Other|1
2624536|NCT00896532|9070949|P10|Months 24-36: Denosumab Extension Phase|Other|0
2624537|NCT00896532|9070950|P9|Months 24-36: Denosumab Extension Phase|Other|0
2624538|NCT00896532|9070951|P8|Months 24-36: Denosumab Extension Phase|Other|0
2624539|NCT00896532|9070952|P7|Months 24-36: Denosumab Extension Phase|Other|0
2624540|NCT00896532|9070953|P6|Months 24-36: Denosumab Extension Phase|Other|0
2624541|NCT00896532|9070954|P5|Months 24-36: Denosumab Extension Phase|Other|0
2624542|NCT00896532|9070955|P4|Months 24-36: Denosumab Extension Phase|Other|0
2624543|NCT00896532|9070956|P3|Months 24-36: Denosumab Extension Phase|Other|0
2624544|NCT00896532|9070957|P2|Months 24-36: Denosumab Extension Phase|Other|0
2624545|NCT00896532|9070958|P1|Months 24-36: Denosumab Extension Phase|Other|0
2624546|NCT00896532|9070936|P23|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2624547|NCT00896532|9070937|P22|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2624548|NCT00896532|9070938|P21|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2624549|NCT00896532|9070939|P20|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2624550|NCT00896532|9070940|P19|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2624551|NCT00896532|9070941|P18|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2624552|NCT00896532|9070942|P17|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2624553|NCT00896532|9070943|P16|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2624554|NCT00896532|9070944|P15|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2624555|NCT00896532|9070945|P14|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1
2624556|NCT00896532|9070946|P13|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1
2624557|NCT00896532|9070947|P12|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2624558|NCT00896532|9070948|P11|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2624559|NCT00896532|9070949|P10|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2624560|NCT00896532|9070950|P9|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2624561|NCT00896532|9070951|P8|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2624562|NCT00896532|9070952|P7|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2624563|NCT00896532|9070953|P6|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2624564|NCT00896532|9070954|P5|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2624565|NCT00896532|9070955|P4|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2624566|NCT00896532|9070956|P3|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2624567|NCT00896532|9070957|P2|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2624568|NCT00896532|9070958|P1|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
2624569|NCT00896532|9070936|P23|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2624570|NCT00896532|9070937|P22|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2624571|NCT00896532|9070938|P21|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2624572|NCT00896532|9070939|P20|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2624851|NCT00896454|9071133|P1|Overall Study|Adverse Event|8
2624573|NCT00896532|9070940|P19|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2624574|NCT00896532|9070941|P18|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2624575|NCT00896532|9070942|P17|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2624576|NCT00896532|9070943|P16|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2624577|NCT00896532|9070944|P15|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2624578|NCT00896532|9070945|P14|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2624579|NCT00896532|9070946|P13|Months 24-36: Denosumab Extension Phase|Adverse Event|1
2624580|NCT00896532|9070947|P12|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2624581|NCT00896532|9070948|P11|Months 24-36: Denosumab Extension Phase|Adverse Event|1
2624582|NCT00896532|9070949|P10|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2624583|NCT00896532|9070950|P9|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2624584|NCT00896532|9070951|P8|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2624585|NCT00896532|9070952|P7|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2624586|NCT00896532|9070953|P6|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2624587|NCT00896532|9070954|P5|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2624588|NCT00896532|9070955|P4|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2624589|NCT00896532|9070956|P3|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2624590|NCT00896532|9070957|P2|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2624591|NCT00896532|9070958|P1|Months 24-36: Denosumab Extension Phase|Adverse Event|0
2624592|NCT00896532|9070936|P23|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2624593|NCT00896532|9070937|P22|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2624594|NCT00896532|9070938|P21|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2624595|NCT00896532|9070939|P20|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2624596|NCT00896532|9070940|P19|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2624597|NCT00896532|9070941|P18|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2624598|NCT00896532|9070942|P17|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2624599|NCT00896532|9070943|P16|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2624600|NCT00896532|9070944|P15|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2624601|NCT00896532|9070945|P14|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2624602|NCT00896532|9070946|P13|Months 24-36: Denosumab Extension Phase|Noncompliance|1
2624603|NCT00896532|9070947|P12|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2624604|NCT00896532|9070948|P11|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2624605|NCT00896532|9070949|P10|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2624606|NCT00896532|9070950|P9|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2624607|NCT00896532|9070951|P8|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2624608|NCT00896532|9070952|P7|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2624609|NCT00896532|9070953|P6|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2624610|NCT00896532|9070954|P5|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2624611|NCT00896532|9070955|P4|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2624612|NCT00896532|9070956|P3|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2624613|NCT00896532|9070957|P2|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2624614|NCT00896532|9070958|P1|Months 24-36: Denosumab Extension Phase|Noncompliance|0
2624615|NCT00896532|9070936|P23|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2624616|NCT00896532|9070937|P22|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2624617|NCT00896532|9070938|P21|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2624618|NCT00896532|9070939|P20|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2624619|NCT00896532|9070940|P19|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2624620|NCT00896532|9070941|P18|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2624621|NCT00896532|9070942|P17|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2624622|NCT00896532|9070943|P16|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2624623|NCT00896532|9070944|P15|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2624624|NCT00896532|9070945|P14|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2624625|NCT00896532|9070946|P13|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2624626|NCT00896532|9070947|P12|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2624627|NCT00896532|9070948|P11|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2624628|NCT00896532|9070949|P10|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2624629|NCT00896532|9070950|P9|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1
2624630|NCT00896532|9070951|P8|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2624631|NCT00896532|9070952|P7|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2624632|NCT00896532|9070953|P6|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2624633|NCT00896532|9070954|P5|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2624634|NCT00896532|9070955|P4|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2624635|NCT00896532|9070956|P3|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2624636|NCT00896532|9070957|P2|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2624637|NCT00896532|9070958|P1|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
2624638|NCT00896532|9070936|P23|Months 1-24: Romosozumab Treatment Phase|Other|0
2624639|NCT00896532|9070937|P22|Months 1-24: Romosozumab Treatment Phase|Other|0
2624640|NCT00896532|9070938|P21|Months 1-24: Romosozumab Treatment Phase|Other|0
2624641|NCT00896532|9070939|P20|Months 1-24: Romosozumab Treatment Phase|Other|0
2624642|NCT00896532|9070940|P19|Months 1-24: Romosozumab Treatment Phase|Other|0
2624643|NCT00896532|9070941|P18|Months 1-24: Romosozumab Treatment Phase|Other|0
2624644|NCT00896532|9070942|P17|Months 1-24: Romosozumab Treatment Phase|Other|0
2624645|NCT00896532|9070943|P16|Months 1-24: Romosozumab Treatment Phase|Other|0
2624646|NCT00896532|9070944|P15|Months 1-24: Romosozumab Treatment Phase|Other|0
2624647|NCT00896532|9070945|P14|Months 1-24: Romosozumab Treatment Phase|Other|0
2624648|NCT00896532|9070946|P13|Months 1-24: Romosozumab Treatment Phase|Other|0
2624649|NCT00896532|9070947|P12|Months 1-24: Romosozumab Treatment Phase|Other|0
2624650|NCT00896532|9070948|P11|Months 1-24: Romosozumab Treatment Phase|Other|0
2624651|NCT00896532|9070949|P10|Months 1-24: Romosozumab Treatment Phase|Other|0
2624652|NCT00896532|9070950|P9|Months 1-24: Romosozumab Treatment Phase|Other|0
2624653|NCT00896532|9070951|P8|Months 1-24: Romosozumab Treatment Phase|Other|0
2624654|NCT00896532|9070952|P7|Months 1-24: Romosozumab Treatment Phase|Other|0
2624655|NCT00896532|9070953|P6|Months 1-24: Romosozumab Treatment Phase|Other|0
2624656|NCT00896532|9070954|P5|Months 1-24: Romosozumab Treatment Phase|Other|1
2624657|NCT00896532|9070955|P4|Months 1-24: Romosozumab Treatment Phase|Other|1
2624658|NCT00896532|9070956|P3|Months 1-24: Romosozumab Treatment Phase|Other|0
2624659|NCT00896532|9070957|P2|Months 1-24: Romosozumab Treatment Phase|Other|1
2624660|NCT00896532|9070958|P1|Months 1-24: Romosozumab Treatment Phase|Other|0
2624661|NCT00896532|9070936|P23|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2624662|NCT00896532|9070937|P22|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2624663|NCT00896532|9070938|P21|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2624664|NCT00896532|9070939|P20|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2624665|NCT00896532|9070940|P19|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2624666|NCT00896532|9070941|P18|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2624667|NCT00896532|9070942|P17|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2624668|NCT00896532|9070943|P16|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2624669|NCT00896532|9070944|P15|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2624670|NCT00896532|9070945|P14|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2624671|NCT00896532|9070946|P13|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2624672|NCT00896532|9070947|P12|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2624673|NCT00896532|9070948|P11|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2624674|NCT00896532|9070949|P10|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2624675|NCT00896532|9070950|P9|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2624676|NCT00896532|9070951|P8|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2624677|NCT00896532|9070952|P7|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2624678|NCT00896532|9070953|P6|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2624679|NCT00896532|9070954|P5|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2624680|NCT00896532|9070955|P4|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1
2624681|NCT00896532|9070956|P3|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2624682|NCT00896532|9070957|P2|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2624683|NCT00896532|9070958|P1|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
2624684|NCT00896532|9070936|P23|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2624685|NCT00896532|9070937|P22|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2624686|NCT00896532|9070938|P21|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2624687|NCT00896532|9070939|P20|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2624688|NCT00896532|9070940|P19|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2624689|NCT00896532|9070941|P18|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2624690|NCT00896532|9070942|P17|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2624691|NCT00896532|9070943|P16|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2624692|NCT00896532|9070944|P15|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2624693|NCT00896532|9070945|P14|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2624694|NCT00896532|9070946|P13|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2624695|NCT00896532|9070947|P12|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2624696|NCT00896532|9070948|P11|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2624697|NCT00896532|9070949|P10|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2624698|NCT00896532|9070950|P9|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2624699|NCT00896532|9070951|P8|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2624700|NCT00896532|9070952|P7|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2624701|NCT00896532|9070953|P6|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2624702|NCT00896532|9070954|P5|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2624703|NCT00896532|9070955|P4|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2624704|NCT00896532|9070956|P3|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1
2624705|NCT00896532|9070957|P2|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2624706|NCT00896532|9070958|P1|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
2624707|NCT00896532|9070936|P23|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2624708|NCT00896532|9070937|P22|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2624709|NCT00896532|9070938|P21|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2624710|NCT00896532|9070939|P20|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2624711|NCT00896532|9070940|P19|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2624712|NCT00896532|9070941|P18|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2624713|NCT00896532|9070942|P17|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2624714|NCT00896532|9070943|P16|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2624715|NCT00896532|9070944|P15|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2624716|NCT00896532|9070945|P14|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2624717|NCT00896532|9070946|P13|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2624718|NCT00896532|9070947|P12|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2624719|NCT00896532|9070948|P11|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2624720|NCT00896532|9070949|P10|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2624721|NCT00896532|9070950|P9|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2624722|NCT00896532|9070951|P8|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2624723|NCT00896532|9070952|P7|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2624724|NCT00896532|9070953|P6|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2624725|NCT00896532|9070954|P5|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2624726|NCT00896532|9070955|P4|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2624727|NCT00896532|9070956|P3|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1
2624728|NCT00896532|9070957|P2|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2624729|NCT00896532|9070958|P1|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
2624730|NCT00896532|9070936|P23|Months 1-24: Romosozumab Treatment Phase|Death|0
2624731|NCT00896532|9070937|P22|Months 1-24: Romosozumab Treatment Phase|Death|0
2624732|NCT00896532|9070938|P21|Months 1-24: Romosozumab Treatment Phase|Death|0
2624733|NCT00896532|9070939|P20|Months 1-24: Romosozumab Treatment Phase|Death|0
2624734|NCT00896532|9070940|P19|Months 1-24: Romosozumab Treatment Phase|Death|0
2624735|NCT00896532|9070941|P18|Months 1-24: Romosozumab Treatment Phase|Death|0
2624736|NCT00896532|9070942|P17|Months 1-24: Romosozumab Treatment Phase|Death|0
2624737|NCT00896532|9070943|P16|Months 1-24: Romosozumab Treatment Phase|Death|0
2624738|NCT00896532|9070944|P15|Months 1-24: Romosozumab Treatment Phase|Death|0
2624739|NCT00896532|9070945|P14|Months 1-24: Romosozumab Treatment Phase|Death|0
2624740|NCT00896532|9070946|P13|Months 1-24: Romosozumab Treatment Phase|Death|0
2624741|NCT00896532|9070947|P12|Months 1-24: Romosozumab Treatment Phase|Death|0
2624742|NCT00896532|9070948|P11|Months 1-24: Romosozumab Treatment Phase|Death|0
2624743|NCT00896532|9070949|P10|Months 1-24: Romosozumab Treatment Phase|Death|0
2624744|NCT00896532|9070950|P9|Months 1-24: Romosozumab Treatment Phase|Death|0
2624745|NCT00896532|9070951|P8|Months 1-24: Romosozumab Treatment Phase|Death|0
2624746|NCT00896532|9070952|P7|Months 1-24: Romosozumab Treatment Phase|Death|0
2624747|NCT00896532|9070953|P6|Months 1-24: Romosozumab Treatment Phase|Death|0
2624748|NCT00896532|9070954|P5|Months 1-24: Romosozumab Treatment Phase|Death|0
2624749|NCT00896532|9070955|P4|Months 1-24: Romosozumab Treatment Phase|Death|1
2624750|NCT00896532|9070956|P3|Months 1-24: Romosozumab Treatment Phase|Death|0
2624751|NCT00896532|9070957|P2|Months 1-24: Romosozumab Treatment Phase|Death|0
2624752|NCT00896532|9070958|P1|Months 1-24: Romosozumab Treatment Phase|Death|1
2624753|NCT00896532|9070936|P23|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2624754|NCT00896532|9070937|P22|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2624755|NCT00896532|9070938|P21|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2624756|NCT00896532|9070939|P20|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2624757|NCT00896532|9070940|P19|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2624758|NCT00896532|9070941|P18|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2624759|NCT00896532|9070942|P17|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2624760|NCT00896532|9070943|P16|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2624761|NCT00896532|9070944|P15|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2624762|NCT00896532|9070945|P14|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2624763|NCT00896532|9070946|P13|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2624764|NCT00896532|9070947|P12|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2624765|NCT00896532|9070948|P11|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2624766|NCT00896532|9070949|P10|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2624767|NCT00896532|9070950|P9|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2624768|NCT00896532|9070951|P8|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2624769|NCT00896532|9070952|P7|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2624770|NCT00896532|9070953|P6|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2624771|NCT00896532|9070954|P5|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1
2624772|NCT00896532|9070955|P4|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2624773|NCT00896532|9070956|P3|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2
2624774|NCT00896532|9070957|P2|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2624775|NCT00896532|9070958|P1|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
2624776|NCT00896532|9070936|P23|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
2624777|NCT00896532|9070937|P22|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
2624778|NCT00896532|9070938|P21|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
2624779|NCT00896532|9070939|P20|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
2624780|NCT00896532|9070940|P19|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
2624781|NCT00896532|9070941|P18|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
2624782|NCT00896532|9070942|P17|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
2624783|NCT00896532|9070943|P16|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
2624784|NCT00896532|9070944|P15|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
2624785|NCT00896532|9070945|P14|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
2624786|NCT00896532|9070946|P13|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
2624787|NCT00896532|9070947|P12|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
2624788|NCT00896532|9070948|P11|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
2624789|NCT00896532|9070949|P10|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
2624790|NCT00896532|9070950|P9|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
2624791|NCT00896532|9070951|P8|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
2624792|NCT00896532|9070952|P7|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
2624793|NCT00896532|9070953|P6|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6
2624794|NCT00896532|9070954|P5|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5
2624795|NCT00896532|9070955|P4|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6
2624796|NCT00896532|9070956|P3|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
2624797|NCT00896532|9070957|P2|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3
2624798|NCT00896532|9070958|P1|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
2624799|NCT00896532|9070936|P23|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
2624800|NCT00896532|9070937|P22|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
2624801|NCT00896532|9070938|P21|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
2624802|NCT00896532|9070939|P20|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
2624803|NCT00896532|9070940|P19|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
2624804|NCT00896532|9070941|P18|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
2624805|NCT00896532|9070942|P17|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
2624806|NCT00896532|9070943|P16|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
2624807|NCT00896532|9070944|P15|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
2624808|NCT00896532|9070945|P14|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
2624809|NCT00896532|9070946|P13|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
2624810|NCT00896532|9070947|P12|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
2624811|NCT00896532|9070948|P11|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
2624812|NCT00896532|9070949|P10|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
2624813|NCT00896532|9070950|P9|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
2624814|NCT00896532|9070951|P8|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
2624815|NCT00896532|9070952|P7|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
2624816|NCT00896532|9070953|P6|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
2624817|NCT00896532|9070954|P5|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
2624818|NCT00896532|9070955|P4|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2
2624819|NCT00896532|9070956|P3|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
2624820|NCT00896532|9070957|P2|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2
2624821|NCT00896532|9070958|P1|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
2624822|NCT00896532|9070936|P23|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2624823|NCT00896532|9070937|P22|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2624824|NCT00896532|9070938|P21|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2624825|NCT00896532|9070939|P20|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2624826|NCT00896532|9070940|P19|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2624827|NCT00896532|9070941|P18|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2624828|NCT00896532|9070942|P17|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2624829|NCT00896532|9070943|P16|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2624830|NCT00896532|9070944|P15|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2624831|NCT00896532|9070945|P14|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2624832|NCT00896532|9070946|P13|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2624833|NCT00896532|9070947|P12|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2624834|NCT00896532|9070948|P11|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2624835|NCT00896532|9070949|P10|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2624836|NCT00896532|9070950|P9|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2624837|NCT00896532|9070951|P8|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2624838|NCT00896532|9070952|P7|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2624839|NCT00896532|9070953|P6|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1
2624840|NCT00896532|9070954|P5|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2624841|NCT00896532|9070955|P4|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1
2624842|NCT00896532|9070956|P3|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2624843|NCT00896532|9070957|P2|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2624844|NCT00896532|9070958|P1|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
2624845|NCT00896480|9071085|P1|Overall Study|Disease progression/recurrence|21
2624846|NCT00896454|9071133|P1|Overall Study|Withdrawal by Subject|1
2624847|NCT00896454|9071133|P1|Overall Study|Ongoing in study|2
2624848|NCT00896454|9071133|P1|Overall Study|Requirement for alternative therapy|3
2624849|NCT00896454|9071133|P1|Overall Study|Other|4
2624850|NCT00896454|9071133|P1|Overall Study|Disease Progression|5
2624852|NCT00896454|9071133|P1|Overall Study|Death|10
2624853|NCT00896363|9071172|P3|Overall Study|Withdrawal by Subject|5
2624854|NCT00896363|9071173|P2|Overall Study|Withdrawal by Subject|5
2624855|NCT00896363|9071174|P1|Overall Study|Withdrawal by Subject|3
2624856|NCT00896363|9071172|P3|Overall Study|Lack of Efficacy|1
2624857|NCT00896363|9071173|P2|Overall Study|Lack of Efficacy|2
2624858|NCT00896363|9071174|P1|Overall Study|Lack of Efficacy|0
2624859|NCT00896363|9071172|P3|Overall Study|Adverse Event|2
2624860|NCT00896363|9071173|P2|Overall Study|Adverse Event|4
2624861|NCT00896363|9071174|P1|Overall Study|Adverse Event|3
2624862|NCT00896337|9071226|P1|Overall Study|Lost to Follow-up|11
2624863|NCT00896337|9071226|P1|Overall Study|Withdrawal by Subject|7
2624864|NCT00896337|9071226|P1|Overall Study|Death|7
2624865|NCT00896233|9071308|P1|Overall Study|Claustrophobia during MRI|1
2624866|NCT00896168|9071321|P2|Overall Study|Other|1
2624867|NCT00896168|9071322|P1|Overall Study|Other|1
2624868|NCT00896168|9071321|P2|Overall Study|Lost to Follow-up|1
2624869|NCT00896168|9071322|P1|Overall Study|Lost to Follow-up|1
2624870|NCT00896168|9071321|P2|Overall Study|Treatment failure|10
2624871|NCT00896168|9071322|P1|Overall Study|Treatment failure|8
2624872|NCT00896168|9071321|P2|Overall Study|Adverse Event|7
2624873|NCT00896168|9071322|P1|Overall Study|Adverse Event|4
2624874|NCT00896051|9071383|P2|Overall Study|Other|1
2624875|NCT00896051|9071384|P1|Overall Study|Other|1
2624876|NCT00896051|9071383|P2|Overall Study|Subject noncompliant|3
2624877|NCT00896051|9071384|P1|Overall Study|Subject noncompliant|1
2624878|NCT00896051|9071383|P2|Overall Study|Withdrawal by Subject|2
2624879|NCT00896051|9071384|P1|Overall Study|Withdrawal by Subject|3
2624880|NCT00896051|9071383|P2|Overall Study|Lost to Follow-up|2
2624881|NCT00896051|9071384|P1|Overall Study|Lost to Follow-up|3
2624882|NCT00896051|9071383|P2|Overall Study|Adverse Event|1
2624883|NCT00896051|9071384|P1|Overall Study|Adverse Event|2
2624884|NCT00895947|9071479|P2|Overall Study|Withdrawal by Subject|0
2624885|NCT00895947|9071480|P1|Overall Study|Withdrawal by Subject|2
2624886|NCT00895947|9071479|P2|Overall Study|Protocol Violation|2
2624887|NCT00895947|9071480|P1|Overall Study|Protocol Violation|4
2624888|NCT00895947|9071479|P2|Overall Study|Lost to Follow-up|4
2624889|NCT00895947|9071480|P1|Overall Study|Lost to Follow-up|3
2624890|NCT00895947|9071479|P2|Overall Study|Adverse Event|4
2624891|NCT00895947|9071480|P1|Overall Study|Adverse Event|3
2624892|NCT00895895|9071518|P5|Period 2|unsatisfactory response-efficacy|0
2624893|NCT00895895|9071519|P4|Period 2|unsatisfactory response-efficacy|0
2624894|NCT00895895|9071520|P3|Period 2|unsatisfactory response-efficacy|0
2624895|NCT00895895|9071521|P2|Period 2|unsatisfactory response-efficacy|1
2624896|NCT00895895|9071522|P1|Period 2|unsatisfactory response-efficacy|2
2624897|NCT00895895|9071518|P5|Period 2|Withdrawal by Subject|5
2624898|NCT00895895|9071519|P4|Period 2|Withdrawal by Subject|3
2624899|NCT00895895|9071520|P3|Period 2|Withdrawal by Subject|0
2624900|NCT00895895|9071521|P2|Period 2|Withdrawal by Subject|2
2624901|NCT00895895|9071522|P1|Period 2|Withdrawal by Subject|0
2624902|NCT00895895|9071518|P5|Period 2|Protocol Violation|1
2624903|NCT00895895|9071519|P4|Period 2|Protocol Violation|1
2624904|NCT00895895|9071520|P3|Period 2|Protocol Violation|1
2624905|NCT00895895|9071521|P2|Period 2|Protocol Violation|0
2624906|NCT00895895|9071522|P1|Period 2|Protocol Violation|1
2624907|NCT00895895|9071518|P5|Period 2|Other|1
2624908|NCT00895895|9071519|P4|Period 2|Other|1
2624909|NCT00895895|9071520|P3|Period 2|Other|3
2624910|NCT00895895|9071521|P2|Period 2|Other|1
2624911|NCT00895895|9071522|P1|Period 2|Other|1
2624912|NCT00895895|9071518|P5|Period 2|Lost to Follow-up|0
2624913|NCT00895895|9071519|P4|Period 2|Lost to Follow-up|1
2624914|NCT00895895|9071520|P3|Period 2|Lost to Follow-up|1
2624915|NCT00895895|9071521|P2|Period 2|Lost to Follow-up|2
2624916|NCT00895895|9071522|P1|Period 2|Lost to Follow-up|1
2624917|NCT00895895|9071518|P5|Period 2|investigator request|0
2624918|NCT00895895|9071519|P4|Period 2|investigator request|0
2624919|NCT00895895|9071520|P3|Period 2|investigator request|0
2624920|NCT00895895|9071521|P2|Period 2|investigator request|0
2624921|NCT00895895|9071522|P1|Period 2|investigator request|2
2624922|NCT00895895|9071518|P5|Period 2|failed to return|0
2624923|NCT00895895|9071519|P4|Period 2|failed to return|0
2624924|NCT00895895|9071520|P3|Period 2|failed to return|0
2624925|NCT00895895|9071521|P2|Period 2|failed to return|0
2624926|NCT00895895|9071522|P1|Period 2|failed to return|2
2624927|NCT00895895|9071518|P5|Period 2|discontinued by sponsor|37
2624928|NCT00895895|9071519|P4|Period 2|discontinued by sponsor|46
2624929|NCT00895895|9071520|P3|Period 2|discontinued by sponsor|38
2624930|NCT00895895|9071521|P2|Period 2|discontinued by sponsor|44
2624931|NCT00895895|9071522|P1|Period 2|discontinued by sponsor|44
2624932|NCT00895895|9071518|P5|Period 2|Death|0
2624933|NCT00895895|9071519|P4|Period 2|Death|0
2624934|NCT00895895|9071520|P3|Period 2|Death|1
2624935|NCT00895895|9071521|P2|Period 2|Death|0
2624936|NCT00895895|9071522|P1|Period 2|Death|0
2624937|NCT00895895|9071518|P5|Period 2|Adverse Event|5
2624938|NCT00895895|9071519|P4|Period 2|Adverse Event|2
2624939|NCT00895895|9071520|P3|Period 2|Adverse Event|5
2624940|NCT00895895|9071521|P2|Period 2|Adverse Event|3
2624941|NCT00895895|9071522|P1|Period 2|Adverse Event|3
2624942|NCT00895895|9071518|P5|After Period 1, Prior to Period 2|Withdrawal by Subject|1
2624943|NCT00895895|9071519|P4|After Period 1, Prior to Period 2|Withdrawal by Subject|0
2624944|NCT00895895|9071520|P3|After Period 1, Prior to Period 2|Withdrawal by Subject|0
2624945|NCT00895895|9071521|P2|After Period 1, Prior to Period 2|Withdrawal by Subject|0
2624946|NCT00895895|9071522|P1|After Period 1, Prior to Period 2|Withdrawal by Subject|0
2624947|NCT00895895|9071518|P5|After Period 1, Prior to Period 2|Protocol Violation|1
2624948|NCT00895895|9071519|P4|After Period 1, Prior to Period 2|Protocol Violation|0
2624949|NCT00895895|9071520|P3|After Period 1, Prior to Period 2|Protocol Violation|0
2624950|NCT00895895|9071521|P2|After Period 1, Prior to Period 2|Protocol Violation|0
2624951|NCT00895895|9071522|P1|After Period 1, Prior to Period 2|Protocol Violation|0
2624952|NCT00895895|9071518|P5|After Period 1, Prior to Period 2|Other|0
2624953|NCT00895895|9071519|P4|After Period 1, Prior to Period 2|Other|0
2624954|NCT00895895|9071520|P3|After Period 1, Prior to Period 2|Other|1
2624955|NCT00895895|9071521|P2|After Period 1, Prior to Period 2|Other|0
2624956|NCT00895895|9071522|P1|After Period 1, Prior to Period 2|Other|0
2624957|NCT00895895|9071518|P5|After Period 1, Prior to Period 2|Adverse Event|0
2624958|NCT00895895|9071519|P4|After Period 1, Prior to Period 2|Adverse Event|0
2624959|NCT00895895|9071520|P3|After Period 1, Prior to Period 2|Adverse Event|1
2624960|NCT00895895|9071521|P2|After Period 1, Prior to Period 2|Adverse Event|0
2624961|NCT00895895|9071522|P1|After Period 1, Prior to Period 2|Adverse Event|0
2624962|NCT00895895|9071518|P5|Period 1|randomized and not treated|2
2624963|NCT00895895|9071519|P4|Period 1|randomized and not treated|1
2624964|NCT00895895|9071520|P3|Period 1|randomized and not treated|1
2624965|NCT00895895|9071521|P2|Period 1|randomized and not treated|3
2624966|NCT00895895|9071522|P1|Period 1|randomized and not treated|1
2624967|NCT00895895|9071518|P5|Period 1|unsatisfactory response-efficacy|0
2624968|NCT00895895|9071519|P4|Period 1|unsatisfactory response-efficacy|0
2624969|NCT00895895|9071520|P3|Period 1|unsatisfactory response-efficacy|0
2624970|NCT00895895|9071521|P2|Period 1|unsatisfactory response-efficacy|0
2624971|NCT00895895|9071522|P1|Period 1|unsatisfactory response-efficacy|2
2624972|NCT00895895|9071518|P5|Period 1|Withdrawal by Subject|4
2624973|NCT00895895|9071519|P4|Period 1|Withdrawal by Subject|2
2624974|NCT00895895|9071520|P3|Period 1|Withdrawal by Subject|8
2624975|NCT00895895|9071521|P2|Period 1|Withdrawal by Subject|6
2624976|NCT00895895|9071522|P1|Period 1|Withdrawal by Subject|6
2624977|NCT00895895|9071518|P5|Period 1|Protocol Violation|0
2624978|NCT00895895|9071519|P4|Period 1|Protocol Violation|0
2624979|NCT00895895|9071520|P3|Period 1|Protocol Violation|0
2624980|NCT00895895|9071521|P2|Period 1|Protocol Violation|1
2624981|NCT00895895|9071522|P1|Period 1|Protocol Violation|0
2624982|NCT00895895|9071518|P5|Period 1|Other|1
2624983|NCT00895895|9071519|P4|Period 1|Other|1
2624984|NCT00895895|9071520|P3|Period 1|Other|1
2624985|NCT00895895|9071521|P2|Period 1|Other|2
2624986|NCT00895895|9071522|P1|Period 1|Other|1
2624987|NCT00895895|9071518|P5|Period 1|Lost to Follow-up|3
2624988|NCT00895895|9071519|P4|Period 1|Lost to Follow-up|2
2624989|NCT00895895|9071520|P3|Period 1|Lost to Follow-up|3
2624990|NCT00895895|9071521|P2|Period 1|Lost to Follow-up|1
2624991|NCT00895895|9071522|P1|Period 1|Lost to Follow-up|2
2624992|NCT00895895|9071518|P5|Period 1|investigator request|0
2624993|NCT00895895|9071519|P4|Period 1|investigator request|0
2624994|NCT00895895|9071520|P3|Period 1|investigator request|0
2624995|NCT00895895|9071521|P2|Period 1|investigator request|1
2624996|NCT00895895|9071522|P1|Period 1|investigator request|0
2624997|NCT00895895|9071518|P5|Period 1|failed to return|1
2624998|NCT00895895|9071519|P4|Period 1|failed to return|0
2624999|NCT00895895|9071520|P3|Period 1|failed to return|1
2625000|NCT00895895|9071521|P2|Period 1|failed to return|0
2625001|NCT00895895|9071522|P1|Period 1|failed to return|0
2625002|NCT00895895|9071518|P5|Period 1|discontinued by sponsor|1
2625003|NCT00895895|9071519|P4|Period 1|discontinued by sponsor|1
2625004|NCT00895895|9071520|P3|Period 1|discontinued by sponsor|2
2625005|NCT00895895|9071521|P2|Period 1|discontinued by sponsor|1
2625006|NCT00895895|9071522|P1|Period 1|discontinued by sponsor|2
2625007|NCT00895895|9071518|P5|Period 1|Death|1
2625008|NCT00895895|9071519|P4|Period 1|Death|0
2625009|NCT00895895|9071520|P3|Period 1|Death|0
2625010|NCT00895895|9071521|P2|Period 1|Death|0
2625011|NCT00895895|9071522|P1|Period 1|Death|0
2625012|NCT00895895|9071518|P5|Period 1|Adverse Event|7
2625013|NCT00895895|9071519|P4|Period 1|Adverse Event|6
2625014|NCT00895895|9071520|P3|Period 1|Adverse Event|4
2625015|NCT00895895|9071521|P2|Period 1|Adverse Event|6
2625016|NCT00895895|9071522|P1|Period 1|Adverse Event|7
2625017|NCT00895843|9071636|P2|Overall Study|Protocol Violation|12
2625018|NCT00895843|9071637|P1|Overall Study|Protocol Violation|12
2625019|NCT00895661|9071684|P1|Overall Study|reason unknown|2
2625020|NCT00895661|9071684|P1|Overall Study|Death|1
2625021|NCT00895622|9071694|P3|Overall Study|Protocol Violation|4
2625022|NCT00895622|9071695|P2|Overall Study|Protocol Violation|4
2625023|NCT00895622|9071696|P1|Overall Study|Protocol Violation|5
2625024|NCT00895583|9071723|P2|Overall Study|Other|1
2625025|NCT00895583|9071724|P1|Overall Study|Other|0
2625026|NCT00895583|9071723|P2|Overall Study|Lack of Efficacy|0
2625027|NCT00895583|9071724|P1|Overall Study|Lack of Efficacy|5
2625028|NCT00895583|9071723|P2|Overall Study|Withdrawal by Subject|2
2625029|NCT00895583|9071724|P1|Overall Study|Withdrawal by Subject|4
2625030|NCT00895583|9071723|P2|Overall Study|Protocol Violation|0
2625031|NCT00895583|9071724|P1|Overall Study|Protocol Violation|1
2625032|NCT00895583|9071723|P2|Overall Study|Lost to Follow-up|3
2625033|NCT00895583|9071724|P1|Overall Study|Lost to Follow-up|1
2625034|NCT00895583|9071723|P2|Overall Study|Physician Decision|1
2625035|NCT00895583|9071724|P1|Overall Study|Physician Decision|3
2625036|NCT00895583|9071723|P2|Overall Study|Death|1
2625037|NCT00895583|9071724|P1|Overall Study|Death|2
2625038|NCT00895583|9071723|P2|Overall Study|Adverse Event|4
2625039|NCT00895583|9071724|P1|Overall Study|Adverse Event|28
2625040|NCT00895453|9071814|P3|Overall Study|Lost to Follow-up|23
2625041|NCT00895453|9071815|P2|Overall Study|Lost to Follow-up|25
2625042|NCT00895453|9071816|P1|Overall Study|Lost to Follow-up|25
2625043|NCT00895414|9071824|P2|First Intervention (14 Days)|Physician Decision|1
2625044|NCT00895414|9071825|P1|First Intervention (14 Days)|Physician Decision|0
2625045|NCT00895414|9071824|P2|First Intervention (14 Days)|Withdrawal by Subject|0
2625046|NCT00895414|9071825|P1|First Intervention (14 Days)|Withdrawal by Subject|1
2625047|NCT00895310|9071835|P1|Overall Study|Withdrawal by Subject|1
2625048|NCT00895245|9071851|P1|Overall Study|Lack of Efficacy|6
2625049|NCT00895154|9071929|P2|Overall Study|Withdrawal by Subject|1
2625050|NCT00895154|9071930|P1|Overall Study|Withdrawal by Subject|0
2625051|NCT00895154|9071929|P2|Overall Study|Lost to Follow-up|1
2625052|NCT00895154|9071930|P1|Overall Study|Lost to Follow-up|1
2625053|NCT00895037|9071965|P3|Overall Study|Death|1
2625054|NCT00895037|9071966|P2|Overall Study|Death|2
2625055|NCT00895037|9071967|P1|Overall Study|Death|0
2625056|NCT00895011|9071998|P3|Overall Study|schedule conflict|0
2625057|NCT00895011|9071999|P2|Overall Study|schedule conflict|0
2625058|NCT00895011|9072000|P1|Overall Study|schedule conflict|1
2625059|NCT00895011|9071998|P3|Overall Study|Adverse Event|2
2625060|NCT00895011|9071999|P2|Overall Study|Adverse Event|2
2625061|NCT00895011|9072000|P1|Overall Study|Adverse Event|1
2625062|NCT00895011|9071998|P3|Overall Study|Protocol Violation|3
2625063|NCT00895011|9071999|P2|Overall Study|Protocol Violation|1
2625064|NCT00895011|9072000|P1|Overall Study|Protocol Violation|3
2625065|NCT00895011|9071998|P3|Overall Study|Lost to Follow-up|1
2625066|NCT00895011|9071999|P2|Overall Study|Lost to Follow-up|4
2625067|NCT00895011|9072000|P1|Overall Study|Lost to Follow-up|5
2625068|NCT00895011|9071998|P3|Overall Study|Withdrawal by Subject|2
2625069|NCT00895011|9071999|P2|Overall Study|Withdrawal by Subject|7
2625070|NCT00895011|9072000|P1|Overall Study|Withdrawal by Subject|14
2625071|NCT00894933|9072014|P1|Overall Study|Did not meeting incl/excl criteria|1
2625072|NCT00894933|9072014|P1|Overall Study|Cancelled Procedure|1
2625073|NCT00894933|9072014|P1|Overall Study|Lost to Follow-up|2
2625074|NCT00894803|9072032|P2|Overall Study|Lost to Follow-up|1
2625075|NCT00894803|9072033|P1|Overall Study|Lost to Follow-up|0
2625076|NCT00894803|9072032|P2|Overall Study|Death|4
2625077|NCT00894803|9072033|P1|Overall Study|Death|20
2625078|NCT00894790|9072069|P2|Overall Study|Did not meet entrance criteria|0
2625079|NCT00894790|9072070|P1|Overall Study|Did not meet entrance criteria|1
2625080|NCT00894790|9072069|P2|Overall Study|Lost to Follow-up|1
2625081|NCT00894790|9072070|P1|Overall Study|Lost to Follow-up|0
2625082|NCT00894790|9072069|P2|Overall Study|Protocol Violation|1
2625083|NCT00894790|9072070|P1|Overall Study|Protocol Violation|0
2625084|NCT00894686|9072112|P1|Overall Study|Other|5
2625085|NCT00894686|9072112|P1|Overall Study|Physician Decision|1
2625086|NCT00894686|9072112|P1|Overall Study|Withdrawal by Subject|50
2625087|NCT00894647|9072136|P2|Overall Study|Other, not due to AE|2
2625088|NCT00894647|9072137|P1|Overall Study|Other, not due to AE|1
2625089|NCT00894647|9072136|P2|Overall Study|Non-compliance with study procedures|2
2625090|NCT00894647|9072137|P1|Overall Study|Non-compliance with study procedures|0
2625091|NCT00894647|9072136|P2|Overall Study|Lost to Follow-up|2
2625092|NCT00894647|9072137|P1|Overall Study|Lost to Follow-up|0
2625093|NCT00894647|9072136|P2|Overall Study|Withdrawal by Subject|4
2625094|NCT00894647|9072137|P1|Overall Study|Withdrawal by Subject|4
2625095|NCT00894647|9072136|P2|Overall Study|Adverse Event|4
2625096|NCT00894647|9072137|P1|Overall Study|Adverse Event|5
2625097|NCT00894556|9072150|P4|Treatment Phase|Lack of Qualifying Event|0
2625098|NCT00894556|9072151|P3|Treatment Phase|Lack of Qualifying Event|0
2625099|NCT00894556|9072152|P2|Treatment Phase|Lack of Qualifying Event|1
2625100|NCT00894556|9072153|P1|Treatment Phase|Lack of Qualifying Event|2
2625101|NCT00894556|9072150|P4|Treatment Phase|Lost to Follow-up|0
2625102|NCT00894556|9072151|P3|Treatment Phase|Lost to Follow-up|1
2625103|NCT00894556|9072152|P2|Treatment Phase|Lost to Follow-up|3
2625104|NCT00894556|9072153|P1|Treatment Phase|Lost to Follow-up|2
2625105|NCT00894556|9072150|P4|Baseline Phase|Did not meet Randomization Criteria|85
2625106|NCT00894556|9072151|P3|Baseline Phase|Did not meet Randomization Criteria|0
2625107|NCT00894556|9072152|P2|Baseline Phase|Did not meet Randomization Criteria|0
2625108|NCT00894556|9072153|P1|Baseline Phase|Did not meet Randomization Criteria|0
2625109|NCT00894543|9072164|P2|Week 4 to Week 8|No diary or lost or withdrew|2
2625110|NCT00894543|9072165|P1|Week 4 to Week 8|No diary or lost or withdrew|4
2625111|NCT00894543|9072164|P2|Baseline to Week 4|No diary or lost or withdrew|2
2625112|NCT00894543|9072165|P1|Baseline to Week 4|No diary or lost or withdrew|3
2625113|NCT00894413|9072231|P2|Overall Study|Withdrawal by Subject|4
2625114|NCT00894413|9072232|P1|Overall Study|Withdrawal by Subject|0
2625115|NCT00894413|9072231|P2|Overall Study|Adverse Event|2
2625116|NCT00894413|9072232|P1|Overall Study|Adverse Event|0
2625117|NCT00894413|9072231|P2|Overall Study|Physician Decision|2
2625118|NCT00894413|9072232|P1|Overall Study|Physician Decision|0
2625119|NCT00894387|9072240|P2|Overall Study|GCP non-compliance|2
2625120|NCT00894387|9072241|P1|Overall Study|GCP non-compliance|0
2625121|NCT00894387|9072240|P2|Overall Study|Mis-randomized|9
2625122|NCT00894387|9072241|P1|Overall Study|Mis-randomized|13
2625123|NCT00894387|9072240|P2|Overall Study|Other (Missing)|3
2625124|NCT00894387|9072241|P1|Overall Study|Other (Missing)|5
2625125|NCT00894387|9072240|P2|Overall Study|Patient's request|30
2625126|NCT00894387|9072241|P1|Overall Study|Patient's request|25
2625127|NCT00894387|9072240|P2|Overall Study|Protocol Deviation|0
2625128|NCT00894387|9072241|P1|Overall Study|Protocol Deviation|4
2625129|NCT00894387|9072240|P2|Overall Study|Death|76
2625130|NCT00894387|9072241|P1|Overall Study|Death|77
2625131|NCT00894387|9072240|P2|Overall Study|Administrative problems|2
2625132|NCT00894387|9072241|P1|Overall Study|Administrative problems|2
2625133|NCT00894387|9072240|P2|Overall Study|Lost to Follow-up|5
2625134|NCT00894387|9072241|P1|Overall Study|Lost to Follow-up|3
2625135|NCT00894387|9072240|P2|Overall Study|Unsatisfactory therapeutic effect|1
2625136|NCT00894387|9072241|P1|Overall Study|Unsatisfactory therapeutic effect|0
2625137|NCT00894387|9072240|P2|Overall Study|Abnormal Laboratory values|2
2625138|NCT00894387|9072241|P1|Overall Study|Abnormal Laboratory values|2
2625139|NCT00894387|9072240|P2|Overall Study|Adverse Event|45
2625140|NCT00894387|9072241|P1|Overall Study|Adverse Event|44
2625141|NCT00894361|9072261|P2|Overall Study|deaths and less than 2 yr followup|64
2625142|NCT00894361|9072262|P1|Overall Study|deaths and less than 2 yr followup|24
2625143|NCT00894322|9072271|P3|Overall Study|Withdrawal by Subject|0
2625144|NCT00894322|9072272|P2|Overall Study|Withdrawal by Subject|0
2625145|NCT00894322|9072273|P1|Overall Study|Withdrawal by Subject|1
2625146|NCT00894166|9072324|P8|Overall Study|Death|0
2625147|NCT00894166|9072325|P7|Overall Study|Death|0
2625148|NCT00894166|9072326|P6|Overall Study|Death|0
2625149|NCT00894166|9072327|P5|Overall Study|Death|0
2625150|NCT00894166|9072328|P4|Overall Study|Death|1
2625151|NCT00894166|9072329|P3|Overall Study|Death|0
2625152|NCT00894166|9072330|P2|Overall Study|Death|0
2625153|NCT00894166|9072331|P1|Overall Study|Death|0
2625154|NCT00894166|9072324|P8|Overall Study|Withdrew or Lost to Follow-Up|34
2625155|NCT00894166|9072325|P7|Overall Study|Withdrew or Lost to Follow-Up|16
2625156|NCT00894166|9072326|P6|Overall Study|Withdrew or Lost to Follow-Up|16
2625157|NCT00894166|9072327|P5|Overall Study|Withdrew or Lost to Follow-Up|24
2625158|NCT00894166|9072328|P4|Overall Study|Withdrew or Lost to Follow-Up|68
2625159|NCT00894166|9072329|P3|Overall Study|Withdrew or Lost to Follow-Up|62
2625160|NCT00894166|9072330|P2|Overall Study|Withdrew or Lost to Follow-Up|63
2625161|NCT00894166|9072331|P1|Overall Study|Withdrew or Lost to Follow-Up|61
2625162|NCT00893971|9072377|P1|Overall Study|Physician Decision|3
2625163|NCT00893789|9072495|P4|Overall Study|Lost to Follow-up|1
2625164|NCT00893789|9072496|P3|Overall Study|Lost to Follow-up|0
2625165|NCT00893789|9072497|P2|Overall Study|Lost to Follow-up|0
2625166|NCT00893789|9072498|P1|Overall Study|Lost to Follow-up|0
2625167|NCT00893789|9072495|P4|Overall Study|Protocol Violation|4
2625168|NCT00893789|9072496|P3|Overall Study|Protocol Violation|1
2625169|NCT00893789|9072497|P2|Overall Study|Protocol Violation|1
2625170|NCT00893789|9072498|P1|Overall Study|Protocol Violation|0
2625171|NCT00893789|9072495|P4|Overall Study|Adverse Event|5
2625172|NCT00893789|9072496|P3|Overall Study|Adverse Event|1
2625173|NCT00893789|9072497|P2|Overall Study|Adverse Event|2
2625174|NCT00893789|9072498|P1|Overall Study|Adverse Event|0
2625175|NCT00893789|9072495|P4|Overall Study|Taking Excluded Concomitant Medication|0
2625176|NCT00893789|9072496|P3|Overall Study|Taking Excluded Concomitant Medication|1
2625177|NCT00893789|9072497|P2|Overall Study|Taking Excluded Concomitant Medication|0
2625178|NCT00893789|9072498|P1|Overall Study|Taking Excluded Concomitant Medication|1
2625179|NCT00893789|9072495|P4|Overall Study|Noncompliance With Study Procedures|0
2625180|NCT00893789|9072496|P3|Overall Study|Noncompliance With Study Procedures|0
2625181|NCT00893789|9072497|P2|Overall Study|Noncompliance With Study Procedures|0
2625182|NCT00893789|9072498|P1|Overall Study|Noncompliance With Study Procedures|1
2625183|NCT00893789|9072495|P4|Overall Study|Noncompliance With Study Drug|2
2625184|NCT00893789|9072496|P3|Overall Study|Noncompliance With Study Drug|1
2625185|NCT00893789|9072497|P2|Overall Study|Noncompliance With Study Drug|0
2625186|NCT00893789|9072498|P1|Overall Study|Noncompliance With Study Drug|1
2625187|NCT00893789|9072495|P4|Overall Study|Withdrawal by Subject|1
2625188|NCT00893789|9072496|P3|Overall Study|Withdrawal by Subject|3
2625189|NCT00893789|9072497|P2|Overall Study|Withdrawal by Subject|1
2625190|NCT00893789|9072498|P1|Overall Study|Withdrawal by Subject|3
2625191|NCT00893763|9072582|P2|Overall Study|extubated|110
2625192|NCT00893763|9072583|P1|Overall Study|extubated|110
2625193|NCT00893737|9072591|P1|Overall Study|Lost to Follow-up|6
2625194|NCT00893737|9072591|P1|Overall Study|Withdrawal by Subject|2
2625195|NCT00893737|9072591|P1|Overall Study|Adverse Event|4
2625196|NCT00893464|9072605|P8|Overall Study|Did not complete therapy/experience PD|2
2625197|NCT00893464|9072606|P7|Overall Study|Did not complete therapy/experience PD|2
2625198|NCT00893464|9072607|P6|Overall Study|Did not complete therapy/experience PD|0
2625199|NCT00893464|9072608|P5|Overall Study|Did not complete therapy/experience PD|0
2625200|NCT00893464|9072609|P4|Overall Study|Did not complete therapy/experience PD|0
2625201|NCT00893464|9072610|P3|Overall Study|Did not complete therapy/experience PD|0
2625202|NCT00893464|9072611|P2|Overall Study|Did not complete therapy/experience PD|0
2625203|NCT00893464|9072612|P1|Overall Study|Did not complete therapy/experience PD|0
2625204|NCT00893113|9072739|P2|Overall Study|Withdrew Consent|7
2625205|NCT00893113|9072740|P1|Overall Study|Withdrew Consent|8
2625206|NCT00893113|9072739|P2|Overall Study|Early Termination|1
2625207|NCT00893113|9072740|P1|Overall Study|Early Termination|1
2625208|NCT00893113|9072739|P2|Overall Study|Lost to Follow-up|8
2625209|NCT00893113|9072740|P1|Overall Study|Lost to Follow-up|4
2625210|NCT00892957|9072770|P2|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2
2625211|NCT00892957|9072771|P1|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0
2625212|NCT00892957|9072770|P2|Between Postoperative Day 1 and Day 14|Death|2
2625213|NCT00892957|9072771|P1|Between Postoperative Day 1 and Day 14|Death|0
2625214|NCT00892775|9072859|P2|Overall Study|Lost to Follow-up|0
2625215|NCT00892775|9072860|P1|Overall Study|Lost to Follow-up|1
2625216|NCT00892775|9072859|P2|Overall Study|Withdrawal by Subject|1
2625217|NCT00892775|9072860|P1|Overall Study|Withdrawal by Subject|0
2625218|NCT00892775|9072859|P2|Overall Study|Migrated/ moved from study area|0
2625219|NCT00892775|9072860|P1|Overall Study|Migrated/ moved from study area|1
2625220|NCT00892775|9072859|P2|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0
2625221|NCT00892775|9072860|P1|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1
2625222|NCT00892775|9072859|P2|Overall Study|Subject difficulties with blood drawing|0
2625223|NCT00892775|9072860|P1|Overall Study|Subject difficulties with blood drawing|1
2625224|NCT00892775|9072859|P2|Overall Study|Protocol Violation|0
2625225|NCT00892775|9072860|P1|Overall Study|Protocol Violation|1
2625226|NCT00892723|9072887|P3|Overall Study|Withdrawal by Subject|1
2625227|NCT00892723|9072888|P2|Overall Study|Withdrawal by Subject|1
2625228|NCT00892723|9072889|P1|Overall Study|Withdrawal by Subject|1
2625229|NCT00892723|9072887|P3|Overall Study|Lost to Follow-up|1
2625230|NCT00892723|9072888|P2|Overall Study|Lost to Follow-up|3
2625231|NCT00892723|9072889|P1|Overall Study|Lost to Follow-up|1
2625232|NCT00892437|9072978|P2|Open-Label Extension Phase|Withdrew Consent|1
2625233|NCT00892437|9072979|P1|Open-Label Extension Phase|Withdrew Consent|3
2625234|NCT00892437|9072978|P2|Open-Label Extension Phase|Investigator's Discretion|0
2625235|NCT00892437|9072979|P1|Open-Label Extension Phase|Investigator's Discretion|1
2625236|NCT00892437|9072978|P2|Open-Label Extension Phase|Lost to Follow-up|1
2625237|NCT00892437|9072979|P1|Open-Label Extension Phase|Lost to Follow-up|3
2625238|NCT00892437|9072978|P2|Open-Label Extension Phase|Lack of Efficacy|0
2625239|NCT00892437|9072979|P1|Open-Label Extension Phase|Lack of Efficacy|1
2625240|NCT00892437|9072978|P2|Open-Label Extension Phase|Adverse Event|2
2625241|NCT00892437|9072979|P1|Open-Label Extension Phase|Adverse Event|4
2625242|NCT00892437|9072978|P2|Randomized Phase|Withdrew Consent|0
2625243|NCT00892437|9072979|P1|Randomized Phase|Withdrew Consent|1
2625244|NCT00892437|9072978|P2|Randomized Phase|Investigator’s Discretion|0
2625245|NCT00892437|9072979|P1|Randomized Phase|Investigator’s Discretion|1
2625246|NCT00892437|9072978|P2|Randomized Phase|Lost to Follow-up|3
2625247|NCT00892437|9072979|P1|Randomized Phase|Lost to Follow-up|1
2625248|NCT00892437|9072978|P2|Randomized Phase|Adverse Event|2
2625249|NCT00892437|9072979|P1|Randomized Phase|Adverse Event|2
2625250|NCT00892437|9072978|P2|Randomized Phase|Randomized but not treated|0
2625251|NCT00892437|9072979|P1|Randomized Phase|Randomized but not treated|6
2625252|NCT00892281|9072998|P2|Overall Study|Visit 4 date out of window|0
2625253|NCT00892281|9072999|P1|Overall Study|Visit 4 date out of window|1
2625254|NCT00892281|9072998|P2|Overall Study|Rash on hand|0
2625255|NCT00892281|9072999|P1|Overall Study|Rash on hand|1
2625256|NCT00892281|9072998|P2|Overall Study|Subject had history of drug abuse|0
2625257|NCT00892281|9072999|P1|Overall Study|Subject had history of drug abuse|1
2625258|NCT00892281|9072998|P2|Overall Study|Non-compliant with visits as scheduled|0
2625259|NCT00892281|9072999|P1|Overall Study|Non-compliant with visits as scheduled|1
2625260|NCT00892281|9072998|P2|Overall Study|Missed visits rescheduled out of window|0
2625261|NCT00892281|9072999|P1|Overall Study|Missed visits rescheduled out of window|1
2625262|NCT00892281|9072998|P2|Overall Study|Missed multiple visits|0
2625263|NCT00892281|9072999|P1|Overall Study|Missed multiple visits|1
2625264|NCT00892281|9072998|P2|Overall Study|No show Visit 2; prescription not filled|0
2625265|NCT00892281|9072999|P1|Overall Study|No show Visit 2; prescription not filled|1
2625266|NCT00892281|9072998|P2|Overall Study|Subject not seen by PI at final visit|0
2625267|NCT00892281|9072999|P1|Overall Study|Subject not seen by PI at final visit|1
2625268|NCT00892281|9072998|P2|Overall Study|Lack of efficacy of study product|0
2625269|NCT00892281|9072999|P1|Overall Study|Lack of efficacy of study product|2
2625270|NCT00892281|9072998|P2|Overall Study|Death in family|0
2625271|NCT00892281|9072999|P1|Overall Study|Death in family|1
2625272|NCT00892281|9072998|P2|Overall Study|Bad taste in mouth after taking Oracea®|1
2625273|NCT00892281|9072999|P1|Overall Study|Bad taste in mouth after taking Oracea®|0
2625274|NCT00892281|9072998|P2|Overall Study|Subject lost interest in program|1
2625275|NCT00892281|9072999|P1|Overall Study|Subject lost interest in program|0
2625276|NCT00892281|9072998|P2|Overall Study|PI complained of inadequate compensation|0
2625277|NCT00892281|9072999|P1|Overall Study|PI complained of inadequate compensation|3
2625278|NCT00892281|9072998|P2|Overall Study|Scheduled for knee replacement|1
2625279|NCT00892281|9072999|P1|Overall Study|Scheduled for knee replacement|0
2625280|NCT00892281|9072998|P2|Overall Study|Missed Visit 4 and off meds for 65 days|1
2625281|NCT00892281|9072999|P1|Overall Study|Missed Visit 4 and off meds for 65 days|1
2625282|NCT00892281|9072998|P2|Overall Study|Subject missed several visits/lost meds|0
2625283|NCT00892281|9072999|P1|Overall Study|Subject missed several visits/lost meds|1
2625284|NCT00892281|9072998|P2|Overall Study|Subject did not return for any visits|0
2625285|NCT00892281|9072999|P1|Overall Study|Subject did not return for any visits|1
2625286|NCT00892281|9072998|P2|Overall Study|Subject not good candidate for study|0
2625287|NCT00892281|9072999|P1|Overall Study|Subject not good candidate for study|1
2625288|NCT00892281|9072998|P2|Overall Study|Unable to redeem the drug voucher|0
2625289|NCT00892281|9072999|P1|Overall Study|Unable to redeem the drug voucher|1
2625290|NCT00892281|9072998|P2|Overall Study|Rosacea cleared; subject D/C'd self|0
2625291|NCT00892281|9072999|P1|Overall Study|Rosacea cleared; subject D/C'd self|1
2625292|NCT00892281|9072998|P2|Overall Study|Did not meet incl/excl criteria|0
2625293|NCT00892281|9072999|P1|Overall Study|Did not meet incl/excl criteria|1
2625294|NCT00892281|9072998|P2|Overall Study|Last visit not done - death in family|0
2625295|NCT00892281|9072999|P1|Overall Study|Last visit not done - death in family|1
2625296|NCT00892281|9072998|P2|Overall Study|Family emergency|0
2625297|NCT00892281|9072999|P1|Overall Study|Family emergency|1
2625298|NCT00892281|9072998|P2|Overall Study|Subject completed day after study closed|0
2625299|NCT00892281|9072999|P1|Overall Study|Subject completed day after study closed|1
2625300|NCT00892281|9072998|P2|Overall Study|Final visit completed 4 weeks late|1
2625301|NCT00892281|9072999|P1|Overall Study|Final visit completed 4 weeks late|0
2625302|NCT00892281|9072998|P2|Overall Study|Subject unable to keep follow-up visits|0
2625303|NCT00892281|9072999|P1|Overall Study|Subject unable to keep follow-up visits|1
2625304|NCT00892281|9072998|P2|Overall Study|Subject failed to return for final visit|0
2625305|NCT00892281|9072999|P1|Overall Study|Subject failed to return for final visit|2
2625306|NCT00892281|9072998|P2|Overall Study|Withdrawal by Subject|14
2625307|NCT00892281|9072999|P1|Overall Study|Withdrawal by Subject|86
2625308|NCT00892281|9072998|P2|Overall Study|Protocol Violation|2
2625309|NCT00892281|9072999|P1|Overall Study|Protocol Violation|7
2625310|NCT00892281|9072998|P2|Overall Study|Pregnancy|0
2625311|NCT00892281|9072999|P1|Overall Study|Pregnancy|1
2625312|NCT00892281|9072998|P2|Overall Study|Lost to Follow-up|8
2625313|NCT00892281|9072999|P1|Overall Study|Lost to Follow-up|81
2625314|NCT00892281|9072998|P2|Overall Study|Adverse Event|8
2625315|NCT00892281|9072999|P1|Overall Study|Adverse Event|65
2625316|NCT00892177|9073012|P6|Phase II|Withdrawal by Subject|1
2625317|NCT00892177|9073013|P5|Phase II|Withdrawal by Subject|4
2625318|NCT00892177|9073014|P4|Phase II|Withdrawal by Subject|0
2625319|NCT00892177|9073015|P3|Phase II|Withdrawal by Subject|0
2625320|NCT00892177|9073016|P2|Phase II|Withdrawal by Subject|0
2625321|NCT00892177|9073017|P1|Phase II|Withdrawal by Subject|0
2625322|NCT00892177|9073012|P6|Phase II|Ineligible|1
2625323|NCT00892177|9073013|P5|Phase II|Ineligible|1
2625324|NCT00892177|9073014|P4|Phase II|Ineligible|0
2625325|NCT00892177|9073015|P3|Phase II|Ineligible|0
2625326|NCT00892177|9073016|P2|Phase II|Ineligible|0
2625327|NCT00892177|9073017|P1|Phase II|Ineligible|0
2625328|NCT00892151|9073042|P1|Overall Study|Protocol Violation|1
2625329|NCT00892099|9073051|P3|Overall Study|Lost to Follow-up|1
2625330|NCT00892099|9073052|P2|Overall Study|Lost to Follow-up|0
2625331|NCT00892099|9073053|P1|Overall Study|Lost to Follow-up|0
2625332|NCT00892099|9073051|P3|Overall Study|investigator decision|1
2625333|NCT00892099|9073052|P2|Overall Study|investigator decision|0
2625334|NCT00892099|9073053|P1|Overall Study|investigator decision|0
2625335|NCT00892099|9073051|P3|Overall Study|kidney function recovered|0
2625336|NCT00892099|9073052|P2|Overall Study|kidney function recovered|1
2625337|NCT00892099|9073053|P1|Overall Study|kidney function recovered|0
2625338|NCT00892099|9073051|P3|Overall Study|no further details|1
2625339|NCT00892099|9073052|P2|Overall Study|no further details|0
2625340|NCT00892099|9073053|P1|Overall Study|no further details|1
2625341|NCT00892099|9073051|P3|Overall Study|Prolonged hospitalization|1
2625342|NCT00892099|9073052|P2|Overall Study|Prolonged hospitalization|0
2625343|NCT00892099|9073053|P1|Overall Study|Prolonged hospitalization|1
2625344|NCT00892099|9073051|P3|Overall Study|replocated|2
2625345|NCT00892099|9073052|P2|Overall Study|replocated|0
2625346|NCT00892099|9073053|P1|Overall Study|replocated|1
2625347|NCT00892099|9073051|P3|Overall Study|Adverse Event|0
2625348|NCT00892099|9073052|P2|Overall Study|Adverse Event|0
2625349|NCT00892099|9073053|P1|Overall Study|Adverse Event|1
2625350|NCT00892099|9073051|P3|Overall Study|Death|1
2625351|NCT00892099|9073052|P2|Overall Study|Death|0
2625352|NCT00892099|9073053|P1|Overall Study|Death|1
2625353|NCT00892047|9073078|P2|Overall Study|Lack of Efficacy|2
2625354|NCT00892047|9073079|P1|Overall Study|Lack of Efficacy|0
2625355|NCT00892047|9073078|P2|Overall Study|subject burden|3
2625356|NCT00892047|9073079|P1|Overall Study|subject burden|2
2625357|NCT00892047|9073078|P2|Overall Study|Adverse Event|2
2625358|NCT00892047|9073079|P1|Overall Study|Adverse Event|2
2625359|NCT00892008|9073095|P1|Overall Study|Adverse Event|37
2625360|NCT00892008|9073095|P1|Overall Study|Other|378
2625361|NCT00892008|9073095|P1|Overall Study|Lost to Follow-up|142
2625362|NCT00892008|9073095|P1|Overall Study|Lack of Efficacy|3
2625363|NCT00892008|9073095|P1|Overall Study|Death|5
2625364|NCT00891930|9073181|P1|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1
2625365|NCT00891930|9073181|P1|Part 2: Panitumumab + Ganitumab|Death|30
2625366|NCT00891930|9073181|P1|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1
2625367|NCT00891930|9073181|P1|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1
2625368|NCT00891930|9073181|P1|Part 1: Panitumumab +Irinotecan|Death|38
2625369|NCT00891904|9073202|P1|Overall Study|Adverse Event|1
2625370|NCT00891904|9073202|P1|Overall Study|Death|1
2625371|NCT00891839|9073228|P1|Overall Study|Disease progression|3
2625372|NCT00891839|9073228|P1|Overall Study|Withdrawal by Subject|2
2625373|NCT00891839|9073228|P1|Overall Study|Adverse Event|2
2625374|NCT00891813|9073237|P1|Overall Study|Protocol Violation|2
2625375|NCT00891813|9073237|P1|Overall Study|Patient Noncompliance|6
2625376|NCT00891813|9073237|P1|Overall Study|Withdrawal by Subject|1
2625377|NCT00891813|9073237|P1|Overall Study|Adverse Event|3
2625378|NCT00891774|9073243|P1|Overall Study|Protocol Violation|4
2625379|NCT00891774|9073243|P1|Overall Study|Withdrawal by Subject|2
2625380|NCT00891774|9073243|P1|Overall Study|Illness (Self/Mother)|3
2625381|NCT00891774|9073243|P1|Overall Study|Lost to Follow-up|5
2625382|NCT00891735|9073254|P4|Overall Study|Patient's decision to withdraw|8
2625383|NCT00891735|9073255|P3|Overall Study|Patient's decision to withdraw|4
2625384|NCT00891735|9073256|P2|Overall Study|Patient's decision to withdraw|9
2625385|NCT00891735|9073257|P1|Overall Study|Patient's decision to withdraw|4
2625386|NCT00891735|9073254|P4|Overall Study|Physician's decision to withdraw patient|0
2625387|NCT00891735|9073255|P3|Overall Study|Physician's decision to withdraw patient|0
2625388|NCT00891735|9073256|P2|Overall Study|Physician's decision to withdraw patient|0
2625389|NCT00891735|9073257|P1|Overall Study|Physician's decision to withdraw patient|1
2625390|NCT00891735|9073254|P4|Overall Study|Lost to Follow-up|2
2625391|NCT00891735|9073255|P3|Overall Study|Lost to Follow-up|2
2625392|NCT00891735|9073256|P2|Overall Study|Lost to Follow-up|2
2625393|NCT00891735|9073257|P1|Overall Study|Lost to Follow-up|2
2625394|NCT00891735|9073254|P4|Overall Study|Death|5
2625395|NCT00891735|9073255|P3|Overall Study|Death|4
2625396|NCT00891735|9073256|P2|Overall Study|Death|5
2625397|NCT00891735|9073257|P1|Overall Study|Death|8
2625398|NCT00891735|9073254|P4|Overall Study|Adverse Event|0
2625399|NCT00891735|9073255|P3|Overall Study|Adverse Event|2
2625400|NCT00891735|9073256|P2|Overall Study|Adverse Event|0
2625401|NCT00891735|9073257|P1|Overall Study|Adverse Event|2
2625402|NCT00891657|9073297|P2|Overall Study|Withdrawal by Subject|1
2625403|NCT00891657|9073298|P1|Overall Study|Withdrawal by Subject|1
2625404|NCT00891618|9073310|P1|Overall Study|Withdrawal by Subject|1
2625405|NCT00891527|9073314|P1|Overall Study|Withdrawal by Subject|2
2625406|NCT00891462|9073323|P3|Overall Study|Lost to Follow-up|0
2625407|NCT00891462|9073324|P2|Overall Study|Lost to Follow-up|2
2625408|NCT00891462|9073325|P1|Overall Study|Lost to Follow-up|0
2625409|NCT00891462|9073323|P3|Overall Study|Inclusion/exclusion criteria|2
2625410|NCT00891462|9073324|P2|Overall Study|Inclusion/exclusion criteria|2
2625411|NCT00891462|9073325|P1|Overall Study|Inclusion/exclusion criteria|0
2625412|NCT00891462|9073323|P3|Overall Study|Protocol Violation|3
2625413|NCT00891462|9073324|P2|Overall Study|Protocol Violation|1
2625414|NCT00891462|9073325|P1|Overall Study|Protocol Violation|2
2625415|NCT00891462|9073323|P3|Overall Study|Other Reason|3
2625416|NCT00891462|9073324|P2|Overall Study|Other Reason|5
2625417|NCT00891462|9073325|P1|Overall Study|Other Reason|2
2625418|NCT00891462|9073323|P3|Overall Study|COPD exacerbation|1
2625419|NCT00891462|9073324|P2|Overall Study|COPD exacerbation|4
2625420|NCT00891462|9073325|P1|Overall Study|COPD exacerbation|7
2625421|NCT00891462|9073323|P3|Overall Study|Lack of Efficacy|1
2625422|NCT00891462|9073324|P2|Overall Study|Lack of Efficacy|5
2625423|NCT00891462|9073325|P1|Overall Study|Lack of Efficacy|10
2625424|NCT00891462|9073323|P3|Overall Study|Adverse Event|7
2625425|NCT00891462|9073324|P2|Overall Study|Adverse Event|8
2625426|NCT00891462|9073325|P1|Overall Study|Adverse Event|7
2625427|NCT00891462|9073323|P3|Overall Study|Withdrawal by Subject|7
2625428|NCT00891462|9073324|P2|Overall Study|Withdrawal by Subject|6
2625429|NCT00891462|9073325|P1|Overall Study|Withdrawal by Subject|9
2625430|NCT00891371|9073347|P1|Treatment|Lost to Follow-up|1
2625431|NCT00891371|9073347|P1|Treatment|Death|1
2625432|NCT00891371|9073347|P1|Treatment|Adverse Event|2
2625433|NCT00891371|9073347|P1|Treatment|Lack of Efficacy|5
2625434|NCT00891371|9073347|P1|Pre-assignment|Consent withdrawal|1
2625435|NCT00891371|9073347|P1|Pre-assignment|Inclusion/exclusion|5
2625436|NCT00891293|9073369|P1|Overall Study|Sponsor termination|62
2625437|NCT00891293|9073369|P1|Overall Study|Subject withdrew consent|7
2625438|NCT00891293|9073369|P1|Overall Study|Lost to Follow-up|7
2625439|NCT00891293|9073369|P1|Overall Study|Laboratory abnormality|4
2625440|NCT00891293|9073369|P1|Overall Study|Protocol Violation|2
2625441|NCT00891293|9073369|P1|Overall Study|Adverse Event|2
2625442|NCT00891228|9073384|P3|Overall Study|Pregnancy|0
2625443|NCT00891228|9073385|P2|Overall Study|Pregnancy|1
2625444|NCT00891228|9073386|P1|Overall Study|Pregnancy|0
2625445|NCT00891228|9073384|P3|Overall Study|Lost to Follow-up|5
2625446|NCT00891228|9073385|P2|Overall Study|Lost to Follow-up|4
2625447|NCT00891228|9073386|P1|Overall Study|Lost to Follow-up|4
2625448|NCT00891228|9073384|P3|Overall Study|Physician Decision|0
2625449|NCT00891228|9073385|P2|Overall Study|Physician Decision|1
2625450|NCT00891228|9073386|P1|Overall Study|Physician Decision|2
2625451|NCT00891228|9073384|P3|Overall Study|Protocol Violation|2
2625452|NCT00891228|9073385|P2|Overall Study|Protocol Violation|1
2625453|NCT00891228|9073386|P1|Overall Study|Protocol Violation|3
2625454|NCT00891228|9073384|P3|Overall Study|Withdrawal by Subject|5
2625455|NCT00891228|9073385|P2|Overall Study|Withdrawal by Subject|4
2625456|NCT00891228|9073386|P1|Overall Study|Withdrawal by Subject|2
2625457|NCT00891228|9073384|P3|Overall Study|Adverse Event|3
2625458|NCT00891228|9073385|P2|Overall Study|Adverse Event|2
2625459|NCT00891228|9073386|P1|Overall Study|Adverse Event|0
2625460|NCT00891202|9073408|P4|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5
2625711|NCT00888173|9074305|P1|Overall Study|Wrong Primary|1
2625461|NCT00891202|9073409|P3|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2
2625462|NCT00891202|9073410|P2|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
2625463|NCT00891202|9073411|P1|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
2625464|NCT00891202|9073408|P4|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
2625465|NCT00891202|9073409|P3|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1
2625466|NCT00891202|9073410|P2|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
2625467|NCT00891202|9073411|P1|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
2625468|NCT00891202|9073408|P4|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
2625469|NCT00891202|9073409|P3|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4
2625470|NCT00891202|9073410|P2|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
2625471|NCT00891202|9073411|P1|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
2625472|NCT00891202|9073408|P4|PAP (Up To Week 39)|Withdrawal by Subject|0
2625473|NCT00891202|9073409|P3|PAP (Up To Week 39)|Withdrawal by Subject|0
2625474|NCT00891202|9073410|P2|PAP (Up To Week 39)|Withdrawal by Subject|0
2625475|NCT00891202|9073411|P1|PAP (Up To Week 39)|Withdrawal by Subject|1
2625476|NCT00891046|9073587|P5|Overall Study|Lost to Follow-up|1
2625477|NCT00891046|9073588|P4|Overall Study|Lost to Follow-up|0
2625478|NCT00891046|9073589|P3|Overall Study|Lost to Follow-up|0
2625479|NCT00891046|9073590|P2|Overall Study|Lost to Follow-up|0
2625480|NCT00891046|9073591|P1|Overall Study|Lost to Follow-up|0
2625481|NCT00891046|9073587|P5|Overall Study|Withdrawal by Subject|1
2625482|NCT00891046|9073588|P4|Overall Study|Withdrawal by Subject|1
2625483|NCT00891046|9073589|P3|Overall Study|Withdrawal by Subject|2
2625484|NCT00891046|9073590|P2|Overall Study|Withdrawal by Subject|1
2625485|NCT00891046|9073591|P1|Overall Study|Withdrawal by Subject|2
2625486|NCT00891046|9073587|P5|Overall Study|Adverse Event|14
2625487|NCT00891046|9073588|P4|Overall Study|Adverse Event|0
2625488|NCT00891046|9073589|P3|Overall Study|Adverse Event|2
2625489|NCT00891046|9073590|P2|Overall Study|Adverse Event|3
2625490|NCT00891046|9073591|P1|Overall Study|Adverse Event|4
2625491|NCT00891046|9073587|P5|Overall Study|Participant no longer required drug|1
2625492|NCT00891046|9073588|P4|Overall Study|Participant no longer required drug|0
2625493|NCT00891046|9073589|P3|Overall Study|Participant no longer required drug|0
2625494|NCT00891046|9073590|P2|Overall Study|Participant no longer required drug|2
2625495|NCT00891046|9073591|P1|Overall Study|Participant no longer required drug|0
2625496|NCT00891046|9073587|P5|Overall Study|Administrative problems|1
2625497|NCT00891046|9073588|P4|Overall Study|Administrative problems|0
2625498|NCT00891046|9073589|P3|Overall Study|Administrative problems|0
2625499|NCT00891046|9073590|P2|Overall Study|Administrative problems|0
2625500|NCT00891046|9073591|P1|Overall Study|Administrative problems|0
2625501|NCT00891046|9073587|P5|Overall Study|Unsatisfactory therapeutic effect|20
2625502|NCT00891046|9073588|P4|Overall Study|Unsatisfactory therapeutic effect|2
2625503|NCT00891046|9073589|P3|Overall Study|Unsatisfactory therapeutic effect|19
2625504|NCT00891046|9073590|P2|Overall Study|Unsatisfactory therapeutic effect|2
2625505|NCT00891046|9073591|P1|Overall Study|Unsatisfactory therapeutic effect|5
2625506|NCT00891046|9073587|P5|Overall Study|Protocol Violation|1
2625507|NCT00891046|9073588|P4|Overall Study|Protocol Violation|0
2625508|NCT00891046|9073589|P3|Overall Study|Protocol Violation|0
2625509|NCT00891046|9073590|P2|Overall Study|Protocol Violation|1
2625510|NCT00891046|9073591|P1|Overall Study|Protocol Violation|1
2625511|NCT00891020|9073667|P3|Long-term Extension Period|Administrative|2
2625512|NCT00891020|9073668|P2|Long-term Extension Period|Administrative|2
2625513|NCT00891020|9073669|P1|Long-term Extension Period|Administrative|1
2625514|NCT00891020|9073667|P3|Long-term Extension Period|Failure to return|3
2625515|NCT00891020|9073668|P2|Long-term Extension Period|Failure to return|2
2625516|NCT00891020|9073669|P1|Long-term Extension Period|Failure to return|0
2625517|NCT00891020|9073667|P3|Long-term Extension Period|Refused treatment/did not cooperate|4
2625518|NCT00891020|9073668|P2|Long-term Extension Period|Refused treatment/did not cooperate|6
2625519|NCT00891020|9073669|P1|Long-term Extension Period|Refused treatment/did not cooperate|1
2625520|NCT00891020|9073667|P3|Long-term Extension Period|Protocol Violation|1
2625521|NCT00891020|9073668|P2|Long-term Extension Period|Protocol Violation|1
2625522|NCT00891020|9073669|P1|Long-term Extension Period|Protocol Violation|0
2625523|NCT00891020|9073667|P3|Long-term Extension Period|Insufficient therapeutic response|2
2625524|NCT00891020|9073668|P2|Long-term Extension Period|Insufficient therapeutic response|2
2625525|NCT00891020|9073669|P1|Long-term Extension Period|Insufficient therapeutic response|3
2625526|NCT00891020|9073667|P3|Long-term Extension Period|Death|1
2625527|NCT00891020|9073668|P2|Long-term Extension Period|Death|0
2625528|NCT00891020|9073669|P1|Long-term Extension Period|Death|0
2625529|NCT00891020|9073667|P3|Long-term Extension Period|Adverse Event|10
2625530|NCT00891020|9073668|P2|Long-term Extension Period|Adverse Event|11
2625531|NCT00891020|9073669|P1|Long-term Extension Period|Adverse Event|1
2625532|NCT00891020|9073667|P3|24 Week Treatment Period|Administrative/Other|1
2625533|NCT00891020|9073668|P2|24 Week Treatment Period|Administrative/Other|6
2625534|NCT00891020|9073669|P1|24 Week Treatment Period|Administrative/Other|5
2625535|NCT00891020|9073667|P3|24 Week Treatment Period|Withdrew consent|15
2625536|NCT00891020|9073668|P2|24 Week Treatment Period|Withdrew consent|3
2625537|NCT00891020|9073669|P1|24 Week Treatment Period|Withdrew consent|6
2625538|NCT00891020|9073667|P3|24 Week Treatment Period|Refused treatment/did not cooperate|1
2625539|NCT00891020|9073668|P2|24 Week Treatment Period|Refused treatment/did not cooperate|2
2625540|NCT00891020|9073669|P1|24 Week Treatment Period|Refused treatment/did not cooperate|3
2625541|NCT00891020|9073667|P3|24 Week Treatment Period|Other protocol violation|2
2625542|NCT00891020|9073668|P2|24 Week Treatment Period|Other protocol violation|1
2625543|NCT00891020|9073669|P1|24 Week Treatment Period|Other protocol violation|1
2625544|NCT00891020|9073667|P3|24 Week Treatment Period|Violation of selection criteria at entry|2
2625545|NCT00891020|9073668|P2|24 Week Treatment Period|Violation of selection criteria at entry|0
2625546|NCT00891020|9073669|P1|24 Week Treatment Period|Violation of selection criteria at entry|1
2625547|NCT00891020|9073667|P3|24 Week Treatment Period|Failure to return|5
2625548|NCT00891020|9073668|P2|24 Week Treatment Period|Failure to return|5
2625549|NCT00891020|9073669|P1|24 Week Treatment Period|Failure to return|4
2625550|NCT00891020|9073667|P3|24 Week Treatment Period|Insufficient therapeutic response|15
2625551|NCT00891020|9073668|P2|24 Week Treatment Period|Insufficient therapeutic response|9
2625552|NCT00891020|9073669|P1|24 Week Treatment Period|Insufficient therapeutic response|6
2625553|NCT00891020|9073667|P3|24 Week Treatment Period|Death|0
2625554|NCT00891020|9073668|P2|24 Week Treatment Period|Death|2
2625555|NCT00891020|9073669|P1|24 Week Treatment Period|Death|0
2625556|NCT00891020|9073667|P3|24 Week Treatment Period|Adverse event or intercurrent illness|17
2625557|NCT00891020|9073668|P2|24 Week Treatment Period|Adverse event or intercurrent illness|32
2625558|NCT00891020|9073669|P1|24 Week Treatment Period|Adverse event or intercurrent illness|11
2625559|NCT00890929|9073733|P1|Overall Study|Physician Decision|1
2625560|NCT00890929|9073733|P1|Overall Study|Withdrawal by Subject|3
2625561|NCT00890929|9073733|P1|Overall Study|Death before treatment|2
2625562|NCT00890825|9073751|P2|Overall Study|Alive at data cut off (DCO)|14
2625563|NCT00890825|9073752|P1|Overall Study|Alive at data cut off (DCO)|13
2625564|NCT00890825|9073751|P2|Overall Study|Withdrawal by Subject|0
2625565|NCT00890825|9073752|P1|Overall Study|Withdrawal by Subject|1
2625566|NCT00890695|9073781|P2|Overall Study|Protocol Violation|0
2625567|NCT00890695|9073782|P1|Overall Study|Protocol Violation|1
2625568|NCT00890591|9073811|P1|Overall Study|Lack of Efficacy|20
2625569|NCT00890552|9073817|P1|On-treatment|Early prog disease/ death|10
2625570|NCT00890552|9073817|P1|Enrollment and Pre-treatment|Death/ lost to follow up|1
2625571|NCT00890409|9073826|P2|Overall Study|Lost to Follow-up|21
2625572|NCT00890409|9073827|P1|Overall Study|Lost to Follow-up|20
2625573|NCT00890201|9073837|P2|Overall Study|Protocol Violation|56
2625574|NCT00890201|9073838|P1|Overall Study|Protocol Violation|5
2625575|NCT00890097|9073856|P3|Overall Study|Protocol Deviation|1
2625576|NCT00890097|9073857|P2|Overall Study|Protocol Deviation|1
2625577|NCT00890097|9073858|P1|Overall Study|Protocol Deviation|1
2625578|NCT00890097|9073856|P3|Overall Study|Subject Moved|0
2625579|NCT00890097|9073857|P2|Overall Study|Subject Moved|4
2625580|NCT00890097|9073858|P1|Overall Study|Subject Moved|0
2625581|NCT00890097|9073856|P3|Overall Study|Transportation|0
2625582|NCT00890097|9073857|P2|Overall Study|Transportation|2
2625583|NCT00890097|9073858|P1|Overall Study|Transportation|0
2625584|NCT00890097|9073856|P3|Overall Study|Failed inclusion criteria|0
2625585|NCT00890097|9073857|P2|Overall Study|Failed inclusion criteria|4
2625586|NCT00890097|9073858|P1|Overall Study|Failed inclusion criteria|3
2625587|NCT00890097|9073856|P3|Overall Study|Randomization Error|0
2625588|NCT00890097|9073857|P2|Overall Study|Randomization Error|0
2625589|NCT00890097|9073858|P1|Overall Study|Randomization Error|2
2625590|NCT00890097|9073856|P3|Overall Study|Subject Decision|6
2625591|NCT00890097|9073857|P2|Overall Study|Subject Decision|2
2625592|NCT00890097|9073858|P1|Overall Study|Subject Decision|3
2625593|NCT00890097|9073856|P3|Overall Study|Did not attend final visit|0
2625594|NCT00890097|9073857|P2|Overall Study|Did not attend final visit|3
2625595|NCT00890097|9073858|P1|Overall Study|Did not attend final visit|2
2625596|NCT00890097|9073856|P3|Overall Study|Sponsor Decision|7
2625597|NCT00890097|9073857|P2|Overall Study|Sponsor Decision|11
2625598|NCT00890097|9073858|P1|Overall Study|Sponsor Decision|7
2625599|NCT00890097|9073856|P3|Overall Study|Noncompliance|4
2625600|NCT00890097|9073857|P2|Overall Study|Noncompliance|4
2625601|NCT00890097|9073858|P1|Overall Study|Noncompliance|0
2625602|NCT00890097|9073856|P3|Overall Study|Lost to Follow-up|5
2625603|NCT00890097|9073857|P2|Overall Study|Lost to Follow-up|5
2625604|NCT00890097|9073858|P1|Overall Study|Lost to Follow-up|5
2625605|NCT00890097|9073856|P3|Overall Study|Withdrew Consent|9
2625606|NCT00890097|9073857|P2|Overall Study|Withdrew Consent|6
2625607|NCT00890097|9073858|P1|Overall Study|Withdrew Consent|9
2625608|NCT00890097|9073856|P3|Overall Study|Decision Unrelated to an Adverse Event|17
2625609|NCT00890097|9073857|P2|Overall Study|Decision Unrelated to an Adverse Event|12
2625610|NCT00890097|9073858|P1|Overall Study|Decision Unrelated to an Adverse Event|15
2625611|NCT00890097|9073856|P3|Overall Study|Adverse Event|28
2625612|NCT00890097|9073857|P2|Overall Study|Adverse Event|32
2625613|NCT00890097|9073858|P1|Overall Study|Adverse Event|21
2625614|NCT00890084|9073866|P1|Overall Study|Lost to Follow-up|126
2625615|NCT00890084|9073866|P1|Overall Study|Adverse Event|16
2625616|NCT00889863|9073906|P2|Part II: Randomized Double Blind|Protocol deviation|1
2625617|NCT00889863|9073907|P1|Part II: Randomized Double Blind|Protocol deviation|0
2625618|NCT00889863|9073906|P2|Part II: Randomized Double Blind|Withdrawal by Subject|1
2625619|NCT00889863|9073907|P1|Part II: Randomized Double Blind|Withdrawal by Subject|0
2625620|NCT00889863|9073906|P2|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20
2625621|NCT00889863|9073907|P1|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11
2625622|NCT00889863|9073906|P2|Part II: Randomized Double Blind|Adverse Event|4
2625623|NCT00889863|9073907|P1|Part II: Randomized Double Blind|Adverse Event|0
2625624|NCT00889863|9073906|P2|Part I: Open Label|Unsatisfactory therapeutic effect|0
2625625|NCT00889863|9073907|P1|Part I: Open Label|Unsatisfactory therapeutic effect|72
2625626|NCT00889863|9073906|P2|Part I: Open Label|Adverse Event|0
2625627|NCT00889863|9073907|P1|Part I: Open Label|Adverse Event|4
2625628|NCT00889863|9073906|P2|Part I: Open Label|Death|0
2625629|NCT00889863|9073907|P1|Part I: Open Label|Death|1
2625630|NCT00889720|9073933|P1|Overall Study|Other|4
2625631|NCT00889720|9073933|P1|Overall Study|Withdrawal by Subject|4
2625632|NCT00889707|9073960|P2|Overall Study|Lack of Efficacy|5
2625633|NCT00889707|9073961|P1|Overall Study|Lack of Efficacy|2
2625634|NCT00889707|9073960|P2|Overall Study|Lost to Follow-up|2
2625635|NCT00889707|9073961|P1|Overall Study|Lost to Follow-up|0
2625636|NCT00889707|9073960|P2|Overall Study|Withdrawal by Subject|3
2625637|NCT00889707|9073961|P1|Overall Study|Withdrawal by Subject|4
2625638|NCT00889707|9073960|P2|Overall Study|Adverse Event|0
2625639|NCT00889707|9073961|P1|Overall Study|Adverse Event|1
2625640|NCT00889681|9073969|P1|Overall Study|Insurance disapproval|1
2625641|NCT00889681|9073969|P1|Overall Study|Not meeting qualification Criteria|2
2625642|NCT00889603|9073976|P1|Overall Study|Other|4
2625643|NCT00889603|9073976|P1|Overall Study|No longer willing to participant in stud|4
2625644|NCT00889603|9073976|P1|Overall Study|Lost to Follow-up|19
2625645|NCT00889603|9073976|P1|Overall Study|Death|3
2625646|NCT00889603|9073976|P1|Overall Study|Adverse Event|7
2625647|NCT00889421|9073998|P1|Overall Study|Lack of Efficacy|3
2625648|NCT00889265|9074039|P1|Overall Study|Protocol Violation|1
2625649|NCT00889265|9074039|P1|Overall Study|Lost to Follow-up|5
2625650|NCT00889265|9074039|P1|Overall Study|Adverse Event|1
2625651|NCT00889252|9074046|P2|Overall Study|Protocol Violation|0
2625652|NCT00889252|9074047|P1|Overall Study|Protocol Violation|2
2625653|NCT00889252|9074046|P2|Overall Study|Withdrawal by Subject|0
2625654|NCT00889252|9074047|P1|Overall Study|Withdrawal by Subject|3
2625655|NCT00889252|9074046|P2|Overall Study|Adverse Event|4
2625656|NCT00889252|9074047|P1|Overall Study|Adverse Event|2
2625657|NCT00889005|9074124|P2|Overall Study|Withdrawal by Subject|0
2625658|NCT00889005|9074125|P1|Overall Study|Withdrawal by Subject|4
2625659|NCT00889005|9074124|P2|Overall Study|Lost to Follow-up|2
2625660|NCT00889005|9074125|P1|Overall Study|Lost to Follow-up|4
2625661|NCT00888940|9074139|P2|Overall Study|Randomized Not Treated|13
2625662|NCT00888940|9074140|P1|Overall Study|Randomized Not Treated|11
2625663|NCT00888940|9074139|P2|Overall Study|Lost to Follow-up|5
2625664|NCT00888940|9074140|P1|Overall Study|Lost to Follow-up|5
2625665|NCT00888940|9074139|P2|Overall Study|Adverse Event|3
2625666|NCT00888940|9074140|P1|Overall Study|Adverse Event|12
2625667|NCT00888849|9074150|P2|Overall Study|Lost to Follow-up|2
2625668|NCT00888849|9074151|P1|Overall Study|Lost to Follow-up|1
2625669|NCT00888849|9074150|P2|Overall Study|Death|7
2625670|NCT00888849|9074151|P1|Overall Study|Death|4
2625671|NCT00888654|9074161|P1|Overall Study|Stopped meds due to headaches|1
2625672|NCT00888654|9074161|P1|Overall Study|Change in surg date|1
2625673|NCT00888654|9074161|P1|Overall Study|Inelig. due to contraindication of med|1
2625674|NCT00888654|9074161|P1|Overall Study|Withdrawal by Subject|1
2625675|NCT00888654|9074161|P1|Overall Study|Surgery aborted|2
2625676|NCT00888654|9074161|P1|Overall Study|Not enough oral meds before surgery|3
2625677|NCT00888654|9074161|P1|Overall Study|Problems swallowing oral meds.|1
2625678|NCT00888615|9074179|P1|Overall Study|No treatment|2
2625679|NCT00888433|9074199|P2|Overall Study|Missed Visit|1
2625680|NCT00888433|9074200|P1|Overall Study|Missed Visit|2
2625681|NCT00888433|9074199|P2|Overall Study|Withdrawal by Subject|2
2625682|NCT00888433|9074200|P1|Overall Study|Withdrawal by Subject|1
2625683|NCT00888381|9074208|P2|Overall Study|Lost to Follow-up|1
2625684|NCT00888381|9074209|P1|Overall Study|Lost to Follow-up|0
2625685|NCT00888355|9074229|P4|Overall Study|Withdrawal by Subject|3
2625686|NCT00888355|9074230|P3|Overall Study|Withdrawal by Subject|1
2625687|NCT00888355|9074231|P2|Overall Study|Withdrawal by Subject|3
2625688|NCT00888355|9074232|P1|Overall Study|Withdrawal by Subject|0
2625689|NCT00888355|9074229|P4|Overall Study|Protocol Violation|2
2625690|NCT00888355|9074230|P3|Overall Study|Protocol Violation|1
2625691|NCT00888355|9074231|P2|Overall Study|Protocol Violation|2
2625692|NCT00888355|9074232|P1|Overall Study|Protocol Violation|3
2625693|NCT00888355|9074229|P4|Overall Study|Lost to Follow-up|0
2625694|NCT00888355|9074230|P3|Overall Study|Lost to Follow-up|2
2625695|NCT00888355|9074231|P2|Overall Study|Lost to Follow-up|2
2625696|NCT00888355|9074232|P1|Overall Study|Lost to Follow-up|0
2625697|NCT00888355|9074229|P4|Overall Study|Lack of Efficacy|2
2625698|NCT00888355|9074230|P3|Overall Study|Lack of Efficacy|5
2625699|NCT00888355|9074231|P2|Overall Study|Lack of Efficacy|2
2625700|NCT00888355|9074232|P1|Overall Study|Lack of Efficacy|9
2625701|NCT00888355|9074229|P4|Overall Study|Adverse Event|3
2625702|NCT00888355|9074230|P3|Overall Study|Adverse Event|3
2625703|NCT00888355|9074231|P2|Overall Study|Adverse Event|0
2625704|NCT00888355|9074232|P1|Overall Study|Adverse Event|10
2625705|NCT00888329|9074288|P2|Overall Study|Physician Decision|9
2625706|NCT00888329|9074289|P1|Overall Study|Physician Decision|6
2625707|NCT00888238|9074295|P3|Washout Period After Period 2|Adverse Event|1
2625708|NCT00888238|9074296|P2|Washout Period After Period 2|Adverse Event|0
2625709|NCT00888238|9074297|P1|Washout Period After Period 2|Adverse Event|0
2625710|NCT00888173|9074305|P1|Overall Study|Ineligible: required test not done|1
2625712|NCT00888134|9074313|P1|Follow-up|being followed for long-term survival|1
2625713|NCT00888134|9074313|P1|Treatment With Study Drug|Withdrawal by Subject|1
2625714|NCT00887978|9074323|P2|Overall Study|Lost to Follow-up|1
2625715|NCT00887978|9074324|P1|Overall Study|Lost to Follow-up|0
2625716|NCT00887978|9074323|P2|Overall Study|Withdrawal by Subject|2
2625717|NCT00887978|9074324|P1|Overall Study|Withdrawal by Subject|1
2625718|NCT00887978|9074323|P2|Overall Study|Death|3
2625719|NCT00887978|9074324|P1|Overall Study|Death|2
2625720|NCT00887978|9074323|P2|Overall Study|Clinical Worsening|4
2625721|NCT00887978|9074324|P1|Overall Study|Clinical Worsening|4
2625722|NCT00887978|9074323|P2|Overall Study|Adverse Event|5
2625723|NCT00887978|9074324|P1|Overall Study|Adverse Event|18
2625724|NCT00887926|9074394|P4|Overall Study|Withdrawal by Subject|0
2625725|NCT00887926|9074395|P3|Overall Study|Withdrawal by Subject|0
2625726|NCT00887926|9074396|P2|Overall Study|Withdrawal by Subject|1
2625727|NCT00887926|9074397|P1|Overall Study|Withdrawal by Subject|0
2625728|NCT00887913|9074432|P1|Overall Study|Withdrawal by Subject|6
2625729|NCT00887822|9074440|P2|Overall Study|Randomized but not treated|1
2625730|NCT00887822|9074441|P1|Overall Study|Randomized but not treated|0
2625731|NCT00887822|9074440|P2|Overall Study|Protocol Violation|1
2625732|NCT00887822|9074441|P1|Overall Study|Protocol Violation|0
2625733|NCT00887822|9074440|P2|Overall Study|Death|3
2625734|NCT00887822|9074441|P1|Overall Study|Death|2
2625735|NCT00887822|9074440|P2|Overall Study|Administrative/Other than specified|4
2625736|NCT00887822|9074441|P1|Overall Study|Administrative/Other than specified|5
2625737|NCT00887822|9074440|P2|Overall Study|Refused treatment/Did not cooperate|10
2625738|NCT00887822|9074441|P1|Overall Study|Refused treatment/Did not cooperate|12
2625739|NCT00887822|9074440|P2|Overall Study|Failure to return|11
2625740|NCT00887822|9074441|P1|Overall Study|Failure to return|11
2625741|NCT00887822|9074440|P2|Overall Study|Adverse Event|17
2625742|NCT00887822|9074441|P1|Overall Study|Adverse Event|14
2625743|NCT00887822|9074440|P2|Overall Study|Insufficient therapeutic response|55
2625744|NCT00887822|9074441|P1|Overall Study|Insufficient therapeutic response|53
2625745|NCT00887809|9074473|P2|Overall Study|Death|0
2625746|NCT00887809|9074474|P1|Overall Study|Death|1
2625747|NCT00887809|9074473|P2|Overall Study|Patient Not Treated|0
2625748|NCT00887809|9074474|P1|Overall Study|Patient Not Treated|3
2625749|NCT00887744|9074480|P1|Overall Study|Various reasons|9
2625750|NCT00887744|9074480|P1|Overall Study|Withdrawal by Subject|18
2625751|NCT00887744|9074480|P1|Overall Study|Lost to Follow-up|3
2625752|NCT00887744|9074480|P1|Overall Study|Death|1
2625753|NCT00887744|9074480|P1|Overall Study|Adverse Event|3
2625754|NCT00887679|9074489|P1|Overall Study|Physician Decision|5
2625755|NCT00887679|9074489|P1|Overall Study|Lost to Follow-up|4
2625756|NCT00887679|9074489|P1|Overall Study|Withdrawal by Subject|1
2625757|NCT00887588|9074519|P2|Extension Period|Lost to Follow-up|0
2625758|NCT00887588|9074520|P1|Extension Period|Lost to Follow-up|1
2625759|NCT00887588|9074519|P2|Extension Period|Protocol deviation|0
2625760|NCT00887588|9074520|P1|Extension Period|Protocol deviation|1
2625761|NCT00887588|9074519|P2|Extension Period|Death|1
2625762|NCT00887588|9074520|P1|Extension Period|Death|0
2625763|NCT00887588|9074519|P2|Extension Period|Adverse Event|4
2625764|NCT00887588|9074520|P1|Extension Period|Adverse Event|4
2625765|NCT00887588|9074519|P2|Core Period|Adverse Event|11
2625766|NCT00887588|9074520|P1|Core Period|Adverse Event|9
2625767|NCT00887588|9074519|P2|Core Period|Withdrawal by Subject|8
2625768|NCT00887588|9074520|P1|Core Period|Withdrawal by Subject|6
2625769|NCT00887588|9074519|P2|Core Period|Lost to Follow-up|1
2625770|NCT00887588|9074520|P1|Core Period|Lost to Follow-up|3
2625771|NCT00887588|9074519|P2|Core Period|Death|1
2625772|NCT00887588|9074520|P1|Core Period|Death|1
2625773|NCT00887549|9074601|P1|Maintenance Therapy|Death due to adverse event|1
2625774|NCT00887549|9074601|P1|Maintenance Therapy|Progressive Disease|25
2625775|NCT00887549|9074601|P1|Maintenance Therapy|Physician Decision|1
2625776|NCT00887549|9074601|P1|Maintenance Therapy|Adverse Event|16
2625777|NCT00887549|9074601|P1|Induction Therapy|Death due to Study Drug Toxicity|1
2625778|NCT00887549|9074601|P1|Induction Therapy|Death due to Study Disease|4
2625779|NCT00887549|9074601|P1|Induction Therapy|Progressive Disease|13
2625780|NCT00887549|9074601|P1|Induction Therapy|Physician Decision|1
2625781|NCT00887549|9074601|P1|Induction Therapy|Adverse Event|8
2625782|NCT00887484|9074619|P1|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1
2625783|NCT00887484|9074619|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
2625784|NCT00887484|9074619|P1|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1
2625785|NCT00887354|9074707|P2|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
2625786|NCT00887354|9074708|P1|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
2625787|NCT00887354|9074707|P2|Open Label Phase (Week 26 to Week 78)|Adverse Event|0
2625788|NCT00887354|9074708|P1|Open Label Phase (Week 26 to Week 78)|Adverse Event|1
2625789|NCT00887354|9074707|P2|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2
2625790|NCT00887354|9074708|P1|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1
2625791|NCT00887354|9074707|P2|Open Label Phase (Week 26 to Week 78)|Physician Decision|1
2625792|NCT00887354|9074708|P1|Open Label Phase (Week 26 to Week 78)|Physician Decision|0
2625793|NCT00887354|9074707|P2|Open Label Phase (Week 26 to Week 78)|Death|2
2625794|NCT00887354|9074708|P1|Open Label Phase (Week 26 to Week 78)|Death|0
2625795|NCT00887354|9074707|P2|Treatment Phase (Week 0 to Week 26)|Not Treated|3
2625796|NCT00887354|9074708|P1|Treatment Phase (Week 0 to Week 26)|Not Treated|5
2625797|NCT00887354|9074707|P2|Treatment Phase (Week 0 to Week 26)|No efficacy data|25
2625798|NCT00887354|9074708|P1|Treatment Phase (Week 0 to Week 26)|No efficacy data|20
2625799|NCT00887354|9074707|P2|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2
2625800|NCT00887354|9074708|P1|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1
2625801|NCT00887354|9074707|P2|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
2625802|NCT00887354|9074708|P1|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
2625803|NCT00887354|9074707|P2|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1
2625804|NCT00887354|9074708|P1|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2
2625805|NCT00887354|9074707|P2|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
2625806|NCT00887354|9074708|P1|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
2625807|NCT00887354|9074707|P2|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8
2625808|NCT00887354|9074708|P1|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14
2625809|NCT00887354|9074707|P2|Treatment Phase (Week 0 to Week 26)|Physician Decision|1
2625810|NCT00887354|9074708|P1|Treatment Phase (Week 0 to Week 26)|Physician Decision|2
2625811|NCT00887354|9074707|P2|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
2625812|NCT00887354|9074708|P1|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
2625813|NCT00887354|9074707|P2|Treatment Phase (Week 0 to Week 26)|Death|1
2625814|NCT00887354|9074708|P1|Treatment Phase (Week 0 to Week 26)|Death|0
2625815|NCT00887341|9074728|P2|Overall Study|Lost to Follow-up|1
2625816|NCT00887341|9074729|P1|Overall Study|Lost to Follow-up|0
2625817|NCT00887341|9074728|P2|Overall Study|Adverse Event|1
2625818|NCT00887341|9074729|P1|Overall Study|Adverse Event|0
2625819|NCT00887341|9074728|P2|Overall Study|Withdrawal by Subject|1
2625820|NCT00887341|9074729|P1|Overall Study|Withdrawal by Subject|1
2625821|NCT00887341|9074728|P2|Overall Study|Refused treatment|0
2625822|NCT00887341|9074729|P1|Overall Study|Refused treatment|1
2625823|NCT00887315|9074765|P2|Overall Study|Study termination|4
2625824|NCT00887315|9074766|P1|Overall Study|Study termination|7
2625825|NCT00887289|9074774|P1|Overall Study|Other|20
2625826|NCT00887289|9074774|P1|Overall Study|Lost to Follow-up|8
2625827|NCT00887289|9074774|P1|Overall Study|Withdrawal by Subject|26
2625828|NCT00887289|9074774|P1|Overall Study|Adverse Event|27
2625829|NCT00887289|9074774|P1|Overall Study|Lack of Efficacy|14
2625830|NCT00887250|9074786|P3|Overall Study|Patient uncooperative|1
2625831|NCT00887250|9074787|P2|Overall Study|Patient uncooperative|0
2625832|NCT00887250|9074788|P1|Overall Study|Patient uncooperative|0
2625833|NCT00887250|9074786|P3|Overall Study|Withdrawal by Subject|2
2625834|NCT00887250|9074787|P2|Overall Study|Withdrawal by Subject|1
2625835|NCT00887250|9074788|P1|Overall Study|Withdrawal by Subject|2
2625836|NCT00887250|9074786|P3|Overall Study|Protocol Violation|1
2625837|NCT00887250|9074787|P2|Overall Study|Protocol Violation|2
2625838|NCT00887250|9074788|P1|Overall Study|Protocol Violation|2
2625839|NCT00887250|9074786|P3|Overall Study|Lost to Follow-up|1
2625840|NCT00887250|9074787|P2|Overall Study|Lost to Follow-up|3
2625841|NCT00887250|9074788|P1|Overall Study|Lost to Follow-up|2
2625842|NCT00887250|9074786|P3|Overall Study|Lack of Efficacy|1
2625843|NCT00887250|9074787|P2|Overall Study|Lack of Efficacy|6
2625844|NCT00887250|9074788|P1|Overall Study|Lack of Efficacy|9
2625845|NCT00887250|9074786|P3|Overall Study|Adverse Event|7
2625846|NCT00887250|9074787|P2|Overall Study|Adverse Event|0
2625847|NCT00887250|9074788|P1|Overall Study|Adverse Event|3
2625848|NCT00887224|9074811|P3|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11
2625849|NCT00887224|9074812|P2|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8
2625850|NCT00887224|9074813|P1|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0
2625851|NCT00887224|9074811|P3|DB Taper Phase / Post Study Follow Up|Protocol Violation|1
2625852|NCT00887224|9074812|P2|DB Taper Phase / Post Study Follow Up|Protocol Violation|4
2625853|NCT00887224|9074813|P1|DB Taper Phase / Post Study Follow Up|Protocol Violation|0
2625854|NCT00887224|9074811|P3|DB Taper Phase / Post Study Follow Up|Other|12
2625855|NCT00887224|9074812|P2|DB Taper Phase / Post Study Follow Up|Other|11
2625856|NCT00887224|9074813|P1|DB Taper Phase / Post Study Follow Up|Other|0
2625857|NCT00887224|9074811|P3|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
2625858|NCT00887224|9074812|P2|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
2625859|NCT00887224|9074813|P1|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0
2625860|NCT00887224|9074811|P3|DB Taper Phase / Post Study Follow Up|Physician Decision|0
2625861|NCT00887224|9074812|P2|DB Taper Phase / Post Study Follow Up|Physician Decision|6
2625862|NCT00887224|9074813|P1|DB Taper Phase / Post Study Follow Up|Physician Decision|0
2625863|NCT00887224|9074811|P3|DB Taper Phase / Post Study Follow Up|Failed to return|4
2625864|NCT00887224|9074812|P2|DB Taper Phase / Post Study Follow Up|Failed to return|5
2625865|NCT00887224|9074813|P1|DB Taper Phase / Post Study Follow Up|Failed to return|0
2625866|NCT00887224|9074811|P3|DB Taper Phase / Post Study Follow Up|Adverse Event|0
2625867|NCT00887224|9074812|P2|DB Taper Phase / Post Study Follow Up|Adverse Event|5
2625868|NCT00887224|9074813|P1|DB Taper Phase / Post Study Follow Up|Adverse Event|0
2625869|NCT00887224|9074811|P3|Double-blind (DB) Phase|Withdrawal by Subject|12
2625870|NCT00887224|9074812|P2|Double-blind (DB) Phase|Withdrawal by Subject|6
2625871|NCT00887224|9074813|P1|Double-blind (DB) Phase|Withdrawal by Subject|0
2625872|NCT00887224|9074811|P3|Double-blind (DB) Phase|Protocol Violation|5
2625873|NCT00887224|9074812|P2|Double-blind (DB) Phase|Protocol Violation|8
2625874|NCT00887224|9074813|P1|Double-blind (DB) Phase|Protocol Violation|0
2625875|NCT00887224|9074811|P3|Double-blind (DB) Phase|Other|0
2625876|NCT00887224|9074812|P2|Double-blind (DB) Phase|Other|2
2625877|NCT00887224|9074813|P1|Double-blind (DB) Phase|Other|0
2625878|NCT00887224|9074811|P3|Double-blind (DB) Phase|Lost to Follow-up|8
2625879|NCT00887224|9074812|P2|Double-blind (DB) Phase|Lost to Follow-up|8
2625880|NCT00887224|9074813|P1|Double-blind (DB) Phase|Lost to Follow-up|0
2625881|NCT00887224|9074811|P3|Double-blind (DB) Phase|Lack of Efficacy|33
2625882|NCT00887224|9074812|P2|Double-blind (DB) Phase|Lack of Efficacy|67
2625883|NCT00887224|9074813|P1|Double-blind (DB) Phase|Lack of Efficacy|0
2625884|NCT00887224|9074811|P3|Double-blind (DB) Phase|Failed to return|2
2625885|NCT00887224|9074812|P2|Double-blind (DB) Phase|Failed to return|2
2625886|NCT00887224|9074813|P1|Double-blind (DB) Phase|Failed to return|0
2625887|NCT00887224|9074811|P3|Double-blind (DB) Phase|Adverse Event|2
2625888|NCT00887224|9074812|P2|Double-blind (DB) Phase|Adverse Event|7
2625889|NCT00887224|9074813|P1|Double-blind (DB) Phase|Adverse Event|0
2625890|NCT00887224|9074811|P3|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
2625891|NCT00887224|9074812|P2|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
2625892|NCT00887224|9074813|P1|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48
2625893|NCT00887224|9074811|P3|OL Taper Phase / OL Follow Up|Protocol Violation|0
2625894|NCT00887224|9074812|P2|OL Taper Phase / OL Follow Up|Protocol Violation|0
2625895|NCT00887224|9074813|P1|OL Taper Phase / OL Follow Up|Protocol Violation|3
2625896|NCT00887224|9074811|P3|OL Taper Phase / OL Follow Up|Other|0
2625897|NCT00887224|9074812|P2|OL Taper Phase / OL Follow Up|Other|0
2625898|NCT00887224|9074813|P1|OL Taper Phase / OL Follow Up|Other|30
2625899|NCT00887224|9074811|P3|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
2625900|NCT00887224|9074812|P2|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
2625901|NCT00887224|9074813|P1|OL Taper Phase / OL Follow Up|Lost to Follow-up|8
2625902|NCT00887224|9074811|P3|OL Taper Phase / OL Follow Up|Physician Decision|0
2625903|NCT00887224|9074812|P2|OL Taper Phase / OL Follow Up|Physician Decision|0
2625904|NCT00887224|9074813|P1|OL Taper Phase / OL Follow Up|Physician Decision|10
2625905|NCT00887224|9074811|P3|OL Taper Phase / OL Follow Up|Failed to return|0
2625906|NCT00887224|9074812|P2|OL Taper Phase / OL Follow Up|Failed to return|0
2625907|NCT00887224|9074813|P1|OL Taper Phase / OL Follow Up|Failed to return|17
2625908|NCT00887224|9074811|P3|OL Taper Phase / OL Follow Up|Adverse Event|0
2625909|NCT00887224|9074812|P2|OL Taper Phase / OL Follow Up|Adverse Event|0
2625910|NCT00887224|9074813|P1|OL Taper Phase / OL Follow Up|Adverse Event|28
2625911|NCT00887224|9074811|P3|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
2625912|NCT00887224|9074812|P2|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
2625913|NCT00887224|9074813|P1|Open-label Stability (OLS) Phase|Withdrawal by Subject|19
2625914|NCT00887224|9074811|P3|Open-label Stability (OLS) Phase|Protocol Violation|0
2625915|NCT00887224|9074812|P2|Open-label Stability (OLS) Phase|Protocol Violation|0
2625916|NCT00887224|9074813|P1|Open-label Stability (OLS) Phase|Protocol Violation|13
2625917|NCT00887224|9074811|P3|Open-label Stability (OLS) Phase|Other|0
2625918|NCT00887224|9074812|P2|Open-label Stability (OLS) Phase|Other|0
2625919|NCT00887224|9074813|P1|Open-label Stability (OLS) Phase|Other|1
2625920|NCT00887224|9074811|P3|Open-label Stability (OLS) Phase|Lost to Follow-up|0
2625921|NCT00887224|9074812|P2|Open-label Stability (OLS) Phase|Lost to Follow-up|0
2625922|NCT00887224|9074813|P1|Open-label Stability (OLS) Phase|Lost to Follow-up|9
2625923|NCT00887224|9074811|P3|Open-label Stability (OLS) Phase|Lack of Efficacy|0
2625924|NCT00887224|9074812|P2|Open-label Stability (OLS) Phase|Lack of Efficacy|0
2625925|NCT00887224|9074813|P1|Open-label Stability (OLS) Phase|Lack of Efficacy|16
2625926|NCT00887224|9074811|P3|Open-label Stability (OLS) Phase|Failed to return|0
2625927|NCT00887224|9074812|P2|Open-label Stability (OLS) Phase|Failed to return|0
2625928|NCT00887224|9074813|P1|Open-label Stability (OLS) Phase|Failed to return|3
2625929|NCT00887224|9074811|P3|Open-label Stability (OLS) Phase|Adverse Event|0
2625930|NCT00887224|9074812|P2|Open-label Stability (OLS) Phase|Adverse Event|0
2625931|NCT00887224|9074813|P1|Open-label Stability (OLS) Phase|Adverse Event|22
2625932|NCT00887224|9074811|P3|Open-label Response (OLR) Phase|Withdrawal by Subject|0
2625933|NCT00887224|9074812|P2|Open-label Response (OLR) Phase|Withdrawal by Subject|0
2625934|NCT00887224|9074813|P1|Open-label Response (OLR) Phase|Withdrawal by Subject|15
2625935|NCT00887224|9074811|P3|Open-label Response (OLR) Phase|Protocol Violation|0
2625936|NCT00887224|9074812|P2|Open-label Response (OLR) Phase|Protocol Violation|0
2625937|NCT00887224|9074813|P1|Open-label Response (OLR) Phase|Protocol Violation|12
2625938|NCT00887224|9074811|P3|Open-label Response (OLR) Phase|Other|0
2625939|NCT00887224|9074812|P2|Open-label Response (OLR) Phase|Other|0
2625940|NCT00887224|9074813|P1|Open-label Response (OLR) Phase|Other|1
2625941|NCT00887224|9074811|P3|Open-label Response (OLR) Phase|Lost to Follow-up|0
2625942|NCT00887224|9074812|P2|Open-label Response (OLR) Phase|Lost to Follow-up|0
2625943|NCT00887224|9074813|P1|Open-label Response (OLR) Phase|Lost to Follow-up|16
2625944|NCT00887224|9074811|P3|Open-label Response (OLR) Phase|Lack of Efficacy|0
2625945|NCT00887224|9074812|P2|Open-label Response (OLR) Phase|Lack of Efficacy|0
2625946|NCT00887224|9074813|P1|Open-label Response (OLR) Phase|Lack of Efficacy|26
2625947|NCT00887224|9074811|P3|Open-label Response (OLR) Phase|Failed to return|0
2625948|NCT00887224|9074812|P2|Open-label Response (OLR) Phase|Failed to return|0
2625949|NCT00887224|9074813|P1|Open-label Response (OLR) Phase|Failed to return|6
2625950|NCT00887224|9074811|P3|Open-label Response (OLR) Phase|Adverse Event|0
2625951|NCT00887224|9074812|P2|Open-label Response (OLR) Phase|Adverse Event|0
2625952|NCT00887224|9074813|P1|Open-label Response (OLR) Phase|Adverse Event|46
2625953|NCT00887198|9074840|P3|Cross Over (Placebo to AA)|Other|19
2625954|NCT00887198|9074841|P2|Cross Over (Placebo to AA)|Other|0
2625955|NCT00887198|9074842|P1|Cross Over (Placebo to AA)|Other|0
2625956|NCT00887198|9074840|P3|Cross Over (Placebo to AA)|Progressive disease|20
2625957|NCT00887198|9074841|P2|Cross Over (Placebo to AA)|Progressive disease|0
2625958|NCT00887198|9074842|P1|Cross Over (Placebo to AA)|Progressive disease|0
2625959|NCT00887198|9074840|P3|Cross Over (Placebo to AA)|Withdrawal by Subject|2
2625960|NCT00887198|9074841|P2|Cross Over (Placebo to AA)|Withdrawal by Subject|0
2625961|NCT00887198|9074842|P1|Cross Over (Placebo to AA)|Withdrawal by Subject|0
2625962|NCT00887198|9074840|P3|Cross Over (Placebo to AA)|Adverse Event|9
2625963|NCT00887198|9074841|P2|Cross Over (Placebo to AA)|Adverse Event|0
2625964|NCT00887198|9074842|P1|Cross Over (Placebo to AA)|Adverse Event|0
2625965|NCT00887198|9074840|P3|Cross Over (Placebo to AA)|Ongoing|35
2625966|NCT00887198|9074841|P2|Cross Over (Placebo to AA)|Ongoing|0
2625967|NCT00887198|9074842|P1|Cross Over (Placebo to AA)|Ongoing|0
2625968|NCT00887198|9074840|P3|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8
2625969|NCT00887198|9074841|P2|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
2625970|NCT00887198|9074842|P1|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
2625971|NCT00887198|9074840|P3|Randomized Period|Randomized, Not treated|0
2625972|NCT00887198|9074841|P2|Randomized Period|Randomized, Not treated|2
2625973|NCT00887198|9074842|P1|Randomized Period|Randomized, Not treated|4
2625974|NCT00887198|9074840|P3|Randomized Period|Other|0
2625975|NCT00887198|9074841|P2|Randomized Period|Other|30
2625976|NCT00887198|9074842|P1|Randomized Period|Other|42
2625977|NCT00887198|9074840|P3|Randomized Period|Progressive disease|0
2625978|NCT00887198|9074841|P2|Randomized Period|Progressive disease|370
2625979|NCT00887198|9074842|P1|Randomized Period|Progressive disease|366
2625980|NCT00887198|9074840|P3|Randomized Period|Withdrawal by Subject|0
2625981|NCT00887198|9074841|P2|Randomized Period|Withdrawal by Subject|56
2625982|NCT00887198|9074842|P1|Randomized Period|Withdrawal by Subject|41
2625983|NCT00887198|9074840|P3|Randomized Period|Cross-over to AA (under amendment 3)|0
2625984|NCT00887198|9074841|P2|Randomized Period|Cross-over to AA (under amendment 3)|51
2625985|NCT00887198|9074842|P1|Randomized Period|Cross-over to AA (under amendment 3)|0
2625986|NCT00887198|9074840|P3|Randomized Period|Lost to Follow-up|0
2625987|NCT00887198|9074841|P2|Randomized Period|Lost to Follow-up|0
2625988|NCT00887198|9074842|P1|Randomized Period|Lost to Follow-up|1
2625989|NCT00887198|9074840|P3|Randomized Period|Adverse Event|0
2625990|NCT00887198|9074841|P2|Randomized Period|Adverse Event|33
2625991|NCT00887198|9074842|P1|Randomized Period|Adverse Event|50
2625992|NCT00887198|9074840|P3|Randomized Period|Ongoing|0
2625993|NCT00887198|9074841|P2|Randomized Period|Ongoing|0
2625994|NCT00887198|9074842|P1|Randomized Period|Ongoing|42
2625995|NCT00887159|9074873|P3|Overall Study|Never started assigned therapy|4
2625996|NCT00887159|9074874|P2|Overall Study|Never started assigned therapy|3
2625997|NCT00887159|9074875|P1|Overall Study|Never started assigned therapy|3
2625998|NCT00887159|9074873|P3|Overall Study|Ineligible|0
2625999|NCT00887159|9074874|P2|Overall Study|Ineligible|1
2626000|NCT00887159|9074875|P1|Overall Study|Ineligible|5
2626001|NCT00887159|9074873|P3|Overall Study|Received more tx instead of observation|0
2626002|NCT00887159|9074874|P2|Overall Study|Received more tx instead of observation|0
2626003|NCT00887159|9074875|P1|Overall Study|Received more tx instead of observation|1
2626004|NCT00887159|9074873|P3|Overall Study|Pt had PD but was SD when re-measured|0
2626005|NCT00887159|9074874|P2|Overall Study|Pt had PD but was SD when re-measured|1
2626006|NCT00887159|9074875|P1|Overall Study|Pt had PD but was SD when re-measured|0
2626007|NCT00887159|9074873|P3|Overall Study|Treatment delayed|0
2626008|NCT00887159|9074874|P2|Overall Study|Treatment delayed|1
2626009|NCT00887159|9074875|P1|Overall Study|Treatment delayed|1
2626010|NCT00887159|9074873|P3|Overall Study|Sympomatic deterioration|0
2626011|NCT00887159|9074874|P2|Overall Study|Sympomatic deterioration|0
2626012|NCT00887159|9074875|P1|Overall Study|Sympomatic deterioration|1
2626013|NCT00887159|9074873|P3|Overall Study|Physician Decision|0
2626014|NCT00887159|9074874|P2|Overall Study|Physician Decision|1
2626015|NCT00887159|9074875|P1|Overall Study|Physician Decision|1
2626016|NCT00887159|9074873|P3|Overall Study|Alternative therapy|0
2626017|NCT00887159|9074874|P2|Overall Study|Alternative therapy|0
2626018|NCT00887159|9074875|P1|Overall Study|Alternative therapy|2
2626019|NCT00887159|9074873|P3|Overall Study|Withdrawal by Subject|2
2626020|NCT00887159|9074874|P2|Overall Study|Withdrawal by Subject|4
2626021|NCT00887159|9074875|P1|Overall Study|Withdrawal by Subject|4
2626022|NCT00887159|9074873|P3|Overall Study|Death|0
2626023|NCT00887159|9074874|P2|Overall Study|Death|2
2626024|NCT00887159|9074875|P1|Overall Study|Death|2
2626025|NCT00887159|9074873|P3|Overall Study|Adverse Event|17
2626026|NCT00887159|9074874|P2|Overall Study|Adverse Event|4
2626027|NCT00887159|9074875|P1|Overall Study|Adverse Event|3
2626028|NCT00887159|9074873|P3|Overall Study|Disease progression|33
2626029|NCT00887159|9074874|P2|Overall Study|Disease progression|39
2626030|NCT00887159|9074875|P1|Overall Study|Disease progression|6
2626031|NCT00887068|9074893|P2|Overall Study|Didn't meet eligibility to start cycle 1|0
2626032|NCT00887068|9074894|P1|Overall Study|Didn't meet eligibility to start cycle 1|4
2626033|NCT00887068|9074893|P2|Overall Study|Withdrawal by Subject|0
2626034|NCT00887068|9074894|P1|Overall Study|Withdrawal by Subject|2
2626035|NCT00886938|9074902|P1|Overall Study|Withdrawal by Subject|1
2626036|NCT00886938|9074902|P1|Overall Study|Adverse Event|1
2626037|NCT00886834|9074915|P2|Overall Study|Protocol Violation|3
2626038|NCT00886834|9074916|P1|Overall Study|Protocol Violation|0
2626039|NCT00886821|9074938|P14|Stage 2|Lost to Follow-up|1
2626040|NCT00886821|9074939|P13|Stage 2|Lost to Follow-up|2
2626041|NCT00886821|9074940|P12|Stage 2|Lost to Follow-up|0
2626042|NCT00886821|9074941|P11|Stage 2|Lost to Follow-up|0
2626043|NCT00886821|9074942|P10|Stage 2|Lost to Follow-up|0
2626044|NCT00886821|9074943|P9|Stage 2|Lost to Follow-up|0
2626045|NCT00886821|9074944|P8|Stage 2|Lost to Follow-up|0
2626046|NCT00886821|9074945|P7|Stage 2|Lost to Follow-up|0
2626047|NCT00886821|9074946|P6|Stage 2|Lost to Follow-up|0
2626048|NCT00886821|9074947|P5|Stage 2|Lost to Follow-up|0
2626049|NCT00886821|9074948|P4|Stage 2|Lost to Follow-up|0
2626050|NCT00886821|9074949|P3|Stage 2|Lost to Follow-up|0
2626051|NCT00886821|9074950|P2|Stage 2|Lost to Follow-up|0
2626052|NCT00886821|9074951|P1|Stage 2|Lost to Follow-up|0
2626053|NCT00886821|9074938|P14|Stage 2|Adverse Event|0
2626054|NCT00886821|9074939|P13|Stage 2|Adverse Event|3
2626055|NCT00886821|9074940|P12|Stage 2|Adverse Event|1
2626056|NCT00886821|9074941|P11|Stage 2|Adverse Event|0
2626057|NCT00886821|9074942|P10|Stage 2|Adverse Event|0
2626058|NCT00886821|9074943|P9|Stage 2|Adverse Event|0
2626059|NCT00886821|9074944|P8|Stage 2|Adverse Event|0
2626060|NCT00886821|9074945|P7|Stage 2|Adverse Event|0
2626061|NCT00886821|9074946|P6|Stage 2|Adverse Event|0
2626062|NCT00886821|9074947|P5|Stage 2|Adverse Event|0
2626063|NCT00886821|9074948|P4|Stage 2|Adverse Event|0
2626064|NCT00886821|9074949|P3|Stage 2|Adverse Event|0
2626065|NCT00886821|9074950|P2|Stage 2|Adverse Event|0
2626066|NCT00886821|9074951|P1|Stage 2|Adverse Event|0
2626067|NCT00886795|9075176|P1|Overall Study|Lack of Efficacy|1
2626068|NCT00886769|9075183|P2|Overall Study|Unsatisfactory therapeutic effect|37
2626069|NCT00886769|9075184|P1|Overall Study|Unsatisfactory therapeutic effect|6
2626070|NCT00886743|9075208|P1|Overall Study|Other|1
2626071|NCT00886743|9075208|P1|Overall Study|Adverse Event|3
2626072|NCT00886639|9075246|P1|Overall Study|non-compliance|2
2626073|NCT00886639|9075246|P1|Overall Study|acute exacerbation|14
2626074|NCT00886613|9075260|P3|Overall Study|Subject withdrew consent (Part A)|2
2626075|NCT00886613|9075261|P2|Overall Study|Subject withdrew consent (Part A)|0
2626076|NCT00886613|9075262|P1|Overall Study|Subject withdrew consent (Part A)|0
2626077|NCT00886613|9075260|P3|Overall Study|Lost to follow-up (Part B)|1
2626078|NCT00886613|9075261|P2|Overall Study|Lost to follow-up (Part B)|0
2626079|NCT00886613|9075262|P1|Overall Study|Lost to follow-up (Part B)|1
2626080|NCT00886613|9075260|P3|Overall Study|Protocol deviation (Part B)|0
2626081|NCT00886613|9075261|P2|Overall Study|Protocol deviation (Part B)|0
2626082|NCT00886613|9075262|P1|Overall Study|Protocol deviation (Part B)|1
2626083|NCT00886600|9075284|P4|Combination Therapy Period|Protocol Violation|0
2626084|NCT00886600|9075285|P3|Combination Therapy Period|Protocol Violation|1
2626085|NCT00886600|9075286|P2|Combination Therapy Period|Protocol Violation|0
2626086|NCT00886600|9075287|P1|Combination Therapy Period|Protocol Violation|0
2626087|NCT00886600|9075284|P4|Combination Therapy Period|Adverse Event|0
2626088|NCT00886600|9075285|P3|Combination Therapy Period|Adverse Event|1
2626089|NCT00886600|9075286|P2|Combination Therapy Period|Adverse Event|0
2626090|NCT00886600|9075287|P1|Combination Therapy Period|Adverse Event|0
2626091|NCT00886600|9075284|P4|Double-blind Monotherapy|Withdrawal by Subject|0
2626092|NCT00886600|9075285|P3|Double-blind Monotherapy|Withdrawal by Subject|0
2626093|NCT00886600|9075286|P2|Double-blind Monotherapy|Withdrawal by Subject|0
2626094|NCT00886600|9075287|P1|Double-blind Monotherapy|Withdrawal by Subject|1
2626095|NCT00886600|9075284|P4|Double-blind Monotherapy|Protocol Violation|1
2626096|NCT00886600|9075285|P3|Double-blind Monotherapy|Protocol Violation|0
2626097|NCT00886600|9075286|P2|Double-blind Monotherapy|Protocol Violation|0
2626098|NCT00886600|9075287|P1|Double-blind Monotherapy|Protocol Violation|0
2626099|NCT00886600|9075284|P4|Double-blind Monotherapy|Adverse Event|1
2626100|NCT00886600|9075285|P3|Double-blind Monotherapy|Adverse Event|1
2626101|NCT00886600|9075286|P2|Double-blind Monotherapy|Adverse Event|1
2626102|NCT00886600|9075287|P1|Double-blind Monotherapy|Adverse Event|1
2626103|NCT00886587|9075311|P2|Overall Study|Withdrawal by Subject|1
2626104|NCT00886587|9075312|P1|Overall Study|Withdrawal by Subject|0
2626105|NCT00886587|9075311|P2|Overall Study|Protocol Violation|0
2626106|NCT00886587|9075312|P1|Overall Study|Protocol Violation|2
2626107|NCT00886587|9075311|P2|Overall Study|Adverse Event|1
2626108|NCT00886587|9075312|P1|Overall Study|Adverse Event|2
2626109|NCT00886483|9075326|P2|Overall Study|Distance to center, poor grades|0
2626110|NCT00886483|9075327|P1|Overall Study|Distance to center, poor grades|1
2626111|NCT00886483|9075326|P2|Overall Study|Pursue medications|2
2626112|NCT00886483|9075327|P1|Overall Study|Pursue medications|1
2626113|NCT00886483|9075326|P2|Overall Study|Lost to Follow-up|1
2626114|NCT00886483|9075327|P1|Overall Study|Lost to Follow-up|0
2626115|NCT00886340|9075345|P2|Overall Study|Withdrawal by Subject|7
2626116|NCT00886340|9075346|P1|Overall Study|Withdrawal by Subject|0
2626117|NCT00886288|9075354|P2|Overall Study|Lost to Follow-up|0
2626118|NCT00886288|9075355|P1|Overall Study|Lost to Follow-up|86
2626119|NCT00886288|9075354|P2|Overall Study|no respect of the 12 weeks period|227
2626120|NCT00886288|9075355|P1|Overall Study|no respect of the 12 weeks period|657
2626121|NCT00886119|9075411|P2|Period 1|Did not meet inclusion criteria|0
2626122|NCT00886119|9075412|P1|Period 1|Did not meet inclusion criteria|1
2626123|NCT00886015|9075420|P2|Overall Study|Death|2
2626124|NCT00886015|9075421|P1|Overall Study|Death|0
2626125|NCT00885846|9075440|P3|Overall Study|Withdrawal by Subject|2
2626126|NCT00885846|9075441|P2|Overall Study|Withdrawal by Subject|5
2626127|NCT00885846|9075442|P1|Overall Study|Withdrawal by Subject|2
2626128|NCT00885755|9075457|P3|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
2626129|NCT00885755|9075458|P2|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
2626130|NCT00885755|9075459|P1|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5
2626131|NCT00885755|9075457|P3|Part I: Trastuzumab+Taxane|Death|1
2626132|NCT00885755|9075458|P2|Part I: Trastuzumab+Taxane|Death|0
2626133|NCT00885755|9075459|P1|Part I: Trastuzumab+Taxane|Death|0
2626134|NCT00885755|9075457|P3|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
2626135|NCT00885755|9075458|P2|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
2626136|NCT00885755|9075459|P1|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1
2626137|NCT00885755|9075457|P3|Part I: Trastuzumab+Taxane|Unknown Reason|0
2626138|NCT00885755|9075458|P2|Part I: Trastuzumab+Taxane|Unknown Reason|0
2626139|NCT00885755|9075459|P1|Part I: Trastuzumab+Taxane|Unknown Reason|16
2626140|NCT00885755|9075457|P3|Part I: Trastuzumab+Taxane|Adverse Event|0
2626141|NCT00885755|9075458|P2|Part I: Trastuzumab+Taxane|Adverse Event|0
2626142|NCT00885755|9075459|P1|Part I: Trastuzumab+Taxane|Adverse Event|1
2626143|NCT00885703|9075502|P7|Overall Study|Ineligible (no CM)|1
2626144|NCT00885703|9075503|P6|Overall Study|Ineligible (no CM)|3
2626145|NCT00885703|9075504|P5|Overall Study|Ineligible (no CM)|2
2626146|NCT00885703|9075505|P4|Overall Study|Ineligible (no CM)|1
2626147|NCT00885703|9075506|P3|Overall Study|Ineligible (no CM)|2
2626148|NCT00885703|9075507|P2|Overall Study|Ineligible (no CM)|3
2626149|NCT00885703|9075508|P1|Overall Study|Ineligible (no CM)|1
2626150|NCT00885703|9075502|P7|Overall Study|Withdrawal by Subject|1
2626151|NCT00885703|9075503|P6|Overall Study|Withdrawal by Subject|1
2626152|NCT00885703|9075504|P5|Overall Study|Withdrawal by Subject|3
2626153|NCT00885703|9075505|P4|Overall Study|Withdrawal by Subject|1
2626154|NCT00885703|9075506|P3|Overall Study|Withdrawal by Subject|0
2626155|NCT00885703|9075507|P2|Overall Study|Withdrawal by Subject|0
2626156|NCT00885703|9075508|P1|Overall Study|Withdrawal by Subject|0
2626157|NCT00885703|9075502|P7|Overall Study|Lost to Follow-up|0
2626158|NCT00885703|9075503|P6|Overall Study|Lost to Follow-up|1
2626159|NCT00885703|9075504|P5|Overall Study|Lost to Follow-up|0
2626160|NCT00885703|9075505|P4|Overall Study|Lost to Follow-up|0
2626161|NCT00885703|9075506|P3|Overall Study|Lost to Follow-up|1
2626162|NCT00885703|9075507|P2|Overall Study|Lost to Follow-up|0
2626163|NCT00885703|9075508|P1|Overall Study|Lost to Follow-up|0
2626164|NCT00885703|9075502|P7|Overall Study|Death|4
2626165|NCT00885703|9075503|P6|Overall Study|Death|8
2626166|NCT00885703|9075504|P5|Overall Study|Death|7
2626167|NCT00885703|9075505|P4|Overall Study|Death|7
2626168|NCT00885703|9075506|P3|Overall Study|Death|8
2626169|NCT00885703|9075507|P2|Overall Study|Death|7
2626170|NCT00885703|9075508|P1|Overall Study|Death|9
2626171|NCT00885677|9075566|P2|Overall Study|Inclusion/exclusion not met|27
2626172|NCT00885677|9075567|P1|Overall Study|Inclusion/exclusion not met|25
2626173|NCT00885677|9075566|P2|Overall Study|Heart transplantation|0
2626174|NCT00885677|9075567|P1|Overall Study|Heart transplantation|1
2626175|NCT00885677|9075566|P2|Overall Study|device/lead revision or replacement|6
2626176|NCT00885677|9075567|P1|Overall Study|device/lead revision or replacement|7
2626177|NCT00885677|9075566|P2|Overall Study|premature study closure|44
2626178|NCT00885677|9075567|P1|Overall Study|premature study closure|41
2626179|NCT00885677|9075566|P2|Overall Study|Protocol Violation|54
2626180|NCT00885677|9075567|P1|Overall Study|Protocol Violation|54
2626181|NCT00885677|9075566|P2|Overall Study|Lost to Follow-up|13
2626182|NCT00885677|9075567|P1|Overall Study|Lost to Follow-up|15
2626183|NCT00885677|9075566|P2|Overall Study|Death|34
2626184|NCT00885677|9075567|P1|Overall Study|Death|40
2626185|NCT00885534|9075583|P1|Overall Study|Patient deemed ineligible|1
2626186|NCT00885482|9075587|P1|Overall Study|low Therapeutic drug monitoring (TDM)|1
2626187|NCT00885482|9075587|P1|Overall Study|Death|1
2626188|NCT00885482|9075587|P1|Overall Study|Lack of Efficacy|1
2626189|NCT00885482|9075587|P1|Overall Study|Pregnancy|1
2626190|NCT00885378|9075593|P2|Overall Study|Protocol Violation|0
2626191|NCT00885378|9075594|P1|Overall Study|Protocol Violation|2
2626192|NCT00885378|9075593|P2|Overall Study|Poor/Noncompliance|2
2626193|NCT00885378|9075594|P1|Overall Study|Poor/Noncompliance|2
2626194|NCT00885378|9075593|P2|Overall Study|Lost to Follow-up|2
2626195|NCT00885378|9075594|P1|Overall Study|Lost to Follow-up|1
2626196|NCT00885378|9075593|P2|Overall Study|Withdrawal by Subject|2
2626197|NCT00885378|9075594|P1|Overall Study|Withdrawal by Subject|1
2626198|NCT00885378|9075593|P2|Overall Study|Lack of Efficacy|2
2626199|NCT00885378|9075594|P1|Overall Study|Lack of Efficacy|2
2626200|NCT00885365|9075624|P2|4 Weeks ON Treatment|Withdrawal by Subject|0
2626201|NCT00885365|9075625|P1|4 Weeks ON Treatment|Withdrawal by Subject|1
2626202|NCT00885365|9075624|P2|4 Weeks ON Treatment|Protocol Violation|2
2626203|NCT00885365|9075625|P1|4 Weeks ON Treatment|Protocol Violation|1
2626204|NCT00885365|9075624|P2|4 Weeks ON Treatment|Adverse Event|4
2626205|NCT00885365|9075625|P1|4 Weeks ON Treatment|Adverse Event|2
2626206|NCT00885352|9075661|P2|Overall Study|Lab abnormalities|1
2626207|NCT00885352|9075662|P1|Overall Study|Lab abnormalities|1
2626208|NCT00885352|9075661|P2|Overall Study|Excluded medication|2
2626209|NCT00885352|9075662|P1|Overall Study|Excluded medication|2
2626210|NCT00885352|9075661|P2|Overall Study|Contradiction to study medication|2
2626211|NCT00885352|9075662|P1|Overall Study|Contradiction to study medication|0
2626212|NCT00885352|9075661|P2|Overall Study|Withdrawal by Subject|5
2626213|NCT00885352|9075662|P1|Overall Study|Withdrawal by Subject|1
2626214|NCT00885352|9075661|P2|Overall Study|Protocol Violation|2
2626215|NCT00885352|9075662|P1|Overall Study|Protocol Violation|0
2626216|NCT00885352|9075661|P2|Overall Study|Physician Decision|3
2626217|NCT00885352|9075662|P1|Overall Study|Physician Decision|0
2626218|NCT00885352|9075661|P2|Overall Study|Lost to Follow-up|2
2626219|NCT00885352|9075662|P1|Overall Study|Lost to Follow-up|2
2626220|NCT00885352|9075661|P2|Overall Study|Adverse Event|3
2626221|NCT00885352|9075662|P1|Overall Study|Adverse Event|2
2626222|NCT00885170|9075674|P2|Overall Study|Withdrawal by Subject|13
2626223|NCT00885170|9075675|P1|Overall Study|Withdrawal by Subject|13
2626224|NCT00885170|9075674|P2|Overall Study|Protocol Violation|1
2626225|NCT00885170|9075675|P1|Overall Study|Protocol Violation|3
2626226|NCT00885170|9075674|P2|Overall Study|Physician Decision|1
2626227|NCT00885170|9075675|P1|Overall Study|Physician Decision|2
2626228|NCT00885170|9075674|P2|Overall Study|Lost to Follow-up|1
2626229|NCT00885170|9075675|P1|Overall Study|Lost to Follow-up|2
2626230|NCT00885170|9075674|P2|Overall Study|Excessive bone loss|3
2626231|NCT00885170|9075675|P1|Overall Study|Excessive bone loss|6
2626232|NCT00885170|9075674|P2|Overall Study|Adverse Event|4
2626233|NCT00885170|9075675|P1|Overall Study|Adverse Event|12
2626234|NCT00885118|9075734|P5|Overall Study|Other reason not defined above|0
2626235|NCT00885118|9075735|P4|Overall Study|Other reason not defined above|0
2626236|NCT00885118|9075736|P3|Overall Study|Other reason not defined above|1
2626237|NCT00885118|9075737|P2|Overall Study|Other reason not defined above|0
2626238|NCT00885118|9075738|P1|Overall Study|Other reason not defined above|0
2626239|NCT00885118|9075734|P5|Overall Study|Withdrawal by Subject|1
2626240|NCT00885118|9075735|P4|Overall Study|Withdrawal by Subject|0
2626241|NCT00885118|9075736|P3|Overall Study|Withdrawal by Subject|0
2626242|NCT00885118|9075737|P2|Overall Study|Withdrawal by Subject|0
2626243|NCT00885118|9075738|P1|Overall Study|Withdrawal by Subject|0
2626244|NCT00885118|9075734|P5|Overall Study|Adverse Event|0
2626245|NCT00885118|9075735|P4|Overall Study|Adverse Event|0
2626246|NCT00885118|9075736|P3|Overall Study|Adverse Event|0
2626247|NCT00885118|9075737|P2|Overall Study|Adverse Event|0
2626248|NCT00885118|9075738|P1|Overall Study|Adverse Event|1
2626249|NCT00885105|9075877|P2|Overall Study|Protocol Violation|2
2626250|NCT00885105|9075878|P1|Overall Study|Protocol Violation|0
2626251|NCT00885105|9075877|P2|Overall Study|Adverse Event|0
2626252|NCT00885105|9075878|P1|Overall Study|Adverse Event|1
2626253|NCT00885105|9075877|P2|Overall Study|Withdrawal by Subject|8
2626254|NCT00885105|9075878|P1|Overall Study|Withdrawal by Subject|0
2626255|NCT00884949|9075918|P1|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1
2626256|NCT00884949|9075918|P1|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1
2626257|NCT00884832|9075953|P2|Overall Study|Withdrawal by Subject|1
2626258|NCT00884832|9075954|P1|Overall Study|Withdrawal by Subject|0
2626259|NCT00884793|9075989|P1|Overall Study|Withdrawal by Subject|1
2626260|NCT00884741|9076008|P4|Randomization|Protocol Violation|8
2626261|NCT00884741|9076009|P3|Randomization|Protocol Violation|8
2626262|NCT00884741|9076010|P2|Randomization|Protocol Violation|0
2626263|NCT00884741|9076011|P1|Randomization|Protocol Violation|0
2626264|NCT00884741|9076008|P4|Step 2 Registration: Tissue Analysis|Disease Progression|0
2626265|NCT00884741|9076009|P3|Step 2 Registration: Tissue Analysis|Disease Progression|0
2626266|NCT00884741|9076010|P2|Step 2 Registration: Tissue Analysis|Disease Progression|4
2626267|NCT00884741|9076011|P1|Step 2 Registration: Tissue Analysis|Disease Progression|0
2626268|NCT00884741|9076008|P4|Step 2 Registration: Tissue Analysis|Patient refusal|0
2626269|NCT00884741|9076009|P3|Step 2 Registration: Tissue Analysis|Patient refusal|0
2626270|NCT00884741|9076010|P2|Step 2 Registration: Tissue Analysis|Patient refusal|7
2626271|NCT00884741|9076011|P1|Step 2 Registration: Tissue Analysis|Patient refusal|0
2626272|NCT00884741|9076008|P4|Step 2 Registration: Tissue Analysis|Adverse Event|0
2626273|NCT00884741|9076009|P3|Step 2 Registration: Tissue Analysis|Adverse Event|0
2626274|NCT00884741|9076010|P2|Step 2 Registration: Tissue Analysis|Adverse Event|2
2626275|NCT00884741|9076011|P1|Step 2 Registration: Tissue Analysis|Adverse Event|0
2626276|NCT00884741|9076008|P4|Step 2 Registration: Tissue Analysis|Death|0
2626277|NCT00884741|9076009|P3|Step 2 Registration: Tissue Analysis|Death|0
2626278|NCT00884741|9076010|P2|Step 2 Registration: Tissue Analysis|Death|1
2626279|NCT00884741|9076011|P1|Step 2 Registration: Tissue Analysis|Death|0
2626280|NCT00884741|9076008|P4|Step 2 Registration: Tissue Analysis|Protocol Violation|0
2626281|NCT00884741|9076009|P3|Step 2 Registration: Tissue Analysis|Protocol Violation|0
2626282|NCT00884741|9076010|P2|Step 2 Registration: Tissue Analysis|Protocol Violation|15
2626283|NCT00884741|9076011|P1|Step 2 Registration: Tissue Analysis|Protocol Violation|0
2626284|NCT00884741|9076008|P4|Step 1 Registration: Tissue Screening|Patient refusal|0
2626285|NCT00884741|9076009|P3|Step 1 Registration: Tissue Screening|Patient refusal|0
2626286|NCT00884741|9076010|P2|Step 1 Registration: Tissue Screening|Patient refusal|0
2626287|NCT00884741|9076011|P1|Step 1 Registration: Tissue Screening|Patient refusal|32
2626288|NCT00884741|9076008|P4|Step 1 Registration: Tissue Screening|Disease progression|0
2626289|NCT00884741|9076009|P3|Step 1 Registration: Tissue Screening|Disease progression|0
2626290|NCT00884741|9076010|P2|Step 1 Registration: Tissue Screening|Disease progression|0
2626291|NCT00884741|9076011|P1|Step 1 Registration: Tissue Screening|Disease progression|12
2626292|NCT00884741|9076008|P4|Step 1 Registration: Tissue Screening|Insufficient tissue|0
2626293|NCT00884741|9076009|P3|Step 1 Registration: Tissue Screening|Insufficient tissue|0
2626294|NCT00884741|9076010|P2|Step 1 Registration: Tissue Screening|Insufficient tissue|0
2626295|NCT00884741|9076011|P1|Step 1 Registration: Tissue Screening|Insufficient tissue|105
2626296|NCT00884741|9076008|P4|Step 1 Registration: Tissue Screening|Physician Decision|0
2626297|NCT00884741|9076009|P3|Step 1 Registration: Tissue Screening|Physician Decision|0
2626298|NCT00884741|9076010|P2|Step 1 Registration: Tissue Screening|Physician Decision|0
2626299|NCT00884741|9076011|P1|Step 1 Registration: Tissue Screening|Physician Decision|3
2626300|NCT00884741|9076008|P4|Step 1 Registration: Tissue Screening|Death|0
2626301|NCT00884741|9076009|P3|Step 1 Registration: Tissue Screening|Death|0
2626302|NCT00884741|9076010|P2|Step 1 Registration: Tissue Screening|Death|0
2626303|NCT00884741|9076011|P1|Step 1 Registration: Tissue Screening|Death|3
2626304|NCT00884741|9076008|P4|Step 1 Registration: Tissue Screening|Protocol Violation|0
2626305|NCT00884741|9076009|P3|Step 1 Registration: Tissue Screening|Protocol Violation|0
2626306|NCT00884741|9076010|P2|Step 1 Registration: Tissue Screening|Protocol Violation|0
2626307|NCT00884741|9076011|P1|Step 1 Registration: Tissue Screening|Protocol Violation|157
2626308|NCT00884390|9076061|P2|Overall Study|Other|1
2626309|NCT00884390|9076062|P1|Overall Study|Other|11
2626310|NCT00884390|9076061|P2|Overall Study|Discontinuation of Study by Sponsor|2
2626311|NCT00884390|9076062|P1|Overall Study|Discontinuation of Study by Sponsor|2
2626312|NCT00884390|9076061|P2|Overall Study|Withdrawal by Subject|1
2626313|NCT00884390|9076062|P1|Overall Study|Withdrawal by Subject|4
2626314|NCT00884390|9076061|P2|Overall Study|Protocol Violation|1
2626315|NCT00884390|9076062|P1|Overall Study|Protocol Violation|4
2626316|NCT00884390|9076061|P2|Overall Study|Physician Decision|1
2626317|NCT00884390|9076062|P1|Overall Study|Physician Decision|2
2626318|NCT00884390|9076061|P2|Overall Study|Lost to Follow-up|1
2626319|NCT00884390|9076062|P1|Overall Study|Lost to Follow-up|0
2626320|NCT00884390|9076061|P2|Overall Study|Adverse Event|1
2626321|NCT00884390|9076062|P1|Overall Study|Adverse Event|0
2626322|NCT00884377|9076080|P2|Overall Study|Physician Decision|1
2626323|NCT00884377|9076081|P1|Overall Study|Physician Decision|0
2626324|NCT00884377|9076080|P2|Overall Study|Could not confirm diagnosis|0
2626325|NCT00884377|9076081|P1|Overall Study|Could not confirm diagnosis|1
2626326|NCT00884377|9076080|P2|Overall Study|Withdrawal by Subject|0
2626327|NCT00884377|9076081|P1|Overall Study|Withdrawal by Subject|1
2626328|NCT00884325|9076103|P2|Overall Study|Not provided|0
2626329|NCT00884325|9076104|P1|Overall Study|Not provided|1
2626330|NCT00884325|9076103|P2|Overall Study|Withdrawal by Subject|1
2626331|NCT00884325|9076104|P1|Overall Study|Withdrawal by Subject|1
2626332|NCT00884325|9076103|P2|Overall Study|Lack of Efficacy|1
2626333|NCT00884325|9076104|P1|Overall Study|Lack of Efficacy|0
2626334|NCT00884325|9076103|P2|Overall Study|Lost to Follow-up|2
2626335|NCT00884325|9076104|P1|Overall Study|Lost to Follow-up|1
2626336|NCT00884312|9076114|P2|Overall Study|Did Not Receive Study Drug|1
2626337|NCT00884312|9076115|P1|Overall Study|Did Not Receive Study Drug|0
2626338|NCT00884312|9076114|P2|Overall Study|Other|4
2626339|NCT00884312|9076115|P1|Overall Study|Other|0
2626340|NCT00884312|9076114|P2|Overall Study|Physician Decision|1
2626341|NCT00884312|9076115|P1|Overall Study|Physician Decision|0
2626342|NCT00884312|9076114|P2|Overall Study|Withdrawal by Subject|6
2626343|NCT00884312|9076115|P1|Overall Study|Withdrawal by Subject|0
2626344|NCT00884312|9076114|P2|Overall Study|Fatal Adverse Event|4
2626345|NCT00884312|9076115|P1|Overall Study|Fatal Adverse Event|1
2626346|NCT00884312|9076114|P2|Overall Study|Non-fatal Adverse Event|0
2626347|NCT00884312|9076115|P1|Overall Study|Non-fatal Adverse Event|1
2626348|NCT00884312|9076114|P2|Overall Study|Fatal Progressive Disease|1
2626349|NCT00884312|9076115|P1|Overall Study|Fatal Progressive Disease|0
2626350|NCT00884312|9076114|P2|Overall Study|Non-fatal Progressive Disease|8
2626351|NCT00884312|9076115|P1|Overall Study|Non-fatal Progressive Disease|0
2626352|NCT00884286|9076131|P2|Overall Study|Comprised lung carcinoma|1
2626353|NCT00884286|9076132|P1|Overall Study|Comprised lung carcinoma|0
2626354|NCT00884286|9076131|P2|Overall Study|Not treated|1
2626355|NCT00884286|9076132|P1|Overall Study|Not treated|2
2626356|NCT00884286|9076131|P2|Overall Study|Thrombus in right auricle|0
2626357|NCT00884286|9076132|P1|Overall Study|Thrombus in right auricle|1
2626358|NCT00884286|9076131|P2|Overall Study|Septic shock|0
2626359|NCT00884286|9076132|P1|Overall Study|Septic shock|1
2626360|NCT00884286|9076131|P2|Overall Study|Physician Decision|0
2626361|NCT00884286|9076132|P1|Overall Study|Physician Decision|1
2626362|NCT00884286|9076131|P2|Overall Study|Death|2
2626363|NCT00884286|9076132|P1|Overall Study|Death|2
2626364|NCT00884286|9076131|P2|Overall Study|Toxicity|1
2626365|NCT00884286|9076132|P1|Overall Study|Toxicity|4
2626366|NCT00884286|9076131|P2|Overall Study|Progressive disease|28
2626367|NCT00884286|9076132|P1|Overall Study|Progressive disease|21
2626368|NCT00884273|9076146|P2|Overall Study|Practical reasons|0
2626369|NCT00884273|9076147|P1|Overall Study|Practical reasons|1
2626370|NCT00884273|9076146|P2|Overall Study|Protocol Violation|3
2626371|NCT00884273|9076147|P1|Overall Study|Protocol Violation|1
2626372|NCT00884273|9076146|P2|Overall Study|Adverse Event|2
2626373|NCT00884273|9076147|P1|Overall Study|Adverse Event|0
2626374|NCT00884221|9076173|P2|Overall Study|Cancellation of Cycle and Other Reason|13
2626375|NCT00884221|9076174|P1|Overall Study|Cancellation of Cycle and Other Reason|12
2626376|NCT00884221|9076173|P2|Overall Study|Protocol Violation|13
2626377|NCT00884221|9076174|P1|Overall Study|Protocol Violation|16
2626378|NCT00884221|9076173|P2|Overall Study|Adverse Event|3
2626379|NCT00884221|9076174|P1|Overall Study|Adverse Event|6
2626380|NCT00884221|9076173|P2|Overall Study|Withdrawal by Subject|3
2626381|NCT00884221|9076174|P1|Overall Study|Withdrawal by Subject|0
2626382|NCT00884117|9076210|P1|Overall Study|Other|12
2626383|NCT00884117|9076210|P1|Overall Study|Lost to Follow-up|143
2626384|NCT00884117|9076210|P1|Overall Study|Death|3
2626385|NCT00884117|9076210|P1|Overall Study|Withdrawal by Subject|89
2626386|NCT00884117|9076210|P1|Overall Study|Adverse Event|2
2626387|NCT00884039|9076281|P2|Overall Study|Lack of Efficacy|0
2626388|NCT00884039|9076282|P1|Overall Study|Lack of Efficacy|2
2626389|NCT00884039|9076281|P2|Overall Study|Withdrawal by Subject|1
2626390|NCT00884039|9076282|P1|Overall Study|Withdrawal by Subject|0
2626391|NCT00883779|9076290|P2|Off-study Phase|Other|21
2626392|NCT00883779|9076291|P1|Off-study Phase|Other|18
2626393|NCT00883779|9076290|P2|Off-study Phase|Failure to return|6
2626394|NCT00883779|9076291|P1|Off-study Phase|Failure to return|5
2626395|NCT00883779|9076290|P2|Off-study Phase|Refused treatment|1
2626396|NCT00883779|9076291|P1|Off-study Phase|Refused treatment|1
2626397|NCT00883779|9076290|P2|Off-study Phase|Death|174
2626398|NCT00883779|9076291|P1|Off-study Phase|Death|185
2626399|NCT00883779|9076290|P2|Post-Study Treatment Phase|Ongoing in the study|6
2626400|NCT00883779|9076291|P1|Post-Study Treatment Phase|Ongoing in the study|0
2626401|NCT00883779|9076290|P2|Post-Study Treatment Phase|Other|0
2626402|NCT00883779|9076291|P1|Post-Study Treatment Phase|Other|3
2626403|NCT00883779|9076290|P2|Post-Study Treatment Phase|Disease progression|122
2626404|NCT00883779|9076291|P1|Post-Study Treatment Phase|Disease progression|103
2626405|NCT00883779|9076290|P2|Post-Study Treatment Phase|Refused Treatment|0
2626406|NCT00883779|9076291|P1|Post-Study Treatment Phase|Refused Treatment|3
2626407|NCT00883779|9076290|P2|Post-Study Treatment Phase|Protocol Violation|1
2626408|NCT00883779|9076291|P1|Post-Study Treatment Phase|Protocol Violation|0
2626409|NCT00883779|9076290|P2|Post-Study Treatment Phase|Death|3
2626410|NCT00883779|9076291|P1|Post-Study Treatment Phase|Death|1
2626411|NCT00883779|9076290|P2|Post-Study Treatment Phase|Adverse Event|3
2626412|NCT00883779|9076291|P1|Post-Study Treatment Phase|Adverse Event|2
2626413|NCT00883779|9076290|P2|Primary Study Treatment Phase|Other|0
2626414|NCT00883779|9076291|P1|Primary Study Treatment Phase|Other|3
2626415|NCT00883779|9076290|P2|Primary Study Treatment Phase|Refused Treatment|4
2626416|NCT00883779|9076291|P1|Primary Study Treatment Phase|Refused Treatment|5
2626417|NCT00883779|9076290|P2|Primary Study Treatment Phase|Death|3
2626418|NCT00883779|9076291|P1|Primary Study Treatment Phase|Death|2
2626419|NCT00883779|9076290|P2|Primary Study Treatment Phase|Adverse Event|16
2626420|NCT00883779|9076291|P1|Primary Study Treatment Phase|Adverse Event|16
2626421|NCT00883779|9076290|P2|Primary Study Treatment Phase|Disease progression|59
2626422|NCT00883779|9076291|P1|Primary Study Treatment Phase|Disease progression|75
2626423|NCT00883779|9076290|P2|Primary Study Treatment Phase|Did not receive allocated intervention|4
2626424|NCT00883779|9076291|P1|Primary Study Treatment Phase|Did not receive allocated intervention|4
2626425|NCT00883753|9076327|P1|Overall Study|Administrative/Other|8
2626426|NCT00883753|9076327|P1|Overall Study|Investigator's decision|17
2626427|NCT00883753|9076327|P1|Overall Study|Withdrew consent|10
2626428|NCT00883753|9076327|P1|Overall Study|Refused treatment|4
2626429|NCT00883753|9076327|P1|Overall Study|Protocol Violation|2
2626430|NCT00883753|9076327|P1|Overall Study|Violation of selection criteria at entry|7
2626431|NCT00883753|9076327|P1|Overall Study|Lost to Follow-up|4
2626432|NCT00883753|9076327|P1|Overall Study|Insufficient therapeutic response|16
2626433|NCT00883753|9076327|P1|Overall Study|Death|2
2626434|NCT00883753|9076327|P1|Overall Study|Adverse Event|37
2626435|NCT00883740|9076367|P2|Second Intervention|No longer willing to participate|1
2626436|NCT00883740|9076368|P1|Second Intervention|No longer willing to participate|0
2626437|NCT00883740|9076367|P2|Second Intervention|Protocol Violation|0
2626438|NCT00883740|9076368|P1|Second Intervention|Protocol Violation|1
2626439|NCT00883740|9076367|P2|First Intervention|Adverse Event|2
2626440|NCT00883740|9076368|P1|First Intervention|Adverse Event|1
2626441|NCT00883740|9076367|P2|First Intervention|Protocol Violation|6
2626442|NCT00883740|9076368|P1|First Intervention|Protocol Violation|3
2626443|NCT00883740|9076367|P2|First Intervention|No longer willing to participate|0
2626444|NCT00883740|9076368|P1|First Intervention|No longer willing to participate|2
2626445|NCT00883740|9076367|P2|First Intervention|Lost to Follow-up|0
2626446|NCT00883740|9076368|P1|First Intervention|Lost to Follow-up|1
2626447|NCT00883558|9076412|P3|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1
2626448|NCT00883558|9076413|P2|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
2626449|NCT00883558|9076414|P1|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
2626450|NCT00883558|9076412|P3|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
2626451|NCT00883558|9076413|P2|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1
2626452|NCT00883558|9076414|P1|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
2626453|NCT00883558|9076412|P3|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
2626454|NCT00883558|9076413|P2|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
2626455|NCT00883558|9076414|P1|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0
2626456|NCT00883558|9076412|P3|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
2626457|NCT00883558|9076413|P2|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1
2626458|NCT00883558|9076414|P1|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
2626459|NCT00883558|9076412|P3|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
2626460|NCT00883558|9076413|P2|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
2626461|NCT00883558|9076414|P1|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2
2626462|NCT00883493|9076426|P2|Overall Study|Other|3
2626463|NCT00883493|9076427|P1|Overall Study|Other|5
2626464|NCT00883493|9076426|P2|Overall Study|Study specific disc. criteria|0
2626465|NCT00883493|9076427|P1|Overall Study|Study specific disc. criteria|2
2626466|NCT00883493|9076426|P2|Overall Study|Eligibility Criteria not fullfilled|6
2626467|NCT00883493|9076427|P1|Overall Study|Eligibility Criteria not fullfilled|6
2626468|NCT00883493|9076426|P2|Overall Study|Withdrawal by Subject|20
2626469|NCT00883493|9076427|P1|Overall Study|Withdrawal by Subject|11
2626470|NCT00883493|9076426|P2|Overall Study|Lost to Follow-up|6
2626471|NCT00883493|9076427|P1|Overall Study|Lost to Follow-up|7
2626472|NCT00883493|9076426|P2|Overall Study|Lack of Efficacy|3
2626473|NCT00883493|9076427|P1|Overall Study|Lack of Efficacy|4
2626474|NCT00883493|9076426|P2|Overall Study|Adverse Event|12
2626475|NCT00883493|9076427|P1|Overall Study|Adverse Event|11
2626476|NCT00883337|9076458|P3|Extension Treatment Period|Other than above|5
2626477|NCT00883337|9076459|P2|Extension Treatment Period|Other than above|9
2626478|NCT00883337|9076460|P1|Extension Treatment Period|Other than above|10
2626479|NCT00883337|9076458|P3|Extension Treatment Period|Lost to Follow-up|0
2626480|NCT00883337|9076459|P2|Extension Treatment Period|Lost to Follow-up|0
2626481|NCT00883337|9076460|P1|Extension Treatment Period|Lost to Follow-up|1
2626482|NCT00883337|9076458|P3|Extension Treatment Period|Poor compliance to protocol|1
2626483|NCT00883337|9076459|P2|Extension Treatment Period|Poor compliance to protocol|1
2626484|NCT00883337|9076460|P1|Extension Treatment Period|Poor compliance to protocol|1
2626485|NCT00883337|9076458|P3|Extension Treatment Period|Lack of Efficacy|8
2626486|NCT00883337|9076459|P2|Extension Treatment Period|Lack of Efficacy|8
2626487|NCT00883337|9076460|P1|Extension Treatment Period|Lack of Efficacy|8
2626488|NCT00883337|9076458|P3|Extension Treatment Period|Adverse Event|5
2626489|NCT00883337|9076459|P2|Extension Treatment Period|Adverse Event|5
2626490|NCT00883337|9076460|P1|Extension Treatment Period|Adverse Event|8
2626491|NCT00883337|9076458|P3|Core Treatment Period|Other than above|1
2626492|NCT00883337|9076459|P2|Core Treatment Period|Other than above|1
2626493|NCT00883337|9076460|P1|Core Treatment Period|Other than above|0
2626494|NCT00883337|9076458|P3|Core Treatment Period|Poor compliance to protocol|1
2626495|NCT00883337|9076459|P2|Core Treatment Period|Poor compliance to protocol|0
2626496|NCT00883337|9076460|P1|Core Treatment Period|Poor compliance to protocol|0
2626497|NCT00883337|9076458|P3|Core Treatment Period|Wish to be pregnant|1
2626498|NCT00883337|9076459|P2|Core Treatment Period|Wish to be pregnant|2
2626499|NCT00883337|9076460|P1|Core Treatment Period|Wish to be pregnant|1
2626500|NCT00883337|9076458|P3|Core Treatment Period|Withdrawal by Subject|6
2626501|NCT00883337|9076459|P2|Core Treatment Period|Withdrawal by Subject|2
2626502|NCT00883337|9076460|P1|Core Treatment Period|Withdrawal by Subject|2
2626503|NCT00883337|9076458|P3|Core Treatment Period|Lost to Follow-up|0
2626504|NCT00883337|9076459|P2|Core Treatment Period|Lost to Follow-up|1
2626505|NCT00883337|9076460|P1|Core Treatment Period|Lost to Follow-up|1
2626506|NCT00883337|9076458|P3|Core Treatment Period|Lack of Efficacy|2
2626507|NCT00883337|9076459|P2|Core Treatment Period|Lack of Efficacy|4
2626508|NCT00883337|9076460|P1|Core Treatment Period|Lack of Efficacy|7
2626509|NCT00883337|9076458|P3|Core Treatment Period|Adverse Event|22
2626510|NCT00883337|9076459|P2|Core Treatment Period|Adverse Event|12
2626511|NCT00883337|9076460|P1|Core Treatment Period|Adverse Event|9
2626512|NCT00883181|9076527|P1|Overall Study|Noncompliance|3
2626513|NCT00883181|9076527|P1|Overall Study|Protocol Deviation|3
2626514|NCT00883181|9076527|P1|Overall Study|Other|38
2626515|NCT00883181|9076527|P1|Overall Study|Death|31
2626516|NCT00883181|9076527|P1|Overall Study|Withdrawal by Subject|4
2626517|NCT00883181|9076527|P1|Overall Study|Administrative Reason|24
2626518|NCT00883181|9076527|P1|Overall Study|Disease Progression|94
2626519|NCT00883181|9076527|P1|Overall Study|Non-hematological Adverse Event|55
2626520|NCT00883181|9076527|P1|Overall Study|Hematological Adverse Event|26
2626521|NCT00883129|9076763|P2|Overall Study|Defined Treatment Failure|2
2626522|NCT00883129|9076764|P1|Overall Study|Defined Treatment Failure|0
2626523|NCT00883129|9076763|P2|Overall Study|Death|2
2626524|NCT00883129|9076764|P1|Overall Study|Death|1
2626525|NCT00883129|9076763|P2|Overall Study|Lost to Follow-up|2
2626526|NCT00883129|9076764|P1|Overall Study|Lost to Follow-up|1
2626527|NCT00883129|9076763|P2|Overall Study|Non-compliance|6
2626528|NCT00883129|9076764|P1|Overall Study|Non-compliance|3
2626529|NCT00883129|9076763|P2|Overall Study|Withdrawal by Subject|9
2626530|NCT00883129|9076764|P1|Overall Study|Withdrawal by Subject|8
2626531|NCT00883129|9076763|P2|Overall Study|Adverse Event|15
2626532|NCT00883129|9076764|P1|Overall Study|Adverse Event|7
2626533|NCT00883116|9076788|P2|Overall Study|No longer meets study criteria|2
2626534|NCT00883116|9076789|P1|Overall Study|No longer meets study criteria|2
2626535|NCT00883116|9076788|P2|Overall Study|Withdrawal by Subject|8
2626536|NCT00883116|9076789|P1|Overall Study|Withdrawal by Subject|14
2626537|NCT00883116|9076788|P2|Overall Study|Study drug toxicity|16
2626538|NCT00883116|9076789|P1|Overall Study|Study drug toxicity|36
2626539|NCT00883116|9076788|P2|Overall Study|Not identified|6
2626540|NCT00883116|9076789|P1|Overall Study|Not identified|3
2626541|NCT00883116|9076788|P2|Overall Study|Maximum clinical benefit|46
2626542|NCT00883116|9076789|P1|Overall Study|Maximum clinical benefit|13
2626543|NCT00883116|9076788|P2|Overall Study|Lost to Follow-up|1
2626544|NCT00883116|9076789|P1|Overall Study|Lost to Follow-up|0
2626545|NCT00883116|9076788|P2|Overall Study|Disease progression|128
2626546|NCT00883116|9076789|P1|Overall Study|Disease progression|130
2626547|NCT00883116|9076788|P2|Overall Study|Death|2
2626548|NCT00883116|9076789|P1|Overall Study|Death|6
2626549|NCT00883116|9076788|P2|Overall Study|Adverse event unrelated to study drug|10
2626550|NCT00883116|9076789|P1|Overall Study|Adverse event unrelated to study drug|5
2626551|NCT00883090|9076811|P1|Overall Study|Withdrawal by Subject|1
2626552|NCT00883090|9076811|P1|Overall Study|Sponsor's decision|1
2626553|NCT00883051|9076831|P5|Overall Study|Did not use study medication|17
2626554|NCT00883051|9076832|P4|Overall Study|Did not use study medication|29
2626555|NCT00883051|9076833|P3|Overall Study|Did not use study medication|29
2626556|NCT00883051|9076834|P2|Overall Study|Did not use study medication|22
2626557|NCT00883051|9076835|P1|Overall Study|Did not use study medication|24
2626558|NCT00883051|9076831|P5|Overall Study|Lost to Follow-up|1
2626559|NCT00883051|9076832|P4|Overall Study|Lost to Follow-up|0
2626560|NCT00883051|9076833|P3|Overall Study|Lost to Follow-up|0
2626561|NCT00883051|9076834|P2|Overall Study|Lost to Follow-up|0
2626562|NCT00883051|9076835|P1|Overall Study|Lost to Follow-up|0
2626563|NCT00882999|9076939|P7|Overall Study|Physician Decision|1
2626564|NCT00882999|9076940|P6|Overall Study|Physician Decision|1
2626565|NCT00882999|9076941|P5|Overall Study|Physician Decision|0
2626566|NCT00882999|9076942|P4|Overall Study|Physician Decision|0
2626567|NCT00882999|9076943|P3|Overall Study|Physician Decision|0
2626568|NCT00882999|9076944|P2|Overall Study|Physician Decision|0
2626569|NCT00882999|9076945|P1|Overall Study|Physician Decision|1
2626570|NCT00882999|9076939|P7|Overall Study|Lost to Follow-up|2
2626571|NCT00882999|9076940|P6|Overall Study|Lost to Follow-up|1
2626572|NCT00882999|9076941|P5|Overall Study|Lost to Follow-up|1
2626573|NCT00882999|9076942|P4|Overall Study|Lost to Follow-up|2
2626574|NCT00882999|9076943|P3|Overall Study|Lost to Follow-up|1
2626575|NCT00882999|9076944|P2|Overall Study|Lost to Follow-up|1
2626576|NCT00882999|9076945|P1|Overall Study|Lost to Follow-up|0
2626577|NCT00882999|9076939|P7|Overall Study|Withdrawal by Subject|5
2626578|NCT00882999|9076940|P6|Overall Study|Withdrawal by Subject|5
2626579|NCT00882999|9076941|P5|Overall Study|Withdrawal by Subject|6
2626580|NCT00882999|9076942|P4|Overall Study|Withdrawal by Subject|3
2626581|NCT00882999|9076943|P3|Overall Study|Withdrawal by Subject|3
2626582|NCT00882999|9076944|P2|Overall Study|Withdrawal by Subject|6
2626583|NCT00882999|9076945|P1|Overall Study|Withdrawal by Subject|7
2626584|NCT00882999|9076939|P7|Overall Study|Death|0
2626585|NCT00882999|9076940|P6|Overall Study|Death|0
2626586|NCT00882999|9076941|P5|Overall Study|Death|0
2626587|NCT00882999|9076942|P4|Overall Study|Death|0
2626588|NCT00882999|9076943|P3|Overall Study|Death|0
2626589|NCT00882999|9076944|P2|Overall Study|Death|1
2626590|NCT00882999|9076945|P1|Overall Study|Death|0
2626591|NCT00882999|9076939|P7|Overall Study|Adverse Event|0
2626592|NCT00882999|9076940|P6|Overall Study|Adverse Event|0
2626593|NCT00882999|9076941|P5|Overall Study|Adverse Event|1
2626594|NCT00882999|9076942|P4|Overall Study|Adverse Event|0
2626595|NCT00882999|9076943|P3|Overall Study|Adverse Event|0
2626596|NCT00882999|9076944|P2|Overall Study|Adverse Event|0
2626597|NCT00882999|9076945|P1|Overall Study|Adverse Event|0
2626598|NCT00882921|9077072|P1|Overall Study|Withdrawal Of Consent|1
2626599|NCT00882921|9077072|P1|Overall Study|Termination By Investigator|3
2626600|NCT00882921|9077072|P1|Overall Study|Lost to Follow-up|2
2626601|NCT00882921|9077072|P1|Overall Study|Other|3
2626602|NCT00882921|9077072|P1|Overall Study|Death|2
2626603|NCT00882908|9077082|P5|Overall Study|Study terminated in error|0
2626604|NCT00882908|9077083|P4|Overall Study|Study terminated in error|1
2626605|NCT00882908|9077084|P3|Overall Study|Study terminated in error|0
2626606|NCT00882908|9077085|P2|Overall Study|Study terminated in error|0
2626607|NCT00882908|9077086|P1|Overall Study|Study terminated in error|0
2626608|NCT00882908|9077082|P5|Overall Study|Subject reached a virologic endpoint|1
2626609|NCT00882908|9077083|P4|Overall Study|Subject reached a virologic endpoint|0
2626610|NCT00882908|9077084|P3|Overall Study|Subject reached a virologic endpoint|0
2626611|NCT00882908|9077085|P2|Overall Study|Subject reached a virologic endpoint|0
2626612|NCT00882908|9077086|P1|Overall Study|Subject reached a virologic endpoint|0
2626613|NCT00882908|9077082|P5|Overall Study|Withdrawal by Subject|2
2626614|NCT00882908|9077083|P4|Overall Study|Withdrawal by Subject|5
2626615|NCT00882908|9077084|P3|Overall Study|Withdrawal by Subject|3
2626616|NCT00882908|9077085|P2|Overall Study|Withdrawal by Subject|0
2626617|NCT00882908|9077086|P1|Overall Study|Withdrawal by Subject|0
2626618|NCT00882908|9077082|P5|Overall Study|Protocol Violation|0
2626619|NCT00882908|9077083|P4|Overall Study|Protocol Violation|0
2626620|NCT00882908|9077084|P3|Overall Study|Protocol Violation|0
2626621|NCT00882908|9077085|P2|Overall Study|Protocol Violation|1
2626622|NCT00882908|9077086|P1|Overall Study|Protocol Violation|0
2626623|NCT00882908|9077082|P5|Overall Study|Lost to Follow-up|2
2626624|NCT00882908|9077083|P4|Overall Study|Lost to Follow-up|1
2626625|NCT00882908|9077084|P3|Overall Study|Lost to Follow-up|3
2626626|NCT00882908|9077085|P2|Overall Study|Lost to Follow-up|5
2626627|NCT00882908|9077086|P1|Overall Study|Lost to Follow-up|3
2626628|NCT00882908|9077082|P5|Overall Study|Adverse Event|1
2626629|NCT00882908|9077083|P4|Overall Study|Adverse Event|0
2626630|NCT00882908|9077084|P3|Overall Study|Adverse Event|1
2626631|NCT00882908|9077085|P2|Overall Study|Adverse Event|0
2626632|NCT00882908|9077086|P1|Overall Study|Adverse Event|0
2626633|NCT00882713|9077192|P1|Overall Study|Other - Reasons|2
2626634|NCT00882713|9077192|P1|Overall Study|Failure to return|2
2626635|NCT00882713|9077192|P1|Overall Study|Insufficient therapeutic response|3
2626636|NCT00882713|9077192|P1|Overall Study|Blood transfusion|2
2626637|NCT00882713|9077192|P1|Overall Study|refused treatment/withdrew consent|4
2626638|NCT00882713|9077192|P1|Overall Study|Administrative reasons|4
2626639|NCT00882713|9077192|P1|Overall Study|Death|3
2626640|NCT00882713|9077192|P1|Overall Study|Adverse Event|2
2626641|NCT00882583|9077285|P2|Overall Study|Adverse Event|1
2626642|NCT00882583|9077286|P1|Overall Study|Adverse Event|0
2626643|NCT00882583|9077285|P2|Overall Study|Physician Decision|0
2626644|NCT00882583|9077286|P1|Overall Study|Physician Decision|1
2626645|NCT00882557|9077294|P2|Overall Study|Randomized Not Treated|1
2626646|NCT00882557|9077295|P1|Overall Study|Randomized Not Treated|0
2626647|NCT00882557|9077294|P2|Overall Study|Trouble with Vein Access|0
2626648|NCT00882557|9077295|P1|Overall Study|Trouble with Vein Access|1
2626649|NCT00882557|9077294|P2|Overall Study|Withdrawal by Subject|0
2626650|NCT00882557|9077295|P1|Overall Study|Withdrawal by Subject|1
2626651|NCT00882518|9077315|P2|Overall Study|Allocating random number by mistake|1
2626652|NCT00882518|9077316|P1|Overall Study|Allocating random number by mistake|0
2626653|NCT00882518|9077315|P2|Overall Study|Central lab closure for National day|0
2626654|NCT00882518|9077316|P1|Overall Study|Central lab closure for National day|1
2626655|NCT00882518|9077315|P2|Overall Study|Incorrect enrolment|2
2626656|NCT00882518|9077316|P1|Overall Study|Incorrect enrolment|4
2626657|NCT00882518|9077315|P2|Overall Study|Severe non-compliance to protocol|1
2626658|NCT00882518|9077316|P1|Overall Study|Severe non-compliance to protocol|3
2626659|NCT00882518|9077315|P2|Overall Study|Lack of Efficacy|9
2626660|NCT00882518|9077316|P1|Overall Study|Lack of Efficacy|12
2626661|NCT00882518|9077315|P2|Overall Study|Withdrawal by Subject|13
2626662|NCT00882518|9077316|P1|Overall Study|Withdrawal by Subject|9
2626663|NCT00882518|9077315|P2|Overall Study|Adverse Event|18
2626664|NCT00882518|9077316|P1|Overall Study|Adverse Event|9
2626665|NCT00882440|9077345|P7|Overall Study|Patient Uncooperative|0
2626666|NCT00882440|9077346|P6|Overall Study|Patient Uncooperative|0
2626667|NCT00882440|9077347|P5|Overall Study|Patient Uncooperative|1
2626668|NCT00882440|9077348|P4|Overall Study|Patient Uncooperative|0
2626669|NCT00882440|9077349|P3|Overall Study|Patient Uncooperative|0
2626670|NCT00882440|9077350|P2|Overall Study|Patient Uncooperative|0
2626671|NCT00882440|9077351|P1|Overall Study|Patient Uncooperative|2
2626672|NCT00882440|9077345|P7|Overall Study|Withdrawal by Subject|1
2626673|NCT00882440|9077346|P6|Overall Study|Withdrawal by Subject|0
2626674|NCT00882440|9077347|P5|Overall Study|Withdrawal by Subject|6
2626675|NCT00882440|9077348|P4|Overall Study|Withdrawal by Subject|0
2626676|NCT00882440|9077349|P3|Overall Study|Withdrawal by Subject|1
2626677|NCT00882440|9077350|P2|Overall Study|Withdrawal by Subject|1
2626678|NCT00882440|9077351|P1|Overall Study|Withdrawal by Subject|2
2626679|NCT00882440|9077345|P7|Overall Study|Protocol Violation|0
2626680|NCT00882440|9077346|P6|Overall Study|Protocol Violation|0
2626681|NCT00882440|9077347|P5|Overall Study|Protocol Violation|1
2626682|NCT00882440|9077348|P4|Overall Study|Protocol Violation|1
2626683|NCT00882440|9077349|P3|Overall Study|Protocol Violation|1
2626684|NCT00882440|9077350|P2|Overall Study|Protocol Violation|0
2626685|NCT00882440|9077351|P1|Overall Study|Protocol Violation|0
2626686|NCT00882440|9077345|P7|Overall Study|Lost to Follow-up|1
2626687|NCT00882440|9077346|P6|Overall Study|Lost to Follow-up|0
2626688|NCT00882440|9077347|P5|Overall Study|Lost to Follow-up|1
2626689|NCT00882440|9077348|P4|Overall Study|Lost to Follow-up|1
2626690|NCT00882440|9077349|P3|Overall Study|Lost to Follow-up|1
2626691|NCT00882440|9077350|P2|Overall Study|Lost to Follow-up|0
2626692|NCT00882440|9077351|P1|Overall Study|Lost to Follow-up|2
2626693|NCT00882440|9077345|P7|Overall Study|Lack of Efficacy|0
2626694|NCT00882440|9077346|P6|Overall Study|Lack of Efficacy|3
2626695|NCT00882440|9077347|P5|Overall Study|Lack of Efficacy|0
2626696|NCT00882440|9077348|P4|Overall Study|Lack of Efficacy|0
2626697|NCT00882440|9077349|P3|Overall Study|Lack of Efficacy|2
2626698|NCT00882440|9077350|P2|Overall Study|Lack of Efficacy|5
2626699|NCT00882440|9077351|P1|Overall Study|Lack of Efficacy|3
2626700|NCT00882440|9077345|P7|Overall Study|Adverse Event|2
2626701|NCT00882440|9077346|P6|Overall Study|Adverse Event|4
2626702|NCT00882440|9077347|P5|Overall Study|Adverse Event|1
2626703|NCT00882440|9077348|P4|Overall Study|Adverse Event|1
2626704|NCT00882440|9077349|P3|Overall Study|Adverse Event|2
2626705|NCT00882440|9077350|P2|Overall Study|Adverse Event|2
2626706|NCT00882440|9077351|P1|Overall Study|Adverse Event|2
2626707|NCT00882362|9077376|P2|Overall Study|change of residence or other commitments|0
2626708|NCT00882362|9077377|P1|Overall Study|change of residence or other commitments|5
2626709|NCT00882362|9077376|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
2626710|NCT00882362|9077377|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2
2626711|NCT00882362|9077376|P2|Overall Study|Physician Decision|1
2626712|NCT00882362|9077377|P1|Overall Study|Physician Decision|5
2626713|NCT00882362|9077376|P2|Overall Study|Pregnancy|0
2626714|NCT00882362|9077377|P1|Overall Study|Pregnancy|1
2626715|NCT00882362|9077376|P2|Overall Study|Protocol Violation|2
2626716|NCT00882362|9077377|P1|Overall Study|Protocol Violation|7
2626717|NCT00882362|9077376|P2|Overall Study|Lack of Efficacy|0
2626718|NCT00882362|9077377|P1|Overall Study|Lack of Efficacy|3
2626719|NCT00882362|9077376|P2|Overall Study|Withdrawal by Subject|10
2626720|NCT00882362|9077377|P1|Overall Study|Withdrawal by Subject|13
2626721|NCT00882362|9077376|P2|Overall Study|Adverse Event|10
2626722|NCT00882362|9077377|P1|Overall Study|Adverse Event|13
2626723|NCT00882310|9077383|P1|Overall Study|Adverse Event|1
2626724|NCT00882310|9077383|P1|Overall Study|Progression of disease|4
2626725|NCT00882310|9077383|P1|Overall Study|Death|6
2626726|NCT00882310|9077383|P1|Overall Study|Never received treatment|1
2626727|NCT00882310|9077383|P1|Overall Study|Screen Failure|10
2626728|NCT00882115|9077396|P1|Overall Study|did not respond to DEP challe|6
2626729|NCT00882115|9077396|P1|Overall Study|Withdrawal by Subject|3
2626730|NCT00881959|9077406|P2|Overall Study|Lost to Follow-up|4
2626731|NCT00881959|9077407|P1|Overall Study|Lost to Follow-up|2
2626732|NCT00881894|9077415|P2|Overall Study|Other reasons for premature termination|2
2626733|NCT00881894|9077416|P1|Overall Study|Other reasons for premature termination|1
2626734|NCT00881894|9077415|P2|Overall Study|Consent withdrawn|1
2626735|NCT00881894|9077416|P1|Overall Study|Consent withdrawn|0
2626736|NCT00881868|9077448|P2|Overall Study|Protocol Violation|0
2626737|NCT00881868|9077449|P1|Overall Study|Protocol Violation|2
2626738|NCT00881868|9077448|P2|Overall Study|Physician Decision|0
2626739|NCT00881868|9077449|P1|Overall Study|Physician Decision|4
2626740|NCT00881868|9077448|P2|Overall Study|Lost to Follow-up|1
2626741|NCT00881868|9077449|P1|Overall Study|Lost to Follow-up|2
2626742|NCT00881868|9077448|P2|Overall Study|Adverse Event|1
2626743|NCT00881868|9077449|P1|Overall Study|Adverse Event|0
2626744|NCT00881751|9077463|P2|Overall Study|Withdrawal by Subject|2
2626745|NCT00881751|9077464|P1|Overall Study|Withdrawal by Subject|0
2626746|NCT00881751|9077463|P2|Overall Study|Adverse Event|2
2626747|NCT00881751|9077464|P1|Overall Study|Adverse Event|0
2626748|NCT00881751|9077463|P2|Overall Study|Physician Decision|1
2626749|NCT00881751|9077464|P1|Overall Study|Physician Decision|0
2626750|NCT00881712|9077479|P3|Overall Study|Withdrawal by Subject|0
2626751|NCT00881712|9077480|P2|Overall Study|Withdrawal by Subject|0
2626752|NCT00881712|9077481|P1|Overall Study|Withdrawal by Subject|1
2626753|NCT00881712|9077479|P3|Overall Study|Death|0
2626754|NCT00881712|9077480|P2|Overall Study|Death|0
2626755|NCT00881712|9077481|P1|Overall Study|Death|1
2626756|NCT00881621|9077514|P1|Overall Study|Physician Decision|34
2626757|NCT00881608|9077526|P1|Overall Study|Study prematurely terminated|11
2626758|NCT00881530|9077549|P6|Overall Study|Other reason not defined above|2
2626759|NCT00881530|9077550|P5|Overall Study|Other reason not defined above|0
2626760|NCT00881530|9077551|P4|Overall Study|Other reason not defined above|0
2626761|NCT00881530|9077552|P3|Overall Study|Other reason not defined above|2
2626762|NCT00881530|9077553|P2|Overall Study|Other reason not defined above|1
2626763|NCT00881530|9077554|P1|Overall Study|Other reason not defined above|1
2626764|NCT00881530|9077549|P6|Overall Study|Refused to continue medication|0
2626765|NCT00881530|9077550|P5|Overall Study|Refused to continue medication|0
2626766|NCT00881530|9077551|P4|Overall Study|Refused to continue medication|2
2626767|NCT00881530|9077552|P3|Overall Study|Refused to continue medication|1
2626768|NCT00881530|9077553|P2|Overall Study|Refused to continue medication|2
2626769|NCT00881530|9077554|P1|Overall Study|Refused to continue medication|7
2626770|NCT00881530|9077549|P6|Overall Study|Lost to Follow-up|0
2626771|NCT00881530|9077550|P5|Overall Study|Lost to Follow-up|1
2626772|NCT00881530|9077551|P4|Overall Study|Lost to Follow-up|3
2626773|NCT00881530|9077552|P3|Overall Study|Lost to Follow-up|1
2626774|NCT00881530|9077553|P2|Overall Study|Lost to Follow-up|1
2626775|NCT00881530|9077554|P1|Overall Study|Lost to Follow-up|0
2626776|NCT00881530|9077549|P6|Overall Study|Not compliant with the protocol|0
2626777|NCT00881530|9077550|P5|Overall Study|Not compliant with the protocol|2
2626778|NCT00881530|9077551|P4|Overall Study|Not compliant with the protocol|0
2626779|NCT00881530|9077552|P3|Overall Study|Not compliant with the protocol|0
2626780|NCT00881530|9077553|P2|Overall Study|Not compliant with the protocol|0
2626781|NCT00881530|9077554|P1|Overall Study|Not compliant with the protocol|0
2626782|NCT00881530|9077549|P6|Overall Study|Lack of Efficacy|1
2626783|NCT00881530|9077550|P5|Overall Study|Lack of Efficacy|1
2626784|NCT00881530|9077551|P4|Overall Study|Lack of Efficacy|0
2626785|NCT00881530|9077552|P3|Overall Study|Lack of Efficacy|0
2626786|NCT00881530|9077553|P2|Overall Study|Lack of Efficacy|0
2626787|NCT00881530|9077554|P1|Overall Study|Lack of Efficacy|1
2626788|NCT00881530|9077549|P6|Overall Study|Adverse Event|2
2626789|NCT00881530|9077550|P5|Overall Study|Adverse Event|10
2626790|NCT00881530|9077551|P4|Overall Study|Adverse Event|4
2626791|NCT00881530|9077552|P3|Overall Study|Adverse Event|1
2626792|NCT00881530|9077553|P2|Overall Study|Adverse Event|1
2626793|NCT00881530|9077554|P1|Overall Study|Adverse Event|5
2626794|NCT00881504|9077610|P1|Overall Study|Withdrawal by Subject|1
2626795|NCT00881361|9077630|P3|Overall Study|Ineligible|2
2626796|NCT00881361|9077631|P2|Overall Study|Ineligible|2
2626797|NCT00881361|9077632|P1|Overall Study|Ineligible|17
2626798|NCT00881361|9077630|P3|Overall Study|Terminated prior to surgery|0
2626799|NCT00881361|9077631|P2|Overall Study|Terminated prior to surgery|7
2626800|NCT00881361|9077632|P1|Overall Study|Terminated prior to surgery|27
2626801|NCT00881335|9077647|P2|Overall Study|Lost to Follow-up|2
2626802|NCT00881335|9077648|P1|Overall Study|Lost to Follow-up|3
2626803|NCT00881205|9077668|P2|Overall Study|Condition no longer requires drug|0
2626804|NCT00881205|9077669|P1|Overall Study|Condition no longer requires drug|1
2626805|NCT00881205|9077668|P2|Overall Study|Administrative problems|1
2626806|NCT00881205|9077669|P1|Overall Study|Administrative problems|1
2626807|NCT00881205|9077668|P2|Overall Study|Lost to Follow-up|1
2626808|NCT00881205|9077669|P1|Overall Study|Lost to Follow-up|0
2626809|NCT00881205|9077668|P2|Overall Study|Withdrawal by Subject|2
2626810|NCT00881205|9077669|P1|Overall Study|Withdrawal by Subject|1
2626811|NCT00881205|9077668|P2|Overall Study|Adverse Event|3
2626812|NCT00881205|9077669|P1|Overall Study|Adverse Event|8
2626813|NCT00880906|9077737|P2|Overall Study|Did not meet criteria following patholog|6
2626814|NCT00880906|9077738|P1|Overall Study|Did not meet criteria following patholog|12
2626815|NCT00880906|9077737|P2|Overall Study|Lost to Follow-up|1
2626816|NCT00880906|9077738|P1|Overall Study|Lost to Follow-up|0
2626817|NCT00880893|9077748|P2|Overall Study|Serious adverse event|0
2626818|NCT00880893|9077749|P1|Overall Study|Serious adverse event|3
2626819|NCT00880893|9077748|P2|Overall Study|Lost to Follow-up|33
2626820|NCT00880893|9077749|P1|Overall Study|Lost to Follow-up|76
2626821|NCT00880893|9077748|P2|Overall Study|Withdrawal by Subject|11
2626822|NCT00880893|9077749|P1|Overall Study|Withdrawal by Subject|15
2626823|NCT00880893|9077748|P2|Overall Study|Protocol Violation|1
2626824|NCT00880893|9077749|P1|Overall Study|Protocol Violation|13
2626825|NCT00880763|9077801|P4|Extension Period (Part 2)|Lack of Efficacy|1
2626826|NCT00880763|9077802|P3|Extension Period (Part 2)|Lack of Efficacy|0
2626827|NCT00880763|9077803|P2|Extension Period (Part 2)|Lack of Efficacy|0
2626828|NCT00880763|9077804|P1|Extension Period (Part 2)|Lack of Efficacy|0
2626829|NCT00880763|9077801|P4|Extension Period (Part 2)|Physician Decision|0
2626830|NCT00880763|9077802|P3|Extension Period (Part 2)|Physician Decision|1
2626831|NCT00880763|9077803|P2|Extension Period (Part 2)|Physician Decision|1
2626832|NCT00880763|9077804|P1|Extension Period (Part 2)|Physician Decision|0
2626833|NCT00880763|9077801|P4|Extension Period (Part 2)|Withdrawal by Subject|1
2626834|NCT00880763|9077802|P3|Extension Period (Part 2)|Withdrawal by Subject|1
2626835|NCT00880763|9077803|P2|Extension Period (Part 2)|Withdrawal by Subject|2
2626836|NCT00880763|9077804|P1|Extension Period (Part 2)|Withdrawal by Subject|0
2626837|NCT00880763|9077801|P4|Extension Period (Part 2)|Adverse Event|1
2626838|NCT00880763|9077802|P3|Extension Period (Part 2)|Adverse Event|1
2626839|NCT00880763|9077803|P2|Extension Period (Part 2)|Adverse Event|0
2626840|NCT00880763|9077804|P1|Extension Period (Part 2)|Adverse Event|0
2626841|NCT00880750|9077836|P2|Second Intervention|Unable to collect urine|0
2626842|NCT00880750|9077837|P1|Second Intervention|Unable to collect urine|1
2626843|NCT00880750|9077836|P2|Second Intervention|Protocol Violation|0
2626844|NCT00880750|9077837|P1|Second Intervention|Protocol Violation|1
2626845|NCT00880750|9077836|P2|Second Intervention|Withdrawal by Subject|2
2626846|NCT00880750|9077837|P1|Second Intervention|Withdrawal by Subject|2
2626847|NCT00880750|9077836|P2|First Intervention|Lost to Follow-up|0
2626848|NCT00880750|9077837|P1|First Intervention|Lost to Follow-up|2
2626849|NCT00880750|9077836|P2|First Intervention|Withdrawal by Subject|0
2626850|NCT00880750|9077837|P1|First Intervention|Withdrawal by Subject|2
2626851|NCT00880750|9077836|P2|First Intervention|Non-compliance with meals|1
2626852|NCT00880750|9077837|P1|First Intervention|Non-compliance with meals|0
2626853|NCT00880750|9077836|P2|First Intervention|Unable to collect urine|0
2626854|NCT00880750|9077837|P1|First Intervention|Unable to collect urine|4
2626855|NCT00880750|9077836|P2|First Intervention|Adverse Event|0
2626856|NCT00880750|9077837|P1|First Intervention|Adverse Event|1
2626857|NCT00880698|9077855|P4|Overall Study|Lost to Follow-up|1
2626858|NCT00880698|9077856|P3|Overall Study|Lost to Follow-up|0
2626859|NCT00880698|9077857|P2|Overall Study|Lost to Follow-up|3
2626860|NCT00880698|9077858|P1|Overall Study|Lost to Follow-up|1
2626861|NCT00880698|9077855|P4|Overall Study|Death|2
2626862|NCT00880698|9077856|P3|Overall Study|Death|1
2626863|NCT00880698|9077857|P2|Overall Study|Death|0
2626864|NCT00880698|9077858|P1|Overall Study|Death|0
2626865|NCT00880685|9077884|P1|Memantine 20mg|Withdrawal by Subject|1
2626866|NCT00880685|9077884|P1|Memantine 10mg|Lost to Follow-up|2
2626867|NCT00880620|9077896|P4|Overall Study|Other|2
2626868|NCT00880620|9077897|P3|Overall Study|Other|2
2626869|NCT00880620|9077898|P2|Overall Study|Other|1
2626870|NCT00880620|9077899|P1|Overall Study|Other|1
2626871|NCT00880620|9077896|P4|Overall Study|Noncompliance|1
2626872|NCT00880620|9077897|P3|Overall Study|Noncompliance|1
2626873|NCT00880620|9077898|P2|Overall Study|Noncompliance|0
2626874|NCT00880620|9077899|P1|Overall Study|Noncompliance|0
2626875|NCT00880620|9077896|P4|Overall Study|Withdrawal by Subject|3
2626876|NCT00880620|9077897|P3|Overall Study|Withdrawal by Subject|1
2626877|NCT00880620|9077898|P2|Overall Study|Withdrawal by Subject|3
2626878|NCT00880620|9077899|P1|Overall Study|Withdrawal by Subject|4
2626879|NCT00880620|9077896|P4|Overall Study|Protocol Violation|2
2626880|NCT00880620|9077897|P3|Overall Study|Protocol Violation|0
2626881|NCT00880620|9077898|P2|Overall Study|Protocol Violation|1
2626882|NCT00880620|9077899|P1|Overall Study|Protocol Violation|0
2626883|NCT00880620|9077896|P4|Overall Study|Lost to Follow-up|0
2626884|NCT00880620|9077897|P3|Overall Study|Lost to Follow-up|1
2626885|NCT00880620|9077898|P2|Overall Study|Lost to Follow-up|1
2626886|NCT00880620|9077899|P1|Overall Study|Lost to Follow-up|0
2626887|NCT00880620|9077896|P4|Overall Study|Lack of Efficacy|1
2626888|NCT00880620|9077897|P3|Overall Study|Lack of Efficacy|0
2626889|NCT00880620|9077898|P2|Overall Study|Lack of Efficacy|4
2626890|NCT00880620|9077899|P1|Overall Study|Lack of Efficacy|12
2626891|NCT00880620|9077896|P4|Overall Study|Death|0
2626892|NCT00880620|9077897|P3|Overall Study|Death|1
2626893|NCT00880620|9077898|P2|Overall Study|Death|0
2626894|NCT00880620|9077899|P1|Overall Study|Death|0
2626895|NCT00880620|9077896|P4|Overall Study|Adverse Event|15
2626896|NCT00880620|9077897|P3|Overall Study|Adverse Event|15
2626897|NCT00880620|9077898|P2|Overall Study|Adverse Event|5
2626898|NCT00880620|9077899|P1|Overall Study|Adverse Event|4
2626899|NCT00880607|9077915|P2|Overall Study|surgery did not extend past L1 level|0
2626900|NCT00880607|9077916|P1|Overall Study|surgery did not extend past L1 level|3
2626901|NCT00880607|9077915|P2|Overall Study|Protocol Violation|1
2626902|NCT00880607|9077916|P1|Overall Study|Protocol Violation|2
2626903|NCT00880607|9077915|P2|Overall Study|Physician Decision|2
2626904|NCT00880607|9077916|P1|Overall Study|Physician Decision|2
2626905|NCT00880568|9077948|P9|Overall Study|Withdrawal by Subject|0
2626906|NCT00880568|9077949|P8|Overall Study|Withdrawal by Subject|1
2626907|NCT00880568|9077950|P7|Overall Study|Withdrawal by Subject|0
2626908|NCT00880568|9077951|P6|Overall Study|Withdrawal by Subject|0
2626909|NCT00880568|9077952|P5|Overall Study|Withdrawal by Subject|0
2626910|NCT00880568|9077953|P4|Overall Study|Withdrawal by Subject|0
2626911|NCT00880568|9077954|P3|Overall Study|Withdrawal by Subject|0
2626912|NCT00880568|9077955|P2|Overall Study|Withdrawal by Subject|0
2626913|NCT00880568|9077956|P1|Overall Study|Withdrawal by Subject|0
2626914|NCT00880568|9077948|P9|Overall Study|Adverse Event|0
2626915|NCT00880568|9077949|P8|Overall Study|Adverse Event|1
2626916|NCT00880568|9077950|P7|Overall Study|Adverse Event|1
2626917|NCT00880568|9077951|P6|Overall Study|Adverse Event|0
2626918|NCT00880568|9077952|P5|Overall Study|Adverse Event|0
2626919|NCT00880568|9077953|P4|Overall Study|Adverse Event|0
2626920|NCT00880568|9077954|P3|Overall Study|Adverse Event|0
2626921|NCT00880568|9077955|P2|Overall Study|Adverse Event|0
2626922|NCT00880568|9077956|P1|Overall Study|Adverse Event|0
2626923|NCT00880568|9077948|P9|Overall Study|Disease progression|3
2626924|NCT00880568|9077949|P8|Overall Study|Disease progression|0
2626925|NCT00880568|9077950|P7|Overall Study|Disease progression|5
2626926|NCT00880568|9077951|P6|Overall Study|Disease progression|3
2626927|NCT00880568|9077952|P5|Overall Study|Disease progression|3
2626928|NCT00880568|9077953|P4|Overall Study|Disease progression|1
2626929|NCT00880568|9077954|P3|Overall Study|Disease progression|3
2626930|NCT00880568|9077955|P2|Overall Study|Disease progression|3
2626931|NCT00880568|9077956|P1|Overall Study|Disease progression|3
2626932|NCT00880555|9078002|P6|Overall Study|Lost to Follow-up|0
2626933|NCT00880555|9078003|P5|Overall Study|Lost to Follow-up|0
2626934|NCT00880555|9078004|P4|Overall Study|Lost to Follow-up|0
2626935|NCT00880555|9078005|P3|Overall Study|Lost to Follow-up|0
2626936|NCT00880555|9078006|P2|Overall Study|Lost to Follow-up|1
2626937|NCT00880555|9078007|P1|Overall Study|Lost to Follow-up|0
2626938|NCT00880555|9078002|P6|Overall Study|Death|1
2626939|NCT00880555|9078003|P5|Overall Study|Death|0
2626940|NCT00880555|9078004|P4|Overall Study|Death|0
2626941|NCT00880555|9078005|P3|Overall Study|Death|0
2626942|NCT00880555|9078006|P2|Overall Study|Death|0
2626943|NCT00880555|9078007|P1|Overall Study|Death|0
2626944|NCT00880555|9078002|P6|Overall Study|Lack of resources (hired rater)|0
2626945|NCT00880555|9078003|P5|Overall Study|Lack of resources (hired rater)|0
2626946|NCT00880555|9078004|P4|Overall Study|Lack of resources (hired rater)|0
2626947|NCT00880555|9078005|P3|Overall Study|Lack of resources (hired rater)|5
2626948|NCT00880555|9078006|P2|Overall Study|Lack of resources (hired rater)|7
2626949|NCT00880555|9078007|P1|Overall Study|Lack of resources (hired rater)|9
2626950|NCT00880555|9078002|P6|Overall Study|Withdrawal by Subject|0
2626951|NCT00880555|9078003|P5|Overall Study|Withdrawal by Subject|0
2626952|NCT00880555|9078004|P4|Overall Study|Withdrawal by Subject|0
2626953|NCT00880555|9078005|P3|Overall Study|Withdrawal by Subject|0
2626954|NCT00880555|9078006|P2|Overall Study|Withdrawal by Subject|1
2626955|NCT00880555|9078007|P1|Overall Study|Withdrawal by Subject|1
2626956|NCT00880555|9078002|P6|Overall Study|Physician Decision|0
2626957|NCT00880555|9078003|P5|Overall Study|Physician Decision|1
2626958|NCT00880555|9078004|P4|Overall Study|Physician Decision|2
2626959|NCT00880555|9078005|P3|Overall Study|Physician Decision|0
2626960|NCT00880555|9078006|P2|Overall Study|Physician Decision|8
2626961|NCT00880555|9078007|P1|Overall Study|Physician Decision|0
2626962|NCT00880542|9078018|P1|REP: Surgical Resection|progressive disease|1
2626963|NCT00880542|9078018|P1|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2
2626964|NCT00880542|9078018|P1|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1
2626965|NCT00880399|9078035|P3|Overall Study|Withdrawal by Subject|3
2626966|NCT00880399|9078036|P2|Overall Study|Withdrawal by Subject|3
2626967|NCT00880399|9078037|P1|Overall Study|Withdrawal by Subject|6
2626968|NCT00880399|9078035|P3|Overall Study|Physician Decision|3
2626969|NCT00880399|9078036|P2|Overall Study|Physician Decision|0
2626970|NCT00880399|9078037|P1|Overall Study|Physician Decision|5
2626971|NCT00880399|9078035|P3|Overall Study|Lost to Follow-up|3
2626972|NCT00880399|9078036|P2|Overall Study|Lost to Follow-up|5
2626973|NCT00880399|9078037|P1|Overall Study|Lost to Follow-up|8
2626974|NCT00880399|9078035|P3|Overall Study|Study closed/terminated|4
2626975|NCT00880399|9078036|P2|Overall Study|Study closed/terminated|7
2626976|NCT00880399|9078037|P1|Overall Study|Study closed/terminated|3
2626977|NCT00880399|9078035|P3|Overall Study|Protocol Violation|6
2626978|NCT00880399|9078036|P2|Overall Study|Protocol Violation|4
2626979|NCT00880399|9078037|P1|Overall Study|Protocol Violation|4
2626980|NCT00880399|9078035|P3|Overall Study|Lack of Efficacy|2
2626981|NCT00880399|9078036|P2|Overall Study|Lack of Efficacy|4
2626982|NCT00880399|9078037|P1|Overall Study|Lack of Efficacy|1
2626983|NCT00880399|9078035|P3|Overall Study|Adverse Event|5
2626984|NCT00880399|9078036|P2|Overall Study|Adverse Event|6
2626985|NCT00880399|9078037|P1|Overall Study|Adverse Event|4
2626986|NCT00880334|9078100|P2|Randomized Phase|Crossover Participants|37
2626987|NCT00880334|9078101|P1|Randomized Phase|Crossover Participants|0
2626988|NCT00880334|9078100|P2|Randomized Phase|Brain Metastasis|1
2626989|NCT00880334|9078101|P1|Randomized Phase|Brain Metastasis|0
2626990|NCT00880334|9078100|P2|Randomized Phase|Inadequate Labs|1
2626991|NCT00880334|9078101|P1|Randomized Phase|Inadequate Labs|1
2626992|NCT00880334|9078100|P2|Randomized Phase|Withdrawal by Subject|1
2626993|NCT00880334|9078101|P1|Randomized Phase|Withdrawal by Subject|2
2626994|NCT00880334|9078100|P2|Randomized Phase|Physician Decision|0
2626995|NCT00880334|9078101|P1|Randomized Phase|Physician Decision|1
2626996|NCT00880269|9078118|P2|Overall Study|Adverse Event|9
2626997|NCT00880269|9078119|P1|Overall Study|Adverse Event|10
2626998|NCT00880269|9078118|P2|Overall Study|Withdrawal by Subject|4
2626999|NCT00880269|9078119|P1|Overall Study|Withdrawal by Subject|3
2627000|NCT00880269|9078118|P2|Overall Study|Lost to Follow-up|1
2627001|NCT00880269|9078119|P1|Overall Study|Lost to Follow-up|0
2627002|NCT00880269|9078118|P2|Overall Study|Death|2
2627003|NCT00880269|9078119|P1|Overall Study|Death|4
2627004|NCT00880269|9078118|P2|Overall Study|New Cancer Therapy|0
2627005|NCT00880269|9078119|P1|Overall Study|New Cancer Therapy|1
2627006|NCT00880269|9078118|P2|Overall Study|Disease Progression|11
2627007|NCT00880269|9078119|P1|Overall Study|Disease Progression|13
2627008|NCT00880269|9078118|P2|Overall Study|Protocol Violation|0
2627009|NCT00880269|9078119|P1|Overall Study|Protocol Violation|1
2627010|NCT00880256|9078135|P1|Overall Study|Lost to Follow-up|28
2627011|NCT00880191|9078162|P2|Overall Study|Hospitalization/efficacy|1
2627012|NCT00880191|9078163|P1|Overall Study|Hospitalization/efficacy|1
2627013|NCT00880191|9078162|P2|Overall Study|Adverse Event|6
2627014|NCT00880191|9078163|P1|Overall Study|Adverse Event|8
2627015|NCT00880191|9078162|P2|Overall Study|Refused further treatment|1
2627016|NCT00880191|9078163|P1|Overall Study|Refused further treatment|4
2627017|NCT00880165|9078183|P2|Overall Study|Lost to follow|15
2627018|NCT00880165|9078184|P1|Overall Study|Lost to follow|9
2627019|NCT00880165|9078183|P2|Overall Study|Required BIPAP or oxygen treatment|4
2627020|NCT00880165|9078184|P1|Overall Study|Required BIPAP or oxygen treatment|12
2627021|NCT00880165|9078183|P2|Overall Study|Not diagnosed with OSA|8
2627022|NCT00880165|9078184|P1|Overall Study|Not diagnosed with OSA|14
2627023|NCT00880165|9078183|P2|Overall Study|Withdrawal by Subject|23
2627024|NCT00880165|9078184|P1|Overall Study|Withdrawal by Subject|27
2627025|NCT00880100|9078194|P1|Treatment Phase With Ultrase® MT12|Protocol Violation|2
2627026|NCT00880100|9078194|P1|Treatment Phase With Ultrase® MT12|Adverse Event|1
2627027|NCT00880100|9078194|P1|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1
2627028|NCT00880087|9078207|P2|Overall Study|Lost to Follow-up|2
2627029|NCT00880087|9078208|P1|Overall Study|Lost to Follow-up|0
2627030|NCT00880048|9078223|P3|Overall Study|Study closed/terminated|6
2627031|NCT00880048|9078224|P2|Overall Study|Study closed/terminated|7
2627032|NCT00880048|9078225|P1|Overall Study|Study closed/terminated|9
2627033|NCT00880048|9078223|P3|Overall Study|Withdrawal by Subject|5
2627034|NCT00880048|9078224|P2|Overall Study|Withdrawal by Subject|8
2627035|NCT00880048|9078225|P1|Overall Study|Withdrawal by Subject|5
2627036|NCT00880048|9078223|P3|Overall Study|Physician Decision|7
2627037|NCT00880048|9078224|P2|Overall Study|Physician Decision|1
2627038|NCT00880048|9078225|P1|Overall Study|Physician Decision|1
2627039|NCT00880048|9078223|P3|Overall Study|Lost to Follow-up|5
2627040|NCT00880048|9078224|P2|Overall Study|Lost to Follow-up|6
2627041|NCT00880048|9078225|P1|Overall Study|Lost to Follow-up|6
2627042|NCT00880048|9078223|P3|Overall Study|Protocol Violation|5
2627043|NCT00880048|9078224|P2|Overall Study|Protocol Violation|6
2627044|NCT00880048|9078225|P1|Overall Study|Protocol Violation|4
2627045|NCT00880048|9078223|P3|Overall Study|Lack of Efficacy|2
2627046|NCT00880048|9078224|P2|Overall Study|Lack of Efficacy|2
2627047|NCT00880048|9078225|P1|Overall Study|Lack of Efficacy|1
2627048|NCT00880048|9078223|P3|Overall Study|Adverse Event|5
2627049|NCT00880048|9078224|P2|Overall Study|Adverse Event|3
2627050|NCT00880048|9078225|P1|Overall Study|Adverse Event|2
2627051|NCT00880009|9078292|P1|Overall Study|Protocol Violation|1
2627052|NCT00880009|9078292|P1|Overall Study|Withdrawal by Subject|1
2627053|NCT00880009|9078292|P1|Overall Study|Study terminated by sponsor|14
2627054|NCT00879996|9078316|P2|Overall Study|put on parole|0
2627055|NCT00879996|9078317|P1|Overall Study|put on parole|1
2627056|NCT00879996|9078316|P2|Overall Study|psychiatric problem|1
2627057|NCT00879996|9078317|P1|Overall Study|psychiatric problem|0
2627058|NCT00879996|9078316|P2|Overall Study|Physician Decision|2
2627059|NCT00879996|9078317|P1|Overall Study|Physician Decision|1
2627060|NCT00879996|9078316|P2|Overall Study|non-compliance|4
2627061|NCT00879996|9078317|P1|Overall Study|non-compliance|6
2627062|NCT00879996|9078316|P2|Overall Study|Lost to Follow-up|6
2627063|NCT00879996|9078317|P1|Overall Study|Lost to Follow-up|7
2627064|NCT00879970|9078332|P5|Period 2 Vitamin D Randomization|Death|0
2627065|NCT00879970|9078333|P4|Period 2 Vitamin D Randomization|Death|2
2627066|NCT00879970|9078334|P3|Period 2 Vitamin D Randomization|Death|0
2627067|NCT00879970|9078335|P2|Period 2 Vitamin D Randomization|Death|0
2627068|NCT00879970|9078336|P1|Period 2 Vitamin D Randomization|Death|0
2627069|NCT00879970|9078332|P5|Period 2 Vitamin D Randomization|Lost to Follow-up|1
2627070|NCT00879970|9078333|P4|Period 2 Vitamin D Randomization|Lost to Follow-up|0
2627071|NCT00879970|9078334|P3|Period 2 Vitamin D Randomization|Lost to Follow-up|0
2627072|NCT00879970|9078335|P2|Period 2 Vitamin D Randomization|Lost to Follow-up|0
2627073|NCT00879970|9078336|P1|Period 2 Vitamin D Randomization|Lost to Follow-up|0
2627074|NCT00879970|9078332|P5|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6
2627075|NCT00879970|9078333|P4|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2
2627076|NCT00879970|9078334|P3|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
2627077|NCT00879970|9078335|P2|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
2627078|NCT00879970|9078336|P1|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
2627079|NCT00879970|9078332|P5|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
2627080|NCT00879970|9078333|P4|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
2627081|NCT00879970|9078334|P3|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1
2627082|NCT00879970|9078335|P2|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
2627083|NCT00879970|9078336|P1|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2
2627084|NCT00879970|9078332|P5|Period 1 TZD Randomization|Death|0
2627085|NCT00879970|9078333|P4|Period 1 TZD Randomization|Death|0
2627086|NCT00879970|9078334|P3|Period 1 TZD Randomization|Death|0
2627087|NCT00879970|9078335|P2|Period 1 TZD Randomization|Death|1
2627088|NCT00879970|9078336|P1|Period 1 TZD Randomization|Death|2
2627089|NCT00879970|9078332|P5|Period 1 TZD Randomization|Lost to Follow-up|0
2627090|NCT00879970|9078333|P4|Period 1 TZD Randomization|Lost to Follow-up|0
2627091|NCT00879970|9078334|P3|Period 1 TZD Randomization|Lost to Follow-up|1
2627092|NCT00879970|9078335|P2|Period 1 TZD Randomization|Lost to Follow-up|0
2627093|NCT00879970|9078336|P1|Period 1 TZD Randomization|Lost to Follow-up|1
2627094|NCT00879970|9078332|P5|Period 1 TZD Randomization|Refused to Attend Final Visit|0
2627095|NCT00879970|9078333|P4|Period 1 TZD Randomization|Refused to Attend Final Visit|0
2627096|NCT00879970|9078334|P3|Period 1 TZD Randomization|Refused to Attend Final Visit|4
2627097|NCT00879970|9078335|P2|Period 1 TZD Randomization|Refused to Attend Final Visit|3
2627098|NCT00879970|9078336|P1|Period 1 TZD Randomization|Refused to Attend Final Visit|3
2627099|NCT00879879|9078418|P1|Overall Study|Physician Decision|1
2627100|NCT00879879|9078418|P1|Overall Study|Withdrawal by Subject|1
2627101|NCT00879879|9078418|P1|Overall Study|Death|1
2627102|NCT00879814|9078426|P4|Overall Study|Other|0
2627103|NCT00879814|9078427|P3|Overall Study|Other|1
2627104|NCT00879814|9078428|P2|Overall Study|Other|0
2627105|NCT00879814|9078429|P1|Overall Study|Other|0
2627106|NCT00879814|9078426|P4|Overall Study|Physician Decision|0
2627107|NCT00879814|9078427|P3|Overall Study|Physician Decision|1
2627108|NCT00879814|9078428|P2|Overall Study|Physician Decision|0
2627109|NCT00879814|9078429|P1|Overall Study|Physician Decision|0
2627110|NCT00879814|9078426|P4|Overall Study|Withdrawal by Subject|2
2627111|NCT00879814|9078427|P3|Overall Study|Withdrawal by Subject|1
2627112|NCT00879814|9078428|P2|Overall Study|Withdrawal by Subject|1
2627113|NCT00879814|9078429|P1|Overall Study|Withdrawal by Subject|3
2627114|NCT00879814|9078426|P4|Overall Study|Participant Failed to Return|1
2627115|NCT00879814|9078427|P3|Overall Study|Participant Failed to Return|0
2627116|NCT00879814|9078428|P2|Overall Study|Participant Failed to Return|0
2627117|NCT00879814|9078429|P1|Overall Study|Participant Failed to Return|0
2627118|NCT00879814|9078426|P4|Overall Study|Lost to Follow-up|2
2627119|NCT00879814|9078427|P3|Overall Study|Lost to Follow-up|0
2627120|NCT00879814|9078428|P2|Overall Study|Lost to Follow-up|0
2627121|NCT00879814|9078429|P1|Overall Study|Lost to Follow-up|1
2627122|NCT00879814|9078426|P4|Overall Study|Adverse Event|0
2627123|NCT00879814|9078427|P3|Overall Study|Adverse Event|0
2627124|NCT00879814|9078428|P2|Overall Study|Adverse Event|1
2627125|NCT00879814|9078429|P1|Overall Study|Adverse Event|0
2627126|NCT00879775|9078537|P2|Overall Study|Lost to Follow-up|1
2627127|NCT00879775|9078538|P1|Overall Study|Lost to Follow-up|2
2627128|NCT00879710|9078554|P4|Phase 1 - 6 Weeks|Adverse Event|0
2627129|NCT00879710|9078555|P3|Phase 1 - 6 Weeks|Adverse Event|1
2627130|NCT00879710|9078556|P2|Phase 1 - 6 Weeks|Adverse Event|0
2627131|NCT00879710|9078557|P1|Phase 1 - 6 Weeks|Adverse Event|0
2627132|NCT00879710|9078554|P4|Phase 1 - 6 Weeks|Lost to Follow-up|4
2627133|NCT00879710|9078555|P3|Phase 1 - 6 Weeks|Lost to Follow-up|1
2627134|NCT00879710|9078556|P2|Phase 1 - 6 Weeks|Lost to Follow-up|3
2627135|NCT00879710|9078557|P1|Phase 1 - 6 Weeks|Lost to Follow-up|2
2627136|NCT00879697|9078567|P2|Overall Study|Physician Decision|2
2627137|NCT00879697|9078568|P1|Overall Study|Physician Decision|2
2627138|NCT00879684|9078574|P7|Stage 2: Expanded Cohort|Investigator declined participation|1
2627139|NCT00879684|9078575|P6|Stage 2: Expanded Cohort|Investigator declined participation|0
2627140|NCT00879684|9078576|P5|Stage 2: Expanded Cohort|Investigator declined participation|0
2627141|NCT00879684|9078577|P4|Stage 2: Expanded Cohort|Investigator declined participation|0
2627142|NCT00879684|9078578|P3|Stage 2: Expanded Cohort|Investigator declined participation|0
2627143|NCT00879684|9078579|P2|Stage 2: Expanded Cohort|Investigator declined participation|0
2627144|NCT00879684|9078580|P1|Stage 2: Expanded Cohort|Investigator declined participation|0
2627145|NCT00879684|9078574|P7|Stage 2: Expanded Cohort|Progressive Disease|11
2627146|NCT00879684|9078575|P6|Stage 2: Expanded Cohort|Progressive Disease|0
2627147|NCT00879684|9078576|P5|Stage 2: Expanded Cohort|Progressive Disease|0
2627148|NCT00879684|9078577|P4|Stage 2: Expanded Cohort|Progressive Disease|0
2627149|NCT00879684|9078578|P3|Stage 2: Expanded Cohort|Progressive Disease|0
2627150|NCT00879684|9078579|P2|Stage 2: Expanded Cohort|Progressive Disease|0
2627151|NCT00879684|9078580|P1|Stage 2: Expanded Cohort|Progressive Disease|0
2627152|NCT00879684|9078574|P7|Stage 2: Expanded Cohort|Lost to Follow-up|1
2627153|NCT00879684|9078575|P6|Stage 2: Expanded Cohort|Lost to Follow-up|0
2627154|NCT00879684|9078576|P5|Stage 2: Expanded Cohort|Lost to Follow-up|0
2627155|NCT00879684|9078577|P4|Stage 2: Expanded Cohort|Lost to Follow-up|0
2627156|NCT00879684|9078578|P3|Stage 2: Expanded Cohort|Lost to Follow-up|0
2627157|NCT00879684|9078579|P2|Stage 2: Expanded Cohort|Lost to Follow-up|0
2627158|NCT00879684|9078580|P1|Stage 2: Expanded Cohort|Lost to Follow-up|0
2627159|NCT00879684|9078574|P7|Stage 1: Dose Escalation|Death|0
2627160|NCT00879684|9078575|P6|Stage 1: Dose Escalation|Death|0
2627161|NCT00879684|9078576|P5|Stage 1: Dose Escalation|Death|0
2627162|NCT00879684|9078577|P4|Stage 1: Dose Escalation|Death|0
2627163|NCT00879684|9078578|P3|Stage 1: Dose Escalation|Death|1
2627164|NCT00879684|9078579|P2|Stage 1: Dose Escalation|Death|0
2627165|NCT00879684|9078580|P1|Stage 1: Dose Escalation|Death|0
2627166|NCT00879684|9078574|P7|Stage 1: Dose Escalation|Investigator declined participation|0
2627167|NCT00879684|9078575|P6|Stage 1: Dose Escalation|Investigator declined participation|0
2627168|NCT00879684|9078576|P5|Stage 1: Dose Escalation|Investigator declined participation|0
2627169|NCT00879684|9078577|P4|Stage 1: Dose Escalation|Investigator declined participation|2
2627170|NCT00879684|9078578|P3|Stage 1: Dose Escalation|Investigator declined participation|2
2627171|NCT00879684|9078579|P2|Stage 1: Dose Escalation|Investigator declined participation|0
2627172|NCT00879684|9078580|P1|Stage 1: Dose Escalation|Investigator declined participation|0
2627173|NCT00879684|9078574|P7|Stage 1: Dose Escalation|Progressive Disease|0
2627174|NCT00879684|9078575|P6|Stage 1: Dose Escalation|Progressive Disease|3
2627175|NCT00879684|9078576|P5|Stage 1: Dose Escalation|Progressive Disease|3
2627176|NCT00879684|9078577|P4|Stage 1: Dose Escalation|Progressive Disease|4
2627177|NCT00879684|9078578|P3|Stage 1: Dose Escalation|Progressive Disease|0
2627178|NCT00879684|9078579|P2|Stage 1: Dose Escalation|Progressive Disease|3
2627179|NCT00879684|9078580|P1|Stage 1: Dose Escalation|Progressive Disease|2
2627180|NCT00879684|9078574|P7|Stage 1: Dose Escalation|Adverse Event|0
2627181|NCT00879684|9078575|P6|Stage 1: Dose Escalation|Adverse Event|0
2627182|NCT00879684|9078576|P5|Stage 1: Dose Escalation|Adverse Event|0
2627183|NCT00879684|9078577|P4|Stage 1: Dose Escalation|Adverse Event|0
2627184|NCT00879684|9078578|P3|Stage 1: Dose Escalation|Adverse Event|0
2627185|NCT00879684|9078579|P2|Stage 1: Dose Escalation|Adverse Event|0
2627186|NCT00879684|9078580|P1|Stage 1: Dose Escalation|Adverse Event|1
2627187|NCT00879658|9078649|P7|Overall Study|misrandomized (never received study med)|0
2627188|NCT00879658|9078650|P6|Overall Study|misrandomized (never received study med)|0
2627189|NCT00879658|9078651|P5|Overall Study|misrandomized (never received study med)|0
2627190|NCT00879658|9078652|P4|Overall Study|misrandomized (never received study med)|1
2627191|NCT00879658|9078653|P3|Overall Study|misrandomized (never received study med)|0
2627192|NCT00879658|9078654|P2|Overall Study|misrandomized (never received study med)|0
2627193|NCT00879658|9078655|P1|Overall Study|misrandomized (never received study med)|0
2627194|NCT00879658|9078649|P7|Overall Study|Lack of Efficacy|0
2627195|NCT00879658|9078650|P6|Overall Study|Lack of Efficacy|0
2627196|NCT00879658|9078651|P5|Overall Study|Lack of Efficacy|0
2627197|NCT00879658|9078652|P4|Overall Study|Lack of Efficacy|0
2627198|NCT00879658|9078653|P3|Overall Study|Lack of Efficacy|2
2627199|NCT00879658|9078654|P2|Overall Study|Lack of Efficacy|0
2627200|NCT00879658|9078655|P1|Overall Study|Lack of Efficacy|0
2627201|NCT00879658|9078649|P7|Overall Study|Withdrawal by Subject|0
2627202|NCT00879658|9078650|P6|Overall Study|Withdrawal by Subject|1
2627203|NCT00879658|9078651|P5|Overall Study|Withdrawal by Subject|0
2627204|NCT00879658|9078652|P4|Overall Study|Withdrawal by Subject|0
2627205|NCT00879658|9078653|P3|Overall Study|Withdrawal by Subject|2
2627206|NCT00879658|9078654|P2|Overall Study|Withdrawal by Subject|0
2627207|NCT00879658|9078655|P1|Overall Study|Withdrawal by Subject|3
2627208|NCT00879658|9078649|P7|Overall Study|Protocol Violation|0
2627209|NCT00879658|9078650|P6|Overall Study|Protocol Violation|0
2627210|NCT00879658|9078651|P5|Overall Study|Protocol Violation|0
2627211|NCT00879658|9078652|P4|Overall Study|Protocol Violation|0
2627212|NCT00879658|9078653|P3|Overall Study|Protocol Violation|0
2627213|NCT00879658|9078654|P2|Overall Study|Protocol Violation|0
2627214|NCT00879658|9078655|P1|Overall Study|Protocol Violation|1
2627215|NCT00879658|9078649|P7|Overall Study|Adverse Event|0
2627216|NCT00879658|9078650|P6|Overall Study|Adverse Event|0
2627217|NCT00879658|9078651|P5|Overall Study|Adverse Event|2
2627218|NCT00879658|9078652|P4|Overall Study|Adverse Event|1
2627219|NCT00879658|9078653|P3|Overall Study|Adverse Event|3
2627220|NCT00879658|9078654|P2|Overall Study|Adverse Event|4
2627221|NCT00879658|9078655|P1|Overall Study|Adverse Event|6
2627222|NCT00879658|9078649|P7|Overall Study|Administrative problems|0
2627223|NCT00879658|9078650|P6|Overall Study|Administrative problems|0
2627224|NCT00879658|9078651|P5|Overall Study|Administrative problems|0
2627225|NCT00879658|9078652|P4|Overall Study|Administrative problems|1
2627226|NCT00879658|9078653|P3|Overall Study|Administrative problems|0
2627227|NCT00879658|9078654|P2|Overall Study|Administrative problems|1
2627228|NCT00879658|9078655|P1|Overall Study|Administrative problems|2
2627229|NCT00879658|9078649|P7|Overall Study|Abnormal laboratory value(s)|0
2627230|NCT00879658|9078650|P6|Overall Study|Abnormal laboratory value(s)|0
2627231|NCT00879658|9078651|P5|Overall Study|Abnormal laboratory value(s)|0
2627232|NCT00879658|9078652|P4|Overall Study|Abnormal laboratory value(s)|1
2627233|NCT00879658|9078653|P3|Overall Study|Abnormal laboratory value(s)|0
2627234|NCT00879658|9078654|P2|Overall Study|Abnormal laboratory value(s)|0
2627235|NCT00879658|9078655|P1|Overall Study|Abnormal laboratory value(s)|3
2627236|NCT00879645|9078741|P4|Overall Study|Adverse Event|0
2627237|NCT00879645|9078742|P3|Overall Study|Adverse Event|0
2627238|NCT00879645|9078743|P2|Overall Study|Adverse Event|0
2627239|NCT00879645|9078744|P1|Overall Study|Adverse Event|1
2627240|NCT00879411|9078771|P1|Overall Study|lost to follow-up (non-AE)|162
2627241|NCT00879398|9078777|P1|Overall Study|Other Reasons|171
2627242|NCT00879398|9078777|P1|Overall Study|Adverse Event|41
2627243|NCT00879398|9078777|P1|Overall Study|Lack of Efficacy|64
2627244|NCT00879398|9078777|P1|Overall Study|Visit Stop|399
2627245|NCT00879333|9078795|P2|Overall Study|Protocol Violation|1
2627246|NCT00879333|9078796|P1|Overall Study|Protocol Violation|1
2627247|NCT00879333|9078795|P2|Overall Study|Disease Progression|169
2627248|NCT00879333|9078796|P1|Overall Study|Disease Progression|292
2627249|NCT00879333|9078795|P2|Overall Study|Death|5
2627250|NCT00879333|9078796|P1|Overall Study|Death|16
2627251|NCT00879333|9078795|P2|Overall Study|Administrative Problems|0
2627252|NCT00879333|9078796|P1|Overall Study|Administrative Problems|2
2627253|NCT00879333|9078795|P2|Overall Study|Lost to Follow-up|1
2627254|NCT00879333|9078796|P1|Overall Study|Lost to Follow-up|2
2627255|NCT00879333|9078795|P2|Overall Study|Withdrawal by Subject|7
2627256|NCT00879333|9078796|P1|Overall Study|Withdrawal by Subject|20
2627257|NCT00879333|9078795|P2|Overall Study|Abnormal Laboratory Value|0
2627258|NCT00879333|9078796|P1|Overall Study|Abnormal Laboratory Value|1
2627259|NCT00879333|9078795|P2|Overall Study|Adverse Event|34
2627260|NCT00879333|9078796|P1|Overall Study|Adverse Event|94
2627261|NCT00879229|9078829|P2|Overall Study|Other|0
2627262|NCT00879229|9078830|P1|Overall Study|Other|1
2627263|NCT00879229|9078829|P2|Overall Study|Clinical status did not improve|0
2627264|NCT00879229|9078830|P1|Overall Study|Clinical status did not improve|1
2627265|NCT00879229|9078829|P2|Overall Study|Withdrawal by Subject|0
2627266|NCT00879229|9078830|P1|Overall Study|Withdrawal by Subject|1
2627267|NCT00879229|9078829|P2|Overall Study|Adverse Event|0
2627268|NCT00879229|9078830|P1|Overall Study|Adverse Event|2
2627269|NCT00879229|9078829|P2|Overall Study|Death|2
2627270|NCT00879229|9078830|P1|Overall Study|Death|4
2627271|NCT00879229|9078829|P2|Overall Study|Study terminated by Sponsor|12
2627272|NCT00879229|9078830|P1|Overall Study|Study terminated by Sponsor|13
2627273|NCT00878995|9078878|P2|Baseline Study - Midpoint Study|Withdrawal by Subject|2
2627274|NCT00878995|9078879|P1|Baseline Study - Midpoint Study|Withdrawal by Subject|0
2627275|NCT00878969|9078980|P3|Overall Study|Pregnancy|0
2627276|NCT00878969|9078981|P2|Overall Study|Pregnancy|1
2627277|NCT00878969|9078982|P1|Overall Study|Pregnancy|0
2627278|NCT00878969|9078980|P3|Overall Study|Death|2
2627279|NCT00878969|9078981|P2|Overall Study|Death|0
2627280|NCT00878969|9078982|P1|Overall Study|Death|0
2627281|NCT00878969|9078980|P3|Overall Study|Protocol Violation|0
2627282|NCT00878969|9078981|P2|Overall Study|Protocol Violation|0
2627283|NCT00878969|9078982|P1|Overall Study|Protocol Violation|2
2627284|NCT00878969|9078980|P3|Overall Study|Lost to Follow-up|0
2627285|NCT00878969|9078981|P2|Overall Study|Lost to Follow-up|1
2627286|NCT00878969|9078982|P1|Overall Study|Lost to Follow-up|2
2627287|NCT00878969|9078980|P3|Overall Study|Adverse Event|2
2627288|NCT00878969|9078981|P2|Overall Study|Adverse Event|1
2627289|NCT00878969|9078982|P1|Overall Study|Adverse Event|3
2627290|NCT00878969|9078980|P3|Overall Study|kidney transplant|2
2627291|NCT00878969|9078981|P2|Overall Study|kidney transplant|3
2627292|NCT00878969|9078982|P1|Overall Study|kidney transplant|2
2627293|NCT00878969|9078980|P3|Overall Study|Withdrawal by Subject|3
2627294|NCT00878969|9078981|P2|Overall Study|Withdrawal by Subject|6
2627295|NCT00878969|9078982|P1|Overall Study|Withdrawal by Subject|1
2627296|NCT00878969|9078980|P3|Overall Study|Physician Decision|2
2627297|NCT00878969|9078981|P2|Overall Study|Physician Decision|3
2627298|NCT00878969|9078982|P1|Overall Study|Physician Decision|5
2627299|NCT00878800|9079030|P5|Overall Study|Other|1
2627300|NCT00878800|9079031|P4|Overall Study|Other|0
2627301|NCT00878800|9079032|P3|Overall Study|Other|0
2627302|NCT00878800|9079033|P2|Overall Study|Other|1
2627303|NCT00878800|9079034|P1|Overall Study|Other|1
2627304|NCT00878800|9079030|P5|Overall Study|Death|0
2627305|NCT00878800|9079031|P4|Overall Study|Death|0
2627306|NCT00878800|9079032|P3|Overall Study|Death|1
2627307|NCT00878800|9079033|P2|Overall Study|Death|0
2627308|NCT00878800|9079034|P1|Overall Study|Death|0
2627309|NCT00878800|9079030|P5|Overall Study|Withdrew consent|1
2627310|NCT00878800|9079031|P4|Overall Study|Withdrew consent|1
2627311|NCT00878800|9079032|P3|Overall Study|Withdrew consent|0
2627312|NCT00878800|9079033|P2|Overall Study|Withdrew consent|1
2627313|NCT00878800|9079034|P1|Overall Study|Withdrew consent|1
2627314|NCT00878800|9079030|P5|Overall Study|Progressive disease|13
2627315|NCT00878800|9079031|P4|Overall Study|Progressive disease|5
2627316|NCT00878800|9079032|P3|Overall Study|Progressive disease|6
2627317|NCT00878800|9079033|P2|Overall Study|Progressive disease|5
2627318|NCT00878800|9079034|P1|Overall Study|Progressive disease|1
2627319|NCT00878800|9079030|P5|Overall Study|Adverse Event|1
2627320|NCT00878800|9079031|P4|Overall Study|Adverse Event|0
2627321|NCT00878800|9079032|P3|Overall Study|Adverse Event|2
2627322|NCT00878800|9079033|P2|Overall Study|Adverse Event|0
2627323|NCT00878800|9079034|P1|Overall Study|Adverse Event|0
2627324|NCT00878722|9079069|P8|Overall Study|Relapse|0
2627325|NCT00878722|9079070|P7|Overall Study|Relapse|0
2627326|NCT00878722|9079071|P6|Overall Study|Relapse|0
2627327|NCT00878722|9079072|P5|Overall Study|Relapse|0
2627328|NCT00878722|9079073|P4|Overall Study|Relapse|1
2627329|NCT00878722|9079074|P3|Overall Study|Relapse|0
2627330|NCT00878722|9079075|P2|Overall Study|Relapse|0
2627331|NCT00878722|9079076|P1|Overall Study|Relapse|0
2627332|NCT00878722|9079069|P8|Overall Study|Withdrawal by Subject|2
2627333|NCT00878722|9079070|P7|Overall Study|Withdrawal by Subject|0
2627334|NCT00878722|9079071|P6|Overall Study|Withdrawal by Subject|0
2627335|NCT00878722|9079072|P5|Overall Study|Withdrawal by Subject|0
2627336|NCT00878722|9079073|P4|Overall Study|Withdrawal by Subject|0
2627337|NCT00878722|9079074|P3|Overall Study|Withdrawal by Subject|0
2627338|NCT00878722|9079075|P2|Overall Study|Withdrawal by Subject|0
2627339|NCT00878722|9079076|P1|Overall Study|Withdrawal by Subject|0
2627340|NCT00878722|9079069|P8|Overall Study|Adverse Event|0
2627341|NCT00878722|9079070|P7|Overall Study|Adverse Event|2
2627342|NCT00878722|9079071|P6|Overall Study|Adverse Event|0
2627343|NCT00878722|9079072|P5|Overall Study|Adverse Event|0
2627344|NCT00878722|9079073|P4|Overall Study|Adverse Event|0
2627345|NCT00878722|9079074|P3|Overall Study|Adverse Event|0
2627346|NCT00878722|9079075|P2|Overall Study|Adverse Event|0
2627347|NCT00878722|9079076|P1|Overall Study|Adverse Event|0
2627348|NCT00878722|9079069|P8|Overall Study|Death|2
2627349|NCT00878722|9079070|P7|Overall Study|Death|0
2627350|NCT00878722|9079071|P6|Overall Study|Death|1
2627351|NCT00878722|9079072|P5|Overall Study|Death|0
2627352|NCT00878722|9079073|P4|Overall Study|Death|1
2627353|NCT00878722|9079074|P3|Overall Study|Death|0
2627354|NCT00878722|9079075|P2|Overall Study|Death|0
2627355|NCT00878722|9079076|P1|Overall Study|Death|0
2627356|NCT00878722|9079069|P8|Overall Study|Progressive disease|3
2627357|NCT00878722|9079070|P7|Overall Study|Progressive disease|4
2627358|NCT00878722|9079071|P6|Overall Study|Progressive disease|1
2627359|NCT00878722|9079072|P5|Overall Study|Progressive disease|7
2627360|NCT00878722|9079073|P4|Overall Study|Progressive disease|7
2627361|NCT00878722|9079074|P3|Overall Study|Progressive disease|3
2627362|NCT00878722|9079075|P2|Overall Study|Progressive disease|3
2627363|NCT00878722|9079076|P1|Overall Study|Progressive disease|3
2627364|NCT00878709|9079161|P2|Overall Study|Other Reasons|84
2627365|NCT00878709|9079162|P1|Overall Study|Other Reasons|93
2627366|NCT00878709|9079161|P2|Overall Study|Lost to Follow-up|33
2627367|NCT00878709|9079162|P1|Overall Study|Lost to Follow-up|35
2627368|NCT00878709|9079161|P2|Overall Study|Withdrawal by Subject|120
2627369|NCT00878709|9079162|P1|Overall Study|Withdrawal by Subject|197
2627370|NCT00878553|9079222|P5|PK Study|Withdrawal by Subject|0
2627371|NCT00878553|9079223|P4|PK Study|Withdrawal by Subject|1
2627372|NCT00878553|9079224|P3|PK Study|Withdrawal by Subject|0
2627373|NCT00878553|9079225|P2|PK Study|Withdrawal by Subject|0
2627374|NCT00878553|9079226|P1|PK Study|Withdrawal by Subject|0
2627375|NCT00878553|9079222|P5|Sleep Study|family emergency|0
2627376|NCT00878553|9079223|P4|Sleep Study|family emergency|0
2627377|NCT00878553|9079224|P3|Sleep Study|family emergency|0
2627378|NCT00878553|9079225|P2|Sleep Study|family emergency|0
2627379|NCT00878553|9079226|P1|Sleep Study|family emergency|1
2627380|NCT00878553|9079222|P5|Sleep Study|car accident|0
2627381|NCT00878553|9079223|P4|Sleep Study|car accident|0
2627382|NCT00878553|9079224|P3|Sleep Study|car accident|0
2627383|NCT00878553|9079225|P2|Sleep Study|car accident|0
2627384|NCT00878553|9079226|P1|Sleep Study|car accident|1
2627385|NCT00878553|9079222|P5|Sleep Study|Lost to Follow-up|0
2627386|NCT00878553|9079223|P4|Sleep Study|Lost to Follow-up|0
2627387|NCT00878553|9079224|P3|Sleep Study|Lost to Follow-up|0
2627388|NCT00878553|9079225|P2|Sleep Study|Lost to Follow-up|0
2627389|NCT00878553|9079226|P1|Sleep Study|Lost to Follow-up|1
2627390|NCT00878553|9079222|P5|Sleep Study|Withdrawal by Subject|0
2627391|NCT00878553|9079223|P4|Sleep Study|Withdrawal by Subject|0
2627392|NCT00878553|9079224|P3|Sleep Study|Withdrawal by Subject|0
2627393|NCT00878553|9079225|P2|Sleep Study|Withdrawal by Subject|0
2627394|NCT00878553|9079226|P1|Sleep Study|Withdrawal by Subject|2
2627395|NCT00878501|9079285|P3|Overall Study|Administrative|1
2627396|NCT00878501|9079286|P2|Overall Study|Administrative|0
2627397|NCT00878501|9079287|P1|Overall Study|Administrative|0
2627398|NCT00878501|9079285|P3|Overall Study|Mis-randomisation of patient|0
2627399|NCT00878501|9079286|P2|Overall Study|Mis-randomisation of patient|0
2627400|NCT00878501|9079287|P1|Overall Study|Mis-randomisation of patient|1
2627401|NCT00878501|9079285|P3|Overall Study|Intake of prohibited concom. medication|1
2627402|NCT00878501|9079286|P2|Overall Study|Intake of prohibited concom. medication|0
2627403|NCT00878501|9079287|P1|Overall Study|Intake of prohibited concom. medication|0
2627404|NCT00878501|9079285|P3|Overall Study|Incorrect enrolment|0
2627405|NCT00878501|9079286|P2|Overall Study|Incorrect enrolment|2
2627406|NCT00878501|9079287|P1|Overall Study|Incorrect enrolment|1
2627407|NCT00878501|9079285|P3|Overall Study|Protocol Violation|1
2627408|NCT00878501|9079286|P2|Overall Study|Protocol Violation|0
2627409|NCT00878501|9079287|P1|Overall Study|Protocol Violation|0
2627410|NCT00878501|9079285|P3|Overall Study|Withdrawal by Subject|2
2627411|NCT00878501|9079286|P2|Overall Study|Withdrawal by Subject|1
2627412|NCT00878501|9079287|P1|Overall Study|Withdrawal by Subject|2
2627413|NCT00878501|9079285|P3|Overall Study|Lack of Efficacy|0
2627414|NCT00878501|9079286|P2|Overall Study|Lack of Efficacy|1
2627415|NCT00878501|9079287|P1|Overall Study|Lack of Efficacy|2
2627416|NCT00878501|9079285|P3|Overall Study|Adverse Event|3
2627417|NCT00878501|9079286|P2|Overall Study|Adverse Event|3
2627418|NCT00878501|9079287|P1|Overall Study|Adverse Event|11
2627419|NCT00878215|9079336|P4|Overall Study|Determined to be ineligible|0
2627420|NCT00878215|9079337|P3|Overall Study|Determined to be ineligible|0
2627421|NCT00878215|9079338|P2|Overall Study|Determined to be ineligible|10
2627422|NCT00878215|9079339|P1|Overall Study|Determined to be ineligible|0
2627423|NCT00878189|9079351|P9|Overall Study|Objection Progression or Relapse|3
2627424|NCT00878189|9079352|P8|Overall Study|Objection Progression or Relapse|0
2627425|NCT00878189|9079353|P7|Overall Study|Objection Progression or Relapse|0
2627426|NCT00878189|9079354|P6|Overall Study|Objection Progression or Relapse|0
2627427|NCT00878189|9079355|P5|Overall Study|Objection Progression or Relapse|0
2627428|NCT00878189|9079356|P4|Overall Study|Objection Progression or Relapse|0
2627429|NCT00878189|9079357|P3|Overall Study|Objection Progression or Relapse|0
2627430|NCT00878189|9079358|P2|Overall Study|Objection Progression or Relapse|0
2627431|NCT00878189|9079359|P1|Overall Study|Objection Progression or Relapse|0
2627432|NCT00878189|9079351|P9|Overall Study|Lost to Follow-up|0
2627433|NCT00878189|9079352|P8|Overall Study|Lost to Follow-up|0
2627434|NCT00878189|9079353|P7|Overall Study|Lost to Follow-up|1
2627435|NCT00878189|9079354|P6|Overall Study|Lost to Follow-up|1
2627436|NCT00878189|9079355|P5|Overall Study|Lost to Follow-up|0
2627437|NCT00878189|9079356|P4|Overall Study|Lost to Follow-up|0
2627438|NCT00878189|9079357|P3|Overall Study|Lost to Follow-up|0
2627439|NCT00878189|9079358|P2|Overall Study|Lost to Follow-up|0
2627440|NCT00878189|9079359|P1|Overall Study|Lost to Follow-up|0
2627441|NCT00878189|9079351|P9|Overall Study|Other|4
2627442|NCT00878189|9079352|P8|Overall Study|Other|3
2627443|NCT00878189|9079353|P7|Overall Study|Other|15
2627444|NCT00878189|9079354|P6|Overall Study|Other|18
2627445|NCT00878189|9079355|P5|Overall Study|Other|4
2627446|NCT00878189|9079356|P4|Overall Study|Other|7
2627447|NCT00878189|9079357|P3|Overall Study|Other|4
2627448|NCT00878189|9079358|P2|Overall Study|Other|2
2627449|NCT00878189|9079359|P1|Overall Study|Other|3
2627450|NCT00878189|9079351|P9|Overall Study|Participant Refused to Follow-up|0
2627451|NCT00878189|9079352|P8|Overall Study|Participant Refused to Follow-up|0
2627452|NCT00878189|9079353|P7|Overall Study|Participant Refused to Follow-up|0
2627453|NCT00878189|9079354|P6|Overall Study|Participant Refused to Follow-up|4
2627454|NCT00878189|9079355|P5|Overall Study|Participant Refused to Follow-up|0
2627455|NCT00878189|9079356|P4|Overall Study|Participant Refused to Follow-up|0
2627456|NCT00878189|9079357|P3|Overall Study|Participant Refused to Follow-up|0
2627457|NCT00878189|9079358|P2|Overall Study|Participant Refused to Follow-up|0
2627458|NCT00878189|9079359|P1|Overall Study|Participant Refused to Follow-up|0
2627459|NCT00878189|9079351|P9|Overall Study|Death|1
2627460|NCT00878189|9079352|P8|Overall Study|Death|0
2627461|NCT00878189|9079353|P7|Overall Study|Death|0
2627462|NCT00878189|9079354|P6|Overall Study|Death|0
2627463|NCT00878189|9079355|P5|Overall Study|Death|0
2627464|NCT00878189|9079356|P4|Overall Study|Death|1
2627465|NCT00878189|9079357|P3|Overall Study|Death|0
2627466|NCT00878189|9079358|P2|Overall Study|Death|1
2627467|NCT00878189|9079359|P1|Overall Study|Death|0
2627468|NCT00877929|9079627|P2|Overall Study|Other reason (not specified)|6
2627469|NCT00877929|9079628|P1|Overall Study|Other reason (not specified)|2
2627470|NCT00877929|9079627|P2|Overall Study|Lack of Efficacy|1
2627471|NCT00877929|9079628|P1|Overall Study|Lack of Efficacy|0
2627472|NCT00877929|9079627|P2|Overall Study|Withdrawal by Subject|4
2627473|NCT00877929|9079628|P1|Overall Study|Withdrawal by Subject|4
2627474|NCT00877929|9079627|P2|Overall Study|Lost to Follow-up|1
2627475|NCT00877929|9079628|P1|Overall Study|Lost to Follow-up|0
2627476|NCT00877929|9079627|P2|Overall Study|Protocol Violation|3
2627477|NCT00877929|9079628|P1|Overall Study|Protocol Violation|3
2627478|NCT00877929|9079627|P2|Overall Study|Adverse Event|20
2627479|NCT00877929|9079628|P1|Overall Study|Adverse Event|11
2627480|NCT00877890|9079716|P2|Overall Study|Loss of Glucose Control|4
2627481|NCT00877890|9079717|P1|Overall Study|Loss of Glucose Control|3
2627482|NCT00877890|9079716|P2|Overall Study|Investigator Decision|2
2627483|NCT00877890|9079717|P1|Overall Study|Investigator Decision|0
2627484|NCT00877890|9079716|P2|Overall Study|Withdrawal of Consent|12
2627485|NCT00877890|9079717|P1|Overall Study|Withdrawal of Consent|6
2627486|NCT00877890|9079716|P2|Overall Study|Protocol Violation|1
2627487|NCT00877890|9079717|P1|Overall Study|Protocol Violation|0
2627488|NCT00877890|9079716|P2|Overall Study|Lost to Follow-up|5
2627489|NCT00877890|9079717|P1|Overall Study|Lost to Follow-up|5
2627490|NCT00877890|9079716|P2|Overall Study|Adverse Event|6
2627491|NCT00877890|9079717|P1|Overall Study|Adverse Event|6
2627492|NCT00877799|9079782|P5|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
2627493|NCT00877799|9079783|P4|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
2627494|NCT00877799|9079784|P3|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
2627495|NCT00877799|9079785|P2|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
2627496|NCT00877799|9079786|P1|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
2627497|NCT00877799|9079782|P5|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
2627498|NCT00877799|9079783|P4|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1
2627499|NCT00877799|9079784|P3|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
2627500|NCT00877799|9079785|P2|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
2627501|NCT00877799|9079786|P1|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
2627502|NCT00877799|9079782|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
2627503|NCT00877799|9079783|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
2627504|NCT00877799|9079784|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
2627505|NCT00877799|9079785|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3
2627506|NCT00877799|9079786|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
2627507|NCT00877799|9079782|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
2627508|NCT00877799|9079783|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
2627509|NCT00877799|9079784|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2
2627510|NCT00877799|9079785|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
2627511|NCT00877799|9079786|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
2627512|NCT00877799|9079782|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
2627513|NCT00877799|9079783|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
2627514|NCT00877799|9079784|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
2627515|NCT00877799|9079785|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
2627516|NCT00877799|9079786|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2
2627517|NCT00877773|9079801|P1|Overall Study|Disease Progression|44
2627518|NCT00877487|9079814|P2|Double-blind Randomized Withdrawal Phase|Moved out of state|0
2627519|NCT00877487|9079815|P1|Double-blind Randomized Withdrawal Phase|Moved out of state|1
2627520|NCT00877487|9079814|P2|Double-blind Randomized Withdrawal Phase|Protocol Violation|1
2627521|NCT00877487|9079815|P1|Double-blind Randomized Withdrawal Phase|Protocol Violation|0
2627522|NCT00877487|9079814|P2|Double-blind Randomized Withdrawal Phase|Adverse Event|1
2627523|NCT00877487|9079815|P1|Double-blind Randomized Withdrawal Phase|Adverse Event|0
2627524|NCT00877487|9079814|P2|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45
2627525|NCT00877487|9079815|P1|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5
2627526|NCT00877487|9079814|P2|Open-label Treatment Phase|Out of country for business|0
2627527|NCT00877487|9079815|P1|Open-label Treatment Phase|Out of country for business|1
2627528|NCT00877487|9079814|P2|Open-label Treatment Phase|Lost to Follow-up|0
2627529|NCT00877487|9079815|P1|Open-label Treatment Phase|Lost to Follow-up|1
2627530|NCT00877487|9079814|P2|Open-label Treatment Phase|Withdrawal by Subject|0
2627531|NCT00877487|9079815|P1|Open-label Treatment Phase|Withdrawal by Subject|1
2627532|NCT00877487|9079814|P2|Open-label Treatment Phase|Protocol Violation|0
2627533|NCT00877487|9079815|P1|Open-label Treatment Phase|Protocol Violation|3
2627534|NCT00877487|9079814|P2|Open-label Treatment Phase|Adverse Event|0
2627535|NCT00877487|9079815|P1|Open-label Treatment Phase|Adverse Event|1
2627536|NCT00877383|9079863|P2|Overall Study|Death|2
2627537|NCT00877383|9079864|P1|Overall Study|Death|1
2627538|NCT00877383|9079863|P2|Overall Study|Unsatisfactory therapeutic effect|0
2627539|NCT00877383|9079864|P1|Overall Study|Unsatisfactory therapeutic effect|1
2627540|NCT00877383|9079863|P2|Overall Study|Protocol deviation|6
2627541|NCT00877383|9079864|P1|Overall Study|Protocol deviation|2
2627542|NCT00877383|9079863|P2|Overall Study|Administrative problems|0
2627543|NCT00877383|9079864|P1|Overall Study|Administrative problems|2
2627544|NCT00877383|9079863|P2|Overall Study|Subject no longer requires study drug|0
2627545|NCT00877383|9079864|P1|Overall Study|Subject no longer requires study drug|2
2627546|NCT00877383|9079863|P2|Overall Study|Subject withdrew consent|12
2627547|NCT00877383|9079864|P1|Overall Study|Subject withdrew consent|3
2627548|NCT00877383|9079863|P2|Overall Study|Lost to Follow-up|3
2627549|NCT00877383|9079864|P1|Overall Study|Lost to Follow-up|5
2627550|NCT00877383|9079863|P2|Overall Study|Adverse Event|14
2627551|NCT00877383|9079864|P1|Overall Study|Adverse Event|13
2627552|NCT00877071|9079884|P1|Overall Study|disease progression|2
2627553|NCT00877032|9079917|P7|Overall Study|Did not meet entrance criteria|2
2627554|NCT00877032|9079918|P6|Overall Study|Did not meet entrance criteria|0
2627555|NCT00877032|9079919|P5|Overall Study|Did not meet entrance criteria|0
2627556|NCT00877032|9079920|P4|Overall Study|Did not meet entrance criteria|1
2627557|NCT00877032|9079921|P3|Overall Study|Did not meet entrance criteria|0
2627558|NCT00877032|9079922|P2|Overall Study|Did not meet entrance criteria|0
2627559|NCT00877032|9079923|P1|Overall Study|Did not meet entrance criteria|0
2627560|NCT00877006|9080024|P2|Long-Term Follow-up Period|Other|9
2627561|NCT00877006|9080025|P1|Long-Term Follow-up Period|Other|7
2627562|NCT00877006|9080024|P2|Long-Term Follow-up Period|Death|18
2627563|NCT00877006|9080025|P1|Long-Term Follow-up Period|Death|26
2627564|NCT00877006|9080024|P2|Long-Term Follow-up Period|Lost to Follow-up|9
2627565|NCT00877006|9080025|P1|Long-Term Follow-up Period|Lost to Follow-up|8
2627566|NCT00877006|9080024|P2|Long-Term Follow-up Period|Withdrawal by Subject|19
2627567|NCT00877006|9080025|P1|Long-Term Follow-up Period|Withdrawal by Subject|12
2627568|NCT00877006|9080024|P2|Treatment Period|Randomized but Not Treated|8
2627569|NCT00877006|9080025|P1|Treatment Period|Randomized but Not Treated|3
2627570|NCT00877006|9080024|P2|Treatment Period|Other|4
2627571|NCT00877006|9080025|P1|Treatment Period|Other|4
2627572|NCT00877006|9080024|P2|Treatment Period|Started New Treatment Regimen|5
2627573|NCT00877006|9080025|P1|Treatment Period|Started New Treatment Regimen|2
2627574|NCT00877006|9080024|P2|Treatment Period|Disease Progression|2
2627575|NCT00877006|9080025|P1|Treatment Period|Disease Progression|1
2627576|NCT00877006|9080024|P2|Treatment Period|Lost to Follow-up|1
2627577|NCT00877006|9080025|P1|Treatment Period|Lost to Follow-up|0
2627578|NCT00877006|9080024|P2|Treatment Period|Protocol Violation|0
2627579|NCT00877006|9080025|P1|Treatment Period|Protocol Violation|1
2627580|NCT00877006|9080024|P2|Treatment Period|Withdrawal by Subject|3
2627581|NCT00877006|9080025|P1|Treatment Period|Withdrawal by Subject|2
2627582|NCT00877006|9080024|P2|Treatment Period|Adverse Event|3
2627583|NCT00877006|9080025|P1|Treatment Period|Adverse Event|10
2627584|NCT00877006|9080024|P2|Treatment Period|Death|1
2627585|NCT00877006|9080025|P1|Treatment Period|Death|2
2627586|NCT00876928|9080101|P2|Overall Study|Hypokalemia-affects insulin secretion|0
2627587|NCT00876928|9080102|P1|Overall Study|Hypokalemia-affects insulin secretion|1
2627588|NCT00876928|9080101|P2|Overall Study|Lost to Follow-up|5
2627589|NCT00876928|9080102|P1|Overall Study|Lost to Follow-up|2
2627590|NCT00876733|9080139|P4|Overall Study|Data not available|1
2627591|NCT00876733|9080140|P3|Overall Study|Data not available|7
2627592|NCT00876733|9080141|P2|Overall Study|Data not available|3
2627593|NCT00876733|9080142|P1|Overall Study|Data not available|14
2627594|NCT00876733|9080139|P4|Overall Study|Lost to Follow-up|2
2627595|NCT00876733|9080140|P3|Overall Study|Lost to Follow-up|3
2627596|NCT00876733|9080141|P2|Overall Study|Lost to Follow-up|10
2627597|NCT00876733|9080142|P1|Overall Study|Lost to Follow-up|26
2627598|NCT00876733|9080139|P4|Overall Study|Lack of Efficacy|1
2627599|NCT00876733|9080140|P3|Overall Study|Lack of Efficacy|10
2627600|NCT00876733|9080141|P2|Overall Study|Lack of Efficacy|9
2627601|NCT00876733|9080142|P1|Overall Study|Lack of Efficacy|17
2627602|NCT00876733|9080139|P4|Overall Study|Adverse Event|3
2627603|NCT00876733|9080140|P3|Overall Study|Adverse Event|10
2627604|NCT00876733|9080141|P2|Overall Study|Adverse Event|20
2627605|NCT00876733|9080142|P1|Overall Study|Adverse Event|34
2627606|NCT00876694|9080250|P2|Overall Study|Death|0
2627607|NCT00876694|9080251|P1|Overall Study|Death|1
2627608|NCT00876694|9080250|P2|Overall Study|Administrative problems|1
2627609|NCT00876694|9080251|P1|Overall Study|Administrative problems|1
2627610|NCT00876694|9080250|P2|Overall Study|Abnormal test procedure result(s)|0
2627611|NCT00876694|9080251|P1|Overall Study|Abnormal test procedure result(s)|1
2627612|NCT00876694|9080250|P2|Overall Study|Unsatisfactory therapeutic effect|0
2627613|NCT00876694|9080251|P1|Overall Study|Unsatisfactory therapeutic effect|2
2627614|NCT00876694|9080250|P2|Overall Study|Subject withdrew consent|4
2627615|NCT00876694|9080251|P1|Overall Study|Subject withdrew consent|6
2627616|NCT00876694|9080250|P2|Overall Study|Adverse Event|7
2627617|NCT00876694|9080251|P1|Overall Study|Adverse Event|10
2627618|NCT00876460|9080277|P8|Mono Therapy Phase|Adverse Event|0
2627619|NCT00876460|9080278|P7|Mono Therapy Phase|Adverse Event|0
2627620|NCT00876460|9080279|P6|Mono Therapy Phase|Adverse Event|0
2627621|NCT00876460|9080280|P5|Mono Therapy Phase|Adverse Event|0
2627622|NCT00876460|9080281|P4|Mono Therapy Phase|Adverse Event|1
2627623|NCT00876460|9080282|P3|Mono Therapy Phase|Adverse Event|0
2627624|NCT00876460|9080283|P2|Mono Therapy Phase|Adverse Event|0
2627625|NCT00876460|9080284|P1|Mono Therapy Phase|Adverse Event|0
2627626|NCT00876460|9080277|P8|Mono Therapy Phase|Withdrawal by Subject|0
2627627|NCT00876460|9080278|P7|Mono Therapy Phase|Withdrawal by Subject|0
2627628|NCT00876460|9080279|P6|Mono Therapy Phase|Withdrawal by Subject|0
2627629|NCT00876460|9080280|P5|Mono Therapy Phase|Withdrawal by Subject|0
2627630|NCT00876460|9080281|P4|Mono Therapy Phase|Withdrawal by Subject|0
2627631|NCT00876460|9080282|P3|Mono Therapy Phase|Withdrawal by Subject|0
2627632|NCT00876460|9080283|P2|Mono Therapy Phase|Withdrawal by Subject|1
2627633|NCT00876460|9080284|P1|Mono Therapy Phase|Withdrawal by Subject|0
2627634|NCT00876460|9080277|P8|Mono Therapy Phase|Progressive disease|3
2627635|NCT00876460|9080278|P7|Mono Therapy Phase|Progressive disease|1
2627636|NCT00876460|9080279|P6|Mono Therapy Phase|Progressive disease|0
2627637|NCT00876460|9080280|P5|Mono Therapy Phase|Progressive disease|2
2627638|NCT00876460|9080281|P4|Mono Therapy Phase|Progressive disease|0
2627639|NCT00876460|9080282|P3|Mono Therapy Phase|Progressive disease|0
2627640|NCT00876460|9080283|P2|Mono Therapy Phase|Progressive disease|0
2627641|NCT00876460|9080284|P1|Mono Therapy Phase|Progressive disease|0
2627642|NCT00876460|9080277|P8|Combination Therapy Phase|Not treated|0
2627643|NCT00876460|9080278|P7|Combination Therapy Phase|Not treated|1
2627644|NCT00876460|9080279|P6|Combination Therapy Phase|Not treated|0
2627645|NCT00876460|9080280|P5|Combination Therapy Phase|Not treated|0
2627646|NCT00876460|9080281|P4|Combination Therapy Phase|Not treated|0
2627647|NCT00876460|9080282|P3|Combination Therapy Phase|Not treated|0
2627648|NCT00876460|9080283|P2|Combination Therapy Phase|Not treated|0
2627649|NCT00876460|9080284|P1|Combination Therapy Phase|Not treated|0
2627650|NCT00876460|9080277|P8|Combination Therapy Phase|Other reason not defined above|2
2627651|NCT00876460|9080278|P7|Combination Therapy Phase|Other reason not defined above|1
2627652|NCT00876460|9080279|P6|Combination Therapy Phase|Other reason not defined above|0
2627653|NCT00876460|9080280|P5|Combination Therapy Phase|Other reason not defined above|0
2627654|NCT00876460|9080281|P4|Combination Therapy Phase|Other reason not defined above|0
2627655|NCT00876460|9080282|P3|Combination Therapy Phase|Other reason not defined above|0
2627656|NCT00876460|9080283|P2|Combination Therapy Phase|Other reason not defined above|0
2627657|NCT00876460|9080284|P1|Combination Therapy Phase|Other reason not defined above|0
2627658|NCT00876460|9080277|P8|Combination Therapy Phase|Withdrawal by Subject|0
2627659|NCT00876460|9080278|P7|Combination Therapy Phase|Withdrawal by Subject|0
2627660|NCT00876460|9080279|P6|Combination Therapy Phase|Withdrawal by Subject|0
2627661|NCT00876460|9080280|P5|Combination Therapy Phase|Withdrawal by Subject|1
2627662|NCT00876460|9080281|P4|Combination Therapy Phase|Withdrawal by Subject|0
2627663|NCT00876460|9080282|P3|Combination Therapy Phase|Withdrawal by Subject|0
2627664|NCT00876460|9080283|P2|Combination Therapy Phase|Withdrawal by Subject|1
2627665|NCT00876460|9080284|P1|Combination Therapy Phase|Withdrawal by Subject|1
2627666|NCT00876460|9080277|P8|Combination Therapy Phase|Adverse Event|2
2627667|NCT00876460|9080278|P7|Combination Therapy Phase|Adverse Event|3
2627668|NCT00876460|9080279|P6|Combination Therapy Phase|Adverse Event|0
2627669|NCT00876460|9080280|P5|Combination Therapy Phase|Adverse Event|2
2627670|NCT00876460|9080281|P4|Combination Therapy Phase|Adverse Event|2
2627671|NCT00876460|9080282|P3|Combination Therapy Phase|Adverse Event|0
2627672|NCT00876460|9080283|P2|Combination Therapy Phase|Adverse Event|2
2627673|NCT00876460|9080284|P1|Combination Therapy Phase|Adverse Event|0
2627674|NCT00876460|9080277|P8|Combination Therapy Phase|Dose limiting toxicity|1
2627675|NCT00876460|9080278|P7|Combination Therapy Phase|Dose limiting toxicity|2
2627676|NCT00876460|9080279|P6|Combination Therapy Phase|Dose limiting toxicity|2
2627677|NCT00876460|9080280|P5|Combination Therapy Phase|Dose limiting toxicity|1
2627678|NCT00876460|9080281|P4|Combination Therapy Phase|Dose limiting toxicity|1
2627679|NCT00876460|9080282|P3|Combination Therapy Phase|Dose limiting toxicity|0
2627680|NCT00876460|9080283|P2|Combination Therapy Phase|Dose limiting toxicity|1
2627681|NCT00876460|9080284|P1|Combination Therapy Phase|Dose limiting toxicity|0
2627682|NCT00876460|9080277|P8|Combination Therapy Phase|Progressive disease|1
2627683|NCT00876460|9080278|P7|Combination Therapy Phase|Progressive disease|1
2627684|NCT00876460|9080279|P6|Combination Therapy Phase|Progressive disease|1
2627685|NCT00876460|9080280|P5|Combination Therapy Phase|Progressive disease|3
2627686|NCT00876460|9080281|P4|Combination Therapy Phase|Progressive disease|3
2627687|NCT00876460|9080282|P3|Combination Therapy Phase|Progressive disease|3
2627688|NCT00876460|9080283|P2|Combination Therapy Phase|Progressive disease|3
2627689|NCT00876460|9080284|P1|Combination Therapy Phase|Progressive disease|2
2627690|NCT00876447|9080356|P2|Overall Study|Adverse Event|8
2627691|NCT00876447|9080357|P1|Overall Study|Adverse Event|4
2627692|NCT00876447|9080356|P2|Overall Study|Lack of Efficacy|3
2627693|NCT00876447|9080357|P1|Overall Study|Lack of Efficacy|5
2627694|NCT00876447|9080356|P2|Overall Study|Pregnancy|2
2627695|NCT00876447|9080357|P1|Overall Study|Pregnancy|4
2627696|NCT00876447|9080356|P2|Overall Study|Lost to Follow-up|15
2627697|NCT00876447|9080357|P1|Overall Study|Lost to Follow-up|6
2627698|NCT00876447|9080356|P2|Overall Study|Personal reasons|28
2627699|NCT00876447|9080357|P1|Overall Study|Personal reasons|30
2627700|NCT00876447|9080356|P2|Overall Study|Protocol Violation|3
2627701|NCT00876447|9080357|P1|Overall Study|Protocol Violation|9
2627702|NCT00876447|9080356|P2|Overall Study|Site closure|14
2627703|NCT00876447|9080357|P1|Overall Study|Site closure|19
2627704|NCT00876447|9080356|P2|Overall Study|Other miscellaneous reasons|8
2627705|NCT00876447|9080357|P1|Overall Study|Other miscellaneous reasons|3
2627706|NCT00876395|9080417|P2|Overall Study|Death|0
2627707|NCT00876395|9080418|P1|Overall Study|Death|12
2627708|NCT00876395|9080417|P2|Overall Study|Administrative problems|23
2627709|NCT00876395|9080418|P1|Overall Study|Administrative problems|39
2627710|NCT00876395|9080417|P2|Overall Study|Lost to Follow-up|0
2627711|NCT00876395|9080418|P1|Overall Study|Lost to Follow-up|2
2627712|NCT00876395|9080417|P2|Overall Study|Withdrawal by Subject|33
2627713|NCT00876395|9080418|P1|Overall Study|Withdrawal by Subject|66
2627714|NCT00876395|9080417|P2|Overall Study|Protocol Violation|2
2627715|NCT00876395|9080418|P1|Overall Study|Protocol Violation|5
2627716|NCT00876395|9080417|P2|Overall Study|New cancer therapy|7
2627717|NCT00876395|9080418|P1|Overall Study|New cancer therapy|25
2627718|NCT00876395|9080417|P2|Overall Study|Disease progression|162
2627719|NCT00876395|9080418|P1|Overall Study|Disease progression|259
2627720|NCT00876395|9080417|P2|Overall Study|Abnormal test procedure result(s)|0
2627721|NCT00876395|9080418|P1|Overall Study|Abnormal test procedure result(s)|1
2627722|NCT00876395|9080417|P2|Overall Study|Adverse Event|11
2627723|NCT00876395|9080418|P1|Overall Study|Adverse Event|63
2627724|NCT00876395|9080417|P2|Overall Study|Untreated|1
2627725|NCT00876395|9080418|P1|Overall Study|Untreated|8
2627726|NCT00876343|9080459|P3|Overall Study|Change of residence or other commitments|3
2627727|NCT00876343|9080460|P2|Overall Study|Change of residence or other commitments|2
2627728|NCT00876343|9080461|P1|Overall Study|Change of residence or other commitments|2
2627729|NCT00876343|9080459|P3|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
2627730|NCT00876343|9080460|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
2627731|NCT00876343|9080461|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
2627732|NCT00876343|9080459|P3|Overall Study|Physician Decision|1
2627733|NCT00876343|9080460|P2|Overall Study|Physician Decision|1
2627734|NCT00876343|9080461|P1|Overall Study|Physician Decision|0
2627735|NCT00876343|9080459|P3|Overall Study|Protocol Violation|1
2627736|NCT00876343|9080460|P2|Overall Study|Protocol Violation|1
2627737|NCT00876343|9080461|P1|Overall Study|Protocol Violation|4
2627738|NCT00876343|9080459|P3|Overall Study|Lack of Efficacy|1
2627739|NCT00876343|9080460|P2|Overall Study|Lack of Efficacy|0
2627740|NCT00876343|9080461|P1|Overall Study|Lack of Efficacy|0
2627741|NCT00876343|9080459|P3|Overall Study|Withdrawal by Subject|3
2627742|NCT00876343|9080460|P2|Overall Study|Withdrawal by Subject|4
2627743|NCT00876343|9080461|P1|Overall Study|Withdrawal by Subject|4
2627744|NCT00876343|9080459|P3|Overall Study|Adverse Event|2
2627745|NCT00876343|9080460|P2|Overall Study|Adverse Event|8
2627746|NCT00876343|9080461|P1|Overall Study|Adverse Event|7
2627747|NCT00876265|9080475|P1|Overall Study|Withdrawal by Subject|2
2627748|NCT00876265|9080475|P1|Overall Study|Lost to Follow-up|6
2627749|NCT00876265|9080475|P1|Overall Study|Miscellaneous reasons|4
2627750|NCT00876018|9080493|P3|Overall Study|Withdrew Consent due to Adverse Event|2
2627751|NCT00876018|9080494|P2|Overall Study|Withdrew Consent due to Adverse Event|4
2627752|NCT00876018|9080495|P1|Overall Study|Withdrew Consent due to Adverse Event|5
2627753|NCT00876018|9080493|P3|Overall Study|Lost to Follow-up|1
2627754|NCT00876018|9080494|P2|Overall Study|Lost to Follow-up|1
2627755|NCT00876018|9080495|P1|Overall Study|Lost to Follow-up|0
2627756|NCT00875979|9080550|P2|Dose Expansion Phase - 3.6 mg/kg|Death|1
2627757|NCT00875979|9080551|P1|Dose Expansion Phase - 3.6 mg/kg|Death|0
2627758|NCT00875979|9080550|P2|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3
2627759|NCT00875979|9080551|P1|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0
2627760|NCT00875979|9080550|P2|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3
2627761|NCT00875979|9080551|P1|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0
2627762|NCT00875979|9080550|P2|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3
2627763|NCT00875979|9080551|P1|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0
2627764|NCT00875979|9080550|P2|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37
2627765|NCT00875979|9080551|P1|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0
2627766|NCT00875979|9080550|P2|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6
2627767|NCT00875979|9080551|P1|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0
2627768|NCT00875979|9080550|P2|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0
2627769|NCT00875979|9080551|P1|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1
2627770|NCT00875979|9080550|P2|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0
2627771|NCT00875979|9080551|P1|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1
2627772|NCT00875979|9080550|P2|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0
2627773|NCT00875979|9080551|P1|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1
2627774|NCT00875810|9080574|P1|Overall Study|Device explanted|1
2627775|NCT00875810|9080574|P1|Overall Study|Patient enroled but not implanted|2
2627776|NCT00875810|9080574|P1|Overall Study|Lost to Follow-up|39
2627777|NCT00875810|9080574|P1|Overall Study|Physician Decision|3
2627778|NCT00875810|9080574|P1|Overall Study|Withdrawal by Subject|1
2627779|NCT00875797|9080583|P2|Overall Study|Protocol Violation|3
2627780|NCT00875797|9080584|P1|Overall Study|Protocol Violation|6
2627781|NCT00875706|9080597|P3|Overall Study|Withdrawal by Subject|0
2627782|NCT00875706|9080598|P2|Overall Study|Withdrawal by Subject|0
2627783|NCT00875706|9080599|P1|Overall Study|Withdrawal by Subject|1
2627784|NCT00875667|9080618|P2|Overall Study|Randomized but no Study Drug Given|1
2627785|NCT00875667|9080619|P1|Overall Study|Randomized but no Study Drug Given|3
2627786|NCT00875667|9080618|P2|Overall Study|Miscellaneous|6
2627787|NCT00875667|9080619|P1|Overall Study|Miscellaneous|12
2627788|NCT00875667|9080618|P2|Overall Study|Disease Progression|49
2627789|NCT00875667|9080619|P1|Overall Study|Disease Progression|100
2627790|NCT00875667|9080618|P2|Overall Study|Protocol Violation|0
2627791|NCT00875667|9080619|P1|Overall Study|Protocol Violation|2
2627792|NCT00875667|9080618|P2|Overall Study|Death|2
2627793|NCT00875667|9080619|P1|Overall Study|Death|7
2627794|NCT00875667|9080618|P2|Overall Study|Withdrawal by Subject|5
2627795|NCT00875667|9080619|P1|Overall Study|Withdrawal by Subject|17
2627796|NCT00875667|9080618|P2|Overall Study|Adverse Event|10
2627797|NCT00875667|9080619|P1|Overall Study|Adverse Event|29
2627798|NCT00875615|9080754|P1|Overall Study|Withdrawal by Subject|1
2627799|NCT00875563|9080768|P1|Overall Study|Still be eligible for follow-up|7
2627800|NCT00875563|9080768|P1|Overall Study|No long-term (3-5 year) consent|6
2627801|NCT00875563|9080768|P1|Overall Study|Withdrawal by Subject|7
2627802|NCT00875563|9080768|P1|Overall Study|Death|4
2627803|NCT00875524|9080793|P2|Overall Study|Withdrawal by Subject|5
2627804|NCT00875524|9080794|P1|Overall Study|Withdrawal by Subject|3
2627805|NCT00875524|9080793|P2|Overall Study|Lost to Follow-up|0
2627806|NCT00875524|9080794|P1|Overall Study|Lost to Follow-up|1
2627807|NCT00875524|9080793|P2|Overall Study|Protocol Violation|0
2627808|NCT00875524|9080794|P1|Overall Study|Protocol Violation|4
2627809|NCT00875524|9080793|P2|Overall Study|Serious adverse event|1
2627810|NCT00875524|9080794|P1|Overall Study|Serious adverse event|0
2627811|NCT00875485|9080812|P2|Challenge Dose Epoch|Pregnancy|0
2627812|NCT00875485|9080813|P1|Challenge Dose Epoch|Pregnancy|1
2627813|NCT00875433|9080853|P1|Overall Study|Other|3
2627814|NCT00875433|9080853|P1|Overall Study|Withdrawal by Subject|2
2627815|NCT00875433|9080853|P1|Overall Study|Other Adverse Event|14
2627816|NCT00875433|9080853|P1|Overall Study|Progressive disease|41
2627817|NCT00875420|9080883|P5|Overall Study|Withdrawal by Subject|0
2627818|NCT00875420|9080884|P4|Overall Study|Withdrawal by Subject|0
2627819|NCT00875420|9080885|P3|Overall Study|Withdrawal by Subject|1
2627820|NCT00875420|9080886|P2|Overall Study|Withdrawal by Subject|0
2627821|NCT00875420|9080887|P1|Overall Study|Withdrawal by Subject|0
2627822|NCT00875420|9080883|P5|Overall Study|Sponsor decision|0
2627823|NCT00875420|9080884|P4|Overall Study|Sponsor decision|0
2627824|NCT00875420|9080885|P3|Overall Study|Sponsor decision|0
2627825|NCT00875420|9080886|P2|Overall Study|Sponsor decision|1
2627826|NCT00875420|9080887|P1|Overall Study|Sponsor decision|0
2627827|NCT00875420|9080883|P5|Overall Study|Prohibited medication|0
2627828|NCT00875420|9080884|P4|Overall Study|Prohibited medication|1
2627829|NCT00875420|9080885|P3|Overall Study|Prohibited medication|0
2627830|NCT00875420|9080886|P2|Overall Study|Prohibited medication|0
2627831|NCT00875420|9080887|P1|Overall Study|Prohibited medication|0
2627832|NCT00875420|9080883|P5|Overall Study|Personal reason|1
2627833|NCT00875420|9080884|P4|Overall Study|Personal reason|0
2627834|NCT00875420|9080885|P3|Overall Study|Personal reason|0
2627835|NCT00875420|9080886|P2|Overall Study|Personal reason|0
2627836|NCT00875420|9080887|P1|Overall Study|Personal reason|0
2627837|NCT00875420|9080883|P5|Overall Study|Lost to Follow-up|0
2627838|NCT00875420|9080884|P4|Overall Study|Lost to Follow-up|0
2627839|NCT00875420|9080885|P3|Overall Study|Lost to Follow-up|0
2627840|NCT00875420|9080886|P2|Overall Study|Lost to Follow-up|0
2627841|NCT00875420|9080887|P1|Overall Study|Lost to Follow-up|1
2627842|NCT00875420|9080883|P5|Overall Study|Inability to complete study procedures|1
2627843|NCT00875420|9080884|P4|Overall Study|Inability to complete study procedures|1
2627844|NCT00875420|9080885|P3|Overall Study|Inability to complete study procedures|1
2627845|NCT00875420|9080886|P2|Overall Study|Inability to complete study procedures|0
2627846|NCT00875420|9080887|P1|Overall Study|Inability to complete study procedures|1
2627847|NCT00875420|9080883|P5|Overall Study|Adverse Event|0
2627848|NCT00875420|9080884|P4|Overall Study|Adverse Event|0
2627849|NCT00875420|9080885|P3|Overall Study|Adverse Event|1
2627850|NCT00875420|9080886|P2|Overall Study|Adverse Event|1
2627851|NCT00875420|9080887|P1|Overall Study|Adverse Event|0
2627852|NCT00875017|9081029|P6|Fourth Intervention|Inability to comply with fasting|1
2627853|NCT00875017|9081030|P5|Fourth Intervention|Inability to comply with fasting|0
2627854|NCT00875017|9081031|P4|Fourth Intervention|Inability to comply with fasting|0
2627855|NCT00875017|9081032|P3|Fourth Intervention|Inability to comply with fasting|0
2627856|NCT00875017|9081033|P2|Fourth Intervention|Inability to comply with fasting|0
2627857|NCT00875017|9081034|P1|Fourth Intervention|Inability to comply with fasting|0
2627858|NCT00875017|9081029|P6|Washout|Withdrawal by Subject|0
2627859|NCT00875017|9081030|P5|Washout|Withdrawal by Subject|1
2627860|NCT00875017|9081031|P4|Washout|Withdrawal by Subject|0
2627861|NCT00875017|9081032|P3|Washout|Withdrawal by Subject|0
2627862|NCT00875017|9081033|P2|Washout|Withdrawal by Subject|0
2627863|NCT00875017|9081034|P1|Washout|Withdrawal by Subject|0
2627864|NCT00875017|9081029|P6|Third Intervention|Adverse Event|0
2627865|NCT00875017|9081030|P5|Third Intervention|Adverse Event|0
2627866|NCT00875017|9081031|P4|Third Intervention|Adverse Event|0
2627867|NCT00875017|9081032|P3|Third Intervention|Adverse Event|1
2627868|NCT00875017|9081033|P2|Third Intervention|Adverse Event|1
2627869|NCT00875017|9081034|P1|Third Intervention|Adverse Event|0
2627870|NCT00875017|9081029|P6|Washout|Problems collecting rectal effluent|0
2627871|NCT00875017|9081030|P5|Washout|Problems collecting rectal effluent|0
2627872|NCT00875017|9081031|P4|Washout|Problems collecting rectal effluent|0
2627873|NCT00875017|9081032|P3|Washout|Problems collecting rectal effluent|0
2627874|NCT00875017|9081033|P2|Washout|Problems collecting rectal effluent|1
2627875|NCT00875017|9081034|P1|Washout|Problems collecting rectal effluent|0
2627876|NCT00875017|9081029|P6|Second Intervention|Adverse Event|0
2627877|NCT00875017|9081030|P5|Second Intervention|Adverse Event|0
2627878|NCT00875017|9081031|P4|Second Intervention|Adverse Event|1
2627879|NCT00875017|9081032|P3|Second Intervention|Adverse Event|0
2627880|NCT00875017|9081033|P2|Second Intervention|Adverse Event|0
2627881|NCT00875017|9081034|P1|Second Intervention|Adverse Event|0
2627882|NCT00875017|9081029|P6|Washout|Problem collecting rectal effluent|0
2627883|NCT00875017|9081030|P5|Washout|Problem collecting rectal effluent|0
2627884|NCT00875017|9081031|P4|Washout|Problem collecting rectal effluent|0
2627885|NCT00875017|9081032|P3|Washout|Problem collecting rectal effluent|1
2627886|NCT00875017|9081033|P2|Washout|Problem collecting rectal effluent|0
2627887|NCT00875017|9081034|P1|Washout|Problem collecting rectal effluent|0
2627888|NCT00875017|9081029|P6|First Intervention|Intolerance to nasogastric tube|0
2627889|NCT00875017|9081030|P5|First Intervention|Intolerance to nasogastric tube|1
2627890|NCT00875017|9081031|P4|First Intervention|Intolerance to nasogastric tube|0
2627891|NCT00875017|9081032|P3|First Intervention|Intolerance to nasogastric tube|0
2627892|NCT00875017|9081033|P2|First Intervention|Intolerance to nasogastric tube|0
2627893|NCT00875017|9081034|P1|First Intervention|Intolerance to nasogastric tube|0
2627894|NCT00875017|9081029|P6|First Intervention|Problems collecting rectal effluent|0
2627895|NCT00875017|9081030|P5|First Intervention|Problems collecting rectal effluent|0
2627896|NCT00875017|9081031|P4|First Intervention|Problems collecting rectal effluent|0
2627897|NCT00875017|9081032|P3|First Intervention|Problems collecting rectal effluent|0
2627898|NCT00875017|9081033|P2|First Intervention|Problems collecting rectal effluent|0
2627899|NCT00875017|9081034|P1|First Intervention|Problems collecting rectal effluent|1
2627900|NCT00875017|9081029|P6|First Intervention|Adverse Event|0
2627901|NCT00875017|9081030|P5|First Intervention|Adverse Event|0
2627902|NCT00875017|9081031|P4|First Intervention|Adverse Event|1
2627903|NCT00875017|9081032|P3|First Intervention|Adverse Event|0
2627904|NCT00875017|9081033|P2|First Intervention|Adverse Event|0
2627905|NCT00875017|9081034|P1|First Intervention|Adverse Event|0
2627906|NCT00875017|9081029|P6|First Intervention|Withdrawal by Subject|0
2627907|NCT00875017|9081030|P5|First Intervention|Withdrawal by Subject|0
2627908|NCT00875017|9081031|P4|First Intervention|Withdrawal by Subject|0
2627909|NCT00875017|9081032|P3|First Intervention|Withdrawal by Subject|1
2627910|NCT00875017|9081033|P2|First Intervention|Withdrawal by Subject|0
2627911|NCT00875017|9081034|P1|First Intervention|Withdrawal by Subject|1
2627912|NCT00874939|9081048|P1|Overall Study|Study terminated|4
2627913|NCT00874848|9081081|P2|Overall Study|Physician Decision|2
2627914|NCT00874848|9081082|P1|Overall Study|Physician Decision|0
2627915|NCT00874848|9081081|P2|Overall Study|Failure to comply with protocol|1
2627916|NCT00874848|9081082|P1|Overall Study|Failure to comply with protocol|0
2627917|NCT00874848|9081081|P2|Overall Study|Noncompliance|1
2627918|NCT00874848|9081082|P1|Overall Study|Noncompliance|1
2627919|NCT00874848|9081081|P2|Overall Study|Withdrawal by Subject|4
2627920|NCT00874848|9081082|P1|Overall Study|Withdrawal by Subject|7
2627921|NCT00874848|9081081|P2|Overall Study|Progressive neoplastic disease|18
2627922|NCT00874848|9081082|P1|Overall Study|Progressive neoplastic disease|38
2627923|NCT00874848|9081081|P2|Overall Study|Adverse Event|2
2627924|NCT00874848|9081082|P1|Overall Study|Adverse Event|13
2627925|NCT00874822|9081098|P1|Overall Study|excluded by criteria|8
2627926|NCT00874770|9081106|P4|Overall Study|Subject no Longer Meets Study Criteria|0
2627927|NCT00874770|9081107|P3|Overall Study|Subject no Longer Meets Study Criteria|0
2627928|NCT00874770|9081108|P2|Overall Study|Subject no Longer Meets Study Criteria|0
2627929|NCT00874770|9081109|P1|Overall Study|Subject no Longer Meets Study Criteria|1
2627930|NCT00874770|9081106|P4|Overall Study|Lost to Follow-up|1
2627931|NCT00874770|9081107|P3|Overall Study|Lost to Follow-up|0
2627932|NCT00874770|9081108|P2|Overall Study|Lost to Follow-up|0
2627933|NCT00874770|9081109|P1|Overall Study|Lost to Follow-up|1
2627934|NCT00874770|9081106|P4|Overall Study|Adverse Event|2
2627935|NCT00874770|9081107|P3|Overall Study|Adverse Event|4
2627936|NCT00874770|9081108|P2|Overall Study|Adverse Event|1
2627937|NCT00874770|9081109|P1|Overall Study|Adverse Event|1
2627938|NCT00874770|9081106|P4|Overall Study|Lack of Efficacy|2
2627939|NCT00874770|9081107|P3|Overall Study|Lack of Efficacy|0
2627940|NCT00874770|9081108|P2|Overall Study|Lack of Efficacy|0
2627941|NCT00874770|9081109|P1|Overall Study|Lack of Efficacy|2
2627942|NCT00874731|9081143|P3|Part 2: Ridaforolimus 40 mg|Disease Progression|19
2627943|NCT00874731|9081144|P2|Part 2: Ridaforolimus 40 mg|Disease Progression|0
2627944|NCT00874731|9081145|P1|Part 2: Ridaforolimus 40 mg|Disease Progression|0
2627945|NCT00874731|9081143|P3|Part 2: Ridaforolimus 40 mg|Adverse Event|3
2627946|NCT00874731|9081144|P2|Part 2: Ridaforolimus 40 mg|Adverse Event|0
2627947|NCT00874731|9081145|P1|Part 2: Ridaforolimus 40 mg|Adverse Event|0
2627948|NCT00874731|9081143|P3|Part 1, Day 1: Placebo|Disease Progression|0
2627949|NCT00874731|9081144|P2|Part 1, Day 1: Placebo|Disease Progression|0
2627950|NCT00874731|9081145|P1|Part 1, Day 1: Placebo|Disease Progression|1
2627951|NCT00874549|9081186|P4|Overall Study|Withdrawal by Subject|1
2627952|NCT00874549|9081187|P3|Overall Study|Withdrawal by Subject|0
2627953|NCT00874549|9081188|P2|Overall Study|Withdrawal by Subject|1
2627954|NCT00874549|9081189|P1|Overall Study|Withdrawal by Subject|0
2627955|NCT00874549|9081186|P4|Overall Study|Lost to Follow-up|0
2627956|NCT00874549|9081187|P3|Overall Study|Lost to Follow-up|1
2627957|NCT00874549|9081188|P2|Overall Study|Lost to Follow-up|0
2627958|NCT00874549|9081189|P1|Overall Study|Lost to Follow-up|0
2627959|NCT00874549|9081186|P4|Overall Study|Protocol Violation|1
2627960|NCT00874549|9081187|P3|Overall Study|Protocol Violation|2
2627961|NCT00874549|9081188|P2|Overall Study|Protocol Violation|0
2627962|NCT00874549|9081189|P1|Overall Study|Protocol Violation|1
2627963|NCT00874549|9081186|P4|Overall Study|Adverse Event|0
2627964|NCT00874549|9081187|P3|Overall Study|Adverse Event|1
2627965|NCT00874549|9081188|P2|Overall Study|Adverse Event|0
2627966|NCT00874549|9081189|P1|Overall Study|Adverse Event|0
2627967|NCT00874497|9081266|P2|Overall Study|Withdrawal by Subject|4
2627968|NCT00874497|9081267|P1|Overall Study|Withdrawal by Subject|5
2627969|NCT00874497|9081266|P2|Overall Study|Physician Decision|1
2627970|NCT00874497|9081267|P1|Overall Study|Physician Decision|1
2627971|NCT00874497|9081266|P2|Overall Study|Met Withdrawal Criteria|2
2627972|NCT00874497|9081267|P1|Overall Study|Met Withdrawal Criteria|4
2627973|NCT00874497|9081266|P2|Overall Study|Sponsor Discontinued Trial|3
2627974|NCT00874497|9081267|P1|Overall Study|Sponsor Discontinued Trial|7
2627975|NCT00874497|9081266|P2|Overall Study|Adverse Event|4
2627976|NCT00874497|9081267|P1|Overall Study|Adverse Event|9
2627977|NCT00874497|9081266|P2|Overall Study|Lost to Follow-up|4
2627978|NCT00874497|9081267|P1|Overall Study|Lost to Follow-up|2
2627979|NCT00874276|9081307|P2|Overall Study|Withdrawal by Subject|1
2627980|NCT00874276|9081308|P1|Overall Study|Withdrawal by Subject|1
2627981|NCT00874237|9081328|P6|Overall Study|Withdrawal by Subject|0
2627982|NCT00874237|9081329|P5|Overall Study|Withdrawal by Subject|0
2627983|NCT00874237|9081330|P4|Overall Study|Withdrawal by Subject|0
2627984|NCT00874237|9081331|P3|Overall Study|Withdrawal by Subject|1
2627985|NCT00874237|9081332|P2|Overall Study|Withdrawal by Subject|0
2627986|NCT00874237|9081333|P1|Overall Study|Withdrawal by Subject|0
2627987|NCT00874237|9081328|P6|Overall Study|Physician Decision|0
2627988|NCT00874237|9081329|P5|Overall Study|Physician Decision|0
2627989|NCT00874237|9081330|P4|Overall Study|Physician Decision|0
2627990|NCT00874237|9081331|P3|Overall Study|Physician Decision|0
2627991|NCT00874237|9081332|P2|Overall Study|Physician Decision|1
2627992|NCT00874237|9081333|P1|Overall Study|Physician Decision|0
2627993|NCT00874120|9081351|P2|Second Intervention|Protocol Violation|0
2627994|NCT00874120|9081352|P1|Second Intervention|Protocol Violation|1
2627995|NCT00874120|9081351|P2|Second Intervention|Withdrawal by Subject|0
2627996|NCT00874120|9081352|P1|Second Intervention|Withdrawal by Subject|1
2627997|NCT00874120|9081351|P2|First Intervention|positive drug test|0
2627998|NCT00874120|9081352|P1|First Intervention|positive drug test|1
2627999|NCT00874120|9081351|P2|First Intervention|Protocol Violation|0
2628000|NCT00874120|9081352|P1|First Intervention|Protocol Violation|3
2628001|NCT00874120|9081351|P2|First Intervention|Lost to Follow-up|1
2628002|NCT00874120|9081352|P1|First Intervention|Lost to Follow-up|0
2628003|NCT00874120|9081351|P2|First Intervention|Withdrawal by Subject|0
2628004|NCT00874120|9081352|P1|First Intervention|Withdrawal by Subject|2
2628005|NCT00874120|9081351|P2|First Intervention|Adverse Event|1
2628006|NCT00874120|9081352|P1|First Intervention|Adverse Event|0
2628007|NCT00874029|9081365|P1|Overall Study|Lost to Follow-up|5
2628008|NCT00874029|9081365|P1|Overall Study|Adverse Event|1
2628009|NCT00874029|9081365|P1|Overall Study|Physician Decision|1
2628010|NCT00874029|9081365|P1|Overall Study|Pregnancy|4
2628011|NCT00874029|9081365|P1|Overall Study|Withdrawal by Subject|10
2628012|NCT00873912|9081381|P2|Overall Study|Lost to Follow-up|0
2628013|NCT00873912|9081382|P1|Overall Study|Lost to Follow-up|2
2628014|NCT00873912|9081381|P2|Overall Study|Withdrawal by Subject|0
2628015|NCT00873912|9081382|P1|Overall Study|Withdrawal by Subject|1
2628016|NCT00873860|9081421|P4|Overall Study|Other|0
2628017|NCT00873860|9081422|P3|Overall Study|Other|1
2628018|NCT00873860|9081423|P2|Overall Study|Other|0
2628019|NCT00873860|9081424|P1|Overall Study|Other|1
2628020|NCT00873860|9081421|P4|Overall Study|Death|0
2628021|NCT00873860|9081422|P3|Overall Study|Death|0
2628022|NCT00873860|9081423|P2|Overall Study|Death|0
2628023|NCT00873860|9081424|P1|Overall Study|Death|1
2628024|NCT00873860|9081421|P4|Overall Study|Withdrawal by Subject|0
2628025|NCT00873860|9081422|P3|Overall Study|Withdrawal by Subject|2
2628026|NCT00873860|9081423|P2|Overall Study|Withdrawal by Subject|0
2628027|NCT00873860|9081424|P1|Overall Study|Withdrawal by Subject|1
2628028|NCT00873860|9081421|P4|Overall Study|Lost to Follow-up|1
2628029|NCT00873860|9081422|P3|Overall Study|Lost to Follow-up|0
2628030|NCT00873860|9081423|P2|Overall Study|Lost to Follow-up|0
2628031|NCT00873860|9081424|P1|Overall Study|Lost to Follow-up|1
2628032|NCT00873730|9081512|P2|Overall Study|Sponsor decision|0
2628033|NCT00873730|9081513|P1|Overall Study|Sponsor decision|1
2628034|NCT00873730|9081512|P2|Overall Study|Withdrawal by Subject|1
2628035|NCT00873730|9081513|P1|Overall Study|Withdrawal by Subject|0
2628036|NCT00873730|9081512|P2|Overall Study|Adverse Event|2
2628037|NCT00873730|9081513|P1|Overall Study|Adverse Event|0
2628038|NCT00873730|9081512|P2|Overall Study|Protocol Deviation|2
2628039|NCT00873730|9081513|P1|Overall Study|Protocol Deviation|5
2628040|NCT00873366|9081556|P1|Overall Study|Refused to continue DM-BT testing|3
2628041|NCT00873366|9081556|P1|Overall Study|Off tamoxifen due to side effects|2
2628042|NCT00873366|9081556|P1|Overall Study|Off tamoxifen for reconstructive surgery|1
2628043|NCT00873119|9081581|P2|Overall Study|Not treated|0
2628044|NCT00873119|9081582|P1|Overall Study|Not treated|2
2628045|NCT00873119|9081581|P2|Overall Study|Other|5
2628046|NCT00873119|9081582|P1|Overall Study|Other|2
2628047|NCT00873119|9081581|P2|Overall Study|Death|1
2628048|NCT00873119|9081582|P1|Overall Study|Death|2
2628049|NCT00873119|9081581|P2|Overall Study|Progressive disease|18
2628050|NCT00873119|9081582|P1|Overall Study|Progressive disease|26
2628051|NCT00873119|9081581|P2|Overall Study|Adverse Event|0
2628052|NCT00873119|9081582|P1|Overall Study|Adverse Event|8
2628053|NCT00873119|9081581|P2|Overall Study|Patient request|2
2628054|NCT00873119|9081582|P1|Overall Study|Patient request|4
2628055|NCT00873093|9081603|P5|Overall Study|Ineligible|0
2628056|NCT00873093|9081604|P4|Overall Study|Ineligible|1
2628057|NCT00873093|9081605|P3|Overall Study|Ineligible|0
2628058|NCT00873093|9081606|P2|Overall Study|Ineligible|1
2628059|NCT00873093|9081607|P1|Overall Study|Ineligible|0
2628060|NCT00873093|9081603|P5|Overall Study|Withdrawal by Subject|0
2628061|NCT00873093|9081604|P4|Overall Study|Withdrawal by Subject|0
2628062|NCT00873093|9081605|P3|Overall Study|Withdrawal by Subject|4
2628063|NCT00873093|9081606|P2|Overall Study|Withdrawal by Subject|4
2628064|NCT00873093|9081607|P1|Overall Study|Withdrawal by Subject|1
2628065|NCT00873093|9081603|P5|Overall Study|Physician Decision|2
2628066|NCT00873093|9081604|P4|Overall Study|Physician Decision|10
2628067|NCT00873093|9081605|P3|Overall Study|Physician Decision|10
2628068|NCT00873093|9081606|P2|Overall Study|Physician Decision|17
2628069|NCT00873093|9081607|P1|Overall Study|Physician Decision|0
2628070|NCT00873093|9081603|P5|Overall Study|Death|0
2628071|NCT00873093|9081604|P4|Overall Study|Death|0
2628072|NCT00873093|9081605|P3|Overall Study|Death|2
2628073|NCT00873093|9081606|P2|Overall Study|Death|3
2628074|NCT00873093|9081607|P1|Overall Study|Death|0
2628075|NCT00873093|9081603|P5|Overall Study|Adverse Event|0
2628076|NCT00873093|9081604|P4|Overall Study|Adverse Event|0
2628077|NCT00873093|9081605|P3|Overall Study|Adverse Event|0
2628078|NCT00873093|9081606|P2|Overall Study|Adverse Event|2
2628079|NCT00873093|9081607|P1|Overall Study|Adverse Event|0
2628080|NCT00873041|9081664|P3|Extension Study|Administrative reasons|1
2628081|NCT00873041|9081665|P2|Extension Study|Administrative reasons|0
2628082|NCT00873041|9081666|P1|Extension Study|Administrative reasons|0
2628083|NCT00873041|9081664|P3|Extension Study|Adverse Event|1
2628084|NCT00873041|9081665|P2|Extension Study|Adverse Event|0
2628085|NCT00873041|9081666|P1|Extension Study|Adverse Event|1
2628086|NCT00873041|9081664|P3|Core Study|Protocol deviation|1
2628087|NCT00873041|9081665|P2|Core Study|Protocol deviation|0
2628088|NCT00873041|9081666|P1|Core Study|Protocol deviation|1
2628089|NCT00873041|9081664|P3|Core Study|Abnormal laboratory value|1
2628090|NCT00873041|9081665|P2|Core Study|Abnormal laboratory value|0
2628091|NCT00873041|9081666|P1|Core Study|Abnormal laboratory value|0
2628092|NCT00873041|9081664|P3|Core Study|Lost to Follow-up|0
2628093|NCT00873041|9081665|P2|Core Study|Lost to Follow-up|1
2628094|NCT00873041|9081666|P1|Core Study|Lost to Follow-up|3
2628095|NCT00873041|9081664|P3|Core Study|Withdrawal by Subject|2
2628096|NCT00873041|9081665|P2|Core Study|Withdrawal by Subject|2
2628097|NCT00873041|9081666|P1|Core Study|Withdrawal by Subject|1
2628098|NCT00873041|9081664|P3|Core Study|Adverse Event|1
2628099|NCT00873041|9081665|P2|Core Study|Adverse Event|3
2628100|NCT00873041|9081666|P1|Core Study|Adverse Event|2
2628101|NCT00873015|9081724|P4|Overall Study|Withdrawal by Subject|0
2628102|NCT00873015|9081725|P3|Overall Study|Withdrawal by Subject|0
2628103|NCT00873015|9081726|P2|Overall Study|Withdrawal by Subject|1
2628104|NCT00873015|9081727|P1|Overall Study|Withdrawal by Subject|0
2628105|NCT00872989|9081736|P2|Overall Study|Not protocol specified|8
2628106|NCT00872989|9081737|P1|Overall Study|Not protocol specified|3
2628107|NCT00872989|9081736|P2|Overall Study|Progression/relapse|35
2628108|NCT00872989|9081737|P1|Overall Study|Progression/relapse|47
2628109|NCT00872989|9081736|P2|Overall Study|Withdrawal by Subject|5
2628110|NCT00872989|9081737|P1|Overall Study|Withdrawal by Subject|8
2628111|NCT00872989|9081736|P2|Overall Study|Adverse Event|15
2628112|NCT00872989|9081737|P1|Overall Study|Adverse Event|7
2628113|NCT00872898|9081756|P2|Part Two - Double Blind|Other reasons|0
2628114|NCT00872898|9081757|P1|Part Two - Double Blind|Other reasons|2
2628115|NCT00872898|9081756|P2|Part Two - Double Blind|Lost to Follow-up|2
2628116|NCT00872898|9081757|P1|Part Two - Double Blind|Lost to Follow-up|0
2628117|NCT00872898|9081756|P2|Part Two - Double Blind|Withdrawal by Subject|1
2628118|NCT00872898|9081757|P1|Part Two - Double Blind|Withdrawal by Subject|3
2628119|NCT00872898|9081756|P2|Part Two - Double Blind|Protocol Violation|0
2628120|NCT00872898|9081757|P1|Part Two - Double Blind|Protocol Violation|1
2628121|NCT00872898|9081756|P2|Part Two - Double Blind|Lack of Efficacy|0
2628122|NCT00872898|9081757|P1|Part Two - Double Blind|Lack of Efficacy|1
2628123|NCT00872898|9081756|P2|Part Two - Double Blind|Adverse Event|3
2628124|NCT00872898|9081757|P1|Part Two - Double Blind|Adverse Event|4
2628125|NCT00872599|9081831|P2|Second Washout Period|Adverse Event|1
2628126|NCT00872599|9081832|P1|Second Washout Period|Adverse Event|1
2628127|NCT00872521|9081852|P3|Secondary Endpoint Analysis|Efficacy data unavailable|1
2628128|NCT00872521|9081853|P2|Secondary Endpoint Analysis|Efficacy data unavailable|2
2628129|NCT00872521|9081854|P1|Secondary Endpoint Analysis|Efficacy data unavailable|0
2628130|NCT00872521|9081852|P3|Completed 3-month Follow up|Physician Decision|0
2628131|NCT00872521|9081853|P2|Completed 3-month Follow up|Physician Decision|1
2628132|NCT00872521|9081854|P1|Completed 3-month Follow up|Physician Decision|0
2628133|NCT00872521|9081852|P3|Completed 3-month Follow up|Other|0
2628134|NCT00872521|9081853|P2|Completed 3-month Follow up|Other|2
2628135|NCT00872521|9081854|P1|Completed 3-month Follow up|Other|0
2628136|NCT00872521|9081852|P3|Primary Endpoint Analysis|Patient response missing|1
2628137|NCT00872521|9081853|P2|Primary Endpoint Analysis|Patient response missing|0
2628138|NCT00872521|9081854|P1|Primary Endpoint Analysis|Patient response missing|0
2628139|NCT00872521|9081852|P3|Primary Endpoint Analysis|Efficacy data unavailable|0
2628140|NCT00872521|9081853|P2|Primary Endpoint Analysis|Efficacy data unavailable|2
2628141|NCT00872521|9081854|P1|Primary Endpoint Analysis|Efficacy data unavailable|0
2628142|NCT00872521|9081852|P3|Primary Endpoint Analysis|Patient choice|0
2628143|NCT00872521|9081853|P2|Primary Endpoint Analysis|Patient choice|1
2628144|NCT00872521|9081854|P1|Primary Endpoint Analysis|Patient choice|0
2628145|NCT00872521|9081852|P3|Primary Endpoint Analysis|Other|0
2628146|NCT00872521|9081853|P2|Primary Endpoint Analysis|Other|2
2628147|NCT00872521|9081854|P1|Primary Endpoint Analysis|Other|1
2628148|NCT00872521|9081852|P3|Completed PAD Induction|Death|0
2628149|NCT00872521|9081853|P2|Completed PAD Induction|Death|1
2628150|NCT00872521|9081854|P1|Completed PAD Induction|Death|1
2628151|NCT00872521|9081852|P3|Completed PAD Induction|Adverse Event|0
2628152|NCT00872521|9081853|P2|Completed PAD Induction|Adverse Event|0
2628153|NCT00872521|9081854|P1|Completed PAD Induction|Adverse Event|4
2628154|NCT00872521|9081852|P3|Completed PAD Induction|Disease progression|0
2628155|NCT00872521|9081853|P2|Completed PAD Induction|Disease progression|2
2628156|NCT00872521|9081854|P1|Completed PAD Induction|Disease progression|0
2628157|NCT00872521|9081852|P3|Completed PAD Induction|Patient choice|0
2628158|NCT00872521|9081853|P2|Completed PAD Induction|Patient choice|1
2628159|NCT00872521|9081854|P1|Completed PAD Induction|Patient choice|0
2628160|NCT00872170|9081925|P2|Overall Study|Adverse Event|0
2628161|NCT00872170|9081926|P1|Overall Study|Adverse Event|1
2628162|NCT00872001|9081956|P2|Overall Study|Administrative|15
2628163|NCT00872001|9081957|P1|Overall Study|Administrative|23
2628164|NCT00872001|9081956|P2|Overall Study|Did Not Meet Protocol Eligibility|36
2628165|NCT00872001|9081957|P1|Overall Study|Did Not Meet Protocol Eligibility|38
2628166|NCT00872001|9081956|P2|Overall Study|Protocol Violation|8
2628167|NCT00872001|9081957|P1|Overall Study|Protocol Violation|5
2628168|NCT00872001|9081956|P2|Overall Study|Withdrawal by Subject|30
2628169|NCT00872001|9081957|P1|Overall Study|Withdrawal by Subject|18
2628170|NCT00872001|9081956|P2|Overall Study|Lost to Follow-up|12
2628171|NCT00872001|9081957|P1|Overall Study|Lost to Follow-up|13
2628172|NCT00872001|9081956|P2|Overall Study|Protocol Defined Clinical Event|7
2628173|NCT00872001|9081957|P1|Overall Study|Protocol Defined Clinical Event|5
2628174|NCT00872001|9081956|P2|Overall Study|Adverse Event|23
2628175|NCT00872001|9081957|P1|Overall Study|Adverse Event|34
2628176|NCT00871975|9081965|P1|Overall Study|Motion artifact, tracing uninterpretable|5
2628177|NCT00871975|9081965|P1|Overall Study|Patient unable to void/insufficient vol|13
2628178|NCT00871975|9081965|P1|Overall Study|Catheters could not be inserted|1
2628179|NCT00871975|9081965|P1|Overall Study|Technical difficulty w155-1ith equipment|3
2628180|NCT00871871|9081971|P4|Part II|Protocol Violation|1
2628181|NCT00871871|9081972|P3|Part II|Protocol Violation|0
2628182|NCT00871871|9081973|P2|Part II|Protocol Violation|0
2628183|NCT00871871|9081974|P1|Part II|Protocol Violation|0
2628184|NCT00871871|9081971|P4|Part II|Adverse Event|2
2628185|NCT00871871|9081972|P3|Part II|Adverse Event|1
2628186|NCT00871871|9081973|P2|Part II|Adverse Event|0
2628187|NCT00871871|9081974|P1|Part II|Adverse Event|0
2628188|NCT00871871|9081971|P4|Part II|Withdrawal by Subject|1
2628189|NCT00871871|9081972|P3|Part II|Withdrawal by Subject|2
2628190|NCT00871871|9081973|P2|Part II|Withdrawal by Subject|0
2628191|NCT00871871|9081974|P1|Part II|Withdrawal by Subject|0
2628192|NCT00871871|9081971|P4|Part II|Lack of Efficacy|0
2628193|NCT00871871|9081972|P3|Part II|Lack of Efficacy|1
2628194|NCT00871871|9081973|P2|Part II|Lack of Efficacy|0
2628195|NCT00871871|9081974|P1|Part II|Lack of Efficacy|0
2628196|NCT00871871|9081971|P4|Part I|Laboratory abnormality|0
2628197|NCT00871871|9081972|P3|Part I|Laboratory abnormality|0
2628198|NCT00871871|9081973|P2|Part I|Laboratory abnormality|1
2628199|NCT00871871|9081974|P1|Part I|Laboratory abnormality|0
2628200|NCT00871871|9081971|P4|Part I|Withdrawal by Subject|0
2628201|NCT00871871|9081972|P3|Part I|Withdrawal by Subject|0
2628202|NCT00871871|9081973|P2|Part I|Withdrawal by Subject|0
2628203|NCT00871871|9081974|P1|Part I|Withdrawal by Subject|3
2628204|NCT00871871|9081971|P4|Part I|Adverse Event|0
2628205|NCT00871871|9081972|P3|Part I|Adverse Event|0
2628206|NCT00871871|9081973|P2|Part I|Adverse Event|2
2628207|NCT00871871|9081974|P1|Part I|Adverse Event|0
2628208|NCT00871780|9082011|P1|Overall Study|Physician Decision|1
2628209|NCT00871780|9082011|P1|Overall Study|Death|1
2628210|NCT00871780|9082011|P1|Overall Study|Voluntary Discontinuation|4
2628211|NCT00871780|9082011|P1|Overall Study|Adverse Event|6
2628212|NCT00871780|9082011|P1|Overall Study|Withdrawal by Subject|9
2628213|NCT00871780|9082011|P1|Overall Study|Enrolled But Not Treated|6
2628214|NCT00871741|9082031|P2|Overall Study|Premature study termination|7
2628215|NCT00871741|9082032|P1|Overall Study|Premature study termination|9
2628216|NCT00871728|9082046|P1|Overall Study|Withdrawal of Informed Consent|5
2628217|NCT00871728|9082046|P1|Overall Study|Participant Non-compliance|1
2628218|NCT00871728|9082046|P1|Overall Study|Failed to Visit Hospital|4
2628219|NCT00871728|9082046|P1|Overall Study|Lost to Follow-up|2
2628220|NCT00871728|9082046|P1|Overall Study|Protocol Violation|7
2628221|NCT00871728|9082046|P1|Overall Study|Adverse Event|1
2628222|NCT00871715|9082059|P3|Overall Study|Lost to Follow-up|9
2628223|NCT00871715|9082060|P2|Overall Study|Lost to Follow-up|6
2628224|NCT00871715|9082061|P1|Overall Study|Lost to Follow-up|3
2628225|NCT00871715|9082059|P3|Overall Study|Physician Decision|2
2628226|NCT00871715|9082060|P2|Overall Study|Physician Decision|0
2628227|NCT00871715|9082061|P1|Overall Study|Physician Decision|6
2628228|NCT00871715|9082059|P3|Overall Study|Withdrawal by Subject|15
2628229|NCT00871715|9082060|P2|Overall Study|Withdrawal by Subject|10
2628230|NCT00871715|9082061|P1|Overall Study|Withdrawal by Subject|6
2628231|NCT00871572|9082138|P4|Overall Study|Withdrawal by Subject|1
2628232|NCT00871572|9082139|P3|Overall Study|Withdrawal by Subject|3
2628233|NCT00871572|9082140|P2|Overall Study|Withdrawal by Subject|2
2628234|NCT00871572|9082141|P1|Overall Study|Withdrawal by Subject|1
2628235|NCT00871572|9082138|P4|Overall Study|Sponsor Decision|0
2628236|NCT00871572|9082139|P3|Overall Study|Sponsor Decision|0
2628237|NCT00871572|9082140|P2|Overall Study|Sponsor Decision|0
2628238|NCT00871572|9082141|P1|Overall Study|Sponsor Decision|1
2628239|NCT00871572|9082138|P4|Overall Study|Protocol Violation|1
2628240|NCT00871572|9082139|P3|Overall Study|Protocol Violation|1
2628241|NCT00871572|9082140|P2|Overall Study|Protocol Violation|0
2628242|NCT00871572|9082141|P1|Overall Study|Protocol Violation|0
2628243|NCT00871572|9082138|P4|Overall Study|Lost to Follow-up|1
2628244|NCT00871572|9082139|P3|Overall Study|Lost to Follow-up|0
2628245|NCT00871572|9082140|P2|Overall Study|Lost to Follow-up|1
2628246|NCT00871572|9082141|P1|Overall Study|Lost to Follow-up|0
2628247|NCT00871572|9082138|P4|Overall Study|Investigator Decision|1
2628248|NCT00871572|9082139|P3|Overall Study|Investigator Decision|0
2628249|NCT00871572|9082140|P2|Overall Study|Investigator Decision|1
2628250|NCT00871572|9082141|P1|Overall Study|Investigator Decision|0
2628251|NCT00871572|9082138|P4|Overall Study|Adverse Event|3
2628252|NCT00871572|9082139|P3|Overall Study|Adverse Event|0
2628253|NCT00871572|9082140|P2|Overall Study|Adverse Event|2
2628254|NCT00871572|9082141|P1|Overall Study|Adverse Event|0
2628255|NCT00871494|9082211|P1|Overall Study|Lost to Follow-up|1
2628256|NCT00871494|9082211|P1|Overall Study|Adverse Event|4
2628257|NCT00871494|9082211|P1|Overall Study|Lack of Efficacy|4
2628258|NCT00871494|9082211|P1|Overall Study|Protocol Violation|5
2628259|NCT00871429|9082218|P1|Overall Study|Questionnaire not completed|1
2628260|NCT00871429|9082218|P1|Overall Study|Withdrawal by Subject|17
2628261|NCT00871429|9082218|P1|Overall Study|Lost to Follow-up|6
2628262|NCT00871403|9082229|P3|Monotherapy Treatment Phase|Adverse Event|0
2628263|NCT00871403|9082230|P2|Monotherapy Treatment Phase|Adverse Event|4
2628264|NCT00871403|9082231|P1|Monotherapy Treatment Phase|Adverse Event|0
2628265|NCT00871403|9082229|P3|Monotherapy Treatment Phase|Disease Progression|1
2628266|NCT00871403|9082230|P2|Monotherapy Treatment Phase|Disease Progression|9
2628267|NCT00871403|9082231|P1|Monotherapy Treatment Phase|Disease Progression|0
2628268|NCT00871403|9082229|P3|Combination Treatment Phase|Physician Decision|3
2628269|NCT00871403|9082230|P2|Combination Treatment Phase|Physician Decision|1
2628270|NCT00871403|9082231|P1|Combination Treatment Phase|Physician Decision|0
2628271|NCT00871403|9082229|P3|Combination Treatment Phase|Withdrawal by Subject|1
2628272|NCT00871403|9082230|P2|Combination Treatment Phase|Withdrawal by Subject|3
2628273|NCT00871403|9082231|P1|Combination Treatment Phase|Withdrawal by Subject|0
2628274|NCT00871403|9082229|P3|Combination Treatment Phase|Disease Progression|5
2628275|NCT00871403|9082230|P2|Combination Treatment Phase|Disease Progression|8
2628276|NCT00871403|9082231|P1|Combination Treatment Phase|Disease Progression|0
2628277|NCT00871403|9082229|P3|Combination Treatment Phase|Adverse Event|2
2628278|NCT00871403|9082230|P2|Combination Treatment Phase|Adverse Event|17
2628279|NCT00871403|9082231|P1|Combination Treatment Phase|Adverse Event|0
2628280|NCT00871403|9082229|P3|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0
2628281|NCT00871403|9082230|P2|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19
2628282|NCT00871403|9082231|P1|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8
2628283|NCT00871403|9082229|P3|Combination Treatment Phase|Randomized but Not Treated|1
2628284|NCT00871403|9082230|P2|Combination Treatment Phase|Randomized but Not Treated|1
2628285|NCT00871403|9082231|P1|Combination Treatment Phase|Randomized but Not Treated|1
2628286|NCT00871377|9082244|P6|Third Intervention (10 Weeks)|Death|0
2628287|NCT00871377|9082245|P5|Third Intervention (10 Weeks)|Death|0
2628288|NCT00871377|9082246|P4|Third Intervention (10 Weeks)|Death|1
2628289|NCT00871377|9082247|P3|Third Intervention (10 Weeks)|Death|0
2628290|NCT00871377|9082248|P2|Third Intervention (10 Weeks)|Death|0
2628291|NCT00871377|9082249|P1|Third Intervention (10 Weeks)|Death|0
2628292|NCT00871377|9082244|P6|Washout (6 Weeks)|Withdrawal by Subject|1
2628293|NCT00871377|9082245|P5|Washout (6 Weeks)|Withdrawal by Subject|0
2628294|NCT00871377|9082246|P4|Washout (6 Weeks)|Withdrawal by Subject|0
2628295|NCT00871377|9082247|P3|Washout (6 Weeks)|Withdrawal by Subject|0
2628296|NCT00871377|9082248|P2|Washout (6 Weeks)|Withdrawal by Subject|0
2628297|NCT00871377|9082249|P1|Washout (6 Weeks)|Withdrawal by Subject|0
2628298|NCT00871377|9082244|P6|Washout (6 Weeks)|Withdrawal by Subject|0
2628299|NCT00871377|9082245|P5|Washout (6 Weeks)|Withdrawal by Subject|0
2628300|NCT00871377|9082246|P4|Washout (6 Weeks)|Withdrawal by Subject|0
2628301|NCT00871377|9082247|P3|Washout (6 Weeks)|Withdrawal by Subject|0
2628302|NCT00871377|9082248|P2|Washout (6 Weeks)|Withdrawal by Subject|0
2628303|NCT00871377|9082249|P1|Washout (6 Weeks)|Withdrawal by Subject|1
2628304|NCT00871377|9082244|P6|First Intervention (10 Weeks)|Lost to Follow-up|1
2628305|NCT00871377|9082245|P5|First Intervention (10 Weeks)|Lost to Follow-up|0
2628306|NCT00871377|9082246|P4|First Intervention (10 Weeks)|Lost to Follow-up|0
2628307|NCT00871377|9082247|P3|First Intervention (10 Weeks)|Lost to Follow-up|0
2628308|NCT00871377|9082248|P2|First Intervention (10 Weeks)|Lost to Follow-up|0
2628309|NCT00871377|9082249|P1|First Intervention (10 Weeks)|Lost to Follow-up|0
2628310|NCT00871377|9082244|P6|First Intervention (10 Weeks)|Withdrawal by Subject|0
2628311|NCT00871377|9082245|P5|First Intervention (10 Weeks)|Withdrawal by Subject|0
2628312|NCT00871377|9082246|P4|First Intervention (10 Weeks)|Withdrawal by Subject|0
2628313|NCT00871377|9082247|P3|First Intervention (10 Weeks)|Withdrawal by Subject|1
2628314|NCT00871377|9082248|P2|First Intervention (10 Weeks)|Withdrawal by Subject|0
2628315|NCT00871377|9082249|P1|First Intervention (10 Weeks)|Withdrawal by Subject|0
2628316|NCT00871351|9082260|P3|Overall Study|Adverse Event|0
2628317|NCT00871351|9082261|P2|Overall Study|Adverse Event|1
2628318|NCT00871351|9082262|P1|Overall Study|Adverse Event|3
2628319|NCT00871351|9082260|P3|Overall Study|Withdrawal by Subject|0
2628320|NCT00871351|9082261|P2|Overall Study|Withdrawal by Subject|0
2628321|NCT00871351|9082262|P1|Overall Study|Withdrawal by Subject|1
2628322|NCT00871338|9082284|P2|Prior to Booster|Lost to Follow-up|0
2628323|NCT00871338|9082285|P1|Prior to Booster|Lost to Follow-up|1
2628324|NCT00871338|9082284|P2|Prior to Booster|Withdrawal by Subject|3
2628325|NCT00871338|9082285|P1|Prior to Booster|Withdrawal by Subject|1
2628326|NCT00871234|9082374|P1|Overall Study|Lost to Follow-up|3
2628327|NCT00871234|9082374|P1|Overall Study|Adverse Event|2
2628328|NCT00871169|9082378|P1|Overall Study|Patient did not receive study treatment|2
2628329|NCT00871169|9082378|P1|Overall Study|Protocol Violation|1
2628330|NCT00871117|9082406|P2|Overall Study|Other|4
2628331|NCT00871117|9082407|P1|Overall Study|Other|0
2628332|NCT00871117|9082406|P2|Overall Study|Lost to Follow-up|6
2628333|NCT00871117|9082407|P1|Overall Study|Lost to Follow-up|5
2628334|NCT00871000|9082441|P2|Overall Study|Withdrawal by Subject|0
2628335|NCT00871000|9082442|P1|Overall Study|Withdrawal by Subject|1
2628336|NCT00870870|9082494|P4|Overall Study|Adverse Event|2
2628337|NCT00870870|9082495|P3|Overall Study|Adverse Event|2
2628338|NCT00870870|9082496|P2|Overall Study|Adverse Event|0
2628339|NCT00870870|9082497|P1|Overall Study|Adverse Event|0
2628340|NCT00870870|9082494|P4|Overall Study|Withdrawal by Subject|3
2628341|NCT00870870|9082495|P3|Overall Study|Withdrawal by Subject|1
2628342|NCT00870870|9082496|P2|Overall Study|Withdrawal by Subject|1
2628343|NCT00870870|9082497|P1|Overall Study|Withdrawal by Subject|0
2628344|NCT00870740|9082541|P6|Overall Study|Other|5
2628345|NCT00870740|9082542|P5|Overall Study|Other|3
2628346|NCT00870740|9082543|P4|Overall Study|Other|4
2628347|NCT00870740|9082544|P3|Overall Study|Other|2
2628348|NCT00870740|9082545|P2|Overall Study|Other|5
2628349|NCT00870740|9082546|P1|Overall Study|Other|2
2628350|NCT00870740|9082541|P6|Overall Study|Death|0
2628351|NCT00870740|9082542|P5|Overall Study|Death|1
2628352|NCT00870740|9082543|P4|Overall Study|Death|0
2628353|NCT00870740|9082544|P3|Overall Study|Death|0
2628354|NCT00870740|9082545|P2|Overall Study|Death|0
2628355|NCT00870740|9082546|P1|Overall Study|Death|0
2628356|NCT00870740|9082541|P6|Overall Study|Subject Non-compliance|1
2628357|NCT00870740|9082542|P5|Overall Study|Subject Non-compliance|0
2628358|NCT00870740|9082543|P4|Overall Study|Subject Non-compliance|0
2628359|NCT00870740|9082544|P3|Overall Study|Subject Non-compliance|0
2628360|NCT00870740|9082545|P2|Overall Study|Subject Non-compliance|0
2628361|NCT00870740|9082546|P1|Overall Study|Subject Non-compliance|0
2628362|NCT00870740|9082541|P6|Overall Study|Investigator Decision|0
2628363|NCT00870740|9082542|P5|Overall Study|Investigator Decision|0
2628364|NCT00870740|9082543|P4|Overall Study|Investigator Decision|0
2628365|NCT00870740|9082544|P3|Overall Study|Investigator Decision|1
2628366|NCT00870740|9082545|P2|Overall Study|Investigator Decision|0
2628367|NCT00870740|9082546|P1|Overall Study|Investigator Decision|2
2628368|NCT00870740|9082541|P6|Overall Study|Consent Withdrawn|5
2628369|NCT00870740|9082542|P5|Overall Study|Consent Withdrawn|6
2628370|NCT00870740|9082543|P4|Overall Study|Consent Withdrawn|6
2628371|NCT00870740|9082544|P3|Overall Study|Consent Withdrawn|4
2628372|NCT00870740|9082545|P2|Overall Study|Consent Withdrawn|3
2628373|NCT00870740|9082546|P1|Overall Study|Consent Withdrawn|6
2628374|NCT00870740|9082541|P6|Overall Study|Adverse Event|6
2628375|NCT00870740|9082542|P5|Overall Study|Adverse Event|1
2628376|NCT00870740|9082543|P4|Overall Study|Adverse Event|2
2628377|NCT00870740|9082544|P3|Overall Study|Adverse Event|3
2628378|NCT00870740|9082545|P2|Overall Study|Adverse Event|1
2628379|NCT00870740|9082546|P1|Overall Study|Adverse Event|2
2628380|NCT00870727|9082622|P2|Overall Study|Adverse Event|1
2628381|NCT00870727|9082623|P1|Overall Study|Adverse Event|0
2628382|NCT00870727|9082622|P2|Overall Study|Lack of Efficacy|3
2628383|NCT00870727|9082623|P1|Overall Study|Lack of Efficacy|1
2628384|NCT00870727|9082622|P2|Overall Study|Lost to Follow-up|1
2628385|NCT00870727|9082623|P1|Overall Study|Lost to Follow-up|0
2628386|NCT00870688|9082639|P1|Overall Study|Granules in the Stools|1
2628387|NCT00870688|9082639|P1|Overall Study|Death, Unrelated|1
2628388|NCT00870688|9082639|P1|Overall Study|Lost to Follow-up|2
2628389|NCT00870584|9082644|P2|Overall Study|Protocol Deviation|2
2628390|NCT00870584|9082645|P1|Overall Study|Protocol Deviation|2
2628391|NCT00870584|9082644|P2|Overall Study|Lost to Follow-up|1
2628392|NCT00870584|9082645|P1|Overall Study|Lost to Follow-up|5
2628393|NCT00870584|9082644|P2|Overall Study|Withdrawal by Subject|7
2628394|NCT00870584|9082645|P1|Overall Study|Withdrawal by Subject|6
2628395|NCT00870584|9082644|P2|Overall Study|Adverse Event|3
2628396|NCT00870584|9082645|P1|Overall Study|Adverse Event|3
2628397|NCT00870233|9082754|P1|Overall Study|Death|1
2628398|NCT00870233|9082754|P1|Overall Study|Incompatible internet browser|2
2628399|NCT00870233|9082754|P1|Overall Study|Did not undergo laparotomy|3
2628400|NCT00870233|9082754|P1|Overall Study|Withdrawal by Subject|18
2628401|NCT00870194|9082763|P2|Overall Study|Subject Decision|2
2628402|NCT00870194|9082764|P1|Overall Study|Subject Decision|7
2628403|NCT00870194|9082763|P2|Overall Study|Entry Criteria Not Met|2
2628404|NCT00870194|9082764|P1|Overall Study|Entry Criteria Not Met|1
2628405|NCT00870194|9082763|P2|Overall Study|Protocol Violation|3
2628406|NCT00870194|9082764|P1|Overall Study|Protocol Violation|3
2628407|NCT00870194|9082763|P2|Overall Study|Physician Decision|1
2628408|NCT00870194|9082764|P1|Overall Study|Physician Decision|3
2628409|NCT00870194|9082763|P2|Overall Study|Lost to Follow-up|0
2628410|NCT00870194|9082764|P1|Overall Study|Lost to Follow-up|2
2628411|NCT00870194|9082763|P2|Overall Study|Lack of Efficacy|1
2628412|NCT00870194|9082764|P1|Overall Study|Lack of Efficacy|0
2628413|NCT00870194|9082763|P2|Overall Study|Adverse Event|5
2628414|NCT00870194|9082764|P1|Overall Study|Adverse Event|10
2628415|NCT00870103|9082802|P1|Overall Study|Lost to Follow-up|2
2628416|NCT00870103|9082802|P1|Overall Study|Physician Decision|2
2628417|NCT00869999|9082807|P1|Overall Study|removed prior to starting therapy|1
2628418|NCT00869999|9082807|P1|Overall Study|Withdrawal by Subject|1
2628419|NCT00869960|9082813|P1|Overall Study|Lost to Follow-up|2
2628420|NCT00869778|9082862|P3|Overall Study|Unblinding|0
2628421|NCT00869778|9082863|P2|Overall Study|Unblinding|0
2628422|NCT00869778|9082864|P1|Overall Study|Unblinding|1
2628423|NCT00869778|9082862|P3|Overall Study|Protocol Violation|5
2628424|NCT00869778|9082863|P2|Overall Study|Protocol Violation|3
2628425|NCT00869778|9082864|P1|Overall Study|Protocol Violation|5
2628426|NCT00869778|9082862|P3|Overall Study|Pregnancy|0
2628427|NCT00869778|9082863|P2|Overall Study|Pregnancy|0
2628428|NCT00869778|9082864|P1|Overall Study|Pregnancy|1
2628429|NCT00869778|9082862|P3|Overall Study|Withdrawal by Subject|5
2628430|NCT00869778|9082863|P2|Overall Study|Withdrawal by Subject|4
2628431|NCT00869778|9082864|P1|Overall Study|Withdrawal by Subject|3
2628432|NCT00869778|9082862|P3|Overall Study|Adverse Event|0
2628433|NCT00869778|9082863|P2|Overall Study|Adverse Event|0
2628434|NCT00869778|9082864|P1|Overall Study|Adverse Event|2
2628435|NCT00869557|9082939|P2|Extension Phase|Withdrew Consent|0
2628436|NCT00869557|9082940|P1|Extension Phase|Withdrew Consent|2
2628437|NCT00869557|9082939|P2|Extension Phase|Investigator's Discretion|0
2628438|NCT00869557|9082940|P1|Extension Phase|Investigator's Discretion|2
2628439|NCT00869557|9082939|P2|Extension Phase|Lost to Follow-up|1
2628440|NCT00869557|9082940|P1|Extension Phase|Lost to Follow-up|3
2628441|NCT00869557|9082939|P2|Extension Phase|Lack of Efficacy|0
2628442|NCT00869557|9082940|P1|Extension Phase|Lack of Efficacy|1
2628443|NCT00869557|9082939|P2|Extension Phase|Adverse Event|2
2628444|NCT00869557|9082940|P1|Extension Phase|Adverse Event|2
2628445|NCT00869557|9082939|P2|Randomized Phase|Withdrew Consent|1
2628446|NCT00869557|9082940|P1|Randomized Phase|Withdrew Consent|0
2628447|NCT00869557|9082939|P2|Randomized Phase|Investigator's Discretion|0
2628448|NCT00869557|9082940|P1|Randomized Phase|Investigator's Discretion|1
2628449|NCT00869557|9082939|P2|Randomized Phase|Lost to Follow-up|1
2628450|NCT00869557|9082940|P1|Randomized Phase|Lost to Follow-up|2
2628451|NCT00869518|9082959|P2|Overall Study|Lost to Follow-up|1
2628452|NCT00869518|9082960|P1|Overall Study|Lost to Follow-up|1
2628453|NCT00869440|9082976|P4|Overall Study|Physician Decision|0
2628454|NCT00869440|9082977|P3|Overall Study|Physician Decision|0
2628455|NCT00869440|9082978|P2|Overall Study|Physician Decision|1
2628456|NCT00869440|9082979|P1|Overall Study|Physician Decision|1
2628457|NCT00869440|9082976|P4|Overall Study|Withdrawal by Subject|0
2628458|NCT00869440|9082977|P3|Overall Study|Withdrawal by Subject|0
2628459|NCT00869440|9082978|P2|Overall Study|Withdrawal by Subject|0
2628460|NCT00869440|9082979|P1|Overall Study|Withdrawal by Subject|1
2628461|NCT00869401|9083013|P5|Overall Study|Withdrawal by Subject|3
2628462|NCT00869401|9083014|P4|Overall Study|Withdrawal by Subject|5
2628463|NCT00869401|9083015|P3|Overall Study|Withdrawal by Subject|0
2628464|NCT00869401|9083016|P2|Overall Study|Withdrawal by Subject|0
2628465|NCT00869401|9083017|P1|Overall Study|Withdrawal by Subject|0
2628466|NCT00869362|9083046|P2|Overall Study|Lost to Follow-up|3
2628467|NCT00869362|9083047|P1|Overall Study|Lost to Follow-up|1
2628468|NCT00869362|9083046|P2|Overall Study|Death|2
2628469|NCT00869362|9083047|P1|Overall Study|Death|0
2628470|NCT00869323|9083068|P1|Maintenance Therapy|concurrent illness|1
2628471|NCT00869258|9083076|P1|Overall Study|Physician Decision|1
2628472|NCT00869128|9083141|P2|Overall Study|lack of Compliance|6
2628473|NCT00869128|9083142|P1|Overall Study|lack of Compliance|6
2628474|NCT00869089|9083146|P1|Overall Study|Screen Fail|1
2628475|NCT00869089|9083146|P1|Overall Study|Withdrawal by Subject|1
2628476|NCT00869089|9083146|P1|Overall Study|Lost to Follow-up|1
2628477|NCT00869050|9083150|P1|Overall Study|Screen Failure|3
2628478|NCT00869024|9083157|P2|Overall Study|Protocol Violation|1
2628479|NCT00869024|9083158|P1|Overall Study|Protocol Violation|0
2628480|NCT00869024|9083157|P2|Overall Study|Lost to Follow-up|1
2628481|NCT00869024|9083158|P1|Overall Study|Lost to Follow-up|0
2628482|NCT00869024|9083157|P2|Overall Study|Death|3
2628483|NCT00869024|9083158|P1|Overall Study|Death|2
2628484|NCT00868998|9083174|P1|Overall Study|Death|1
2628485|NCT00868998|9083174|P1|Overall Study|Progression of disease|2
2628486|NCT00868998|9083174|P1|Overall Study|Withdrawal by Subject|1
2628487|NCT00868998|9083174|P1|Overall Study|Screen Failure|1
2628488|NCT00868790|9083185|P14|Post-study|Excluded Medication|0
2628489|NCT00868790|9083186|P13|Post-study|Excluded Medication|0
2628490|NCT00868790|9083187|P12|Post-study|Excluded Medication|0
2628491|NCT00868790|9083188|P11|Post-study|Excluded Medication|0
2628492|NCT00868790|9083189|P10|Post-study|Excluded Medication|1
2628493|NCT00868790|9083190|P9|Post-study|Excluded Medication|0
2628494|NCT00868790|9083191|P8|Post-study|Excluded Medication|2
2628495|NCT00868790|9083192|P7|Post-study|Excluded Medication|0
2628496|NCT00868790|9083193|P6|Post-study|Excluded Medication|0
2628497|NCT00868790|9083194|P5|Post-study|Excluded Medication|0
2628498|NCT00868790|9083195|P4|Post-study|Excluded Medication|0
2628499|NCT00868790|9083196|P3|Post-study|Excluded Medication|0
2628500|NCT00868790|9083197|P2|Post-study|Excluded Medication|0
2628501|NCT00868790|9083198|P1|Post-study|Excluded Medication|0
2628502|NCT00868790|9083185|P14|Post-study|Withdrawal by Subject|0
2628503|NCT00868790|9083186|P13|Post-study|Withdrawal by Subject|0
2628504|NCT00868790|9083187|P12|Post-study|Withdrawal by Subject|0
2628505|NCT00868790|9083188|P11|Post-study|Withdrawal by Subject|0
2628506|NCT00868790|9083189|P10|Post-study|Withdrawal by Subject|0
2628507|NCT00868790|9083190|P9|Post-study|Withdrawal by Subject|0
2628508|NCT00868790|9083191|P8|Post-study|Withdrawal by Subject|0
2628509|NCT00868790|9083192|P7|Post-study|Withdrawal by Subject|0
2628510|NCT00868790|9083193|P6|Post-study|Withdrawal by Subject|0
2628511|NCT00868790|9083194|P5|Post-study|Withdrawal by Subject|1
2628512|NCT00868790|9083195|P4|Post-study|Withdrawal by Subject|0
2628513|NCT00868790|9083196|P3|Post-study|Withdrawal by Subject|0
2628514|NCT00868790|9083197|P2|Post-study|Withdrawal by Subject|0
2628515|NCT00868790|9083198|P1|Post-study|Withdrawal by Subject|0
2628516|NCT00868790|9083185|P14|Period 4|Abnormal ALT/AST|0
2628517|NCT00868790|9083186|P13|Period 4|Abnormal ALT/AST|0
2628518|NCT00868790|9083187|P12|Period 4|Abnormal ALT/AST|0
2628519|NCT00868790|9083188|P11|Period 4|Abnormal ALT/AST|0
2628520|NCT00868790|9083189|P10|Period 4|Abnormal ALT/AST|0
2628521|NCT00868790|9083190|P9|Period 4|Abnormal ALT/AST|0
2628522|NCT00868790|9083191|P8|Period 4|Abnormal ALT/AST|0
2628523|NCT00868790|9083192|P7|Period 4|Abnormal ALT/AST|0
2628524|NCT00868790|9083193|P6|Period 4|Abnormal ALT/AST|0
2628525|NCT00868790|9083194|P5|Period 4|Abnormal ALT/AST|0
2628526|NCT00868790|9083195|P4|Period 4|Abnormal ALT/AST|0
2628527|NCT00868790|9083196|P3|Period 4|Abnormal ALT/AST|1
2628528|NCT00868790|9083197|P2|Period 4|Abnormal ALT/AST|0
2628529|NCT00868790|9083198|P1|Period 4|Abnormal ALT/AST|0
2628530|NCT00868790|9083185|P14|Period 4|Study Terminated by Sponsor|1
2628531|NCT00868790|9083186|P13|Period 4|Study Terminated by Sponsor|0
2628532|NCT00868790|9083187|P12|Period 4|Study Terminated by Sponsor|1
2628533|NCT00868790|9083188|P11|Period 4|Study Terminated by Sponsor|2
2628534|NCT00868790|9083189|P10|Period 4|Study Terminated by Sponsor|0
2628535|NCT00868790|9083190|P9|Period 4|Study Terminated by Sponsor|2
2628536|NCT00868790|9083191|P8|Period 4|Study Terminated by Sponsor|1
2628537|NCT00868790|9083192|P7|Period 4|Study Terminated by Sponsor|0
2628538|NCT00868790|9083193|P6|Period 4|Study Terminated by Sponsor|0
2628539|NCT00868790|9083194|P5|Period 4|Study Terminated by Sponsor|0
2628540|NCT00868790|9083195|P4|Period 4|Study Terminated by Sponsor|0
2628541|NCT00868790|9083196|P3|Period 4|Study Terminated by Sponsor|0
2628542|NCT00868790|9083197|P2|Period 4|Study Terminated by Sponsor|0
2628543|NCT00868790|9083198|P1|Period 4|Study Terminated by Sponsor|2
2628544|NCT00868790|9083185|P14|Period 4|Lost to Follow-up|0
2628545|NCT00868790|9083186|P13|Period 4|Lost to Follow-up|0
2628546|NCT00868790|9083187|P12|Period 4|Lost to Follow-up|0
2628547|NCT00868790|9083188|P11|Period 4|Lost to Follow-up|0
2628548|NCT00868790|9083189|P10|Period 4|Lost to Follow-up|0
2628549|NCT00868790|9083190|P9|Period 4|Lost to Follow-up|0
2628550|NCT00868790|9083191|P8|Period 4|Lost to Follow-up|1
2628551|NCT00868790|9083192|P7|Period 4|Lost to Follow-up|0
2628552|NCT00868790|9083193|P6|Period 4|Lost to Follow-up|0
2628553|NCT00868790|9083194|P5|Period 4|Lost to Follow-up|0
2628554|NCT00868790|9083195|P4|Period 4|Lost to Follow-up|0
2628555|NCT00868790|9083196|P3|Period 4|Lost to Follow-up|0
2628556|NCT00868790|9083197|P2|Period 4|Lost to Follow-up|0
2628557|NCT00868790|9083198|P1|Period 4|Lost to Follow-up|0
2628558|NCT00868790|9083185|P14|Period 4|Adverse Event|0
2628559|NCT00868790|9083186|P13|Period 4|Adverse Event|1
2628560|NCT00868790|9083187|P12|Period 4|Adverse Event|0
2628561|NCT00868790|9083188|P11|Period 4|Adverse Event|1
2628562|NCT00868790|9083189|P10|Period 4|Adverse Event|0
2628563|NCT00868790|9083190|P9|Period 4|Adverse Event|0
2628564|NCT00868790|9083191|P8|Period 4|Adverse Event|1
2628565|NCT00868790|9083192|P7|Period 4|Adverse Event|0
2628566|NCT00868790|9083193|P6|Period 4|Adverse Event|0
2628567|NCT00868790|9083194|P5|Period 4|Adverse Event|0
2628568|NCT00868790|9083195|P4|Period 4|Adverse Event|0
2628569|NCT00868790|9083196|P3|Period 4|Adverse Event|0
2628570|NCT00868790|9083197|P2|Period 4|Adverse Event|0
2628571|NCT00868790|9083198|P1|Period 4|Adverse Event|0
2628572|NCT00868790|9083185|P14|Period 3|Study Terminated by Sponsor|0
2628573|NCT00868790|9083186|P13|Period 3|Study Terminated by Sponsor|0
2628574|NCT00868790|9083187|P12|Period 3|Study Terminated by Sponsor|0
2628575|NCT00868790|9083188|P11|Period 3|Study Terminated by Sponsor|0
2628576|NCT00868790|9083189|P10|Period 3|Study Terminated by Sponsor|0
2628577|NCT00868790|9083190|P9|Period 3|Study Terminated by Sponsor|0
2628578|NCT00868790|9083191|P8|Period 3|Study Terminated by Sponsor|0
2628579|NCT00868790|9083192|P7|Period 3|Study Terminated by Sponsor|0
2628580|NCT00868790|9083193|P6|Period 3|Study Terminated by Sponsor|0
2628581|NCT00868790|9083194|P5|Period 3|Study Terminated by Sponsor|0
2628582|NCT00868790|9083195|P4|Period 3|Study Terminated by Sponsor|1
2628583|NCT00868790|9083196|P3|Period 3|Study Terminated by Sponsor|0
2628584|NCT00868790|9083197|P2|Period 3|Study Terminated by Sponsor|0
2628585|NCT00868790|9083198|P1|Period 3|Study Terminated by Sponsor|0
2628586|NCT00868790|9083185|P14|Period 3|Protocol Violation|0
2628587|NCT00868790|9083186|P13|Period 3|Protocol Violation|0
2628588|NCT00868790|9083187|P12|Period 3|Protocol Violation|0
2628589|NCT00868790|9083188|P11|Period 3|Protocol Violation|1
2628590|NCT00868790|9083189|P10|Period 3|Protocol Violation|0
2628591|NCT00868790|9083190|P9|Period 3|Protocol Violation|0
2628592|NCT00868790|9083191|P8|Period 3|Protocol Violation|0
2628593|NCT00868790|9083192|P7|Period 3|Protocol Violation|0
2628594|NCT00868790|9083193|P6|Period 3|Protocol Violation|0
2628595|NCT00868790|9083194|P5|Period 3|Protocol Violation|0
2628596|NCT00868790|9083195|P4|Period 3|Protocol Violation|0
2628597|NCT00868790|9083196|P3|Period 3|Protocol Violation|0
2628598|NCT00868790|9083197|P2|Period 3|Protocol Violation|0
2628599|NCT00868790|9083198|P1|Period 3|Protocol Violation|0
2628600|NCT00868790|9083185|P14|Period 3|Adverse Event|0
2628601|NCT00868790|9083186|P13|Period 3|Adverse Event|0
2628602|NCT00868790|9083187|P12|Period 3|Adverse Event|0
2628603|NCT00868790|9083188|P11|Period 3|Adverse Event|0
2628604|NCT00868790|9083189|P10|Period 3|Adverse Event|1
2628605|NCT00868790|9083190|P9|Period 3|Adverse Event|0
2628606|NCT00868790|9083191|P8|Period 3|Adverse Event|0
2628607|NCT00868790|9083192|P7|Period 3|Adverse Event|0
2628608|NCT00868790|9083193|P6|Period 3|Adverse Event|0
2628609|NCT00868790|9083194|P5|Period 3|Adverse Event|0
2628610|NCT00868790|9083195|P4|Period 3|Adverse Event|0
2628611|NCT00868790|9083196|P3|Period 3|Adverse Event|0
2628612|NCT00868790|9083197|P2|Period 3|Adverse Event|0
2628613|NCT00868790|9083198|P1|Period 3|Adverse Event|0
2628614|NCT00868790|9083185|P14|Period 2|Withdrawal by Subject|1
2628615|NCT00868790|9083186|P13|Period 2|Withdrawal by Subject|0
2628616|NCT00868790|9083187|P12|Period 2|Withdrawal by Subject|0
2628617|NCT00868790|9083188|P11|Period 2|Withdrawal by Subject|0
2628618|NCT00868790|9083189|P10|Period 2|Withdrawal by Subject|0
2628619|NCT00868790|9083190|P9|Period 2|Withdrawal by Subject|1
2628620|NCT00868790|9083191|P8|Period 2|Withdrawal by Subject|0
2628621|NCT00868790|9083192|P7|Period 2|Withdrawal by Subject|0
2628622|NCT00868790|9083193|P6|Period 2|Withdrawal by Subject|0
2628623|NCT00868790|9083194|P5|Period 2|Withdrawal by Subject|0
2628624|NCT00868790|9083195|P4|Period 2|Withdrawal by Subject|0
2628625|NCT00868790|9083196|P3|Period 2|Withdrawal by Subject|0
2628626|NCT00868790|9083197|P2|Period 2|Withdrawal by Subject|0
2628627|NCT00868790|9083198|P1|Period 2|Withdrawal by Subject|0
2628628|NCT00868790|9083185|P14|Period 2|Lost to Follow-up|0
2628629|NCT00868790|9083186|P13|Period 2|Lost to Follow-up|0
2628630|NCT00868790|9083187|P12|Period 2|Lost to Follow-up|0
2628631|NCT00868790|9083188|P11|Period 2|Lost to Follow-up|0
2628632|NCT00868790|9083189|P10|Period 2|Lost to Follow-up|0
2628633|NCT00868790|9083190|P9|Period 2|Lost to Follow-up|0
2628634|NCT00868790|9083191|P8|Period 2|Lost to Follow-up|0
2628635|NCT00868790|9083192|P7|Period 2|Lost to Follow-up|0
2628636|NCT00868790|9083193|P6|Period 2|Lost to Follow-up|1
2628637|NCT00868790|9083194|P5|Period 2|Lost to Follow-up|0
2628638|NCT00868790|9083195|P4|Period 2|Lost to Follow-up|0
2628639|NCT00868790|9083196|P3|Period 2|Lost to Follow-up|0
2628640|NCT00868790|9083197|P2|Period 2|Lost to Follow-up|1
2628641|NCT00868790|9083198|P1|Period 2|Lost to Follow-up|0
2628642|NCT00868790|9083185|P14|Period 2|Adverse Event|0
2628643|NCT00868790|9083186|P13|Period 2|Adverse Event|0
2628644|NCT00868790|9083187|P12|Period 2|Adverse Event|0
2628645|NCT00868790|9083188|P11|Period 2|Adverse Event|0
2628646|NCT00868790|9083189|P10|Period 2|Adverse Event|0
2628647|NCT00868790|9083190|P9|Period 2|Adverse Event|1
2628648|NCT00868790|9083191|P8|Period 2|Adverse Event|0
2628649|NCT00868790|9083192|P7|Period 2|Adverse Event|0
2628650|NCT00868790|9083193|P6|Period 2|Adverse Event|0
2628651|NCT00868790|9083194|P5|Period 2|Adverse Event|0
2628652|NCT00868790|9083195|P4|Period 2|Adverse Event|0
2628653|NCT00868790|9083196|P3|Period 2|Adverse Event|0
2628654|NCT00868790|9083197|P2|Period 2|Adverse Event|0
2628655|NCT00868790|9083198|P1|Period 2|Adverse Event|0
2628656|NCT00868790|9083185|P14|Period 1|Lost to Follow-up|0
2628657|NCT00868790|9083186|P13|Period 1|Lost to Follow-up|0
2628658|NCT00868790|9083187|P12|Period 1|Lost to Follow-up|0
2628659|NCT00868790|9083188|P11|Period 1|Lost to Follow-up|0
2628660|NCT00868790|9083189|P10|Period 1|Lost to Follow-up|0
2628661|NCT00868790|9083190|P9|Period 1|Lost to Follow-up|0
2628662|NCT00868790|9083191|P8|Period 1|Lost to Follow-up|0
2628663|NCT00868790|9083192|P7|Period 1|Lost to Follow-up|0
2628664|NCT00868790|9083193|P6|Period 1|Lost to Follow-up|1
2628665|NCT00868790|9083194|P5|Period 1|Lost to Follow-up|0
2628666|NCT00868790|9083195|P4|Period 1|Lost to Follow-up|0
2628667|NCT00868790|9083196|P3|Period 1|Lost to Follow-up|0
2628668|NCT00868790|9083197|P2|Period 1|Lost to Follow-up|0
2628669|NCT00868790|9083198|P1|Period 1|Lost to Follow-up|0
2628670|NCT00868790|9083185|P14|Period 1|Abnormal Triglycerides|0
2628671|NCT00868790|9083186|P13|Period 1|Abnormal Triglycerides|0
2628672|NCT00868790|9083187|P12|Period 1|Abnormal Triglycerides|0
2628673|NCT00868790|9083188|P11|Period 1|Abnormal Triglycerides|0
2628674|NCT00868790|9083189|P10|Period 1|Abnormal Triglycerides|0
2628675|NCT00868790|9083190|P9|Period 1|Abnormal Triglycerides|0
2628676|NCT00868790|9083191|P8|Period 1|Abnormal Triglycerides|0
2628677|NCT00868790|9083192|P7|Period 1|Abnormal Triglycerides|0
2628678|NCT00868790|9083193|P6|Period 1|Abnormal Triglycerides|0
2628679|NCT00868790|9083194|P5|Period 1|Abnormal Triglycerides|1
2628680|NCT00868790|9083195|P4|Period 1|Abnormal Triglycerides|0
2628681|NCT00868790|9083196|P3|Period 1|Abnormal Triglycerides|0
2628682|NCT00868790|9083197|P2|Period 1|Abnormal Triglycerides|0
2628683|NCT00868790|9083198|P1|Period 1|Abnormal Triglycerides|0
2628684|NCT00868790|9083185|P14|Period 1|Withdrawal by Subject|1
2628685|NCT00868790|9083186|P13|Period 1|Withdrawal by Subject|0
2628686|NCT00868790|9083187|P12|Period 1|Withdrawal by Subject|0
2628687|NCT00868790|9083188|P11|Period 1|Withdrawal by Subject|0
2628688|NCT00868790|9083189|P10|Period 1|Withdrawal by Subject|0
2628689|NCT00868790|9083190|P9|Period 1|Withdrawal by Subject|0
2628690|NCT00868790|9083191|P8|Period 1|Withdrawal by Subject|0
2628691|NCT00868790|9083192|P7|Period 1|Withdrawal by Subject|0
2628692|NCT00868790|9083193|P6|Period 1|Withdrawal by Subject|0
2628693|NCT00868790|9083194|P5|Period 1|Withdrawal by Subject|0
2628694|NCT00868790|9083195|P4|Period 1|Withdrawal by Subject|0
2628695|NCT00868790|9083196|P3|Period 1|Withdrawal by Subject|0
2628696|NCT00868790|9083197|P2|Period 1|Withdrawal by Subject|1
2628697|NCT00868790|9083198|P1|Period 1|Withdrawal by Subject|0
2628698|NCT00868790|9083185|P14|Period 1|Protocol Violation|0
2628699|NCT00868790|9083186|P13|Period 1|Protocol Violation|0
2628700|NCT00868790|9083187|P12|Period 1|Protocol Violation|0
2628701|NCT00868790|9083188|P11|Period 1|Protocol Violation|0
2628702|NCT00868790|9083189|P10|Period 1|Protocol Violation|0
2628703|NCT00868790|9083190|P9|Period 1|Protocol Violation|0
2628704|NCT00868790|9083191|P8|Period 1|Protocol Violation|0
2628705|NCT00868790|9083192|P7|Period 1|Protocol Violation|0
2628706|NCT00868790|9083193|P6|Period 1|Protocol Violation|0
2628707|NCT00868790|9083194|P5|Period 1|Protocol Violation|0
2628708|NCT00868790|9083195|P4|Period 1|Protocol Violation|0
2628709|NCT00868790|9083196|P3|Period 1|Protocol Violation|0
2628710|NCT00868790|9083197|P2|Period 1|Protocol Violation|0
2628711|NCT00868790|9083198|P1|Period 1|Protocol Violation|1
2628712|NCT00868790|9083185|P14|Period 1|Adverse Event|1
2628713|NCT00868790|9083186|P13|Period 1|Adverse Event|0
2628714|NCT00868790|9083187|P12|Period 1|Adverse Event|0
2628715|NCT00868790|9083188|P11|Period 1|Adverse Event|0
2628716|NCT00868790|9083189|P10|Period 1|Adverse Event|0
2628717|NCT00868790|9083190|P9|Period 1|Adverse Event|1
2628718|NCT00868790|9083191|P8|Period 1|Adverse Event|3
2628719|NCT00868790|9083192|P7|Period 1|Adverse Event|0
2628720|NCT00868790|9083193|P6|Period 1|Adverse Event|0
2628721|NCT00868790|9083194|P5|Period 1|Adverse Event|0
2628722|NCT00868790|9083195|P4|Period 1|Adverse Event|0
2628723|NCT00868790|9083196|P3|Period 1|Adverse Event|0
2628724|NCT00868790|9083197|P2|Period 1|Adverse Event|0
2628725|NCT00868790|9083198|P1|Period 1|Adverse Event|1
2628726|NCT00868608|9083281|P3|Overall Study|Other - Unspecified|0
2628727|NCT00868608|9083282|P2|Overall Study|Other - Unspecified|0
2628728|NCT00868608|9083283|P1|Overall Study|Other - Unspecified|1
2628729|NCT00868608|9083281|P3|Overall Study|Death|4
2628730|NCT00868608|9083282|P2|Overall Study|Death|2
2628731|NCT00868608|9083283|P1|Overall Study|Death|16
2628732|NCT00868608|9083281|P3|Overall Study|Lost to Follow-up|1
2628733|NCT00868608|9083282|P2|Overall Study|Lost to Follow-up|0
2628734|NCT00868608|9083283|P1|Overall Study|Lost to Follow-up|3
2628735|NCT00868608|9083281|P3|Overall Study|Withdrawal by Subject|0
2628736|NCT00868608|9083282|P2|Overall Study|Withdrawal by Subject|1
2628737|NCT00868608|9083283|P1|Overall Study|Withdrawal by Subject|3
2628738|NCT00868530|9083307|P1|Overall Study|Lost to Follow-up|1
2628739|NCT00868530|9083307|P1|Overall Study|Adverse Event|3
2628740|NCT00868517|9083322|P3|Overall Study|Protocol Violation|0
2628741|NCT00868517|9083323|P2|Overall Study|Protocol Violation|1
2628742|NCT00868517|9083324|P1|Overall Study|Protocol Violation|1
2628743|NCT00868517|9083322|P3|Overall Study|Withdrawal by Subject|2
2628744|NCT00868517|9083323|P2|Overall Study|Withdrawal by Subject|3
2628745|NCT00868517|9083324|P1|Overall Study|Withdrawal by Subject|3
2628746|NCT00868439|9083362|P2|Overall Study|Withdrawal by Subject|1
2628747|NCT00868439|9083363|P1|Overall Study|Withdrawal by Subject|0
2628748|NCT00868439|9083362|P2|Overall Study|Physician Decision|0
2628749|NCT00868439|9083363|P1|Overall Study|Physician Decision|1
2628750|NCT00868439|9083362|P2|Overall Study|Protocol Violation|1
2628751|NCT00868439|9083363|P1|Overall Study|Protocol Violation|1
2628752|NCT00868439|9083362|P2|Overall Study|Death|1
2628753|NCT00868439|9083363|P1|Overall Study|Death|0
2628754|NCT00868439|9083362|P2|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3
2628755|NCT00868439|9083363|P1|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2
2628756|NCT00868439|9083362|P2|Overall Study|Adverse Event|3
2628757|NCT00868439|9083363|P1|Overall Study|Adverse Event|4
2628758|NCT00868296|9083420|P2|Overall Study|Withdrawal by Subject|1
2628759|NCT00868296|9083421|P1|Overall Study|Withdrawal by Subject|0
2628760|NCT00868296|9083420|P2|Overall Study|Adverse Event|2
2628761|NCT00868296|9083421|P1|Overall Study|Adverse Event|0
2628762|NCT00868231|9083429|P6|Treatment Period 3|Adverse Event|0
2628763|NCT00868231|9083430|P5|Treatment Period 3|Adverse Event|0
2628764|NCT00868231|9083431|P4|Treatment Period 3|Adverse Event|0
2628765|NCT00868231|9083432|P3|Treatment Period 3|Adverse Event|1
2628766|NCT00868231|9083433|P2|Treatment Period 3|Adverse Event|0
2628767|NCT00868231|9083434|P1|Treatment Period 3|Adverse Event|0
2628768|NCT00868231|9083429|P6|Treatment Period 2|Adverse Event|0
2628769|NCT00868231|9083430|P5|Treatment Period 2|Adverse Event|0
2628770|NCT00868231|9083431|P4|Treatment Period 2|Adverse Event|0
2628771|NCT00868231|9083432|P3|Treatment Period 2|Adverse Event|0
2628772|NCT00868231|9083433|P2|Treatment Period 2|Adverse Event|0
2628773|NCT00868231|9083434|P1|Treatment Period 2|Adverse Event|1
2628774|NCT00868231|9083429|P6|Treatment Period 1|Adverse Event|0
2628775|NCT00868231|9083430|P5|Treatment Period 1|Adverse Event|1
2628776|NCT00868231|9083431|P4|Treatment Period 1|Adverse Event|0
2628777|NCT00868231|9083432|P3|Treatment Period 1|Adverse Event|0
2628778|NCT00868231|9083433|P2|Treatment Period 1|Adverse Event|0
2628779|NCT00868231|9083434|P1|Treatment Period 1|Adverse Event|0
2628780|NCT00868192|9083500|P1|Overall Study|Ineligible|4
2628781|NCT00868166|9083517|P2|Overall Study|Non-compliance with IMP|1
2628782|NCT00868166|9083518|P1|Overall Study|Non-compliance with IMP|1
2628783|NCT00868166|9083517|P2|Overall Study|Lack of efficacy, logistics, unwell|10
2628784|NCT00868166|9083518|P1|Overall Study|Lack of efficacy, logistics, unwell|9
2628785|NCT00868166|9083517|P2|Overall Study|Adverse Event|10
2628786|NCT00868166|9083518|P1|Overall Study|Adverse Event|9
2628787|NCT00868166|9083517|P2|Overall Study|Lost to Follow-up|3
2628788|NCT00868166|9083518|P1|Overall Study|Lost to Follow-up|1
2628789|NCT00868166|9083517|P2|Overall Study|Protocol Violation|0
2628790|NCT00868166|9083518|P1|Overall Study|Protocol Violation|1
2628791|NCT00868166|9083517|P2|Overall Study|Withdrawal by Subject|25
2628792|NCT00868166|9083518|P1|Overall Study|Withdrawal by Subject|33
2628793|NCT00868166|9083517|P2|Overall Study|Death|65
2628794|NCT00868166|9083518|P1|Overall Study|Death|58
2628795|NCT00867815|9083580|P1|Overall Study|Lost to Follow-up|1
2628796|NCT00867568|9083591|P1|Overall Study|Withdrawal by Subject|1
2628797|NCT00867568|9083591|P1|Overall Study|Adverse Event|4
2628798|NCT00867568|9083591|P1|Overall Study|Lack of Efficacy|10
2628799|NCT00867503|9083608|P1|Overall Study|Withdrawal by Subject|1
2628800|NCT00867490|9083614|P1|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1
2628801|NCT00867490|9083614|P1|Phase 2 - Aliskiren+HCTZ|Adverse Event|2
2628802|NCT00867490|9083614|P1|Phase 1 - Candesartan+HCTZ|Administrative Problems|1
2628803|NCT00867490|9083614|P1|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4
2628804|NCT00867490|9083614|P1|Phase 1 - Candesartan+HCTZ|Adverse Event|5
2628805|NCT00867360|9083656|P2|Overall Study|Physician Decision|1
2628806|NCT00867360|9083657|P1|Overall Study|Physician Decision|0
2628807|NCT00867360|9083656|P2|Overall Study|Withdrawal by Subject|0
2628808|NCT00867360|9083657|P1|Overall Study|Withdrawal by Subject|1
2628809|NCT00867334|9083669|P2|Overall Study|Physician Decision|0
2628810|NCT00867334|9083670|P1|Overall Study|Physician Decision|1
2628811|NCT00867334|9083669|P2|Overall Study|Withdrawal by Subject|0
2628812|NCT00867334|9083670|P1|Overall Study|Withdrawal by Subject|1
2628813|NCT00867334|9083669|P2|Overall Study|Withdrawal by Subject|1
2628814|NCT00867334|9083670|P1|Overall Study|Withdrawal by Subject|0
2628815|NCT00867308|9083706|P2|Overall Study|Withdrawal by Subject|2
2628816|NCT00867308|9083707|P1|Overall Study|Withdrawal by Subject|1
2628817|NCT00867308|9083706|P2|Overall Study|Lack of Efficacy|12
2628818|NCT00867308|9083707|P1|Overall Study|Lack of Efficacy|6
2628819|NCT00867308|9083706|P2|Overall Study|Adverse Event|4
2628820|NCT00867308|9083707|P1|Overall Study|Adverse Event|1
2628821|NCT00867308|9083706|P2|Overall Study|Death|0
2628822|NCT00867308|9083707|P1|Overall Study|Death|1
2628823|NCT00867165|9083726|P2|Overall Study|Withdrawal by Subject|0
2628824|NCT00867165|9083727|P1|Overall Study|Withdrawal by Subject|1
2628825|NCT00867165|9083726|P2|Overall Study|Adverse Event|0
2628826|NCT00867165|9083727|P1|Overall Study|Adverse Event|3
2628827|NCT00867113|9083875|P1|Post Treatment After Survival Follow-up|Administrative problems|4
2628828|NCT00867113|9083875|P1|Post Treatment After Survival Follow-up|Lost to Follow-up|5
2628829|NCT00867113|9083875|P1|Post Treatment After Survival Follow-up|Withdrawal by Subject|1
2628830|NCT00867113|9083875|P1|Post Treatment After Survival Follow-up|Death|1
2628831|NCT00867113|9083875|P1|Treatment Period|Protocol Violation|4
2628832|NCT00867113|9083875|P1|Treatment Period|Disease progression/relapse|1
2628833|NCT00867113|9083875|P1|Treatment Period|Administrative problems|1
2628834|NCT00867113|9083875|P1|Treatment Period|Lost to Follow-up|3
2628835|NCT00867113|9083875|P1|Treatment Period|Withdrawal by Subject|19
2628836|NCT00867113|9083875|P1|Treatment Period|Death|2
2628837|NCT00867113|9083875|P1|Treatment Period|Adverse Event|15
2628838|NCT00867087|9083939|P1|Overall Study|Death|37
2628839|NCT00867087|9083939|P1|Overall Study|Withdrawal by Subject|4
2628840|NCT00867087|9083939|P1|Overall Study|Other|1
2628841|NCT00867035|9083955|P2|Baseline to 1 Week|Withdrawal by Subject|0
2628842|NCT00867035|9083956|P1|Baseline to 1 Week|Withdrawal by Subject|1
2628843|NCT00867035|9083955|P2|Baseline to 1 Hour|Withdrawal by Subject|1
2628844|NCT00867035|9083956|P1|Baseline to 1 Hour|Withdrawal by Subject|1
2628845|NCT00867009|9083982|P1|Maintenance Period|On-going in the Study at Data Cut-off|4
2628846|NCT00867009|9083982|P1|Induction Period|Progressive Disease (PD)|25
2628847|NCT00867009|9083982|P1|Induction Period|Physician Decision|3
2628848|NCT00867009|9083982|P1|Induction Period|Withdrawal by Subject|8
2628849|NCT00867009|9083982|P1|Induction Period|Protocol Violation|1
2628850|NCT00867009|9083982|P1|Induction Period|Death due to Study Disease|4
2628851|NCT00867009|9083982|P1|Induction Period|Death due to serious adverse event|6
2628852|NCT00867009|9083982|P1|Induction Period|Serious Adverse Event|10
2628853|NCT00867009|9083982|P1|Induction Period|Nonserious Adverse Event|5
2628854|NCT00866918|9083991|P2|Overall Study|Secondary malignancy|0
2628855|NCT00866918|9083992|P1|Overall Study|Secondary malignancy|1
2628856|NCT00866918|9083991|P2|Overall Study|Inevaluable- RQPCR negative at diagnosi|0
2628857|NCT00866918|9083992|P1|Overall Study|Inevaluable- RQPCR negative at diagnosi|1
2628858|NCT00866918|9083991|P2|Overall Study|Ineligible|4
2628859|NCT00866918|9083992|P1|Overall Study|Ineligible|2
2628860|NCT00866918|9083991|P2|Overall Study|Physician Decision|2
2628861|NCT00866918|9083992|P1|Overall Study|Physician Decision|10
2628862|NCT00866918|9083991|P2|Overall Study|Lack of Efficacy|1
2628863|NCT00866918|9083992|P1|Overall Study|Lack of Efficacy|1
2628864|NCT00866918|9083991|P2|Overall Study|Death|5
2628865|NCT00866918|9083992|P1|Overall Study|Death|1
2628866|NCT00866814|9084026|P1|Overall Study|Moved to area without study site|1
2628867|NCT00866814|9084026|P1|Overall Study|Unable to meet follow-up requirements|2
2628868|NCT00866814|9084026|P1|Overall Study|No longer wished to participate|1
2628869|NCT00866814|9084026|P1|Overall Study|Death|1
2628870|NCT00866814|9084026|P1|Overall Study|Physician Decision|1
2628871|NCT00866814|9084026|P1|Overall Study|Adverse Event|2
2628872|NCT00866814|9084026|P1|Overall Study|Lost to Follow-up|12
2628873|NCT00866788|9084039|P4|Overall Study|Physician Decision|1
2628874|NCT00866788|9084040|P3|Overall Study|Physician Decision|1
2628875|NCT00866788|9084041|P2|Overall Study|Physician Decision|0
2628876|NCT00866788|9084042|P1|Overall Study|Physician Decision|0
2628877|NCT00866788|9084039|P4|Overall Study|Disease progression|0
2628878|NCT00866788|9084040|P3|Overall Study|Disease progression|1
2628879|NCT00866788|9084041|P2|Overall Study|Disease progression|1
2628880|NCT00866788|9084042|P1|Overall Study|Disease progression|3
2628881|NCT00866788|9084039|P4|Overall Study|Pregnancy|0
2628882|NCT00866788|9084040|P3|Overall Study|Pregnancy|0
2628883|NCT00866788|9084041|P2|Overall Study|Pregnancy|1
2628884|NCT00866788|9084042|P1|Overall Study|Pregnancy|0
2628885|NCT00866788|9084039|P4|Overall Study|Withdrawal by Subject|1
2628886|NCT00866788|9084040|P3|Overall Study|Withdrawal by Subject|0
2628887|NCT00866788|9084041|P2|Overall Study|Withdrawal by Subject|1
2628888|NCT00866788|9084042|P1|Overall Study|Withdrawal by Subject|2
2628889|NCT00866788|9084039|P4|Overall Study|Lost to Follow-up|2
2628890|NCT00866788|9084040|P3|Overall Study|Lost to Follow-up|0
2628891|NCT00866788|9084041|P2|Overall Study|Lost to Follow-up|1
2628892|NCT00866788|9084042|P1|Overall Study|Lost to Follow-up|1
2628893|NCT00866788|9084039|P4|Overall Study|Adverse Event|1
2628894|NCT00866788|9084040|P3|Overall Study|Adverse Event|0
2628895|NCT00866788|9084041|P2|Overall Study|Adverse Event|2
2628896|NCT00866788|9084042|P1|Overall Study|Adverse Event|0
2628897|NCT00866775|9084090|P2|Overall Study|discontinued due to communication error|1
2628898|NCT00866775|9084091|P1|Overall Study|discontinued due to communication error|0
2628899|NCT00866775|9084090|P2|Overall Study|met exit criteria|17
2628900|NCT00866775|9084091|P1|Overall Study|met exit criteria|23
2628901|NCT00866775|9084090|P2|Overall Study|Withdrawal by Subject|4
2628902|NCT00866775|9084091|P1|Overall Study|Withdrawal by Subject|4
2628903|NCT00866775|9084090|P2|Overall Study|Protocol Violation|4
2628904|NCT00866775|9084091|P1|Overall Study|Protocol Violation|3
2628905|NCT00866775|9084090|P2|Overall Study|Physician Decision|3
2628906|NCT00866775|9084091|P1|Overall Study|Physician Decision|0
2628907|NCT00866775|9084090|P2|Overall Study|Lost to Follow-up|4
2628908|NCT00866775|9084091|P1|Overall Study|Lost to Follow-up|0
2628909|NCT00866775|9084090|P2|Overall Study|Death|0
2628910|NCT00866775|9084091|P1|Overall Study|Death|1
2628911|NCT00866775|9084090|P2|Overall Study|Adverse Event|19
2628912|NCT00866775|9084091|P1|Overall Study|Adverse Event|5
2628913|NCT00866723|9084134|P1|Overall Study|Disease Progression|4
2628914|NCT00866723|9084134|P1|Overall Study|Withdrawal by Subject|1
2628915|NCT00866697|9084141|P2|Overall Study|Withdrawal by Subject|57
2628916|NCT00866697|9084142|P1|Overall Study|Withdrawal by Subject|33
2628917|NCT00866697|9084141|P2|Overall Study|Physician Decision|5
2628918|NCT00866697|9084142|P1|Overall Study|Physician Decision|3
2628919|NCT00866697|9084141|P2|Overall Study|Lost to Follow-up|28
2628920|NCT00866697|9084142|P1|Overall Study|Lost to Follow-up|22
2628921|NCT00866697|9084141|P2|Overall Study|Study closed/terminated|138
2628922|NCT00866697|9084142|P1|Overall Study|Study closed/terminated|156
2628923|NCT00866658|9084184|P2|Overall Study|Familial and Personal Reasons|5
2628924|NCT00866658|9084185|P1|Overall Study|Familial and Personal Reasons|4
2628925|NCT00866658|9084184|P2|Overall Study|Protocol Violation|1
2628926|NCT00866658|9084185|P1|Overall Study|Protocol Violation|1
2628927|NCT00866658|9084184|P2|Overall Study|Withdrawal by Subject|0
2628928|NCT00866658|9084185|P1|Overall Study|Withdrawal by Subject|1
2628929|NCT00866658|9084184|P2|Overall Study|Lack of Efficacy|1
2628930|NCT00866658|9084185|P1|Overall Study|Lack of Efficacy|2
2628931|NCT00866658|9084184|P2|Overall Study|Adverse Event|14
2628932|NCT00866658|9084185|P1|Overall Study|Adverse Event|5
2628933|NCT00866619|9084217|P4|Overall Study|Lost to Follow-up|425
2628934|NCT00866619|9084218|P3|Overall Study|Lost to Follow-up|568
2628935|NCT00866619|9084219|P2|Overall Study|Lost to Follow-up|830
2628936|NCT00866619|9084220|P1|Overall Study|Lost to Follow-up|1145
2628937|NCT00866619|9084217|P4|Overall Study|Withdrawal by Subject|144
2628938|NCT00866619|9084218|P3|Overall Study|Withdrawal by Subject|272
2628939|NCT00866619|9084219|P2|Overall Study|Withdrawal by Subject|295
2628940|NCT00866619|9084220|P1|Overall Study|Withdrawal by Subject|587
2628941|NCT00866619|9084217|P4|Overall Study|Protocol Violation|17
2628942|NCT00866619|9084218|P3|Overall Study|Protocol Violation|2
2628943|NCT00866619|9084219|P2|Overall Study|Protocol Violation|39
2628944|NCT00866619|9084220|P1|Overall Study|Protocol Violation|2
2628945|NCT00866619|9084217|P4|Overall Study|Adverse Event|44
2628946|NCT00866619|9084218|P3|Overall Study|Adverse Event|47
2628947|NCT00866619|9084219|P2|Overall Study|Adverse Event|106
2628948|NCT00866619|9084220|P1|Overall Study|Adverse Event|112
2628949|NCT00866606|9084540|P1|Overall Study|Adverse Event|1
2628950|NCT00866606|9084540|P1|Overall Study|Lost to Follow-up|3
2628951|NCT00866359|9084554|P4|Extension Phase (Day 86 to 169)|Adverse Event|3
2628952|NCT00866359|9084555|P3|Extension Phase (Day 86 to 169)|Adverse Event|1
2628953|NCT00866359|9084556|P2|Extension Phase (Day 86 to 169)|Adverse Event|0
2628954|NCT00866359|9084557|P1|Extension Phase (Day 86 to 169)|Adverse Event|0
2628955|NCT00866359|9084554|P4|Treatment Phase (Days 1 to 85)|Other|0
2628956|NCT00866359|9084555|P3|Treatment Phase (Days 1 to 85)|Other|0
2628957|NCT00866359|9084556|P2|Treatment Phase (Days 1 to 85)|Other|0
2628958|NCT00866359|9084557|P1|Treatment Phase (Days 1 to 85)|Other|1
2628959|NCT00866359|9084554|P4|Treatment Phase (Days 1 to 85)|Protocol Violation|0
2628960|NCT00866359|9084555|P3|Treatment Phase (Days 1 to 85)|Protocol Violation|0
2628961|NCT00866359|9084556|P2|Treatment Phase (Days 1 to 85)|Protocol Violation|1
2628962|NCT00866359|9084557|P1|Treatment Phase (Days 1 to 85)|Protocol Violation|1
2628963|NCT00866359|9084554|P4|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
2628964|NCT00866359|9084555|P3|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
2628965|NCT00866359|9084556|P2|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
2628966|NCT00866359|9084557|P1|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1
2628967|NCT00866359|9084554|P4|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
2628968|NCT00866359|9084555|P3|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
2628969|NCT00866359|9084556|P2|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
2628970|NCT00866359|9084557|P1|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3
2628971|NCT00866359|9084554|P4|Treatment Phase (Days 1 to 85)|Adverse Event|0
2628972|NCT00866359|9084555|P3|Treatment Phase (Days 1 to 85)|Adverse Event|0
2628973|NCT00866359|9084556|P2|Treatment Phase (Days 1 to 85)|Adverse Event|4
2628974|NCT00866359|9084557|P1|Treatment Phase (Days 1 to 85)|Adverse Event|5
2628975|NCT00866333|9084613|P3|Overall Study|Study Terminated by Sponsor|9
2628976|NCT00866333|9084614|P2|Overall Study|Study Terminated by Sponsor|5
2628977|NCT00866333|9084615|P1|Overall Study|Study Terminated by Sponsor|2
2628978|NCT00866333|9084613|P3|Overall Study|Reason not Specified|1
2628979|NCT00866333|9084614|P2|Overall Study|Reason not Specified|1
2628980|NCT00866333|9084615|P1|Overall Study|Reason not Specified|3
2628981|NCT00866333|9084613|P3|Overall Study|Withdrawal of consent|2
2628982|NCT00866333|9084614|P2|Overall Study|Withdrawal of consent|1
2628983|NCT00866333|9084615|P1|Overall Study|Withdrawal of consent|0
2628984|NCT00866320|9084632|P1|Overall Study|Death|2
2628985|NCT00866320|9084632|P1|Overall Study|Withdrawal by Subject|4
2628986|NCT00866307|9084639|P3|Consolidation/Maintenance|Patient moved to non-participating inst|0
2628987|NCT00866307|9084640|P2|Consolidation/Maintenance|Patient moved to non-participating inst|1
2628988|NCT00866307|9084641|P1|Consolidation/Maintenance|Patient moved to non-participating inst|0
2628989|NCT00866307|9084639|P3|Consolidation/Maintenance|Non-compliance|1
2628990|NCT00866307|9084640|P2|Consolidation/Maintenance|Non-compliance|0
2628991|NCT00866307|9084641|P1|Consolidation/Maintenance|Non-compliance|0
2628992|NCT00866307|9084639|P3|Consolidation/Maintenance|Therapy error|0
2628993|NCT00866307|9084640|P2|Consolidation/Maintenance|Therapy error|1
2628994|NCT00866307|9084641|P1|Consolidation/Maintenance|Therapy error|0
2628995|NCT00866307|9084639|P3|Consolidation/Maintenance|Recurrent leukemia following remission|1
2628996|NCT00866307|9084640|P2|Consolidation/Maintenance|Recurrent leukemia following remission|3
2628997|NCT00866307|9084641|P1|Consolidation/Maintenance|Recurrent leukemia following remission|0
2628998|NCT00866307|9084639|P3|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2
2628999|NCT00866307|9084640|P2|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
2629000|NCT00866307|9084641|P1|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
2629001|NCT00866307|9084639|P3|Consolidation/Maintenance|Withdrawal by Subject|1
2629002|NCT00866307|9084640|P2|Consolidation/Maintenance|Withdrawal by Subject|1
2629003|NCT00866307|9084641|P1|Consolidation/Maintenance|Withdrawal by Subject|0
2629004|NCT00866307|9084639|P3|Consolidation/Maintenance|Physician Decision|2
2629005|NCT00866307|9084640|P2|Consolidation/Maintenance|Physician Decision|3
2629006|NCT00866307|9084641|P1|Consolidation/Maintenance|Physician Decision|0
2629007|NCT00866307|9084639|P3|Consolidation/Maintenance|Death|1
2629008|NCT00866307|9084640|P2|Consolidation/Maintenance|Death|0
2629009|NCT00866307|9084641|P1|Consolidation/Maintenance|Death|0
2629010|NCT00866307|9084639|P3|Consolidation/Maintenance|Adverse Event|8
2629011|NCT00866307|9084640|P2|Consolidation/Maintenance|Adverse Event|0
2629012|NCT00866307|9084641|P1|Consolidation/Maintenance|Adverse Event|0
2629013|NCT00866307|9084639|P3|Induction|Study was closed at the time|0
2629014|NCT00866307|9084640|P2|Induction|Study was closed at the time|0
2629015|NCT00866307|9084641|P1|Induction|Study was closed at the time|1
2629016|NCT00866307|9084639|P3|Induction|Improper post-induction consent|0
2629017|NCT00866307|9084640|P2|Induction|Improper post-induction consent|0
2629018|NCT00866307|9084641|P1|Induction|Improper post-induction consent|2
2629019|NCT00866307|9084639|P3|Induction|Inadequate cytognetic samples th|0
2629020|NCT00866307|9084640|P2|Induction|Inadequate cytognetic samples th|0
2629021|NCT00866307|9084641|P1|Induction|Inadequate cytognetic samples th|1
2629022|NCT00866307|9084639|P3|Induction|Identification of Patients with Day 29 M|0
2629023|NCT00866307|9084640|P2|Induction|Identification of Patients with Day 29 M|0
2629024|NCT00866307|9084641|P1|Induction|Identification of Patients with Day 29 M|3
2629025|NCT00866307|9084639|P3|Induction|Progressive Disease|0
2629026|NCT00866307|9084640|P2|Induction|Progressive Disease|0
2629027|NCT00866307|9084641|P1|Induction|Progressive Disease|1
2629028|NCT00866307|9084639|P3|Induction|Physician Decision|0
2629029|NCT00866307|9084640|P2|Induction|Physician Decision|0
2629030|NCT00866307|9084641|P1|Induction|Physician Decision|5
2629031|NCT00866307|9084639|P3|Induction|Death|0
2629032|NCT00866307|9084640|P2|Induction|Death|0
2629033|NCT00866307|9084641|P1|Induction|Death|2
2629034|NCT00866307|9084639|P3|Induction|Adverse Event|0
2629035|NCT00866307|9084640|P2|Induction|Adverse Event|0
2629036|NCT00866307|9084641|P1|Induction|Adverse Event|5
2629037|NCT00866294|9084651|P3|Overall Study|Physician Decision|1
2629038|NCT00866294|9084652|P2|Overall Study|Physician Decision|2
2629039|NCT00866294|9084653|P1|Overall Study|Physician Decision|6
2629040|NCT00866294|9084651|P3|Overall Study|Lost to Follow-up|0
2629041|NCT00866294|9084652|P2|Overall Study|Lost to Follow-up|3
2629042|NCT00866294|9084653|P1|Overall Study|Lost to Follow-up|1
2629043|NCT00866294|9084651|P3|Overall Study|Met Protocol-defined Stopping Criteria|1
2629044|NCT00866294|9084652|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
2629045|NCT00866294|9084653|P1|Overall Study|Met Protocol-defined Stopping Criteria|5
2629046|NCT00866294|9084651|P3|Overall Study|Protocol Violation|0
2629047|NCT00866294|9084652|P2|Overall Study|Protocol Violation|0
2629048|NCT00866294|9084653|P1|Overall Study|Protocol Violation|2
2629049|NCT00866294|9084651|P3|Overall Study|Lack of Efficacy|0
2629050|NCT00866294|9084652|P2|Overall Study|Lack of Efficacy|1
2629051|NCT00866294|9084653|P1|Overall Study|Lack of Efficacy|7
2629052|NCT00866294|9084651|P3|Overall Study|Adverse Event|9
2629053|NCT00866294|9084652|P2|Overall Study|Adverse Event|13
2629054|NCT00866294|9084653|P1|Overall Study|Adverse Event|12
2629055|NCT00866281|9084682|P2|Overall Study|New cancer therapy|4
2629056|NCT00866281|9084683|P1|Overall Study|New cancer therapy|0
2629057|NCT00866281|9084682|P2|Overall Study|Disease progression|11
2629058|NCT00866281|9084683|P1|Overall Study|Disease progression|3
2629059|NCT00866281|9084682|P2|Overall Study|Withdrawal by participants|0
2629060|NCT00866281|9084683|P1|Overall Study|Withdrawal by participants|3
2629061|NCT00866281|9084682|P2|Overall Study|Adverse Event|0
2629062|NCT00866281|9084683|P1|Overall Study|Adverse Event|1
2629063|NCT00866177|9084699|P1|Overall Study|Not Treated|151
2629064|NCT00866177|9084699|P1|Overall Study|Withdrawal by Subject|1
2629065|NCT00866047|9084703|P1|Follow-up Period|Lost to Follow-up|5
2629066|NCT00866047|9084703|P1|Treatment Period|Withdrawal by Subject|5
2629067|NCT00866047|9084703|P1|Treatment Period|Physician Decision|14
2629068|NCT00866047|9084703|P1|Treatment Period|Adverse Event|16
2629069|NCT00866047|9084703|P1|Treatment Period|Progressive disease|13
2629070|NCT00865904|9084735|P5|Overall Study|Randomized but not Treated|1
2629071|NCT00865904|9084736|P4|Overall Study|Randomized but not Treated|1
2629072|NCT00865904|9084737|P3|Overall Study|Randomized but not Treated|0
2629073|NCT00865904|9084738|P2|Overall Study|Randomized but not Treated|0
2629074|NCT00865904|9084739|P1|Overall Study|Randomized but not Treated|2
2629075|NCT00865709|9084796|P2|Treatment|Surgery|3
2629076|NCT00865709|9084797|P1|Treatment|Surgery|8
2629077|NCT00865709|9084796|P2|Treatment|Physician Decision|2
2629078|NCT00865709|9084797|P1|Treatment|Physician Decision|3
2629079|NCT00865709|9084796|P2|Treatment|Withdrawal by Subject|7
2629080|NCT00865709|9084797|P1|Treatment|Withdrawal by Subject|10
2629081|NCT00865709|9084796|P2|Treatment|Adverse Event|6
2629082|NCT00865709|9084797|P1|Treatment|Adverse Event|9
2629083|NCT00865566|9084815|P2|Overall Study|HIV infection|7
2629084|NCT00865566|9084816|P1|Overall Study|HIV infection|5
2629085|NCT00865566|9084815|P2|Overall Study|Other; N=245 due to early study closure|139
2629086|NCT00865566|9084816|P1|Overall Study|Other; N=245 due to early study closure|154
2629087|NCT00865566|9084815|P2|Overall Study|Participant unable to adhere|42
2629088|NCT00865566|9084816|P1|Overall Study|Participant unable to adhere|27
2629089|NCT00865566|9084815|P2|Overall Study|Participant relocated|107
2629090|NCT00865566|9084816|P1|Overall Study|Participant relocated|78
2629091|NCT00865566|9084815|P2|Overall Study|Physician Decision|1
2629092|NCT00865566|9084816|P1|Overall Study|Physician Decision|0
2629093|NCT00865566|9084815|P2|Overall Study|Withdrawal by Subject|65
2629094|NCT00865566|9084816|P1|Overall Study|Withdrawal by Subject|45
2629095|NCT00865566|9084815|P2|Overall Study|Lost to Follow-up|315
2629096|NCT00865566|9084816|P1|Overall Study|Lost to Follow-up|314
2629097|NCT00865566|9084815|P2|Overall Study|Death|11
2629098|NCT00865566|9084816|P1|Overall Study|Death|1
2629099|NCT00865514|9084836|P1|Overall Study|Infusion cost exceeded funding|2
2629100|NCT00865345|9084841|P1|Overall Study|Withdrawal by Subject|2
2629101|NCT00865306|9084848|P2|Controlled Trial|Withdrawal by Subject|1
2629102|NCT00865306|9084849|P1|Controlled Trial|Withdrawal by Subject|0
2629103|NCT00865306|9084848|P2|Controlled Trial|Sought treatment for conduct disorder|0
2629104|NCT00865306|9084849|P1|Controlled Trial|Sought treatment for conduct disorder|1
2629105|NCT00865306|9084848|P2|Controlled Trial|Improved btw baseline and first session|0
2629106|NCT00865306|9084849|P1|Controlled Trial|Improved btw baseline and first session|1
2629107|NCT00865306|9084848|P2|Controlled Trial|Difficulty commuting|0
2629108|NCT00865306|9084849|P1|Controlled Trial|Difficulty commuting|2
2629109|NCT00865306|9084848|P2|Controlled Trial|Lost to Follow-up|1
2629110|NCT00865306|9084849|P1|Controlled Trial|Lost to Follow-up|1
2629111|NCT00865189|9084878|P2|Overall Study|Withdrawal by Subject|0
2629112|NCT00865189|9084879|P1|Overall Study|Withdrawal by Subject|1
2629113|NCT00865189|9084878|P2|Overall Study|Lost to Follow-up|6
2629114|NCT00865189|9084879|P1|Overall Study|Lost to Follow-up|6
2629115|NCT00865189|9084878|P2|Overall Study|Death|11
2629116|NCT00865189|9084879|P1|Overall Study|Death|4
2629117|NCT00865189|9084878|P2|Overall Study|Other|2
2629118|NCT00865189|9084879|P1|Overall Study|Other|1
2629119|NCT00865124|9084907|P3|Overall Study|Withdrawn consent|0
2629120|NCT00865124|9084908|P2|Overall Study|Withdrawn consent|0
2629121|NCT00865124|9084909|P1|Overall Study|Withdrawn consent|2
2629122|NCT00865124|9084907|P3|Overall Study|Physician Decision|0
2629123|NCT00865124|9084908|P2|Overall Study|Physician Decision|1
2629124|NCT00865124|9084909|P1|Overall Study|Physician Decision|2
2629125|NCT00865098|9084926|P1|Overall Study|Progressive disease|1
2629126|NCT00865046|9084938|P3|Overall Study|Withdrawal by Subject|0
2629127|NCT00865046|9084939|P2|Overall Study|Withdrawal by Subject|0
2629128|NCT00865046|9084940|P1|Overall Study|Withdrawal by Subject|5
2629129|NCT00865046|9084938|P3|Overall Study|Death|1
2629130|NCT00865046|9084939|P2|Overall Study|Death|1
2629131|NCT00865046|9084940|P1|Overall Study|Death|0
2629132|NCT00865046|9084938|P3|Overall Study|Lost to Follow-up|0
2629133|NCT00865046|9084939|P2|Overall Study|Lost to Follow-up|4
2629134|NCT00865046|9084940|P1|Overall Study|Lost to Follow-up|1
2629135|NCT00865020|9084950|P2|Overall Study|Randomized but discontinued|4
2629136|NCT00865020|9084951|P1|Overall Study|Randomized but discontinued|2
2629137|NCT00865020|9084950|P2|Overall Study|Death|1
2629138|NCT00865020|9084951|P1|Overall Study|Death|0
2629139|NCT00865020|9084950|P2|Overall Study|Abnormal laboratory value(s)|1
2629140|NCT00865020|9084951|P1|Overall Study|Abnormal laboratory value(s)|0
2629141|NCT00865020|9084950|P2|Overall Study|Administrative problems|2
2629142|NCT00865020|9084951|P1|Overall Study|Administrative problems|0
2629143|NCT00865020|9084950|P2|Overall Study|Protocol deviation|1
2629144|NCT00865020|9084951|P1|Overall Study|Protocol deviation|4
2629145|NCT00865020|9084950|P2|Overall Study|Lost to Follow-up|4
2629146|NCT00865020|9084951|P1|Overall Study|Lost to Follow-up|6
2629147|NCT00865020|9084950|P2|Overall Study|Abnormal test procedure result(s)|8
2629148|NCT00865020|9084951|P1|Overall Study|Abnormal test procedure result(s)|6
2629149|NCT00865020|9084950|P2|Overall Study|Adverse Event|14
2629150|NCT00865020|9084951|P1|Overall Study|Adverse Event|9
2629151|NCT00865020|9084950|P2|Overall Study|Withdrawal by Subject|16
2629152|NCT00865020|9084951|P1|Overall Study|Withdrawal by Subject|22
2629153|NCT00864916|9084967|P2|Overall Study|Withdrawal by Subject|0
2629154|NCT00864916|9084968|P1|Overall Study|Withdrawal by Subject|1
2629155|NCT00864916|9084967|P2|Overall Study|Protocol Violation|0
2629156|NCT00864916|9084968|P1|Overall Study|Protocol Violation|1
2629157|NCT00864916|9084967|P2|Overall Study|Lost to Follow-up|4
2629158|NCT00864916|9084968|P1|Overall Study|Lost to Follow-up|4
2629159|NCT00864851|9084977|P3|Overall Study|Patient uncooperative|0
2629160|NCT00864851|9084978|P2|Overall Study|Patient uncooperative|0
2629161|NCT00864851|9084979|P1|Overall Study|Patient uncooperative|1
2629162|NCT00864851|9084977|P3|Overall Study|Death|0
2629163|NCT00864851|9084978|P2|Overall Study|Death|0
2629164|NCT00864851|9084979|P1|Overall Study|Death|1
2629165|NCT00864851|9084977|P3|Overall Study|Physician Decision|0
2629166|NCT00864851|9084978|P2|Overall Study|Physician Decision|0
2629167|NCT00864851|9084979|P1|Overall Study|Physician Decision|1
2629168|NCT00864851|9084977|P3|Overall Study|Withdrawal by Subject|0
2629169|NCT00864851|9084978|P2|Overall Study|Withdrawal by Subject|1
2629170|NCT00864851|9084979|P1|Overall Study|Withdrawal by Subject|0
2629171|NCT00864721|9085013|P1|Overall Study|Adverse Event|21
2629172|NCT00864721|9085013|P1|Overall Study|Drug hold/delay more than 4 weeks|1
2629173|NCT00864721|9085013|P1|Overall Study|Hospitalized|1
2629174|NCT00864721|9085013|P1|Overall Study|Patient request|11
2629175|NCT00864682|9085033|P3|Overall Study|Protocol Violation|2
2629176|NCT00864682|9085034|P2|Overall Study|Protocol Violation|1
2629177|NCT00864682|9085035|P1|Overall Study|Protocol Violation|2
2629178|NCT00864513|9085074|P1|Overall Study|Withdrawal by Subject|3
2629179|NCT00864253|9085158|P2|Overall Study|Untreated|7
2629180|NCT00864253|9085159|P1|Overall Study|Untreated|7
2629181|NCT00864253|9085158|P2|Overall Study|Ongoing|3
2629182|NCT00864253|9085159|P1|Overall Study|Ongoing|2
2629183|NCT00864253|9085158|P2|Overall Study|Death|0
2629184|NCT00864253|9085159|P1|Overall Study|Death|1
2629185|NCT00864253|9085158|P2|Overall Study|Withdrawal by Subject|18
2629186|NCT00864253|9085159|P1|Overall Study|Withdrawal by Subject|18
2629187|NCT00864253|9085158|P2|Overall Study|Lost to Follow-up|1
2629188|NCT00864253|9085159|P1|Overall Study|Lost to Follow-up|1
2629189|NCT00864253|9085158|P2|Overall Study|Protocol Violation|2
2629190|NCT00864253|9085159|P1|Overall Study|Protocol Violation|0
2629191|NCT00864253|9085158|P2|Overall Study|Physician Decision|15
2629192|NCT00864253|9085159|P1|Overall Study|Physician Decision|11
2629193|NCT00864253|9085158|P2|Overall Study|Unrelated Adverse Event|1
2629194|NCT00864253|9085159|P1|Overall Study|Unrelated Adverse Event|3
2629195|NCT00864253|9085158|P2|Overall Study|Adverse Event|11
2629196|NCT00864253|9085159|P1|Overall Study|Adverse Event|56
2629197|NCT00864227|9085189|P1|Overall Study|Disease Relapse/Progression|3
2629198|NCT00864227|9085189|P1|Overall Study|Withdrawal by Subject|1
2629199|NCT00863928|9085250|P2|Overall Study|medication allergy|0
2629200|NCT00863928|9085251|P1|Overall Study|medication allergy|3
2629201|NCT00863928|9085250|P2|Overall Study|surgery cancellation|0
2629202|NCT00863928|9085251|P1|Overall Study|surgery cancellation|4
2629203|NCT00863928|9085250|P2|Overall Study|Withdrawal by Subject|0
2629204|NCT00863928|9085251|P1|Overall Study|Withdrawal by Subject|3
2629205|NCT00863928|9085250|P2|Overall Study|Protocol Violation|0
2629206|NCT00863928|9085251|P1|Overall Study|Protocol Violation|26
2629207|NCT00863798|9085260|P3|Overall Study|Randomized not treated|3
2629208|NCT00863798|9085261|P2|Overall Study|Randomized not treated|2
2629209|NCT00863798|9085262|P1|Overall Study|Randomized not treated|4
2629210|NCT00863798|9085260|P3|Overall Study|Withdrawal by Subject|4
2629211|NCT00863798|9085261|P2|Overall Study|Withdrawal by Subject|7
2629212|NCT00863798|9085262|P1|Overall Study|Withdrawal by Subject|8
2629213|NCT00863798|9085260|P3|Overall Study|Protocol Violation|1
2629214|NCT00863798|9085261|P2|Overall Study|Protocol Violation|1
2629215|NCT00863798|9085262|P1|Overall Study|Protocol Violation|0
2629216|NCT00863798|9085260|P3|Overall Study|Other|1
2629217|NCT00863798|9085261|P2|Overall Study|Other|3
2629218|NCT00863798|9085262|P1|Overall Study|Other|2
2629219|NCT00863798|9085260|P3|Overall Study|Lost to Follow-up|5
2629220|NCT00863798|9085261|P2|Overall Study|Lost to Follow-up|9
2629221|NCT00863798|9085262|P1|Overall Study|Lost to Follow-up|6
2629222|NCT00863798|9085260|P3|Overall Study|Lack of Efficacy|6
2629223|NCT00863798|9085261|P2|Overall Study|Lack of Efficacy|3
2629224|NCT00863798|9085262|P1|Overall Study|Lack of Efficacy|4
2629225|NCT00863798|9085260|P3|Overall Study|Investigator request|1
2629226|NCT00863798|9085261|P2|Overall Study|Investigator request|2
2629227|NCT00863798|9085262|P1|Overall Study|Investigator request|1
2629228|NCT00863798|9085260|P3|Overall Study|Participant failed to return|0
2629229|NCT00863798|9085261|P2|Overall Study|Participant failed to return|1
2629230|NCT00863798|9085262|P1|Overall Study|Participant failed to return|2
2629231|NCT00863798|9085260|P3|Overall Study|Adverse Event|4
2629232|NCT00863798|9085261|P2|Overall Study|Adverse Event|2
2629233|NCT00863798|9085262|P1|Overall Study|Adverse Event|5
2629234|NCT00863746|9085314|P2|Survival Follow up|Consent Withdrawn|8
2629235|NCT00863746|9085315|P1|Survival Follow up|Consent Withdrawn|7
2629236|NCT00863746|9085314|P2|Survival Follow up|Lost to Follow-up|1
2629237|NCT00863746|9085315|P1|Survival Follow up|Lost to Follow-up|2
2629238|NCT00863746|9085314|P2|Survival Follow up|Death|271
2629239|NCT00863746|9085315|P1|Survival Follow up|Death|244
2629240|NCT00863746|9085314|P2|Treatment|Other|0
2629241|NCT00863746|9085315|P1|Treatment|Other|1
2629242|NCT00863746|9085314|P2|Treatment|Protocol Violation|3
2629243|NCT00863746|9085315|P1|Treatment|Protocol Violation|5
2629244|NCT00863746|9085314|P2|Treatment|Lost to Follow-up|0
2629245|NCT00863746|9085315|P1|Treatment|Lost to Follow-up|1
2629246|NCT00863746|9085314|P2|Treatment|Consent withdrawn|14
2629247|NCT00863746|9085315|P1|Treatment|Consent withdrawn|15
2629248|NCT00863746|9085314|P2|Treatment|non-compliant with study medication|0
2629249|NCT00863746|9085315|P1|Treatment|non-compliant with study medication|4
2629250|NCT00863746|9085314|P2|Treatment|Adverse Event|16
2629251|NCT00863746|9085315|P1|Treatment|Adverse Event|41
2629252|NCT00863746|9085314|P2|Treatment|Not treated|2
2629253|NCT00863746|9085315|P1|Treatment|Not treated|4
2629254|NCT00863707|9085341|P2|Overall Study|Randomized, but drug not received|3
2629255|NCT00863707|9085342|P1|Overall Study|Randomized, but drug not received|4
2629256|NCT00863655|9085350|P2|Overall Study|Treatment completed as per protocol|1
2629257|NCT00863655|9085351|P1|Overall Study|Treatment completed as per protocol|5
2629258|NCT00863655|9085350|P2|Overall Study|Disease progression|221
2629259|NCT00863655|9085351|P1|Overall Study|Disease progression|364
2629260|NCT00863655|9085350|P2|Overall Study|New cancer therapy|1
2629261|NCT00863655|9085351|P1|Overall Study|New cancer therapy|5
2629262|NCT00863655|9085350|P2|Overall Study|Death|1
2629263|NCT00863655|9085351|P1|Overall Study|Death|7
2629264|NCT00863655|9085350|P2|Overall Study|Administrative problems|0
2629265|NCT00863655|9085351|P1|Overall Study|Administrative problems|1
2629266|NCT00863655|9085350|P2|Overall Study|Withdrawal by Subject|7
2629267|NCT00863655|9085351|P1|Overall Study|Withdrawal by Subject|47
2629268|NCT00863655|9085350|P2|Overall Study|Adverse Event|8
2629269|NCT00863655|9085351|P1|Overall Study|Adverse Event|52
2629270|NCT00863655|9085350|P2|Overall Study|Protocol Violation|0
2629271|NCT00863655|9085351|P1|Overall Study|Protocol Violation|4
2629272|NCT00863512|9085388|P2|Overall Study|Physician Decision|0
2629273|NCT00863512|9085389|P1|Overall Study|Physician Decision|1
2629274|NCT00863512|9085388|P2|Overall Study|Withdrawal by Subject|0
2629275|NCT00863512|9085389|P1|Overall Study|Withdrawal by Subject|11
2629276|NCT00863512|9085388|P2|Overall Study|Adverse Event|0
2629277|NCT00863512|9085389|P1|Overall Study|Adverse Event|2
2629278|NCT00863330|9085420|P1|Overall Study|study terminated early due to administra|6
2629279|NCT00863317|9085426|P2|Overall Study|Lost to Follow-up|9
2629280|NCT00863317|9085427|P1|Overall Study|Lost to Follow-up|8
2629281|NCT00863057|9085483|P4|Period 2 (Weeks 6-10)|Physician Decision|1
2629282|NCT00863057|9085484|P3|Period 2 (Weeks 6-10)|Physician Decision|0
2629283|NCT00863057|9085485|P2|Period 2 (Weeks 6-10)|Physician Decision|0
2629284|NCT00863057|9085486|P1|Period 2 (Weeks 6-10)|Physician Decision|0
2629285|NCT00863057|9085483|P4|Period 2 (Weeks 6-10)|Adverse Event|0
2629286|NCT00863057|9085484|P3|Period 2 (Weeks 6-10)|Adverse Event|1
2629287|NCT00863057|9085485|P2|Period 2 (Weeks 6-10)|Adverse Event|1
2629288|NCT00863057|9085486|P1|Period 2 (Weeks 6-10)|Adverse Event|0
2629289|NCT00863057|9085483|P4|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
2629290|NCT00863057|9085484|P3|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
2629291|NCT00863057|9085485|P2|Milestones Period 1 (Weeks 0-5)|Physician Decision|1
2629292|NCT00863057|9085486|P1|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
2629293|NCT00863057|9085483|P4|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
2629294|NCT00863057|9085484|P3|Milestones Period 1 (Weeks 0-5)|Adverse Event|0
2629295|NCT00863057|9085485|P2|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
2629296|NCT00863057|9085486|P1|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
2629297|NCT00862979|9085544|P2|Overall Study|Death|1
2629298|NCT00862979|9085545|P1|Overall Study|Death|0
2629299|NCT00862979|9085544|P2|Overall Study|Administrative problems|1
2629300|NCT00862979|9085545|P1|Overall Study|Administrative problems|0
2629301|NCT00862979|9085544|P2|Overall Study|Patient withdrew consent|1
2629302|NCT00862979|9085545|P1|Overall Study|Patient withdrew consent|2
2629303|NCT00862979|9085544|P2|Overall Study|Protocol Violation|1
2629304|NCT00862979|9085545|P1|Overall Study|Protocol Violation|0
2629305|NCT00862979|9085544|P2|Overall Study|Adverse Event|3
2629306|NCT00862979|9085545|P1|Overall Study|Adverse Event|6
2629307|NCT00862940|9085563|P2|Overall Study|Administrative or other reason(s)|3
2629308|NCT00862940|9085564|P1|Overall Study|Administrative or other reason(s)|4
2629309|NCT00862940|9085563|P2|Overall Study|Lost to Follow-up|1
2629310|NCT00862940|9085564|P1|Overall Study|Lost to Follow-up|0
2629311|NCT00862940|9085563|P2|Overall Study|Non-compliance|0
2629312|NCT00862940|9085564|P1|Overall Study|Non-compliance|4
2629313|NCT00862940|9085563|P2|Overall Study|Withdrawal by Subject|6
2629314|NCT00862940|9085564|P1|Overall Study|Withdrawal by Subject|4
2629315|NCT00862940|9085563|P2|Overall Study|Protocol Violation|5
2629316|NCT00862940|9085564|P1|Overall Study|Protocol Violation|2
2629317|NCT00862940|9085563|P2|Overall Study|Lack of Efficacy|3
2629318|NCT00862940|9085564|P1|Overall Study|Lack of Efficacy|1
2629319|NCT00862940|9085563|P2|Overall Study|Adverse Event|12
2629320|NCT00862940|9085564|P1|Overall Study|Adverse Event|15
2629321|NCT00862849|9085576|P6|Washout 2 (3 to 14 Days)|Protocol Violation|0
2629322|NCT00862849|9085577|P5|Washout 2 (3 to 14 Days)|Protocol Violation|0
2629323|NCT00862849|9085578|P4|Washout 2 (3 to 14 Days)|Protocol Violation|0
2629324|NCT00862849|9085579|P3|Washout 2 (3 to 14 Days)|Protocol Violation|0
2629325|NCT00862849|9085580|P2|Washout 2 (3 to 14 Days)|Protocol Violation|1
2629326|NCT00862849|9085581|P1|Washout 2 (3 to 14 Days)|Protocol Violation|0
2629327|NCT00862849|9085576|P6|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
2629328|NCT00862849|9085577|P5|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
2629329|NCT00862849|9085578|P4|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
2629330|NCT00862849|9085579|P3|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
2629331|NCT00862849|9085580|P2|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1
2629332|NCT00862849|9085581|P1|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
2629333|NCT00862836|9085604|P1|Overall Study|Withdrawal by Subject|1
2629334|NCT00862823|9085615|P2|First Intervention|Withdrawal by Subject|1
2629335|NCT00862823|9085616|P1|First Intervention|Withdrawal by Subject|1
2629336|NCT00862719|9085665|P4|Overall Study|Veno-Occlusive Disease|0
2629337|NCT00862719|9085666|P3|Overall Study|Veno-Occlusive Disease|1
2629338|NCT00862719|9085667|P2|Overall Study|Veno-Occlusive Disease|0
2629339|NCT00862719|9085668|P1|Overall Study|Veno-Occlusive Disease|0
2629340|NCT00862719|9085665|P4|Overall Study|Engraftment failure|0
2629341|NCT00862719|9085666|P3|Overall Study|Engraftment failure|1
2629342|NCT00862719|9085667|P2|Overall Study|Engraftment failure|0
2629343|NCT00862719|9085668|P1|Overall Study|Engraftment failure|0
2629344|NCT00862719|9085665|P4|Overall Study|Death|1
2629345|NCT00862719|9085666|P3|Overall Study|Death|1
2629346|NCT00862719|9085667|P2|Overall Study|Death|6
2629347|NCT00862719|9085668|P1|Overall Study|Death|5
2629348|NCT00862719|9085665|P4|Overall Study|Disease Progression|0
2629349|NCT00862719|9085666|P3|Overall Study|Disease Progression|1
2629350|NCT00862719|9085667|P2|Overall Study|Disease Progression|0
2629351|NCT00862719|9085668|P1|Overall Study|Disease Progression|5
2629352|NCT00862654|9085691|P4|Overall Study|Included after end of inclusions|0
2629353|NCT00862654|9085692|P3|Overall Study|Included after end of inclusions|1
2629354|NCT00862654|9085693|P2|Overall Study|Included after end of inclusions|0
2629355|NCT00862654|9085694|P1|Overall Study|Included after end of inclusions|0
2629356|NCT00862654|9085691|P4|Overall Study|Never used study drugs|0
2629357|NCT00862654|9085692|P3|Overall Study|Never used study drugs|0
2629358|NCT00862654|9085693|P2|Overall Study|Never used study drugs|0
2629359|NCT00862654|9085694|P1|Overall Study|Never used study drugs|1
2629360|NCT00862654|9085691|P4|Overall Study|Familly constraint|0
2629361|NCT00862654|9085692|P3|Overall Study|Familly constraint|0
2629362|NCT00862654|9085693|P2|Overall Study|Familly constraint|1
2629363|NCT00862654|9085694|P1|Overall Study|Familly constraint|0
2629364|NCT00862654|9085691|P4|Overall Study|Subject mistake|0
2629365|NCT00862654|9085692|P3|Overall Study|Subject mistake|0
2629366|NCT00862654|9085693|P2|Overall Study|Subject mistake|1
2629367|NCT00862654|9085694|P1|Overall Study|Subject mistake|0
2629368|NCT00862654|9085691|P4|Overall Study|Withdrawal by Subject|3
2629369|NCT00862654|9085692|P3|Overall Study|Withdrawal by Subject|2
2629370|NCT00862654|9085693|P2|Overall Study|Withdrawal by Subject|2
2629371|NCT00862654|9085694|P1|Overall Study|Withdrawal by Subject|2
2629372|NCT00862654|9085691|P4|Overall Study|Pregnancy|0
2629373|NCT00862654|9085692|P3|Overall Study|Pregnancy|0
2629374|NCT00862654|9085693|P2|Overall Study|Pregnancy|1
2629375|NCT00862654|9085694|P1|Overall Study|Pregnancy|1
2629376|NCT00862654|9085691|P4|Overall Study|Adverse Event|0
2629377|NCT00862654|9085692|P3|Overall Study|Adverse Event|1
2629378|NCT00862654|9085693|P2|Overall Study|Adverse Event|1
2629379|NCT00862654|9085694|P1|Overall Study|Adverse Event|0
2629380|NCT00862654|9085691|P4|Overall Study|Lost to Follow-up|3
2629381|NCT00862654|9085692|P3|Overall Study|Lost to Follow-up|1
2629382|NCT00862654|9085693|P2|Overall Study|Lost to Follow-up|2
2629383|NCT00862654|9085694|P1|Overall Study|Lost to Follow-up|1
2629384|NCT00862654|9085691|P4|Overall Study|Lack of Efficacy|0
2629385|NCT00862654|9085692|P3|Overall Study|Lack of Efficacy|1
2629386|NCT00862654|9085693|P2|Overall Study|Lack of Efficacy|0
2629387|NCT00862654|9085694|P1|Overall Study|Lack of Efficacy|1
2629388|NCT00862641|9085708|P4|Overall Study|Randomized, but drug not received|4
2629389|NCT00862641|9085709|P3|Overall Study|Randomized, but drug not received|1
2629390|NCT00862641|9085710|P2|Overall Study|Randomized, but drug not received|4
2629391|NCT00862641|9085711|P1|Overall Study|Randomized, but drug not received|1
2629392|NCT00862459|9085805|P3|Overall Study|Administrative problems|0
2629393|NCT00862459|9085806|P2|Overall Study|Administrative problems|1
2629394|NCT00862459|9085807|P1|Overall Study|Administrative problems|0
2629395|NCT00862459|9085805|P3|Overall Study|Inclusion/exclusion criteria not met|0
2629396|NCT00862459|9085806|P2|Overall Study|Inclusion/exclusion criteria not met|1
2629397|NCT00862459|9085807|P1|Overall Study|Inclusion/exclusion criteria not met|0
2629398|NCT00862459|9085805|P3|Overall Study|Unable to hold still for imaging|0
2629399|NCT00862459|9085806|P2|Overall Study|Unable to hold still for imaging|1
2629400|NCT00862459|9085807|P1|Overall Study|Unable to hold still for imaging|0
2629401|NCT00862459|9085805|P3|Overall Study|Intravenous (IV) site problems|1
2629402|NCT00862459|9085806|P2|Overall Study|Intravenous (IV) site problems|0
2629403|NCT00862459|9085807|P1|Overall Study|Intravenous (IV) site problems|1
2629404|NCT00862459|9085805|P3|Overall Study|Operation|0
2629405|NCT00862459|9085806|P2|Overall Study|Operation|1
2629406|NCT00862459|9085807|P1|Overall Study|Operation|1
2629407|NCT00862459|9085805|P3|Overall Study|Personal reasons|0
2629408|NCT00862459|9085806|P2|Overall Study|Personal reasons|0
2629409|NCT00862459|9085807|P1|Overall Study|Personal reasons|1
2629410|NCT00862459|9085805|P3|Overall Study|Adverse Event|0
2629411|NCT00862459|9085806|P2|Overall Study|Adverse Event|1
2629412|NCT00862459|9085807|P1|Overall Study|Adverse Event|0
2629413|NCT00862459|9085805|P3|Overall Study|Withdrawal by Subject|3
2629414|NCT00862459|9085806|P2|Overall Study|Withdrawal by Subject|1
2629415|NCT00862459|9085807|P1|Overall Study|Withdrawal by Subject|1
2629416|NCT00862459|9085805|P3|Overall Study|Protocol Violation|0
2629417|NCT00862459|9085806|P2|Overall Study|Protocol Violation|0
2629418|NCT00862459|9085807|P1|Overall Study|Protocol Violation|1
2629419|NCT00862459|9085805|P3|Overall Study|Lost to Follow-up|2
2629420|NCT00862459|9085806|P2|Overall Study|Lost to Follow-up|2
2629421|NCT00862459|9085807|P1|Overall Study|Lost to Follow-up|1
2629422|NCT00862277|9085954|P3|Overall Study|Protocol Violation|5
2629423|NCT00862277|9085955|P2|Overall Study|Protocol Violation|2
2629424|NCT00862277|9085956|P1|Overall Study|Protocol Violation|1
2629425|NCT00862251|9085970|P3|Overall Study|Withdrawal by Subject|6
2629426|NCT00862251|9085971|P2|Overall Study|Withdrawal by Subject|2
2629427|NCT00862251|9085972|P1|Overall Study|Withdrawal by Subject|9
2629428|NCT00862251|9085970|P3|Overall Study|Protocol Violation|1
2629429|NCT00862251|9085971|P2|Overall Study|Protocol Violation|0
2629430|NCT00862251|9085972|P1|Overall Study|Protocol Violation|2
2629431|NCT00862251|9085970|P3|Overall Study|Lost to Follow-up|1
2629432|NCT00862251|9085971|P2|Overall Study|Lost to Follow-up|0
2629433|NCT00862251|9085972|P1|Overall Study|Lost to Follow-up|0
2629434|NCT00862251|9085970|P3|Overall Study|Adverse Event|1
2629435|NCT00862251|9085971|P2|Overall Study|Adverse Event|3
2629436|NCT00862251|9085972|P1|Overall Study|Adverse Event|8
2629437|NCT00862134|9086032|P2|Overall Study|Withdrew prior to dosing|0
2629438|NCT00862134|9086033|P1|Overall Study|Withdrew prior to dosing|2
2629439|NCT00862134|9086032|P2|Overall Study|Adverse Event|2
2629440|NCT00862134|9086033|P1|Overall Study|Adverse Event|2
2629441|NCT00862134|9086032|P2|Overall Study|Sponsor terminated study|7
2629442|NCT00862134|9086033|P1|Overall Study|Sponsor terminated study|5
2629443|NCT00862134|9086032|P2|Overall Study|Withdrawal by Subject|2
2629444|NCT00862134|9086033|P1|Overall Study|Withdrawal by Subject|1
2629445|NCT00862134|9086032|P2|Overall Study|Physician Decision|1
2629446|NCT00862134|9086033|P1|Overall Study|Physician Decision|0
2629447|NCT00862134|9086032|P2|Overall Study|Death|0
2629448|NCT00862134|9086033|P1|Overall Study|Death|1
2629449|NCT00862121|9086045|P2|Overall Study|Incorrect randomisation|1
2629450|NCT00862121|9086046|P1|Overall Study|Incorrect randomisation|0
2629451|NCT00862121|9086045|P2|Overall Study|Exclusion criterion violation|1
2629452|NCT00862121|9086046|P1|Overall Study|Exclusion criterion violation|0
2629453|NCT00862121|9086045|P2|Overall Study|Protocol Violation|1
2629454|NCT00862121|9086046|P1|Overall Study|Protocol Violation|0
2629455|NCT00862121|9086045|P2|Overall Study|Lack of Efficacy|3
2629456|NCT00862121|9086046|P1|Overall Study|Lack of Efficacy|0
2629457|NCT00862121|9086045|P2|Overall Study|Adverse Event|2
2629458|NCT00862121|9086046|P1|Overall Study|Adverse Event|1
2629459|NCT00862082|9086064|P2|Overall Study|Withdrawal by Subject|1
2629460|NCT00862082|9086065|P1|Overall Study|Withdrawal by Subject|0
2629461|NCT00862082|9086064|P2|Overall Study|Sponsor decision to terminate the study|0
2629462|NCT00862082|9086065|P1|Overall Study|Sponsor decision to terminate the study|5
2629463|NCT00861757|9086120|P4|Overall Study|Withdrawal by Subject|2
2629464|NCT00861757|9086121|P3|Overall Study|Withdrawal by Subject|5
2629465|NCT00861757|9086122|P2|Overall Study|Withdrawal by Subject|5
2629466|NCT00861757|9086123|P1|Overall Study|Withdrawal by Subject|1
2629467|NCT00861757|9086120|P4|Overall Study|Protocol Violation|1
2629468|NCT00861757|9086121|P3|Overall Study|Protocol Violation|4
2629469|NCT00861757|9086122|P2|Overall Study|Protocol Violation|2
2629470|NCT00861757|9086123|P1|Overall Study|Protocol Violation|2
2629471|NCT00861757|9086120|P4|Overall Study|Physician Decision|1
2629472|NCT00861757|9086121|P3|Overall Study|Physician Decision|0
2629473|NCT00861757|9086122|P2|Overall Study|Physician Decision|0
2629474|NCT00861757|9086123|P1|Overall Study|Physician Decision|0
2629475|NCT00861757|9086120|P4|Overall Study|Lost to Follow-up|1
2629476|NCT00861757|9086121|P3|Overall Study|Lost to Follow-up|1
2629477|NCT00861757|9086122|P2|Overall Study|Lost to Follow-up|0
2629478|NCT00861757|9086123|P1|Overall Study|Lost to Follow-up|1
2629479|NCT00861757|9086120|P4|Overall Study|Lack of Efficacy|1
2629480|NCT00861757|9086121|P3|Overall Study|Lack of Efficacy|0
2629481|NCT00861757|9086122|P2|Overall Study|Lack of Efficacy|1
2629482|NCT00861757|9086123|P1|Overall Study|Lack of Efficacy|3
2629483|NCT00861757|9086120|P4|Overall Study|Entry Criteria Not Met|1
2629484|NCT00861757|9086121|P3|Overall Study|Entry Criteria Not Met|1
2629485|NCT00861757|9086122|P2|Overall Study|Entry Criteria Not Met|2
2629486|NCT00861757|9086123|P1|Overall Study|Entry Criteria Not Met|1
2629487|NCT00861757|9086120|P4|Overall Study|Adverse Event|2
2629488|NCT00861757|9086121|P3|Overall Study|Adverse Event|7
2629489|NCT00861757|9086122|P2|Overall Study|Adverse Event|5
2629490|NCT00861757|9086123|P1|Overall Study|Adverse Event|1
2629491|NCT00861744|9086181|P4|Overall Study|Blood draws|1
2629492|NCT00861744|9086182|P3|Overall Study|Blood draws|0
2629493|NCT00861744|9086183|P2|Overall Study|Blood draws|0
2629494|NCT00861744|9086184|P1|Overall Study|Blood draws|0
2629495|NCT00861744|9086181|P4|Overall Study|Migration from study area|0
2629496|NCT00861744|9086182|P3|Overall Study|Migration from study area|1
2629497|NCT00861744|9086183|P2|Overall Study|Migration from study area|3
2629498|NCT00861744|9086184|P1|Overall Study|Migration from study area|0
2629499|NCT00861744|9086181|P4|Overall Study|Protocol Violation|0
2629500|NCT00861744|9086182|P3|Overall Study|Protocol Violation|0
2629501|NCT00861744|9086183|P2|Overall Study|Protocol Violation|1
2629502|NCT00861744|9086184|P1|Overall Study|Protocol Violation|0
2629503|NCT00861744|9086181|P4|Overall Study|Withdrawal by Subject|19
2629504|NCT00861744|9086182|P3|Overall Study|Withdrawal by Subject|6
2629505|NCT00861744|9086183|P2|Overall Study|Withdrawal by Subject|6
2629506|NCT00861744|9086184|P1|Overall Study|Withdrawal by Subject|10
2629507|NCT00861744|9086181|P4|Overall Study|Lost to Follow-up|12
2629508|NCT00861744|9086182|P3|Overall Study|Lost to Follow-up|17
2629509|NCT00861744|9086183|P2|Overall Study|Lost to Follow-up|19
2629510|NCT00861744|9086184|P1|Overall Study|Lost to Follow-up|7
2629511|NCT00861744|9086181|P4|Overall Study|Adverse Event|1
2629512|NCT00861744|9086182|P3|Overall Study|Adverse Event|0
2629513|NCT00861744|9086183|P2|Overall Study|Adverse Event|0
2629514|NCT00861744|9086184|P1|Overall Study|Adverse Event|0
2629515|NCT00861705|9086366|P4|Overall Study|Never Began Treatment|1
2629516|NCT00861705|9086367|P3|Overall Study|Never Began Treatment|0
2629517|NCT00861705|9086368|P2|Overall Study|Never Began Treatment|3
2629518|NCT00861705|9086369|P1|Overall Study|Never Began Treatment|7
2629519|NCT00861692|9086409|P1|Overall Study|Death|6
2629520|NCT00861614|9086421|P2|Overall Study|Other|22
2629521|NCT00861614|9086422|P1|Overall Study|Other|17
2629522|NCT00861614|9086421|P2|Overall Study|Withdrawal by Subject|35
2629523|NCT00861614|9086422|P1|Overall Study|Withdrawal by Subject|34
2629524|NCT00861614|9086421|P2|Overall Study|Adverse Event|23
2629525|NCT00861614|9086422|P1|Overall Study|Adverse Event|27
2629526|NCT00861614|9086421|P2|Overall Study|Death|19
2629527|NCT00861614|9086422|P1|Overall Study|Death|32
2629528|NCT00861614|9086421|P2|Overall Study|Study Drug Toxicity|6
2629529|NCT00861614|9086422|P1|Overall Study|Study Drug Toxicity|79
2629530|NCT00861614|9086421|P2|Overall Study|Disease Progression|263
2629531|NCT00861614|9086422|P1|Overall Study|Disease Progression|182
2629532|NCT00861471|9086507|P1|Overall Study|Physician Decision|2
2629533|NCT00861471|9086507|P1|Overall Study|treatment for lumbar laminectomy|1
2629534|NCT00861471|9086507|P1|Overall Study|Lack of Efficacy|3
2629535|NCT00861471|9086507|P1|Overall Study|Adverse Event|2
2629536|NCT00861471|9086507|P1|Overall Study|Withdrawal by Subject|1
2629537|NCT00861341|9086515|P1|Overall Study|Withdrawal by Subject|2
2629538|NCT00861198|9086524|P1|Overall Study|SpyGlass Failed|5
2629539|NCT00860951|9086541|P1|Overall Study|Lost to Follow-up|5
2629540|NCT00860951|9086541|P1|Overall Study|Withdrawal by Subject|2
2629541|NCT00860743|9086598|P2|Overall Study|Withdrawal by Subject|0
2629542|NCT00860743|9086599|P1|Overall Study|Withdrawal by Subject|3
2629543|NCT00860470|9086612|P2|Overall Study|Lost to Follow-up|39
2629544|NCT00860470|9086613|P1|Overall Study|Lost to Follow-up|34
2629545|NCT00860470|9086612|P2|Overall Study|Moved away|10
2629546|NCT00860470|9086613|P1|Overall Study|Moved away|8
2629547|NCT00860470|9086612|P2|Overall Study|Death|10
2629548|NCT00860470|9086613|P1|Overall Study|Death|6
2629549|NCT00860405|9086643|P2|Overall Study|Main reason: Follow-up data not complete|4
2629550|NCT00860405|9086644|P1|Overall Study|Main reason: Follow-up data not complete|5
2629551|NCT00860262|9086684|P3|Overall Study|Other|1
2629552|NCT00860262|9086685|P2|Overall Study|Other|3
2629553|NCT00860262|9086686|P1|Overall Study|Other|5
2629554|NCT00860262|9086684|P3|Overall Study|Lack of Efficacy|3
2629555|NCT00860262|9086685|P2|Overall Study|Lack of Efficacy|4
2629556|NCT00860262|9086686|P1|Overall Study|Lack of Efficacy|0
2629557|NCT00860262|9086684|P3|Overall Study|Withdrawal by Subject|6
2629558|NCT00860262|9086685|P2|Overall Study|Withdrawal by Subject|8
2629559|NCT00860262|9086686|P1|Overall Study|Withdrawal by Subject|4
2629560|NCT00860262|9086684|P3|Overall Study|Lost to Follow-up|1
2629561|NCT00860262|9086685|P2|Overall Study|Lost to Follow-up|0
2629562|NCT00860262|9086686|P1|Overall Study|Lost to Follow-up|2
2629563|NCT00860262|9086684|P3|Overall Study|Protocol Violation|0
2629564|NCT00860262|9086685|P2|Overall Study|Protocol Violation|1
2629565|NCT00860262|9086686|P1|Overall Study|Protocol Violation|0
2629566|NCT00860262|9086684|P3|Overall Study|Adverse Event|7
2629567|NCT00860262|9086685|P2|Overall Study|Adverse Event|6
2629568|NCT00860262|9086686|P1|Overall Study|Adverse Event|9
2629569|NCT00860249|9086799|P3|Overall Study|trial was terminated prior to completion|21
2629570|NCT00860249|9086800|P2|Overall Study|trial was terminated prior to completion|18
2629571|NCT00860249|9086801|P1|Overall Study|trial was terminated prior to completion|21
2629572|NCT00860158|9086821|P1|Overall Study|Study Terminated|1
2629573|NCT00860067|9086833|P3|Overall Study|Pregnancy|0
2629574|NCT00860067|9086834|P2|Overall Study|Pregnancy|0
2629575|NCT00860067|9086835|P1|Overall Study|Pregnancy|1
2629576|NCT00860067|9086833|P3|Overall Study|Withdrawal by Subject|0
2629577|NCT00860067|9086834|P2|Overall Study|Withdrawal by Subject|0
2629578|NCT00860067|9086835|P1|Overall Study|Withdrawal by Subject|4
2629579|NCT00860067|9086833|P3|Overall Study|Lost to Follow-up|9
2629580|NCT00860067|9086834|P2|Overall Study|Lost to Follow-up|9
2629581|NCT00860067|9086835|P1|Overall Study|Lost to Follow-up|46
2629582|NCT00860028|9086895|P2|Placebo Controlled Pretreatment Period|No longer interested in treatment|1
2629583|NCT00860028|9086896|P1|Placebo Controlled Pretreatment Period|No longer interested in treatment|2
2629584|NCT00859937|9086934|P2|Overall Study|Protocol Violation|0
2629585|NCT00859937|9086935|P1|Overall Study|Protocol Violation|1
2629586|NCT00859898|9086950|P3|Overall Study|non-specified|1
2629587|NCT00859898|9086951|P2|Overall Study|non-specified|1
2629588|NCT00859898|9086952|P1|Overall Study|non-specified|1
2629589|NCT00859898|9086950|P3|Overall Study|No longer meets criteria|0
2629590|NCT00859898|9086951|P2|Overall Study|No longer meets criteria|1
2629591|NCT00859898|9086952|P1|Overall Study|No longer meets criteria|0
2629592|NCT00859898|9086950|P3|Overall Study|poor/non-compliance|0
2629593|NCT00859898|9086951|P2|Overall Study|poor/non-compliance|0
2629594|NCT00859898|9086952|P1|Overall Study|poor/non-compliance|2
2629595|NCT00859898|9086950|P3|Overall Study|Lost to Follow-up|5
2629596|NCT00859898|9086951|P2|Overall Study|Lost to Follow-up|11
2629597|NCT00859898|9086952|P1|Overall Study|Lost to Follow-up|10
2629598|NCT00859898|9086950|P3|Overall Study|Death|1
2629599|NCT00859898|9086951|P2|Overall Study|Death|0
2629600|NCT00859898|9086952|P1|Overall Study|Death|0
2629601|NCT00859898|9086950|P3|Overall Study|Withdrawal by Subject|11
2629602|NCT00859898|9086951|P2|Overall Study|Withdrawal by Subject|8
2629603|NCT00859898|9086952|P1|Overall Study|Withdrawal by Subject|11
2629604|NCT00859898|9086950|P3|Overall Study|Adverse Event|8
2629605|NCT00859898|9086951|P2|Overall Study|Adverse Event|9
2629606|NCT00859898|9086952|P1|Overall Study|Adverse Event|4
2629607|NCT00859898|9086950|P3|Overall Study|Lack of Efficacy|1
2629608|NCT00859898|9086951|P2|Overall Study|Lack of Efficacy|1
2629609|NCT00859898|9086952|P1|Overall Study|Lack of Efficacy|0
2629610|NCT00859638|9087011|P2|Overall Study|Ill health|1
2629611|NCT00859638|9087012|P1|Overall Study|Ill health|1
2629612|NCT00859638|9087011|P2|Overall Study|Withdrawal by Subject|2
2629613|NCT00859638|9087012|P1|Overall Study|Withdrawal by Subject|3
2629614|NCT00859638|9087011|P2|Overall Study|Lost to Follow-up|1
2629615|NCT00859638|9087012|P1|Overall Study|Lost to Follow-up|6
2629616|NCT00859586|9087018|P1|Overall Study|Donors|4
2629617|NCT00859573|9087024|P2|Overall Study|Physician Decision|1
2629618|NCT00859573|9087025|P1|Overall Study|Physician Decision|1
2629619|NCT00859573|9087024|P2|Overall Study|Withdrawal by Subject|1
2629620|NCT00859573|9087025|P1|Overall Study|Withdrawal by Subject|4
2629621|NCT00859547|9087031|P1|Overall Study|Parent withdrew consent|1
2629622|NCT00859547|9087031|P1|Overall Study|Lost to Follow-up|1
2629623|NCT00859521|9087044|P2|Washout|Withdrawal by Subject|1
2629624|NCT00859521|9087045|P1|Washout|Withdrawal by Subject|0
2629625|NCT00859469|9087062|P1|Overall Study|Death|16
2629626|NCT00859469|9087062|P1|Overall Study|Withdrawal by Subject|1
2629627|NCT00859469|9087062|P1|Overall Study|Lack of Efficacy|9
2629628|NCT00859469|9087062|P1|Overall Study|Adverse Event|2
2629629|NCT00859456|9087068|P1|Overall Study|Non-compliance|3
2629630|NCT00859456|9087068|P1|Overall Study|Progressive disease|2
2629631|NCT00859456|9087068|P1|Overall Study|Adverse Event|3
2629632|NCT00859430|9087074|P2|First Intervention|Withdrawal by Subject|1
2629633|NCT00859430|9087075|P1|First Intervention|Withdrawal by Subject|0
2629634|NCT00859313|9087091|P1|Overall Study|staff error|1
2629635|NCT00859313|9087091|P1|Overall Study|Adverse Event|1
2629636|NCT00859313|9087091|P1|Overall Study|Lack of Efficacy|2
2629637|NCT00859222|9087098|P5|Overall Study|DLT|0
2629638|NCT00859222|9087099|P4|Overall Study|DLT|0
2629639|NCT00859222|9087100|P3|Overall Study|DLT|0
2629640|NCT00859222|9087101|P2|Overall Study|DLT|0
2629641|NCT00859222|9087102|P1|Overall Study|DLT|1
2629642|NCT00859222|9087098|P5|Overall Study|Adverse Event|15
2629643|NCT00859222|9087099|P4|Overall Study|Adverse Event|24
2629644|NCT00859222|9087100|P3|Overall Study|Adverse Event|6
2629645|NCT00859222|9087101|P2|Overall Study|Adverse Event|3
2629646|NCT00859222|9087102|P1|Overall Study|Adverse Event|2
2629647|NCT00859014|9087224|P1|Overall Study|Lost to Follow-up|1
2629648|NCT00859014|9087224|P1|Overall Study|Death|4
2629649|NCT00858988|9087231|P2|Analysis|Lactulose unable to be detected in urine|1
2629650|NCT00858988|9087232|P1|Analysis|Lactulose unable to be detected in urine|2
2629651|NCT00858845|9087248|P2|Overall Study|Patient underwent heart transplant.|1
2629652|NCT00858845|9087249|P1|Overall Study|Patient underwent heart transplant.|0
2629653|NCT00858832|9087261|P2|Overall Study|Adverse Event|1
2629654|NCT00858832|9087262|P1|Overall Study|Adverse Event|0
2629655|NCT00858832|9087261|P2|Overall Study|became ineligible: delivered vaginally|0
2629656|NCT00858832|9087262|P1|Overall Study|became ineligible: delivered vaginally|1
2629657|NCT00858780|9087268|P5|OL Re-Treatment (Failure to Week 48)|Other|1
2629658|NCT00858780|9087269|P4|OL Re-Treatment (Failure to Week 48)|Other|0
2629659|NCT00858780|9087270|P3|OL Re-Treatment (Failure to Week 48)|Other|0
2629660|NCT00858780|9087271|P2|OL Re-Treatment (Failure to Week 48)|Other|0
2629661|NCT00858780|9087272|P1|OL Re-Treatment (Failure to Week 48)|Other|0
2629662|NCT00858780|9087268|P5|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1
2629663|NCT00858780|9087269|P4|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
2629664|NCT00858780|9087270|P3|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
2629665|NCT00858780|9087271|P2|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
2629666|NCT00858780|9087272|P1|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
2629667|NCT00858780|9087268|P5|Double-Blind (Week 0 to Failure/Week 48)|Other|0
2629668|NCT00858780|9087269|P4|Double-Blind (Week 0 to Failure/Week 48)|Other|0
2629669|NCT00858780|9087270|P3|Double-Blind (Week 0 to Failure/Week 48)|Other|0
2629670|NCT00858780|9087271|P2|Double-Blind (Week 0 to Failure/Week 48)|Other|1
2629671|NCT00858780|9087272|P1|Double-Blind (Week 0 to Failure/Week 48)|Other|0
2629672|NCT00858780|9087268|P5|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
2629673|NCT00858780|9087269|P4|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
2629674|NCT00858780|9087270|P3|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
2629675|NCT00858780|9087271|P2|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
2629676|NCT00858780|9087272|P1|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
2629677|NCT00858780|9087268|P5|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
2629678|NCT00858780|9087269|P4|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
2629679|NCT00858780|9087270|P3|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1
2629680|NCT00858780|9087271|P2|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
2629681|NCT00858780|9087272|P1|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
2629682|NCT00858780|9087268|P5|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
2629683|NCT00858780|9087269|P4|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
2629684|NCT00858780|9087270|P3|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
2629685|NCT00858780|9087271|P2|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
2629686|NCT00858780|9087272|P1|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18
2629687|NCT00858702|9087347|P2|Overall Study|Withdrawal by Subject|0
2629688|NCT00858702|9087348|P1|Overall Study|Withdrawal by Subject|1
2629689|NCT00858702|9087347|P2|Overall Study|Other|1
2629690|NCT00858702|9087348|P1|Overall Study|Other|2
2629691|NCT00858702|9087347|P2|Overall Study|Protocol Violation|1
2629692|NCT00858702|9087348|P1|Overall Study|Protocol Violation|1
2629693|NCT00858702|9087347|P2|Overall Study|Lack of Efficacy|0
2629694|NCT00858702|9087348|P1|Overall Study|Lack of Efficacy|1
2629695|NCT00858637|9087363|P6|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1
2629696|NCT00858637|9087364|P5|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
2629697|NCT00858637|9087365|P4|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
2629698|NCT00858637|9087366|P3|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
2629699|NCT00858637|9087367|P2|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
2629700|NCT00858637|9087368|P1|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
2629701|NCT00858637|9087363|P6|Placebo-controlled Withdrawal Phase|Death|0
2629702|NCT00858637|9087364|P5|Placebo-controlled Withdrawal Phase|Death|1
2629703|NCT00858637|9087365|P4|Placebo-controlled Withdrawal Phase|Death|0
2629704|NCT00858637|9087366|P3|Placebo-controlled Withdrawal Phase|Death|1
2629705|NCT00858637|9087367|P2|Placebo-controlled Withdrawal Phase|Death|0
2629706|NCT00858637|9087368|P1|Placebo-controlled Withdrawal Phase|Death|0
2629707|NCT00858637|9087363|P6|Active Comparison Phase|Other Reasons|0
2629708|NCT00858637|9087364|P5|Active Comparison Phase|Other Reasons|0
2629709|NCT00858637|9087365|P4|Active Comparison Phase|Other Reasons|1
2629710|NCT00858637|9087366|P3|Active Comparison Phase|Other Reasons|0
2629711|NCT00858637|9087367|P2|Active Comparison Phase|Other Reasons|0
2629712|NCT00858637|9087368|P1|Active Comparison Phase|Other Reasons|1
2629713|NCT00858637|9087363|P6|Active Comparison Phase|Withdrawal by Subject|0
2629714|NCT00858637|9087364|P5|Active Comparison Phase|Withdrawal by Subject|0
2629715|NCT00858637|9087365|P4|Active Comparison Phase|Withdrawal by Subject|6
2629716|NCT00858637|9087366|P3|Active Comparison Phase|Withdrawal by Subject|0
2629717|NCT00858637|9087367|P2|Active Comparison Phase|Withdrawal by Subject|0
2629718|NCT00858637|9087368|P1|Active Comparison Phase|Withdrawal by Subject|7
2629719|NCT00858637|9087363|P6|Active Comparison Phase|Physician Decision|0
2629720|NCT00858637|9087364|P5|Active Comparison Phase|Physician Decision|0
2629721|NCT00858637|9087365|P4|Active Comparison Phase|Physician Decision|1
2629722|NCT00858637|9087366|P3|Active Comparison Phase|Physician Decision|0
2629723|NCT00858637|9087367|P2|Active Comparison Phase|Physician Decision|0
2629724|NCT00858637|9087368|P1|Active Comparison Phase|Physician Decision|1
2629725|NCT00858637|9087363|P6|Active Comparison Phase|Death|0
2629726|NCT00858637|9087364|P5|Active Comparison Phase|Death|0
2629727|NCT00858637|9087365|P4|Active Comparison Phase|Death|1
2629728|NCT00858637|9087366|P3|Active Comparison Phase|Death|0
2629729|NCT00858637|9087367|P2|Active Comparison Phase|Death|0
2629730|NCT00858637|9087368|P1|Active Comparison Phase|Death|1
2629731|NCT00858637|9087363|P6|Active Comparison Phase|Adverse Event|0
2629732|NCT00858637|9087364|P5|Active Comparison Phase|Adverse Event|0
2629733|NCT00858637|9087365|P4|Active Comparison Phase|Adverse Event|9
2629734|NCT00858637|9087366|P3|Active Comparison Phase|Adverse Event|0
2629735|NCT00858637|9087367|P2|Active Comparison Phase|Adverse Event|0
2629736|NCT00858637|9087368|P1|Active Comparison Phase|Adverse Event|14
2629737|NCT00858442|9087409|P2|Compression:Start to Finish|Lost to Follow-up|3
2629738|NCT00858442|9087410|P1|Compression:Start to Finish|Lost to Follow-up|1
2629739|NCT00858403|9087420|P1|Overall Study|Disease Progression|1
2629740|NCT00858403|9087420|P1|Overall Study|Death|3
2629741|NCT00858403|9087420|P1|Overall Study|Withdrawal by Subject|1
2629742|NCT00858364|9087441|P2|Overall Study|Still on-study|247
2629743|NCT00858364|9087442|P1|Overall Study|Still on-study|114
2629744|NCT00858364|9087441|P2|Overall Study|Missing|1
2629745|NCT00858364|9087442|P1|Overall Study|Missing|1
2629746|NCT00858364|9087441|P2|Overall Study|Other|17
2629747|NCT00858364|9087442|P1|Overall Study|Other|9
2629748|NCT00858364|9087441|P2|Overall Study|Protocol Deviation|2
2629749|NCT00858364|9087442|P1|Overall Study|Protocol Deviation|0
2629750|NCT00858364|9087441|P2|Overall Study|Noncompliance|4
2629751|NCT00858364|9087442|P1|Overall Study|Noncompliance|3
2629752|NCT00858364|9087441|P2|Overall Study|Lost to Follow-up|54
2629753|NCT00858364|9087442|P1|Overall Study|Lost to Follow-up|24
2629754|NCT00858364|9087441|P2|Overall Study|Ineligibility Determined|10
2629755|NCT00858364|9087442|P1|Overall Study|Ineligibility Determined|1
2629756|NCT00858364|9087441|P2|Overall Study|Withdrawal by Subject|118
2629757|NCT00858364|9087442|P1|Overall Study|Withdrawal by Subject|44
2629758|NCT00858364|9087441|P2|Overall Study|Adverse Event|2
2629759|NCT00858364|9087442|P1|Overall Study|Adverse Event|5
2629760|NCT00858364|9087441|P2|Overall Study|Administrative Decision|2
2629761|NCT00858364|9087442|P1|Overall Study|Administrative Decision|3
2629762|NCT00858247|9087464|P2|Week 12 Follow-up|Withdrawal by Subject|1
2629763|NCT00858247|9087465|P1|Week 12 Follow-up|Withdrawal by Subject|0
2629764|NCT00858247|9087464|P2|Baseline Assessment|Protocol Violation|1
2629765|NCT00858247|9087465|P1|Baseline Assessment|Protocol Violation|0
2629766|NCT00858247|9087464|P2|Baseline Assessment|Poor IV access|0
2629767|NCT00858247|9087465|P1|Baseline Assessment|Poor IV access|1
2629768|NCT00858247|9087464|P2|Baseline Assessment|Withdrawal by Subject|1
2629769|NCT00858247|9087465|P1|Baseline Assessment|Withdrawal by Subject|1
2629770|NCT00858208|9087481|P1|Overall Study|Other|10
2629771|NCT00858208|9087481|P1|Overall Study|Participant refused|40
2629772|NCT00858208|9087481|P1|Overall Study|Lost to Follow-up|26
2629773|NCT00858208|9087481|P1|Overall Study|Adverse Event|3
2629774|NCT00858143|9087498|P1|Overall Study|Other|23
2629775|NCT00858143|9087498|P1|Overall Study|Death|7
2629776|NCT00858143|9087498|P1|Overall Study|Lack of Efficacy|4
2629777|NCT00858143|9087498|P1|Overall Study|Adverse Event|16
2629778|NCT00857948|9087610|P4|Overall Study|Protocol Violation|0
2629779|NCT00857948|9087611|P3|Overall Study|Protocol Violation|1
2629780|NCT00857948|9087612|P2|Overall Study|Protocol Violation|0
2629781|NCT00857948|9087613|P1|Overall Study|Protocol Violation|1
2629782|NCT00857948|9087610|P4|Overall Study|Withdrawal by Subject|0
2629783|NCT00857948|9087611|P3|Overall Study|Withdrawal by Subject|0
2629784|NCT00857948|9087612|P2|Overall Study|Withdrawal by Subject|0
2629785|NCT00857948|9087613|P1|Overall Study|Withdrawal by Subject|2
2629786|NCT00857896|9087635|P1|Baseline to Week 4|Withdrawal by Subject|1
2629787|NCT00857818|9087791|P2|Overall Study|Investigator decision|0
2629788|NCT00857818|9087792|P1|Overall Study|Investigator decision|1
2629789|NCT00857818|9087791|P2|Overall Study|Sponsor terminated study|4
2629790|NCT00857818|9087792|P1|Overall Study|Sponsor terminated study|6
2629791|NCT00857818|9087791|P2|Overall Study|Withdrawal by Subject|4
2629792|NCT00857818|9087792|P1|Overall Study|Withdrawal by Subject|0
2629793|NCT00857818|9087791|P2|Overall Study|Adverse Event|0
2629794|NCT00857818|9087792|P1|Overall Study|Adverse Event|3
2629795|NCT00857818|9087791|P2|Overall Study|Lack of Efficacy|0
2629796|NCT00857818|9087792|P1|Overall Study|Lack of Efficacy|1
2629797|NCT00857792|9087820|P1|Overall Study|inadequate image quality for analysis|12
2629798|NCT00857766|9087826|P2|Overall Study|Participant Withdrew Consent|4
2629799|NCT00857766|9087827|P1|Overall Study|Participant Withdrew Consent|4
2629800|NCT00857766|9087826|P2|Overall Study|Investigator Discretion|3
2629801|NCT00857766|9087827|P1|Overall Study|Investigator Discretion|2
2629802|NCT00857766|9087826|P2|Overall Study|Lost to Follow-up|0
2629803|NCT00857766|9087827|P1|Overall Study|Lost to Follow-up|1
2629804|NCT00857766|9087826|P2|Overall Study|Protocol Violation|11
2629805|NCT00857766|9087827|P1|Overall Study|Protocol Violation|11
2629806|NCT00857766|9087826|P2|Overall Study|Adverse Event|12
2629807|NCT00857766|9087827|P1|Overall Study|Adverse Event|13
2629808|NCT00857649|9087869|P2|Overall Study|Other Reasons|3
2629809|NCT00857649|9087870|P1|Overall Study|Other Reasons|1
2629810|NCT00857649|9087869|P2|Overall Study|Nursing Home Placement|9
2629811|NCT00857649|9087870|P1|Overall Study|Nursing Home Placement|2
2629812|NCT00857649|9087869|P2|Overall Study|Withdrawal of Consent|7
2629813|NCT00857649|9087870|P1|Overall Study|Withdrawal of Consent|10
2629814|NCT00857649|9087869|P2|Overall Study|Protocol Violation|2
2629815|NCT00857649|9087870|P1|Overall Study|Protocol Violation|2
2629816|NCT00857649|9087869|P2|Overall Study|Non-compliance|1
2629817|NCT00857649|9087870|P1|Overall Study|Non-compliance|1
2629818|NCT00857649|9087869|P2|Overall Study|Adverse Event|10
2629819|NCT00857649|9087870|P1|Overall Study|Adverse Event|15
2629820|NCT00857623|9087886|P2|Overall Study|Positive for HEP C|1
2629821|NCT00857623|9087887|P1|Overall Study|Positive for HEP C|0
2629822|NCT00857623|9087886|P2|Overall Study|Intake of prohibited medication|1
2629823|NCT00857623|9087887|P1|Overall Study|Intake of prohibited medication|0
2629824|NCT00857623|9087886|P2|Overall Study|Severe non-compliance to protocol|1
2629825|NCT00857623|9087887|P1|Overall Study|Severe non-compliance to protocol|1
2629826|NCT00857623|9087886|P2|Overall Study|Lack of Efficacy|1
2629827|NCT00857623|9087887|P1|Overall Study|Lack of Efficacy|1
2629828|NCT00857623|9087886|P2|Overall Study|Withdrawal by Subject|1
2629829|NCT00857623|9087887|P1|Overall Study|Withdrawal by Subject|2
2629830|NCT00857623|9087886|P2|Overall Study|Study-specific discontinuation criteria|3
2629831|NCT00857623|9087887|P1|Overall Study|Study-specific discontinuation criteria|5
2629832|NCT00857623|9087886|P2|Overall Study|Adverse Event|2
2629833|NCT00857623|9087887|P1|Overall Study|Adverse Event|5
2629834|NCT00857584|9087911|P2|Overall Study|Physician Decision|1
2629835|NCT00857584|9087912|P1|Overall Study|Physician Decision|1
2629836|NCT00857584|9087911|P2|Overall Study|Adverse Event|2
2629837|NCT00857584|9087912|P1|Overall Study|Adverse Event|2
2629838|NCT00857584|9087911|P2|Overall Study|Lack of Efficacy|2
2629839|NCT00857584|9087912|P1|Overall Study|Lack of Efficacy|1
2629840|NCT00857454|9088039|P1|Overall Study|MTE09 enrollment criteria not met|6
2629841|NCT00857454|9088039|P1|Overall Study|Total Testosterone <300 ng/dL|8
2629842|NCT00857454|9088039|P1|Overall Study|Total Testosterone >1050 ng/dL|1
2629843|NCT00857454|9088039|P1|Overall Study|Adverse Event|2
2629844|NCT00857454|9088039|P1|Overall Study|Lost to Follow-up|1
2629845|NCT00857454|9088039|P1|Overall Study|Withdrawal by Subject|2
2629846|NCT00857415|9088052|P2|Overall Study|Deceased with no autopsy|0
2629847|NCT00857415|9088053|P1|Overall Study|Deceased with no autopsy|2
2629848|NCT00857415|9088052|P2|Overall Study|Subject still living at end of study|0
2629849|NCT00857415|9088053|P1|Overall Study|Subject still living at end of study|110
2629850|NCT00857415|9088052|P2|Overall Study|Invalid image or not imaged|0
2629851|NCT00857415|9088053|P1|Overall Study|Invalid image or not imaged|3
2629852|NCT00857415|9088052|P2|Overall Study|Image acquisition failure|0
2629853|NCT00857415|9088053|P1|Overall Study|Image acquisition failure|2
2629854|NCT00857389|9088060|P1|Overall Study|Did not proceed to transplant|2
2629855|NCT00857311|9088074|P4|Overall Study|Lost to Follow-up|0
2629856|NCT00857311|9088075|P3|Overall Study|Lost to Follow-up|0
2629857|NCT00857311|9088076|P2|Overall Study|Lost to Follow-up|0
2629858|NCT00857311|9088077|P1|Overall Study|Lost to Follow-up|1
2629859|NCT00857285|9088089|P2|Overall Study|Randomization criteria not met|1
2629860|NCT00857285|9088090|P1|Overall Study|Randomization criteria not met|1
2629861|NCT00857285|9088089|P2|Overall Study|Withdrawal by Subject|0
2629862|NCT00857285|9088090|P1|Overall Study|Withdrawal by Subject|4
2629863|NCT00857285|9088089|P2|Overall Study|Protocol Violation|1
2629864|NCT00857285|9088090|P1|Overall Study|Protocol Violation|3
2629865|NCT00857285|9088089|P2|Overall Study|Lack of Efficacy|2
2629866|NCT00857285|9088090|P1|Overall Study|Lack of Efficacy|0
2629867|NCT00857285|9088089|P2|Overall Study|Adverse Event|2
2629868|NCT00857285|9088090|P1|Overall Study|Adverse Event|4
2629869|NCT00857259|9088106|P3|Overall Study|Protocol Violation|1
2629870|NCT00857259|9088107|P2|Overall Study|Protocol Violation|0
2629871|NCT00857259|9088108|P1|Overall Study|Protocol Violation|1
2629872|NCT00857246|9088118|P1|ChemoRT|Adverse Event|2
2629873|NCT00857246|9088118|P1|ChemoRT|Withdrawal by Subject|1
2629874|NCT00857246|9088118|P1|Surgery (Curative)|disease progression|6
2629875|NCT00857246|9088118|P1|Induction Regimen|Withdrawal by Subject|1
2629876|NCT00857246|9088118|P1|Induction Regimen|disease-related complications|1
2629877|NCT00857246|9088118|P1|Induction Regimen|Adverse Event|1
2629878|NCT00857233|9088128|P1|Overall Study|Other Reasons|2
2629879|NCT00857233|9088128|P1|Overall Study|Nursing Home Placement|14
2629880|NCT00857233|9088128|P1|Overall Study|Lost to Follow-up|4
2629881|NCT00857233|9088128|P1|Overall Study|Withdrawal of Consent|9
2629882|NCT00857233|9088128|P1|Overall Study|Non-compliance|1
2629883|NCT00857233|9088128|P1|Overall Study|Lack of Efficacy|1
2629884|NCT00857233|9088128|P1|Overall Study|Adverse Event|24
2629885|NCT00857220|9088137|P1|Overall Study|Miscellaneous|8
2629886|NCT00857220|9088137|P1|Overall Study|Site Closed|5
2629887|NCT00857220|9088137|P1|Overall Study|Clinical Hold|6
2629888|NCT00857220|9088137|P1|Overall Study|Withdrawal by Subject|67
2629889|NCT00857220|9088137|P1|Overall Study|Protocol Violation|16
2629890|NCT00857220|9088137|P1|Overall Study|Physician Decision|4
2629891|NCT00857220|9088137|P1|Overall Study|Lost to Follow-up|30
2629892|NCT00857220|9088137|P1|Overall Study|Lack of Efficacy|11
2629893|NCT00857220|9088137|P1|Overall Study|Death|1
2629894|NCT00857220|9088137|P1|Overall Study|Adverse Event|35
2629895|NCT00856999|9088154|P1|Overall Study|Withdrawal by Subject|5
2629896|NCT00856986|9088164|P5|Extension Period, Weeks 26-52|Unclassified|0
2629897|NCT00856986|9088165|P4|Extension Period, Weeks 26-52|Unclassified|0
2629898|NCT00856986|9088166|P3|Extension Period, Weeks 26-52|Unclassified|11
2629899|NCT00856986|9088167|P2|Extension Period, Weeks 26-52|Unclassified|2
2629900|NCT00856986|9088168|P1|Extension Period, Weeks 26-52|Unclassified|4
2629901|NCT00856986|9088164|P5|Extension Period, Weeks 26-52|Lack of Efficacy|0
2629902|NCT00856986|9088165|P4|Extension Period, Weeks 26-52|Lack of Efficacy|0
2629903|NCT00856986|9088166|P3|Extension Period, Weeks 26-52|Lack of Efficacy|2
2629904|NCT00856986|9088167|P2|Extension Period, Weeks 26-52|Lack of Efficacy|2
2629905|NCT00856986|9088168|P1|Extension Period, Weeks 26-52|Lack of Efficacy|4
2629906|NCT00856986|9088164|P5|Extension Period, Weeks 26-52|Lost to Follow-up|0
2629907|NCT00856986|9088165|P4|Extension Period, Weeks 26-52|Lost to Follow-up|0
2629908|NCT00856986|9088166|P3|Extension Period, Weeks 26-52|Lost to Follow-up|2
2629909|NCT00856986|9088167|P2|Extension Period, Weeks 26-52|Lost to Follow-up|5
2629910|NCT00856986|9088168|P1|Extension Period, Weeks 26-52|Lost to Follow-up|0
2629911|NCT00856986|9088164|P5|Extension Period, Weeks 26-52|Withdrawal Criteria|0
2629912|NCT00856986|9088165|P4|Extension Period, Weeks 26-52|Withdrawal Criteria|0
2629913|NCT00856986|9088166|P3|Extension Period, Weeks 26-52|Withdrawal Criteria|8
2629914|NCT00856986|9088167|P2|Extension Period, Weeks 26-52|Withdrawal Criteria|0
2629915|NCT00856986|9088168|P1|Extension Period, Weeks 26-52|Withdrawal Criteria|2
2629916|NCT00856986|9088164|P5|Extension Period, Weeks 26-52|Protocol Violation|0
2629917|NCT00856986|9088165|P4|Extension Period, Weeks 26-52|Protocol Violation|0
2629918|NCT00856986|9088166|P3|Extension Period, Weeks 26-52|Protocol Violation|5
2629919|NCT00856986|9088167|P2|Extension Period, Weeks 26-52|Protocol Violation|2
2629920|NCT00856986|9088168|P1|Extension Period, Weeks 26-52|Protocol Violation|6
2629921|NCT00856986|9088164|P5|Extension Period, Weeks 26-52|Adverse Event|0
2629922|NCT00856986|9088165|P4|Extension Period, Weeks 26-52|Adverse Event|0
2629923|NCT00856986|9088166|P3|Extension Period, Weeks 26-52|Adverse Event|10
2629924|NCT00856986|9088167|P2|Extension Period, Weeks 26-52|Adverse Event|3
2629925|NCT00856986|9088168|P1|Extension Period, Weeks 26-52|Adverse Event|3
2629926|NCT00856986|9088164|P5|Main Period, Weeks 0-26|Unclassified|0
2629927|NCT00856986|9088165|P4|Main Period, Weeks 0-26|Unclassified|0
2629928|NCT00856986|9088166|P3|Main Period, Weeks 0-26|Unclassified|7
2629929|NCT00856986|9088167|P2|Main Period, Weeks 0-26|Unclassified|6
2629930|NCT00856986|9088168|P1|Main Period, Weeks 0-26|Unclassified|7
2629931|NCT00856986|9088164|P5|Main Period, Weeks 0-26|Lack of Efficacy|0
2629932|NCT00856986|9088165|P4|Main Period, Weeks 0-26|Lack of Efficacy|0
2629933|NCT00856986|9088166|P3|Main Period, Weeks 0-26|Lack of Efficacy|0
2629934|NCT00856986|9088167|P2|Main Period, Weeks 0-26|Lack of Efficacy|2
2629935|NCT00856986|9088168|P1|Main Period, Weeks 0-26|Lack of Efficacy|5
2629936|NCT00856986|9088164|P5|Main Period, Weeks 0-26|Lost to Follow-up|0
2629937|NCT00856986|9088165|P4|Main Period, Weeks 0-26|Lost to Follow-up|0
2629938|NCT00856986|9088166|P3|Main Period, Weeks 0-26|Lost to Follow-up|2
2629939|NCT00856986|9088167|P2|Main Period, Weeks 0-26|Lost to Follow-up|1
2629940|NCT00856986|9088168|P1|Main Period, Weeks 0-26|Lost to Follow-up|1
2629941|NCT00856986|9088164|P5|Main Period, Weeks 0-26|Withdrawal Criteria|0
2629942|NCT00856986|9088165|P4|Main Period, Weeks 0-26|Withdrawal Criteria|0
2629943|NCT00856986|9088166|P3|Main Period, Weeks 0-26|Withdrawal Criteria|3
2629944|NCT00856986|9088167|P2|Main Period, Weeks 0-26|Withdrawal Criteria|0
2629945|NCT00856986|9088168|P1|Main Period, Weeks 0-26|Withdrawal Criteria|11
2629946|NCT00856986|9088164|P5|Main Period, Weeks 0-26|Protocol Violation|0
2629947|NCT00856986|9088165|P4|Main Period, Weeks 0-26|Protocol Violation|0
2629948|NCT00856986|9088166|P3|Main Period, Weeks 0-26|Protocol Violation|7
2629949|NCT00856986|9088167|P2|Main Period, Weeks 0-26|Protocol Violation|5
2629950|NCT00856986|9088168|P1|Main Period, Weeks 0-26|Protocol Violation|4
2629951|NCT00856986|9088164|P5|Main Period, Weeks 0-26|Adverse Event|0
2629952|NCT00856986|9088165|P4|Main Period, Weeks 0-26|Adverse Event|0
2629953|NCT00856986|9088166|P3|Main Period, Weeks 0-26|Adverse Event|9
2629954|NCT00856986|9088167|P2|Main Period, Weeks 0-26|Adverse Event|4
2629955|NCT00856986|9088168|P1|Main Period, Weeks 0-26|Adverse Event|6
2629956|NCT00856986|9088164|P5|Run-in Period, Weeks -12-0|Unclassified|0
2629957|NCT00856986|9088165|P4|Run-in Period, Weeks -12-0|Unclassified|24
2629958|NCT00856986|9088166|P3|Run-in Period, Weeks -12-0|Unclassified|0
2629959|NCT00856986|9088167|P2|Run-in Period, Weeks -12-0|Unclassified|0
2629960|NCT00856986|9088168|P1|Run-in Period, Weeks -12-0|Unclassified|0
2629961|NCT00856986|9088164|P5|Run-in Period, Weeks -12-0|Lack of Efficacy|0
2629962|NCT00856986|9088165|P4|Run-in Period, Weeks -12-0|Lack of Efficacy|6
2629963|NCT00856986|9088166|P3|Run-in Period, Weeks -12-0|Lack of Efficacy|0
2629964|NCT00856986|9088167|P2|Run-in Period, Weeks -12-0|Lack of Efficacy|0
2629965|NCT00856986|9088168|P1|Run-in Period, Weeks -12-0|Lack of Efficacy|0
2629966|NCT00856986|9088164|P5|Run-in Period, Weeks -12-0|Lost to Follow-up|0
2629967|NCT00856986|9088165|P4|Run-in Period, Weeks -12-0|Lost to Follow-up|11
2629968|NCT00856986|9088166|P3|Run-in Period, Weeks -12-0|Lost to Follow-up|0
2629969|NCT00856986|9088167|P2|Run-in Period, Weeks -12-0|Lost to Follow-up|0
2629970|NCT00856986|9088168|P1|Run-in Period, Weeks -12-0|Lost to Follow-up|0
2629971|NCT00856986|9088164|P5|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
2629972|NCT00856986|9088165|P4|Run-in Period, Weeks -12-0|Withdrawal Criteria|10
2629973|NCT00856986|9088166|P3|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
2629974|NCT00856986|9088167|P2|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
2629975|NCT00856986|9088168|P1|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
2629976|NCT00856986|9088164|P5|Run-in Period, Weeks -12-0|Protocol Violation|0
2629977|NCT00856986|9088165|P4|Run-in Period, Weeks -12-0|Protocol Violation|24
2629978|NCT00856986|9088166|P3|Run-in Period, Weeks -12-0|Protocol Violation|0
2629979|NCT00856986|9088167|P2|Run-in Period, Weeks -12-0|Protocol Violation|0
2629980|NCT00856986|9088168|P1|Run-in Period, Weeks -12-0|Protocol Violation|0
2629981|NCT00856986|9088164|P5|Run-in Period, Weeks -12-0|Adverse Event|0
2629982|NCT00856986|9088165|P4|Run-in Period, Weeks -12-0|Adverse Event|92
2629983|NCT00856986|9088166|P3|Run-in Period, Weeks -12-0|Adverse Event|0
2629984|NCT00856986|9088167|P2|Run-in Period, Weeks -12-0|Adverse Event|0
2629985|NCT00856986|9088168|P1|Run-in Period, Weeks -12-0|Adverse Event|0
2629986|NCT00856973|9088338|P3|Overall Study|Other|13
2629987|NCT00856973|9088339|P2|Overall Study|Other|12
2629988|NCT00856973|9088340|P1|Overall Study|Other|11
2629989|NCT00856973|9088338|P3|Overall Study|Withdrawal by Subject|15
2629990|NCT00856973|9088339|P2|Overall Study|Withdrawal by Subject|16
2629991|NCT00856973|9088340|P1|Overall Study|Withdrawal by Subject|13
2629992|NCT00856973|9088338|P3|Overall Study|Protocol Violation|1
2629993|NCT00856973|9088339|P2|Overall Study|Protocol Violation|2
2629994|NCT00856973|9088340|P1|Overall Study|Protocol Violation|1
2629995|NCT00856973|9088338|P3|Overall Study|Physician Decision|1
2629996|NCT00856973|9088339|P2|Overall Study|Physician Decision|3
2629997|NCT00856973|9088340|P1|Overall Study|Physician Decision|0
2629998|NCT00856973|9088338|P3|Overall Study|Lost to Follow-up|5
2629999|NCT00856973|9088339|P2|Overall Study|Lost to Follow-up|3
2630000|NCT00856973|9088340|P1|Overall Study|Lost to Follow-up|6
2630001|NCT00856973|9088338|P3|Overall Study|Adverse Event|3
2630002|NCT00856973|9088339|P2|Overall Study|Adverse Event|5
2630003|NCT00856973|9088340|P1|Overall Study|Adverse Event|5
2630004|NCT00856908|9088420|P2|Overall Study|Lost to Follow-up|0
2630005|NCT00856908|9088421|P1|Overall Study|Lost to Follow-up|1
2630006|NCT00856856|9088446|P1|4-year Clinical Follow-up|Missed visit|1
2630007|NCT00856856|9088446|P1|2-year Clinical Follow-up|Lost to Follow-up|1
2630008|NCT00856843|9088645|P2|Overall Study|Lack of Efficacy|0
2630009|NCT00856843|9088646|P1|Overall Study|Lack of Efficacy|1
2630010|NCT00856843|9088645|P2|Overall Study|Withdrawal by Subject|5
2630011|NCT00856843|9088646|P1|Overall Study|Withdrawal by Subject|1
2630012|NCT00856830|9088682|P4|Irinotecan & Bendamustine|Physician Decision|1
2630013|NCT00856830|9088683|P3|Irinotecan & Bendamustine|Physician Decision|0
2630014|NCT00856830|9088684|P2|Irinotecan & Bendamustine|Physician Decision|0
2630015|NCT00856830|9088685|P1|Irinotecan & Bendamustine|Physician Decision|0
2630016|NCT00856830|9088682|P4|Irinotecan & Bendamustine|Death|2
2630017|NCT00856830|9088683|P3|Irinotecan & Bendamustine|Death|0
2630018|NCT00856830|9088684|P2|Irinotecan & Bendamustine|Death|0
2630019|NCT00856830|9088685|P1|Irinotecan & Bendamustine|Death|0
2630020|NCT00856778|9088696|P1|Overall Study|Lost to Follow-up|5
2630021|NCT00856778|9088696|P1|Overall Study|Study deviation|2
2630022|NCT00856778|9088696|P1|Overall Study|Withdrawal by Subject|10
2630023|NCT00856778|9088696|P1|Overall Study|Adverse Event|7
2630024|NCT00856661|9088739|P2|Overall Study|Physician Judgement|5
2630025|NCT00856661|9088740|P1|Overall Study|Physician Judgement|8
2630026|NCT00856661|9088739|P2|Overall Study|Lost to Follow-up|3
2630027|NCT00856661|9088740|P1|Overall Study|Lost to Follow-up|1
2630028|NCT00856661|9088739|P2|Overall Study|Withdrawal by Subject|2
2630029|NCT00856661|9088740|P1|Overall Study|Withdrawal by Subject|1
2630030|NCT00856661|9088739|P2|Overall Study|Protocol Violation|1
2630031|NCT00856661|9088740|P1|Overall Study|Protocol Violation|2
2630032|NCT00856661|9088739|P2|Overall Study|Death|18
2630033|NCT00856661|9088740|P1|Overall Study|Death|15
2630034|NCT00856635|9088754|P2|Overall Study|Discontinued at Randomization|2
2630035|NCT00856635|9088755|P1|Overall Study|Discontinued at Randomization|2
2630036|NCT00856635|9088754|P2|Overall Study|Other|0
2630037|NCT00856635|9088755|P1|Overall Study|Other|1
2630038|NCT00856635|9088754|P2|Overall Study|Serious Adverse Event|0
2630039|NCT00856635|9088755|P1|Overall Study|Serious Adverse Event|1
2630040|NCT00856635|9088754|P2|Overall Study|Withdrawal by Subject|1
2630041|NCT00856635|9088755|P1|Overall Study|Withdrawal by Subject|3
2630042|NCT00856635|9088754|P2|Overall Study|Pregnancy|0
2630043|NCT00856635|9088755|P1|Overall Study|Pregnancy|1
2630044|NCT00856635|9088754|P2|Overall Study|Lost to Follow-up|5
2630045|NCT00856635|9088755|P1|Overall Study|Lost to Follow-up|2
2630046|NCT00856609|9088765|P2|Overall Study|Adverse Event|0
2630047|NCT00856609|9088766|P1|Overall Study|Adverse Event|1
2630048|NCT00856583|9088778|P2|Overall Study|Non-evaluable: Patient on Polytherapy|604
2630049|NCT00856583|9088779|P1|Overall Study|Non-evaluable: Patient on Polytherapy|694
2630050|NCT00856583|9088778|P2|Overall Study|Other|104
2630051|NCT00856583|9088779|P1|Overall Study|Other|92
2630052|NCT00856583|9088778|P2|Overall Study|Pregnancy|5
2630053|NCT00856583|9088779|P1|Overall Study|Pregnancy|14
2630054|NCT00856583|9088778|P2|Overall Study|Physician Decision|82
2630055|NCT00856583|9088779|P1|Overall Study|Physician Decision|59
2630056|NCT00856583|9088778|P2|Overall Study|Withdrawal by Subject|919
2630057|NCT00856583|9088779|P1|Overall Study|Withdrawal by Subject|1092
2630058|NCT00856583|9088778|P2|Overall Study|Non-compliance|262
2630059|NCT00856583|9088779|P1|Overall Study|Non-compliance|305
2630060|NCT00856583|9088778|P2|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179
2630061|NCT00856583|9088779|P1|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393
2630062|NCT00856583|9088778|P2|Overall Study|Serious Adverse Event (SAE)|65
2630063|NCT00856583|9088779|P1|Overall Study|Serious Adverse Event (SAE)|99
2630064|NCT00856583|9088778|P2|Overall Study|Lack of Efficacy|377
2630065|NCT00856583|9088779|P1|Overall Study|Lack of Efficacy|389
2630066|NCT00856557|9088809|P2|Overall Study|No patients with contextual flags|16
2630067|NCT00856557|9088810|P1|Overall Study|No patients with contextual flags|12
2630068|NCT00856544|9088824|P4|Overall Study|Withdrawal by Subject|1
2630069|NCT00856544|9088825|P3|Overall Study|Withdrawal by Subject|0
2630070|NCT00856544|9088826|P2|Overall Study|Withdrawal by Subject|5
2630071|NCT00856544|9088827|P1|Overall Study|Withdrawal by Subject|8
2630072|NCT00856544|9088824|P4|Overall Study|Lost to Follow-up|0
2630073|NCT00856544|9088825|P3|Overall Study|Lost to Follow-up|2
2630074|NCT00856544|9088826|P2|Overall Study|Lost to Follow-up|2
2630075|NCT00856544|9088827|P1|Overall Study|Lost to Follow-up|1
2630076|NCT00856544|9088824|P4|Overall Study|Other|6
2630077|NCT00856544|9088825|P3|Overall Study|Other|1
2630078|NCT00856544|9088826|P2|Overall Study|Other|16
2630079|NCT00856544|9088827|P1|Overall Study|Other|9
2630080|NCT00856544|9088824|P4|Overall Study|Lack of Efficacy|3
2630081|NCT00856544|9088825|P3|Overall Study|Lack of Efficacy|3
2630082|NCT00856544|9088826|P2|Overall Study|Lack of Efficacy|12
2630083|NCT00856544|9088827|P1|Overall Study|Lack of Efficacy|16
2630084|NCT00856544|9088824|P4|Overall Study|Adverse Event|3
2630085|NCT00856544|9088825|P3|Overall Study|Adverse Event|2
2630086|NCT00856544|9088826|P2|Overall Study|Adverse Event|29
2630087|NCT00856544|9088827|P1|Overall Study|Adverse Event|20
2630088|NCT00856544|9088824|P4|Overall Study|Death|0
2630089|NCT00856544|9088825|P3|Overall Study|Death|0
2630090|NCT00856544|9088826|P2|Overall Study|Death|2
2630091|NCT00856544|9088827|P1|Overall Study|Death|0
2630092|NCT00856544|9088824|P4|Overall Study|Randomized but not treated|0
2630093|NCT00856544|9088825|P3|Overall Study|Randomized but not treated|0
2630094|NCT00856544|9088826|P2|Overall Study|Randomized but not treated|0
2630095|NCT00856544|9088827|P1|Overall Study|Randomized but not treated|3
2630096|NCT00856518|9089006|P2|Overall Study|Lost to Follow-up|2
2630097|NCT00856518|9089007|P1|Overall Study|Lost to Follow-up|4
2630098|NCT00856492|9089020|P3|Overall Study|Ineligible or withdrew consent|2
2630099|NCT00856492|9089021|P2|Overall Study|Ineligible or withdrew consent|1
2630100|NCT00856492|9089022|P1|Overall Study|Ineligible or withdrew consent|1
2630101|NCT00856388|9089044|P1|Overall Study|Other|1
2630102|NCT00856349|9089055|P1|Overall Study|Subject changed Dr, insurance issue, etc|130
2630103|NCT00856349|9089055|P1|Overall Study|Site closure|78
2630104|NCT00856349|9089055|P1|Overall Study|Device explant|33
2630105|NCT00856349|9089055|P1|Overall Study|Subject relocation|104
2630106|NCT00856349|9089055|P1|Overall Study|Physician Decision|13
2630107|NCT00856349|9089055|P1|Overall Study|Protocol Violation|38
2630108|NCT00856349|9089055|P1|Overall Study|Lost to Follow-up|91
2630109|NCT00856349|9089055|P1|Overall Study|Withdrawal by Subject|116
2630110|NCT00856349|9089055|P1|Overall Study|Death|418
2630111|NCT00856323|9089064|P1|Overall Study|Withdrawal by Subject|2
2630112|NCT00856297|9089076|P5|Overall Study|Unable to classify|0
2630113|NCT00856297|9089077|P4|Overall Study|Unable to classify|0
2630114|NCT00856297|9089078|P3|Overall Study|Unable to classify|0
2630115|NCT00856297|9089079|P2|Overall Study|Unable to classify|0
2630116|NCT00856297|9089080|P1|Overall Study|Unable to classify|2
2630117|NCT00856284|9089113|P3|Overall Study|Randomized in error|1
2630118|NCT00856284|9089114|P2|Overall Study|Randomized in error|0
2630119|NCT00856284|9089115|P1|Overall Study|Randomized in error|0
2630120|NCT00856284|9089113|P3|Overall Study|Other|14
2630121|NCT00856284|9089114|P2|Overall Study|Other|17
2630122|NCT00856284|9089115|P1|Overall Study|Other|15
2630123|NCT00856284|9089113|P3|Overall Study|Investigator discretion|10
2630124|NCT00856284|9089114|P2|Overall Study|Investigator discretion|8
2630125|NCT00856284|9089115|P1|Overall Study|Investigator discretion|9
2630126|NCT00856284|9089113|P3|Overall Study|Pregnancy|0
2630127|NCT00856284|9089114|P2|Overall Study|Pregnancy|2
2630128|NCT00856284|9089115|P1|Overall Study|Pregnancy|1
2630129|NCT00856284|9089113|P3|Overall Study|Voluntary withdrawal|62
2630130|NCT00856284|9089114|P2|Overall Study|Voluntary withdrawal|52
2630131|NCT00856284|9089115|P1|Overall Study|Voluntary withdrawal|48
2630132|NCT00856284|9089113|P3|Overall Study|Lost to Follow-up|28
2630133|NCT00856284|9089114|P2|Overall Study|Lost to Follow-up|22
2630134|NCT00856284|9089115|P1|Overall Study|Lost to Follow-up|20
2630135|NCT00856284|9089113|P3|Overall Study|Major protocol deviation|15
2630136|NCT00856284|9089114|P2|Overall Study|Major protocol deviation|16
2630137|NCT00856284|9089115|P1|Overall Study|Major protocol deviation|24
2630138|NCT00856284|9089113|P3|Overall Study|Adverse Event|82
2630139|NCT00856284|9089114|P2|Overall Study|Adverse Event|74
2630140|NCT00856284|9089115|P1|Overall Study|Adverse Event|60
2630141|NCT00856284|9089113|P3|Overall Study|Hyperglycemic rescue|235
2630142|NCT00856284|9089114|P2|Overall Study|Hyperglycemic rescue|201
2630143|NCT00856284|9089115|P1|Overall Study|Hyperglycemic rescue|231
2630144|NCT00856245|9089141|P1|Overall Study|Was not transplanted|5
2630145|NCT00856206|9089164|P2|Overall Study|Other than specified above|10
2630146|NCT00856206|9089165|P1|Overall Study|Other than specified above|3
2630147|NCT00856206|9089164|P2|Overall Study|Decision by the Sponsor|8
2630148|NCT00856206|9089165|P1|Overall Study|Decision by the Sponsor|4
2630149|NCT00856206|9089164|P2|Overall Study|Death|2
2630150|NCT00856206|9089165|P1|Overall Study|Death|2
2630151|NCT00856206|9089164|P2|Overall Study|Lost to Follow-up|39
2630152|NCT00856206|9089165|P1|Overall Study|Lost to Follow-up|13
2630153|NCT00856206|9089164|P2|Overall Study|Withdrawal by Subject|36
2630154|NCT00856206|9089165|P1|Overall Study|Withdrawal by Subject|15
2630155|NCT00856206|9089164|P2|Overall Study|Lack of Efficacy|2
2630156|NCT00856206|9089165|P1|Overall Study|Lack of Efficacy|1
2630157|NCT00856206|9089164|P2|Overall Study|Adverse Event|46
2630158|NCT00856206|9089165|P1|Overall Study|Adverse Event|10
2630159|NCT00856206|9089164|P2|Overall Study|Protocol Violation|18
2630160|NCT00856206|9089165|P1|Overall Study|Protocol Violation|6
2630161|NCT00856193|9089179|P2|Period 2|Lost to Follow-up|1
2630162|NCT00856193|9089180|P1|Period 2|Lost to Follow-up|0
2630163|NCT00856193|9089179|P2|Period 2|Abnormal test procedure results|1
2630164|NCT00856193|9089180|P1|Period 2|Abnormal test procedure results|0
2630165|NCT00856180|9089192|P1|Overall Study|Progressive Disease|16
2630166|NCT00856180|9089192|P1|Overall Study|Adverse Event|4
2630167|NCT00855959|9089217|P1|Overall Study|Incorrect enrolment|1
2630168|NCT00855959|9089217|P1|Overall Study|Pregnancy|1
2630169|NCT00855959|9089217|P1|Overall Study|Withdrawal by Subject|3
2630170|NCT00855959|9089217|P1|Overall Study|Lost to Follow-up|2
2630171|NCT00855959|9089217|P1|Overall Study|Adverse Event|2
2630172|NCT00855933|9089234|P2|Overall Study|Withdrawal by Subject|1
2630173|NCT00855933|9089235|P1|Overall Study|Withdrawal by Subject|0
2630174|NCT00855920|9089244|P3|Overall Study|Other than specified above|1
2630175|NCT00855920|9089245|P2|Overall Study|Other than specified above|1
2630176|NCT00855920|9089246|P1|Overall Study|Other than specified above|1
2630177|NCT00855920|9089244|P3|Overall Study|Decision by the sponsor|1
2630178|NCT00855920|9089245|P2|Overall Study|Decision by the sponsor|1
2630179|NCT00855920|9089246|P1|Overall Study|Decision by the sponsor|0
2630180|NCT00855920|9089244|P3|Overall Study|Death|0
2630181|NCT00855920|9089245|P2|Overall Study|Death|1
2630182|NCT00855920|9089246|P1|Overall Study|Death|0
2630183|NCT00855920|9089244|P3|Overall Study|Lost to Follow-up|2
2630184|NCT00855920|9089245|P2|Overall Study|Lost to Follow-up|0
2630185|NCT00855920|9089246|P1|Overall Study|Lost to Follow-up|1
2630186|NCT00855920|9089244|P3|Overall Study|Withdrawal by Subject|2
2630187|NCT00855920|9089245|P2|Overall Study|Withdrawal by Subject|3
2630188|NCT00855920|9089246|P1|Overall Study|Withdrawal by Subject|2
2630189|NCT00855920|9089244|P3|Overall Study|Lack of Efficacy|2
2630190|NCT00855920|9089245|P2|Overall Study|Lack of Efficacy|2
2630191|NCT00855920|9089246|P1|Overall Study|Lack of Efficacy|2
2630192|NCT00855920|9089244|P3|Overall Study|Adverse Event|1
2630193|NCT00855920|9089245|P2|Overall Study|Adverse Event|1
2630194|NCT00855920|9089246|P1|Overall Study|Adverse Event|2
2630195|NCT00855920|9089244|P3|Overall Study|Protocol Violation|2
2630196|NCT00855920|9089245|P2|Overall Study|Protocol Violation|0
2630197|NCT00855920|9089246|P1|Overall Study|Protocol Violation|0
2630198|NCT00855894|9089263|P1|Overall Study|Disease progression|1
2630199|NCT00855894|9089263|P1|Overall Study|Patient's decision|1
2630200|NCT00855894|9089263|P1|Overall Study|Death|31
2630201|NCT00855816|9089286|P2|Overall Study|Became ineligible|1
2630202|NCT00855816|9089287|P1|Overall Study|Became ineligible|0
2630203|NCT00855816|9089286|P2|Overall Study|Death|0
2630204|NCT00855816|9089287|P1|Overall Study|Death|1
2630205|NCT00855816|9089286|P2|Overall Study|Lost to Follow-up|5
2630206|NCT00855816|9089287|P1|Overall Study|Lost to Follow-up|3
2630207|NCT00855816|9089286|P2|Overall Study|Withdrawal by Subject|15
2630208|NCT00855816|9089287|P1|Overall Study|Withdrawal by Subject|22
2630209|NCT00855738|9089293|P1|Overall Study|Death|1
2630210|NCT00855738|9089293|P1|Overall Study|Subject Defaulted|1
2630211|NCT00855738|9089293|P1|Overall Study|Adverse Event|1
2630212|NCT00855738|9089293|P1|Overall Study|Lost to Follow-up|2
2630213|NCT00855595|9089321|P2|Overall Study|patient left country|1
2630214|NCT00855595|9089322|P1|Overall Study|patient left country|0
2630215|NCT00855595|9089321|P2|Overall Study|patient moved out of state|0
2630216|NCT00855595|9089322|P1|Overall Study|patient moved out of state|1
2630217|NCT00855595|9089321|P2|Overall Study|Adverse Event|1
2630218|NCT00855595|9089322|P1|Overall Study|Adverse Event|1
2630219|NCT00855595|9089321|P2|Overall Study|Lost to Follow-up|3
2630220|NCT00855595|9089322|P1|Overall Study|Lost to Follow-up|3
2630221|NCT00855595|9089321|P2|Overall Study|Withdrawal by Subject|2
2630222|NCT00855595|9089322|P1|Overall Study|Withdrawal by Subject|1
2630223|NCT00855582|9089361|P3|Overall Study|Withdrawal by Subject|8
2630224|NCT00855582|9089362|P2|Overall Study|Withdrawal by Subject|4
2630225|NCT00855582|9089363|P1|Overall Study|Withdrawal by Subject|7
2630226|NCT00855582|9089361|P3|Overall Study|Entry Criteria Not Met|3
2630227|NCT00855582|9089362|P2|Overall Study|Entry Criteria Not Met|6
2630228|NCT00855582|9089363|P1|Overall Study|Entry Criteria Not Met|8
2630229|NCT00855582|9089361|P3|Overall Study|Protocol Violation|6
2630230|NCT00855582|9089362|P2|Overall Study|Protocol Violation|2
2630231|NCT00855582|9089363|P1|Overall Study|Protocol Violation|6
2630232|NCT00855582|9089361|P3|Overall Study|Physician Decision|1
2630233|NCT00855582|9089362|P2|Overall Study|Physician Decision|0
2630234|NCT00855582|9089363|P1|Overall Study|Physician Decision|0
2630235|NCT00855582|9089361|P3|Overall Study|Lost to Follow-up|1
2630236|NCT00855582|9089362|P2|Overall Study|Lost to Follow-up|3
2630237|NCT00855582|9089363|P1|Overall Study|Lost to Follow-up|1
2630238|NCT00855582|9089361|P3|Overall Study|Lack of Efficacy|8
2630239|NCT00855582|9089362|P2|Overall Study|Lack of Efficacy|3
2630240|NCT00855582|9089363|P1|Overall Study|Lack of Efficacy|1
2630241|NCT00855582|9089361|P3|Overall Study|Death|0
2630242|NCT00855582|9089362|P2|Overall Study|Death|0
2630243|NCT00855582|9089363|P1|Overall Study|Death|1
2630244|NCT00855582|9089361|P3|Overall Study|Adverse Event|3
2630245|NCT00855582|9089362|P2|Overall Study|Adverse Event|6
2630246|NCT00855582|9089363|P1|Overall Study|Adverse Event|2
2630247|NCT00855465|9089452|P2|Follow-up Period (FUP)|Missing|0
2630248|NCT00855465|9089453|P1|Follow-up Period (FUP)|Missing|1
2630249|NCT00855465|9089452|P2|Follow-up Period (FUP)|Withdrawal by Subject|0
2630250|NCT00855465|9089453|P1|Follow-up Period (FUP)|Withdrawal by Subject|4
2630251|NCT00855465|9089452|P2|Follow-up Period (FUP)|Lost to Follow-up|0
2630252|NCT00855465|9089453|P1|Follow-up Period (FUP)|Lost to Follow-up|3
2630253|NCT00855465|9089452|P2|Follow-up Period (FUP)|Death|1
2630254|NCT00855465|9089453|P1|Follow-up Period (FUP)|Death|0
2630255|NCT00855465|9089452|P2|Follow-up Period (FUP)|Adverse Event|1
2630256|NCT00855465|9089453|P1|Follow-up Period (FUP)|Adverse Event|0
2630257|NCT00855465|9089452|P2|Treatment Period|Not treated|0
2630258|NCT00855465|9089453|P1|Treatment Period|Not treated|1
2630259|NCT00855465|9089452|P2|Treatment Period|Withdrawal by Subject|0
2630260|NCT00855465|9089453|P1|Treatment Period|Withdrawal by Subject|2
2630261|NCT00855465|9089452|P2|Treatment Period|Protocol Violation|0
2630262|NCT00855465|9089453|P1|Treatment Period|Protocol Violation|2
2630263|NCT00855465|9089452|P2|Treatment Period|Non-compliance|0
2630264|NCT00855465|9089453|P1|Treatment Period|Non-compliance|1
2630265|NCT00855465|9089452|P2|Treatment Period|Lack of Efficacy|1
2630266|NCT00855465|9089453|P1|Treatment Period|Lack of Efficacy|2
2630267|NCT00855465|9089452|P2|Treatment Period|Death|2
2630268|NCT00855465|9089453|P1|Treatment Period|Death|2
2630269|NCT00855465|9089452|P2|Treatment Period|Adverse Event|2
2630270|NCT00855465|9089453|P1|Treatment Period|Adverse Event|4
2630271|NCT00855439|9089543|P2|Overall Study|Pregnancy|0
2630272|NCT00855439|9089544|P1|Overall Study|Pregnancy|1
2630273|NCT00855439|9089543|P2|Overall Study|Withdrawal by Subject|0
2630274|NCT00855439|9089544|P1|Overall Study|Withdrawal by Subject|2
2630275|NCT00855335|9089602|P5|Overall Study|Other|1
2630276|NCT00855335|9089603|P4|Overall Study|Other|5
2630277|NCT00855335|9089604|P3|Overall Study|Other|2
2630278|NCT00855335|9089605|P2|Overall Study|Other|1
2630279|NCT00855335|9089606|P1|Overall Study|Other|2
2630280|NCT00855335|9089602|P5|Overall Study|Physician Decision|0
2630281|NCT00855335|9089603|P4|Overall Study|Physician Decision|0
2630282|NCT00855335|9089604|P3|Overall Study|Physician Decision|0
2630283|NCT00855335|9089605|P2|Overall Study|Physician Decision|1
2630284|NCT00855335|9089606|P1|Overall Study|Physician Decision|1
2630285|NCT00855335|9089602|P5|Overall Study|Adverse Event|0
2630286|NCT00855335|9089603|P4|Overall Study|Adverse Event|0
2630287|NCT00855335|9089604|P3|Overall Study|Adverse Event|0
2630288|NCT00855335|9089605|P2|Overall Study|Adverse Event|0
2630289|NCT00855335|9089606|P1|Overall Study|Adverse Event|2
2630290|NCT00855335|9089602|P5|Overall Study|Withdrawal by Subject|0
2630291|NCT00855335|9089603|P4|Overall Study|Withdrawal by Subject|1
2630292|NCT00855335|9089604|P3|Overall Study|Withdrawal by Subject|0
2630293|NCT00855335|9089605|P2|Overall Study|Withdrawal by Subject|0
2630294|NCT00855335|9089606|P1|Overall Study|Withdrawal by Subject|0
2630295|NCT00855335|9089602|P5|Overall Study|Lost to Follow-up|0
2630296|NCT00855335|9089603|P4|Overall Study|Lost to Follow-up|1
2630297|NCT00855335|9089604|P3|Overall Study|Lost to Follow-up|3
2630298|NCT00855335|9089605|P2|Overall Study|Lost to Follow-up|0
2630299|NCT00855335|9089606|P1|Overall Study|Lost to Follow-up|0
2630300|NCT00855309|9089693|P2|Overall Study|patient never recieved drug|0
2630301|NCT00855309|9089694|P1|Overall Study|patient never recieved drug|1
2630302|NCT00855218|9089702|P2|Overall Study|Clinical endpoint reached|13
2630303|NCT00855218|9089703|P1|Overall Study|Clinical endpoint reached|10
2630304|NCT00855218|9089702|P2|Overall Study|Progression measurement proven|15
2630305|NCT00855218|9089703|P1|Overall Study|Progression measurement proven|7
2630306|NCT00855218|9089702|P2|Overall Study|Second malignancy|1
2630307|NCT00855218|9089703|P1|Overall Study|Second malignancy|0
2630308|NCT00855218|9089702|P2|Overall Study|Untreatable disease progression|67
2630309|NCT00855218|9089703|P1|Overall Study|Untreatable disease progression|54
2630310|NCT00855218|9089702|P2|Overall Study|Still treated with study medication|1
2630311|NCT00855218|9089703|P1|Overall Study|Still treated with study medication|0
2630312|NCT00855218|9089702|P2|Overall Study|technical problems|1
2630313|NCT00855218|9089703|P1|Overall Study|technical problems|2
2630314|NCT00855218|9089702|P2|Overall Study|patient convenience|0
2630315|NCT00855218|9089703|P1|Overall Study|patient convenience|2
2630316|NCT00855218|9089702|P2|Overall Study|non-compliant with study drug|1
2630317|NCT00855218|9089703|P1|Overall Study|non-compliant with study drug|3
2630318|NCT00855218|9089702|P2|Overall Study|Protocol Violation|9
2630319|NCT00855218|9089703|P1|Overall Study|Protocol Violation|5
2630320|NCT00855218|9089702|P2|Overall Study|Lost to Follow-up|1
2630321|NCT00855218|9089703|P1|Overall Study|Lost to Follow-up|0
2630322|NCT00855218|9089702|P2|Overall Study|Physician Decision|11
2630323|NCT00855218|9089703|P1|Overall Study|Physician Decision|18
2630324|NCT00855218|9089702|P2|Overall Study|Withdrawal by Subject|6
2630325|NCT00855218|9089703|P1|Overall Study|Withdrawal by Subject|10
2630326|NCT00855218|9089702|P2|Overall Study|Adverse Event|27
2630327|NCT00855218|9089703|P1|Overall Study|Adverse Event|43
2630328|NCT00855166|9089721|P2|Overall Study|Subject no longer meets study criteria|1
2630329|NCT00855166|9089722|P1|Overall Study|Subject no longer meets study criteria|1
2630330|NCT00855166|9089721|P2|Overall Study|Administrative reasons by sponsor|0
2630331|NCT00855166|9089722|P1|Overall Study|Administrative reasons by sponsor|1
2630332|NCT00855166|9089721|P2|Overall Study|Poor/non-compliance|0
2630333|NCT00855166|9089722|P1|Overall Study|Poor/non-compliance|2
2630334|NCT00855166|9089721|P2|Overall Study|Withdrawal by Subject|4
2630335|NCT00855166|9089722|P1|Overall Study|Withdrawal by Subject|1
2630336|NCT00855166|9089721|P2|Overall Study|Death|1
2630337|NCT00855166|9089722|P1|Overall Study|Death|0
2630338|NCT00855166|9089721|P2|Overall Study|Adverse Event|2
2630339|NCT00855166|9089722|P1|Overall Study|Adverse Event|0
2630340|NCT00855062|9089742|P2|Step2|Initiation of antiretroviral therapy/ART|1
2630341|NCT00855062|9089743|P1|Step2|Initiation of antiretroviral therapy/ART|0
2630342|NCT00855062|9089742|P2|Step2|Adverse Event|3
2630343|NCT00855062|9089743|P1|Step2|Adverse Event|0
2630344|NCT00855062|9089742|P2|Step2|Early Study Closure|2
2630345|NCT00855062|9089743|P1|Step2|Early Study Closure|6
2630346|NCT00855062|9089742|P2|Step1|Withdrawal by Subject|3
2630347|NCT00855062|9089743|P1|Step1|Withdrawal by Subject|2
2630348|NCT00855062|9089742|P2|Step1|Pregnancy|0
2630349|NCT00855062|9089743|P1|Step1|Pregnancy|1
2630350|NCT00855062|9089742|P2|Step1|Protocol Violation|0
2630351|NCT00855062|9089743|P1|Step1|Protocol Violation|1
2630352|NCT00855062|9089742|P2|Step1|Adverse Event|1
2630353|NCT00855062|9089743|P1|Step1|Adverse Event|1
2630354|NCT00855062|9089742|P2|Step1|Early Study Closure|7
2630355|NCT00855062|9089743|P1|Step1|Early Study Closure|5
2630356|NCT00854906|9089792|P1|Overall Study|One person had no ocular history|1
2630357|NCT00854724|9089801|P2|Second Intervention|Physician Decision|1
2630358|NCT00854724|9089802|P1|Second Intervention|Physician Decision|0
2630359|NCT00854724|9089801|P2|Second Intervention|Protocol Violation|0
2630360|NCT00854724|9089802|P1|Second Intervention|Protocol Violation|1
2630361|NCT00854724|9089801|P2|Washout|Withdrawal by Subject|1
2630362|NCT00854724|9089802|P1|Washout|Withdrawal by Subject|0
2630363|NCT00854724|9089801|P2|Washout|Protocol Violation|0
2630364|NCT00854724|9089802|P1|Washout|Protocol Violation|1
2630365|NCT00854724|9089801|P2|First Intervention|Withdrawal by Subject|1
2630366|NCT00854724|9089802|P1|First Intervention|Withdrawal by Subject|1
2630367|NCT00854620|9089808|P1|Overall Study|Adverse Event|1
2630368|NCT00854607|9089812|P1|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65
2630369|NCT00854581|9089860|P1|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3
2630370|NCT00854581|9089860|P1|Induction (Up to Day 21)|Physician Decision|1
2630371|NCT00854581|9089860|P1|Induction (Up to Day 21)|Death|1
2630372|NCT00854581|9089860|P1|Induction (Up to Day 21)|Lack of Efficacy|4
2630373|NCT00854373|9089875|P2|Overall Study|Forgot to take study drug|1
2630374|NCT00854373|9089876|P1|Overall Study|Forgot to take study drug|1
2630375|NCT00854373|9089875|P2|Overall Study|Withdrawal by Subject|3
2630376|NCT00854373|9089876|P1|Overall Study|Withdrawal by Subject|1
2630377|NCT00854360|9089890|P4|Overall Study|Other|3
2630378|NCT00854360|9089891|P3|Overall Study|Other|0
2630379|NCT00854360|9089892|P2|Overall Study|Other|0
2630380|NCT00854360|9089893|P1|Overall Study|Other|0
2630381|NCT00854360|9089890|P4|Overall Study|Lack of Efficacy|0
2630382|NCT00854360|9089891|P3|Overall Study|Lack of Efficacy|0
2630383|NCT00854360|9089892|P2|Overall Study|Lack of Efficacy|1
2630384|NCT00854360|9089893|P1|Overall Study|Lack of Efficacy|2
2630385|NCT00854360|9089890|P4|Overall Study|Pregnancy|0
2630386|NCT00854360|9089891|P3|Overall Study|Pregnancy|0
2630387|NCT00854360|9089892|P2|Overall Study|Pregnancy|1
2630388|NCT00854360|9089893|P1|Overall Study|Pregnancy|0
2630389|NCT00854360|9089890|P4|Overall Study|Withdrawal by Subject|1
2630390|NCT00854360|9089891|P3|Overall Study|Withdrawal by Subject|0
2630391|NCT00854360|9089892|P2|Overall Study|Withdrawal by Subject|0
2630392|NCT00854360|9089893|P1|Overall Study|Withdrawal by Subject|0
2630393|NCT00854360|9089890|P4|Overall Study|Adverse Event|6
2630394|NCT00854360|9089891|P3|Overall Study|Adverse Event|2
2630395|NCT00854360|9089892|P2|Overall Study|Adverse Event|1
2630396|NCT00854360|9089893|P1|Overall Study|Adverse Event|0
2630397|NCT00854308|9089925|P2|Overall Study|Sponsor's decision to terminate study|1
2630398|NCT00854308|9089926|P1|Overall Study|Sponsor's decision to terminate study|0
2630399|NCT00854308|9089925|P2|Overall Study|Withdrawal by Subject|2
2630400|NCT00854308|9089926|P1|Overall Study|Withdrawal by Subject|4
2630401|NCT00854308|9089925|P2|Overall Study|Physician Decision|6
2630402|NCT00854308|9089926|P1|Overall Study|Physician Decision|6
2630403|NCT00854308|9089925|P2|Overall Study|Death|5
2630404|NCT00854308|9089926|P1|Overall Study|Death|2
2630405|NCT00854308|9089925|P2|Overall Study|Adverse Event|3
2630406|NCT00854308|9089926|P1|Overall Study|Adverse Event|8
2630407|NCT00854308|9089925|P2|Overall Study|Disease progression|50
2630408|NCT00854308|9089926|P1|Overall Study|Disease progression|42
2630409|NCT00854113|9089951|P11|Overall Study|Withdrawal by Subject|0
2630410|NCT00854113|9089952|P10|Overall Study|Withdrawal by Subject|0
2630411|NCT00854113|9089953|P9|Overall Study|Withdrawal by Subject|1
2630412|NCT00854113|9089954|P8|Overall Study|Withdrawal by Subject|1
2630413|NCT00854113|9089955|P7|Overall Study|Withdrawal by Subject|0
2630414|NCT00854113|9089956|P6|Overall Study|Withdrawal by Subject|0
2630415|NCT00854113|9089957|P5|Overall Study|Withdrawal by Subject|0
2630416|NCT00854113|9089958|P4|Overall Study|Withdrawal by Subject|0
2630417|NCT00854113|9089959|P3|Overall Study|Withdrawal by Subject|0
2630418|NCT00854113|9089960|P2|Overall Study|Withdrawal by Subject|0
2630419|NCT00854113|9089961|P1|Overall Study|Withdrawal by Subject|0
2630420|NCT00854113|9089951|P11|Overall Study|Adverse Event|0
2630421|NCT00854113|9089952|P10|Overall Study|Adverse Event|0
2630422|NCT00854113|9089953|P9|Overall Study|Adverse Event|0
2630423|NCT00854113|9089954|P8|Overall Study|Adverse Event|2
2630424|NCT00854113|9089955|P7|Overall Study|Adverse Event|0
2630425|NCT00854113|9089956|P6|Overall Study|Adverse Event|0
2630426|NCT00854113|9089957|P5|Overall Study|Adverse Event|0
2630427|NCT00854113|9089958|P4|Overall Study|Adverse Event|0
2630428|NCT00854113|9089959|P3|Overall Study|Adverse Event|0
2630429|NCT00854113|9089960|P2|Overall Study|Adverse Event|0
2630430|NCT00854113|9089961|P1|Overall Study|Adverse Event|0
2630431|NCT00854100|9090065|P3|Overall Study|Adverse Event|2
2630432|NCT00854100|9090066|P2|Overall Study|Adverse Event|1
2630433|NCT00854100|9090067|P1|Overall Study|Adverse Event|2
2630434|NCT00854100|9090065|P3|Overall Study|Protocol Violation|3
2630435|NCT00854100|9090066|P2|Overall Study|Protocol Violation|4
2630436|NCT00854100|9090067|P1|Overall Study|Protocol Violation|2
2630437|NCT00854100|9090065|P3|Overall Study|Withdrawal by Subject|2
2630438|NCT00854100|9090066|P2|Overall Study|Withdrawal by Subject|1
2630439|NCT00854100|9090067|P1|Overall Study|Withdrawal by Subject|3
2630440|NCT00854100|9090065|P3|Overall Study|Lost to Follow-up|3
2630441|NCT00854100|9090066|P2|Overall Study|Lost to Follow-up|0
2630442|NCT00854100|9090067|P1|Overall Study|Lost to Follow-up|2
2630443|NCT00854100|9090065|P3|Overall Study|Inability to complete the study visits|1
2630444|NCT00854100|9090066|P2|Overall Study|Inability to complete the study visits|0
2630445|NCT00854100|9090067|P1|Overall Study|Inability to complete the study visits|0
2630446|NCT00853970|9090100|P2|Overall Study|Cancelled surgery|2
2630447|NCT00853970|9090101|P1|Overall Study|Cancelled surgery|4
2630448|NCT00853970|9090100|P2|Overall Study|Withdrawal by Subject|1
2630449|NCT00853970|9090101|P1|Overall Study|Withdrawal by Subject|2
2630450|NCT00853957|9090111|P2|Overall Study|Protocol deviation|3
2630451|NCT00853957|9090112|P1|Overall Study|Protocol deviation|0
2630452|NCT00853957|9090111|P2|Overall Study|Lost to Follow-up|6
2630453|NCT00853957|9090112|P1|Overall Study|Lost to Follow-up|1
2630454|NCT00853957|9090111|P2|Overall Study|Subject withdrew consent|5
2630455|NCT00853957|9090112|P1|Overall Study|Subject withdrew consent|4
2630456|NCT00853957|9090111|P2|Overall Study|Unsatisfactory therapeutic effect|2
2630457|NCT00853957|9090112|P1|Overall Study|Unsatisfactory therapeutic effect|0
2630458|NCT00853957|9090111|P2|Overall Study|Adverse Event|3
2630459|NCT00853957|9090112|P1|Overall Study|Adverse Event|9
2630460|NCT00853905|9090130|P2|Overall Study|never had surgery|0
2630461|NCT00853905|9090131|P1|Overall Study|never had surgery|1
2630462|NCT00853905|9090130|P2|Overall Study|Withdrawal by Subject|1
2630463|NCT00853905|9090131|P1|Overall Study|Withdrawal by Subject|0
2630464|NCT00853905|9090130|P2|Overall Study|Lost to Follow-up|3
2630465|NCT00853905|9090131|P1|Overall Study|Lost to Follow-up|1
2630466|NCT00853827|9090163|P2|Double Blind Period (103 Weeks)|Death|6
2630467|NCT00853827|9090164|P1|Double Blind Period (103 Weeks)|Death|1
2630468|NCT00853827|9090163|P2|Double Blind Period (103 Weeks)|Administrative problems|56
2630469|NCT00853827|9090164|P1|Double Blind Period (103 Weeks)|Administrative problems|45
2630470|NCT00853827|9090163|P2|Double Blind Period (103 Weeks)|Lost to Follow-up|10
2630471|NCT00853827|9090164|P1|Double Blind Period (103 Weeks)|Lost to Follow-up|8
2630472|NCT00853827|9090163|P2|Double Blind Period (103 Weeks)|Withdrawal by Subject|18
2630473|NCT00853827|9090164|P1|Double Blind Period (103 Weeks)|Withdrawal by Subject|19
2630474|NCT00853827|9090163|P2|Double Blind Period (103 Weeks)|Protocol Violation|1
2630475|NCT00853827|9090164|P1|Double Blind Period (103 Weeks)|Protocol Violation|2
2630476|NCT00853827|9090163|P2|Double Blind Period (103 Weeks)|Patient’s no longer requires study drug|1
2630477|NCT00853827|9090164|P1|Double Blind Period (103 Weeks)|Patient’s no longer requires study drug|3
2630478|NCT00853827|9090163|P2|Double Blind Period (103 Weeks)|Lack of Efficacy|0
2630479|NCT00853827|9090164|P1|Double Blind Period (103 Weeks)|Lack of Efficacy|1
2630480|NCT00853827|9090163|P2|Double Blind Period (103 Weeks)|Abnormal laboratory values|3
2630481|NCT00853827|9090164|P1|Double Blind Period (103 Weeks)|Abnormal laboratory values|0
2630482|NCT00853827|9090163|P2|Double Blind Period (103 Weeks)|Adverse Event|14
2630483|NCT00853827|9090164|P1|Double Blind Period (103 Weeks)|Adverse Event|25
2630484|NCT00853827|9090163|P2|Single Blind Period (1 Week)|Protocol Violation|0
2630485|NCT00853827|9090164|P1|Single Blind Period (1 Week)|Protocol Violation|12
2630486|NCT00853827|9090163|P2|Single Blind Period (1 Week)|Lost to Follow-up|0
2630487|NCT00853827|9090164|P1|Single Blind Period (1 Week)|Lost to Follow-up|1
2630488|NCT00853827|9090163|P2|Single Blind Period (1 Week)|Withdrawal by Subject|0
2630489|NCT00853827|9090164|P1|Single Blind Period (1 Week)|Withdrawal by Subject|9
2630490|NCT00853827|9090163|P2|Single Blind Period (1 Week)|Abnormal test procedure result|0
2630491|NCT00853827|9090164|P1|Single Blind Period (1 Week)|Abnormal test procedure result|1
2630492|NCT00853827|9090163|P2|Single Blind Period (1 Week)|Abnormal laboratory value|0
2630493|NCT00853827|9090164|P1|Single Blind Period (1 Week)|Abnormal laboratory value|3
2630494|NCT00853827|9090163|P2|Single Blind Period (1 Week)|Adverse Event|0
2630495|NCT00853827|9090164|P1|Single Blind Period (1 Week)|Adverse Event|9
2630496|NCT00853827|9090163|P2|Single Blind Period (1 Week)|Other|0
2630497|NCT00853827|9090164|P1|Single Blind Period (1 Week)|Other|4
2630498|NCT00853762|9090180|P4|Overall Study|Randomised but not Treated|0
2630499|NCT00853762|9090181|P3|Overall Study|Randomised but not Treated|2
2630500|NCT00853762|9090182|P2|Overall Study|Randomised but not Treated|2
2630501|NCT00853762|9090183|P1|Overall Study|Randomised but not Treated|0
2630502|NCT00853762|9090180|P4|Overall Study|Other|0
2630503|NCT00853762|9090181|P3|Overall Study|Other|0
2630504|NCT00853762|9090182|P2|Overall Study|Other|2
2630505|NCT00853762|9090183|P1|Overall Study|Other|0
2630506|NCT00853762|9090180|P4|Overall Study|Withdrawal by Subject|0
2630507|NCT00853762|9090181|P3|Overall Study|Withdrawal by Subject|1
2630508|NCT00853762|9090182|P2|Overall Study|Withdrawal by Subject|0
2630509|NCT00853762|9090183|P1|Overall Study|Withdrawal by Subject|0
2630510|NCT00853762|9090180|P4|Overall Study|Protocol Violation|1
2630511|NCT00853762|9090181|P3|Overall Study|Protocol Violation|0
2630512|NCT00853762|9090182|P2|Overall Study|Protocol Violation|0
2630513|NCT00853762|9090183|P1|Overall Study|Protocol Violation|0
2630514|NCT00853762|9090180|P4|Overall Study|Premature Termination|21
2630515|NCT00853762|9090181|P3|Overall Study|Premature Termination|14
2630516|NCT00853762|9090182|P2|Overall Study|Premature Termination|15
2630517|NCT00853762|9090183|P1|Overall Study|Premature Termination|16
2630518|NCT00853749|9090251|P2|Overall Study|Lost to Follow-up|1
2630519|NCT00853749|9090252|P1|Overall Study|Lost to Follow-up|0
2630520|NCT00853723|9090273|P3|Overall Study|Protocol Violation|1
2630521|NCT00853723|9090274|P2|Overall Study|Protocol Violation|2
2630522|NCT00853723|9090275|P1|Overall Study|Protocol Violation|1
2630523|NCT00853723|9090273|P3|Overall Study|Withdrawal by Subject|0
2630524|NCT00853723|9090274|P2|Overall Study|Withdrawal by Subject|1
2630525|NCT00853723|9090275|P1|Overall Study|Withdrawal by Subject|2
2630526|NCT00853723|9090273|P3|Overall Study|Adverse Event|1
2630527|NCT00853723|9090274|P2|Overall Study|Adverse Event|4
2630528|NCT00853723|9090275|P1|Overall Study|Adverse Event|3
2630529|NCT00853658|9090329|P3|Overall Study|Missing study completion information|6
2630530|NCT00853658|9090330|P2|Overall Study|Missing study completion information|4
2630531|NCT00853658|9090331|P1|Overall Study|Missing study completion information|5
2630532|NCT00853658|9090329|P3|Overall Study|Patient's request|11
2630533|NCT00853658|9090330|P2|Overall Study|Patient's request|17
2630534|NCT00853658|9090331|P1|Overall Study|Patient's request|21
2630535|NCT00853658|9090329|P3|Overall Study|Vital Status at study end N/A|10
2630536|NCT00853658|9090330|P2|Overall Study|Vital Status at study end N/A|10
2630537|NCT00853658|9090331|P1|Overall Study|Vital Status at study end N/A|8
2630538|NCT00853658|9090329|P3|Overall Study|Vital Status unknown at study end|0
2630539|NCT00853658|9090330|P2|Overall Study|Vital Status unknown at study end|1
2630540|NCT00853658|9090331|P1|Overall Study|Vital Status unknown at study end|1
2630541|NCT00853658|9090329|P3|Overall Study|Vital Status known (alive) at study end|3
2630542|NCT00853658|9090330|P2|Overall Study|Vital Status known (alive) at study end|3
2630543|NCT00853658|9090331|P1|Overall Study|Vital Status known (alive) at study end|2
2630544|NCT00853658|9090329|P3|Overall Study|IRB request|2
2630545|NCT00853658|9090330|P2|Overall Study|IRB request|0
2630546|NCT00853658|9090331|P1|Overall Study|IRB request|0
2630547|NCT00853658|9090329|P3|Overall Study|H.A. Request|19
2630548|NCT00853658|9090330|P2|Overall Study|H.A. Request|23
2630549|NCT00853658|9090331|P1|Overall Study|H.A. Request|26
2630550|NCT00853658|9090329|P3|Overall Study|Lost to Follow-up|11
2630551|NCT00853658|9090330|P2|Overall Study|Lost to Follow-up|6
2630552|NCT00853658|9090331|P1|Overall Study|Lost to Follow-up|11
2630553|NCT00853658|9090329|P3|Overall Study|Death|753
2630554|NCT00853658|9090330|P2|Overall Study|Death|768
2630555|NCT00853658|9090331|P1|Overall Study|Death|713
2630556|NCT00853593|9090351|P1|Overall Study|Implant not attempted|4
2630557|NCT00853593|9090351|P1|Overall Study|Model 4396 lead not attempted|29
2630558|NCT00853593|9090351|P1|Overall Study|Subjects did not receive a 4396 lead|12
2630559|NCT00853580|9090378|P2|Overall Study|Commenced contraindicated therapy|2
2630560|NCT00853580|9090379|P1|Overall Study|Commenced contraindicated therapy|0
2630561|NCT00853580|9090378|P2|Overall Study|Withdrawal by Subject|8
2630562|NCT00853580|9090379|P1|Overall Study|Withdrawal by Subject|2
2630563|NCT00853580|9090378|P2|Overall Study|Protocol Violation|1
2630564|NCT00853580|9090379|P1|Overall Study|Protocol Violation|2
2630565|NCT00853580|9090378|P2|Overall Study|Lost to Follow-up|5
2630566|NCT00853580|9090379|P1|Overall Study|Lost to Follow-up|3
2630567|NCT00853567|9090426|P1|Overall Study|Study prematurely terminated|71
2630568|NCT00853489|9090436|P2|Overall Study|Lost to Follow-up|2
2630569|NCT00853489|9090437|P1|Overall Study|Lost to Follow-up|5
2630570|NCT00853385|9090452|P5|Overall Study|Other|12
2630571|NCT00853385|9090453|P4|Overall Study|Other|4
2630572|NCT00853385|9090454|P3|Overall Study|Other|4
2630573|NCT00853385|9090455|P2|Overall Study|Other|9
2630574|NCT00853385|9090456|P1|Overall Study|Other|18
2630575|NCT00853385|9090452|P5|Overall Study|Withdrawal by Subject|1
2630576|NCT00853385|9090453|P4|Overall Study|Withdrawal by Subject|1
2630577|NCT00853385|9090454|P3|Overall Study|Withdrawal by Subject|0
2630578|NCT00853385|9090455|P2|Overall Study|Withdrawal by Subject|2
2630579|NCT00853385|9090456|P1|Overall Study|Withdrawal by Subject|4
2630580|NCT00853385|9090452|P5|Overall Study|Lost to Follow-up|0
2630581|NCT00853385|9090453|P4|Overall Study|Lost to Follow-up|0
2630582|NCT00853385|9090454|P3|Overall Study|Lost to Follow-up|0
2630583|NCT00853385|9090455|P2|Overall Study|Lost to Follow-up|1
2630584|NCT00853385|9090456|P1|Overall Study|Lost to Follow-up|2
2630585|NCT00853385|9090452|P5|Overall Study|Lack of Efficacy|6
2630586|NCT00853385|9090453|P4|Overall Study|Lack of Efficacy|3
2630587|NCT00853385|9090454|P3|Overall Study|Lack of Efficacy|3
2630588|NCT00853385|9090455|P2|Overall Study|Lack of Efficacy|7
2630589|NCT00853385|9090456|P1|Overall Study|Lack of Efficacy|6
2630590|NCT00853385|9090452|P5|Overall Study|Adverse Event|22
2630591|NCT00853385|9090453|P4|Overall Study|Adverse Event|5
2630592|NCT00853385|9090454|P3|Overall Study|Adverse Event|2
2630593|NCT00853385|9090455|P2|Overall Study|Adverse Event|24
2630594|NCT00853385|9090456|P1|Overall Study|Adverse Event|24
2630595|NCT00853385|9090452|P5|Overall Study|Death|1
2630596|NCT00853385|9090453|P4|Overall Study|Death|0
2630597|NCT00853385|9090454|P3|Overall Study|Death|0
2630598|NCT00853385|9090455|P2|Overall Study|Death|0
2630599|NCT00853385|9090456|P1|Overall Study|Death|0
2630600|NCT00853307|9090684|P2|Overall Study|Reason Not Specified|1
2630601|NCT00853307|9090685|P1|Overall Study|Reason Not Specified|0
2630602|NCT00853307|9090684|P2|Overall Study|Withdrawal by Subject|2
2630603|NCT00853307|9090685|P1|Overall Study|Withdrawal by Subject|1
2630604|NCT00853307|9090684|P2|Overall Study|Adverse Event|2
2630605|NCT00853307|9090685|P1|Overall Study|Adverse Event|1
2630606|NCT00853242|9090712|P7|Overall Study|Other|2
2630607|NCT00853242|9090713|P6|Overall Study|Other|1
2630608|NCT00853242|9090714|P5|Overall Study|Other|0
2630609|NCT00853242|9090715|P4|Overall Study|Other|0
2630610|NCT00853242|9090716|P3|Overall Study|Other|2
2630611|NCT00853242|9090717|P2|Overall Study|Other|0
2630612|NCT00853242|9090718|P1|Overall Study|Other|2
2630613|NCT00853242|9090712|P7|Overall Study|Withdrawal by Subject|2
2630614|NCT00853242|9090713|P6|Overall Study|Withdrawal by Subject|0
2630615|NCT00853242|9090714|P5|Overall Study|Withdrawal by Subject|0
2630616|NCT00853242|9090715|P4|Overall Study|Withdrawal by Subject|4
2630617|NCT00853242|9090716|P3|Overall Study|Withdrawal by Subject|0
2630618|NCT00853242|9090717|P2|Overall Study|Withdrawal by Subject|2
2630619|NCT00853242|9090718|P1|Overall Study|Withdrawal by Subject|1
2630620|NCT00853242|9090712|P7|Overall Study|Noncompliant|0
2630621|NCT00853242|9090713|P6|Overall Study|Noncompliant|0
2630622|NCT00853242|9090714|P5|Overall Study|Noncompliant|1
2630623|NCT00853242|9090715|P4|Overall Study|Noncompliant|0
2630624|NCT00853242|9090716|P3|Overall Study|Noncompliant|0
2630625|NCT00853242|9090717|P2|Overall Study|Noncompliant|0
2630626|NCT00853242|9090718|P1|Overall Study|Noncompliant|0
2630627|NCT00853242|9090712|P7|Overall Study|Adverse Event|1
2630628|NCT00853242|9090713|P6|Overall Study|Adverse Event|1
2630629|NCT00853242|9090714|P5|Overall Study|Adverse Event|3
2630630|NCT00853242|9090715|P4|Overall Study|Adverse Event|0
2630631|NCT00853242|9090716|P3|Overall Study|Adverse Event|1
2630632|NCT00853242|9090717|P2|Overall Study|Adverse Event|1
2630633|NCT00853242|9090718|P1|Overall Study|Adverse Event|0
2630634|NCT00853229|9090760|P2|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
2630635|NCT00853229|9090761|P1|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
2630636|NCT00853151|9090771|P4|Overall Study|Sponsor Decision|0
2630637|NCT00853151|9090772|P3|Overall Study|Sponsor Decision|0
2630638|NCT00853151|9090773|P2|Overall Study|Sponsor Decision|3
2630639|NCT00853151|9090774|P1|Overall Study|Sponsor Decision|0
2630640|NCT00853151|9090771|P4|Overall Study|Physician Decision|0
2630641|NCT00853151|9090772|P3|Overall Study|Physician Decision|1
2630642|NCT00853151|9090773|P2|Overall Study|Physician Decision|2
2630643|NCT00853151|9090774|P1|Overall Study|Physician Decision|0
2630644|NCT00853151|9090771|P4|Overall Study|Withdrawal by Subject|1
2630645|NCT00853151|9090772|P3|Overall Study|Withdrawal by Subject|2
2630646|NCT00853151|9090773|P2|Overall Study|Withdrawal by Subject|4
2630647|NCT00853151|9090774|P1|Overall Study|Withdrawal by Subject|5
2630648|NCT00853151|9090771|P4|Overall Study|Protocol Violation|1
2630649|NCT00853151|9090772|P3|Overall Study|Protocol Violation|0
2630650|NCT00853151|9090773|P2|Overall Study|Protocol Violation|0
2630651|NCT00853151|9090774|P1|Overall Study|Protocol Violation|0
2630652|NCT00853151|9090771|P4|Overall Study|Death|1
2630653|NCT00853151|9090772|P3|Overall Study|Death|0
2630654|NCT00853151|9090773|P2|Overall Study|Death|0
2630655|NCT00853151|9090774|P1|Overall Study|Death|1
2630656|NCT00853151|9090771|P4|Overall Study|Lost to Follow-up|0
2630657|NCT00853151|9090772|P3|Overall Study|Lost to Follow-up|3
2630658|NCT00853151|9090773|P2|Overall Study|Lost to Follow-up|0
2630659|NCT00853151|9090774|P1|Overall Study|Lost to Follow-up|2
2630660|NCT00853151|9090771|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
2630661|NCT00853151|9090772|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
2630662|NCT00853151|9090773|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
2630663|NCT00853151|9090774|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
2630664|NCT00853151|9090771|P4|Overall Study|Adverse Event|0
2630665|NCT00853151|9090772|P3|Overall Study|Adverse Event|2
2630666|NCT00853151|9090773|P2|Overall Study|Adverse Event|4
2630667|NCT00853151|9090774|P1|Overall Study|Adverse Event|1
2630668|NCT00853125|9090916|P1|Overall Study|Study participant's donor was CMV +|1
2630669|NCT00853112|9090928|P7|Overall Study|Randomized but not treated|1
2630670|NCT00853112|9090929|P6|Overall Study|Randomized but not treated|0
2630671|NCT00853112|9090930|P5|Overall Study|Randomized but not treated|0
2630672|NCT00853112|9090931|P4|Overall Study|Randomized but not treated|2
2630673|NCT00853112|9090932|P3|Overall Study|Randomized but not treated|0
2630674|NCT00853112|9090933|P2|Overall Study|Randomized but not treated|1
2630675|NCT00853112|9090934|P1|Overall Study|Randomized but not treated|0
2630676|NCT00853099|9091044|P4|Double-blind + Open-label Periods|Other|6
2630677|NCT00853099|9091045|P3|Double-blind + Open-label Periods|Other|0
2630678|NCT00853099|9091046|P2|Double-blind + Open-label Periods|Other|0
2630679|NCT00853099|9091047|P1|Double-blind + Open-label Periods|Other|0
2630680|NCT00853099|9091044|P4|Double-blind + Open-label Periods|Withdrawal by Subject|20
2630681|NCT00853099|9091045|P3|Double-blind + Open-label Periods|Withdrawal by Subject|0
2630682|NCT00853099|9091046|P2|Double-blind + Open-label Periods|Withdrawal by Subject|0
2630683|NCT00853099|9091047|P1|Double-blind + Open-label Periods|Withdrawal by Subject|0
2630684|NCT00853099|9091044|P4|Double-blind + Open-label Periods|Adverse Event|47
2630685|NCT00853099|9091045|P3|Double-blind + Open-label Periods|Adverse Event|0
2630686|NCT00853099|9091046|P2|Double-blind + Open-label Periods|Adverse Event|0
2630687|NCT00853099|9091047|P1|Double-blind + Open-label Periods|Adverse Event|0
2630688|NCT00853099|9091044|P4|Double-blind + Open-label Periods|Lack of Efficacy|74
2630689|NCT00853099|9091045|P3|Double-blind + Open-label Periods|Lack of Efficacy|0
2630690|NCT00853099|9091046|P2|Double-blind + Open-label Periods|Lack of Efficacy|0
2630691|NCT00853099|9091047|P1|Double-blind + Open-label Periods|Lack of Efficacy|0
2630692|NCT00853099|9091044|P4|Double-blind Period|Mistreated with rescue study drug|0
2630693|NCT00853099|9091045|P3|Double-blind Period|Mistreated with rescue study drug|1
2630694|NCT00853099|9091046|P2|Double-blind Period|Mistreated with rescue study drug|0
2630695|NCT00853099|9091047|P1|Double-blind Period|Mistreated with rescue study drug|0
2630696|NCT00853099|9091044|P4|Double-blind Period|Other|0
2630697|NCT00853099|9091045|P3|Double-blind Period|Other|1
2630698|NCT00853099|9091046|P2|Double-blind Period|Other|0
2630699|NCT00853099|9091047|P1|Double-blind Period|Other|0
2630700|NCT00853099|9091044|P4|Double-blind Period|Lack of Efficacy|0
2630701|NCT00853099|9091045|P3|Double-blind Period|Lack of Efficacy|16
2630702|NCT00853099|9091046|P2|Double-blind Period|Lack of Efficacy|17
2630703|NCT00853099|9091047|P1|Double-blind Period|Lack of Efficacy|14
2630704|NCT00853099|9091044|P4|Double-blind Period|Withdrawal by Subject|0
2630705|NCT00853099|9091045|P3|Double-blind Period|Withdrawal by Subject|0
2630706|NCT00853099|9091046|P2|Double-blind Period|Withdrawal by Subject|3
2630707|NCT00853099|9091047|P1|Double-blind Period|Withdrawal by Subject|2
2630708|NCT00853099|9091044|P4|Double-blind Period|Adverse Event|0
2630709|NCT00853099|9091045|P3|Double-blind Period|Adverse Event|13
2630710|NCT00853099|9091046|P2|Double-blind Period|Adverse Event|9
2630711|NCT00853099|9091047|P1|Double-blind Period|Adverse Event|7
2630712|NCT00853073|9091089|P2|Overall Study|Withdrawal by Subject|2
2630713|NCT00853073|9091090|P1|Overall Study|Withdrawal by Subject|3
2630714|NCT00853047|9091103|P6|Open-Label Extension Phase|Reason Not Specified|6
2630715|NCT00853047|9091104|P5|Open-Label Extension Phase|Reason Not Specified|0
2630716|NCT00853047|9091105|P4|Open-Label Extension Phase|Reason Not Specified|0
2630717|NCT00853047|9091106|P3|Open-Label Extension Phase|Reason Not Specified|0
2630718|NCT00853047|9091107|P2|Open-Label Extension Phase|Reason Not Specified|0
2630719|NCT00853047|9091108|P1|Open-Label Extension Phase|Reason Not Specified|0
2630720|NCT00853047|9091103|P6|Open-Label Extension Phase|Investigator Decision|1
2630721|NCT00853047|9091104|P5|Open-Label Extension Phase|Investigator Decision|0
2630722|NCT00853047|9091105|P4|Open-Label Extension Phase|Investigator Decision|0
2630723|NCT00853047|9091106|P3|Open-Label Extension Phase|Investigator Decision|0
2630724|NCT00853047|9091107|P2|Open-Label Extension Phase|Investigator Decision|0
2630725|NCT00853047|9091108|P1|Open-Label Extension Phase|Investigator Decision|0
2630726|NCT00853047|9091103|P6|Open-Label Extension Phase|Transfer to LX1606-302|2
2630727|NCT00853047|9091104|P5|Open-Label Extension Phase|Transfer to LX1606-302|0
2630728|NCT00853047|9091105|P4|Open-Label Extension Phase|Transfer to LX1606-302|0
2630729|NCT00853047|9091106|P3|Open-Label Extension Phase|Transfer to LX1606-302|0
2630730|NCT00853047|9091107|P2|Open-Label Extension Phase|Transfer to LX1606-302|0
2630731|NCT00853047|9091108|P1|Open-Label Extension Phase|Transfer to LX1606-302|0
2630732|NCT00853047|9091103|P6|Open-Label Extension Phase|Lost to Follow-up|1
2630733|NCT00853047|9091104|P5|Open-Label Extension Phase|Lost to Follow-up|0
2630734|NCT00853047|9091105|P4|Open-Label Extension Phase|Lost to Follow-up|0
2630735|NCT00853047|9091106|P3|Open-Label Extension Phase|Lost to Follow-up|0
2630736|NCT00853047|9091107|P2|Open-Label Extension Phase|Lost to Follow-up|0
2630737|NCT00853047|9091108|P1|Open-Label Extension Phase|Lost to Follow-up|0
2630738|NCT00853047|9091103|P6|Open-Label Extension Phase|Participant Request|7
2630739|NCT00853047|9091104|P5|Open-Label Extension Phase|Participant Request|0
2630740|NCT00853047|9091105|P4|Open-Label Extension Phase|Participant Request|0
2630741|NCT00853047|9091106|P3|Open-Label Extension Phase|Participant Request|0
2630742|NCT00853047|9091107|P2|Open-Label Extension Phase|Participant Request|0
2630743|NCT00853047|9091108|P1|Open-Label Extension Phase|Participant Request|0
2630744|NCT00853047|9091103|P6|Core Phase|Participant Request|0
2630745|NCT00853047|9091104|P5|Core Phase|Participant Request|0
2630746|NCT00853047|9091105|P4|Core Phase|Participant Request|1
2630747|NCT00853047|9091106|P3|Core Phase|Participant Request|0
2630748|NCT00853047|9091107|P2|Core Phase|Participant Request|0
2630749|NCT00853047|9091108|P1|Core Phase|Participant Request|0
2630750|NCT00853021|9091174|P1|Overall Study|Death|1
2630751|NCT00853021|9091174|P1|Overall Study|Withdrawal by Subject|2
2630752|NCT00853021|9091174|P1|Overall Study|Adverse Event|2
2630753|NCT00852995|9091186|P5|Overall Study|Moved Out of Area|0
2630754|NCT00852995|9091187|P4|Overall Study|Moved Out of Area|0
2630755|NCT00852995|9091188|P3|Overall Study|Moved Out of Area|0
2630756|NCT00852995|9091189|P2|Overall Study|Moved Out of Area|0
2630757|NCT00852995|9091190|P1|Overall Study|Moved Out of Area|1
2630758|NCT00852995|9091186|P5|Overall Study|Protocol Violation|1
2630759|NCT00852995|9091187|P4|Overall Study|Protocol Violation|0
2630760|NCT00852995|9091188|P3|Overall Study|Protocol Violation|0
2630761|NCT00852995|9091189|P2|Overall Study|Protocol Violation|0
2630762|NCT00852995|9091190|P1|Overall Study|Protocol Violation|0
2630763|NCT00852995|9091186|P5|Overall Study|Physician Decision|0
2630764|NCT00852995|9091187|P4|Overall Study|Physician Decision|0
2630765|NCT00852995|9091188|P3|Overall Study|Physician Decision|0
2630766|NCT00852995|9091189|P2|Overall Study|Physician Decision|0
2630767|NCT00852995|9091190|P1|Overall Study|Physician Decision|1
2630768|NCT00852995|9091186|P5|Overall Study|Progressive Disease|1
2630769|NCT00852995|9091187|P4|Overall Study|Progressive Disease|2
2630770|NCT00852995|9091188|P3|Overall Study|Progressive Disease|0
2630771|NCT00852995|9091189|P2|Overall Study|Progressive Disease|0
2630772|NCT00852995|9091190|P1|Overall Study|Progressive Disease|1
2630773|NCT00852995|9091186|P5|Overall Study|Non-Compliance|0
2630774|NCT00852995|9091187|P4|Overall Study|Non-Compliance|2
2630775|NCT00852995|9091188|P3|Overall Study|Non-Compliance|0
2630776|NCT00852995|9091189|P2|Overall Study|Non-Compliance|0
2630777|NCT00852995|9091190|P1|Overall Study|Non-Compliance|0
2630778|NCT00852995|9091186|P5|Overall Study|Withdrawal by Subject|2
2630779|NCT00852995|9091187|P4|Overall Study|Withdrawal by Subject|1
2630780|NCT00852995|9091188|P3|Overall Study|Withdrawal by Subject|0
2630781|NCT00852995|9091189|P2|Overall Study|Withdrawal by Subject|0
2630782|NCT00852995|9091190|P1|Overall Study|Withdrawal by Subject|4
2630783|NCT00852995|9091186|P5|Overall Study|Lost to Follow-up|0
2630784|NCT00852995|9091187|P4|Overall Study|Lost to Follow-up|0
2630785|NCT00852995|9091188|P3|Overall Study|Lost to Follow-up|1
2630786|NCT00852995|9091189|P2|Overall Study|Lost to Follow-up|1
2630787|NCT00852995|9091190|P1|Overall Study|Lost to Follow-up|0
2630788|NCT00852995|9091186|P5|Overall Study|Adverse Event|0
2630789|NCT00852995|9091187|P4|Overall Study|Adverse Event|0
2630790|NCT00852995|9091188|P3|Overall Study|Adverse Event|4
2630791|NCT00852995|9091189|P2|Overall Study|Adverse Event|0
2630792|NCT00852995|9091190|P1|Overall Study|Adverse Event|1
2630793|NCT00852969|9091234|P2|Overall Study|Lost to Follow-up|1
2630794|NCT00852969|9091235|P1|Overall Study|Lost to Follow-up|0
2630795|NCT00852969|9091234|P2|Overall Study|Adverse Event|1
2630796|NCT00852969|9091235|P1|Overall Study|Adverse Event|0
2630797|NCT00852930|9091246|P3|Overall Study|Physician Decision|1
2630798|NCT00852930|9091247|P2|Overall Study|Physician Decision|0
2630799|NCT00852930|9091248|P1|Overall Study|Physician Decision|0
2630800|NCT00852930|9091246|P3|Overall Study|Withdrawal by Subject|1
2630801|NCT00852930|9091247|P2|Overall Study|Withdrawal by Subject|1
2630802|NCT00852930|9091248|P1|Overall Study|Withdrawal by Subject|1
2630803|NCT00852917|9091269|P4|Overall Study|Death|1
2630804|NCT00852917|9091270|P3|Overall Study|Death|0
2630805|NCT00852917|9091271|P2|Overall Study|Death|0
2630806|NCT00852917|9091272|P1|Overall Study|Death|0
2630807|NCT00852917|9091269|P4|Overall Study|Physician Decision|19
2630808|NCT00852917|9091270|P3|Overall Study|Physician Decision|2
2630809|NCT00852917|9091271|P2|Overall Study|Physician Decision|7
2630810|NCT00852917|9091272|P1|Overall Study|Physician Decision|6
2630811|NCT00852917|9091269|P4|Overall Study|Withdrawal by Subject|9
2630812|NCT00852917|9091270|P3|Overall Study|Withdrawal by Subject|10
2630813|NCT00852917|9091271|P2|Overall Study|Withdrawal by Subject|8
2630814|NCT00852917|9091272|P1|Overall Study|Withdrawal by Subject|4
2630815|NCT00852917|9091269|P4|Overall Study|Lack of Efficacy|47
2630816|NCT00852917|9091270|P3|Overall Study|Lack of Efficacy|11
2630817|NCT00852917|9091271|P2|Overall Study|Lack of Efficacy|11
2630818|NCT00852917|9091272|P1|Overall Study|Lack of Efficacy|21
2630819|NCT00852917|9091269|P4|Overall Study|Adverse Event|17
2630820|NCT00852917|9091270|P3|Overall Study|Adverse Event|35
2630821|NCT00852917|9091271|P2|Overall Study|Adverse Event|20
2630822|NCT00852917|9091272|P1|Overall Study|Adverse Event|13
2630823|NCT00852540|9091400|P2|Overall Study|Did Not Receive Study Drug|3
2630824|NCT00852540|9091401|P1|Overall Study|Did Not Receive Study Drug|3
2630825|NCT00852540|9091400|P2|Overall Study|Withdrawal by Subject|1
2630826|NCT00852540|9091401|P1|Overall Study|Withdrawal by Subject|3
2630827|NCT00852540|9091400|P2|Overall Study|Investigator Discretion|3
2630828|NCT00852540|9091401|P1|Overall Study|Investigator Discretion|2
2630829|NCT00852540|9091400|P2|Overall Study|Lost to Follow-up|3
2630830|NCT00852540|9091401|P1|Overall Study|Lost to Follow-up|2
2630831|NCT00852540|9091400|P2|Overall Study|Protocol Violation|2
2630832|NCT00852540|9091401|P1|Overall Study|Protocol Violation|1
2630833|NCT00852540|9091400|P2|Overall Study|Lack of Efficacy|3
2630834|NCT00852540|9091401|P1|Overall Study|Lack of Efficacy|15
2630835|NCT00852540|9091400|P2|Overall Study|Adverse Event|3
2630836|NCT00852540|9091401|P1|Overall Study|Adverse Event|10
2630837|NCT00852475|9091435|P2|Overall Study|Lost to Follow-up|4
2630838|NCT00852475|9091436|P1|Overall Study|Lost to Follow-up|3
2630839|NCT00852397|9091447|P3|Overall Study|Protocol Violation|1
2630840|NCT00852397|9091448|P2|Overall Study|Protocol Violation|0
2630841|NCT00852397|9091449|P1|Overall Study|Protocol Violation|0
2630842|NCT00852397|9091447|P3|Overall Study|Difficulty in study site visit|0
2630843|NCT00852397|9091448|P2|Overall Study|Difficulty in study site visit|0
2630844|NCT00852397|9091449|P1|Overall Study|Difficulty in study site visit|1
2630845|NCT00852397|9091447|P3|Overall Study|Study terminated by sponsor|6
2630846|NCT00852397|9091448|P2|Overall Study|Study terminated by sponsor|1
2630847|NCT00852397|9091449|P1|Overall Study|Study terminated by sponsor|2
2630848|NCT00852397|9091447|P3|Overall Study|Withdrawal by Subject|2
2630849|NCT00852397|9091448|P2|Overall Study|Withdrawal by Subject|1
2630850|NCT00852397|9091449|P1|Overall Study|Withdrawal by Subject|4
2630851|NCT00852397|9091447|P3|Overall Study|Death|1
2630852|NCT00852397|9091448|P2|Overall Study|Death|0
2630853|NCT00852397|9091449|P1|Overall Study|Death|0
2630854|NCT00852397|9091447|P3|Overall Study|Adverse Event|4
2630855|NCT00852397|9091448|P2|Overall Study|Adverse Event|6
2630856|NCT00852397|9091449|P1|Overall Study|Adverse Event|4
2630857|NCT00852241|9091478|P1|Overall Study|Physician Decision|18
2630858|NCT00852202|9091485|P3|Overall Study|pregnancy,moving away and surgery|2
2630859|NCT00852202|9091486|P2|Overall Study|pregnancy,moving away and surgery|0
2630860|NCT00852202|9091487|P1|Overall Study|pregnancy,moving away and surgery|1
2630861|NCT00852202|9091485|P3|Overall Study|Lost to Follow-up|6
2630862|NCT00852202|9091486|P2|Overall Study|Lost to Follow-up|5
2630863|NCT00852202|9091487|P1|Overall Study|Lost to Follow-up|5
2630864|NCT00852202|9091485|P3|Overall Study|Withdrawal by Subject|2
2630865|NCT00852202|9091486|P2|Overall Study|Withdrawal by Subject|1
2630866|NCT00852202|9091487|P1|Overall Study|Withdrawal by Subject|3
2630867|NCT00852202|9091485|P3|Overall Study|Protocol Violation|7
2630868|NCT00852202|9091486|P2|Overall Study|Protocol Violation|2
2630869|NCT00852202|9091487|P1|Overall Study|Protocol Violation|2
2630870|NCT00852202|9091485|P3|Overall Study|Lack of Efficacy|2
2630871|NCT00852202|9091486|P2|Overall Study|Lack of Efficacy|1
2630872|NCT00852202|9091487|P1|Overall Study|Lack of Efficacy|4
2630873|NCT00852202|9091485|P3|Overall Study|Adverse Event|7
2630874|NCT00852202|9091486|P2|Overall Study|Adverse Event|3
2630875|NCT00852202|9091487|P1|Overall Study|Adverse Event|2
2630876|NCT00851903|9091529|P1|Overall Study|Withdrawal by Subject|2
2630877|NCT00851890|9091543|P4|Overall Study|Lost to Follow-up|1
2630878|NCT00851890|9091544|P3|Overall Study|Lost to Follow-up|0
2630879|NCT00851890|9091545|P2|Overall Study|Lost to Follow-up|1
2630880|NCT00851890|9091546|P1|Overall Study|Lost to Follow-up|0
2630881|NCT00851877|9091603|P3|Phase II|Withdrawal by Subject|3
2630882|NCT00851877|9091604|P2|Phase II|Withdrawal by Subject|0
2630883|NCT00851877|9091605|P1|Phase II|Withdrawal by Subject|0
2630884|NCT00851877|9091603|P3|Phase I-1|Death|0
2630885|NCT00851877|9091604|P2|Phase I-1|Death|0
2630886|NCT00851877|9091605|P1|Phase I-1|Death|1
2630887|NCT00851799|9091615|P3|Overall Study|Completed protocol due to pregnancy|1
2630888|NCT00851799|9091616|P2|Overall Study|Completed protocol due to pregnancy|0
2630889|NCT00851799|9091617|P1|Overall Study|Completed protocol due to pregnancy|0
2630890|NCT00851799|9091615|P3|Overall Study|Severe Debilitation|0
2630891|NCT00851799|9091616|P2|Overall Study|Severe Debilitation|1
2630892|NCT00851799|9091617|P1|Overall Study|Severe Debilitation|0
2630893|NCT00851799|9091615|P3|Overall Study|Withdrew consent prior study completion|1
2630894|NCT00851799|9091616|P2|Overall Study|Withdrew consent prior study completion|2
2630895|NCT00851799|9091617|P1|Overall Study|Withdrew consent prior study completion|1
2630896|NCT00851799|9091615|P3|Overall Study|Not willing to adhere to requirements|2
2630897|NCT00851799|9091616|P2|Overall Study|Not willing to adhere to requirements|2
2630898|NCT00851799|9091617|P1|Overall Study|Not willing to adhere to requirements|1
2630899|NCT00851799|9091615|P3|Overall Study|Not able to get to clinic|9
2630900|NCT00851799|9091616|P2|Overall Study|Not able to get to clinic|5
2630901|NCT00851799|9091617|P1|Overall Study|Not able to get to clinic|8
2630902|NCT00851799|9091615|P3|Overall Study|Lost to Follow-up|10
2630903|NCT00851799|9091616|P2|Overall Study|Lost to Follow-up|3
2630904|NCT00851799|9091617|P1|Overall Study|Lost to Follow-up|5
2630905|NCT00851799|9091615|P3|Overall Study|Death|1
2630906|NCT00851799|9091616|P2|Overall Study|Death|0
2630907|NCT00851799|9091617|P1|Overall Study|Death|1
2630908|NCT00851786|9091705|P2|Overall Study|Cannot Adhere to Protocol Requirement|0
2630909|NCT00851786|9091706|P1|Overall Study|Cannot Adhere to Protocol Requirement|2
2630910|NCT00851786|9091705|P2|Overall Study|Site Closure|0
2630911|NCT00851786|9091706|P1|Overall Study|Site Closure|1
2630912|NCT00851786|9091705|P2|Overall Study|Incarceration|0
2630913|NCT00851786|9091706|P1|Overall Study|Incarceration|1
2630914|NCT00851786|9091705|P2|Overall Study|Lost to Follow-up|0
2630915|NCT00851786|9091706|P1|Overall Study|Lost to Follow-up|1
2630916|NCT00851786|9091705|P2|Overall Study|Protocol Violation|1
2630917|NCT00851786|9091706|P1|Overall Study|Protocol Violation|0
2630918|NCT00851786|9091705|P2|Overall Study|Withdrawal by Subject|1
2630919|NCT00851786|9091706|P1|Overall Study|Withdrawal by Subject|0
2630920|NCT00851747|9091719|P3|Overall Study|Physician Decision|6
2630921|NCT00851747|9091720|P2|Overall Study|Physician Decision|6
2630922|NCT00851747|9091721|P1|Overall Study|Physician Decision|6
2630923|NCT00851721|9091730|P2|Overall Study|Adverse Event|1
2630924|NCT00851721|9091731|P1|Overall Study|Adverse Event|0
2630925|NCT00851721|9091730|P2|Overall Study|Death|0
2630926|NCT00851721|9091731|P1|Overall Study|Death|1
2630927|NCT00851721|9091730|P2|Overall Study|planned surgery|0
2630928|NCT00851721|9091731|P1|Overall Study|planned surgery|1
2630929|NCT00851682|9091821|P2|Overall Study|screen failure|0
2630930|NCT00851682|9091822|P1|Overall Study|screen failure|5
2630931|NCT00851643|9091836|P6|Extension Study (Up to 36 Months)|Moved|1
2630932|NCT00851643|9091837|P5|Extension Study (Up to 36 Months)|Moved|0
2630933|NCT00851643|9091838|P4|Extension Study (Up to 36 Months)|Moved|1
2630934|NCT00851643|9091839|P3|Extension Study (Up to 36 Months)|Moved|1
2630935|NCT00851643|9091840|P2|Extension Study (Up to 36 Months)|Moved|2
2630936|NCT00851643|9091841|P1|Extension Study (Up to 36 Months)|Moved|0
2630937|NCT00851643|9091836|P6|Extension Study (Up to 36 Months)|Lost to Follow-up|0
2630938|NCT00851643|9091837|P5|Extension Study (Up to 36 Months)|Lost to Follow-up|2
2630939|NCT00851643|9091838|P4|Extension Study (Up to 36 Months)|Lost to Follow-up|1
2630940|NCT00851643|9091839|P3|Extension Study (Up to 36 Months)|Lost to Follow-up|4
2630941|NCT00851643|9091840|P2|Extension Study (Up to 36 Months)|Lost to Follow-up|2
2630942|NCT00851643|9091841|P1|Extension Study (Up to 36 Months)|Lost to Follow-up|4
2630943|NCT00851643|9091836|P6|Base Study (Up to 12 Months)|Other|1
2630944|NCT00851643|9091837|P5|Base Study (Up to 12 Months)|Other|0
2630945|NCT00851643|9091838|P4|Base Study (Up to 12 Months)|Other|0
2630946|NCT00851643|9091839|P3|Base Study (Up to 12 Months)|Other|0
2630947|NCT00851643|9091840|P2|Base Study (Up to 12 Months)|Other|0
2630948|NCT00851643|9091841|P1|Base Study (Up to 12 Months)|Other|0
2630949|NCT00851643|9091836|P6|Base Study (Up to 12 Months)|Withdrawal by Subject|0
2630950|NCT00851643|9091837|P5|Base Study (Up to 12 Months)|Withdrawal by Subject|0
2630951|NCT00851643|9091838|P4|Base Study (Up to 12 Months)|Withdrawal by Subject|0
2630952|NCT00851643|9091839|P3|Base Study (Up to 12 Months)|Withdrawal by Subject|0
2630953|NCT00851643|9091840|P2|Base Study (Up to 12 Months)|Withdrawal by Subject|0
2630954|NCT00851643|9091841|P1|Base Study (Up to 12 Months)|Withdrawal by Subject|1
2630955|NCT00851630|9091862|P2|Overall Study|Clinical failure|1
2630956|NCT00851630|9091863|P1|Overall Study|Clinical failure|0
2630957|NCT00851630|9091862|P2|Overall Study|Death|1
2630958|NCT00851630|9091863|P1|Overall Study|Death|2
2630959|NCT00851591|9091877|P2|Overall Study|Withdrawal by Subject|0
2630960|NCT00851591|9091878|P1|Overall Study|Withdrawal by Subject|2
2630961|NCT00851552|9091884|P1|Overall Study|Disease Progression|4
2630962|NCT00851552|9091884|P1|Overall Study|Adverse Event|1
2630963|NCT00851552|9091884|P1|Overall Study|Death|2
2630964|NCT00851318|9091914|P4|Overall Study|Physician Decision|1
2630965|NCT00851318|9091915|P3|Overall Study|Physician Decision|1
2630966|NCT00851318|9091916|P2|Overall Study|Physician Decision|0
2630967|NCT00851318|9091917|P1|Overall Study|Physician Decision|0
2630968|NCT00851318|9091914|P4|Overall Study|Non-compliance with Study Procedures|0
2630969|NCT00851318|9091915|P3|Overall Study|Non-compliance with Study Procedures|1
2630970|NCT00851318|9091916|P2|Overall Study|Non-compliance with Study Procedures|0
2630971|NCT00851318|9091917|P1|Overall Study|Non-compliance with Study Procedures|2
2630972|NCT00851318|9091914|P4|Overall Study|Lack of Efficacy|2
2630973|NCT00851318|9091915|P3|Overall Study|Lack of Efficacy|4
2630974|NCT00851318|9091916|P2|Overall Study|Lack of Efficacy|2
2630975|NCT00851318|9091917|P1|Overall Study|Lack of Efficacy|8
2630976|NCT00851318|9091914|P4|Overall Study|Pregnancy|1
2630977|NCT00851318|9091915|P3|Overall Study|Pregnancy|1
2630978|NCT00851318|9091916|P2|Overall Study|Pregnancy|0
2630979|NCT00851318|9091917|P1|Overall Study|Pregnancy|0
2630980|NCT00851318|9091914|P4|Overall Study|Adverse Event|12
2630981|NCT00851318|9091915|P3|Overall Study|Adverse Event|9
2630982|NCT00851318|9091916|P2|Overall Study|Adverse Event|2
2630983|NCT00851318|9091917|P1|Overall Study|Adverse Event|13
2630984|NCT00851318|9091914|P4|Overall Study|Withdrawal by Subject|3
2630985|NCT00851318|9091915|P3|Overall Study|Withdrawal by Subject|5
2630986|NCT00851318|9091916|P2|Overall Study|Withdrawal by Subject|1
2630987|NCT00851318|9091917|P1|Overall Study|Withdrawal by Subject|7
2630988|NCT00851253|9091953|P2|Overall Study|Disease Progression|0
2630989|NCT00851253|9091954|P1|Overall Study|Disease Progression|1
2630990|NCT00851084|9091964|P2|Overall Study|Other|1
2630991|NCT00851084|9091965|P1|Overall Study|Other|7
2630992|NCT00851084|9091964|P2|Overall Study|Metastatic surgery|6
2630993|NCT00851084|9091965|P1|Overall Study|Metastatic surgery|6
2630994|NCT00851084|9091964|P2|Overall Study|Withdrawal by Subject|12
2630995|NCT00851084|9091965|P1|Overall Study|Withdrawal by Subject|11
2630996|NCT00851084|9091964|P2|Overall Study|Consent withdrawn|2
2630997|NCT00851084|9091965|P1|Overall Study|Consent withdrawn|0
2630998|NCT00851084|9091964|P2|Overall Study|Physician Decision|14
2630999|NCT00851084|9091965|P1|Overall Study|Physician Decision|13
2631000|NCT00851084|9091964|P2|Overall Study|Poor compliance to protocol|1
2631001|NCT00851084|9091965|P1|Overall Study|Poor compliance to protocol|1
2631002|NCT00851084|9091964|P2|Overall Study|Disease progression|47
2631003|NCT00851084|9091965|P1|Overall Study|Disease progression|52
2631004|NCT00851084|9091964|P2|Overall Study|Adverse Event|36
2631005|NCT00851084|9091965|P1|Overall Study|Adverse Event|26
2631006|NCT00851084|9091964|P2|Overall Study|Randomized but not treated|0
2631007|NCT00851084|9091965|P1|Overall Study|Randomized but not treated|1
2631008|NCT00850993|9091993|P4|Overall Study|Parent/Guardian Voluntarily Withdrew|1
2631009|NCT00850993|9091994|P3|Overall Study|Parent/Guardian Voluntarily Withdrew|0
2631010|NCT00850993|9091995|P2|Overall Study|Parent/Guardian Voluntarily Withdrew|0
2631011|NCT00850993|9091996|P1|Overall Study|Parent/Guardian Voluntarily Withdrew|1
2631012|NCT00850759|9092025|P4|Overall Study|Lost to Follow-up|3
2631013|NCT00850759|9092026|P3|Overall Study|Lost to Follow-up|5
2631014|NCT00850759|9092027|P2|Overall Study|Lost to Follow-up|5
2631015|NCT00850759|9092028|P1|Overall Study|Lost to Follow-up|7
2631016|NCT00850564|9092109|P1|Overall Study|Withdrawal by Subject|2
2631017|NCT00850538|9092114|P1|Overall Study|Protocol Violation|2
2631018|NCT00850538|9092114|P1|Overall Study|radiology error|2
2631019|NCT00850538|9092114|P1|Overall Study|Withdrawal by Subject|3
2631020|NCT00850538|9092114|P1|Overall Study|specimen unusable|7
2631021|NCT00850538|9092114|P1|Overall Study|specimen missed due to scheduling error|14
2631022|NCT00850538|9092114|P1|Overall Study|unable/unwilling to complete MRI|13
2631023|NCT00850499|9092120|P2|Overall Study|Lack of Efficacy|1
2631024|NCT00850499|9092121|P1|Overall Study|Lack of Efficacy|0
2631025|NCT00850499|9092120|P2|Overall Study|Adverse Event|1
2631026|NCT00850499|9092121|P1|Overall Study|Adverse Event|3
2631027|NCT00850460|9092135|P2|Overall Study|Lost to Follow-up|4
2631028|NCT00850460|9092136|P1|Overall Study|Lost to Follow-up|4
2631029|NCT00850395|9092150|P1|Overall Study|Other|5
2631030|NCT00850395|9092150|P1|Overall Study|Insufficient clinical response|3
2631031|NCT00850395|9092150|P1|Overall Study|Adverse Event|1
2631032|NCT00850395|9092150|P1|Overall Study|Death|1
2631033|NCT00850343|9092170|P4|Overall Study|Physician Decision|1
2631034|NCT00850343|9092171|P3|Overall Study|Physician Decision|1
2631035|NCT00850343|9092172|P2|Overall Study|Physician Decision|1
2631036|NCT00850343|9092173|P1|Overall Study|Physician Decision|2
2631037|NCT00850343|9092170|P4|Overall Study|Non-compliance with Study Procedures|1
2631038|NCT00850343|9092171|P3|Overall Study|Non-compliance with Study Procedures|1
2631039|NCT00850343|9092172|P2|Overall Study|Non-compliance with Study Procedures|0
2631040|NCT00850343|9092173|P1|Overall Study|Non-compliance with Study Procedures|1
2631041|NCT00850343|9092170|P4|Overall Study|Lack of Efficacy|2
2631042|NCT00850343|9092171|P3|Overall Study|Lack of Efficacy|3
2631043|NCT00850343|9092172|P2|Overall Study|Lack of Efficacy|0
2631044|NCT00850343|9092173|P1|Overall Study|Lack of Efficacy|17
2631045|NCT00850343|9092170|P4|Overall Study|Pregnancy|1
2631046|NCT00850343|9092171|P3|Overall Study|Pregnancy|0
2631047|NCT00850343|9092172|P2|Overall Study|Pregnancy|0
2631048|NCT00850343|9092173|P1|Overall Study|Pregnancy|0
2631049|NCT00850343|9092170|P4|Overall Study|Adverse Event|6
2631050|NCT00850343|9092171|P3|Overall Study|Adverse Event|6
2631051|NCT00850343|9092172|P2|Overall Study|Adverse Event|2
2631052|NCT00850343|9092173|P1|Overall Study|Adverse Event|15
2631053|NCT00850343|9092170|P4|Overall Study|Withdrawal by Subject|2
2631054|NCT00850343|9092171|P3|Overall Study|Withdrawal by Subject|3
2631055|NCT00850343|9092172|P2|Overall Study|Withdrawal by Subject|0
2631056|NCT00850343|9092173|P1|Overall Study|Withdrawal by Subject|11
2631057|NCT00850200|9092203|P1|Overall Study|Withdrawal by Subject|1
2631058|NCT00850200|9092203|P1|Overall Study|Did not recieve treatment|2
2631059|NCT00850200|9092203|P1|Overall Study|Physician Decision|2
2631060|NCT00850174|9092213|P2|Second Intervention|Withdrawal by Subject|0
2631061|NCT00850174|9092214|P1|Second Intervention|Withdrawal by Subject|1
2631062|NCT00850174|9092213|P2|Washout: One Week|Withdrawal by Subject|2
2631063|NCT00850174|9092214|P1|Washout: One Week|Withdrawal by Subject|0
2631064|NCT00850135|9092228|P1|Overall Study|Physician Decision|1
2631065|NCT00850070|9092247|P2|Overall Study|Adverse Event|0
2631066|NCT00850070|9092248|P1|Overall Study|Adverse Event|2
2631067|NCT00850070|9092247|P2|Overall Study|Lack of Efficacy|1
2631068|NCT00850070|9092248|P1|Overall Study|Lack of Efficacy|1
2631069|NCT00849940|9092277|P1|Overall Study|Physician Decision|4
2631070|NCT00849901|9092288|P3|Extension Phase|Lack of Efficacy|1
2631071|NCT00849901|9092289|P2|Extension Phase|Lack of Efficacy|4
2631072|NCT00849901|9092290|P1|Extension Phase|Lack of Efficacy|2
2631073|NCT00849901|9092288|P3|Extension Phase|Physician Decision|0
2631074|NCT00849901|9092289|P2|Extension Phase|Physician Decision|2
2631075|NCT00849901|9092290|P1|Extension Phase|Physician Decision|1
2631076|NCT00849901|9092288|P3|Extension Phase|Parent or Caregiver Decision|4
2631077|NCT00849901|9092289|P2|Extension Phase|Parent or Caregiver Decision|4
2631078|NCT00849901|9092290|P1|Extension Phase|Parent or Caregiver Decision|10
2631079|NCT00849901|9092288|P3|Extension Phase|Withdrawal by Subject|3
2631080|NCT00849901|9092289|P2|Extension Phase|Withdrawal by Subject|6
2631081|NCT00849901|9092290|P1|Extension Phase|Withdrawal by Subject|7
2631082|NCT00849901|9092288|P3|Extension Phase|Protocol Violation|4
2631083|NCT00849901|9092289|P2|Extension Phase|Protocol Violation|2
2631084|NCT00849901|9092290|P1|Extension Phase|Protocol Violation|2
2631085|NCT00849901|9092288|P3|Extension Phase|Lost to Follow-up|1
2631086|NCT00849901|9092289|P2|Extension Phase|Lost to Follow-up|0
2631087|NCT00849901|9092290|P1|Extension Phase|Lost to Follow-up|3
2631088|NCT00849901|9092288|P3|Extension Phase|Adverse Event|4
2631089|NCT00849901|9092289|P2|Extension Phase|Adverse Event|8
2631090|NCT00849901|9092290|P1|Extension Phase|Adverse Event|2
2631091|NCT00849901|9092288|P3|Acute Treatment Phase|Lack of Efficacy|2
2631092|NCT00849901|9092289|P2|Acute Treatment Phase|Lack of Efficacy|3
2631093|NCT00849901|9092290|P1|Acute Treatment Phase|Lack of Efficacy|2
2631094|NCT00849901|9092288|P3|Acute Treatment Phase|Sponsor Decision|0
2631095|NCT00849901|9092289|P2|Acute Treatment Phase|Sponsor Decision|0
2631096|NCT00849901|9092290|P1|Acute Treatment Phase|Sponsor Decision|1
2631097|NCT00849901|9092288|P3|Acute Treatment Phase|Physician Decision|1
2631098|NCT00849901|9092289|P2|Acute Treatment Phase|Physician Decision|1
2631099|NCT00849901|9092290|P1|Acute Treatment Phase|Physician Decision|1
2631100|NCT00849901|9092288|P3|Acute Treatment Phase|Parent or Caregiver Decision|4
2631101|NCT00849901|9092289|P2|Acute Treatment Phase|Parent or Caregiver Decision|5
2631102|NCT00849901|9092290|P1|Acute Treatment Phase|Parent or Caregiver Decision|11
2631103|NCT00849901|9092288|P3|Acute Treatment Phase|Withdrawal by Subject|4
2631104|NCT00849901|9092289|P2|Acute Treatment Phase|Withdrawal by Subject|10
2631105|NCT00849901|9092290|P1|Acute Treatment Phase|Withdrawal by Subject|4
2631106|NCT00849901|9092288|P3|Acute Treatment Phase|Protocol Violation|1
2631107|NCT00849901|9092289|P2|Acute Treatment Phase|Protocol Violation|2
2631108|NCT00849901|9092290|P1|Acute Treatment Phase|Protocol Violation|0
2631109|NCT00849901|9092288|P3|Acute Treatment Phase|Lost to Follow-up|1
2631110|NCT00849901|9092289|P2|Acute Treatment Phase|Lost to Follow-up|4
2631111|NCT00849901|9092290|P1|Acute Treatment Phase|Lost to Follow-up|2
2631112|NCT00849901|9092288|P3|Acute Treatment Phase|Adverse Event|3
2631113|NCT00849901|9092289|P2|Acute Treatment Phase|Adverse Event|1
2631114|NCT00849901|9092290|P1|Acute Treatment Phase|Adverse Event|9
2631115|NCT00849875|9092337|P1|Overall Study|Lost to Follow-up|2
2631116|NCT00849875|9092337|P1|Overall Study|Others|6
2631117|NCT00849875|9092337|P1|Overall Study|Ongoing (unknown completion status)|11
2631118|NCT00849875|9092337|P1|Overall Study|Death|28
2631119|NCT00849797|9092434|P2|Washout: One Week|Withdrawal by Subject|2
2631120|NCT00849797|9092435|P1|Washout: One Week|Withdrawal by Subject|0
2631121|NCT00849797|9092434|P2|First Intervention|Adverse Event|1
2631122|NCT00849797|9092435|P1|First Intervention|Adverse Event|0
2631123|NCT00849797|9092434|P2|First Intervention|bad veins|0
2631124|NCT00849797|9092435|P1|First Intervention|bad veins|1
2631125|NCT00849693|9092453|P4|Extension Phase|Lack of Efficacy|1
2631126|NCT00849693|9092454|P3|Extension Phase|Lack of Efficacy|2
2631127|NCT00849693|9092455|P2|Extension Phase|Lack of Efficacy|2
2631128|NCT00849693|9092456|P1|Extension Phase|Lack of Efficacy|2
2631129|NCT00849693|9092453|P4|Extension Phase|Sponsor decision|1
2631130|NCT00849693|9092454|P3|Extension Phase|Sponsor decision|0
2631131|NCT00849693|9092455|P2|Extension Phase|Sponsor decision|0
2631132|NCT00849693|9092456|P1|Extension Phase|Sponsor decision|1
2631133|NCT00849693|9092453|P4|Extension Phase|Physician Decision|0
2631134|NCT00849693|9092454|P3|Extension Phase|Physician Decision|2
2631135|NCT00849693|9092455|P2|Extension Phase|Physician Decision|1
2631136|NCT00849693|9092456|P1|Extension Phase|Physician Decision|1
2631137|NCT00849693|9092453|P4|Extension Phase|Parent or caregiver decision|5
2631138|NCT00849693|9092454|P3|Extension Phase|Parent or caregiver decision|10
2631139|NCT00849693|9092455|P2|Extension Phase|Parent or caregiver decision|4
2631140|NCT00849693|9092456|P1|Extension Phase|Parent or caregiver decision|9
2631141|NCT00849693|9092453|P4|Extension Phase|Withdrawal by Subject|15
2631142|NCT00849693|9092454|P3|Extension Phase|Withdrawal by Subject|10
2631143|NCT00849693|9092455|P2|Extension Phase|Withdrawal by Subject|9
2631144|NCT00849693|9092456|P1|Extension Phase|Withdrawal by Subject|6
2631145|NCT00849693|9092453|P4|Extension Phase|Protocol Violation|3
2631146|NCT00849693|9092454|P3|Extension Phase|Protocol Violation|2
2631147|NCT00849693|9092455|P2|Extension Phase|Protocol Violation|3
2631148|NCT00849693|9092456|P1|Extension Phase|Protocol Violation|0
2631149|NCT00849693|9092453|P4|Extension Phase|Lost to Follow-up|6
2631150|NCT00849693|9092454|P3|Extension Phase|Lost to Follow-up|6
2631151|NCT00849693|9092455|P2|Extension Phase|Lost to Follow-up|5
2631152|NCT00849693|9092456|P1|Extension Phase|Lost to Follow-up|7
2631153|NCT00849693|9092453|P4|Extension Phase|Adverse Event|7
2631154|NCT00849693|9092454|P3|Extension Phase|Adverse Event|3
2631155|NCT00849693|9092455|P2|Extension Phase|Adverse Event|6
2631156|NCT00849693|9092456|P1|Extension Phase|Adverse Event|4
2631157|NCT00849693|9092453|P4|Acute Treatment Phase|Lack of Efficacy|2
2631158|NCT00849693|9092454|P3|Acute Treatment Phase|Lack of Efficacy|1
2631159|NCT00849693|9092455|P2|Acute Treatment Phase|Lack of Efficacy|3
2631160|NCT00849693|9092456|P1|Acute Treatment Phase|Lack of Efficacy|1
2631161|NCT00849693|9092453|P4|Acute Treatment Phase|Sponsor decision|0
2631162|NCT00849693|9092454|P3|Acute Treatment Phase|Sponsor decision|1
2631163|NCT00849693|9092455|P2|Acute Treatment Phase|Sponsor decision|0
2631164|NCT00849693|9092456|P1|Acute Treatment Phase|Sponsor decision|0
2631165|NCT00849693|9092453|P4|Acute Treatment Phase|Physician Decision|1
2631166|NCT00849693|9092454|P3|Acute Treatment Phase|Physician Decision|2
2631167|NCT00849693|9092455|P2|Acute Treatment Phase|Physician Decision|1
2631168|NCT00849693|9092456|P1|Acute Treatment Phase|Physician Decision|2
2631169|NCT00849693|9092453|P4|Acute Treatment Phase|Parent or caregiver decision|7
2631170|NCT00849693|9092454|P3|Acute Treatment Phase|Parent or caregiver decision|7
2631171|NCT00849693|9092455|P2|Acute Treatment Phase|Parent or caregiver decision|6
2631172|NCT00849693|9092456|P1|Acute Treatment Phase|Parent or caregiver decision|7
2631173|NCT00849693|9092453|P4|Acute Treatment Phase|Withdrawal by Subject|8
2631174|NCT00849693|9092454|P3|Acute Treatment Phase|Withdrawal by Subject|3
2631175|NCT00849693|9092455|P2|Acute Treatment Phase|Withdrawal by Subject|5
2631176|NCT00849693|9092456|P1|Acute Treatment Phase|Withdrawal by Subject|5
2631177|NCT00849693|9092453|P4|Acute Treatment Phase|Protocol Violation|6
2631178|NCT00849693|9092454|P3|Acute Treatment Phase|Protocol Violation|2
2631179|NCT00849693|9092455|P2|Acute Treatment Phase|Protocol Violation|5
2631180|NCT00849693|9092456|P1|Acute Treatment Phase|Protocol Violation|1
2631181|NCT00849693|9092453|P4|Acute Treatment Phase|Lost to Follow-up|9
2631182|NCT00849693|9092454|P3|Acute Treatment Phase|Lost to Follow-up|11
2631183|NCT00849693|9092455|P2|Acute Treatment Phase|Lost to Follow-up|8
2631184|NCT00849693|9092456|P1|Acute Treatment Phase|Lost to Follow-up|5
2631185|NCT00849693|9092453|P4|Acute Treatment Phase|Adverse Event|4
2631186|NCT00849693|9092454|P3|Acute Treatment Phase|Adverse Event|6
2631187|NCT00849693|9092455|P2|Acute Treatment Phase|Adverse Event|7
2631188|NCT00849693|9092456|P1|Acute Treatment Phase|Adverse Event|12
2631189|NCT00849680|9092523|P8|Overall Study|Subject unable to comply with protocol|0
2631190|NCT00849680|9092524|P7|Overall Study|Subject unable to comply with protocol|0
2631191|NCT00849680|9092525|P6|Overall Study|Subject unable to comply with protocol|0
2631192|NCT00849680|9092526|P5|Overall Study|Subject unable to comply with protocol|0
2631193|NCT00849680|9092527|P4|Overall Study|Subject unable to comply with protocol|0
2631194|NCT00849680|9092528|P3|Overall Study|Subject unable to comply with protocol|0
2631195|NCT00849680|9092529|P2|Overall Study|Subject unable to comply with protocol|0
2631196|NCT00849680|9092530|P1|Overall Study|Subject unable to comply with protocol|1
2631197|NCT00849680|9092523|P8|Overall Study|Withdrawal by Subject|1
2631198|NCT00849680|9092524|P7|Overall Study|Withdrawal by Subject|1
2631199|NCT00849680|9092525|P6|Overall Study|Withdrawal by Subject|2
2631200|NCT00849680|9092526|P5|Overall Study|Withdrawal by Subject|2
2631201|NCT00849680|9092527|P4|Overall Study|Withdrawal by Subject|2
2631202|NCT00849680|9092528|P3|Overall Study|Withdrawal by Subject|0
2631203|NCT00849680|9092529|P2|Overall Study|Withdrawal by Subject|0
2631204|NCT00849680|9092530|P1|Overall Study|Withdrawal by Subject|2
2631205|NCT00849680|9092523|P8|Overall Study|Subject moved|2
2631206|NCT00849680|9092524|P7|Overall Study|Subject moved|2
2631207|NCT00849680|9092525|P6|Overall Study|Subject moved|2
2631208|NCT00849680|9092526|P5|Overall Study|Subject moved|0
2631209|NCT00849680|9092527|P4|Overall Study|Subject moved|1
2631210|NCT00849680|9092528|P3|Overall Study|Subject moved|3
2631211|NCT00849680|9092529|P2|Overall Study|Subject moved|0
2631212|NCT00849680|9092530|P1|Overall Study|Subject moved|1
2631213|NCT00849680|9092523|P8|Overall Study|Lost to Follow-up|5
2631214|NCT00849680|9092524|P7|Overall Study|Lost to Follow-up|12
2631215|NCT00849680|9092525|P6|Overall Study|Lost to Follow-up|11
2631216|NCT00849680|9092526|P5|Overall Study|Lost to Follow-up|8
2631217|NCT00849680|9092527|P4|Overall Study|Lost to Follow-up|11
2631218|NCT00849680|9092528|P3|Overall Study|Lost to Follow-up|12
2631219|NCT00849680|9092529|P2|Overall Study|Lost to Follow-up|3
2631220|NCT00849680|9092530|P1|Overall Study|Lost to Follow-up|7
2631221|NCT00849680|9092523|P8|Overall Study|Adverse Event|0
2631222|NCT00849680|9092524|P7|Overall Study|Adverse Event|2
2631223|NCT00849680|9092525|P6|Overall Study|Adverse Event|0
2631224|NCT00849680|9092526|P5|Overall Study|Adverse Event|0
2631225|NCT00849680|9092527|P4|Overall Study|Adverse Event|0
2631226|NCT00849680|9092528|P3|Overall Study|Adverse Event|0
2631227|NCT00849680|9092529|P2|Overall Study|Adverse Event|0
2631228|NCT00849680|9092530|P1|Overall Study|Adverse Event|0
2631229|NCT00849524|9092572|P1|Overall Study|Lack of Efficacy|3
2631230|NCT00849472|9092589|P1|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1
2631231|NCT00849472|9092589|P1|Pazopanib Postsurgery Treatment|Moved|1
2631232|NCT00849472|9092589|P1|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5
2631233|NCT00849472|9092589|P1|Pazopanib Postsurgery Treatment|Adverse Event|19
2631234|NCT00849472|9092589|P1|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1
2631235|NCT00849472|9092589|P1|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1
2631236|NCT00849472|9092589|P1|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4
2631237|NCT00849472|9092589|P1|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52
2631238|NCT00849472|9092589|P1|Weekly Paclitaxel|Physician Decision|3
2631239|NCT00849472|9092589|P1|Weekly Paclitaxel|Withdrawal by Subject|1
2631240|NCT00849472|9092589|P1|Weekly Paclitaxel|Adverse Event|11
2631241|NCT00849472|9092589|P1|Weekly Paclitaxel|Disease Progression|1
2631242|NCT00849472|9092589|P1|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1
2631243|NCT00849472|9092589|P1|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1
2631244|NCT00849472|9092589|P1|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1
2631245|NCT00849472|9092589|P1|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1
2631246|NCT00849472|9092589|P1|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2
2631247|NCT00849381|9092603|P1|Overall Study|Other|4
2631248|NCT00849381|9092603|P1|Overall Study|Withdrawal by Subject|6
2631249|NCT00849381|9092603|P1|Overall Study|Protocol Violation|5
2631250|NCT00849381|9092603|P1|Overall Study|Lost to Follow-up|129
2631251|NCT00849381|9092603|P1|Overall Study|Adverse Event|1
2631252|NCT00849290|9092609|P1|Overall Study|Disease Progression|20
2631253|NCT00849290|9092609|P1|Overall Study|Protocol Violation|5
2631254|NCT00849290|9092609|P1|Overall Study|Lost to Follow-up|2
2631255|NCT00849290|9092609|P1|Overall Study|Withdrawal by Subject|11
2631256|NCT00849290|9092609|P1|Overall Study|Death|14
2631257|NCT00849290|9092609|P1|Overall Study|Adverse Event|3
2631258|NCT00849212|9092620|P1|Overall Study|Miscellaneous|1
2631259|NCT00849212|9092620|P1|Overall Study|Adverse Event|2
2631260|NCT00849212|9092620|P1|Overall Study|Withdrawal by Subject|3
2631261|NCT00849212|9092620|P1|Overall Study|Lack of Efficacy|1
2631262|NCT00849186|9092625|P1|Overall Study|Other|1
2631263|NCT00849186|9092625|P1|Overall Study|not treated|6
2631264|NCT00849186|9092625|P1|Overall Study|Withdrawal by Subject|1
2631265|NCT00849186|9092625|P1|Overall Study|Adverse Event|2
2631266|NCT00849147|9092631|P1|Overall Study|Disease Relapse/Progression|2
2631267|NCT00849147|9092631|P1|Overall Study|Protocol Violation|2
2631268|NCT00849147|9092631|P1|Overall Study|Withdrawal by Subject|1
2631269|NCT00849108|9092664|P2|Cohort 2 Efficacy|Other|9
2631270|NCT00849108|9092665|P1|Cohort 2 Efficacy|Other|0
2631271|NCT00849108|9092664|P2|Cohort 2 Efficacy|Adverse Event|1
2631272|NCT00849108|9092665|P1|Cohort 2 Efficacy|Adverse Event|0
2631273|NCT00849108|9092664|P2|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0
2631274|NCT00849108|9092665|P1|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1
2631275|NCT00849056|9092675|P2|Follow-up Period (FUP) (8 Weeks)|Early Termination|0
2631276|NCT00849056|9092676|P1|Follow-up Period (FUP) (8 Weeks)|Early Termination|1
2631277|NCT00849056|9092675|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4
2631278|NCT00849056|9092676|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1
2631279|NCT00849056|9092675|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
2631280|NCT00849056|9092676|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
2631281|NCT00849056|9092675|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7
2631282|NCT00849056|9092676|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9
2631283|NCT00849056|9092675|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9
2631284|NCT00849056|9092676|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14
2631285|NCT00849056|9092675|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
2631286|NCT00849056|9092676|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
2631287|NCT00849056|9092675|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3
2631288|NCT00849056|9092676|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
2631289|NCT00849056|9092675|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|0
2631290|NCT00849056|9092676|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|1
2631291|NCT00849056|9092675|P2|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0
2631292|NCT00849056|9092676|P1|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1
2631293|NCT00849056|9092675|P2|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4
2631294|NCT00849056|9092676|P1|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1
2631295|NCT00849056|9092675|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|3
2631296|NCT00849056|9092676|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|3
2631297|NCT00849056|9092675|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18
2631298|NCT00849056|9092676|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31
2631299|NCT00849056|9092675|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5
2631300|NCT00849056|9092676|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
2631301|NCT00849056|9092675|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|3
2631302|NCT00849056|9092676|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|3
2631303|NCT00849056|9092675|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|6
2631304|NCT00849056|9092676|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|3
2631305|NCT00849056|9092675|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|11
2631306|NCT00849056|9092676|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|13
2631307|NCT00849017|9092701|P3|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
2631308|NCT00849017|9092702|P2|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
2631309|NCT00849017|9092703|P1|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1
2631310|NCT00849017|9092701|P3|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
2631311|NCT00849017|9092702|P2|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
2631312|NCT00849017|9092703|P1|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3
2631313|NCT00849017|9092701|P3|Follow-up Period (8 Weeks)|Physician Decision|1
2631314|NCT00849017|9092702|P2|Follow-up Period (8 Weeks)|Physician Decision|1
2631315|NCT00849017|9092703|P1|Follow-up Period (8 Weeks)|Physician Decision|0
2631316|NCT00849017|9092701|P3|Follow-up Period (8 Weeks)|Withdrawal by Subject|3
2631317|NCT00849017|9092702|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
2631318|NCT00849017|9092703|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
2631319|NCT00849017|9092701|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4
2631320|NCT00849017|9092702|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
2631321|NCT00849017|9092703|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
2631322|NCT00849017|9092701|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|16
2631323|NCT00849017|9092702|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
2631324|NCT00849017|9092703|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|13
2631325|NCT00849017|9092701|P3|Follow-up Period (8 Weeks)|Noncompliance|0
2631326|NCT00849017|9092702|P2|Follow-up Period (8 Weeks)|Noncompliance|1
2631327|NCT00849017|9092703|P1|Follow-up Period (8 Weeks)|Noncompliance|2
2631328|NCT00849017|9092701|P3|Follow-up Period (8 Weeks)|Adverse Event|0
2631329|NCT00849017|9092702|P2|Follow-up Period (8 Weeks)|Adverse Event|0
2631330|NCT00849017|9092703|P1|Follow-up Period (8 Weeks)|Adverse Event|1
2631331|NCT00849017|9092701|P3|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1
2631332|NCT00849017|9092702|P2|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
2631333|NCT00849017|9092703|P1|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
2631334|NCT00849017|9092701|P3|Treatment Period (156 Weeks)|Pregnancy|1
2631335|NCT00849017|9092702|P2|Treatment Period (156 Weeks)|Pregnancy|0
2631336|NCT00849017|9092703|P1|Treatment Period (156 Weeks)|Pregnancy|1
2631337|NCT00849017|9092701|P3|Treatment Period (156 Weeks)|Participant Moved to Africa|0
2631338|NCT00849017|9092702|P2|Treatment Period (156 Weeks)|Participant Moved to Africa|0
2631339|NCT00849017|9092703|P1|Treatment Period (156 Weeks)|Participant Moved to Africa|1
2631340|NCT00849017|9092701|P3|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
2631341|NCT00849017|9092702|P2|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
2631342|NCT00849017|9092703|P1|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1
2631343|NCT00849017|9092701|P3|Treatment Period (156 Weeks)|Increased Calcitonin|0
2631344|NCT00849017|9092702|P2|Treatment Period (156 Weeks)|Increased Calcitonin|0
2631345|NCT00849017|9092703|P1|Treatment Period (156 Weeks)|Increased Calcitonin|1
2631346|NCT00849017|9092701|P3|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
2631347|NCT00849017|9092702|P2|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
2631348|NCT00849017|9092703|P1|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3
2631349|NCT00849017|9092701|P3|Treatment Period (156 Weeks)|Physician Decision|1
2631350|NCT00849017|9092702|P2|Treatment Period (156 Weeks)|Physician Decision|2
2631351|NCT00849017|9092703|P1|Treatment Period (156 Weeks)|Physician Decision|0
2631352|NCT00849017|9092701|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|11
2631353|NCT00849017|9092702|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|14
2631354|NCT00849017|9092703|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|18
2631355|NCT00849017|9092701|P3|Treatment Period (156 Weeks)|Lost to Follow-up|8
2631356|NCT00849017|9092702|P2|Treatment Period (156 Weeks)|Lost to Follow-up|7
2631357|NCT00849017|9092703|P1|Treatment Period (156 Weeks)|Lost to Follow-up|10
2631358|NCT00849017|9092701|P3|Treatment Period (156 Weeks)|Noncompliance|4
2631359|NCT00849017|9092702|P2|Treatment Period (156 Weeks)|Noncompliance|3
2631360|NCT00849017|9092703|P1|Treatment Period (156 Weeks)|Noncompliance|3
2631361|NCT00849017|9092701|P3|Treatment Period (156 Weeks)|Adverse Event|15
2631362|NCT00849017|9092702|P2|Treatment Period (156 Weeks)|Adverse Event|6
2631363|NCT00849017|9092703|P1|Treatment Period (156 Weeks)|Adverse Event|5
2631364|NCT00848965|9092746|P1|Overall Study|Withdrawal by Subject|1
2631365|NCT00848965|9092746|P1|Overall Study|Adverse Event|1
2631366|NCT00848926|9092788|P1|Follow-up Period|Other|2
2631367|NCT00848926|9092788|P1|Follow-up Period|Withdrawal by Subject|3
2631368|NCT00848926|9092788|P1|Follow-up Period|Lost to Follow-up|7
2631369|NCT00848926|9092788|P1|Treatment Period|Withdrawal by Subject|7
2631370|NCT00848926|9092788|P1|Treatment Period|Physician Decision|12
2631371|NCT00848926|9092788|P1|Treatment Period|Adverse Event|20
2631372|NCT00848926|9092788|P1|Treatment Period|Progressive disease|45
2631373|NCT00848718|9092838|P13|Overall Study|Progressive disease during treatment|2
2631374|NCT00848718|9092839|P12|Overall Study|Progressive disease during treatment|0
2631375|NCT00848718|9092840|P11|Overall Study|Progressive disease during treatment|0
2631376|NCT00848718|9092841|P10|Overall Study|Progressive disease during treatment|0
2631377|NCT00848718|9092842|P9|Overall Study|Progressive disease during treatment|0
2631378|NCT00848718|9092843|P8|Overall Study|Progressive disease during treatment|2
2631379|NCT00848718|9092844|P7|Overall Study|Progressive disease during treatment|0
2631380|NCT00848718|9092845|P6|Overall Study|Progressive disease during treatment|0
2631381|NCT00848718|9092846|P5|Overall Study|Progressive disease during treatment|0
2631382|NCT00848718|9092847|P4|Overall Study|Progressive disease during treatment|0
2631383|NCT00848718|9092848|P3|Overall Study|Progressive disease during treatment|3
2631384|NCT00848718|9092849|P2|Overall Study|Progressive disease during treatment|0
2631385|NCT00848718|9092850|P1|Overall Study|Progressive disease during treatment|3
2631386|NCT00848718|9092838|P13|Overall Study|Withdrawal by Subject|0
2631387|NCT00848718|9092839|P12|Overall Study|Withdrawal by Subject|0
2631388|NCT00848718|9092840|P11|Overall Study|Withdrawal by Subject|1
2631389|NCT00848718|9092841|P10|Overall Study|Withdrawal by Subject|0
2631390|NCT00848718|9092842|P9|Overall Study|Withdrawal by Subject|0
2631391|NCT00848718|9092843|P8|Overall Study|Withdrawal by Subject|0
2631392|NCT00848718|9092844|P7|Overall Study|Withdrawal by Subject|0
2631393|NCT00848718|9092845|P6|Overall Study|Withdrawal by Subject|0
2631394|NCT00848718|9092846|P5|Overall Study|Withdrawal by Subject|0
2631395|NCT00848718|9092847|P4|Overall Study|Withdrawal by Subject|1
2631396|NCT00848718|9092848|P3|Overall Study|Withdrawal by Subject|0
2631397|NCT00848718|9092849|P2|Overall Study|Withdrawal by Subject|0
2631398|NCT00848718|9092850|P1|Overall Study|Withdrawal by Subject|1
2631399|NCT00848718|9092838|P13|Overall Study|Protocol Violation|1
2631400|NCT00848718|9092839|P12|Overall Study|Protocol Violation|0
2631401|NCT00848718|9092840|P11|Overall Study|Protocol Violation|0
2631402|NCT00848718|9092841|P10|Overall Study|Protocol Violation|0
2631403|NCT00848718|9092842|P9|Overall Study|Protocol Violation|0
2631404|NCT00848718|9092843|P8|Overall Study|Protocol Violation|1
2631405|NCT00848718|9092844|P7|Overall Study|Protocol Violation|0
2631406|NCT00848718|9092845|P6|Overall Study|Protocol Violation|0
2631407|NCT00848718|9092846|P5|Overall Study|Protocol Violation|0
2631408|NCT00848718|9092847|P4|Overall Study|Protocol Violation|0
2631409|NCT00848718|9092848|P3|Overall Study|Protocol Violation|0
2631410|NCT00848718|9092849|P2|Overall Study|Protocol Violation|1
2631411|NCT00848718|9092850|P1|Overall Study|Protocol Violation|0
2631412|NCT00848718|9092838|P13|Overall Study|Progressive disease before treatment|2
2631413|NCT00848718|9092839|P12|Overall Study|Progressive disease before treatment|6
2631414|NCT00848718|9092840|P11|Overall Study|Progressive disease before treatment|3
2631415|NCT00848718|9092841|P10|Overall Study|Progressive disease before treatment|7
2631416|NCT00848718|9092842|P9|Overall Study|Progressive disease before treatment|2
2631417|NCT00848718|9092843|P8|Overall Study|Progressive disease before treatment|1
2631418|NCT00848718|9092844|P7|Overall Study|Progressive disease before treatment|2
2631419|NCT00848718|9092845|P6|Overall Study|Progressive disease before treatment|4
2631420|NCT00848718|9092846|P5|Overall Study|Progressive disease before treatment|4
2631421|NCT00848718|9092847|P4|Overall Study|Progressive disease before treatment|3
2631422|NCT00848718|9092848|P3|Overall Study|Progressive disease before treatment|1
2631423|NCT00848718|9092849|P2|Overall Study|Progressive disease before treatment|5
2631424|NCT00848718|9092850|P1|Overall Study|Progressive disease before treatment|1
2631425|NCT00848718|9092838|P13|Overall Study|Physician Decision|1
2631426|NCT00848718|9092839|P12|Overall Study|Physician Decision|0
2631427|NCT00848718|9092840|P11|Overall Study|Physician Decision|0
2631428|NCT00848718|9092841|P10|Overall Study|Physician Decision|2
2631429|NCT00848718|9092842|P9|Overall Study|Physician Decision|1
2631430|NCT00848718|9092843|P8|Overall Study|Physician Decision|0
2631431|NCT00848718|9092844|P7|Overall Study|Physician Decision|0
2631432|NCT00848718|9092845|P6|Overall Study|Physician Decision|1
2631433|NCT00848718|9092846|P5|Overall Study|Physician Decision|1
2631434|NCT00848718|9092847|P4|Overall Study|Physician Decision|0
2631435|NCT00848718|9092848|P3|Overall Study|Physician Decision|0
2631436|NCT00848718|9092849|P2|Overall Study|Physician Decision|1
2631437|NCT00848718|9092850|P1|Overall Study|Physician Decision|0
2631438|NCT00848718|9092838|P13|Overall Study|Lack of Efficacy|0
2631439|NCT00848718|9092839|P12|Overall Study|Lack of Efficacy|0
2631440|NCT00848718|9092840|P11|Overall Study|Lack of Efficacy|0
2631441|NCT00848718|9092841|P10|Overall Study|Lack of Efficacy|0
2631442|NCT00848718|9092842|P9|Overall Study|Lack of Efficacy|0
2631443|NCT00848718|9092843|P8|Overall Study|Lack of Efficacy|0
2631444|NCT00848718|9092844|P7|Overall Study|Lack of Efficacy|1
2631445|NCT00848718|9092845|P6|Overall Study|Lack of Efficacy|0
2631446|NCT00848718|9092846|P5|Overall Study|Lack of Efficacy|0
2631447|NCT00848718|9092847|P4|Overall Study|Lack of Efficacy|0
2631448|NCT00848718|9092848|P3|Overall Study|Lack of Efficacy|1
2631449|NCT00848718|9092849|P2|Overall Study|Lack of Efficacy|0
2631450|NCT00848718|9092850|P1|Overall Study|Lack of Efficacy|0
2631451|NCT00848718|9092838|P13|Overall Study|Adverse Event|2
2631452|NCT00848718|9092839|P12|Overall Study|Adverse Event|0
2631453|NCT00848718|9092840|P11|Overall Study|Adverse Event|0
2631454|NCT00848718|9092841|P10|Overall Study|Adverse Event|0
2631455|NCT00848718|9092842|P9|Overall Study|Adverse Event|1
2631456|NCT00848718|9092843|P8|Overall Study|Adverse Event|1
2631457|NCT00848718|9092844|P7|Overall Study|Adverse Event|0
2631458|NCT00848718|9092845|P6|Overall Study|Adverse Event|0
2631459|NCT00848718|9092846|P5|Overall Study|Adverse Event|1
2631460|NCT00848718|9092847|P4|Overall Study|Adverse Event|1
2631461|NCT00848718|9092848|P3|Overall Study|Adverse Event|1
2631462|NCT00848718|9092849|P2|Overall Study|Adverse Event|2
2631463|NCT00848718|9092850|P1|Overall Study|Adverse Event|2
2631464|NCT00848549|9092951|P2|E2090-E044-314 (Extension Study)|Other|6
2631465|NCT00848549|9092952|P1|E2090-E044-314 (Extension Study)|Other|5
2631466|NCT00848549|9092951|P2|E2090-E044-314 (Extension Study)|Physician Decision|2
2631467|NCT00848549|9092952|P1|E2090-E044-314 (Extension Study)|Physician Decision|0
2631468|NCT00848549|9092951|P2|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
2631469|NCT00848549|9092952|P1|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
2631470|NCT00848549|9092951|P2|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12
2631471|NCT00848549|9092952|P1|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8
2631472|NCT00848549|9092951|P2|E2090-E044-314 (Extension Study)|Protocol Violation|2
2631473|NCT00848549|9092952|P1|E2090-E044-314 (Extension Study)|Protocol Violation|1
2631474|NCT00848549|9092951|P2|E2090-E044-314 (Extension Study)|Adverse Event|1
2631475|NCT00848549|9092952|P1|E2090-E044-314 (Extension Study)|Adverse Event|2
2631476|NCT00848549|9092951|P2|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34
2631477|NCT00848549|9092952|P1|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24
2631478|NCT00848549|9092951|P2|E2090-E044-310 (Base Study) Disposition|Other|3
2631479|NCT00848549|9092952|P1|E2090-E044-310 (Base Study) Disposition|Other|4
2631480|NCT00848549|9092951|P2|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11
2631481|NCT00848549|9092952|P1|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21
2631482|NCT00848549|9092951|P2|E2090-E044-310 (Base Study) Disposition|Physician Decision|5
2631483|NCT00848549|9092952|P1|E2090-E044-310 (Base Study) Disposition|Physician Decision|4
2631484|NCT00848549|9092951|P2|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8
2631485|NCT00848549|9092952|P1|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3
2631486|NCT00848549|9092951|P2|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
2631487|NCT00848549|9092952|P1|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
2631488|NCT00848549|9092951|P2|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24
2631489|NCT00848549|9092952|P1|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35
2631490|NCT00848549|9092951|P2|E2090-E044-310 (Base Study) Disposition|Adverse Event|35
2631491|NCT00848549|9092952|P1|E2090-E044-310 (Base Study) Disposition|Adverse Event|31
2631492|NCT00848536|9092970|P2|Overall Study|Patient Moved|2
2631493|NCT00848536|9092971|P1|Overall Study|Patient Moved|0
2631494|NCT00848536|9092970|P2|Overall Study|Inadequate Control of IOP|1
2631495|NCT00848536|9092971|P1|Overall Study|Inadequate Control of IOP|1
2631496|NCT00848536|9092970|P2|Overall Study|Noncompliance|0
2631497|NCT00848536|9092971|P1|Overall Study|Noncompliance|1
2631498|NCT00848536|9092970|P2|Overall Study|Protocol Violation|1
2631499|NCT00848536|9092971|P1|Overall Study|Protocol Violation|0
2631500|NCT00848536|9092970|P2|Overall Study|Withdrawal by Subject|1
2631501|NCT00848536|9092971|P1|Overall Study|Withdrawal by Subject|0
2631502|NCT00848536|9092970|P2|Overall Study|Adverse Event|2
2631503|NCT00848536|9092971|P1|Overall Study|Adverse Event|2
2631504|NCT00848497|9093036|P2|Overall Study|Withdrawal by Subject|1
2631505|NCT00848497|9093037|P1|Overall Study|Withdrawal by Subject|0
2631506|NCT00848497|9093036|P2|Overall Study|Screen failure|0
2631507|NCT00848497|9093037|P1|Overall Study|Screen failure|2
2631508|NCT00848484|9093051|P2|Second Intervention (Treatment Period 2)|Lost to Follow-up|1
2631509|NCT00848484|9093052|P1|Second Intervention (Treatment Period 2)|Lost to Follow-up|0
2631510|NCT00848484|9093051|P2|Washout Period of Two Weeks|Withdrawal by Subject|3
2631511|NCT00848484|9093052|P1|Washout Period of Two Weeks|Withdrawal by Subject|0
2631512|NCT00848484|9093051|P2|First Intervention (Treatment Period 1)|Withdrawal by Subject|1
2631513|NCT00848484|9093052|P1|First Intervention (Treatment Period 1)|Withdrawal by Subject|0
2631514|NCT00848484|9093051|P2|First Intervention (Treatment Period 1)|Physician Decision|1
2631515|NCT00848484|9093052|P1|First Intervention (Treatment Period 1)|Physician Decision|0
2631516|NCT00848484|9093051|P2|First Intervention (Treatment Period 1)|Adverse Event|1
2631517|NCT00848484|9093052|P1|First Intervention (Treatment Period 1)|Adverse Event|2
2631518|NCT00848393|9093071|P3|Overall Study|surgical complications unrelated to stud|2
2631519|NCT00848393|9093072|P2|Overall Study|surgical complications unrelated to stud|0
2631520|NCT00848393|9093073|P1|Overall Study|surgical complications unrelated to stud|0
2631521|NCT00848393|9093071|P3|Overall Study|Protocol Violation|1
2631522|NCT00848393|9093072|P2|Overall Study|Protocol Violation|0
2631523|NCT00848393|9093073|P1|Overall Study|Protocol Violation|0
2631524|NCT00848354|9093112|P2|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0
2631525|NCT00848354|9093113|P1|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2
2631526|NCT00848354|9093112|P2|Phase 2 Year 2|Subject Request|1
2631527|NCT00848354|9093113|P1|Phase 2 Year 2|Subject Request|1
2631528|NCT00848354|9093112|P2|Phase 2 Year 2|Protocol Violation|1
2631529|NCT00848354|9093113|P1|Phase 2 Year 2|Protocol Violation|1
2631530|NCT00848354|9093112|P2|Phase 2 Year 2|Unspecified Reason|0
2631531|NCT00848354|9093113|P1|Phase 2 Year 2|Unspecified Reason|1
2631532|NCT00848354|9093112|P2|Phase 2 Year 2|Lost to Follow-up|3
2631533|NCT00848354|9093113|P1|Phase 2 Year 2|Lost to Follow-up|1
2631534|NCT00848354|9093112|P2|Phase 2 Year 2|Failed to return|0
2631535|NCT00848354|9093113|P1|Phase 2 Year 2|Failed to return|3
2631536|NCT00848354|9093112|P2|Phase 2 Year 2|Death|0
2631537|NCT00848354|9093113|P1|Phase 2 Year 2|Death|2
2631538|NCT00848354|9093112|P2|Phase 2 Year 2|Adverse Event|2
2631539|NCT00848354|9093113|P1|Phase 2 Year 2|Adverse Event|12
2631540|NCT00848354|9093112|P2|Phase 2 Year 1|Subject Request|2
2631541|NCT00848354|9093113|P1|Phase 2 Year 1|Subject Request|1
2631542|NCT00848354|9093112|P2|Phase 2 Year 1|Protocol Violation|1
2631543|NCT00848354|9093113|P1|Phase 2 Year 1|Protocol Violation|4
2631544|NCT00848354|9093112|P2|Phase 2 Year 1|Unspecified Reason|0
2631545|NCT00848354|9093113|P1|Phase 2 Year 1|Unspecified Reason|3
2631546|NCT00848354|9093112|P2|Phase 2 Year 1|Lost to Follow-up|0
2631547|NCT00848354|9093113|P1|Phase 2 Year 1|Lost to Follow-up|1
2631548|NCT00848354|9093112|P2|Phase 2 Year 1|Failed to Return|1
2631549|NCT00848354|9093113|P1|Phase 2 Year 1|Failed to Return|1
2631550|NCT00848354|9093112|P2|Phase 2 Year 1|Death|0
2631551|NCT00848354|9093113|P1|Phase 2 Year 1|Death|1
2631552|NCT00848354|9093112|P2|Phase 2 Year 1|Adverse Event|2
2631553|NCT00848354|9093113|P1|Phase 2 Year 1|Adverse Event|7
2631554|NCT00848354|9093112|P2|Phase 1|Lack of Efficacy|1
2631555|NCT00848354|9093113|P1|Phase 1|Lack of Efficacy|0
2631556|NCT00848354|9093112|P2|Phase 1|Withdrawal by Subject|4
2631557|NCT00848354|9093113|P1|Phase 1|Withdrawal by Subject|2
2631558|NCT00848354|9093112|P2|Phase 1|Protocol Violation|1
2631559|NCT00848354|9093113|P1|Phase 1|Protocol Violation|1
2631560|NCT00848354|9093112|P2|Phase 1|Unspecified Reason|1
2631561|NCT00848354|9093113|P1|Phase 1|Unspecified Reason|1
2631562|NCT00848354|9093112|P2|Phase 1|Lost to Follow-up|1
2631563|NCT00848354|9093113|P1|Phase 1|Lost to Follow-up|1
2631564|NCT00848354|9093112|P2|Phase 1|Failed to return|1
2631565|NCT00848354|9093113|P1|Phase 1|Failed to return|0
2631566|NCT00848354|9093112|P2|Phase 1|Discontinuation of study by sponsor|1
2631567|NCT00848354|9093113|P1|Phase 1|Discontinuation of study by sponsor|2
2631568|NCT00848354|9093112|P2|Phase 1|Adverse Event|4
2631569|NCT00848354|9093113|P1|Phase 1|Adverse Event|5
2631570|NCT00848250|9093265|P2|Overall Study|surgery was completed without cardiopulm|1
2631571|NCT00848250|9093266|P1|Overall Study|surgery was completed without cardiopulm|0
2631572|NCT00848211|9093297|P4|Overall Study|Adverse Event|0
2631573|NCT00848211|9093298|P3|Overall Study|Adverse Event|0
2631574|NCT00848211|9093299|P2|Overall Study|Adverse Event|0
2631575|NCT00848211|9093300|P1|Overall Study|Adverse Event|0
2631576|NCT00848211|9093297|P4|Overall Study|Protocol Violation|0
2631577|NCT00848211|9093298|P3|Overall Study|Protocol Violation|1
2631578|NCT00848211|9093299|P2|Overall Study|Protocol Violation|1
2631579|NCT00848211|9093300|P1|Overall Study|Protocol Violation|0
2631580|NCT00848198|9093318|P1|Overall Study|Incomplete Case Report Forms|15
2631581|NCT00848120|9093383|P1|Overall Study|Adverse Event|1
2631582|NCT00848107|9093395|P1|Overall Study|Pregnancy|1
2631583|NCT00848107|9093395|P1|Overall Study|Death|1
2631584|NCT00848107|9093395|P1|Overall Study|Adverse Event|9
2631585|NCT00848107|9093395|P1|Overall Study|Withdrawal by Subject|8
2631586|NCT00848107|9093395|P1|Overall Study|Lost to Follow-up|2
2631587|NCT00848081|9093405|P2|Overall Study|Withdrawal by Subject|3
2631588|NCT00848081|9093406|P1|Overall Study|Withdrawal by Subject|5
2631589|NCT00848081|9093405|P2|Overall Study|Physician Decision|3
2631590|NCT00848081|9093406|P1|Overall Study|Physician Decision|0
2631591|NCT00848081|9093405|P2|Overall Study|Lost to Follow-up|0
2631592|NCT00848081|9093406|P1|Overall Study|Lost to Follow-up|1
2631593|NCT00848081|9093405|P2|Overall Study|Protocol Violation|5
2631594|NCT00848081|9093406|P1|Overall Study|Protocol Violation|8
2631595|NCT00848081|9093405|P2|Overall Study|Adverse Event|7
2631596|NCT00848081|9093406|P1|Overall Study|Adverse Event|6
2631597|NCT00848042|9093423|P3|Overall Study|Other Therapy|0
2631598|NCT00848042|9093424|P2|Overall Study|Other Therapy|0
2631599|NCT00848042|9093425|P1|Overall Study|Other Therapy|3
2631600|NCT00848042|9093423|P3|Overall Study|Death|0
2631601|NCT00848042|9093424|P2|Overall Study|Death|2
2631602|NCT00848042|9093425|P1|Overall Study|Death|1
2631603|NCT00847912|9093461|P2|Overall Study|Withdrawal by Subject|6
2631604|NCT00847912|9093462|P1|Overall Study|Withdrawal by Subject|3
2631605|NCT00847912|9093461|P2|Overall Study|Protocol Violation|7
2631606|NCT00847912|9093462|P1|Overall Study|Protocol Violation|6
2631607|NCT00847886|9093472|P2|Overall Study|Adverse Event|1
2631608|NCT00847886|9093473|P1|Overall Study|Adverse Event|0
2631609|NCT00847808|9093499|P1|Overall Study|Participant Took Excluded Medication|1
2631610|NCT00847808|9093499|P1|Overall Study|Participant Reported Lack of Efficacy|1
2631611|NCT00847808|9093499|P1|Overall Study|Withdrawal by Subject|4
2631612|NCT00847808|9093499|P1|Overall Study|Lost to Follow-up|1
2631613|NCT00847808|9093499|P1|Overall Study|Protocol Violation|1
2631614|NCT00847808|9093499|P1|Overall Study|Adverse Event|7
2631615|NCT00847730|9093516|P1|Overall Study|Multiple interruptions in therapy|8
2631616|NCT00847704|9093520|P1|Overall Study|Withdrawal by Subject|1
2631617|NCT00847665|9093531|P2|Overall Study|Withdrawal by Subject|0
2631618|NCT00847665|9093532|P1|Overall Study|Withdrawal by Subject|1
2631619|NCT00847626|9093555|P11|Overall Study|Other|3
2631620|NCT00847626|9093556|P10|Overall Study|Other|1
2631621|NCT00847626|9093557|P9|Overall Study|Other|1
2631622|NCT00847626|9093558|P8|Overall Study|Other|3
2631623|NCT00847626|9093559|P7|Overall Study|Other|2
2631624|NCT00847626|9093560|P6|Overall Study|Other|2
2631625|NCT00847626|9093561|P5|Overall Study|Other|2
2631626|NCT00847626|9093562|P4|Overall Study|Other|1
2631627|NCT00847626|9093563|P3|Overall Study|Other|4
2631628|NCT00847626|9093564|P2|Overall Study|Other|5
2631629|NCT00847626|9093565|P1|Overall Study|Other|1
2631630|NCT00847626|9093555|P11|Overall Study|Lack of Efficacy|7
2631631|NCT00847626|9093556|P10|Overall Study|Lack of Efficacy|1
2631632|NCT00847626|9093557|P9|Overall Study|Lack of Efficacy|5
2631633|NCT00847626|9093558|P8|Overall Study|Lack of Efficacy|2
2631634|NCT00847626|9093559|P7|Overall Study|Lack of Efficacy|6
2631635|NCT00847626|9093560|P6|Overall Study|Lack of Efficacy|0
2631636|NCT00847626|9093561|P5|Overall Study|Lack of Efficacy|2
2631637|NCT00847626|9093562|P4|Overall Study|Lack of Efficacy|1
2631638|NCT00847626|9093563|P3|Overall Study|Lack of Efficacy|0
2631639|NCT00847626|9093564|P2|Overall Study|Lack of Efficacy|1
2631640|NCT00847626|9093565|P1|Overall Study|Lack of Efficacy|3
2631641|NCT00847626|9093555|P11|Overall Study|Withdrawal by Subject|2
2631642|NCT00847626|9093556|P10|Overall Study|Withdrawal by Subject|5
2631643|NCT00847626|9093557|P9|Overall Study|Withdrawal by Subject|4
2631644|NCT00847626|9093558|P8|Overall Study|Withdrawal by Subject|4
2631645|NCT00847626|9093559|P7|Overall Study|Withdrawal by Subject|8
2631646|NCT00847626|9093560|P6|Overall Study|Withdrawal by Subject|9
2631647|NCT00847626|9093561|P5|Overall Study|Withdrawal by Subject|12
2631648|NCT00847626|9093562|P4|Overall Study|Withdrawal by Subject|8
2631649|NCT00847626|9093563|P3|Overall Study|Withdrawal by Subject|3
2631650|NCT00847626|9093564|P2|Overall Study|Withdrawal by Subject|5
2631651|NCT00847626|9093565|P1|Overall Study|Withdrawal by Subject|5
2631652|NCT00847626|9093555|P11|Overall Study|Lost to Follow-up|1
2631653|NCT00847626|9093556|P10|Overall Study|Lost to Follow-up|0
2631654|NCT00847626|9093557|P9|Overall Study|Lost to Follow-up|1
2631655|NCT00847626|9093558|P8|Overall Study|Lost to Follow-up|3
2631656|NCT00847626|9093559|P7|Overall Study|Lost to Follow-up|1
2631657|NCT00847626|9093560|P6|Overall Study|Lost to Follow-up|3
2631658|NCT00847626|9093561|P5|Overall Study|Lost to Follow-up|0
2631659|NCT00847626|9093562|P4|Overall Study|Lost to Follow-up|1
2631660|NCT00847626|9093563|P3|Overall Study|Lost to Follow-up|1
2631661|NCT00847626|9093564|P2|Overall Study|Lost to Follow-up|1
2631662|NCT00847626|9093565|P1|Overall Study|Lost to Follow-up|0
2631663|NCT00847626|9093555|P11|Overall Study|Protocol Violation|1
2631664|NCT00847626|9093556|P10|Overall Study|Protocol Violation|1
2631665|NCT00847626|9093557|P9|Overall Study|Protocol Violation|0
2631666|NCT00847626|9093558|P8|Overall Study|Protocol Violation|1
2631667|NCT00847626|9093559|P7|Overall Study|Protocol Violation|1
2631668|NCT00847626|9093560|P6|Overall Study|Protocol Violation|1
2631669|NCT00847626|9093561|P5|Overall Study|Protocol Violation|1
2631670|NCT00847626|9093562|P4|Overall Study|Protocol Violation|1
2631671|NCT00847626|9093563|P3|Overall Study|Protocol Violation|2
2631672|NCT00847626|9093564|P2|Overall Study|Protocol Violation|1
2631673|NCT00847626|9093565|P1|Overall Study|Protocol Violation|2
2631674|NCT00847626|9093555|P11|Overall Study|Adverse Event|6
2631675|NCT00847626|9093556|P10|Overall Study|Adverse Event|6
2631676|NCT00847626|9093557|P9|Overall Study|Adverse Event|3
2631677|NCT00847626|9093558|P8|Overall Study|Adverse Event|6
2631678|NCT00847626|9093559|P7|Overall Study|Adverse Event|4
2631679|NCT00847626|9093560|P6|Overall Study|Adverse Event|22
2631680|NCT00847626|9093561|P5|Overall Study|Adverse Event|11
2631681|NCT00847626|9093562|P4|Overall Study|Adverse Event|19
2631682|NCT00847626|9093563|P3|Overall Study|Adverse Event|6
2631683|NCT00847626|9093564|P2|Overall Study|Adverse Event|10
2631684|NCT00847626|9093565|P1|Overall Study|Adverse Event|10
2631685|NCT00847613|9093764|P4|Overall Study|Other|0
2631686|NCT00847613|9093765|P3|Overall Study|Other|2
2631687|NCT00847613|9093766|P2|Overall Study|Other|1
2631688|NCT00847613|9093767|P1|Overall Study|Other|1
2631689|NCT00847613|9093764|P4|Overall Study|Randomized, but not treated|0
2631690|NCT00847613|9093765|P3|Overall Study|Randomized, but not treated|0
2631691|NCT00847613|9093766|P2|Overall Study|Randomized, but not treated|3
2631692|NCT00847613|9093767|P1|Overall Study|Randomized, but not treated|0
2631693|NCT00847613|9093764|P4|Overall Study|Sponsor request|0
2631694|NCT00847613|9093765|P3|Overall Study|Sponsor request|0
2631695|NCT00847613|9093766|P2|Overall Study|Sponsor request|1
2631696|NCT00847613|9093767|P1|Overall Study|Sponsor request|0
2631697|NCT00847613|9093764|P4|Overall Study|Participant moved|0
2631698|NCT00847613|9093765|P3|Overall Study|Participant moved|0
2631699|NCT00847613|9093766|P2|Overall Study|Participant moved|1
2631700|NCT00847613|9093767|P1|Overall Study|Participant moved|4
2631701|NCT00847613|9093764|P4|Overall Study|Withdrawal by Subject|2
2631702|NCT00847613|9093765|P3|Overall Study|Withdrawal by Subject|2
2631703|NCT00847613|9093766|P2|Overall Study|Withdrawal by Subject|11
2631704|NCT00847613|9093767|P1|Overall Study|Withdrawal by Subject|8
2631705|NCT00847613|9093764|P4|Overall Study|Site closure|1
2631706|NCT00847613|9093765|P3|Overall Study|Site closure|0
2631707|NCT00847613|9093766|P2|Overall Study|Site closure|0
2631708|NCT00847613|9093767|P1|Overall Study|Site closure|1
2631709|NCT00847613|9093764|P4|Overall Study|Pregnancy|0
2631710|NCT00847613|9093765|P3|Overall Study|Pregnancy|0
2631711|NCT00847613|9093766|P2|Overall Study|Pregnancy|1
2631712|NCT00847613|9093767|P1|Overall Study|Pregnancy|1
2631713|NCT00847613|9093764|P4|Overall Study|Protocol Violation|1
2631714|NCT00847613|9093765|P3|Overall Study|Protocol Violation|3
2631715|NCT00847613|9093766|P2|Overall Study|Protocol Violation|6
2631716|NCT00847613|9093767|P1|Overall Study|Protocol Violation|6
2631717|NCT00847613|9093764|P4|Overall Study|Lost to Follow-up|3
2631718|NCT00847613|9093765|P3|Overall Study|Lost to Follow-up|0
2631719|NCT00847613|9093766|P2|Overall Study|Lost to Follow-up|0
2631720|NCT00847613|9093767|P1|Overall Study|Lost to Follow-up|5
2631721|NCT00847613|9093764|P4|Overall Study|Study terminated by Sponsor|1
2631722|NCT00847613|9093765|P3|Overall Study|Study terminated by Sponsor|2
2631723|NCT00847613|9093766|P2|Overall Study|Study terminated by Sponsor|0
2631724|NCT00847613|9093767|P1|Overall Study|Study terminated by Sponsor|1
2631725|NCT00847613|9093764|P4|Overall Study|Lack of Efficacy|1
2631726|NCT00847613|9093765|P3|Overall Study|Lack of Efficacy|3
2631727|NCT00847613|9093766|P2|Overall Study|Lack of Efficacy|3
2631728|NCT00847613|9093767|P1|Overall Study|Lack of Efficacy|7
2631729|NCT00847613|9093764|P4|Overall Study|Adverse Event|6
2631730|NCT00847613|9093765|P3|Overall Study|Adverse Event|5
2631731|NCT00847613|9093766|P2|Overall Study|Adverse Event|26
2631732|NCT00847613|9093767|P1|Overall Study|Adverse Event|36
2631733|NCT00847613|9093764|P4|Overall Study|Death|0
2631734|NCT00847613|9093765|P3|Overall Study|Death|0
2631735|NCT00847613|9093766|P2|Overall Study|Death|1
2631736|NCT00847613|9093767|P1|Overall Study|Death|1
2631737|NCT00847613|9093764|P4|Overall Study|Ongoing at cut-off date|64
2631738|NCT00847613|9093765|P3|Overall Study|Ongoing at cut-off date|64
2631739|NCT00847613|9093766|P2|Overall Study|Ongoing at cut-off date|265
2631740|NCT00847613|9093767|P1|Overall Study|Ongoing at cut-off date|250
2631741|NCT00847561|9094018|P2|Overall Study|Unable to schedule|1
2631742|NCT00847561|9094019|P1|Overall Study|Unable to schedule|9
2631743|NCT00847561|9094018|P2|Overall Study|Withdrawal by Subject|3
2631744|NCT00847561|9094019|P1|Overall Study|Withdrawal by Subject|4
2631745|NCT00847535|9094025|P3|Overall Study|Lost to Follow-up|0
2631746|NCT00847535|9094026|P2|Overall Study|Lost to Follow-up|1
2631747|NCT00847535|9094027|P1|Overall Study|Lost to Follow-up|0
2631748|NCT00847535|9094025|P3|Overall Study|Withdrawal by Subject|1
2631749|NCT00847535|9094026|P2|Overall Study|Withdrawal by Subject|1
2631750|NCT00847535|9094027|P1|Overall Study|Withdrawal by Subject|2
2631751|NCT00847405|9094046|P2|Washout of 7 Days|Withdrawal by Subject|0
2631752|NCT00847405|9094047|P1|Washout of 7 Days|Withdrawal by Subject|1
2631753|NCT00847405|9094046|P2|First Intervention|Adverse Event|1
2631754|NCT00847405|9094047|P1|First Intervention|Adverse Event|0
2631755|NCT00847301|9094055|P1|Overall Study|Other reason not defined above|1
2631756|NCT00847301|9094055|P1|Overall Study|No prescription after hospital discharge|1
2631757|NCT00847301|9094055|P1|Overall Study|Lost to Follow-up|1
2631758|NCT00847301|9094055|P1|Overall Study|Switch to other anticoagulants|16
2631759|NCT00847301|9094055|P1|Overall Study|Adverse Event|35
2631760|NCT00847197|9094103|P2|Overall Study|Withdrawal by Subject|1
2631761|NCT00847197|9094104|P1|Overall Study|Withdrawal by Subject|3
2631762|NCT00847197|9094103|P2|Overall Study|Protocol Violation|1
2631763|NCT00847197|9094104|P1|Overall Study|Protocol Violation|0
2631764|NCT00847197|9094103|P2|Overall Study|Adverse Event|3
2631765|NCT00847197|9094104|P1|Overall Study|Adverse Event|21
2631766|NCT00847145|9094128|P8|Overall Study|Protocol Violation|1
2631767|NCT00847145|9094129|P7|Overall Study|Protocol Violation|0
2631768|NCT00847145|9094130|P6|Overall Study|Protocol Violation|0
2631769|NCT00847145|9094131|P5|Overall Study|Protocol Violation|1
2631770|NCT00847145|9094132|P4|Overall Study|Protocol Violation|0
2631771|NCT00847145|9094133|P3|Overall Study|Protocol Violation|3
2631772|NCT00847145|9094134|P2|Overall Study|Protocol Violation|0
2631773|NCT00847145|9094135|P1|Overall Study|Protocol Violation|0
2631774|NCT00847145|9094128|P8|Overall Study|Inappropriate enrollment|0
2631775|NCT00847145|9094129|P7|Overall Study|Inappropriate enrollment|0
2631776|NCT00847145|9094130|P6|Overall Study|Inappropriate enrollment|0
2631777|NCT00847145|9094131|P5|Overall Study|Inappropriate enrollment|1
2631778|NCT00847145|9094132|P4|Overall Study|Inappropriate enrollment|0
2631779|NCT00847145|9094133|P3|Overall Study|Inappropriate enrollment|0
2631780|NCT00847145|9094134|P2|Overall Study|Inappropriate enrollment|0
2631781|NCT00847145|9094135|P1|Overall Study|Inappropriate enrollment|0
2631782|NCT00847145|9094128|P8|Overall Study|Lost to Follow-up|2
2631783|NCT00847145|9094129|P7|Overall Study|Lost to Follow-up|8
2631784|NCT00847145|9094130|P6|Overall Study|Lost to Follow-up|4
2631785|NCT00847145|9094131|P5|Overall Study|Lost to Follow-up|4
2631786|NCT00847145|9094132|P4|Overall Study|Lost to Follow-up|0
2631787|NCT00847145|9094133|P3|Overall Study|Lost to Follow-up|1
2631788|NCT00847145|9094134|P2|Overall Study|Lost to Follow-up|1
2631789|NCT00847145|9094135|P1|Overall Study|Lost to Follow-up|3
2631790|NCT00847145|9094128|P8|Overall Study|Withdrawal by Subject|1
2631791|NCT00847145|9094129|P7|Overall Study|Withdrawal by Subject|1
2631792|NCT00847145|9094130|P6|Overall Study|Withdrawal by Subject|0
2631793|NCT00847145|9094131|P5|Overall Study|Withdrawal by Subject|0
2631794|NCT00847145|9094132|P4|Overall Study|Withdrawal by Subject|1
2631795|NCT00847145|9094133|P3|Overall Study|Withdrawal by Subject|6
2631796|NCT00847145|9094134|P2|Overall Study|Withdrawal by Subject|4
2631797|NCT00847145|9094135|P1|Overall Study|Withdrawal by Subject|3
2631798|NCT00847145|9094128|P8|Overall Study|AE or Death|0
2631799|NCT00847145|9094129|P7|Overall Study|AE or Death|0
2631800|NCT00847145|9094130|P6|Overall Study|AE or Death|0
2631801|NCT00847145|9094131|P5|Overall Study|AE or Death|0
2631802|NCT00847145|9094132|P4|Overall Study|AE or Death|0
2631803|NCT00847145|9094133|P3|Overall Study|AE or Death|1
2631804|NCT00847145|9094134|P2|Overall Study|AE or Death|1
2631805|NCT00847145|9094135|P1|Overall Study|AE or Death|0
2631806|NCT00847132|9094185|P2|Overall Study|Death|1
2631807|NCT00847132|9094186|P1|Overall Study|Death|1
2631808|NCT00847015|9094194|P1|Overall Study|partial cystectomy vs radical cystectomy|1
2631809|NCT00847015|9094194|P1|Overall Study|declined any surgery|1
2631810|NCT00847015|9094194|P1|Overall Study|Withdrawal by Subject|1
2631811|NCT00846846|9094222|P1|Overall Study|Withdrawal by Subject|19
2631812|NCT00846846|9094222|P1|Overall Study|Death|56
2631813|NCT00846807|9094227|P1|Overall Study|Other|60
2631814|NCT00846807|9094227|P1|Overall Study|No prescription after hospital discharge|56
2631815|NCT00846807|9094227|P1|Overall Study|Switch to other anticoagulants|89
2631816|NCT00846807|9094227|P1|Overall Study|Non compliant with European label|7
2631817|NCT00846807|9094227|P1|Overall Study|Withdrawal by Subject|56
2631818|NCT00846807|9094227|P1|Overall Study|Lost to Follow-up|94
2631819|NCT00846807|9094227|P1|Overall Study|Adverse Event|270
2631820|NCT00846768|9094235|P4|Overall Study|Adverse Event|0
2631821|NCT00846768|9094236|P3|Overall Study|Adverse Event|0
2631822|NCT00846768|9094237|P2|Overall Study|Adverse Event|1
2631823|NCT00846768|9094238|P1|Overall Study|Adverse Event|0
2631824|NCT00846742|9094308|P1|Overall Study|Withdrawal by Subject|1
2631825|NCT00846586|9094335|P2|Overall Study|Unsatisfactory therapeutic effect|1
2631826|NCT00846586|9094336|P1|Overall Study|Unsatisfactory therapeutic effect|0
2631827|NCT00846586|9094335|P2|Overall Study|Lost to Follow-up|4
2631828|NCT00846586|9094336|P1|Overall Study|Lost to Follow-up|1
2631829|NCT00846586|9094335|P2|Overall Study|Abnormal test procedure result(s)|0
2631830|NCT00846586|9094336|P1|Overall Study|Abnormal test procedure result(s)|1
2631831|NCT00846586|9094335|P2|Overall Study|Protocol deviation|6
2631832|NCT00846586|9094336|P1|Overall Study|Protocol deviation|2
2631833|NCT00846586|9094335|P2|Overall Study|Death|0
2631834|NCT00846586|9094336|P1|Overall Study|Death|2
2631835|NCT00846586|9094335|P2|Overall Study|Administrative problems|4
2631836|NCT00846586|9094336|P1|Overall Study|Administrative problems|5
2631837|NCT00846586|9094335|P2|Overall Study|Subject withdrew consent|10
2631838|NCT00846586|9094336|P1|Overall Study|Subject withdrew consent|8
2631839|NCT00846586|9094335|P2|Overall Study|Adverse Event|10
2631840|NCT00846586|9094336|P1|Overall Study|Adverse Event|20
2631841|NCT00846521|9094370|P1|Overall Study|Protocol Violation|1
2631842|NCT00846521|9094370|P1|Overall Study|Did not meet OGTT/ CGMS criteria|5
2631843|NCT00846521|9094370|P1|Overall Study|Withdrawal by Subject|5
2631844|NCT00846495|9094377|P2|Overall Study|Physician Decision|0
2631845|NCT00846495|9094378|P1|Overall Study|Physician Decision|1
2631846|NCT00846495|9094377|P2|Overall Study|Lack of Efficacy|2
2631847|NCT00846495|9094378|P1|Overall Study|Lack of Efficacy|1
2631848|NCT00846495|9094377|P2|Overall Study|Adverse Event|1
2631849|NCT00846495|9094378|P1|Overall Study|Adverse Event|5
2631850|NCT00846495|9094377|P2|Overall Study|Lost to Follow-up|0
2631851|NCT00846495|9094378|P1|Overall Study|Lost to Follow-up|1
2631852|NCT00846391|9094401|P3|Overall Study|Study Terminated by Sponsor|2
2631853|NCT00846391|9094402|P2|Overall Study|Study Terminated by Sponsor|2
2631854|NCT00846391|9094403|P1|Overall Study|Study Terminated by Sponsor|1
2631855|NCT00846391|9094401|P3|Overall Study|Physician Decision|1
2631856|NCT00846391|9094402|P2|Overall Study|Physician Decision|0
2631857|NCT00846391|9094403|P1|Overall Study|Physician Decision|0
2631858|NCT00846365|9094414|P3|Overall Study|Other|6
2631859|NCT00846365|9094415|P2|Overall Study|Other|1
2631860|NCT00846365|9094416|P1|Overall Study|Other|9
2631861|NCT00846365|9094414|P3|Overall Study|Lack of Efficacy|2
2631862|NCT00846365|9094415|P2|Overall Study|Lack of Efficacy|1
2631863|NCT00846365|9094416|P1|Overall Study|Lack of Efficacy|1
2631864|NCT00846365|9094414|P3|Overall Study|Pregnancy|0
2631865|NCT00846365|9094415|P2|Overall Study|Pregnancy|0
2631866|NCT00846365|9094416|P1|Overall Study|Pregnancy|1
2631867|NCT00846365|9094414|P3|Overall Study|Withdrawal by Subject|9
2631868|NCT00846365|9094415|P2|Overall Study|Withdrawal by Subject|11
2631869|NCT00846365|9094416|P1|Overall Study|Withdrawal by Subject|11
2631870|NCT00846365|9094414|P3|Overall Study|Lost to Follow-up|5
2631871|NCT00846365|9094415|P2|Overall Study|Lost to Follow-up|2
2631872|NCT00846365|9094416|P1|Overall Study|Lost to Follow-up|8
2631873|NCT00846365|9094414|P3|Overall Study|Protocol Violation|0
2631874|NCT00846365|9094415|P2|Overall Study|Protocol Violation|4
2631875|NCT00846365|9094416|P1|Overall Study|Protocol Violation|5
2631876|NCT00846365|9094414|P3|Overall Study|Adverse Event|11
2631877|NCT00846365|9094415|P2|Overall Study|Adverse Event|30
2631878|NCT00846365|9094416|P1|Overall Study|Adverse Event|20
2631879|NCT00846053|9094497|P2|Overall Study|Physician Decision|0
2631880|NCT00846053|9094498|P1|Overall Study|Physician Decision|3
2631881|NCT00846027|9094506|P1|Overall Study|Subject Not Treated|7
2631882|NCT00846027|9094506|P1|Overall Study|Protocol Violation|2
2631883|NCT00846027|9094506|P1|Overall Study|Investigator Discretion|29
2631884|NCT00846027|9094506|P1|Overall Study|Patient Decision|7
2631885|NCT00846027|9094506|P1|Overall Study|Toxicity|12
2631886|NCT00846027|9094506|P1|Overall Study|Disease Progression|30
2631887|NCT00846027|9094506|P1|Overall Study|Death|3
2631888|NCT00845897|9094529|P3|Overall Study|Too ill to participate|0
2631889|NCT00845897|9094530|P2|Overall Study|Too ill to participate|1
2631890|NCT00845897|9094531|P1|Overall Study|Too ill to participate|0
2631891|NCT00845897|9094529|P3|Overall Study|Ulcer did not heal|1
2631892|NCT00845897|9094530|P2|Overall Study|Ulcer did not heal|0
2631893|NCT00845897|9094531|P1|Overall Study|Ulcer did not heal|1
2631894|NCT00845897|9094529|P3|Overall Study|Withdrawal by Subject|2
2631895|NCT00845897|9094530|P2|Overall Study|Withdrawal by Subject|3
2631896|NCT00845897|9094531|P1|Overall Study|Withdrawal by Subject|0
2631897|NCT00845897|9094529|P3|Overall Study|Lost to Follow-up|0
2631898|NCT00845897|9094530|P2|Overall Study|Lost to Follow-up|1
2631899|NCT00845897|9094531|P1|Overall Study|Lost to Follow-up|1
2631900|NCT00845858|9094545|P3|Overall Study|not eligible|2
2631901|NCT00845858|9094546|P2|Overall Study|not eligible|3
2631902|NCT00845858|9094547|P1|Overall Study|not eligible|0
2631903|NCT00845858|9094545|P3|Overall Study|Protocol Violation|1
2631904|NCT00845858|9094546|P2|Overall Study|Protocol Violation|0
2631905|NCT00845858|9094547|P1|Overall Study|Protocol Violation|0
2631906|NCT00845858|9094545|P3|Overall Study|Adverse Event|4
2631907|NCT00845858|9094546|P2|Overall Study|Adverse Event|8
2631908|NCT00845858|9094547|P1|Overall Study|Adverse Event|3
2631909|NCT00845858|9094545|P3|Overall Study|Withdrawal by Subject|1
2631910|NCT00845858|9094546|P2|Overall Study|Withdrawal by Subject|1
2631911|NCT00845858|9094547|P1|Overall Study|Withdrawal by Subject|5
2631912|NCT00845845|9094560|P2|Overall Study|Lost to Follow-up|4
2631913|NCT00845845|9094561|P1|Overall Study|Lost to Follow-up|0
2631914|NCT00845832|9094572|P3|Extended Safety Follow-Up|Withdrawal by Subject|7
2631915|NCT00845832|9094573|P2|Extended Safety Follow-Up|Withdrawal by Subject|0
2631916|NCT00845832|9094574|P1|Extended Safety Follow-Up|Withdrawal by Subject|0
2631917|NCT00845832|9094572|P3|Safety Follow-Up|Withdrawal by Subject|0
2631918|NCT00845832|9094573|P2|Safety Follow-Up|Withdrawal by Subject|0
2631919|NCT00845832|9094574|P1|Safety Follow-Up|Withdrawal by Subject|1
2631920|NCT00845832|9094572|P3|Treatment Period|Protocol Violation|0
2631921|NCT00845832|9094573|P2|Treatment Period|Protocol Violation|1
2631922|NCT00845832|9094574|P1|Treatment Period|Protocol Violation|1
2631923|NCT00845832|9094572|P3|Treatment Period|Adverse Event|0
2631924|NCT00845832|9094573|P2|Treatment Period|Adverse Event|2
2631925|NCT00845832|9094574|P1|Treatment Period|Adverse Event|0
2631926|NCT00845728|9094620|P2|Overall Study|Withdrawal by Subject|108
2631927|NCT00845728|9094621|P1|Overall Study|Withdrawal by Subject|105
2631928|NCT00845728|9094620|P2|Overall Study|Adverse Event|96
2631929|NCT00845728|9094621|P1|Overall Study|Adverse Event|101
2631930|NCT00845728|9094620|P2|Overall Study|Lack of Efficacy|39
2631931|NCT00845728|9094621|P1|Overall Study|Lack of Efficacy|51
2631932|NCT00845728|9094620|P2|Overall Study|Protocol Violation|24
2631933|NCT00845728|9094621|P1|Overall Study|Protocol Violation|36
2631934|NCT00845728|9094620|P2|Overall Study|Administrative Problems|26
2631935|NCT00845728|9094621|P1|Overall Study|Administrative Problems|34
2631936|NCT00845728|9094620|P2|Overall Study|Death|26
2631937|NCT00845728|9094621|P1|Overall Study|Death|24
2631938|NCT00845728|9094620|P2|Overall Study|Lost to Follow-up|13
2631939|NCT00845728|9094621|P1|Overall Study|Lost to Follow-up|22
2631940|NCT00845728|9094620|P2|Overall Study|Abnormal test procedure result (s)|2
2631941|NCT00845728|9094621|P1|Overall Study|Abnormal test procedure result (s)|7
2631942|NCT00845728|9094620|P2|Overall Study|Patient's inability to use the device|6
2631943|NCT00845728|9094621|P1|Overall Study|Patient's inability to use the device|4
2631944|NCT00845728|9094620|P2|Overall Study|Abnormal laboratory value (s)|2
2631945|NCT00845728|9094621|P1|Overall Study|Abnormal laboratory value (s)|2
2631946|NCT00845676|9094635|P1|Overall Study|Adverse Event|1
2631947|NCT00845676|9094635|P1|Overall Study|Virologic breakthrough at week 20|1
2631948|NCT00845650|9094696|P6|Overall Study|Unable to access IV line|0
2631949|NCT00845650|9094697|P5|Overall Study|Unable to access IV line|0
2631950|NCT00845650|9094698|P4|Overall Study|Unable to access IV line|0
2631951|NCT00845650|9094699|P3|Overall Study|Unable to access IV line|0
2631952|NCT00845650|9094700|P2|Overall Study|Unable to access IV line|0
2631953|NCT00845650|9094701|P1|Overall Study|Unable to access IV line|1
2631954|NCT00845650|9094696|P6|Overall Study|Sponsor hold on dosing|1
2631955|NCT00845650|9094697|P5|Overall Study|Sponsor hold on dosing|1
2631956|NCT00845650|9094698|P4|Overall Study|Sponsor hold on dosing|0
2631957|NCT00845650|9094699|P3|Overall Study|Sponsor hold on dosing|0
2631958|NCT00845650|9094700|P2|Overall Study|Sponsor hold on dosing|0
2631959|NCT00845650|9094701|P1|Overall Study|Sponsor hold on dosing|0
2631960|NCT00845650|9094696|P6|Overall Study|Lost to Follow-up|1
2631961|NCT00845650|9094697|P5|Overall Study|Lost to Follow-up|0
2631962|NCT00845650|9094698|P4|Overall Study|Lost to Follow-up|1
2631963|NCT00845650|9094699|P3|Overall Study|Lost to Follow-up|3
2631964|NCT00845650|9094700|P2|Overall Study|Lost to Follow-up|0
2631965|NCT00845650|9094701|P1|Overall Study|Lost to Follow-up|0
2631966|NCT00845650|9094696|P6|Overall Study|Withdrawal by Subject|0
2631967|NCT00845650|9094697|P5|Overall Study|Withdrawal by Subject|2
2631968|NCT00845650|9094698|P4|Overall Study|Withdrawal by Subject|0
2631969|NCT00845650|9094699|P3|Overall Study|Withdrawal by Subject|0
2631970|NCT00845650|9094700|P2|Overall Study|Withdrawal by Subject|0
2631971|NCT00845650|9094701|P1|Overall Study|Withdrawal by Subject|0
2631972|NCT00845520|9094739|P3|Overall Study|Adverse Event|1
2631973|NCT00845520|9094740|P2|Overall Study|Adverse Event|0
2631974|NCT00845520|9094741|P1|Overall Study|Adverse Event|0
2631975|NCT00845520|9094739|P3|Overall Study|Lost to Follow-up|0
2631976|NCT00845520|9094740|P2|Overall Study|Lost to Follow-up|0
2631977|NCT00845520|9094741|P1|Overall Study|Lost to Follow-up|1
2631978|NCT00845520|9094739|P3|Overall Study|Death|0
2631979|NCT00845520|9094740|P2|Overall Study|Death|2
2631980|NCT00845520|9094741|P1|Overall Study|Death|1
2631981|NCT00845429|9094778|P3|Overall Study|Serious adverse event|1
2631982|NCT00845429|9094779|P2|Overall Study|Serious adverse event|0
2631983|NCT00845429|9094780|P1|Overall Study|Serious adverse event|0
2631984|NCT00845429|9094778|P3|Overall Study|Withdrawal by Subject|2
2631985|NCT00845429|9094779|P2|Overall Study|Withdrawal by Subject|2
2631986|NCT00845429|9094780|P1|Overall Study|Withdrawal by Subject|2
2631987|NCT00845429|9094778|P3|Overall Study|Lost to Follow-up|10
2631988|NCT00845429|9094779|P2|Overall Study|Lost to Follow-up|9
2631989|NCT00845429|9094780|P1|Overall Study|Lost to Follow-up|7
2631990|NCT00845429|9094778|P3|Overall Study|Protocol Violation|7
2631991|NCT00845429|9094779|P2|Overall Study|Protocol Violation|4
2631992|NCT00845429|9094780|P1|Overall Study|Protocol Violation|5
2631993|NCT00845182|9094815|P3|Overall Study|Physician Decision|1
2631994|NCT00845182|9094816|P2|Overall Study|Physician Decision|0
2631995|NCT00845182|9094817|P1|Overall Study|Physician Decision|0
2631996|NCT00845182|9094815|P3|Overall Study|Adverse Event|1
2631997|NCT00845182|9094816|P2|Overall Study|Adverse Event|1
2631998|NCT00845182|9094817|P1|Overall Study|Adverse Event|0
2631999|NCT00845182|9094815|P3|Overall Study|Lost to Follow-up|4
2632000|NCT00845182|9094816|P2|Overall Study|Lost to Follow-up|3
2632001|NCT00845182|9094817|P1|Overall Study|Lost to Follow-up|3
2632002|NCT00845065|9094842|P2|Overall Study|Non-Medical Reasons|11
2632003|NCT00845065|9094843|P1|Overall Study|Non-Medical Reasons|1
2632004|NCT00845065|9094842|P2|Overall Study|Lack of Efficacy|21
2632005|NCT00845065|9094843|P1|Overall Study|Lack of Efficacy|43
2632006|NCT00845065|9094842|P2|Overall Study|Adverse Event|23
2632007|NCT00845065|9094843|P1|Overall Study|Adverse Event|3
2632008|NCT00844896|9094911|P2|Overall Study|Parents did not have time to complete|1
2632009|NCT00844896|9094912|P1|Overall Study|Parents did not have time to complete|0
2632010|NCT00844896|9094911|P2|Overall Study|Lost to Follow-up|16
2632011|NCT00844896|9094912|P1|Overall Study|Lost to Follow-up|12
2632012|NCT00844883|9094934|P1|Overall Study|Bridged to resection|1
2632013|NCT00844883|9094934|P1|Overall Study|Bridged to liver transplant|3
2632014|NCT00844857|9094946|P2|Overall Study|Good Clinical Practice Violations|11
2632015|NCT00844857|9094947|P1|Overall Study|Good Clinical Practice Violations|21
2632016|NCT00844857|9094946|P2|Overall Study|Did Not Take Study Drug|1
2632017|NCT00844857|9094947|P1|Overall Study|Did Not Take Study Drug|3
2632018|NCT00844857|9094946|P2|Overall Study|Lost to Follow-up|3
2632019|NCT00844857|9094947|P1|Overall Study|Lost to Follow-up|2
2632020|NCT00844857|9094946|P2|Overall Study|Entry Criteria Not Met|1
2632021|NCT00844857|9094947|P1|Overall Study|Entry Criteria Not Met|0
2632022|NCT00844857|9094946|P2|Overall Study|Clinical Relapse|1
2632023|NCT00844857|9094947|P1|Overall Study|Clinical Relapse|0
2632024|NCT00844857|9094946|P2|Overall Study|Lack of Efficacy|5
2632025|NCT00844857|9094947|P1|Overall Study|Lack of Efficacy|5
2632026|NCT00844857|9094946|P2|Overall Study|Protocol Violation|0
2632027|NCT00844857|9094947|P1|Overall Study|Protocol Violation|6
2632028|NCT00844857|9094946|P2|Overall Study|Withdrawal by Subject|7
2632029|NCT00844857|9094947|P1|Overall Study|Withdrawal by Subject|8
2632030|NCT00844857|9094946|P2|Overall Study|Parent/Caregiver Decision|2
2632031|NCT00844857|9094947|P1|Overall Study|Parent/Caregiver Decision|6
2632032|NCT00844857|9094946|P2|Overall Study|Physician Decision|0
2632033|NCT00844857|9094947|P1|Overall Study|Physician Decision|2
2632034|NCT00844857|9094946|P2|Overall Study|Sponsor Decision|1
2632035|NCT00844857|9094947|P1|Overall Study|Sponsor Decision|1
2632036|NCT00844857|9094946|P2|Overall Study|Adverse Event|5
2632037|NCT00844857|9094947|P1|Overall Study|Adverse Event|24
2632038|NCT00844844|9094991|P1|Post Treatment Period|Withdrawal by Subject|1
2632039|NCT00844844|9094991|P1|Extension Treatment Period|Adverse Event|2
2632040|NCT00844844|9094991|P1|Treatment Period (26 Weeks)|Protocol Violation|1
2632041|NCT00844844|9094991|P1|Treatment Period (26 Weeks)|Adverse Event|1
2632042|NCT00844831|9095005|P1|Overall Study|Physician Decision|1
2632043|NCT00844831|9095005|P1|Overall Study|Adverse Event|1
2632044|NCT00844831|9095005|P1|Overall Study|Withdrawal by Subject|4
2632045|NCT00844805|9095015|P4|Follow-Up Phase|Did Not Meet Protocol Eligibility|1
2632046|NCT00844805|9095016|P3|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
2632047|NCT00844805|9095017|P2|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
2632048|NCT00844805|9095018|P1|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
2632049|NCT00844805|9095015|P4|Follow-Up Phase|Relapse/Recurrence|4
2632050|NCT00844805|9095016|P3|Follow-Up Phase|Relapse/Recurrence|2
2632051|NCT00844805|9095017|P2|Follow-Up Phase|Relapse/Recurrence|0
2632052|NCT00844805|9095018|P1|Follow-Up Phase|Relapse/Recurrence|0
2632053|NCT00844805|9095015|P4|Follow-Up Phase|Noncompliance With Protocol|1
2632054|NCT00844805|9095016|P3|Follow-Up Phase|Noncompliance With Protocol|0
2632055|NCT00844805|9095017|P2|Follow-Up Phase|Noncompliance With Protocol|0
2632056|NCT00844805|9095018|P1|Follow-Up Phase|Noncompliance With Protocol|0
2632057|NCT00844805|9095015|P4|Follow-Up Phase|Withdrawal by Subject|3
2632058|NCT00844805|9095016|P3|Follow-Up Phase|Withdrawal by Subject|6
2632059|NCT00844805|9095017|P2|Follow-Up Phase|Withdrawal by Subject|0
2632060|NCT00844805|9095018|P1|Follow-Up Phase|Withdrawal by Subject|0
2632061|NCT00844805|9095015|P4|Follow-Up Phase|Adverse Event|0
2632062|NCT00844805|9095016|P3|Follow-Up Phase|Adverse Event|1
2632063|NCT00844805|9095017|P2|Follow-Up Phase|Adverse Event|0
2632064|NCT00844805|9095018|P1|Follow-Up Phase|Adverse Event|0
2632065|NCT00844805|9095015|P4|Treatment Phase|Did Not Meet Protocol Eligibility|0
2632066|NCT00844805|9095016|P3|Treatment Phase|Did Not Meet Protocol Eligibility|0
2632067|NCT00844805|9095017|P2|Treatment Phase|Did Not Meet Protocol Eligibility|2
2632068|NCT00844805|9095018|P1|Treatment Phase|Did Not Meet Protocol Eligibility|1
2632069|NCT00844805|9095015|P4|Treatment Phase|Noncompliance With Protocol|0
2632070|NCT00844805|9095016|P3|Treatment Phase|Noncompliance With Protocol|0
2632071|NCT00844805|9095017|P2|Treatment Phase|Noncompliance With Protocol|0
2632072|NCT00844805|9095018|P1|Treatment Phase|Noncompliance With Protocol|1
2632073|NCT00844805|9095015|P4|Treatment Phase|Withdrawal by Subject|0
2632074|NCT00844805|9095016|P3|Treatment Phase|Withdrawal by Subject|0
2632075|NCT00844805|9095017|P2|Treatment Phase|Withdrawal by Subject|4
2632076|NCT00844805|9095018|P1|Treatment Phase|Withdrawal by Subject|3
2632077|NCT00844805|9095015|P4|Treatment Phase|Adverse Event|0
2632078|NCT00844805|9095016|P3|Treatment Phase|Adverse Event|0
2632079|NCT00844805|9095017|P2|Treatment Phase|Adverse Event|1
2632080|NCT00844805|9095018|P1|Treatment Phase|Adverse Event|5
2632081|NCT00844753|9095062|P4|Overall Study|Withdrawal by Subject|3
2632082|NCT00844753|9095063|P3|Overall Study|Withdrawal by Subject|0
2632083|NCT00844753|9095064|P2|Overall Study|Withdrawal by Subject|0
2632084|NCT00844753|9095065|P1|Overall Study|Withdrawal by Subject|1
2632085|NCT00844753|9095062|P4|Overall Study|could not swallow medication|0
2632086|NCT00844753|9095063|P3|Overall Study|could not swallow medication|0
2632087|NCT00844753|9095064|P2|Overall Study|could not swallow medication|0
2632088|NCT00844753|9095065|P1|Overall Study|could not swallow medication|2
2632089|NCT00844753|9095062|P4|Overall Study|Lost to Follow-up|1
2632090|NCT00844753|9095063|P3|Overall Study|Lost to Follow-up|0
2632091|NCT00844753|9095064|P2|Overall Study|Lost to Follow-up|1
2632092|NCT00844753|9095065|P1|Overall Study|Lost to Follow-up|1
2632093|NCT00844753|9095062|P4|Overall Study|Adverse Event|5
2632094|NCT00844753|9095063|P3|Overall Study|Adverse Event|5
2632095|NCT00844753|9095064|P2|Overall Study|Adverse Event|2
2632096|NCT00844753|9095065|P1|Overall Study|Adverse Event|3
2632097|NCT00844753|9095062|P4|Overall Study|Lack of Efficacy|2
2632098|NCT00844753|9095063|P3|Overall Study|Lack of Efficacy|2
2632099|NCT00844753|9095064|P2|Overall Study|Lack of Efficacy|0
2632100|NCT00844753|9095065|P1|Overall Study|Lack of Efficacy|1
2632101|NCT00844649|9095083|P2|Overall Study|Withdrew prior to starting treatment|27
2632102|NCT00844649|9095084|P1|Overall Study|Withdrew prior to starting treatment|11
2632103|NCT00844649|9095083|P2|Overall Study|Other|10
2632104|NCT00844649|9095084|P1|Overall Study|Other|7
2632105|NCT00844649|9095083|P2|Overall Study|Withdrawal by Subject|39
2632106|NCT00844649|9095084|P1|Overall Study|Withdrawal by Subject|28
2632107|NCT00844649|9095083|P2|Overall Study|Protocol Violation|6
2632108|NCT00844649|9095084|P1|Overall Study|Protocol Violation|10
2632109|NCT00844649|9095083|P2|Overall Study|Physician Decision|18
2632110|NCT00844649|9095084|P1|Overall Study|Physician Decision|25
2632111|NCT00844649|9095083|P2|Overall Study|Adverse Event|73
2632112|NCT00844649|9095084|P1|Overall Study|Adverse Event|128
2632113|NCT00844649|9095083|P2|Overall Study|Progressive Disease|245
2632114|NCT00844649|9095084|P1|Overall Study|Progressive Disease|196
2632115|NCT00844597|9095108|P6|Overall Study|Adverse Event|0
2632116|NCT00844597|9095109|P5|Overall Study|Adverse Event|0
2632117|NCT00844597|9095110|P4|Overall Study|Adverse Event|1
2632118|NCT00844597|9095111|P3|Overall Study|Adverse Event|0
2632119|NCT00844597|9095112|P2|Overall Study|Adverse Event|0
2632120|NCT00844597|9095113|P1|Overall Study|Adverse Event|0
2632121|NCT00844558|9095133|P2|Overall Study|Physician Decision|0
2632122|NCT00844558|9095134|P1|Overall Study|Physician Decision|1
2632123|NCT00844558|9095133|P2|Overall Study|Lost to Follow-up|1
2632124|NCT00844558|9095134|P1|Overall Study|Lost to Follow-up|0
2632125|NCT00844558|9095133|P2|Overall Study|Protocol Violation|1
2632126|NCT00844558|9095134|P1|Overall Study|Protocol Violation|1
2632127|NCT00844558|9095133|P2|Overall Study|Death|0
2632128|NCT00844558|9095134|P1|Overall Study|Death|1
2632129|NCT00844558|9095133|P2|Overall Study|Withdrawal by Subject|2
2632130|NCT00844558|9095134|P1|Overall Study|Withdrawal by Subject|9
2632131|NCT00844545|9095150|P1|Post Treatment Period|Withdrawal by Subject|1
2632132|NCT00844545|9095150|P1|Extension Treatment Period|Adverse Event|2
2632133|NCT00844545|9095150|P1|Treatment Period (26 Weeks)|Protocol Violation|1
2632134|NCT00844545|9095150|P1|Treatment Period (26 Weeks)|Adverse Event|1
2632135|NCT00844532|9095164|P1|Overall Study|Lost to Follow-up|7
2632136|NCT00844532|9095164|P1|Overall Study|Withdrawal by Subject|16
2632137|NCT00844532|9095164|P1|Overall Study|Death|16
2632138|NCT00844519|9095250|P2|Overall Study|Adverse Event|0
2632139|NCT00844519|9095251|P1|Overall Study|Adverse Event|1
2632140|NCT00844519|9095250|P2|Overall Study|Withdrawal by Subject|1
2632141|NCT00844519|9095251|P1|Overall Study|Withdrawal by Subject|1
2632142|NCT00844480|9095259|P2|Overall Study|Withdrawal by Subject|3
2632143|NCT00844480|9095260|P1|Overall Study|Withdrawal by Subject|2
2632144|NCT00844428|9095268|P1|Post Treatment Period (Patients Who Disc|Death|1
2632145|NCT00844428|9095268|P1|Extension Treatment Period|Death|1
2632146|NCT00844428|9095268|P1|Screening Period|Screen Failure|3
2632147|NCT00844415|9095284|P1|Overall Study|Withdrawal by Subject|1
2632148|NCT00844376|9095298|P2|Period 1: First Intervention|Withdrawal by Subject|0
2632149|NCT00844376|9095299|P1|Period 1: First Intervention|Withdrawal by Subject|1
2632150|NCT00844194|9095323|P2|Overall Study|Other reason (not specified)|0
2632151|NCT00844194|9095324|P1|Overall Study|Other reason (not specified)|1
2632152|NCT00844194|9095323|P2|Overall Study|Lack of Efficacy|0
2632153|NCT00844194|9095324|P1|Overall Study|Lack of Efficacy|3
2632154|NCT00844194|9095323|P2|Overall Study|Withdrawal by Subject|1
2632155|NCT00844194|9095324|P1|Overall Study|Withdrawal by Subject|2
2632156|NCT00844194|9095323|P2|Overall Study|Lost to Follow-up|1
2632157|NCT00844194|9095324|P1|Overall Study|Lost to Follow-up|1
2632158|NCT00844194|9095323|P2|Overall Study|Protocol Violation|1
2632159|NCT00844194|9095324|P1|Overall Study|Protocol Violation|1
2632160|NCT00844194|9095323|P2|Overall Study|Adverse Event|5
2632161|NCT00844194|9095324|P1|Overall Study|Adverse Event|17
2632162|NCT00843856|9095579|P2|Overall Study|Lost to Follow-up|2
2632163|NCT00843856|9095580|P1|Overall Study|Lost to Follow-up|1
2632164|NCT00843843|9095590|P2|Overall Study|Protocol Violation|1
2632165|NCT00843843|9095591|P1|Overall Study|Protocol Violation|1
2632166|NCT00843843|9095590|P2|Overall Study|Physician Decision|1
2632167|NCT00843843|9095591|P1|Overall Study|Physician Decision|1
2632168|NCT00843778|9095604|P1|Overall Study|Withdrawal by Subject|4
2632169|NCT00843778|9095604|P1|Overall Study|Loss of efficacy|2
2632170|NCT00843778|9095604|P1|Overall Study|Lack of Efficacy|14
2632171|NCT00843778|9095604|P1|Overall Study|Adverse Event|15
2632172|NCT00843635|9095649|P3|Overall Study|Adverse Event|0
2632173|NCT00843635|9095650|P2|Overall Study|Adverse Event|2
2632174|NCT00843635|9095651|P1|Overall Study|Adverse Event|2
2632175|NCT00843518|9095680|P2|Period 2 (Double-blind Treatment)|Caregiver decision|7
2632176|NCT00843518|9095681|P1|Period 2 (Double-blind Treatment)|Caregiver decision|7
2632177|NCT00843518|9095680|P2|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0
2632178|NCT00843518|9095681|P1|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2
2632179|NCT00843518|9095680|P2|Period 2 (Double-blind Treatment)|Protocol Violation|5
2632180|NCT00843518|9095681|P1|Period 2 (Double-blind Treatment)|Protocol Violation|2
2632181|NCT00843518|9095680|P2|Period 2 (Double-blind Treatment)|Physician Decision|1
2632182|NCT00843518|9095681|P1|Period 2 (Double-blind Treatment)|Physician Decision|2
2632183|NCT00843518|9095680|P2|Period 2 (Double-blind Treatment)|Lost to Follow-up|3
2632184|NCT00843518|9095681|P1|Period 2 (Double-blind Treatment)|Lost to Follow-up|2
2632185|NCT00843518|9095680|P2|Period 2 (Double-blind Treatment)|Death|1
2632186|NCT00843518|9095681|P1|Period 2 (Double-blind Treatment)|Death|0
2632187|NCT00843518|9095680|P2|Period 2 (Double-blind Treatment)|Adverse Event|3
2632188|NCT00843518|9095681|P1|Period 2 (Double-blind Treatment)|Adverse Event|5
2632189|NCT00843492|9095711|P2|Overall Study|Deep-vein Thrombosis|0
2632190|NCT00843492|9095712|P1|Overall Study|Deep-vein Thrombosis|1
2632191|NCT00843492|9095711|P2|Overall Study|Visit Not Performed|0
2632192|NCT00843492|9095712|P1|Overall Study|Visit Not Performed|1
2632193|NCT00843492|9095711|P2|Overall Study|Orthopedic Surgery|2
2632194|NCT00843492|9095712|P1|Overall Study|Orthopedic Surgery|0
2632195|NCT00843492|9095711|P2|Overall Study|Investigator/Orthopedic Surgeon Decision|1
2632196|NCT00843492|9095712|P1|Overall Study|Investigator/Orthopedic Surgeon Decision|1
2632197|NCT00843492|9095711|P2|Overall Study|Immobilization Stopped|0
2632198|NCT00843492|9095712|P1|Overall Study|Immobilization Stopped|1
2632199|NCT00843492|9095711|P2|Overall Study|Withdrawal by Subject|4
2632200|NCT00843492|9095712|P1|Overall Study|Withdrawal by Subject|0
2632201|NCT00843492|9095711|P2|Overall Study|Lost to Follow-up|4
2632202|NCT00843492|9095712|P1|Overall Study|Lost to Follow-up|4
2632203|NCT00843492|9095711|P2|Overall Study|Adverse Event|3
2632204|NCT00843492|9095712|P1|Overall Study|Adverse Event|0
2632205|NCT00843284|9095783|P1|Overall Study|Death|3
2632206|NCT00843284|9095783|P1|Overall Study|Withdrawal by Subject|4
2632207|NCT00843284|9095783|P1|Overall Study|Other|10
2632208|NCT00843284|9095783|P1|Overall Study|Lost to Follow-up|11
2632209|NCT00843284|9095783|P1|Overall Study|Lack of Efficacy|5
2632210|NCT00843284|9095783|P1|Overall Study|Adverse Event|39
2632211|NCT00843193|9095793|P2|Overall Study|Withdrawal by Subject|3
2632212|NCT00843193|9095794|P1|Overall Study|Withdrawal by Subject|3
2632213|NCT00843193|9095793|P2|Overall Study|Physician Decision|1
2632214|NCT00843193|9095794|P1|Overall Study|Physician Decision|0
2632215|NCT00843193|9095793|P2|Overall Study|Lost to Follow-up|0
2632216|NCT00843193|9095794|P1|Overall Study|Lost to Follow-up|1
2632217|NCT00843193|9095793|P2|Overall Study|Protocol Violation|2
2632218|NCT00843193|9095794|P1|Overall Study|Protocol Violation|1
2632219|NCT00843193|9095793|P2|Overall Study|Lack of Efficacy|1
2632220|NCT00843193|9095794|P1|Overall Study|Lack of Efficacy|1
2632221|NCT00843193|9095793|P2|Overall Study|Adverse Event|4
2632222|NCT00843193|9095794|P1|Overall Study|Adverse Event|2
2632223|NCT00843167|9095845|P2|Treatment Period|Withdrawal by Subject|3
2632224|NCT00843167|9095846|P1|Treatment Period|Withdrawal by Subject|2
2632225|NCT00843167|9095845|P2|Treatment Period|Adverse Event|5
2632226|NCT00843167|9095846|P1|Treatment Period|Adverse Event|1
2632227|NCT00843115|9095859|P1|Overall Study|Syndrome De Glissement|1
2632228|NCT00843115|9095859|P1|Overall Study|week 12 not done|1
2632229|NCT00843115|9095859|P1|Overall Study|hospitalized due to deterioration|1
2632230|NCT00843115|9095859|P1|Overall Study|patient never took the medication|1
2632231|NCT00843115|9095859|P1|Overall Study|patient took for 2 days then stopped|1
2632232|NCT00843115|9095859|P1|Overall Study|Family discontinued meds|1
2632233|NCT00843115|9095859|P1|Overall Study|Physician Decision|1
2632234|NCT00843115|9095859|P1|Overall Study|Does not meet entrance criteria|1
2632235|NCT00843115|9095859|P1|Overall Study|Patient forgot to take meds|1
2632236|NCT00843115|9095859|P1|Overall Study|Family does not want continuation|1
2632237|NCT00843115|9095859|P1|Overall Study|Family wanted meds stopped|1
2632238|NCT00843115|9095859|P1|Overall Study|Withdrawal by Subject|17
2632239|NCT00843115|9095859|P1|Overall Study|Lost to Follow-up|4
2632240|NCT00843115|9095859|P1|Overall Study|Adverse Event|30
2632241|NCT00843115|9095859|P1|Overall Study|Death|4
2632242|NCT00843024|9095915|P6|Double-blind Treatment Phase|Lack of Efficacy|0
2632243|NCT00843024|9095916|P5|Double-blind Treatment Phase|Lack of Efficacy|1
2632244|NCT00843024|9095917|P4|Double-blind Treatment Phase|Lack of Efficacy|0
2632245|NCT00843024|9095918|P3|Double-blind Treatment Phase|Lack of Efficacy|0
2632246|NCT00843024|9095919|P2|Double-blind Treatment Phase|Lack of Efficacy|0
2632247|NCT00843024|9095920|P1|Double-blind Treatment Phase|Lack of Efficacy|0
2632248|NCT00843024|9095915|P6|Double-blind Treatment Phase|Adverse Event|1
2632249|NCT00843024|9095916|P5|Double-blind Treatment Phase|Adverse Event|1
2632250|NCT00843024|9095917|P4|Double-blind Treatment Phase|Adverse Event|0
2632251|NCT00843024|9095918|P3|Double-blind Treatment Phase|Adverse Event|0
2632252|NCT00843024|9095919|P2|Double-blind Treatment Phase|Adverse Event|0
2632253|NCT00843024|9095920|P1|Double-blind Treatment Phase|Adverse Event|0
2632254|NCT00843024|9095915|P6|Double-blind Treatment Phase|Physician Decision|1
2632255|NCT00843024|9095916|P5|Double-blind Treatment Phase|Physician Decision|1
2632256|NCT00843024|9095917|P4|Double-blind Treatment Phase|Physician Decision|3
2632257|NCT00843024|9095918|P3|Double-blind Treatment Phase|Physician Decision|0
2632258|NCT00843024|9095919|P2|Double-blind Treatment Phase|Physician Decision|0
2632259|NCT00843024|9095920|P1|Double-blind Treatment Phase|Physician Decision|0
2632260|NCT00843024|9095915|P6|Double-blind Treatment Phase|Protocol Violation|3
2632261|NCT00843024|9095916|P5|Double-blind Treatment Phase|Protocol Violation|0
2632262|NCT00843024|9095917|P4|Double-blind Treatment Phase|Protocol Violation|0
2632263|NCT00843024|9095918|P3|Double-blind Treatment Phase|Protocol Violation|3
2632264|NCT00843024|9095919|P2|Double-blind Treatment Phase|Protocol Violation|0
2632265|NCT00843024|9095920|P1|Double-blind Treatment Phase|Protocol Violation|0
2632266|NCT00843024|9095915|P6|Double-blind Treatment Phase|Withdrawal by Subject|2
2632267|NCT00843024|9095916|P5|Double-blind Treatment Phase|Withdrawal by Subject|0
2632268|NCT00843024|9095917|P4|Double-blind Treatment Phase|Withdrawal by Subject|6
2632269|NCT00843024|9095918|P3|Double-blind Treatment Phase|Withdrawal by Subject|0
2632270|NCT00843024|9095919|P2|Double-blind Treatment Phase|Withdrawal by Subject|0
2632271|NCT00843024|9095920|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
2632272|NCT00843024|9095915|P6|Double-blind Treatment Phase|Lost to Follow-up|4
2632273|NCT00843024|9095916|P5|Double-blind Treatment Phase|Lost to Follow-up|4
2632274|NCT00843024|9095917|P4|Double-blind Treatment Phase|Lost to Follow-up|4
2632275|NCT00843024|9095918|P3|Double-blind Treatment Phase|Lost to Follow-up|8
2632276|NCT00843024|9095919|P2|Double-blind Treatment Phase|Lost to Follow-up|0
2632277|NCT00843024|9095920|P1|Double-blind Treatment Phase|Lost to Follow-up|0
2632278|NCT00843024|9095915|P6|Double-blind Treatment Phase|No opportunity to treat migraine|14
2632279|NCT00843024|9095916|P5|Double-blind Treatment Phase|No opportunity to treat migraine|13
2632280|NCT00843024|9095917|P4|Double-blind Treatment Phase|No opportunity to treat migraine|10
2632281|NCT00843024|9095918|P3|Double-blind Treatment Phase|No opportunity to treat migraine|20
2632282|NCT00843024|9095919|P2|Double-blind Treatment Phase|No opportunity to treat migraine|0
2632283|NCT00843024|9095920|P1|Double-blind Treatment Phase|No opportunity to treat migraine|0
2632284|NCT00843024|9095915|P6|Single-blind Placebo Run-In Phase|Other|0
2632285|NCT00843024|9095916|P5|Single-blind Placebo Run-In Phase|Other|0
2632286|NCT00843024|9095917|P4|Single-blind Placebo Run-In Phase|Other|0
2632287|NCT00843024|9095918|P3|Single-blind Placebo Run-In Phase|Other|0
2632288|NCT00843024|9095919|P2|Single-blind Placebo Run-In Phase|Other|1
2632289|NCT00843024|9095920|P1|Single-blind Placebo Run-In Phase|Other|0
2632290|NCT00843024|9095915|P6|Single-blind Placebo Run-In Phase|Adverse Event|0
2632291|NCT00843024|9095916|P5|Single-blind Placebo Run-In Phase|Adverse Event|0
2632292|NCT00843024|9095917|P4|Single-blind Placebo Run-In Phase|Adverse Event|0
2632293|NCT00843024|9095918|P3|Single-blind Placebo Run-In Phase|Adverse Event|0
2632294|NCT00843024|9095919|P2|Single-blind Placebo Run-In Phase|Adverse Event|1
2632295|NCT00843024|9095920|P1|Single-blind Placebo Run-In Phase|Adverse Event|0
2632296|NCT00843024|9095915|P6|Single-blind Placebo Run-In Phase|Physician Decision|0
2632297|NCT00843024|9095916|P5|Single-blind Placebo Run-In Phase|Physician Decision|0
2632298|NCT00843024|9095917|P4|Single-blind Placebo Run-In Phase|Physician Decision|0
2632299|NCT00843024|9095918|P3|Single-blind Placebo Run-In Phase|Physician Decision|0
2632300|NCT00843024|9095919|P2|Single-blind Placebo Run-In Phase|Physician Decision|6
2632301|NCT00843024|9095920|P1|Single-blind Placebo Run-In Phase|Physician Decision|2
2632302|NCT00843024|9095915|P6|Single-blind Placebo Run-In Phase|Protocol Violation|0
2632303|NCT00843024|9095916|P5|Single-blind Placebo Run-In Phase|Protocol Violation|0
2632304|NCT00843024|9095917|P4|Single-blind Placebo Run-In Phase|Protocol Violation|0
2632305|NCT00843024|9095918|P3|Single-blind Placebo Run-In Phase|Protocol Violation|0
2632306|NCT00843024|9095919|P2|Single-blind Placebo Run-In Phase|Protocol Violation|5
2632307|NCT00843024|9095920|P1|Single-blind Placebo Run-In Phase|Protocol Violation|4
2632308|NCT00843024|9095915|P6|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
2632309|NCT00843024|9095916|P5|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
2632310|NCT00843024|9095917|P4|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
2632311|NCT00843024|9095918|P3|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
2632312|NCT00843024|9095919|P2|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18
2632313|NCT00843024|9095920|P1|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19
2632314|NCT00843024|9095915|P6|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
2632315|NCT00843024|9095916|P5|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
2632316|NCT00843024|9095917|P4|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
2632317|NCT00843024|9095918|P3|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
2632318|NCT00843024|9095919|P2|Single-blind Placebo Run-In Phase|Lost to Follow-up|31
2632319|NCT00843024|9095920|P1|Single-blind Placebo Run-In Phase|Lost to Follow-up|36
2632320|NCT00843024|9095915|P6|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
2632321|NCT00843024|9095916|P5|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
2632322|NCT00843024|9095917|P4|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
2632323|NCT00843024|9095918|P3|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
2632324|NCT00843024|9095919|P2|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74
2632325|NCT00843024|9095920|P1|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79
2632326|NCT00842985|9095985|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
2632327|NCT00842985|9095985|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
2632328|NCT00842985|9095985|P1|First Intervention|Protocol Violation|3
2632329|NCT00842985|9095985|P1|First Intervention|Withdrawal by Subject|3
2632330|NCT00842985|9095985|P1|Screening|Did not meet entrance requirements|27
2632331|NCT00842829|9096003|P3|Continuation Period|Non-compliance to study drug|1
2632332|NCT00842829|9096004|P2|Continuation Period|Non-compliance to study drug|0
2632333|NCT00842829|9096005|P1|Continuation Period|Non-compliance to study drug|0
2632334|NCT00842829|9096003|P3|Continuation Period|Non-compliance to study procedures|2
2632335|NCT00842829|9096004|P2|Continuation Period|Non-compliance to study procedures|0
2632336|NCT00842829|9096005|P1|Continuation Period|Non-compliance to study procedures|0
2632337|NCT00842829|9096003|P3|Continuation Period|Other|7
2632338|NCT00842829|9096004|P2|Continuation Period|Other|0
2632339|NCT00842829|9096005|P1|Continuation Period|Other|0
2632340|NCT00842829|9096003|P3|Continuation Period|Withdrawal by Subject|10
2632341|NCT00842829|9096004|P2|Continuation Period|Withdrawal by Subject|0
2632342|NCT00842829|9096005|P1|Continuation Period|Withdrawal by Subject|0
2632343|NCT00842829|9096003|P3|Continuation Period|Unstable persistent cancer pain|3
2632344|NCT00842829|9096004|P2|Continuation Period|Unstable persistent cancer pain|0
2632345|NCT00842829|9096005|P1|Continuation Period|Unstable persistent cancer pain|0
2632346|NCT00842829|9096003|P3|Continuation Period|Lack of Efficacy|6
2632347|NCT00842829|9096004|P2|Continuation Period|Lack of Efficacy|0
2632348|NCT00842829|9096005|P1|Continuation Period|Lack of Efficacy|0
2632349|NCT00842829|9096003|P3|Continuation Period|Adverse Event|32
2632350|NCT00842829|9096004|P2|Continuation Period|Adverse Event|0
2632351|NCT00842829|9096005|P1|Continuation Period|Adverse Event|0
2632352|NCT00842829|9096003|P3|Treatment Period|Unclear completion status|1
2632353|NCT00842829|9096004|P2|Treatment Period|Unclear completion status|0
2632354|NCT00842829|9096005|P1|Treatment Period|Unclear completion status|0
2632355|NCT00842829|9096003|P3|Treatment Period|Non-compliance to study procedures|4
2632356|NCT00842829|9096004|P2|Treatment Period|Non-compliance to study procedures|0
2632357|NCT00842829|9096005|P1|Treatment Period|Non-compliance to study procedures|0
2632358|NCT00842829|9096003|P3|Treatment Period|Other|18
2632359|NCT00842829|9096004|P2|Treatment Period|Other|0
2632360|NCT00842829|9096005|P1|Treatment Period|Other|0
2632361|NCT00842829|9096003|P3|Treatment Period|Protocol Violation|2
2632362|NCT00842829|9096004|P2|Treatment Period|Protocol Violation|0
2632363|NCT00842829|9096005|P1|Treatment Period|Protocol Violation|0
2632364|NCT00842829|9096003|P3|Treatment Period|Consistently >4 BTP episodes daily|1
2632365|NCT00842829|9096004|P2|Treatment Period|Consistently >4 BTP episodes daily|0
2632366|NCT00842829|9096005|P1|Treatment Period|Consistently >4 BTP episodes daily|0
2632367|NCT00842829|9096003|P3|Treatment Period|Withdrawal by Subject|11
2632368|NCT00842829|9096004|P2|Treatment Period|Withdrawal by Subject|0
2632369|NCT00842829|9096005|P1|Treatment Period|Withdrawal by Subject|0
2632370|NCT00842829|9096003|P3|Treatment Period|Unstable persistent cancer pain|5
2632371|NCT00842829|9096004|P2|Treatment Period|Unstable persistent cancer pain|0
2632372|NCT00842829|9096005|P1|Treatment Period|Unstable persistent cancer pain|0
2632373|NCT00842829|9096003|P3|Treatment Period|Lack of Efficacy|6
2632374|NCT00842829|9096004|P2|Treatment Period|Lack of Efficacy|0
2632375|NCT00842829|9096005|P1|Treatment Period|Lack of Efficacy|0
2632376|NCT00842829|9096003|P3|Treatment Period|Adverse Event|15
2632377|NCT00842829|9096004|P2|Treatment Period|Adverse Event|0
2632378|NCT00842829|9096005|P1|Treatment Period|Adverse Event|0
2632379|NCT00842829|9096003|P3|Dose Titration Period|Non-compliance to study drug|0
2632380|NCT00842829|9096004|P2|Dose Titration Period|Non-compliance to study drug|1
2632381|NCT00842829|9096005|P1|Dose Titration Period|Non-compliance to study drug|2
2632382|NCT00842829|9096003|P3|Dose Titration Period|Non-compliance to study procedures|0
2632383|NCT00842829|9096004|P2|Dose Titration Period|Non-compliance to study procedures|1
2632384|NCT00842829|9096005|P1|Dose Titration Period|Non-compliance to study procedures|1
2632385|NCT00842829|9096003|P3|Dose Titration Period|Other|0
2632386|NCT00842829|9096004|P2|Dose Titration Period|Other|4
2632387|NCT00842829|9096005|P1|Dose Titration Period|Other|5
2632388|NCT00842829|9096003|P3|Dose Titration Period|Withdrawal by Subject|0
2632389|NCT00842829|9096004|P2|Dose Titration Period|Withdrawal by Subject|6
2632390|NCT00842829|9096005|P1|Dose Titration Period|Withdrawal by Subject|2
2632391|NCT00842829|9096003|P3|Dose Titration Period|Unstable persistent cancer pain|0
2632392|NCT00842829|9096004|P2|Dose Titration Period|Unstable persistent cancer pain|0
2632393|NCT00842829|9096005|P1|Dose Titration Period|Unstable persistent cancer pain|1
2632394|NCT00842829|9096003|P3|Dose Titration Period|Lack of Efficacy|0
2632395|NCT00842829|9096004|P2|Dose Titration Period|Lack of Efficacy|1
2632396|NCT00842829|9096005|P1|Dose Titration Period|Lack of Efficacy|4
2632397|NCT00842829|9096003|P3|Dose Titration Period|Adverse Event|0
2632398|NCT00842829|9096004|P2|Dose Titration Period|Adverse Event|10
2632399|NCT00842829|9096005|P1|Dose Titration Period|Adverse Event|11
2632400|NCT00842712|9096064|P7|Randomized Part|Ongoing at cut-off date|2
2632401|NCT00842712|9096065|P6|Randomized Part|Ongoing at cut-off date|0
2632402|NCT00842712|9096066|P5|Randomized Part|Ongoing at cut-off date|0
2632403|NCT00842712|9096067|P4|Randomized Part|Ongoing at cut-off date|0
2632404|NCT00842712|9096068|P3|Randomized Part|Ongoing at cut-off date|0
2632405|NCT00842712|9096069|P2|Randomized Part|Ongoing at cut-off date|0
2632406|NCT00842712|9096070|P1|Randomized Part|Ongoing at cut-off date|0
2632407|NCT00842712|9096064|P7|Randomized Part|Randomized but not treated|4
2632408|NCT00842712|9096065|P6|Randomized Part|Randomized but not treated|1
2632409|NCT00842712|9096066|P5|Randomized Part|Randomized but not treated|0
2632410|NCT00842712|9096067|P4|Randomized Part|Randomized but not treated|0
2632411|NCT00842712|9096068|P3|Randomized Part|Randomized but not treated|0
2632412|NCT00842712|9096069|P2|Randomized Part|Randomized but not treated|0
2632413|NCT00842712|9096070|P1|Randomized Part|Randomized but not treated|0
2632414|NCT00842712|9096064|P7|Safety Run-in Part|Progressive disease|0
2632415|NCT00842712|9096065|P6|Safety Run-in Part|Progressive disease|0
2632416|NCT00842712|9096066|P5|Safety Run-in Part|Progressive disease|0
2632417|NCT00842712|9096067|P4|Safety Run-in Part|Progressive disease|1
2632418|NCT00842712|9096068|P3|Safety Run-in Part|Progressive disease|0
2632419|NCT00842712|9096069|P2|Safety Run-in Part|Progressive disease|1
2632420|NCT00842712|9096070|P1|Safety Run-in Part|Progressive disease|3
2632421|NCT00842712|9096064|P7|Safety Run-in Part|Adverse Event|0
2632422|NCT00842712|9096065|P6|Safety Run-in Part|Adverse Event|0
2632423|NCT00842712|9096066|P5|Safety Run-in Part|Adverse Event|0
2632424|NCT00842712|9096067|P4|Safety Run-in Part|Adverse Event|0
2632425|NCT00842712|9096068|P3|Safety Run-in Part|Adverse Event|0
2632426|NCT00842712|9096069|P2|Safety Run-in Part|Adverse Event|1
2632427|NCT00842712|9096070|P1|Safety Run-in Part|Adverse Event|0
2632428|NCT00842543|9096127|P4|Overall Study|Withdrawal by Subject|4
2632429|NCT00842543|9096128|P3|Overall Study|Withdrawal by Subject|3
2632430|NCT00842543|9096129|P2|Overall Study|Withdrawal by Subject|0
2632431|NCT00842543|9096130|P1|Overall Study|Withdrawal by Subject|2
2632432|NCT00842530|9096144|P2|Overall Study|Withdrawal by Subject|28
2632433|NCT00842530|9096145|P1|Overall Study|Withdrawal by Subject|73
2632434|NCT00842530|9096144|P2|Overall Study|Lost to Follow-up|8
2632435|NCT00842530|9096145|P1|Overall Study|Lost to Follow-up|6
2632436|NCT00842530|9096144|P2|Overall Study|Protocol Violation|14
2632437|NCT00842530|9096145|P1|Overall Study|Protocol Violation|32
2632438|NCT00842530|9096144|P2|Overall Study|Other adverse event|1
2632439|NCT00842530|9096145|P1|Overall Study|Other adverse event|6
2632440|NCT00842530|9096144|P2|Overall Study|Serious adverse event|6
2632441|NCT00842530|9096145|P1|Overall Study|Serious adverse event|0
2632442|NCT00842361|9096175|P2|Overall Study|Unclassified|2
2632443|NCT00842361|9096176|P1|Overall Study|Unclassified|0
2632444|NCT00842361|9096175|P2|Overall Study|Protocol Violation|0
2632445|NCT00842361|9096176|P1|Overall Study|Protocol Violation|1
2632446|NCT00842348|9096196|P2|Study 729|Surgical resection|0
2632447|NCT00842348|9096197|P1|Study 729|Surgical resection|1
2632448|NCT00842348|9096196|P2|Study 729|Sponsor's decision|0
2632449|NCT00842348|9096197|P1|Study 729|Sponsor's decision|1
2632450|NCT00842348|9096196|P2|Study 729|Due to non-availability of IP|1
2632451|NCT00842348|9096197|P1|Study 729|Due to non-availability of IP|0
2632452|NCT00842348|9096196|P2|Study 729|Due to Sponsor stopping the study|1
2632453|NCT00842348|9096197|P1|Study 729|Due to Sponsor stopping the study|1
2632454|NCT00842348|9096196|P2|Study 729|Withdrawal by Subject|4
2632455|NCT00842348|9096197|P1|Study 729|Withdrawal by Subject|2
2632456|NCT00842348|9096196|P2|Study 729|Protocol Violation|1
2632457|NCT00842348|9096197|P1|Study 729|Protocol Violation|1
2632458|NCT00842348|9096196|P2|Study 729|Adverse Event|1
2632459|NCT00842348|9096197|P1|Study 729|Adverse Event|1
2632460|NCT00842348|9096196|P2|Study 729|Disease progression/death|30
2632461|NCT00842348|9096197|P1|Study 729|Disease progression/death|19
2632462|NCT00842348|9096196|P2|Patients Randomised in Study 726|Did not enter Study 729|56
2632463|NCT00842348|9096197|P1|Patients Randomised in Study 726|Did not enter Study 729|59
2632464|NCT00842309|9096216|P2|Overall Study|Withdrawal by Subject|1
2632465|NCT00842309|9096217|P1|Overall Study|Withdrawal by Subject|3
2632466|NCT00842257|9096251|P1|Overall Study|Adverse Event|1
2632467|NCT00842244|9096258|P1|Overall Study|Other|17
2632468|NCT00842244|9096258|P1|Overall Study|Withdrawal by Subject|1
2632469|NCT00842244|9096258|P1|Overall Study|Death|3
2632470|NCT00842153|9096285|P2|Overall Study|Lost to Follow-up|2
2632471|NCT00842153|9096286|P1|Overall Study|Lost to Follow-up|1
2632472|NCT00842153|9096285|P2|Overall Study|Adverse Event|1
2632473|NCT00842153|9096286|P1|Overall Study|Adverse Event|0
2632474|NCT00841906|9096361|P2|Overall Study|Withdrawal by Subject|0
2632475|NCT00841906|9096362|P1|Overall Study|Withdrawal by Subject|2
2632476|NCT00841815|9096387|P2|Washout|Withdrawal by Subject|1
2632477|NCT00841815|9096388|P1|Washout|Withdrawal by Subject|0
2632478|NCT00841776|9096398|P2|Overall Study|Withdrawal by Subject|1
2632479|NCT00841776|9096399|P1|Overall Study|Withdrawal by Subject|0
2632480|NCT00841776|9096398|P2|Overall Study|Lost to Follow-up|1
2632481|NCT00841776|9096399|P1|Overall Study|Lost to Follow-up|2
2632482|NCT00841776|9096398|P2|Overall Study|Lack of Efficacy|1
2632483|NCT00841776|9096399|P1|Overall Study|Lack of Efficacy|0
2632484|NCT00841763|9096417|P4|Overall Study|Unable to Classify|0
2632485|NCT00841763|9096418|P3|Overall Study|Unable to Classify|0
2632486|NCT00841763|9096419|P2|Overall Study|Unable to Classify|1
2632487|NCT00841763|9096420|P1|Overall Study|Unable to Classify|7
2632488|NCT00841763|9096417|P4|Overall Study|Administrative Reasons|0
2632489|NCT00841763|9096418|P3|Overall Study|Administrative Reasons|0
2632490|NCT00841763|9096419|P2|Overall Study|Administrative Reasons|1
2632491|NCT00841763|9096420|P1|Overall Study|Administrative Reasons|3
2632492|NCT00841763|9096417|P4|Overall Study|Protocol Violation|0
2632493|NCT00841763|9096418|P3|Overall Study|Protocol Violation|1
2632494|NCT00841763|9096419|P2|Overall Study|Protocol Violation|3
2632495|NCT00841763|9096420|P1|Overall Study|Protocol Violation|20
2632496|NCT00841763|9096417|P4|Overall Study|Lost to Follow-up|0
2632497|NCT00841763|9096418|P3|Overall Study|Lost to Follow-up|0
2632498|NCT00841763|9096419|P2|Overall Study|Lost to Follow-up|25
2632499|NCT00841763|9096420|P1|Overall Study|Lost to Follow-up|63
2632500|NCT00841763|9096417|P4|Overall Study|Adverse Event|2
2632501|NCT00841763|9096418|P3|Overall Study|Adverse Event|3
2632502|NCT00841763|9096419|P2|Overall Study|Adverse Event|10
2632503|NCT00841763|9096420|P1|Overall Study|Adverse Event|9
2632504|NCT00841763|9096417|P4|Overall Study|Withdrawal by Subject|1
2632505|NCT00841763|9096418|P3|Overall Study|Withdrawal by Subject|4
2632506|NCT00841763|9096419|P2|Overall Study|Withdrawal by Subject|17
2632507|NCT00841763|9096420|P1|Overall Study|Withdrawal by Subject|60
2632508|NCT00841698|9096482|P2|First Intervention|Withdrawal by Subject|0
2632509|NCT00841698|9096483|P1|First Intervention|Withdrawal by Subject|1
2632510|NCT00841672|9096493|P2|Overall Study|Protocol Deviation|1
2632511|NCT00841672|9096494|P1|Overall Study|Protocol Deviation|0
2632512|NCT00841672|9096493|P2|Overall Study|Misrandomized|0
2632513|NCT00841672|9096494|P1|Overall Study|Misrandomized|1
2632514|NCT00841672|9096493|P2|Overall Study|Administrative problems|9
2632515|NCT00841672|9096494|P1|Overall Study|Administrative problems|9
2632516|NCT00841672|9096493|P2|Overall Study|Lost to Follow-up|1
2632517|NCT00841672|9096494|P1|Overall Study|Lost to Follow-up|1
2632518|NCT00841672|9096493|P2|Overall Study|Subject withdrew consent|4
2632519|NCT00841672|9096494|P1|Overall Study|Subject withdrew consent|2
2632520|NCT00841672|9096493|P2|Overall Study|Abnormal test procedure result(s)|1
2632521|NCT00841672|9096494|P1|Overall Study|Abnormal test procedure result(s)|0
2632522|NCT00841672|9096493|P2|Overall Study|Adverse Event|16
2632523|NCT00841672|9096494|P1|Overall Study|Adverse Event|7
2632524|NCT00841659|9096510|P2|Washout: 2 Weeks|Protocol Violation|0
2632525|NCT00841659|9096511|P1|Washout: 2 Weeks|Protocol Violation|1
2632526|NCT00841568|9096519|P1|Overall Study|Creatinine over the withdrawal criteria|1
2632527|NCT00841568|9096519|P1|Overall Study|Withdrawal by Subject|2
2632528|NCT00841568|9096519|P1|Overall Study|Death|1
2632529|NCT00841568|9096519|P1|Overall Study|Adverse Event|1
2632530|NCT00841542|9096547|P2|Period 1|Adverse Event|0
2632531|NCT00841542|9096548|P1|Period 1|Adverse Event|1
2632532|NCT00841321|9096563|P2|Overall Study|Adverse Event|2
2632533|NCT00841321|9096564|P1|Overall Study|Adverse Event|0
2632534|NCT00841321|9096563|P2|Overall Study|Lost to Follow-up|1
2632535|NCT00841321|9096564|P1|Overall Study|Lost to Follow-up|1
2632536|NCT00841100|9096611|P1|Phase 1 (28 Days)|Participant non-compliance|2
2632537|NCT00841100|9096611|P1|Phase 1 (28 Days)|Adverse Event|1
2632538|NCT00841035|9096636|P1|Phase 1 Overall Study|Physician Decision|13
2632539|NCT00840996|9096643|P2|Overall Study|Withdrawal by Subject|0
2632540|NCT00840996|9096644|P1|Overall Study|Withdrawal by Subject|1
2632541|NCT00840879|9096664|P2|Second Intervention|Withdrawal by Subject|0
2632542|NCT00840879|9096665|P1|Second Intervention|Withdrawal by Subject|1
2632543|NCT00840827|9096701|P1|Overall Study|Physician Decision|1
2632544|NCT00840827|9096701|P1|Overall Study|Lack of Efficacy|4
2632545|NCT00840827|9096701|P1|Overall Study|Adverse Event|1
2632546|NCT00840658|9096718|P4|Overall Study|Lost to Follow-up|1
2632547|NCT00840658|9096719|P3|Overall Study|Lost to Follow-up|2
2632548|NCT00840658|9096720|P2|Overall Study|Lost to Follow-up|1
2632549|NCT00840658|9096721|P1|Overall Study|Lost to Follow-up|3
2632550|NCT00840658|9096718|P4|Overall Study|Death|3
2632551|NCT00840658|9096719|P3|Overall Study|Death|3
2632552|NCT00840658|9096720|P2|Overall Study|Death|2
2632553|NCT00840658|9096721|P1|Overall Study|Death|2
2632554|NCT00840632|9096739|P2|Washout|Withdrawal by Subject|1
2632555|NCT00840632|9096740|P1|Washout|Withdrawal by Subject|1
2632556|NCT00840632|9096739|P2|First Intervention|Withdrawal by Subject|1
2632557|NCT00840632|9096740|P1|First Intervention|Withdrawal by Subject|0
2632558|NCT00840463|9096767|P2|Overall Study|Adverse Event|0
2632559|NCT00840463|9096768|P1|Overall Study|Adverse Event|1
2632560|NCT00840450|9096782|P1|Overall Study|Lack of Efficacy|2
2632561|NCT00840450|9096782|P1|Overall Study|Adverse Event|1
2632562|NCT00840411|9096790|P2|Washout|Withdrawal by Subject|0
2632563|NCT00840411|9096791|P1|Washout|Withdrawal by Subject|1
2632564|NCT00840411|9096790|P2|First Intervention|Adverse Event|0
2632565|NCT00840411|9096791|P1|First Intervention|Adverse Event|1
2632566|NCT00840294|9096805|P2|Overall Study|Illness|1
2632567|NCT00840294|9096806|P1|Overall Study|Illness|0
2632568|NCT00840294|9096805|P2|Overall Study|Protocol Violation|3
2632569|NCT00840294|9096806|P1|Overall Study|Protocol Violation|1
2632570|NCT00840294|9096805|P2|Overall Study|Withdrawal by Subject|1
2632571|NCT00840294|9096806|P1|Overall Study|Withdrawal by Subject|2
2632572|NCT00840216|9096827|P2|Washout: 7 Days|Withdrawal by Subject|0
2632573|NCT00840216|9096828|P1|Washout: 7 Days|Withdrawal by Subject|1
2632574|NCT00840203|9096838|P2|Washout|Protocol Violation|0
2632575|NCT00840203|9096839|P1|Washout|Protocol Violation|1
2632576|NCT00840203|9096838|P2|First Intervention|Protocol Violation|1
2632577|NCT00840203|9096839|P1|First Intervention|Protocol Violation|1
2632578|NCT00840177|9096856|P3|Overall Study|Did not start treatment|1
2632579|NCT00840177|9096857|P2|Overall Study|Did not start treatment|0
2632580|NCT00840177|9096858|P1|Overall Study|Did not start treatment|0
2632581|NCT00840177|9096856|P3|Overall Study|Ineligible|3
2632582|NCT00840177|9096857|P2|Overall Study|Ineligible|0
2632583|NCT00840177|9096858|P1|Overall Study|Ineligible|0
2632584|NCT00840177|9096856|P3|Overall Study|not protocol specified|0
2632585|NCT00840177|9096857|P2|Overall Study|not protocol specified|3
2632586|NCT00840177|9096858|P1|Overall Study|not protocol specified|6
2632587|NCT00840177|9096856|P3|Overall Study|Death|5
2632588|NCT00840177|9096857|P2|Overall Study|Death|5
2632589|NCT00840177|9096858|P1|Overall Study|Death|4
2632590|NCT00840177|9096856|P3|Overall Study|Progression/relapse|0
2632591|NCT00840177|9096857|P2|Overall Study|Progression/relapse|0
2632592|NCT00840177|9096858|P1|Overall Study|Progression/relapse|2
2632593|NCT00840177|9096856|P3|Overall Study|Refusal unrelated to adverse events|1
2632594|NCT00840177|9096857|P2|Overall Study|Refusal unrelated to adverse events|0
2632595|NCT00840177|9096858|P1|Overall Study|Refusal unrelated to adverse events|1
2632596|NCT00840177|9096856|P3|Overall Study|Adverse Event|1
2632597|NCT00840177|9096857|P2|Overall Study|Adverse Event|1
2632598|NCT00840177|9096858|P1|Overall Study|Adverse Event|5
2632599|NCT00840086|9096892|P1|Overall Study|Lost to Follow-up|1
2632600|NCT00840086|9096892|P1|Overall Study|Protocol Violation|2
2632601|NCT00840086|9096892|P1|Overall Study|Adverse Event|1
2632602|NCT00840073|9096901|P2|Second Intervention|Missed 72 hour blood draw|1
2632603|NCT00840073|9096902|P1|Second Intervention|Missed 72 hour blood draw|1
2632604|NCT00840060|9096916|P2|Overall Study|Change in emotional/behavioral status|1
2632605|NCT00840060|9096917|P1|Overall Study|Change in emotional/behavioral status|0
2632606|NCT00840060|9096916|P2|Overall Study|Withdrawal by Subject|0
2632607|NCT00840060|9096917|P1|Overall Study|Withdrawal by Subject|1
2632608|NCT00840034|9096927|P2|Taper Phase|Withdrawal by Subject|1
2632609|NCT00840034|9096928|P1|Taper Phase|Withdrawal by Subject|1
2632610|NCT00840034|9096927|P2|Taper Phase|Lost to Follow-up|1
2632611|NCT00840034|9096928|P1|Taper Phase|Lost to Follow-up|1
2632612|NCT00840034|9096927|P2|Taper Phase|Adverse Event|0
2632613|NCT00840034|9096928|P1|Taper Phase|Adverse Event|1
2632614|NCT00840034|9096927|P2|Acute Treatment Phase|Withdrawal by Subject|11
2632615|NCT00840034|9096928|P1|Acute Treatment Phase|Withdrawal by Subject|6
2632616|NCT00840034|9096927|P2|Acute Treatment Phase|Protocol Violation|4
2632617|NCT00840034|9096928|P1|Acute Treatment Phase|Protocol Violation|2
2632618|NCT00840034|9096927|P2|Acute Treatment Phase|Physician Decision|1
2632619|NCT00840034|9096928|P1|Acute Treatment Phase|Physician Decision|0
2632620|NCT00840034|9096927|P2|Acute Treatment Phase|Lost to Follow-up|12
2632621|NCT00840034|9096928|P1|Acute Treatment Phase|Lost to Follow-up|5
2632622|NCT00840034|9096927|P2|Acute Treatment Phase|Lack of Efficacy|0
2632623|NCT00840034|9096928|P1|Acute Treatment Phase|Lack of Efficacy|2
2632624|NCT00840034|9096927|P2|Acute Treatment Phase|Adverse Event|8
2632625|NCT00840034|9096928|P1|Acute Treatment Phase|Adverse Event|6
2632626|NCT00839956|9096981|P1|Overall Study|Withdrawal by Subject|3
2632627|NCT00839956|9096981|P1|Overall Study|Physician Decision|1
2632628|NCT00839956|9096981|P1|Overall Study|Lack of Efficacy|6
2632629|NCT00839956|9096981|P1|Overall Study|Adverse Event|2
2632630|NCT00839917|9097001|P2|Overall Study|Did not receive vaccine|1
2632631|NCT00839917|9097002|P1|Overall Study|Did not receive vaccine|0
2632632|NCT00839917|9097001|P2|Overall Study|Lost to Follow-up|0
2632633|NCT00839917|9097002|P1|Overall Study|Lost to Follow-up|1
2632634|NCT00839852|9097038|P1|Overall Study|Pregnancy|1
2632635|NCT00839852|9097038|P1|Overall Study|Lack of Compliance While in Jail|1
2632636|NCT00839852|9097038|P1|Overall Study|Lost to Follow-up|7
2632637|NCT00839852|9097038|P1|Overall Study|Withdrawal of Consent|16
2632638|NCT00839852|9097038|P1|Overall Study|Protocol Violation|9
2632639|NCT00839852|9097038|P1|Overall Study|Insufficient Therapeutic Response|3
2632640|NCT00839852|9097038|P1|Overall Study|Adverse Event|10
2632641|NCT00839800|9097045|P2|Overall Study|Severe Non-Compliance to Protocol|7
2632642|NCT00839800|9097046|P1|Overall Study|Severe Non-Compliance to Protocol|7
2632643|NCT00839800|9097045|P2|Overall Study|Other|14
2632644|NCT00839800|9097046|P1|Overall Study|Other|8
2632645|NCT00839800|9097045|P2|Overall Study|Safety Reasons|1
2632646|NCT00839800|9097046|P1|Overall Study|Safety Reasons|2
2632647|NCT00839800|9097045|P2|Overall Study|Study-Specific Discontinuation Criteria|13
2632648|NCT00839800|9097046|P1|Overall Study|Study-Specific Discontinuation Criteria|6
2632649|NCT00839800|9097045|P2|Overall Study|Incorrect Enrolment|3
2632650|NCT00839800|9097046|P1|Overall Study|Incorrect Enrolment|3
2632651|NCT00839800|9097045|P2|Overall Study|Withdrawal by Subject|34
2632652|NCT00839800|9097046|P1|Overall Study|Withdrawal by Subject|28
2632653|NCT00839800|9097045|P2|Overall Study|Lost to Follow-up|26
2632654|NCT00839800|9097046|P1|Overall Study|Lost to Follow-up|31
2632655|NCT00839800|9097045|P2|Overall Study|Adverse Event|12
2632656|NCT00839800|9097046|P1|Overall Study|Adverse Event|8
2632657|NCT00839527|9097092|P3|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
2632658|NCT00839527|9097093|P2|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
2632659|NCT00839527|9097094|P1|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0
2632660|NCT00839527|9097092|P3|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
2632661|NCT00839527|9097093|P2|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1
2632662|NCT00839527|9097094|P1|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
2632663|NCT00839527|9097092|P3|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
2632664|NCT00839527|9097093|P2|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0
2632665|NCT00839527|9097094|P1|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
2632666|NCT00839527|9097092|P3|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
2632667|NCT00839527|9097093|P2|Follow-up Period (FUP) (8 Weeks)|Site Closed|1
2632668|NCT00839527|9097094|P1|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
2632742|NCT00839423|9097143|P4|Overall Study|Lost to Follow-up|0
2632669|NCT00839527|9097092|P3|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
2632670|NCT00839527|9097093|P2|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
2632671|NCT00839527|9097094|P1|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1
2632672|NCT00839527|9097092|P3|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
2632673|NCT00839527|9097093|P2|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
2632674|NCT00839527|9097094|P1|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1
2632675|NCT00839527|9097092|P3|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5
2632676|NCT00839527|9097093|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10
2632677|NCT00839527|9097094|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3
2632678|NCT00839527|9097092|P3|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
2632679|NCT00839527|9097093|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
2632680|NCT00839527|9097094|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
2632681|NCT00839527|9097092|P3|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19
2632682|NCT00839527|9097093|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21
2632683|NCT00839527|9097094|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12
2632684|NCT00839527|9097092|P3|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29
2632685|NCT00839527|9097093|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20
2632686|NCT00839527|9097094|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8
2632687|NCT00839527|9097092|P3|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5
2632688|NCT00839527|9097093|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
2632689|NCT00839527|9097094|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
2632690|NCT00839527|9097092|P3|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
2632691|NCT00839527|9097093|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2
2632692|NCT00839527|9097094|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
2632693|NCT00839527|9097092|P3|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1
2632694|NCT00839527|9097093|P2|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
2632695|NCT00839527|9097094|P1|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
2632696|NCT00839527|9097092|P3|Treatment Period (TP) (156 Weeks)|Site Closed|0
2632697|NCT00839527|9097093|P2|Treatment Period (TP) (156 Weeks)|Site Closed|2
2632698|NCT00839527|9097094|P1|Treatment Period (TP) (156 Weeks)|Site Closed|1
2632699|NCT00839527|9097092|P3|Treatment Period (TP) (156 Weeks)|Pregnancy|1
2632700|NCT00839527|9097093|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|1
2632701|NCT00839527|9097094|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|0
2632702|NCT00839527|9097092|P3|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1
2632703|NCT00839527|9097093|P2|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
2632704|NCT00839527|9097094|P1|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
2632705|NCT00839527|9097092|P3|Treatment Period (TP) (156 Weeks)|Missing|0
2632706|NCT00839527|9097093|P2|Treatment Period (TP) (156 Weeks)|Missing|1
2632707|NCT00839527|9097094|P1|Treatment Period (TP) (156 Weeks)|Missing|0
2632708|NCT00839527|9097092|P3|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5
2632709|NCT00839527|9097093|P2|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8
2632710|NCT00839527|9097094|P1|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3
2632711|NCT00839527|9097092|P3|Treatment Period (TP) (156 Weeks)|Physician Decision|1
2632712|NCT00839527|9097093|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|6
2632713|NCT00839527|9097094|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|1
2632714|NCT00839527|9097092|P3|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64
2632715|NCT00839527|9097093|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46
2632716|NCT00839527|9097094|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32
2632717|NCT00839527|9097092|P3|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
2632718|NCT00839527|9097093|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12
2632719|NCT00839527|9097094|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3
2632720|NCT00839527|9097092|P3|Treatment Period (TP) (156 Weeks)|Noncompliance|16
2632721|NCT00839527|9097093|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|6
2632722|NCT00839527|9097094|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|5
2632723|NCT00839527|9097092|P3|Treatment Period (TP) (156 Weeks)|Protocol Violation|1
2632724|NCT00839527|9097093|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|7
2632725|NCT00839527|9097094|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|4
2632726|NCT00839527|9097092|P3|Treatment Period (TP) (156 Weeks)|Adverse Event|22
2632727|NCT00839527|9097093|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|29
2632728|NCT00839527|9097094|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|11
2632729|NCT00839436|9097129|P3|Overall Study|Study drug no longer available|1
2632730|NCT00839436|9097130|P2|Overall Study|Study drug no longer available|0
2632731|NCT00839436|9097131|P1|Overall Study|Study drug no longer available|0
2632732|NCT00839436|9097129|P3|Overall Study|Withdrawal by Subject|0
2632733|NCT00839436|9097130|P2|Overall Study|Withdrawal by Subject|1
2632734|NCT00839436|9097131|P1|Overall Study|Withdrawal by Subject|0
2632735|NCT00839436|9097129|P3|Overall Study|Developed exclusionary condition|0
2632736|NCT00839436|9097130|P2|Overall Study|Developed exclusionary condition|0
2632737|NCT00839436|9097131|P1|Overall Study|Developed exclusionary condition|1
2632738|NCT00839423|9097143|P4|Overall Study|Administrative or other reasons|0
2632739|NCT00839423|9097144|P3|Overall Study|Administrative or other reasons|1
2632740|NCT00839423|9097145|P2|Overall Study|Administrative or other reasons|0
2632741|NCT00839423|9097146|P1|Overall Study|Administrative or other reasons|3
2632743|NCT00839423|9097144|P3|Overall Study|Lost to Follow-up|1
2632744|NCT00839423|9097145|P2|Overall Study|Lost to Follow-up|0
2632745|NCT00839423|9097146|P1|Overall Study|Lost to Follow-up|1
2632746|NCT00839423|9097143|P4|Overall Study|Withdrawal of consent|1
2632747|NCT00839423|9097144|P3|Overall Study|Withdrawal of consent|4
2632748|NCT00839423|9097145|P2|Overall Study|Withdrawal of consent|0
2632749|NCT00839423|9097146|P1|Overall Study|Withdrawal of consent|4
2632750|NCT00839423|9097143|P4|Overall Study|Protocol Violation|0
2632751|NCT00839423|9097144|P3|Overall Study|Protocol Violation|2
2632752|NCT00839423|9097145|P2|Overall Study|Protocol Violation|1
2632753|NCT00839423|9097146|P1|Overall Study|Protocol Violation|0
2632754|NCT00839423|9097143|P4|Overall Study|Non-compliance|1
2632755|NCT00839423|9097144|P3|Overall Study|Non-compliance|0
2632756|NCT00839423|9097145|P2|Overall Study|Non-compliance|0
2632757|NCT00839423|9097146|P1|Overall Study|Non-compliance|0
2632758|NCT00839423|9097143|P4|Overall Study|Lack of Efficacy|2
2632759|NCT00839423|9097144|P3|Overall Study|Lack of Efficacy|3
2632760|NCT00839423|9097145|P2|Overall Study|Lack of Efficacy|6
2632761|NCT00839423|9097146|P1|Overall Study|Lack of Efficacy|6
2632762|NCT00839423|9097143|P4|Overall Study|Adverse Event|16
2632763|NCT00839423|9097144|P3|Overall Study|Adverse Event|7
2632764|NCT00839423|9097145|P2|Overall Study|Adverse Event|3
2632765|NCT00839423|9097146|P1|Overall Study|Adverse Event|4
2632766|NCT00839332|9097187|P3|Phase 2|Lost to Follow-up|1
2632767|NCT00839332|9097188|P2|Phase 2|Lost to Follow-up|0
2632768|NCT00839332|9097189|P1|Phase 2|Lost to Follow-up|0
2632769|NCT00839332|9097187|P3|Phase 2|Physician Decision|1
2632770|NCT00839332|9097188|P2|Phase 2|Physician Decision|4
2632771|NCT00839332|9097189|P1|Phase 2|Physician Decision|0
2632772|NCT00839332|9097187|P3|Phase 2|Withdrawal by Subject|8
2632773|NCT00839332|9097188|P2|Phase 2|Withdrawal by Subject|5
2632774|NCT00839332|9097189|P1|Phase 2|Withdrawal by Subject|0
2632775|NCT00839332|9097187|P3|Phase 2|Death|2
2632776|NCT00839332|9097188|P2|Phase 2|Death|4
2632777|NCT00839332|9097189|P1|Phase 2|Death|0
2632778|NCT00839332|9097187|P3|Phase 2|Adverse Event|6
2632779|NCT00839332|9097188|P2|Phase 2|Adverse Event|8
2632780|NCT00839332|9097189|P1|Phase 2|Adverse Event|0
2632781|NCT00839332|9097187|P3|Phase 2|Disease Progression|21
2632782|NCT00839332|9097188|P2|Phase 2|Disease Progression|46
2632783|NCT00839332|9097189|P1|Phase 2|Disease Progression|0
2632784|NCT00839332|9097187|P3|Phase 2|Protocol Violation|0
2632785|NCT00839332|9097188|P2|Phase 2|Protocol Violation|1
2632786|NCT00839332|9097189|P1|Phase 2|Protocol Violation|0
2632787|NCT00839332|9097187|P3|Phase 1|Physician Decision|0
2632788|NCT00839332|9097188|P2|Phase 1|Physician Decision|0
2632789|NCT00839332|9097189|P1|Phase 1|Physician Decision|2
2632790|NCT00839332|9097187|P3|Phase 1|Withdrawal by Subject|0
2632791|NCT00839332|9097188|P2|Phase 1|Withdrawal by Subject|0
2632792|NCT00839332|9097189|P1|Phase 1|Withdrawal by Subject|4
2632793|NCT00839332|9097187|P3|Phase 1|Adverse Event|0
2632794|NCT00839332|9097188|P2|Phase 1|Adverse Event|0
2632795|NCT00839332|9097189|P1|Phase 1|Adverse Event|6
2632796|NCT00839332|9097187|P3|Phase 1|Disease Progression|0
2632797|NCT00839332|9097188|P2|Phase 1|Disease Progression|0
2632798|NCT00839332|9097189|P1|Phase 1|Disease Progression|38
2632799|NCT00839306|9097250|P2|Overall Study|Other|18
2632800|NCT00839306|9097251|P1|Overall Study|Other|6
2632801|NCT00839306|9097250|P2|Overall Study|Lack of Efficacy|4
2632802|NCT00839306|9097251|P1|Overall Study|Lack of Efficacy|5
2632803|NCT00839306|9097250|P2|Overall Study|Withdrawal by Subject|7
2632804|NCT00839306|9097251|P1|Overall Study|Withdrawal by Subject|5
2632805|NCT00839306|9097250|P2|Overall Study|Lost to Follow-up|9
2632806|NCT00839306|9097251|P1|Overall Study|Lost to Follow-up|6
2632807|NCT00839306|9097250|P2|Overall Study|Adverse Event|5
2632808|NCT00839306|9097251|P1|Overall Study|Adverse Event|3
2632809|NCT00839098|9097349|P3|Overall Study|Withdrawal by Subject|7
2632810|NCT00839098|9097350|P2|Overall Study|Withdrawal by Subject|1
2632811|NCT00839098|9097351|P1|Overall Study|Withdrawal by Subject|2
2632812|NCT00839072|9097377|P2|Second Intervention Period|Withdrawal by Subject|0
2632813|NCT00839072|9097378|P1|Second Intervention Period|Withdrawal by Subject|1
2632814|NCT00839072|9097377|P2|First Intervention Period|Adverse Event|1
2632815|NCT00839072|9097378|P1|First Intervention Period|Adverse Event|1
2632816|NCT00839072|9097377|P2|First Intervention Period|Withdrawal by Subject|0
2632817|NCT00839072|9097378|P1|First Intervention Period|Withdrawal by Subject|1
2632818|NCT00838929|9097422|P3|Overall Study|Disease progression|1
2632819|NCT00838929|9097423|P2|Overall Study|Disease progression|2
2632820|NCT00838929|9097424|P1|Overall Study|Disease progression|0
2632821|NCT00838929|9097422|P3|Overall Study|Protocol Violation|0
2632822|NCT00838929|9097423|P2|Overall Study|Protocol Violation|1
2632823|NCT00838929|9097424|P1|Overall Study|Protocol Violation|0
2632824|NCT00838916|9097432|P2|Follow-up Period (8 Weeks)|Missing|0
2632825|NCT00838916|9097433|P1|Follow-up Period (8 Weeks)|Missing|3
2632826|NCT00838916|9097432|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|0
2632827|NCT00838916|9097433|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
2632828|NCT00838916|9097432|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
2632829|NCT00838916|9097433|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2
2632830|NCT00838916|9097432|P2|Follow-up Period (8 Weeks)|Physician Decision|0
2632831|NCT00838916|9097433|P1|Follow-up Period (8 Weeks)|Physician Decision|2
2632832|NCT00838916|9097432|P2|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12
2632833|NCT00838916|9097433|P1|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26
2632834|NCT00838916|9097432|P2|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
2632835|NCT00838916|9097433|P1|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
2632836|NCT00838916|9097432|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|22
2632837|NCT00838916|9097433|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|38
2632838|NCT00838916|9097432|P2|Follow-up Period (8 Weeks)|Noncompliance|5
2632839|NCT00838916|9097433|P1|Follow-up Period (8 Weeks)|Noncompliance|6
2632840|NCT00838916|9097432|P2|Follow-up Period (8 Weeks)|Adverse Event|5
2632841|NCT00838916|9097433|P1|Follow-up Period (8 Weeks)|Adverse Event|10
2632842|NCT00838916|9097432|P2|Treatment Period (156 Weeks)|Pregnancy|0
2632843|NCT00838916|9097433|P1|Treatment Period (156 Weeks)|Pregnancy|2
2632844|NCT00838916|9097432|P2|Treatment Period (156 Weeks)|Missing|1
2632845|NCT00838916|9097433|P1|Treatment Period (156 Weeks)|Missing|3
2632846|NCT00838916|9097432|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0
2632847|NCT00838916|9097433|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1
2632848|NCT00838916|9097432|P2|Treatment Period (156 Weeks)|Physician Decision|1
2632849|NCT00838916|9097433|P1|Treatment Period (156 Weeks)|Physician Decision|6
2632850|NCT00838916|9097432|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|29
2632851|NCT00838916|9097433|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|81
2632852|NCT00838916|9097432|P2|Treatment Period (156 Weeks)|Lost to Follow-up|18
2632853|NCT00838916|9097433|P1|Treatment Period (156 Weeks)|Lost to Follow-up|19
2632854|NCT00838916|9097432|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
2632855|NCT00838916|9097433|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
2632856|NCT00838916|9097432|P2|Treatment Period (156 Weeks)|Noncompliance|14
2632857|NCT00838916|9097433|P1|Treatment Period (156 Weeks)|Noncompliance|21
2632858|NCT00838916|9097432|P2|Treatment Period (156 Weeks)|Protocol Violation|3
2632859|NCT00838916|9097433|P1|Treatment Period (156 Weeks)|Protocol Violation|12
2632860|NCT00838916|9097432|P2|Treatment Period (156 Weeks)|Adverse Event|11
2632861|NCT00838916|9097433|P1|Treatment Period (156 Weeks)|Adverse Event|50
2632862|NCT00838903|9097462|P4|Follow-up Period (8 Weeks)|Missing|1
2632863|NCT00838903|9097463|P3|Follow-up Period (8 Weeks)|Missing|1
2632864|NCT00838903|9097464|P2|Follow-up Period (8 Weeks)|Missing|2
2632865|NCT00838903|9097465|P1|Follow-up Period (8 Weeks)|Missing|1
2632866|NCT00838903|9097462|P4|Follow-up Period (8 Weeks)|Subject Moved out of Town|1
2632867|NCT00838903|9097463|P3|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
2632868|NCT00838903|9097464|P2|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
2632869|NCT00838903|9097465|P1|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
2632870|NCT00838903|9097462|P4|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
2632871|NCT00838903|9097463|P3|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
2632872|NCT00838903|9097464|P2|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1
2632873|NCT00838903|9097465|P1|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
2632874|NCT00838903|9097462|P4|Follow-up Period (8 Weeks)|ICF Withdrawn|0
2632875|NCT00838903|9097463|P3|Follow-up Period (8 Weeks)|ICF Withdrawn|0
2632876|NCT00838903|9097464|P2|Follow-up Period (8 Weeks)|ICF Withdrawn|1
2632877|NCT00838903|9097465|P1|Follow-up Period (8 Weeks)|ICF Withdrawn|0
2632878|NCT00838903|9097462|P4|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
2632879|NCT00838903|9097463|P3|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6
2632880|NCT00838903|9097464|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
2632881|NCT00838903|9097465|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3
2632882|NCT00838903|9097462|P4|Follow-up Period (8 Weeks)|Physician Decision|1
2632883|NCT00838903|9097463|P3|Follow-up Period (8 Weeks)|Physician Decision|1
2632884|NCT00838903|9097464|P2|Follow-up Period (8 Weeks)|Physician Decision|1
2632885|NCT00838903|9097465|P1|Follow-up Period (8 Weeks)|Physician Decision|1
2632886|NCT00838903|9097462|P4|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
2632887|NCT00838903|9097463|P3|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
2632888|NCT00838903|9097464|P2|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13
2632889|NCT00838903|9097465|P1|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8
2632890|NCT00838903|9097462|P4|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
2632891|NCT00838903|9097463|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12
2632892|NCT00838903|9097464|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
2632893|NCT00838903|9097465|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5
2632894|NCT00838903|9097462|P4|Follow-up Period (8 Weeks)|Lost to Follow-up|24
2632895|NCT00838903|9097463|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|22
2632896|NCT00838903|9097464|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|28
2632897|NCT00838903|9097465|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|6
2632898|NCT00838903|9097462|P4|Follow-up Period (8 Weeks)|Noncompliance|5
2632899|NCT00838903|9097463|P3|Follow-up Period (8 Weeks)|Noncompliance|5
2632900|NCT00838903|9097464|P2|Follow-up Period (8 Weeks)|Noncompliance|8
2632901|NCT00838903|9097465|P1|Follow-up Period (8 Weeks)|Noncompliance|2
2632902|NCT00838903|9097462|P4|Follow-up Period (8 Weeks)|Adverse Event|1
2632903|NCT00838903|9097463|P3|Follow-up Period (8 Weeks)|Adverse Event|3
2632904|NCT00838903|9097464|P2|Follow-up Period (8 Weeks)|Adverse Event|0
2632905|NCT00838903|9097465|P1|Follow-up Period (8 Weeks)|Adverse Event|0
2632906|NCT00838903|9097462|P4|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
2632907|NCT00838903|9097463|P3|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
2632908|NCT00838903|9097464|P2|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
2632909|NCT00838903|9097465|P1|Treatment Period (156 Weeks)|Missing Active Treatment Status|1
2632910|NCT00838903|9097462|P4|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
2632911|NCT00838903|9097463|P3|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
2632912|NCT00838903|9097464|P2|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
2632913|NCT00838903|9097465|P1|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
2632914|NCT00838903|9097462|P4|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
2632915|NCT00838903|9097463|P3|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
2632916|NCT00838903|9097464|P2|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
2632917|NCT00838903|9097465|P1|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1
2632918|NCT00838903|9097462|P4|Treatment Period (156 Weeks)|Site closed|0
2632919|NCT00838903|9097463|P3|Treatment Period (156 Weeks)|Site closed|1
2632920|NCT00838903|9097464|P2|Treatment Period (156 Weeks)|Site closed|0
2632921|NCT00838903|9097465|P1|Treatment Period (156 Weeks)|Site closed|0
2632922|NCT00838903|9097462|P4|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
2632923|NCT00838903|9097463|P3|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1
2632924|NCT00838903|9097464|P2|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
2632925|NCT00838903|9097465|P1|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
2632926|NCT00838903|9097462|P4|Treatment Period (156 Weeks)|Pregnancy|0
2632927|NCT00838903|9097463|P3|Treatment Period (156 Weeks)|Pregnancy|1
2632928|NCT00838903|9097464|P2|Treatment Period (156 Weeks)|Pregnancy|0
2632929|NCT00838903|9097465|P1|Treatment Period (156 Weeks)|Pregnancy|0
2632930|NCT00838903|9097462|P4|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
2632931|NCT00838903|9097463|P3|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
2632932|NCT00838903|9097464|P2|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
2632933|NCT00838903|9097465|P1|Treatment Period (156 Weeks)|Poor Therapeutic Response|1
2632934|NCT00838903|9097462|P4|Treatment Period (156 Weeks)|Poor Glycemic Control|1
2632935|NCT00838903|9097463|P3|Treatment Period (156 Weeks)|Poor Glycemic Control|0
2632936|NCT00838903|9097464|P2|Treatment Period (156 Weeks)|Poor Glycemic Control|0
2632937|NCT00838903|9097465|P1|Treatment Period (156 Weeks)|Poor Glycemic Control|0
2632938|NCT00838903|9097462|P4|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
2632939|NCT00838903|9097463|P3|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
2632940|NCT00838903|9097464|P2|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1
2632941|NCT00838903|9097465|P1|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
2632942|NCT00838903|9097462|P4|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4
2632943|NCT00838903|9097463|P3|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
2632944|NCT00838903|9097464|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
2632945|NCT00838903|9097465|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3
2632946|NCT00838903|9097462|P4|Treatment Period (156 Weeks)|Physician Decision|2
2632947|NCT00838903|9097463|P3|Treatment Period (156 Weeks)|Physician Decision|1
2632948|NCT00838903|9097464|P2|Treatment Period (156 Weeks)|Physician Decision|2
2632949|NCT00838903|9097465|P1|Treatment Period (156 Weeks)|Physician Decision|1
2632950|NCT00838903|9097462|P4|Treatment Period (156 Weeks)|Withdrawal by Subject|53
2632951|NCT00838903|9097463|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|56
2632952|NCT00838903|9097464|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|55
2632953|NCT00838903|9097465|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|20
2632954|NCT00838903|9097462|P4|Treatment Period (156 Weeks)|Lost to Follow-up|13
2632955|NCT00838903|9097463|P3|Treatment Period (156 Weeks)|Lost to Follow-up|15
2632956|NCT00838903|9097464|P2|Treatment Period (156 Weeks)|Lost to Follow-up|16
2632957|NCT00838903|9097465|P1|Treatment Period (156 Weeks)|Lost to Follow-up|4
2632958|NCT00838903|9097462|P4|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
2632959|NCT00838903|9097463|P3|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
2632960|NCT00838903|9097464|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
2632961|NCT00838903|9097465|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
2632962|NCT00838903|9097462|P4|Treatment Period (156 Weeks)|Noncompliance|6
2632963|NCT00838903|9097463|P3|Treatment Period (156 Weeks)|Noncompliance|12
2632964|NCT00838903|9097464|P2|Treatment Period (156 Weeks)|Noncompliance|13
2632965|NCT00838903|9097465|P1|Treatment Period (156 Weeks)|Noncompliance|9
2632966|NCT00838903|9097462|P4|Treatment Period (156 Weeks)|Protocol Violation|5
2632967|NCT00838903|9097463|P3|Treatment Period (156 Weeks)|Protocol Violation|6
2632968|NCT00838903|9097464|P2|Treatment Period (156 Weeks)|Protocol Violation|6
2632969|NCT00838903|9097465|P1|Treatment Period (156 Weeks)|Protocol Violation|1
2632970|NCT00838903|9097462|P4|Treatment Period (156 Weeks)|Adverse Event|25
2632971|NCT00838903|9097463|P3|Treatment Period (156 Weeks)|Adverse Event|17
2632972|NCT00838903|9097464|P2|Treatment Period (156 Weeks)|Adverse Event|13
2632973|NCT00838903|9097465|P1|Treatment Period (156 Weeks)|Adverse Event|5
2632974|NCT00838682|9097520|P2|Overall Study|Withdrawal by Subject|1
2632975|NCT00838682|9097521|P1|Overall Study|Withdrawal by Subject|0
2632976|NCT00838682|9097520|P2|Overall Study|Protocol Violation|1
2632977|NCT00838682|9097521|P1|Overall Study|Protocol Violation|0
2632978|NCT00838682|9097520|P2|Overall Study|detection of exclusion criteria|3
2632979|NCT00838682|9097521|P1|Overall Study|detection of exclusion criteria|4
2632980|NCT00838682|9097520|P2|Overall Study|Lost to Follow-up|14
2632981|NCT00838682|9097521|P1|Overall Study|Lost to Follow-up|21
2632982|NCT00838630|9097539|P2|Washout: 7 Days|Protocol Violation|0
2632983|NCT00838630|9097540|P1|Washout: 7 Days|Protocol Violation|1
2632984|NCT00838630|9097539|P2|First Intervention|Adverse Event|0
2632985|NCT00838630|9097540|P1|First Intervention|Adverse Event|1
2632986|NCT00838578|9097548|P1|Overall Study|Protocol Violation|2
2632987|NCT00838565|9097562|P6|Overall Study|Randomized but not Treated|0
2632988|NCT00838565|9097563|P5|Overall Study|Randomized but not Treated|0
2632989|NCT00838565|9097564|P4|Overall Study|Randomized but not Treated|0
2632990|NCT00838565|9097565|P3|Overall Study|Randomized but not Treated|0
2632991|NCT00838565|9097566|P2|Overall Study|Randomized but not Treated|1
2632992|NCT00838565|9097567|P1|Overall Study|Randomized but not Treated|0
2632993|NCT00838565|9097562|P6|Overall Study|Other|0
2632994|NCT00838565|9097563|P5|Overall Study|Other|0
2632995|NCT00838565|9097564|P4|Overall Study|Other|0
2632996|NCT00838565|9097565|P3|Overall Study|Other|0
2632997|NCT00838565|9097566|P2|Overall Study|Other|2
2632998|NCT00838565|9097567|P1|Overall Study|Other|0
2632999|NCT00838565|9097562|P6|Overall Study|Withdrawal by Subject|2
2633000|NCT00838565|9097563|P5|Overall Study|Withdrawal by Subject|0
2633001|NCT00838565|9097564|P4|Overall Study|Withdrawal by Subject|0
2633002|NCT00838565|9097565|P3|Overall Study|Withdrawal by Subject|1
2633003|NCT00838565|9097566|P2|Overall Study|Withdrawal by Subject|0
2633004|NCT00838565|9097567|P1|Overall Study|Withdrawal by Subject|0
2633005|NCT00838539|9097672|P12|Overall Study|Symptomatic Deterioration|0
2633006|NCT00838539|9097673|P11|Overall Study|Symptomatic Deterioration|0
2633007|NCT00838539|9097674|P10|Overall Study|Symptomatic Deterioration|1
2633008|NCT00838539|9097675|P9|Overall Study|Symptomatic Deterioration|0
2633009|NCT00838539|9097676|P8|Overall Study|Symptomatic Deterioration|0
2633010|NCT00838539|9097677|P7|Overall Study|Symptomatic Deterioration|0
2633011|NCT00838539|9097678|P6|Overall Study|Symptomatic Deterioration|1
2633012|NCT00838539|9097679|P5|Overall Study|Symptomatic Deterioration|0
2633013|NCT00838539|9097680|P4|Overall Study|Symptomatic Deterioration|1
2633014|NCT00838539|9097681|P3|Overall Study|Symptomatic Deterioration|1
2633015|NCT00838539|9097682|P2|Overall Study|Symptomatic Deterioration|0
2633016|NCT00838539|9097683|P1|Overall Study|Symptomatic Deterioration|0
2633017|NCT00838539|9097672|P12|Overall Study|Clinical Progression|0
2633018|NCT00838539|9097673|P11|Overall Study|Clinical Progression|0
2633019|NCT00838539|9097674|P10|Overall Study|Clinical Progression|0
2633020|NCT00838539|9097675|P9|Overall Study|Clinical Progression|0
2633021|NCT00838539|9097676|P8|Overall Study|Clinical Progression|0
2633022|NCT00838539|9097677|P7|Overall Study|Clinical Progression|1
2633023|NCT00838539|9097678|P6|Overall Study|Clinical Progression|0
2633024|NCT00838539|9097679|P5|Overall Study|Clinical Progression|0
2633025|NCT00838539|9097680|P4|Overall Study|Clinical Progression|0
2633026|NCT00838539|9097681|P3|Overall Study|Clinical Progression|0
2633027|NCT00838539|9097682|P2|Overall Study|Clinical Progression|0
2633028|NCT00838539|9097683|P1|Overall Study|Clinical Progression|0
2633029|NCT00838539|9097672|P12|Overall Study|Physician Decision|0
2633030|NCT00838539|9097673|P11|Overall Study|Physician Decision|0
2633031|NCT00838539|9097674|P10|Overall Study|Physician Decision|0
2633032|NCT00838539|9097675|P9|Overall Study|Physician Decision|1
2633033|NCT00838539|9097676|P8|Overall Study|Physician Decision|0
2633034|NCT00838539|9097677|P7|Overall Study|Physician Decision|0
2633035|NCT00838539|9097678|P6|Overall Study|Physician Decision|0
2633036|NCT00838539|9097679|P5|Overall Study|Physician Decision|0
2633037|NCT00838539|9097680|P4|Overall Study|Physician Decision|0
2633038|NCT00838539|9097681|P3|Overall Study|Physician Decision|0
2633039|NCT00838539|9097682|P2|Overall Study|Physician Decision|0
2633040|NCT00838539|9097683|P1|Overall Study|Physician Decision|0
2633041|NCT00838539|9097672|P12|Overall Study|Death|0
2633042|NCT00838539|9097673|P11|Overall Study|Death|0
2633043|NCT00838539|9097674|P10|Overall Study|Death|0
2633044|NCT00838539|9097675|P9|Overall Study|Death|0
2633045|NCT00838539|9097676|P8|Overall Study|Death|0
2633046|NCT00838539|9097677|P7|Overall Study|Death|1
2633047|NCT00838539|9097678|P6|Overall Study|Death|0
2633048|NCT00838539|9097679|P5|Overall Study|Death|0
2633049|NCT00838539|9097680|P4|Overall Study|Death|0
2633050|NCT00838539|9097681|P3|Overall Study|Death|0
2633051|NCT00838539|9097682|P2|Overall Study|Death|0
2633052|NCT00838539|9097683|P1|Overall Study|Death|0
2633053|NCT00838539|9097672|P12|Overall Study|Withdrawal by Subject|0
2633054|NCT00838539|9097673|P11|Overall Study|Withdrawal by Subject|2
2633055|NCT00838539|9097674|P10|Overall Study|Withdrawal by Subject|1
2633056|NCT00838539|9097675|P9|Overall Study|Withdrawal by Subject|0
2633057|NCT00838539|9097676|P8|Overall Study|Withdrawal by Subject|0
2633058|NCT00838539|9097677|P7|Overall Study|Withdrawal by Subject|0
2633059|NCT00838539|9097678|P6|Overall Study|Withdrawal by Subject|0
2633060|NCT00838539|9097679|P5|Overall Study|Withdrawal by Subject|0
2633061|NCT00838539|9097680|P4|Overall Study|Withdrawal by Subject|0
2633062|NCT00838539|9097681|P3|Overall Study|Withdrawal by Subject|0
2633063|NCT00838539|9097682|P2|Overall Study|Withdrawal by Subject|1
2633064|NCT00838539|9097683|P1|Overall Study|Withdrawal by Subject|0
2633065|NCT00838539|9097672|P12|Overall Study|Adverse Event|0
2633066|NCT00838539|9097673|P11|Overall Study|Adverse Event|2
2633067|NCT00838539|9097674|P10|Overall Study|Adverse Event|1
2633068|NCT00838539|9097675|P9|Overall Study|Adverse Event|0
2633069|NCT00838539|9097676|P8|Overall Study|Adverse Event|2
2633070|NCT00838539|9097677|P7|Overall Study|Adverse Event|0
2633071|NCT00838539|9097678|P6|Overall Study|Adverse Event|1
2633072|NCT00838539|9097679|P5|Overall Study|Adverse Event|2
2633073|NCT00838539|9097680|P4|Overall Study|Adverse Event|1
2633074|NCT00838539|9097681|P3|Overall Study|Adverse Event|1
2633075|NCT00838539|9097682|P2|Overall Study|Adverse Event|1
2633076|NCT00838539|9097683|P1|Overall Study|Adverse Event|1
2633077|NCT00838539|9097672|P12|Overall Study|Disease Progression|4
2633078|NCT00838539|9097673|P11|Overall Study|Disease Progression|1
2633079|NCT00838539|9097674|P10|Overall Study|Disease Progression|5
2633080|NCT00838539|9097675|P9|Overall Study|Disease Progression|4
2633081|NCT00838539|9097676|P8|Overall Study|Disease Progression|4
2633082|NCT00838539|9097677|P7|Overall Study|Disease Progression|3
2633083|NCT00838539|9097678|P6|Overall Study|Disease Progression|2
2633084|NCT00838539|9097679|P5|Overall Study|Disease Progression|4
2633085|NCT00838539|9097680|P4|Overall Study|Disease Progression|2
2633086|NCT00838539|9097681|P3|Overall Study|Disease Progression|3
2633087|NCT00838539|9097682|P2|Overall Study|Disease Progression|4
2633088|NCT00838539|9097683|P1|Overall Study|Disease Progression|2
2633089|NCT00838526|9097733|P2|Overall Study|Other|7
2633090|NCT00838526|9097734|P1|Overall Study|Other|11
2633091|NCT00838526|9097733|P2|Overall Study|Lack of Efficacy|3
2633092|NCT00838526|9097734|P1|Overall Study|Lack of Efficacy|2
2633093|NCT00838526|9097733|P2|Overall Study|Withdrawal by Subject|5
2633094|NCT00838526|9097734|P1|Overall Study|Withdrawal by Subject|4
2633095|NCT00838526|9097733|P2|Overall Study|Lost to Follow-up|12
2633096|NCT00838526|9097734|P1|Overall Study|Lost to Follow-up|4
2633097|NCT00838526|9097733|P2|Overall Study|Adverse Event|12
2633098|NCT00838526|9097734|P1|Overall Study|Adverse Event|3
2633099|NCT00838513|9097742|P1|Post Treatment Period (Patients Who Disc|Death|1
2633100|NCT00838513|9097742|P1|Extension Treatment Period|Death|1
2633101|NCT00838513|9097742|P1|Screening Period|Screen Failure|3
2633102|NCT00838331|9097758|P1|Aged Blood Transfusion|Withdrawal by Subject|9
2633103|NCT00838279|9097764|P2|Washout|Withdrawal by Subject|1
2633104|NCT00838279|9097765|P1|Washout|Withdrawal by Subject|0
2633105|NCT00838279|9097764|P2|Washout|Protocol Violation|0
2633106|NCT00838279|9097765|P1|Washout|Protocol Violation|1
2633107|NCT00838201|9097775|P2|Overall Study|Death|13
2633108|NCT00838201|9097776|P1|Overall Study|Death|11
2633109|NCT00838201|9097775|P2|Overall Study|Adverse Event|9
2633110|NCT00838201|9097776|P1|Overall Study|Adverse Event|5
2633111|NCT00838201|9097775|P2|Overall Study|Lost to Follow-up|3
2633112|NCT00838201|9097776|P1|Overall Study|Lost to Follow-up|4
2633113|NCT00838201|9097775|P2|Overall Study|Consent withdrawn|19
2633114|NCT00838201|9097776|P1|Overall Study|Consent withdrawn|16
2633115|NCT00838201|9097775|P2|Overall Study|Disease progression|3
2633116|NCT00838201|9097776|P1|Overall Study|Disease progression|3
2633117|NCT00838201|9097775|P2|Overall Study|Administrative decision|2
2633118|NCT00838201|9097776|P1|Overall Study|Administrative decision|1
2633119|NCT00838201|9097775|P2|Overall Study|Noncompliance|1
2633120|NCT00838201|9097776|P1|Overall Study|Noncompliance|0
2633121|NCT00838201|9097775|P2|Overall Study|Investigator decision, or other reasons|3
2633122|NCT00838201|9097776|P1|Overall Study|Investigator decision, or other reasons|2
2633123|NCT00838110|9097844|P4|Overall Study|Randomized but not treated|0
2633124|NCT00838110|9097845|P3|Overall Study|Randomized but not treated|0
2633125|NCT00838110|9097846|P2|Overall Study|Randomized but not treated|1
2633126|NCT00838110|9097847|P1|Overall Study|Randomized but not treated|0
2633127|NCT00838110|9097844|P4|Overall Study|Did not meet eligibility criteria|2
2633128|NCT00838110|9097845|P3|Overall Study|Did not meet eligibility criteria|1
2633129|NCT00838110|9097846|P2|Overall Study|Did not meet eligibility criteria|0
2633130|NCT00838110|9097847|P1|Overall Study|Did not meet eligibility criteria|0
2633131|NCT00838110|9097844|P4|Overall Study|Lost to Follow-up|0
2633132|NCT00838110|9097845|P3|Overall Study|Lost to Follow-up|0
2633133|NCT00838110|9097846|P2|Overall Study|Lost to Follow-up|0
2633134|NCT00838110|9097847|P1|Overall Study|Lost to Follow-up|3
2633135|NCT00838110|9097844|P4|Overall Study|Protocol Violation|1
2633136|NCT00838110|9097845|P3|Overall Study|Protocol Violation|1
2633137|NCT00838110|9097846|P2|Overall Study|Protocol Violation|2
2633138|NCT00838110|9097847|P1|Overall Study|Protocol Violation|0
2633139|NCT00838110|9097844|P4|Overall Study|Other|2
2633140|NCT00838110|9097845|P3|Overall Study|Other|3
2633141|NCT00838110|9097846|P2|Overall Study|Other|3
2633142|NCT00838110|9097847|P1|Overall Study|Other|3
2633143|NCT00838110|9097844|P4|Overall Study|Withdrawal by Subject|4
2633144|NCT00838110|9097845|P3|Overall Study|Withdrawal by Subject|3
2633145|NCT00838110|9097846|P2|Overall Study|Withdrawal by Subject|6
2633146|NCT00838110|9097847|P1|Overall Study|Withdrawal by Subject|5
2633147|NCT00838110|9097844|P4|Overall Study|Adverse Event|7
2633148|NCT00838110|9097845|P3|Overall Study|Adverse Event|8
2633149|NCT00838110|9097846|P2|Overall Study|Adverse Event|10
2633150|NCT00838110|9097847|P1|Overall Study|Adverse Event|11
2633151|NCT00838110|9097844|P4|Overall Study|Death|2
2633152|NCT00838110|9097845|P3|Overall Study|Death|1
2633153|NCT00838110|9097846|P2|Overall Study|Death|0
2633154|NCT00838110|9097847|P1|Overall Study|Death|0
2633155|NCT00838097|9097867|P1|Overall Study|Protocol-specified criteria|142
2633156|NCT00838097|9097867|P1|Overall Study|Death|6
2633157|NCT00838097|9097867|P1|Overall Study|Lost to Follow-up|11
2633158|NCT00838097|9097867|P1|Overall Study|Physician Decision|4
2633159|NCT00838097|9097867|P1|Overall Study|Requirement for alternative therapy|2
2633160|NCT00838097|9097867|P1|Overall Study|Withdrawal by Subject|3
2633161|NCT00838097|9097867|P1|Overall Study|Adverse Event|2
2633162|NCT00838097|9097867|P1|Overall Study|Ineligibility determined|6
2633163|NCT00837967|9097875|P2|Washout Period of 7 - 14 Days|Adverse Event|0
2633164|NCT00837967|9097876|P1|Washout Period of 7 - 14 Days|Adverse Event|2
2633165|NCT00837876|9097902|P1|Overall Study|disease progression|24
2633166|NCT00837876|9097902|P1|Overall Study|Withdrawal by Subject|3
2633167|NCT00837876|9097902|P1|Overall Study|Physician Decision|1
2633168|NCT00837876|9097902|P1|Overall Study|Adverse Event|7
2633169|NCT00837876|9097902|P1|Overall Study|Death|2
2633170|NCT00837811|9097924|P3|Overall Study|Sponsor Decision|0
2633171|NCT00837811|9097925|P2|Overall Study|Sponsor Decision|2
2633172|NCT00837811|9097926|P1|Overall Study|Sponsor Decision|0
2633173|NCT00837811|9097924|P3|Overall Study|Withdrawal by Subject|0
2633174|NCT00837811|9097925|P2|Overall Study|Withdrawal by Subject|9
2633175|NCT00837811|9097926|P1|Overall Study|Withdrawal by Subject|1
2633176|NCT00837811|9097924|P3|Overall Study|Physician Decision|1
2633177|NCT00837811|9097925|P2|Overall Study|Physician Decision|2
2633178|NCT00837811|9097926|P1|Overall Study|Physician Decision|0
2633179|NCT00837811|9097924|P3|Overall Study|Lost to Follow-up|0
2633180|NCT00837811|9097925|P2|Overall Study|Lost to Follow-up|3
2633181|NCT00837811|9097926|P1|Overall Study|Lost to Follow-up|1
2633182|NCT00837811|9097924|P3|Overall Study|Lack of Efficacy|0
2633183|NCT00837811|9097925|P2|Overall Study|Lack of Efficacy|11
2633184|NCT00837811|9097926|P1|Overall Study|Lack of Efficacy|0
2633185|NCT00837811|9097924|P3|Overall Study|Death|0
2633186|NCT00837811|9097925|P2|Overall Study|Death|1
2633187|NCT00837811|9097926|P1|Overall Study|Death|1
2633188|NCT00837811|9097924|P3|Overall Study|Adverse Event|0
2633189|NCT00837811|9097925|P2|Overall Study|Adverse Event|6
2633190|NCT00837811|9097926|P1|Overall Study|Adverse Event|4
2633191|NCT00837759|9098011|P1|Overall Study|Lost to Follow-up|1
2633192|NCT00837759|9098011|P1|Overall Study|Protocol Violation|3
2633193|NCT00837694|9098026|P6|Overall Study|Lost to Follow-up|1
2633194|NCT00837694|9098027|P5|Overall Study|Lost to Follow-up|1
2633195|NCT00837694|9098028|P4|Overall Study|Lost to Follow-up|1
2633196|NCT00837694|9098029|P3|Overall Study|Lost to Follow-up|2
2633197|NCT00837694|9098030|P2|Overall Study|Lost to Follow-up|0
2633198|NCT00837694|9098031|P1|Overall Study|Lost to Follow-up|2
2633199|NCT00837616|9098047|P2|Overall Study|Withdrawal by Subject|1
2633200|NCT00837616|9098048|P1|Overall Study|Withdrawal by Subject|0
2633201|NCT00837577|9098087|P2|Open-label Period|Other Reason|1
2633202|NCT00837577|9098088|P1|Open-label Period|Other Reason|1
2633203|NCT00837577|9098087|P2|Open-label Period|Withdrawal by Subject|2
2633204|NCT00837577|9098088|P1|Open-label Period|Withdrawal by Subject|1
2633205|NCT00837577|9098087|P2|Open-label Period|Lack of Efficacy|3
2633206|NCT00837577|9098088|P1|Open-label Period|Lack of Efficacy|4
2633207|NCT00837577|9098087|P2|Open-label Period|Laboratory Adverse Event|1
2633208|NCT00837577|9098088|P1|Open-label Period|Laboratory Adverse Event|0
2633209|NCT00837577|9098087|P2|Open-label Period|Clinical Adverse Event|2
2633210|NCT00837577|9098088|P1|Open-label Period|Clinical Adverse Event|2
2633211|NCT00837577|9098087|P2|Double-blind Period|Withdrawal by Subject|0
2633212|NCT00837577|9098088|P1|Double-blind Period|Withdrawal by Subject|1
2633213|NCT00837577|9098087|P2|Double-blind Period|Clinical Adverse Event|0
2633214|NCT00837577|9098088|P1|Double-blind Period|Clinical Adverse Event|1
2633215|NCT00837486|9098108|P2|Long-term Follow-up Phase - Open Label|Death|0
2633216|NCT00837486|9098109|P1|Long-term Follow-up Phase - Open Label|Death|1
2633217|NCT00837486|9098108|P2|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0
2633218|NCT00837486|9098109|P1|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2
2633219|NCT00837486|9098108|P2|Long-term Follow-up Phase - Open Label|Physician Decision|0
2633220|NCT00837486|9098109|P1|Long-term Follow-up Phase - Open Label|Physician Decision|2
2633221|NCT00837486|9098108|P2|Blinded-treatment Phase|Physician Decision|0
2633222|NCT00837486|9098109|P1|Blinded-treatment Phase|Physician Decision|1
2633223|NCT00837473|9098121|P1|Overall Study|Withdrawal by Subject|2
2633224|NCT00837473|9098121|P1|Overall Study|Lost to Follow-up|1
2633225|NCT00837434|9098141|P2|Overall Study|Unable to obtain study drug|0
2633226|NCT00837434|9098142|P1|Overall Study|Unable to obtain study drug|1
2633227|NCT00837434|9098141|P2|Overall Study|Baseline assessments not done in time|0
2633228|NCT00837434|9098142|P1|Overall Study|Baseline assessments not done in time|1
2633229|NCT00837434|9098141|P2|Overall Study|Noncompliant|0
2633230|NCT00837434|9098142|P1|Overall Study|Noncompliant|2
2633231|NCT00837434|9098141|P2|Overall Study|Withdrawn by sponsor/regulatory agency|0
2633232|NCT00837434|9098142|P1|Overall Study|Withdrawn by sponsor/regulatory agency|1
2633233|NCT00837434|9098141|P2|Overall Study|Lost to Follow-up|1
2633234|NCT00837434|9098142|P1|Overall Study|Lost to Follow-up|1
2633235|NCT00837434|9098141|P2|Overall Study|Physician Decision|0
2633236|NCT00837434|9098142|P1|Overall Study|Physician Decision|3
2633237|NCT00837330|9098162|P2|Overall Study|Lost to Follow-up|3
2633238|NCT00837330|9098163|P1|Overall Study|Lost to Follow-up|1
2633239|NCT00837213|9098186|P2|Overall Study|not stated|1
2633240|NCT00837213|9098187|P1|Overall Study|not stated|1
2633241|NCT00837213|9098186|P2|Overall Study|Withdrawal by Subject|2
2633242|NCT00837213|9098187|P1|Overall Study|Withdrawal by Subject|2
2633243|NCT00837213|9098186|P2|Overall Study|Lost to Follow-up|2
2633244|NCT00837213|9098187|P1|Overall Study|Lost to Follow-up|3
2633245|NCT00837161|9098213|P1|Overall Study|refused hysterectomy|2
2633246|NCT00837148|9098221|P1|Overall Study|Death|1
2633247|NCT00837148|9098221|P1|Overall Study|Adverse Event|1
2633248|NCT00837096|9098227|P2|Overall Study|Not reported|8
2633249|NCT00837096|9098228|P1|Overall Study|Not reported|9
2633250|NCT00837096|9098227|P2|Overall Study|Physician Decision|1
2633251|NCT00837096|9098228|P1|Overall Study|Physician Decision|1
2633252|NCT00836953|9098240|P1|Overall Study|Lost to Follow-up|1
2633253|NCT00836953|9098240|P1|Overall Study|Withdrawal by Subject|1
2633254|NCT00836927|9098251|P5|Overall Study|Withdrawal by Subject|0
2633255|NCT00836927|9098252|P4|Overall Study|Withdrawal by Subject|0
2633256|NCT00836927|9098253|P3|Overall Study|Withdrawal by Subject|0
2633257|NCT00836927|9098254|P2|Overall Study|Withdrawal by Subject|0
2633258|NCT00836927|9098255|P1|Overall Study|Withdrawal by Subject|1
2633259|NCT00836927|9098251|P5|Overall Study|Progressive disease|1
2633260|NCT00836927|9098252|P4|Overall Study|Progressive disease|1
2633261|NCT00836927|9098253|P3|Overall Study|Progressive disease|0
2633262|NCT00836927|9098254|P2|Overall Study|Progressive disease|0
2633263|NCT00836927|9098255|P1|Overall Study|Progressive disease|2
2633264|NCT00836901|9098291|P2|First Intervention|Withdrawal by Subject|0
2633265|NCT00836901|9098292|P1|First Intervention|Withdrawal by Subject|1
2633266|NCT00836875|9098308|P2|Overall Study|Withdrawal by Subject|1
2633267|NCT00836875|9098309|P1|Overall Study|Withdrawal by Subject|0
2633268|NCT00836875|9098308|P2|Overall Study|Death|2
2633269|NCT00836875|9098309|P1|Overall Study|Death|3
2633270|NCT00836810|9098325|P2|Overall Study|New diagnosis|0
2633271|NCT00836810|9098326|P1|Overall Study|New diagnosis|1
2633272|NCT00836745|9098348|P1|Overall Study|Other|2
2633273|NCT00836745|9098348|P1|Overall Study|Objective progression or relapse|4
2633274|NCT00836745|9098348|P1|Overall Study|Adverse Event|3
2633275|NCT00836745|9098348|P1|Overall Study|Lost to Follow-up|10
2633276|NCT00836745|9098348|P1|Overall Study|Death|2
2633277|NCT00836706|9098362|P2|Washout: 7 Days|Withdrawal by Subject|1
2633278|NCT00836706|9098363|P1|Washout: 7 Days|Withdrawal by Subject|0
2633279|NCT00836693|9098373|P2|Overall Study|Lost to Follow-up|0
2633280|NCT00836693|9098374|P1|Overall Study|Lost to Follow-up|1
2633281|NCT00836693|9098373|P2|Overall Study|Protocol Violation|0
2633282|NCT00836693|9098374|P1|Overall Study|Protocol Violation|1
2633283|NCT00836693|9098373|P2|Overall Study|Withdrawal by Subject|4
2633284|NCT00836693|9098374|P1|Overall Study|Withdrawal by Subject|9
2633285|NCT00836693|9098373|P2|Overall Study|Physician Decision|0
2633286|NCT00836693|9098374|P1|Overall Study|Physician Decision|2
2633287|NCT00836693|9098373|P2|Overall Study|Sponsor Decision|1
2633288|NCT00836693|9098374|P1|Overall Study|Sponsor Decision|0
2633289|NCT00836693|9098373|P2|Overall Study|Adverse Event|1
2633290|NCT00836693|9098374|P1|Overall Study|Adverse Event|4
2633291|NCT00836589|9098424|P1|Overall Study|Withdrawal by Subject or Physician|591
2633292|NCT00836589|9098424|P1|Overall Study|Death|429
2633293|NCT00836589|9098424|P1|Overall Study|Lost to Follow-up|246
2633294|NCT00836498|9098457|P2|Overall Study|Withdrawal by Subject|1
2633295|NCT00836498|9098458|P1|Overall Study|Withdrawal by Subject|2
2633296|NCT00836498|9098457|P2|Overall Study|Lost to Follow-up|0
2633297|NCT00836498|9098458|P1|Overall Study|Lost to Follow-up|1
2633298|NCT00836498|9098457|P2|Overall Study|Adverse Event|0
2633299|NCT00836498|9098458|P1|Overall Study|Adverse Event|1
2633300|NCT00836472|9098490|P2|Washout|Withdrawal by Subject|1
2633301|NCT00836472|9098491|P1|Washout|Withdrawal by Subject|1
2633302|NCT00836472|9098490|P2|Washout|Adverse Event|2
2633303|NCT00836472|9098491|P1|Washout|Adverse Event|1
2633304|NCT00836277|9098568|P1|Overall Study|Not evaluable for response|6
2633305|NCT00836095|9098578|P2|Overall Study|Physician Decision|3
2633306|NCT00836095|9098579|P1|Overall Study|Physician Decision|0
2633307|NCT00836056|9098589|P2|First Intervention|Adverse Event|0
2633308|NCT00836056|9098590|P1|First Intervention|Adverse Event|1
2633309|NCT00835991|9098619|P2|Washout|Withdrawal by Subject|1
2633310|NCT00835991|9098620|P1|Washout|Withdrawal by Subject|3
2633311|NCT00835991|9098619|P2|Washout|Protocol Violation|2
2633312|NCT00835991|9098620|P1|Washout|Protocol Violation|0
2633313|NCT00835991|9098619|P2|First Intervention|Adverse Event|1
2633314|NCT00835991|9098620|P1|First Intervention|Adverse Event|0
2633315|NCT00835978|9098638|P4|Overall Study|Study terminated by sponsor|0
2633316|NCT00835978|9098639|P3|Overall Study|Study terminated by sponsor|30
2633317|NCT00835978|9098640|P2|Overall Study|Study terminated by sponsor|8
2633318|NCT00835978|9098641|P1|Overall Study|Study terminated by sponsor|12
2633319|NCT00835978|9098638|P4|Overall Study|Withdrawal by Subject|5
2633320|NCT00835978|9098639|P3|Overall Study|Withdrawal by Subject|0
2633321|NCT00835978|9098640|P2|Overall Study|Withdrawal by Subject|3
2633322|NCT00835978|9098641|P1|Overall Study|Withdrawal by Subject|0
2633323|NCT00835978|9098638|P4|Overall Study|Adverse Event|0
2633324|NCT00835978|9098639|P3|Overall Study|Adverse Event|1
2633325|NCT00835978|9098640|P2|Overall Study|Adverse Event|0
2633326|NCT00835978|9098641|P1|Overall Study|Adverse Event|1
2633327|NCT00835978|9098638|P4|Overall Study|Objective progression or relapse|0
2633328|NCT00835978|9098639|P3|Overall Study|Objective progression or relapse|1
2633329|NCT00835978|9098640|P2|Overall Study|Objective progression or relapse|0
2633330|NCT00835978|9098641|P1|Overall Study|Objective progression or relapse|2
2633331|NCT00835978|9098638|P4|Overall Study|Other|0
2633332|NCT00835978|9098639|P3|Overall Study|Other|8
2633333|NCT00835978|9098640|P2|Overall Study|Other|1
2633334|NCT00835978|9098641|P1|Overall Study|Other|5
2633335|NCT00835978|9098638|P4|Overall Study|Lost to Follow-up|1
2633336|NCT00835978|9098639|P3|Overall Study|Lost to Follow-up|2
2633337|NCT00835978|9098640|P2|Overall Study|Lost to Follow-up|4
2633338|NCT00835978|9098641|P1|Overall Study|Lost to Follow-up|3
2633339|NCT00835978|9098638|P4|Overall Study|Death|4
2633340|NCT00835978|9098639|P3|Overall Study|Death|49
2633341|NCT00835978|9098640|P2|Overall Study|Death|40
2633342|NCT00835978|9098641|P1|Overall Study|Death|33
2633343|NCT00835796|9098752|P2|First Intervention|Withdrawal by Subject|1
2633344|NCT00835796|9098753|P1|First Intervention|Withdrawal by Subject|0
2633345|NCT00835731|9098763|P2|Overall Study|Physician Decision|1
2633346|NCT00835731|9098764|P1|Overall Study|Physician Decision|1
2633347|NCT00835731|9098763|P2|Overall Study|Withdrawal by Subject|0
2633348|NCT00835731|9098764|P1|Overall Study|Withdrawal by Subject|1
2633349|NCT00835705|9098784|P2|Second Intervention|Difficulty with vein|0
2633350|NCT00835705|9098785|P1|Second Intervention|Difficulty with vein|1
2633351|NCT00835705|9098784|P2|First Intervention|Difficulty with vein|0
2633352|NCT00835705|9098785|P1|First Intervention|Difficulty with vein|1
2633353|NCT00835692|9098801|P2|First Intervention|Withdrawal by Subject|0
2633354|NCT00835692|9098802|P1|First Intervention|Withdrawal by Subject|1
2633355|NCT00835679|9098814|P4|Overall Study|Withdrawal by Subject|0
2633356|NCT00835679|9098815|P3|Overall Study|Withdrawal by Subject|0
2633357|NCT00835679|9098816|P2|Overall Study|Withdrawal by Subject|0
2633358|NCT00835679|9098817|P1|Overall Study|Withdrawal by Subject|1
2633359|NCT00835666|9098841|P2|Washout|Withdrawal by Subject|0
2633360|NCT00835666|9098842|P1|Washout|Withdrawal by Subject|1
2633361|NCT00835666|9098841|P2|Washout|Protocol Violation|0
2633362|NCT00835666|9098842|P1|Washout|Protocol Violation|1
2633363|NCT00835640|9098852|P2|Second Intervention|Protocol Violation|0
2633364|NCT00835640|9098853|P1|Second Intervention|Protocol Violation|1
2633365|NCT00835575|9098885|P2|Washout of 14 Days|Withdrawal by Subject|0
2633366|NCT00835575|9098886|P1|Washout of 14 Days|Withdrawal by Subject|1
2633367|NCT00835549|9098896|P2|Washout of 7 Days|Withdrawal by Subject|0
2633368|NCT00835549|9098897|P1|Washout of 7 Days|Withdrawal by Subject|2
2633369|NCT00835536|9098907|P2|Washout of 5 Weeks|Withdrawal by Subject|0
2633370|NCT00835536|9098908|P1|Washout of 5 Weeks|Withdrawal by Subject|1
2633371|NCT00835406|9098969|P2|Period: Washout of 7 Days|Withdrawal by Subject|2
2633372|NCT00835406|9098970|P1|Period: Washout of 7 Days|Withdrawal by Subject|0
2633373|NCT00835406|9098969|P2|Period: First Intervention|Withdrawal by Subject|0
2633374|NCT00835406|9098970|P1|Period: First Intervention|Withdrawal by Subject|2
2633375|NCT00835406|9098969|P2|Period: First Intervention|Adverse Event|1
2633376|NCT00835406|9098970|P1|Period: First Intervention|Adverse Event|0
2633377|NCT00835380|9098976|P1|Overall Study|Withdrawal by Subject|2
2633378|NCT00835367|9098983|P2|Second Intervention|Adverse Event|1
2633379|NCT00835367|9098984|P1|Second Intervention|Adverse Event|1
2633380|NCT00835367|9098983|P2|Washout|Withdrawal by Subject|0
2633381|NCT00835367|9098984|P1|Washout|Withdrawal by Subject|1
2633382|NCT00835367|9098983|P2|Washout|Adverse Event|0
2633383|NCT00835367|9098984|P1|Washout|Adverse Event|2
2633384|NCT00835354|9099006|P2|First Intervention|Adverse Event|1
2633385|NCT00835354|9099007|P1|First Intervention|Adverse Event|0
2633386|NCT00835341|9099017|P2|Overall Study|Lost to Follow-up|12
2633387|NCT00835341|9099018|P1|Overall Study|Lost to Follow-up|3
2633388|NCT00835263|9099037|P2|Second Intervention|Adverse Event|0
2633389|NCT00835263|9099038|P1|Second Intervention|Adverse Event|1
2633390|NCT00835237|9099048|P2|Overall Study|Withdrawal by Subject|0
2633391|NCT00835237|9099049|P1|Overall Study|Withdrawal by Subject|2
2633392|NCT00835237|9099048|P2|Overall Study|Lost to Follow-up|0
2633393|NCT00835237|9099049|P1|Overall Study|Lost to Follow-up|4
2633394|NCT00835211|9099089|P2|Washout: 7 Days|Withdrawal by Subject|0
2633395|NCT00835211|9099090|P1|Washout: 7 Days|Withdrawal by Subject|1
2633396|NCT00835211|9099089|P2|Washout: 7 Days|Adverse Event|1
2633397|NCT00835211|9099090|P1|Washout: 7 Days|Adverse Event|2
2633398|NCT00835211|9099089|P2|First Intervention|Withdrawal by Subject|1
2633399|NCT00835211|9099090|P1|First Intervention|Withdrawal by Subject|0
2633400|NCT00835172|9099136|P2|Washout|Protocol Violation|1
2633401|NCT00835172|9099137|P1|Washout|Protocol Violation|0
2633402|NCT00835120|9099163|P1|Overall Study|Withdrawal by Subject|2
2633403|NCT00835120|9099163|P1|Overall Study|Adverse Event|2
2633404|NCT00835120|9099163|P1|Overall Study|Lost to Follow-up|3
2633405|NCT00835120|9099163|P1|Overall Study|Lack of Efficacy|1
2633406|NCT00835081|9099173|P2|Washout of 7 Days|Withdrawal by Subject|0
2633407|NCT00835081|9099174|P1|Washout of 7 Days|Withdrawal by Subject|1
2633408|NCT00835068|9099184|P2|Overall Study|Withdrawal by Subject|0
2633409|NCT00835068|9099185|P1|Overall Study|Withdrawal by Subject|1
2633410|NCT00835068|9099184|P2|Overall Study|Other|0
2633411|NCT00835068|9099185|P1|Overall Study|Other|8
2633412|NCT00835068|9099184|P2|Overall Study|Adverse Event|1
2633413|NCT00835068|9099185|P1|Overall Study|Adverse Event|0
2633414|NCT00835068|9099184|P2|Overall Study|Death|0
2633415|NCT00835068|9099185|P1|Overall Study|Death|1
2633416|NCT00835042|9099205|P2|Washout of 21 Days|Withdrawal by Subject|2
2633417|NCT00835042|9099206|P1|Washout of 21 Days|Withdrawal by Subject|0
2633418|NCT00835042|9099205|P2|First Intervention|Adverse Event|2
2633419|NCT00835042|9099206|P1|First Intervention|Adverse Event|1
2633420|NCT00835042|9099205|P2|First Intervention|Withdrawal by Subject|0
2633421|NCT00835042|9099206|P1|First Intervention|Withdrawal by Subject|3
2633422|NCT00834912|9099292|P6|Treatment Period 2|Withdrawal by Subject|0
2633423|NCT00834912|9099293|P5|Treatment Period 2|Withdrawal by Subject|1
2633424|NCT00834912|9099294|P4|Treatment Period 2|Withdrawal by Subject|0
2633425|NCT00834912|9099295|P3|Treatment Period 2|Withdrawal by Subject|1
2633426|NCT00834912|9099296|P2|Treatment Period 2|Withdrawal by Subject|0
2633427|NCT00834912|9099297|P1|Treatment Period 2|Withdrawal by Subject|0
2633428|NCT00834912|9099292|P6|Treatment Period 1|Adverse Event|0
2633429|NCT00834912|9099293|P5|Treatment Period 1|Adverse Event|0
2633430|NCT00834912|9099294|P4|Treatment Period 1|Adverse Event|1
2633431|NCT00834912|9099295|P3|Treatment Period 1|Adverse Event|0
2633432|NCT00834912|9099296|P2|Treatment Period 1|Adverse Event|1
2633433|NCT00834912|9099297|P1|Treatment Period 1|Adverse Event|0
2633434|NCT00834899|9099319|P2|Overall Study|Withdrawal by Subject|1
2633435|NCT00834899|9099320|P1|Overall Study|Withdrawal by Subject|1
2633436|NCT00834873|9099359|P2|First Intervention|Adverse Event|1
2633437|NCT00834873|9099360|P1|First Intervention|Adverse Event|0
2633438|NCT00834834|9099370|P2|Overall Study|Withdrawal by Subject|3
2633439|NCT00834834|9099371|P1|Overall Study|Withdrawal by Subject|4
2633440|NCT00834795|9099406|P2|Second Intervention|Adverse Event|0
2633441|NCT00834795|9099407|P1|Second Intervention|Adverse Event|1
2633442|NCT00834795|9099406|P2|Washout: 7 Days|Withdrawal by Subject|1
2633443|NCT00834795|9099407|P1|Washout: 7 Days|Withdrawal by Subject|0
2633444|NCT00834756|9099417|P2|Washout: 21 Days|Withdrawal by Subject|0
2633445|NCT00834756|9099418|P1|Washout: 21 Days|Withdrawal by Subject|1
2633446|NCT00834756|9099417|P2|First Intervention|Adverse Event|0
2633447|NCT00834756|9099418|P1|First Intervention|Adverse Event|1
2633448|NCT00834743|9099428|P2|Second Intervention|Withdrawal by Subject|0
2633449|NCT00834743|9099429|P1|Second Intervention|Withdrawal by Subject|1
2633450|NCT00834717|9099439|P2|First Intervention|Withdrawal by Subject|1
2633451|NCT00834717|9099440|P1|First Intervention|Withdrawal by Subject|0
2633452|NCT00834717|9099439|P2|First Intervention|Adverse Event|0
2633453|NCT00834717|9099440|P1|First Intervention|Adverse Event|1
2633454|NCT00834639|9099471|P2|Second Intervention|Physician Decision|2
2633455|NCT00834639|9099472|P1|Second Intervention|Physician Decision|0
2633456|NCT00834613|9099489|P2|First Intervention|Protocol Violation|0
2633457|NCT00834613|9099490|P1|First Intervention|Protocol Violation|1
2633458|NCT00834587|9099500|P2|Washout: 7 Days|Withdrawal by Subject|0
2633459|NCT00834587|9099501|P1|Washout: 7 Days|Withdrawal by Subject|1
2633460|NCT00834522|9099550|P2|Washout|Withdrawal by Subject|1
2633461|NCT00834522|9099551|P1|Washout|Withdrawal by Subject|2
2633462|NCT00834522|9099550|P2|Washout|Adverse Event|0
2633463|NCT00834522|9099551|P1|Washout|Adverse Event|1
2633464|NCT00834444|9099574|P2|Second Intervention|Adverse Event|0
2633465|NCT00834444|9099575|P1|Second Intervention|Adverse Event|1
2633466|NCT00834444|9099574|P2|Washout of 7 Days|Withdrawal by Subject|1
2633467|NCT00834444|9099575|P1|Washout of 7 Days|Withdrawal by Subject|0
2633468|NCT00834444|9099574|P2|First Intervention|Intolerance to Venopuncture|1
2633469|NCT00834444|9099575|P1|First Intervention|Intolerance to Venopuncture|0
2633470|NCT00834444|9099574|P2|First Intervention|Adverse Event|0
2633471|NCT00834444|9099575|P1|First Intervention|Adverse Event|1
2633472|NCT00834431|9099585|P2|Washout of 7 Days|Withdrawal by Subject|1
2633473|NCT00834431|9099586|P1|Washout of 7 Days|Withdrawal by Subject|0
2633474|NCT00834431|9099585|P2|First Intervention|Adverse Event|1
2633475|NCT00834431|9099586|P1|First Intervention|Adverse Event|0
2633476|NCT00834418|9099596|P2|Overall Study|Adverse Event|2
2633477|NCT00834418|9099597|P1|Overall Study|Adverse Event|0
2633478|NCT00834366|9099614|P2|Treatment Period 1|Adverse Event|1
2633479|NCT00834366|9099615|P1|Treatment Period 1|Adverse Event|1
2633480|NCT00834340|9099631|P2|Washout|Withdrawal by Subject|0
2633481|NCT00834340|9099632|P1|Washout|Withdrawal by Subject|1
2633482|NCT00834340|9099631|P2|Washout|Adverse Event|0
2633483|NCT00834340|9099632|P1|Washout|Adverse Event|1
2633484|NCT00834249|9099676|P2|Second Intervention|Adverse Event|0
2633485|NCT00834249|9099677|P1|Second Intervention|Adverse Event|1
2633486|NCT00834249|9099676|P2|Washout: 7 Days|Withdrawal by Subject|1
2633487|NCT00834249|9099677|P1|Washout: 7 Days|Withdrawal by Subject|1
2633488|NCT00834080|9099773|P1|Overall Study|Subject Relocated|1
2633489|NCT00834080|9099773|P1|Overall Study|Physician Decision|1
2633490|NCT00834080|9099773|P1|Overall Study|Other - False positive tests of the UDS|1
2633491|NCT00834080|9099773|P1|Overall Study|Other - Pregnancy|1
2633492|NCT00834080|9099773|P1|Overall Study|Withdrawal by Subject|5
2633493|NCT00834080|9099773|P1|Overall Study|Lost to Follow-up|7
2633494|NCT00834080|9099773|P1|Overall Study|Adverse Event|7
2633495|NCT00834067|9099779|P2|Washout of 21 Days|Protocol Violation|1
2633496|NCT00834067|9099780|P1|Washout of 21 Days|Protocol Violation|0
2633497|NCT00834041|9099802|P2|Overall Study|Lost to Follow-up|1
2633498|NCT00834041|9099803|P1|Overall Study|Lost to Follow-up|0
2633499|NCT00834041|9099802|P2|Overall Study|Withdrawal by Subject|0
2633500|NCT00834041|9099803|P1|Overall Study|Withdrawal by Subject|1
2633501|NCT00833989|9099821|P4|Overall Study|Withdrawal by Subject|1
2633502|NCT00833989|9099822|P3|Overall Study|Withdrawal by Subject|1
2633503|NCT00833989|9099823|P2|Overall Study|Withdrawal by Subject|0
2633504|NCT00833989|9099824|P1|Overall Study|Withdrawal by Subject|3
2633505|NCT00833989|9099821|P4|Overall Study|Physician Decision|1
2633506|NCT00833989|9099822|P3|Overall Study|Physician Decision|0
2633507|NCT00833989|9099823|P2|Overall Study|Physician Decision|0
2633508|NCT00833989|9099824|P1|Overall Study|Physician Decision|0
2633509|NCT00833976|9099928|P1|Overall Study|Physician Decision|1
2633510|NCT00833976|9099928|P1|Overall Study|Did not meet eligibility criteria|41
2633511|NCT00833976|9099928|P1|Overall Study|Lost to Follow-up|4
2633512|NCT00833976|9099928|P1|Overall Study|Withdrawal by Subject|5
2633513|NCT00833937|9099936|P2|Washout|Withdrawal by Subject|0
2633514|NCT00833937|9099937|P1|Washout|Withdrawal by Subject|1
2633515|NCT00833924|9099945|P1|Overall Study|In study follow-up|71
2633516|NCT00833924|9099945|P1|Overall Study|Withdrawal by Subject|13
2633517|NCT00833924|9099945|P1|Overall Study|Lost to Follow-up|2
2633518|NCT00833924|9099945|P1|Overall Study|Conversion|2
2633519|NCT00833924|9099945|P1|Overall Study|Death|21
2633520|NCT00833911|9099950|P1|Maintenance Phase II|Lack of Efficacy|1
2633521|NCT00833911|9099950|P1|Maintenance Phase II|Withdrawal by Subject|1
2633522|NCT00833911|9099950|P1|Maintenance Phase II|Physician Decision|2
2633523|NCT00833911|9099950|P1|Maintenance Phase II|Adverse Event|6
2633524|NCT00833911|9099950|P1|Maintenance Phase I|Lack of Efficacy|4
2633525|NCT00833911|9099950|P1|Maintenance Phase I|Physician Decision|10
2633526|NCT00833911|9099950|P1|Maintenance Phase I|Withdrawal by Subject|11
2633527|NCT00833911|9099950|P1|Maintenance Phase I|Adverse Event|73
2633528|NCT00833911|9099950|P1|Titration|Withdrawal by Subject|3
2633529|NCT00833911|9099950|P1|Titration|Adverse Event|18
2633530|NCT00833898|9099960|P2|Overall Study|Patient did not receive transplant|2
2633531|NCT00833898|9099961|P1|Overall Study|Patient did not receive transplant|0
2633532|NCT00833898|9099960|P2|Overall Study|Lost to Follow-up|7
2633533|NCT00833898|9099961|P1|Overall Study|Lost to Follow-up|7
2633534|NCT00833898|9099960|P2|Overall Study|Withdrawal by Subject|27
2633535|NCT00833898|9099961|P1|Overall Study|Withdrawal by Subject|33
2633536|NCT00833833|9100020|P6|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1
2633537|NCT00833833|9100021|P5|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
2633538|NCT00833833|9100022|P4|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
2633539|NCT00833833|9100023|P3|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
2633540|NCT00833833|9100024|P2|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
2633541|NCT00833833|9100025|P1|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
2633542|NCT00833833|9100020|P6|Phase 2 (as of 01 April 2011)|Other|3
2633543|NCT00833833|9100021|P5|Phase 2 (as of 01 April 2011)|Other|4
2633544|NCT00833833|9100022|P4|Phase 2 (as of 01 April 2011)|Other|0
2633545|NCT00833833|9100023|P3|Phase 2 (as of 01 April 2011)|Other|0
2633546|NCT00833833|9100024|P2|Phase 2 (as of 01 April 2011)|Other|0
2633547|NCT00833833|9100025|P1|Phase 2 (as of 01 April 2011)|Other|0
2633548|NCT00833833|9100020|P6|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7
2633549|NCT00833833|9100021|P5|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5
2633550|NCT00833833|9100022|P4|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
2633551|NCT00833833|9100023|P3|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
2633552|NCT00833833|9100024|P2|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
2633553|NCT00833833|9100025|P1|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
2633554|NCT00833833|9100020|P6|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6
2633555|NCT00833833|9100021|P5|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7
2633556|NCT00833833|9100022|P4|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
2633557|NCT00833833|9100023|P3|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
2633558|NCT00833833|9100024|P2|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
2633559|NCT00833833|9100025|P1|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
2633560|NCT00833833|9100020|P6|Phase 2 (as of 01 April 2011)|Death|9
2633561|NCT00833833|9100021|P5|Phase 2 (as of 01 April 2011)|Death|8
2633562|NCT00833833|9100022|P4|Phase 2 (as of 01 April 2011)|Death|0
2633563|NCT00833833|9100023|P3|Phase 2 (as of 01 April 2011)|Death|0
2633564|NCT00833833|9100024|P2|Phase 2 (as of 01 April 2011)|Death|0
2633565|NCT00833833|9100025|P1|Phase 2 (as of 01 April 2011)|Death|0
2633566|NCT00833833|9100020|P6|Phase 2 (as of 01 April 2011)|Adverse Event|13
2633567|NCT00833833|9100021|P5|Phase 2 (as of 01 April 2011)|Adverse Event|8
2633568|NCT00833833|9100022|P4|Phase 2 (as of 01 April 2011)|Adverse Event|0
2633569|NCT00833833|9100023|P3|Phase 2 (as of 01 April 2011)|Adverse Event|0
2633570|NCT00833833|9100024|P2|Phase 2 (as of 01 April 2011)|Adverse Event|0
2633571|NCT00833833|9100025|P1|Phase 2 (as of 01 April 2011)|Adverse Event|0
2633572|NCT00833833|9100020|P6|Phase 2 (as of 01 April 2011)|Still active in study|22
2633573|NCT00833833|9100021|P5|Phase 2 (as of 01 April 2011)|Still active in study|23
2633574|NCT00833833|9100022|P4|Phase 2 (as of 01 April 2011)|Still active in study|0
2633575|NCT00833833|9100023|P3|Phase 2 (as of 01 April 2011)|Still active in study|0
2633576|NCT00833833|9100024|P2|Phase 2 (as of 01 April 2011)|Still active in study|0
2633577|NCT00833833|9100025|P1|Phase 2 (as of 01 April 2011)|Still active in study|0
2633578|NCT00833833|9100020|P6|Phase 1 (as of 01 April 2011)|Other|0
2633579|NCT00833833|9100021|P5|Phase 1 (as of 01 April 2011)|Other|0
2633580|NCT00833833|9100022|P4|Phase 1 (as of 01 April 2011)|Other|1
2633581|NCT00833833|9100023|P3|Phase 1 (as of 01 April 2011)|Other|0
2633582|NCT00833833|9100024|P2|Phase 1 (as of 01 April 2011)|Other|3
2633583|NCT00833833|9100025|P1|Phase 1 (as of 01 April 2011)|Other|1
2633584|NCT00833833|9100020|P6|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
2633585|NCT00833833|9100021|P5|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
2633586|NCT00833833|9100022|P4|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
2633587|NCT00833833|9100023|P3|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
2633588|NCT00833833|9100024|P2|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
2633589|NCT00833833|9100025|P1|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
2633590|NCT00833833|9100020|P6|Phase 1 (as of 01 April 2011)|Death|0
2633591|NCT00833833|9100021|P5|Phase 1 (as of 01 April 2011)|Death|0
2633592|NCT00833833|9100022|P4|Phase 1 (as of 01 April 2011)|Death|0
2633593|NCT00833833|9100023|P3|Phase 1 (as of 01 April 2011)|Death|2
2633594|NCT00833833|9100024|P2|Phase 1 (as of 01 April 2011)|Death|1
2633595|NCT00833833|9100025|P1|Phase 1 (as of 01 April 2011)|Death|0
2633596|NCT00833833|9100020|P6|Phase 1 (as of 01 April 2011)|Adverse Event|0
2633597|NCT00833833|9100021|P5|Phase 1 (as of 01 April 2011)|Adverse Event|0
2633598|NCT00833833|9100022|P4|Phase 1 (as of 01 April 2011)|Adverse Event|1
2633599|NCT00833833|9100023|P3|Phase 1 (as of 01 April 2011)|Adverse Event|2
2633600|NCT00833833|9100024|P2|Phase 1 (as of 01 April 2011)|Adverse Event|0
2633601|NCT00833833|9100025|P1|Phase 1 (as of 01 April 2011)|Adverse Event|1
2633602|NCT00833833|9100020|P6|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
2633603|NCT00833833|9100021|P5|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
2633604|NCT00833833|9100022|P4|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
2633605|NCT00833833|9100023|P3|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
2633606|NCT00833833|9100024|P2|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
2633607|NCT00833833|9100025|P1|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
2633608|NCT00833833|9100020|P6|Phase 1 (as of 01 April 2011)|Still active in study|0
2633609|NCT00833833|9100021|P5|Phase 1 (as of 01 April 2011)|Still active in study|0
2633610|NCT00833833|9100022|P4|Phase 1 (as of 01 April 2011)|Still active in study|2
2633611|NCT00833833|9100023|P3|Phase 1 (as of 01 April 2011)|Still active in study|2
2633612|NCT00833833|9100024|P2|Phase 1 (as of 01 April 2011)|Still active in study|0
2633613|NCT00833833|9100025|P1|Phase 1 (as of 01 April 2011)|Still active in study|0
2633614|NCT00833794|9100065|P2|Double-blind Phase|Administrative reason|3
2633615|NCT00833794|9100066|P1|Double-blind Phase|Administrative reason|1
2633616|NCT00833794|9100065|P2|Double-blind Phase|Physician Decision|7
2633617|NCT00833794|9100066|P1|Double-blind Phase|Physician Decision|4
2633618|NCT00833794|9100065|P2|Double-blind Phase|Withdrawal by Subject|6
2633619|NCT00833794|9100066|P1|Double-blind Phase|Withdrawal by Subject|23
2633620|NCT00833794|9100065|P2|Double-blind Phase|Lack of Efficacy|22
2633621|NCT00833794|9100066|P1|Double-blind Phase|Lack of Efficacy|34
2633622|NCT00833794|9100065|P2|Double-blind Phase|Adverse Event|11
2633623|NCT00833794|9100066|P1|Double-blind Phase|Adverse Event|44
2633624|NCT00833794|9100065|P2|Open-label Phase|enrolled in error (immediately D/C)|0
2633625|NCT00833794|9100066|P1|Open-label Phase|enrolled in error (immediately D/C)|1
2633626|NCT00833794|9100065|P2|Open-label Phase|Did not complete wash-out period|0
2633627|NCT00833794|9100066|P1|Open-label Phase|Did not complete wash-out period|12
2633628|NCT00833794|9100065|P2|Open-label Phase|Protocol Violation|0
2633629|NCT00833794|9100066|P1|Open-label Phase|Protocol Violation|47
2633630|NCT00833794|9100065|P2|Open-label Phase|Administrative reason|0
2633631|NCT00833794|9100066|P1|Open-label Phase|Administrative reason|1
2633632|NCT00833794|9100065|P2|Open-label Phase|Physician Decision|0
2633633|NCT00833794|9100066|P1|Open-label Phase|Physician Decision|20
2633634|NCT00833794|9100065|P2|Open-label Phase|Withdrawal by Subject|0
2633635|NCT00833794|9100066|P1|Open-label Phase|Withdrawal by Subject|48
2633636|NCT00833794|9100065|P2|Open-label Phase|Lack of Efficacy|0
2633637|NCT00833794|9100066|P1|Open-label Phase|Lack of Efficacy|28
2633638|NCT00833794|9100065|P2|Open-label Phase|Adverse Event|0
2633639|NCT00833794|9100066|P1|Open-label Phase|Adverse Event|225
2633640|NCT00833755|9100110|P4|Overall Study|Subject had scheduling issues|0
2633641|NCT00833755|9100111|P3|Overall Study|Subject had scheduling issues|0
2633642|NCT00833755|9100112|P2|Overall Study|Subject had scheduling issues|1
2633643|NCT00833755|9100113|P1|Overall Study|Subject had scheduling issues|0
2633644|NCT00833755|9100110|P4|Overall Study|Physician Decision|6
2633645|NCT00833755|9100111|P3|Overall Study|Physician Decision|2
2633646|NCT00833755|9100112|P2|Overall Study|Physician Decision|4
2633647|NCT00833755|9100113|P1|Overall Study|Physician Decision|4
2633648|NCT00833703|9100133|P2|Overall Study|Parent(s)/guardian(s)'s request|1
2633649|NCT00833703|9100134|P1|Overall Study|Parent(s)/guardian(s)'s request|0
2633650|NCT00833690|9100147|P3|Overall Study|Discontinued study drug|0
2633651|NCT00833690|9100148|P2|Overall Study|Discontinued study drug|2
2633652|NCT00833690|9100149|P1|Overall Study|Discontinued study drug|3
2633653|NCT00833690|9100147|P3|Overall Study|Withdrawal by Subject|0
2633654|NCT00833690|9100148|P2|Overall Study|Withdrawal by Subject|0
2633655|NCT00833690|9100149|P1|Overall Study|Withdrawal by Subject|1
2633656|NCT00833638|9100285|P3|Phase 3: Open-label Extension Phase|Protocol Violation|2
2633657|NCT00833638|9100286|P2|Phase 3: Open-label Extension Phase|Protocol Violation|1
2633658|NCT00833638|9100287|P1|Phase 3: Open-label Extension Phase|Protocol Violation|0
2633659|NCT00833638|9100285|P3|Phase 3: Open-label Extension Phase|Lost to Follow-up|0
2633660|NCT00833638|9100286|P2|Phase 3: Open-label Extension Phase|Lost to Follow-up|2
2633661|NCT00833638|9100287|P1|Phase 3: Open-label Extension Phase|Lost to Follow-up|1
2633662|NCT00833638|9100285|P3|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2
2633663|NCT00833638|9100286|P2|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
2633664|NCT00833638|9100287|P1|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
2633665|NCT00833638|9100285|P3|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2
2633666|NCT00833638|9100286|P2|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
2633667|NCT00833638|9100287|P1|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
2633668|NCT00833638|9100285|P3|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
2633669|NCT00833638|9100286|P2|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
2633670|NCT00833638|9100287|P1|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
2633671|NCT00833638|9100285|P3|Phase 2: Double-blind Treatment Phase|Physician Decision|0
2633672|NCT00833638|9100286|P2|Phase 2: Double-blind Treatment Phase|Physician Decision|0
2633673|NCT00833638|9100287|P1|Phase 2: Double-blind Treatment Phase|Physician Decision|1
2633674|NCT00833638|9100285|P3|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
2633675|NCT00833638|9100286|P2|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2
2633676|NCT00833638|9100287|P1|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
2633677|NCT00833638|9100285|P3|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1
2633678|NCT00833638|9100286|P2|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2
2633679|NCT00833638|9100287|P1|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3
2633680|NCT00833638|9100285|P3|Phase 2: Double-blind Treatment Phase|Adverse Event|0
2633681|NCT00833638|9100286|P2|Phase 2: Double-blind Treatment Phase|Adverse Event|2
2633682|NCT00833638|9100287|P1|Phase 2: Double-blind Treatment Phase|Adverse Event|1
2633683|NCT00833560|9100338|P1|Overall Study|Other|5
2633684|NCT00833560|9100338|P1|Overall Study|Pregression of other disease|1
2633685|NCT00833560|9100338|P1|Overall Study|Death|2
2633686|NCT00833560|9100338|P1|Overall Study|Lack of Efficacy|4
2633687|NCT00833560|9100338|P1|Overall Study|Protocol Violation|6
2633688|NCT00833560|9100338|P1|Overall Study|Adverse Event|11
2633689|NCT00833560|9100338|P1|Overall Study|Toxicity|13
2633690|NCT00833547|9100347|P2|Overall Study|Withdrawal by Subject|2
2633691|NCT00833547|9100348|P1|Overall Study|Withdrawal by Subject|2
2633692|NCT00833482|9100369|P6|Days 21-30|Withdrawal by Subject|0
2633693|NCT00833482|9100370|P5|Days 21-30|Withdrawal by Subject|1
2633694|NCT00833482|9100371|P4|Days 21-30|Withdrawal by Subject|0
2633695|NCT00833482|9100372|P3|Days 21-30|Withdrawal by Subject|0
2633696|NCT00833482|9100373|P2|Days 21-30|Withdrawal by Subject|0
2633697|NCT00833482|9100374|P1|Days 21-30|Withdrawal by Subject|0
2633698|NCT00833482|9100369|P6|Days 21-30|Adverse Event|0
2633699|NCT00833482|9100370|P5|Days 21-30|Adverse Event|0
2633700|NCT00833482|9100371|P4|Days 21-30|Adverse Event|0
2633701|NCT00833482|9100372|P3|Days 21-30|Adverse Event|1
2633702|NCT00833482|9100373|P2|Days 21-30|Adverse Event|0
2633703|NCT00833482|9100374|P1|Days 21-30|Adverse Event|0
2633704|NCT00833482|9100369|P6|Days 11-20|Withdrawal by Subject|0
2633705|NCT00833482|9100370|P5|Days 11-20|Withdrawal by Subject|0
2633706|NCT00833482|9100371|P4|Days 11-20|Withdrawal by Subject|0
2633707|NCT00833482|9100372|P3|Days 11-20|Withdrawal by Subject|0
2633708|NCT00833482|9100373|P2|Days 11-20|Withdrawal by Subject|1
2633709|NCT00833482|9100374|P1|Days 11-20|Withdrawal by Subject|0
2633710|NCT00833482|9100369|P6|Days 11-20|Adverse Event|0
2633711|NCT00833482|9100370|P5|Days 11-20|Adverse Event|0
2633712|NCT00833482|9100371|P4|Days 11-20|Adverse Event|0
2633713|NCT00833482|9100372|P3|Days 11-20|Adverse Event|0
2633714|NCT00833482|9100373|P2|Days 11-20|Adverse Event|2
2633715|NCT00833482|9100374|P1|Days 11-20|Adverse Event|0
2633716|NCT00833469|9100430|P1|Overall Study|Lost to Follow-up|1
2633717|NCT00833469|9100430|P1|Overall Study|Withdrawal by Subject|1
2633718|NCT00833417|9100453|P2|Overall Study|Reason Not Specified|1
2633719|NCT00833417|9100454|P1|Overall Study|Reason Not Specified|0
2633720|NCT00833417|9100453|P2|Overall Study|Disease Progression|17
2633721|NCT00833417|9100454|P1|Overall Study|Disease Progression|18
2633722|NCT00833417|9100453|P2|Overall Study|Sponsor Decision to Terminate Study|2
2633723|NCT00833417|9100454|P1|Overall Study|Sponsor Decision to Terminate Study|1
2633724|NCT00833417|9100453|P2|Overall Study|Patient Decision to Withdraw|23
2633725|NCT00833417|9100454|P1|Overall Study|Patient Decision to Withdraw|4
2633726|NCT00833417|9100453|P2|Overall Study|Physician Decision to Withdraw Patient|7
2633727|NCT00833417|9100454|P1|Overall Study|Physician Decision to Withdraw Patient|3
2633728|NCT00833417|9100453|P2|Overall Study|Lost to Follow-up|2
2633729|NCT00833417|9100454|P1|Overall Study|Lost to Follow-up|1
2633730|NCT00833417|9100453|P2|Overall Study|Death|3
2633731|NCT00833417|9100454|P1|Overall Study|Death|1
2633732|NCT00833417|9100453|P2|Overall Study|Adverse Event|16
2633733|NCT00833417|9100454|P1|Overall Study|Adverse Event|5
2633734|NCT00833261|9100478|P1|Overall Study|Withdrawal by Subject|4
2633735|NCT00833248|9100485|P2|Overall Study|Withdrawal by Subject|1
2633736|NCT00833248|9100486|P1|Overall Study|Withdrawal by Subject|0
2633737|NCT00833248|9100485|P2|Overall Study|Protocol Violation|2
2633738|NCT00833248|9100486|P1|Overall Study|Protocol Violation|1
2633739|NCT00833248|9100485|P2|Overall Study|Adverse Event|0
2633740|NCT00833248|9100486|P1|Overall Study|Adverse Event|3
2633741|NCT00833105|9100508|P1|Overall Study|Adverse Event|2
2633742|NCT00833105|9100508|P1|Overall Study|Withdrawal by Subject|1
2633743|NCT00833092|9100526|P2|Overall Study|constipation|1
2633744|NCT00833092|9100527|P1|Overall Study|constipation|0
2633745|NCT00833092|9100526|P2|Overall Study|Diarrhea|2
2633746|NCT00833092|9100527|P1|Overall Study|Diarrhea|0
2633747|NCT00833092|9100526|P2|Overall Study|Protocol Violation|1
2633748|NCT00833092|9100527|P1|Overall Study|Protocol Violation|2
2633749|NCT00833092|9100526|P2|Overall Study|Withdrawal by Subject|3
2633750|NCT00833092|9100527|P1|Overall Study|Withdrawal by Subject|2
2633751|NCT00833053|9100535|P2|Overall Study|Protocol Violation|1
2633752|NCT00833053|9100536|P1|Overall Study|Protocol Violation|2
2633753|NCT00833053|9100535|P2|Overall Study|Withdrawal by Subject|1
2633754|NCT00833053|9100536|P1|Overall Study|Withdrawal by Subject|0
2633755|NCT00833053|9100535|P2|Overall Study|Treatment Failure|1
2633756|NCT00833053|9100536|P1|Overall Study|Treatment Failure|3
2633757|NCT00833053|9100535|P2|Overall Study|Adverse Event|0
2633758|NCT00833053|9100536|P1|Overall Study|Adverse Event|4
2633759|NCT00833040|9100554|P6|Overall Study|Adverse Event|1
2633760|NCT00833040|9100555|P5|Overall Study|Adverse Event|0
2633761|NCT00833040|9100556|P4|Overall Study|Adverse Event|0
2633762|NCT00833040|9100557|P3|Overall Study|Adverse Event|0
2633763|NCT00833040|9100558|P2|Overall Study|Adverse Event|0
2633764|NCT00833040|9100559|P1|Overall Study|Adverse Event|0
2633765|NCT00833027|9100564|P1|Overall Study|Missing|10
2633766|NCT00833027|9100564|P1|Overall Study|Withdrawal by Subject|16
2633767|NCT00833027|9100564|P1|Overall Study|Protocol Violation|115
2633768|NCT00833027|9100564|P1|Overall Study|Lost to Follow-up|24
2633769|NCT00833027|9100564|P1|Overall Study|Lack of Efficacy|12
2633770|NCT00833027|9100564|P1|Overall Study|Death|1
2633771|NCT00833027|9100564|P1|Overall Study|Adverse Event|33
2633772|NCT00832975|9100569|P1|Overall Study|Other reasons|14
2633773|NCT00832975|9100569|P1|Overall Study|Withdrawal by Subject|3
2633774|NCT00832975|9100569|P1|Overall Study|Physician Decision|4
2633775|NCT00832975|9100569|P1|Overall Study|Death|5
2633776|NCT00832975|9100569|P1|Overall Study|Protocol Violation|6
2633777|NCT00832975|9100569|P1|Overall Study|Lost to Follow-up|7
2633778|NCT00832819|9100583|P3|Overall Study|Protocol Violation|1
2633779|NCT00832819|9100584|P2|Overall Study|Protocol Violation|0
2633780|NCT00832819|9100585|P1|Overall Study|Protocol Violation|0
2633781|NCT00832819|9100583|P3|Overall Study|Adverse Event|0
2633782|NCT00832819|9100584|P2|Overall Study|Adverse Event|1
2633783|NCT00832819|9100585|P1|Overall Study|Adverse Event|0
2633784|NCT00832780|9100591|P1|Overall Study|Physician Decision|1
2633785|NCT00832780|9100591|P1|Overall Study|other complicating condition|2
2633786|NCT00832780|9100591|P1|Overall Study|no reason given|2
2633787|NCT00832780|9100591|P1|Overall Study|Lost to Follow-up|4
2633788|NCT00832780|9100591|P1|Overall Study|Death|16
2633789|NCT00832650|9100633|P3|Overall Study|Randomized but not treated|1
2633790|NCT00832650|9100634|P2|Overall Study|Randomized but not treated|0
2633791|NCT00832650|9100635|P1|Overall Study|Randomized but not treated|0
2633792|NCT00832624|9100675|P1|Overall Study|Study Terminated|10
2633793|NCT00832585|9100685|P1|Overall Study|Lost to Follow-up|1
2633794|NCT00832585|9100685|P1|Overall Study|Withdrawal by Subject|1
2633795|NCT00832455|9100710|P1|Overall Study|Patient moved|1
2633796|NCT00832455|9100710|P1|Overall Study|No improvement|3
2633797|NCT00832455|9100710|P1|Overall Study|Parent dissatisfied|1
2633798|NCT00832455|9100710|P1|Overall Study|Parent misunderstood study|1
2633799|NCT00832455|9100710|P1|Overall Study|Stopped Medication|4
2633800|NCT00832455|9100710|P1|Overall Study|Screening Failure|2
2633801|NCT00832455|9100710|P1|Overall Study|Withdrawal by Subject|17
2633802|NCT00832455|9100710|P1|Overall Study|Protocol Violation|4
2633803|NCT00832455|9100710|P1|Overall Study|Lost to Follow-up|26
2633804|NCT00832455|9100710|P1|Overall Study|Adverse Event|13
2633805|NCT00832416|9100734|P4|Overall Study|Death|0
2633806|NCT00832416|9100735|P3|Overall Study|Death|0
2633807|NCT00832416|9100736|P2|Overall Study|Death|0
2633808|NCT00832416|9100737|P1|Overall Study|Death|1
2633809|NCT00832416|9100734|P4|Overall Study|Adverse Event|10
2633810|NCT00832416|9100735|P3|Overall Study|Adverse Event|41
2633811|NCT00832416|9100736|P2|Overall Study|Adverse Event|19
2633812|NCT00832416|9100737|P1|Overall Study|Adverse Event|21
2633813|NCT00832416|9100734|P4|Overall Study|Administrative|1
2633814|NCT00832416|9100735|P3|Overall Study|Administrative|0
2633815|NCT00832416|9100736|P2|Overall Study|Administrative|0
2633816|NCT00832416|9100737|P1|Overall Study|Administrative|0
2633817|NCT00832416|9100734|P4|Overall Study|Physician Decision|10
2633818|NCT00832416|9100735|P3|Overall Study|Physician Decision|5
2633819|NCT00832416|9100736|P2|Overall Study|Physician Decision|12
2633820|NCT00832416|9100737|P1|Overall Study|Physician Decision|2
2633821|NCT00832416|9100734|P4|Overall Study|Withdrawal by Subject|10
2633822|NCT00832416|9100735|P3|Overall Study|Withdrawal by Subject|2
2633823|NCT00832416|9100736|P2|Overall Study|Withdrawal by Subject|7
2633824|NCT00832416|9100737|P1|Overall Study|Withdrawal by Subject|5
2633825|NCT00832416|9100734|P4|Overall Study|Lack of Efficacy|52
2633826|NCT00832416|9100735|P3|Overall Study|Lack of Efficacy|13
2633827|NCT00832416|9100736|P2|Overall Study|Lack of Efficacy|15
2633828|NCT00832416|9100737|P1|Overall Study|Lack of Efficacy|17
2633829|NCT00832377|9100788|P1|Overall Study|Protocol Violation|1
2633830|NCT00832117|9100834|P1|Overall Study|Disease Progression|11
2633831|NCT00832117|9100834|P1|Overall Study|Death|1
2633832|NCT00832091|9100853|P2|Overall Study|Prohibited Medication|0
2633833|NCT00832091|9100854|P1|Overall Study|Prohibited Medication|1
2633834|NCT00832091|9100853|P2|Overall Study|Withdrawal by Subject|1
2633835|NCT00832091|9100854|P1|Overall Study|Withdrawal by Subject|2
2633836|NCT00832091|9100853|P2|Overall Study|Protocol Violation|0
2633837|NCT00832091|9100854|P1|Overall Study|Protocol Violation|1
2633838|NCT00832091|9100853|P2|Overall Study|Adverse Event|1
2633839|NCT00832091|9100854|P1|Overall Study|Adverse Event|1
2633840|NCT00832078|9100862|P2|Test Day 2 - 2 Period|Lack of Efficacy|0
2633841|NCT00832078|9100863|P1|Test Day 2 - 2 Period|Lack of Efficacy|1
2633842|NCT00832078|9100862|P2|Test Day 1-2 Period|Lack of Efficacy|2
2633843|NCT00832078|9100863|P1|Test Day 1-2 Period|Lack of Efficacy|0
2633844|NCT00832000|9100869|P2|Overall Study|No calls to IVR in period 2|0
2633845|NCT00832000|9100870|P1|Overall Study|No calls to IVR in period 2|2
2633846|NCT00832000|9100869|P2|Overall Study|No calls to IVR in either period|1
2633847|NCT00832000|9100870|P1|Overall Study|No calls to IVR in either period|1
2633848|NCT00832000|9100869|P2|Overall Study|Withdrawal by Subject|0
2633849|NCT00832000|9100870|P1|Overall Study|Withdrawal by Subject|1
2633850|NCT00832000|9100869|P2|Overall Study|Adverse Event|0
2633851|NCT00832000|9100870|P1|Overall Study|Adverse Event|2
2633852|NCT00831844|9100931|P10|Overall Study|Ineligible|0
2633853|NCT00831844|9100932|P9|Overall Study|Ineligible|0
2633854|NCT00831844|9100933|P8|Overall Study|Ineligible|0
2633855|NCT00831844|9100934|P7|Overall Study|Ineligible|0
2633856|NCT00831844|9100935|P6|Overall Study|Ineligible|0
2633857|NCT00831844|9100936|P5|Overall Study|Ineligible|1
2633858|NCT00831844|9100937|P4|Overall Study|Ineligible|0
2633859|NCT00831844|9100938|P3|Overall Study|Ineligible|1
2633860|NCT00831844|9100939|P2|Overall Study|Ineligible|1
2633861|NCT00831844|9100940|P1|Overall Study|Ineligible|0
2633862|NCT00831844|9100931|P10|Overall Study|Withdrawal by Subject|0
2633863|NCT00831844|9100932|P9|Overall Study|Withdrawal by Subject|1
2633864|NCT00831844|9100933|P8|Overall Study|Withdrawal by Subject|1
2633865|NCT00831844|9100934|P7|Overall Study|Withdrawal by Subject|0
2633866|NCT00831844|9100935|P6|Overall Study|Withdrawal by Subject|0
2633867|NCT00831844|9100936|P5|Overall Study|Withdrawal by Subject|0
2633868|NCT00831844|9100937|P4|Overall Study|Withdrawal by Subject|0
2633869|NCT00831844|9100938|P3|Overall Study|Withdrawal by Subject|1
2633870|NCT00831844|9100939|P2|Overall Study|Withdrawal by Subject|0
2633871|NCT00831844|9100940|P1|Overall Study|Withdrawal by Subject|0
2633872|NCT00831844|9100931|P10|Overall Study|Physician Decision|0
2633873|NCT00831844|9100932|P9|Overall Study|Physician Decision|1
2633874|NCT00831844|9100933|P8|Overall Study|Physician Decision|0
2633875|NCT00831844|9100934|P7|Overall Study|Physician Decision|0
2633876|NCT00831844|9100935|P6|Overall Study|Physician Decision|1
2633877|NCT00831844|9100936|P5|Overall Study|Physician Decision|1
2633878|NCT00831844|9100937|P4|Overall Study|Physician Decision|1
2633879|NCT00831844|9100938|P3|Overall Study|Physician Decision|3
2633880|NCT00831844|9100939|P2|Overall Study|Physician Decision|1
2633881|NCT00831844|9100940|P1|Overall Study|Physician Decision|0
2633882|NCT00831844|9100931|P10|Overall Study|Lack of Efficacy|0
2633883|NCT00831844|9100932|P9|Overall Study|Lack of Efficacy|7
2633884|NCT00831844|9100933|P8|Overall Study|Lack of Efficacy|9
2633885|NCT00831844|9100934|P7|Overall Study|Lack of Efficacy|8
2633886|NCT00831844|9100935|P6|Overall Study|Lack of Efficacy|17
2633887|NCT00831844|9100936|P5|Overall Study|Lack of Efficacy|11
2633888|NCT00831844|9100937|P4|Overall Study|Lack of Efficacy|8
2633889|NCT00831844|9100938|P3|Overall Study|Lack of Efficacy|15
2633890|NCT00831844|9100939|P2|Overall Study|Lack of Efficacy|10
2633891|NCT00831844|9100940|P1|Overall Study|Lack of Efficacy|8
2633892|NCT00831844|9100931|P10|Overall Study|Death|0
2633893|NCT00831844|9100932|P9|Overall Study|Death|0
2633894|NCT00831844|9100933|P8|Overall Study|Death|0
2633895|NCT00831844|9100934|P7|Overall Study|Death|0
2633896|NCT00831844|9100935|P6|Overall Study|Death|0
2633897|NCT00831844|9100936|P5|Overall Study|Death|0
2633898|NCT00831844|9100937|P4|Overall Study|Death|1
2633899|NCT00831844|9100938|P3|Overall Study|Death|0
2633900|NCT00831844|9100939|P2|Overall Study|Death|0
2633901|NCT00831844|9100940|P1|Overall Study|Death|0
2633902|NCT00831844|9100931|P10|Overall Study|Adverse Event|0
2633903|NCT00831844|9100932|P9|Overall Study|Adverse Event|0
2633904|NCT00831844|9100933|P8|Overall Study|Adverse Event|0
2633905|NCT00831844|9100934|P7|Overall Study|Adverse Event|2
2633906|NCT00831844|9100935|P6|Overall Study|Adverse Event|1
2633907|NCT00831844|9100936|P5|Overall Study|Adverse Event|1
2633908|NCT00831844|9100937|P4|Overall Study|Adverse Event|0
2633909|NCT00831844|9100938|P3|Overall Study|Adverse Event|0
2633910|NCT00831844|9100939|P2|Overall Study|Adverse Event|0
2633911|NCT00831844|9100940|P1|Overall Study|Adverse Event|2
2633912|NCT00831792|9100962|P1|Overall Study|Lack of Efficacy|1
2633913|NCT00831792|9100962|P1|Overall Study|Death|1
2633914|NCT00831792|9100962|P1|Overall Study|Adverse Event|1
2633915|NCT00831792|9100962|P1|Overall Study|Not Eligible|3
2633916|NCT00831779|9100968|P2|Overall Study|No longer met criteria|1
2633917|NCT00831779|9100969|P1|Overall Study|No longer met criteria|0
2633918|NCT00831779|9100968|P2|Overall Study|Lost to Follow-up|0
2633919|NCT00831779|9100969|P1|Overall Study|Lost to Follow-up|1
2633920|NCT00831701|9101006|P2|Overall Study|Lost to Follow-up|3
2633921|NCT00831701|9101007|P1|Overall Study|Lost to Follow-up|1
2633922|NCT00831701|9101006|P2|Overall Study|Stone expulsion before first medication|2
2633923|NCT00831701|9101007|P1|Overall Study|Stone expulsion before first medication|2
2633924|NCT00831701|9101006|P2|Overall Study|Withdrawal by Subject|0
2633925|NCT00831701|9101007|P1|Overall Study|Withdrawal by Subject|2
2633926|NCT00831493|9101036|P1|Overall Study|Intractable nausea and vomiting|1
2633927|NCT00831441|9101046|P2|Follow Up (30 Days)|missing end of study status|1
2633928|NCT00831441|9101047|P1|Follow Up (30 Days)|missing end of study status|0
2633929|NCT00831441|9101046|P2|Follow Up (30 Days)|non-specified|26
2633930|NCT00831441|9101047|P1|Follow Up (30 Days)|non-specified|16
2633931|NCT00831441|9101046|P2|Follow Up (30 Days)|Death|86
2633932|NCT00831441|9101047|P1|Follow Up (30 Days)|Death|63
2633933|NCT00831441|9101046|P2|Follow Up (30 Days)|Lost to Follow-up|27
2633934|NCT00831441|9101047|P1|Follow Up (30 Days)|Lost to Follow-up|13
2633935|NCT00831441|9101046|P2|Follow Up (30 Days)|Withdrawal by Subject|34
2633936|NCT00831441|9101047|P1|Follow Up (30 Days)|Withdrawal by Subject|41
2633937|NCT00831441|9101046|P2|Randomized|non-specified|266
2633938|NCT00831441|9101047|P1|Randomized|non-specified|276
2633939|NCT00831441|9101046|P2|Randomized|poor/non-compliance|38
2633940|NCT00831441|9101047|P1|Randomized|poor/non-compliance|30
2633941|NCT00831441|9101046|P2|Randomized|Administrative reason by sponsor|2671
2633942|NCT00831441|9101047|P1|Randomized|Administrative reason by sponsor|2780
2633943|NCT00831441|9101046|P2|Randomized|Lost to Follow-up|35
2633944|NCT00831441|9101047|P1|Randomized|Lost to Follow-up|26
2633945|NCT00831441|9101046|P2|Randomized|Withdrawal by Subject|212
2633946|NCT00831441|9101047|P1|Randomized|Withdrawal by Subject|178
2633947|NCT00831441|9101046|P2|Randomized|No longer met criteria|19
2633948|NCT00831441|9101047|P1|Randomized|No longer met criteria|13
2633949|NCT00831441|9101046|P2|Randomized|Physician Decision|35
2633950|NCT00831441|9101047|P1|Randomized|Physician Decision|26
2633951|NCT00831441|9101046|P2|Randomized|Elective procedure|25
2633952|NCT00831441|9101047|P1|Randomized|Elective procedure|26
2633953|NCT00831441|9101046|P2|Randomized|Emergency procedure|2
2633954|NCT00831441|9101047|P1|Randomized|Emergency procedure|2
2633955|NCT00831441|9101046|P2|Randomized|Adverse Event|321
2633956|NCT00831441|9101047|P1|Randomized|Adverse Event|248
2633957|NCT00831441|9101046|P2|Randomized|Death|81
2633958|NCT00831441|9101047|P1|Randomized|Death|82
2633959|NCT00831415|9101079|P1|Overall Study|Death|1
2633960|NCT00831415|9101079|P1|Overall Study|Unsatisfactory response - Efficacy|4
2633961|NCT00831415|9101079|P1|Overall Study|Withdrawal by Subject|35
2633962|NCT00831415|9101079|P1|Overall Study|Protocol Violation|3
2633963|NCT00831415|9101079|P1|Overall Study|Lost to Follow-up|9
2633964|NCT00831415|9101079|P1|Overall Study|Physician Decision|6
2633965|NCT00831415|9101079|P1|Overall Study|Failed to return|3
2633966|NCT00831415|9101079|P1|Overall Study|Adverse Event|14
2633967|NCT00831389|9101088|P2|Overall Study|Withdrawal by Subject|1
2633968|NCT00831389|9101089|P1|Overall Study|Withdrawal by Subject|0
2633969|NCT00831311|9101115|P2|Overall Study|Withdrawal by Subject|4
2633970|NCT00831311|9101116|P1|Overall Study|Withdrawal by Subject|6
2633971|NCT00831311|9101115|P2|Overall Study|Physician Decision|1
2633972|NCT00831311|9101116|P1|Overall Study|Physician Decision|0
2633973|NCT00831311|9101115|P2|Overall Study|Lost to Follow-up|0
2633974|NCT00831311|9101116|P1|Overall Study|Lost to Follow-up|3
2633975|NCT00831311|9101115|P2|Overall Study|Definitive Contraindication|3
2633976|NCT00831311|9101116|P1|Overall Study|Definitive Contraindication|3
2633977|NCT00831233|9101153|P2|Overall Study|Selection Criteria Not Met|0
2633978|NCT00831233|9101154|P1|Overall Study|Selection Criteria Not Met|2
2633979|NCT00831233|9101153|P2|Overall Study|Protocol Violation|0
2633980|NCT00831233|9101154|P1|Overall Study|Protocol Violation|1
2633981|NCT00831233|9101153|P2|Overall Study|Adverse Event|1
2633982|NCT00831233|9101154|P1|Overall Study|Adverse Event|0
2633983|NCT00831181|9101178|P1|Overall Study|Adverse Event|12
2633984|NCT00831129|9101191|P2|Overall Study|9 lost to follow-up reasons uknown|9
2633985|NCT00831129|9101192|P1|Overall Study|9 lost to follow-up reasons uknown|0
2633986|NCT00831129|9101191|P2|Overall Study|Adverse Event|1
2633987|NCT00831129|9101192|P1|Overall Study|Adverse Event|0
2633988|NCT00830960|9101234|P6|Overall Study|No study drug received|7
2633989|NCT00830960|9101235|P5|Overall Study|No study drug received|5
2633990|NCT00830960|9101236|P4|Overall Study|No study drug received|3
2633991|NCT00830960|9101237|P3|Overall Study|No study drug received|4
2633992|NCT00830960|9101238|P2|Overall Study|No study drug received|2
2633993|NCT00830960|9101239|P1|Overall Study|No study drug received|7
2633994|NCT00830960|9101234|P6|Overall Study|Sponsor Decision|7
2633995|NCT00830960|9101235|P5|Overall Study|Sponsor Decision|5
2633996|NCT00830960|9101236|P4|Overall Study|Sponsor Decision|4
2633997|NCT00830960|9101237|P3|Overall Study|Sponsor Decision|3
2633998|NCT00830960|9101238|P2|Overall Study|Sponsor Decision|2
2633999|NCT00830960|9101239|P1|Overall Study|Sponsor Decision|1
2634000|NCT00830960|9101234|P6|Overall Study|Withdrawal by Subject|21
2634001|NCT00830960|9101235|P5|Overall Study|Withdrawal by Subject|16
2634002|NCT00830960|9101236|P4|Overall Study|Withdrawal by Subject|23
2634003|NCT00830960|9101237|P3|Overall Study|Withdrawal by Subject|18
2634004|NCT00830960|9101238|P2|Overall Study|Withdrawal by Subject|19
2634005|NCT00830960|9101239|P1|Overall Study|Withdrawal by Subject|19
2634006|NCT00830960|9101234|P6|Overall Study|Lost to Follow-up|1
2634007|NCT00830960|9101235|P5|Overall Study|Lost to Follow-up|0
2634008|NCT00830960|9101236|P4|Overall Study|Lost to Follow-up|0
2634009|NCT00830960|9101237|P3|Overall Study|Lost to Follow-up|1
2634010|NCT00830960|9101238|P2|Overall Study|Lost to Follow-up|1
2634011|NCT00830960|9101239|P1|Overall Study|Lost to Follow-up|1
2634012|NCT00830960|9101234|P6|Overall Study|Death|1
2634013|NCT00830960|9101235|P5|Overall Study|Death|6
2634014|NCT00830960|9101236|P4|Overall Study|Death|2
2634015|NCT00830960|9101237|P3|Overall Study|Death|3
2634016|NCT00830960|9101238|P2|Overall Study|Death|4
2634017|NCT00830960|9101239|P1|Overall Study|Death|5
2634018|NCT00830947|9101355|P2|Overall Study|Lost to Follow-up|4
2634019|NCT00830947|9101356|P1|Overall Study|Lost to Follow-up|4
2634020|NCT00830869|9101374|P12|Period 2: Part 2|Other|0
2634021|NCT00830869|9101375|P11|Period 2: Part 2|Other|0
2634022|NCT00830869|9101376|P10|Period 2: Part 2|Other|1
2634023|NCT00830869|9101377|P9|Period 2: Part 2|Other|0
2634024|NCT00830869|9101378|P8|Period 2: Part 2|Other|0
2634025|NCT00830869|9101379|P7|Period 2: Part 2|Other|0
2634026|NCT00830869|9101380|P6|Period 2: Part 2|Other|0
2634027|NCT00830869|9101381|P5|Period 2: Part 2|Other|0
2634028|NCT00830869|9101382|P4|Period 2: Part 2|Other|0
2634029|NCT00830869|9101383|P3|Period 2: Part 2|Other|0
2634030|NCT00830869|9101384|P2|Period 2: Part 2|Other|0
2634031|NCT00830869|9101385|P1|Period 2: Part 2|Other|0
2634032|NCT00830869|9101374|P12|Period 2: Part 2|Progressive disease|15
2634033|NCT00830869|9101375|P11|Period 2: Part 2|Progressive disease|8
2634034|NCT00830869|9101376|P10|Period 2: Part 2|Progressive disease|12
2634035|NCT00830869|9101377|P9|Period 2: Part 2|Progressive disease|11
2634036|NCT00830869|9101378|P8|Period 2: Part 2|Progressive disease|14
2634037|NCT00830869|9101379|P7|Period 2: Part 2|Progressive disease|0
2634038|NCT00830869|9101380|P6|Period 2: Part 2|Progressive disease|0
2634039|NCT00830869|9101381|P5|Period 2: Part 2|Progressive disease|0
2634040|NCT00830869|9101382|P4|Period 2: Part 2|Progressive disease|0
2634041|NCT00830869|9101383|P3|Period 2: Part 2|Progressive disease|0
2634042|NCT00830869|9101384|P2|Period 2: Part 2|Progressive disease|0
2634043|NCT00830869|9101385|P1|Period 2: Part 2|Progressive disease|0
2634044|NCT00830869|9101374|P12|Period 2: Part 2|Symptomatic Deterioration|4
2634045|NCT00830869|9101375|P11|Period 2: Part 2|Symptomatic Deterioration|1
2634046|NCT00830869|9101376|P10|Period 2: Part 2|Symptomatic Deterioration|3
2634047|NCT00830869|9101377|P9|Period 2: Part 2|Symptomatic Deterioration|6
2634048|NCT00830869|9101378|P8|Period 2: Part 2|Symptomatic Deterioration|0
2634049|NCT00830869|9101379|P7|Period 2: Part 2|Symptomatic Deterioration|0
2634050|NCT00830869|9101380|P6|Period 2: Part 2|Symptomatic Deterioration|0
2634051|NCT00830869|9101381|P5|Period 2: Part 2|Symptomatic Deterioration|0
2634052|NCT00830869|9101382|P4|Period 2: Part 2|Symptomatic Deterioration|0
2634053|NCT00830869|9101383|P3|Period 2: Part 2|Symptomatic Deterioration|0
2634054|NCT00830869|9101384|P2|Period 2: Part 2|Symptomatic Deterioration|0
2634055|NCT00830869|9101385|P1|Period 2: Part 2|Symptomatic Deterioration|0
2634056|NCT00830869|9101374|P12|Period 2: Part 2|Adverse Event|0
2634057|NCT00830869|9101375|P11|Period 2: Part 2|Adverse Event|2
2634058|NCT00830869|9101376|P10|Period 2: Part 2|Adverse Event|2
2634059|NCT00830869|9101377|P9|Period 2: Part 2|Adverse Event|3
2634060|NCT00830869|9101378|P8|Period 2: Part 2|Adverse Event|4
2634061|NCT00830869|9101379|P7|Period 2: Part 2|Adverse Event|0
2634062|NCT00830869|9101380|P6|Period 2: Part 2|Adverse Event|0
2634063|NCT00830869|9101381|P5|Period 2: Part 2|Adverse Event|0
2634064|NCT00830869|9101382|P4|Period 2: Part 2|Adverse Event|0
2634065|NCT00830869|9101383|P3|Period 2: Part 2|Adverse Event|0
2634066|NCT00830869|9101384|P2|Period 2: Part 2|Adverse Event|0
2634067|NCT00830869|9101385|P1|Period 2: Part 2|Adverse Event|0
2634068|NCT00830869|9101374|P12|Period 2: Part 2|Withdrawal by Subject|1
2634069|NCT00830869|9101375|P11|Period 2: Part 2|Withdrawal by Subject|0
2634070|NCT00830869|9101376|P10|Period 2: Part 2|Withdrawal by Subject|1
2634071|NCT00830869|9101377|P9|Period 2: Part 2|Withdrawal by Subject|2
2634072|NCT00830869|9101378|P8|Period 2: Part 2|Withdrawal by Subject|1
2634073|NCT00830869|9101379|P7|Period 2: Part 2|Withdrawal by Subject|0
2634074|NCT00830869|9101380|P6|Period 2: Part 2|Withdrawal by Subject|0
2634075|NCT00830869|9101381|P5|Period 2: Part 2|Withdrawal by Subject|0
2634076|NCT00830869|9101382|P4|Period 2: Part 2|Withdrawal by Subject|0
2634077|NCT00830869|9101383|P3|Period 2: Part 2|Withdrawal by Subject|0
2634078|NCT00830869|9101384|P2|Period 2: Part 2|Withdrawal by Subject|0
2634079|NCT00830869|9101385|P1|Period 2: Part 2|Withdrawal by Subject|0
2634080|NCT00830869|9101374|P12|Period 2: Part 2|Protocol Violation|0
2634081|NCT00830869|9101375|P11|Period 2: Part 2|Protocol Violation|0
2634082|NCT00830869|9101376|P10|Period 2: Part 2|Protocol Violation|1
2634083|NCT00830869|9101377|P9|Period 2: Part 2|Protocol Violation|0
2634084|NCT00830869|9101378|P8|Period 2: Part 2|Protocol Violation|1
2634085|NCT00830869|9101379|P7|Period 2: Part 2|Protocol Violation|0
2634086|NCT00830869|9101380|P6|Period 2: Part 2|Protocol Violation|0
2634087|NCT00830869|9101381|P5|Period 2: Part 2|Protocol Violation|0
2634088|NCT00830869|9101382|P4|Period 2: Part 2|Protocol Violation|0
2634089|NCT00830869|9101383|P3|Period 2: Part 2|Protocol Violation|0
2634090|NCT00830869|9101384|P2|Period 2: Part 2|Protocol Violation|0
2634091|NCT00830869|9101385|P1|Period 2: Part 2|Protocol Violation|0
2634092|NCT00830869|9101374|P12|Period 1: Part 1|Progressive disease|0
2634093|NCT00830869|9101375|P11|Period 1: Part 1|Progressive disease|0
2634094|NCT00830869|9101376|P10|Period 1: Part 1|Progressive disease|0
2634095|NCT00830869|9101377|P9|Period 1: Part 1|Progressive disease|0
2634096|NCT00830869|9101378|P8|Period 1: Part 1|Progressive disease|0
2634097|NCT00830869|9101379|P7|Period 1: Part 1|Progressive disease|1
2634098|NCT00830869|9101380|P6|Period 1: Part 1|Progressive disease|4
2634099|NCT00830869|9101381|P5|Period 1: Part 1|Progressive disease|4
2634100|NCT00830869|9101382|P4|Period 1: Part 1|Progressive disease|6
2634101|NCT00830869|9101383|P3|Period 1: Part 1|Progressive disease|1
2634102|NCT00830869|9101384|P2|Period 1: Part 1|Progressive disease|0
2634103|NCT00830869|9101385|P1|Period 1: Part 1|Progressive disease|1
2634104|NCT00830869|9101374|P12|Period 1: Part 1|Adverse Event|0
2634105|NCT00830869|9101375|P11|Period 1: Part 1|Adverse Event|0
2634106|NCT00830869|9101376|P10|Period 1: Part 1|Adverse Event|0
2634107|NCT00830869|9101377|P9|Period 1: Part 1|Adverse Event|0
2634108|NCT00830869|9101378|P8|Period 1: Part 1|Adverse Event|0
2634109|NCT00830869|9101379|P7|Period 1: Part 1|Adverse Event|1
2634110|NCT00830869|9101380|P6|Period 1: Part 1|Adverse Event|1
2634111|NCT00830869|9101381|P5|Period 1: Part 1|Adverse Event|0
2634112|NCT00830869|9101382|P4|Period 1: Part 1|Adverse Event|0
2634113|NCT00830869|9101383|P3|Period 1: Part 1|Adverse Event|0
2634114|NCT00830869|9101384|P2|Period 1: Part 1|Adverse Event|0
2634115|NCT00830869|9101385|P1|Period 1: Part 1|Adverse Event|0
2634116|NCT00830869|9101374|P12|Period 1: Part 1|Withdrawal by Subject|0
2634117|NCT00830869|9101375|P11|Period 1: Part 1|Withdrawal by Subject|0
2634118|NCT00830869|9101376|P10|Period 1: Part 1|Withdrawal by Subject|0
2634119|NCT00830869|9101377|P9|Period 1: Part 1|Withdrawal by Subject|0
2634120|NCT00830869|9101378|P8|Period 1: Part 1|Withdrawal by Subject|0
2634121|NCT00830869|9101379|P7|Period 1: Part 1|Withdrawal by Subject|0
2634122|NCT00830869|9101380|P6|Period 1: Part 1|Withdrawal by Subject|0
2634123|NCT00830869|9101381|P5|Period 1: Part 1|Withdrawal by Subject|0
2634124|NCT00830869|9101382|P4|Period 1: Part 1|Withdrawal by Subject|0
2634125|NCT00830869|9101383|P3|Period 1: Part 1|Withdrawal by Subject|0
2634126|NCT00830869|9101384|P2|Period 1: Part 1|Withdrawal by Subject|1
2634127|NCT00830869|9101385|P1|Period 1: Part 1|Withdrawal by Subject|0
2634128|NCT00830869|9101374|P12|Period 1: Part 1|Symptomatic deterioration|0
2634129|NCT00830869|9101375|P11|Period 1: Part 1|Symptomatic deterioration|0
2634130|NCT00830869|9101376|P10|Period 1: Part 1|Symptomatic deterioration|0
2634131|NCT00830869|9101377|P9|Period 1: Part 1|Symptomatic deterioration|0
2634132|NCT00830869|9101378|P8|Period 1: Part 1|Symptomatic deterioration|0
2634133|NCT00830869|9101379|P7|Period 1: Part 1|Symptomatic deterioration|1
2634134|NCT00830869|9101380|P6|Period 1: Part 1|Symptomatic deterioration|1
2634135|NCT00830869|9101381|P5|Period 1: Part 1|Symptomatic deterioration|0
2634136|NCT00830869|9101382|P4|Period 1: Part 1|Symptomatic deterioration|1
2634137|NCT00830869|9101383|P3|Period 1: Part 1|Symptomatic deterioration|0
2634138|NCT00830869|9101384|P2|Period 1: Part 1|Symptomatic deterioration|0
2634139|NCT00830869|9101385|P1|Period 1: Part 1|Symptomatic deterioration|0
2634140|NCT00830804|9101521|P1|Overall Study|Unwilling to adhere to study requirement|1
2634141|NCT00830804|9101521|P1|Overall Study|Consent withdrawn|2
2634142|NCT00830804|9101521|P1|Overall Study|Unable to get to clinic|7
2634143|NCT00830804|9101521|P1|Overall Study|Death|1
2634144|NCT00830804|9101521|P1|Overall Study|Lost to Follow-up|4
2634145|NCT00830765|9101601|P2|Overall Study|Protocol Violation|2
2634146|NCT00830765|9101602|P1|Overall Study|Protocol Violation|3
2634147|NCT00830518|9101635|P2|Overall Study|Reason not Specified|1
2634148|NCT00830518|9101636|P1|Overall Study|Reason not Specified|8
2634149|NCT00830518|9101635|P2|Overall Study|Withdrawal by Patient|0
2634150|NCT00830518|9101636|P1|Overall Study|Withdrawal by Patient|2
2634151|NCT00830518|9101635|P2|Overall Study|Adverse Event|1
2634152|NCT00830518|9101636|P1|Overall Study|Adverse Event|14
2634153|NCT00830518|9101635|P2|Overall Study|Symptomatic Deterioration|1
2634154|NCT00830518|9101636|P1|Overall Study|Symptomatic Deterioration|4
2634155|NCT00830518|9101635|P2|Overall Study|Progressive Disease|8
2634156|NCT00830518|9101636|P1|Overall Study|Progressive Disease|18
2634157|NCT00830440|9101655|P2|Overall Study|Adverse Event|0
2634158|NCT00830440|9101656|P1|Overall Study|Adverse Event|2
2634159|NCT00830440|9101655|P2|Overall Study|unsuccessful procedure|0
2634160|NCT00830440|9101656|P1|Overall Study|unsuccessful procedure|4
2634161|NCT00830440|9101655|P2|Overall Study|Withdrawal by Subject|0
2634162|NCT00830440|9101656|P1|Overall Study|Withdrawal by Subject|1
2634163|NCT00830440|9101655|P2|Overall Study|Protocol Violation|0
2634164|NCT00830440|9101656|P1|Overall Study|Protocol Violation|1
2634165|NCT00830375|9101671|P1|Overall Study|Lost to Follow-up|1
2634166|NCT00830336|9101686|P2|Washout: 21 Days|Withdrawal by Subject|0
2634167|NCT00830336|9101687|P1|Washout: 21 Days|Withdrawal by Subject|1
2634168|NCT00830258|9101714|P2|Washout: 7 Days|Protocol Violation|0
2634169|NCT00830258|9101715|P1|Washout: 7 Days|Protocol Violation|1
2634170|NCT00830258|9101714|P2|First Intervention|Adverse Event|0
2634171|NCT00830258|9101715|P1|First Intervention|Adverse Event|1
2634172|NCT00830219|9101734|P2|Washout of 7 Days|Withdrawal by Subject|1
2634173|NCT00830219|9101735|P1|Washout of 7 Days|Withdrawal by Subject|1
2634174|NCT00830206|9101745|P2|Washout: 21 Days|Withdrawal by Subject|1
2634175|NCT00830206|9101746|P1|Washout: 21 Days|Withdrawal by Subject|1
2634176|NCT00830167|9101756|P2|Overall Study|Other|2
2634177|NCT00830167|9101757|P1|Overall Study|Other|2
2634178|NCT00830167|9101756|P2|Overall Study|Protocol Violation|1
2634179|NCT00830167|9101757|P1|Overall Study|Protocol Violation|0
2634180|NCT00830167|9101756|P2|Overall Study|Lost to Follow-up|1
2634181|NCT00830167|9101757|P1|Overall Study|Lost to Follow-up|0
2634182|NCT00830167|9101756|P2|Overall Study|Withdrawal by Subject|0
2634183|NCT00830167|9101757|P1|Overall Study|Withdrawal by Subject|2
2634184|NCT00830167|9101756|P2|Overall Study|Not meeting entrance criteria|5
2634185|NCT00830167|9101757|P1|Overall Study|Not meeting entrance criteria|2
2634186|NCT00830167|9101756|P2|Overall Study|Adverse Event|24
2634187|NCT00830167|9101757|P1|Overall Study|Adverse Event|8
2634188|NCT00830167|9101756|P2|Overall Study|Lack of Efficacy|10
2634189|NCT00830167|9101757|P1|Overall Study|Lack of Efficacy|26
2634190|NCT00830128|9101827|P1|Overall Study|Operating a vehicle|1
2634191|NCT00830128|9101827|P1|Overall Study|Work obligation|1
2634192|NCT00830128|9101827|P1|Overall Study|Relocation|1
2634193|NCT00830128|9101827|P1|Overall Study|Family obligation|1
2634194|NCT00830128|9101827|P1|Overall Study|Withdrawal by Subject|2
2634195|NCT00830128|9101827|P1|Overall Study|Protocol Violation|1
2634196|NCT00830128|9101827|P1|Overall Study|Lack of Efficacy|7
2634197|NCT00830128|9101827|P1|Overall Study|Adverse Event|5
2634198|NCT00830115|9101842|P1|Overall Study|Improvement/recovery|1
2634199|NCT00830115|9101842|P1|Overall Study|Adverse Event|2
2634200|NCT00830037|9101869|P2|Overall Study|Active when terminated by DSMB|14
2634201|NCT00830037|9101870|P1|Overall Study|Active when terminated by DSMB|15
2634202|NCT00830037|9101869|P2|Overall Study|Lost to Follow-up|2
2634203|NCT00830037|9101870|P1|Overall Study|Lost to Follow-up|1
2634204|NCT00830037|9101869|P2|Overall Study|Withdrawal by Subject|3
2634205|NCT00830037|9101870|P1|Overall Study|Withdrawal by Subject|2
2634206|NCT00830024|9101880|P2|Washout: 7 Days|Withdrawal by Subject|0
2634207|NCT00830024|9101881|P1|Washout: 7 Days|Withdrawal by Subject|1
2634208|NCT00829998|9101891|P2|Washout|Adverse Event|1
2634209|NCT00829998|9101892|P1|Washout|Adverse Event|0
2634210|NCT00829933|9101921|P4|Overall Study|withdrew before treatment started|9
2634211|NCT00829933|9101922|P3|Overall Study|withdrew before treatment started|2
2634212|NCT00829933|9101923|P2|Overall Study|withdrew before treatment started|1
2634213|NCT00829933|9101924|P1|Overall Study|withdrew before treatment started|5
2634214|NCT00829933|9101921|P4|Overall Study|Protocol Violation|0
2634215|NCT00829933|9101922|P3|Overall Study|Protocol Violation|0
2634216|NCT00829933|9101923|P2|Overall Study|Protocol Violation|1
2634217|NCT00829933|9101924|P1|Overall Study|Protocol Violation|2
2634218|NCT00829933|9101921|P4|Overall Study|Pregnancy|2
2634219|NCT00829933|9101922|P3|Overall Study|Pregnancy|0
2634220|NCT00829933|9101923|P2|Overall Study|Pregnancy|0
2634221|NCT00829933|9101924|P1|Overall Study|Pregnancy|0
2634222|NCT00829933|9101921|P4|Overall Study|Physician Decision|1
2634223|NCT00829933|9101922|P3|Overall Study|Physician Decision|8
2634224|NCT00829933|9101923|P2|Overall Study|Physician Decision|7
2634225|NCT00829933|9101924|P1|Overall Study|Physician Decision|5
2634226|NCT00829933|9101921|P4|Overall Study|Lack of Efficacy|0
2634227|NCT00829933|9101922|P3|Overall Study|Lack of Efficacy|0
2634228|NCT00829933|9101923|P2|Overall Study|Lack of Efficacy|1
2634229|NCT00829933|9101924|P1|Overall Study|Lack of Efficacy|0
2634230|NCT00829933|9101921|P4|Overall Study|Death|1
2634231|NCT00829933|9101922|P3|Overall Study|Death|1
2634232|NCT00829933|9101923|P2|Overall Study|Death|0
2634233|NCT00829933|9101924|P1|Overall Study|Death|0
2634234|NCT00829933|9101921|P4|Overall Study|Adverse Event|1
2634235|NCT00829933|9101922|P3|Overall Study|Adverse Event|2
2634236|NCT00829933|9101923|P2|Overall Study|Adverse Event|3
2634237|NCT00829933|9101924|P1|Overall Study|Adverse Event|2
2634238|NCT00829868|9101936|P2|Washout|Physician Decision|0
2634239|NCT00829868|9101937|P1|Washout|Physician Decision|1
2634240|NCT00829829|9101948|P3|Overall Study|Other than specified above|1
2634241|NCT00829829|9101949|P2|Overall Study|Other than specified above|2
2634242|NCT00829829|9101950|P1|Overall Study|Other than specified above|2
2634243|NCT00829829|9101948|P3|Overall Study|Lost to Follow-up|3
2634244|NCT00829829|9101949|P2|Overall Study|Lost to Follow-up|3
2634245|NCT00829829|9101950|P1|Overall Study|Lost to Follow-up|7
2634246|NCT00829829|9101948|P3|Overall Study|Decision by the Sponsor|2
2634247|NCT00829829|9101949|P2|Overall Study|Decision by the Sponsor|0
2634248|NCT00829829|9101950|P1|Overall Study|Decision by the Sponsor|1
2634249|NCT00829829|9101948|P3|Overall Study|Withdrawal by Subject|2
2634250|NCT00829829|9101949|P2|Overall Study|Withdrawal by Subject|4
2634251|NCT00829829|9101950|P1|Overall Study|Withdrawal by Subject|8
2634252|NCT00829829|9101948|P3|Overall Study|Adverse Event|3
2634253|NCT00829829|9101949|P2|Overall Study|Adverse Event|4
2634254|NCT00829829|9101950|P1|Overall Study|Adverse Event|4
2634255|NCT00829829|9101948|P3|Overall Study|Protocol Violation|0
2634256|NCT00829829|9101949|P2|Overall Study|Protocol Violation|3
2634257|NCT00829829|9101950|P1|Overall Study|Protocol Violation|0
2634258|NCT00829790|9101975|P2|Washout of 14 Days|Withdrawal by Subject|1
2634259|NCT00829790|9101976|P1|Washout of 14 Days|Withdrawal by Subject|0
2634260|NCT00829764|9101986|P2|First Intervention|Withdrawal by Subject|1
2634261|NCT00829764|9101987|P1|First Intervention|Withdrawal by Subject|1
2634262|NCT00829764|9101986|P2|First Intervention|Adverse Event|0
2634263|NCT00829764|9101987|P1|First Intervention|Adverse Event|1
2634264|NCT00829712|9102013|P2|Washout of 7 Days|Withdrawal by Subject|1
2634265|NCT00829712|9102014|P1|Washout of 7 Days|Withdrawal by Subject|0
2634266|NCT00829673|9102033|P2|Washout of 7 Days|Withdrawal by Subject|0
2634267|NCT00829673|9102034|P1|Washout of 7 Days|Withdrawal by Subject|1
2634268|NCT00829621|9102044|P2|Overall Study|Lost to Follow-up|4
2634269|NCT00829621|9102045|P1|Overall Study|Lost to Follow-up|3
2634270|NCT00829621|9102044|P2|Overall Study|Death|0
2634271|NCT00829621|9102045|P1|Overall Study|Death|1
2634272|NCT00829530|9102053|P2|Second Intervention|Intolerance to Venopuncture|0
2634273|NCT00829530|9102054|P1|Second Intervention|Intolerance to Venopuncture|1
2634274|NCT00829530|9102053|P2|First Intervention|Intolerance to Venopuncture|1
2634275|NCT00829530|9102054|P1|First Intervention|Intolerance to Venopuncture|0
2634276|NCT00829530|9102053|P2|First Intervention|Adverse Event|1
2634277|NCT00829530|9102054|P1|First Intervention|Adverse Event|0
2634278|NCT00829504|9102068|P2|Second Intervention|Physician Decision|0
2634279|NCT00829504|9102069|P1|Second Intervention|Physician Decision|1
2634280|NCT00829504|9102068|P2|Washout of 7 Days|Withdrawal by Subject|0
2634281|NCT00829504|9102069|P1|Washout of 7 Days|Withdrawal by Subject|1
2634282|NCT00829504|9102068|P2|First Intervention|Adverse Event|0
2634283|NCT00829504|9102069|P1|First Intervention|Adverse Event|1
2634284|NCT00829452|9102079|P2|Second Intervention|Physician Decision|1
2634285|NCT00829452|9102080|P1|Second Intervention|Physician Decision|0
2634286|NCT00829452|9102079|P2|Washout of 42 Days|Withdrawal by Subject|1
2634287|NCT00829452|9102080|P1|Washout of 42 Days|Withdrawal by Subject|0
2634288|NCT00829452|9102079|P2|First Intervention|Withdrawal by Subject|1
2634289|NCT00829452|9102080|P1|First Intervention|Withdrawal by Subject|0
2634290|NCT00829439|9102092|P4|Overall Study|Adverse Event|0
2634291|NCT00829439|9102093|P3|Overall Study|Adverse Event|1
2634292|NCT00829439|9102094|P2|Overall Study|Adverse Event|0
2634293|NCT00829439|9102095|P1|Overall Study|Adverse Event|0
2634294|NCT00829426|9102101|P2|Washout: 7 Days|Withdrawal by Subject|0
2634295|NCT00829426|9102102|P1|Washout: 7 Days|Withdrawal by Subject|1
2634296|NCT00829413|9102110|P1|Overall Study|Indeterminate diagnosis from truth stand|3
2634297|NCT00829413|9102110|P1|Overall Study|Technically inadequate truth standard|2
2634298|NCT00829413|9102110|P1|Overall Study|No truth standard procedure available|9
2634299|NCT00829413|9102110|P1|Overall Study|Training Patients|67
2634300|NCT00829413|9102110|P1|Overall Study|No study drug admimnistered|13
2634301|NCT00829387|9102159|P2|Overall Study|Disqualified by PI|0
2634302|NCT00829387|9102160|P1|Overall Study|Disqualified by PI|1
2634303|NCT00829387|9102159|P2|Overall Study|Withdrawal by Subject|3
2634304|NCT00829387|9102160|P1|Overall Study|Withdrawal by Subject|2
2634305|NCT00829309|9102178|P2|Washout: 7 Days|Protocol Violation|0
2634306|NCT00829309|9102179|P1|Washout: 7 Days|Protocol Violation|1
2634307|NCT00829296|9102189|P2|Overall Study|Adverse Event|4
2634308|NCT00829296|9102190|P1|Overall Study|Adverse Event|5
2634309|NCT00829283|9102204|P2|Overall Study|Lost to Follow-up|25
2634310|NCT00829283|9102205|P1|Overall Study|Lost to Follow-up|7
2634311|NCT00829244|9102215|P2|Overall Study|No embryo cleavage|2
2634312|NCT00829244|9102216|P1|Overall Study|No embryo cleavage|0
2634313|NCT00829244|9102215|P2|Overall Study|All embryos discarded|3
2634314|NCT00829244|9102216|P1|Overall Study|All embryos discarded|0
2634315|NCT00829244|9102215|P2|Overall Study|No fertilization|2
2634316|NCT00829244|9102216|P1|Overall Study|No fertilization|2
2634317|NCT00829244|9102215|P2|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6
2634318|NCT00829244|9102216|P1|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1
2634319|NCT00829244|9102215|P2|Overall Study|Lack of ovarian response to stimulation|5
2634320|NCT00829244|9102216|P1|Overall Study|Lack of ovarian response to stimulation|9
2634321|NCT00829244|9102215|P2|Overall Study|Protocol Violation|0
2634322|NCT00829244|9102216|P1|Overall Study|Protocol Violation|1
2634323|NCT00829244|9102215|P2|Overall Study|Adverse Event|3
2634324|NCT00829244|9102216|P1|Overall Study|Adverse Event|1
2634325|NCT00829179|9102246|P1|Overall Study|Withdrawal by Subject|1
2634326|NCT00829166|9102252|P2|Overall Study|Reason Not Specified|3
2634327|NCT00829166|9102253|P1|Overall Study|Reason Not Specified|3
2634328|NCT00829166|9102252|P2|Overall Study|Sponsor’s Decision|98
2634329|NCT00829166|9102253|P1|Overall Study|Sponsor’s Decision|137
2634330|NCT00829166|9102252|P2|Overall Study|Subject's Decision|55
2634331|NCT00829166|9102253|P1|Overall Study|Subject's Decision|41
2634332|NCT00829166|9102252|P2|Overall Study|Physician's Decision|3
2634333|NCT00829166|9102253|P1|Overall Study|Physician's Decision|4
2634334|NCT00829166|9102252|P2|Overall Study|Lost to Follow-up|4
2634335|NCT00829166|9102253|P1|Overall Study|Lost to Follow-up|5
2634336|NCT00829166|9102252|P2|Overall Study|Death|333
2634337|NCT00829166|9102253|P1|Overall Study|Death|305
2634338|NCT00829010|9102316|P5|Overall Study|Migrated/Moved from study area|0
2634339|NCT00829010|9102317|P4|Overall Study|Migrated/Moved from study area|5
2634340|NCT00829010|9102318|P3|Overall Study|Migrated/Moved from study area|0
2634341|NCT00829010|9102319|P2|Overall Study|Migrated/Moved from study area|4
2634342|NCT00829010|9102320|P1|Overall Study|Migrated/Moved from study area|3
2634343|NCT00829010|9102316|P5|Overall Study|Fatality|0
2634344|NCT00829010|9102317|P4|Overall Study|Fatality|3
2634345|NCT00829010|9102318|P3|Overall Study|Fatality|0
2634346|NCT00829010|9102319|P2|Overall Study|Fatality|4
2634347|NCT00829010|9102320|P1|Overall Study|Fatality|5
2634348|NCT00829010|9102316|P5|Overall Study|Lost to Follow-up|0
2634349|NCT00829010|9102317|P4|Overall Study|Lost to Follow-up|0
2634350|NCT00829010|9102318|P3|Overall Study|Lost to Follow-up|2
2634351|NCT00829010|9102319|P2|Overall Study|Lost to Follow-up|0
2634352|NCT00829010|9102320|P1|Overall Study|Lost to Follow-up|1
2634353|NCT00829010|9102316|P5|Overall Study|Withdrawal by Subject|2
2634354|NCT00829010|9102317|P4|Overall Study|Withdrawal by Subject|0
2634355|NCT00829010|9102318|P3|Overall Study|Withdrawal by Subject|1
2634356|NCT00829010|9102319|P2|Overall Study|Withdrawal by Subject|1
2634357|NCT00829010|9102320|P1|Overall Study|Withdrawal by Subject|0
2634358|NCT00829010|9102316|P5|Overall Study|Adverse Event|0
2634359|NCT00829010|9102317|P4|Overall Study|Adverse Event|0
2634360|NCT00829010|9102318|P3|Overall Study|Adverse Event|0
2634361|NCT00829010|9102319|P2|Overall Study|Adverse Event|0
2634362|NCT00829010|9102320|P1|Overall Study|Adverse Event|1
2634363|NCT00828984|9102485|P3|Overall Study|ConMed|1
2634364|NCT00828984|9102486|P2|Overall Study|ConMed|1
2634365|NCT00828984|9102487|P1|Overall Study|ConMed|1
2634366|NCT00828984|9102485|P3|Overall Study|Noncompliant|3
2634367|NCT00828984|9102486|P2|Overall Study|Noncompliant|2
2634368|NCT00828984|9102487|P1|Overall Study|Noncompliant|1
2634369|NCT00828984|9102485|P3|Overall Study|Medical Contraindication|0
2634370|NCT00828984|9102486|P2|Overall Study|Medical Contraindication|1
2634371|NCT00828984|9102487|P1|Overall Study|Medical Contraindication|0
2634372|NCT00828984|9102485|P3|Overall Study|Ineligable|0
2634373|NCT00828984|9102486|P2|Overall Study|Ineligable|2
2634374|NCT00828984|9102487|P1|Overall Study|Ineligable|1
2634375|NCT00828984|9102485|P3|Overall Study|Withdrawal by Subject|4
2634376|NCT00828984|9102486|P2|Overall Study|Withdrawal by Subject|4
2634377|NCT00828984|9102487|P1|Overall Study|Withdrawal by Subject|4
2634378|NCT00828984|9102485|P3|Overall Study|Lost to Follow-up|1
2634379|NCT00828984|9102486|P2|Overall Study|Lost to Follow-up|3
2634380|NCT00828984|9102487|P1|Overall Study|Lost to Follow-up|5
2634381|NCT00828984|9102485|P3|Overall Study|Adverse Event|0
2634382|NCT00828984|9102486|P2|Overall Study|Adverse Event|3
2634383|NCT00828984|9102487|P1|Overall Study|Adverse Event|2
2634384|NCT00828945|9102510|P1|Overall Study|Other|36
2634385|NCT00828945|9102510|P1|Overall Study|Participant was missing|1
2634386|NCT00828945|9102510|P1|Overall Study|Death|4
2634387|NCT00828750|9102542|P1|Overall Study|Normal PC Remained While No Treatment|1
2634388|NCT00828750|9102542|P1|Overall Study|Lack of Efficacy|3
2634389|NCT00828711|9102556|P3|Overall Study|Lost to Follow-up|0
2634390|NCT00828711|9102557|P2|Overall Study|Lost to Follow-up|0
2634391|NCT00828711|9102558|P1|Overall Study|Lost to Follow-up|1
2634392|NCT00828672|9102589|P2|Post-surgery (<30 Days)|No central review materials|1
2634393|NCT00828672|9102590|P1|Post-surgery (<30 Days)|No central review materials|0
2634394|NCT00828672|9102589|P2|Study Treatment|Complete response, no surgery|1
2634395|NCT00828672|9102590|P1|Study Treatment|Complete response, no surgery|1
2634396|NCT00828672|9102589|P2|Study Treatment|Adverse Event|1
2634397|NCT00828672|9102590|P1|Study Treatment|Adverse Event|0
2634398|NCT00828672|9102589|P2|Study Treatment|Lost to Follow-up|0
2634399|NCT00828672|9102590|P1|Study Treatment|Lost to Follow-up|1
2634400|NCT00828568|9102611|P3|Treated - Received at Least One Dose|Protocol Violation|3
2634401|NCT00828568|9102612|P2|Treated - Received at Least One Dose|Protocol Violation|5
2634402|NCT00828568|9102613|P1|Treated - Received at Least One Dose|Protocol Violation|9
2634403|NCT00828568|9102611|P3|Treated - Received at Least One Dose|Lost to Follow-up|1
2634404|NCT00828568|9102612|P2|Treated - Received at Least One Dose|Lost to Follow-up|5
2634405|NCT00828568|9102613|P1|Treated - Received at Least One Dose|Lost to Follow-up|1
2634406|NCT00828568|9102611|P3|Treated - Received at Least One Dose|Withdrawal by Subject|0
2634407|NCT00828568|9102612|P2|Treated - Received at Least One Dose|Withdrawal by Subject|11
2634408|NCT00828568|9102613|P1|Treated - Received at Least One Dose|Withdrawal by Subject|9
2634409|NCT00828568|9102611|P3|Treated - Received at Least One Dose|Adverse Event|1
2634410|NCT00828568|9102612|P2|Treated - Received at Least One Dose|Adverse Event|8
2634411|NCT00828568|9102613|P1|Treated - Received at Least One Dose|Adverse Event|11
2634412|NCT00828568|9102611|P3|Randomized|Withdrawal by Subject|2
2634413|NCT00828568|9102612|P2|Randomized|Withdrawal by Subject|0
2634414|NCT00828568|9102613|P1|Randomized|Withdrawal by Subject|1
2634415|NCT00828516|9102635|P1|Clinical Phase: Series 1|Withdrawal by Subject|2
2634416|NCT00828464|9102640|P1|Overall Study|Withdrawal by Subject|1
2634417|NCT00828451|9102657|P1|Overall Study|Deterioration in clinical status|1
2634418|NCT00828451|9102657|P1|Overall Study|Withdrawal by Subject|1
2634419|NCT00828451|9102657|P1|Overall Study|Lack of intravenous line|7
2634420|NCT00828451|9102657|P1|Overall Study|Death|2
2634421|NCT00828321|9102683|P2|Second Intervention|Protocol Violation|1
2634422|NCT00828321|9102684|P1|Second Intervention|Protocol Violation|0
2634423|NCT00828321|9102683|P2|Washout of 42 Days|Withdrawal by Subject|0
2634424|NCT00828321|9102684|P1|Washout of 42 Days|Withdrawal by Subject|2
2634425|NCT00828204|9102713|P2|Extension Study|Physician Decision|2
2634426|NCT00828204|9102714|P1|Extension Study|Physician Decision|0
2634427|NCT00828204|9102713|P2|Extension Study|Lost to Follow-up|1
2634428|NCT00828204|9102714|P1|Extension Study|Lost to Follow-up|0
2634429|NCT00828204|9102713|P2|Main Study: After Study Restart|Noncompliance|1
2634430|NCT00828204|9102714|P1|Main Study: After Study Restart|Noncompliance|0
2634431|NCT00828204|9102713|P2|Main Study: After Study Restart|Adverse Event|2
2634432|NCT00828204|9102714|P1|Main Study: After Study Restart|Adverse Event|0
2634433|NCT00828204|9102713|P2|Main Study: Prior to Study Suspension|Study Suspension|0
2634434|NCT00828204|9102714|P1|Main Study: Prior to Study Suspension|Study Suspension|11
2634435|NCT00828204|9102713|P2|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0
2634436|NCT00828204|9102714|P1|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2
2634437|NCT00828204|9102713|P2|Main Study: Prior to Study Suspension|Adverse Event|0
2634438|NCT00828204|9102714|P1|Main Study: Prior to Study Suspension|Adverse Event|1
2634439|NCT00828139|9102761|P4|Overall Study|Other|2
2634440|NCT00828139|9102762|P3|Overall Study|Other|5
2634441|NCT00828139|9102763|P2|Overall Study|Other|2
2634442|NCT00828139|9102764|P1|Overall Study|Other|4
2634443|NCT00828139|9102761|P4|Overall Study|Disease Progression|39
2634444|NCT00828139|9102762|P3|Overall Study|Disease Progression|35
2634445|NCT00828139|9102763|P2|Overall Study|Disease Progression|33
2634446|NCT00828139|9102764|P1|Overall Study|Disease Progression|24
2634447|NCT00828139|9102761|P4|Overall Study|Refusal unrelated to toxicity|3
2634448|NCT00828139|9102762|P3|Overall Study|Refusal unrelated to toxicity|5
2634449|NCT00828139|9102763|P2|Overall Study|Refusal unrelated to toxicity|4
2634450|NCT00828139|9102764|P1|Overall Study|Refusal unrelated to toxicity|3
2634451|NCT00828139|9102761|P4|Overall Study|Death|2
2634452|NCT00828139|9102762|P3|Overall Study|Death|0
2634453|NCT00828139|9102763|P2|Overall Study|Death|1
2634454|NCT00828139|9102764|P1|Overall Study|Death|2
2634455|NCT00828139|9102761|P4|Overall Study|Adverse Event|5
2634456|NCT00828139|9102762|P3|Overall Study|Adverse Event|10
2634457|NCT00828139|9102763|P2|Overall Study|Adverse Event|1
2634458|NCT00828139|9102764|P1|Overall Study|Adverse Event|8
2634459|NCT00828113|9102784|P2|Overall Study|Lost to Follow-up|5
2634460|NCT00828113|9102785|P1|Overall Study|Lost to Follow-up|3
2634461|NCT00828113|9102784|P2|Overall Study|Withdrawal by Subject|26
2634462|NCT00828113|9102785|P1|Overall Study|Withdrawal by Subject|27
2634463|NCT00828009|9102823|P1|Step 2 - Maintenance Therapy|Other|1
2634464|NCT00828009|9102823|P1|Step 2 - Maintenance Therapy|Complicating disease|2
2634465|NCT00828009|9102823|P1|Step 2 - Maintenance Therapy|Withdrawal by Subject|4
2634466|NCT00828009|9102823|P1|Step 2 - Maintenance Therapy|Death|1
2634467|NCT00828009|9102823|P1|Step 2 - Maintenance Therapy|Adverse Event|13
2634468|NCT00828009|9102823|P1|Step 2 - Maintenance Therapy|Progressive disease|12
2634469|NCT00828009|9102823|P1|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2
2634470|NCT00828009|9102823|P1|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2
2634471|NCT00828009|9102823|P1|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1
2634472|NCT00828009|9102823|P1|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11
2634473|NCT00828009|9102823|P1|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3
2634474|NCT00828009|9102823|P1|Step 1 - Chemo RT/Consolidation Chemo|Death|2
2634475|NCT00828009|9102823|P1|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10
2634476|NCT00827931|9102866|P2|Overall Study|Other|0
2634477|NCT00827931|9102867|P1|Overall Study|Other|1
2634478|NCT00827931|9102866|P2|Overall Study|Withdrawal by Subject|1
2634479|NCT00827931|9102867|P1|Overall Study|Withdrawal by Subject|0
2634480|NCT00827931|9102866|P2|Overall Study|Lost to Follow-up|0
2634481|NCT00827931|9102867|P1|Overall Study|Lost to Follow-up|1
2634482|NCT00827931|9102866|P2|Overall Study|Adverse Event|0
2634483|NCT00827931|9102867|P1|Overall Study|Adverse Event|1
2634484|NCT00827931|9102866|P2|Overall Study|Death|5
2634485|NCT00827931|9102867|P1|Overall Study|Death|3
2634486|NCT00827918|9102888|P3|Overall Study|Withdrawal by Subject|6
2634487|NCT00827918|9102889|P2|Overall Study|Withdrawal by Subject|2
2634488|NCT00827918|9102890|P1|Overall Study|Withdrawal by Subject|6
2634489|NCT00827918|9102888|P3|Overall Study|Protocol Violation|0
2634490|NCT00827918|9102889|P2|Overall Study|Protocol Violation|1
2634491|NCT00827918|9102890|P1|Overall Study|Protocol Violation|0
2634492|NCT00827918|9102888|P3|Overall Study|Progressive Disease|0
2634493|NCT00827918|9102889|P2|Overall Study|Progressive Disease|1
2634494|NCT00827918|9102890|P1|Overall Study|Progressive Disease|1
2634495|NCT00827918|9102888|P3|Overall Study|Pregnancy|0
2634496|NCT00827918|9102889|P2|Overall Study|Pregnancy|1
2634497|NCT00827918|9102890|P1|Overall Study|Pregnancy|0
2634498|NCT00827918|9102888|P3|Overall Study|Physician Decision|0
2634499|NCT00827918|9102889|P2|Overall Study|Physician Decision|0
2634500|NCT00827918|9102890|P1|Overall Study|Physician Decision|1
2634501|NCT00827918|9102888|P3|Overall Study|Lack of Efficacy|15
2634502|NCT00827918|9102889|P2|Overall Study|Lack of Efficacy|4
2634503|NCT00827918|9102890|P1|Overall Study|Lack of Efficacy|16
2634504|NCT00827918|9102888|P3|Overall Study|Adverse Event|0
2634505|NCT00827918|9102889|P2|Overall Study|Adverse Event|0
2634506|NCT00827918|9102890|P1|Overall Study|Adverse Event|4
2634507|NCT00827827|9102918|P2|Overall Study|Burned with water at home|0
2634508|NCT00827827|9102919|P1|Overall Study|Burned with water at home|1
2634509|NCT00827827|9102918|P2|Overall Study|Transportation issues|0
2634510|NCT00827827|9102919|P1|Overall Study|Transportation issues|1
2634511|NCT00827827|9102918|P2|Overall Study|Gout|0
2634512|NCT00827827|9102919|P1|Overall Study|Gout|1
2634513|NCT00827827|9102918|P2|Overall Study|Another cerebrovascular accident (CVA)|0
2634514|NCT00827827|9102919|P1|Overall Study|Another cerebrovascular accident (CVA)|1
2634515|NCT00827827|9102918|P2|Overall Study|Fall at home- hospitalization|0
2634516|NCT00827827|9102919|P1|Overall Study|Fall at home- hospitalization|1
2634517|NCT00827827|9102918|P2|Overall Study|Lost to Follow-up|0
2634518|NCT00827827|9102919|P1|Overall Study|Lost to Follow-up|3
2634519|NCT00827632|9102963|P2|Overall Study|Early withdrawal|11
2634520|NCT00827632|9102964|P1|Overall Study|Early withdrawal|14
2634521|NCT00827632|9102963|P2|Overall Study|Lost to Follow-up|12
2634522|NCT00827632|9102964|P1|Overall Study|Lost to Follow-up|8
2634523|NCT00827606|9102976|P2|Overall Study|Adverse Event|2
2634524|NCT00827606|9102977|P1|Overall Study|Adverse Event|4
2634525|NCT00827606|9102976|P2|Overall Study|LDL below 2.59 mmol/L|12
2634526|NCT00827606|9102977|P1|Overall Study|LDL below 2.59 mmol/L|4
2634527|NCT00827606|9102976|P2|Overall Study|Other|13
2634528|NCT00827606|9102977|P1|Overall Study|Other|5
2634529|NCT00827606|9102976|P2|Overall Study|Pregnancy|1
2634530|NCT00827606|9102977|P1|Overall Study|Pregnancy|0
2634531|NCT00827606|9102976|P2|Overall Study|Withdrawal by Subject|6
2634532|NCT00827606|9102977|P1|Overall Study|Withdrawal by Subject|7
2634533|NCT00827606|9102976|P2|Overall Study|Lost to Follow-up|1
2634534|NCT00827606|9102977|P1|Overall Study|Lost to Follow-up|3
2634535|NCT00827606|9102976|P2|Overall Study|Protocol Violation|3
2634536|NCT00827606|9102977|P1|Overall Study|Protocol Violation|4
2634537|NCT00827567|9103038|P1|Overall Study|Progression of Disease/Screen Failure|4
2634538|NCT00827541|9103044|P2|Overall Study|Lack of effectiveness|0
2634539|NCT00827541|9103045|P1|Overall Study|Lack of effectiveness|1
2634540|NCT00827541|9103044|P2|Overall Study|Pathogen not susceptible|0
2634541|NCT00827541|9103045|P1|Overall Study|Pathogen not susceptible|1
2634542|NCT00827541|9103044|P2|Overall Study|Other|3
2634543|NCT00827541|9103045|P1|Overall Study|Other|1
2634544|NCT00827541|9103044|P2|Overall Study|Exitus|8
2634545|NCT00827541|9103045|P1|Overall Study|Exitus|1
2634546|NCT00827502|9103057|P1|Overall Study|Withdrawal by Subject|5
2634547|NCT00827502|9103057|P1|Overall Study|Lost to Follow-up|4
2634548|NCT00827502|9103057|P1|Overall Study|Adverse Event|1
2634549|NCT00827502|9103057|P1|Overall Study|randomized but not treated|11
2634550|NCT00827372|9103063|P1|Overall Study|Lack of Efficacy|3
2634551|NCT00827372|9103063|P1|Overall Study|Adverse Event|5
2634552|NCT00827242|9103078|P2|Overall Study|Lack of Efficacy|0
2634553|NCT00827242|9103079|P1|Overall Study|Lack of Efficacy|1
2634554|NCT00827242|9103078|P2|Overall Study|Death|0
2634555|NCT00827242|9103079|P1|Overall Study|Death|1
2634556|NCT00827242|9103078|P2|Overall Study|Physician Decision|0
2634557|NCT00827242|9103079|P1|Overall Study|Physician Decision|2
2634558|NCT00827242|9103078|P2|Overall Study|Entry Criteria Not Met|1
2634559|NCT00827242|9103079|P1|Overall Study|Entry Criteria Not Met|4
2634560|NCT00827242|9103078|P2|Overall Study|Adverse Event Excluding Death|1
2634561|NCT00827242|9103079|P1|Overall Study|Adverse Event Excluding Death|2
2634562|NCT00827242|9103078|P2|Overall Study|Lost to Follow-up|3
2634563|NCT00827242|9103079|P1|Overall Study|Lost to Follow-up|0
2634564|NCT00827242|9103078|P2|Overall Study|Protocol Violation|3
2634565|NCT00827242|9103079|P1|Overall Study|Protocol Violation|1
2634566|NCT00827242|9103078|P2|Overall Study|Withdrawal by Subject|4
2634567|NCT00827242|9103079|P1|Overall Study|Withdrawal by Subject|2
2634568|NCT00827112|9103117|P2|Overall Study|Other|3
2634569|NCT00827112|9103118|P1|Overall Study|Other|1
2634570|NCT00827112|9103117|P2|Overall Study|Randomized but not treated|3
2634571|NCT00827112|9103118|P1|Overall Study|Randomized but not treated|5
2634572|NCT00827112|9103117|P2|Overall Study|Withdrawal by Subject|1
2634573|NCT00827112|9103118|P1|Overall Study|Withdrawal by Subject|2
2634574|NCT00827112|9103117|P2|Overall Study|Protocol Violation|2
2634575|NCT00827112|9103118|P1|Overall Study|Protocol Violation|0
2634576|NCT00827112|9103117|P2|Overall Study|Pregnancy|1
2634577|NCT00827112|9103118|P1|Overall Study|Pregnancy|0
2634578|NCT00827112|9103117|P2|Overall Study|Lost to Follow-up|2
2634579|NCT00827112|9103118|P1|Overall Study|Lost to Follow-up|3
2634580|NCT00827112|9103117|P2|Overall Study|Lack of Efficacy|0
2634581|NCT00827112|9103118|P1|Overall Study|Lack of Efficacy|2
2634582|NCT00827112|9103117|P2|Overall Study|Adverse Event|0
2634583|NCT00827112|9103118|P1|Overall Study|Adverse Event|2
2634584|NCT00826943|9103171|P6|Overall Study|Withdrawal by Subject|0
2634585|NCT00826943|9103172|P5|Overall Study|Withdrawal by Subject|1
2634586|NCT00826943|9103173|P4|Overall Study|Withdrawal by Subject|0
2634587|NCT00826943|9103174|P3|Overall Study|Withdrawal by Subject|0
2634588|NCT00826943|9103175|P2|Overall Study|Withdrawal by Subject|0
2634589|NCT00826943|9103176|P1|Overall Study|Withdrawal by Subject|0
2634590|NCT00826748|9103197|P3|Overall Study|Samples Did Not pass QC|1
2634591|NCT00826748|9103198|P2|Overall Study|Samples Did Not pass QC|0
2634592|NCT00826748|9103199|P1|Overall Study|Samples Did Not pass QC|0
2634593|NCT00826748|9103197|P3|Overall Study|Physician Decision|1
2634594|NCT00826748|9103198|P2|Overall Study|Physician Decision|0
2634595|NCT00826748|9103199|P1|Overall Study|Physician Decision|0
2634596|NCT00826748|9103197|P3|Overall Study|Withdrawal by Subject|2
2634597|NCT00826748|9103198|P2|Overall Study|Withdrawal by Subject|0
2634598|NCT00826748|9103199|P1|Overall Study|Withdrawal by Subject|0
2634599|NCT00826618|9103207|P1|Overall Study|Withdrawal by Subject|1
2634600|NCT00826540|9103211|P1|Overall Study|Withdrawal by Subject|1
2634601|NCT00826540|9103211|P1|Overall Study|ineligible|3
2634602|NCT00826449|9103217|P1|Overall Study|Withdrawal by Subject|1
2634603|NCT00826449|9103217|P1|Overall Study|Disease Progression|4
2634604|NCT00826280|9103226|P3|Overall Study|One or more non-interpretable scan|1
2634605|NCT00826280|9103227|P2|Overall Study|One or more non-interpretable scan|1
2634606|NCT00826280|9103228|P1|Overall Study|One or more non-interpretable scan|0
2634607|NCT00826280|9103226|P3|Overall Study|Machine Failure|0
2634608|NCT00826280|9103227|P2|Overall Study|Machine Failure|1
2634609|NCT00826280|9103228|P1|Overall Study|Machine Failure|1
2634610|NCT00826280|9103226|P3|Overall Study|Interpretation Failure|0
2634611|NCT00826280|9103227|P2|Overall Study|Interpretation Failure|0
2634612|NCT00826280|9103228|P1|Overall Study|Interpretation Failure|1
2634613|NCT00826280|9103226|P3|Overall Study|Reversible ischemic defect not present|44
2634614|NCT00826280|9103227|P2|Overall Study|Reversible ischemic defect not present|40
2634615|NCT00826280|9103228|P1|Overall Study|Reversible ischemic defect not present|43
2634616|NCT00826280|9103226|P3|Overall Study|Sponsor discontinued subject or study|0
2634617|NCT00826280|9103227|P2|Overall Study|Sponsor discontinued subject or study|0
2634618|NCT00826280|9103228|P1|Overall Study|Sponsor discontinued subject or study|1
2634619|NCT00826280|9103226|P3|Overall Study|Lost to Follow-up|0
2634620|NCT00826280|9103227|P2|Overall Study|Lost to Follow-up|1
2634621|NCT00826280|9103228|P1|Overall Study|Lost to Follow-up|0
2634622|NCT00826280|9103226|P3|Overall Study|Adverse Event|0
2634623|NCT00826280|9103227|P2|Overall Study|Adverse Event|3
2634624|NCT00826280|9103228|P1|Overall Study|Adverse Event|1
2634625|NCT00826280|9103226|P3|Overall Study|Randomized but drug not received|1
2634626|NCT00826280|9103227|P2|Overall Study|Randomized but drug not received|0
2634627|NCT00826280|9103228|P1|Overall Study|Randomized but drug not received|1
2634628|NCT00826267|9103257|P3|Overall Study|Other Adverse Event|0
2634629|NCT00826267|9103258|P2|Overall Study|Other Adverse Event|0
2634630|NCT00826267|9103259|P1|Overall Study|Other Adverse Event|1
2634631|NCT00826241|9103277|P1|Overall Study|Pt opt not to proceed w/trmt|1
2634632|NCT00826241|9103277|P1|Overall Study|Pt unable to proceed to registration|1
2634633|NCT00826241|9103277|P1|Overall Study|Screen failure|2
2634634|NCT00826241|9103277|P1|Overall Study|Could not obtain records|1
2634635|NCT00826241|9103277|P1|Overall Study|Lost to Follow-up|9
2634636|NCT00826241|9103277|P1|Overall Study|Patient refused follow-up|3
2634637|NCT00826241|9103277|P1|Overall Study|Progression of disease|1
2634638|NCT00826241|9103277|P1|Overall Study|Non-compliance|1
2634639|NCT00826241|9103277|P1|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1
2634640|NCT00826241|9103277|P1|Overall Study|Death|4
2634641|NCT00826241|9103277|P1|Overall Study|Withdrew consent|2
2634642|NCT00826241|9103277|P1|Overall Study|Withdrawal from Follow-up|1
2634643|NCT00826228|9103283|P1|Overall Study|Withdrawal by Subject|1
2634644|NCT00826176|9103305|P2|Overall Study|Administrative|0
2634645|NCT00826176|9103306|P1|Overall Study|Administrative|9
2634646|NCT00826176|9103305|P2|Overall Study|Subject Withdrew Consent|0
2634647|NCT00826176|9103306|P1|Overall Study|Subject Withdrew Consent|3
2634648|NCT00826176|9103305|P2|Overall Study|Lost to Follow-up|0
2634649|NCT00826176|9103306|P1|Overall Study|Lost to Follow-up|1
2634650|NCT00826111|9103355|P2|Overall Study|Physician Decision|1
2634651|NCT00826111|9103356|P1|Overall Study|Physician Decision|1
2634652|NCT00826111|9103355|P2|Overall Study|Withdrawal by Subject|0
2634653|NCT00826111|9103356|P1|Overall Study|Withdrawal by Subject|5
2634654|NCT00826111|9103355|P2|Overall Study|Protocol Violation|0
2634655|NCT00826111|9103356|P1|Overall Study|Protocol Violation|1
2634656|NCT00826111|9103355|P2|Overall Study|Lost to Follow-up|1
2634657|NCT00826111|9103356|P1|Overall Study|Lost to Follow-up|0
2634658|NCT00825994|9103391|P1|Overall Study|Placebo Responder at V2|1
2634659|NCT00825994|9103391|P1|Overall Study|Protocol Violation|1
2634660|NCT00825994|9103391|P1|Overall Study|Lost to Follow-up|1
2634661|NCT00825994|9103391|P1|Overall Study|Withdrawal by Subject|2
2634662|NCT00825916|9103399|P3|Overall Study|Lost to Follow-up|1
2634663|NCT00825916|9103400|P2|Overall Study|Lost to Follow-up|2
2634664|NCT00825916|9103401|P1|Overall Study|Lost to Follow-up|4
2634665|NCT00825825|9103442|P6|Third Medication Period (14 Days)|poor data quality|0
2634666|NCT00825825|9103443|P5|Third Medication Period (14 Days)|poor data quality|0
2634667|NCT00825825|9103444|P4|Third Medication Period (14 Days)|poor data quality|0
2634668|NCT00825825|9103445|P3|Third Medication Period (14 Days)|poor data quality|0
2634669|NCT00825825|9103446|P2|Third Medication Period (14 Days)|poor data quality|1
2634670|NCT00825825|9103447|P1|Third Medication Period (14 Days)|poor data quality|0
2634671|NCT00825825|9103442|P6|Third Medication Period (14 Days)|Protocol Violation|2
2634672|NCT00825825|9103443|P5|Third Medication Period (14 Days)|Protocol Violation|0
2634673|NCT00825825|9103444|P4|Third Medication Period (14 Days)|Protocol Violation|0
2634674|NCT00825825|9103445|P3|Third Medication Period (14 Days)|Protocol Violation|0
2634675|NCT00825825|9103446|P2|Third Medication Period (14 Days)|Protocol Violation|0
2634676|NCT00825825|9103447|P1|Third Medication Period (14 Days)|Protocol Violation|0
2634677|NCT00825825|9103442|P6|Third Medication Period (14 Days)|Adverse Event|0
2634678|NCT00825825|9103443|P5|Third Medication Period (14 Days)|Adverse Event|0
2634679|NCT00825825|9103444|P4|Third Medication Period (14 Days)|Adverse Event|0
2634680|NCT00825825|9103445|P3|Third Medication Period (14 Days)|Adverse Event|0
2634681|NCT00825825|9103446|P2|Third Medication Period (14 Days)|Adverse Event|1
2634682|NCT00825825|9103447|P1|Third Medication Period (14 Days)|Adverse Event|0
2634683|NCT00825825|9103442|P6|Second Medication Period (14 Days)|Protocol Violation|0
2634684|NCT00825825|9103443|P5|Second Medication Period (14 Days)|Protocol Violation|1
2634685|NCT00825825|9103444|P4|Second Medication Period (14 Days)|Protocol Violation|0
2634686|NCT00825825|9103445|P3|Second Medication Period (14 Days)|Protocol Violation|0
2634687|NCT00825825|9103446|P2|Second Medication Period (14 Days)|Protocol Violation|0
2634688|NCT00825825|9103447|P1|Second Medication Period (14 Days)|Protocol Violation|1
2634689|NCT00825825|9103442|P6|Second Medication Period (14 Days)|Physician Decision|0
2634690|NCT00825825|9103443|P5|Second Medication Period (14 Days)|Physician Decision|0
2634691|NCT00825825|9103444|P4|Second Medication Period (14 Days)|Physician Decision|2
2634692|NCT00825825|9103445|P3|Second Medication Period (14 Days)|Physician Decision|0
2634693|NCT00825825|9103446|P2|Second Medication Period (14 Days)|Physician Decision|0
2634694|NCT00825825|9103447|P1|Second Medication Period (14 Days)|Physician Decision|1
2634695|NCT00825825|9103442|P6|First Medication Period (14 Days)|Physician Decision|1
2634696|NCT00825825|9103443|P5|First Medication Period (14 Days)|Physician Decision|0
2634697|NCT00825825|9103444|P4|First Medication Period (14 Days)|Physician Decision|0
2634698|NCT00825825|9103445|P3|First Medication Period (14 Days)|Physician Decision|1
2634699|NCT00825825|9103446|P2|First Medication Period (14 Days)|Physician Decision|0
2634700|NCT00825825|9103447|P1|First Medication Period (14 Days)|Physician Decision|2
2634701|NCT00825825|9103442|P6|First Medication Period (14 Days)|Adverse Event|1
2634702|NCT00825825|9103443|P5|First Medication Period (14 Days)|Adverse Event|0
2634703|NCT00825825|9103444|P4|First Medication Period (14 Days)|Adverse Event|0
2634704|NCT00825825|9103445|P3|First Medication Period (14 Days)|Adverse Event|0
2634705|NCT00825825|9103446|P2|First Medication Period (14 Days)|Adverse Event|0
2634706|NCT00825825|9103447|P1|First Medication Period (14 Days)|Adverse Event|1
2634707|NCT00825812|9103463|P4|Overall Study|Administrative|5
2634708|NCT00825812|9103464|P3|Overall Study|Administrative|3
2634709|NCT00825812|9103465|P2|Overall Study|Administrative|1
2634710|NCT00825812|9103466|P1|Overall Study|Administrative|0
2634711|NCT00825812|9103463|P4|Overall Study|Non-compliance with protocol|1
2634712|NCT00825812|9103464|P3|Overall Study|Non-compliance with protocol|0
2634713|NCT00825812|9103465|P2|Overall Study|Non-compliance with protocol|0
2634714|NCT00825812|9103466|P1|Overall Study|Non-compliance with protocol|0
2634715|NCT00825812|9103463|P4|Overall Study|Subject withdrew consent|2
2634716|NCT00825812|9103464|P3|Overall Study|Subject withdrew consent|3
2634717|NCT00825812|9103465|P2|Overall Study|Subject withdrew consent|0
2634718|NCT00825812|9103466|P1|Overall Study|Subject withdrew consent|0
2634719|NCT00825812|9103463|P4|Overall Study|Adverse Event|1
2634720|NCT00825812|9103464|P3|Overall Study|Adverse Event|0
2634721|NCT00825812|9103465|P2|Overall Study|Adverse Event|0
2634722|NCT00825812|9103466|P1|Overall Study|Adverse Event|0
2634723|NCT00825812|9103463|P4|Overall Study|Never entered follow up|1
2634724|NCT00825812|9103464|P3|Overall Study|Never entered follow up|0
2634725|NCT00825812|9103465|P2|Overall Study|Never entered follow up|0
2634726|NCT00825812|9103466|P1|Overall Study|Never entered follow up|0
2634727|NCT00825682|9103513|P2|Overall Study|personal reasons/ inconvenience|5
2634728|NCT00825682|9103514|P1|Overall Study|personal reasons/ inconvenience|13
2634729|NCT00825305|9103605|P2|Overall Study|Can not be classified|1
2634730|NCT00825305|9103606|P1|Overall Study|Can not be classified|0
2634731|NCT00825305|9103605|P2|Overall Study|Protocol Violation|9
2634732|NCT00825305|9103606|P1|Overall Study|Protocol Violation|9
2634733|NCT00825305|9103605|P2|Overall Study|Inappropriate inclusion|0
2634734|NCT00825305|9103606|P1|Overall Study|Inappropriate inclusion|1
2634735|NCT00825305|9103605|P2|Overall Study|Withdrawal by Subject|12
2634736|NCT00825305|9103606|P1|Overall Study|Withdrawal by Subject|6
2634737|NCT00825305|9103605|P2|Overall Study|Adverse Event|1
2634738|NCT00825305|9103606|P1|Overall Study|Adverse Event|1
2634739|NCT00825175|9103646|P2|Overall Study|Withdrawal by Subject|5
2634740|NCT00825175|9103647|P1|Overall Study|Withdrawal by Subject|0
2634741|NCT00825162|9103656|P3|Overall Study|Unable to attend the study visit|0
2634742|NCT00825162|9103657|P2|Overall Study|Unable to attend the study visit|2
2634743|NCT00825162|9103658|P1|Overall Study|Unable to attend the study visit|5
2634744|NCT00825162|9103656|P3|Overall Study|Move away from the study area|0
2634745|NCT00825162|9103657|P2|Overall Study|Move away from the study area|0
2634746|NCT00825162|9103658|P1|Overall Study|Move away from the study area|1
2634747|NCT00825162|9103656|P3|Overall Study|Physician Decision|0
2634748|NCT00825162|9103657|P2|Overall Study|Physician Decision|0
2634749|NCT00825162|9103658|P1|Overall Study|Physician Decision|2
2634750|NCT00825162|9103656|P3|Overall Study|Lost to Follow-up|3
2634751|NCT00825162|9103657|P2|Overall Study|Lost to Follow-up|6
2634752|NCT00825162|9103658|P1|Overall Study|Lost to Follow-up|9
2634753|NCT00825162|9103656|P3|Overall Study|Withdrawal by Subject|3
2634754|NCT00825162|9103657|P2|Overall Study|Withdrawal by Subject|13
2634755|NCT00825162|9103658|P1|Overall Study|Withdrawal by Subject|11
2634756|NCT00824993|9103684|P2|Overall Study|Death|3
2634757|NCT00824993|9103685|P1|Overall Study|Death|0
2634758|NCT00824993|9103684|P2|Overall Study|Insurance Issue|1
2634759|NCT00824993|9103685|P1|Overall Study|Insurance Issue|2
2634760|NCT00824993|9103684|P2|Overall Study|Non-Compliant|1
2634761|NCT00824993|9103685|P1|Overall Study|Non-Compliant|2
2634762|NCT00824993|9103684|P2|Overall Study|Rapid Bone Loss|1
2634763|NCT00824993|9103685|P1|Overall Study|Rapid Bone Loss|0
2634764|NCT00824993|9103684|P2|Overall Study|Malignancy Relapse|10
2634765|NCT00824993|9103685|P1|Overall Study|Malignancy Relapse|9
2634766|NCT00824993|9103684|P2|Overall Study|Withdrawal by Subject|1
2634767|NCT00824993|9103685|P1|Overall Study|Withdrawal by Subject|1
2634768|NCT00824850|9103693|P2|Overall Study|Withdrawal by Subject|1
2634769|NCT00824850|9103694|P1|Overall Study|Withdrawal by Subject|0
2634770|NCT00824772|9103747|P1|Overall Study|Withdrawal by Subject|8
2634771|NCT00824720|9103767|P3|Overall Study|Protocol Violation|1
2634772|NCT00824720|9103768|P2|Overall Study|Protocol Violation|0
2634773|NCT00824720|9103769|P1|Overall Study|Protocol Violation|0
2634774|NCT00824720|9103767|P3|Overall Study|failed plug insertion|0
2634775|NCT00824720|9103768|P2|Overall Study|failed plug insertion|1
2634776|NCT00824720|9103769|P1|Overall Study|failed plug insertion|3
2634777|NCT00824655|9103785|P2|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0
2634778|NCT00824655|9103786|P1|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1
2634779|NCT00824655|9103785|P2|Toddler Dose (12 Months of Age)|Adverse Event|0
2634780|NCT00824655|9103786|P1|Toddler Dose (12 Months of Age)|Adverse Event|1
2634781|NCT00824616|9103806|P2|Overall Study|Withdrawal by Subject|1
2634782|NCT00824616|9103807|P1|Overall Study|Withdrawal by Subject|1
2634783|NCT00824616|9103806|P2|Overall Study|Lost to Follow-up|1
2634784|NCT00824616|9103807|P1|Overall Study|Lost to Follow-up|0
2634785|NCT00824616|9103806|P2|Overall Study|Lack of Efficacy|1
2634786|NCT00824616|9103807|P1|Overall Study|Lack of Efficacy|2
2634787|NCT00824616|9103806|P2|Overall Study|Hyperglycemia|1
2634788|NCT00824616|9103807|P1|Overall Study|Hyperglycemia|1
2634789|NCT00824616|9103806|P2|Overall Study|Creatinine/Creatinine Clearance|2
2634790|NCT00824616|9103807|P1|Overall Study|Creatinine/Creatinine Clearance|0
2634791|NCT00824616|9103806|P2|Overall Study|Adverse Event|1
2634792|NCT00824616|9103807|P1|Overall Study|Adverse Event|2
2634793|NCT00824564|9103817|P2|Overall Study|Randomized, but not treated|0
2634794|NCT00824564|9103818|P1|Overall Study|Randomized, but not treated|1
2634795|NCT00824564|9103817|P2|Overall Study|Other|2
2634796|NCT00824564|9103818|P1|Overall Study|Other|1
2634797|NCT00824564|9103817|P2|Overall Study|Withdrawal by Subject|1
2634798|NCT00824564|9103818|P1|Overall Study|Withdrawal by Subject|1
2634799|NCT00824564|9103817|P2|Overall Study|Lost to Follow-up|7
2634800|NCT00824564|9103818|P1|Overall Study|Lost to Follow-up|5
2634801|NCT00824473|9103897|P2|Overall Study|Other|1
2634802|NCT00824473|9103898|P1|Overall Study|Other|1
2634803|NCT00824473|9103897|P2|Overall Study|Withdrawal by Subject|3
2634804|NCT00824473|9103898|P1|Overall Study|Withdrawal by Subject|2
2634805|NCT00824473|9103897|P2|Overall Study|Non-Compliance|2
2634806|NCT00824473|9103898|P1|Overall Study|Non-Compliance|4
2634807|NCT00824473|9103897|P2|Overall Study|Protocol Violation|0
2634808|NCT00824473|9103898|P1|Overall Study|Protocol Violation|2
2634809|NCT00824473|9103897|P2|Overall Study|Lack of Efficacy|2
2634810|NCT00824473|9103898|P1|Overall Study|Lack of Efficacy|2
2634811|NCT00824473|9103897|P2|Overall Study|Adverse Event|5
2634812|NCT00824473|9103898|P1|Overall Study|Adverse Event|4
2634813|NCT00824421|9103979|P3|Overall Study|Other|0
2634814|NCT00824421|9103980|P2|Overall Study|Other|1
2634815|NCT00824421|9103981|P1|Overall Study|Other|0
2634816|NCT00824421|9103979|P3|Overall Study|Randomized but not Treated|0
2634817|NCT00824421|9103980|P2|Overall Study|Randomized but not Treated|1
2634818|NCT00824421|9103981|P1|Overall Study|Randomized but not Treated|1
2634819|NCT00824421|9103979|P3|Overall Study|Withdrawal by Subject|3
2634820|NCT00824421|9103980|P2|Overall Study|Withdrawal by Subject|3
2634821|NCT00824421|9103981|P1|Overall Study|Withdrawal by Subject|2
2634822|NCT00824421|9103979|P3|Overall Study|Pregnancy|1
2634823|NCT00824421|9103980|P2|Overall Study|Pregnancy|0
2634824|NCT00824421|9103981|P1|Overall Study|Pregnancy|1
2634825|NCT00824421|9103979|P3|Overall Study|Lost to Follow-up|0
2634826|NCT00824421|9103980|P2|Overall Study|Lost to Follow-up|3
2634827|NCT00824421|9103981|P1|Overall Study|Lost to Follow-up|2
2634828|NCT00824421|9103979|P3|Overall Study|Lack of Efficacy|4
2634829|NCT00824421|9103980|P2|Overall Study|Lack of Efficacy|7
2634830|NCT00824421|9103981|P1|Overall Study|Lack of Efficacy|5
2634831|NCT00824421|9103979|P3|Overall Study|Death|0
2634832|NCT00824421|9103980|P2|Overall Study|Death|1
2634833|NCT00824421|9103981|P1|Overall Study|Death|0
2634834|NCT00824421|9103979|P3|Overall Study|Adverse Event|6
2634835|NCT00824421|9103980|P2|Overall Study|Adverse Event|6
2634836|NCT00824421|9103981|P1|Overall Study|Adverse Event|6
2634837|NCT00824408|9104032|P5|Randomized Phase|Other reason not defined above|4
2634838|NCT00824408|9104033|P4|Randomized Phase|Other reason not defined above|2
2634839|NCT00824408|9104034|P3|Randomized Phase|Other reason not defined above|4
2634840|NCT00824408|9104035|P2|Randomized Phase|Other reason not defined above|0
2634841|NCT00824408|9104036|P1|Randomized Phase|Other reason not defined above|0
2634842|NCT00824408|9104032|P5|Randomized Phase|Refused to continue medication|2
2634843|NCT00824408|9104033|P4|Randomized Phase|Refused to continue medication|2
2634844|NCT00824408|9104034|P3|Randomized Phase|Refused to continue medication|2
2634845|NCT00824408|9104035|P2|Randomized Phase|Refused to continue medication|0
2634846|NCT00824408|9104036|P1|Randomized Phase|Refused to continue medication|0
2634847|NCT00824408|9104032|P5|Randomized Phase|Adverse Event|5
2634848|NCT00824408|9104033|P4|Randomized Phase|Adverse Event|5
2634849|NCT00824408|9104034|P3|Randomized Phase|Adverse Event|4
2634850|NCT00824408|9104035|P2|Randomized Phase|Adverse Event|0
2634851|NCT00824408|9104036|P1|Randomized Phase|Adverse Event|0
2634852|NCT00824408|9104032|P5|Randomized Phase|Progressive disease|34
2634853|NCT00824408|9104033|P4|Randomized Phase|Progressive disease|36
2634854|NCT00824408|9104034|P3|Randomized Phase|Progressive disease|25
2634855|NCT00824408|9104035|P2|Randomized Phase|Progressive disease|0
2634856|NCT00824408|9104036|P1|Randomized Phase|Progressive disease|0
2634857|NCT00824408|9104032|P5|Randomized Phase|Not treated|1
2634858|NCT00824408|9104033|P4|Randomized Phase|Not treated|1
2634859|NCT00824408|9104034|P3|Randomized Phase|Not treated|1
2634860|NCT00824408|9104035|P2|Randomized Phase|Not treated|0
2634861|NCT00824408|9104036|P1|Randomized Phase|Not treated|0
2634862|NCT00824408|9104032|P5|Run-in Phase|Other reason not defined above|0
2634863|NCT00824408|9104033|P4|Run-in Phase|Other reason not defined above|0
2634864|NCT00824408|9104034|P3|Run-in Phase|Other reason not defined above|0
2634865|NCT00824408|9104035|P2|Run-in Phase|Other reason not defined above|1
2634866|NCT00824408|9104036|P1|Run-in Phase|Other reason not defined above|0
2634867|NCT00824408|9104032|P5|Run-in Phase|Refused to continue medication|0
2634868|NCT00824408|9104033|P4|Run-in Phase|Refused to continue medication|0
2634869|NCT00824408|9104034|P3|Run-in Phase|Refused to continue medication|0
2634870|NCT00824408|9104035|P2|Run-in Phase|Refused to continue medication|0
2634871|NCT00824408|9104036|P1|Run-in Phase|Refused to continue medication|1
2634872|NCT00824408|9104032|P5|Run-in Phase|Adverse Event|0
2634873|NCT00824408|9104033|P4|Run-in Phase|Adverse Event|0
2634874|NCT00824408|9104034|P3|Run-in Phase|Adverse Event|0
2634875|NCT00824408|9104035|P2|Run-in Phase|Adverse Event|1
2634876|NCT00824408|9104036|P1|Run-in Phase|Adverse Event|1
2634877|NCT00824408|9104032|P5|Run-in Phase|Progressive disease|0
2634878|NCT00824408|9104033|P4|Run-in Phase|Progressive disease|0
2634879|NCT00824408|9104034|P3|Run-in Phase|Progressive disease|0
2634880|NCT00824408|9104035|P2|Run-in Phase|Progressive disease|4
2634881|NCT00824408|9104036|P1|Run-in Phase|Progressive disease|4
2634882|NCT00824382|9104088|P4|Overall Study|Investigator's decision|0
2634883|NCT00824382|9104089|P3|Overall Study|Investigator's decision|2
2634884|NCT00824382|9104090|P2|Overall Study|Investigator's decision|1
2634885|NCT00824382|9104091|P1|Overall Study|Investigator's decision|0
2634886|NCT00824382|9104088|P4|Overall Study|Protocol Violation|1
2634887|NCT00824382|9104089|P3|Overall Study|Protocol Violation|0
2634888|NCT00824382|9104090|P2|Overall Study|Protocol Violation|0
2634889|NCT00824382|9104091|P1|Overall Study|Protocol Violation|1
2634890|NCT00824382|9104088|P4|Overall Study|Adverse Event|4
2634891|NCT00824382|9104089|P3|Overall Study|Adverse Event|1
2634892|NCT00824382|9104090|P2|Overall Study|Adverse Event|1
2634893|NCT00824382|9104091|P1|Overall Study|Adverse Event|4
2634894|NCT00824369|9104167|P6|Overall Study|Lost to Follow-up|0
2634895|NCT00824369|9104168|P5|Overall Study|Lost to Follow-up|1
2634896|NCT00824369|9104169|P4|Overall Study|Lost to Follow-up|0
2634897|NCT00824369|9104170|P3|Overall Study|Lost to Follow-up|0
2634898|NCT00824369|9104171|P2|Overall Study|Lost to Follow-up|0
2634899|NCT00824369|9104172|P1|Overall Study|Lost to Follow-up|0
2634900|NCT00824369|9104167|P6|Overall Study|Nolonger willing to participate in study|1
2634901|NCT00824369|9104168|P5|Overall Study|Nolonger willing to participate in study|0
2634902|NCT00824369|9104169|P4|Overall Study|Nolonger willing to participate in study|2
2634903|NCT00824369|9104170|P3|Overall Study|Nolonger willing to participate in study|1
2634904|NCT00824369|9104171|P2|Overall Study|Nolonger willing to participate in study|0
2634905|NCT00824369|9104172|P1|Overall Study|Nolonger willing to participate in study|1
2634906|NCT00824291|9104212|P2|Overall Study|Participant on prohibited medication|0
2634907|NCT00824291|9104213|P1|Overall Study|Participant on prohibited medication|1
2634908|NCT00824291|9104212|P2|Overall Study|Lack of Efficacy|8
2634909|NCT00824291|9104213|P1|Overall Study|Lack of Efficacy|7
2634910|NCT00824291|9104212|P2|Overall Study|Withdrawal by Subject|8
2634911|NCT00824291|9104213|P1|Overall Study|Withdrawal by Subject|14
2634912|NCT00824291|9104212|P2|Overall Study|Protocol Violation|1
2634913|NCT00824291|9104213|P1|Overall Study|Protocol Violation|4
2634914|NCT00824291|9104212|P2|Overall Study|Non-compliance|1
2634915|NCT00824291|9104213|P1|Overall Study|Non-compliance|1
2634916|NCT00824291|9104212|P2|Overall Study|Lost to Follow-up|9
2634917|NCT00824291|9104213|P1|Overall Study|Lost to Follow-up|11
2634918|NCT00824291|9104212|P2|Overall Study|Discontinuation of Study by Sponsor|2
2634919|NCT00824291|9104213|P1|Overall Study|Discontinuation of Study by Sponsor|1
2634920|NCT00824291|9104212|P2|Overall Study|Adverse Event|6
2634921|NCT00824291|9104213|P1|Overall Study|Adverse Event|15
2634922|NCT00824265|9104235|P2|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16
2634923|NCT00824265|9104236|P1|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9
2634924|NCT00824265|9104235|P2|Follow-up Phase|w/drew consent, no f/u, or MD choice|31
2634925|NCT00824265|9104236|P1|Follow-up Phase|w/drew consent, no f/u, or MD choice|18
2634926|NCT00824265|9104235|P2|Treatment Phase|Withdrawal by Subject|15
2634927|NCT00824265|9104236|P1|Treatment Phase|Withdrawal by Subject|6
2634928|NCT00824265|9104235|P2|Treatment Phase|Physician Decision|12
2634929|NCT00824265|9104236|P1|Treatment Phase|Physician Decision|6
2634930|NCT00824265|9104235|P2|Treatment Phase|Lost to Follow-up|1
2634931|NCT00824265|9104236|P1|Treatment Phase|Lost to Follow-up|1
2634932|NCT00824265|9104235|P2|Treatment Phase|Protocol Violation|0
2634933|NCT00824265|9104236|P1|Treatment Phase|Protocol Violation|1
2634934|NCT00824265|9104235|P2|Treatment Phase|Adverse Event,non-fatal|52
2634935|NCT00824265|9104236|P1|Treatment Phase|Adverse Event,non-fatal|50
2634936|NCT00824161|9104297|P1|Overall Study|Screen Failure|1
2634937|NCT00824161|9104297|P1|Overall Study|Withdrawal by Subject|1
2634938|NCT00824005|9104363|P2|Overall Study|Lost to Follow-up|1
2634939|NCT00824005|9104364|P1|Overall Study|Lost to Follow-up|0
2634940|NCT00824005|9104363|P2|Overall Study|Death|1
2634941|NCT00824005|9104364|P1|Overall Study|Death|0
2634942|NCT00823979|9104399|P3|Overall Study|Study Terminated by Sponsor|7
2634943|NCT00823979|9104400|P2|Overall Study|Study Terminated by Sponsor|5
2634944|NCT00823979|9104401|P1|Overall Study|Study Terminated by Sponsor|5
2634945|NCT00823979|9104399|P3|Overall Study|Randomized but not Treated|1
2634946|NCT00823979|9104400|P2|Overall Study|Randomized but not Treated|3
2634947|NCT00823979|9104401|P1|Overall Study|Randomized but not Treated|4
2634948|NCT00823979|9104399|P3|Overall Study|Other|1
2634949|NCT00823979|9104400|P2|Overall Study|Other|0
2634950|NCT00823979|9104401|P1|Overall Study|Other|2
2634951|NCT00823979|9104399|P3|Overall Study|Adverse Event|4
2634952|NCT00823979|9104400|P2|Overall Study|Adverse Event|2
2634953|NCT00823979|9104401|P1|Overall Study|Adverse Event|0
2634954|NCT00823979|9104399|P3|Overall Study|Pregnancy|0
2634955|NCT00823979|9104400|P2|Overall Study|Pregnancy|1
2634956|NCT00823979|9104401|P1|Overall Study|Pregnancy|0
2634957|NCT00823979|9104399|P3|Overall Study|Protocol Violation|0
2634958|NCT00823979|9104400|P2|Overall Study|Protocol Violation|1
2634959|NCT00823979|9104401|P1|Overall Study|Protocol Violation|1
2634960|NCT00823979|9104399|P3|Overall Study|Withdrawal by Subject|2
2634961|NCT00823979|9104400|P2|Overall Study|Withdrawal by Subject|3
2634962|NCT00823979|9104401|P1|Overall Study|Withdrawal by Subject|2
2634963|NCT00823979|9104399|P3|Overall Study|Lost to Follow-up|0
2634964|NCT00823979|9104400|P2|Overall Study|Lost to Follow-up|1
2634965|NCT00823979|9104401|P1|Overall Study|Lost to Follow-up|2
2634966|NCT00823979|9104399|P3|Overall Study|Lack of Efficacy|9
2634967|NCT00823979|9104400|P2|Overall Study|Lack of Efficacy|16
2634968|NCT00823979|9104401|P1|Overall Study|Lack of Efficacy|13
2634969|NCT00823901|9104446|P2|Overall Study|Lost to Follow-up|1
2634970|NCT00823901|9104447|P1|Overall Study|Lost to Follow-up|2
2634971|NCT00823901|9104446|P2|Overall Study|Lack of Efficacy|0
2634972|NCT00823901|9104447|P1|Overall Study|Lack of Efficacy|1
2634973|NCT00823901|9104446|P2|Overall Study|Adverse Event|1
2634974|NCT00823901|9104447|P1|Overall Study|Adverse Event|1
2634975|NCT00823836|9104455|P2|Long-term Phase|Withdrawal by Subject|1
2634976|NCT00823836|9104456|P1|Long-term Phase|Withdrawal by Subject|1
2634977|NCT00823836|9104455|P2|Long-term Phase|Physician Decision|2
2634978|NCT00823836|9104456|P1|Long-term Phase|Physician Decision|1
2634979|NCT00823836|9104455|P2|Long-term Phase|Adverse Event|2
2634980|NCT00823836|9104456|P1|Long-term Phase|Adverse Event|3
2634981|NCT00823836|9104455|P2|NV and PR/XR Switching Phases|Withdrawal by Subject|5
2634982|NCT00823836|9104456|P1|NV and PR/XR Switching Phases|Withdrawal by Subject|4
2634983|NCT00823836|9104455|P2|NV and PR/XR Switching Phases|Physician Decision|2
2634984|NCT00823836|9104456|P1|NV and PR/XR Switching Phases|Physician Decision|5
2634985|NCT00823836|9104455|P2|NV and PR/XR Switching Phases|Protocol Violation|1
2634986|NCT00823836|9104456|P1|NV and PR/XR Switching Phases|Protocol Violation|1
2634987|NCT00823836|9104455|P2|NV and PR/XR Switching Phases|Adverse Event|21
2634988|NCT00823836|9104456|P1|NV and PR/XR Switching Phases|Adverse Event|22
2634989|NCT00823823|9104562|P2|Overall Study|Protocol Violation|5
2634990|NCT00823823|9104563|P1|Overall Study|Protocol Violation|5
2634991|NCT00823823|9104562|P2|Overall Study|Lost to Follow-up|1
2634992|NCT00823823|9104563|P1|Overall Study|Lost to Follow-up|3
2634993|NCT00823719|9104587|P2|Overall Study|Disease Progression|4
2634994|NCT00823719|9104588|P1|Overall Study|Disease Progression|4
2634995|NCT00823719|9104587|P2|Overall Study|Withdrawal by Subject|1
2634996|NCT00823719|9104588|P1|Overall Study|Withdrawal by Subject|0
2634997|NCT00823719|9104587|P2|Overall Study|Physician Decision|4
2634998|NCT00823719|9104588|P1|Overall Study|Physician Decision|1
2634999|NCT00823719|9104587|P2|Overall Study|Adverse Event|2
2635000|NCT00823719|9104588|P1|Overall Study|Adverse Event|1
2635001|NCT00823615|9104641|P2|Period 2|Time/Job Conflict|2
2635002|NCT00823615|9104642|P1|Period 2|Time/Job Conflict|1
2635003|NCT00823615|9104641|P2|Period 2|Lost to Follow-up|0
2635004|NCT00823615|9104642|P1|Period 2|Lost to Follow-up|2
2635005|NCT00823472|9104652|P2|Overall Study|Physician Decision|28
2635006|NCT00823472|9104653|P1|Overall Study|Physician Decision|24
2635007|NCT00823264|9104680|P2|Overall Study|Protocol Violation|0
2635008|NCT00823264|9104681|P1|Overall Study|Protocol Violation|2
2635009|NCT00823212|9104689|P2|Overall Study|Missed 12-month visit|21
2635010|NCT00823212|9104690|P1|Overall Study|Missed 12-month visit|21
2635011|NCT00823212|9104689|P2|Overall Study|Incarcerated|1
2635012|NCT00823212|9104690|P1|Overall Study|Incarcerated|0
2635013|NCT00823212|9104689|P2|Overall Study|Withdrawal by Subject|1
2635014|NCT00823212|9104690|P1|Overall Study|Withdrawal by Subject|6
2635015|NCT00823212|9104689|P2|Overall Study|Death|10
2635016|NCT00823212|9104690|P1|Overall Study|Death|8
2635017|NCT00823199|9104772|P1|Overall Study|Withdrawal by Subject|2
2635018|NCT00822926|9104841|P2|Second Injection Visit|Withdrawal by Subject|1
2635019|NCT00822926|9104842|P1|Second Injection Visit|Withdrawal by Subject|0
2635020|NCT00822926|9104841|P2|Second Injection Visit|Lost to Follow-up|0
2635021|NCT00822926|9104842|P1|Second Injection Visit|Lost to Follow-up|1
2635022|NCT00822900|9104856|P2|Overall Study|Became a ward of the state|1
2635023|NCT00822900|9104857|P1|Overall Study|Became a ward of the state|2
2635024|NCT00822900|9104856|P2|Overall Study|Death|69
2635025|NCT00822900|9104857|P1|Overall Study|Death|83
2635026|NCT00822900|9104856|P2|Overall Study|Lost to Follow-up|9
2635027|NCT00822900|9104857|P1|Overall Study|Lost to Follow-up|9
2635028|NCT00822900|9104856|P2|Overall Study|Withdrawal by Subject|14
2635029|NCT00822900|9104857|P1|Overall Study|Withdrawal by Subject|14
2635030|NCT00822692|9104904|P2|Overall Study|Lost to Follow-up|25
2635031|NCT00822692|9104905|P1|Overall Study|Lost to Follow-up|17
2635032|NCT00822237|9105043|P2|Dose 2 Vaccination|Lost to Follow-up|9
2635033|NCT00822237|9105044|P1|Dose 2 Vaccination|Lost to Follow-up|2
2635034|NCT00822237|9105043|P2|Dose 2 Vaccination|Withdrawal by Subject|2
2635035|NCT00822237|9105044|P1|Dose 2 Vaccination|Withdrawal by Subject|2
2635036|NCT00822237|9105043|P2|Dose 1 Vaccination|Lost to Follow-up|12
2635037|NCT00822237|9105044|P1|Dose 1 Vaccination|Lost to Follow-up|9
2635038|NCT00822237|9105043|P2|Dose 1 Vaccination|Withdrawal by Subject|14
2635039|NCT00822237|9105044|P1|Dose 1 Vaccination|Withdrawal by Subject|13
2635040|NCT00822237|9105043|P2|Dose 1 Vaccination|Not vaccinated|0
2635041|NCT00822237|9105044|P1|Dose 1 Vaccination|Not vaccinated|3
2635042|NCT00822172|9105125|P2|Overall Study|Other|1
2635043|NCT00822172|9105126|P1|Overall Study|Other|0
2635044|NCT00822172|9105125|P2|Overall Study|site closed|1
2635045|NCT00822172|9105126|P1|Overall Study|site closed|0
2635046|NCT00822172|9105125|P2|Overall Study|Withdrawal by Subject|4
2635047|NCT00822172|9105126|P1|Overall Study|Withdrawal by Subject|1
2635048|NCT00822172|9105125|P2|Overall Study|Lost to Follow-up|1
2635049|NCT00822172|9105126|P1|Overall Study|Lost to Follow-up|3
2635050|NCT00822172|9105125|P2|Overall Study|Death|0
2635051|NCT00822172|9105126|P1|Overall Study|Death|1
2635052|NCT00822172|9105125|P2|Overall Study|Adverse Event|12
2635053|NCT00822172|9105126|P1|Overall Study|Adverse Event|10
2635054|NCT00822120|9105146|P6|PET-directed Therapy|Protocol Violation|0
2635055|NCT00822120|9105147|P5|PET-directed Therapy|Protocol Violation|0
2635056|NCT00822120|9105148|P4|PET-directed Therapy|Protocol Violation|6
2635057|NCT00822120|9105149|P3|PET-directed Therapy|Protocol Violation|0
2635058|NCT00822120|9105150|P2|PET-directed Therapy|Protocol Violation|0
2635059|NCT00822120|9105151|P1|PET-directed Therapy|Protocol Violation|0
2635060|NCT00822120|9105146|P6|PET-directed Therapy|Death|0
2635061|NCT00822120|9105147|P5|PET-directed Therapy|Death|0
2635062|NCT00822120|9105148|P4|PET-directed Therapy|Death|2
2635063|NCT00822120|9105149|P3|PET-directed Therapy|Death|0
2635064|NCT00822120|9105150|P2|PET-directed Therapy|Death|0
2635065|NCT00822120|9105151|P1|PET-directed Therapy|Death|0
2635066|NCT00822120|9105146|P6|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
2635067|NCT00822120|9105147|P5|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
2635068|NCT00822120|9105148|P4|PET-directed Therapy|Refusal Unrelated to Adverse Event|1
2635069|NCT00822120|9105149|P3|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
2635070|NCT00822120|9105150|P2|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
2635071|NCT00822120|9105151|P1|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
2635072|NCT00822120|9105146|P6|PET-directed Therapy|Adverse Event|0
2635073|NCT00822120|9105147|P5|PET-directed Therapy|Adverse Event|0
2635074|NCT00822120|9105148|P4|PET-directed Therapy|Adverse Event|1
2635075|NCT00822120|9105149|P3|PET-directed Therapy|Adverse Event|0
2635076|NCT00822120|9105150|P2|PET-directed Therapy|Adverse Event|0
2635077|NCT00822120|9105151|P1|PET-directed Therapy|Adverse Event|0
2635078|NCT00822120|9105146|P6|Initial Registration|Ineligible|0
2635079|NCT00822120|9105147|P5|Initial Registration|Ineligible|0
2635080|NCT00822120|9105148|P4|Initial Registration|Ineligible|0
2635081|NCT00822120|9105149|P3|Initial Registration|Ineligible|0
2635082|NCT00822120|9105150|P2|Initial Registration|Ineligible|1
2635083|NCT00822120|9105151|P1|Initial Registration|Ineligible|22
2635084|NCT00822120|9105146|P6|Initial Registration|Reasons not Protocol Specified|0
2635085|NCT00822120|9105147|P5|Initial Registration|Reasons not Protocol Specified|0
2635086|NCT00822120|9105148|P4|Initial Registration|Reasons not Protocol Specified|0
2635087|NCT00822120|9105149|P3|Initial Registration|Reasons not Protocol Specified|0
2635088|NCT00822120|9105150|P2|Initial Registration|Reasons not Protocol Specified|0
2635089|NCT00822120|9105151|P1|Initial Registration|Reasons not Protocol Specified|2
2635090|NCT00822120|9105146|P6|Initial Registration|Refusal Unrelated to Adverse Event|0
2635091|NCT00822120|9105147|P5|Initial Registration|Refusal Unrelated to Adverse Event|0
2635092|NCT00822120|9105148|P4|Initial Registration|Refusal Unrelated to Adverse Event|0
2635093|NCT00822120|9105149|P3|Initial Registration|Refusal Unrelated to Adverse Event|0
2635094|NCT00822120|9105150|P2|Initial Registration|Refusal Unrelated to Adverse Event|0
2635095|NCT00822120|9105151|P1|Initial Registration|Refusal Unrelated to Adverse Event|1
2635096|NCT00822120|9105146|P6|Initial Registration|Adverse Event|0
2635097|NCT00822120|9105147|P5|Initial Registration|Adverse Event|0
2635098|NCT00822120|9105148|P4|Initial Registration|Adverse Event|0
2635099|NCT00822120|9105149|P3|Initial Registration|Adverse Event|0
2635100|NCT00822120|9105150|P2|Initial Registration|Adverse Event|0
2635101|NCT00822120|9105151|P1|Initial Registration|Adverse Event|1
2635102|NCT00821873|9105217|P1|Overall Study|Lost to Follow-up|4
2635103|NCT00821678|9105247|P2|Overall Study|Death|2
2635104|NCT00821678|9105248|P1|Overall Study|Death|0
2635105|NCT00821678|9105247|P2|Overall Study|Lost to Follow-up|12
2635106|NCT00821678|9105248|P1|Overall Study|Lost to Follow-up|13
2635107|NCT00821678|9105247|P2|Overall Study|Withdrawal by Subject|0
2635108|NCT00821678|9105248|P1|Overall Study|Withdrawal by Subject|8
2635109|NCT00821587|9105283|P2|Overall Study|Physician Decision|1
2635110|NCT00821587|9105284|P1|Overall Study|Physician Decision|0
2635111|NCT00821509|9105293|P3|Overall Study|Withdrawal by Subject|34
2635112|NCT00821509|9105294|P2|Overall Study|Withdrawal by Subject|11
2635113|NCT00821509|9105295|P1|Overall Study|Withdrawal by Subject|12
2635114|NCT00821431|9105308|P2|Overall Study|Physician Decision|1
2635115|NCT00821431|9105309|P1|Overall Study|Physician Decision|0
2635116|NCT00821431|9105308|P2|Overall Study|Protocol Violation|1
2635117|NCT00821431|9105309|P1|Overall Study|Protocol Violation|3
2635118|NCT00821431|9105308|P2|Overall Study|Lost to Follow-up|0
2635119|NCT00821431|9105309|P1|Overall Study|Lost to Follow-up|1
2635120|NCT00821431|9105308|P2|Overall Study|Withdrawal by Subject|0
2635121|NCT00821431|9105309|P1|Overall Study|Withdrawal by Subject|5
2635122|NCT00821431|9105308|P2|Overall Study|Adverse Event|3
2635123|NCT00821431|9105309|P1|Overall Study|Adverse Event|6
2635124|NCT00821327|9105317|P1|Overall Study|Other/Unknown|5
2635125|NCT00821327|9105317|P1|Overall Study|Disease Progression|13
2635126|NCT00821327|9105317|P1|Overall Study|Sponsor Request|1
2635127|NCT00821327|9105317|P1|Overall Study|Investigator Request|2
2635128|NCT00821327|9105317|P1|Overall Study|Patient Request|1
2635129|NCT00821327|9105317|P1|Overall Study|Adverse Event|13
2635130|NCT00821236|9105326|P1|Overall Study|Lost to Follow-up|3
2635131|NCT00821093|9105366|P2|Overall Study|Administrative problems|2
2635132|NCT00821093|9105367|P1|Overall Study|Administrative problems|1
2635133|NCT00821093|9105366|P2|Overall Study|Abnormal test procedure result(s)|1
2635134|NCT00821093|9105367|P1|Overall Study|Abnormal test procedure result(s)|1
2635135|NCT00821093|9105366|P2|Overall Study|Death|1
2635136|NCT00821093|9105367|P1|Overall Study|Death|2
2635137|NCT00821093|9105366|P2|Overall Study|Lack of Efficacy|2
2635138|NCT00821093|9105367|P1|Overall Study|Lack of Efficacy|2
2635139|NCT00821093|9105366|P2|Overall Study|Abnormal laboratory value(s)|0
2635140|NCT00821093|9105367|P1|Overall Study|Abnormal laboratory value(s)|2
2635141|NCT00821093|9105366|P2|Overall Study|Protocol deviation|6
2635142|NCT00821093|9105367|P1|Overall Study|Protocol deviation|3
2635143|NCT00821093|9105366|P2|Overall Study|Lost to Follow-up|3
2635144|NCT00821093|9105367|P1|Overall Study|Lost to Follow-up|9
2635145|NCT00821093|9105366|P2|Overall Study|Withdrawal by Subject|13
2635146|NCT00821093|9105367|P1|Overall Study|Withdrawal by Subject|9
2635147|NCT00821093|9105366|P2|Overall Study|Adverse Event|12
2635148|NCT00821093|9105367|P1|Overall Study|Adverse Event|20
2635149|NCT00821015|9105386|P1|Overall Study|Lost to Follow-up|12
2635150|NCT00820898|9105397|P1|Overall Study|Inelgible - wrong primary site|1
2635234|NCT00819832|9105687|P4|Overall Study|Sponsor Termination of Study|0
2635151|NCT00820755|9105411|P3|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
2635152|NCT00820755|9105412|P2|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
2635153|NCT00820755|9105413|P1|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0
2635154|NCT00820755|9105411|P3|Period 1: Combination Therapy Phase|Other|0
2635155|NCT00820755|9105412|P2|Period 1: Combination Therapy Phase|Other|0
2635156|NCT00820755|9105413|P1|Period 1: Combination Therapy Phase|Other|11
2635157|NCT00820755|9105411|P3|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
2635158|NCT00820755|9105412|P2|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
2635159|NCT00820755|9105413|P1|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14
2635160|NCT00820755|9105411|P3|Period 1: Combination Therapy Phase|Progressive disease|0
2635161|NCT00820755|9105412|P2|Period 1: Combination Therapy Phase|Progressive disease|0
2635162|NCT00820755|9105413|P1|Period 1: Combination Therapy Phase|Progressive disease|114
2635163|NCT00820755|9105411|P3|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
2635164|NCT00820755|9105412|P2|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
2635165|NCT00820755|9105413|P1|Period 1: Combination Therapy Phase|Withdrawal by Subject|21
2635166|NCT00820755|9105411|P3|Period 1: Combination Therapy Phase|Lost to Follow-up|0
2635167|NCT00820755|9105412|P2|Period 1: Combination Therapy Phase|Lost to Follow-up|0
2635168|NCT00820755|9105413|P1|Period 1: Combination Therapy Phase|Lost to Follow-up|1
2635169|NCT00820755|9105411|P3|Period 1: Combination Therapy Phase|Protocol Violation|0
2635170|NCT00820755|9105412|P2|Period 1: Combination Therapy Phase|Protocol Violation|0
2635171|NCT00820755|9105413|P1|Period 1: Combination Therapy Phase|Protocol Violation|4
2635172|NCT00820755|9105411|P3|Period 1: Combination Therapy Phase|Death|0
2635173|NCT00820755|9105412|P2|Period 1: Combination Therapy Phase|Death|0
2635174|NCT00820755|9105413|P1|Period 1: Combination Therapy Phase|Death|28
2635175|NCT00820755|9105411|P3|Period 1: Combination Therapy Phase|Adverse Event|0
2635176|NCT00820755|9105412|P2|Period 1: Combination Therapy Phase|Adverse Event|0
2635177|NCT00820755|9105413|P1|Period 1: Combination Therapy Phase|Adverse Event|77
2635178|NCT00820248|9105506|P2|Overall Study|No treated|1
2635179|NCT00820248|9105507|P1|Overall Study|No treated|4
2635180|NCT00820222|9105517|P2|Overall Study|Unkown|7
2635181|NCT00820222|9105518|P1|Overall Study|Unkown|11
2635182|NCT00820222|9105517|P2|Overall Study|Sponsor Terminated Study|65
2635183|NCT00820222|9105518|P1|Overall Study|Sponsor Terminated Study|43
2635184|NCT00820222|9105517|P2|Overall Study|Physician Decision|88
2635185|NCT00820222|9105518|P1|Overall Study|Physician Decision|93
2635186|NCT00820222|9105517|P2|Overall Study|Withdrawal by Subject|21
2635187|NCT00820222|9105518|P1|Overall Study|Withdrawal by Subject|19
2635188|NCT00820222|9105517|P2|Overall Study|Lost to Follow-up|9
2635189|NCT00820222|9105518|P1|Overall Study|Lost to Follow-up|10
2635190|NCT00820170|9105549|P5|Overall Study|Progressive Disease|2
2635191|NCT00820170|9105550|P4|Overall Study|Progressive Disease|0
2635192|NCT00820170|9105551|P3|Overall Study|Progressive Disease|0
2635193|NCT00820170|9105552|P2|Overall Study|Progressive Disease|0
2635194|NCT00820170|9105553|P1|Overall Study|Progressive Disease|0
2635195|NCT00820170|9105549|P5|Overall Study|Adverse Event|2
2635196|NCT00820170|9105550|P4|Overall Study|Adverse Event|0
2635197|NCT00820170|9105551|P3|Overall Study|Adverse Event|0
2635198|NCT00820170|9105552|P2|Overall Study|Adverse Event|0
2635199|NCT00820170|9105553|P1|Overall Study|Adverse Event|0
2635200|NCT00820027|9105605|P4|Overall Study|Withdrawal by Subject|6
2635201|NCT00820027|9105606|P3|Overall Study|Withdrawal by Subject|4
2635202|NCT00820027|9105607|P2|Overall Study|Withdrawal by Subject|4
2635203|NCT00820027|9105608|P1|Overall Study|Withdrawal by Subject|6
2635204|NCT00820027|9105605|P4|Overall Study|Protocol Violation|0
2635205|NCT00820027|9105606|P3|Overall Study|Protocol Violation|4
2635206|NCT00820027|9105607|P2|Overall Study|Protocol Violation|0
2635207|NCT00820027|9105608|P1|Overall Study|Protocol Violation|3
2635208|NCT00820027|9105605|P4|Overall Study|Physician Decision|0
2635209|NCT00820027|9105606|P3|Overall Study|Physician Decision|1
2635210|NCT00820027|9105607|P2|Overall Study|Physician Decision|1
2635211|NCT00820027|9105608|P1|Overall Study|Physician Decision|0
2635212|NCT00820027|9105605|P4|Overall Study|Lack of Efficacy|2
2635213|NCT00820027|9105606|P3|Overall Study|Lack of Efficacy|2
2635214|NCT00820027|9105607|P2|Overall Study|Lack of Efficacy|1
2635215|NCT00820027|9105608|P1|Overall Study|Lack of Efficacy|2
2635216|NCT00820027|9105605|P4|Overall Study|Adverse Event|5
2635217|NCT00820027|9105606|P3|Overall Study|Adverse Event|10
2635218|NCT00820027|9105607|P2|Overall Study|Adverse Event|8
2635219|NCT00820027|9105608|P1|Overall Study|Adverse Event|15
2635220|NCT00819910|9105650|P4|Overall Study|Lost to Follow-up|0
2635221|NCT00819910|9105651|P3|Overall Study|Lost to Follow-up|0
2635222|NCT00819910|9105652|P2|Overall Study|Lost to Follow-up|0
2635223|NCT00819910|9105653|P1|Overall Study|Lost to Follow-up|1
2635224|NCT00819910|9105650|P4|Overall Study|Withdrawal by Subject|0
2635225|NCT00819910|9105651|P3|Overall Study|Withdrawal by Subject|1
2635226|NCT00819910|9105652|P2|Overall Study|Withdrawal by Subject|1
2635227|NCT00819910|9105653|P1|Overall Study|Withdrawal by Subject|1
2635228|NCT00819910|9105650|P4|Overall Study|Adverse Event|1
2635229|NCT00819910|9105651|P3|Overall Study|Adverse Event|2
2635230|NCT00819910|9105652|P2|Overall Study|Adverse Event|0
2635231|NCT00819910|9105653|P1|Overall Study|Adverse Event|0
2635232|NCT00819832|9105685|P6|Overall Study|Sponsor Termination of Study|0
2635233|NCT00819832|9105686|P5|Overall Study|Sponsor Termination of Study|0
2635235|NCT00819832|9105688|P3|Overall Study|Sponsor Termination of Study|0
2635236|NCT00819832|9105689|P2|Overall Study|Sponsor Termination of Study|0
2635237|NCT00819832|9105690|P1|Overall Study|Sponsor Termination of Study|3
2635238|NCT00819780|9105711|P2|Overall Study|Still in treatment|17
2635239|NCT00819780|9105712|P1|Overall Study|Still in treatment|25
2635240|NCT00819780|9105711|P2|Overall Study|Did not receive study drug|4
2635241|NCT00819780|9105712|P1|Overall Study|Did not receive study drug|3
2635242|NCT00819767|9105746|P2|Overall Study|Unsatisfactory therapeutic effect|2
2635243|NCT00819767|9105747|P1|Overall Study|Unsatisfactory therapeutic effect|1
2635244|NCT00819741|9105759|P2|Overall Study|Reasons unknown|3
2635245|NCT00819741|9105760|P1|Overall Study|Reasons unknown|3
2635246|NCT00819741|9105759|P2|Overall Study|Unclassified|0
2635247|NCT00819741|9105760|P1|Overall Study|Unclassified|6
2635248|NCT00819741|9105759|P2|Overall Study|Withdrawal by Subject|2
2635249|NCT00819741|9105760|P1|Overall Study|Withdrawal by Subject|2
2635250|NCT00819741|9105759|P2|Overall Study|Protocol Violation|4
2635251|NCT00819741|9105760|P1|Overall Study|Protocol Violation|3
2635252|NCT00819741|9105759|P2|Overall Study|Lost to Follow-up|1
2635253|NCT00819741|9105760|P1|Overall Study|Lost to Follow-up|3
2635254|NCT00819741|9105759|P2|Overall Study|Lack of Efficacy|2
2635255|NCT00819741|9105760|P1|Overall Study|Lack of Efficacy|0
2635256|NCT00819741|9105759|P2|Overall Study|Adverse Event|2
2635257|NCT00819741|9105760|P1|Overall Study|Adverse Event|5
2635258|NCT00819585|9105814|P11|Extension Study|Death|0
2635259|NCT00819585|9105815|P10|Extension Study|Death|0
2635260|NCT00819585|9105816|P9|Extension Study|Death|2
2635261|NCT00819585|9105817|P8|Extension Study|Death|0
2635262|NCT00819585|9105818|P7|Extension Study|Death|0
2635263|NCT00819585|9105819|P6|Extension Study|Death|0
2635264|NCT00819585|9105820|P5|Extension Study|Death|0
2635265|NCT00819585|9105821|P4|Extension Study|Death|0
2635266|NCT00819585|9105822|P3|Extension Study|Death|0
2635267|NCT00819585|9105823|P2|Extension Study|Death|0
2635268|NCT00819585|9105824|P1|Extension Study|Death|0
2635269|NCT00819585|9105814|P11|Extension Study|Lost to Follow-up|1
2635270|NCT00819585|9105815|P10|Extension Study|Lost to Follow-up|1
2635271|NCT00819585|9105816|P9|Extension Study|Lost to Follow-up|2
2635272|NCT00819585|9105817|P8|Extension Study|Lost to Follow-up|0
2635273|NCT00819585|9105818|P7|Extension Study|Lost to Follow-up|0
2635274|NCT00819585|9105819|P6|Extension Study|Lost to Follow-up|0
2635275|NCT00819585|9105820|P5|Extension Study|Lost to Follow-up|0
2635276|NCT00819585|9105821|P4|Extension Study|Lost to Follow-up|0
2635277|NCT00819585|9105822|P3|Extension Study|Lost to Follow-up|0
2635278|NCT00819585|9105823|P2|Extension Study|Lost to Follow-up|0
2635279|NCT00819585|9105824|P1|Extension Study|Lost to Follow-up|0
2635280|NCT00819585|9105814|P11|Extension Study|Subject Withdrew Consent|1
2635281|NCT00819585|9105815|P10|Extension Study|Subject Withdrew Consent|0
2635282|NCT00819585|9105816|P9|Extension Study|Subject Withdrew Consent|3
2635283|NCT00819585|9105817|P8|Extension Study|Subject Withdrew Consent|0
2635284|NCT00819585|9105818|P7|Extension Study|Subject Withdrew Consent|0
2635285|NCT00819585|9105819|P6|Extension Study|Subject Withdrew Consent|0
2635286|NCT00819585|9105820|P5|Extension Study|Subject Withdrew Consent|0
2635287|NCT00819585|9105821|P4|Extension Study|Subject Withdrew Consent|0
2635288|NCT00819585|9105822|P3|Extension Study|Subject Withdrew Consent|0
2635289|NCT00819585|9105823|P2|Extension Study|Subject Withdrew Consent|0
2635290|NCT00819585|9105824|P1|Extension Study|Subject Withdrew Consent|0
2635291|NCT00819585|9105814|P11|Extension Study|Abnormal Laboratory Value(s)|0
2635292|NCT00819585|9105815|P10|Extension Study|Abnormal Laboratory Value(s)|0
2635293|NCT00819585|9105816|P9|Extension Study|Abnormal Laboratory Value(s)|1
2635294|NCT00819585|9105817|P8|Extension Study|Abnormal Laboratory Value(s)|0
2635295|NCT00819585|9105818|P7|Extension Study|Abnormal Laboratory Value(s)|0
2635296|NCT00819585|9105819|P6|Extension Study|Abnormal Laboratory Value(s)|0
2635297|NCT00819585|9105820|P5|Extension Study|Abnormal Laboratory Value(s)|0
2635298|NCT00819585|9105821|P4|Extension Study|Abnormal Laboratory Value(s)|0
2635299|NCT00819585|9105822|P3|Extension Study|Abnormal Laboratory Value(s)|0
2635300|NCT00819585|9105823|P2|Extension Study|Abnormal Laboratory Value(s)|0
2635301|NCT00819585|9105824|P1|Extension Study|Abnormal Laboratory Value(s)|0
2635302|NCT00819585|9105814|P11|Core Study|Protocol Violation|0
2635303|NCT00819585|9105815|P10|Core Study|Protocol Violation|0
2635304|NCT00819585|9105816|P9|Core Study|Protocol Violation|0
2635305|NCT00819585|9105817|P8|Core Study|Protocol Violation|0
2635306|NCT00819585|9105818|P7|Core Study|Protocol Violation|3
2635307|NCT00819585|9105819|P6|Core Study|Protocol Violation|1
2635308|NCT00819585|9105820|P5|Core Study|Protocol Violation|0
2635309|NCT00819585|9105821|P4|Core Study|Protocol Violation|0
2635310|NCT00819585|9105822|P3|Core Study|Protocol Violation|1
2635311|NCT00819585|9105823|P2|Core Study|Protocol Violation|0
2635312|NCT00819585|9105824|P1|Core Study|Protocol Violation|0
2635313|NCT00819585|9105814|P11|Core Study|Death|0
2635314|NCT00819585|9105815|P10|Core Study|Death|0
2635315|NCT00819585|9105816|P9|Core Study|Death|0
2635316|NCT00819585|9105817|P8|Core Study|Death|0
2635317|NCT00819585|9105818|P7|Core Study|Death|1
2635318|NCT00819585|9105819|P6|Core Study|Death|0
2635319|NCT00819585|9105820|P5|Core Study|Death|0
2635320|NCT00819585|9105821|P4|Core Study|Death|0
2635321|NCT00819585|9105822|P3|Core Study|Death|0
2635322|NCT00819585|9105823|P2|Core Study|Death|0
2635323|NCT00819585|9105824|P1|Core Study|Death|0
2635324|NCT00819585|9105814|P11|Core Study|Administrative Problems|0
2635325|NCT00819585|9105815|P10|Core Study|Administrative Problems|0
2635326|NCT00819585|9105816|P9|Core Study|Administrative Problems|0
2635327|NCT00819585|9105817|P8|Core Study|Administrative Problems|0
2635328|NCT00819585|9105818|P7|Core Study|Administrative Problems|2
2635329|NCT00819585|9105819|P6|Core Study|Administrative Problems|0
2635330|NCT00819585|9105820|P5|Core Study|Administrative Problems|0
2635331|NCT00819585|9105821|P4|Core Study|Administrative Problems|0
2635332|NCT00819585|9105822|P3|Core Study|Administrative Problems|0
2635333|NCT00819585|9105823|P2|Core Study|Administrative Problems|0
2635334|NCT00819585|9105824|P1|Core Study|Administrative Problems|0
2635335|NCT00819585|9105814|P11|Core Study|Lost to Follow-up|0
2635336|NCT00819585|9105815|P10|Core Study|Lost to Follow-up|0
2635337|NCT00819585|9105816|P9|Core Study|Lost to Follow-up|0
2635338|NCT00819585|9105817|P8|Core Study|Lost to Follow-up|0
2635339|NCT00819585|9105818|P7|Core Study|Lost to Follow-up|1
2635340|NCT00819585|9105819|P6|Core Study|Lost to Follow-up|1
2635341|NCT00819585|9105820|P5|Core Study|Lost to Follow-up|1
2635342|NCT00819585|9105821|P4|Core Study|Lost to Follow-up|0
2635343|NCT00819585|9105822|P3|Core Study|Lost to Follow-up|2
2635344|NCT00819585|9105823|P2|Core Study|Lost to Follow-up|1
2635345|NCT00819585|9105824|P1|Core Study|Lost to Follow-up|2
2635346|NCT00819585|9105814|P11|Core Study|Subject Withdrew Consent|0
2635347|NCT00819585|9105815|P10|Core Study|Subject Withdrew Consent|0
2635348|NCT00819585|9105816|P9|Core Study|Subject Withdrew Consent|0
2635349|NCT00819585|9105817|P8|Core Study|Subject Withdrew Consent|0
2635350|NCT00819585|9105818|P7|Core Study|Subject Withdrew Consent|3
2635351|NCT00819585|9105819|P6|Core Study|Subject Withdrew Consent|0
2635352|NCT00819585|9105820|P5|Core Study|Subject Withdrew Consent|0
2635353|NCT00819585|9105821|P4|Core Study|Subject Withdrew Consent|1
2635354|NCT00819585|9105822|P3|Core Study|Subject Withdrew Consent|2
2635355|NCT00819585|9105823|P2|Core Study|Subject Withdrew Consent|3
2635356|NCT00819585|9105824|P1|Core Study|Subject Withdrew Consent|0
2635357|NCT00819585|9105814|P11|Core Study|Subject No Longer Requires Study Drug|0
2635358|NCT00819585|9105815|P10|Core Study|Subject No Longer Requires Study Drug|0
2635359|NCT00819585|9105816|P9|Core Study|Subject No Longer Requires Study Drug|0
2635360|NCT00819585|9105817|P8|Core Study|Subject No Longer Requires Study Drug|0
2635361|NCT00819585|9105818|P7|Core Study|Subject No Longer Requires Study Drug|0
2635362|NCT00819585|9105819|P6|Core Study|Subject No Longer Requires Study Drug|0
2635363|NCT00819585|9105820|P5|Core Study|Subject No Longer Requires Study Drug|1
2635364|NCT00819585|9105821|P4|Core Study|Subject No Longer Requires Study Drug|0
2635365|NCT00819585|9105822|P3|Core Study|Subject No Longer Requires Study Drug|0
2635366|NCT00819585|9105823|P2|Core Study|Subject No Longer Requires Study Drug|0
2635367|NCT00819585|9105824|P1|Core Study|Subject No Longer Requires Study Drug|0
2635368|NCT00819585|9105814|P11|Core Study|Unsatisfactory Therapeutic Effect|0
2635369|NCT00819585|9105815|P10|Core Study|Unsatisfactory Therapeutic Effect|0
2635370|NCT00819585|9105816|P9|Core Study|Unsatisfactory Therapeutic Effect|0
2635371|NCT00819585|9105817|P8|Core Study|Unsatisfactory Therapeutic Effect|0
2635372|NCT00819585|9105818|P7|Core Study|Unsatisfactory Therapeutic Effect|1
2635373|NCT00819585|9105819|P6|Core Study|Unsatisfactory Therapeutic Effect|0
2635374|NCT00819585|9105820|P5|Core Study|Unsatisfactory Therapeutic Effect|0
2635375|NCT00819585|9105821|P4|Core Study|Unsatisfactory Therapeutic Effect|0
2635376|NCT00819585|9105822|P3|Core Study|Unsatisfactory Therapeutic Effect|0
2635377|NCT00819585|9105823|P2|Core Study|Unsatisfactory Therapeutic Effect|1
2635378|NCT00819585|9105824|P1|Core Study|Unsatisfactory Therapeutic Effect|0
2635379|NCT00819585|9105814|P11|Core Study|Abnormal Laboratory Value(s)|0
2635380|NCT00819585|9105815|P10|Core Study|Abnormal Laboratory Value(s)|0
2635381|NCT00819585|9105816|P9|Core Study|Abnormal Laboratory Value(s)|0
2635382|NCT00819585|9105817|P8|Core Study|Abnormal Laboratory Value(s)|0
2635383|NCT00819585|9105818|P7|Core Study|Abnormal Laboratory Value(s)|0
2635384|NCT00819585|9105819|P6|Core Study|Abnormal Laboratory Value(s)|0
2635385|NCT00819585|9105820|P5|Core Study|Abnormal Laboratory Value(s)|0
2635386|NCT00819585|9105821|P4|Core Study|Abnormal Laboratory Value(s)|0
2635387|NCT00819585|9105822|P3|Core Study|Abnormal Laboratory Value(s)|0
2635388|NCT00819585|9105823|P2|Core Study|Abnormal Laboratory Value(s)|0
2635389|NCT00819585|9105824|P1|Core Study|Abnormal Laboratory Value(s)|2
2635390|NCT00819585|9105814|P11|Core Study|Adverse Event|0
2635391|NCT00819585|9105815|P10|Core Study|Adverse Event|0
2635392|NCT00819585|9105816|P9|Core Study|Adverse Event|0
2635393|NCT00819585|9105817|P8|Core Study|Adverse Event|0
2635394|NCT00819585|9105818|P7|Core Study|Adverse Event|2
2635395|NCT00819585|9105819|P6|Core Study|Adverse Event|0
2635396|NCT00819585|9105820|P5|Core Study|Adverse Event|1
2635397|NCT00819585|9105821|P4|Core Study|Adverse Event|4
2635398|NCT00819585|9105822|P3|Core Study|Adverse Event|1
2635399|NCT00819585|9105823|P2|Core Study|Adverse Event|1
2635400|NCT00819585|9105824|P1|Core Study|Adverse Event|2
2635401|NCT00819390|9105915|P4|Overall Study|Adverse Event|0
2635402|NCT00819390|9105916|P3|Overall Study|Adverse Event|1
2635403|NCT00819390|9105917|P2|Overall Study|Adverse Event|0
2635404|NCT00819390|9105918|P1|Overall Study|Adverse Event|0
2635405|NCT00819390|9105915|P4|Overall Study|Withdrawal by Subject|0
2635406|NCT00819390|9105916|P3|Overall Study|Withdrawal by Subject|0
2635407|NCT00819390|9105917|P2|Overall Study|Withdrawal by Subject|0
2635408|NCT00819390|9105918|P1|Overall Study|Withdrawal by Subject|2
2635409|NCT00819390|9105915|P4|Overall Study|Lost to Follow-up|0
2635410|NCT00819390|9105916|P3|Overall Study|Lost to Follow-up|0
2635411|NCT00819390|9105917|P2|Overall Study|Lost to Follow-up|1
2635412|NCT00819390|9105918|P1|Overall Study|Lost to Follow-up|1
2635413|NCT00819247|9106054|P3|Overall Study|Other|0
2635414|NCT00819247|9106055|P2|Overall Study|Other|0
2635415|NCT00819247|9106056|P1|Overall Study|Other|1
2635416|NCT00819247|9106054|P3|Overall Study|Bad prostate-specific antigen response|0
2635417|NCT00819247|9106055|P2|Overall Study|Bad prostate-specific antigen response|2
2635418|NCT00819247|9106056|P1|Overall Study|Bad prostate-specific antigen response|3
2635419|NCT00819247|9106054|P3|Overall Study|Mistakenly withdrawn|0
2635420|NCT00819247|9106055|P2|Overall Study|Mistakenly withdrawn|1
2635421|NCT00819247|9106056|P1|Overall Study|Mistakenly withdrawn|0
2635422|NCT00819247|9106054|P3|Overall Study|Protocol Violation|1
2635423|NCT00819247|9106055|P2|Overall Study|Protocol Violation|0
2635424|NCT00819247|9106056|P1|Overall Study|Protocol Violation|1
2635425|NCT00819247|9106054|P3|Overall Study|Withdrawal by Subject|0
2635426|NCT00819247|9106055|P2|Overall Study|Withdrawal by Subject|0
2635427|NCT00819247|9106056|P1|Overall Study|Withdrawal by Subject|1
2635428|NCT00819247|9106054|P3|Overall Study|Insufficient testosterone response|10
2635429|NCT00819247|9106055|P2|Overall Study|Insufficient testosterone response|8
2635430|NCT00819247|9106056|P1|Overall Study|Insufficient testosterone response|5
2635431|NCT00819247|9106054|P3|Overall Study|Adverse Event|3
2635432|NCT00819247|9106055|P2|Overall Study|Adverse Event|5
2635433|NCT00819247|9106056|P1|Overall Study|Adverse Event|0
2635434|NCT00819234|9106082|P10|Overall Study|Lost to Follow-up|2
2635435|NCT00819234|9106083|P9|Overall Study|Lost to Follow-up|1
2635436|NCT00819234|9106084|P8|Overall Study|Lost to Follow-up|1
2635437|NCT00819234|9106085|P7|Overall Study|Lost to Follow-up|1
2635438|NCT00819234|9106086|P6|Overall Study|Lost to Follow-up|1
2635439|NCT00819234|9106087|P5|Overall Study|Lost to Follow-up|1
2635440|NCT00819234|9106088|P4|Overall Study|Lost to Follow-up|2
2635441|NCT00819234|9106089|P3|Overall Study|Lost to Follow-up|0
2635442|NCT00819234|9106090|P2|Overall Study|Lost to Follow-up|2
2635443|NCT00819234|9106091|P1|Overall Study|Lost to Follow-up|2
2635444|NCT00819234|9106082|P10|Overall Study|Protocol Violation|0
2635445|NCT00819234|9106083|P9|Overall Study|Protocol Violation|0
2635446|NCT00819234|9106084|P8|Overall Study|Protocol Violation|0
2635447|NCT00819234|9106085|P7|Overall Study|Protocol Violation|0
2635448|NCT00819234|9106086|P6|Overall Study|Protocol Violation|0
2635449|NCT00819234|9106087|P5|Overall Study|Protocol Violation|0
2635450|NCT00819234|9106088|P4|Overall Study|Protocol Violation|0
2635451|NCT00819234|9106089|P3|Overall Study|Protocol Violation|1
2635452|NCT00819234|9106090|P2|Overall Study|Protocol Violation|0
2635453|NCT00819234|9106091|P1|Overall Study|Protocol Violation|0
2635454|NCT00819234|9106082|P10|Overall Study|Physician Decision|2
2635455|NCT00819234|9106083|P9|Overall Study|Physician Decision|0
2635456|NCT00819234|9106084|P8|Overall Study|Physician Decision|0
2635457|NCT00819234|9106085|P7|Overall Study|Physician Decision|0
2635458|NCT00819234|9106086|P6|Overall Study|Physician Decision|0
2635459|NCT00819234|9106087|P5|Overall Study|Physician Decision|0
2635460|NCT00819234|9106088|P4|Overall Study|Physician Decision|1
2635461|NCT00819234|9106089|P3|Overall Study|Physician Decision|0
2635462|NCT00819234|9106090|P2|Overall Study|Physician Decision|0
2635463|NCT00819234|9106091|P1|Overall Study|Physician Decision|0
2635464|NCT00819234|9106082|P10|Overall Study|Adverse Event|0
2635465|NCT00819234|9106083|P9|Overall Study|Adverse Event|0
2635466|NCT00819234|9106084|P8|Overall Study|Adverse Event|0
2635467|NCT00819234|9106085|P7|Overall Study|Adverse Event|0
2635468|NCT00819234|9106086|P6|Overall Study|Adverse Event|2
2635469|NCT00819234|9106087|P5|Overall Study|Adverse Event|0
2635470|NCT00819234|9106088|P4|Overall Study|Adverse Event|0
2635471|NCT00819234|9106089|P3|Overall Study|Adverse Event|1
2635472|NCT00819234|9106090|P2|Overall Study|Adverse Event|0
2635473|NCT00819234|9106091|P1|Overall Study|Adverse Event|0
2635474|NCT00819234|9106082|P10|Overall Study|Withdrawal by Subject|3
2635475|NCT00819234|9106083|P9|Overall Study|Withdrawal by Subject|5
2635476|NCT00819234|9106084|P8|Overall Study|Withdrawal by Subject|8
2635477|NCT00819234|9106085|P7|Overall Study|Withdrawal by Subject|4
2635478|NCT00819234|9106086|P6|Overall Study|Withdrawal by Subject|4
2635479|NCT00819234|9106087|P5|Overall Study|Withdrawal by Subject|0
2635480|NCT00819234|9106088|P4|Overall Study|Withdrawal by Subject|3
2635481|NCT00819234|9106089|P3|Overall Study|Withdrawal by Subject|6
2635482|NCT00819234|9106090|P2|Overall Study|Withdrawal by Subject|13
2635483|NCT00819234|9106091|P1|Overall Study|Withdrawal by Subject|8
2635484|NCT00819156|9106290|P6|Overall Study|Prostate-specific antigen progression|0
2635485|NCT00819156|9106291|P5|Overall Study|Prostate-specific antigen progression|1
2635486|NCT00819156|9106292|P4|Overall Study|Prostate-specific antigen progression|0
2635487|NCT00819156|9106293|P3|Overall Study|Prostate-specific antigen progression|0
2635488|NCT00819156|9106294|P2|Overall Study|Prostate-specific antigen progression|0
2635489|NCT00819156|9106295|P1|Overall Study|Prostate-specific antigen progression|0
2635490|NCT00819156|9106290|P6|Overall Study|Testosterone >=.5ng/ml 2 visits|0
2635491|NCT00819156|9106291|P5|Overall Study|Testosterone >=.5ng/ml 2 visits|1
2635492|NCT00819156|9106292|P4|Overall Study|Testosterone >=.5ng/ml 2 visits|0
2635493|NCT00819156|9106293|P3|Overall Study|Testosterone >=.5ng/ml 2 visits|0
2635494|NCT00819156|9106294|P2|Overall Study|Testosterone >=.5ng/ml 2 visits|0
2635495|NCT00819156|9106295|P1|Overall Study|Testosterone >=.5ng/ml 2 visits|3
2635496|NCT00819156|9106290|P6|Overall Study|Testosterone >1ng/ml from Day 28+|2
2635497|NCT00819156|9106291|P5|Overall Study|Testosterone >1ng/ml from Day 28+|1
2635498|NCT00819156|9106292|P4|Overall Study|Testosterone >1ng/ml from Day 28+|1
2635499|NCT00819156|9106293|P3|Overall Study|Testosterone >1ng/ml from Day 28+|1
2635500|NCT00819156|9106294|P2|Overall Study|Testosterone >1ng/ml from Day 28+|2
2635501|NCT00819156|9106295|P1|Overall Study|Testosterone >1ng/ml from Day 28+|5
2635502|NCT00819156|9106290|P6|Overall Study|Lost to Follow-up|2
2635503|NCT00819156|9106291|P5|Overall Study|Lost to Follow-up|0
2635504|NCT00819156|9106292|P4|Overall Study|Lost to Follow-up|0
2635505|NCT00819156|9106293|P3|Overall Study|Lost to Follow-up|0
2635506|NCT00819156|9106294|P2|Overall Study|Lost to Follow-up|1
2635507|NCT00819156|9106295|P1|Overall Study|Lost to Follow-up|0
2635508|NCT00819156|9106290|P6|Overall Study|Protocol Violation|1
2635509|NCT00819156|9106291|P5|Overall Study|Protocol Violation|0
2635510|NCT00819156|9106292|P4|Overall Study|Protocol Violation|0
2635511|NCT00819156|9106293|P3|Overall Study|Protocol Violation|1
2635512|NCT00819156|9106294|P2|Overall Study|Protocol Violation|0
2635513|NCT00819156|9106295|P1|Overall Study|Protocol Violation|1
2635514|NCT00819156|9106290|P6|Overall Study|Withdrawal by Subject|0
2635515|NCT00819156|9106291|P5|Overall Study|Withdrawal by Subject|1
2635516|NCT00819156|9106292|P4|Overall Study|Withdrawal by Subject|0
2635517|NCT00819156|9106293|P3|Overall Study|Withdrawal by Subject|2
2635518|NCT00819156|9106294|P2|Overall Study|Withdrawal by Subject|3
2635519|NCT00819156|9106295|P1|Overall Study|Withdrawal by Subject|0
2635520|NCT00819156|9106290|P6|Overall Study|Adverse Event|3
2635521|NCT00819156|9106291|P5|Overall Study|Adverse Event|2
2635522|NCT00819156|9106292|P4|Overall Study|Adverse Event|1
2635523|NCT00819156|9106293|P3|Overall Study|Adverse Event|2
2635524|NCT00819156|9106294|P2|Overall Study|Adverse Event|4
2635525|NCT00819156|9106295|P1|Overall Study|Adverse Event|1
2635526|NCT00819091|9106385|P2|Overall Study|Other|2
2635527|NCT00819091|9106386|P1|Overall Study|Other|1
2635528|NCT00819091|9106385|P2|Overall Study|Withdrawal by Subject|2
2635529|NCT00819091|9106386|P1|Overall Study|Withdrawal by Subject|1
2635530|NCT00819091|9106385|P2|Overall Study|Lost to Follow-up|0
2635531|NCT00819091|9106386|P1|Overall Study|Lost to Follow-up|2
2635532|NCT00819091|9106385|P2|Overall Study|Protocol Violation|1
2635533|NCT00819091|9106386|P1|Overall Study|Protocol Violation|0
2635534|NCT00819091|9106385|P2|Overall Study|Adverse Event|5
2635535|NCT00819091|9106386|P1|Overall Study|Adverse Event|3
2635536|NCT00819052|9106412|P2|Overall Study|Death or events leading to death|0
2635537|NCT00819052|9106413|P1|Overall Study|Death or events leading to death|1
2635538|NCT00819052|9106412|P2|Overall Study|Pregnancy|2
2635539|NCT00819052|9106413|P1|Overall Study|Pregnancy|1
2635540|NCT00819052|9106412|P2|Overall Study|Lack of Efficacy|1
2635541|NCT00819052|9106413|P1|Overall Study|Lack of Efficacy|1
2635542|NCT00819052|9106412|P2|Overall Study|Withdrawal by Subject|2
2635543|NCT00819052|9106413|P1|Overall Study|Withdrawal by Subject|1
2635544|NCT00819052|9106412|P2|Overall Study|Lost to Follow-up|2
2635545|NCT00819052|9106413|P1|Overall Study|Lost to Follow-up|1
2635546|NCT00819052|9106412|P2|Overall Study|Protocol Violation|2
2635547|NCT00819052|9106413|P1|Overall Study|Protocol Violation|1
2635548|NCT00819052|9106412|P2|Overall Study|Adverse Event|5
2635549|NCT00819052|9106413|P1|Overall Study|Adverse Event|0
2635550|NCT00819039|9106528|P3|Overall Study|Protocol Violation|0
2635551|NCT00819039|9106529|P2|Overall Study|Protocol Violation|0
2635552|NCT00819039|9106530|P1|Overall Study|Protocol Violation|1
2635553|NCT00819039|9106528|P3|Overall Study|Physician Decision|1
2635554|NCT00819039|9106529|P2|Overall Study|Physician Decision|0
2635555|NCT00819039|9106530|P1|Overall Study|Physician Decision|1
2635556|NCT00819013|9106560|P4|Overall Study|Death|1
2635557|NCT00819013|9106561|P3|Overall Study|Death|0
2635558|NCT00819013|9106562|P2|Overall Study|Death|0
2635559|NCT00819013|9106563|P1|Overall Study|Death|0
2635560|NCT00819013|9106560|P4|Overall Study|Lost to Follow-up|2
2635561|NCT00819013|9106561|P3|Overall Study|Lost to Follow-up|1
2635562|NCT00819013|9106562|P2|Overall Study|Lost to Follow-up|0
2635563|NCT00819013|9106563|P1|Overall Study|Lost to Follow-up|0
2635564|NCT00819013|9106560|P4|Overall Study|Withdrawal by Subject|0
2635565|NCT00819013|9106561|P3|Overall Study|Withdrawal by Subject|1
2635566|NCT00819013|9106562|P2|Overall Study|Withdrawal by Subject|0
2635567|NCT00819013|9106563|P1|Overall Study|Withdrawal by Subject|1
2635568|NCT00819013|9106560|P4|Overall Study|Adverse Event|0
2635569|NCT00819013|9106561|P3|Overall Study|Adverse Event|1
2635570|NCT00819013|9106562|P2|Overall Study|Adverse Event|0
2635571|NCT00819013|9106563|P1|Overall Study|Adverse Event|0
2635572|NCT00819013|9106560|P4|Overall Study|Not meeting continuing study eligibility|1
2635573|NCT00819013|9106561|P3|Overall Study|Not meeting continuing study eligibility|2
2635574|NCT00819013|9106562|P2|Overall Study|Not meeting continuing study eligibility|1
2635575|NCT00819013|9106563|P1|Overall Study|Not meeting continuing study eligibility|2
2635576|NCT00818883|9106629|P2|Overall Study|Other|7
2635577|NCT00818883|9106630|P1|Overall Study|Other|2
2635578|NCT00818883|9106629|P2|Overall Study|Lack of Efficacy|2
2635579|NCT00818883|9106630|P1|Overall Study|Lack of Efficacy|0
2635580|NCT00818883|9106629|P2|Overall Study|Withdrawal by Subject|14
2635581|NCT00818883|9106630|P1|Overall Study|Withdrawal by Subject|16
2635582|NCT00818883|9106629|P2|Overall Study|Lost to Follow-up|2
2635583|NCT00818883|9106630|P1|Overall Study|Lost to Follow-up|3
2635584|NCT00818883|9106629|P2|Overall Study|Protocol Violation|2
2635585|NCT00818883|9106630|P1|Overall Study|Protocol Violation|2
2635586|NCT00818883|9106629|P2|Overall Study|Adverse Event|19
2635587|NCT00818883|9106630|P1|Overall Study|Adverse Event|28
2635588|NCT00818779|9106677|P2|Overall Study|Adverse Event|1
2635589|NCT00818779|9106678|P1|Overall Study|Adverse Event|4
2635590|NCT00818779|9106677|P2|Overall Study|Lost to Follow-up|0
2635591|NCT00818779|9106678|P1|Overall Study|Lost to Follow-up|1
2635592|NCT00818779|9106677|P2|Overall Study|Protocol Violation|0
2635593|NCT00818779|9106678|P1|Overall Study|Protocol Violation|1
2635594|NCT00818766|9106694|P2|Overall Study|Did not Receive Allocated Intervention|0
2635595|NCT00818766|9106695|P1|Overall Study|Did not Receive Allocated Intervention|3
2635596|NCT00818766|9106694|P2|Overall Study|Death|0
2635597|NCT00818766|9106695|P1|Overall Study|Death|1
2635598|NCT00818766|9106694|P2|Overall Study|Could not be Contacted on Day 28|10
2635599|NCT00818766|9106695|P1|Overall Study|Could not be Contacted on Day 28|11
2635600|NCT00818753|9106724|P3|Overall Study|Randomised and not treated|0
2635601|NCT00818753|9106725|P2|Overall Study|Randomised and not treated|0
2635602|NCT00818753|9106726|P1|Overall Study|Randomised and not treated|2
2635603|NCT00818753|9106724|P3|Overall Study|Other reason (not specified)|1
2635604|NCT00818753|9106725|P2|Overall Study|Other reason (not specified)|0
2635605|NCT00818753|9106726|P1|Overall Study|Other reason (not specified)|0
2635606|NCT00818753|9106724|P3|Overall Study|Protocol Violation|0
2635607|NCT00818753|9106725|P2|Overall Study|Protocol Violation|0
2635608|NCT00818753|9106726|P1|Overall Study|Protocol Violation|1
2635609|NCT00818662|9106750|P4|Overall Study|Admitted to long term nursing care|0
2635610|NCT00818662|9106751|P3|Overall Study|Admitted to long term nursing care|0
2635611|NCT00818662|9106752|P2|Overall Study|Admitted to long term nursing care|1
2635612|NCT00818662|9106753|P1|Overall Study|Admitted to long term nursing care|0
2635613|NCT00818662|9106750|P4|Overall Study|Study partner decision|1
2635614|NCT00818662|9106751|P3|Overall Study|Study partner decision|0
2635615|NCT00818662|9106752|P2|Overall Study|Study partner decision|0
2635616|NCT00818662|9106753|P1|Overall Study|Study partner decision|0
2635617|NCT00818662|9106750|P4|Overall Study|Change in living situation|1
2635618|NCT00818662|9106751|P3|Overall Study|Change in living situation|0
2635619|NCT00818662|9106752|P2|Overall Study|Change in living situation|0
2635620|NCT00818662|9106753|P1|Overall Study|Change in living situation|0
2635621|NCT00818662|9106750|P4|Overall Study|Declined move to another study site|0
2635622|NCT00818662|9106751|P3|Overall Study|Declined move to another study site|0
2635623|NCT00818662|9106752|P2|Overall Study|Declined move to another study site|0
2635624|NCT00818662|9106753|P1|Overall Study|Declined move to another study site|1
2635625|NCT00818662|9106750|P4|Overall Study|Moving out of state|1
2635626|NCT00818662|9106751|P3|Overall Study|Moving out of state|0
2635627|NCT00818662|9106752|P2|Overall Study|Moving out of state|0
2635628|NCT00818662|9106753|P1|Overall Study|Moving out of state|0
2635629|NCT00818662|9106750|P4|Overall Study|Caregiver to pursue other treatment|0
2635630|NCT00818662|9106751|P3|Overall Study|Caregiver to pursue other treatment|0
2635631|NCT00818662|9106752|P2|Overall Study|Caregiver to pursue other treatment|1
2635632|NCT00818662|9106753|P1|Overall Study|Caregiver to pursue other treatment|0
2635633|NCT00818662|9106750|P4|Overall Study|Participant's health declined|1
2635634|NCT00818662|9106751|P3|Overall Study|Participant's health declined|0
2635635|NCT00818662|9106752|P2|Overall Study|Participant's health declined|0
2635636|NCT00818662|9106753|P1|Overall Study|Participant's health declined|0
2635637|NCT00818662|9106750|P4|Overall Study|Study Partner Unwilling or Unable|1
2635638|NCT00818662|9106751|P3|Overall Study|Study Partner Unwilling or Unable|1
2635639|NCT00818662|9106752|P2|Overall Study|Study Partner Unwilling or Unable|2
2635640|NCT00818662|9106753|P1|Overall Study|Study Partner Unwilling or Unable|3
2635641|NCT00818662|9106750|P4|Overall Study|Safety Risk|1
2635642|NCT00818662|9106751|P3|Overall Study|Safety Risk|0
2635643|NCT00818662|9106752|P2|Overall Study|Safety Risk|1
2635644|NCT00818662|9106753|P1|Overall Study|Safety Risk|1
2635645|NCT00818662|9106750|P4|Overall Study|Requires a Prohibited Medication|0
2635646|NCT00818662|9106751|P3|Overall Study|Requires a Prohibited Medication|0
2635647|NCT00818662|9106752|P2|Overall Study|Requires a Prohibited Medication|0
2635648|NCT00818662|9106753|P1|Overall Study|Requires a Prohibited Medication|1
2635649|NCT00818662|9106750|P4|Overall Study|Protocol Violation|0
2635650|NCT00818662|9106751|P3|Overall Study|Protocol Violation|0
2635651|NCT00818662|9106752|P2|Overall Study|Protocol Violation|1
2635652|NCT00818662|9106753|P1|Overall Study|Protocol Violation|1
2635653|NCT00818662|9106750|P4|Overall Study|Unwilling or Unable to Participate|4
2635654|NCT00818662|9106751|P3|Overall Study|Unwilling or Unable to Participate|2
2635655|NCT00818662|9106752|P2|Overall Study|Unwilling or Unable to Participate|6
2635656|NCT00818662|9106753|P1|Overall Study|Unwilling or Unable to Participate|4
2635657|NCT00818662|9106750|P4|Overall Study|Lost to Follow-up|1
2635658|NCT00818662|9106751|P3|Overall Study|Lost to Follow-up|0
2635659|NCT00818662|9106752|P2|Overall Study|Lost to Follow-up|0
2635660|NCT00818662|9106753|P1|Overall Study|Lost to Follow-up|0
2635661|NCT00818662|9106750|P4|Overall Study|Physician Decision|0
2635662|NCT00818662|9106751|P3|Overall Study|Physician Decision|0
2635663|NCT00818662|9106752|P2|Overall Study|Physician Decision|0
2635664|NCT00818662|9106753|P1|Overall Study|Physician Decision|1
2635665|NCT00818662|9106750|P4|Overall Study|Death|0
2635666|NCT00818662|9106751|P3|Overall Study|Death|0
2635667|NCT00818662|9106752|P2|Overall Study|Death|3
2635668|NCT00818662|9106753|P1|Overall Study|Death|1
2635669|NCT00818662|9106750|P4|Overall Study|Withdrawal by Subject|2
2635670|NCT00818662|9106751|P3|Overall Study|Withdrawal by Subject|2
2635671|NCT00818662|9106752|P2|Overall Study|Withdrawal by Subject|4
2635672|NCT00818662|9106753|P1|Overall Study|Withdrawal by Subject|5
2635673|NCT00818662|9106750|P4|Overall Study|Adverse Event|3
2635674|NCT00818662|9106751|P3|Overall Study|Adverse Event|4
2635675|NCT00818662|9106752|P2|Overall Study|Adverse Event|14
2635676|NCT00818662|9106753|P1|Overall Study|Adverse Event|5
2635677|NCT00818649|9106839|P1|Overall Study|Adverse Event|1
2635678|NCT00818649|9106839|P1|Overall Study|Unrelated hip fracture-unable to proceed|1
2635679|NCT00818649|9106839|P1|Overall Study|Declining performance status|2
2635680|NCT00818623|9106853|P8|Overall Study|Disease progression|0
2635681|NCT00818623|9106854|P7|Overall Study|Disease progression|1
2635682|NCT00818623|9106855|P6|Overall Study|Disease progression|0
2635683|NCT00818623|9106856|P5|Overall Study|Disease progression|0
2635684|NCT00818623|9106857|P4|Overall Study|Disease progression|0
2635685|NCT00818623|9106858|P3|Overall Study|Disease progression|0
2635686|NCT00818623|9106859|P2|Overall Study|Disease progression|0
2635687|NCT00818623|9106860|P1|Overall Study|Disease progression|0
2635688|NCT00818623|9106853|P8|Overall Study|Lack of trial drug at site|0
2635689|NCT00818623|9106854|P7|Overall Study|Lack of trial drug at site|1
2635690|NCT00818623|9106855|P6|Overall Study|Lack of trial drug at site|0
2635691|NCT00818623|9106856|P5|Overall Study|Lack of trial drug at site|2
2635692|NCT00818623|9106857|P4|Overall Study|Lack of trial drug at site|0
2635693|NCT00818623|9106858|P3|Overall Study|Lack of trial drug at site|0
2635694|NCT00818623|9106859|P2|Overall Study|Lack of trial drug at site|0
2635695|NCT00818623|9106860|P1|Overall Study|Lack of trial drug at site|0
2635696|NCT00818623|9106853|P8|Overall Study|Need of additional treatment|0
2635697|NCT00818623|9106854|P7|Overall Study|Need of additional treatment|0
2635698|NCT00818623|9106855|P6|Overall Study|Need of additional treatment|0
2635699|NCT00818623|9106856|P5|Overall Study|Need of additional treatment|1
2635700|NCT00818623|9106857|P4|Overall Study|Need of additional treatment|0
2635701|NCT00818623|9106858|P3|Overall Study|Need of additional treatment|0
2635702|NCT00818623|9106859|P2|Overall Study|Need of additional treatment|0
2635703|NCT00818623|9106860|P1|Overall Study|Need of additional treatment|0
2635704|NCT00818623|9106853|P8|Overall Study|Protocol Violation|0
2635705|NCT00818623|9106854|P7|Overall Study|Protocol Violation|1
2635706|NCT00818623|9106855|P6|Overall Study|Protocol Violation|0
2635707|NCT00818623|9106856|P5|Overall Study|Protocol Violation|1
2635708|NCT00818623|9106857|P4|Overall Study|Protocol Violation|0
2635709|NCT00818623|9106858|P3|Overall Study|Protocol Violation|0
2635710|NCT00818623|9106859|P2|Overall Study|Protocol Violation|0
2635711|NCT00818623|9106860|P1|Overall Study|Protocol Violation|1
2635712|NCT00818623|9106853|P8|Overall Study|Withdrawal by Subject|1
2635713|NCT00818623|9106854|P7|Overall Study|Withdrawal by Subject|1
2635714|NCT00818623|9106855|P6|Overall Study|Withdrawal by Subject|1
2635715|NCT00818623|9106856|P5|Overall Study|Withdrawal by Subject|0
2635716|NCT00818623|9106857|P4|Overall Study|Withdrawal by Subject|0
2635717|NCT00818623|9106858|P3|Overall Study|Withdrawal by Subject|1
2635718|NCT00818623|9106859|P2|Overall Study|Withdrawal by Subject|1
2635719|NCT00818623|9106860|P1|Overall Study|Withdrawal by Subject|0
2635720|NCT00818623|9106853|P8|Overall Study|Bad prostate specific antigen response|0
2635721|NCT00818623|9106854|P7|Overall Study|Bad prostate specific antigen response|0
2635722|NCT00818623|9106855|P6|Overall Study|Bad prostate specific antigen response|1
2635723|NCT00818623|9106856|P5|Overall Study|Bad prostate specific antigen response|0
2635724|NCT00818623|9106857|P4|Overall Study|Bad prostate specific antigen response|5
2635725|NCT00818623|9106858|P3|Overall Study|Bad prostate specific antigen response|2
2635726|NCT00818623|9106859|P2|Overall Study|Bad prostate specific antigen response|3
2635727|NCT00818623|9106860|P1|Overall Study|Bad prostate specific antigen response|0
2635728|NCT00818623|9106853|P8|Overall Study|Adverse Event|0
2635729|NCT00818623|9106854|P7|Overall Study|Adverse Event|0
2635730|NCT00818623|9106855|P6|Overall Study|Adverse Event|1
2635731|NCT00818623|9106856|P5|Overall Study|Adverse Event|0
2635732|NCT00818623|9106857|P4|Overall Study|Adverse Event|0
2635733|NCT00818623|9106858|P3|Overall Study|Adverse Event|1
2635734|NCT00818623|9106859|P2|Overall Study|Adverse Event|0
2635735|NCT00818623|9106860|P1|Overall Study|Adverse Event|1
2635736|NCT00818519|9106936|P2|Overall Study|participant will leave for long tme|0
2635737|NCT00818519|9106937|P1|Overall Study|participant will leave for long tme|1
2635738|NCT00818519|9106936|P2|Overall Study|participant recovered completely|0
2635739|NCT00818519|9106937|P1|Overall Study|participant recovered completely|1
2635740|NCT00818519|9106936|P2|Overall Study|Withdrawal by Subject|9
2635741|NCT00818519|9106937|P1|Overall Study|Withdrawal by Subject|4
2635742|NCT00818519|9106936|P2|Overall Study|Pregnancy|1
2635743|NCT00818519|9106937|P1|Overall Study|Pregnancy|0
2635744|NCT00818519|9106936|P2|Overall Study|Protocol Violation|1
2635745|NCT00818519|9106937|P1|Overall Study|Protocol Violation|2
2635746|NCT00818519|9106936|P2|Overall Study|Lost to Follow-up|6
2635747|NCT00818519|9106937|P1|Overall Study|Lost to Follow-up|4
2635748|NCT00818519|9106936|P2|Overall Study|Adverse Event|2
2635749|NCT00818519|9106937|P1|Overall Study|Adverse Event|2
2635750|NCT00818454|9106967|P4|Treatment Period 3|Adverse Event|1
2635751|NCT00818454|9106968|P3|Treatment Period 3|Adverse Event|0
2635752|NCT00818454|9106969|P2|Treatment Period 3|Adverse Event|0
2635753|NCT00818454|9106970|P1|Treatment Period 3|Adverse Event|0
2635754|NCT00818454|9106967|P4|Treatment Period 2|Other|0
2635755|NCT00818454|9106968|P3|Treatment Period 2|Other|0
2635756|NCT00818454|9106969|P2|Treatment Period 2|Other|1
2635757|NCT00818454|9106970|P1|Treatment Period 2|Other|2
2635758|NCT00818454|9106967|P4|Washout Period of 1 Week|Other|0
2635759|NCT00818454|9106968|P3|Washout Period of 1 Week|Other|0
2635760|NCT00818454|9106969|P2|Washout Period of 1 Week|Other|2
2635761|NCT00818454|9106970|P1|Washout Period of 1 Week|Other|1
2635762|NCT00818454|9106967|P4|Washout Period of 1 Week|Protocol Violation|0
2635763|NCT00818454|9106968|P3|Washout Period of 1 Week|Protocol Violation|0
2635764|NCT00818454|9106969|P2|Washout Period of 1 Week|Protocol Violation|0
2635765|NCT00818454|9106970|P1|Washout Period of 1 Week|Protocol Violation|2
2635766|NCT00818454|9106967|P4|Washout Period of 1 Week|Adverse Event|0
2635767|NCT00818454|9106968|P3|Washout Period of 1 Week|Adverse Event|0
2635768|NCT00818454|9106969|P2|Washout Period of 1 Week|Adverse Event|1
2635769|NCT00818454|9106970|P1|Washout Period of 1 Week|Adverse Event|1
2635770|NCT00818454|9106967|P4|Treatment Period 1|Other|0
2635771|NCT00818454|9106968|P3|Treatment Period 1|Other|0
2635772|NCT00818454|9106969|P2|Treatment Period 1|Other|0
2635773|NCT00818454|9106970|P1|Treatment Period 1|Other|3
2635774|NCT00818454|9106967|P4|Treatment Period 1|Adverse Event|0
2635775|NCT00818454|9106968|P3|Treatment Period 1|Adverse Event|0
2635776|NCT00818454|9106969|P2|Treatment Period 1|Adverse Event|1
2635777|NCT00818454|9106970|P1|Treatment Period 1|Adverse Event|0
2635778|NCT00818441|9106998|P2|Overall Study|Study terminated by sponsor|2
2635779|NCT00818441|9106999|P1|Overall Study|Study terminated by sponsor|11
2635780|NCT00818441|9106998|P2|Overall Study|Adverse Event|1
2635781|NCT00818441|9106999|P1|Overall Study|Adverse Event|0
2635782|NCT00818441|9106998|P2|Overall Study|Withdrawal by Subject|0
2635783|NCT00818441|9106999|P1|Overall Study|Withdrawal by Subject|2
2635784|NCT00818441|9106998|P2|Overall Study|Lost to Follow-up|1
2635785|NCT00818441|9106999|P1|Overall Study|Lost to Follow-up|2
2635786|NCT00818441|9106998|P2|Overall Study|Other|0
2635787|NCT00818441|9106999|P1|Overall Study|Other|5
2635788|NCT00818441|9106998|P2|Overall Study|Death|26
2635789|NCT00818441|9106999|P1|Overall Study|Death|69
2635790|NCT00818389|9107021|P2|Overall Study|Adverse Event|1
2635791|NCT00818389|9107022|P1|Overall Study|Adverse Event|0
2635792|NCT00818389|9107021|P2|Overall Study|Withdrawal by Subject|2
2635793|NCT00818389|9107022|P1|Overall Study|Withdrawal by Subject|2
2635794|NCT00818389|9107021|P2|Overall Study|ALS Disease Progression|0
2635795|NCT00818389|9107022|P1|Overall Study|ALS Disease Progression|1
2635796|NCT00818389|9107021|P2|Overall Study|Death|3
2635797|NCT00818389|9107022|P1|Overall Study|Death|1
2635798|NCT00818259|9107057|P9|Part V|Adverse Event|0
2635799|NCT00818259|9107058|P8|Part V|Adverse Event|1
2635800|NCT00818259|9107059|P7|Part V|Adverse Event|0
2635801|NCT00818259|9107060|P6|Part V|Adverse Event|0
2635802|NCT00818259|9107061|P5|Part V|Adverse Event|0
2635803|NCT00818259|9107062|P4|Part V|Adverse Event|0
2635804|NCT00818259|9107063|P3|Part V|Adverse Event|0
2635805|NCT00818259|9107064|P2|Part V|Adverse Event|0
2635806|NCT00818259|9107065|P1|Part V|Adverse Event|0
2635807|NCT00818259|9107057|P9|Part IV|Physician Decision|0
2635808|NCT00818259|9107058|P8|Part IV|Physician Decision|0
2635809|NCT00818259|9107059|P7|Part IV|Physician Decision|0
2635810|NCT00818259|9107060|P6|Part IV|Physician Decision|1
2635811|NCT00818259|9107061|P5|Part IV|Physician Decision|0
2635812|NCT00818259|9107062|P4|Part IV|Physician Decision|0
2635813|NCT00818259|9107063|P3|Part IV|Physician Decision|0
2635814|NCT00818259|9107064|P2|Part IV|Physician Decision|0
2635815|NCT00818259|9107065|P1|Part IV|Physician Decision|0
2635816|NCT00818259|9107057|P9|Part II|Not Treated|0
2635817|NCT00818259|9107058|P8|Part II|Not Treated|0
2635818|NCT00818259|9107059|P7|Part II|Not Treated|0
2635819|NCT00818259|9107060|P6|Part II|Not Treated|0
2635820|NCT00818259|9107061|P5|Part II|Not Treated|0
2635821|NCT00818259|9107062|P4|Part II|Not Treated|1
2635822|NCT00818259|9107063|P3|Part II|Not Treated|0
2635823|NCT00818259|9107064|P2|Part II|Not Treated|0
2635824|NCT00818259|9107065|P1|Part II|Not Treated|0
2635825|NCT00818259|9107057|P9|Part II|Lack of Efficacy|0
2635826|NCT00818259|9107058|P8|Part II|Lack of Efficacy|0
2635827|NCT00818259|9107059|P7|Part II|Lack of Efficacy|0
2635828|NCT00818259|9107060|P6|Part II|Lack of Efficacy|0
2635829|NCT00818259|9107061|P5|Part II|Lack of Efficacy|0
2635830|NCT00818259|9107062|P4|Part II|Lack of Efficacy|1
2635831|NCT00818259|9107063|P3|Part II|Lack of Efficacy|0
2635832|NCT00818259|9107064|P2|Part II|Lack of Efficacy|0
2635833|NCT00818259|9107065|P1|Part II|Lack of Efficacy|0
2635834|NCT00818259|9107057|P9|Part II|Physician Decision|0
2635835|NCT00818259|9107058|P8|Part II|Physician Decision|0
2635836|NCT00818259|9107059|P7|Part II|Physician Decision|0
2635837|NCT00818259|9107060|P6|Part II|Physician Decision|0
2635838|NCT00818259|9107061|P5|Part II|Physician Decision|0
2635839|NCT00818259|9107062|P4|Part II|Physician Decision|0
2635840|NCT00818259|9107063|P3|Part II|Physician Decision|1
2635841|NCT00818259|9107064|P2|Part II|Physician Decision|0
2635842|NCT00818259|9107065|P1|Part II|Physician Decision|0
2635843|NCT00818259|9107057|P9|Part I|Withdrawal by Subject|0
2635844|NCT00818259|9107058|P8|Part I|Withdrawal by Subject|0
2635845|NCT00818259|9107059|P7|Part I|Withdrawal by Subject|0
2635846|NCT00818259|9107060|P6|Part I|Withdrawal by Subject|0
2635847|NCT00818259|9107061|P5|Part I|Withdrawal by Subject|0
2635848|NCT00818259|9107062|P4|Part I|Withdrawal by Subject|0
2635849|NCT00818259|9107063|P3|Part I|Withdrawal by Subject|0
2635850|NCT00818259|9107064|P2|Part I|Withdrawal by Subject|0
2635851|NCT00818259|9107065|P1|Part I|Withdrawal by Subject|1
2635852|NCT00818246|9107137|P1|Overall Study|Impossible to match pictures|5
2635853|NCT00818207|9107146|P2|Overall Study|Death|5
2635854|NCT00818207|9107147|P1|Overall Study|Death|3
2635855|NCT00818207|9107146|P2|Overall Study|Withdrawal by Subject|104
2635856|NCT00818207|9107147|P1|Overall Study|Withdrawal by Subject|42
2635857|NCT00818207|9107146|P2|Overall Study|Multiple reasons|12
2635858|NCT00818207|9107147|P1|Overall Study|Multiple reasons|11
2635859|NCT00818207|9107146|P2|Overall Study|Lost to Follow-up|146
2635860|NCT00818207|9107147|P1|Overall Study|Lost to Follow-up|160
2635861|NCT00818207|9107146|P2|Overall Study|Adverse Event|0
2635862|NCT00818207|9107147|P1|Overall Study|Adverse Event|6
2635863|NCT00818168|9107161|P1|Overall Study|Participant Moved|2
2635864|NCT00818168|9107161|P1|Overall Study|Reason for Non-completion Not reported|6
2635865|NCT00818168|9107161|P1|Overall Study|Adverse Event|19
2635866|NCT00818168|9107161|P1|Overall Study|Lost to Follow-up|7
2635867|NCT00818168|9107161|P1|Overall Study|Withdrawal by Subject|16
2635868|NCT00818168|9107161|P1|Overall Study|Pregnancy|2
2635869|NCT00818168|9107161|P1|Overall Study|Lack of Efficacy|18
2635870|NCT00817778|9107201|P2|Overall Study|Poor venous access|0
2635871|NCT00817778|9107202|P1|Overall Study|Poor venous access|1
2635872|NCT00817778|9107201|P2|Overall Study|Study-specific discontinuation criteria|1
2635873|NCT00817778|9107202|P1|Overall Study|Study-specific discontinuation criteria|0
2635874|NCT00817778|9107201|P2|Overall Study|Protocol Violation|1
2635875|NCT00817778|9107202|P1|Overall Study|Protocol Violation|0
2635876|NCT00817778|9107201|P2|Overall Study|Withdrawal by Subject|1
2635877|NCT00817778|9107202|P1|Overall Study|Withdrawal by Subject|1
2635878|NCT00817778|9107201|P2|Overall Study|Adverse Event|0
2635879|NCT00817778|9107202|P1|Overall Study|Adverse Event|1
2635880|NCT00817531|9107231|P1|Overall Study|Lack of Efficacy|1
2635881|NCT00817531|9107231|P1|Overall Study|Adverse Event|1
2635882|NCT00817479|9107237|P2|Overall Study|Physician Decision|1
2635883|NCT00817479|9107238|P1|Overall Study|Physician Decision|1
2635884|NCT00817336|9107248|P2|Overall Study|Withdrawal by Subject|1
2635885|NCT00817336|9107249|P1|Overall Study|Withdrawal by Subject|1
2635886|NCT00817206|9107275|P2|Overall Study|Physician Decision|0
2635887|NCT00817206|9107276|P1|Overall Study|Physician Decision|2
2635888|NCT00817206|9107275|P2|Overall Study|Withdrawal by Subject|3
2635889|NCT00817206|9107276|P1|Overall Study|Withdrawal by Subject|7
2635890|NCT00817206|9107275|P2|Overall Study|Death|0
2635891|NCT00817206|9107276|P1|Overall Study|Death|2
2635892|NCT00817206|9107275|P2|Overall Study|Lost to Follow-up|1
2635893|NCT00817206|9107276|P1|Overall Study|Lost to Follow-up|0
2635894|NCT00817206|9107275|P2|Overall Study|Protocol Violation|2
2635895|NCT00817206|9107276|P1|Overall Study|Protocol Violation|0
2635896|NCT00817206|9107275|P2|Overall Study|Adverse Event|3
2635897|NCT00817206|9107276|P1|Overall Study|Adverse Event|10
2635898|NCT00817089|9107286|P4|Second Alcohol Challenge|Lost to Follow-up|0
2635899|NCT00817089|9107287|P3|Second Alcohol Challenge|Lost to Follow-up|0
2635900|NCT00817089|9107288|P2|Second Alcohol Challenge|Lost to Follow-up|1
2635901|NCT00817089|9107289|P1|Second Alcohol Challenge|Lost to Follow-up|0
2635902|NCT00817089|9107286|P4|First Alcohol Challenge|Lost to Follow-up|1
2635903|NCT00817089|9107287|P3|First Alcohol Challenge|Lost to Follow-up|0
2635904|NCT00817089|9107288|P2|First Alcohol Challenge|Lost to Follow-up|0
2635905|NCT00817089|9107289|P1|First Alcohol Challenge|Lost to Follow-up|0
2635906|NCT00817063|9107305|P2|Overall Study|Abnormality of Laboratory Test|1
2635907|NCT00817063|9107306|P1|Overall Study|Abnormality of Laboratory Test|2
2635908|NCT00817063|9107305|P2|Overall Study|Administrative|4
2635909|NCT00817063|9107306|P1|Overall Study|Administrative|10
2635910|NCT00817063|9107305|P2|Overall Study|Early Improvement|4
2635911|NCT00817063|9107306|P1|Overall Study|Early Improvement|19
2635912|NCT00817063|9107305|P2|Overall Study|Withdrawal by Subject|37
2635913|NCT00817063|9107306|P1|Overall Study|Withdrawal by Subject|17
2635914|NCT00817063|9107305|P2|Overall Study|Protocol Violation|8
2635915|NCT00817063|9107306|P1|Overall Study|Protocol Violation|3
2635916|NCT00817063|9107305|P2|Overall Study|Violation of Selection at Entry|4
2635917|NCT00817063|9107306|P1|Overall Study|Violation of Selection at Entry|7
2635918|NCT00817063|9107305|P2|Overall Study|Failure to Return|12
2635919|NCT00817063|9107306|P1|Overall Study|Failure to Return|13
2635920|NCT00817063|9107305|P2|Overall Study|Lack of Efficacy|86
2635921|NCT00817063|9107306|P1|Overall Study|Lack of Efficacy|33
2635922|NCT00817063|9107305|P2|Overall Study|Death|1
2635923|NCT00817063|9107306|P1|Overall Study|Death|1
2635924|NCT00817063|9107305|P2|Overall Study|Adverse Event|13
2635925|NCT00817063|9107306|P1|Overall Study|Adverse Event|32
2635926|NCT00816595|9107434|P2|Overall Study|Withdrawal by Subject|0
2635927|NCT00816595|9107435|P1|Overall Study|Withdrawal by Subject|2
2635928|NCT00816556|9107448|P3|Overall Study|Lost to Follow-up|1
2635929|NCT00816556|9107449|P2|Overall Study|Lost to Follow-up|0
2635930|NCT00816556|9107450|P1|Overall Study|Lost to Follow-up|0
2635931|NCT00816556|9107448|P3|Overall Study|Withdrawal by Subject|1
2635932|NCT00816556|9107449|P2|Overall Study|Withdrawal by Subject|1
2635933|NCT00816556|9107450|P1|Overall Study|Withdrawal by Subject|1
2635934|NCT00816556|9107448|P3|Overall Study|Adverse Event|1
2635935|NCT00816556|9107449|P2|Overall Study|Adverse Event|1
2635936|NCT00816556|9107450|P1|Overall Study|Adverse Event|1
2635937|NCT00816400|9107473|P9|Overall Study|In hospice care at the end of the study|0
2635938|NCT00816400|9107474|P8|Overall Study|In hospice care at the end of the study|0
2635939|NCT00816400|9107475|P7|Overall Study|In hospice care at the end of the study|0
2635940|NCT00816400|9107476|P6|Overall Study|In hospice care at the end of the study|0
2635941|NCT00816400|9107477|P5|Overall Study|In hospice care at the end of the study|0
2635942|NCT00816400|9107478|P4|Overall Study|In hospice care at the end of the study|0
2635943|NCT00816400|9107479|P3|Overall Study|In hospice care at the end of the study|2
2635944|NCT00816400|9107480|P2|Overall Study|In hospice care at the end of the study|0
2635945|NCT00816400|9107481|P1|Overall Study|In hospice care at the end of the study|0
2635946|NCT00816400|9107473|P9|Overall Study|Death|6
2635947|NCT00816400|9107474|P8|Overall Study|Death|5
2635948|NCT00816400|9107475|P7|Overall Study|Death|2
2635949|NCT00816400|9107476|P6|Overall Study|Death|3
2635950|NCT00816400|9107477|P5|Overall Study|Death|2
2635951|NCT00816400|9107478|P4|Overall Study|Death|3
2635952|NCT00816400|9107479|P3|Overall Study|Death|3
2635953|NCT00816400|9107480|P2|Overall Study|Death|3
2635954|NCT00816400|9107481|P1|Overall Study|Death|2
2635955|NCT00816361|9107672|P9|Overall Study|Other|1
2635956|NCT00816361|9107673|P8|Overall Study|Other|0
2635957|NCT00816361|9107674|P7|Overall Study|Other|0
2635958|NCT00816361|9107675|P6|Overall Study|Other|0
2635959|NCT00816361|9107676|P5|Overall Study|Other|0
2635960|NCT00816361|9107677|P4|Overall Study|Other|0
2635961|NCT00816361|9107678|P3|Overall Study|Other|0
2635962|NCT00816361|9107679|P2|Overall Study|Other|0
2635963|NCT00816361|9107680|P1|Overall Study|Other|0
2635964|NCT00816361|9107672|P9|Overall Study|Death|8
2635965|NCT00816361|9107673|P8|Overall Study|Death|7
2635966|NCT00816361|9107674|P7|Overall Study|Death|3
2635967|NCT00816361|9107675|P6|Overall Study|Death|1
2635968|NCT00816361|9107676|P5|Overall Study|Death|1
2635969|NCT00816361|9107677|P4|Overall Study|Death|3
2635970|NCT00816361|9107678|P3|Overall Study|Death|3
2635971|NCT00816361|9107679|P2|Overall Study|Death|3
2635972|NCT00816361|9107680|P1|Overall Study|Death|4
2635973|NCT00816361|9107672|P9|Overall Study|Withdrawal by Subject|1
2635974|NCT00816361|9107673|P8|Overall Study|Withdrawal by Subject|2
2635975|NCT00816361|9107674|P7|Overall Study|Withdrawal by Subject|0
2635976|NCT00816361|9107675|P6|Overall Study|Withdrawal by Subject|2
2635977|NCT00816361|9107676|P5|Overall Study|Withdrawal by Subject|1
2635978|NCT00816361|9107677|P4|Overall Study|Withdrawal by Subject|0
2635979|NCT00816361|9107678|P3|Overall Study|Withdrawal by Subject|0
2635980|NCT00816361|9107679|P2|Overall Study|Withdrawal by Subject|0
2635981|NCT00816361|9107680|P1|Overall Study|Withdrawal by Subject|0
2635982|NCT00816166|9107839|P2|Overall Study|Death|2
2635983|NCT00816166|9107840|P1|Overall Study|Death|4
2635984|NCT00816166|9107839|P2|Overall Study|Lost to Follow-up|10
2635985|NCT00816166|9107840|P1|Overall Study|Lost to Follow-up|6
2635986|NCT00816036|9107872|P2|Overall Study|Withdrawal by Subject|23
2635987|NCT00816036|9107873|P1|Overall Study|Withdrawal by Subject|54
2635988|NCT00816036|9107872|P2|Overall Study|Lost to Follow-up|57
2635989|NCT00816036|9107873|P1|Overall Study|Lost to Follow-up|75
2635990|NCT00816036|9107872|P2|Overall Study|Death|28
2635991|NCT00816036|9107873|P1|Overall Study|Death|47
2635992|NCT00816023|9107887|P4|Overall Study|Randomized Not Treated|11
2635993|NCT00816023|9107888|P3|Overall Study|Randomized Not Treated|6
2635994|NCT00816023|9107889|P2|Overall Study|Randomized Not Treated|4
2635995|NCT00816023|9107890|P1|Overall Study|Randomized Not Treated|6
2635996|NCT00816023|9107887|P4|Overall Study|assessments complete prior to window|1
2635997|NCT00816023|9107888|P3|Overall Study|assessments complete prior to window|2
2635998|NCT00816023|9107889|P2|Overall Study|assessments complete prior to window|1
2635999|NCT00816023|9107890|P1|Overall Study|assessments complete prior to window|1
2636000|NCT00816023|9107887|P4|Overall Study|Physician Decision|0
2636001|NCT00816023|9107888|P3|Overall Study|Physician Decision|1
2636002|NCT00816023|9107889|P2|Overall Study|Physician Decision|0
2636003|NCT00816023|9107890|P1|Overall Study|Physician Decision|0
2636004|NCT00816023|9107887|P4|Overall Study|Withdrawal by Subject|0
2636005|NCT00816023|9107888|P3|Overall Study|Withdrawal by Subject|0
2636006|NCT00816023|9107889|P2|Overall Study|Withdrawal by Subject|0
2636007|NCT00816023|9107890|P1|Overall Study|Withdrawal by Subject|1
2636008|NCT00816023|9107887|P4|Overall Study|Lost to Follow-up|0
2636009|NCT00816023|9107888|P3|Overall Study|Lost to Follow-up|0
2636010|NCT00816023|9107889|P2|Overall Study|Lost to Follow-up|1
2636011|NCT00816023|9107890|P1|Overall Study|Lost to Follow-up|1
2636012|NCT00815919|9107927|P1|Overall Study|Lack of Efficacy|2
2636013|NCT00815919|9107927|P1|Overall Study|AML Relapse|1
2636014|NCT00815919|9107927|P1|Overall Study|Unrelated Fungal Infection|1
2636015|NCT00815659|9107970|P1|Overall Study|Protocol Violation|1
2636016|NCT00815659|9107970|P1|Overall Study|Lost to Follow-up|4
2636017|NCT00815659|9107970|P1|Overall Study|Withdrawal by Subject|9
2636018|NCT00815659|9107970|P1|Overall Study|Adverse Event|9
2636019|NCT00815633|9108013|P1|Overall Study|study terminated|1
2636020|NCT00815516|9108020|P2|Overall Study|Physician Decision|0
2636021|NCT00815516|9108021|P1|Overall Study|Physician Decision|1
2636022|NCT00815516|9108020|P2|Overall Study|Death|1
2636023|NCT00815516|9108021|P1|Overall Study|Death|3
2636024|NCT00815308|9108086|P1|Overall Study|Protocol Violation|6
2636025|NCT00815308|9108086|P1|Overall Study|Withdrawal by Subject|0
2636026|NCT00815308|9108086|P1|Overall Study|Adverse Event|4
2636027|NCT00815295|9108095|P3|Overall Study|Cetuximab hypersensitivity reaction|3
2636028|NCT00815295|9108096|P2|Overall Study|Cetuximab hypersensitivity reaction|1
2636029|NCT00815295|9108097|P1|Overall Study|Cetuximab hypersensitivity reaction|0
2636030|NCT00815191|9108109|P2|Overall Study|Protocol Violation|1
2636031|NCT00815191|9108110|P1|Overall Study|Protocol Violation|1
2636032|NCT00814983|9108147|P2|Overall Study|Graft failure|0
2636033|NCT00814983|9108148|P1|Overall Study|Graft failure|1
2636034|NCT00814983|9108147|P2|Overall Study|Withdrawal by Subject|0
2636035|NCT00814983|9108148|P1|Overall Study|Withdrawal by Subject|1
2636036|NCT00814983|9108147|P2|Overall Study|Screen failure|0
2636037|NCT00814983|9108148|P1|Overall Study|Screen failure|1
2636038|NCT00814892|9108179|P1|Overall Study|Study Termination|1
2636039|NCT00814892|9108179|P1|Overall Study|Disease Progression|1
2636040|NCT00814879|9108191|P2|By Week 48|Death|1
2636041|NCT00814879|9108192|P1|By Week 48|Death|0
2636042|NCT00814879|9108191|P2|By Week 48|Lost to Follow-up|2
2636043|NCT00814879|9108192|P1|By Week 48|Lost to Follow-up|2
2636044|NCT00814879|9108191|P2|By Week 24|Incarceration|1
2636045|NCT00814879|9108192|P1|By Week 24|Incarceration|0
2636046|NCT00814879|9108191|P2|By Week 24|Cancer Diagnosis|0
2636047|NCT00814879|9108192|P1|By Week 24|Cancer Diagnosis|1
2636048|NCT00814801|9108211|P3|Overall Study|Other|4
2636049|NCT00814801|9108212|P2|Overall Study|Other|6
2636050|NCT00814801|9108213|P1|Overall Study|Other|2
2636051|NCT00814801|9108211|P3|Overall Study|Non-compliance|1
2636052|NCT00814801|9108212|P2|Overall Study|Non-compliance|1
2636053|NCT00814801|9108213|P1|Overall Study|Non-compliance|0
2636054|NCT00814801|9108211|P3|Overall Study|Missing or change of caregiver|4
2636055|NCT00814801|9108212|P2|Overall Study|Missing or change of caregiver|2
2636056|NCT00814801|9108213|P1|Overall Study|Missing or change of caregiver|6
2636057|NCT00814801|9108211|P3|Overall Study|Change of patients for CIBIC plus-J|0
2636058|NCT00814801|9108212|P2|Overall Study|Change of patients for CIBIC plus-J|1
2636059|NCT00814801|9108213|P1|Overall Study|Change of patients for CIBIC plus-J|1
2636060|NCT00814801|9108211|P3|Overall Study|Inappropriate as a subject|1
2636061|NCT00814801|9108212|P2|Overall Study|Inappropriate as a subject|1
2636062|NCT00814801|9108213|P1|Overall Study|Inappropriate as a subject|1
2636063|NCT00814801|9108211|P3|Overall Study|Withdrawal by Subject|14
2636064|NCT00814801|9108212|P2|Overall Study|Withdrawal by Subject|11
2636065|NCT00814801|9108213|P1|Overall Study|Withdrawal by Subject|9
2636066|NCT00814801|9108211|P3|Overall Study|Adverse Event|19
2636067|NCT00814801|9108212|P2|Overall Study|Adverse Event|16
2636068|NCT00814801|9108213|P1|Overall Study|Adverse Event|15
2636069|NCT00814710|9108252|P2|Overall Study|Lost to Follow-up|3
2636070|NCT00814710|9108253|P1|Overall Study|Lost to Follow-up|7
2636071|NCT00814710|9108252|P2|Overall Study|Adverse Event|0
2636072|NCT00814710|9108253|P1|Overall Study|Adverse Event|1
2636073|NCT00814658|9108321|P2|Overall Study|Adverse Event|3
2636074|NCT00814658|9108322|P1|Overall Study|Adverse Event|3
2636075|NCT00814658|9108321|P2|Overall Study|Physician Decision|0
2636076|NCT00814658|9108322|P1|Overall Study|Physician Decision|1
2636077|NCT00814658|9108321|P2|Overall Study|Lost to Follow-up|1
2636078|NCT00814658|9108322|P1|Overall Study|Lost to Follow-up|0
2636079|NCT00814632|9108388|P1|Overall Study|Lack of Efficacy|2
2636080|NCT00814580|9108394|P2|Overall Study|Did Not Take Drug|2
2636081|NCT00814580|9108395|P1|Overall Study|Did Not Take Drug|2
2636082|NCT00814580|9108394|P2|Overall Study|Other|3
2636083|NCT00814580|9108395|P1|Overall Study|Other|1
2636084|NCT00814580|9108394|P2|Overall Study|Withdrawal by Subject|2
2636085|NCT00814580|9108395|P1|Overall Study|Withdrawal by Subject|2
2636086|NCT00814580|9108394|P2|Overall Study|Protocol Violation|0
2636087|NCT00814580|9108395|P1|Overall Study|Protocol Violation|2
2636088|NCT00814580|9108394|P2|Overall Study|Lack of Efficacy|25
2636089|NCT00814580|9108395|P1|Overall Study|Lack of Efficacy|18
2636090|NCT00814580|9108394|P2|Overall Study|Adverse Event|15
2636091|NCT00814580|9108395|P1|Overall Study|Adverse Event|6
2636092|NCT00814502|9108525|P2|Overall Study|Withdrawal by Subject|2
2636093|NCT00814502|9108526|P1|Overall Study|Withdrawal by Subject|0
2636094|NCT00814502|9108525|P2|Overall Study|Adverse Event|0
2636095|NCT00814502|9108526|P1|Overall Study|Adverse Event|1
2636096|NCT00814489|9108539|P3|Overall Study|Other|1
2636097|NCT00814489|9108540|P2|Overall Study|Other|0
2636098|NCT00814489|9108541|P1|Overall Study|Other|2
2636099|NCT00814463|9108573|P1|Overall Study|Lost to Follow-up|1
2636100|NCT00814346|9108586|P2|Open Phase (17 Months)|Not otherwise specified|0
2636101|NCT00814346|9108587|P1|Open Phase (17 Months)|Not otherwise specified|1
2636102|NCT00814346|9108586|P2|Open Phase (17 Months)|Lost to Follow-up|0
2636103|NCT00814346|9108587|P1|Open Phase (17 Months)|Lost to Follow-up|2
2636104|NCT00814346|9108586|P2|Open Phase (17 Months)|Consent|0
2636105|NCT00814346|9108587|P1|Open Phase (17 Months)|Consent|2
2636106|NCT00814346|9108586|P2|Open Phase (17 Months)|Adverse Event|0
2636107|NCT00814346|9108587|P1|Open Phase (17 Months)|Adverse Event|5
2636108|NCT00814346|9108586|P2|Double-blind Phase (4 Weeks)|Not otherwise specified|2
2636109|NCT00814346|9108587|P1|Double-blind Phase (4 Weeks)|Not otherwise specified|0
2636110|NCT00814346|9108586|P2|Double-blind Phase (4 Weeks)|Adverse Event|1
2636111|NCT00814346|9108587|P1|Double-blind Phase (4 Weeks)|Adverse Event|0
2636112|NCT00814333|9108653|P2|Enrollment|Lost to Follow-up|0
2636113|NCT00814333|9108654|P1|Enrollment|Lost to Follow-up|1
2636114|NCT00814320|9108662|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3
2636115|NCT00814320|9108663|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0
2636116|NCT00814320|9108662|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1
2636117|NCT00814320|9108663|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0
2636366|NCT00813150|9109439|P1|Long Term Follow-up|Lost to Follow-up|2
2636118|NCT00814320|9108662|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1
2636119|NCT00814320|9108663|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0
2636120|NCT00814320|9108662|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1
2636121|NCT00814320|9108663|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2
2636122|NCT00814320|9108662|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4
2636123|NCT00814320|9108663|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1
2636124|NCT00814320|9108662|P2|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0
2636125|NCT00814320|9108663|P1|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1
2636126|NCT00814320|9108662|P2|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0
2636127|NCT00814320|9108663|P1|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1
2636128|NCT00814320|9108662|P2|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1
2636129|NCT00814320|9108663|P1|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0
2636130|NCT00814320|9108662|P2|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2
2636131|NCT00814320|9108663|P1|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0
2636132|NCT00814320|9108662|P2|Epoch 1 (IV Treatment)|Withdrawal by Subject|0
2636133|NCT00814320|9108663|P1|Epoch 1 (IV Treatment)|Withdrawal by Subject|1
2636134|NCT00814307|9108795|P4|Overall Study|Death|0
2636135|NCT00814307|9108796|P3|Overall Study|Death|0
2636136|NCT00814307|9108797|P2|Overall Study|Death|1
2636137|NCT00814307|9108798|P1|Overall Study|Death|0
2636138|NCT00814307|9108795|P4|Overall Study|Withdrawal by Subject|2
2636139|NCT00814307|9108796|P3|Overall Study|Withdrawal by Subject|0
2636140|NCT00814307|9108797|P2|Overall Study|Withdrawal by Subject|6
2636141|NCT00814307|9108798|P1|Overall Study|Withdrawal by Subject|4
2636142|NCT00814307|9108795|P4|Overall Study|Protocol Violation|1
2636143|NCT00814307|9108796|P3|Overall Study|Protocol Violation|1
2636144|NCT00814307|9108797|P2|Overall Study|Protocol Violation|8
2636145|NCT00814307|9108798|P1|Overall Study|Protocol Violation|2
2636146|NCT00814307|9108795|P4|Overall Study|Other|1
2636147|NCT00814307|9108796|P3|Overall Study|Other|0
2636148|NCT00814307|9108797|P2|Overall Study|Other|2
2636149|NCT00814307|9108798|P1|Overall Study|Other|1
2636150|NCT00814307|9108795|P4|Overall Study|Lack of Efficacy|4
2636151|NCT00814307|9108796|P3|Overall Study|Lack of Efficacy|3
2636152|NCT00814307|9108797|P2|Overall Study|Lack of Efficacy|1
2636153|NCT00814307|9108798|P1|Overall Study|Lack of Efficacy|1
2636154|NCT00814307|9108795|P4|Overall Study|Adverse Event|2
2636155|NCT00814307|9108796|P3|Overall Study|Adverse Event|3
2636156|NCT00814307|9108797|P2|Overall Study|Adverse Event|9
2636157|NCT00814307|9108798|P1|Overall Study|Adverse Event|3
2636158|NCT00814307|9108795|P4|Overall Study|Randomized but not treated|0
2636159|NCT00814307|9108796|P3|Overall Study|Randomized but not treated|0
2636160|NCT00814307|9108797|P2|Overall Study|Randomized but not treated|0
2636161|NCT00814307|9108798|P1|Overall Study|Randomized but not treated|1
2636162|NCT00814164|9108994|P1|Overall Study|Death|5
2636163|NCT00814164|9108994|P1|Overall Study|not stated|7
2636164|NCT00814164|9108994|P1|Overall Study|Progression|7
2636165|NCT00813995|9109028|P2|Overall Study|Withdrawal by Subject|5
2636166|NCT00813995|9109029|P1|Overall Study|Withdrawal by Subject|0
2636167|NCT00813995|9109028|P2|Overall Study|Subject moved|0
2636168|NCT00813995|9109029|P1|Overall Study|Subject moved|4
2636169|NCT00813995|9109028|P2|Overall Study|Protocol Violation|2
2636170|NCT00813995|9109029|P1|Overall Study|Protocol Violation|3
2636171|NCT00813995|9109028|P2|Overall Study|Other reason|2
2636172|NCT00813995|9109029|P1|Overall Study|Other reason|2
2636173|NCT00813995|9109028|P2|Overall Study|Lost to Follow-up|2
2636174|NCT00813995|9109029|P1|Overall Study|Lost to Follow-up|4
2636175|NCT00813995|9109028|P2|Overall Study|Lack of Efficacy|0
2636176|NCT00813995|9109029|P1|Overall Study|Lack of Efficacy|1
2636177|NCT00813995|9109028|P2|Overall Study|Laboratory adverse event|2
2636178|NCT00813995|9109029|P1|Overall Study|Laboratory adverse event|0
2636179|NCT00813995|9109028|P2|Overall Study|Clinical adverse event|3
2636180|NCT00813995|9109029|P1|Overall Study|Clinical adverse event|9
2636181|NCT00813943|9109052|P3|Overall Study|Ongoing at cut-off date|3
2636182|NCT00813943|9109053|P2|Overall Study|Ongoing at cut-off date|5
2636183|NCT00813943|9109054|P1|Overall Study|Ongoing at cut-off date|5
2636184|NCT00813917|9109084|P2|Overall Study|Lost to Follow-up|1
2636185|NCT00813917|9109085|P1|Overall Study|Lost to Follow-up|3
2636186|NCT00813917|9109084|P2|Overall Study|Withdrawal by Subject|4
2636187|NCT00813917|9109085|P1|Overall Study|Withdrawal by Subject|3
2636188|NCT00813917|9109084|P2|Overall Study|Adverse Event|1
2636189|NCT00813917|9109085|P1|Overall Study|Adverse Event|0
2636190|NCT00813904|9109091|P1|Overall Study|Death|1
2636191|NCT00813865|9109097|P1|Overall Study|Withdrawal by Subject|1
2636192|NCT00813865|9109097|P1|Overall Study|Lost to Follow-up|3
2636193|NCT00813865|9109097|P1|Overall Study|Failure to Respond|3
2636194|NCT00813813|9109105|P2|Overall Study|Other|1
2636195|NCT00813813|9109106|P1|Overall Study|Other|0
2636196|NCT00813813|9109105|P2|Overall Study|Lost to Follow-up|7
2636197|NCT00813813|9109106|P1|Overall Study|Lost to Follow-up|2
2636198|NCT00813813|9109105|P2|Overall Study|Withdrawal by Subject|1
2636199|NCT00813813|9109106|P1|Overall Study|Withdrawal by Subject|1
2636200|NCT00813800|9109122|P1|Overall Study|Physician Decision|1
2636201|NCT00813800|9109122|P1|Overall Study|Worsening of depression|2
2636202|NCT00813800|9109122|P1|Overall Study|Adverse Event|1
2636203|NCT00813800|9109122|P1|Overall Study|Screen Failure after Consent|2
2636204|NCT00813761|9109130|P4|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
2636205|NCT00813761|9109131|P3|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6
2636206|NCT00813761|9109132|P2|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
2636207|NCT00813761|9109133|P1|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9
2636208|NCT00813761|9109130|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3
2636209|NCT00813761|9109131|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0
2636210|NCT00813761|9109132|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4
2636211|NCT00813761|9109133|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1
2636212|NCT00813761|9109130|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0
2636213|NCT00813761|9109131|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
2636214|NCT00813761|9109132|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
2636215|NCT00813761|9109133|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
2636216|NCT00813761|9109130|P4|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
2636217|NCT00813761|9109131|P3|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
2636218|NCT00813761|9109132|P2|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
2636219|NCT00813761|9109133|P1|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
2636220|NCT00813761|9109130|P4|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1
2636221|NCT00813761|9109131|P3|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2
2636222|NCT00813761|9109132|P2|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0
2636223|NCT00813761|9109133|P1|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3
2636224|NCT00813761|9109130|P4|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
2636225|NCT00813761|9109131|P3|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
2636226|NCT00813761|9109132|P2|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3
2636227|NCT00813761|9109133|P1|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2
2636228|NCT00813761|9109130|P4|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
2636229|NCT00813761|9109131|P3|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
2636230|NCT00813761|9109132|P2|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1
2636231|NCT00813761|9109133|P1|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
2636232|NCT00813761|9109130|P4|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
2636233|NCT00813761|9109131|P3|Phase 1 (Baseline to 4 Weeks)|poor comfort|5
2636234|NCT00813761|9109132|P2|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
2636235|NCT00813761|9109133|P1|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
2636236|NCT00813761|9109130|P4|Phase 1 (Baseline to 4 Weeks)|poor vision|0
2636237|NCT00813761|9109131|P3|Phase 1 (Baseline to 4 Weeks)|poor vision|3
2636238|NCT00813761|9109132|P2|Phase 1 (Baseline to 4 Weeks)|poor vision|0
2636239|NCT00813761|9109133|P1|Phase 1 (Baseline to 4 Weeks)|poor vision|0
2636240|NCT00813761|9109130|P4|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0
2636241|NCT00813761|9109131|P3|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
2636242|NCT00813761|9109132|P2|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
2636243|NCT00813761|9109133|P1|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
2636244|NCT00813761|9109130|P4|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1
2636245|NCT00813761|9109131|P3|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3
2636246|NCT00813761|9109132|P2|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
2636247|NCT00813761|9109133|P1|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
2636248|NCT00813761|9109130|P4|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
2636249|NCT00813761|9109131|P3|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
2636250|NCT00813761|9109132|P2|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
2636251|NCT00813761|9109133|P1|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2
2636252|NCT00813748|9109183|P2|Skin Test Substudy|Physician Decision|1
2636253|NCT00813748|9109184|P1|Skin Test Substudy|Physician Decision|0
2636254|NCT00813709|9109213|P6|Open Label Period|Other|6
2636255|NCT00813709|9109214|P5|Open Label Period|Other|5
2636256|NCT00813709|9109215|P4|Open Label Period|Other|11
2636257|NCT00813709|9109216|P3|Open Label Period|Other|0
2636258|NCT00813709|9109217|P2|Open Label Period|Other|0
2636259|NCT00813709|9109218|P1|Open Label Period|Other|0
2636260|NCT00813709|9109213|P6|Open Label Period|Randomized but not treated|1
2636261|NCT00813709|9109214|P5|Open Label Period|Randomized but not treated|0
2636262|NCT00813709|9109215|P4|Open Label Period|Randomized but not treated|1
2636263|NCT00813709|9109216|P3|Open Label Period|Randomized but not treated|0
2636264|NCT00813709|9109217|P2|Open Label Period|Randomized but not treated|0
2636265|NCT00813709|9109218|P1|Open Label Period|Randomized but not treated|0
2636266|NCT00813709|9109213|P6|Open Label Period|Lack of Efficacy|1
2636267|NCT00813709|9109214|P5|Open Label Period|Lack of Efficacy|1
2636268|NCT00813709|9109215|P4|Open Label Period|Lack of Efficacy|3
2636269|NCT00813709|9109216|P3|Open Label Period|Lack of Efficacy|0
2636270|NCT00813709|9109217|P2|Open Label Period|Lack of Efficacy|0
2636271|NCT00813709|9109218|P1|Open Label Period|Lack of Efficacy|0
2636272|NCT00813709|9109213|P6|Open Label Period|Adverse Event|3
2636273|NCT00813709|9109214|P5|Open Label Period|Adverse Event|4
2636274|NCT00813709|9109215|P4|Open Label Period|Adverse Event|5
2636275|NCT00813709|9109216|P3|Open Label Period|Adverse Event|0
2636276|NCT00813709|9109217|P2|Open Label Period|Adverse Event|0
2636277|NCT00813709|9109218|P1|Open Label Period|Adverse Event|0
2636278|NCT00813709|9109213|P6|Double Blind Period|Other|0
2636279|NCT00813709|9109214|P5|Double Blind Period|Other|0
2636280|NCT00813709|9109215|P4|Double Blind Period|Other|0
2636281|NCT00813709|9109216|P3|Double Blind Period|Other|6
2636282|NCT00813709|9109217|P2|Double Blind Period|Other|9
2636283|NCT00813709|9109218|P1|Double Blind Period|Other|14
2636284|NCT00813709|9109213|P6|Double Blind Period|Randomized but not treated|0
2636285|NCT00813709|9109214|P5|Double Blind Period|Randomized but not treated|0
2636286|NCT00813709|9109215|P4|Double Blind Period|Randomized but not treated|0
2636287|NCT00813709|9109216|P3|Double Blind Period|Randomized but not treated|1
2636288|NCT00813709|9109217|P2|Double Blind Period|Randomized but not treated|3
2636289|NCT00813709|9109218|P1|Double Blind Period|Randomized but not treated|1
2636290|NCT00813709|9109213|P6|Double Blind Period|Switched to open label phase|0
2636291|NCT00813709|9109214|P5|Double Blind Period|Switched to open label phase|0
2636292|NCT00813709|9109215|P4|Double Blind Period|Switched to open label phase|0
2636293|NCT00813709|9109216|P3|Double Blind Period|Switched to open label phase|18
2636294|NCT00813709|9109217|P2|Double Blind Period|Switched to open label phase|26
2636295|NCT00813709|9109218|P1|Double Blind Period|Switched to open label phase|9
2636296|NCT00813709|9109213|P6|Double Blind Period|Lost to Follow-up|0
2636297|NCT00813709|9109214|P5|Double Blind Period|Lost to Follow-up|0
2636298|NCT00813709|9109215|P4|Double Blind Period|Lost to Follow-up|0
2636299|NCT00813709|9109216|P3|Double Blind Period|Lost to Follow-up|2
2636300|NCT00813709|9109217|P2|Double Blind Period|Lost to Follow-up|2
2636301|NCT00813709|9109218|P1|Double Blind Period|Lost to Follow-up|3
2636302|NCT00813709|9109213|P6|Double Blind Period|Adverse Event|0
2636303|NCT00813709|9109214|P5|Double Blind Period|Adverse Event|0
2636304|NCT00813709|9109215|P4|Double Blind Period|Adverse Event|0
2636305|NCT00813709|9109216|P3|Double Blind Period|Adverse Event|4
2636306|NCT00813709|9109217|P2|Double Blind Period|Adverse Event|1
2636307|NCT00813709|9109218|P1|Double Blind Period|Adverse Event|4
2636308|NCT00813592|9109298|P1|Overall Study|Disease assessment was not completed per|2
2636309|NCT00813488|9109307|P2|Open-label Extension|Other|0
2636310|NCT00813488|9109308|P1|Open-label Extension|Other|1
2636311|NCT00813488|9109307|P2|Open-label Extension|Non-compliance study procedures|1
2636312|NCT00813488|9109308|P1|Open-label Extension|Non-compliance study procedures|2
2636313|NCT00813488|9109307|P2|Open-label Extension|Non-compliance study medication|0
2636314|NCT00813488|9109308|P1|Open-label Extension|Non-compliance study medication|4
2636315|NCT00813488|9109307|P2|Open-label Extension|Protocol Violation|2
2636316|NCT00813488|9109308|P1|Open-label Extension|Protocol Violation|1
2636317|NCT00813488|9109307|P2|Open-label Extension|Withdrawal by Subject|2
2636318|NCT00813488|9109308|P1|Open-label Extension|Withdrawal by Subject|0
2636319|NCT00813488|9109307|P2|Open-label Extension|Lack of Efficacy|0
2636320|NCT00813488|9109308|P1|Open-label Extension|Lack of Efficacy|3
2636321|NCT00813488|9109307|P2|Open-label Extension|Adverse Event|2
2636322|NCT00813488|9109308|P1|Open-label Extension|Adverse Event|1
2636323|NCT00813488|9109307|P2|Double-blind Treatment Period 2|Other|0
2636324|NCT00813488|9109308|P1|Double-blind Treatment Period 2|Other|1
2636325|NCT00813488|9109307|P2|Double-blind Treatment Period 2|Protocol Violation|0
2636326|NCT00813488|9109308|P1|Double-blind Treatment Period 2|Protocol Violation|2
2636327|NCT00813488|9109307|P2|Double-blind Treatment Period 2|Withdrawal by Subject|1
2636328|NCT00813488|9109308|P1|Double-blind Treatment Period 2|Withdrawal by Subject|1
2636329|NCT00813488|9109307|P2|Double-blind Treatment Period 2|Adverse Event|0
2636330|NCT00813488|9109308|P1|Double-blind Treatment Period 2|Adverse Event|1
2636331|NCT00813488|9109307|P2|Double-blind Treatment Period 1|Lost to Follow-up|1
2636332|NCT00813488|9109308|P1|Double-blind Treatment Period 1|Lost to Follow-up|0
2636333|NCT00813488|9109307|P2|Double-blind Treatment Period 1|Protocol Violation|2
2636334|NCT00813488|9109308|P1|Double-blind Treatment Period 1|Protocol Violation|0
2636335|NCT00813488|9109307|P2|Double-blind Treatment Period 1|Withdrawal by Subject|1
2636336|NCT00813488|9109308|P1|Double-blind Treatment Period 1|Withdrawal by Subject|0
2636337|NCT00813488|9109307|P2|Double-blind Treatment Period 1|Adverse Event|1
2636338|NCT00813488|9109308|P1|Double-blind Treatment Period 1|Adverse Event|1
2636339|NCT00813488|9109307|P2|Titration Period 2|Non-compliance with study procedures|1
2636340|NCT00813488|9109308|P1|Titration Period 2|Non-compliance with study procedures|2
2636341|NCT00813488|9109307|P2|Titration Period 2|Lost to Follow-up|0
2636342|NCT00813488|9109308|P1|Titration Period 2|Lost to Follow-up|1
2636343|NCT00813488|9109307|P2|Titration Period 2|Protocol Violation|2
2636344|NCT00813488|9109308|P1|Titration Period 2|Protocol Violation|3
2636345|NCT00813488|9109307|P2|Titration Period 2|Lack of Efficacy|4
2636346|NCT00813488|9109308|P1|Titration Period 2|Lack of Efficacy|8
2636347|NCT00813488|9109307|P2|Titration Period 2|Adverse Event|3
2636348|NCT00813488|9109308|P1|Titration Period 2|Adverse Event|2
2636349|NCT00813488|9109307|P2|Titration Period 1|Technical Difficulties|1
2636350|NCT00813488|9109308|P1|Titration Period 1|Technical Difficulties|0
2636351|NCT00813488|9109307|P2|Titration Period 1|Non-compliance to study procedures|2
2636352|NCT00813488|9109308|P1|Titration Period 1|Non-compliance to study procedures|2
2636353|NCT00813488|9109307|P2|Titration Period 1|Non-compliance to study medication|1
2636354|NCT00813488|9109308|P1|Titration Period 1|Non-compliance to study medication|4
2636355|NCT00813488|9109307|P2|Titration Period 1|Protocol Violation|3
2636356|NCT00813488|9109308|P1|Titration Period 1|Protocol Violation|4
2636357|NCT00813488|9109307|P2|Titration Period 1|Withdrawal by Subject|2
2636358|NCT00813488|9109308|P1|Titration Period 1|Withdrawal by Subject|2
2636359|NCT00813488|9109307|P2|Titration Period 1|Lack of Efficacy|7
2636360|NCT00813488|9109308|P1|Titration Period 1|Lack of Efficacy|9
2636361|NCT00813488|9109307|P2|Titration Period 1|Adverse Event|1
2636362|NCT00813488|9109308|P1|Titration Period 1|Adverse Event|6
2636363|NCT00813150|9109438|P2|Long Term Follow-up|Progression/Relapse|24
2636364|NCT00813150|9109439|P1|Long Term Follow-up|Progression/Relapse|22
2636365|NCT00813150|9109438|P2|Long Term Follow-up|Lost to Follow-up|0
2636367|NCT00813150|9109438|P2|Long Term Follow-up|Other|3
2636368|NCT00813150|9109439|P1|Long Term Follow-up|Other|0
2636369|NCT00813150|9109438|P2|Long Term Follow-up|Death|4
2636370|NCT00813150|9109439|P1|Long Term Follow-up|Death|0
2636371|NCT00813150|9109438|P2|Treatment Period|Data not available|2
2636372|NCT00813150|9109439|P1|Treatment Period|Data not available|1
2636373|NCT00813150|9109438|P2|Treatment Period|Reason not specified|4
2636374|NCT00813150|9109439|P1|Treatment Period|Reason not specified|3
2636375|NCT00813150|9109438|P2|Treatment Period|Non compliance|1
2636376|NCT00813150|9109439|P1|Treatment Period|Non compliance|0
2636377|NCT00813150|9109438|P2|Treatment Period|Withdrawal by Subject|3
2636378|NCT00813150|9109439|P1|Treatment Period|Withdrawal by Subject|5
2636379|NCT00813150|9109438|P2|Treatment Period|Protocol Violation|4
2636380|NCT00813150|9109439|P1|Treatment Period|Protocol Violation|3
2636381|NCT00813150|9109438|P2|Treatment Period|Stable disease|2
2636382|NCT00813150|9109439|P1|Treatment Period|Stable disease|1
2636383|NCT00813150|9109438|P2|Treatment Period|Complete response|1
2636384|NCT00813150|9109439|P1|Treatment Period|Complete response|0
2636385|NCT00813150|9109438|P2|Treatment Period|Progressive disease|0
2636386|NCT00813150|9109439|P1|Treatment Period|Progressive disease|1
2636387|NCT00813150|9109438|P2|Treatment Period|Death|0
2636388|NCT00813150|9109439|P1|Treatment Period|Death|2
2636389|NCT00813150|9109438|P2|Treatment Period|Adverse Event|15
2636390|NCT00813150|9109439|P1|Treatment Period|Adverse Event|16
2636391|NCT00813098|9109463|P3|Overall Study|Withdrew Consent|0
2636392|NCT00813098|9109464|P2|Overall Study|Withdrew Consent|1
2636393|NCT00813098|9109465|P1|Overall Study|Withdrew Consent|0
2636394|NCT00813098|9109463|P3|Overall Study|Principal Investigator decision|0
2636395|NCT00813098|9109464|P2|Overall Study|Principal Investigator decision|1
2636396|NCT00813098|9109465|P1|Overall Study|Principal Investigator decision|0
2636397|NCT00813098|9109463|P3|Overall Study|Protocol Violation|1
2636398|NCT00813098|9109464|P2|Overall Study|Protocol Violation|0
2636399|NCT00813098|9109465|P1|Overall Study|Protocol Violation|0
2636400|NCT00813098|9109463|P3|Overall Study|Lost to Follow-up|0
2636401|NCT00813098|9109464|P2|Overall Study|Lost to Follow-up|1
2636402|NCT00813098|9109465|P1|Overall Study|Lost to Follow-up|0
2636403|NCT00813098|9109463|P3|Overall Study|Inability to complete study procedures|0
2636404|NCT00813098|9109464|P2|Overall Study|Inability to complete study procedures|0
2636405|NCT00813098|9109465|P1|Overall Study|Inability to complete study procedures|1
2636406|NCT00813098|9109463|P3|Overall Study|Withdrawal by Subject|0
2636407|NCT00813098|9109464|P2|Overall Study|Withdrawal by Subject|1
2636408|NCT00813098|9109465|P1|Overall Study|Withdrawal by Subject|0
2636409|NCT00813098|9109463|P3|Overall Study|Adverse Event|1
2636410|NCT00813098|9109464|P2|Overall Study|Adverse Event|4
2636411|NCT00813098|9109465|P1|Overall Study|Adverse Event|2
2636412|NCT00812981|9109490|P2|Overall Study|Other|1
2636413|NCT00812981|9109491|P1|Overall Study|Other|0
2636414|NCT00812968|9109529|P1|Overall Study|Study closed due to marketing approval|3
2636415|NCT00812968|9109529|P1|Overall Study|No further treatment required|1
2636416|NCT00812968|9109529|P1|Overall Study|Disease progression|1
2636417|NCT00812968|9109529|P1|Overall Study|Relapse after erythroid response|6
2636418|NCT00812955|9109564|P4|Overall Study|randomized in error|0
2636419|NCT00812955|9109565|P3|Overall Study|randomized in error|1
2636420|NCT00812955|9109566|P2|Overall Study|randomized in error|0
2636421|NCT00812955|9109567|P1|Overall Study|randomized in error|0
2636422|NCT00812955|9109564|P4|Overall Study|Withdrawal by Subject|2
2636423|NCT00812955|9109565|P3|Overall Study|Withdrawal by Subject|1
2636424|NCT00812955|9109566|P2|Overall Study|Withdrawal by Subject|0
2636425|NCT00812955|9109567|P1|Overall Study|Withdrawal by Subject|1
2636426|NCT00812955|9109564|P4|Overall Study|Lost to Follow-up|2
2636427|NCT00812955|9109565|P3|Overall Study|Lost to Follow-up|1
2636428|NCT00812955|9109566|P2|Overall Study|Lost to Follow-up|1
2636429|NCT00812955|9109567|P1|Overall Study|Lost to Follow-up|2
2636430|NCT00812955|9109564|P4|Overall Study|Adverse Event|4
2636431|NCT00812955|9109565|P3|Overall Study|Adverse Event|3
2636432|NCT00812955|9109566|P2|Overall Study|Adverse Event|6
2636433|NCT00812955|9109567|P1|Overall Study|Adverse Event|7
2636434|NCT00812929|9109587|P10|Washout Period 3 (7 Days)|Adverse Event|0
2636435|NCT00812929|9109588|P9|Washout Period 3 (7 Days)|Adverse Event|0
2636436|NCT00812929|9109589|P8|Washout Period 3 (7 Days)|Adverse Event|0
2636437|NCT00812929|9109590|P7|Washout Period 3 (7 Days)|Adverse Event|0
2636438|NCT00812929|9109591|P6|Washout Period 3 (7 Days)|Adverse Event|1
2636439|NCT00812929|9109592|P5|Washout Period 3 (7 Days)|Adverse Event|0
2636440|NCT00812929|9109593|P4|Washout Period 3 (7 Days)|Adverse Event|0
2636441|NCT00812929|9109594|P3|Washout Period 3 (7 Days)|Adverse Event|0
2636442|NCT00812929|9109595|P2|Washout Period 3 (7 Days)|Adverse Event|0
2636443|NCT00812929|9109596|P1|Washout Period 3 (7 Days)|Adverse Event|0
2636444|NCT00812929|9109587|P10|Washout Period 2 (7 Days)|Physician Decision|1
2636445|NCT00812929|9109588|P9|Washout Period 2 (7 Days)|Physician Decision|0
2636446|NCT00812929|9109589|P8|Washout Period 2 (7 Days)|Physician Decision|0
2636447|NCT00812929|9109590|P7|Washout Period 2 (7 Days)|Physician Decision|0
2636448|NCT00812929|9109591|P6|Washout Period 2 (7 Days)|Physician Decision|0
2636449|NCT00812929|9109592|P5|Washout Period 2 (7 Days)|Physician Decision|0
2636450|NCT00812929|9109593|P4|Washout Period 2 (7 Days)|Physician Decision|0
2636451|NCT00812929|9109594|P3|Washout Period 2 (7 Days)|Physician Decision|0
2636452|NCT00812929|9109595|P2|Washout Period 2 (7 Days)|Physician Decision|0
2636453|NCT00812929|9109596|P1|Washout Period 2 (7 Days)|Physician Decision|0
2636454|NCT00812929|9109587|P10|Washout Period 1 (7 Days)|Physician Decision|0
2636455|NCT00812929|9109588|P9|Washout Period 1 (7 Days)|Physician Decision|0
2636456|NCT00812929|9109589|P8|Washout Period 1 (7 Days)|Physician Decision|0
2636457|NCT00812929|9109590|P7|Washout Period 1 (7 Days)|Physician Decision|0
2636458|NCT00812929|9109591|P6|Washout Period 1 (7 Days)|Physician Decision|0
2636459|NCT00812929|9109592|P5|Washout Period 1 (7 Days)|Physician Decision|0
2636460|NCT00812929|9109593|P4|Washout Period 1 (7 Days)|Physician Decision|0
2636461|NCT00812929|9109594|P3|Washout Period 1 (7 Days)|Physician Decision|1
2636462|NCT00812929|9109595|P2|Washout Period 1 (7 Days)|Physician Decision|0
2636463|NCT00812929|9109596|P1|Washout Period 1 (7 Days)|Physician Decision|0
2636464|NCT00812812|9109751|P2|Overall Study|Withdrawal by Subject|2
2636465|NCT00812812|9109752|P1|Overall Study|Withdrawal by Subject|0
2636466|NCT00812812|9109751|P2|Overall Study|Lost to Follow-up|1
2636467|NCT00812812|9109752|P1|Overall Study|Lost to Follow-up|0
2636468|NCT00812812|9109751|P2|Overall Study|Lack of Efficacy|0
2636469|NCT00812812|9109752|P1|Overall Study|Lack of Efficacy|1
2636470|NCT00812812|9109751|P2|Overall Study|Adverse Event|1
2636471|NCT00812812|9109752|P1|Overall Study|Adverse Event|2
2636472|NCT00812708|9109765|P1|Overall Study|Signed consent but later withdrew|3
2636473|NCT00812708|9109765|P1|Overall Study|Surgery cancelled due to uveitis|1
2636474|NCT00812708|9109765|P1|Overall Study|Switched to another study|1
2636475|NCT00812708|9109765|P1|Overall Study|Lack of medical insurance|1
2636476|NCT00812708|9109765|P1|Overall Study|Device could not be implanted|2
2636477|NCT00812565|9109793|P8|Overall Study|Reason Not Specified|0
2636478|NCT00812565|9109794|P7|Overall Study|Reason Not Specified|0
2636479|NCT00812565|9109795|P6|Overall Study|Reason Not Specified|1
2636480|NCT00812565|9109796|P5|Overall Study|Reason Not Specified|0
2636481|NCT00812565|9109797|P4|Overall Study|Reason Not Specified|0
2636482|NCT00812565|9109798|P3|Overall Study|Reason Not Specified|0
2636483|NCT00812565|9109799|P2|Overall Study|Reason Not Specified|0
2636484|NCT00812565|9109800|P1|Overall Study|Reason Not Specified|0
2636485|NCT00812565|9109793|P8|Overall Study|Withdrawal of Consent|0
2636486|NCT00812565|9109794|P7|Overall Study|Withdrawal of Consent|0
2636487|NCT00812565|9109795|P6|Overall Study|Withdrawal of Consent|0
2636488|NCT00812565|9109796|P5|Overall Study|Withdrawal of Consent|1
2636489|NCT00812565|9109797|P4|Overall Study|Withdrawal of Consent|0
2636490|NCT00812565|9109798|P3|Overall Study|Withdrawal of Consent|0
2636491|NCT00812565|9109799|P2|Overall Study|Withdrawal of Consent|0
2636492|NCT00812565|9109800|P1|Overall Study|Withdrawal of Consent|1
2636493|NCT00812565|9109793|P8|Overall Study|Did Not Come to Study Visit|0
2636494|NCT00812565|9109794|P7|Overall Study|Did Not Come to Study Visit|0
2636495|NCT00812565|9109795|P6|Overall Study|Did Not Come to Study Visit|0
2636496|NCT00812565|9109796|P5|Overall Study|Did Not Come to Study Visit|0
2636497|NCT00812565|9109797|P4|Overall Study|Did Not Come to Study Visit|0
2636498|NCT00812565|9109798|P3|Overall Study|Did Not Come to Study Visit|0
2636499|NCT00812565|9109799|P2|Overall Study|Did Not Come to Study Visit|0
2636500|NCT00812565|9109800|P1|Overall Study|Did Not Come to Study Visit|1
2636501|NCT00812565|9109793|P8|Overall Study|Adverse Event|1
2636502|NCT00812565|9109794|P7|Overall Study|Adverse Event|0
2636503|NCT00812565|9109795|P6|Overall Study|Adverse Event|0
2636504|NCT00812565|9109796|P5|Overall Study|Adverse Event|0
2636505|NCT00812565|9109797|P4|Overall Study|Adverse Event|2
2636506|NCT00812565|9109798|P3|Overall Study|Adverse Event|0
2636507|NCT00812565|9109799|P2|Overall Study|Adverse Event|0
2636508|NCT00812565|9109800|P1|Overall Study|Adverse Event|0
2636509|NCT00812565|9109793|P8|Overall Study|Did Not Receive Study Medication|0
2636510|NCT00812565|9109794|P7|Overall Study|Did Not Receive Study Medication|0
2636511|NCT00812565|9109795|P6|Overall Study|Did Not Receive Study Medication|0
2636512|NCT00812565|9109796|P5|Overall Study|Did Not Receive Study Medication|0
2636513|NCT00812565|9109797|P4|Overall Study|Did Not Receive Study Medication|0
2636514|NCT00812565|9109798|P3|Overall Study|Did Not Receive Study Medication|0
2636515|NCT00812565|9109799|P2|Overall Study|Did Not Receive Study Medication|1
2636516|NCT00812565|9109800|P1|Overall Study|Did Not Receive Study Medication|1
2636517|NCT00812487|9109924|P2|Overall Study|Protocol Violation|1
2636518|NCT00812487|9109925|P1|Overall Study|Protocol Violation|0
2636519|NCT00812487|9109924|P2|Overall Study|Transfer to ICU prior to intervention|0
2636520|NCT00812487|9109925|P1|Overall Study|Transfer to ICU prior to intervention|1
2636521|NCT00812487|9109924|P2|Overall Study|Withdrawal by Subject|2
2636522|NCT00812487|9109925|P1|Overall Study|Withdrawal by Subject|3
2636523|NCT00812487|9109924|P2|Overall Study|Lost to Follow-up|0
2636524|NCT00812487|9109925|P1|Overall Study|Lost to Follow-up|2
2636525|NCT00812461|9109951|P2|All Treated Patients|Other Reason|21
2636526|NCT00812461|9109952|P1|All Treated Patients|Other Reason|13
2636527|NCT00812461|9109951|P2|All Treated Patients|Lost to Follow-up|14
2636528|NCT00812461|9109952|P1|All Treated Patients|Lost to Follow-up|11
2636529|NCT00812461|9109951|P2|All Treated Patients|Withdrawal by Subject|54
2636530|NCT00812461|9109952|P1|All Treated Patients|Withdrawal by Subject|45
2636531|NCT00812461|9109951|P2|All Treated Patients|Protocol Violation|27
2636532|NCT00812461|9109952|P1|All Treated Patients|Protocol Violation|36
2636533|NCT00812461|9109951|P2|All Treated Patients|Non-compliance|9
2636534|NCT00812461|9109952|P1|All Treated Patients|Non-compliance|6
2636535|NCT00812461|9109951|P2|All Treated Patients|Lack of Efficacy|7
2636536|NCT00812461|9109952|P1|All Treated Patients|Lack of Efficacy|13
2636537|NCT00812461|9109951|P2|All Treated Patients|Adverse Event|15
2636538|NCT00812461|9109952|P1|All Treated Patients|Adverse Event|8
2636539|NCT00812461|9109951|P2|All Randomised Patients|Did not receive placebo/nalmefene|17
2636540|NCT00812461|9109952|P1|All Randomised Patients|Did not receive placebo/nalmefene|23
2636541|NCT00812331|9109975|P5|Overall Study|Adverse Event|0
2636542|NCT00812331|9109976|P4|Overall Study|Adverse Event|0
2636543|NCT00812331|9109977|P3|Overall Study|Adverse Event|0
2636544|NCT00812331|9109978|P2|Overall Study|Adverse Event|0
2636545|NCT00812331|9109979|P1|Overall Study|Adverse Event|1
2636546|NCT00812253|9110054|P2|Overall Study|Lost to Follow-up|0
2636547|NCT00812253|9110055|P1|Overall Study|Lost to Follow-up|2
2636548|NCT00812253|9110054|P2|Overall Study|Protocol Violation|1
2636549|NCT00812253|9110055|P1|Overall Study|Protocol Violation|1
2636550|NCT00812253|9110054|P2|Overall Study|Withdrawal by Subject|2
2636551|NCT00812253|9110055|P1|Overall Study|Withdrawal by Subject|3
2636552|NCT00812097|9110080|P4|Overall Study|Unknown reasons and patient/doctor moves|5
2636553|NCT00812097|9110081|P3|Overall Study|Unknown reasons and patient/doctor moves|15
2636554|NCT00812097|9110082|P2|Overall Study|Unknown reasons and patient/doctor moves|24
2636555|NCT00812097|9110083|P1|Overall Study|Unknown reasons and patient/doctor moves|111
2636556|NCT00812097|9110080|P4|Overall Study|Explantation of study device(s)|20
2636557|NCT00812097|9110081|P3|Overall Study|Explantation of study device(s)|14
2636558|NCT00812097|9110082|P2|Overall Study|Explantation of study device(s)|29
2636559|NCT00812097|9110083|P1|Overall Study|Explantation of study device(s)|27
2636560|NCT00812097|9110080|P4|Overall Study|Lost to Follow-up|5
2636561|NCT00812097|9110081|P3|Overall Study|Lost to Follow-up|17
2636562|NCT00812097|9110082|P2|Overall Study|Lost to Follow-up|14
2636563|NCT00812097|9110083|P1|Overall Study|Lost to Follow-up|90
2636564|NCT00812097|9110080|P4|Overall Study|Withdrawal by Subject|2
2636565|NCT00812097|9110081|P3|Overall Study|Withdrawal by Subject|8
2636566|NCT00812097|9110082|P2|Overall Study|Withdrawal by Subject|12
2636567|NCT00812097|9110083|P1|Overall Study|Withdrawal by Subject|14
2636568|NCT00812097|9110080|P4|Overall Study|Death|3
2636569|NCT00812097|9110081|P3|Overall Study|Death|3
2636570|NCT00812097|9110082|P2|Overall Study|Death|10
2636571|NCT00812097|9110083|P1|Overall Study|Death|3
2636572|NCT00812006|9110112|P3|Overall Study|Lack of Qualifying Event|2
2636573|NCT00812006|9110113|P2|Overall Study|Lack of Qualifying Event|2
2636574|NCT00812006|9110114|P1|Overall Study|Lack of Qualifying Event|4
2636575|NCT00812006|9110112|P3|Overall Study|Withdrawal by Subject|1
2636576|NCT00812006|9110113|P2|Overall Study|Withdrawal by Subject|1
2636577|NCT00812006|9110114|P1|Overall Study|Withdrawal by Subject|2
2636578|NCT00812006|9110112|P3|Overall Study|Physician Decision|1
2636579|NCT00812006|9110113|P2|Overall Study|Physician Decision|0
2636580|NCT00812006|9110114|P1|Overall Study|Physician Decision|0
2636581|NCT00812006|9110112|P3|Overall Study|Lost to Follow-up|2
2636582|NCT00812006|9110113|P2|Overall Study|Lost to Follow-up|0
2636583|NCT00812006|9110114|P1|Overall Study|Lost to Follow-up|0
2636584|NCT00811954|9110131|P3|Overall Study|Complete Protocol: No follow-up|1
2636585|NCT00811954|9110132|P2|Overall Study|Complete Protocol: No follow-up|0
2636586|NCT00811954|9110133|P1|Overall Study|Complete Protocol: No follow-up|0
2636587|NCT00811954|9110131|P3|Overall Study|Severe Debilitation|1
2636588|NCT00811954|9110132|P2|Overall Study|Severe Debilitation|0
2636589|NCT00811954|9110133|P1|Overall Study|Severe Debilitation|2
2636590|NCT00811954|9110131|P3|Overall Study|Site Closure|1
2636591|NCT00811954|9110132|P2|Overall Study|Site Closure|0
2636592|NCT00811954|9110133|P1|Overall Study|Site Closure|4
2636593|NCT00811954|9110131|P3|Overall Study|Withdraw consent prior study completion|5
2636594|NCT00811954|9110132|P2|Overall Study|Withdraw consent prior study completion|6
2636595|NCT00811954|9110133|P1|Overall Study|Withdraw consent prior study completion|4
2636596|NCT00811954|9110131|P3|Overall Study|Not willing to adhere to requirements|16
2636597|NCT00811954|9110132|P2|Overall Study|Not willing to adhere to requirements|2
2636598|NCT00811954|9110133|P1|Overall Study|Not willing to adhere to requirements|12
2636599|NCT00811954|9110131|P3|Overall Study|Not able to get to clinic|30
2636600|NCT00811954|9110132|P2|Overall Study|Not able to get to clinic|35
2636601|NCT00811954|9110133|P1|Overall Study|Not able to get to clinic|28
2636602|NCT00811954|9110131|P3|Overall Study|Lost to Follow-up|34
2636603|NCT00811954|9110132|P2|Overall Study|Lost to Follow-up|23
2636604|NCT00811954|9110133|P1|Overall Study|Lost to Follow-up|29
2636605|NCT00811954|9110131|P3|Overall Study|Death|13
2636606|NCT00811954|9110132|P2|Overall Study|Death|6
2636607|NCT00811954|9110133|P1|Overall Study|Death|10
2636608|NCT00811941|9110197|P2|All Treated Patients|Other Reason|14
2636609|NCT00811941|9110198|P1|All Treated Patients|Other Reason|4
2636610|NCT00811941|9110197|P2|All Treated Patients|Lost to Follow-up|12
2636611|NCT00811941|9110198|P1|All Treated Patients|Lost to Follow-up|3
2636612|NCT00811941|9110197|P2|All Treated Patients|Withdrawal by Subject|94
2636613|NCT00811941|9110198|P1|All Treated Patients|Withdrawal by Subject|35
2636614|NCT00811941|9110197|P2|All Treated Patients|Protocol Violation|17
2636615|NCT00811941|9110198|P1|All Treated Patients|Protocol Violation|5
2636616|NCT00811941|9110197|P2|All Treated Patients|Non-compliance|8
2636617|NCT00811941|9110198|P1|All Treated Patients|Non-compliance|1
2636618|NCT00811941|9110197|P2|All Treated Patients|Lack of Efficacy|3
2636619|NCT00811941|9110198|P1|All Treated Patients|Lack of Efficacy|2
2636620|NCT00811941|9110197|P2|All Treated Patients|Adverse Event|43
2636621|NCT00811941|9110198|P1|All Treated Patients|Adverse Event|2
2636622|NCT00811941|9110197|P2|All Randomised Patients|Did not receive placebo/nalmefene|8
2636623|NCT00811941|9110198|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
2636624|NCT00811928|9110236|P2|Overall Study|Poor Compliance|5
2636625|NCT00811928|9110237|P1|Overall Study|Poor Compliance|2
2636626|NCT00811928|9110236|P2|Overall Study|Investigator Decision|1
2636627|NCT00811928|9110237|P1|Overall Study|Investigator Decision|2
2636628|NCT00811928|9110236|P2|Overall Study|Without Primary Efficacy Endpoint Data|4
2636629|NCT00811928|9110237|P1|Overall Study|Without Primary Efficacy Endpoint Data|7
2636630|NCT00811928|9110236|P2|Overall Study|Did Not Take Study Drug|0
2636631|NCT00811928|9110237|P1|Overall Study|Did Not Take Study Drug|3
2636632|NCT00811928|9110236|P2|Overall Study|Withdrawal by Subject|12
2636633|NCT00811928|9110237|P1|Overall Study|Withdrawal by Subject|18
2636634|NCT00811928|9110236|P2|Overall Study|AEs and SAEs Including Death|11
2636635|NCT00811928|9110237|P1|Overall Study|AEs and SAEs Including Death|7
2636636|NCT00811733|9110281|P2|Overall Study|Withdrawal by Subject|2
2636637|NCT00811733|9110282|P1|Overall Study|Withdrawal by Subject|1
2636638|NCT00811733|9110281|P2|Overall Study|Investigator Discretion|8
2636639|NCT00811733|9110282|P1|Overall Study|Investigator Discretion|10
2636640|NCT00811720|9110330|P2|All Treated Patients|Other Reason|4
2636641|NCT00811720|9110331|P1|All Treated Patients|Other Reason|7
2636642|NCT00811720|9110330|P2|All Treated Patients|Lost to Follow-up|16
2636643|NCT00811720|9110331|P1|All Treated Patients|Lost to Follow-up|10
2636644|NCT00811720|9110330|P2|All Treated Patients|Withdrawal by Subject|34
2636645|NCT00811720|9110331|P1|All Treated Patients|Withdrawal by Subject|28
2636646|NCT00811720|9110330|P2|All Treated Patients|Protocol Violation|16
2636647|NCT00811720|9110331|P1|All Treated Patients|Protocol Violation|9
2636648|NCT00811720|9110330|P2|All Treated Patients|Non-compliance|14
2636649|NCT00811720|9110331|P1|All Treated Patients|Non-compliance|0
2636650|NCT00811720|9110330|P2|All Treated Patients|Lack of Efficacy|18
2636651|NCT00811720|9110331|P1|All Treated Patients|Lack of Efficacy|22
2636652|NCT00811720|9110330|P2|All Treated Patients|Adverse Event|62
2636653|NCT00811720|9110331|P1|All Treated Patients|Adverse Event|20
2636654|NCT00811720|9110330|P2|All Randomised Patients|Did not receive placebo/nalmefene|4
2636655|NCT00811720|9110331|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
2636656|NCT00811655|9110349|P1|Overall Study|Physician Decision|1
2636657|NCT00811642|9110361|P1|Overall Study|Cumulative use of antifungal agent|2
2636658|NCT00811642|9110361|P1|Overall Study|Withdrawal by Subject|7
2636659|NCT00811642|9110361|P1|Overall Study|Death|2
2636660|NCT00811642|9110361|P1|Overall Study|Protocol Violation|1
2636661|NCT00811642|9110361|P1|Overall Study|Adverse Event|3
2636662|NCT00811577|9110377|P2|Overall Study|Withdrawal by Subject|0
2636663|NCT00811577|9110378|P1|Overall Study|Withdrawal by Subject|3
2636664|NCT00811577|9110377|P2|Overall Study|Lost to Follow-up|1
2636665|NCT00811577|9110378|P1|Overall Study|Lost to Follow-up|7
2636666|NCT00811473|9110438|P2|Overall Study|Safety Reasons|0
2636667|NCT00811473|9110439|P1|Overall Study|Safety Reasons|1
2636668|NCT00811473|9110438|P2|Overall Study|Incorrect Enrollment|0
2636669|NCT00811473|9110439|P1|Overall Study|Incorrect Enrollment|1
2636670|NCT00811473|9110438|P2|Overall Study|Other 2|1
2636671|NCT00811473|9110439|P1|Overall Study|Other 2|4
2636672|NCT00811473|9110438|P2|Overall Study|Condition under investigation worsened|3
2636673|NCT00811473|9110439|P1|Overall Study|Condition under investigation worsened|1
2636674|NCT00811473|9110438|P2|Overall Study|Lack of therapeutic response|1
2636675|NCT00811473|9110439|P1|Overall Study|Lack of therapeutic response|4
2636676|NCT00811473|9110438|P2|Overall Study|Severe non-compliance to protocol|4
2636677|NCT00811473|9110439|P1|Overall Study|Severe non-compliance to protocol|2
2636678|NCT00811473|9110438|P2|Overall Study|Withdrawal by Subject|4
2636679|NCT00811473|9110439|P1|Overall Study|Withdrawal by Subject|2
2636680|NCT00811473|9110438|P2|Overall Study|Lost to Follow-up|1
2636681|NCT00811473|9110439|P1|Overall Study|Lost to Follow-up|5
2636682|NCT00811473|9110438|P2|Overall Study|Adverse Event|12
2636683|NCT00811473|9110439|P1|Overall Study|Adverse Event|3
2636684|NCT00811395|9110470|P6|Extension Treatment|Other than above|0
2636685|NCT00811395|9110471|P5|Extension Treatment|Other than above|0
2636686|NCT00811395|9110472|P4|Extension Treatment|Other than above|0
2636687|NCT00811395|9110473|P3|Extension Treatment|Other than above|1
2636688|NCT00811395|9110474|P2|Extension Treatment|Other than above|0
2636689|NCT00811395|9110475|P1|Extension Treatment|Other than above|0
2636690|NCT00811395|9110470|P6|Extension Treatment|Participant did not wish to continue|1
2636691|NCT00811395|9110471|P5|Extension Treatment|Participant did not wish to continue|0
2636692|NCT00811395|9110472|P4|Extension Treatment|Participant did not wish to continue|1
2636693|NCT00811395|9110473|P3|Extension Treatment|Participant did not wish to continue|0
2636694|NCT00811395|9110474|P2|Extension Treatment|Participant did not wish to continue|3
2636695|NCT00811395|9110475|P1|Extension Treatment|Participant did not wish to continue|0
2636696|NCT00811395|9110470|P6|Extension Treatment|Progressive disease|0
2636697|NCT00811395|9110471|P5|Extension Treatment|Progressive disease|0
2636698|NCT00811395|9110472|P4|Extension Treatment|Progressive disease|0
2636699|NCT00811395|9110473|P3|Extension Treatment|Progressive disease|0
2636700|NCT00811395|9110474|P2|Extension Treatment|Progressive disease|1
2636701|NCT00811395|9110475|P1|Extension Treatment|Progressive disease|1
2636702|NCT00811395|9110470|P6|Extension Treatment|Adverse Event|1
2636703|NCT00811395|9110471|P5|Extension Treatment|Adverse Event|0
2636704|NCT00811395|9110472|P4|Extension Treatment|Adverse Event|2
2636705|NCT00811395|9110473|P3|Extension Treatment|Adverse Event|2
2636706|NCT00811395|9110474|P2|Extension Treatment|Adverse Event|2
2636707|NCT00811395|9110475|P1|Extension Treatment|Adverse Event|1
2636708|NCT00811252|9110581|P3|Overall Study|Administrative or Other Reasons|2
2636709|NCT00811252|9110582|P2|Overall Study|Administrative or Other Reasons|3
2636710|NCT00811252|9110583|P1|Overall Study|Administrative or Other Reasons|0
2636711|NCT00811252|9110581|P3|Overall Study|Lost to Follow-up|2
2636712|NCT00811252|9110582|P2|Overall Study|Lost to Follow-up|0
2636713|NCT00811252|9110583|P1|Overall Study|Lost to Follow-up|0
2636714|NCT00811252|9110581|P3|Overall Study|Withdrawal of Consent|2
2636715|NCT00811252|9110582|P2|Overall Study|Withdrawal of Consent|2
2636716|NCT00811252|9110583|P1|Overall Study|Withdrawal of Consent|1
2636717|NCT00811252|9110581|P3|Overall Study|Protocol Violation|2
2636718|NCT00811252|9110582|P2|Overall Study|Protocol Violation|3
2636719|NCT00811252|9110583|P1|Overall Study|Protocol Violation|3
2636720|NCT00811252|9110581|P3|Overall Study|Lack of Efficacy|0
2636721|NCT00811252|9110582|P2|Overall Study|Lack of Efficacy|2
2636722|NCT00811252|9110583|P1|Overall Study|Lack of Efficacy|7
2636723|NCT00811252|9110581|P3|Overall Study|Adverse Event|15
2636724|NCT00811252|9110582|P2|Overall Study|Adverse Event|10
2636725|NCT00811252|9110583|P1|Overall Study|Adverse Event|6
2636726|NCT00811187|9110629|P2|Overall Study|Unable to place device / procedure abort|3
2636727|NCT00811187|9110630|P1|Overall Study|Unable to place device / procedure abort|3
2636728|NCT00811174|9110636|P1|Overall Study|Sponsors Decision|1
2636729|NCT00811174|9110636|P1|Overall Study|Protocol Violation|2
2636730|NCT00811135|9110647|P1|Overall Study|Ongoing|59
2636731|NCT00811135|9110647|P1|Overall Study|Administrative/Other Unspecified|11
2636732|NCT00811135|9110647|P1|Overall Study|Withdrawal by Subject|3
2636733|NCT00811135|9110647|P1|Overall Study|Refused Treatment|1
2636734|NCT00811135|9110647|P1|Overall Study|Violation of Selection Criteria|1
2636735|NCT00811135|9110647|P1|Overall Study|Protocol Violation|2
2636736|NCT00811135|9110647|P1|Overall Study|Death|3
2636737|NCT00811135|9110647|P1|Overall Study|Adverse Event/Intercurrent Illness|8
2636738|NCT00811070|9110665|P6|Overall Study|Physician Decision|1
2636739|NCT00811070|9110666|P5|Overall Study|Physician Decision|0
2636740|NCT00811070|9110667|P4|Overall Study|Physician Decision|0
2636741|NCT00811070|9110668|P3|Overall Study|Physician Decision|0
2636742|NCT00811070|9110669|P2|Overall Study|Physician Decision|0
2636743|NCT00811070|9110670|P1|Overall Study|Physician Decision|0
2636744|NCT00811070|9110665|P6|Overall Study|Withdrawal by Subject|0
2636745|NCT00811070|9110666|P5|Overall Study|Withdrawal by Subject|0
2636746|NCT00811070|9110667|P4|Overall Study|Withdrawal by Subject|0
2636747|NCT00811070|9110668|P3|Overall Study|Withdrawal by Subject|0
2636748|NCT00811070|9110669|P2|Overall Study|Withdrawal by Subject|1
2636749|NCT00811070|9110670|P1|Overall Study|Withdrawal by Subject|0
2636750|NCT00811070|9110665|P6|Overall Study|Other|0
2636751|NCT00811070|9110666|P5|Overall Study|Other|0
2636752|NCT00811070|9110667|P4|Overall Study|Other|0
2636753|NCT00811070|9110668|P3|Overall Study|Other|0
2636754|NCT00811070|9110669|P2|Overall Study|Other|0
2636755|NCT00811070|9110670|P1|Overall Study|Other|1
2636756|NCT00811070|9110665|P6|Overall Study|Death|0
2636757|NCT00811070|9110666|P5|Overall Study|Death|5
2636758|NCT00811070|9110667|P4|Overall Study|Death|2
2636759|NCT00811070|9110668|P3|Overall Study|Death|0
2636760|NCT00811070|9110669|P2|Overall Study|Death|0
2636761|NCT00811070|9110670|P1|Overall Study|Death|0
2636762|NCT00811057|9110730|P3|Overall Study|Protocol Violation|10
2636763|NCT00811057|9110731|P2|Overall Study|Protocol Violation|10
2636764|NCT00811057|9110732|P1|Overall Study|Protocol Violation|5
2636765|NCT00811018|9110743|P1|Overall Study|Other|26
2636766|NCT00811018|9110743|P1|Overall Study|WHO FC deterioration and 6MWD decrease|9
2636767|NCT00811018|9110743|P1|Overall Study|Withdrawal by Subject|70
2636768|NCT00811018|9110743|P1|Overall Study|Sponsor Decision|450
2636769|NCT00811018|9110743|P1|Overall Study|Pregnancy|6
2636770|NCT00811018|9110743|P1|Overall Study|Lost to Follow-up|19
2636771|NCT00811018|9110743|P1|Overall Study|Investigator Decision|57
2636772|NCT00811018|9110743|P1|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70
2636773|NCT00811018|9110743|P1|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4
2636774|NCT00811018|9110743|P1|Overall Study|Death|147
2636775|NCT00811018|9110743|P1|Overall Study|Adverse Event|79
2636776|NCT00811018|9110743|P1|Overall Study|Additional Chronic Treatment|31
2636777|NCT00810901|9110761|P2|Overall Study|Lost to Follow-up|58
2636778|NCT00810901|9110762|P1|Overall Study|Lost to Follow-up|88
2636779|NCT00810810|9110808|P4|Overall Study|Physician Decision|5
2636780|NCT00810810|9110809|P3|Overall Study|Physician Decision|1
2636781|NCT00810810|9110810|P2|Overall Study|Physician Decision|3
2636782|NCT00810810|9110811|P1|Overall Study|Physician Decision|0
2636783|NCT00810810|9110808|P4|Overall Study|Withdrawal by Subject|8
2636784|NCT00810810|9110809|P3|Overall Study|Withdrawal by Subject|10
2636785|NCT00810810|9110810|P2|Overall Study|Withdrawal by Subject|8
2636786|NCT00810810|9110811|P1|Overall Study|Withdrawal by Subject|0
2636787|NCT00810693|9110859|P3|Follow-up Period (FUP)|Withdrawal by Subject|0
2636788|NCT00810693|9110860|P2|Follow-up Period (FUP)|Withdrawal by Subject|1
2636789|NCT00810693|9110861|P1|Follow-up Period (FUP)|Withdrawal by Subject|2
2636790|NCT00810693|9110859|P3|Follow-up Period (FUP)|Protocol Violation|0
2636791|NCT00810693|9110860|P2|Follow-up Period (FUP)|Protocol Violation|1
2636792|NCT00810693|9110861|P1|Follow-up Period (FUP)|Protocol Violation|0
2636793|NCT00810693|9110859|P3|Follow-up Period (FUP)|Lost to Follow-up|2
2636794|NCT00810693|9110860|P2|Follow-up Period (FUP)|Lost to Follow-up|0
2636795|NCT00810693|9110861|P1|Follow-up Period (FUP)|Lost to Follow-up|1
2636796|NCT00810693|9110859|P3|Follow-up Period (FUP)|Death|1
2636797|NCT00810693|9110860|P2|Follow-up Period (FUP)|Death|0
2636798|NCT00810693|9110861|P1|Follow-up Period (FUP)|Death|2
2636799|NCT00810693|9110859|P3|Follow-up Period (FUP)|Adverse Event|1
2636800|NCT00810693|9110860|P2|Follow-up Period (FUP)|Adverse Event|1
2636801|NCT00810693|9110861|P1|Follow-up Period (FUP)|Adverse Event|3
2636802|NCT00810693|9110859|P3|Treatment Period|Not treated|1
2636803|NCT00810693|9110860|P2|Treatment Period|Not treated|1
2636804|NCT00810693|9110861|P1|Treatment Period|Not treated|0
2636805|NCT00810693|9110859|P3|Treatment Period|Withdrawal by Subject|3
2636806|NCT00810693|9110860|P2|Treatment Period|Withdrawal by Subject|2
2636807|NCT00810693|9110861|P1|Treatment Period|Withdrawal by Subject|6
2636808|NCT00810693|9110859|P3|Treatment Period|Protocol Violation|2
2636809|NCT00810693|9110860|P2|Treatment Period|Protocol Violation|2
2636810|NCT00810693|9110861|P1|Treatment Period|Protocol Violation|1
2636811|NCT00810693|9110859|P3|Treatment Period|Non-compliance|0
2636812|NCT00810693|9110860|P2|Treatment Period|Non-compliance|0
2636813|NCT00810693|9110861|P1|Treatment Period|Non-compliance|1
2636814|NCT00810693|9110859|P3|Treatment Period|Lost to Follow-up|0
2636815|NCT00810693|9110860|P2|Treatment Period|Lost to Follow-up|0
2636816|NCT00810693|9110861|P1|Treatment Period|Lost to Follow-up|1
2636817|NCT00810693|9110859|P3|Treatment Period|Lack of Efficacy|1
2636818|NCT00810693|9110860|P2|Treatment Period|Lack of Efficacy|0
2636819|NCT00810693|9110861|P1|Treatment Period|Lack of Efficacy|0
2636820|NCT00810693|9110859|P3|Treatment Period|Death|2
2636821|NCT00810693|9110860|P2|Treatment Period|Death|1
2636822|NCT00810693|9110861|P1|Treatment Period|Death|0
2636823|NCT00810693|9110859|P3|Treatment Period|Adverse Event|7
2636824|NCT00810693|9110860|P2|Treatment Period|Adverse Event|1
2636825|NCT00810693|9110861|P1|Treatment Period|Adverse Event|8
2636826|NCT00810641|9110893|P3|Overall Study|Withdrawal by Subject|2
2636827|NCT00810641|9110894|P2|Overall Study|Withdrawal by Subject|1
2636828|NCT00810641|9110895|P1|Overall Study|Withdrawal by Subject|0
2636829|NCT00810615|9110905|P2|Overall Study|Withdrawal by Subject|1
2636830|NCT00810615|9110906|P1|Overall Study|Withdrawal by Subject|1
2636831|NCT00810602|9110956|P2|Overall Study|Withdrawal by Subject|3
2636832|NCT00810602|9110957|P1|Overall Study|Withdrawal by Subject|8
2636833|NCT00810511|9110970|P2|Overall Study|deposits on contact lens|1
2636834|NCT00810511|9110971|P1|Overall Study|deposits on contact lens|0
2636835|NCT00810511|9110970|P2|Overall Study|Lost to Follow-up|0
2636836|NCT00810511|9110971|P1|Overall Study|Lost to Follow-up|1
2636837|NCT00810511|9110970|P2|Overall Study|death in the family|1
2636838|NCT00810511|9110971|P1|Overall Study|death in the family|0
2636839|NCT00810511|9110970|P2|Overall Study|Lack of Efficacy|1
2636840|NCT00810511|9110971|P1|Overall Study|Lack of Efficacy|9
2636841|NCT00810511|9110970|P2|Overall Study|Protocol Violation|1
2636842|NCT00810511|9110971|P1|Overall Study|Protocol Violation|0
2636843|NCT00810407|9110989|P1|Overall Study|No Visit After First Day of Treatment|3
2636844|NCT00810407|9110989|P1|Overall Study|Protocol Violation|3
2636845|NCT00810394|9111001|P1|Overall Study|Withdrawal by Subject|3
2636846|NCT00810368|9111009|P2|Overall Study|Lack of Efficacy|0
2636847|NCT00810368|9111010|P1|Overall Study|Lack of Efficacy|2
2636848|NCT00810368|9111009|P2|Overall Study|Lost to Follow-up|2
2636849|NCT00810368|9111010|P1|Overall Study|Lost to Follow-up|4
2636850|NCT00810355|9111031|P3|Overall Study|Withdrawal by Subject|0
2636851|NCT00810355|9111032|P2|Overall Study|Withdrawal by Subject|0
2636852|NCT00810355|9111033|P1|Overall Study|Withdrawal by Subject|1
2636853|NCT00810355|9111031|P3|Overall Study|Lost to Follow-up|11
2636854|NCT00810355|9111032|P2|Overall Study|Lost to Follow-up|17
2636855|NCT00810355|9111033|P1|Overall Study|Lost to Follow-up|13
2636856|NCT00810342|9111049|P2|12-month Followup|Lost to Follow-up|1
2636857|NCT00810342|9111050|P1|12-month Followup|Lost to Follow-up|3
2636858|NCT00810342|9111049|P2|12-month Followup|Pregnancy|10
2636859|NCT00810342|9111050|P1|12-month Followup|Pregnancy|9
2636860|NCT00810342|9111049|P2|6-month Follow-up|Pregnancy|2
2636861|NCT00810342|9111050|P1|6-month Follow-up|Pregnancy|6
2636862|NCT00810342|9111049|P2|6-month Follow-up|Lost to Follow-up|6
2636863|NCT00810342|9111050|P1|6-month Follow-up|Lost to Follow-up|18
2636864|NCT00810342|9111049|P2|Month 1 Follow-up|Pregnancy|0
2636865|NCT00810342|9111050|P1|Month 1 Follow-up|Pregnancy|1
2636866|NCT00810342|9111049|P2|Month 1 Follow-up|Lost to Follow-up|2
2636867|NCT00810342|9111050|P1|Month 1 Follow-up|Lost to Follow-up|4
2636868|NCT00810277|9111083|P1|Overall Study|Adverse Event|1
2636869|NCT00810264|9111096|P1|Overall Study|Death|641
2636870|NCT00810264|9111096|P1|Overall Study|Withdrawal by subject or physician|721
2636871|NCT00810264|9111096|P1|Overall Study|Lost to Follow-up|191
2636872|NCT00810199|9111123|P2|Overall Study|Did not receive study drug|1
2636873|NCT00810199|9111124|P1|Overall Study|Did not receive study drug|2
2636874|NCT00810199|9111123|P2|Overall Study|Failure to return|4
2636875|NCT00810199|9111124|P1|Overall Study|Failure to return|1
2636876|NCT00810199|9111123|P2|Overall Study|Protocol Violation|6
2636877|NCT00810199|9111124|P1|Overall Study|Protocol Violation|2
2636878|NCT00810199|9111123|P2|Overall Study|Administrative/Other|6
2636879|NCT00810199|9111124|P1|Overall Study|Administrative/Other|5
2636880|NCT00810199|9111123|P2|Overall Study|Refused treatment/Did not cooperate|7
2636881|NCT00810199|9111124|P1|Overall Study|Refused treatment/Did not cooperate|7
2636882|NCT00810199|9111123|P2|Overall Study|Insufficient therapeutic response|14
2636883|NCT00810199|9111124|P1|Overall Study|Insufficient therapeutic response|5
2636884|NCT00810199|9111123|P2|Overall Study|Withdrew consent|12
2636885|NCT00810199|9111124|P1|Overall Study|Withdrew consent|9
2636886|NCT00810199|9111123|P2|Overall Study|Death|6
2636887|NCT00810199|9111124|P1|Overall Study|Death|4
2636888|NCT00810199|9111123|P2|Overall Study|Adverse Event|26
2636889|NCT00810199|9111124|P1|Overall Study|Adverse Event|24
2636890|NCT00810108|9111202|P2|Overall Study|Withdrawal by Subject|0
2636891|NCT00810108|9111203|P1|Overall Study|Withdrawal by Subject|1
2636892|NCT00810082|9111217|P2|Overall Study|Lost to Follow-up|4
2636893|NCT00810082|9111218|P1|Overall Study|Lost to Follow-up|0
2636894|NCT00810069|9111226|P3|Double-Blind Period II|Protocol Violation|6
2636895|NCT00810069|9111227|P2|Double-Blind Period II|Protocol Violation|7
2636896|NCT00810069|9111228|P1|Double-Blind Period II|Protocol Violation|0
2636897|NCT00810069|9111226|P3|Double-Blind Period II|Clinical relapse|0
2636898|NCT00810069|9111227|P2|Double-Blind Period II|Clinical relapse|3
2636899|NCT00810069|9111228|P1|Double-Blind Period II|Clinical relapse|0
2636900|NCT00810069|9111226|P3|Double-Blind Period II|Protocol entry criterion not met|1
2636901|NCT00810069|9111227|P2|Double-Blind Period II|Protocol entry criterion not met|0
2636902|NCT00810069|9111228|P1|Double-Blind Period II|Protocol entry criterion not met|0
2636903|NCT00810069|9111226|P3|Double-Blind Period II|Withdrawal by Subject|35
2636904|NCT00810069|9111227|P2|Double-Blind Period II|Withdrawal by Subject|21
2636905|NCT00810069|9111228|P1|Double-Blind Period II|Withdrawal by Subject|0
2636906|NCT00810069|9111226|P3|Double-Blind Period II|Physician Decision|1
2636907|NCT00810069|9111227|P2|Double-Blind Period II|Physician Decision|0
2636908|NCT00810069|9111228|P1|Double-Blind Period II|Physician Decision|0
2636909|NCT00810069|9111226|P3|Double-Blind Period II|Lost to Follow-up|9
2636910|NCT00810069|9111227|P2|Double-Blind Period II|Lost to Follow-up|9
2636911|NCT00810069|9111228|P1|Double-Blind Period II|Lost to Follow-up|0
2636912|NCT00810069|9111226|P3|Double-Blind Period II|Lack of Efficacy|12
2636913|NCT00810069|9111227|P2|Double-Blind Period II|Lack of Efficacy|7
2636914|NCT00810069|9111228|P1|Double-Blind Period II|Lack of Efficacy|0
2636915|NCT00810069|9111226|P3|Double-Blind Period II|Adverse Event|8
2636916|NCT00810069|9111227|P2|Double-Blind Period II|Adverse Event|9
2636917|NCT00810069|9111228|P1|Double-Blind Period II|Adverse Event|0
2636918|NCT00810069|9111226|P3|Lead-in Period I|Randomization criteria not met|0
2636919|NCT00810069|9111227|P2|Lead-in Period I|Randomization criteria not met|0
2636920|NCT00810069|9111228|P1|Lead-in Period I|Randomization criteria not met|158
2636921|NCT00810069|9111226|P3|Lead-in Period I|Protocol entry criterion not met|0
2636922|NCT00810069|9111227|P2|Lead-in Period I|Protocol entry criterion not met|0
2636923|NCT00810069|9111228|P1|Lead-in Period I|Protocol entry criterion not met|5
2636924|NCT00810069|9111226|P3|Lead-in Period I|Withdrawal by Subject|0
2636925|NCT00810069|9111227|P2|Lead-in Period I|Withdrawal by Subject|0
2636926|NCT00810069|9111228|P1|Lead-in Period I|Withdrawal by Subject|46
2636927|NCT00810069|9111226|P3|Lead-in Period I|Protocol Violation|0
2636928|NCT00810069|9111227|P2|Lead-in Period I|Protocol Violation|0
2636929|NCT00810069|9111228|P1|Lead-in Period I|Protocol Violation|1
2636930|NCT00810069|9111226|P3|Lead-in Period I|Physician Decision|0
2636931|NCT00810069|9111227|P2|Lead-in Period I|Physician Decision|0
2636932|NCT00810069|9111228|P1|Lead-in Period I|Physician Decision|1
2636933|NCT00810069|9111226|P3|Lead-in Period I|Lost to Follow-up|0
2636934|NCT00810069|9111227|P2|Lead-in Period I|Lost to Follow-up|0
2636935|NCT00810069|9111228|P1|Lead-in Period I|Lost to Follow-up|19
2636936|NCT00810069|9111226|P3|Lead-in Period I|Lack of Efficacy|0
2636937|NCT00810069|9111227|P2|Lead-in Period I|Lack of Efficacy|0
2636938|NCT00810069|9111228|P1|Lead-in Period I|Lack of Efficacy|1
2636939|NCT00810069|9111226|P3|Lead-in Period I|Adverse Event|0
2636940|NCT00810069|9111227|P2|Lead-in Period I|Adverse Event|0
2636941|NCT00810069|9111228|P1|Lead-in Period I|Adverse Event|43
2636942|NCT00810043|9111273|P3|Overall Study|No longer met enrollment criteria|3
2636943|NCT00810043|9111274|P2|Overall Study|No longer met enrollment criteria|0
2636944|NCT00810043|9111275|P1|Overall Study|No longer met enrollment criteria|0
2636945|NCT00810043|9111273|P3|Overall Study|Non-medical problem|1
2636946|NCT00810043|9111274|P2|Overall Study|Non-medical problem|0
2636947|NCT00810043|9111275|P1|Overall Study|Non-medical problem|0
2636948|NCT00810043|9111273|P3|Overall Study|Unrelated medical problem|0
2636949|NCT00810043|9111274|P2|Overall Study|Unrelated medical problem|1
2636950|NCT00810043|9111275|P1|Overall Study|Unrelated medical problem|0
2636951|NCT00810043|9111273|P3|Overall Study|Death|0
2636952|NCT00810043|9111274|P2|Overall Study|Death|0
2636953|NCT00810043|9111275|P1|Overall Study|Death|2
2636954|NCT00810043|9111273|P3|Overall Study|Physician Decision|2
2636955|NCT00810043|9111274|P2|Overall Study|Physician Decision|0
2636956|NCT00810043|9111275|P1|Overall Study|Physician Decision|0
2636957|NCT00810043|9111273|P3|Overall Study|Lost to Follow-up|0
2636958|NCT00810043|9111274|P2|Overall Study|Lost to Follow-up|0
2636959|NCT00810043|9111275|P1|Overall Study|Lost to Follow-up|1
2636960|NCT00810043|9111273|P3|Overall Study|Withdrawal by Subject|2
2636961|NCT00810043|9111274|P2|Overall Study|Withdrawal by Subject|0
2636962|NCT00810043|9111275|P1|Overall Study|Withdrawal by Subject|1
2636963|NCT00809965|9111297|P3|Overall Study|Other Reason|189
2636964|NCT00809965|9111298|P2|Overall Study|Other Reason|170
2636965|NCT00809965|9111299|P1|Overall Study|Other Reason|167
2636966|NCT00809965|9111297|P3|Overall Study|Withdrawal by Subject|441
2636967|NCT00809965|9111298|P2|Overall Study|Withdrawal by Subject|448
2636968|NCT00809965|9111299|P1|Overall Study|Withdrawal by Subject|405
2636969|NCT00809965|9111297|P3|Overall Study|Lost to Follow-up|18
2636970|NCT00809965|9111298|P2|Overall Study|Lost to Follow-up|10
2636971|NCT00809965|9111299|P1|Overall Study|Lost to Follow-up|17
2636972|NCT00809965|9111297|P3|Overall Study|Death|196
2636973|NCT00809965|9111298|P2|Overall Study|Death|147
2636974|NCT00809965|9111299|P1|Overall Study|Death|194
2636975|NCT00809926|9111321|P2|Overall Study|Protocol deviation|2
2636976|NCT00809926|9111322|P1|Overall Study|Protocol deviation|0
2636977|NCT00809926|9111321|P2|Overall Study|Administrative Problems|1
2636978|NCT00809926|9111322|P1|Overall Study|Administrative Problems|0
2636979|NCT00809926|9111321|P2|Overall Study|Lost to Follow-up|1
2636980|NCT00809926|9111322|P1|Overall Study|Lost to Follow-up|2
2636981|NCT00809926|9111321|P2|Overall Study|Patient withdrew consent|6
2636982|NCT00809926|9111322|P1|Overall Study|Patient withdrew consent|8
2636983|NCT00809926|9111321|P2|Overall Study|Unsatisfactory therapeutic effect|3
2636984|NCT00809926|9111322|P1|Overall Study|Unsatisfactory therapeutic effect|3
2636985|NCT00809926|9111321|P2|Overall Study|Adverse Event|10
2636986|NCT00809926|9111322|P1|Overall Study|Adverse Event|18
2636987|NCT00809835|9111376|P4|Overall Study|Withdrawal by Subject|0
2636988|NCT00809835|9111377|P3|Overall Study|Withdrawal by Subject|1
2636989|NCT00809835|9111378|P2|Overall Study|Withdrawal by Subject|1
2636990|NCT00809835|9111379|P1|Overall Study|Withdrawal by Subject|1
2636991|NCT00809835|9111376|P4|Overall Study|Lost to Follow-up|2
2636992|NCT00809835|9111377|P3|Overall Study|Lost to Follow-up|10
2636993|NCT00809835|9111378|P2|Overall Study|Lost to Follow-up|6
2636994|NCT00809835|9111379|P1|Overall Study|Lost to Follow-up|7
2636995|NCT00809757|9111409|P3|Overall Study|Noncompliance with Medication|1
2636996|NCT00809757|9111410|P2|Overall Study|Noncompliance with Medication|0
2636997|NCT00809757|9111411|P1|Overall Study|Noncompliance with Medication|0
2636998|NCT00809757|9111409|P3|Overall Study|Subject Uncooperative|2
2636999|NCT00809757|9111410|P2|Overall Study|Subject Uncooperative|0
2637000|NCT00809757|9111411|P1|Overall Study|Subject Uncooperative|1
2637001|NCT00809757|9111409|P3|Overall Study|Withdrawal by Subject|3
2637002|NCT00809757|9111410|P2|Overall Study|Withdrawal by Subject|1
2637003|NCT00809757|9111411|P1|Overall Study|Withdrawal by Subject|2
2637004|NCT00809757|9111409|P3|Overall Study|Protocol Violation|1
2637005|NCT00809757|9111410|P2|Overall Study|Protocol Violation|1
2637006|NCT00809757|9111411|P1|Overall Study|Protocol Violation|1
2637007|NCT00809757|9111409|P3|Overall Study|Lost to Follow-up|1
2637008|NCT00809757|9111410|P2|Overall Study|Lost to Follow-up|0
2637009|NCT00809757|9111411|P1|Overall Study|Lost to Follow-up|0
2637010|NCT00809757|9111409|P3|Overall Study|Adverse Event|3
2637011|NCT00809757|9111410|P2|Overall Study|Adverse Event|3
2637012|NCT00809757|9111411|P1|Overall Study|Adverse Event|2
2637013|NCT00809614|9111496|P2|Overall Study|Withdrawal by Subject|1
2637014|NCT00809614|9111497|P1|Overall Study|Withdrawal by Subject|1
2637015|NCT00809614|9111496|P2|Overall Study|Lack of Efficacy|3
2637016|NCT00809614|9111497|P1|Overall Study|Lack of Efficacy|2
2637017|NCT00809471|9111541|P3|Overall Study|Requirement for restricted medication|0
2637018|NCT00809471|9111542|P2|Overall Study|Requirement for restricted medication|1
2637019|NCT00809471|9111543|P1|Overall Study|Requirement for restricted medication|1
2637020|NCT00809471|9111541|P3|Overall Study|Adverse Event|2
2637021|NCT00809471|9111542|P2|Overall Study|Adverse Event|2
2637022|NCT00809471|9111543|P1|Overall Study|Adverse Event|0
2637023|NCT00809471|9111541|P3|Overall Study|Lost to Follow-up|9
2637024|NCT00809471|9111542|P2|Overall Study|Lost to Follow-up|2
2637025|NCT00809471|9111543|P1|Overall Study|Lost to Follow-up|4
2637026|NCT00809471|9111541|P3|Overall Study|Protocol non-compliance|6
2637027|NCT00809471|9111542|P2|Overall Study|Protocol non-compliance|15
2637028|NCT00809471|9111543|P1|Overall Study|Protocol non-compliance|15
2637029|NCT00809445|9111573|P3|6 Month Follow-up|Withdrew consent|1
2637030|NCT00809445|9111574|P2|6 Month Follow-up|Withdrew consent|0
2637031|NCT00809445|9111575|P1|6 Month Follow-up|Withdrew consent|0
2637032|NCT00809445|9111573|P3|6 Month Follow-up|Incarcerated|8
2637033|NCT00809445|9111574|P2|6 Month Follow-up|Incarcerated|8
2637034|NCT00809445|9111575|P1|6 Month Follow-up|Incarcerated|6
2637035|NCT00809445|9111573|P3|6 Month Follow-up|Death|1
2637036|NCT00809445|9111574|P2|6 Month Follow-up|Death|1
2637037|NCT00809445|9111575|P1|6 Month Follow-up|Death|2
2637038|NCT00809445|9111573|P3|6 Month Follow-up|Lost contact|14
2637039|NCT00809445|9111574|P2|6 Month Follow-up|Lost contact|14
2637040|NCT00809445|9111575|P1|6 Month Follow-up|Lost contact|16
2637041|NCT00809445|9111573|P3|1 Month Follow-up|Incarcerated|1
2637042|NCT00809445|9111574|P2|1 Month Follow-up|Incarcerated|0
2637043|NCT00809445|9111575|P1|1 Month Follow-up|Incarcerated|0
2637044|NCT00809445|9111573|P3|1 Month Follow-up|Death|1
2637045|NCT00809445|9111574|P2|1 Month Follow-up|Death|1
2637046|NCT00809445|9111575|P1|1 Month Follow-up|Death|0
2637047|NCT00809445|9111573|P3|1 Month Follow-up|Withdrew consent|1
2637048|NCT00809445|9111574|P2|1 Month Follow-up|Withdrew consent|1
2637049|NCT00809445|9111575|P1|1 Month Follow-up|Withdrew consent|1
2637050|NCT00809445|9111573|P3|1 Month Follow-up|Lost contact|1
2637051|NCT00809445|9111574|P2|1 Month Follow-up|Lost contact|2
2637052|NCT00809445|9111575|P1|1 Month Follow-up|Lost contact|1
2637053|NCT00809341|9111594|P2|Overall Study|Physician Decision|1
2637054|NCT00809341|9111595|P1|Overall Study|Physician Decision|0
2637055|NCT00809328|9111603|P1|Overall Study|Withdrawal by Subject|2
2637056|NCT00809328|9111603|P1|Overall Study|Protocol Violation|3
2637057|NCT00809328|9111603|P1|Overall Study|Adverse Event|6
2637058|NCT00809328|9111603|P1|Overall Study|Lack of Efficacy|18
2637059|NCT00809159|9111625|P6|Part 1 and 2|Withdrawal by Subject|1
2637060|NCT00809159|9111626|P5|Part 1 and 2|Withdrawal by Subject|0
2637061|NCT00809159|9111627|P4|Part 1 and 2|Withdrawal by Subject|0
2637062|NCT00809159|9111628|P3|Part 1 and 2|Withdrawal by Subject|4
2637063|NCT00809159|9111629|P2|Part 1 and 2|Withdrawal by Subject|0
2637064|NCT00809159|9111630|P1|Part 1 and 2|Withdrawal by Subject|0
2637065|NCT00809159|9111625|P6|Part 1 and 2|Lost to Follow-up|0
2637066|NCT00809159|9111626|P5|Part 1 and 2|Lost to Follow-up|0
2637067|NCT00809159|9111627|P4|Part 1 and 2|Lost to Follow-up|1
2637068|NCT00809159|9111628|P3|Part 1 and 2|Lost to Follow-up|1
2637069|NCT00809159|9111629|P2|Part 1 and 2|Lost to Follow-up|0
2637070|NCT00809159|9111630|P1|Part 1 and 2|Lost to Follow-up|0
2637071|NCT00809159|9111625|P6|Part 1 and 2|Adverse Event|1
2637072|NCT00809159|9111626|P5|Part 1 and 2|Adverse Event|1
2637073|NCT00809159|9111627|P4|Part 1 and 2|Adverse Event|0
2637074|NCT00809159|9111628|P3|Part 1 and 2|Adverse Event|1
2637075|NCT00809159|9111629|P2|Part 1 and 2|Adverse Event|0
2637076|NCT00809159|9111630|P1|Part 1 and 2|Adverse Event|0
2637077|NCT00809159|9111625|P6|Part 1 and 2|Administrative problems|0
2637078|NCT00809159|9111626|P5|Part 1 and 2|Administrative problems|0
2637079|NCT00809159|9111627|P4|Part 1 and 2|Administrative problems|1
2637080|NCT00809159|9111628|P3|Part 1 and 2|Administrative problems|0
2637081|NCT00809159|9111629|P2|Part 1 and 2|Administrative problems|0
2637082|NCT00809159|9111630|P1|Part 1 and 2|Administrative problems|0
2637083|NCT00809159|9111625|P6|Part 1 and 2|Unsatisfactory therapeutic effect|1
2637084|NCT00809159|9111626|P5|Part 1 and 2|Unsatisfactory therapeutic effect|5
2637085|NCT00809159|9111627|P4|Part 1 and 2|Unsatisfactory therapeutic effect|3
2637086|NCT00809159|9111628|P3|Part 1 and 2|Unsatisfactory therapeutic effect|4
2637087|NCT00809159|9111629|P2|Part 1 and 2|Unsatisfactory therapeutic effect|0
2637088|NCT00809159|9111630|P1|Part 1 and 2|Unsatisfactory therapeutic effect|0
2637089|NCT00809159|9111625|P6|Part 1|Unsatisfactory therapeutic effect|0
2637090|NCT00809159|9111626|P5|Part 1|Unsatisfactory therapeutic effect|0
2637091|NCT00809159|9111627|P4|Part 1|Unsatisfactory therapeutic effect|0
2637092|NCT00809159|9111628|P3|Part 1|Unsatisfactory therapeutic effect|0
2637093|NCT00809159|9111629|P2|Part 1|Unsatisfactory therapeutic effect|1
2637094|NCT00809159|9111630|P1|Part 1|Unsatisfactory therapeutic effect|3
2637095|NCT00809159|9111625|P6|Part 1|Withdrawal by Subject|0
2637096|NCT00809159|9111626|P5|Part 1|Withdrawal by Subject|0
2637097|NCT00809159|9111627|P4|Part 1|Withdrawal by Subject|0
2637098|NCT00809159|9111628|P3|Part 1|Withdrawal by Subject|0
2637099|NCT00809159|9111629|P2|Part 1|Withdrawal by Subject|1
2637100|NCT00809159|9111630|P1|Part 1|Withdrawal by Subject|3
2637101|NCT00809159|9111625|P6|Part 1|Lost to Follow-up|0
2637102|NCT00809159|9111626|P5|Part 1|Lost to Follow-up|0
2637103|NCT00809159|9111627|P4|Part 1|Lost to Follow-up|0
2637104|NCT00809159|9111628|P3|Part 1|Lost to Follow-up|0
2637105|NCT00809159|9111629|P2|Part 1|Lost to Follow-up|0
2637106|NCT00809159|9111630|P1|Part 1|Lost to Follow-up|1
2637107|NCT00809159|9111625|P6|Part 1|Adverse Event|0
2637108|NCT00809159|9111626|P5|Part 1|Adverse Event|0
2637109|NCT00809159|9111627|P4|Part 1|Adverse Event|0
2637110|NCT00809159|9111628|P3|Part 1|Adverse Event|0
2637111|NCT00809159|9111629|P2|Part 1|Adverse Event|1
2637112|NCT00809159|9111630|P1|Part 1|Adverse Event|1
2637113|NCT00809133|9111735|P14|Overall Study|Other not mentioned above|0
2637114|NCT00809133|9111736|P13|Overall Study|Other not mentioned above|0
2637115|NCT00809133|9111737|P12|Overall Study|Other not mentioned above|0
2637116|NCT00809133|9111738|P11|Overall Study|Other not mentioned above|0
2637117|NCT00809133|9111739|P10|Overall Study|Other not mentioned above|0
2637118|NCT00809133|9111740|P9|Overall Study|Other not mentioned above|0
2637119|NCT00809133|9111741|P8|Overall Study|Other not mentioned above|0
2637120|NCT00809133|9111742|P7|Overall Study|Other not mentioned above|0
2637121|NCT00809133|9111743|P6|Overall Study|Other not mentioned above|1
2637122|NCT00809133|9111744|P5|Overall Study|Other not mentioned above|0
2637123|NCT00809133|9111745|P4|Overall Study|Other not mentioned above|0
2637124|NCT00809133|9111746|P3|Overall Study|Other not mentioned above|0
2637125|NCT00809133|9111747|P2|Overall Study|Other not mentioned above|1
2637126|NCT00809133|9111748|P1|Overall Study|Other not mentioned above|0
2637127|NCT00809133|9111735|P14|Overall Study|Consent withdrawn|0
2637128|NCT00809133|9111736|P13|Overall Study|Consent withdrawn|0
2637129|NCT00809133|9111737|P12|Overall Study|Consent withdrawn|0
2637130|NCT00809133|9111738|P11|Overall Study|Consent withdrawn|0
2637131|NCT00809133|9111739|P10|Overall Study|Consent withdrawn|0
2637132|NCT00809133|9111740|P9|Overall Study|Consent withdrawn|0
2637133|NCT00809133|9111741|P8|Overall Study|Consent withdrawn|0
2637134|NCT00809133|9111742|P7|Overall Study|Consent withdrawn|0
2637135|NCT00809133|9111743|P6|Overall Study|Consent withdrawn|0
2637136|NCT00809133|9111744|P5|Overall Study|Consent withdrawn|1
2637137|NCT00809133|9111745|P4|Overall Study|Consent withdrawn|0
2637138|NCT00809133|9111746|P3|Overall Study|Consent withdrawn|0
2637139|NCT00809133|9111747|P2|Overall Study|Consent withdrawn|0
2637140|NCT00809133|9111748|P1|Overall Study|Consent withdrawn|0
2637141|NCT00809133|9111735|P14|Overall Study|Lost to Follow-up|0
2637142|NCT00809133|9111736|P13|Overall Study|Lost to Follow-up|0
2637143|NCT00809133|9111737|P12|Overall Study|Lost to Follow-up|0
2637144|NCT00809133|9111738|P11|Overall Study|Lost to Follow-up|0
2637145|NCT00809133|9111739|P10|Overall Study|Lost to Follow-up|0
2637146|NCT00809133|9111740|P9|Overall Study|Lost to Follow-up|0
2637147|NCT00809133|9111741|P8|Overall Study|Lost to Follow-up|0
2637148|NCT00809133|9111742|P7|Overall Study|Lost to Follow-up|0
2637149|NCT00809133|9111743|P6|Overall Study|Lost to Follow-up|1
2637150|NCT00809133|9111744|P5|Overall Study|Lost to Follow-up|0
2637151|NCT00809133|9111745|P4|Overall Study|Lost to Follow-up|0
2637152|NCT00809133|9111746|P3|Overall Study|Lost to Follow-up|0
2637153|NCT00809133|9111747|P2|Overall Study|Lost to Follow-up|0
2637154|NCT00809133|9111748|P1|Overall Study|Lost to Follow-up|0
2637155|NCT00809133|9111735|P14|Overall Study|Other adverse event|1
2637156|NCT00809133|9111736|P13|Overall Study|Other adverse event|0
2637157|NCT00809133|9111737|P12|Overall Study|Other adverse event|1
2637158|NCT00809133|9111738|P11|Overall Study|Other adverse event|1
2637159|NCT00809133|9111739|P10|Overall Study|Other adverse event|0
2637160|NCT00809133|9111740|P9|Overall Study|Other adverse event|0
2637161|NCT00809133|9111741|P8|Overall Study|Other adverse event|4
2637162|NCT00809133|9111742|P7|Overall Study|Other adverse event|2
2637163|NCT00809133|9111743|P6|Overall Study|Other adverse event|3
2637164|NCT00809133|9111744|P5|Overall Study|Other adverse event|0
2637165|NCT00809133|9111745|P4|Overall Study|Other adverse event|0
2637166|NCT00809133|9111746|P3|Overall Study|Other adverse event|1
2637167|NCT00809133|9111747|P2|Overall Study|Other adverse event|1
2637168|NCT00809133|9111748|P1|Overall Study|Other adverse event|1
2637169|NCT00809133|9111735|P14|Overall Study|Dose Limiting Toxicity (DLT)|2
2637170|NCT00809133|9111736|P13|Overall Study|Dose Limiting Toxicity (DLT)|0
2637171|NCT00809133|9111737|P12|Overall Study|Dose Limiting Toxicity (DLT)|0
2637172|NCT00809133|9111738|P11|Overall Study|Dose Limiting Toxicity (DLT)|0
2637173|NCT00809133|9111739|P10|Overall Study|Dose Limiting Toxicity (DLT)|0
2637174|NCT00809133|9111740|P9|Overall Study|Dose Limiting Toxicity (DLT)|0
2637175|NCT00809133|9111741|P8|Overall Study|Dose Limiting Toxicity (DLT)|1
2637176|NCT00809133|9111742|P7|Overall Study|Dose Limiting Toxicity (DLT)|1
2637177|NCT00809133|9111743|P6|Overall Study|Dose Limiting Toxicity (DLT)|1
2637178|NCT00809133|9111744|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
2637179|NCT00809133|9111745|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
2637180|NCT00809133|9111746|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
2637181|NCT00809133|9111747|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
2637182|NCT00809133|9111748|P1|Overall Study|Dose Limiting Toxicity (DLT)|0
2637183|NCT00809133|9111735|P14|Overall Study|Progressive disease|4
2637184|NCT00809133|9111736|P13|Overall Study|Progressive disease|5
2637185|NCT00809133|9111737|P12|Overall Study|Progressive disease|7
2637186|NCT00809133|9111738|P11|Overall Study|Progressive disease|5
2637187|NCT00809133|9111739|P10|Overall Study|Progressive disease|9
2637188|NCT00809133|9111740|P9|Overall Study|Progressive disease|3
2637189|NCT00809133|9111741|P8|Overall Study|Progressive disease|3
2637190|NCT00809133|9111742|P7|Overall Study|Progressive disease|3
2637191|NCT00809133|9111743|P6|Overall Study|Progressive disease|1
2637192|NCT00809133|9111744|P5|Overall Study|Progressive disease|4
2637193|NCT00809133|9111745|P4|Overall Study|Progressive disease|3
2637194|NCT00809133|9111746|P3|Overall Study|Progressive disease|5
2637195|NCT00809133|9111747|P2|Overall Study|Progressive disease|5
2637196|NCT00809133|9111748|P1|Overall Study|Progressive disease|2
2637197|NCT00809094|9111902|P2|Overall Study|Lost to Follow-up|1
2637198|NCT00809094|9111903|P1|Overall Study|Lost to Follow-up|0
2637199|NCT00808899|9111948|P1|Overall Study|Physician Decision|3
2637200|NCT00808899|9111948|P1|Overall Study|Death|1
2637201|NCT00808808|9111962|P3|Overall Study|Employee was not vaccinated.|2255
2637202|NCT00808808|9111963|P2|Overall Study|Employee was not vaccinated.|2268
2637203|NCT00808808|9111964|P1|Overall Study|Employee was not vaccinated.|2686
2637204|NCT00808808|9111962|P3|Overall Study|Vaccinated; survey not completed|302
2637205|NCT00808808|9111963|P2|Overall Study|Vaccinated; survey not completed|169
2637206|NCT00808808|9111964|P1|Overall Study|Vaccinated; survey not completed|131
2637207|NCT00808665|9111999|P2|Overall Study|Medication stopped by resident|1
2637208|NCT00808665|9112000|P1|Overall Study|Medication stopped by resident|0
2637209|NCT00808665|9111999|P2|Overall Study|Physician Decision|1
2637210|NCT00808665|9112000|P1|Overall Study|Physician Decision|3
2637211|NCT00808665|9111999|P2|Overall Study|required an additional procedure|1
2637212|NCT00808665|9112000|P1|Overall Study|required an additional procedure|0
2637213|NCT00808665|9111999|P2|Overall Study|surgery cancelled|0
2637214|NCT00808665|9112000|P1|Overall Study|surgery cancelled|1
2637215|NCT00808665|9111999|P2|Overall Study|only required minimally invasive surgery|0
2637216|NCT00808665|9112000|P1|Overall Study|only required minimally invasive surgery|1
2637217|NCT00808665|9111999|P2|Overall Study|Withdrawal by Subject|0
2637218|NCT00808665|9112000|P1|Overall Study|Withdrawal by Subject|1
2637219|NCT00808639|9112006|P1|Overall Study|Disease progression before surgery.|1
2637220|NCT00808509|9112014|P2|Randomized Phase|Patient refused rescue therapy|3
2637221|NCT00808509|9112015|P1|Randomized Phase|Patient refused rescue therapy|0
2637222|NCT00808509|9112014|P2|Randomized Phase|Reduced methotrexate dose|2
2637223|NCT00808509|9112015|P1|Randomized Phase|Reduced methotrexate dose|1
2637224|NCT00808509|9112014|P2|Randomized Phase|Did not meet eligibility criteria|0
2637225|NCT00808509|9112015|P1|Randomized Phase|Did not meet eligibility criteria|1
2637226|NCT00808483|9112113|P2|From 5 Months to 12 Months|Lack of Efficacy|0
2637227|NCT00808483|9112114|P1|From 5 Months to 12 Months|Lack of Efficacy|1
2637228|NCT00808483|9112113|P2|From 3 to 5 Months After Surgery|Lack of Efficacy|0
2637229|NCT00808483|9112114|P1|From 3 to 5 Months After Surgery|Lack of Efficacy|1
2637230|NCT00808483|9112113|P2|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
2637231|NCT00808483|9112114|P1|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
2637232|NCT00808444|9112151|P2|Overall Study|Lost to Follow-up|1
2637233|NCT00808444|9112152|P1|Overall Study|Lost to Follow-up|0
2637234|NCT00808444|9112151|P2|Overall Study|Withdrawal by Subject|0
2637235|NCT00808444|9112152|P1|Overall Study|Withdrawal by Subject|1
2637236|NCT00808249|9112227|P4|Overall Study|All other reasons|1
2637237|NCT00808249|9112228|P3|Overall Study|All other reasons|3
2637238|NCT00808249|9112229|P2|Overall Study|All other reasons|1
2637239|NCT00808249|9112230|P1|Overall Study|All other reasons|2
2637240|NCT00808249|9112227|P4|Overall Study|study specific discontinuation criteria|0
2637241|NCT00808249|9112228|P3|Overall Study|study specific discontinuation criteria|1
2637242|NCT00808249|9112229|P2|Overall Study|study specific discontinuation criteria|0
2637243|NCT00808249|9112230|P1|Overall Study|study specific discontinuation criteria|1
2637244|NCT00808249|9112227|P4|Overall Study|Lack of Efficacy|0
2637245|NCT00808249|9112228|P3|Overall Study|Lack of Efficacy|0
2637246|NCT00808249|9112229|P2|Overall Study|Lack of Efficacy|1
2637247|NCT00808249|9112230|P1|Overall Study|Lack of Efficacy|1
2637248|NCT00808249|9112227|P4|Overall Study|Protocol Violation|0
2637249|NCT00808249|9112228|P3|Overall Study|Protocol Violation|3
2637250|NCT00808249|9112229|P2|Overall Study|Protocol Violation|3
2637251|NCT00808249|9112230|P1|Overall Study|Protocol Violation|3
2637252|NCT00808249|9112227|P4|Overall Study|Withdrawal by Subject|4
2637253|NCT00808249|9112228|P3|Overall Study|Withdrawal by Subject|2
2637254|NCT00808249|9112229|P2|Overall Study|Withdrawal by Subject|0
2637255|NCT00808249|9112230|P1|Overall Study|Withdrawal by Subject|4
2637256|NCT00808249|9112227|P4|Overall Study|Lost to Follow-up|5
2637257|NCT00808249|9112228|P3|Overall Study|Lost to Follow-up|3
2637258|NCT00808249|9112229|P2|Overall Study|Lost to Follow-up|3
2637259|NCT00808249|9112230|P1|Overall Study|Lost to Follow-up|2
2637260|NCT00808249|9112227|P4|Overall Study|Adverse Event|6
2637261|NCT00808249|9112228|P3|Overall Study|Adverse Event|10
2637262|NCT00808249|9112229|P2|Overall Study|Adverse Event|7
2637263|NCT00808249|9112230|P1|Overall Study|Adverse Event|4
2637264|NCT00808236|9112258|P2|Overall Study|Death|30
2637265|NCT00808236|9112259|P1|Overall Study|Death|18
2637266|NCT00808236|9112258|P2|Overall Study|Physician Decision|1
2637267|NCT00808236|9112259|P1|Overall Study|Physician Decision|0
2637268|NCT00808236|9112258|P2|Overall Study|Lost to Follow-up|1
2637269|NCT00808236|9112259|P1|Overall Study|Lost to Follow-up|1
2637270|NCT00808236|9112258|P2|Overall Study|Pre-defined exclusion|3
2637271|NCT00808236|9112259|P1|Overall Study|Pre-defined exclusion|13
2637272|NCT00808236|9112258|P2|Overall Study|Was not resuscitated|56
2637273|NCT00808236|9112259|P1|Overall Study|Was not resuscitated|50
2637274|NCT00808132|9112292|P5|Overall Study|Unsatisfactory response|12
2637275|NCT00808132|9112293|P4|Overall Study|Unsatisfactory response|4
2637276|NCT00808132|9112294|P3|Overall Study|Unsatisfactory response|6
2637277|NCT00808132|9112295|P2|Overall Study|Unsatisfactory response|6
2637278|NCT00808132|9112296|P1|Overall Study|Unsatisfactory response|5
2637279|NCT00808132|9112292|P5|Overall Study|Randomized, but not treated|9
2637280|NCT00808132|9112293|P4|Overall Study|Randomized, but not treated|8
2637281|NCT00808132|9112294|P3|Overall Study|Randomized, but not treated|9
2637282|NCT00808132|9112295|P2|Overall Study|Randomized, but not treated|7
2637283|NCT00808132|9112296|P1|Overall Study|Randomized, but not treated|10
2637284|NCT00808132|9112292|P5|Overall Study|Other|15
2637285|NCT00808132|9112293|P4|Overall Study|Other|2
2637286|NCT00808132|9112294|P3|Overall Study|Other|6
2637287|NCT00808132|9112295|P2|Overall Study|Other|4
2637288|NCT00808132|9112296|P1|Overall Study|Other|6
2637289|NCT00808132|9112292|P5|Overall Study|Withdrawal by Subject|16
2637290|NCT00808132|9112293|P4|Overall Study|Withdrawal by Subject|7
2637291|NCT00808132|9112294|P3|Overall Study|Withdrawal by Subject|2
2637292|NCT00808132|9112295|P2|Overall Study|Withdrawal by Subject|18
2637293|NCT00808132|9112296|P1|Overall Study|Withdrawal by Subject|27
2637294|NCT00808132|9112292|P5|Overall Study|Protocol Violation|5
2637295|NCT00808132|9112293|P4|Overall Study|Protocol Violation|9
2637296|NCT00808132|9112294|P3|Overall Study|Protocol Violation|4
2637297|NCT00808132|9112295|P2|Overall Study|Protocol Violation|9
2637298|NCT00808132|9112296|P1|Overall Study|Protocol Violation|8
2637299|NCT00808132|9112292|P5|Overall Study|Lost to Follow-up|9
2637300|NCT00808132|9112293|P4|Overall Study|Lost to Follow-up|8
2637301|NCT00808132|9112294|P3|Overall Study|Lost to Follow-up|11
2637302|NCT00808132|9112295|P2|Overall Study|Lost to Follow-up|10
2637303|NCT00808132|9112296|P1|Overall Study|Lost to Follow-up|8
2637304|NCT00808132|9112292|P5|Overall Study|Physician Decision|0
2637305|NCT00808132|9112293|P4|Overall Study|Physician Decision|0
2637306|NCT00808132|9112294|P3|Overall Study|Physician Decision|0
2637307|NCT00808132|9112295|P2|Overall Study|Physician Decision|1
2637308|NCT00808132|9112296|P1|Overall Study|Physician Decision|0
2637309|NCT00808132|9112292|P5|Overall Study|Death|1
2637310|NCT00808132|9112293|P4|Overall Study|Death|0
2637311|NCT00808132|9112294|P3|Overall Study|Death|0
2637312|NCT00808132|9112295|P2|Overall Study|Death|0
2637313|NCT00808132|9112296|P1|Overall Study|Death|0
2637314|NCT00808132|9112292|P5|Overall Study|Adverse Event|33
2637315|NCT00808132|9112293|P4|Overall Study|Adverse Event|31
2637316|NCT00808132|9112294|P3|Overall Study|Adverse Event|16
2637317|NCT00808132|9112295|P2|Overall Study|Adverse Event|33
2637318|NCT00808132|9112296|P1|Overall Study|Adverse Event|34
2637319|NCT00808080|9112368|P1|Overall Study|Patients Became Ineligible for infusion|6
2637320|NCT00808067|9112375|P2|Overall Study|Excluded from analysis|19
2637321|NCT00808067|9112376|P1|Overall Study|Excluded from analysis|13
2637322|NCT00808067|9112375|P2|Overall Study|Other reason not defined above|5
2637323|NCT00808067|9112376|P1|Overall Study|Other reason not defined above|5
2637324|NCT00808067|9112375|P2|Overall Study|Site closed for cause|19
2637325|NCT00808067|9112376|P1|Overall Study|Site closed for cause|19
2637326|NCT00808067|9112375|P2|Overall Study|Patient elected|9
2637327|NCT00808067|9112376|P1|Overall Study|Patient elected|7
2637328|NCT00808067|9112375|P2|Overall Study|Protocol Violation|11
2637329|NCT00808067|9112376|P1|Overall Study|Protocol Violation|3
2637330|NCT00808067|9112375|P2|Overall Study|Physician Decision|38
2637331|NCT00808067|9112376|P1|Overall Study|Physician Decision|47
2637332|NCT00808067|9112375|P2|Overall Study|Site closed|3
2637333|NCT00808067|9112376|P1|Overall Study|Site closed|4
2637334|NCT00808067|9112375|P2|Overall Study|Withdrawal by Subject|25
2637335|NCT00808067|9112376|P1|Overall Study|Withdrawal by Subject|21
2637336|NCT00808067|9112375|P2|Overall Study|Procedure|7
2637337|NCT00808067|9112376|P1|Overall Study|Procedure|6
2637338|NCT00808067|9112375|P2|Overall Study|Death|1
2637339|NCT00808067|9112376|P1|Overall Study|Death|1
2637340|NCT00808067|9112375|P2|Overall Study|Missing|0
2637341|NCT00808067|9112376|P1|Overall Study|Missing|1
2637342|NCT00808067|9112375|P2|Overall Study|Patient refused to take study medication|76
2637343|NCT00808067|9112376|P1|Overall Study|Patient refused to take study medication|65
2637344|NCT00808067|9112375|P2|Overall Study|Elevated LFT results|3
2637345|NCT00808067|9112376|P1|Overall Study|Elevated LFT results|7
2637346|NCT00808067|9112375|P2|Overall Study|Reduced creatinine clearance|55
2637347|NCT00808067|9112376|P1|Overall Study|Reduced creatinine clearance|53
2637348|NCT00808067|9112375|P2|Overall Study|Hospitalization due to surgery|40
2637349|NCT00808067|9112376|P1|Overall Study|Hospitalization due to surgery|37
2637350|NCT00808067|9112375|P2|Overall Study|Hospitalization (not including surgery)|17
2637351|NCT00808067|9112376|P1|Overall Study|Hospitalization (not including surgery)|18
2637352|NCT00808067|9112375|P2|Overall Study|Adverse Event|121
2637353|NCT00808067|9112376|P1|Overall Study|Adverse Event|111
2637354|NCT00808067|9112375|P2|Overall Study|Outcome event - other|25
2637355|NCT00808067|9112376|P1|Overall Study|Outcome event - other|33
2637356|NCT00808067|9112375|P2|Overall Study|Major/minor bleed|44
2637357|NCT00808067|9112376|P1|Overall Study|Major/minor bleed|30
2637358|NCT00808028|9112412|P4|Stage 2 (Followed up to 48 Months )|Non-compliance|0
2637359|NCT00808028|9112413|P3|Stage 2 (Followed up to 48 Months )|Non-compliance|1
2637360|NCT00808028|9112414|P2|Stage 2 (Followed up to 48 Months )|Non-compliance|0
2637361|NCT00808028|9112415|P1|Stage 2 (Followed up to 48 Months )|Non-compliance|0
2637362|NCT00808028|9112412|P4|Stage 2 (Followed up to 48 Months )|Death|0
2637363|NCT00808028|9112413|P3|Stage 2 (Followed up to 48 Months )|Death|1
2637364|NCT00808028|9112414|P2|Stage 2 (Followed up to 48 Months )|Death|0
2637365|NCT00808028|9112415|P1|Stage 2 (Followed up to 48 Months )|Death|0
2637366|NCT00808028|9112412|P4|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
2637367|NCT00808028|9112413|P3|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2
2637368|NCT00808028|9112414|P2|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
2637369|NCT00808028|9112415|P1|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
2637370|NCT00808028|9112412|P4|Stage 2 (Followed up to 48 Months )|Other|1
2637371|NCT00808028|9112413|P3|Stage 2 (Followed up to 48 Months )|Other|1
2637372|NCT00808028|9112414|P2|Stage 2 (Followed up to 48 Months )|Other|0
2637373|NCT00808028|9112415|P1|Stage 2 (Followed up to 48 Months )|Other|0
2637374|NCT00808028|9112412|P4|Stage 2 (Followed up to 48 Months )|Adverse Event|0
2637375|NCT00808028|9112413|P3|Stage 2 (Followed up to 48 Months )|Adverse Event|1
2637376|NCT00808028|9112414|P2|Stage 2 (Followed up to 48 Months )|Adverse Event|0
2637377|NCT00808028|9112415|P1|Stage 2 (Followed up to 48 Months )|Adverse Event|1
2637378|NCT00808028|9112412|P4|Stage 2 (Followed up to 48 Months )|Failed to return|4
2637379|NCT00808028|9112413|P3|Stage 2 (Followed up to 48 Months )|Failed to return|5
2637380|NCT00808028|9112414|P2|Stage 2 (Followed up to 48 Months )|Failed to return|0
2637381|NCT00808028|9112415|P1|Stage 2 (Followed up to 48 Months )|Failed to return|2
2637382|NCT00808028|9112412|P4|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7
2637383|NCT00808028|9112413|P3|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8
2637384|NCT00808028|9112414|P2|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0
2637385|NCT00808028|9112415|P1|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2
2637386|NCT00808028|9112412|P4|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
2637387|NCT00808028|9112413|P3|Stage 2 (Followed up to 48 Months )|Protocol Violation|1
2637388|NCT00808028|9112414|P2|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
2637389|NCT00808028|9112415|P1|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
2637390|NCT00808028|9112412|P4|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11
2637391|NCT00808028|9112413|P3|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9
2637392|NCT00808028|9112414|P2|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0
2637393|NCT00808028|9112415|P1|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6
2637394|NCT00808028|9112412|P4|Stage 1 (6 Months)|Protocol Violation|1
2637395|NCT00808028|9112413|P3|Stage 1 (6 Months)|Protocol Violation|0
2637396|NCT00808028|9112414|P2|Stage 1 (6 Months)|Protocol Violation|0
2637397|NCT00808028|9112415|P1|Stage 1 (6 Months)|Protocol Violation|0
2637398|NCT00808028|9112412|P4|Stage 1 (6 Months)|Lost to Follow-up|0
2637399|NCT00808028|9112413|P3|Stage 1 (6 Months)|Lost to Follow-up|1
2637400|NCT00808028|9112414|P2|Stage 1 (6 Months)|Lost to Follow-up|0
2637401|NCT00808028|9112415|P1|Stage 1 (6 Months)|Lost to Follow-up|1
2637402|NCT00808028|9112412|P4|Stage 1 (6 Months)|Adverse Event|2
2637403|NCT00808028|9112413|P3|Stage 1 (6 Months)|Adverse Event|1
2637404|NCT00808028|9112414|P2|Stage 1 (6 Months)|Adverse Event|0
2637405|NCT00808028|9112415|P1|Stage 1 (6 Months)|Adverse Event|0
2637406|NCT00808028|9112412|P4|Stage 1 (6 Months)|Parent/legal guardian request|3
2637407|NCT00808028|9112413|P3|Stage 1 (6 Months)|Parent/legal guardian request|1
2637408|NCT00808028|9112414|P2|Stage 1 (6 Months)|Parent/legal guardian request|1
2637409|NCT00808028|9112415|P1|Stage 1 (6 Months)|Parent/legal guardian request|0
2637410|NCT00808028|9112412|P4|Stage 1 (6 Months)|Other|4
2637411|NCT00808028|9112413|P3|Stage 1 (6 Months)|Other|2
2637412|NCT00808028|9112414|P2|Stage 1 (6 Months)|Other|0
2637413|NCT00808028|9112415|P1|Stage 1 (6 Months)|Other|1
2637414|NCT00808028|9112412|P4|Stage 1 (6 Months)|Withdrawal by Subject|5
2637415|NCT00808028|9112413|P3|Stage 1 (6 Months)|Withdrawal by Subject|2
2637416|NCT00808028|9112414|P2|Stage 1 (6 Months)|Withdrawal by Subject|0
2637417|NCT00808028|9112415|P1|Stage 1 (6 Months)|Withdrawal by Subject|3
2637418|NCT00808015|9112451|P1|Overall Study|Enrolled but not treated|4
2637419|NCT00808015|9112451|P1|Overall Study|Other|25
2637420|NCT00808015|9112451|P1|Overall Study|Adverse Event|22
2637421|NCT00808015|9112451|P1|Overall Study|Participants not willing to participate|158
2637422|NCT00808015|9112451|P1|Overall Study|Lost to Follow-up|76
2637423|NCT00808015|9112451|P1|Overall Study|Lack of Efficacy|58
2637424|NCT00808015|9112451|P1|Overall Study|Death|1
2637425|NCT00807937|9112480|P4|Overall Study|All other reasons (not provided)|1
2637426|NCT00807937|9112481|P3|Overall Study|All other reasons (not provided)|0
2637427|NCT00807937|9112482|P2|Overall Study|All other reasons (not provided)|4
2637428|NCT00807937|9112483|P1|Overall Study|All other reasons (not provided)|2
2637429|NCT00807937|9112480|P4|Overall Study|Intake of prohibited medicine|0
2637430|NCT00807937|9112481|P3|Overall Study|Intake of prohibited medicine|2
2637431|NCT00807937|9112482|P2|Overall Study|Intake of prohibited medicine|0
2637432|NCT00807937|9112483|P1|Overall Study|Intake of prohibited medicine|0
2637433|NCT00807937|9112480|P4|Overall Study|Lack of Efficacy|2
2637434|NCT00807937|9112481|P3|Overall Study|Lack of Efficacy|1
2637435|NCT00807937|9112482|P2|Overall Study|Lack of Efficacy|0
2637436|NCT00807937|9112483|P1|Overall Study|Lack of Efficacy|0
2637437|NCT00807937|9112480|P4|Overall Study|Lost to Follow-up|1
2637438|NCT00807937|9112481|P3|Overall Study|Lost to Follow-up|2
2637439|NCT00807937|9112482|P2|Overall Study|Lost to Follow-up|0
2637440|NCT00807937|9112483|P1|Overall Study|Lost to Follow-up|4
2637441|NCT00807937|9112480|P4|Overall Study|Withdrawal by Subject|4
2637442|NCT00807937|9112481|P3|Overall Study|Withdrawal by Subject|1
2637443|NCT00807937|9112482|P2|Overall Study|Withdrawal by Subject|4
2637444|NCT00807937|9112483|P1|Overall Study|Withdrawal by Subject|5
2637445|NCT00807937|9112480|P4|Overall Study|Protocol Violation|3
2637446|NCT00807937|9112481|P3|Overall Study|Protocol Violation|3
2637447|NCT00807937|9112482|P2|Overall Study|Protocol Violation|5
2637448|NCT00807937|9112483|P1|Overall Study|Protocol Violation|4
2637449|NCT00807937|9112480|P4|Overall Study|Adverse Event|4
2637450|NCT00807937|9112481|P3|Overall Study|Adverse Event|5
2637451|NCT00807937|9112482|P2|Overall Study|Adverse Event|12
2637452|NCT00807937|9112483|P1|Overall Study|Adverse Event|12
2637453|NCT00807885|9112518|P9|Overall Study|Lost to Follow-up|0
2637454|NCT00807885|9112519|P8|Overall Study|Lost to Follow-up|0
2637455|NCT00807885|9112520|P7|Overall Study|Lost to Follow-up|0
2637456|NCT00807885|9112521|P6|Overall Study|Lost to Follow-up|1
2637457|NCT00807885|9112522|P5|Overall Study|Lost to Follow-up|0
2637458|NCT00807885|9112523|P4|Overall Study|Lost to Follow-up|0
2637459|NCT00807885|9112524|P3|Overall Study|Lost to Follow-up|0
2637460|NCT00807885|9112525|P2|Overall Study|Lost to Follow-up|0
2637461|NCT00807885|9112526|P1|Overall Study|Lost to Follow-up|0
2637462|NCT00807846|9112575|P2|Overall Study|Other|2
2637463|NCT00807846|9112576|P1|Overall Study|Other|1
2637464|NCT00807846|9112575|P2|Overall Study|Withdrawal by Subject|1
2637465|NCT00807846|9112576|P1|Overall Study|Withdrawal by Subject|2
2637466|NCT00807846|9112575|P2|Overall Study|Protocol Violation|1
2637467|NCT00807846|9112576|P1|Overall Study|Protocol Violation|2
2637468|NCT00807846|9112575|P2|Overall Study|Lack of Efficacy|0
2637469|NCT00807846|9112576|P1|Overall Study|Lack of Efficacy|2
2637470|NCT00807846|9112575|P2|Overall Study|Adverse Event|0
2637471|NCT00807846|9112576|P1|Overall Study|Adverse Event|5
2637472|NCT00807742|9112629|P2|Overall Study|Lost to Follow-up|51
2637473|NCT00807742|9112630|P1|Overall Study|Lost to Follow-up|35
2637474|NCT00807742|9112629|P2|Overall Study|Withdrawal by Subject|1
2637475|NCT00807742|9112630|P1|Overall Study|Withdrawal by Subject|2
2637476|NCT00807742|9112629|P2|Overall Study|Death|2
2637477|NCT00807742|9112630|P1|Overall Study|Death|9
2637478|NCT00807599|9112689|P3|Overall Study|Withdrawal by Subject|1
2637479|NCT00807599|9112690|P2|Overall Study|Withdrawal by Subject|0
2637480|NCT00807599|9112691|P1|Overall Study|Withdrawal by Subject|0
2637481|NCT00807599|9112689|P3|Overall Study|Inadequate response to induction|9
2637482|NCT00807599|9112690|P2|Overall Study|Inadequate response to induction|0
2637483|NCT00807599|9112691|P1|Overall Study|Inadequate response to induction|0
2637484|NCT00807599|9112689|P3|Overall Study|Adverse Event|5
2637485|NCT00807599|9112690|P2|Overall Study|Adverse Event|0
2637486|NCT00807599|9112691|P1|Overall Study|Adverse Event|0
2637487|NCT00807599|9112689|P3|Overall Study|Not treated on protocol study|2
2637488|NCT00807599|9112690|P2|Overall Study|Not treated on protocol study|0
2637489|NCT00807599|9112691|P1|Overall Study|Not treated on protocol study|0
2637490|NCT00807573|9112718|P1|Overall Study|Adverse Event|1
2637491|NCT00807573|9112718|P1|Overall Study|Withdrawal by Subject|1
2637492|NCT00807495|9112764|P5|Overall Study|Reason Not Specified|3
2637493|NCT00807495|9112765|P4|Overall Study|Reason Not Specified|0
2637494|NCT00807495|9112766|P3|Overall Study|Reason Not Specified|2
2637495|NCT00807495|9112767|P2|Overall Study|Reason Not Specified|3
2637496|NCT00807495|9112768|P1|Overall Study|Reason Not Specified|0
2637497|NCT00807495|9112764|P5|Overall Study|Withdrawal by Patient|0
2637498|NCT00807495|9112765|P4|Overall Study|Withdrawal by Patient|0
2637499|NCT00807495|9112766|P3|Overall Study|Withdrawal by Patient|1
2637500|NCT00807495|9112767|P2|Overall Study|Withdrawal by Patient|0
2637501|NCT00807495|9112768|P1|Overall Study|Withdrawal by Patient|2
2637502|NCT00807495|9112764|P5|Overall Study|Adverse Event|2
2637503|NCT00807495|9112765|P4|Overall Study|Adverse Event|1
2637504|NCT00807495|9112766|P3|Overall Study|Adverse Event|1
2637505|NCT00807495|9112767|P2|Overall Study|Adverse Event|3
2637506|NCT00807495|9112768|P1|Overall Study|Adverse Event|6
2637507|NCT00807365|9112814|P1|Overall Study|Study Terminated|5
2637508|NCT00807248|9112822|P4|Overall Study|Other Reason|0
2637509|NCT00807248|9112823|P3|Overall Study|Other Reason|2
2637510|NCT00807248|9112824|P2|Overall Study|Other Reason|0
2637511|NCT00807248|9112825|P1|Overall Study|Other Reason|0
2637512|NCT00807248|9112822|P4|Overall Study|Lost to Follow-up|0
2637513|NCT00807248|9112823|P3|Overall Study|Lost to Follow-up|0
2637514|NCT00807248|9112824|P2|Overall Study|Lost to Follow-up|0
2637515|NCT00807248|9112825|P1|Overall Study|Lost to Follow-up|1
2637516|NCT00807248|9112822|P4|Overall Study|Withdrawal of Consent|5
2637517|NCT00807248|9112823|P3|Overall Study|Withdrawal of Consent|5
2637518|NCT00807248|9112824|P2|Overall Study|Withdrawal of Consent|5
2637519|NCT00807248|9112825|P1|Overall Study|Withdrawal of Consent|5
2637520|NCT00807248|9112822|P4|Overall Study|Protocol Violation|0
2637521|NCT00807248|9112823|P3|Overall Study|Protocol Violation|1
2637522|NCT00807248|9112824|P2|Overall Study|Protocol Violation|1
2637523|NCT00807248|9112825|P1|Overall Study|Protocol Violation|0
2637524|NCT00807248|9112822|P4|Overall Study|Lack of Efficacy|3
2637525|NCT00807248|9112823|P3|Overall Study|Lack of Efficacy|8
2637526|NCT00807248|9112824|P2|Overall Study|Lack of Efficacy|4
2637527|NCT00807248|9112825|P1|Overall Study|Lack of Efficacy|14
2637528|NCT00807248|9112822|P4|Overall Study|Adverse Event|6
2637529|NCT00807248|9112823|P3|Overall Study|Adverse Event|2
2637530|NCT00807248|9112824|P2|Overall Study|Adverse Event|2
2637531|NCT00807248|9112825|P1|Overall Study|Adverse Event|1
2637532|NCT00807235|9112869|P2|Overall Study|Adverse Event|0
2637533|NCT00807235|9112870|P1|Overall Study|Adverse Event|1
2637534|NCT00807092|9112915|P2|Overall Study|CGMS data collection failed|1
2637535|NCT00807092|9112916|P1|Overall Study|CGMS data collection failed|0
2637536|NCT00807092|9112915|P2|Overall Study|Withdrawal by Subject|0
2637537|NCT00807092|9112916|P1|Overall Study|Withdrawal by Subject|1
2637538|NCT00807092|9112915|P2|Overall Study|Protocol Violation|2
2637539|NCT00807092|9112916|P1|Overall Study|Protocol Violation|0
2637540|NCT00807092|9112915|P2|Overall Study|Adverse Event|1
2637541|NCT00807092|9112916|P1|Overall Study|Adverse Event|0
2637542|NCT00807040|9112946|P2|Overall Study|Lost to Follow-up|6
2637543|NCT00807040|9112947|P1|Overall Study|Lost to Follow-up|4
2637544|NCT00807040|9112946|P2|Overall Study|Withdrawal by Subject|6
2637545|NCT00807040|9112947|P1|Overall Study|Withdrawal by Subject|8
2637546|NCT00807040|9112946|P2|Overall Study|Death|29
2637547|NCT00807040|9112947|P1|Overall Study|Death|24
2637548|NCT00807014|9112957|P2|Overall Study|Missed Visit 2 Due to Personal Reasons|1
2637549|NCT00807014|9112958|P1|Overall Study|Missed Visit 2 Due to Personal Reasons|0
2637550|NCT00807014|9112957|P2|Overall Study|Recovery|0
2637551|NCT00807014|9112958|P1|Overall Study|Recovery|1
2637552|NCT00807014|9112957|P2|Overall Study|Lost to Follow-up|7
2637553|NCT00807014|9112958|P1|Overall Study|Lost to Follow-up|9
2637554|NCT00807014|9112957|P2|Overall Study|Adverse Event|2
2637555|NCT00807014|9112958|P1|Overall Study|Adverse Event|0
2637556|NCT00807014|9112957|P2|Overall Study|Protocol Violation|8
2637557|NCT00807014|9112958|P1|Overall Study|Protocol Violation|2
2637558|NCT00807014|9112957|P2|Overall Study|Participant Considered Disease Not Cured|7
2637559|NCT00807014|9112958|P1|Overall Study|Participant Considered Disease Not Cured|2
2637560|NCT00807014|9112957|P2|Overall Study|Participant Considered Disease Cured|2
2637561|NCT00807014|9112958|P1|Overall Study|Participant Considered Disease Cured|13
2637562|NCT00807001|9112989|P5|Overall Study|Non-compliance|0
2637563|NCT00807001|9112990|P4|Overall Study|Non-compliance|0
2637564|NCT00807001|9112991|P3|Overall Study|Non-compliance|0
2637565|NCT00807001|9112992|P2|Overall Study|Non-compliance|1
2637566|NCT00807001|9112993|P1|Overall Study|Non-compliance|0
2637567|NCT00806988|9113012|P2|Overall Study|Lost to Follow-up|19
2637568|NCT00806988|9113013|P1|Overall Study|Lost to Follow-up|4
2637569|NCT00806988|9113012|P2|Overall Study|Withdrawal by Subject|8
2637570|NCT00806988|9113013|P1|Overall Study|Withdrawal by Subject|8
2637571|NCT00806988|9113012|P2|Overall Study|Death|16
2637572|NCT00806988|9113013|P1|Overall Study|Death|15
2637573|NCT00806819|9113023|P2|Overall Study|Reasons other than stated above|41
2637574|NCT00806819|9113024|P1|Overall Study|Reasons other than stated above|25
2637575|NCT00806819|9113023|P2|Overall Study|Not treated|3
2637576|NCT00806819|9113024|P1|Overall Study|Not treated|6
2637577|NCT00806819|9113023|P2|Overall Study|Withdrawal by Subject|29
2637578|NCT00806819|9113024|P1|Overall Study|Withdrawal by Subject|32
2637579|NCT00806819|9113023|P2|Overall Study|Lost to Follow-up|0
2637580|NCT00806819|9113024|P1|Overall Study|Lost to Follow-up|1
2637581|NCT00806819|9113023|P2|Overall Study|Protocol Violation|4
2637582|NCT00806819|9113024|P1|Overall Study|Protocol Violation|9
2637583|NCT00806819|9113023|P2|Overall Study|Other AE|40
2637584|NCT00806819|9113024|P1|Overall Study|Other AE|38
2637585|NCT00806819|9113023|P2|Overall Study|Worsening or AE of underlying disease|25
2637586|NCT00806819|9113024|P1|Overall Study|Worsening or AE of underlying disease|18
2637587|NCT00806819|9113023|P2|Overall Study|progressive disease (modified RECIST )|216
2637588|NCT00806819|9113024|P1|Overall Study|progressive disease (modified RECIST )|217
2637589|NCT00806624|9113093|P3|Overall Study|discontinued before start of treatment|1
2637590|NCT00806624|9113094|P2|Overall Study|discontinued before start of treatment|0
2637591|NCT00806624|9113095|P1|Overall Study|discontinued before start of treatment|0
2637592|NCT00806624|9113093|P3|Overall Study|Withdrawal by Subject|3
2637593|NCT00806624|9113094|P2|Overall Study|Withdrawal by Subject|3
2637594|NCT00806624|9113095|P1|Overall Study|Withdrawal by Subject|6
2637595|NCT00806624|9113093|P3|Overall Study|Lost to Follow-up|1
2637596|NCT00806624|9113094|P2|Overall Study|Lost to Follow-up|0
2637597|NCT00806624|9113095|P1|Overall Study|Lost to Follow-up|1
2637598|NCT00806624|9113093|P3|Overall Study|Death|1
2637599|NCT00806624|9113094|P2|Overall Study|Death|1
2637600|NCT00806624|9113095|P1|Overall Study|Death|0
2637601|NCT00806624|9113093|P3|Overall Study|Adverse Event|0
2637602|NCT00806624|9113094|P2|Overall Study|Adverse Event|8
2637603|NCT00806624|9113095|P1|Overall Study|Adverse Event|2
2637604|NCT00806585|9113112|P5|Overall Study|Completion status unknown|12
2637605|NCT00806585|9113113|P4|Overall Study|Completion status unknown|4
2637606|NCT00806585|9113114|P3|Overall Study|Completion status unknown|12
2637607|NCT00806585|9113115|P2|Overall Study|Completion status unknown|14
2637608|NCT00806585|9113116|P1|Overall Study|Completion status unknown|15
2637609|NCT00806585|9113112|P5|Overall Study|Withdrawal by Subject|11
2637610|NCT00806585|9113113|P4|Overall Study|Withdrawal by Subject|3
2637611|NCT00806585|9113114|P3|Overall Study|Withdrawal by Subject|9
2637612|NCT00806585|9113115|P2|Overall Study|Withdrawal by Subject|8
2637613|NCT00806585|9113116|P1|Overall Study|Withdrawal by Subject|10
2637614|NCT00806585|9113112|P5|Overall Study|Adverse Event|2
2637615|NCT00806585|9113113|P4|Overall Study|Adverse Event|4
2637616|NCT00806585|9113114|P3|Overall Study|Adverse Event|3
2637617|NCT00806585|9113115|P2|Overall Study|Adverse Event|5
2637618|NCT00806585|9113116|P1|Overall Study|Adverse Event|1
2637619|NCT00806585|9113112|P5|Overall Study|Lack of Efficacy|0
2637620|NCT00806585|9113113|P4|Overall Study|Lack of Efficacy|0
2637621|NCT00806585|9113114|P3|Overall Study|Lack of Efficacy|0
2637622|NCT00806585|9113115|P2|Overall Study|Lack of Efficacy|0
2637623|NCT00806585|9113116|P1|Overall Study|Lack of Efficacy|1
2637624|NCT00806585|9113112|P5|Overall Study|Lost to Follow-up|5
2637625|NCT00806585|9113113|P4|Overall Study|Lost to Follow-up|2
2637626|NCT00806585|9113114|P3|Overall Study|Lost to Follow-up|2
2637627|NCT00806585|9113115|P2|Overall Study|Lost to Follow-up|1
2637628|NCT00806585|9113116|P1|Overall Study|Lost to Follow-up|2
2637629|NCT00806585|9113112|P5|Overall Study|Physician Decision|1
2637630|NCT00806585|9113113|P4|Overall Study|Physician Decision|0
2637631|NCT00806585|9113114|P3|Overall Study|Physician Decision|3
2637632|NCT00806585|9113115|P2|Overall Study|Physician Decision|2
2637633|NCT00806585|9113116|P1|Overall Study|Physician Decision|0
2637634|NCT00806585|9113112|P5|Overall Study|Protocol Violation|0
2637635|NCT00806585|9113113|P4|Overall Study|Protocol Violation|0
2637636|NCT00806585|9113114|P3|Overall Study|Protocol Violation|2
2637637|NCT00806585|9113115|P2|Overall Study|Protocol Violation|1
2637638|NCT00806585|9113116|P1|Overall Study|Protocol Violation|3
2637639|NCT00806585|9113112|P5|Overall Study|Study terminated by Sponsor|0
2637640|NCT00806585|9113113|P4|Overall Study|Study terminated by Sponsor|2
2637641|NCT00806585|9113114|P3|Overall Study|Study terminated by Sponsor|1
2637642|NCT00806585|9113115|P2|Overall Study|Study terminated by Sponsor|0
2637643|NCT00806585|9113116|P1|Overall Study|Study terminated by Sponsor|0
2637644|NCT00806546|9113148|P1|Overall Study|Various|42
2637645|NCT00806546|9113148|P1|Overall Study|Protocol Violation|49
2637646|NCT00806546|9113148|P1|Overall Study|Withdrawal by Subject|75
2637647|NCT00806546|9113148|P1|Overall Study|Adverse Event|74
2637648|NCT00806546|9113148|P1|Overall Study|Lost to Follow-up|32
2637649|NCT00806546|9113148|P1|Overall Study|Enrolled, not treated|35
2637650|NCT00806494|9113152|P1|Overall Study|Withdrawal by Subject|5
2637651|NCT00806494|9113152|P1|Overall Study|Other|30
2637652|NCT00806494|9113152|P1|Overall Study|Lost to Follow-up|10
2637653|NCT00806494|9113152|P1|Overall Study|Lack of Efficacy|6
2637654|NCT00806494|9113152|P1|Overall Study|Adverse Event|29
2637655|NCT00806442|9113176|P2|Overall Study|Withdrawal by Subject|5
2637656|NCT00806442|9113177|P1|Overall Study|Withdrawal by Subject|1
2637657|NCT00806442|9113176|P2|Overall Study|Lost to Follow-up|2
2637658|NCT00806442|9113177|P1|Overall Study|Lost to Follow-up|3
2637659|NCT00806416|9113199|P4|Period 1 - Part II|Withdrawal by Subject|2
2637660|NCT00806416|9113200|P3|Period 1 - Part II|Withdrawal by Subject|0
2637661|NCT00806416|9113201|P2|Period 1 - Part II|Withdrawal by Subject|0
2637662|NCT00806416|9113202|P1|Period 1 - Part II|Withdrawal by Subject|0
2637663|NCT00806416|9113199|P4|Period 1 - Part I|Withdrawal by Subject|0
2637664|NCT00806416|9113200|P3|Period 1 - Part I|Withdrawal by Subject|0
2637665|NCT00806416|9113201|P2|Period 1 - Part I|Withdrawal by Subject|1
2637666|NCT00806416|9113202|P1|Period 1 - Part I|Withdrawal by Subject|3
2637667|NCT00806416|9113199|P4|Period 1 - Part I|Lost to Follow-up|0
2637668|NCT00806416|9113200|P3|Period 1 - Part I|Lost to Follow-up|0
2637669|NCT00806416|9113201|P2|Period 1 - Part I|Lost to Follow-up|2
2637670|NCT00806416|9113202|P1|Period 1 - Part I|Lost to Follow-up|0
2637671|NCT00806416|9113199|P4|Period 1 - Part I|Adverse Event|0
2637672|NCT00806416|9113200|P3|Period 1 - Part I|Adverse Event|0
2637673|NCT00806416|9113201|P2|Period 1 - Part I|Adverse Event|1
2637674|NCT00806416|9113202|P1|Period 1 - Part I|Adverse Event|0
2637675|NCT00806403|9113215|P2|Overall Study|Death|3
2637676|NCT00806403|9113216|P1|Overall Study|Death|4
2637677|NCT00806351|9113239|P2|Overall Study|Death|4
2637678|NCT00806351|9113240|P1|Overall Study|Death|5
2637679|NCT00806260|9113277|P6|Period 3|Pregnancy|0
2637680|NCT00806260|9113278|P5|Period 3|Pregnancy|0
2637681|NCT00806260|9113279|P4|Period 3|Pregnancy|0
2637682|NCT00806260|9113280|P3|Period 3|Pregnancy|0
2637683|NCT00806260|9113281|P2|Period 3|Pregnancy|0
2637684|NCT00806260|9113282|P1|Period 3|Pregnancy|1
2637685|NCT00806260|9113277|P6|Period 3|Protocol Violation|0
2637686|NCT00806260|9113278|P5|Period 3|Protocol Violation|0
2637687|NCT00806260|9113279|P4|Period 3|Protocol Violation|0
2637688|NCT00806260|9113280|P3|Period 3|Protocol Violation|1
2637689|NCT00806260|9113281|P2|Period 3|Protocol Violation|1
2637690|NCT00806260|9113282|P1|Period 3|Protocol Violation|0
2637691|NCT00806260|9113277|P6|Period 2|sponsor request|0
2637692|NCT00806260|9113278|P5|Period 2|sponsor request|0
2637693|NCT00806260|9113279|P4|Period 2|sponsor request|1
2637694|NCT00806260|9113280|P3|Period 2|sponsor request|1
2637695|NCT00806260|9113281|P2|Period 2|sponsor request|0
2637696|NCT00806260|9113282|P1|Period 2|sponsor request|0
2637697|NCT00806260|9113277|P6|Period 2|Need to take concomitant medication|0
2637698|NCT00806260|9113278|P5|Period 2|Need to take concomitant medication|0
2637699|NCT00806260|9113279|P4|Period 2|Need to take concomitant medication|0
2637700|NCT00806260|9113280|P3|Period 2|Need to take concomitant medication|0
2637701|NCT00806260|9113281|P2|Period 2|Need to take concomitant medication|0
2637702|NCT00806260|9113282|P1|Period 2|Need to take concomitant medication|1
2637703|NCT00806260|9113277|P6|Period 2|Protocol Violation|0
2637704|NCT00806260|9113278|P5|Period 2|Protocol Violation|0
2637705|NCT00806260|9113279|P4|Period 2|Protocol Violation|0
2637706|NCT00806260|9113280|P3|Period 2|Protocol Violation|1
2637707|NCT00806260|9113281|P2|Period 2|Protocol Violation|0
2637708|NCT00806260|9113282|P1|Period 2|Protocol Violation|1
2637709|NCT00806260|9113277|P6|Period 2|Adverse Event|0
2637710|NCT00806260|9113278|P5|Period 2|Adverse Event|0
2637711|NCT00806260|9113279|P4|Period 2|Adverse Event|1
2637712|NCT00806260|9113280|P3|Period 2|Adverse Event|0
2637713|NCT00806260|9113281|P2|Period 2|Adverse Event|0
2637714|NCT00806260|9113282|P1|Period 2|Adverse Event|0
2637715|NCT00806260|9113277|P6|Period 1 (1 Day)|Adverse Event|0
2637716|NCT00806260|9113278|P5|Period 1 (1 Day)|Adverse Event|3
2637717|NCT00806260|9113279|P4|Period 1 (1 Day)|Adverse Event|0
2637718|NCT00806260|9113280|P3|Period 1 (1 Day)|Adverse Event|0
2637719|NCT00806260|9113281|P2|Period 1 (1 Day)|Adverse Event|0
2637720|NCT00806260|9113282|P1|Period 1 (1 Day)|Adverse Event|0
2637721|NCT00806195|9113327|P4|Overall Study|Protocol Violation|9
2637722|NCT00806195|9113328|P3|Overall Study|Protocol Violation|26
2637723|NCT00806195|9113329|P2|Overall Study|Protocol Violation|24
2637724|NCT00806195|9113330|P1|Overall Study|Protocol Violation|34
2637725|NCT00806195|9113327|P4|Overall Study|Administrative Reason|26
2637726|NCT00806195|9113328|P3|Overall Study|Administrative Reason|66
2637727|NCT00806195|9113329|P2|Overall Study|Administrative Reason|35
2637728|NCT00806195|9113330|P1|Overall Study|Administrative Reason|113
2637729|NCT00806195|9113327|P4|Overall Study|Inappropriate Enrollment|0
2637730|NCT00806195|9113328|P3|Overall Study|Inappropriate Enrollment|0
2637731|NCT00806195|9113329|P2|Overall Study|Inappropriate Enrollment|1
2637732|NCT00806195|9113330|P1|Overall Study|Inappropriate Enrollment|0
2637733|NCT00806195|9113327|P4|Overall Study|Lost to Follow-up|34
2637734|NCT00806195|9113328|P3|Overall Study|Lost to Follow-up|90
2637735|NCT00806195|9113329|P2|Overall Study|Lost to Follow-up|66
2637736|NCT00806195|9113330|P1|Overall Study|Lost to Follow-up|217
2637737|NCT00806195|9113327|P4|Overall Study|Withdrawal by Subject|35
2637738|NCT00806195|9113328|P3|Overall Study|Withdrawal by Subject|76
2637739|NCT00806195|9113329|P2|Overall Study|Withdrawal by Subject|31
2637740|NCT00806195|9113330|P1|Overall Study|Withdrawal by Subject|119
2637741|NCT00806195|9113327|P4|Overall Study|Adverse Event|2
2637742|NCT00806195|9113328|P3|Overall Study|Adverse Event|11
2637743|NCT00806195|9113329|P2|Overall Study|Adverse Event|5
2637744|NCT00806195|9113330|P1|Overall Study|Adverse Event|25
2637745|NCT00806195|9113327|P4|Overall Study|Death|0
2637746|NCT00806195|9113328|P3|Overall Study|Death|1
2637747|NCT00806195|9113329|P2|Overall Study|Death|0
2637748|NCT00806195|9113330|P1|Overall Study|Death|6
2637749|NCT00806026|9113361|P6|Overall Study|Adverse Event|9
2637750|NCT00806026|9113362|P5|Overall Study|Adverse Event|9
2637751|NCT00806026|9113363|P4|Overall Study|Adverse Event|17
2637752|NCT00806026|9113364|P3|Overall Study|Adverse Event|44
2637753|NCT00806026|9113365|P2|Overall Study|Adverse Event|35
2637754|NCT00806026|9113366|P1|Overall Study|Adverse Event|52
2637755|NCT00806026|9113361|P6|Overall Study|Protocol Violation|3
2637756|NCT00806026|9113362|P5|Overall Study|Protocol Violation|2
2637757|NCT00806026|9113363|P4|Overall Study|Protocol Violation|0
2637758|NCT00806026|9113364|P3|Overall Study|Protocol Violation|9
2637759|NCT00806026|9113365|P2|Overall Study|Protocol Violation|9
2637760|NCT00806026|9113366|P1|Overall Study|Protocol Violation|6
2637761|NCT00806026|9113361|P6|Overall Study|Other|4
2637762|NCT00806026|9113362|P5|Overall Study|Other|0
2637763|NCT00806026|9113363|P4|Overall Study|Other|2
2637764|NCT00806026|9113364|P3|Overall Study|Other|8
2637765|NCT00806026|9113365|P2|Overall Study|Other|6
2637766|NCT00806026|9113366|P1|Overall Study|Other|3
2637767|NCT00806026|9113361|P6|Overall Study|Withdrawal by Subject|3
2637768|NCT00806026|9113362|P5|Overall Study|Withdrawal by Subject|5
2637769|NCT00806026|9113363|P4|Overall Study|Withdrawal by Subject|2
2637770|NCT00806026|9113364|P3|Overall Study|Withdrawal by Subject|9
2637771|NCT00806026|9113365|P2|Overall Study|Withdrawal by Subject|17
2637772|NCT00806026|9113366|P1|Overall Study|Withdrawal by Subject|14
2637773|NCT00806026|9113361|P6|Overall Study|Lost to Follow-up|6
2637774|NCT00806026|9113362|P5|Overall Study|Lost to Follow-up|6
2637775|NCT00806026|9113363|P4|Overall Study|Lost to Follow-up|2
2637776|NCT00806026|9113364|P3|Overall Study|Lost to Follow-up|8
2637777|NCT00806026|9113365|P2|Overall Study|Lost to Follow-up|15
2637778|NCT00806026|9113366|P1|Overall Study|Lost to Follow-up|8
2637779|NCT00806026|9113361|P6|Overall Study|Lack of Efficacy|7
2637780|NCT00806026|9113362|P5|Overall Study|Lack of Efficacy|8
2637781|NCT00806026|9113363|P4|Overall Study|Lack of Efficacy|4
2637782|NCT00806026|9113364|P3|Overall Study|Lack of Efficacy|13
2637783|NCT00806026|9113365|P2|Overall Study|Lack of Efficacy|18
2637784|NCT00806026|9113366|P1|Overall Study|Lack of Efficacy|5
2637785|NCT00806026|9113361|P6|Overall Study|Did not meet entrance criteria|0
2637786|NCT00806026|9113362|P5|Overall Study|Did not meet entrance criteria|0
2637787|NCT00806026|9113363|P4|Overall Study|Did not meet entrance criteria|1
2637788|NCT00806026|9113364|P3|Overall Study|Did not meet entrance criteria|2
2637789|NCT00806026|9113365|P2|Overall Study|Did not meet entrance criteria|1
2637790|NCT00806026|9113366|P1|Overall Study|Did not meet entrance criteria|4
2637791|NCT00806026|9113361|P6|Overall Study|Death|0
2637792|NCT00806026|9113362|P5|Overall Study|Death|0
2637793|NCT00806026|9113363|P4|Overall Study|Death|1
2637794|NCT00806026|9113364|P3|Overall Study|Death|0
2637795|NCT00806026|9113365|P2|Overall Study|Death|0
2637796|NCT00806026|9113366|P1|Overall Study|Death|0
2637797|NCT00805961|9113461|P1|Maintenance Treatment|Withdrawn Consent|1
2637798|NCT00805961|9113461|P1|Maintenance Treatment|Symptomatic Deterioration|2
2637799|NCT00805961|9113461|P1|Maintenance Treatment|Withdrawal by Subject|5
2637800|NCT00805961|9113461|P1|Maintenance Treatment|Adverse Event|6
2637801|NCT00805961|9113461|P1|Maintenance Treatment|Intercurrent Illness|7
2637802|NCT00805961|9113461|P1|Maintenance Treatment|Lack of Efficacy|13
2637803|NCT00805961|9113461|P1|Treatment-Free Interval|Lack of Efficacy|1
2637804|NCT00805961|9113461|P1|Treatment-Free Interval|Physician Decision|1
2637805|NCT00805961|9113461|P1|Treatment-Free Interval|Intercurrent Illness|2
2637806|NCT00805961|9113461|P1|Treatment-Free Interval|Adverse Event|3
2637807|NCT00805961|9113461|P1|Modality Therapy|Disease Progression|2
2637808|NCT00805961|9113461|P1|Modality Therapy|Adverse Event|1
2637809|NCT00805961|9113461|P1|Modality Therapy|Withdrawal by Subject|1
2637810|NCT00805935|9113485|P4|Overall Study|Serious Adverse Event-congenital anomaly|0
2637811|NCT00805935|9113486|P3|Overall Study|Serious Adverse Event-congenital anomaly|0
2637812|NCT00805935|9113487|P2|Overall Study|Serious Adverse Event-congenital anomaly|1
2637813|NCT00805935|9113488|P1|Overall Study|Serious Adverse Event-congenital anomaly|0
2637814|NCT00805935|9113485|P4|Overall Study|Ectopic pregnancy|0
2637815|NCT00805935|9113486|P3|Overall Study|Ectopic pregnancy|1
2637816|NCT00805935|9113487|P2|Overall Study|Ectopic pregnancy|0
2637817|NCT00805935|9113488|P1|Overall Study|Ectopic pregnancy|0
2637818|NCT00805935|9113485|P4|Overall Study|Chemical pregnancy|2
2637819|NCT00805935|9113486|P3|Overall Study|Chemical pregnancy|3
2637820|NCT00805935|9113487|P2|Overall Study|Chemical pregnancy|5
2637821|NCT00805935|9113488|P1|Overall Study|Chemical pregnancy|0
2637822|NCT00805935|9113485|P4|Overall Study|Biochemical pregnancy|0
2637823|NCT00805935|9113486|P3|Overall Study|Biochemical pregnancy|0
2637824|NCT00805935|9113487|P2|Overall Study|Biochemical pregnancy|1
2637825|NCT00805935|9113488|P1|Overall Study|Biochemical pregnancy|0
2637826|NCT00805935|9113485|P4|Overall Study|Pregnancy loss/miscarriage|0
2637827|NCT00805935|9113486|P3|Overall Study|Pregnancy loss/miscarriage|0
2637828|NCT00805935|9113487|P2|Overall Study|Pregnancy loss/miscarriage|0
2637829|NCT00805935|9113488|P1|Overall Study|Pregnancy loss/miscarriage|2
2637830|NCT00805935|9113485|P4|Overall Study|Pregnancy not confirmed by ultrasound|1
2637831|NCT00805935|9113486|P3|Overall Study|Pregnancy not confirmed by ultrasound|0
2637832|NCT00805935|9113487|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
2637833|NCT00805935|9113488|P1|Overall Study|Pregnancy not confirmed by ultrasound|0
2637834|NCT00805935|9113485|P4|Overall Study|No positive serum pregnancy|5
2637835|NCT00805935|9113486|P3|Overall Study|No positive serum pregnancy|6
2637836|NCT00805935|9113487|P2|Overall Study|No positive serum pregnancy|7
2637837|NCT00805935|9113488|P1|Overall Study|No positive serum pregnancy|8
2637838|NCT00805935|9113485|P4|Overall Study|Lost to Follow-up|0
2637839|NCT00805935|9113486|P3|Overall Study|Lost to Follow-up|0
2637840|NCT00805935|9113487|P2|Overall Study|Lost to Follow-up|0
2637841|NCT00805935|9113488|P1|Overall Study|Lost to Follow-up|1
2637842|NCT00805935|9113485|P4|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1
2637843|NCT00805935|9113486|P3|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
2637844|NCT00805935|9113487|P2|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
2637845|NCT00805935|9113488|P1|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
2637846|NCT00805935|9113485|P4|Overall Study|Cycle cancellation for risk of OHSS|0
2637847|NCT00805935|9113486|P3|Overall Study|Cycle cancellation for risk of OHSS|1
2637848|NCT00805935|9113487|P2|Overall Study|Cycle cancellation for risk of OHSS|0
2637849|NCT00805935|9113488|P1|Overall Study|Cycle cancellation for risk of OHSS|1
2637850|NCT00805935|9113485|P4|Overall Study|Cycle cancelled|0
2637851|NCT00805935|9113486|P3|Overall Study|Cycle cancelled|2
2637852|NCT00805935|9113487|P2|Overall Study|Cycle cancelled|0
2637853|NCT00805935|9113488|P1|Overall Study|Cycle cancelled|0
2637854|NCT00805935|9113485|P4|Overall Study|Stimulation Failure|2
2637855|NCT00805935|9113486|P3|Overall Study|Stimulation Failure|2
2637856|NCT00805935|9113487|P2|Overall Study|Stimulation Failure|5
2637857|NCT00805935|9113488|P1|Overall Study|Stimulation Failure|1
2637858|NCT00805792|9113555|P1|Overall Study|Lost to Follow-up|2
2637859|NCT00805792|9113555|P1|Overall Study|Death|3
2637860|NCT00805766|9113563|P1|Increased Dose Period|Withdrawal by Subject|1
2637861|NCT00805766|9113563|P1|Increased Dose Period|Pregnancy|1
2637862|NCT00805766|9113563|P1|Increased Dose Period|Lack of Efficacy|7
2637863|NCT00805766|9113563|P1|Increased Dose Period|Adverse Event|4
2637864|NCT00805766|9113563|P1|Screening Period|Responder|2
2637865|NCT00805766|9113563|P1|Screening Period|Pregnancy|1
2637866|NCT00805766|9113563|P1|Screening Period|Lack of Efficacy|2
2637867|NCT00805766|9113563|P1|Screening Period|Adverse Event|1
2637868|NCT00805740|9113577|P2|Overall Study|Randomized, but not treated|0
2637869|NCT00805740|9113578|P1|Overall Study|Randomized, but not treated|2
2637870|NCT00805740|9113577|P2|Overall Study|Lost to Follow-up|0
2637871|NCT00805740|9113578|P1|Overall Study|Lost to Follow-up|1
2637872|NCT00805740|9113577|P2|Overall Study|Withdrawal by Subject|0
2637873|NCT00805740|9113578|P1|Overall Study|Withdrawal by Subject|1
2637874|NCT00805740|9113577|P2|Overall Study|Death|4
2637875|NCT00805740|9113578|P1|Overall Study|Death|7
2637876|NCT00805675|9113603|P3|Overall Study|Adverse Event|1
2637877|NCT00805675|9113604|P2|Overall Study|Adverse Event|0
2637878|NCT00805675|9113605|P1|Overall Study|Adverse Event|0
2637879|NCT00805545|9113639|P2|Overall Study|Protocol Violation|1
2637880|NCT00805545|9113640|P1|Overall Study|Protocol Violation|3
2637881|NCT00805545|9113639|P2|Overall Study|Protocol Violation|2
2637882|NCT00805545|9113640|P1|Overall Study|Protocol Violation|3
2637883|NCT00805532|9113648|P2|Overall Study|invalid data|1
2637884|NCT00805532|9113649|P1|Overall Study|invalid data|0
2637885|NCT00805480|9113683|P4|Overall Study|Adverse Event|0
2637886|NCT00805480|9113684|P3|Overall Study|Adverse Event|1
2637887|NCT00805480|9113685|P2|Overall Study|Adverse Event|0
2637888|NCT00805480|9113686|P1|Overall Study|Adverse Event|0
2637889|NCT00805480|9113683|P4|Overall Study|Lost to Follow-up|0
2637890|NCT00805480|9113684|P3|Overall Study|Lost to Follow-up|0
2637891|NCT00805480|9113685|P2|Overall Study|Lost to Follow-up|2
2637892|NCT00805480|9113686|P1|Overall Study|Lost to Follow-up|1
2637893|NCT00805480|9113683|P4|Overall Study|Withdrawal by Subject|5
2637894|NCT00805480|9113684|P3|Overall Study|Withdrawal by Subject|11
2637895|NCT00805480|9113685|P2|Overall Study|Withdrawal by Subject|5
2637896|NCT00805480|9113686|P1|Overall Study|Withdrawal by Subject|13
2637897|NCT00805467|9113715|P4|Overall Study|Not reported|7
2637898|NCT00805467|9113716|P3|Overall Study|Not reported|3
2637899|NCT00805467|9113717|P2|Overall Study|Not reported|0
2637900|NCT00805467|9113718|P1|Overall Study|Not reported|0
2637901|NCT00805467|9113715|P4|Overall Study|Physician Decision|6
2637902|NCT00805467|9113716|P3|Overall Study|Physician Decision|2
2637903|NCT00805467|9113717|P2|Overall Study|Physician Decision|1
2637904|NCT00805467|9113718|P1|Overall Study|Physician Decision|0
2637905|NCT00805467|9113715|P4|Overall Study|Death|5
2637906|NCT00805467|9113716|P3|Overall Study|Death|7
2637907|NCT00805467|9113717|P2|Overall Study|Death|2
2637908|NCT00805467|9113718|P1|Overall Study|Death|0
2637909|NCT00805467|9113715|P4|Overall Study|Adverse Event|57
2637910|NCT00805467|9113716|P3|Overall Study|Adverse Event|26
2637911|NCT00805467|9113717|P2|Overall Study|Adverse Event|13
2637912|NCT00805467|9113718|P1|Overall Study|Adverse Event|0
2637913|NCT00805467|9113715|P4|Overall Study|Protocol Violation|5
2637914|NCT00805467|9113716|P3|Overall Study|Protocol Violation|0
2637915|NCT00805467|9113717|P2|Overall Study|Protocol Violation|3
2637916|NCT00805467|9113718|P1|Overall Study|Protocol Violation|0
2637917|NCT00805467|9113715|P4|Overall Study|Withdrawal by Subject|50
2637918|NCT00805467|9113716|P3|Overall Study|Withdrawal by Subject|45
2637919|NCT00805467|9113717|P2|Overall Study|Withdrawal by Subject|6
2637920|NCT00805467|9113718|P1|Overall Study|Withdrawal by Subject|0
2637921|NCT00805467|9113715|P4|Overall Study|Lost to Follow-up|21
2637922|NCT00805467|9113716|P3|Overall Study|Lost to Follow-up|7
2637923|NCT00805467|9113717|P2|Overall Study|Lost to Follow-up|1
2637924|NCT00805467|9113718|P1|Overall Study|Lost to Follow-up|0
2637925|NCT00805467|9113715|P4|Overall Study|Lack of Efficacy|86
2637926|NCT00805467|9113716|P3|Overall Study|Lack of Efficacy|13
2637927|NCT00805467|9113717|P2|Overall Study|Lack of Efficacy|8
2637928|NCT00805467|9113718|P1|Overall Study|Lack of Efficacy|0
2637929|NCT00805441|9113738|P2|Overall Study|Acute Alcohol Withdrawal|1
2637930|NCT00805441|9113739|P1|Overall Study|Acute Alcohol Withdrawal|0
2637931|NCT00805441|9113738|P2|Overall Study|Physician Decision|1
2637932|NCT00805441|9113739|P1|Overall Study|Physician Decision|0
2637933|NCT00805441|9113738|P2|Overall Study|Withdrawal by Subject|9
2637934|NCT00805441|9113739|P1|Overall Study|Withdrawal by Subject|15
2637935|NCT00805441|9113738|P2|Overall Study|Lost to Follow-up|13
2637936|NCT00805441|9113739|P1|Overall Study|Lost to Follow-up|10
2637937|NCT00805441|9113738|P2|Overall Study|Protocol Violation|8
2637938|NCT00805441|9113739|P1|Overall Study|Protocol Violation|4
2637939|NCT00805441|9113738|P2|Overall Study|Lack of Efficacy|2
2637940|NCT00805441|9113739|P1|Overall Study|Lack of Efficacy|0
2637941|NCT00805441|9113738|P2|Overall Study|Adverse Event|2
2637942|NCT00805441|9113739|P1|Overall Study|Adverse Event|5
2637943|NCT00805389|9113774|P5|Overall Study|Withdrawal by Subject|4
2637944|NCT00805389|9113775|P4|Overall Study|Withdrawal by Subject|5
2637945|NCT00805389|9113776|P3|Overall Study|Withdrawal by Subject|4
2637946|NCT00805389|9113777|P2|Overall Study|Withdrawal by Subject|2
2637947|NCT00805389|9113778|P1|Overall Study|Withdrawal by Subject|3
2637948|NCT00805389|9113774|P5|Overall Study|Protocol Violation|0
2637949|NCT00805389|9113775|P4|Overall Study|Protocol Violation|0
2637950|NCT00805389|9113776|P3|Overall Study|Protocol Violation|1
2637951|NCT00805389|9113777|P2|Overall Study|Protocol Violation|0
2637952|NCT00805389|9113778|P1|Overall Study|Protocol Violation|0
2637953|NCT00805389|9113774|P5|Overall Study|Lost to Follow-up|9
2637954|NCT00805389|9113775|P4|Overall Study|Lost to Follow-up|10
2637955|NCT00805389|9113776|P3|Overall Study|Lost to Follow-up|6
2637956|NCT00805389|9113777|P2|Overall Study|Lost to Follow-up|3
2637957|NCT00805389|9113778|P1|Overall Study|Lost to Follow-up|4
2637958|NCT00805389|9113774|P5|Overall Study|Adverse Event|0
2637959|NCT00805389|9113775|P4|Overall Study|Adverse Event|2
2637960|NCT00805389|9113776|P3|Overall Study|Adverse Event|1
2637961|NCT00805389|9113777|P2|Overall Study|Adverse Event|0
2637962|NCT00805389|9113778|P1|Overall Study|Adverse Event|0
2637963|NCT00805285|9114025|P1|Overall Study|Lack of Efficacy|1
2637964|NCT00805207|9114042|P9|Overall Study|Withdrawal by Subject|0
2637965|NCT00805207|9114043|P8|Overall Study|Withdrawal by Subject|0
2637966|NCT00805207|9114044|P7|Overall Study|Withdrawal by Subject|0
2637967|NCT00805207|9114045|P6|Overall Study|Withdrawal by Subject|2
2637968|NCT00805207|9114046|P5|Overall Study|Withdrawal by Subject|1
2637969|NCT00805207|9114047|P4|Overall Study|Withdrawal by Subject|0
2637970|NCT00805207|9114048|P3|Overall Study|Withdrawal by Subject|0
2637971|NCT00805207|9114049|P2|Overall Study|Withdrawal by Subject|1
2637972|NCT00805207|9114050|P1|Overall Study|Withdrawal by Subject|0
2637973|NCT00805207|9114042|P9|Overall Study|Physician Decision|0
2637974|NCT00805207|9114043|P8|Overall Study|Physician Decision|0
2637975|NCT00805207|9114044|P7|Overall Study|Physician Decision|0
2637976|NCT00805207|9114045|P6|Overall Study|Physician Decision|1
2637977|NCT00805207|9114046|P5|Overall Study|Physician Decision|0
2637978|NCT00805207|9114047|P4|Overall Study|Physician Decision|0
2637979|NCT00805207|9114048|P3|Overall Study|Physician Decision|0
2637980|NCT00805207|9114049|P2|Overall Study|Physician Decision|1
2637981|NCT00805207|9114050|P1|Overall Study|Physician Decision|0
2637982|NCT00805207|9114042|P9|Overall Study|Protocol Violation|0
2637983|NCT00805207|9114043|P8|Overall Study|Protocol Violation|0
2637984|NCT00805207|9114044|P7|Overall Study|Protocol Violation|0
2637985|NCT00805207|9114045|P6|Overall Study|Protocol Violation|0
2637986|NCT00805207|9114046|P5|Overall Study|Protocol Violation|0
2637987|NCT00805207|9114047|P4|Overall Study|Protocol Violation|0
2637988|NCT00805207|9114048|P3|Overall Study|Protocol Violation|1
2637989|NCT00805207|9114049|P2|Overall Study|Protocol Violation|0
2637990|NCT00805207|9114050|P1|Overall Study|Protocol Violation|0
2637991|NCT00805194|9114108|P2|Overall Study|Reasons other than stated above|16
2637992|NCT00805194|9114109|P1|Overall Study|Reasons other than stated above|20
2637993|NCT00805194|9114108|P2|Overall Study|Not treated|4
2637994|NCT00805194|9114109|P1|Overall Study|Not treated|3
2637995|NCT00805194|9114108|P2|Overall Study|Withdrawal by Subject|42
2637996|NCT00805194|9114109|P1|Overall Study|Withdrawal by Subject|60
2637997|NCT00805194|9114108|P2|Overall Study|Lost to Follow-up|5
2637998|NCT00805194|9114109|P1|Overall Study|Lost to Follow-up|5
2637999|NCT00805194|9114108|P2|Overall Study|Protocol Violation|9
2638000|NCT00805194|9114109|P1|Overall Study|Protocol Violation|9
2638001|NCT00805194|9114108|P2|Overall Study|Other AE|73
2638002|NCT00805194|9114109|P1|Overall Study|Other AE|84
2638003|NCT00805194|9114108|P2|Overall Study|Worsening or AE of underlying disease|70
2638004|NCT00805194|9114109|P1|Overall Study|Worsening or AE of underlying disease|64
2638005|NCT00805194|9114108|P2|Overall Study|Progressive disease (modified RECIST)|435
2638006|NCT00805194|9114109|P1|Overall Study|Progressive disease (modified RECIST)|404
2638007|NCT00805142|9114143|P2|Maintenance Period|Other|1
2638008|NCT00805142|9114144|P1|Maintenance Period|Other|0
2638009|NCT00805142|9114143|P2|Maintenance Period|Adverse Event|1
2638010|NCT00805142|9114144|P1|Maintenance Period|Adverse Event|0
2638011|NCT00805142|9114143|P2|Titration Period|Other|3
2638012|NCT00805142|9114144|P1|Titration Period|Other|0
2638013|NCT00805142|9114143|P2|Titration Period|Withdrawal of consent|1
2638014|NCT00805142|9114144|P1|Titration Period|Withdrawal of consent|0
2638015|NCT00805142|9114143|P2|Titration Period|Disease Progression|1
2638016|NCT00805142|9114144|P1|Titration Period|Disease Progression|2
2638017|NCT00805142|9114143|P2|Titration Period|Lost to Follow-up|1
2638018|NCT00805142|9114144|P1|Titration Period|Lost to Follow-up|0
2638019|NCT00805142|9114143|P2|Titration Period|Lack of Efficacy|1
2638020|NCT00805142|9114144|P1|Titration Period|Lack of Efficacy|1
2638021|NCT00805142|9114143|P2|Titration Period|Adverse Event|3
2638022|NCT00805142|9114144|P1|Titration Period|Adverse Event|3
2638023|NCT00805025|9114177|P1|Overall Study|Physician Decision|1
2638024|NCT00805025|9114177|P1|Overall Study|Withdrawal by Subject|2
2638025|NCT00805025|9114177|P1|Overall Study|Adverse Event|4
2638026|NCT00805025|9114177|P1|Overall Study|Screened but not enrolled/treated|42
2638027|NCT00804986|9114206|P6|Overall Study|Physician Decision|0
2638028|NCT00804986|9114207|P5|Overall Study|Physician Decision|0
2638029|NCT00804986|9114208|P4|Overall Study|Physician Decision|0
2638030|NCT00804986|9114209|P3|Overall Study|Physician Decision|0
2638031|NCT00804986|9114210|P2|Overall Study|Physician Decision|0
2638032|NCT00804986|9114211|P1|Overall Study|Physician Decision|1
2638033|NCT00804986|9114206|P6|Overall Study|Sponsor Decision|0
2638034|NCT00804986|9114207|P5|Overall Study|Sponsor Decision|0
2638035|NCT00804986|9114208|P4|Overall Study|Sponsor Decision|0
2638036|NCT00804986|9114209|P3|Overall Study|Sponsor Decision|0
2638037|NCT00804986|9114210|P2|Overall Study|Sponsor Decision|1
2638038|NCT00804986|9114211|P1|Overall Study|Sponsor Decision|0
2638039|NCT00804986|9114206|P6|Overall Study|Inclusion/Exclusion criteria not met|1
2638040|NCT00804986|9114207|P5|Overall Study|Inclusion/Exclusion criteria not met|0
2638041|NCT00804986|9114208|P4|Overall Study|Inclusion/Exclusion criteria not met|1
2638042|NCT00804986|9114209|P3|Overall Study|Inclusion/Exclusion criteria not met|0
2638043|NCT00804986|9114210|P2|Overall Study|Inclusion/Exclusion criteria not met|2
2638044|NCT00804986|9114211|P1|Overall Study|Inclusion/Exclusion criteria not met|0
2638045|NCT00804986|9114206|P6|Overall Study|Withdrawal by Subject|3
2638046|NCT00804986|9114207|P5|Overall Study|Withdrawal by Subject|5
2638047|NCT00804986|9114208|P4|Overall Study|Withdrawal by Subject|3
2638048|NCT00804986|9114209|P3|Overall Study|Withdrawal by Subject|0
2638049|NCT00804986|9114210|P2|Overall Study|Withdrawal by Subject|3
2638050|NCT00804986|9114211|P1|Overall Study|Withdrawal by Subject|0
2638051|NCT00804986|9114206|P6|Overall Study|Protocol Violation|0
2638052|NCT00804986|9114207|P5|Overall Study|Protocol Violation|0
2638053|NCT00804986|9114208|P4|Overall Study|Protocol Violation|1
2638054|NCT00804986|9114209|P3|Overall Study|Protocol Violation|0
2638055|NCT00804986|9114210|P2|Overall Study|Protocol Violation|1
2638056|NCT00804986|9114211|P1|Overall Study|Protocol Violation|0
2638057|NCT00804986|9114206|P6|Overall Study|Lost to Follow-up|3
2638058|NCT00804986|9114207|P5|Overall Study|Lost to Follow-up|1
2638059|NCT00804986|9114208|P4|Overall Study|Lost to Follow-up|1
2638060|NCT00804986|9114209|P3|Overall Study|Lost to Follow-up|0
2638061|NCT00804986|9114210|P2|Overall Study|Lost to Follow-up|0
2638062|NCT00804986|9114211|P1|Overall Study|Lost to Follow-up|0
2638063|NCT00804986|9114206|P6|Overall Study|Lack of Efficacy|3
2638064|NCT00804986|9114207|P5|Overall Study|Lack of Efficacy|0
2638065|NCT00804986|9114208|P4|Overall Study|Lack of Efficacy|1
2638066|NCT00804986|9114209|P3|Overall Study|Lack of Efficacy|0
2638067|NCT00804986|9114210|P2|Overall Study|Lack of Efficacy|0
2638068|NCT00804986|9114211|P1|Overall Study|Lack of Efficacy|0
2638069|NCT00804986|9114206|P6|Overall Study|Adverse Event|0
2638070|NCT00804986|9114207|P5|Overall Study|Adverse Event|3
2638071|NCT00804986|9114208|P4|Overall Study|Adverse Event|1
2638072|NCT00804986|9114209|P3|Overall Study|Adverse Event|2
2638073|NCT00804986|9114210|P2|Overall Study|Adverse Event|1
2638074|NCT00804986|9114211|P1|Overall Study|Adverse Event|0
2638075|NCT00804908|9114306|P3|Overall Study|Other|114
2638076|NCT00804908|9114307|P2|Overall Study|Other|116
2638077|NCT00804908|9114308|P1|Overall Study|Other|115
2638078|NCT00804843|9114339|P2|Overall Study|Withdrawal by Subject|2
2638079|NCT00804843|9114340|P1|Overall Study|Withdrawal by Subject|1
2638080|NCT00804843|9114339|P2|Overall Study|Adverse Event|5
2638081|NCT00804843|9114340|P1|Overall Study|Adverse Event|8
2638082|NCT00804843|9114339|P2|Overall Study|Protocol Violation|0
2638083|NCT00804843|9114340|P1|Overall Study|Protocol Violation|1
2638084|NCT00804687|9114358|P6|Period 5: Treatment Period|Positive drug test|0
2638085|NCT00804687|9114359|P5|Period 5: Treatment Period|Positive drug test|0
2638086|NCT00804687|9114360|P4|Period 5: Treatment Period|Positive drug test|0
2638087|NCT00804687|9114361|P3|Period 5: Treatment Period|Positive drug test|0
2638088|NCT00804687|9114362|P2|Period 5: Treatment Period|Positive drug test|0
2638089|NCT00804687|9114363|P1|Period 5: Treatment Period|Positive drug test|1
2638090|NCT00804687|9114358|P6|Period 5: Treatment Period|Positive drugs of abuse|0
2638091|NCT00804687|9114359|P5|Period 5: Treatment Period|Positive drugs of abuse|0
2638092|NCT00804687|9114360|P4|Period 5: Treatment Period|Positive drugs of abuse|0
2638093|NCT00804687|9114361|P3|Period 5: Treatment Period|Positive drugs of abuse|1
2638094|NCT00804687|9114362|P2|Period 5: Treatment Period|Positive drugs of abuse|0
2638095|NCT00804687|9114363|P1|Period 5: Treatment Period|Positive drugs of abuse|0
2638096|NCT00804687|9114358|P6|Period 5: Treatment Period|Withdrawal by Subject|0
2638097|NCT00804687|9114359|P5|Period 5: Treatment Period|Withdrawal by Subject|1
2638098|NCT00804687|9114360|P4|Period 5: Treatment Period|Withdrawal by Subject|0
2638099|NCT00804687|9114361|P3|Period 5: Treatment Period|Withdrawal by Subject|0
2638273|NCT00803101|9114932|P2|Overall Study|Death / Serious Adverse Event|6
2638100|NCT00804687|9114362|P2|Period 5: Treatment Period|Withdrawal by Subject|0
2638101|NCT00804687|9114363|P1|Period 5: Treatment Period|Withdrawal by Subject|0
2638102|NCT00804687|9114358|P6|Period 3: Treatment Period|Positive Drug screen|0
2638103|NCT00804687|9114359|P5|Period 3: Treatment Period|Positive Drug screen|0
2638104|NCT00804687|9114360|P4|Period 3: Treatment Period|Positive Drug screen|1
2638105|NCT00804687|9114361|P3|Period 3: Treatment Period|Positive Drug screen|0
2638106|NCT00804687|9114362|P2|Period 3: Treatment Period|Positive Drug screen|0
2638107|NCT00804687|9114363|P1|Period 3: Treatment Period|Positive Drug screen|0
2638108|NCT00804570|9114442|P2|Overall Study|Withdrawal by Subject|38
2638109|NCT00804570|9114443|P1|Overall Study|Withdrawal by Subject|21
2638110|NCT00804570|9114442|P2|Overall Study|Sponsor decision|4
2638111|NCT00804570|9114443|P1|Overall Study|Sponsor decision|1
2638112|NCT00804570|9114442|P2|Overall Study|Physician Decision|2
2638113|NCT00804570|9114443|P1|Overall Study|Physician Decision|1
2638114|NCT00804570|9114442|P2|Overall Study|Protocol Violation|16
2638115|NCT00804570|9114443|P1|Overall Study|Protocol Violation|12
2638116|NCT00804570|9114442|P2|Overall Study|Entry criteria not met|5
2638117|NCT00804570|9114443|P1|Overall Study|Entry criteria not met|5
2638118|NCT00804570|9114442|P2|Overall Study|Lost to Follow-up|21
2638119|NCT00804570|9114443|P1|Overall Study|Lost to Follow-up|18
2638120|NCT00804570|9114442|P2|Overall Study|Lack of Efficacy|1
2638121|NCT00804570|9114443|P1|Overall Study|Lack of Efficacy|0
2638122|NCT00804570|9114442|P2|Overall Study|Adverse Event|7
2638123|NCT00804570|9114443|P1|Overall Study|Adverse Event|14
2638124|NCT00804193|9114517|P3|Overall Study|Withdrawal by Subject|2
2638125|NCT00804193|9114518|P2|Overall Study|Withdrawal by Subject|1
2638126|NCT00804193|9114519|P1|Overall Study|Withdrawal by Subject|3
2638127|NCT00804193|9114517|P3|Overall Study|Lost to Follow-up|4
2638128|NCT00804193|9114518|P2|Overall Study|Lost to Follow-up|3
2638129|NCT00804193|9114519|P1|Overall Study|Lost to Follow-up|3
2638130|NCT00804193|9114517|P3|Overall Study|Protocol Violation|2
2638131|NCT00804193|9114518|P2|Overall Study|Protocol Violation|8
2638132|NCT00804193|9114519|P1|Overall Study|Protocol Violation|0
2638133|NCT00804193|9114517|P3|Overall Study|Lack of Efficacy|3
2638134|NCT00804193|9114518|P2|Overall Study|Lack of Efficacy|1
2638135|NCT00804193|9114519|P1|Overall Study|Lack of Efficacy|1
2638136|NCT00804193|9114517|P3|Overall Study|Adverse Event|2
2638137|NCT00804193|9114518|P2|Overall Study|Adverse Event|0
2638138|NCT00804193|9114519|P1|Overall Study|Adverse Event|0
2638139|NCT00804193|9114517|P3|Overall Study|Lack of baseline fungus|19
2638140|NCT00804193|9114518|P2|Overall Study|Lack of baseline fungus|31
2638141|NCT00804193|9114519|P1|Overall Study|Lack of baseline fungus|32
2638142|NCT00804141|9114533|P1|Overall Study|Enrolled but not treated|6
2638143|NCT00804141|9114533|P1|Overall Study|Other than specified|30
2638144|NCT00804141|9114533|P1|Overall Study|Lack of Efficacy|46
2638145|NCT00804141|9114533|P1|Overall Study|Withdrawal by Subject|131
2638146|NCT00804141|9114533|P1|Overall Study|Protocol Violation|85
2638147|NCT00804141|9114533|P1|Overall Study|Investigator request|8
2638148|NCT00804141|9114533|P1|Overall Study|Failed to return|96
2638149|NCT00804141|9114533|P1|Overall Study|Death|4
2638150|NCT00804141|9114533|P1|Overall Study|Adverse Event|157
2638151|NCT00803790|9114573|P4|Period 2|Positive Drug Screen or Personal Reasons|0
2638152|NCT00803790|9114574|P3|Period 2|Positive Drug Screen or Personal Reasons|0
2638153|NCT00803790|9114575|P2|Period 2|Positive Drug Screen or Personal Reasons|0
2638154|NCT00803790|9114576|P1|Period 2|Positive Drug Screen or Personal Reasons|1
2638155|NCT00803790|9114573|P4|Period 2|Withdrawal by Subject|0
2638156|NCT00803790|9114574|P3|Period 2|Withdrawal by Subject|0
2638157|NCT00803790|9114575|P2|Period 2|Withdrawal by Subject|0
2638158|NCT00803790|9114576|P1|Period 2|Withdrawal by Subject|1
2638159|NCT00803790|9114573|P4|Period 2|Adverse Event|1
2638160|NCT00803790|9114574|P3|Period 2|Adverse Event|1
2638161|NCT00803790|9114575|P2|Period 2|Adverse Event|0
2638162|NCT00803790|9114576|P1|Period 2|Adverse Event|0
2638163|NCT00803790|9114573|P4|Period 1|Protocol Violation|0
2638164|NCT00803790|9114574|P3|Period 1|Protocol Violation|1
2638165|NCT00803790|9114575|P2|Period 1|Protocol Violation|0
2638166|NCT00803790|9114576|P1|Period 1|Protocol Violation|0
2638167|NCT00803790|9114573|P4|Period 1|positive drug screen or personal reasons|4
2638168|NCT00803790|9114574|P3|Period 1|positive drug screen or personal reasons|0
2638169|NCT00803790|9114575|P2|Period 1|positive drug screen or personal reasons|3
2638170|NCT00803790|9114576|P1|Period 1|positive drug screen or personal reasons|0
2638171|NCT00803790|9114573|P4|Period 1|Withdrawal by Subject|0
2638172|NCT00803790|9114574|P3|Period 1|Withdrawal by Subject|0
2638173|NCT00803790|9114575|P2|Period 1|Withdrawal by Subject|6
2638174|NCT00803790|9114576|P1|Period 1|Withdrawal by Subject|8
2638175|NCT00803790|9114573|P4|Period 1|Lost to Follow-up|0
2638176|NCT00803790|9114574|P3|Period 1|Lost to Follow-up|0
2638177|NCT00803790|9114575|P2|Period 1|Lost to Follow-up|2
2638178|NCT00803790|9114576|P1|Period 1|Lost to Follow-up|1
2638179|NCT00803790|9114573|P4|Period 1|Adverse Event|0
2638180|NCT00803790|9114574|P3|Period 1|Adverse Event|0
2638181|NCT00803790|9114575|P2|Period 1|Adverse Event|1
2638182|NCT00803790|9114576|P1|Period 1|Adverse Event|0
2638183|NCT00803738|9114616|P2|Overall Study|Positive Results for STD or abnormal PAP|8
2638184|NCT00803738|9114617|P1|Overall Study|Positive Results for STD or abnormal PAP|2
2638185|NCT00803738|9114616|P2|Overall Study|Negative Baseline Culture of Candida|63
2640724|NCT00788957|9122823|P5|Part 1|Death|0
2638186|NCT00803738|9114617|P1|Overall Study|Negative Baseline Culture of Candida|56
2638187|NCT00803738|9114616|P2|Overall Study|Lack of Efficacy|16
2638188|NCT00803738|9114617|P1|Overall Study|Lack of Efficacy|10
2638189|NCT00803738|9114616|P2|Overall Study|Withdrawal by Subject|4
2638190|NCT00803738|9114617|P1|Overall Study|Withdrawal by Subject|1
2638191|NCT00803738|9114616|P2|Overall Study|Protocol Violation|10
2638192|NCT00803738|9114617|P1|Overall Study|Protocol Violation|18
2638193|NCT00803738|9114616|P2|Overall Study|Lost to Follow-up|4
2638194|NCT00803738|9114617|P1|Overall Study|Lost to Follow-up|4
2638195|NCT00803738|9114616|P2|Overall Study|Adverse Event|5
2638196|NCT00803738|9114617|P1|Overall Study|Adverse Event|3
2638197|NCT00803712|9114629|P2|Overall Study|Protocol criteria (parathyroidectomy)|1
2638198|NCT00803712|9114630|P1|Overall Study|Protocol criteria (parathyroidectomy)|1
2638199|NCT00803712|9114629|P2|Overall Study|Administrative decision|3
2638200|NCT00803712|9114630|P1|Overall Study|Administrative decision|2
2638201|NCT00803712|9114629|P2|Overall Study|Protocol criteria (renal transplant)|8
2638202|NCT00803712|9114630|P1|Overall Study|Protocol criteria (renal transplant)|12
2638203|NCT00803712|9114629|P2|Overall Study|Protocol criteria (other)|2
2638204|NCT00803712|9114630|P1|Overall Study|Protocol criteria (other)|0
2638205|NCT00803712|9114629|P2|Overall Study|"Other in electronic Case Report Form"|1
2638206|NCT00803712|9114630|P1|Overall Study|"Other in electronic Case Report Form"|0
2638207|NCT00803712|9114629|P2|Overall Study|Withdrawal by Subject|4
2638208|NCT00803712|9114630|P1|Overall Study|Withdrawal by Subject|2
2638209|NCT00803712|9114629|P2|Overall Study|Lost to Follow-up|1
2638210|NCT00803712|9114630|P1|Overall Study|Lost to Follow-up|3
2638211|NCT00803712|9114629|P2|Overall Study|Death|7
2638212|NCT00803712|9114630|P1|Overall Study|Death|8
2638213|NCT00803712|9114629|P2|Overall Study|Adverse Event|0
2638214|NCT00803712|9114630|P1|Overall Study|Adverse Event|5
2638215|NCT00803712|9114629|P2|Overall Study|Noncompliance|0
2638216|NCT00803712|9114630|P1|Overall Study|Noncompliance|3
2638217|NCT00803634|9114729|P2|Overall Study|Death|2
2638218|NCT00803634|9114730|P1|Overall Study|Death|3
2638219|NCT00803634|9114729|P2|Overall Study|Lost to Follow-up|3
2638220|NCT00803634|9114730|P1|Overall Study|Lost to Follow-up|2
2638221|NCT00803634|9114729|P2|Overall Study|Withdrew Consent|0
2638222|NCT00803634|9114730|P1|Overall Study|Withdrew Consent|1
2638223|NCT00803595|9114759|P3|Overall Study|Withdrawal by Subject|3
2638224|NCT00803595|9114760|P2|Overall Study|Withdrawal by Subject|2
2638225|NCT00803595|9114761|P1|Overall Study|Withdrawal by Subject|5
2638226|NCT00803595|9114759|P3|Overall Study|Protocol Violation|12
2638227|NCT00803595|9114760|P2|Overall Study|Protocol Violation|2
2638228|NCT00803595|9114761|P1|Overall Study|Protocol Violation|7
2638229|NCT00803595|9114759|P3|Overall Study|Adverse Event|1
2638230|NCT00803595|9114760|P2|Overall Study|Adverse Event|4
2638231|NCT00803595|9114761|P1|Overall Study|Adverse Event|3
2638232|NCT00803569|9114772|P1|Overall Study|Noncompliance|1
2638233|NCT00803569|9114772|P1|Overall Study|Progressive Disease|3
2638234|NCT00803452|9114806|P2|Overall Study|Lost to Follow-up|3
2638235|NCT00803452|9114807|P1|Overall Study|Lost to Follow-up|0
2638236|NCT00803452|9114806|P2|Overall Study|Adverse Event|2
2638237|NCT00803452|9114807|P1|Overall Study|Adverse Event|0
2638238|NCT00803361|9114845|P2|Overall Study|Withdrawal by Subject|6
2638239|NCT00803361|9114846|P1|Overall Study|Withdrawal by Subject|5
2638240|NCT00803361|9114845|P2|Overall Study|Protocol Violation|4
2638241|NCT00803361|9114846|P1|Overall Study|Protocol Violation|2
2638242|NCT00803361|9114845|P2|Overall Study|Physician Decision|0
2638243|NCT00803361|9114846|P1|Overall Study|Physician Decision|1
2638244|NCT00803361|9114845|P2|Overall Study|Lost to Follow-up|2
2638245|NCT00803361|9114846|P1|Overall Study|Lost to Follow-up|1
2638246|NCT00803361|9114845|P2|Overall Study|Lack of Efficacy|13
2638247|NCT00803361|9114846|P1|Overall Study|Lack of Efficacy|4
2638248|NCT00803361|9114845|P2|Overall Study|Adverse Event|3
2638249|NCT00803361|9114846|P1|Overall Study|Adverse Event|13
2638250|NCT00803270|9114893|P2|Overall Study|Lost to Follow-up|2
2638251|NCT00803270|9114894|P1|Overall Study|Lost to Follow-up|1
2638252|NCT00803244|9114904|P2|Overall Study|Any other reason not above-mentioned|10
2638253|NCT00803244|9114905|P1|Overall Study|Any other reason not above-mentioned|4
2638254|NCT00803244|9114904|P2|Overall Study|Withdrawal by Subject|3
2638255|NCT00803244|9114905|P1|Overall Study|Withdrawal by Subject|2
2638256|NCT00803244|9114904|P2|Overall Study|Adverse Event|2
2638257|NCT00803244|9114905|P1|Overall Study|Adverse Event|1
2638258|NCT00803179|9114913|P1|Overall Study|Lost to Follow-up|3
2638259|NCT00803101|9114932|P2|Overall Study|Patient did not have surgery|1
2638260|NCT00803101|9114933|P1|Overall Study|Patient did not have surgery|1
2638261|NCT00803101|9114932|P2|Overall Study|Patient did not attend scheduled visit|1
2638262|NCT00803101|9114933|P1|Overall Study|Patient did not attend scheduled visit|2
2638263|NCT00803101|9114932|P2|Overall Study|Patient died outside SAE report period|0
2638264|NCT00803101|9114933|P1|Overall Study|Patient died outside SAE report period|1
2638265|NCT00803101|9114932|P2|Overall Study|Surgery finished outside protocol window|1
2638266|NCT00803101|9114933|P1|Overall Study|Surgery finished outside protocol window|1
2638267|NCT00803101|9114932|P2|Overall Study|Protocol Violation|7
2638268|NCT00803101|9114933|P1|Overall Study|Protocol Violation|1
2638269|NCT00803101|9114932|P2|Overall Study|Lost to Follow-up|2
2638270|NCT00803101|9114933|P1|Overall Study|Lost to Follow-up|2
2638271|NCT00803101|9114932|P2|Overall Study|Withdrawal by Subject|4
2638272|NCT00803101|9114933|P1|Overall Study|Withdrawal by Subject|6
2638274|NCT00803101|9114933|P1|Overall Study|Death / Serious Adverse Event|4
2638275|NCT00803049|9114984|P4|Overall Study|Other than Specified Above|5
2638276|NCT00803049|9114985|P3|Overall Study|Other than Specified Above|2
2638277|NCT00803049|9114986|P2|Overall Study|Other than Specified Above|9
2638278|NCT00803049|9114987|P1|Overall Study|Other than Specified Above|3
2638279|NCT00803049|9114984|P4|Overall Study|Randomized and Not Treated|2
2638280|NCT00803049|9114985|P3|Overall Study|Randomized and Not Treated|0
2638281|NCT00803049|9114986|P2|Overall Study|Randomized and Not Treated|0
2638282|NCT00803049|9114987|P1|Overall Study|Randomized and Not Treated|0
2638283|NCT00803049|9114984|P4|Overall Study|Protocol Violation|0
2638284|NCT00803049|9114985|P3|Overall Study|Protocol Violation|1
2638285|NCT00803049|9114986|P2|Overall Study|Protocol Violation|1
2638286|NCT00803049|9114987|P1|Overall Study|Protocol Violation|0
2638287|NCT00803049|9114984|P4|Overall Study|Withdrawal by Subject|44
2638288|NCT00803049|9114985|P3|Overall Study|Withdrawal by Subject|16
2638289|NCT00803049|9114986|P2|Overall Study|Withdrawal by Subject|43
2638290|NCT00803049|9114987|P1|Overall Study|Withdrawal by Subject|19
2638291|NCT00803049|9114984|P4|Overall Study|Progressive Disease|6
2638292|NCT00803049|9114985|P3|Overall Study|Progressive Disease|6
2638293|NCT00803049|9114986|P2|Overall Study|Progressive Disease|10
2638294|NCT00803049|9114987|P1|Overall Study|Progressive Disease|6
2638295|NCT00803049|9114984|P4|Overall Study|Death|2
2638296|NCT00803049|9114985|P3|Overall Study|Death|0
2638297|NCT00803049|9114986|P2|Overall Study|Death|1
2638298|NCT00803049|9114987|P1|Overall Study|Death|2
2638299|NCT00803049|9114984|P4|Overall Study|Lost to Follow-up|3
2638300|NCT00803049|9114985|P3|Overall Study|Lost to Follow-up|0
2638301|NCT00803049|9114986|P2|Overall Study|Lost to Follow-up|2
2638302|NCT00803049|9114987|P1|Overall Study|Lost to Follow-up|0
2638303|NCT00803049|9114984|P4|Overall Study|Lack of Efficacy|13
2638304|NCT00803049|9114985|P3|Overall Study|Lack of Efficacy|6
2638305|NCT00803049|9114986|P2|Overall Study|Lack of Efficacy|19
2638306|NCT00803049|9114987|P1|Overall Study|Lack of Efficacy|10
2638307|NCT00803049|9114984|P4|Overall Study|Adverse Event|27
2638308|NCT00803049|9114985|P3|Overall Study|Adverse Event|13
2638309|NCT00803049|9114986|P2|Overall Study|Adverse Event|33
2638310|NCT00803049|9114987|P1|Overall Study|Adverse Event|21
2638311|NCT00803023|9115021|P4|Overall Study|Lack of Efficacy|1
2638312|NCT00803023|9115022|P3|Overall Study|Lack of Efficacy|1
2638313|NCT00803023|9115023|P2|Overall Study|Lack of Efficacy|1
2638314|NCT00803023|9115024|P1|Overall Study|Lack of Efficacy|0
2638315|NCT00803023|9115021|P4|Overall Study|Lost to Follow-up|1
2638316|NCT00803023|9115022|P3|Overall Study|Lost to Follow-up|2
2638317|NCT00803023|9115023|P2|Overall Study|Lost to Follow-up|1
2638318|NCT00803023|9115024|P1|Overall Study|Lost to Follow-up|0
2638319|NCT00803023|9115021|P4|Overall Study|Withdrawal by Subject|0
2638320|NCT00803023|9115022|P3|Overall Study|Withdrawal by Subject|0
2638321|NCT00803023|9115023|P2|Overall Study|Withdrawal by Subject|2
2638322|NCT00803023|9115024|P1|Overall Study|Withdrawal by Subject|0
2638323|NCT00803023|9115021|P4|Overall Study|Adverse Event|6
2638324|NCT00803023|9115022|P3|Overall Study|Adverse Event|8
2638325|NCT00803023|9115023|P2|Overall Study|Adverse Event|4
2638326|NCT00803023|9115024|P1|Overall Study|Adverse Event|5
2638327|NCT00802945|9115062|P2|Overall Study|Terminated by sponsor|12
2638328|NCT00802945|9115063|P1|Overall Study|Terminated by sponsor|8
2638329|NCT00802945|9115062|P2|Overall Study|Death|23
2638330|NCT00802945|9115063|P1|Overall Study|Death|27
2638331|NCT00802893|9115094|P1|Overall Study|study terminated|3
2638332|NCT00802867|9115118|P1|Overall Study|Withdrawal by Subject|1
2638333|NCT00802867|9115118|P1|Overall Study|Protocol Violation|6
2638334|NCT00802867|9115118|P1|Overall Study|Lost to Follow-up|6
2638335|NCT00802841|9115141|P2|Overall Study|Treatment duration completed|76
2638336|NCT00802841|9115142|P1|Overall Study|Treatment duration completed|66
2638337|NCT00802841|9115141|P2|Overall Study|Protocol deviation|6
2638338|NCT00802841|9115142|P1|Overall Study|Protocol deviation|2
2638339|NCT00802841|9115141|P2|Overall Study|Withdrawal by Subject|5
2638340|NCT00802841|9115142|P1|Overall Study|Withdrawal by Subject|9
2638341|NCT00802841|9115141|P2|Overall Study|Disease progression|3
2638342|NCT00802841|9115142|P1|Overall Study|Disease progression|7
2638343|NCT00802841|9115141|P2|Overall Study|Adverse Event|2
2638344|NCT00802841|9115142|P1|Overall Study|Adverse Event|8
2638345|NCT00802841|9115141|P2|Overall Study|Death|2
2638346|NCT00802841|9115142|P1|Overall Study|Death|1
2638347|NCT00802841|9115141|P2|Overall Study|Lost to Follow-up|1
2638348|NCT00802841|9115142|P1|Overall Study|Lost to Follow-up|2
2638349|NCT00802841|9115141|P2|Overall Study|Administrative problems|0
2638350|NCT00802841|9115142|P1|Overall Study|Administrative problems|1
2638351|NCT00802737|9115167|P3|Overall Study|Participant too Unwell|0
2638352|NCT00802737|9115168|P2|Overall Study|Participant too Unwell|2
2638353|NCT00802737|9115169|P1|Overall Study|Participant too Unwell|0
2638354|NCT00802737|9115167|P3|Overall Study|Ongoing CLL-Treatment|0
2638355|NCT00802737|9115168|P2|Overall Study|Ongoing CLL-Treatment|1
2638356|NCT00802737|9115169|P1|Overall Study|Ongoing CLL-Treatment|0
2638357|NCT00802737|9115167|P3|Overall Study|Received Prohibited Therapy|0
2638358|NCT00802737|9115168|P2|Overall Study|Received Prohibited Therapy|0
2638359|NCT00802737|9115169|P1|Overall Study|Received Prohibited Therapy|1
2638360|NCT00802737|9115167|P3|Overall Study|Adverse Event|0
2638361|NCT00802737|9115168|P2|Overall Study|Adverse Event|0
2638362|NCT00802737|9115169|P1|Overall Study|Adverse Event|1
2638363|NCT00802737|9115167|P3|Overall Study|Death|1
2638364|NCT00802737|9115168|P2|Overall Study|Death|5
2638365|NCT00802737|9115169|P1|Overall Study|Death|6
2638366|NCT00802737|9115167|P3|Overall Study|Withdrawn due to Disease Progression|0
2638367|NCT00802737|9115168|P2|Overall Study|Withdrawn due to Disease Progression|3
2638368|NCT00802737|9115169|P1|Overall Study|Withdrawn due to Disease Progression|9
2638369|NCT00802672|9115229|P3|Overall Study|other|2
2638370|NCT00802672|9115230|P2|Overall Study|other|1
2638371|NCT00802672|9115231|P1|Overall Study|other|3
2638372|NCT00802672|9115229|P3|Overall Study|Withdrawal by Subject|2
2638373|NCT00802672|9115230|P2|Overall Study|Withdrawal by Subject|1
2638374|NCT00802672|9115231|P1|Overall Study|Withdrawal by Subject|1
2638375|NCT00802672|9115229|P3|Overall Study|Lost to Follow-up|3
2638376|NCT00802672|9115230|P2|Overall Study|Lost to Follow-up|5
2638377|NCT00802672|9115231|P1|Overall Study|Lost to Follow-up|5
2638378|NCT00802672|9115229|P3|Overall Study|Protocol Violation|1
2638379|NCT00802672|9115230|P2|Overall Study|Protocol Violation|1
2638380|NCT00802672|9115231|P1|Overall Study|Protocol Violation|2
2638381|NCT00802672|9115229|P3|Overall Study|Adverse Event|1
2638382|NCT00802672|9115230|P2|Overall Study|Adverse Event|1
2638383|NCT00802672|9115231|P1|Overall Study|Adverse Event|1
2638384|NCT00802672|9115229|P3|Overall Study|Lack of fungal pathogen at baseline|25
2638385|NCT00802672|9115230|P2|Overall Study|Lack of fungal pathogen at baseline|43
2638386|NCT00802672|9115231|P1|Overall Study|Lack of fungal pathogen at baseline|56
2638387|NCT00802659|9115249|P4|Overall Study|Physician Decision|0
2638388|NCT00802659|9115250|P3|Overall Study|Physician Decision|0
2638389|NCT00802659|9115251|P2|Overall Study|Physician Decision|1
2638390|NCT00802659|9115252|P1|Overall Study|Physician Decision|0
2638391|NCT00802529|9115291|P2|Overall Study|Lost to Follow-up|1
2638392|NCT00802529|9115292|P1|Overall Study|Lost to Follow-up|0
2638393|NCT00802464|9115331|P4|Month 8 - Month 14|Lost to Follow-up|0
2638394|NCT00802464|9115332|P3|Month 8 - Month 14|Lost to Follow-up|1
2638395|NCT00802464|9115333|P2|Month 8 - Month 14|Lost to Follow-up|0
2638396|NCT00802464|9115334|P1|Month 8 - Month 14|Lost to Follow-up|0
2638397|NCT00802464|9115331|P4|Month 8 - Month 14|Withdrawal by Subject|0
2638398|NCT00802464|9115332|P3|Month 8 - Month 14|Withdrawal by Subject|0
2638399|NCT00802464|9115333|P2|Month 8 - Month 14|Withdrawal by Subject|1
2638400|NCT00802464|9115334|P1|Month 8 - Month 14|Withdrawal by Subject|1
2638401|NCT00802464|9115331|P4|Month 8 - Month 14|Adverse Event|0
2638402|NCT00802464|9115332|P3|Month 8 - Month 14|Adverse Event|0
2638403|NCT00802464|9115333|P2|Month 8 - Month 14|Adverse Event|1
2638404|NCT00802464|9115334|P1|Month 8 - Month 14|Adverse Event|0
2638405|NCT00802464|9115331|P4|Month 0 - Month 8|Other|0
2638406|NCT00802464|9115332|P3|Month 0 - Month 8|Other|1
2638407|NCT00802464|9115333|P2|Month 0 - Month 8|Other|0
2638408|NCT00802464|9115334|P1|Month 0 - Month 8|Other|0
2638409|NCT00802464|9115331|P4|Month 0 - Month 8|Lost to Follow-up|2
2638410|NCT00802464|9115332|P3|Month 0 - Month 8|Lost to Follow-up|2
2638411|NCT00802464|9115333|P2|Month 0 - Month 8|Lost to Follow-up|1
2638412|NCT00802464|9115334|P1|Month 0 - Month 8|Lost to Follow-up|0
2638413|NCT00802464|9115331|P4|Month 0 - Month 8|Withdrawal by Subject|5
2638414|NCT00802464|9115332|P3|Month 0 - Month 8|Withdrawal by Subject|2
2638415|NCT00802464|9115333|P2|Month 0 - Month 8|Withdrawal by Subject|1
2638416|NCT00802464|9115334|P1|Month 0 - Month 8|Withdrawal by Subject|0
2638417|NCT00802464|9115331|P4|Month 0 - Month 8|Protocol Violation|0
2638418|NCT00802464|9115332|P3|Month 0 - Month 8|Protocol Violation|1
2638419|NCT00802464|9115333|P2|Month 0 - Month 8|Protocol Violation|0
2638420|NCT00802464|9115334|P1|Month 0 - Month 8|Protocol Violation|0
2638421|NCT00802464|9115331|P4|Month 0 - Month 8|Adverse Event|2
2638422|NCT00802464|9115332|P3|Month 0 - Month 8|Adverse Event|1
2638423|NCT00802464|9115333|P2|Month 0 - Month 8|Adverse Event|1
2638424|NCT00802464|9115334|P1|Month 0 - Month 8|Adverse Event|0
2638425|NCT00802438|9115420|P1|Overall Study|Physician Decision|1
2638426|NCT00802438|9115420|P1|Overall Study|Withdrawal by Subject|7
2638427|NCT00802438|9115420|P1|Overall Study|Screen Failure|20
2638428|NCT00802360|9115440|P4|Overall Study|Other|3
2638429|NCT00802360|9115441|P3|Overall Study|Other|6
2638430|NCT00802360|9115442|P2|Overall Study|Other|3
2638431|NCT00802360|9115443|P1|Overall Study|Other|2
2638432|NCT00802360|9115440|P4|Overall Study|Pregnancy loss/miscarriage|3
2638433|NCT00802360|9115441|P3|Overall Study|Pregnancy loss/miscarriage|0
2638434|NCT00802360|9115442|P2|Overall Study|Pregnancy loss/miscarriage|2
2638435|NCT00802360|9115443|P1|Overall Study|Pregnancy loss/miscarriage|0
2638436|NCT00802360|9115440|P4|Overall Study|Pregnancy not confirmed by ultrasound|0
2638437|NCT00802360|9115441|P3|Overall Study|Pregnancy not confirmed by ultrasound|1
2638438|NCT00802360|9115442|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
2638439|NCT00802360|9115443|P1|Overall Study|Pregnancy not confirmed by ultrasound|1
2638440|NCT00802360|9115440|P4|Overall Study|No positive serum pregnancy|10
2638441|NCT00802360|9115441|P3|Overall Study|No positive serum pregnancy|14
2638442|NCT00802360|9115442|P2|Overall Study|No positive serum pregnancy|20
2638443|NCT00802360|9115443|P1|Overall Study|No positive serum pregnancy|17
2638444|NCT00802360|9115440|P4|Overall Study|Risk of ovarian hyperstimulation syndrom|1
2638445|NCT00802360|9115441|P3|Overall Study|Risk of ovarian hyperstimulation syndrom|0
2638446|NCT00802360|9115442|P2|Overall Study|Risk of ovarian hyperstimulation syndrom|0
2638447|NCT00802360|9115443|P1|Overall Study|Risk of ovarian hyperstimulation syndrom|0
2638448|NCT00802360|9115440|P4|Overall Study|Cycle cancelled|1
2638449|NCT00802360|9115441|P3|Overall Study|Cycle cancelled|1
2640725|NCT00788957|9122824|P4|Part 1|Death|0
2638450|NCT00802360|9115442|P2|Overall Study|Cycle cancelled|1
2638451|NCT00802360|9115443|P1|Overall Study|Cycle cancelled|0
2638452|NCT00802360|9115440|P4|Overall Study|Inadequate number of oocytes retrieved|1
2638453|NCT00802360|9115441|P3|Overall Study|Inadequate number of oocytes retrieved|0
2638454|NCT00802360|9115442|P2|Overall Study|Inadequate number of oocytes retrieved|0
2638455|NCT00802360|9115443|P1|Overall Study|Inadequate number of oocytes retrieved|0
2638456|NCT00802360|9115440|P4|Overall Study|Stimulation failure|3
2638457|NCT00802360|9115441|P3|Overall Study|Stimulation failure|3
2638458|NCT00802360|9115442|P2|Overall Study|Stimulation failure|0
2638459|NCT00802360|9115443|P1|Overall Study|Stimulation failure|4
2638460|NCT00802178|9115510|P1|Overall Study|Patients wish and other reason|1
2638461|NCT00802178|9115510|P1|Overall Study|IT and patient wish|8
2638462|NCT00802178|9115510|P1|Overall Study|Lack of efficacy and patient wish|1
2638463|NCT00802178|9115510|P1|Overall Study|Other|32
2638464|NCT00802178|9115510|P1|Overall Study|Withdrawal by Subject|18
2638465|NCT00802178|9115510|P1|Overall Study|Insufficient tolerability (IT)|17
2638466|NCT00802178|9115510|P1|Overall Study|Lack of Efficacy|36
2638467|NCT00802074|9115558|P6|Overall Study|Withdrawal by Subject|0
2638468|NCT00802074|9115559|P5|Overall Study|Withdrawal by Subject|0
2638469|NCT00802074|9115560|P4|Overall Study|Withdrawal by Subject|0
2638470|NCT00802074|9115561|P3|Overall Study|Withdrawal by Subject|0
2638471|NCT00802074|9115562|P2|Overall Study|Withdrawal by Subject|0
2638472|NCT00802074|9115563|P1|Overall Study|Withdrawal by Subject|1
2638473|NCT00802074|9115558|P6|Overall Study|Adverse Event|0
2638474|NCT00802074|9115559|P5|Overall Study|Adverse Event|0
2638475|NCT00802074|9115560|P4|Overall Study|Adverse Event|0
2638476|NCT00802074|9115561|P3|Overall Study|Adverse Event|1
2638477|NCT00802074|9115562|P2|Overall Study|Adverse Event|1
2638478|NCT00802074|9115563|P1|Overall Study|Adverse Event|1
2638479|NCT00801983|9115597|P2|Period 2|Withdrawal by Subject|1
2638480|NCT00801983|9115598|P1|Period 2|Withdrawal by Subject|2
2638481|NCT00801983|9115597|P2|Period 1|Withdrawal by Subject|8
2638482|NCT00801983|9115598|P1|Period 1|Withdrawal by Subject|2
2638483|NCT00801983|9115597|P2|Period 1|Lost to Follow-up|0
2638484|NCT00801983|9115598|P1|Period 1|Lost to Follow-up|2
2638485|NCT00801892|9115613|P2|Sham Crossover Period|Lost to Follow-up|2
2638486|NCT00801892|9115614|P1|Sham Crossover Period|Lost to Follow-up|0
2638487|NCT00801892|9115613|P2|Main Study Period|Withdrawal by Subject|1
2638488|NCT00801892|9115614|P1|Main Study Period|Withdrawal by Subject|0
2638489|NCT00801632|9115661|P1|Overall Study|Re-transplant|1
2638490|NCT00801242|9115739|P1|Overall Study|Miscellaneous reasons|20
2638491|NCT00801242|9115739|P1|Overall Study|Lost to Follow-up|1
2638492|NCT00801242|9115739|P1|Overall Study|Physician Decision|3
2638493|NCT00801242|9115739|P1|Overall Study|Protocol Violation|5
2638494|NCT00801242|9115739|P1|Overall Study|Withdrawal by Subject|13
2638495|NCT00801242|9115739|P1|Overall Study|Adverse Event|10
2638496|NCT00801229|9115752|P2|Received Study Drug/Placebo|Adverse Event|1
2638497|NCT00801229|9115753|P1|Received Study Drug/Placebo|Adverse Event|1
2638498|NCT00801229|9115752|P2|Received Study Drug/Placebo|Lost to Follow-up|1
2638499|NCT00801229|9115753|P1|Received Study Drug/Placebo|Lost to Follow-up|0
2638500|NCT00801229|9115752|P2|Received Study Drug/Placebo|Withdrawal by Subject|0
2638501|NCT00801229|9115753|P1|Received Study Drug/Placebo|Withdrawal by Subject|1
2638502|NCT00801229|9115752|P2|Received Study Drug/Placebo|Simulator sickness|1
2638503|NCT00801229|9115753|P1|Received Study Drug/Placebo|Simulator sickness|1
2638504|NCT00801229|9115752|P2|Received Study Drug/Placebo|Sub-threshold ADHD|1
2638505|NCT00801229|9115753|P1|Received Study Drug/Placebo|Sub-threshold ADHD|0
2638506|NCT00801229|9115752|P2|Received Study Drug/Placebo|Elevated SGOT level|0
2638507|NCT00801229|9115753|P1|Received Study Drug/Placebo|Elevated SGOT level|1
2638508|NCT00801229|9115752|P2|Signed Consent|Found Ineligible|1
2638509|NCT00801229|9115753|P1|Signed Consent|Found Ineligible|1
2638510|NCT00801229|9115752|P2|Signed Consent|Withdrawal by Subject|2
2638511|NCT00801229|9115753|P1|Signed Consent|Withdrawal by Subject|2
2638512|NCT00801099|9115788|P1|Overall Study|Lost to Follow-up|101
2638513|NCT00800982|9115794|P2|Overall Study|Patient moved out of state|0
2638514|NCT00800982|9115795|P1|Overall Study|Patient moved out of state|1
2638515|NCT00800982|9115794|P2|Overall Study|Withdrawal by Subject|1
2638516|NCT00800982|9115795|P1|Overall Study|Withdrawal by Subject|0
2638517|NCT00800982|9115794|P2|Overall Study|Lost to Follow-up|2
2638518|NCT00800982|9115795|P1|Overall Study|Lost to Follow-up|1
2638519|NCT00800735|9115821|P1|Overall Study|Withdrew Consent|3
2638520|NCT00800735|9115821|P1|Overall Study|Violation of Selection Criteria at Entry|7
2638521|NCT00800735|9115821|P1|Overall Study|Insufficient Therapeutic Response|2
2638522|NCT00800735|9115821|P1|Overall Study|Administrative/Other|2
2638523|NCT00800683|9115827|P2|Overall Study|Other|2
2638524|NCT00800683|9115828|P1|Overall Study|Other|1
2638525|NCT00800683|9115827|P2|Overall Study|Lack of Efficacy|1
2638526|NCT00800683|9115828|P1|Overall Study|Lack of Efficacy|1
2638527|NCT00800683|9115827|P2|Overall Study|Withdrawal by Subject|7
2638528|NCT00800683|9115828|P1|Overall Study|Withdrawal by Subject|1
2638529|NCT00800683|9115827|P2|Overall Study|Lost to Follow-up|1
2638530|NCT00800683|9115828|P1|Overall Study|Lost to Follow-up|3
2638531|NCT00800683|9115827|P2|Overall Study|Adverse Event|8
2638532|NCT00800683|9115828|P1|Overall Study|Adverse Event|11
2638533|NCT00800540|9115874|P2|Period 2: 6 Weeks|Adverse Event|1
2638534|NCT00800540|9115875|P1|Period 2: 6 Weeks|Adverse Event|0
2638535|NCT00800540|9115874|P2|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1
2638536|NCT00800540|9115875|P1|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0
2638537|NCT00800540|9115874|P2|Period One: 6 Weeks|Noncompliance|0
2638538|NCT00800540|9115875|P1|Period One: 6 Weeks|Noncompliance|1
2638539|NCT00800436|9115910|P7|Overall Study|Withdrawal by Subject|0
2638540|NCT00800436|9115911|P6|Overall Study|Withdrawal by Subject|0
2638541|NCT00800436|9115912|P5|Overall Study|Withdrawal by Subject|0
2638542|NCT00800436|9115913|P4|Overall Study|Withdrawal by Subject|1
2638543|NCT00800436|9115914|P3|Overall Study|Withdrawal by Subject|1
2638544|NCT00800436|9115915|P2|Overall Study|Withdrawal by Subject|0
2638545|NCT00800436|9115916|P1|Overall Study|Withdrawal by Subject|0
2638546|NCT00800384|9115962|P2|Overall Study|Lost to Follow-up|26
2638547|NCT00800384|9115963|P1|Overall Study|Lost to Follow-up|17
2638548|NCT00800384|9115962|P2|Overall Study|Withdrawal by Subject|17
2638549|NCT00800384|9115963|P1|Overall Study|Withdrawal by Subject|24
2638550|NCT00800202|9116001|P2|Overall Study|Disease Progression|18
2638551|NCT00800202|9116002|P1|Overall Study|Disease Progression|54
2638552|NCT00800202|9116001|P2|Overall Study|Other|0
2638553|NCT00800202|9116002|P1|Overall Study|Other|5
2638554|NCT00800202|9116001|P2|Overall Study|Death|0
2638555|NCT00800202|9116002|P1|Overall Study|Death|1
2638556|NCT00800202|9116001|P2|Overall Study|Adverse Event|6
2638557|NCT00800202|9116002|P1|Overall Study|Adverse Event|7
2638558|NCT00799903|9116022|P2|Overall Study|Lost to Follow-up|80
2638559|NCT00799903|9116023|P1|Overall Study|Lost to Follow-up|69
2638560|NCT00799903|9116022|P2|Overall Study|Withdrawal by Subject|175
2638561|NCT00799903|9116023|P1|Overall Study|Withdrawal by Subject|179
2638562|NCT00799903|9116022|P2|Overall Study|Investigator Site Closed|23
2638563|NCT00799903|9116023|P1|Overall Study|Investigator Site Closed|25
2638564|NCT00799825|9116043|P1|Overall Study|Pregnancy|3
2638565|NCT00799825|9116043|P1|Overall Study|Lost to Follow-up|38
2638566|NCT00799825|9116043|P1|Overall Study|Withdrawal by Subject|6
2638567|NCT00799825|9116043|P1|Overall Study|Adverse Event|1
2638568|NCT00799708|9116083|P3|Overall Study|non-compliance|0
2638569|NCT00799708|9116084|P2|Overall Study|non-compliance|0
2638570|NCT00799708|9116085|P1|Overall Study|non-compliance|1
2638571|NCT00799617|9116108|P2|Anemia Trial|Withdrawal by Subject|3
2638572|NCT00799617|9116109|P1|Anemia Trial|Withdrawal by Subject|3
2638573|NCT00799617|9116108|P2|Cognitive Function Trial|Lost to Follow-up|1
2638574|NCT00799617|9116109|P1|Cognitive Function Trial|Lost to Follow-up|0
2638575|NCT00799617|9116108|P2|Bone Trial|Month 12 scan not available|16
2638576|NCT00799617|9116109|P1|Bone Trial|Month 12 scan not available|6
2638577|NCT00799617|9116108|P2|Cardiovascular Trial|Baseline scan not analyzable|2
2638578|NCT00799617|9116109|P1|Cardiovascular Trial|Baseline scan not analyzable|0
2638579|NCT00799617|9116108|P2|Cardiovascular Trial|Month 12 scan not available|15
2638580|NCT00799617|9116109|P1|Cardiovascular Trial|Month 12 scan not available|15
2638581|NCT00799617|9116108|P2|Vitality Trial|Lost to Follow-up|22
2638582|NCT00799617|9116109|P1|Vitality Trial|Lost to Follow-up|7
2638583|NCT00799617|9116108|P2|Physical Function Trial|Lost to Follow-up|11
2638584|NCT00799617|9116109|P1|Physical Function Trial|Lost to Follow-up|6
2638585|NCT00799617|9116108|P2|Sexual Funtion Trial|No Baseline Data|7
2638586|NCT00799617|9116109|P1|Sexual Funtion Trial|No Baseline Data|4
2638587|NCT00799617|9116108|P2|Sexual Funtion Trial|Lost to Follow-up|14
2638588|NCT00799617|9116109|P1|Sexual Funtion Trial|Lost to Follow-up|12
2638589|NCT00799617|9116108|P2|Main Testosterone Trial|Lost to Follow-up|20
2638590|NCT00799617|9116109|P1|Main Testosterone Trial|Lost to Follow-up|18
2638591|NCT00799617|9116108|P2|Main Testosterone Trial|Randomized in error|1
2638592|NCT00799617|9116109|P1|Main Testosterone Trial|Randomized in error|1
2638593|NCT00799591|9116216|P1|Overall Study|Infectious origin not probable|1
2638594|NCT00799591|9116216|P1|Overall Study|Antibiotic changed, no apparent reason|1
2638595|NCT00799591|9116216|P1|Overall Study|Persistance of fever undetermined origin|1
2638596|NCT00799591|9116216|P1|Overall Study|Resistance germ and technical failure|2
2638597|NCT00799591|9116216|P1|Overall Study|New infection|4
2638598|NCT00799591|9116216|P1|Overall Study|Resistant germ|11
2638599|NCT00799591|9116216|P1|Overall Study|Technical failure|12
2638600|NCT00799591|9116216|P1|Overall Study|Death|14
2638601|NCT00799591|9116216|P1|Overall Study|De-escalation of doses|20
2638602|NCT00799487|9116234|P3|Double-Blind Assessment Period|Overslept and missed lab day 2|0
2638603|NCT00799487|9116235|P2|Double-Blind Assessment Period|Overslept and missed lab day 2|1
2638604|NCT00799487|9116236|P1|Double-Blind Assessment Period|Overslept and missed lab day 2|0
2638605|NCT00799487|9116234|P3|Double-Blind Assessment Period|Subject was out of the state|1
2638606|NCT00799487|9116235|P2|Double-Blind Assessment Period|Subject was out of the state|0
2638607|NCT00799487|9116236|P1|Double-Blind Assessment Period|Subject was out of the state|0
2638608|NCT00799487|9116234|P3|Double-Blind Assessment Period|Lost to Follow-up|1
2638609|NCT00799487|9116235|P2|Double-Blind Assessment Period|Lost to Follow-up|0
2638610|NCT00799487|9116236|P1|Double-Blind Assessment Period|Lost to Follow-up|0
2638611|NCT00799487|9116234|P3|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
2638612|NCT00799487|9116235|P2|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
2638613|NCT00799487|9116236|P1|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2
2638614|NCT00799487|9116234|P3|Dose Adjustment Period|Missed laboratory day 1|0
2638615|NCT00799487|9116235|P2|Dose Adjustment Period|Missed laboratory day 1|0
2638616|NCT00799487|9116236|P1|Dose Adjustment Period|Missed laboratory day 1|1
2638617|NCT00799487|9116234|P3|Dose Adjustment Period|Child too young (exclusion)|0
2638618|NCT00799487|9116235|P2|Dose Adjustment Period|Child too young (exclusion)|0
2638619|NCT00799487|9116236|P1|Dose Adjustment Period|Child too young (exclusion)|1
2638620|NCT00799487|9116234|P3|Dose Adjustment Period|Parent to home school child (exclusion)|0
2638621|NCT00799487|9116235|P2|Dose Adjustment Period|Parent to home school child (exclusion)|0
2638622|NCT00799487|9116236|P1|Dose Adjustment Period|Parent to home school child (exclusion)|1
2638623|NCT00799487|9116234|P3|Dose Adjustment Period|Withdrawal by Subject|0
2638624|NCT00799487|9116235|P2|Dose Adjustment Period|Withdrawal by Subject|0
2638625|NCT00799487|9116236|P1|Dose Adjustment Period|Withdrawal by Subject|3
2638626|NCT00799487|9116234|P3|Dose Adjustment Period|Investigator Discretion|0
2638627|NCT00799487|9116235|P2|Dose Adjustment Period|Investigator Discretion|0
2638628|NCT00799487|9116236|P1|Dose Adjustment Period|Investigator Discretion|2
2638629|NCT00799487|9116234|P3|Dose Adjustment Period|Optimal Dose Not Achieved|0
2638630|NCT00799487|9116235|P2|Dose Adjustment Period|Optimal Dose Not Achieved|0
2638631|NCT00799487|9116236|P1|Dose Adjustment Period|Optimal Dose Not Achieved|8
2638632|NCT00799487|9116234|P3|Dose Adjustment Period|Adverse Event|0
2638633|NCT00799487|9116235|P2|Dose Adjustment Period|Adverse Event|0
2638634|NCT00799487|9116236|P1|Dose Adjustment Period|Adverse Event|2
2638635|NCT00799487|9116234|P3|Dose Adjustment Period|Lost to Follow-up|0
2638636|NCT00799487|9116235|P2|Dose Adjustment Period|Lost to Follow-up|0
2638637|NCT00799487|9116236|P1|Dose Adjustment Period|Lost to Follow-up|1
2638638|NCT00799422|9116331|P6|First Week of Wear|Adverse Event|0
2638639|NCT00799422|9116332|P5|First Week of Wear|Adverse Event|0
2638640|NCT00799422|9116333|P4|First Week of Wear|Adverse Event|1
2638641|NCT00799422|9116334|P3|First Week of Wear|Adverse Event|0
2638642|NCT00799422|9116335|P2|First Week of Wear|Adverse Event|0
2638643|NCT00799422|9116336|P1|First Week of Wear|Adverse Event|0
2638644|NCT00799422|9116331|P6|First Week of Wear|Lost to Follow-up|0
2638645|NCT00799422|9116332|P5|First Week of Wear|Lost to Follow-up|0
2638646|NCT00799422|9116333|P4|First Week of Wear|Lost to Follow-up|0
2638647|NCT00799422|9116334|P3|First Week of Wear|Lost to Follow-up|1
2638648|NCT00799422|9116335|P2|First Week of Wear|Lost to Follow-up|0
2638649|NCT00799422|9116336|P1|First Week of Wear|Lost to Follow-up|0
2638650|NCT00799409|9116353|P3|Overall Study|medication compliance|0
2638651|NCT00799409|9116354|P2|Overall Study|medication compliance|0
2638652|NCT00799409|9116355|P1|Overall Study|medication compliance|1
2638653|NCT00799409|9116353|P3|Overall Study|Did not attend lab school day 1|0
2638654|NCT00799409|9116354|P2|Overall Study|Did not attend lab school day 1|0
2638655|NCT00799409|9116355|P1|Overall Study|Did not attend lab school day 1|1
2638656|NCT00799409|9116353|P3|Overall Study|Failure to follow study protocol)|0
2638657|NCT00799409|9116354|P2|Overall Study|Failure to follow study protocol)|0
2638658|NCT00799409|9116355|P1|Overall Study|Failure to follow study protocol)|1
2638659|NCT00799409|9116353|P3|Overall Study|Optimal Dose Not Achieved|0
2638660|NCT00799409|9116354|P2|Overall Study|Optimal Dose Not Achieved|0
2638661|NCT00799409|9116355|P1|Overall Study|Optimal Dose Not Achieved|2
2638662|NCT00799409|9116353|P3|Overall Study|Lost to Follow-up|0
2638663|NCT00799409|9116354|P2|Overall Study|Lost to Follow-up|0
2638664|NCT00799409|9116355|P1|Overall Study|Lost to Follow-up|1
2638665|NCT00799409|9116353|P3|Overall Study|Withdrawal by Subject|0
2638666|NCT00799409|9116354|P2|Overall Study|Withdrawal by Subject|0
2638667|NCT00799409|9116355|P1|Overall Study|Withdrawal by Subject|1
2638668|NCT00799396|9116435|P1|Clopidogrel Plus Aspirin|Physician Decision|4
2638669|NCT00799396|9116435|P1|Clopidogrel Plus Aspirin|Adverse Event|2
2638670|NCT00799396|9116435|P1|Clopidogrel Treatment|Withdrawal by Subject|2
2638671|NCT00799396|9116435|P1|Clopidogrel Treatment|Physician Decision|5
2638672|NCT00799396|9116435|P1|Clopidogrel Treatment|Adverse Event|6
2638673|NCT00799383|9116442|P2|Overall Study|Withdrawal by Subject|1
2638674|NCT00799383|9116443|P1|Overall Study|Withdrawal by Subject|0
2638675|NCT00799383|9116442|P2|Overall Study|Urinary Calcium/Creatinine > 0.2|1
2638676|NCT00799383|9116443|P1|Overall Study|Urinary Calcium/Creatinine > 0.2|1
2638677|NCT00799383|9116442|P2|Overall Study|Lost to Follow-up|2
2638678|NCT00799383|9116443|P1|Overall Study|Lost to Follow-up|1
2638679|NCT00799383|9116442|P2|Overall Study|Adverse Event|1
2638680|NCT00799383|9116443|P1|Overall Study|Adverse Event|0
2638681|NCT00799383|9116442|P2|Overall Study|Protocol Violation|1
2638682|NCT00799383|9116443|P1|Overall Study|Protocol Violation|1
2638683|NCT00799266|9116472|P2|Overall Study|Subject withdrew consent|0
2638684|NCT00799266|9116473|P1|Overall Study|Subject withdrew consent|3
2638685|NCT00799266|9116472|P2|Overall Study|Adverse Event|1
2638686|NCT00799266|9116473|P1|Overall Study|Adverse Event|0
2638687|NCT00798967|9116513|P2|Overall Study|Randomized in error by site|0
2638688|NCT00798967|9116514|P1|Overall Study|Randomized in error by site|1
2638689|NCT00798967|9116513|P2|Overall Study|Physician Decision|0
2638690|NCT00798967|9116514|P1|Overall Study|Physician Decision|1
2638691|NCT00798967|9116513|P2|Overall Study|Withdrawal by Subject|1
2638692|NCT00798967|9116514|P1|Overall Study|Withdrawal by Subject|0
2638693|NCT00798967|9116513|P2|Overall Study|Adverse Event|3
2638694|NCT00798967|9116514|P1|Overall Study|Adverse Event|2
2638695|NCT00798889|9116522|P1|Overall Study|Enrolled, Not treated|3
2638696|NCT00798889|9116522|P1|Overall Study|Decision of Sponsor|11
2638697|NCT00798889|9116522|P1|Overall Study|Lack of Efficacy|213
2638698|NCT00798889|9116522|P1|Overall Study|Lost to Follow-up|1
2638699|NCT00798889|9116522|P1|Overall Study|Withdrawal by Subject|31
2638700|NCT00798889|9116522|P1|Overall Study|Protocol Violation|2
2638701|NCT00798889|9116522|P1|Overall Study|Adverse Event|53
2638702|NCT00798759|9116528|P2|Overall Study|Other|1
2638703|NCT00798759|9116529|P1|Overall Study|Other|0
2638704|NCT00798759|9116528|P2|Overall Study|Protocol Violation|8
2638705|NCT00798759|9116529|P1|Overall Study|Protocol Violation|4
2638706|NCT00798759|9116528|P2|Overall Study|Lost to Follow-up|1
2638707|NCT00798759|9116529|P1|Overall Study|Lost to Follow-up|1
2638708|NCT00798759|9116528|P2|Overall Study|Adverse Event|3
2638709|NCT00798759|9116529|P1|Overall Study|Adverse Event|3
2638710|NCT00798707|9116547|P3|Overall Study|Randomized not treated|1
2638711|NCT00798707|9116548|P2|Overall Study|Randomized not treated|5
2638712|NCT00798707|9116549|P1|Overall Study|Randomized not treated|4
2638713|NCT00798707|9116547|P3|Overall Study|Withdrawal by Subject|2
2638714|NCT00798707|9116548|P2|Overall Study|Withdrawal by Subject|8
2638715|NCT00798707|9116549|P1|Overall Study|Withdrawal by Subject|3
2638716|NCT00798707|9116547|P3|Overall Study|Protocol Violation|2
2638717|NCT00798707|9116548|P2|Overall Study|Protocol Violation|0
2638718|NCT00798707|9116549|P1|Overall Study|Protocol Violation|4
2638719|NCT00798707|9116547|P3|Overall Study|Other|0
2638720|NCT00798707|9116548|P2|Overall Study|Other|1
2638721|NCT00798707|9116549|P1|Overall Study|Other|0
2638722|NCT00798707|9116547|P3|Overall Study|Lost to Follow-up|6
2638723|NCT00798707|9116548|P2|Overall Study|Lost to Follow-up|6
2638724|NCT00798707|9116549|P1|Overall Study|Lost to Follow-up|5
2638725|NCT00798707|9116547|P3|Overall Study|Lack of Efficacy|1
2638726|NCT00798707|9116548|P2|Overall Study|Lack of Efficacy|2
2638727|NCT00798707|9116549|P1|Overall Study|Lack of Efficacy|2
2638728|NCT00798707|9116547|P3|Overall Study|Investigator|2
2638729|NCT00798707|9116548|P2|Overall Study|Investigator|1
2638730|NCT00798707|9116549|P1|Overall Study|Investigator|0
2638731|NCT00798707|9116547|P3|Overall Study|Failed to return|0
2638732|NCT00798707|9116548|P2|Overall Study|Failed to return|2
2638733|NCT00798707|9116549|P1|Overall Study|Failed to return|2
2638734|NCT00798707|9116547|P3|Overall Study|Adverse Event|8
2638735|NCT00798707|9116548|P2|Overall Study|Adverse Event|8
2638736|NCT00798707|9116549|P1|Overall Study|Adverse Event|6
2638737|NCT00798694|9116601|P2|Overall Study|Physician Decision|0
2638738|NCT00798694|9116602|P1|Overall Study|Physician Decision|1
2638739|NCT00798694|9116601|P2|Overall Study|Lost to Follow-up|1
2638740|NCT00798694|9116602|P1|Overall Study|Lost to Follow-up|1
2638741|NCT00798655|9116626|P1|Overall Study|Did not receive at least one dose of pan|2
2638742|NCT00798603|9116631|P1|Overall Study|Lack of insurance coverage|1
2638743|NCT00798603|9116631|P1|Overall Study|Physician Decision|1
2638744|NCT00798603|9116631|P1|Overall Study|Adverse Event|22
2638745|NCT00798603|9116631|P1|Overall Study|Withdrawal by Subject|10
2638746|NCT00798603|9116631|P1|Overall Study|Still on treatment as of 11/6/2012|1
2638747|NCT00798590|9116653|P2|Overall Study|P.I, Left institution. Study terminated|8
2638748|NCT00798590|9116654|P1|Overall Study|P.I, Left institution. Study terminated|11
2638749|NCT00798434|9116688|P2|Open-Label|Not Treated|1
2638750|NCT00798434|9116689|P1|Open-Label|Not Treated|0
2638751|NCT00798434|9116688|P2|Open-Label|Other|2
2638752|NCT00798434|9116689|P1|Open-Label|Other|1
2638753|NCT00798434|9116688|P2|Open-Label|Protocol Violation|0
2638754|NCT00798434|9116689|P1|Open-Label|Protocol Violation|1
2638755|NCT00798434|9116688|P2|Open-Label|Withdrawal by Subject|7
2638756|NCT00798434|9116689|P1|Open-Label|Withdrawal by Subject|2
2638757|NCT00798434|9116688|P2|Open-Label|Lack of Efficacy|11
2638758|NCT00798434|9116689|P1|Open-Label|Lack of Efficacy|5
2638759|NCT00798434|9116688|P2|Open-Label|Adverse Event|11
2638760|NCT00798434|9116689|P1|Open-Label|Adverse Event|33
2638761|NCT00798434|9116688|P2|Double-Blind|Not Treated|6
2638762|NCT00798434|9116689|P1|Double-Blind|Not Treated|3
2638763|NCT00798434|9116688|P2|Double-Blind|Other|0
2638764|NCT00798434|9116689|P1|Double-Blind|Other|1
2638765|NCT00798434|9116688|P2|Double-Blind|Did Not Meet Entrance Criteria|1
2638766|NCT00798434|9116689|P1|Double-Blind|Did Not Meet Entrance Criteria|2
2638767|NCT00798434|9116688|P2|Double-Blind|Protocol Violation|4
2638768|NCT00798434|9116689|P1|Double-Blind|Protocol Violation|1
2638769|NCT00798434|9116688|P2|Double-Blind|Withdrawal by Subject|14
2638770|NCT00798434|9116689|P1|Double-Blind|Withdrawal by Subject|17
2638771|NCT00798434|9116688|P2|Double-Blind|Lack of Efficacy|12
2638772|NCT00798434|9116689|P1|Double-Blind|Lack of Efficacy|8
2638773|NCT00798434|9116688|P2|Double-Blind|Lost to Follow-up|0
2638774|NCT00798434|9116689|P1|Double-Blind|Lost to Follow-up|1
2638775|NCT00798434|9116688|P2|Double-Blind|Death|1
2638776|NCT00798434|9116689|P1|Double-Blind|Death|0
2638777|NCT00798434|9116688|P2|Double-Blind|Adverse Event|46
2638778|NCT00798434|9116689|P1|Double-Blind|Adverse Event|22
2638779|NCT00798369|9116775|P6|Overall Study|Adminstrative problems|1
2638780|NCT00798369|9116776|P5|Overall Study|Adminstrative problems|0
2638781|NCT00798369|9116777|P4|Overall Study|Adminstrative problems|0
2638782|NCT00798369|9116778|P3|Overall Study|Adminstrative problems|0
2638783|NCT00798369|9116779|P2|Overall Study|Adminstrative problems|0
2638784|NCT00798369|9116780|P1|Overall Study|Adminstrative problems|0
2638785|NCT00798369|9116775|P6|Overall Study|Lost to Follow-up|0
2638786|NCT00798369|9116776|P5|Overall Study|Lost to Follow-up|1
2638787|NCT00798369|9116777|P4|Overall Study|Lost to Follow-up|0
2638788|NCT00798369|9116778|P3|Overall Study|Lost to Follow-up|1
2638789|NCT00798369|9116779|P2|Overall Study|Lost to Follow-up|1
2638790|NCT00798369|9116780|P1|Overall Study|Lost to Follow-up|1
2638791|NCT00798369|9116775|P6|Overall Study|Subject withdrew consent|2
2638792|NCT00798369|9116776|P5|Overall Study|Subject withdrew consent|0
2640726|NCT00788957|9122825|P3|Part 1|Death|0
2638793|NCT00798369|9116777|P4|Overall Study|Subject withdrew consent|1
2638794|NCT00798369|9116778|P3|Overall Study|Subject withdrew consent|1
2638795|NCT00798369|9116779|P2|Overall Study|Subject withdrew consent|0
2638796|NCT00798369|9116780|P1|Overall Study|Subject withdrew consent|0
2638797|NCT00798317|9116827|P2|Overall Study|Death|0
2638798|NCT00798317|9116828|P1|Overall Study|Death|1
2638799|NCT00798317|9116827|P2|Overall Study|Adverse Event|0
2638800|NCT00798317|9116828|P1|Overall Study|Adverse Event|2
2638801|NCT00798317|9116827|P2|Overall Study|Lost to Follow-up|2
2638802|NCT00798317|9116828|P1|Overall Study|Lost to Follow-up|2
2638803|NCT00798317|9116827|P2|Overall Study|Withdrawal by Subject|4
2638804|NCT00798317|9116828|P1|Overall Study|Withdrawal by Subject|5
2638805|NCT00798317|9116827|P2|Overall Study|Physician Decision|1
2638806|NCT00798317|9116828|P1|Overall Study|Physician Decision|0
2638807|NCT00798304|9116839|P3|Overall Study|Discontinuation by Sponsor|9
2638808|NCT00798304|9116840|P2|Overall Study|Discontinuation by Sponsor|21
2638809|NCT00798304|9116841|P1|Overall Study|Discontinuation by Sponsor|14
2638810|NCT00798304|9116839|P3|Overall Study|Adverse Event|1
2638811|NCT00798304|9116840|P2|Overall Study|Adverse Event|1
2638812|NCT00798304|9116841|P1|Overall Study|Adverse Event|0
2638813|NCT00798174|9116867|P2|Overall Study|Inability to sedate for DFT testing|0
2638814|NCT00798174|9116868|P1|Overall Study|Inability to sedate for DFT testing|1
2638815|NCT00798174|9116867|P2|Overall Study|inability to implant azygos coil|3
2638816|NCT00798174|9116868|P1|Overall Study|inability to implant azygos coil|3
2638817|NCT00798161|9116879|P7|Overall Study|Other reason (incl. lack of efficacy)|5
2638818|NCT00798161|9116880|P6|Overall Study|Other reason (incl. lack of efficacy)|4
2638819|NCT00798161|9116881|P5|Overall Study|Other reason (incl. lack of efficacy)|2
2638820|NCT00798161|9116882|P4|Overall Study|Other reason (incl. lack of efficacy)|5
2638821|NCT00798161|9116883|P3|Overall Study|Other reason (incl. lack of efficacy)|3
2638822|NCT00798161|9116884|P2|Overall Study|Other reason (incl. lack of efficacy)|5
2638823|NCT00798161|9116885|P1|Overall Study|Other reason (incl. lack of efficacy)|7
2638824|NCT00798161|9116879|P7|Overall Study|Withdrawal by Subject|1
2638825|NCT00798161|9116880|P6|Overall Study|Withdrawal by Subject|3
2638826|NCT00798161|9116881|P5|Overall Study|Withdrawal by Subject|2
2638827|NCT00798161|9116882|P4|Overall Study|Withdrawal by Subject|4
2638828|NCT00798161|9116883|P3|Overall Study|Withdrawal by Subject|5
2638829|NCT00798161|9116884|P2|Overall Study|Withdrawal by Subject|4
2638830|NCT00798161|9116885|P1|Overall Study|Withdrawal by Subject|5
2638831|NCT00798161|9116879|P7|Overall Study|Lost to Follow-up|0
2638832|NCT00798161|9116880|P6|Overall Study|Lost to Follow-up|0
2638833|NCT00798161|9116881|P5|Overall Study|Lost to Follow-up|4
2638834|NCT00798161|9116882|P4|Overall Study|Lost to Follow-up|3
2638835|NCT00798161|9116883|P3|Overall Study|Lost to Follow-up|4
2638836|NCT00798161|9116884|P2|Overall Study|Lost to Follow-up|3
2638837|NCT00798161|9116885|P1|Overall Study|Lost to Follow-up|1
2638838|NCT00798161|9116879|P7|Overall Study|Protocol Violation|0
2638839|NCT00798161|9116880|P6|Overall Study|Protocol Violation|2
2638840|NCT00798161|9116881|P5|Overall Study|Protocol Violation|3
2638841|NCT00798161|9116882|P4|Overall Study|Protocol Violation|3
2638842|NCT00798161|9116883|P3|Overall Study|Protocol Violation|3
2638843|NCT00798161|9116884|P2|Overall Study|Protocol Violation|1
2638844|NCT00798161|9116885|P1|Overall Study|Protocol Violation|2
2638845|NCT00798161|9116879|P7|Overall Study|Adverse Event|4
2638846|NCT00798161|9116880|P6|Overall Study|Adverse Event|2
2638847|NCT00798161|9116881|P5|Overall Study|Adverse Event|5
2638848|NCT00798161|9116882|P4|Overall Study|Adverse Event|6
2638849|NCT00798161|9116883|P3|Overall Study|Adverse Event|6
2638850|NCT00798161|9116884|P2|Overall Study|Adverse Event|4
2638851|NCT00798161|9116885|P1|Overall Study|Adverse Event|3
2638852|NCT00798135|9116992|P1|Overall Study|Physician Decision|1
2638853|NCT00798135|9116992|P1|Overall Study|Disease progression, refractory|1
2638854|NCT00798135|9116992|P1|Overall Study|Disease progression, relapse|11
2638855|NCT00798096|9116998|P1|Overall Study|Ongoing|2
2638856|NCT00797966|9117026|P6|Phase A+|Protocol deviation|4
2638857|NCT00797966|9117027|P5|Phase A+|Protocol deviation|0
2638858|NCT00797966|9117028|P4|Phase A+|Protocol deviation|0
2638859|NCT00797966|9117029|P3|Phase A+|Protocol deviation|0
2638860|NCT00797966|9117030|P2|Phase A+|Protocol deviation|0
2638861|NCT00797966|9117031|P1|Phase A+|Protocol deviation|0
2638862|NCT00797966|9117026|P6|Phase A+|Adverse Event|4
2638863|NCT00797966|9117027|P5|Phase A+|Adverse Event|0
2638864|NCT00797966|9117028|P4|Phase A+|Adverse Event|0
2638865|NCT00797966|9117029|P3|Phase A+|Adverse Event|0
2638866|NCT00797966|9117030|P2|Phase A+|Adverse Event|0
2638867|NCT00797966|9117031|P1|Phase A+|Adverse Event|0
2638868|NCT00797966|9117026|P6|Phase A+|Withdrawal by Subject|6
2638869|NCT00797966|9117027|P5|Phase A+|Withdrawal by Subject|0
2638870|NCT00797966|9117028|P4|Phase A+|Withdrawal by Subject|0
2638871|NCT00797966|9117029|P3|Phase A+|Withdrawal by Subject|0
2638872|NCT00797966|9117030|P2|Phase A+|Withdrawal by Subject|0
2638873|NCT00797966|9117031|P1|Phase A+|Withdrawal by Subject|0
2638874|NCT00797966|9117026|P6|Phase A+|Met withdrawal criteria|5
2638875|NCT00797966|9117027|P5|Phase A+|Met withdrawal criteria|0
2638876|NCT00797966|9117028|P4|Phase A+|Met withdrawal criteria|0
2638877|NCT00797966|9117029|P3|Phase A+|Met withdrawal criteria|0
2638878|NCT00797966|9117030|P2|Phase A+|Met withdrawal criteria|0
2638879|NCT00797966|9117031|P1|Phase A+|Met withdrawal criteria|0
2638880|NCT00797966|9117026|P6|Phase A+|Lost to Follow-up|9
2638881|NCT00797966|9117027|P5|Phase A+|Lost to Follow-up|0
2638882|NCT00797966|9117028|P4|Phase A+|Lost to Follow-up|0
2638883|NCT00797966|9117029|P3|Phase A+|Lost to Follow-up|0
2638884|NCT00797966|9117030|P2|Phase A+|Lost to Follow-up|0
2638885|NCT00797966|9117031|P1|Phase A+|Lost to Follow-up|0
2638886|NCT00797966|9117026|P6|Phase B|Lack of Efficacy|0
2638887|NCT00797966|9117027|P5|Phase B|Lack of Efficacy|0
2638888|NCT00797966|9117028|P4|Phase B|Lack of Efficacy|4
2638889|NCT00797966|9117029|P3|Phase B|Lack of Efficacy|1
2638890|NCT00797966|9117030|P2|Phase B|Lack of Efficacy|1
2638891|NCT00797966|9117031|P1|Phase B|Lack of Efficacy|0
2638892|NCT00797966|9117026|P6|Phase B|Protocol Deviation|0
2638893|NCT00797966|9117027|P5|Phase B|Protocol Deviation|0
2638894|NCT00797966|9117028|P4|Phase B|Protocol Deviation|6
2638895|NCT00797966|9117029|P3|Phase B|Protocol Deviation|2
2638896|NCT00797966|9117030|P2|Phase B|Protocol Deviation|8
2638897|NCT00797966|9117031|P1|Phase B|Protocol Deviation|4
2638898|NCT00797966|9117026|P6|Phase B|Withdrawal by Subject|0
2638899|NCT00797966|9117027|P5|Phase B|Withdrawal by Subject|0
2638900|NCT00797966|9117028|P4|Phase B|Withdrawal by Subject|3
2638901|NCT00797966|9117029|P3|Phase B|Withdrawal by Subject|3
2638902|NCT00797966|9117030|P2|Phase B|Withdrawal by Subject|4
2638903|NCT00797966|9117031|P1|Phase B|Withdrawal by Subject|1
2638904|NCT00797966|9117026|P6|Phase B|Physician Decision|0
2638905|NCT00797966|9117027|P5|Phase B|Physician Decision|0
2638906|NCT00797966|9117028|P4|Phase B|Physician Decision|1
2638907|NCT00797966|9117029|P3|Phase B|Physician Decision|3
2638908|NCT00797966|9117030|P2|Phase B|Physician Decision|0
2638909|NCT00797966|9117031|P1|Phase B|Physician Decision|1
2638910|NCT00797966|9117026|P6|Phase B|Met Withdrawal Criteria|0
2638911|NCT00797966|9117027|P5|Phase B|Met Withdrawal Criteria|0
2638912|NCT00797966|9117028|P4|Phase B|Met Withdrawal Criteria|1
2638913|NCT00797966|9117029|P3|Phase B|Met Withdrawal Criteria|6
2638914|NCT00797966|9117030|P2|Phase B|Met Withdrawal Criteria|3
2638915|NCT00797966|9117031|P1|Phase B|Met Withdrawal Criteria|3
2638916|NCT00797966|9117026|P6|Phase B|Adverse Event|0
2638917|NCT00797966|9117027|P5|Phase B|Adverse Event|0
2638918|NCT00797966|9117028|P4|Phase B|Adverse Event|1
2638919|NCT00797966|9117029|P3|Phase B|Adverse Event|3
2638920|NCT00797966|9117030|P2|Phase B|Adverse Event|1
2638921|NCT00797966|9117031|P1|Phase B|Adverse Event|2
2638922|NCT00797966|9117026|P6|Phase B|Lost to Follow-up|0
2638923|NCT00797966|9117027|P5|Phase B|Lost to Follow-up|0
2638924|NCT00797966|9117028|P4|Phase B|Lost to Follow-up|0
2638925|NCT00797966|9117029|P3|Phase B|Lost to Follow-up|3
2638926|NCT00797966|9117030|P2|Phase B|Lost to Follow-up|1
2638927|NCT00797966|9117031|P1|Phase B|Lost to Follow-up|0
2638928|NCT00797966|9117026|P6|Phase A|Protocol deviation|0
2638929|NCT00797966|9117027|P5|Phase A|Protocol deviation|56
2638930|NCT00797966|9117028|P4|Phase A|Protocol deviation|0
2638931|NCT00797966|9117029|P3|Phase A|Protocol deviation|0
2638932|NCT00797966|9117030|P2|Phase A|Protocol deviation|0
2638933|NCT00797966|9117031|P1|Phase A|Protocol deviation|0
2638934|NCT00797966|9117026|P6|Phase A|Withdrawal by Subject|0
2638935|NCT00797966|9117027|P5|Phase A|Withdrawal by Subject|33
2638936|NCT00797966|9117028|P4|Phase A|Withdrawal by Subject|0
2638937|NCT00797966|9117029|P3|Phase A|Withdrawal by Subject|0
2638938|NCT00797966|9117030|P2|Phase A|Withdrawal by Subject|0
2638939|NCT00797966|9117031|P1|Phase A|Withdrawal by Subject|0
2638940|NCT00797966|9117026|P6|Phase A|Physician Decision|0
2638941|NCT00797966|9117027|P5|Phase A|Physician Decision|13
2638942|NCT00797966|9117028|P4|Phase A|Physician Decision|0
2638943|NCT00797966|9117029|P3|Phase A|Physician Decision|0
2638944|NCT00797966|9117030|P2|Phase A|Physician Decision|0
2638945|NCT00797966|9117031|P1|Phase A|Physician Decision|0
2638946|NCT00797966|9117026|P6|Phase A|Met withdrawal criteria|0
2638947|NCT00797966|9117027|P5|Phase A|Met withdrawal criteria|4
2638948|NCT00797966|9117028|P4|Phase A|Met withdrawal criteria|0
2638949|NCT00797966|9117029|P3|Phase A|Met withdrawal criteria|0
2638950|NCT00797966|9117030|P2|Phase A|Met withdrawal criteria|0
2638951|NCT00797966|9117031|P1|Phase A|Met withdrawal criteria|0
2638952|NCT00797966|9117026|P6|Phase A|Adverse Event|0
2638953|NCT00797966|9117027|P5|Phase A|Adverse Event|46
2638954|NCT00797966|9117028|P4|Phase A|Adverse Event|0
2638955|NCT00797966|9117029|P3|Phase A|Adverse Event|0
2638956|NCT00797966|9117030|P2|Phase A|Adverse Event|0
2638957|NCT00797966|9117031|P1|Phase A|Adverse Event|0
2638958|NCT00797966|9117026|P6|Phase A|Lost to Follow-up|0
2638959|NCT00797966|9117027|P5|Phase A|Lost to Follow-up|33
2638960|NCT00797966|9117028|P4|Phase A|Lost to Follow-up|0
2638961|NCT00797966|9117029|P3|Phase A|Lost to Follow-up|0
2638962|NCT00797966|9117030|P2|Phase A|Lost to Follow-up|0
2638963|NCT00797966|9117031|P1|Phase A|Lost to Follow-up|0
2638964|NCT00797862|9117096|P3|Overall Study|Mis-randomized|1
2638965|NCT00797862|9117097|P2|Overall Study|Mis-randomized|3
2638966|NCT00797862|9117098|P1|Overall Study|Mis-randomized|3
2638967|NCT00797862|9117096|P3|Overall Study|Protocol Violation|8
2638968|NCT00797862|9117097|P2|Overall Study|Protocol Violation|6
2638969|NCT00797862|9117098|P1|Overall Study|Protocol Violation|4
2638970|NCT00797862|9117096|P3|Overall Study|Administrative Problem|0
2638971|NCT00797862|9117097|P2|Overall Study|Administrative Problem|0
2638972|NCT00797862|9117098|P1|Overall Study|Administrative Problem|4
2638973|NCT00797862|9117096|P3|Overall Study|Lost to Follow-up|5
2638974|NCT00797862|9117097|P2|Overall Study|Lost to Follow-up|0
2638975|NCT00797862|9117098|P1|Overall Study|Lost to Follow-up|11
2638976|NCT00797862|9117096|P3|Overall Study|Withdrawal by Subject|7
2638977|NCT00797862|9117097|P2|Overall Study|Withdrawal by Subject|7
2638978|NCT00797862|9117098|P1|Overall Study|Withdrawal by Subject|14
2638979|NCT00797862|9117096|P3|Overall Study|No longer required study medication|0
2638980|NCT00797862|9117097|P2|Overall Study|No longer required study medication|0
2638981|NCT00797862|9117098|P1|Overall Study|No longer required study medication|1
2638982|NCT00797862|9117096|P3|Overall Study|Lack of Efficacy|6
2638983|NCT00797862|9117097|P2|Overall Study|Lack of Efficacy|7
2638984|NCT00797862|9117098|P1|Overall Study|Lack of Efficacy|1
2638985|NCT00797862|9117096|P3|Overall Study|Abnormal Test Procedure Result|1
2638986|NCT00797862|9117097|P2|Overall Study|Abnormal Test Procedure Result|1
2638987|NCT00797862|9117098|P1|Overall Study|Abnormal Test Procedure Result|0
2638988|NCT00797862|9117096|P3|Overall Study|Adverse Event|58
2638989|NCT00797862|9117097|P2|Overall Study|Adverse Event|44
2638990|NCT00797862|9117098|P1|Overall Study|Adverse Event|86
2638991|NCT00797823|9117127|P3|First Period (Initial Randomization)|Physician Decision|0
2638992|NCT00797823|9117128|P2|First Period (Initial Randomization)|Physician Decision|0
2638993|NCT00797823|9117129|P1|First Period (Initial Randomization)|Physician Decision|1
2638994|NCT00797732|9117151|P3|Overall Study|Refused to Participate|123
2638995|NCT00797732|9117152|P2|Overall Study|Refused to Participate|0
2638996|NCT00797732|9117153|P1|Overall Study|Refused to Participate|0
2638997|NCT00797732|9117151|P3|Overall Study|Excluded due to time constraints|24
2638998|NCT00797732|9117152|P2|Overall Study|Excluded due to time constraints|0
2638999|NCT00797732|9117153|P1|Overall Study|Excluded due to time constraints|0
2639000|NCT00797732|9117151|P3|Overall Study|Not meet inclusion criteria|7
2639001|NCT00797732|9117152|P2|Overall Study|Not meet inclusion criteria|0
2639002|NCT00797732|9117153|P1|Overall Study|Not meet inclusion criteria|0
2639003|NCT00797732|9117151|P3|Overall Study|Death|0
2639004|NCT00797732|9117152|P2|Overall Study|Death|0
2639005|NCT00797732|9117153|P1|Overall Study|Death|1
2639006|NCT00797732|9117151|P3|Overall Study|Lost to Follow-up|0
2639007|NCT00797732|9117152|P2|Overall Study|Lost to Follow-up|0
2639008|NCT00797732|9117153|P1|Overall Study|Lost to Follow-up|1
2639009|NCT00797732|9117151|P3|Overall Study|Withdrawal by Subject|0
2639010|NCT00797732|9117152|P2|Overall Study|Withdrawal by Subject|3
2639011|NCT00797732|9117153|P1|Overall Study|Withdrawal by Subject|3
2639012|NCT00797667|9117168|P3|Overall Study|Adverse Event|8
2639013|NCT00797667|9117169|P2|Overall Study|Adverse Event|8
2639014|NCT00797667|9117170|P1|Overall Study|Adverse Event|19
2639015|NCT00797667|9117168|P3|Overall Study|Withdrawal by Subject|2
2639016|NCT00797667|9117169|P2|Overall Study|Withdrawal by Subject|14
2639017|NCT00797667|9117170|P1|Overall Study|Withdrawal by Subject|9
2639018|NCT00797667|9117168|P3|Overall Study|Study Terminated by Sponsor|115
2639019|NCT00797667|9117169|P2|Overall Study|Study Terminated by Sponsor|216
2639020|NCT00797667|9117170|P1|Overall Study|Study Terminated by Sponsor|217
2639021|NCT00797667|9117168|P3|Overall Study|Protocol Violation|0
2639022|NCT00797667|9117169|P2|Overall Study|Protocol Violation|7
2639023|NCT00797667|9117170|P1|Overall Study|Protocol Violation|2
2639024|NCT00797667|9117168|P3|Overall Study|Pregnancy|0
2639025|NCT00797667|9117169|P2|Overall Study|Pregnancy|0
2639026|NCT00797667|9117170|P1|Overall Study|Pregnancy|2
2639027|NCT00797667|9117168|P3|Overall Study|Physician Decision|0
2639028|NCT00797667|9117169|P2|Overall Study|Physician Decision|1
2639029|NCT00797667|9117170|P1|Overall Study|Physician Decision|3
2639030|NCT00797667|9117168|P3|Overall Study|Lost to Follow-up|2
2639031|NCT00797667|9117169|P2|Overall Study|Lost to Follow-up|12
2639032|NCT00797667|9117170|P1|Overall Study|Lost to Follow-up|8
2639033|NCT00797667|9117168|P3|Overall Study|Lack of Efficacy|0
2639034|NCT00797667|9117169|P2|Overall Study|Lack of Efficacy|1
2639035|NCT00797667|9117170|P1|Overall Study|Lack of Efficacy|0
2639036|NCT00797563|9117196|P1|Overall Study|Adverse Event|1
2639037|NCT00797511|9117202|P1|Overall Study|Withdrawal by Subject|1
2639038|NCT00797316|9117220|P2|Overall Study|Unsatisfactory therapeutic effect|13
2639039|NCT00797316|9117221|P1|Overall Study|Unsatisfactory therapeutic effect|0
2639040|NCT00797316|9117220|P2|Overall Study|Patient withdrew consent|6
2639041|NCT00797316|9117221|P1|Overall Study|Patient withdrew consent|12
2639042|NCT00797316|9117220|P2|Overall Study|Protocol Deviation|2
2639043|NCT00797316|9117221|P1|Overall Study|Protocol Deviation|1
2639044|NCT00797316|9117220|P2|Overall Study|Lost to Follow-up|8
2639045|NCT00797316|9117221|P1|Overall Study|Lost to Follow-up|4
2639046|NCT00797316|9117220|P2|Overall Study|Adverse Event|3
2639047|NCT00797316|9117221|P1|Overall Study|Adverse Event|5
2639048|NCT00797316|9117220|P2|Overall Study|Administrative problems|0
2639049|NCT00797316|9117221|P1|Overall Study|Administrative problems|1
2639050|NCT00797225|9117250|P8|Weeks 13 to 24|Sponsor Decision|0
2639051|NCT00797225|9117251|P7|Weeks 13 to 24|Sponsor Decision|1
2639052|NCT00797225|9117252|P6|Weeks 13 to 24|Sponsor Decision|0
2639053|NCT00797225|9117253|P5|Weeks 13 to 24|Sponsor Decision|0
2639054|NCT00797225|9117254|P4|Weeks 13 to 24|Sponsor Decision|0
2639055|NCT00797225|9117255|P3|Weeks 13 to 24|Sponsor Decision|0
2639056|NCT00797225|9117256|P2|Weeks 13 to 24|Sponsor Decision|0
2639057|NCT00797225|9117257|P1|Weeks 13 to 24|Sponsor Decision|0
2639058|NCT00797225|9117250|P8|Weeks 13 to 24|Adverse Event|0
2639059|NCT00797225|9117251|P7|Weeks 13 to 24|Adverse Event|1
2639060|NCT00797225|9117252|P6|Weeks 13 to 24|Adverse Event|0
2639061|NCT00797225|9117253|P5|Weeks 13 to 24|Adverse Event|0
2639062|NCT00797225|9117254|P4|Weeks 13 to 24|Adverse Event|0
2639063|NCT00797225|9117255|P3|Weeks 13 to 24|Adverse Event|0
2639064|NCT00797225|9117256|P2|Weeks 13 to 24|Adverse Event|1
2639065|NCT00797225|9117257|P1|Weeks 13 to 24|Adverse Event|0
2639066|NCT00797225|9117250|P8|Weeks 13 to 24|Lost to Follow-up|0
2639067|NCT00797225|9117251|P7|Weeks 13 to 24|Lost to Follow-up|0
2639068|NCT00797225|9117252|P6|Weeks 13 to 24|Lost to Follow-up|0
2639069|NCT00797225|9117253|P5|Weeks 13 to 24|Lost to Follow-up|1
2639070|NCT00797225|9117254|P4|Weeks 13 to 24|Lost to Follow-up|0
2639071|NCT00797225|9117255|P3|Weeks 13 to 24|Lost to Follow-up|1
2639072|NCT00797225|9117256|P2|Weeks 13 to 24|Lost to Follow-up|0
2639073|NCT00797225|9117257|P1|Weeks 13 to 24|Lost to Follow-up|0
2639074|NCT00797225|9117250|P8|Weeks 13 to 24|Withdrawal by Subject|0
2639075|NCT00797225|9117251|P7|Weeks 13 to 24|Withdrawal by Subject|0
2639076|NCT00797225|9117252|P6|Weeks 13 to 24|Withdrawal by Subject|0
2639077|NCT00797225|9117253|P5|Weeks 13 to 24|Withdrawal by Subject|0
2639078|NCT00797225|9117254|P4|Weeks 13 to 24|Withdrawal by Subject|0
2639079|NCT00797225|9117255|P3|Weeks 13 to 24|Withdrawal by Subject|1
2639080|NCT00797225|9117256|P2|Weeks 13 to 24|Withdrawal by Subject|1
2639081|NCT00797225|9117257|P1|Weeks 13 to 24|Withdrawal by Subject|0
2639082|NCT00797225|9117250|P8|Weeks 13 to 24|Non-compliance|0
2639083|NCT00797225|9117251|P7|Weeks 13 to 24|Non-compliance|0
2639084|NCT00797225|9117252|P6|Weeks 13 to 24|Non-compliance|0
2639085|NCT00797225|9117253|P5|Weeks 13 to 24|Non-compliance|0
2639086|NCT00797225|9117254|P4|Weeks 13 to 24|Non-compliance|0
2639087|NCT00797225|9117255|P3|Weeks 13 to 24|Non-compliance|0
2639088|NCT00797225|9117256|P2|Weeks 13 to 24|Non-compliance|2
2639089|NCT00797225|9117257|P1|Weeks 13 to 24|Non-compliance|0
2639090|NCT00797225|9117250|P8|Weeks 1 to 12|Sponsor Decision|0
2639091|NCT00797225|9117251|P7|Weeks 1 to 12|Sponsor Decision|0
2639092|NCT00797225|9117252|P6|Weeks 1 to 12|Sponsor Decision|0
2639093|NCT00797225|9117253|P5|Weeks 1 to 12|Sponsor Decision|0
2639094|NCT00797225|9117254|P4|Weeks 1 to 12|Sponsor Decision|0
2639095|NCT00797225|9117255|P3|Weeks 1 to 12|Sponsor Decision|0
2639096|NCT00797225|9117256|P2|Weeks 1 to 12|Sponsor Decision|0
2639097|NCT00797225|9117257|P1|Weeks 1 to 12|Sponsor Decision|1
2639098|NCT00797225|9117250|P8|Weeks 1 to 12|Lack of Efficacy|0
2639099|NCT00797225|9117251|P7|Weeks 1 to 12|Lack of Efficacy|0
2639100|NCT00797225|9117252|P6|Weeks 1 to 12|Lack of Efficacy|0
2639101|NCT00797225|9117253|P5|Weeks 1 to 12|Lack of Efficacy|0
2639102|NCT00797225|9117254|P4|Weeks 1 to 12|Lack of Efficacy|0
2639103|NCT00797225|9117255|P3|Weeks 1 to 12|Lack of Efficacy|0
2639104|NCT00797225|9117256|P2|Weeks 1 to 12|Lack of Efficacy|0
2639105|NCT00797225|9117257|P1|Weeks 1 to 12|Lack of Efficacy|1
2639106|NCT00797225|9117250|P8|Weeks 1 to 12|Non-compliance|0
2639107|NCT00797225|9117251|P7|Weeks 1 to 12|Non-compliance|0
2639108|NCT00797225|9117252|P6|Weeks 1 to 12|Non-compliance|0
2639109|NCT00797225|9117253|P5|Weeks 1 to 12|Non-compliance|0
2639110|NCT00797225|9117254|P4|Weeks 1 to 12|Non-compliance|0
2639111|NCT00797225|9117255|P3|Weeks 1 to 12|Non-compliance|0
2639112|NCT00797225|9117256|P2|Weeks 1 to 12|Non-compliance|1
2639113|NCT00797225|9117257|P1|Weeks 1 to 12|Non-compliance|0
2639114|NCT00797225|9117250|P8|Weeks 1 to 12|Adverse Event|0
2639115|NCT00797225|9117251|P7|Weeks 1 to 12|Adverse Event|0
2639116|NCT00797225|9117252|P6|Weeks 1 to 12|Adverse Event|0
2639117|NCT00797225|9117253|P5|Weeks 1 to 12|Adverse Event|0
2639118|NCT00797225|9117254|P4|Weeks 1 to 12|Adverse Event|0
2639119|NCT00797225|9117255|P3|Weeks 1 to 12|Adverse Event|1
2639120|NCT00797225|9117256|P2|Weeks 1 to 12|Adverse Event|0
2639121|NCT00797225|9117257|P1|Weeks 1 to 12|Adverse Event|0
2639122|NCT00797108|9117374|P3|Overall Study|Randomized but not Treated|0
2639123|NCT00797108|9117375|P2|Overall Study|Randomized but not Treated|0
2639124|NCT00797108|9117376|P1|Overall Study|Randomized but not Treated|2
2639125|NCT00797108|9117374|P3|Overall Study|Other|2
2639126|NCT00797108|9117375|P2|Overall Study|Other|0
2639127|NCT00797108|9117376|P1|Overall Study|Other|0
2639128|NCT00797108|9117374|P3|Overall Study|Lack of Efficacy|1
2639129|NCT00797108|9117375|P2|Overall Study|Lack of Efficacy|0
2639130|NCT00797108|9117376|P1|Overall Study|Lack of Efficacy|1
2639131|NCT00797108|9117374|P3|Overall Study|Global Deterioration of Health Status|0
2639132|NCT00797108|9117375|P2|Overall Study|Global Deterioration of Health Status|1
2639133|NCT00797108|9117376|P1|Overall Study|Global Deterioration of Health Status|0
2639134|NCT00797108|9117374|P3|Overall Study|Did Not Meet Entrance Criteria|0
2639135|NCT00797108|9117375|P2|Overall Study|Did Not Meet Entrance Criteria|1
2639136|NCT00797108|9117376|P1|Overall Study|Did Not Meet Entrance Criteria|0
2639137|NCT00797108|9117374|P3|Overall Study|Adverse Event|3
2639138|NCT00797108|9117375|P2|Overall Study|Adverse Event|0
2639139|NCT00797108|9117376|P1|Overall Study|Adverse Event|1
2639140|NCT00796991|9117411|P3|Overall Study|Withdrawal by Subject|1
2639141|NCT00796991|9117412|P2|Overall Study|Withdrawal by Subject|0
2639142|NCT00796991|9117413|P1|Overall Study|Withdrawal by Subject|0
2639143|NCT00796991|9117411|P3|Overall Study|Study Drug Toxicity|5
2639144|NCT00796991|9117412|P2|Overall Study|Study Drug Toxicity|3
2639145|NCT00796991|9117413|P1|Overall Study|Study Drug Toxicity|3
2639146|NCT00796991|9117411|P3|Overall Study|Disease Progression|7
2639147|NCT00796991|9117412|P2|Overall Study|Disease Progression|9
2639148|NCT00796991|9117413|P1|Overall Study|Disease Progression|10
2639149|NCT00796991|9117411|P3|Overall Study|Death|0
2639150|NCT00796991|9117412|P2|Overall Study|Death|0
2639151|NCT00796991|9117413|P1|Overall Study|Death|2
2640727|NCT00788957|9122826|P2|Part 1|Death|0
2639152|NCT00796991|9117411|P3|Overall Study|Adverse Event|1
2639153|NCT00796991|9117412|P2|Overall Study|Adverse Event|0
2639154|NCT00796991|9117413|P1|Overall Study|Adverse Event|0
2639155|NCT00796861|9117520|P1|Overall Study|Death|2
2639156|NCT00796861|9117520|P1|Overall Study|Withdrawal by Subject|2
2639157|NCT00796822|9117526|P2|Overall Study|Adverse Event|0
2639158|NCT00796822|9117527|P1|Overall Study|Adverse Event|1
2639159|NCT00796822|9117526|P2|Overall Study|Lost to Follow-up|0
2639160|NCT00796822|9117527|P1|Overall Study|Lost to Follow-up|2
2639161|NCT00796757|9117535|P1|Overall Study|Other|7
2639162|NCT00796757|9117535|P1|Overall Study|Investigator's decision|2
2639163|NCT00796757|9117535|P1|Overall Study|Participant noncompliance|1
2639164|NCT00796757|9117535|P1|Overall Study|Protocol Violation|1
2639165|NCT00796757|9117535|P1|Overall Study|Death|61
2639166|NCT00796757|9117535|P1|Overall Study|Withdrawal by Subject|14
2639167|NCT00796718|9117569|P1|Overall Study|Withdrawal by Informed Consent|1
2639168|NCT00796718|9117569|P1|Overall Study|Lost to Follow-up|5
2639169|NCT00796718|9117569|P1|Overall Study|Exclusion Criteria|1
2639170|NCT00796718|9117569|P1|Overall Study|Adverse Event|2
2639171|NCT00796666|9117621|P2|Overall Study|Randomized and not treated|0
2639172|NCT00796666|9117622|P1|Overall Study|Randomized and not treated|1
2639173|NCT00796666|9117621|P2|Overall Study|Terminated by sponsor|55
2639174|NCT00796666|9117622|P1|Overall Study|Terminated by sponsor|53
2639175|NCT00796666|9117621|P2|Overall Study|Other|0
2639176|NCT00796666|9117622|P1|Overall Study|Other|1
2639177|NCT00796666|9117621|P2|Overall Study|Protocol Violation|0
2639178|NCT00796666|9117622|P1|Overall Study|Protocol Violation|1
2639179|NCT00796666|9117621|P2|Overall Study|Adverse Event|5
2639180|NCT00796666|9117622|P1|Overall Study|Adverse Event|7
2639181|NCT00796666|9117621|P2|Overall Study|Withdrawal by Subject|0
2639182|NCT00796666|9117622|P1|Overall Study|Withdrawal by Subject|2
2639183|NCT00796666|9117621|P2|Overall Study|Death|4
2639184|NCT00796666|9117622|P1|Overall Study|Death|2
2639185|NCT00796653|9117656|P4|Overall Study|Other reason not described above|4
2639186|NCT00796653|9117657|P3|Overall Study|Other reason not described above|7
2639187|NCT00796653|9117658|P2|Overall Study|Other reason not described above|9
2639188|NCT00796653|9117659|P1|Overall Study|Other reason not described above|4
2639189|NCT00796653|9117656|P4|Overall Study|Non compliance with protocol|2
2639190|NCT00796653|9117657|P3|Overall Study|Non compliance with protocol|0
2639191|NCT00796653|9117658|P2|Overall Study|Non compliance with protocol|2
2639192|NCT00796653|9117659|P1|Overall Study|Non compliance with protocol|2
2639193|NCT00796653|9117656|P4|Overall Study|Lack of Efficacy|2
2639194|NCT00796653|9117657|P3|Overall Study|Lack of Efficacy|3
2639195|NCT00796653|9117658|P2|Overall Study|Lack of Efficacy|1
2639196|NCT00796653|9117659|P1|Overall Study|Lack of Efficacy|8
2639197|NCT00796653|9117656|P4|Overall Study|Withdrawal by Subject|13
2639198|NCT00796653|9117657|P3|Overall Study|Withdrawal by Subject|8
2639199|NCT00796653|9117658|P2|Overall Study|Withdrawal by Subject|8
2639200|NCT00796653|9117659|P1|Overall Study|Withdrawal by Subject|16
2639201|NCT00796653|9117656|P4|Overall Study|Lost to Follow-up|3
2639202|NCT00796653|9117657|P3|Overall Study|Lost to Follow-up|2
2639203|NCT00796653|9117658|P2|Overall Study|Lost to Follow-up|1
2639204|NCT00796653|9117659|P1|Overall Study|Lost to Follow-up|2
2639205|NCT00796653|9117656|P4|Overall Study|Adverse Event|16
2639206|NCT00796653|9117657|P3|Overall Study|Adverse Event|16
2639207|NCT00796653|9117658|P2|Overall Study|Adverse Event|16
2639208|NCT00796653|9117659|P1|Overall Study|Adverse Event|19
2639209|NCT00796614|9117944|P4|Overall Study|Other than stated|0
2639210|NCT00796614|9117945|P3|Overall Study|Other than stated|0
2639211|NCT00796614|9117946|P2|Overall Study|Other than stated|0
2639212|NCT00796614|9117947|P1|Overall Study|Other than stated|1
2639213|NCT00796614|9117944|P4|Overall Study|Withdrawal by Subject|1
2639214|NCT00796614|9117945|P3|Overall Study|Withdrawal by Subject|0
2639215|NCT00796614|9117946|P2|Overall Study|Withdrawal by Subject|0
2639216|NCT00796614|9117947|P1|Overall Study|Withdrawal by Subject|1
2639217|NCT00796614|9117944|P4|Overall Study|Lost to Follow-up|0
2639218|NCT00796614|9117945|P3|Overall Study|Lost to Follow-up|1
2639219|NCT00796614|9117946|P2|Overall Study|Lost to Follow-up|2
2639220|NCT00796614|9117947|P1|Overall Study|Lost to Follow-up|2
2639221|NCT00796614|9117944|P4|Overall Study|Protocol Violation|0
2639222|NCT00796614|9117945|P3|Overall Study|Protocol Violation|2
2639223|NCT00796614|9117946|P2|Overall Study|Protocol Violation|0
2639224|NCT00796614|9117947|P1|Overall Study|Protocol Violation|0
2639225|NCT00796614|9117944|P4|Overall Study|Adverse Event|0
2639226|NCT00796614|9117945|P3|Overall Study|Adverse Event|0
2639227|NCT00796614|9117946|P2|Overall Study|Adverse Event|2
2639228|NCT00796614|9117947|P1|Overall Study|Adverse Event|1
2639229|NCT00796562|9117989|P1|Overall Study|Death|49
2639230|NCT00796549|9117998|P1|Overall Study|Progressive disease|56
2639231|NCT00796549|9117998|P1|Overall Study|Other|2
2639232|NCT00796549|9117998|P1|Overall Study|not entered|149
2639233|NCT00796549|9117998|P1|Overall Study|Adverse Event|11
2639234|NCT00796523|9118015|P2|Overall Study|Lost to Follow-up|7
2639235|NCT00796523|9118016|P1|Overall Study|Lost to Follow-up|9
2639236|NCT00796510|9118026|P2|Overall Study|Study Terminated|0
2639237|NCT00796510|9118027|P1|Overall Study|Study Terminated|2
2639238|NCT00796510|9118026|P2|Overall Study|Death|0
2639239|NCT00796510|9118027|P1|Overall Study|Death|1
2639240|NCT00796445|9118039|P2|Overall Study|Withdrawal by Subject|9
2639241|NCT00796445|9118040|P1|Overall Study|Withdrawal by Subject|18
2640728|NCT00788957|9122827|P1|Part 1|Death|8
2639242|NCT00796445|9118039|P2|Overall Study|Other|7
2639243|NCT00796445|9118040|P1|Overall Study|Other|10
2639244|NCT00796445|9118039|P2|Overall Study|Disease progression/recurrence|268
2639245|NCT00796445|9118040|P1|Overall Study|Disease progression/recurrence|537
2639246|NCT00796445|9118039|P2|Overall Study|Adverse event, non-fatal|0
2639247|NCT00796445|9118040|P1|Overall Study|Adverse event, non-fatal|4
2639248|NCT00796445|9118039|P2|Overall Study|Adverse event, serious fatal|5
2639249|NCT00796445|9118040|P1|Overall Study|Adverse event, serious fatal|10
2639250|NCT00796445|9118039|P2|Overall Study|Protocol Violation|3
2639251|NCT00796445|9118040|P1|Overall Study|Protocol Violation|5
2639252|NCT00796419|9118092|P2|Overall Study|Death|1
2639253|NCT00796419|9118093|P1|Overall Study|Death|0
2639254|NCT00796367|9118106|P3|Overall Study|other|3
2639255|NCT00796367|9118107|P2|Overall Study|other|4
2639256|NCT00796367|9118108|P1|Overall Study|other|2
2639257|NCT00796367|9118106|P3|Overall Study|Requirement for restricted medication|2
2639258|NCT00796367|9118107|P2|Overall Study|Requirement for restricted medication|0
2639259|NCT00796367|9118108|P1|Overall Study|Requirement for restricted medication|2
2639260|NCT00796367|9118106|P3|Overall Study|Pregnancy|1
2639261|NCT00796367|9118107|P2|Overall Study|Pregnancy|0
2639262|NCT00796367|9118108|P1|Overall Study|Pregnancy|1
2639263|NCT00796367|9118106|P3|Overall Study|non compliance|1
2639264|NCT00796367|9118107|P2|Overall Study|non compliance|1
2639265|NCT00796367|9118108|P1|Overall Study|non compliance|3
2639266|NCT00796367|9118106|P3|Overall Study|Lack of Efficacy|0
2639267|NCT00796367|9118107|P2|Overall Study|Lack of Efficacy|1
2639268|NCT00796367|9118108|P1|Overall Study|Lack of Efficacy|2
2639269|NCT00796367|9118106|P3|Overall Study|Withdrawal by Subject|12
2639270|NCT00796367|9118107|P2|Overall Study|Withdrawal by Subject|11
2639271|NCT00796367|9118108|P1|Overall Study|Withdrawal by Subject|9
2639272|NCT00796367|9118106|P3|Overall Study|Lost to Follow-up|21
2639273|NCT00796367|9118107|P2|Overall Study|Lost to Follow-up|4
2639274|NCT00796367|9118108|P1|Overall Study|Lost to Follow-up|5
2639275|NCT00796367|9118106|P3|Overall Study|Adverse Event|7
2639276|NCT00796367|9118107|P2|Overall Study|Adverse Event|4
2639277|NCT00796367|9118108|P1|Overall Study|Adverse Event|6
2639278|NCT00796328|9118119|P1|Overall Study|experienced hypotension requiring tx|6
2639279|NCT00796315|9118123|P3|Overall Study|Protocol Violation|0
2639280|NCT00796315|9118124|P2|Overall Study|Protocol Violation|1
2639281|NCT00796315|9118125|P1|Overall Study|Protocol Violation|0
2639282|NCT00796224|9118153|P2|Overall Study|Protocol Violation|1
2639283|NCT00796224|9118154|P1|Overall Study|Protocol Violation|0
2639284|NCT00796224|9118153|P2|Overall Study|Adverse Event|0
2639285|NCT00796224|9118154|P1|Overall Study|Adverse Event|1
2639286|NCT00796120|9118174|P2|Overall Study|Randomized but not treated|3
2639287|NCT00796120|9118175|P1|Overall Study|Randomized but not treated|0
2639288|NCT00796120|9118174|P2|Overall Study|Physician Decision|17
2639289|NCT00796120|9118175|P1|Overall Study|Physician Decision|16
2639290|NCT00796120|9118174|P2|Overall Study|Other|17
2639291|NCT00796120|9118175|P1|Overall Study|Other|6
2639292|NCT00796120|9118174|P2|Overall Study|Participant refusal|4
2639293|NCT00796120|9118175|P1|Overall Study|Participant refusal|3
2639294|NCT00796120|9118174|P2|Overall Study|Progressive disease|13
2639295|NCT00796120|9118175|P1|Overall Study|Progressive disease|22
2639296|NCT00796120|9118174|P2|Overall Study|Adverse Event|6
2639297|NCT00796120|9118175|P1|Overall Study|Adverse Event|11
2639298|NCT00796120|9118174|P2|Overall Study|Death|0
2639299|NCT00796120|9118175|P1|Overall Study|Death|3
2639300|NCT00796003|9118191|P2|Overall Study|Participants Not treated|2
2639301|NCT00796003|9118192|P1|Overall Study|Participants Not treated|0
2639302|NCT00796003|9118191|P2|Overall Study|Other|1
2639303|NCT00796003|9118192|P1|Overall Study|Other|0
2639304|NCT00796003|9118191|P2|Overall Study|Withdrawal by Subject|1
2639305|NCT00796003|9118192|P1|Overall Study|Withdrawal by Subject|0
2639306|NCT00796003|9118191|P2|Overall Study|Physician Decision|4
2639307|NCT00796003|9118192|P1|Overall Study|Physician Decision|0
2639308|NCT00796003|9118191|P2|Overall Study|Specified organ function not met|1
2639309|NCT00796003|9118192|P1|Overall Study|Specified organ function not met|0
2639310|NCT00796003|9118191|P2|Overall Study|Adverse Event|7
2639311|NCT00796003|9118192|P1|Overall Study|Adverse Event|1
2639312|NCT00796003|9118191|P2|Overall Study|Disease Progression|13
2639313|NCT00796003|9118192|P1|Overall Study|Disease Progression|2
2639314|NCT00795951|9118213|P1|Overall Study|Withdrawal by Subject|1
2639315|NCT00795951|9118213|P1|Overall Study|Lost to Follow-up|1
2639316|NCT00795886|9118250|P1|Overall Study|Death|10
2639317|NCT00795821|9118258|P2|Taper Phase|Withdrawal by Subject|0
2639318|NCT00795821|9118259|P1|Taper Phase|Withdrawal by Subject|4
2639319|NCT00795821|9118258|P2|Taper Phase|Physician Decision|0
2639320|NCT00795821|9118259|P1|Taper Phase|Physician Decision|2
2639321|NCT00795821|9118258|P2|Taper Phase|Lost to Follow-up|0
2639322|NCT00795821|9118259|P1|Taper Phase|Lost to Follow-up|1
2639323|NCT00795821|9118258|P2|Taper Phase|Adverse Event|0
2639324|NCT00795821|9118259|P1|Taper Phase|Adverse Event|2
2639325|NCT00795821|9118258|P2|Long-term Extension Phase|Withdrawal by Subject|25
2639326|NCT00795821|9118259|P1|Long-term Extension Phase|Withdrawal by Subject|25
2639327|NCT00795821|9118258|P2|Long-term Extension Phase|Protocol Violation|5
2639328|NCT00795821|9118259|P1|Long-term Extension Phase|Protocol Violation|3
2639329|NCT00795821|9118258|P2|Long-term Extension Phase|Physician Decision|2
2639330|NCT00795821|9118259|P1|Long-term Extension Phase|Physician Decision|1
2639331|NCT00795821|9118258|P2|Long-term Extension Phase|Lost to Follow-up|16
2639332|NCT00795821|9118259|P1|Long-term Extension Phase|Lost to Follow-up|20
2639333|NCT00795821|9118258|P2|Long-term Extension Phase|Lack of Efficacy|12
2639334|NCT00795821|9118259|P1|Long-term Extension Phase|Lack of Efficacy|16
2639335|NCT00795821|9118258|P2|Long-term Extension Phase|Adverse Event|32
2639336|NCT00795821|9118259|P1|Long-term Extension Phase|Adverse Event|25
2639337|NCT00795821|9118258|P2|Acute Treatment Phase|Withdrawal by Subject|10
2639338|NCT00795821|9118259|P1|Acute Treatment Phase|Withdrawal by Subject|16
2639339|NCT00795821|9118258|P2|Acute Treatment Phase|Protocol Violation|2
2639340|NCT00795821|9118259|P1|Acute Treatment Phase|Protocol Violation|1
2639341|NCT00795821|9118258|P2|Acute Treatment Phase|Physician Decision|1
2639342|NCT00795821|9118259|P1|Acute Treatment Phase|Physician Decision|1
2639343|NCT00795821|9118258|P2|Acute Treatment Phase|Lost to Follow-up|12
2639344|NCT00795821|9118259|P1|Acute Treatment Phase|Lost to Follow-up|9
2639345|NCT00795821|9118258|P2|Acute Treatment Phase|Lack of Efficacy|2
2639346|NCT00795821|9118259|P1|Acute Treatment Phase|Lack of Efficacy|5
2639347|NCT00795821|9118258|P2|Acute Treatment Phase|Death|0
2639348|NCT00795821|9118259|P1|Acute Treatment Phase|Death|1
2639349|NCT00795821|9118258|P2|Acute Treatment Phase|Adverse Event|4
2639350|NCT00795821|9118259|P1|Acute Treatment Phase|Adverse Event|23
2639351|NCT00795717|9118334|P2|Phase II|too busy|1
2639352|NCT00795717|9118335|P1|Phase II|too busy|0
2639353|NCT00795717|9118334|P2|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1
2639354|NCT00795717|9118335|P1|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0
2639355|NCT00795717|9118334|P2|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
2639356|NCT00795717|9118335|P1|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
2639357|NCT00795717|9118334|P2|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0
2639358|NCT00795717|9118335|P1|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1
2639359|NCT00795704|9118347|P2|Overall Study|Adverse Event|1
2639360|NCT00795704|9118348|P1|Overall Study|Adverse Event|1
2639361|NCT00795704|9118347|P2|Overall Study|Withdrawal by Subject|2
2639362|NCT00795704|9118348|P1|Overall Study|Withdrawal by Subject|3
2639363|NCT00795639|9118360|P2|Overall Study|Randomized and not treated|1
2639364|NCT00795639|9118361|P1|Overall Study|Randomized and not treated|0
2639365|NCT00795639|9118360|P2|Overall Study|Terminated by sponsor|12
2639366|NCT00795639|9118361|P1|Overall Study|Terminated by sponsor|13
2639367|NCT00795639|9118360|P2|Overall Study|Other|2
2639368|NCT00795639|9118361|P1|Overall Study|Other|0
2639369|NCT00795639|9118360|P2|Overall Study|Adverse Event|2
2639370|NCT00795639|9118361|P1|Overall Study|Adverse Event|5
2639371|NCT00795639|9118360|P2|Overall Study|Pregnancy|0
2639372|NCT00795639|9118361|P1|Overall Study|Pregnancy|1
2639373|NCT00795639|9118360|P2|Overall Study|Withdrawal by Subject|3
2639374|NCT00795639|9118361|P1|Overall Study|Withdrawal by Subject|1
2639375|NCT00795639|9118360|P2|Overall Study|Death|6
2639376|NCT00795639|9118361|P1|Overall Study|Death|1
2639377|NCT00795600|9118373|P2|Overall Study|Unclassified|1
2639378|NCT00795600|9118374|P1|Overall Study|Unclassified|1
2639379|NCT00795600|9118373|P2|Overall Study|Withdrawal by Subject|0
2639380|NCT00795600|9118374|P1|Overall Study|Withdrawal by Subject|1
2639381|NCT00795600|9118373|P2|Overall Study|Protocol Violation|2
2639382|NCT00795600|9118374|P1|Overall Study|Protocol Violation|1
2639383|NCT00795600|9118373|P2|Overall Study|Adverse Event|1
2639384|NCT00795600|9118374|P1|Overall Study|Adverse Event|1
2639385|NCT00795535|9118494|P1|Overall Study|incomplete data and technical problems|20
2639386|NCT00795509|9118501|P1|Overall Study|Protocol Violation|31
2639387|NCT00795184|9118570|P2|Overall Study|Tissue sampling incomplete/conclusive|13
2639388|NCT00795184|9118571|P1|Overall Study|Tissue sampling incomplete/conclusive|8
2639389|NCT00795132|9118632|P1|Overall Study|Relapse|2
2639390|NCT00795132|9118632|P1|Overall Study|Death|1
2639391|NCT00794963|9118659|P2|Overall Study|Withdrawal by Subject|4
2639392|NCT00794963|9118660|P1|Overall Study|Withdrawal by Subject|1
2639393|NCT00794950|9118666|P1|Beginning Sunitinib Treatment|Lost to Follow-up|1
2639394|NCT00794950|9118666|P1|Beginning Sunitinib Treatment|Withdrawal by Subject|1
2639395|NCT00794950|9118666|P1|Beginning Sunitinib Treatment|Physician Decision|5
2639396|NCT00794950|9118666|P1|Beginning Sunitinib Treatment|cystectomy|5
2639397|NCT00794950|9118666|P1|BCG Induction|Adverse Event|1
2639398|NCT00794950|9118666|P1|BCG Induction|noncompliant w. BCG|1
2639399|NCT00794950|9118666|P1|BCG Induction|ineligible|3
2639400|NCT00794950|9118666|P1|BCG Induction|Withdrawal by Subject|2
2639401|NCT00794924|9118675|P2|Overall Study|Adverse Event|2
2639402|NCT00794924|9118676|P1|Overall Study|Adverse Event|6
2639403|NCT00794924|9118675|P2|Overall Study|Withdrawal by Subject|60
2639404|NCT00794924|9118676|P1|Overall Study|Withdrawal by Subject|48
2639405|NCT00794924|9118675|P2|Overall Study|Lost to Follow-up|8
2639406|NCT00794924|9118676|P1|Overall Study|Lost to Follow-up|6
2639407|NCT00794820|9118680|P1|Overall Study|Ineligible/Screen Failure|1
2639408|NCT00794820|9118680|P1|Overall Study|Resistant Disease|2
2639409|NCT00794820|9118680|P1|Overall Study|Secondary Malignancies|2
2639410|NCT00794820|9118680|P1|Overall Study|Adverse Event|11
2639411|NCT00794677|9118688|P2|First Intervention|Withdrawal by Subject|0
2639412|NCT00794677|9118689|P1|First Intervention|Withdrawal by Subject|2
2639413|NCT00794664|9118711|P2|Follow-up Period|Protocol non-compliance|1
2639414|NCT00794664|9118712|P1|Follow-up Period|Protocol non-compliance|0
2639415|NCT00794664|9118711|P2|Follow-up Period|Withdrawal by Subject|2
2639416|NCT00794664|9118712|P1|Follow-up Period|Withdrawal by Subject|0
2639417|NCT00794664|9118711|P2|Follow-up Period|Other|2
2639418|NCT00794664|9118712|P1|Follow-up Period|Other|1
2639419|NCT00794664|9118711|P2|Treatment Period|Adverse Event|8
2639420|NCT00794664|9118712|P1|Treatment Period|Adverse Event|1
2639421|NCT00794664|9118711|P2|Treatment Period|Other|1
2639422|NCT00794664|9118712|P1|Treatment Period|Other|0
2639423|NCT00794664|9118711|P2|Treatment Period|Protocol non-compliance|1
2639424|NCT00794664|9118712|P1|Treatment Period|Protocol non-compliance|0
2639425|NCT00794664|9118711|P2|Treatment Period|Withdrawal by Subject|2
2639426|NCT00794664|9118712|P1|Treatment Period|Withdrawal by Subject|0
2639427|NCT00794573|9118758|P2|Overall Study|Lost to Follow-up|33
2639428|NCT00794573|9118759|P1|Overall Study|Lost to Follow-up|26
2639429|NCT00794573|9118758|P2|Overall Study|Withdrawal by Subject|12
2639430|NCT00794573|9118759|P1|Overall Study|Withdrawal by Subject|9
2639431|NCT00794573|9118758|P2|Overall Study|Death|0
2639432|NCT00794573|9118759|P1|Overall Study|Death|3
2639433|NCT00794365|9118828|P1|Overall Study|Lack of Efficacy|3
2639434|NCT00794365|9118828|P1|Overall Study|Adverse Event|10
2639435|NCT00794365|9118828|P1|Overall Study|Poor Compliance|11
2639436|NCT00794365|9118828|P1|Overall Study|Other|17
2639437|NCT00794365|9118828|P1|Overall Study|Lost to Follow-up|38
2639438|NCT00794196|9118849|P2|Overall Study|Lost to Follow-up|23
2639439|NCT00794196|9118850|P1|Overall Study|Lost to Follow-up|5
2639440|NCT00794157|9118870|P3|Overall Study|Protocol deviation|1
2639441|NCT00794157|9118871|P2|Overall Study|Protocol deviation|1
2639442|NCT00794157|9118872|P1|Overall Study|Protocol deviation|0
2639443|NCT00794157|9118870|P3|Overall Study|Abnormal test procedure result(s)|0
2639444|NCT00794157|9118871|P2|Overall Study|Abnormal test procedure result(s)|1
2639445|NCT00794157|9118872|P1|Overall Study|Abnormal test procedure result(s)|0
2639446|NCT00794157|9118870|P3|Overall Study|Administrative problems|4
2639447|NCT00794157|9118871|P2|Overall Study|Administrative problems|7
2639448|NCT00794157|9118872|P1|Overall Study|Administrative problems|1
2639449|NCT00794157|9118870|P3|Overall Study|Unsatisfactory therapeutic effect|2
2639450|NCT00794157|9118871|P2|Overall Study|Unsatisfactory therapeutic effect|0
2639451|NCT00794157|9118872|P1|Overall Study|Unsatisfactory therapeutic effect|1
2639452|NCT00794157|9118870|P3|Overall Study|Lost to Follow-up|1
2639453|NCT00794157|9118871|P2|Overall Study|Lost to Follow-up|0
2639454|NCT00794157|9118872|P1|Overall Study|Lost to Follow-up|2
2639455|NCT00794157|9118870|P3|Overall Study|Subject withdrew consent|3
2639456|NCT00794157|9118871|P2|Overall Study|Subject withdrew consent|0
2639457|NCT00794157|9118872|P1|Overall Study|Subject withdrew consent|2
2639458|NCT00794157|9118870|P3|Overall Study|Adverse Event|8
2639459|NCT00794157|9118871|P2|Overall Study|Adverse Event|1
2639460|NCT00794157|9118872|P1|Overall Study|Adverse Event|4
2639461|NCT00794118|9118901|P1|Overall Study|Changed hospital center|2
2639462|NCT00794118|9118901|P1|Overall Study|Withdrawal by Subject|9
2639463|NCT00794118|9118901|P1|Overall Study|Lost to Follow-up|16
2639464|NCT00794040|9118961|P2|Overall Study|Physician Decision|1
2639465|NCT00794040|9118962|P1|Overall Study|Physician Decision|0
2639466|NCT00794040|9118961|P2|Overall Study|Withdrawal by Subject|4
2639467|NCT00794040|9118962|P1|Overall Study|Withdrawal by Subject|3
2639468|NCT00793910|9118978|P2|Overall Study|Withdrawal by Subject|1
2639469|NCT00793910|9118979|P1|Overall Study|Withdrawal by Subject|0
2639470|NCT00793910|9118978|P2|Overall Study|decided to undergo LASIK instead of PRK|1
2639471|NCT00793910|9118979|P1|Overall Study|decided to undergo LASIK instead of PRK|2
2639472|NCT00793910|9118978|P2|Overall Study|ineligible based on entry criteria|3
2639473|NCT00793910|9118979|P1|Overall Study|ineligible based on entry criteria|2
2639474|NCT00793910|9118978|P2|Overall Study|did not pick up medications|1
2639475|NCT00793910|9118979|P1|Overall Study|did not pick up medications|1
2639476|NCT00793910|9118978|P2|Overall Study|discarded study pills|1
2639477|NCT00793910|9118979|P1|Overall Study|discarded study pills|0
2639478|NCT00793871|9118993|P1|Overall Study|Study terminated by the Sponsor|7
2639479|NCT00793871|9118993|P1|Overall Study|Lost to Follow-up|3
2639480|NCT00793871|9118993|P1|Overall Study|Death|50
2639481|NCT00793819|9119007|P2|Overall Study|Lost to Follow-up|1
2639482|NCT00793819|9119008|P1|Overall Study|Lost to Follow-up|1
2639483|NCT00793819|9119007|P2|Overall Study|Withdrawal by Subject|3
2639484|NCT00793819|9119008|P1|Overall Study|Withdrawal by Subject|4
2639485|NCT00793819|9119007|P2|Overall Study|Lack of Efficacy|1
2639486|NCT00793819|9119008|P1|Overall Study|Lack of Efficacy|1
2639487|NCT00793819|9119007|P2|Overall Study|Adverse Event|4
2639488|NCT00793819|9119008|P1|Overall Study|Adverse Event|8
2639489|NCT00793793|9119026|P12|Overall Study|reason not specified|4
2639490|NCT00793793|9119027|P11|Overall Study|reason not specified|2
2639491|NCT00793793|9119028|P10|Overall Study|reason not specified|6
2639492|NCT00793793|9119029|P9|Overall Study|reason not specified|7
2639493|NCT00793793|9119030|P8|Overall Study|reason not specified|0
2639494|NCT00793793|9119031|P7|Overall Study|reason not specified|2
2639495|NCT00793793|9119032|P6|Overall Study|reason not specified|1
2639496|NCT00793793|9119033|P5|Overall Study|reason not specified|1
2639497|NCT00793793|9119034|P4|Overall Study|reason not specified|1
2639498|NCT00793793|9119035|P3|Overall Study|reason not specified|0
2639499|NCT00793793|9119036|P2|Overall Study|reason not specified|1
2639500|NCT00793793|9119037|P1|Overall Study|reason not specified|0
2639501|NCT00793793|9119026|P12|Overall Study|Withdrawal by Subject|0
2639502|NCT00793793|9119027|P11|Overall Study|Withdrawal by Subject|0
2639503|NCT00793793|9119028|P10|Overall Study|Withdrawal by Subject|0
2639504|NCT00793793|9119029|P9|Overall Study|Withdrawal by Subject|1
2639505|NCT00793793|9119030|P8|Overall Study|Withdrawal by Subject|0
2639506|NCT00793793|9119031|P7|Overall Study|Withdrawal by Subject|0
2639507|NCT00793793|9119032|P6|Overall Study|Withdrawal by Subject|0
2639508|NCT00793793|9119033|P5|Overall Study|Withdrawal by Subject|1
2639509|NCT00793793|9119034|P4|Overall Study|Withdrawal by Subject|0
2639510|NCT00793793|9119035|P3|Overall Study|Withdrawal by Subject|0
2639511|NCT00793793|9119036|P2|Overall Study|Withdrawal by Subject|0
2639512|NCT00793793|9119037|P1|Overall Study|Withdrawal by Subject|0
2639513|NCT00793793|9119026|P12|Overall Study|Lost to Follow-up|0
2639514|NCT00793793|9119027|P11|Overall Study|Lost to Follow-up|1
2639515|NCT00793793|9119028|P10|Overall Study|Lost to Follow-up|3
2639516|NCT00793793|9119029|P9|Overall Study|Lost to Follow-up|1
2639517|NCT00793793|9119030|P8|Overall Study|Lost to Follow-up|0
2639518|NCT00793793|9119031|P7|Overall Study|Lost to Follow-up|0
2639519|NCT00793793|9119032|P6|Overall Study|Lost to Follow-up|0
2639520|NCT00793793|9119033|P5|Overall Study|Lost to Follow-up|0
2639521|NCT00793793|9119034|P4|Overall Study|Lost to Follow-up|0
2639522|NCT00793793|9119035|P3|Overall Study|Lost to Follow-up|1
2639523|NCT00793793|9119036|P2|Overall Study|Lost to Follow-up|0
2639524|NCT00793793|9119037|P1|Overall Study|Lost to Follow-up|0
2639525|NCT00793793|9119026|P12|Overall Study|Protocol Violation|0
2639526|NCT00793793|9119027|P11|Overall Study|Protocol Violation|0
2639527|NCT00793793|9119028|P10|Overall Study|Protocol Violation|0
2639528|NCT00793793|9119029|P9|Overall Study|Protocol Violation|0
2639529|NCT00793793|9119030|P8|Overall Study|Protocol Violation|0
2639530|NCT00793793|9119031|P7|Overall Study|Protocol Violation|0
2639531|NCT00793793|9119032|P6|Overall Study|Protocol Violation|0
2639532|NCT00793793|9119033|P5|Overall Study|Protocol Violation|0
2639533|NCT00793793|9119034|P4|Overall Study|Protocol Violation|1
2639534|NCT00793793|9119035|P3|Overall Study|Protocol Violation|0
2639535|NCT00793793|9119036|P2|Overall Study|Protocol Violation|0
2639536|NCT00793793|9119037|P1|Overall Study|Protocol Violation|0
2639537|NCT00793793|9119026|P12|Overall Study|Adverse Event|2
2639538|NCT00793793|9119027|P11|Overall Study|Adverse Event|0
2639539|NCT00793793|9119028|P10|Overall Study|Adverse Event|0
2639540|NCT00793793|9119029|P9|Overall Study|Adverse Event|0
2639541|NCT00793793|9119030|P8|Overall Study|Adverse Event|0
2639542|NCT00793793|9119031|P7|Overall Study|Adverse Event|2
2639543|NCT00793793|9119032|P6|Overall Study|Adverse Event|1
2639544|NCT00793793|9119033|P5|Overall Study|Adverse Event|0
2639545|NCT00793793|9119034|P4|Overall Study|Adverse Event|1
2639546|NCT00793793|9119035|P3|Overall Study|Adverse Event|1
2639547|NCT00793793|9119036|P2|Overall Study|Adverse Event|0
2639548|NCT00793793|9119037|P1|Overall Study|Adverse Event|0
2639549|NCT00793780|9119412|P2|Overall Study|Withdrawal by Subject|1
2639550|NCT00793780|9119413|P1|Overall Study|Withdrawal by Subject|2
2639551|NCT00793624|9119444|P4|Overall Study|Other reason not described above|3
2639552|NCT00793624|9119445|P3|Overall Study|Other reason not described above|6
2639553|NCT00793624|9119446|P2|Overall Study|Other reason not described above|4
2639554|NCT00793624|9119447|P1|Overall Study|Other reason not described above|6
2639555|NCT00793624|9119444|P4|Overall Study|Non compliance with protocol|3
2639556|NCT00793624|9119445|P3|Overall Study|Non compliance with protocol|2
2639557|NCT00793624|9119446|P2|Overall Study|Non compliance with protocol|3
2639558|NCT00793624|9119447|P1|Overall Study|Non compliance with protocol|2
2639559|NCT00793624|9119444|P4|Overall Study|Lack of Efficacy|3
2639560|NCT00793624|9119445|P3|Overall Study|Lack of Efficacy|1
2639561|NCT00793624|9119446|P2|Overall Study|Lack of Efficacy|2
2639562|NCT00793624|9119447|P1|Overall Study|Lack of Efficacy|9
2639563|NCT00793624|9119444|P4|Overall Study|Withdrawal by Subject|14
2639564|NCT00793624|9119445|P3|Overall Study|Withdrawal by Subject|11
2639565|NCT00793624|9119446|P2|Overall Study|Withdrawal by Subject|9
2639566|NCT00793624|9119447|P1|Overall Study|Withdrawal by Subject|20
2639567|NCT00793624|9119444|P4|Overall Study|Lost to Follow-up|0
2639568|NCT00793624|9119445|P3|Overall Study|Lost to Follow-up|4
2639569|NCT00793624|9119446|P2|Overall Study|Lost to Follow-up|2
2639570|NCT00793624|9119447|P1|Overall Study|Lost to Follow-up|2
2639571|NCT00793624|9119444|P4|Overall Study|Adverse Event|20
2639572|NCT00793624|9119445|P3|Overall Study|Adverse Event|15
2639573|NCT00793624|9119446|P2|Overall Study|Adverse Event|16
2639574|NCT00793624|9119447|P1|Overall Study|Adverse Event|18
2639575|NCT00793585|9119728|P2|Overall Study|Protocol Violation|2
2639576|NCT00793585|9119729|P1|Overall Study|Protocol Violation|1
2639577|NCT00793585|9119728|P2|Overall Study|Adverse Event|1
2639578|NCT00793585|9119729|P1|Overall Study|Adverse Event|1
2639579|NCT00793546|9119748|P2|Overall Study|Other|0
2639580|NCT00793546|9119749|P1|Overall Study|Other|1
2639581|NCT00793546|9119748|P2|Overall Study|Study Terminated by Sponsor|27
2639582|NCT00793546|9119749|P1|Overall Study|Study Terminated by Sponsor|8
2639583|NCT00793546|9119748|P2|Overall Study|Withdrawal by Subject|1
2639584|NCT00793546|9119749|P1|Overall Study|Withdrawal by Subject|1
2639585|NCT00793546|9119748|P2|Overall Study|Lost to Follow-up|0
2639586|NCT00793546|9119749|P1|Overall Study|Lost to Follow-up|1
2639587|NCT00793546|9119748|P2|Overall Study|Death|0
2639588|NCT00793546|9119749|P1|Overall Study|Death|3
2639589|NCT00793403|9119799|P1|Overall Study|Other|73
2639590|NCT00793325|9119846|P1|Overall Study|Lost to Follow-up|1
2639591|NCT00793325|9119846|P1|Overall Study|Protocol Violation|18
2639592|NCT00793182|9119872|P2|Overall Study|Adverse Event|1
2639593|NCT00793182|9119873|P1|Overall Study|Adverse Event|0
2639594|NCT00793104|9119883|P1|Overall Study|Lost to Follow-up|1
2639595|NCT00792948|9119891|P1|Overall Study|Protocol Violation|1
2639596|NCT00792948|9119891|P1|Overall Study|Physician Decision|11
2639597|NCT00792948|9119891|P1|Overall Study|Insurance denial - not treated|1
2639598|NCT00792948|9119891|P1|Overall Study|Ineligible|2
2639599|NCT00792948|9119891|P1|Overall Study|Withdrawal by Subject|3
2639600|NCT00792948|9119891|P1|Overall Study|Death|4
2639601|NCT00792948|9119891|P1|Overall Study|Adverse Event|6
2639602|NCT00792935|9119902|P2|Overall Study|Withdrawal by Subject|1
2639603|NCT00792935|9119903|P1|Overall Study|Withdrawal by Subject|0
2639604|NCT00792935|9119902|P2|Overall Study|Protocol Violation|0
2639605|NCT00792935|9119903|P1|Overall Study|Protocol Violation|2
2639606|NCT00792935|9119902|P2|Overall Study|Lost to Follow-up|1
2639607|NCT00792935|9119903|P1|Overall Study|Lost to Follow-up|0
2639608|NCT00792935|9119902|P2|Overall Study|Adverse Event|1
2639609|NCT00792935|9119903|P1|Overall Study|Adverse Event|2
2639610|NCT00792909|9119935|P3|Overall Study|Withdrawal by Subject|0
2639611|NCT00792909|9119936|P2|Overall Study|Withdrawal by Subject|1
2639612|NCT00792909|9119937|P1|Overall Study|Withdrawal by Subject|0
2639613|NCT00792805|9119993|P3|Overall Study|Protocol deviation|1
2639614|NCT00792805|9119994|P2|Overall Study|Protocol deviation|1
2639615|NCT00792805|9119995|P1|Overall Study|Protocol deviation|0
2639616|NCT00792805|9119993|P3|Overall Study|Abnormal laboratory value(s)|1
2639617|NCT00792805|9119994|P2|Overall Study|Abnormal laboratory value(s)|0
2639618|NCT00792805|9119995|P1|Overall Study|Abnormal laboratory value(s)|0
2639619|NCT00792805|9119993|P3|Overall Study|Lost to Follow-up|6
2639620|NCT00792805|9119994|P2|Overall Study|Lost to Follow-up|1
2639621|NCT00792805|9119995|P1|Overall Study|Lost to Follow-up|1
2639622|NCT00792805|9119993|P3|Overall Study|Unsatisfactory therapeutic effect|6
2639623|NCT00792805|9119994|P2|Overall Study|Unsatisfactory therapeutic effect|6
2639624|NCT00792805|9119995|P1|Overall Study|Unsatisfactory therapeutic effect|1
2639625|NCT00792805|9119993|P3|Overall Study|Abnormal test procedure result(s)|0
2639626|NCT00792805|9119994|P2|Overall Study|Abnormal test procedure result(s)|2
2639627|NCT00792805|9119995|P1|Overall Study|Abnormal test procedure result(s)|1
2639628|NCT00792805|9119993|P3|Overall Study|Administrative problems|4
2639629|NCT00792805|9119994|P2|Overall Study|Administrative problems|0
2639630|NCT00792805|9119995|P1|Overall Study|Administrative problems|2
2639631|NCT00792805|9119993|P3|Overall Study|Subject withdrew consent|5
2639632|NCT00792805|9119994|P2|Overall Study|Subject withdrew consent|6
2639633|NCT00792805|9119995|P1|Overall Study|Subject withdrew consent|5
2639634|NCT00792805|9119993|P3|Overall Study|Adverse Event|10
2639635|NCT00792805|9119994|P2|Overall Study|Adverse Event|10
2639636|NCT00792805|9119995|P1|Overall Study|Adverse Event|12
2639637|NCT00792701|9120005|P2|Overall Study|Not protocol specified|0
2639638|NCT00792701|9120006|P1|Overall Study|Not protocol specified|17
2639639|NCT00792701|9120005|P2|Overall Study|Withdrawal by Subject|19
2639640|NCT00792701|9120006|P1|Overall Study|Withdrawal by Subject|1
2639641|NCT00792701|9120005|P2|Overall Study|Ineligible|3
2639642|NCT00792701|9120006|P1|Overall Study|Ineligible|1
2639643|NCT00792701|9120005|P2|Overall Study|Adverse Event|22
2639644|NCT00792701|9120006|P1|Overall Study|Adverse Event|0
2639645|NCT00792636|9120036|P3|Overall Study|Investigator Discretion|2
2639646|NCT00792636|9120037|P2|Overall Study|Investigator Discretion|0
2639647|NCT00792636|9120038|P1|Overall Study|Investigator Discretion|2
2639648|NCT00792636|9120036|P3|Overall Study|Adverse Event|3
2639649|NCT00792636|9120037|P2|Overall Study|Adverse Event|2
2639650|NCT00792636|9120038|P1|Overall Study|Adverse Event|4
2639651|NCT00792636|9120036|P3|Overall Study|Lack of Efficacy|13
2639652|NCT00792636|9120037|P2|Overall Study|Lack of Efficacy|4
2639653|NCT00792636|9120038|P1|Overall Study|Lack of Efficacy|3
2639654|NCT00792636|9120036|P3|Overall Study|Withdrew Consent|9
2639655|NCT00792636|9120037|P2|Overall Study|Withdrew Consent|13
2639656|NCT00792636|9120038|P1|Overall Study|Withdrew Consent|10
2639657|NCT00792636|9120036|P3|Overall Study|Lost to Follow-up|14
2639658|NCT00792636|9120037|P2|Overall Study|Lost to Follow-up|19
2639659|NCT00792636|9120038|P1|Overall Study|Lost to Follow-up|13
2639660|NCT00792636|9120036|P3|Overall Study|Met Protocol-defined Stopping Criteria|20
2639661|NCT00792636|9120037|P2|Overall Study|Met Protocol-defined Stopping Criteria|20
2639662|NCT00792636|9120038|P1|Overall Study|Met Protocol-defined Stopping Criteria|19
2639663|NCT00792636|9120036|P3|Overall Study|Protocol Violation|20
2639664|NCT00792636|9120037|P2|Overall Study|Protocol Violation|23
2639665|NCT00792636|9120038|P1|Overall Study|Protocol Violation|17
2639666|NCT00792623|9120075|P1|Overall Study|Withdrawal by Subject|5
2639667|NCT00792623|9120075|P1|Overall Study|Adverse Event|2
2639668|NCT00792571|9120092|P1|Overall Study|Other|4
2639669|NCT00792571|9120092|P1|Overall Study|Withdrawal by Subject|1
2639670|NCT00792571|9120092|P1|Overall Study|Adverse Event|4
2639671|NCT00792571|9120092|P1|Overall Study|Death|1
2639672|NCT00792298|9120112|P8|Treatment Period 2|Withdrawal by Subject|2
2639673|NCT00792298|9120113|P7|Treatment Period 2|Withdrawal by Subject|0
2639674|NCT00792298|9120114|P6|Treatment Period 2|Withdrawal by Subject|0
2639675|NCT00792298|9120115|P5|Treatment Period 2|Withdrawal by Subject|1
2639676|NCT00792298|9120116|P4|Treatment Period 2|Withdrawal by Subject|2
2639677|NCT00792298|9120117|P3|Treatment Period 2|Withdrawal by Subject|0
2639678|NCT00792298|9120118|P2|Treatment Period 2|Withdrawal by Subject|1
2639679|NCT00792298|9120119|P1|Treatment Period 2|Withdrawal by Subject|1
2639680|NCT00792298|9120112|P8|Treatment Period 2|Pregnancy|0
2639681|NCT00792298|9120113|P7|Treatment Period 2|Pregnancy|0
2639682|NCT00792298|9120114|P6|Treatment Period 2|Pregnancy|0
2639683|NCT00792298|9120115|P5|Treatment Period 2|Pregnancy|0
2639684|NCT00792298|9120116|P4|Treatment Period 2|Pregnancy|0
2639685|NCT00792298|9120117|P3|Treatment Period 2|Pregnancy|1
2639686|NCT00792298|9120118|P2|Treatment Period 2|Pregnancy|0
2639687|NCT00792298|9120119|P1|Treatment Period 2|Pregnancy|0
2639688|NCT00792298|9120112|P8|Treatment Period 2|Physician Decision|0
2639689|NCT00792298|9120113|P7|Treatment Period 2|Physician Decision|1
2639690|NCT00792298|9120114|P6|Treatment Period 2|Physician Decision|0
2639691|NCT00792298|9120115|P5|Treatment Period 2|Physician Decision|0
2639692|NCT00792298|9120116|P4|Treatment Period 2|Physician Decision|0
2639693|NCT00792298|9120117|P3|Treatment Period 2|Physician Decision|0
2639694|NCT00792298|9120118|P2|Treatment Period 2|Physician Decision|0
2639695|NCT00792298|9120119|P1|Treatment Period 2|Physician Decision|0
2639696|NCT00792298|9120112|P8|Treatment Period 2|Lack of Efficacy|0
2639697|NCT00792298|9120113|P7|Treatment Period 2|Lack of Efficacy|0
2639698|NCT00792298|9120114|P6|Treatment Period 2|Lack of Efficacy|0
2639699|NCT00792298|9120115|P5|Treatment Period 2|Lack of Efficacy|1
2639700|NCT00792298|9120116|P4|Treatment Period 2|Lack of Efficacy|0
2639701|NCT00792298|9120117|P3|Treatment Period 2|Lack of Efficacy|0
2639702|NCT00792298|9120118|P2|Treatment Period 2|Lack of Efficacy|0
2639703|NCT00792298|9120119|P1|Treatment Period 2|Lack of Efficacy|0
2639704|NCT00792298|9120112|P8|Washout|Withdrawal by Subject|0
2639705|NCT00792298|9120113|P7|Washout|Withdrawal by Subject|0
2639706|NCT00792298|9120114|P6|Washout|Withdrawal by Subject|1
2639707|NCT00792298|9120115|P5|Washout|Withdrawal by Subject|0
2639708|NCT00792298|9120116|P4|Washout|Withdrawal by Subject|0
2639709|NCT00792298|9120117|P3|Washout|Withdrawal by Subject|1
2639710|NCT00792298|9120118|P2|Washout|Withdrawal by Subject|0
2639711|NCT00792298|9120119|P1|Washout|Withdrawal by Subject|0
2639712|NCT00792298|9120112|P8|Washout|Adverse Event|0
2639713|NCT00792298|9120113|P7|Washout|Adverse Event|0
2639714|NCT00792298|9120114|P6|Washout|Adverse Event|1
2639715|NCT00792298|9120115|P5|Washout|Adverse Event|0
2639716|NCT00792298|9120116|P4|Washout|Adverse Event|0
2639717|NCT00792298|9120117|P3|Washout|Adverse Event|0
2639718|NCT00792298|9120118|P2|Washout|Adverse Event|0
2639719|NCT00792298|9120119|P1|Washout|Adverse Event|0
2639720|NCT00792298|9120112|P8|Treatment Period 1|Protocol Violation|1
2639721|NCT00792298|9120113|P7|Treatment Period 1|Protocol Violation|0
2639722|NCT00792298|9120114|P6|Treatment Period 1|Protocol Violation|0
2639723|NCT00792298|9120115|P5|Treatment Period 1|Protocol Violation|0
2639724|NCT00792298|9120116|P4|Treatment Period 1|Protocol Violation|0
2639725|NCT00792298|9120117|P3|Treatment Period 1|Protocol Violation|0
2639726|NCT00792298|9120118|P2|Treatment Period 1|Protocol Violation|0
2639727|NCT00792298|9120119|P1|Treatment Period 1|Protocol Violation|0
2639728|NCT00792298|9120112|P8|Treatment Period 1|Physician Decision|0
2639729|NCT00792298|9120113|P7|Treatment Period 1|Physician Decision|1
2639730|NCT00792298|9120114|P6|Treatment Period 1|Physician Decision|0
2639731|NCT00792298|9120115|P5|Treatment Period 1|Physician Decision|0
2639732|NCT00792298|9120116|P4|Treatment Period 1|Physician Decision|1
2639733|NCT00792298|9120117|P3|Treatment Period 1|Physician Decision|0
2639734|NCT00792298|9120118|P2|Treatment Period 1|Physician Decision|0
2639735|NCT00792298|9120119|P1|Treatment Period 1|Physician Decision|0
2639736|NCT00792298|9120112|P8|Treatment Period 1|Lost to Follow-up|0
2639737|NCT00792298|9120113|P7|Treatment Period 1|Lost to Follow-up|1
2639738|NCT00792298|9120114|P6|Treatment Period 1|Lost to Follow-up|0
2639739|NCT00792298|9120115|P5|Treatment Period 1|Lost to Follow-up|0
2639740|NCT00792298|9120116|P4|Treatment Period 1|Lost to Follow-up|0
2639741|NCT00792298|9120117|P3|Treatment Period 1|Lost to Follow-up|0
2639742|NCT00792298|9120118|P2|Treatment Period 1|Lost to Follow-up|0
2639743|NCT00792298|9120119|P1|Treatment Period 1|Lost to Follow-up|0
2639744|NCT00792298|9120112|P8|Treatment Period 1|Withdrawal by Subject|0
2639745|NCT00792298|9120113|P7|Treatment Period 1|Withdrawal by Subject|1
2639746|NCT00792298|9120114|P6|Treatment Period 1|Withdrawal by Subject|2
2639747|NCT00792298|9120115|P5|Treatment Period 1|Withdrawal by Subject|0
2639748|NCT00792298|9120116|P4|Treatment Period 1|Withdrawal by Subject|2
2639749|NCT00792298|9120117|P3|Treatment Period 1|Withdrawal by Subject|1
2639750|NCT00792298|9120118|P2|Treatment Period 1|Withdrawal by Subject|0
2639751|NCT00792298|9120119|P1|Treatment Period 1|Withdrawal by Subject|1
2639752|NCT00792298|9120112|P8|Treatment Period 1|Lack of Efficacy|0
2639753|NCT00792298|9120113|P7|Treatment Period 1|Lack of Efficacy|0
2639754|NCT00792298|9120114|P6|Treatment Period 1|Lack of Efficacy|0
2639755|NCT00792298|9120115|P5|Treatment Period 1|Lack of Efficacy|0
2639756|NCT00792298|9120116|P4|Treatment Period 1|Lack of Efficacy|0
2639757|NCT00792298|9120117|P3|Treatment Period 1|Lack of Efficacy|1
2639758|NCT00792298|9120118|P2|Treatment Period 1|Lack of Efficacy|0
2639759|NCT00792298|9120119|P1|Treatment Period 1|Lack of Efficacy|0
2639760|NCT00792298|9120112|P8|Treatment Period 1|Adverse Event|0
2639761|NCT00792298|9120113|P7|Treatment Period 1|Adverse Event|1
2639762|NCT00792298|9120114|P6|Treatment Period 1|Adverse Event|1
2639763|NCT00792298|9120115|P5|Treatment Period 1|Adverse Event|0
2639764|NCT00792298|9120116|P4|Treatment Period 1|Adverse Event|1
2639765|NCT00792298|9120117|P3|Treatment Period 1|Adverse Event|0
2639766|NCT00792298|9120118|P2|Treatment Period 1|Adverse Event|1
2639767|NCT00792298|9120119|P1|Treatment Period 1|Adverse Event|0
2639768|NCT00792259|9120149|P3|Overall Study|Poor Quality Scans|0
2639769|NCT00792259|9120150|P2|Overall Study|Poor Quality Scans|0
2639770|NCT00792259|9120151|P1|Overall Study|Poor Quality Scans|1
2639771|NCT00792116|9120161|P2|Overall Study|Discontnued intervention|0
2639772|NCT00792116|9120162|P1|Overall Study|Discontnued intervention|1
2639773|NCT00792116|9120161|P2|Overall Study|Lost to Follow-up|1
2639774|NCT00792116|9120162|P1|Overall Study|Lost to Follow-up|0
2639775|NCT00792103|9120172|P1|Overall Study|Did not apply 6 patches in 1st 3 mths|14
2639776|NCT00792103|9120172|P1|Overall Study|Protocol Violation|10
2639777|NCT00792103|9120172|P1|Overall Study|Withdrawal by Subject|52
2639778|NCT00792103|9120172|P1|Overall Study|Adverse Event|25
2639779|NCT00792103|9120172|P1|Overall Study|Lost to Follow-up|17
2639780|NCT00792103|9120172|P1|Overall Study|Enrolled, not treated|15
2639781|NCT00791999|9120184|P4|Overall Study|Reason other than those above|0
2639782|NCT00791999|9120185|P3|Overall Study|Reason other than those above|1
2639783|NCT00791999|9120186|P2|Overall Study|Reason other than those above|0
2639784|NCT00791999|9120187|P1|Overall Study|Reason other than those above|1
2639785|NCT00791999|9120184|P4|Overall Study|Lack of Efficacy|2
2639786|NCT00791999|9120185|P3|Overall Study|Lack of Efficacy|0
2639787|NCT00791999|9120186|P2|Overall Study|Lack of Efficacy|1
2639788|NCT00791999|9120187|P1|Overall Study|Lack of Efficacy|0
2639789|NCT00791999|9120184|P4|Overall Study|Adverse Event|3
2639790|NCT00791999|9120185|P3|Overall Study|Adverse Event|7
2639791|NCT00791999|9120186|P2|Overall Study|Adverse Event|3
2639792|NCT00791999|9120187|P1|Overall Study|Adverse Event|3
2639793|NCT00791999|9120184|P4|Overall Study|Protocol Violation|0
2639794|NCT00791999|9120185|P3|Overall Study|Protocol Violation|1
2639795|NCT00791999|9120186|P2|Overall Study|Protocol Violation|0
2639796|NCT00791999|9120187|P1|Overall Study|Protocol Violation|3
2639797|NCT00791999|9120184|P4|Overall Study|Withdrawal by Subject|2
2639798|NCT00791999|9120185|P3|Overall Study|Withdrawal by Subject|0
2639799|NCT00791999|9120186|P2|Overall Study|Withdrawal by Subject|1
2639800|NCT00791999|9120187|P1|Overall Study|Withdrawal by Subject|0
2639801|NCT00791999|9120184|P4|Overall Study|Protocol planed withdrawal|45
2639802|NCT00791999|9120185|P3|Overall Study|Protocol planed withdrawal|11
2639803|NCT00791999|9120186|P2|Overall Study|Protocol planed withdrawal|11
2639804|NCT00791999|9120187|P1|Overall Study|Protocol planed withdrawal|14
2639805|NCT00791934|9120212|P1|Overall Study|Did not consent for extended follow-up|13
2639806|NCT00791934|9120212|P1|Overall Study|Withdrawal by Subject|2
2639807|NCT00791921|9120222|P2|Overall Study|Reason other than those above|1
2639808|NCT00791921|9120223|P1|Overall Study|Reason other than those above|0
2639809|NCT00791921|9120222|P2|Overall Study|Lack of study drug administration|1
2639810|NCT00791921|9120223|P1|Overall Study|Lack of study drug administration|1
2639811|NCT00791921|9120222|P2|Overall Study|Lack of Efficacy|2
2639812|NCT00791921|9120223|P1|Overall Study|Lack of Efficacy|0
2639813|NCT00791921|9120222|P2|Overall Study|Adverse Event|2
2639814|NCT00791921|9120223|P1|Overall Study|Adverse Event|8
2639815|NCT00791921|9120222|P2|Overall Study|Withdrawal by Subject|2
2639816|NCT00791921|9120223|P1|Overall Study|Withdrawal by Subject|1
2639817|NCT00791921|9120222|P2|Overall Study|Protocol planed|88
2639818|NCT00791921|9120223|P1|Overall Study|Protocol planed|24
2639819|NCT00791778|9120254|P2|Follow-up|Lost to Follow-up|1
2639820|NCT00791778|9120255|P1|Follow-up|Lost to Follow-up|2
2639821|NCT00791778|9120254|P2|Follow-up|Withdrawal by Subject|0
2639822|NCT00791778|9120255|P1|Follow-up|Withdrawal by Subject|3
2639823|NCT00791778|9120254|P2|Double-blind Treatment|Non-compliant with study medication|0
2639824|NCT00791778|9120255|P1|Double-blind Treatment|Non-compliant with study medication|2
2639825|NCT00791778|9120254|P2|Double-blind Treatment|Withdrawal by Subject|9
2639826|NCT00791778|9120255|P1|Double-blind Treatment|Withdrawal by Subject|20
2639827|NCT00791778|9120254|P2|Double-blind Treatment|Protocol Violation|4
2639828|NCT00791778|9120255|P1|Double-blind Treatment|Protocol Violation|0
2639829|NCT00791778|9120254|P2|Double-blind Treatment|Physician Decision|26
2639830|NCT00791778|9120255|P1|Double-blind Treatment|Physician Decision|6
2639831|NCT00791778|9120254|P2|Double-blind Treatment|Adverse Event|9
2639832|NCT00791778|9120255|P1|Double-blind Treatment|Adverse Event|49
2639833|NCT00791765|9120309|P2|Weeks 13 to 24|Other|1
2639834|NCT00791765|9120310|P1|Weeks 13 to 24|Other|0
2639835|NCT00791765|9120309|P2|Weeks 13 to 24|Lost to Follow-up|2
2639836|NCT00791765|9120310|P1|Weeks 13 to 24|Lost to Follow-up|1
2639837|NCT00791765|9120309|P2|Weeks 13 to 24|Disease progression|1
2639838|NCT00791765|9120310|P1|Weeks 13 to 24|Disease progression|0
2639839|NCT00791765|9120309|P2|Weeks 13 to 24|Withdrawal by Subject|1
2639840|NCT00791765|9120310|P1|Weeks 13 to 24|Withdrawal by Subject|2
2639841|NCT00791765|9120309|P2|Weeks 13 to 24|Adverse Event|3
2639842|NCT00791765|9120310|P1|Weeks 13 to 24|Adverse Event|0
2639843|NCT00791765|9120309|P2|Weeks 13 to 24|Protocol deviation|0
2639844|NCT00791765|9120310|P1|Weeks 13 to 24|Protocol deviation|2
2639845|NCT00791765|9120309|P2|Weeks 1 to 12|Ineligibility determined|3
2639846|NCT00791765|9120310|P1|Weeks 1 to 12|Ineligibility determined|0
2639847|NCT00791765|9120309|P2|Weeks 1 to 12|Disease progression|0
2639848|NCT00791765|9120310|P1|Weeks 1 to 12|Disease progression|3
2639849|NCT00791765|9120309|P2|Weeks 1 to 12|Physician Decision|0
2639850|NCT00791765|9120310|P1|Weeks 1 to 12|Physician Decision|1
2639851|NCT00791765|9120309|P2|Weeks 1 to 12|Withdrawal by Subject|0
2639852|NCT00791765|9120310|P1|Weeks 1 to 12|Withdrawal by Subject|3
2639853|NCT00791765|9120309|P2|Weeks 1 to 12|Lost to Follow-up|0
2639854|NCT00791765|9120310|P1|Weeks 1 to 12|Lost to Follow-up|1
2639855|NCT00791765|9120309|P2|Weeks 1 to 12|Adverse Event|1
2639856|NCT00791765|9120310|P1|Weeks 1 to 12|Adverse Event|0
2639857|NCT00791700|9120325|P4|Overall Study|Adverse Event|1
2639858|NCT00791700|9120326|P3|Overall Study|Adverse Event|1
2639859|NCT00791700|9120327|P2|Overall Study|Adverse Event|0
2639860|NCT00791700|9120328|P1|Overall Study|Adverse Event|0
2639861|NCT00791700|9120325|P4|Overall Study|Lost to Follow-up|6
2639862|NCT00791700|9120326|P3|Overall Study|Lost to Follow-up|4
2639863|NCT00791700|9120327|P2|Overall Study|Lost to Follow-up|3
2639864|NCT00791700|9120328|P1|Overall Study|Lost to Follow-up|4
2639865|NCT00791700|9120325|P4|Overall Study|Death|1
2639866|NCT00791700|9120326|P3|Overall Study|Death|0
2639867|NCT00791700|9120327|P2|Overall Study|Death|0
2639868|NCT00791700|9120328|P1|Overall Study|Death|0
2639869|NCT00791700|9120325|P4|Overall Study|Other|1
2639870|NCT00791700|9120326|P3|Overall Study|Other|0
2639871|NCT00791700|9120327|P2|Overall Study|Other|1
2639872|NCT00791700|9120328|P1|Overall Study|Other|0
2639873|NCT00791700|9120325|P4|Overall Study|Withdrawn due to pregnancy|1
2639874|NCT00791700|9120326|P3|Overall Study|Withdrawn due to pregnancy|0
2639875|NCT00791700|9120327|P2|Overall Study|Withdrawn due to pregnancy|0
2639876|NCT00791700|9120328|P1|Overall Study|Withdrawn due to pregnancy|0
2639877|NCT00791700|9120325|P4|Overall Study|Non-compliance with study treatment|4
2639878|NCT00791700|9120326|P3|Overall Study|Non-compliance with study treatment|0
2639879|NCT00791700|9120327|P2|Overall Study|Non-compliance with study treatment|2
2639880|NCT00791700|9120328|P1|Overall Study|Non-compliance with study treatment|0
2639881|NCT00791700|9120325|P4|Overall Study|No longer willing to participate|8
2639882|NCT00791700|9120326|P3|Overall Study|No longer willing to participate|0
2639883|NCT00791700|9120327|P2|Overall Study|No longer willing to participate|1
2639884|NCT00791700|9120328|P1|Overall Study|No longer willing to participate|1
2639885|NCT00791700|9120325|P4|Overall Study|Insufficient clinical response|8
2639886|NCT00791700|9120326|P3|Overall Study|Insufficient clinical response|1
2639887|NCT00791700|9120327|P2|Overall Study|Insufficient clinical response|4
2639888|NCT00791700|9120328|P1|Overall Study|Insufficient clinical response|1
2639889|NCT00791661|9120416|P3|7 Day Wash-out|Abnormal Clinical Laboratory Test|1
2639890|NCT00791661|9120417|P2|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
2639891|NCT00791661|9120418|P1|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
2639892|NCT00791661|9120416|P3|7 Day Wash-out|Adverse Event|1
2639893|NCT00791661|9120417|P2|7 Day Wash-out|Adverse Event|0
2639894|NCT00791661|9120418|P1|7 Day Wash-out|Adverse Event|0
2639895|NCT00791648|9120511|P2|Overall Study|Withdrawal by Subject|1
2639896|NCT00791648|9120512|P1|Overall Study|Withdrawal by Subject|0
2639897|NCT00791648|9120511|P2|Overall Study|Physician Decision|1
2639898|NCT00791648|9120512|P1|Overall Study|Physician Decision|0
2639899|NCT00791557|9120548|P1|Overall Study|Adverse Event|1
2639900|NCT00791518|9120552|P1|Overall Study|Protocol Violation|93
2639901|NCT00791492|9120580|P2|Overall Study|Liver transplantation|1
2639902|NCT00791492|9120581|P1|Overall Study|Liver transplantation|5
2639903|NCT00791492|9120580|P2|Overall Study|Withdrawal by Subject|2
2639904|NCT00791492|9120581|P1|Overall Study|Withdrawal by Subject|1
2639905|NCT00791479|9120629|P6|Overall Study|Withdrawal by Subject|1
2639906|NCT00791479|9120630|P5|Overall Study|Withdrawal by Subject|0
2639907|NCT00791479|9120631|P4|Overall Study|Withdrawal by Subject|1
2639908|NCT00791479|9120632|P3|Overall Study|Withdrawal by Subject|0
2639909|NCT00791479|9120633|P2|Overall Study|Withdrawal by Subject|0
2639910|NCT00791479|9120634|P1|Overall Study|Withdrawal by Subject|0
2639911|NCT00791479|9120629|P6|Overall Study|Protocol Violation|0
2639912|NCT00791479|9120630|P5|Overall Study|Protocol Violation|0
2639913|NCT00791479|9120631|P4|Overall Study|Protocol Violation|1
2639914|NCT00791479|9120632|P3|Overall Study|Protocol Violation|0
2639915|NCT00791479|9120633|P2|Overall Study|Protocol Violation|1
2639916|NCT00791479|9120634|P1|Overall Study|Protocol Violation|2
2639917|NCT00791479|9120629|P6|Overall Study|Lost to Follow-up|1
2639918|NCT00791479|9120630|P5|Overall Study|Lost to Follow-up|0
2639919|NCT00791479|9120631|P4|Overall Study|Lost to Follow-up|0
2639920|NCT00791479|9120632|P3|Overall Study|Lost to Follow-up|0
2639921|NCT00791479|9120633|P2|Overall Study|Lost to Follow-up|1
2639922|NCT00791479|9120634|P1|Overall Study|Lost to Follow-up|0
2639923|NCT00791479|9120629|P6|Overall Study|Adverse Event|1
2639924|NCT00791479|9120630|P5|Overall Study|Adverse Event|0
2639925|NCT00791479|9120631|P4|Overall Study|Adverse Event|2
2639926|NCT00791479|9120632|P3|Overall Study|Adverse Event|0
2639927|NCT00791479|9120633|P2|Overall Study|Adverse Event|1
2639928|NCT00791479|9120634|P1|Overall Study|Adverse Event|0
2639929|NCT00791479|9120629|P6|Overall Study|Dose Discontinued per Sponsor Decision|0
2639930|NCT00791479|9120630|P5|Overall Study|Dose Discontinued per Sponsor Decision|3
2639931|NCT00791479|9120631|P4|Overall Study|Dose Discontinued per Sponsor Decision|0
2639932|NCT00791479|9120632|P3|Overall Study|Dose Discontinued per Sponsor Decision|0
2639933|NCT00791479|9120633|P2|Overall Study|Dose Discontinued per Sponsor Decision|0
2639934|NCT00791479|9120634|P1|Overall Study|Dose Discontinued per Sponsor Decision|0
2639935|NCT00791388|9120733|P5|Period 4 - 400 mg Dose Group|Adverse Event|4
2639936|NCT00791388|9120734|P4|Period 4 - 400 mg Dose Group|Adverse Event|0
2639937|NCT00791388|9120735|P3|Period 4 - 400 mg Dose Group|Adverse Event|0
2639938|NCT00791388|9120736|P2|Period 4 - 400 mg Dose Group|Adverse Event|0
2639939|NCT00791388|9120737|P1|Period 4 - 400 mg Dose Group|Adverse Event|0
2639940|NCT00791388|9120733|P5|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
2639941|NCT00791388|9120734|P4|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
2639942|NCT00791388|9120735|P3|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
2639943|NCT00791388|9120736|P2|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
2639944|NCT00791388|9120737|P1|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1
2639945|NCT00791388|9120733|P5|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
2639946|NCT00791388|9120734|P4|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
2639947|NCT00791388|9120735|P3|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
2639948|NCT00791388|9120736|P2|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1
2639949|NCT00791388|9120737|P1|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
2639950|NCT00791258|9120779|P1|Overall Study|Lack of Efficacy|1
2639951|NCT00791258|9120779|P1|Overall Study|Subject required restricted medication|1
2639952|NCT00791258|9120779|P1|Overall Study|Subject incarcerated|1
2639953|NCT00791258|9120779|P1|Overall Study|non-compliance|3
2639954|NCT00791258|9120779|P1|Overall Study|subject left area|2
2639955|NCT00791258|9120779|P1|Overall Study|Did not take medication for >3 days|1
2639956|NCT00791258|9120779|P1|Overall Study|Withdrawal by Subject|40
2639957|NCT00791258|9120779|P1|Overall Study|Protocol Violation|109
2639958|NCT00791258|9120779|P1|Overall Study|Lost to Follow-up|18
2639959|NCT00791258|9120779|P1|Overall Study|Adverse Event|87
2639960|NCT00791128|9120841|P1|Overall Study|abdominal tumor, unrelated to device|1
2639961|NCT00791128|9120841|P1|Overall Study|non-compliance by subject|2
2639962|NCT00791128|9120841|P1|Overall Study|Device migration|2
2639963|NCT00791128|9120841|P1|Overall Study|Adverse Event|4
2639964|NCT00791076|9120872|P1|Overall Study|Study was terminated,PI left institution|8
2639965|NCT00790933|9120892|P5|Overall Study|Reason Not Specified|9
2639966|NCT00790933|9120893|P4|Overall Study|Reason Not Specified|1
2639967|NCT00790933|9120894|P3|Overall Study|Reason Not Specified|4
2639968|NCT00790933|9120895|P2|Overall Study|Reason Not Specified|16
2639969|NCT00790933|9120896|P1|Overall Study|Reason Not Specified|8
2639970|NCT00790933|9120892|P5|Overall Study|Lost to Follow-up|15
2639971|NCT00790933|9120893|P4|Overall Study|Lost to Follow-up|1
2639972|NCT00790933|9120894|P3|Overall Study|Lost to Follow-up|10
2639973|NCT00790933|9120895|P2|Overall Study|Lost to Follow-up|31
2639974|NCT00790933|9120896|P1|Overall Study|Lost to Follow-up|13
2639975|NCT00790933|9120892|P5|Overall Study|Withdrawal by Subject|50
2639976|NCT00790933|9120893|P4|Overall Study|Withdrawal by Subject|6
2639977|NCT00790933|9120894|P3|Overall Study|Withdrawal by Subject|52
2639978|NCT00790933|9120895|P2|Overall Study|Withdrawal by Subject|120
2639979|NCT00790933|9120896|P1|Overall Study|Withdrawal by Subject|123
2639980|NCT00790933|9120892|P5|Overall Study|Study Terminated by Sponsor|0
2639981|NCT00790933|9120893|P4|Overall Study|Study Terminated by Sponsor|0
2639982|NCT00790933|9120894|P3|Overall Study|Study Terminated by Sponsor|1
2639983|NCT00790933|9120895|P2|Overall Study|Study Terminated by Sponsor|0
2639984|NCT00790933|9120896|P1|Overall Study|Study Terminated by Sponsor|0
2639985|NCT00790933|9120892|P5|Overall Study|Lack of Efficacy|121
2639986|NCT00790933|9120893|P4|Overall Study|Lack of Efficacy|1
2639987|NCT00790933|9120894|P3|Overall Study|Lack of Efficacy|130
2639988|NCT00790933|9120895|P2|Overall Study|Lack of Efficacy|176
2639989|NCT00790933|9120896|P1|Overall Study|Lack of Efficacy|192
2639990|NCT00790933|9120892|P5|Overall Study|Protocol Violation(s)|12
2639991|NCT00790933|9120893|P4|Overall Study|Protocol Violation(s)|0
2639992|NCT00790933|9120894|P3|Overall Study|Protocol Violation(s)|7
2639993|NCT00790933|9120895|P2|Overall Study|Protocol Violation(s)|18
2639994|NCT00790933|9120896|P1|Overall Study|Protocol Violation(s)|8
2639995|NCT00790933|9120892|P5|Overall Study|Adverse Event|69
2639996|NCT00790933|9120893|P4|Overall Study|Adverse Event|5
2639997|NCT00790933|9120894|P3|Overall Study|Adverse Event|65
2639998|NCT00790933|9120895|P2|Overall Study|Adverse Event|119
2639999|NCT00790933|9120896|P1|Overall Study|Adverse Event|94
2640000|NCT00790907|9121427|P3|Overall Study|Did Not Receive Study Drug|0
2640001|NCT00790907|9121428|P2|Overall Study|Did Not Receive Study Drug|0
2640002|NCT00790907|9121429|P1|Overall Study|Did Not Receive Study Drug|10
2640003|NCT00790907|9121427|P3|Overall Study|Verbatim Reason on the Case Report Form|29
2640004|NCT00790907|9121428|P2|Overall Study|Verbatim Reason on the Case Report Form|20
2640005|NCT00790907|9121429|P1|Overall Study|Verbatim Reason on the Case Report Form|74
2640006|NCT00790907|9121427|P3|Overall Study|Qualifying Condition Not Present|16
2640007|NCT00790907|9121428|P2|Overall Study|Qualifying Condition Not Present|14
2640008|NCT00790907|9121429|P1|Overall Study|Qualifying Condition Not Present|29
2640009|NCT00790907|9121427|P3|Overall Study|Required Protocol-prohibited Therapy|7
2640010|NCT00790907|9121428|P2|Overall Study|Required Protocol-prohibited Therapy|5
2640011|NCT00790907|9121429|P1|Overall Study|Required Protocol-prohibited Therapy|17
2640012|NCT00790907|9121427|P3|Overall Study|Bleeding Event|21
2640013|NCT00790907|9121428|P2|Overall Study|Bleeding Event|16
2640014|NCT00790907|9121429|P1|Overall Study|Bleeding Event|11
2640015|NCT00790907|9121427|P3|Overall Study|Withdrawal by Subject|5
2640016|NCT00790907|9121428|P2|Overall Study|Withdrawal by Subject|7
2640017|NCT00790907|9121429|P1|Overall Study|Withdrawal by Subject|1
2640018|NCT00790907|9121427|P3|Overall Study|Physician Decision|255
2640019|NCT00790907|9121428|P2|Overall Study|Physician Decision|271
2640020|NCT00790907|9121429|P1|Overall Study|Physician Decision|304
2640021|NCT00790907|9121427|P3|Overall Study|Adverse Event|6
2640022|NCT00790907|9121428|P2|Overall Study|Adverse Event|7
2640023|NCT00790907|9121429|P1|Overall Study|Adverse Event|9
2640024|NCT00790868|9121452|P2|Overall Study|Lost to Follow-up|12
2640025|NCT00790868|9121453|P1|Overall Study|Lost to Follow-up|2
2640026|NCT00790868|9121452|P2|Overall Study|Withdrawal by Subject|5
2640027|NCT00790868|9121453|P1|Overall Study|Withdrawal by Subject|4
2640028|NCT00790842|9121475|P11|Expansion Cohort|Study Closure|0
2640029|NCT00790842|9121476|P10|Expansion Cohort|Study Closure|0
2640030|NCT00790842|9121477|P9|Expansion Cohort|Study Closure|0
2640031|NCT00790842|9121478|P8|Expansion Cohort|Study Closure|0
2640032|NCT00790842|9121479|P7|Expansion Cohort|Study Closure|0
2640033|NCT00790842|9121480|P6|Expansion Cohort|Study Closure|0
2640034|NCT00790842|9121481|P5|Expansion Cohort|Study Closure|0
2640035|NCT00790842|9121482|P4|Expansion Cohort|Study Closure|0
2640036|NCT00790842|9121483|P3|Expansion Cohort|Study Closure|1
2640037|NCT00790842|9121484|P2|Expansion Cohort|Study Closure|0
2640038|NCT00790842|9121485|P1|Expansion Cohort|Study Closure|0
2640039|NCT00790842|9121475|P11|Expansion Cohort|Withdrawal by Subject|0
2640040|NCT00790842|9121476|P10|Expansion Cohort|Withdrawal by Subject|0
2640041|NCT00790842|9121477|P9|Expansion Cohort|Withdrawal by Subject|0
2640042|NCT00790842|9121478|P8|Expansion Cohort|Withdrawal by Subject|0
2640043|NCT00790842|9121479|P7|Expansion Cohort|Withdrawal by Subject|0
2640044|NCT00790842|9121480|P6|Expansion Cohort|Withdrawal by Subject|0
2640045|NCT00790842|9121481|P5|Expansion Cohort|Withdrawal by Subject|0
2640046|NCT00790842|9121482|P4|Expansion Cohort|Withdrawal by Subject|0
2640047|NCT00790842|9121483|P3|Expansion Cohort|Withdrawal by Subject|3
2640048|NCT00790842|9121484|P2|Expansion Cohort|Withdrawal by Subject|0
2640049|NCT00790842|9121485|P1|Expansion Cohort|Withdrawal by Subject|0
2640050|NCT00790842|9121475|P11|Expansion Cohort|Physician Decision|0
2640051|NCT00790842|9121476|P10|Expansion Cohort|Physician Decision|0
2640052|NCT00790842|9121477|P9|Expansion Cohort|Physician Decision|0
2640053|NCT00790842|9121478|P8|Expansion Cohort|Physician Decision|0
2640054|NCT00790842|9121479|P7|Expansion Cohort|Physician Decision|0
2640055|NCT00790842|9121480|P6|Expansion Cohort|Physician Decision|0
2640056|NCT00790842|9121481|P5|Expansion Cohort|Physician Decision|0
2640057|NCT00790842|9121482|P4|Expansion Cohort|Physician Decision|0
2640058|NCT00790842|9121483|P3|Expansion Cohort|Physician Decision|1
2640059|NCT00790842|9121484|P2|Expansion Cohort|Physician Decision|0
2640060|NCT00790842|9121485|P1|Expansion Cohort|Physician Decision|0
2640061|NCT00790842|9121475|P11|Expansion Cohort|Death|0
2640062|NCT00790842|9121476|P10|Expansion Cohort|Death|0
2640063|NCT00790842|9121477|P9|Expansion Cohort|Death|0
2640064|NCT00790842|9121478|P8|Expansion Cohort|Death|0
2640065|NCT00790842|9121479|P7|Expansion Cohort|Death|0
2640066|NCT00790842|9121480|P6|Expansion Cohort|Death|0
2640067|NCT00790842|9121481|P5|Expansion Cohort|Death|0
2640068|NCT00790842|9121482|P4|Expansion Cohort|Death|0
2640069|NCT00790842|9121483|P3|Expansion Cohort|Death|2
2640070|NCT00790842|9121484|P2|Expansion Cohort|Death|0
2640071|NCT00790842|9121485|P1|Expansion Cohort|Death|0
2640072|NCT00790842|9121475|P11|Expansion Cohort|Adverse Event|0
2640073|NCT00790842|9121476|P10|Expansion Cohort|Adverse Event|0
2640074|NCT00790842|9121477|P9|Expansion Cohort|Adverse Event|0
2640075|NCT00790842|9121478|P8|Expansion Cohort|Adverse Event|0
2640076|NCT00790842|9121479|P7|Expansion Cohort|Adverse Event|1
2640077|NCT00790842|9121480|P6|Expansion Cohort|Adverse Event|0
2640078|NCT00790842|9121481|P5|Expansion Cohort|Adverse Event|0
2640079|NCT00790842|9121482|P4|Expansion Cohort|Adverse Event|0
2640080|NCT00790842|9121483|P3|Expansion Cohort|Adverse Event|0
2640081|NCT00790842|9121484|P2|Expansion Cohort|Adverse Event|0
2640082|NCT00790842|9121485|P1|Expansion Cohort|Adverse Event|0
2640083|NCT00790842|9121475|P11|Dose Level 4|Withdrawal by Subject|1
2640084|NCT00790842|9121476|P10|Dose Level 4|Withdrawal by Subject|0
2640085|NCT00790842|9121477|P9|Dose Level 4|Withdrawal by Subject|0
2640086|NCT00790842|9121478|P8|Dose Level 4|Withdrawal by Subject|0
2640087|NCT00790842|9121479|P7|Dose Level 4|Withdrawal by Subject|0
2640088|NCT00790842|9121480|P6|Dose Level 4|Withdrawal by Subject|0
2640089|NCT00790842|9121481|P5|Dose Level 4|Withdrawal by Subject|0
2640090|NCT00790842|9121482|P4|Dose Level 4|Withdrawal by Subject|0
2640091|NCT00790842|9121483|P3|Dose Level 4|Withdrawal by Subject|0
2640092|NCT00790842|9121484|P2|Dose Level 4|Withdrawal by Subject|0
2640093|NCT00790842|9121485|P1|Dose Level 4|Withdrawal by Subject|0
2640094|NCT00790842|9121475|P11|Dose Level 4|Physician Decision|1
2640095|NCT00790842|9121476|P10|Dose Level 4|Physician Decision|0
2640096|NCT00790842|9121477|P9|Dose Level 4|Physician Decision|0
2640097|NCT00790842|9121478|P8|Dose Level 4|Physician Decision|0
2640098|NCT00790842|9121479|P7|Dose Level 4|Physician Decision|1
2640099|NCT00790842|9121480|P6|Dose Level 4|Physician Decision|0
2640100|NCT00790842|9121481|P5|Dose Level 4|Physician Decision|0
2640101|NCT00790842|9121482|P4|Dose Level 4|Physician Decision|0
2640102|NCT00790842|9121483|P3|Dose Level 4|Physician Decision|0
2640103|NCT00790842|9121484|P2|Dose Level 4|Physician Decision|0
2640104|NCT00790842|9121485|P1|Dose Level 4|Physician Decision|0
2640105|NCT00790842|9121475|P11|Dose Level 4|Adverse Event|0
2640106|NCT00790842|9121476|P10|Dose Level 4|Adverse Event|0
2640107|NCT00790842|9121477|P9|Dose Level 4|Adverse Event|0
2640108|NCT00790842|9121478|P8|Dose Level 4|Adverse Event|0
2640109|NCT00790842|9121479|P7|Dose Level 4|Adverse Event|1
2640110|NCT00790842|9121480|P6|Dose Level 4|Adverse Event|0
2640111|NCT00790842|9121481|P5|Dose Level 4|Adverse Event|0
2640112|NCT00790842|9121482|P4|Dose Level 4|Adverse Event|0
2640113|NCT00790842|9121483|P3|Dose Level 4|Adverse Event|0
2640114|NCT00790842|9121484|P2|Dose Level 4|Adverse Event|0
2640115|NCT00790842|9121485|P1|Dose Level 4|Adverse Event|0
2640116|NCT00790842|9121475|P11|Dose Level 3|Ineligible/Withdrew before Treatment|0
2640117|NCT00790842|9121476|P10|Dose Level 3|Ineligible/Withdrew before Treatment|0
2640118|NCT00790842|9121477|P9|Dose Level 3|Ineligible/Withdrew before Treatment|0
2640119|NCT00790842|9121478|P8|Dose Level 3|Ineligible/Withdrew before Treatment|0
2640120|NCT00790842|9121479|P7|Dose Level 3|Ineligible/Withdrew before Treatment|0
2640121|NCT00790842|9121480|P6|Dose Level 3|Ineligible/Withdrew before Treatment|0
2640122|NCT00790842|9121481|P5|Dose Level 3|Ineligible/Withdrew before Treatment|0
2640123|NCT00790842|9121482|P4|Dose Level 3|Ineligible/Withdrew before Treatment|0
2640124|NCT00790842|9121483|P3|Dose Level 3|Ineligible/Withdrew before Treatment|1
2640125|NCT00790842|9121484|P2|Dose Level 3|Ineligible/Withdrew before Treatment|0
2640126|NCT00790842|9121485|P1|Dose Level 3|Ineligible/Withdrew before Treatment|0
2640127|NCT00790842|9121475|P11|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
2640128|NCT00790842|9121476|P10|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
2640129|NCT00790842|9121477|P9|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
2640130|NCT00790842|9121478|P8|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
2640131|NCT00790842|9121479|P7|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
2640132|NCT00790842|9121480|P6|Dose Level 3|Intercurrent Illness/Alternative Therapy|1
2640133|NCT00790842|9121481|P5|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
2640134|NCT00790842|9121482|P4|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
2640135|NCT00790842|9121483|P3|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
2640136|NCT00790842|9121484|P2|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
2640137|NCT00790842|9121485|P1|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
2640138|NCT00790842|9121475|P11|Dose Level 3|Withdrawal by Subject|0
2640139|NCT00790842|9121476|P10|Dose Level 3|Withdrawal by Subject|2
2640140|NCT00790842|9121477|P9|Dose Level 3|Withdrawal by Subject|0
2640141|NCT00790842|9121478|P8|Dose Level 3|Withdrawal by Subject|0
2640142|NCT00790842|9121479|P7|Dose Level 3|Withdrawal by Subject|0
2640143|NCT00790842|9121480|P6|Dose Level 3|Withdrawal by Subject|0
2640144|NCT00790842|9121481|P5|Dose Level 3|Withdrawal by Subject|0
2640145|NCT00790842|9121482|P4|Dose Level 3|Withdrawal by Subject|0
2640146|NCT00790842|9121483|P3|Dose Level 3|Withdrawal by Subject|3
2640147|NCT00790842|9121484|P2|Dose Level 3|Withdrawal by Subject|0
2640148|NCT00790842|9121485|P1|Dose Level 3|Withdrawal by Subject|0
2640149|NCT00790842|9121475|P11|Dose Level 3|Adverse Event|0
2640150|NCT00790842|9121476|P10|Dose Level 3|Adverse Event|0
2640151|NCT00790842|9121477|P9|Dose Level 3|Adverse Event|0
2640152|NCT00790842|9121478|P8|Dose Level 3|Adverse Event|0
2640153|NCT00790842|9121479|P7|Dose Level 3|Adverse Event|0
2640154|NCT00790842|9121480|P6|Dose Level 3|Adverse Event|0
2640155|NCT00790842|9121481|P5|Dose Level 3|Adverse Event|0
2640156|NCT00790842|9121482|P4|Dose Level 3|Adverse Event|0
2640157|NCT00790842|9121483|P3|Dose Level 3|Adverse Event|1
2640158|NCT00790842|9121484|P2|Dose Level 3|Adverse Event|0
2640159|NCT00790842|9121485|P1|Dose Level 3|Adverse Event|0
2640160|NCT00790842|9121475|P11|Dose Level 2|Intercurrent Illness/Other Treatment|0
2640161|NCT00790842|9121476|P10|Dose Level 2|Intercurrent Illness/Other Treatment|0
2640162|NCT00790842|9121477|P9|Dose Level 2|Intercurrent Illness/Other Treatment|2
2640163|NCT00790842|9121478|P8|Dose Level 2|Intercurrent Illness/Other Treatment|0
2640164|NCT00790842|9121479|P7|Dose Level 2|Intercurrent Illness/Other Treatment|0
2640165|NCT00790842|9121480|P6|Dose Level 2|Intercurrent Illness/Other Treatment|0
2640166|NCT00790842|9121481|P5|Dose Level 2|Intercurrent Illness/Other Treatment|0
2640167|NCT00790842|9121482|P4|Dose Level 2|Intercurrent Illness/Other Treatment|0
2640168|NCT00790842|9121483|P3|Dose Level 2|Intercurrent Illness/Other Treatment|0
2640169|NCT00790842|9121484|P2|Dose Level 2|Intercurrent Illness/Other Treatment|0
2640170|NCT00790842|9121485|P1|Dose Level 2|Intercurrent Illness/Other Treatment|0
2640171|NCT00790842|9121475|P11|Dose Level 2|Withdrawal by Subject|0
2640172|NCT00790842|9121476|P10|Dose Level 2|Withdrawal by Subject|0
2640173|NCT00790842|9121477|P9|Dose Level 2|Withdrawal by Subject|0
2640174|NCT00790842|9121478|P8|Dose Level 2|Withdrawal by Subject|0
2640175|NCT00790842|9121479|P7|Dose Level 2|Withdrawal by Subject|0
2640176|NCT00790842|9121480|P6|Dose Level 2|Withdrawal by Subject|0
2640177|NCT00790842|9121481|P5|Dose Level 2|Withdrawal by Subject|0
2640178|NCT00790842|9121482|P4|Dose Level 2|Withdrawal by Subject|0
2640179|NCT00790842|9121483|P3|Dose Level 2|Withdrawal by Subject|0
2640180|NCT00790842|9121484|P2|Dose Level 2|Withdrawal by Subject|1
2640181|NCT00790842|9121485|P1|Dose Level 2|Withdrawal by Subject|0
2640182|NCT00790842|9121475|P11|Dose Level 2|Physician Decision|0
2640183|NCT00790842|9121476|P10|Dose Level 2|Physician Decision|0
2640184|NCT00790842|9121477|P9|Dose Level 2|Physician Decision|0
2640185|NCT00790842|9121478|P8|Dose Level 2|Physician Decision|0
2640186|NCT00790842|9121479|P7|Dose Level 2|Physician Decision|0
2640187|NCT00790842|9121480|P6|Dose Level 2|Physician Decision|0
2640188|NCT00790842|9121481|P5|Dose Level 2|Physician Decision|0
2640189|NCT00790842|9121482|P4|Dose Level 2|Physician Decision|0
2640190|NCT00790842|9121483|P3|Dose Level 2|Physician Decision|0
2640191|NCT00790842|9121484|P2|Dose Level 2|Physician Decision|1
2640192|NCT00790842|9121485|P1|Dose Level 2|Physician Decision|0
2640193|NCT00790842|9121475|P11|Dose Level 2|Death|0
2640194|NCT00790842|9121476|P10|Dose Level 2|Death|0
2640195|NCT00790842|9121477|P9|Dose Level 2|Death|0
2640196|NCT00790842|9121478|P8|Dose Level 2|Death|0
2640197|NCT00790842|9121479|P7|Dose Level 2|Death|0
2640198|NCT00790842|9121480|P6|Dose Level 2|Death|0
2640199|NCT00790842|9121481|P5|Dose Level 2|Death|1
2640200|NCT00790842|9121482|P4|Dose Level 2|Death|0
2640201|NCT00790842|9121483|P3|Dose Level 2|Death|0
2640202|NCT00790842|9121484|P2|Dose Level 2|Death|1
2640203|NCT00790842|9121485|P1|Dose Level 2|Death|0
2640204|NCT00790842|9121475|P11|Dose Level 1|Withdrawal by Subject|0
2640205|NCT00790842|9121476|P10|Dose Level 1|Withdrawal by Subject|0
2640206|NCT00790842|9121477|P9|Dose Level 1|Withdrawal by Subject|0
2640207|NCT00790842|9121478|P8|Dose Level 1|Withdrawal by Subject|0
2640208|NCT00790842|9121479|P7|Dose Level 1|Withdrawal by Subject|0
2640209|NCT00790842|9121480|P6|Dose Level 1|Withdrawal by Subject|0
2640210|NCT00790842|9121481|P5|Dose Level 1|Withdrawal by Subject|0
2640211|NCT00790842|9121482|P4|Dose Level 1|Withdrawal by Subject|0
2640212|NCT00790842|9121483|P3|Dose Level 1|Withdrawal by Subject|0
2640213|NCT00790842|9121484|P2|Dose Level 1|Withdrawal by Subject|0
2640214|NCT00790842|9121485|P1|Dose Level 1|Withdrawal by Subject|1
2640215|NCT00790842|9121475|P11|Dose Level 1|Physician Decision|0
2640216|NCT00790842|9121476|P10|Dose Level 1|Physician Decision|0
2640217|NCT00790842|9121477|P9|Dose Level 1|Physician Decision|0
2640218|NCT00790842|9121478|P8|Dose Level 1|Physician Decision|1
2640219|NCT00790842|9121479|P7|Dose Level 1|Physician Decision|0
2640220|NCT00790842|9121480|P6|Dose Level 1|Physician Decision|0
2640221|NCT00790842|9121481|P5|Dose Level 1|Physician Decision|0
2640222|NCT00790842|9121482|P4|Dose Level 1|Physician Decision|0
2640223|NCT00790842|9121483|P3|Dose Level 1|Physician Decision|0
2640224|NCT00790842|9121484|P2|Dose Level 1|Physician Decision|0
2640225|NCT00790842|9121485|P1|Dose Level 1|Physician Decision|1
2640226|NCT00790842|9121475|P11|Dose Level 1|Adverse Event|0
2640227|NCT00790842|9121476|P10|Dose Level 1|Adverse Event|0
2640228|NCT00790842|9121477|P9|Dose Level 1|Adverse Event|0
2640229|NCT00790842|9121478|P8|Dose Level 1|Adverse Event|1
2640230|NCT00790842|9121479|P7|Dose Level 1|Adverse Event|0
2640231|NCT00790842|9121480|P6|Dose Level 1|Adverse Event|0
2640232|NCT00790842|9121481|P5|Dose Level 1|Adverse Event|0
2640233|NCT00790842|9121482|P4|Dose Level 1|Adverse Event|2
2640234|NCT00790842|9121483|P3|Dose Level 1|Adverse Event|0
2640235|NCT00790842|9121484|P2|Dose Level 1|Adverse Event|0
2640236|NCT00790842|9121485|P1|Dose Level 1|Adverse Event|1
2640237|NCT00790790|9121553|P3|Study Period 2: Therapy Phase|Physician Decision|0
2640238|NCT00790790|9121554|P2|Study Period 2: Therapy Phase|Physician Decision|1
2640239|NCT00790790|9121555|P1|Study Period 2: Therapy Phase|Physician Decision|0
2640240|NCT00790790|9121553|P3|Study Period 2: Therapy Phase|Lack of Efficacy|3
2640241|NCT00790790|9121554|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
2640242|NCT00790790|9121555|P1|Study Period 2: Therapy Phase|Lack of Efficacy|1
2640243|NCT00790790|9121553|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|2
2640244|NCT00790790|9121554|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|0
2640245|NCT00790790|9121555|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|7
2640246|NCT00790790|9121553|P3|Study Period 2: Therapy Phase|Protocol Violation|0
2640247|NCT00790790|9121554|P2|Study Period 2: Therapy Phase|Protocol Violation|1
2640248|NCT00790790|9121555|P1|Study Period 2: Therapy Phase|Protocol Violation|1
2640249|NCT00790790|9121553|P3|Study Period 2: Therapy Phase|Adverse Event|16
2640250|NCT00790790|9121554|P2|Study Period 2: Therapy Phase|Adverse Event|16
2640251|NCT00790790|9121555|P1|Study Period 2: Therapy Phase|Adverse Event|3
2640252|NCT00790751|9121632|P4|Overall Study|Physician Decision|1
2640253|NCT00790751|9121633|P3|Overall Study|Physician Decision|0
2640254|NCT00790751|9121634|P2|Overall Study|Physician Decision|0
2640255|NCT00790751|9121635|P1|Overall Study|Physician Decision|0
2640256|NCT00790751|9121632|P4|Overall Study|Death|0
2640257|NCT00790751|9121633|P3|Overall Study|Death|1
2640258|NCT00790751|9121634|P2|Overall Study|Death|0
2640259|NCT00790751|9121635|P1|Overall Study|Death|0
2640260|NCT00790751|9121632|P4|Overall Study|Requirement for restricted medication|0
2640261|NCT00790751|9121633|P3|Overall Study|Requirement for restricted medication|0
2640262|NCT00790751|9121634|P2|Overall Study|Requirement for restricted medication|2
2640263|NCT00790751|9121635|P1|Overall Study|Requirement for restricted medication|0
2640264|NCT00790751|9121632|P4|Overall Study|Adverse Event|4
2640265|NCT00790751|9121633|P3|Overall Study|Adverse Event|5
2640266|NCT00790751|9121634|P2|Overall Study|Adverse Event|3
2640267|NCT00790751|9121635|P1|Overall Study|Adverse Event|5
2640268|NCT00790751|9121632|P4|Overall Study|Lost to Follow-up|5
2640269|NCT00790751|9121633|P3|Overall Study|Lost to Follow-up|4
2640270|NCT00790751|9121634|P2|Overall Study|Lost to Follow-up|9
2640271|NCT00790751|9121635|P1|Overall Study|Lost to Follow-up|4
2640272|NCT00790751|9121632|P4|Overall Study|Protocol non-compliance|11
2640273|NCT00790751|9121633|P3|Overall Study|Protocol non-compliance|10
2640274|NCT00790751|9121634|P2|Overall Study|Protocol non-compliance|16
2640275|NCT00790751|9121635|P1|Overall Study|Protocol non-compliance|16
2640276|NCT00790647|9121683|P1|Overall Study|Adverse Event|1
2640277|NCT00790569|9121693|P3|End of Study (12 Month Interview)|Lost to Follow-up|50
2640278|NCT00790569|9121694|P2|End of Study (12 Month Interview)|Lost to Follow-up|19
2640279|NCT00790569|9121695|P1|End of Study (12 Month Interview)|Lost to Follow-up|66
2640280|NCT00790569|9121693|P3|End of Treatment (6 Month Interview)|Incarcerated|3
2640281|NCT00790569|9121694|P2|End of Treatment (6 Month Interview)|Incarcerated|0
2640282|NCT00790569|9121695|P1|End of Treatment (6 Month Interview)|Incarcerated|0
2640283|NCT00790569|9121693|P3|End of Treatment (6 Month Interview)|Residential Treatment|2
2640284|NCT00790569|9121694|P2|End of Treatment (6 Month Interview)|Residential Treatment|0
2640285|NCT00790569|9121695|P1|End of Treatment (6 Month Interview)|Residential Treatment|0
2640286|NCT00790569|9121693|P3|End of Treatment (6 Month Interview)|Hospitalized|0
2640287|NCT00790569|9121694|P2|End of Treatment (6 Month Interview)|Hospitalized|0
2640288|NCT00790569|9121695|P1|End of Treatment (6 Month Interview)|Hospitalized|2
2640289|NCT00790569|9121693|P3|End of Treatment (6 Month Interview)|Death|1
2640290|NCT00790569|9121694|P2|End of Treatment (6 Month Interview)|Death|2
2640291|NCT00790569|9121695|P1|End of Treatment (6 Month Interview)|Death|0
2640292|NCT00790569|9121693|P3|End of Treatment (6 Month Interview)|Lost to Follow-up|20
2640293|NCT00790569|9121694|P2|End of Treatment (6 Month Interview)|Lost to Follow-up|8
2640294|NCT00790569|9121695|P1|End of Treatment (6 Month Interview)|Lost to Follow-up|20
2640295|NCT00790556|9121736|P2|Treatment Period 1|Withdrawal by Subject|0
2640296|NCT00790556|9121737|P1|Treatment Period 1|Withdrawal by Subject|1
2640297|NCT00790556|9121736|P2|Treatment Period 1|Physician Decision|0
2640298|NCT00790556|9121737|P1|Treatment Period 1|Physician Decision|1
2640299|NCT00790452|9121749|P2|Overall Study|Drug supply issue|0
2640300|NCT00790452|9121750|P1|Overall Study|Drug supply issue|1
2640301|NCT00790400|9121758|P2|Everolimus Period (Core or Extension)|New treatment|0
2640302|NCT00790400|9121759|P1|Everolimus Period (Core or Extension)|New treatment|2
2640303|NCT00790400|9121758|P2|Everolimus Period (Core or Extension)|Protocol Violation|0
2640304|NCT00790400|9121759|P1|Everolimus Period (Core or Extension)|Protocol Violation|1
2640305|NCT00790400|9121758|P2|Everolimus Period (Core or Extension)|Disease progression|0
2640306|NCT00790400|9121759|P1|Everolimus Period (Core or Extension)|Disease progression|5
2640307|NCT00790400|9121758|P2|Everolimus Period (Core or Extension)|Death|0
2640308|NCT00790400|9121759|P1|Everolimus Period (Core or Extension)|Death|1
2640309|NCT00790400|9121758|P2|Everolimus Period (Core or Extension)|Administrative problems|0
2640310|NCT00790400|9121759|P1|Everolimus Period (Core or Extension)|Administrative problems|2
2640311|NCT00790400|9121758|P2|Everolimus Period (Core or Extension)|Lost to Follow-up|0
2640312|NCT00790400|9121759|P1|Everolimus Period (Core or Extension)|Lost to Follow-up|1
2640313|NCT00790400|9121758|P2|Everolimus Period (Core or Extension)|Withdrawal by Subject|0
2640314|NCT00790400|9121759|P1|Everolimus Period (Core or Extension)|Withdrawal by Subject|7
2640315|NCT00790400|9121758|P2|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0
2640316|NCT00790400|9121759|P1|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1
2640317|NCT00790400|9121758|P2|Everolimus Period (Core or Extension)|Adverse Event|0
2640318|NCT00790400|9121759|P1|Everolimus Period (Core or Extension)|Adverse Event|9
2640319|NCT00790400|9121758|P2|Double-blind Period (Core Phase)|Death|0
2640320|NCT00790400|9121759|P1|Double-blind Period (Core Phase)|Death|1
2640321|NCT00790400|9121758|P2|Double-blind Period (Core Phase)|Administrative problems|0
2640322|NCT00790400|9121759|P1|Double-blind Period (Core Phase)|Administrative problems|1
2640323|NCT00790400|9121758|P2|Double-blind Period (Core Phase)|Withdrawal by Subject|0
2640324|NCT00790400|9121759|P1|Double-blind Period (Core Phase)|Withdrawal by Subject|1
2640325|NCT00790400|9121758|P2|Double-blind Period (Core Phase)|Abnormal lab value (s)|0
2640326|NCT00790400|9121759|P1|Double-blind Period (Core Phase)|Abnormal lab value (s)|1
2640327|NCT00790400|9121758|P2|Double-blind Period (Core Phase)|Adverse Event|4
2640328|NCT00790400|9121759|P1|Double-blind Period (Core Phase)|Adverse Event|2
2640329|NCT00790400|9121758|P2|Double-blind Period (Core Phase)|Progressive disease|9
2640330|NCT00790400|9121759|P1|Double-blind Period (Core Phase)|Progressive disease|0
2640331|NCT00790400|9121758|P2|Double-blind Period (Core Phase)|Protocol Violation|0
2640332|NCT00790400|9121759|P1|Double-blind Period (Core Phase)|Protocol Violation|1
2640333|NCT00790296|9121849|P2|Overall Study|Adverse Event|1
2640334|NCT00790296|9121850|P1|Overall Study|Adverse Event|0
2640335|NCT00790296|9121849|P2|Overall Study|Did not meet study eligibility criteria|1
2640336|NCT00790296|9121850|P1|Overall Study|Did not meet study eligibility criteria|1
2640337|NCT00790218|9121872|P3|Overall Study|Death|0
2640338|NCT00790218|9121873|P2|Overall Study|Death|0
2640339|NCT00790218|9121874|P1|Overall Study|Death|1
2640340|NCT00790205|9121884|P2|Overall Study|Withdrawal by Subject|363
2640341|NCT00790205|9121885|P1|Overall Study|Withdrawal by Subject|299
2640342|NCT00790205|9121884|P2|Overall Study|Lost to Follow-up|71
2640343|NCT00790205|9121885|P1|Overall Study|Lost to Follow-up|61
2640344|NCT00790088|9121946|P1|Overall Study|Physician Decision|4
2640345|NCT00790088|9121946|P1|Overall Study|Lost to Follow-up|7
2640346|NCT00790088|9121946|P1|Overall Study|Withdrawal by Subject|17
2640347|NCT00790088|9121946|P1|Overall Study|Protocol Violation|11
2640348|NCT00790036|9121992|P2|Overall Study|Subject/guardian decision|7
2640349|NCT00790036|9121993|P1|Overall Study|Subject/guardian decision|20
2640350|NCT00790036|9121992|P2|Overall Study|Withdrawal by Subject|7
2640351|NCT00790036|9121993|P1|Overall Study|Withdrawal by Subject|18
2640352|NCT00790036|9121992|P2|Overall Study|Protocol Violation|2
2640353|NCT00790036|9121993|P1|Overall Study|Protocol Violation|10
2640354|NCT00790036|9121992|P2|Overall Study|Lost to Follow-up|2
2640355|NCT00790036|9121993|P1|Overall Study|Lost to Follow-up|1
2640356|NCT00790036|9121992|P2|Overall Study|Disease progression|48
2640357|NCT00790036|9121993|P1|Overall Study|Disease progression|24
2640358|NCT00790036|9121992|P2|Overall Study|Death|0
2640359|NCT00790036|9121993|P1|Overall Study|Death|1
2640360|NCT00790036|9121992|P2|Overall Study|Adverse Event|44
2640361|NCT00790036|9121993|P1|Overall Study|Adverse Event|113
2640362|NCT00790036|9121992|P2|Overall Study|Administrative problems|9
2640363|NCT00790036|9121993|P1|Overall Study|Administrative problems|5
2640364|NCT00790036|9121992|P2|Overall Study|Abnormal lab values|2
2640365|NCT00790036|9121993|P1|Overall Study|Abnormal lab values|3
2640366|NCT00790023|9122007|P3|Overall Study|Other|8
2640367|NCT00790023|9122008|P2|Overall Study|Other|5
2640368|NCT00790023|9122009|P1|Overall Study|Other|5
2640369|NCT00790023|9122007|P3|Overall Study|Lost to Follow-up|1
2640370|NCT00790023|9122008|P2|Overall Study|Lost to Follow-up|0
2640371|NCT00790023|9122009|P1|Overall Study|Lost to Follow-up|0
2640372|NCT00790023|9122007|P3|Overall Study|Withdrawal by Subject|6
2640373|NCT00790023|9122008|P2|Overall Study|Withdrawal by Subject|0
2640374|NCT00790023|9122009|P1|Overall Study|Withdrawal by Subject|2
2640375|NCT00790023|9122007|P3|Overall Study|Protocol Violation|2
2640376|NCT00790023|9122008|P2|Overall Study|Protocol Violation|4
2640377|NCT00790023|9122009|P1|Overall Study|Protocol Violation|2
2640378|NCT00790023|9122007|P3|Overall Study|Adverse Event|4
2640379|NCT00790023|9122008|P2|Overall Study|Adverse Event|1
2640380|NCT00790023|9122009|P1|Overall Study|Adverse Event|2
2640381|NCT00789958|9122108|P1|Overall Study|Not eligible/not analyzable|26
2640382|NCT00789958|9122108|P1|Overall Study|not protocol specified|1
2640383|NCT00789958|9122108|P1|Overall Study|Progression|3
2640384|NCT00789958|9122108|P1|Overall Study|Withdrawal by Subject|4
2640385|NCT00789958|9122108|P1|Overall Study|Adverse Event|3
2640386|NCT00789880|9122127|P6|Overall Study|Withdrawal by Subject|0
2640387|NCT00789880|9122128|P5|Overall Study|Withdrawal by Subject|2
2640388|NCT00789880|9122129|P4|Overall Study|Withdrawal by Subject|0
2640389|NCT00789880|9122130|P3|Overall Study|Withdrawal by Subject|0
2640390|NCT00789880|9122131|P2|Overall Study|Withdrawal by Subject|0
2640391|NCT00789880|9122132|P1|Overall Study|Withdrawal by Subject|1
2640392|NCT00789880|9122127|P6|Overall Study|Protocol Violation|0
2640393|NCT00789880|9122128|P5|Overall Study|Protocol Violation|0
2640394|NCT00789880|9122129|P4|Overall Study|Protocol Violation|1
2640395|NCT00789880|9122130|P3|Overall Study|Protocol Violation|0
2640396|NCT00789880|9122131|P2|Overall Study|Protocol Violation|1
2640397|NCT00789880|9122132|P1|Overall Study|Protocol Violation|0
2640398|NCT00789880|9122127|P6|Overall Study|Adverse Event|0
2640399|NCT00789880|9122128|P5|Overall Study|Adverse Event|1
2640400|NCT00789880|9122129|P4|Overall Study|Adverse Event|0
2640401|NCT00789880|9122130|P3|Overall Study|Adverse Event|0
2640402|NCT00789880|9122131|P2|Overall Study|Adverse Event|0
2640403|NCT00789880|9122132|P1|Overall Study|Adverse Event|0
2640404|NCT00789854|9122189|P3|Overall Study|Other|5
2640405|NCT00789854|9122190|P2|Overall Study|Other|0
2640406|NCT00789854|9122191|P1|Overall Study|Other|6
2640407|NCT00789854|9122189|P3|Overall Study|Safety reasons|2
2640408|NCT00789854|9122190|P2|Overall Study|Safety reasons|0
2640409|NCT00789854|9122191|P1|Overall Study|Safety reasons|0
2640410|NCT00789854|9122189|P3|Overall Study|Severe non-compliance to the protocol|0
2640411|NCT00789854|9122190|P2|Overall Study|Severe non-compliance to the protocol|0
2640412|NCT00789854|9122191|P1|Overall Study|Severe non-compliance to the protocol|3
2640413|NCT00789854|9122189|P3|Overall Study|Eligibility criteria not fulfilled|1
2640414|NCT00789854|9122190|P2|Overall Study|Eligibility criteria not fulfilled|5
2640415|NCT00789854|9122191|P1|Overall Study|Eligibility criteria not fulfilled|2
2640416|NCT00789854|9122189|P3|Overall Study|Withdrawal by Subject|17
2640417|NCT00789854|9122190|P2|Overall Study|Withdrawal by Subject|6
2640418|NCT00789854|9122191|P1|Overall Study|Withdrawal by Subject|9
2640419|NCT00789854|9122189|P3|Overall Study|Lost to Follow-up|4
2640420|NCT00789854|9122190|P2|Overall Study|Lost to Follow-up|1
2640421|NCT00789854|9122191|P1|Overall Study|Lost to Follow-up|1
2640422|NCT00789854|9122189|P3|Overall Study|Adverse Event|18
2640423|NCT00789854|9122190|P2|Overall Study|Adverse Event|23
2640424|NCT00789854|9122191|P1|Overall Study|Adverse Event|28
2640425|NCT00789828|9122288|P2|Open-label Extension Period (4 Years)|New treatment for indication under study|0
2640426|NCT00789828|9122289|P1|Open-label Extension Period (4 Years)|New treatment for indication under study|1
2640427|NCT00789828|9122288|P2|Open-label Extension Period (4 Years)|Disease progression|0
2640428|NCT00789828|9122289|P1|Open-label Extension Period (4 Years)|Disease progression|1
2640429|NCT00789828|9122288|P2|Open-label Extension Period (4 Years)|Death|0
2640430|NCT00789828|9122289|P1|Open-label Extension Period (4 Years)|Death|1
2640431|NCT00789828|9122288|P2|Open-label Extension Period (4 Years)|Administrative problems|0
2640432|NCT00789828|9122289|P1|Open-label Extension Period (4 Years)|Administrative problems|7
2640433|NCT00789828|9122288|P2|Open-label Extension Period (4 Years)|Lost to Follow-up|0
2640434|NCT00789828|9122289|P1|Open-label Extension Period (4 Years)|Lost to Follow-up|3
2640435|NCT00789828|9122288|P2|Open-label Extension Period (4 Years)|Withdrawal by Subject|0
2640436|NCT00789828|9122289|P1|Open-label Extension Period (4 Years)|Withdrawal by Subject|6
2640437|NCT00789828|9122288|P2|Open-label Extension Period (4 Years)|Adverse Event|0
2640438|NCT00789828|9122289|P1|Open-label Extension Period (4 Years)|Adverse Event|10
2640439|NCT00789828|9122288|P2|Core Period (48 Weeks)|Lost to Follow-up|1
2640440|NCT00789828|9122289|P1|Core Period (48 Weeks)|Lost to Follow-up|0
2640441|NCT00789828|9122288|P2|Core Period (48 Weeks)|Withdrawal by Subject|4
2640442|NCT00789828|9122289|P1|Core Period (48 Weeks)|Withdrawal by Subject|0
2640443|NCT00789828|9122288|P2|Core Period (48 Weeks)|Administrative problems|1
2640444|NCT00789828|9122289|P1|Core Period (48 Weeks)|Administrative problems|0
2640445|NCT00789815|9122323|P2|Overall Study|Intubation due to massive bleeding|0
2640446|NCT00789815|9122324|P1|Overall Study|Intubation due to massive bleeding|1
2640447|NCT00789815|9122323|P2|Overall Study|Protocol Violation|1
2640448|NCT00789815|9122324|P1|Overall Study|Protocol Violation|6
2640449|NCT00789737|9122434|P2|Overall Study|Other|7
2640450|NCT00789737|9122435|P1|Overall Study|Other|11
2640451|NCT00789737|9122434|P2|Overall Study|hyperglycemia that met protocol-specifie|4
2640452|NCT00789737|9122435|P1|Overall Study|hyperglycemia that met protocol-specifie|0
2640453|NCT00789737|9122434|P2|Overall Study|Lack of Efficacy|0
2640454|NCT00789737|9122435|P1|Overall Study|Lack of Efficacy|3
2640455|NCT00789737|9122434|P2|Overall Study|Protocol Violation|0
2640456|NCT00789737|9122435|P1|Overall Study|Protocol Violation|3
2640457|NCT00789737|9122434|P2|Overall Study|Adverse Event|8
2640458|NCT00789737|9122435|P1|Overall Study|Adverse Event|8
2640459|NCT00789737|9122434|P2|Overall Study|Lost to Follow-up|14
2640460|NCT00789737|9122435|P1|Overall Study|Lost to Follow-up|10
2640461|NCT00789737|9122434|P2|Overall Study|Withdrawal by Subject|22
2640462|NCT00789737|9122435|P1|Overall Study|Withdrawal by Subject|13
2640463|NCT00789698|9122478|P4|Overall Study|Administrative|1
2640464|NCT00789698|9122479|P3|Overall Study|Administrative|3
2640465|NCT00789698|9122480|P2|Overall Study|Administrative|3
2640466|NCT00789698|9122481|P1|Overall Study|Administrative|0
2640467|NCT00789698|9122478|P4|Overall Study|Withdrawal by Subject|19
2640468|NCT00789698|9122479|P3|Overall Study|Withdrawal by Subject|12
2640469|NCT00789698|9122480|P2|Overall Study|Withdrawal by Subject|15
2640470|NCT00789698|9122481|P1|Overall Study|Withdrawal by Subject|14
2640471|NCT00789698|9122478|P4|Overall Study|Protocol Violation|1
2640472|NCT00789698|9122479|P3|Overall Study|Protocol Violation|2
2640473|NCT00789698|9122480|P2|Overall Study|Protocol Violation|1
2640474|NCT00789698|9122481|P1|Overall Study|Protocol Violation|6
2640475|NCT00789698|9122478|P4|Overall Study|Lost to Follow-up|9
2640476|NCT00789698|9122479|P3|Overall Study|Lost to Follow-up|2
2640477|NCT00789698|9122480|P2|Overall Study|Lost to Follow-up|5
2640478|NCT00789698|9122481|P1|Overall Study|Lost to Follow-up|5
2640479|NCT00789698|9122478|P4|Overall Study|Adverse Event|4
2640480|NCT00789698|9122479|P3|Overall Study|Adverse Event|3
2640481|NCT00789698|9122480|P2|Overall Study|Adverse Event|5
2640482|NCT00789698|9122481|P1|Overall Study|Adverse Event|5
2640483|NCT00789698|9122478|P4|Overall Study|Lack of Efficacy|18
2640484|NCT00789698|9122479|P3|Overall Study|Lack of Efficacy|5
2640485|NCT00789698|9122480|P2|Overall Study|Lack of Efficacy|4
2640486|NCT00789698|9122481|P1|Overall Study|Lack of Efficacy|10
2640487|NCT00789581|9122536|P2|Adjuvant Therapy|Other|1
2640488|NCT00789581|9122537|P1|Adjuvant Therapy|Other|0
2640489|NCT00789581|9122536|P2|Adjuvant Therapy|Protocol Violation|1
2640490|NCT00789581|9122537|P1|Adjuvant Therapy|Protocol Violation|1
2640491|NCT00789581|9122536|P2|Adjuvant Therapy|Intercurrent Illness|3
2640492|NCT00789581|9122537|P1|Adjuvant Therapy|Intercurrent Illness|1
2640493|NCT00789581|9122536|P2|Adjuvant Therapy|Disease recurrence|1
2640494|NCT00789581|9122537|P1|Adjuvant Therapy|Disease recurrence|2
2640495|NCT00789581|9122536|P2|Adjuvant Therapy|Withdrawal by Subject|5
2640496|NCT00789581|9122537|P1|Adjuvant Therapy|Withdrawal by Subject|14
2640497|NCT00789581|9122536|P2|Adjuvant Therapy|Adverse Event|44
2640498|NCT00789581|9122537|P1|Adjuvant Therapy|Adverse Event|20
2640499|NCT00789581|9122536|P2|Adjuvant Therapy|Never treated|2
2640500|NCT00789581|9122537|P1|Adjuvant Therapy|Never treated|2
2640501|NCT00789581|9122536|P2|AC Therapy|Other|2
2640502|NCT00789581|9122537|P1|AC Therapy|Other|0
2640503|NCT00789581|9122536|P2|AC Therapy|Never Treated|4
2640504|NCT00789581|9122537|P1|AC Therapy|Never Treated|1
2640505|NCT00789581|9122536|P2|AC Therapy|Intercurrent Illness|0
2640506|NCT00789581|9122537|P1|AC Therapy|Intercurrent Illness|1
2640507|NCT00789581|9122536|P2|AC Therapy|Disease recurrence|1
2640508|NCT00789581|9122537|P1|AC Therapy|Disease recurrence|3
2640509|NCT00789581|9122536|P2|AC Therapy|Withdrawal by Subject|7
2640510|NCT00789581|9122537|P1|AC Therapy|Withdrawal by Subject|4
2640511|NCT00789581|9122536|P2|AC Therapy|Adverse Event|3
2640512|NCT00789581|9122537|P1|AC Therapy|Adverse Event|2
2640513|NCT00789555|9122548|P3|Overall Study|Protocol Violation|13
2640514|NCT00789555|9122549|P2|Overall Study|Protocol Violation|9
2640515|NCT00789555|9122550|P1|Overall Study|Protocol Violation|6
2640516|NCT00789555|9122548|P3|Overall Study|Treatment failure|12
2640517|NCT00789555|9122549|P2|Overall Study|Treatment failure|8
2640518|NCT00789555|9122550|P1|Overall Study|Treatment failure|11
2640519|NCT00789555|9122548|P3|Overall Study|Patient decision unnrelated to adv event|26
2640520|NCT00789555|9122549|P2|Overall Study|Patient decision unnrelated to adv event|29
2640521|NCT00789555|9122550|P1|Overall Study|Patient decision unnrelated to adv event|38
2640522|NCT00789555|9122548|P3|Overall Study|Lost to Follow-up|18
2640523|NCT00789555|9122549|P2|Overall Study|Lost to Follow-up|10
2640524|NCT00789555|9122550|P1|Overall Study|Lost to Follow-up|9
2640525|NCT00789555|9122548|P3|Overall Study|Adverse Event|10
2640526|NCT00789555|9122549|P2|Overall Study|Adverse Event|7
2640527|NCT00789555|9122550|P1|Overall Study|Adverse Event|17
2640528|NCT00789555|9122548|P3|Overall Study|Protocol Amendment|80
2640529|NCT00789555|9122549|P2|Overall Study|Protocol Amendment|76
2640530|NCT00789555|9122550|P1|Overall Study|Protocol Amendment|78
2640531|NCT00789529|9122575|P2|Overall Study|Other Reason|0
2640532|NCT00789529|9122576|P1|Overall Study|Other Reason|1
2640533|NCT00789529|9122575|P2|Overall Study|Withdrawal by Subject|1
2640534|NCT00789529|9122576|P1|Overall Study|Withdrawal by Subject|0
2640535|NCT00789477|9122589|P5|Overall Study|Other|0
2640536|NCT00789477|9122590|P4|Overall Study|Other|3
2640537|NCT00789477|9122591|P3|Overall Study|Other|1
2640538|NCT00789477|9122592|P2|Overall Study|Other|0
2640539|NCT00789477|9122593|P1|Overall Study|Other|2
2640540|NCT00789477|9122589|P5|Overall Study|Lack of Efficacy|0
2640541|NCT00789477|9122590|P4|Overall Study|Lack of Efficacy|0
2640542|NCT00789477|9122591|P3|Overall Study|Lack of Efficacy|0
2640543|NCT00789477|9122592|P2|Overall Study|Lack of Efficacy|0
2640544|NCT00789477|9122593|P1|Overall Study|Lack of Efficacy|2
2640545|NCT00789477|9122589|P5|Overall Study|Lost to Follow-up|4
2640546|NCT00789477|9122590|P4|Overall Study|Lost to Follow-up|2
2640547|NCT00789477|9122591|P3|Overall Study|Lost to Follow-up|4
2640548|NCT00789477|9122592|P2|Overall Study|Lost to Follow-up|1
2640549|NCT00789477|9122593|P1|Overall Study|Lost to Follow-up|0
2640550|NCT00789477|9122589|P5|Overall Study|Death|0
2640551|NCT00789477|9122590|P4|Overall Study|Death|2
2640552|NCT00789477|9122591|P3|Overall Study|Death|2
2640553|NCT00789477|9122592|P2|Overall Study|Death|1
2640554|NCT00789477|9122593|P1|Overall Study|Death|1
2640555|NCT00789477|9122589|P5|Overall Study|Adverse Event|0
2640556|NCT00789477|9122590|P4|Overall Study|Adverse Event|0
2640557|NCT00789477|9122591|P3|Overall Study|Adverse Event|1
2640558|NCT00789477|9122592|P2|Overall Study|Adverse Event|3
2640559|NCT00789477|9122593|P1|Overall Study|Adverse Event|3
2640560|NCT00789477|9122589|P5|Overall Study|Protocol Violation|0
2640561|NCT00789477|9122590|P4|Overall Study|Protocol Violation|1
2640562|NCT00789477|9122591|P3|Overall Study|Protocol Violation|0
2640563|NCT00789477|9122592|P2|Overall Study|Protocol Violation|0
2640564|NCT00789477|9122593|P1|Overall Study|Protocol Violation|1
2640565|NCT00789477|9122589|P5|Overall Study|Withdrawal by Subject|3
2640566|NCT00789477|9122590|P4|Overall Study|Withdrawal by Subject|2
2640567|NCT00789477|9122591|P3|Overall Study|Withdrawal by Subject|3
2640568|NCT00789477|9122592|P2|Overall Study|Withdrawal by Subject|1
2640569|NCT00789477|9122593|P1|Overall Study|Withdrawal by Subject|2
2640570|NCT00789373|9122638|P3|Maintenance|Participants On-Going at Data Cut-Off|0
2640571|NCT00789373|9122639|P2|Maintenance|Participants On-Going at Data Cut-Off|4
2640572|NCT00789373|9122640|P1|Maintenance|Participants On-Going at Data Cut-Off|0
2640573|NCT00789373|9122638|P3|Maintenance|Sponsor Decision|2
2640574|NCT00789373|9122639|P2|Maintenance|Sponsor Decision|0
2640575|NCT00789373|9122640|P1|Maintenance|Sponsor Decision|0
2640576|NCT00789373|9122638|P3|Maintenance|Withdrawal by Subject|8
2640577|NCT00789373|9122639|P2|Maintenance|Withdrawal by Subject|21
2640578|NCT00789373|9122640|P1|Maintenance|Withdrawal by Subject|0
2640579|NCT00789373|9122638|P3|Maintenance|Progressive Disease|152
2640580|NCT00789373|9122639|P2|Maintenance|Progressive Disease|253
2640581|NCT00789373|9122640|P1|Maintenance|Progressive Disease|0
2640582|NCT00789373|9122638|P3|Maintenance|Lost to Follow-up|0
2640583|NCT00789373|9122639|P2|Maintenance|Lost to Follow-up|2
2640584|NCT00789373|9122640|P1|Maintenance|Lost to Follow-up|0
2640585|NCT00789373|9122638|P3|Maintenance|Protocol entry criteria not met|0
2640586|NCT00789373|9122639|P2|Maintenance|Protocol entry criteria not met|2
2640587|NCT00789373|9122640|P1|Maintenance|Protocol entry criteria not met|0
2640588|NCT00789373|9122638|P3|Maintenance|Investigator Decision|2
2640589|NCT00789373|9122639|P2|Maintenance|Investigator Decision|4
2640590|NCT00789373|9122640|P1|Maintenance|Investigator Decision|0
2640591|NCT00789373|9122638|P3|Maintenance|Death due to toxicity|2
2640592|NCT00789373|9122639|P2|Maintenance|Death due to toxicity|1
2640593|NCT00789373|9122640|P1|Maintenance|Death due to toxicity|0
2640594|NCT00789373|9122638|P3|Maintenance|Death due to adverse event|1
2640595|NCT00789373|9122639|P2|Maintenance|Death due to adverse event|4
2640596|NCT00789373|9122640|P1|Maintenance|Death due to adverse event|0
2640597|NCT00789373|9122638|P3|Maintenance|Death due to study disease|1
2640598|NCT00789373|9122639|P2|Maintenance|Death due to study disease|3
2640599|NCT00789373|9122640|P1|Maintenance|Death due to study disease|0
2640600|NCT00789373|9122638|P3|Maintenance|Adverse Event|12
2640601|NCT00789373|9122639|P2|Maintenance|Adverse Event|65
2640602|NCT00789373|9122640|P1|Maintenance|Adverse Event|0
2640603|NCT00789373|9122638|P3|Induction|Withdrawal by Subject|0
2640604|NCT00789373|9122639|P2|Induction|Withdrawal by Subject|0
2640605|NCT00789373|9122640|P1|Induction|Withdrawal by Subject|37
2640606|NCT00789373|9122638|P3|Induction|Progressive Disease|0
2640607|NCT00789373|9122639|P2|Induction|Progressive Disease|0
2640608|NCT00789373|9122640|P1|Induction|Progressive Disease|220
2640609|NCT00789373|9122638|P3|Induction|Protocol Violation|0
2640610|NCT00789373|9122639|P2|Induction|Protocol Violation|0
2640611|NCT00789373|9122640|P1|Induction|Protocol Violation|1
2640612|NCT00789373|9122638|P3|Induction|Lost to Follow-up|0
2640613|NCT00789373|9122639|P2|Induction|Lost to Follow-up|0
2640614|NCT00789373|9122640|P1|Induction|Lost to Follow-up|6
2640615|NCT00789373|9122638|P3|Induction|Protocol entry criteria not met|0
2640616|NCT00789373|9122639|P2|Induction|Protocol entry criteria not met|0
2640617|NCT00789373|9122640|P1|Induction|Protocol entry criteria not met|9
2640618|NCT00789373|9122638|P3|Induction|Investigator decision|0
2640619|NCT00789373|9122639|P2|Induction|Investigator decision|0
2640620|NCT00789373|9122640|P1|Induction|Investigator decision|7
2640621|NCT00789373|9122638|P3|Induction|Death due to procedure|0
2640622|NCT00789373|9122639|P2|Induction|Death due to procedure|0
2640623|NCT00789373|9122640|P1|Induction|Death due to procedure|1
2640624|NCT00789373|9122638|P3|Induction|Death due to toxicity|0
2640625|NCT00789373|9122639|P2|Induction|Death due to toxicity|0
2640626|NCT00789373|9122640|P1|Induction|Death due to toxicity|11
2640627|NCT00789373|9122638|P3|Induction|Death due to adverse event|0
2640628|NCT00789373|9122639|P2|Induction|Death due to adverse event|0
2640629|NCT00789373|9122640|P1|Induction|Death due to adverse event|19
2640630|NCT00789373|9122638|P3|Induction|Death Due to study disease|0
2640631|NCT00789373|9122639|P2|Induction|Death Due to study disease|0
2640632|NCT00789373|9122640|P1|Induction|Death Due to study disease|24
2640633|NCT00789373|9122638|P3|Induction|Adverse Event|0
2640634|NCT00789373|9122639|P2|Induction|Adverse Event|0
2640635|NCT00789373|9122640|P1|Induction|Adverse Event|64
2640636|NCT00789360|9122667|P2|Overall Study|Protocol Violation|1
2640637|NCT00789360|9122668|P1|Overall Study|Protocol Violation|3
2640638|NCT00789321|9122678|P2|Overall Study|Adverse Event|1
2640639|NCT00789321|9122679|P1|Overall Study|Adverse Event|0
2640640|NCT00789191|9122701|P2|Overall Study|Unclassified|3
2640641|NCT00789191|9122702|P1|Overall Study|Unclassified|5
2640642|NCT00789191|9122701|P2|Overall Study|Withdrawal Criteria|4
2640643|NCT00789191|9122702|P1|Overall Study|Withdrawal Criteria|2
2640644|NCT00789191|9122701|P2|Overall Study|Protocol Violation|3
2640645|NCT00789191|9122702|P1|Overall Study|Protocol Violation|5
2640646|NCT00789191|9122701|P2|Overall Study|Lack of Efficacy|5
2640647|NCT00789191|9122702|P1|Overall Study|Lack of Efficacy|0
2640648|NCT00789191|9122701|P2|Overall Study|Adverse Event|4
2640649|NCT00789191|9122702|P1|Overall Study|Adverse Event|2
2640650|NCT00789035|9122759|P5|Overall Study|Other reason not defined above|1
2640651|NCT00789035|9122760|P4|Overall Study|Other reason not defined above|0
2640652|NCT00789035|9122761|P3|Overall Study|Other reason not defined above|1
2640653|NCT00789035|9122762|P2|Overall Study|Other reason not defined above|3
2640654|NCT00789035|9122763|P1|Overall Study|Other reason not defined above|2
2640655|NCT00789035|9122759|P5|Overall Study|Withdrawal by Subject|0
2640656|NCT00789035|9122760|P4|Overall Study|Withdrawal by Subject|0
2640657|NCT00789035|9122761|P3|Overall Study|Withdrawal by Subject|0
2640658|NCT00789035|9122762|P2|Overall Study|Withdrawal by Subject|2
2640659|NCT00789035|9122763|P1|Overall Study|Withdrawal by Subject|0
2640660|NCT00789035|9122759|P5|Overall Study|Protocol Violation|0
2640661|NCT00789035|9122760|P4|Overall Study|Protocol Violation|0
2640662|NCT00789035|9122761|P3|Overall Study|Protocol Violation|0
2640663|NCT00789035|9122762|P2|Overall Study|Protocol Violation|0
2640664|NCT00789035|9122763|P1|Overall Study|Protocol Violation|1
2640665|NCT00789035|9122759|P5|Overall Study|Lack of Efficacy|2
2640666|NCT00789035|9122760|P4|Overall Study|Lack of Efficacy|0
2640667|NCT00789035|9122761|P3|Overall Study|Lack of Efficacy|0
2640668|NCT00789035|9122762|P2|Overall Study|Lack of Efficacy|0
2640669|NCT00789035|9122763|P1|Overall Study|Lack of Efficacy|3
2640670|NCT00789035|9122759|P5|Overall Study|Adverse Event|3
2640671|NCT00789035|9122760|P4|Overall Study|Adverse Event|1
2640672|NCT00789035|9122761|P3|Overall Study|Adverse Event|0
2640673|NCT00789035|9122762|P2|Overall Study|Adverse Event|2
2640674|NCT00789035|9122763|P1|Overall Study|Adverse Event|0
2640675|NCT00788957|9122822|P6|Part 3|On-study at time of data cut-off|0
2640676|NCT00788957|9122823|P5|Part 3|On-study at time of data cut-off|1
2640677|NCT00788957|9122824|P4|Part 3|On-study at time of data cut-off|0
2640678|NCT00788957|9122825|P3|Part 3|On-study at time of data cut-off|0
2640679|NCT00788957|9122826|P2|Part 3|On-study at time of data cut-off|0
2640680|NCT00788957|9122827|P1|Part 3|On-study at time of data cut-off|0
2640681|NCT00788957|9122822|P6|Part 3|Death|9
2640682|NCT00788957|9122823|P5|Part 3|Death|8
2640683|NCT00788957|9122824|P4|Part 3|Death|0
2640684|NCT00788957|9122825|P3|Part 3|Death|0
2640685|NCT00788957|9122826|P2|Part 3|Death|0
2640686|NCT00788957|9122827|P1|Part 3|Death|0
2640687|NCT00788957|9122822|P6|Part 3|Withdrawal by Subject|2
2640688|NCT00788957|9122823|P5|Part 3|Withdrawal by Subject|0
2640689|NCT00788957|9122824|P4|Part 3|Withdrawal by Subject|0
2640690|NCT00788957|9122825|P3|Part 3|Withdrawal by Subject|0
2640691|NCT00788957|9122826|P2|Part 3|Withdrawal by Subject|0
2640692|NCT00788957|9122827|P1|Part 3|Withdrawal by Subject|0
2640693|NCT00788957|9122822|P6|Part 2|On-study at time of data cut-off|0
2640694|NCT00788957|9122823|P5|Part 2|On-study at time of data cut-off|0
2640695|NCT00788957|9122824|P4|Part 2|On-study at time of data cut-off|1
2640696|NCT00788957|9122825|P3|Part 2|On-study at time of data cut-off|1
2640697|NCT00788957|9122826|P2|Part 2|On-study at time of data cut-off|1
2640698|NCT00788957|9122827|P1|Part 2|On-study at time of data cut-off|0
2640699|NCT00788957|9122822|P6|Part 2|Lost to Follow-up|0
2640700|NCT00788957|9122823|P5|Part 2|Lost to Follow-up|0
2640701|NCT00788957|9122824|P4|Part 2|Lost to Follow-up|0
2640702|NCT00788957|9122825|P3|Part 2|Lost to Follow-up|3
2640703|NCT00788957|9122826|P2|Part 2|Lost to Follow-up|0
2640704|NCT00788957|9122827|P1|Part 2|Lost to Follow-up|0
2640705|NCT00788957|9122822|P6|Part 2|Death|0
2640706|NCT00788957|9122823|P5|Part 2|Death|0
2640707|NCT00788957|9122824|P4|Part 2|Death|37
2640708|NCT00788957|9122825|P3|Part 2|Death|35
2640709|NCT00788957|9122826|P2|Part 2|Death|32
2640710|NCT00788957|9122827|P1|Part 2|Death|0
2640711|NCT00788957|9122822|P6|Part 2|Withdrawal by Subject|0
2640712|NCT00788957|9122823|P5|Part 2|Withdrawal by Subject|0
2640713|NCT00788957|9122824|P4|Part 2|Withdrawal by Subject|3
2640714|NCT00788957|9122825|P3|Part 2|Withdrawal by Subject|5
2640715|NCT00788957|9122826|P2|Part 2|Withdrawal by Subject|9
2640716|NCT00788957|9122827|P1|Part 2|Withdrawal by Subject|0
2640717|NCT00788957|9122822|P6|Part 1|Lost to Follow-up|0
2640718|NCT00788957|9122823|P5|Part 1|Lost to Follow-up|0
2640719|NCT00788957|9122824|P4|Part 1|Lost to Follow-up|0
2640720|NCT00788957|9122825|P3|Part 1|Lost to Follow-up|0
2640721|NCT00788957|9122826|P2|Part 1|Lost to Follow-up|0
2640722|NCT00788957|9122827|P1|Part 1|Lost to Follow-up|1
2640723|NCT00788957|9122822|P6|Part 1|Death|0
2640729|NCT00788827|9122900|P1|Overall Study|Lack of Efficacy|2
2640730|NCT00788775|9122914|P2|Overall Study|Patient's measurable disease resected.|0
2640731|NCT00788775|9122915|P1|Overall Study|Patient's measurable disease resected.|1
2640732|NCT00788775|9122914|P2|Overall Study|Patient Non-Compliance|0
2640733|NCT00788775|9122915|P1|Overall Study|Patient Non-Compliance|1
2640734|NCT00788775|9122914|P2|Overall Study|Withdrawal by Subject|2
2640735|NCT00788775|9122915|P1|Overall Study|Withdrawal by Subject|0
2640736|NCT00788775|9122914|P2|Overall Study|Progressive Disease|6
2640737|NCT00788775|9122915|P1|Overall Study|Progressive Disease|8
2640738|NCT00788710|9122930|P3|Overall Study|Withdrawal by Subject|0
2640739|NCT00788710|9122931|P2|Overall Study|Withdrawal by Subject|2
2640740|NCT00788710|9122932|P1|Overall Study|Withdrawal by Subject|2
2640741|NCT00788710|9122930|P3|Overall Study|Protocol Violation|1
2640742|NCT00788710|9122931|P2|Overall Study|Protocol Violation|1
2640743|NCT00788710|9122932|P1|Overall Study|Protocol Violation|0
2640744|NCT00788710|9122930|P3|Overall Study|Physician Decision|0
2640745|NCT00788710|9122931|P2|Overall Study|Physician Decision|1
2640746|NCT00788710|9122932|P1|Overall Study|Physician Decision|2
2640747|NCT00788710|9122930|P3|Overall Study|Lost to Follow-up|0
2640748|NCT00788710|9122931|P2|Overall Study|Lost to Follow-up|1
2640749|NCT00788710|9122932|P1|Overall Study|Lost to Follow-up|0
2640750|NCT00788710|9122930|P3|Overall Study|Lack of Efficacy|1
2640751|NCT00788710|9122931|P2|Overall Study|Lack of Efficacy|0
2640752|NCT00788710|9122932|P1|Overall Study|Lack of Efficacy|0
2640753|NCT00788710|9122930|P3|Overall Study|Adverse Event|4
2640754|NCT00788710|9122931|P2|Overall Study|Adverse Event|3
2640755|NCT00788710|9122932|P1|Overall Study|Adverse Event|1
2640756|NCT00788697|9122946|P1|Overall Study|Indeterminate diagnosis from truth stand|17
2640757|NCT00788697|9122946|P1|Overall Study|Technically inadequate truth standard|1
2640758|NCT00788697|9122946|P1|Overall Study|no truth standard procedure available|5
2640759|NCT00788697|9122946|P1|Overall Study|Training Patients|74
2640760|NCT00788697|9122946|P1|Overall Study|No study drug administered|12
2640761|NCT00788593|9122993|P3|Second Intervention Period|Other|1
2640762|NCT00788593|9122994|P2|Second Intervention Period|Other|0
2640763|NCT00788593|9122995|P1|Second Intervention Period|Other|0
2640764|NCT00788593|9122993|P3|Second Intervention Period|Lost to Follow-up|0
2640765|NCT00788593|9122994|P2|Second Intervention Period|Lost to Follow-up|1
2640766|NCT00788593|9122995|P1|Second Intervention Period|Lost to Follow-up|0
2640767|NCT00788593|9122993|P3|First Intervention Period|Adverse Event|0
2640768|NCT00788593|9122994|P2|First Intervention Period|Adverse Event|1
2640769|NCT00788593|9122995|P1|First Intervention Period|Adverse Event|0
2640770|NCT00788593|9122993|P3|Placebo Run-in Phase|Protocol Violation|0
2640771|NCT00788593|9122994|P2|Placebo Run-in Phase|Protocol Violation|0
2640772|NCT00788593|9122995|P1|Placebo Run-in Phase|Protocol Violation|2
2640773|NCT00788593|9122993|P3|Placebo Run-in Phase|Withdrawal by Subject|0
2640774|NCT00788593|9122994|P2|Placebo Run-in Phase|Withdrawal by Subject|0
2640775|NCT00788593|9122995|P1|Placebo Run-in Phase|Withdrawal by Subject|2
2640776|NCT00788593|9122993|P3|Placebo Run-in Phase|Adverse Event|0
2640777|NCT00788593|9122994|P2|Placebo Run-in Phase|Adverse Event|0
2640778|NCT00788593|9122995|P1|Placebo Run-in Phase|Adverse Event|2
2640779|NCT00788372|9123012|P1|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1
2640780|NCT00788372|9123012|P1|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9
2640781|NCT00788372|9123012|P1|Period 2 (Week 4 to Week 52)|Physician Decision|9
2640782|NCT00788372|9123012|P1|Period 2 (Week 4 to Week 52)|Adverse Event|13
2640783|NCT00788372|9123012|P1|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4
2640784|NCT00788372|9123012|P1|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9
2640785|NCT00788372|9123012|P1|Period 1 (up to 4 Weeks)|Adverse Event|18
2640786|NCT00788151|9123041|P2|Overall Study|Enrolled but not treated|1
2640787|NCT00788151|9123042|P1|Overall Study|Enrolled but not treated|1
2640788|NCT00788151|9123041|P2|Overall Study|Withdrawal by Subject|6
2640789|NCT00788151|9123042|P1|Overall Study|Withdrawal by Subject|13
2640790|NCT00788151|9123041|P2|Overall Study|Protocol Violation|1
2640791|NCT00788151|9123042|P1|Overall Study|Protocol Violation|0
2640792|NCT00788151|9123041|P2|Overall Study|Other adverse event|2
2640793|NCT00788151|9123042|P1|Overall Study|Other adverse event|0
2640794|NCT00788073|9123086|P2|Placebo Then STX209|Protocol Violation|1
2640795|NCT00788073|9123087|P1|Placebo Then STX209|Protocol Violation|0
2640796|NCT00788073|9123086|P2|Placebo Then STX209|Adverse Event|0
2640797|NCT00788073|9123087|P1|Placebo Then STX209|Adverse Event|2
2640798|NCT00788073|9123086|P2|STX209 Then Placebo|unable to return due to travel|1
2640799|NCT00788073|9123087|P1|STX209 Then Placebo|unable to return due to travel|0
2640800|NCT00788073|9123086|P2|STX209 Then Placebo|Withdrawal by Subject|1
2640801|NCT00788073|9123087|P1|STX209 Then Placebo|Withdrawal by Subject|0
2640802|NCT00788073|9123086|P2|STX209 Then Placebo|Lost to Follow-up|1
2640803|NCT00788073|9123087|P1|STX209 Then Placebo|Lost to Follow-up|0
2640804|NCT00788073|9123086|P2|STX209 Then Placebo|Adverse Event|0
2640805|NCT00788073|9123087|P1|STX209 Then Placebo|Adverse Event|1
2640806|NCT00787930|9123112|P1|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3
2640807|NCT00787917|9123127|P2|Open Label|Administrative problems|0
2640808|NCT00787917|9123128|P1|Open Label|Administrative problems|3
2640809|NCT00787917|9123127|P2|Open Label|Unsatisfactory therapeutic effect|0
2640810|NCT00787917|9123128|P1|Open Label|Unsatisfactory therapeutic effect|1
2640811|NCT00787917|9123127|P2|Blinded Treatment|Administrative problems|2
2640812|NCT00787917|9123128|P1|Blinded Treatment|Administrative problems|3
2640813|NCT00787917|9123127|P2|Blinded Treatment|Lack of Efficacy|0
2640814|NCT00787917|9123128|P1|Blinded Treatment|Lack of Efficacy|1
2640815|NCT00787917|9123127|P2|Blinded Treatment|Adverse Event|0
2640816|NCT00787917|9123128|P1|Blinded Treatment|Adverse Event|1
2640817|NCT00787891|9123158|P2|Maintenance Double-blind Phase (Part 2)|Other|2
2640818|NCT00787891|9123159|P1|Maintenance Double-blind Phase (Part 2)|Other|5
2640819|NCT00787891|9123158|P2|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3
2640820|NCT00787891|9123159|P1|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1
2640821|NCT00787891|9123158|P2|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
2640822|NCT00787891|9123159|P1|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
2640823|NCT00787891|9123158|P2|Maintenance Double-blind Phase (Part 2)|Adverse Event|1
2640824|NCT00787891|9123159|P1|Maintenance Double-blind Phase (Part 2)|Adverse Event|0
2640825|NCT00787891|9123158|P2|Short-term Double-blind Phase (Part 1)|Other|2
2640826|NCT00787891|9123159|P1|Short-term Double-blind Phase (Part 1)|Other|0
2640827|NCT00787891|9123158|P2|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2
2640828|NCT00787891|9123159|P1|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6
2640829|NCT00787891|9123158|P2|Short-term Double-blind Phase (Part 1)|Physician Decision|0
2640830|NCT00787891|9123159|P1|Short-term Double-blind Phase (Part 1)|Physician Decision|1
2640831|NCT00787891|9123158|P2|Short-term Double-blind Phase (Part 1)|Protocol Violation|1
2640832|NCT00787891|9123159|P1|Short-term Double-blind Phase (Part 1)|Protocol Violation|0
2640833|NCT00787891|9123158|P2|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
2640834|NCT00787891|9123159|P1|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
2640835|NCT00787891|9123158|P2|Short-term Double-blind Phase (Part 1)|Adverse Event|2
2640836|NCT00787891|9123159|P1|Short-term Double-blind Phase (Part 1)|Adverse Event|1
2640837|NCT00787839|9123186|P1|Overall Study|Failure to have the OGTT was most common|404
2640838|NCT00787800|9123209|P2|Overall Study|Death|2
2640839|NCT00787800|9123210|P1|Overall Study|Death|0
2640840|NCT00787800|9123209|P2|Overall Study|Withdrawal by Subject|5
2640841|NCT00787800|9123210|P1|Overall Study|Withdrawal by Subject|3
2640842|NCT00787787|9123226|P1|Overall Study|Adverse Event|3
2640843|NCT00787787|9123226|P1|Overall Study|Lack of Efficacy|4
2640844|NCT00787644|9123254|P2|Overall Study|Withdrawal by Subject|1
2640845|NCT00787644|9123255|P1|Overall Study|Withdrawal by Subject|1
2640846|NCT00787644|9123254|P2|Overall Study|Lost to Follow-up|1
2640847|NCT00787644|9123255|P1|Overall Study|Lost to Follow-up|1
2640848|NCT00787605|9123276|P2|Overall Study|Lack of Efficacy|9
2640849|NCT00787605|9123277|P1|Overall Study|Lack of Efficacy|13
2640850|NCT00787605|9123276|P2|Overall Study|Withdrawal by Subject|13
2640851|NCT00787605|9123277|P1|Overall Study|Withdrawal by Subject|6
2640852|NCT00787605|9123276|P2|Overall Study|Protocol Violation|3
2640853|NCT00787605|9123277|P1|Overall Study|Protocol Violation|7
2640854|NCT00787605|9123276|P2|Overall Study|Lost to Follow-up|6
2640855|NCT00787605|9123277|P1|Overall Study|Lost to Follow-up|3
2640856|NCT00787605|9123276|P2|Overall Study|Adverse Event|25
2640857|NCT00787605|9123277|P1|Overall Study|Adverse Event|14
2640858|NCT00787605|9123276|P2|Overall Study|Administrative Problems|0
2640859|NCT00787605|9123277|P1|Overall Study|Administrative Problems|3
2640860|NCT00787566|9123296|P3|Overall Study|AE related to chemotherapy|0
2640861|NCT00787566|9123297|P2|Overall Study|AE related to chemotherapy|1
2640862|NCT00787566|9123298|P1|Overall Study|AE related to chemotherapy|0
2640863|NCT00787527|9123306|P1|Overall Study|Toxicity|3
2640864|NCT00787319|9123323|P1|Overall Study|Inactive disease|5
2640865|NCT00787319|9123323|P1|Overall Study|Stabilized disease findings|3
2640866|NCT00787319|9123323|P1|Overall Study|No health insurance reimbursement|2
2640867|NCT00787319|9123323|P1|Overall Study|Unresponsiveness to visit invitation|1
2640868|NCT00787319|9123323|P1|Overall Study|Budget exhausted/exceeded|1
2640869|NCT00787319|9123323|P1|Overall Study|Lack of Efficacy|1
2640870|NCT00787319|9123323|P1|Overall Study|Objective progression or relapse|30
2640871|NCT00787319|9123323|P1|Overall Study|Adverse Event|3
2640872|NCT00787319|9123323|P1|Overall Study|Withdrawal by Subject|15
2640873|NCT00787319|9123323|P1|Overall Study|Lost to Follow-up|2
2640874|NCT00787267|9123335|P1|Overall Study|Withdrawal by Subject|1
2640875|NCT00787267|9123335|P1|Overall Study|No Reason Provided|1
2640876|NCT00787267|9123335|P1|Overall Study|Screen failure/Ineligible|10
2640877|NCT00787254|9123345|P2|Overall Study|Physician Decision|8
2640878|NCT00787254|9123346|P1|Overall Study|Physician Decision|4
2640879|NCT00787254|9123345|P2|Overall Study|Institution closed|0
2640880|NCT00787254|9123346|P1|Overall Study|Institution closed|1
2640881|NCT00787254|9123345|P2|Overall Study|NSAIDs discontinuation|2
2640882|NCT00787254|9123346|P1|Overall Study|NSAIDs discontinuation|1
2640883|NCT00787254|9123345|P2|Overall Study|Lack of Efficacy|15
2640884|NCT00787254|9123346|P1|Overall Study|Lack of Efficacy|4
2640885|NCT00787254|9123345|P2|Overall Study|Withdrawal by Subject|11
2640886|NCT00787254|9123346|P1|Overall Study|Withdrawal by Subject|16
2640887|NCT00787254|9123345|P2|Overall Study|Protocol Violation|23
2640888|NCT00787254|9123346|P1|Overall Study|Protocol Violation|26
2640889|NCT00787254|9123345|P2|Overall Study|Adverse Event|23
2640890|NCT00787254|9123346|P1|Overall Study|Adverse Event|24
2640891|NCT00787202|9123470|P5|Overall Study|Randomized, not treated|0
2640892|NCT00787202|9123471|P4|Overall Study|Randomized, not treated|0
2640893|NCT00787202|9123472|P3|Overall Study|Randomized, not treated|0
2640894|NCT00787202|9123473|P2|Overall Study|Randomized, not treated|0
2640895|NCT00787202|9123474|P1|Overall Study|Randomized, not treated|1
2640896|NCT00787202|9123470|P5|Overall Study|Protocol Violation|1
2640897|NCT00787202|9123471|P4|Overall Study|Protocol Violation|0
2640898|NCT00787202|9123472|P3|Overall Study|Protocol Violation|0
2640899|NCT00787202|9123473|P2|Overall Study|Protocol Violation|1
2640900|NCT00787202|9123474|P1|Overall Study|Protocol Violation|2
2640901|NCT00787202|9123470|P5|Overall Study|Withdrawal by Subject|0
2640902|NCT00787202|9123471|P4|Overall Study|Withdrawal by Subject|0
2640903|NCT00787202|9123472|P3|Overall Study|Withdrawal by Subject|2
2640904|NCT00787202|9123473|P2|Overall Study|Withdrawal by Subject|2
2640905|NCT00787202|9123474|P1|Overall Study|Withdrawal by Subject|2
2640906|NCT00787202|9123470|P5|Overall Study|Lost to Follow-up|0
2640907|NCT00787202|9123471|P4|Overall Study|Lost to Follow-up|0
2640908|NCT00787202|9123472|P3|Overall Study|Lost to Follow-up|0
2640909|NCT00787202|9123473|P2|Overall Study|Lost to Follow-up|0
2640910|NCT00787202|9123474|P1|Overall Study|Lost to Follow-up|1
2640911|NCT00787202|9123470|P5|Overall Study|Lack of Efficacy|1
2640912|NCT00787202|9123471|P4|Overall Study|Lack of Efficacy|2
2640913|NCT00787202|9123472|P3|Overall Study|Lack of Efficacy|5
2640914|NCT00787202|9123473|P2|Overall Study|Lack of Efficacy|6
2640915|NCT00787202|9123474|P1|Overall Study|Lack of Efficacy|5
2640916|NCT00787202|9123470|P5|Overall Study|Adverse Event|2
2640917|NCT00787202|9123471|P4|Overall Study|Adverse Event|0
2640918|NCT00787202|9123472|P3|Overall Study|Adverse Event|0
2640919|NCT00787202|9123473|P2|Overall Study|Adverse Event|2
2640920|NCT00787202|9123474|P1|Overall Study|Adverse Event|3
2640921|NCT00787189|9123527|P2|Overall Study|Lost to Follow-up|2
2640922|NCT00787189|9123528|P1|Overall Study|Lost to Follow-up|2
2640923|NCT00787150|9123537|P3|Overall Study|Dosing incorrect study durg|0
2640924|NCT00787150|9123538|P2|Overall Study|Dosing incorrect study durg|0
2640925|NCT00787150|9123539|P1|Overall Study|Dosing incorrect study durg|2
2640926|NCT00787150|9123537|P3|Overall Study|Withdrawal by Subject|0
2640927|NCT00787150|9123538|P2|Overall Study|Withdrawal by Subject|1
2640928|NCT00787150|9123539|P1|Overall Study|Withdrawal by Subject|2
2640929|NCT00787150|9123537|P3|Overall Study|Physician Decision|1
2640930|NCT00787150|9123538|P2|Overall Study|Physician Decision|2
2640931|NCT00787150|9123539|P1|Overall Study|Physician Decision|1
2640932|NCT00787150|9123537|P3|Overall Study|Adverse Event|4
2640933|NCT00787150|9123538|P2|Overall Study|Adverse Event|4
2640934|NCT00787150|9123539|P1|Overall Study|Adverse Event|4
2640935|NCT00787137|9123584|P3|Overall Study|Study Termination|1
2640936|NCT00787137|9123585|P2|Overall Study|Study Termination|0
2640937|NCT00787137|9123586|P1|Overall Study|Study Termination|0
2640938|NCT00786864|9123661|P2|Overall Study|Sustained serious back injury|0
2640939|NCT00786864|9123662|P1|Overall Study|Sustained serious back injury|1
2640940|NCT00786864|9123661|P2|Overall Study|Lost to Follow-up|1
2640941|NCT00786864|9123662|P1|Overall Study|Lost to Follow-up|0
2640942|NCT00786838|9123674|P1|Overall Study|Withdrawal by Subject|4
2640943|NCT00786838|9123674|P1|Overall Study|Progressive disease|31
2640944|NCT00786838|9123674|P1|Overall Study|Adverse Event|6
2640945|NCT00786838|9123674|P1|Overall Study|Death|4
2640946|NCT00786838|9123674|P1|Overall Study|Physician Decision|4
2640947|NCT00786799|9123710|P2|Overall Study|Lost to Follow-up|1
2640948|NCT00786799|9123711|P1|Overall Study|Lost to Follow-up|1
2640949|NCT00786565|9123741|P1|Post Surgery|Adapt AO implanted posterior side up|1
2640950|NCT00786565|9123741|P1|Post Surgery|Abnormal macular pucker|1
2640951|NCT00786565|9123741|P1|Enrollment Prior to Surgery|Protocol Violation|3
2640952|NCT00786565|9123741|P1|Enrollment Prior to Surgery|Site Closed|3
2640953|NCT00786474|9123798|P2|Overall Study|Other|4
2640954|NCT00786474|9123799|P1|Overall Study|Other|4
2640955|NCT00786474|9123798|P2|Overall Study|Physician Decision|1
2640956|NCT00786474|9123799|P1|Overall Study|Physician Decision|2
2640957|NCT00786474|9123798|P2|Overall Study|Lost to Follow-up|3
2640958|NCT00786474|9123799|P1|Overall Study|Lost to Follow-up|3
2640959|NCT00786474|9123798|P2|Overall Study|Withdrawal by Subject|31
2640960|NCT00786474|9123799|P1|Overall Study|Withdrawal by Subject|23
2640961|NCT00786474|9123798|P2|Overall Study|Death|4
2640962|NCT00786474|9123799|P1|Overall Study|Death|5
2640963|NCT00786422|9123811|P1|Follow-up Period|End-of-study done up to 4 days early|2
2640964|NCT00786422|9123811|P1|Follow-up Period|Death|1
2640965|NCT00786422|9123811|P1|Rivaroxaban Treatment|Adverse Event|2
2640966|NCT00786422|9123811|P1|Rivaroxaban Treatment|Non-compliance with study drug treatment|1
2640967|NCT00786422|9123811|P1|Rivaroxaban Treatment|Withdrawal by Subject|1
2640968|NCT00786422|9123811|P1|Rivaroxaban Treatment|Physician Decision|1
2640969|NCT00786422|9123811|P1|Rivaroxaban Treatment|Lack of Efficacy|1
2640970|NCT00786422|9123811|P1|Rivaroxaban Treatment|Final visit earlier than planned|3
2640971|NCT00786422|9123811|P1|Rivaroxaban Treatment|Death|2
2640972|NCT00786409|9123827|P1|Overall Study|Lost to Follow-up|1
2640973|NCT00786409|9123827|P1|Overall Study|Pregnancy|2
2640974|NCT00786409|9123827|P1|Overall Study|Adverse Event|2
2640975|NCT00786409|9123827|P1|Overall Study|Withdrawal by Subject|2
2640976|NCT00786188|9123844|P2|Overall Study|Withdrawal by Subject|0
2640977|NCT00786188|9123845|P1|Overall Study|Withdrawal by Subject|2
2640978|NCT00786188|9123844|P2|Overall Study|Adverse Event|1
2640979|NCT00786188|9123845|P1|Overall Study|Adverse Event|3
2640980|NCT00786032|9123871|P1|Overall Study|Did not complete in the timeframe|6
2640981|NCT00786032|9123871|P1|Overall Study|Withdrawal by Subject|14
2640982|NCT00786032|9123871|P1|Overall Study|Death|4
2640983|NCT00785980|9123892|P1|7 Day Washout Period|Protocol Violation|3
2640984|NCT00785928|9123910|P7|Treatment Phase|Withdrawal by Subject|0
2640985|NCT00785928|9123911|P6|Treatment Phase|Withdrawal by Subject|0
2640986|NCT00785928|9123912|P5|Treatment Phase|Withdrawal by Subject|1
2640987|NCT00785928|9123913|P4|Treatment Phase|Withdrawal by Subject|0
2640988|NCT00785928|9123914|P3|Treatment Phase|Withdrawal by Subject|0
2640989|NCT00785928|9123915|P2|Treatment Phase|Withdrawal by Subject|2
2640990|NCT00785928|9123916|P1|Treatment Phase|Withdrawal by Subject|1
2640991|NCT00785928|9123910|P7|Treatment Phase|Sponsor Decision|1
2640992|NCT00785928|9123911|P6|Treatment Phase|Sponsor Decision|0
2640993|NCT00785928|9123912|P5|Treatment Phase|Sponsor Decision|0
2640994|NCT00785928|9123913|P4|Treatment Phase|Sponsor Decision|0
2640995|NCT00785928|9123914|P3|Treatment Phase|Sponsor Decision|0
2640996|NCT00785928|9123915|P2|Treatment Phase|Sponsor Decision|0
2640997|NCT00785928|9123916|P1|Treatment Phase|Sponsor Decision|1
2640998|NCT00785928|9123910|P7|Treatment Phase|Physician Decision|0
2640999|NCT00785928|9123911|P6|Treatment Phase|Physician Decision|0
2641000|NCT00785928|9123912|P5|Treatment Phase|Physician Decision|1
2641001|NCT00785928|9123913|P4|Treatment Phase|Physician Decision|0
2641002|NCT00785928|9123914|P3|Treatment Phase|Physician Decision|0
2641003|NCT00785928|9123915|P2|Treatment Phase|Physician Decision|0
2641004|NCT00785928|9123916|P1|Treatment Phase|Physician Decision|0
2641005|NCT00785928|9123910|P7|Treatment Phase|Lack of Efficacy|0
2641006|NCT00785928|9123911|P6|Treatment Phase|Lack of Efficacy|0
2641007|NCT00785928|9123912|P5|Treatment Phase|Lack of Efficacy|0
2641008|NCT00785928|9123913|P4|Treatment Phase|Lack of Efficacy|0
2641009|NCT00785928|9123914|P3|Treatment Phase|Lack of Efficacy|1
2641010|NCT00785928|9123915|P2|Treatment Phase|Lack of Efficacy|1
2641011|NCT00785928|9123916|P1|Treatment Phase|Lack of Efficacy|0
2641012|NCT00785928|9123910|P7|Treatment Phase|Inadequate Response|0
2641013|NCT00785928|9123911|P6|Treatment Phase|Inadequate Response|0
2641014|NCT00785928|9123912|P5|Treatment Phase|Inadequate Response|0
2641015|NCT00785928|9123913|P4|Treatment Phase|Inadequate Response|0
2641016|NCT00785928|9123914|P3|Treatment Phase|Inadequate Response|0
2641017|NCT00785928|9123915|P2|Treatment Phase|Inadequate Response|1
2641018|NCT00785928|9123916|P1|Treatment Phase|Inadequate Response|0
2641019|NCT00785928|9123910|P7|Treatment Phase|Adverse Event|2
2641020|NCT00785928|9123911|P6|Treatment Phase|Adverse Event|0
2641021|NCT00785928|9123912|P5|Treatment Phase|Adverse Event|0
2641022|NCT00785928|9123913|P4|Treatment Phase|Adverse Event|0
2641023|NCT00785928|9123914|P3|Treatment Phase|Adverse Event|2
2641024|NCT00785928|9123915|P2|Treatment Phase|Adverse Event|1
2641025|NCT00785928|9123916|P1|Treatment Phase|Adverse Event|1
2641026|NCT00785785|9124063|P2|Optional Extension Phase|Study terminated by sponsor|37
2641027|NCT00785785|9124064|P1|Optional Extension Phase|Study terminated by sponsor|3
2641028|NCT00785785|9124063|P2|Optional Extension Phase|Protocol deviation|2
2641029|NCT00785785|9124064|P1|Optional Extension Phase|Protocol deviation|0
2641030|NCT00785785|9124063|P2|Optional Extension Phase|Disease progression|70
2641031|NCT00785785|9124064|P1|Optional Extension Phase|Disease progression|22
2641032|NCT00785785|9124063|P2|Optional Extension Phase|Death|5
2641033|NCT00785785|9124064|P1|Optional Extension Phase|Death|1
2641034|NCT00785785|9124063|P2|Optional Extension Phase|Administrative problems|0
2641035|NCT00785785|9124064|P1|Optional Extension Phase|Administrative problems|2
2641036|NCT00785785|9124063|P2|Optional Extension Phase|Lost to Follow-up|0
2641037|NCT00785785|9124064|P1|Optional Extension Phase|Lost to Follow-up|1
2641038|NCT00785785|9124063|P2|Optional Extension Phase|Withdrawal by Subject|6
2641039|NCT00785785|9124064|P1|Optional Extension Phase|Withdrawal by Subject|6
2641040|NCT00785785|9124063|P2|Optional Extension Phase|Adverse Event|5
2641041|NCT00785785|9124064|P1|Optional Extension Phase|Adverse Event|4
2641042|NCT00785785|9124063|P2|Core Phase up to 36 Months|Study terminated by sponsor|133
2641043|NCT00785785|9124064|P1|Core Phase up to 36 Months|Study terminated by sponsor|116
2641044|NCT00785785|9124063|P2|Core Phase up to 36 Months|Protocol deviation|6
2641045|NCT00785785|9124064|P1|Core Phase up to 36 Months|Protocol deviation|5
2641046|NCT00785785|9124063|P2|Core Phase up to 36 Months|Disease progression|119
2641047|NCT00785785|9124064|P1|Core Phase up to 36 Months|Disease progression|139
2641048|NCT00785785|9124063|P2|Core Phase up to 36 Months|Death|8
2641049|NCT00785785|9124064|P1|Core Phase up to 36 Months|Death|5
2641050|NCT00785785|9124063|P2|Core Phase up to 36 Months|Administrative problems|3
2641051|NCT00785785|9124064|P1|Core Phase up to 36 Months|Administrative problems|3
2641052|NCT00785785|9124063|P2|Core Phase up to 36 Months|Lost to Follow-up|7
2641053|NCT00785785|9124064|P1|Core Phase up to 36 Months|Lost to Follow-up|3
2641054|NCT00785785|9124063|P2|Core Phase up to 36 Months|Withdrawal by Subject|17
2641055|NCT00785785|9124064|P1|Core Phase up to 36 Months|Withdrawal by Subject|16
2641056|NCT00785785|9124063|P2|Core Phase up to 36 Months|Abnormal test procedure result|2
2641057|NCT00785785|9124064|P1|Core Phase up to 36 Months|Abnormal test procedure result|2
2641058|NCT00785785|9124063|P2|Core Phase up to 36 Months|Abnormal laboratory value|0
2641059|NCT00785785|9124064|P1|Core Phase up to 36 Months|Abnormal laboratory value|1
2641060|NCT00785785|9124063|P2|Core Phase up to 36 Months|Adverse Event|21
2641061|NCT00785785|9124064|P1|Core Phase up to 36 Months|Adverse Event|31
2641062|NCT00785785|9124063|P2|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4
2641063|NCT00785785|9124064|P1|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3
2641064|NCT00785707|9124078|P1|Overall Study|Lost to Follow-up|7
2641065|NCT00785629|9124087|P4|Overall Study|Withdrawal by Subject|2
2641066|NCT00785629|9124088|P3|Overall Study|Withdrawal by Subject|2
2641067|NCT00785629|9124089|P2|Overall Study|Withdrawal by Subject|1
2641068|NCT00785629|9124090|P1|Overall Study|Withdrawal by Subject|0
2641069|NCT00785629|9124087|P4|Overall Study|administrative decision|4
2641070|NCT00785629|9124088|P3|Overall Study|administrative decision|3
2641071|NCT00785629|9124089|P2|Overall Study|administrative decision|1
2641072|NCT00785629|9124090|P1|Overall Study|administrative decision|5
2641073|NCT00785629|9124087|P4|Overall Study|Protocol Violation|5
2641074|NCT00785629|9124088|P3|Overall Study|Protocol Violation|4
2641075|NCT00785629|9124089|P2|Overall Study|Protocol Violation|2
2641076|NCT00785629|9124090|P1|Overall Study|Protocol Violation|1
2641077|NCT00785629|9124087|P4|Overall Study|Adverse Event|5
2641078|NCT00785629|9124088|P3|Overall Study|Adverse Event|1
2641079|NCT00785629|9124089|P2|Overall Study|Adverse Event|1
2641080|NCT00785629|9124090|P1|Overall Study|Adverse Event|2
2641081|NCT00785577|9124103|P5|Study Period 3: 1-Week Washout Phase|Death|1
2641082|NCT00785577|9124104|P4|Study Period 3: 1-Week Washout Phase|Death|0
2641083|NCT00785577|9124105|P3|Study Period 3: 1-Week Washout Phase|Death|0
2641084|NCT00785577|9124106|P2|Study Period 3: 1-Week Washout Phase|Death|0
2641085|NCT00785577|9124107|P1|Study Period 3: 1-Week Washout Phase|Death|0
2641086|NCT00785577|9124103|P5|Study Period 3: 1-Week Washout Phase|Adverse Event|0
2641087|NCT00785577|9124104|P4|Study Period 3: 1-Week Washout Phase|Adverse Event|1
2641088|NCT00785577|9124105|P3|Study Period 3: 1-Week Washout Phase|Adverse Event|0
2641089|NCT00785577|9124106|P2|Study Period 3: 1-Week Washout Phase|Adverse Event|0
2641090|NCT00785577|9124107|P1|Study Period 3: 1-Week Washout Phase|Adverse Event|0
2641091|NCT00785577|9124103|P5|Study Period 2: Therapy Phase|Sponsor Decision|0
2641092|NCT00785577|9124104|P4|Study Period 2: Therapy Phase|Sponsor Decision|1
2641093|NCT00785577|9124105|P3|Study Period 2: Therapy Phase|Sponsor Decision|1
2641094|NCT00785577|9124106|P2|Study Period 2: Therapy Phase|Sponsor Decision|0
2641095|NCT00785577|9124107|P1|Study Period 2: Therapy Phase|Sponsor Decision|1
2641096|NCT00785577|9124103|P5|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
2641097|NCT00785577|9124104|P4|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
2641098|NCT00785577|9124105|P3|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
2641099|NCT00785577|9124106|P2|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
2641100|NCT00785577|9124107|P1|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
2641101|NCT00785577|9124103|P5|Study Period 2: Therapy Phase|Withdrawal by Subject|1
2641102|NCT00785577|9124104|P4|Study Period 2: Therapy Phase|Withdrawal by Subject|0
2641103|NCT00785577|9124105|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|1
2641104|NCT00785577|9124106|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|1
2641105|NCT00785577|9124107|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|2
2641106|NCT00785577|9124103|P5|Study Period 2: Therapy Phase|Protocol Violation|1
2641107|NCT00785577|9124104|P4|Study Period 2: Therapy Phase|Protocol Violation|0
2641108|NCT00785577|9124105|P3|Study Period 2: Therapy Phase|Protocol Violation|1
2641109|NCT00785577|9124106|P2|Study Period 2: Therapy Phase|Protocol Violation|1
2641110|NCT00785577|9124107|P1|Study Period 2: Therapy Phase|Protocol Violation|1
2641111|NCT00785577|9124103|P5|Study Period 2: Therapy Phase|Physician Decision|0
2641112|NCT00785577|9124104|P4|Study Period 2: Therapy Phase|Physician Decision|0
2641113|NCT00785577|9124105|P3|Study Period 2: Therapy Phase|Physician Decision|0
2641114|NCT00785577|9124106|P2|Study Period 2: Therapy Phase|Physician Decision|0
2641115|NCT00785577|9124107|P1|Study Period 2: Therapy Phase|Physician Decision|1
2641116|NCT00785577|9124103|P5|Study Period 2: Therapy Phase|Lost to Follow-up|0
2641117|NCT00785577|9124104|P4|Study Period 2: Therapy Phase|Lost to Follow-up|1
2641118|NCT00785577|9124105|P3|Study Period 2: Therapy Phase|Lost to Follow-up|0
2641119|NCT00785577|9124106|P2|Study Period 2: Therapy Phase|Lost to Follow-up|0
2641120|NCT00785577|9124107|P1|Study Period 2: Therapy Phase|Lost to Follow-up|0
2641121|NCT00785577|9124103|P5|Study Period 2: Therapy Phase|Lack of Efficacy|1
2641122|NCT00785577|9124104|P4|Study Period 2: Therapy Phase|Lack of Efficacy|0
2641123|NCT00785577|9124105|P3|Study Period 2: Therapy Phase|Lack of Efficacy|0
2641124|NCT00785577|9124106|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
2641125|NCT00785577|9124107|P1|Study Period 2: Therapy Phase|Lack of Efficacy|0
2641126|NCT00785577|9124103|P5|Study Period 2: Therapy Phase|Adverse Event|17
2641127|NCT00785577|9124104|P4|Study Period 2: Therapy Phase|Adverse Event|10
2641128|NCT00785577|9124105|P3|Study Period 2: Therapy Phase|Adverse Event|14
2641129|NCT00785577|9124106|P2|Study Period 2: Therapy Phase|Adverse Event|7
2641130|NCT00785577|9124107|P1|Study Period 2: Therapy Phase|Adverse Event|5
2641131|NCT00785538|9124247|P4|Treatment Period|Withdrawal by Subject|1
2641132|NCT00785538|9124248|P3|Treatment Period|Withdrawal by Subject|0
2641133|NCT00785538|9124249|P2|Treatment Period|Withdrawal by Subject|0
2641134|NCT00785538|9124250|P1|Treatment Period|Withdrawal by Subject|0
2641135|NCT00785538|9124247|P4|Treatment Period|Adverse Event|0
2641136|NCT00785538|9124248|P3|Treatment Period|Adverse Event|2
2641137|NCT00785538|9124249|P2|Treatment Period|Adverse Event|2
2641138|NCT00785538|9124250|P1|Treatment Period|Adverse Event|1
2641139|NCT00785512|9124298|P2|Overall Study|Lack of compliance|1
2641140|NCT00785512|9124299|P1|Overall Study|Lack of compliance|0
2641141|NCT00785512|9124298|P2|Overall Study|Physician Decision|0
2641142|NCT00785512|9124299|P1|Overall Study|Physician Decision|0
2641143|NCT00785512|9124298|P2|Overall Study|IVRS Programing Error|0
2641144|NCT00785512|9124299|P1|Overall Study|IVRS Programing Error|0
2641145|NCT00785512|9124298|P2|Overall Study|Precedure Refused|0
2641146|NCT00785512|9124299|P1|Overall Study|Precedure Refused|0
2641147|NCT00785512|9124298|P2|Overall Study|Lost to Follow-up|0
2641148|NCT00785512|9124299|P1|Overall Study|Lost to Follow-up|3
2641149|NCT00785512|9124298|P2|Overall Study|Withdrawal by Subject|1
2641150|NCT00785512|9124299|P1|Overall Study|Withdrawal by Subject|0
2641151|NCT00785512|9124298|P2|Overall Study|Lack of Efficacy|2
2641152|NCT00785512|9124299|P1|Overall Study|Lack of Efficacy|0
2641153|NCT00785512|9124298|P2|Overall Study|Adverse Event|0
2641154|NCT00785512|9124299|P1|Overall Study|Adverse Event|0
2641155|NCT00785512|9124298|P2|Overall Study|Inclusion/Exclusion not meet|0
2641156|NCT00785512|9124299|P1|Overall Study|Inclusion/Exclusion not meet|0
2641157|NCT00785486|9124308|P1|Midazolam Alone|Withdrawal by Subject|1
2641158|NCT00785356|9124332|P1|Overall Study|Study prematurely terminated|8
2641159|NCT00785291|9124343|P3|Overall Study|Other Medical Reasons|15
2641160|NCT00785291|9124344|P2|Overall Study|Other Medical Reasons|25
2641161|NCT00785291|9124345|P1|Overall Study|Other Medical Reasons|29
2641162|NCT00785291|9124343|P3|Overall Study|Complicating illness|4
2641163|NCT00785291|9124344|P2|Overall Study|Complicating illness|4
2641164|NCT00785291|9124345|P1|Overall Study|Complicating illness|6
2641165|NCT00785291|9124343|P3|Overall Study|Alternative Therapy|7
2641166|NCT00785291|9124344|P2|Overall Study|Alternative Therapy|6
2641167|NCT00785291|9124345|P1|Overall Study|Alternative Therapy|12
2641168|NCT00785291|9124343|P3|Overall Study|Withdrawal by Subject|17
2641169|NCT00785291|9124344|P2|Overall Study|Withdrawal by Subject|36
2641170|NCT00785291|9124345|P1|Overall Study|Withdrawal by Subject|35
2641171|NCT00785291|9124343|P3|Overall Study|Death|3
2641172|NCT00785291|9124344|P2|Overall Study|Death|4
2641173|NCT00785291|9124345|P1|Overall Study|Death|7
2641174|NCT00785291|9124343|P3|Overall Study|Adverse Event|56
2641175|NCT00785291|9124344|P2|Overall Study|Adverse Event|70
2641176|NCT00785291|9124345|P1|Overall Study|Adverse Event|39
2641177|NCT00785291|9124343|P3|Overall Study|Never began treatment|4
2641178|NCT00785291|9124344|P2|Overall Study|Never began treatment|4
2641179|NCT00785291|9124345|P1|Overall Study|Never began treatment|8
2641180|NCT00785213|9124365|P1|Rosiglitazone With Quinine Sulfate|Adverse Event|1
2641181|NCT00785213|9124365|P1|Quinine Sulfate Alone|Adverse Event|4
2641182|NCT00785044|9124376|P1|Overall Study|Withdrawal by Subject|1
2641183|NCT00785044|9124376|P1|Overall Study|Lost to Follow-up|266
2641184|NCT00785044|9124376|P1|Overall Study|Death|77
2641185|NCT00785044|9124376|P1|Overall Study|Dosed at non-participating sites|152
2641186|NCT00784979|9124381|P1|Overall Study|incomplete data|6
2641187|NCT00784927|9124385|P1|Overall Study|Ineligible|1
2641188|NCT00784927|9124385|P1|Overall Study|Protocol Violation|1
2641189|NCT00784927|9124385|P1|Overall Study|Cancel Prior to Initiating Treatment|1
2641190|NCT00784875|9124397|P4|Period D|Lost to Follow-up|1
2641191|NCT00784875|9124398|P3|Period D|Lost to Follow-up|1
2641192|NCT00784875|9124399|P2|Period D|Lost to Follow-up|0
2641193|NCT00784875|9124400|P1|Period D|Lost to Follow-up|1
2641194|NCT00784875|9124397|P4|Period D|Sponsor Decision|0
2641195|NCT00784875|9124398|P3|Period D|Sponsor Decision|1
2641196|NCT00784875|9124399|P2|Period D|Sponsor Decision|1
2641197|NCT00784875|9124400|P1|Period D|Sponsor Decision|1
2641198|NCT00784875|9124397|P4|Period D|Physician Decision|0
2641199|NCT00784875|9124398|P3|Period D|Physician Decision|0
2641200|NCT00784875|9124399|P2|Period D|Physician Decision|1
2641201|NCT00784875|9124400|P1|Period D|Physician Decision|0
2641202|NCT00784875|9124397|P4|Period D|Withdrawal by Subject|0
2641203|NCT00784875|9124398|P3|Period D|Withdrawal by Subject|2
2641204|NCT00784875|9124399|P2|Period D|Withdrawal by Subject|0
2641205|NCT00784875|9124400|P1|Period D|Withdrawal by Subject|2
2641206|NCT00784875|9124397|P4|Period D|Protocol Violation|0
2641207|NCT00784875|9124398|P3|Period D|Protocol Violation|0
2641208|NCT00784875|9124399|P2|Period D|Protocol Violation|0
2641209|NCT00784875|9124400|P1|Period D|Protocol Violation|1
2641210|NCT00784875|9124397|P4|Period D|Adverse Event|0
2641211|NCT00784875|9124398|P3|Period D|Adverse Event|2
2641212|NCT00784875|9124399|P2|Period D|Adverse Event|2
2641213|NCT00784875|9124400|P1|Period D|Adverse Event|0
2641214|NCT00784875|9124397|P4|Period C|Sponsor Decision|2
2641215|NCT00784875|9124398|P3|Period C|Sponsor Decision|4
2641216|NCT00784875|9124399|P2|Period C|Sponsor Decision|5
2641217|NCT00784875|9124400|P1|Period C|Sponsor Decision|5
2641218|NCT00784875|9124397|P4|Period C|Physician Decision|1
2641219|NCT00784875|9124398|P3|Period C|Physician Decision|1
2641220|NCT00784875|9124399|P2|Period C|Physician Decision|0
2641221|NCT00784875|9124400|P1|Period C|Physician Decision|0
2641222|NCT00784875|9124397|P4|Period C|Withdrawal by Subject|0
2641223|NCT00784875|9124398|P3|Period C|Withdrawal by Subject|2
2641224|NCT00784875|9124399|P2|Period C|Withdrawal by Subject|1
2641225|NCT00784875|9124400|P1|Period C|Withdrawal by Subject|1
2641226|NCT00784875|9124397|P4|Period C|Lack of Efficacy|0
2641227|NCT00784875|9124398|P3|Period C|Lack of Efficacy|1
2641228|NCT00784875|9124399|P2|Period C|Lack of Efficacy|0
2641229|NCT00784875|9124400|P1|Period C|Lack of Efficacy|0
2641230|NCT00784875|9124397|P4|Period C|Protocol Violation|2
2641231|NCT00784875|9124398|P3|Period C|Protocol Violation|1
2641232|NCT00784875|9124399|P2|Period C|Protocol Violation|0
2641233|NCT00784875|9124400|P1|Period C|Protocol Violation|0
2641234|NCT00784875|9124397|P4|Period C|Adverse Event|2
2641235|NCT00784875|9124398|P3|Period C|Adverse Event|4
2641236|NCT00784875|9124399|P2|Period C|Adverse Event|0
2641237|NCT00784875|9124400|P1|Period C|Adverse Event|1
2641238|NCT00784875|9124397|P4|Period B - Efficacy Endpoint|Lost to Follow-up|0
2641239|NCT00784875|9124398|P3|Period B - Efficacy Endpoint|Lost to Follow-up|1
2641240|NCT00784875|9124399|P2|Period B - Efficacy Endpoint|Lost to Follow-up|0
2641241|NCT00784875|9124400|P1|Period B - Efficacy Endpoint|Lost to Follow-up|0
2641242|NCT00784875|9124397|P4|Period B - Efficacy Endpoint|Sponsor Decision|12
2641243|NCT00784875|9124398|P3|Period B - Efficacy Endpoint|Sponsor Decision|12
2641244|NCT00784875|9124399|P2|Period B - Efficacy Endpoint|Sponsor Decision|6
2641245|NCT00784875|9124400|P1|Period B - Efficacy Endpoint|Sponsor Decision|9
2641246|NCT00784875|9124397|P4|Period B - Efficacy Endpoint|Physician Decision|0
2641247|NCT00784875|9124398|P3|Period B - Efficacy Endpoint|Physician Decision|1
2641248|NCT00784875|9124399|P2|Period B - Efficacy Endpoint|Physician Decision|0
2641249|NCT00784875|9124400|P1|Period B - Efficacy Endpoint|Physician Decision|0
2641250|NCT00784875|9124397|P4|Period B - Efficacy Endpoint|Withdrawal by Subject|2
2641251|NCT00784875|9124398|P3|Period B - Efficacy Endpoint|Withdrawal by Subject|1
2641252|NCT00784875|9124399|P2|Period B - Efficacy Endpoint|Withdrawal by Subject|1
2641253|NCT00784875|9124400|P1|Period B - Efficacy Endpoint|Withdrawal by Subject|4
2641254|NCT00784875|9124397|P4|Period B - Efficacy Endpoint|Lack of Efficacy|0
2641255|NCT00784875|9124398|P3|Period B - Efficacy Endpoint|Lack of Efficacy|0
2641256|NCT00784875|9124399|P2|Period B - Efficacy Endpoint|Lack of Efficacy|1
2641257|NCT00784875|9124400|P1|Period B - Efficacy Endpoint|Lack of Efficacy|0
2641258|NCT00784875|9124397|P4|Period B - Efficacy Endpoint|Protocol Violation|3
2641259|NCT00784875|9124398|P3|Period B - Efficacy Endpoint|Protocol Violation|2
2641260|NCT00784875|9124399|P2|Period B - Efficacy Endpoint|Protocol Violation|1
2641261|NCT00784875|9124400|P1|Period B - Efficacy Endpoint|Protocol Violation|1
2641262|NCT00784875|9124397|P4|Period B - Efficacy Endpoint|Adverse Event|1
2641263|NCT00784875|9124398|P3|Period B - Efficacy Endpoint|Adverse Event|2
2641264|NCT00784875|9124399|P2|Period B - Efficacy Endpoint|Adverse Event|3
2641265|NCT00784875|9124400|P1|Period B - Efficacy Endpoint|Adverse Event|0
2641266|NCT00784875|9124397|P4|Period B - Efficacy Endpoint|Entry Criteria Not Met|1
2641267|NCT00784875|9124398|P3|Period B - Efficacy Endpoint|Entry Criteria Not Met|2
2641268|NCT00784875|9124399|P2|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
2641269|NCT00784875|9124400|P1|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
2641270|NCT00784875|9124397|P4|Period A - Baseline|Lost to Follow-up|2
2641271|NCT00784875|9124398|P3|Period A - Baseline|Lost to Follow-up|0
2641272|NCT00784875|9124399|P2|Period A - Baseline|Lost to Follow-up|0
2641273|NCT00784875|9124400|P1|Period A - Baseline|Lost to Follow-up|0
2641274|NCT00784875|9124397|P4|Period A - Baseline|Sponsor Decision|113
2641275|NCT00784875|9124398|P3|Period A - Baseline|Sponsor Decision|0
2641276|NCT00784875|9124399|P2|Period A - Baseline|Sponsor Decision|0
2641277|NCT00784875|9124400|P1|Period A - Baseline|Sponsor Decision|0
2641278|NCT00784875|9124397|P4|Period A - Baseline|Physician Decision|2
2641279|NCT00784875|9124398|P3|Period A - Baseline|Physician Decision|0
2641280|NCT00784875|9124399|P2|Period A - Baseline|Physician Decision|0
2641281|NCT00784875|9124400|P1|Period A - Baseline|Physician Decision|0
2641282|NCT00784875|9124397|P4|Period A - Baseline|Withdrawal by Subject|27
2641283|NCT00784875|9124398|P3|Period A - Baseline|Withdrawal by Subject|0
2641284|NCT00784875|9124399|P2|Period A - Baseline|Withdrawal by Subject|0
2641285|NCT00784875|9124400|P1|Period A - Baseline|Withdrawal by Subject|0
2641286|NCT00784875|9124397|P4|Period A - Baseline|Protocol Violation|25
2641287|NCT00784875|9124398|P3|Period A - Baseline|Protocol Violation|0
2641288|NCT00784875|9124399|P2|Period A - Baseline|Protocol Violation|0
2641289|NCT00784875|9124400|P1|Period A - Baseline|Protocol Violation|0
2641290|NCT00784875|9124397|P4|Period A - Baseline|Adverse Event|8
2641291|NCT00784875|9124398|P3|Period A - Baseline|Adverse Event|0
2641292|NCT00784875|9124399|P2|Period A - Baseline|Adverse Event|0
2641293|NCT00784875|9124400|P1|Period A - Baseline|Adverse Event|0
2641294|NCT00784875|9124397|P4|Period A - Baseline|Entry Criteria Not Met|5
2641295|NCT00784875|9124398|P3|Period A - Baseline|Entry Criteria Not Met|0
2641296|NCT00784875|9124399|P2|Period A - Baseline|Entry Criteria Not Met|0
2641297|NCT00784875|9124400|P1|Period A - Baseline|Entry Criteria Not Met|0
2641298|NCT00784836|9124520|P1|Overall Study|Early Study Termination|3
2641299|NCT00784810|9124527|P2|Overall Study|Lost to Follow-up|1
2641300|NCT00784810|9124528|P1|Overall Study|Lost to Follow-up|1
2641301|NCT00784810|9124527|P2|Overall Study|Administrative|8
2641302|NCT00784810|9124528|P1|Overall Study|Administrative|5
2641303|NCT00784810|9124527|P2|Overall Study|Withdrawal by Subject|9
2641304|NCT00784810|9124528|P1|Overall Study|Withdrawal by Subject|11
2641305|NCT00784810|9124527|P2|Overall Study|Lack of Efficacy|11
2641306|NCT00784810|9124528|P1|Overall Study|Lack of Efficacy|14
2641307|NCT00784810|9124527|P2|Overall Study|Adverse Event|20
2641308|NCT00784810|9124528|P1|Overall Study|Adverse Event|32
2641309|NCT00784784|9124538|P2|Overall Study|Withdrawal by Subject|2
2641310|NCT00784784|9124539|P1|Overall Study|Withdrawal by Subject|2
2641311|NCT00784758|9124549|P2|Overall Study|Adverse Event|0
2641312|NCT00784758|9124550|P1|Overall Study|Adverse Event|1
2641313|NCT00784758|9124549|P2|Overall Study|Withdrawal by Subject|0
2641314|NCT00784758|9124550|P1|Overall Study|Withdrawal by Subject|3
2641315|NCT00784719|9124599|P7|Overall Study|Withdrawal by Subject|1
2641316|NCT00784719|9124600|P6|Overall Study|Withdrawal by Subject|0
2641317|NCT00784719|9124601|P5|Overall Study|Withdrawal by Subject|2
2641318|NCT00784719|9124602|P4|Overall Study|Withdrawal by Subject|0
2641319|NCT00784719|9124603|P3|Overall Study|Withdrawal by Subject|0
2641320|NCT00784719|9124604|P2|Overall Study|Withdrawal by Subject|0
2641321|NCT00784719|9124605|P1|Overall Study|Withdrawal by Subject|1
2641322|NCT00784719|9124599|P7|Overall Study|Other|3
2641323|NCT00784719|9124600|P6|Overall Study|Other|1
2641324|NCT00784719|9124601|P5|Overall Study|Other|2
2641325|NCT00784719|9124602|P4|Overall Study|Other|0
2641326|NCT00784719|9124603|P3|Overall Study|Other|1
2641327|NCT00784719|9124604|P2|Overall Study|Other|1
2641328|NCT00784719|9124605|P1|Overall Study|Other|2
2641329|NCT00784719|9124599|P7|Overall Study|Lost to Follow-up|0
2641330|NCT00784719|9124600|P6|Overall Study|Lost to Follow-up|1
2641331|NCT00784719|9124601|P5|Overall Study|Lost to Follow-up|1
2641332|NCT00784719|9124602|P4|Overall Study|Lost to Follow-up|0
2641333|NCT00784719|9124603|P3|Overall Study|Lost to Follow-up|0
2641334|NCT00784719|9124604|P2|Overall Study|Lost to Follow-up|0
2641335|NCT00784719|9124605|P1|Overall Study|Lost to Follow-up|0
2641336|NCT00784719|9124599|P7|Overall Study|Adverse Event|1
2641337|NCT00784719|9124600|P6|Overall Study|Adverse Event|1
2641338|NCT00784719|9124601|P5|Overall Study|Adverse Event|1
2641339|NCT00784719|9124602|P4|Overall Study|Adverse Event|0
2641340|NCT00784719|9124603|P3|Overall Study|Adverse Event|0
2641341|NCT00784719|9124604|P2|Overall Study|Adverse Event|2
2641342|NCT00784719|9124605|P1|Overall Study|Adverse Event|0
2641343|NCT00784654|9124775|P3|Randomized Withdrawal Period|Family reasons|1
2641344|NCT00784654|9124776|P2|Randomized Withdrawal Period|Family reasons|0
2641345|NCT00784654|9124777|P1|Randomized Withdrawal Period|Family reasons|0
2641346|NCT00784654|9124775|P3|Randomized Withdrawal Period|Did not complete a visit|0
2641347|NCT00784654|9124776|P2|Randomized Withdrawal Period|Did not complete a visit|1
2641348|NCT00784654|9124777|P1|Randomized Withdrawal Period|Did not complete a visit|0
2641349|NCT00784654|9124775|P3|Randomized Withdrawal Period|Adverse Event|1
2641350|NCT00784654|9124776|P2|Randomized Withdrawal Period|Adverse Event|1
2641351|NCT00784654|9124777|P1|Randomized Withdrawal Period|Adverse Event|0
2641352|NCT00784654|9124775|P3|Randomized Withdrawal Period|Protocol Violation|1
2641353|NCT00784654|9124776|P2|Randomized Withdrawal Period|Protocol Violation|2
2641354|NCT00784654|9124777|P1|Randomized Withdrawal Period|Protocol Violation|0
2641355|NCT00784654|9124775|P3|Randomized Withdrawal Period|Withdrawal by Subject|7
2641356|NCT00784654|9124776|P2|Randomized Withdrawal Period|Withdrawal by Subject|1
2641357|NCT00784654|9124777|P1|Randomized Withdrawal Period|Withdrawal by Subject|0
2641358|NCT00784654|9124775|P3|Randomized Withdrawal Period|Lack of Efficacy|18
2641359|NCT00784654|9124776|P2|Randomized Withdrawal Period|Lack of Efficacy|5
2641360|NCT00784654|9124777|P1|Randomized Withdrawal Period|Lack of Efficacy|0
2641361|NCT00784654|9124775|P3|Randomized Withdrawal Period|Met relapse criteria per investigator|35
2641362|NCT00784654|9124776|P2|Randomized Withdrawal Period|Met relapse criteria per investigator|8
2641363|NCT00784654|9124777|P1|Randomized Withdrawal Period|Met relapse criteria per investigator|0
2641364|NCT00784654|9124775|P3|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
2641365|NCT00784654|9124776|P2|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
2641366|NCT00784654|9124777|P1|Open-Label Period (Non-Randomized)|Did not provide end of study page|1
2641367|NCT00784654|9124775|P3|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
2641368|NCT00784654|9124776|P2|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
2641369|NCT00784654|9124777|P1|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1
2641370|NCT00784654|9124775|P3|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
2641371|NCT00784654|9124776|P2|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
2641372|NCT00784654|9124777|P1|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1
2641373|NCT00784654|9124775|P3|Open-Label Period (Non-Randomized)|Home situation intolerable|0
2641374|NCT00784654|9124776|P2|Open-Label Period (Non-Randomized)|Home situation intolerable|0
2641375|NCT00784654|9124777|P1|Open-Label Period (Non-Randomized)|Home situation intolerable|1
2641376|NCT00784654|9124775|P3|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
2641377|NCT00784654|9124776|P2|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
2641378|NCT00784654|9124777|P1|Open-Label Period (Non-Randomized)|Decision of medical monitor|1
2641379|NCT00784654|9124775|P3|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
2641380|NCT00784654|9124776|P2|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
2641381|NCT00784654|9124777|P1|Open-Label Period (Non-Randomized)|Mother is a drug addict|1
2641382|NCT00784654|9124775|P3|Open-Label Period (Non-Randomized)|Protocol Violation|0
2641383|NCT00784654|9124776|P2|Open-Label Period (Non-Randomized)|Protocol Violation|0
2641384|NCT00784654|9124777|P1|Open-Label Period (Non-Randomized)|Protocol Violation|7
2641385|NCT00784654|9124775|P3|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
2641386|NCT00784654|9124776|P2|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
2641387|NCT00784654|9124777|P1|Open-Label Period (Non-Randomized)|Lost to Follow-up|11
2641388|NCT00784654|9124775|P3|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
2641389|NCT00784654|9124776|P2|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
2641390|NCT00784654|9124777|P1|Open-Label Period (Non-Randomized)|Lack of Efficacy|21
2641391|NCT00784654|9124775|P3|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
2641392|NCT00784654|9124776|P2|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
2641393|NCT00784654|9124777|P1|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22
2641394|NCT00784654|9124775|P3|Open-Label Period (Non-Randomized)|Adverse Event|0
2641395|NCT00784654|9124776|P2|Open-Label Period (Non-Randomized)|Adverse Event|0
2641396|NCT00784654|9124777|P1|Open-Label Period (Non-Randomized)|Adverse Event|44
2641397|NCT00784563|9124812|P3|Year 3|Adverse Event|1
2641398|NCT00784563|9124813|P2|Year 3|Adverse Event|0
2641399|NCT00784563|9124814|P1|Year 3|Adverse Event|0
2641400|NCT00784563|9124812|P3|Year 3|Withdrawal by Subject|2
2641401|NCT00784563|9124813|P2|Year 3|Withdrawal by Subject|0
2641402|NCT00784563|9124814|P1|Year 3|Withdrawal by Subject|0
2641403|NCT00784563|9124812|P3|Years 1 & 2|Adverse Event|0
2641404|NCT00784563|9124813|P2|Years 1 & 2|Adverse Event|3
2641405|NCT00784563|9124814|P1|Years 1 & 2|Adverse Event|0
2641406|NCT00784563|9124812|P3|Years 1 & 2|Withdrawal by Subject|0
2641407|NCT00784563|9124813|P2|Years 1 & 2|Withdrawal by Subject|2
2641408|NCT00784563|9124814|P1|Years 1 & 2|Withdrawal by Subject|3
2641409|NCT00784550|9124832|P2|Overall Study|Withdrawal by Subject|13
2641410|NCT00784550|9124833|P1|Overall Study|Withdrawal by Subject|4
2641411|NCT00784550|9124832|P2|Overall Study|Physician Decision|3
2641412|NCT00784550|9124833|P1|Overall Study|Physician Decision|2
2641413|NCT00784550|9124832|P2|Overall Study|Lost to Follow-up|5
2641414|NCT00784550|9124833|P1|Overall Study|Lost to Follow-up|8
2641415|NCT00784550|9124832|P2|Overall Study|Protocol Violation|10
2641416|NCT00784550|9124833|P1|Overall Study|Protocol Violation|10
2641417|NCT00784550|9124832|P2|Overall Study|Lack of Efficacy|1
2641418|NCT00784550|9124833|P1|Overall Study|Lack of Efficacy|0
2641419|NCT00784550|9124832|P2|Overall Study|Adverse Event|10
2641420|NCT00784550|9124833|P1|Overall Study|Adverse Event|12
2641421|NCT00784459|9124859|P2|Overall Study|Adverse Event|2
2641422|NCT00784459|9124860|P1|Overall Study|Adverse Event|0
2641423|NCT00784368|9124871|P3|Overall Study|Withdrawal of informed consent|0
2641424|NCT00784368|9124872|P2|Overall Study|Withdrawal of informed consent|1
2641425|NCT00784368|9124873|P1|Overall Study|Withdrawal of informed consent|0
2641426|NCT00784368|9124871|P3|Overall Study|Worsening of symptoms|0
2641427|NCT00784368|9124872|P2|Overall Study|Worsening of symptoms|1
2641428|NCT00784368|9124873|P1|Overall Study|Worsening of symptoms|0
2641429|NCT00784368|9124871|P3|Overall Study|Worsening of complications|1
2641430|NCT00784368|9124872|P2|Overall Study|Worsening of complications|0
2641431|NCT00784368|9124873|P1|Overall Study|Worsening of complications|0
2641432|NCT00784368|9124871|P3|Overall Study|Diagnosis of fever|1
2641433|NCT00784368|9124872|P2|Overall Study|Diagnosis of fever|0
2641434|NCT00784368|9124873|P1|Overall Study|Diagnosis of fever|0
2641435|NCT00784368|9124871|P3|Overall Study|Adverse Event|2
2641436|NCT00784368|9124872|P2|Overall Study|Adverse Event|9
2641437|NCT00784368|9124873|P1|Overall Study|Adverse Event|6
2641438|NCT00784368|9124871|P3|Overall Study|Lack of Efficacy|1
2641439|NCT00784368|9124872|P2|Overall Study|Lack of Efficacy|0
2641440|NCT00784368|9124873|P1|Overall Study|Lack of Efficacy|2
2641441|NCT00784368|9124871|P3|Overall Study|Physician Decision|6
2641442|NCT00784368|9124872|P2|Overall Study|Physician Decision|0
2641443|NCT00784368|9124873|P1|Overall Study|Physician Decision|0
2641444|NCT00784277|9124949|P7|ER Treatment|Other|2
2641445|NCT00784277|9124950|P6|ER Treatment|Other|3
2641446|NCT00784277|9124951|P5|ER Treatment|Other|1
2641447|NCT00784277|9124952|P4|ER Treatment|Other|0
2641448|NCT00784277|9124953|P3|ER Treatment|Other|0
2641449|NCT00784277|9124954|P2|ER Treatment|Other|0
2641450|NCT00784277|9124955|P1|ER Treatment|Other|0
2641451|NCT00784277|9124949|P7|ER Treatment|Study Medication Non-Compliant|3
2641452|NCT00784277|9124950|P6|ER Treatment|Study Medication Non-Compliant|3
2641453|NCT00784277|9124951|P5|ER Treatment|Study Medication Non-Compliant|2
2641454|NCT00784277|9124952|P4|ER Treatment|Study Medication Non-Compliant|0
2641455|NCT00784277|9124953|P3|ER Treatment|Study Medication Non-Compliant|0
2641456|NCT00784277|9124954|P2|ER Treatment|Study Medication Non-Compliant|0
2641457|NCT00784277|9124955|P1|ER Treatment|Study Medication Non-Compliant|0
2641458|NCT00784277|9124949|P7|ER Treatment|Withdrawal by Subject|3
2641459|NCT00784277|9124950|P6|ER Treatment|Withdrawal by Subject|5
2641460|NCT00784277|9124951|P5|ER Treatment|Withdrawal by Subject|2
2641461|NCT00784277|9124952|P4|ER Treatment|Withdrawal by Subject|0
2641462|NCT00784277|9124953|P3|ER Treatment|Withdrawal by Subject|0
2641463|NCT00784277|9124954|P2|ER Treatment|Withdrawal by Subject|0
2641464|NCT00784277|9124955|P1|ER Treatment|Withdrawal by Subject|0
2641465|NCT00784277|9124949|P7|ER Treatment|Lost to Follow-up|0
2641466|NCT00784277|9124950|P6|ER Treatment|Lost to Follow-up|2
2641467|NCT00784277|9124951|P5|ER Treatment|Lost to Follow-up|0
2641468|NCT00784277|9124952|P4|ER Treatment|Lost to Follow-up|0
2641469|NCT00784277|9124953|P3|ER Treatment|Lost to Follow-up|0
2641470|NCT00784277|9124954|P2|ER Treatment|Lost to Follow-up|0
2641471|NCT00784277|9124955|P1|ER Treatment|Lost to Follow-up|0
2641472|NCT00784277|9124949|P7|ER Treatment|Lack of Efficacy|0
2641473|NCT00784277|9124950|P6|ER Treatment|Lack of Efficacy|4
2641474|NCT00784277|9124951|P5|ER Treatment|Lack of Efficacy|3
2641475|NCT00784277|9124952|P4|ER Treatment|Lack of Efficacy|0
2641476|NCT00784277|9124953|P3|ER Treatment|Lack of Efficacy|0
2641477|NCT00784277|9124954|P2|ER Treatment|Lack of Efficacy|0
2641478|NCT00784277|9124955|P1|ER Treatment|Lack of Efficacy|0
2641479|NCT00784277|9124949|P7|ER Treatment|Adverse Event|7
2641480|NCT00784277|9124950|P6|ER Treatment|Adverse Event|7
2641481|NCT00784277|9124951|P5|ER Treatment|Adverse Event|1
2641482|NCT00784277|9124952|P4|ER Treatment|Adverse Event|0
2641483|NCT00784277|9124953|P3|ER Treatment|Adverse Event|0
2641484|NCT00784277|9124954|P2|ER Treatment|Adverse Event|0
2641485|NCT00784277|9124955|P1|ER Treatment|Adverse Event|0
2641486|NCT00784277|9124949|P7|IR Treatment|Other|0
2641487|NCT00784277|9124950|P6|IR Treatment|Other|0
2641488|NCT00784277|9124951|P5|IR Treatment|Other|0
2641489|NCT00784277|9124952|P4|IR Treatment|Other|2
2641490|NCT00784277|9124953|P3|IR Treatment|Other|3
2641491|NCT00784277|9124954|P2|IR Treatment|Other|3
2641492|NCT00784277|9124955|P1|IR Treatment|Other|2
2641493|NCT00784277|9124949|P7|IR Treatment|Resolution Of Pain|0
2641494|NCT00784277|9124950|P6|IR Treatment|Resolution Of Pain|0
2641495|NCT00784277|9124951|P5|IR Treatment|Resolution Of Pain|0
2641496|NCT00784277|9124952|P4|IR Treatment|Resolution Of Pain|0
2641497|NCT00784277|9124953|P3|IR Treatment|Resolution Of Pain|0
2641498|NCT00784277|9124954|P2|IR Treatment|Resolution Of Pain|1
2641499|NCT00784277|9124955|P1|IR Treatment|Resolution Of Pain|0
2641500|NCT00784277|9124949|P7|IR Treatment|Withdrawal by Subject|0
2641501|NCT00784277|9124950|P6|IR Treatment|Withdrawal by Subject|0
2641502|NCT00784277|9124951|P5|IR Treatment|Withdrawal by Subject|0
2641503|NCT00784277|9124952|P4|IR Treatment|Withdrawal by Subject|6
2641504|NCT00784277|9124953|P3|IR Treatment|Withdrawal by Subject|4
2641505|NCT00784277|9124954|P2|IR Treatment|Withdrawal by Subject|1
2641506|NCT00784277|9124955|P1|IR Treatment|Withdrawal by Subject|5
2641507|NCT00784277|9124949|P7|IR Treatment|Lost to Follow-up|0
2641508|NCT00784277|9124950|P6|IR Treatment|Lost to Follow-up|0
2641509|NCT00784277|9124951|P5|IR Treatment|Lost to Follow-up|0
2641510|NCT00784277|9124952|P4|IR Treatment|Lost to Follow-up|0
2641511|NCT00784277|9124953|P3|IR Treatment|Lost to Follow-up|1
2641512|NCT00784277|9124954|P2|IR Treatment|Lost to Follow-up|0
2641513|NCT00784277|9124955|P1|IR Treatment|Lost to Follow-up|1
2641514|NCT00784277|9124949|P7|IR Treatment|Lack of Efficacy|0
2641515|NCT00784277|9124950|P6|IR Treatment|Lack of Efficacy|0
2641516|NCT00784277|9124951|P5|IR Treatment|Lack of Efficacy|0
2641517|NCT00784277|9124952|P4|IR Treatment|Lack of Efficacy|0
2641518|NCT00784277|9124953|P3|IR Treatment|Lack of Efficacy|1
2641519|NCT00784277|9124954|P2|IR Treatment|Lack of Efficacy|4
2641520|NCT00784277|9124955|P1|IR Treatment|Lack of Efficacy|4
2641521|NCT00784277|9124949|P7|IR Treatment|Adverse Event|0
2641522|NCT00784277|9124950|P6|IR Treatment|Adverse Event|0
2641523|NCT00784277|9124951|P5|IR Treatment|Adverse Event|0
2641524|NCT00784277|9124952|P4|IR Treatment|Adverse Event|35
2641525|NCT00784277|9124953|P3|IR Treatment|Adverse Event|19
2641526|NCT00784277|9124954|P2|IR Treatment|Adverse Event|8
2641527|NCT00784277|9124955|P1|IR Treatment|Adverse Event|4
2641528|NCT00784238|9124972|P1|Overall Study|Other|14
2641529|NCT00784238|9124972|P1|Overall Study|Withdrawal by Subject|26
2641530|NCT00784238|9124972|P1|Overall Study|Pregnancy|1
2641531|NCT00784238|9124972|P1|Overall Study|Lost to Follow-up|29
2641532|NCT00784238|9124972|P1|Overall Study|Lack of Efficacy|33
2641533|NCT00784238|9124972|P1|Overall Study|Death|2
2641534|NCT00784238|9124972|P1|Overall Study|Adverse Event|14
2641535|NCT00784147|9125044|P2|Overall Study|Death|0
2641536|NCT00784147|9125045|P1|Overall Study|Death|2
2641537|NCT00784147|9125044|P2|Overall Study|Protocol Violation|1
2641538|NCT00784147|9125045|P1|Overall Study|Protocol Violation|1
2641539|NCT00784147|9125044|P2|Overall Study|Physician Decision|1
2641540|NCT00784147|9125045|P1|Overall Study|Physician Decision|2
2641541|NCT00784147|9125044|P2|Overall Study|Withdrawal by Subject|3
2641542|NCT00784147|9125045|P1|Overall Study|Withdrawal by Subject|1
2641543|NCT00784147|9125044|P2|Overall Study|Lost to Follow-up|4
2641544|NCT00784147|9125045|P1|Overall Study|Lost to Follow-up|2
2641545|NCT00784134|9125065|P2|Overall Study|Lost to Follow-up|6
2641546|NCT00784134|9125066|P1|Overall Study|Lost to Follow-up|3
2641547|NCT00784043|9125189|P2|Overall Study|Protocol Terminated|1
2641548|NCT00784043|9125190|P1|Overall Study|Protocol Terminated|23
2641549|NCT00784043|9125189|P2|Overall Study|Withdrawal by Subject|5
2641550|NCT00784043|9125190|P1|Overall Study|Withdrawal by Subject|8
2641551|NCT00783835|9125225|P1|Overall Study|Participant not Adherent|3
2641552|NCT00783835|9125225|P1|Overall Study|Lost to Follow-up|1
2641553|NCT00783835|9125225|P1|Overall Study|Withdrawal by Subject|2
2641554|NCT00783835|9125225|P1|Overall Study|Medical Criteria|1
2641555|NCT00783835|9125225|P1|Overall Study|Adverse Event|3
2641556|NCT00783796|9125237|P1|Overall Study|Received commercial XIENCE V stent|1
2641557|NCT00783796|9125237|P1|Overall Study|Received non-XIENCE V stent|1
2641558|NCT00783796|9125237|P1|Overall Study|Did not receive any stent|4
2641559|NCT00783718|9125342|P7|Maintenance Phase|Lost to Follow-up|2
2641560|NCT00783718|9125343|P6|Maintenance Phase|Lost to Follow-up|0
2641561|NCT00783718|9125344|P5|Maintenance Phase|Lost to Follow-up|2
2641562|NCT00783718|9125345|P4|Maintenance Phase|Lost to Follow-up|0
2641563|NCT00783718|9125346|P3|Maintenance Phase|Lost to Follow-up|0
2641564|NCT00783718|9125347|P2|Maintenance Phase|Lost to Follow-up|0
2641565|NCT00783718|9125348|P1|Maintenance Phase|Lost to Follow-up|3
2641566|NCT00783718|9125342|P7|Maintenance Phase|Withdrawal by Subject|20
2641567|NCT00783718|9125343|P6|Maintenance Phase|Withdrawal by Subject|2
2641568|NCT00783718|9125344|P5|Maintenance Phase|Withdrawal by Subject|5
2641569|NCT00783718|9125345|P4|Maintenance Phase|Withdrawal by Subject|2
2641570|NCT00783718|9125346|P3|Maintenance Phase|Withdrawal by Subject|0
2641571|NCT00783718|9125347|P2|Maintenance Phase|Withdrawal by Subject|0
2641572|NCT00783718|9125348|P1|Maintenance Phase|Withdrawal by Subject|6
2641573|NCT00783718|9125342|P7|Maintenance Phase|Lack of Efficacy|155
2641574|NCT00783718|9125343|P6|Maintenance Phase|Lack of Efficacy|33
2641575|NCT00783718|9125344|P5|Maintenance Phase|Lack of Efficacy|31
2641576|NCT00783718|9125345|P4|Maintenance Phase|Lack of Efficacy|61
2641577|NCT00783718|9125346|P3|Maintenance Phase|Lack of Efficacy|0
2641578|NCT00783718|9125347|P2|Maintenance Phase|Lack of Efficacy|0
2641579|NCT00783718|9125348|P1|Maintenance Phase|Lack of Efficacy|83
2641580|NCT00783718|9125342|P7|Maintenance Phase|Protocol Violation|2
2641581|NCT00783718|9125343|P6|Maintenance Phase|Protocol Violation|0
2641582|NCT00783718|9125344|P5|Maintenance Phase|Protocol Violation|0
2641583|NCT00783718|9125345|P4|Maintenance Phase|Protocol Violation|0
2641584|NCT00783718|9125346|P3|Maintenance Phase|Protocol Violation|0
2641585|NCT00783718|9125347|P2|Maintenance Phase|Protocol Violation|0
2641586|NCT00783718|9125348|P1|Maintenance Phase|Protocol Violation|1
2641587|NCT00783718|9125342|P7|Maintenance Phase|Adverse Event|16
2641588|NCT00783718|9125343|P6|Maintenance Phase|Adverse Event|6
2641589|NCT00783718|9125344|P5|Maintenance Phase|Adverse Event|7
2641590|NCT00783718|9125345|P4|Maintenance Phase|Adverse Event|15
2641591|NCT00783718|9125346|P3|Maintenance Phase|Adverse Event|0
2641592|NCT00783718|9125347|P2|Maintenance Phase|Adverse Event|0
2641593|NCT00783718|9125348|P1|Maintenance Phase|Adverse Event|12
2641594|NCT00783718|9125342|P7|Induction Phase|Lost to Follow-up|0
2641595|NCT00783718|9125343|P6|Induction Phase|Lost to Follow-up|0
2641596|NCT00783718|9125344|P5|Induction Phase|Lost to Follow-up|0
2641597|NCT00783718|9125345|P4|Induction Phase|Lost to Follow-up|0
2641598|NCT00783718|9125346|P3|Induction Phase|Lost to Follow-up|1
2641599|NCT00783718|9125347|P2|Induction Phase|Lost to Follow-up|0
2641600|NCT00783718|9125348|P1|Induction Phase|Lost to Follow-up|1
2641601|NCT00783718|9125342|P7|Induction Phase|Withdrawal by Subject|0
2641602|NCT00783718|9125343|P6|Induction Phase|Withdrawal by Subject|0
2641603|NCT00783718|9125344|P5|Induction Phase|Withdrawal by Subject|0
2641604|NCT00783718|9125345|P4|Induction Phase|Withdrawal by Subject|0
2641605|NCT00783718|9125346|P3|Induction Phase|Withdrawal by Subject|8
2641606|NCT00783718|9125347|P2|Induction Phase|Withdrawal by Subject|4
2641607|NCT00783718|9125348|P1|Induction Phase|Withdrawal by Subject|3
2641608|NCT00783718|9125342|P7|Induction Phase|Lack of Efficacy|0
2641609|NCT00783718|9125343|P6|Induction Phase|Lack of Efficacy|0
2641610|NCT00783718|9125344|P5|Induction Phase|Lack of Efficacy|0
2641611|NCT00783718|9125345|P4|Induction Phase|Lack of Efficacy|0
2641612|NCT00783718|9125346|P3|Induction Phase|Lack of Efficacy|14
2641613|NCT00783718|9125347|P2|Induction Phase|Lack of Efficacy|2
2641614|NCT00783718|9125348|P1|Induction Phase|Lack of Efficacy|5
2641615|NCT00783718|9125342|P7|Induction Phase|Protocol Violation|0
2641616|NCT00783718|9125343|P6|Induction Phase|Protocol Violation|0
2641617|NCT00783718|9125344|P5|Induction Phase|Protocol Violation|0
2641618|NCT00783718|9125345|P4|Induction Phase|Protocol Violation|0
2641619|NCT00783718|9125346|P3|Induction Phase|Protocol Violation|6
2641620|NCT00783718|9125347|P2|Induction Phase|Protocol Violation|1
2641621|NCT00783718|9125348|P1|Induction Phase|Protocol Violation|1
2641622|NCT00783718|9125342|P7|Induction Phase|Adverse Event|0
2641623|NCT00783718|9125343|P6|Induction Phase|Adverse Event|0
2641624|NCT00783718|9125344|P5|Induction Phase|Adverse Event|0
2641625|NCT00783718|9125345|P4|Induction Phase|Adverse Event|0
2641626|NCT00783718|9125346|P3|Induction Phase|Adverse Event|7
2641627|NCT00783718|9125347|P2|Induction Phase|Adverse Event|0
2641628|NCT00783718|9125348|P1|Induction Phase|Adverse Event|4
2641629|NCT00783705|9125376|P2|Overall Study|Lost to Follow-up|3
2641630|NCT00783705|9125377|P1|Overall Study|Lost to Follow-up|1
2641631|NCT00783705|9125376|P2|Overall Study|Withdrawal by Subject|2
2641632|NCT00783705|9125377|P1|Overall Study|Withdrawal by Subject|3
2641633|NCT00783705|9125376|P2|Overall Study|Adverse Event|0
2641634|NCT00783705|9125377|P1|Overall Study|Adverse Event|2
2641635|NCT00783692|9125424|P7|Maintenance Phase|Other|1
2641636|NCT00783692|9125425|P6|Maintenance Phase|Other|1
2641637|NCT00783692|9125426|P5|Maintenance Phase|Other|0
2641638|NCT00783692|9125427|P4|Maintenance Phase|Other|1
2641639|NCT00783692|9125428|P3|Maintenance Phase|Other|0
2641640|NCT00783692|9125429|P2|Maintenance Phase|Other|0
2641641|NCT00783692|9125430|P1|Maintenance Phase|Other|0
2641642|NCT00783692|9125424|P7|Maintenance Phase|Lost to Follow-up|5
2641643|NCT00783692|9125425|P6|Maintenance Phase|Lost to Follow-up|2
2641644|NCT00783692|9125426|P5|Maintenance Phase|Lost to Follow-up|3
2641645|NCT00783692|9125427|P4|Maintenance Phase|Lost to Follow-up|1
2641646|NCT00783692|9125428|P3|Maintenance Phase|Lost to Follow-up|0
2641647|NCT00783692|9125429|P2|Maintenance Phase|Lost to Follow-up|0
2641648|NCT00783692|9125430|P1|Maintenance Phase|Lost to Follow-up|2
2641649|NCT00783692|9125424|P7|Maintenance Phase|Withdrawal by Subject|24
2641650|NCT00783692|9125425|P6|Maintenance Phase|Withdrawal by Subject|9
2641651|NCT00783692|9125426|P5|Maintenance Phase|Withdrawal by Subject|6
2641652|NCT00783692|9125427|P4|Maintenance Phase|Withdrawal by Subject|7
2641653|NCT00783692|9125428|P3|Maintenance Phase|Withdrawal by Subject|0
2641654|NCT00783692|9125429|P2|Maintenance Phase|Withdrawal by Subject|0
2641655|NCT00783692|9125430|P1|Maintenance Phase|Withdrawal by Subject|7
2641656|NCT00783692|9125424|P7|Maintenance Phase|Lack of Efficacy|177
2641657|NCT00783692|9125425|P6|Maintenance Phase|Lack of Efficacy|48
2641658|NCT00783692|9125426|P5|Maintenance Phase|Lack of Efficacy|58
2641659|NCT00783692|9125427|P4|Maintenance Phase|Lack of Efficacy|64
2641660|NCT00783692|9125428|P3|Maintenance Phase|Lack of Efficacy|0
2641661|NCT00783692|9125429|P2|Maintenance Phase|Lack of Efficacy|0
2641662|NCT00783692|9125430|P1|Maintenance Phase|Lack of Efficacy|79
2641663|NCT00783692|9125424|P7|Maintenance Phase|Protocol Violation|4
2641664|NCT00783692|9125425|P6|Maintenance Phase|Protocol Violation|3
2641665|NCT00783692|9125426|P5|Maintenance Phase|Protocol Violation|2
2641666|NCT00783692|9125427|P4|Maintenance Phase|Protocol Violation|1
2641667|NCT00783692|9125428|P3|Maintenance Phase|Protocol Violation|0
2641668|NCT00783692|9125429|P2|Maintenance Phase|Protocol Violation|0
2641669|NCT00783692|9125430|P1|Maintenance Phase|Protocol Violation|0
2641670|NCT00783692|9125424|P7|Maintenance Phase|Adverse Event|38
2641671|NCT00783692|9125425|P6|Maintenance Phase|Adverse Event|9
2641672|NCT00783692|9125426|P5|Maintenance Phase|Adverse Event|12
2641673|NCT00783692|9125427|P4|Maintenance Phase|Adverse Event|15
2641674|NCT00783692|9125428|P3|Maintenance Phase|Adverse Event|0
2641675|NCT00783692|9125429|P2|Maintenance Phase|Adverse Event|0
2641676|NCT00783692|9125430|P1|Maintenance Phase|Adverse Event|7
2641677|NCT00783692|9125424|P7|Induction Phase|Other|0
2641678|NCT00783692|9125425|P6|Induction Phase|Other|0
2641679|NCT00783692|9125426|P5|Induction Phase|Other|0
2641680|NCT00783692|9125427|P4|Induction Phase|Other|0
2641681|NCT00783692|9125428|P3|Induction Phase|Other|2
2641682|NCT00783692|9125429|P2|Induction Phase|Other|0
2641683|NCT00783692|9125430|P1|Induction Phase|Other|0
2641684|NCT00783692|9125424|P7|Induction Phase|Lost to Follow-up|0
2641685|NCT00783692|9125425|P6|Induction Phase|Lost to Follow-up|0
2641686|NCT00783692|9125426|P5|Induction Phase|Lost to Follow-up|0
2641687|NCT00783692|9125427|P4|Induction Phase|Lost to Follow-up|0
2641688|NCT00783692|9125428|P3|Induction Phase|Lost to Follow-up|3
2641689|NCT00783692|9125429|P2|Induction Phase|Lost to Follow-up|0
2641690|NCT00783692|9125430|P1|Induction Phase|Lost to Follow-up|0
2641691|NCT00783692|9125424|P7|Induction Phase|Withdrawal by Subject|0
2641692|NCT00783692|9125425|P6|Induction Phase|Withdrawal by Subject|0
2641693|NCT00783692|9125426|P5|Induction Phase|Withdrawal by Subject|0
2641694|NCT00783692|9125427|P4|Induction Phase|Withdrawal by Subject|0
2641695|NCT00783692|9125428|P3|Induction Phase|Withdrawal by Subject|16
2641696|NCT00783692|9125429|P2|Induction Phase|Withdrawal by Subject|9
2641697|NCT00783692|9125430|P1|Induction Phase|Withdrawal by Subject|3
2641698|NCT00783692|9125424|P7|Induction Phase|Lack of Efficacy|0
2641699|NCT00783692|9125425|P6|Induction Phase|Lack of Efficacy|0
2641700|NCT00783692|9125426|P5|Induction Phase|Lack of Efficacy|0
2641701|NCT00783692|9125427|P4|Induction Phase|Lack of Efficacy|0
2641702|NCT00783692|9125428|P3|Induction Phase|Lack of Efficacy|28
2641703|NCT00783692|9125429|P2|Induction Phase|Lack of Efficacy|3
2641704|NCT00783692|9125430|P1|Induction Phase|Lack of Efficacy|1
2641705|NCT00783692|9125424|P7|Induction Phase|Protocol Violation|0
2641706|NCT00783692|9125425|P6|Induction Phase|Protocol Violation|0
2641707|NCT00783692|9125426|P5|Induction Phase|Protocol Violation|0
2641708|NCT00783692|9125427|P4|Induction Phase|Protocol Violation|0
2641709|NCT00783692|9125428|P3|Induction Phase|Protocol Violation|1
2641710|NCT00783692|9125429|P2|Induction Phase|Protocol Violation|0
2641711|NCT00783692|9125430|P1|Induction Phase|Protocol Violation|0
2641712|NCT00783692|9125424|P7|Induction Phase|Adverse Event|0
2641713|NCT00783692|9125425|P6|Induction Phase|Adverse Event|0
2641714|NCT00783692|9125426|P5|Induction Phase|Adverse Event|0
2641715|NCT00783692|9125427|P4|Induction Phase|Adverse Event|0
2641716|NCT00783692|9125428|P3|Induction Phase|Adverse Event|24
2641717|NCT00783692|9125429|P2|Induction Phase|Adverse Event|9
2641718|NCT00783692|9125430|P1|Induction Phase|Adverse Event|7
2641719|NCT00783432|9125476|P2|Overall Study|Protocol Violation|9
2641720|NCT00783432|9125477|P1|Overall Study|Protocol Violation|6
2641721|NCT00783432|9125476|P2|Overall Study|subject moved|5
2641722|NCT00783432|9125477|P1|Overall Study|subject moved|3
2641723|NCT00783432|9125476|P2|Overall Study|Withdrawal by Subject|20
2641724|NCT00783432|9125477|P1|Overall Study|Withdrawal by Subject|23
2641725|NCT00783432|9125476|P2|Overall Study|Lost to Follow-up|6
2641726|NCT00783432|9125477|P1|Overall Study|Lost to Follow-up|11
2641727|NCT00783432|9125476|P2|Overall Study|Lack of Efficacy|21
2641728|NCT00783432|9125477|P1|Overall Study|Lack of Efficacy|20
2641729|NCT00783432|9125476|P2|Overall Study|Adverse Event|17
2641730|NCT00783432|9125477|P1|Overall Study|Adverse Event|22
2641731|NCT00783302|9125487|P1|Overall Study|Withdrawal by Subject|3
2641732|NCT00783302|9125487|P1|Overall Study|Physician Decision|1
2641733|NCT00783302|9125487|P1|Overall Study|Protocol Violation|3
2641734|NCT00783302|9125487|P1|Overall Study|Technical Problems|11
2641735|NCT00783302|9125487|P1|Overall Study|Lost to Follow-up|17
2641736|NCT00783289|9125509|P4|Overall Study|Protocol Violation|0
2641737|NCT00783289|9125510|P3|Overall Study|Protocol Violation|0
2641738|NCT00783289|9125511|P2|Overall Study|Protocol Violation|1
2641739|NCT00783289|9125512|P1|Overall Study|Protocol Violation|0
2641740|NCT00783263|9125542|P4|Overall Study|Withdrawal by Subject|2
2641741|NCT00783263|9125543|P3|Overall Study|Withdrawal by Subject|1
2641742|NCT00783263|9125544|P2|Overall Study|Withdrawal by Subject|1
2641743|NCT00783263|9125545|P1|Overall Study|Withdrawal by Subject|0
2641744|NCT00783263|9125542|P4|Overall Study|Lost to Follow-up|0
2641745|NCT00783263|9125543|P3|Overall Study|Lost to Follow-up|0
2641746|NCT00783263|9125544|P2|Overall Study|Lost to Follow-up|1
2641747|NCT00783263|9125545|P1|Overall Study|Lost to Follow-up|1
2641748|NCT00783263|9125542|P4|Overall Study|Adverse Event|1
2641749|NCT00783263|9125543|P3|Overall Study|Adverse Event|2
2641750|NCT00783263|9125544|P2|Overall Study|Adverse Event|0
2641751|NCT00783263|9125545|P1|Overall Study|Adverse Event|3
2641752|NCT00783224|9125575|P4|Overall Study|Inappropriate as a study subject|1
2641753|NCT00783224|9125576|P3|Overall Study|Inappropriate as a study subject|0
2641754|NCT00783224|9125577|P2|Overall Study|Inappropriate as a study subject|0
2641755|NCT00783224|9125578|P1|Overall Study|Inappropriate as a study subject|0
2641756|NCT00783224|9125575|P4|Overall Study|Discarded the Investigational Drug Used|1
2641757|NCT00783224|9125576|P3|Overall Study|Discarded the Investigational Drug Used|0
2641758|NCT00783224|9125577|P2|Overall Study|Discarded the Investigational Drug Used|0
2641759|NCT00783224|9125578|P1|Overall Study|Discarded the Investigational Drug Used|0
2641760|NCT00783224|9125575|P4|Overall Study|Adverse Event|0
2641761|NCT00783224|9125576|P3|Overall Study|Adverse Event|1
2641762|NCT00783224|9125577|P2|Overall Study|Adverse Event|0
2641763|NCT00783224|9125578|P1|Overall Study|Adverse Event|0
2641764|NCT00783198|9125590|P3|Overall Study|Administrative|2
2641765|NCT00783198|9125591|P2|Overall Study|Administrative|1
2641766|NCT00783198|9125592|P1|Overall Study|Administrative|2
2641767|NCT00783198|9125590|P3|Overall Study|Did not meet protocol eligibility|0
2641768|NCT00783198|9125591|P2|Overall Study|Did not meet protocol eligibility|1
2641769|NCT00783198|9125592|P1|Overall Study|Did not meet protocol eligibility|0
2641770|NCT00783198|9125590|P3|Overall Study|Noncompliance with protocol|10
2641771|NCT00783198|9125591|P2|Overall Study|Noncompliance with protocol|7
2641772|NCT00783198|9125592|P1|Overall Study|Noncompliance with protocol|7
2641773|NCT00783198|9125590|P3|Overall Study|Withdrawal by Subject|20
2641774|NCT00783198|9125591|P2|Overall Study|Withdrawal by Subject|14
2641775|NCT00783198|9125592|P1|Overall Study|Withdrawal by Subject|22
2641776|NCT00783198|9125590|P3|Overall Study|Lost to Follow-up|7
2641777|NCT00783198|9125591|P2|Overall Study|Lost to Follow-up|1
2641778|NCT00783198|9125592|P1|Overall Study|Lost to Follow-up|11
2641779|NCT00783198|9125590|P3|Overall Study|Adverse Event|3
2641780|NCT00783198|9125591|P2|Overall Study|Adverse Event|19
2641781|NCT00783198|9125592|P1|Overall Study|Adverse Event|15
2641782|NCT00783094|9125615|P3|Open-Label Extension Period|Lack of Efficacy|0
2641783|NCT00783094|9125616|P2|Open-Label Extension Period|Lack of Efficacy|4
2641784|NCT00783094|9125617|P1|Open-Label Extension Period|Lack of Efficacy|1
2641785|NCT00783094|9125615|P3|Open-Label Extension Period|Physician Decision|3
2641786|NCT00783094|9125616|P2|Open-Label Extension Period|Physician Decision|2
2641787|NCT00783094|9125617|P1|Open-Label Extension Period|Physician Decision|4
2641788|NCT00783094|9125615|P3|Open-Label Extension Period|Withdrawal by Subject|3
2641789|NCT00783094|9125616|P2|Open-Label Extension Period|Withdrawal by Subject|1
2641790|NCT00783094|9125617|P1|Open-Label Extension Period|Withdrawal by Subject|1
2641791|NCT00783094|9125615|P3|Open-Label Extension Period|Protocol Violation|7
2641792|NCT00783094|9125616|P2|Open-Label Extension Period|Protocol Violation|5
2641793|NCT00783094|9125617|P1|Open-Label Extension Period|Protocol Violation|4
2641794|NCT00783094|9125615|P3|Open-Label Extension Period|Death|1
2641795|NCT00783094|9125616|P2|Open-Label Extension Period|Death|0
2641796|NCT00783094|9125617|P1|Open-Label Extension Period|Death|0
2641797|NCT00783094|9125615|P3|Open-Label Extension Period|Adverse Event|16
2641798|NCT00783094|9125616|P2|Open-Label Extension Period|Adverse Event|7
2641799|NCT00783094|9125617|P1|Open-Label Extension Period|Adverse Event|12
2641800|NCT00783094|9125615|P3|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
2641801|NCT00783094|9125616|P2|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1
2641802|NCT00783094|9125617|P1|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
2641803|NCT00783094|9125615|P3|Randomized Double-Blind Treatment Period|Protocol Violation|1
2641804|NCT00783094|9125616|P2|Randomized Double-Blind Treatment Period|Protocol Violation|2
2641805|NCT00783094|9125617|P1|Randomized Double-Blind Treatment Period|Protocol Violation|1
2641806|NCT00783094|9125615|P3|Randomized Double-Blind Treatment Period|Physician Decision|0
2641807|NCT00783094|9125616|P2|Randomized Double-Blind Treatment Period|Physician Decision|2
2641808|NCT00783094|9125617|P1|Randomized Double-Blind Treatment Period|Physician Decision|0
2641809|NCT00783094|9125615|P3|Randomized Double-Blind Treatment Period|Lack of Efficacy|1
2641810|NCT00783094|9125616|P2|Randomized Double-Blind Treatment Period|Lack of Efficacy|2
2641811|NCT00783094|9125617|P1|Randomized Double-Blind Treatment Period|Lack of Efficacy|0
2641812|NCT00783094|9125615|P3|Randomized Double-Blind Treatment Period|Adverse Event|5
2641813|NCT00783094|9125616|P2|Randomized Double-Blind Treatment Period|Adverse Event|5
2641814|NCT00783094|9125617|P1|Randomized Double-Blind Treatment Period|Adverse Event|4
2641815|NCT00782834|9125693|P1|Treatment Phase|fibrous tumor not GIST|1
2641816|NCT00782795|9125733|P2|Overall Study|Withdrawal by Subject|2
2641817|NCT00782795|9125734|P1|Overall Study|Withdrawal by Subject|1
2641818|NCT00782717|9125774|P2|Overall Study|Exited in error|2
2641819|NCT00782717|9125775|P1|Overall Study|Exited in error|0
2641820|NCT00782717|9125774|P2|Overall Study|Did not meet entrance criteria|3
2641821|NCT00782717|9125775|P1|Overall Study|Did not meet entrance criteria|1
2641822|NCT00782717|9125774|P2|Overall Study|Enrollment close prior to surgery|0
2641823|NCT00782717|9125775|P1|Overall Study|Enrollment close prior to surgery|1
2641824|NCT00782717|9125774|P2|Overall Study|Treatment failure|14
2641825|NCT00782717|9125775|P1|Overall Study|Treatment failure|3
2641826|NCT00782717|9125774|P2|Overall Study|Noncompliance|1
2641827|NCT00782717|9125775|P1|Overall Study|Noncompliance|2
2641828|NCT00782717|9125774|P2|Overall Study|Patient decision unrelated to AE|3
2641829|NCT00782717|9125775|P1|Overall Study|Patient decision unrelated to AE|6
2641830|NCT00782717|9125774|P2|Overall Study|Adverse Event|5
2641831|NCT00782717|9125775|P1|Overall Study|Adverse Event|2
2641832|NCT00782626|9125802|P1|Overall Study|Other Complicating Disease|1
2641833|NCT00782626|9125802|P1|Overall Study|Progressive Disease|5
2641834|NCT00782626|9125802|P1|Overall Study|Adverse Event|1
2641835|NCT00782509|9125809|P3|Overall Study|Lack of Efficacy|2
2641836|NCT00782509|9125810|P2|Overall Study|Lack of Efficacy|5
2641837|NCT00782509|9125811|P1|Overall Study|Lack of Efficacy|10
2641838|NCT00782509|9125809|P3|Overall Study|Other reasons not stated above|3
2641839|NCT00782509|9125810|P2|Overall Study|Other reasons not stated above|2
2641840|NCT00782509|9125811|P1|Overall Study|Other reasons not stated above|5
2641841|NCT00782509|9125809|P3|Overall Study|Non compliance with protocol|0
2641842|NCT00782509|9125810|P2|Overall Study|Non compliance with protocol|0
2641843|NCT00782509|9125811|P1|Overall Study|Non compliance with protocol|2
2641844|NCT00782509|9125809|P3|Overall Study|Withdrawal by Subject|8
2641845|NCT00782509|9125810|P2|Overall Study|Withdrawal by Subject|5
2641846|NCT00782509|9125811|P1|Overall Study|Withdrawal by Subject|3
2641847|NCT00782509|9125809|P3|Overall Study|Lost to Follow-up|3
2641848|NCT00782509|9125810|P2|Overall Study|Lost to Follow-up|2
2641849|NCT00782509|9125811|P1|Overall Study|Lost to Follow-up|1
2641850|NCT00782509|9125809|P3|Overall Study|Adverse Event|20
2641851|NCT00782509|9125810|P2|Overall Study|Adverse Event|10
2641852|NCT00782509|9125811|P1|Overall Study|Adverse Event|20
2641853|NCT00782496|9126004|P2|Overall Study|Lost to Follow-up|15
2641854|NCT00782496|9126005|P1|Overall Study|Lost to Follow-up|14
2641855|NCT00782483|9126012|P1|Overall Study|Early Termination of Protocol - PI Reloc|6
2641856|NCT00782418|9126016|P7|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
2641857|NCT00782418|9126017|P6|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
2641858|NCT00782418|9126018|P5|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
2641859|NCT00782418|9126019|P4|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
2641860|NCT00782418|9126020|P3|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
2641861|NCT00782418|9126021|P2|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
2641862|NCT00782418|9126022|P1|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
2641863|NCT00782418|9126016|P7|Period 1 Procedure/Treatment Groups|Adverse Event|0
2641864|NCT00782418|9126017|P6|Period 1 Procedure/Treatment Groups|Adverse Event|0
2641865|NCT00782418|9126018|P5|Period 1 Procedure/Treatment Groups|Adverse Event|0
2641866|NCT00782418|9126019|P4|Period 1 Procedure/Treatment Groups|Adverse Event|0
2641867|NCT00782418|9126020|P3|Period 1 Procedure/Treatment Groups|Adverse Event|0
2641868|NCT00782418|9126021|P2|Period 1 Procedure/Treatment Groups|Adverse Event|0
2641869|NCT00782418|9126022|P1|Period 1 Procedure/Treatment Groups|Adverse Event|1
2641870|NCT00782340|9126059|P3|Open Label Titration|Randomized in error|0
2641871|NCT00782340|9126060|P2|Open Label Titration|Randomized in error|0
2641872|NCT00782340|9126061|P1|Open Label Titration|Randomized in error|6
2641873|NCT00782340|9126059|P3|Open Label Titration|Lost to Follow-up|0
2641874|NCT00782340|9126060|P2|Open Label Titration|Lost to Follow-up|0
2641875|NCT00782340|9126061|P1|Open Label Titration|Lost to Follow-up|5
2641876|NCT00782340|9126059|P3|Open Label Titration|Did not meet responder criteria|0
2641877|NCT00782340|9126060|P2|Open Label Titration|Did not meet responder criteria|0
2641878|NCT00782340|9126061|P1|Open Label Titration|Did not meet responder criteria|2
2641879|NCT00782340|9126059|P3|Open Label Titration|Enrollment capped|0
2641880|NCT00782340|9126060|P2|Open Label Titration|Enrollment capped|0
2641881|NCT00782340|9126061|P1|Open Label Titration|Enrollment capped|16
2641882|NCT00782340|9126059|P3|Open Label Titration|Withdrawal by Subject|0
2641883|NCT00782340|9126060|P2|Open Label Titration|Withdrawal by Subject|0
2641884|NCT00782340|9126061|P1|Open Label Titration|Withdrawal by Subject|5
2641885|NCT00782340|9126059|P3|Open Label Titration|Protocol Violation|0
2641886|NCT00782340|9126060|P2|Open Label Titration|Protocol Violation|0
2641887|NCT00782340|9126061|P1|Open Label Titration|Protocol Violation|5
2641888|NCT00782340|9126059|P3|Open Label Titration|Treatment failure|0
2641889|NCT00782340|9126060|P2|Open Label Titration|Treatment failure|0
2641890|NCT00782340|9126061|P1|Open Label Titration|Treatment failure|50
2641891|NCT00782340|9126059|P3|Open Label Titration|Adverse Event|0
2641892|NCT00782340|9126060|P2|Open Label Titration|Adverse Event|0
2641893|NCT00782340|9126061|P1|Open Label Titration|Adverse Event|12
2641894|NCT00782275|9126131|P1|Overall Study|Other|3
2641895|NCT00782275|9126131|P1|Overall Study|Not started treatment|1
2641896|NCT00782275|9126131|P1|Overall Study|Physician Decision|4
2641897|NCT00782275|9126131|P1|Overall Study|Progressive Disease|21
2641898|NCT00782275|9126131|P1|Overall Study|Withdrawal by Subject|1
2641899|NCT00782275|9126131|P1|Overall Study|Adverse Event|11
2641900|NCT00782210|9126140|P3|Overall Study|Other reason not described above|3
2641901|NCT00782210|9126141|P2|Overall Study|Other reason not described above|2
2641902|NCT00782210|9126142|P1|Overall Study|Other reason not described above|3
2641903|NCT00782210|9126140|P3|Overall Study|Lack of Efficacy|1
2641904|NCT00782210|9126141|P2|Overall Study|Lack of Efficacy|4
2641905|NCT00782210|9126142|P1|Overall Study|Lack of Efficacy|13
2641906|NCT00782210|9126140|P3|Overall Study|Non compliance with protocol|2
2641907|NCT00782210|9126141|P2|Overall Study|Non compliance with protocol|3
2641908|NCT00782210|9126142|P1|Overall Study|Non compliance with protocol|0
2641909|NCT00782210|9126140|P3|Overall Study|Withdrawal by Subject|11
2641910|NCT00782210|9126141|P2|Overall Study|Withdrawal by Subject|8
2641911|NCT00782210|9126142|P1|Overall Study|Withdrawal by Subject|11
2641912|NCT00782210|9126140|P3|Overall Study|Lost to Follow-up|2
2641913|NCT00782210|9126141|P2|Overall Study|Lost to Follow-up|1
2641914|NCT00782210|9126142|P1|Overall Study|Lost to Follow-up|2
2641915|NCT00782210|9126140|P3|Overall Study|Adverse Event|16
2641916|NCT00782210|9126141|P2|Overall Study|Adverse Event|17
2641917|NCT00782210|9126142|P1|Overall Study|Adverse Event|21
2641918|NCT00782184|9126335|P2|Overall Study|Withdrawal by Subject|2
2641919|NCT00782184|9126336|P1|Overall Study|Withdrawal by Subject|3
2641920|NCT00782184|9126335|P2|Overall Study|Protocol Violation|1
2641921|NCT00782184|9126336|P1|Overall Study|Protocol Violation|0
2641922|NCT00782184|9126335|P2|Overall Study|Adverse Event|2
2641923|NCT00782184|9126336|P1|Overall Study|Adverse Event|1
2641924|NCT00782171|9126373|P2|Overall Study|not eligible|6
2641925|NCT00782171|9126374|P1|Overall Study|not eligible|8
2641926|NCT00782171|9126373|P2|Overall Study|others|9
2641927|NCT00782171|9126374|P1|Overall Study|others|7
2641928|NCT00782171|9126373|P2|Overall Study|complications|1
2641929|NCT00782171|9126374|P1|Overall Study|complications|3
2641930|NCT00782171|9126373|P2|Overall Study|Withdrawal by Subject|1
2641931|NCT00782171|9126374|P1|Overall Study|Withdrawal by Subject|2
2641932|NCT00782171|9126373|P2|Overall Study|Lost to Follow-up|2
2641933|NCT00782171|9126374|P1|Overall Study|Lost to Follow-up|2
2641934|NCT00782067|9126406|P1|Overall Study|Protocol deviation|2
2641935|NCT00782067|9126406|P1|Overall Study|Disease progression|43
2641936|NCT00782067|9126406|P1|Overall Study|Death|9
2641937|NCT00782067|9126406|P1|Overall Study|Administrative problems|14
2641938|NCT00782067|9126406|P1|Overall Study|Lost to Follow-up|2
2641939|NCT00782067|9126406|P1|Overall Study|Subject withdrew consent|11
2641940|NCT00782067|9126406|P1|Overall Study|Adverse Event|35
2641941|NCT00781963|9126418|P2|Overall Study|Refused follow-up|0
2641942|NCT00781963|9126419|P1|Overall Study|Refused follow-up|9
2641943|NCT00781963|9126418|P2|Overall Study|Withdrawal by Subject|1
2641944|NCT00781963|9126419|P1|Overall Study|Withdrawal by Subject|3
2641945|NCT00781963|9126418|P2|Overall Study|Lost to Follow-up|1
2641946|NCT00781963|9126419|P1|Overall Study|Lost to Follow-up|2
2641947|NCT00781963|9126418|P2|Overall Study|Death|0
2641948|NCT00781963|9126419|P1|Overall Study|Death|3
2641949|NCT00781937|9126448|P2|Follow up Period (Week 56-68)|Unclassified|4
2641950|NCT00781937|9126449|P1|Follow up Period (Week 56-68)|Unclassified|5
2641951|NCT00781937|9126448|P2|Follow up Period (Week 56-68)|Protocol Violation|1
2641952|NCT00781937|9126449|P1|Follow up Period (Week 56-68)|Protocol Violation|1
2641953|NCT00781937|9126448|P2|Main Trial Period Through Week 56|Unclassified|15
2641954|NCT00781937|9126449|P1|Main Trial Period Through Week 56|Unclassified|10
2641955|NCT00781937|9126448|P2|Main Trial Period Through Week 56|Withdrawal by Subject|24
2641956|NCT00781937|9126449|P1|Main Trial Period Through Week 56|Withdrawal by Subject|17
2641957|NCT00781937|9126448|P2|Main Trial Period Through Week 56|Protocol Violation|5
2641958|NCT00781937|9126449|P1|Main Trial Period Through Week 56|Protocol Violation|8
2641959|NCT00781937|9126448|P2|Main Trial Period Through Week 56|Lack of Efficacy|2
2641960|NCT00781937|9126449|P1|Main Trial Period Through Week 56|Lack of Efficacy|0
2641961|NCT00781937|9126448|P2|Main Trial Period Through Week 56|Adverse Event|18
2641962|NCT00781937|9126449|P1|Main Trial Period Through Week 56|Adverse Event|18
2641963|NCT00781911|9126507|P2|Overall Study|Sponsor Decision|0
2641964|NCT00781911|9126508|P1|Overall Study|Sponsor Decision|1
2641965|NCT00781911|9126507|P2|Overall Study|Physician Decision|2
2641966|NCT00781911|9126508|P1|Overall Study|Physician Decision|0
2641967|NCT00781911|9126507|P2|Overall Study|Withdrawal by Subject|2
2641968|NCT00781911|9126508|P1|Overall Study|Withdrawal by Subject|1
2641969|NCT00781911|9126507|P2|Overall Study|Adverse Event|4
2641970|NCT00781911|9126508|P1|Overall Study|Adverse Event|4
2641971|NCT00781859|9126545|P2|Overall Study|Death|0
2641972|NCT00781859|9126546|P1|Overall Study|Death|3
2641973|NCT00781859|9126545|P2|Overall Study|Lost to Follow-up|3
2641974|NCT00781859|9126546|P1|Overall Study|Lost to Follow-up|6
2641975|NCT00781859|9126545|P2|Overall Study|Withdrawal by Subject|4
2641976|NCT00781859|9126546|P1|Overall Study|Withdrawal by Subject|8
2641977|NCT00781859|9126545|P2|Overall Study|Adverse Event|2
2641978|NCT00781859|9126546|P1|Overall Study|Adverse Event|2
2641979|NCT00781768|9126556|P2|Overall Study|Not transplanted.|2
2641980|NCT00781768|9126557|P1|Overall Study|Not transplanted.|0
2641981|NCT00781599|9126565|P2|Overall Study|Lost to Follow-up|4
2641982|NCT00781599|9126566|P1|Overall Study|Lost to Follow-up|7
2641983|NCT00781456|9126591|P2|Overall Study|Other Reason, Unknown|1
2641984|NCT00781456|9126592|P1|Overall Study|Other Reason, Unknown|0
2641985|NCT00781456|9126591|P2|Overall Study|Lost to Follow-up|5
2641986|NCT00781456|9126592|P1|Overall Study|Lost to Follow-up|10
2641987|NCT00781456|9126591|P2|Overall Study|Noncompliance With Protocol|1
2641988|NCT00781456|9126592|P1|Overall Study|Noncompliance With Protocol|1
2641989|NCT00781456|9126591|P2|Overall Study|Protocol Violation|1
2641990|NCT00781456|9126592|P1|Overall Study|Protocol Violation|4
2641991|NCT00781456|9126591|P2|Overall Study|Withdrawal by Subject|5
2641992|NCT00781456|9126592|P1|Overall Study|Withdrawal by Subject|3
2641993|NCT00781456|9126591|P2|Overall Study|Adverse Event|3
2641994|NCT00781456|9126592|P1|Overall Study|Adverse Event|3
2641995|NCT00781391|9126615|P3|Overall Study|Lost to Follow-up|1
2641996|NCT00781391|9126616|P2|Overall Study|Lost to Follow-up|0
2641997|NCT00781391|9126617|P1|Overall Study|Lost to Follow-up|0
2641998|NCT00781391|9126615|P3|Overall Study|Withdrawal by Subject|25
2641999|NCT00781391|9126616|P2|Overall Study|Withdrawal by Subject|37
2642000|NCT00781391|9126617|P1|Overall Study|Withdrawal by Subject|47
2642001|NCT00781391|9126615|P3|Overall Study|Death|706
2642002|NCT00781391|9126616|P2|Overall Study|Death|730
2642003|NCT00781391|9126617|P1|Overall Study|Death|789
2642004|NCT00781391|9126615|P3|Overall Study|Protocol Violation|20
2642005|NCT00781391|9126616|P2|Overall Study|Protocol Violation|17
2642006|NCT00781391|9126617|P1|Overall Study|Protocol Violation|19
2642007|NCT00781391|9126615|P3|Overall Study|never received study drug|32
2642008|NCT00781391|9126616|P2|Overall Study|never received study drug|23
2642009|NCT00781391|9126617|P1|Overall Study|never received study drug|24
2642010|NCT00781365|9126651|P2|Overall Study|Language barrier|0
2642011|NCT00781365|9126652|P1|Overall Study|Language barrier|1
2642012|NCT00781365|9126651|P2|Overall Study|Did Not Attend Visit|28
2642013|NCT00781365|9126652|P1|Overall Study|Did Not Attend Visit|20
2642014|NCT00781365|9126651|P2|Overall Study|Withdrawal by Subject|8
2642015|NCT00781365|9126652|P1|Overall Study|Withdrawal by Subject|13
2642016|NCT00781326|9126662|P1|Phase I|Physician Decision|2
2642017|NCT00781326|9126662|P1|Phase I|Withdrawal by Subject|1
2642018|NCT00781326|9126662|P1|Phase I|Adverse Event|1
2642019|NCT00781274|9126666|P1|Overall Study|Withdrawal by Subject|2
2642020|NCT00780910|9126698|P1|Overall Study|Adverse Event|2
2642021|NCT00780559|9126760|P2|Overall Study|Death|0
2642022|NCT00780559|9126761|P1|Overall Study|Death|1
2642023|NCT00780559|9126760|P2|Overall Study|Lost to Follow-up|7
2642024|NCT00780559|9126761|P1|Overall Study|Lost to Follow-up|2
2642025|NCT00780416|9126829|P2|Overall Study|Withdrawal by Subject|6
2642026|NCT00780416|9126830|P1|Overall Study|Withdrawal by Subject|8
2642027|NCT00780416|9126829|P2|Overall Study|Protocol Violation|0
2642028|NCT00780416|9126830|P1|Overall Study|Protocol Violation|1
2642029|NCT00780416|9126829|P2|Overall Study|Physician Decision|3
2642030|NCT00780416|9126830|P1|Overall Study|Physician Decision|3
2642031|NCT00780273|9126875|P1|Overall Study|Lost to Follow-up|1
2642032|NCT00780273|9126875|P1|Overall Study|Death|1
2642033|NCT00780143|9126898|P1|Overall Study|Adverse Event|1
2642034|NCT00780143|9126898|P1|Overall Study|Toxicity|1
2642035|NCT00780143|9126898|P1|Overall Study|Progressive disease|1
2642036|NCT00779909|9126929|P4|Overall Study|Withdrawal by Subject|0
2642037|NCT00779909|9126930|P3|Overall Study|Withdrawal by Subject|0
2642038|NCT00779909|9126931|P2|Overall Study|Withdrawal by Subject|1
2642039|NCT00779909|9126932|P1|Overall Study|Withdrawal by Subject|0
2642040|NCT00779909|9126929|P4|Overall Study|Lost to Follow-up|1
2642041|NCT00779909|9126930|P3|Overall Study|Lost to Follow-up|0
2642042|NCT00779909|9126931|P2|Overall Study|Lost to Follow-up|0
2642043|NCT00779909|9126932|P1|Overall Study|Lost to Follow-up|1
2642044|NCT00779857|9126996|P1|Overall Study|Missed Visit|2
2642045|NCT00779857|9126996|P1|Overall Study|Withdrawal by Subject|3
2642046|NCT00779857|9126996|P1|Overall Study|Death|1
2642047|NCT00779779|9127001|P1|Overall Study|Lost to Follow-up|5
2642048|NCT00779779|9127001|P1|Overall Study|Withdrawal by Subject|4
2642049|NCT00779779|9127001|P1|Overall Study|Protocol Violation|14
2642050|NCT00779779|9127001|P1|Overall Study|Adverse Event|1
2642051|NCT00779766|9127010|P2|Month 72|Other|1
2642052|NCT00779766|9127011|P1|Month 72|Other|0
2642053|NCT00779766|9127010|P2|Month 72|Lost to Follow-up|8
2642054|NCT00779766|9127011|P1|Month 72|Lost to Follow-up|6
2642055|NCT00779766|9127010|P2|Month 72|Migrated/moved from study area|109
2642056|NCT00779766|9127011|P1|Month 72|Migrated/moved from study area|124
2642057|NCT00779766|9127010|P2|Month 72|Withdrawal by Subject|71
2642058|NCT00779766|9127011|P1|Month 72|Withdrawal by Subject|55
2642059|NCT00779766|9127010|P2|Month 48|Other|0
2642060|NCT00779766|9127011|P1|Month 48|Other|1
2642061|NCT00779766|9127010|P2|Month 48|Lost to Follow-up|30
2642062|NCT00779766|9127011|P1|Month 48|Lost to Follow-up|29
2642063|NCT00779766|9127010|P2|Month 48|Migrated/moved from study area|75
2642064|NCT00779766|9127011|P1|Month 48|Migrated/moved from study area|76
2642065|NCT00779766|9127010|P2|Month 48|Withdrawal by Subject|63
2642066|NCT00779766|9127011|P1|Month 48|Withdrawal by Subject|68
2642067|NCT00779766|9127010|P2|Month 24|Other|27
2642068|NCT00779766|9127011|P1|Month 24|Other|18
2642069|NCT00779766|9127010|P2|Month 24|Lost to Follow-up|9
2642070|NCT00779766|9127011|P1|Month 24|Lost to Follow-up|9
2642071|NCT00779766|9127010|P2|Month 24|Migrated/moved from study area|162
2642072|NCT00779766|9127011|P1|Month 24|Migrated/moved from study area|138
2642073|NCT00779766|9127010|P2|Month 24|Withdrawal by Subject|127
2642074|NCT00779766|9127011|P1|Month 24|Withdrawal by Subject|159
2642075|NCT00779766|9127010|P2|Month 24|Protocol Violation|1
2642076|NCT00779766|9127011|P1|Month 24|Protocol Violation|3
2642077|NCT00779766|9127010|P2|Month 24|Adverse Event|3
2642078|NCT00779766|9127011|P1|Month 24|Adverse Event|3
2642079|NCT00779766|9127010|P2|Month 24|Serious Adverse Event|3
2642080|NCT00779766|9127011|P1|Month 24|Serious Adverse Event|2
2642081|NCT00779675|9127099|P1|Extended Treatment Period|Lost to Follow-up|6
2642082|NCT00779675|9127099|P1|Extended Treatment Period|Protocol defined clinical event|1
2642083|NCT00779675|9127099|P1|Extended Treatment Period|Treatment Failure|11
2642084|NCT00779675|9127099|P1|Extended Treatment Period|Adverse Event|6
2642085|NCT00779675|9127099|P1|Extended Treatment Period|Protocol Violation|13
2642086|NCT00779675|9127099|P1|Extended Treatment Period|Reasons unrelated to study treatment|9
2642087|NCT00779675|9127099|P1|Treatment Period|Administrative|3
2642088|NCT00779675|9127099|P1|Treatment Period|Did Not Meet Protocol Eligibility|1
2642089|NCT00779675|9127099|P1|Treatment Period|Protocol Violation|54
2642090|NCT00779675|9127099|P1|Treatment Period|Withdrawal by Subject|46
2642091|NCT00779675|9127099|P1|Treatment Period|Lost to Follow-up|23
2642092|NCT00779675|9127099|P1|Treatment Period|Transferred to Another Study|38
2642093|NCT00779675|9127099|P1|Treatment Period|Treatment Failure|80
2642094|NCT00779675|9127099|P1|Treatment Period|Adverse Event|87
2642095|NCT00779584|9127127|P9|Overall Study|Ongoing in Study|0
2642096|NCT00779584|9127128|P8|Overall Study|Ongoing in Study|0
2642097|NCT00779584|9127129|P7|Overall Study|Ongoing in Study|0
2642098|NCT00779584|9127130|P6|Overall Study|Ongoing in Study|1
2642099|NCT00779584|9127131|P5|Overall Study|Ongoing in Study|1
2642100|NCT00779584|9127132|P4|Overall Study|Ongoing in Study|0
2642101|NCT00779584|9127133|P3|Overall Study|Ongoing in Study|0
2642102|NCT00779584|9127134|P2|Overall Study|Ongoing in Study|0
2642103|NCT00779584|9127135|P1|Overall Study|Ongoing in Study|0
2642104|NCT00779584|9127127|P9|Overall Study|Symptomatic Deterioration|0
2642105|NCT00779584|9127128|P8|Overall Study|Symptomatic Deterioration|0
2642106|NCT00779584|9127129|P7|Overall Study|Symptomatic Deterioration|1
2642107|NCT00779584|9127130|P6|Overall Study|Symptomatic Deterioration|1
2642108|NCT00779584|9127131|P5|Overall Study|Symptomatic Deterioration|0
2642109|NCT00779584|9127132|P4|Overall Study|Symptomatic Deterioration|0
2642110|NCT00779584|9127133|P3|Overall Study|Symptomatic Deterioration|1
2642111|NCT00779584|9127134|P2|Overall Study|Symptomatic Deterioration|1
2642112|NCT00779584|9127135|P1|Overall Study|Symptomatic Deterioration|1
2642113|NCT00779584|9127127|P9|Overall Study|Adverse Event|1
2642114|NCT00779584|9127128|P8|Overall Study|Adverse Event|1
2642115|NCT00779584|9127129|P7|Overall Study|Adverse Event|2
2642116|NCT00779584|9127130|P6|Overall Study|Adverse Event|0
2642117|NCT00779584|9127131|P5|Overall Study|Adverse Event|0
2642118|NCT00779584|9127132|P4|Overall Study|Adverse Event|0
2642119|NCT00779584|9127133|P3|Overall Study|Adverse Event|2
2642120|NCT00779584|9127134|P2|Overall Study|Adverse Event|0
2642121|NCT00779584|9127135|P1|Overall Study|Adverse Event|1
2642122|NCT00779584|9127127|P9|Overall Study|Progression of Disease|1
2642123|NCT00779584|9127128|P8|Overall Study|Progression of Disease|2
2642124|NCT00779584|9127129|P7|Overall Study|Progression of Disease|4
2642125|NCT00779584|9127130|P6|Overall Study|Progression of Disease|1
2642126|NCT00779584|9127131|P5|Overall Study|Progression of Disease|5
2642127|NCT00779584|9127132|P4|Overall Study|Progression of Disease|6
2642128|NCT00779584|9127133|P3|Overall Study|Progression of Disease|2
2642129|NCT00779584|9127134|P2|Overall Study|Progression of Disease|1
2642130|NCT00779584|9127135|P1|Overall Study|Progression of Disease|0
2642131|NCT00779584|9127127|P9|Overall Study|Lost to Follow-up|0
2642132|NCT00779584|9127128|P8|Overall Study|Lost to Follow-up|0
2642133|NCT00779584|9127129|P7|Overall Study|Lost to Follow-up|0
2642134|NCT00779584|9127130|P6|Overall Study|Lost to Follow-up|0
2642135|NCT00779584|9127131|P5|Overall Study|Lost to Follow-up|1
2642136|NCT00779584|9127132|P4|Overall Study|Lost to Follow-up|0
2642137|NCT00779584|9127133|P3|Overall Study|Lost to Follow-up|0
2642138|NCT00779584|9127134|P2|Overall Study|Lost to Follow-up|0
2642139|NCT00779584|9127135|P1|Overall Study|Lost to Follow-up|0
2642140|NCT00779584|9127127|P9|Overall Study|Withdrawal by Subject|0
2642141|NCT00779584|9127128|P8|Overall Study|Withdrawal by Subject|0
2642142|NCT00779584|9127129|P7|Overall Study|Withdrawal by Subject|1
2642143|NCT00779584|9127130|P6|Overall Study|Withdrawal by Subject|2
2642144|NCT00779584|9127131|P5|Overall Study|Withdrawal by Subject|0
2642145|NCT00779584|9127132|P4|Overall Study|Withdrawal by Subject|0
2642146|NCT00779584|9127133|P3|Overall Study|Withdrawal by Subject|2
2642147|NCT00779584|9127134|P2|Overall Study|Withdrawal by Subject|1
2642148|NCT00779584|9127135|P1|Overall Study|Withdrawal by Subject|1
2642149|NCT00779584|9127127|P9|Overall Study|Protocol Violation|0
2642150|NCT00779584|9127128|P8|Overall Study|Protocol Violation|0
2642151|NCT00779584|9127129|P7|Overall Study|Protocol Violation|0
2642152|NCT00779584|9127130|P6|Overall Study|Protocol Violation|1
2642153|NCT00779584|9127131|P5|Overall Study|Protocol Violation|0
2642154|NCT00779584|9127132|P4|Overall Study|Protocol Violation|0
2642155|NCT00779584|9127133|P3|Overall Study|Protocol Violation|0
2642156|NCT00779584|9127134|P2|Overall Study|Protocol Violation|0
2642157|NCT00779584|9127135|P1|Overall Study|Protocol Violation|0
2642158|NCT00779506|9127226|P1|Overall Study|Lost to Follow-up|1
2642159|NCT00779506|9127226|P1|Overall Study|Withdrawal by Subject|6
2642160|NCT00779506|9127226|P1|Overall Study|Protocol Violation|5
2642161|NCT00779506|9127226|P1|Overall Study|Lack of Efficacy|11
2642162|NCT00779506|9127226|P1|Overall Study|Adverse Event|4
2642163|NCT00779506|9127226|P1|Overall Study|Screening Failed|2
2642164|NCT00779467|9127240|P4|Overall Study|unavailable research staff|1
2642165|NCT00779467|9127241|P3|Overall Study|unavailable research staff|0
2642166|NCT00779467|9127242|P2|Overall Study|unavailable research staff|0
2642167|NCT00779467|9127243|P1|Overall Study|unavailable research staff|0
2642168|NCT00779467|9127240|P4|Overall Study|technical issue|1
2642169|NCT00779467|9127241|P3|Overall Study|technical issue|2
2642170|NCT00779467|9127242|P2|Overall Study|technical issue|0
2642171|NCT00779467|9127243|P1|Overall Study|technical issue|0
2642172|NCT00779467|9127240|P4|Overall Study|missing data|4
2642173|NCT00779467|9127241|P3|Overall Study|missing data|1
2642174|NCT00779467|9127242|P2|Overall Study|missing data|0
2642175|NCT00779467|9127243|P1|Overall Study|missing data|1
2642176|NCT00779467|9127240|P4|Overall Study|failed inclusion criteria|2
2642177|NCT00779467|9127241|P3|Overall Study|failed inclusion criteria|1
2642178|NCT00779467|9127242|P2|Overall Study|failed inclusion criteria|3
2642179|NCT00779467|9127243|P1|Overall Study|failed inclusion criteria|3
2642180|NCT00779467|9127240|P4|Overall Study|Lack of Efficacy|11
2642181|NCT00779467|9127241|P3|Overall Study|Lack of Efficacy|6
2642182|NCT00779467|9127242|P2|Overall Study|Lack of Efficacy|2
2642183|NCT00779467|9127243|P1|Overall Study|Lack of Efficacy|11
2642184|NCT00779402|9127283|P2|Long-term Follow-up|Completed Protocol Visits|2
2642185|NCT00779402|9127284|P1|Long-term Follow-up|Completed Protocol Visits|6
2642186|NCT00779402|9127283|P2|Long-term Follow-up|Closure of Study|4
2642187|NCT00779402|9127284|P1|Long-term Follow-up|Closure of Study|8
2642188|NCT00779402|9127283|P2|Long-term Follow-up|Other|0
2642189|NCT00779402|9127284|P1|Long-term Follow-up|Other|5
2642190|NCT00779402|9127283|P2|Long-term Follow-up|Patient refused to continue|0
2642191|NCT00779402|9127284|P1|Long-term Follow-up|Patient refused to continue|2
2642192|NCT00779402|9127283|P2|Surveillance Phase|Completed Protocol Visits|2
2642193|NCT00779402|9127284|P1|Surveillance Phase|Completed Protocol Visits|3
2642194|NCT00779402|9127283|P2|Surveillance Phase|Closure of study|6
2642195|NCT00779402|9127284|P1|Surveillance Phase|Closure of study|5
2642196|NCT00779402|9127283|P2|Surveillance Phase|Withdrawal by Subject|1
2642197|NCT00779402|9127284|P1|Surveillance Phase|Withdrawal by Subject|4
2642198|NCT00779402|9127283|P2|Surveillance Phase|Other|5
2642199|NCT00779402|9127284|P1|Surveillance Phase|Other|5
2642200|NCT00779402|9127283|P2|Surveillance Phase|Intercurrent Illness|0
2642201|NCT00779402|9127284|P1|Surveillance Phase|Intercurrent Illness|2
2642202|NCT00779402|9127283|P2|Surveillance Phase|Death|1
2642203|NCT00779402|9127284|P1|Surveillance Phase|Death|0
2642204|NCT00779402|9127283|P2|Surveillance Phase|Lost to Follow-up|1
2642205|NCT00779402|9127284|P1|Surveillance Phase|Lost to Follow-up|2
2642206|NCT00779402|9127283|P2|Surveillance Phase|Patient refused to continue|14
2642207|NCT00779402|9127284|P1|Surveillance Phase|Patient refused to continue|22
2642208|NCT00779402|9127283|P2|Surveillance Phase|Protocol Violation|1
2642209|NCT00779402|9127284|P1|Surveillance Phase|Protocol Violation|0
2642210|NCT00779402|9127283|P2|Treatment Phase 1|Completed Protocol Visits|6
2642211|NCT00779402|9127284|P1|Treatment Phase 1|Completed Protocol Visits|3
2642212|NCT00779402|9127283|P2|Treatment Phase 1|Closure of Study|2
2642213|NCT00779402|9127284|P1|Treatment Phase 1|Closure of Study|3
2642214|NCT00779402|9127283|P2|Treatment Phase 1|Other|2
2642215|NCT00779402|9127284|P1|Treatment Phase 1|Other|4
2642216|NCT00779402|9127283|P2|Treatment Phase 1|Withdrawal by Subject|0
2642217|NCT00779402|9127284|P1|Treatment Phase 1|Withdrawal by Subject|1
2642218|NCT00779402|9127283|P2|Treatment Phase 1|Intercurrent Illness|1
2642219|NCT00779402|9127284|P1|Treatment Phase 1|Intercurrent Illness|1
2642220|NCT00779402|9127283|P2|Treatment Phase 1|Death|1
2642221|NCT00779402|9127284|P1|Treatment Phase 1|Death|0
2642222|NCT00779402|9127283|P2|Treatment Phase 1|Lost to Follow-up|1
2642223|NCT00779402|9127284|P1|Treatment Phase 1|Lost to Follow-up|0
2642224|NCT00779402|9127283|P2|Treatment Phase 1|Patient Refused to Continue|2
2642225|NCT00779402|9127284|P1|Treatment Phase 1|Patient Refused to Continue|17
2642226|NCT00779402|9127283|P2|Treatment Phase 1|Protocol Violation|0
2642227|NCT00779402|9127284|P1|Treatment Phase 1|Protocol Violation|1
2642228|NCT00779402|9127283|P2|Treatment Phase 1|Adverse Event|0
2642229|NCT00779402|9127284|P1|Treatment Phase 1|Adverse Event|2
2642230|NCT00779402|9127283|P2|Treatment Phase 1|Disease Progression|0
2642231|NCT00779402|9127284|P1|Treatment Phase 1|Disease Progression|1
2642232|NCT00779259|9127327|P1|Quinine Alone|Adverse Event|2
2642233|NCT00779246|9127348|P2|Overall Study|Missing sufficient data for analysis|53
2642234|NCT00779246|9127349|P1|Overall Study|Missing sufficient data for analysis|33
2642235|NCT00779142|9127368|P1|Overall Study|Screen Failures|3
2642236|NCT00779038|9127382|P1|Overall Study|Study Prematurely Terminated|13
2642237|NCT00779025|9127391|P1|Overall Study|Withdrawal by Subject|1
2642238|NCT00778999|9127402|P2|Overall Study|Did not receive recFSH|20
2642239|NCT00778999|9127403|P1|Overall Study|Did not receive recFSH|14
2642240|NCT00778999|9127402|P2|Overall Study|Discontinuation: no embryo transfer|14
2642241|NCT00778999|9127403|P1|Overall Study|Discontinuation: no embryo transfer|14
2642242|NCT00778921|9127412|P3|Overall Study|Not treated|2
2642243|NCT00778921|9127413|P2|Overall Study|Not treated|2
2642244|NCT00778921|9127414|P1|Overall Study|Not treated|0
2642245|NCT00778921|9127412|P3|Overall Study|Protocol Violation|2
2642246|NCT00778921|9127413|P2|Overall Study|Protocol Violation|0
2642247|NCT00778921|9127414|P1|Overall Study|Protocol Violation|3
2642248|NCT00778921|9127412|P3|Overall Study|Administrative Problems|0
2642249|NCT00778921|9127413|P2|Overall Study|Administrative Problems|2
2642250|NCT00778921|9127414|P1|Overall Study|Administrative Problems|1
2642251|NCT00778921|9127412|P3|Overall Study|Lost to Follow-up|1
2642252|NCT00778921|9127413|P2|Overall Study|Lost to Follow-up|2
2642253|NCT00778921|9127414|P1|Overall Study|Lost to Follow-up|0
2642254|NCT00778921|9127412|P3|Overall Study|Patient withdrew request|6
2642255|NCT00778921|9127413|P2|Overall Study|Patient withdrew request|1
2642256|NCT00778921|9127414|P1|Overall Study|Patient withdrew request|3
2642257|NCT00778921|9127412|P3|Overall Study|Patient No Longer Requires Study Drug|0
2642258|NCT00778921|9127413|P2|Overall Study|Patient No Longer Requires Study Drug|1
2642259|NCT00778921|9127414|P1|Overall Study|Patient No Longer Requires Study Drug|0
2642260|NCT00778921|9127412|P3|Overall Study|Unsatisfactory therapeutic response|1
2642261|NCT00778921|9127413|P2|Overall Study|Unsatisfactory therapeutic response|1
2642262|NCT00778921|9127414|P1|Overall Study|Unsatisfactory therapeutic response|1
2642263|NCT00778921|9127412|P3|Overall Study|Abnormal Test Procedure Result(s)|2
2642264|NCT00778921|9127413|P2|Overall Study|Abnormal Test Procedure Result(s)|0
2642265|NCT00778921|9127414|P1|Overall Study|Abnormal Test Procedure Result(s)|0
2642266|NCT00778921|9127412|P3|Overall Study|Abnormal Laboratory Value(s)|0
2642267|NCT00778921|9127413|P2|Overall Study|Abnormal Laboratory Value(s)|0
2642268|NCT00778921|9127414|P1|Overall Study|Abnormal Laboratory Value(s)|1
2642269|NCT00778921|9127412|P3|Overall Study|Adverse Event|14
2642270|NCT00778921|9127413|P2|Overall Study|Adverse Event|10
2642271|NCT00778921|9127414|P1|Overall Study|Adverse Event|9
2642272|NCT00778895|9127431|P3|ESFU Phase|Other|0
2642273|NCT00778895|9127432|P2|ESFU Phase|Other|0
2642274|NCT00778895|9127433|P1|ESFU Phase|Other|2
2642275|NCT00778895|9127431|P3|ESFU Phase|Lost to Follow-up|2
2642276|NCT00778895|9127432|P2|ESFU Phase|Lost to Follow-up|7
2642277|NCT00778895|9127433|P1|ESFU Phase|Lost to Follow-up|6
2642278|NCT00778895|9127431|P3|ESFU Phase|Withdrawal by Subject|0
2642279|NCT00778895|9127432|P2|ESFU Phase|Withdrawal by Subject|4
2642280|NCT00778895|9127433|P1|ESFU Phase|Withdrawal by Subject|1
2642281|NCT00778895|9127431|P3|ESFU Phase|Adverse Event|0
2642282|NCT00778895|9127432|P2|ESFU Phase|Adverse Event|1
2642283|NCT00778895|9127433|P1|ESFU Phase|Adverse Event|2
2642284|NCT00778895|9127431|P3|Active Phase|Other|0
2642285|NCT00778895|9127432|P2|Active Phase|Other|0
2642286|NCT00778895|9127433|P1|Active Phase|Other|2
2642287|NCT00778895|9127431|P3|Active Phase|Lost to Follow-up|0
2642288|NCT00778895|9127432|P2|Active Phase|Lost to Follow-up|1
2642289|NCT00778895|9127433|P1|Active Phase|Lost to Follow-up|1
2642290|NCT00778895|9127431|P3|Active Phase|Withdrawal by Subject|0
2642291|NCT00778895|9127432|P2|Active Phase|Withdrawal by Subject|4
2642292|NCT00778895|9127433|P1|Active Phase|Withdrawal by Subject|1
2642293|NCT00778895|9127431|P3|Active Phase|Adverse Event|0
2642294|NCT00778895|9127432|P2|Active Phase|Adverse Event|1
2642295|NCT00778895|9127433|P1|Active Phase|Adverse Event|3
2642296|NCT00778830|9127477|P2|Overall Study|Ongoing at data cut-off|1
2642297|NCT00778830|9127478|P1|Overall Study|Ongoing at data cut-off|0
2642298|NCT00778817|9127490|P1|Overall Study|Withdrawal by Subject|2
2642299|NCT00778817|9127490|P1|Overall Study|Adverse Event|2
2642300|NCT00778622|9127517|P3|Overall Study|Other|1
2642301|NCT00778622|9127518|P2|Overall Study|Other|0
2642302|NCT00778622|9127519|P1|Overall Study|Other|1
2642303|NCT00778622|9127517|P3|Overall Study|immigration|0
2642304|NCT00778622|9127518|P2|Overall Study|immigration|0
2642305|NCT00778622|9127519|P1|Overall Study|immigration|1
2642306|NCT00778622|9127517|P3|Overall Study|Lack of Efficacy|0
2642307|NCT00778622|9127518|P2|Overall Study|Lack of Efficacy|0
2642308|NCT00778622|9127519|P1|Overall Study|Lack of Efficacy|2
2642309|NCT00778622|9127517|P3|Overall Study|Protocol Violation|0
2642310|NCT00778622|9127518|P2|Overall Study|Protocol Violation|3
2642311|NCT00778622|9127519|P1|Overall Study|Protocol Violation|0
2642312|NCT00778622|9127517|P3|Overall Study|Lost to Follow-up|2
2642313|NCT00778622|9127518|P2|Overall Study|Lost to Follow-up|3
2642314|NCT00778622|9127519|P1|Overall Study|Lost to Follow-up|3
2642315|NCT00778622|9127517|P3|Overall Study|Withdrawal by Subject|5
2642316|NCT00778622|9127518|P2|Overall Study|Withdrawal by Subject|5
2642317|NCT00778622|9127519|P1|Overall Study|Withdrawal by Subject|4
2642318|NCT00778622|9127517|P3|Overall Study|Adverse Event|7
2642319|NCT00778622|9127518|P2|Overall Study|Adverse Event|4
2642320|NCT00778622|9127519|P1|Overall Study|Adverse Event|5
2642321|NCT00778375|9127572|P1|Overall Study|Ineligible|3
2642322|NCT00778336|9127586|P4|3 Month Follow Up|Death|0
2642323|NCT00778336|9127587|P3|3 Month Follow Up|Death|2
2642324|NCT00778336|9127588|P2|3 Month Follow Up|Death|3
2642325|NCT00778336|9127589|P1|3 Month Follow Up|Death|8
2642326|NCT00778336|9127586|P4|3 Month Follow Up|Lost to Follow-up|0
2642327|NCT00778336|9127587|P3|3 Month Follow Up|Lost to Follow-up|3
2642328|NCT00778336|9127588|P2|3 Month Follow Up|Lost to Follow-up|20
2642329|NCT00778336|9127589|P1|3 Month Follow Up|Lost to Follow-up|15
2642330|NCT00778336|9127586|P4|Index Procedure-Discharge|Death|0
2642331|NCT00778336|9127587|P3|Index Procedure-Discharge|Death|2
2642332|NCT00778336|9127588|P2|Index Procedure-Discharge|Death|3
2642333|NCT00778336|9127589|P1|Index Procedure-Discharge|Death|6
2642334|NCT00778258|9127627|P9|Overall Study|Other|0
2642335|NCT00778258|9127628|P8|Overall Study|Other|0
2642336|NCT00778258|9127629|P7|Overall Study|Other|1
2642337|NCT00778258|9127630|P6|Overall Study|Other|0
2642338|NCT00778258|9127631|P5|Overall Study|Other|0
2642339|NCT00778258|9127632|P4|Overall Study|Other|0
2642340|NCT00778258|9127633|P3|Overall Study|Other|0
2642341|NCT00778258|9127634|P2|Overall Study|Other|0
2642342|NCT00778258|9127635|P1|Overall Study|Other|0
2642343|NCT00778258|9127627|P9|Overall Study|Non-compliance|0
2642344|NCT00778258|9127628|P8|Overall Study|Non-compliance|0
2642345|NCT00778258|9127629|P7|Overall Study|Non-compliance|0
2642346|NCT00778258|9127630|P6|Overall Study|Non-compliance|0
2642347|NCT00778258|9127631|P5|Overall Study|Non-compliance|0
2642348|NCT00778258|9127632|P4|Overall Study|Non-compliance|1
2642349|NCT00778258|9127633|P3|Overall Study|Non-compliance|0
2642350|NCT00778258|9127634|P2|Overall Study|Non-compliance|0
2642351|NCT00778258|9127635|P1|Overall Study|Non-compliance|0
2642352|NCT00778258|9127627|P9|Overall Study|New Contraindication|0
2642353|NCT00778258|9127628|P8|Overall Study|New Contraindication|1
2642354|NCT00778258|9127629|P7|Overall Study|New Contraindication|0
2642355|NCT00778258|9127630|P6|Overall Study|New Contraindication|0
2642356|NCT00778258|9127631|P5|Overall Study|New Contraindication|0
2642357|NCT00778258|9127632|P4|Overall Study|New Contraindication|0
2642358|NCT00778258|9127633|P3|Overall Study|New Contraindication|0
2642359|NCT00778258|9127634|P2|Overall Study|New Contraindication|0
2642360|NCT00778258|9127635|P1|Overall Study|New Contraindication|0
2642361|NCT00778258|9127627|P9|Overall Study|Withdrawal by Subject|4
2642362|NCT00778258|9127628|P8|Overall Study|Withdrawal by Subject|12
2642363|NCT00778258|9127629|P7|Overall Study|Withdrawal by Subject|12
2642364|NCT00778258|9127630|P6|Overall Study|Withdrawal by Subject|6
2642365|NCT00778258|9127631|P5|Overall Study|Withdrawal by Subject|0
2642366|NCT00778258|9127632|P4|Overall Study|Withdrawal by Subject|2
2642367|NCT00778258|9127633|P3|Overall Study|Withdrawal by Subject|8
2642368|NCT00778258|9127634|P2|Overall Study|Withdrawal by Subject|2
2642369|NCT00778258|9127635|P1|Overall Study|Withdrawal by Subject|6
2642370|NCT00778258|9127627|P9|Overall Study|Lost to Follow-up|0
2642371|NCT00778258|9127628|P8|Overall Study|Lost to Follow-up|2
2642372|NCT00778258|9127629|P7|Overall Study|Lost to Follow-up|2
2642373|NCT00778258|9127630|P6|Overall Study|Lost to Follow-up|3
2642374|NCT00778258|9127631|P5|Overall Study|Lost to Follow-up|0
2642375|NCT00778258|9127632|P4|Overall Study|Lost to Follow-up|0
2642376|NCT00778258|9127633|P3|Overall Study|Lost to Follow-up|2
2642377|NCT00778258|9127634|P2|Overall Study|Lost to Follow-up|0
2642378|NCT00778258|9127635|P1|Overall Study|Lost to Follow-up|0
2642379|NCT00778258|9127627|P9|Overall Study|Adverse Event|0
2642380|NCT00778258|9127628|P8|Overall Study|Adverse Event|0
2642381|NCT00778258|9127629|P7|Overall Study|Adverse Event|0
2642382|NCT00778258|9127630|P6|Overall Study|Adverse Event|1
2642383|NCT00778258|9127631|P5|Overall Study|Adverse Event|0
2642384|NCT00778258|9127632|P4|Overall Study|Adverse Event|0
2642385|NCT00778258|9127633|P3|Overall Study|Adverse Event|0
2642386|NCT00778258|9127634|P2|Overall Study|Adverse Event|0
2642387|NCT00778258|9127635|P1|Overall Study|Adverse Event|1
2642388|NCT00778102|9127702|P2|Overall Study|Administrative Reason|10
2642389|NCT00778102|9127703|P1|Overall Study|Administrative Reason|7
2642390|NCT00778102|9127702|P2|Overall Study|Withdrawal by Subject|1
2642391|NCT00778102|9127703|P1|Overall Study|Withdrawal by Subject|1
2642392|NCT00778102|9127702|P2|Overall Study|Refused Treatment|3
2642393|NCT00778102|9127703|P1|Overall Study|Refused Treatment|2
2642394|NCT00778102|9127702|P2|Overall Study|Protocol Violation|1
2642395|NCT00778102|9127703|P1|Overall Study|Protocol Violation|0
2642396|NCT00778102|9127702|P2|Overall Study|Violation of Selection Criteria|1
2642397|NCT00778102|9127703|P1|Overall Study|Violation of Selection Criteria|1
2642398|NCT00778102|9127702|P2|Overall Study|Lost to Follow-up|0
2642399|NCT00778102|9127703|P1|Overall Study|Lost to Follow-up|1
2642400|NCT00778102|9127702|P2|Overall Study|Death|1
2642401|NCT00778102|9127703|P1|Overall Study|Death|1
2642402|NCT00778102|9127702|P2|Overall Study|Adverse Event|5
2642403|NCT00778102|9127703|P1|Overall Study|Adverse Event|8
2642404|NCT00777946|9127738|P3|Overall Study|Randomized in error|0
2642405|NCT00777946|9127739|P2|Overall Study|Randomized in error|1
2642406|NCT00777946|9127740|P1|Overall Study|Randomized in error|1
2642407|NCT00777946|9127738|P3|Overall Study|Protocol deviation|1
2642408|NCT00777946|9127739|P2|Overall Study|Protocol deviation|1
2642409|NCT00777946|9127740|P1|Overall Study|Protocol deviation|2
2642410|NCT00777946|9127738|P3|Overall Study|Lost to Follow-up|0
2642411|NCT00777946|9127739|P2|Overall Study|Lost to Follow-up|1
2642412|NCT00777946|9127740|P1|Overall Study|Lost to Follow-up|3
2642413|NCT00777946|9127738|P3|Overall Study|Patient withdrew consent|3
2642414|NCT00777946|9127739|P2|Overall Study|Patient withdrew consent|2
2642415|NCT00777946|9127740|P1|Overall Study|Patient withdrew consent|3
2642416|NCT00777946|9127738|P3|Overall Study|Condition no longer required study drug|0
2642417|NCT00777946|9127739|P2|Overall Study|Condition no longer required study drug|0
2642418|NCT00777946|9127740|P1|Overall Study|Condition no longer required study drug|1
2642419|NCT00777946|9127738|P3|Overall Study|Lack of Efficacy|9
2642420|NCT00777946|9127739|P2|Overall Study|Lack of Efficacy|0
2642421|NCT00777946|9127740|P1|Overall Study|Lack of Efficacy|0
2642422|NCT00777946|9127738|P3|Overall Study|Adverse Event|3
2642423|NCT00777946|9127739|P2|Overall Study|Adverse Event|1
2642424|NCT00777946|9127740|P1|Overall Study|Adverse Event|11
2642425|NCT00777803|9127775|P2|Overall Study|Non-compliance|2
2642426|NCT00777803|9127776|P1|Overall Study|Non-compliance|2
2642427|NCT00777803|9127775|P2|Overall Study|Adverse Event|0
2642428|NCT00777803|9127776|P1|Overall Study|Adverse Event|1
2642429|NCT00777803|9127775|P2|Overall Study|Lost to Follow-up|5
2642430|NCT00777803|9127776|P1|Overall Study|Lost to Follow-up|12
2642431|NCT00777608|9127855|P2|Overall Study|Investigator Decision|2
2642432|NCT00777608|9127856|P1|Overall Study|Investigator Decision|1
2642433|NCT00777608|9127855|P2|Overall Study|Protocol Violation|0
2642434|NCT00777608|9127856|P1|Overall Study|Protocol Violation|1
2642435|NCT00777608|9127855|P2|Overall Study|Withdrawal by Subject|3
2642436|NCT00777608|9127856|P1|Overall Study|Withdrawal by Subject|1
2642437|NCT00777608|9127855|P2|Overall Study|Lost to Follow-up|1
2642438|NCT00777608|9127856|P1|Overall Study|Lost to Follow-up|1
2642439|NCT00777556|9127866|P1|Overall Study|Did not complete all 3 follow-up visits|20
2642440|NCT00777556|9127866|P1|Overall Study|Dispensed but did not use product|12
2642441|NCT00777556|9127866|P1|Overall Study|Inappropriate self-selection|34
2642442|NCT00777491|9127875|P2|Overall Study|Did not receive any protocol treatment|0
2642443|NCT00777491|9127876|P1|Overall Study|Did not receive any protocol treatment|2
2642444|NCT00777491|9127875|P2|Overall Study|Protocol Violation|2
2642445|NCT00777491|9127876|P1|Overall Study|Protocol Violation|0
2642446|NCT00777296|9127909|P4|Overall Study|CRF form not completed|0
2642447|NCT00777296|9127910|P3|Overall Study|CRF form not completed|2
2642448|NCT00777296|9127911|P2|Overall Study|CRF form not completed|0
2642449|NCT00777296|9127912|P1|Overall Study|CRF form not completed|0
2642450|NCT00777296|9127909|P4|Overall Study|Withdrawal by Subject|0
2642451|NCT00777296|9127910|P3|Overall Study|Withdrawal by Subject|0
2642452|NCT00777296|9127911|P2|Overall Study|Withdrawal by Subject|0
2642453|NCT00777296|9127912|P1|Overall Study|Withdrawal by Subject|1
2642454|NCT00777296|9127909|P4|Overall Study|Adverse Event|1
2642455|NCT00777296|9127910|P3|Overall Study|Adverse Event|0
2642456|NCT00777296|9127911|P2|Overall Study|Adverse Event|1
2642457|NCT00777296|9127912|P1|Overall Study|Adverse Event|0
2642458|NCT00777257|9127954|P3|Overall Study|Withdrawal by Subject|5
2642459|NCT00777257|9127955|P2|Overall Study|Withdrawal by Subject|6
2642460|NCT00777257|9127956|P1|Overall Study|Withdrawal by Subject|3
2642461|NCT00777257|9127954|P3|Overall Study|Protocol Violation|2
2642462|NCT00777257|9127955|P2|Overall Study|Protocol Violation|2
2642463|NCT00777257|9127956|P1|Overall Study|Protocol Violation|2
2642464|NCT00777257|9127954|P3|Overall Study|Lost to Follow-up|2
2642465|NCT00777257|9127955|P2|Overall Study|Lost to Follow-up|3
2642466|NCT00777257|9127956|P1|Overall Study|Lost to Follow-up|3
2642467|NCT00777257|9127954|P3|Overall Study|Adverse Event|0
2642468|NCT00777257|9127955|P2|Overall Study|Adverse Event|1
2642469|NCT00777257|9127956|P1|Overall Study|Adverse Event|3
2642470|NCT00777205|9127975|P2|Overall Study|Protocol Violation|56
2642471|NCT00777205|9127976|P1|Overall Study|Protocol Violation|0
2642472|NCT00777205|9127975|P2|Overall Study|Death|2
2642473|NCT00777205|9127976|P1|Overall Study|Death|0
2642474|NCT00777205|9127975|P2|Overall Study|Withdrawal by Subject|4
2642475|NCT00777205|9127976|P1|Overall Study|Withdrawal by Subject|6
2642476|NCT00777205|9127975|P2|Overall Study|Lost to Follow-up|9
2642477|NCT00777205|9127976|P1|Overall Study|Lost to Follow-up|25
2642478|NCT00777153|9128010|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|1
2642479|NCT00777153|9128011|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|5
2642480|NCT00777153|9128012|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|1
2642481|NCT00777153|9128010|P3|Overall Study|Withdrawal by Subject|3
2642482|NCT00777153|9128011|P2|Overall Study|Withdrawal by Subject|4
2642483|NCT00777153|9128012|P1|Overall Study|Withdrawal by Subject|3
2642484|NCT00777153|9128010|P3|Overall Study|Death|33
2642485|NCT00777153|9128011|P2|Overall Study|Death|73
2642486|NCT00777153|9128012|P1|Overall Study|Death|85
2642487|NCT00777153|9128010|P3|Overall Study|Lost to Follow-up|0
2642488|NCT00777153|9128011|P2|Overall Study|Lost to Follow-up|1
2642489|NCT00777153|9128012|P1|Overall Study|Lost to Follow-up|1
2642490|NCT00777101|9128037|P2|Overall Study|Failed to Return|1
2642491|NCT00777101|9128038|P1|Overall Study|Failed to Return|0
2642492|NCT00777101|9128037|P2|Overall Study|Discontinuation of Study by Sponsor|0
2642493|NCT00777101|9128038|P1|Overall Study|Discontinuation of Study by Sponsor|1
2642494|NCT00777101|9128037|P2|Overall Study|Lost to Follow-up|1
2642495|NCT00777101|9128038|P1|Overall Study|Lost to Follow-up|2
2642496|NCT00777101|9128037|P2|Overall Study|Withdrawal by Subject|6
2642497|NCT00777101|9128038|P1|Overall Study|Withdrawal by Subject|11
2642498|NCT00777101|9128037|P2|Overall Study|Death|43
2642499|NCT00777101|9128038|P1|Overall Study|Death|48
2642500|NCT00777088|9128056|P1|Overall Study|PED Treatment not attempted|1
2642501|NCT00777049|9128081|P2|Overall Study|No treatment (elevated liver enzymes)|1
2642502|NCT00777049|9128082|P1|Overall Study|No treatment (elevated liver enzymes)|0
2642503|NCT00777049|9128081|P2|Overall Study|Withdrawal by Subject|0
2642504|NCT00777049|9128082|P1|Overall Study|Withdrawal by Subject|1
2642505|NCT00777036|9128091|P3|Follow-Up|Death|0
2642506|NCT00777036|9128092|P2|Follow-Up|Death|8
2642507|NCT00777036|9128093|P1|Follow-Up|Death|1
2642508|NCT00777036|9128091|P3|Follow-Up|Withdrawal by Subject|4
2642509|NCT00777036|9128092|P2|Follow-Up|Withdrawal by Subject|0
2642510|NCT00777036|9128093|P1|Follow-Up|Withdrawal by Subject|1
2642511|NCT00777036|9128091|P3|Follow-Up|Reason Not Specified|0
2642512|NCT00777036|9128092|P2|Follow-Up|Reason Not Specified|0
2642513|NCT00777036|9128093|P1|Follow-Up|Reason Not Specified|2
2642514|NCT00777036|9128091|P3|Follow-Up|Lost to Follow-up|0
2642515|NCT00777036|9128092|P2|Follow-Up|Lost to Follow-up|0
2642516|NCT00777036|9128093|P1|Follow-Up|Lost to Follow-up|1
2642517|NCT00777036|9128091|P3|On Treatment|Progressive Disease|6
2642518|NCT00777036|9128092|P2|On Treatment|Progressive Disease|4
2642519|NCT00777036|9128093|P1|On Treatment|Progressive Disease|5
2642520|NCT00777036|9128091|P3|On Treatment|Study Drug Toxicity|1
2642521|NCT00777036|9128092|P2|On Treatment|Study Drug Toxicity|0
2642522|NCT00777036|9128093|P1|On Treatment|Study Drug Toxicity|0
2642523|NCT00777036|9128091|P3|On Treatment|Death|0
2642524|NCT00777036|9128092|P2|On Treatment|Death|2
2642525|NCT00777036|9128093|P1|On Treatment|Death|0
2642526|NCT00777036|9128091|P3|On Treatment|Withdrawal by Subject|3
2642527|NCT00777036|9128092|P2|On Treatment|Withdrawal by Subject|2
2642528|NCT00777036|9128093|P1|On Treatment|Withdrawal by Subject|3
2642529|NCT00777036|9128091|P3|On Treatment|Maximum Clinical Benefit|1
2642530|NCT00777036|9128092|P2|On Treatment|Maximum Clinical Benefit|0
2642531|NCT00777036|9128093|P1|On Treatment|Maximum Clinical Benefit|2
2642532|NCT00777036|9128091|P3|On Treatment|Non-compliance with Study Drug|0
2642533|NCT00777036|9128092|P2|On Treatment|Non-compliance with Study Drug|0
2642534|NCT00777036|9128093|P1|On Treatment|Non-compliance with Study Drug|1
2642535|NCT00777036|9128091|P3|On Treatment|Failure to Meet Study Criteria|0
2642536|NCT00777036|9128092|P2|On Treatment|Failure to Meet Study Criteria|1
2642537|NCT00777036|9128093|P1|On Treatment|Failure to Meet Study Criteria|0
2642538|NCT00777036|9128091|P3|On Treatment|Reason Not Specified|12
2642539|NCT00777036|9128092|P2|On Treatment|Reason Not Specified|7
2642540|NCT00777036|9128093|P1|On Treatment|Reason Not Specified|4
2642541|NCT00777023|9128189|P3|Overall Study|Last dose date unknown|1
2642542|NCT00777023|9128190|P2|Overall Study|Last dose date unknown|3
2642543|NCT00777023|9128191|P1|Overall Study|Last dose date unknown|3
2642544|NCT00777023|9128189|P3|Overall Study|Reasons not specified|2
2642545|NCT00777023|9128190|P2|Overall Study|Reasons not specified|4
2642546|NCT00777023|9128191|P1|Overall Study|Reasons not specified|4
2642547|NCT00777023|9128189|P3|Overall Study|Missing data|0
2642548|NCT00777023|9128190|P2|Overall Study|Missing data|1
2642549|NCT00777023|9128191|P1|Overall Study|Missing data|1
2642550|NCT00777023|9128189|P3|Overall Study|Withdrawal by Subject|8
2642551|NCT00777023|9128190|P2|Overall Study|Withdrawal by Subject|7
2642552|NCT00777023|9128191|P1|Overall Study|Withdrawal by Subject|7
2642553|NCT00777023|9128189|P3|Overall Study|Death|0
2642554|NCT00777023|9128190|P2|Overall Study|Death|1
2642555|NCT00777023|9128191|P1|Overall Study|Death|0
2642556|NCT00777023|9128189|P3|Overall Study|Lost to Follow-up|3
2642557|NCT00777023|9128190|P2|Overall Study|Lost to Follow-up|3
2642558|NCT00777023|9128191|P1|Overall Study|Lost to Follow-up|2
2642559|NCT00777023|9128189|P3|Overall Study|Protocol Violation|1
2642560|NCT00777023|9128190|P2|Overall Study|Protocol Violation|1
2642561|NCT00777023|9128191|P1|Overall Study|Protocol Violation|2
2642562|NCT00777023|9128189|P3|Overall Study|Lack of Efficacy|14
2642563|NCT00777023|9128190|P2|Overall Study|Lack of Efficacy|0
2642564|NCT00777023|9128191|P1|Overall Study|Lack of Efficacy|1
2642565|NCT00777023|9128189|P3|Overall Study|Adverse Event|8
2642566|NCT00777023|9128190|P2|Overall Study|Adverse Event|21
2642567|NCT00777023|9128191|P1|Overall Study|Adverse Event|15
2642568|NCT00776997|9128208|P1|Overall Study|Adverse Event|2
2642569|NCT00776984|9128217|P2|Overall Study|Other|9
2642570|NCT00776984|9128218|P1|Overall Study|Other|5
2642571|NCT00776984|9128217|P2|Overall Study|Lack of Efficacy|1
2642572|NCT00776984|9128218|P1|Overall Study|Lack of Efficacy|0
2642573|NCT00776984|9128217|P2|Overall Study|Withdrawal by Subject|7
2642574|NCT00776984|9128218|P1|Overall Study|Withdrawal by Subject|12
2642575|NCT00776984|9128217|P2|Overall Study|Lost to Follow-up|0
2642576|NCT00776984|9128218|P1|Overall Study|Lost to Follow-up|2
2642577|NCT00776984|9128217|P2|Overall Study|Protocol Violation|2
2642578|NCT00776984|9128218|P1|Overall Study|Protocol Violation|4
2642579|NCT00776984|9128217|P2|Overall Study|Adverse Event|2
2642580|NCT00776984|9128218|P1|Overall Study|Adverse Event|8
2642581|NCT00776919|9128292|P4|Overall Study|Other: Lack of Efficacy/Lost Medication|2
2642582|NCT00776919|9128293|P3|Overall Study|Other: Lack of Efficacy/Lost Medication|4
2642583|NCT00776919|9128294|P2|Overall Study|Other: Lack of Efficacy/Lost Medication|5
2642584|NCT00776919|9128295|P1|Overall Study|Other: Lack of Efficacy/Lost Medication|1
2642585|NCT00776919|9128292|P4|Overall Study|Protocol Violation|1
2642586|NCT00776919|9128293|P3|Overall Study|Protocol Violation|0
2642587|NCT00776919|9128294|P2|Overall Study|Protocol Violation|2
2642588|NCT00776919|9128295|P1|Overall Study|Protocol Violation|1
2642589|NCT00776919|9128292|P4|Overall Study|Adverse Event|2
2642590|NCT00776919|9128293|P3|Overall Study|Adverse Event|2
2642591|NCT00776919|9128294|P2|Overall Study|Adverse Event|0
2642592|NCT00776919|9128295|P1|Overall Study|Adverse Event|1
2642593|NCT00776919|9128292|P4|Overall Study|Lost to Follow-up|8
2642594|NCT00776919|9128293|P3|Overall Study|Lost to Follow-up|11
2642595|NCT00776919|9128294|P2|Overall Study|Lost to Follow-up|12
2642596|NCT00776919|9128295|P1|Overall Study|Lost to Follow-up|8
2642597|NCT00776919|9128292|P4|Overall Study|Withdrawal by Subject|26
2642598|NCT00776919|9128293|P3|Overall Study|Withdrawal by Subject|15
2642599|NCT00776919|9128294|P2|Overall Study|Withdrawal by Subject|14
2642600|NCT00776919|9128295|P1|Overall Study|Withdrawal by Subject|16
2642601|NCT00776789|9128359|P2|Overall Study|Poor quality video|1
2642602|NCT00776789|9128360|P1|Overall Study|Poor quality video|1
2642603|NCT00776789|9128359|P2|Overall Study|Consent refusal|2
2642604|NCT00776789|9128360|P1|Overall Study|Consent refusal|2
2642605|NCT00776659|9128372|P1|Overall Study|Study Terminated by Sponsor|1
2642606|NCT00776659|9128372|P1|Overall Study|Withdrawal by Subject|10
2642607|NCT00776659|9128372|P1|Overall Study|Lost to Follow-up|15
2642608|NCT00776555|9128399|P2|Overall Study|Study terminated|0
2642609|NCT00776555|9128400|P1|Overall Study|Study terminated|3
2642610|NCT00776230|9128418|P3|Overall Study|Subject missed Visit 4|0
2642611|NCT00776230|9128419|P2|Overall Study|Subject missed Visit 4|1
2642612|NCT00776230|9128420|P1|Overall Study|Subject missed Visit 4|0
2642613|NCT00776230|9128418|P3|Overall Study|Withdrawal by Subject|0
2642614|NCT00776230|9128419|P2|Overall Study|Withdrawal by Subject|1
2642615|NCT00776230|9128420|P1|Overall Study|Withdrawal by Subject|0
2642616|NCT00776230|9128418|P3|Overall Study|Not vaccinated at Day 0|0
2642617|NCT00776230|9128419|P2|Overall Study|Not vaccinated at Day 0|0
2642618|NCT00776230|9128420|P1|Overall Study|Not vaccinated at Day 0|1
2642619|NCT00776230|9128418|P3|Overall Study|Lost to Follow-up|5
2642620|NCT00776230|9128419|P2|Overall Study|Lost to Follow-up|1
2642621|NCT00776230|9128420|P1|Overall Study|Lost to Follow-up|2
2642622|NCT00776100|9128430|P2|Overall Study|Disease Progression|0
2642623|NCT00776100|9128431|P1|Overall Study|Disease Progression|1
2642624|NCT00776009|9128453|P6|Period 3: Third Intervention|Withdrawal by Subject|0
2642625|NCT00776009|9128454|P5|Period 3: Third Intervention|Withdrawal by Subject|0
2642626|NCT00776009|9128455|P4|Period 3: Third Intervention|Withdrawal by Subject|0
2642627|NCT00776009|9128456|P3|Period 3: Third Intervention|Withdrawal by Subject|0
2642628|NCT00776009|9128457|P2|Period 3: Third Intervention|Withdrawal by Subject|0
2642629|NCT00776009|9128458|P1|Period 3: Third Intervention|Withdrawal by Subject|1
2642630|NCT00776009|9128453|P6|Period 2: Second Intervention|Protocol Violation|0
2642631|NCT00776009|9128454|P5|Period 2: Second Intervention|Protocol Violation|0
2642632|NCT00776009|9128455|P4|Period 2: Second Intervention|Protocol Violation|0
2642633|NCT00776009|9128456|P3|Period 2: Second Intervention|Protocol Violation|1
2642634|NCT00776009|9128457|P2|Period 2: Second Intervention|Protocol Violation|0
2642635|NCT00776009|9128458|P1|Period 2: Second Intervention|Protocol Violation|1
2642636|NCT00776009|9128453|P6|Period 2: Second Intervention|Withdrawal by Subject|1
2642637|NCT00776009|9128454|P5|Period 2: Second Intervention|Withdrawal by Subject|0
2642638|NCT00776009|9128455|P4|Period 2: Second Intervention|Withdrawal by Subject|0
2642639|NCT00776009|9128456|P3|Period 2: Second Intervention|Withdrawal by Subject|0
2642640|NCT00776009|9128457|P2|Period 2: Second Intervention|Withdrawal by Subject|0
2642641|NCT00776009|9128458|P1|Period 2: Second Intervention|Withdrawal by Subject|0
2642642|NCT00776009|9128453|P6|Period 1: First Intervention|Protocol Violation|0
2642643|NCT00776009|9128454|P5|Period 1: First Intervention|Protocol Violation|1
2642644|NCT00776009|9128455|P4|Period 1: First Intervention|Protocol Violation|0
2642645|NCT00776009|9128456|P3|Period 1: First Intervention|Protocol Violation|0
2642646|NCT00776009|9128457|P2|Period 1: First Intervention|Protocol Violation|1
2642647|NCT00776009|9128458|P1|Period 1: First Intervention|Protocol Violation|0
2642648|NCT00776009|9128453|P6|Period 1: First Intervention|Withdrawal by Subject|0
2642649|NCT00776009|9128454|P5|Period 1: First Intervention|Withdrawal by Subject|1
2642650|NCT00776009|9128455|P4|Period 1: First Intervention|Withdrawal by Subject|0
2642651|NCT00776009|9128456|P3|Period 1: First Intervention|Withdrawal by Subject|1
2642652|NCT00776009|9128457|P2|Period 1: First Intervention|Withdrawal by Subject|0
2642653|NCT00776009|9128458|P1|Period 1: First Intervention|Withdrawal by Subject|0
2642654|NCT00775983|9128480|P2|Overall Study|Protocol Violation|2
2642655|NCT00775983|9128481|P1|Overall Study|Protocol Violation|1
2642656|NCT00775606|9128607|P2|Overall Study|Study sponsor terminated funding|0
2642657|NCT00775606|9128608|P1|Overall Study|Study sponsor terminated funding|3
2642658|NCT00775593|9128618|P1|Overall Study|Death|1
2642659|NCT00775593|9128618|P1|Overall Study|Unmet eligibility criteria|6
2642660|NCT00775528|9128625|P1|Overall Study|Protocol Violation|1
2642661|NCT00775463|9128634|P2|Overall Study|Lack of Efficacy|1
2642662|NCT00775463|9128635|P1|Overall Study|Lack of Efficacy|1
2642663|NCT00775463|9128634|P2|Overall Study|Lost to Follow-up|0
2642664|NCT00775463|9128635|P1|Overall Study|Lost to Follow-up|1
2642665|NCT00775463|9128634|P2|Overall Study|Protocol Violation|2
2642666|NCT00775463|9128635|P1|Overall Study|Protocol Violation|2
2642667|NCT00775463|9128634|P2|Overall Study|Adverse Event|9
2642668|NCT00775463|9128635|P1|Overall Study|Adverse Event|7
2642669|NCT00775463|9128634|P2|Overall Study|Withdrawal by Subject|1
2642670|NCT00775463|9128635|P1|Overall Study|Withdrawal by Subject|0
2642671|NCT00775450|9128672|P5|Overall Study|Withdrawal by Subject|1
2642672|NCT00775450|9128673|P4|Overall Study|Withdrawal by Subject|0
2642673|NCT00775450|9128674|P3|Overall Study|Withdrawal by Subject|0
2642674|NCT00775450|9128675|P2|Overall Study|Withdrawal by Subject|0
2642675|NCT00775450|9128676|P1|Overall Study|Withdrawal by Subject|1
2642676|NCT00775450|9128672|P5|Overall Study|Protocol Violation|1
2642677|NCT00775450|9128673|P4|Overall Study|Protocol Violation|0
2642678|NCT00775450|9128674|P3|Overall Study|Protocol Violation|0
2642679|NCT00775450|9128675|P2|Overall Study|Protocol Violation|0
2642680|NCT00775450|9128676|P1|Overall Study|Protocol Violation|0
2642681|NCT00775450|9128672|P5|Overall Study|Serious Adverse Event|0
2642682|NCT00775450|9128673|P4|Overall Study|Serious Adverse Event|0
2642683|NCT00775450|9128674|P3|Overall Study|Serious Adverse Event|0
2642684|NCT00775450|9128675|P2|Overall Study|Serious Adverse Event|0
2642685|NCT00775450|9128676|P1|Overall Study|Serious Adverse Event|2
2642686|NCT00775437|9128703|P1|Overall Study|Lost to Follow-up|1
2642687|NCT00775437|9128703|P1|Overall Study|Withdrawal by Subject|3
2642688|NCT00775437|9128703|P1|Overall Study|Loss of efficacy|2
2642689|NCT00775203|9128778|P2|Overall Study|Physician Decision|1
2642690|NCT00775203|9128779|P1|Overall Study|Physician Decision|0
2642691|NCT00775203|9128778|P2|Overall Study|Entered other study|0
2642692|NCT00775203|9128779|P1|Overall Study|Entered other study|1
2642693|NCT00775203|9128778|P2|Overall Study|Protocol Violation|1
2642694|NCT00775203|9128779|P1|Overall Study|Protocol Violation|0
2642695|NCT00775203|9128778|P2|Overall Study|Noncompliance|2
2642696|NCT00775203|9128779|P1|Overall Study|Noncompliance|4
2642697|NCT00775203|9128778|P2|Overall Study|Administrative reason|0
2642698|NCT00775203|9128779|P1|Overall Study|Administrative reason|2
2642699|NCT00775203|9128778|P2|Overall Study|Lost to Follow-up|15
2642700|NCT00775203|9128779|P1|Overall Study|Lost to Follow-up|11
2642701|NCT00775203|9128778|P2|Overall Study|Withdrawal by Subject|9
2642702|NCT00775203|9128779|P1|Overall Study|Withdrawal by Subject|11
2642703|NCT00775203|9128778|P2|Overall Study|Lack of Efficacy|9
2642704|NCT00775203|9128779|P1|Overall Study|Lack of Efficacy|8
2642705|NCT00775203|9128778|P2|Overall Study|Adverse Event|6
2642706|NCT00775203|9128779|P1|Overall Study|Adverse Event|25
2642707|NCT00775190|9128813|P2|Overall Study|Protocol Violation|0
2642708|NCT00775190|9128814|P1|Overall Study|Protocol Violation|1
2642709|NCT00775190|9128813|P2|Overall Study|Withdrawal by Subject|2
2642710|NCT00775190|9128814|P1|Overall Study|Withdrawal by Subject|1
2642711|NCT00775190|9128813|P2|Overall Study|Lost to Follow-up|3
2642712|NCT00775190|9128814|P1|Overall Study|Lost to Follow-up|2
2642713|NCT00775138|9128840|P4|Overall Study|Adverse Event|0
2642714|NCT00775138|9128841|P3|Overall Study|Adverse Event|1
2642715|NCT00775138|9128842|P2|Overall Study|Adverse Event|0
2642716|NCT00775138|9128843|P1|Overall Study|Adverse Event|0
2642717|NCT00775138|9128840|P4|Overall Study|Withdrawal by Subject|2
2642718|NCT00775138|9128841|P3|Overall Study|Withdrawal by Subject|2
2642719|NCT00775138|9128842|P2|Overall Study|Withdrawal by Subject|0
2642720|NCT00775138|9128843|P1|Overall Study|Withdrawal by Subject|0
2642721|NCT00775021|9128889|P2|Second Intervention|Adverse Event|1
2642722|NCT00775021|9128890|P1|Second Intervention|Adverse Event|0
2642723|NCT00775021|9128889|P2|First Intervention|Lost to Follow-up|0
2642724|NCT00775021|9128890|P1|First Intervention|Lost to Follow-up|1
2642725|NCT00774995|9128908|P4|Overall Study|Protocol Violation|0
2642726|NCT00774995|9128909|P3|Overall Study|Protocol Violation|1
2642727|NCT00774995|9128910|P2|Overall Study|Protocol Violation|0
2642728|NCT00774995|9128911|P1|Overall Study|Protocol Violation|0
2642729|NCT00774930|9128951|P2|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1
2642730|NCT00774930|9128952|P1|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0
2642731|NCT00774930|9128951|P2|LTOLE Phase|Tumour Progression of Hepatic Metastases|1
2642732|NCT00774930|9128952|P1|LTOLE Phase|Tumour Progression of Hepatic Metastases|0
2642733|NCT00774930|9128951|P2|LTOLE Phase|Disease Progression|5
2642734|NCT00774930|9128952|P1|LTOLE Phase|Disease Progression|2
2642735|NCT00774930|9128951|P2|LTOLE Phase|Sponsor decision|1
2642736|NCT00774930|9128952|P1|LTOLE Phase|Sponsor decision|2
2642737|NCT00774930|9128951|P2|LTOLE Phase|Physician Decision|1
2642738|NCT00774930|9128952|P1|LTOLE Phase|Physician Decision|4
2642739|NCT00774930|9128951|P2|LTOLE Phase|Subject decision|5
2642740|NCT00774930|9128952|P1|LTOLE Phase|Subject decision|0
2642741|NCT00774930|9128951|P2|LTOLE Phase|Adverse Event|3
2642742|NCT00774930|9128952|P1|LTOLE Phase|Adverse Event|7
2642743|NCT00774930|9128951|P2|IOL Phase|Brain radiation|1
2642744|NCT00774930|9128952|P1|IOL Phase|Brain radiation|0
2642745|NCT00774930|9128951|P2|IOL Phase|Other|0
2642746|NCT00774930|9128952|P1|IOL Phase|Other|1
2642747|NCT00774930|9128951|P2|IOL Phase|Peptide Receptor Radionuclide Therapy|1
2642748|NCT00774930|9128952|P1|IOL Phase|Peptide Receptor Radionuclide Therapy|0
2642749|NCT00774930|9128951|P2|IOL Phase|Subject Consumed Prohibited Medication|0
2642750|NCT00774930|9128952|P1|IOL Phase|Subject Consumed Prohibited Medication|1
2642751|NCT00774930|9128951|P2|IOL Phase|Disease Progression|1
2642752|NCT00774930|9128952|P1|IOL Phase|Disease Progression|2
2642753|NCT00774930|9128951|P2|IOL Phase|Sponsor Decision|0
2642754|NCT00774930|9128952|P1|IOL Phase|Sponsor Decision|1
2642755|NCT00774930|9128951|P2|IOL Phase|Physician Decision|2
2642756|NCT00774930|9128952|P1|IOL Phase|Physician Decision|3
2642757|NCT00774930|9128951|P2|IOL Phase|Subject Decision|3
2642758|NCT00774930|9128952|P1|IOL Phase|Subject Decision|4
2642759|NCT00774930|9128951|P2|IOL Phase|Adverse Event|1
2642760|NCT00774930|9128952|P1|IOL Phase|Adverse Event|1
2642761|NCT00774930|9128951|P2|DB Phase|Started Nonprotocol Radiation therapy|1
2642762|NCT00774930|9128952|P1|DB Phase|Started Nonprotocol Radiation therapy|0
2642763|NCT00774930|9128951|P2|DB Phase|Disease Progression|1
2642764|NCT00774930|9128952|P1|DB Phase|Disease Progression|1
2642765|NCT00774930|9128951|P2|DB Phase|Sponsor Decision|1
2642766|NCT00774930|9128952|P1|DB Phase|Sponsor Decision|0
2642767|NCT00774930|9128951|P2|DB Phase|Subject Decision|5
2642768|NCT00774930|9128952|P1|DB Phase|Subject Decision|1
2642769|NCT00774930|9128951|P2|DB Phase|Adverse Event|2
2642770|NCT00774930|9128952|P1|DB Phase|Adverse Event|1
2642771|NCT00774930|9128951|P2|DB Phase|Early Roll Over (ERO) to IOL phase|12
2642772|NCT00774930|9128952|P1|DB Phase|Early Roll Over (ERO) to IOL phase|11
2642773|NCT00774852|9128980|P2|Overall Study|Subject received prohibited medication|0
2642774|NCT00774852|9128981|P1|Overall Study|Subject received prohibited medication|1
2642775|NCT00774852|9128980|P2|Overall Study|Protocol Violation|0
2642776|NCT00774852|9128981|P1|Overall Study|Protocol Violation|1
2642777|NCT00774852|9128980|P2|Overall Study|Subject non-compliance|1
2642778|NCT00774852|9128981|P1|Overall Study|Subject non-compliance|0
2642779|NCT00774852|9128980|P2|Overall Study|Non-responder|11
2642780|NCT00774852|9128981|P1|Overall Study|Non-responder|15
2642781|NCT00774852|9128980|P2|Overall Study|Withdrawal by Subject|2
2642782|NCT00774852|9128981|P1|Overall Study|Withdrawal by Subject|2
2642783|NCT00774852|9128980|P2|Overall Study|Pregnancy|2
2642784|NCT00774852|9128981|P1|Overall Study|Pregnancy|1
2642785|NCT00774852|9128980|P2|Overall Study|Physician Decision|6
2642786|NCT00774852|9128981|P1|Overall Study|Physician Decision|2
2642787|NCT00774852|9128980|P2|Overall Study|Lost to Follow-up|5
2642788|NCT00774852|9128981|P1|Overall Study|Lost to Follow-up|9
2642789|NCT00774852|9128980|P2|Overall Study|Lack of Efficacy|7
2642790|NCT00774852|9128981|P1|Overall Study|Lack of Efficacy|3
2642791|NCT00774852|9128980|P2|Overall Study|Death|1
2642792|NCT00774852|9128981|P1|Overall Study|Death|2
2642793|NCT00774852|9128980|P2|Overall Study|Adverse Event|6
2642794|NCT00774852|9128981|P1|Overall Study|Adverse Event|9
2642795|NCT00774800|9129029|P1|Intervention 4|Withdrawal by Subject|1
2642796|NCT00774787|9129051|P1|Overall Study|Lost to Follow-up|1
2642797|NCT00774748|9129058|P1|Overall Study|Lost to Follow-up|3
2642798|NCT00774397|9129084|P7|Overall Study|Other than those stated above|1
2642799|NCT00774397|9129085|P6|Overall Study|Other than those stated above|0
2642800|NCT00774397|9129086|P5|Overall Study|Other than those stated above|2
2642801|NCT00774397|9129087|P4|Overall Study|Other than those stated above|2
2642802|NCT00774397|9129088|P3|Overall Study|Other than those stated above|3
2642803|NCT00774397|9129089|P2|Overall Study|Other than those stated above|1
2642804|NCT00774397|9129090|P1|Overall Study|Other than those stated above|1
2642805|NCT00774397|9129084|P7|Overall Study|Not treated|1
2642806|NCT00774397|9129085|P6|Overall Study|Not treated|0
2642807|NCT00774397|9129086|P5|Overall Study|Not treated|1
2642808|NCT00774397|9129087|P4|Overall Study|Not treated|0
2642809|NCT00774397|9129088|P3|Overall Study|Not treated|0
2642810|NCT00774397|9129089|P2|Overall Study|Not treated|0
2642811|NCT00774397|9129090|P1|Overall Study|Not treated|0
2642812|NCT00774397|9129084|P7|Overall Study|Refused to continue trial medication|3
2642813|NCT00774397|9129085|P6|Overall Study|Refused to continue trial medication|2
2642814|NCT00774397|9129086|P5|Overall Study|Refused to continue trial medication|6
2642815|NCT00774397|9129087|P4|Overall Study|Refused to continue trial medication|2
2642816|NCT00774397|9129088|P3|Overall Study|Refused to continue trial medication|2
2642817|NCT00774397|9129089|P2|Overall Study|Refused to continue trial medication|3
2642818|NCT00774397|9129090|P1|Overall Study|Refused to continue trial medication|1
2642819|NCT00774397|9129084|P7|Overall Study|Lost to Follow-up|0
2642820|NCT00774397|9129085|P6|Overall Study|Lost to Follow-up|1
2642821|NCT00774397|9129086|P5|Overall Study|Lost to Follow-up|0
2642822|NCT00774397|9129087|P4|Overall Study|Lost to Follow-up|1
2642823|NCT00774397|9129088|P3|Overall Study|Lost to Follow-up|1
2642824|NCT00774397|9129089|P2|Overall Study|Lost to Follow-up|1
2642825|NCT00774397|9129090|P1|Overall Study|Lost to Follow-up|0
2642826|NCT00774397|9129084|P7|Overall Study|Protocol Violation|0
2642827|NCT00774397|9129085|P6|Overall Study|Protocol Violation|1
2642828|NCT00774397|9129086|P5|Overall Study|Protocol Violation|2
2642829|NCT00774397|9129087|P4|Overall Study|Protocol Violation|1
2642830|NCT00774397|9129088|P3|Overall Study|Protocol Violation|3
2642831|NCT00774397|9129089|P2|Overall Study|Protocol Violation|1
2642832|NCT00774397|9129090|P1|Overall Study|Protocol Violation|0
2642833|NCT00774397|9129084|P7|Overall Study|Lack of Efficacy|9
2642834|NCT00774397|9129085|P6|Overall Study|Lack of Efficacy|15
2642835|NCT00774397|9129086|P5|Overall Study|Lack of Efficacy|27
2642836|NCT00774397|9129087|P4|Overall Study|Lack of Efficacy|3
2642837|NCT00774397|9129088|P3|Overall Study|Lack of Efficacy|5
2642838|NCT00774397|9129089|P2|Overall Study|Lack of Efficacy|4
2642839|NCT00774397|9129090|P1|Overall Study|Lack of Efficacy|11
2642840|NCT00774397|9129084|P7|Overall Study|Adverse Event|16
2642841|NCT00774397|9129085|P6|Overall Study|Adverse Event|3
2642842|NCT00774397|9129086|P5|Overall Study|Adverse Event|8
2642843|NCT00774397|9129087|P4|Overall Study|Adverse Event|8
2642844|NCT00774397|9129088|P3|Overall Study|Adverse Event|16
2642845|NCT00774397|9129089|P2|Overall Study|Adverse Event|3
2642846|NCT00774397|9129090|P1|Overall Study|Adverse Event|1
2642847|NCT00774306|9129326|P4|Overall Study|Death|0
2642848|NCT00774306|9129327|P3|Overall Study|Death|0
2642849|NCT00774306|9129328|P2|Overall Study|Death|1
2642850|NCT00774306|9129329|P1|Overall Study|Death|1
2642851|NCT00774306|9129326|P4|Overall Study|Lost to Follow-up|5
2642852|NCT00774306|9129327|P3|Overall Study|Lost to Follow-up|4
2642853|NCT00774306|9129328|P2|Overall Study|Lost to Follow-up|0
2642854|NCT00774306|9129329|P1|Overall Study|Lost to Follow-up|6
2642855|NCT00774306|9129326|P4|Overall Study|Withdrawal by Subject|0
2642856|NCT00774306|9129327|P3|Overall Study|Withdrawal by Subject|1
2642857|NCT00774306|9129328|P2|Overall Study|Withdrawal by Subject|1
2642858|NCT00774306|9129329|P1|Overall Study|Withdrawal by Subject|6
2642859|NCT00774306|9129326|P4|Overall Study|Protocol Violation|0
2642860|NCT00774306|9129327|P3|Overall Study|Protocol Violation|3
2642861|NCT00774306|9129328|P2|Overall Study|Protocol Violation|0
2642862|NCT00774306|9129329|P1|Overall Study|Protocol Violation|2
2642863|NCT00774306|9129326|P4|Overall Study|Adverse Event|0
2642864|NCT00774306|9129327|P3|Overall Study|Adverse Event|0
2642865|NCT00774306|9129328|P2|Overall Study|Adverse Event|0
2642866|NCT00774306|9129329|P1|Overall Study|Adverse Event|3
2642867|NCT00774046|9129410|P1|Stem Cell Mobilization|Count too low (2), sudden death (1)|3
2642868|NCT00774046|9129410|P1|Enrollment|Desired other therapy/refused|28
2642869|NCT00774046|9129410|P1|Screening|Not eligible|56
2642870|NCT00773968|9129420|P1|Overall Study|Other|8
2642871|NCT00773968|9129420|P1|Overall Study|Screen Failure|17
2642872|NCT00773968|9129420|P1|Overall Study|Withdrawal by Subject|11
2642873|NCT00773968|9129420|P1|Overall Study|Protocol Violation|1
2642874|NCT00773968|9129420|P1|Overall Study|Lack of Efficacy|3
2642875|NCT00773968|9129420|P1|Overall Study|Failure to Return|2
2642876|NCT00773968|9129420|P1|Overall Study|Death|1
2642877|NCT00773968|9129420|P1|Overall Study|Adverse Event|2
2642878|NCT00773734|9129451|P6|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
2642879|NCT00773734|9129452|P5|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
2642880|NCT00773734|9129453|P4|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
2642881|NCT00773734|9129454|P3|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
2642882|NCT00773734|9129455|P2|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
2642883|NCT00773734|9129456|P1|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
2642884|NCT00773734|9129451|P6|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
2642885|NCT00773734|9129452|P5|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
2642886|NCT00773734|9129453|P4|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3
2642887|NCT00773734|9129454|P3|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6
2642888|NCT00773734|9129455|P2|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
2642889|NCT00773734|9129456|P1|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
2642890|NCT00773734|9129451|P6|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
2642891|NCT00773734|9129452|P5|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
2642892|NCT00773734|9129453|P4|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4
2642893|NCT00773734|9129454|P3|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2
2642894|NCT00773734|9129455|P2|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
2642895|NCT00773734|9129456|P1|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
2642896|NCT00773734|9129451|P6|LTE Period: Week 52 to 6 Years|Adverse Event|0
2642897|NCT00773734|9129452|P5|LTE Period: Week 52 to 6 Years|Adverse Event|0
2642898|NCT00773734|9129453|P4|LTE Period: Week 52 to 6 Years|Adverse Event|1
2642899|NCT00773734|9129454|P3|LTE Period: Week 52 to 6 Years|Adverse Event|0
2642900|NCT00773734|9129455|P2|LTE Period: Week 52 to 6 Years|Adverse Event|0
2642901|NCT00773734|9129456|P1|LTE Period: Week 52 to 6 Years|Adverse Event|0
2642902|NCT00773734|9129451|P6|Extension: Active Treatment Week 24-52|Other|1
2642903|NCT00773734|9129452|P5|Extension: Active Treatment Week 24-52|Other|0
2642904|NCT00773734|9129453|P4|Extension: Active Treatment Week 24-52|Other|2
2642905|NCT00773734|9129454|P3|Extension: Active Treatment Week 24-52|Other|1
2642906|NCT00773734|9129455|P2|Extension: Active Treatment Week 24-52|Other|0
2642907|NCT00773734|9129456|P1|Extension: Active Treatment Week 24-52|Other|0
2642908|NCT00773734|9129451|P6|Extension: Active Treatment Week 24-52|Lost to Follow-up|1
2642909|NCT00773734|9129452|P5|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
2642910|NCT00773734|9129453|P4|Extension: Active Treatment Week 24-52|Lost to Follow-up|3
2642911|NCT00773734|9129454|P3|Extension: Active Treatment Week 24-52|Lost to Follow-up|5
2642912|NCT00773734|9129455|P2|Extension: Active Treatment Week 24-52|Lost to Follow-up|2
2642913|NCT00773734|9129456|P1|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
2642914|NCT00773734|9129451|P6|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
2642915|NCT00773734|9129452|P5|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
2642916|NCT00773734|9129453|P4|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
2642917|NCT00773734|9129454|P3|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1
2642918|NCT00773734|9129455|P2|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
2642919|NCT00773734|9129456|P1|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0
2642920|NCT00773734|9129451|P6|Extension: Active Treatment Week 24-52|Lack of Efficacy|2
2642921|NCT00773734|9129452|P5|Extension: Active Treatment Week 24-52|Lack of Efficacy|1
2642922|NCT00773734|9129453|P4|Extension: Active Treatment Week 24-52|Lack of Efficacy|3
2642923|NCT00773734|9129454|P3|Extension: Active Treatment Week 24-52|Lack of Efficacy|10
2642924|NCT00773734|9129455|P2|Extension: Active Treatment Week 24-52|Lack of Efficacy|8
2642925|NCT00773734|9129456|P1|Extension: Active Treatment Week 24-52|Lack of Efficacy|0
2642926|NCT00773734|9129451|P6|Extension: Active Treatment Week 24-52|Adverse Event|1
2642927|NCT00773734|9129452|P5|Extension: Active Treatment Week 24-52|Adverse Event|2
2642928|NCT00773734|9129453|P4|Extension: Active Treatment Week 24-52|Adverse Event|0
2642929|NCT00773734|9129454|P3|Extension: Active Treatment Week 24-52|Adverse Event|0
2642930|NCT00773734|9129455|P2|Extension: Active Treatment Week 24-52|Adverse Event|0
2642931|NCT00773734|9129456|P1|Extension: Active Treatment Week 24-52|Adverse Event|0
2642932|NCT00773734|9129451|P6|Core: Active Treatment Phase Week 16-24|Other|0
2642933|NCT00773734|9129452|P5|Core: Active Treatment Phase Week 16-24|Other|0
2642934|NCT00773734|9129453|P4|Core: Active Treatment Phase Week 16-24|Other|0
2642935|NCT00773734|9129454|P3|Core: Active Treatment Phase Week 16-24|Other|0
2642936|NCT00773734|9129455|P2|Core: Active Treatment Phase Week 16-24|Other|1
2642937|NCT00773734|9129456|P1|Core: Active Treatment Phase Week 16-24|Other|0
2642938|NCT00773734|9129451|P6|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
2642939|NCT00773734|9129452|P5|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
2642940|NCT00773734|9129453|P4|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
2642941|NCT00773734|9129454|P3|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
2642942|NCT00773734|9129455|P2|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
2642943|NCT00773734|9129456|P1|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
2642944|NCT00773734|9129451|P6|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
2642945|NCT00773734|9129452|P5|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
2642946|NCT00773734|9129453|P4|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
2642947|NCT00773734|9129454|P3|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
2642948|NCT00773734|9129455|P2|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
2642949|NCT00773734|9129456|P1|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
2642950|NCT00773734|9129451|P6|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2
2642951|NCT00773734|9129452|P5|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
2642952|NCT00773734|9129453|P4|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
2642953|NCT00773734|9129454|P3|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
2642954|NCT00773734|9129455|P2|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
2642955|NCT00773734|9129456|P1|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
2642956|NCT00773734|9129451|P6|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
2642957|NCT00773734|9129452|P5|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
2642958|NCT00773734|9129453|P4|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1
2642959|NCT00773734|9129454|P3|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
2642960|NCT00773734|9129455|P2|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
2642961|NCT00773734|9129456|P1|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
2642962|NCT00773734|9129451|P6|Core: Active Treatment Phase Week 16-24|Adverse Event|2
2642963|NCT00773734|9129452|P5|Core: Active Treatment Phase Week 16-24|Adverse Event|1
2642964|NCT00773734|9129453|P4|Core: Active Treatment Phase Week 16-24|Adverse Event|0
2642965|NCT00773734|9129454|P3|Core: Active Treatment Phase Week 16-24|Adverse Event|0
2642966|NCT00773734|9129455|P2|Core: Active Treatment Phase Week 16-24|Adverse Event|4
2642967|NCT00773734|9129456|P1|Core: Active Treatment Phase Week 16-24|Adverse Event|0
2642968|NCT00773734|9129451|P6|Core: Placebo Controlled Phase Week 0-16|Other|0
2642969|NCT00773734|9129452|P5|Core: Placebo Controlled Phase Week 0-16|Other|0
2642970|NCT00773734|9129453|P4|Core: Placebo Controlled Phase Week 0-16|Other|1
2642971|NCT00773734|9129454|P3|Core: Placebo Controlled Phase Week 0-16|Other|1
2642972|NCT00773734|9129455|P2|Core: Placebo Controlled Phase Week 0-16|Other|1
2642973|NCT00773734|9129456|P1|Core: Placebo Controlled Phase Week 0-16|Other|1
2642974|NCT00773734|9129451|P6|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
2642975|NCT00773734|9129452|P5|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
2642976|NCT00773734|9129453|P4|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
2642977|NCT00773734|9129454|P3|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4
2642978|NCT00773734|9129455|P2|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3
2642979|NCT00773734|9129456|P1|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1
2642980|NCT00773734|9129451|P6|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
2642981|NCT00773734|9129452|P5|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
2642982|NCT00773734|9129453|P4|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1
2642983|NCT00773734|9129454|P3|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
2642984|NCT00773734|9129455|P2|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
2642985|NCT00773734|9129456|P1|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2
2642986|NCT00773734|9129451|P6|Core: Placebo Controlled Phase Week 0-16|Death|0
2642987|NCT00773734|9129452|P5|Core: Placebo Controlled Phase Week 0-16|Death|0
2642988|NCT00773734|9129453|P4|Core: Placebo Controlled Phase Week 0-16|Death|0
2642989|NCT00773734|9129454|P3|Core: Placebo Controlled Phase Week 0-16|Death|0
2642990|NCT00773734|9129455|P2|Core: Placebo Controlled Phase Week 0-16|Death|0
2642991|NCT00773734|9129456|P1|Core: Placebo Controlled Phase Week 0-16|Death|1
2642992|NCT00773734|9129451|P6|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
2642993|NCT00773734|9129452|P5|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
2642994|NCT00773734|9129453|P4|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4
2642995|NCT00773734|9129454|P3|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6
2642996|NCT00773734|9129455|P2|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
2642997|NCT00773734|9129456|P1|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
2642998|NCT00773734|9129451|P6|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
2642999|NCT00773734|9129452|P5|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
2643000|NCT00773734|9129453|P4|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
2643001|NCT00773734|9129454|P3|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
2643002|NCT00773734|9129455|P2|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3
2643003|NCT00773734|9129456|P1|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4
2643004|NCT00773734|9129451|P6|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
2643005|NCT00773734|9129452|P5|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
2643006|NCT00773734|9129453|P4|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10
2643007|NCT00773734|9129454|P3|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8
2643008|NCT00773734|9129455|P2|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1
2643009|NCT00773734|9129456|P1|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5
2643010|NCT00773513|9130024|P2|Overall Study|Death|545
2643011|NCT00773513|9130025|P1|Overall Study|Death|531
2643012|NCT00773513|9130024|P2|Overall Study|Reason Not Specified|126
2643013|NCT00773513|9130025|P1|Overall Study|Reason Not Specified|159
2643014|NCT00773513|9130024|P2|Overall Study|Insufficient Therapeutic Response|18
2643015|NCT00773513|9130025|P1|Overall Study|Insufficient Therapeutic Response|1
2643016|NCT00773513|9130024|P2|Overall Study|Failure to Return|8
2643017|NCT00773513|9130025|P1|Overall Study|Failure to Return|22
2643018|NCT00773513|9130024|P2|Overall Study|Refused Treatment / Did not Cooperate|32
2643019|NCT00773513|9130025|P1|Overall Study|Refused Treatment / Did not Cooperate|26
2643020|NCT00773513|9130024|P2|Overall Study|Withdrew Consent|69
2643021|NCT00773513|9130025|P1|Overall Study|Withdrew Consent|68
2643022|NCT00773513|9130024|P2|Overall Study|Adverse Event / Intercurrent Illness|48
2643023|NCT00773513|9130025|P1|Overall Study|Adverse Event / Intercurrent Illness|40
2643024|NCT00773513|9130024|P2|Overall Study|Renal Transplant|263
2643025|NCT00773513|9130025|P1|Overall Study|Renal Transplant|254
2643026|NCT00773461|9130054|P2|Overall Study|Withdrawal by Subject|1
2643027|NCT00773461|9130055|P1|Overall Study|Withdrawal by Subject|4
2643028|NCT00773461|9130054|P2|Overall Study|Adverse Event|3
2643029|NCT00773461|9130055|P1|Overall Study|Adverse Event|1
2643030|NCT00773383|9130109|P1|Overall Study|No study dose received|1
2643031|NCT00773383|9130109|P1|Overall Study|Other|2
2643032|NCT00773383|9130109|P1|Overall Study|Progression of Disease|23
2643033|NCT00773383|9130109|P1|Overall Study|Death|1
2643034|NCT00773383|9130109|P1|Overall Study|Adverse Event|4
2643035|NCT00773279|9130144|P2|Period 2|Unclassified|2
2643036|NCT00773279|9130145|P1|Period 2|Unclassified|2
2643037|NCT00773279|9130144|P2|Period 2|Protocol Violation|3
2643038|NCT00773279|9130145|P1|Period 2|Protocol Violation|0
2643039|NCT00773279|9130144|P2|Period 2|Lack of Efficacy|0
2643040|NCT00773279|9130145|P1|Period 2|Lack of Efficacy|1
2643041|NCT00773279|9130144|P2|Period 2|Adverse Event|1
2643042|NCT00773279|9130145|P1|Period 2|Adverse Event|0
2643043|NCT00773279|9130144|P2|Period 1|Unclassified|1
2643044|NCT00773279|9130145|P1|Period 1|Unclassified|5
2643045|NCT00773279|9130144|P2|Period 1|Lack of Efficacy|2
2643046|NCT00773279|9130145|P1|Period 1|Lack of Efficacy|0
2643047|NCT00773279|9130144|P2|Period 1|Adverse Event|1
2643048|NCT00773279|9130145|P1|Period 1|Adverse Event|2
2643049|NCT00773253|9130166|P2|First Intervention (Week 0-24)|Frontalis Test Negative|1
2643050|NCT00773253|9130167|P1|First Intervention (Week 0-24)|Frontalis Test Negative|0
2643051|NCT00773175|9130177|P2|Overall Study|Consent Withdrawn|2
2643052|NCT00773175|9130178|P1|Overall Study|Consent Withdrawn|0
2643053|NCT00773175|9130177|P2|Overall Study|Adverse Event|0
2643054|NCT00773175|9130178|P1|Overall Study|Adverse Event|2
2643055|NCT00773136|9130270|P1|Overall Study|Physician Decision|2
2643056|NCT00773097|9130275|P1|Overall Study|Physician Decision|6
2643057|NCT00773097|9130275|P1|Overall Study|Withdrawal by Subject|1
2643058|NCT00772967|9130281|P6|Crossover Treatment 3|Adverse Event|0
2643059|NCT00772967|9130282|P5|Crossover Treatment 3|Adverse Event|1
2643060|NCT00772967|9130283|P4|Crossover Treatment 3|Adverse Event|0
2643061|NCT00772967|9130284|P3|Crossover Treatment 3|Adverse Event|0
2643062|NCT00772967|9130285|P2|Crossover Treatment 3|Adverse Event|0
2643063|NCT00772967|9130286|P1|Crossover Treatment 3|Adverse Event|0
2643064|NCT00772967|9130281|P6|Break 1 (4-7 Days)|Withdrawal by Subject|0
2643065|NCT00772967|9130282|P5|Break 1 (4-7 Days)|Withdrawal by Subject|0
2643066|NCT00772967|9130283|P4|Break 1 (4-7 Days)|Withdrawal by Subject|0
2643067|NCT00772967|9130284|P3|Break 1 (4-7 Days)|Withdrawal by Subject|0
2643068|NCT00772967|9130285|P2|Break 1 (4-7 Days)|Withdrawal by Subject|1
2643069|NCT00772967|9130286|P1|Break 1 (4-7 Days)|Withdrawal by Subject|0
2643070|NCT00772967|9130281|P6|Crossover Treatment 1|Adverse Event (Pain)|0
2643071|NCT00772967|9130282|P5|Crossover Treatment 1|Adverse Event (Pain)|0
2643072|NCT00772967|9130283|P4|Crossover Treatment 1|Adverse Event (Pain)|1
2643073|NCT00772967|9130284|P3|Crossover Treatment 1|Adverse Event (Pain)|0
2643074|NCT00772967|9130285|P2|Crossover Treatment 1|Adverse Event (Pain)|0
2643075|NCT00772967|9130286|P1|Crossover Treatment 1|Adverse Event (Pain)|0
2643076|NCT00772954|9130306|P3|Overall Study|Adverse Event|1
2643077|NCT00772954|9130307|P2|Overall Study|Adverse Event|0
2643078|NCT00772954|9130308|P1|Overall Study|Adverse Event|0
2643079|NCT00772941|9130316|P1|Overall Study|GPSP Violation|90
2643080|NCT00772941|9130316|P1|Overall Study|Poor Compliance|7
2643081|NCT00772941|9130316|P1|Overall Study|Missed Visits|374
2643082|NCT00772941|9130316|P1|Overall Study|Study not completed|16
2643083|NCT00772941|9130316|P1|Overall Study|CRFs not available|195
2643084|NCT00772928|9130347|P2|Overall Study|Did not receive vaccine|1
2643085|NCT00772928|9130348|P1|Overall Study|Did not receive vaccine|0
2643086|NCT00772928|9130347|P2|Overall Study|Withdrawal by Subject|22
2643087|NCT00772928|9130348|P1|Overall Study|Withdrawal by Subject|25
2643088|NCT00772928|9130347|P2|Overall Study|Protocol Violation|12
2643089|NCT00772928|9130348|P1|Overall Study|Protocol Violation|10
2643090|NCT00772928|9130347|P2|Overall Study|Lost to Follow-up|6
2643091|NCT00772928|9130348|P1|Overall Study|Lost to Follow-up|9
2643092|NCT00772889|9130369|P3|Overall Study|Lost to Follow-up|7
2643093|NCT00772889|9130370|P2|Overall Study|Lost to Follow-up|6
2643094|NCT00772889|9130371|P1|Overall Study|Lost to Follow-up|6
2643095|NCT00772889|9130369|P3|Overall Study|Withdrawal by Subject|9
2643096|NCT00772889|9130370|P2|Overall Study|Withdrawal by Subject|8
2643097|NCT00772889|9130371|P1|Overall Study|Withdrawal by Subject|9
2643098|NCT00772889|9130369|P3|Overall Study|Adverse Event|0
2643099|NCT00772889|9130370|P2|Overall Study|Adverse Event|4
2643100|NCT00772889|9130371|P1|Overall Study|Adverse Event|7
2643101|NCT00772707|9130429|P1|Overall Study|Withdrawn|3
2643102|NCT00772668|9130434|P1|Overall Study|Physician Decision|3
2643103|NCT00772629|9130443|P2|Overall Study|Subject was not vaccinated|0
2643104|NCT00772629|9130444|P1|Overall Study|Subject was not vaccinated|1
2643105|NCT00772603|9130453|P3|Overall Study|Other|2
2643106|NCT00772603|9130454|P2|Overall Study|Other|0
2643107|NCT00772603|9130455|P1|Overall Study|Other|2
2643108|NCT00772603|9130453|P3|Overall Study|Physician Decision|1
2643109|NCT00772603|9130454|P2|Overall Study|Physician Decision|0
2643110|NCT00772603|9130455|P1|Overall Study|Physician Decision|0
2643111|NCT00772603|9130453|P3|Overall Study|Lost to Follow-up|2
2643112|NCT00772603|9130454|P2|Overall Study|Lost to Follow-up|5
2643113|NCT00772603|9130455|P1|Overall Study|Lost to Follow-up|1
2643114|NCT00772603|9130453|P3|Overall Study|Protocol Violation|1
2643115|NCT00772603|9130454|P2|Overall Study|Protocol Violation|1
2643116|NCT00772603|9130455|P1|Overall Study|Protocol Violation|0
2643117|NCT00772603|9130453|P3|Overall Study|Subject Non-compliance|4
2643118|NCT00772603|9130454|P2|Overall Study|Subject Non-compliance|6
2643119|NCT00772603|9130455|P1|Overall Study|Subject Non-compliance|1
2643120|NCT00772603|9130453|P3|Overall Study|Adverse Event|10
2643121|NCT00772603|9130454|P2|Overall Study|Adverse Event|18
2643122|NCT00772603|9130455|P1|Overall Study|Adverse Event|37
2643123|NCT00772603|9130453|P3|Overall Study|Withdrawal by Subject|6
2643124|NCT00772603|9130454|P2|Overall Study|Withdrawal by Subject|10
2643125|NCT00772603|9130455|P1|Overall Study|Withdrawal by Subject|11
2643126|NCT00772577|9130494|P2|Overall Study|Protocol Deviation|2
2643127|NCT00772577|9130495|P1|Overall Study|Protocol Deviation|3
2643128|NCT00772577|9130494|P2|Overall Study|Administrative problems|1
2643129|NCT00772577|9130495|P1|Overall Study|Administrative problems|2
2643130|NCT00772577|9130494|P2|Overall Study|Lost to Follow-up|3
2643131|NCT00772577|9130495|P1|Overall Study|Lost to Follow-up|4
2643132|NCT00772577|9130494|P2|Overall Study|Patient withdrew consent|5
2643133|NCT00772577|9130495|P1|Overall Study|Patient withdrew consent|8
2643134|NCT00772577|9130494|P2|Overall Study|Unsatisfactory therapeutic effect|8
2643135|NCT00772577|9130495|P1|Overall Study|Unsatisfactory therapeutic effect|0
2643136|NCT00772577|9130494|P2|Overall Study|Abnormal laboratory values|1
2643137|NCT00772577|9130495|P1|Overall Study|Abnormal laboratory values|0
2643138|NCT00772577|9130494|P2|Overall Study|Adverse Event|3
2643139|NCT00772577|9130495|P1|Overall Study|Adverse Event|6
2643140|NCT00772538|9130511|P2|Overall Study|Other|7
2643141|NCT00772538|9130512|P1|Overall Study|Other|7
2643142|NCT00772538|9130511|P2|Overall Study|Lack of Efficacy|1
2643143|NCT00772538|9130512|P1|Overall Study|Lack of Efficacy|0
2643144|NCT00772538|9130511|P2|Overall Study|Withdrawal by Subject|8
2643145|NCT00772538|9130512|P1|Overall Study|Withdrawal by Subject|3
2643146|NCT00772538|9130511|P2|Overall Study|Lost to Follow-up|1
2643147|NCT00772538|9130512|P1|Overall Study|Lost to Follow-up|1
2643148|NCT00772538|9130511|P2|Overall Study|Protocol Violation|3
2643149|NCT00772538|9130512|P1|Overall Study|Protocol Violation|3
2643150|NCT00772538|9130511|P2|Overall Study|Adverse Event|6
2643151|NCT00772538|9130512|P1|Overall Study|Adverse Event|6
2643152|NCT00772447|9130584|P2|Overall Study|all others|2
2643153|NCT00772447|9130585|P1|Overall Study|all others|2
2643154|NCT00772447|9130584|P2|Overall Study|Protocol Violation|1
2643155|NCT00772447|9130585|P1|Overall Study|Protocol Violation|0
2643156|NCT00772447|9130584|P2|Overall Study|incorrect enrolment|4
2643157|NCT00772447|9130585|P1|Overall Study|incorrect enrolment|3
2643158|NCT00772447|9130584|P2|Overall Study|Lost to Follow-up|4
2643159|NCT00772447|9130585|P1|Overall Study|Lost to Follow-up|2
2643160|NCT00772447|9130584|P2|Overall Study|Physician Decision|8
2643161|NCT00772447|9130585|P1|Overall Study|Physician Decision|4
2643162|NCT00772447|9130584|P2|Overall Study|Withdrawal by Subject|5
2643163|NCT00772447|9130585|P1|Overall Study|Withdrawal by Subject|9
2643164|NCT00772382|9130613|P1|Overall Study|Other Reasons|10
2643165|NCT00772382|9130613|P1|Overall Study|Withdrawal by Subject|10
2643166|NCT00772382|9130613|P1|Overall Study|Protocol Violation|1
2643167|NCT00772382|9130613|P1|Overall Study|Physician Decision|5
2643168|NCT00772382|9130613|P1|Overall Study|Lack of Efficacy|4
2643169|NCT00772382|9130613|P1|Overall Study|Death|6
2643170|NCT00772382|9130613|P1|Overall Study|Adverse Event|19
2643171|NCT00772369|9130618|P1|Overall Study|Did not return record release form|1
2643172|NCT00772148|9130629|P2|Maintenance Phase (Week 52)|Administrative/other|2
2643173|NCT00772148|9130630|P1|Maintenance Phase (Week 52)|Administrative/other|1
2643174|NCT00772148|9130629|P2|Maintenance Phase (Week 52)|Withdrawal by Subject|1
2643175|NCT00772148|9130630|P1|Maintenance Phase (Week 52)|Withdrawal by Subject|0
2643176|NCT00772148|9130629|P2|Maintenance Phase (Week 52)|Adverse Event|0
2643177|NCT00772148|9130630|P1|Maintenance Phase (Week 52)|Adverse Event|1
2643178|NCT00772148|9130629|P2|Maintenance Phase (Week 52)|Death|2
2643179|NCT00772148|9130630|P1|Maintenance Phase (Week 52)|Death|2
2643180|NCT00772148|9130629|P2|Pharmacokinetic Phase (14 Days)|Administrative/other|0
2643181|NCT00772148|9130630|P1|Pharmacokinetic Phase (14 Days)|Administrative/other|2
2643182|NCT00772148|9130629|P2|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5
2643183|NCT00772148|9130630|P1|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3
2643184|NCT00772148|9130629|P2|Pharmacokinetic Phase (14 Days)|Adverse Event|1
2643185|NCT00772148|9130630|P1|Pharmacokinetic Phase (14 Days)|Adverse Event|3
2643186|NCT00772109|9130650|P4|Overall Study|Withdrawal by Subject|16
2643187|NCT00772109|9130651|P3|Overall Study|Withdrawal by Subject|6
2643188|NCT00772109|9130652|P2|Overall Study|Withdrawal by Subject|8
2643189|NCT00772109|9130653|P1|Overall Study|Withdrawal by Subject|8
2643190|NCT00772109|9130650|P4|Overall Study|Lost to Follow-up|9
2643191|NCT00772109|9130651|P3|Overall Study|Lost to Follow-up|5
2643192|NCT00772109|9130652|P2|Overall Study|Lost to Follow-up|3
2643193|NCT00772109|9130653|P1|Overall Study|Lost to Follow-up|7
2643194|NCT00772109|9130650|P4|Overall Study|Protocol Violation|6
2643195|NCT00772109|9130651|P3|Overall Study|Protocol Violation|7
2643196|NCT00772109|9130652|P2|Overall Study|Protocol Violation|8
2643197|NCT00772109|9130653|P1|Overall Study|Protocol Violation|5
2643198|NCT00772109|9130650|P4|Overall Study|Serious adverse event|0
2643199|NCT00772109|9130651|P3|Overall Study|Serious adverse event|1
2643200|NCT00772109|9130652|P2|Overall Study|Serious adverse event|0
2643201|NCT00772109|9130653|P1|Overall Study|Serious adverse event|1
2643202|NCT00772070|9130677|P2|Overall Study|Vaccination error-wrong dose/expired lot|0
2643203|NCT00772070|9130678|P1|Overall Study|Vaccination error-wrong dose/expired lot|2
2643204|NCT00772070|9130677|P2|Overall Study|Withdrawal by Subject|2
2643205|NCT00772070|9130678|P1|Overall Study|Withdrawal by Subject|0
2643206|NCT00772070|9130677|P2|Overall Study|Lost to Follow-up|8
2643207|NCT00772070|9130678|P1|Overall Study|Lost to Follow-up|0
2643208|NCT00772031|9130690|P2|Overall Study|Lost to Follow-up|33
2643209|NCT00772031|9130691|P1|Overall Study|Lost to Follow-up|20
2643210|NCT00772031|9130690|P2|Overall Study|Early termination of trial|10
2643211|NCT00772031|9130691|P1|Overall Study|Early termination of trial|12
2643212|NCT00772005|9130717|P4|Overall Study|Non-compliance with drug administration|1
2643213|NCT00772005|9130718|P3|Overall Study|Non-compliance with drug administration|1
2643214|NCT00772005|9130719|P2|Overall Study|Non-compliance with drug administration|0
2643215|NCT00772005|9130720|P1|Overall Study|Non-compliance with drug administration|3
2643216|NCT00772005|9130717|P4|Overall Study|Non-compliance with study procedures|1
2643217|NCT00772005|9130718|P3|Overall Study|Non-compliance with study procedures|0
2643218|NCT00772005|9130719|P2|Overall Study|Non-compliance with study procedures|1
2643219|NCT00772005|9130720|P1|Overall Study|Non-compliance with study procedures|1
2643220|NCT00772005|9130717|P4|Overall Study|Lost to Follow-up|3
2643221|NCT00772005|9130718|P3|Overall Study|Lost to Follow-up|6
2643222|NCT00772005|9130719|P2|Overall Study|Lost to Follow-up|3
2643223|NCT00772005|9130720|P1|Overall Study|Lost to Follow-up|7
2643224|NCT00772005|9130717|P4|Overall Study|Protocol Violation|6
2643225|NCT00772005|9130718|P3|Overall Study|Protocol Violation|1
2643226|NCT00772005|9130719|P2|Overall Study|Protocol Violation|4
2643227|NCT00772005|9130720|P1|Overall Study|Protocol Violation|2
2643228|NCT00772005|9130717|P4|Overall Study|Withdrawal by Subject|2
2643229|NCT00772005|9130718|P3|Overall Study|Withdrawal by Subject|10
2643230|NCT00772005|9130719|P2|Overall Study|Withdrawal by Subject|7
2643231|NCT00772005|9130720|P1|Overall Study|Withdrawal by Subject|3
2643232|NCT00772005|9130717|P4|Overall Study|Lack of Efficacy|0
2643233|NCT00772005|9130718|P3|Overall Study|Lack of Efficacy|0
2643234|NCT00772005|9130719|P2|Overall Study|Lack of Efficacy|1
2643235|NCT00772005|9130720|P1|Overall Study|Lack of Efficacy|0
2643236|NCT00772005|9130717|P4|Overall Study|Adverse Event|13
2643237|NCT00772005|9130718|P3|Overall Study|Adverse Event|10
2643238|NCT00772005|9130719|P2|Overall Study|Adverse Event|14
2643239|NCT00772005|9130720|P1|Overall Study|Adverse Event|9
2643240|NCT00771953|9131408|P2|Overall Study|Withdrawal by Subject|3
2643241|NCT00771953|9131409|P1|Overall Study|Withdrawal by Subject|0
2643242|NCT00771953|9131408|P2|Overall Study|Other complicating disease|0
2643243|NCT00771953|9131409|P1|Overall Study|Other complicating disease|1
2643244|NCT00771953|9131408|P2|Overall Study|Sponsor decision|0
2643245|NCT00771953|9131409|P1|Overall Study|Sponsor decision|1
2643246|NCT00771953|9131408|P2|Overall Study|Progression before active Tx|2
2643247|NCT00771953|9131409|P1|Overall Study|Progression before active Tx|1
2643248|NCT00771953|9131408|P2|Overall Study|Death|2
2643249|NCT00771953|9131409|P1|Overall Study|Death|2
2643250|NCT00771953|9131408|P2|Overall Study|Adverse Event|3
2643251|NCT00771953|9131409|P1|Overall Study|Adverse Event|5
2643252|NCT00771927|9131419|P2|Overall Study|Other reason|27
2643253|NCT00771927|9131420|P1|Overall Study|Other reason|23
2643254|NCT00771927|9131419|P2|Overall Study|Withdrawal by Subject|17
2643255|NCT00771927|9131420|P1|Overall Study|Withdrawal by Subject|16
2643256|NCT00771927|9131419|P2|Overall Study|Lost to Follow-up|46
2643257|NCT00771927|9131420|P1|Overall Study|Lost to Follow-up|46
2643258|NCT00771927|9131419|P2|Overall Study|Lack of Efficacy|42
2643259|NCT00771927|9131420|P1|Overall Study|Lack of Efficacy|70
2643260|NCT00771927|9131419|P2|Overall Study|Adverse Event|105
2643261|NCT00771927|9131420|P1|Overall Study|Adverse Event|100
2643262|NCT00771914|9131432|P4|Overall Study|Lost to Follow-up|1
2643263|NCT00771914|9131433|P3|Overall Study|Lost to Follow-up|0
2643264|NCT00771914|9131434|P2|Overall Study|Lost to Follow-up|0
2643265|NCT00771914|9131435|P1|Overall Study|Lost to Follow-up|0
2643266|NCT00771914|9131432|P4|Overall Study|Physician Decision|1
2643267|NCT00771914|9131433|P3|Overall Study|Physician Decision|0
2643268|NCT00771914|9131434|P2|Overall Study|Physician Decision|0
2643269|NCT00771914|9131435|P1|Overall Study|Physician Decision|0
2643270|NCT00771901|9131448|P3|Overall Study|Dissat w/# of study medication (40/day)|4
2643271|NCT00771901|9131449|P2|Overall Study|Dissat w/# of study medication (40/day)|0
2643272|NCT00771901|9131450|P1|Overall Study|Dissat w/# of study medication (40/day)|0
2643273|NCT00771849|9131497|P2|Overall Study|Not vaccinated|1
2643274|NCT00771849|9131498|P1|Overall Study|Not vaccinated|0
2643275|NCT00771849|9131497|P2|Overall Study|Withdrawal by Subject|1
2643276|NCT00771849|9131498|P1|Overall Study|Withdrawal by Subject|1
2643277|NCT00771849|9131497|P2|Overall Study|Lost to Follow-up|2
2643278|NCT00771849|9131498|P1|Overall Study|Lost to Follow-up|1
2643279|NCT00771810|9131509|P3|Overall Study|Other|1
2643280|NCT00771810|9131510|P2|Overall Study|Other|0
2643281|NCT00771810|9131511|P1|Overall Study|Other|0
2643282|NCT00771810|9131509|P3|Overall Study|Withdrawal by Subject|0
2643283|NCT00771810|9131510|P2|Overall Study|Withdrawal by Subject|2
2643284|NCT00771810|9131511|P1|Overall Study|Withdrawal by Subject|1
2643285|NCT00771810|9131509|P3|Overall Study|Protocol Violation|1
2643286|NCT00771810|9131510|P2|Overall Study|Protocol Violation|1
2643287|NCT00771810|9131511|P1|Overall Study|Protocol Violation|0
2643288|NCT00771810|9131509|P3|Overall Study|Physician Decision|2
2643289|NCT00771810|9131510|P2|Overall Study|Physician Decision|2
2643290|NCT00771810|9131511|P1|Overall Study|Physician Decision|1
2643291|NCT00771810|9131509|P3|Overall Study|Lost to Follow-up|1
2643292|NCT00771810|9131510|P2|Overall Study|Lost to Follow-up|0
2643293|NCT00771810|9131511|P1|Overall Study|Lost to Follow-up|0
2643294|NCT00771810|9131509|P3|Overall Study|Adverse Event|2
2643295|NCT00771810|9131510|P2|Overall Study|Adverse Event|0
2643296|NCT00771810|9131511|P1|Overall Study|Adverse Event|3
2643297|NCT00771758|9131549|P3|Overall Study|Other|0
2643298|NCT00771758|9131550|P2|Overall Study|Other|2
2643299|NCT00771758|9131551|P1|Overall Study|Other|3
2643300|NCT00771758|9131549|P3|Overall Study|Withdrawal by Subject|0
2643301|NCT00771758|9131550|P2|Overall Study|Withdrawal by Subject|0
2643302|NCT00771758|9131551|P1|Overall Study|Withdrawal by Subject|1
2643303|NCT00771758|9131549|P3|Overall Study|Protocol Violation|0
2643304|NCT00771758|9131550|P2|Overall Study|Protocol Violation|0
2643305|NCT00771758|9131551|P1|Overall Study|Protocol Violation|1
2643306|NCT00771758|9131549|P3|Overall Study|Lost to Follow-up|0
2643307|NCT00771758|9131550|P2|Overall Study|Lost to Follow-up|0
2643308|NCT00771758|9131551|P1|Overall Study|Lost to Follow-up|1
2643309|NCT00771758|9131549|P3|Overall Study|Lack of Efficacy|1
2643310|NCT00771758|9131550|P2|Overall Study|Lack of Efficacy|2
2643311|NCT00771758|9131551|P1|Overall Study|Lack of Efficacy|0
2643312|NCT00771758|9131549|P3|Overall Study|Adverse Event|1
2643313|NCT00771758|9131550|P2|Overall Study|Adverse Event|8
2643314|NCT00771758|9131551|P1|Overall Study|Adverse Event|2
2643315|NCT00771667|9131712|P10|Maintenance Phase|Other|3
2643316|NCT00771667|9131713|P9|Maintenance Phase|Other|3
2643317|NCT00771667|9131714|P8|Maintenance Phase|Other|2
2643318|NCT00771667|9131715|P7|Maintenance Phase|Other|2
2643319|NCT00771667|9131716|P6|Maintenance Phase|Other|1
2643320|NCT00771667|9131717|P5|Maintenance Phase|Other|0
2643321|NCT00771667|9131718|P4|Maintenance Phase|Other|0
2643322|NCT00771667|9131719|P3|Maintenance Phase|Other|0
2643323|NCT00771667|9131720|P2|Maintenance Phase|Other|0
2643324|NCT00771667|9131721|P1|Maintenance Phase|Other|0
2643325|NCT00771667|9131712|P10|Maintenance Phase|Lack of Efficacy|7
2643326|NCT00771667|9131713|P9|Maintenance Phase|Lack of Efficacy|11
2643327|NCT00771667|9131714|P8|Maintenance Phase|Lack of Efficacy|2
2643328|NCT00771667|9131715|P7|Maintenance Phase|Lack of Efficacy|3
2643329|NCT00771667|9131716|P6|Maintenance Phase|Lack of Efficacy|3
2643330|NCT00771667|9131717|P5|Maintenance Phase|Lack of Efficacy|1
2643331|NCT00771667|9131718|P4|Maintenance Phase|Lack of Efficacy|0
2643332|NCT00771667|9131719|P3|Maintenance Phase|Lack of Efficacy|0
2643333|NCT00771667|9131720|P2|Maintenance Phase|Lack of Efficacy|0
2643334|NCT00771667|9131721|P1|Maintenance Phase|Lack of Efficacy|0
2643335|NCT00771667|9131712|P10|Maintenance Phase|Adverse Event|7
2643336|NCT00771667|9131713|P9|Maintenance Phase|Adverse Event|8
2643337|NCT00771667|9131714|P8|Maintenance Phase|Adverse Event|1
2643338|NCT00771667|9131715|P7|Maintenance Phase|Adverse Event|5
2643339|NCT00771667|9131716|P6|Maintenance Phase|Adverse Event|3
2643340|NCT00771667|9131717|P5|Maintenance Phase|Adverse Event|1
2643341|NCT00771667|9131718|P4|Maintenance Phase|Adverse Event|0
2643342|NCT00771667|9131719|P3|Maintenance Phase|Adverse Event|0
2643343|NCT00771667|9131720|P2|Maintenance Phase|Adverse Event|0
2643344|NCT00771667|9131721|P1|Maintenance Phase|Adverse Event|0
2643345|NCT00771667|9131712|P10|Induction Phase|Other|0
2643346|NCT00771667|9131713|P9|Induction Phase|Other|0
2643347|NCT00771667|9131714|P8|Induction Phase|Other|0
2643348|NCT00771667|9131715|P7|Induction Phase|Other|0
2643349|NCT00771667|9131716|P6|Induction Phase|Other|0
2643350|NCT00771667|9131717|P5|Induction Phase|Other|0
2643351|NCT00771667|9131718|P4|Induction Phase|Other|4
2643352|NCT00771667|9131719|P3|Induction Phase|Other|3
2643353|NCT00771667|9131720|P2|Induction Phase|Other|6
2643354|NCT00771667|9131721|P1|Induction Phase|Other|4
2643355|NCT00771667|9131712|P10|Induction Phase|Lost to Follow-up|0
2643356|NCT00771667|9131713|P9|Induction Phase|Lost to Follow-up|0
2643357|NCT00771667|9131714|P8|Induction Phase|Lost to Follow-up|0
2643358|NCT00771667|9131715|P7|Induction Phase|Lost to Follow-up|0
2643359|NCT00771667|9131716|P6|Induction Phase|Lost to Follow-up|0
2643360|NCT00771667|9131717|P5|Induction Phase|Lost to Follow-up|0
2643361|NCT00771667|9131718|P4|Induction Phase|Lost to Follow-up|0
2643362|NCT00771667|9131719|P3|Induction Phase|Lost to Follow-up|1
2643363|NCT00771667|9131720|P2|Induction Phase|Lost to Follow-up|0
2643364|NCT00771667|9131721|P1|Induction Phase|Lost to Follow-up|1
2643365|NCT00771667|9131712|P10|Induction Phase|Lack of Efficacy|0
2643366|NCT00771667|9131713|P9|Induction Phase|Lack of Efficacy|0
2643367|NCT00771667|9131714|P8|Induction Phase|Lack of Efficacy|0
2643368|NCT00771667|9131715|P7|Induction Phase|Lack of Efficacy|0
2643369|NCT00771667|9131716|P6|Induction Phase|Lack of Efficacy|0
2643370|NCT00771667|9131717|P5|Induction Phase|Lack of Efficacy|0
2643371|NCT00771667|9131718|P4|Induction Phase|Lack of Efficacy|3
2643372|NCT00771667|9131719|P3|Induction Phase|Lack of Efficacy|4
2643373|NCT00771667|9131720|P2|Induction Phase|Lack of Efficacy|2
2643374|NCT00771667|9131721|P1|Induction Phase|Lack of Efficacy|9
2643375|NCT00771667|9131712|P10|Induction Phase|Adverse Event|0
2643376|NCT00771667|9131713|P9|Induction Phase|Adverse Event|0
2643377|NCT00771667|9131714|P8|Induction Phase|Adverse Event|0
2643378|NCT00771667|9131715|P7|Induction Phase|Adverse Event|0
2643379|NCT00771667|9131716|P6|Induction Phase|Adverse Event|0
2643380|NCT00771667|9131717|P5|Induction Phase|Adverse Event|0
2643381|NCT00771667|9131718|P4|Induction Phase|Adverse Event|1
2643382|NCT00771667|9131719|P3|Induction Phase|Adverse Event|4
2643383|NCT00771667|9131720|P2|Induction Phase|Adverse Event|2
2643384|NCT00771667|9131721|P1|Induction Phase|Adverse Event|5
2643385|NCT00771615|9131766|P9|Overall Study|Lost to Follow-up|0
2643386|NCT00771615|9131767|P8|Overall Study|Lost to Follow-up|0
2643387|NCT00771615|9131768|P7|Overall Study|Lost to Follow-up|1
2643388|NCT00771615|9131769|P6|Overall Study|Lost to Follow-up|1
2643389|NCT00771615|9131770|P5|Overall Study|Lost to Follow-up|0
2643390|NCT00771615|9131771|P4|Overall Study|Lost to Follow-up|1
2643391|NCT00771615|9131772|P3|Overall Study|Lost to Follow-up|1
2643392|NCT00771615|9131773|P2|Overall Study|Lost to Follow-up|1
2643393|NCT00771615|9131774|P1|Overall Study|Lost to Follow-up|1
2643394|NCT00771615|9131766|P9|Overall Study|Withdrawal by Subject|0
2643395|NCT00771615|9131767|P8|Overall Study|Withdrawal by Subject|1
2643396|NCT00771615|9131768|P7|Overall Study|Withdrawal by Subject|0
2643397|NCT00771615|9131769|P6|Overall Study|Withdrawal by Subject|0
2643398|NCT00771615|9131770|P5|Overall Study|Withdrawal by Subject|0
2643399|NCT00771615|9131771|P4|Overall Study|Withdrawal by Subject|0
2643400|NCT00771615|9131772|P3|Overall Study|Withdrawal by Subject|0
2643401|NCT00771615|9131773|P2|Overall Study|Withdrawal by Subject|1
2643402|NCT00771615|9131774|P1|Overall Study|Withdrawal by Subject|0
2643403|NCT00771472|9132035|P2|Overall Study|Protocol Violation|0
2643404|NCT00771472|9132036|P1|Overall Study|Protocol Violation|1
2643405|NCT00771472|9132035|P2|Overall Study|Progressive Disease|1
2643406|NCT00771472|9132036|P1|Overall Study|Progressive Disease|3
2643407|NCT00771472|9132035|P2|Overall Study|Physician Decision|3
2643408|NCT00771472|9132036|P1|Overall Study|Physician Decision|2
2643409|NCT00771316|9132056|P2|Overall Study|Discontinued due to early termination|0
2643410|NCT00771316|9132057|P1|Overall Study|Discontinued due to early termination|1
2643411|NCT00771316|9132056|P2|Overall Study|Patient withdrew consent|0
2643412|NCT00771316|9132057|P1|Overall Study|Patient withdrew consent|1
2643413|NCT00771316|9132056|P2|Overall Study|Adverse Event|1
2643414|NCT00771316|9132057|P1|Overall Study|Adverse Event|0
2643415|NCT00770991|9132109|P2|Overall Study|Pregnancy|0
2643416|NCT00770991|9132110|P1|Overall Study|Pregnancy|1
2643417|NCT00770991|9132109|P2|Overall Study|Adverse Event|5
2643418|NCT00770991|9132110|P1|Overall Study|Adverse Event|1
2643419|NCT00770991|9132109|P2|Overall Study|Withdrawal by Subject|0
2643420|NCT00770991|9132110|P1|Overall Study|Withdrawal by Subject|1
2643421|NCT00770991|9132109|P2|Overall Study|Physician Decision|0
2643422|NCT00770991|9132110|P1|Overall Study|Physician Decision|2
2643423|NCT00770965|9132126|P4|Excluded Set|Withdrawal by Subject|3
2643424|NCT00770965|9132127|P3|Excluded Set|Withdrawal by Subject|2
2643425|NCT00770965|9132128|P2|Excluded Set|Withdrawal by Subject|1
2643426|NCT00770965|9132129|P1|Excluded Set|Withdrawal by Subject|1
2643427|NCT00770965|9132126|P4|Excluded Set|Administrative problems|10
2643428|NCT00770965|9132127|P3|Excluded Set|Administrative problems|12
2643429|NCT00770965|9132128|P2|Excluded Set|Administrative problems|12
2643430|NCT00770965|9132129|P1|Excluded Set|Administrative problems|14
2643431|NCT00770965|9132126|P4|Safety Set|Protocol deviation|0
2643432|NCT00770965|9132127|P3|Safety Set|Protocol deviation|1
2643433|NCT00770965|9132128|P2|Safety Set|Protocol deviation|0
2643434|NCT00770965|9132129|P1|Safety Set|Protocol deviation|0
2643435|NCT00770965|9132126|P4|Safety Set|Withdrawal by Subject|1
2643436|NCT00770965|9132127|P3|Safety Set|Withdrawal by Subject|0
2643437|NCT00770965|9132128|P2|Safety Set|Withdrawal by Subject|0
2643438|NCT00770965|9132129|P1|Safety Set|Withdrawal by Subject|0
2643439|NCT00770913|9132150|P3|Overall Study|Incorrect drug was allocated|0
2643440|NCT00770913|9132151|P2|Overall Study|Incorrect drug was allocated|0
2643441|NCT00770913|9132152|P1|Overall Study|Incorrect drug was allocated|1
2643442|NCT00770913|9132150|P3|Overall Study|Protocol Violation|1
2643443|NCT00770913|9132151|P2|Overall Study|Protocol Violation|0
2643444|NCT00770913|9132152|P1|Overall Study|Protocol Violation|3
2643445|NCT00770913|9132150|P3|Overall Study|Physician Decision|1
2643446|NCT00770913|9132151|P2|Overall Study|Physician Decision|1
2643447|NCT00770913|9132152|P1|Overall Study|Physician Decision|0
2643448|NCT00770913|9132150|P3|Overall Study|Refusal to continue participation|5
2643449|NCT00770913|9132151|P2|Overall Study|Refusal to continue participation|4
2643450|NCT00770913|9132152|P1|Overall Study|Refusal to continue participation|6
2643451|NCT00770913|9132150|P3|Overall Study|Adverse Event|6
2643452|NCT00770913|9132151|P2|Overall Study|Adverse Event|3
2643453|NCT00770913|9132152|P1|Overall Study|Adverse Event|1
2643454|NCT00770809|9132185|P3|Overall Study|Other Medical Reasons|3
2643455|NCT00770809|9132186|P2|Overall Study|Other Medical Reasons|4
2643456|NCT00770809|9132187|P1|Overall Study|Other Medical Reasons|2
2643457|NCT00770809|9132185|P3|Overall Study|Complicating illness|1
2643458|NCT00770809|9132186|P2|Overall Study|Complicating illness|0
2643459|NCT00770809|9132187|P1|Overall Study|Complicating illness|0
2643460|NCT00770809|9132185|P3|Overall Study|Progression|0
2643461|NCT00770809|9132186|P2|Overall Study|Progression|2
2643462|NCT00770809|9132187|P1|Overall Study|Progression|2
2643463|NCT00770809|9132185|P3|Overall Study|Withdrawal by Subject|7
2643464|NCT00770809|9132186|P2|Overall Study|Withdrawal by Subject|3
2643465|NCT00770809|9132187|P1|Overall Study|Withdrawal by Subject|3
2643466|NCT00770809|9132185|P3|Overall Study|Death|0
2643467|NCT00770809|9132186|P2|Overall Study|Death|0
2643468|NCT00770809|9132187|P1|Overall Study|Death|1
2643469|NCT00770809|9132185|P3|Overall Study|Adverse Event|12
2643470|NCT00770809|9132186|P2|Overall Study|Adverse Event|1
2643471|NCT00770809|9132187|P1|Overall Study|Adverse Event|9
2643472|NCT00770770|9132197|P2|Overall Study|Study Terminated|0
2643473|NCT00770770|9132198|P1|Overall Study|Study Terminated|8
2643474|NCT00770770|9132197|P2|Overall Study|Death|1
2643475|NCT00770770|9132198|P1|Overall Study|Death|0
2643476|NCT00770770|9132197|P2|Overall Study|Withdrawal by Subject|0
2643477|NCT00770770|9132198|P1|Overall Study|Withdrawal by Subject|1
2643478|NCT00770770|9132197|P2|Overall Study|Lost to Follow-up|0
2643479|NCT00770770|9132198|P1|Overall Study|Lost to Follow-up|1
2643480|NCT00770692|9132216|P4|Overall Study|Investigator judgment|1
2643481|NCT00770692|9132217|P3|Overall Study|Investigator judgment|1
2643482|NCT00770692|9132218|P2|Overall Study|Investigator judgment|0
2643483|NCT00770692|9132219|P1|Overall Study|Investigator judgment|2
2643484|NCT00770692|9132216|P4|Overall Study|Adverse Event|4
2643485|NCT00770692|9132217|P3|Overall Study|Adverse Event|4
2643486|NCT00770692|9132218|P2|Overall Study|Adverse Event|0
2643487|NCT00770692|9132219|P1|Overall Study|Adverse Event|3
2643488|NCT00770692|9132216|P4|Overall Study|Withdrawal by Subject|6
2643489|NCT00770692|9132217|P3|Overall Study|Withdrawal by Subject|9
2643490|NCT00770692|9132218|P2|Overall Study|Withdrawal by Subject|9
2643491|NCT00770692|9132219|P1|Overall Study|Withdrawal by Subject|7
2643492|NCT00770679|9132245|P1|Overall Study|Follow-up LDL measurement not collected|3
2643493|NCT00770679|9132245|P1|Overall Study|Lost to Follow-up|3
2643494|NCT00770653|9132253|P2|Overall Study|Physician Decision|0
2643495|NCT00770653|9132254|P1|Overall Study|Physician Decision|1
2643496|NCT00770653|9132253|P2|Overall Study|Lost to Follow-up|2
2643497|NCT00770653|9132254|P1|Overall Study|Lost to Follow-up|1
2643498|NCT00770653|9132253|P2|Overall Study|> Three Moderate Hypoglycemic Episodes|2
2643499|NCT00770653|9132254|P1|Overall Study|> Three Moderate Hypoglycemic Episodes|0
2643500|NCT00770653|9132253|P2|Overall Study|Fasting Glucose > 240 mg/dL|1
2643501|NCT00770653|9132254|P1|Overall Study|Fasting Glucose > 240 mg/dL|2
2643502|NCT00770653|9132253|P2|Overall Study|Worsening of Glycosolated Hemoglobin|2
2643503|NCT00770653|9132254|P1|Overall Study|Worsening of Glycosolated Hemoglobin|2
2643504|NCT00770653|9132253|P2|Overall Study|Lack of Compliance|4
2643505|NCT00770653|9132254|P1|Overall Study|Lack of Compliance|1
2643506|NCT00770653|9132253|P2|Overall Study|Withdrawal by Subject|7
2643507|NCT00770653|9132254|P1|Overall Study|Withdrawal by Subject|4
2643508|NCT00770653|9132253|P2|Overall Study|Protocol Violation|6
2643509|NCT00770653|9132254|P1|Overall Study|Protocol Violation|8
2643510|NCT00770653|9132253|P2|Overall Study|Adverse Event|5
2643511|NCT00770653|9132254|P1|Overall Study|Adverse Event|13
2643512|NCT00770588|9132324|P2|Overall Study|Withdrawal by Subject|1
2643513|NCT00770588|9132325|P1|Overall Study|Withdrawal by Subject|1
2643514|NCT00770588|9132324|P2|Overall Study|Lost to Follow-up|1
2643515|NCT00770588|9132325|P1|Overall Study|Lost to Follow-up|1
2643516|NCT00770588|9132324|P2|Overall Study|Death caused by progression of disease|91
2643517|NCT00770588|9132325|P1|Overall Study|Death caused by progression of disease|70
2643518|NCT00770588|9132324|P2|Overall Study|Adverse Event|2
2643519|NCT00770588|9132325|P1|Overall Study|Adverse Event|9
2643520|NCT00770562|9132341|P2|Overall Study|Did not take treatment|1
2643521|NCT00770562|9132342|P1|Overall Study|Did not take treatment|1
2643522|NCT00770510|9132353|P1|Overall Study|Withdrawal by Subject|2
2643523|NCT00770510|9132353|P1|Overall Study|Pregnancy|1
2643524|NCT00770510|9132353|P1|Overall Study|Lost to Follow-up|2
2643525|NCT00770484|9132392|P2|Overall Study|Withdrawal by Subject|0
2643526|NCT00770484|9132393|P1|Overall Study|Withdrawal by Subject|1
2643527|NCT00770432|9132401|P2|Overall Study|Non-compliance|1
2643528|NCT00770432|9132402|P1|Overall Study|Non-compliance|0
2643529|NCT00770432|9132401|P2|Overall Study|Other|6
2643530|NCT00770432|9132402|P1|Overall Study|Other|4
2643531|NCT00770367|9132410|P2|Second Intervention|Lost to Follow-up|0
2643532|NCT00770367|9132411|P1|Second Intervention|Lost to Follow-up|2
2643533|NCT00770367|9132410|P2|Washout Period of 4 Weeks|Withdrawal by Subject|1
2643534|NCT00770367|9132411|P1|Washout Period of 4 Weeks|Withdrawal by Subject|0
2643535|NCT00770367|9132410|P2|First Intervention|Withdrawal by Subject|2
2643536|NCT00770367|9132411|P1|First Intervention|Withdrawal by Subject|0
2643537|NCT00770341|9132422|P3|Overall Study|Not treated|0
2643538|NCT00770341|9132423|P2|Overall Study|Not treated|0
2643539|NCT00770341|9132424|P1|Overall Study|Not treated|1
2643540|NCT00770341|9132422|P3|Overall Study|Other|0
2643541|NCT00770341|9132423|P2|Overall Study|Other|0
2643542|NCT00770341|9132424|P1|Overall Study|Other|1
2643543|NCT00770341|9132422|P3|Overall Study|Lack of Efficacy|1
2643544|NCT00770341|9132423|P2|Overall Study|Lack of Efficacy|0
2643545|NCT00770341|9132424|P1|Overall Study|Lack of Efficacy|3
2643546|NCT00770341|9132422|P3|Overall Study|Laboratory adverse event|0
2643547|NCT00770341|9132423|P2|Overall Study|Laboratory adverse event|3
2643548|NCT00770341|9132424|P1|Overall Study|Laboratory adverse event|3
2643549|NCT00770341|9132422|P3|Overall Study|Clinical Adverse Event|2
2643550|NCT00770341|9132423|P2|Overall Study|Clinical Adverse Event|1
2643551|NCT00770341|9132424|P1|Overall Study|Clinical Adverse Event|3
2643552|NCT00770341|9132422|P3|Overall Study|Withdrawal by Subject|0
2643553|NCT00770341|9132423|P2|Overall Study|Withdrawal by Subject|1
2643554|NCT00770341|9132424|P1|Overall Study|Withdrawal by Subject|0
2643555|NCT00770341|9132422|P3|Overall Study|Did not meet eligibility criteria|0
2643556|NCT00770341|9132423|P2|Overall Study|Did not meet eligibility criteria|0
2643557|NCT00770341|9132424|P1|Overall Study|Did not meet eligibility criteria|1
2643558|NCT00770328|9132450|P2|Overall Study|Lost to Follow-up|2
2643559|NCT00770328|9132451|P1|Overall Study|Lost to Follow-up|2
2643560|NCT00770328|9132450|P2|Overall Study|Adverse Event|2
2643561|NCT00770328|9132451|P1|Overall Study|Adverse Event|11
2643562|NCT00770315|9132467|P4|Overall Study|Noncompliance with Protocol|9
2643563|NCT00770315|9132468|P3|Overall Study|Noncompliance with Protocol|7
2643564|NCT00770315|9132469|P2|Overall Study|Noncompliance with Protocol|4
2643565|NCT00770315|9132470|P1|Overall Study|Noncompliance with Protocol|7
2643566|NCT00770315|9132467|P4|Overall Study|Withdrawal by Subject|20
2643567|NCT00770315|9132468|P3|Overall Study|Withdrawal by Subject|24
2643568|NCT00770315|9132469|P2|Overall Study|Withdrawal by Subject|17
2643569|NCT00770315|9132470|P1|Overall Study|Withdrawal by Subject|13
2643570|NCT00770315|9132467|P4|Overall Study|Lost to Follow-up|3
2643571|NCT00770315|9132468|P3|Overall Study|Lost to Follow-up|10
2643572|NCT00770315|9132469|P2|Overall Study|Lost to Follow-up|5
2643573|NCT00770315|9132470|P1|Overall Study|Lost to Follow-up|9
2643574|NCT00770315|9132467|P4|Overall Study|Adverse Event|6
2643575|NCT00770315|9132468|P3|Overall Study|Adverse Event|16
2643576|NCT00770315|9132469|P2|Overall Study|Adverse Event|17
2643577|NCT00770315|9132470|P1|Overall Study|Adverse Event|11
2643578|NCT00770289|9132496|P1|Overall Study|Other|6
2643579|NCT00770224|9132505|P2|Step 2: Maintenance|Ineligible|2
2643580|NCT00770224|9132506|P1|Step 2: Maintenance|Ineligible|0
2643581|NCT00770224|9132505|P2|Step 2: Maintenance|Other reason not protocol specified|7
2643582|NCT00770224|9132506|P1|Step 2: Maintenance|Other reason not protocol specified|0
2643583|NCT00770224|9132505|P2|Step 2: Maintenance|Death|2
2643584|NCT00770224|9132506|P1|Step 2: Maintenance|Death|0
2643585|NCT00770224|9132505|P2|Step 2: Maintenance|Progression/relapse|1
2643586|NCT00770224|9132506|P1|Step 2: Maintenance|Progression/relapse|0
2643587|NCT00770224|9132505|P2|Step 2: Maintenance|Refusal unrelated to adverse event|8
2643588|NCT00770224|9132506|P1|Step 2: Maintenance|Refusal unrelated to adverse event|0
2643589|NCT00770224|9132505|P2|Step 2: Maintenance|Adverse Event|10
2643590|NCT00770224|9132506|P1|Step 2: Maintenance|Adverse Event|0
2643591|NCT00770224|9132505|P2|Step 1: Induction|No protocol treatment given|0
2643592|NCT00770224|9132506|P1|Step 1: Induction|No protocol treatment given|1
2643593|NCT00770224|9132505|P2|Step 1: Induction|Ineligible|0
2643594|NCT00770224|9132506|P1|Step 1: Induction|Ineligible|2
2643595|NCT00770224|9132505|P2|Step 1: Induction|Other reason not protocol specified|0
2643596|NCT00770224|9132506|P1|Step 1: Induction|Other reason not protocol specified|2
2643597|NCT00770224|9132505|P2|Step 1: Induction|Refusal unrelated to adverse event|0
2643598|NCT00770224|9132506|P1|Step 1: Induction|Refusal unrelated to adverse event|6
2643599|NCT00770224|9132505|P2|Step 1: Induction|Adverse Event|0
2643600|NCT00770224|9132506|P1|Step 1: Induction|Adverse Event|3
2643601|NCT00770211|9132518|P2|Overall Study|Withdrawal by Subject|2
2643602|NCT00770211|9132519|P1|Overall Study|Withdrawal by Subject|0
2643603|NCT00770211|9132518|P2|Overall Study|Lost to Follow-up|0
2643604|NCT00770211|9132519|P1|Overall Study|Lost to Follow-up|1
2643605|NCT00770146|9132535|P2|Follow-up Period|Other|5
2643606|NCT00770146|9132536|P1|Follow-up Period|Other|4
2643607|NCT00770146|9132535|P2|Follow-up Period|Adverse Event|2
2643608|NCT00770146|9132536|P1|Follow-up Period|Adverse Event|0
2643609|NCT00770146|9132535|P2|Follow-up Period|Withdrawal by Subject|13
2643610|NCT00770146|9132536|P1|Follow-up Period|Withdrawal by Subject|7
2643611|NCT00770146|9132535|P2|Treatment Period|Protocol non-compliance|1
2643612|NCT00770146|9132536|P1|Treatment Period|Protocol non-compliance|0
2643613|NCT00770146|9132535|P2|Treatment Period|Other|5
2643614|NCT00770146|9132536|P1|Treatment Period|Other|1
2643615|NCT00770146|9132535|P2|Treatment Period|Adverse Event|26
2643616|NCT00770146|9132536|P1|Treatment Period|Adverse Event|2
2643617|NCT00770146|9132535|P2|Treatment Period|Withdrawal by Subject|13
2643618|NCT00770146|9132536|P1|Treatment Period|Withdrawal by Subject|6
2643619|NCT00770120|9132580|P1|Overall Study|Reason under Review|1
2643620|NCT00770120|9132580|P1|Overall Study|Never Received Treatment/Not Analyzable|1
2643621|NCT00770120|9132580|P1|Overall Study|Ineligible|1
2643622|NCT00770120|9132580|P1|Overall Study|Withdrawal by Subject|2
2643623|NCT00770120|9132580|P1|Overall Study|Death|3
2643624|NCT00770120|9132580|P1|Overall Study|Not Protocol Specified|11
2643625|NCT00770120|9132580|P1|Overall Study|Adverse Event|11
2643626|NCT00770120|9132580|P1|Overall Study|Progression|31
2643627|NCT00770029|9132589|P2|Overall Study|Adverse Event|0
2643628|NCT00770029|9132590|P1|Overall Study|Adverse Event|1
2643629|NCT00770029|9132589|P2|Overall Study|Withdrawal by Subject|3
2643630|NCT00770029|9132590|P1|Overall Study|Withdrawal by Subject|3
2643631|NCT00770029|9132589|P2|Overall Study|Lost to Follow-up|0
2643632|NCT00770029|9132590|P1|Overall Study|Lost to Follow-up|2
2643633|NCT00769860|9132606|P2|Overall Study|Withdrawal by Subject|0
2643634|NCT00769860|9132607|P1|Overall Study|Withdrawal by Subject|2
2643635|NCT00769704|9132635|P2|Overall Study|Other|2
2643636|NCT00769704|9132636|P1|Overall Study|Other|1
2643637|NCT00769704|9132635|P2|Overall Study|Withdrawal by Subject|5
2643638|NCT00769704|9132636|P1|Overall Study|Withdrawal by Subject|12
2643639|NCT00769704|9132635|P2|Overall Study|Death|190
2643640|NCT00769704|9132636|P1|Overall Study|Death|95
2643641|NCT00769704|9132635|P2|Overall Study|Lost to Follow-up|2
2643642|NCT00769704|9132636|P1|Overall Study|Lost to Follow-up|3
2643643|NCT00769561|9132686|P2|Overall Study|Lost to Follow-up|3
2643644|NCT00769561|9132687|P1|Overall Study|Lost to Follow-up|1
2643645|NCT00769561|9132686|P2|Overall Study|Withdrawal by Subject|2
2643646|NCT00769561|9132687|P1|Overall Study|Withdrawal by Subject|2
2643647|NCT00769483|9132713|P6|Overall Study|Withdrawal by Subject|0
2643648|NCT00769483|9132714|P5|Overall Study|Withdrawal by Subject|1
2643649|NCT00769483|9132715|P4|Overall Study|Withdrawal by Subject|0
2643650|NCT00769483|9132716|P3|Overall Study|Withdrawal by Subject|0
2643651|NCT00769483|9132717|P2|Overall Study|Withdrawal by Subject|1
2643652|NCT00769483|9132718|P1|Overall Study|Withdrawal by Subject|0
2643653|NCT00769184|9132790|P2|No Treatment (6 Weeks)|Adverse Event|1
2643654|NCT00769184|9132791|P1|No Treatment (6 Weeks)|Adverse Event|1
2643655|NCT00769184|9132790|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1
2643656|NCT00769184|9132791|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0
2643657|NCT00769184|9132790|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0
2643658|NCT00769184|9132791|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1
2643659|NCT00769132|9132799|P4|Period 4|Withdrawal by Subject|0
2643660|NCT00769132|9132800|P3|Period 4|Withdrawal by Subject|0
2643661|NCT00769132|9132801|P2|Period 4|Withdrawal by Subject|1
2643662|NCT00769132|9132802|P1|Period 4|Withdrawal by Subject|0
2643663|NCT00769132|9132799|P4|Period 3|Withdrawal by Subject|0
2643664|NCT00769132|9132800|P3|Period 3|Withdrawal by Subject|0
2643665|NCT00769132|9132801|P2|Period 3|Withdrawal by Subject|0
2643666|NCT00769132|9132802|P1|Period 3|Withdrawal by Subject|1
2643667|NCT00769132|9132799|P4|Period 2|Withdrawal by Subject|1
2643668|NCT00769132|9132800|P3|Period 2|Withdrawal by Subject|0
2643669|NCT00769132|9132801|P2|Period 2|Withdrawal by Subject|0
2643670|NCT00769132|9132802|P1|Period 2|Withdrawal by Subject|0
2643671|NCT00769132|9132799|P4|Period 1|Adverse Event|1
2643672|NCT00769132|9132800|P3|Period 1|Adverse Event|0
2643673|NCT00769132|9132801|P2|Period 1|Adverse Event|0
2643674|NCT00769132|9132802|P1|Period 1|Adverse Event|1
2643675|NCT00769119|9132818|P2|Overall Study|Disallowed medication|0
2643676|NCT00769119|9132819|P1|Overall Study|Disallowed medication|1
2643677|NCT00769119|9132818|P2|Overall Study|Adverse Event|1
2643678|NCT00769119|9132819|P1|Overall Study|Adverse Event|1
2643679|NCT00769119|9132818|P2|Overall Study|Voluntary discontinuation|2
2643680|NCT00769119|9132819|P1|Overall Study|Voluntary discontinuation|0
2643681|NCT00769067|9132865|P2|Overall Study|Withdrawal by Subject|1
2643682|NCT00769067|9132866|P1|Overall Study|Withdrawal by Subject|0
2643683|NCT00769067|9132865|P2|Overall Study|Other|3
2643684|NCT00769067|9132866|P1|Overall Study|Other|1
2643685|NCT00769067|9132865|P2|Overall Study|Study terminated by sponsor|3
2643686|NCT00769067|9132866|P1|Overall Study|Study terminated by sponsor|1
2643687|NCT00769067|9132865|P2|Overall Study|Lost to Follow-up|1
2643688|NCT00769067|9132866|P1|Overall Study|Lost to Follow-up|3
2643689|NCT00769067|9132865|P2|Overall Study|Death|86
2643690|NCT00769067|9132866|P1|Overall Study|Death|89
2643691|NCT00768989|9132914|P2|On or After Week 36|Sponsor Termination|26
2643692|NCT00768989|9132915|P1|On or After Week 36|Sponsor Termination|45
2643693|NCT00768989|9132914|P2|On or After Week 36|Did not attend termination visit|0
2643694|NCT00768989|9132915|P1|On or After Week 36|Did not attend termination visit|2
2643695|NCT00768989|9132914|P2|On or After Week 36|Protocol Violation|0
2643696|NCT00768989|9132915|P1|On or After Week 36|Protocol Violation|1
2643697|NCT00768989|9132914|P2|On or After Week 36|Poor Compliance|0
2643698|NCT00768989|9132915|P1|On or After Week 36|Poor Compliance|1
2643699|NCT00768989|9132914|P2|On or After Week 36|Lost to Follow-up|0
2643700|NCT00768989|9132915|P1|On or After Week 36|Lost to Follow-up|1
2643701|NCT00768989|9132914|P2|On or After Week 36|Adverse Event|1
2643702|NCT00768989|9132915|P1|On or After Week 36|Adverse Event|0
2643703|NCT00768989|9132914|P2|On or After Week 36|Lack of Efficacy|0
2643704|NCT00768989|9132915|P1|On or After Week 36|Lack of Efficacy|1
2643705|NCT00768989|9132914|P2|Week 24 to Prior to Week 36|Withdrawal by Subject|0
2643706|NCT00768989|9132915|P1|Week 24 to Prior to Week 36|Withdrawal by Subject|1
2643707|NCT00768989|9132914|P2|Week 24 to Prior to Week 36|Lack of Efficacy|0
2643708|NCT00768989|9132915|P1|Week 24 to Prior to Week 36|Lack of Efficacy|6
2643709|NCT00768989|9132914|P2|Week 24 to Prior to Week 36|Adverse Event|0
2643710|NCT00768989|9132915|P1|Week 24 to Prior to Week 36|Adverse Event|1
2643711|NCT00768989|9132914|P2|Prior to Week 24|Protocol Violation|2
2643712|NCT00768989|9132915|P1|Prior to Week 24|Protocol Violation|0
2643713|NCT00768989|9132914|P2|Prior to Week 24|Lost to Follow-up|1
2643714|NCT00768989|9132915|P1|Prior to Week 24|Lost to Follow-up|0
2643715|NCT00768989|9132914|P2|Prior to Week 24|Adverse Event|0
2643716|NCT00768989|9132915|P1|Prior to Week 24|Adverse Event|3
2643717|NCT00768989|9132914|P2|Prior to Week 24|Withdrawal by Subject|0
2643718|NCT00768989|9132915|P1|Prior to Week 24|Withdrawal by Subject|1
2643719|NCT00768898|9132963|P1|Overall Study|Headache|1
2643720|NCT00768898|9132963|P1|Overall Study|Unrelated injury|1
2643721|NCT00768755|9132987|P4|Phase 2|Randomized but not treated|2
2643722|NCT00768755|9132988|P3|Phase 2|Randomized but not treated|0
2643723|NCT00768755|9132989|P2|Phase 2|Randomized but not treated|0
2643724|NCT00768755|9132990|P1|Phase 2|Randomized but not treated|0
2643725|NCT00768755|9132987|P4|Phase 2|Study Terminated by Sponsor|14
2643726|NCT00768755|9132988|P3|Phase 2|Study Terminated by Sponsor|7
2643727|NCT00768755|9132989|P2|Phase 2|Study Terminated by Sponsor|13
2643728|NCT00768755|9132990|P1|Phase 2|Study Terminated by Sponsor|0
2643729|NCT00768755|9132987|P4|Phase 2|Other|4
2643730|NCT00768755|9132988|P3|Phase 2|Other|2
2643731|NCT00768755|9132989|P2|Phase 2|Other|1
2643732|NCT00768755|9132990|P1|Phase 2|Other|0
2643733|NCT00768755|9132987|P4|Phase 2|Withdrawal by Subject|1
2643734|NCT00768755|9132988|P3|Phase 2|Withdrawal by Subject|0
2643735|NCT00768755|9132989|P2|Phase 2|Withdrawal by Subject|1
2643736|NCT00768755|9132990|P1|Phase 2|Withdrawal by Subject|0
2643737|NCT00768755|9132987|P4|Phase 2|Lost to Follow-up|4
2643738|NCT00768755|9132988|P3|Phase 2|Lost to Follow-up|1
2643739|NCT00768755|9132989|P2|Phase 2|Lost to Follow-up|1
2643740|NCT00768755|9132990|P1|Phase 2|Lost to Follow-up|0
2643741|NCT00768755|9132987|P4|Phase 2|Protocol Violation|1
2643742|NCT00768755|9132988|P3|Phase 2|Protocol Violation|0
2643743|NCT00768755|9132989|P2|Phase 2|Protocol Violation|2
2643744|NCT00768755|9132990|P1|Phase 2|Protocol Violation|0
2643745|NCT00768755|9132987|P4|Phase 2|Death|31
2643746|NCT00768755|9132988|P3|Phase 2|Death|48
2643747|NCT00768755|9132989|P2|Phase 2|Death|37
2643748|NCT00768755|9132990|P1|Phase 2|Death|0
2643749|NCT00768755|9132987|P4|Phase 1|Other|0
2643750|NCT00768755|9132988|P3|Phase 1|Other|0
2643751|NCT00768755|9132989|P2|Phase 1|Other|0
2643752|NCT00768755|9132990|P1|Phase 1|Other|4
2643753|NCT00768755|9132987|P4|Phase 1|Death|0
2643754|NCT00768755|9132988|P3|Phase 1|Death|0
2643755|NCT00768755|9132989|P2|Phase 1|Death|0
2643756|NCT00768755|9132990|P1|Phase 1|Death|6
2643757|NCT00768651|9133038|P1|Overall Study|Withdrawal by Subject|1
2643758|NCT00768560|9133077|P6|Intervention Set 1|Adverse Event|0
2643759|NCT00768560|9133078|P5|Intervention Set 1|Adverse Event|0
2643760|NCT00768560|9133079|P4|Intervention Set 1|Adverse Event|0
2643761|NCT00768560|9133080|P3|Intervention Set 1|Adverse Event|0
2643762|NCT00768560|9133081|P2|Intervention Set 1|Adverse Event|1
2643763|NCT00768560|9133082|P1|Intervention Set 1|Adverse Event|0
2643764|NCT00768469|9133119|P2|Overall Study|Withdrawal by Subject|1
2643765|NCT00768469|9133120|P1|Overall Study|Withdrawal by Subject|0
2643766|NCT00768469|9133119|P2|Overall Study|Disease Progression|4
2643767|NCT00768469|9133120|P1|Overall Study|Disease Progression|3
2643768|NCT00768469|9133119|P2|Overall Study|Adverse Event|2
2643769|NCT00768469|9133120|P1|Overall Study|Adverse Event|0
2643770|NCT00768430|9133135|P2|7 Day Endpoint|Withdrawal by Subject|3
2643771|NCT00768430|9133136|P1|7 Day Endpoint|Withdrawal by Subject|2
2643772|NCT00768300|9133144|P2|Overall Study|Missing data|0
2643773|NCT00768300|9133145|P1|Overall Study|Missing data|1
2643774|NCT00768300|9133144|P2|Overall Study|Treated but never dosed with Study drug|0
2643775|NCT00768300|9133145|P1|Overall Study|Treated but never dosed with Study drug|1
2643776|NCT00768300|9133144|P2|Overall Study|Began prohibited concomitant medication|1
2643777|NCT00768300|9133145|P1|Overall Study|Began prohibited concomitant medication|0
2643778|NCT00768300|9133144|P2|Overall Study|Lost to Follow-up|1
2643779|NCT00768300|9133145|P1|Overall Study|Lost to Follow-up|0
2643780|NCT00768300|9133144|P2|Overall Study|Received lung transplant|1
2643781|NCT00768300|9133145|P1|Overall Study|Received lung transplant|1
2643782|NCT00768300|9133144|P2|Overall Study|Screen failure following randomization|0
2643783|NCT00768300|9133145|P1|Overall Study|Screen failure following randomization|1
2643784|NCT00768300|9133144|P2|Overall Study|Subject moved to pursue lung transplant|1
2643785|NCT00768300|9133145|P1|Overall Study|Subject moved to pursue lung transplant|1
2643786|NCT00768300|9133144|P2|Overall Study|Death|5
2643787|NCT00768300|9133145|P1|Overall Study|Death|21
2643788|NCT00768300|9133144|P2|Overall Study|Study discontinued by Sponsor|140
2643789|NCT00768300|9133145|P1|Overall Study|Study discontinued by Sponsor|271
2643790|NCT00768300|9133144|P2|Overall Study|Physician Decision|3
2643791|NCT00768300|9133145|P1|Overall Study|Physician Decision|2
2643792|NCT00768300|9133144|P2|Overall Study|Withdrawal by Subject|7
2643793|NCT00768300|9133145|P1|Overall Study|Withdrawal by Subject|13
2643794|NCT00768300|9133144|P2|Overall Study|Protocol Violation|1
2643795|NCT00768300|9133145|P1|Overall Study|Protocol Violation|6
2643796|NCT00768300|9133144|P2|Overall Study|Adverse Event|2
2643797|NCT00768300|9133145|P1|Overall Study|Adverse Event|10
2643798|NCT00768300|9133144|P2|Overall Study|Randomized but not treated|1
2643799|NCT00768300|9133145|P1|Overall Study|Randomized but not treated|1
2643800|NCT00768248|9133229|P2|Overall Study|Research coordinator didn't collect data|1
2643801|NCT00768248|9133230|P1|Overall Study|Research coordinator didn't collect data|1
2643802|NCT00768222|9133246|P2|Overall Study|Protocol Violation|2
2643803|NCT00768222|9133247|P1|Overall Study|Protocol Violation|0
2643804|NCT00768222|9133246|P2|Overall Study|Withdrawal by Subject|1
2643805|NCT00768222|9133247|P1|Overall Study|Withdrawal by Subject|3
2643806|NCT00768222|9133246|P2|Overall Study|Lost to Follow-up|1
2643807|NCT00768222|9133247|P1|Overall Study|Lost to Follow-up|1
2643808|NCT00768144|9133269|P1|Overall Study|Pt Withdrew Consent|1
2643809|NCT00768144|9133269|P1|Overall Study|Patient or MD Decision to End Treatment|1
2643810|NCT00768144|9133269|P1|Overall Study|Progressive Disease|21
2643811|NCT00768144|9133269|P1|Overall Study|Adverse Event|13
2643812|NCT00768066|9133282|P3|Overall Study|Did not receive study product injection.|0
2643813|NCT00768066|9133283|P2|Overall Study|Did not receive study product injection.|3
2643814|NCT00768066|9133284|P1|Overall Study|Did not receive study product injection.|3
2643815|NCT00768053|9133316|P1|Overall Study|Lost to Follow-up|1
2643816|NCT00768053|9133316|P1|Overall Study|Adverse Event|10
2643817|NCT00768040|9133347|P2|Overall Study|Abnormal laboratory value|1
2643818|NCT00768040|9133348|P1|Overall Study|Abnormal laboratory value|1
2643819|NCT00768040|9133347|P2|Overall Study|Adverse Event|2
2643820|NCT00768040|9133348|P1|Overall Study|Adverse Event|3
2643821|NCT00767819|9133357|P3|Overall Study|Lost to Follow-up|0
2643822|NCT00767819|9133358|P2|Overall Study|Lost to Follow-up|0
2643823|NCT00767819|9133359|P1|Overall Study|Lost to Follow-up|1
2643824|NCT00767819|9133357|P3|Overall Study|Abnormal lab values|0
2643825|NCT00767819|9133358|P2|Overall Study|Abnormal lab values|0
2643826|NCT00767819|9133359|P1|Overall Study|Abnormal lab values|1
2643827|NCT00767819|9133357|P3|Overall Study|Adverse Event|0
2643828|NCT00767819|9133358|P2|Overall Study|Adverse Event|0
2643829|NCT00767819|9133359|P1|Overall Study|Adverse Event|2
2643830|NCT00767819|9133357|P3|Overall Study|Death|0
2643831|NCT00767819|9133358|P2|Overall Study|Death|3
2643832|NCT00767819|9133359|P1|Overall Study|Death|2
2643833|NCT00767819|9133357|P3|Overall Study|Administrative problems|0
2643834|NCT00767819|9133358|P2|Overall Study|Administrative problems|1
2643835|NCT00767819|9133359|P1|Overall Study|Administrative problems|0
2643836|NCT00767819|9133357|P3|Overall Study|Withdrawal by Subject|0
2643837|NCT00767819|9133358|P2|Overall Study|Withdrawal by Subject|1
2643838|NCT00767819|9133359|P1|Overall Study|Withdrawal by Subject|1
2643839|NCT00767819|9133357|P3|Overall Study|Unsatisfactory therapeutic effect|0
2643840|NCT00767819|9133358|P2|Overall Study|Unsatisfactory therapeutic effect|14
2643841|NCT00767819|9133359|P1|Overall Study|Unsatisfactory therapeutic effect|18
2643842|NCT00767806|9133384|P2|Overall Study|Sponsor Decision|1
2643843|NCT00767806|9133385|P1|Overall Study|Sponsor Decision|0
2643844|NCT00767806|9133384|P2|Overall Study|Entry Criteria Not Met|1
2643845|NCT00767806|9133385|P1|Overall Study|Entry Criteria Not Met|1
2643846|NCT00767806|9133384|P2|Overall Study|Lost to Follow-up|4
2643847|NCT00767806|9133385|P1|Overall Study|Lost to Follow-up|1
2643848|NCT00767806|9133384|P2|Overall Study|Physician Decision|3
2643849|NCT00767806|9133385|P1|Overall Study|Physician Decision|4
2643850|NCT00767806|9133384|P2|Overall Study|Lack of Efficacy|9
2643851|NCT00767806|9133385|P1|Overall Study|Lack of Efficacy|1
2643852|NCT00767806|9133384|P2|Overall Study|Protocol Violation|5
2643853|NCT00767806|9133385|P1|Overall Study|Protocol Violation|6
2643854|NCT00767806|9133384|P2|Overall Study|Withdrawal by Subject|13
2643855|NCT00767806|9133385|P1|Overall Study|Withdrawal by Subject|8
2643856|NCT00767806|9133384|P2|Overall Study|Adverse Event|11
2643857|NCT00767806|9133385|P1|Overall Study|Adverse Event|30
2643858|NCT00767676|9133462|P1|Overall Study|Investigator error|54
2643859|NCT00767520|9133485|P2|Overall Study|Randomized in error and Never treated|2
2643860|NCT00767520|9133486|P1|Overall Study|Randomized in error and Never treated|0
2643861|NCT00767520|9133485|P2|Overall Study|Participants still on treatment|15
2643862|NCT00767520|9133486|P1|Overall Study|Participants still on treatment|11
2643863|NCT00767455|9133539|P1|Overall Study|Investigator error|19
2643864|NCT00767325|9133573|P1|Overall Study|Missed visit due to family reasons|1
2643865|NCT00767325|9133573|P1|Overall Study|No longer met study criteria|2
2643866|NCT00767325|9133573|P1|Overall Study|Lost to Follow-up|3
2643867|NCT00767325|9133573|P1|Overall Study|Adverse Event|7
2643868|NCT00767325|9133573|P1|Overall Study|Lack of Efficacy|2
2643869|NCT00767104|9133584|P2|Overall Study|Lost to Follow-up|2
2643870|NCT00767104|9133585|P1|Overall Study|Lost to Follow-up|1
2643871|NCT00767039|9133595|P2|Overall Study|Death|2
2643872|NCT00767039|9133596|P1|Overall Study|Death|5
2643873|NCT00767000|9133627|P5|Optional 104-week Extension|Study terminated by sponsor|4
2643874|NCT00767000|9133628|P4|Optional 104-week Extension|Study terminated by sponsor|2
2643875|NCT00767000|9133629|P3|Optional 104-week Extension|Study terminated by sponsor|7
2643876|NCT00767000|9133630|P2|Optional 104-week Extension|Study terminated by sponsor|3
2643877|NCT00767000|9133631|P1|Optional 104-week Extension|Study terminated by sponsor|7
2643878|NCT00767000|9133627|P5|54-week Study|Reason not reported|0
2643879|NCT00767000|9133628|P4|54-week Study|Reason not reported|1
2643880|NCT00767000|9133629|P3|54-week Study|Reason not reported|0
2643881|NCT00767000|9133630|P2|54-week Study|Reason not reported|0
2643882|NCT00767000|9133631|P1|54-week Study|Reason not reported|0
2643883|NCT00767000|9133627|P5|54-week Study|Study terminated by sponsor|194
2643884|NCT00767000|9133628|P4|54-week Study|Study terminated by sponsor|196
2643885|NCT00767000|9133629|P3|54-week Study|Study terminated by sponsor|89
2643886|NCT00767000|9133630|P2|54-week Study|Study terminated by sponsor|102
2643887|NCT00767000|9133631|P1|54-week Study|Study terminated by sponsor|90
2643888|NCT00767000|9133627|P5|54-week Study|Withdrawal by Subject|13
2643889|NCT00767000|9133628|P4|54-week Study|Withdrawal by Subject|11
2643890|NCT00767000|9133629|P3|54-week Study|Withdrawal by Subject|5
2643891|NCT00767000|9133630|P2|54-week Study|Withdrawal by Subject|3
2643892|NCT00767000|9133631|P1|54-week Study|Withdrawal by Subject|2
2643893|NCT00767000|9133627|P5|54-week Study|Protocol Violation|0
2643894|NCT00767000|9133628|P4|54-week Study|Protocol Violation|2
2643895|NCT00767000|9133629|P3|54-week Study|Protocol Violation|1
2643896|NCT00767000|9133630|P2|54-week Study|Protocol Violation|0
2643897|NCT00767000|9133631|P1|54-week Study|Protocol Violation|0
2643898|NCT00767000|9133627|P5|54-week Study|Progressive disease|0
2643899|NCT00767000|9133628|P4|54-week Study|Progressive disease|0
2643900|NCT00767000|9133629|P3|54-week Study|Progressive disease|1
2643901|NCT00767000|9133630|P2|54-week Study|Progressive disease|0
2643902|NCT00767000|9133631|P1|54-week Study|Progressive disease|0
2643903|NCT00767000|9133627|P5|54-week Study|Physician Decision|1
2643904|NCT00767000|9133628|P4|54-week Study|Physician Decision|1
2643905|NCT00767000|9133629|P3|54-week Study|Physician Decision|1
2643906|NCT00767000|9133630|P2|54-week Study|Physician Decision|0
2643907|NCT00767000|9133631|P1|54-week Study|Physician Decision|4
2643908|NCT00767000|9133627|P5|54-week Study|Lost to Follow-up|2
2643909|NCT00767000|9133628|P4|54-week Study|Lost to Follow-up|4
2643910|NCT00767000|9133629|P3|54-week Study|Lost to Follow-up|1
2643911|NCT00767000|9133630|P2|54-week Study|Lost to Follow-up|0
2643912|NCT00767000|9133631|P1|54-week Study|Lost to Follow-up|4
2643913|NCT00767000|9133627|P5|54-week Study|Lack of Efficacy|5
2643914|NCT00767000|9133628|P4|54-week Study|Lack of Efficacy|0
2643915|NCT00767000|9133629|P3|54-week Study|Lack of Efficacy|1
2643916|NCT00767000|9133630|P2|54-week Study|Lack of Efficacy|0
2643917|NCT00767000|9133631|P1|54-week Study|Lack of Efficacy|2
2643918|NCT00767000|9133627|P5|54-week Study|Interruption of study medication|0
2643919|NCT00767000|9133628|P4|54-week Study|Interruption of study medication|0
2643920|NCT00767000|9133629|P3|54-week Study|Interruption of study medication|1
2643921|NCT00767000|9133630|P2|54-week Study|Interruption of study medication|0
2643922|NCT00767000|9133631|P1|54-week Study|Interruption of study medication|0
2643923|NCT00767000|9133627|P5|54-week Study|Hypoglycemia|0
2643924|NCT00767000|9133628|P4|54-week Study|Hypoglycemia|0
2643925|NCT00767000|9133629|P3|54-week Study|Hypoglycemia|0
2643926|NCT00767000|9133630|P2|54-week Study|Hypoglycemia|1
2643927|NCT00767000|9133631|P1|54-week Study|Hypoglycemia|0
2643928|NCT00767000|9133627|P5|54-week Study|Hyperglycemia|1
2643929|NCT00767000|9133628|P4|54-week Study|Hyperglycemia|0
2643930|NCT00767000|9133629|P3|54-week Study|Hyperglycemia|1
2643931|NCT00767000|9133630|P2|54-week Study|Hyperglycemia|0
2643932|NCT00767000|9133631|P1|54-week Study|Hyperglycemia|0
2643933|NCT00767000|9133627|P5|54-week Study|Creaninine/creatinine clearance|4
2643934|NCT00767000|9133628|P4|54-week Study|Creaninine/creatinine clearance|2
2643935|NCT00767000|9133629|P3|54-week Study|Creaninine/creatinine clearance|2
2643936|NCT00767000|9133630|P2|54-week Study|Creaninine/creatinine clearance|1
2643937|NCT00767000|9133631|P1|54-week Study|Creaninine/creatinine clearance|2
2643938|NCT00767000|9133627|P5|54-week Study|Adverse Event|4
2643939|NCT00767000|9133628|P4|54-week Study|Adverse Event|8
2643940|NCT00767000|9133629|P3|54-week Study|Adverse Event|6
2643941|NCT00767000|9133630|P2|54-week Study|Adverse Event|6
2643942|NCT00767000|9133631|P1|54-week Study|Adverse Event|4
2643943|NCT00766831|9133673|P1|Overall Study|Other|28
2643944|NCT00766831|9133673|P1|Overall Study|Non cooperation by participants|14
2643945|NCT00766831|9133673|P1|Overall Study|Withdrawal of consent|26
2643946|NCT00766831|9133673|P1|Overall Study|Physician Decision|5
2643947|NCT00766831|9133673|P1|Overall Study|Protocol Violation|15
2643948|NCT00766831|9133673|P1|Overall Study|Adverse Event|20
2643949|NCT00766831|9133673|P1|Overall Study|Lost to Follow-up|3
2643950|NCT00766831|9133673|P1|Overall Study|Withdrawal by Subject|4
2643951|NCT00766675|9133703|P1|Overall Study|Insufficient therapy|1
2643952|NCT00766675|9133703|P1|Overall Study|Receive other anti-neoplastic treatment|1
2643953|NCT00766675|9133703|P1|Overall Study|Participant took prohibited medication|1
2643954|NCT00766675|9133703|P1|Overall Study|Protocol Violation|8
2643955|NCT00766675|9133703|P1|Overall Study|Withdrawal by Subject|11
2643956|NCT00766675|9133703|P1|Overall Study|Lost to Follow-up|2
2643957|NCT00766675|9133703|P1|Overall Study|Adverse Event|16
2643958|NCT00766636|9133730|P2|Overall Study|Disease Progression|0
2643959|NCT00766636|9133731|P1|Overall Study|Disease Progression|1
2643960|NCT00766636|9133730|P2|Overall Study|Adverse Event|0
2643961|NCT00766636|9133731|P1|Overall Study|Adverse Event|1
2643962|NCT00766636|9133730|P2|Overall Study|Incomplete Treatment|1
2643963|NCT00766636|9133731|P1|Overall Study|Incomplete Treatment|0
2643964|NCT00766636|9133730|P2|Overall Study|Withdrawal by Subject|1
2643965|NCT00766636|9133731|P1|Overall Study|Withdrawal by Subject|1
2643966|NCT00766597|9133737|P1|Overall Study|Without CCR5-tropic virus|5
2643967|NCT00766597|9133737|P1|Overall Study|Unexpected closure of study|4
2643968|NCT00766532|9133749|P1|Overall Study|Protocol Violation|2
2643969|NCT00766506|9133755|P2|Overall Study|Other|2
2643970|NCT00766506|9133756|P1|Overall Study|Other|2
2643971|NCT00766506|9133755|P2|Overall Study|Use rescue medication after 3 hours|0
2643972|NCT00766506|9133756|P1|Overall Study|Use rescue medication after 3 hours|3
2643973|NCT00766493|9133780|P1|30 Days Post-Procedure|Missed Visit - No Phone Contact|1
2643974|NCT00766493|9133780|P1|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4
2643975|NCT00766493|9133780|P1|30 Days Post-Procedure|Discontinued|7
2643976|NCT00766467|9133790|P2|Overall Study|Physician Decision|0
2643977|NCT00766467|9133791|P1|Overall Study|Physician Decision|1
2643978|NCT00766467|9133790|P2|Overall Study|Tumor Progression on Study|1
2643979|NCT00766467|9133791|P1|Overall Study|Tumor Progression on Study|0
2643980|NCT00766467|9133790|P2|Overall Study|Protocol Violation|4
2643981|NCT00766467|9133791|P1|Overall Study|Protocol Violation|2
2643982|NCT00766467|9133790|P2|Overall Study|Adverse Event|1
2643983|NCT00766467|9133791|P1|Overall Study|Adverse Event|1
2643984|NCT00766467|9133790|P2|Overall Study|Withdrawal by Subject|2
2643985|NCT00766467|9133791|P1|Overall Study|Withdrawal by Subject|7
2643986|NCT00766415|9133803|P2|Overall Study|Withdrawal by Subject|1
2643987|NCT00766415|9133804|P1|Overall Study|Withdrawal by Subject|0
2643988|NCT00766376|9133852|P1|Overall Study|Withdrawal by Subject|27
2643989|NCT00766363|9133861|P4|Overall Study|Adverse Event Prior to Randomization|0
2643990|NCT00766363|9133862|P3|Overall Study|Adverse Event Prior to Randomization|0
2643991|NCT00766363|9133863|P2|Overall Study|Adverse Event Prior to Randomization|1
2643992|NCT00766363|9133864|P1|Overall Study|Adverse Event Prior to Randomization|0
2643993|NCT00766363|9133861|P4|Overall Study|Withdrawal by Subject|0
2643994|NCT00766363|9133862|P3|Overall Study|Withdrawal by Subject|0
2643995|NCT00766363|9133863|P2|Overall Study|Withdrawal by Subject|0
2643996|NCT00766363|9133864|P1|Overall Study|Withdrawal by Subject|1
2643997|NCT00766090|9133910|P12|Treatment Period 3 (28 Days)|Lost to Follow-up|0
2643998|NCT00766090|9133911|P11|Treatment Period 3 (28 Days)|Lost to Follow-up|0
2643999|NCT00766090|9133912|P10|Treatment Period 3 (28 Days)|Lost to Follow-up|0
2644000|NCT00766090|9133913|P9|Treatment Period 3 (28 Days)|Lost to Follow-up|0
2644001|NCT00766090|9133914|P8|Treatment Period 3 (28 Days)|Lost to Follow-up|0
2644002|NCT00766090|9133915|P7|Treatment Period 3 (28 Days)|Lost to Follow-up|0
2644003|NCT00766090|9133916|P6|Treatment Period 3 (28 Days)|Lost to Follow-up|0
2644004|NCT00766090|9133917|P5|Treatment Period 3 (28 Days)|Lost to Follow-up|1
2644005|NCT00766090|9133918|P4|Treatment Period 3 (28 Days)|Lost to Follow-up|0
2644006|NCT00766090|9133919|P3|Treatment Period 3 (28 Days)|Lost to Follow-up|0
2644007|NCT00766090|9133920|P2|Treatment Period 3 (28 Days)|Lost to Follow-up|0
2644008|NCT00766090|9133921|P1|Treatment Period 3 (28 Days)|Lost to Follow-up|0
2644009|NCT00766090|9133910|P12|Treatment Period 3 (28 Days)|Lack of Efficacy|1
2644010|NCT00766090|9133911|P11|Treatment Period 3 (28 Days)|Lack of Efficacy|0
2644011|NCT00766090|9133912|P10|Treatment Period 3 (28 Days)|Lack of Efficacy|0
2644012|NCT00766090|9133913|P9|Treatment Period 3 (28 Days)|Lack of Efficacy|0
2644013|NCT00766090|9133914|P8|Treatment Period 3 (28 Days)|Lack of Efficacy|0
2644014|NCT00766090|9133915|P7|Treatment Period 3 (28 Days)|Lack of Efficacy|0
2644015|NCT00766090|9133916|P6|Treatment Period 3 (28 Days)|Lack of Efficacy|0
2644016|NCT00766090|9133917|P5|Treatment Period 3 (28 Days)|Lack of Efficacy|0
2644017|NCT00766090|9133918|P4|Treatment Period 3 (28 Days)|Lack of Efficacy|1
2644018|NCT00766090|9133919|P3|Treatment Period 3 (28 Days)|Lack of Efficacy|0
2644019|NCT00766090|9133920|P2|Treatment Period 3 (28 Days)|Lack of Efficacy|1
2644020|NCT00766090|9133921|P1|Treatment Period 3 (28 Days)|Lack of Efficacy|0
2644021|NCT00766090|9133910|P12|Treatment Period 3 (28 Days)|Protocol Violation|0
2644022|NCT00766090|9133911|P11|Treatment Period 3 (28 Days)|Protocol Violation|0
2644023|NCT00766090|9133912|P10|Treatment Period 3 (28 Days)|Protocol Violation|0
2644024|NCT00766090|9133913|P9|Treatment Period 3 (28 Days)|Protocol Violation|0
2644025|NCT00766090|9133914|P8|Treatment Period 3 (28 Days)|Protocol Violation|0
2644026|NCT00766090|9133915|P7|Treatment Period 3 (28 Days)|Protocol Violation|0
2644027|NCT00766090|9133916|P6|Treatment Period 3 (28 Days)|Protocol Violation|1
2644028|NCT00766090|9133917|P5|Treatment Period 3 (28 Days)|Protocol Violation|0
2644029|NCT00766090|9133918|P4|Treatment Period 3 (28 Days)|Protocol Violation|0
2644030|NCT00766090|9133919|P3|Treatment Period 3 (28 Days)|Protocol Violation|0
2644031|NCT00766090|9133920|P2|Treatment Period 3 (28 Days)|Protocol Violation|0
2644032|NCT00766090|9133921|P1|Treatment Period 3 (28 Days)|Protocol Violation|0
2644033|NCT00766090|9133910|P12|Washout Period 2 (14 Days)|Physician Decision|0
2644034|NCT00766090|9133911|P11|Washout Period 2 (14 Days)|Physician Decision|0
2644035|NCT00766090|9133912|P10|Washout Period 2 (14 Days)|Physician Decision|0
2644036|NCT00766090|9133913|P9|Washout Period 2 (14 Days)|Physician Decision|0
2644037|NCT00766090|9133914|P8|Washout Period 2 (14 Days)|Physician Decision|0
2644038|NCT00766090|9133915|P7|Washout Period 2 (14 Days)|Physician Decision|0
2644039|NCT00766090|9133916|P6|Washout Period 2 (14 Days)|Physician Decision|0
2644040|NCT00766090|9133917|P5|Washout Period 2 (14 Days)|Physician Decision|0
2644041|NCT00766090|9133918|P4|Washout Period 2 (14 Days)|Physician Decision|0
2644042|NCT00766090|9133919|P3|Washout Period 2 (14 Days)|Physician Decision|1
2644043|NCT00766090|9133920|P2|Washout Period 2 (14 Days)|Physician Decision|0
2644044|NCT00766090|9133921|P1|Washout Period 2 (14 Days)|Physician Decision|0
2644045|NCT00766090|9133910|P12|Treatment Period 2 (28 Days)|Lack of Efficacy|0
2644046|NCT00766090|9133911|P11|Treatment Period 2 (28 Days)|Lack of Efficacy|0
2644047|NCT00766090|9133912|P10|Treatment Period 2 (28 Days)|Lack of Efficacy|0
2644048|NCT00766090|9133913|P9|Treatment Period 2 (28 Days)|Lack of Efficacy|0
2644049|NCT00766090|9133914|P8|Treatment Period 2 (28 Days)|Lack of Efficacy|0
2644050|NCT00766090|9133915|P7|Treatment Period 2 (28 Days)|Lack of Efficacy|0
2644051|NCT00766090|9133916|P6|Treatment Period 2 (28 Days)|Lack of Efficacy|0
2644052|NCT00766090|9133917|P5|Treatment Period 2 (28 Days)|Lack of Efficacy|0
2644053|NCT00766090|9133918|P4|Treatment Period 2 (28 Days)|Lack of Efficacy|0
2644054|NCT00766090|9133919|P3|Treatment Period 2 (28 Days)|Lack of Efficacy|1
2644055|NCT00766090|9133920|P2|Treatment Period 2 (28 Days)|Lack of Efficacy|0
2644056|NCT00766090|9133921|P1|Treatment Period 2 (28 Days)|Lack of Efficacy|0
2644057|NCT00766090|9133910|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2644058|NCT00766090|9133911|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2644059|NCT00766090|9133912|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2644060|NCT00766090|9133913|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2644061|NCT00766090|9133914|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2644062|NCT00766090|9133915|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2644063|NCT00766090|9133916|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2644064|NCT00766090|9133917|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|2
2644065|NCT00766090|9133918|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2644066|NCT00766090|9133919|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2644067|NCT00766090|9133920|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2644068|NCT00766090|9133921|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
2644069|NCT00766090|9133910|P12|Washout Period 1 (14 Days)|Protocol Violation|0
2644070|NCT00766090|9133911|P11|Washout Period 1 (14 Days)|Protocol Violation|0
2644071|NCT00766090|9133912|P10|Washout Period 1 (14 Days)|Protocol Violation|0
2644072|NCT00766090|9133913|P9|Washout Period 1 (14 Days)|Protocol Violation|0
2644073|NCT00766090|9133914|P8|Washout Period 1 (14 Days)|Protocol Violation|0
2644074|NCT00766090|9133915|P7|Washout Period 1 (14 Days)|Protocol Violation|0
2644075|NCT00766090|9133916|P6|Washout Period 1 (14 Days)|Protocol Violation|0
2644076|NCT00766090|9133917|P5|Washout Period 1 (14 Days)|Protocol Violation|0
2644077|NCT00766090|9133918|P4|Washout Period 1 (14 Days)|Protocol Violation|0
2644078|NCT00766090|9133919|P3|Washout Period 1 (14 Days)|Protocol Violation|1
2644079|NCT00766090|9133920|P2|Washout Period 1 (14 Days)|Protocol Violation|0
2644080|NCT00766090|9133921|P1|Washout Period 1 (14 Days)|Protocol Violation|0
2644081|NCT00766090|9133910|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2644082|NCT00766090|9133911|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2644083|NCT00766090|9133912|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2644084|NCT00766090|9133913|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2644085|NCT00766090|9133914|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2644086|NCT00766090|9133915|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2644087|NCT00766090|9133916|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2644088|NCT00766090|9133917|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2644089|NCT00766090|9133918|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
2644090|NCT00766090|9133919|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2644091|NCT00766090|9133920|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
2644092|NCT00766090|9133921|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
2644093|NCT00766090|9133910|P12|Treatment Period 1 (28 Days)|Lack of Efficacy|0
2644094|NCT00766090|9133911|P11|Treatment Period 1 (28 Days)|Lack of Efficacy|0
2644095|NCT00766090|9133912|P10|Treatment Period 1 (28 Days)|Lack of Efficacy|0
2644096|NCT00766090|9133913|P9|Treatment Period 1 (28 Days)|Lack of Efficacy|0
2644097|NCT00766090|9133914|P8|Treatment Period 1 (28 Days)|Lack of Efficacy|0
2644098|NCT00766090|9133915|P7|Treatment Period 1 (28 Days)|Lack of Efficacy|0
2644099|NCT00766090|9133916|P6|Treatment Period 1 (28 Days)|Lack of Efficacy|0
2644100|NCT00766090|9133917|P5|Treatment Period 1 (28 Days)|Lack of Efficacy|0
2644101|NCT00766090|9133918|P4|Treatment Period 1 (28 Days)|Lack of Efficacy|0
2644102|NCT00766090|9133919|P3|Treatment Period 1 (28 Days)|Lack of Efficacy|0
2644103|NCT00766090|9133920|P2|Treatment Period 1 (28 Days)|Lack of Efficacy|0
2644104|NCT00766090|9133921|P1|Treatment Period 1 (28 Days)|Lack of Efficacy|2
2644105|NCT00766090|9133910|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2644106|NCT00766090|9133911|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2644107|NCT00766090|9133912|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2644108|NCT00766090|9133913|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|1
2644109|NCT00766090|9133914|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2644110|NCT00766090|9133915|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2644111|NCT00766090|9133916|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2644112|NCT00766090|9133917|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2644113|NCT00766090|9133918|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2644114|NCT00766090|9133919|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2644115|NCT00766090|9133920|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2644116|NCT00766090|9133921|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
2644117|NCT00766051|9133962|P2|Overall Study|Withdrawal by Subject|0
2644118|NCT00766051|9133963|P1|Overall Study|Withdrawal by Subject|2
2644119|NCT00766038|9133975|P2|Overall Study|Lost to Follow-up|14
2644120|NCT00766038|9133976|P1|Overall Study|Lost to Follow-up|15
2644121|NCT00765999|9133992|P1|Overall Study|Other Miscellaneous Reasons|51
2644122|NCT00765999|9133992|P1|Overall Study|Study Terminated by Sponsor|2
2644123|NCT00765999|9133992|P1|Overall Study|Lost to Follow-up|131
2644124|NCT00765999|9133992|P1|Overall Study|Consent Withdrawn|202
2644125|NCT00765999|9133992|P1|Overall Study|Protocol Violation|95
2644126|NCT00765999|9133992|P1|Overall Study|Insufficient Therapeutic Response|100
2644127|NCT00765999|9133992|P1|Overall Study|Adverse Event|203
2644128|NCT00765882|9134019|P3|Overall Study|Other Reason|2
2644129|NCT00765882|9134020|P2|Overall Study|Other Reason|1
2644130|NCT00765882|9134021|P1|Overall Study|Other Reason|3
2644131|NCT00765882|9134019|P3|Overall Study|Lost to Follow-up|6
2644132|NCT00765882|9134020|P2|Overall Study|Lost to Follow-up|9
2644133|NCT00765882|9134021|P1|Overall Study|Lost to Follow-up|1
2644134|NCT00765882|9134019|P3|Overall Study|Withdrawal by Subject|6
2644135|NCT00765882|9134020|P2|Overall Study|Withdrawal by Subject|6
2644136|NCT00765882|9134021|P1|Overall Study|Withdrawal by Subject|2
2644137|NCT00765882|9134019|P3|Overall Study|Protocol Violation|1
2644138|NCT00765882|9134020|P2|Overall Study|Protocol Violation|3
2644139|NCT00765882|9134021|P1|Overall Study|Protocol Violation|4
2644140|NCT00765882|9134019|P3|Overall Study|Lack of Efficacy|1
2644141|NCT00765882|9134020|P2|Overall Study|Lack of Efficacy|0
2644142|NCT00765882|9134021|P1|Overall Study|Lack of Efficacy|4
2644143|NCT00765882|9134019|P3|Overall Study|Adverse Event|20
2644144|NCT00765882|9134020|P2|Overall Study|Adverse Event|21
2644145|NCT00765882|9134021|P1|Overall Study|Adverse Event|10
2644146|NCT00765843|9134053|P3|Overall Study|Adverse Event|1
2644147|NCT00765843|9134054|P2|Overall Study|Adverse Event|0
2644148|NCT00765843|9134055|P1|Overall Study|Adverse Event|0
2644149|NCT00765843|9134053|P3|Overall Study|did not return to receive intervention|0
2644150|NCT00765843|9134054|P2|Overall Study|did not return to receive intervention|1
2644151|NCT00765843|9134055|P1|Overall Study|did not return to receive intervention|0
2644152|NCT00765843|9134053|P3|Overall Study|Lost to Follow-up|2
2644153|NCT00765843|9134054|P2|Overall Study|Lost to Follow-up|3
2644154|NCT00765843|9134055|P1|Overall Study|Lost to Follow-up|1
2644155|NCT00765817|9134065|P2|Overall Study|Subject decision|11
2644156|NCT00765817|9134066|P1|Overall Study|Subject decision|7
2644157|NCT00765817|9134065|P2|Overall Study|Protocol Violation|1
2644158|NCT00765817|9134066|P1|Overall Study|Protocol Violation|1
2644159|NCT00765817|9134065|P2|Overall Study|Physician Decision|1
2644160|NCT00765817|9134066|P1|Overall Study|Physician Decision|2
2644161|NCT00765817|9134065|P2|Overall Study|Lost to Follow-up|3
2644162|NCT00765817|9134066|P1|Overall Study|Lost to Follow-up|1
2644163|NCT00765817|9134065|P2|Overall Study|Loss of glucose control|2
2644164|NCT00765817|9134066|P1|Overall Study|Loss of glucose control|0
2644165|NCT00765817|9134065|P2|Overall Study|Entry criteria not met|2
2644166|NCT00765817|9134066|P1|Overall Study|Entry criteria not met|2
2644167|NCT00765817|9134065|P2|Overall Study|Death|1
2644168|NCT00765817|9134066|P1|Overall Study|Death|0
2644169|NCT00765817|9134065|P2|Overall Study|Adverse Event|1
2644170|NCT00765817|9134066|P1|Overall Study|Adverse Event|13
2644171|NCT00765726|9134114|P1|Overall Study|Discontinuation of study by sponsor|8
2644172|NCT00765726|9134114|P1|Overall Study|Withdrawal by Subject|1
2644173|NCT00765674|9134122|P4|Overall Study|Randomized in Error - No Study Drug|1
2644174|NCT00765674|9134123|P3|Overall Study|Randomized in Error - No Study Drug|0
2644175|NCT00765674|9134124|P2|Overall Study|Randomized in Error - No Study Drug|1
2644176|NCT00765674|9134125|P1|Overall Study|Randomized in Error - No Study Drug|0
2644177|NCT00765674|9134122|P4|Overall Study|Lost to Follow-up|1
2644178|NCT00765674|9134123|P3|Overall Study|Lost to Follow-up|2
2644179|NCT00765674|9134124|P2|Overall Study|Lost to Follow-up|6
2644180|NCT00765674|9134125|P1|Overall Study|Lost to Follow-up|4
2644181|NCT00765674|9134122|P4|Overall Study|Withdrawal by Subject|8
2644182|NCT00765674|9134123|P3|Overall Study|Withdrawal by Subject|3
2644183|NCT00765674|9134124|P2|Overall Study|Withdrawal by Subject|7
2644184|NCT00765674|9134125|P1|Overall Study|Withdrawal by Subject|5
2644185|NCT00765674|9134122|P4|Overall Study|Protocol Violation|0
2644186|NCT00765674|9134123|P3|Overall Study|Protocol Violation|1
2644187|NCT00765674|9134124|P2|Overall Study|Protocol Violation|0
2644188|NCT00765674|9134125|P1|Overall Study|Protocol Violation|2
2644189|NCT00765674|9134122|P4|Overall Study|Lack of Efficacy|2
2644190|NCT00765674|9134123|P3|Overall Study|Lack of Efficacy|1
2644191|NCT00765674|9134124|P2|Overall Study|Lack of Efficacy|3
2644192|NCT00765674|9134125|P1|Overall Study|Lack of Efficacy|2
2644193|NCT00765674|9134122|P4|Overall Study|Abnormal Test Procedure Result(s)|2
2644194|NCT00765674|9134123|P3|Overall Study|Abnormal Test Procedure Result(s)|1
2644195|NCT00765674|9134124|P2|Overall Study|Abnormal Test Procedure Result(s)|3
2644196|NCT00765674|9134125|P1|Overall Study|Abnormal Test Procedure Result(s)|1
2644197|NCT00765674|9134122|P4|Overall Study|Abnormal Laboratory Value(s)|0
2644198|NCT00765674|9134123|P3|Overall Study|Abnormal Laboratory Value(s)|1
2644199|NCT00765674|9134124|P2|Overall Study|Abnormal Laboratory Value(s)|0
2644200|NCT00765674|9134125|P1|Overall Study|Abnormal Laboratory Value(s)|0
2644201|NCT00765674|9134122|P4|Overall Study|Adverse Event|11
2644202|NCT00765674|9134123|P3|Overall Study|Adverse Event|8
2644203|NCT00765674|9134124|P2|Overall Study|Adverse Event|2
2644204|NCT00765674|9134125|P1|Overall Study|Adverse Event|7
2644205|NCT00765388|9134192|P2|Period 1|Hip operation|1
2644206|NCT00765388|9134193|P1|Period 1|Hip operation|0
2644207|NCT00765388|9134192|P2|Period 1|Herpes Zoster|1
2644208|NCT00765388|9134193|P1|Period 1|Herpes Zoster|0
2644209|NCT00765388|9134192|P2|Period 1|Lost to Follow-up|1
2644210|NCT00765388|9134193|P1|Period 1|Lost to Follow-up|0
2644211|NCT00765388|9134192|P2|Period 1|Lack of Efficacy|2
2644212|NCT00765388|9134193|P1|Period 1|Lack of Efficacy|1
2644213|NCT00765362|9134227|P1|Overall Study|Lost to Follow-up|95
2644214|NCT00765362|9134227|P1|Overall Study|Withdrawal by Subject|13
2644215|NCT00765362|9134227|P1|Overall Study|Protocol Violation|18
2644216|NCT00765362|9134227|P1|Overall Study|Adverse Event|2
2644217|NCT00765362|9134227|P1|Overall Study|Death|9
2644218|NCT00765336|9134235|P2|Overall Study|Adverse Event|1
2644219|NCT00765336|9134236|P1|Overall Study|Adverse Event|2
2644220|NCT00765336|9134235|P2|Overall Study|Lost to Follow-up|9
2644221|NCT00765336|9134236|P1|Overall Study|Lost to Follow-up|7
2644222|NCT00765336|9134235|P2|Overall Study|Withdrawal by Subject|4
2644223|NCT00765336|9134236|P1|Overall Study|Withdrawal by Subject|6
2644224|NCT00765336|9134235|P2|Overall Study|Protocol Violation|2
2644225|NCT00765336|9134236|P1|Overall Study|Protocol Violation|4
2644226|NCT00765245|9134244|P2|Overall Study|Death|0
2644227|NCT00765245|9134245|P1|Overall Study|Death|1
2644228|NCT00765245|9134244|P2|Overall Study|Physician Decision|0
2644229|NCT00765245|9134245|P1|Overall Study|Physician Decision|1
2644230|NCT00765245|9134244|P2|Overall Study|Adverse Event|0
2644231|NCT00765245|9134245|P1|Overall Study|Adverse Event|5
2644232|NCT00765245|9134244|P2|Overall Study|Withdrawal by Subject|0
2644233|NCT00765245|9134245|P1|Overall Study|Withdrawal by Subject|3
2644234|NCT00765245|9134244|P2|Overall Study|disease progression|2
2644235|NCT00765245|9134245|P1|Overall Study|disease progression|3
2644236|NCT00765102|9134291|P1|Overall Study|Protocol Violation|1
2644237|NCT00765102|9134291|P1|Overall Study|Withdrawal by Subject|2
2644238|NCT00765102|9134291|P1|Overall Study|Physician Decision|4
2644239|NCT00765102|9134291|P1|Overall Study|Adverse Event|6
2644240|NCT00765102|9134291|P1|Overall Study|Progressive disease|18
2644241|NCT00765076|9134316|P3|Overall Study|Withdrawal by Subject|1
2644242|NCT00765076|9134317|P2|Overall Study|Withdrawal by Subject|0
2644243|NCT00765076|9134318|P1|Overall Study|Withdrawal by Subject|0
2644244|NCT00765076|9134316|P3|Overall Study|Adverse Event|0
2644245|NCT00765076|9134317|P2|Overall Study|Adverse Event|0
2644246|NCT00765076|9134318|P1|Overall Study|Adverse Event|1
2644247|NCT00765063|9134371|P1|Overall Study|Adverse Event|4
2644248|NCT00765063|9134371|P1|Overall Study|Protocol Violation|6
2644249|NCT00765063|9134371|P1|Overall Study|Other|16
2644250|NCT00765063|9134371|P1|Overall Study|Withdrawal by Subject|1
2644251|NCT00765063|9134371|P1|Overall Study|Lack of Efficacy|5
2644252|NCT00765037|9134387|P1|Overall Study|Adverse Event|1
2644253|NCT00765037|9134387|P1|Overall Study|Lost to Follow-up|5
2644254|NCT00764946|9134394|P3|Overall Study|Never Treated|1
2644255|NCT00764946|9134395|P2|Overall Study|Never Treated|1
2644256|NCT00764946|9134396|P1|Overall Study|Never Treated|1
2644257|NCT00764946|9134394|P3|Overall Study|Withdrawal by Subject|2
2644258|NCT00764946|9134395|P2|Overall Study|Withdrawal by Subject|6
2644259|NCT00764946|9134396|P1|Overall Study|Withdrawal by Subject|3
2644260|NCT00764946|9134394|P3|Overall Study|Adverse Event|1
2644261|NCT00764946|9134395|P2|Overall Study|Adverse Event|2
2644262|NCT00764946|9134396|P1|Overall Study|Adverse Event|3
2644263|NCT00764946|9134394|P3|Overall Study|Physician Decision|0
2644264|NCT00764946|9134395|P2|Overall Study|Physician Decision|4
2644265|NCT00764946|9134396|P1|Overall Study|Physician Decision|2
2644266|NCT00764946|9134394|P3|Overall Study|Lost to Follow-up|0
2644267|NCT00764946|9134395|P2|Overall Study|Lost to Follow-up|4
2644268|NCT00764946|9134396|P1|Overall Study|Lost to Follow-up|3
2644269|NCT00764946|9134394|P3|Overall Study|Lack of Efficacy|0
2644270|NCT00764946|9134395|P2|Overall Study|Lack of Efficacy|0
2644271|NCT00764946|9134396|P1|Overall Study|Lack of Efficacy|1
2644272|NCT00764881|9134424|P2|Overall Study|no treatment or no observation|2
2644273|NCT00764881|9134425|P1|Overall Study|no treatment or no observation|2
2644274|NCT00764881|9134424|P2|Overall Study|Possibly noncompliant (study drug)|2
2644275|NCT00764881|9134425|P1|Overall Study|Possibly noncompliant (study drug)|0
2644276|NCT00764881|9134424|P2|Overall Study|Carcinoma detected|0
2644277|NCT00764881|9134425|P1|Overall Study|Carcinoma detected|1
2644278|NCT00764881|9134424|P2|Overall Study|Wished to become pregnant|0
2644279|NCT00764881|9134425|P1|Overall Study|Wished to become pregnant|1
2644280|NCT00764881|9134424|P2|Overall Study|Accidentally discontinued study drug|0
2644281|NCT00764881|9134425|P1|Overall Study|Accidentally discontinued study drug|1
2644282|NCT00764881|9134424|P2|Overall Study|Noncompliant|0
2644283|NCT00764881|9134425|P1|Overall Study|Noncompliant|1
2644284|NCT00764881|9134424|P2|Overall Study|Lost to Follow-up|0
2644285|NCT00764881|9134425|P1|Overall Study|Lost to Follow-up|2
2644286|NCT00764881|9134424|P2|Overall Study|Protocol Violation|2
2644287|NCT00764881|9134425|P1|Overall Study|Protocol Violation|2
2644288|NCT00764881|9134424|P2|Overall Study|Withdrawal by Subject|3
2644289|NCT00764881|9134425|P1|Overall Study|Withdrawal by Subject|1
2644290|NCT00764881|9134424|P2|Overall Study|Adverse Event|1
2644291|NCT00764881|9134425|P1|Overall Study|Adverse Event|5
2644292|NCT00764868|9134649|P1|Overall Study|Sponsor requested withdrawal|1
2644293|NCT00764868|9134649|P1|Overall Study|Positive drug screen|2
2644294|NCT00764868|9134649|P1|Overall Study|Met an exclusion criteria|1
2644295|NCT00764868|9134649|P1|Overall Study|Subject sent to boarding school|1
2644296|NCT00764868|9134649|P1|Overall Study|Misuse and compliance of study drug|1
2644297|NCT00764868|9134649|P1|Overall Study|Out of town|1
2644298|NCT00764868|9134649|P1|Overall Study|Prohibited medication|1
2644299|NCT00764868|9134649|P1|Overall Study|Pregnancy|3
2644300|NCT00764868|9134649|P1|Overall Study|Subject moved|7
2644301|NCT00764868|9134649|P1|Overall Study|Lack of Efficacy|5
2644302|NCT00764868|9134649|P1|Overall Study|Lost to Follow-up|25
2644303|NCT00764868|9134649|P1|Overall Study|Non-compliance|16
2644304|NCT00764868|9134649|P1|Overall Study|Withdrawal by Subject|31
2644305|NCT00764868|9134649|P1|Overall Study|Adverse Event|18
2644306|NCT00764790|9134658|P3|Overall Study|Lost to Follow-up|23
2644307|NCT00764790|9134659|P2|Overall Study|Lost to Follow-up|29
2644308|NCT00764790|9134660|P1|Overall Study|Lost to Follow-up|28
2644309|NCT00764790|9134658|P3|Overall Study|Withdrawal by Subject|6
2644310|NCT00764790|9134659|P2|Overall Study|Withdrawal by Subject|12
2644311|NCT00764790|9134660|P1|Overall Study|Withdrawal by Subject|10
2644312|NCT00764790|9134658|P3|Overall Study|Protocol Violation|1
2644313|NCT00764790|9134659|P2|Overall Study|Protocol Violation|0
2644314|NCT00764790|9134660|P1|Overall Study|Protocol Violation|0
2644315|NCT00764751|9134694|P2|Overall Study|Psoriasis flare up on the scalp|0
2644316|NCT00764751|9134695|P1|Overall Study|Psoriasis flare up on the scalp|1
2644317|NCT00764751|9134694|P2|Overall Study|Adverse Event|1
2644318|NCT00764751|9134695|P1|Overall Study|Adverse Event|1
2644319|NCT00764699|9134729|P1|Overall Study|PI left and study terminated|3
2644320|NCT00764673|9134733|P1|Overall Study|Revision of Device|2
2644321|NCT00764673|9134733|P1|Overall Study|Withdrawal by Subject|6
2644322|NCT00764673|9134733|P1|Overall Study|Lost to Follow-up|3
2644323|NCT00764673|9134733|P1|Overall Study|Death|1
2644324|NCT00764660|9134743|P2|Overall Study|Did Not Meet Protocol Eligibility|0
2644325|NCT00764660|9134744|P1|Overall Study|Did Not Meet Protocol Eligibility|1
2644326|NCT00764660|9134743|P2|Overall Study|Noncompliance With Protocol|1
2644327|NCT00764660|9134744|P1|Overall Study|Noncompliance With Protocol|5
2644328|NCT00764660|9134743|P2|Overall Study|Withdrawal by Subject|3
2644329|NCT00764660|9134744|P1|Overall Study|Withdrawal by Subject|7
2644330|NCT00764660|9134743|P2|Overall Study|Lost to Follow-up|4
2644331|NCT00764660|9134744|P1|Overall Study|Lost to Follow-up|3
2644332|NCT00764660|9134743|P2|Overall Study|Adverse Event|3
2644333|NCT00764660|9134744|P1|Overall Study|Adverse Event|6
2644334|NCT00764517|9134778|P2|Overall Study|Physician Decision|0
2644335|NCT00764517|9134779|P1|Overall Study|Physician Decision|3
2644336|NCT00764517|9134778|P2|Overall Study|Death|11
2644337|NCT00764517|9134779|P1|Overall Study|Death|3
2644338|NCT00764517|9134778|P2|Overall Study|Adverse Event|3
2644339|NCT00764517|9134779|P1|Overall Study|Adverse Event|9
2644340|NCT00764504|9134800|P3|Overall Study|Lost to Follow-up|72
2644341|NCT00764504|9134801|P2|Overall Study|Lost to Follow-up|34
2644342|NCT00764504|9134802|P1|Overall Study|Lost to Follow-up|40
2644343|NCT00764504|9134800|P3|Overall Study|Withdrawal by Subject|4
2644344|NCT00764504|9134801|P2|Overall Study|Withdrawal by Subject|7
2644345|NCT00764504|9134802|P1|Overall Study|Withdrawal by Subject|1
2644346|NCT00764504|9134800|P3|Overall Study|Physician Decision|0
2644347|NCT00764504|9134801|P2|Overall Study|Physician Decision|0
2644348|NCT00764504|9134802|P1|Overall Study|Physician Decision|1
2644349|NCT00764504|9134800|P3|Overall Study|Revision of Device|14
2644350|NCT00764504|9134801|P2|Overall Study|Revision of Device|23
2644351|NCT00764504|9134802|P1|Overall Study|Revision of Device|12
2644352|NCT00764504|9134800|P3|Overall Study|Death|13
2644353|NCT00764504|9134801|P2|Overall Study|Death|6
2644354|NCT00764504|9134802|P1|Overall Study|Death|12
2644355|NCT00764478|9134831|P3|Overall Study|Protocol Violation|1
2644356|NCT00764478|9134832|P2|Overall Study|Protocol Violation|1
2644357|NCT00764478|9134833|P1|Overall Study|Protocol Violation|0
2644358|NCT00764478|9134831|P3|Overall Study|Lost to Follow-up|5
2644359|NCT00764478|9134832|P2|Overall Study|Lost to Follow-up|8
2644360|NCT00764478|9134833|P1|Overall Study|Lost to Follow-up|7
2644361|NCT00764478|9134831|P3|Overall Study|Withdrawal by Subject|1
2644362|NCT00764478|9134832|P2|Overall Study|Withdrawal by Subject|12
2644363|NCT00764478|9134833|P1|Overall Study|Withdrawal by Subject|7
2644364|NCT00764478|9134831|P3|Overall Study|Adverse Event|1
2644365|NCT00764478|9134832|P2|Overall Study|Adverse Event|1
2644366|NCT00764478|9134833|P1|Overall Study|Adverse Event|1
2644367|NCT00764465|9134913|P6|Overall Study|Withdrawal by Subject|0
2644368|NCT00764465|9134914|P5|Overall Study|Withdrawal by Subject|0
2644369|NCT00764465|9134915|P4|Overall Study|Withdrawal by Subject|0
2644370|NCT00764465|9134916|P3|Overall Study|Withdrawal by Subject|1
2644371|NCT00764465|9134917|P2|Overall Study|Withdrawal by Subject|1
2644372|NCT00764465|9134918|P1|Overall Study|Withdrawal by Subject|0
2644373|NCT00764465|9134913|P6|Overall Study|Adverse Event|1
2644374|NCT00764465|9134914|P5|Overall Study|Adverse Event|1
2644375|NCT00764465|9134915|P4|Overall Study|Adverse Event|1
2644376|NCT00764465|9134916|P3|Overall Study|Adverse Event|0
2644377|NCT00764465|9134917|P2|Overall Study|Adverse Event|0
2644378|NCT00764465|9134918|P1|Overall Study|Adverse Event|2
2644379|NCT00764361|9134946|P2|Overall Study|Adverse Event|1
2644380|NCT00764361|9134947|P1|Overall Study|Adverse Event|0
2644381|NCT00764361|9134946|P2|Overall Study|Withdrawal by Subject|3
2644382|NCT00764361|9134947|P1|Overall Study|Withdrawal by Subject|2
2644383|NCT00764322|9134955|P1|Overall Study|No CYP2D6 genotyping|9
2644384|NCT00764322|9134955|P1|Overall Study|Withdrawal by Subject|11
2644385|NCT00763971|9134982|P3|Overall Study|Participation in 489-326 required|0
2644386|NCT00763971|9134983|P2|Overall Study|Participation in 489-326 required|0
2644387|NCT00763971|9134984|P1|Overall Study|Participation in 489-326 required|1
2644388|NCT00763971|9134982|P3|Overall Study|Performed final visit on phone|0
2644389|NCT00763971|9134983|P2|Overall Study|Performed final visit on phone|1
2644390|NCT00763971|9134984|P1|Overall Study|Performed final visit on phone|0
2644391|NCT00763971|9134982|P3|Overall Study|Lack of availability|0
2644392|NCT00763971|9134983|P2|Overall Study|Lack of availability|1
2644393|NCT00763971|9134984|P1|Overall Study|Lack of availability|0
2644394|NCT00763971|9134982|P3|Overall Study|Subject wanted dose reduction|0
2644395|NCT00763971|9134983|P2|Overall Study|Subject wanted dose reduction|1
2644396|NCT00763971|9134984|P1|Overall Study|Subject wanted dose reduction|0
2644397|NCT00763971|9134982|P3|Overall Study|Moved to another country|0
2644398|NCT00763971|9134983|P2|Overall Study|Moved to another country|1
2644399|NCT00763971|9134984|P1|Overall Study|Moved to another country|0
2644400|NCT00763971|9134982|P3|Overall Study|Medical monitor decision|1
2644401|NCT00763971|9134983|P2|Overall Study|Medical monitor decision|0
2644402|NCT00763971|9134984|P1|Overall Study|Medical monitor decision|0
2644403|NCT00763971|9134982|P3|Overall Study|Randomization error|1
2644404|NCT00763971|9134983|P2|Overall Study|Randomization error|0
2644405|NCT00763971|9134984|P1|Overall Study|Randomization error|0
2644406|NCT00763971|9134982|P3|Overall Study|Due to holiday season|1
2644407|NCT00763971|9134983|P2|Overall Study|Due to holiday season|0
2644408|NCT00763971|9134984|P1|Overall Study|Due to holiday season|2
2644409|NCT00763971|9134982|P3|Overall Study|Sponsor decision|0
2644410|NCT00763971|9134983|P2|Overall Study|Sponsor decision|0
2644411|NCT00763971|9134984|P1|Overall Study|Sponsor decision|1
2644412|NCT00763971|9134982|P3|Overall Study|Exclusion criteria met|0
2644413|NCT00763971|9134983|P2|Overall Study|Exclusion criteria met|0
2644414|NCT00763971|9134984|P1|Overall Study|Exclusion criteria met|1
2644415|NCT00763971|9134982|P3|Overall Study|Personal reason|0
2644416|NCT00763971|9134983|P2|Overall Study|Personal reason|0
2644417|NCT00763971|9134984|P1|Overall Study|Personal reason|3
2644418|NCT00763971|9134982|P3|Overall Study|Unable to swallow capsule|1
2644419|NCT00763971|9134983|P2|Overall Study|Unable to swallow capsule|1
2644420|NCT00763971|9134984|P1|Overall Study|Unable to swallow capsule|2
2644421|NCT00763971|9134982|P3|Overall Study|Lack of Efficacy|54
2644422|NCT00763971|9134983|P2|Overall Study|Lack of Efficacy|22
2644423|NCT00763971|9134984|P1|Overall Study|Lack of Efficacy|11
2644424|NCT00763971|9134982|P3|Overall Study|Lost to Follow-up|0
2644425|NCT00763971|9134983|P2|Overall Study|Lost to Follow-up|1
2644426|NCT00763971|9134984|P1|Overall Study|Lost to Follow-up|0
2644427|NCT00763971|9134982|P3|Overall Study|Withdrawal by Subject|5
2644428|NCT00763971|9134983|P2|Overall Study|Withdrawal by Subject|5
2644429|NCT00763971|9134984|P1|Overall Study|Withdrawal by Subject|4
2644430|NCT00763971|9134982|P3|Overall Study|Protocol Violation|2
2644431|NCT00763971|9134983|P2|Overall Study|Protocol Violation|3
2644432|NCT00763971|9134984|P1|Overall Study|Protocol Violation|3
2644433|NCT00763971|9134982|P3|Overall Study|Adverse Event|4
2644434|NCT00763971|9134983|P2|Overall Study|Adverse Event|2
2644435|NCT00763971|9134984|P1|Overall Study|Adverse Event|5
2644436|NCT00763958|9135015|P2|Overall Study|Believed they were receiving placebo|5
2644437|NCT00763958|9135016|P1|Overall Study|Believed they were receiving placebo|0
2644438|NCT00763958|9135015|P2|Overall Study|Lost to Follow-up|2
2644439|NCT00763958|9135016|P1|Overall Study|Lost to Follow-up|10
2644440|NCT00763958|9135015|P2|Overall Study|did not meet final criteria|4
2644441|NCT00763958|9135016|P1|Overall Study|did not meet final criteria|4
2644442|NCT00763815|9135151|P2|Overall Study|Sponsor's Decision|1
2644443|NCT00763815|9135152|P1|Overall Study|Sponsor's Decision|0
2644444|NCT00763815|9135151|P2|Overall Study|Protocol Violation|5
2644445|NCT00763815|9135152|P1|Overall Study|Protocol Violation|2
2644446|NCT00763815|9135151|P2|Overall Study|Withdrawal by Subject|12
2644447|NCT00763815|9135152|P1|Overall Study|Withdrawal by Subject|7
2644448|NCT00763815|9135151|P2|Overall Study|Physician Decision|0
2644449|NCT00763815|9135152|P1|Overall Study|Physician Decision|1
2644450|NCT00763815|9135151|P2|Overall Study|Familial and Personal Reasons|16
2644451|NCT00763815|9135152|P1|Overall Study|Familial and Personal Reasons|9
2644452|NCT00763815|9135151|P2|Overall Study|Early Termination|0
2644453|NCT00763815|9135152|P1|Overall Study|Early Termination|1
2644454|NCT00763815|9135151|P2|Overall Study|Lost to Follow-up|4
2644455|NCT00763815|9135152|P1|Overall Study|Lost to Follow-up|2
2644456|NCT00763815|9135151|P2|Overall Study|Poor Compliance to Protocol|6
2644457|NCT00763815|9135152|P1|Overall Study|Poor Compliance to Protocol|6
2644458|NCT00763815|9135151|P2|Overall Study|Lack of Efficacy|11
2644459|NCT00763815|9135152|P1|Overall Study|Lack of Efficacy|10
2644460|NCT00763815|9135151|P2|Overall Study|Adverse Event|29
2644461|NCT00763815|9135152|P1|Overall Study|Adverse Event|14
2644462|NCT00763698|9135180|P1|Overall Study|Withdrawal by Subject|1
2644463|NCT00763698|9135180|P1|Overall Study|Death|4
2644464|NCT00763698|9135180|P1|Overall Study|Unsuccessful Implant|5
2644465|NCT00763451|9135197|P4|Overall Study|Study Site Reason|1
2644466|NCT00763451|9135198|P3|Overall Study|Study Site Reason|1
2644467|NCT00763451|9135199|P2|Overall Study|Study Site Reason|1
2644468|NCT00763451|9135200|P1|Overall Study|Study Site Reason|0
2644469|NCT00763451|9135197|P4|Overall Study|Randomized but not Treated|0
2644470|NCT00763451|9135198|P3|Overall Study|Randomized but not Treated|0
2644471|NCT00763451|9135199|P2|Overall Study|Randomized but not Treated|1
2644472|NCT00763451|9135200|P1|Overall Study|Randomized but not Treated|1
2644473|NCT00763451|9135197|P4|Overall Study|Familial and Personal Reasons|4
2644474|NCT00763451|9135198|P3|Overall Study|Familial and Personal Reasons|5
2644475|NCT00763451|9135199|P2|Overall Study|Familial and Personal Reasons|3
2644476|NCT00763451|9135200|P1|Overall Study|Familial and Personal Reasons|5
2644477|NCT00763451|9135197|P4|Overall Study|Poor Compliance to Protocol|2
2644478|NCT00763451|9135198|P3|Overall Study|Poor Compliance to Protocol|2
2644479|NCT00763451|9135199|P2|Overall Study|Poor Compliance to Protocol|1
2644480|NCT00763451|9135200|P1|Overall Study|Poor Compliance to Protocol|1
2644481|NCT00763451|9135197|P4|Overall Study|Protocol Violation|0
2644482|NCT00763451|9135198|P3|Overall Study|Protocol Violation|1
2644483|NCT00763451|9135199|P2|Overall Study|Protocol Violation|0
2644484|NCT00763451|9135200|P1|Overall Study|Protocol Violation|0
2644485|NCT00763451|9135197|P4|Overall Study|Withdrawal by Subject|7
2644486|NCT00763451|9135198|P3|Overall Study|Withdrawal by Subject|9
2644487|NCT00763451|9135199|P2|Overall Study|Withdrawal by Subject|6
2644488|NCT00763451|9135200|P1|Overall Study|Withdrawal by Subject|1
2644489|NCT00763451|9135197|P4|Overall Study|Lack of Efficacy|2
2644490|NCT00763451|9135198|P3|Overall Study|Lack of Efficacy|3
2644491|NCT00763451|9135199|P2|Overall Study|Lack of Efficacy|4
2644492|NCT00763451|9135200|P1|Overall Study|Lack of Efficacy|1
2644493|NCT00763451|9135197|P4|Overall Study|Adverse Event|14
2644494|NCT00763451|9135198|P3|Overall Study|Adverse Event|19
2644495|NCT00763451|9135199|P2|Overall Study|Adverse Event|6
2644496|NCT00763451|9135200|P1|Overall Study|Adverse Event|4
2644497|NCT00763386|9135259|P2|Overall Study|Study Prosthesis Removed|0
2644498|NCT00763386|9135260|P1|Overall Study|Study Prosthesis Removed|1
2644499|NCT00763386|9135259|P2|Overall Study|CRF missing|1
2644500|NCT00763386|9135260|P1|Overall Study|CRF missing|0
2644501|NCT00763386|9135259|P2|Overall Study|Withdrawal by Subject|1
2644502|NCT00763386|9135260|P1|Overall Study|Withdrawal by Subject|0
2644503|NCT00763386|9135259|P2|Overall Study|Lost to Follow-up|3
2644504|NCT00763386|9135260|P1|Overall Study|Lost to Follow-up|3
2644505|NCT00763386|9135259|P2|Overall Study|Death|2
2644506|NCT00763386|9135260|P1|Overall Study|Death|1
2644507|NCT00763386|9135259|P2|Overall Study|Adverse Event|33
2644508|NCT00763386|9135260|P1|Overall Study|Adverse Event|43
2644509|NCT00763321|9135293|P3|Double-blind Period|Other|3
2644510|NCT00763321|9135294|P2|Double-blind Period|Other|2
2644511|NCT00763321|9135295|P1|Double-blind Period|Other|0
2644512|NCT00763321|9135293|P3|Double-blind Period|Withdrawal by Subject|3
2644513|NCT00763321|9135294|P2|Double-blind Period|Withdrawal by Subject|2
2644514|NCT00763321|9135295|P1|Double-blind Period|Withdrawal by Subject|0
2644515|NCT00763321|9135293|P3|Double-blind Period|Lost to Follow-up|2
2644516|NCT00763321|9135294|P2|Double-blind Period|Lost to Follow-up|4
2644517|NCT00763321|9135295|P1|Double-blind Period|Lost to Follow-up|0
2644518|NCT00763321|9135293|P3|Double-blind Period|Adverse Event|4
2644519|NCT00763321|9135294|P2|Double-blind Period|Adverse Event|4
2644520|NCT00763321|9135295|P1|Double-blind Period|Adverse Event|0
2644521|NCT00763321|9135293|P3|Double-blind Period|Lack of Efficacy|17
2644522|NCT00763321|9135294|P2|Double-blind Period|Lack of Efficacy|9
2644523|NCT00763321|9135295|P1|Double-blind Period|Lack of Efficacy|0
2644524|NCT00763321|9135293|P3|Open-label Period|Other|0
2644525|NCT00763321|9135294|P2|Open-label Period|Other|0
2644526|NCT00763321|9135295|P1|Open-label Period|Other|4
2644527|NCT00763321|9135293|P3|Open-label Period|Lack of Efficacy|0
2644528|NCT00763321|9135294|P2|Open-label Period|Lack of Efficacy|0
2644529|NCT00763321|9135295|P1|Open-label Period|Lack of Efficacy|2
2644530|NCT00763321|9135293|P3|Open-label Period|Did not meet DB randomization criteria|0
2644531|NCT00763321|9135294|P2|Open-label Period|Did not meet DB randomization criteria|0
2644532|NCT00763321|9135295|P1|Open-label Period|Did not meet DB randomization criteria|5
2644533|NCT00763321|9135293|P3|Open-label Period|Subject noncompliant|0
2644534|NCT00763321|9135294|P2|Open-label Period|Subject noncompliant|0
2644535|NCT00763321|9135295|P1|Open-label Period|Subject noncompliant|7
2644536|NCT00763321|9135293|P3|Open-label Period|Withdrawal by Subject|0
2644537|NCT00763321|9135294|P2|Open-label Period|Withdrawal by Subject|0
2644538|NCT00763321|9135295|P1|Open-label Period|Withdrawal by Subject|7
2644539|NCT00763321|9135293|P3|Open-label Period|Lost to Follow-up|0
2644540|NCT00763321|9135294|P2|Open-label Period|Lost to Follow-up|0
2644541|NCT00763321|9135295|P1|Open-label Period|Lost to Follow-up|14
2644542|NCT00763321|9135293|P3|Open-label Period|Adverse Event|0
2644543|NCT00763321|9135294|P2|Open-label Period|Adverse Event|0
2644544|NCT00763321|9135295|P1|Open-label Period|Adverse Event|24
2644545|NCT00763282|9135306|P2|Overall Study|Lost to Follow-up|26
2644546|NCT00763282|9135307|P1|Overall Study|Lost to Follow-up|22
2644547|NCT00763282|9135306|P2|Overall Study|Death|3
2644548|NCT00763282|9135307|P1|Overall Study|Death|4
2644549|NCT00763282|9135306|P2|Overall Study|Withdrawal by Subject|5
2644550|NCT00763282|9135307|P1|Overall Study|Withdrawal by Subject|6
2644551|NCT00763269|9135323|P2|Overall Study|Lost to Follow-up|13
2644552|NCT00763269|9135324|P1|Overall Study|Lost to Follow-up|12
2644553|NCT00763256|9135338|P2|Overall Study|Didn't return for appointments|10
2644554|NCT00763256|9135339|P1|Overall Study|Didn't return for appointments|7
2644555|NCT00763139|9135375|P2|Overall Study|med change not allowed by protocol|0
2644556|NCT00763139|9135376|P1|Overall Study|med change not allowed by protocol|1
2644557|NCT00763139|9135375|P2|Overall Study|Withdrawal by Subject|1
2644558|NCT00763139|9135376|P1|Overall Study|Withdrawal by Subject|0
2644559|NCT00763139|9135375|P2|Overall Study|Adverse Event|2
2644560|NCT00763139|9135376|P1|Overall Study|Adverse Event|4
2644561|NCT00763035|9135438|P2|Second Intervention|Physician Decision|0
2644562|NCT00763035|9135439|P1|Second Intervention|Physician Decision|2
2644563|NCT00763035|9135438|P2|Second Intervention|Adverse Event|0
2644564|NCT00763035|9135439|P1|Second Intervention|Adverse Event|1
2644565|NCT00763035|9135438|P2|First Intervention|Adverse Event|1
2644566|NCT00763035|9135439|P1|First Intervention|Adverse Event|0
2644567|NCT00763035|9135438|P2|First Intervention|Did not meeting inclusion/exclusion|0
2644568|NCT00763035|9135439|P1|First Intervention|Did not meeting inclusion/exclusion|1
2644569|NCT00763009|9135457|P1|Overall Study|Coronary Anatomy unsuitable|1
2644570|NCT00762996|9135462|P4|Period One|Withdrawal by Subject|0
2644571|NCT00762996|9135463|P3|Period One|Withdrawal by Subject|1
2644572|NCT00762996|9135464|P2|Period One|Withdrawal by Subject|0
2644573|NCT00762996|9135465|P1|Period One|Withdrawal by Subject|0
2644574|NCT00762996|9135462|P4|Period One|Adverse Event|0
2644575|NCT00762996|9135463|P3|Period One|Adverse Event|1
2644576|NCT00762996|9135464|P2|Period One|Adverse Event|0
2644577|NCT00762996|9135465|P1|Period One|Adverse Event|0
2644578|NCT00762996|9135462|P4|Period One|ineligible|1
2644579|NCT00762996|9135463|P3|Period One|ineligible|1
2644580|NCT00762996|9135464|P2|Period One|ineligible|0
2644581|NCT00762996|9135465|P1|Period One|ineligible|0
2644582|NCT00762996|9135462|P4|Period One|Protocol Violation|0
2644583|NCT00762996|9135463|P3|Period One|Protocol Violation|1
2644584|NCT00762996|9135464|P2|Period One|Protocol Violation|0
2644585|NCT00762996|9135465|P1|Period One|Protocol Violation|0
2644586|NCT00762970|9135478|P3|Overall Study|Difficulty of handling lens|0
2644587|NCT00762970|9135479|P2|Overall Study|Difficulty of handling lens|2
2644588|NCT00762970|9135480|P1|Overall Study|Difficulty of handling lens|1
2644589|NCT00762970|9135478|P3|Overall Study|Lost to Follow-up|0
2644590|NCT00762970|9135479|P2|Overall Study|Lost to Follow-up|2
2644591|NCT00762970|9135480|P1|Overall Study|Lost to Follow-up|1
2644592|NCT00762970|9135478|P3|Overall Study|Protocol Violation|1
2644593|NCT00762970|9135479|P2|Overall Study|Protocol Violation|1
2644594|NCT00762970|9135480|P1|Overall Study|Protocol Violation|3
2644595|NCT00762970|9135478|P3|Overall Study|Withdrawal by Subject|0
2644596|NCT00762970|9135479|P2|Overall Study|Withdrawal by Subject|4
2644597|NCT00762970|9135480|P1|Overall Study|Withdrawal by Subject|7
2644598|NCT00762892|9135498|P2|Overall Study|Incarceration|0
2644599|NCT00762892|9135499|P1|Overall Study|Incarceration|1
2644600|NCT00762892|9135498|P2|Overall Study|Pregnancy|0
2644601|NCT00762892|9135499|P1|Overall Study|Pregnancy|1
2644602|NCT00762892|9135498|P2|Overall Study|Death|0
2644603|NCT00762892|9135499|P1|Overall Study|Death|1
2644604|NCT00762892|9135498|P2|Overall Study|Withdrawal by Subject|1
2644605|NCT00762892|9135499|P1|Overall Study|Withdrawal by Subject|0
2644606|NCT00762892|9135498|P2|Overall Study|Lost to Follow-up|5
2644607|NCT00762892|9135499|P1|Overall Study|Lost to Follow-up|2
2644608|NCT00762788|9135528|P6|Overall Study|Lost to Follow-up|21
2644609|NCT00762788|9135529|P5|Overall Study|Lost to Follow-up|13
2644610|NCT00762788|9135530|P4|Overall Study|Lost to Follow-up|26
2644611|NCT00762788|9135531|P3|Overall Study|Lost to Follow-up|21
2644612|NCT00762788|9135532|P2|Overall Study|Lost to Follow-up|37
2644613|NCT00762788|9135533|P1|Overall Study|Lost to Follow-up|26
2644614|NCT00762762|9135555|P2|Overall Study|Did not report for appointments|10
2644615|NCT00762762|9135556|P1|Overall Study|Did not report for appointments|8
2644616|NCT00762723|9135573|P3|Overall Study|Study Terminated slow enrollement|3
2644617|NCT00762723|9135574|P2|Overall Study|Study Terminated slow enrollement|5
2644618|NCT00762723|9135575|P1|Overall Study|Study Terminated slow enrollement|5
2644619|NCT00762606|9135739|P2|Overall Study|Lost to Follow-up|13
2644620|NCT00762606|9135740|P1|Overall Study|Lost to Follow-up|18
2644621|NCT00762502|9135785|P3|Month 3 to Month 6 (Period 2)|Pregnancy|0
2644622|NCT00762502|9135786|P2|Month 3 to Month 6 (Period 2)|Pregnancy|1
2644623|NCT00762502|9135787|P1|Month 3 to Month 6 (Period 2)|Pregnancy|0
2644624|NCT00762502|9135785|P3|Baseline to Month 3 (Period 1)|Lost to Follow-up|13
2644625|NCT00762502|9135786|P2|Baseline to Month 3 (Period 1)|Lost to Follow-up|3
2644626|NCT00762502|9135787|P1|Baseline to Month 3 (Period 1)|Lost to Follow-up|6
2644627|NCT00762502|9135785|P3|Baseline to Month 3 (Period 1)|Adverse Event|6
2644628|NCT00762502|9135786|P2|Baseline to Month 3 (Period 1)|Adverse Event|3
2644629|NCT00762502|9135787|P1|Baseline to Month 3 (Period 1)|Adverse Event|4
2644630|NCT00762476|9135801|P2|Overall Study|Seasonal allergies|0
2644631|NCT00762476|9135802|P1|Overall Study|Seasonal allergies|1
2644632|NCT00762476|9135801|P2|Overall Study|non-compliance with study visits|2
2644633|NCT00762476|9135802|P1|Overall Study|non-compliance with study visits|0
2644634|NCT00762476|9135801|P2|Overall Study|antibiotic use|1
2644635|NCT00762476|9135802|P1|Overall Study|antibiotic use|0
2644636|NCT00762476|9135801|P2|Overall Study|Withdrawal by Subject|12
2644637|NCT00762476|9135802|P1|Overall Study|Withdrawal by Subject|6
2644638|NCT00762476|9135801|P2|Overall Study|Physician Decision|14
2644639|NCT00762476|9135802|P1|Overall Study|Physician Decision|2
2644640|NCT00762476|9135801|P2|Overall Study|Protocol Violation|6
2644641|NCT00762476|9135802|P1|Overall Study|Protocol Violation|5
2644642|NCT00762476|9135801|P2|Overall Study|Lost to Follow-up|0
2644643|NCT00762476|9135802|P1|Overall Study|Lost to Follow-up|2
2644644|NCT00762476|9135801|P2|Overall Study|Adverse Event|1
2644645|NCT00762476|9135802|P1|Overall Study|Adverse Event|7
2644646|NCT00762463|9135814|P4|Extension Phase (Week 6 to Week 12)|Other|1
2644647|NCT00762463|9135815|P3|Extension Phase (Week 6 to Week 12)|Other|0
2644648|NCT00762463|9135816|P2|Extension Phase (Week 6 to Week 12)|Other|0
2644649|NCT00762463|9135817|P1|Extension Phase (Week 6 to Week 12)|Other|0
2644650|NCT00762463|9135814|P4|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
2644651|NCT00762463|9135815|P3|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3
2644652|NCT00762463|9135816|P2|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
2644653|NCT00762463|9135817|P1|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1
2644654|NCT00762463|9135814|P4|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
2644655|NCT00762463|9135815|P3|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0
2644656|NCT00762463|9135816|P2|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
2644657|NCT00762463|9135817|P1|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
2644658|NCT00762463|9135814|P4|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
2644659|NCT00762463|9135815|P3|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
2644660|NCT00762463|9135816|P2|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
2644661|NCT00762463|9135817|P1|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
2644662|NCT00762463|9135814|P4|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
2644663|NCT00762463|9135815|P3|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
2644664|NCT00762463|9135816|P2|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1
2644665|NCT00762463|9135817|P1|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4
2644666|NCT00762463|9135814|P4|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
2644667|NCT00762463|9135815|P3|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
2644668|NCT00762463|9135816|P2|Double-blind Phase (Baseline to Week 6)|Adverse Event|4
2644669|NCT00762463|9135817|P1|Double-blind Phase (Baseline to Week 6)|Adverse Event|2
2644670|NCT00762463|9135814|P4|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
2644671|NCT00762463|9135815|P3|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
2644672|NCT00762463|9135816|P2|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4
2644673|NCT00762463|9135817|P1|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3
2644674|NCT00762463|9135814|P4|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
2644675|NCT00762463|9135815|P3|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
2644676|NCT00762463|9135816|P2|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
2644677|NCT00762463|9135817|P1|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
2644678|NCT00762411|9135923|P2|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54
2644679|NCT00762411|9135924|P1|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48
2644680|NCT00762411|9135923|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
2644681|NCT00762411|9135924|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
2644682|NCT00762411|9135923|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
2644683|NCT00762411|9135924|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6
2644684|NCT00762411|9135923|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46
2644685|NCT00762411|9135924|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21
2644686|NCT00762411|9135923|P2|Safety Follow Up (SFU)-Optional|Adverse Event|1
2644687|NCT00762411|9135924|P1|Safety Follow Up (SFU)-Optional|Adverse Event|0
2644688|NCT00762411|9135923|P2|Safety Follow Up (SFU)-Optional|Death|8
2644689|NCT00762411|9135924|P1|Safety Follow Up (SFU)-Optional|Death|1
2644690|NCT00762411|9135923|P2|Delayed Start|Caregiver Decision|1
2644691|NCT00762411|9135924|P1|Delayed Start|Caregiver Decision|1
2644692|NCT00762411|9135923|P2|Delayed Start|Sponsor Decision|20
2644693|NCT00762411|9135924|P1|Delayed Start|Sponsor Decision|16
2644694|NCT00762411|9135923|P2|Delayed Start|Protocol Violation|1
2644695|NCT00762411|9135924|P1|Delayed Start|Protocol Violation|0
2644696|NCT00762411|9135923|P2|Delayed Start|Adverse Event|4
2644697|NCT00762411|9135924|P1|Delayed Start|Adverse Event|0
2644698|NCT00762411|9135923|P2|Initial Treatment|Entry Criteria Exclusion|1
2644699|NCT00762411|9135924|P1|Initial Treatment|Entry Criteria Exclusion|0
2644700|NCT00762411|9135923|P2|Initial Treatment|Abnormal Lab/ECG Result|4
2644701|NCT00762411|9135924|P1|Initial Treatment|Abnormal Lab/ECG Result|6
2644702|NCT00762411|9135923|P2|Initial Treatment|Caregiver Decision|16
2644703|NCT00762411|9135924|P1|Initial Treatment|Caregiver Decision|21
2644704|NCT00762411|9135923|P2|Initial Treatment|Lost to Follow-up|0
2644705|NCT00762411|9135924|P1|Initial Treatment|Lost to Follow-up|5
2644706|NCT00762411|9135923|P2|Initial Treatment|Sponsor Decision|401
2644707|NCT00762411|9135924|P1|Initial Treatment|Sponsor Decision|293
2644708|NCT00762411|9135923|P2|Initial Treatment|Physician Decision|0
2644709|NCT00762411|9135924|P1|Initial Treatment|Physician Decision|1
2644710|NCT00762411|9135923|P2|Initial Treatment|Withdrawal by Subject|52
2644711|NCT00762411|9135924|P1|Initial Treatment|Withdrawal by Subject|65
2644712|NCT00762411|9135923|P2|Initial Treatment|Protocol Violation|1
2644713|NCT00762411|9135924|P1|Initial Treatment|Protocol Violation|4
2644714|NCT00762411|9135923|P2|Initial Treatment|Adverse Event|40
2644715|NCT00762411|9135924|P1|Initial Treatment|Adverse Event|132
2644716|NCT00762411|9135923|P2|Initial Treatment|Death|6
2644717|NCT00762411|9135924|P1|Initial Treatment|Death|7
2644718|NCT00762385|9135988|P2|Second Intervention|Protocol Violation|3
2644719|NCT00762385|9135989|P1|Second Intervention|Protocol Violation|3
2644720|NCT00762385|9135988|P2|First Intervention|Protocol Violation|1
2644721|NCT00762385|9135989|P1|First Intervention|Protocol Violation|0
2644722|NCT00762385|9135988|P2|First Intervention|Ineligible|0
2644723|NCT00762385|9135989|P1|First Intervention|Ineligible|1
2644724|NCT00762385|9135988|P2|First Intervention|Lost to Follow-up|2
2644725|NCT00762385|9135989|P1|First Intervention|Lost to Follow-up|0
2644726|NCT00762385|9135988|P2|First Intervention|Lens Issue|1
2644727|NCT00762385|9135989|P1|First Intervention|Lens Issue|1
2644728|NCT00762372|9136002|P3|Overall Study|Adverse Event|0
2644729|NCT00762372|9136003|P2|Overall Study|Adverse Event|0
2644730|NCT00762372|9136004|P1|Overall Study|Adverse Event|1
2644731|NCT00762359|9136080|P2|Overall Study|Withdrew consent|0
2644732|NCT00762359|9136081|P1|Overall Study|Withdrew consent|1
2644733|NCT00762359|9136080|P2|Overall Study|Removal|1
2644734|NCT00762359|9136081|P1|Overall Study|Removal|0
2644735|NCT00762359|9136080|P2|Overall Study|Physician Decision|3
2644736|NCT00762359|9136081|P1|Overall Study|Physician Decision|2
2644737|NCT00762359|9136080|P2|Overall Study|Institution closed|3
2644738|NCT00762359|9136081|P1|Overall Study|Institution closed|2
2644739|NCT00762359|9136080|P2|Overall Study|Lack of Efficacy|4
2644740|NCT00762359|9136081|P1|Overall Study|Lack of Efficacy|0
2644741|NCT00762359|9136080|P2|Overall Study|Withdrawal by Subject|10
2644742|NCT00762359|9136081|P1|Overall Study|Withdrawal by Subject|13
2644743|NCT00762359|9136080|P2|Overall Study|Protocol Violation|13
2644744|NCT00762359|9136081|P1|Overall Study|Protocol Violation|21
2644745|NCT00762359|9136080|P2|Overall Study|Adverse Event|23
2644746|NCT00762359|9136081|P1|Overall Study|Adverse Event|20
2644747|NCT00762268|9136198|P2|Overall Study|Withdrawal by Subject|3
2644748|NCT00762268|9136199|P1|Overall Study|Withdrawal by Subject|3
2644749|NCT00762229|9136211|P2|Overall Study|did not recveive intervention|1
2644750|NCT00762229|9136212|P1|Overall Study|did not recveive intervention|0
2644751|NCT00762229|9136211|P2|Overall Study|Lost to Follow-up|1
2644752|NCT00762229|9136212|P1|Overall Study|Lost to Follow-up|1
2644753|NCT00762164|9136309|P2|Overall Study|Withdrawal by Subject|1
2644754|NCT00762164|9136310|P1|Overall Study|Withdrawal by Subject|0
2644755|NCT00762164|9136309|P2|Overall Study|Discontinued medication|0
2644756|NCT00762164|9136310|P1|Overall Study|Discontinued medication|2
2644757|NCT00762164|9136309|P2|Overall Study|Lost to Follow-up|1
2644758|NCT00762164|9136310|P1|Overall Study|Lost to Follow-up|1
2644759|NCT00762086|9136320|P2|Overall Study|Ineligible to participate in the study|0
2644760|NCT00762086|9136321|P1|Overall Study|Ineligible to participate in the study|1
2644761|NCT00762086|9136320|P2|Overall Study|Withdrawal by Subject|2
2644762|NCT00762086|9136321|P1|Overall Study|Withdrawal by Subject|2
2644763|NCT00762086|9136320|P2|Overall Study|Non compliance|0
2644764|NCT00762086|9136321|P1|Overall Study|Non compliance|1
2644765|NCT00762086|9136320|P2|Overall Study|Lost to Follow-up|2
2644766|NCT00762086|9136321|P1|Overall Study|Lost to Follow-up|0
2644767|NCT00762086|9136320|P2|Overall Study|Adverse Event|0
2644768|NCT00762086|9136321|P1|Overall Study|Adverse Event|2
2644769|NCT00762073|9136331|P4|Overall Study|Not on treatment for >/= 77 days|0
2644770|NCT00762073|9136332|P3|Overall Study|Not on treatment for >/= 77 days|0
2644771|NCT00762073|9136333|P2|Overall Study|Not on treatment for >/= 77 days|0
2644772|NCT00762073|9136334|P1|Overall Study|Not on treatment for >/= 77 days|1
2644773|NCT00762073|9136331|P4|Overall Study|Withdrawal by Subject|1
2644774|NCT00762073|9136332|P3|Overall Study|Withdrawal by Subject|1
2644775|NCT00762073|9136333|P2|Overall Study|Withdrawal by Subject|2
2644776|NCT00762073|9136334|P1|Overall Study|Withdrawal by Subject|1
2644777|NCT00762073|9136331|P4|Overall Study|Significant Subject Noncompliance|1
2644778|NCT00762073|9136332|P3|Overall Study|Significant Subject Noncompliance|0
2644779|NCT00762073|9136333|P2|Overall Study|Significant Subject Noncompliance|1
2644780|NCT00762073|9136334|P1|Overall Study|Significant Subject Noncompliance|0
2644781|NCT00762073|9136331|P4|Overall Study|Adverse Event|1
2644782|NCT00762073|9136332|P3|Overall Study|Adverse Event|1
2644783|NCT00762073|9136333|P2|Overall Study|Adverse Event|0
2644784|NCT00762073|9136334|P1|Overall Study|Adverse Event|1
2644785|NCT00762073|9136331|P4|Overall Study|Lack of Efficacy|0
2644786|NCT00762073|9136332|P3|Overall Study|Lack of Efficacy|0
2644787|NCT00762073|9136333|P2|Overall Study|Lack of Efficacy|1
2644788|NCT00762073|9136334|P1|Overall Study|Lack of Efficacy|1
2644789|NCT00762034|9136398|P2|Maintenance Period|Other|1
2644790|NCT00762034|9136399|P1|Maintenance Period|Other|1
2644791|NCT00762034|9136398|P2|Maintenance Period|Death due to study disease|3
2644792|NCT00762034|9136399|P1|Maintenance Period|Death due to study disease|3
2644793|NCT00762034|9136398|P2|Maintenance Period|Death not due to study disease|5
2644794|NCT00762034|9136399|P1|Maintenance Period|Death not due to study disease|2
2644795|NCT00762034|9136398|P2|Maintenance Period|Withdrawal by Subject|14
2644796|NCT00762034|9136399|P1|Maintenance Period|Withdrawal by Subject|34
2644797|NCT00762034|9136398|P2|Maintenance Period|Physician Decision|20
2644798|NCT00762034|9136399|P1|Maintenance Period|Physician Decision|25
2644799|NCT00762034|9136398|P2|Maintenance Period|Progressive Disease|224
2644800|NCT00762034|9136399|P1|Maintenance Period|Progressive Disease|186
2644801|NCT00762034|9136398|P2|Maintenance Period|Adverse Event|26
2644802|NCT00762034|9136399|P1|Maintenance Period|Adverse Event|42
2644803|NCT00762034|9136398|P2|Maintenance Period|Entry Criterion Not Met|2
2644804|NCT00762034|9136399|P1|Maintenance Period|Entry Criterion Not Met|0
2644805|NCT00762034|9136398|P2|Maintenance Period|Protocol Violation|3
2644806|NCT00762034|9136399|P1|Maintenance Period|Protocol Violation|1
2644807|NCT00762034|9136398|P2|Induction Period|Deaths Due to Study Disease|9
2644808|NCT00762034|9136399|P1|Induction Period|Deaths Due to Study Disease|9
2644809|NCT00762034|9136398|P2|Induction Period|Deaths Not Due to Study Disease|14
2644810|NCT00762034|9136399|P1|Induction Period|Deaths Not Due to Study Disease|19
2644811|NCT00762034|9136398|P2|Induction Period|Withdrawal by Subject|19
2644812|NCT00762034|9136399|P1|Induction Period|Withdrawal by Subject|15
2644813|NCT00762034|9136398|P2|Induction Period|Physician Decision|20
2644814|NCT00762034|9136399|P1|Induction Period|Physician Decision|21
2644815|NCT00762034|9136398|P2|Induction Period|Progressive Disease|55
2644816|NCT00762034|9136399|P1|Induction Period|Progressive Disease|73
2644817|NCT00762034|9136398|P2|Induction Period|Lost to Follow-up|1
2644818|NCT00762034|9136399|P1|Induction Period|Lost to Follow-up|1
2644819|NCT00762034|9136398|P2|Induction Period|Adverse Event|38
2644820|NCT00762034|9136399|P1|Induction Period|Adverse Event|27
2644821|NCT00762034|9136398|P2|Induction Period|Entry Criterion Not Met|11
2644822|NCT00762034|9136399|P1|Induction Period|Entry Criterion Not Met|12
2644823|NCT00762034|9136398|P2|Induction Period|Protocol Violation|2
2644824|NCT00762034|9136399|P1|Induction Period|Protocol Violation|1
2644825|NCT00761969|9136471|P2|Overall Study|Lost to Follow-up|93
2644826|NCT00761969|9136472|P1|Overall Study|Lost to Follow-up|88
2644827|NCT00761969|9136471|P2|Overall Study|Death|47
2644828|NCT00761969|9136472|P1|Overall Study|Death|112
2644829|NCT00761956|9136482|P2|Overall Study|Adverse Event|34
2644830|NCT00761956|9136483|P1|Overall Study|Adverse Event|26
2644831|NCT00761956|9136482|P2|Overall Study|Death|1
2644832|NCT00761956|9136483|P1|Overall Study|Death|0
2644833|NCT00761956|9136482|P2|Overall Study|Withdrawal by Subject|8
2644834|NCT00761956|9136483|P1|Overall Study|Withdrawal by Subject|3
2644835|NCT00761956|9136482|P2|Overall Study|Lost to Follow-up|11
2644836|NCT00761956|9136483|P1|Overall Study|Lost to Follow-up|6
2644837|NCT00761891|9136510|P1|Overall Study|Withdrawal by Subject|10
2644838|NCT00761865|9136517|P2|Overall Study|Lost to Follow-up|7
2644839|NCT00761865|9136518|P1|Overall Study|Lost to Follow-up|8
2644840|NCT00761774|9136539|P1|Overall Study|IP stopped by hospital physician|1
2644841|NCT00761774|9136539|P1|Overall Study|Subject IP non-compliance|1
2644842|NCT00761774|9136539|P1|Overall Study|Coordinator leaving site|1
2644843|NCT00761774|9136539|P1|Overall Study|Patient moved out of study area|1
2644844|NCT00761774|9136539|P1|Overall Study|Investigator clinical judgement|1
2644845|NCT00761774|9136539|P1|Overall Study|Sponsor decision|1
2644846|NCT00761774|9136539|P1|Overall Study|Medical decision to read SUSAR reports|1
2644847|NCT00761774|9136539|P1|Overall Study|Reclassification of seizures|1
2644848|NCT00761774|9136539|P1|Overall Study|End of study|2
2644849|NCT00761774|9136539|P1|Overall Study|Non-compliance|4
2644850|NCT00761774|9136539|P1|Overall Study|Withdrawal by Subject|9
2644851|NCT00761774|9136539|P1|Overall Study|Lost to Follow-up|2
2644852|NCT00761774|9136539|P1|Overall Study|Lack of Efficacy|37
2644853|NCT00761774|9136539|P1|Overall Study|Adverse Event|17
2644854|NCT00761761|9136550|P2|Overall Study|Withdrawal by Subject|0
2644855|NCT00761761|9136551|P1|Overall Study|Withdrawal by Subject|3
2644856|NCT00761761|9136550|P2|Overall Study|Lost to Follow-up|1
2644857|NCT00761761|9136551|P1|Overall Study|Lost to Follow-up|3
2644858|NCT00761748|9136563|P2|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3
2644859|NCT00761748|9136564|P1|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0
2644860|NCT00761748|9136563|P2|First Intervention (21 +/- 3 Days)|Adverse Event|0
2644861|NCT00761748|9136564|P1|First Intervention (21 +/- 3 Days)|Adverse Event|3
2644862|NCT00761735|9136570|P1|Overall Study|Administrative|1
2644863|NCT00761735|9136570|P1|Overall Study|Non-compliance with protocol|1
2644864|NCT00761735|9136570|P1|Overall Study|Withdrawal by Subject|6
2644865|NCT00761735|9136570|P1|Overall Study|Lost to Follow-up|6
2644866|NCT00761631|9136586|P6|Overall Study|Other|1
2644867|NCT00761631|9136587|P5|Overall Study|Other|1
2644868|NCT00761631|9136588|P4|Overall Study|Other|0
2644869|NCT00761631|9136589|P3|Overall Study|Other|0
2644870|NCT00761631|9136590|P2|Overall Study|Other|0
2644871|NCT00761631|9136591|P1|Overall Study|Other|0
2644872|NCT00761631|9136586|P6|Overall Study|Physician Decision|0
2644873|NCT00761631|9136587|P5|Overall Study|Physician Decision|0
2644874|NCT00761631|9136588|P4|Overall Study|Physician Decision|0
2644875|NCT00761631|9136589|P3|Overall Study|Physician Decision|0
2644876|NCT00761631|9136590|P2|Overall Study|Physician Decision|0
2644877|NCT00761631|9136591|P1|Overall Study|Physician Decision|1
2644878|NCT00761631|9136586|P6|Overall Study|Failed to return|2
2644879|NCT00761631|9136587|P5|Overall Study|Failed to return|5
2644880|NCT00761631|9136588|P4|Overall Study|Failed to return|1
2644881|NCT00761631|9136589|P3|Overall Study|Failed to return|1
2644882|NCT00761631|9136590|P2|Overall Study|Failed to return|0
2644883|NCT00761631|9136591|P1|Overall Study|Failed to return|1
2644884|NCT00761631|9136586|P6|Overall Study|Randomized, not treated|0
2644885|NCT00761631|9136587|P5|Overall Study|Randomized, not treated|0
2644886|NCT00761631|9136588|P4|Overall Study|Randomized, not treated|0
2644887|NCT00761631|9136589|P3|Overall Study|Randomized, not treated|0
2644888|NCT00761631|9136590|P2|Overall Study|Randomized, not treated|0
2644889|NCT00761631|9136591|P1|Overall Study|Randomized, not treated|1
2644890|NCT00761631|9136586|P6|Overall Study|Protocol Violation|1
2644891|NCT00761631|9136587|P5|Overall Study|Protocol Violation|5
2644892|NCT00761631|9136588|P4|Overall Study|Protocol Violation|1
2644893|NCT00761631|9136589|P3|Overall Study|Protocol Violation|0
2644894|NCT00761631|9136590|P2|Overall Study|Protocol Violation|0
2644895|NCT00761631|9136591|P1|Overall Study|Protocol Violation|2
2644896|NCT00761631|9136586|P6|Overall Study|Lost to Follow-up|1
2644897|NCT00761631|9136587|P5|Overall Study|Lost to Follow-up|6
2644898|NCT00761631|9136588|P4|Overall Study|Lost to Follow-up|1
2644899|NCT00761631|9136589|P3|Overall Study|Lost to Follow-up|7
2644900|NCT00761631|9136590|P2|Overall Study|Lost to Follow-up|4
2644901|NCT00761631|9136591|P1|Overall Study|Lost to Follow-up|2
2644902|NCT00761631|9136586|P6|Overall Study|Parent/legal guardian request|0
2644903|NCT00761631|9136587|P5|Overall Study|Parent/legal guardian request|5
2644904|NCT00761631|9136588|P4|Overall Study|Parent/legal guardian request|0
2644905|NCT00761631|9136589|P3|Overall Study|Parent/legal guardian request|8
2644906|NCT00761631|9136590|P2|Overall Study|Parent/legal guardian request|3
2644907|NCT00761631|9136591|P1|Overall Study|Parent/legal guardian request|8
2644908|NCT00761605|9136626|P1|Overall Study|Other|21
2644909|NCT00761605|9136626|P1|Overall Study|Withdrawal by Subject|37
2644910|NCT00761605|9136626|P1|Overall Study|Lost to Follow-up|29
2644911|NCT00761605|9136626|P1|Overall Study|Lack of Efficacy|26
2644912|NCT00761605|9136626|P1|Overall Study|Death|2
2644913|NCT00761605|9136626|P1|Overall Study|Adverse Event|26
2644914|NCT00761579|9136670|P1|Overall Study|Intake of prohibited concomitant drug|1
2644915|NCT00761579|9136670|P1|Overall Study|Lost survey form|1
2644916|NCT00761579|9136670|P1|Overall Study|Aggravation of symptoms by changing drug|1
2644917|NCT00761579|9136670|P1|Overall Study|Aggravation of depression|1
2644918|NCT00761579|9136670|P1|Overall Study|Drug overdose|1
2644919|NCT00761579|9136670|P1|Overall Study|Protocol deviation|1
2644920|NCT00761579|9136670|P1|Overall Study|Lack of compliance|2
2644921|NCT00761579|9136670|P1|Overall Study|Withdrawal by Subject|34
2644922|NCT00761579|9136670|P1|Overall Study|Pregnancy|1
2644923|NCT00761579|9136670|P1|Overall Study|Lost to Follow-up|16
2644924|NCT00761579|9136670|P1|Overall Study|Lack of Efficacy|21
2644925|NCT00761579|9136670|P1|Overall Study|Death|2
2644926|NCT00761579|9136670|P1|Overall Study|Adverse Event|10
2644927|NCT00761527|9136703|P1|Overall Study|Unknown reason|2
2644928|NCT00761527|9136703|P1|Overall Study|Lost to Follow-up|9
2644929|NCT00761527|9136703|P1|Overall Study|Poor Compliance|8
2644930|NCT00761527|9136703|P1|Overall Study|Adverse Event|3
2644931|NCT00761514|9136710|P1|Overall Study|Unable to pay for medications|1
2644932|NCT00761514|9136710|P1|Overall Study|Problem complying with study visit|1
2644933|NCT00761514|9136710|P1|Overall Study|Health insurance didn't cover study drug|1
2644934|NCT00761514|9136710|P1|Overall Study|Lost to Follow-up|1
2644935|NCT00761514|9136710|P1|Overall Study|Withdrawal by Subject|2
2644936|NCT00761514|9136710|P1|Overall Study|Adverse Event|1
2644937|NCT00761462|9136717|P2|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21
2644938|NCT00761462|9136718|P1|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75
2644939|NCT00761462|9136717|P2|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30
2644940|NCT00761462|9136718|P1|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75
2644941|NCT00761462|9136717|P2|2 or 5 Years Long-term Safety Follow-up|Death|0
2644942|NCT00761462|9136718|P1|2 or 5 Years Long-term Safety Follow-up|Death|4
2644943|NCT00761462|9136717|P2|Treatment|Subjects never received study medication|12
2644944|NCT00761462|9136718|P1|Treatment|Subjects never received study medication|23
2644945|NCT00761319|9136732|P2|Overall Study|Missing|0
2644946|NCT00761319|9136733|P1|Overall Study|Missing|1
2644947|NCT00761319|9136732|P2|Overall Study|Nonspecified|2
2644948|NCT00761319|9136733|P1|Overall Study|Nonspecified|2
2644949|NCT00761319|9136732|P2|Overall Study|Lost to Follow-up|1
2644950|NCT00761319|9136733|P1|Overall Study|Lost to Follow-up|1
2644951|NCT00761319|9136732|P2|Overall Study|Noncompliance|3
2644952|NCT00761319|9136733|P1|Overall Study|Noncompliance|4
2644953|NCT00761319|9136732|P2|Overall Study|Withdrawal by Subject|7
2644954|NCT00761319|9136733|P1|Overall Study|Withdrawal by Subject|8
2644955|NCT00761319|9136732|P2|Overall Study|Adverse Event|7
2644956|NCT00761319|9136733|P1|Overall Study|Adverse Event|11
2644957|NCT00761319|9136732|P2|Overall Study|Protocol Violation|14
2644958|NCT00761319|9136733|P1|Overall Study|Protocol Violation|21
2644959|NCT00761306|9136741|P1|Overall Study|Administrative or Other Reasons|5
2644960|NCT00761306|9136741|P1|Overall Study|Lost to Follow-up|1
2644961|NCT00761306|9136741|P1|Overall Study|Withdrawal of Consent|3
2644962|NCT00761306|9136741|P1|Overall Study|Protocol Violation|2
2644963|NCT00761306|9136741|P1|Overall Study|Lack of Efficacy|4
2644964|NCT00761306|9136741|P1|Overall Study|Adverse Event|5
2644965|NCT00761280|9136752|P2|First Dose to End of Study|Lost to Follow-up|1
2644966|NCT00761280|9136753|P1|First Dose to End of Study|Lost to Follow-up|0
2644967|NCT00761280|9136752|P2|First Dose to End of Study|Death|0
2644968|NCT00761280|9136753|P1|First Dose to End of Study|Death|1
2644969|NCT00761280|9136752|P2|First Dose to End of Study|Sponsor decision|2
2644970|NCT00761280|9136753|P1|First Dose to End of Study|Sponsor decision|1
2644971|NCT00761280|9136752|P2|First Dose to End of Study|Progressive disease|3
2644972|NCT00761280|9136753|P1|First Dose to End of Study|Progressive disease|5
2644973|NCT00761280|9136752|P2|First Dose to End of Study|End of trial|5
2644974|NCT00761280|9136753|P1|First Dose to End of Study|End of trial|5
2644975|NCT00761280|9136752|P2|Randomization to First Dose|Other|0
2644976|NCT00761280|9136753|P1|Randomization to First Dose|Other|1
2644977|NCT00761280|9136752|P2|Randomization to First Dose|Sponsor decision|0
2644978|NCT00761280|9136753|P1|Randomization to First Dose|Sponsor decision|1
2644979|NCT00761280|9136752|P2|Randomization to First Dose|Withdrawal by Subject|2
2644980|NCT00761280|9136753|P1|Randomization to First Dose|Withdrawal by Subject|0
2644981|NCT00761267|9136784|P3|Overall Study|Withdrawal by Subject|0
2644982|NCT00761267|9136785|P2|Overall Study|Withdrawal by Subject|1
2644983|NCT00761267|9136786|P1|Overall Study|Withdrawal by Subject|0
2644984|NCT00761267|9136784|P3|Overall Study|Randomized but not treated|0
2644985|NCT00761267|9136785|P2|Overall Study|Randomized but not treated|1
2644986|NCT00761267|9136786|P1|Overall Study|Randomized but not treated|1
2644987|NCT00761267|9136784|P3|Overall Study|Lost to Follow-up|1
2644988|NCT00761267|9136785|P2|Overall Study|Lost to Follow-up|0
2644989|NCT00761267|9136786|P1|Overall Study|Lost to Follow-up|0
2644990|NCT00761267|9136784|P3|Overall Study|Death|5
2644991|NCT00761267|9136785|P2|Overall Study|Death|2
2644992|NCT00761267|9136786|P1|Overall Study|Death|1
2644993|NCT00761215|9136837|P3|Overall Study|Bacteremia|0
2644994|NCT00761215|9136838|P2|Overall Study|Bacteremia|0
2644995|NCT00761215|9136839|P1|Overall Study|Bacteremia|1
2644996|NCT00761215|9136837|P3|Overall Study|Withdrawal by Subject|0
2644997|NCT00761215|9136838|P2|Overall Study|Withdrawal by Subject|0
2644998|NCT00761215|9136839|P1|Overall Study|Withdrawal by Subject|1
2644999|NCT00761215|9136837|P3|Overall Study|Lost to Follow-up|6
2645000|NCT00761215|9136838|P2|Overall Study|Lost to Follow-up|3
2645001|NCT00761215|9136839|P1|Overall Study|Lost to Follow-up|6
2645002|NCT00761215|9136837|P3|Overall Study|Randomized but didn't receive drug|2
2645003|NCT00761215|9136838|P2|Overall Study|Randomized but didn't receive drug|1
2645004|NCT00761215|9136839|P1|Overall Study|Randomized but didn't receive drug|1
2645005|NCT00761189|9136881|P1|Overall Study|Other|13
2645006|NCT00761189|9136881|P1|Overall Study|Withdrawal by Subject|49
2645007|NCT00761189|9136881|P1|Overall Study|Lost to Follow-up|36
2645008|NCT00761189|9136881|P1|Overall Study|Lack of Efficacy|45
2645009|NCT00761189|9136881|P1|Overall Study|Adverse Event|42
2645010|NCT00761176|9136898|P2|Overall Study|Withdrawal by Subject|1
2645011|NCT00761176|9136899|P1|Overall Study|Withdrawal by Subject|1
2645012|NCT00761176|9136898|P2|Overall Study|Death|0
2645013|NCT00761176|9136899|P1|Overall Study|Death|1
2645014|NCT00761150|9136908|P3|Double-blind Period|Other|3
2645015|NCT00761150|9136909|P2|Double-blind Period|Other|3
2645016|NCT00761150|9136910|P1|Double-blind Period|Other|0
2645017|NCT00761150|9136908|P3|Double-blind Period|Noncompliance|0
2645018|NCT00761150|9136909|P2|Double-blind Period|Noncompliance|1
2645019|NCT00761150|9136910|P1|Double-blind Period|Noncompliance|0
2645020|NCT00761150|9136908|P3|Double-blind Period|Did not meet DB randomization criteria|1
2645021|NCT00761150|9136909|P2|Double-blind Period|Did not meet DB randomization criteria|0
2645022|NCT00761150|9136910|P1|Double-blind Period|Did not meet DB randomization criteria|0
2645023|NCT00761150|9136908|P3|Double-blind Period|Lost to Follow-up|1
2645024|NCT00761150|9136909|P2|Double-blind Period|Lost to Follow-up|2
2645025|NCT00761150|9136910|P1|Double-blind Period|Lost to Follow-up|0
2645026|NCT00761150|9136908|P3|Double-blind Period|Withdrawal by Subject|2
2645027|NCT00761150|9136909|P2|Double-blind Period|Withdrawal by Subject|3
2645028|NCT00761150|9136910|P1|Double-blind Period|Withdrawal by Subject|0
2645029|NCT00761150|9136908|P3|Double-blind Period|Adverse Event|3
2645030|NCT00761150|9136909|P2|Double-blind Period|Adverse Event|3
2645031|NCT00761150|9136910|P1|Double-blind Period|Adverse Event|0
2645032|NCT00761150|9136908|P3|Double-blind Period|Lack of Efficacy|19
2645033|NCT00761150|9136909|P2|Double-blind Period|Lack of Efficacy|2
2645034|NCT00761150|9136910|P1|Double-blind Period|Lack of Efficacy|0
2645035|NCT00761150|9136908|P3|Open-label Period|Other|0
2645036|NCT00761150|9136909|P2|Open-label Period|Other|0
2645037|NCT00761150|9136910|P1|Open-label Period|Other|5
2645038|NCT00761150|9136908|P3|Open-label Period|Noncompliance|0
2645039|NCT00761150|9136909|P2|Open-label Period|Noncompliance|0
2645040|NCT00761150|9136910|P1|Open-label Period|Noncompliance|2
2645041|NCT00761150|9136908|P3|Open-label Period|Withdrawal by Subject|0
2645042|NCT00761150|9136909|P2|Open-label Period|Withdrawal by Subject|0
2645043|NCT00761150|9136910|P1|Open-label Period|Withdrawal by Subject|5
2645044|NCT00761150|9136908|P3|Open-label Period|Lack of Efficacy|0
2645045|NCT00761150|9136909|P2|Open-label Period|Lack of Efficacy|0
2645046|NCT00761150|9136910|P1|Open-label Period|Lack of Efficacy|4
2645047|NCT00761150|9136908|P3|Open-label Period|Lost to Follow-up|0
2645048|NCT00761150|9136909|P2|Open-label Period|Lost to Follow-up|0
2645049|NCT00761150|9136910|P1|Open-label Period|Lost to Follow-up|7
2645050|NCT00761150|9136908|P3|Open-label Period|Did not meet DB randomization criteria|0
2645051|NCT00761150|9136909|P2|Open-label Period|Did not meet DB randomization criteria|0
2645052|NCT00761150|9136910|P1|Open-label Period|Did not meet DB randomization criteria|11
2645053|NCT00761150|9136908|P3|Open-label Period|Adverse Event|0
2645054|NCT00761150|9136909|P2|Open-label Period|Adverse Event|0
2645055|NCT00761150|9136910|P1|Open-label Period|Adverse Event|36
2645056|NCT00760877|9136982|P2|Overall Study|Treatment failure|0
2645057|NCT00760877|9136983|P1|Overall Study|Treatment failure|1
2645058|NCT00760877|9136982|P2|Overall Study|Participants transferred to AMN107A2408|1
2645059|NCT00760877|9136983|P1|Overall Study|Participants transferred to AMN107A2408|11
2645060|NCT00760877|9136982|P2|Overall Study|Physician Decision|2
2645061|NCT00760877|9136983|P1|Overall Study|Physician Decision|1
2645062|NCT00760877|9136982|P2|Overall Study|Participant not eligible to cross-over|1
2645063|NCT00760877|9136983|P1|Overall Study|Participant not eligible to cross-over|0
2645064|NCT00760877|9136982|P2|Overall Study|Participant diagnosed with AML|1
2645065|NCT00760877|9136983|P1|Overall Study|Participant diagnosed with AML|0
2645066|NCT00760877|9136982|P2|Overall Study|Adverse Event|12
2645067|NCT00760877|9136983|P1|Overall Study|Adverse Event|19
2645068|NCT00760877|9136982|P2|Overall Study|Withdrawal by Subject|3
2645069|NCT00760877|9136983|P1|Overall Study|Withdrawal by Subject|7
2645070|NCT00760877|9136982|P2|Overall Study|Death|1
2645071|NCT00760877|9136983|P1|Overall Study|Death|2
2645072|NCT00760877|9136982|P2|Overall Study|Pregnancy|4
2645073|NCT00760877|9136983|P1|Overall Study|Pregnancy|1
2645074|NCT00760877|9136982|P2|Overall Study|Non-compliance with protocol treatment|1
2645075|NCT00760877|9136983|P1|Overall Study|Non-compliance with protocol treatment|2
2645076|NCT00760877|9136982|P2|Overall Study|Protocol Violation|0
2645077|NCT00760877|9136983|P1|Overall Study|Protocol Violation|1
2645078|NCT00760838|9137001|P2|Overall Study|Withdrawal by Subject|1
2645079|NCT00760838|9137002|P1|Overall Study|Withdrawal by Subject|1
2645080|NCT00760838|9137001|P2|Overall Study|Lost to Follow-up|0
2645081|NCT00760838|9137002|P1|Overall Study|Lost to Follow-up|2
2645082|NCT00760838|9137001|P2|Overall Study|Lack of Efficacy|0
2645083|NCT00760838|9137002|P1|Overall Study|Lack of Efficacy|1
2645084|NCT00760838|9137001|P2|Overall Study|Adverse Event|1
2645085|NCT00760838|9137002|P1|Overall Study|Adverse Event|1
2645086|NCT00760747|9137020|P2|Study Period III|Physician Decision|1
2645087|NCT00760747|9137021|P1|Study Period III|Physician Decision|0
2645088|NCT00760747|9137020|P2|Study Period III|Protocol Violation|1
2645089|NCT00760747|9137021|P1|Study Period III|Protocol Violation|1
2645090|NCT00760747|9137020|P2|Study Period III|Parent/Caregiver Decision|1
2645091|NCT00760747|9137021|P1|Study Period III|Parent/Caregiver Decision|0
2645092|NCT00760747|9137020|P2|Study Period III|Lack of Efficacy|0
2645093|NCT00760747|9137021|P1|Study Period III|Lack of Efficacy|1
2645094|NCT00760747|9137020|P2|Study Period III|Adverse Event|0
2645095|NCT00760747|9137021|P1|Study Period III|Adverse Event|1
2645096|NCT00760747|9137020|P2|Study Period II|No drug administered|1
2645097|NCT00760747|9137021|P1|Study Period II|No drug administered|0
2645098|NCT00760747|9137020|P2|Study Period II|Withdrawal by Subject|0
2645099|NCT00760747|9137021|P1|Study Period II|Withdrawal by Subject|1
2645100|NCT00760747|9137020|P2|Study Period II|Protocol Violation|3
2645101|NCT00760747|9137021|P1|Study Period II|Protocol Violation|6
2645102|NCT00760747|9137020|P2|Study Period II|Parent/Caregiver Decision|0
2645103|NCT00760747|9137021|P1|Study Period II|Parent/Caregiver Decision|3
2645104|NCT00760747|9137020|P2|Study Period II|Lack of Efficacy|6
2645105|NCT00760747|9137021|P1|Study Period II|Lack of Efficacy|0
2645106|NCT00760747|9137020|P2|Study Period II|Adverse Event|4
2645107|NCT00760747|9137021|P1|Study Period II|Adverse Event|3
2645108|NCT00760669|9137049|P1|Overall Study|Took drug before entering in contract|5
2645109|NCT00760669|9137049|P1|Overall Study|Participants with overlapping cases|1
2645110|NCT00760669|9137049|P1|Overall Study|Participants missing efficacy assessment|6
2645111|NCT00760669|9137049|P1|Overall Study|Not assessed for overall improvement|18
2645112|NCT00760617|9137066|P3|Overall Study|Lost to Follow-up|5
2645113|NCT00760617|9137067|P2|Overall Study|Lost to Follow-up|0
2645114|NCT00760617|9137068|P1|Overall Study|Lost to Follow-up|0
2645115|NCT00760617|9137066|P3|Overall Study|Adverse Event|0
2645116|NCT00760617|9137067|P2|Overall Study|Adverse Event|2
2645117|NCT00760617|9137068|P1|Overall Study|Adverse Event|5
2645118|NCT00760552|9137182|P2|Overall Study|Lost to Follow-up|10
2645119|NCT00760552|9137183|P1|Overall Study|Lost to Follow-up|11
2645120|NCT00760552|9137182|P2|Overall Study|Death|0
2645121|NCT00760552|9137183|P1|Overall Study|Death|2
2645122|NCT00760513|9137219|P2|Overall Study|Withdrawal by Subject|7
2645123|NCT00760513|9137220|P1|Overall Study|Withdrawal by Subject|5
2645124|NCT00760487|9137230|P1|Overall Study|Unilateral implantation|3
2645125|NCT00760474|9137236|P2|Period 2 (P2)|Adverse Event|1
2645126|NCT00760474|9137237|P1|Period 2 (P2)|Adverse Event|0
2645127|NCT00760474|9137236|P2|Period 2 (P2)|Lost to Follow-up|0
2645128|NCT00760474|9137237|P1|Period 2 (P2)|Lost to Follow-up|1
2645129|NCT00760474|9137236|P2|Placebo Washout Period|Other|1
2645130|NCT00760474|9137237|P1|Placebo Washout Period|Other|0
2645131|NCT00760474|9137236|P2|Period 1 (P1)|Discontinued then re-entered|1
2645132|NCT00760474|9137237|P1|Period 1 (P1)|Discontinued then re-entered|1
2645133|NCT00760383|9137294|P2|Overall Study|moved away; withdrew; medical reasons|7
2645134|NCT00760383|9137295|P1|Overall Study|moved away; withdrew; medical reasons|5
2645135|NCT00760266|9137307|P2|Overall Study|Administrative Problems|1
2645136|NCT00760266|9137308|P1|Overall Study|Administrative Problems|0
2645137|NCT00760266|9137307|P2|Overall Study|Lost to Follow-up|1
2645138|NCT00760266|9137308|P1|Overall Study|Lost to Follow-up|2
2645139|NCT00760266|9137307|P2|Overall Study|Patient withdrew consent|3
2645140|NCT00760266|9137308|P1|Overall Study|Patient withdrew consent|3
2645141|NCT00760266|9137307|P2|Overall Study|Protocol deviation|4
2645142|NCT00760266|9137308|P1|Overall Study|Protocol deviation|2
2645143|NCT00760266|9137307|P2|Overall Study|Lack of Efficacy|2
2645144|NCT00760266|9137308|P1|Overall Study|Lack of Efficacy|2
2645145|NCT00760266|9137307|P2|Overall Study|Abnormal test procedure result(s)|0
2645146|NCT00760266|9137308|P1|Overall Study|Abnormal test procedure result(s)|1
2645147|NCT00760266|9137307|P2|Overall Study|Abnormal laboratory value(s)|0
2645148|NCT00760266|9137308|P1|Overall Study|Abnormal laboratory value(s)|1
2645149|NCT00760266|9137307|P2|Overall Study|Adverse Event|7
2645150|NCT00760266|9137308|P1|Overall Study|Adverse Event|13
2645151|NCT00760214|9137325|P3|Overall Study|Other|6
2645152|NCT00760214|9137326|P2|Overall Study|Other|4
2645153|NCT00760214|9137327|P1|Overall Study|Other|3
2645154|NCT00760214|9137325|P3|Overall Study|Physician Decision|1
2645155|NCT00760214|9137326|P2|Overall Study|Physician Decision|1
2645156|NCT00760214|9137327|P1|Overall Study|Physician Decision|1
2645157|NCT00760214|9137325|P3|Overall Study|Pregnancy|1
2645158|NCT00760214|9137326|P2|Overall Study|Pregnancy|0
2645159|NCT00760214|9137327|P1|Overall Study|Pregnancy|0
2645160|NCT00760214|9137325|P3|Overall Study|Lack of Efficacy|4
2645161|NCT00760214|9137326|P2|Overall Study|Lack of Efficacy|2
2645162|NCT00760214|9137327|P1|Overall Study|Lack of Efficacy|3
2645163|NCT00760214|9137325|P3|Overall Study|Withdrawal by Subject|13
2645164|NCT00760214|9137326|P2|Overall Study|Withdrawal by Subject|14
2645165|NCT00760214|9137327|P1|Overall Study|Withdrawal by Subject|12
2645166|NCT00760214|9137325|P3|Overall Study|Lost to Follow-up|1
2645167|NCT00760214|9137326|P2|Overall Study|Lost to Follow-up|0
2645168|NCT00760214|9137327|P1|Overall Study|Lost to Follow-up|0
2645169|NCT00760214|9137325|P3|Overall Study|Protocol Violation|3
2645170|NCT00760214|9137326|P2|Overall Study|Protocol Violation|0
2645171|NCT00760214|9137327|P1|Overall Study|Protocol Violation|3
2645172|NCT00760214|9137325|P3|Overall Study|Adverse Event|12
2645173|NCT00760214|9137326|P2|Overall Study|Adverse Event|9
2645174|NCT00760214|9137327|P1|Overall Study|Adverse Event|8
2645175|NCT00760084|9137368|P1|Overall Study|Progressive Disease|3
2645176|NCT00760084|9137368|P1|Overall Study|Withdrawal by Subject|2
2645177|NCT00760084|9137368|P1|Overall Study|Physician Decision|5
2645178|NCT00759954|9137411|P2|Overall Study|Adverse Event|2
2645179|NCT00759954|9137412|P1|Overall Study|Adverse Event|1
2645180|NCT00759954|9137411|P2|Overall Study|Personal reason|0
2645181|NCT00759954|9137412|P1|Overall Study|Personal reason|1
2645182|NCT00759941|9137426|P2|Overall Study|Exited in error by site|1
2645183|NCT00759941|9137427|P1|Overall Study|Exited in error by site|1
2645184|NCT00759941|9137426|P2|Overall Study|Adverse Event|0
2645185|NCT00759941|9137427|P1|Overall Study|Adverse Event|1
2645186|NCT00759941|9137426|P2|Overall Study|Use of medication|0
2645187|NCT00759941|9137427|P1|Overall Study|Use of medication|1
2645188|NCT00759915|9137441|P2|Overall Study|Adverse Event|1
2645189|NCT00759915|9137442|P1|Overall Study|Adverse Event|0
2645190|NCT00759915|9137441|P2|Overall Study|Withdrawal by Subject|0
2645191|NCT00759915|9137442|P1|Overall Study|Withdrawal by Subject|1
2645192|NCT00759902|9137456|P2|Overall Study|Adverse Event|1
2645193|NCT00759902|9137457|P1|Overall Study|Adverse Event|0
2645194|NCT00759863|9137471|P2|Overall Study|Death, moved, or lost contact|18
2645195|NCT00759863|9137472|P1|Overall Study|Death, moved, or lost contact|20
2645196|NCT00759785|9137493|P2|Overall Study|Withdrawal by Subject|1
2645197|NCT00759785|9137494|P1|Overall Study|Withdrawal by Subject|0
2645198|NCT00759785|9137493|P2|Overall Study|Physician Decision|1
2645199|NCT00759785|9137494|P1|Overall Study|Physician Decision|0
2645200|NCT00759785|9137493|P2|Overall Study|Protocol Violation|0
2645201|NCT00759785|9137494|P1|Overall Study|Protocol Violation|1
2645202|NCT00759785|9137493|P2|Overall Study|Participant sample lost|1
2645203|NCT00759785|9137494|P1|Overall Study|Participant sample lost|0
2645204|NCT00759785|9137493|P2|Overall Study|Participant sample not evaluable|2
2645205|NCT00759785|9137494|P1|Overall Study|Participant sample not evaluable|11
2645206|NCT00759759|9137517|P2|Overall Study|Withdrawal by Subject|1
2645207|NCT00759759|9137518|P1|Overall Study|Withdrawal by Subject|2
2645208|NCT00759759|9137517|P2|Overall Study|Didn't receive drug in period 2|0
2645209|NCT00759759|9137518|P1|Overall Study|Didn't receive drug in period 2|1
2645210|NCT00759759|9137517|P2|Overall Study|didn't return for period 2|0
2645211|NCT00759759|9137518|P1|Overall Study|didn't return for period 2|1
2645212|NCT00759681|9137536|P2|Overall Study|Lost to Follow-up|5
2645213|NCT00759681|9137537|P1|Overall Study|Lost to Follow-up|8
2645214|NCT00759681|9137536|P2|Overall Study|Death|5
2645215|NCT00759681|9137537|P1|Overall Study|Death|2
2645216|NCT00759655|9137564|P1|Overall Study|Termination of the study by sponsor|1
2645217|NCT00759564|9137592|P5|Washout Period (at Least 14 Days)|Adverse Event|1
2645218|NCT00759564|9137593|P4|Washout Period (at Least 14 Days)|Adverse Event|0
2645219|NCT00759564|9137594|P3|Washout Period (at Least 14 Days)|Adverse Event|0
2645220|NCT00759564|9137595|P2|Washout Period (at Least 14 Days)|Adverse Event|0
2645221|NCT00759564|9137596|P1|Washout Period (at Least 14 Days)|Adverse Event|0
2645222|NCT00759395|9137773|P2|Overall Study|Lack of Efficacy|2
2645223|NCT00759395|9137774|P1|Overall Study|Lack of Efficacy|0
2645224|NCT00759395|9137773|P2|Overall Study|Withdrawal by Subject|0
2645225|NCT00759395|9137774|P1|Overall Study|Withdrawal by Subject|1
2645226|NCT00759395|9137773|P2|Overall Study|Adverse Event|0
2645227|NCT00759395|9137774|P1|Overall Study|Adverse Event|1
2645228|NCT00759356|9137790|P2|Overall Study|Subject was unable to return|0
2645229|NCT00759356|9137791|P1|Overall Study|Subject was unable to return|1
2645230|NCT00759356|9137790|P2|Overall Study|Withdrawal by Subject|2
2645231|NCT00759356|9137791|P1|Overall Study|Withdrawal by Subject|0
2645232|NCT00759356|9137790|P2|Overall Study|Adverse Event|1
2645233|NCT00759356|9137791|P1|Overall Study|Adverse Event|0
2645234|NCT00759174|9137871|P2|Overall Study|Other|2
2645235|NCT00759174|9137872|P1|Overall Study|Other|0
2645236|NCT00759148|9137896|P2|Overall Study|Reason not given|0
2645237|NCT00759148|9137897|P1|Overall Study|Reason not given|1
2645238|NCT00759148|9137896|P2|Overall Study|Treatment Failure|10
2645239|NCT00759148|9137897|P1|Overall Study|Treatment Failure|6
2645240|NCT00759148|9137896|P2|Overall Study|Lost to Follow-up|9
2645241|NCT00759148|9137897|P1|Overall Study|Lost to Follow-up|3
2645242|NCT00759148|9137896|P2|Overall Study|Withdrawal by Subject|7
2645243|NCT00759148|9137897|P1|Overall Study|Withdrawal by Subject|3
2645244|NCT00759148|9137896|P2|Overall Study|Adverse Event|6
2645245|NCT00759148|9137897|P1|Overall Study|Adverse Event|1
2645246|NCT00759109|9137907|P2|Overall Study|Lost during study|0
2645247|NCT00759109|9137908|P1|Overall Study|Lost during study|1
2645248|NCT00759109|9137907|P2|Overall Study|Participant had a liver transplant|1
2645249|NCT00759109|9137908|P1|Overall Study|Participant had a liver transplant|0
2645250|NCT00759109|9137907|P2|Overall Study|Participant moved to a different city|1
2645251|NCT00759109|9137908|P1|Overall Study|Participant moved to a different city|0
2645252|NCT00759109|9137907|P2|Overall Study|HCV RNA negative|0
2645253|NCT00759109|9137908|P1|Overall Study|HCV RNA negative|1
2645254|NCT00759109|9137907|P2|Overall Study|Started new therapy|6
2645255|NCT00759109|9137908|P1|Overall Study|Started new therapy|2
2645256|NCT00759109|9137907|P2|Overall Study|Lost to Follow-up|6
2645257|NCT00759109|9137908|P1|Overall Study|Lost to Follow-up|4
2645258|NCT00759109|9137907|P2|Overall Study|Death|3
2645259|NCT00759109|9137908|P1|Overall Study|Death|4
2645260|NCT00759109|9137907|P2|Overall Study|Withdrawal by Subject|5
2645261|NCT00759109|9137908|P1|Overall Study|Withdrawal by Subject|9
2645262|NCT00759109|9137907|P2|Overall Study|Inability to comply|1
2645263|NCT00759109|9137908|P1|Overall Study|Inability to comply|1
2645264|NCT00759109|9137907|P2|Overall Study|Adverse Event|12
2645265|NCT00759109|9137908|P1|Overall Study|Adverse Event|17
2645266|NCT00759031|9137930|P2|First Intervention (1 Day)|Screening failure|0
2645267|NCT00759031|9137931|P1|First Intervention (1 Day)|Screening failure|1
2645268|NCT00759031|9137930|P2|First Intervention (1 Day)|Withdrawal by Subject|1
2645269|NCT00759031|9137931|P1|First Intervention (1 Day)|Withdrawal by Subject|0
2645270|NCT00759031|9137930|P2|First Intervention (1 Day)|Physician Decision|0
2645271|NCT00759031|9137931|P1|First Intervention (1 Day)|Physician Decision|1
2645272|NCT00758771|9137984|P2|Overall Study|Did not meet eligibility criteria|4
2645273|NCT00758771|9137985|P1|Overall Study|Did not meet eligibility criteria|2
2645274|NCT00758771|9137984|P2|Overall Study|Withdrawal by Subject|1
2645275|NCT00758771|9137985|P1|Overall Study|Withdrawal by Subject|1
2645276|NCT00758706|9138043|P2|Overall Study|Adverse Event|4
2645277|NCT00758706|9138044|P1|Overall Study|Adverse Event|4
2645278|NCT00758680|9138080|P10|Overall Study|Withdrawal by Subject|0
2645279|NCT00758680|9138081|P9|Overall Study|Withdrawal by Subject|1
2645280|NCT00758680|9138082|P8|Overall Study|Withdrawal by Subject|0
2645281|NCT00758680|9138083|P7|Overall Study|Withdrawal by Subject|1
2645282|NCT00758680|9138084|P6|Overall Study|Withdrawal by Subject|0
2645283|NCT00758680|9138085|P5|Overall Study|Withdrawal by Subject|0
2645284|NCT00758680|9138086|P4|Overall Study|Withdrawal by Subject|0
2645285|NCT00758680|9138087|P3|Overall Study|Withdrawal by Subject|0
2645286|NCT00758680|9138088|P2|Overall Study|Withdrawal by Subject|0
2645287|NCT00758680|9138089|P1|Overall Study|Withdrawal by Subject|0
2645288|NCT00758680|9138080|P10|Overall Study|Laboratory Adverse Event|0
2645289|NCT00758680|9138081|P9|Overall Study|Laboratory Adverse Event|1
2645290|NCT00758680|9138082|P8|Overall Study|Laboratory Adverse Event|0
2645291|NCT00758680|9138083|P7|Overall Study|Laboratory Adverse Event|0
2645292|NCT00758680|9138084|P6|Overall Study|Laboratory Adverse Event|0
2645293|NCT00758680|9138085|P5|Overall Study|Laboratory Adverse Event|0
2645294|NCT00758680|9138086|P4|Overall Study|Laboratory Adverse Event|0
2645295|NCT00758680|9138087|P3|Overall Study|Laboratory Adverse Event|0
2645296|NCT00758680|9138088|P2|Overall Study|Laboratory Adverse Event|0
2645297|NCT00758680|9138089|P1|Overall Study|Laboratory Adverse Event|0
2645298|NCT00758680|9138080|P10|Overall Study|Adverse Event|1
2645299|NCT00758680|9138081|P9|Overall Study|Adverse Event|0
2645300|NCT00758680|9138082|P8|Overall Study|Adverse Event|1
2645301|NCT00758680|9138083|P7|Overall Study|Adverse Event|0
2645302|NCT00758680|9138084|P6|Overall Study|Adverse Event|0
2645303|NCT00758680|9138085|P5|Overall Study|Adverse Event|0
2645304|NCT00758680|9138086|P4|Overall Study|Adverse Event|0
2645305|NCT00758680|9138087|P3|Overall Study|Adverse Event|0
2645306|NCT00758680|9138088|P2|Overall Study|Adverse Event|0
2645307|NCT00758680|9138089|P1|Overall Study|Adverse Event|0
2645308|NCT00758602|9138142|P2|Overall Study|Reason not specified|3
2645309|NCT00758602|9138143|P1|Overall Study|Reason not specified|3
2645310|NCT00758602|9138142|P2|Overall Study|Death|1
2645311|NCT00758602|9138143|P1|Overall Study|Death|0
2645312|NCT00758602|9138142|P2|Overall Study|Protocol Violation|2
2645313|NCT00758602|9138143|P1|Overall Study|Protocol Violation|0
2645314|NCT00758602|9138142|P2|Overall Study|Withdrawal by Subject|3
2645315|NCT00758602|9138143|P1|Overall Study|Withdrawal by Subject|1
2645316|NCT00758602|9138142|P2|Overall Study|Lost to Follow-up|3
2645317|NCT00758602|9138143|P1|Overall Study|Lost to Follow-up|4
2645318|NCT00758602|9138142|P2|Overall Study|Adverse Event|10
2645319|NCT00758602|9138143|P1|Overall Study|Adverse Event|11
2645320|NCT00758589|9138169|P4|Overall Study|Palm stopped to work|1
2645321|NCT00758589|9138170|P3|Overall Study|Palm stopped to work|0
2645322|NCT00758589|9138171|P2|Overall Study|Palm stopped to work|0
2645323|NCT00758589|9138172|P1|Overall Study|Palm stopped to work|0
2645324|NCT00758589|9138169|P4|Overall Study|Withdrawal by Subject|1
2645325|NCT00758589|9138170|P3|Overall Study|Withdrawal by Subject|1
2645326|NCT00758589|9138171|P2|Overall Study|Withdrawal by Subject|1
2645327|NCT00758589|9138172|P1|Overall Study|Withdrawal by Subject|0
2645328|NCT00758589|9138169|P4|Overall Study|Adverse Event|4
2645329|NCT00758589|9138170|P3|Overall Study|Adverse Event|5
2645330|NCT00758589|9138171|P2|Overall Study|Adverse Event|2
2645331|NCT00758589|9138172|P1|Overall Study|Adverse Event|3
2645332|NCT00758498|9138265|P3|Overall Study|Noncompliance to study procedures|1
2645333|NCT00758498|9138266|P2|Overall Study|Noncompliance to study procedures|0
2645334|NCT00758498|9138267|P1|Overall Study|Noncompliance to study procedures|0
2645335|NCT00758498|9138265|P3|Overall Study|Withdrawal by Subject|1
2645336|NCT00758498|9138266|P2|Overall Study|Withdrawal by Subject|0
2645337|NCT00758498|9138267|P1|Overall Study|Withdrawal by Subject|0
2645338|NCT00758498|9138265|P3|Overall Study|Subject legally detained out of state|0
2645339|NCT00758498|9138266|P2|Overall Study|Subject legally detained out of state|0
2645340|NCT00758498|9138267|P1|Overall Study|Subject legally detained out of state|1
2645341|NCT00758498|9138265|P3|Overall Study|Adverse Event|3
2645342|NCT00758498|9138266|P2|Overall Study|Adverse Event|2
2645343|NCT00758498|9138267|P1|Overall Study|Adverse Event|2
2645344|NCT00758485|9138352|P2|Overall Study|Not Treated|2
2645345|NCT00758485|9138353|P1|Overall Study|Not Treated|1
2645346|NCT00758485|9138352|P2|Overall Study|Lost to Follow-up|1
2645347|NCT00758485|9138353|P1|Overall Study|Lost to Follow-up|0
2645348|NCT00758459|9138365|P2|Overall Study|Withdrawal by Subject|1
2645349|NCT00758459|9138366|P1|Overall Study|Withdrawal by Subject|0
2645350|NCT00758459|9138365|P2|Overall Study|Protocol Violation|1
2645351|NCT00758459|9138366|P1|Overall Study|Protocol Violation|0
2645352|NCT00758459|9138365|P2|Overall Study|Adverse Event|2
2645353|NCT00758459|9138366|P1|Overall Study|Adverse Event|3
2645354|NCT00758394|9138411|P4|3rd Intervention|Lost to Follow-up|1
2645355|NCT00758394|9138412|P3|3rd Intervention|Lost to Follow-up|0
2645356|NCT00758394|9138413|P2|3rd Intervention|Lost to Follow-up|0
2645357|NCT00758394|9138414|P1|3rd Intervention|Lost to Follow-up|1
2645358|NCT00758394|9138411|P4|2nd Intervention Order|Lost to Follow-up|0
2645359|NCT00758394|9138412|P3|2nd Intervention Order|Lost to Follow-up|0
2645360|NCT00758394|9138413|P2|2nd Intervention Order|Lost to Follow-up|1
2645361|NCT00758394|9138414|P1|2nd Intervention Order|Lost to Follow-up|0
2645362|NCT00758264|9138443|P3|Active Phase|Other|4
2645363|NCT00758264|9138444|P2|Active Phase|Other|0
2645364|NCT00758264|9138445|P1|Active Phase|Other|0
2645365|NCT00758264|9138443|P3|Active Phase|Lost to Follow-up|0
2645366|NCT00758264|9138444|P2|Active Phase|Lost to Follow-up|0
2645367|NCT00758264|9138445|P1|Active Phase|Lost to Follow-up|1
2645368|NCT00758264|9138443|P3|Active Phase|Withdrawal by Subject|1
2645369|NCT00758264|9138444|P2|Active Phase|Withdrawal by Subject|0
2645370|NCT00758264|9138445|P1|Active Phase|Withdrawal by Subject|0
2645371|NCT00758160|9138504|P1|Overall Study|Withdrawal by Subject|8
2645372|NCT00758160|9138504|P1|Overall Study|Protocol Violation|12
2645373|NCT00758160|9138504|P1|Overall Study|Lost to Follow-up|14
2645374|NCT00758160|9138504|P1|Overall Study|Lack of Efficacy|10
2645375|NCT00758160|9138504|P1|Overall Study|Adverse Event|15
2645376|NCT00758160|9138504|P1|Overall Study|Administration Problems|3
2645377|NCT00758160|9138504|P1|Overall Study|No Longer Requires Study Medication|4
2645378|NCT00758069|9138525|P3|Overall Study|Incorrect Study Drug|0
2645379|NCT00758069|9138526|P2|Overall Study|Incorrect Study Drug|0
2645380|NCT00758069|9138527|P1|Overall Study|Incorrect Study Drug|1
2645381|NCT00758069|9138525|P3|Overall Study|Lack of Efficacy|1
2645382|NCT00758069|9138526|P2|Overall Study|Lack of Efficacy|0
2645383|NCT00758069|9138527|P1|Overall Study|Lack of Efficacy|0
2645384|NCT00758043|9138542|P4|Overall Study|Other Reasons|5
2645385|NCT00758043|9138543|P3|Overall Study|Other Reasons|0
2645386|NCT00758043|9138544|P2|Overall Study|Other Reasons|1
2645387|NCT00758043|9138545|P1|Overall Study|Other Reasons|0
2645388|NCT00758043|9138542|P4|Overall Study|Non-Compliant With study Drug|1
2645389|NCT00758043|9138543|P3|Overall Study|Non-Compliant With study Drug|0
2645390|NCT00758043|9138544|P2|Overall Study|Non-Compliant With study Drug|0
2645391|NCT00758043|9138545|P1|Overall Study|Non-Compliant With study Drug|0
2645392|NCT00758043|9138542|P4|Overall Study|Required Prohibited Medication|3
2645393|NCT00758043|9138543|P3|Overall Study|Required Prohibited Medication|1
2645394|NCT00758043|9138544|P2|Overall Study|Required Prohibited Medication|0
2645395|NCT00758043|9138545|P1|Overall Study|Required Prohibited Medication|0
2645396|NCT00758043|9138542|P4|Overall Study|Withdrawal by Subject|4
2645397|NCT00758043|9138543|P3|Overall Study|Withdrawal by Subject|1
2645398|NCT00758043|9138544|P2|Overall Study|Withdrawal by Subject|1
2645399|NCT00758043|9138545|P1|Overall Study|Withdrawal by Subject|0
2645400|NCT00758043|9138542|P4|Overall Study|Lost to Follow-up|5
2645401|NCT00758043|9138543|P3|Overall Study|Lost to Follow-up|2
2645402|NCT00758043|9138544|P2|Overall Study|Lost to Follow-up|2
2645403|NCT00758043|9138545|P1|Overall Study|Lost to Follow-up|0
2645404|NCT00758043|9138542|P4|Overall Study|Refused Further Treatment|8
2645405|NCT00758043|9138543|P3|Overall Study|Refused Further Treatment|5
2645406|NCT00758043|9138544|P2|Overall Study|Refused Further Treatment|11
2645407|NCT00758043|9138545|P1|Overall Study|Refused Further Treatment|0
2645408|NCT00758043|9138542|P4|Overall Study|Lack of Efficacy|12
2645409|NCT00758043|9138543|P3|Overall Study|Lack of Efficacy|18
2645410|NCT00758043|9138544|P2|Overall Study|Lack of Efficacy|6
2645411|NCT00758043|9138545|P1|Overall Study|Lack of Efficacy|0
2645412|NCT00758043|9138542|P4|Overall Study|Adverse Event|62
2645413|NCT00758043|9138543|P3|Overall Study|Adverse Event|12
2645414|NCT00758043|9138544|P2|Overall Study|Adverse Event|20
2645415|NCT00758043|9138545|P1|Overall Study|Adverse Event|1
2645416|NCT00757848|9138573|P2|Overall Study|Incorrect enrolment|0
2645417|NCT00757848|9138574|P1|Overall Study|Incorrect enrolment|1
2645418|NCT00757848|9138573|P2|Overall Study|Adverse Event|2
2645419|NCT00757848|9138574|P1|Overall Study|Adverse Event|1
2645420|NCT00757848|9138573|P2|Overall Study|Voluntary discontinuation|0
2645421|NCT00757848|9138574|P1|Overall Study|Voluntary discontinuation|1
2645422|NCT00757783|9138643|P2|Overall Study|Other|2
2645423|NCT00757783|9138644|P1|Overall Study|Other|1
2645424|NCT00757783|9138643|P2|Overall Study|Withdrawal by Subject|1
2645425|NCT00757783|9138644|P1|Overall Study|Withdrawal by Subject|2
2645426|NCT00757783|9138643|P2|Overall Study|Protocol Violation|0
2645427|NCT00757783|9138644|P1|Overall Study|Protocol Violation|1
2645428|NCT00757783|9138643|P2|Overall Study|Lost to Follow-up|1
2645429|NCT00757783|9138644|P1|Overall Study|Lost to Follow-up|1
2645430|NCT00757783|9138643|P2|Overall Study|Adverse Event|2
2645431|NCT00757783|9138644|P1|Overall Study|Adverse Event|0
2645432|NCT00757705|9138680|P1|Overall Study|Other|18
2645433|NCT00757705|9138680|P1|Overall Study|Non-compliant|9
2645434|NCT00757705|9138680|P1|Overall Study|Ineligible to continue|8
2645435|NCT00757705|9138680|P1|Overall Study|Insufficient Response|26
2645436|NCT00757705|9138680|P1|Overall Study|Withdrawal by Subject|25
2645437|NCT00757705|9138680|P1|Overall Study|Lost to Follow-up|16
2645438|NCT00757705|9138680|P1|Overall Study|Adverse Event|19
2645439|NCT00757627|9138709|P1|Overall Study|Other|1
2645440|NCT00757627|9138709|P1|Overall Study|Withdrawal by Subject|27
2645441|NCT00757627|9138709|P1|Overall Study|Lost to Follow-up|28
2645442|NCT00757627|9138709|P1|Overall Study|Lack of Efficacy|10
2645443|NCT00757627|9138709|P1|Overall Study|Adverse Event|15
2645444|NCT00757588|9138844|P2|Period 2: Long-term (52-week) Phase|Other|0
2645445|NCT00757588|9138845|P1|Period 2: Long-term (52-week) Phase|Other|1
2645446|NCT00757588|9138844|P2|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4
2645447|NCT00757588|9138845|P1|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5
2645448|NCT00757588|9138844|P2|Period 2: Long-term (52-week) Phase|Pregnancy|0
2645449|NCT00757588|9138845|P1|Period 2: Long-term (52-week) Phase|Pregnancy|1
2645450|NCT00757588|9138844|P2|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2
2645451|NCT00757588|9138845|P1|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5
2645452|NCT00757588|9138844|P2|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
2645453|NCT00757588|9138845|P1|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
2645454|NCT00757588|9138844|P2|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2
2645455|NCT00757588|9138845|P1|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4
2645456|NCT00757588|9138844|P2|Period 2: Long-term (52-week) Phase|Adverse Event|0
2645457|NCT00757588|9138845|P1|Period 2: Long-term (52-week) Phase|Adverse Event|4
2645458|NCT00757588|9138844|P2|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0
2645459|NCT00757588|9138845|P1|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1
2645460|NCT00757588|9138844|P2|Period 1: Short-term (24-week) Phase|Other|1
2645461|NCT00757588|9138845|P1|Period 1: Short-term (24-week) Phase|Other|0
2645462|NCT00757588|9138844|P2|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0
2645463|NCT00757588|9138845|P1|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5
2645464|NCT00757588|9138844|P2|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1
2645465|NCT00757588|9138845|P1|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5
2645466|NCT00757588|9138844|P2|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5
2645467|NCT00757588|9138845|P1|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3
2645468|NCT00757588|9138844|P2|Period 1: Short-term (24-week) Phase|Death|0
2645469|NCT00757588|9138845|P1|Period 1: Short-term (24-week) Phase|Death|1
2645470|NCT00757588|9138844|P2|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5
2645471|NCT00757588|9138845|P1|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13
2645472|NCT00757588|9138844|P2|Period 1: Short-term (24-week) Phase|Adverse Event|3
2645473|NCT00757588|9138845|P1|Period 1: Short-term (24-week) Phase|Adverse Event|6
2645474|NCT00757588|9138844|P2|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2
2645475|NCT00757588|9138845|P1|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3
2645476|NCT00757237|9138886|P2|Overall Study|Other|2
2645477|NCT00757237|9138887|P1|Overall Study|Other|0
2645478|NCT00757237|9138886|P2|Overall Study|Safety or Tolerability|5
2645479|NCT00757237|9138887|P1|Overall Study|Safety or Tolerability|3
2645480|NCT00757237|9138886|P2|Overall Study|Withdrawal by Subject|12
2645481|NCT00757237|9138887|P1|Overall Study|Withdrawal by Subject|8
2645482|NCT00757237|9138886|P2|Overall Study|Physician Decision|3
2645483|NCT00757237|9138887|P1|Overall Study|Physician Decision|2
2645484|NCT00757237|9138886|P2|Overall Study|Protocol Violation|2
2645485|NCT00757237|9138887|P1|Overall Study|Protocol Violation|0
2645486|NCT00757237|9138886|P2|Overall Study|Lost to Follow-up|1
2645487|NCT00757237|9138887|P1|Overall Study|Lost to Follow-up|0
2645488|NCT00757172|9138915|P1|Overall Study|Progression|4
2645489|NCT00757172|9138915|P1|Overall Study|Physician Decision|3
2645490|NCT00757172|9138915|P1|Overall Study|Withdrawal by Subject|4
2645491|NCT00757003|9138923|P1|Overall Study|Not implanted|1
2645492|NCT00757003|9138923|P1|Overall Study|Surgically explanted|2
2645493|NCT00757003|9138923|P1|Overall Study|Withdrawal by Subject|4
2645494|NCT00757003|9138923|P1|Overall Study|Lost to Follow-up|9
2645495|NCT00757003|9138923|P1|Overall Study|Death|33
2645496|NCT00756938|9138970|P4|Optional Extension|Adverse Event|1
2645497|NCT00756938|9138971|P3|Optional Extension|Adverse Event|0
2645498|NCT00756938|9138972|P2|Optional Extension|Adverse Event|0
2645499|NCT00756938|9138973|P1|Optional Extension|Adverse Event|0
2645500|NCT00756938|9138970|P4|Optional Extension|Withdrawal by Subject|10
2645501|NCT00756938|9138971|P3|Optional Extension|Withdrawal by Subject|0
2645502|NCT00756938|9138972|P2|Optional Extension|Withdrawal by Subject|0
2645503|NCT00756938|9138973|P1|Optional Extension|Withdrawal by Subject|0
2645504|NCT00756938|9138970|P4|Optional Extension|Protocol Violation|1
2645505|NCT00756938|9138971|P3|Optional Extension|Protocol Violation|0
2645506|NCT00756938|9138972|P2|Optional Extension|Protocol Violation|0
2645507|NCT00756938|9138973|P1|Optional Extension|Protocol Violation|0
2645508|NCT00756938|9138970|P4|Optional Extension|Lost to Follow-up|1
2645509|NCT00756938|9138971|P3|Optional Extension|Lost to Follow-up|0
2645510|NCT00756938|9138972|P2|Optional Extension|Lost to Follow-up|0
2645511|NCT00756938|9138973|P1|Optional Extension|Lost to Follow-up|0
2645512|NCT00756938|9138970|P4|Optional Extension|Physician Decision|3
2645513|NCT00756938|9138971|P3|Optional Extension|Physician Decision|0
2645514|NCT00756938|9138972|P2|Optional Extension|Physician Decision|0
2645515|NCT00756938|9138973|P1|Optional Extension|Physician Decision|0
2645516|NCT00756938|9138970|P4|Optional Extension|Protocol-specific criteria met|9
2645517|NCT00756938|9138971|P3|Optional Extension|Protocol-specific criteria met|0
2645518|NCT00756938|9138972|P2|Optional Extension|Protocol-specific criteria met|0
2645519|NCT00756938|9138973|P1|Optional Extension|Protocol-specific criteria met|0
2645520|NCT00756938|9138970|P4|Optional Extension|End of Study|11
2645521|NCT00756938|9138971|P3|Optional Extension|End of Study|0
2645522|NCT00756938|9138972|P2|Optional Extension|End of Study|0
2645523|NCT00756938|9138973|P1|Optional Extension|End of Study|0
2645524|NCT00756938|9138970|P4|Optional Extension|Lack of Efficacy|1
2645525|NCT00756938|9138971|P3|Optional Extension|Lack of Efficacy|0
2645526|NCT00756938|9138972|P2|Optional Extension|Lack of Efficacy|0
2645527|NCT00756938|9138973|P1|Optional Extension|Lack of Efficacy|0
2645528|NCT00756938|9138970|P4|12-week Base Study|Lost to Follow-up|0
2645529|NCT00756938|9138971|P3|12-week Base Study|Lost to Follow-up|0
2645530|NCT00756938|9138972|P2|12-week Base Study|Lost to Follow-up|0
2645531|NCT00756938|9138973|P1|12-week Base Study|Lost to Follow-up|1
2645532|NCT00756938|9138970|P4|12-week Base Study|Protocol Violation|0
2645533|NCT00756938|9138971|P3|12-week Base Study|Protocol Violation|1
2645534|NCT00756938|9138972|P2|12-week Base Study|Protocol Violation|0
2645535|NCT00756938|9138973|P1|12-week Base Study|Protocol Violation|0
2645536|NCT00756938|9138970|P4|12-week Base Study|Protocol-specific Criteria Met|0
2645537|NCT00756938|9138971|P3|12-week Base Study|Protocol-specific Criteria Met|1
2645538|NCT00756938|9138972|P2|12-week Base Study|Protocol-specific Criteria Met|0
2645539|NCT00756938|9138973|P1|12-week Base Study|Protocol-specific Criteria Met|1
2645540|NCT00756886|9139001|P2|Overall Study|Ineligible|4
2645541|NCT00756886|9139002|P1|Overall Study|Ineligible|9
2645542|NCT00756886|9139001|P2|Overall Study|Lack of Efficacy|0
2645543|NCT00756886|9139002|P1|Overall Study|Lack of Efficacy|1
2645544|NCT00756886|9139001|P2|Overall Study|Adverse Event|3
2645545|NCT00756886|9139002|P1|Overall Study|Adverse Event|0
2645546|NCT00756886|9139001|P2|Overall Study|Lost to Follow-up|0
2645547|NCT00756886|9139002|P1|Overall Study|Lost to Follow-up|1
2645548|NCT00756730|9139010|P2|Overall Study|persistent low-level viremmia|1
2645549|NCT00756730|9139011|P1|Overall Study|persistent low-level viremmia|0
2645550|NCT00756730|9139010|P2|Overall Study|discontinued due to rash prior to week 4|1
2645551|NCT00756730|9139011|P1|Overall Study|discontinued due to rash prior to week 4|0
2645552|NCT00756717|9139031|P1|Overall Study|Withdrawal by Subject|2
2645553|NCT00756574|9139151|P2|Overall Study|Lost to Follow-up|4
2645554|NCT00756574|9139152|P1|Overall Study|Lost to Follow-up|4
2645555|NCT00756574|9139151|P2|Overall Study|Withdrawal by Subject|7
2645556|NCT00756574|9139152|P1|Overall Study|Withdrawal by Subject|9
2645557|NCT00756470|9139196|P1|Overall Study|Adverse Event|4
2645558|NCT00756470|9139196|P1|Overall Study|Withdrawal by Subject|1
2645559|NCT00756457|9139203|P2|Overall Study|Lost to Follow-up|2
2645560|NCT00756457|9139204|P1|Overall Study|Lost to Follow-up|1
2645561|NCT00756444|9139234|P2|Overall Study|Ineligibility Determined|0
2645562|NCT00756444|9139235|P1|Overall Study|Ineligibility Determined|1
2645563|NCT00756444|9139234|P2|Overall Study|Disease Progression|7
2645564|NCT00756444|9139235|P1|Overall Study|Disease Progression|2
2645565|NCT00756444|9139234|P2|Overall Study|Death|4
2645566|NCT00756444|9139235|P1|Overall Study|Death|5
2645567|NCT00756444|9139234|P2|Overall Study|Lost to Follow-up|1
2645568|NCT00756444|9139235|P1|Overall Study|Lost to Follow-up|0
2645569|NCT00756444|9139234|P2|Overall Study|Withdrawal by Subject|8
2645570|NCT00756444|9139235|P1|Overall Study|Withdrawal by Subject|6
2645571|NCT00756444|9139234|P2|Overall Study|Adverse Event|1
2645572|NCT00756444|9139235|P1|Overall Study|Adverse Event|1
2645573|NCT00756314|9139246|P2|Overall Study|Lost to Follow-up|59
2645574|NCT00756314|9139247|P1|Overall Study|Lost to Follow-up|2
2645575|NCT00756275|9139263|P2|Overall Study|Withdrawal by Subject|7
2645576|NCT00756275|9139264|P1|Overall Study|Withdrawal by Subject|4
2645577|NCT00756275|9139263|P2|Overall Study|Lost to Follow-up|21
2645578|NCT00756275|9139264|P1|Overall Study|Lost to Follow-up|25
2645579|NCT00756002|9139328|P2|Double-Blind Treatment Period|Other|2
2645580|NCT00756002|9139329|P1|Double-Blind Treatment Period|Other|2
2645581|NCT00756002|9139328|P2|Double-Blind Treatment Period|Protocol Violation|5
2645582|NCT00756002|9139329|P1|Double-Blind Treatment Period|Protocol Violation|6
2645583|NCT00756002|9139328|P2|Double-Blind Treatment Period|Withdrawal by Subject|6
2645584|NCT00756002|9139329|P1|Double-Blind Treatment Period|Withdrawal by Subject|6
2645585|NCT00756002|9139328|P2|Double-Blind Treatment Period|Lost to Follow-up|1
2645586|NCT00756002|9139329|P1|Double-Blind Treatment Period|Lost to Follow-up|0
2645587|NCT00756002|9139328|P2|Double-Blind Treatment Period|Lack of Efficacy|1
2645588|NCT00756002|9139329|P1|Double-Blind Treatment Period|Lack of Efficacy|1
2645589|NCT00755937|9139423|P1|Observational Follow-up|Lost to Follow-up|148
2645590|NCT00755937|9139423|P1|Recruitment|Unknown if infliximab received|164
2645591|NCT00755846|9139450|P6|Overall Study|Participant Non-compliance|0
2645592|NCT00755846|9139451|P5|Overall Study|Participant Non-compliance|1
2645593|NCT00755846|9139452|P4|Overall Study|Participant Non-compliance|0
2645594|NCT00755846|9139453|P3|Overall Study|Participant Non-compliance|0
2645595|NCT00755846|9139454|P2|Overall Study|Participant Non-compliance|0
2645596|NCT00755846|9139455|P1|Overall Study|Participant Non-compliance|0
2645597|NCT00755846|9139450|P6|Overall Study|Administrative Error|0
2645598|NCT00755846|9139451|P5|Overall Study|Administrative Error|0
2645599|NCT00755846|9139452|P4|Overall Study|Administrative Error|0
2645600|NCT00755846|9139453|P3|Overall Study|Administrative Error|0
2645601|NCT00755846|9139454|P2|Overall Study|Administrative Error|1
2645602|NCT00755846|9139455|P1|Overall Study|Administrative Error|0
2645603|NCT00755846|9139450|P6|Overall Study|Physician Decision|1
2645604|NCT00755846|9139451|P5|Overall Study|Physician Decision|0
2645605|NCT00755846|9139452|P4|Overall Study|Physician Decision|1
2645606|NCT00755846|9139453|P3|Overall Study|Physician Decision|0
2645607|NCT00755846|9139454|P2|Overall Study|Physician Decision|3
2645608|NCT00755846|9139455|P1|Overall Study|Physician Decision|1
2645609|NCT00755846|9139450|P6|Overall Study|Hyperglycemic Rescue|7
2645610|NCT00755846|9139451|P5|Overall Study|Hyperglycemic Rescue|8
2645611|NCT00755846|9139452|P4|Overall Study|Hyperglycemic Rescue|8
2645612|NCT00755846|9139453|P3|Overall Study|Hyperglycemic Rescue|5
2645613|NCT00755846|9139454|P2|Overall Study|Hyperglycemic Rescue|7
2645614|NCT00755846|9139455|P1|Overall Study|Hyperglycemic Rescue|21
2645615|NCT00755846|9139450|P6|Overall Study|Withdrawal by Subject|1
2645616|NCT00755846|9139451|P5|Overall Study|Withdrawal by Subject|0
2645617|NCT00755846|9139452|P4|Overall Study|Withdrawal by Subject|2
2645618|NCT00755846|9139453|P3|Overall Study|Withdrawal by Subject|5
2645619|NCT00755846|9139454|P2|Overall Study|Withdrawal by Subject|3
2645620|NCT00755846|9139455|P1|Overall Study|Withdrawal by Subject|2
2645621|NCT00755846|9139450|P6|Overall Study|Lost to Follow-up|2
2645622|NCT00755846|9139451|P5|Overall Study|Lost to Follow-up|4
2645623|NCT00755846|9139452|P4|Overall Study|Lost to Follow-up|0
2645624|NCT00755846|9139453|P3|Overall Study|Lost to Follow-up|1
2645625|NCT00755846|9139454|P2|Overall Study|Lost to Follow-up|2
2645626|NCT00755846|9139455|P1|Overall Study|Lost to Follow-up|0
2645627|NCT00755846|9139450|P6|Overall Study|Protocol Violation|1
2645628|NCT00755846|9139451|P5|Overall Study|Protocol Violation|1
2645629|NCT00755846|9139452|P4|Overall Study|Protocol Violation|1
2645630|NCT00755846|9139453|P3|Overall Study|Protocol Violation|1
2645631|NCT00755846|9139454|P2|Overall Study|Protocol Violation|1
2645632|NCT00755846|9139455|P1|Overall Study|Protocol Violation|1
2645633|NCT00755846|9139450|P6|Overall Study|Adverse Event|2
2645634|NCT00755846|9139451|P5|Overall Study|Adverse Event|3
2645635|NCT00755846|9139452|P4|Overall Study|Adverse Event|1
2645636|NCT00755846|9139453|P3|Overall Study|Adverse Event|0
2645637|NCT00755846|9139454|P2|Overall Study|Adverse Event|0
2645638|NCT00755846|9139455|P1|Overall Study|Adverse Event|0
2645639|NCT00755807|9139555|P2|Open-label Extension Phase|Sponsor Decision|1
2645640|NCT00755807|9139556|P1|Open-label Extension Phase|Sponsor Decision|0
2645641|NCT00755807|9139555|P2|Open-label Extension Phase|Lost to Follow-up|0
2645642|NCT00755807|9139556|P1|Open-label Extension Phase|Lost to Follow-up|2
2645643|NCT00755807|9139555|P2|Open-label Extension Phase|Withdrawal by Subject|3
2645644|NCT00755807|9139556|P1|Open-label Extension Phase|Withdrawal by Subject|1
2645645|NCT00755807|9139555|P2|Open-label Extension Phase|Lack of Efficacy|3
2645646|NCT00755807|9139556|P1|Open-label Extension Phase|Lack of Efficacy|3
2645647|NCT00755807|9139555|P2|Open-label Extension Phase|Protocol Violation|2
2645648|NCT00755807|9139556|P1|Open-label Extension Phase|Protocol Violation|5
2645649|NCT00755807|9139555|P2|Open-label Extension Phase|Adverse Event|7
2645650|NCT00755807|9139556|P1|Open-label Extension Phase|Adverse Event|7
2645651|NCT00755807|9139555|P2|Acute Phase|Physician Decision|1
2645652|NCT00755807|9139556|P1|Acute Phase|Physician Decision|0
2645653|NCT00755807|9139555|P2|Acute Phase|Lack of Efficacy|1
2645654|NCT00755807|9139556|P1|Acute Phase|Lack of Efficacy|0
2645655|NCT00755807|9139555|P2|Acute Phase|Withdrawal by Subject|2
2645656|NCT00755807|9139556|P1|Acute Phase|Withdrawal by Subject|1
2645657|NCT00755807|9139555|P2|Acute Phase|Protocol Violation|3
2645658|NCT00755807|9139556|P1|Acute Phase|Protocol Violation|1
2645659|NCT00755807|9139555|P2|Acute Phase|Adverse Event|5
2645660|NCT00755807|9139556|P1|Acute Phase|Adverse Event|16
2645661|NCT00755716|9139636|P3|Overall Study|work schedule issues|1
2645662|NCT00755716|9139637|P2|Overall Study|work schedule issues|1
2645663|NCT00755716|9139638|P1|Overall Study|work schedule issues|0
2645664|NCT00755716|9139636|P3|Overall Study|Lost to Follow-up|1
2645665|NCT00755716|9139637|P2|Overall Study|Lost to Follow-up|3
2645666|NCT00755716|9139638|P1|Overall Study|Lost to Follow-up|5
2645667|NCT00755716|9139636|P3|Overall Study|Lack of Efficacy|0
2645668|NCT00755716|9139637|P2|Overall Study|Lack of Efficacy|0
2645669|NCT00755716|9139638|P1|Overall Study|Lack of Efficacy|2
2645670|NCT00755716|9139636|P3|Overall Study|Adverse Event|1
2645671|NCT00755716|9139637|P2|Overall Study|Adverse Event|4
2645672|NCT00755716|9139638|P1|Overall Study|Adverse Event|1
2645673|NCT00755417|9139652|P3|Overall Study|Not specified or missing data|12
2645674|NCT00755417|9139653|P2|Overall Study|Not specified or missing data|18
2645675|NCT00755417|9139654|P1|Overall Study|Not specified or missing data|9
2645676|NCT00755417|9139652|P3|Overall Study|Withdrawal by Subject|12
2645677|NCT00755417|9139653|P2|Overall Study|Withdrawal by Subject|12
2645678|NCT00755417|9139654|P1|Overall Study|Withdrawal by Subject|12
2645679|NCT00755417|9139652|P3|Overall Study|Lost to Follow-up|1
2645680|NCT00755417|9139653|P2|Overall Study|Lost to Follow-up|0
2645681|NCT00755417|9139654|P1|Overall Study|Lost to Follow-up|3
2645682|NCT00755417|9139652|P3|Overall Study|Protocol Violation|1
2645683|NCT00755417|9139653|P2|Overall Study|Protocol Violation|1
2645684|NCT00755417|9139654|P1|Overall Study|Protocol Violation|2
2645685|NCT00755417|9139652|P3|Overall Study|Lack of Efficacy|9
2645686|NCT00755417|9139653|P2|Overall Study|Lack of Efficacy|4
2645687|NCT00755417|9139654|P1|Overall Study|Lack of Efficacy|8
2645688|NCT00755417|9139652|P3|Overall Study|Adverse Event|7
2645689|NCT00755417|9139653|P2|Overall Study|Adverse Event|20
2645690|NCT00755417|9139654|P1|Overall Study|Adverse Event|28
2645691|NCT00755326|9139673|P2|Overall Study|Lost to Follow-up|3
2645692|NCT00755326|9139674|P1|Overall Study|Lost to Follow-up|2
2645693|NCT00755222|9139724|P2|Overall Study|Protocol Violation|0
2645694|NCT00755222|9139725|P1|Overall Study|Protocol Violation|2
2645695|NCT00755222|9139724|P2|Overall Study|Adverse Event|0
2645696|NCT00755222|9139725|P1|Overall Study|Adverse Event|2
2645697|NCT00755222|9139724|P2|Overall Study|Withdrawal by Subject|2
2645698|NCT00755222|9139725|P1|Overall Study|Withdrawal by Subject|4
2645699|NCT00755196|9139739|P1|Overall Study|Lack of Efficiency|1
2645700|NCT00755196|9139739|P1|Overall Study|Lost to Follow-up|1
2645701|NCT00755105|9139760|P3|Overall Study|Withdrawal by Subject|4
2645702|NCT00755105|9139761|P2|Overall Study|Withdrawal by Subject|11
2645703|NCT00755105|9139762|P1|Overall Study|Withdrawal by Subject|9
2645704|NCT00755079|9139772|P2|Overall Study|Withdrawal by Subject|2
2645705|NCT00755079|9139773|P1|Overall Study|Withdrawal by Subject|0
2645706|NCT00755079|9139772|P2|Overall Study|Adverse Event|1
2645707|NCT00755079|9139773|P1|Overall Study|Adverse Event|0
2645708|NCT00755079|9139772|P2|Overall Study|Lost to Follow-up|3
2645709|NCT00755079|9139773|P1|Overall Study|Lost to Follow-up|1
2645710|NCT00754936|9139792|P1|Overall Study|Inter-current medical events|3
2645711|NCT00754936|9139792|P1|Overall Study|Side Effects|3
2645712|NCT00754936|9139792|P1|Overall Study|Withdrawal by Subject|2
2645713|NCT00754936|9139792|P1|Overall Study|Physician Decision|1
2645714|NCT00754936|9139792|P1|Overall Study|Lost to Follow-up|3
2645715|NCT00754793|9139832|P2|Overall Study|voluntary withdrawn from study|1
2645716|NCT00754793|9139833|P1|Overall Study|voluntary withdrawn from study|0
2645717|NCT00754741|9139851|P3|Overall Study|Died or disenrolled|54
2645718|NCT00754741|9139852|P2|Overall Study|Died or disenrolled|69
2645719|NCT00754741|9139853|P1|Overall Study|Died or disenrolled|57
2645720|NCT00754650|9139900|P1|Overall Study|Disease Progression|2
2645721|NCT00754624|9139905|P1|Overall Study|Lost to Follow-up|3
2645722|NCT00754624|9139905|P1|Overall Study|Various|12
2645723|NCT00754624|9139905|P1|Overall Study|Withdrawal by Subject|28
2645724|NCT00754624|9139905|P1|Overall Study|Protocol Violation|1
2645725|NCT00754624|9139905|P1|Overall Study|Physician Decision|8
2645726|NCT00754624|9139905|P1|Overall Study|Death|1
2645727|NCT00754624|9139905|P1|Overall Study|Adverse Event|16
2645728|NCT00754572|9139915|P1|Overall Study|Lost to Follow-up|1
2645729|NCT00754572|9139915|P1|Overall Study|Administrative Reason|3
2645730|NCT00754572|9139915|P1|Overall Study|Death|1
2645731|NCT00754572|9139915|P1|Overall Study|Lack of Efficacy|2
2645732|NCT00754572|9139915|P1|Overall Study|Withdrawal by Subject|3
2645733|NCT00754572|9139915|P1|Overall Study|Protocol Violation|3
2645734|NCT00754572|9139915|P1|Overall Study|Other|39
2645735|NCT00754572|9139915|P1|Overall Study|Adverse Event|19
2645736|NCT00754559|9139942|P1|Overall Study|Withdrawal by Subject|3
2645737|NCT00754559|9139942|P1|Overall Study|Other|5
2645738|NCT00754559|9139942|P1|Overall Study|Administrative reason|1
2645739|NCT00754559|9139942|P1|Overall Study|Lost to Follow-up|2
2645740|NCT00754559|9139942|P1|Overall Study|Lack of Efficacy|10
2645741|NCT00754559|9139942|P1|Overall Study|Protocol Violation|11
2645742|NCT00754559|9139942|P1|Overall Study|Adverse Event|15
2645743|NCT00754442|9140042|P2|Overall Study|Withdrawal by Subject|3
2645744|NCT00754442|9140043|P1|Overall Study|Withdrawal by Subject|5
2645745|NCT00754390|9140050|P1|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1
2645746|NCT00754390|9140050|P1|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1
2645747|NCT00754390|9140050|P1|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2
2645748|NCT00754390|9140050|P1|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3
2645749|NCT00754338|9140072|P4|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
2645750|NCT00754338|9140073|P3|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
2645751|NCT00754338|9140074|P2|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
2645752|NCT00754338|9140075|P1|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
2645753|NCT00754338|9140072|P4|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
2645754|NCT00754338|9140073|P3|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
2645755|NCT00754338|9140074|P2|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
2645756|NCT00754338|9140075|P1|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
2645757|NCT00754325|9140107|P2|Initial Treatment|Disease Progression|35
2645758|NCT00754325|9140108|P1|Initial Treatment|Disease Progression|35
2645759|NCT00754325|9140107|P2|Initial Treatment|Sponsor Request|1
2645760|NCT00754325|9140108|P1|Initial Treatment|Sponsor Request|0
2645761|NCT00754325|9140107|P2|Initial Treatment|Physician Decision|0
2645762|NCT00754325|9140108|P1|Initial Treatment|Physician Decision|2
2645763|NCT00754325|9140107|P2|Initial Treatment|Withdrawal by Subject|2
2645764|NCT00754325|9140108|P1|Initial Treatment|Withdrawal by Subject|2
2645765|NCT00754325|9140107|P2|Initial Treatment|Adverse Event|6
2645766|NCT00754325|9140108|P1|Initial Treatment|Adverse Event|7
2645767|NCT00754325|9140107|P2|Initial Treatment|Continuing Active Treatment|5
2645768|NCT00754325|9140108|P1|Initial Treatment|Continuing Active Treatment|4
2645769|NCT00754234|9140161|P1|Overall Study|Withdrawal by Subject|3
2645770|NCT00754065|9140247|P2|Overall Study|Reason not specified or unknown, etc.|27
2645771|NCT00754065|9140248|P1|Overall Study|Reason not specified or unknown, etc.|21
2645772|NCT00754065|9140247|P2|Overall Study|Pregnancy|0
2645773|NCT00754065|9140248|P1|Overall Study|Pregnancy|6
2645774|NCT00754065|9140247|P2|Overall Study|Withdrawal by Subject|5
2645775|NCT00754065|9140248|P1|Overall Study|Withdrawal by Subject|4
2645776|NCT00754065|9140247|P2|Overall Study|Protocol Violation|10
2645777|NCT00754065|9140248|P1|Overall Study|Protocol Violation|12
2645778|NCT00754065|9140247|P2|Overall Study|Lost to Follow-up|11
2645779|NCT00754065|9140248|P1|Overall Study|Lost to Follow-up|7
2645780|NCT00754065|9140247|P2|Overall Study|Adverse Event|25
2645781|NCT00754065|9140248|P1|Overall Study|Adverse Event|19
2645782|NCT00754065|9140247|P2|Overall Study|Never received treatment|2
2645783|NCT00754065|9140248|P1|Overall Study|Never received treatment|12
2645784|NCT00754052|9140488|P2|Overall Study|Study terminated by Sponsor|3
2645785|NCT00754052|9140489|P1|Overall Study|Study terminated by Sponsor|5
2645786|NCT00754013|9140503|P2|Overall Study|didn't return after study termed|4
2645787|NCT00754013|9140504|P1|Overall Study|didn't return after study termed|3
2645788|NCT00754013|9140503|P2|Overall Study|Lost to Follow-up|1
2645789|NCT00754013|9140504|P1|Overall Study|Lost to Follow-up|1
2645790|NCT00753922|9140541|P4|Overall Study|Discontinuation Due to Explantation|4
2645791|NCT00753922|9140542|P3|Overall Study|Discontinuation Due to Explantation|14
2645792|NCT00753922|9140543|P2|Overall Study|Discontinuation Due to Explantation|14
2645793|NCT00753922|9140544|P1|Overall Study|Discontinuation Due to Explantation|14
2645794|NCT00753922|9140541|P4|Overall Study|Death|1
2645795|NCT00753922|9140542|P3|Overall Study|Death|2
2645796|NCT00753922|9140543|P2|Overall Study|Death|23
2645797|NCT00753922|9140544|P1|Overall Study|Death|2
2645798|NCT00753922|9140541|P4|Overall Study|Patients Not Completing Visit|0
2645799|NCT00753922|9140542|P3|Overall Study|Patients Not Completing Visit|1
2645800|NCT00753922|9140543|P2|Overall Study|Patients Not Completing Visit|0
2645801|NCT00753922|9140544|P1|Overall Study|Patients Not Completing Visit|11
2645802|NCT00753922|9140541|P4|Overall Study|Patient Non-compliance|11
2645803|NCT00753922|9140542|P3|Overall Study|Patient Non-compliance|14
2645804|NCT00753922|9140543|P2|Overall Study|Patient Non-compliance|22
2645805|NCT00753922|9140544|P1|Overall Study|Patient Non-compliance|55
2645806|NCT00753922|9140541|P4|Overall Study|Withdrawal by Subject|2
2645807|NCT00753922|9140542|P3|Overall Study|Withdrawal by Subject|4
2645808|NCT00753922|9140543|P2|Overall Study|Withdrawal by Subject|11
2645809|NCT00753922|9140544|P1|Overall Study|Withdrawal by Subject|9
2645810|NCT00753922|9140541|P4|Overall Study|Lost to Follow-up|5
2645811|NCT00753922|9140542|P3|Overall Study|Lost to Follow-up|28
2645812|NCT00753922|9140543|P2|Overall Study|Lost to Follow-up|24
2645813|NCT00753922|9140544|P1|Overall Study|Lost to Follow-up|155
2645814|NCT00753896|9140574|P1|Overall Study|Entry Criteria Not Met|4
2645815|NCT00753896|9140574|P1|Overall Study|Withdrawal by Subject|4
2645816|NCT00753896|9140574|P1|Overall Study|Protocol Violation|1
2645817|NCT00753896|9140574|P1|Overall Study|Lost to Follow-up|2
2645818|NCT00753896|9140574|P1|Overall Study|Death|1
2645819|NCT00753896|9140574|P1|Overall Study|Adverse Event|4
2645820|NCT00753766|9140590|P2|Overall Study|Physician Decision|0
2645821|NCT00753766|9140591|P1|Overall Study|Physician Decision|1
2645822|NCT00753714|9140613|P2|Overall Study|Other|5
2645823|NCT00753714|9140614|P1|Overall Study|Other|7
2645824|NCT00753714|9140613|P2|Overall Study|Death|3
2645825|NCT00753714|9140614|P1|Overall Study|Death|3
2645826|NCT00753714|9140613|P2|Overall Study|Withdrawal by Subject|1
2645827|NCT00753714|9140614|P1|Overall Study|Withdrawal by Subject|2
2645828|NCT00753714|9140613|P2|Overall Study|Lost to Follow-up|1
2645829|NCT00753714|9140614|P1|Overall Study|Lost to Follow-up|0
2645830|NCT00753714|9140613|P2|Overall Study|Protocol Violation|0
2645831|NCT00753714|9140614|P1|Overall Study|Protocol Violation|1
2645832|NCT00753714|9140613|P2|Overall Study|Adverse Event|18
2645833|NCT00753714|9140614|P1|Overall Study|Adverse Event|26
2645834|NCT00753714|9140613|P2|Overall Study|Lack of Efficacy|34
2645835|NCT00753714|9140614|P1|Overall Study|Lack of Efficacy|21
2645836|NCT00753688|9140630|P2|Overall Study|Adverse Event|1
2645837|NCT00753688|9140631|P1|Overall Study|Adverse Event|0
2645838|NCT00753688|9140630|P2|Overall Study|Ongoing - in Follow-up|31
2645839|NCT00753688|9140631|P1|Overall Study|Ongoing - in Follow-up|15
2645840|NCT00753688|9140630|P2|Overall Study|Participant Withdrew Consent|2
2645841|NCT00753688|9140631|P1|Overall Study|Participant Withdrew Consent|2
2645842|NCT00753688|9140630|P2|Overall Study|Missing|9
2645843|NCT00753688|9140631|P1|Overall Study|Missing|4
2645844|NCT00753688|9140630|P2|Overall Study|Death|203
2645845|NCT00753688|9140631|P1|Overall Study|Death|102
2645846|NCT00753675|9140660|P3|Overall Study|Lost to Follow-up|0
2645847|NCT00753675|9140661|P2|Overall Study|Lost to Follow-up|0
2645848|NCT00753675|9140662|P1|Overall Study|Lost to Follow-up|1
2645849|NCT00753675|9140660|P3|Overall Study|Withdrawal by Subject|0
2645850|NCT00753675|9140661|P2|Overall Study|Withdrawal by Subject|1
2645851|NCT00753675|9140662|P1|Overall Study|Withdrawal by Subject|0
2645852|NCT00753675|9140660|P3|Overall Study|Objective progression of disease|35
2645853|NCT00753675|9140661|P2|Overall Study|Objective progression of disease|35
2645854|NCT00753675|9140662|P1|Overall Study|Objective progression of disease|35
2645855|NCT00753675|9140660|P3|Overall Study|Adverse Event|4
2645856|NCT00753675|9140661|P2|Overall Study|Adverse Event|9
2645857|NCT00753675|9140662|P1|Overall Study|Adverse Event|11
2645858|NCT00753675|9140660|P3|Overall Study|Death|4
2645859|NCT00753675|9140661|P2|Overall Study|Death|2
2645860|NCT00753675|9140662|P1|Overall Study|Death|1
2645861|NCT00753675|9140660|P3|Overall Study|other reason|13
2645862|NCT00753675|9140661|P2|Overall Study|other reason|12
2645863|NCT00753675|9140662|P1|Overall Study|other reason|11
2645864|NCT00753649|9140684|P2|Overall Study|Protocol Violation|0
2645865|NCT00753649|9140685|P1|Overall Study|Protocol Violation|2
2645866|NCT00753649|9140684|P2|Overall Study|Lost to follow-up-complete vaccination|0
2645867|NCT00753649|9140685|P1|Overall Study|Lost to follow-up-complete vaccination|1
2645868|NCT00753649|9140684|P2|Overall Study|Lost to follow-up-incomplete vaccination|0
2645869|NCT00753649|9140685|P1|Overall Study|Lost to follow-up-incomplete vaccination|3
2645870|NCT00753649|9140684|P2|Overall Study|Migrated/moved from study area|0
2645871|NCT00753649|9140685|P1|Overall Study|Migrated/moved from study area|1
2645872|NCT00753623|9140717|P2|Phase II (14 Days)|Physician Decision|1
2645873|NCT00753623|9140718|P1|Phase II (14 Days)|Physician Decision|0
2645874|NCT00753623|9140717|P2|Washout (7 Days)|Physician Decision|0
2645875|NCT00753623|9140718|P1|Washout (7 Days)|Physician Decision|1
2645876|NCT00753623|9140717|P2|Phase I (14 Days)|Adverse Event|1
2645877|NCT00753623|9140718|P1|Phase I (14 Days)|Adverse Event|0
2645878|NCT00753623|9140717|P2|Phase I (14 Days)|Physician Decision|2
2645879|NCT00753623|9140718|P1|Phase I (14 Days)|Physician Decision|1
2645880|NCT00753623|9140717|P2|Phase I (14 Days)|Withdrawal by Subject|1
2645881|NCT00753623|9140718|P1|Phase I (14 Days)|Withdrawal by Subject|1
2645882|NCT00753545|9140726|P2|Overall Study|Voluntary Discontinuation of Patient|3
2645883|NCT00753545|9140727|P1|Overall Study|Voluntary Discontinuation of Patient|7
2645884|NCT00753545|9140726|P2|Overall Study|Protocol Violation|0
2645885|NCT00753545|9140727|P1|Overall Study|Protocol Violation|1
2645886|NCT00753545|9140726|P2|Overall Study|Lost to Follow-up|3
2645887|NCT00753545|9140727|P1|Overall Study|Lost to Follow-up|2
2645888|NCT00753545|9140726|P2|Overall Study|Death|112
2645889|NCT00753545|9140727|P1|Overall Study|Death|98
2645890|NCT00753519|9140765|P2|Overall Study|Withdrawal by Subject|2
2645891|NCT00753519|9140766|P1|Overall Study|Withdrawal by Subject|0
2645892|NCT00753506|9140788|P2|Overall Study|Other reason|1
2645893|NCT00753506|9140789|P1|Overall Study|Other reason|1
2645894|NCT00753506|9140788|P2|Overall Study|Lost to Follow-up|0
2645895|NCT00753506|9140789|P1|Overall Study|Lost to Follow-up|2
2645896|NCT00753506|9140788|P2|Overall Study|Withdrawal by Subject|1
2645897|NCT00753506|9140789|P1|Overall Study|Withdrawal by Subject|4
2645898|NCT00753454|9140795|P1|Overall Study|Investigator Decision|1
2645899|NCT00753454|9140795|P1|Overall Study|Withdrawal by Subject|5
2645900|NCT00753454|9140795|P1|Overall Study|Lost to Follow-up|3
2645901|NCT00753454|9140795|P1|Overall Study|Lack of Efficacy|1
2645902|NCT00753454|9140795|P1|Overall Study|Adverse Event|4
2645903|NCT00753415|9140829|P10|Part B|Disease progression|1
2645904|NCT00753415|9140830|P9|Part B|Disease progression|2
2645905|NCT00753415|9140831|P8|Part B|Disease progression|0
2645906|NCT00753415|9140832|P7|Part B|Disease progression|0
2645907|NCT00753415|9140833|P6|Part B|Disease progression|0
2645908|NCT00753415|9140834|P5|Part B|Disease progression|0
2645909|NCT00753415|9140835|P4|Part B|Disease progression|0
2645910|NCT00753415|9140836|P3|Part B|Disease progression|0
2645911|NCT00753415|9140837|P2|Part B|Disease progression|0
2645912|NCT00753415|9140838|P1|Part B|Disease progression|0
2645913|NCT00753415|9140829|P10|Part B|Lost to Follow-up|0
2645914|NCT00753415|9140830|P9|Part B|Lost to Follow-up|1
2645915|NCT00753415|9140831|P8|Part B|Lost to Follow-up|1
2645916|NCT00753415|9140832|P7|Part B|Lost to Follow-up|0
2645917|NCT00753415|9140833|P6|Part B|Lost to Follow-up|0
2645918|NCT00753415|9140834|P5|Part B|Lost to Follow-up|0
2645919|NCT00753415|9140835|P4|Part B|Lost to Follow-up|0
2645920|NCT00753415|9140836|P3|Part B|Lost to Follow-up|0
2645921|NCT00753415|9140837|P2|Part B|Lost to Follow-up|0
2645922|NCT00753415|9140838|P1|Part B|Lost to Follow-up|0
2645923|NCT00753415|9140829|P10|Part A|Withdrawal by Subject|0
2645924|NCT00753415|9140830|P9|Part A|Withdrawal by Subject|0
2645925|NCT00753415|9140831|P8|Part A|Withdrawal by Subject|0
2645926|NCT00753415|9140832|P7|Part A|Withdrawal by Subject|0
2645927|NCT00753415|9140833|P6|Part A|Withdrawal by Subject|0
2645928|NCT00753415|9140834|P5|Part A|Withdrawal by Subject|0
2645929|NCT00753415|9140835|P4|Part A|Withdrawal by Subject|0
2645930|NCT00753415|9140836|P3|Part A|Withdrawal by Subject|1
2645931|NCT00753415|9140837|P2|Part A|Withdrawal by Subject|0
2645932|NCT00753415|9140838|P1|Part A|Withdrawal by Subject|0
2645933|NCT00753415|9140829|P10|Part A|Disease progression|0
2645934|NCT00753415|9140830|P9|Part A|Disease progression|0
2645935|NCT00753415|9140831|P8|Part A|Disease progression|0
2645936|NCT00753415|9140832|P7|Part A|Disease progression|0
2645937|NCT00753415|9140833|P6|Part A|Disease progression|0
2645938|NCT00753415|9140834|P5|Part A|Disease progression|0
2645939|NCT00753415|9140835|P4|Part A|Disease progression|2
2645940|NCT00753415|9140836|P3|Part A|Disease progression|1
2645941|NCT00753415|9140837|P2|Part A|Disease progression|0
2645942|NCT00753415|9140838|P1|Part A|Disease progression|1
2645943|NCT00753272|9140928|P2|Overall Study|Other|1088
2645944|NCT00753272|9140929|P1|Overall Study|Other|1104
2645945|NCT00753272|9140928|P2|Overall Study|Lost to Follow-up|497
2645946|NCT00753272|9140929|P1|Overall Study|Lost to Follow-up|491
2645947|NCT00753272|9140928|P2|Overall Study|Withdrawal by Subject|2407
2645948|NCT00753272|9140929|P1|Overall Study|Withdrawal by Subject|2481
2645949|NCT00753272|9140928|P2|Overall Study|Protocol Violation|46
2645950|NCT00753272|9140929|P1|Overall Study|Protocol Violation|28
2645951|NCT00753272|9140928|P2|Overall Study|Adverse Event|869
2645952|NCT00753272|9140929|P1|Overall Study|Adverse Event|878
2645953|NCT00753012|9141013|P2|Overall Study|Confounded endpoint data|0
2645954|NCT00753012|9141014|P1|Overall Study|Confounded endpoint data|1
2645955|NCT00753012|9141013|P2|Overall Study|Lost to Follow-up|0
2645956|NCT00753012|9141014|P1|Overall Study|Lost to Follow-up|4
2645957|NCT00753012|9141013|P2|Overall Study|Withdrawal by Subject|1
2645958|NCT00753012|9141014|P1|Overall Study|Withdrawal by Subject|0
2645959|NCT00753012|9141013|P2|Overall Study|Adverse Event|0
2645960|NCT00753012|9141014|P1|Overall Study|Adverse Event|2
2645961|NCT00753012|9141013|P2|Overall Study|Ineligible, abnormal cardiac histo|0
2645962|NCT00753012|9141014|P1|Overall Study|Ineligible, abnormal cardiac histo|1
2645963|NCT00752986|9141027|P3|Overall Study|Protocol Violation|0
2645964|NCT00752986|9141028|P2|Overall Study|Protocol Violation|0
2645965|NCT00752986|9141029|P1|Overall Study|Protocol Violation|3
2645966|NCT00752986|9141027|P3|Overall Study|Withdrawal by Subject|2
2645967|NCT00752986|9141028|P2|Overall Study|Withdrawal by Subject|1
2645968|NCT00752986|9141029|P1|Overall Study|Withdrawal by Subject|2
2645969|NCT00752895|9141069|P2|Overall Study|Withdrawal by Subject|3
2645970|NCT00752895|9141070|P1|Overall Study|Withdrawal by Subject|8
2645971|NCT00752791|9141078|P1|Overall Study|Protocol deviation|1
2645972|NCT00752791|9141078|P1|Overall Study|Switched to hemodialysis|2
2645973|NCT00752791|9141078|P1|Overall Study|Renal transplant|3
2645974|NCT00752791|9141078|P1|Overall Study|Death|1
2645975|NCT00752791|9141078|P1|Overall Study|Physician Decision|1
2645976|NCT00752791|9141078|P1|Overall Study|Withdrawal by Subject|1
2645977|NCT00752791|9141078|P1|Overall Study|Adverse Event|7
2645978|NCT00752726|9141090|P2|Overall Study|Other Reason|2
2645979|NCT00752726|9141091|P1|Overall Study|Other Reason|1
2645980|NCT00752726|9141090|P2|Overall Study|Withdrawal by Subject|10
2645981|NCT00752726|9141091|P1|Overall Study|Withdrawal by Subject|5
2645982|NCT00752726|9141090|P2|Overall Study|Adverse Event|0
2645983|NCT00752726|9141091|P1|Overall Study|Adverse Event|3
2645984|NCT00752726|9141090|P2|Overall Study|Lost to Follow-up|1
2645985|NCT00752726|9141091|P1|Overall Study|Lost to Follow-up|2
2645986|NCT00752622|9141116|P1|Interventional Phase|Premature Study Termination|5
2645987|NCT00752622|9141116|P1|Interventional Phase|Physician Decision|1
2645988|NCT00752622|9141116|P1|Interventional Phase|Non-responder|2
2645989|NCT00752622|9141116|P1|Observational Phase|Other|2
2645990|NCT00752622|9141116|P1|Observational Phase|Adverse Event|1
2645991|NCT00752622|9141116|P1|Observational Phase|Withdrawal by Subject|2
2645992|NCT00752622|9141116|P1|Observational Phase|Non-responder|2
2645993|NCT00752622|9141116|P1|Observational Phase|Premature Study Termination|36
2645994|NCT00752622|9141116|P1|Induction Phase|Premature study termination|14
2645995|NCT00752622|9141116|P1|Induction Phase|Withdrawal by Subject|1
2645996|NCT00752622|9141116|P1|Induction Phase|Non-responder|14
2645997|NCT00752622|9141116|P1|Induction Phase|Other|3
2645998|NCT00752622|9141116|P1|Induction Phase|Adverse Event|3
2645999|NCT00752609|9141129|P2|Overall Study|Received Aranesp in error|0
2646000|NCT00752609|9141130|P1|Overall Study|Received Aranesp in error|1
2646001|NCT00752609|9141129|P2|Overall Study|Met exclusion criteria|0
2646002|NCT00752609|9141130|P1|Overall Study|Met exclusion criteria|1
2646003|NCT00752609|9141129|P2|Overall Study|Death|0
2646004|NCT00752609|9141130|P1|Overall Study|Death|1
2646005|NCT00752609|9141129|P2|Overall Study|Physician Decision|0
2646006|NCT00752609|9141130|P1|Overall Study|Physician Decision|1
2646007|NCT00752609|9141129|P2|Overall Study|Withdrawal by Subject|0
2646008|NCT00752609|9141130|P1|Overall Study|Withdrawal by Subject|3
2646009|NCT00752609|9141129|P2|Overall Study|Adverse Event|2
2646010|NCT00752609|9141130|P1|Overall Study|Adverse Event|2
2646011|NCT00752557|9141152|P3|Overall Study|Lost to Follow-up|1
2646012|NCT00752557|9141153|P2|Overall Study|Lost to Follow-up|0
2646013|NCT00752557|9141154|P1|Overall Study|Lost to Follow-up|1
2646014|NCT00752557|9141152|P3|Overall Study|Unspecified resaons|2
2646015|NCT00752557|9141153|P2|Overall Study|Unspecified resaons|2
2646016|NCT00752557|9141154|P1|Overall Study|Unspecified resaons|0
2646017|NCT00752557|9141152|P3|Overall Study|Withdrawal by Subject|3
2646018|NCT00752557|9141153|P2|Overall Study|Withdrawal by Subject|3
2646019|NCT00752557|9141154|P1|Overall Study|Withdrawal by Subject|4
2646020|NCT00752232|9141186|P7|Overall Study|Caregiver could not attend the subject|0
2646021|NCT00752232|9141187|P6|Overall Study|Caregiver could not attend the subject|0
2646022|NCT00752232|9141188|P5|Overall Study|Caregiver could not attend the subject|1
2646023|NCT00752232|9141189|P4|Overall Study|Caregiver could not attend the subject|0
2646024|NCT00752232|9141190|P3|Overall Study|Caregiver could not attend the subject|0
2646025|NCT00752232|9141191|P2|Overall Study|Caregiver could not attend the subject|0
2646026|NCT00752232|9141192|P1|Overall Study|Caregiver could not attend the subject|0
2646027|NCT00752232|9141186|P7|Overall Study|Group home admission|0
2646028|NCT00752232|9141187|P6|Overall Study|Group home admission|0
2646029|NCT00752232|9141188|P5|Overall Study|Group home admission|0
2646030|NCT00752232|9141189|P4|Overall Study|Group home admission|1
2646031|NCT00752232|9141190|P3|Overall Study|Group home admission|0
2646032|NCT00752232|9141191|P2|Overall Study|Group home admission|0
2646033|NCT00752232|9141192|P1|Overall Study|Group home admission|0
2646034|NCT00752232|9141186|P7|Overall Study|Subject request|0
2646035|NCT00752232|9141187|P6|Overall Study|Subject request|0
2646036|NCT00752232|9141188|P5|Overall Study|Subject request|0
2646037|NCT00752232|9141189|P4|Overall Study|Subject request|0
2646038|NCT00752232|9141190|P3|Overall Study|Subject request|1
2646039|NCT00752232|9141191|P2|Overall Study|Subject request|0
2646040|NCT00752232|9141192|P1|Overall Study|Subject request|0
2646041|NCT00752232|9141186|P7|Overall Study|Investigator request|0
2646042|NCT00752232|9141187|P6|Overall Study|Investigator request|0
2646043|NCT00752232|9141188|P5|Overall Study|Investigator request|1
2646044|NCT00752232|9141189|P4|Overall Study|Investigator request|0
2646045|NCT00752232|9141190|P3|Overall Study|Investigator request|0
2646046|NCT00752232|9141191|P2|Overall Study|Investigator request|0
2646047|NCT00752232|9141192|P1|Overall Study|Investigator request|0
2646048|NCT00752232|9141186|P7|Overall Study|Caregiver request|0
2646049|NCT00752232|9141187|P6|Overall Study|Caregiver request|0
2646050|NCT00752232|9141188|P5|Overall Study|Caregiver request|1
2646051|NCT00752232|9141189|P4|Overall Study|Caregiver request|0
2646052|NCT00752232|9141190|P3|Overall Study|Caregiver request|0
2646053|NCT00752232|9141191|P2|Overall Study|Caregiver request|0
2646054|NCT00752232|9141192|P1|Overall Study|Caregiver request|2
2646055|NCT00752232|9141186|P7|Overall Study|Protocol Violation|0
2646056|NCT00752232|9141187|P6|Overall Study|Protocol Violation|1
2646057|NCT00752232|9141188|P5|Overall Study|Protocol Violation|0
2646058|NCT00752232|9141189|P4|Overall Study|Protocol Violation|0
2646059|NCT00752232|9141190|P3|Overall Study|Protocol Violation|0
2646060|NCT00752232|9141191|P2|Overall Study|Protocol Violation|0
2646061|NCT00752232|9141192|P1|Overall Study|Protocol Violation|0
2646062|NCT00752219|9141266|P2|Overall Study|Other|0
2646063|NCT00752219|9141267|P1|Overall Study|Other|3
2646064|NCT00752219|9141266|P2|Overall Study|Randomized but not treated|0
2646065|NCT00752219|9141267|P1|Overall Study|Randomized but not treated|1
2646066|NCT00752219|9141266|P2|Overall Study|Lost to Follow-up|2
2646067|NCT00752219|9141267|P1|Overall Study|Lost to Follow-up|1
2646068|NCT00752219|9141266|P2|Overall Study|Protocol deviation|0
2646069|NCT00752219|9141267|P1|Overall Study|Protocol deviation|1
2646070|NCT00752219|9141266|P2|Overall Study|Adverse Event|3
2646071|NCT00752219|9141267|P1|Overall Study|Adverse Event|5
2646072|NCT00752219|9141266|P2|Overall Study|Clinical failure|1
2646073|NCT00752219|9141267|P1|Overall Study|Clinical failure|0
2646074|NCT00752206|9141293|P2|Overall Study|Pregnancy|0
2646075|NCT00752206|9141294|P1|Overall Study|Pregnancy|1
2646076|NCT00752206|9141293|P2|Overall Study|Disease progression|11
2646077|NCT00752206|9141294|P1|Overall Study|Disease progression|8
2646078|NCT00752128|9141312|P1|Overall Study|Withdrawal by Subject|4
2646079|NCT00752089|9141326|P1|Overall Study|Cannot continue the study|1
2646080|NCT00752089|9141326|P1|Overall Study|Not capable of wearing partial denture|1
2646081|NCT00752089|9141326|P1|Overall Study|Could not attend visit 9|1
2646082|NCT00752089|9141326|P1|Overall Study|Protocol Deviation|2
2646083|NCT00752089|9141326|P1|Overall Study|Adverse Event|1
2646084|NCT00751998|9141340|P1|Overall Study|Withdrawal by Subject|2
2646085|NCT00751998|9141340|P1|Overall Study|Death|11
2646086|NCT00751998|9141340|P1|Overall Study|Lost to Follow-up|7
2646087|NCT00751933|9141359|P4|Overall Study|Physician Decision|1
2646088|NCT00751933|9141360|P3|Overall Study|Physician Decision|1
2646089|NCT00751933|9141361|P2|Overall Study|Physician Decision|0
2646090|NCT00751933|9141362|P1|Overall Study|Physician Decision|0
2646091|NCT00751933|9141359|P4|Overall Study|Withdrawal by Subject|0
2646092|NCT00751933|9141360|P3|Overall Study|Withdrawal by Subject|0
2646093|NCT00751933|9141361|P2|Overall Study|Withdrawal by Subject|1
2646094|NCT00751933|9141362|P1|Overall Study|Withdrawal by Subject|0
2646095|NCT00751881|9141370|P3|Extension Study Period|Other than specified above|18
2646096|NCT00751881|9141371|P2|Extension Study Period|Other than specified above|30
2646097|NCT00751881|9141372|P1|Extension Study Period|Other than specified above|26
2646098|NCT00751881|9141370|P3|Extension Study Period|Poor Compliance to Protocol|1
2646099|NCT00751881|9141371|P2|Extension Study Period|Poor Compliance to Protocol|2
2646100|NCT00751881|9141372|P1|Extension Study Period|Poor Compliance to Protocol|3
2646101|NCT00751881|9141370|P3|Extension Study Period|Lost to Follow-up|6
2646102|NCT00751881|9141371|P2|Extension Study Period|Lost to Follow-up|9
2646103|NCT00751881|9141372|P1|Extension Study Period|Lost to Follow-up|4
2646104|NCT00751881|9141370|P3|Extension Study Period|Lack of Efficacy|20
2646105|NCT00751881|9141371|P2|Extension Study Period|Lack of Efficacy|10
2646106|NCT00751881|9141372|P1|Extension Study Period|Lack of Efficacy|14
2646107|NCT00751881|9141370|P3|Extension Study Period|Adverse Event|21
2646108|NCT00751881|9141371|P2|Extension Study Period|Adverse Event|20
2646109|NCT00751881|9141372|P1|Extension Study Period|Adverse Event|18
2646110|NCT00751881|9141370|P3|Core Treatment Period|Other:participant's decision/unspecified|16
2646111|NCT00751881|9141371|P2|Core Treatment Period|Other:participant's decision/unspecified|22
2646112|NCT00751881|9141372|P1|Core Treatment Period|Other:participant's decision/unspecified|19
2646113|NCT00751881|9141370|P3|Core Treatment Period|Other: tolerability complaints|0
2646114|NCT00751881|9141371|P2|Core Treatment Period|Other: tolerability complaints|0
2646115|NCT00751881|9141372|P1|Core Treatment Period|Other: tolerability complaints|2
2646116|NCT00751881|9141370|P3|Core Treatment Period|Other: MS treatment change|4
2646117|NCT00751881|9141371|P2|Core Treatment Period|Other: MS treatment change|4
2646118|NCT00751881|9141372|P1|Core Treatment Period|Other: MS treatment change|6
2646119|NCT00751881|9141370|P3|Core Treatment Period|Other: personal/family constraints|10
2646120|NCT00751881|9141371|P2|Core Treatment Period|Other: personal/family constraints|7
2646121|NCT00751881|9141372|P1|Core Treatment Period|Other: personal/family constraints|6
2646122|NCT00751881|9141370|P3|Core Treatment Period|Other: wish to parent|4
2646123|NCT00751881|9141371|P2|Core Treatment Period|Other: wish to parent|7
2646124|NCT00751881|9141372|P1|Core Treatment Period|Other: wish to parent|5
2646125|NCT00751881|9141370|P3|Core Treatment Period|Other: protocol deviation|7
2646126|NCT00751881|9141371|P2|Core Treatment Period|Other: protocol deviation|3
2646127|NCT00751881|9141372|P1|Core Treatment Period|Other: protocol deviation|3
2646128|NCT00751881|9141370|P3|Core Treatment Period|Lost to Follow-up|3
2646129|NCT00751881|9141371|P2|Core Treatment Period|Lost to Follow-up|4
2646130|NCT00751881|9141372|P1|Core Treatment Period|Lost to Follow-up|6
2646131|NCT00751881|9141370|P3|Core Treatment Period|Poor compliance to protocol|4
2646132|NCT00751881|9141371|P2|Core Treatment Period|Poor compliance to protocol|3
2646133|NCT00751881|9141372|P1|Core Treatment Period|Poor compliance to protocol|15
2646134|NCT00751881|9141370|P3|Core Treatment Period|Lack of Efficacy|20
2646135|NCT00751881|9141371|P2|Core Treatment Period|Lack of Efficacy|30
2646136|NCT00751881|9141372|P1|Core Treatment Period|Lack of Efficacy|37
2646137|NCT00751881|9141370|P3|Core Treatment Period|Adverse Event|58
2646138|NCT00751881|9141371|P2|Core Treatment Period|Adverse Event|54
2646139|NCT00751881|9141372|P1|Core Treatment Period|Adverse Event|26
2646140|NCT00751881|9141370|P3|Core Treatment Period|Not treated|2
2646141|NCT00751881|9141371|P2|Core Treatment Period|Not treated|1
2646142|NCT00751881|9141372|P1|Core Treatment Period|Not treated|1
2646143|NCT00751790|9141419|P1|Overall Study|Withdrawal by Subject|1
2646144|NCT00751790|9141419|P1|Overall Study|Death|3
2646145|NCT00751790|9141419|P1|Overall Study|Lost to Follow-up|1
2646146|NCT00751621|9141450|P1|Overall Study|Poor adherence to asthma treatment|1
2646147|NCT00751621|9141450|P1|Overall Study|Subject moved to another country|1
2646148|NCT00751621|9141450|P1|Overall Study|Withdrawal by Subject|1
2646149|NCT00751621|9141450|P1|Overall Study|Adverse Event|1
2646150|NCT00751400|9141484|P1|Overall Study|Lost to Follow-up|10
2646151|NCT00751348|9141499|P2|Overall Study|Migration from study area|0
2646152|NCT00751348|9141500|P1|Overall Study|Migration from study area|1
2646153|NCT00751348|9141499|P2|Overall Study|Withdrawal by Subject|2
2646154|NCT00751348|9141500|P1|Overall Study|Withdrawal by Subject|5
2646155|NCT00751296|9141522|P1|Overall Study|Adverse Event|2
2646156|NCT00751140|9141550|P1|Overall Study|benign angioma excluded from analysis|1
2646157|NCT00751114|9141560|P2|Overall Study|Move to another city|0
2646158|NCT00751114|9141561|P1|Overall Study|Move to another city|1
2646159|NCT00751114|9141560|P2|Overall Study|Out of country for 2 months|0
2646160|NCT00751114|9141561|P1|Overall Study|Out of country for 2 months|1
2646161|NCT00751114|9141560|P2|Overall Study|Not Treated|1
2646162|NCT00751114|9141561|P1|Overall Study|Not Treated|13
2646163|NCT00751114|9141560|P2|Overall Study|Lack of Efficacy|7
2646164|NCT00751114|9141561|P1|Overall Study|Lack of Efficacy|0
2646165|NCT00751114|9141560|P2|Overall Study|Lost to Follow-up|7
2646166|NCT00751114|9141561|P1|Overall Study|Lost to Follow-up|4
2646167|NCT00751114|9141560|P2|Overall Study|Withdrawal by Subject|4
2646168|NCT00751114|9141561|P1|Overall Study|Withdrawal by Subject|9
2646169|NCT00751114|9141560|P2|Overall Study|Protocol Violation|9
2646170|NCT00751114|9141561|P1|Overall Study|Protocol Violation|8
2646171|NCT00751114|9141560|P2|Overall Study|Adverse Event|4
2646172|NCT00751114|9141561|P1|Overall Study|Adverse Event|2
2646173|NCT00751036|9141586|P2|Overall Study|Missing end of Treatment Page|3
2646174|NCT00751036|9141587|P1|Overall Study|Missing end of Treatment Page|2
2646175|NCT00751036|9141586|P2|Overall Study|Protocol Violation|0
2646176|NCT00751036|9141587|P1|Overall Study|Protocol Violation|1
2646177|NCT00751036|9141586|P2|Overall Study|Lost to Follow-up|1
2646178|NCT00751036|9141587|P1|Overall Study|Lost to Follow-up|0
2646179|NCT00751036|9141586|P2|Overall Study|Death|3
2646180|NCT00751036|9141587|P1|Overall Study|Death|3
2646181|NCT00751036|9141586|P2|Overall Study|Withdrawal by Subject|2
2646182|NCT00751036|9141587|P1|Overall Study|Withdrawal by Subject|5
2646183|NCT00751036|9141586|P2|Overall Study|Administrative Problems|4
2646184|NCT00751036|9141587|P1|Overall Study|Administrative Problems|3
2646185|NCT00751036|9141586|P2|Overall Study|Adverse Event|4
2646186|NCT00751036|9141587|P1|Overall Study|Adverse Event|6
2646187|NCT00751036|9141586|P2|Overall Study|Disease Progression|29
2646188|NCT00751036|9141587|P1|Overall Study|Disease Progression|28
2646189|NCT00751023|9141601|P2|Overall Study|Lost to Follow-up|7
2646190|NCT00751023|9141602|P1|Overall Study|Lost to Follow-up|11
2646191|NCT00750919|9141622|P1|Overall Study|Other|36
2646192|NCT00750919|9141622|P1|Overall Study|Could not cooperate, unrelated to trial|4
2646193|NCT00750919|9141622|P1|Overall Study|Lack of Efficacy|8
2646194|NCT00750919|9141622|P1|Overall Study|Withdrawal by Subject|1
2646195|NCT00750919|9141622|P1|Overall Study|Adverse Event|9
2646196|NCT00750893|9141630|P1|Overall Study|Other|17
2646197|NCT00750893|9141630|P1|Overall Study|Lost to Follow-up|510
2646198|NCT00750893|9141630|P1|Overall Study|Withdrawal by Subject|10
2646199|NCT00750893|9141630|P1|Overall Study|Adverse Event|5
2646200|NCT00750880|9141642|P1|Overall Study|Administrative|11
2646201|NCT00750880|9141642|P1|Overall Study|Physician Decision|20
2646202|NCT00750880|9141642|P1|Overall Study|Withdrawal by Subject|33
2646203|NCT00750880|9141642|P1|Overall Study|Protocol Violation|15
2646204|NCT00750880|9141642|P1|Overall Study|Lost to Follow-up|10
2646205|NCT00750880|9141642|P1|Overall Study|Lack of Efficacy|46
2646206|NCT00750880|9141642|P1|Overall Study|Death|4
2646207|NCT00750880|9141642|P1|Overall Study|Adverse Event|76
2646208|NCT00750867|9141665|P1|Overall Study|Adverse Event|2
2646209|NCT00750737|9141686|P2|Overall Study|Withdrawal by Subject|3
2646210|NCT00750737|9141687|P1|Overall Study|Withdrawal by Subject|3
2646211|NCT00750438|9141702|P2|Overall Study|Withdrawal by Subject|1
2646212|NCT00750438|9141703|P1|Overall Study|Withdrawal by Subject|1
2646213|NCT00750438|9141702|P2|Overall Study|Physician Decision|2
2646214|NCT00750438|9141703|P1|Overall Study|Physician Decision|2
2646215|NCT00750438|9141702|P2|Overall Study|Protocol Violation|1
2646216|NCT00750438|9141703|P1|Overall Study|Protocol Violation|4
2646217|NCT00750308|9141769|P12|Third Treatment|Withdrawal by Subject|0
2646218|NCT00750308|9141770|P11|Third Treatment|Withdrawal by Subject|0
2646219|NCT00750308|9141771|P10|Third Treatment|Withdrawal by Subject|0
2646220|NCT00750308|9141772|P9|Third Treatment|Withdrawal by Subject|0
2646221|NCT00750308|9141773|P8|Third Treatment|Withdrawal by Subject|0
2646222|NCT00750308|9141774|P7|Third Treatment|Withdrawal by Subject|0
2646223|NCT00750308|9141775|P6|Third Treatment|Withdrawal by Subject|0
2646224|NCT00750308|9141776|P5|Third Treatment|Withdrawal by Subject|0
2646225|NCT00750308|9141777|P4|Third Treatment|Withdrawal by Subject|0
2646226|NCT00750308|9141778|P3|Third Treatment|Withdrawal by Subject|0
2646227|NCT00750308|9141779|P2|Third Treatment|Withdrawal by Subject|1
2646228|NCT00750308|9141780|P1|Third Treatment|Withdrawal by Subject|0
2646229|NCT00750308|9141769|P12|Second Treatment|Withdrawal by Subject|0
2646230|NCT00750308|9141770|P11|Second Treatment|Withdrawal by Subject|0
2646231|NCT00750308|9141771|P10|Second Treatment|Withdrawal by Subject|0
2646232|NCT00750308|9141772|P9|Second Treatment|Withdrawal by Subject|0
2646233|NCT00750308|9141773|P8|Second Treatment|Withdrawal by Subject|0
2646234|NCT00750308|9141774|P7|Second Treatment|Withdrawal by Subject|0
2646235|NCT00750308|9141775|P6|Second Treatment|Withdrawal by Subject|0
2646236|NCT00750308|9141776|P5|Second Treatment|Withdrawal by Subject|1
2646237|NCT00750308|9141777|P4|Second Treatment|Withdrawal by Subject|0
2646238|NCT00750308|9141778|P3|Second Treatment|Withdrawal by Subject|0
2646239|NCT00750308|9141779|P2|Second Treatment|Withdrawal by Subject|0
2646240|NCT00750308|9141780|P1|Second Treatment|Withdrawal by Subject|0
2646241|NCT00750308|9141769|P12|Second Treatment|Adverse Event|0
2646242|NCT00750308|9141770|P11|Second Treatment|Adverse Event|0
2646243|NCT00750308|9141771|P10|Second Treatment|Adverse Event|0
2646244|NCT00750308|9141772|P9|Second Treatment|Adverse Event|1
2646245|NCT00750308|9141773|P8|Second Treatment|Adverse Event|0
2646246|NCT00750308|9141774|P7|Second Treatment|Adverse Event|0
2646247|NCT00750308|9141775|P6|Second Treatment|Adverse Event|1
2646248|NCT00750308|9141776|P5|Second Treatment|Adverse Event|0
2646249|NCT00750308|9141777|P4|Second Treatment|Adverse Event|0
2646250|NCT00750308|9141778|P3|Second Treatment|Adverse Event|0
2646251|NCT00750308|9141779|P2|Second Treatment|Adverse Event|0
2646252|NCT00750308|9141780|P1|Second Treatment|Adverse Event|0
2646253|NCT00750308|9141769|P12|First Treatment|Withdrawal by Subject|0
2646254|NCT00750308|9141770|P11|First Treatment|Withdrawal by Subject|0
2646255|NCT00750308|9141771|P10|First Treatment|Withdrawal by Subject|0
2646256|NCT00750308|9141772|P9|First Treatment|Withdrawal by Subject|0
2646257|NCT00750308|9141773|P8|First Treatment|Withdrawal by Subject|1
2646258|NCT00750308|9141774|P7|First Treatment|Withdrawal by Subject|0
2646259|NCT00750308|9141775|P6|First Treatment|Withdrawal by Subject|0
2646260|NCT00750308|9141776|P5|First Treatment|Withdrawal by Subject|0
2646261|NCT00750308|9141777|P4|First Treatment|Withdrawal by Subject|1
2646262|NCT00750308|9141778|P3|First Treatment|Withdrawal by Subject|0
2646263|NCT00750308|9141779|P2|First Treatment|Withdrawal by Subject|0
2646264|NCT00750308|9141780|P1|First Treatment|Withdrawal by Subject|0
2646265|NCT00750308|9141769|P12|First Treatment|Adverse Event|1
2646266|NCT00750308|9141770|P11|First Treatment|Adverse Event|1
2646267|NCT00750308|9141771|P10|First Treatment|Adverse Event|0
2646268|NCT00750308|9141772|P9|First Treatment|Adverse Event|0
2646269|NCT00750308|9141773|P8|First Treatment|Adverse Event|0
2646270|NCT00750308|9141774|P7|First Treatment|Adverse Event|0
2646271|NCT00750308|9141775|P6|First Treatment|Adverse Event|0
2646272|NCT00750308|9141776|P5|First Treatment|Adverse Event|0
2646273|NCT00750308|9141777|P4|First Treatment|Adverse Event|0
2646274|NCT00750308|9141778|P3|First Treatment|Adverse Event|0
2646275|NCT00750308|9141779|P2|First Treatment|Adverse Event|1
2646276|NCT00750308|9141780|P1|First Treatment|Adverse Event|0
2646277|NCT00750269|9141830|P5|Overall Study|Fiducials could not be placed|1
2646278|NCT00750269|9141831|P4|Overall Study|Fiducials could not be placed|0
2646279|NCT00750269|9141832|P3|Overall Study|Fiducials could not be placed|0
2646280|NCT00750269|9141833|P2|Overall Study|Fiducials could not be placed|0
2646281|NCT00750269|9141834|P1|Overall Study|Fiducials could not be placed|0
2646282|NCT00750269|9141830|P5|Overall Study|SBRT plan could not be drawn|1
2646283|NCT00750269|9141831|P4|Overall Study|SBRT plan could not be drawn|0
2646284|NCT00750269|9141832|P3|Overall Study|SBRT plan could not be drawn|0
2646285|NCT00750269|9141833|P2|Overall Study|SBRT plan could not be drawn|0
2646286|NCT00750269|9141834|P1|Overall Study|SBRT plan could not be drawn|0
2646287|NCT00750269|9141830|P5|Overall Study|Site error|0
2646288|NCT00750269|9141831|P4|Overall Study|Site error|1
2646289|NCT00750269|9141832|P3|Overall Study|Site error|0
2646290|NCT00750269|9141833|P2|Overall Study|Site error|0
2646291|NCT00750269|9141834|P1|Overall Study|Site error|0
2646292|NCT00750269|9141830|P5|Overall Study|Patient too large for positioning|0
2646293|NCT00750269|9141831|P4|Overall Study|Patient too large for positioning|0
2646294|NCT00750269|9141832|P3|Overall Study|Patient too large for positioning|1
2646295|NCT00750269|9141833|P2|Overall Study|Patient too large for positioning|0
2646296|NCT00750269|9141834|P1|Overall Study|Patient too large for positioning|0
2646297|NCT00750269|9141830|P5|Overall Study|Physician Decision|2
2646298|NCT00750269|9141831|P4|Overall Study|Physician Decision|0
2646299|NCT00750269|9141832|P3|Overall Study|Physician Decision|0
2646300|NCT00750269|9141833|P2|Overall Study|Physician Decision|0
2646301|NCT00750269|9141834|P1|Overall Study|Physician Decision|0
2646302|NCT00750269|9141830|P5|Overall Study|Withdrawal by Subject|2
2646303|NCT00750269|9141831|P4|Overall Study|Withdrawal by Subject|2
2646304|NCT00750269|9141832|P3|Overall Study|Withdrawal by Subject|2
2646305|NCT00750269|9141833|P2|Overall Study|Withdrawal by Subject|0
2646306|NCT00750269|9141834|P1|Overall Study|Withdrawal by Subject|0
2646307|NCT00750269|9141830|P5|Overall Study|Protocol Violation|4
2646308|NCT00750269|9141831|P4|Overall Study|Protocol Violation|2
2646309|NCT00750269|9141832|P3|Overall Study|Protocol Violation|1
2646310|NCT00750269|9141833|P2|Overall Study|Protocol Violation|1
2646311|NCT00750269|9141834|P1|Overall Study|Protocol Violation|0
2646312|NCT00750204|9141881|P2|Overall Study|study halted prematurely|1
2646313|NCT00750204|9141882|P1|Overall Study|study halted prematurely|1
2646314|NCT00750152|9141912|P2|Overall Study|Other|8
2646315|NCT00750152|9141913|P1|Overall Study|Other|7
2646316|NCT00750152|9141912|P2|Overall Study|Termination by sponsor|0
2646317|NCT00750152|9141913|P1|Overall Study|Termination by sponsor|1
2646318|NCT00750152|9141912|P2|Overall Study|Non-compliance|1
2646319|NCT00750152|9141913|P1|Overall Study|Non-compliance|0
2646320|NCT00750152|9141912|P2|Overall Study|Physician Decision|1
2646321|NCT00750152|9141913|P1|Overall Study|Physician Decision|1
2646322|NCT00750152|9141912|P2|Overall Study|Withdrawal by Subject|3
2646323|NCT00750152|9141913|P1|Overall Study|Withdrawal by Subject|3
2646324|NCT00750152|9141912|P2|Overall Study|Lost to Follow-up|13
2646325|NCT00750152|9141913|P1|Overall Study|Lost to Follow-up|8
2646326|NCT00750152|9141912|P2|Overall Study|Adverse Event|1
2646327|NCT00750152|9141913|P1|Overall Study|Adverse Event|2
2646328|NCT00750139|9141925|P4|Overall Study|Non-specific|33
2646329|NCT00750139|9141926|P3|Overall Study|Non-specific|79
2646330|NCT00750139|9141927|P2|Overall Study|Non-specific|42
2646331|NCT00750139|9141928|P1|Overall Study|Non-specific|62
2646332|NCT00750139|9141925|P4|Overall Study|Termination by sponsor|1
2646333|NCT00750139|9141926|P3|Overall Study|Termination by sponsor|0
2646334|NCT00750139|9141927|P2|Overall Study|Termination by sponsor|0
2646335|NCT00750139|9141928|P1|Overall Study|Termination by sponsor|4
2646336|NCT00750139|9141925|P4|Overall Study|Non-compliance|3
2646337|NCT00750139|9141926|P3|Overall Study|Non-compliance|1
2646338|NCT00750139|9141927|P2|Overall Study|Non-compliance|0
2646339|NCT00750139|9141928|P1|Overall Study|Non-compliance|1
2646340|NCT00750139|9141925|P4|Overall Study|Physician Decision|0
2646341|NCT00750139|9141926|P3|Overall Study|Physician Decision|0
2646342|NCT00750139|9141927|P2|Overall Study|Physician Decision|1
2646343|NCT00750139|9141928|P1|Overall Study|Physician Decision|1
2646344|NCT00750139|9141925|P4|Overall Study|Withdrawal by Subject|2
2646345|NCT00750139|9141926|P3|Overall Study|Withdrawal by Subject|6
2646346|NCT00750139|9141927|P2|Overall Study|Withdrawal by Subject|2
2646347|NCT00750139|9141928|P1|Overall Study|Withdrawal by Subject|3
2646348|NCT00750139|9141925|P4|Overall Study|Lost to Follow-up|6
2646349|NCT00750139|9141926|P3|Overall Study|Lost to Follow-up|15
2646350|NCT00750139|9141927|P2|Overall Study|Lost to Follow-up|12
2646351|NCT00750139|9141928|P1|Overall Study|Lost to Follow-up|17
2646352|NCT00750139|9141925|P4|Overall Study|Adverse Event|1
2646353|NCT00750139|9141926|P3|Overall Study|Adverse Event|0
2646354|NCT00750139|9141927|P2|Overall Study|Adverse Event|2
2646355|NCT00750139|9141928|P1|Overall Study|Adverse Event|1
2646356|NCT00750061|9141944|P2|Overall Study|Physician Decision|1
2646357|NCT00750061|9141945|P1|Overall Study|Physician Decision|0
2646358|NCT00750061|9141944|P2|Overall Study|Withdrawal by Subject|1
2646359|NCT00750061|9141945|P1|Overall Study|Withdrawal by Subject|0
2646360|NCT00750061|9141944|P2|Overall Study|Adverse Event|0
2646361|NCT00750061|9141945|P1|Overall Study|Adverse Event|2
2646362|NCT00749996|9141955|P2|Overall Study|Death|0
2646363|NCT00749996|9141956|P1|Overall Study|Death|1
2646364|NCT00749996|9141955|P2|Overall Study|Adverse Event|0
2646365|NCT00749996|9141956|P1|Overall Study|Adverse Event|1
2646366|NCT00749996|9141955|P2|Overall Study|Pregnancy|2
2646367|NCT00749996|9141956|P1|Overall Study|Pregnancy|0
2646368|NCT00749996|9141955|P2|Overall Study|Physician Decision|0
2646369|NCT00749996|9141956|P1|Overall Study|Physician Decision|2
2646370|NCT00749996|9141955|P2|Overall Study|Protocol Violation|3
2646371|NCT00749996|9141956|P1|Overall Study|Protocol Violation|2
2646372|NCT00749996|9141955|P2|Overall Study|Withdrawal by Subject|4
2646373|NCT00749996|9141956|P1|Overall Study|Withdrawal by Subject|5
2646374|NCT00749996|9141955|P2|Overall Study|Lost to Follow-up|4
2646375|NCT00749996|9141956|P1|Overall Study|Lost to Follow-up|7
2646376|NCT00749944|9141979|P2|Overall Study|Withdrawal by Subject|0
2646377|NCT00749944|9141980|P1|Overall Study|Withdrawal by Subject|2
2646378|NCT00749944|9141979|P2|Overall Study|Other|0
2646379|NCT00749944|9141980|P1|Overall Study|Other|1
2646380|NCT00749944|9141979|P2|Overall Study|Lost to Follow-up|1
2646381|NCT00749944|9141980|P1|Overall Study|Lost to Follow-up|2
2646382|NCT00749775|9142091|P1|Overall Study|No drug administration|3
2646383|NCT00749775|9142091|P1|Overall Study|No visit after first day of treatment|44
2646384|NCT00749775|9142091|P1|Overall Study|Lost to Follow-up|36
2646385|NCT00749775|9142091|P1|Overall Study|Protocol Violation|24
2646386|NCT00749684|9142107|P1|Overall Study|Missing|9
2646387|NCT00749684|9142107|P1|Overall Study|AE+discontinuation on participants wish|1
2646388|NCT00749684|9142107|P1|Overall Study|Therapy according to protocol + AE|2
2646389|NCT00749684|9142107|P1|Overall Study|Progressive Desease|31
2646390|NCT00749684|9142107|P1|Overall Study|Not Documented|1
2646391|NCT00749684|9142107|P1|Overall Study|Participant's Wish|10
2646392|NCT00749684|9142107|P1|Overall Study|Adverse Event|27
2646393|NCT00749684|9142107|P1|Overall Study|Death|1
2646394|NCT00749580|9142146|P2|Overall Study|Adverse Event|1
2646395|NCT00749580|9142147|P1|Overall Study|Adverse Event|0
2646396|NCT00749580|9142146|P2|Overall Study|Lost to Follow-up|8
2646397|NCT00749580|9142147|P1|Overall Study|Lost to Follow-up|4
2646398|NCT00749463|9142181|P3|Overall Study|Withdrawal by Subject|0
2646399|NCT00749463|9142182|P2|Overall Study|Withdrawal by Subject|0
2646400|NCT00749463|9142183|P1|Overall Study|Withdrawal by Subject|1
2646401|NCT00749463|9142181|P3|Overall Study|Adverse Event|1
2646402|NCT00749463|9142182|P2|Overall Study|Adverse Event|4
2646403|NCT00749463|9142183|P1|Overall Study|Adverse Event|0
2646404|NCT00749398|9142209|P1|Overall Study|Unknown reason|1
2646405|NCT00749398|9142209|P1|Overall Study|Reason not specified|2
2646406|NCT00749398|9142209|P1|Overall Study|Lost to Follow-up|11
2646407|NCT00749398|9142209|P1|Overall Study|Withdrawal by Subject|17
2646408|NCT00749398|9142209|P1|Overall Study|Serious adverse event|11
2646409|NCT00749398|9142209|P1|Overall Study|Adverse Event|4
2646410|NCT00749398|9142209|P1|Overall Study|Lack of Efficacy|7
2646411|NCT00749203|9142252|P2|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1
2646412|NCT00749203|9142253|P1|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0
2646413|NCT00749203|9142252|P2|Second Infusion at 2 Weeks|Protocol Violation|1
2646414|NCT00749203|9142253|P1|Second Infusion at 2 Weeks|Protocol Violation|0
2646415|NCT00749203|9142252|P2|no Infusion at Week 1|low baseline PTSD symptoms level|1
2646416|NCT00749203|9142253|P1|no Infusion at Week 1|low baseline PTSD symptoms level|0
2646417|NCT00749203|9142252|P2|no Infusion at Week 1|delayed-onset sedation|1
2646418|NCT00749203|9142253|P1|no Infusion at Week 1|delayed-onset sedation|0
2646419|NCT00749203|9142252|P2|no Infusion at Week 1|Withdrawal by Subject|1
2646420|NCT00749203|9142253|P1|no Infusion at Week 1|Withdrawal by Subject|0
2646421|NCT00749203|9142252|P2|no Infusion at Week 1|Lost to Follow-up|1
2646422|NCT00749203|9142253|P1|no Infusion at Week 1|Lost to Follow-up|0
2646423|NCT00749190|9142274|P7|Overall Study|Other reason not defined above|0
2646424|NCT00749190|9142275|P6|Overall Study|Other reason not defined above|0
2646425|NCT00749190|9142276|P5|Overall Study|Other reason not defined above|0
2646426|NCT00749190|9142277|P4|Overall Study|Other reason not defined above|1
2646427|NCT00749190|9142278|P3|Overall Study|Other reason not defined above|0
2646428|NCT00749190|9142279|P2|Overall Study|Other reason not defined above|0
2646429|NCT00749190|9142280|P1|Overall Study|Other reason not defined above|0
2646430|NCT00749190|9142274|P7|Overall Study|Protocol Violation|1
2646431|NCT00749190|9142275|P6|Overall Study|Protocol Violation|0
2646432|NCT00749190|9142276|P5|Overall Study|Protocol Violation|0
2646433|NCT00749190|9142277|P4|Overall Study|Protocol Violation|0
2646434|NCT00749190|9142278|P3|Overall Study|Protocol Violation|0
2646435|NCT00749190|9142279|P2|Overall Study|Protocol Violation|1
2646436|NCT00749190|9142280|P1|Overall Study|Protocol Violation|0
2646437|NCT00749190|9142274|P7|Overall Study|Withdrawal by Subject|0
2646438|NCT00749190|9142275|P6|Overall Study|Withdrawal by Subject|1
2646439|NCT00749190|9142276|P5|Overall Study|Withdrawal by Subject|0
2646440|NCT00749190|9142277|P4|Overall Study|Withdrawal by Subject|0
2646441|NCT00749190|9142278|P3|Overall Study|Withdrawal by Subject|0
2646442|NCT00749190|9142279|P2|Overall Study|Withdrawal by Subject|1
2646443|NCT00749190|9142280|P1|Overall Study|Withdrawal by Subject|2
2646444|NCT00749190|9142274|P7|Overall Study|Lack of Efficacy|0
2646445|NCT00749190|9142275|P6|Overall Study|Lack of Efficacy|1
2646446|NCT00749190|9142276|P5|Overall Study|Lack of Efficacy|0
2646447|NCT00749190|9142277|P4|Overall Study|Lack of Efficacy|0
2646448|NCT00749190|9142278|P3|Overall Study|Lack of Efficacy|1
2646449|NCT00749190|9142279|P2|Overall Study|Lack of Efficacy|1
2646450|NCT00749190|9142280|P1|Overall Study|Lack of Efficacy|3
2646451|NCT00749190|9142274|P7|Overall Study|Adverse Event|0
2646452|NCT00749190|9142275|P6|Overall Study|Adverse Event|3
2646453|NCT00749190|9142276|P5|Overall Study|Adverse Event|0
2646454|NCT00749190|9142277|P4|Overall Study|Adverse Event|4
2646455|NCT00749190|9142278|P3|Overall Study|Adverse Event|0
2646456|NCT00749190|9142279|P2|Overall Study|Adverse Event|2
2646457|NCT00749190|9142280|P1|Overall Study|Adverse Event|0
2646458|NCT00748969|9142389|P2|Overall Study|Withdrawal by Subject|1
2646459|NCT00748969|9142390|P1|Overall Study|Withdrawal by Subject|0
2646460|NCT00748969|9142389|P2|Overall Study|Withdrawal by Subject|0
2646461|NCT00748969|9142390|P1|Overall Study|Withdrawal by Subject|1
2646462|NCT00748709|9142440|P1|Overall Study|Other Reasons|1
2646463|NCT00748709|9142440|P1|Overall Study|Withdrawal by Subject|1
2646464|NCT00748709|9142440|P1|Overall Study|Other Adverse Event|1
2646465|NCT00748709|9142440|P1|Overall Study|Drug reducing Toxity|2
2646466|NCT00748709|9142440|P1|Overall Study|Progressive disease|15
2646467|NCT00748566|9142483|P1|Overall Study|Other|9
2646468|NCT00748566|9142483|P1|Overall Study|Study terminated by sponsor|5
2646469|NCT00748566|9142483|P1|Overall Study|Withdrawal by Subject|22
2646470|NCT00748566|9142483|P1|Overall Study|Protocol Violation|13
2646471|NCT00748566|9142483|P1|Overall Study|Lost to Follow-up|1
2646472|NCT00748566|9142483|P1|Overall Study|Lack of Efficacy|12
2646473|NCT00748566|9142483|P1|Overall Study|Death|1
2646474|NCT00748566|9142483|P1|Overall Study|Adverse Event|49
2646475|NCT00748553|9142513|P2|Overall Study|noncompliance|0
2646476|NCT00748553|9142514|P1|Overall Study|noncompliance|1
2646477|NCT00748553|9142513|P2|Overall Study|disease progression|0
2646478|NCT00748553|9142514|P1|Overall Study|disease progression|2
2646479|NCT00748553|9142513|P2|Overall Study|Adverse Event|1
2646480|NCT00748553|9142514|P1|Overall Study|Adverse Event|0
2646481|NCT00748540|9142521|P1|Overall Study|Physician Decision|1
2646482|NCT00748241|9142547|P1|Overall Study|Death|2
2646483|NCT00748241|9142547|P1|Overall Study|Lost to Follow-up|5
2646484|NCT00748241|9142547|P1|Overall Study|Implant failure|1
2646485|NCT00748189|9142557|P2|Overall Study|Study terminated by Sponsor|79
2646486|NCT00748189|9142558|P1|Overall Study|Study terminated by Sponsor|70
2646487|NCT00748189|9142557|P2|Overall Study|Lost to Follow-up|15
2646488|NCT00748189|9142558|P1|Overall Study|Lost to Follow-up|8
2646489|NCT00748189|9142557|P2|Overall Study|Physician Decision|5
2646490|NCT00748189|9142558|P1|Overall Study|Physician Decision|16
2646491|NCT00748189|9142557|P2|Overall Study|Withdrawal by Subject|29
2646492|NCT00748189|9142558|P1|Overall Study|Withdrawal by Subject|23
2646493|NCT00748189|9142557|P2|Overall Study|Death|84
2646494|NCT00748189|9142558|P1|Overall Study|Death|99
2646495|NCT00748098|9142613|P2|Second Treatment Intervention Period|Withdrawal by Subject|1
2646496|NCT00748098|9142614|P1|Second Treatment Intervention Period|Withdrawal by Subject|1
2646497|NCT00748098|9142613|P2|Second Treatment Intervention Period|Lost to Follow-up|1
2646498|NCT00748098|9142614|P1|Second Treatment Intervention Period|Lost to Follow-up|1
2646499|NCT00748098|9142613|P2|Second Treatment Intervention Period|Adverse Event|1
2646500|NCT00748098|9142614|P1|Second Treatment Intervention Period|Adverse Event|4
2646501|NCT00748098|9142613|P2|1-Week Washout Period|Withdrawal by Subject|0
2646502|NCT00748098|9142614|P1|1-Week Washout Period|Withdrawal by Subject|2
2646503|NCT00748098|9142613|P2|1-Week Washout Period|Adverse Event|1
2646504|NCT00748098|9142614|P1|1-Week Washout Period|Adverse Event|0
2646505|NCT00748098|9142613|P2|First Taper Period|Protocol Stopping Criteria Met|1
2646506|NCT00748098|9142614|P1|First Taper Period|Protocol Stopping Criteria Met|0
2646507|NCT00748098|9142613|P2|First Taper Period|Withdrawal by Subject|0
2646508|NCT00748098|9142614|P1|First Taper Period|Withdrawal by Subject|2
2646509|NCT00748098|9142613|P2|First Taper Period|Protocol Violation|0
2646510|NCT00748098|9142614|P1|First Taper Period|Protocol Violation|1
2646511|NCT00748098|9142613|P2|First Treatment Intervention Period|Withdrawal by Subject|0
2646512|NCT00748098|9142614|P1|First Treatment Intervention Period|Withdrawal by Subject|2
2646513|NCT00748098|9142613|P2|First Treatment Intervention Period|Lost to Follow-up|0
2646514|NCT00748098|9142614|P1|First Treatment Intervention Period|Lost to Follow-up|1
2646515|NCT00748098|9142613|P2|First Treatment Intervention Period|Protocol Violation|0
2646516|NCT00748098|9142614|P1|First Treatment Intervention Period|Protocol Violation|1
2646517|NCT00748098|9142613|P2|First Treatment Intervention Period|Adverse Event|1
2646518|NCT00748098|9142614|P1|First Treatment Intervention Period|Adverse Event|1
2646519|NCT00747812|9142695|P2|Overall Study|Research Site Staff Relocation|3
2646520|NCT00747812|9142696|P1|Overall Study|Research Site Staff Relocation|5
2646521|NCT00747643|9142734|P2|Overall Study|Withdrawal by Subject|27
2646522|NCT00747643|9142735|P1|Overall Study|Withdrawal by Subject|36
2646523|NCT00747617|9142749|P2|Overall Study|Lost to Follow-up|1
2646524|NCT00747617|9142750|P1|Overall Study|Lost to Follow-up|3
2646525|NCT00747565|9142760|P2|Overall Study|Lost to Follow-up|1
2646526|NCT00747565|9142761|P1|Overall Study|Lost to Follow-up|4
2646527|NCT00747565|9142760|P2|Overall Study|Withdrawal by Subject|6
2646528|NCT00747565|9142761|P1|Overall Study|Withdrawal by Subject|10
2646529|NCT00747474|9142774|P12|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
2646530|NCT00747474|9142775|P11|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
2646531|NCT00747474|9142776|P10|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
2646532|NCT00747474|9142777|P9|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
2646533|NCT00747474|9142778|P8|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1
2646534|NCT00747474|9142779|P7|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
2646535|NCT00747474|9142780|P6|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
2646536|NCT00747474|9142781|P5|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
2646537|NCT00747474|9142782|P4|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
2646538|NCT00747474|9142783|P3|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
2646539|NCT00747474|9142784|P2|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
2646540|NCT00747474|9142785|P1|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
2646541|NCT00747461|9142811|P1|Overall Study|study terminated by sponsor|5
2646542|NCT00747435|9142816|P1|Overall Study|Still undergoing follow up|1
2646543|NCT00747435|9142816|P1|Overall Study|Withdrawal by Subject|3
2646544|NCT00747435|9142816|P1|Overall Study|Lost to Follow-up|2
2646545|NCT00747344|9142826|P4|After Controlled Period|Adverse Event|1
2646546|NCT00747344|9142827|P3|After Controlled Period|Adverse Event|0
2646547|NCT00747344|9142828|P2|After Controlled Period|Adverse Event|0
2646548|NCT00747344|9142829|P1|After Controlled Period|Adverse Event|0
2646549|NCT00747344|9142826|P4|Controlled Period|Other|0
2646550|NCT00747344|9142827|P3|Controlled Period|Other|0
2646551|NCT00747344|9142828|P2|Controlled Period|Other|3
2646552|NCT00747344|9142829|P1|Controlled Period|Other|0
2646553|NCT00747344|9142826|P4|Controlled Period|Lack of Efficacy|0
2646554|NCT00747344|9142827|P3|Controlled Period|Lack of Efficacy|0
2646555|NCT00747344|9142828|P2|Controlled Period|Lack of Efficacy|1
2646556|NCT00747344|9142829|P1|Controlled Period|Lack of Efficacy|2
2646557|NCT00747344|9142826|P4|Controlled Period|Adverse Event|0
2646558|NCT00747344|9142827|P3|Controlled Period|Adverse Event|0
2646559|NCT00747344|9142828|P2|Controlled Period|Adverse Event|0
2646560|NCT00747344|9142829|P1|Controlled Period|Adverse Event|3
2646561|NCT00747227|9142843|P2|Overall Study|Illness|1
2646562|NCT00747227|9142844|P1|Overall Study|Illness|1
2646563|NCT00747227|9142843|P2|Overall Study|Lost to Follow-up|2
2646564|NCT00747227|9142844|P1|Overall Study|Lost to Follow-up|1
2646565|NCT00747227|9142843|P2|Overall Study|Withdrawal by Subject|0
2646566|NCT00747227|9142844|P1|Overall Study|Withdrawal by Subject|1
2646567|NCT00747227|9142843|P2|Overall Study|Death|1
2646568|NCT00747227|9142844|P1|Overall Study|Death|3
2646569|NCT00747149|9142873|P2|Overall Study|Not reported|4
2646570|NCT00747149|9142874|P1|Overall Study|Not reported|1
2646571|NCT00747149|9142873|P2|Overall Study|Severe non-compliance to protocol|1
2646572|NCT00747149|9142874|P1|Overall Study|Severe non-compliance to protocol|0
2646573|NCT00747149|9142873|P2|Overall Study|Incorrect enrollment|6
2646574|NCT00747149|9142874|P1|Overall Study|Incorrect enrollment|0
2646575|NCT00747149|9142873|P2|Overall Study|Did not receive treatment|1
2646576|NCT00747149|9142874|P1|Overall Study|Did not receive treatment|0
2646577|NCT00747149|9142873|P2|Overall Study|Withdrawal by Subject|6
2646578|NCT00747149|9142874|P1|Overall Study|Withdrawal by Subject|0
2646579|NCT00747149|9142873|P2|Overall Study|Lost to Follow-up|10
2646580|NCT00747149|9142874|P1|Overall Study|Lost to Follow-up|0
2646581|NCT00747149|9142873|P2|Overall Study|Adverse Event|15
2646582|NCT00747149|9142874|P1|Overall Study|Adverse Event|0
2646583|NCT00747006|9142889|P3|Overall Study|Physician Decision|1
2646584|NCT00747006|9142890|P2|Overall Study|Physician Decision|0
2646585|NCT00747006|9142891|P1|Overall Study|Physician Decision|2
2646586|NCT00747006|9142889|P3|Overall Study|Lost to Follow-up|0
2646587|NCT00747006|9142890|P2|Overall Study|Lost to Follow-up|1
2646588|NCT00747006|9142891|P1|Overall Study|Lost to Follow-up|0
2646589|NCT00747006|9142889|P3|Overall Study|Adverse Event|0
2646590|NCT00747006|9142890|P2|Overall Study|Adverse Event|0
2646591|NCT00747006|9142891|P1|Overall Study|Adverse Event|1
2646592|NCT00746941|9142969|P4|Overall Study|Adverse Event|1
2646593|NCT00746941|9142970|P3|Overall Study|Adverse Event|0
2646594|NCT00746941|9142971|P2|Overall Study|Adverse Event|0
2646595|NCT00746941|9142972|P1|Overall Study|Adverse Event|0
2646596|NCT00746941|9142969|P4|Overall Study|Other, reason not provided|4
2646597|NCT00746941|9142970|P3|Overall Study|Other, reason not provided|0
2646598|NCT00746941|9142971|P2|Overall Study|Other, reason not provided|4
2646599|NCT00746941|9142972|P1|Overall Study|Other, reason not provided|2
2646600|NCT00746941|9142969|P4|Overall Study|Withdrawal by Subject|2
2646601|NCT00746941|9142970|P3|Overall Study|Withdrawal by Subject|0
2646602|NCT00746941|9142971|P2|Overall Study|Withdrawal by Subject|0
2646603|NCT00746941|9142972|P1|Overall Study|Withdrawal by Subject|3
2646604|NCT00746941|9142969|P4|Overall Study|Physician Decision|0
2646605|NCT00746941|9142970|P3|Overall Study|Physician Decision|2
2646606|NCT00746941|9142971|P2|Overall Study|Physician Decision|0
2646607|NCT00746941|9142972|P1|Overall Study|Physician Decision|0
2646608|NCT00746941|9142969|P4|Overall Study|Death|6
2646609|NCT00746941|9142970|P3|Overall Study|Death|0
2646610|NCT00746941|9142971|P2|Overall Study|Death|0
2646611|NCT00746941|9142972|P1|Overall Study|Death|2
2646612|NCT00746798|9143030|P4|Overall Study|Participant unable to return for visit|0
2646613|NCT00746798|9143031|P3|Overall Study|Participant unable to return for visit|0
2646614|NCT00746798|9143032|P2|Overall Study|Participant unable to return for visit|0
2646615|NCT00746798|9143033|P1|Overall Study|Participant unable to return for visit|1
2646616|NCT00746798|9143030|P4|Overall Study|Death|0
2646617|NCT00746798|9143031|P3|Overall Study|Death|2
2646618|NCT00746798|9143032|P2|Overall Study|Death|0
2646619|NCT00746798|9143033|P1|Overall Study|Death|0
2646620|NCT00746798|9143030|P4|Overall Study|Withdrawal by Subject|0
2646621|NCT00746798|9143031|P3|Overall Study|Withdrawal by Subject|1
2646622|NCT00746798|9143032|P2|Overall Study|Withdrawal by Subject|1
2646623|NCT00746798|9143033|P1|Overall Study|Withdrawal by Subject|0
2646624|NCT00746798|9143030|P4|Overall Study|Protocol Violation|0
2646625|NCT00746798|9143031|P3|Overall Study|Protocol Violation|0
2646626|NCT00746798|9143032|P2|Overall Study|Protocol Violation|1
2646627|NCT00746798|9143033|P1|Overall Study|Protocol Violation|0
2646628|NCT00746785|9143058|P3|Overall Study|Lost to Follow-up|27
2646629|NCT00746785|9143059|P2|Overall Study|Lost to Follow-up|25
2646630|NCT00746785|9143060|P1|Overall Study|Lost to Follow-up|29
2646631|NCT00746733|9143068|P2|Third Intervention|Withdrawal by Subject|1
2646632|NCT00746733|9143069|P1|Third Intervention|Withdrawal by Subject|1
2646633|NCT00746733|9143068|P2|Second Intervention|Adverse Event|0
2646634|NCT00746733|9143069|P1|Second Intervention|Adverse Event|1
2646635|NCT00746590|9143153|P1|Overall Study|Death|1
2646636|NCT00746564|9143157|P1|Overall Study|Required Pacemaker/ICD Implant|2
2646637|NCT00746551|9143172|P2|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8
2646638|NCT00746551|9143173|P1|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6
2646639|NCT00746551|9143172|P2|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7
2646640|NCT00746551|9143173|P1|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9
2646641|NCT00746551|9143172|P2|At Gestational Age of 36 Weeks|Lost to Follow-up|4
2646642|NCT00746551|9143173|P1|At Gestational Age of 36 Weeks|Lost to Follow-up|2
2646643|NCT00746356|9143224|P2|Overall Study|Patient relocated|0
2646644|NCT00746356|9143225|P1|Overall Study|Patient relocated|1
2646645|NCT00746356|9143224|P2|Overall Study|Removal of Device|1
2646646|NCT00746356|9143225|P1|Overall Study|Removal of Device|0
2646647|NCT00746356|9143224|P2|Overall Study|Lost to Follow-up|0
2646648|NCT00746356|9143225|P1|Overall Study|Lost to Follow-up|1
2646649|NCT00746356|9143224|P2|Overall Study|Death|3
2646650|NCT00746356|9143225|P1|Overall Study|Death|7
2646651|NCT00746356|9143224|P2|Overall Study|Withdrawal by Subject|3
2646652|NCT00746356|9143225|P1|Overall Study|Withdrawal by Subject|2
2646653|NCT00746330|9143237|P4|Period 1|Abnormal test procedure result|0
2646654|NCT00746330|9143238|P3|Period 1|Abnormal test procedure result|1
2646655|NCT00746330|9143239|P2|Period 1|Abnormal test procedure result|0
2646656|NCT00746330|9143240|P1|Period 1|Abnormal test procedure result|0
2646657|NCT00746252|9143270|P2|Overall Study|weight gain >7.5 %|2
2646658|NCT00746252|9143271|P1|Overall Study|weight gain >7.5 %|1
2646659|NCT00746096|9143306|P2|Overall Study|No study drug treatment|1
2646660|NCT00746096|9143307|P1|Overall Study|No study drug treatment|1
2646661|NCT00746096|9143306|P2|Overall Study|Protocol Violation|0
2646662|NCT00746096|9143307|P1|Overall Study|Protocol Violation|1
2646663|NCT00746096|9143306|P2|Overall Study|Lost to Follow-up|1
2646664|NCT00746096|9143307|P1|Overall Study|Lost to Follow-up|2
2646665|NCT00746096|9143306|P2|Overall Study|Withdrawal by Subject|1
2646666|NCT00746096|9143307|P1|Overall Study|Withdrawal by Subject|5
2646667|NCT00746096|9143306|P2|Overall Study|Adverse Event|0
2646668|NCT00746096|9143307|P1|Overall Study|Adverse Event|1
2646669|NCT00745901|9143338|P2|Overall Study|Patient didn't take any study medication|3
2646670|NCT00745901|9143339|P1|Overall Study|Patient didn't take any study medication|7
2646671|NCT00745901|9143338|P2|Overall Study|Chlamydia test at Visit 1 was positive|1
2646672|NCT00745901|9143339|P1|Overall Study|Chlamydia test at Visit 1 was positive|1
2646673|NCT00745901|9143338|P2|Overall Study|Results of Pap smear at Vis 1 malignant|2
2646674|NCT00745901|9143339|P1|Overall Study|Results of Pap smear at Vis 1 malignant|0
2646675|NCT00745901|9143338|P2|Overall Study|Patient's next menses did not start with|0
2646676|NCT00745901|9143339|P1|Overall Study|Patient's next menses did not start with|1
2646677|NCT00745901|9143338|P2|Overall Study|Lack of compliance|2
2646678|NCT00745901|9143339|P1|Overall Study|Lack of compliance|2
2646679|NCT00745901|9143338|P2|Overall Study|Pregnancy|4
2646680|NCT00745901|9143339|P1|Overall Study|Pregnancy|2
2646681|NCT00745901|9143338|P2|Overall Study|Lost to Follow-up|4
2646682|NCT00745901|9143339|P1|Overall Study|Lost to Follow-up|7
2646683|NCT00745901|9143338|P2|Overall Study|Withdrawal by Subject|0
2646684|NCT00745901|9143339|P1|Overall Study|Withdrawal by Subject|1
2646685|NCT00745901|9143338|P2|Overall Study|Protocol Violation|1
2646686|NCT00745901|9143339|P1|Overall Study|Protocol Violation|0
2646687|NCT00745901|9143338|P2|Overall Study|Adverse Event|4
2646688|NCT00745901|9143339|P1|Overall Study|Adverse Event|3
2646689|NCT00745875|9143385|P2|Overall Study|Continuing study treatment|4
2646690|NCT00745875|9143386|P1|Overall Study|Continuing study treatment|4
2646691|NCT00745849|9143394|P2|Second Intervention|Lost to Follow-up|1
2646692|NCT00745849|9143395|P1|Second Intervention|Lost to Follow-up|2
2646693|NCT00745849|9143394|P2|First Intervention|Lost to Follow-up|1
2646694|NCT00745849|9143395|P1|First Intervention|Lost to Follow-up|1
2646695|NCT00745849|9143394|P2|First Intervention|Withdrawal by Subject|1
2646696|NCT00745849|9143395|P1|First Intervention|Withdrawal by Subject|0
2646697|NCT00745823|9143403|P2|Overall Study|Study Terminated by Sponsor|349
2646698|NCT00745823|9143404|P1|Overall Study|Study Terminated by Sponsor|326
2646699|NCT00745823|9143403|P2|Overall Study|Withdrawal by Subject|8
2646700|NCT00745823|9143404|P1|Overall Study|Withdrawal by Subject|14
2646701|NCT00745823|9143403|P2|Overall Study|Pregnancy|4
2646702|NCT00745823|9143404|P1|Overall Study|Pregnancy|0
2646703|NCT00745823|9143403|P2|Overall Study|Physician Decision|5
2646704|NCT00745823|9143404|P1|Overall Study|Physician Decision|10
2646705|NCT00745823|9143403|P2|Overall Study|Lost to Follow-up|11
2646706|NCT00745823|9143404|P1|Overall Study|Lost to Follow-up|10
2646707|NCT00745823|9143403|P2|Overall Study|Lack of Efficacy|6
2646708|NCT00745823|9143404|P1|Overall Study|Lack of Efficacy|20
2646709|NCT00745823|9143403|P2|Overall Study|Adverse Event|3
2646710|NCT00745823|9143404|P1|Overall Study|Adverse Event|5
2646711|NCT00745615|9143432|P6|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10
2646712|NCT00745615|9143433|P5|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8
2646713|NCT00745615|9143434|P4|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
2646714|NCT00745615|9143435|P3|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
2646715|NCT00745615|9143436|P2|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
2646716|NCT00745615|9143437|P1|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
2646717|NCT00745615|9143432|P6|Open-Label (up to Approx 10.5 Years)|Death|1
2646718|NCT00745615|9143433|P5|Open-Label (up to Approx 10.5 Years)|Death|0
2646719|NCT00745615|9143434|P4|Open-Label (up to Approx 10.5 Years)|Death|0
2646720|NCT00745615|9143435|P3|Open-Label (up to Approx 10.5 Years)|Death|0
2646721|NCT00745615|9143436|P2|Open-Label (up to Approx 10.5 Years)|Death|0
2646722|NCT00745615|9143437|P1|Open-Label (up to Approx 10.5 Years)|Death|0
2646723|NCT00745615|9143432|P6|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1
2646724|NCT00745615|9143433|P5|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
2646725|NCT00745615|9143434|P4|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
2646726|NCT00745615|9143435|P3|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
2646727|NCT00745615|9143436|P2|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
2646728|NCT00745615|9143437|P1|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
2646729|NCT00745615|9143432|P6|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3
2646730|NCT00745615|9143433|P5|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1
2646731|NCT00745615|9143434|P4|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
2646732|NCT00745615|9143435|P3|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
2646733|NCT00745615|9143436|P2|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
2646734|NCT00745615|9143437|P1|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
2646735|NCT00745615|9143432|P6|Open-Label (up to Approx 10.5 Years)|Pregnancy|5
2646736|NCT00745615|9143433|P5|Open-Label (up to Approx 10.5 Years)|Pregnancy|2
2646737|NCT00745615|9143434|P4|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
2646813|NCT00745121|9143552|P2|Overall Study|Withdrawal by Subject|2
2646738|NCT00745615|9143435|P3|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
2646739|NCT00745615|9143436|P2|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
2646740|NCT00745615|9143437|P1|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
2646741|NCT00745615|9143432|P6|Open-Label (up to Approx 10.5 Years)|Adverse Event|8
2646742|NCT00745615|9143433|P5|Open-Label (up to Approx 10.5 Years)|Adverse Event|2
2646743|NCT00745615|9143434|P4|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
2646744|NCT00745615|9143435|P3|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
2646745|NCT00745615|9143436|P2|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
2646746|NCT00745615|9143437|P1|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
2646747|NCT00745615|9143432|P6|Open-Label (up to Approx 10.5 Years)|Physician Decision|11
2646748|NCT00745615|9143433|P5|Open-Label (up to Approx 10.5 Years)|Physician Decision|9
2646749|NCT00745615|9143434|P4|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
2646750|NCT00745615|9143435|P3|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
2646751|NCT00745615|9143436|P2|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
2646752|NCT00745615|9143437|P1|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
2646753|NCT00745615|9143432|P6|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19
2646754|NCT00745615|9143433|P5|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19
2646755|NCT00745615|9143434|P4|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
2646756|NCT00745615|9143435|P3|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
2646757|NCT00745615|9143436|P2|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
2646758|NCT00745615|9143437|P1|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
2646759|NCT00745615|9143432|P6|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50
2646760|NCT00745615|9143433|P5|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50
2646761|NCT00745615|9143434|P4|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
2646762|NCT00745615|9143435|P3|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
2646763|NCT00745615|9143436|P2|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
2646764|NCT00745615|9143437|P1|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
2646765|NCT00745615|9143432|P6|Double-Blind Extension (36 Weeks)|Other Than Specified|0
2646766|NCT00745615|9143433|P5|Double-Blind Extension (36 Weeks)|Other Than Specified|0
2646767|NCT00745615|9143434|P4|Double-Blind Extension (36 Weeks)|Other Than Specified|0
2646768|NCT00745615|9143435|P3|Double-Blind Extension (36 Weeks)|Other Than Specified|0
2646769|NCT00745615|9143436|P2|Double-Blind Extension (36 Weeks)|Other Than Specified|1
2646770|NCT00745615|9143437|P1|Double-Blind Extension (36 Weeks)|Other Than Specified|0
2646771|NCT00745615|9143432|P6|Double-Blind Extension (36 Weeks)|Pregnancy|0
2646772|NCT00745615|9143433|P5|Double-Blind Extension (36 Weeks)|Pregnancy|0
2646773|NCT00745615|9143434|P4|Double-Blind Extension (36 Weeks)|Pregnancy|0
2646774|NCT00745615|9143435|P3|Double-Blind Extension (36 Weeks)|Pregnancy|0
2646775|NCT00745615|9143436|P2|Double-Blind Extension (36 Weeks)|Pregnancy|1
2646776|NCT00745615|9143437|P1|Double-Blind Extension (36 Weeks)|Pregnancy|0
2646777|NCT00745615|9143432|P6|Double-Blind Extension (36 Weeks)|Adverse Event|0
2646778|NCT00745615|9143433|P5|Double-Blind Extension (36 Weeks)|Adverse Event|0
2646779|NCT00745615|9143434|P4|Double-Blind Extension (36 Weeks)|Adverse Event|1
2646780|NCT00745615|9143435|P3|Double-Blind Extension (36 Weeks)|Adverse Event|1
2646781|NCT00745615|9143436|P2|Double-Blind Extension (36 Weeks)|Adverse Event|3
2646782|NCT00745615|9143437|P1|Double-Blind Extension (36 Weeks)|Adverse Event|2
2646783|NCT00745615|9143432|P6|Double-Blind Extension (36 Weeks)|Physician Decision|0
2646784|NCT00745615|9143433|P5|Double-Blind Extension (36 Weeks)|Physician Decision|0
2646785|NCT00745615|9143434|P4|Double-Blind Extension (36 Weeks)|Physician Decision|0
2646786|NCT00745615|9143435|P3|Double-Blind Extension (36 Weeks)|Physician Decision|0
2646787|NCT00745615|9143436|P2|Double-Blind Extension (36 Weeks)|Physician Decision|1
2646788|NCT00745615|9143437|P1|Double-Blind Extension (36 Weeks)|Physician Decision|0
2646789|NCT00745615|9143432|P6|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
2646790|NCT00745615|9143433|P5|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
2646791|NCT00745615|9143434|P4|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4
2646792|NCT00745615|9143435|P3|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
2646793|NCT00745615|9143436|P2|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1
2646794|NCT00745615|9143437|P1|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3
2646795|NCT00745498|9143486|P3|Overall Study|Edophthalmitis after preoperative IVB|0
2646796|NCT00745498|9143487|P2|Overall Study|Edophthalmitis after preoperative IVB|0
2646797|NCT00745498|9143488|P1|Overall Study|Edophthalmitis after preoperative IVB|1
2646798|NCT00745498|9143486|P3|Overall Study|Non-PDR related VH|1
2646799|NCT00745498|9143487|P2|Overall Study|Non-PDR related VH|1
2646800|NCT00745498|9143488|P1|Overall Study|Non-PDR related VH|0
2646801|NCT00745498|9143486|P3|Overall Study|Injection of intravitreal silicone oil o|4
2646802|NCT00745498|9143487|P2|Overall Study|Injection of intravitreal silicone oil o|4
2646803|NCT00745498|9143488|P1|Overall Study|Injection of intravitreal silicone oil o|3
2646804|NCT00745498|9143486|P3|Overall Study|Lost to Follow-up|3
2646805|NCT00745498|9143487|P2|Overall Study|Lost to Follow-up|1
2646806|NCT00745498|9143488|P1|Overall Study|Lost to Follow-up|1
2646807|NCT00745420|9143502|P1|Overall Study|Ineligible|1
2646808|NCT00745368|9143519|P1|Overall Study|Unable to provide sample|3
2646809|NCT00745251|9143541|P2|Overall Study|Withdrawal by Subject|1
2646810|NCT00745251|9143542|P1|Overall Study|Withdrawal by Subject|1
2646811|NCT00745251|9143541|P2|Overall Study|Adverse Event|2
2646812|NCT00745251|9143542|P1|Overall Study|Adverse Event|1
2646814|NCT00745121|9143553|P1|Overall Study|Withdrawal by Subject|4
2646815|NCT00745121|9143552|P2|Overall Study|Lost to Follow-up|0
2646816|NCT00745121|9143553|P1|Overall Study|Lost to Follow-up|1
2646817|NCT00745121|9143552|P2|Overall Study|Adverse Event|0
2646818|NCT00745121|9143553|P1|Overall Study|Adverse Event|1
2646819|NCT00745121|9143552|P2|Overall Study|Death|0
2646820|NCT00745121|9143553|P1|Overall Study|Death|3
2646821|NCT00745095|9143565|P6|Overall Study|Ineligible due to GFR criteria|28
2646822|NCT00745095|9143566|P5|Overall Study|Ineligible due to GFR criteria|30
2646823|NCT00745095|9143567|P4|Overall Study|Ineligible due to GFR criteria|3
2646824|NCT00745095|9143568|P3|Overall Study|Ineligible due to GFR criteria|3
2646825|NCT00745095|9143569|P2|Overall Study|Ineligible due to GFR criteria|2
2646826|NCT00745095|9143570|P1|Overall Study|Ineligible due to GFR criteria|0
2646827|NCT00745095|9143565|P6|Overall Study|Declined to participate|95
2646828|NCT00745095|9143566|P5|Overall Study|Declined to participate|92
2646829|NCT00745095|9143567|P4|Overall Study|Declined to participate|0
2646830|NCT00745095|9143568|P3|Overall Study|Declined to participate|0
2646831|NCT00745095|9143569|P2|Overall Study|Declined to participate|0
2646832|NCT00745095|9143570|P1|Overall Study|Declined to participate|1
2646833|NCT00744978|9143601|P2|Period 2|Adverse Event|1
2646834|NCT00744978|9143602|P1|Period 2|Adverse Event|0
2646835|NCT00744978|9143601|P2|Period 1|Randomized but not Treated|1
2646836|NCT00744978|9143602|P1|Period 1|Randomized but not Treated|1
2646837|NCT00744978|9143601|P2|Period 1|Adverse Event|0
2646838|NCT00744978|9143602|P1|Period 1|Adverse Event|4
2646839|NCT00744978|9143601|P2|Period 1|Other|2
2646840|NCT00744978|9143602|P1|Period 1|Other|0
2646841|NCT00744978|9143601|P2|Period 1|Withdrawal by Subject|2
2646842|NCT00744978|9143602|P1|Period 1|Withdrawal by Subject|0
2646843|NCT00744978|9143601|P2|Period 1|Lost to Follow-up|0
2646844|NCT00744978|9143602|P1|Period 1|Lost to Follow-up|1
2646845|NCT00744939|9143683|P1|Overall Study|incorrect race|1
2646846|NCT00744939|9143683|P1|Overall Study|coma|1
2646847|NCT00744939|9143683|P1|Overall Study|Failed inclusion/exclusion criteria|19
2646848|NCT00744939|9143683|P1|Overall Study|Did not receive Magnevist|7
2646849|NCT00744939|9143683|P1|Overall Study|Medical history exclusionary|1
2646850|NCT00744939|9143683|P1|Overall Study|Lost to Follow-up|12
2646851|NCT00744939|9143683|P1|Overall Study|distance|4
2646852|NCT00744939|9143683|P1|Overall Study|Death|24
2646853|NCT00744939|9143683|P1|Overall Study|Protocol Violation|13
2646854|NCT00744939|9143683|P1|Overall Study|Withdrawal by Subject|9
2646855|NCT00744874|9143719|P1|Overall Study|Unable to accomodate schedule|1
2646856|NCT00744874|9143719|P1|Overall Study|Study Device not available at procedure|1
2646857|NCT00744874|9143719|P1|Overall Study|Withdrawal by Subject|1
2646858|NCT00744874|9143719|P1|Overall Study|Lost to Follow-up|1
2646859|NCT00744757|9143744|P1|Overall Study|Adverse Event|2
2646860|NCT00744757|9143744|P1|Overall Study|Death|6
2646861|NCT00744757|9143744|P1|Overall Study|Withdrawal by Subject|1
2646862|NCT00744757|9143744|P1|Overall Study|Physician Decision|5
2646863|NCT00744757|9143744|P1|Overall Study|Objective disease progression|7
2646864|NCT00744653|9143769|P1|Overall Study|Physician Decision|3
2646865|NCT00744653|9143769|P1|Overall Study|Lost to Follow-up|1
2646866|NCT00744653|9143769|P1|Overall Study|Death|1
2646867|NCT00744653|9143769|P1|Overall Study|antineoplastic treatment|11
2646868|NCT00744627|9143777|P2|Overall Study|Other|0
2646869|NCT00744627|9143778|P1|Overall Study|Other|1
2646870|NCT00744627|9143777|P2|Overall Study|Lost to Follow-up|1
2646871|NCT00744627|9143778|P1|Overall Study|Lost to Follow-up|2
2646872|NCT00744627|9143777|P2|Overall Study|Voluntary Withdrawal|6
2646873|NCT00744627|9143778|P1|Overall Study|Voluntary Withdrawal|9
2646874|NCT00744627|9143777|P2|Overall Study|Protocol Deviations|2
2646875|NCT00744627|9143778|P1|Overall Study|Protocol Deviations|0
2646876|NCT00744627|9143777|P2|Overall Study|Noncompliance|1
2646877|NCT00744627|9143778|P1|Overall Study|Noncompliance|0
2646878|NCT00744627|9143777|P2|Overall Study|Lack of Efficacy|3
2646879|NCT00744627|9143778|P1|Overall Study|Lack of Efficacy|7
2646880|NCT00744627|9143777|P2|Overall Study|Adverse Event|9
2646881|NCT00744627|9143778|P1|Overall Study|Adverse Event|6
2646882|NCT00744523|9143834|P2|30 Days After the Procedure|Insufficient follow-up|5
2646883|NCT00744523|9143835|P1|30 Days After the Procedure|Insufficient follow-up|0
2646884|NCT00744497|9143855|P2|Overall Study|Not defined|13
2646885|NCT00744497|9143856|P1|Overall Study|Not defined|19
2646886|NCT00744497|9143855|P2|Overall Study|Maximum clinical benefit|142
2646887|NCT00744497|9143856|P1|Overall Study|Maximum clinical benefit|141
2646888|NCT00744497|9143855|P2|Overall Study|Patient requested to stop study drug|80
2646889|NCT00744497|9143856|P1|Overall Study|Patient requested to stop study drug|65
2646890|NCT00744497|9143855|P2|Overall Study|Adverse event unrelated to study drug|122
2646891|NCT00744497|9143856|P1|Overall Study|Adverse event unrelated to study drug|78
2646892|NCT00744497|9143855|P2|Overall Study|Study drug toxicity|141
2646893|NCT00744497|9143856|P1|Overall Study|Study drug toxicity|68
2646894|NCT00744497|9143855|P2|Overall Study|Disease progression|219
2646895|NCT00744497|9143856|P1|Overall Study|Disease progression|312
2646896|NCT00744497|9143855|P2|Overall Study|Administrative Reason By Sponsor|8
2646897|NCT00744497|9143856|P1|Overall Study|Administrative Reason By Sponsor|25
2646898|NCT00744497|9143855|P2|Overall Study|No longer meets study criteria|3
2646899|NCT00744497|9143856|P1|Overall Study|No longer meets study criteria|7
2646900|NCT00744497|9143855|P2|Overall Study|Poor compliance/noncompliance|5
2646901|NCT00744497|9143856|P1|Overall Study|Poor compliance/noncompliance|9
2646902|NCT00744497|9143855|P2|Overall Study|Lost to Follow-up|2
2646903|NCT00744497|9143856|P1|Overall Study|Lost to Follow-up|4
2646904|NCT00744497|9143855|P2|Overall Study|Death|9
2646905|NCT00744497|9143856|P1|Overall Study|Death|11
2646906|NCT00744497|9143855|P2|Overall Study|Withdrawal by Subject|18
2646907|NCT00744497|9143856|P1|Overall Study|Withdrawal by Subject|21
2646908|NCT00744328|9143916|P3|Overall Study|Found ineligible after randomization|1
2646909|NCT00744328|9143917|P2|Overall Study|Found ineligible after randomization|0
2646910|NCT00744328|9143918|P1|Overall Study|Found ineligible after randomization|0
2646911|NCT00744328|9143916|P3|Overall Study|Withdrawal by Subject|4
2646912|NCT00744328|9143917|P2|Overall Study|Withdrawal by Subject|3
2646913|NCT00744328|9143918|P1|Overall Study|Withdrawal by Subject|5
2646914|NCT00744328|9143916|P3|Overall Study|Lost to Follow-up|3
2646915|NCT00744328|9143917|P2|Overall Study|Lost to Follow-up|5
2646916|NCT00744328|9143918|P1|Overall Study|Lost to Follow-up|2
2646917|NCT00744263|9143931|P2|Overall Study|Other|2
2646918|NCT00744263|9143932|P1|Overall Study|Other|2
2646919|NCT00744263|9143931|P2|Overall Study|Adverse Event|0
2646920|NCT00744263|9143932|P1|Overall Study|Adverse Event|1
2646921|NCT00744263|9143931|P2|Overall Study|Protocol Violation|5
2646922|NCT00744263|9143932|P1|Overall Study|Protocol Violation|3
2646923|NCT00744263|9143931|P2|Overall Study|Physician Decision|23
2646924|NCT00744263|9143932|P1|Overall Study|Physician Decision|20
2646925|NCT00744263|9143931|P2|Overall Study|Withdrawal by Subject|150
2646926|NCT00744263|9143932|P1|Overall Study|Withdrawal by Subject|166
2646927|NCT00744263|9143931|P2|Overall Study|Lost to Follow-up|2135
2646928|NCT00744263|9143932|P1|Overall Study|Lost to Follow-up|2038
2646929|NCT00744263|9143931|P2|Overall Study|Death|3005
2646930|NCT00744263|9143932|P1|Overall Study|Death|3006
2646931|NCT00744237|9143955|P3|Overall Study|Adverse Event|5
2646932|NCT00744237|9143956|P2|Overall Study|Adverse Event|13
2646933|NCT00744237|9143957|P1|Overall Study|Adverse Event|9
2646934|NCT00744237|9143955|P3|Overall Study|Administrative. Site Closed|1
2646935|NCT00744237|9143956|P2|Overall Study|Administrative. Site Closed|1
2646936|NCT00744237|9143957|P1|Overall Study|Administrative. Site Closed|1
2646937|NCT00744237|9143955|P3|Overall Study|Poor Compliance|0
2646938|NCT00744237|9143956|P2|Overall Study|Poor Compliance|2
2646939|NCT00744237|9143957|P1|Overall Study|Poor Compliance|0
2646940|NCT00744237|9143955|P3|Overall Study|Prohibited Concomitant Medication|1
2646941|NCT00744237|9143956|P2|Overall Study|Prohibited Concomitant Medication|0
2646942|NCT00744237|9143957|P1|Overall Study|Prohibited Concomitant Medication|0
2646943|NCT00744237|9143955|P3|Overall Study|Study Drug Error|0
2646944|NCT00744237|9143956|P2|Overall Study|Study Drug Error|0
2646945|NCT00744237|9143957|P1|Overall Study|Study Drug Error|1
2646946|NCT00744237|9143955|P3|Overall Study|Dosing Error|1
2646947|NCT00744237|9143956|P2|Overall Study|Dosing Error|0
2646948|NCT00744237|9143957|P1|Overall Study|Dosing Error|1
2646949|NCT00744237|9143955|P3|Overall Study|Inclusion/Exclusion criteria not met|0
2646950|NCT00744237|9143956|P2|Overall Study|Inclusion/Exclusion criteria not met|0
2646951|NCT00744237|9143957|P1|Overall Study|Inclusion/Exclusion criteria not met|1
2646952|NCT00744237|9143955|P3|Overall Study|Protocol Violation|3
2646953|NCT00744237|9143956|P2|Overall Study|Protocol Violation|4
2646954|NCT00744237|9143957|P1|Overall Study|Protocol Violation|3
2646955|NCT00744237|9143955|P3|Overall Study|Lost to Follow-up|1
2646956|NCT00744237|9143956|P2|Overall Study|Lost to Follow-up|1
2646957|NCT00744237|9143957|P1|Overall Study|Lost to Follow-up|1
2646958|NCT00744237|9143955|P3|Overall Study|Withdrawal by Subject|3
2646959|NCT00744237|9143956|P2|Overall Study|Withdrawal by Subject|5
2646960|NCT00744237|9143957|P1|Overall Study|Withdrawal by Subject|9
2646961|NCT00744237|9143955|P3|Overall Study|Lack of Efficacy|0
2646962|NCT00744237|9143956|P2|Overall Study|Lack of Efficacy|1
2646963|NCT00744237|9143957|P1|Overall Study|Lack of Efficacy|1
2646964|NCT00744055|9143991|P2|Overall Study|Lost to Follow-up|1
2646965|NCT00744055|9143992|P1|Overall Study|Lost to Follow-up|0
2646966|NCT00744055|9143991|P2|Overall Study|Protocol Violation|1
2646967|NCT00744055|9143992|P1|Overall Study|Protocol Violation|1
2646968|NCT00744055|9143991|P2|Overall Study|Physician Decision|2
2646969|NCT00744055|9143992|P1|Overall Study|Physician Decision|0
2646970|NCT00744055|9143991|P2|Overall Study|Lack of Efficacy|1
2646971|NCT00744055|9143992|P1|Overall Study|Lack of Efficacy|0
2646972|NCT00744055|9143991|P2|Overall Study|Withdrawal by Subject|9
2646973|NCT00744055|9143992|P1|Overall Study|Withdrawal by Subject|6
2646974|NCT00744042|9144000|P1|Overall Study|Withdrawal by Subject|1
2646975|NCT00743652|9144046|P5|Overall Study|Lost to Follow-up|0
2646976|NCT00743652|9144047|P4|Overall Study|Lost to Follow-up|0
2646977|NCT00743652|9144048|P3|Overall Study|Lost to Follow-up|0
2646978|NCT00743652|9144049|P2|Overall Study|Lost to Follow-up|0
2646979|NCT00743652|9144050|P1|Overall Study|Lost to Follow-up|1
2646980|NCT00743652|9144046|P5|Overall Study|Other|0
2646981|NCT00743652|9144047|P4|Overall Study|Other|0
2646982|NCT00743652|9144048|P3|Overall Study|Other|0
2646983|NCT00743652|9144049|P2|Overall Study|Other|1
2646984|NCT00743652|9144050|P1|Overall Study|Other|1
2646985|NCT00743652|9144046|P5|Overall Study|Investigator Request|0
2646986|NCT00743652|9144047|P4|Overall Study|Investigator Request|2
2646987|NCT00743652|9144048|P3|Overall Study|Investigator Request|0
2646988|NCT00743652|9144049|P2|Overall Study|Investigator Request|0
2646989|NCT00743652|9144050|P1|Overall Study|Investigator Request|0
2646990|NCT00743652|9144046|P5|Overall Study|Death|0
2646991|NCT00743652|9144047|P4|Overall Study|Death|0
2646992|NCT00743652|9144048|P3|Overall Study|Death|0
2646993|NCT00743652|9144049|P2|Overall Study|Death|0
2646994|NCT00743652|9144050|P1|Overall Study|Death|2
2646995|NCT00743652|9144046|P5|Overall Study|Adverse Event|0
2646996|NCT00743652|9144047|P4|Overall Study|Adverse Event|0
2646997|NCT00743652|9144048|P3|Overall Study|Adverse Event|0
2646998|NCT00743652|9144049|P2|Overall Study|Adverse Event|0
2646999|NCT00743652|9144050|P1|Overall Study|Adverse Event|3
2647000|NCT00743652|9144046|P5|Overall Study|Parent/Legal Guardian Request|0
2647001|NCT00743652|9144047|P4|Overall Study|Parent/Legal Guardian Request|2
2647002|NCT00743652|9144048|P3|Overall Study|Parent/Legal Guardian Request|2
2647003|NCT00743652|9144049|P2|Overall Study|Parent/Legal Guardian Request|2
2647004|NCT00743652|9144050|P1|Overall Study|Parent/Legal Guardian Request|3
2647005|NCT00743509|9144134|P1|Overall Study|Withdrawal by Subject|2
2647006|NCT00743483|9144139|P1|Treatment Period|Adverse Event|1
2647007|NCT00743483|9144139|P1|Baseline Period|Physician Decision|1
2647008|NCT00743444|9144143|P2|Washout Period|Adverse Event|1
2647009|NCT00743444|9144144|P1|Washout Period|Adverse Event|0
2647010|NCT00743444|9144143|P2|First Intervention|Catheter placement problems|1
2647011|NCT00743444|9144144|P1|First Intervention|Catheter placement problems|0
2647012|NCT00743431|9144153|P1|Overall Study|No documentation available|13
2647013|NCT00743431|9144153|P1|Overall Study|Reason for discontinuation not specified|29
2647014|NCT00743431|9144153|P1|Overall Study|Death|9
2647015|NCT00743431|9144153|P1|Overall Study|Withdrawal by Subject|13
2647016|NCT00743431|9144153|P1|Overall Study|Tumor progression|56
2647017|NCT00743431|9144153|P1|Overall Study|Toxicity|6
2647018|NCT00743366|9144157|P2|Intervention 1 (8 Days)|Withdrawal by Subject|3
2647019|NCT00743366|9144158|P1|Intervention 1 (8 Days)|Withdrawal by Subject|3
2647020|NCT00743340|9144164|P1|Overall Study|Participant Relocated|1
2647021|NCT00743340|9144164|P1|Overall Study|Rolled over to other Gilead Study|23
2647022|NCT00743340|9144164|P1|Overall Study|Pregnancy|1
2647023|NCT00743340|9144164|P1|Overall Study|Virologic failure|8
2647024|NCT00743340|9144164|P1|Overall Study|Protocol Violation|1
2647025|NCT00743340|9144164|P1|Overall Study|Withdrawal from the Study|5
2647026|NCT00743340|9144164|P1|Overall Study|Lost to Follow-up|1
2647027|NCT00743340|9144164|P1|Overall Study|Study medication non-compliance|1
2647028|NCT00743288|9144168|P7|Overall Study|Worsening of condition (Not PD)|0
2647029|NCT00743288|9144169|P6|Overall Study|Worsening of condition (Not PD)|0
2647030|NCT00743288|9144170|P5|Overall Study|Worsening of condition (Not PD)|0
2647031|NCT00743288|9144171|P4|Overall Study|Worsening of condition (Not PD)|1
2647032|NCT00743288|9144172|P3|Overall Study|Worsening of condition (Not PD)|1
2647033|NCT00743288|9144173|P2|Overall Study|Worsening of condition (Not PD)|2
2647034|NCT00743288|9144174|P1|Overall Study|Worsening of condition (Not PD)|0
2647035|NCT00743288|9144168|P7|Overall Study|Progressive disease (PD)|6
2647036|NCT00743288|9144169|P6|Overall Study|Progressive disease (PD)|3
2647037|NCT00743288|9144170|P5|Overall Study|Progressive disease (PD)|5
2647038|NCT00743288|9144171|P4|Overall Study|Progressive disease (PD)|4
2647039|NCT00743288|9144172|P3|Overall Study|Progressive disease (PD)|1
2647040|NCT00743288|9144173|P2|Overall Study|Progressive disease (PD)|0
2647041|NCT00743288|9144174|P1|Overall Study|Progressive disease (PD)|2
2647042|NCT00743288|9144168|P7|Overall Study|Withdrawal by Subject|1
2647043|NCT00743288|9144169|P6|Overall Study|Withdrawal by Subject|1
2647044|NCT00743288|9144170|P5|Overall Study|Withdrawal by Subject|0
2647045|NCT00743288|9144171|P4|Overall Study|Withdrawal by Subject|0
2647046|NCT00743288|9144172|P3|Overall Study|Withdrawal by Subject|1
2647047|NCT00743288|9144173|P2|Overall Study|Withdrawal by Subject|0
2647048|NCT00743288|9144174|P1|Overall Study|Withdrawal by Subject|0
2647049|NCT00743288|9144168|P7|Overall Study|Adverse Event|2
2647050|NCT00743288|9144169|P6|Overall Study|Adverse Event|1
2647051|NCT00743288|9144170|P5|Overall Study|Adverse Event|1
2647052|NCT00743288|9144171|P4|Overall Study|Adverse Event|2
2647053|NCT00743288|9144172|P3|Overall Study|Adverse Event|2
2647054|NCT00743288|9144173|P2|Overall Study|Adverse Event|1
2647055|NCT00743288|9144174|P1|Overall Study|Adverse Event|1
2647056|NCT00743275|9144188|P2|Overall Study|Protocol Violation|1
2647057|NCT00743275|9144189|P1|Overall Study|Protocol Violation|0
2647058|NCT00743249|9144209|P2|Overall Study|Unsuccessful insertion of stent|1
2647059|NCT00743249|9144210|P1|Overall Study|Unsuccessful insertion of stent|2
2647060|NCT00743249|9144209|P2|Overall Study|Patient Decision Unrelated to Ad Event|1
2647061|NCT00743249|9144210|P1|Overall Study|Patient Decision Unrelated to Ad Event|0
2647062|NCT00743249|9144209|P2|Overall Study|Adverse Event|4
2647063|NCT00743249|9144210|P1|Overall Study|Adverse Event|0
2647064|NCT00743197|9144220|P2|Overall Study|Study terminated due to departure of PI.|2
2647065|NCT00743197|9144221|P1|Overall Study|Study terminated due to departure of PI.|1
2647066|NCT00743145|9144227|P1|Overall Study|Pregnancy|1
2647067|NCT00743145|9144227|P1|Overall Study|Adverse Event|2
2647068|NCT00743145|9144227|P1|Overall Study|Withdrawal by Subject|1
2647069|NCT00743119|9144241|P1|Overall Study|Withdrawal by Subject|1
2647070|NCT00743119|9144241|P1|Overall Study|unreliable|3
2647071|NCT00743106|9144255|P2|Overall Study|Met intraoperative exclusion criterion|5
2647072|NCT00743106|9144256|P1|Overall Study|Met intraoperative exclusion criterion|8
2647073|NCT00742924|9144283|P4|Overall Study|Withdrawal by Subject|0
2647074|NCT00742924|9144284|P3|Overall Study|Withdrawal by Subject|1
2647075|NCT00742924|9144285|P2|Overall Study|Withdrawal by Subject|1
2647076|NCT00742924|9144286|P1|Overall Study|Withdrawal by Subject|0
2647077|NCT00742924|9144283|P4|Overall Study|Physician Decision|1
2647078|NCT00742924|9144284|P3|Overall Study|Physician Decision|0
2647079|NCT00742924|9144285|P2|Overall Study|Physician Decision|0
2647080|NCT00742924|9144286|P1|Overall Study|Physician Decision|0
2647081|NCT00742924|9144283|P4|Overall Study|Lack of Efficacy|4
2647082|NCT00742924|9144284|P3|Overall Study|Lack of Efficacy|2
2647083|NCT00742924|9144285|P2|Overall Study|Lack of Efficacy|1
2647084|NCT00742924|9144286|P1|Overall Study|Lack of Efficacy|5
2647085|NCT00742924|9144283|P4|Overall Study|Adverse Event|1
2647086|NCT00742924|9144284|P3|Overall Study|Adverse Event|1
2647087|NCT00742924|9144285|P2|Overall Study|Adverse Event|0
2647088|NCT00742924|9144286|P1|Overall Study|Adverse Event|0
2647089|NCT00742885|9144298|P2|Overall Study|Lost to Follow-up|0
2647090|NCT00742885|9144299|P1|Overall Study|Lost to Follow-up|1
2647091|NCT00742859|9144358|P4|Overall Study|Site error|1
2647092|NCT00742859|9144359|P3|Overall Study|Site error|1
2647093|NCT00742859|9144360|P2|Overall Study|Site error|0
2647094|NCT00742859|9144361|P1|Overall Study|Site error|0
2647095|NCT00742859|9144358|P4|Overall Study|Sponsor request patient out of town|1
2647096|NCT00742859|9144359|P3|Overall Study|Sponsor request patient out of town|1
2647097|NCT00742859|9144360|P2|Overall Study|Sponsor request patient out of town|0
2647098|NCT00742859|9144361|P1|Overall Study|Sponsor request patient out of town|0
2647099|NCT00742859|9144358|P4|Overall Study|Sponsor req visit schedule noncompliance|1
2647100|NCT00742859|9144359|P3|Overall Study|Sponsor req visit schedule noncompliance|0
2647101|NCT00742859|9144360|P2|Overall Study|Sponsor req visit schedule noncompliance|0
2647102|NCT00742859|9144361|P1|Overall Study|Sponsor req visit schedule noncompliance|0
2647103|NCT00742859|9144358|P4|Overall Study|Amendment 2 patient off study drug >4wks|0
2647104|NCT00742859|9144359|P3|Overall Study|Amendment 2 patient off study drug >4wks|1
2647105|NCT00742859|9144360|P2|Overall Study|Amendment 2 patient off study drug >4wks|1
2647106|NCT00742859|9144361|P1|Overall Study|Amendment 2 patient off study drug >4wks|0
2647107|NCT00742859|9144358|P4|Overall Study|Endpoint|2
2647108|NCT00742859|9144359|P3|Overall Study|Endpoint|1
2647109|NCT00742859|9144360|P2|Overall Study|Endpoint|1
2647110|NCT00742859|9144361|P1|Overall Study|Endpoint|0
2647111|NCT00742859|9144358|P4|Overall Study|Withdrawal by Subject|1
2647112|NCT00742859|9144359|P3|Overall Study|Withdrawal by Subject|4
2647113|NCT00742859|9144360|P2|Overall Study|Withdrawal by Subject|2
2647114|NCT00742859|9144361|P1|Overall Study|Withdrawal by Subject|4
2647115|NCT00742859|9144358|P4|Overall Study|Physician Decision|0
2647116|NCT00742859|9144359|P3|Overall Study|Physician Decision|0
2647117|NCT00742859|9144360|P2|Overall Study|Physician Decision|2
2647118|NCT00742859|9144361|P1|Overall Study|Physician Decision|1
2647119|NCT00742859|9144358|P4|Overall Study|Death|1
2647120|NCT00742859|9144359|P3|Overall Study|Death|0
2647121|NCT00742859|9144360|P2|Overall Study|Death|0
2647122|NCT00742859|9144361|P1|Overall Study|Death|1
2647123|NCT00742859|9144358|P4|Overall Study|Adverse Event|1
2647124|NCT00742859|9144359|P3|Overall Study|Adverse Event|3
2647125|NCT00742859|9144360|P2|Overall Study|Adverse Event|6
2647126|NCT00742859|9144361|P1|Overall Study|Adverse Event|5
2647127|NCT00742781|9144375|P1|Overall Study|Withdrawal by Subject|3
2647128|NCT00742625|9144384|P1|Consolidation|Non protocol therapy|13
2647129|NCT00742625|9144384|P1|Consolidation|Refused|1
2647130|NCT00742625|9144384|P1|Consolidation|Death|1
2647131|NCT00742625|9144384|P1|Consolidation|Adverse Event|1
2647132|NCT00742625|9144384|P1|Consolidation|Progression|5
2647133|NCT00742625|9144384|P1|Remission Induction|Other, not specified|5
2647134|NCT00742625|9144384|P1|Remission Induction|Non protocol treatment|17
2647135|NCT00742625|9144384|P1|Remission Induction|Refusal|5
2647136|NCT00742625|9144384|P1|Remission Induction|Death|10
2647137|NCT00742625|9144384|P1|Remission Induction|Adverse Event|3
2647138|NCT00742625|9144384|P1|Remission Induction|Failed induction|8
2647139|NCT00742625|9144384|P1|Remission Induction|Progression|6
2647140|NCT00742560|9144409|P5|Overall Study|MIssing|1
2647141|NCT00742560|9144410|P4|Overall Study|MIssing|0
2647142|NCT00742560|9144411|P3|Overall Study|MIssing|0
2647143|NCT00742560|9144412|P2|Overall Study|MIssing|0
2647144|NCT00742560|9144413|P1|Overall Study|MIssing|0
2647145|NCT00742560|9144409|P5|Overall Study|Other|9
2647146|NCT00742560|9144410|P4|Overall Study|Other|9
2647147|NCT00742560|9144411|P3|Overall Study|Other|8
2647148|NCT00742560|9144412|P2|Overall Study|Other|1
2647149|NCT00742560|9144413|P1|Overall Study|Other|0
2647150|NCT00742560|9144409|P5|Overall Study|New Multiple Myeloma Therapy|4
2647151|NCT00742560|9144410|P4|Overall Study|New Multiple Myeloma Therapy|3
2647152|NCT00742560|9144411|P3|Overall Study|New Multiple Myeloma Therapy|2
2647153|NCT00742560|9144412|P2|Overall Study|New Multiple Myeloma Therapy|0
2647154|NCT00742560|9144413|P1|Overall Study|New Multiple Myeloma Therapy|1
2647155|NCT00742560|9144409|P5|Overall Study|Disease Progression|16
2647156|NCT00742560|9144410|P4|Overall Study|Disease Progression|17
2647157|NCT00742560|9144411|P3|Overall Study|Disease Progression|5
2647158|NCT00742560|9144412|P2|Overall Study|Disease Progression|0
2647159|NCT00742560|9144413|P1|Overall Study|Disease Progression|1
2647160|NCT00742560|9144409|P5|Overall Study|Investigator's Decision|0
2647161|NCT00742560|9144410|P4|Overall Study|Investigator's Decision|1
2647162|NCT00742560|9144411|P3|Overall Study|Investigator's Decision|4
2647163|NCT00742560|9144412|P2|Overall Study|Investigator's Decision|0
2647164|NCT00742560|9144413|P1|Overall Study|Investigator's Decision|0
2647165|NCT00742560|9144409|P5|Overall Study|Subject's Decision|3
2647166|NCT00742560|9144410|P4|Overall Study|Subject's Decision|3
2647167|NCT00742560|9144411|P3|Overall Study|Subject's Decision|2
2647168|NCT00742560|9144412|P2|Overall Study|Subject's Decision|0
2647169|NCT00742560|9144413|P1|Overall Study|Subject's Decision|1
2647170|NCT00742560|9144409|P5|Overall Study|Death|3
2647171|NCT00742560|9144410|P4|Overall Study|Death|2
2647172|NCT00742560|9144411|P3|Overall Study|Death|0
2647173|NCT00742560|9144412|P2|Overall Study|Death|2
2647174|NCT00742560|9144413|P1|Overall Study|Death|0
2647175|NCT00742560|9144409|P5|Overall Study|Adverse Event|1
2647176|NCT00742560|9144410|P4|Overall Study|Adverse Event|1
2647177|NCT00742560|9144411|P3|Overall Study|Adverse Event|1
2647178|NCT00742560|9144412|P2|Overall Study|Adverse Event|0
2647179|NCT00742560|9144413|P1|Overall Study|Adverse Event|0
2647180|NCT00742508|9144487|P2|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1
2647181|NCT00742508|9144488|P1|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0
2647182|NCT00742508|9144487|P2|8-Week Primary Evaluation Period|Withdrawal by Subject|2
2647183|NCT00742508|9144488|P1|8-Week Primary Evaluation Period|Withdrawal by Subject|0
2647184|NCT00742508|9144487|P2|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5
2647185|NCT00742508|9144488|P1|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8
2647186|NCT00742508|9144487|P2|8-Week Primary Evaluation Period|Protocol Violation|0
2647187|NCT00742508|9144488|P1|8-Week Primary Evaluation Period|Protocol Violation|1
2647188|NCT00742508|9144487|P2|8-Week Primary Evaluation Period|Adverse Event|4
2647189|NCT00742508|9144488|P1|8-Week Primary Evaluation Period|Adverse Event|2
2647190|NCT00742417|9144561|P2|Intensive Period|Adverse Event|0
2647191|NCT00742417|9144562|P1|Intensive Period|Adverse Event|2
2647192|NCT00742417|9144561|P2|Intensive Period|Withdrawal by Subject|1
2647193|NCT00742417|9144562|P1|Intensive Period|Withdrawal by Subject|1
2647194|NCT00742417|9144561|P2|Randomized|Physician Decision|0
2647195|NCT00742417|9144562|P1|Randomized|Physician Decision|1
2647196|NCT00742417|9144561|P2|Randomized|Withdrawal by Subject|0
2647197|NCT00742417|9144562|P1|Randomized|Withdrawal by Subject|1
2647198|NCT00742417|9144561|P2|Randomized|Withdrawal by legal representative|1
2647199|NCT00742417|9144562|P1|Randomized|Withdrawal by legal representative|0
2647200|NCT00742391|9144586|P2|Overall Study|Protocol Violation|0
2647201|NCT00742391|9144587|P1|Overall Study|Protocol Violation|1
2647202|NCT00742391|9144586|P2|Overall Study|Lost to Follow-up|0
2647203|NCT00742391|9144587|P1|Overall Study|Lost to Follow-up|1
2647204|NCT00742391|9144586|P2|Overall Study|Adverse Event|1
2647205|NCT00742391|9144587|P1|Overall Study|Adverse Event|2
2647206|NCT00742326|9144597|P2|Overall Study|Physician Decision|1
2647207|NCT00742326|9144598|P1|Overall Study|Physician Decision|0
2647208|NCT00742274|9144617|P2|Overall Study|Removed for medical reasons|1
2647209|NCT00742274|9144618|P1|Overall Study|Removed for medical reasons|1
2647210|NCT00742274|9144617|P2|Overall Study|Withdrawal by Subject|2
2647211|NCT00742274|9144618|P1|Overall Study|Withdrawal by Subject|1
2647212|NCT00742274|9144617|P2|Overall Study|Death|0
2647213|NCT00742274|9144618|P1|Overall Study|Death|1
2647214|NCT00742235|9144626|P2|Overall Study|Lost to Follow-up|31
2647215|NCT00742235|9144627|P1|Overall Study|Lost to Follow-up|0
2647216|NCT00742209|9144640|P5|Overall Study|Investigator Discretion|1
2647217|NCT00742209|9144641|P4|Overall Study|Investigator Discretion|1
2647218|NCT00742209|9144642|P3|Overall Study|Investigator Discretion|5
2647219|NCT00742209|9144643|P2|Overall Study|Investigator Discretion|0
2647220|NCT00742209|9144644|P1|Overall Study|Investigator Discretion|0
2647221|NCT00742209|9144640|P5|Overall Study|Lack of Efficacy|1
2647222|NCT00742209|9144641|P4|Overall Study|Lack of Efficacy|3
2647223|NCT00742209|9144642|P3|Overall Study|Lack of Efficacy|1
2647224|NCT00742209|9144643|P2|Overall Study|Lack of Efficacy|1
2647225|NCT00742209|9144644|P1|Overall Study|Lack of Efficacy|6
2647226|NCT00742209|9144640|P5|Overall Study|Lost to Follow-up|3
2647227|NCT00742209|9144641|P4|Overall Study|Lost to Follow-up|5
2647228|NCT00742209|9144642|P3|Overall Study|Lost to Follow-up|5
2647229|NCT00742209|9144643|P2|Overall Study|Lost to Follow-up|4
2647230|NCT00742209|9144644|P1|Overall Study|Lost to Follow-up|3
2647231|NCT00742209|9144640|P5|Overall Study|Protocol Violation|3
2647232|NCT00742209|9144641|P4|Overall Study|Protocol Violation|5
2647233|NCT00742209|9144642|P3|Overall Study|Protocol Violation|4
2647234|NCT00742209|9144643|P2|Overall Study|Protocol Violation|5
2647235|NCT00742209|9144644|P1|Overall Study|Protocol Violation|6
2647236|NCT00742209|9144640|P5|Overall Study|Participant Withdrew Consent|4
2647237|NCT00742209|9144641|P4|Overall Study|Participant Withdrew Consent|7
2647238|NCT00742209|9144642|P3|Overall Study|Participant Withdrew Consent|14
2647239|NCT00742209|9144643|P2|Overall Study|Participant Withdrew Consent|4
2647240|NCT00742209|9144644|P1|Overall Study|Participant Withdrew Consent|8
2647241|NCT00742209|9144640|P5|Overall Study|Adverse Event|13
2647242|NCT00742209|9144641|P4|Overall Study|Adverse Event|16
2647243|NCT00742209|9144642|P3|Overall Study|Adverse Event|17
2647244|NCT00742209|9144643|P2|Overall Study|Adverse Event|4
2647245|NCT00742209|9144644|P1|Overall Study|Adverse Event|11
2647246|NCT00742183|9144747|P2|Overall Study|Lack of Efficacy|3
2647247|NCT00742183|9144748|P1|Overall Study|Lack of Efficacy|0
2647248|NCT00742183|9144747|P2|Overall Study|Withdrawal by Subject|0
2647249|NCT00742183|9144748|P1|Overall Study|Withdrawal by Subject|1
2647250|NCT00742183|9144747|P2|Overall Study|Required skin-graft|1
2647251|NCT00742183|9144748|P1|Overall Study|Required skin-graft|1
2647252|NCT00742183|9144747|P2|Overall Study|Lost to Follow-up|4
2647253|NCT00742183|9144748|P1|Overall Study|Lost to Follow-up|4
2647254|NCT00742183|9144747|P2|Overall Study|Physician Decision|2
2647255|NCT00742183|9144748|P1|Overall Study|Physician Decision|0
2647256|NCT00742183|9144747|P2|Overall Study|Death|0
2647257|NCT00742183|9144748|P1|Overall Study|Death|1
2647258|NCT00742183|9144747|P2|Overall Study|Adverse Event|2
2647259|NCT00742183|9144748|P1|Overall Study|Adverse Event|2
2647260|NCT00742079|9144767|P2|Overall Study|Lost to Follow-up|1
2647261|NCT00742079|9144768|P1|Overall Study|Lost to Follow-up|0
2647262|NCT00742001|9144789|P3|Overall Study|Withdrawn; health exclusion (flu)|1
2647263|NCT00742001|9144790|P2|Overall Study|Withdrawn; health exclusion (flu)|0
2647264|NCT00742001|9144791|P1|Overall Study|Withdrawn; health exclusion (flu)|0
2647265|NCT00741988|9144807|P2|Overall Study|Lack of Efficacy|0
2647266|NCT00741988|9144808|P1|Overall Study|Lack of Efficacy|2
2647267|NCT00741988|9144807|P2|Overall Study|Adverse Event|4
2647268|NCT00741988|9144808|P1|Overall Study|Adverse Event|2
2647269|NCT00741936|9144820|P2|Overall Study|Low compliance|0
2647270|NCT00741936|9144821|P1|Overall Study|Low compliance|3
2647271|NCT00741936|9144820|P2|Overall Study|Lack of Efficacy|2
2647272|NCT00741936|9144821|P1|Overall Study|Lack of Efficacy|0
2647273|NCT00741936|9144820|P2|Overall Study|Protocol Violation|0
2647274|NCT00741936|9144821|P1|Overall Study|Protocol Violation|2
2647275|NCT00741936|9144820|P2|Overall Study|Pregnancy|1
2647276|NCT00741936|9144821|P1|Overall Study|Pregnancy|0
2647277|NCT00741936|9144820|P2|Overall Study|Adverse Event|4
2647278|NCT00741936|9144821|P1|Overall Study|Adverse Event|3
2647279|NCT00741936|9144820|P2|Overall Study|Lost to Follow-up|1
2647280|NCT00741936|9144821|P1|Overall Study|Lost to Follow-up|1
2647281|NCT00741819|9144856|P1|Overall Study|Disease progression|1
2647282|NCT00741819|9144856|P1|Overall Study|Death|1
2647283|NCT00741819|9144856|P1|Overall Study|Withdrawal by Subject|3
2647284|NCT00741819|9144856|P1|Overall Study|Adverse Event|3
2647285|NCT00741611|9144870|P3|Overall Study|Withdrawal by Subject|2
2647286|NCT00741611|9144871|P2|Overall Study|Withdrawal by Subject|2
2647287|NCT00741611|9144872|P1|Overall Study|Withdrawal by Subject|0
2647288|NCT00741611|9144870|P3|Overall Study|Death|1
2647289|NCT00741611|9144871|P2|Overall Study|Death|0
2647290|NCT00741611|9144872|P1|Overall Study|Death|0
2647291|NCT00741598|9144891|P2|Overall Study|Withdrawal by Subject|2
2647292|NCT00741598|9144892|P1|Overall Study|Withdrawal by Subject|3
2647293|NCT00741598|9144891|P2|Overall Study|Pregnancy|0
2647294|NCT00741598|9144892|P1|Overall Study|Pregnancy|1
2647295|NCT00741598|9144891|P2|Overall Study|Physician Decision|1
2647296|NCT00741598|9144892|P1|Overall Study|Physician Decision|1
2647297|NCT00741598|9144891|P2|Overall Study|Lack of Efficacy|2
2647298|NCT00741598|9144892|P1|Overall Study|Lack of Efficacy|1
2647299|NCT00741598|9144891|P2|Overall Study|Lost to Follow-up|4
2647300|NCT00741598|9144892|P1|Overall Study|Lost to Follow-up|3
2647301|NCT00741338|9144938|P2|Overall Study|Adverse Event|1
2647302|NCT00741338|9144939|P1|Overall Study|Adverse Event|0
2647303|NCT00741286|9144949|P2|Overall Study|Primary Outcome|1
2647304|NCT00741286|9144950|P1|Overall Study|Primary Outcome|1
2647305|NCT00741286|9144949|P2|Overall Study|Protocol Violation|2
2647306|NCT00741286|9144950|P1|Overall Study|Protocol Violation|3
2647307|NCT00741286|9144949|P2|Overall Study|Adverse Event|6
2647308|NCT00741286|9144950|P1|Overall Study|Adverse Event|1
2647309|NCT00741286|9144949|P2|Overall Study|Lost to Follow-up|10
2647310|NCT00741286|9144950|P1|Overall Study|Lost to Follow-up|15
2647311|NCT00741260|9144984|P7|Overall Study|Other|1
2647312|NCT00741260|9144985|P6|Overall Study|Other|3
2647313|NCT00741260|9144986|P5|Overall Study|Other|1
2647314|NCT00741260|9144987|P4|Overall Study|Other|2
2647315|NCT00741260|9144988|P3|Overall Study|Other|1
2647316|NCT00741260|9144989|P2|Overall Study|Other|1
2647317|NCT00741260|9144990|P1|Overall Study|Other|2
2647318|NCT00741260|9144984|P7|Overall Study|Physician Decision|0
2647319|NCT00741260|9144985|P6|Overall Study|Physician Decision|0
2647320|NCT00741260|9144986|P5|Overall Study|Physician Decision|0
2647321|NCT00741260|9144987|P4|Overall Study|Physician Decision|0
2647322|NCT00741260|9144988|P3|Overall Study|Physician Decision|0
2647323|NCT00741260|9144989|P2|Overall Study|Physician Decision|1
2647324|NCT00741260|9144990|P1|Overall Study|Physician Decision|1
2647325|NCT00741260|9144984|P7|Overall Study|Withdrawal by Subject|1
2647326|NCT00741260|9144985|P6|Overall Study|Withdrawal by Subject|3
2647327|NCT00741260|9144986|P5|Overall Study|Withdrawal by Subject|1
2647328|NCT00741260|9144987|P4|Overall Study|Withdrawal by Subject|0
2647329|NCT00741260|9144988|P3|Overall Study|Withdrawal by Subject|0
2647330|NCT00741260|9144989|P2|Overall Study|Withdrawal by Subject|0
2647331|NCT00741260|9144990|P1|Overall Study|Withdrawal by Subject|0
2647332|NCT00741260|9144984|P7|Overall Study|Death|1
2647333|NCT00741260|9144985|P6|Overall Study|Death|2
2647334|NCT00741260|9144986|P5|Overall Study|Death|2
2647335|NCT00741260|9144987|P4|Overall Study|Death|1
2647336|NCT00741260|9144988|P3|Overall Study|Death|0
2647337|NCT00741260|9144989|P2|Overall Study|Death|1
2647338|NCT00741260|9144990|P1|Overall Study|Death|0
2647339|NCT00741260|9144984|P7|Overall Study|Disease Progression|4
2647340|NCT00741260|9144985|P6|Overall Study|Disease Progression|37
2647341|NCT00741260|9144986|P5|Overall Study|Disease Progression|5
2647342|NCT00741260|9144987|P4|Overall Study|Disease Progression|3
2647343|NCT00741260|9144988|P3|Overall Study|Disease Progression|3
2647344|NCT00741260|9144989|P2|Overall Study|Disease Progression|5
2647345|NCT00741260|9144990|P1|Overall Study|Disease Progression|3
2647346|NCT00741091|9145039|P1|Overall Study|Missed Visit|22
2647347|NCT00741091|9145039|P1|Overall Study|Withdrawal by Subject|6
2647348|NCT00741091|9145039|P1|Overall Study|Lost to Follow-up|16
2647349|NCT00741091|9145039|P1|Overall Study|Death|13
2647350|NCT00741039|9145049|P2|Overall Study|Patient non-compliance|0
2647351|NCT00741039|9145050|P1|Overall Study|Patient non-compliance|2
2647352|NCT00741013|9145087|P3|Overall Study|Discovered failed screen after enrolled|0
2647353|NCT00741013|9145088|P2|Overall Study|Discovered failed screen after enrolled|2
2647354|NCT00741013|9145089|P1|Overall Study|Discovered failed screen after enrolled|0
2647355|NCT00741013|9145087|P3|Overall Study|Withdrawal by Subject|1
2647356|NCT00741013|9145088|P2|Overall Study|Withdrawal by Subject|0
2647357|NCT00741013|9145089|P1|Overall Study|Withdrawal by Subject|0
2647358|NCT00741013|9145087|P3|Overall Study|Adverse Event|0
2647359|NCT00741013|9145088|P2|Overall Study|Adverse Event|0
2647360|NCT00741013|9145089|P1|Overall Study|Adverse Event|1
2647361|NCT00740870|9145100|P1|Overall Study|Further testing contraindicated implant|17
2647362|NCT00740870|9145100|P1|Overall Study|Not Catheterized|4
2647363|NCT00740857|9145115|P3|Overall Study|Withdrawal by Subject|0
2647364|NCT00740857|9145116|P2|Overall Study|Withdrawal by Subject|0
2647365|NCT00740857|9145117|P1|Overall Study|Withdrawal by Subject|1
2647366|NCT00740792|9145172|P4|Overall Study|administrative|2
2647367|NCT00740792|9145173|P3|Overall Study|administrative|8
2647368|NCT00740792|9145174|P2|Overall Study|administrative|3
2647369|NCT00740792|9145175|P1|Overall Study|administrative|3
2647370|NCT00740792|9145172|P4|Overall Study|Withdrawal by Subject|0
2647371|NCT00740792|9145173|P3|Overall Study|Withdrawal by Subject|0
2647372|NCT00740792|9145174|P2|Overall Study|Withdrawal by Subject|1
2647373|NCT00740792|9145175|P1|Overall Study|Withdrawal by Subject|1
2647374|NCT00740792|9145172|P4|Overall Study|Protocol Violation|2
2647375|NCT00740792|9145173|P3|Overall Study|Protocol Violation|0
2647376|NCT00740792|9145174|P2|Overall Study|Protocol Violation|1
2647377|NCT00740792|9145175|P1|Overall Study|Protocol Violation|0
2647378|NCT00740792|9145172|P4|Overall Study|Lost to Follow-up|0
2647379|NCT00740792|9145173|P3|Overall Study|Lost to Follow-up|0
2647380|NCT00740792|9145174|P2|Overall Study|Lost to Follow-up|1
2647381|NCT00740792|9145175|P1|Overall Study|Lost to Follow-up|2
2647382|NCT00740792|9145172|P4|Overall Study|Lack of Efficacy|3
2647383|NCT00740792|9145173|P3|Overall Study|Lack of Efficacy|0
2647384|NCT00740792|9145174|P2|Overall Study|Lack of Efficacy|1
2647385|NCT00740792|9145175|P1|Overall Study|Lack of Efficacy|1
2647386|NCT00740792|9145172|P4|Overall Study|Adverse Event|3
2647387|NCT00740792|9145173|P3|Overall Study|Adverse Event|1
2647388|NCT00740792|9145174|P2|Overall Study|Adverse Event|1
2647389|NCT00740792|9145175|P1|Overall Study|Adverse Event|3
2647390|NCT00740779|9145196|P3|Overall Study|Lost to Follow-up|5
2647391|NCT00740779|9145197|P2|Overall Study|Lost to Follow-up|3
2647392|NCT00740779|9145198|P1|Overall Study|Lost to Follow-up|2
2647393|NCT00740779|9145196|P3|Overall Study|Withdrawal by Subject|2
2647394|NCT00740779|9145197|P2|Overall Study|Withdrawal by Subject|4
2647395|NCT00740779|9145198|P1|Overall Study|Withdrawal by Subject|2
2647396|NCT00740779|9145196|P3|Overall Study|Lack of Efficacy|2
2647397|NCT00740779|9145197|P2|Overall Study|Lack of Efficacy|0
2647398|NCT00740779|9145198|P1|Overall Study|Lack of Efficacy|0
2647399|NCT00740779|9145196|P3|Overall Study|Protocol Violation|1
2647400|NCT00740779|9145197|P2|Overall Study|Protocol Violation|1
2647401|NCT00740779|9145198|P1|Overall Study|Protocol Violation|1
2647402|NCT00740779|9145196|P3|Overall Study|Adverse Event|3
2647403|NCT00740779|9145197|P2|Overall Study|Adverse Event|6
2647404|NCT00740779|9145198|P1|Overall Study|Adverse Event|4
2647405|NCT00740714|9145215|P3|Overall Study|Withdrawal by Subject|29
2647406|NCT00740714|9145216|P2|Overall Study|Withdrawal by Subject|19
2647407|NCT00740714|9145217|P1|Overall Study|Withdrawal by Subject|17
2647408|NCT00740636|9145293|P2|Overall Study|Death|0
2647409|NCT00740636|9145294|P1|Overall Study|Death|1
2647410|NCT00740636|9145293|P2|Overall Study|Progressive Disease|0
2647411|NCT00740636|9145294|P1|Overall Study|Progressive Disease|1
2647412|NCT00740636|9145293|P2|Overall Study|Patient Not Treated|1
2647413|NCT00740636|9145294|P1|Overall Study|Patient Not Treated|0
2647414|NCT00740636|9145293|P2|Overall Study|Patient Ineligible|1
2647415|NCT00740636|9145294|P1|Overall Study|Patient Ineligible|0
2647416|NCT00740636|9145293|P2|Overall Study|Adverse Event|2
2647417|NCT00740636|9145294|P1|Overall Study|Adverse Event|0
2647418|NCT00740597|9145300|P1|Overall Study|insurance would not cover treatment|1
2647419|NCT00740584|9145304|P1|Overall Study|Withdrawal by Subject|1
2647420|NCT00740480|9145309|P1|Overall Study|Physician Decision|1
2647421|NCT00740480|9145309|P1|Overall Study|Adverse Event|1
2647422|NCT00740220|9145334|P1|Overall Study|screen failures (non-COPD patients)|9
2647423|NCT00740051|9145359|P2|Overall Study|Other reason (not specified)|1
2647424|NCT00740051|9145360|P1|Overall Study|Other reason (not specified)|4
2647425|NCT00740051|9145359|P2|Overall Study|Withdrawal by Subject|8
2647426|NCT00740051|9145360|P1|Overall Study|Withdrawal by Subject|6
2647427|NCT00740051|9145359|P2|Overall Study|Lost to Follow-up|8
2647428|NCT00740051|9145360|P1|Overall Study|Lost to Follow-up|3
2647429|NCT00740051|9145359|P2|Overall Study|Protocol Violation|6
2647430|NCT00740051|9145360|P1|Overall Study|Protocol Violation|2
2647431|NCT00740051|9145359|P2|Overall Study|Adverse Event|4
2647432|NCT00740051|9145360|P1|Overall Study|Adverse Event|1
2647433|NCT00740051|9145359|P2|Overall Study|Lack of Efficacy|5
2647434|NCT00740051|9145360|P1|Overall Study|Lack of Efficacy|2
2647435|NCT00739973|9145463|P9|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
2647436|NCT00739973|9145464|P8|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
2647437|NCT00739973|9145465|P7|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2
2647438|NCT00739973|9145466|P6|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
2647439|NCT00739973|9145467|P5|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
2647440|NCT00739973|9145468|P4|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
2647441|NCT00739973|9145469|P3|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
2647442|NCT00739973|9145470|P2|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1
2647443|NCT00739973|9145471|P1|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
2647444|NCT00739973|9145463|P9|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
2647445|NCT00739973|9145464|P8|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
2647446|NCT00739973|9145465|P7|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
2647447|NCT00739973|9145466|P6|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
2647448|NCT00739973|9145467|P5|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
2647449|NCT00739973|9145468|P4|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
2647450|NCT00739973|9145469|P3|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
2647451|NCT00739973|9145470|P2|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
2647452|NCT00739973|9145471|P1|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5
2647453|NCT00739973|9145463|P9|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
2647454|NCT00739973|9145464|P8|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
2647455|NCT00739973|9145465|P7|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1
2647456|NCT00739973|9145466|P6|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
2647457|NCT00739973|9145467|P5|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
2647458|NCT00739973|9145468|P4|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
2647459|NCT00739973|9145469|P3|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
2647460|NCT00739973|9145470|P2|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
2647461|NCT00739973|9145471|P1|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
2647462|NCT00739973|9145463|P9|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
2647463|NCT00739973|9145464|P8|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3
2647464|NCT00739973|9145465|P7|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
2647465|NCT00739973|9145466|P6|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
2647466|NCT00739973|9145467|P5|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
2647467|NCT00739973|9145468|P4|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
2647468|NCT00739973|9145469|P3|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4
2647469|NCT00739973|9145470|P2|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
2647470|NCT00739973|9145471|P1|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
2647471|NCT00739973|9145463|P9|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
2647472|NCT00739973|9145464|P8|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
2647473|NCT00739973|9145465|P7|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
2647474|NCT00739973|9145466|P6|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
2647475|NCT00739973|9145467|P5|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
2647476|NCT00739973|9145468|P4|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
2647477|NCT00739973|9145469|P3|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
2647478|NCT00739973|9145470|P2|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
2647479|NCT00739973|9145471|P1|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
2647480|NCT00739973|9145463|P9|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
2647481|NCT00739973|9145464|P8|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
2647482|NCT00739973|9145465|P7|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
2647483|NCT00739973|9145466|P6|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
2647484|NCT00739973|9145467|P5|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
2647485|NCT00739973|9145468|P4|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
2647486|NCT00739973|9145469|P3|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1
2647487|NCT00739973|9145470|P2|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
2647488|NCT00739973|9145471|P1|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
2647489|NCT00739973|9145463|P9|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
2647490|NCT00739973|9145464|P8|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
2647491|NCT00739973|9145465|P7|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
2647492|NCT00739973|9145466|P6|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
2647493|NCT00739973|9145467|P5|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
2647494|NCT00739973|9145468|P4|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4
2647495|NCT00739973|9145469|P3|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
2647496|NCT00739973|9145470|P2|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
2647497|NCT00739973|9145471|P1|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17
2647498|NCT00739973|9145463|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
2647499|NCT00739973|9145464|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
2647500|NCT00739973|9145465|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
2647501|NCT00739973|9145466|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
2647502|NCT00739973|9145467|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
2647503|NCT00739973|9145468|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
2647504|NCT00739973|9145469|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
2647505|NCT00739973|9145470|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
2647506|NCT00739973|9145471|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
2647507|NCT00739973|9145463|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
2647508|NCT00739973|9145464|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
2647509|NCT00739973|9145465|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
2647510|NCT00739973|9145466|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
2647511|NCT00739973|9145467|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
2647512|NCT00739973|9145468|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
2647513|NCT00739973|9145469|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
2647514|NCT00739973|9145470|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
2647515|NCT00739973|9145471|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
2647516|NCT00739973|9145463|P9|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
2647517|NCT00739973|9145464|P8|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
2647518|NCT00739973|9145465|P7|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
2647519|NCT00739973|9145466|P6|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
2647520|NCT00739973|9145467|P5|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7
2647521|NCT00739973|9145468|P4|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2
2647522|NCT00739973|9145469|P3|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
2647523|NCT00739973|9145470|P2|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
2647524|NCT00739973|9145471|P1|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
2647525|NCT00739973|9145463|P9|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
2647526|NCT00739973|9145464|P8|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
2647527|NCT00739973|9145465|P7|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
2647528|NCT00739973|9145466|P6|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
2647529|NCT00739973|9145467|P5|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
2647530|NCT00739973|9145468|P4|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
2647531|NCT00739973|9145469|P3|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
2647532|NCT00739973|9145470|P2|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
2647533|NCT00739973|9145471|P1|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11
2647534|NCT00739973|9145463|P9|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
2647535|NCT00739973|9145464|P8|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
2647536|NCT00739973|9145465|P7|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
2647537|NCT00739973|9145466|P6|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
2647538|NCT00739973|9145467|P5|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
2647539|NCT00739973|9145468|P4|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
2647540|NCT00739973|9145469|P3|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
2647541|NCT00739973|9145470|P2|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
2647542|NCT00739973|9145471|P1|Single-blind Period (2 to 4 Weeks)|Administrative problems|12
2647543|NCT00739973|9145463|P9|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
2647544|NCT00739973|9145464|P8|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
2647545|NCT00739973|9145465|P7|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
2647546|NCT00739973|9145466|P6|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
2647547|NCT00739973|9145467|P5|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
2647548|NCT00739973|9145468|P4|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
2647549|NCT00739973|9145469|P3|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
2647550|NCT00739973|9145470|P2|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
2647551|NCT00739973|9145471|P1|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17
2647552|NCT00739973|9145463|P9|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
2647553|NCT00739973|9145464|P8|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
2647554|NCT00739973|9145465|P7|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
2647555|NCT00739973|9145466|P6|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
2647556|NCT00739973|9145467|P5|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
2647557|NCT00739973|9145468|P4|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
2647558|NCT00739973|9145469|P3|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
2647559|NCT00739973|9145470|P2|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
2647560|NCT00739973|9145471|P1|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86
2647561|NCT00739973|9145463|P9|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
2647562|NCT00739973|9145464|P8|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
2647563|NCT00739973|9145465|P7|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
2647564|NCT00739973|9145466|P6|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
2647565|NCT00739973|9145467|P5|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
2647566|NCT00739973|9145468|P4|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
2647567|NCT00739973|9145469|P3|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
2647568|NCT00739973|9145470|P2|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
2647569|NCT00739973|9145471|P1|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810
2647570|NCT00739973|9145463|P9|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
2647571|NCT00739973|9145464|P8|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
2647572|NCT00739973|9145465|P7|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
2647573|NCT00739973|9145466|P6|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
2647574|NCT00739973|9145467|P5|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
2647575|NCT00739973|9145468|P4|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
2647576|NCT00739973|9145469|P3|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
2647577|NCT00739973|9145470|P2|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
2647578|NCT00739973|9145471|P1|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38
2647579|NCT00739973|9145463|P9|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
2647580|NCT00739973|9145464|P8|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
2647581|NCT00739973|9145465|P7|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
2647582|NCT00739973|9145466|P6|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
2647583|NCT00739973|9145467|P5|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
2647584|NCT00739973|9145468|P4|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
2647585|NCT00739973|9145469|P3|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
2647586|NCT00739973|9145470|P2|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
2647587|NCT00739973|9145471|P1|Single-blind Period (2 to 4 Weeks)|Adverse Event|35
2647588|NCT00739934|9145562|P1|Voriconazole Oral|Other|3
2647589|NCT00739934|9145562|P1|Voriconazole IV|Adverse Event|6
2647590|NCT00739908|9145584|P2|Overall Study|Relocation|1
2647591|NCT00739908|9145585|P1|Overall Study|Relocation|0
2647592|NCT00739908|9145584|P2|Overall Study|Lack of Efficacy|1
2647593|NCT00739908|9145585|P1|Overall Study|Lack of Efficacy|0
2647594|NCT00739908|9145584|P2|Overall Study|Non-Compliance With Study Medication|3
2647595|NCT00739908|9145585|P1|Overall Study|Non-Compliance With Study Medication|0
2647596|NCT00739908|9145584|P2|Overall Study|Non-Compliance With Study Procedures|3
2647597|NCT00739908|9145585|P1|Overall Study|Non-Compliance With Study Procedures|2
2647598|NCT00739908|9145584|P2|Overall Study|Lost to Follow-up|9
2647599|NCT00739908|9145585|P1|Overall Study|Lost to Follow-up|14
2647600|NCT00739908|9145584|P2|Overall Study|Withdrawal by Subject|2
2647601|NCT00739908|9145585|P1|Overall Study|Withdrawal by Subject|4
2647602|NCT00739908|9145584|P2|Overall Study|Adverse Event|6
2647603|NCT00739908|9145585|P1|Overall Study|Adverse Event|5
2647604|NCT00739882|9145605|P2|Open-label Period|Other|5
2647605|NCT00739882|9145606|P1|Open-label Period|Other|9
2647606|NCT00739882|9145605|P2|Open-label Period|Adverse Event|0
2647607|NCT00739882|9145606|P1|Open-label Period|Adverse Event|1
2647608|NCT00739882|9145605|P2|Double-blind Period|Other|8
2647609|NCT00739882|9145606|P1|Double-blind Period|Other|16
2647610|NCT00739882|9145605|P2|Double-blind Period|Lack of Efficacy|1
2647611|NCT00739882|9145606|P1|Double-blind Period|Lack of Efficacy|1
2647612|NCT00739882|9145605|P2|Double-blind Period|Protocol Violation|0
2647613|NCT00739882|9145606|P1|Double-blind Period|Protocol Violation|1
2647614|NCT00739882|9145605|P2|Double-blind Period|Adverse Event|2
2647615|NCT00739882|9145606|P1|Double-blind Period|Adverse Event|1
2647616|NCT00739674|9145667|P2|Overall Study|Erectile dysfunction|1
2647617|NCT00739674|9145668|P1|Overall Study|Erectile dysfunction|0
2647618|NCT00739674|9145667|P2|Overall Study|Home monitoring off meds|0
2647619|NCT00739674|9145668|P1|Overall Study|Home monitoring off meds|1
2647620|NCT00739674|9145667|P2|Overall Study|Unable to attend visit|1
2647621|NCT00739674|9145668|P1|Overall Study|Unable to attend visit|3
2647622|NCT00739674|9145667|P2|Overall Study|Non compliant|0
2647623|NCT00739674|9145668|P1|Overall Study|Non compliant|4
2647624|NCT00739674|9145667|P2|Overall Study|Patient moved|2
2647625|NCT00739674|9145668|P1|Overall Study|Patient moved|3
2647626|NCT00739674|9145667|P2|Overall Study|Clinic closed|4
2647627|NCT00739674|9145668|P1|Overall Study|Clinic closed|6
2647628|NCT00739674|9145667|P2|Overall Study|Reason missing|0
2647629|NCT00739674|9145668|P1|Overall Study|Reason missing|2
2647630|NCT00739674|9145667|P2|Overall Study|Withdrawal by Subject|9
2647631|NCT00739674|9145668|P1|Overall Study|Withdrawal by Subject|9
2647632|NCT00739674|9145667|P2|Overall Study|Protocol Violation|5
2647633|NCT00739674|9145668|P1|Overall Study|Protocol Violation|5
2647634|NCT00739674|9145667|P2|Overall Study|Lost to Follow-up|30
2647635|NCT00739674|9145668|P1|Overall Study|Lost to Follow-up|52
2647636|NCT00739674|9145667|P2|Overall Study|Lack of Efficacy|0
2647637|NCT00739674|9145668|P1|Overall Study|Lack of Efficacy|1
2647638|NCT00739674|9145667|P2|Overall Study|Death|0
2647639|NCT00739674|9145668|P1|Overall Study|Death|1
2647640|NCT00739674|9145667|P2|Overall Study|Adverse Event|13
2647641|NCT00739674|9145668|P1|Overall Study|Adverse Event|22
2647642|NCT00739674|9145667|P2|Overall Study|Dietician consultation >30 days|9
2647643|NCT00739674|9145668|P1|Overall Study|Dietician consultation >30 days|1
2647644|NCT00739674|9145667|P2|Overall Study|No follow-up data|18
2647645|NCT00739674|9145668|P1|Overall Study|No follow-up data|33
2647646|NCT00739674|9145667|P2|Overall Study|Site 212 removal|13
2647647|NCT00739674|9145668|P1|Overall Study|Site 212 removal|19
2647648|NCT00739674|9145667|P2|Overall Study|Screening failures|17
2647649|NCT00739674|9145668|P1|Overall Study|Screening failures|19
2647650|NCT00739661|9145696|P2|Overall Study|Reason for discontinuation not available|1
2647651|NCT00739661|9145697|P1|Overall Study|Reason for discontinuation not available|1
2647652|NCT00739661|9145696|P2|Overall Study|Disease progression, radiographic|37
2647653|NCT00739661|9145697|P1|Overall Study|Disease progression, radiographic|33
2647654|NCT00739661|9145696|P2|Overall Study|Patient decision to withdraw|4
2647655|NCT00739661|9145697|P1|Overall Study|Patient decision to withdraw|9
2647656|NCT00739661|9145696|P2|Overall Study|Physician decision to withdraw patient|0
2647657|NCT00739661|9145697|P1|Overall Study|Physician decision to withdraw patient|1
2647658|NCT00739661|9145696|P2|Overall Study|Adverse Event|0
2647659|NCT00739661|9145697|P1|Overall Study|Adverse Event|2
2647660|NCT00739648|9145709|P2|Overall Study|Do not know|6
2647661|NCT00739648|9145710|P1|Overall Study|Do not know|4
2647662|NCT00739648|9145709|P2|Overall Study|Death|0
2647663|NCT00739648|9145710|P1|Overall Study|Death|2
2647664|NCT00739648|9145709|P2|Overall Study|Lost to Follow-up|7
2647665|NCT00739648|9145710|P1|Overall Study|Lost to Follow-up|4
2647666|NCT00739648|9145709|P2|Overall Study|Withdrawal by Subject|25
2647667|NCT00739648|9145710|P1|Overall Study|Withdrawal by Subject|13
2647668|NCT00739648|9145709|P2|Overall Study|Adverse Event|15
2647669|NCT00739648|9145710|P1|Overall Study|Adverse Event|3
2647670|NCT00739596|9145724|P2|Overall Study|Protocol Deviation|1
2647671|NCT00739596|9145725|P1|Overall Study|Protocol Deviation|1
2647672|NCT00739596|9145724|P2|Overall Study|Lost to Follow-up|2
2647673|NCT00739596|9145725|P1|Overall Study|Lost to Follow-up|0
2647674|NCT00739596|9145724|P2|Overall Study|Patient Withdrew Consent|8
2647675|NCT00739596|9145725|P1|Overall Study|Patient Withdrew Consent|8
2647676|NCT00739596|9145724|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
2647677|NCT00739596|9145725|P1|Overall Study|Unsatisfactory Therapeutic Effect|4
2647678|NCT00739596|9145724|P2|Overall Study|Adverse Event|6
2647679|NCT00739596|9145725|P1|Overall Study|Adverse Event|12
2647680|NCT00739310|9145767|P1|Overall Study|Lost to Follow-up|2
2647681|NCT00739310|9145767|P1|Overall Study|Withdrawal by Subject|1
2647682|NCT00739310|9145767|P1|Overall Study|Poor adherance to prescribed therapy|4
2647683|NCT00739297|9145772|P7|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
2647684|NCT00739297|9145773|P6|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
2647685|NCT00739297|9145774|P5|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
2647686|NCT00739297|9145775|P4|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
2647687|NCT00739297|9145776|P3|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
2647688|NCT00739297|9145777|P2|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
2647689|NCT00739297|9145778|P1|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
2647690|NCT00739297|9145772|P7|First Washout Period of 4-7 Days|Adverse Event|2
2647691|NCT00739297|9145773|P6|First Washout Period of 4-7 Days|Adverse Event|0
2647692|NCT00739297|9145774|P5|First Washout Period of 4-7 Days|Adverse Event|0
2647693|NCT00739297|9145775|P4|First Washout Period of 4-7 Days|Adverse Event|2
2647694|NCT00739297|9145776|P3|First Washout Period of 4-7 Days|Adverse Event|0
2647695|NCT00739297|9145777|P2|First Washout Period of 4-7 Days|Adverse Event|0
2647696|NCT00739297|9145778|P1|First Washout Period of 4-7 Days|Adverse Event|0
2647697|NCT00739102|9145806|P1|Overall Study|Withdrawal by Subject|10
2647698|NCT00739102|9145806|P1|Overall Study|Death|5
2647699|NCT00739063|9145822|P1|Overall Study|Screen failures|8
2647700|NCT00738894|9145867|P2|Overall Study|Death|0
2647701|NCT00738894|9145868|P1|Overall Study|Death|2
2647702|NCT00738894|9145867|P2|Overall Study|Physician Decision|5
2647703|NCT00738894|9145868|P1|Overall Study|Physician Decision|4
2647704|NCT00738894|9145867|P2|Overall Study|Withdrawal by Subject|15
2647705|NCT00738894|9145868|P1|Overall Study|Withdrawal by Subject|10
2647706|NCT00738894|9145867|P2|Overall Study|Lost to Follow-up|13
2647707|NCT00738894|9145868|P1|Overall Study|Lost to Follow-up|23
2647708|NCT00738881|9145881|P2|Overall Study|Withdrawal by Subject|2
2647709|NCT00738881|9145882|P1|Overall Study|Withdrawal by Subject|0
2647710|NCT00738699|9145896|P2|Overall Study|Other|0
2647711|NCT00738699|9145897|P1|Overall Study|Other|2
2647712|NCT00738699|9145896|P2|Overall Study|Discontinuation of study by Sponsor|72
2647713|NCT00738699|9145897|P1|Overall Study|Discontinuation of study by Sponsor|123
2647714|NCT00738699|9145896|P2|Overall Study|Death|68
2647715|NCT00738699|9145897|P1|Overall Study|Death|144
2647716|NCT00738699|9145896|P2|Overall Study|Lost to Follow-up|0
2647717|NCT00738699|9145897|P1|Overall Study|Lost to Follow-up|1
2647718|NCT00738699|9145896|P2|Overall Study|Withdrawal by Subject|0
2647719|NCT00738699|9145897|P1|Overall Study|Withdrawal by Subject|5
2647720|NCT00738673|9145915|P2|Overall Study|Withdrawal by Subject|1
2647721|NCT00738673|9145916|P1|Overall Study|Withdrawal by Subject|3
2647722|NCT00738673|9145915|P2|Overall Study|Protocol Violation|2
2647723|NCT00738673|9145916|P1|Overall Study|Protocol Violation|1
2647724|NCT00738673|9145915|P2|Overall Study|Lack of Efficacy|8
2647725|NCT00738673|9145916|P1|Overall Study|Lack of Efficacy|19
2647726|NCT00738673|9145915|P2|Overall Study|Adverse Event|0
2647727|NCT00738673|9145916|P1|Overall Study|Adverse Event|1
2647728|NCT00738530|9145954|P2|Overall Study|Withdrawal by Subject|8
2647729|NCT00738530|9145955|P1|Overall Study|Withdrawal by Subject|6
2647730|NCT00738530|9145954|P2|Overall Study|Lost to Follow-up|6
2647731|NCT00738530|9145955|P1|Overall Study|Lost to Follow-up|8
2647732|NCT00738530|9145954|P2|Overall Study|Death|224
2647733|NCT00738530|9145955|P1|Overall Study|Death|220
2647734|NCT00738400|9145990|P2|Overall Study|Non-compliant with study medication|1
2647735|NCT00738400|9145991|P1|Overall Study|Non-compliant with study medication|0
2647736|NCT00738400|9145990|P2|Overall Study|Protocol Violation|0
2647737|NCT00738400|9145991|P1|Overall Study|Protocol Violation|1
2647738|NCT00738400|9145990|P2|Overall Study|Lost to Follow-up|3
2647739|NCT00738400|9145991|P1|Overall Study|Lost to Follow-up|0
2647740|NCT00738400|9145990|P2|Overall Study|Lack of Efficacy|1
2647741|NCT00738400|9145991|P1|Overall Study|Lack of Efficacy|0
2647742|NCT00738400|9145990|P2|Overall Study|Withdrawal by Subject|1
2647743|NCT00738400|9145991|P1|Overall Study|Withdrawal by Subject|0
2647744|NCT00738400|9145990|P2|Overall Study|Adverse Event|1
2647745|NCT00738400|9145991|P1|Overall Study|Adverse Event|3
2647746|NCT00738374|9146012|P4|Maintenance Treatment/Observation Phase|Other|0
2647747|NCT00738374|9146013|P3|Maintenance Treatment/Observation Phase|Other|0
2647748|NCT00738374|9146014|P2|Maintenance Treatment/Observation Phase|Other|1
2647749|NCT00738374|9146015|P1|Maintenance Treatment/Observation Phase|Other|0
2647750|NCT00738374|9146012|P4|Maintenance Treatment/Observation Phase|Protocol Violation|0
2647751|NCT00738374|9146013|P3|Maintenance Treatment/Observation Phase|Protocol Violation|0
2647752|NCT00738374|9146014|P2|Maintenance Treatment/Observation Phase|Protocol Violation|1
2647753|NCT00738374|9146015|P1|Maintenance Treatment/Observation Phase|Protocol Violation|0
2647754|NCT00738374|9146012|P4|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1
2647755|NCT00738374|9146013|P3|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
2647756|NCT00738374|9146014|P2|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
2647757|NCT00738374|9146015|P1|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
2647758|NCT00738374|9146012|P4|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11
2647759|NCT00738374|9146013|P3|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5
2647760|NCT00738374|9146014|P2|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4
2647761|NCT00738374|9146015|P1|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0
2647762|NCT00738374|9146012|P4|Maintenance Treatment/Observation Phase|Adverse Event|0
2647763|NCT00738374|9146013|P3|Maintenance Treatment/Observation Phase|Adverse Event|2
2647764|NCT00738374|9146014|P2|Maintenance Treatment/Observation Phase|Adverse Event|1
2647765|NCT00738374|9146015|P1|Maintenance Treatment/Observation Phase|Adverse Event|0
2647766|NCT00738374|9146012|P4|Induction Treatment Phase|Withdrawal by Subject|0
2647767|NCT00738374|9146013|P3|Induction Treatment Phase|Withdrawal by Subject|0
2647768|NCT00738374|9146014|P2|Induction Treatment Phase|Withdrawal by Subject|0
2647769|NCT00738374|9146015|P1|Induction Treatment Phase|Withdrawal by Subject|1
2647770|NCT00738374|9146012|P4|Induction Treatment Phase|Non-compliance|0
2647771|NCT00738374|9146013|P3|Induction Treatment Phase|Non-compliance|0
2647772|NCT00738374|9146014|P2|Induction Treatment Phase|Non-compliance|0
2647773|NCT00738374|9146015|P1|Induction Treatment Phase|Non-compliance|1
2647774|NCT00738374|9146012|P4|Induction Treatment Phase|Protocol Violation|0
2647775|NCT00738374|9146013|P3|Induction Treatment Phase|Protocol Violation|0
2647776|NCT00738374|9146014|P2|Induction Treatment Phase|Protocol Violation|0
2647777|NCT00738374|9146015|P1|Induction Treatment Phase|Protocol Violation|2
2647778|NCT00738374|9146012|P4|Induction Treatment Phase|Physician Decision|0
2647779|NCT00738374|9146013|P3|Induction Treatment Phase|Physician Decision|0
2647780|NCT00738374|9146014|P2|Induction Treatment Phase|Physician Decision|0
2647781|NCT00738374|9146015|P1|Induction Treatment Phase|Physician Decision|2
2647782|NCT00738374|9146012|P4|Induction Treatment Phase|Disease progression/relapse/stable|0
2647783|NCT00738374|9146013|P3|Induction Treatment Phase|Disease progression/relapse/stable|0
2647784|NCT00738374|9146014|P2|Induction Treatment Phase|Disease progression/relapse/stable|0
2647785|NCT00738374|9146015|P1|Induction Treatment Phase|Disease progression/relapse/stable|4
2647786|NCT00738374|9146012|P4|Induction Treatment Phase|Adverse Event|0
2647787|NCT00738374|9146013|P3|Induction Treatment Phase|Adverse Event|0
2647788|NCT00738374|9146014|P2|Induction Treatment Phase|Adverse Event|0
2647789|NCT00738374|9146015|P1|Induction Treatment Phase|Adverse Event|14
2647790|NCT00738283|9146053|P1|Overall Study|Discharge home prior to end of study|1
2647791|NCT00738283|9146053|P1|Overall Study|Transfer to another facility|2
2647792|NCT00738283|9146053|P1|Overall Study|Death|1
2647793|NCT00738062|9146060|P3|Open-Label Extension|Study Terminated|0
2647794|NCT00738062|9146061|P2|Open-Label Extension|Study Terminated|0
2647795|NCT00738062|9146062|P1|Open-Label Extension|Study Terminated|2
2647796|NCT00738062|9146060|P3|Open-Label Extension|Protocol Violation|0
2647797|NCT00738062|9146061|P2|Open-Label Extension|Protocol Violation|0
2647798|NCT00738062|9146062|P1|Open-Label Extension|Protocol Violation|1
2647799|NCT00738062|9146060|P3|Open-Label Extension|Withdrawal by Subject|0
2647800|NCT00738062|9146061|P2|Open-Label Extension|Withdrawal by Subject|0
2647801|NCT00738062|9146062|P1|Open-Label Extension|Withdrawal by Subject|6
2647802|NCT00738062|9146060|P3|Open-Label Extension|Lack of Efficacy|0
2647803|NCT00738062|9146061|P2|Open-Label Extension|Lack of Efficacy|0
2647804|NCT00738062|9146062|P1|Open-Label Extension|Lack of Efficacy|2
2647805|NCT00738062|9146060|P3|Open-Label Extension|Physician Decision|0
2647806|NCT00738062|9146061|P2|Open-Label Extension|Physician Decision|0
2647807|NCT00738062|9146062|P1|Open-Label Extension|Physician Decision|1
2647808|NCT00738062|9146060|P3|Open-Label Extension|Adverse Event|0
2647809|NCT00738062|9146061|P2|Open-Label Extension|Adverse Event|0
2647810|NCT00738062|9146062|P1|Open-Label Extension|Adverse Event|5
2647811|NCT00738062|9146060|P3|Open Label Treatment|Investigator Decision|0
2647812|NCT00738062|9146061|P2|Open Label Treatment|Investigator Decision|0
2647813|NCT00738062|9146062|P1|Open Label Treatment|Investigator Decision|1
2647814|NCT00738062|9146060|P3|Open Label Treatment|Withdrawal by Subject|0
2647815|NCT00738062|9146061|P2|Open Label Treatment|Withdrawal by Subject|0
2647816|NCT00738062|9146062|P1|Open Label Treatment|Withdrawal by Subject|9
2647817|NCT00738062|9146060|P3|Open Label Treatment|Protocol Violation|0
2647818|NCT00738062|9146061|P2|Open Label Treatment|Protocol Violation|0
2647819|NCT00738062|9146062|P1|Open Label Treatment|Protocol Violation|2
2647820|NCT00738062|9146060|P3|Open Label Treatment|Adverse Event|0
2647821|NCT00738062|9146061|P2|Open Label Treatment|Adverse Event|0
2647822|NCT00738062|9146062|P1|Open Label Treatment|Adverse Event|11
2647823|NCT00738062|9146060|P3|Open Label Treatment|Lack of Efficacy|0
2647824|NCT00738062|9146061|P2|Open Label Treatment|Lack of Efficacy|0
2647825|NCT00738062|9146062|P1|Open Label Treatment|Lack of Efficacy|5
2647826|NCT00737711|9146124|P1|Overall Study|Other|5
2647827|NCT00737711|9146124|P1|Overall Study|Blood transfusion|6
2647828|NCT00737711|9146124|P1|Overall Study|Withdrawal by Subject|5
2647829|NCT00737711|9146124|P1|Overall Study|Protocol Violation|1
2647830|NCT00737711|9146124|P1|Overall Study|Failure to return|4
2647831|NCT00737711|9146124|P1|Overall Study|Death|8
2647832|NCT00737711|9146124|P1|Overall Study|Adverse Event|2
2647833|NCT00737698|9146158|P3|Overall Study|Death|1
2647834|NCT00737698|9146159|P2|Overall Study|Death|0
2647835|NCT00737698|9146160|P1|Overall Study|Death|0
2647836|NCT00737698|9146158|P3|Overall Study|Withdrawal by Subject|3
2647837|NCT00737698|9146159|P2|Overall Study|Withdrawal by Subject|5
2647838|NCT00737698|9146160|P1|Overall Study|Withdrawal by Subject|6
2647839|NCT00737672|9146170|P2|Overall Study|Physician Decision|2
2647840|NCT00737672|9146171|P1|Overall Study|Physician Decision|0
2647841|NCT00737672|9146170|P2|Overall Study|Miscellaneous|1
2647842|NCT00737672|9146171|P1|Overall Study|Miscellaneous|7
2647843|NCT00737672|9146170|P2|Overall Study|Lost to Follow-up|0
2647844|NCT00737672|9146171|P1|Overall Study|Lost to Follow-up|1
2647845|NCT00737672|9146170|P2|Overall Study|Withdrawal by Subject|2
2647846|NCT00737672|9146171|P1|Overall Study|Withdrawal by Subject|1
2647847|NCT00737672|9146170|P2|Overall Study|Death|22
2647848|NCT00737672|9146171|P1|Overall Study|Death|23
2647849|NCT00737672|9146170|P2|Overall Study|Graft Abandonment|56
2647850|NCT00737672|9146171|P1|Overall Study|Graft Abandonment|48
2647851|NCT00737633|9146209|P2|Overall Study|protocol non-compliance|1
2647852|NCT00737633|9146210|P1|Overall Study|protocol non-compliance|0
2647853|NCT00737633|9146209|P2|Overall Study|Lost to Follow-up|1
2647854|NCT00737633|9146210|P1|Overall Study|Lost to Follow-up|0
2647855|NCT00737633|9146209|P2|Overall Study|Study terminated by sponsor|55
2647856|NCT00737633|9146210|P1|Overall Study|Study terminated by sponsor|44
2647857|NCT00737568|9146233|P2|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0
2647858|NCT00737568|9146234|P1|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1
2647859|NCT00737568|9146233|P2|Treatment-Free Follow-up (TFFU) Period|Death|1
2647860|NCT00737568|9146234|P1|Treatment-Free Follow-up (TFFU) Period|Death|0
2647861|NCT00737568|9146233|P2|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17
2647862|NCT00737568|9146234|P1|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25
2647863|NCT00737568|9146233|P2|Treatment Period Through Week 240|Study Discontinued by Sponsor|0
2647864|NCT00737568|9146234|P1|Treatment Period Through Week 240|Study Discontinued by Sponsor|1
2647865|NCT00737568|9146233|P2|Treatment Period Through Week 240|Protocol Violation|3
2647866|NCT00737568|9146234|P1|Treatment Period Through Week 240|Protocol Violation|2
2647867|NCT00737568|9146233|P2|Treatment Period Through Week 240|Lost to Follow-up|3
2647868|NCT00737568|9146234|P1|Treatment Period Through Week 240|Lost to Follow-up|3
2647869|NCT00737568|9146233|P2|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4
2647870|NCT00737568|9146234|P1|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3
2647871|NCT00737568|9146233|P2|Treatment Period Through Week 240|Withdrew Consent|6
2647872|NCT00737568|9146234|P1|Treatment Period Through Week 240|Withdrew Consent|5
2647873|NCT00737568|9146233|P2|Treatment Period Through Week 240|Investigator’s Discretion|5
2647874|NCT00737568|9146234|P1|Treatment Period Through Week 240|Investigator’s Discretion|6
2647875|NCT00737529|9146264|P1|Overall Study|Other|4
2647876|NCT00737529|9146264|P1|Overall Study|Protocol Violation|1
2647877|NCT00737529|9146264|P1|Overall Study|Death|4
2647878|NCT00737529|9146264|P1|Overall Study|Withdrawal by Subject|5
2647879|NCT00737529|9146264|P1|Overall Study|Adverse Event|24
2647880|NCT00737529|9146264|P1|Overall Study|Disease Progression|95
2647881|NCT00737477|9146278|P1|Overall Study|Other|4
2647882|NCT00737477|9146278|P1|Overall Study|Renal Transplantation|10
2647883|NCT00737477|9146278|P1|Overall Study|Withdrawal by Subject|1
2647884|NCT00737477|9146278|P1|Overall Study|Treatment Refusal|1
2647885|NCT00737477|9146278|P1|Overall Study|Death|9
2647886|NCT00737477|9146278|P1|Overall Study|Adverse Event|9
2647887|NCT00737464|9146294|P1|Overall Study|Other reasons|4
2647888|NCT00737464|9146294|P1|Overall Study|Refused Treatment / Withdrew Consent|6
2647889|NCT00737464|9146294|P1|Overall Study|Other - Failure to Return|1
2647890|NCT00737464|9146294|P1|Overall Study|Death|6
2647891|NCT00737464|9146294|P1|Overall Study|Adverse Event|1
2647892|NCT00737438|9146315|P1|Overall Study|Patient ineligible|1
2647893|NCT00737438|9146315|P1|Overall Study|Withdrawal by Subject|2
2647894|NCT00737282|9146328|P1|Overall Study|Study prematurely terminated|175
2647895|NCT00737100|9146371|P3|Overall Study|Reason discontinued not explained above|1
2647896|NCT00737100|9146372|P2|Overall Study|Reason discontinued not explained above|1
2647897|NCT00737100|9146373|P1|Overall Study|Reason discontinued not explained above|1
2647898|NCT00737100|9146371|P3|Overall Study|Withdrawal by Subject|3
2647899|NCT00737100|9146372|P2|Overall Study|Withdrawal by Subject|0
2647900|NCT00737100|9146373|P1|Overall Study|Withdrawal by Subject|0
2647901|NCT00737100|9146371|P3|Overall Study|Lost to Follow-up|0
2647902|NCT00737100|9146372|P2|Overall Study|Lost to Follow-up|1
2647903|NCT00737100|9146373|P1|Overall Study|Lost to Follow-up|0
2647904|NCT00737100|9146371|P3|Overall Study|Adverse Event|3
2647905|NCT00737100|9146372|P2|Overall Study|Adverse Event|5
2647906|NCT00737100|9146373|P1|Overall Study|Adverse Event|6
2647907|NCT00737061|9146417|P1|1 Year Wearing Period|Terminated for protocol non-compliance|1
2647908|NCT00737061|9146417|P1|1 Year Wearing Period|Discontinued reilance|3
2647909|NCT00737061|9146417|P1|1 Year Wearing Period|Withdrawal by Subject|2
2647910|NCT00737061|9146417|P1|1 Year Wearing Period|Lost to Follow-up|11
2647911|NCT00737061|9146417|P1|Waiting Period|Elected surgical tubal ligation|5
2647912|NCT00737061|9146417|P1|Waiting Period|Alternative contraception failure|3
2647913|NCT00737061|9146417|P1|Waiting Period|Deemed patent following HSG|26
2647914|NCT00737061|9146417|P1|Waiting Period|Bilateral placement failure|34
2647915|NCT00737061|9146417|P1|Waiting Period|Withdrawal by Subject|1
2647916|NCT00737061|9146417|P1|Waiting Period|Lost to Follow-up|6
2647917|NCT00737048|9146434|P3|Overall Study|Worsening of the symptoms|3
2647918|NCT00737048|9146435|P2|Overall Study|Worsening of the symptoms|5
2647919|NCT00737048|9146436|P1|Overall Study|Worsening of the symptoms|3
2647920|NCT00737048|9146434|P3|Overall Study|Adverse Event|0
2647921|NCT00737048|9146435|P2|Overall Study|Adverse Event|1
2647922|NCT00737048|9146436|P1|Overall Study|Adverse Event|0
2647923|NCT00737048|9146434|P3|Overall Study|Physician Decision|1
2647924|NCT00737048|9146435|P2|Overall Study|Physician Decision|0
2647925|NCT00737048|9146436|P1|Overall Study|Physician Decision|0
2647926|NCT00736996|9146480|P3|Overall Study|Lost to Follow-up|2
2647927|NCT00736996|9146481|P2|Overall Study|Lost to Follow-up|9
2647928|NCT00736996|9146482|P1|Overall Study|Lost to Follow-up|1
2647929|NCT00736957|9146496|P1|Overall Study|Physician Decision|5
2647930|NCT00736957|9146496|P1|Overall Study|not eligible for Treatment Period I|22
2647931|NCT00736957|9146496|P1|Overall Study|did not attend hospital appointments|1
2647932|NCT00736957|9146496|P1|Overall Study|violation of eligibility criteria|2
2647933|NCT00736957|9146496|P1|Overall Study|Withdrawal by Subject|49
2647934|NCT00736957|9146496|P1|Overall Study|Adverse Event|43
2647935|NCT00736944|9146506|P1|Definitive Treatment|Physician Decision|1
2647936|NCT00736944|9146506|P1|Induction|Death|1
2647937|NCT00736879|9146537|P4|Follow up Period - No Drug Treatment|non-specified|0
2647938|NCT00736879|9146538|P3|Follow up Period - No Drug Treatment|non-specified|0
2647939|NCT00736879|9146539|P2|Follow up Period - No Drug Treatment|non-specified|2
2647940|NCT00736879|9146540|P1|Follow up Period - No Drug Treatment|non-specified|1
2647941|NCT00736879|9146537|P4|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
2647942|NCT00736879|9146538|P3|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
2647943|NCT00736879|9146539|P2|Follow up Period - No Drug Treatment|Withdrawal by Subject|1
2647944|NCT00736879|9146540|P1|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
2647945|NCT00736879|9146537|P4|Double Blind Treatment Period|non-specified|0
2647946|NCT00736879|9146538|P3|Double Blind Treatment Period|non-specified|0
2647947|NCT00736879|9146539|P2|Double Blind Treatment Period|non-specified|1
2647948|NCT00736879|9146540|P1|Double Blind Treatment Period|non-specified|0
2647949|NCT00736879|9146537|P4|Double Blind Treatment Period|No longer met criteria|0
2647950|NCT00736879|9146538|P3|Double Blind Treatment Period|No longer met criteria|0
2647951|NCT00736879|9146539|P2|Double Blind Treatment Period|No longer met criteria|1
2647952|NCT00736879|9146540|P1|Double Blind Treatment Period|No longer met criteria|0
2647953|NCT00736879|9146537|P4|Double Blind Treatment Period|Poor non-compliance|1
2647954|NCT00736879|9146538|P3|Double Blind Treatment Period|Poor non-compliance|1
2647955|NCT00736879|9146539|P2|Double Blind Treatment Period|Poor non-compliance|0
2647956|NCT00736879|9146540|P1|Double Blind Treatment Period|Poor non-compliance|0
2647957|NCT00736879|9146537|P4|Double Blind Treatment Period|Lost to Follow-up|1
2647958|NCT00736879|9146538|P3|Double Blind Treatment Period|Lost to Follow-up|2
2647959|NCT00736879|9146539|P2|Double Blind Treatment Period|Lost to Follow-up|0
2647960|NCT00736879|9146540|P1|Double Blind Treatment Period|Lost to Follow-up|0
2647961|NCT00736879|9146537|P4|Double Blind Treatment Period|Withdrawal by Subject|3
2647962|NCT00736879|9146538|P3|Double Blind Treatment Period|Withdrawal by Subject|3
2647963|NCT00736879|9146539|P2|Double Blind Treatment Period|Withdrawal by Subject|1
2647964|NCT00736879|9146540|P1|Double Blind Treatment Period|Withdrawal by Subject|2
2647965|NCT00736879|9146537|P4|Double Blind Treatment Period|Adverse Event|0
2647966|NCT00736879|9146538|P3|Double Blind Treatment Period|Adverse Event|1
2647967|NCT00736879|9146539|P2|Double Blind Treatment Period|Adverse Event|1
2647968|NCT00736879|9146540|P1|Double Blind Treatment Period|Adverse Event|0
2647969|NCT00736879|9146537|P4|Double Blind Treatment Period|Lack of Efficacy|0
2647970|NCT00736879|9146538|P3|Double Blind Treatment Period|Lack of Efficacy|0
2647971|NCT00736879|9146539|P2|Double Blind Treatment Period|Lack of Efficacy|0
2647972|NCT00736879|9146540|P1|Double Blind Treatment Period|Lack of Efficacy|1
2647973|NCT00736853|9146594|P3|Double-Blind Period|Ineligible to participate the study|0
2647974|NCT00736853|9146595|P2|Double-Blind Period|Ineligible to participate the study|1
2647975|NCT00736853|9146596|P1|Double-Blind Period|Ineligible to participate the study|0
2647976|NCT00736853|9146594|P3|Double-Blind Period|Withdrawal by Subject|4
2647977|NCT00736853|9146595|P2|Double-Blind Period|Withdrawal by Subject|1
2647978|NCT00736853|9146596|P1|Double-Blind Period|Withdrawal by Subject|0
2647979|NCT00736853|9146594|P3|Double-Blind Period|Adverse Event|2
2647980|NCT00736853|9146595|P2|Double-Blind Period|Adverse Event|3
2647981|NCT00736853|9146596|P1|Double-Blind Period|Adverse Event|0
2647982|NCT00736853|9146594|P3|Double-Blind Period|Lack of Efficacy|42
2647983|NCT00736853|9146595|P2|Double-Blind Period|Lack of Efficacy|19
2647984|NCT00736853|9146596|P1|Double-Blind Period|Lack of Efficacy|0
2647985|NCT00736853|9146594|P3|Open-Label Period|Unable to attend hospital appointments|0
2647986|NCT00736853|9146595|P2|Open-Label Period|Unable to attend hospital appointments|0
2647987|NCT00736853|9146596|P1|Open-Label Period|Unable to attend hospital appointments|1
2647988|NCT00736853|9146594|P3|Open-Label Period|Failed to meet the transfer criteria|0
2647989|NCT00736853|9146595|P2|Open-Label Period|Failed to meet the transfer criteria|0
2647990|NCT00736853|9146596|P1|Open-Label Period|Failed to meet the transfer criteria|40
2647991|NCT00736853|9146594|P3|Open-Label Period|Started but not treated|0
2647992|NCT00736853|9146595|P2|Open-Label Period|Started but not treated|0
2647993|NCT00736853|9146596|P1|Open-Label Period|Started but not treated|42
2647994|NCT00736853|9146594|P3|Open-Label Period|Withdrawal by Subject|0
2647995|NCT00736853|9146595|P2|Open-Label Period|Withdrawal by Subject|0
2647996|NCT00736853|9146596|P1|Open-Label Period|Withdrawal by Subject|16
2647997|NCT00736853|9146594|P3|Open-Label Period|Adverse Event|0
2647998|NCT00736853|9146595|P2|Open-Label Period|Adverse Event|0
2647999|NCT00736853|9146596|P1|Open-Label Period|Adverse Event|31
2648000|NCT00736853|9146594|P3|Open-Label Period|Physician Decision|0
2648001|NCT00736853|9146595|P2|Open-Label Period|Physician Decision|0
2648002|NCT00736853|9146596|P1|Open-Label Period|Physician Decision|2
2648003|NCT00736840|9146636|P1|Overall Study|Lost to Follow-up|13
2648004|NCT00736723|9146643|P2|Overall Study|Withdrawal by Subject|3
2648005|NCT00736723|9146644|P1|Overall Study|Withdrawal by Subject|4
2648006|NCT00736645|9146654|P4|Overall Study|Adverse Event|0
2648007|NCT00736645|9146655|P3|Overall Study|Adverse Event|0
2648008|NCT00736645|9146656|P2|Overall Study|Adverse Event|2
2648009|NCT00736645|9146657|P1|Overall Study|Adverse Event|0
2648010|NCT00736502|9146707|P1|Overall Study|Lost to Follow-up|27
2648011|NCT00736502|9146707|P1|Overall Study|Lack of Efficacy|16
2648012|NCT00736502|9146707|P1|Overall Study|Adverse Event|22
2648013|NCT00736489|9146713|P6|Period 1|Withdrawal by Subject|1
2648014|NCT00736489|9146714|P5|Period 1|Withdrawal by Subject|0
2648015|NCT00736489|9146715|P4|Period 1|Withdrawal by Subject|0
2648016|NCT00736489|9146716|P3|Period 1|Withdrawal by Subject|0
2648017|NCT00736489|9146717|P2|Period 1|Withdrawal by Subject|0
2648018|NCT00736489|9146718|P1|Period 1|Withdrawal by Subject|0
2648019|NCT00736489|9146713|P6|Period 1|Lost to Follow-up|0
2648020|NCT00736489|9146714|P5|Period 1|Lost to Follow-up|0
2648021|NCT00736489|9146715|P4|Period 1|Lost to Follow-up|0
2648022|NCT00736489|9146716|P3|Period 1|Lost to Follow-up|0
2648023|NCT00736489|9146717|P2|Period 1|Lost to Follow-up|0
2648024|NCT00736489|9146718|P1|Period 1|Lost to Follow-up|1
2648025|NCT00736476|9146872|P2|Overall Study|Adverse Event|0
2648026|NCT00736476|9146873|P1|Overall Study|Adverse Event|1
2648027|NCT00736450|9146893|P1|Overall Study|Physician Decision|1
2648028|NCT00736450|9146893|P1|Overall Study|Withdrawal by Subject|5
2648029|NCT00736450|9146893|P1|Overall Study|Not ABC gene eligible|19
2648030|NCT00736385|9146901|P2|Overall Study|Adverse Event|1
2648031|NCT00736385|9146902|P1|Overall Study|Adverse Event|0
2648032|NCT00736385|9146901|P2|Overall Study|Withdrawal by Subject|2
2648033|NCT00736385|9146902|P1|Overall Study|Withdrawal by Subject|2
2648034|NCT00736333|9146914|P1|Overall Study|Other|4
2648035|NCT00736333|9146914|P1|Overall Study|Death|7
2648036|NCT00736333|9146914|P1|Overall Study|Withdrawal by Subject|10
2648037|NCT00736333|9146914|P1|Overall Study|Toxicity|6
2648038|NCT00736333|9146914|P1|Overall Study|Tumor Progression|75
2648039|NCT00736333|9146914|P1|Overall Study|Data Missing|2
2648040|NCT00736333|9146914|P1|Overall Study|Did Not Receive Drug or Not Documented|7
2648041|NCT00736255|9146925|P2|Overall Study|Non-compliance|1
2648042|NCT00736255|9146926|P1|Overall Study|Non-compliance|1
2648043|NCT00736255|9146925|P2|Overall Study|Physician Decision|0
2648044|NCT00736255|9146926|P1|Overall Study|Physician Decision|1
2648045|NCT00736255|9146925|P2|Overall Study|Adverse Event|0
2648046|NCT00736255|9146926|P1|Overall Study|Adverse Event|1
2648047|NCT00736190|9146973|P1|Overall Study|Adverse Event|1
2648048|NCT00736190|9146973|P1|Overall Study|Withdrawal by Subject|1
2648049|NCT00736190|9146973|P1|Overall Study|Pregnancy|1
2648050|NCT00736099|9147003|P2|Overall Study|Other reason|10
2648051|NCT00736099|9147004|P1|Overall Study|Other reason|43
2648052|NCT00736099|9147003|P2|Overall Study|Lack of Efficacy|8
2648053|NCT00736099|9147004|P1|Overall Study|Lack of Efficacy|15
2648054|NCT00736099|9147003|P2|Overall Study|Withdrawal by Subject|13
2648055|NCT00736099|9147004|P1|Overall Study|Withdrawal by Subject|42
2648056|NCT00736099|9147003|P2|Overall Study|Lost to Follow-up|5
2648057|NCT00736099|9147004|P1|Overall Study|Lost to Follow-up|12
2648058|NCT00736099|9147003|P2|Overall Study|Protocol Violation|4
2648059|NCT00736099|9147004|P1|Overall Study|Protocol Violation|10
2648060|NCT00736099|9147003|P2|Overall Study|Adverse Event|18
2648061|NCT00736099|9147004|P1|Overall Study|Adverse Event|61
2648062|NCT00736034|9147113|P1|Overall Study|Adverse Event|2
2648063|NCT00735943|9147121|P1|Overall Study|Adverse Event|1
2648064|NCT00735943|9147121|P1|Overall Study|Lost to Follow-up|1
2648065|NCT00735904|9147146|P1|Overall Study|Other|8
2648066|NCT00735904|9147146|P1|Overall Study|Study Terminated by Sponsor|5
2648067|NCT00735904|9147146|P1|Overall Study|Withdrawal by Subject|1
2648068|NCT00735904|9147146|P1|Overall Study|Protocol Violation|1
2648069|NCT00735904|9147146|P1|Overall Study|Death|20
2648070|NCT00735904|9147146|P1|Overall Study|Adverse Event|3
2648071|NCT00735878|9147156|P3|Phase I- Dose Determination|Withdrawal by Subject|1
2648072|NCT00735878|9147157|P2|Phase I- Dose Determination|Withdrawal by Subject|0
2648073|NCT00735878|9147158|P1|Phase I- Dose Determination|Withdrawal by Subject|0
2648074|NCT00735709|9147237|P4|Overall Study|Excluded medication|1
2648075|NCT00735709|9147238|P3|Overall Study|Excluded medication|0
2648076|NCT00735709|9147239|P2|Overall Study|Excluded medication|0
2648077|NCT00735709|9147240|P1|Overall Study|Excluded medication|1
2648078|NCT00735709|9147237|P4|Overall Study|Lost to Follow-up|1
2648079|NCT00735709|9147238|P3|Overall Study|Lost to Follow-up|1
2648080|NCT00735709|9147239|P2|Overall Study|Lost to Follow-up|1
2648081|NCT00735709|9147240|P1|Overall Study|Lost to Follow-up|0
2648082|NCT00735709|9147237|P4|Overall Study|Voluntary Withdrawal|7
2648083|NCT00735709|9147238|P3|Overall Study|Voluntary Withdrawal|5
2648084|NCT00735709|9147239|P2|Overall Study|Voluntary Withdrawal|3
2648085|NCT00735709|9147240|P1|Overall Study|Voluntary Withdrawal|1
2648086|NCT00735709|9147237|P4|Overall Study|Protocol deviations|1
2648087|NCT00735709|9147238|P3|Overall Study|Protocol deviations|1
2648088|NCT00735709|9147239|P2|Overall Study|Protocol deviations|2
2648089|NCT00735709|9147240|P1|Overall Study|Protocol deviations|1
2648090|NCT00735709|9147237|P4|Overall Study|Noncompliance|0
2648091|NCT00735709|9147238|P3|Overall Study|Noncompliance|1
2648092|NCT00735709|9147239|P2|Overall Study|Noncompliance|0
2648093|NCT00735709|9147240|P1|Overall Study|Noncompliance|0
2648094|NCT00735709|9147237|P4|Overall Study|Lack of Efficacy|3
2648095|NCT00735709|9147238|P3|Overall Study|Lack of Efficacy|2
2648096|NCT00735709|9147239|P2|Overall Study|Lack of Efficacy|4
2648097|NCT00735709|9147240|P1|Overall Study|Lack of Efficacy|8
2648098|NCT00735709|9147237|P4|Overall Study|Adverse Event|5
2648099|NCT00735709|9147238|P3|Overall Study|Adverse Event|1
2648100|NCT00735709|9147239|P2|Overall Study|Adverse Event|3
2648101|NCT00735709|9147240|P1|Overall Study|Adverse Event|2
2648102|NCT00735696|9147350|P1|Overall Study|Enrolled but never Treated|1
2648103|NCT00735696|9147350|P1|Overall Study|Withdrawal by Subject|1
2648104|NCT00735644|9147378|P5|Overall Study|Withdrawal by Subject|0
2648105|NCT00735644|9147379|P4|Overall Study|Withdrawal by Subject|1
2648106|NCT00735644|9147380|P3|Overall Study|Withdrawal by Subject|1
2648107|NCT00735644|9147381|P2|Overall Study|Withdrawal by Subject|1
2648108|NCT00735644|9147382|P1|Overall Study|Withdrawal by Subject|0
2648109|NCT00735644|9147378|P5|Overall Study|Did not receive study vaccine|0
2648110|NCT00735644|9147379|P4|Overall Study|Did not receive study vaccine|0
2648111|NCT00735644|9147380|P3|Overall Study|Did not receive study vaccine|0
2648112|NCT00735644|9147381|P2|Overall Study|Did not receive study vaccine|1
2648113|NCT00735644|9147382|P1|Overall Study|Did not receive study vaccine|0
2648114|NCT00735553|9147426|P1|Overall Study|Study prematurely terminated|77
2648115|NCT00735475|9147436|P2|Overall Study|Withdrawal by Subject|5
2648116|NCT00735475|9147437|P1|Overall Study|Withdrawal by Subject|4
2648117|NCT00735475|9147436|P2|Overall Study|Physician Decision|1
2648118|NCT00735475|9147437|P1|Overall Study|Physician Decision|0
2648119|NCT00735475|9147436|P2|Overall Study|Lost to Follow-up|3
2648120|NCT00735475|9147437|P1|Overall Study|Lost to Follow-up|3
2648121|NCT00735475|9147436|P2|Overall Study|Death|1
2648122|NCT00735475|9147437|P1|Overall Study|Death|1
2648123|NCT00735475|9147436|P2|Overall Study|Adverse Event|1
2648124|NCT00735475|9147437|P1|Overall Study|Adverse Event|0
2648125|NCT00735397|9147497|P1|Overall Study|Administrative/Other|502
2648126|NCT00735397|9147497|P1|Overall Study|Inadequate therapeutic effect|202
2648127|NCT00735397|9147497|P1|Overall Study|Participant choice|252
2648128|NCT00735397|9147497|P1|Overall Study|Lost to Follow-up|33
2648129|NCT00735397|9147497|P1|Overall Study|Adverse Event|194
2648130|NCT00735371|9147511|P4|Overall Study|Exclusion criteria|0
2648131|NCT00735371|9147512|P3|Overall Study|Exclusion criteria|0
2648132|NCT00735371|9147513|P2|Overall Study|Exclusion criteria|0
2648133|NCT00735371|9147514|P1|Overall Study|Exclusion criteria|1
2648134|NCT00735371|9147511|P4|Overall Study|Prior Vyvanse Exposure|0
2648135|NCT00735371|9147512|P3|Overall Study|Prior Vyvanse Exposure|0
2648136|NCT00735371|9147513|P2|Overall Study|Prior Vyvanse Exposure|1
2648137|NCT00735371|9147514|P1|Overall Study|Prior Vyvanse Exposure|1
2648138|NCT00735371|9147511|P4|Overall Study|Protocol Violation|0
2648139|NCT00735371|9147512|P3|Overall Study|Protocol Violation|2
2648140|NCT00735371|9147513|P2|Overall Study|Protocol Violation|1
2648141|NCT00735371|9147514|P1|Overall Study|Protocol Violation|0
2648142|NCT00735371|9147511|P4|Overall Study|Sponsor Decision|1
2648143|NCT00735371|9147512|P3|Overall Study|Sponsor Decision|0
2648144|NCT00735371|9147513|P2|Overall Study|Sponsor Decision|1
2648145|NCT00735371|9147514|P1|Overall Study|Sponsor Decision|3
2648146|NCT00735371|9147511|P4|Overall Study|Lack of Efficacy|4
2648147|NCT00735371|9147512|P3|Overall Study|Lack of Efficacy|0
2648148|NCT00735371|9147513|P2|Overall Study|Lack of Efficacy|2
2648149|NCT00735371|9147514|P1|Overall Study|Lack of Efficacy|4
2648150|NCT00735371|9147511|P4|Overall Study|Lost to Follow-up|1
2648151|NCT00735371|9147512|P3|Overall Study|Lost to Follow-up|3
2648152|NCT00735371|9147513|P2|Overall Study|Lost to Follow-up|1
2648153|NCT00735371|9147514|P1|Overall Study|Lost to Follow-up|1
2648154|NCT00735371|9147511|P4|Overall Study|Withdrawal by Subject|0
2648155|NCT00735371|9147512|P3|Overall Study|Withdrawal by Subject|2
2648156|NCT00735371|9147513|P2|Overall Study|Withdrawal by Subject|2
2648157|NCT00735371|9147514|P1|Overall Study|Withdrawal by Subject|0
2648158|NCT00735371|9147511|P4|Overall Study|Protocol Violation|3
2648159|NCT00735371|9147512|P3|Overall Study|Protocol Violation|0
2648160|NCT00735371|9147513|P2|Overall Study|Protocol Violation|2
2648161|NCT00735371|9147514|P1|Overall Study|Protocol Violation|2
2648162|NCT00735371|9147511|P4|Overall Study|Adverse Event|1
2648163|NCT00735371|9147512|P3|Overall Study|Adverse Event|4
2648164|NCT00735371|9147513|P2|Overall Study|Adverse Event|3
2648165|NCT00735371|9147514|P1|Overall Study|Adverse Event|3
2648166|NCT00735254|9147542|P4|Overall Study|Protocol Violation|0
2648167|NCT00735254|9147543|P3|Overall Study|Protocol Violation|1
2648168|NCT00735254|9147544|P2|Overall Study|Protocol Violation|1
2648169|NCT00735254|9147545|P1|Overall Study|Protocol Violation|1
2648170|NCT00735072|9147557|P2|Overall Study|Subject interrupted ARVs (non-adherence)|1
2648171|NCT00735072|9147558|P1|Overall Study|Subject interrupted ARVs (non-adherence)|0
2648172|NCT00735072|9147557|P2|Overall Study|interrupted study med during ARV change|0
2648173|NCT00735072|9147558|P1|Overall Study|interrupted study med during ARV change|1
2648174|NCT00735007|9147564|P1|Overall Study|Protocol Violation|1
2648175|NCT00735007|9147564|P1|Overall Study|Adverse Event|4
2648176|NCT00734994|9147589|P1|Overall Study|Withdrawal by Subject|1
2648177|NCT00734929|9147609|P2|Overall Study|No intervention/ screen fail|3
2648178|NCT00734929|9147610|P1|Overall Study|No intervention/ screen fail|5
2648179|NCT00734929|9147609|P2|Overall Study|Lost to Follow-up|2
2648180|NCT00734929|9147610|P1|Overall Study|Lost to Follow-up|1
2648181|NCT00734851|9147667|P1|Overall Study|Physician Decision|18
2648182|NCT00734851|9147667|P1|Overall Study|Lost to Follow-up|1
2648183|NCT00734851|9147667|P1|Overall Study|Withdrawal by Subject|2
2648184|NCT00734747|9147688|P1|6 Month Follow-up|Did not meet inclusion criteria|3
2648185|NCT00734747|9147688|P1|SRS Procedure|No staples placed|3
2648186|NCT00734656|9147702|P4|Lab Session 4|Withdrawal by Subject|1
2648187|NCT00734656|9147703|P3|Lab Session 4|Withdrawal by Subject|0
2648188|NCT00734656|9147704|P2|Lab Session 4|Withdrawal by Subject|0
2648189|NCT00734656|9147705|P1|Lab Session 4|Withdrawal by Subject|0
2648190|NCT00734656|9147702|P4|Washout 3|Withdrawal by Subject|1
2648191|NCT00734656|9147703|P3|Washout 3|Withdrawal by Subject|0
2648192|NCT00734656|9147704|P2|Washout 3|Withdrawal by Subject|0
2648193|NCT00734656|9147705|P1|Washout 3|Withdrawal by Subject|1
2648194|NCT00734656|9147702|P4|Washout 2|Withdrawal by Subject|0
2648195|NCT00734656|9147703|P3|Washout 2|Withdrawal by Subject|1
2648196|NCT00734656|9147704|P2|Washout 2|Withdrawal by Subject|1
2648197|NCT00734656|9147705|P1|Washout 2|Withdrawal by Subject|1
2648198|NCT00734656|9147702|P4|Lab Session 2|Withdrawal by Subject|1
2648199|NCT00734656|9147703|P3|Lab Session 2|Withdrawal by Subject|0
2648200|NCT00734656|9147704|P2|Lab Session 2|Withdrawal by Subject|0
2648201|NCT00734656|9147705|P1|Lab Session 2|Withdrawal by Subject|1
2648202|NCT00734656|9147702|P4|Washout 1|Withdrawal by Subject|3
2648203|NCT00734656|9147703|P3|Washout 1|Withdrawal by Subject|2
2648204|NCT00734656|9147704|P2|Washout 1|Withdrawal by Subject|5
2648205|NCT00734656|9147705|P1|Washout 1|Withdrawal by Subject|1
2648206|NCT00734656|9147702|P4|Lab Session 1|Withdrawal by Subject|0
2648207|NCT00734656|9147703|P3|Lab Session 1|Withdrawal by Subject|0
2648208|NCT00734656|9147704|P2|Lab Session 1|Withdrawal by Subject|0
2648209|NCT00734656|9147705|P1|Lab Session 1|Withdrawal by Subject|2
2648210|NCT00734630|9147729|P2|Overall Study|Poor Compliance|1
2648211|NCT00734630|9147730|P1|Overall Study|Poor Compliance|1
2648212|NCT00734630|9147729|P2|Overall Study|Tested Positive for Illegal Drug Use|1
2648213|NCT00734630|9147730|P1|Overall Study|Tested Positive for Illegal Drug Use|1
2648214|NCT00734630|9147729|P2|Overall Study|Randomized in Error|1
2648215|NCT00734630|9147730|P1|Overall Study|Randomized in Error|0
2648216|NCT00734630|9147729|P2|Overall Study|Adverse Event|6
2648217|NCT00734630|9147730|P1|Overall Study|Adverse Event|3
2648218|NCT00734630|9147729|P2|Overall Study|Inclusion/Exclusion criteria not met|1
2648219|NCT00734630|9147730|P1|Overall Study|Inclusion/Exclusion criteria not met|0
2648220|NCT00734630|9147729|P2|Overall Study|Protocol Violation|3
2648221|NCT00734630|9147730|P1|Overall Study|Protocol Violation|0
2648222|NCT00734630|9147729|P2|Overall Study|Lost to Follow-up|7
2648223|NCT00734630|9147730|P1|Overall Study|Lost to Follow-up|13
2648224|NCT00734630|9147729|P2|Overall Study|Withdrawal by Subject|9
2648225|NCT00734630|9147730|P1|Overall Study|Withdrawal by Subject|7
2648226|NCT00734630|9147729|P2|Overall Study|Lack of Efficacy|4
2648227|NCT00734630|9147730|P1|Overall Study|Lack of Efficacy|4
2648228|NCT00734617|9147740|P2|Overall Study|Withdrawal by Subject|95
2648229|NCT00734617|9147741|P1|Overall Study|Withdrawal by Subject|103
2648230|NCT00734617|9147740|P2|Overall Study|Adverse Event|7
2648231|NCT00734617|9147741|P1|Overall Study|Adverse Event|4
2648232|NCT00734604|9147753|P6|Overall Study|Lack of Efficacy|0
2648233|NCT00734604|9147754|P5|Overall Study|Lack of Efficacy|0
2648234|NCT00734604|9147755|P4|Overall Study|Lack of Efficacy|0
2648235|NCT00734604|9147756|P3|Overall Study|Lack of Efficacy|1
2648236|NCT00734604|9147757|P2|Overall Study|Lack of Efficacy|1
2648237|NCT00734604|9147758|P1|Overall Study|Lack of Efficacy|0
2648238|NCT00734604|9147753|P6|Overall Study|Withdrawal by Subject|1
2648239|NCT00734604|9147754|P5|Overall Study|Withdrawal by Subject|2
2648240|NCT00734604|9147755|P4|Overall Study|Withdrawal by Subject|1
2648241|NCT00734604|9147756|P3|Overall Study|Withdrawal by Subject|0
2648242|NCT00734604|9147757|P2|Overall Study|Withdrawal by Subject|2
2648243|NCT00734604|9147758|P1|Overall Study|Withdrawal by Subject|0
2648244|NCT00734604|9147753|P6|Overall Study|Sponsor Decision|0
2648245|NCT00734604|9147754|P5|Overall Study|Sponsor Decision|2
2648246|NCT00734604|9147755|P4|Overall Study|Sponsor Decision|0
2648247|NCT00734604|9147756|P3|Overall Study|Sponsor Decision|1
2648248|NCT00734604|9147757|P2|Overall Study|Sponsor Decision|2
2648249|NCT00734604|9147758|P1|Overall Study|Sponsor Decision|1
2648250|NCT00734604|9147753|P6|Overall Study|Protocol Violation|0
2648251|NCT00734604|9147754|P5|Overall Study|Protocol Violation|1
2648252|NCT00734604|9147755|P4|Overall Study|Protocol Violation|0
2648253|NCT00734604|9147756|P3|Overall Study|Protocol Violation|0
2648254|NCT00734604|9147757|P2|Overall Study|Protocol Violation|2
2648255|NCT00734604|9147758|P1|Overall Study|Protocol Violation|0
2648256|NCT00734604|9147753|P6|Overall Study|Physician Decision|0
2648257|NCT00734604|9147754|P5|Overall Study|Physician Decision|0
2648258|NCT00734604|9147755|P4|Overall Study|Physician Decision|0
2648259|NCT00734604|9147756|P3|Overall Study|Physician Decision|1
2648260|NCT00734604|9147757|P2|Overall Study|Physician Decision|1
2648261|NCT00734604|9147758|P1|Overall Study|Physician Decision|0
2648262|NCT00734604|9147753|P6|Overall Study|Lost to Follow-up|3
2648263|NCT00734604|9147754|P5|Overall Study|Lost to Follow-up|2
2648264|NCT00734604|9147755|P4|Overall Study|Lost to Follow-up|4
2648265|NCT00734604|9147756|P3|Overall Study|Lost to Follow-up|2
2648266|NCT00734604|9147757|P2|Overall Study|Lost to Follow-up|2
2648267|NCT00734604|9147758|P1|Overall Study|Lost to Follow-up|1
2648268|NCT00734604|9147753|P6|Overall Study|Serious Adverse Event|1
2648269|NCT00734604|9147754|P5|Overall Study|Serious Adverse Event|0
2648270|NCT00734604|9147755|P4|Overall Study|Serious Adverse Event|2
2648271|NCT00734604|9147756|P3|Overall Study|Serious Adverse Event|1
2648272|NCT00734604|9147757|P2|Overall Study|Serious Adverse Event|0
2648273|NCT00734604|9147758|P1|Overall Study|Serious Adverse Event|1
2648274|NCT00734604|9147753|P6|Overall Study|Adverse Event|1
2648275|NCT00734604|9147754|P5|Overall Study|Adverse Event|1
2648276|NCT00734604|9147755|P4|Overall Study|Adverse Event|2
2648277|NCT00734604|9147756|P3|Overall Study|Adverse Event|0
2648278|NCT00734604|9147757|P2|Overall Study|Adverse Event|2
2648279|NCT00734604|9147758|P1|Overall Study|Adverse Event|0
2648280|NCT00734591|9147808|P2|Prospective Period|Other|2
2648281|NCT00734591|9147809|P1|Prospective Period|Other|2
2648282|NCT00734591|9147808|P2|Prospective Period|Study Terminated|0
2648283|NCT00734591|9147809|P1|Prospective Period|Study Terminated|1
2648284|NCT00734591|9147808|P2|Prospective Period|Lost to Follow-up|33
2648285|NCT00734591|9147809|P1|Prospective Period|Lost to Follow-up|37
2648286|NCT00734591|9147808|P2|Prospective Period|Withdrawal by Subject|9
2648287|NCT00734591|9147809|P1|Prospective Period|Withdrawal by Subject|11
2648288|NCT00734591|9147808|P2|Screening for Prospective Period|Patient at partic. site not enrolled|803
2648289|NCT00734591|9147809|P1|Screening for Prospective Period|Patient at partic. site not enrolled|913
2648290|NCT00734591|9147808|P2|Screening for Prospective Period|Site did not participate|1488
2648291|NCT00734591|9147809|P1|Screening for Prospective Period|Site did not participate|1604
2648292|NCT00734578|9147824|P3|Overall Study|Exclusion criteria|0
2648293|NCT00734578|9147825|P2|Overall Study|Exclusion criteria|0
2648294|NCT00734578|9147826|P1|Overall Study|Exclusion criteria|1
2648295|NCT00734578|9147824|P3|Overall Study|Randomized in error|0
2648296|NCT00734578|9147825|P2|Overall Study|Randomized in error|0
2648297|NCT00734578|9147826|P1|Overall Study|Randomized in error|1
2648298|NCT00734578|9147824|P3|Overall Study|Lack of Efficacy|5
2648299|NCT00734578|9147825|P2|Overall Study|Lack of Efficacy|2
2648300|NCT00734578|9147826|P1|Overall Study|Lack of Efficacy|3
2648301|NCT00734578|9147824|P3|Overall Study|Lost to Follow-up|5
2648302|NCT00734578|9147825|P2|Overall Study|Lost to Follow-up|3
2648303|NCT00734578|9147826|P1|Overall Study|Lost to Follow-up|9
2648304|NCT00734578|9147824|P3|Overall Study|Withdrawal by Subject|11
2648305|NCT00734578|9147825|P2|Overall Study|Withdrawal by Subject|8
2648306|NCT00734578|9147826|P1|Overall Study|Withdrawal by Subject|7
2648307|NCT00734578|9147824|P3|Overall Study|Protocol Violation|3
2648308|NCT00734578|9147825|P2|Overall Study|Protocol Violation|6
2648309|NCT00734578|9147826|P1|Overall Study|Protocol Violation|8
2648310|NCT00734578|9147824|P3|Overall Study|Adverse Event|1
2648311|NCT00734578|9147825|P2|Overall Study|Adverse Event|6
2648312|NCT00734578|9147826|P1|Overall Study|Adverse Event|4
2648313|NCT00734539|9147860|P2|Main Study|Enrolled in error; ineligible|0
2648314|NCT00734539|9147861|P1|Main Study|Enrolled in error; ineligible|1
2648315|NCT00734539|9147860|P2|Main Study|Withdrawal by Subject|3
2648316|NCT00734539|9147861|P1|Main Study|Withdrawal by Subject|1
2648317|NCT00734539|9147860|P2|Main Study|Physician Decision|0
2648318|NCT00734539|9147861|P1|Main Study|Physician Decision|2
2648319|NCT00734539|9147860|P2|Main Study|Death|32
2648320|NCT00734539|9147861|P1|Main Study|Death|33
2648321|NCT00734474|9147903|P9|Overall Study|Lack of Efficacy|6
2648322|NCT00734474|9147904|P8|Overall Study|Lack of Efficacy|4
2648323|NCT00734474|9147905|P7|Overall Study|Lack of Efficacy|0
2648324|NCT00734474|9147906|P6|Overall Study|Lack of Efficacy|0
2648325|NCT00734474|9147907|P5|Overall Study|Lack of Efficacy|0
2648326|NCT00734474|9147908|P4|Overall Study|Lack of Efficacy|0
2648327|NCT00734474|9147909|P3|Overall Study|Lack of Efficacy|4
2648328|NCT00734474|9147910|P2|Overall Study|Lack of Efficacy|0
2648329|NCT00734474|9147911|P1|Overall Study|Lack of Efficacy|0
2648330|NCT00734474|9147903|P9|Overall Study|Death|1
2648331|NCT00734474|9147904|P8|Overall Study|Death|2
2648332|NCT00734474|9147905|P7|Overall Study|Death|0
2648333|NCT00734474|9147906|P6|Overall Study|Death|0
2648334|NCT00734474|9147907|P5|Overall Study|Death|0
2648335|NCT00734474|9147908|P4|Overall Study|Death|0
2648336|NCT00734474|9147909|P3|Overall Study|Death|1
2648337|NCT00734474|9147910|P2|Overall Study|Death|0
2648338|NCT00734474|9147911|P1|Overall Study|Death|0
2648339|NCT00734474|9147903|P9|Overall Study|Sponsor Decision|0
2648340|NCT00734474|9147904|P8|Overall Study|Sponsor Decision|0
2648341|NCT00734474|9147905|P7|Overall Study|Sponsor Decision|0
2648342|NCT00734474|9147906|P6|Overall Study|Sponsor Decision|0
2648343|NCT00734474|9147907|P5|Overall Study|Sponsor Decision|2
2648344|NCT00734474|9147908|P4|Overall Study|Sponsor Decision|0
2648345|NCT00734474|9147909|P3|Overall Study|Sponsor Decision|0
2648346|NCT00734474|9147910|P2|Overall Study|Sponsor Decision|0
2648347|NCT00734474|9147911|P1|Overall Study|Sponsor Decision|0
2648348|NCT00734474|9147903|P9|Overall Study|Sponsor Decision, Arm Discontinued|0
2648349|NCT00734474|9147904|P8|Overall Study|Sponsor Decision, Arm Discontinued|0
2648350|NCT00734474|9147905|P7|Overall Study|Sponsor Decision, Arm Discontinued|23
2648351|NCT00734474|9147906|P6|Overall Study|Sponsor Decision, Arm Discontinued|21
2648352|NCT00734474|9147907|P5|Overall Study|Sponsor Decision, Arm Discontinued|0
2648353|NCT00734474|9147908|P4|Overall Study|Sponsor Decision, Arm Discontinued|8
2648354|NCT00734474|9147909|P3|Overall Study|Sponsor Decision, Arm Discontinued|0
2648355|NCT00734474|9147910|P2|Overall Study|Sponsor Decision, Arm Discontinued|25
2648356|NCT00734474|9147911|P1|Overall Study|Sponsor Decision, Arm Discontinued|8
2648357|NCT00734474|9147903|P9|Overall Study|Protocol Violation|1
2648358|NCT00734474|9147904|P8|Overall Study|Protocol Violation|3
2648359|NCT00734474|9147905|P7|Overall Study|Protocol Violation|0
2648360|NCT00734474|9147906|P6|Overall Study|Protocol Violation|0
2648361|NCT00734474|9147907|P5|Overall Study|Protocol Violation|3
2648362|NCT00734474|9147908|P4|Overall Study|Protocol Violation|0
2648363|NCT00734474|9147909|P3|Overall Study|Protocol Violation|4
2648364|NCT00734474|9147910|P2|Overall Study|Protocol Violation|0
2648365|NCT00734474|9147911|P1|Overall Study|Protocol Violation|0
2648366|NCT00734474|9147903|P9|Overall Study|Adverse Event|39
2648367|NCT00734474|9147904|P8|Overall Study|Adverse Event|65
2648368|NCT00734474|9147905|P7|Overall Study|Adverse Event|1
2648369|NCT00734474|9147906|P6|Overall Study|Adverse Event|0
2648370|NCT00734474|9147907|P5|Overall Study|Adverse Event|64
2648371|NCT00734474|9147908|P4|Overall Study|Adverse Event|1
2648372|NCT00734474|9147909|P3|Overall Study|Adverse Event|63
2648373|NCT00734474|9147910|P2|Overall Study|Adverse Event|4
2648374|NCT00734474|9147911|P1|Overall Study|Adverse Event|4
2648375|NCT00734474|9147903|P9|Overall Study|Physician Decision|9
2648376|NCT00734474|9147904|P8|Overall Study|Physician Decision|9
2648377|NCT00734474|9147905|P7|Overall Study|Physician Decision|0
2648378|NCT00734474|9147906|P6|Overall Study|Physician Decision|0
2648379|NCT00734474|9147907|P5|Overall Study|Physician Decision|11
2648380|NCT00734474|9147908|P4|Overall Study|Physician Decision|1
2648381|NCT00734474|9147909|P3|Overall Study|Physician Decision|4
2648382|NCT00734474|9147910|P2|Overall Study|Physician Decision|0
2648383|NCT00734474|9147911|P1|Overall Study|Physician Decision|0
2648384|NCT00734474|9147903|P9|Overall Study|Withdrawal by Subject|21
2648385|NCT00734474|9147904|P8|Overall Study|Withdrawal by Subject|36
2648386|NCT00734474|9147905|P7|Overall Study|Withdrawal by Subject|0
2648387|NCT00734474|9147906|P6|Overall Study|Withdrawal by Subject|2
2648388|NCT00734474|9147907|P5|Overall Study|Withdrawal by Subject|24
2648389|NCT00734474|9147908|P4|Overall Study|Withdrawal by Subject|0
2648390|NCT00734474|9147909|P3|Overall Study|Withdrawal by Subject|18
2648391|NCT00734474|9147910|P2|Overall Study|Withdrawal by Subject|1
2648392|NCT00734474|9147911|P1|Overall Study|Withdrawal by Subject|2
2648393|NCT00734474|9147903|P9|Overall Study|Lost to Follow-up|4
2648394|NCT00734474|9147904|P8|Overall Study|Lost to Follow-up|9
2648395|NCT00734474|9147905|P7|Overall Study|Lost to Follow-up|0
2648396|NCT00734474|9147906|P6|Overall Study|Lost to Follow-up|1
2648397|NCT00734474|9147907|P5|Overall Study|Lost to Follow-up|11
2648398|NCT00734474|9147908|P4|Overall Study|Lost to Follow-up|0
2648399|NCT00734474|9147909|P3|Overall Study|Lost to Follow-up|13
2648400|NCT00734474|9147910|P2|Overall Study|Lost to Follow-up|0
2648401|NCT00734474|9147911|P1|Overall Study|Lost to Follow-up|1
2648402|NCT00734474|9147903|P9|Overall Study|Entry Criteria Not Met|1
2648403|NCT00734474|9147904|P8|Overall Study|Entry Criteria Not Met|1
2648404|NCT00734474|9147905|P7|Overall Study|Entry Criteria Not Met|0
2648405|NCT00734474|9147906|P6|Overall Study|Entry Criteria Not Met|1
2648406|NCT00734474|9147907|P5|Overall Study|Entry Criteria Not Met|3
2648407|NCT00734474|9147908|P4|Overall Study|Entry Criteria Not Met|0
2648408|NCT00734474|9147909|P3|Overall Study|Entry Criteria Not Met|5
2648409|NCT00734474|9147910|P2|Overall Study|Entry Criteria Not Met|0
2648410|NCT00734474|9147911|P1|Overall Study|Entry Criteria Not Met|0
2648411|NCT00734214|9148201|P2|Overall Study|MD withdrawal|0
2648412|NCT00734214|9148202|P1|Overall Study|MD withdrawal|1
2648413|NCT00734214|9148201|P2|Overall Study|Withdrawal by Subject|4
2648414|NCT00734214|9148202|P1|Overall Study|Withdrawal by Subject|3
2648415|NCT00734162|9148212|P4|Open-Label Phase|Did Not Meet Entrance Criteria|1
2648416|NCT00734162|9148213|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
2648417|NCT00734162|9148214|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
2648418|NCT00734162|9148215|P1|Open-Label Phase|Did Not Meet Entrance Criteria|0
2648419|NCT00734162|9148212|P4|Open-Label Phase|Lost to Follow-up|1
2648420|NCT00734162|9148213|P3|Open-Label Phase|Lost to Follow-up|0
2648421|NCT00734162|9148214|P2|Open-Label Phase|Lost to Follow-up|2
2648422|NCT00734162|9148215|P1|Open-Label Phase|Lost to Follow-up|1
2648423|NCT00734162|9148212|P4|Open-Label Phase|Withdrew Consent|1
2648424|NCT00734162|9148213|P3|Open-Label Phase|Withdrew Consent|1
2648425|NCT00734162|9148214|P2|Open-Label Phase|Withdrew Consent|0
2648426|NCT00734162|9148215|P1|Open-Label Phase|Withdrew Consent|1
2648427|NCT00734162|9148212|P4|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
2648428|NCT00734162|9148213|P3|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
2648429|NCT00734162|9148214|P2|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
2648430|NCT00734162|9148215|P1|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1
2648431|NCT00734162|9148212|P4|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2
2648432|NCT00734162|9148213|P3|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
2648433|NCT00734162|9148214|P2|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
2648434|NCT00734162|9148215|P1|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
2648435|NCT00734162|9148212|P4|Randomized Phase (Through Week 72)|Investigator's Discretion|2
2648436|NCT00734162|9148213|P3|Randomized Phase (Through Week 72)|Investigator's Discretion|0
2648437|NCT00734162|9148214|P2|Randomized Phase (Through Week 72)|Investigator's Discretion|1
2648438|NCT00734162|9148215|P1|Randomized Phase (Through Week 72)|Investigator's Discretion|0
2648439|NCT00734149|9148439|P1|Overall Study|Withdrawal by Subject|1
2648440|NCT00734097|9148446|P1|Open Label|Protocol Violation|4
2648441|NCT00734097|9148446|P1|Open Label|Withdrawal by Subject|5
2648442|NCT00734097|9148446|P1|Open Label|Lost to Follow-up|7
2648443|NCT00734097|9148446|P1|Screening|Unconfirmed pregnancy|1
2648444|NCT00734097|9148446|P1|Screening|Lost to Follow-up|2
2648445|NCT00734097|9148446|P1|Screening|Withdrawal by Subject|5
2648446|NCT00734097|9148446|P1|Screening|Protocol Violation|12
2648447|NCT00734071|9148463|P2|Overall Study|Other|2
2648448|NCT00734071|9148464|P1|Overall Study|Other|1
2648449|NCT00734071|9148463|P2|Overall Study|Lost to Follow-up|8
2648450|NCT00734071|9148464|P1|Overall Study|Lost to Follow-up|16
2648451|NCT00734071|9148463|P2|Overall Study|Voluntary Withdrawal|7
2648452|NCT00734071|9148464|P1|Overall Study|Voluntary Withdrawal|9
2648453|NCT00734071|9148463|P2|Overall Study|Protocol Deviations|4
2648454|NCT00734071|9148464|P1|Overall Study|Protocol Deviations|3
2648455|NCT00734071|9148463|P2|Overall Study|Noncompliance|2
2648456|NCT00734071|9148464|P1|Overall Study|Noncompliance|2
2648457|NCT00734071|9148463|P2|Overall Study|Lack of Efficacy|1
2648458|NCT00734071|9148464|P1|Overall Study|Lack of Efficacy|3
2648459|NCT00734071|9148463|P2|Overall Study|Adverse Event|3
2648460|NCT00734071|9148464|P1|Overall Study|Adverse Event|4
2648461|NCT00734032|9148522|P4|Overall Study|Adverse Event|0
2648462|NCT00734032|9148523|P3|Overall Study|Adverse Event|0
2648463|NCT00734032|9148524|P2|Overall Study|Adverse Event|1
2648464|NCT00734032|9148525|P1|Overall Study|Adverse Event|0
2648465|NCT00733980|9148581|P2|Overall Study|Withdrawal by Subject|2
2648466|NCT00733980|9148582|P1|Overall Study|Withdrawal by Subject|6
2648467|NCT00733980|9148581|P2|Overall Study|Physician Decision|3
2648468|NCT00733980|9148582|P1|Overall Study|Physician Decision|2
2648469|NCT00733980|9148581|P2|Overall Study|Lost to Follow-up|11
2648470|NCT00733980|9148582|P1|Overall Study|Lost to Follow-up|6
2648471|NCT00733980|9148581|P2|Overall Study|Protocol defined stopping criteria reach|1
2648472|NCT00733980|9148582|P1|Overall Study|Protocol defined stopping criteria reach|1
2648473|NCT00733980|9148581|P2|Overall Study|Protocol Violation|1
2648474|NCT00733980|9148582|P1|Overall Study|Protocol Violation|2
2648475|NCT00733980|9148581|P2|Overall Study|Lack of Efficacy|1
2648476|NCT00733980|9148582|P1|Overall Study|Lack of Efficacy|0
2648477|NCT00733980|9148581|P2|Overall Study|Adverse Event|2
2648478|NCT00733980|9148582|P1|Overall Study|Adverse Event|5
2648479|NCT00733954|9148626|P2|Overall Study|Withdrawal by Subject|0
2648480|NCT00733954|9148627|P1|Overall Study|Withdrawal by Subject|2
2648481|NCT00733954|9148626|P2|Overall Study|Protocol Violation|0
2648482|NCT00733954|9148627|P1|Overall Study|Protocol Violation|1
2648483|NCT00733954|9148626|P2|Overall Study|Lost to Follow-up|2
2648484|NCT00733954|9148627|P1|Overall Study|Lost to Follow-up|5
2648485|NCT00733824|9148674|P5|Phase I|Withdrawal by Subject|0
2648486|NCT00733824|9148675|P4|Phase I|Withdrawal by Subject|0
2648487|NCT00733824|9148676|P3|Phase I|Withdrawal by Subject|0
2648488|NCT00733824|9148677|P2|Phase I|Withdrawal by Subject|0
2648489|NCT00733824|9148678|P1|Phase I|Withdrawal by Subject|1
2648490|NCT00733746|9148697|P1|Overall Study|Ineligible|5
2648491|NCT00733499|9148712|P2|10 Year Followup|missing, unable to locate|2
2648492|NCT00733499|9148713|P1|10 Year Followup|missing, unable to locate|0
2648493|NCT00733499|9148712|P2|10 Year Followup|Withdrawal by Subject|5
2648494|NCT00733499|9148713|P1|10 Year Followup|Withdrawal by Subject|5
2648495|NCT00733499|9148712|P2|10 Year Followup|Lost to Follow-up|2
2648496|NCT00733499|9148713|P1|10 Year Followup|Lost to Follow-up|3
2648497|NCT00733499|9148712|P2|10 Year Followup|Adverse Event|3
2648498|NCT00733499|9148713|P1|10 Year Followup|Adverse Event|3
2648499|NCT00733499|9148712|P2|10 Year Followup|Death|7
2648500|NCT00733499|9148713|P1|10 Year Followup|Death|9
2648501|NCT00733499|9148712|P2|5 Year Followup|Withdrawal by Subject|1
2648502|NCT00733499|9148713|P1|5 Year Followup|Withdrawal by Subject|4
2648503|NCT00733499|9148712|P2|5 Year Followup|missing, unable to locate|1
2648504|NCT00733499|9148713|P1|5 Year Followup|missing, unable to locate|0
2648505|NCT00733499|9148712|P2|5 Year Followup|Death|19
2648506|NCT00733499|9148713|P1|5 Year Followup|Death|13
2648507|NCT00733499|9148712|P2|5 Year Followup|Lost to Follow-up|0
2648508|NCT00733499|9148713|P1|5 Year Followup|Lost to Follow-up|2
2648509|NCT00733499|9148712|P2|5 Year Followup|Revision of Study Implant|1
2648510|NCT00733499|9148713|P1|5 Year Followup|Revision of Study Implant|0
2648511|NCT00733499|9148712|P2|5 Year Followup|Non device related AE|1
2648512|NCT00733499|9148713|P1|5 Year Followup|Non device related AE|0
2648513|NCT00733499|9148712|P2|5 Year Followup|Adverse Event|2
2648514|NCT00733499|9148713|P1|5 Year Followup|Adverse Event|2
2648515|NCT00733499|9148712|P2|24 Months Follow-up|Death|1
2648516|NCT00733499|9148713|P1|24 Months Follow-up|Death|0
2648517|NCT00733499|9148712|P2|12 Months Follow-up|Death|1
2648518|NCT00733499|9148713|P1|12 Months Follow-up|Death|2
2648519|NCT00733499|9148712|P2|6 Months Follow-up|Adverse Event|1
2648520|NCT00733499|9148713|P1|6 Months Follow-up|Adverse Event|0
2648521|NCT00733499|9148712|P2|6 Months Follow-up|Death|2
2648522|NCT00733499|9148713|P1|6 Months Follow-up|Death|0
2648523|NCT00733499|9148712|P2|3 Months Follow-up|Death|2
2648524|NCT00733499|9148713|P1|3 Months Follow-up|Death|1
2648525|NCT00733499|9148712|P2|Pre-operative|Protocol Violation|1
2648526|NCT00733499|9148713|P1|Pre-operative|Protocol Violation|0
2648527|NCT00733421|9148773|P2|Overall Study|Withdrawal by Subject|1
2648528|NCT00733421|9148774|P1|Overall Study|Withdrawal by Subject|1
2648529|NCT00733408|9148796|P1|Overall Study|Adverse Event|4
2648530|NCT00733369|9148808|P2|Overall Study|Protocol Violation|4
2648531|NCT00733369|9148809|P1|Overall Study|Protocol Violation|4
2648532|NCT00733369|9148808|P2|Overall Study|Adverse Event|4
2648533|NCT00733369|9148809|P1|Overall Study|Adverse Event|4
2648534|NCT00733369|9148808|P2|Overall Study|Lost to Follow-up|1
2648535|NCT00733369|9148809|P1|Overall Study|Lost to Follow-up|2
2648536|NCT00733304|9149017|P3|Overall Study|Withdrawal by Subject|0
2648537|NCT00733304|9149018|P2|Overall Study|Withdrawal by Subject|1
2648538|NCT00733304|9149019|P1|Overall Study|Withdrawal by Subject|1
2648539|NCT00733304|9149017|P3|Overall Study|Physician Decision|3
2648540|NCT00733304|9149018|P2|Overall Study|Physician Decision|1
2648541|NCT00733304|9149019|P1|Overall Study|Physician Decision|3
2648542|NCT00733304|9149017|P3|Overall Study|Lost to Follow-up|0
2648543|NCT00733304|9149018|P2|Overall Study|Lost to Follow-up|1
2648544|NCT00733304|9149019|P1|Overall Study|Lost to Follow-up|0
2648545|NCT00733304|9149017|P3|Overall Study|Lack of Efficacy|2
2648546|NCT00733304|9149018|P2|Overall Study|Lack of Efficacy|0
2648547|NCT00733304|9149019|P1|Overall Study|Lack of Efficacy|0
2648548|NCT00733304|9149017|P3|Overall Study|Adverse Event|0
2648549|NCT00733304|9149018|P2|Overall Study|Adverse Event|0
2648550|NCT00733304|9149019|P1|Overall Study|Adverse Event|3
2648551|NCT00733291|9149101|P4|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
2648552|NCT00733291|9149102|P3|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
2648553|NCT00733291|9149103|P2|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
2648554|NCT00733291|9149104|P1|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1
2648555|NCT00733226|9149133|P2|Overall Study|moved to another place|0
2648556|NCT00733226|9149134|P1|Overall Study|moved to another place|2
2648557|NCT00733226|9149133|P2|Overall Study|Lost to Follow-up|0
2648558|NCT00733226|9149134|P1|Overall Study|Lost to Follow-up|2
2648559|NCT00733226|9149133|P2|Overall Study|Withdrawal by Subject|0
2648560|NCT00733226|9149134|P1|Overall Study|Withdrawal by Subject|1
2648561|NCT00733005|9149183|P2|Overall Study|Protocol Violation|0
2648562|NCT00733005|9149184|P1|Overall Study|Protocol Violation|2
2648563|NCT00733005|9149183|P2|Overall Study|Withdrawal by Subject|1
2648564|NCT00733005|9149184|P1|Overall Study|Withdrawal by Subject|0
2648565|NCT00733005|9149183|P2|Overall Study|Treatment Failure|1
2648566|NCT00733005|9149184|P1|Overall Study|Treatment Failure|0
2648567|NCT00733005|9149183|P2|Overall Study|Adverse Event|1
2648568|NCT00733005|9149184|P1|Overall Study|Adverse Event|0
2648569|NCT00732992|9149194|P2|Overall Study|Withdrawal by Subject|0
2648570|NCT00732992|9149195|P1|Overall Study|Withdrawal by Subject|1
2648571|NCT00732992|9149194|P2|Overall Study|Global Deterioration of Health Status|0
2648572|NCT00732992|9149195|P1|Overall Study|Global Deterioration of Health Status|1
2648573|NCT00732992|9149194|P2|Overall Study|Objective Progression or Relapse|5
2648574|NCT00732992|9149195|P1|Overall Study|Objective Progression or Relapse|3
2648575|NCT00732992|9149194|P2|Overall Study|Adverse Event|1
2648576|NCT00732992|9149195|P1|Overall Study|Adverse Event|1
2648577|NCT00732940|9149214|P2|Overall Study|Lost to Follow-up|0
2648578|NCT00732940|9149215|P1|Overall Study|Lost to Follow-up|1
2648579|NCT00732940|9149214|P2|Overall Study|Adverse Event|1
2648580|NCT00732940|9149215|P1|Overall Study|Adverse Event|0
2648581|NCT00732940|9149214|P2|Overall Study|Withdrawal by Subject|2
2648582|NCT00732940|9149215|P1|Overall Study|Withdrawal by Subject|1
2648583|NCT00732875|9149296|P1|Overall Study|Lack of Efficacy|13
2648584|NCT00732875|9149296|P1|Overall Study|Withdrawal by Subject|6
2648585|NCT00732875|9149296|P1|Overall Study|Adverse Event|16
2648586|NCT00732758|9149304|P2|Overall Study|Lost to Follow-up|16
2648587|NCT00732758|9149305|P1|Overall Study|Lost to Follow-up|8
2648588|NCT00732641|9149345|P2|Overall Study|Other|5
2648589|NCT00732641|9149346|P1|Overall Study|Other|18
2648590|NCT00732641|9149345|P2|Overall Study|Unable to Complete|1
2648591|NCT00732641|9149346|P1|Overall Study|Unable to Complete|1
2648592|NCT00732641|9149345|P2|Overall Study|Withdrawal by Subject|2
2648593|NCT00732641|9149346|P1|Overall Study|Withdrawal by Subject|4
2648594|NCT00732641|9149345|P2|Overall Study|Physician Decision|0
2648595|NCT00732641|9149346|P1|Overall Study|Physician Decision|6
2648596|NCT00732641|9149345|P2|Overall Study|Serious Adverse Events|3
2648597|NCT00732641|9149346|P1|Overall Study|Serious Adverse Events|12
2648598|NCT00732641|9149345|P2|Overall Study|Relapse or Progressive Disease|101
2648599|NCT00732641|9149346|P1|Overall Study|Relapse or Progressive Disease|65
2648600|NCT00732615|9149366|P2|Overall Study|Non-Compliance, Subject/Physician Dec.|1
2648601|NCT00732615|9149367|P1|Overall Study|Non-Compliance, Subject/Physician Dec.|1
2648602|NCT00732615|9149366|P2|Overall Study|Physician Decision|0
2648603|NCT00732615|9149367|P1|Overall Study|Physician Decision|3
2648604|NCT00732615|9149366|P2|Overall Study|Adverse Event|2
2648605|NCT00732615|9149367|P1|Overall Study|Adverse Event|0
2648606|NCT00732615|9149366|P2|Overall Study|Lost to Follow-up|1
2648607|NCT00732615|9149367|P1|Overall Study|Lost to Follow-up|0
2648608|NCT00732615|9149366|P2|Overall Study|Withdrawal by Subject|1
2648609|NCT00732615|9149367|P1|Overall Study|Withdrawal by Subject|3
2648610|NCT00732498|9149379|P1|Overall Study|Physician Decision|3
2648611|NCT00732498|9149379|P1|Overall Study|Adverse Event|2
2648612|NCT00732498|9149379|P1|Overall Study|Ineligible|1
2648613|NCT00732472|9149390|P4|Overall Study|Withdrawal by Subject|1
2648614|NCT00732472|9149391|P3|Overall Study|Withdrawal by Subject|0
2648615|NCT00732472|9149392|P2|Overall Study|Withdrawal by Subject|2
2648616|NCT00732472|9149393|P1|Overall Study|Withdrawal by Subject|0
2648617|NCT00732472|9149390|P4|Overall Study|Protocol Violation|1
2648618|NCT00732472|9149391|P3|Overall Study|Protocol Violation|0
2648619|NCT00732472|9149392|P2|Overall Study|Protocol Violation|0
2648620|NCT00732472|9149393|P1|Overall Study|Protocol Violation|0
2648621|NCT00732472|9149390|P4|Overall Study|Adverse Event|1
2648622|NCT00732472|9149391|P3|Overall Study|Adverse Event|1
2648623|NCT00732472|9149392|P2|Overall Study|Adverse Event|1
2648624|NCT00732472|9149393|P1|Overall Study|Adverse Event|0
2648625|NCT00732381|9149493|P2|Overall Study|Treatment Failure|1
2648626|NCT00732381|9149494|P1|Overall Study|Treatment Failure|1
2648627|NCT00732381|9149493|P2|Overall Study|Adverse Event|0
2648628|NCT00732381|9149494|P1|Overall Study|Adverse Event|1
2648629|NCT00732303|9149502|P1|Overall Study|Study Terminated|2
2648630|NCT00732251|9149508|P1|Overall Study|Early Term due to Site Closure|1
2648631|NCT00732251|9149508|P1|Overall Study|Withdrawal by Subject|3
2648632|NCT00732251|9149508|P1|Overall Study|Lost to Follow-up|3
2648633|NCT00732238|9149516|P2|Overall Study|Asymptomatic bacteriuria|0
2648634|NCT00732238|9149517|P1|Overall Study|Asymptomatic bacteriuria|1
2648635|NCT00732238|9149516|P2|Overall Study|Bacteremia|1
2648636|NCT00732238|9149517|P1|Overall Study|Bacteremia|4
2648637|NCT00732199|9149618|P2|Overall Study|sleep apnea, inadequate signals/sleep|8
2648638|NCT00732199|9149619|P1|Overall Study|sleep apnea, inadequate signals/sleep|9
2648639|NCT00732199|9149618|P2|Overall Study|Withdrawal by Subject|18
2648640|NCT00732199|9149619|P1|Overall Study|Withdrawal by Subject|25
2648641|NCT00732160|9149634|P4|Overall Study|scheduling|1
2648642|NCT00732160|9149635|P3|Overall Study|scheduling|2
2648643|NCT00732160|9149636|P2|Overall Study|scheduling|4
2648644|NCT00732160|9149637|P1|Overall Study|scheduling|4
2648645|NCT00732160|9149634|P4|Overall Study|Adverse Event|1
2648646|NCT00732160|9149635|P3|Overall Study|Adverse Event|1
2648647|NCT00732160|9149636|P2|Overall Study|Adverse Event|0
2648648|NCT00732160|9149637|P1|Overall Study|Adverse Event|1
2648649|NCT00732069|9149651|P6|Washout After First Study Drug|Adverse Event|0
2648650|NCT00732069|9149652|P5|Washout After First Study Drug|Adverse Event|0
2648651|NCT00732069|9149653|P4|Washout After First Study Drug|Adverse Event|0
2648652|NCT00732069|9149654|P3|Washout After First Study Drug|Adverse Event|0
2648653|NCT00732069|9149655|P2|Washout After First Study Drug|Adverse Event|0
2648654|NCT00732069|9149656|P1|Washout After First Study Drug|Adverse Event|1
2648655|NCT00731939|9149674|P1|Overall Study|Did not meet enrollment criteria|2
2648656|NCT00731939|9149674|P1|Overall Study|Withdrawal by Subject|2
2648657|NCT00731939|9149674|P1|Overall Study|Not implanted with study device|9
2648658|NCT00731939|9149674|P1|Overall Study|Lost to Follow-up|15
2648659|NCT00731939|9149674|P1|Overall Study|Adverse Event|6
2648660|NCT00731822|9149751|P2|Overall Study|Lost to Follow-up|0
2648661|NCT00731822|9149752|P1|Overall Study|Lost to Follow-up|1
2648662|NCT00731822|9149751|P2|Overall Study|Protocol Violation|0
2648663|NCT00731822|9149752|P1|Overall Study|Protocol Violation|1
2648664|NCT00731822|9149751|P2|Overall Study|Adverse Event|1
2648665|NCT00731822|9149752|P1|Overall Study|Adverse Event|2
2648666|NCT00731783|9149766|P2|12 Month Follow-Up Visit|Lost to Follow-up|7
2648667|NCT00731783|9149767|P1|12 Month Follow-Up Visit|Lost to Follow-up|6
2648668|NCT00731783|9149766|P2|Six Month Follow-Up Visit|Lost to Follow-up|3
2648669|NCT00731783|9149767|P1|Six Month Follow-Up Visit|Lost to Follow-up|6
2648670|NCT00731783|9149766|P2|Three Month Follow-Up Visit|Lost to Follow-up|16
2648671|NCT00731783|9149767|P1|Three Month Follow-Up Visit|Lost to Follow-up|7
2648672|NCT00731783|9149766|P2|One Month Follow-Up Visit|Lost to Follow-up|22
2648673|NCT00731783|9149767|P1|One Month Follow-Up Visit|Lost to Follow-up|14
2648674|NCT00731731|9149801|P3|Overall Study|Cancel prior to treatment|2
2648675|NCT00731731|9149802|P2|Overall Study|Cancel prior to treatment|0
2648676|NCT00731731|9149803|P1|Overall Study|Cancel prior to treatment|0
2648677|NCT00731731|9149801|P3|Overall Study|Protocol Violation|1
2648678|NCT00731731|9149802|P2|Overall Study|Protocol Violation|0
2648679|NCT00731731|9149803|P1|Overall Study|Protocol Violation|0
2648680|NCT00731692|9149821|P3|Extension Phase|Adverse Event|15
2648681|NCT00731692|9149822|P2|Extension Phase|Adverse Event|1
2648682|NCT00731692|9149823|P1|Extension Phase|Adverse Event|1
2648683|NCT00731692|9149821|P3|Extension Phase|Withdrawal by Subject|3
2648684|NCT00731692|9149822|P2|Extension Phase|Withdrawal by Subject|5
2648685|NCT00731692|9149823|P1|Extension Phase|Withdrawal by Subject|4
2648686|NCT00731692|9149821|P3|Extension Phase|Lost to Follow-up|4
2648687|NCT00731692|9149822|P2|Extension Phase|Lost to Follow-up|1
2648688|NCT00731692|9149823|P1|Extension Phase|Lost to Follow-up|0
2648689|NCT00731692|9149821|P3|Extension Phase|Abnormal lab values|1
2648690|NCT00731692|9149822|P2|Extension Phase|Abnormal lab values|0
2648691|NCT00731692|9149823|P1|Extension Phase|Abnormal lab values|0
2648692|NCT00731692|9149821|P3|Extension Phase|Abnormal test procedure|1
2648693|NCT00731692|9149822|P2|Extension Phase|Abnormal test procedure|0
2648694|NCT00731692|9149823|P1|Extension Phase|Abnormal test procedure|0
2648695|NCT00731692|9149821|P3|Extension Phase|Admin Problems: Terminated # patients|277
2648696|NCT00731692|9149822|P2|Extension Phase|Admin Problems: Terminated # patients|189
2648697|NCT00731692|9149823|P1|Extension Phase|Admin Problems: Terminated # patients|69
2648698|NCT00731692|9149821|P3|Core Study (36 Months)|Withdrawal by Subject|46
2648699|NCT00731692|9149822|P2|Core Study (36 Months)|Withdrawal by Subject|32
2648700|NCT00731692|9149823|P1|Core Study (36 Months)|Withdrawal by Subject|12
2648701|NCT00731692|9149821|P3|Core Study (36 Months)|Adverse Event|29
2648702|NCT00731692|9149822|P2|Core Study (36 Months)|Adverse Event|28
2648703|NCT00731692|9149823|P1|Core Study (36 Months)|Adverse Event|25
2648704|NCT00731692|9149821|P3|Core Study (36 Months)|Abnormal Lab values|5
2648705|NCT00731692|9149822|P2|Core Study (36 Months)|Abnormal Lab values|19
2648706|NCT00731692|9149823|P1|Core Study (36 Months)|Abnormal Lab values|6
2648707|NCT00731692|9149821|P3|Core Study (36 Months)|Protocol Violation|8
2648708|NCT00731692|9149822|P2|Core Study (36 Months)|Protocol Violation|5
2648709|NCT00731692|9149823|P1|Core Study (36 Months)|Protocol Violation|4
2648710|NCT00731692|9149821|P3|Core Study (36 Months)|Abnormal Test Procedure Result|5
2648711|NCT00731692|9149822|P2|Core Study (36 Months)|Abnormal Test Procedure Result|3
2648712|NCT00731692|9149823|P1|Core Study (36 Months)|Abnormal Test Procedure Result|4
2648713|NCT00731692|9149821|P3|Core Study (36 Months)|Administrative|6
2648714|NCT00731692|9149822|P2|Core Study (36 Months)|Administrative|2
2648715|NCT00731692|9149823|P1|Core Study (36 Months)|Administrative|2
2648716|NCT00731692|9149821|P3|Core Study (36 Months)|Lost to Follow-up|3
2648717|NCT00731692|9149822|P2|Core Study (36 Months)|Lost to Follow-up|3
2648718|NCT00731692|9149823|P1|Core Study (36 Months)|Lost to Follow-up|1
2648719|NCT00731692|9149821|P3|Core Study (36 Months)|Death|2
2648720|NCT00731692|9149822|P2|Core Study (36 Months)|Death|1
2648721|NCT00731692|9149823|P1|Core Study (36 Months)|Death|2
2648722|NCT00731692|9149821|P3|Core Study (36 Months)|Physician Decision|2
2648723|NCT00731692|9149822|P2|Core Study (36 Months)|Physician Decision|0
2648724|NCT00731692|9149823|P1|Core Study (36 Months)|Physician Decision|1
2648725|NCT00731692|9149821|P3|Core Study (36 Months)|Lack of Efficacy|64
2648726|NCT00731692|9149822|P2|Core Study (36 Months)|Lack of Efficacy|23
2648727|NCT00731692|9149823|P1|Core Study (36 Months)|Lack of Efficacy|11
2648728|NCT00731679|9149869|P2|Overall Study|Pregnancy|1
2648729|NCT00731679|9149870|P1|Overall Study|Pregnancy|0
2648730|NCT00731679|9149869|P2|Overall Study|Noncompliance|1
2648731|NCT00731679|9149870|P1|Overall Study|Noncompliance|0
2648732|NCT00731679|9149869|P2|Overall Study|Lost to Follow-up|8
2648733|NCT00731679|9149870|P1|Overall Study|Lost to Follow-up|7
2648734|NCT00731679|9149869|P2|Overall Study|Withdrawal by Subject|8
2648735|NCT00731679|9149870|P1|Overall Study|Withdrawal by Subject|8
2648736|NCT00731679|9149869|P2|Overall Study|Adverse Event|8
2648737|NCT00731679|9149870|P1|Overall Study|Adverse Event|7
2648738|NCT00731666|9149878|P1|Overall Study|Withdrawal by Subject|2
2648739|NCT00731666|9149878|P1|Overall Study|Lost to Follow-up|8
2648740|NCT00731666|9149878|P1|Overall Study|Adverse Event|2
2648741|NCT00731549|9149914|P1|Overall Study|Lack of efficacy without AE|6
2648742|NCT00731549|9149914|P1|Overall Study|Lack of efficacy with AE|37
2648743|NCT00731549|9149914|P1|Overall Study|Adverse Event|31
2648744|NCT00731549|9149914|P1|Overall Study|Protocol deviation|1
2648745|NCT00731549|9149914|P1|Overall Study|Withdrawal by Subject|89
2648746|NCT00731549|9149914|P1|Overall Study|Physician Decision|16
2648747|NCT00731549|9149914|P1|Overall Study|Met withdrawal criteria|24
2648748|NCT00731549|9149914|P1|Overall Study|Lost to Follow-up|19
2648749|NCT00731133|9149954|P1|Overall Study|Withdrawal by Subject|10
2648750|NCT00731120|9149962|P3|Overall Study|Other|1
2648751|NCT00731120|9149963|P2|Overall Study|Other|0
2648752|NCT00731120|9149964|P1|Overall Study|Other|4
2648753|NCT00731120|9149962|P3|Overall Study|Lost to Follow-up|17
2648754|NCT00731120|9149963|P2|Overall Study|Lost to Follow-up|15
2648755|NCT00731120|9149964|P1|Overall Study|Lost to Follow-up|10
2648756|NCT00731120|9149962|P3|Overall Study|Withdrawal of Consent|4
2648757|NCT00731120|9149963|P2|Overall Study|Withdrawal of Consent|8
2648758|NCT00731120|9149964|P1|Overall Study|Withdrawal of Consent|13
2648759|NCT00731120|9149962|P3|Overall Study|Protocol Deviations|1
2648760|NCT00731120|9149963|P2|Overall Study|Protocol Deviations|6
2648761|NCT00731120|9149964|P1|Overall Study|Protocol Deviations|1
2648762|NCT00731120|9149962|P3|Overall Study|Noncompliance with Study Drug|1
2648763|NCT00731120|9149963|P2|Overall Study|Noncompliance with Study Drug|3
2648764|NCT00731120|9149964|P1|Overall Study|Noncompliance with Study Drug|3
2648765|NCT00731120|9149962|P3|Overall Study|Lack of Efficacy|4
2648766|NCT00731120|9149963|P2|Overall Study|Lack of Efficacy|5
2648767|NCT00731120|9149964|P1|Overall Study|Lack of Efficacy|4
2648768|NCT00731120|9149962|P3|Overall Study|Adverse Event|8
2648769|NCT00731120|9149963|P2|Overall Study|Adverse Event|6
2648770|NCT00731120|9149964|P1|Overall Study|Adverse Event|7
2648771|NCT00731042|9150081|P2|Second Intervention|Did not meet inclusion criteria|2
2648772|NCT00731042|9150082|P1|Second Intervention|Did not meet inclusion criteria|0
2648773|NCT00730925|9150093|P1|Overall Study|Other|1
2648774|NCT00730925|9150093|P1|Overall Study|Switch to combination therapy|8
2648775|NCT00730925|9150093|P1|Overall Study|Withdrawal by Subject|1
2648776|NCT00730925|9150093|P1|Overall Study|Protocol Violation|1
2648777|NCT00730925|9150093|P1|Overall Study|Other Averse Event|7
2648778|NCT00730925|9150093|P1|Overall Study|Dose reducing Event|2
2648779|NCT00730925|9150093|P1|Overall Study|Progressive Disease|21
2648780|NCT00730912|9150103|P3|Overall Study|Discontinued|1
2648781|NCT00730912|9150104|P2|Overall Study|Discontinued|0
2648782|NCT00730912|9150105|P1|Overall Study|Discontinued|0
2648783|NCT00730886|9150118|P2|Overall Study|Physician Decision|0
2648784|NCT00730886|9150119|P1|Overall Study|Physician Decision|1
2648785|NCT00730886|9150118|P2|Overall Study|Lost to Follow-up|0
2648786|NCT00730886|9150119|P1|Overall Study|Lost to Follow-up|1
2648787|NCT00730847|9150143|P1|Overall Study|Other|24
2648788|NCT00730847|9150143|P1|Overall Study|Unknown completion status|21
2648789|NCT00730847|9150143|P1|Overall Study|Lost to Follow-up|67
2648790|NCT00730847|9150143|P1|Overall Study|Withdrawal by Subject|16
2648791|NCT00730847|9150143|P1|Overall Study|Protocol Violation|2
2648792|NCT00730847|9150143|P1|Overall Study|Adverse Event|1
2648793|NCT00730756|9150152|P2|Overall Study|Withdrew Consent|1
2648794|NCT00730756|9150153|P1|Overall Study|Withdrew Consent|0
2648795|NCT00730756|9150152|P2|Overall Study|Lost to Follow-up|1
2648796|NCT00730756|9150153|P1|Overall Study|Lost to Follow-up|0
2648797|NCT00730756|9150152|P2|Overall Study|Protocol Deviation|2
2648798|NCT00730756|9150153|P1|Overall Study|Protocol Deviation|1
2648799|NCT00730756|9150152|P2|Overall Study|Lack of Efficacy|1
2648800|NCT00730756|9150153|P1|Overall Study|Lack of Efficacy|1
2648801|NCT00730756|9150152|P2|Overall Study|Adverse Event|0
2648802|NCT00730756|9150153|P1|Overall Study|Adverse Event|2
2648803|NCT00730691|9150187|P5|Overall Study|Other|2
2648804|NCT00730691|9150188|P4|Overall Study|Other|2
2648805|NCT00730691|9150189|P3|Overall Study|Other|1
2648806|NCT00730691|9150190|P2|Overall Study|Other|1
2648807|NCT00730691|9150191|P1|Overall Study|Other|1
2648808|NCT00730691|9150187|P5|Overall Study|Lost to Follow-up|13
2648809|NCT00730691|9150188|P4|Overall Study|Lost to Follow-up|15
2648810|NCT00730691|9150189|P3|Overall Study|Lost to Follow-up|13
2648811|NCT00730691|9150190|P2|Overall Study|Lost to Follow-up|8
2648812|NCT00730691|9150191|P1|Overall Study|Lost to Follow-up|11
2648813|NCT00730691|9150187|P5|Overall Study|Withdrawal of Consent|3
2648814|NCT00730691|9150188|P4|Overall Study|Withdrawal of Consent|6
2648815|NCT00730691|9150189|P3|Overall Study|Withdrawal of Consent|3
2648816|NCT00730691|9150190|P2|Overall Study|Withdrawal of Consent|9
2648817|NCT00730691|9150191|P1|Overall Study|Withdrawal of Consent|7
2648818|NCT00730691|9150187|P5|Overall Study|Protocol Deviations|5
2648819|NCT00730691|9150188|P4|Overall Study|Protocol Deviations|7
2648820|NCT00730691|9150189|P3|Overall Study|Protocol Deviations|3
2648821|NCT00730691|9150190|P2|Overall Study|Protocol Deviations|5
2648822|NCT00730691|9150191|P1|Overall Study|Protocol Deviations|3
2648823|NCT00730691|9150187|P5|Overall Study|Non-compliance with Study Drug|3
2648824|NCT00730691|9150188|P4|Overall Study|Non-compliance with Study Drug|3
2648825|NCT00730691|9150189|P3|Overall Study|Non-compliance with Study Drug|6
2648826|NCT00730691|9150190|P2|Overall Study|Non-compliance with Study Drug|1
2648827|NCT00730691|9150191|P1|Overall Study|Non-compliance with Study Drug|6
2648828|NCT00730691|9150187|P5|Overall Study|Lack of Efficacy|1
2648829|NCT00730691|9150188|P4|Overall Study|Lack of Efficacy|1
2648830|NCT00730691|9150189|P3|Overall Study|Lack of Efficacy|2
2648831|NCT00730691|9150190|P2|Overall Study|Lack of Efficacy|4
2648832|NCT00730691|9150191|P1|Overall Study|Lack of Efficacy|4
2648833|NCT00730691|9150187|P5|Overall Study|Adverse Event|23
2648834|NCT00730691|9150188|P4|Overall Study|Adverse Event|11
2648835|NCT00730691|9150189|P3|Overall Study|Adverse Event|11
2648836|NCT00730691|9150190|P2|Overall Study|Adverse Event|8
2648837|NCT00730691|9150191|P1|Overall Study|Adverse Event|4
2648838|NCT00730639|9150283|P5|Overall Study|Treatment on-going|4
2648839|NCT00730639|9150284|P4|Overall Study|Treatment on-going|4
2648840|NCT00730639|9150285|P3|Overall Study|Treatment on-going|5
2648841|NCT00730639|9150286|P2|Overall Study|Treatment on-going|5
2648842|NCT00730639|9150287|P1|Overall Study|Treatment on-going|2
2648843|NCT00730639|9150283|P5|Overall Study|Withdrawal by Subject|4
2648844|NCT00730639|9150284|P4|Overall Study|Withdrawal by Subject|3
2648845|NCT00730639|9150285|P3|Overall Study|Withdrawal by Subject|6
2648846|NCT00730639|9150286|P2|Overall Study|Withdrawal by Subject|0
2648847|NCT00730639|9150287|P1|Overall Study|Withdrawal by Subject|0
2648848|NCT00730639|9150283|P5|Overall Study|Protocol Violation|0
2648849|NCT00730639|9150284|P4|Overall Study|Protocol Violation|0
2648850|NCT00730639|9150285|P3|Overall Study|Protocol Violation|1
2648851|NCT00730639|9150286|P2|Overall Study|Protocol Violation|0
2648852|NCT00730639|9150287|P1|Overall Study|Protocol Violation|0
2648853|NCT00730639|9150283|P5|Overall Study|non-specified|3
2648854|NCT00730639|9150284|P4|Overall Study|non-specified|2
2648855|NCT00730639|9150285|P3|Overall Study|non-specified|4
2648856|NCT00730639|9150286|P2|Overall Study|non-specified|0
2648857|NCT00730639|9150287|P1|Overall Study|non-specified|0
2648858|NCT00730639|9150283|P5|Overall Study|Disease Progression|88
2648859|NCT00730639|9150284|P4|Overall Study|Disease Progression|32
2648860|NCT00730639|9150285|P3|Overall Study|Disease Progression|48
2648861|NCT00730639|9150286|P2|Overall Study|Disease Progression|13
2648862|NCT00730639|9150287|P1|Overall Study|Disease Progression|12
2648863|NCT00730639|9150283|P5|Overall Study|Death|2
2648864|NCT00730639|9150284|P4|Overall Study|Death|0
2648865|NCT00730639|9150285|P3|Overall Study|Death|0
2648866|NCT00730639|9150286|P2|Overall Study|Death|0
2648867|NCT00730639|9150287|P1|Overall Study|Death|0
2648868|NCT00730639|9150283|P5|Overall Study|Completed Maximum Cycles|6
2648869|NCT00730639|9150284|P4|Overall Study|Completed Maximum Cycles|3
2648870|NCT00730639|9150285|P3|Overall Study|Completed Maximum Cycles|11
2648871|NCT00730639|9150286|P2|Overall Study|Completed Maximum Cycles|0
2648872|NCT00730639|9150287|P1|Overall Study|Completed Maximum Cycles|0
2648873|NCT00730639|9150283|P5|Overall Study|Complete Response|1
2648874|NCT00730639|9150284|P4|Overall Study|Complete Response|2
2648875|NCT00730639|9150285|P3|Overall Study|Complete Response|2
2648876|NCT00730639|9150286|P2|Overall Study|Complete Response|0
2648877|NCT00730639|9150287|P1|Overall Study|Complete Response|0
2648878|NCT00730639|9150283|P5|Overall Study|Adverse Event|23
2648879|NCT00730639|9150284|P4|Overall Study|Adverse Event|8
2648880|NCT00730639|9150285|P3|Overall Study|Adverse Event|9
2648881|NCT00730639|9150286|P2|Overall Study|Adverse Event|0
2648882|NCT00730639|9150287|P1|Overall Study|Adverse Event|3
2648883|NCT00730405|9150364|P5|Overall Study-follow-up Phase|Atrial fibrillation history|0
2648884|NCT00730405|9150365|P4|Overall Study-follow-up Phase|Atrial fibrillation history|0
2648885|NCT00730405|9150366|P3|Overall Study-follow-up Phase|Atrial fibrillation history|0
2648886|NCT00730405|9150367|P2|Overall Study-follow-up Phase|Atrial fibrillation history|0
2648887|NCT00730405|9150368|P1|Overall Study-follow-up Phase|Atrial fibrillation history|1
2648888|NCT00730405|9150364|P5|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
2648889|NCT00730405|9150365|P4|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1
2648890|NCT00730405|9150366|P3|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
2648891|NCT00730405|9150367|P2|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
2648892|NCT00730405|9150368|P1|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
2648893|NCT00730405|9150364|P5|Overall Study-follow-up Phase|Other Protocol violation|0
2648894|NCT00730405|9150365|P4|Overall Study-follow-up Phase|Other Protocol violation|0
2648895|NCT00730405|9150366|P3|Overall Study-follow-up Phase|Other Protocol violation|1
2648896|NCT00730405|9150367|P2|Overall Study-follow-up Phase|Other Protocol violation|0
2648897|NCT00730405|9150368|P1|Overall Study-follow-up Phase|Other Protocol violation|0
2648898|NCT00730405|9150364|P5|Overall Study-follow-up Phase|Mis-randomized|0
2648899|NCT00730405|9150365|P4|Overall Study-follow-up Phase|Mis-randomized|0
2648900|NCT00730405|9150366|P3|Overall Study-follow-up Phase|Mis-randomized|0
2648901|NCT00730405|9150367|P2|Overall Study-follow-up Phase|Mis-randomized|1
2648902|NCT00730405|9150368|P1|Overall Study-follow-up Phase|Mis-randomized|0
2648903|NCT00730405|9150364|P5|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
2648904|NCT00730405|9150365|P4|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
2648905|NCT00730405|9150366|P3|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1
2648906|NCT00730405|9150367|P2|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
2648907|NCT00730405|9150368|P1|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
2648908|NCT00730405|9150364|P5|Overall Study-follow-up Phase|Use an exclusionary medication|1
2648909|NCT00730405|9150365|P4|Overall Study-follow-up Phase|Use an exclusionary medication|0
2648910|NCT00730405|9150366|P3|Overall Study-follow-up Phase|Use an exclusionary medication|0
2648911|NCT00730405|9150367|P2|Overall Study-follow-up Phase|Use an exclusionary medication|0
2648912|NCT00730405|9150368|P1|Overall Study-follow-up Phase|Use an exclusionary medication|0
2648913|NCT00730405|9150364|P5|Overall Study-follow-up Phase|Missing|0
2648914|NCT00730405|9150365|P4|Overall Study-follow-up Phase|Missing|0
2648915|NCT00730405|9150366|P3|Overall Study-follow-up Phase|Missing|2
2648916|NCT00730405|9150367|P2|Overall Study-follow-up Phase|Missing|0
2648917|NCT00730405|9150368|P1|Overall Study-follow-up Phase|Missing|0
2648918|NCT00730405|9150364|P5|Overall Study-follow-up Phase|Non-compliance|0
2648919|NCT00730405|9150365|P4|Overall Study-follow-up Phase|Non-compliance|0
2648920|NCT00730405|9150366|P3|Overall Study-follow-up Phase|Non-compliance|2
2648921|NCT00730405|9150367|P2|Overall Study-follow-up Phase|Non-compliance|0
2648922|NCT00730405|9150368|P1|Overall Study-follow-up Phase|Non-compliance|1
2648923|NCT00730405|9150364|P5|Overall Study-follow-up Phase|Use of restricted medication|0
2648924|NCT00730405|9150365|P4|Overall Study-follow-up Phase|Use of restricted medication|0
2648925|NCT00730405|9150366|P3|Overall Study-follow-up Phase|Use of restricted medication|0
2648926|NCT00730405|9150367|P2|Overall Study-follow-up Phase|Use of restricted medication|1
2648927|NCT00730405|9150368|P1|Overall Study-follow-up Phase|Use of restricted medication|0
2648928|NCT00730405|9150364|P5|Overall Study-follow-up Phase|Declined to continue with follow-up|0
2648929|NCT00730405|9150365|P4|Overall Study-follow-up Phase|Declined to continue with follow-up|0
2648930|NCT00730405|9150366|P3|Overall Study-follow-up Phase|Declined to continue with follow-up|0
2648931|NCT00730405|9150367|P2|Overall Study-follow-up Phase|Declined to continue with follow-up|1
2648932|NCT00730405|9150368|P1|Overall Study-follow-up Phase|Declined to continue with follow-up|1
2648933|NCT00730405|9150364|P5|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
2648934|NCT00730405|9150365|P4|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
2648935|NCT00730405|9150366|P3|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
2648936|NCT00730405|9150367|P2|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
2648937|NCT00730405|9150368|P1|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
2648938|NCT00730405|9150364|P5|Overall Study-follow-up Phase|Refused follow-up due to AE|0
2648939|NCT00730405|9150365|P4|Overall Study-follow-up Phase|Refused follow-up due to AE|1
2648940|NCT00730405|9150366|P3|Overall Study-follow-up Phase|Refused follow-up due to AE|0
2648941|NCT00730405|9150367|P2|Overall Study-follow-up Phase|Refused follow-up due to AE|0
2648942|NCT00730405|9150368|P1|Overall Study-follow-up Phase|Refused follow-up due to AE|0
2648943|NCT00730405|9150364|P5|Overall Study-follow-up Phase|Prohibited concomitant medication|0
2648944|NCT00730405|9150365|P4|Overall Study-follow-up Phase|Prohibited concomitant medication|0
2648945|NCT00730405|9150366|P3|Overall Study-follow-up Phase|Prohibited concomitant medication|0
2648946|NCT00730405|9150367|P2|Overall Study-follow-up Phase|Prohibited concomitant medication|0
2648947|NCT00730405|9150368|P1|Overall Study-follow-up Phase|Prohibited concomitant medication|1
2648948|NCT00730405|9150364|P5|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1
2648949|NCT00730405|9150365|P4|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
2648950|NCT00730405|9150366|P3|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
2648951|NCT00730405|9150367|P2|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
2648952|NCT00730405|9150368|P1|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
2648953|NCT00730405|9150364|P5|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
2648954|NCT00730405|9150365|P4|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
2648955|NCT00730405|9150366|P3|Overall Study-follow-up Phase|Participant meets exclusion criteria|1
2648956|NCT00730405|9150367|P2|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
2648957|NCT00730405|9150368|P1|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
2648958|NCT00730405|9150364|P5|Overall Study-follow-up Phase|Non-compliance with study treatment|0
2648959|NCT00730405|9150365|P4|Overall Study-follow-up Phase|Non-compliance with study treatment|0
2648960|NCT00730405|9150366|P3|Overall Study-follow-up Phase|Non-compliance with study treatment|1
2648961|NCT00730405|9150367|P2|Overall Study-follow-up Phase|Non-compliance with study treatment|0
2648962|NCT00730405|9150368|P1|Overall Study-follow-up Phase|Non-compliance with study treatment|0
2648963|NCT00730405|9150364|P5|Overall Study-follow-up Phase|Did not met eligibility|0
2648964|NCT00730405|9150365|P4|Overall Study-follow-up Phase|Did not met eligibility|0
2648965|NCT00730405|9150366|P3|Overall Study-follow-up Phase|Did not met eligibility|1
2648966|NCT00730405|9150367|P2|Overall Study-follow-up Phase|Did not met eligibility|0
2648967|NCT00730405|9150368|P1|Overall Study-follow-up Phase|Did not met eligibility|0
2648968|NCT00730405|9150364|P5|Overall Study-follow-up Phase|Change of location|0
2648969|NCT00730405|9150365|P4|Overall Study-follow-up Phase|Change of location|1
2648970|NCT00730405|9150366|P3|Overall Study-follow-up Phase|Change of location|0
2648971|NCT00730405|9150367|P2|Overall Study-follow-up Phase|Change of location|1
2648972|NCT00730405|9150368|P1|Overall Study-follow-up Phase|Change of location|1
2648973|NCT00730405|9150364|P5|Overall Study-follow-up Phase|Death|0
2648974|NCT00730405|9150365|P4|Overall Study-follow-up Phase|Death|1
2648975|NCT00730405|9150366|P3|Overall Study-follow-up Phase|Death|0
2648976|NCT00730405|9150367|P2|Overall Study-follow-up Phase|Death|1
2648977|NCT00730405|9150368|P1|Overall Study-follow-up Phase|Death|0
2648978|NCT00730405|9150364|P5|Overall Study-follow-up Phase|Withdrawal by Subject|10
2648979|NCT00730405|9150365|P4|Overall Study-follow-up Phase|Withdrawal by Subject|6
2648980|NCT00730405|9150366|P3|Overall Study-follow-up Phase|Withdrawal by Subject|3
2648981|NCT00730405|9150367|P2|Overall Study-follow-up Phase|Withdrawal by Subject|3
2648982|NCT00730405|9150368|P1|Overall Study-follow-up Phase|Withdrawal by Subject|7
2648983|NCT00730405|9150364|P5|Overall Study-follow-up Phase|Lost to Follow-up|6
2648984|NCT00730405|9150365|P4|Overall Study-follow-up Phase|Lost to Follow-up|4
2648985|NCT00730405|9150366|P3|Overall Study-follow-up Phase|Lost to Follow-up|8
2648986|NCT00730405|9150367|P2|Overall Study-follow-up Phase|Lost to Follow-up|6
2648987|NCT00730405|9150368|P1|Overall Study-follow-up Phase|Lost to Follow-up|7
2648988|NCT00730405|9150364|P5|Overall Study-follow-up Phase|Adverse Event|4
2648989|NCT00730405|9150365|P4|Overall Study-follow-up Phase|Adverse Event|3
2648990|NCT00730405|9150366|P3|Overall Study-follow-up Phase|Adverse Event|2
2648991|NCT00730405|9150367|P2|Overall Study-follow-up Phase|Adverse Event|6
2648992|NCT00730405|9150368|P1|Overall Study-follow-up Phase|Adverse Event|2
2648993|NCT00730405|9150364|P5|Overall Study-Treatment Phase|Atrial fibrillation history|0
2648994|NCT00730405|9150365|P4|Overall Study-Treatment Phase|Atrial fibrillation history|0
2648995|NCT00730405|9150366|P3|Overall Study-Treatment Phase|Atrial fibrillation history|0
2648996|NCT00730405|9150367|P2|Overall Study-Treatment Phase|Atrial fibrillation history|0
2648997|NCT00730405|9150368|P1|Overall Study-Treatment Phase|Atrial fibrillation history|1
2648998|NCT00730405|9150364|P5|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1
2648999|NCT00730405|9150365|P4|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
2649158|NCT00730015|9150630|P3|Overall Study|Protocol Violation|4
2649000|NCT00730405|9150366|P3|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
2649001|NCT00730405|9150367|P2|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
2649002|NCT00730405|9150368|P1|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
2649003|NCT00730405|9150364|P5|Overall Study-Treatment Phase|Pregnancy|0
2649004|NCT00730405|9150365|P4|Overall Study-Treatment Phase|Pregnancy|0
2649005|NCT00730405|9150366|P3|Overall Study-Treatment Phase|Pregnancy|0
2649006|NCT00730405|9150367|P2|Overall Study-Treatment Phase|Pregnancy|1
2649007|NCT00730405|9150368|P1|Overall Study-Treatment Phase|Pregnancy|0
2649008|NCT00730405|9150364|P5|Overall Study-Treatment Phase|Change of location|0
2649009|NCT00730405|9150365|P4|Overall Study-Treatment Phase|Change of location|1
2649010|NCT00730405|9150366|P3|Overall Study-Treatment Phase|Change of location|0
2649011|NCT00730405|9150367|P2|Overall Study-Treatment Phase|Change of location|0
2649012|NCT00730405|9150368|P1|Overall Study-Treatment Phase|Change of location|0
2649013|NCT00730405|9150364|P5|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
2649014|NCT00730405|9150365|P4|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
2649015|NCT00730405|9150366|P3|Overall Study-Treatment Phase|Protocol violation due to eligibility|1
2649016|NCT00730405|9150367|P2|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
2649017|NCT00730405|9150368|P1|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
2649018|NCT00730405|9150364|P5|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
2649019|NCT00730405|9150365|P4|Overall Study-Treatment Phase|Due to in-vitro fertilization|1
2649020|NCT00730405|9150366|P3|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
2649021|NCT00730405|9150367|P2|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
2649022|NCT00730405|9150368|P1|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
2649023|NCT00730405|9150364|P5|Overall Study-Treatment Phase|Study drug interrupted|0
2649024|NCT00730405|9150365|P4|Overall Study-Treatment Phase|Study drug interrupted|0
2649025|NCT00730405|9150366|P3|Overall Study-Treatment Phase|Study drug interrupted|0
2649026|NCT00730405|9150367|P2|Overall Study-Treatment Phase|Study drug interrupted|1
2649027|NCT00730405|9150368|P1|Overall Study-Treatment Phase|Study drug interrupted|0
2649028|NCT00730405|9150364|P5|Overall Study-Treatment Phase|Misrandomized|0
2649029|NCT00730405|9150365|P4|Overall Study-Treatment Phase|Misrandomized|0
2649030|NCT00730405|9150366|P3|Overall Study-Treatment Phase|Misrandomized|0
2649031|NCT00730405|9150367|P2|Overall Study-Treatment Phase|Misrandomized|1
2649032|NCT00730405|9150368|P1|Overall Study-Treatment Phase|Misrandomized|0
2649033|NCT00730405|9150364|P5|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
2649034|NCT00730405|9150365|P4|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
2649035|NCT00730405|9150366|P3|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1
2649036|NCT00730405|9150367|P2|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
2649037|NCT00730405|9150368|P1|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
2649038|NCT00730405|9150364|P5|Overall Study-Treatment Phase|Use of prohibited medication|2
2649039|NCT00730405|9150365|P4|Overall Study-Treatment Phase|Use of prohibited medication|0
2649040|NCT00730405|9150366|P3|Overall Study-Treatment Phase|Use of prohibited medication|0
2649041|NCT00730405|9150367|P2|Overall Study-Treatment Phase|Use of prohibited medication|1
2649042|NCT00730405|9150368|P1|Overall Study-Treatment Phase|Use of prohibited medication|0
2649043|NCT00730405|9150364|P5|Overall Study-Treatment Phase|Withdrew from study treatment|0
2649044|NCT00730405|9150365|P4|Overall Study-Treatment Phase|Withdrew from study treatment|0
2649045|NCT00730405|9150366|P3|Overall Study-Treatment Phase|Withdrew from study treatment|0
2649046|NCT00730405|9150367|P2|Overall Study-Treatment Phase|Withdrew from study treatment|1
2649047|NCT00730405|9150368|P1|Overall Study-Treatment Phase|Withdrew from study treatment|0
2649048|NCT00730405|9150364|P5|Overall Study-Treatment Phase|Prohibited concomitant medication|0
2649049|NCT00730405|9150365|P4|Overall Study-Treatment Phase|Prohibited concomitant medication|0
2649050|NCT00730405|9150366|P3|Overall Study-Treatment Phase|Prohibited concomitant medication|0
2649051|NCT00730405|9150367|P2|Overall Study-Treatment Phase|Prohibited concomitant medication|0
2649052|NCT00730405|9150368|P1|Overall Study-Treatment Phase|Prohibited concomitant medication|1
2649053|NCT00730405|9150364|P5|Overall Study-Treatment Phase|Participant meets exclusion|0
2649054|NCT00730405|9150365|P4|Overall Study-Treatment Phase|Participant meets exclusion|0
2649055|NCT00730405|9150366|P3|Overall Study-Treatment Phase|Participant meets exclusion|1
2649056|NCT00730405|9150367|P2|Overall Study-Treatment Phase|Participant meets exclusion|0
2649057|NCT00730405|9150368|P1|Overall Study-Treatment Phase|Participant meets exclusion|0
2649058|NCT00730405|9150364|P5|Overall Study-Treatment Phase|Did not met eligibility|0
2649059|NCT00730405|9150365|P4|Overall Study-Treatment Phase|Did not met eligibility|0
2649060|NCT00730405|9150366|P3|Overall Study-Treatment Phase|Did not met eligibility|1
2649061|NCT00730405|9150367|P2|Overall Study-Treatment Phase|Did not met eligibility|0
2649062|NCT00730405|9150368|P1|Overall Study-Treatment Phase|Did not met eligibility|0
2649063|NCT00730405|9150364|P5|Overall Study-Treatment Phase|Withdrawal by Subject|8
2649064|NCT00730405|9150365|P4|Overall Study-Treatment Phase|Withdrawal by Subject|5
2649065|NCT00730405|9150366|P3|Overall Study-Treatment Phase|Withdrawal by Subject|2
2649066|NCT00730405|9150367|P2|Overall Study-Treatment Phase|Withdrawal by Subject|1
2649067|NCT00730405|9150368|P1|Overall Study-Treatment Phase|Withdrawal by Subject|7
2649068|NCT00730405|9150364|P5|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
2649069|NCT00730405|9150365|P4|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
2649070|NCT00730405|9150366|P3|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5
2649071|NCT00730405|9150367|P2|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
2649072|NCT00730405|9150368|P1|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
2649073|NCT00730405|9150364|P5|Overall Study-Treatment Phase|Lost to Follow-up|4
2649074|NCT00730405|9150365|P4|Overall Study-Treatment Phase|Lost to Follow-up|4
2649075|NCT00730405|9150366|P3|Overall Study-Treatment Phase|Lost to Follow-up|6
2649076|NCT00730405|9150367|P2|Overall Study-Treatment Phase|Lost to Follow-up|5
2649077|NCT00730405|9150368|P1|Overall Study-Treatment Phase|Lost to Follow-up|4
2649078|NCT00730405|9150364|P5|Overall Study-Treatment Phase|Adverse Event|4
2649079|NCT00730405|9150365|P4|Overall Study-Treatment Phase|Adverse Event|8
2649080|NCT00730405|9150366|P3|Overall Study-Treatment Phase|Adverse Event|4
2649081|NCT00730405|9150367|P2|Overall Study-Treatment Phase|Adverse Event|10
2649082|NCT00730405|9150368|P1|Overall Study-Treatment Phase|Adverse Event|5
2649083|NCT00730327|9150415|P2|Overall Study|Subject withdrew (reason not specified)|7
2649084|NCT00730327|9150416|P1|Overall Study|Subject withdrew (reason not specified)|2
2649085|NCT00730327|9150415|P2|Overall Study|Withdrawal by Subject|13
2649086|NCT00730327|9150416|P1|Overall Study|Withdrawal by Subject|3
2649087|NCT00730327|9150415|P2|Overall Study|Adverse Event|1
2649088|NCT00730327|9150416|P1|Overall Study|Adverse Event|8
2649089|NCT00730327|9150415|P2|Overall Study|Lost to Follow-up|16
2649090|NCT00730327|9150416|P1|Overall Study|Lost to Follow-up|14
2649091|NCT00730275|9150441|P4|Overall Study|Withdrawal by Subject|1
2649092|NCT00730275|9150442|P3|Overall Study|Withdrawal by Subject|0
2649093|NCT00730275|9150443|P2|Overall Study|Withdrawal by Subject|0
2649094|NCT00730275|9150444|P1|Overall Study|Withdrawal by Subject|0
2649095|NCT00730236|9150470|P1|Overall Study|Non-compliance|1
2649096|NCT00730236|9150470|P1|Overall Study|Withdrawal by Subject|1
2649097|NCT00730236|9150470|P1|Overall Study|Adverse Event|4
2649098|NCT00730171|9150485|P1|Overall Study|Other|61
2649099|NCT00730171|9150485|P1|Overall Study|Insufficient Therapeutic Response|141
2649100|NCT00730171|9150485|P1|Overall Study|Lost to Follow-up|121
2649101|NCT00730171|9150485|P1|Overall Study|Withdrawal by Subject|202
2649102|NCT00730171|9150485|P1|Overall Study|Protocol Violation|48
2649103|NCT00730171|9150485|P1|Overall Study|Adverse Event|193
2649104|NCT00730171|9150485|P1|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5
2649105|NCT00730158|9150495|P2|Overall Study|Withdrawal by Subject|1
2649106|NCT00730158|9150496|P1|Overall Study|Withdrawal by Subject|1
2649107|NCT00730132|9150534|P1|Overall Study|Death|1
2649108|NCT00730132|9150534|P1|Overall Study|Protocol Violation|154
2649109|NCT00730041|9150552|P2|Overall Study|Lost to Follow-up|2
2649110|NCT00730041|9150553|P1|Overall Study|Lost to Follow-up|0
2649111|NCT00730028|9150576|P5|Overall Study|Randomization Error|2
2649112|NCT00730028|9150577|P4|Overall Study|Randomization Error|0
2649113|NCT00730028|9150578|P3|Overall Study|Randomization Error|0
2649114|NCT00730028|9150579|P2|Overall Study|Randomization Error|0
2649115|NCT00730028|9150580|P1|Overall Study|Randomization Error|1
2649116|NCT00730028|9150576|P5|Overall Study|Treatment Failure|1
2649117|NCT00730028|9150577|P4|Overall Study|Treatment Failure|0
2649118|NCT00730028|9150578|P3|Overall Study|Treatment Failure|0
2649119|NCT00730028|9150579|P2|Overall Study|Treatment Failure|5
2649120|NCT00730028|9150580|P1|Overall Study|Treatment Failure|5
2649121|NCT00730028|9150576|P5|Overall Study|Physician Decision|2
2649122|NCT00730028|9150577|P4|Overall Study|Physician Decision|3
2649123|NCT00730028|9150578|P3|Overall Study|Physician Decision|2
2649124|NCT00730028|9150579|P2|Overall Study|Physician Decision|3
2649125|NCT00730028|9150580|P1|Overall Study|Physician Decision|3
2649126|NCT00730028|9150576|P5|Overall Study|Withdrawal by Subject|9
2649127|NCT00730028|9150577|P4|Overall Study|Withdrawal by Subject|5
2649128|NCT00730028|9150578|P3|Overall Study|Withdrawal by Subject|4
2649129|NCT00730028|9150579|P2|Overall Study|Withdrawal by Subject|5
2649130|NCT00730028|9150580|P1|Overall Study|Withdrawal by Subject|9
2649131|NCT00730028|9150576|P5|Overall Study|Protocol Violation|0
2649132|NCT00730028|9150577|P4|Overall Study|Protocol Violation|2
2649133|NCT00730028|9150578|P3|Overall Study|Protocol Violation|1
2649134|NCT00730028|9150579|P2|Overall Study|Protocol Violation|1
2649135|NCT00730028|9150580|P1|Overall Study|Protocol Violation|6
2649136|NCT00730028|9150576|P5|Overall Study|Lost to Follow-up|25
2649137|NCT00730028|9150577|P4|Overall Study|Lost to Follow-up|26
2649138|NCT00730028|9150578|P3|Overall Study|Lost to Follow-up|22
2649139|NCT00730028|9150579|P2|Overall Study|Lost to Follow-up|26
2649140|NCT00730028|9150580|P1|Overall Study|Lost to Follow-up|13
2649141|NCT00730028|9150576|P5|Overall Study|Adverse Event|43
2649142|NCT00730028|9150577|P4|Overall Study|Adverse Event|20
2649143|NCT00730028|9150578|P3|Overall Study|Adverse Event|16
2649144|NCT00730028|9150579|P2|Overall Study|Adverse Event|26
2649145|NCT00730028|9150580|P1|Overall Study|Adverse Event|23
2649146|NCT00730015|9150630|P3|Overall Study|Other Reason|1
2649147|NCT00730015|9150631|P2|Overall Study|Other Reason|0
2649148|NCT00730015|9150632|P1|Overall Study|Other Reason|1
2649149|NCT00730015|9150630|P3|Overall Study|Lack of Efficacy|8
2649150|NCT00730015|9150631|P2|Overall Study|Lack of Efficacy|2
2649151|NCT00730015|9150632|P1|Overall Study|Lack of Efficacy|1
2649152|NCT00730015|9150630|P3|Overall Study|Lost to Follow-up|3
2649153|NCT00730015|9150631|P2|Overall Study|Lost to Follow-up|10
2649154|NCT00730015|9150632|P1|Overall Study|Lost to Follow-up|4
2649155|NCT00730015|9150630|P3|Overall Study|Withdrawal by Subject|8
2649156|NCT00730015|9150631|P2|Overall Study|Withdrawal by Subject|12
2649157|NCT00730015|9150632|P1|Overall Study|Withdrawal by Subject|12
2649159|NCT00730015|9150631|P2|Overall Study|Protocol Violation|6
2649160|NCT00730015|9150632|P1|Overall Study|Protocol Violation|2
2649161|NCT00730015|9150630|P3|Overall Study|Adverse Event|8
2649162|NCT00730015|9150631|P2|Overall Study|Adverse Event|10
2649163|NCT00730015|9150632|P1|Overall Study|Adverse Event|11
2649164|NCT00729937|9150672|P6|Overall Study|Incarcerated|0
2649165|NCT00729937|9150673|P5|Overall Study|Incarcerated|0
2649166|NCT00729937|9150674|P4|Overall Study|Incarcerated|1
2649167|NCT00729937|9150675|P3|Overall Study|Incarcerated|1
2649168|NCT00729937|9150676|P2|Overall Study|Incarcerated|2
2649169|NCT00729937|9150677|P1|Overall Study|Incarcerated|0
2649170|NCT00729937|9150672|P6|Overall Study|Did not meet eligibility criteria|0
2649171|NCT00729937|9150673|P5|Overall Study|Did not meet eligibility criteria|0
2649172|NCT00729937|9150674|P4|Overall Study|Did not meet eligibility criteria|0
2649173|NCT00729937|9150675|P3|Overall Study|Did not meet eligibility criteria|0
2649174|NCT00729937|9150676|P2|Overall Study|Did not meet eligibility criteria|1
2649175|NCT00729937|9150677|P1|Overall Study|Did not meet eligibility criteria|2
2649176|NCT00729937|9150672|P6|Overall Study|Randomized but not treated|3
2649177|NCT00729937|9150673|P5|Overall Study|Randomized but not treated|1
2649178|NCT00729937|9150674|P4|Overall Study|Randomized but not treated|0
2649179|NCT00729937|9150675|P3|Overall Study|Randomized but not treated|1
2649180|NCT00729937|9150676|P2|Overall Study|Randomized but not treated|6
2649181|NCT00729937|9150677|P1|Overall Study|Randomized but not treated|12
2649182|NCT00729937|9150672|P6|Overall Study|Withdrawal by Subject|2
2649183|NCT00729937|9150673|P5|Overall Study|Withdrawal by Subject|4
2649184|NCT00729937|9150674|P4|Overall Study|Withdrawal by Subject|0
2649185|NCT00729937|9150675|P3|Overall Study|Withdrawal by Subject|6
2649186|NCT00729937|9150676|P2|Overall Study|Withdrawal by Subject|5
2649187|NCT00729937|9150677|P1|Overall Study|Withdrawal by Subject|3
2649188|NCT00729937|9150672|P6|Overall Study|Death|1
2649189|NCT00729937|9150673|P5|Overall Study|Death|0
2649190|NCT00729937|9150674|P4|Overall Study|Death|0
2649191|NCT00729937|9150675|P3|Overall Study|Death|1
2649192|NCT00729937|9150676|P2|Overall Study|Death|0
2649193|NCT00729937|9150677|P1|Overall Study|Death|1
2649194|NCT00729937|9150672|P6|Overall Study|Physician Decision|8
2649195|NCT00729937|9150673|P5|Overall Study|Physician Decision|5
2649196|NCT00729937|9150674|P4|Overall Study|Physician Decision|0
2649197|NCT00729937|9150675|P3|Overall Study|Physician Decision|2
2649198|NCT00729937|9150676|P2|Overall Study|Physician Decision|16
2649199|NCT00729937|9150677|P1|Overall Study|Physician Decision|7
2649200|NCT00729937|9150672|P6|Overall Study|Lost to Follow-up|23
2649201|NCT00729937|9150673|P5|Overall Study|Lost to Follow-up|18
2649202|NCT00729937|9150674|P4|Overall Study|Lost to Follow-up|33
2649203|NCT00729937|9150675|P3|Overall Study|Lost to Follow-up|18
2649204|NCT00729937|9150676|P2|Overall Study|Lost to Follow-up|58
2649205|NCT00729937|9150677|P1|Overall Study|Lost to Follow-up|49
2649206|NCT00729859|9150881|P3|Overall Study|Withdrawal by Subject|0
2649207|NCT00729859|9150882|P2|Overall Study|Withdrawal by Subject|1
2649208|NCT00729859|9150883|P1|Overall Study|Withdrawal by Subject|0
2649209|NCT00729859|9150881|P3|Overall Study|Adverse Event|0
2649210|NCT00729859|9150882|P2|Overall Study|Adverse Event|1
2649211|NCT00729859|9150883|P1|Overall Study|Adverse Event|0
2649212|NCT00729833|9150927|P4|Overall Study|Unspecified Reasons|1
2649213|NCT00729833|9150928|P3|Overall Study|Unspecified Reasons|5
2649214|NCT00729833|9150929|P2|Overall Study|Unspecified Reasons|5
2649215|NCT00729833|9150930|P1|Overall Study|Unspecified Reasons|11
2649216|NCT00729833|9150927|P4|Overall Study|Withdrawal by Subject|0
2649217|NCT00729833|9150928|P3|Overall Study|Withdrawal by Subject|3
2649218|NCT00729833|9150929|P2|Overall Study|Withdrawal by Subject|1
2649219|NCT00729833|9150930|P1|Overall Study|Withdrawal by Subject|3
2649220|NCT00729833|9150927|P4|Overall Study|Lost to Follow-up|0
2649221|NCT00729833|9150928|P3|Overall Study|Lost to Follow-up|0
2649222|NCT00729833|9150929|P2|Overall Study|Lost to Follow-up|0
2649223|NCT00729833|9150930|P1|Overall Study|Lost to Follow-up|1
2649224|NCT00729833|9150927|P4|Overall Study|Study Terminated by Sponsor|0
2649225|NCT00729833|9150928|P3|Overall Study|Study Terminated by Sponsor|1
2649226|NCT00729833|9150929|P2|Overall Study|Study Terminated by Sponsor|0
2649227|NCT00729833|9150930|P1|Overall Study|Study Terminated by Sponsor|0
2649228|NCT00729833|9150927|P4|Overall Study|Death|5
2649229|NCT00729833|9150928|P3|Overall Study|Death|3
2649230|NCT00729833|9150929|P2|Overall Study|Death|1
2649231|NCT00729833|9150930|P1|Overall Study|Death|5
2649232|NCT00729690|9150988|P3|Overall Study|IT Catheter Malfunction|2
2649233|NCT00729690|9150989|P2|Overall Study|IT Catheter Malfunction|2
2649234|NCT00729690|9150990|P1|Overall Study|IT Catheter Malfunction|0
2649235|NCT00729651|9151020|P2|Overall Study|Subject’s private reason|0
2649236|NCT00729651|9151021|P1|Overall Study|Subject’s private reason|2
2649237|NCT00729651|9151020|P2|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4
2649238|NCT00729651|9151021|P1|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0
2649239|NCT00729651|9151020|P2|Overall Study|Adverse Event|3
2649240|NCT00729651|9151021|P1|Overall Study|Adverse Event|7
2649241|NCT00729651|9151020|P2|Overall Study|Protocol Violation|1
2649242|NCT00729651|9151021|P1|Overall Study|Protocol Violation|0
2649243|NCT00729651|9151020|P2|Overall Study|Lost to Follow-up|4
2649244|NCT00729651|9151021|P1|Overall Study|Lost to Follow-up|5
2649245|NCT00729651|9151020|P2|Overall Study|Withdrawal by Subject|6
2649246|NCT00729651|9151021|P1|Overall Study|Withdrawal by Subject|5
2649247|NCT00729612|9151033|P1|Overall Study|Non evaluable for response|10
2649248|NCT00729586|9151042|P2|Overall Study|never treated|0
2649249|NCT00729586|9151043|P1|Overall Study|never treated|1
2649250|NCT00729586|9151042|P2|Overall Study|Ineligible|1
2649251|NCT00729586|9151043|P1|Overall Study|Ineligible|0
2649252|NCT00729560|9151056|P1|Overall Study|Withdrawal by Subject|3
2649253|NCT00729469|9151082|P2|Overall Study|Other-Not mentioned|4
2649254|NCT00729469|9151083|P1|Overall Study|Other-Not mentioned|9
2649255|NCT00729469|9151082|P2|Overall Study|Withdrawal by Subject|8
2649256|NCT00729469|9151083|P1|Overall Study|Withdrawal by Subject|19
2649257|NCT00729469|9151082|P2|Overall Study|Protocol Violation|1
2649258|NCT00729469|9151083|P1|Overall Study|Protocol Violation|2
2649259|NCT00729469|9151082|P2|Overall Study|Lost to Follow-up|9
2649260|NCT00729469|9151083|P1|Overall Study|Lost to Follow-up|9
2649261|NCT00729469|9151082|P2|Overall Study|Adverse Event|25
2649262|NCT00729469|9151083|P1|Overall Study|Adverse Event|14
2649263|NCT00729378|9151136|P2|36-months|Lost to Follow-up|6
2649264|NCT00729378|9151137|P1|36-months|Lost to Follow-up|15
2649265|NCT00729378|9151136|P2|24-months|Lost to Follow-up|51
2649266|NCT00729378|9151137|P1|24-months|Lost to Follow-up|72
2649267|NCT00729378|9151136|P2|12-months|Lost to Follow-up|65
2649268|NCT00729378|9151137|P1|12-months|Lost to Follow-up|100
2649269|NCT00729378|9151136|P2|Baseline|Withdrawal by Subject|59
2649270|NCT00729378|9151137|P1|Baseline|Withdrawal by Subject|66
2649271|NCT00729378|9151136|P2|Baseline|Did not complete study measurements|33
2649272|NCT00729378|9151137|P1|Baseline|Did not complete study measurements|72
2649273|NCT00729365|9151336|P3|Overall Study|Physician Decision|7
2649274|NCT00729365|9151337|P2|Overall Study|Physician Decision|6
2649275|NCT00729365|9151338|P1|Overall Study|Physician Decision|33
2649276|NCT00729326|9151351|P2|Overall Study|Sponsor Decision|2
2649277|NCT00729326|9151352|P1|Overall Study|Sponsor Decision|1
2649278|NCT00729326|9151351|P2|Overall Study|Subject Decision|4
2649279|NCT00729326|9151352|P1|Overall Study|Subject Decision|4
2649280|NCT00729326|9151351|P2|Overall Study|Protocol Violation|2
2649281|NCT00729326|9151352|P1|Overall Study|Protocol Violation|3
2649282|NCT00729326|9151351|P2|Overall Study|Physician Decision|1
2649283|NCT00729326|9151352|P1|Overall Study|Physician Decision|0
2649284|NCT00729326|9151351|P2|Overall Study|Lost to Follow-up|0
2649285|NCT00729326|9151352|P1|Overall Study|Lost to Follow-up|2
2649286|NCT00729248|9151394|P1|Overall Study|Physician Decision|2
2649287|NCT00729183|9151401|P2|Overall Study|Withdrawal by Subject|7
2649288|NCT00729183|9151402|P1|Overall Study|Withdrawal by Subject|9
2649289|NCT00729183|9151401|P2|Overall Study|Protocol Violation|0
2649290|NCT00729183|9151402|P1|Overall Study|Protocol Violation|1
2649291|NCT00729183|9151401|P2|Overall Study|Physician Decision|1
2649292|NCT00729183|9151402|P1|Overall Study|Physician Decision|1
2649293|NCT00729183|9151401|P2|Overall Study|Lost to Follow-up|1
2649294|NCT00729183|9151402|P1|Overall Study|Lost to Follow-up|3
2649295|NCT00729183|9151401|P2|Overall Study|Lack of Efficacy|1
2649296|NCT00729183|9151402|P1|Overall Study|Lack of Efficacy|0
2649297|NCT00729183|9151401|P2|Overall Study|Adverse Event|5
2649298|NCT00729183|9151402|P1|Overall Study|Adverse Event|11
2649299|NCT00729157|9151434|P1|Overall Study|Withdrawal by Subject|1
2649300|NCT00728988|9151477|P2|Overall Study|Withdrawal by Subject|6
2649301|NCT00728988|9151478|P1|Overall Study|Withdrawal by Subject|2
2649302|NCT00728988|9151477|P2|Overall Study|Other|77
2649303|NCT00728988|9151478|P1|Overall Study|Other|85
2649304|NCT00728988|9151477|P2|Overall Study|Adverse Event|2
2649305|NCT00728988|9151478|P1|Overall Study|Adverse Event|3
2649306|NCT00728988|9151477|P2|Overall Study|Death|1
2649307|NCT00728988|9151478|P1|Overall Study|Death|1
2649308|NCT00728988|9151477|P2|Overall Study|Not Treated|2
2649309|NCT00728988|9151478|P1|Overall Study|Not Treated|2
2649310|NCT00728962|9151496|P1|Two Year Post Placement Follow-up|Lost to Follow-up|3
2649311|NCT00728962|9151496|P1|Permanent Prosthesis Placement|Adverse Event|3
2649312|NCT00728962|9151496|P1|Implant Placement Surgery|Protocol Violation|1
2649313|NCT00728962|9151496|P1|Implant Placement Surgery|Lost to Follow-up|1
2649314|NCT00728962|9151496|P1|Implant Placement Surgery|Adverse Event|8
2649315|NCT00728949|9151502|P2|Overall Study|On treatment at cutoff date|0
2649316|NCT00728949|9151503|P1|Overall Study|On treatment at cutoff date|1
2649317|NCT00728949|9151502|P2|Overall Study|Abnormal Lab Results|2
2649318|NCT00728949|9151503|P1|Overall Study|Abnormal Lab Results|0
2649319|NCT00728949|9151502|P2|Overall Study|Withdrawal by Subject|2
2649320|NCT00728949|9151503|P1|Overall Study|Withdrawal by Subject|2
2649321|NCT00728949|9151502|P2|Overall Study|Adverse Event|0
2649322|NCT00728949|9151503|P1|Overall Study|Adverse Event|8
2649323|NCT00728936|9151528|P7|Overall Study|Withdrawal by Subject|0
2649324|NCT00728936|9151529|P6|Overall Study|Withdrawal by Subject|1
2649325|NCT00728936|9151530|P5|Overall Study|Withdrawal by Subject|0
2649326|NCT00728936|9151531|P4|Overall Study|Withdrawal by Subject|0
2649327|NCT00728936|9151532|P3|Overall Study|Withdrawal by Subject|0
2649328|NCT00728936|9151533|P2|Overall Study|Withdrawal by Subject|0
2649329|NCT00728936|9151534|P1|Overall Study|Withdrawal by Subject|0
2649330|NCT00728884|9151567|P1|One Year Post Placement Follow-up|Lost to Follow-up|4
2649331|NCT00728884|9151567|P1|Permanent Prosthesis Placement|Lost to Follow-up|13
2649332|NCT00728754|9151603|P2|One Year Post Placement Follow-up|Adverse Event|0
2649333|NCT00728754|9151604|P1|One Year Post Placement Follow-up|Adverse Event|1
2649334|NCT00728754|9151603|P2|Permanent Prosthesis Placement|Lost to Follow-up|3
2649335|NCT00728754|9151604|P1|Permanent Prosthesis Placement|Lost to Follow-up|3
2649336|NCT00728754|9151603|P2|Permanent Prosthesis Placement|Adverse Event|1
2649337|NCT00728754|9151604|P1|Permanent Prosthesis Placement|Adverse Event|1
2649338|NCT00728689|9151633|P2|Washout Period (Days 4 - 10)|Death in family|0
2649339|NCT00728689|9151634|P1|Washout Period (Days 4 - 10)|Death in family|1
2649340|NCT00728494|9151663|P2|Overall Study|No data available|1
2649341|NCT00728494|9151664|P1|Overall Study|No data available|0
2649342|NCT00728494|9151663|P2|Overall Study|Lack of Efficacy|4
2649343|NCT00728494|9151664|P1|Overall Study|Lack of Efficacy|2
2649344|NCT00728494|9151663|P2|Overall Study|Withdrawal by Subject|2
2649345|NCT00728494|9151664|P1|Overall Study|Withdrawal by Subject|0
2649346|NCT00728494|9151663|P2|Overall Study|Adverse Event|0
2649347|NCT00728494|9151664|P1|Overall Study|Adverse Event|7
2649348|NCT00728481|9151682|P2|Overall Study|Incorrectly assigned to opposite arm|0
2649349|NCT00728481|9151683|P1|Overall Study|Incorrectly assigned to opposite arm|1
2649350|NCT00728481|9151682|P2|Overall Study|Study medication non-compliance|2
2649351|NCT00728481|9151683|P1|Overall Study|Study medication non-compliance|0
2649352|NCT00728481|9151682|P2|Overall Study|Adverse Event|1
2649353|NCT00728481|9151683|P1|Overall Study|Adverse Event|0
2649354|NCT00728481|9151682|P2|Overall Study|Withdrawal by Subject|1
2649355|NCT00728481|9151683|P1|Overall Study|Withdrawal by Subject|0
2649356|NCT00728468|9151699|P1|Overall Study|Study terminated by sponsor|1
2649357|NCT00728468|9151699|P1|Overall Study|Objective progression or relapse|9
2649358|NCT00728468|9151699|P1|Overall Study|Protocol Violation|4
2649359|NCT00728468|9151699|P1|Overall Study|Death|1
2649360|NCT00728468|9151699|P1|Overall Study|Enrolled but not treated|1
2649361|NCT00728416|9151723|P2|Overall Study|Withdrawal by Subject|0
2649362|NCT00728416|9151724|P1|Overall Study|Withdrawal by Subject|1
2649363|NCT00728416|9151723|P2|Overall Study|Treatment Failure|1
2649364|NCT00728416|9151724|P1|Overall Study|Treatment Failure|0
2649365|NCT00728416|9151723|P2|Overall Study|Adverse Event|1
2649366|NCT00728416|9151724|P1|Overall Study|Adverse Event|1
2649367|NCT00728182|9151740|P2|Overall Study|Protocol Noncompliance|1
2649368|NCT00728182|9151741|P1|Overall Study|Protocol Noncompliance|0
2649369|NCT00728182|9151740|P2|Overall Study|Death|2
2649370|NCT00728182|9151741|P1|Overall Study|Death|0
2649371|NCT00728182|9151740|P2|Overall Study|Lost to Follow-up|0
2649372|NCT00728182|9151741|P1|Overall Study|Lost to Follow-up|2
2649373|NCT00728182|9151740|P2|Overall Study|Adverse Event|0
2649374|NCT00728182|9151741|P1|Overall Study|Adverse Event|1
2649375|NCT00728130|9151769|P1|Overall Study|Physician Decision|1
2649376|NCT00728130|9151769|P1|Overall Study|Paperwork not completed in time|1
2649377|NCT00728130|9151769|P1|Overall Study|Withdrawal by Subject|1
2649378|NCT00727961|9151774|P1|Overall Study|Progression|30
2649379|NCT00727961|9151774|P1|Overall Study|Patient's refusal|2
2649380|NCT00727961|9151774|P1|Overall Study|Adverse Event|4
2649381|NCT00727961|9151774|P1|Overall Study|Lost to Follow-up|1
2649382|NCT00727909|9151784|P4|Overall Study|Death|0
2649383|NCT00727909|9151785|P3|Overall Study|Death|1
2649384|NCT00727909|9151786|P2|Overall Study|Death|0
2649385|NCT00727909|9151787|P1|Overall Study|Death|0
2649386|NCT00727909|9151784|P4|Overall Study|Withdrawal by Subject|5
2649387|NCT00727909|9151785|P3|Overall Study|Withdrawal by Subject|8
2649388|NCT00727909|9151786|P2|Overall Study|Withdrawal by Subject|11
2649389|NCT00727909|9151787|P1|Overall Study|Withdrawal by Subject|5
2649390|NCT00727844|9151884|P4|Initial Randomization|Physician Decision|0
2649391|NCT00727844|9151885|P3|Initial Randomization|Physician Decision|0
2649392|NCT00727844|9151886|P2|Initial Randomization|Physician Decision|0
2649393|NCT00727844|9151887|P1|Initial Randomization|Physician Decision|2
2649394|NCT00727714|9151901|P1|Overall Study|Lost to Follow-up|2
2649395|NCT00727649|9151911|P2|Second Intervention (4-weeks)|Withdrawal by Subject|2
2649396|NCT00727649|9151912|P1|Second Intervention (4-weeks)|Withdrawal by Subject|0
2649397|NCT00727649|9151911|P2|Second Intervention (4-weeks)|Lost to Follow-up|1
2649398|NCT00727649|9151912|P1|Second Intervention (4-weeks)|Lost to Follow-up|0
2649399|NCT00727649|9151911|P2|Second Intervention (4-weeks)|Death|0
2649400|NCT00727649|9151912|P1|Second Intervention (4-weeks)|Death|1
2649401|NCT00727649|9151911|P2|Wash-out (2-weeks)|Withdrawal by Subject|2
2649402|NCT00727649|9151912|P1|Wash-out (2-weeks)|Withdrawal by Subject|1
2649403|NCT00727649|9151911|P2|Wash-out (2-weeks)|Lost to Follow-up|1
2649404|NCT00727649|9151912|P1|Wash-out (2-weeks)|Lost to Follow-up|3
2649405|NCT00727649|9151911|P2|First Intervention (4-weeks)|Withdrawal by Subject|1
2649406|NCT00727649|9151912|P1|First Intervention (4-weeks)|Withdrawal by Subject|2
2649407|NCT00727649|9151911|P2|First Intervention (4-weeks)|Lost to Follow-up|2
2649408|NCT00727649|9151912|P1|First Intervention (4-weeks)|Lost to Follow-up|1
2649409|NCT00727571|9151954|P4|Overall Study|Other|0
2649410|NCT00727571|9151955|P3|Overall Study|Other|6
2649411|NCT00727571|9151956|P2|Overall Study|Other|4
2649412|NCT00727571|9151957|P1|Overall Study|Other|0
2649413|NCT00727571|9151954|P4|Overall Study|AE not leading to hospitalization|0
2649414|NCT00727571|9151955|P3|Overall Study|AE not leading to hospitalization|2
2649415|NCT00727571|9151956|P2|Overall Study|AE not leading to hospitalization|0
2649416|NCT00727571|9151957|P1|Overall Study|AE not leading to hospitalization|0
2649417|NCT00727571|9151954|P4|Overall Study|Hospitalization|1
2649418|NCT00727571|9151955|P3|Overall Study|Hospitalization|0
2649419|NCT00727571|9151956|P2|Overall Study|Hospitalization|1
2649420|NCT00727571|9151957|P1|Overall Study|Hospitalization|0
2649421|NCT00727571|9151954|P4|Overall Study|Dismissed from nursing home|0
2649422|NCT00727571|9151955|P3|Overall Study|Dismissed from nursing home|5
2649423|NCT00727571|9151956|P2|Overall Study|Dismissed from nursing home|9
2649424|NCT00727571|9151957|P1|Overall Study|Dismissed from nursing home|0
2649425|NCT00727571|9151954|P4|Overall Study|Subject Non Compliance|4
2649426|NCT00727571|9151955|P3|Overall Study|Subject Non Compliance|0
2649427|NCT00727571|9151956|P2|Overall Study|Subject Non Compliance|6
2649428|NCT00727571|9151957|P1|Overall Study|Subject Non Compliance|0
2649429|NCT00727571|9151954|P4|Overall Study|Withdrawal by Subject|0
2649430|NCT00727571|9151955|P3|Overall Study|Withdrawal by Subject|11
2649431|NCT00727571|9151956|P2|Overall Study|Withdrawal by Subject|10
2649432|NCT00727571|9151957|P1|Overall Study|Withdrawal by Subject|0
2649433|NCT00727571|9151954|P4|Overall Study|Physician Decision|0
2649434|NCT00727571|9151955|P3|Overall Study|Physician Decision|0
2649435|NCT00727571|9151956|P2|Overall Study|Physician Decision|5
2649436|NCT00727571|9151957|P1|Overall Study|Physician Decision|0
2649437|NCT00727571|9151954|P4|Overall Study|Death|1
2649438|NCT00727571|9151955|P3|Overall Study|Death|5
2649439|NCT00727571|9151956|P2|Overall Study|Death|19
2649440|NCT00727571|9151957|P1|Overall Study|Death|0
2649441|NCT00727571|9151954|P4|Overall Study|Ineligibility determined|0
2649442|NCT00727571|9151955|P3|Overall Study|Ineligibility determined|1
2649443|NCT00727571|9151956|P2|Overall Study|Ineligibility determined|1
2649444|NCT00727571|9151957|P1|Overall Study|Ineligibility determined|1
2649445|NCT00727558|9151984|P2|Overall Study|Lost to Follow-up|0
2649446|NCT00727558|9151985|P1|Overall Study|Lost to Follow-up|1
2649447|NCT00727558|9151984|P2|Overall Study|Subject unable to return for follow-up|1
2649448|NCT00727558|9151985|P1|Overall Study|Subject unable to return for follow-up|1
2649449|NCT00727558|9151984|P2|Overall Study|Adverse Event|1
2649450|NCT00727558|9151985|P1|Overall Study|Adverse Event|0
2649451|NCT00727558|9151984|P2|Overall Study|Lens issue|1
2649452|NCT00727558|9151985|P1|Overall Study|Lens issue|0
2649453|NCT00727532|9152003|P1|Overall Study|Withdrawal by Subject|1
2649454|NCT00727532|9152003|P1|Overall Study|Adverse Event|1
2649455|NCT00727506|9152015|P6|Overall Study|Other reason not described above|1
2649456|NCT00727506|9152016|P5|Overall Study|Other reason not described above|1
2649457|NCT00727506|9152017|P4|Overall Study|Other reason not described above|4
2649458|NCT00727506|9152018|P3|Overall Study|Other reason not described above|1
2649459|NCT00727506|9152019|P2|Overall Study|Other reason not described above|0
2649460|NCT00727506|9152020|P1|Overall Study|Other reason not described above|0
2649461|NCT00727506|9152015|P6|Overall Study|Refused to continue medication|2
2649462|NCT00727506|9152016|P5|Overall Study|Refused to continue medication|1
2649463|NCT00727506|9152017|P4|Overall Study|Refused to continue medication|3
2649464|NCT00727506|9152018|P3|Overall Study|Refused to continue medication|2
2649465|NCT00727506|9152019|P2|Overall Study|Refused to continue medication|1
2649466|NCT00727506|9152020|P1|Overall Study|Refused to continue medication|0
2649467|NCT00727506|9152015|P6|Overall Study|Progressive disease|28
2649468|NCT00727506|9152016|P5|Overall Study|Progressive disease|38
2649469|NCT00727506|9152017|P4|Overall Study|Progressive disease|28
2649470|NCT00727506|9152018|P3|Overall Study|Progressive disease|9
2649471|NCT00727506|9152019|P2|Overall Study|Progressive disease|7
2649472|NCT00727506|9152020|P1|Overall Study|Progressive disease|4
2649473|NCT00727506|9152015|P6|Overall Study|Dose Limiting Toxicity (DLT)|0
2649474|NCT00727506|9152016|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
2649475|NCT00727506|9152017|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
2649476|NCT00727506|9152018|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
2649477|NCT00727506|9152019|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
2649478|NCT00727506|9152020|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
2649479|NCT00727506|9152015|P6|Overall Study|Adverse Event|8
2649480|NCT00727506|9152016|P5|Overall Study|Adverse Event|1
2649481|NCT00727506|9152017|P4|Overall Study|Adverse Event|4
2649482|NCT00727506|9152018|P3|Overall Study|Adverse Event|4
2649483|NCT00727506|9152019|P2|Overall Study|Adverse Event|0
2649484|NCT00727506|9152020|P1|Overall Study|Adverse Event|0
2649485|NCT00727441|9152116|P3|Overall Study|Withdrawal by Subject|0
2649486|NCT00727441|9152117|P2|Overall Study|Withdrawal by Subject|1
2649487|NCT00727441|9152118|P1|Overall Study|Withdrawal by Subject|0
2649488|NCT00727441|9152116|P3|Overall Study|Physician Decision|0
2649489|NCT00727441|9152117|P2|Overall Study|Physician Decision|1
2649490|NCT00727441|9152118|P1|Overall Study|Physician Decision|0
2649491|NCT00727441|9152116|P3|Overall Study|Death|1
2649492|NCT00727441|9152117|P2|Overall Study|Death|1
2649493|NCT00727441|9152118|P1|Overall Study|Death|0
2649494|NCT00727441|9152116|P3|Overall Study|Eligibility|7
2649495|NCT00727441|9152117|P2|Overall Study|Eligibility|5
2649496|NCT00727441|9152118|P1|Overall Study|Eligibility|7
2649497|NCT00727441|9152116|P3|Overall Study|Disease Progression|17
2649498|NCT00727441|9152117|P2|Overall Study|Disease Progression|14
2649499|NCT00727441|9152118|P1|Overall Study|Disease Progression|11
2649500|NCT00727415|9152138|P1|Phase I|Dose Limiting Toxicity|2
2649501|NCT00727402|9152147|P1|Overall Study|Physician Decision|116
2649502|NCT00727311|9152176|P1|Overall Study|Multiple reasons|39
2649503|NCT00727311|9152176|P1|Overall Study|Other|97
2649504|NCT00727311|9152176|P1|Overall Study|Withdrawal by Subject|77
2649505|NCT00727311|9152176|P1|Overall Study|Lost to Follow-up|73
2649506|NCT00727311|9152176|P1|Overall Study|Lack of Efficacy|242
2649507|NCT00727311|9152176|P1|Overall Study|Adverse Event|58
2649508|NCT00727311|9152176|P1|Overall Study|Missing end of therapy data|205
2649509|NCT00727311|9152176|P1|Overall Study|Did not receive drug|316
2649510|NCT00727272|9152189|P3|Washout Period B|Withdrawal by Subject|1
2649511|NCT00727272|9152190|P2|Washout Period B|Withdrawal by Subject|0
2649512|NCT00727272|9152191|P1|Washout Period B|Withdrawal by Subject|0
2649513|NCT00727272|9152189|P3|Washout Period A|Adverse Event|1
2649514|NCT00727272|9152190|P2|Washout Period A|Adverse Event|0
2649515|NCT00727272|9152191|P1|Washout Period A|Adverse Event|0
2649516|NCT00727259|9152208|P1|Overall Study|Not all questionnaires completed|1055
2649517|NCT00727246|9152217|P4|Overall Study|withdrawn|0
2649518|NCT00727246|9152218|P3|Overall Study|withdrawn|1
2649519|NCT00727246|9152219|P2|Overall Study|withdrawn|0
2649520|NCT00727246|9152220|P1|Overall Study|withdrawn|0
2649521|NCT00727246|9152217|P4|Overall Study|incidental finding|1
2649522|NCT00727246|9152218|P3|Overall Study|incidental finding|0
2649523|NCT00727246|9152219|P2|Overall Study|incidental finding|0
2649524|NCT00727246|9152220|P1|Overall Study|incidental finding|0
2649525|NCT00727246|9152217|P4|Overall Study|could not complete MRI|1
2649526|NCT00727246|9152218|P3|Overall Study|could not complete MRI|0
2649527|NCT00727246|9152219|P2|Overall Study|could not complete MRI|1
2649528|NCT00727246|9152220|P1|Overall Study|could not complete MRI|0
2649529|NCT00727194|9152243|P3|Treatment Period 2|Lack of Efficacy|0
2649530|NCT00727194|9152244|P2|Treatment Period 2|Lack of Efficacy|1
2649531|NCT00727194|9152245|P1|Treatment Period 2|Lack of Efficacy|0
2649532|NCT00727194|9152243|P3|Screening Period|History of thymoma|1
2649533|NCT00727194|9152244|P2|Screening Period|History of thymoma|0
2649534|NCT00727194|9152245|P1|Screening Period|History of thymoma|0
2649535|NCT00727194|9152243|P3|Screening Period|Severe infections|2
2649536|NCT00727194|9152244|P2|Screening Period|Severe infections|0
2649537|NCT00727194|9152245|P1|Screening Period|Severe infections|0
2649538|NCT00727194|9152243|P3|Screening Period|Not stable on concomitant MG therapy|2
2649539|NCT00727194|9152244|P2|Screening Period|Not stable on concomitant MG therapy|0
2649540|NCT00727194|9152245|P1|Screening Period|Not stable on concomitant MG therapy|0
2649541|NCT00727194|9152243|P3|Screening Period|Lacked AChR antibodies|5
2649542|NCT00727194|9152244|P2|Screening Period|Lacked AChR antibodies|0
2649543|NCT00727194|9152245|P1|Screening Period|Lacked AChR antibodies|0
2649544|NCT00727194|9152243|P3|Screening Period|Low QMG scores|6
2649545|NCT00727194|9152244|P2|Screening Period|Low QMG scores|0
2649546|NCT00727194|9152245|P1|Screening Period|Low QMG scores|0
2649547|NCT00727025|9152317|P1|Overall Study|Physician Decision|23
2649548|NCT00726999|9152329|P2|Overall Study|Protocol Violation|0
2649549|NCT00726999|9152330|P1|Overall Study|Protocol Violation|1
2649550|NCT00726999|9152329|P2|Overall Study|Withdrawal by Subject|0
2649551|NCT00726999|9152330|P1|Overall Study|Withdrawal by Subject|2
2649552|NCT00726999|9152329|P2|Overall Study|Physician Decision|1
2649553|NCT00726999|9152330|P1|Overall Study|Physician Decision|0
2649554|NCT00726986|9152342|P1|Maintenance Phase|Lack of Efficacy|2
2649555|NCT00726986|9152342|P1|Maintenance Phase|Adverse Event|1
2649556|NCT00726986|9152342|P1|Induction Phase|Secondary Disease|2
2649557|NCT00726986|9152342|P1|Induction Phase|Lack of Efficacy|5
2649558|NCT00726986|9152342|P1|Induction Phase|Death|2
2649559|NCT00726986|9152342|P1|Induction Phase|Withdrawal by Subject|2
2649560|NCT00726986|9152342|P1|Induction Phase|Adverse Event|4
2649561|NCT00726895|9152349|P2|Washout Period of 7 Days|Withdrawal by Subject|1
2649562|NCT00726895|9152350|P1|Washout Period of 7 Days|Withdrawal by Subject|0
2649563|NCT00726882|9152363|P1|Overall Study|Other|10
2649564|NCT00726882|9152363|P1|Overall Study|Lost to Follow-up|7
2649565|NCT00726882|9152363|P1|Overall Study|Withdrawal by Subject|5
2649566|NCT00726752|9152378|P1|Overall Study|Lack of Efficacy|6
2649567|NCT00726661|9152440|P2|Overall Study|Other|35
2649568|NCT00726661|9152441|P1|Overall Study|Other|47
2649569|NCT00726661|9152440|P2|Overall Study|Physician Decision|13
2649570|NCT00726661|9152441|P1|Overall Study|Physician Decision|25
2649571|NCT00726661|9152440|P2|Overall Study|Death|159
2649572|NCT00726661|9152441|P1|Overall Study|Death|475
2649573|NCT00726661|9152440|P2|Overall Study|Trial terminated by sponsor|187
2649574|NCT00726661|9152441|P1|Overall Study|Trial terminated by sponsor|214
2649575|NCT00726661|9152440|P2|Overall Study|Withdrawal by Subject|13
2649576|NCT00726661|9152441|P1|Overall Study|Withdrawal by Subject|17
2649577|NCT00726661|9152440|P2|Overall Study|Lost to Follow-up|11
2649578|NCT00726661|9152441|P1|Overall Study|Lost to Follow-up|36
2649579|NCT00726622|9152458|P2|Overall Study|Metastasis|0
2649580|NCT00726622|9152459|P1|Overall Study|Metastasis|2
2649581|NCT00726622|9152458|P2|Overall Study|Physician Decision|1
2649582|NCT00726622|9152459|P1|Overall Study|Physician Decision|0
2649583|NCT00726622|9152458|P2|Overall Study|Withdrawal by Subject|2
2649584|NCT00726622|9152459|P1|Overall Study|Withdrawal by Subject|16
2649585|NCT00726609|9152477|P1|Overall Study|Other|3
2649586|NCT00726609|9152477|P1|Overall Study|Missing|42
2649587|NCT00726609|9152477|P1|Overall Study|Other|16
2649588|NCT00726609|9152477|P1|Overall Study|Lack of Efficacy|25
2649589|NCT00726609|9152477|P1|Overall Study|Withdrawal by Subject|2
2649590|NCT00726609|9152477|P1|Overall Study|Adverse Event|10
2649591|NCT00726557|9152481|P1|Overall Study|Inclusion criteria not met|15
2649592|NCT00726557|9152481|P1|Overall Study|Treatment less than 3 months|17
2649593|NCT00726557|9152481|P1|Overall Study|No follow-up documentation available|55
2649594|NCT00726557|9152481|P1|Overall Study|No end of treatment documentation|37
2649595|NCT00726557|9152481|P1|Overall Study|Screening failure|4
2649596|NCT00726453|9152488|P2|38 mm Length Group|Death|3
2649597|NCT00726453|9152489|P1|38 mm Length Group|Death|0
2649598|NCT00726453|9152488|P2|Primary Enrollment Group|Withdrawal by Subject|0
2649599|NCT00726453|9152489|P1|Primary Enrollment Group|Withdrawal by Subject|13
2649600|NCT00726453|9152488|P2|Primary Enrollment Group|Death|0
2649601|NCT00726453|9152489|P1|Primary Enrollment Group|Death|18
2649602|NCT00726323|9152517|P2|Overall Study|Metastatic lesions inferred cyst|1
2649603|NCT00726323|9152518|P1|Overall Study|Metastatic lesions inferred cyst|0
2649604|NCT00726323|9152517|P2|Overall Study|Participant wished to discontinue|1
2649605|NCT00726323|9152518|P1|Overall Study|Participant wished to discontinue|0
2649606|NCT00726323|9152517|P2|Overall Study|Death|0
2649607|NCT00726323|9152518|P1|Overall Study|Death|1
2649608|NCT00726323|9152517|P2|Overall Study|Adverse Event|9
2649609|NCT00726323|9152518|P1|Overall Study|Adverse Event|9
2649610|NCT00726323|9152517|P2|Overall Study|Clinical progression|3
2649611|NCT00726323|9152518|P1|Overall Study|Clinical progression|0
2649612|NCT00726323|9152517|P2|Overall Study|Progressive disease|16
2649613|NCT00726323|9152518|P1|Overall Study|Progressive disease|23
2649614|NCT00726323|9152517|P2|Overall Study|Physician Decision|0
2649615|NCT00726323|9152518|P1|Overall Study|Physician Decision|1
2649616|NCT00726323|9152517|P2|Overall Study|Withdrawal by Subject|1
2649617|NCT00726323|9152518|P1|Overall Study|Withdrawal by Subject|3
2649618|NCT00726232|9152548|P8|Expansion Phase|Unspecified reason|0
2649619|NCT00726232|9152549|P7|Expansion Phase|Unspecified reason|1
2649620|NCT00726232|9152550|P6|Expansion Phase|Unspecified reason|0
2649621|NCT00726232|9152551|P5|Expansion Phase|Unspecified reason|0
2649622|NCT00726232|9152552|P4|Expansion Phase|Unspecified reason|0
2649623|NCT00726232|9152553|P3|Expansion Phase|Unspecified reason|0
2649624|NCT00726232|9152554|P2|Expansion Phase|Unspecified reason|0
2649625|NCT00726232|9152555|P1|Expansion Phase|Unspecified reason|0
2649626|NCT00726232|9152548|P8|Expansion Phase|Per Investigator: lack of response|7
2649627|NCT00726232|9152549|P7|Expansion Phase|Per Investigator: lack of response|1
2649628|NCT00726232|9152550|P6|Expansion Phase|Per Investigator: lack of response|0
2649629|NCT00726232|9152551|P5|Expansion Phase|Per Investigator: lack of response|0
2649630|NCT00726232|9152552|P4|Expansion Phase|Per Investigator: lack of response|0
2649631|NCT00726232|9152553|P3|Expansion Phase|Per Investigator: lack of response|0
2649632|NCT00726232|9152554|P2|Expansion Phase|Per Investigator: lack of response|0
2649633|NCT00726232|9152555|P1|Expansion Phase|Per Investigator: lack of response|0
2649634|NCT00726232|9152548|P8|Expansion Phase|Termination of the trial by sponsor|16
2649635|NCT00726232|9152549|P7|Expansion Phase|Termination of the trial by sponsor|10
2649636|NCT00726232|9152550|P6|Expansion Phase|Termination of the trial by sponsor|0
2649637|NCT00726232|9152551|P5|Expansion Phase|Termination of the trial by sponsor|0
2649638|NCT00726232|9152552|P4|Expansion Phase|Termination of the trial by sponsor|0
2649639|NCT00726232|9152553|P3|Expansion Phase|Termination of the trial by sponsor|0
2649640|NCT00726232|9152554|P2|Expansion Phase|Termination of the trial by sponsor|0
2649641|NCT00726232|9152555|P1|Expansion Phase|Termination of the trial by sponsor|0
2649642|NCT00726232|9152548|P8|Expansion Phase|Disease progression|0
2649643|NCT00726232|9152549|P7|Expansion Phase|Disease progression|4
2649644|NCT00726232|9152550|P6|Expansion Phase|Disease progression|0
2649645|NCT00726232|9152551|P5|Expansion Phase|Disease progression|0
2649646|NCT00726232|9152552|P4|Expansion Phase|Disease progression|0
2649647|NCT00726232|9152553|P3|Expansion Phase|Disease progression|0
2649648|NCT00726232|9152554|P2|Expansion Phase|Disease progression|0
2649649|NCT00726232|9152555|P1|Expansion Phase|Disease progression|0
2649650|NCT00726232|9152548|P8|Expansion Phase|Withdrawal by Subject|3
2649651|NCT00726232|9152549|P7|Expansion Phase|Withdrawal by Subject|2
2649652|NCT00726232|9152550|P6|Expansion Phase|Withdrawal by Subject|0
2649653|NCT00726232|9152551|P5|Expansion Phase|Withdrawal by Subject|0
2649654|NCT00726232|9152552|P4|Expansion Phase|Withdrawal by Subject|0
2649655|NCT00726232|9152553|P3|Expansion Phase|Withdrawal by Subject|0
2649656|NCT00726232|9152554|P2|Expansion Phase|Withdrawal by Subject|0
2649657|NCT00726232|9152555|P1|Expansion Phase|Withdrawal by Subject|0
2649658|NCT00726232|9152548|P8|Expansion Phase|Adverse Event|11
2649659|NCT00726232|9152549|P7|Expansion Phase|Adverse Event|6
2649660|NCT00726232|9152550|P6|Expansion Phase|Adverse Event|0
2649661|NCT00726232|9152551|P5|Expansion Phase|Adverse Event|0
2649662|NCT00726232|9152552|P4|Expansion Phase|Adverse Event|0
2649663|NCT00726232|9152553|P3|Expansion Phase|Adverse Event|0
2649664|NCT00726232|9152554|P2|Expansion Phase|Adverse Event|0
2649665|NCT00726232|9152555|P1|Expansion Phase|Adverse Event|0
2649666|NCT00726232|9152548|P8|Expansion Phase|Death|1
2649667|NCT00726232|9152549|P7|Expansion Phase|Death|0
2649668|NCT00726232|9152550|P6|Expansion Phase|Death|0
2649669|NCT00726232|9152551|P5|Expansion Phase|Death|0
2649670|NCT00726232|9152552|P4|Expansion Phase|Death|0
2649671|NCT00726232|9152553|P3|Expansion Phase|Death|0
2649672|NCT00726232|9152554|P2|Expansion Phase|Death|0
2649673|NCT00726232|9152555|P1|Expansion Phase|Death|0
2649674|NCT00726232|9152548|P8|Initial Phase (Dose-finding)|Unspecified reason|0
2649675|NCT00726232|9152549|P7|Initial Phase (Dose-finding)|Unspecified reason|0
2649676|NCT00726232|9152550|P6|Initial Phase (Dose-finding)|Unspecified reason|0
2649677|NCT00726232|9152551|P5|Initial Phase (Dose-finding)|Unspecified reason|0
2649678|NCT00726232|9152552|P4|Initial Phase (Dose-finding)|Unspecified reason|0
2649679|NCT00726232|9152553|P3|Initial Phase (Dose-finding)|Unspecified reason|0
2649680|NCT00726232|9152554|P2|Initial Phase (Dose-finding)|Unspecified reason|0
2649681|NCT00726232|9152555|P1|Initial Phase (Dose-finding)|Unspecified reason|1
2649855|NCT00725985|9152625|P9|ITP (Up to 96 Weeks)|Converted to CDMS|0
2649682|NCT00726232|9152548|P8|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
2649683|NCT00726232|9152549|P7|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
2649684|NCT00726232|9152550|P6|Initial Phase (Dose-finding)|Per Investigator: lack of response|1
2649685|NCT00726232|9152551|P5|Initial Phase (Dose-finding)|Per Investigator: lack of response|4
2649686|NCT00726232|9152552|P4|Initial Phase (Dose-finding)|Per Investigator: lack of response|2
2649687|NCT00726232|9152553|P3|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
2649688|NCT00726232|9152554|P2|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
2649689|NCT00726232|9152555|P1|Initial Phase (Dose-finding)|Per Investigator: lack of response|1
2649690|NCT00726232|9152548|P8|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0
2649691|NCT00726232|9152549|P7|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0
2649692|NCT00726232|9152550|P6|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
2649693|NCT00726232|9152551|P5|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9
2649694|NCT00726232|9152552|P4|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4
2649695|NCT00726232|9152553|P3|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
2649696|NCT00726232|9152554|P2|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
2649697|NCT00726232|9152555|P1|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4
2649698|NCT00726232|9152548|P8|Initial Phase (Dose-finding)|Disease progression|0
2649699|NCT00726232|9152549|P7|Initial Phase (Dose-finding)|Disease progression|0
2649700|NCT00726232|9152550|P6|Initial Phase (Dose-finding)|Disease progression|0
2649701|NCT00726232|9152551|P5|Initial Phase (Dose-finding)|Disease progression|0
2649702|NCT00726232|9152552|P4|Initial Phase (Dose-finding)|Disease progression|0
2649703|NCT00726232|9152553|P3|Initial Phase (Dose-finding)|Disease progression|0
2649704|NCT00726232|9152554|P2|Initial Phase (Dose-finding)|Disease progression|1
2649705|NCT00726232|9152555|P1|Initial Phase (Dose-finding)|Disease progression|3
2649706|NCT00726232|9152548|P8|Initial Phase (Dose-finding)|Withdrawal by Subject|0
2649707|NCT00726232|9152549|P7|Initial Phase (Dose-finding)|Withdrawal by Subject|0
2649708|NCT00726232|9152550|P6|Initial Phase (Dose-finding)|Withdrawal by Subject|2
2649709|NCT00726232|9152551|P5|Initial Phase (Dose-finding)|Withdrawal by Subject|0
2649710|NCT00726232|9152552|P4|Initial Phase (Dose-finding)|Withdrawal by Subject|1
2649711|NCT00726232|9152553|P3|Initial Phase (Dose-finding)|Withdrawal by Subject|0
2649712|NCT00726232|9152554|P2|Initial Phase (Dose-finding)|Withdrawal by Subject|0
2649713|NCT00726232|9152555|P1|Initial Phase (Dose-finding)|Withdrawal by Subject|2
2649714|NCT00726232|9152548|P8|Initial Phase (Dose-finding)|Adverse Event|0
2649715|NCT00726232|9152549|P7|Initial Phase (Dose-finding)|Adverse Event|0
2649716|NCT00726232|9152550|P6|Initial Phase (Dose-finding)|Adverse Event|3
2649717|NCT00726232|9152551|P5|Initial Phase (Dose-finding)|Adverse Event|7
2649718|NCT00726232|9152552|P4|Initial Phase (Dose-finding)|Adverse Event|1
2649719|NCT00726232|9152553|P3|Initial Phase (Dose-finding)|Adverse Event|2
2649720|NCT00726232|9152554|P2|Initial Phase (Dose-finding)|Adverse Event|2
2649721|NCT00726232|9152555|P1|Initial Phase (Dose-finding)|Adverse Event|2
2649722|NCT00726232|9152548|P8|Initial Phase (Dose-finding)|Death|0
2649723|NCT00726232|9152549|P7|Initial Phase (Dose-finding)|Death|0
2649724|NCT00726232|9152550|P6|Initial Phase (Dose-finding)|Death|0
2649725|NCT00726232|9152551|P5|Initial Phase (Dose-finding)|Death|1
2649726|NCT00726232|9152552|P4|Initial Phase (Dose-finding)|Death|0
2649727|NCT00726232|9152553|P3|Initial Phase (Dose-finding)|Death|0
2649728|NCT00726232|9152554|P2|Initial Phase (Dose-finding)|Death|0
2649729|NCT00726232|9152555|P1|Initial Phase (Dose-finding)|Death|0
2649730|NCT00726063|9152607|P2|Overall Study|Adverse Event|7
2649731|NCT00726063|9152608|P1|Overall Study|Adverse Event|9
2649732|NCT00725985|9152622|P12|LTFU (No Cladribine Treatment)|Other|14
2649733|NCT00725985|9152623|P11|LTFU (No Cladribine Treatment)|Other|36
2649734|NCT00725985|9152624|P10|LTFU (No Cladribine Treatment)|Other|34
2649735|NCT00725985|9152625|P9|LTFU (No Cladribine Treatment)|Other|0
2649736|NCT00725985|9152626|P8|LTFU (No Cladribine Treatment)|Other|0
2649737|NCT00725985|9152627|P7|LTFU (No Cladribine Treatment)|Other|0
2649738|NCT00725985|9152628|P6|LTFU (No Cladribine Treatment)|Other|0
2649739|NCT00725985|9152629|P5|LTFU (No Cladribine Treatment)|Other|0
2649740|NCT00725985|9152630|P4|LTFU (No Cladribine Treatment)|Other|0
2649741|NCT00725985|9152631|P3|LTFU (No Cladribine Treatment)|Other|0
2649742|NCT00725985|9152632|P2|LTFU (No Cladribine Treatment)|Other|0
2649743|NCT00725985|9152633|P1|LTFU (No Cladribine Treatment)|Other|0
2649744|NCT00725985|9152622|P12|LTFU (With Cladribine Treatment)|Other|0
2649745|NCT00725985|9152623|P11|LTFU (With Cladribine Treatment)|Other|0
2649746|NCT00725985|9152624|P10|LTFU (With Cladribine Treatment)|Other|0
2649747|NCT00725985|9152625|P9|LTFU (With Cladribine Treatment)|Other|16
2649748|NCT00725985|9152626|P8|LTFU (With Cladribine Treatment)|Other|8
2649749|NCT00725985|9152627|P7|LTFU (With Cladribine Treatment)|Other|9
2649750|NCT00725985|9152628|P6|LTFU (With Cladribine Treatment)|Other|0
2649751|NCT00725985|9152629|P5|LTFU (With Cladribine Treatment)|Other|0
2649752|NCT00725985|9152630|P4|LTFU (With Cladribine Treatment)|Other|0
2649753|NCT00725985|9152631|P3|LTFU (With Cladribine Treatment)|Other|0
2649754|NCT00725985|9152632|P2|LTFU (With Cladribine Treatment)|Other|0
2649755|NCT00725985|9152633|P1|LTFU (With Cladribine Treatment)|Other|0
2649756|NCT00725985|9152622|P12|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
2649757|NCT00725985|9152623|P11|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
2649758|NCT00725985|9152624|P10|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
2649856|NCT00725985|9152626|P8|ITP (Up to 96 Weeks)|Converted to CDMS|0
2649759|NCT00725985|9152625|P9|LTFU (With Cladribine Treatment)|Lost to Follow-up|1
2649760|NCT00725985|9152626|P8|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
2649761|NCT00725985|9152627|P7|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
2649762|NCT00725985|9152628|P6|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
2649763|NCT00725985|9152629|P5|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
2649764|NCT00725985|9152630|P4|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
2649765|NCT00725985|9152631|P3|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
2649766|NCT00725985|9152632|P2|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
2649767|NCT00725985|9152633|P1|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
2649768|NCT00725985|9152622|P12|LTFU (With Cladribine Treatment)|Adverse Event|0
2649769|NCT00725985|9152623|P11|LTFU (With Cladribine Treatment)|Adverse Event|0
2649770|NCT00725985|9152624|P10|LTFU (With Cladribine Treatment)|Adverse Event|0
2649771|NCT00725985|9152625|P9|LTFU (With Cladribine Treatment)|Adverse Event|0
2649772|NCT00725985|9152626|P8|LTFU (With Cladribine Treatment)|Adverse Event|1
2649773|NCT00725985|9152627|P7|LTFU (With Cladribine Treatment)|Adverse Event|0
2649774|NCT00725985|9152628|P6|LTFU (With Cladribine Treatment)|Adverse Event|0
2649775|NCT00725985|9152629|P5|LTFU (With Cladribine Treatment)|Adverse Event|0
2649776|NCT00725985|9152630|P4|LTFU (With Cladribine Treatment)|Adverse Event|0
2649777|NCT00725985|9152631|P3|LTFU (With Cladribine Treatment)|Adverse Event|0
2649778|NCT00725985|9152632|P2|LTFU (With Cladribine Treatment)|Adverse Event|0
2649779|NCT00725985|9152633|P1|LTFU (With Cladribine Treatment)|Adverse Event|0
2649780|NCT00725985|9152622|P12|OLMP|Other|0
2649781|NCT00725985|9152623|P11|OLMP|Other|0
2649782|NCT00725985|9152624|P10|OLMP|Other|0
2649783|NCT00725985|9152625|P9|OLMP|Other|0
2649784|NCT00725985|9152626|P8|OLMP|Other|0
2649785|NCT00725985|9152627|P7|OLMP|Other|0
2649786|NCT00725985|9152628|P6|OLMP|Other|44
2649787|NCT00725985|9152629|P5|OLMP|Other|20
2649788|NCT00725985|9152630|P4|OLMP|Other|15
2649789|NCT00725985|9152631|P3|OLMP|Other|0
2649790|NCT00725985|9152632|P2|OLMP|Other|0
2649791|NCT00725985|9152633|P1|OLMP|Other|0
2649792|NCT00725985|9152622|P12|OLMP|Disease progression|0
2649793|NCT00725985|9152623|P11|OLMP|Disease progression|0
2649794|NCT00725985|9152624|P10|OLMP|Disease progression|0
2649795|NCT00725985|9152625|P9|OLMP|Disease progression|0
2649796|NCT00725985|9152626|P8|OLMP|Disease progression|0
2649797|NCT00725985|9152627|P7|OLMP|Disease progression|0
2649798|NCT00725985|9152628|P6|OLMP|Disease progression|4
2649799|NCT00725985|9152629|P5|OLMP|Disease progression|0
2649800|NCT00725985|9152630|P4|OLMP|Disease progression|0
2649801|NCT00725985|9152631|P3|OLMP|Disease progression|0
2649802|NCT00725985|9152632|P2|OLMP|Disease progression|0
2649803|NCT00725985|9152633|P1|OLMP|Disease progression|0
2649804|NCT00725985|9152622|P12|OLMP|Lost to Follow-up|0
2649805|NCT00725985|9152623|P11|OLMP|Lost to Follow-up|0
2649806|NCT00725985|9152624|P10|OLMP|Lost to Follow-up|0
2649807|NCT00725985|9152625|P9|OLMP|Lost to Follow-up|0
2649808|NCT00725985|9152626|P8|OLMP|Lost to Follow-up|0
2649809|NCT00725985|9152627|P7|OLMP|Lost to Follow-up|0
2649810|NCT00725985|9152628|P6|OLMP|Lost to Follow-up|0
2649811|NCT00725985|9152629|P5|OLMP|Lost to Follow-up|0
2649812|NCT00725985|9152630|P4|OLMP|Lost to Follow-up|1
2649813|NCT00725985|9152631|P3|OLMP|Lost to Follow-up|0
2649814|NCT00725985|9152632|P2|OLMP|Lost to Follow-up|0
2649815|NCT00725985|9152633|P1|OLMP|Lost to Follow-up|0
2649816|NCT00725985|9152622|P12|OLMP|Death|0
2649817|NCT00725985|9152623|P11|OLMP|Death|0
2649818|NCT00725985|9152624|P10|OLMP|Death|0
2649819|NCT00725985|9152625|P9|OLMP|Death|0
2649820|NCT00725985|9152626|P8|OLMP|Death|0
2649821|NCT00725985|9152627|P7|OLMP|Death|0
2649822|NCT00725985|9152628|P6|OLMP|Death|0
2649823|NCT00725985|9152629|P5|OLMP|Death|1
2649824|NCT00725985|9152630|P4|OLMP|Death|0
2649825|NCT00725985|9152631|P3|OLMP|Death|0
2649826|NCT00725985|9152632|P2|OLMP|Death|0
2649827|NCT00725985|9152633|P1|OLMP|Death|0
2649828|NCT00725985|9152622|P12|OLMP|Adverse Event|0
2649829|NCT00725985|9152623|P11|OLMP|Adverse Event|0
2649830|NCT00725985|9152624|P10|OLMP|Adverse Event|0
2649831|NCT00725985|9152625|P9|OLMP|Adverse Event|0
2649832|NCT00725985|9152626|P8|OLMP|Adverse Event|0
2649833|NCT00725985|9152627|P7|OLMP|Adverse Event|0
2649834|NCT00725985|9152628|P6|OLMP|Adverse Event|5
2649835|NCT00725985|9152629|P5|OLMP|Adverse Event|2
2649836|NCT00725985|9152630|P4|OLMP|Adverse Event|2
2649837|NCT00725985|9152631|P3|OLMP|Adverse Event|0
2649838|NCT00725985|9152632|P2|OLMP|Adverse Event|0
2649839|NCT00725985|9152633|P1|OLMP|Adverse Event|0
2649840|NCT00725985|9152622|P12|ITP (Up to 96 Weeks)|Other|0
2649841|NCT00725985|9152623|P11|ITP (Up to 96 Weeks)|Other|0
2649842|NCT00725985|9152624|P10|ITP (Up to 96 Weeks)|Other|0
2649843|NCT00725985|9152625|P9|ITP (Up to 96 Weeks)|Other|0
2649844|NCT00725985|9152626|P8|ITP (Up to 96 Weeks)|Other|0
2649845|NCT00725985|9152627|P7|ITP (Up to 96 Weeks)|Other|0
2649846|NCT00725985|9152628|P6|ITP (Up to 96 Weeks)|Other|0
2649847|NCT00725985|9152629|P5|ITP (Up to 96 Weeks)|Other|0
2649848|NCT00725985|9152630|P4|ITP (Up to 96 Weeks)|Other|0
2649849|NCT00725985|9152631|P3|ITP (Up to 96 Weeks)|Other|24
2649850|NCT00725985|9152632|P2|ITP (Up to 96 Weeks)|Other|38
2649851|NCT00725985|9152633|P1|ITP (Up to 96 Weeks)|Other|50
2649852|NCT00725985|9152622|P12|ITP (Up to 96 Weeks)|Converted to CDMS|0
2649853|NCT00725985|9152623|P11|ITP (Up to 96 Weeks)|Converted to CDMS|0
2649854|NCT00725985|9152624|P10|ITP (Up to 96 Weeks)|Converted to CDMS|0
2649857|NCT00725985|9152627|P7|ITP (Up to 96 Weeks)|Converted to CDMS|0
2649858|NCT00725985|9152628|P6|ITP (Up to 96 Weeks)|Converted to CDMS|0
2649859|NCT00725985|9152629|P5|ITP (Up to 96 Weeks)|Converted to CDMS|0
2649860|NCT00725985|9152630|P4|ITP (Up to 96 Weeks)|Converted to CDMS|0
2649861|NCT00725985|9152631|P3|ITP (Up to 96 Weeks)|Converted to CDMS|71
2649862|NCT00725985|9152632|P2|ITP (Up to 96 Weeks)|Converted to CDMS|27
2649863|NCT00725985|9152633|P1|ITP (Up to 96 Weeks)|Converted to CDMS|30
2649864|NCT00725985|9152622|P12|ITP (Up to 96 Weeks)|Randomized but not treated|0
2649865|NCT00725985|9152623|P11|ITP (Up to 96 Weeks)|Randomized but not treated|0
2649866|NCT00725985|9152624|P10|ITP (Up to 96 Weeks)|Randomized but not treated|0
2649867|NCT00725985|9152625|P9|ITP (Up to 96 Weeks)|Randomized but not treated|0
2649868|NCT00725985|9152626|P8|ITP (Up to 96 Weeks)|Randomized but not treated|0
2649869|NCT00725985|9152627|P7|ITP (Up to 96 Weeks)|Randomized but not treated|0
2649870|NCT00725985|9152628|P6|ITP (Up to 96 Weeks)|Randomized but not treated|0
2649871|NCT00725985|9152629|P5|ITP (Up to 96 Weeks)|Randomized but not treated|0
2649872|NCT00725985|9152630|P4|ITP (Up to 96 Weeks)|Randomized but not treated|0
2649873|NCT00725985|9152631|P3|ITP (Up to 96 Weeks)|Randomized but not treated|0
2649874|NCT00725985|9152632|P2|ITP (Up to 96 Weeks)|Randomized but not treated|0
2649875|NCT00725985|9152633|P1|ITP (Up to 96 Weeks)|Randomized but not treated|1
2649876|NCT00725985|9152622|P12|ITP (Up to 96 Weeks)|Lost to Follow-up|0
2649877|NCT00725985|9152623|P11|ITP (Up to 96 Weeks)|Lost to Follow-up|0
2649878|NCT00725985|9152624|P10|ITP (Up to 96 Weeks)|Lost to Follow-up|0
2649879|NCT00725985|9152625|P9|ITP (Up to 96 Weeks)|Lost to Follow-up|0
2649880|NCT00725985|9152626|P8|ITP (Up to 96 Weeks)|Lost to Follow-up|0
2649881|NCT00725985|9152627|P7|ITP (Up to 96 Weeks)|Lost to Follow-up|0
2649882|NCT00725985|9152628|P6|ITP (Up to 96 Weeks)|Lost to Follow-up|0
2649883|NCT00725985|9152629|P5|ITP (Up to 96 Weeks)|Lost to Follow-up|0
2649884|NCT00725985|9152630|P4|ITP (Up to 96 Weeks)|Lost to Follow-up|0
2649885|NCT00725985|9152631|P3|ITP (Up to 96 Weeks)|Lost to Follow-up|2
2649886|NCT00725985|9152632|P2|ITP (Up to 96 Weeks)|Lost to Follow-up|0
2649887|NCT00725985|9152633|P1|ITP (Up to 96 Weeks)|Lost to Follow-up|0
2649888|NCT00725985|9152622|P12|ITP (Up to 96 Weeks)|Adverse Event|0
2649889|NCT00725985|9152623|P11|ITP (Up to 96 Weeks)|Adverse Event|0
2649890|NCT00725985|9152624|P10|ITP (Up to 96 Weeks)|Adverse Event|0
2649891|NCT00725985|9152625|P9|ITP (Up to 96 Weeks)|Adverse Event|0
2649892|NCT00725985|9152626|P8|ITP (Up to 96 Weeks)|Adverse Event|0
2649893|NCT00725985|9152627|P7|ITP (Up to 96 Weeks)|Adverse Event|0
2649894|NCT00725985|9152628|P6|ITP (Up to 96 Weeks)|Adverse Event|0
2649895|NCT00725985|9152629|P5|ITP (Up to 96 Weeks)|Adverse Event|0
2649896|NCT00725985|9152630|P4|ITP (Up to 96 Weeks)|Adverse Event|0
2649897|NCT00725985|9152631|P3|ITP (Up to 96 Weeks)|Adverse Event|5
2649898|NCT00725985|9152632|P2|ITP (Up to 96 Weeks)|Adverse Event|10
2649899|NCT00725985|9152633|P1|ITP (Up to 96 Weeks)|Adverse Event|20
2649900|NCT00725920|9152670|P2|Overall Study|Lack of Efficacy|6
2649901|NCT00725920|9152671|P1|Overall Study|Lack of Efficacy|3
2649902|NCT00725842|9152677|P1|Overall Study|No Visit 1 data|1
2649903|NCT00725842|9152677|P1|Overall Study|Inclusion criterion not met|1
2649904|NCT00725842|9152677|P1|Overall Study|Consent date prior to study start date|5
2649905|NCT00725842|9152677|P1|Overall Study|Positive HCV-RNA at Visit 2|13
2649906|NCT00725842|9152677|P1|Overall Study|Death|1
2649907|NCT00725842|9152677|P1|Overall Study|Lost to Follow-up|19
2649908|NCT00725764|9152684|P1|Overall Study|Decline in performance status|1
2649909|NCT00725764|9152684|P1|Overall Study|Participant non compliant with protocol|1
2649910|NCT00725764|9152684|P1|Overall Study|Death|1
2649911|NCT00725764|9152684|P1|Overall Study|Lost to Follow-up|1
2649912|NCT00725764|9152684|P1|Overall Study|Progressive Disease|7
2649913|NCT00725764|9152684|P1|Overall Study|Physician Decision|1
2649914|NCT00725764|9152684|P1|Overall Study|Withdrawal by Subject|2
2649915|NCT00725725|9152717|P3|Overall Study|Protocol Violation|0
2649916|NCT00725725|9152718|P2|Overall Study|Protocol Violation|1
2649917|NCT00725725|9152719|P1|Overall Study|Protocol Violation|0
2649918|NCT00725725|9152717|P3|Overall Study|Withdrawal by Subject|1
2649919|NCT00725725|9152718|P2|Overall Study|Withdrawal by Subject|0
2649920|NCT00725725|9152719|P1|Overall Study|Withdrawal by Subject|1
2649921|NCT00725725|9152717|P3|Overall Study|Lost to Follow-up|2
2649922|NCT00725725|9152718|P2|Overall Study|Lost to Follow-up|0
2649923|NCT00725725|9152719|P1|Overall Study|Lost to Follow-up|2
2649924|NCT00725725|9152717|P3|Overall Study|Adverse Event|2
2649925|NCT00725725|9152718|P2|Overall Study|Adverse Event|3
2649926|NCT00725725|9152719|P1|Overall Study|Adverse Event|1
2649927|NCT00725712|9152762|P2|Overall Study|Hospitalized, unable to continue|1
2649928|NCT00725712|9152763|P1|Overall Study|Hospitalized, unable to continue|0
2649929|NCT00725712|9152762|P2|Overall Study|Other: Death|0
2649930|NCT00725712|9152763|P1|Overall Study|Other: Death|1
2649931|NCT00725712|9152762|P2|Overall Study|Death|0
2649932|NCT00725712|9152763|P1|Overall Study|Death|2
2649933|NCT00725712|9152762|P2|Overall Study|Adverse Event|5
2649934|NCT00725712|9152763|P1|Overall Study|Adverse Event|5
2649935|NCT00725712|9152762|P2|Overall Study|Clinical progression not based on RECIST|3
2649936|NCT00725712|9152763|P1|Overall Study|Clinical progression not based on RECIST|0
2649937|NCT00725712|9152762|P2|Overall Study|Progressive disease|16
2649938|NCT00725712|9152763|P1|Overall Study|Progressive disease|37
2649939|NCT00725712|9152762|P2|Overall Study|Protocol Violation|0
2649940|NCT00725712|9152763|P1|Overall Study|Protocol Violation|1
2649941|NCT00725712|9152762|P2|Overall Study|Withdrawal by Subject|1
2649942|NCT00725712|9152763|P1|Overall Study|Withdrawal by Subject|2
2649943|NCT00725621|9152799|P1|Overall Study|Reason not specified|55
2649944|NCT00725621|9152799|P1|Overall Study|Prepared for elective surgery|1
2649945|NCT00725621|9152799|P1|Overall Study|Switched to other drug|1
2649946|NCT00725621|9152799|P1|Overall Study|Switched to other study|1
2649947|NCT00725621|9152799|P1|Overall Study|Continued treatment by other physician|6
2649948|NCT00725621|9152799|P1|Overall Study|Non-compliance|8
2649949|NCT00725621|9152799|P1|Overall Study|Lost to Follow-up|52
2649950|NCT00725621|9152799|P1|Overall Study|Physician Decision|19
2649951|NCT00725621|9152799|P1|Overall Study|Withdrawal by Subject|57
2649952|NCT00725621|9152799|P1|Overall Study|Lack of Efficacy|46
2649953|NCT00725621|9152799|P1|Overall Study|Adverse Event|25
2649954|NCT00725608|9152822|P1|Overall Study|Other|7
2649955|NCT00725608|9152822|P1|Overall Study|Individual reasons|86
2649956|NCT00725608|9152822|P1|Overall Study|Adverse Event|14
2649957|NCT00725608|9152822|P1|Overall Study|Lost to Follow-up|60
2649958|NCT00725543|9152828|P1|Overall Study|Other|119
2649959|NCT00725543|9152828|P1|Overall Study|Non-compliance|2
2649960|NCT00725543|9152828|P1|Overall Study|Lost to Follow-up|4
2649961|NCT00725543|9152828|P1|Overall Study|Physician Decision|5
2649962|NCT00725543|9152828|P1|Overall Study|Withdrawal by Subject|10
2649963|NCT00725543|9152828|P1|Overall Study|Lack of Efficacy|3
2649964|NCT00725543|9152828|P1|Overall Study|Adverse Event|10
2649965|NCT00725491|9152853|P2|Overall Study|No/too few embryos/ bad quality embryos|2
2649966|NCT00725491|9152854|P1|Overall Study|No/too few embryos/ bad quality embryos|3
2649967|NCT00725491|9152853|P2|Overall Study|Fertilization failure|1
2649968|NCT00725491|9152854|P1|Overall Study|Fertilization failure|0
2649969|NCT00725491|9152853|P2|Overall Study|No/too few oocytes/bad quality oocytes|1
2649970|NCT00725491|9152854|P1|Overall Study|No/too few oocytes/bad quality oocytes|1
2649971|NCT00725491|9152853|P2|Overall Study|Risk for hyperstimulation|9
2649972|NCT00725491|9152854|P1|Overall Study|Risk for hyperstimulation|2
2649973|NCT00725491|9152853|P2|Overall Study|Pregnancy|3
2649974|NCT00725491|9152854|P1|Overall Study|Pregnancy|0
2649975|NCT00725491|9152853|P2|Overall Study|Adverse Event|2
2649976|NCT00725491|9152854|P1|Overall Study|Adverse Event|3
2649977|NCT00725452|9152860|P1|Overall Study|Lost to Follow-up|1
2649978|NCT00725452|9152860|P1|Overall Study|Withdrawal by Subject|3
2649979|NCT00725452|9152860|P1|Overall Study|Physician Decision|1
2649980|NCT00725452|9152860|P1|Overall Study|Reason not specified|1
2649981|NCT00725452|9152860|P1|Overall Study|Lack of Efficacy|2
2649982|NCT00725452|9152860|P1|Overall Study|Adverse Event|3
2649983|NCT00725322|9152879|P2|Washout (28 Days)|Protocol Violation|1
2649984|NCT00725322|9152880|P1|Washout (28 Days)|Protocol Violation|0
2649985|NCT00725322|9152879|P2|Washout (28 Days)|Withdrawal by Subject|0
2649986|NCT00725322|9152880|P1|Washout (28 Days)|Withdrawal by Subject|2
2649987|NCT00725296|9152888|P1|Overall Study|Other|38
2649988|NCT00725296|9152888|P1|Overall Study|Lost to Follow-up|1
2649989|NCT00725296|9152888|P1|Overall Study|Non-Compliance|2
2649990|NCT00725296|9152888|P1|Overall Study|Withdrawal by Subject|3
2649991|NCT00725296|9152888|P1|Overall Study|Lack of Efficacy|7
2649992|NCT00725296|9152888|P1|Overall Study|Adverse Event|11
2649993|NCT00725283|9152897|P1|Overall Study|Withdrawal by Subject|10
2649994|NCT00725283|9152897|P1|Overall Study|Other|6
2649995|NCT00725283|9152897|P1|Overall Study|Death|5
2649996|NCT00725283|9152897|P1|Overall Study|Missing Code|3
2649997|NCT00725205|9152918|P1|Overall Study|Treatment Failure|41
2649998|NCT00725205|9152918|P1|Overall Study|Protocol Defined Clinical Event|1
2649999|NCT00725205|9152918|P1|Overall Study|Other|8
2650000|NCT00725205|9152918|P1|Overall Study|Non-compliance With Protocol|14
2650001|NCT00725205|9152918|P1|Overall Study|Investigator Discontinued|1
2650002|NCT00725205|9152918|P1|Overall Study|Adverse Event|22
2650003|NCT00725101|9152931|P1|Overall Study|not specified/no reason given|11
2650004|NCT00725101|9152931|P1|Overall Study|Withdrawal by Subject|127
2650005|NCT00725101|9152931|P1|Overall Study|Protocol Violation|1
2650006|NCT00725101|9152931|P1|Overall Study|Lost to Follow-up|353
2650007|NCT00725101|9152931|P1|Overall Study|Death|3
2650008|NCT00725075|9152954|P3|Overall Study|Other|0
2650009|NCT00725075|9152955|P2|Overall Study|Other|0
2650010|NCT00725075|9152956|P1|Overall Study|Other|1
2650011|NCT00725075|9152954|P3|Overall Study|Inclusion/Exclusion Criteria|1
2650012|NCT00725075|9152955|P2|Overall Study|Inclusion/Exclusion Criteria|0
2650013|NCT00725075|9152956|P1|Overall Study|Inclusion/Exclusion Criteria|1
2650014|NCT00725075|9152954|P3|Overall Study|Worsening of Disease|2
2650015|NCT00725075|9152955|P2|Overall Study|Worsening of Disease|1
2650016|NCT00725075|9152956|P1|Overall Study|Worsening of Disease|2
2650017|NCT00725075|9152954|P3|Overall Study|Adverse Event|1
2650018|NCT00725075|9152955|P2|Overall Study|Adverse Event|1
2650019|NCT00725075|9152956|P1|Overall Study|Adverse Event|2
2650020|NCT00725075|9152954|P3|Overall Study|Withdrawal by Subject|4
2650021|NCT00725075|9152955|P2|Overall Study|Withdrawal by Subject|5
2650022|NCT00725075|9152956|P1|Overall Study|Withdrawal by Subject|4
2650023|NCT00725075|9152954|P3|Overall Study|Lost to Follow-up|0
2650024|NCT00725075|9152955|P2|Overall Study|Lost to Follow-up|0
2650025|NCT00725075|9152956|P1|Overall Study|Lost to Follow-up|1
2650026|NCT00725075|9152954|P3|Overall Study|Protocol Violation|1
2650027|NCT00725075|9152955|P2|Overall Study|Protocol Violation|0
2650028|NCT00725075|9152956|P1|Overall Study|Protocol Violation|0
2650029|NCT00725075|9152954|P3|Overall Study|Use of Excluded Medication|0
2650030|NCT00725075|9152955|P2|Overall Study|Use of Excluded Medication|1
2650031|NCT00725075|9152956|P1|Overall Study|Use of Excluded Medication|0
2650032|NCT00725010|9153009|P1|Overall Study|Intensified treatment scheme: 3 on 1 off|2
2650033|NCT00725010|9153009|P1|Overall Study|No further documentation|1
2650034|NCT00725010|9153009|P1|Overall Study|Suspect lymph nodes neck thorax abdomen|1
2650035|NCT00725010|9153009|P1|Overall Study|Hepatopathy probably not Temodal-related|1
2650036|NCT00725010|9153009|P1|Overall Study|Lost to Follow-up|1
2650037|NCT00725010|9153009|P1|Overall Study|Death|1
2650038|NCT00725010|9153009|P1|Overall Study|Withdrawal by Subject|2
2650039|NCT00725010|9153009|P1|Overall Study|Tumor Progression|7
2650040|NCT00725010|9153009|P1|Overall Study|Toxicity|9
2650041|NCT00724971|9153042|P1|Overall Study|Withdrawal by Subject|1
2650042|NCT00724971|9153042|P1|Overall Study|Adverse Event|5
2650043|NCT00724958|9153057|P1|Overall Study|No documentation for end of therapy|13
2650044|NCT00724958|9153057|P1|Overall Study|Other Reason|76
2650045|NCT00724958|9153057|P1|Overall Study|Remission|7
2650046|NCT00724958|9153057|P1|Overall Study|No Response|18
2650047|NCT00724958|9153057|P1|Overall Study|Loss of Response|40
2650048|NCT00724958|9153057|P1|Overall Study|Adverse Event|28
2650049|NCT00724945|9153066|P2|Period 2|lens physiology issue|0
2650050|NCT00724945|9153067|P1|Period 2|lens physiology issue|1
2650051|NCT00724945|9153066|P2|Period 2|lens comfort issue|0
2650052|NCT00724945|9153067|P1|Period 2|lens comfort issue|3
2650053|NCT00724945|9153066|P2|Period 1|Lost to Follow-up|0
2650054|NCT00724945|9153067|P1|Period 1|Lost to Follow-up|1
2650055|NCT00724945|9153066|P2|Period 1|Adverse Event|1
2650056|NCT00724945|9153067|P1|Period 1|Adverse Event|1
2650057|NCT00724945|9153066|P2|Period 1|non-compliance|0
2650058|NCT00724945|9153067|P1|Period 1|non-compliance|1
2650059|NCT00724932|9153079|P2|Overall Study|Not treated|3
2650060|NCT00724932|9153080|P1|Overall Study|Not treated|4
2650061|NCT00724932|9153079|P2|Overall Study|Lost to Follow-up|0
2650062|NCT00724932|9153080|P1|Overall Study|Lost to Follow-up|1
2650063|NCT00724893|9153151|P2|Overall Study|Unknown, missing data|1
2650064|NCT00724893|9153152|P1|Overall Study|Unknown, missing data|1
2650065|NCT00724893|9153151|P2|Overall Study|Lost to Follow-up|52
2650066|NCT00724893|9153152|P1|Overall Study|Lost to Follow-up|0
2650067|NCT00724893|9153151|P2|Overall Study|Assigned shorter treatment|2
2650068|NCT00724893|9153152|P1|Overall Study|Assigned shorter treatment|0
2650069|NCT00724893|9153151|P2|Overall Study|Financial reasons|2
2650070|NCT00724893|9153152|P1|Overall Study|Financial reasons|0
2650071|NCT00724893|9153151|P2|Overall Study|Substance abuse|3
2650072|NCT00724893|9153152|P1|Overall Study|Substance abuse|0
2650073|NCT00724893|9153151|P2|Overall Study|Incarceration|9
2650074|NCT00724893|9153152|P1|Overall Study|Incarceration|0
2650075|NCT00724893|9153151|P2|Overall Study|Geographic reasons|11
2650076|NCT00724893|9153152|P1|Overall Study|Geographic reasons|0
2650077|NCT00724893|9153151|P2|Overall Study|Patient choice|26
2650078|NCT00724893|9153152|P1|Overall Study|Patient choice|0
2650079|NCT00724893|9153151|P2|Overall Study|Reason not specified|7
2650080|NCT00724893|9153152|P1|Overall Study|Reason not specified|193
2650081|NCT00724893|9153151|P2|Overall Study|Lack of virologic response|202
2650082|NCT00724893|9153152|P1|Overall Study|Lack of virologic response|94
2650083|NCT00724893|9153151|P2|Overall Study|Withdrawal by Subject|1
2650084|NCT00724893|9153152|P1|Overall Study|Withdrawal by Subject|0
2650085|NCT00724893|9153151|P2|Overall Study|Adverse Event|142
2650086|NCT00724893|9153152|P1|Overall Study|Adverse Event|76
2650087|NCT00724867|9153220|P1|Overall Study|Elected to exit due to site closure|2
2650088|NCT00724867|9153220|P1|Overall Study|Subject moved out of state|1
2650089|NCT00724867|9153220|P1|Overall Study|Developed withdrawal criteria- pregnancy|4
2650090|NCT00724867|9153220|P1|Overall Study|Subject incarcerated|1
2650091|NCT00724867|9153220|P1|Overall Study|Sponsor decision to end study|14
2650092|NCT00724867|9153220|P1|Overall Study|Withdrawal by Subject|31
2650093|NCT00724867|9153220|P1|Overall Study|Protocol Violation|1
2650094|NCT00724867|9153220|P1|Overall Study|Physician Decision|17
2650095|NCT00724867|9153220|P1|Overall Study|Non-compliance with study drug|6
2650096|NCT00724867|9153220|P1|Overall Study|Lost to Follow-up|12
2650097|NCT00724867|9153220|P1|Overall Study|Lack of Efficacy|14
2650098|NCT00724867|9153220|P1|Overall Study|Adverse Event|25
2650099|NCT00724854|9153260|P2|Overall Study|Adverse event + lack of efficacy|1
2650100|NCT00724854|9153261|P1|Overall Study|Adverse event + lack of efficacy|2
2650101|NCT00724854|9153260|P2|Overall Study|Withdrawal by Subject|0
2650102|NCT00724854|9153261|P1|Overall Study|Withdrawal by Subject|5
2650103|NCT00724854|9153260|P2|Overall Study|Change of treatment|0
2650104|NCT00724854|9153261|P1|Overall Study|Change of treatment|7
2650105|NCT00724854|9153260|P2|Overall Study|Death|0
2650106|NCT00724854|9153261|P1|Overall Study|Death|11
2650107|NCT00724854|9153260|P2|Overall Study|Other|3
2650108|NCT00724854|9153261|P1|Overall Study|Other|42
2650109|NCT00724854|9153260|P2|Overall Study|Adverse Event|4
2650110|NCT00724854|9153261|P1|Overall Study|Adverse Event|62
2650111|NCT00724854|9153260|P2|Overall Study|Lost to Follow-up|10
2650112|NCT00724854|9153261|P1|Overall Study|Lost to Follow-up|87
2650113|NCT00724854|9153260|P2|Overall Study|Lack of Efficacy|13
2650114|NCT00724854|9153261|P1|Overall Study|Lack of Efficacy|187
2650115|NCT00724815|9153278|P2|Overall Study|Other Various|5
2650116|NCT00724815|9153279|P1|Overall Study|Other Various|3
2650117|NCT00724815|9153278|P2|Overall Study|Lost to Follow-up|1
2650118|NCT00724815|9153279|P1|Overall Study|Lost to Follow-up|4
2650119|NCT00724815|9153278|P2|Overall Study|Adverse Event|3
2650120|NCT00724815|9153279|P1|Overall Study|Adverse Event|5
2650121|NCT00724815|9153278|P2|Overall Study|Randomized, not treated|30
2650122|NCT00724815|9153279|P1|Overall Study|Randomized, not treated|31
2650123|NCT00724711|9153312|P2|Overall Study|Protocol Violation|0
2650124|NCT00724711|9153313|P1|Overall Study|Protocol Violation|1
2650125|NCT00724711|9153312|P2|Overall Study|Lost to Follow-up|5
2650126|NCT00724711|9153313|P1|Overall Study|Lost to Follow-up|4
2650127|NCT00724711|9153312|P2|Overall Study|Withdrawal by Subject|4
2650128|NCT00724711|9153313|P1|Overall Study|Withdrawal by Subject|5
2650129|NCT00724711|9153312|P2|Overall Study|Physician Decision|3
2650130|NCT00724711|9153313|P1|Overall Study|Physician Decision|0
2650131|NCT00724711|9153312|P2|Overall Study|Lack of Efficacy|1
2650132|NCT00724711|9153313|P1|Overall Study|Lack of Efficacy|0
2650133|NCT00724711|9153312|P2|Overall Study|Pregnancy|1
2650134|NCT00724711|9153313|P1|Overall Study|Pregnancy|0
2650135|NCT00724711|9153312|P2|Overall Study|Adverse Event|3
2650136|NCT00724711|9153313|P1|Overall Study|Adverse Event|7
2650137|NCT00724698|9153345|P1|Overall Study|No Info|25
2650138|NCT00724698|9153345|P1|Overall Study|Lost to Follow-up|36
2650139|NCT00724698|9153345|P1|Overall Study|Poor Compliance|16
2650140|NCT00724698|9153345|P1|Overall Study|Failure of Therapy|4
2650141|NCT00724698|9153345|P1|Overall Study|Adverse Event|9
2650142|NCT00724503|9153398|P2|Overall Study|Not otherwise specified|7
2650143|NCT00724503|9153399|P1|Overall Study|Not otherwise specified|4
2650144|NCT00724503|9153398|P2|Overall Study|Adverse Event|0
2650145|NCT00724503|9153399|P1|Overall Study|Adverse Event|1
2650146|NCT00724503|9153398|P2|Overall Study|Death|182
2650147|NCT00724503|9153399|P1|Overall Study|Death|190
2650148|NCT00724503|9153398|P2|Overall Study|Withdrawal by Subject|23
2650149|NCT00724503|9153399|P1|Overall Study|Withdrawal by Subject|11
2650150|NCT00724503|9153398|P2|Overall Study|Lost to Follow-up|8
2650151|NCT00724503|9153399|P1|Overall Study|Lost to Follow-up|4
2650152|NCT00724451|9153423|P1|Overall Study|Investigator + Participant Decision|13
2650153|NCT00724451|9153423|P1|Overall Study|Withdrawal by Subject|45
2650154|NCT00724451|9153423|P1|Overall Study|Physician Decision|116
2650155|NCT00724451|9153423|P1|Overall Study|Unknown; No Data Sources Available|9
2650156|NCT00724451|9153423|P1|Overall Study|Never Started Treatment|89
2650157|NCT00724451|9153423|P1|Overall Study|Participant Refused Treatment|89
2650158|NCT00724451|9153423|P1|Overall Study|Not Eligible for Treatment|431
2650159|NCT00724451|9153423|P1|Overall Study|Excluded - Hepatitis C Virus Negative|3
2650160|NCT00724451|9153423|P1|Overall Study|Excluded - Prior Use of Peginterferon|7
2650161|NCT00724373|9153429|P1|Overall Study|Tolerability|23
2650162|NCT00724373|9153429|P1|Overall Study|Drug Relapse|1
2650163|NCT00724373|9153429|P1|Overall Study|Acute HCV infection|1
2650164|NCT00724373|9153429|P1|Overall Study|Viral Relapse|1
2650165|NCT00724373|9153429|P1|Overall Study|Only to have 24 week regimen|1
2650166|NCT00724373|9153429|P1|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2
2650167|NCT00724373|9153429|P1|Overall Study|Participant moved away|1
2650168|NCT00724373|9153429|P1|Overall Study|HCV RNA negative after 4 weeks|9
2650169|NCT00724373|9153429|P1|Overall Study|Non-compliance|2
2650170|NCT00724373|9153429|P1|Overall Study|Lost to Follow-up|7
2650171|NCT00724373|9153429|P1|Overall Study|Lack of Efficacy|82
2650172|NCT00724373|9153429|P1|Overall Study|Adverse Event|41
2650173|NCT00724282|9153446|P1|Overall Study|Physician Decision|1
2650174|NCT00724282|9153446|P1|Overall Study|Withdrawal by Subject|3
2650175|NCT00724243|9153450|P1|Overall Study|Adverse Event|5
2650176|NCT00724243|9153450|P1|Overall Study|Lack of Efficacy|10
2650177|NCT00724152|9153460|P3|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
2650178|NCT00724152|9153461|P2|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2
2650179|NCT00724152|9153462|P1|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
2650180|NCT00724152|9153460|P3|Two-arm Study Period|Withdrawal by Subject|0
2650181|NCT00724152|9153461|P2|Two-arm Study Period|Withdrawal by Subject|2
2650182|NCT00724152|9153462|P1|Two-arm Study Period|Withdrawal by Subject|3
2650183|NCT00724126|9153479|P2|Overall Study|Subject had to leave vicinity of site|1
2650184|NCT00724126|9153480|P1|Overall Study|Subject had to leave vicinity of site|0
2650185|NCT00724126|9153479|P2|Overall Study|Subject randomized although ineligible|1
2650186|NCT00724126|9153480|P1|Overall Study|Subject randomized although ineligible|1
2650187|NCT00724126|9153479|P2|Overall Study|Noncompliance|1
2650188|NCT00724126|9153480|P1|Overall Study|Noncompliance|2
2650189|NCT00724126|9153479|P2|Overall Study|Lost to Follow-up|6
2650190|NCT00724126|9153480|P1|Overall Study|Lost to Follow-up|6
2650191|NCT00724126|9153479|P2|Overall Study|Withdrawal by Subject|6
2650192|NCT00724126|9153480|P1|Overall Study|Withdrawal by Subject|8
2650193|NCT00724126|9153479|P2|Overall Study|Adverse Event|0
2650194|NCT00724126|9153480|P1|Overall Study|Adverse Event|2
2650195|NCT00724061|9153488|P1|Dose Escalation Phase|Disease Progression|3
2650196|NCT00724061|9153488|P1|Dose Escalation Phase|Adverse Event|2
2650197|NCT00723957|9153508|P2|Overall Study|Never received treatment|3
2650198|NCT00723957|9153509|P1|Overall Study|Never received treatment|3
2650199|NCT00723957|9153508|P2|Overall Study|Reason not analyzed|0
2650200|NCT00723957|9153509|P1|Overall Study|Reason not analyzed|1
2650201|NCT00723957|9153508|P2|Overall Study|Withdrawal by Subject|5
2650202|NCT00723957|9153509|P1|Overall Study|Withdrawal by Subject|7
2650203|NCT00723957|9153508|P2|Overall Study|Study drug toxicity|6
2650204|NCT00723957|9153509|P1|Overall Study|Study drug toxicity|4
2650205|NCT00723957|9153508|P2|Overall Study|Investigator decision|1
2650206|NCT00723957|9153509|P1|Overall Study|Investigator decision|1
2650207|NCT00723957|9153508|P2|Overall Study|Maximum clinical benefit|5
2650208|NCT00723957|9153509|P1|Overall Study|Maximum clinical benefit|4
2650209|NCT00723957|9153508|P2|Overall Study|Disease progression|25
2650210|NCT00723957|9153509|P1|Overall Study|Disease progression|27
2650211|NCT00723957|9153508|P2|Overall Study|Death|4
2650212|NCT00723957|9153509|P1|Overall Study|Death|3
2650213|NCT00723957|9153508|P2|Overall Study|Adverse event unrelated to study drug|4
2650214|NCT00723957|9153509|P1|Overall Study|Adverse event unrelated to study drug|1
2650215|NCT00723944|9153533|P2|One Year Post Placement Follow-up|Lost to Follow-up|4
2650216|NCT00723944|9153534|P1|One Year Post Placement Follow-up|Lost to Follow-up|1
2650217|NCT00723944|9153533|P2|Permanent Prosthesis Placement|Lost to Follow-up|2
2650218|NCT00723944|9153534|P1|Permanent Prosthesis Placement|Lost to Follow-up|2
2650219|NCT00723944|9153533|P2|Permanent Prosthesis Placement|Adverse Event|7
2650220|NCT00723944|9153534|P1|Permanent Prosthesis Placement|Adverse Event|1
2650221|NCT00723892|9153547|P2|Overall Study|Drug addiction|0
2650222|NCT00723892|9153548|P1|Overall Study|Drug addiction|1
2650223|NCT00723892|9153547|P2|Overall Study|Intercurrent infection|0
2650224|NCT00723892|9153548|P1|Overall Study|Intercurrent infection|2
2650225|NCT00723892|9153547|P2|Overall Study|Alcohol abuse|1
2650226|NCT00723892|9153548|P1|Overall Study|Alcohol abuse|0
2650227|NCT00723892|9153547|P2|Overall Study|Weight loss|3
2650228|NCT00723892|9153548|P1|Overall Study|Weight loss|1
2650229|NCT00723892|9153547|P2|Overall Study|Study end|3
2650230|NCT00723892|9153548|P1|Overall Study|Study end|1
2650231|NCT00723892|9153547|P2|Overall Study|Other|3
2650232|NCT00723892|9153548|P1|Overall Study|Other|6
2650233|NCT00723892|9153547|P2|Overall Study|Multiple reasons|12
2650234|NCT00723892|9153548|P1|Overall Study|Multiple reasons|17
2650235|NCT00723892|9153547|P2|Overall Study|Bad tolerance|5
2650236|NCT00723892|9153548|P1|Overall Study|Bad tolerance|5
2650237|NCT00723892|9153547|P2|Overall Study|End planned|7
2650238|NCT00723892|9153548|P1|Overall Study|End planned|11
2650239|NCT00723892|9153547|P2|Overall Study|Withdrawal by Subject|9
2650240|NCT00723892|9153548|P1|Overall Study|Withdrawal by Subject|6
2650241|NCT00723892|9153547|P2|Overall Study|Virological criterion|9
2650242|NCT00723892|9153548|P1|Overall Study|Virological criterion|24
2650243|NCT00723892|9153547|P2|Overall Study|Participant not tracked|35
2650244|NCT00723892|9153548|P1|Overall Study|Participant not tracked|33
2650245|NCT00723840|9153555|P1|Overall Study|Unspecified reason|2
2650246|NCT00723840|9153555|P1|Overall Study|Other Medical Event|2
2650247|NCT00723840|9153555|P1|Overall Study|Serious Adverse Events|3
2650248|NCT00723840|9153555|P1|Overall Study|Withdrawal by Subject|55
2650249|NCT00723840|9153555|P1|Overall Study|Failure to return|18
2650250|NCT00723840|9153555|P1|Overall Study|Lost to Follow-up|2
2650251|NCT00723801|9153576|P2|Overall Study|Protocol Violation|1
2650252|NCT00723801|9153577|P1|Overall Study|Protocol Violation|2
2650253|NCT00723801|9153576|P2|Overall Study|Lost to Follow-up|2
2650254|NCT00723801|9153577|P1|Overall Study|Lost to Follow-up|1
2650255|NCT00723710|9153602|P1|Overall Study|Physician Decision|2
2650256|NCT00723710|9153602|P1|Overall Study|Withdrawal by Subject|36
2650257|NCT00723710|9153602|P1|Overall Study|Adverse Event|88
2650258|NCT00723710|9153602|P1|Overall Study|Disease progression|48
2650259|NCT00723697|9153606|P1|Overall Study|Other exclusion criteria applied|6
2650260|NCT00723697|9153606|P1|Overall Study|Missing Informed Consent Form|10
2650261|NCT00723697|9153606|P1|Overall Study|Physician questionnaires not received|2
2650262|NCT00723606|9153627|P2|Overall Study|Withdrawal by Subject|2
2650263|NCT00723606|9153628|P1|Overall Study|Withdrawal by Subject|0
2650264|NCT00723606|9153627|P2|Overall Study|Other|0
2650265|NCT00723606|9153628|P1|Overall Study|Other|2
2650266|NCT00723606|9153627|P2|Overall Study|Adverse Event|5
2650267|NCT00723606|9153628|P1|Overall Study|Adverse Event|2
2650268|NCT00723554|9153648|P1|Overall Study|Non-compliance|1
2650269|NCT00723554|9153648|P1|Overall Study|Lost to Follow-up|1
2650270|NCT00723554|9153648|P1|Overall Study|Other|3
2650271|NCT00723554|9153648|P1|Overall Study|Withdrawal of consent|3
2650272|NCT00723554|9153648|P1|Overall Study|Inhaled medication other than iloprost|4
2650273|NCT00723554|9153648|P1|Overall Study|Investigator's judgement|5
2650274|NCT00723554|9153648|P1|Overall Study|Adverse Event|12
2650275|NCT00723528|9153698|P7|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1
2650276|NCT00723528|9153699|P6|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
2650277|NCT00723528|9153700|P5|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
2650278|NCT00723528|9153701|P4|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
2650279|NCT00723528|9153702|P3|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
2650280|NCT00723528|9153703|P2|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
2650281|NCT00723528|9153704|P1|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
2650282|NCT00723528|9153698|P7|Period 2: After Controlled Period|Use of prohibited concomitant medication|1
2650283|NCT00723528|9153699|P6|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
2650284|NCT00723528|9153700|P5|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
2650285|NCT00723528|9153701|P4|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
2650286|NCT00723528|9153702|P3|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
2650287|NCT00723528|9153703|P2|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
2650288|NCT00723528|9153704|P1|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
2650289|NCT00723528|9153698|P7|Period 2: After Controlled Period|Adverse Event|1
2650290|NCT00723528|9153699|P6|Period 2: After Controlled Period|Adverse Event|0
2650291|NCT00723528|9153700|P5|Period 2: After Controlled Period|Adverse Event|1
2650292|NCT00723528|9153701|P4|Period 2: After Controlled Period|Adverse Event|0
2650293|NCT00723528|9153702|P3|Period 2: After Controlled Period|Adverse Event|0
2650294|NCT00723528|9153703|P2|Period 2: After Controlled Period|Adverse Event|0
2650295|NCT00723528|9153704|P1|Period 2: After Controlled Period|Adverse Event|0
2650296|NCT00723528|9153698|P7|Period 2: After Controlled Period|Other|0
2650297|NCT00723528|9153699|P6|Period 2: After Controlled Period|Other|4
2650298|NCT00723528|9153700|P5|Period 2: After Controlled Period|Other|1
2650299|NCT00723528|9153701|P4|Period 2: After Controlled Period|Other|0
2650300|NCT00723528|9153702|P3|Period 2: After Controlled Period|Other|0
2650301|NCT00723528|9153703|P2|Period 2: After Controlled Period|Other|0
2650302|NCT00723528|9153704|P1|Period 2: After Controlled Period|Other|0
2650303|NCT00723528|9153698|P7|Period 2: After Controlled Period|Onset of tuberculosis infection|0
2650304|NCT00723528|9153699|P6|Period 2: After Controlled Period|Onset of tuberculosis infection|1
2650305|NCT00723528|9153700|P5|Period 2: After Controlled Period|Onset of tuberculosis infection|0
2650306|NCT00723528|9153701|P4|Period 2: After Controlled Period|Onset of tuberculosis infection|0
2650307|NCT00723528|9153702|P3|Period 2: After Controlled Period|Onset of tuberculosis infection|0
2650308|NCT00723528|9153703|P2|Period 2: After Controlled Period|Onset of tuberculosis infection|0
2650309|NCT00723528|9153704|P1|Period 2: After Controlled Period|Onset of tuberculosis infection|0
2650310|NCT00723528|9153698|P7|Period 2: After Controlled Period|Withdrawal by Subject|1
2650311|NCT00723528|9153699|P6|Period 2: After Controlled Period|Withdrawal by Subject|1
2650312|NCT00723528|9153700|P5|Period 2: After Controlled Period|Withdrawal by Subject|0
2650313|NCT00723528|9153701|P4|Period 2: After Controlled Period|Withdrawal by Subject|1
2650314|NCT00723528|9153702|P3|Period 2: After Controlled Period|Withdrawal by Subject|0
2650315|NCT00723528|9153703|P2|Period 2: After Controlled Period|Withdrawal by Subject|0
2650316|NCT00723528|9153704|P1|Period 2: After Controlled Period|Withdrawal by Subject|0
2650317|NCT00723528|9153698|P7|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
2650318|NCT00723528|9153699|P6|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
2650319|NCT00723528|9153700|P5|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
2650320|NCT00723528|9153701|P4|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
2650321|NCT00723528|9153702|P3|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1
2650322|NCT00723528|9153703|P2|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
2650323|NCT00723528|9153704|P1|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2
2650324|NCT00723528|9153698|P7|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
2650325|NCT00723528|9153699|P6|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
2650326|NCT00723528|9153700|P5|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
2650327|NCT00723528|9153701|P4|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
2650328|NCT00723528|9153702|P3|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1
2650329|NCT00723528|9153703|P2|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
2650330|NCT00723528|9153704|P1|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
2650331|NCT00723528|9153698|P7|Period 1: Controlled Period (CP)|Physician Decision|0
2650332|NCT00723528|9153699|P6|Period 1: Controlled Period (CP)|Physician Decision|0
2650333|NCT00723528|9153700|P5|Period 1: Controlled Period (CP)|Physician Decision|0
2650334|NCT00723528|9153701|P4|Period 1: Controlled Period (CP)|Physician Decision|0
2650335|NCT00723528|9153702|P3|Period 1: Controlled Period (CP)|Physician Decision|1
2650336|NCT00723528|9153703|P2|Period 1: Controlled Period (CP)|Physician Decision|0
2650337|NCT00723528|9153704|P1|Period 1: Controlled Period (CP)|Physician Decision|0
2650338|NCT00723528|9153698|P7|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
2650339|NCT00723528|9153699|P6|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
2650340|NCT00723528|9153700|P5|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
2650341|NCT00723528|9153701|P4|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
2650342|NCT00723528|9153702|P3|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
2650343|NCT00723528|9153703|P2|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
2650344|NCT00723528|9153704|P1|Period 1: Controlled Period (CP)|Withdrawal by Subject|2
2650345|NCT00723528|9153698|P7|Period 1: Controlled Period (CP)|Adverse Event|0
2650346|NCT00723528|9153699|P6|Period 1: Controlled Period (CP)|Adverse Event|0
2650347|NCT00723528|9153700|P5|Period 1: Controlled Period (CP)|Adverse Event|0
2650348|NCT00723528|9153701|P4|Period 1: Controlled Period (CP)|Adverse Event|0
2650349|NCT00723528|9153702|P3|Period 1: Controlled Period (CP)|Adverse Event|1
2650350|NCT00723528|9153703|P2|Period 1: Controlled Period (CP)|Adverse Event|0
2650351|NCT00723528|9153704|P1|Period 1: Controlled Period (CP)|Adverse Event|0
2650352|NCT00723489|9153766|P4|Overall Study|Samples Collected Out of Window|0
2650353|NCT00723489|9153767|P3|Overall Study|Samples Collected Out of Window|0
2650354|NCT00723489|9153768|P2|Overall Study|Samples Collected Out of Window|3
2650355|NCT00723489|9153769|P1|Overall Study|Samples Collected Out of Window|0
2650356|NCT00723489|9153766|P4|Overall Study|Prohibited Medication|1
2650357|NCT00723489|9153767|P3|Overall Study|Prohibited Medication|0
2650358|NCT00723489|9153768|P2|Overall Study|Prohibited Medication|0
2650359|NCT00723489|9153769|P1|Overall Study|Prohibited Medication|0
2650360|NCT00723489|9153766|P4|Overall Study|Seropositive at baseline|0
2650361|NCT00723489|9153767|P3|Overall Study|Seropositive at baseline|0
2650362|NCT00723489|9153768|P2|Overall Study|Seropositive at baseline|0
2650363|NCT00723489|9153769|P1|Overall Study|Seropositive at baseline|1
2650364|NCT00723489|9153766|P4|Overall Study|Withdrawal by Subject|1
2650365|NCT00723489|9153767|P3|Overall Study|Withdrawal by Subject|0
2650366|NCT00723489|9153768|P2|Overall Study|Withdrawal by Subject|0
2650367|NCT00723489|9153769|P1|Overall Study|Withdrawal by Subject|0
2650368|NCT00723489|9153766|P4|Overall Study|Pregnancy|1
2650369|NCT00723489|9153767|P3|Overall Study|Pregnancy|0
2650370|NCT00723489|9153768|P2|Overall Study|Pregnancy|0
2650371|NCT00723489|9153769|P1|Overall Study|Pregnancy|0
2650372|NCT00723489|9153766|P4|Overall Study|Physician Decision|0
2650373|NCT00723489|9153767|P3|Overall Study|Physician Decision|0
2650374|NCT00723489|9153768|P2|Overall Study|Physician Decision|1
2650375|NCT00723489|9153769|P1|Overall Study|Physician Decision|0
2650376|NCT00723450|9153797|P3|Randomized Phase|Withdrawal by Subject|22
2650377|NCT00723450|9153798|P2|Randomized Phase|Withdrawal by Subject|14
2650378|NCT00723450|9153799|P1|Randomized Phase|Withdrawal by Subject|0
2650379|NCT00723450|9153797|P3|Randomized Phase|Physician Decision|1
2650380|NCT00723450|9153798|P2|Randomized Phase|Physician Decision|3
2650381|NCT00723450|9153799|P1|Randomized Phase|Physician Decision|0
2650382|NCT00723450|9153797|P3|Randomized Phase|Lost to Follow-up|3
2650383|NCT00723450|9153798|P2|Randomized Phase|Lost to Follow-up|2
2650384|NCT00723450|9153799|P1|Randomized Phase|Lost to Follow-up|0
2650385|NCT00723450|9153797|P3|Randomized Phase|Protocol Violation|13
2650386|NCT00723450|9153798|P2|Randomized Phase|Protocol Violation|9
2650387|NCT00723450|9153799|P1|Randomized Phase|Protocol Violation|0
2650388|NCT00723450|9153797|P3|Randomized Phase|Lack of Efficacy|11
2650389|NCT00723450|9153798|P2|Randomized Phase|Lack of Efficacy|11
2650390|NCT00723450|9153799|P1|Randomized Phase|Lack of Efficacy|0
2650391|NCT00723450|9153797|P3|Randomized Phase|Adverse Event|17
2650392|NCT00723450|9153798|P2|Randomized Phase|Adverse Event|26
2650393|NCT00723450|9153799|P1|Randomized Phase|Adverse Event|0
2650394|NCT00723450|9153797|P3|Open-Label Phase|Withdrawal by Subject|0
2650395|NCT00723450|9153798|P2|Open-Label Phase|Withdrawal by Subject|0
2650396|NCT00723450|9153799|P1|Open-Label Phase|Withdrawal by Subject|37
2650397|NCT00723450|9153797|P3|Open-Label Phase|Physician Decision|0
2650398|NCT00723450|9153798|P2|Open-Label Phase|Physician Decision|0
2650399|NCT00723450|9153799|P1|Open-Label Phase|Physician Decision|2
2650400|NCT00723450|9153797|P3|Open-Label Phase|Lost to Follow-up|0
2650401|NCT00723450|9153798|P2|Open-Label Phase|Lost to Follow-up|0
2650402|NCT00723450|9153799|P1|Open-Label Phase|Lost to Follow-up|7
2650403|NCT00723450|9153797|P3|Open-Label Phase|Protocol Violation|0
2650404|NCT00723450|9153798|P2|Open-Label Phase|Protocol Violation|0
2650405|NCT00723450|9153799|P1|Open-Label Phase|Protocol Violation|35
2650406|NCT00723450|9153797|P3|Open-Label Phase|Lack of Efficacy|0
2650407|NCT00723450|9153798|P2|Open-Label Phase|Lack of Efficacy|0
2650408|NCT00723450|9153799|P1|Open-Label Phase|Lack of Efficacy|18
2650409|NCT00723450|9153797|P3|Open-Label Phase|Adverse Event|0
2650410|NCT00723450|9153798|P2|Open-Label Phase|Adverse Event|0
2650411|NCT00723450|9153799|P1|Open-Label Phase|Adverse Event|26
2650412|NCT00723398|9153845|P5|Overall Study|Lost to Follow-up|0
2650413|NCT00723398|9153846|P4|Overall Study|Lost to Follow-up|0
2650414|NCT00723398|9153847|P3|Overall Study|Lost to Follow-up|0
2650415|NCT00723398|9153848|P2|Overall Study|Lost to Follow-up|1
2650416|NCT00723398|9153849|P1|Overall Study|Lost to Follow-up|0
2650417|NCT00723398|9153845|P5|Overall Study|Adverse Event|4
2650418|NCT00723398|9153846|P4|Overall Study|Adverse Event|1
2650419|NCT00723398|9153847|P3|Overall Study|Adverse Event|3
2650420|NCT00723398|9153848|P2|Overall Study|Adverse Event|5
2650421|NCT00723398|9153849|P1|Overall Study|Adverse Event|0
2650422|NCT00723398|9153845|P5|Overall Study|Physician Decision|1
2650423|NCT00723398|9153846|P4|Overall Study|Physician Decision|0
2650424|NCT00723398|9153847|P3|Overall Study|Physician Decision|5
2650425|NCT00723398|9153848|P2|Overall Study|Physician Decision|2
2650426|NCT00723398|9153849|P1|Overall Study|Physician Decision|2
2650427|NCT00723398|9153845|P5|Overall Study|Protocol Violation|0
2650428|NCT00723398|9153846|P4|Overall Study|Protocol Violation|0
2650429|NCT00723398|9153847|P3|Overall Study|Protocol Violation|5
2650430|NCT00723398|9153848|P2|Overall Study|Protocol Violation|1
2650431|NCT00723398|9153849|P1|Overall Study|Protocol Violation|2
2650432|NCT00723398|9153845|P5|Overall Study|Withdrawal by Subject|4
2650433|NCT00723398|9153846|P4|Overall Study|Withdrawal by Subject|4
2650434|NCT00723398|9153847|P3|Overall Study|Withdrawal by Subject|4
2650435|NCT00723398|9153848|P2|Overall Study|Withdrawal by Subject|6
2650436|NCT00723398|9153849|P1|Overall Study|Withdrawal by Subject|2
2650437|NCT00723294|9153911|P1|Overall Study|No treatment due to probe failure|1
2650438|NCT00723294|9153911|P1|Overall Study|Withdrawal by Subject|1
2650439|NCT00723294|9153911|P1|Overall Study|Benign lesion|1
2650440|NCT00723294|9153911|P1|Overall Study|Treated by non-credentialed surgeon|1
2650441|NCT00723294|9153911|P1|Overall Study|Treated prior to registration|1
2650442|NCT00723294|9153911|P1|Overall Study|Did not undergo surgery|1
2650443|NCT00723294|9153911|P1|Overall Study|No cryoabalation|2
2650444|NCT00723294|9153911|P1|Overall Study|1.0-Tesla MRI|1
2650445|NCT00723294|9153911|P1|Overall Study|No MRI tumor enhancement|1
2650446|NCT00723294|9153911|P1|Overall Study|>25% intraductal component|1
2650447|NCT00723294|9153911|P1|Overall Study|Lobular histology|2
2650448|NCT00723255|9153916|P1|Overall Study|Ineligible: Wrong Primary|2
2650449|NCT00723255|9153916|P1|Overall Study|Ineligible: Second primary|1
2650450|NCT00723255|9153916|P1|Overall Study|Ineligible: Inadequate pathology|1
2650451|NCT00723229|9153943|P2|First Intervention|Lost to Follow-up|3
2650452|NCT00723229|9153944|P1|First Intervention|Lost to Follow-up|7
2650453|NCT00723203|9153956|P1|Overall Study|Withdrawal by Subject|3
2650454|NCT00723190|9153960|P1|Overall Study|Other-Not included in safety population|2
2650455|NCT00723190|9153960|P1|Overall Study|Other-Premature Discontinuation|9
2650456|NCT00723190|9153960|P1|Overall Study|Protocol Violation|15
2650457|NCT00723190|9153960|P1|Overall Study|Lack of Efficacy|16
2650458|NCT00723190|9153960|P1|Overall Study|Adverse Event|18
2650459|NCT00723190|9153960|P1|Overall Study|Lost to Follow-up|37
2650460|NCT00723190|9153960|P1|Overall Study|Withdrawal by Subject|45
2650461|NCT00723125|9153993|P2|Overall Study|Adverse Event|0
2650462|NCT00723125|9153994|P1|Overall Study|Adverse Event|2
2650463|NCT00723125|9153993|P2|Overall Study|Withdrawal by Subject|6
2650464|NCT00723125|9153994|P1|Overall Study|Withdrawal by Subject|15
2650465|NCT00723125|9153993|P2|Overall Study|Met Dx|0
2650466|NCT00723125|9153994|P1|Overall Study|Met Dx|1
2650467|NCT00723021|9154043|P5|Intervention Period 4|Adverse Event|1
2650468|NCT00723021|9154044|P4|Intervention Period 4|Adverse Event|0
2650469|NCT00723021|9154045|P3|Intervention Period 4|Adverse Event|0
2650470|NCT00723021|9154046|P2|Intervention Period 4|Adverse Event|0
2650471|NCT00723021|9154047|P1|Intervention Period 4|Adverse Event|0
2650472|NCT00723008|9154101|P2|4-Week Unblinded Treatment|Lost to Follow-up|1
2650473|NCT00723008|9154102|P1|4-Week Unblinded Treatment|Lost to Follow-up|0
2650474|NCT00723008|9154101|P2|4-Week Unblinded Treatment|Adverse Event|0
2650475|NCT00723008|9154102|P1|4-Week Unblinded Treatment|Adverse Event|1
2650476|NCT00723008|9154101|P2|4-Week Double Blinded|Lost to Follow-up|3
2650477|NCT00723008|9154102|P1|4-Week Double Blinded|Lost to Follow-up|4
2650478|NCT00723008|9154101|P2|4-Week Double Blinded|Withdrawal by Subject|1
2650479|NCT00723008|9154102|P1|4-Week Double Blinded|Withdrawal by Subject|1
2650480|NCT00723008|9154101|P2|4-Week Double Blinded|Lack of Efficacy|1
2650481|NCT00723008|9154102|P1|4-Week Double Blinded|Lack of Efficacy|0
2650482|NCT00723008|9154101|P2|Enrollment|Lost to Follow-up|0
2650483|NCT00723008|9154102|P1|Enrollment|Lost to Follow-up|1
2650484|NCT00722800|9154134|P2|Overall Study|Physician Decision|0
2650485|NCT00722800|9154135|P1|Overall Study|Physician Decision|1
2650486|NCT00722800|9154134|P2|Overall Study|Withdrawal by Subject|0
2650487|NCT00722800|9154135|P1|Overall Study|Withdrawal by Subject|1
2650488|NCT00722761|9154147|P2|Overall Study|Withdrawal by Subject|2
2650489|NCT00722761|9154148|P1|Overall Study|Withdrawal by Subject|5
2650490|NCT00722761|9154147|P2|Overall Study|Lost to Follow-up|4
2650491|NCT00722761|9154148|P1|Overall Study|Lost to Follow-up|1
2650492|NCT00722423|9154205|P2|Overall Study|Protocol Violation|1
2650493|NCT00722423|9154206|P1|Overall Study|Protocol Violation|0
2650494|NCT00722371|9154221|P7|Overall Study|Withdrawal by Subject|26
2650495|NCT00722371|9154222|P6|Overall Study|Withdrawal by Subject|18
2650496|NCT00722371|9154223|P5|Overall Study|Withdrawal by Subject|19
2650497|NCT00722371|9154224|P4|Overall Study|Withdrawal by Subject|23
2650498|NCT00722371|9154225|P3|Overall Study|Withdrawal by Subject|19
2650499|NCT00722371|9154226|P2|Overall Study|Withdrawal by Subject|27
2650500|NCT00722371|9154227|P1|Overall Study|Withdrawal by Subject|18
2650501|NCT00722371|9154221|P7|Overall Study|Protocol Violation|1
2650502|NCT00722371|9154222|P6|Overall Study|Protocol Violation|2
2650503|NCT00722371|9154223|P5|Overall Study|Protocol Violation|4
2650504|NCT00722371|9154224|P4|Overall Study|Protocol Violation|1
2650505|NCT00722371|9154225|P3|Overall Study|Protocol Violation|0
2650506|NCT00722371|9154226|P2|Overall Study|Protocol Violation|1
2650507|NCT00722371|9154227|P1|Overall Study|Protocol Violation|6
2650508|NCT00722371|9154221|P7|Overall Study|Pregnancy|0
2650509|NCT00722371|9154222|P6|Overall Study|Pregnancy|1
2650510|NCT00722371|9154223|P5|Overall Study|Pregnancy|0
2650511|NCT00722371|9154224|P4|Overall Study|Pregnancy|0
2650512|NCT00722371|9154225|P3|Overall Study|Pregnancy|0
2650513|NCT00722371|9154226|P2|Overall Study|Pregnancy|1
2650514|NCT00722371|9154227|P1|Overall Study|Pregnancy|1
2650515|NCT00722371|9154221|P7|Overall Study|Physician Decision|4
2650516|NCT00722371|9154222|P6|Overall Study|Physician Decision|3
2650517|NCT00722371|9154223|P5|Overall Study|Physician Decision|2
2650518|NCT00722371|9154224|P4|Overall Study|Physician Decision|5
2650519|NCT00722371|9154225|P3|Overall Study|Physician Decision|2
2650520|NCT00722371|9154226|P2|Overall Study|Physician Decision|2
2650521|NCT00722371|9154227|P1|Overall Study|Physician Decision|5
2650522|NCT00722371|9154221|P7|Overall Study|Lost to Follow-up|13
2650523|NCT00722371|9154222|P6|Overall Study|Lost to Follow-up|16
2650524|NCT00722371|9154223|P5|Overall Study|Lost to Follow-up|8
2650525|NCT00722371|9154224|P4|Overall Study|Lost to Follow-up|13
2650526|NCT00722371|9154225|P3|Overall Study|Lost to Follow-up|21
2650527|NCT00722371|9154226|P2|Overall Study|Lost to Follow-up|14
2650528|NCT00722371|9154227|P1|Overall Study|Lost to Follow-up|11
2650529|NCT00722371|9154221|P7|Overall Study|Lack of Efficacy|0
2650530|NCT00722371|9154222|P6|Overall Study|Lack of Efficacy|3
2650531|NCT00722371|9154223|P5|Overall Study|Lack of Efficacy|2
2650532|NCT00722371|9154224|P4|Overall Study|Lack of Efficacy|6
2650533|NCT00722371|9154225|P3|Overall Study|Lack of Efficacy|6
2650534|NCT00722371|9154226|P2|Overall Study|Lack of Efficacy|6
2650535|NCT00722371|9154227|P1|Overall Study|Lack of Efficacy|4
2650536|NCT00722371|9154221|P7|Overall Study|Hypoglycemia|0
2650537|NCT00722371|9154222|P6|Overall Study|Hypoglycemia|0
2650538|NCT00722371|9154223|P5|Overall Study|Hypoglycemia|0
2650539|NCT00722371|9154224|P4|Overall Study|Hypoglycemia|0
2650540|NCT00722371|9154225|P3|Overall Study|Hypoglycemia|0
2650541|NCT00722371|9154226|P2|Overall Study|Hypoglycemia|0
2650542|NCT00722371|9154227|P1|Overall Study|Hypoglycemia|1
2650543|NCT00722371|9154221|P7|Overall Study|Hyperglycemia|1
2650544|NCT00722371|9154222|P6|Overall Study|Hyperglycemia|1
2650545|NCT00722371|9154223|P5|Overall Study|Hyperglycemia|5
2650546|NCT00722371|9154224|P4|Overall Study|Hyperglycemia|2
2650547|NCT00722371|9154225|P3|Overall Study|Hyperglycemia|4
2650548|NCT00722371|9154226|P2|Overall Study|Hyperglycemia|6
2650549|NCT00722371|9154227|P1|Overall Study|Hyperglycemia|2
2650550|NCT00722371|9154221|P7|Overall Study|Excluded medication|1
2650551|NCT00722371|9154222|P6|Overall Study|Excluded medication|0
2650552|NCT00722371|9154223|P5|Overall Study|Excluded medication|0
2650553|NCT00722371|9154224|P4|Overall Study|Excluded medication|0
2650554|NCT00722371|9154225|P3|Overall Study|Excluded medication|1
2650555|NCT00722371|9154226|P2|Overall Study|Excluded medication|1
2650556|NCT00722371|9154227|P1|Overall Study|Excluded medication|0
2650557|NCT00722371|9154221|P7|Overall Study|Creatinine / Creatinine clearance|1
2650558|NCT00722371|9154222|P6|Overall Study|Creatinine / Creatinine clearance|1
2650559|NCT00722371|9154223|P5|Overall Study|Creatinine / Creatinine clearance|2
2650560|NCT00722371|9154224|P4|Overall Study|Creatinine / Creatinine clearance|3
2650561|NCT00722371|9154225|P3|Overall Study|Creatinine / Creatinine clearance|2
2650562|NCT00722371|9154226|P2|Overall Study|Creatinine / Creatinine clearance|1
2650563|NCT00722371|9154227|P1|Overall Study|Creatinine / Creatinine clearance|2
2650564|NCT00722371|9154221|P7|Overall Study|Contraindication|0
2650565|NCT00722371|9154222|P6|Overall Study|Contraindication|0
2650566|NCT00722371|9154223|P5|Overall Study|Contraindication|0
2650567|NCT00722371|9154224|P4|Overall Study|Contraindication|0
2650568|NCT00722371|9154225|P3|Overall Study|Contraindication|1
2650569|NCT00722371|9154226|P2|Overall Study|Contraindication|0
2650570|NCT00722371|9154227|P1|Overall Study|Contraindication|0
2650571|NCT00722371|9154221|P7|Overall Study|Adverse Event|4
2650572|NCT00722371|9154222|P6|Overall Study|Adverse Event|8
2650573|NCT00722371|9154223|P5|Overall Study|Adverse Event|6
2650574|NCT00722371|9154224|P4|Overall Study|Adverse Event|10
2650575|NCT00722371|9154225|P3|Overall Study|Adverse Event|9
2650576|NCT00722371|9154226|P2|Overall Study|Adverse Event|13
2650577|NCT00722371|9154227|P1|Overall Study|Adverse Event|6
2650578|NCT00722137|9154280|P2|Overall Study|Randomized But Not Treated|3
2650579|NCT00722137|9154281|P1|Overall Study|Randomized But Not Treated|2
2650580|NCT00722137|9154280|P2|Overall Study|Other Reason Unknown|4
2650581|NCT00722137|9154281|P1|Overall Study|Other Reason Unknown|3
2650582|NCT00722137|9154280|P2|Overall Study|Withdrawal by Subject|9
2650583|NCT00722137|9154281|P1|Overall Study|Withdrawal by Subject|6
2650584|NCT00722137|9154280|P2|Overall Study|Death|7
2650585|NCT00722137|9154281|P1|Overall Study|Death|12
2650586|NCT00722137|9154280|P2|Overall Study|Adverse Event|21
2650587|NCT00722137|9154281|P1|Overall Study|Adverse Event|17
2650588|NCT00722137|9154280|P2|Overall Study|Overt Disease Progression|4
2650589|NCT00722137|9154281|P1|Overall Study|Overt Disease Progression|5
2650590|NCT00721968|9154359|P2|Overall Study|Lost to Follow-up|0
2650591|NCT00721968|9154360|P1|Overall Study|Lost to Follow-up|2
2650592|NCT00721955|9154371|P3|Overall Study|Adverse Event|2
2650593|NCT00721955|9154372|P2|Overall Study|Adverse Event|0
2650594|NCT00721955|9154373|P1|Overall Study|Adverse Event|0
2650595|NCT00721799|9154387|P1|Overall Study|withdraw by subject after scan 1|1
2650596|NCT00721799|9154387|P1|Overall Study|Withdrawal by Subject|7
2650597|NCT00721734|9154427|P5|Overall Study|Other|0
2650598|NCT00721734|9154428|P4|Overall Study|Other|1
2650599|NCT00721734|9154429|P3|Overall Study|Other|0
2650600|NCT00721734|9154430|P2|Overall Study|Other|0
2650601|NCT00721734|9154431|P1|Overall Study|Other|0
2650602|NCT00721734|9154427|P5|Overall Study|Withdrawal by Subject|1
2650603|NCT00721734|9154428|P4|Overall Study|Withdrawal by Subject|0
2650604|NCT00721734|9154429|P3|Overall Study|Withdrawal by Subject|0
2650605|NCT00721734|9154430|P2|Overall Study|Withdrawal by Subject|1
2650606|NCT00721734|9154431|P1|Overall Study|Withdrawal by Subject|2
2650607|NCT00721734|9154427|P5|Overall Study|Adverse Event|3
2650608|NCT00721734|9154428|P4|Overall Study|Adverse Event|0
2650609|NCT00721734|9154429|P3|Overall Study|Adverse Event|4
2650610|NCT00721734|9154430|P2|Overall Study|Adverse Event|1
2650611|NCT00721734|9154431|P1|Overall Study|Adverse Event|3
2650612|NCT00721734|9154427|P5|Overall Study|Progressive Disease|2
2650613|NCT00721734|9154428|P4|Overall Study|Progressive Disease|5
2650614|NCT00721734|9154429|P3|Overall Study|Progressive Disease|4
2650615|NCT00721734|9154430|P2|Overall Study|Progressive Disease|10
2650616|NCT00721734|9154431|P1|Overall Study|Progressive Disease|3
2650617|NCT00721630|9154543|P1|Overall Study|Participant found to be ineligible|1
2650618|NCT00721578|9154572|P2|Overall Study|Withdrawal by Subject|1
2650619|NCT00721578|9154573|P1|Overall Study|Withdrawal by Subject|1
2650620|NCT00721578|9154572|P2|Overall Study|Death|1
2650621|NCT00721578|9154573|P1|Overall Study|Death|1
2650622|NCT00721409|9154628|P3|Overall Study|Objective progression or relapse|62
2650623|NCT00721409|9154629|P2|Overall Study|Objective progression or relapse|55
2650624|NCT00721409|9154630|P1|Overall Study|Objective progression or relapse|8
2650625|NCT00721409|9154628|P3|Overall Study|Withdrawal by Subject|5
2650626|NCT00721409|9154629|P2|Overall Study|Withdrawal by Subject|6
2650627|NCT00721409|9154630|P1|Overall Study|Withdrawal by Subject|1
2650628|NCT00721409|9154628|P3|Overall Study|Lost to Follow-up|1
2650629|NCT00721409|9154629|P2|Overall Study|Lost to Follow-up|0
2650630|NCT00721409|9154630|P1|Overall Study|Lost to Follow-up|0
2650631|NCT00721409|9154628|P3|Overall Study|Adverse Event|2
2650632|NCT00721409|9154629|P2|Overall Study|Adverse Event|13
2650633|NCT00721409|9154630|P1|Overall Study|Adverse Event|0
2650634|NCT00721409|9154628|P3|Overall Study|Reason not specified|2
2650635|NCT00721409|9154629|P2|Overall Study|Reason not specified|0
2650636|NCT00721409|9154630|P1|Overall Study|Reason not specified|1
2650637|NCT00721409|9154628|P3|Overall Study|Randomized not Treated|4
2650638|NCT00721409|9154629|P2|Overall Study|Randomized not Treated|1
2650639|NCT00721409|9154630|P1|Overall Study|Randomized not Treated|0
2650640|NCT00721409|9154628|P3|Overall Study|Death|0
2650641|NCT00721409|9154629|P2|Overall Study|Death|1
2650642|NCT00721409|9154630|P1|Overall Study|Death|0
2650643|NCT00721409|9154628|P3|Overall Study|Global deterioration of health status|3
2650644|NCT00721409|9154629|P2|Overall Study|Global deterioration of health status|6
2650645|NCT00721409|9154630|P1|Overall Study|Global deterioration of health status|2
2650646|NCT00721396|9154757|P4|Overall Study|Administrative reason|0
2650647|NCT00721396|9154758|P3|Overall Study|Administrative reason|1
2650648|NCT00721396|9154759|P2|Overall Study|Administrative reason|0
2650649|NCT00721396|9154760|P1|Overall Study|Administrative reason|3
2650650|NCT00721396|9154757|P4|Overall Study|Inappropriate enrollment|0
2650651|NCT00721396|9154758|P3|Overall Study|Inappropriate enrollment|0
2650652|NCT00721396|9154759|P2|Overall Study|Inappropriate enrollment|2
2650653|NCT00721396|9154760|P1|Overall Study|Inappropriate enrollment|0
2650654|NCT00721396|9154757|P4|Overall Study|Protocol Violation|0
2650655|NCT00721396|9154758|P3|Overall Study|Protocol Violation|1
2650656|NCT00721396|9154759|P2|Overall Study|Protocol Violation|3
2650657|NCT00721396|9154760|P1|Overall Study|Protocol Violation|4
2650658|NCT00721396|9154757|P4|Overall Study|Lost to Follow-up|3
2650659|NCT00721396|9154758|P3|Overall Study|Lost to Follow-up|3
2650660|NCT00721396|9154759|P2|Overall Study|Lost to Follow-up|9
2650661|NCT00721396|9154760|P1|Overall Study|Lost to Follow-up|7
2650662|NCT00721396|9154757|P4|Overall Study|Withdrawal by Subject|7
2650663|NCT00721396|9154758|P3|Overall Study|Withdrawal by Subject|3
2650664|NCT00721396|9154759|P2|Overall Study|Withdrawal by Subject|15
2650665|NCT00721396|9154760|P1|Overall Study|Withdrawal by Subject|12
2650666|NCT00721396|9154757|P4|Overall Study|Adverse Event|0
2650667|NCT00721396|9154758|P3|Overall Study|Adverse Event|2
2650668|NCT00721396|9154759|P2|Overall Study|Adverse Event|7
2650669|NCT00721396|9154760|P1|Overall Study|Adverse Event|4
2650670|NCT00721279|9154811|P2|Overall Study|Other|16
2650671|NCT00721279|9154812|P1|Overall Study|Other|12
2650672|NCT00721279|9154811|P2|Overall Study|Withdrawal by Subject|3
2650673|NCT00721279|9154812|P1|Overall Study|Withdrawal by Subject|13
2650674|NCT00721279|9154811|P2|Overall Study|Tolerability insufficient|2
2650675|NCT00721279|9154812|P1|Overall Study|Tolerability insufficient|5
2650676|NCT00721279|9154811|P2|Overall Study|Lack of Efficacy|3
2650677|NCT00721279|9154812|P1|Overall Study|Lack of Efficacy|6
2650678|NCT00721227|9154840|P2|Overall Study|Noncompliance with scheduled visits.|0
2650679|NCT00721227|9154841|P1|Overall Study|Noncompliance with scheduled visits.|1
2650680|NCT00721227|9154840|P2|Overall Study|Lost to Follow-up|0
2650681|NCT00721227|9154841|P1|Overall Study|Lost to Follow-up|3
2650682|NCT00721214|9154851|P1|Overall Study|Death|3
2650683|NCT00721214|9154851|P1|Overall Study|Chose another center for transplant|1
2650684|NCT00721149|9154901|P1|Overall Study|Physician Decision|1
2650685|NCT00721123|9154935|P1|Overall Study|Withdrawal by Subject|5
2650686|NCT00721123|9154935|P1|Overall Study|Failure to Return|9
2650687|NCT00721123|9154935|P1|Overall Study|Refused Treatment|41
2650688|NCT00721123|9154935|P1|Overall Study|Protocol Violation|1
2650689|NCT00721123|9154935|P1|Overall Study|Insufficient Therapeutic Response|21
2650690|NCT00721123|9154935|P1|Overall Study|Death|10
2650691|NCT00721123|9154935|P1|Overall Study|Adverse Event|96
2650692|NCT00721110|9155013|P4|Overall Study|vertical incision|0
2650693|NCT00721110|9155014|P3|Overall Study|vertical incision|1
2650694|NCT00721110|9155015|P2|Overall Study|vertical incision|0
2650695|NCT00721110|9155016|P1|Overall Study|vertical incision|0
2650696|NCT00721110|9155013|P4|Overall Study|Ultram use|0
2650697|NCT00721110|9155014|P3|Overall Study|Ultram use|0
2650698|NCT00721110|9155015|P2|Overall Study|Ultram use|0
2650699|NCT00721110|9155016|P1|Overall Study|Ultram use|1
2650700|NCT00720941|9155044|P2|Overall Study|Ongoing|23
2650701|NCT00720941|9155045|P1|Overall Study|Ongoing|34
2650702|NCT00720941|9155044|P2|Overall Study|Withdrawal by Subject|35
2650703|NCT00720941|9155045|P1|Overall Study|Withdrawal by Subject|27
2650704|NCT00720941|9155044|P2|Overall Study|Physician Decision|5
2650705|NCT00720941|9155045|P1|Overall Study|Physician Decision|1
2650706|NCT00720941|9155044|P2|Overall Study|Lost to Follow-up|15
2650707|NCT00720941|9155045|P1|Overall Study|Lost to Follow-up|17
2650708|NCT00720941|9155044|P2|Overall Study|Protocol Violation|2
2650709|NCT00720941|9155045|P1|Overall Study|Protocol Violation|0
2650710|NCT00720941|9155044|P2|Overall Study|Death|335
2650711|NCT00720941|9155045|P1|Overall Study|Death|334
2650712|NCT00720876|9155085|P1|Overall Study|found to be ineligible after starting tx|2
2650713|NCT00720798|9155091|P1|Overall Study|Reason not Specified|83
2650714|NCT00720798|9155091|P1|Overall Study|Failure to Return|46
2650715|NCT00720798|9155091|P1|Overall Study|Refused Treatment|151
2650716|NCT00720798|9155091|P1|Overall Study|Protocol Violation|4
2650717|NCT00720798|9155091|P1|Overall Study|Insufficient Therapeutic Response|129
2650718|NCT00720798|9155091|P1|Overall Study|Death|39
2650719|NCT00720798|9155091|P1|Overall Study|Adverse Event|304
2650720|NCT00720759|9155114|P4|Overall Study|Lost to Follow-up|0
2650721|NCT00720759|9155115|P3|Overall Study|Lost to Follow-up|1
2650722|NCT00720759|9155116|P2|Overall Study|Lost to Follow-up|1
2650723|NCT00720759|9155117|P1|Overall Study|Lost to Follow-up|0
2650724|NCT00720499|9155137|P2|Treatment Period 2 (4 Weeks)|Adverse Event|3
2650725|NCT00720499|9155138|P1|Treatment Period 2 (4 Weeks)|Adverse Event|2
2650726|NCT00720499|9155137|P2|Treatment Period 1 (4 Weeks)|Protocol Violation|2
2650727|NCT00720499|9155138|P1|Treatment Period 1 (4 Weeks)|Protocol Violation|1
2650728|NCT00720499|9155137|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
2650729|NCT00720499|9155138|P1|Treatment Period 1 (4 Weeks)|Adverse Event|2
2650730|NCT00720434|9155231|P4|Open-Label Period (Week 5-72)|Other|2
2650731|NCT00720434|9155232|P3|Open-Label Period (Week 5-72)|Other|3
2650732|NCT00720434|9155233|P2|Open-Label Period (Week 5-72)|Other|3
2650733|NCT00720434|9155234|P1|Open-Label Period (Week 5-72)|Other|4
2650734|NCT00720434|9155231|P4|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
2650735|NCT00720434|9155232|P3|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
2650736|NCT00720434|9155233|P2|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
2650737|NCT00720434|9155234|P1|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
2650738|NCT00720434|9155231|P4|Open-Label Period (Week 5-72)|Lost to Follow-up|0
2650739|NCT00720434|9155232|P3|Open-Label Period (Week 5-72)|Lost to Follow-up|0
2650740|NCT00720434|9155233|P2|Open-Label Period (Week 5-72)|Lost to Follow-up|0
2650741|NCT00720434|9155234|P1|Open-Label Period (Week 5-72)|Lost to Follow-up|1
2650742|NCT00720434|9155231|P4|Open-Label Period (Week 5-72)|Adverse Event|2
2650743|NCT00720434|9155232|P3|Open-Label Period (Week 5-72)|Adverse Event|0
2650744|NCT00720434|9155233|P2|Open-Label Period (Week 5-72)|Adverse Event|0
2650745|NCT00720434|9155234|P1|Open-Label Period (Week 5-72)|Adverse Event|0
2650746|NCT00720434|9155231|P4|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
2650747|NCT00720434|9155232|P3|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
2650748|NCT00720434|9155233|P2|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1
2650749|NCT00720434|9155234|P1|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
2650750|NCT00720382|9155258|P2|Overall Study|administrative|5
2650751|NCT00720382|9155259|P1|Overall Study|administrative|14
2650752|NCT00720382|9155258|P2|Overall Study|Lost to Follow-up|14
2650753|NCT00720382|9155259|P1|Overall Study|Lost to Follow-up|28
2650754|NCT00720382|9155258|P2|Overall Study|Withdrawal by Subject|11
2650755|NCT00720382|9155259|P1|Overall Study|Withdrawal by Subject|47
2650756|NCT00720382|9155258|P2|Overall Study|Non-Compliance|5
2650757|NCT00720382|9155259|P1|Overall Study|Non-Compliance|15
2650758|NCT00720382|9155258|P2|Overall Study|Lack of Efficacy|7
2650759|NCT00720382|9155259|P1|Overall Study|Lack of Efficacy|18
2650760|NCT00720382|9155258|P2|Overall Study|Adverse Event|17
2650761|NCT00720382|9155259|P1|Overall Study|Adverse Event|54
2650762|NCT00720356|9155278|P1|Follow up Until Death|Alive at last data collection|4
2650763|NCT00720356|9155278|P1|Follow up Until Death|Withdrawal by Subject|1
2650764|NCT00720356|9155278|P1|Went on to be Treated Cycle 3|Physician Decision|1
2650765|NCT00720356|9155278|P1|Went on to be Treated Cycle 3|Adverse Event|1
2650766|NCT00720356|9155278|P1|Reached 1st Response/2 Cycles|Withdrawal by Subject|1
2650767|NCT00720356|9155278|P1|Reached 1st Response/2 Cycles|Progressive Disease|1
2650768|NCT00720356|9155278|P1|Registration to Study|Determined to have methylated MGMT|67
2650769|NCT00720343|9155292|P1|Overall Study|No data|3
2650770|NCT00720343|9155292|P1|Overall Study|Physician Decision|3
2650771|NCT00720278|9155326|P3|Overall Study|eligibility criteria violation|1
2650772|NCT00720278|9155327|P2|Overall Study|eligibility criteria violation|0
2650773|NCT00720278|9155328|P1|Overall Study|eligibility criteria violation|1
2650774|NCT00720278|9155326|P3|Overall Study|Non-compliance|0
2650775|NCT00720278|9155327|P2|Overall Study|Non-compliance|0
2650776|NCT00720278|9155328|P1|Overall Study|Non-compliance|1
2650777|NCT00720278|9155326|P3|Overall Study|Lost to Follow-up|1
2650778|NCT00720278|9155327|P2|Overall Study|Lost to Follow-up|0
2650779|NCT00720278|9155328|P1|Overall Study|Lost to Follow-up|0
2650780|NCT00720278|9155326|P3|Overall Study|Withdrawal by Subject|0
2650781|NCT00720278|9155327|P2|Overall Study|Withdrawal by Subject|1
2650782|NCT00720278|9155328|P1|Overall Study|Withdrawal by Subject|0
2650783|NCT00720278|9155326|P3|Overall Study|Adverse Event|4
2650784|NCT00720278|9155327|P2|Overall Study|Adverse Event|3
2650785|NCT00720278|9155328|P1|Overall Study|Adverse Event|5
2650786|NCT00720226|9155350|P2|Overall Study|Withdrawal by Subject|4
2650787|NCT00720226|9155351|P1|Overall Study|Withdrawal by Subject|7
2650788|NCT00720213|9155359|P3|Screening Phase With Diagnostic PSG|Screen Failure|0
2650789|NCT00720213|9155360|P2|Screening Phase With Diagnostic PSG|Screen Failure|0
2650790|NCT00720213|9155361|P1|Screening Phase With Diagnostic PSG|Screen Failure|7
2650791|NCT00720122|9155399|P1|Overall Study|Withdrawal by Subject|7
2650792|NCT00720122|9155399|P1|Overall Study|Physician Decision|1
2650793|NCT00720122|9155399|P1|Overall Study|Lost to Follow-up|1
2650794|NCT00720109|9155403|P3|Risk Stratification Period|Development of second malignant neoplasm|0
2650795|NCT00720109|9155404|P2|Risk Stratification Period|Development of second malignant neoplasm|1
2650796|NCT00720109|9155405|P1|Risk Stratification Period|Development of second malignant neoplasm|0
2650797|NCT00720109|9155403|P3|Risk Stratification Period|Disease progression or relapse|0
2650798|NCT00720109|9155404|P2|Risk Stratification Period|Disease progression or relapse|2
2650799|NCT00720109|9155405|P1|Risk Stratification Period|Disease progression or relapse|0
2650800|NCT00720109|9155403|P3|Risk Stratification Period|Bone marrow transplant|7
2650801|NCT00720109|9155404|P2|Risk Stratification Period|Bone marrow transplant|9
2650802|NCT00720109|9155405|P1|Risk Stratification Period|Bone marrow transplant|0
2650803|NCT00720109|9155403|P3|Risk Stratification Period|Physician Decision|1
2650804|NCT00720109|9155404|P2|Risk Stratification Period|Physician Decision|2
2650805|NCT00720109|9155405|P1|Risk Stratification Period|Physician Decision|0
2650806|NCT00720109|9155403|P3|Risk Stratification Period|Adverse Event|0
2650807|NCT00720109|9155404|P2|Risk Stratification Period|Adverse Event|1
2650808|NCT00720109|9155405|P1|Risk Stratification Period|Adverse Event|0
2650809|NCT00720109|9155403|P3|Induction Period|Physician Decision|0
2650810|NCT00720109|9155404|P2|Induction Period|Physician Decision|0
2650811|NCT00720109|9155405|P1|Induction Period|Physician Decision|1
2650812|NCT00720109|9155403|P3|Induction Period|Bone Marrow Transplant|0
2650813|NCT00720109|9155404|P2|Induction Period|Bone Marrow Transplant|0
2650814|NCT00720109|9155405|P1|Induction Period|Bone Marrow Transplant|2
2650815|NCT00720109|9155403|P3|Induction Period|Did not meet eligibility criteria|0
2650816|NCT00720109|9155404|P2|Induction Period|Did not meet eligibility criteria|0
2650817|NCT00720109|9155405|P1|Induction Period|Did not meet eligibility criteria|3
2650818|NCT00720096|9155425|P2|Overall Study|Withdrawal by Subject|2
2650819|NCT00720096|9155426|P1|Overall Study|Withdrawal by Subject|0
2650820|NCT00720083|9155438|P2|Overall Study|Ineligible|2
2650821|NCT00720083|9155439|P1|Overall Study|Ineligible|1
2650822|NCT00720057|9155447|P2|Overall Study|Withdrawal by Subject|1
2650823|NCT00720057|9155448|P1|Overall Study|Withdrawal by Subject|0
2650824|NCT00720057|9155447|P2|Overall Study|Protocol Violation|0
2650825|NCT00720057|9155448|P1|Overall Study|Protocol Violation|1
2650826|NCT00720057|9155447|P2|Overall Study|Lost to Follow-up|2
2650827|NCT00720057|9155448|P1|Overall Study|Lost to Follow-up|0
2650828|NCT00719953|9155464|P1|Overall Study|Adverse Event|4
2650829|NCT00719901|9155477|P1|Overall Study|Availability of Study Drug|1
2650830|NCT00719901|9155477|P1|Overall Study|Disease Progression|3
2650831|NCT00719901|9155477|P1|Overall Study|Alternate Treatment|1
2650832|NCT00719901|9155477|P1|Overall Study|Withdrawal by Subject|1
2650833|NCT00719901|9155477|P1|Overall Study|Adverse Event|5
2650834|NCT00719862|9155489|P2|Overall Study|Other|3
2650835|NCT00719862|9155490|P1|Overall Study|Other|2
2650836|NCT00719862|9155489|P2|Overall Study|Lost to Follow-up|1
2650837|NCT00719862|9155490|P1|Overall Study|Lost to Follow-up|0
2650838|NCT00719862|9155489|P2|Overall Study|Withdrawal by Subject|0
2650839|NCT00719862|9155490|P1|Overall Study|Withdrawal by Subject|1
2650840|NCT00719862|9155489|P2|Overall Study|Non-Compliance|0
2650841|NCT00719862|9155490|P1|Overall Study|Non-Compliance|1
2650842|NCT00719862|9155489|P2|Overall Study|Lack of Efficacy|0
2650843|NCT00719862|9155490|P1|Overall Study|Lack of Efficacy|3
2650844|NCT00719862|9155489|P2|Overall Study|Adverse Event|2
2650845|NCT00719862|9155490|P1|Overall Study|Adverse Event|1
2650846|NCT00719849|9155508|P2|Overall Study|Death|1
2650847|NCT00719849|9155509|P1|Overall Study|Death|0
2650848|NCT00719810|9155548|P3|Overall Study|Withdrawal by Subject|2
2650849|NCT00719810|9155549|P2|Overall Study|Withdrawal by Subject|1
2650850|NCT00719810|9155550|P1|Overall Study|Withdrawal by Subject|1
2650851|NCT00719810|9155548|P3|Overall Study|Physician Decision|0
2650852|NCT00719810|9155549|P2|Overall Study|Physician Decision|1
2650853|NCT00719810|9155550|P1|Overall Study|Physician Decision|0
2650854|NCT00719810|9155548|P3|Overall Study|Lost to Follow-up|3
2650855|NCT00719810|9155549|P2|Overall Study|Lost to Follow-up|0
2650856|NCT00719810|9155550|P1|Overall Study|Lost to Follow-up|2
2650857|NCT00719810|9155548|P3|Overall Study|Adverse Event|3
2650858|NCT00719810|9155549|P2|Overall Study|Adverse Event|2
2650859|NCT00719810|9155550|P1|Overall Study|Adverse Event|0
2650860|NCT00719732|9155561|P1|Overall Study|Illness not associated with device|1
2650861|NCT00719732|9155561|P1|Overall Study|Unilateral (not bilateral) implantation|1
2650862|NCT00719732|9155561|P1|Overall Study|Lost to Follow-up|20
2650863|NCT00719706|9155567|P2|Overall Study|Protocol Violation|0
2650864|NCT00719706|9155568|P1|Overall Study|Protocol Violation|3
2650865|NCT00719706|9155567|P2|Overall Study|Withdrawal by Subject|2
2650866|NCT00719706|9155568|P1|Overall Study|Withdrawal by Subject|1
2650867|NCT00719706|9155567|P2|Overall Study|Adverse Event|4
2650868|NCT00719706|9155568|P1|Overall Study|Adverse Event|5
2650869|NCT00719680|9155582|P1|Overall Study|Withdrawal by Subject|3
2650870|NCT00719680|9155582|P1|Overall Study|Lost to Follow-up|1
2650871|NCT00719680|9155582|P1|Overall Study|Adverse Event|1
2650872|NCT00719563|9155638|P2|Overall Study|Lost to Follow-up|3
2650873|NCT00719563|9155639|P1|Overall Study|Lost to Follow-up|5
2650874|NCT00719563|9155638|P2|Overall Study|Noncompliant|1
2650875|NCT00719563|9155639|P1|Overall Study|Noncompliant|1
2650876|NCT00719563|9155638|P2|Overall Study|Unknown reasons|6
2650877|NCT00719563|9155639|P1|Overall Study|Unknown reasons|4
2650878|NCT00719563|9155638|P2|Overall Study|Personal reasons|7
2650879|NCT00719563|9155639|P1|Overall Study|Personal reasons|6
2650880|NCT00719563|9155638|P2|Overall Study|Lack of Efficacy|7
2650881|NCT00719563|9155639|P1|Overall Study|Lack of Efficacy|3
2650882|NCT00719563|9155638|P2|Overall Study|Medical condition changed|5
2650883|NCT00719563|9155639|P1|Overall Study|Medical condition changed|3
2650884|NCT00719563|9155638|P2|Overall Study|Adverse Event|13
2650885|NCT00719563|9155639|P1|Overall Study|Adverse Event|16
2650886|NCT00719537|9155671|P2|Overall Study|Lost to Follow-up|1
2650887|NCT00719537|9155672|P1|Overall Study|Lost to Follow-up|0
2650888|NCT00719537|9155671|P2|Overall Study|Withdrawal by Subject|0
2650889|NCT00719537|9155672|P1|Overall Study|Withdrawal by Subject|1
2650890|NCT00719472|9155678|P1|Received Cycle 2 Treatment|Various Reasons|25
2650891|NCT00719472|9155678|P1|Received Cycle 2 Treatment|Subject decision to withdraw|6
2650892|NCT00719472|9155678|P1|Received Cycle 2 Treatment|Physician decision to withdraw patient|13
2650893|NCT00719472|9155678|P1|Received Cycle 2 Treatment|Lost to Follow-up|3
2650894|NCT00719472|9155678|P1|Received Cycle 2 Treatment|Disease progression|3
2650895|NCT00719472|9155678|P1|Received Cycle 2 Treatment|Death|6
2650896|NCT00719472|9155678|P1|Received Cycle 2 Treatment|Adverse Event|12
2650897|NCT00719472|9155678|P1|Received Cycle 1 Treatment|Various Reasons|13
2650898|NCT00719472|9155678|P1|Received Cycle 1 Treatment|Subject decision to withdraw|9
2650899|NCT00719472|9155678|P1|Received Cycle 1 Treatment|Physician decision to withdraw patient|7
2650900|NCT00719472|9155678|P1|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11
2650901|NCT00719472|9155678|P1|Received Cycle 1 Treatment|Death|5
2650902|NCT00719472|9155678|P1|Received Cycle 1 Treatment|Adverse Event|8
2650903|NCT00719472|9155678|P1|Enrolled in Study|Various Reasons|17
2650904|NCT00719472|9155678|P1|Enrolled in Study|Subject decision to withdraw|8
2650905|NCT00719472|9155678|P1|Enrolled in Study|Physician decision to withdraw patient|1
2650906|NCT00719355|9155689|P2|Overall Study|Moved|1
2650907|NCT00719355|9155690|P1|Overall Study|Moved|0
2650908|NCT00719355|9155689|P2|Overall Study|Compliance|6
2650909|NCT00719355|9155690|P1|Overall Study|Compliance|4
2650910|NCT00719355|9155689|P2|Overall Study|Medical|5
2650911|NCT00719355|9155690|P1|Overall Study|Medical|14
2650912|NCT00719355|9155689|P2|Overall Study|Death|1
2650913|NCT00719355|9155690|P1|Overall Study|Death|0
2650914|NCT00719264|9155719|P2|Overall Study|Disease Progression|107
2650915|NCT00719264|9155720|P1|Overall Study|Disease Progression|104
2650916|NCT00719264|9155719|P2|Overall Study|New Cancer Therapy|2
2650917|NCT00719264|9155720|P1|Overall Study|New Cancer Therapy|4
2650918|NCT00719264|9155719|P2|Overall Study|Protocol Deviation|3
2650919|NCT00719264|9155720|P1|Overall Study|Protocol Deviation|1
2650920|NCT00719264|9155719|P2|Overall Study|Withdrawal by Subject|7
2650921|NCT00719264|9155720|P1|Overall Study|Withdrawal by Subject|12
2650922|NCT00719264|9155719|P2|Overall Study|Lost to Follow-up|1
2650923|NCT00719264|9155720|P1|Overall Study|Lost to Follow-up|1
2650924|NCT00719264|9155719|P2|Overall Study|Administrative Problems|4
2650925|NCT00719264|9155720|P1|Overall Study|Administrative Problems|6
2650926|NCT00719264|9155719|P2|Overall Study|Death|10
2650927|NCT00719264|9155720|P1|Overall Study|Death|13
2650928|NCT00719264|9155719|P2|Overall Study|Adverse Event|49
2650929|NCT00719264|9155720|P1|Overall Study|Adverse Event|41
2650930|NCT00719212|9155739|P1|Overall Study|Withdrawal by Subject|1
2650931|NCT00719212|9155739|P1|Overall Study|Lost to Follow-up|2
2650932|NCT00719212|9155739|P1|Overall Study|Death|41
2650933|NCT00719043|9155787|P7|Overall Study|Withdrawal by Subject|14
2650934|NCT00719043|9155788|P6|Overall Study|Withdrawal by Subject|18
2650935|NCT00719043|9155789|P5|Overall Study|Withdrawal by Subject|16
2650936|NCT00719043|9155790|P4|Overall Study|Withdrawal by Subject|10
2650937|NCT00719043|9155791|P3|Overall Study|Withdrawal by Subject|9
2650938|NCT00719043|9155792|P2|Overall Study|Withdrawal by Subject|14
2650939|NCT00719043|9155793|P1|Overall Study|Withdrawal by Subject|12
2650940|NCT00719043|9155787|P7|Overall Study|Other|1
2650941|NCT00719043|9155788|P6|Overall Study|Other|2
2650942|NCT00719043|9155789|P5|Overall Study|Other|0
2650943|NCT00719043|9155790|P4|Overall Study|Other|2
2650944|NCT00719043|9155791|P3|Overall Study|Other|1
2650945|NCT00719043|9155792|P2|Overall Study|Other|0
2650946|NCT00719043|9155793|P1|Overall Study|Other|1
2650947|NCT00719043|9155787|P7|Overall Study|Protocol Violation|0
2650948|NCT00719043|9155788|P6|Overall Study|Protocol Violation|1
2650949|NCT00719043|9155789|P5|Overall Study|Protocol Violation|0
2650950|NCT00719043|9155790|P4|Overall Study|Protocol Violation|0
2650951|NCT00719043|9155791|P3|Overall Study|Protocol Violation|0
2650952|NCT00719043|9155792|P2|Overall Study|Protocol Violation|0
2650953|NCT00719043|9155793|P1|Overall Study|Protocol Violation|0
2650954|NCT00719043|9155787|P7|Overall Study|Lost to Follow-up|9
2650955|NCT00719043|9155788|P6|Overall Study|Lost to Follow-up|9
2650956|NCT00719043|9155789|P5|Overall Study|Lost to Follow-up|10
2650957|NCT00719043|9155790|P4|Overall Study|Lost to Follow-up|9
2650958|NCT00719043|9155791|P3|Overall Study|Lost to Follow-up|8
2650959|NCT00719043|9155792|P2|Overall Study|Lost to Follow-up|10
2650960|NCT00719043|9155793|P1|Overall Study|Lost to Follow-up|14
2650961|NCT00719043|9155787|P7|Overall Study|Adverse Event|4
2650962|NCT00719043|9155788|P6|Overall Study|Adverse Event|4
2650963|NCT00719043|9155789|P5|Overall Study|Adverse Event|1
2650964|NCT00719043|9155790|P4|Overall Study|Adverse Event|2
2650965|NCT00719043|9155791|P3|Overall Study|Adverse Event|2
2650966|NCT00719043|9155792|P2|Overall Study|Adverse Event|1
2650967|NCT00719043|9155793|P1|Overall Study|Adverse Event|5
2650968|NCT00718887|9155917|P2|Overall Study|Not identified|7
2650969|NCT00718887|9155918|P1|Overall Study|Not identified|2
2650970|NCT00718887|9155917|P2|Overall Study|Withdrawal by Subject|2
2650971|NCT00718887|9155918|P1|Overall Study|Withdrawal by Subject|3
2650972|NCT00718861|9155942|P2|Overall Study|Death|5
2650973|NCT00718861|9155943|P1|Overall Study|Death|1
2650974|NCT00718861|9155942|P2|Overall Study|Administrative Problems|1
2650975|NCT00718861|9155943|P1|Overall Study|Administrative Problems|1
2650976|NCT00718861|9155942|P2|Overall Study|Lost to Follow-up|1
2650977|NCT00718861|9155943|P1|Overall Study|Lost to Follow-up|2
2650978|NCT00718861|9155942|P2|Overall Study|Adverse Event|1
2650979|NCT00718861|9155943|P1|Overall Study|Adverse Event|2
2650980|NCT00718861|9155942|P2|Overall Study|Withdrawal by Subject|10
2650981|NCT00718861|9155943|P1|Overall Study|Withdrawal by Subject|15
2650982|NCT00718809|9155971|P2|Overall Study|Noncompliance|0
2650983|NCT00718809|9155972|P1|Overall Study|Noncompliance|1
2650984|NCT00718809|9155971|P2|Overall Study|Lost to Follow-up|0
2650985|NCT00718809|9155972|P1|Overall Study|Lost to Follow-up|1
2650986|NCT00718809|9155971|P2|Overall Study|Withdrawal by Subject|1
2650987|NCT00718809|9155972|P1|Overall Study|Withdrawal by Subject|0
2650988|NCT00718809|9155971|P2|Overall Study|Adverse Event|1
2650989|NCT00718809|9155972|P1|Overall Study|Adverse Event|1
2650990|NCT00718809|9155971|P2|Overall Study|Disease progression|7
2650991|NCT00718809|9155972|P1|Overall Study|Disease progression|9
2650992|NCT00718770|9155986|P1|Overall Study|Adverse Event|1
2650993|NCT00718770|9155986|P1|Overall Study|Lack of Efficacy|1
2650994|NCT00718770|9155986|P1|Overall Study|Adverse Event|1
2650995|NCT00718770|9155986|P1|Overall Study|Lack of Efficacy|1
2650996|NCT00718770|9155986|P1|Overall Study|Adverse Event|1
2650997|NCT00718770|9155986|P1|Overall Study|Lack of Efficacy|1
2650998|NCT00718770|9155986|P1|Overall Study|Lack of Efficacy|1
2650999|NCT00718770|9155986|P1|Overall Study|Adverse Event|1
2651000|NCT00718718|9155997|P10|Week 12 to End of Study|Other|0
2651001|NCT00718718|9155998|P9|Week 12 to End of Study|Other|0
2651002|NCT00718718|9155999|P8|Week 12 to End of Study|Other|0
2651003|NCT00718718|9156000|P7|Week 12 to End of Study|Other|1
2651004|NCT00718718|9156001|P6|Week 12 to End of Study|Other|0
2651005|NCT00718718|9156002|P5|Week 12 to End of Study|Other|0
2651006|NCT00718718|9156003|P4|Week 12 to End of Study|Other|1
2651007|NCT00718718|9156004|P3|Week 12 to End of Study|Other|0
2651008|NCT00718718|9156005|P2|Week 12 to End of Study|Other|1
2651009|NCT00718718|9156006|P1|Week 12 to End of Study|Other|0
2651010|NCT00718718|9155997|P10|Week 12 to End of Study|Lost to Follow-up|0
2651011|NCT00718718|9155998|P9|Week 12 to End of Study|Lost to Follow-up|1
2651012|NCT00718718|9155999|P8|Week 12 to End of Study|Lost to Follow-up|0
2651013|NCT00718718|9156000|P7|Week 12 to End of Study|Lost to Follow-up|0
2651014|NCT00718718|9156001|P6|Week 12 to End of Study|Lost to Follow-up|0
2651015|NCT00718718|9156002|P5|Week 12 to End of Study|Lost to Follow-up|0
2651016|NCT00718718|9156003|P4|Week 12 to End of Study|Lost to Follow-up|0
2651017|NCT00718718|9156004|P3|Week 12 to End of Study|Lost to Follow-up|0
2651018|NCT00718718|9156005|P2|Week 12 to End of Study|Lost to Follow-up|0
2651019|NCT00718718|9156006|P1|Week 12 to End of Study|Lost to Follow-up|0
2651020|NCT00718718|9155997|P10|Week 12 to End of Study|Withdrawal by Subject|0
2651021|NCT00718718|9155998|P9|Week 12 to End of Study|Withdrawal by Subject|0
2651022|NCT00718718|9155999|P8|Week 12 to End of Study|Withdrawal by Subject|0
2651023|NCT00718718|9156000|P7|Week 12 to End of Study|Withdrawal by Subject|1
2651024|NCT00718718|9156001|P6|Week 12 to End of Study|Withdrawal by Subject|2
2651025|NCT00718718|9156002|P5|Week 12 to End of Study|Withdrawal by Subject|0
2651026|NCT00718718|9156003|P4|Week 12 to End of Study|Withdrawal by Subject|0
2651027|NCT00718718|9156004|P3|Week 12 to End of Study|Withdrawal by Subject|0
2651028|NCT00718718|9156005|P2|Week 12 to End of Study|Withdrawal by Subject|0
2651029|NCT00718718|9156006|P1|Week 12 to End of Study|Withdrawal by Subject|0
2651030|NCT00718718|9155997|P10|Week 12 to End of Study|Death|0
2651031|NCT00718718|9155998|P9|Week 12 to End of Study|Death|0
2651032|NCT00718718|9155999|P8|Week 12 to End of Study|Death|0
2651033|NCT00718718|9156000|P7|Week 12 to End of Study|Death|0
2651034|NCT00718718|9156001|P6|Week 12 to End of Study|Death|1
2651035|NCT00718718|9156002|P5|Week 12 to End of Study|Death|0
2651036|NCT00718718|9156003|P4|Week 12 to End of Study|Death|0
2651037|NCT00718718|9156004|P3|Week 12 to End of Study|Death|0
2651038|NCT00718718|9156005|P2|Week 12 to End of Study|Death|0
2651039|NCT00718718|9156006|P1|Week 12 to End of Study|Death|0
2651040|NCT00718718|9155997|P10|Week 12 to End of Study|Adverse Event|0
2651041|NCT00718718|9155998|P9|Week 12 to End of Study|Adverse Event|0
2651042|NCT00718718|9155999|P8|Week 12 to End of Study|Adverse Event|1
2651043|NCT00718718|9156000|P7|Week 12 to End of Study|Adverse Event|0
2651044|NCT00718718|9156001|P6|Week 12 to End of Study|Adverse Event|0
2651045|NCT00718718|9156002|P5|Week 12 to End of Study|Adverse Event|0
2651046|NCT00718718|9156003|P4|Week 12 to End of Study|Adverse Event|0
2651047|NCT00718718|9156004|P3|Week 12 to End of Study|Adverse Event|0
2651048|NCT00718718|9156005|P2|Week 12 to End of Study|Adverse Event|0
2651049|NCT00718718|9156006|P1|Week 12 to End of Study|Adverse Event|0
2651050|NCT00718718|9155997|P10|Prior to Week 12|Other|0
2651051|NCT00718718|9155998|P9|Prior to Week 12|Other|0
2651052|NCT00718718|9155999|P8|Prior to Week 12|Other|0
2651053|NCT00718718|9156000|P7|Prior to Week 12|Other|0
2651054|NCT00718718|9156001|P6|Prior to Week 12|Other|0
2651055|NCT00718718|9156002|P5|Prior to Week 12|Other|0
2651056|NCT00718718|9156003|P4|Prior to Week 12|Other|0
2651057|NCT00718718|9156004|P3|Prior to Week 12|Other|1
2651058|NCT00718718|9156005|P2|Prior to Week 12|Other|0
2651059|NCT00718718|9156006|P1|Prior to Week 12|Other|1
2651060|NCT00718718|9155997|P10|Prior to Week 12|Withdrawal by Subject|0
2651061|NCT00718718|9155998|P9|Prior to Week 12|Withdrawal by Subject|1
2651062|NCT00718718|9155999|P8|Prior to Week 12|Withdrawal by Subject|1
2651063|NCT00718718|9156000|P7|Prior to Week 12|Withdrawal by Subject|1
2651064|NCT00718718|9156001|P6|Prior to Week 12|Withdrawal by Subject|0
2651065|NCT00718718|9156002|P5|Prior to Week 12|Withdrawal by Subject|3
2651066|NCT00718718|9156003|P4|Prior to Week 12|Withdrawal by Subject|0
2651067|NCT00718718|9156004|P3|Prior to Week 12|Withdrawal by Subject|0
2651068|NCT00718718|9156005|P2|Prior to Week 12|Withdrawal by Subject|0
2651069|NCT00718718|9156006|P1|Prior to Week 12|Withdrawal by Subject|0
2651070|NCT00718718|9155997|P10|Prior to Week 12|Adverse Event|0
2651071|NCT00718718|9155998|P9|Prior to Week 12|Adverse Event|1
2651072|NCT00718718|9155999|P8|Prior to Week 12|Adverse Event|1
2651073|NCT00718718|9156000|P7|Prior to Week 12|Adverse Event|0
2651074|NCT00718718|9156001|P6|Prior to Week 12|Adverse Event|0
2651075|NCT00718718|9156002|P5|Prior to Week 12|Adverse Event|0
2651076|NCT00718718|9156003|P4|Prior to Week 12|Adverse Event|0
2651077|NCT00718718|9156004|P3|Prior to Week 12|Adverse Event|0
2651078|NCT00718718|9156005|P2|Prior to Week 12|Adverse Event|0
2651079|NCT00718718|9156006|P1|Prior to Week 12|Adverse Event|0
2651080|NCT00718666|9156049|P3|Booster Phase Year 5|Lost to Follow-up|4
2651081|NCT00718666|9156050|P2|Booster Phase Year 5|Lost to Follow-up|0
2651082|NCT00718666|9156051|P1|Booster Phase Year 5|Lost to Follow-up|1
2651083|NCT00718666|9156049|P3|Booster Phase Year 5|Withdrawal by Subject|1
2651084|NCT00718666|9156050|P2|Booster Phase Year 5|Withdrawal by Subject|0
2651085|NCT00718666|9156051|P1|Booster Phase Year 5|Withdrawal by Subject|0
2651086|NCT00718666|9156049|P3|Booster Phase Year 5|Declined v-4 serology|0
2651087|NCT00718666|9156050|P2|Booster Phase Year 5|Declined v-4 serology|0
2651088|NCT00718666|9156051|P1|Booster Phase Year 5|Declined v-4 serology|1
2651089|NCT00718666|9156049|P3|Booster Phase Year 5|No active participation request|1
2651090|NCT00718666|9156050|P2|Booster Phase Year 5|No active participation request|0
2651091|NCT00718666|9156051|P1|Booster Phase Year 5|No active participation request|0
2651092|NCT00718640|9156135|P1|Overall Study|Unresolved toxicity after 2 weeks|2
2651093|NCT00718640|9156135|P1|Overall Study|Death|1
2651094|NCT00718640|9156135|P1|Overall Study|Adverse Event|4
2651095|NCT00718549|9156147|P3|Maintenance/ Observation Phase|Relapse|2
2651096|NCT00718549|9156148|P2|Maintenance/ Observation Phase|Relapse|3
2651097|NCT00718549|9156149|P1|Maintenance/ Observation Phase|Relapse|0
2651098|NCT00718549|9156147|P3|Maintenance/ Observation Phase|Progression|14
2651099|NCT00718549|9156148|P2|Maintenance/ Observation Phase|Progression|5
2651100|NCT00718549|9156149|P1|Maintenance/ Observation Phase|Progression|0
2651101|NCT00718549|9156147|P3|Maintenance/ Observation Phase|Lost to Follow-up|4
2651102|NCT00718549|9156148|P2|Maintenance/ Observation Phase|Lost to Follow-up|4
2651103|NCT00718549|9156149|P1|Maintenance/ Observation Phase|Lost to Follow-up|0
2651104|NCT00718549|9156147|P3|Maintenance/ Observation Phase|Death|2
2651105|NCT00718549|9156148|P2|Maintenance/ Observation Phase|Death|1
2651106|NCT00718549|9156149|P1|Maintenance/ Observation Phase|Death|0
2651107|NCT00718549|9156147|P3|Maintenance/ Observation Phase|Early Termination - No Additional Info|8
2651108|NCT00718549|9156148|P2|Maintenance/ Observation Phase|Early Termination - No Additional Info|15
2651109|NCT00718549|9156149|P1|Maintenance/ Observation Phase|Early Termination - No Additional Info|0
2651110|NCT00718549|9156147|P3|Induction Phase|Early Termination - No Additional Info|0
2651111|NCT00718549|9156148|P2|Induction Phase|Early Termination - No Additional Info|0
2651112|NCT00718549|9156149|P1|Induction Phase|Early Termination - No Additional Info|59
2651113|NCT00718549|9156147|P3|Induction Phase|Eligibility Criteria Violation|0
2651114|NCT00718549|9156148|P2|Induction Phase|Eligibility Criteria Violation|0
2651115|NCT00718549|9156149|P1|Induction Phase|Eligibility Criteria Violation|2
2651116|NCT00718549|9156147|P3|Induction Phase|Disease Progression|0
2651117|NCT00718549|9156148|P2|Induction Phase|Disease Progression|0
2651118|NCT00718549|9156149|P1|Induction Phase|Disease Progression|1
2651119|NCT00718523|9156174|P2|Overall Study|Death|17
2651120|NCT00718523|9156175|P1|Overall Study|Death|13
2651121|NCT00718523|9156174|P2|Overall Study|Withdrawal by Subject|7
2651122|NCT00718523|9156175|P1|Overall Study|Withdrawal by Subject|5
2651123|NCT00718510|9156187|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|0
2651124|NCT00718510|9156188|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|1
2651125|NCT00718510|9156187|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
2651126|NCT00718510|9156188|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
2651127|NCT00718328|9156200|P2|Overall Study|Lost to Follow-up|0
2651128|NCT00718328|9156201|P1|Overall Study|Lost to Follow-up|1
2651129|NCT00718315|9156210|P3|Overall Study|Use of ATB and Corticoids|2
2651130|NCT00718315|9156211|P2|Overall Study|Use of ATB and Corticoids|1
2651131|NCT00718315|9156212|P1|Overall Study|Use of ATB and Corticoids|0
2651132|NCT00718315|9156210|P3|Overall Study|Other|1
2651133|NCT00718315|9156211|P2|Overall Study|Other|0
2651134|NCT00718315|9156212|P1|Overall Study|Other|0
2651135|NCT00718315|9156210|P3|Overall Study|Disease progression|1
2651136|NCT00718315|9156211|P2|Overall Study|Disease progression|1
2651137|NCT00718315|9156212|P1|Overall Study|Disease progression|0
2651138|NCT00718315|9156210|P3|Overall Study|Use of Minocyclin|1
2651139|NCT00718315|9156211|P2|Overall Study|Use of Minocyclin|1
2651140|NCT00718315|9156212|P1|Overall Study|Use of Minocyclin|1
2651141|NCT00718315|9156210|P3|Overall Study|Erlotinib dose decreased|1
2651142|NCT00718315|9156211|P2|Overall Study|Erlotinib dose decreased|3
2651143|NCT00718315|9156212|P1|Overall Study|Erlotinib dose decreased|4
2651144|NCT00718315|9156210|P3|Overall Study|Protocol Violation|3
2651145|NCT00718315|9156211|P2|Overall Study|Protocol Violation|5
2651146|NCT00718315|9156212|P1|Overall Study|Protocol Violation|5
2651147|NCT00718315|9156210|P3|Overall Study|Lost to Follow-up|4
2651148|NCT00718315|9156211|P2|Overall Study|Lost to Follow-up|3
2651149|NCT00718315|9156212|P1|Overall Study|Lost to Follow-up|2
2651150|NCT00718315|9156210|P3|Overall Study|Death|5
2651151|NCT00718315|9156211|P2|Overall Study|Death|6
2651152|NCT00718315|9156212|P1|Overall Study|Death|6
2651153|NCT00718315|9156210|P3|Overall Study|Adverse Event|3
2651154|NCT00718315|9156211|P2|Overall Study|Adverse Event|2
2651155|NCT00718315|9156212|P1|Overall Study|Adverse Event|1
2651156|NCT00718237|9156263|P2|Overall Study|Withdrawal by Subject|10
2651157|NCT00718237|9156264|P1|Overall Study|Withdrawal by Subject|9
2651158|NCT00718237|9156263|P2|Overall Study|Physician Decision|0
2651159|NCT00718237|9156264|P1|Overall Study|Physician Decision|1
2651160|NCT00718237|9156263|P2|Overall Study|Lost to Follow-up|2
2651161|NCT00718237|9156264|P1|Overall Study|Lost to Follow-up|2
2651162|NCT00718237|9156263|P2|Overall Study|Adverse Event|3
2651163|NCT00718237|9156264|P1|Overall Study|Adverse Event|1
2651164|NCT00718159|9156281|P7|Overall Study|Investigator Decision|1
2651165|NCT00718159|9156282|P6|Overall Study|Investigator Decision|1
2651166|NCT00718159|9156283|P5|Overall Study|Investigator Decision|0
2651167|NCT00718159|9156284|P4|Overall Study|Investigator Decision|0
2651168|NCT00718159|9156285|P3|Overall Study|Investigator Decision|0
2651169|NCT00718159|9156286|P2|Overall Study|Investigator Decision|0
2651170|NCT00718159|9156287|P1|Overall Study|Investigator Decision|0
2651171|NCT00718159|9156281|P7|Overall Study|Death due to Study Drug Toxicity|0
2651172|NCT00718159|9156282|P6|Overall Study|Death due to Study Drug Toxicity|0
2651173|NCT00718159|9156283|P5|Overall Study|Death due to Study Drug Toxicity|0
2651174|NCT00718159|9156284|P4|Overall Study|Death due to Study Drug Toxicity|2
2651175|NCT00718159|9156285|P3|Overall Study|Death due to Study Drug Toxicity|1
2651176|NCT00718159|9156286|P2|Overall Study|Death due to Study Drug Toxicity|0
2651177|NCT00718159|9156287|P1|Overall Study|Death due to Study Drug Toxicity|0
2651178|NCT00718159|9156281|P7|Overall Study|Death due to Adverse Event|0
2651179|NCT00718159|9156282|P6|Overall Study|Death due to Adverse Event|0
2651180|NCT00718159|9156283|P5|Overall Study|Death due to Adverse Event|2
2651181|NCT00718159|9156284|P4|Overall Study|Death due to Adverse Event|2
2651182|NCT00718159|9156285|P3|Overall Study|Death due to Adverse Event|0
2651183|NCT00718159|9156286|P2|Overall Study|Death due to Adverse Event|0
2651184|NCT00718159|9156287|P1|Overall Study|Death due to Adverse Event|0
2651185|NCT00718159|9156281|P7|Overall Study|Progressive Disease|0
2651186|NCT00718159|9156282|P6|Overall Study|Progressive Disease|0
2651187|NCT00718159|9156283|P5|Overall Study|Progressive Disease|6
2651188|NCT00718159|9156284|P4|Overall Study|Progressive Disease|0
2651189|NCT00718159|9156285|P3|Overall Study|Progressive Disease|2
2651190|NCT00718159|9156286|P2|Overall Study|Progressive Disease|3
2651191|NCT00718159|9156287|P1|Overall Study|Progressive Disease|3
2651192|NCT00718081|9156344|P3|Overall Study|Lack of Efficacy|21
2651193|NCT00718081|9156345|P2|Overall Study|Lack of Efficacy|3
2651194|NCT00718081|9156346|P1|Overall Study|Lack of Efficacy|7
2651195|NCT00718081|9156344|P3|Overall Study|Adverse Event|0
2651196|NCT00718081|9156345|P2|Overall Study|Adverse Event|1
2651197|NCT00718081|9156346|P1|Overall Study|Adverse Event|0
2651198|NCT00718042|9156363|P6|Donor Follow-up|Lost to Follow-up|0
2651199|NCT00718042|9156364|P5|Donor Follow-up|Lost to Follow-up|19
2651200|NCT00718042|9156365|P4|Donor Follow-up|Lost to Follow-up|0
2651201|NCT00718042|9156366|P3|Donor Follow-up|Lost to Follow-up|0
2651202|NCT00718042|9156367|P2|Donor Follow-up|Lost to Follow-up|0
2651203|NCT00718042|9156368|P1|Donor Follow-up|Lost to Follow-up|13
2651204|NCT00718042|9156363|P6|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
2651205|NCT00718042|9156364|P5|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
2651206|NCT00718042|9156365|P4|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
2651207|NCT00718042|9156366|P3|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
2651208|NCT00718042|9156367|P2|ABBOTT PRISM Chagas Testing|No result on comparator assay|1
2651209|NCT00718042|9156368|P1|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
2651210|NCT00718042|9156363|P6|ABBOTT PRISM Chagas Testing|Insufficient sample|0
2651211|NCT00718042|9156364|P5|ABBOTT PRISM Chagas Testing|Insufficient sample|0
2651212|NCT00718042|9156365|P4|ABBOTT PRISM Chagas Testing|Insufficient sample|0
2651213|NCT00718042|9156366|P3|ABBOTT PRISM Chagas Testing|Insufficient sample|1
2651214|NCT00718042|9156367|P2|ABBOTT PRISM Chagas Testing|Insufficient sample|1
2651215|NCT00718042|9156368|P1|ABBOTT PRISM Chagas Testing|Insufficient sample|0
2651216|NCT00718042|9156363|P6|ABBOTT PRISM Chagas Testing|Protocol Violation|0
2651217|NCT00718042|9156364|P5|ABBOTT PRISM Chagas Testing|Protocol Violation|36
2651218|NCT00718042|9156365|P4|ABBOTT PRISM Chagas Testing|Protocol Violation|0
2651219|NCT00718042|9156366|P3|ABBOTT PRISM Chagas Testing|Protocol Violation|0
2651220|NCT00718042|9156367|P2|ABBOTT PRISM Chagas Testing|Protocol Violation|0
2651221|NCT00718042|9156368|P1|ABBOTT PRISM Chagas Testing|Protocol Violation|64
2651222|NCT00718042|9156363|P6|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
2651223|NCT00718042|9156364|P5|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2
2651224|NCT00718042|9156365|P4|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
2651225|NCT00718042|9156366|P3|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
2651226|NCT00718042|9156367|P2|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
2651227|NCT00718042|9156368|P1|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
2651228|NCT00717886|9156424|P1|Overall Study|Treatment Failure|1
2651229|NCT00717886|9156424|P1|Overall Study|Withdrawal by Subject|3
2651230|NCT00717860|9156439|P2|Overall Study|Withdrew consent|3
2651231|NCT00717860|9156440|P1|Overall Study|Withdrew consent|7
2651232|NCT00717860|9156439|P2|Overall Study|Discontinued for other reason|1
2651233|NCT00717860|9156440|P1|Overall Study|Discontinued for other reason|6
2651234|NCT00717860|9156439|P2|Overall Study|Lack of Efficacy|13
2651235|NCT00717860|9156440|P1|Overall Study|Lack of Efficacy|7
2651236|NCT00717860|9156439|P2|Overall Study|Laboratory adverse experience|2
2651237|NCT00717860|9156440|P1|Overall Study|Laboratory adverse experience|2
2651238|NCT00717860|9156439|P2|Overall Study|Clinical adverse experience|9
2651239|NCT00717860|9156440|P1|Overall Study|Clinical adverse experience|5
2651240|NCT00717756|9156450|P1|Overall Study|Withdrawal by Subject|1
2651241|NCT00717522|9156463|P1|Overall Study|Death|1
2651242|NCT00717522|9156463|P1|Overall Study|Adverse Event|1
2651243|NCT00717522|9156463|P1|Overall Study|Disease Progression|5
2651244|NCT00717366|9156499|P2|Extension Period (52 Weeks)|Withdrew consent|1
2651245|NCT00717366|9156500|P1|Extension Period (52 Weeks)|Withdrew consent|1
2651246|NCT00717366|9156499|P2|Extension Period (52 Weeks)|Admin/Other than specified|2
2651247|NCT00717366|9156500|P1|Extension Period (52 Weeks)|Admin/Other than specified|0
2651248|NCT00717366|9156499|P2|Extension Period (52 Weeks)|Renal transplant|13
2651249|NCT00717366|9156500|P1|Extension Period (52 Weeks)|Renal transplant|3
2651250|NCT00717366|9156499|P2|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1
2651251|NCT00717366|9156500|P1|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0
2651252|NCT00717366|9156499|P2|Core Study Period (20 Weeks)|Death|1
2651253|NCT00717366|9156500|P1|Core Study Period (20 Weeks)|Death|0
2651254|NCT00717366|9156499|P2|Core Study Period (20 Weeks)|Admin/Other than specified|2
2651255|NCT00717366|9156500|P1|Core Study Period (20 Weeks)|Admin/Other than specified|0
2651256|NCT00717366|9156499|P2|Core Study Period (20 Weeks)|Renal transplant|9
2651257|NCT00717366|9156500|P1|Core Study Period (20 Weeks)|Renal transplant|4
2651258|NCT00717314|9156524|P2|Overall Study|Withdrawal by Subject|3
2651259|NCT00717314|9156525|P1|Overall Study|Withdrawal by Subject|1
2651260|NCT00717314|9156524|P2|Overall Study|Lost to Follow-up|5
2651261|NCT00717314|9156525|P1|Overall Study|Lost to Follow-up|1
2651262|NCT00717314|9156524|P2|Overall Study|Protocol Violation|0
2651263|NCT00717314|9156525|P1|Overall Study|Protocol Violation|1
2651264|NCT00717314|9156524|P2|Overall Study|Adverse Event|2
2651265|NCT00717314|9156525|P1|Overall Study|Adverse Event|3
2651266|NCT00717275|9156562|P1|Overall Study|Premature study termination.|3
2651267|NCT00717249|9156568|P2|Overall Study|Headaches|0
2651268|NCT00717249|9156569|P1|Overall Study|Headaches|1
2651269|NCT00717249|9156568|P2|Overall Study|Subject relocated|0
2651270|NCT00717249|9156569|P1|Overall Study|Subject relocated|1
2651271|NCT00717249|9156568|P2|Overall Study|Diagnosed with Multiple Scletosis|0
2651272|NCT00717249|9156569|P1|Overall Study|Diagnosed with Multiple Scletosis|1
2651273|NCT00717249|9156568|P2|Overall Study|Diagnosed with Diabetes|0
2651274|NCT00717249|9156569|P1|Overall Study|Diagnosed with Diabetes|1
2651275|NCT00717249|9156568|P2|Overall Study|Gastric Surgery|1
2651276|NCT00717249|9156569|P1|Overall Study|Gastric Surgery|0
2651277|NCT00717249|9156568|P2|Overall Study|Unsatisfactory Physiological Response|1
2651278|NCT00717249|9156569|P1|Overall Study|Unsatisfactory Physiological Response|0
2651279|NCT00717249|9156568|P2|Overall Study|Subject became Ineligible|1
2651280|NCT00717249|9156569|P1|Overall Study|Subject became Ineligible|1
2651281|NCT00717249|9156568|P2|Overall Study|Protocol Violation|2
2651282|NCT00717249|9156569|P1|Overall Study|Protocol Violation|0
2651283|NCT00717249|9156568|P2|Overall Study|Pregnancy|3
2651284|NCT00717249|9156569|P1|Overall Study|Pregnancy|6
2651285|NCT00717249|9156568|P2|Overall Study|Withdrawal by Subject|2
2651286|NCT00717249|9156569|P1|Overall Study|Withdrawal by Subject|1
2651287|NCT00717249|9156568|P2|Overall Study|Lost to Follow-up|0
2651288|NCT00717249|9156569|P1|Overall Study|Lost to Follow-up|2
2651289|NCT00717249|9156568|P2|Overall Study|Adverse Event|2
2651290|NCT00717249|9156569|P1|Overall Study|Adverse Event|4
2651291|NCT00717249|9156568|P2|Overall Study|Unsatisfactory visual Response|2
2651292|NCT00717249|9156569|P1|Overall Study|Unsatisfactory visual Response|0
2651293|NCT00717249|9156568|P2|Overall Study|Lens Discomfort|1
2651294|NCT00717249|9156569|P1|Overall Study|Lens Discomfort|4
2651295|NCT00717236|9156583|P2|Open-Label Period|Other: Medical Monitor Recommendation|0
2651296|NCT00717236|9156584|P1|Open-Label Period|Other: Medical Monitor Recommendation|1
2651297|NCT00717236|9156583|P2|Open-Label Period|Other: Completion Accidently Performed|0
2651298|NCT00717236|9156584|P1|Open-Label Period|Other: Completion Accidently Performed|1
2651299|NCT00717236|9156583|P2|Open-Label Period|Other: Administration of Golimumab|0
2651300|NCT00717236|9156584|P1|Open-Label Period|Other: Administration of Golimumab|1
2651301|NCT00717236|9156583|P2|Open-Label Period|Other: Cataract Surgery|0
2651302|NCT00717236|9156584|P1|Open-Label Period|Other: Cataract Surgery|1
2651303|NCT00717236|9156583|P2|Open-Label Period|Other: Sponsor Request|0
2651304|NCT00717236|9156584|P1|Open-Label Period|Other: Sponsor Request|3
2651305|NCT00717236|9156583|P2|Open-Label Period|Other: Loss of Staff (unblinded)|0
2651306|NCT00717236|9156584|P1|Open-Label Period|Other: Loss of Staff (unblinded)|1
2651307|NCT00717236|9156583|P2|Open-Label Period|Other: Investigator Decision|0
2651308|NCT00717236|9156584|P1|Open-Label Period|Other: Investigator Decision|1
2651309|NCT00717236|9156583|P2|Open-Label Period|Other: Moved|0
2651310|NCT00717236|9156584|P1|Open-Label Period|Other: Moved|1
2651311|NCT00717236|9156583|P2|Open-Label Period|Other: History of Basal Cell Carcinoma|0
2651312|NCT00717236|9156584|P1|Open-Label Period|Other: History of Basal Cell Carcinoma|1
2651313|NCT00717236|9156583|P2|Open-Label Period|Other: Lack of Compliance|1
2651314|NCT00717236|9156584|P1|Open-Label Period|Other: Lack of Compliance|1
2651315|NCT00717236|9156583|P2|Open-Label Period|Other: Peripheral Neuropathy|1
2651316|NCT00717236|9156584|P1|Open-Label Period|Other: Peripheral Neuropathy|0
2651317|NCT00717236|9156583|P2|Open-Label Period|Loss of Efficacy|1
2651318|NCT00717236|9156584|P1|Open-Label Period|Loss of Efficacy|6
2651319|NCT00717236|9156583|P2|Open-Label Period|Withdrawal by Subject|2
2651320|NCT00717236|9156584|P1|Open-Label Period|Withdrawal by Subject|20
2651321|NCT00717236|9156583|P2|Open-Label Period|Lost to Follow-up|4
2651322|NCT00717236|9156584|P1|Open-Label Period|Lost to Follow-up|28
2651323|NCT00717236|9156583|P2|Open-Label Period|Lack of Efficacy|8
2651324|NCT00717236|9156584|P1|Open-Label Period|Lack of Efficacy|30
2651325|NCT00717236|9156583|P2|Open-Label Period|Adverse Event|4
2651326|NCT00717236|9156584|P1|Open-Label Period|Adverse Event|29
2651327|NCT00717236|9156583|P2|Double-Blind Period|Other: Investigator Decision|1
2651328|NCT00717236|9156584|P1|Double-Blind Period|Other: Investigator Decision|0
2651329|NCT00717236|9156583|P2|Double-Blind Period|Other: Transportation problems|1
2651330|NCT00717236|9156584|P1|Double-Blind Period|Other: Transportation problems|0
2651331|NCT00717236|9156583|P2|Double-Blind Period|Other: Prohibited medication taken|2
2651332|NCT00717236|9156584|P1|Double-Blind Period|Other: Prohibited medication taken|2
2651333|NCT00717236|9156583|P2|Double-Blind Period|Other: Stopped taking DMARD|0
2651334|NCT00717236|9156584|P1|Double-Blind Period|Other: Stopped taking DMARD|1
2651335|NCT00717236|9156583|P2|Double-Blind Period|Other: Subject moved|1
2651336|NCT00717236|9156584|P1|Double-Blind Period|Other: Subject moved|1
2651337|NCT00717236|9156583|P2|Double-Blind Period|Other: Detection of Hepatitis C Virus|0
2651338|NCT00717236|9156584|P1|Double-Blind Period|Other: Detection of Hepatitis C Virus|1
2651339|NCT00717236|9156583|P2|Double-Blind Period|Other: Inappropriate randomization|0
2651340|NCT00717236|9156584|P1|Double-Blind Period|Other: Inappropriate randomization|1
2651341|NCT00717236|9156583|P2|Double-Blind Period|Other: Sponsor request|0
2651342|NCT00717236|9156584|P1|Double-Blind Period|Other: Sponsor request|1
2651343|NCT00717236|9156583|P2|Double-Blind Period|Other: History of cancer|0
2651344|NCT00717236|9156584|P1|Double-Blind Period|Other: History of cancer|1
2651345|NCT00717236|9156583|P2|Double-Blind Period|Other: History of adenoid grown|0
2651346|NCT00717236|9156584|P1|Double-Blind Period|Other: History of adenoid grown|1
2651347|NCT00717236|9156583|P2|Double-Blind Period|Other: Abnormal chest X-ray|1
2651348|NCT00717236|9156584|P1|Double-Blind Period|Other: Abnormal chest X-ray|2
2651349|NCT00717236|9156583|P2|Double-Blind Period|Other: subject withdrew consent|1
2651350|NCT00717236|9156584|P1|Double-Blind Period|Other: subject withdrew consent|1
2651351|NCT00717236|9156583|P2|Double-Blind Period|Other: Screening failure|0
2651352|NCT00717236|9156584|P1|Double-Blind Period|Other: Screening failure|1
2651353|NCT00717236|9156583|P2|Double-Blind Period|Other: Site withdrew|0
2651354|NCT00717236|9156584|P1|Double-Blind Period|Other: Site withdrew|2
2651355|NCT00717236|9156583|P2|Double-Blind Period|Other: Inclusion/Exclusion criteria|2
2651356|NCT00717236|9156584|P1|Double-Blind Period|Other: Inclusion/Exclusion criteria|6
2651357|NCT00717236|9156583|P2|Double-Blind Period|Other: Protocol Violation|0
2651358|NCT00717236|9156584|P1|Double-Blind Period|Other: Protocol Violation|2
2651359|NCT00717236|9156583|P2|Double-Blind Period|Other: Pregnancy|0
2651360|NCT00717236|9156584|P1|Double-Blind Period|Other: Pregnancy|1
2651361|NCT00717236|9156583|P2|Double-Blind Period|Other: Death|0
2651362|NCT00717236|9156584|P1|Double-Blind Period|Other: Death|1
2651363|NCT00717236|9156583|P2|Double-Blind Period|Loss of efficacy|0
2651364|NCT00717236|9156584|P1|Double-Blind Period|Loss of efficacy|3
2651365|NCT00717236|9156583|P2|Double-Blind Period|Withdrawal by Subject|2
2651366|NCT00717236|9156584|P1|Double-Blind Period|Withdrawal by Subject|10
2651367|NCT00717236|9156583|P2|Double-Blind Period|Lost to Follow-up|5
2651368|NCT00717236|9156584|P1|Double-Blind Period|Lost to Follow-up|3
2651369|NCT00717236|9156583|P2|Double-Blind Period|Lack of Efficacy|6
2651370|NCT00717236|9156584|P1|Double-Blind Period|Lack of Efficacy|6
2651371|NCT00717236|9156583|P2|Double-Blind Period|Adverse Event|6
2651372|NCT00717236|9156584|P1|Double-Blind Period|Adverse Event|33
2651373|NCT00717197|9156653|P1|Overall Study|Physician Decision|1
2651374|NCT00717197|9156653|P1|Overall Study|Tumor Progression|1
2651375|NCT00717197|9156653|P1|Overall Study|Unable to purchase study drug|5
2651376|NCT00717093|9156659|P2|Overall Study|Randomized but not treated|0
2651377|NCT00717093|9156660|P1|Overall Study|Randomized but not treated|1
2651378|NCT00717093|9156659|P2|Overall Study|Other|1
2651379|NCT00717093|9156660|P1|Overall Study|Other|0
2651380|NCT00717093|9156659|P2|Overall Study|Withdrawal by Subject|19
2651381|NCT00717093|9156660|P1|Overall Study|Withdrawal by Subject|12
2651382|NCT00717093|9156659|P2|Overall Study|Lost to Follow-up|6
2651383|NCT00717093|9156660|P1|Overall Study|Lost to Follow-up|9
2651384|NCT00717093|9156659|P2|Overall Study|Lack of Efficacy|13
2651385|NCT00717093|9156660|P1|Overall Study|Lack of Efficacy|3
2651386|NCT00717093|9156659|P2|Overall Study|Adverse Event|9
2651387|NCT00717093|9156660|P1|Overall Study|Adverse Event|19
2651388|NCT00717067|9156677|P5|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
2651389|NCT00717067|9156678|P4|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
2651390|NCT00717067|9156679|P3|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1
2651391|NCT00717067|9156680|P2|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
2651392|NCT00717067|9156681|P1|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
2651393|NCT00716976|9156788|P2|Overall Study|Ineligibles|2
2651394|NCT00716976|9156789|P1|Overall Study|Ineligibles|4
2651395|NCT00716976|9156788|P2|Overall Study|Radiation during protocol|0
2651396|NCT00716976|9156789|P1|Overall Study|Radiation during protocol|1
2651397|NCT00716976|9156788|P2|Overall Study|Premature discontinuation cisplatin|4
2651398|NCT00716976|9156789|P1|Overall Study|Premature discontinuation cisplatin|5
2651399|NCT00716976|9156788|P2|Overall Study|Withdrawal by Subject|1
2651400|NCT00716976|9156789|P1|Overall Study|Withdrawal by Subject|5
2651401|NCT00716976|9156788|P2|Overall Study|Physician Decision|2
2651402|NCT00716976|9156789|P1|Overall Study|Physician Decision|2
2651403|NCT00716976|9156788|P2|Overall Study|Death|0
2651404|NCT00716976|9156789|P1|Overall Study|Death|1
2651405|NCT00716976|9156788|P2|Overall Study|Adverse Event|0
2651406|NCT00716976|9156789|P1|Overall Study|Adverse Event|2
2651407|NCT00716859|9156829|P2|Overall Study|Not treated|1
2651408|NCT00716859|9156830|P1|Overall Study|Not treated|1
2651409|NCT00716859|9156829|P2|Overall Study|Withdrawal by Subject|3
2651410|NCT00716859|9156830|P1|Overall Study|Withdrawal by Subject|1
2651411|NCT00716859|9156829|P2|Overall Study|Lack of Efficacy|0
2651412|NCT00716859|9156830|P1|Overall Study|Lack of Efficacy|3
2651413|NCT00716859|9156829|P2|Overall Study|Adverse Event|1
2651414|NCT00716859|9156830|P1|Overall Study|Adverse Event|4
2651415|NCT00716625|9156915|P1|Overall Study|Safety was not Assessable|1
2651416|NCT00716482|9156940|P1|Overall Study|inclusion/exclusion criteria not met|25
2651417|NCT00716482|9156940|P1|Overall Study|technical/machine error|28
2651418|NCT00716482|9156940|P1|Overall Study|no pathology obtained|10
2651419|NCT00716482|9156940|P1|Overall Study|Inadequate acquisition or analysis|50
2651420|NCT00716482|9156940|P1|Overall Study|Lost to Follow-up|6
2651421|NCT00716456|9156953|P3|Overall Study|Adverse Event|0
2651422|NCT00716456|9156954|P2|Overall Study|Adverse Event|2
2651423|NCT00716456|9156955|P1|Overall Study|Adverse Event|0
2651424|NCT00716417|9157006|P10|Overall Study|On patient request due to toxicities|0
2651425|NCT00716417|9157007|P9|Overall Study|On patient request due to toxicities|0
2651426|NCT00716417|9157008|P8|Overall Study|On patient request due to toxicities|1
2651427|NCT00716417|9157009|P7|Overall Study|On patient request due to toxicities|0
2651428|NCT00716417|9157010|P6|Overall Study|On patient request due to toxicities|0
2651429|NCT00716417|9157011|P5|Overall Study|On patient request due to toxicities|0
2651430|NCT00716417|9157012|P4|Overall Study|On patient request due to toxicities|0
2651431|NCT00716417|9157013|P3|Overall Study|On patient request due to toxicities|0
2651432|NCT00716417|9157014|P2|Overall Study|On patient request due to toxicities|0
2651433|NCT00716417|9157015|P1|Overall Study|On patient request due to toxicities|0
2651434|NCT00716417|9157006|P10|Overall Study|Dose limiting toxicity (DLT)|0
2651435|NCT00716417|9157007|P9|Overall Study|Dose limiting toxicity (DLT)|0
2651436|NCT00716417|9157008|P8|Overall Study|Dose limiting toxicity (DLT)|0
2651437|NCT00716417|9157009|P7|Overall Study|Dose limiting toxicity (DLT)|0
2651438|NCT00716417|9157010|P6|Overall Study|Dose limiting toxicity (DLT)|0
2651439|NCT00716417|9157011|P5|Overall Study|Dose limiting toxicity (DLT)|1
2651440|NCT00716417|9157012|P4|Overall Study|Dose limiting toxicity (DLT)|0
2651441|NCT00716417|9157013|P3|Overall Study|Dose limiting toxicity (DLT)|0
2651442|NCT00716417|9157014|P2|Overall Study|Dose limiting toxicity (DLT)|0
2651443|NCT00716417|9157015|P1|Overall Study|Dose limiting toxicity (DLT)|0
2651444|NCT00716417|9157006|P10|Overall Study|Progressive disease|0
2651445|NCT00716417|9157007|P9|Overall Study|Progressive disease|5
2651446|NCT00716417|9157008|P8|Overall Study|Progressive disease|1
2651447|NCT00716417|9157009|P7|Overall Study|Progressive disease|3
2651448|NCT00716417|9157010|P6|Overall Study|Progressive disease|3
2651449|NCT00716417|9157011|P5|Overall Study|Progressive disease|0
2651450|NCT00716417|9157012|P4|Overall Study|Progressive disease|8
2651451|NCT00716417|9157013|P3|Overall Study|Progressive disease|3
2651452|NCT00716417|9157014|P2|Overall Study|Progressive disease|5
2651453|NCT00716417|9157015|P1|Overall Study|Progressive disease|3
2651454|NCT00716417|9157006|P10|Overall Study|Withdrawal by Subject|0
2651455|NCT00716417|9157007|P9|Overall Study|Withdrawal by Subject|0
2651456|NCT00716417|9157008|P8|Overall Study|Withdrawal by Subject|0
2651457|NCT00716417|9157009|P7|Overall Study|Withdrawal by Subject|1
2651458|NCT00716417|9157010|P6|Overall Study|Withdrawal by Subject|0
2651459|NCT00716417|9157011|P5|Overall Study|Withdrawal by Subject|0
2651460|NCT00716417|9157012|P4|Overall Study|Withdrawal by Subject|2
2651461|NCT00716417|9157013|P3|Overall Study|Withdrawal by Subject|0
2651462|NCT00716417|9157014|P2|Overall Study|Withdrawal by Subject|1
2651463|NCT00716417|9157015|P1|Overall Study|Withdrawal by Subject|0
2651464|NCT00716417|9157006|P10|Overall Study|Adverse Event|3
2651465|NCT00716417|9157007|P9|Overall Study|Adverse Event|0
2651466|NCT00716417|9157008|P8|Overall Study|Adverse Event|1
2651467|NCT00716417|9157009|P7|Overall Study|Adverse Event|3
2651468|NCT00716417|9157010|P6|Overall Study|Adverse Event|0
2651469|NCT00716417|9157011|P5|Overall Study|Adverse Event|0
2651470|NCT00716417|9157012|P4|Overall Study|Adverse Event|1
2651471|NCT00716417|9157013|P3|Overall Study|Adverse Event|2
2651472|NCT00716417|9157014|P2|Overall Study|Adverse Event|0
2651473|NCT00716417|9157015|P1|Overall Study|Adverse Event|0
2651474|NCT00716274|9157062|P6|Study Period III (16-Weeks)|Adverse Event|0
2651475|NCT00716274|9157063|P5|Study Period III (16-Weeks)|Adverse Event|1
2651476|NCT00716274|9157064|P4|Study Period III (16-Weeks)|Adverse Event|0
2651477|NCT00716274|9157065|P3|Study Period III (16-Weeks)|Adverse Event|0
2651478|NCT00716274|9157066|P2|Study Period III (16-Weeks)|Adverse Event|0
2651479|NCT00716274|9157067|P1|Study Period III (16-Weeks)|Adverse Event|0
2651480|NCT00716274|9157062|P6|Study Period III (16-Weeks)|Parent Caregiver Decision|0
2651481|NCT00716274|9157063|P5|Study Period III (16-Weeks)|Parent Caregiver Decision|1
2651482|NCT00716274|9157064|P4|Study Period III (16-Weeks)|Parent Caregiver Decision|1
2651483|NCT00716274|9157065|P3|Study Period III (16-Weeks)|Parent Caregiver Decision|0
2651484|NCT00716274|9157066|P2|Study Period III (16-Weeks)|Parent Caregiver Decision|0
2651485|NCT00716274|9157067|P1|Study Period III (16-Weeks)|Parent Caregiver Decision|0
2651486|NCT00716274|9157062|P6|Study Period III (16-Weeks)|Physician Decision|0
2651487|NCT00716274|9157063|P5|Study Period III (16-Weeks)|Physician Decision|1
2651488|NCT00716274|9157064|P4|Study Period III (16-Weeks)|Physician Decision|0
2651489|NCT00716274|9157065|P3|Study Period III (16-Weeks)|Physician Decision|0
2651490|NCT00716274|9157066|P2|Study Period III (16-Weeks)|Physician Decision|0
2651491|NCT00716274|9157067|P1|Study Period III (16-Weeks)|Physician Decision|0
2651492|NCT00716274|9157062|P6|Study Period III (16-Weeks)|Withdrawal by Subject|0
2651493|NCT00716274|9157063|P5|Study Period III (16-Weeks)|Withdrawal by Subject|0
2651494|NCT00716274|9157064|P4|Study Period III (16-Weeks)|Withdrawal by Subject|0
2651495|NCT00716274|9157065|P3|Study Period III (16-Weeks)|Withdrawal by Subject|2
2651496|NCT00716274|9157066|P2|Study Period III (16-Weeks)|Withdrawal by Subject|0
2651497|NCT00716274|9157067|P1|Study Period III (16-Weeks)|Withdrawal by Subject|0
2651498|NCT00716274|9157062|P6|Study Period II (16-Weeks)|Lost to Follow-up|0
2651499|NCT00716274|9157063|P5|Study Period II (16-Weeks)|Lost to Follow-up|0
2651500|NCT00716274|9157064|P4|Study Period II (16-Weeks)|Lost to Follow-up|0
2651501|NCT00716274|9157065|P3|Study Period II (16-Weeks)|Lost to Follow-up|0
2651502|NCT00716274|9157066|P2|Study Period II (16-Weeks)|Lost to Follow-up|2
2651503|NCT00716274|9157067|P1|Study Period II (16-Weeks)|Lost to Follow-up|0
2651504|NCT00716274|9157062|P6|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
2651505|NCT00716274|9157063|P5|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
2651506|NCT00716274|9157064|P4|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
2651507|NCT00716274|9157065|P3|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
2651508|NCT00716274|9157066|P2|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
2651509|NCT00716274|9157067|P1|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
2651510|NCT00716274|9157062|P6|Study Period II (16-Weeks)|Physician Decision|1
2651511|NCT00716274|9157063|P5|Study Period II (16-Weeks)|Physician Decision|0
2651512|NCT00716274|9157064|P4|Study Period II (16-Weeks)|Physician Decision|0
2651513|NCT00716274|9157065|P3|Study Period II (16-Weeks)|Physician Decision|0
2651514|NCT00716274|9157066|P2|Study Period II (16-Weeks)|Physician Decision|1
2651515|NCT00716274|9157067|P1|Study Period II (16-Weeks)|Physician Decision|3
2651516|NCT00716274|9157062|P6|Study Period II (16-Weeks)|Withdrawal by Subject|0
2651517|NCT00716274|9157063|P5|Study Period II (16-Weeks)|Withdrawal by Subject|0
2651518|NCT00716274|9157064|P4|Study Period II (16-Weeks)|Withdrawal by Subject|0
2651519|NCT00716274|9157065|P3|Study Period II (16-Weeks)|Withdrawal by Subject|0
2651520|NCT00716274|9157066|P2|Study Period II (16-Weeks)|Withdrawal by Subject|0
2651521|NCT00716274|9157067|P1|Study Period II (16-Weeks)|Withdrawal by Subject|1
2651522|NCT00716274|9157062|P6|Study Period II (16-Weeks)|Protocol Violation|1
2651523|NCT00716274|9157063|P5|Study Period II (16-Weeks)|Protocol Violation|0
2651524|NCT00716274|9157064|P4|Study Period II (16-Weeks)|Protocol Violation|0
2651525|NCT00716274|9157065|P3|Study Period II (16-Weeks)|Protocol Violation|0
2651526|NCT00716274|9157066|P2|Study Period II (16-Weeks)|Protocol Violation|3
2651527|NCT00716274|9157067|P1|Study Period II (16-Weeks)|Protocol Violation|0
2651528|NCT00716274|9157062|P6|Study Period II (16-Weeks)|Entry Criteria Not Met|0
2651529|NCT00716274|9157063|P5|Study Period II (16-Weeks)|Entry Criteria Not Met|0
2651530|NCT00716274|9157064|P4|Study Period II (16-Weeks)|Entry Criteria Not Met|0
2651531|NCT00716274|9157065|P3|Study Period II (16-Weeks)|Entry Criteria Not Met|0
2651532|NCT00716274|9157066|P2|Study Period II (16-Weeks)|Entry Criteria Not Met|0
2651533|NCT00716274|9157067|P1|Study Period II (16-Weeks)|Entry Criteria Not Met|2
2651534|NCT00716144|9157201|P4|Overall Study|Clinical Depression|0
2651535|NCT00716144|9157202|P3|Overall Study|Clinical Depression|0
2651536|NCT00716144|9157203|P2|Overall Study|Clinical Depression|1
2651537|NCT00716144|9157204|P1|Overall Study|Clinical Depression|0
2651538|NCT00716144|9157201|P4|Overall Study|Adverse event: left foot pain|0
2651539|NCT00716144|9157202|P3|Overall Study|Adverse event: left foot pain|0
2651540|NCT00716144|9157203|P2|Overall Study|Adverse event: left foot pain|1
2651541|NCT00716144|9157204|P1|Overall Study|Adverse event: left foot pain|0
2651542|NCT00716144|9157201|P4|Overall Study|Withdrew consent, allowed use of data|0
2651543|NCT00716144|9157202|P3|Overall Study|Withdrew consent, allowed use of data|1
2651544|NCT00716144|9157203|P2|Overall Study|Withdrew consent, allowed use of data|0
2651545|NCT00716144|9157204|P1|Overall Study|Withdrew consent, allowed use of data|0
2651546|NCT00716144|9157201|P4|Overall Study|Intercurrent illness|0
2651547|NCT00716144|9157202|P3|Overall Study|Intercurrent illness|1
2651548|NCT00716144|9157203|P2|Overall Study|Intercurrent illness|0
2651549|NCT00716144|9157204|P1|Overall Study|Intercurrent illness|0
2651550|NCT00716144|9157201|P4|Overall Study|Physician Decision|2
2651551|NCT00716144|9157202|P3|Overall Study|Physician Decision|2
2651552|NCT00716144|9157203|P2|Overall Study|Physician Decision|1
2651553|NCT00716144|9157204|P1|Overall Study|Physician Decision|0
2651554|NCT00716144|9157201|P4|Overall Study|Protocol Violation|0
2651555|NCT00716144|9157202|P3|Overall Study|Protocol Violation|1
2651556|NCT00716144|9157203|P2|Overall Study|Protocol Violation|0
2651557|NCT00716144|9157204|P1|Overall Study|Protocol Violation|2
2651558|NCT00716144|9157201|P4|Overall Study|Non-compliance|0
2651559|NCT00716144|9157202|P3|Overall Study|Non-compliance|0
2651560|NCT00716144|9157203|P2|Overall Study|Non-compliance|0
2651561|NCT00716144|9157204|P1|Overall Study|Non-compliance|1
2651562|NCT00716144|9157201|P4|Overall Study|Adverse Event|2
2651563|NCT00716144|9157202|P3|Overall Study|Adverse Event|0
2651564|NCT00716144|9157203|P2|Overall Study|Adverse Event|0
2651565|NCT00716144|9157204|P1|Overall Study|Adverse Event|0
2651566|NCT00716144|9157201|P4|Overall Study|Lost to Follow-up|2
2651567|NCT00716144|9157202|P3|Overall Study|Lost to Follow-up|1
2651568|NCT00716144|9157203|P2|Overall Study|Lost to Follow-up|2
2651569|NCT00716144|9157204|P1|Overall Study|Lost to Follow-up|2
2651570|NCT00716144|9157201|P4|Overall Study|Withdrawal by Subject|6
2651571|NCT00716144|9157202|P3|Overall Study|Withdrawal by Subject|6
2651572|NCT00716144|9157203|P2|Overall Study|Withdrawal by Subject|2
2651573|NCT00716144|9157204|P1|Overall Study|Withdrawal by Subject|4
2651574|NCT00716092|9157229|P3|Overall Study|Other incl. Lack of Efficacy|0
2651575|NCT00716092|9157230|P2|Overall Study|Other incl. Lack of Efficacy|1
2651576|NCT00716092|9157231|P1|Overall Study|Other incl. Lack of Efficacy|2
2651577|NCT00715949|9157284|P1|Overall Study|could not finish first test|4
2651578|NCT00715910|9157292|P6|Booster and ESFU Phase|Other|0
2651579|NCT00715910|9157293|P5|Booster and ESFU Phase|Other|1
2651580|NCT00715910|9157294|P4|Booster and ESFU Phase|Other|5
2651581|NCT00715910|9157295|P3|Booster and ESFU Phase|Other|0
2651582|NCT00715910|9157296|P2|Booster and ESFU Phase|Other|0
2651583|NCT00715910|9157297|P1|Booster and ESFU Phase|Other|0
2651584|NCT00715910|9157292|P6|Booster and ESFU Phase|Lost to Follow-up|13
2651585|NCT00715910|9157293|P5|Booster and ESFU Phase|Lost to Follow-up|1
2651586|NCT00715910|9157294|P4|Booster and ESFU Phase|Lost to Follow-up|6
2651587|NCT00715910|9157295|P3|Booster and ESFU Phase|Lost to Follow-up|0
2651588|NCT00715910|9157296|P2|Booster and ESFU Phase|Lost to Follow-up|0
2651589|NCT00715910|9157297|P1|Booster and ESFU Phase|Lost to Follow-up|0
2651590|NCT00715793|9157416|P2|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2
2651591|NCT00715793|9157417|P1|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0
2651592|NCT00715793|9157416|P2|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0
2651593|NCT00715793|9157417|P1|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1
2651594|NCT00715676|9157478|P3|Overall Study|Elevated Blood Glucose|0
2651595|NCT00715676|9157479|P2|Overall Study|Elevated Blood Glucose|1
2651596|NCT00715676|9157480|P1|Overall Study|Elevated Blood Glucose|0
2651597|NCT00715676|9157478|P3|Overall Study|Use of Exclusionary Medication|1
2651598|NCT00715676|9157479|P2|Overall Study|Use of Exclusionary Medication|0
2651599|NCT00715676|9157480|P1|Overall Study|Use of Exclusionary Medication|0
2651600|NCT00715676|9157478|P3|Overall Study|Did Not Meet Entry Criteria|1
2651601|NCT00715676|9157479|P2|Overall Study|Did Not Meet Entry Criteria|0
2651602|NCT00715676|9157480|P1|Overall Study|Did Not Meet Entry Criteria|0
2651603|NCT00715676|9157478|P3|Overall Study|Terminated by Sponsor|0
2651604|NCT00715676|9157479|P2|Overall Study|Terminated by Sponsor|0
2651605|NCT00715676|9157480|P1|Overall Study|Terminated by Sponsor|1
2651606|NCT00715676|9157478|P3|Overall Study|Lost to Follow-up|1
2651607|NCT00715676|9157479|P2|Overall Study|Lost to Follow-up|2
2651608|NCT00715676|9157480|P1|Overall Study|Lost to Follow-up|1
2651609|NCT00715676|9157478|P3|Overall Study|Withdrawal by Subject|8
2651610|NCT00715676|9157479|P2|Overall Study|Withdrawal by Subject|3
2651611|NCT00715676|9157480|P1|Overall Study|Withdrawal by Subject|1
2651612|NCT00715676|9157478|P3|Overall Study|Adverse Event|21
2651613|NCT00715676|9157479|P2|Overall Study|Adverse Event|5
2651614|NCT00715676|9157480|P1|Overall Study|Adverse Event|3
2651615|NCT00715624|9157523|P2|Overall Study|Other|1
2651616|NCT00715624|9157524|P1|Overall Study|Other|0
2651617|NCT00715624|9157523|P2|Overall Study|Incorrect randomization (not treated)|1
2651618|NCT00715624|9157524|P1|Overall Study|Incorrect randomization (not treated)|0
2651619|NCT00715624|9157523|P2|Overall Study|Sponsor decision|4
2651620|NCT00715624|9157524|P1|Overall Study|Sponsor decision|0
2651621|NCT00715624|9157523|P2|Overall Study|Poor compliance|13
2651622|NCT00715624|9157524|P1|Overall Study|Poor compliance|6
2651623|NCT00715624|9157523|P2|Overall Study|Familial and personal reasons|22
2651624|NCT00715624|9157524|P1|Overall Study|Familial and personal reasons|10
2651625|NCT00715624|9157523|P2|Overall Study|Withdrawal by Subject|25
2651626|NCT00715624|9157524|P1|Overall Study|Withdrawal by Subject|11
2651627|NCT00715624|9157523|P2|Overall Study|Protocol Violation|0
2651628|NCT00715624|9157524|P1|Overall Study|Protocol Violation|1
2651629|NCT00715624|9157523|P2|Overall Study|Lost to Follow-up|2
2651630|NCT00715624|9157524|P1|Overall Study|Lost to Follow-up|1
2651631|NCT00715624|9157523|P2|Overall Study|Lack of Efficacy|11
2651632|NCT00715624|9157524|P1|Overall Study|Lack of Efficacy|11
2651633|NCT00715624|9157523|P2|Overall Study|Adverse Event|37
2651634|NCT00715624|9157524|P1|Overall Study|Adverse Event|12
2651635|NCT00715559|9157552|P1|Overall Study|medication not tolerated - nausea|1
2651636|NCT00715520|9157562|P3|Overall Study|Withdrawal by Subject|1
2651637|NCT00715520|9157563|P2|Overall Study|Withdrawal by Subject|0
2651638|NCT00715520|9157564|P1|Overall Study|Withdrawal by Subject|2
2651639|NCT00715520|9157562|P3|Overall Study|Screen failure|1
2651640|NCT00715520|9157563|P2|Overall Study|Screen failure|1
2651641|NCT00715520|9157564|P1|Overall Study|Screen failure|8
2651642|NCT00715429|9157579|P2|Overall Study|Did not complete the study diary|1
2651643|NCT00715429|9157580|P1|Overall Study|Did not complete the study diary|0
2651644|NCT00715403|9157595|P7|Overall Study|Other reason not defined above|0
2651645|NCT00715403|9157596|P6|Overall Study|Other reason not defined above|1
2651646|NCT00715403|9157597|P5|Overall Study|Other reason not defined above|1
2651647|NCT00715403|9157598|P4|Overall Study|Other reason not defined above|0
2651648|NCT00715403|9157599|P3|Overall Study|Other reason not defined above|1
2651649|NCT00715403|9157600|P2|Overall Study|Other reason not defined above|0
2651650|NCT00715403|9157601|P1|Overall Study|Other reason not defined above|0
2651651|NCT00715403|9157595|P7|Overall Study|Protocol Violation|0
2651652|NCT00715403|9157596|P6|Overall Study|Protocol Violation|1
2651653|NCT00715403|9157597|P5|Overall Study|Protocol Violation|0
2651654|NCT00715403|9157598|P4|Overall Study|Protocol Violation|0
2651655|NCT00715403|9157599|P3|Overall Study|Protocol Violation|0
2651656|NCT00715403|9157600|P2|Overall Study|Protocol Violation|0
2651657|NCT00715403|9157601|P1|Overall Study|Protocol Violation|0
2651658|NCT00715403|9157595|P7|Overall Study|Other Adverse Event than DLT|0
2651659|NCT00715403|9157596|P6|Overall Study|Other Adverse Event than DLT|2
2651660|NCT00715403|9157597|P5|Overall Study|Other Adverse Event than DLT|0
2651661|NCT00715403|9157598|P4|Overall Study|Other Adverse Event than DLT|0
2651662|NCT00715403|9157599|P3|Overall Study|Other Adverse Event than DLT|0
2651663|NCT00715403|9157600|P2|Overall Study|Other Adverse Event than DLT|0
2651664|NCT00715403|9157601|P1|Overall Study|Other Adverse Event than DLT|1
2651665|NCT00715403|9157595|P7|Overall Study|Dose limiting Toxicity (DLT)|0
2651666|NCT00715403|9157596|P6|Overall Study|Dose limiting Toxicity (DLT)|1
2651667|NCT00715403|9157597|P5|Overall Study|Dose limiting Toxicity (DLT)|0
2651668|NCT00715403|9157598|P4|Overall Study|Dose limiting Toxicity (DLT)|0
2651669|NCT00715403|9157599|P3|Overall Study|Dose limiting Toxicity (DLT)|0
2651670|NCT00715403|9157600|P2|Overall Study|Dose limiting Toxicity (DLT)|0
2651671|NCT00715403|9157601|P1|Overall Study|Dose limiting Toxicity (DLT)|0
2651672|NCT00715403|9157595|P7|Overall Study|Progressive disease|1
2651673|NCT00715403|9157596|P6|Overall Study|Progressive disease|14
2651674|NCT00715403|9157597|P5|Overall Study|Progressive disease|5
2651675|NCT00715403|9157598|P4|Overall Study|Progressive disease|9
2651676|NCT00715403|9157599|P3|Overall Study|Progressive disease|3
2651677|NCT00715403|9157600|P2|Overall Study|Progressive disease|1
2651678|NCT00715403|9157601|P1|Overall Study|Progressive disease|0
2651679|NCT00715299|9157740|P1|Overall Study|failed the pre-screen exercise test|2
2651680|NCT00715299|9157740|P1|Overall Study|Adverse Event|3
2651681|NCT00715299|9157740|P1|Overall Study|Withdrawal by Subject|1
2651682|NCT00715208|9157746|P2|Overall Study|Lack of Efficacy|2
2651683|NCT00715208|9157747|P1|Overall Study|Lack of Efficacy|0
2651684|NCT00715208|9157746|P2|Overall Study|Adverse Event|6
2651685|NCT00715208|9157747|P1|Overall Study|Adverse Event|0
2651686|NCT00715208|9157746|P2|Overall Study|Withdrawal by Subject|1
2651687|NCT00715208|9157747|P1|Overall Study|Withdrawal by Subject|1
2651688|NCT00715117|9157763|P2|Overall Study|Crohn's flare and rescue with steroids|1
2651689|NCT00715117|9157764|P1|Overall Study|Crohn's flare and rescue with steroids|0
2651690|NCT00715078|9157832|P3|Overall Study|Unable to start due to disease prog.|1
2651691|NCT00715078|9157833|P2|Overall Study|Unable to start due to disease prog.|0
2651692|NCT00715078|9157834|P1|Overall Study|Unable to start due to disease prog.|0
2651693|NCT00715078|9157832|P3|Overall Study|Withdrawal by Subject|1
2651694|NCT00715078|9157833|P2|Overall Study|Withdrawal by Subject|0
2651695|NCT00715078|9157834|P1|Overall Study|Withdrawal by Subject|1
2651696|NCT00715078|9157832|P3|Overall Study|Death|36
2651697|NCT00715078|9157833|P2|Overall Study|Death|36
2651698|NCT00715078|9157834|P1|Overall Study|Death|29
2651699|NCT00715026|9157842|P1|Overall Study|Surgery done on non-study consented hip|1
2651700|NCT00715026|9157842|P1|Overall Study|Protocol Violation|1
2651701|NCT00715026|9157842|P1|Overall Study|Lost to Follow-up|3
2651702|NCT00715026|9157842|P1|Overall Study|Withdrawal by Subject|5
2651703|NCT00714948|9157847|P1|Overall Study|Adverse Event|2
2651704|NCT00714870|9157853|P2|Overall Study|did not attend minimum of 4 sessions|0
2651705|NCT00714870|9157854|P1|Overall Study|did not attend minimum of 4 sessions|4
2651706|NCT00714870|9157853|P2|Overall Study|patient unable to come b/c back pain|0
2651707|NCT00714870|9157854|P1|Overall Study|patient unable to come b/c back pain|1
2651708|NCT00714870|9157853|P2|Overall Study|Lost to Follow-up|5
2651709|NCT00714870|9157854|P1|Overall Study|Lost to Follow-up|22
2651710|NCT00714714|9157878|P1|Overall Study|Adverse Event|1
2651711|NCT00714688|9157887|P3|Overall Study|Other|5
2651712|NCT00714688|9157888|P2|Overall Study|Other|6
2651713|NCT00714688|9157889|P1|Overall Study|Other|1
2651714|NCT00714688|9157887|P3|Overall Study|Sponsor's Decision|0
2651715|NCT00714688|9157888|P2|Overall Study|Sponsor's Decision|2
2651716|NCT00714688|9157889|P1|Overall Study|Sponsor's Decision|0
2651717|NCT00714688|9157887|P3|Overall Study|Ineligible to Continue the Study|1
2651718|NCT00714688|9157888|P2|Overall Study|Ineligible to Continue the Study|1
2651719|NCT00714688|9157889|P1|Overall Study|Ineligible to Continue the Study|0
2651720|NCT00714688|9157887|P3|Overall Study|Subject Non-compliant|5
2651721|NCT00714688|9157888|P2|Overall Study|Subject Non-compliant|5
2651722|NCT00714688|9157889|P1|Overall Study|Subject Non-compliant|3
2651723|NCT00714688|9157887|P3|Overall Study|Adverse Event|19
2651724|NCT00714688|9157888|P2|Overall Study|Adverse Event|15
2651725|NCT00714688|9157889|P1|Overall Study|Adverse Event|2
2651726|NCT00714688|9157887|P3|Overall Study|Lost to Follow-up|0
2651727|NCT00714688|9157888|P2|Overall Study|Lost to Follow-up|2
2651728|NCT00714688|9157889|P1|Overall Study|Lost to Follow-up|5
2651729|NCT00714688|9157887|P3|Overall Study|Withdrawal by Subject|3
2651730|NCT00714688|9157888|P2|Overall Study|Withdrawal by Subject|3
2651731|NCT00714688|9157889|P1|Overall Study|Withdrawal by Subject|4
2651732|NCT00714688|9157887|P3|Overall Study|Lack of Efficacy|4
2651733|NCT00714688|9157888|P2|Overall Study|Lack of Efficacy|1
2651734|NCT00714688|9157889|P1|Overall Study|Lack of Efficacy|14
2651735|NCT00714493|9157931|P1|Overall Study|OTHER|2
2651736|NCT00714493|9157931|P1|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8
2651737|NCT00714493|9157931|P1|Overall Study|Protocol Violation|12
2651738|NCT00714493|9157931|P1|Overall Study|Lost to Follow-up|3
2651739|NCT00714493|9157931|P1|Overall Study|Lack of Efficacy|10
2651740|NCT00714493|9157931|P1|Overall Study|Death|3
2651741|NCT00714493|9157931|P1|Overall Study|Adverse Event|11
2651742|NCT00714415|9157943|P2|Overall Study|Death|0
2651743|NCT00714415|9157944|P1|Overall Study|Death|1
2651744|NCT00714415|9157943|P2|Overall Study|Lack of Efficacy|0
2651745|NCT00714415|9157944|P1|Overall Study|Lack of Efficacy|1
2651746|NCT00714285|9157994|P4|Overall Study|Migrated/moved from study area|0
2651747|NCT00714285|9157995|P3|Overall Study|Migrated/moved from study area|0
2651748|NCT00714285|9157996|P2|Overall Study|Migrated/moved from study area|1
2651749|NCT00714285|9157997|P1|Overall Study|Migrated/moved from study area|0
2651750|NCT00714285|9157994|P4|Overall Study|Lost to Follow-up|1
2651751|NCT00714285|9157995|P3|Overall Study|Lost to Follow-up|0
2651752|NCT00714285|9157996|P2|Overall Study|Lost to Follow-up|2
2651753|NCT00714285|9157997|P1|Overall Study|Lost to Follow-up|0
2651754|NCT00714259|9158047|P1|Overall Study|Death|2
2651755|NCT00714168|9158093|P2|Overall Study|Non-study medical condition|2
2651756|NCT00714168|9158094|P1|Overall Study|Non-study medical condition|3
2651757|NCT00714168|9158093|P2|Overall Study|Relocation|3
2651758|NCT00714168|9158094|P1|Overall Study|Relocation|4
2651759|NCT00714168|9158093|P2|Overall Study|Lost to Follow-up|50
2651760|NCT00714168|9158094|P1|Overall Study|Lost to Follow-up|32
2651761|NCT00714168|9158093|P2|Overall Study|Pregnancy|4
2651762|NCT00714168|9158094|P1|Overall Study|Pregnancy|5
2651763|NCT00714051|9158110|P2|Overall Study|Death|1
2651764|NCT00714051|9158111|P1|Overall Study|Death|0
2651765|NCT00714051|9158110|P2|Overall Study|Withdrawal by Subject|0
2651766|NCT00714051|9158111|P1|Overall Study|Withdrawal by Subject|1
2651767|NCT00713830|9158119|P2|Overall Study|Sponsor Decision|10
2651768|NCT00713830|9158120|P1|Overall Study|Sponsor Decision|4
2651769|NCT00713830|9158119|P2|Overall Study|Familial and Personal Reasons|34
2651770|NCT00713830|9158120|P1|Overall Study|Familial and Personal Reasons|9
2651771|NCT00713830|9158119|P2|Overall Study|Poor Compliance to Protocol|14
2651772|NCT00713830|9158120|P1|Overall Study|Poor Compliance to Protocol|7
2651773|NCT00713830|9158119|P2|Overall Study|Withdrawal by Subject|23
2651774|NCT00713830|9158120|P1|Overall Study|Withdrawal by Subject|13
2651775|NCT00713830|9158119|P2|Overall Study|Lost to Follow-up|9
2651776|NCT00713830|9158120|P1|Overall Study|Lost to Follow-up|2
2651777|NCT00713830|9158119|P2|Overall Study|Lack of Efficacy|16
2651778|NCT00713830|9158120|P1|Overall Study|Lack of Efficacy|24
2651779|NCT00713830|9158119|P2|Overall Study|Adverse Event|71
2651780|NCT00713830|9158120|P1|Overall Study|Adverse Event|23
2651781|NCT00713700|9158177|P1|Overall Study|Withdrawal by Subject|1
2651782|NCT00713700|9158177|P1|Overall Study|Lost to Follow-up|3
2651783|NCT00713648|9158203|P1|Overall Study|Development of antibodies|3
2651784|NCT00713648|9158203|P1|Overall Study|According to Protocol|2
2651785|NCT00713648|9158203|P1|Overall Study|Unclassified|2
2651786|NCT00713648|9158203|P1|Overall Study|Adverse Event|1
2651787|NCT00713609|9158216|P6|Overall Study|Protocol Violation|0
2651788|NCT00713609|9158217|P5|Overall Study|Protocol Violation|2
2651789|NCT00713609|9158218|P4|Overall Study|Protocol Violation|1
2651790|NCT00713609|9158219|P3|Overall Study|Protocol Violation|1
2651791|NCT00713609|9158220|P2|Overall Study|Protocol Violation|3
2651792|NCT00713609|9158221|P1|Overall Study|Protocol Violation|6
2651793|NCT00713609|9158216|P6|Overall Study|Withdrawal by Subject|7
2651794|NCT00713609|9158217|P5|Overall Study|Withdrawal by Subject|5
2651795|NCT00713609|9158218|P4|Overall Study|Withdrawal by Subject|1
2651796|NCT00713609|9158219|P3|Overall Study|Withdrawal by Subject|5
2651797|NCT00713609|9158220|P2|Overall Study|Withdrawal by Subject|1
2651798|NCT00713609|9158221|P1|Overall Study|Withdrawal by Subject|6
2651799|NCT00713609|9158216|P6|Overall Study|Non-Compliance with Study Treatment|0
2651800|NCT00713609|9158217|P5|Overall Study|Non-Compliance with Study Treatment|1
2651801|NCT00713609|9158218|P4|Overall Study|Non-Compliance with Study Treatment|0
2651802|NCT00713609|9158219|P3|Overall Study|Non-Compliance with Study Treatment|2
2651803|NCT00713609|9158220|P2|Overall Study|Non-Compliance with Study Treatment|1
2651804|NCT00713609|9158221|P1|Overall Study|Non-Compliance with Study Treatment|1
2651805|NCT00713609|9158216|P6|Overall Study|Lack of Efficacy|0
2651806|NCT00713609|9158217|P5|Overall Study|Lack of Efficacy|1
2651807|NCT00713609|9158218|P4|Overall Study|Lack of Efficacy|0
2651808|NCT00713609|9158219|P3|Overall Study|Lack of Efficacy|0
2651809|NCT00713609|9158220|P2|Overall Study|Lack of Efficacy|3
2651810|NCT00713609|9158221|P1|Overall Study|Lack of Efficacy|1
2651811|NCT00713609|9158216|P6|Overall Study|Lost to Follow-up|0
2651812|NCT00713609|9158217|P5|Overall Study|Lost to Follow-up|7
2651813|NCT00713609|9158218|P4|Overall Study|Lost to Follow-up|5
2651814|NCT00713609|9158219|P3|Overall Study|Lost to Follow-up|5
2651815|NCT00713609|9158220|P2|Overall Study|Lost to Follow-up|7
2651816|NCT00713609|9158221|P1|Overall Study|Lost to Follow-up|5
2651817|NCT00713609|9158216|P6|Overall Study|Adverse Event|1
2651818|NCT00713609|9158217|P5|Overall Study|Adverse Event|3
2651819|NCT00713609|9158218|P4|Overall Study|Adverse Event|2
2651820|NCT00713609|9158219|P3|Overall Study|Adverse Event|2
2651821|NCT00713609|9158220|P2|Overall Study|Adverse Event|0
2651822|NCT00713609|9158221|P1|Overall Study|Adverse Event|2
2651823|NCT00713596|9158256|P3|Overall Study|Study was terminated|2
2651824|NCT00713596|9158257|P2|Overall Study|Study was terminated|3
2651825|NCT00713596|9158258|P1|Overall Study|Study was terminated|2
2651826|NCT00713544|9158284|P6|Overall Study|Hepatotoxicity - not an AE|0
2651827|NCT00713544|9158285|P5|Overall Study|Hepatotoxicity - not an AE|1
2651828|NCT00713544|9158286|P4|Overall Study|Hepatotoxicity - not an AE|0
2651829|NCT00713544|9158287|P3|Overall Study|Hepatotoxicity - not an AE|0
2651830|NCT00713544|9158288|P2|Overall Study|Hepatotoxicity - not an AE|0
2651831|NCT00713544|9158289|P1|Overall Study|Hepatotoxicity - not an AE|0
2651832|NCT00713544|9158284|P6|Overall Study|Incorrect enrollment|0
2651833|NCT00713544|9158285|P5|Overall Study|Incorrect enrollment|0
2651834|NCT00713544|9158286|P4|Overall Study|Incorrect enrollment|0
2651835|NCT00713544|9158287|P3|Overall Study|Incorrect enrollment|0
2651836|NCT00713544|9158288|P2|Overall Study|Incorrect enrollment|1
2651837|NCT00713544|9158289|P1|Overall Study|Incorrect enrollment|0
2651838|NCT00713544|9158284|P6|Overall Study|AZ decision - Hepatitis C ab reactive|0
2651839|NCT00713544|9158285|P5|Overall Study|AZ decision - Hepatitis C ab reactive|0
2651840|NCT00713544|9158286|P4|Overall Study|AZ decision - Hepatitis C ab reactive|0
2651841|NCT00713544|9158287|P3|Overall Study|AZ decision - Hepatitis C ab reactive|0
2651842|NCT00713544|9158288|P2|Overall Study|AZ decision - Hepatitis C ab reactive|1
2651843|NCT00713544|9158289|P1|Overall Study|AZ decision - Hepatitis C ab reactive|0
2651844|NCT00713544|9158284|P6|Overall Study|Lost to Follow-up|0
2651845|NCT00713544|9158285|P5|Overall Study|Lost to Follow-up|0
2651846|NCT00713544|9158286|P4|Overall Study|Lost to Follow-up|0
2651847|NCT00713544|9158287|P3|Overall Study|Lost to Follow-up|1
2651848|NCT00713544|9158288|P2|Overall Study|Lost to Follow-up|0
2651849|NCT00713544|9158289|P1|Overall Study|Lost to Follow-up|0
2651850|NCT00713544|9158284|P6|Overall Study|Lack of Efficacy|0
2651851|NCT00713544|9158285|P5|Overall Study|Lack of Efficacy|1
2651852|NCT00713544|9158286|P4|Overall Study|Lack of Efficacy|1
2651853|NCT00713544|9158287|P3|Overall Study|Lack of Efficacy|0
2651854|NCT00713544|9158288|P2|Overall Study|Lack of Efficacy|1
2651855|NCT00713544|9158289|P1|Overall Study|Lack of Efficacy|0
2651856|NCT00713544|9158284|P6|Overall Study|Physician Decision|2
2651857|NCT00713544|9158285|P5|Overall Study|Physician Decision|0
2651858|NCT00713544|9158286|P4|Overall Study|Physician Decision|0
2651859|NCT00713544|9158287|P3|Overall Study|Physician Decision|0
2651860|NCT00713544|9158288|P2|Overall Study|Physician Decision|0
2651861|NCT00713544|9158289|P1|Overall Study|Physician Decision|0
2651862|NCT00713544|9158284|P6|Overall Study|Protocol Violation|1
2651863|NCT00713544|9158285|P5|Overall Study|Protocol Violation|0
2651864|NCT00713544|9158286|P4|Overall Study|Protocol Violation|0
2651865|NCT00713544|9158287|P3|Overall Study|Protocol Violation|0
2651866|NCT00713544|9158288|P2|Overall Study|Protocol Violation|0
2651867|NCT00713544|9158289|P1|Overall Study|Protocol Violation|0
2651868|NCT00713544|9158284|P6|Overall Study|Withdrawal by Subject|1
2651869|NCT00713544|9158285|P5|Overall Study|Withdrawal by Subject|3
2651870|NCT00713544|9158286|P4|Overall Study|Withdrawal by Subject|2
2651871|NCT00713544|9158287|P3|Overall Study|Withdrawal by Subject|3
2651872|NCT00713544|9158288|P2|Overall Study|Withdrawal by Subject|0
2651873|NCT00713544|9158289|P1|Overall Study|Withdrawal by Subject|2
2651874|NCT00713544|9158284|P6|Overall Study|Adverse Event|5
2651875|NCT00713544|9158285|P5|Overall Study|Adverse Event|3
2651876|NCT00713544|9158286|P4|Overall Study|Adverse Event|7
2651877|NCT00713544|9158287|P3|Overall Study|Adverse Event|7
2651878|NCT00713544|9158288|P2|Overall Study|Adverse Event|3
2651879|NCT00713544|9158289|P1|Overall Study|Adverse Event|5
2651880|NCT00713349|9158340|P1|Overall Study|Protocol Violation|1
2651881|NCT00713323|9158346|P1|Overall Study|Treatment that may interact with Sativex|1
2651882|NCT00713323|9158346|P1|Overall Study|Subject travelling to Dominica Republic|1
2651883|NCT00713323|9158346|P1|Overall Study|Subject travelling to USA|1
2651884|NCT00713323|9158346|P1|Overall Study|Pain resolved|1
2651885|NCT00713323|9158346|P1|Overall Study|Non-compliance|1
2651886|NCT00713323|9158346|P1|Overall Study|Pain free|1
2651887|NCT00713323|9158346|P1|Overall Study|Surgery cured allodynic pain|1
2651888|NCT00713323|9158346|P1|Overall Study|Withdrawn due to exclusion criteria 11|1
2651889|NCT00713323|9158346|P1|Overall Study|Low creatine clearance at screening|1
2651890|NCT00713323|9158346|P1|Overall Study|Lack of Efficacy|36
2651891|NCT00713323|9158346|P1|Overall Study|Lost to Follow-up|11
2651892|NCT00713323|9158346|P1|Overall Study|Withdrawal by Subject|15
2651893|NCT00713323|9158346|P1|Overall Study|Adverse Event|75
2651894|NCT00713310|9158359|P2|Overall Study|Withdrawal by Subject|2
2651895|NCT00713310|9158360|P1|Overall Study|Withdrawal by Subject|0
2651896|NCT00713310|9158359|P2|Overall Study|Lack of Efficacy|2
2651897|NCT00713310|9158360|P1|Overall Study|Lack of Efficacy|0
2651898|NCT00713310|9158359|P2|Overall Study|Adverse Event|2
2651899|NCT00713310|9158360|P1|Overall Study|Adverse Event|5
2651900|NCT00713258|9158370|P2|Overall Study|Other|1
2651901|NCT00713258|9158371|P1|Overall Study|Other|1
2651902|NCT00713258|9158370|P2|Overall Study|Non-Compliance|1
2651903|NCT00713258|9158371|P1|Overall Study|Non-Compliance|2
2651904|NCT00713258|9158370|P2|Overall Study|Adverse Event|4
2651905|NCT00713258|9158371|P1|Overall Study|Adverse Event|2
2651906|NCT00713219|9158379|P1|Overall Study|Protocol Violation|1
2651907|NCT00713219|9158379|P1|Overall Study|Death|1
2651908|NCT00713206|9158385|P2|Overall Study|Adverse Event|1
2651909|NCT00713206|9158386|P1|Overall Study|Adverse Event|2
2651910|NCT00713206|9158385|P2|Overall Study|Lost to Follow-up|2
2651911|NCT00713206|9158386|P1|Overall Study|Lost to Follow-up|5
2651912|NCT00712985|9158392|P1|Overall Study|Lack of Efficacy|3
2651913|NCT00712985|9158392|P1|Overall Study|1 patient moved out of state|1
2651914|NCT00712985|9158392|P1|Overall Study|1 withdrew prior to start of drug|1
2651915|NCT00712959|9158398|P2|Overall Study|Withdrawal by Subject|0
2651916|NCT00712959|9158399|P1|Overall Study|Withdrawal by Subject|3
2651917|NCT00712959|9158398|P2|Overall Study|Lost to Follow-up|2
2651918|NCT00712959|9158399|P1|Overall Study|Lost to Follow-up|13
2651919|NCT00712959|9158398|P2|Overall Study|Protocol Violation|1
2651920|NCT00712959|9158399|P1|Overall Study|Protocol Violation|3
2651921|NCT00712933|9158417|P1|Overall Study|Withdrawal by Subject|151
2651922|NCT00712933|9158417|P1|Overall Study|Protocol Violation|4
2651923|NCT00712933|9158417|P1|Overall Study|Physician Decision|36
2651924|NCT00712933|9158417|P1|Overall Study|Participant received medication|1
2651925|NCT00712933|9158417|P1|Overall Study|Not committed to contraception|1
2651926|NCT00712933|9158417|P1|Overall Study|Other Physician decision|1
2651927|NCT00712933|9158417|P1|Overall Study|Death of patient|1
2651928|NCT00712933|9158417|P1|Overall Study|Participant travelled overseas|2
2651929|NCT00712933|9158417|P1|Overall Study|Participant hospitalized|1
2651930|NCT00712933|9158417|P1|Overall Study|Involved in Clinical research|3
2651931|NCT00712933|9158417|P1|Overall Study|Hip replacement surgery|1
2651932|NCT00712933|9158417|P1|Overall Study|Withdrew consent|4
2651933|NCT00712933|9158417|P1|Overall Study|Sponsor decision|14
2651934|NCT00712933|9158417|P1|Overall Study|Other Pregnancy|37
2651935|NCT00712933|9158417|P1|Overall Study|Non-compliance with study drug|13
2651936|NCT00712933|9158417|P1|Overall Study|Lost to Follow-up|22
2651937|NCT00712933|9158417|P1|Overall Study|Lack of Efficacy|6
2651938|NCT00712933|9158417|P1|Overall Study|Adverse Event|69
2651939|NCT00712920|9158447|P3|Overall Study|Non-compliance|0
2651940|NCT00712920|9158448|P2|Overall Study|Non-compliance|0
2651941|NCT00712920|9158449|P1|Overall Study|Non-compliance|3
2651942|NCT00712920|9158447|P3|Overall Study|Other|3
2651943|NCT00712920|9158448|P2|Overall Study|Other|7
2651944|NCT00712920|9158449|P1|Overall Study|Other|5
2651945|NCT00712920|9158447|P3|Overall Study|Lack of Efficacy|1
2651946|NCT00712920|9158448|P2|Overall Study|Lack of Efficacy|0
2651947|NCT00712920|9158449|P1|Overall Study|Lack of Efficacy|1
2651948|NCT00712920|9158447|P3|Overall Study|Lost to Follow-up|0
2651949|NCT00712920|9158448|P2|Overall Study|Lost to Follow-up|4
2651950|NCT00712920|9158449|P1|Overall Study|Lost to Follow-up|1
2651951|NCT00712920|9158447|P3|Overall Study|Withdrawal by Subject|1
2651952|NCT00712920|9158448|P2|Overall Study|Withdrawal by Subject|2
2651953|NCT00712920|9158449|P1|Overall Study|Withdrawal by Subject|4
2651954|NCT00712920|9158447|P3|Overall Study|Adverse Event|7
2651955|NCT00712920|9158448|P2|Overall Study|Adverse Event|4
2651956|NCT00712920|9158449|P1|Overall Study|Adverse Event|3
2651957|NCT00712725|9158477|P8|Overall Study|Protocol Specified Criteria|1
2651958|NCT00712725|9158478|P7|Overall Study|Protocol Specified Criteria|2
2651959|NCT00712725|9158479|P6|Overall Study|Protocol Specified Criteria|0
2651960|NCT00712725|9158480|P5|Overall Study|Protocol Specified Criteria|1
2651961|NCT00712725|9158481|P4|Overall Study|Protocol Specified Criteria|2
2651962|NCT00712725|9158482|P3|Overall Study|Protocol Specified Criteria|1
2651963|NCT00712725|9158483|P2|Overall Study|Protocol Specified Criteria|0
2651964|NCT00712725|9158484|P1|Overall Study|Protocol Specified Criteria|3
2651965|NCT00712725|9158477|P8|Overall Study|Lack of Qualifying Event|6
2651966|NCT00712725|9158478|P7|Overall Study|Lack of Qualifying Event|11
2651967|NCT00712725|9158479|P6|Overall Study|Lack of Qualifying Event|13
2651968|NCT00712725|9158480|P5|Overall Study|Lack of Qualifying Event|11
2651969|NCT00712725|9158481|P4|Overall Study|Lack of Qualifying Event|8
2651970|NCT00712725|9158482|P3|Overall Study|Lack of Qualifying Event|6
2651971|NCT00712725|9158483|P2|Overall Study|Lack of Qualifying Event|2
2651972|NCT00712725|9158484|P1|Overall Study|Lack of Qualifying Event|16
2651973|NCT00712725|9158477|P8|Overall Study|Withdrawal by Subject|2
2651974|NCT00712725|9158478|P7|Overall Study|Withdrawal by Subject|1
2651975|NCT00712725|9158479|P6|Overall Study|Withdrawal by Subject|1
2651976|NCT00712725|9158480|P5|Overall Study|Withdrawal by Subject|1
2651977|NCT00712725|9158481|P4|Overall Study|Withdrawal by Subject|2
2651978|NCT00712725|9158482|P3|Overall Study|Withdrawal by Subject|1
2651979|NCT00712725|9158483|P2|Overall Study|Withdrawal by Subject|1
2651980|NCT00712725|9158484|P1|Overall Study|Withdrawal by Subject|2
2651981|NCT00712725|9158477|P8|Overall Study|Protocol Violation|1
2651982|NCT00712725|9158478|P7|Overall Study|Protocol Violation|1
2651983|NCT00712725|9158479|P6|Overall Study|Protocol Violation|0
2651984|NCT00712725|9158480|P5|Overall Study|Protocol Violation|2
2651985|NCT00712725|9158481|P4|Overall Study|Protocol Violation|3
2651986|NCT00712725|9158482|P3|Overall Study|Protocol Violation|1
2651987|NCT00712725|9158483|P2|Overall Study|Protocol Violation|0
2651988|NCT00712725|9158484|P1|Overall Study|Protocol Violation|2
2651989|NCT00712725|9158477|P8|Overall Study|Pregnancy|0
2651990|NCT00712725|9158478|P7|Overall Study|Pregnancy|2
2651991|NCT00712725|9158479|P6|Overall Study|Pregnancy|0
2651992|NCT00712725|9158480|P5|Overall Study|Pregnancy|1
2651993|NCT00712725|9158481|P4|Overall Study|Pregnancy|0
2651994|NCT00712725|9158482|P3|Overall Study|Pregnancy|0
2651995|NCT00712725|9158483|P2|Overall Study|Pregnancy|1
2651996|NCT00712725|9158484|P1|Overall Study|Pregnancy|0
2651997|NCT00712725|9158477|P8|Overall Study|Physician Decision|0
2651998|NCT00712725|9158478|P7|Overall Study|Physician Decision|2
2651999|NCT00712725|9158479|P6|Overall Study|Physician Decision|0
2652000|NCT00712725|9158480|P5|Overall Study|Physician Decision|1
2652001|NCT00712725|9158481|P4|Overall Study|Physician Decision|0
2652002|NCT00712725|9158482|P3|Overall Study|Physician Decision|0
2652003|NCT00712725|9158483|P2|Overall Study|Physician Decision|0
2652004|NCT00712725|9158484|P1|Overall Study|Physician Decision|2
2652005|NCT00712725|9158477|P8|Overall Study|Lost to Follow-up|1
2652006|NCT00712725|9158478|P7|Overall Study|Lost to Follow-up|3
2652007|NCT00712725|9158479|P6|Overall Study|Lost to Follow-up|2
2652008|NCT00712725|9158480|P5|Overall Study|Lost to Follow-up|2
2652009|NCT00712725|9158481|P4|Overall Study|Lost to Follow-up|1
2652010|NCT00712725|9158482|P3|Overall Study|Lost to Follow-up|1
2652011|NCT00712725|9158483|P2|Overall Study|Lost to Follow-up|2
2652012|NCT00712725|9158484|P1|Overall Study|Lost to Follow-up|3
2652013|NCT00712725|9158477|P8|Overall Study|Adverse Event|0
2652014|NCT00712725|9158478|P7|Overall Study|Adverse Event|0
2652015|NCT00712725|9158479|P6|Overall Study|Adverse Event|0
2652016|NCT00712725|9158480|P5|Overall Study|Adverse Event|0
2652017|NCT00712725|9158481|P4|Overall Study|Adverse Event|1
2652018|NCT00712725|9158482|P3|Overall Study|Adverse Event|0
2652019|NCT00712725|9158483|P2|Overall Study|Adverse Event|0
2652020|NCT00712725|9158484|P1|Overall Study|Adverse Event|1
2652021|NCT00712673|9158545|P4|Overall Study|Protocol Violation|0
2652022|NCT00712673|9158546|P3|Overall Study|Protocol Violation|2
2652023|NCT00712673|9158547|P2|Overall Study|Protocol Violation|0
2652024|NCT00712673|9158548|P1|Overall Study|Protocol Violation|0
2652025|NCT00712673|9158545|P4|Overall Study|Investigator's Decision|0
2652026|NCT00712673|9158546|P3|Overall Study|Investigator's Decision|0
2652027|NCT00712673|9158547|P2|Overall Study|Investigator's Decision|0
2652028|NCT00712673|9158548|P1|Overall Study|Investigator's Decision|1
2652029|NCT00712673|9158545|P4|Overall Study|Familial and Personal Reasons|2
2652030|NCT00712673|9158546|P3|Overall Study|Familial and Personal Reasons|5
2652031|NCT00712673|9158547|P2|Overall Study|Familial and Personal Reasons|0
2652032|NCT00712673|9158548|P1|Overall Study|Familial and Personal Reasons|5
2652033|NCT00712673|9158545|P4|Overall Study|Withdrawal by Subject|20
2652034|NCT00712673|9158546|P3|Overall Study|Withdrawal by Subject|15
2652035|NCT00712673|9158547|P2|Overall Study|Withdrawal by Subject|7
2652036|NCT00712673|9158548|P1|Overall Study|Withdrawal by Subject|6
2652037|NCT00712673|9158545|P4|Overall Study|Lost to Follow-up|0
2652038|NCT00712673|9158546|P3|Overall Study|Lost to Follow-up|2
2652039|NCT00712673|9158547|P2|Overall Study|Lost to Follow-up|0
2652040|NCT00712673|9158548|P1|Overall Study|Lost to Follow-up|1
2652041|NCT00712673|9158545|P4|Overall Study|Poor Compliance to Protocol|16
2652042|NCT00712673|9158546|P3|Overall Study|Poor Compliance to Protocol|4
2652043|NCT00712673|9158547|P2|Overall Study|Poor Compliance to Protocol|3
2652044|NCT00712673|9158548|P1|Overall Study|Poor Compliance to Protocol|3
2652045|NCT00712673|9158545|P4|Overall Study|Lack of Efficacy|6
2652046|NCT00712673|9158546|P3|Overall Study|Lack of Efficacy|8
2652047|NCT00712673|9158547|P2|Overall Study|Lack of Efficacy|8
2652048|NCT00712673|9158548|P1|Overall Study|Lack of Efficacy|2
2652049|NCT00712673|9158545|P4|Overall Study|Adverse Event|26
2652050|NCT00712673|9158546|P3|Overall Study|Adverse Event|21
2652051|NCT00712673|9158547|P2|Overall Study|Adverse Event|3
2652052|NCT00712673|9158548|P1|Overall Study|Adverse Event|3
2652053|NCT00712543|9158612|P2|Day 8-14|Lost to Follow-up|2
2652054|NCT00712543|9158613|P1|Day 8-14|Lost to Follow-up|0
2652055|NCT00712348|9158647|P1|Overall Study|Withdrawal by Subject|1
2652056|NCT00712335|9158659|P5|Overall Study|Other Reason|0
2652057|NCT00712335|9158660|P4|Overall Study|Other Reason|0
2652058|NCT00712335|9158661|P3|Overall Study|Other Reason|1
2652059|NCT00712335|9158662|P2|Overall Study|Other Reason|3
2652060|NCT00712335|9158663|P1|Overall Study|Other Reason|0
2652061|NCT00712335|9158659|P5|Overall Study|Lack of Efficacy|0
2652062|NCT00712335|9158660|P4|Overall Study|Lack of Efficacy|1
2652063|NCT00712335|9158661|P3|Overall Study|Lack of Efficacy|1
2652064|NCT00712335|9158662|P2|Overall Study|Lack of Efficacy|0
2652065|NCT00712335|9158663|P1|Overall Study|Lack of Efficacy|0
2652066|NCT00712335|9158659|P5|Overall Study|Protocol Violation|0
2652067|NCT00712335|9158660|P4|Overall Study|Protocol Violation|0
2652068|NCT00712335|9158661|P3|Overall Study|Protocol Violation|1
2652069|NCT00712335|9158662|P2|Overall Study|Protocol Violation|2
2652070|NCT00712335|9158663|P1|Overall Study|Protocol Violation|1
2652071|NCT00712335|9158659|P5|Overall Study|Lost to Follow-up|0
2652072|NCT00712335|9158660|P4|Overall Study|Lost to Follow-up|1
2652073|NCT00712335|9158661|P3|Overall Study|Lost to Follow-up|0
2652074|NCT00712335|9158662|P2|Overall Study|Lost to Follow-up|5
2652075|NCT00712335|9158663|P1|Overall Study|Lost to Follow-up|2
2652076|NCT00712335|9158659|P5|Overall Study|Withdrawal by Subject|0
2652077|NCT00712335|9158660|P4|Overall Study|Withdrawal by Subject|3
2652078|NCT00712335|9158661|P3|Overall Study|Withdrawal by Subject|2
2652079|NCT00712335|9158662|P2|Overall Study|Withdrawal by Subject|7
2652080|NCT00712335|9158663|P1|Overall Study|Withdrawal by Subject|0
2652081|NCT00712270|9158708|P1|Overall Study|Screen Failure|3
2652082|NCT00712270|9158708|P1|Overall Study|Withdrawal by Subject|11
2652083|NCT00712166|9158772|P2|Overall Study|Noncompliance|1
2652084|NCT00712166|9158773|P1|Overall Study|Noncompliance|0
2652085|NCT00712010|9158816|P1|Washout (7 Days)|Withdrawal by Subject|1
2652086|NCT00711971|9158855|P3|Overall Study|Lost to Follow-up|1
2652087|NCT00711971|9158856|P2|Overall Study|Lost to Follow-up|4
2652088|NCT00711971|9158857|P1|Overall Study|Lost to Follow-up|3
2652089|NCT00711958|9158891|P2|Overall Study|Progression of disease|0
2652090|NCT00711958|9158892|P1|Overall Study|Progression of disease|1
2652091|NCT00711958|9158891|P2|Overall Study|Death|5
2652092|NCT00711958|9158892|P1|Overall Study|Death|10
2652093|NCT00711958|9158891|P2|Overall Study|Lost to Follow-up|2
2652094|NCT00711958|9158892|P1|Overall Study|Lost to Follow-up|2
2652095|NCT00711958|9158891|P2|Overall Study|Protocol Violation|0
2652096|NCT00711958|9158892|P1|Overall Study|Protocol Violation|1
2652097|NCT00711958|9158891|P2|Overall Study|Adverse Event|7
2652098|NCT00711958|9158892|P1|Overall Study|Adverse Event|9
2652099|NCT00711958|9158891|P2|Overall Study|Clinical deterioration|0
2652100|NCT00711958|9158892|P1|Overall Study|Clinical deterioration|1
2652101|NCT00711958|9158891|P2|Overall Study|Lack of Efficacy|1
2652102|NCT00711958|9158892|P1|Overall Study|Lack of Efficacy|3
2652103|NCT00711958|9158891|P2|Overall Study|Withdrawal by Subject|8
2652104|NCT00711958|9158892|P1|Overall Study|Withdrawal by Subject|6
2652105|NCT00711880|9158900|P2|Overall Study|Lack of Efficacy|5
2652106|NCT00711880|9158901|P1|Overall Study|Lack of Efficacy|1
2652107|NCT00711880|9158900|P2|Overall Study|Patient non-compliance|0
2652108|NCT00711880|9158901|P1|Overall Study|Patient non-compliance|1
2652109|NCT00711880|9158900|P2|Overall Study|Adverse Event|2
2652110|NCT00711880|9158901|P1|Overall Study|Adverse Event|11
2652111|NCT00711802|9158963|P8|Overall Study|Reason not reported|0
2652112|NCT00711802|9158964|P7|Overall Study|Reason not reported|1
2652113|NCT00711802|9158965|P6|Overall Study|Reason not reported|0
2652114|NCT00711802|9158966|P5|Overall Study|Reason not reported|1
2652115|NCT00711802|9158967|P4|Overall Study|Reason not reported|0
2652116|NCT00711802|9158968|P3|Overall Study|Reason not reported|1
2652117|NCT00711802|9158969|P2|Overall Study|Reason not reported|1
2652118|NCT00711802|9158970|P1|Overall Study|Reason not reported|0
2652119|NCT00711802|9158963|P8|Overall Study|Lost to Follow-up|2
2652120|NCT00711802|9158964|P7|Overall Study|Lost to Follow-up|4
2652121|NCT00711802|9158965|P6|Overall Study|Lost to Follow-up|6
2652122|NCT00711802|9158966|P5|Overall Study|Lost to Follow-up|10
2652123|NCT00711802|9158967|P4|Overall Study|Lost to Follow-up|1
2652124|NCT00711802|9158968|P3|Overall Study|Lost to Follow-up|3
2652125|NCT00711802|9158969|P2|Overall Study|Lost to Follow-up|0
2652126|NCT00711802|9158970|P1|Overall Study|Lost to Follow-up|0
2652127|NCT00711802|9158963|P8|Overall Study|Withdrawal by Subject|0
2652128|NCT00711802|9158964|P7|Overall Study|Withdrawal by Subject|0
2652129|NCT00711802|9158965|P6|Overall Study|Withdrawal by Subject|0
2652130|NCT00711802|9158966|P5|Overall Study|Withdrawal by Subject|0
2652131|NCT00711802|9158967|P4|Overall Study|Withdrawal by Subject|1
2652132|NCT00711802|9158968|P3|Overall Study|Withdrawal by Subject|0
2652133|NCT00711802|9158969|P2|Overall Study|Withdrawal by Subject|1
2652134|NCT00711802|9158970|P1|Overall Study|Withdrawal by Subject|0
2652135|NCT00711802|9158963|P8|Overall Study|Physician Decision|0
2652136|NCT00711802|9158964|P7|Overall Study|Physician Decision|0
2652137|NCT00711802|9158965|P6|Overall Study|Physician Decision|0
2652138|NCT00711802|9158966|P5|Overall Study|Physician Decision|0
2652139|NCT00711802|9158967|P4|Overall Study|Physician Decision|0
2652140|NCT00711802|9158968|P3|Overall Study|Physician Decision|0
2652141|NCT00711802|9158969|P2|Overall Study|Physician Decision|2
2652142|NCT00711802|9158970|P1|Overall Study|Physician Decision|0
2652143|NCT00711802|9158963|P8|Overall Study|Protocol Violation|0
2652144|NCT00711802|9158964|P7|Overall Study|Protocol Violation|0
2652145|NCT00711802|9158965|P6|Overall Study|Protocol Violation|0
2652146|NCT00711802|9158966|P5|Overall Study|Protocol Violation|0
2652147|NCT00711802|9158967|P4|Overall Study|Protocol Violation|1
2652148|NCT00711802|9158968|P3|Overall Study|Protocol Violation|0
2652149|NCT00711802|9158969|P2|Overall Study|Protocol Violation|0
2652150|NCT00711802|9158970|P1|Overall Study|Protocol Violation|0
2652151|NCT00711802|9158963|P8|Overall Study|Microbiological failure|0
2652152|NCT00711802|9158964|P7|Overall Study|Microbiological failure|0
2652153|NCT00711802|9158965|P6|Overall Study|Microbiological failure|1
2652154|NCT00711802|9158966|P5|Overall Study|Microbiological failure|0
2652155|NCT00711802|9158967|P4|Overall Study|Microbiological failure|0
2652156|NCT00711802|9158968|P3|Overall Study|Microbiological failure|0
2652157|NCT00711802|9158969|P2|Overall Study|Microbiological failure|1
2652158|NCT00711802|9158970|P1|Overall Study|Microbiological failure|0
2652159|NCT00711802|9158963|P8|Overall Study|Adverse Event|0
2652160|NCT00711802|9158964|P7|Overall Study|Adverse Event|0
2652161|NCT00711802|9158965|P6|Overall Study|Adverse Event|1
2652162|NCT00711802|9158966|P5|Overall Study|Adverse Event|1
2652163|NCT00711802|9158967|P4|Overall Study|Adverse Event|0
2652164|NCT00711802|9158968|P3|Overall Study|Adverse Event|0
2652165|NCT00711802|9158969|P2|Overall Study|Adverse Event|0
2652166|NCT00711802|9158970|P1|Overall Study|Adverse Event|0
2652167|NCT00711802|9158963|P8|Overall Study|Not treated (no further detail)|0
2652168|NCT00711802|9158964|P7|Overall Study|Not treated (no further detail)|0
2652169|NCT00711802|9158965|P6|Overall Study|Not treated (no further detail)|0
2652170|NCT00711802|9158966|P5|Overall Study|Not treated (no further detail)|2
2652171|NCT00711802|9158967|P4|Overall Study|Not treated (no further detail)|0
2652172|NCT00711802|9158968|P3|Overall Study|Not treated (no further detail)|2
2652173|NCT00711802|9158969|P2|Overall Study|Not treated (no further detail)|1
2652174|NCT00711802|9158970|P1|Overall Study|Not treated (no further detail)|2
2652175|NCT00711646|9159013|P2|Overall Study|patient non-compliance|0
2652176|NCT00711646|9159014|P1|Overall Study|patient non-compliance|1
2652177|NCT00711646|9159013|P2|Overall Study|administrative decision|1
2652178|NCT00711646|9159014|P1|Overall Study|administrative decision|0
2652179|NCT00711646|9159013|P2|Overall Study|Lost to Follow-up|0
2652180|NCT00711646|9159014|P1|Overall Study|Lost to Follow-up|1
2652181|NCT00711646|9159013|P2|Overall Study|Protocol Violation|1
2652182|NCT00711646|9159014|P1|Overall Study|Protocol Violation|0
2652183|NCT00711646|9159013|P2|Overall Study|Withdrawal by Subject|0
2652184|NCT00711646|9159014|P1|Overall Study|Withdrawal by Subject|4
2652185|NCT00711646|9159013|P2|Overall Study|Adverse Event|1
2652186|NCT00711646|9159014|P1|Overall Study|Adverse Event|6
2652187|NCT00711594|9159036|P4|Overall Study|Withdrawal by Subject|2
2652188|NCT00711594|9159037|P3|Overall Study|Withdrawal by Subject|0
2652189|NCT00711594|9159038|P2|Overall Study|Withdrawal by Subject|1
2652190|NCT00711594|9159039|P1|Overall Study|Withdrawal by Subject|0
2652191|NCT00711594|9159036|P4|Overall Study|Other Adverse Event|16
2652192|NCT00711594|9159037|P3|Overall Study|Other Adverse Event|0
2652193|NCT00711594|9159038|P2|Overall Study|Other Adverse Event|0
2652194|NCT00711594|9159039|P1|Overall Study|Other Adverse Event|1
2652195|NCT00711594|9159036|P4|Overall Study|Progressive disease|44
2652196|NCT00711594|9159037|P3|Overall Study|Progressive disease|6
2652197|NCT00711594|9159038|P2|Overall Study|Progressive disease|2
2652198|NCT00711594|9159039|P1|Overall Study|Progressive disease|2
2652199|NCT00711555|9159076|P1|Overall Study|Adverse Event|3
2652200|NCT00711529|9159085|P2|Overall Study|Withdrawal by Subject|6
2652201|NCT00711529|9159086|P1|Overall Study|Withdrawal by Subject|2
2652202|NCT00711529|9159085|P2|Overall Study|Protocol Violation|0
2652203|NCT00711529|9159086|P1|Overall Study|Protocol Violation|2
2652204|NCT00711516|9159110|P2|Overall Study|Protocol Violation|1
2652205|NCT00711516|9159111|P1|Overall Study|Protocol Violation|0
2652206|NCT00711516|9159110|P2|Overall Study|Withdrawal by Subject|1
2652207|NCT00711516|9159111|P1|Overall Study|Withdrawal by Subject|0
2652208|NCT00711516|9159110|P2|Overall Study|Adverse Event|1
2652209|NCT00711516|9159111|P1|Overall Study|Adverse Event|1
2652210|NCT00711477|9159218|P2|Overall Study|Noncompliance|1
2652211|NCT00711477|9159219|P1|Overall Study|Noncompliance|0
2652212|NCT00711477|9159218|P2|Overall Study|Lost to Follow-up|1
2652213|NCT00711477|9159219|P1|Overall Study|Lost to Follow-up|0
2652214|NCT00711477|9159218|P2|Overall Study|Adverse Event|1
2652215|NCT00711477|9159219|P1|Overall Study|Adverse Event|3
2652216|NCT00711425|9159265|P1|Overall Study|Lost to Follow-up|1
2652217|NCT00711425|9159265|P1|Overall Study|Death|2
2652218|NCT00711425|9159265|P1|Overall Study|Protocol Violation|1
2652219|NCT00711412|9159271|P1|Survival Follow up Until Death|Other|12
2652220|NCT00711412|9159271|P1|Evaluation for Response and Surgery|Death|1
2652221|NCT00711412|9159271|P1|Evaluation for Response and Surgery|Withdrawal by Subject|1
2652222|NCT00711412|9159271|P1|Evaluation for Response and Surgery|Too high risk for surgery|2
2652223|NCT00711412|9159271|P1|Evaluation for Response and Surgery|Progressive Disease|2
2652224|NCT00711412|9159271|P1|Combination Treatment|Progressive Disease|1
2652225|NCT00711412|9159271|P1|Evaluated for Combination Treatment|Progressive disease|2
2652226|NCT00711412|9159271|P1|Evaluated for Combination Treatment|Withdrawal by Subject|1
2652227|NCT00711412|9159271|P1|Evaluated for Combination Treatment|Death|1
2652228|NCT00711412|9159271|P1|Evaluated for Combination Treatment|Adverse Event|2
2652229|NCT00711412|9159271|P1|Induction Treatment|Other|1
2652230|NCT00711412|9159271|P1|Induction Treatment|Adverse Event|1
2652231|NCT00711412|9159271|P1|Induction Treatment|Death|2
2652232|NCT00711243|9159349|P6|Follow up Every 3 Months Until Death|Lost to Follow-up|2
2652233|NCT00711243|9159350|P5|Follow up Every 3 Months Until Death|Lost to Follow-up|0
2652234|NCT00711243|9159351|P4|Follow up Every 3 Months Until Death|Lost to Follow-up|0
2652235|NCT00711243|9159352|P3|Follow up Every 3 Months Until Death|Lost to Follow-up|0
2652236|NCT00711243|9159353|P2|Follow up Every 3 Months Until Death|Lost to Follow-up|0
2652237|NCT00711243|9159354|P1|Follow up Every 3 Months Until Death|Lost to Follow-up|0
2652238|NCT00711243|9159349|P6|Treated Cycle 5 After First Response|Decline in performance status|1
2652239|NCT00711243|9159350|P5|Treated Cycle 5 After First Response|Decline in performance status|0
2652240|NCT00711243|9159351|P4|Treated Cycle 5 After First Response|Decline in performance status|0
2652241|NCT00711243|9159352|P3|Treated Cycle 5 After First Response|Decline in performance status|0
2652242|NCT00711243|9159353|P2|Treated Cycle 5 After First Response|Decline in performance status|0
2652243|NCT00711243|9159354|P1|Treated Cycle 5 After First Response|Decline in performance status|0
2652244|NCT00711243|9159349|P6|Treated Cycle 5 After First Response|Death|2
2652245|NCT00711243|9159350|P5|Treated Cycle 5 After First Response|Death|0
2652246|NCT00711243|9159351|P4|Treated Cycle 5 After First Response|Death|0
2652247|NCT00711243|9159352|P3|Treated Cycle 5 After First Response|Death|0
2652248|NCT00711243|9159353|P2|Treated Cycle 5 After First Response|Death|0
2652249|NCT00711243|9159354|P1|Treated Cycle 5 After First Response|Death|0
2652250|NCT00711243|9159349|P6|Treated Cycle 5 After First Response|Progressive disease|1
2652251|NCT00711243|9159350|P5|Treated Cycle 5 After First Response|Progressive disease|1
2652252|NCT00711243|9159351|P4|Treated Cycle 5 After First Response|Progressive disease|0
2652253|NCT00711243|9159352|P3|Treated Cycle 5 After First Response|Progressive disease|0
2652254|NCT00711243|9159353|P2|Treated Cycle 5 After First Response|Progressive disease|2
2652255|NCT00711243|9159354|P1|Treated Cycle 5 After First Response|Progressive disease|1
2652256|NCT00711243|9159349|P6|Reached First Response/4 Cycles|Progressive disease|0
2652257|NCT00711243|9159350|P5|Reached First Response/4 Cycles|Progressive disease|0
2652258|NCT00711243|9159351|P4|Reached First Response/4 Cycles|Progressive disease|1
2652259|NCT00711243|9159352|P3|Reached First Response/4 Cycles|Progressive disease|0
2652260|NCT00711243|9159353|P2|Reached First Response/4 Cycles|Progressive disease|0
2652261|NCT00711243|9159354|P1|Reached First Response/4 Cycles|Progressive disease|0
2652262|NCT00711243|9159349|P6|Reached First Response/4 Cycles|Death|2
2652263|NCT00711243|9159350|P5|Reached First Response/4 Cycles|Death|0
2652264|NCT00711243|9159351|P4|Reached First Response/4 Cycles|Death|0
2652265|NCT00711243|9159352|P3|Reached First Response/4 Cycles|Death|0
2652266|NCT00711243|9159353|P2|Reached First Response/4 Cycles|Death|0
2652267|NCT00711243|9159354|P1|Reached First Response/4 Cycles|Death|0
2652268|NCT00711243|9159349|P6|Registed and Started Treatment|Withdrawal by Subject|1
2652269|NCT00711243|9159350|P5|Registed and Started Treatment|Withdrawal by Subject|0
2652270|NCT00711243|9159351|P4|Registed and Started Treatment|Withdrawal by Subject|0
2652271|NCT00711243|9159352|P3|Registed and Started Treatment|Withdrawal by Subject|0
2652272|NCT00711243|9159353|P2|Registed and Started Treatment|Withdrawal by Subject|0
2652273|NCT00711243|9159354|P1|Registed and Started Treatment|Withdrawal by Subject|0
2652274|NCT00711191|9159377|P3|Overall Study|Withdrawal by Subject|3
2652275|NCT00711191|9159378|P2|Overall Study|Withdrawal by Subject|1
2652276|NCT00711191|9159379|P1|Overall Study|Withdrawal by Subject|0
2652277|NCT00711191|9159377|P3|Overall Study|Objective progression or relapse|7
2652278|NCT00711191|9159378|P2|Overall Study|Objective progression or relapse|3
2652279|NCT00711191|9159379|P1|Overall Study|Objective progression or relapse|2
2652280|NCT00711191|9159377|P3|Overall Study|Adverse Event|2
2652281|NCT00711191|9159378|P2|Overall Study|Adverse Event|1
2652282|NCT00711191|9159379|P1|Overall Study|Adverse Event|1
2652283|NCT00711113|9159416|P1|Overall Study|Implant lost|2
2652284|NCT00711113|9159416|P1|Overall Study|Lost to Follow-up|9
2652285|NCT00711100|9159422|P1|Overall Study|Withdrawal by Subject|8
2652286|NCT00711100|9159422|P1|Overall Study|Lack of Efficacy|5
2652287|NCT00711087|9159440|P2|Overall Study|Lost to Follow-up|0
2652288|NCT00711087|9159441|P1|Overall Study|Lost to Follow-up|1
2652289|NCT00711009|9159453|P2|Overall Study|Dose adjustment|0
2652290|NCT00711009|9159454|P1|Overall Study|Dose adjustment|1
2652291|NCT00711009|9159453|P2|Overall Study|Site closing|1
2652292|NCT00711009|9159454|P1|Overall Study|Site closing|0
2652293|NCT00711009|9159453|P2|Overall Study|Pregnancy|0
2652294|NCT00711009|9159454|P1|Overall Study|Pregnancy|1
2652295|NCT00711009|9159453|P2|Overall Study|Virologic Failure|1
2652296|NCT00711009|9159454|P1|Overall Study|Virologic Failure|2
2652297|NCT00711009|9159453|P2|Overall Study|Participant Noncompliant|1
2652298|NCT00711009|9159454|P1|Overall Study|Participant Noncompliant|0
2652299|NCT00711009|9159453|P2|Overall Study|Lost to Follow-up|9
2652300|NCT00711009|9159454|P1|Overall Study|Lost to Follow-up|3
2652301|NCT00711009|9159453|P2|Overall Study|Withdrawal by Subject|2
2652302|NCT00711009|9159454|P1|Overall Study|Withdrawal by Subject|4
2652303|NCT00711009|9159453|P2|Overall Study|Adverse Event/HIV-Related Event|5
2652304|NCT00711009|9159454|P1|Overall Study|Adverse Event/HIV-Related Event|4
2652305|NCT00710970|9159635|P1|Overall Study|Never took drug|2
2652306|NCT00710970|9159635|P1|Overall Study|Lost to Follow-up|8
2652307|NCT00710879|9159662|P2|Overall Study|Protocol Violation|3
2652308|NCT00710879|9159663|P1|Overall Study|Protocol Violation|0
2652309|NCT00710879|9159662|P2|Overall Study|Lost to Follow-up|1
2652310|NCT00710879|9159663|P1|Overall Study|Lost to Follow-up|2
2652311|NCT00710866|9159675|P2|Overall Study|Failed to meet eligibility|1
2652312|NCT00710866|9159676|P1|Overall Study|Failed to meet eligibility|1
2652313|NCT00710866|9159675|P2|Overall Study|Lost to Follow-up|0
2652314|NCT00710866|9159676|P1|Overall Study|Lost to Follow-up|1
2652315|NCT00710866|9159675|P2|Overall Study|Withdrawal by Subject|1
2652316|NCT00710866|9159676|P1|Overall Study|Withdrawal by Subject|2
2652317|NCT00710866|9159675|P2|Overall Study|Protocol Violation|4
2652318|NCT00710866|9159676|P1|Overall Study|Protocol Violation|5
2652319|NCT00710762|9159722|P2|Overall Study|Reason other than listed above|2
2652320|NCT00710762|9159723|P1|Overall Study|Reason other than listed above|2
2652321|NCT00710762|9159722|P2|Overall Study|Lost to Follow-up|0
2652322|NCT00710762|9159723|P1|Overall Study|Lost to Follow-up|1
2652323|NCT00710762|9159722|P2|Overall Study|Other Adverse Event|7
2652324|NCT00710762|9159723|P1|Overall Study|Other Adverse Event|7
2652325|NCT00710762|9159722|P2|Overall Study|Adverse Event other disease worsening|1
2652326|NCT00710762|9159723|P1|Overall Study|Adverse Event other disease worsening|2
2652327|NCT00710762|9159722|P2|Overall Study|Progressive disease|30
2652328|NCT00710762|9159723|P1|Overall Study|Progressive disease|27
2652329|NCT00710749|9159739|P2|First Intervention|Withdrawal by Subject|0
2652330|NCT00710749|9159740|P1|First Intervention|Withdrawal by Subject|1
2652331|NCT00710684|9159751|P3|Overall Study|Did not continue after week 24|16
2652332|NCT00710684|9159752|P2|Overall Study|Did not continue after week 24|21
2652333|NCT00710684|9159753|P1|Overall Study|Did not continue after week 24|25
2652334|NCT00710684|9159751|P3|Overall Study|Missing|0
2652335|NCT00710684|9159752|P2|Overall Study|Missing|0
2652336|NCT00710684|9159753|P1|Overall Study|Missing|1
2652337|NCT00710684|9159751|P3|Overall Study|Withdrawal by Subject|11
2652338|NCT00710684|9159752|P2|Overall Study|Withdrawal by Subject|18
2652339|NCT00710684|9159753|P1|Overall Study|Withdrawal by Subject|24
2652340|NCT00710684|9159751|P3|Overall Study|Physician Decision|4
2652341|NCT00710684|9159752|P2|Overall Study|Physician Decision|2
2652342|NCT00710684|9159753|P1|Overall Study|Physician Decision|0
2652343|NCT00710684|9159751|P3|Overall Study|Lost to Follow-up|7
2652344|NCT00710684|9159752|P2|Overall Study|Lost to Follow-up|6
2652345|NCT00710684|9159753|P1|Overall Study|Lost to Follow-up|4
2652346|NCT00710684|9159751|P3|Overall Study|Protocol Violation|5
2652347|NCT00710684|9159752|P2|Overall Study|Protocol Violation|5
2652348|NCT00710684|9159753|P1|Overall Study|Protocol Violation|5
2652349|NCT00710684|9159751|P3|Overall Study|Lack of Efficacy|5
2652350|NCT00710684|9159752|P2|Overall Study|Lack of Efficacy|3
2652351|NCT00710684|9159753|P1|Overall Study|Lack of Efficacy|4
2652352|NCT00710684|9159751|P3|Overall Study|Adverse Event|16
2652353|NCT00710684|9159752|P2|Overall Study|Adverse Event|19
2652354|NCT00710684|9159753|P1|Overall Study|Adverse Event|11
2652355|NCT00710606|9159810|P2|Overall Study|Adverse Event|2
2652356|NCT00710606|9159811|P1|Overall Study|Adverse Event|0
2652357|NCT00710593|9159823|P2|Overall Study|Prem disc vaccine, completed all visits|2
2652358|NCT00710593|9159824|P1|Overall Study|Prem disc vaccine, completed all visits|6
2652359|NCT00710593|9159823|P2|Overall Study|Protocol Violation|1
2652360|NCT00710593|9159824|P1|Overall Study|Protocol Violation|1
2652361|NCT00710593|9159823|P2|Overall Study|Failure to adhere or complete study eval|1
2652362|NCT00710593|9159824|P1|Overall Study|Failure to adhere or complete study eval|1
2652363|NCT00710593|9159823|P2|Overall Study|Moved out of area|0
2652364|NCT00710593|9159824|P1|Overall Study|Moved out of area|1
2652365|NCT00710593|9159823|P2|Overall Study|Lost to Follow-up|1
2652366|NCT00710593|9159824|P1|Overall Study|Lost to Follow-up|3
2652367|NCT00710593|9159823|P2|Overall Study|Unable to complete Wk 48 within window|0
2652368|NCT00710593|9159824|P1|Overall Study|Unable to complete Wk 48 within window|2
2652369|NCT00710593|9159823|P2|Overall Study|Incarceration|0
2652370|NCT00710593|9159824|P1|Overall Study|Incarceration|1
2652371|NCT00710554|9159867|P2|Overall Study|Receiving radiotherapy - prostate cancer|1
2652372|NCT00710554|9159868|P1|Overall Study|Receiving radiotherapy - prostate cancer|0
2652373|NCT00710554|9159867|P2|Overall Study|Lack of Efficacy|12
2652374|NCT00710554|9159868|P1|Overall Study|Lack of Efficacy|11
2652375|NCT00710554|9159867|P2|Overall Study|Lost to Follow-up|1
2652376|NCT00710554|9159868|P1|Overall Study|Lost to Follow-up|7
2652377|NCT00710554|9159867|P2|Overall Study|Withdrawal by Subject|3
2652378|NCT00710554|9159868|P1|Overall Study|Withdrawal by Subject|7
2652379|NCT00710554|9159867|P2|Overall Study|Adverse Event|7
2652380|NCT00710554|9159868|P1|Overall Study|Adverse Event|24
2652381|NCT00710424|9159896|P2|Overall Study|Felt good so stopped treatment|1
2652382|NCT00710424|9159897|P1|Overall Study|Felt good so stopped treatment|0
2652383|NCT00710424|9159896|P2|Overall Study|Subject preferred paracetamol|1
2652384|NCT00710424|9159897|P1|Overall Study|Subject preferred paracetamol|0
2652385|NCT00710424|9159896|P2|Overall Study|Ceased treatment due to travel|0
2652386|NCT00710424|9159897|P1|Overall Study|Ceased treatment due to travel|1
2652387|NCT00710424|9159896|P2|Overall Study|Subject thought medication changed|0
2652388|NCT00710424|9159897|P1|Overall Study|Subject thought medication changed|1
2652389|NCT00710424|9159896|P2|Overall Study|Did not meet entry criteria at visit 1|0
2652390|NCT00710424|9159897|P1|Overall Study|Did not meet entry criteria at visit 1|1
2652391|NCT00710424|9159896|P2|Overall Study|Non-compliance with stable analgesia|0
2652392|NCT00710424|9159897|P1|Overall Study|Non-compliance with stable analgesia|1
2652393|NCT00710424|9159896|P2|Overall Study|Refused medication, no side effects|0
2652394|NCT00710424|9159897|P1|Overall Study|Refused medication, no side effects|1
2652395|NCT00710424|9159896|P2|Overall Study|Lost to Follow-up|1
2652396|NCT00710424|9159897|P1|Overall Study|Lost to Follow-up|0
2652397|NCT00710424|9159896|P2|Overall Study|Withdrawal by Subject|3
2652398|NCT00710424|9159897|P1|Overall Study|Withdrawal by Subject|5
2652399|NCT00710424|9159896|P2|Overall Study|Lack of Efficacy|5
2652400|NCT00710424|9159897|P1|Overall Study|Lack of Efficacy|4
2652401|NCT00710424|9159896|P2|Overall Study|Adverse Event|12
2652402|NCT00710424|9159897|P1|Overall Study|Adverse Event|30
2652403|NCT00710385|9159921|P1|Overall Study|Undisclosed excessive methadone use|1
2652404|NCT00710385|9159921|P1|Overall Study|Physician Decision|1
2652405|NCT00710385|9159921|P1|Overall Study|Undisclosed back pain|1
2652406|NCT00710385|9159921|P1|Overall Study|Withdrawal by Subject|1
2652407|NCT00710385|9159921|P1|Overall Study|Did not qualify|1
2652408|NCT00710034|9159966|P2|Completed 12 Weeks of Treatment|Withdrawal by Subject|2
2652409|NCT00710034|9159967|P1|Completed 12 Weeks of Treatment|Withdrawal by Subject|8
2652410|NCT00710034|9159966|P2|Completed 12 Weeks of Treatment|Product Dissatisfaction|1
2652411|NCT00710034|9159967|P1|Completed 12 Weeks of Treatment|Product Dissatisfaction|0
2652412|NCT00710034|9159966|P2|Completed 12 Weeks of Treatment|Lost to Follow-up|5
2652413|NCT00710034|9159967|P1|Completed 12 Weeks of Treatment|Lost to Follow-up|5
2652414|NCT00710034|9159966|P2|Completed 12 Weeks of Treatment|Lack of Efficacy|2
2652415|NCT00710034|9159967|P1|Completed 12 Weeks of Treatment|Lack of Efficacy|0
2652416|NCT00710034|9159966|P2|Completed 12 Weeks of Treatment|Adverse Event|1
2652417|NCT00710034|9159967|P1|Completed 12 Weeks of Treatment|Adverse Event|0
2652418|NCT00710034|9159966|P2|Completed 6 Weeks of Treatment|Physician Decision|0
2652419|NCT00710034|9159967|P1|Completed 6 Weeks of Treatment|Physician Decision|1
2652420|NCT00710034|9159966|P2|Completed 6 Weeks of Treatment|Withdrawal by Subject|4
2652421|NCT00710034|9159967|P1|Completed 6 Weeks of Treatment|Withdrawal by Subject|6
2652422|NCT00710034|9159966|P2|Completed 6 Weeks of Treatment|Product dissatisfaction|6
2652423|NCT00710034|9159967|P1|Completed 6 Weeks of Treatment|Product dissatisfaction|2
2652424|NCT00710034|9159966|P2|Completed 6 Weeks of Treatment|Lost to Follow-up|17
2652425|NCT00710034|9159967|P1|Completed 6 Weeks of Treatment|Lost to Follow-up|15
2652426|NCT00710034|9159966|P2|Completed 6 Weeks of Treatment|Lack of Efficacy|8
2652427|NCT00710034|9159967|P1|Completed 6 Weeks of Treatment|Lack of Efficacy|12
2652428|NCT00710034|9159966|P2|Completed 6 Weeks of Treatment|Adverse Event|12
2652429|NCT00710034|9159967|P1|Completed 6 Weeks of Treatment|Adverse Event|5
2652430|NCT00710021|9159984|P3|Overall Study|Physician Decision|0
2652431|NCT00710021|9159985|P2|Overall Study|Physician Decision|1
2652432|NCT00710021|9159986|P1|Overall Study|Physician Decision|0
2652433|NCT00710021|9159984|P3|Overall Study|Subject misrandomized|1
2652434|NCT00710021|9159985|P2|Overall Study|Subject misrandomized|1
2652435|NCT00710021|9159986|P1|Overall Study|Subject misrandomized|0
2652436|NCT00710021|9159984|P3|Overall Study|Subject's Decision|0
2652437|NCT00710021|9159985|P2|Overall Study|Subject's Decision|1
2652438|NCT00710021|9159986|P1|Overall Study|Subject's Decision|0
2652439|NCT00710021|9159984|P3|Overall Study|Lost to Follow-up|0
2652440|NCT00710021|9159985|P2|Overall Study|Lost to Follow-up|0
2652441|NCT00710021|9159986|P1|Overall Study|Lost to Follow-up|1
2652442|NCT00709995|9160101|P2|Overall Study|Withdrawal by Subject|3
2652443|NCT00709995|9160102|P1|Overall Study|Withdrawal by Subject|1
2652444|NCT00709995|9160101|P2|Overall Study|Adverse Event|2
2652445|NCT00709995|9160102|P1|Overall Study|Adverse Event|4
2652446|NCT00709956|9160120|P2|Overall Study|Inclusion/exclusion criteria violation|3
2652447|NCT00709956|9160121|P1|Overall Study|Inclusion/exclusion criteria violation|2
2652448|NCT00709956|9160120|P2|Overall Study|Withdrawal by Subject|1
2652449|NCT00709956|9160121|P1|Overall Study|Withdrawal by Subject|1
2652450|NCT00709852|9160151|P2|Period 2|No 72-hour follow-up|0
2652451|NCT00709852|9160152|P1|Period 2|No 72-hour follow-up|3
2652452|NCT00709852|9160151|P2|Period 2|Lost to Follow-up|0
2652453|NCT00709852|9160152|P1|Period 2|Lost to Follow-up|1
2652454|NCT00709852|9160151|P2|Period 2|Adverse Event|1
2652455|NCT00709852|9160152|P1|Period 2|Adverse Event|1
2652456|NCT00709852|9160151|P2|Period 2|Protocol Violation|1
2652457|NCT00709852|9160152|P1|Period 2|Protocol Violation|4
2652458|NCT00709852|9160151|P2|Period 1|Lost to Follow-up|0
2652459|NCT00709852|9160152|P1|Period 1|Lost to Follow-up|1
2652460|NCT00709852|9160151|P2|Period 1|Defective scanner|1
2652461|NCT00709852|9160152|P1|Period 1|Defective scanner|0
2652462|NCT00709852|9160151|P2|Period 1|Protocol Violation|0
2652463|NCT00709852|9160152|P1|Period 1|Protocol Violation|1
2652464|NCT00709852|9160151|P2|Period 1|Withdrawal by Subject|2
2652465|NCT00709852|9160152|P1|Period 1|Withdrawal by Subject|4
2652466|NCT00709852|9160151|P2|Period 1|Adverse Event|0
2652467|NCT00709852|9160152|P1|Period 1|Adverse Event|2
2652468|NCT00709761|9160316|P1|Overall Study|Lost to Follow-up|2
2652469|NCT00709761|9160316|P1|Overall Study|study closed/terminated|17
2652470|NCT00709761|9160316|P1|Overall Study|Withdrawal by Subject|8
2652471|NCT00709735|9160327|P2|Overall Study|Did not meet PTSD Diagnostic Criteria|0
2652472|NCT00709735|9160328|P1|Overall Study|Did not meet PTSD Diagnostic Criteria|2
2652473|NCT00709735|9160327|P2|Overall Study|Relapse into Opioid Abuse|1
2652474|NCT00709735|9160328|P1|Overall Study|Relapse into Opioid Abuse|0
2652475|NCT00709735|9160327|P2|Overall Study|Lost to Follow-up|1
2652476|NCT00709735|9160328|P1|Overall Study|Lost to Follow-up|1
2652477|NCT00709722|9160336|P1|Overall Study|Adverse Event|1
2652478|NCT00709618|9160351|P1|Overall Study|Study Closed/Terminated|25
2652479|NCT00709618|9160351|P1|Overall Study|Lost to Follow-up|1
2652480|NCT00709618|9160351|P1|Overall Study|Withdrawal by Subject|4
2652481|NCT00709592|9160363|P2|Overall Study|Unable to proceed to transplant|1
2652482|NCT00709592|9160364|P1|Overall Study|Unable to proceed to transplant|0
2652483|NCT00709319|9160386|P1|Overall Study|Withdrawal by Subject|2
2652484|NCT00709319|9160386|P1|Overall Study|Death|4
2652485|NCT00709228|9160415|P1|Overall Study|Non-compliance|5
2652486|NCT00709228|9160415|P1|Overall Study|Lost to Follow-up|6
2652487|NCT00709228|9160415|P1|Overall Study|Disease progression|1
2652488|NCT00709228|9160415|P1|Overall Study|Discontinued follow-up|5
2652489|NCT00709228|9160415|P1|Overall Study|Did not enter follow-up|4
2652490|NCT00709228|9160415|P1|Overall Study|Discontinued treatment|14
2652491|NCT00709228|9160415|P1|Overall Study|Adverse events|2
2652492|NCT00709228|9160415|P1|Overall Study|Eligibility criteria not met|281
2652493|NCT00709228|9160415|P1|Overall Study|Not treated|14
2652494|NCT00709202|9160421|P2|Overall Study|Withdrawal by Subject|6
2652495|NCT00709202|9160422|P1|Overall Study|Withdrawal by Subject|6
2652496|NCT00709124|9160450|P2|Overall Study|encephalopathy; can't do assessment|0
2652497|NCT00709124|9160451|P1|Overall Study|encephalopathy; can't do assessment|1
2652498|NCT00709124|9160450|P2|Overall Study|Death|1
2652499|NCT00709124|9160451|P1|Overall Study|Death|3
2652500|NCT00709111|9160485|P1|Overall Study|Unable to attend clinic visits|1
2652501|NCT00709111|9160485|P1|Overall Study|Withdrawal by Subject|1
2652502|NCT00709098|9160526|P3|Open-label Period|Lost to Follow-up|1
2652503|NCT00709098|9160527|P2|Open-label Period|Lost to Follow-up|0
2652504|NCT00709098|9160528|P1|Open-label Period|Lost to Follow-up|0
2652505|NCT00709098|9160526|P3|Open-label Period|Death|1
2652506|NCT00709098|9160527|P2|Open-label Period|Death|0
2652507|NCT00709098|9160528|P1|Open-label Period|Death|0
2652508|NCT00709098|9160526|P3|Open-label Period|Administrative reason|5
2652509|NCT00709098|9160527|P2|Open-label Period|Administrative reason|0
2652510|NCT00709098|9160528|P1|Open-label Period|Administrative reason|0
2652511|NCT00709098|9160526|P3|Open-label Period|Withdrawal of consent|7
2652512|NCT00709098|9160527|P2|Open-label Period|Withdrawal of consent|0
2652513|NCT00709098|9160528|P1|Open-label Period|Withdrawal of consent|0
2652514|NCT00709098|9160526|P3|Double-blind Period|Lost to Follow-up|0
2652515|NCT00709098|9160527|P2|Double-blind Period|Lost to Follow-up|1
2652516|NCT00709098|9160528|P1|Double-blind Period|Lost to Follow-up|1
2652517|NCT00709098|9160526|P3|Double-blind Period|Death|0
2652518|NCT00709098|9160527|P2|Double-blind Period|Death|1
2652519|NCT00709098|9160528|P1|Double-blind Period|Death|1
2652520|NCT00709098|9160526|P3|Double-blind Period|Administrative reason|0
2652521|NCT00709098|9160527|P2|Double-blind Period|Administrative reason|3
2652522|NCT00709098|9160528|P1|Double-blind Period|Administrative reason|1
2652523|NCT00709098|9160526|P3|Double-blind Period|Withdrawal of consent|0
2652524|NCT00709098|9160527|P2|Double-blind Period|Withdrawal of consent|3
2652525|NCT00709098|9160528|P1|Double-blind Period|Withdrawal of consent|3
2652526|NCT00709059|9160547|P1|Overall Study|Serious side effects|11
2652527|NCT00709059|9160547|P1|Overall Study|Side effects|20
2652528|NCT00709059|9160547|P1|Overall Study|Disease complication|3
2652529|NCT00709059|9160547|P1|Overall Study|Physician Decision|7
2652530|NCT00709059|9160547|P1|Overall Study|Withdrawal by Subject|19
2652531|NCT00709059|9160547|P1|Overall Study|Lost to Follow-up|34
2652532|NCT00708734|9160594|P1|Overall Study|leg fracture|1
2652533|NCT00708734|9160594|P1|Overall Study|vertigo|1
2652534|NCT00708734|9160594|P1|Overall Study|knee replacement|1
2652535|NCT00708734|9160594|P1|Overall Study|leg injury|1
2652536|NCT00708734|9160594|P1|Overall Study|moved|1
2652537|NCT00708734|9160594|P1|Overall Study|scheduling conflict|2
2652538|NCT00708708|9160614|P1|Overall Study|Missing values|392
2652539|NCT00708708|9160614|P1|Overall Study|Adverse Event|3
2652540|NCT00708708|9160614|P1|Overall Study|Pregnancy|3
2652541|NCT00708708|9160614|P1|Overall Study|Lack of compliance|3
2652542|NCT00708708|9160614|P1|Overall Study|Lack of effectiveness|4
2652543|NCT00708708|9160614|P1|Overall Study|Administrative reasons|7
2652544|NCT00708708|9160614|P1|Overall Study|Ineffectiveness (no systemic therapy)|9
2652545|NCT00708708|9160614|P1|Overall Study|Good effectiveness|9
2652546|NCT00708708|9160614|P1|Overall Study|Other unspecified|11
2652547|NCT00708708|9160614|P1|Overall Study|Another therapy along with Enbrel|15
2652548|NCT00708708|9160614|P1|Overall Study|Intolerance|42
2652549|NCT00708708|9160614|P1|Overall Study|Withdrawal by Subject|51
2652550|NCT00708708|9160614|P1|Overall Study|Lost to Follow-up|52
2652551|NCT00708708|9160614|P1|Overall Study|Another therapy instead of Enbrel|141
2652552|NCT00708682|9160662|P1|Toddler Dose|Failed to Return|4
2652553|NCT00708682|9160662|P1|Toddler Dose|Lost to Follow-up|3
2652554|NCT00708682|9160662|P1|Toddler Dose|Parent/Legal Guardian Request|1
2652555|NCT00708682|9160662|P1|After Infant Series|Parent/Legal Guardian Request|1
2652556|NCT00708682|9160662|P1|Infant Series|Other|19
2652557|NCT00708682|9160662|P1|Infant Series|Failed to return|2
2652558|NCT00708682|9160662|P1|Infant Series|Parent/legal guardian request|6
2652559|NCT00708682|9160662|P1|Infant Series|Protocol Violation|1
2652560|NCT00708682|9160662|P1|Infant Series|Lost to Follow-up|4
2652561|NCT00708682|9160662|P1|Infant Series|Adverse Event|1
2652562|NCT00708643|9160683|P2|Overall Study|Adverse Event|1
2652563|NCT00708643|9160684|P1|Overall Study|Adverse Event|0
2652564|NCT00708552|9160704|P4|Overall Study|Withdrawal by Subject|10
2652565|NCT00708552|9160705|P3|Overall Study|Withdrawal by Subject|8
2652566|NCT00708552|9160706|P2|Overall Study|Withdrawal by Subject|7
2652567|NCT00708552|9160707|P1|Overall Study|Withdrawal by Subject|12
2652568|NCT00708552|9160704|P4|Overall Study|Physician Decision|0
2652569|NCT00708552|9160705|P3|Overall Study|Physician Decision|0
2652570|NCT00708552|9160706|P2|Overall Study|Physician Decision|2
2652571|NCT00708552|9160707|P1|Overall Study|Physician Decision|1
2652572|NCT00708552|9160704|P4|Overall Study|Lost to Follow-up|1
2652573|NCT00708552|9160705|P3|Overall Study|Lost to Follow-up|0
2652574|NCT00708552|9160706|P2|Overall Study|Lost to Follow-up|2
2652575|NCT00708552|9160707|P1|Overall Study|Lost to Follow-up|4
2652576|NCT00708552|9160704|P4|Overall Study|Protocol Violation|4
2652577|NCT00708552|9160705|P3|Overall Study|Protocol Violation|2
2652578|NCT00708552|9160706|P2|Overall Study|Protocol Violation|0
2652579|NCT00708552|9160707|P1|Overall Study|Protocol Violation|0
2652580|NCT00708552|9160704|P4|Overall Study|Lack of Efficacy|0
2652581|NCT00708552|9160705|P3|Overall Study|Lack of Efficacy|1
2652582|NCT00708552|9160706|P2|Overall Study|Lack of Efficacy|4
2652583|NCT00708552|9160707|P1|Overall Study|Lack of Efficacy|0
2652584|NCT00708552|9160704|P4|Overall Study|Adverse Event|6
2652585|NCT00708552|9160705|P3|Overall Study|Adverse Event|4
2652586|NCT00708552|9160706|P2|Overall Study|Adverse Event|3
2652587|NCT00708552|9160707|P1|Overall Study|Adverse Event|10
2652588|NCT00708500|9160869|P3|FOLLOWUP|Non-compliance with protocol|1
2652589|NCT00708500|9160870|P2|FOLLOWUP|Non-compliance with protocol|0
2652590|NCT00708500|9160871|P1|FOLLOWUP|Non-compliance with protocol|5
2652591|NCT00708500|9160869|P3|FOLLOWUP|Subject withdrew consent|5
2652592|NCT00708500|9160870|P2|FOLLOWUP|Subject withdrew consent|4
2652593|NCT00708500|9160871|P1|FOLLOWUP|Subject withdrew consent|31
2652594|NCT00708500|9160869|P3|FOLLOWUP|Subject withdrawal unrelated to Tx|5
2652595|NCT00708500|9160870|P2|FOLLOWUP|Subject withdrawal unrelated to Tx|4
2652596|NCT00708500|9160871|P1|FOLLOWUP|Subject withdrawal unrelated to Tx|3
2652597|NCT00708500|9160869|P3|FOLLOWUP|Lost to Follow-up|4
2652598|NCT00708500|9160870|P2|FOLLOWUP|Lost to Follow-up|6
2652599|NCT00708500|9160871|P1|FOLLOWUP|Lost to Follow-up|1
2652600|NCT00708500|9160869|P3|FOLLOWUP|Adverse Event|0
2652601|NCT00708500|9160870|P2|FOLLOWUP|Adverse Event|1
2652602|NCT00708500|9160871|P1|FOLLOWUP|Adverse Event|0
2652603|NCT00708500|9160869|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
2652604|NCT00708500|9160870|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1
2652605|NCT00708500|9160871|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
2652606|NCT00708500|9160869|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
2652607|NCT00708500|9160870|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
2652608|NCT00708500|9160871|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0
2652609|NCT00708500|9160869|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1
2652610|NCT00708500|9160870|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2
2652611|NCT00708500|9160871|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0
2652612|NCT00708500|9160869|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1
2652613|NCT00708500|9160870|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0
2652614|NCT00708500|9160871|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2
2652615|NCT00708500|9160869|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4
2652616|NCT00708500|9160870|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1
2652617|NCT00708500|9160871|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3
2652618|NCT00708500|9160869|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
2652619|NCT00708500|9160870|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1
2652620|NCT00708500|9160871|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
2652621|NCT00708500|9160869|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29
2652622|NCT00708500|9160870|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36
2652623|NCT00708500|9160871|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49
2652624|NCT00708500|9160869|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19
2652625|NCT00708500|9160870|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10
2652626|NCT00708500|9160871|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1
2652627|NCT00708500|9160869|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1
2652628|NCT00708500|9160870|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
2652629|NCT00708500|9160871|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
2652630|NCT00708500|9160869|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
2652631|NCT00708500|9160870|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2
2652632|NCT00708500|9160871|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
2652633|NCT00708500|9160869|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
2652634|NCT00708500|9160870|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1
2652635|NCT00708500|9160871|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
2652636|NCT00708500|9160869|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
2652637|NCT00708500|9160870|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
2652638|NCT00708500|9160871|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1
2652639|NCT00708500|9160869|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
2652640|NCT00708500|9160870|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3
2652641|NCT00708500|9160871|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
2652642|NCT00708461|9160890|P2|Overall Study|left workforce|180
2652643|NCT00708461|9160891|P1|Overall Study|left workforce|115
2652644|NCT00708461|9160890|P2|Overall Study|Withdrawal by Subject|9
2652645|NCT00708461|9160891|P1|Overall Study|Withdrawal by Subject|8
2652646|NCT00708461|9160890|P2|Overall Study|Lost to Follow-up|11
2652647|NCT00708461|9160891|P1|Overall Study|Lost to Follow-up|18
2652648|NCT00708435|9160899|P2|Overall Study|Refused hospitalization|0
2652649|NCT00708435|9160900|P1|Overall Study|Refused hospitalization|1
2652650|NCT00708435|9160899|P2|Overall Study|Intervention by primary care physician|0
2652651|NCT00708435|9160900|P1|Overall Study|Intervention by primary care physician|1
2652652|NCT00708435|9160899|P2|Overall Study|Protocol Violation|1
2652653|NCT00708435|9160900|P1|Overall Study|Protocol Violation|0
2652654|NCT00708435|9160899|P2|Overall Study|Adverse Event|0
2652655|NCT00708435|9160900|P1|Overall Study|Adverse Event|1
2652656|NCT00708435|9160899|P2|Overall Study|Withdrawal by Subject|7
2652657|NCT00708435|9160900|P1|Overall Study|Withdrawal by Subject|3
2652658|NCT00708435|9160899|P2|Overall Study|Lost to Follow-up|4
2652659|NCT00708435|9160900|P1|Overall Study|Lost to Follow-up|9
2652660|NCT00708435|9160899|P2|Overall Study|Death / Serious Adverse Event|5
2652661|NCT00708435|9160900|P1|Overall Study|Death / Serious Adverse Event|10
2652662|NCT00708422|9160927|P2|Overall Study|Withdrawal by Subject|0
2652663|NCT00708422|9160928|P1|Overall Study|Withdrawal by Subject|1
2652664|NCT00708422|9160927|P2|Overall Study|Adverse Event|1
2652665|NCT00708422|9160928|P1|Overall Study|Adverse Event|3
2652666|NCT00708305|9160936|P4|Period 3|Other Reason|0
2652667|NCT00708305|9160937|P3|Period 3|Other Reason|0
2652668|NCT00708305|9160938|P2|Period 3|Other Reason|0
2652669|NCT00708305|9160939|P1|Period 3|Other Reason|1
2652670|NCT00708305|9160936|P4|Period 3|Protocol Violation|0
2652671|NCT00708305|9160937|P3|Period 3|Protocol Violation|0
2652672|NCT00708305|9160938|P2|Period 3|Protocol Violation|2
2652673|NCT00708305|9160939|P1|Period 3|Protocol Violation|0
2652674|NCT00708305|9160936|P4|Period 2|Other Reason|1
2652675|NCT00708305|9160937|P3|Period 2|Other Reason|0
2652676|NCT00708305|9160938|P2|Period 2|Other Reason|0
2652677|NCT00708305|9160939|P1|Period 2|Other Reason|1
2652678|NCT00708305|9160936|P4|Period 2|Protocol Violation|0
2652679|NCT00708305|9160937|P3|Period 2|Protocol Violation|0
2652680|NCT00708305|9160938|P2|Period 2|Protocol Violation|1
2652681|NCT00708305|9160939|P1|Period 2|Protocol Violation|0
2652682|NCT00708305|9160936|P4|Period 2|Lost to Follow-up|0
2652683|NCT00708305|9160937|P3|Period 2|Lost to Follow-up|0
2652684|NCT00708305|9160938|P2|Period 2|Lost to Follow-up|1
2652685|NCT00708305|9160939|P1|Period 2|Lost to Follow-up|0
2652686|NCT00708305|9160936|P4|Period 1|Other Reason|2
2652687|NCT00708305|9160937|P3|Period 1|Other Reason|0
2652688|NCT00708305|9160938|P2|Period 1|Other Reason|0
2652689|NCT00708305|9160939|P1|Period 1|Other Reason|0
2652690|NCT00708305|9160936|P4|Period 1|Protocol Violation|0
2652691|NCT00708305|9160937|P3|Period 1|Protocol Violation|1
2652692|NCT00708305|9160938|P2|Period 1|Protocol Violation|0
2652693|NCT00708305|9160939|P1|Period 1|Protocol Violation|1
2652694|NCT00708227|9160975|P4|Overall Study|Withdrawal by Subject|1
2652695|NCT00708227|9160976|P3|Overall Study|Withdrawal by Subject|0
2652696|NCT00708227|9160977|P2|Overall Study|Withdrawal by Subject|2
2652697|NCT00708227|9160978|P1|Overall Study|Withdrawal by Subject|1
2652698|NCT00708227|9160975|P4|Overall Study|Physician Decision|2
2652699|NCT00708227|9160976|P3|Overall Study|Physician Decision|1
2652700|NCT00708227|9160977|P2|Overall Study|Physician Decision|3
2652701|NCT00708227|9160978|P1|Overall Study|Physician Decision|0
2652702|NCT00708214|9161011|P3|Overall Study|Progressive Disease|5
2652703|NCT00708214|9161012|P2|Overall Study|Progressive Disease|6
2652704|NCT00708214|9161013|P1|Overall Study|Progressive Disease|4
2652705|NCT00708214|9161011|P3|Overall Study|Other|1
2652706|NCT00708214|9161012|P2|Overall Study|Other|1
2652707|NCT00708214|9161013|P1|Overall Study|Other|0
2652708|NCT00708214|9161011|P3|Overall Study|Other Adverse Event|2
2652709|NCT00708214|9161012|P2|Overall Study|Other Adverse Event|6
2652710|NCT00708214|9161013|P1|Overall Study|Other Adverse Event|3
2652711|NCT00708201|9161056|P2|Overall Study|Protocol Violation|1
2652712|NCT00708201|9161057|P1|Overall Study|Protocol Violation|0
2652713|NCT00708201|9161056|P2|Overall Study|Lost to Follow-up|0
2652714|NCT00708201|9161057|P1|Overall Study|Lost to Follow-up|2
2652715|NCT00708201|9161056|P2|Overall Study|Withdrawal by Subject|1
2652716|NCT00708201|9161057|P1|Overall Study|Withdrawal by Subject|1
2652717|NCT00708201|9161056|P2|Overall Study|Adverse Event|4
2652718|NCT00708201|9161057|P1|Overall Study|Adverse Event|4
2652719|NCT00708175|9161081|P2|Overall Study|BMD loss >7%|3
2652720|NCT00708175|9161082|P1|Overall Study|BMD loss >7%|2
2652721|NCT00708175|9161081|P2|Overall Study|Withdrawal by Subject|7
2652722|NCT00708175|9161082|P1|Overall Study|Withdrawal by Subject|5
2652723|NCT00708175|9161081|P2|Overall Study|Lost to Follow-up|3
2652724|NCT00708175|9161082|P1|Overall Study|Lost to Follow-up|5
2652725|NCT00708175|9161081|P2|Overall Study|Protocol Violation|3
2652726|NCT00708175|9161082|P1|Overall Study|Protocol Violation|2
2652727|NCT00708175|9161081|P2|Overall Study|Adverse Event|5
2652728|NCT00708175|9161082|P1|Overall Study|Adverse Event|4
2652729|NCT00708162|9161098|P2|Open-Label Phase|Other|0
2652730|NCT00708162|9161099|P1|Open-Label Phase|Other|1
2652731|NCT00708162|9161098|P2|Open-Label Phase|Adverse Event|2
2652732|NCT00708162|9161099|P1|Open-Label Phase|Adverse Event|1
2652733|NCT00708162|9161098|P2|Open-Label Phase|Death|1
2652734|NCT00708162|9161099|P1|Open-Label Phase|Death|3
2652735|NCT00708162|9161098|P2|Open-Label Phase|Investigator's Discretion|2
2652736|NCT00708162|9161099|P1|Open-Label Phase|Investigator's Discretion|3
2652737|NCT00708162|9161098|P2|Open-Label Phase|Lack of Efficacy|4
2652738|NCT00708162|9161099|P1|Open-Label Phase|Lack of Efficacy|7
2652739|NCT00708162|9161098|P2|Open-Label Phase|Participant Noncompliance|7
2652740|NCT00708162|9161099|P1|Open-Label Phase|Participant Noncompliance|7
2652741|NCT00708162|9161098|P2|Open-Label Phase|Withdrew Consent|6
2652742|NCT00708162|9161099|P1|Open-Label Phase|Withdrew Consent|12
2652743|NCT00708162|9161098|P2|Open-Label Phase|Lost to Follow-up|8
2652744|NCT00708162|9161099|P1|Open-Label Phase|Lost to Follow-up|10
2652745|NCT00708162|9161098|P2|Randomized Phase|Pregnancy|0
2652746|NCT00708162|9161099|P1|Randomized Phase|Pregnancy|3
2652747|NCT00708162|9161098|P2|Randomized Phase|Death|9
2652748|NCT00708162|9161099|P1|Randomized Phase|Death|2
2652749|NCT00708162|9161098|P2|Randomized Phase|Investigator’s Discretion|10
2652750|NCT00708162|9161099|P1|Randomized Phase|Investigator’s Discretion|7
2652751|NCT00708162|9161098|P2|Randomized Phase|Adverse Event|12
2652752|NCT00708162|9161099|P1|Randomized Phase|Adverse Event|8
2652753|NCT00708162|9161098|P2|Randomized Phase|Protocol Violation|11
2652754|NCT00708162|9161099|P1|Randomized Phase|Protocol Violation|10
2652755|NCT00708162|9161098|P2|Randomized Phase|Lack of Efficacy|19
2652756|NCT00708162|9161099|P1|Randomized Phase|Lack of Efficacy|14
2652757|NCT00708162|9161098|P2|Randomized Phase|Withdrew Consent|22
2652758|NCT00708162|9161099|P1|Randomized Phase|Withdrew Consent|31
2652759|NCT00708162|9161098|P2|Randomized Phase|Lost to Follow-up|34
2652760|NCT00708162|9161099|P1|Randomized Phase|Lost to Follow-up|34
2652761|NCT00708162|9161098|P2|Randomized Phase|Participant Noncompliance|32
2652762|NCT00708162|9161099|P1|Randomized Phase|Participant Noncompliance|40
2652763|NCT00708162|9161098|P2|Randomized Phase|Randomized but Not Treated|5
2652764|NCT00708162|9161099|P1|Randomized Phase|Randomized but Not Treated|7
2652765|NCT00708123|9161140|P5|Period 4|Protocol Violation|0
2652766|NCT00708123|9161141|P4|Period 4|Protocol Violation|0
2652767|NCT00708123|9161142|P3|Period 4|Protocol Violation|0
2652768|NCT00708123|9161143|P2|Period 4|Protocol Violation|1
2652769|NCT00708123|9161144|P1|Period 4|Protocol Violation|0
2652770|NCT00708123|9161140|P5|Period 3|Lost to Follow-up|0
2652771|NCT00708123|9161141|P4|Period 3|Lost to Follow-up|1
2652772|NCT00708123|9161142|P3|Period 3|Lost to Follow-up|1
2652773|NCT00708123|9161143|P2|Period 3|Lost to Follow-up|0
2652774|NCT00708123|9161144|P1|Period 3|Lost to Follow-up|0
2652775|NCT00708123|9161140|P5|Period 2|Other Reason|0
2652776|NCT00708123|9161141|P4|Period 2|Other Reason|0
2652777|NCT00708123|9161142|P3|Period 2|Other Reason|0
2652778|NCT00708123|9161143|P2|Period 2|Other Reason|0
2652779|NCT00708123|9161144|P1|Period 2|Other Reason|1
2652780|NCT00708123|9161140|P5|Period 2|Protocol Violation|0
2652781|NCT00708123|9161141|P4|Period 2|Protocol Violation|1
2652782|NCT00708123|9161142|P3|Period 2|Protocol Violation|0
2652783|NCT00708123|9161143|P2|Period 2|Protocol Violation|0
2652784|NCT00708123|9161144|P1|Period 2|Protocol Violation|0
2652785|NCT00708123|9161140|P5|Period 1|Adverse Event|0
2652786|NCT00708123|9161141|P4|Period 1|Adverse Event|0
2652787|NCT00708123|9161142|P3|Period 1|Adverse Event|1
2652788|NCT00708123|9161143|P2|Period 1|Adverse Event|0
2652789|NCT00708123|9161144|P1|Period 1|Adverse Event|0
2652790|NCT00708123|9161140|P5|Period 1|Protocol Violation|0
2652791|NCT00708123|9161141|P4|Period 1|Protocol Violation|1
2652792|NCT00708123|9161142|P3|Period 1|Protocol Violation|0
2652793|NCT00708123|9161143|P2|Period 1|Protocol Violation|1
2652794|NCT00708123|9161144|P1|Period 1|Protocol Violation|0
2652795|NCT00708097|9161277|P5|Period 2|Protocol Violation|0
2652796|NCT00708097|9161278|P4|Period 2|Protocol Violation|1
2652797|NCT00708097|9161279|P3|Period 2|Protocol Violation|1
2652798|NCT00708097|9161280|P2|Period 2|Protocol Violation|1
2652799|NCT00708097|9161281|P1|Period 2|Protocol Violation|0
2652800|NCT00708097|9161277|P5|Period 1|Other Reason|1
2652801|NCT00708097|9161278|P4|Period 1|Other Reason|0
2652802|NCT00708097|9161279|P3|Period 1|Other Reason|0
2652803|NCT00708097|9161280|P2|Period 1|Other Reason|0
2652804|NCT00708097|9161281|P1|Period 1|Other Reason|0
2652805|NCT00708097|9161277|P5|Period 1|Protocol Violation|0
2652806|NCT00708097|9161278|P4|Period 1|Protocol Violation|2
2652807|NCT00708097|9161279|P3|Period 1|Protocol Violation|0
2652808|NCT00708097|9161280|P2|Period 1|Protocol Violation|1
2652809|NCT00708097|9161281|P1|Period 1|Protocol Violation|0
2652810|NCT00708032|9161391|P2|Overall Study|Withdrawal by Subject|1
2652811|NCT00708032|9161392|P1|Overall Study|Withdrawal by Subject|0
2652812|NCT00708032|9161391|P2|Overall Study|Protocol Violation|1
2652813|NCT00708032|9161392|P1|Overall Study|Protocol Violation|4
2652814|NCT00708032|9161391|P2|Overall Study|Did not meet protocol criteria|2
2652815|NCT00708032|9161392|P1|Overall Study|Did not meet protocol criteria|1
2652816|NCT00708032|9161391|P2|Overall Study|Visit out of range at month 12|1
2652817|NCT00708032|9161392|P1|Overall Study|Visit out of range at month 12|4
2652818|NCT00708032|9161391|P2|Overall Study|Poor vision|6
2652819|NCT00708032|9161392|P1|Overall Study|Poor vision|0
2652820|NCT00708032|9161391|P2|Overall Study|Pregnancy|1
2652821|NCT00708032|9161392|P1|Overall Study|Pregnancy|0
2652822|NCT00708032|9161391|P2|Overall Study|Lost to Follow-up|2
2652823|NCT00708032|9161392|P1|Overall Study|Lost to Follow-up|1
2652824|NCT00708032|9161391|P2|Overall Study|Adverse Event|2
2652825|NCT00708032|9161392|P1|Overall Study|Adverse Event|0
2652826|NCT00707993|9161419|P2|Overall Study|Other|0
2652827|NCT00707993|9161420|P1|Overall Study|Other|2
2652828|NCT00707993|9161419|P2|Overall Study|Hyperglycemic Rescue|47
2652829|NCT00707993|9161420|P1|Overall Study|Hyperglycemic Rescue|55
2652830|NCT00707993|9161419|P2|Overall Study|Withdrawal by Subject|16
2652831|NCT00707993|9161420|P1|Overall Study|Withdrawal by Subject|12
2652832|NCT00707993|9161419|P2|Overall Study|Lost to Follow-up|4
2652833|NCT00707993|9161420|P1|Overall Study|Lost to Follow-up|0
2652834|NCT00707993|9161419|P2|Overall Study|Protocol Violation|7
2652835|NCT00707993|9161420|P1|Overall Study|Protocol Violation|4
2652836|NCT00707993|9161419|P2|Overall Study|Adverse Event|20
2652837|NCT00707993|9161420|P1|Overall Study|Adverse Event|16
2652838|NCT00707980|9161462|P1|Overall Study|Other|39
2652839|NCT00707980|9161462|P1|Overall Study|Lost to Follow-up|59
2652840|NCT00707980|9161462|P1|Overall Study|Withdrawal of Consent|81
2652841|NCT00707980|9161462|P1|Overall Study|Protocol Deviations|19
2652842|NCT00707980|9161462|P1|Overall Study|Non-Compliance with Study Drug|28
2652843|NCT00707980|9161462|P1|Overall Study|Lack of Efficacy|35
2652844|NCT00707980|9161462|P1|Overall Study|Adverse Event|49
2652845|NCT00707954|9161546|P5|Overall Study|Physician Decision|1
2652846|NCT00707954|9161547|P4|Overall Study|Physician Decision|0
2652847|NCT00707954|9161548|P3|Overall Study|Physician Decision|0
2652848|NCT00707954|9161549|P2|Overall Study|Physician Decision|0
2652849|NCT00707954|9161550|P1|Overall Study|Physician Decision|0
2652850|NCT00707746|9161591|P2|Treatment Period|Ineligibility|1
2652851|NCT00707746|9161592|P1|Treatment Period|Ineligibility|0
2652852|NCT00707746|9161591|P2|Treatment Period|Adverse Event|4
2652853|NCT00707746|9161592|P1|Treatment Period|Adverse Event|2
2652854|NCT00707577|9161653|P2|Overall Study|Pregnancy|1
2652855|NCT00707577|9161654|P1|Overall Study|Pregnancy|4
2652856|NCT00707577|9161653|P2|Overall Study|Left employment|10
2652857|NCT00707577|9161654|P1|Overall Study|Left employment|13
2652858|NCT00707577|9161653|P2|Overall Study|Lost to Follow-up|25
2652859|NCT00707577|9161654|P1|Overall Study|Lost to Follow-up|34
2652860|NCT00707577|9161653|P2|Overall Study|Withdrawal by Subject|2
2652861|NCT00707577|9161654|P1|Overall Study|Withdrawal by Subject|3
2652862|NCT00707486|9161660|P1|Overall Study|Withdrawal by Subject|1
2652863|NCT00707434|9161696|P1|Overall Study|Adverse Event|1
2652864|NCT00707239|9161707|P3|Overall Study|Other|5
2652865|NCT00707239|9161708|P2|Overall Study|Other|3
2652866|NCT00707239|9161709|P1|Overall Study|Other|8
2652867|NCT00707239|9161707|P3|Overall Study|Randomized, but not treated|1
2652868|NCT00707239|9161708|P2|Overall Study|Randomized, but not treated|1
2652869|NCT00707239|9161709|P1|Overall Study|Randomized, but not treated|1
2652870|NCT00707239|9161707|P3|Overall Study|Lack of Efficacy|0
2652871|NCT00707239|9161708|P2|Overall Study|Lack of Efficacy|2
2652872|NCT00707239|9161709|P1|Overall Study|Lack of Efficacy|1
2652873|NCT00707239|9161707|P3|Overall Study|Protocol Violation|1
2652874|NCT00707239|9161708|P2|Overall Study|Protocol Violation|0
2652875|NCT00707239|9161709|P1|Overall Study|Protocol Violation|0
2652876|NCT00707239|9161707|P3|Overall Study|Physician Decision|2
2652877|NCT00707239|9161708|P2|Overall Study|Physician Decision|1
2652878|NCT00707239|9161709|P1|Overall Study|Physician Decision|1
2652879|NCT00707239|9161707|P3|Overall Study|Death|3
2652880|NCT00707239|9161708|P2|Overall Study|Death|1
2652881|NCT00707239|9161709|P1|Overall Study|Death|3
2652882|NCT00707239|9161707|P3|Overall Study|Adverse Event|2
2652883|NCT00707239|9161708|P2|Overall Study|Adverse Event|3
2652884|NCT00707239|9161709|P1|Overall Study|Adverse Event|5
2652885|NCT00707174|9161757|P2|Overall Study|Withdrawal by Subject|1
2652886|NCT00707174|9161758|P1|Overall Study|Withdrawal by Subject|4
2652887|NCT00707174|9161757|P2|Overall Study|Adverse Event|6
2652888|NCT00707174|9161758|P1|Overall Study|Adverse Event|1
2652889|NCT00707161|9161764|P1|Overall Study|Physician Decision|6
2652890|NCT00707057|9161770|P2|Overall Study|Dosed incorrectly|1
2652891|NCT00707057|9161771|P1|Overall Study|Dosed incorrectly|0
2652892|NCT00707057|9161770|P2|Overall Study|Withdrawal by Subject|3
2652893|NCT00707057|9161771|P1|Overall Study|Withdrawal by Subject|8
2652894|NCT00707031|9161805|P2|Overall Study|Sponsor Decision|8
2652895|NCT00707031|9161806|P1|Overall Study|Sponsor Decision|9
2652896|NCT00707031|9161805|P2|Overall Study|Serious Noncompliance|3
2652897|NCT00707031|9161806|P1|Overall Study|Serious Noncompliance|2
2652898|NCT00707031|9161805|P2|Overall Study|Familial or Personal Reasons|15
2652899|NCT00707031|9161806|P1|Overall Study|Familial or Personal Reasons|12
2652900|NCT00707031|9161805|P2|Overall Study|Poor Compliance to Protocol|13
2652901|NCT00707031|9161806|P1|Overall Study|Poor Compliance to Protocol|7
2652902|NCT00707031|9161805|P2|Overall Study|Withdrawal by Subject|8
2652903|NCT00707031|9161806|P1|Overall Study|Withdrawal by Subject|7
2652904|NCT00707031|9161805|P2|Overall Study|Protocol Violation|0
2652905|NCT00707031|9161806|P1|Overall Study|Protocol Violation|1
2652906|NCT00707031|9161805|P2|Overall Study|Lost to Follow-up|1
2652907|NCT00707031|9161806|P1|Overall Study|Lost to Follow-up|2
2652908|NCT00707031|9161805|P2|Overall Study|Lack of Efficacy|6
2652909|NCT00707031|9161806|P1|Overall Study|Lack of Efficacy|19
2652910|NCT00707031|9161805|P2|Overall Study|Adverse Event|45
2652911|NCT00707031|9161806|P1|Overall Study|Adverse Event|45
2652912|NCT00706992|9161835|P7|Overall Study|Disease progression before treatment|0
2652913|NCT00706992|9161836|P6|Overall Study|Disease progression before treatment|0
2652914|NCT00706992|9161837|P5|Overall Study|Disease progression before treatment|1
2652915|NCT00706992|9161838|P4|Overall Study|Disease progression before treatment|0
2652916|NCT00706992|9161839|P3|Overall Study|Disease progression before treatment|0
2652917|NCT00706992|9161840|P2|Overall Study|Disease progression before treatment|0
2652918|NCT00706992|9161841|P1|Overall Study|Disease progression before treatment|0
2652919|NCT00706992|9161835|P7|Overall Study|Study termination|3
2652920|NCT00706992|9161836|P6|Overall Study|Study termination|2
2652921|NCT00706992|9161837|P5|Overall Study|Study termination|3
2652922|NCT00706992|9161838|P4|Overall Study|Study termination|2
2652923|NCT00706992|9161839|P3|Overall Study|Study termination|6
2652924|NCT00706992|9161840|P2|Overall Study|Study termination|5
2652925|NCT00706992|9161841|P1|Overall Study|Study termination|5
2652926|NCT00706966|9161873|P1|Overall Study|Adverse Event|1
2652927|NCT00706914|9161909|P3|Overall Study|Protocol Violation|1
2652928|NCT00706914|9161910|P2|Overall Study|Protocol Violation|1
2652929|NCT00706914|9161911|P1|Overall Study|Protocol Violation|3
2652930|NCT00706914|9161909|P3|Overall Study|Adverse Event|0
2652931|NCT00706914|9161910|P2|Overall Study|Adverse Event|2
2652932|NCT00706914|9161911|P1|Overall Study|Adverse Event|2
2652933|NCT00706914|9161909|P3|Overall Study|Lost to Follow-up|0
2652934|NCT00706914|9161910|P2|Overall Study|Lost to Follow-up|0
2652935|NCT00706914|9161911|P1|Overall Study|Lost to Follow-up|1
2652936|NCT00706914|9161909|P3|Overall Study|Lack of Efficacy|0
2652937|NCT00706914|9161910|P2|Overall Study|Lack of Efficacy|1
2652938|NCT00706914|9161911|P1|Overall Study|Lack of Efficacy|0
2652939|NCT00706901|9161934|P3|Overall Study|Death|0
2652940|NCT00706901|9161935|P2|Overall Study|Death|0
2652941|NCT00706901|9161936|P1|Overall Study|Death|1
2652942|NCT00706901|9161934|P3|Overall Study|In Jail|1
2652943|NCT00706901|9161935|P2|Overall Study|In Jail|0
2652944|NCT00706901|9161936|P1|Overall Study|In Jail|1
2652945|NCT00706901|9161934|P3|Overall Study|Withdrawal by Subject|5
2652946|NCT00706901|9161935|P2|Overall Study|Withdrawal by Subject|2
2652947|NCT00706901|9161936|P1|Overall Study|Withdrawal by Subject|4
2652948|NCT00706901|9161934|P3|Overall Study|Lost to Follow-up|2
2652949|NCT00706901|9161935|P2|Overall Study|Lost to Follow-up|3
2652950|NCT00706901|9161936|P1|Overall Study|Lost to Follow-up|2
2652951|NCT00706849|9161961|P2|Follow-up Period|Protocol non-compliance|1
2652952|NCT00706849|9161962|P1|Follow-up Period|Protocol non-compliance|0
2652953|NCT00706849|9161961|P2|Follow-up Period|Withdrawal by Subject|2
2652954|NCT00706849|9161962|P1|Follow-up Period|Withdrawal by Subject|0
2652955|NCT00706849|9161961|P2|Treatment Period|Other|1
2652956|NCT00706849|9161962|P1|Treatment Period|Other|0
2652957|NCT00706849|9161961|P2|Treatment Period|Adverse Event|9
2652958|NCT00706849|9161962|P1|Treatment Period|Adverse Event|0
2652959|NCT00706797|9162040|P2|Overall Study|Other|0
2652960|NCT00706797|9162041|P1|Overall Study|Other|1
2652961|NCT00706797|9162040|P2|Overall Study|Lost to Follow-up|2
2652962|NCT00706797|9162041|P1|Overall Study|Lost to Follow-up|1
2652963|NCT00706797|9162040|P2|Overall Study|Protocol Violation|2
2652964|NCT00706797|9162041|P1|Overall Study|Protocol Violation|3
2652965|NCT00706797|9162040|P2|Overall Study|Discontinuation of study by sponsor|63
2652966|NCT00706797|9162041|P1|Overall Study|Discontinuation of study by sponsor|52
2652967|NCT00706797|9162040|P2|Overall Study|Death|0
2652968|NCT00706797|9162041|P1|Overall Study|Death|1
2652969|NCT00706797|9162040|P2|Overall Study|Withdrawal by Subject|1
2652970|NCT00706797|9162041|P1|Overall Study|Withdrawal by Subject|8
2652971|NCT00706797|9162040|P2|Overall Study|Adverse Event|3
2652972|NCT00706797|9162041|P1|Overall Study|Adverse Event|0
2652973|NCT00706797|9162040|P2|Overall Study|Lack of Efficacy|0
2652974|NCT00706797|9162041|P1|Overall Study|Lack of Efficacy|3
2652975|NCT00706706|9162110|P1|Overall Study|Study endpoint had reached|45
2652976|NCT00706706|9162110|P1|Overall Study|Lost to Follow-up|7
2652977|NCT00706706|9162110|P1|Overall Study|Death|53
2652978|NCT00706654|9162120|P4|Depot Maintenance Phase|Impending Relapse without Adverse Event|12
2652979|NCT00706654|9162121|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
2652980|NCT00706654|9162122|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
2652981|NCT00706654|9162123|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
2652982|NCT00706654|9162120|P4|Depot Maintenance Phase|Impending Relapse with Adverse Event|17
2652983|NCT00706654|9162121|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|12
2652984|NCT00706654|9162122|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
2652985|NCT00706654|9162123|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
2652986|NCT00706654|9162120|P4|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
2652987|NCT00706654|9162121|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
2652988|NCT00706654|9162122|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|8
2652989|NCT00706654|9162123|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
2652990|NCT00706654|9162120|P4|Depot Maintenance Phase|Protocol Deviation|1
2652991|NCT00706654|9162121|P3|Depot Maintenance Phase|Protocol Deviation|3
2652992|NCT00706654|9162122|P2|Depot Maintenance Phase|Protocol Deviation|2
2652993|NCT00706654|9162123|P1|Depot Maintenance Phase|Protocol Deviation|0
2652994|NCT00706654|9162120|P4|Depot Maintenance Phase|Withdrew Consent|14
2652995|NCT00706654|9162121|P3|Depot Maintenance Phase|Withdrew Consent|29
2652996|NCT00706654|9162122|P2|Depot Maintenance Phase|Withdrew Consent|21
2652997|NCT00706654|9162123|P1|Depot Maintenance Phase|Withdrew Consent|0
2652998|NCT00706654|9162120|P4|Depot Maintenance Phase|Withdrawn by Investigator|8
2652999|NCT00706654|9162121|P3|Depot Maintenance Phase|Withdrawn by Investigator|12
2653000|NCT00706654|9162122|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
2653001|NCT00706654|9162123|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
2653002|NCT00706654|9162120|P4|Depot Maintenance Phase|Met Withdrawal Criteria|5
2653003|NCT00706654|9162121|P3|Depot Maintenance Phase|Met Withdrawal Criteria|6
2653004|NCT00706654|9162122|P2|Depot Maintenance Phase|Met Withdrawal Criteria|4
2653005|NCT00706654|9162123|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
2653006|NCT00706654|9162120|P4|Depot Maintenance Phase|Lost to Follow-up|6
2653007|NCT00706654|9162121|P3|Depot Maintenance Phase|Lost to Follow-up|10
2653008|NCT00706654|9162122|P2|Depot Maintenance Phase|Lost to Follow-up|4
2653009|NCT00706654|9162123|P1|Depot Maintenance Phase|Lost to Follow-up|0
2653010|NCT00706654|9162120|P4|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
2653011|NCT00706654|9162121|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
2653012|NCT00706654|9162122|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
2653013|NCT00706654|9162123|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10
2653014|NCT00706654|9162120|P4|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
2653015|NCT00706654|9162121|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
2653016|NCT00706654|9162122|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
2653017|NCT00706654|9162123|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20
2653018|NCT00706654|9162120|P4|Oral Stabilization Phase|Adverse Event|0
2653019|NCT00706654|9162121|P3|Oral Stabilization Phase|Adverse Event|0
2653020|NCT00706654|9162122|P2|Oral Stabilization Phase|Adverse Event|0
2653021|NCT00706654|9162123|P1|Oral Stabilization Phase|Adverse Event|21
2653022|NCT00706654|9162120|P4|Oral Stabilization Phase|Protocol Deviation|0
2653023|NCT00706654|9162121|P3|Oral Stabilization Phase|Protocol Deviation|0
2653024|NCT00706654|9162122|P2|Oral Stabilization Phase|Protocol Deviation|0
2653025|NCT00706654|9162123|P1|Oral Stabilization Phase|Protocol Deviation|2
2653026|NCT00706654|9162120|P4|Oral Stabilization Phase|Withdrew consent|0
2653027|NCT00706654|9162121|P3|Oral Stabilization Phase|Withdrew consent|0
2653028|NCT00706654|9162122|P2|Oral Stabilization Phase|Withdrew consent|0
2653029|NCT00706654|9162123|P1|Oral Stabilization Phase|Withdrew consent|55
2653030|NCT00706654|9162120|P4|Oral Stabilization Phase|Withdrawn by Investigator|0
2653031|NCT00706654|9162121|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
2653032|NCT00706654|9162122|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
2653033|NCT00706654|9162123|P1|Oral Stabilization Phase|Withdrawn by Investigator|21
2653034|NCT00706654|9162120|P4|Oral Stabilization Phase|Met Withdrawal Criteria|0
2653035|NCT00706654|9162121|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
2653036|NCT00706654|9162122|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
2653037|NCT00706654|9162123|P1|Oral Stabilization Phase|Met Withdrawal Criteria|15
2653038|NCT00706654|9162120|P4|Oral Stabilization Phase|Sponsor Discontinue Trial|0
2653039|NCT00706654|9162121|P3|Oral Stabilization Phase|Sponsor Discontinue Trial|0
2653040|NCT00706654|9162122|P2|Oral Stabilization Phase|Sponsor Discontinue Trial|0
2653041|NCT00706654|9162123|P1|Oral Stabilization Phase|Sponsor Discontinue Trial|19
2653042|NCT00706654|9162120|P4|Oral Stabilization Phase|Lost to Follow-up|0
2653043|NCT00706654|9162121|P3|Oral Stabilization Phase|Lost to Follow-up|0
2653044|NCT00706654|9162122|P2|Oral Stabilization Phase|Lost to Follow-up|0
2653045|NCT00706654|9162123|P1|Oral Stabilization Phase|Lost to Follow-up|17
2653046|NCT00706654|9162120|P4|Conversion Phase|Lack of Efficacy without Adverse Event|0
2653047|NCT00706654|9162121|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
2653048|NCT00706654|9162122|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
2653049|NCT00706654|9162123|P1|Conversion Phase|Lack of Efficacy without Adverse Event|2
2653050|NCT00706654|9162120|P4|Conversion Phase|Lack of Efficacy with Adverse Event|0
2653051|NCT00706654|9162121|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
2653052|NCT00706654|9162122|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
2653053|NCT00706654|9162123|P1|Conversion Phase|Lack of Efficacy with Adverse Event|9
2653054|NCT00706654|9162120|P4|Conversion Phase|Adverse Event|0
2653055|NCT00706654|9162121|P3|Conversion Phase|Adverse Event|0
2653056|NCT00706654|9162122|P2|Conversion Phase|Adverse Event|0
2653057|NCT00706654|9162123|P1|Conversion Phase|Adverse Event|18
2653058|NCT00706654|9162120|P4|Conversion Phase|Withdrew Consent|0
2653059|NCT00706654|9162121|P3|Conversion Phase|Withdrew Consent|0
2653060|NCT00706654|9162122|P2|Conversion Phase|Withdrew Consent|0
2653061|NCT00706654|9162123|P1|Conversion Phase|Withdrew Consent|38
2653062|NCT00706654|9162120|P4|Conversion Phase|Withdrawn by Investigator|0
2653063|NCT00706654|9162121|P3|Conversion Phase|Withdrawn by Investigator|0
2653064|NCT00706654|9162122|P2|Conversion Phase|Withdrawn by Investigator|0
2653065|NCT00706654|9162123|P1|Conversion Phase|Withdrawn by Investigator|14
2653066|NCT00706654|9162120|P4|Conversion Phase|Met Withdrawal Criteria|0
2653067|NCT00706654|9162121|P3|Conversion Phase|Met Withdrawal Criteria|0
2653068|NCT00706654|9162122|P2|Conversion Phase|Met Withdrawal Criteria|0
2653069|NCT00706654|9162123|P1|Conversion Phase|Met Withdrawal Criteria|2
2653070|NCT00706654|9162120|P4|Conversion Phase|Sponsor Discontinued Trial|0
2653071|NCT00706654|9162121|P3|Conversion Phase|Sponsor Discontinued Trial|0
2653072|NCT00706654|9162122|P2|Conversion Phase|Sponsor Discontinued Trial|0
2653073|NCT00706654|9162123|P1|Conversion Phase|Sponsor Discontinued Trial|8
2653074|NCT00706654|9162120|P4|Conversion Phase|Lost to Follow-up|0
2653075|NCT00706654|9162121|P3|Conversion Phase|Lost to Follow-up|0
2653076|NCT00706654|9162122|P2|Conversion Phase|Lost to Follow-up|0
2653077|NCT00706654|9162123|P1|Conversion Phase|Lost to Follow-up|4
2653078|NCT00706641|9162142|P1|Radical Cystectomy|Deemed unresectable upon exploration|1
2653079|NCT00706641|9162142|P1|Dasatinib Administration|Ineligible after start of therapy|1
2653080|NCT00706641|9162142|P1|Dasatinib Administration|Withdrawal by Subject|1
2653081|NCT00706628|9162156|P4|Overall Study|Not treated|0
2653082|NCT00706628|9162157|P3|Overall Study|Not treated|0
2653083|NCT00706628|9162158|P2|Overall Study|Not treated|1
2653084|NCT00706628|9162159|P1|Overall Study|Not treated|1
2653085|NCT00706628|9162156|P4|Overall Study|Other than those stated above|0
2653086|NCT00706628|9162157|P3|Overall Study|Other than those stated above|0
2653087|NCT00706628|9162158|P2|Overall Study|Other than those stated above|0
2653088|NCT00706628|9162159|P1|Overall Study|Other than those stated above|4
2653089|NCT00706628|9162156|P4|Overall Study|Progressive disease|1
2653090|NCT00706628|9162157|P3|Overall Study|Progressive disease|8
2653091|NCT00706628|9162158|P2|Overall Study|Progressive disease|13
2653092|NCT00706628|9162159|P1|Overall Study|Progressive disease|20
2653093|NCT00706628|9162156|P4|Overall Study|Consent withdrawn|0
2653094|NCT00706628|9162157|P3|Overall Study|Consent withdrawn|3
2653095|NCT00706628|9162158|P2|Overall Study|Consent withdrawn|1
2653096|NCT00706628|9162159|P1|Overall Study|Consent withdrawn|6
2653097|NCT00706628|9162156|P4|Overall Study|Non compliant with protocol|0
2653098|NCT00706628|9162157|P3|Overall Study|Non compliant with protocol|0
2653099|NCT00706628|9162158|P2|Overall Study|Non compliant with protocol|1
2653100|NCT00706628|9162159|P1|Overall Study|Non compliant with protocol|0
2653101|NCT00706628|9162156|P4|Overall Study|Other Adverse Event|2
2653102|NCT00706628|9162157|P3|Overall Study|Other Adverse Event|5
2653103|NCT00706628|9162158|P2|Overall Study|Other Adverse Event|5
2653104|NCT00706628|9162159|P1|Overall Study|Other Adverse Event|16
2653105|NCT00706511|9162264|P4|Overall Study|Withdrawal by Subject|0
2653106|NCT00706511|9162265|P3|Overall Study|Withdrawal by Subject|0
2653107|NCT00706511|9162266|P2|Overall Study|Withdrawal by Subject|0
2653108|NCT00706511|9162267|P1|Overall Study|Withdrawal by Subject|1
2653109|NCT00706433|9162358|P4|Overall Study|new job|1
2653110|NCT00706433|9162359|P3|Overall Study|new job|0
2653111|NCT00706433|9162360|P2|Overall Study|new job|0
2653112|NCT00706433|9162361|P1|Overall Study|new job|0
2653113|NCT00706433|9162358|P4|Overall Study|Protocol Violation|0
2653114|NCT00706433|9162359|P3|Overall Study|Protocol Violation|0
2653115|NCT00706433|9162360|P2|Overall Study|Protocol Violation|0
2653116|NCT00706433|9162361|P1|Overall Study|Protocol Violation|1
2653117|NCT00706433|9162358|P4|Overall Study|Adverse Event|0
2653118|NCT00706433|9162359|P3|Overall Study|Adverse Event|1
2653119|NCT00706433|9162360|P2|Overall Study|Adverse Event|0
2653120|NCT00706433|9162361|P1|Overall Study|Adverse Event|0
2653121|NCT00706433|9162358|P4|Overall Study|Withdrawal by Subject|1
2653122|NCT00706433|9162359|P3|Overall Study|Withdrawal by Subject|3
2653123|NCT00706433|9162360|P2|Overall Study|Withdrawal by Subject|2
2653124|NCT00706433|9162361|P1|Overall Study|Withdrawal by Subject|1
2653125|NCT00706433|9162358|P4|Overall Study|Lost to Follow-up|0
2653126|NCT00706433|9162359|P3|Overall Study|Lost to Follow-up|6
2653127|NCT00706433|9162360|P2|Overall Study|Lost to Follow-up|1
2653128|NCT00706433|9162361|P1|Overall Study|Lost to Follow-up|3
2653129|NCT00706355|9162688|P4|Period 4: PF-04217903 150 mg|Objective progression or relapse|2
2653130|NCT00706355|9162689|P3|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
2653131|NCT00706355|9162690|P2|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
2653132|NCT00706355|9162691|P1|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
2653133|NCT00706355|9162688|P4|Period 4: PF-04217903 150 mg|Adverse Event|2
2653134|NCT00706355|9162689|P3|Period 4: PF-04217903 150 mg|Adverse Event|0
2653135|NCT00706355|9162690|P2|Period 4: PF-04217903 150 mg|Adverse Event|0
2653136|NCT00706355|9162691|P1|Period 4: PF-04217903 150 mg|Adverse Event|0
2653137|NCT00706355|9162688|P4|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
2653138|NCT00706355|9162689|P3|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1
2653139|NCT00706355|9162690|P2|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
2653140|NCT00706355|9162691|P1|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
2653141|NCT00706355|9162688|P4|Period 3: PF-04217903 200 mg|Adverse Event|0
2653142|NCT00706355|9162689|P3|Period 3: PF-04217903 200 mg|Adverse Event|1
2653143|NCT00706355|9162690|P2|Period 3: PF-04217903 200 mg|Adverse Event|0
2653144|NCT00706355|9162691|P1|Period 3: PF-04217903 200 mg|Adverse Event|0
2653145|NCT00706355|9162688|P4|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
2653146|NCT00706355|9162689|P3|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
2653147|NCT00706355|9162690|P2|Period 2: PF-04217903 100 mg|Objective progression or relapse|5
2653148|NCT00706355|9162691|P1|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
2653149|NCT00706355|9162688|P4|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
2653150|NCT00706355|9162689|P3|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
2653151|NCT00706355|9162690|P2|Period 2: PF-04217903 100 mg|Global deterioration of health status|1
2653152|NCT00706355|9162691|P1|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
2653153|NCT00706355|9162688|P4|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
2653154|NCT00706355|9162689|P3|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
2653155|NCT00706355|9162690|P2|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1
2653156|NCT00706355|9162691|P1|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
2653157|NCT00706355|9162688|P4|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
2653158|NCT00706355|9162689|P3|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
2653159|NCT00706355|9162690|P2|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
2653160|NCT00706355|9162691|P1|Period 1: PF-04217903 50 mg|Objective progression or relapse|2
2653161|NCT00706355|9162688|P4|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
2653162|NCT00706355|9162689|P3|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
2653163|NCT00706355|9162690|P2|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
2653164|NCT00706355|9162691|P1|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1
2653165|NCT00706342|9162743|P1|Overall Study|WIthdrawal of consent|1
2653166|NCT00706342|9162743|P1|Overall Study|Ongoing|6
2653167|NCT00706342|9162743|P1|Overall Study|Non-responder Week 12|1
2653168|NCT00706342|9162743|P1|Overall Study|Investigator discretion|2
2653169|NCT00706342|9162743|P1|Overall Study|Withdrew from the study on his own.|1
2653170|NCT00706342|9162743|P1|Overall Study|Death|1
2653171|NCT00706342|9162743|P1|Overall Study|Withdrawn due to failure to respond|1
2653172|NCT00706342|9162743|P1|Overall Study|Not responding to treatment|2
2653173|NCT00706342|9162743|P1|Overall Study|Adverse Event|3
2653174|NCT00706238|9162756|P1|Overall Study|Other|1
2653175|NCT00706238|9162756|P1|Overall Study|Disease progression|4
2653176|NCT00706134|9162773|P4|Overall Study|Did not meet study criteria|0
2653177|NCT00706134|9162774|P3|Overall Study|Did not meet study criteria|0
2653178|NCT00706134|9162775|P2|Overall Study|Did not meet study criteria|0
2653179|NCT00706134|9162776|P1|Overall Study|Did not meet study criteria|2
2653180|NCT00706134|9162773|P4|Overall Study|Unsatisfactory therapeutic effect|5
2653181|NCT00706134|9162774|P3|Overall Study|Unsatisfactory therapeutic effect|3
2653182|NCT00706134|9162775|P2|Overall Study|Unsatisfactory therapeutic effect|3
2653183|NCT00706134|9162776|P1|Overall Study|Unsatisfactory therapeutic effect|9
2653184|NCT00706134|9162773|P4|Overall Study|Withdrawal by Subject|0
2653185|NCT00706134|9162774|P3|Overall Study|Withdrawal by Subject|1
2653186|NCT00706134|9162775|P2|Overall Study|Withdrawal by Subject|2
2653187|NCT00706134|9162776|P1|Overall Study|Withdrawal by Subject|1
2653188|NCT00706134|9162773|P4|Overall Study|Protocol Violation|3
2653189|NCT00706134|9162774|P3|Overall Study|Protocol Violation|0
2653190|NCT00706134|9162775|P2|Overall Study|Protocol Violation|6
2653191|NCT00706134|9162776|P1|Overall Study|Protocol Violation|0
2653192|NCT00706134|9162773|P4|Overall Study|Lost to Follow-up|0
2653193|NCT00706134|9162774|P3|Overall Study|Lost to Follow-up|0
2653194|NCT00706134|9162775|P2|Overall Study|Lost to Follow-up|1
2653195|NCT00706134|9162776|P1|Overall Study|Lost to Follow-up|0
2653196|NCT00706134|9162773|P4|Overall Study|Adverse Event|3
2653197|NCT00706134|9162774|P3|Overall Study|Adverse Event|2
2653198|NCT00706134|9162775|P2|Overall Study|Adverse Event|7
2653199|NCT00706134|9162776|P1|Overall Study|Adverse Event|8
2653200|NCT00706095|9162842|P3|Overall Study|Withdrawal by Subject|0
2653201|NCT00706095|9162843|P2|Overall Study|Withdrawal by Subject|0
2653202|NCT00706095|9162844|P1|Overall Study|Withdrawal by Subject|1
2653203|NCT00706095|9162842|P3|Overall Study|Clinical Progression|2
2653204|NCT00706095|9162843|P2|Overall Study|Clinical Progression|2
2653205|NCT00706095|9162844|P1|Overall Study|Clinical Progression|1
2653206|NCT00706095|9162842|P3|Overall Study|Progressive Disease|3
2653207|NCT00706095|9162843|P2|Overall Study|Progressive Disease|5
2653208|NCT00706095|9162844|P1|Overall Study|Progressive Disease|4
2653209|NCT00706030|9162862|P4|Overall Study|Death|0
2653210|NCT00706030|9162863|P3|Overall Study|Death|1
2653211|NCT00706030|9162864|P2|Overall Study|Death|0
2653212|NCT00706030|9162865|P1|Overall Study|Death|0
2653213|NCT00706030|9162862|P4|Overall Study|No treatment received|1
2653214|NCT00706030|9162863|P3|Overall Study|No treatment received|0
2653215|NCT00706030|9162864|P2|Overall Study|No treatment received|0
2653216|NCT00706030|9162865|P1|Overall Study|No treatment received|0
2653217|NCT00706030|9162862|P4|Overall Study|Symptomatic Deterioration|0
2653218|NCT00706030|9162863|P3|Overall Study|Symptomatic Deterioration|1
2653219|NCT00706030|9162864|P2|Overall Study|Symptomatic Deterioration|0
2653220|NCT00706030|9162865|P1|Overall Study|Symptomatic Deterioration|0
2653221|NCT00706030|9162862|P4|Overall Study|Failed to return|0
2653222|NCT00706030|9162863|P3|Overall Study|Failed to return|1
2653223|NCT00706030|9162864|P2|Overall Study|Failed to return|0
2653224|NCT00706030|9162865|P1|Overall Study|Failed to return|0
2653225|NCT00706030|9162862|P4|Overall Study|Protocol Violation|1
2653226|NCT00706030|9162863|P3|Overall Study|Protocol Violation|1
2653227|NCT00706030|9162864|P2|Overall Study|Protocol Violation|0
2653228|NCT00706030|9162865|P1|Overall Study|Protocol Violation|0
2653229|NCT00706030|9162862|P4|Overall Study|Not recorded|0
2653230|NCT00706030|9162863|P3|Overall Study|Not recorded|2
2653231|NCT00706030|9162864|P2|Overall Study|Not recorded|0
2653232|NCT00706030|9162865|P1|Overall Study|Not recorded|0
2653233|NCT00706030|9162862|P4|Overall Study|Physician Decision|0
2653234|NCT00706030|9162863|P3|Overall Study|Physician Decision|2
2653235|NCT00706030|9162864|P2|Overall Study|Physician Decision|0
2653236|NCT00706030|9162865|P1|Overall Study|Physician Decision|0
2653237|NCT00706030|9162862|P4|Overall Study|Withdrawal by Subject|0
2653238|NCT00706030|9162863|P3|Overall Study|Withdrawal by Subject|2
2653239|NCT00706030|9162864|P2|Overall Study|Withdrawal by Subject|0
2653240|NCT00706030|9162865|P1|Overall Study|Withdrawal by Subject|1
2653241|NCT00706030|9162862|P4|Overall Study|Adverse Event|2
2653242|NCT00706030|9162863|P3|Overall Study|Adverse Event|4
2653243|NCT00706030|9162864|P2|Overall Study|Adverse Event|0
2653244|NCT00706030|9162865|P1|Overall Study|Adverse Event|1
2653245|NCT00706030|9162862|P4|Overall Study|Disease Progression|12
2653246|NCT00706030|9162863|P3|Overall Study|Disease Progression|46
2653247|NCT00706030|9162864|P2|Overall Study|Disease Progression|6
2653248|NCT00706030|9162865|P1|Overall Study|Disease Progression|4
2653249|NCT00706004|9162880|P1|Overall Study|Did not meet eligibility criteria|2
2653250|NCT00705939|9162908|P3|Overall Study|Physician Decision|0
2653251|NCT00705939|9162909|P2|Overall Study|Physician Decision|1
2653252|NCT00705939|9162910|P1|Overall Study|Physician Decision|0
2653253|NCT00705939|9162908|P3|Overall Study|Withdrawal by Subject|3
2653254|NCT00705939|9162909|P2|Overall Study|Withdrawal by Subject|1
2653255|NCT00705939|9162910|P1|Overall Study|Withdrawal by Subject|0
2653256|NCT00705939|9162908|P3|Overall Study|Protocol Violation|1
2653257|NCT00705939|9162909|P2|Overall Study|Protocol Violation|0
2653258|NCT00705939|9162910|P1|Overall Study|Protocol Violation|0
2653259|NCT00705783|9162964|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|40
2653260|NCT00705783|9162965|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|16
2653261|NCT00705783|9162966|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
2653262|NCT00705783|9162964|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
2653263|NCT00705783|9162965|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|11
2653264|NCT00705783|9162966|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
2653265|NCT00705783|9162964|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|5
2653266|NCT00705783|9162965|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|9
2653267|NCT00705783|9162966|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
2653268|NCT00705783|9162964|P3|Depot Maintenance Phase|Protocol Deviation|0
2653269|NCT00705783|9162965|P2|Depot Maintenance Phase|Protocol Deviation|2
2653270|NCT00705783|9162966|P1|Depot Maintenance Phase|Protocol Deviation|0
2653271|NCT00705783|9162964|P3|Depot Maintenance Phase|Withdrew Consent|4
2653272|NCT00705783|9162965|P2|Depot Maintenance Phase|Withdrew Consent|14
2653273|NCT00705783|9162966|P1|Depot Maintenance Phase|Withdrew Consent|0
2653274|NCT00705783|9162964|P3|Depot Maintenance Phase|Withdrawn by Investigator|6
2653275|NCT00705783|9162965|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
2653276|NCT00705783|9162966|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
2653277|NCT00705783|9162964|P3|Depot Maintenance Phase|Met Withdrawal Criteria|2
2653278|NCT00705783|9162965|P2|Depot Maintenance Phase|Met Withdrawal Criteria|2
2653279|NCT00705783|9162966|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
2653280|NCT00705783|9162964|P3|Depot Maintenance Phase|Lost to Follow-up|3
2653281|NCT00705783|9162965|P2|Depot Maintenance Phase|Lost to Follow-up|5
2653282|NCT00705783|9162966|P1|Depot Maintenance Phase|Lost to Follow-up|0
2653283|NCT00705783|9162964|P3|Depot Maintenance Phase|Sponsor Discontinued Study|58
2653284|NCT00705783|9162965|P2|Depot Maintenance Phase|Sponsor Discontinued Study|179
2653285|NCT00705783|9162966|P1|Depot Maintenance Phase|Sponsor Discontinued Study|0
2653286|NCT00705783|9162964|P3|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
2653287|NCT00705783|9162965|P2|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
2653288|NCT00705783|9162966|P1|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1
2653289|NCT00705783|9162964|P3|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
2653290|NCT00705783|9162965|P2|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
2653291|NCT00705783|9162966|P1|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12
2653292|NCT00705783|9162964|P3|Depot Stabilization Phase|Adverse Event|0
2653293|NCT00705783|9162965|P2|Depot Stabilization Phase|Adverse Event|0
2653294|NCT00705783|9162966|P1|Depot Stabilization Phase|Adverse Event|17
2653295|NCT00705783|9162964|P3|Depot Stabilization Phase|Withdrew Consent|0
2653296|NCT00705783|9162965|P2|Depot Stabilization Phase|Withdrew Consent|0
2653297|NCT00705783|9162966|P1|Depot Stabilization Phase|Withdrew Consent|29
2653298|NCT00705783|9162964|P3|Depot Stabilization Phase|Withdrawn by Investigator|0
2653299|NCT00705783|9162965|P2|Depot Stabilization Phase|Withdrawn by Investigator|0
2653300|NCT00705783|9162966|P1|Depot Stabilization Phase|Withdrawn by Investigator|9
2653301|NCT00705783|9162964|P3|Depot Stabilization Phase|Met Withdrawal Criteria|0
2653302|NCT00705783|9162965|P2|Depot Stabilization Phase|Met Withdrawal Criteria|0
2653303|NCT00705783|9162966|P1|Depot Stabilization Phase|Met Withdrawal Criteria|8
2653304|NCT00705783|9162964|P3|Depot Stabilization Phase|Lost to Follow-up|0
2653305|NCT00705783|9162965|P2|Depot Stabilization Phase|Lost to Follow-up|0
2653306|NCT00705783|9162966|P1|Depot Stabilization Phase|Lost to Follow-up|11
2653307|NCT00705783|9162964|P3|Depot Stabilization Phase|Sponsor Discontinued Study|0
2653308|NCT00705783|9162965|P2|Depot Stabilization Phase|Sponsor Discontinued Study|0
2653309|NCT00705783|9162966|P1|Depot Stabilization Phase|Sponsor Discontinued Study|86
2653310|NCT00705783|9162964|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
2653311|NCT00705783|9162965|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
2653312|NCT00705783|9162966|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4
2653313|NCT00705783|9162964|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
2653314|NCT00705783|9162965|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
2653315|NCT00705783|9162966|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7
2653316|NCT00705783|9162964|P3|Oral Stabilization Phase|Adverse Event|0
2653317|NCT00705783|9162965|P2|Oral Stabilization Phase|Adverse Event|0
2653318|NCT00705783|9162966|P1|Oral Stabilization Phase|Adverse Event|14
2653319|NCT00705783|9162964|P3|Oral Stabilization Phase|Withdrew Consent|0
2653320|NCT00705783|9162965|P2|Oral Stabilization Phase|Withdrew Consent|0
2653321|NCT00705783|9162966|P1|Oral Stabilization Phase|Withdrew Consent|29
2653322|NCT00705783|9162964|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
2653323|NCT00705783|9162965|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
2653324|NCT00705783|9162966|P1|Oral Stabilization Phase|Withdrawn by Investigator|12
2653325|NCT00705783|9162964|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
2653326|NCT00705783|9162965|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
2653327|NCT00705783|9162966|P1|Oral Stabilization Phase|Met Withdrawal Criteria|19
2653328|NCT00705783|9162964|P3|Oral Stabilization Phase|Lost to Follow-up|0
2653329|NCT00705783|9162965|P2|Oral Stabilization Phase|Lost to Follow-up|0
2653330|NCT00705783|9162966|P1|Oral Stabilization Phase|Lost to Follow-up|7
2653331|NCT00705783|9162964|P3|Oral Stabilization Phase|Sponsor Discontinue Study|0
2653332|NCT00705783|9162965|P2|Oral Stabilization Phase|Sponsor Discontinue Study|0
2653333|NCT00705783|9162966|P1|Oral Stabilization Phase|Sponsor Discontinue Study|42
2653334|NCT00705783|9162964|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
2653335|NCT00705783|9162965|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
2653336|NCT00705783|9162966|P1|Conversion Phase|Lack of Efficacy without Adverse Event|8
2653337|NCT00705783|9162964|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
2653338|NCT00705783|9162965|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
2653339|NCT00705783|9162966|P1|Conversion Phase|Lack of Efficacy with Adverse Event|13
2653340|NCT00705783|9162964|P3|Conversion Phase|Adverse Event|0
2653341|NCT00705783|9162965|P2|Conversion Phase|Adverse Event|0
2653342|NCT00705783|9162966|P1|Conversion Phase|Adverse Event|11
2653343|NCT00705783|9162964|P3|Conversion Phase|Protocol Deviation|0
2653344|NCT00705783|9162965|P2|Conversion Phase|Protocol Deviation|0
2653345|NCT00705783|9162966|P1|Conversion Phase|Protocol Deviation|2
2653346|NCT00705783|9162964|P3|Conversion Phase|Withdrew Consent|0
2653347|NCT00705783|9162965|P2|Conversion Phase|Withdrew Consent|0
2653348|NCT00705783|9162966|P1|Conversion Phase|Withdrew Consent|24
2653349|NCT00705783|9162964|P3|Conversion Phase|Withdrawn by Investigator|0
2653350|NCT00705783|9162965|P2|Conversion Phase|Withdrawn by Investigator|0
2653351|NCT00705783|9162966|P1|Conversion Phase|Withdrawn by Investigator|4
2653352|NCT00705783|9162964|P3|Conversion Phase|Met Withdrawal Criteria|0
2653353|NCT00705783|9162965|P2|Conversion Phase|Met Withdrawal Criteria|0
2653354|NCT00705783|9162966|P1|Conversion Phase|Met Withdrawal Criteria|4
2653355|NCT00705783|9162964|P3|Conversion Phase|Lost to Follow-up|0
2653356|NCT00705783|9162965|P2|Conversion Phase|Lost to Follow-up|0
2653357|NCT00705783|9162966|P1|Conversion Phase|Lost to Follow-up|13
2653358|NCT00705783|9162964|P3|Conversion Phase|Sponsor Discontinued Study|0
2653359|NCT00705783|9162965|P2|Conversion Phase|Sponsor Discontinued Study|0
2653360|NCT00705783|9162966|P1|Conversion Phase|Sponsor Discontinued Study|54
2653361|NCT00705757|9162996|P3|Overall Study|Withdrawal by Subject|2
2653362|NCT00705757|9162997|P2|Overall Study|Withdrawal by Subject|1
2653363|NCT00705757|9162998|P1|Overall Study|Withdrawal by Subject|1
2653364|NCT00705757|9162996|P3|Overall Study|Lost to Follow-up|6
2653365|NCT00705757|9162997|P2|Overall Study|Lost to Follow-up|6
2653366|NCT00705757|9162998|P1|Overall Study|Lost to Follow-up|7
2653367|NCT00705757|9162996|P3|Overall Study|Lack of Efficacy|3
2653368|NCT00705757|9162997|P2|Overall Study|Lack of Efficacy|1
2653369|NCT00705757|9162998|P1|Overall Study|Lack of Efficacy|5
2653370|NCT00705718|9163008|P2|Overall Study|Follow up not done|4
2653371|NCT00705718|9163009|P1|Overall Study|Follow up not done|1
2653372|NCT00705718|9163008|P2|Overall Study|Not due for Visit|12
2653373|NCT00705718|9163009|P1|Overall Study|Not due for Visit|0
2653374|NCT00705718|9163008|P2|Overall Study|Death|6
2653375|NCT00705718|9163009|P1|Overall Study|Death|6
2653376|NCT00705679|9163030|P5|Overall Study|Withdrawal by Subject|33
2653377|NCT00705679|9163031|P4|Overall Study|Withdrawal by Subject|47
2653378|NCT00705679|9163032|P3|Overall Study|Withdrawal by Subject|68
2653379|NCT00705679|9163033|P2|Overall Study|Withdrawal by Subject|77
2653380|NCT00705679|9163034|P1|Overall Study|Withdrawal by Subject|32
2653381|NCT00705679|9163030|P5|Overall Study|Physician Decision|0
2653382|NCT00705679|9163031|P4|Overall Study|Physician Decision|1
2653383|NCT00705679|9163032|P3|Overall Study|Physician Decision|0
2653384|NCT00705679|9163033|P2|Overall Study|Physician Decision|1
2653385|NCT00705679|9163034|P1|Overall Study|Physician Decision|0
2653386|NCT00705679|9163030|P5|Overall Study|Lost to Follow-up|35
2653387|NCT00705679|9163031|P4|Overall Study|Lost to Follow-up|30
2653388|NCT00705679|9163032|P3|Overall Study|Lost to Follow-up|44
2653389|NCT00705679|9163033|P2|Overall Study|Lost to Follow-up|60
2653390|NCT00705679|9163034|P1|Overall Study|Lost to Follow-up|32
2653391|NCT00705679|9163030|P5|Overall Study|Death|1
2653392|NCT00705679|9163031|P4|Overall Study|Death|2
2653393|NCT00705679|9163032|P3|Overall Study|Death|3
2653394|NCT00705679|9163033|P2|Overall Study|Death|0
2653395|NCT00705679|9163034|P1|Overall Study|Death|0
2653396|NCT00705679|9163030|P5|Overall Study|Adverse Event|0
2653397|NCT00705679|9163031|P4|Overall Study|Adverse Event|0
2653398|NCT00705679|9163032|P3|Overall Study|Adverse Event|0
2653399|NCT00705679|9163033|P2|Overall Study|Adverse Event|1
2653400|NCT00705679|9163034|P1|Overall Study|Adverse Event|1
2653401|NCT00705666|9163069|P1|Overall Study|Untreated|5
2653402|NCT00705666|9163069|P1|Overall Study|Lack of data|3
2653403|NCT00705666|9163069|P1|Overall Study|Other|2
2653404|NCT00705666|9163069|P1|Overall Study|Other|12
2653405|NCT00705666|9163069|P1|Overall Study|Adverse Event|4
2653406|NCT00705666|9163069|P1|Overall Study|Death|1
2653407|NCT00705666|9163069|P1|Overall Study|Lost to Follow-up|5
2653408|NCT00705666|9163069|P1|Overall Study|Physician Decision|7
2653409|NCT00705666|9163069|P1|Overall Study|Withdrawal by Subject|21
2653410|NCT00705666|9163069|P1|Overall Study|No post-treatment questionnaire|279
2653411|NCT00705614|9163080|P2|Switch to Remicade|Administrative Reason|9
2653412|NCT00705614|9163081|P1|Switch to Remicade|Administrative Reason|0
2653413|NCT00705614|9163080|P2|Switch to Remicade|Withdrawal by Subject|12
2653414|NCT00705614|9163081|P1|Switch to Remicade|Withdrawal by Subject|0
2653415|NCT00705614|9163080|P2|Switch to Remicade|Lost to Follow-up|23
2653416|NCT00705614|9163081|P1|Switch to Remicade|Lost to Follow-up|0
2653417|NCT00705614|9163080|P2|Switch to Remicade|Adverse Event|5
2653418|NCT00705614|9163081|P1|Switch to Remicade|Adverse Event|0
2653419|NCT00705614|9163080|P2|Initial Intervention|Status completion unknown|0
2653420|NCT00705614|9163081|P1|Initial Intervention|Status completion unknown|3
2653421|NCT00705614|9163080|P2|Initial Intervention|Administrative Reason|38
2653422|NCT00705614|9163081|P1|Initial Intervention|Administrative Reason|51
2653423|NCT00705614|9163080|P2|Initial Intervention|Withdrawal by Subject|71
2653424|NCT00705614|9163081|P1|Initial Intervention|Withdrawal by Subject|114
2653425|NCT00705614|9163080|P2|Initial Intervention|Lost to Follow-up|191
2653426|NCT00705614|9163081|P1|Initial Intervention|Lost to Follow-up|310
2653427|NCT00705614|9163080|P2|Initial Intervention|Adverse Event|21
2653428|NCT00705614|9163081|P1|Initial Intervention|Adverse Event|40
2653429|NCT00705575|9163130|P2|Overall Study|Withdrawal by Subject|10
2653430|NCT00705575|9163131|P1|Overall Study|Withdrawal by Subject|5
2653431|NCT00705575|9163130|P2|Overall Study|Protocol Violation|2
2653432|NCT00705575|9163131|P1|Overall Study|Protocol Violation|2
2653433|NCT00705575|9163130|P2|Overall Study|Lost to Follow-up|4
2653434|NCT00705575|9163131|P1|Overall Study|Lost to Follow-up|3
2653435|NCT00705575|9163130|P2|Overall Study|Adverse Event|15
2653436|NCT00705575|9163131|P1|Overall Study|Adverse Event|11
2653437|NCT00705575|9163130|P2|Overall Study|Abnormal test procedure result(s)|12
2653438|NCT00705575|9163131|P1|Overall Study|Abnormal test procedure result(s)|2
2653439|NCT00705575|9163130|P2|Overall Study|Abnormal laboratory value(s)|3
2653440|NCT00705575|9163131|P1|Overall Study|Abnormal laboratory value(s)|0
2653441|NCT00705536|9163145|P4|Start Period 1|Withdrawal by Subject|1
2653442|NCT00705536|9163146|P3|Start Period 1|Withdrawal by Subject|0
2653443|NCT00705536|9163147|P2|Start Period 1|Withdrawal by Subject|0
2653444|NCT00705536|9163148|P1|Start Period 1|Withdrawal by Subject|0
2653445|NCT00705523|9163209|P2|Overall Study|Lost to Follow-up|3
2653446|NCT00705523|9163210|P1|Overall Study|Lost to Follow-up|2
2653447|NCT00705484|9163220|P2|Overall Study|Administrative|59
2653448|NCT00705484|9163221|P1|Overall Study|Administrative|89
2653449|NCT00705484|9163220|P2|Overall Study|Withdrawal by Subject|72
2653450|NCT00705484|9163221|P1|Overall Study|Withdrawal by Subject|96
2653451|NCT00705484|9163220|P2|Overall Study|Lost to Follow-up|250
2653452|NCT00705484|9163221|P1|Overall Study|Lost to Follow-up|169
2653453|NCT00705484|9163220|P2|Overall Study|Adverse Event|27
2653454|NCT00705484|9163221|P1|Overall Study|Adverse Event|28
2653455|NCT00705432|9163235|P6|Follow-up Period (Upto Week 72)|Non medical reason|7
2653456|NCT00705432|9163236|P5|Follow-up Period (Upto Week 72)|Non medical reason|6
2653457|NCT00705432|9163237|P4|Follow-up Period (Upto Week 72)|Non medical reason|14
2653458|NCT00705432|9163238|P3|Follow-up Period (Upto Week 72)|Non medical reason|24
2653459|NCT00705432|9163239|P2|Follow-up Period (Upto Week 72)|Non medical reason|42
2653460|NCT00705432|9163240|P1|Follow-up Period (Upto Week 72)|Non medical reason|69
2653461|NCT00705432|9163235|P6|Follow-up Period (Upto Week 72)|Adverse Event|0
2653462|NCT00705432|9163236|P5|Follow-up Period (Upto Week 72)|Adverse Event|0
2653463|NCT00705432|9163237|P4|Follow-up Period (Upto Week 72)|Adverse Event|0
2653464|NCT00705432|9163238|P3|Follow-up Period (Upto Week 72)|Adverse Event|1
2653465|NCT00705432|9163239|P2|Follow-up Period (Upto Week 72)|Adverse Event|1
2653466|NCT00705432|9163240|P1|Follow-up Period (Upto Week 72)|Adverse Event|2
2653467|NCT00705432|9163235|P6|Treatment Period|Non medical reason|7
2653468|NCT00705432|9163236|P5|Treatment Period|Non medical reason|7
2653469|NCT00705432|9163237|P4|Treatment Period|Non medical reason|4
2653470|NCT00705432|9163238|P3|Treatment Period|Non medical reason|37
2653471|NCT00705432|9163239|P2|Treatment Period|Non medical reason|32
2653472|NCT00705432|9163240|P1|Treatment Period|Non medical reason|26
2653473|NCT00705432|9163235|P6|Treatment Period|Treatment failure|14
2653474|NCT00705432|9163236|P5|Treatment Period|Treatment failure|13
2653475|NCT00705432|9163237|P4|Treatment Period|Treatment failure|25
2653476|NCT00705432|9163238|P3|Treatment Period|Treatment failure|33
2653477|NCT00705432|9163239|P2|Treatment Period|Treatment failure|42
2653478|NCT00705432|9163240|P1|Treatment Period|Treatment failure|92
2653479|NCT00705432|9163235|P6|Treatment Period|Adverse Event|9
2653480|NCT00705432|9163236|P5|Treatment Period|Adverse Event|8
2653481|NCT00705432|9163237|P4|Treatment Period|Adverse Event|12
2653482|NCT00705432|9163238|P3|Treatment Period|Adverse Event|51
2653483|NCT00705432|9163239|P2|Treatment Period|Adverse Event|37
2653484|NCT00705432|9163240|P1|Treatment Period|Adverse Event|45
2653485|NCT00705406|9163277|P2|Overall Study|Did not receive study drug|2
2653486|NCT00705406|9163278|P1|Overall Study|Did not receive study drug|1
2653487|NCT00705406|9163277|P2|Overall Study|Lost to Follow-up|3
2653488|NCT00705406|9163278|P1|Overall Study|Lost to Follow-up|3
2653489|NCT00705367|9163302|P2|Long-term Extension Period|Administrative reason by sponsor|0
2653490|NCT00705367|9163303|P1|Long-term Extension Period|Administrative reason by sponsor|3
2653491|NCT00705367|9163302|P2|Long-term Extension Period|No longer met study criteria|0
2653492|NCT00705367|9163303|P1|Long-term Extension Period|No longer met study criteria|1
2653493|NCT00705367|9163302|P2|Long-term Extension Period|Lack of Efficacy|0
2653494|NCT00705367|9163303|P1|Long-term Extension Period|Lack of Efficacy|1
2653495|NCT00705367|9163302|P2|Long-term Extension Period|Withdrawal by Subject|0
2653496|NCT00705367|9163303|P1|Long-term Extension Period|Withdrawal by Subject|2
2653497|NCT00705367|9163302|P2|Long-term Extension Period|Adverse Event|0
2653498|NCT00705367|9163303|P1|Long-term Extension Period|Adverse Event|2
2653499|NCT00705341|9163330|P4|Phase 2: Trial|Did not meet post-diluent threshold|0
2653500|NCT00705341|9163331|P3|Phase 2: Trial|Did not meet post-diluent threshold|1
2653501|NCT00705341|9163332|P2|Phase 2: Trial|Did not meet post-diluent threshold|0
2653502|NCT00705341|9163333|P1|Phase 2: Trial|Did not meet post-diluent threshold|0
2653503|NCT00705341|9163330|P4|Phase 2: Trial|Withdrawal by Subject|4
2653504|NCT00705341|9163331|P3|Phase 2: Trial|Withdrawal by Subject|6
2653505|NCT00705341|9163332|P2|Phase 2: Trial|Withdrawal by Subject|0
2653506|NCT00705341|9163333|P1|Phase 2: Trial|Withdrawal by Subject|0
2653507|NCT00705289|9163341|P1|Overall Study|Subject or treating physician's choice|131
2653508|NCT00705263|9163365|P1|Overall Study|Withdrawal by Subject|2
2653509|NCT00705250|9163369|P1|Overall Study|Patient died in car accident|1
2653510|NCT00705250|9163369|P1|Overall Study|Withdrawal by Subject|1
2653511|NCT00705224|9163373|P1|Overall Study|Lost to Follow-up|5
2653512|NCT00705224|9163373|P1|Overall Study|Withdrawal by Subject|3
2653513|NCT00705224|9163373|P1|Overall Study|Lack of Efficacy|2
2653514|NCT00705224|9163373|P1|Overall Study|Adverse Event|1
2653515|NCT00705159|9163389|P4|Overall Study|Screen Failure|1
2653516|NCT00705159|9163390|P3|Overall Study|Screen Failure|0
2653517|NCT00705159|9163391|P2|Overall Study|Screen Failure|0
2653518|NCT00705159|9163392|P1|Overall Study|Screen Failure|0
2653519|NCT00705159|9163389|P4|Overall Study|Lost to Follow-up|2
2653520|NCT00705159|9163390|P3|Overall Study|Lost to Follow-up|3
2653521|NCT00705159|9163391|P2|Overall Study|Lost to Follow-up|0
2653522|NCT00705159|9163392|P1|Overall Study|Lost to Follow-up|0
2653523|NCT00705159|9163389|P4|Overall Study|Adverse Event|0
2653524|NCT00705159|9163390|P3|Overall Study|Adverse Event|1
2653525|NCT00705159|9163391|P2|Overall Study|Adverse Event|0
2653526|NCT00705159|9163392|P1|Overall Study|Adverse Event|0
2653527|NCT00705159|9163389|P4|Overall Study|Protocol Violation|0
2653528|NCT00705159|9163390|P3|Overall Study|Protocol Violation|0
2653529|NCT00705159|9163391|P2|Overall Study|Protocol Violation|1
2653530|NCT00705159|9163392|P1|Overall Study|Protocol Violation|0
2653531|NCT00705159|9163389|P4|Overall Study|Withdrawal by Subject|1
2653532|NCT00705159|9163390|P3|Overall Study|Withdrawal by Subject|1
2653533|NCT00705159|9163391|P2|Overall Study|Withdrawal by Subject|1
2653534|NCT00705159|9163392|P1|Overall Study|Withdrawal by Subject|0
2653535|NCT00705146|9163412|P2|Overall Study|Lost to Follow-up|1
2653536|NCT00705146|9163413|P1|Overall Study|Lost to Follow-up|1
2653537|NCT00705016|9163442|P3|Overall Study|Other|6
2653538|NCT00705016|9163443|P2|Overall Study|Other|6
2653539|NCT00705016|9163444|P1|Overall Study|Other|9
2653540|NCT00705016|9163442|P3|Overall Study|Symptomatic Deterioration|1
2653541|NCT00705016|9163443|P2|Overall Study|Symptomatic Deterioration|1
2653542|NCT00705016|9163444|P1|Overall Study|Symptomatic Deterioration|3
2653543|NCT00705016|9163442|P3|Overall Study|Progressive Disease|33
2653544|NCT00705016|9163443|P2|Overall Study|Progressive Disease|29
2653545|NCT00705016|9163444|P1|Overall Study|Progressive Disease|33
2653546|NCT00705016|9163442|P3|Overall Study|Withdrawal by Subject|2
2653547|NCT00705016|9163443|P2|Overall Study|Withdrawal by Subject|3
2653548|NCT00705016|9163444|P1|Overall Study|Withdrawal by Subject|4
2653549|NCT00705016|9163442|P3|Overall Study|Protocol Violation|1
2653550|NCT00705016|9163443|P2|Overall Study|Protocol Violation|1
2653551|NCT00705016|9163444|P1|Overall Study|Protocol Violation|0
2653552|NCT00705016|9163442|P3|Overall Study|Death|5
2653553|NCT00705016|9163443|P2|Overall Study|Death|7
2653554|NCT00705016|9163444|P1|Overall Study|Death|5
2653555|NCT00705016|9163442|P3|Overall Study|Adverse Event|10
2653556|NCT00705016|9163443|P2|Overall Study|Adverse Event|11
2653557|NCT00705016|9163444|P1|Overall Study|Adverse Event|6
2653558|NCT00704964|9163495|P1|Overall Study|Not completed on time|328
2653559|NCT00704808|9163556|P1|Overall Study|Treatment change|1
2653560|NCT00704808|9163556|P1|Overall Study|Lost to Follow-up|1
2653561|NCT00704808|9163556|P1|Overall Study|Adverse Event|1
2653562|NCT00704808|9163556|P1|Overall Study|Early therapy discontinuation|16
2653563|NCT00704808|9163556|P1|Overall Study|Patient's decision|11
2653564|NCT00704808|9163556|P1|Overall Study|Tumor progression|80
2653565|NCT00704808|9163556|P1|Overall Study|Death|7
2653566|NCT00704808|9163556|P1|Overall Study|Discontinued prior to starting treatment|14
2653567|NCT00704730|9163567|P2|Overall Study|Withdrawal by Subject|13
2653568|NCT00704730|9163568|P1|Overall Study|Withdrawal by Subject|9
2653569|NCT00704730|9163567|P2|Overall Study|data unavailable|0
2653570|NCT00704730|9163568|P1|Overall Study|data unavailable|1
2653571|NCT00704730|9163567|P2|Overall Study|Disease progression per PI|67
2653572|NCT00704730|9163568|P1|Overall Study|Disease progression per PI|58
2653573|NCT00704730|9163567|P2|Overall Study|Did not receive drug|2
2653574|NCT00704730|9163568|P1|Overall Study|Did not receive drug|5
2653575|NCT00704730|9163567|P2|Overall Study|Physician Decision|0
2653576|NCT00704730|9163568|P1|Overall Study|Physician Decision|2
2653577|NCT00704730|9163567|P2|Overall Study|Death|5
2653578|NCT00704730|9163568|P1|Overall Study|Death|11
2653579|NCT00704730|9163567|P2|Overall Study|Adverse Event|9
2653580|NCT00704730|9163568|P1|Overall Study|Adverse Event|35
2653581|NCT00704535|9163588|P1|Overall Study|Completed status not on Case Report Form|124
2653582|NCT00704535|9163588|P1|Overall Study|Protocol Violation|10
2653583|NCT00704535|9163588|P1|Overall Study|Lost to Follow-up|8
2653584|NCT00704535|9163588|P1|Overall Study|Death|2
2653585|NCT00704535|9163588|P1|Overall Study|Adverse Event|2
2653586|NCT00704522|9163601|P2|Overall Study|No information on therapy end|2
2653587|NCT00704522|9163602|P1|Overall Study|No information on therapy end|27
2653588|NCT00704522|9163601|P2|Overall Study|Undefined causes|7
2653589|NCT00704522|9163602|P1|Overall Study|Undefined causes|9
2653590|NCT00704522|9163601|P2|Overall Study|Adverse Event|1
2653591|NCT00704522|9163602|P1|Overall Study|Adverse Event|9
2653592|NCT00704522|9163601|P2|Overall Study|Withdrawal by Subject|8
2653593|NCT00704522|9163602|P1|Overall Study|Withdrawal by Subject|17
2653594|NCT00704522|9163601|P2|Overall Study|Failure to appear again at hospital|10
2653595|NCT00704522|9163602|P1|Overall Study|Failure to appear again at hospital|56
2653596|NCT00704522|9163601|P2|Overall Study|Lack of Efficacy|17
2653597|NCT00704522|9163602|P1|Overall Study|Lack of Efficacy|65
2653598|NCT00704418|9163622|P2|Overall Study|Over-enrolled/surgery postponed|6
2653599|NCT00704418|9163623|P1|Overall Study|Over-enrolled/surgery postponed|3
2653600|NCT00704418|9163622|P2|Overall Study|Withdrawal by Subject|0
2653601|NCT00704418|9163623|P1|Overall Study|Withdrawal by Subject|2
2653602|NCT00704405|9163636|P5|Overall Study (C Population)|Lost to Follow-up|0
2653603|NCT00704405|9163637|P4|Overall Study (C Population)|Lost to Follow-up|0
2653604|NCT00704405|9163638|P3|Overall Study (C Population)|Lost to Follow-up|0
2653605|NCT00704405|9163639|P2|Overall Study (C Population)|Lost to Follow-up|2
2653606|NCT00704405|9163640|P1|Overall Study (C Population)|Lost to Follow-up|0
2653607|NCT00704405|9163636|P5|Overall Study (C Population)|Withdrawal by Subject|0
2653608|NCT00704405|9163637|P4|Overall Study (C Population)|Withdrawal by Subject|1
2653609|NCT00704405|9163638|P3|Overall Study (C Population)|Withdrawal by Subject|1
2653610|NCT00704405|9163639|P2|Overall Study (C Population)|Withdrawal by Subject|1
2653611|NCT00704405|9163640|P1|Overall Study (C Population)|Withdrawal by Subject|1
2653612|NCT00704405|9163636|P5|Overall Study (NC Population)|Other|1
2653613|NCT00704405|9163637|P4|Overall Study (NC Population)|Other|0
2653614|NCT00704405|9163638|P3|Overall Study (NC Population)|Other|0
2653615|NCT00704405|9163639|P2|Overall Study (NC Population)|Other|0
2653616|NCT00704405|9163640|P1|Overall Study (NC Population)|Other|0
2653617|NCT00704405|9163636|P5|Overall Study (NC Population)|Withdrawal by Subject|2
2653618|NCT00704405|9163637|P4|Overall Study (NC Population)|Withdrawal by Subject|2
2653619|NCT00704405|9163638|P3|Overall Study (NC Population)|Withdrawal by Subject|2
2653620|NCT00704405|9163639|P2|Overall Study (NC Population)|Withdrawal by Subject|3
2653621|NCT00704405|9163640|P1|Overall Study (NC Population)|Withdrawal by Subject|2
2653622|NCT00704405|9163636|P5|Overall Study (NC Population)|Lost to Follow-up|2
2653623|NCT00704405|9163637|P4|Overall Study (NC Population)|Lost to Follow-up|2
2653624|NCT00704405|9163638|P3|Overall Study (NC Population)|Lost to Follow-up|1
2653625|NCT00704405|9163639|P2|Overall Study (NC Population)|Lost to Follow-up|1
2653626|NCT00704405|9163640|P1|Overall Study (NC Population)|Lost to Follow-up|2
2653627|NCT00704405|9163636|P5|Overall Study (NC Population)|Adverse Event|0
2653628|NCT00704405|9163637|P4|Overall Study (NC Population)|Adverse Event|0
2653629|NCT00704405|9163638|P3|Overall Study (NC Population)|Adverse Event|0
2653630|NCT00704405|9163639|P2|Overall Study (NC Population)|Adverse Event|0
2653631|NCT00704405|9163640|P1|Overall Study (NC Population)|Adverse Event|1
2653632|NCT00704340|9163698|P2|Overall Study|Death|1
2653633|NCT00704340|9163699|P1|Overall Study|Death|0
2653634|NCT00704340|9163698|P2|Overall Study|Lost to Follow-up|1
2653635|NCT00704340|9163699|P1|Overall Study|Lost to Follow-up|2
2653636|NCT00704184|9163714|P5|Open-Label Treatment|Withdrawal by Subject|0
2653637|NCT00704184|9163715|P4|Open-Label Treatment|Withdrawal by Subject|3
2653638|NCT00704184|9163716|P3|Open-Label Treatment|Withdrawal by Subject|0
2653639|NCT00704184|9163717|P2|Open-Label Treatment|Withdrawal by Subject|0
2653640|NCT00704184|9163718|P1|Open-Label Treatment|Withdrawal by Subject|1
2653641|NCT00704184|9163714|P5|Open-Label Treatment|Physician Decision|1
2653642|NCT00704184|9163715|P4|Open-Label Treatment|Physician Decision|0
2653643|NCT00704184|9163716|P3|Open-Label Treatment|Physician Decision|0
2653644|NCT00704184|9163717|P2|Open-Label Treatment|Physician Decision|0
2653645|NCT00704184|9163718|P1|Open-Label Treatment|Physician Decision|0
2653646|NCT00704184|9163714|P5|Open-Label Treatment|Lack of Efficacy|1
2653647|NCT00704184|9163715|P4|Open-Label Treatment|Lack of Efficacy|2
2653648|NCT00704184|9163716|P3|Open-Label Treatment|Lack of Efficacy|2
2653649|NCT00704184|9163717|P2|Open-Label Treatment|Lack of Efficacy|2
2653650|NCT00704184|9163718|P1|Open-Label Treatment|Lack of Efficacy|0
2653651|NCT00704184|9163714|P5|Open-Label Treatment|Adverse Event|1
2653652|NCT00704184|9163715|P4|Open-Label Treatment|Adverse Event|0
2653653|NCT00704184|9163716|P3|Open-Label Treatment|Adverse Event|2
2653654|NCT00704184|9163717|P2|Open-Label Treatment|Adverse Event|0
2653655|NCT00704184|9163718|P1|Open-Label Treatment|Adverse Event|0
2653656|NCT00704184|9163714|P5|Double-Blind Treatment|Withdrawal by Subject|0
2653657|NCT00704184|9163715|P4|Double-Blind Treatment|Withdrawal by Subject|0
2653658|NCT00704184|9163716|P3|Double-Blind Treatment|Withdrawal by Subject|0
2653659|NCT00704184|9163717|P2|Double-Blind Treatment|Withdrawal by Subject|0
2653660|NCT00704184|9163718|P1|Double-Blind Treatment|Withdrawal by Subject|1
2653661|NCT00704171|9163757|P2|Overall Study|Withdrawal by Subject|0
2653662|NCT00704171|9163758|P1|Overall Study|Withdrawal by Subject|1
2653663|NCT00704132|9163776|P2|Overall Study|Withdrawal by Subject|1
2653664|NCT00704132|9163777|P1|Overall Study|Withdrawal by Subject|0
2653665|NCT00704132|9163776|P2|Overall Study|Lack of Efficacy|1
2653666|NCT00704132|9163777|P1|Overall Study|Lack of Efficacy|0
2653667|NCT00704132|9163776|P2|Overall Study|Clinical Adverse Experience|0
2653668|NCT00704132|9163777|P1|Overall Study|Clinical Adverse Experience|1
2653669|NCT00703963|9163805|P2|Overall Study|Physician Decision|1
2653670|NCT00703963|9163806|P1|Overall Study|Physician Decision|0
2653671|NCT00703963|9163805|P2|Overall Study|Withdrawal by Subject|13
2653672|NCT00703963|9163806|P1|Overall Study|Withdrawal by Subject|7
2653673|NCT00703924|9163827|P2|Overall Study|Withdrawal by Subject|1
2653674|NCT00703924|9163828|P1|Overall Study|Withdrawal by Subject|1
2653675|NCT00703911|9163844|P1|Overall Study|Withdrawal by Subject|2
2653676|NCT00703911|9163844|P1|Overall Study|Lost to Follow-up|1
2653677|NCT00703911|9163844|P1|Overall Study|Physician Decision|6
2653678|NCT00703911|9163844|P1|Overall Study|Death|1
2653679|NCT00703846|9163877|P1|Overall Study|Did Not Receive Study Drug|2
2653680|NCT00703846|9163877|P1|Overall Study|Other|14
2653681|NCT00703846|9163877|P1|Overall Study|Death|1
2653682|NCT00703846|9163877|P1|Overall Study|Withdrawal by Subject|40
2653683|NCT00703846|9163877|P1|Overall Study|Noncompliance with Study Treatment|2
2653684|NCT00703846|9163877|P1|Overall Study|Lack of Efficacy|15
2653685|NCT00703846|9163877|P1|Overall Study|Lost to Follow-up|55
2653686|NCT00703846|9163877|P1|Overall Study|Adverse Event|8
2653687|NCT00703820|9163893|P2|Overall Study|Withdrawal by Subject|1
2653688|NCT00703820|9163894|P1|Overall Study|Withdrawal by Subject|2
2653689|NCT00703820|9163893|P2|Overall Study|Physician Decision|5
2653690|NCT00703820|9163894|P1|Overall Study|Physician Decision|4
2653691|NCT00703820|9163893|P2|Overall Study|Received non-protocol therapy|0
2653692|NCT00703820|9163894|P1|Overall Study|Received non-protocol therapy|1
2653693|NCT00703820|9163893|P2|Overall Study|Lack of Efficacy|11
2653694|NCT00703820|9163894|P1|Overall Study|Lack of Efficacy|11
2653695|NCT00703820|9163893|P2|Overall Study|Death|0
2653696|NCT00703820|9163894|P1|Overall Study|Death|5
2653697|NCT00703820|9163893|P2|Overall Study|Adverse Event|17
2653698|NCT00703820|9163894|P1|Overall Study|Adverse Event|12
2653699|NCT00703781|9163903|P2|Overall Study|Cancelled surgery|0
2653700|NCT00703781|9163904|P1|Overall Study|Cancelled surgery|1
2653701|NCT00703781|9163903|P2|Overall Study|Withdrawal by Subject|2
2653702|NCT00703781|9163904|P1|Overall Study|Withdrawal by Subject|1
2653703|NCT00703677|9163949|P1|Overall Study|Dropout-withdrawal not related to drug|3
2653704|NCT00703534|9163989|P2|Overall Study|Severe Non Compliance|5
2653705|NCT00703534|9163990|P1|Overall Study|Severe Non Compliance|1
2653706|NCT00703534|9163989|P2|Overall Study|Lost to Follow-up|4
2653707|NCT00703534|9163990|P1|Overall Study|Lost to Follow-up|1
2653708|NCT00703534|9163989|P2|Overall Study|Incorrect Enrollment|6
2653709|NCT00703534|9163990|P1|Overall Study|Incorrect Enrollment|6
2653710|NCT00703534|9163989|P2|Overall Study|Withdrawal by Subject|7
2653711|NCT00703534|9163990|P1|Overall Study|Withdrawal by Subject|8
2653712|NCT00703534|9163989|P2|Overall Study|Adverse Event|3
2653713|NCT00703534|9163990|P1|Overall Study|Adverse Event|14
2653714|NCT00703326|9164062|P2|Overall Study|Withdrawal by Subject|20
2653715|NCT00703326|9164063|P1|Overall Study|Withdrawal by Subject|42
2653716|NCT00703326|9164062|P2|Overall Study|Lost to Follow-up|8
2653717|NCT00703326|9164063|P1|Overall Study|Lost to Follow-up|25
2653718|NCT00703326|9164062|P2|Overall Study|Still on study|197
2653719|NCT00703326|9164063|P1|Overall Study|Still on study|380
2653720|NCT00703157|9164095|P2|Overall Study|source data permanently lost/ other|1
2653721|NCT00703157|9164096|P1|Overall Study|source data permanently lost/ other|4
2653722|NCT00703157|9164095|P2|Overall Study|Lost to Follow-up|1
2653723|NCT00703157|9164096|P1|Overall Study|Lost to Follow-up|0
2653724|NCT00703118|9164130|P3|Overall Study|Other|1
2653725|NCT00703118|9164131|P2|Overall Study|Other|0
2653726|NCT00703118|9164132|P1|Overall Study|Other|0
2653727|NCT00703118|9164130|P3|Overall Study|Withdrawal by Subject|13
2653728|NCT00703118|9164131|P2|Overall Study|Withdrawal by Subject|7
2653729|NCT00703118|9164132|P1|Overall Study|Withdrawal by Subject|8
2653730|NCT00703118|9164130|P3|Overall Study|Lost to Follow-up|4
2653731|NCT00703118|9164131|P2|Overall Study|Lost to Follow-up|4
2653732|NCT00703118|9164132|P1|Overall Study|Lost to Follow-up|6
2653733|NCT00703118|9164130|P3|Overall Study|Subject Ineligible To Continue The Trial|2
2653734|NCT00703118|9164131|P2|Overall Study|Subject Ineligible To Continue The Trial|3
2653735|NCT00703118|9164132|P1|Overall Study|Subject Ineligible To Continue The Trial|6
2653736|NCT00703118|9164130|P3|Overall Study|Adverse Event|2
2653737|NCT00703118|9164131|P2|Overall Study|Adverse Event|2
2653738|NCT00703118|9164132|P1|Overall Study|Adverse Event|1
2653739|NCT00703092|9164163|P1|Overall Study|Withdrawal by Subject|2
2653740|NCT00703014|9164371|P4|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42
2653741|NCT00703014|9164372|P3|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47
2653742|NCT00703014|9164373|P2|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
2653743|NCT00703014|9164374|P1|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
2653744|NCT00703014|9164371|P4|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
2653745|NCT00703014|9164372|P3|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
2653746|NCT00703014|9164373|P2|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32
2653747|NCT00703014|9164374|P1|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33
2653748|NCT00702962|9164394|P2|Overall Study|Hospitalized for other health disorder|0
2653749|NCT00702962|9164395|P1|Overall Study|Hospitalized for other health disorder|1
2653750|NCT00702962|9164394|P2|Overall Study|Progressive disease|1
2653751|NCT00702962|9164395|P1|Overall Study|Progressive disease|0
2653752|NCT00702949|9164406|P3|Overall Study|Other Medical Reason/unknown|3
2653753|NCT00702949|9164407|P2|Overall Study|Other Medical Reason/unknown|1
2653754|NCT00702949|9164408|P1|Overall Study|Other Medical Reason/unknown|1
2653755|NCT00702949|9164406|P3|Overall Study|Adverse Event|3
2653756|NCT00702949|9164407|P2|Overall Study|Adverse Event|6
2653757|NCT00702949|9164408|P1|Overall Study|Adverse Event|1
2653758|NCT00702949|9164406|P3|Overall Study|Refusal|2
2653759|NCT00702949|9164407|P2|Overall Study|Refusal|2
2653760|NCT00702949|9164408|P1|Overall Study|Refusal|3
2653761|NCT00702923|9164433|P1|Overall Study|Adverse Event|1
2653762|NCT00702845|9164456|P2|Overall Study|Not randomized|1
2653763|NCT00702845|9164457|P1|Overall Study|Not randomized|0
2653764|NCT00702845|9164456|P2|Overall Study|Patient's decision|1
2653765|NCT00702845|9164457|P1|Overall Study|Patient's decision|2
2653766|NCT00702845|9164456|P2|Overall Study|No or abnormal fertilization|2
2653767|NCT00702845|9164457|P1|Overall Study|No or abnormal fertilization|4
2653768|NCT00702845|9164456|P2|Overall Study|No/too few/bad quality embryos retrieved|1
2653769|NCT00702845|9164457|P1|Overall Study|No/too few/bad quality embryos retrieved|7
2653770|NCT00702845|9164456|P2|Overall Study|Insufficient ovarian response|0
2653771|NCT00702845|9164457|P1|Overall Study|Insufficient ovarian response|1
2653772|NCT00702845|9164456|P2|Overall Study|Risk of ovarian hyperstimulation synd.|0
2653773|NCT00702845|9164457|P1|Overall Study|Risk of ovarian hyperstimulation synd.|1
2653774|NCT00702845|9164456|P2|Overall Study|Too high ovarian response|1
2653775|NCT00702845|9164457|P1|Overall Study|Too high ovarian response|5
2653776|NCT00702845|9164456|P2|Overall Study|No/too few/bad quality oocytes retrieved|2
2653777|NCT00702845|9164457|P1|Overall Study|No/too few/bad quality oocytes retrieved|2
2653778|NCT00702715|9164519|P2|Overall Study|Lost to Follow-up|0
2653779|NCT00702715|9164520|P1|Overall Study|Lost to Follow-up|1
2653780|NCT00702702|9164533|P1|Overall Study|Study prematurely terminated|56
2653781|NCT00702689|9164541|P1|Overall Study|Adverse Event|1
2653782|NCT00702689|9164541|P1|Overall Study|Recurrent malignancy|1
2653783|NCT00702689|9164541|P1|Overall Study|Withdrawal by Subject|4
2653784|NCT00702650|9164552|P1|Overall Study|Adverse Event|3
2653785|NCT00702650|9164552|P1|Overall Study|Screening Testosterone Levels >300 ng/dL|1
2653786|NCT00702650|9164552|P1|Overall Study|Sponsor Request|1
2653787|NCT00702650|9164552|P1|Overall Study|Non-Compliance with Site Directives|1
2653788|NCT00702650|9164552|P1|Overall Study|Lost to Follow-up|2
2653789|NCT00702650|9164552|P1|Overall Study|Non-Compliance of Study Drug|3
2653790|NCT00702650|9164552|P1|Overall Study|Withdrawal by Subject|9
2653791|NCT00702520|9164614|P4|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
2653792|NCT00702520|9164615|P3|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
2653793|NCT00702520|9164616|P2|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10
2653794|NCT00702520|9164617|P1|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15
2653795|NCT00702520|9164614|P4|Base Study P05788 - Embryo Transfer|No embryo transfer|0
2653796|NCT00702520|9164615|P3|Base Study P05788 - Embryo Transfer|No embryo transfer|0
2653797|NCT00702520|9164616|P2|Base Study P05788 - Embryo Transfer|No embryo transfer|6
2653798|NCT00702520|9164617|P1|Base Study P05788 - Embryo Transfer|No embryo transfer|3
2653799|NCT00702520|9164614|P4|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
2653800|NCT00702520|9164615|P3|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
2653801|NCT00702520|9164616|P2|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1
2653802|NCT00702520|9164617|P1|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
2653803|NCT00702507|9164633|P1|Follow-up Phase|Late Enrollment|1
2653804|NCT00702507|9164633|P1|Follow-up Phase|Lost to Follow-up|23
2653805|NCT00702507|9164633|P1|Follow-up Phase|Protocol Violation|2
2653806|NCT00702507|9164633|P1|Follow-up Phase|Participant's Caretaker Withdrew Consent|1
2653807|NCT00702507|9164633|P1|Initial Treatment Phase|Negative Candida Culture|34
2653808|NCT00702507|9164633|P1|Initial Treatment Phase|Lost to Follow-up|2
2653809|NCT00702507|9164633|P1|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3
2653810|NCT00702507|9164633|P1|Initial Treatment Phase|Adverse Event|2
2653811|NCT00702403|9164670|P1|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5
2653812|NCT00702403|9164670|P1|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1
2653813|NCT00702403|9164670|P1|From Engraftment to Study Completion|Acute respiratory distress syndrome|1
2653814|NCT00702403|9164670|P1|From Engraftment to Study Completion|Suicide|1
2653815|NCT00702403|9164670|P1|From Engraftment to Study Completion|Liver GVHD|1
2653816|NCT00702403|9164670|P1|From Engraftment to Study Completion|Adenocarcinoma|1
2653817|NCT00702403|9164670|P1|From Engraftment to Study Completion|Non-compliance|2
2653818|NCT00702403|9164670|P1|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4
2653819|NCT00702403|9164670|P1|From Engraftment to Study Completion|Failed pre-1st dose criteria|11
2653820|NCT00702403|9164670|P1|From Consent to Engraftment|Miscellaneous (unanticipated) other|2
2653821|NCT00702403|9164670|P1|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4
2653822|NCT00702403|9164670|P1|From Consent to Engraftment|Myocardial infarction|1
2653823|NCT00702403|9164670|P1|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2
2653824|NCT00702403|9164670|P1|From Consent to Engraftment|Critically ill|2
2653825|NCT00702403|9164670|P1|From Consent to Engraftment|Progressive leukemia|6
2653826|NCT00702325|9164724|P2|Overall Study|Incorrectly Discontinued|1
2653827|NCT00702325|9164725|P1|Overall Study|Incorrectly Discontinued|0
2653828|NCT00702325|9164724|P2|Overall Study|Withdrew consent|1
2653829|NCT00702325|9164725|P1|Overall Study|Withdrew consent|0
2653830|NCT00702325|9164724|P2|Overall Study|Didn't follow study medication dosage|2
2653831|NCT00702325|9164725|P1|Overall Study|Didn't follow study medication dosage|0
2653832|NCT00702325|9164724|P2|Overall Study|Termination due to lab results|0
2653833|NCT00702325|9164725|P1|Overall Study|Termination due to lab results|1
2653834|NCT00702325|9164724|P2|Overall Study|Severe noncompliance to protocol|3
2653835|NCT00702325|9164725|P1|Overall Study|Severe noncompliance to protocol|3
2653836|NCT00702325|9164724|P2|Overall Study|Developed study discontinuation criteria|28
2653837|NCT00702325|9164725|P1|Overall Study|Developed study discontinuation criteria|18
2653838|NCT00702325|9164724|P2|Overall Study|Incorrect enrollment|7
2653839|NCT00702325|9164725|P1|Overall Study|Incorrect enrollment|5
2653840|NCT00702325|9164724|P2|Overall Study|Lost to Follow-up|4
2653841|NCT00702325|9164725|P1|Overall Study|Lost to Follow-up|3
2653842|NCT00702325|9164724|P2|Overall Study|Withdrawal by Subject|7
2653843|NCT00702325|9164725|P1|Overall Study|Withdrawal by Subject|7
2653844|NCT00702325|9164724|P2|Overall Study|Adverse Event|0
2653845|NCT00702325|9164725|P1|Overall Study|Adverse Event|1
2653846|NCT00702221|9164821|P2|Overall Study|Adverse Event|3
2653847|NCT00702221|9164822|P1|Overall Study|Adverse Event|4
2653848|NCT00702208|9164828|P1|Overall Study|Unsatisfactory colposcopy|2
2653849|NCT00702208|9164828|P1|Overall Study|Did not self-lavage|1
2653850|NCT00702208|9164828|P1|Overall Study|Lost to Follow-up|28
2653851|NCT00702143|9164837|P3|Overall Study|Lost to Follow-up|1
2653852|NCT00702143|9164838|P2|Overall Study|Lost to Follow-up|0
2653853|NCT00702143|9164839|P1|Overall Study|Lost to Follow-up|0
2653854|NCT00701805|9164888|P4|Overall Study|Resumption criteria were not met|0
2653855|NCT00701805|9164889|P3|Overall Study|Resumption criteria were not met|0
2653856|NCT00701805|9164890|P2|Overall Study|Resumption criteria were not met|1
2653857|NCT00701805|9164891|P1|Overall Study|Resumption criteria were not met|0
2653858|NCT00701805|9164888|P4|Overall Study|Difficult to travel to dialysis site|0
2653859|NCT00701805|9164889|P3|Overall Study|Difficult to travel to dialysis site|1
2653860|NCT00701805|9164890|P2|Overall Study|Difficult to travel to dialysis site|0
2653861|NCT00701805|9164891|P1|Overall Study|Difficult to travel to dialysis site|0
2653862|NCT00701805|9164888|P4|Overall Study|Physician decision, change of therapy|1
2653863|NCT00701805|9164889|P3|Overall Study|Physician decision, change of therapy|0
2653864|NCT00701805|9164890|P2|Overall Study|Physician decision, change of therapy|0
2653865|NCT00701805|9164891|P1|Overall Study|Physician decision, change of therapy|0
2653866|NCT00701805|9164888|P4|Overall Study|Admitted to hospital for 2 weeks|0
2653867|NCT00701805|9164889|P3|Overall Study|Admitted to hospital for 2 weeks|1
2653868|NCT00701805|9164890|P2|Overall Study|Admitted to hospital for 2 weeks|0
2653869|NCT00701805|9164891|P1|Overall Study|Admitted to hospital for 2 weeks|0
2653870|NCT00701805|9164888|P4|Overall Study|Missed 7 consecutive doses|0
2653871|NCT00701805|9164889|P3|Overall Study|Missed 7 consecutive doses|0
2653872|NCT00701805|9164890|P2|Overall Study|Missed 7 consecutive doses|1
2653873|NCT00701805|9164891|P1|Overall Study|Missed 7 consecutive doses|0
2653874|NCT00701805|9164888|P4|Overall Study|Adverse Event|0
2653875|NCT00701805|9164889|P3|Overall Study|Adverse Event|1
2653876|NCT00701805|9164890|P2|Overall Study|Adverse Event|1
2653877|NCT00701805|9164891|P1|Overall Study|Adverse Event|0
2653878|NCT00701805|9164888|P4|Overall Study|Withdrawal by Subject|3
2653879|NCT00701805|9164889|P3|Overall Study|Withdrawal by Subject|4
2653880|NCT00701805|9164890|P2|Overall Study|Withdrawal by Subject|1
2653881|NCT00701805|9164891|P1|Overall Study|Withdrawal by Subject|3
2653882|NCT00701779|9164941|P1|Overall Study|Withdrawal by Subject|2
2653883|NCT00701779|9164941|P1|Overall Study|Lost to Follow-up|1
2653884|NCT00701779|9164941|P1|Overall Study|Adverse Event|6
2653885|NCT00701727|9164953|P2|Second Treatment Period|Withdrawal by Subject|0
2653886|NCT00701727|9164954|P1|Second Treatment Period|Withdrawal by Subject|2
2653887|NCT00701727|9164953|P2|First Treatment Period|Lost to Follow-up|1
2653888|NCT00701727|9164954|P1|First Treatment Period|Lost to Follow-up|0
2653889|NCT00701727|9164953|P2|First Treatment Period|sponsor decision|1
2653890|NCT00701727|9164954|P1|First Treatment Period|sponsor decision|0
2653891|NCT00701727|9164953|P2|First Treatment Period|Withdrawal by Subject|0
2653892|NCT00701727|9164954|P1|First Treatment Period|Withdrawal by Subject|1
2653893|NCT00701727|9164953|P2|First Treatment Period|Adverse Event|0
2653894|NCT00701727|9164954|P1|First Treatment Period|Adverse Event|0
2653895|NCT00701662|9165000|P1|Overall Study|Lack of Efficacy|1
2653896|NCT00701558|9165025|P1|Overall Study|Lost to Follow-up|8
2653897|NCT00701558|9165025|P1|Overall Study|Death|7
2653898|NCT00701441|9165033|P2|Overall Study|failure in cpap compliance|4
2653899|NCT00701441|9165034|P1|Overall Study|failure in cpap compliance|0
2653900|NCT00701415|9165046|P2|Overall Study|Social/family issues and needle phobia|0
2653901|NCT00701415|9165047|P1|Overall Study|Social/family issues and needle phobia|1
2653902|NCT00701415|9165046|P2|Overall Study|Adverse Event|1
2653903|NCT00701415|9165047|P1|Overall Study|Adverse Event|0
2653904|NCT00701363|9165082|P4|Treatment Phase 2|Withdrawal by Subject|0
2653905|NCT00701363|9165083|P3|Treatment Phase 2|Withdrawal by Subject|1
2653906|NCT00701363|9165084|P2|Treatment Phase 2|Withdrawal by Subject|0
2653907|NCT00701363|9165085|P1|Treatment Phase 2|Withdrawal by Subject|0
2653908|NCT00701363|9165082|P4|Treatment Phase 2|Adverse Event|0
2653909|NCT00701363|9165083|P3|Treatment Phase 2|Adverse Event|1
2653910|NCT00701363|9165084|P2|Treatment Phase 2|Adverse Event|0
2653911|NCT00701363|9165085|P1|Treatment Phase 2|Adverse Event|0
2653912|NCT00701363|9165082|P4|Treatment Phase 1|Lack of Efficacy|0
2653913|NCT00701363|9165083|P3|Treatment Phase 1|Lack of Efficacy|0
2653914|NCT00701363|9165084|P2|Treatment Phase 1|Lack of Efficacy|0
2653915|NCT00701363|9165085|P1|Treatment Phase 1|Lack of Efficacy|1
2653916|NCT00701363|9165082|P4|Treatment Phase 1|Withdrawal by Subject|0
2653917|NCT00701363|9165083|P3|Treatment Phase 1|Withdrawal by Subject|0
2653918|NCT00701363|9165084|P2|Treatment Phase 1|Withdrawal by Subject|0
2653919|NCT00701363|9165085|P1|Treatment Phase 1|Withdrawal by Subject|5
2653920|NCT00701363|9165082|P4|Treatment Phase 1|Protocol Violation|0
2653921|NCT00701363|9165083|P3|Treatment Phase 1|Protocol Violation|0
2653922|NCT00701363|9165084|P2|Treatment Phase 1|Protocol Violation|0
2653923|NCT00701363|9165085|P1|Treatment Phase 1|Protocol Violation|1
2653924|NCT00701363|9165082|P4|Treatment Phase 1|Adverse Event|0
2653925|NCT00701363|9165083|P3|Treatment Phase 1|Adverse Event|0
2653926|NCT00701363|9165084|P2|Treatment Phase 1|Adverse Event|0
2653927|NCT00701363|9165085|P1|Treatment Phase 1|Adverse Event|7
2653928|NCT00701363|9165082|P4|Treatment Phase 1|Does not meet entry Criteria|0
2653929|NCT00701363|9165083|P3|Treatment Phase 1|Does not meet entry Criteria|0
2653930|NCT00701363|9165084|P2|Treatment Phase 1|Does not meet entry Criteria|0
2653931|NCT00701363|9165085|P1|Treatment Phase 1|Does not meet entry Criteria|1
2653932|NCT00701363|9165082|P4|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
2654023|NCT00700882|9165344|P1|Overall Study|No KIT mutation|51
2653933|NCT00701363|9165083|P3|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
2653934|NCT00701363|9165084|P2|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
2653935|NCT00701363|9165085|P1|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4
2653936|NCT00701311|9165125|P1|Overall Study|Withdrawal by Subject|2
2653937|NCT00701311|9165125|P1|Overall Study|Adverse Event|3
2653938|NCT00701311|9165125|P1|Overall Study|Lack of Efficacy|3
2653939|NCT00701129|9165129|P1|Overall Study|Death|2
2653940|NCT00701103|9165151|P11|Overall Study|Other|0
2653941|NCT00701103|9165152|P10|Overall Study|Other|1
2653942|NCT00701103|9165153|P9|Overall Study|Other|1
2653943|NCT00701103|9165154|P8|Overall Study|Other|0
2653944|NCT00701103|9165155|P7|Overall Study|Other|0
2653945|NCT00701103|9165156|P6|Overall Study|Other|0
2653946|NCT00701103|9165157|P5|Overall Study|Other|0
2653947|NCT00701103|9165158|P4|Overall Study|Other|0
2653948|NCT00701103|9165159|P3|Overall Study|Other|0
2653949|NCT00701103|9165160|P2|Overall Study|Other|0
2653950|NCT00701103|9165161|P1|Overall Study|Other|0
2653951|NCT00701103|9165151|P11|Overall Study|Withdrawal by Subject|0
2653952|NCT00701103|9165152|P10|Overall Study|Withdrawal by Subject|0
2653953|NCT00701103|9165153|P9|Overall Study|Withdrawal by Subject|0
2653954|NCT00701103|9165154|P8|Overall Study|Withdrawal by Subject|0
2653955|NCT00701103|9165155|P7|Overall Study|Withdrawal by Subject|0
2653956|NCT00701103|9165156|P6|Overall Study|Withdrawal by Subject|0
2653957|NCT00701103|9165157|P5|Overall Study|Withdrawal by Subject|0
2653958|NCT00701103|9165158|P4|Overall Study|Withdrawal by Subject|0
2653959|NCT00701103|9165159|P3|Overall Study|Withdrawal by Subject|1
2653960|NCT00701103|9165160|P2|Overall Study|Withdrawal by Subject|1
2653961|NCT00701103|9165161|P1|Overall Study|Withdrawal by Subject|0
2653962|NCT00701103|9165151|P11|Overall Study|Progressive Disease|11
2653963|NCT00701103|9165152|P10|Overall Study|Progressive Disease|8
2653964|NCT00701103|9165153|P9|Overall Study|Progressive Disease|8
2653965|NCT00701103|9165154|P8|Overall Study|Progressive Disease|7
2653966|NCT00701103|9165155|P7|Overall Study|Progressive Disease|7
2653967|NCT00701103|9165156|P6|Overall Study|Progressive Disease|5
2653968|NCT00701103|9165157|P5|Overall Study|Progressive Disease|6
2653969|NCT00701103|9165158|P4|Overall Study|Progressive Disease|5
2653970|NCT00701103|9165159|P3|Overall Study|Progressive Disease|6
2653971|NCT00701103|9165160|P2|Overall Study|Progressive Disease|2
2653972|NCT00701103|9165161|P1|Overall Study|Progressive Disease|5
2653973|NCT00701103|9165151|P11|Overall Study|Adverse Event|0
2653974|NCT00701103|9165152|P10|Overall Study|Adverse Event|2
2653975|NCT00701103|9165153|P9|Overall Study|Adverse Event|0
2653976|NCT00701103|9165154|P8|Overall Study|Adverse Event|0
2653977|NCT00701103|9165155|P7|Overall Study|Adverse Event|1
2653978|NCT00701103|9165156|P6|Overall Study|Adverse Event|1
2653979|NCT00701103|9165157|P5|Overall Study|Adverse Event|0
2653980|NCT00701103|9165158|P4|Overall Study|Adverse Event|1
2653981|NCT00701103|9165159|P3|Overall Study|Adverse Event|1
2653982|NCT00701103|9165160|P2|Overall Study|Adverse Event|0
2653983|NCT00701103|9165161|P1|Overall Study|Adverse Event|0
2653984|NCT00701090|9165267|P2|Overall Study|Other|12
2653985|NCT00701090|9165268|P1|Overall Study|Other|7
2653986|NCT00701090|9165267|P2|Overall Study|Withdrawal by Subject|16
2653987|NCT00701090|9165268|P1|Overall Study|Withdrawal by Subject|11
2653988|NCT00701090|9165267|P2|Overall Study|Protocol Violation|3
2653989|NCT00701090|9165268|P1|Overall Study|Protocol Violation|2
2653990|NCT00701090|9165267|P2|Overall Study|Physician Decision|4
2653991|NCT00701090|9165268|P1|Overall Study|Physician Decision|3
2653992|NCT00701090|9165267|P2|Overall Study|Lost to Follow-up|9
2653993|NCT00701090|9165268|P1|Overall Study|Lost to Follow-up|9
2653994|NCT00701090|9165267|P2|Overall Study|Lack of Efficacy|4
2653995|NCT00701090|9165268|P1|Overall Study|Lack of Efficacy|5
2653996|NCT00701090|9165267|P2|Overall Study|Death|1
2653997|NCT00701090|9165268|P1|Overall Study|Death|0
2653998|NCT00701090|9165267|P2|Overall Study|Adverse Event|2
2653999|NCT00701090|9165268|P1|Overall Study|Adverse Event|11
2654000|NCT00701064|9165286|P2|Overall Study|initiated other PTSD treatment|2
2654001|NCT00701064|9165287|P1|Overall Study|initiated other PTSD treatment|2
2654002|NCT00701064|9165286|P2|Overall Study|Withdrawal by Subject|1
2654003|NCT00701064|9165287|P1|Overall Study|Withdrawal by Subject|1
2654004|NCT00701064|9165286|P2|Overall Study|Protocol Violation|1
2654005|NCT00701064|9165287|P1|Overall Study|Protocol Violation|1
2654006|NCT00701051|9165299|P3|Exercise Intervention|time conflict; non-study related illness|3
2654007|NCT00701051|9165300|P2|Exercise Intervention|time conflict; non-study related illness|5
2654008|NCT00701051|9165301|P1|Exercise Intervention|time conflict; non-study related illness|0
2654009|NCT00701051|9165299|P3|Screening|Time conflicts|0
2654010|NCT00701051|9165300|P2|Screening|Time conflicts|0
2654011|NCT00701051|9165301|P1|Screening|Time conflicts|19
2654012|NCT00701051|9165299|P3|Screening|Failed Screening|0
2654013|NCT00701051|9165300|P2|Screening|Failed Screening|0
2654014|NCT00701051|9165301|P1|Screening|Failed Screening|40
2654015|NCT00701038|9165319|P2|Overall Study|study amended pilot group of patients|4
2654016|NCT00701038|9165320|P1|Overall Study|study amended pilot group of patients|4
2654017|NCT00700999|9165328|P2|Overall Study|Withdrawal by Subject|1
2654018|NCT00700999|9165329|P1|Overall Study|Withdrawal by Subject|8
2654019|NCT00700999|9165328|P2|Overall Study|Excluded - did not meet study criteria|1
2654020|NCT00700999|9165329|P1|Overall Study|Excluded - did not meet study criteria|0
2654021|NCT00700999|9165328|P2|Overall Study|Lost to Follow-up|7
2654022|NCT00700999|9165329|P1|Overall Study|Lost to Follow-up|7
2654024|NCT00700882|9165344|P1|Overall Study|Ineligible|2
2654025|NCT00700882|9165344|P1|Overall Study|Never received treatment|6
2654026|NCT00700817|9165353|P5|Week 52-78 (Extension Period 2)|Unclassified|1
2654027|NCT00700817|9165354|P4|Week 52-78 (Extension Period 2)|Unclassified|0
2654028|NCT00700817|9165355|P3|Week 52-78 (Extension Period 2)|Unclassified|0
2654029|NCT00700817|9165356|P2|Week 52-78 (Extension Period 2)|Unclassified|4
2654030|NCT00700817|9165357|P1|Week 52-78 (Extension Period 2)|Unclassified|2
2654031|NCT00700817|9165353|P5|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
2654032|NCT00700817|9165354|P4|Week 52-78 (Extension Period 2)|Withdrawal criteria|1
2654033|NCT00700817|9165355|P3|Week 52-78 (Extension Period 2)|Withdrawal criteria|0
2654034|NCT00700817|9165356|P2|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
2654035|NCT00700817|9165357|P1|Week 52-78 (Extension Period 2)|Withdrawal criteria|4
2654036|NCT00700817|9165353|P5|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
2654037|NCT00700817|9165354|P4|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
2654038|NCT00700817|9165355|P3|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
2654039|NCT00700817|9165356|P2|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
2654040|NCT00700817|9165357|P1|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
2654041|NCT00700817|9165353|P5|Week 52-78 (Extension Period 2)|Protocol Violation|1
2654042|NCT00700817|9165354|P4|Week 52-78 (Extension Period 2)|Protocol Violation|1
2654043|NCT00700817|9165355|P3|Week 52-78 (Extension Period 2)|Protocol Violation|0
2654044|NCT00700817|9165356|P2|Week 52-78 (Extension Period 2)|Protocol Violation|2
2654045|NCT00700817|9165357|P1|Week 52-78 (Extension Period 2)|Protocol Violation|1
2654046|NCT00700817|9165353|P5|Week 52-78 (Extension Period 2)|Adverse Event|0
2654047|NCT00700817|9165354|P4|Week 52-78 (Extension Period 2)|Adverse Event|6
2654048|NCT00700817|9165355|P3|Week 52-78 (Extension Period 2)|Adverse Event|0
2654049|NCT00700817|9165356|P2|Week 52-78 (Extension Period 2)|Adverse Event|3
2654050|NCT00700817|9165357|P1|Week 52-78 (Extension Period 2)|Adverse Event|0
2654051|NCT00700817|9165353|P5|Week 26-52 (Extension Period 1)|Unclassified|0
2654052|NCT00700817|9165354|P4|Week 26-52 (Extension Period 1)|Unclassified|0
2654053|NCT00700817|9165355|P3|Week 26-52 (Extension Period 1)|Unclassified|1
2654054|NCT00700817|9165356|P2|Week 26-52 (Extension Period 1)|Unclassified|3
2654055|NCT00700817|9165357|P1|Week 26-52 (Extension Period 1)|Unclassified|4
2654056|NCT00700817|9165353|P5|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
2654057|NCT00700817|9165354|P4|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
2654058|NCT00700817|9165355|P3|Week 26-52 (Extension Period 1)|Withdrawal criteria|2
2654059|NCT00700817|9165356|P2|Week 26-52 (Extension Period 1)|Withdrawal criteria|8
2654060|NCT00700817|9165357|P1|Week 26-52 (Extension Period 1)|Withdrawal criteria|6
2654061|NCT00700817|9165353|P5|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
2654062|NCT00700817|9165354|P4|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
2654063|NCT00700817|9165355|P3|Week 26-52 (Extension Period 1)|Lack of Efficacy|7
2654064|NCT00700817|9165356|P2|Week 26-52 (Extension Period 1)|Lack of Efficacy|3
2654065|NCT00700817|9165357|P1|Week 26-52 (Extension Period 1)|Lack of Efficacy|2
2654066|NCT00700817|9165353|P5|Week 26-52 (Extension Period 1)|Protocol Violation|0
2654067|NCT00700817|9165354|P4|Week 26-52 (Extension Period 1)|Protocol Violation|0
2654068|NCT00700817|9165355|P3|Week 26-52 (Extension Period 1)|Protocol Violation|2
2654069|NCT00700817|9165356|P2|Week 26-52 (Extension Period 1)|Protocol Violation|2
2654070|NCT00700817|9165357|P1|Week 26-52 (Extension Period 1)|Protocol Violation|3
2654071|NCT00700817|9165353|P5|Week 26-52 (Extension Period 1)|Adverse Event|0
2654072|NCT00700817|9165354|P4|Week 26-52 (Extension Period 1)|Adverse Event|0
2654073|NCT00700817|9165355|P3|Week 26-52 (Extension Period 1)|Adverse Event|3
2654074|NCT00700817|9165356|P2|Week 26-52 (Extension Period 1)|Adverse Event|10
2654075|NCT00700817|9165357|P1|Week 26-52 (Extension Period 1)|Adverse Event|5
2654076|NCT00700817|9165353|P5|Week 0-26 (Main Period)|Unclassified|0
2654077|NCT00700817|9165354|P4|Week 0-26 (Main Period)|Unclassified|0
2654078|NCT00700817|9165355|P3|Week 0-26 (Main Period)|Unclassified|8
2654079|NCT00700817|9165356|P2|Week 0-26 (Main Period)|Unclassified|4
2654080|NCT00700817|9165357|P1|Week 0-26 (Main Period)|Unclassified|14
2654081|NCT00700817|9165353|P5|Week 0-26 (Main Period)|Withdrawal criteria|0
2654082|NCT00700817|9165354|P4|Week 0-26 (Main Period)|Withdrawal criteria|0
2654083|NCT00700817|9165355|P3|Week 0-26 (Main Period)|Withdrawal criteria|5
2654084|NCT00700817|9165356|P2|Week 0-26 (Main Period)|Withdrawal criteria|7
2654085|NCT00700817|9165357|P1|Week 0-26 (Main Period)|Withdrawal criteria|10
2654086|NCT00700817|9165353|P5|Week 0-26 (Main Period)|Protocol Violation|0
2654087|NCT00700817|9165354|P4|Week 0-26 (Main Period)|Protocol Violation|0
2654088|NCT00700817|9165355|P3|Week 0-26 (Main Period)|Protocol Violation|4
2654089|NCT00700817|9165356|P2|Week 0-26 (Main Period)|Protocol Violation|4
2654090|NCT00700817|9165357|P1|Week 0-26 (Main Period)|Protocol Violation|14
2654091|NCT00700817|9165353|P5|Week 0-26 (Main Period)|Lack of Efficacy|0
2654092|NCT00700817|9165354|P4|Week 0-26 (Main Period)|Lack of Efficacy|0
2654093|NCT00700817|9165355|P3|Week 0-26 (Main Period)|Lack of Efficacy|4
2654094|NCT00700817|9165356|P2|Week 0-26 (Main Period)|Lack of Efficacy|0
2654095|NCT00700817|9165357|P1|Week 0-26 (Main Period)|Lack of Efficacy|4
2654096|NCT00700817|9165353|P5|Week 0-26 (Main Period)|Adverse Event|0
2654097|NCT00700817|9165354|P4|Week 0-26 (Main Period)|Adverse Event|0
2654098|NCT00700817|9165355|P3|Week 0-26 (Main Period)|Adverse Event|4
2654099|NCT00700817|9165356|P2|Week 0-26 (Main Period)|Adverse Event|15
2654100|NCT00700817|9165357|P1|Week 0-26 (Main Period)|Adverse Event|14
2654101|NCT00700804|9165739|P2|Overall Study|Loose Stools|1
2654102|NCT00700804|9165740|P1|Overall Study|Loose Stools|1
2654103|NCT00700804|9165739|P2|Overall Study|Protocol Violation|1
2654104|NCT00700804|9165740|P1|Overall Study|Protocol Violation|1
2654105|NCT00700804|9165739|P2|Overall Study|Withdrawal by Subject|2
2654106|NCT00700804|9165740|P1|Overall Study|Withdrawal by Subject|1
2654107|NCT00700752|9165748|P2|First Intervention|Withdrawal by Subject|2
2654108|NCT00700752|9165749|P1|First Intervention|Withdrawal by Subject|0
2654109|NCT00700739|9165757|P2|Overall Study|Lost to Follow-up|4
2654110|NCT00700739|9165758|P1|Overall Study|Lost to Follow-up|4
2654111|NCT00700713|9165797|P3|Overall Study|Withdrawal by Subject|1
2654112|NCT00700713|9165798|P2|Overall Study|Withdrawal by Subject|0
2654113|NCT00700713|9165799|P1|Overall Study|Withdrawal by Subject|0
2654114|NCT00700713|9165797|P3|Overall Study|Protocol Violation|1
2654115|NCT00700713|9165798|P2|Overall Study|Protocol Violation|0
2654116|NCT00700713|9165799|P1|Overall Study|Protocol Violation|1
2654117|NCT00700635|9165816|P3|Overall Study|Withdrawal by Subject|1
2654118|NCT00700635|9165817|P2|Overall Study|Withdrawal by Subject|3
2654119|NCT00700635|9165818|P1|Overall Study|Withdrawal by Subject|7
2654120|NCT00700635|9165816|P3|Overall Study|Protocol Violation|0
2654121|NCT00700635|9165817|P2|Overall Study|Protocol Violation|2
2654122|NCT00700635|9165818|P1|Overall Study|Protocol Violation|2
2654123|NCT00700635|9165816|P3|Overall Study|Lost to Follow-up|0
2654124|NCT00700635|9165817|P2|Overall Study|Lost to Follow-up|3
2654125|NCT00700635|9165818|P1|Overall Study|Lost to Follow-up|1
2654126|NCT00700635|9165816|P3|Overall Study|Adverse Event|0
2654127|NCT00700635|9165817|P2|Overall Study|Adverse Event|0
2654128|NCT00700635|9165818|P1|Overall Study|Adverse Event|1
2654129|NCT00700622|9165840|P2|Overall Study|Other|1
2654130|NCT00700622|9165841|P1|Overall Study|Other|3
2654131|NCT00700622|9165840|P2|Overall Study|Withdrawal by Subject|1
2654132|NCT00700622|9165841|P1|Overall Study|Withdrawal by Subject|4
2654133|NCT00700622|9165840|P2|Overall Study|Protocol Violation|1
2654134|NCT00700622|9165841|P1|Overall Study|Protocol Violation|0
2654135|NCT00700622|9165840|P2|Overall Study|Physician Decision|1
2654136|NCT00700622|9165841|P1|Overall Study|Physician Decision|2
2654137|NCT00700622|9165840|P2|Overall Study|Lost to Follow-up|1
2654138|NCT00700622|9165841|P1|Overall Study|Lost to Follow-up|0
2654139|NCT00700622|9165840|P2|Overall Study|Adverse Event|0
2654140|NCT00700622|9165841|P1|Overall Study|Adverse Event|4
2654141|NCT00700570|9165849|P2|Overall Study|Withdrawal by Subject|6
2654142|NCT00700570|9165850|P1|Overall Study|Withdrawal by Subject|1
2654143|NCT00700570|9165849|P2|Overall Study|Disease Progression|11
2654144|NCT00700570|9165850|P1|Overall Study|Disease Progression|8
2654145|NCT00700570|9165849|P2|Overall Study|Discretion of Investigator or Sponsor|3
2654146|NCT00700570|9165850|P1|Overall Study|Discretion of Investigator or Sponsor|0
2654147|NCT00700570|9165849|P2|Overall Study|Adverse Event|6
2654148|NCT00700570|9165850|P1|Overall Study|Adverse Event|2
2654149|NCT00700427|9165866|P5|Study Period 4 (Open-Label Extension)|Clinical Relapse|1
2654150|NCT00700427|9165867|P4|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
2654151|NCT00700427|9165868|P3|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
2654152|NCT00700427|9165869|P2|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
2654153|NCT00700427|9165870|P1|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
2654154|NCT00700427|9165866|P5|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11
2654155|NCT00700427|9165867|P4|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
2654156|NCT00700427|9165868|P3|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
2654157|NCT00700427|9165869|P2|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
2654158|NCT00700427|9165870|P1|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
2654159|NCT00700427|9165866|P5|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1
2654160|NCT00700427|9165867|P4|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
2654161|NCT00700427|9165868|P3|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
2654162|NCT00700427|9165869|P2|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
2654163|NCT00700427|9165870|P1|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
2654164|NCT00700427|9165866|P5|Study Period 4 (Open-Label Extension)|Sponsor Decision|2
2654165|NCT00700427|9165867|P4|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
2654166|NCT00700427|9165868|P3|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
2654167|NCT00700427|9165869|P2|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
2654168|NCT00700427|9165870|P1|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
2654169|NCT00700427|9165866|P5|Study Period 4 (Open-Label Extension)|Physician Decision|2
2654170|NCT00700427|9165867|P4|Study Period 4 (Open-Label Extension)|Physician Decision|0
2654171|NCT00700427|9165868|P3|Study Period 4 (Open-Label Extension)|Physician Decision|0
2654172|NCT00700427|9165869|P2|Study Period 4 (Open-Label Extension)|Physician Decision|0
2654173|NCT00700427|9165870|P1|Study Period 4 (Open-Label Extension)|Physician Decision|0
2654174|NCT00700427|9165866|P5|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38
2654175|NCT00700427|9165867|P4|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
2654176|NCT00700427|9165868|P3|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
2654177|NCT00700427|9165869|P2|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
2654178|NCT00700427|9165870|P1|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
2654179|NCT00700427|9165866|P5|Study Period 4 (Open-Label Extension)|Protocol Violation|12
2654180|NCT00700427|9165867|P4|Study Period 4 (Open-Label Extension)|Protocol Violation|0
2654181|NCT00700427|9165868|P3|Study Period 4 (Open-Label Extension)|Protocol Violation|0
2654182|NCT00700427|9165869|P2|Study Period 4 (Open-Label Extension)|Protocol Violation|0
2654183|NCT00700427|9165870|P1|Study Period 4 (Open-Label Extension)|Protocol Violation|0
2654184|NCT00700427|9165866|P5|Study Period 4 (Open-Label Extension)|Death|1
2654185|NCT00700427|9165867|P4|Study Period 4 (Open-Label Extension)|Death|0
2654186|NCT00700427|9165868|P3|Study Period 4 (Open-Label Extension)|Death|0
2654187|NCT00700427|9165869|P2|Study Period 4 (Open-Label Extension)|Death|0
2654188|NCT00700427|9165870|P1|Study Period 4 (Open-Label Extension)|Death|0
2654189|NCT00700427|9165866|P5|Study Period 4 (Open-Label Extension)|Adverse Event|16
2654190|NCT00700427|9165867|P4|Study Period 4 (Open-Label Extension)|Adverse Event|0
2654191|NCT00700427|9165868|P3|Study Period 4 (Open-Label Extension)|Adverse Event|0
2654192|NCT00700427|9165869|P2|Study Period 4 (Open-Label Extension)|Adverse Event|0
2654193|NCT00700427|9165870|P1|Study Period 4 (Open-Label Extension)|Adverse Event|0
2654194|NCT00700427|9165866|P5|Study Period 3B (Randomized Withdrawal)|Death|0
2654195|NCT00700427|9165867|P4|Study Period 3B (Randomized Withdrawal)|Death|0
2654196|NCT00700427|9165868|P3|Study Period 3B (Randomized Withdrawal)|Death|1
2654197|NCT00700427|9165869|P2|Study Period 3B (Randomized Withdrawal)|Death|0
2654198|NCT00700427|9165870|P1|Study Period 3B (Randomized Withdrawal)|Death|0
2654199|NCT00700427|9165866|P5|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
2654200|NCT00700427|9165867|P4|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
2654201|NCT00700427|9165868|P3|Study Period 3B (Randomized Withdrawal)|Physician Decision|2
2654202|NCT00700427|9165869|P2|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
2654203|NCT00700427|9165870|P1|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
2654204|NCT00700427|9165866|P5|Study Period 3B (Randomized Withdrawal)|Missing|0
2654205|NCT00700427|9165867|P4|Study Period 3B (Randomized Withdrawal)|Missing|1
2654206|NCT00700427|9165868|P3|Study Period 3B (Randomized Withdrawal)|Missing|1
2654207|NCT00700427|9165869|P2|Study Period 3B (Randomized Withdrawal)|Missing|0
2654208|NCT00700427|9165870|P1|Study Period 3B (Randomized Withdrawal)|Missing|0
2654209|NCT00700427|9165866|P5|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
2654210|NCT00700427|9165867|P4|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3
2654211|NCT00700427|9165868|P3|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
2654212|NCT00700427|9165869|P2|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
2654213|NCT00700427|9165870|P1|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
2654214|NCT00700427|9165866|P5|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
2654215|NCT00700427|9165867|P4|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5
2654216|NCT00700427|9165868|P3|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
2654217|NCT00700427|9165869|P2|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
2654218|NCT00700427|9165870|P1|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
2654219|NCT00700427|9165866|P5|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
2654220|NCT00700427|9165867|P4|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11
2654221|NCT00700427|9165868|P3|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3
2654222|NCT00700427|9165869|P2|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
2654223|NCT00700427|9165870|P1|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
2654224|NCT00700427|9165866|P5|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
2654225|NCT00700427|9165867|P4|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9
2654226|NCT00700427|9165868|P3|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19
2654227|NCT00700427|9165869|P2|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
2654228|NCT00700427|9165870|P1|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
2654229|NCT00700427|9165866|P5|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
2654230|NCT00700427|9165867|P4|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25
2654231|NCT00700427|9165868|P3|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23
2654232|NCT00700427|9165869|P2|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
2654233|NCT00700427|9165870|P1|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
2654234|NCT00700427|9165866|P5|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
2654235|NCT00700427|9165867|P4|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34
2654236|NCT00700427|9165868|P3|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25
2654237|NCT00700427|9165869|P2|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
2654238|NCT00700427|9165870|P1|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
2654239|NCT00700427|9165866|P5|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
2654240|NCT00700427|9165867|P4|Study Period 3B (Randomized Withdrawal)|Adverse Event|5
2654241|NCT00700427|9165868|P3|Study Period 3B (Randomized Withdrawal)|Adverse Event|8
2654242|NCT00700427|9165869|P2|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
2654243|NCT00700427|9165870|P1|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
2654244|NCT00700427|9165866|P5|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
2654245|NCT00700427|9165867|P4|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
2654246|NCT00700427|9165868|P3|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
2654247|NCT00700427|9165869|P2|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5
2654248|NCT00700427|9165870|P1|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
2654249|NCT00700427|9165866|P5|Study Period 3A (Blinded Maintenance)|Physician Decision|0
2654250|NCT00700427|9165867|P4|Study Period 3A (Blinded Maintenance)|Physician Decision|0
2654251|NCT00700427|9165868|P3|Study Period 3A (Blinded Maintenance)|Physician Decision|0
2654252|NCT00700427|9165869|P2|Study Period 3A (Blinded Maintenance)|Physician Decision|2
2654253|NCT00700427|9165870|P1|Study Period 3A (Blinded Maintenance)|Physician Decision|0
2654254|NCT00700427|9165866|P5|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
2654255|NCT00700427|9165867|P4|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
2654256|NCT00700427|9165868|P3|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
2654257|NCT00700427|9165869|P2|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3
2654258|NCT00700427|9165870|P1|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
2654259|NCT00700427|9165866|P5|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
2654260|NCT00700427|9165867|P4|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
2654261|NCT00700427|9165868|P3|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
2654262|NCT00700427|9165869|P2|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32
2654263|NCT00700427|9165870|P1|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
2654264|NCT00700427|9165866|P5|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
2654265|NCT00700427|9165867|P4|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
2654266|NCT00700427|9165868|P3|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
2654267|NCT00700427|9165869|P2|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41
2654268|NCT00700427|9165870|P1|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
2654269|NCT00700427|9165866|P5|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
2654270|NCT00700427|9165867|P4|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
2654271|NCT00700427|9165868|P3|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
2654272|NCT00700427|9165869|P2|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49
2654273|NCT00700427|9165870|P1|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
2654274|NCT00700427|9165866|P5|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
2654275|NCT00700427|9165867|P4|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
2654276|NCT00700427|9165868|P3|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
2654277|NCT00700427|9165869|P2|Study Period 3A (Blinded Maintenance)|Protocol Violation|56
2654278|NCT00700427|9165870|P1|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
2654279|NCT00700427|9165866|P5|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
2654280|NCT00700427|9165867|P4|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
2654281|NCT00700427|9165868|P3|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
2654282|NCT00700427|9165869|P2|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81
2654283|NCT00700427|9165870|P1|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
2654284|NCT00700427|9165866|P5|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
2654285|NCT00700427|9165867|P4|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
2654286|NCT00700427|9165868|P3|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
2654287|NCT00700427|9165869|P2|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162
2654288|NCT00700427|9165870|P1|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
2654289|NCT00700427|9165866|P5|Study Period 3A (Blinded Maintenance)|Adverse Event|0
2654290|NCT00700427|9165867|P4|Study Period 3A (Blinded Maintenance)|Adverse Event|0
2654291|NCT00700427|9165868|P3|Study Period 3A (Blinded Maintenance)|Adverse Event|0
2654292|NCT00700427|9165869|P2|Study Period 3A (Blinded Maintenance)|Adverse Event|50
2654293|NCT00700427|9165870|P1|Study Period 3A (Blinded Maintenance)|Adverse Event|0
2654294|NCT00700427|9165866|P5|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
2654295|NCT00700427|9165867|P4|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
2654296|NCT00700427|9165868|P3|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
2654297|NCT00700427|9165869|P2|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
2654298|NCT00700427|9165870|P1|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2
2654299|NCT00700427|9165866|P5|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
2654300|NCT00700427|9165867|P4|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
2654301|NCT00700427|9165868|P3|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
2654302|NCT00700427|9165869|P2|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
2654303|NCT00700427|9165870|P1|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7
2654304|NCT00700427|9165866|P5|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
2654305|NCT00700427|9165867|P4|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
2654306|NCT00700427|9165868|P3|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
2654307|NCT00700427|9165869|P2|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
2654308|NCT00700427|9165870|P1|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8
2654309|NCT00700427|9165866|P5|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
2654310|NCT00700427|9165867|P4|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
2654311|NCT00700427|9165868|P3|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
2654312|NCT00700427|9165869|P2|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
2654313|NCT00700427|9165870|P1|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90
2654314|NCT00700427|9165866|P5|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
2654315|NCT00700427|9165867|P4|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
2654316|NCT00700427|9165868|P3|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
2654317|NCT00700427|9165869|P2|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
2654318|NCT00700427|9165870|P1|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108
2654319|NCT00700427|9165866|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
2654320|NCT00700427|9165867|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
2654321|NCT00700427|9165868|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
2654322|NCT00700427|9165869|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
2654323|NCT00700427|9165870|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161
2654324|NCT00700427|9165866|P5|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
2654325|NCT00700427|9165867|P4|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
2654326|NCT00700427|9165868|P3|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
2654327|NCT00700427|9165869|P2|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
2654328|NCT00700427|9165870|P1|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164
2654329|NCT00700427|9165866|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
2654330|NCT00700427|9165867|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
2654331|NCT00700427|9165868|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
2654332|NCT00700427|9165869|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
2654333|NCT00700427|9165870|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173
2654334|NCT00700427|9165866|P5|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
2654335|NCT00700427|9165867|P4|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
2654336|NCT00700427|9165868|P3|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
2654337|NCT00700427|9165869|P2|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
2654338|NCT00700427|9165870|P1|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298
2654339|NCT00700401|9165892|P1|Overall Study|Withdrawal by Subject|2
2654340|NCT00700401|9165892|P1|Overall Study|HCV RNA not detected at baseline and SAE|1
2654341|NCT00700401|9165892|P1|Overall Study|Treatment never started|1
2654342|NCT00700401|9165892|P1|Overall Study|Lost to Follow-up|1
2654343|NCT00700401|9165892|P1|Overall Study|Refused Treatment|2
2654344|NCT00700401|9165892|P1|Overall Study|Adverse Event|5
2654345|NCT00700401|9165892|P1|Overall Study|Detectable HCV RNA after Week 4|82
2654346|NCT00700310|9165916|P4|Overall Study|Randomized, Not Treated|2
2654347|NCT00700310|9165917|P3|Overall Study|Randomized, Not Treated|2
2654348|NCT00700310|9165918|P2|Overall Study|Randomized, Not Treated|0
2654349|NCT00700310|9165919|P1|Overall Study|Randomized, Not Treated|2
2654350|NCT00700310|9165916|P4|Overall Study|Administrative/Other|3
2654351|NCT00700310|9165917|P3|Overall Study|Administrative/Other|1
2654352|NCT00700310|9165918|P2|Overall Study|Administrative/Other|3
2654353|NCT00700310|9165919|P1|Overall Study|Administrative/Other|1
2654354|NCT00700310|9165916|P4|Overall Study|Lack of Efficacy|1
2654355|NCT00700310|9165917|P3|Overall Study|Lack of Efficacy|0
2654356|NCT00700310|9165918|P2|Overall Study|Lack of Efficacy|3
2654357|NCT00700310|9165919|P1|Overall Study|Lack of Efficacy|0
2654358|NCT00700310|9165916|P4|Overall Study|Withdrawal by Subject|8
2654359|NCT00700310|9165917|P3|Overall Study|Withdrawal by Subject|8
2654360|NCT00700310|9165918|P2|Overall Study|Withdrawal by Subject|9
2654361|NCT00700310|9165919|P1|Overall Study|Withdrawal by Subject|8
2654362|NCT00700310|9165916|P4|Overall Study|Lost to Follow-up|1
2654363|NCT00700310|9165917|P3|Overall Study|Lost to Follow-up|0
2654364|NCT00700310|9165918|P2|Overall Study|Lost to Follow-up|1
2654365|NCT00700310|9165919|P1|Overall Study|Lost to Follow-up|4
2654366|NCT00700310|9165916|P4|Overall Study|Adverse Event|11
2654367|NCT00700310|9165917|P3|Overall Study|Adverse Event|5
2654368|NCT00700310|9165918|P2|Overall Study|Adverse Event|10
2654369|NCT00700310|9165919|P1|Overall Study|Adverse Event|6
2654370|NCT00700271|9165939|P2|Overall Study|Lost to Follow-up|2
2654371|NCT00700271|9165940|P1|Overall Study|Lost to Follow-up|2
2654372|NCT00700271|9165939|P2|Overall Study|Withdrawal by Subject|4
2654373|NCT00700271|9165940|P1|Overall Study|Withdrawal by Subject|6
2654374|NCT00700271|9165939|P2|Overall Study|Administrative Reasons|0
2654375|NCT00700271|9165940|P1|Overall Study|Administrative Reasons|1
2654376|NCT00700271|9165939|P2|Overall Study|Protocol Violation|0
2654377|NCT00700271|9165940|P1|Overall Study|Protocol Violation|1
2654378|NCT00700271|9165939|P2|Overall Study|Adverse Event|6
2654379|NCT00700271|9165940|P1|Overall Study|Adverse Event|4
2654380|NCT00700180|9165968|P2|Overall Study|Lost to Follow-up|5
2654381|NCT00700180|9165969|P1|Overall Study|Lost to Follow-up|4
2654382|NCT00700180|9165968|P2|Overall Study|Alive in follow-up|27
2654383|NCT00700180|9165969|P1|Overall Study|Alive in follow-up|46
2654384|NCT00700180|9165968|P2|Overall Study|Alive on treatment|3
2654385|NCT00700180|9165969|P1|Overall Study|Alive on treatment|5
2654386|NCT00700180|9165968|P2|Overall Study|Death|114
2654387|NCT00700180|9165969|P1|Overall Study|Death|99
2654388|NCT00700115|9165998|P2|Overall Study|Lost to Follow-up|1
2654389|NCT00700115|9165999|P1|Overall Study|Lost to Follow-up|0
2654390|NCT00700115|9165998|P2|Overall Study|Withdrawal by Subject|0
2654391|NCT00700115|9165999|P1|Overall Study|Withdrawal by Subject|1
2654392|NCT00700102|9166009|P2|Overall Study|Lost to Follow-up|10
2654393|NCT00700102|9166010|P1|Overall Study|Lost to Follow-up|8
2654394|NCT00700102|9166009|P2|Overall Study|Died|385
2654395|NCT00700102|9166010|P1|Overall Study|Died|394
2654396|NCT00700011|9166149|P2|Overall Study|Death|1
2654397|NCT00700011|9166150|P1|Overall Study|Death|0
2654398|NCT00699998|9166166|P4|Overall Study|Lost to Follow-up|1
2654399|NCT00699998|9166167|P3|Overall Study|Lost to Follow-up|3
2654400|NCT00699998|9166168|P2|Overall Study|Lost to Follow-up|1
2654401|NCT00699998|9166169|P1|Overall Study|Lost to Follow-up|2
2654402|NCT00699998|9166166|P4|Overall Study|Physician Decision|1
2654403|NCT00699998|9166167|P3|Overall Study|Physician Decision|1
2654404|NCT00699998|9166168|P2|Overall Study|Physician Decision|2
2654405|NCT00699998|9166169|P1|Overall Study|Physician Decision|3
2654406|NCT00699998|9166166|P4|Overall Study|Withdrawal by Subject|80
2654407|NCT00699998|9166167|P3|Overall Study|Withdrawal by Subject|202
2654408|NCT00699998|9166168|P2|Overall Study|Withdrawal by Subject|83
2654409|NCT00699998|9166169|P1|Overall Study|Withdrawal by Subject|194
2654410|NCT00699972|9166214|P3|Overall Study|Randomized, Not Treated|1
2654411|NCT00699972|9166215|P2|Overall Study|Randomized, Not Treated|0
2654412|NCT00699972|9166216|P1|Overall Study|Randomized, Not Treated|1
2654413|NCT00699972|9166214|P3|Overall Study|Administrative/Other|4
2654414|NCT00699972|9166215|P2|Overall Study|Administrative/Other|1
2654415|NCT00699972|9166216|P1|Overall Study|Administrative/Other|3
2654416|NCT00699972|9166214|P3|Overall Study|Lack of Efficacy|2
2654417|NCT00699972|9166215|P2|Overall Study|Lack of Efficacy|0
2654418|NCT00699972|9166216|P1|Overall Study|Lack of Efficacy|2
2654419|NCT00699972|9166214|P3|Overall Study|Withdrawal by Subject|4
2654420|NCT00699972|9166215|P2|Overall Study|Withdrawal by Subject|7
2654421|NCT00699972|9166216|P1|Overall Study|Withdrawal by Subject|3
2654422|NCT00699972|9166214|P3|Overall Study|Lost to Follow-up|0
2654423|NCT00699972|9166215|P2|Overall Study|Lost to Follow-up|2
2654424|NCT00699972|9166216|P1|Overall Study|Lost to Follow-up|0
2654425|NCT00699972|9166214|P3|Overall Study|Adverse Event|24
2654426|NCT00699972|9166215|P2|Overall Study|Adverse Event|9
2654427|NCT00699972|9166216|P1|Overall Study|Adverse Event|7
2654428|NCT00699907|9166233|P3|Overall Study|No usable sample|8
2654429|NCT00699907|9166234|P2|Overall Study|No usable sample|9
2654430|NCT00699907|9166235|P1|Overall Study|No usable sample|0
2654431|NCT00699907|9166233|P3|Overall Study|Withdrawal by Subject|0
2654432|NCT00699907|9166234|P2|Overall Study|Withdrawal by Subject|1
2654433|NCT00699907|9166235|P1|Overall Study|Withdrawal by Subject|2
2654434|NCT00699842|9166270|P3|Overall Study|Death|0
2654435|NCT00699842|9166271|P2|Overall Study|Death|1
2654436|NCT00699842|9166272|P1|Overall Study|Death|0
2654437|NCT00699816|9166285|P2|Overall Study|Protocol Violation|3
2654438|NCT00699816|9166286|P1|Overall Study|Protocol Violation|1
2654439|NCT00699751|9166304|P2|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4
2654440|NCT00699751|9166305|P1|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0
2654441|NCT00699751|9166304|P2|Period 2:Switched From Placebo to Xofigo|Investigator Request|1
2654442|NCT00699751|9166305|P1|Period 2:Switched From Placebo to Xofigo|Investigator Request|0
2654443|NCT00699751|9166304|P2|Period 2:Switched From Placebo to Xofigo|Adverse Event|4
2654444|NCT00699751|9166305|P1|Period 2:Switched From Placebo to Xofigo|Adverse Event|0
2654445|NCT00699751|9166304|P2|Period 1: Without/Before Drug Switch|Adverse Event|63
2654446|NCT00699751|9166305|P1|Period 1: Without/Before Drug Switch|Adverse Event|97
2654447|NCT00699751|9166304|P2|Period 1: Without/Before Drug Switch|Other|20
2654448|NCT00699751|9166305|P1|Period 1: Without/Before Drug Switch|Other|30
2654449|NCT00699751|9166304|P2|Period 1: Without/Before Drug Switch|Subject Request|23
2654450|NCT00699751|9166305|P1|Period 1: Without/Before Drug Switch|Subject Request|43
2654451|NCT00699751|9166304|P2|Period 1: Without/Before Drug Switch|Death|29
2654452|NCT00699751|9166305|P1|Period 1: Without/Before Drug Switch|Death|28
2654453|NCT00699751|9166304|P2|Period 1: Without/Before Drug Switch|Investigator Request|27
2654454|NCT00699751|9166305|P1|Period 1: Without/Before Drug Switch|Investigator Request|27
2654455|NCT00699699|9166390|P1|Overall Study|Individual different reasons|21
2654456|NCT00699699|9166390|P1|Overall Study|Adverse Event|36
2654457|NCT00699660|9166399|P2|Overall Study|missing reports and recording failures|6
2654458|NCT00699660|9166400|P1|Overall Study|missing reports and recording failures|10
2654459|NCT00699660|9166399|P2|Overall Study|Lost to Follow-up|2
2654460|NCT00699660|9166400|P1|Overall Study|Lost to Follow-up|4
2654461|NCT00699608|9166412|P6|Second Intervention|Withdrawal by Subject|0
2654462|NCT00699608|9166413|P5|Second Intervention|Withdrawal by Subject|0
2654463|NCT00699608|9166414|P4|Second Intervention|Withdrawal by Subject|1
2654464|NCT00699608|9166415|P3|Second Intervention|Withdrawal by Subject|0
2654465|NCT00699608|9166416|P2|Second Intervention|Withdrawal by Subject|0
2654466|NCT00699608|9166417|P1|Second Intervention|Withdrawal by Subject|0
2654467|NCT00699608|9166412|P6|Second Intervention|Adverse Event|0
2654468|NCT00699608|9166413|P5|Second Intervention|Adverse Event|0
2654469|NCT00699608|9166414|P4|Second Intervention|Adverse Event|0
2654470|NCT00699608|9166415|P3|Second Intervention|Adverse Event|1
2654471|NCT00699608|9166416|P2|Second Intervention|Adverse Event|0
2654472|NCT00699608|9166417|P1|Second Intervention|Adverse Event|0
2654473|NCT00699608|9166412|P6|First Intervention|Protocol Violation|0
2654474|NCT00699608|9166413|P5|First Intervention|Protocol Violation|1
2654475|NCT00699608|9166414|P4|First Intervention|Protocol Violation|0
2654476|NCT00699608|9166415|P3|First Intervention|Protocol Violation|0
2654477|NCT00699608|9166416|P2|First Intervention|Protocol Violation|0
2654478|NCT00699608|9166417|P1|First Intervention|Protocol Violation|0
2654479|NCT00699608|9166412|P6|First Intervention|Withdrawal by Subject|0
2654480|NCT00699608|9166413|P5|First Intervention|Withdrawal by Subject|0
2654481|NCT00699608|9166414|P4|First Intervention|Withdrawal by Subject|0
2654482|NCT00699608|9166415|P3|First Intervention|Withdrawal by Subject|1
2654483|NCT00699608|9166416|P2|First Intervention|Withdrawal by Subject|0
2654484|NCT00699608|9166417|P1|First Intervention|Withdrawal by Subject|0
2654485|NCT00699582|9166470|P3|Overall Study|Randomized, Not Treated|0
2654486|NCT00699582|9166471|P2|Overall Study|Randomized, Not Treated|1
2654487|NCT00699582|9166472|P1|Overall Study|Randomized, Not Treated|2
2654488|NCT00699582|9166470|P3|Overall Study|Administrative/Other|0
2654489|NCT00699582|9166471|P2|Overall Study|Administrative/Other|3
2654490|NCT00699582|9166472|P1|Overall Study|Administrative/Other|4
2654491|NCT00699582|9166470|P3|Overall Study|Progressive Disease|0
2654492|NCT00699582|9166471|P2|Overall Study|Progressive Disease|0
2654493|NCT00699582|9166472|P1|Overall Study|Progressive Disease|1
2654494|NCT00699582|9166470|P3|Overall Study|Lack of Efficacy|1
2654495|NCT00699582|9166471|P2|Overall Study|Lack of Efficacy|0
2654496|NCT00699582|9166472|P1|Overall Study|Lack of Efficacy|1
2654497|NCT00699582|9166470|P3|Overall Study|Withdrawal by Subject|4
2654498|NCT00699582|9166471|P2|Overall Study|Withdrawal by Subject|7
2654499|NCT00699582|9166472|P1|Overall Study|Withdrawal by Subject|6
2654500|NCT00699582|9166470|P3|Overall Study|Adverse Event|23
2654501|NCT00699582|9166471|P2|Overall Study|Adverse Event|11
2654502|NCT00699582|9166472|P1|Overall Study|Adverse Event|4
2654503|NCT00699413|9166527|P2|Overall Study|Study terminated by sponsor|2
2654504|NCT00699413|9166528|P1|Overall Study|Study terminated by sponsor|4
2654505|NCT00699413|9166527|P2|Overall Study|Withdrawal by Subject|2
2654506|NCT00699413|9166528|P1|Overall Study|Withdrawal by Subject|0
2654507|NCT00699374|9166582|P2|Overall Study|Died 28 days after last dose|9
2654508|NCT00699374|9166583|P1|Overall Study|Died 28 days after last dose|5
2654509|NCT00699374|9166582|P2|Overall Study|Randomized but not treated|2
2654510|NCT00699374|9166583|P1|Overall Study|Randomized but not treated|4
2654511|NCT00699374|9166582|P2|Overall Study|Study terminated by sponsor|28
2654512|NCT00699374|9166583|P1|Overall Study|Study terminated by sponsor|13
2654513|NCT00699374|9166582|P2|Overall Study|Protocol Violation|6
2654514|NCT00699374|9166583|P1|Overall Study|Protocol Violation|2
2654515|NCT00699374|9166582|P2|Overall Study|Other|15
2654516|NCT00699374|9166583|P1|Overall Study|Other|18
2654517|NCT00699374|9166582|P2|Overall Study|Objective progression or relapse|277
2654518|NCT00699374|9166583|P1|Overall Study|Objective progression or relapse|281
2654519|NCT00699374|9166582|P2|Overall Study|Withdrawal by Subject|44
2654520|NCT00699374|9166583|P1|Overall Study|Withdrawal by Subject|34
2654521|NCT00699374|9166582|P2|Overall Study|Lost to Follow-up|5
2654522|NCT00699374|9166583|P1|Overall Study|Lost to Follow-up|3
2654523|NCT00699374|9166582|P2|Overall Study|Global deterioration of health status|8
2654524|NCT00699374|9166583|P1|Overall Study|Global deterioration of health status|7
2654525|NCT00699374|9166582|P2|Overall Study|Adverse Event|67
2654526|NCT00699374|9166583|P1|Overall Study|Adverse Event|70
2654527|NCT00699374|9166582|P2|Overall Study|Death|83
2654528|NCT00699374|9166583|P1|Overall Study|Death|93
2654529|NCT00699348|9166595|P1|Overall Study|Other|5
2654530|NCT00699348|9166595|P1|Overall Study|Renal transplantation|10
2654531|NCT00699348|9166595|P1|Overall Study|Blood transfusion|24
2654532|NCT00699348|9166595|P1|Overall Study|Failure to return|1
2654533|NCT00699348|9166595|P1|Overall Study|Lack of Efficacy|8
2654534|NCT00699348|9166595|P1|Overall Study|Protocol Violation|10
2654535|NCT00699348|9166595|P1|Overall Study|Withdrawal by Subject|11
2654536|NCT00699348|9166595|P1|Overall Study|Adverse Event|15
2654537|NCT00699348|9166595|P1|Overall Study|Death|6
2654538|NCT00699335|9166604|P1|Overall Study|Missing data|52
2654539|NCT00699335|9166604|P1|Overall Study|Combination of multiple reasons|176
2654540|NCT00699283|9166637|P2|Overall Study|AE of unknown type|0
2654541|NCT00699283|9166638|P1|Overall Study|AE of unknown type|1
2654542|NCT00699283|9166637|P2|Overall Study|AE, non-serious non-fatal|1
2654543|NCT00699283|9166638|P1|Overall Study|AE, non-serious non-fatal|8
2654544|NCT00699283|9166637|P2|Overall Study|SAE, non-fatal|1
2654545|NCT00699283|9166638|P1|Overall Study|SAE, non-fatal|1
2654546|NCT00699283|9166637|P2|Overall Study|Other Reason|1
2654547|NCT00699283|9166638|P1|Overall Study|Other Reason|5
2654548|NCT00699283|9166637|P2|Overall Study|Withdrawal by Subject|0
2654549|NCT00699283|9166638|P1|Overall Study|Withdrawal by Subject|1
2654550|NCT00699283|9166637|P2|Overall Study|Lost to Follow-up|0
2654551|NCT00699283|9166638|P1|Overall Study|Lost to Follow-up|2
2654552|NCT00699283|9166637|P2|Overall Study|Lack of Efficacy|5
2654553|NCT00699283|9166638|P1|Overall Study|Lack of Efficacy|15
2654554|NCT00699192|9166651|P3|Overall Study|Protocol Violation|0
2654555|NCT00699192|9166652|P2|Overall Study|Protocol Violation|2
2654556|NCT00699192|9166653|P1|Overall Study|Protocol Violation|2
2654557|NCT00699192|9166651|P3|Overall Study|Administrative problems|1
2654558|NCT00699192|9166652|P2|Overall Study|Administrative problems|3
2654559|NCT00699192|9166653|P1|Overall Study|Administrative problems|1
2654560|NCT00699192|9166651|P3|Overall Study|Withdrawal by Subject|4
2654561|NCT00699192|9166652|P2|Overall Study|Withdrawal by Subject|2
2654562|NCT00699192|9166653|P1|Overall Study|Withdrawal by Subject|3
2654563|NCT00699192|9166651|P3|Overall Study|Lack of Efficacy|1
2654564|NCT00699192|9166652|P2|Overall Study|Lack of Efficacy|0
2654565|NCT00699192|9166653|P1|Overall Study|Lack of Efficacy|0
2654566|NCT00699192|9166651|P3|Overall Study|Abnormal test procedure result(s)|1
2654567|NCT00699192|9166652|P2|Overall Study|Abnormal test procedure result(s)|0
2654568|NCT00699192|9166653|P1|Overall Study|Abnormal test procedure result(s)|0
2654569|NCT00699192|9166651|P3|Overall Study|Adverse Event|3
2654570|NCT00699192|9166652|P2|Overall Study|Adverse Event|4
2654571|NCT00699192|9166653|P1|Overall Study|Adverse Event|9
2654572|NCT00699192|9166651|P3|Overall Study|Missing|1
2654573|NCT00699192|9166652|P2|Overall Study|Missing|1
2654574|NCT00699192|9166653|P1|Overall Study|Missing|1
2654575|NCT00699153|9166675|P2|Overall Study|Travel Problem|0
2654576|NCT00699153|9166676|P1|Overall Study|Travel Problem|1
2654577|NCT00699153|9166675|P2|Overall Study|Protocol Violation|0
2654578|NCT00699153|9166676|P1|Overall Study|Protocol Violation|1
2654579|NCT00699153|9166675|P2|Overall Study|Adverse Event|2
2654580|NCT00699153|9166676|P1|Overall Study|Adverse Event|0
2654581|NCT00699153|9166675|P2|Overall Study|Lost to Follow-up|0
2654582|NCT00699153|9166676|P1|Overall Study|Lost to Follow-up|1
2654583|NCT00698997|9166711|P2|Overall Study|Withdrawal by Subject|27
2654584|NCT00698997|9166712|P1|Overall Study|Withdrawal by Subject|7
2654585|NCT00698997|9166711|P2|Overall Study|Lost to Follow-up|0
2654586|NCT00698997|9166712|P1|Overall Study|Lost to Follow-up|3
2654587|NCT00698932|9166726|P2|Overall Study|Death|0
2654588|NCT00698932|9166727|P1|Overall Study|Death|1
2654589|NCT00698932|9166726|P2|Overall Study|Safety reasons|2
2654590|NCT00698932|9166727|P1|Overall Study|Safety reasons|0
2654591|NCT00698932|9166726|P2|Overall Study|Severe non-compliance to protocol|2
2654592|NCT00698932|9166727|P1|Overall Study|Severe non-compliance to protocol|1
2654593|NCT00698932|9166726|P2|Overall Study|Lost to Follow-up|1
2654594|NCT00698932|9166727|P1|Overall Study|Lost to Follow-up|6
2654595|NCT00698932|9166726|P2|Overall Study|Withdrawal by Subject|23
2654596|NCT00698932|9166727|P1|Overall Study|Withdrawal by Subject|11
2654597|NCT00698932|9166726|P2|Overall Study|Study specific discontinuation criteria|4
2654598|NCT00698932|9166727|P1|Overall Study|Study specific discontinuation criteria|3
2654599|NCT00698932|9166726|P2|Overall Study|Incorrect enrollment|2
2654600|NCT00698932|9166727|P1|Overall Study|Incorrect enrollment|0
2654601|NCT00698932|9166726|P2|Overall Study|Adverse Event|2
2654602|NCT00698932|9166727|P1|Overall Study|Adverse Event|0
2654603|NCT00698841|9166753|P1|Overall Study|Other|2
2654604|NCT00698841|9166753|P1|Overall Study|Study drug toxicity|2
2654605|NCT00698841|9166753|P1|Overall Study|Failure to meet eligibility criteria|2
2654606|NCT00698841|9166753|P1|Overall Study|Disease progression|7
2654607|NCT00698841|9166753|P1|Overall Study|Adverse Event|3
2654608|NCT00698841|9166753|P1|Overall Study|Withdrawal by Subject|2
2654609|NCT00698815|9166767|P3|Overall Study|Did not receive protocol treatment|2
2654610|NCT00698815|9166768|P2|Overall Study|Did not receive protocol treatment|2
2654611|NCT00698815|9166769|P1|Overall Study|Did not receive protocol treatment|1
2654612|NCT00698815|9166767|P3|Overall Study|MD discretion|2
2654613|NCT00698815|9166768|P2|Overall Study|MD discretion|7
2654614|NCT00698815|9166769|P1|Overall Study|MD discretion|2
2654615|NCT00698815|9166767|P3|Overall Study|Withdrawal by Subject|2
2654616|NCT00698815|9166768|P2|Overall Study|Withdrawal by Subject|3
2654617|NCT00698815|9166769|P1|Overall Study|Withdrawal by Subject|6
2654618|NCT00698815|9166767|P3|Overall Study|Death|4
2654619|NCT00698815|9166768|P2|Overall Study|Death|2
2654620|NCT00698815|9166769|P1|Overall Study|Death|1
2654621|NCT00698685|9166786|P1|Overall Study|Off study pre transplant by clinic MD|1
2654622|NCT00698685|9166786|P1|Overall Study|Sister withdrew as donor|1
2654623|NCT00698646|9166794|P3|Overall Study|Administrative problems|1
2654624|NCT00698646|9166795|P2|Overall Study|Administrative problems|0
2654625|NCT00698646|9166796|P1|Overall Study|Administrative problems|1
2654626|NCT00698646|9166794|P3|Overall Study|Lost to Follow-up|2
2654627|NCT00698646|9166795|P2|Overall Study|Lost to Follow-up|0
2654628|NCT00698646|9166796|P1|Overall Study|Lost to Follow-up|0
2654629|NCT00698646|9166794|P3|Overall Study|Withdrawal by Subject|8
2654630|NCT00698646|9166795|P2|Overall Study|Withdrawal by Subject|11
2654631|NCT00698646|9166796|P1|Overall Study|Withdrawal by Subject|10
2654632|NCT00698646|9166794|P3|Overall Study|Protocol Deviation|3
2654633|NCT00698646|9166795|P2|Overall Study|Protocol Deviation|2
2654634|NCT00698646|9166796|P1|Overall Study|Protocol Deviation|6
2654635|NCT00698646|9166794|P3|Overall Study|Unsatisfactory Therapeutic Effect|7
2654636|NCT00698646|9166795|P2|Overall Study|Unsatisfactory Therapeutic Effect|11
2654637|NCT00698646|9166796|P1|Overall Study|Unsatisfactory Therapeutic Effect|11
2654638|NCT00698646|9166794|P3|Overall Study|Adverse Event|8
2654639|NCT00698646|9166795|P2|Overall Study|Adverse Event|7
2654640|NCT00698646|9166796|P1|Overall Study|Adverse Event|8
2654641|NCT00698581|9166821|P2|Overall Study|AE of unknown type|0
2654642|NCT00698581|9166822|P1|Overall Study|AE of unknown type|1
2654643|NCT00698581|9166821|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
2654644|NCT00698581|9166822|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
2654645|NCT00698581|9166821|P2|Overall Study|AE, non-serious non-fatal|0
2654646|NCT00698581|9166822|P1|Overall Study|AE, non-serious non-fatal|4
2654647|NCT00698581|9166821|P2|Overall Study|SAE, non-fatal|0
2654648|NCT00698581|9166822|P1|Overall Study|SAE, non-fatal|1
2654649|NCT00698581|9166821|P2|Overall Study|Other reason|1
2654650|NCT00698581|9166822|P1|Overall Study|Other reason|9
2654651|NCT00698581|9166821|P2|Overall Study|Withdrawal by Subject|0
2654652|NCT00698581|9166822|P1|Overall Study|Withdrawal by Subject|6
2654653|NCT00698581|9166821|P2|Overall Study|Lack of Efficacy|11
2654654|NCT00698581|9166822|P1|Overall Study|Lack of Efficacy|23
2654655|NCT00698516|9166833|P1|Overall Study|Withdrawal by Subject|3
2654656|NCT00698516|9166833|P1|Overall Study|Study Termination|2
2654657|NCT00698451|9166851|P1|Overall Study|Disease progression|3
2654658|NCT00698451|9166851|P1|Overall Study|Withdrawal by Subject|6
2654659|NCT00698451|9166851|P1|Overall Study|Protocol Violation|6
2654660|NCT00698451|9166851|P1|Overall Study|Physician Decision|2
2654661|NCT00698451|9166851|P1|Overall Study|Adverse Event|22
2654662|NCT00698204|9166858|P2|Overall Study|Withdrawal by Subject|0
2654663|NCT00698204|9166859|P1|Overall Study|Withdrawal by Subject|1
2654664|NCT00698009|9166919|P1|Overall Study|Withdrawal by Subject|1
2654665|NCT00697827|9166925|P2|Overall Study|enrolled but not treated|1
2654666|NCT00697827|9166926|P1|Overall Study|enrolled but not treated|2
2654667|NCT00697788|9166953|P8|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
2654668|NCT00697788|9166954|P7|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
2654669|NCT00697788|9166955|P6|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
2654670|NCT00697788|9166956|P5|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1
2654671|NCT00697788|9166957|P4|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
2654672|NCT00697788|9166958|P3|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
2654673|NCT00697788|9166959|P2|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
2654674|NCT00697788|9166960|P1|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
2654675|NCT00697788|9166953|P8|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
2654676|NCT00697788|9166954|P7|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
2654677|NCT00697788|9166955|P6|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
2654678|NCT00697788|9166956|P5|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
2654679|NCT00697788|9166957|P4|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
2654680|NCT00697788|9166958|P3|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
2654681|NCT00697788|9166959|P2|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2
2654682|NCT00697788|9166960|P1|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
2654683|NCT00697619|9167015|P2|Overall Study|Adverse Event|6
2654684|NCT00697619|9167016|P1|Overall Study|Adverse Event|4
2654685|NCT00697619|9167015|P2|Overall Study|Lack of Efficacy|2
2654686|NCT00697619|9167016|P1|Overall Study|Lack of Efficacy|2
2654687|NCT00697593|9167022|P1|Overall Study|Suspension of the study by sponsor|12
2654688|NCT00697593|9167022|P1|Overall Study|Lack of Efficacy|3
2654689|NCT00697593|9167022|P1|Overall Study|Protocol Violation|1
2654690|NCT00697593|9167022|P1|Overall Study|Adverse Event|3
2654691|NCT00697515|9167066|P2|Second Intervention (Crossover Period)|Withdrawal by Subject|1
2654692|NCT00697515|9167067|P1|Second Intervention (Crossover Period)|Withdrawal by Subject|1
2654693|NCT00697515|9167066|P2|First Intervention (Crossover Period)|Withdrawal by Subject|1
2654694|NCT00697515|9167067|P1|First Intervention (Crossover Period)|Withdrawal by Subject|2
2654695|NCT00697515|9167066|P2|First Intervention (Crossover Period)|Adverse Event|2
2654696|NCT00697515|9167067|P1|First Intervention (Crossover Period)|Adverse Event|0
2654697|NCT00697515|9167066|P2|First Intervention (Crossover Period)|Natural disaster|9
2654698|NCT00697515|9167067|P1|First Intervention (Crossover Period)|Natural disaster|8
2654699|NCT00697515|9167066|P2|Dose Optimization Period|elevated QTc|0
2654700|NCT00697515|9167067|P1|Dose Optimization Period|elevated QTc|1
2654701|NCT00697515|9167066|P2|Dose Optimization Period|called to active duty|0
2654702|NCT00697515|9167067|P1|Dose Optimization Period|called to active duty|1
2654703|NCT00697515|9167066|P2|Dose Optimization Period|sponsor request|0
2654704|NCT00697515|9167067|P1|Dose Optimization Period|sponsor request|2
2654705|NCT00697515|9167066|P2|Dose Optimization Period|Lost to Follow-up|0
2654706|NCT00697515|9167067|P1|Dose Optimization Period|Lost to Follow-up|2
2654707|NCT00697515|9167066|P2|Dose Optimization Period|Withdrawal by Subject|0
2654708|NCT00697515|9167067|P1|Dose Optimization Period|Withdrawal by Subject|5
2654709|NCT00697515|9167066|P2|Dose Optimization Period|Adverse Event|0
2654710|NCT00697515|9167067|P1|Dose Optimization Period|Adverse Event|4
2654711|NCT00697463|9167095|P1|Overall Study|Withdrawal by Subject|1
2654712|NCT00697346|9167102|P3|Overall Study|Reason not Specified|1
2654713|NCT00697346|9167103|P2|Overall Study|Reason not Specified|0
2654714|NCT00697346|9167104|P1|Overall Study|Reason not Specified|3
2654715|NCT00697346|9167102|P3|Overall Study|Withdrawal by Subject|0
2654716|NCT00697346|9167103|P2|Overall Study|Withdrawal by Subject|2
2654717|NCT00697346|9167104|P1|Overall Study|Withdrawal by Subject|2
2654718|NCT00697346|9167102|P3|Overall Study|Symptomatic Deterioration|0
2654719|NCT00697346|9167103|P2|Overall Study|Symptomatic Deterioration|1
2654720|NCT00697346|9167104|P1|Overall Study|Symptomatic Deterioration|0
2654721|NCT00697346|9167102|P3|Overall Study|Progressive Disease|0
2654722|NCT00697346|9167103|P2|Overall Study|Progressive Disease|18
2654723|NCT00697346|9167104|P1|Overall Study|Progressive Disease|19
2654724|NCT00697346|9167102|P3|Overall Study|Adverse Event|0
2654725|NCT00697346|9167103|P2|Overall Study|Adverse Event|5
2654726|NCT00697346|9167104|P1|Overall Study|Adverse Event|4
2654727|NCT00697255|9167212|P2|Stage 1b|Insufficient ovarian response|1
2654728|NCT00697255|9167213|P1|Stage 1b|Insufficient ovarian response|0
2654729|NCT00697255|9167212|P2|Stage 1b|Not growing of dominant follicle|1
2654730|NCT00697255|9167213|P1|Stage 1b|Not growing of dominant follicle|0
2654731|NCT00697255|9167212|P2|Stage 1a|Not growing of dominant follicle|0
2654732|NCT00697255|9167213|P1|Stage 1a|Not growing of dominant follicle|1
2654733|NCT00697255|9167212|P2|Stage 1a|Multifollicular growth|0
2654734|NCT00697255|9167213|P1|Stage 1a|Multifollicular growth|1
2654735|NCT00697255|9167212|P2|Stage 1a|Insufficient ovarian response|0
2654736|NCT00697255|9167213|P1|Stage 1a|Insufficient ovarian response|1
2654737|NCT00697112|9167301|P1|Overall Study|Did not meet inclusion criteria|1
2654738|NCT00697112|9167301|P1|Overall Study|Lost to Follow-up|1
2654739|NCT00697112|9167301|P1|Overall Study|Adverse Event|8
2654740|NCT00697073|9167325|P1|Overall Study|non compliance and other|6
2654741|NCT00697073|9167325|P1|Overall Study|Pregnancy|1
2654742|NCT00697073|9167325|P1|Overall Study|Withdrawal by Subject|2
2654743|NCT00696878|9167329|P1|Overall Study|Other reason (not specified)|55
2654744|NCT00696878|9167329|P1|Overall Study|Trial stopped|32
2654745|NCT00696878|9167329|P1|Overall Study|Pregnant prior to Treat Cycle 3|304
2654746|NCT00696878|9167329|P1|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18
2654747|NCT00696878|9167329|P1|Overall Study|Withdrawal by Subject|87
2654748|NCT00696878|9167329|P1|Overall Study|Adverse Event|8
2654749|NCT00696800|9167403|P2|Overall Study|Not treated|2
2654750|NCT00696800|9167404|P1|Overall Study|Not treated|1
2654751|NCT00696800|9167403|P2|Overall Study|Other Reasons|3
2654752|NCT00696800|9167404|P1|Overall Study|Other Reasons|5
2654753|NCT00696800|9167403|P2|Overall Study|No/too few/bad quality embryos|18
2654754|NCT00696800|9167404|P1|Overall Study|No/too few/bad quality embryos|24
2654755|NCT00696800|9167403|P2|Overall Study|No/abnormal fertilization|13
2654756|NCT00696800|9167404|P1|Overall Study|No/abnormal fertilization|11
2654757|NCT00696800|9167403|P2|Overall Study|No/too few/bad quality oocytes|3
2654758|NCT00696800|9167404|P1|Overall Study|No/too few/bad quality oocytes|4
2654759|NCT00696800|9167403|P2|Overall Study|Too high ovarian response|1
2654760|NCT00696800|9167404|P1|Overall Study|Too high ovarian response|6
2654761|NCT00696800|9167403|P2|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2
2654762|NCT00696800|9167404|P1|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8
2654763|NCT00696800|9167403|P2|Overall Study|Insufficient ovarian response|1
2654764|NCT00696800|9167404|P1|Overall Study|Insufficient ovarian response|4
2654765|NCT00696800|9167403|P2|Overall Study|Insufficient ovarian response on Day 8|1
2654766|NCT00696800|9167404|P1|Overall Study|Insufficient ovarian response on Day 8|4
2654767|NCT00696800|9167403|P2|Overall Study|Insufficient compliance with medication|1
2654768|NCT00696800|9167404|P1|Overall Study|Insufficient compliance with medication|2
2654769|NCT00696800|9167403|P2|Overall Study|Adverse Event|3
2654770|NCT00696800|9167404|P1|Overall Study|Adverse Event|16
2654771|NCT00696787|9167457|P3|Overall Study|Failed to return|1
2654772|NCT00696787|9167458|P2|Overall Study|Failed to return|3
2654773|NCT00696787|9167459|P1|Overall Study|Failed to return|1
2654774|NCT00696787|9167457|P3|Overall Study|Withdrawal by Subject|2
2654775|NCT00696787|9167458|P2|Overall Study|Withdrawal by Subject|3
2654776|NCT00696787|9167459|P1|Overall Study|Withdrawal by Subject|0
2654777|NCT00696787|9167457|P3|Overall Study|Lost to Follow-up|3
2654778|NCT00696787|9167458|P2|Overall Study|Lost to Follow-up|0
2654779|NCT00696787|9167459|P1|Overall Study|Lost to Follow-up|4
2654780|NCT00696787|9167457|P3|Overall Study|Lack of Efficacy|0
2654781|NCT00696787|9167458|P2|Overall Study|Lack of Efficacy|1
2654782|NCT00696787|9167459|P1|Overall Study|Lack of Efficacy|0
2654783|NCT00696787|9167457|P3|Overall Study|Discontinuation by Sponsor|14
2654784|NCT00696787|9167458|P2|Overall Study|Discontinuation by Sponsor|13
2654785|NCT00696787|9167459|P1|Overall Study|Discontinuation by Sponsor|9
2654786|NCT00696787|9167457|P3|Overall Study|Adverse Event|6
2654787|NCT00696787|9167458|P2|Overall Study|Adverse Event|0
2654788|NCT00696787|9167459|P1|Overall Study|Adverse Event|1
2654789|NCT00696774|9167473|P3|Period III|Lack of Efficacy|0
2654790|NCT00696774|9167474|P2|Period III|Lack of Efficacy|2
2654791|NCT00696774|9167475|P1|Period III|Lack of Efficacy|0
2654792|NCT00696774|9167473|P3|Period III|Sponsor Decision|0
2654793|NCT00696774|9167474|P2|Period III|Sponsor Decision|0
2654794|NCT00696774|9167475|P1|Period III|Sponsor Decision|2
2654795|NCT00696774|9167473|P3|Period III|Withdrawal by Subject|0
2654796|NCT00696774|9167474|P2|Period III|Withdrawal by Subject|2
2654797|NCT00696774|9167475|P1|Period III|Withdrawal by Subject|1
2654798|NCT00696774|9167473|P3|Period III|Protocol Violation|0
2654799|NCT00696774|9167474|P2|Period III|Protocol Violation|1
2654800|NCT00696774|9167475|P1|Period III|Protocol Violation|1
2654801|NCT00696774|9167473|P3|Period III|Lost to Follow-up|0
2654802|NCT00696774|9167474|P2|Period III|Lost to Follow-up|1
2654803|NCT00696774|9167475|P1|Period III|Lost to Follow-up|2
2654804|NCT00696774|9167473|P3|Period III|Adverse Event|0
2654805|NCT00696774|9167474|P2|Period III|Adverse Event|1
2654806|NCT00696774|9167475|P1|Period III|Adverse Event|1
2654807|NCT00696774|9167473|P3|Period II|Lack of Efficacy|2
2654808|NCT00696774|9167474|P2|Period II|Lack of Efficacy|0
2654809|NCT00696774|9167475|P1|Period II|Lack of Efficacy|0
2654810|NCT00696774|9167473|P3|Period II|Sponsor Decision|0
2654811|NCT00696774|9167474|P2|Period II|Sponsor Decision|0
2654812|NCT00696774|9167475|P1|Period II|Sponsor Decision|0
2654813|NCT00696774|9167473|P3|Period II|Withdrawal by Subject|4
2654814|NCT00696774|9167474|P2|Period II|Withdrawal by Subject|0
2654815|NCT00696774|9167475|P1|Period II|Withdrawal by Subject|0
2654816|NCT00696774|9167473|P3|Period II|Protocol Violation|11
2654817|NCT00696774|9167474|P2|Period II|Protocol Violation|0
2654818|NCT00696774|9167475|P1|Period II|Protocol Violation|0
2654819|NCT00696774|9167473|P3|Period II|Lost to Follow-up|4
2654820|NCT00696774|9167474|P2|Period II|Lost to Follow-up|0
2654821|NCT00696774|9167475|P1|Period II|Lost to Follow-up|0
2654822|NCT00696774|9167473|P3|Period II|Adverse Event|15
2654823|NCT00696774|9167474|P2|Period II|Adverse Event|0
2654824|NCT00696774|9167475|P1|Period II|Adverse Event|0
2654825|NCT00696709|9167535|P5|Overall Study|Adverse Event|0
2654826|NCT00696709|9167536|P4|Overall Study|Adverse Event|1
2654827|NCT00696709|9167537|P3|Overall Study|Adverse Event|0
2654828|NCT00696709|9167538|P2|Overall Study|Adverse Event|0
2654829|NCT00696709|9167539|P1|Overall Study|Adverse Event|0
2654830|NCT00696709|9167535|P5|Overall Study|Lost to Follow-up|0
2654831|NCT00696709|9167536|P4|Overall Study|Lost to Follow-up|0
2654832|NCT00696709|9167537|P3|Overall Study|Lost to Follow-up|0
2654833|NCT00696709|9167538|P2|Overall Study|Lost to Follow-up|1
2654834|NCT00696709|9167539|P1|Overall Study|Lost to Follow-up|1
2654835|NCT00696709|9167535|P5|Overall Study|Protocol Violation|0
2654836|NCT00696709|9167536|P4|Overall Study|Protocol Violation|0
2654837|NCT00696709|9167537|P3|Overall Study|Protocol Violation|0
2654838|NCT00696709|9167538|P2|Overall Study|Protocol Violation|0
2654839|NCT00696709|9167539|P1|Overall Study|Protocol Violation|1
2654840|NCT00696709|9167535|P5|Overall Study|Withdrawal by Subject|3
2654841|NCT00696709|9167536|P4|Overall Study|Withdrawal by Subject|4
2654842|NCT00696709|9167537|P3|Overall Study|Withdrawal by Subject|1
2654843|NCT00696709|9167538|P2|Overall Study|Withdrawal by Subject|2
2654844|NCT00696709|9167539|P1|Overall Study|Withdrawal by Subject|1
2654845|NCT00696696|9167575|P1|Overall Study|Death|3
2654846|NCT00696696|9167575|P1|Overall Study|Physician Decision|2
2654847|NCT00696696|9167575|P1|Overall Study|Withdrawal by Subject|8
2654848|NCT00696696|9167575|P1|Overall Study|Adverse Event|5
2654849|NCT00696657|9167590|P9|Overall Study|Adverse Event|5
2654850|NCT00696657|9167591|P8|Overall Study|Adverse Event|2
2654851|NCT00696657|9167592|P7|Overall Study|Adverse Event|14
2654852|NCT00696657|9167593|P6|Overall Study|Adverse Event|9
2654853|NCT00696657|9167594|P5|Overall Study|Adverse Event|6
2654854|NCT00696657|9167595|P4|Overall Study|Adverse Event|7
2654855|NCT00696657|9167596|P3|Overall Study|Adverse Event|3
2654856|NCT00696657|9167597|P2|Overall Study|Adverse Event|0
2654857|NCT00696657|9167598|P1|Overall Study|Adverse Event|0
2654858|NCT00696657|9167590|P9|Overall Study|Unclassified|1
2654859|NCT00696657|9167591|P8|Overall Study|Unclassified|0
2654860|NCT00696657|9167592|P7|Overall Study|Unclassified|0
2654861|NCT00696657|9167593|P6|Overall Study|Unclassified|2
2654862|NCT00696657|9167594|P5|Overall Study|Unclassified|4
2654863|NCT00696657|9167595|P4|Overall Study|Unclassified|2
2654864|NCT00696657|9167596|P3|Overall Study|Unclassified|3
2654865|NCT00696657|9167597|P2|Overall Study|Unclassified|1
2654866|NCT00696657|9167598|P1|Overall Study|Unclassified|0
2654867|NCT00696657|9167590|P9|Overall Study|Withdrawal criteria|2
2654868|NCT00696657|9167591|P8|Overall Study|Withdrawal criteria|1
2654869|NCT00696657|9167592|P7|Overall Study|Withdrawal criteria|1
2654870|NCT00696657|9167593|P6|Overall Study|Withdrawal criteria|0
2654871|NCT00696657|9167594|P5|Overall Study|Withdrawal criteria|0
2654872|NCT00696657|9167595|P4|Overall Study|Withdrawal criteria|2
2654873|NCT00696657|9167596|P3|Overall Study|Withdrawal criteria|2
2654874|NCT00696657|9167597|P2|Overall Study|Withdrawal criteria|3
2654875|NCT00696657|9167598|P1|Overall Study|Withdrawal criteria|1
2654876|NCT00696657|9167590|P9|Overall Study|Lack of Efficacy|0
2654877|NCT00696657|9167591|P8|Overall Study|Lack of Efficacy|0
2654878|NCT00696657|9167592|P7|Overall Study|Lack of Efficacy|0
2654879|NCT00696657|9167593|P6|Overall Study|Lack of Efficacy|0
2654880|NCT00696657|9167594|P5|Overall Study|Lack of Efficacy|0
2654881|NCT00696657|9167595|P4|Overall Study|Lack of Efficacy|0
2654882|NCT00696657|9167596|P3|Overall Study|Lack of Efficacy|0
2654883|NCT00696657|9167597|P2|Overall Study|Lack of Efficacy|1
2654884|NCT00696657|9167598|P1|Overall Study|Lack of Efficacy|0
2654885|NCT00696657|9167590|P9|Overall Study|Protocol Violation|1
2654886|NCT00696657|9167591|P8|Overall Study|Protocol Violation|0
2654887|NCT00696657|9167592|P7|Overall Study|Protocol Violation|0
2654888|NCT00696657|9167593|P6|Overall Study|Protocol Violation|1
2654889|NCT00696657|9167594|P5|Overall Study|Protocol Violation|0
2654890|NCT00696657|9167595|P4|Overall Study|Protocol Violation|0
2654891|NCT00696657|9167596|P3|Overall Study|Protocol Violation|0
2654892|NCT00696657|9167597|P2|Overall Study|Protocol Violation|0
2654893|NCT00696657|9167598|P1|Overall Study|Protocol Violation|0
2654894|NCT00696436|9167967|P5|Overall Study|Missing|0
2654895|NCT00696436|9167968|P4|Overall Study|Missing|0
2654896|NCT00696436|9167969|P3|Overall Study|Missing|1
2654897|NCT00696436|9167970|P2|Overall Study|Missing|1
2654898|NCT00696436|9167971|P1|Overall Study|Missing|0
2654899|NCT00696436|9167967|P5|Overall Study|Administrative Decision|0
2654900|NCT00696436|9167968|P4|Overall Study|Administrative Decision|0
2654901|NCT00696436|9167969|P3|Overall Study|Administrative Decision|0
2654902|NCT00696436|9167970|P2|Overall Study|Administrative Decision|0
2654903|NCT00696436|9167971|P1|Overall Study|Administrative Decision|1
2654904|NCT00696436|9167967|P5|Overall Study|Participant Non-compliance|0
2654905|NCT00696436|9167968|P4|Overall Study|Participant Non-compliance|2
2654906|NCT00696436|9167969|P3|Overall Study|Participant Non-compliance|1
2654907|NCT00696436|9167970|P2|Overall Study|Participant Non-compliance|0
2654908|NCT00696436|9167971|P1|Overall Study|Participant Non-compliance|0
2654909|NCT00696436|9167967|P5|Overall Study|Administrative Error|0
2654910|NCT00696436|9167968|P4|Overall Study|Administrative Error|0
2654911|NCT00696436|9167969|P3|Overall Study|Administrative Error|2
2654912|NCT00696436|9167970|P2|Overall Study|Administrative Error|0
2654913|NCT00696436|9167971|P1|Overall Study|Administrative Error|2
2654914|NCT00696436|9167967|P5|Overall Study|Participant Unavailability|0
2654915|NCT00696436|9167968|P4|Overall Study|Participant Unavailability|1
2654916|NCT00696436|9167969|P3|Overall Study|Participant Unavailability|2
2654917|NCT00696436|9167970|P2|Overall Study|Participant Unavailability|0
2654918|NCT00696436|9167971|P1|Overall Study|Participant Unavailability|2
2654919|NCT00696436|9167967|P5|Overall Study|Lack of Efficacy|4
2654920|NCT00696436|9167968|P4|Overall Study|Lack of Efficacy|2
2654921|NCT00696436|9167969|P3|Overall Study|Lack of Efficacy|5
2654922|NCT00696436|9167970|P2|Overall Study|Lack of Efficacy|1
2654923|NCT00696436|9167971|P1|Overall Study|Lack of Efficacy|3
2654924|NCT00696436|9167967|P5|Overall Study|Withdrawal by Subject|1
2654925|NCT00696436|9167968|P4|Overall Study|Withdrawal by Subject|7
2654926|NCT00696436|9167969|P3|Overall Study|Withdrawal by Subject|5
2654927|NCT00696436|9167970|P2|Overall Study|Withdrawal by Subject|11
2654928|NCT00696436|9167971|P1|Overall Study|Withdrawal by Subject|4
2654929|NCT00696436|9167967|P5|Overall Study|Lost to Follow-up|3
2654930|NCT00696436|9167968|P4|Overall Study|Lost to Follow-up|4
2654931|NCT00696436|9167969|P3|Overall Study|Lost to Follow-up|2
2654932|NCT00696436|9167970|P2|Overall Study|Lost to Follow-up|6
2654933|NCT00696436|9167971|P1|Overall Study|Lost to Follow-up|1
2654934|NCT00696436|9167967|P5|Overall Study|Protocol Violation|1
2654935|NCT00696436|9167968|P4|Overall Study|Protocol Violation|0
2654936|NCT00696436|9167969|P3|Overall Study|Protocol Violation|2
2654937|NCT00696436|9167970|P2|Overall Study|Protocol Violation|2
2654938|NCT00696436|9167971|P1|Overall Study|Protocol Violation|3
2654939|NCT00696436|9167967|P5|Overall Study|Adverse Event|4
2654940|NCT00696436|9167968|P4|Overall Study|Adverse Event|6
2654941|NCT00696436|9167969|P3|Overall Study|Adverse Event|8
2654942|NCT00696436|9167970|P2|Overall Study|Adverse Event|9
2654943|NCT00696436|9167971|P1|Overall Study|Adverse Event|7
2654944|NCT00696423|9168055|P2|Overall Study|Lost to Follow-up|5
2654945|NCT00696423|9168056|P1|Overall Study|Lost to Follow-up|0
2654946|NCT00696410|9168088|P2|Overall Study|Physician Decision|0
2654947|NCT00696410|9168089|P1|Overall Study|Physician Decision|3
2654948|NCT00696410|9168088|P2|Overall Study|Withdrawal by Subject|0
2654949|NCT00696410|9168089|P1|Overall Study|Withdrawal by Subject|8
2654950|NCT00696410|9168088|P2|Overall Study|Lost to Follow-up|0
2654951|NCT00696410|9168089|P1|Overall Study|Lost to Follow-up|2
2654952|NCT00696384|9168103|P3|Double Blind Phase|Physician Decision|0
2654953|NCT00696384|9168104|P2|Double Blind Phase|Physician Decision|2
2654954|NCT00696384|9168105|P1|Double Blind Phase|Physician Decision|0
2654955|NCT00696384|9168103|P3|Double Blind Phase|Lack of Efficacy|0
2654956|NCT00696384|9168104|P2|Double Blind Phase|Lack of Efficacy|1
2654957|NCT00696384|9168105|P1|Double Blind Phase|Lack of Efficacy|0
2654958|NCT00696384|9168103|P3|Double Blind Phase|Withdrawal by Subject|3
2654959|NCT00696384|9168104|P2|Double Blind Phase|Withdrawal by Subject|4
2654960|NCT00696384|9168105|P1|Double Blind Phase|Withdrawal by Subject|0
2654961|NCT00696384|9168103|P3|Double Blind Phase|Lost to Follow-up|1
2654962|NCT00696384|9168104|P2|Double Blind Phase|Lost to Follow-up|2
2654963|NCT00696384|9168105|P1|Double Blind Phase|Lost to Follow-up|0
2654964|NCT00696384|9168103|P3|Double Blind Phase|Adverse Event|2
2654965|NCT00696384|9168104|P2|Double Blind Phase|Adverse Event|2
2654966|NCT00696384|9168105|P1|Double Blind Phase|Adverse Event|0
2654967|NCT00696384|9168103|P3|Open Label Phase|Physician Decision|0
2654968|NCT00696384|9168104|P2|Open Label Phase|Physician Decision|0
2654969|NCT00696384|9168105|P1|Open Label Phase|Physician Decision|4
2654970|NCT00696384|9168103|P3|Open Label Phase|Lack of Efficacy|0
2654971|NCT00696384|9168104|P2|Open Label Phase|Lack of Efficacy|0
2654972|NCT00696384|9168105|P1|Open Label Phase|Lack of Efficacy|3
2654973|NCT00696384|9168103|P3|Open Label Phase|Other|0
2654974|NCT00696384|9168104|P2|Open Label Phase|Other|0
2654975|NCT00696384|9168105|P1|Open Label Phase|Other|6
2654976|NCT00696384|9168103|P3|Open Label Phase|Withdrawal by Subject|0
2654977|NCT00696384|9168104|P2|Open Label Phase|Withdrawal by Subject|0
2654978|NCT00696384|9168105|P1|Open Label Phase|Withdrawal by Subject|37
2654979|NCT00696384|9168103|P3|Open Label Phase|Lost to Follow-up|0
2654980|NCT00696384|9168104|P2|Open Label Phase|Lost to Follow-up|0
2654981|NCT00696384|9168105|P1|Open Label Phase|Lost to Follow-up|24
2654982|NCT00696384|9168103|P3|Open Label Phase|Protocol Violation|0
2654983|NCT00696384|9168104|P2|Open Label Phase|Protocol Violation|0
2654984|NCT00696384|9168105|P1|Open Label Phase|Protocol Violation|18
2654985|NCT00696384|9168103|P3|Open Label Phase|Adverse Event|0
2654986|NCT00696384|9168104|P2|Open Label Phase|Adverse Event|0
2654987|NCT00696384|9168105|P1|Open Label Phase|Adverse Event|27
2654988|NCT00696241|9168129|P5|Overall Study|Other|1
2654989|NCT00696241|9168130|P4|Overall Study|Other|2
2654990|NCT00696241|9168131|P3|Overall Study|Other|5
2654991|NCT00696241|9168132|P2|Overall Study|Other|1
2654992|NCT00696241|9168133|P1|Overall Study|Other|6
2654993|NCT00696241|9168129|P5|Overall Study|Lack of Efficacy|3
2654994|NCT00696241|9168130|P4|Overall Study|Lack of Efficacy|5
2654995|NCT00696241|9168131|P3|Overall Study|Lack of Efficacy|4
2654996|NCT00696241|9168132|P2|Overall Study|Lack of Efficacy|5
2654997|NCT00696241|9168133|P1|Overall Study|Lack of Efficacy|1
2654998|NCT00696241|9168129|P5|Overall Study|Withdrawal by Subject|0
2654999|NCT00696241|9168130|P4|Overall Study|Withdrawal by Subject|1
2655000|NCT00696241|9168131|P3|Overall Study|Withdrawal by Subject|6
2655001|NCT00696241|9168132|P2|Overall Study|Withdrawal by Subject|8
2655002|NCT00696241|9168133|P1|Overall Study|Withdrawal by Subject|4
2655003|NCT00696241|9168129|P5|Overall Study|Lost to Follow-up|0
2655004|NCT00696241|9168130|P4|Overall Study|Lost to Follow-up|2
2655005|NCT00696241|9168131|P3|Overall Study|Lost to Follow-up|1
2655006|NCT00696241|9168132|P2|Overall Study|Lost to Follow-up|4
2655007|NCT00696241|9168133|P1|Overall Study|Lost to Follow-up|1
2655008|NCT00696241|9168129|P5|Overall Study|Protocol Violation|3
2655009|NCT00696241|9168130|P4|Overall Study|Protocol Violation|0
2655010|NCT00696241|9168131|P3|Overall Study|Protocol Violation|2
2655011|NCT00696241|9168132|P2|Overall Study|Protocol Violation|1
2655012|NCT00696241|9168133|P1|Overall Study|Protocol Violation|1
2655013|NCT00696241|9168129|P5|Overall Study|Adverse Event|5
2655014|NCT00696241|9168130|P4|Overall Study|Adverse Event|4
2655015|NCT00696241|9168131|P3|Overall Study|Adverse Event|6
2655016|NCT00696241|9168132|P2|Overall Study|Adverse Event|3
2655017|NCT00696241|9168133|P1|Overall Study|Adverse Event|11
2655018|NCT00696137|9168215|P1|Overall Study|Withdrawal by Subject|2
2655019|NCT00696072|9168221|P2|Overall Study|Non-specified|2
2655020|NCT00696072|9168222|P1|Overall Study|Non-specified|1
2655021|NCT00696072|9168221|P2|Overall Study|Disease Progression|30
2655022|NCT00696072|9168222|P1|Overall Study|Disease Progression|32
2655023|NCT00696072|9168221|P2|Overall Study|Sponsor Request|1
2655024|NCT00696072|9168222|P1|Overall Study|Sponsor Request|0
2655025|NCT00696072|9168221|P2|Overall Study|Investigator Request|4
2655026|NCT00696072|9168222|P1|Overall Study|Investigator Request|1
2655027|NCT00696072|9168221|P2|Overall Study|Patient Request|7
2655028|NCT00696072|9168222|P1|Overall Study|Patient Request|3
2655029|NCT00696072|9168221|P2|Overall Study|Adverse Event|6
2655030|NCT00696072|9168222|P1|Overall Study|Adverse Event|10
2655031|NCT00696072|9168221|P2|Overall Study|continuing active treatment|13
2655032|NCT00696072|9168222|P1|Overall Study|continuing active treatment|10
2655033|NCT00696020|9168243|P4|Overall Study|Other not stated above|1
2655034|NCT00696020|9168244|P3|Overall Study|Other not stated above|1
2655035|NCT00696020|9168245|P2|Overall Study|Other not stated above|0
2655036|NCT00696020|9168246|P1|Overall Study|Other not stated above|0
2655037|NCT00696020|9168243|P4|Overall Study|Withdrawal by Subject|1
2655038|NCT00696020|9168244|P3|Overall Study|Withdrawal by Subject|0
2655039|NCT00696020|9168245|P2|Overall Study|Withdrawal by Subject|1
2655040|NCT00696020|9168246|P1|Overall Study|Withdrawal by Subject|0
2655041|NCT00696020|9168243|P4|Overall Study|Protocol Violation|1
2655042|NCT00696020|9168244|P3|Overall Study|Protocol Violation|0
2655043|NCT00696020|9168245|P2|Overall Study|Protocol Violation|0
2655044|NCT00696020|9168246|P1|Overall Study|Protocol Violation|0
2655045|NCT00696020|9168243|P4|Overall Study|Lack of Efficacy|0
2655046|NCT00696020|9168244|P3|Overall Study|Lack of Efficacy|0
2655047|NCT00696020|9168245|P2|Overall Study|Lack of Efficacy|0
2655048|NCT00696020|9168246|P1|Overall Study|Lack of Efficacy|1
2655049|NCT00696020|9168243|P4|Overall Study|Adverse Event|1
2655050|NCT00696020|9168244|P3|Overall Study|Adverse Event|2
2655051|NCT00696020|9168245|P2|Overall Study|Adverse Event|1
2655052|NCT00696020|9168246|P1|Overall Study|Adverse Event|3
2655053|NCT00695955|9168354|P1|Cohort 2|Other|5
2655054|NCT00695955|9168354|P1|Cohort 2|Lack of Efficacy|4
2655055|NCT00695955|9168354|P1|Cohort 2|Withdrawal by Subject|28
2655056|NCT00695955|9168354|P1|Cohort 2|Lost to Follow-up|38
2655057|NCT00695955|9168354|P1|Cohort 2|Protocol Violation|5
2655058|NCT00695955|9168354|P1|Cohort 2|Adverse Event|24
2655059|NCT00695955|9168354|P1|Cohort 1|Other|16
2655060|NCT00695955|9168354|P1|Cohort 1|Lack of Efficacy|3
2655061|NCT00695955|9168354|P1|Cohort 1|Withdrawal by Subject|25
2655062|NCT00695955|9168354|P1|Cohort 1|Lost to Follow-up|30
2655063|NCT00695955|9168354|P1|Cohort 1|Protocol Violation|2
2655064|NCT00695955|9168354|P1|Cohort 1|Adverse Event|26
2655065|NCT00695903|9168366|P2|Had Test of Cure (TOC) Assessment|Adverse Event|1
2655066|NCT00695903|9168367|P1|Had Test of Cure (TOC) Assessment|Adverse Event|0
2655067|NCT00695903|9168366|P2|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0
2655068|NCT00695903|9168367|P1|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1
2655069|NCT00695903|9168366|P2|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0
2655070|NCT00695903|9168367|P1|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1
2655071|NCT00695903|9168366|P2|Had End of Therapy (EOT) Assessment|Protocol Violation|2
2655072|NCT00695903|9168367|P1|Had End of Therapy (EOT) Assessment|Protocol Violation|1
2655073|NCT00695903|9168366|P2|Had End of Therapy (EOT) Assessment|Physician Decision|1
2655074|NCT00695903|9168367|P1|Had End of Therapy (EOT) Assessment|Physician Decision|0
2655075|NCT00695903|9168366|P2|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
2655076|NCT00695903|9168367|P1|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
2655077|NCT00695903|9168366|P2|Had End of Therapy (EOT) Assessment|Adverse Event|0
2655078|NCT00695903|9168367|P1|Had End of Therapy (EOT) Assessment|Adverse Event|1
2655079|NCT00695903|9168366|P2|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
2655080|NCT00695903|9168367|P1|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
2655081|NCT00695903|9168366|P2|Had End of Therapy (EOT) Assessment|Randomized not treated|2
2655082|NCT00695903|9168367|P1|Had End of Therapy (EOT) Assessment|Randomized not treated|0
2655083|NCT00695864|9168379|P1|Placebo|Physician Decision|4
2655084|NCT00695864|9168379|P1|Placebo|Withdrawal by Subject|1
2655085|NCT00695669|9168389|P4|Overall Study|Lost to Follow-up|4
2655086|NCT00695669|9168390|P3|Overall Study|Lost to Follow-up|1
2655087|NCT00695669|9168391|P2|Overall Study|Lost to Follow-up|4
2655088|NCT00695669|9168392|P1|Overall Study|Lost to Follow-up|4
2655089|NCT00695669|9168389|P4|Overall Study|Adverse Event|0
2655090|NCT00695669|9168390|P3|Overall Study|Adverse Event|2
2655091|NCT00695669|9168391|P2|Overall Study|Adverse Event|0
2655092|NCT00695669|9168392|P1|Overall Study|Adverse Event|0
2655093|NCT00695565|9168477|P2|Overall Study|Subject did not follow instructions|1
2655094|NCT00695565|9168478|P1|Overall Study|Subject did not follow instructions|1
2655095|NCT00695565|9168477|P2|Overall Study|Lack of Efficacy|1
2655096|NCT00695565|9168478|P1|Overall Study|Lack of Efficacy|1
2655097|NCT00695565|9168477|P2|Overall Study|Withdrawal by Subject|1
2655098|NCT00695565|9168478|P1|Overall Study|Withdrawal by Subject|1
2655099|NCT00695565|9168477|P2|Overall Study|Protocol Violation|1
2655100|NCT00695565|9168478|P1|Overall Study|Protocol Violation|3
2655101|NCT00695565|9168477|P2|Overall Study|Adverse Event|1
2655102|NCT00695565|9168478|P1|Overall Study|Adverse Event|3
2655103|NCT00695565|9168477|P2|Overall Study|Lost to Follow-up|4
2655104|NCT00695565|9168478|P1|Overall Study|Lost to Follow-up|4
2655105|NCT00695396|9168551|P3|Overall Study|Withdrawal by Subject|0
2655106|NCT00695396|9168552|P2|Overall Study|Withdrawal by Subject|2
2655107|NCT00695396|9168553|P1|Overall Study|Withdrawal by Subject|2
2655108|NCT00695396|9168551|P3|Overall Study|Study Closed Prematurely|8
2655109|NCT00695396|9168552|P2|Overall Study|Study Closed Prematurely|6
2655110|NCT00695396|9168553|P1|Overall Study|Study Closed Prematurely|5
2655111|NCT00695318|9168569|P2|Overall Study|Study Terminated|0
2655112|NCT00695318|9168570|P1|Overall Study|Study Terminated|1
2655113|NCT00695318|9168569|P2|Overall Study|Death|1
2655114|NCT00695318|9168570|P1|Overall Study|Death|1
2655115|NCT00695318|9168569|P2|Overall Study|Withdrawal by Subject|0
2655116|NCT00695318|9168570|P1|Overall Study|Withdrawal by Subject|2
2655117|NCT00695318|9168569|P2|Overall Study|Lost to Follow-up|0
2655118|NCT00695318|9168570|P1|Overall Study|Lost to Follow-up|1
2655119|NCT00695136|9168595|P1|Overall Study|unrelated adverse event|1
2655120|NCT00695136|9168595|P1|Overall Study|Withdrawal by Subject|1
2655121|NCT00695019|9168611|P3|Overall Study|Various|4
2655122|NCT00695019|9168612|P2|Overall Study|Various|5
2655123|NCT00695019|9168613|P1|Overall Study|Various|4
2655124|NCT00695019|9168611|P3|Overall Study|Lack of Efficacy|1
2655125|NCT00695019|9168612|P2|Overall Study|Lack of Efficacy|0
2655126|NCT00695019|9168613|P1|Overall Study|Lack of Efficacy|0
2655127|NCT00695019|9168611|P3|Overall Study|Protocol Violation|1
2655128|NCT00695019|9168612|P2|Overall Study|Protocol Violation|3
2655129|NCT00695019|9168613|P1|Overall Study|Protocol Violation|1
2655130|NCT00695019|9168611|P3|Overall Study|Withdrawal by Subject|4
2655131|NCT00695019|9168612|P2|Overall Study|Withdrawal by Subject|6
2655132|NCT00695019|9168613|P1|Overall Study|Withdrawal by Subject|8
2655133|NCT00694707|9168647|P5|Overall Study|Notification of Past Head Injury|0
2655134|NCT00694707|9168648|P4|Overall Study|Notification of Past Head Injury|1
2655135|NCT00694707|9168649|P3|Overall Study|Notification of Past Head Injury|0
2655136|NCT00694707|9168650|P2|Overall Study|Notification of Past Head Injury|0
2655137|NCT00694707|9168651|P1|Overall Study|Notification of Past Head Injury|0
2655138|NCT00694707|9168647|P5|Overall Study|Administrative Reasons|0
2655139|NCT00694707|9168648|P4|Overall Study|Administrative Reasons|2
2655140|NCT00694707|9168649|P3|Overall Study|Administrative Reasons|0
2655141|NCT00694707|9168650|P2|Overall Study|Administrative Reasons|1
2655142|NCT00694707|9168651|P1|Overall Study|Administrative Reasons|0
2655143|NCT00694707|9168647|P5|Overall Study|Arrest by Police|0
2655144|NCT00694707|9168648|P4|Overall Study|Arrest by Police|0
2655145|NCT00694707|9168649|P3|Overall Study|Arrest by Police|0
2655146|NCT00694707|9168650|P2|Overall Study|Arrest by Police|1
2655147|NCT00694707|9168651|P1|Overall Study|Arrest by Police|0
2655148|NCT00694707|9168647|P5|Overall Study|Death in the Family|0
2655149|NCT00694707|9168648|P4|Overall Study|Death in the Family|0
2655150|NCT00694707|9168649|P3|Overall Study|Death in the Family|0
2655151|NCT00694707|9168650|P2|Overall Study|Death in the Family|0
2655152|NCT00694707|9168651|P1|Overall Study|Death in the Family|1
2655153|NCT00694707|9168647|P5|Overall Study|Jeopardizing Parole Status|0
2655154|NCT00694707|9168648|P4|Overall Study|Jeopardizing Parole Status|0
2655155|NCT00694707|9168649|P3|Overall Study|Jeopardizing Parole Status|0
2655156|NCT00694707|9168650|P2|Overall Study|Jeopardizing Parole Status|0
2655157|NCT00694707|9168651|P1|Overall Study|Jeopardizing Parole Status|1
2655158|NCT00694707|9168647|P5|Overall Study|Lost to Follow-up|0
2655159|NCT00694707|9168648|P4|Overall Study|Lost to Follow-up|0
2655160|NCT00694707|9168649|P3|Overall Study|Lost to Follow-up|2
2655161|NCT00694707|9168650|P2|Overall Study|Lost to Follow-up|1
2655162|NCT00694707|9168651|P1|Overall Study|Lost to Follow-up|0
2655163|NCT00694707|9168647|P5|Overall Study|Withdrawal of Consent|15
2655164|NCT00694707|9168648|P4|Overall Study|Withdrawal of Consent|16
2655165|NCT00694707|9168649|P3|Overall Study|Withdrawal of Consent|22
2655166|NCT00694707|9168650|P2|Overall Study|Withdrawal of Consent|18
2655167|NCT00694707|9168651|P1|Overall Study|Withdrawal of Consent|14
2655168|NCT00694707|9168647|P5|Overall Study|Protocol Violation|1
2655169|NCT00694707|9168648|P4|Overall Study|Protocol Violation|3
2655170|NCT00694707|9168649|P3|Overall Study|Protocol Violation|1
2655171|NCT00694707|9168650|P2|Overall Study|Protocol Violation|2
2655172|NCT00694707|9168651|P1|Overall Study|Protocol Violation|1
2655173|NCT00694707|9168647|P5|Overall Study|Insufficient Therapeutic Response|10
2655174|NCT00694707|9168648|P4|Overall Study|Insufficient Therapeutic Response|15
2655175|NCT00694707|9168649|P3|Overall Study|Insufficient Therapeutic Response|17
2655176|NCT00694707|9168650|P2|Overall Study|Insufficient Therapeutic Response|18
2655177|NCT00694707|9168651|P1|Overall Study|Insufficient Therapeutic Response|33
2655178|NCT00694707|9168647|P5|Overall Study|Adverse Event|13
2655179|NCT00694707|9168648|P4|Overall Study|Adverse Event|12
2655180|NCT00694707|9168649|P3|Overall Study|Adverse Event|8
2655181|NCT00694707|9168650|P2|Overall Study|Adverse Event|14
2655182|NCT00694707|9168651|P1|Overall Study|Adverse Event|22
2655183|NCT00694707|9168647|P5|Overall Study|Did Not Receive Treatment|1
2655184|NCT00694707|9168648|P4|Overall Study|Did Not Receive Treatment|1
2655185|NCT00694707|9168649|P3|Overall Study|Did Not Receive Treatment|1
2655186|NCT00694707|9168650|P2|Overall Study|Did Not Receive Treatment|0
2655187|NCT00694707|9168651|P1|Overall Study|Did Not Receive Treatment|0
2655188|NCT00694551|9168680|P3|Overall Study|Disease Progression|1
2655189|NCT00694551|9168681|P2|Overall Study|Disease Progression|0
2655190|NCT00694551|9168682|P1|Overall Study|Disease Progression|1
2655191|NCT00694369|9168711|P5|Overall Study|Withdrawal by Subject|2
2655192|NCT00694369|9168712|P4|Overall Study|Withdrawal by Subject|1
2655193|NCT00694369|9168713|P3|Overall Study|Withdrawal by Subject|1
2655194|NCT00694369|9168714|P2|Overall Study|Withdrawal by Subject|1
2655195|NCT00694369|9168715|P1|Overall Study|Withdrawal by Subject|1
2655196|NCT00694369|9168711|P5|Overall Study|Protocol Violation|0
2655197|NCT00694369|9168712|P4|Overall Study|Protocol Violation|0
2655198|NCT00694369|9168713|P3|Overall Study|Protocol Violation|0
2655199|NCT00694369|9168714|P2|Overall Study|Protocol Violation|1
2655200|NCT00694369|9168715|P1|Overall Study|Protocol Violation|0
2655201|NCT00694369|9168711|P5|Overall Study|Physician Decision|1
2655202|NCT00694369|9168712|P4|Overall Study|Physician Decision|0
2655203|NCT00694369|9168713|P3|Overall Study|Physician Decision|0
2655204|NCT00694369|9168714|P2|Overall Study|Physician Decision|0
2655205|NCT00694369|9168715|P1|Overall Study|Physician Decision|0
2655206|NCT00694369|9168711|P5|Overall Study|Lost to Follow-up|0
2655207|NCT00694369|9168712|P4|Overall Study|Lost to Follow-up|1
2655208|NCT00694369|9168713|P3|Overall Study|Lost to Follow-up|1
2655209|NCT00694369|9168714|P2|Overall Study|Lost to Follow-up|0
2655210|NCT00694369|9168715|P1|Overall Study|Lost to Follow-up|0
2655211|NCT00694369|9168711|P5|Overall Study|Adverse Event|3
2655212|NCT00694369|9168712|P4|Overall Study|Adverse Event|1
2655213|NCT00694369|9168713|P3|Overall Study|Adverse Event|0
2655214|NCT00694369|9168714|P2|Overall Study|Adverse Event|1
2655215|NCT00694369|9168715|P1|Overall Study|Adverse Event|0
2655216|NCT00694356|9168735|P3|Overall Study|Progressive Disease|6
2655217|NCT00694356|9168736|P2|Overall Study|Progressive Disease|6
2655218|NCT00694356|9168737|P1|Overall Study|Progressive Disease|2
2655219|NCT00694356|9168735|P3|Overall Study|Adverse Event|0
2655220|NCT00694356|9168736|P2|Overall Study|Adverse Event|0
2655221|NCT00694356|9168737|P1|Overall Study|Adverse Event|1
2655222|NCT00694304|9168772|P1|Overall Study|Administrative or Other Reasons|32
2655223|NCT00694304|9168772|P1|Overall Study|Lost to Follow-up|15
2655224|NCT00694304|9168772|P1|Overall Study|Withdrawal of Consent|61
2655225|NCT00694304|9168772|P1|Overall Study|Protocol Violation|6
2655226|NCT00694304|9168772|P1|Overall Study|Non-compliance With Study Product|16
2655227|NCT00694304|9168772|P1|Overall Study|Lack of Efficacy|35
2655228|NCT00694304|9168772|P1|Overall Study|Adverse Event|42
2655229|NCT00694161|9168785|P1|Part 2 (After Week 6 up to Month 12)|Death|1
2655230|NCT00694161|9168785|P1|Part 2 (After Week 6 up to Month 12)|Physician Decision|1
2655231|NCT00694161|9168785|P1|Part 2 (After Week 6 up to Month 12)|Adverse Event|1
2655232|NCT00694122|9168824|P2|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1
2655233|NCT00694122|9168825|P1|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2
2655234|NCT00694122|9168824|P2|First Intervention (3-4 Weeks)|Lost to Follow-up|1
2655235|NCT00694122|9168825|P1|First Intervention (3-4 Weeks)|Lost to Follow-up|1
2655236|NCT00694122|9168824|P2|First Intervention (3-4 Weeks)|Withdrawal by Subject|0
2655237|NCT00694122|9168825|P1|First Intervention (3-4 Weeks)|Withdrawal by Subject|7
2655238|NCT00694109|9168841|P1|Overall Study|Consented but no additional treatment|3
2655239|NCT00694109|9168841|P1|Overall Study|Other|2
2655240|NCT00694109|9168841|P1|Overall Study|Enrolled but not treated|1
2655241|NCT00694109|9168841|P1|Overall Study|Pregnancy|1
2655242|NCT00694109|9168841|P1|Overall Study|Withdrawal by Subject|13
2655243|NCT00694109|9168841|P1|Overall Study|Lack of Efficacy|2
2655244|NCT00694109|9168841|P1|Overall Study|Not consent of more 2 years of treatment|18
2655245|NCT00694109|9168841|P1|Overall Study|Adverse Event|74
2655246|NCT00694109|9168841|P1|Overall Study|Physician Decision|3
2655247|NCT00694096|9168865|P1|Overall Study|Withdrawal by Subject|5
2655248|NCT00693784|9168905|P1|Overall Study|Withdrawal by Subject|2
2655249|NCT00693784|9168905|P1|Overall Study|Lost to Follow-up|2
2655250|NCT00693706|9168918|P2|Overall Study|Protocol Violation|1
2655251|NCT00693706|9168919|P1|Overall Study|Protocol Violation|0
2655252|NCT00693693|9168946|P3|Overall Study|Lost to Follow-up|2
2655253|NCT00693693|9168947|P2|Overall Study|Lost to Follow-up|1
2655254|NCT00693693|9168948|P1|Overall Study|Lost to Follow-up|1
2655255|NCT00693472|9169007|P4|Part 2|Withdrew - reason unrelated to treatment|2
2655256|NCT00693472|9169008|P3|Part 2|Withdrew - reason unrelated to treatment|1
2655257|NCT00693472|9169009|P2|Part 2|Withdrew - reason unrelated to treatment|0
2655258|NCT00693472|9169010|P1|Part 2|Withdrew - reason unrelated to treatment|0
2655259|NCT00693472|9169007|P4|Part 2|Adverse Event|0
2655260|NCT00693472|9169008|P3|Part 2|Adverse Event|1
2655261|NCT00693472|9169009|P2|Part 2|Adverse Event|0
2655262|NCT00693472|9169010|P1|Part 2|Adverse Event|0
2655263|NCT00693472|9169007|P4|Part 1|Withdrew - reason unrelated to treatment|0
2655264|NCT00693472|9169008|P3|Part 1|Withdrew - reason unrelated to treatment|0
2655265|NCT00693472|9169009|P2|Part 1|Withdrew - reason unrelated to treatment|2
2655266|NCT00693472|9169010|P1|Part 1|Withdrew - reason unrelated to treatment|5
2655267|NCT00693472|9169007|P4|Part 1|Lost to Follow-up|0
2655268|NCT00693472|9169008|P3|Part 1|Lost to Follow-up|0
2655269|NCT00693472|9169009|P2|Part 1|Lost to Follow-up|1
2655270|NCT00693472|9169010|P1|Part 1|Lost to Follow-up|0
2655271|NCT00693472|9169007|P4|Part 1|Adverse Event|0
2655272|NCT00693472|9169008|P3|Part 1|Adverse Event|0
2655273|NCT00693472|9169009|P2|Part 1|Adverse Event|1
2655274|NCT00693472|9169010|P1|Part 1|Adverse Event|1
2655275|NCT00693420|9169030|P2|Overall Study|Personal Reasons|4
2655276|NCT00693420|9169031|P1|Overall Study|Personal Reasons|1
2655277|NCT00693420|9169030|P2|Overall Study|Sponsor Request - Conflict of Interest|2
2655278|NCT00693420|9169031|P1|Overall Study|Sponsor Request - Conflict of Interest|0
2655279|NCT00693420|9169030|P2|Overall Study|Protocol Violation|2
2655280|NCT00693420|9169031|P1|Overall Study|Protocol Violation|0
2655281|NCT00693420|9169030|P2|Overall Study|Withdrawal by Subject|0
2655282|NCT00693420|9169031|P1|Overall Study|Withdrawal by Subject|1
2655283|NCT00693420|9169030|P2|Overall Study|Lost to Follow-up|3
2655284|NCT00693420|9169031|P1|Overall Study|Lost to Follow-up|0
2655285|NCT00693420|9169030|P2|Overall Study|Adverse Event|4
2655286|NCT00693420|9169031|P1|Overall Study|Adverse Event|4
2655287|NCT00693225|9169070|P2|Overall Study|Adverse Event|3
2655288|NCT00693225|9169071|P1|Overall Study|Adverse Event|1
2655289|NCT00693225|9169070|P2|Overall Study|Lost to Follow-up|2
2655290|NCT00693225|9169071|P1|Overall Study|Lost to Follow-up|1
2655291|NCT00693017|9169094|P2|Overall Study|Death|1
2655292|NCT00693017|9169095|P1|Overall Study|Death|0
2655293|NCT00693017|9169094|P2|Overall Study|Sponsor Decision|1
2655294|NCT00693017|9169095|P1|Overall Study|Sponsor Decision|2
2655295|NCT00692913|9169105|P2|Overall Study|Withdrawal by Subject|20
2655296|NCT00692913|9169106|P1|Overall Study|Withdrawal by Subject|15
2655297|NCT00692913|9169105|P2|Overall Study|Protocol Violation|1
2655298|NCT00692913|9169106|P1|Overall Study|Protocol Violation|1
2655299|NCT00692913|9169105|P2|Overall Study|Physician Decision|0
2655300|NCT00692913|9169106|P1|Overall Study|Physician Decision|2
2655301|NCT00692913|9169105|P2|Overall Study|Lost to Follow-up|5
2655302|NCT00692913|9169106|P1|Overall Study|Lost to Follow-up|3
2655303|NCT00692913|9169105|P2|Overall Study|Adverse Event|4
2655304|NCT00692913|9169106|P1|Overall Study|Adverse Event|8
2655305|NCT00692770|9169128|P2|Overall Study|Randomized but not treated|4
2655306|NCT00692770|9169129|P1|Overall Study|Randomized but not treated|3
2655307|NCT00692770|9169128|P2|Overall Study|Study terminated by sponsor|2
2655308|NCT00692770|9169129|P1|Overall Study|Study terminated by sponsor|2
2655309|NCT00692770|9169128|P2|Overall Study|Clinical endpoint reached|43
2655310|NCT00692770|9169129|P1|Overall Study|Clinical endpoint reached|16
2655311|NCT00692770|9169128|P2|Overall Study|Radiological and clinical progression|8
2655312|NCT00692770|9169129|P1|Overall Study|Radiological and clinical progression|8
2655313|NCT00692770|9169128|P2|Overall Study|Completed all planned assessments|101
2655314|NCT00692770|9169129|P1|Overall Study|Completed all planned assessments|79
2655315|NCT00692770|9169128|P2|Overall Study|Protocol driven decision point|7
2655316|NCT00692770|9169129|P1|Overall Study|Protocol driven decision point|3
2655317|NCT00692770|9169128|P2|Overall Study|Disease progression, recurrence/relapse|279
2655318|NCT00692770|9169129|P1|Overall Study|Disease progression, recurrence/relapse|170
2655319|NCT00692770|9169128|P2|Overall Study|Physician decision not protocol driven|14
2655320|NCT00692770|9169129|P1|Overall Study|Physician decision not protocol driven|10
2655321|NCT00692770|9169128|P2|Overall Study|Progression by clinical judgment|3
2655322|NCT00692770|9169129|P1|Overall Study|Progression by clinical judgment|2
2655323|NCT00692770|9169128|P2|Overall Study|Non-compliant with study medication|5
2655324|NCT00692770|9169129|P1|Overall Study|Non-compliant with study medication|11
2655325|NCT00692770|9169128|P2|Overall Study|Lost to Follow-up|3
2655326|NCT00692770|9169129|P1|Overall Study|Lost to Follow-up|7
2655327|NCT00692770|9169128|P2|Overall Study|Death|5
2655328|NCT00692770|9169129|P1|Overall Study|Death|10
2655329|NCT00692770|9169128|P2|Overall Study|Adverse Event|41
2655330|NCT00692770|9169129|P1|Overall Study|Adverse Event|136
2655331|NCT00692770|9169128|P2|Overall Study|Withdrawal by Subject|36
2655332|NCT00692770|9169129|P1|Overall Study|Withdrawal by Subject|97
2655333|NCT00692770|9169128|P2|Overall Study|Protocol Violation|7
2655334|NCT00692770|9169129|P1|Overall Study|Protocol Violation|2
2655335|NCT00692406|9169175|P1|Overall Study|PI dropped, bad data|57
2655336|NCT00692237|9169237|P2|Overall Study|Adverse Event|1
2655337|NCT00692237|9169238|P1|Overall Study|Adverse Event|0
2655338|NCT00692237|9169237|P2|Overall Study|Withdrawal by Subject|3
2655339|NCT00692237|9169238|P1|Overall Study|Withdrawal by Subject|1
2655340|NCT00692003|9169325|P2|Overall Study|Sponsor Decision|1
2655341|NCT00692003|9169326|P1|Overall Study|Sponsor Decision|5
2655342|NCT00691938|9169341|P7|Overall Study|QTc prolongation|0
2655343|NCT00691938|9169342|P6|Overall Study|QTc prolongation|0
2655344|NCT00691938|9169343|P5|Overall Study|QTc prolongation|0
2655345|NCT00691938|9169344|P4|Overall Study|QTc prolongation|0
2655346|NCT00691938|9169345|P3|Overall Study|QTc prolongation|0
2655347|NCT00691938|9169346|P2|Overall Study|QTc prolongation|0
2655348|NCT00691938|9169347|P1|Overall Study|QTc prolongation|1
2655349|NCT00691704|9169414|P1|Two Years of Maintenance Therapy|Withdrawal by Subject|1
2655350|NCT00691704|9169414|P1|Two Years of Maintenance Therapy|Physician Decision|4
2655351|NCT00691704|9169414|P1|Two Years of Maintenance Therapy|Disease Progression|8
2655352|NCT00691704|9169414|P1|Induction Therapy|Active Hepatitis|1
2655353|NCT00691704|9169414|P1|Induction Therapy|Disease Progression|1
2655354|NCT00691483|9169462|P2|Overall Study|Randomized by not treated|1
2655355|NCT00691483|9169463|P1|Overall Study|Randomized by not treated|7
2655356|NCT00691483|9169462|P2|Overall Study|Other known cause|1
2655357|NCT00691483|9169463|P1|Overall Study|Other known cause|6
2655358|NCT00691483|9169462|P2|Overall Study|Withdrawal by Subject|7
2655359|NCT00691483|9169463|P1|Overall Study|Withdrawal by Subject|24
2655360|NCT00691483|9169462|P2|Overall Study|Lost to Follow-up|10
2655361|NCT00691483|9169463|P1|Overall Study|Lost to Follow-up|17
2655362|NCT00691483|9169462|P2|Overall Study|Adverse Event|6
2655363|NCT00691483|9169463|P1|Overall Study|Adverse Event|14
2655364|NCT00691301|9169506|P1|Overall Study|Did not initiate study treatment|1
2655365|NCT00691301|9169506|P1|Overall Study|other reason|3
2655366|NCT00691301|9169506|P1|Overall Study|Concurrent illness|2
2655367|NCT00691301|9169506|P1|Overall Study|Withdrawal by Subject|4
2655368|NCT00691301|9169506|P1|Overall Study|Lack of Efficacy|32
2655369|NCT00691301|9169506|P1|Overall Study|Death|2
2655370|NCT00691301|9169506|P1|Overall Study|Adverse Event|10
2655371|NCT00691210|9169526|P8|Overall Study|Lack of Efficacy|0
2655372|NCT00691210|9169527|P7|Overall Study|Lack of Efficacy|0
2655373|NCT00691210|9169528|P6|Overall Study|Lack of Efficacy|1
2655374|NCT00691210|9169529|P5|Overall Study|Lack of Efficacy|0
2655375|NCT00691210|9169530|P4|Overall Study|Lack of Efficacy|1
2655376|NCT00691210|9169531|P3|Overall Study|Lack of Efficacy|0
2655377|NCT00691210|9169532|P2|Overall Study|Lack of Efficacy|0
2655378|NCT00691210|9169533|P1|Overall Study|Lack of Efficacy|0
2655379|NCT00691210|9169526|P8|Overall Study|Progression of Disease|0
2655380|NCT00691210|9169527|P7|Overall Study|Progression of Disease|0
2655381|NCT00691210|9169528|P6|Overall Study|Progression of Disease|0
2655382|NCT00691210|9169529|P5|Overall Study|Progression of Disease|0
2655383|NCT00691210|9169530|P4|Overall Study|Progression of Disease|2
2655384|NCT00691210|9169531|P3|Overall Study|Progression of Disease|0
2655385|NCT00691210|9169532|P2|Overall Study|Progression of Disease|0
2655386|NCT00691210|9169533|P1|Overall Study|Progression of Disease|0
2655387|NCT00691132|9169568|P2|Overall Study|Withdrawal by Subject|10
2655388|NCT00691132|9169569|P1|Overall Study|Withdrawal by Subject|10
2655389|NCT00691132|9169568|P2|Overall Study|Adverse Event|3
2655390|NCT00691132|9169569|P1|Overall Study|Adverse Event|2
2655391|NCT00691093|9169588|P1|Overall Study|Ongoing at Date of Cut-Off|4
2655392|NCT00691093|9169588|P1|Overall Study|Lack of Efficacy|1
2655393|NCT00691093|9169588|P1|Overall Study|Lost to Follow-up|1
2655394|NCT00691093|9169588|P1|Overall Study|Adverse Event|1
2655395|NCT00691054|9169622|P1|Overall Study|Withdrawal by Subject|1
2655396|NCT00691028|9169634|P4|Double-blind Period|not come to a hospital.|0
2655397|NCT00691028|9169635|P3|Double-blind Period|not come to a hospital.|0
2655398|NCT00691028|9169636|P2|Double-blind Period|not come to a hospital.|1
2655399|NCT00691028|9169637|P1|Double-blind Period|not come to a hospital.|0
2655400|NCT00691028|9169634|P4|Double-blind Period|Withdrawal by Subject|0
2655401|NCT00691028|9169635|P3|Double-blind Period|Withdrawal by Subject|1
2655402|NCT00691028|9169636|P2|Double-blind Period|Withdrawal by Subject|0
2655403|NCT00691028|9169637|P1|Double-blind Period|Withdrawal by Subject|1
2655404|NCT00691028|9169634|P4|Double-blind Period|Lack of Efficacy|0
2655405|NCT00691028|9169635|P3|Double-blind Period|Lack of Efficacy|2
2655406|NCT00691028|9169636|P2|Double-blind Period|Lack of Efficacy|3
2655407|NCT00691028|9169637|P1|Double-blind Period|Lack of Efficacy|4
2655408|NCT00691028|9169634|P4|Double-blind Period|Adverse Event|0
2655409|NCT00691028|9169635|P3|Double-blind Period|Adverse Event|6
2655410|NCT00691028|9169636|P2|Double-blind Period|Adverse Event|9
2655411|NCT00691028|9169637|P1|Double-blind Period|Adverse Event|8
2655412|NCT00691028|9169634|P4|Open-label Period|not come to a hospital|1
2655413|NCT00691028|9169635|P3|Open-label Period|not come to a hospital|0
2655414|NCT00691028|9169636|P2|Open-label Period|not come to a hospital|0
2655415|NCT00691028|9169637|P1|Open-label Period|not come to a hospital|0
2655416|NCT00691028|9169634|P4|Open-label Period|Withdrawal by Subject|3
2655417|NCT00691028|9169635|P3|Open-label Period|Withdrawal by Subject|0
2655418|NCT00691028|9169636|P2|Open-label Period|Withdrawal by Subject|0
2655419|NCT00691028|9169637|P1|Open-label Period|Withdrawal by Subject|0
2655420|NCT00691028|9169634|P4|Open-label Period|Adverse Event|16
2655421|NCT00691028|9169635|P3|Open-label Period|Adverse Event|0
2655422|NCT00691028|9169636|P2|Open-label Period|Adverse Event|0
2655423|NCT00691028|9169637|P1|Open-label Period|Adverse Event|0
2655424|NCT00691015|9169670|P1|Overall Study|Refused further treatment|1
2655425|NCT00690898|9169685|P1|TREATMENT|Other (not otherwise specified)|1
2655426|NCT00690898|9169685|P1|TREATMENT|Withdrawal by Subject|4
2655427|NCT00690898|9169685|P1|TREATMENT|Lack of Efficacy|18
2655428|NCT00690898|9169685|P1|TREATMENT|Adverse Event|3
2655429|NCT00690898|9169685|P1|SCREENING|Screen failure|18
2655430|NCT00690820|9169705|P2|Period 1|Withdrawal by Subject|1
2655431|NCT00690820|9169706|P1|Period 1|Withdrawal by Subject|0
2655432|NCT00690794|9169728|P2|Overall Study|Other not specified|3
2655433|NCT00690794|9169729|P1|Overall Study|Other not specified|1
2655434|NCT00690794|9169728|P2|Overall Study|Noncompliance|2
2655435|NCT00690794|9169729|P1|Overall Study|Noncompliance|1
2655436|NCT00690794|9169728|P2|Overall Study|Protocol Violation|7
2655437|NCT00690794|9169729|P1|Overall Study|Protocol Violation|6
2655438|NCT00690794|9169728|P2|Overall Study|Withdrawal by Subject|9
2655439|NCT00690794|9169729|P1|Overall Study|Withdrawal by Subject|0
2655440|NCT00690794|9169728|P2|Overall Study|Lost to Follow-up|4
2655441|NCT00690794|9169729|P1|Overall Study|Lost to Follow-up|1
2655442|NCT00690794|9169728|P2|Overall Study|Adverse Event|10
2655443|NCT00690794|9169729|P1|Overall Study|Adverse Event|12
2655444|NCT00690755|9169744|P7|Overall Study|Physician Decision|0
2655445|NCT00690755|9169745|P6|Overall Study|Physician Decision|4
2655446|NCT00690755|9169746|P5|Overall Study|Physician Decision|0
2655447|NCT00690755|9169747|P4|Overall Study|Physician Decision|5
2655448|NCT00690755|9169748|P3|Overall Study|Physician Decision|46
2655449|NCT00690755|9169749|P2|Overall Study|Physician Decision|0
2655450|NCT00690755|9169750|P1|Overall Study|Physician Decision|2
2655451|NCT00690612|9169766|P1|Overall Study|Withdrawal by Subject|2
2655452|NCT00690612|9169766|P1|Overall Study|Adverse Event|1
2655453|NCT00690573|9169771|P1|Overall Study|Withdrawal by Subject|1
2655454|NCT00690573|9169771|P1|Overall Study|Lack of Efficacy|8
2655455|NCT00690482|9169790|P2|Overall Study|withdrew consent at rand.day|1
2655456|NCT00690482|9169791|P1|Overall Study|withdrew consent at rand.day|0
2655457|NCT00690482|9169790|P2|Overall Study|Intake of prohibited medicine|0
2655458|NCT00690482|9169791|P1|Overall Study|Intake of prohibited medicine|1
2655459|NCT00690482|9169790|P2|Overall Study|Study-specific discontinuation criteria|0
2655460|NCT00690482|9169791|P1|Overall Study|Study-specific discontinuation criteria|1
2655461|NCT00690482|9169790|P2|Overall Study|Incorrect enrolment|1
2655462|NCT00690482|9169791|P1|Overall Study|Incorrect enrolment|0
2655463|NCT00690482|9169790|P2|Overall Study|Adverse Event|1
2655464|NCT00690482|9169791|P1|Overall Study|Adverse Event|2
2655465|NCT00690443|9169825|P2|Overall Study|Adverse Event|2
2655466|NCT00690443|9169826|P1|Overall Study|Adverse Event|1
2655467|NCT00690430|9169836|P3|Extension Phase|Early Termination|3
2655468|NCT00690430|9169837|P2|Extension Phase|Early Termination|1
2655469|NCT00690430|9169838|P1|Extension Phase|Early Termination|10
2655470|NCT00690430|9169836|P3|Extension Phase|Withdrawal by Subject|2
2655471|NCT00690430|9169837|P2|Extension Phase|Withdrawal by Subject|0
2655472|NCT00690430|9169838|P1|Extension Phase|Withdrawal by Subject|0
2655473|NCT00690430|9169836|P3|Extension Phase|Death|1
2655474|NCT00690430|9169837|P2|Extension Phase|Death|1
2655475|NCT00690430|9169838|P1|Extension Phase|Death|1
2655476|NCT00690430|9169836|P3|Extension Phase|Adverse Event|2
2655477|NCT00690430|9169837|P2|Extension Phase|Adverse Event|1
2655478|NCT00690430|9169838|P1|Extension Phase|Adverse Event|2
2655479|NCT00690430|9169836|P3|Extension Phase|Administrative Problems|1
2655480|NCT00690430|9169837|P2|Extension Phase|Administrative Problems|1
2655481|NCT00690430|9169838|P1|Extension Phase|Administrative Problems|0
2655482|NCT00690430|9169836|P3|Extension Phase|Abnormal test procedure results|0
2655483|NCT00690430|9169837|P2|Extension Phase|Abnormal test procedure results|0
2655484|NCT00690430|9169838|P1|Extension Phase|Abnormal test procedure results|1
2655485|NCT00690430|9169836|P3|Extension Phase|Abnormal Lab Values|0
2655486|NCT00690430|9169837|P2|Extension Phase|Abnormal Lab Values|0
2655487|NCT00690430|9169838|P1|Extension Phase|Abnormal Lab Values|1
2655488|NCT00690430|9169836|P3|Extension Phase|Lack of Efficacy|4
2655489|NCT00690430|9169837|P2|Extension Phase|Lack of Efficacy|1
2655490|NCT00690430|9169838|P1|Extension Phase|Lack of Efficacy|3
2655491|NCT00690430|9169836|P3|Core Phase|Early Termination|0
2655492|NCT00690430|9169837|P2|Core Phase|Early Termination|5
2655493|NCT00690430|9169838|P1|Core Phase|Early Termination|0
2655494|NCT00690430|9169836|P3|Core Phase|Administrative Problems|0
2655495|NCT00690430|9169837|P2|Core Phase|Administrative Problems|1
2655496|NCT00690430|9169838|P1|Core Phase|Administrative Problems|0
2655497|NCT00690430|9169836|P3|Core Phase|Lack of Efficacy|0
2655498|NCT00690430|9169837|P2|Core Phase|Lack of Efficacy|10
2655499|NCT00690430|9169838|P1|Core Phase|Lack of Efficacy|8
2655500|NCT00690430|9169836|P3|Core Phase|Subject no longer requires study drug|0
2655501|NCT00690430|9169837|P2|Core Phase|Subject no longer requires study drug|0
2655502|NCT00690430|9169838|P1|Core Phase|Subject no longer requires study drug|1
2655503|NCT00690430|9169836|P3|Core Phase|Withdrawal by Subject|0
2655504|NCT00690430|9169837|P2|Core Phase|Withdrawal by Subject|3
2655505|NCT00690430|9169838|P1|Core Phase|Withdrawal by Subject|3
2655506|NCT00690430|9169836|P3|Core Phase|Protocol Violation|0
2655507|NCT00690430|9169837|P2|Core Phase|Protocol Violation|0
2655508|NCT00690430|9169838|P1|Core Phase|Protocol Violation|1
2655509|NCT00690430|9169836|P3|Core Phase|Death|0
2655510|NCT00690430|9169837|P2|Core Phase|Death|2
2655511|NCT00690430|9169838|P1|Core Phase|Death|0
2655512|NCT00690430|9169836|P3|Core Phase|Adverse Event|0
2655513|NCT00690430|9169837|P2|Core Phase|Adverse Event|1
2655514|NCT00690430|9169838|P1|Core Phase|Adverse Event|5
2655515|NCT00690430|9169836|P3|Core Phase|Abnormal Laboratory value|0
2655516|NCT00690430|9169837|P2|Core Phase|Abnormal Laboratory value|1
2655517|NCT00690430|9169838|P1|Core Phase|Abnormal Laboratory value|0
2655518|NCT00690378|9169867|P2|Overall Study|Social problem|0
2655519|NCT00690378|9169868|P1|Overall Study|Social problem|1
2655520|NCT00690378|9169867|P2|Overall Study|Did not meet inc/exc criteria|11
2655521|NCT00690378|9169868|P1|Overall Study|Did not meet inc/exc criteria|13
2655522|NCT00690378|9169867|P2|Overall Study|Lost to Follow-up|3
2655523|NCT00690378|9169868|P1|Overall Study|Lost to Follow-up|2
2655524|NCT00690378|9169867|P2|Overall Study|Protocol Violation|0
2655525|NCT00690378|9169868|P1|Overall Study|Protocol Violation|1
2655526|NCT00690378|9169867|P2|Overall Study|Withdrawal by Subject|0
2655527|NCT00690378|9169868|P1|Overall Study|Withdrawal by Subject|2
2655528|NCT00690378|9169867|P2|Overall Study|Adverse Event|0
2655529|NCT00690378|9169868|P1|Overall Study|Adverse Event|1
2655530|NCT00689936|9169965|P3|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144
2655531|NCT00689936|9169966|P2|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188
2655532|NCT00689936|9169967|P1|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127
2655533|NCT00689936|9169965|P3|Active Treatment Phase|Miscellaneous|47
2655534|NCT00689936|9169966|P2|Active Treatment Phase|Miscellaneous|34
2655535|NCT00689936|9169967|P1|Active Treatment Phase|Miscellaneous|52
2655536|NCT00689936|9169965|P3|Active Treatment Phase|Study Close Out|21
2655537|NCT00689936|9169966|P2|Active Treatment Phase|Study Close Out|26
2655538|NCT00689936|9169967|P1|Active Treatment Phase|Study Close Out|64
2655539|NCT00689936|9169965|P3|Active Treatment Phase|Protocol Violation|4
2655540|NCT00689936|9169966|P2|Active Treatment Phase|Protocol Violation|2
2655541|NCT00689936|9169967|P1|Active Treatment Phase|Protocol Violation|2
2655542|NCT00689936|9169965|P3|Active Treatment Phase|Lost to Follow-up|2
2655543|NCT00689936|9169966|P2|Active Treatment Phase|Lost to Follow-up|2
2655544|NCT00689936|9169967|P1|Active Treatment Phase|Lost to Follow-up|0
2655545|NCT00689936|9169965|P3|Active Treatment Phase|Death|37
2655546|NCT00689936|9169966|P2|Active Treatment Phase|Death|28
2655547|NCT00689936|9169967|P1|Active Treatment Phase|Death|60
2655548|NCT00689936|9169965|P3|Active Treatment Phase|Withdrawal by Subject|21
2655549|NCT00689936|9169966|P2|Active Treatment Phase|Withdrawal by Subject|16
2655550|NCT00689936|9169967|P1|Active Treatment Phase|Withdrawal by Subject|16
2655551|NCT00689936|9169965|P3|Active Treatment Phase|Disease Progression|339
2655552|NCT00689936|9169966|P2|Active Treatment Phase|Disease Progression|362
2655553|NCT00689936|9169967|P1|Active Treatment Phase|Disease Progression|273
2655554|NCT00689936|9169965|P3|Active Treatment Phase|Adverse Event|76
2655555|NCT00689936|9169966|P2|Active Treatment Phase|Adverse Event|71
2655556|NCT00689936|9169967|P1|Active Treatment Phase|Adverse Event|68
2655557|NCT00689871|9170116|P4|Overall Study|Physician Decision|0
2655558|NCT00689871|9170117|P3|Overall Study|Physician Decision|1
2655559|NCT00689871|9170118|P2|Overall Study|Physician Decision|1
2655560|NCT00689871|9170119|P1|Overall Study|Physician Decision|2
2655561|NCT00689871|9170116|P4|Overall Study|Death|2
2655562|NCT00689871|9170117|P3|Overall Study|Death|2
2655563|NCT00689871|9170118|P2|Overall Study|Death|10
2655564|NCT00689871|9170119|P1|Overall Study|Death|1
2655565|NCT00689871|9170116|P4|Overall Study|Withdrawal by Subject|1
2655566|NCT00689871|9170117|P3|Overall Study|Withdrawal by Subject|4
2655567|NCT00689871|9170118|P2|Overall Study|Withdrawal by Subject|3
2655568|NCT00689871|9170119|P1|Overall Study|Withdrawal by Subject|13
2655569|NCT00689871|9170116|P4|Overall Study|Explanted of All Study Devices|3
2655570|NCT00689871|9170117|P3|Overall Study|Explanted of All Study Devices|29
2655571|NCT00689871|9170118|P2|Overall Study|Explanted of All Study Devices|25
2655572|NCT00689871|9170119|P1|Overall Study|Explanted of All Study Devices|36
2655573|NCT00689871|9170116|P4|Overall Study|Lost to Follow-up|1
2655574|NCT00689871|9170117|P3|Overall Study|Lost to Follow-up|37
2655575|NCT00689871|9170118|P2|Overall Study|Lost to Follow-up|13
2655576|NCT00689871|9170119|P1|Overall Study|Lost to Follow-up|123
2655577|NCT00689793|9170146|P2|Overall Study|Lost to Follow-up|5
2655578|NCT00689793|9170147|P1|Overall Study|Lost to Follow-up|4
2655579|NCT00689728|9170166|P3|Optional Follow-Up|Withdrawal by Subject|3
2655580|NCT00689728|9170167|P2|Optional Follow-Up|Withdrawal by Subject|4
2655581|NCT00689728|9170168|P1|Optional Follow-Up|Withdrawal by Subject|2
2655582|NCT00689728|9170166|P3|Optional Follow-Up|Protocol Violation|1
2655583|NCT00689728|9170167|P2|Optional Follow-Up|Protocol Violation|0
2655584|NCT00689728|9170168|P1|Optional Follow-Up|Protocol Violation|0
2655585|NCT00689728|9170166|P3|Optional Follow-Up|Lost to Follow-up|1
2655586|NCT00689728|9170167|P2|Optional Follow-Up|Lost to Follow-up|1
2655587|NCT00689728|9170168|P1|Optional Follow-Up|Lost to Follow-up|0
2655588|NCT00689728|9170166|P3|Optional Follow-Up|Lack of Efficacy|1
2655589|NCT00689728|9170167|P2|Optional Follow-Up|Lack of Efficacy|1
2655590|NCT00689728|9170168|P1|Optional Follow-Up|Lack of Efficacy|0
2655591|NCT00689728|9170166|P3|Optional Follow-Up|Adverse Event|0
2655592|NCT00689728|9170167|P2|Optional Follow-Up|Adverse Event|0
2655593|NCT00689728|9170168|P1|Optional Follow-Up|Adverse Event|1
2655594|NCT00689728|9170166|P3|Rescue|Withdrawal by Subject|1
2655595|NCT00689728|9170167|P2|Rescue|Withdrawal by Subject|1
2655596|NCT00689728|9170168|P1|Rescue|Withdrawal by Subject|1
2655597|NCT00689728|9170166|P3|Rescue|Adverse Event|0
2655598|NCT00689728|9170167|P2|Rescue|Adverse Event|1
2655599|NCT00689728|9170168|P1|Rescue|Adverse Event|0
2655600|NCT00689728|9170166|P3|Double-Blind Treatment|Lack of Efficacy|2
2655601|NCT00689728|9170167|P2|Double-Blind Treatment|Lack of Efficacy|1
2655602|NCT00689728|9170168|P1|Double-Blind Treatment|Lack of Efficacy|0
2655603|NCT00689728|9170166|P3|Double-Blind Treatment|Withdrawal by Subject|2
2655604|NCT00689728|9170167|P2|Double-Blind Treatment|Withdrawal by Subject|3
2655605|NCT00689728|9170168|P1|Double-Blind Treatment|Withdrawal by Subject|3
2655606|NCT00689728|9170166|P3|Double-Blind Treatment|Protocol Violation|1
2655607|NCT00689728|9170167|P2|Double-Blind Treatment|Protocol Violation|0
2655608|NCT00689728|9170168|P1|Double-Blind Treatment|Protocol Violation|0
2655609|NCT00689728|9170166|P3|Double-Blind Treatment|Adverse Event|0
2655610|NCT00689728|9170167|P2|Double-Blind Treatment|Adverse Event|0
2655611|NCT00689728|9170168|P1|Double-Blind Treatment|Adverse Event|1
2655612|NCT00689611|9170251|P2|Overall Study|Lost to Follow-up|28
2655613|NCT00689611|9170252|P1|Overall Study|Lost to Follow-up|27
2655614|NCT00689611|9170251|P2|Overall Study|Withdrawal by Subject|9
2655615|NCT00689611|9170252|P1|Overall Study|Withdrawal by Subject|8
2655616|NCT00689611|9170251|P2|Overall Study|Death|9
2655617|NCT00689611|9170252|P1|Overall Study|Death|6
2655618|NCT00689481|9170262|P2|Overall Study|Subject early term, left on vacation|1
2655619|NCT00689481|9170263|P1|Overall Study|Subject early term, left on vacation|0
2655620|NCT00689481|9170262|P2|Overall Study|Excluded medication started during study|1
2655621|NCT00689481|9170263|P1|Overall Study|Excluded medication started during study|0
2655622|NCT00689481|9170262|P2|Overall Study|Withdrawal by Subject|4
2655623|NCT00689481|9170263|P1|Overall Study|Withdrawal by Subject|8
2655624|NCT00689481|9170262|P2|Overall Study|Non-compliance with study treatment|1
2655625|NCT00689481|9170263|P1|Overall Study|Non-compliance with study treatment|1
2655626|NCT00689481|9170262|P2|Overall Study|Lack of Efficacy|3
2655627|NCT00689481|9170263|P1|Overall Study|Lack of Efficacy|4
2655628|NCT00689481|9170262|P2|Overall Study|Lost to Follow-up|3
2655629|NCT00689481|9170263|P1|Overall Study|Lost to Follow-up|4
2655630|NCT00689481|9170262|P2|Overall Study|Adverse Event|1
2655631|NCT00689481|9170263|P1|Overall Study|Adverse Event|7
2655632|NCT00689390|9170281|P2|Overall Study|Administrative|0
2655633|NCT00689390|9170282|P1|Overall Study|Administrative|37
2655634|NCT00689390|9170281|P2|Overall Study|Did Not Meet Protocol Eligibility|0
2655635|NCT00689390|9170282|P1|Overall Study|Did Not Meet Protocol Eligibility|1
2655636|NCT00689390|9170281|P2|Overall Study|Non-Compliance With Protocol|0
2655637|NCT00689390|9170282|P1|Overall Study|Non-Compliance With Protocol|21
2655638|NCT00689390|9170281|P2|Overall Study|Withdrew Consent-Retreatment Opportunity|0
2655639|NCT00689390|9170282|P1|Overall Study|Withdrew Consent-Retreatment Opportunity|52
2655640|NCT00689390|9170281|P2|Overall Study|Withdrawal by Subject|3
2655641|NCT00689390|9170282|P1|Overall Study|Withdrawal by Subject|117
2655642|NCT00689390|9170281|P2|Overall Study|Lost to Follow-up|7
2655643|NCT00689390|9170282|P1|Overall Study|Lost to Follow-up|179
2655644|NCT00689390|9170281|P2|Overall Study|Adverse Event|0
2655645|NCT00689390|9170282|P1|Overall Study|Adverse Event|19
2655646|NCT00689351|9170300|P2|After Infant Series|Parent/legal guardian request|0
2655647|NCT00689351|9170301|P1|After Infant Series|Parent/legal guardian request|1
2655648|NCT00689351|9170300|P2|Infant Series of Dosing|Lost to Follow-up|1
2655649|NCT00689351|9170301|P1|Infant Series of Dosing|Lost to Follow-up|0
2655650|NCT00689351|9170300|P2|Infant Series of Dosing|Adverse Event|0
2655651|NCT00689351|9170301|P1|Infant Series of Dosing|Adverse Event|1
2655652|NCT00689351|9170300|P2|Infant Series of Dosing|Parent/legal guardian request|0
2655653|NCT00689351|9170301|P1|Infant Series of Dosing|Parent/legal guardian request|5
2655654|NCT00689338|9170333|P1|Overall Study|Protocol Violation|15
2655655|NCT00689338|9170333|P1|Overall Study|Withdrawal by Subject|3
2655656|NCT00689338|9170333|P1|Overall Study|Lost to Follow-up|5
2655657|NCT00689338|9170333|P1|Overall Study|Did not Meet Entrance Criteria|27
2655658|NCT00689338|9170333|P1|Overall Study|Other|8
2655659|NCT00689338|9170333|P1|Overall Study|Lack of Efficacy|6
2655660|NCT00689338|9170333|P1|Overall Study|Insufficient Clinical Response|1
2655661|NCT00689338|9170333|P1|Overall Study|Adverse Event|13
2655662|NCT00689338|9170333|P1|Overall Study|Death|65
2655663|NCT00689299|9170346|P3|Overall Study|Protocol Violation|0
2655664|NCT00689299|9170347|P2|Overall Study|Protocol Violation|0
2655665|NCT00689299|9170348|P1|Overall Study|Protocol Violation|1
2655666|NCT00689299|9170346|P3|Overall Study|Withdrawal by Subject|3
2655667|NCT00689299|9170347|P2|Overall Study|Withdrawal by Subject|1
2655668|NCT00689299|9170348|P1|Overall Study|Withdrawal by Subject|4
2655669|NCT00689299|9170346|P3|Overall Study|Lost to Follow-up|1
2655670|NCT00689299|9170347|P2|Overall Study|Lost to Follow-up|1
2655671|NCT00689299|9170348|P1|Overall Study|Lost to Follow-up|0
2655672|NCT00689299|9170346|P3|Overall Study|Adverse Event|1
2655673|NCT00689299|9170347|P2|Overall Study|Adverse Event|1
2655674|NCT00689299|9170348|P1|Overall Study|Adverse Event|2
2655675|NCT00689221|9170377|P2|Overall Study|Ongoing at cut-off date|36
2655676|NCT00689221|9170378|P1|Overall Study|Ongoing at cut-off date|39
2655677|NCT00689117|9170407|P4|Overall Study|Dispensing Error|0
2655678|NCT00689117|9170408|P3|Overall Study|Dispensing Error|0
2655679|NCT00689117|9170409|P2|Overall Study|Dispensing Error|1
2655680|NCT00689117|9170410|P1|Overall Study|Dispensing Error|0
2655681|NCT00689117|9170407|P4|Overall Study|Personal Reason|0
2655682|NCT00689117|9170408|P3|Overall Study|Personal Reason|0
2655683|NCT00689117|9170409|P2|Overall Study|Personal Reason|1
2655684|NCT00689117|9170410|P1|Overall Study|Personal Reason|0
2655685|NCT00689117|9170407|P4|Overall Study|Patient Withdrew from Study|1
2655686|NCT00689117|9170408|P3|Overall Study|Patient Withdrew from Study|0
2655687|NCT00689117|9170409|P2|Overall Study|Patient Withdrew from Study|0
2655688|NCT00689117|9170410|P1|Overall Study|Patient Withdrew from Study|0
2655689|NCT00689117|9170407|P4|Overall Study|Transportation|0
2655690|NCT00689117|9170408|P3|Overall Study|Transportation|0
2655691|NCT00689117|9170409|P2|Overall Study|Transportation|0
2655692|NCT00689117|9170410|P1|Overall Study|Transportation|1
2655693|NCT00689117|9170407|P4|Overall Study|Fear of Birth Defects|0
2655694|NCT00689117|9170408|P3|Overall Study|Fear of Birth Defects|1
2655695|NCT00689117|9170409|P2|Overall Study|Fear of Birth Defects|0
2655696|NCT00689117|9170410|P1|Overall Study|Fear of Birth Defects|0
2655697|NCT00689117|9170407|P4|Overall Study|Incarceration|0
2655698|NCT00689117|9170408|P3|Overall Study|Incarceration|0
2655699|NCT00689117|9170409|P2|Overall Study|Incarceration|0
2655700|NCT00689117|9170410|P1|Overall Study|Incarceration|2
2655701|NCT00689117|9170407|P4|Overall Study|Pregnancy|2
2655702|NCT00689117|9170408|P3|Overall Study|Pregnancy|0
2655703|NCT00689117|9170409|P2|Overall Study|Pregnancy|2
2655704|NCT00689117|9170410|P1|Overall Study|Pregnancy|0
2655705|NCT00689117|9170407|P4|Overall Study|Use of Prohibitive Medication|0
2655706|NCT00689117|9170408|P3|Overall Study|Use of Prohibitive Medication|3
2655707|NCT00689117|9170409|P2|Overall Study|Use of Prohibitive Medication|1
2655708|NCT00689117|9170410|P1|Overall Study|Use of Prohibitive Medication|2
2655709|NCT00689117|9170407|P4|Overall Study|Change/Discontinuation of Birth Control|0
2655710|NCT00689117|9170408|P3|Overall Study|Change/Discontinuation of Birth Control|1
2655711|NCT00689117|9170409|P2|Overall Study|Change/Discontinuation of Birth Control|1
2655712|NCT00689117|9170410|P1|Overall Study|Change/Discontinuation of Birth Control|1
2655713|NCT00689117|9170407|P4|Overall Study|Non-compliance with Treatment Regimen|0
2655714|NCT00689117|9170408|P3|Overall Study|Non-compliance with Treatment Regimen|0
2655715|NCT00689117|9170409|P2|Overall Study|Non-compliance with Treatment Regimen|1
2655716|NCT00689117|9170410|P1|Overall Study|Non-compliance with Treatment Regimen|0
2655717|NCT00689117|9170407|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
2655718|NCT00689117|9170408|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
2655719|NCT00689117|9170409|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
2655720|NCT00689117|9170410|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
2655721|NCT00689117|9170407|P4|Overall Study|Unable to Comply with Visit Schedule|1
2655722|NCT00689117|9170408|P3|Overall Study|Unable to Comply with Visit Schedule|1
2655723|NCT00689117|9170409|P2|Overall Study|Unable to Comply with Visit Schedule|0
2655724|NCT00689117|9170410|P1|Overall Study|Unable to Comply with Visit Schedule|0
2655725|NCT00689117|9170407|P4|Overall Study|Withdrawal by Subject|13
2655726|NCT00689117|9170408|P3|Overall Study|Withdrawal by Subject|26
2655727|NCT00689117|9170409|P2|Overall Study|Withdrawal by Subject|18
2655728|NCT00689117|9170410|P1|Overall Study|Withdrawal by Subject|19
2655729|NCT00689117|9170407|P4|Overall Study|Non-Compliance with Study Treatment|1
2655730|NCT00689117|9170408|P3|Overall Study|Non-Compliance with Study Treatment|3
2655731|NCT00689117|9170409|P2|Overall Study|Non-Compliance with Study Treatment|3
2655732|NCT00689117|9170410|P1|Overall Study|Non-Compliance with Study Treatment|3
2655733|NCT00689117|9170407|P4|Overall Study|Lack of Efficacy|2
2655734|NCT00689117|9170408|P3|Overall Study|Lack of Efficacy|2
2655735|NCT00689117|9170409|P2|Overall Study|Lack of Efficacy|2
2655736|NCT00689117|9170410|P1|Overall Study|Lack of Efficacy|1
2655737|NCT00689117|9170407|P4|Overall Study|Lost to Follow-up|11
2655738|NCT00689117|9170408|P3|Overall Study|Lost to Follow-up|17
2655739|NCT00689117|9170409|P2|Overall Study|Lost to Follow-up|19
2655740|NCT00689117|9170410|P1|Overall Study|Lost to Follow-up|26
2655741|NCT00689117|9170407|P4|Overall Study|Adverse Event|0
2655742|NCT00689117|9170408|P3|Overall Study|Adverse Event|5
2655743|NCT00689117|9170409|P2|Overall Study|Adverse Event|0
2655744|NCT00689117|9170410|P1|Overall Study|Adverse Event|6
2655745|NCT00689104|9170440|P4|Overall Study|Non-compliance with study procedures|0
2655746|NCT00689104|9170441|P3|Overall Study|Non-compliance with study procedures|1
2655747|NCT00689104|9170442|P2|Overall Study|Non-compliance with study procedures|0
2655748|NCT00689104|9170443|P1|Overall Study|Non-compliance with study procedures|0
2655749|NCT00689104|9170440|P4|Overall Study|Physician Decision|0
2655750|NCT00689104|9170441|P3|Overall Study|Physician Decision|0
2655751|NCT00689104|9170442|P2|Overall Study|Physician Decision|0
2655752|NCT00689104|9170443|P1|Overall Study|Physician Decision|1
2655753|NCT00689104|9170440|P4|Overall Study|Randomized but never received study drug|0
2655754|NCT00689104|9170441|P3|Overall Study|Randomized but never received study drug|1
2655755|NCT00689104|9170442|P2|Overall Study|Randomized but never received study drug|1
2655756|NCT00689104|9170443|P1|Overall Study|Randomized but never received study drug|2
2655757|NCT00689104|9170440|P4|Overall Study|Protocol Violation|3
2655758|NCT00689104|9170441|P3|Overall Study|Protocol Violation|5
2655759|NCT00689104|9170442|P2|Overall Study|Protocol Violation|3
2655760|NCT00689104|9170443|P1|Overall Study|Protocol Violation|2
2655761|NCT00689104|9170440|P4|Overall Study|Lost to Follow-up|5
2655762|NCT00689104|9170441|P3|Overall Study|Lost to Follow-up|2
2655763|NCT00689104|9170442|P2|Overall Study|Lost to Follow-up|3
2655764|NCT00689104|9170443|P1|Overall Study|Lost to Follow-up|4
2655765|NCT00689104|9170440|P4|Overall Study|Withdrawal by Subject|11
2655766|NCT00689104|9170441|P3|Overall Study|Withdrawal by Subject|18
2655767|NCT00689104|9170442|P2|Overall Study|Withdrawal by Subject|11
2655768|NCT00689104|9170443|P1|Overall Study|Withdrawal by Subject|12
2655769|NCT00689104|9170440|P4|Overall Study|Lack of Efficacy|3
2655770|NCT00689104|9170441|P3|Overall Study|Lack of Efficacy|2
2655771|NCT00689104|9170442|P2|Overall Study|Lack of Efficacy|6
2655772|NCT00689104|9170443|P1|Overall Study|Lack of Efficacy|5
2655773|NCT00689104|9170440|P4|Overall Study|Adverse Event|24
2655774|NCT00689104|9170441|P3|Overall Study|Adverse Event|16
2655775|NCT00689104|9170442|P2|Overall Study|Adverse Event|25
2655776|NCT00689104|9170443|P1|Overall Study|Adverse Event|13
2655777|NCT00689104|9170440|P4|Overall Study|Eligibility criterion not met|4
2655778|NCT00689104|9170441|P3|Overall Study|Eligibility criterion not met|0
2655779|NCT00689104|9170442|P2|Overall Study|Eligibility criterion not met|8
2655780|NCT00689104|9170443|P1|Overall Study|Eligibility criterion not met|5
2655781|NCT00689052|9170649|P2|Overall Study|Early termination of the trial|24
2655782|NCT00689052|9170650|P1|Overall Study|Early termination of the trial|22
2655783|NCT00689052|9170649|P2|Overall Study|Withdrawal by Subject|0
2655784|NCT00689052|9170650|P1|Overall Study|Withdrawal by Subject|2
2655785|NCT00689052|9170649|P2|Overall Study|Lost to Follow-up|0
2655786|NCT00689052|9170650|P1|Overall Study|Lost to Follow-up|2
2655787|NCT00689052|9170649|P2|Overall Study|Protocol Violation|0
2655788|NCT00689052|9170650|P1|Overall Study|Protocol Violation|1
2655789|NCT00689052|9170649|P2|Overall Study|Adverse Event|6
2655790|NCT00689052|9170650|P1|Overall Study|Adverse Event|4
2655791|NCT00689026|9170682|P2|Overall Study|Withdrawal by Subject|6
2655792|NCT00689026|9170683|P1|Overall Study|Withdrawal by Subject|13
2655793|NCT00688870|9170696|P2|Infant Series|Parent or legal guardian request|0
2655794|NCT00688870|9170697|P1|Infant Series|Parent or legal guardian request|4
2655795|NCT00688844|9170729|P1|Overall Study|Lost to Follow-up|10
2655796|NCT00688753|9170739|P1|Overall Study|Lost to Follow-up|3
2655797|NCT00688753|9170739|P1|Overall Study|Protocol Violation|1
2655798|NCT00688753|9170739|P1|Overall Study|Adverse Event|20
2655799|NCT00688753|9170739|P1|Overall Study|Withdrawal by Subject|3
2655800|NCT00688753|9170739|P1|Overall Study|Death|9
2655801|NCT00688753|9170739|P1|Overall Study|Missing|1
2655802|NCT00688753|9170739|P1|Overall Study|Disease progression|55
2655803|NCT00688740|9170750|P2|Overall Study|Violation of Inclusion Criteria|3
2655804|NCT00688740|9170751|P1|Overall Study|Violation of Inclusion Criteria|1
2655805|NCT00688740|9170750|P2|Overall Study|Breast Cancer Relapse|4
2655806|NCT00688740|9170751|P1|Overall Study|Breast Cancer Relapse|1
2655807|NCT00688740|9170750|P2|Overall Study|Consent Withdrawn|17
2655808|NCT00688740|9170751|P1|Overall Study|Consent Withdrawn|17
2655809|NCT00688740|9170750|P2|Overall Study|Lost to Follow-up|1
2655810|NCT00688740|9170751|P1|Overall Study|Lost to Follow-up|0
2655811|NCT00688740|9170750|P2|Overall Study|Death|2
2655812|NCT00688740|9170751|P1|Overall Study|Death|2
2655813|NCT00688740|9170750|P2|Overall Study|Adverse Event|8
2655814|NCT00688740|9170751|P1|Overall Study|Adverse Event|45
2655815|NCT00688701|9170764|P4|Overall Study|Poor compliance to protocol|0
2655816|NCT00688701|9170765|P3|Overall Study|Poor compliance to protocol|1
2655817|NCT00688701|9170766|P2|Overall Study|Poor compliance to protocol|1
2655818|NCT00688701|9170767|P1|Overall Study|Poor compliance to protocol|0
2655819|NCT00688701|9170764|P4|Overall Study|Withdrawal by Subject|8
2655820|NCT00688701|9170765|P3|Overall Study|Withdrawal by Subject|4
2655821|NCT00688701|9170766|P2|Overall Study|Withdrawal by Subject|3
2655822|NCT00688701|9170767|P1|Overall Study|Withdrawal by Subject|3
2655823|NCT00688701|9170764|P4|Overall Study|Lack of Efficacy|0
2655824|NCT00688701|9170765|P3|Overall Study|Lack of Efficacy|0
2655825|NCT00688701|9170766|P2|Overall Study|Lack of Efficacy|1
2655826|NCT00688701|9170767|P1|Overall Study|Lack of Efficacy|0
2655827|NCT00688701|9170764|P4|Overall Study|Adverse Event|3
2655828|NCT00688701|9170765|P3|Overall Study|Adverse Event|5
2655829|NCT00688701|9170766|P2|Overall Study|Adverse Event|0
2655830|NCT00688701|9170767|P1|Overall Study|Adverse Event|1
2655831|NCT00688688|9170808|P3|Overall Study|Violation of exclusion criterion|0
2655832|NCT00688688|9170809|P2|Overall Study|Violation of exclusion criterion|1
2655833|NCT00688688|9170810|P1|Overall Study|Violation of exclusion criterion|0
2655834|NCT00688688|9170808|P3|Overall Study|Site closure|0
2655835|NCT00688688|9170809|P2|Overall Study|Site closure|1
2655836|NCT00688688|9170810|P1|Overall Study|Site closure|0
2655837|NCT00688688|9170808|P3|Overall Study|Taking exclusionary medications|0
2655838|NCT00688688|9170809|P2|Overall Study|Taking exclusionary medications|0
2655839|NCT00688688|9170810|P1|Overall Study|Taking exclusionary medications|1
2655840|NCT00688688|9170808|P3|Overall Study|Non-compliance with study procedures|4
2655841|NCT00688688|9170809|P2|Overall Study|Non-compliance with study procedures|3
2655842|NCT00688688|9170810|P1|Overall Study|Non-compliance with study procedures|5
2655843|NCT00688688|9170808|P3|Overall Study|Randomized but never received study drug|0
2655844|NCT00688688|9170809|P2|Overall Study|Randomized but never received study drug|0
2655845|NCT00688688|9170810|P1|Overall Study|Randomized but never received study drug|1
2655846|NCT00688688|9170808|P3|Overall Study|Protocol Violation|11
2655847|NCT00688688|9170809|P2|Overall Study|Protocol Violation|9
2655848|NCT00688688|9170810|P1|Overall Study|Protocol Violation|6
2655849|NCT00688688|9170808|P3|Overall Study|Lost to Follow-up|7
2655850|NCT00688688|9170809|P2|Overall Study|Lost to Follow-up|7
2655851|NCT00688688|9170810|P1|Overall Study|Lost to Follow-up|14
2655852|NCT00688688|9170808|P3|Overall Study|Withdrawal by Subject|65
2655853|NCT00688688|9170809|P2|Overall Study|Withdrawal by Subject|75
2655854|NCT00688688|9170810|P1|Overall Study|Withdrawal by Subject|66
2655855|NCT00688688|9170808|P3|Overall Study|Lack of Efficacy|45
2655856|NCT00688688|9170809|P2|Overall Study|Lack of Efficacy|25
2655857|NCT00688688|9170810|P1|Overall Study|Lack of Efficacy|34
2655858|NCT00688688|9170808|P3|Overall Study|Adverse Event|50
2655859|NCT00688688|9170809|P2|Overall Study|Adverse Event|51
2655860|NCT00688688|9170810|P1|Overall Study|Adverse Event|52
2655861|NCT00688688|9170808|P3|Overall Study|Eligibility criterion not met|10
2655862|NCT00688688|9170809|P2|Overall Study|Eligibility criterion not met|7
2655863|NCT00688688|9170810|P1|Overall Study|Eligibility criterion not met|7
2655864|NCT00688636|9170912|P2|Overall Study|Adverse Event|1
2655865|NCT00688636|9170913|P1|Overall Study|Adverse Event|2
2655866|NCT00688623|9170927|P1|Overall Study|Protocol Violation|2
2655867|NCT00688623|9170927|P1|Overall Study|disease progression|23
2655868|NCT00688623|9170927|P1|Overall Study|Death|3
2655869|NCT00688623|9170927|P1|Overall Study|Withdrawal by Subject|4
2655870|NCT00688623|9170927|P1|Overall Study|abnormal lab value|1
2655871|NCT00688623|9170927|P1|Overall Study|Adverse Event|22
2655872|NCT00688597|9170941|P3|Overall Study|Physician Decision|0
2655873|NCT00688597|9170942|P2|Overall Study|Physician Decision|0
2655874|NCT00688597|9170943|P1|Overall Study|Physician Decision|1
2655875|NCT00688597|9170941|P3|Overall Study|Adverse Event|0
2655876|NCT00688597|9170942|P2|Overall Study|Adverse Event|0
2655877|NCT00688597|9170943|P1|Overall Study|Adverse Event|2
2655878|NCT00688545|9170956|P2|Overall Study|Unspecified, unrelated to AE/Toxicity|7
2655879|NCT00688545|9170957|P1|Overall Study|Unspecified, unrelated to AE/Toxicity|2
2655880|NCT00688545|9170956|P2|Overall Study|Withdrawal by Subject|3
2655881|NCT00688545|9170957|P1|Overall Study|Withdrawal by Subject|2
2655882|NCT00688545|9170956|P2|Overall Study|Insurance/cost of drug|1
2655883|NCT00688545|9170957|P1|Overall Study|Insurance/cost of drug|0
2655884|NCT00688545|9170956|P2|Overall Study|Lost to Follow-up|4
2655885|NCT00688545|9170957|P1|Overall Study|Lost to Follow-up|1
2655886|NCT00688519|9170967|P2|Overall Study|Pregnancy|1
2655887|NCT00688519|9170968|P1|Overall Study|Pregnancy|0
2655888|NCT00688519|9170967|P2|Overall Study|Subject moved out of area|0
2655889|NCT00688519|9170968|P1|Overall Study|Subject moved out of area|1
2655890|NCT00688519|9170967|P2|Overall Study|Investigator decision|0
2655891|NCT00688519|9170968|P1|Overall Study|Investigator decision|1
2655892|NCT00688519|9170967|P2|Overall Study|Subject moved out of state|0
2655893|NCT00688519|9170968|P1|Overall Study|Subject moved out of state|1
2655894|NCT00688519|9170967|P2|Overall Study|Non-compliance|1
2655895|NCT00688519|9170968|P1|Overall Study|Non-compliance|0
2655896|NCT00688519|9170967|P2|Overall Study|Prohibited medication|0
2655897|NCT00688519|9170968|P1|Overall Study|Prohibited medication|1
2655898|NCT00688519|9170967|P2|Overall Study|Withdrawal by Subject|6
2655899|NCT00688519|9170968|P1|Overall Study|Withdrawal by Subject|7
2655900|NCT00688519|9170967|P2|Overall Study|Lack of Efficacy|1
2655901|NCT00688519|9170968|P1|Overall Study|Lack of Efficacy|3
2655902|NCT00688519|9170967|P2|Overall Study|Lost to Follow-up|3
2655903|NCT00688519|9170968|P1|Overall Study|Lost to Follow-up|3
2655904|NCT00688519|9170967|P2|Overall Study|Adverse Event|3
2655905|NCT00688519|9170968|P1|Overall Study|Adverse Event|2
2655906|NCT00688467|9170986|P2|Treatment Period 2|Adverse Event|1
2655907|NCT00688467|9170987|P1|Treatment Period 2|Adverse Event|0
2655908|NCT00688467|9170986|P2|Treatment Period 2|Protocol Violation|1
2655909|NCT00688467|9170987|P1|Treatment Period 2|Protocol Violation|0
2655910|NCT00688467|9170986|P2|Treatment Period 1|Did not meet protocol eligibility|1
2655911|NCT00688467|9170987|P1|Treatment Period 1|Did not meet protocol eligibility|0
2655912|NCT00688467|9170986|P2|Treatment Period 1|Adverse Event|1
2655913|NCT00688467|9170987|P1|Treatment Period 1|Adverse Event|2
2655914|NCT00688376|9171019|P2|Blinded Extension Phase|Other|0
2655915|NCT00688376|9171020|P1|Blinded Extension Phase|Other|1
2655916|NCT00688376|9171019|P2|Blinded Extension Phase|Physician Decision|0
2655917|NCT00688376|9171020|P1|Blinded Extension Phase|Physician Decision|1
2655918|NCT00688376|9171019|P2|Blinded Extension Phase|Withdrawal by Subject|1
2655919|NCT00688376|9171020|P1|Blinded Extension Phase|Withdrawal by Subject|0
2655920|NCT00688376|9171019|P2|Blinded Extension Phase|Adverse Event|4
2655921|NCT00688376|9171020|P1|Blinded Extension Phase|Adverse Event|3
2655922|NCT00688376|9171019|P2|Double-Blind Phase|Not treated|1
2655923|NCT00688376|9171020|P1|Double-Blind Phase|Not treated|0
2655924|NCT00688376|9171019|P2|Double-Blind Phase|Withdrawal by Subject|0
2655925|NCT00688376|9171020|P1|Double-Blind Phase|Withdrawal by Subject|1
2655926|NCT00688376|9171019|P2|Double-Blind Phase|Protocol Violation|2
2655927|NCT00688376|9171020|P1|Double-Blind Phase|Protocol Violation|1
2655928|NCT00688376|9171019|P2|Double-Blind Phase|Adverse Event|4
2655929|NCT00688376|9171020|P1|Double-Blind Phase|Adverse Event|4
2655930|NCT00688324|9171034|P1|Overall Study|Lost to Follow-up|1
2655931|NCT00688324|9171034|P1|Overall Study|Physician Decision|5
2655932|NCT00688324|9171034|P1|Overall Study|Withdrawal by Subject|2
2655933|NCT00688259|9171079|P2|Overall Study|Hospitalized at Follow-up|1
2655934|NCT00688259|9171080|P1|Overall Study|Hospitalized at Follow-up|0
2655935|NCT00688259|9171079|P2|Overall Study|Declined Interview|3
2655936|NCT00688259|9171080|P1|Overall Study|Declined Interview|2
2655937|NCT00688259|9171079|P2|Overall Study|Withdrawal by Subject|0
2655938|NCT00688259|9171080|P1|Overall Study|Withdrawal by Subject|2
2655939|NCT00688259|9171079|P2|Overall Study|Physician Decision|0
2655940|NCT00688259|9171080|P1|Overall Study|Physician Decision|1
2655941|NCT00688259|9171079|P2|Overall Study|Lost to Follow-up|4
2655942|NCT00688259|9171080|P1|Overall Study|Lost to Follow-up|2
2655943|NCT00688155|9171100|P4|Overall Study|Withdrawal by Subject|1
2655944|NCT00688155|9171101|P3|Overall Study|Withdrawal by Subject|1
2655945|NCT00688155|9171102|P2|Overall Study|Withdrawal by Subject|2
2655946|NCT00688155|9171103|P1|Overall Study|Withdrawal by Subject|2
2655947|NCT00688103|9171123|P2|Overall Study|complex reasons|9
2655948|NCT00688103|9171124|P1|Overall Study|complex reasons|11
2655949|NCT00688103|9171123|P2|Overall Study|Withdrawal by Subject|2
2655950|NCT00688103|9171124|P1|Overall Study|Withdrawal by Subject|4
2655951|NCT00688103|9171123|P2|Overall Study|Lack of Efficacy|1
2655952|NCT00688103|9171124|P1|Overall Study|Lack of Efficacy|11
2655953|NCT00688103|9171123|P2|Overall Study|Adverse Event|1
2655954|NCT00688103|9171124|P1|Overall Study|Adverse Event|4
2655955|NCT00688064|9171136|P2|Overall Study|Any other reasons|3
2655956|NCT00688064|9171137|P1|Overall Study|Any other reasons|1
2655957|NCT00688064|9171136|P2|Overall Study|Pregnancy|0
2655958|NCT00688064|9171137|P1|Overall Study|Pregnancy|1
2655959|NCT00688064|9171136|P2|Overall Study|Lack of Efficacy|1
2655960|NCT00688064|9171137|P1|Overall Study|Lack of Efficacy|0
2655961|NCT00688064|9171136|P2|Overall Study|Lost to Follow-up|10
2655962|NCT00688064|9171137|P1|Overall Study|Lost to Follow-up|10
2655963|NCT00688064|9171136|P2|Overall Study|Withdrawal by Subject|7
2655964|NCT00688064|9171137|P1|Overall Study|Withdrawal by Subject|7
2655965|NCT00688064|9171136|P2|Overall Study|Adverse Event|4
2655966|NCT00688064|9171137|P1|Overall Study|Adverse Event|2
2655967|NCT00688064|9171136|P2|Overall Study|Protocol Violation|1
2655968|NCT00688064|9171137|P1|Overall Study|Protocol Violation|0
2655969|NCT00687973|9171153|P2|Overall Study|Withdrawal by Subject|3
2655970|NCT00687973|9171154|P1|Overall Study|Withdrawal by Subject|3
2655971|NCT00687973|9171153|P2|Overall Study|Administrative Reasons|2
2655972|NCT00687973|9171154|P1|Overall Study|Administrative Reasons|0
2655973|NCT00687973|9171153|P2|Overall Study|Protocol Violation|2
2655974|NCT00687973|9171154|P1|Overall Study|Protocol Violation|1
2655975|NCT00687973|9171153|P2|Overall Study|Lack of Efficacy|3
2655976|NCT00687973|9171154|P1|Overall Study|Lack of Efficacy|2
2655977|NCT00687973|9171153|P2|Overall Study|Adverse Event|28
2655978|NCT00687973|9171154|P1|Overall Study|Adverse Event|18
2655979|NCT00687804|9171216|P3|Open-Label Extension Study|Death|3
2655980|NCT00687804|9171217|P2|Open-Label Extension Study|Death|3
2655981|NCT00687804|9171218|P1|Open-Label Extension Study|Death|2
2655982|NCT00687804|9171216|P3|Open-Label Extension Study|Administrative problems|0
2655983|NCT00687804|9171217|P2|Open-Label Extension Study|Administrative problems|1
2655984|NCT00687804|9171218|P1|Open-Label Extension Study|Administrative problems|1
2655985|NCT00687804|9171216|P3|Open-Label Extension Study|Lost to Follow-up|2
2655986|NCT00687804|9171217|P2|Open-Label Extension Study|Lost to Follow-up|1
2655987|NCT00687804|9171218|P1|Open-Label Extension Study|Lost to Follow-up|2
2655988|NCT00687804|9171216|P3|Open-Label Extension Study|Subject withdrew consent|4
2655989|NCT00687804|9171217|P2|Open-Label Extension Study|Subject withdrew consent|4
2655990|NCT00687804|9171218|P1|Open-Label Extension Study|Subject withdrew consent|3
2655991|NCT00687804|9171216|P3|Open-Label Extension Study|Adverse Event|2
2655992|NCT00687804|9171217|P2|Open-Label Extension Study|Adverse Event|2
2655993|NCT00687804|9171218|P1|Open-Label Extension Study|Adverse Event|2
2655994|NCT00687804|9171216|P3|Core Study|Protocol Violation|0
2655995|NCT00687804|9171217|P2|Core Study|Protocol Violation|1
2655996|NCT00687804|9171218|P1|Core Study|Protocol Violation|1
2655997|NCT00687804|9171216|P3|Core Study|Death|2
2655998|NCT00687804|9171217|P2|Core Study|Death|2
2655999|NCT00687804|9171218|P1|Core Study|Death|2
2656000|NCT00687804|9171216|P3|Core Study|Lost to Follow-up|0
2656001|NCT00687804|9171217|P2|Core Study|Lost to Follow-up|1
2656002|NCT00687804|9171218|P1|Core Study|Lost to Follow-up|0
2656003|NCT00687804|9171216|P3|Core Study|Withdrawal by Subject|7
2656004|NCT00687804|9171217|P2|Core Study|Withdrawal by Subject|7
2656005|NCT00687804|9171218|P1|Core Study|Withdrawal by Subject|4
2656006|NCT00687804|9171216|P3|Core Study|Lack of Efficacy|1
2656007|NCT00687804|9171217|P2|Core Study|Lack of Efficacy|1
2656008|NCT00687804|9171218|P1|Core Study|Lack of Efficacy|1
2656009|NCT00687804|9171216|P3|Core Study|Abnormal laboratory value(s)|0
2656010|NCT00687804|9171217|P2|Core Study|Abnormal laboratory value(s)|0
2656011|NCT00687804|9171218|P1|Core Study|Abnormal laboratory value(s)|1
2656012|NCT00687804|9171216|P3|Core Study|Adverse Event|3
2656013|NCT00687804|9171217|P2|Core Study|Adverse Event|3
2656014|NCT00687804|9171218|P1|Core Study|Adverse Event|5
2656015|NCT00687739|9171265|P4|Overall Study|Adverse Event|0
2656016|NCT00687739|9171266|P3|Overall Study|Adverse Event|1
2656017|NCT00687739|9171267|P2|Overall Study|Adverse Event|1
2656018|NCT00687739|9171268|P1|Overall Study|Adverse Event|0
2656019|NCT00687739|9171265|P4|Overall Study|Lost to Follow-up|2
2656020|NCT00687739|9171266|P3|Overall Study|Lost to Follow-up|1
2656021|NCT00687739|9171267|P2|Overall Study|Lost to Follow-up|2
2656022|NCT00687739|9171268|P1|Overall Study|Lost to Follow-up|2
2656023|NCT00687609|9171310|P1|Overall Study|Withdrawal by Subject|2
2656024|NCT00687609|9171310|P1|Overall Study|Physician Decision|1
2656025|NCT00687531|9171333|P1|Overall Study|Lost to Follow-up|26
2656026|NCT00687531|9171333|P1|Overall Study|Adverse Event|5
2656027|NCT00687531|9171333|P1|Overall Study|Did not meet protocol eligibility|104
2656028|NCT00687440|9171356|P1|Overall Study|Missing|1
2656029|NCT00687440|9171356|P1|Overall Study|Other|1
2656030|NCT00687440|9171356|P1|Overall Study|Death|2
2656031|NCT00687440|9171356|P1|Overall Study|Lack of Efficacy|2
2656032|NCT00687440|9171356|P1|Overall Study|Lost to Follow-up|3
2656033|NCT00687440|9171356|P1|Overall Study|Adverse Event|3
2656034|NCT00687401|9171360|P1|Overall Study|For reasons different from those above|4
2656035|NCT00687401|9171360|P1|Overall Study|Did not return for visit|3
2656036|NCT00687401|9171360|P1|Overall Study|Withdrawal by Subject|4
2656037|NCT00687401|9171360|P1|Overall Study|Lack of Efficacy|6
2656038|NCT00687401|9171360|P1|Overall Study|Adverse Event|6
2656039|NCT00687401|9171360|P1|Overall Study|Protocol Violation|7
2656040|NCT00687362|9171365|P1|Overall Study|Withdrawal by Subject|1
2656041|NCT00687362|9171365|P1|Overall Study|Protocol Violation|2
2656042|NCT00687323|9171369|P1|Overall Study|Screen failure|148
2656043|NCT00687323|9171369|P1|Overall Study|Excluded from efficacy evaluations|6
2656044|NCT00687323|9171369|P1|Overall Study|Withdrawal by Subject|1
2656045|NCT00687323|9171369|P1|Overall Study|Death|25
2656046|NCT00687297|9171385|P2|Induction|Other|1
2656047|NCT00687297|9171386|P1|Induction|Other|0
2656048|NCT00687297|9171385|P2|Induction|Physician Decision|2
2656049|NCT00687297|9171386|P1|Induction|Physician Decision|0
2656050|NCT00687297|9171385|P2|Induction|Patient Noncompliance|0
2656051|NCT00687297|9171386|P1|Induction|Patient Noncompliance|1
2656052|NCT00687297|9171385|P2|Induction|Ineligible|1
2656053|NCT00687297|9171386|P1|Induction|Ineligible|0
2656054|NCT00687297|9171385|P2|Induction|Lack of Efficacy|21
2656055|NCT00687297|9171386|P1|Induction|Lack of Efficacy|17
2656056|NCT00687297|9171385|P2|Induction|Death|11
2656057|NCT00687297|9171386|P1|Induction|Death|7
2656058|NCT00687297|9171385|P2|Induction|Adverse Event|15
2656059|NCT00687297|9171386|P1|Induction|Adverse Event|16
2656060|NCT00687297|9171385|P2|Induction|Withdrawal by Subject|4
2656061|NCT00687297|9171386|P1|Induction|Withdrawal by Subject|4
2656062|NCT00687297|9171385|P2|Randomization|Withdrew before treatment, ineligible|1
2656063|NCT00687297|9171386|P1|Randomization|Withdrew before treatment, ineligible|1
2656064|NCT00687297|9171385|P2|Randomization|Withdrawal by Subject|0
2656065|NCT00687297|9171386|P1|Randomization|Withdrawal by Subject|2
2656066|NCT00687271|9171400|P4|Overall Study|Withdrawal by Subject|0
2656067|NCT00687271|9171401|P3|Overall Study|Withdrawal by Subject|3
2656068|NCT00687271|9171402|P2|Overall Study|Withdrawal by Subject|1
2656069|NCT00687271|9171403|P1|Overall Study|Withdrawal by Subject|0
2656070|NCT00687271|9171400|P4|Overall Study|Protocol Violation|0
2656071|NCT00687271|9171401|P3|Overall Study|Protocol Violation|1
2656072|NCT00687271|9171402|P2|Overall Study|Protocol Violation|1
2656073|NCT00687271|9171403|P1|Overall Study|Protocol Violation|2
2656074|NCT00687271|9171400|P4|Overall Study|Lost to Follow-up|0
2656075|NCT00687271|9171401|P3|Overall Study|Lost to Follow-up|0
2656076|NCT00687271|9171402|P2|Overall Study|Lost to Follow-up|1
2656077|NCT00687271|9171403|P1|Overall Study|Lost to Follow-up|0
2656078|NCT00687271|9171400|P4|Overall Study|Adverse Event|0
2656079|NCT00687271|9171401|P3|Overall Study|Adverse Event|1
2656080|NCT00687271|9171402|P2|Overall Study|Adverse Event|3
2656081|NCT00687271|9171403|P1|Overall Study|Adverse Event|1
2656082|NCT00687219|9171441|P1|Overall Study|Lack of Efficacy|1
2656083|NCT00687219|9171441|P1|Overall Study|Withdrawal by Subject|1
2656084|NCT00687219|9171441|P1|Overall Study|HCV-RNA positive conversion|34
2656085|NCT00687219|9171441|P1|Overall Study|Discontinuance criteria met|7
2656086|NCT00687219|9171441|P1|Overall Study|Adverse Event|8
2656087|NCT00687193|9171453|P6|Overall Study|Protocol Violation|0
2656088|NCT00687193|9171454|P5|Overall Study|Protocol Violation|2
2656089|NCT00687193|9171455|P4|Overall Study|Protocol Violation|1
2656090|NCT00687193|9171456|P3|Overall Study|Protocol Violation|0
2656091|NCT00687193|9171457|P2|Overall Study|Protocol Violation|2
2656092|NCT00687193|9171458|P1|Overall Study|Protocol Violation|1
2656093|NCT00687193|9171453|P6|Overall Study|Lack of Efficacy|2
2656094|NCT00687193|9171454|P5|Overall Study|Lack of Efficacy|0
2656095|NCT00687193|9171455|P4|Overall Study|Lack of Efficacy|0
2656096|NCT00687193|9171456|P3|Overall Study|Lack of Efficacy|0
2656097|NCT00687193|9171457|P2|Overall Study|Lack of Efficacy|1
2656098|NCT00687193|9171458|P1|Overall Study|Lack of Efficacy|1
2656099|NCT00687193|9171453|P6|Overall Study|Adverse Event|2
2656100|NCT00687193|9171454|P5|Overall Study|Adverse Event|0
2656101|NCT00687193|9171455|P4|Overall Study|Adverse Event|3
2656102|NCT00687193|9171456|P3|Overall Study|Adverse Event|2
2656103|NCT00687193|9171457|P2|Overall Study|Adverse Event|1
2656104|NCT00687193|9171458|P1|Overall Study|Adverse Event|0
2656105|NCT00686998|9171668|P3|Overall Study|Safety Reasons|0
2656106|NCT00686998|9171669|P2|Overall Study|Safety Reasons|0
2656107|NCT00686998|9171670|P1|Overall Study|Safety Reasons|1
2656108|NCT00686998|9171668|P3|Overall Study|Other|1
2656109|NCT00686998|9171669|P2|Overall Study|Other|0
2656110|NCT00686998|9171670|P1|Overall Study|Other|0
2656111|NCT00686998|9171668|P3|Overall Study|Lack of Efficacy|0
2656112|NCT00686998|9171669|P2|Overall Study|Lack of Efficacy|5
2656113|NCT00686998|9171670|P1|Overall Study|Lack of Efficacy|7
2656114|NCT00686998|9171668|P3|Overall Study|Withdrawal by Subject|2
2656115|NCT00686998|9171669|P2|Overall Study|Withdrawal by Subject|1
2656116|NCT00686998|9171670|P1|Overall Study|Withdrawal by Subject|2
2656117|NCT00686998|9171668|P3|Overall Study|Adverse Event|1
2656118|NCT00686998|9171669|P2|Overall Study|Adverse Event|2
2656119|NCT00686998|9171670|P1|Overall Study|Adverse Event|3
2656120|NCT00686972|9171678|P1|Overall Study|P.I, Left institution. Study terminated|51
2656121|NCT00686959|9171684|P2|Overall Study|Participants censored (no death events)|117
2656122|NCT00686959|9171685|P1|Overall Study|Participants censored (no death events)|124
2656123|NCT00686920|9171705|P2|Overall Study|Principal Investigator Decision|0
2656124|NCT00686920|9171706|P1|Overall Study|Principal Investigator Decision|2
2656125|NCT00686920|9171705|P2|Overall Study|Noncompliance|0
2656126|NCT00686920|9171706|P1|Overall Study|Noncompliance|9
2656127|NCT00686920|9171705|P2|Overall Study|Transferred to Nursing Home|0
2656128|NCT00686920|9171706|P1|Overall Study|Transferred to Nursing Home|1
2656129|NCT00686920|9171705|P2|Overall Study|Moved to Another State|0
2656130|NCT00686920|9171706|P1|Overall Study|Moved to Another State|1
2656131|NCT00686920|9171705|P2|Overall Study|Lost to Follow-up|3
2656132|NCT00686920|9171706|P1|Overall Study|Lost to Follow-up|15
2656133|NCT00686920|9171705|P2|Overall Study|Personal Reason|1
2656134|NCT00686920|9171706|P1|Overall Study|Personal Reason|0
2656135|NCT00686920|9171705|P2|Overall Study|Adverse Event|2
2656136|NCT00686920|9171706|P1|Overall Study|Adverse Event|10
2656137|NCT00686920|9171705|P2|Overall Study|Protocol Violation|1
2656138|NCT00686920|9171706|P1|Overall Study|Protocol Violation|2
2656139|NCT00686920|9171705|P2|Overall Study|Withdrawal by Subject|5
2656140|NCT00686920|9171706|P1|Overall Study|Withdrawal by Subject|23
2656141|NCT00686920|9171705|P2|Overall Study|Recurrent Hepatic Encephalopathy Episode|2
2656142|NCT00686920|9171706|P1|Overall Study|Recurrent Hepatic Encephalopathy Episode|1
2656143|NCT00686920|9171705|P2|Overall Study|Liver Transplant|8
2656144|NCT00686920|9171706|P1|Overall Study|Liver Transplant|23
2656145|NCT00686920|9171705|P2|Overall Study|Death|14
2656146|NCT00686920|9171706|P1|Overall Study|Death|45
2656147|NCT00686894|9171718|P1|Overall Study|Protocol Violation|4
2656148|NCT00686894|9171718|P1|Overall Study|Relapse|2
2656149|NCT00686881|9171724|P2|Overall Study|Never received study drug|6
2656150|NCT00686881|9171725|P1|Overall Study|Never received study drug|2
2656151|NCT00686881|9171724|P2|Overall Study|Study discontinuation|32
2656152|NCT00686881|9171725|P1|Overall Study|Study discontinuation|35
2656153|NCT00686881|9171724|P2|Overall Study|Irregular visits|0
2656154|NCT00686881|9171725|P1|Overall Study|Irregular visits|1
2656155|NCT00686881|9171724|P2|Overall Study|Did not meet protocol eligibility|0
2656156|NCT00686881|9171725|P1|Overall Study|Did not meet protocol eligibility|1
2656157|NCT00686881|9171724|P2|Overall Study|Circumstances of site|1
2656158|NCT00686881|9171725|P1|Overall Study|Circumstances of site|1
2656159|NCT00686881|9171724|P2|Overall Study|Physician Decision|0
2656160|NCT00686881|9171725|P1|Overall Study|Physician Decision|1
2656161|NCT00686881|9171724|P2|Overall Study|Lack of Efficacy|3
2656162|NCT00686881|9171725|P1|Overall Study|Lack of Efficacy|4
2656163|NCT00686881|9171724|P2|Overall Study|Onset of malignant tumor|11
2656164|NCT00686881|9171725|P1|Overall Study|Onset of malignant tumor|11
2656165|NCT00686881|9171724|P2|Overall Study|Met discontinuation criteria|0
2656166|NCT00686881|9171725|P1|Overall Study|Met discontinuation criteria|5
2656167|NCT00686881|9171724|P2|Overall Study|Treatment-related adverse event|9
2656168|NCT00686881|9171725|P1|Overall Study|Treatment-related adverse event|10
2656169|NCT00686881|9171724|P2|Overall Study|Lost to Follow-up|1
2656170|NCT00686881|9171725|P1|Overall Study|Lost to Follow-up|0
2656171|NCT00686881|9171724|P2|Overall Study|Withdrawal by Subject|18
2656172|NCT00686881|9171725|P1|Overall Study|Withdrawal by Subject|11
2656173|NCT00686855|9171737|P2|Overall Study|Progressive GVHD|1
2656174|NCT00686855|9171738|P1|Overall Study|Progressive GVHD|0
2656175|NCT00686855|9171737|P2|Overall Study|Lost to Follow-up|0
2656176|NCT00686855|9171738|P1|Overall Study|Lost to Follow-up|1
2656177|NCT00686790|9171764|P1|Overall Study|Lost to Follow-up|12
2656178|NCT00686790|9171764|P1|Overall Study|Death|1
2656179|NCT00686790|9171764|P1|Overall Study|Withdrawal by Subject|1
2656180|NCT00686790|9171764|P1|Overall Study|Adverse Event|2
2656181|NCT00686777|9171772|P1|Overall Study|No Visit|1
2656182|NCT00686777|9171772|P1|Overall Study|Discontinuance Criteria (specified AEs)|4
2656183|NCT00686777|9171772|P1|Overall Study|Withdrawal by Subject|2
2656184|NCT00686777|9171772|P1|Overall Study|Pregnancy|1
2656185|NCT00686777|9171772|P1|Overall Study|Adverse Event|2
2656186|NCT00686725|9171780|P2|Overall Study|Other|3
2656187|NCT00686725|9171781|P1|Overall Study|Other|1
2656188|NCT00686725|9171780|P2|Overall Study|Protocol Violation|3
2656189|NCT00686725|9171781|P1|Overall Study|Protocol Violation|1
2656190|NCT00686725|9171780|P2|Overall Study|Withdrawal by Subject|4
2656191|NCT00686725|9171781|P1|Overall Study|Withdrawal by Subject|13
2656192|NCT00686725|9171780|P2|Overall Study|Death|3
2656193|NCT00686725|9171781|P1|Overall Study|Death|6
2656194|NCT00686725|9171780|P2|Overall Study|Lost to Follow-up|5
2656195|NCT00686725|9171781|P1|Overall Study|Lost to Follow-up|7
2656196|NCT00686725|9171780|P2|Overall Study|Progressive Disease|23
2656197|NCT00686725|9171781|P1|Overall Study|Progressive Disease|17
2656198|NCT00686725|9171780|P2|Overall Study|Adverse Event|1
2656199|NCT00686725|9171781|P1|Overall Study|Adverse Event|1
2656200|NCT00686712|9171806|P3|Overall Study|Adverse Event|0
2656201|NCT00686712|9171807|P2|Overall Study|Adverse Event|1
2656202|NCT00686712|9171808|P1|Overall Study|Adverse Event|1
2656203|NCT00686712|9171806|P3|Overall Study|Lost to Follow-up|3
2656204|NCT00686712|9171807|P2|Overall Study|Lost to Follow-up|2
2656205|NCT00686712|9171808|P1|Overall Study|Lost to Follow-up|1
2656206|NCT00686712|9171806|P3|Overall Study|Protocol Violation|10
2656207|NCT00686712|9171807|P2|Overall Study|Protocol Violation|8
2656208|NCT00686712|9171808|P1|Overall Study|Protocol Violation|8
2656209|NCT00686699|9171836|P2|Treatment Period 1|Adverse Event|2
2656210|NCT00686699|9171837|P1|Treatment Period 1|Adverse Event|0
2656211|NCT00686686|9171861|P1|Overall Study|Lost to Follow-up|3
2656212|NCT00686686|9171861|P1|Overall Study|Adverse Event|2
2656213|NCT00686686|9171861|P1|Overall Study|Non-compliance|1
2656214|NCT00686647|9171869|P1|Overall Study|Death|1
2656215|NCT00686647|9171869|P1|Overall Study|Lost to Follow-up|1
2656216|NCT00686634|9171875|P1|Overall Study|Protocol Violation|6
2656217|NCT00686595|9171882|P1|Overall Study|Poor Compliance|1
2656218|NCT00686595|9171882|P1|Overall Study|Lack of Efficacy|1
2656219|NCT00686595|9171882|P1|Overall Study|Lost to Follow-up|1
2656220|NCT00686595|9171882|P1|Overall Study|Protocol Violation|1
2656221|NCT00686595|9171882|P1|Overall Study|Adverse Event|3
2656222|NCT00686543|9171942|P4|Overall Study|Protocol Violation|1
2656223|NCT00686543|9171943|P3|Overall Study|Protocol Violation|2
2656224|NCT00686543|9171944|P2|Overall Study|Protocol Violation|0
2656225|NCT00686543|9171945|P1|Overall Study|Protocol Violation|3
2656226|NCT00686543|9171942|P4|Overall Study|Withdrawal by Subject|0
2656227|NCT00686543|9171943|P3|Overall Study|Withdrawal by Subject|0
2656228|NCT00686543|9171944|P2|Overall Study|Withdrawal by Subject|0
2656229|NCT00686543|9171945|P1|Overall Study|Withdrawal by Subject|2
2656230|NCT00686543|9171942|P4|Overall Study|Adverse Event|2
2656231|NCT00686543|9171943|P3|Overall Study|Adverse Event|3
2656232|NCT00686543|9171944|P2|Overall Study|Adverse Event|1
2656233|NCT00686543|9171945|P1|Overall Study|Adverse Event|9
2656234|NCT00686517|9171966|P3|Treatment|Protocol Violation|0
2656235|NCT00686517|9171967|P2|Treatment|Protocol Violation|1
2656236|NCT00686517|9171968|P1|Treatment|Protocol Violation|2
2656237|NCT00686517|9171966|P3|Treatment|Poor Protocol Compliance|0
2656238|NCT00686517|9171967|P2|Treatment|Poor Protocol Compliance|0
2656239|NCT00686517|9171968|P1|Treatment|Poor Protocol Compliance|1
2656240|NCT00686517|9171966|P3|Treatment|Adverse Event|0
2656241|NCT00686517|9171967|P2|Treatment|Adverse Event|0
2656242|NCT00686517|9171968|P1|Treatment|Adverse Event|2
2656243|NCT00686517|9171966|P3|Treatment|Serious Adverse Event|1
2656244|NCT00686517|9171967|P2|Treatment|Serious Adverse Event|2
2656245|NCT00686517|9171968|P1|Treatment|Serious Adverse Event|1
2656246|NCT00686374|9171991|P1|Overall Study|Other, not specified|4
2656247|NCT00686374|9171991|P1|Overall Study|Missing reason|33
2656248|NCT00686374|9171991|P1|Overall Study|Lost to Follow-up|1
2656249|NCT00686374|9171991|P1|Overall Study|Withdrew consent|5
2656250|NCT00686374|9171991|P1|Overall Study|Adverse Event|8
2656251|NCT00686374|9171991|P1|Overall Study|Lack of Efficacy|10
2656252|NCT00686335|9172002|P1|Run-in Period|violation of inclusion/exclusion criteri|3
2656253|NCT00686335|9172002|P1|Run-in Period|asthma exacerbation|1
2656254|NCT00686335|9172002|P1|Run-in Period|Adverse Event|1
2656255|NCT00686205|9172046|P2|Overall Study|Specimens not confirmed HIV positive|981
2656256|NCT00686205|9172047|P1|Overall Study|Specimens not confirmed HIV positive|0
2656257|NCT00686205|9172046|P2|Overall Study|Specimen handling procedure altered|0
2656258|NCT00686205|9172047|P1|Overall Study|Specimen handling procedure altered|5878
2656259|NCT00686205|9172046|P2|Overall Study|Withdrawal by Subject|0
2656260|NCT00686205|9172047|P1|Overall Study|Withdrawal by Subject|2
2656261|NCT00686205|9172046|P2|Overall Study|Protocol Violation|0
2656262|NCT00686205|9172047|P1|Overall Study|Protocol Violation|127
2656263|NCT00686166|9172053|P1|Overall Study|Did not begin protocol therapy|4
2656264|NCT00686166|9172053|P1|Overall Study|Ineligible|5
2656265|NCT00686166|9172053|P1|Overall Study|Not Protocol Specified|1
2656266|NCT00686166|9172053|P1|Overall Study|Death|1
2656267|NCT00686166|9172053|P1|Overall Study|Progression/Relapse|1
2656268|NCT00686166|9172053|P1|Overall Study|Withdrawal by Subject|1
2656269|NCT00686166|9172053|P1|Overall Study|Adverse Event|7
2656270|NCT00686127|9172065|P2|Overall Study|Withdrawal by Subject|6
2656271|NCT00686127|9172066|P1|Overall Study|Withdrawal by Subject|14
2656272|NCT00686075|9172082|P10|Overall Study|Other|1
2656273|NCT00686075|9172083|P9|Overall Study|Other|0
2656274|NCT00686075|9172084|P8|Overall Study|Other|0
2656275|NCT00686075|9172085|P7|Overall Study|Other|0
2656276|NCT00686075|9172086|P6|Overall Study|Other|0
2656277|NCT00686075|9172087|P5|Overall Study|Other|0
2656278|NCT00686075|9172088|P4|Overall Study|Other|0
2656279|NCT00686075|9172089|P3|Overall Study|Other|0
2656280|NCT00686075|9172090|P2|Overall Study|Other|1
2656281|NCT00686075|9172091|P1|Overall Study|Other|1
2656282|NCT00686075|9172082|P10|Overall Study|Lost to Follow-up|3
2656283|NCT00686075|9172083|P9|Overall Study|Lost to Follow-up|2
2656284|NCT00686075|9172084|P8|Overall Study|Lost to Follow-up|0
2656285|NCT00686075|9172085|P7|Overall Study|Lost to Follow-up|0
2656286|NCT00686075|9172086|P6|Overall Study|Lost to Follow-up|3
2656287|NCT00686075|9172087|P5|Overall Study|Lost to Follow-up|3
2656288|NCT00686075|9172088|P4|Overall Study|Lost to Follow-up|2
2656289|NCT00686075|9172089|P3|Overall Study|Lost to Follow-up|3
2656290|NCT00686075|9172090|P2|Overall Study|Lost to Follow-up|6
2656291|NCT00686075|9172091|P1|Overall Study|Lost to Follow-up|3
2656292|NCT00686075|9172082|P10|Overall Study|Withdrawal by Subject|6
2656293|NCT00686075|9172083|P9|Overall Study|Withdrawal by Subject|4
2656294|NCT00686075|9172084|P8|Overall Study|Withdrawal by Subject|2
2656295|NCT00686075|9172085|P7|Overall Study|Withdrawal by Subject|0
2656296|NCT00686075|9172086|P6|Overall Study|Withdrawal by Subject|0
2656297|NCT00686075|9172087|P5|Overall Study|Withdrawal by Subject|1
2656298|NCT00686075|9172088|P4|Overall Study|Withdrawal by Subject|7
2656299|NCT00686075|9172089|P3|Overall Study|Withdrawal by Subject|3
2656300|NCT00686075|9172090|P2|Overall Study|Withdrawal by Subject|3
2656301|NCT00686075|9172091|P1|Overall Study|Withdrawal by Subject|4
2656302|NCT00686036|9172285|P2|Overall Study|Other reasons not identified|4
2656303|NCT00686036|9172286|P1|Overall Study|Other reasons not identified|0
2656304|NCT00686036|9172285|P2|Overall Study|PSA ≥ 10ng/mL|0
2656305|NCT00686036|9172286|P1|Overall Study|PSA ≥ 10ng/mL|1
2656306|NCT00686036|9172285|P2|Overall Study|Study terminated by AstraZeneca|1
2656307|NCT00686036|9172286|P1|Overall Study|Study terminated by AstraZeneca|2
2656308|NCT00686036|9172285|P2|Overall Study|Withdrawal by Subject|1
2656309|NCT00686036|9172286|P1|Overall Study|Withdrawal by Subject|3
2656310|NCT00686036|9172285|P2|Overall Study|Adverse Event|0
2656311|NCT00686036|9172286|P1|Overall Study|Adverse Event|3
2656312|NCT00685945|9172298|P1|L-NMMA + Bradykinin|Physician Decision|1
2656313|NCT00685802|9172333|P2|Washout Period of 7 Days|Withdrawal by Subject|1
2656314|NCT00685802|9172334|P1|Washout Period of 7 Days|Withdrawal by Subject|0
2656315|NCT00685802|9172333|P2|Washout Period of 7 Days|Protocol Violation|0
2656316|NCT00685802|9172334|P1|Washout Period of 7 Days|Protocol Violation|2
2656317|NCT00685763|9172344|P1|Overall Study|Protocol Violation|1
2656318|NCT00685763|9172344|P1|Overall Study|Intercurrent death-incomplete treatment|1
2656319|NCT00685750|9172355|P7|Overall Study|Eligibility criteria not fulfilled|0
2656320|NCT00685750|9172356|P6|Overall Study|Eligibility criteria not fulfilled|0
2656408|NCT00685399|9172580|P6|Treatment Period 2|Withdrawal by Subject|0
2656321|NCT00685750|9172357|P5|Overall Study|Eligibility criteria not fulfilled|0
2656322|NCT00685750|9172358|P4|Overall Study|Eligibility criteria not fulfilled|0
2656323|NCT00685750|9172359|P3|Overall Study|Eligibility criteria not fulfilled|1
2656324|NCT00685750|9172360|P2|Overall Study|Eligibility criteria not fulfilled|0
2656325|NCT00685750|9172361|P1|Overall Study|Eligibility criteria not fulfilled|0
2656326|NCT00685750|9172355|P7|Overall Study|Patient didn't receive the treatment|1
2656327|NCT00685750|9172356|P6|Overall Study|Patient didn't receive the treatment|0
2656328|NCT00685750|9172357|P5|Overall Study|Patient didn't receive the treatment|0
2656329|NCT00685750|9172358|P4|Overall Study|Patient didn't receive the treatment|0
2656330|NCT00685750|9172359|P3|Overall Study|Patient didn't receive the treatment|0
2656331|NCT00685750|9172360|P2|Overall Study|Patient didn't receive the treatment|0
2656332|NCT00685750|9172361|P1|Overall Study|Patient didn't receive the treatment|0
2656333|NCT00685750|9172355|P7|Overall Study|Tumor sampling failure|0
2656334|NCT00685750|9172356|P6|Overall Study|Tumor sampling failure|0
2656335|NCT00685750|9172357|P5|Overall Study|Tumor sampling failure|0
2656336|NCT00685750|9172358|P4|Overall Study|Tumor sampling failure|0
2656337|NCT00685750|9172359|P3|Overall Study|Tumor sampling failure|1
2656338|NCT00685750|9172360|P2|Overall Study|Tumor sampling failure|0
2656339|NCT00685750|9172361|P1|Overall Study|Tumor sampling failure|0
2656340|NCT00685698|9172389|P1|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1
2656341|NCT00685698|9172389|P1|Overall Study|CULTURE RESULTS: GRAM-VE|1
2656342|NCT00685698|9172389|P1|Overall Study|CULTURE GRAM NEG SPECIES|1
2656343|NCT00685698|9172389|P1|Overall Study|Adverse Event|3
2656344|NCT00685698|9172389|P1|Overall Study|Protocol Violation|6
2656345|NCT00685698|9172389|P1|Overall Study|Withdrawal by Subject|1
2656346|NCT00685685|9172424|P2|Washout Period of 7 Days|Withdrawal by Subject|1
2656347|NCT00685685|9172425|P1|Washout Period of 7 Days|Withdrawal by Subject|0
2656348|NCT00685685|9172424|P2|Washout Period of 7 Days|Adverse Event|0
2656349|NCT00685685|9172425|P1|Washout Period of 7 Days|Adverse Event|2
2656350|NCT00685399|9172578|P8|Extension|Adverse Event|0
2656351|NCT00685399|9172579|P7|Extension|Adverse Event|0
2656352|NCT00685399|9172580|P6|Extension|Adverse Event|0
2656353|NCT00685399|9172581|P5|Extension|Adverse Event|0
2656354|NCT00685399|9172582|P4|Extension|Adverse Event|2
2656355|NCT00685399|9172583|P3|Extension|Adverse Event|0
2656356|NCT00685399|9172584|P2|Extension|Adverse Event|0
2656357|NCT00685399|9172585|P1|Extension|Adverse Event|0
2656358|NCT00685399|9172578|P8|Extension|Lack of Efficacy|0
2656359|NCT00685399|9172579|P7|Extension|Lack of Efficacy|0
2656360|NCT00685399|9172580|P6|Extension|Lack of Efficacy|0
2656361|NCT00685399|9172581|P5|Extension|Lack of Efficacy|0
2656362|NCT00685399|9172582|P4|Extension|Lack of Efficacy|2
2656363|NCT00685399|9172583|P3|Extension|Lack of Efficacy|0
2656364|NCT00685399|9172584|P2|Extension|Lack of Efficacy|0
2656365|NCT00685399|9172585|P1|Extension|Lack of Efficacy|0
2656366|NCT00685399|9172578|P8|Extension|Protocol Violation|0
2656367|NCT00685399|9172579|P7|Extension|Protocol Violation|0
2656368|NCT00685399|9172580|P6|Extension|Protocol Violation|0
2656369|NCT00685399|9172581|P5|Extension|Protocol Violation|0
2656370|NCT00685399|9172582|P4|Extension|Protocol Violation|1
2656371|NCT00685399|9172583|P3|Extension|Protocol Violation|0
2656372|NCT00685399|9172584|P2|Extension|Protocol Violation|0
2656373|NCT00685399|9172585|P1|Extension|Protocol Violation|0
2656374|NCT00685399|9172578|P8|Extension|Withdrawal by Subject|0
2656375|NCT00685399|9172579|P7|Extension|Withdrawal by Subject|0
2656376|NCT00685399|9172580|P6|Extension|Withdrawal by Subject|0
2656377|NCT00685399|9172581|P5|Extension|Withdrawal by Subject|0
2656378|NCT00685399|9172582|P4|Extension|Withdrawal by Subject|1
2656379|NCT00685399|9172583|P3|Extension|Withdrawal by Subject|0
2656380|NCT00685399|9172584|P2|Extension|Withdrawal by Subject|0
2656381|NCT00685399|9172585|P1|Extension|Withdrawal by Subject|0
2656382|NCT00685399|9172578|P8|Extension|Administrative Issues|0
2656383|NCT00685399|9172579|P7|Extension|Administrative Issues|0
2656384|NCT00685399|9172580|P6|Extension|Administrative Issues|0
2656385|NCT00685399|9172581|P5|Extension|Administrative Issues|0
2656386|NCT00685399|9172582|P4|Extension|Administrative Issues|1
2656387|NCT00685399|9172583|P3|Extension|Administrative Issues|0
2656388|NCT00685399|9172584|P2|Extension|Administrative Issues|0
2656389|NCT00685399|9172585|P1|Extension|Administrative Issues|0
2656390|NCT00685399|9172578|P8|Treatment Period 2|Lack of Efficacy|0
2656391|NCT00685399|9172579|P7|Treatment Period 2|Lack of Efficacy|0
2656392|NCT00685399|9172580|P6|Treatment Period 2|Lack of Efficacy|1
2656393|NCT00685399|9172581|P5|Treatment Period 2|Lack of Efficacy|0
2656394|NCT00685399|9172582|P4|Treatment Period 2|Lack of Efficacy|0
2656395|NCT00685399|9172583|P3|Treatment Period 2|Lack of Efficacy|2
2656396|NCT00685399|9172584|P2|Treatment Period 2|Lack of Efficacy|10
2656397|NCT00685399|9172585|P1|Treatment Period 2|Lack of Efficacy|0
2656398|NCT00685399|9172578|P8|Treatment Period 2|Adverse Event|0
2656399|NCT00685399|9172579|P7|Treatment Period 2|Adverse Event|0
2656400|NCT00685399|9172580|P6|Treatment Period 2|Adverse Event|1
2656401|NCT00685399|9172581|P5|Treatment Period 2|Adverse Event|0
2656402|NCT00685399|9172582|P4|Treatment Period 2|Adverse Event|0
2656403|NCT00685399|9172583|P3|Treatment Period 2|Adverse Event|0
2656404|NCT00685399|9172584|P2|Treatment Period 2|Adverse Event|0
2656405|NCT00685399|9172585|P1|Treatment Period 2|Adverse Event|0
2656406|NCT00685399|9172578|P8|Treatment Period 2|Withdrawal by Subject|2
2656407|NCT00685399|9172579|P7|Treatment Period 2|Withdrawal by Subject|0
2656409|NCT00685399|9172581|P5|Treatment Period 2|Withdrawal by Subject|0
2656410|NCT00685399|9172582|P4|Treatment Period 2|Withdrawal by Subject|0
2656411|NCT00685399|9172583|P3|Treatment Period 2|Withdrawal by Subject|0
2656412|NCT00685399|9172584|P2|Treatment Period 2|Withdrawal by Subject|0
2656413|NCT00685399|9172585|P1|Treatment Period 2|Withdrawal by Subject|0
2656414|NCT00685399|9172578|P8|Treatment Period 2|Administrative Problems|0
2656415|NCT00685399|9172579|P7|Treatment Period 2|Administrative Problems|0
2656416|NCT00685399|9172580|P6|Treatment Period 2|Administrative Problems|0
2656417|NCT00685399|9172581|P5|Treatment Period 2|Administrative Problems|0
2656418|NCT00685399|9172582|P4|Treatment Period 2|Administrative Problems|0
2656419|NCT00685399|9172583|P3|Treatment Period 2|Administrative Problems|1
2656420|NCT00685399|9172584|P2|Treatment Period 2|Administrative Problems|2
2656421|NCT00685399|9172585|P1|Treatment Period 2|Administrative Problems|0
2656422|NCT00685399|9172578|P8|Treatment Period 1|Lack of Efficacy|0
2656423|NCT00685399|9172579|P7|Treatment Period 1|Lack of Efficacy|0
2656424|NCT00685399|9172580|P6|Treatment Period 1|Lack of Efficacy|0
2656425|NCT00685399|9172581|P5|Treatment Period 1|Lack of Efficacy|0
2656426|NCT00685399|9172582|P4|Treatment Period 1|Lack of Efficacy|0
2656427|NCT00685399|9172583|P3|Treatment Period 1|Lack of Efficacy|0
2656428|NCT00685399|9172584|P2|Treatment Period 1|Lack of Efficacy|0
2656429|NCT00685399|9172585|P1|Treatment Period 1|Lack of Efficacy|1
2656430|NCT00685399|9172578|P8|Treatment Period 1|Administrative|0
2656431|NCT00685399|9172579|P7|Treatment Period 1|Administrative|0
2656432|NCT00685399|9172580|P6|Treatment Period 1|Administrative|0
2656433|NCT00685399|9172581|P5|Treatment Period 1|Administrative|0
2656434|NCT00685399|9172582|P4|Treatment Period 1|Administrative|0
2656435|NCT00685399|9172583|P3|Treatment Period 1|Administrative|0
2656436|NCT00685399|9172584|P2|Treatment Period 1|Administrative|0
2656437|NCT00685399|9172585|P1|Treatment Period 1|Administrative|2
2656438|NCT00685399|9172578|P8|Treatment Period 1|Protocol Violation|0
2656439|NCT00685399|9172579|P7|Treatment Period 1|Protocol Violation|0
2656440|NCT00685399|9172580|P6|Treatment Period 1|Protocol Violation|0
2656441|NCT00685399|9172581|P5|Treatment Period 1|Protocol Violation|0
2656442|NCT00685399|9172582|P4|Treatment Period 1|Protocol Violation|0
2656443|NCT00685399|9172583|P3|Treatment Period 1|Protocol Violation|0
2656444|NCT00685399|9172584|P2|Treatment Period 1|Protocol Violation|0
2656445|NCT00685399|9172585|P1|Treatment Period 1|Protocol Violation|1
2656446|NCT00685399|9172578|P8|Treatment Period 1|Withdrawal by Subject|0
2656447|NCT00685399|9172579|P7|Treatment Period 1|Withdrawal by Subject|0
2656448|NCT00685399|9172580|P6|Treatment Period 1|Withdrawal by Subject|0
2656449|NCT00685399|9172581|P5|Treatment Period 1|Withdrawal by Subject|0
2656450|NCT00685399|9172582|P4|Treatment Period 1|Withdrawal by Subject|0
2656451|NCT00685399|9172583|P3|Treatment Period 1|Withdrawal by Subject|0
2656452|NCT00685399|9172584|P2|Treatment Period 1|Withdrawal by Subject|0
2656453|NCT00685399|9172585|P1|Treatment Period 1|Withdrawal by Subject|2
2656454|NCT00685373|9172618|P1|Overall Study|Protocol Violation|1
2656455|NCT00685373|9172618|P1|Overall Study|Lost to Follow-up|2
2656456|NCT00685373|9172618|P1|Overall Study|Condition no longer requires study drug|1
2656457|NCT00685373|9172618|P1|Overall Study|Lack of Efficacy|3
2656458|NCT00685373|9172618|P1|Overall Study|Withdrawal by Subject|5
2656459|NCT00685373|9172618|P1|Overall Study|Adverse Event|3
2656460|NCT00685334|9172627|P2|Overall Study|Chose to enter hospital|1
2656461|NCT00685334|9172628|P1|Overall Study|Chose to enter hospital|1
2656462|NCT00685334|9172627|P2|Overall Study|Lost to Follow-up|0
2656463|NCT00685334|9172628|P1|Overall Study|Lost to Follow-up|4
2656464|NCT00685334|9172627|P2|Overall Study|Withdrawal by Subject|6
2656465|NCT00685334|9172628|P1|Overall Study|Withdrawal by Subject|5
2656466|NCT00685178|9172653|P4|Overall Study|Pregnancy|1
2656467|NCT00685178|9172654|P3|Overall Study|Pregnancy|0
2656468|NCT00685178|9172655|P2|Overall Study|Pregnancy|0
2656469|NCT00685178|9172656|P1|Overall Study|Pregnancy|0
2656470|NCT00685178|9172653|P4|Overall Study|administrative (disciplinary) discharge|2
2656471|NCT00685178|9172654|P3|Overall Study|administrative (disciplinary) discharge|0
2656472|NCT00685178|9172655|P2|Overall Study|administrative (disciplinary) discharge|1
2656473|NCT00685178|9172656|P1|Overall Study|administrative (disciplinary) discharge|0
2656474|NCT00685178|9172653|P4|Overall Study|incarcerated|0
2656475|NCT00685178|9172654|P3|Overall Study|incarcerated|7
2656476|NCT00685178|9172655|P2|Overall Study|incarcerated|3
2656477|NCT00685178|9172656|P1|Overall Study|incarcerated|1
2656478|NCT00685178|9172653|P4|Overall Study|voluntary study discharge|1
2656479|NCT00685178|9172654|P3|Overall Study|voluntary study discharge|1
2656480|NCT00685178|9172655|P2|Overall Study|voluntary study discharge|5
2656481|NCT00685178|9172656|P1|Overall Study|voluntary study discharge|4
2656482|NCT00685178|9172653|P4|Overall Study|missed 3 consecutive methadone clin days|6
2656483|NCT00685178|9172654|P3|Overall Study|missed 3 consecutive methadone clin days|2
2656484|NCT00685178|9172655|P2|Overall Study|missed 3 consecutive methadone clin days|5
2656485|NCT00685178|9172656|P1|Overall Study|missed 3 consecutive methadone clin days|7
2656486|NCT00685178|9172653|P4|Overall Study|Adverse Event|4
2656487|NCT00685178|9172654|P3|Overall Study|Adverse Event|2
2656488|NCT00685178|9172655|P2|Overall Study|Adverse Event|5
2656489|NCT00685178|9172656|P1|Overall Study|Adverse Event|1
2656490|NCT00685165|9172670|P2|Washout Period of 14 Days|Adverse Event|0
2656491|NCT00685165|9172671|P1|Washout Period of 14 Days|Adverse Event|1
2656573|NCT00684307|9172988|P5|Overall Study|Adverse Event|8
2656492|NCT00685035|9172690|P2|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0
2656493|NCT00685035|9172691|P1|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1
2656494|NCT00684996|9172715|P1|Overall Study|Other reasons not protocol specified|1
2656495|NCT00684996|9172715|P1|Overall Study|Progression/relapse|2
2656496|NCT00684996|9172715|P1|Overall Study|Refusal unrelated to adverse event|1
2656497|NCT00684996|9172715|P1|Overall Study|Adverse Event|1
2656498|NCT00684814|9172747|P2|Second Intervention|Adverse Event|0
2656499|NCT00684814|9172748|P1|Second Intervention|Adverse Event|1
2656500|NCT00684814|9172747|P2|Washout Period of 7 Days|Withdrawal by Subject|2
2656501|NCT00684814|9172748|P1|Washout Period of 7 Days|Withdrawal by Subject|1
2656502|NCT00684814|9172747|P2|Washout Period of 7 Days|Adverse Event|2
2656503|NCT00684814|9172748|P1|Washout Period of 7 Days|Adverse Event|1
2656504|NCT00684762|9172800|P2|Washout Period of 7 Days|Withdrawal by Subject|2
2656505|NCT00684762|9172801|P1|Washout Period of 7 Days|Withdrawal by Subject|2
2656506|NCT00684671|9172829|P3|Overall Study|Alcoholic dependance|0
2656507|NCT00684671|9172830|P2|Overall Study|Alcoholic dependance|0
2656508|NCT00684671|9172831|P1|Overall Study|Alcoholic dependance|1
2656509|NCT00684671|9172829|P3|Overall Study|Lost to Follow-up|0
2656510|NCT00684671|9172830|P2|Overall Study|Lost to Follow-up|0
2656511|NCT00684671|9172831|P1|Overall Study|Lost to Follow-up|1
2656512|NCT00684671|9172829|P3|Overall Study|Adverse Event|0
2656513|NCT00684671|9172830|P2|Overall Study|Adverse Event|0
2656514|NCT00684671|9172831|P1|Overall Study|Adverse Event|1
2656515|NCT00684645|9172860|P1|Overall Study|Other|15
2656516|NCT00684645|9172860|P1|Overall Study|Lost to Follow-up|3
2656517|NCT00684645|9172860|P1|Overall Study|Adverse Event|27
2656518|NCT00684645|9172860|P1|Overall Study|Progressive disease|67
2656519|NCT00684645|9172860|P1|Overall Study|Death|2
2656520|NCT00684593|9172880|P2|Overall Study|Adverse Event|2
2656521|NCT00684593|9172881|P1|Overall Study|Adverse Event|0
2656522|NCT00684567|9172893|P1|Monotherapy Period|Progression of primary disease|11
2656523|NCT00684567|9172893|P1|Monotherapy Period|Death|1
2656524|NCT00684567|9172893|P1|Monotherapy Period|Adverse Event|2
2656525|NCT00684567|9172893|P1|Concomitant Radiotherapy Period|Adverse Event|2
2656526|NCT00684515|9172926|P3|Overall Study|Protocol-Defined Clinical Event|0
2656527|NCT00684515|9172927|P2|Overall Study|Protocol-Defined Clinical Event|0
2656528|NCT00684515|9172928|P1|Overall Study|Protocol-Defined Clinical Event|1
2656529|NCT00684515|9172926|P3|Overall Study|Adverse Event|1
2656530|NCT00684515|9172927|P2|Overall Study|Adverse Event|3
2656531|NCT00684515|9172928|P1|Overall Study|Adverse Event|3
2656532|NCT00684424|9172951|P1|Overall Study|Other|2
2656533|NCT00684424|9172951|P1|Overall Study|Lost to Follow-up|2
2656534|NCT00684424|9172951|P1|Overall Study|Adverse Event|1
2656535|NCT00684411|9172966|P1|Overall Study|Adverse Event|1
2656536|NCT00684411|9172966|P1|Overall Study|Disease Progression|10
2656537|NCT00684411|9172966|P1|Overall Study|New Primary Cancer|1
2656538|NCT00684307|9172988|P5|Overall Study|Criteria from the CSR|3
2656539|NCT00684307|9172989|P4|Overall Study|Criteria from the CSR|3
2656540|NCT00684307|9172990|P3|Overall Study|Criteria from the CSR|1
2656541|NCT00684307|9172991|P2|Overall Study|Criteria from the CSR|0
2656542|NCT00684307|9172992|P1|Overall Study|Criteria from the CSR|0
2656543|NCT00684307|9172988|P5|Overall Study|Participant not willing to continue|8
2656544|NCT00684307|9172989|P4|Overall Study|Participant not willing to continue|5
2656545|NCT00684307|9172990|P3|Overall Study|Participant not willing to continue|11
2656546|NCT00684307|9172991|P2|Overall Study|Participant not willing to continue|10
2656547|NCT00684307|9172992|P1|Overall Study|Participant not willing to continue|7
2656548|NCT00684307|9172988|P5|Overall Study|Severe non compliance to protocol|2
2656549|NCT00684307|9172989|P4|Overall Study|Severe non compliance to protocol|1
2656550|NCT00684307|9172990|P3|Overall Study|Severe non compliance to protocol|0
2656551|NCT00684307|9172991|P2|Overall Study|Severe non compliance to protocol|0
2656552|NCT00684307|9172992|P1|Overall Study|Severe non compliance to protocol|1
2656553|NCT00684307|9172988|P5|Overall Study|Interupted IP for more than 7 days|3
2656554|NCT00684307|9172989|P4|Overall Study|Interupted IP for more than 7 days|3
2656555|NCT00684307|9172990|P3|Overall Study|Interupted IP for more than 7 days|1
2656556|NCT00684307|9172991|P2|Overall Study|Interupted IP for more than 7 days|4
2656557|NCT00684307|9172992|P1|Overall Study|Interupted IP for more than 7 days|0
2656558|NCT00684307|9172988|P5|Overall Study|Incorrect enrolment or randomization|0
2656559|NCT00684307|9172989|P4|Overall Study|Incorrect enrolment or randomization|0
2656560|NCT00684307|9172990|P3|Overall Study|Incorrect enrolment or randomization|0
2656561|NCT00684307|9172991|P2|Overall Study|Incorrect enrolment or randomization|0
2656562|NCT00684307|9172992|P1|Overall Study|Incorrect enrolment or randomization|4
2656563|NCT00684307|9172988|P5|Overall Study|Fullfillment of exclusion criteria|1
2656564|NCT00684307|9172989|P4|Overall Study|Fullfillment of exclusion criteria|3
2656565|NCT00684307|9172990|P3|Overall Study|Fullfillment of exclusion criteria|0
2656566|NCT00684307|9172991|P2|Overall Study|Fullfillment of exclusion criteria|0
2656567|NCT00684307|9172992|P1|Overall Study|Fullfillment of exclusion criteria|1
2656568|NCT00684307|9172988|P5|Overall Study|Development of increasing Liver Function|0
2656569|NCT00684307|9172989|P4|Overall Study|Development of increasing Liver Function|1
2656570|NCT00684307|9172990|P3|Overall Study|Development of increasing Liver Function|0
2656571|NCT00684307|9172991|P2|Overall Study|Development of increasing Liver Function|2
2656572|NCT00684307|9172992|P1|Overall Study|Development of increasing Liver Function|0
2656574|NCT00684307|9172989|P4|Overall Study|Adverse Event|16
2656575|NCT00684307|9172990|P3|Overall Study|Adverse Event|15
2656576|NCT00684307|9172991|P2|Overall Study|Adverse Event|6
2656577|NCT00684307|9172992|P1|Overall Study|Adverse Event|11
2656578|NCT00684203|9173074|P6|Overall Study|Did not meet protocol eligibility|0
2656579|NCT00684203|9173075|P5|Overall Study|Did not meet protocol eligibility|0
2656580|NCT00684203|9173076|P4|Overall Study|Did not meet protocol eligibility|0
2656581|NCT00684203|9173077|P3|Overall Study|Did not meet protocol eligibility|0
2656582|NCT00684203|9173078|P2|Overall Study|Did not meet protocol eligibility|1
2656583|NCT00684203|9173079|P1|Overall Study|Did not meet protocol eligibility|0
2656584|NCT00684203|9173074|P6|Overall Study|Withdrawal by Subject|0
2656585|NCT00684203|9173075|P5|Overall Study|Withdrawal by Subject|0
2656586|NCT00684203|9173076|P4|Overall Study|Withdrawal by Subject|0
2656587|NCT00684203|9173077|P3|Overall Study|Withdrawal by Subject|1
2656588|NCT00684203|9173078|P2|Overall Study|Withdrawal by Subject|2
2656589|NCT00684203|9173079|P1|Overall Study|Withdrawal by Subject|0
2656590|NCT00684203|9173074|P6|Overall Study|Protocol-defined clinical event|0
2656591|NCT00684203|9173075|P5|Overall Study|Protocol-defined clinical event|0
2656592|NCT00684203|9173076|P4|Overall Study|Protocol-defined clinical event|0
2656593|NCT00684203|9173077|P3|Overall Study|Protocol-defined clinical event|0
2656594|NCT00684203|9173078|P2|Overall Study|Protocol-defined clinical event|1
2656595|NCT00684203|9173079|P1|Overall Study|Protocol-defined clinical event|3
2656596|NCT00684203|9173074|P6|Overall Study|Adverse Event|0
2656597|NCT00684203|9173075|P5|Overall Study|Adverse Event|0
2656598|NCT00684203|9173076|P4|Overall Study|Adverse Event|0
2656599|NCT00684203|9173077|P3|Overall Study|Adverse Event|8
2656600|NCT00684203|9173078|P2|Overall Study|Adverse Event|4
2656601|NCT00684203|9173079|P1|Overall Study|Adverse Event|6
2656602|NCT00684177|9173140|P2|Overall Study|Other|2
2656603|NCT00684177|9173141|P1|Overall Study|Other|1
2656604|NCT00684177|9173140|P2|Overall Study|Withdrawal by Subject|2
2656605|NCT00684177|9173141|P1|Overall Study|Withdrawal by Subject|1
2656606|NCT00684177|9173140|P2|Overall Study|Physician Decision|0
2656607|NCT00684177|9173141|P1|Overall Study|Physician Decision|2
2656608|NCT00684177|9173140|P2|Overall Study|Lost to Follow-up|1
2656609|NCT00684177|9173141|P1|Overall Study|Lost to Follow-up|2
2656610|NCT00684177|9173140|P2|Overall Study|Protocol Violation|0
2656611|NCT00684177|9173141|P1|Overall Study|Protocol Violation|1
2656612|NCT00684177|9173140|P2|Overall Study|Lack of Efficacy|15
2656613|NCT00684177|9173141|P1|Overall Study|Lack of Efficacy|10
2656614|NCT00684177|9173140|P2|Overall Study|Adverse Event|3
2656615|NCT00684177|9173141|P1|Overall Study|Adverse Event|4
2656616|NCT00684073|9173176|P1|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1
2656617|NCT00684073|9173176|P1|Selection|request of the sponsor|1
2656618|NCT00684073|9173176|P1|Selection|Lost to Follow-up|1
2656619|NCT00684073|9173176|P1|Selection|noncompliance|1
2656620|NCT00684073|9173176|P1|Selection|Death|1
2656621|NCT00684073|9173176|P1|Selection|Selection/non-selection criteria|3
2656622|NCT00684060|9173186|P2|Overall Study|Death|1
2656623|NCT00684060|9173187|P1|Overall Study|Death|0
2656624|NCT00684060|9173186|P2|Overall Study|Unable to collect MRI|2
2656625|NCT00684060|9173187|P1|Overall Study|Unable to collect MRI|1
2656626|NCT00684060|9173186|P2|Overall Study|New stenosis identified|0
2656627|NCT00684060|9173187|P1|Overall Study|New stenosis identified|1
2656628|NCT00684060|9173186|P2|Overall Study|Lost to Follow-up|0
2656629|NCT00684060|9173187|P1|Overall Study|Lost to Follow-up|1
2656630|NCT00684021|9173226|P4|Overall Study|Death|0
2656631|NCT00684021|9173227|P3|Overall Study|Death|0
2656632|NCT00684021|9173228|P2|Overall Study|Death|0
2656633|NCT00684021|9173229|P1|Overall Study|Death|1
2656634|NCT00684021|9173226|P4|Overall Study|MRI not performed|2
2656635|NCT00684021|9173227|P3|Overall Study|MRI not performed|1
2656636|NCT00684021|9173228|P2|Overall Study|MRI not performed|1
2656637|NCT00684021|9173229|P1|Overall Study|MRI not performed|0
2656638|NCT00684021|9173226|P4|Overall Study|MRI Contraindicated|0
2656639|NCT00684021|9173227|P3|Overall Study|MRI Contraindicated|1
2656640|NCT00684021|9173228|P2|Overall Study|MRI Contraindicated|1
2656641|NCT00684021|9173229|P1|Overall Study|MRI Contraindicated|1
2656642|NCT00683917|9173290|P1|Overall Study|Study prematurely terminated|10
2656643|NCT00683904|9173300|P2|Dose Level 2|Adverse Event|2
2656644|NCT00683904|9173301|P1|Dose Level 2|Adverse Event|0
2656645|NCT00683904|9173300|P2|Dose Level 1|Adverse Event|0
2656646|NCT00683904|9173301|P1|Dose Level 1|Adverse Event|1
2656647|NCT00683904|9173300|P2|Dose Level 1|Disease progression|0
2656648|NCT00683904|9173301|P1|Dose Level 1|Disease progression|2
2656649|NCT00683878|9173337|P3|Overall Study|Non-compliance, not met criteria etc.|0
2656650|NCT00683878|9173338|P2|Overall Study|Non-compliance, not met criteria etc.|2
2656651|NCT00683878|9173339|P1|Overall Study|Non-compliance, not met criteria etc.|3
2656652|NCT00683878|9173337|P3|Overall Study|Lost to Follow-up|4
2656653|NCT00683878|9173338|P2|Overall Study|Lost to Follow-up|2
2656654|NCT00683878|9173339|P1|Overall Study|Lost to Follow-up|4
2656655|NCT00683878|9173337|P3|Overall Study|Death|0
2656656|NCT00683878|9173338|P2|Overall Study|Death|1
2656657|NCT00683878|9173339|P1|Overall Study|Death|0
2656658|NCT00683878|9173337|P3|Overall Study|Withdrawal by Subject|6
2656659|NCT00683878|9173338|P2|Overall Study|Withdrawal by Subject|8
2656660|NCT00683878|9173339|P1|Overall Study|Withdrawal by Subject|9
2656661|NCT00683878|9173337|P3|Overall Study|Adverse Event|3
2656662|NCT00683878|9173338|P2|Overall Study|Adverse Event|3
2656663|NCT00683878|9173339|P1|Overall Study|Adverse Event|4
2656664|NCT00683878|9173337|P3|Overall Study|Lack of Efficacy|1
2656665|NCT00683878|9173338|P2|Overall Study|Lack of Efficacy|0
2656666|NCT00683878|9173339|P1|Overall Study|Lack of Efficacy|3
2656667|NCT00683800|9173413|P2|Overall Study|Randomized, not treated|33
2656668|NCT00683800|9173414|P1|Overall Study|Randomized, not treated|35
2656669|NCT00683800|9173413|P2|Overall Study|Lack of Efficacy|104
2656670|NCT00683800|9173414|P1|Overall Study|Lack of Efficacy|61
2656671|NCT00683800|9173413|P2|Overall Study|Withdrawal by Subject|64
2656672|NCT00683800|9173414|P1|Overall Study|Withdrawal by Subject|66
2656673|NCT00683800|9173413|P2|Overall Study|Protocol Violation|16
2656674|NCT00683800|9173414|P1|Overall Study|Protocol Violation|13
2656675|NCT00683800|9173413|P2|Overall Study|Other|2
2656676|NCT00683800|9173414|P1|Overall Study|Other|5
2656677|NCT00683800|9173413|P2|Overall Study|Lost to Follow-up|44
2656678|NCT00683800|9173414|P1|Overall Study|Lost to Follow-up|57
2656679|NCT00683800|9173413|P2|Overall Study|Death|1
2656680|NCT00683800|9173414|P1|Overall Study|Death|0
2656681|NCT00683800|9173413|P2|Overall Study|Adverse Event|102
2656682|NCT00683800|9173414|P1|Overall Study|Adverse Event|195
2656683|NCT00683787|9173481|P3|Overall Study|Adverse Event|2
2656684|NCT00683787|9173482|P2|Overall Study|Adverse Event|0
2656685|NCT00683787|9173483|P1|Overall Study|Adverse Event|0
2656686|NCT00683787|9173481|P3|Overall Study|Progression|0
2656687|NCT00683787|9173482|P2|Overall Study|Progression|3
2656688|NCT00683787|9173483|P1|Overall Study|Progression|3
2656689|NCT00683774|9173502|P2|Overall Study|Physician Decision|0
2656690|NCT00683774|9173503|P1|Overall Study|Physician Decision|3
2656691|NCT00683774|9173502|P2|Overall Study|Withdrawal by Subject|1
2656692|NCT00683774|9173503|P1|Overall Study|Withdrawal by Subject|0
2656693|NCT00683696|9173513|P2|Overall Study|Death|30
2656694|NCT00683696|9173514|P1|Overall Study|Death|46
2656695|NCT00683696|9173513|P2|Overall Study|Vital status follow-up only|3
2656696|NCT00683696|9173514|P1|Overall Study|Vital status follow-up only|3
2656697|NCT00683696|9173513|P2|Overall Study|Lost to Follow-up|6
2656698|NCT00683696|9173514|P1|Overall Study|Lost to Follow-up|5
2656699|NCT00683696|9173513|P2|Overall Study|Withdrawn prior to study closure|28
2656700|NCT00683696|9173514|P1|Overall Study|Withdrawn prior to study closure|13
2656701|NCT00683696|9173513|P2|Overall Study|Withdrawn due to study closure|338
2656702|NCT00683696|9173514|P1|Overall Study|Withdrawn due to study closure|337
2656703|NCT00683657|9173533|P2|Overall Study|Subject Withdrew Consent|0
2656704|NCT00683657|9173534|P1|Overall Study|Subject Withdrew Consent|1
2656705|NCT00683657|9173533|P2|Overall Study|Adverse Event|1
2656706|NCT00683657|9173534|P1|Overall Study|Adverse Event|0
2656707|NCT00683644|9173550|P2|Overall Study|Low copper, other health problems,|6
2656708|NCT00683644|9173551|P1|Overall Study|Low copper, other health problems,|7
2656709|NCT00683644|9173550|P2|Overall Study|Adverse Event|2
2656710|NCT00683644|9173551|P1|Overall Study|Adverse Event|1
2656711|NCT00683644|9173550|P2|Overall Study|Lost to Follow-up|4
2656712|NCT00683644|9173551|P1|Overall Study|Lost to Follow-up|1
2656713|NCT00683644|9173550|P2|Overall Study|Withdrawal by Subject|2
2656714|NCT00683644|9173551|P1|Overall Study|Withdrawal by Subject|4
2656715|NCT00683618|9173564|P3|Extension Treatment Period|Protocol Violation|0
2656716|NCT00683618|9173565|P2|Extension Treatment Period|Protocol Violation|0
2656717|NCT00683618|9173566|P1|Extension Treatment Period|Protocol Violation|1
2656718|NCT00683618|9173564|P3|Extension Treatment Period|Adverse Event|0
2656719|NCT00683618|9173565|P2|Extension Treatment Period|Adverse Event|0
2656720|NCT00683618|9173566|P1|Extension Treatment Period|Adverse Event|1
2656721|NCT00683618|9173564|P3|Extension Treatment Period|Withdrawal by Subject|0
2656722|NCT00683618|9173565|P2|Extension Treatment Period|Withdrawal by Subject|0
2656723|NCT00683618|9173566|P1|Extension Treatment Period|Withdrawal by Subject|1
2656724|NCT00683618|9173564|P3|Randomised Treatment Period|Reason not provided|2
2656725|NCT00683618|9173565|P2|Randomised Treatment Period|Reason not provided|0
2656726|NCT00683618|9173566|P1|Randomised Treatment Period|Reason not provided|0
2656727|NCT00683618|9173564|P3|Randomised Treatment Period|Adverse Event|2
2656728|NCT00683618|9173565|P2|Randomised Treatment Period|Adverse Event|0
2656729|NCT00683618|9173566|P1|Randomised Treatment Period|Adverse Event|2
2656730|NCT00683618|9173564|P3|Randomised Treatment Period|Protocol Violation|0
2656731|NCT00683618|9173565|P2|Randomised Treatment Period|Protocol Violation|1
2656732|NCT00683618|9173566|P1|Randomised Treatment Period|Protocol Violation|0
2656733|NCT00683618|9173564|P3|Randomised Treatment Period|Withdrawal by Subject|2
2656734|NCT00683618|9173565|P2|Randomised Treatment Period|Withdrawal by Subject|1
2656735|NCT00683618|9173566|P1|Randomised Treatment Period|Withdrawal by Subject|4
2656736|NCT00683592|9173616|P2|Overall Study|Other|1
2656737|NCT00683592|9173617|P1|Overall Study|Other|1
2656738|NCT00683592|9173616|P2|Overall Study|Non-compliance|5
2656739|NCT00683592|9173617|P1|Overall Study|Non-compliance|3
2656740|NCT00683592|9173616|P2|Overall Study|Physician Decision|1
2656741|NCT00683592|9173617|P1|Overall Study|Physician Decision|0
2656742|NCT00683592|9173616|P2|Overall Study|Lack of Efficacy|7
2656743|NCT00683592|9173617|P1|Overall Study|Lack of Efficacy|3
2656744|NCT00683592|9173616|P2|Overall Study|Lost to Follow-up|17
2656745|NCT00683592|9173617|P1|Overall Study|Lost to Follow-up|17
2656746|NCT00683592|9173616|P2|Overall Study|Withdrawal by Subject|11
2656747|NCT00683592|9173617|P1|Overall Study|Withdrawal by Subject|11
2656748|NCT00683592|9173616|P2|Overall Study|Adverse Event|4
2656749|NCT00683592|9173617|P1|Overall Study|Adverse Event|12
2656750|NCT00683475|9173635|P2|Overall Study|Never Treated: Progressive Disease|0
2656751|NCT00683475|9173636|P1|Overall Study|Never Treated: Progressive Disease|1
2656752|NCT00683475|9173635|P2|Overall Study|Never Treated: Adverse Event|3
2656753|NCT00683475|9173636|P1|Overall Study|Never Treated: Adverse Event|2
2656754|NCT00683475|9173635|P2|Overall Study|Withdrawal by Subject|0
2656755|NCT00683475|9173636|P1|Overall Study|Withdrawal by Subject|1
2656756|NCT00683449|9173671|P5|Overall Study|Lost to Follow-up|0
2656757|NCT00683449|9173672|P4|Overall Study|Lost to Follow-up|0
2656758|NCT00683449|9173673|P3|Overall Study|Lost to Follow-up|0
2656759|NCT00683449|9173674|P2|Overall Study|Lost to Follow-up|1
2656760|NCT00683449|9173675|P1|Overall Study|Lost to Follow-up|0
2656761|NCT00683384|9173701|P1|Overall Study|Adverse Event|1
2656762|NCT00683384|9173701|P1|Overall Study|Death|1
2656763|NCT00683293|9173711|P2|Overall Study|Withdrawal by Subject|3
2656764|NCT00683293|9173712|P1|Overall Study|Withdrawal by Subject|2
2656765|NCT00682929|9173775|P3|Overall Study|lag in DEA renewal|0
2656766|NCT00682929|9173776|P2|Overall Study|lag in DEA renewal|0
2656767|NCT00682929|9173777|P1|Overall Study|lag in DEA renewal|1
2656768|NCT00682929|9173775|P3|Overall Study|dosing compliance < 80%|0
2656769|NCT00682929|9173776|P2|Overall Study|dosing compliance < 80%|2
2656770|NCT00682929|9173777|P1|Overall Study|dosing compliance < 80%|0
2656771|NCT00682929|9173775|P3|Overall Study|Withdrawal by Subject|1
2656772|NCT00682929|9173776|P2|Overall Study|Withdrawal by Subject|2
2656773|NCT00682929|9173777|P1|Overall Study|Withdrawal by Subject|1
2656774|NCT00682929|9173775|P3|Overall Study|Adverse Event|1
2656775|NCT00682929|9173776|P2|Overall Study|Adverse Event|1
2656776|NCT00682929|9173777|P1|Overall Study|Adverse Event|4
2656777|NCT00682890|9173946|P2|Overall Study|heavy menstrual bleeding|0
2656778|NCT00682890|9173947|P1|Overall Study|heavy menstrual bleeding|1
2656779|NCT00682890|9173946|P2|Overall Study|subject moved away|1
2656780|NCT00682890|9173947|P1|Overall Study|subject moved away|0
2656781|NCT00682890|9173946|P2|Overall Study|Lost to Follow-up|1
2656782|NCT00682890|9173947|P1|Overall Study|Lost to Follow-up|1
2656783|NCT00682786|9173989|P2|Overall Study|Did not receive irinotecan|1
2656784|NCT00682786|9173990|P1|Overall Study|Did not receive irinotecan|0
2656785|NCT00682786|9173989|P2|Overall Study|Withdrawal by Subject|2
2656786|NCT00682786|9173990|P1|Overall Study|Withdrawal by Subject|2
2656787|NCT00682643|9174039|P2|Overall Study|Did Not Receive Study Drug|1
2656788|NCT00682643|9174040|P1|Overall Study|Did Not Receive Study Drug|1
2656789|NCT00682643|9174039|P2|Overall Study|Withdrawal by Subject|53
2656790|NCT00682643|9174040|P1|Overall Study|Withdrawal by Subject|19
2656791|NCT00682643|9174039|P2|Overall Study|Physician Decision|6
2656792|NCT00682643|9174040|P1|Overall Study|Physician Decision|2
2656793|NCT00682643|9174039|P2|Overall Study|Lost to Follow-up|6
2656794|NCT00682643|9174040|P1|Overall Study|Lost to Follow-up|1
2656795|NCT00682643|9174039|P2|Overall Study|Met Protocol-defined Stopping Criteria|4
2656796|NCT00682643|9174040|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
2656797|NCT00682643|9174039|P2|Overall Study|Protocol Violation|76
2656798|NCT00682643|9174040|P1|Overall Study|Protocol Violation|38
2656799|NCT00682643|9174039|P2|Overall Study|Lack of Efficacy|0
2656800|NCT00682643|9174040|P1|Overall Study|Lack of Efficacy|2
2656801|NCT00682643|9174039|P2|Overall Study|Adverse Event|23
2656802|NCT00682643|9174040|P1|Overall Study|Adverse Event|12
2656803|NCT00682539|9174114|P3|Ranibizumab vs Triamcinolone|Lost to Follow-up|8
2656804|NCT00682539|9174115|P2|Ranibizumab vs Triamcinolone|Lost to Follow-up|3
2656805|NCT00682539|9174116|P1|Ranibizumab vs Triamcinolone|Lost to Follow-up|0
2656806|NCT00682539|9174114|P3|Bevacizumab vs Triamcinolone|Lost to Follow-up|0
2656807|NCT00682539|9174115|P2|Bevacizumab vs Triamcinolone|Lost to Follow-up|1
2656808|NCT00682539|9174116|P1|Bevacizumab vs Triamcinolone|Lost to Follow-up|3
2656809|NCT00682461|9174129|P2|Overall Study|Withdrawal by Subject|19
2656810|NCT00682461|9174130|P1|Overall Study|Withdrawal by Subject|12
2656811|NCT00682461|9174129|P2|Overall Study|Lost to Follow-up|5
2656812|NCT00682461|9174130|P1|Overall Study|Lost to Follow-up|8
2656813|NCT00682461|9174129|P2|Overall Study|Adverse Event|7
2656814|NCT00682461|9174130|P1|Overall Study|Adverse Event|5
2656815|NCT00682435|9174144|P1|Overall Study|Erroneously enrolled twice|2
2656816|NCT00682435|9174144|P1|Overall Study|Insufficient data|5
2656817|NCT00681863|9174177|P1|Overall Study|Other|18
2656818|NCT00681863|9174177|P1|Overall Study|Lack of Efficacy|2
2656819|NCT00681863|9174177|P1|Overall Study|Lost to Follow-up|2
2656820|NCT00681863|9174177|P1|Overall Study|Adverse Event|1
2656821|NCT00681824|9174225|P3|Overall Study|Death|0
2656822|NCT00681824|9174226|P2|Overall Study|Death|1
2656823|NCT00681824|9174227|P1|Overall Study|Death|0
2656824|NCT00681824|9174225|P3|Overall Study|scheduling conflict|0
2656825|NCT00681824|9174226|P2|Overall Study|scheduling conflict|0
2656826|NCT00681824|9174227|P1|Overall Study|scheduling conflict|1
2656827|NCT00681824|9174225|P3|Overall Study|withdrawn by investigator|1
2656828|NCT00681824|9174226|P2|Overall Study|withdrawn by investigator|0
2656829|NCT00681824|9174227|P1|Overall Study|withdrawn by investigator|0
2656830|NCT00681811|9174245|P2|Overall Study|Non-compliance|1
2656831|NCT00681811|9174246|P1|Overall Study|Non-compliance|0
2656832|NCT00681811|9174245|P2|Overall Study|Withdrawal by Subject|2
2656833|NCT00681811|9174246|P1|Overall Study|Withdrawal by Subject|2
2656834|NCT00681811|9174245|P2|Overall Study|Adverse Event|1
2656835|NCT00681811|9174246|P1|Overall Study|Adverse Event|1
2656836|NCT00681668|9174274|P1|Overall Study|Withdrawal by Subject|1
2656837|NCT00681668|9174274|P1|Overall Study|Protocol Violation|1
2656838|NCT00681629|9174283|P2|Overall Study|Adverse Event|0
2656839|NCT00681629|9174284|P1|Overall Study|Adverse Event|1
2656840|NCT00681629|9174283|P2|Overall Study|Study termination|2
2656841|NCT00681629|9174284|P1|Overall Study|Study termination|4
2656842|NCT00681590|9174330|P2|Overall Study|Withdrawal by Subject|12
2656843|NCT00681590|9174331|P1|Overall Study|Withdrawal by Subject|2
2656844|NCT00681564|9174341|P2|Overall Study|Death|1
2656845|NCT00681564|9174342|P1|Overall Study|Death|0
2656846|NCT00681564|9174341|P2|Overall Study|Withdrawal by Subject|1
2656847|NCT00681564|9174342|P1|Overall Study|Withdrawal by Subject|0
2656848|NCT00681564|9174341|P2|Overall Study|Lost to Follow-up|6
2656849|NCT00681564|9174342|P1|Overall Study|Lost to Follow-up|6
2656850|NCT00681187|9174434|P2|Overall Study|Adverse Event|1
2656851|NCT00681187|9174435|P1|Overall Study|Adverse Event|0
2656852|NCT00681187|9174434|P2|Overall Study|Death|1
2656853|NCT00681187|9174435|P1|Overall Study|Death|0
2656854|NCT00681187|9174434|P2|Overall Study|Withdrawal by Subject|0
2656855|NCT00681187|9174435|P1|Overall Study|Withdrawal by Subject|1
2656856|NCT00681109|9174470|P3|Overall Study|Lost to Follow-up|0
2656857|NCT00681109|9174471|P2|Overall Study|Lost to Follow-up|6
2656858|NCT00681109|9174472|P1|Overall Study|Lost to Follow-up|2
2656859|NCT00680992|9174513|P3|Overall Study|Ineligibility Determined|0
2656860|NCT00680992|9174514|P2|Overall Study|Ineligibility Determined|1
2656861|NCT00680992|9174515|P1|Overall Study|Ineligibility Determined|0
2656862|NCT00680992|9174513|P3|Overall Study|Death|0
2656863|NCT00680992|9174514|P2|Overall Study|Death|1
2656864|NCT00680992|9174515|P1|Overall Study|Death|5
2656865|NCT00680992|9174513|P3|Overall Study|Pregnancy|1
2656866|NCT00680992|9174514|P2|Overall Study|Pregnancy|0
2656867|NCT00680992|9174515|P1|Overall Study|Pregnancy|5
2656868|NCT00680992|9174513|P3|Overall Study|Requirement for Alternative Therapy|0
2656869|NCT00680992|9174514|P2|Overall Study|Requirement for Alternative Therapy|2
2656870|NCT00680992|9174515|P1|Overall Study|Requirement for Alternative Therapy|8
2656871|NCT00680992|9174513|P3|Overall Study|Noncompliance|0
2656872|NCT00680992|9174514|P2|Overall Study|Noncompliance|6
2656873|NCT00680992|9174515|P1|Overall Study|Noncompliance|4
2656874|NCT00680992|9174513|P3|Overall Study|Lost to Follow-up|0
2656875|NCT00680992|9174514|P2|Overall Study|Lost to Follow-up|14
2656876|NCT00680992|9174515|P1|Overall Study|Lost to Follow-up|12
2656877|NCT00680992|9174513|P3|Overall Study|Disease Progression|0
2656878|NCT00680992|9174514|P2|Overall Study|Disease Progression|9
2656879|NCT00680992|9174515|P1|Overall Study|Disease Progression|21
2656880|NCT00680992|9174513|P3|Overall Study|Other|1
2656881|NCT00680992|9174514|P2|Overall Study|Other|14
2656882|NCT00680992|9174515|P1|Overall Study|Other|19
2656883|NCT00680992|9174513|P3|Overall Study|Adverse Event|1
2656884|NCT00680992|9174514|P2|Overall Study|Adverse Event|19
2656885|NCT00680992|9174515|P1|Overall Study|Adverse Event|21
2656886|NCT00680992|9174513|P3|Overall Study|Withdrawal by Subject|1
2656887|NCT00680992|9174514|P2|Overall Study|Withdrawal by Subject|11
2656888|NCT00680992|9174515|P1|Overall Study|Withdrawal by Subject|33
2656889|NCT00680992|9174513|P3|Overall Study|End of Trial|3
2656890|NCT00680992|9174514|P2|Overall Study|End of Trial|12
2656891|NCT00680992|9174515|P1|Overall Study|End of Trial|32
2656892|NCT00680992|9174513|P3|Overall Study|Administrative Decision|5
2656893|NCT00680992|9174514|P2|Overall Study|Administrative Decision|42
2656894|NCT00680992|9174515|P1|Overall Study|Administrative Decision|83
2656895|NCT00680992|9174513|P3|Overall Study|Complete Resection (as per protocol)|0
2656896|NCT00680992|9174514|P2|Overall Study|Complete Resection (as per protocol)|121
2656897|NCT00680992|9174515|P1|Overall Study|Complete Resection (as per protocol)|25
2656898|NCT00680914|9174549|P2|Overall Study|serious adverse event (SAE)|1
2656899|NCT00680914|9174550|P1|Overall Study|serious adverse event (SAE)|0
2656900|NCT00680914|9174549|P2|Overall Study|Lost to Follow-up|0
2656901|NCT00680914|9174550|P1|Overall Study|Lost to Follow-up|4
2656902|NCT00680914|9174549|P2|Overall Study|Consent withdrawal|3
2656903|NCT00680914|9174550|P1|Overall Study|Consent withdrawal|6
2656904|NCT00680901|9174584|P2|Overall Study|Ongoing: In Follow Up|41
2656905|NCT00680901|9174585|P1|Overall Study|Ongoing: In Follow Up|45
2656906|NCT00680901|9174584|P2|Overall Study|Ongoing: On Study Treatment|13
2656907|NCT00680901|9174585|P1|Overall Study|Ongoing: On Study Treatment|16
2656908|NCT00680901|9174584|P2|Overall Study|Physician Decision|1
2656909|NCT00680901|9174585|P1|Overall Study|Physician Decision|0
2656910|NCT00680901|9174584|P2|Overall Study|Withdrawal by Subject|13
2656911|NCT00680901|9174585|P1|Overall Study|Withdrawal by Subject|4
2656912|NCT00680901|9174584|P2|Overall Study|Lost to Follow-up|8
2656913|NCT00680901|9174585|P1|Overall Study|Lost to Follow-up|8
2656914|NCT00680836|9174623|P2|Overall Study|Physician Decision|1
2656915|NCT00680836|9174624|P1|Overall Study|Physician Decision|2
2656916|NCT00680836|9174623|P2|Overall Study|Lost to Follow-up|1
2656917|NCT00680836|9174624|P1|Overall Study|Lost to Follow-up|3
2656918|NCT00680836|9174623|P2|Overall Study|Withdrawal by Subject|0
2656919|NCT00680836|9174624|P1|Overall Study|Withdrawal by Subject|3
2656920|NCT00680771|9174678|P2|Overall Study|Prior Exposure to Hepatitus B Vaccine|2
2656921|NCT00680771|9174679|P1|Overall Study|Prior Exposure to Hepatitus B Vaccine|4
2656922|NCT00680771|9174678|P2|Overall Study|Sleep Apnea suspected after PSG|0
2656923|NCT00680771|9174679|P1|Overall Study|Sleep Apnea suspected after PSG|1
2656924|NCT00680771|9174678|P2|Overall Study|Withdrawal by Subject|0
2656925|NCT00680771|9174679|P1|Overall Study|Withdrawal by Subject|1
2656926|NCT00680745|9174689|P4|Overall Study|False Treatment|0
2656927|NCT00680745|9174690|P3|Overall Study|False Treatment|3
2656928|NCT00680745|9174691|P2|Overall Study|False Treatment|1
2656929|NCT00680745|9174692|P1|Overall Study|False Treatment|0
2656930|NCT00680745|9174689|P4|Overall Study|Subject No Longer Meets Study Criteria|2
2656931|NCT00680745|9174690|P3|Overall Study|Subject No Longer Meets Study Criteria|0
2656932|NCT00680745|9174691|P2|Overall Study|Subject No Longer Meets Study Criteria|2
2656933|NCT00680745|9174692|P1|Overall Study|Subject No Longer Meets Study Criteria|0
2656934|NCT00680745|9174689|P4|Overall Study|Poor/Non-compliance|0
2656935|NCT00680745|9174690|P3|Overall Study|Poor/Non-compliance|0
2656936|NCT00680745|9174691|P2|Overall Study|Poor/Non-compliance|3
2656937|NCT00680745|9174692|P1|Overall Study|Poor/Non-compliance|0
2656938|NCT00680745|9174689|P4|Overall Study|Adverse Event|3
2656939|NCT00680745|9174690|P3|Overall Study|Adverse Event|3
2656940|NCT00680745|9174691|P2|Overall Study|Adverse Event|3
2656941|NCT00680745|9174692|P1|Overall Study|Adverse Event|5
2656942|NCT00680745|9174689|P4|Overall Study|Death|0
2656943|NCT00680745|9174690|P3|Overall Study|Death|1
2656944|NCT00680745|9174691|P2|Overall Study|Death|0
2656945|NCT00680745|9174692|P1|Overall Study|Death|1
2656946|NCT00680745|9174689|P4|Overall Study|Lost to Follow-up|0
2656947|NCT00680745|9174690|P3|Overall Study|Lost to Follow-up|1
2656948|NCT00680745|9174691|P2|Overall Study|Lost to Follow-up|1
2656949|NCT00680745|9174692|P1|Overall Study|Lost to Follow-up|0
2656950|NCT00680745|9174689|P4|Overall Study|Withdrawal by Subject|8
2656951|NCT00680745|9174690|P3|Overall Study|Withdrawal by Subject|2
2656952|NCT00680745|9174691|P2|Overall Study|Withdrawal by Subject|3
2656953|NCT00680745|9174692|P1|Overall Study|Withdrawal by Subject|8
2656954|NCT00680407|9174766|P3|Overall Study|Withdrawal by Subject|2
2656955|NCT00680407|9174767|P2|Overall Study|Withdrawal by Subject|2
2656956|NCT00680407|9174768|P1|Overall Study|Withdrawal by Subject|5
2656957|NCT00680407|9174766|P3|Overall Study|Lost to Follow-up|1
2656958|NCT00680407|9174767|P2|Overall Study|Lost to Follow-up|3
2656959|NCT00680407|9174768|P1|Overall Study|Lost to Follow-up|3
2656960|NCT00680368|9174782|P1|Overall Study|not supervised, not eligible|15
2656961|NCT00680186|9174810|P2|Overall Study|Other|1
2656962|NCT00680186|9174811|P1|Overall Study|Other|4
2656963|NCT00680186|9174810|P2|Overall Study|Withdrawal by Subject|39
2656964|NCT00680186|9174811|P1|Overall Study|Withdrawal by Subject|32
2656965|NCT00680186|9174810|P2|Overall Study|Lost to Follow-up|6
2656966|NCT00680186|9174811|P1|Overall Study|Lost to Follow-up|11
2656967|NCT00680186|9174810|P2|Overall Study|Protocol Violation|26
2656968|NCT00680186|9174811|P1|Overall Study|Protocol Violation|31
2656969|NCT00680186|9174810|P2|Overall Study|Adverse Event|44
2656970|NCT00680186|9174811|P1|Overall Study|Adverse Event|47
2656971|NCT00680121|9174837|P2|Overall Study|Lost to Follow-up|23
2656972|NCT00680121|9174838|P1|Overall Study|Lost to Follow-up|27
2656973|NCT00680056|9174852|P2|Second Intervention|Protocol Violation|1
2656974|NCT00680056|9174853|P1|Second Intervention|Protocol Violation|3
2656975|NCT00680056|9174852|P2|First Intervention|Mainly Exacerbation of COPD|2
2656976|NCT00680056|9174853|P1|First Intervention|Mainly Exacerbation of COPD|1
2656977|NCT00680043|9174864|P3|Overall Study|Renal Transplant|4
2656978|NCT00680043|9174865|P2|Overall Study|Renal Transplant|0
2656979|NCT00680043|9174866|P1|Overall Study|Renal Transplant|1
2656980|NCT00680043|9174864|P3|Overall Study|Patient Not Compliant With Study Reqs.|0
2656981|NCT00680043|9174865|P2|Overall Study|Patient Not Compliant With Study Reqs.|1
2656982|NCT00680043|9174866|P1|Overall Study|Patient Not Compliant With Study Reqs.|0
2656983|NCT00680043|9174864|P3|Overall Study|Withdrawal by Subject|0
2656984|NCT00680043|9174865|P2|Overall Study|Withdrawal by Subject|0
2656985|NCT00680043|9174866|P1|Overall Study|Withdrawal by Subject|1
2656986|NCT00680017|9174882|P2|Overall Study|Lost to Follow-up|0
2656987|NCT00680017|9174883|P1|Overall Study|Lost to Follow-up|2
2656988|NCT00680017|9174882|P2|Overall Study|Withdrawal by Subject|5
2656989|NCT00680017|9174883|P1|Overall Study|Withdrawal by Subject|2
2656990|NCT00680017|9174882|P2|Overall Study|Adverse Event|7
2656991|NCT00680017|9174883|P1|Overall Study|Adverse Event|13
2656992|NCT00679939|9174902|P2|24-Week Open-Label (OL) Period|Withdrawal by Subject|1
2656993|NCT00679939|9174903|P1|24-Week Open-Label (OL) Period|Withdrawal by Subject|2
2656994|NCT00679939|9174902|P2|24-Week Open-Label (OL) Period|Physician Decision|0
2656995|NCT00679939|9174903|P1|24-Week Open-Label (OL) Period|Physician Decision|1
2656996|NCT00679939|9174902|P2|24-Week Open-Label (OL) Period|Met Stopping Criteria|1
2656997|NCT00679939|9174903|P1|24-Week Open-Label (OL) Period|Met Stopping Criteria|3
2656998|NCT00679939|9174902|P2|24-Week Open-Label (OL) Period|Protocol Violation|1
2656999|NCT00679939|9174903|P1|24-Week Open-Label (OL) Period|Protocol Violation|1
2657000|NCT00679939|9174902|P2|24-Week Open-Label (OL) Period|Adverse Event|1
2657001|NCT00679939|9174903|P1|24-Week Open-Label (OL) Period|Adverse Event|0
2657002|NCT00679939|9174902|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|2
2657003|NCT00679939|9174903|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
2657004|NCT00679939|9174902|P2|52-Week Double-Blind (DB) Period|Protocol Violation|0
2657005|NCT00679939|9174903|P1|52-Week Double-Blind (DB) Period|Protocol Violation|1
2657006|NCT00679939|9174902|P2|52-Week Double-Blind (DB) Period|Investigator Discretion|0
2657007|NCT00679939|9174903|P1|52-Week Double-Blind (DB) Period|Investigator Discretion|5
2657008|NCT00679939|9174902|P2|52-Week Double-Blind (DB) Period|Adverse Event|12
2657009|NCT00679939|9174903|P1|52-Week Double-Blind (DB) Period|Adverse Event|14
2657010|NCT00679939|9174902|P2|52-Week Double-Blind (DB) Period|Withdrew Consent|13
2657011|NCT00679939|9174903|P1|52-Week Double-Blind (DB) Period|Withdrew Consent|17
2657012|NCT00679913|9175054|P2|Overall Study|Protocol Violation|13
2657013|NCT00679913|9175055|P1|Overall Study|Protocol Violation|18
2657014|NCT00679783|9175070|P7|Overall Study|Ongoing at data cut-off|0
2657015|NCT00679783|9175071|P6|Overall Study|Ongoing at data cut-off|0
2657016|NCT00679783|9175072|P5|Overall Study|Ongoing at data cut-off|1
2657017|NCT00679783|9175073|P4|Overall Study|Ongoing at data cut-off|9
2657018|NCT00679783|9175074|P3|Overall Study|Ongoing at data cut-off|0
2657019|NCT00679783|9175075|P2|Overall Study|Ongoing at data cut-off|2
2657020|NCT00679783|9175076|P1|Overall Study|Ongoing at data cut-off|2
2657021|NCT00679783|9175070|P7|Overall Study|Not Captured|0
2657022|NCT00679783|9175071|P6|Overall Study|Not Captured|0
2657023|NCT00679783|9175072|P5|Overall Study|Not Captured|0
2657024|NCT00679783|9175073|P4|Overall Study|Not Captured|5
2657025|NCT00679783|9175074|P3|Overall Study|Not Captured|0
2657026|NCT00679783|9175075|P2|Overall Study|Not Captured|0
2657027|NCT00679783|9175076|P1|Overall Study|Not Captured|0
2657028|NCT00679783|9175070|P7|Overall Study|Withdrawal by Subject|0
2657029|NCT00679783|9175071|P6|Overall Study|Withdrawal by Subject|0
2657030|NCT00679783|9175072|P5|Overall Study|Withdrawal by Subject|0
2657031|NCT00679783|9175073|P4|Overall Study|Withdrawal by Subject|1
2657032|NCT00679783|9175074|P3|Overall Study|Withdrawal by Subject|1
2657033|NCT00679783|9175075|P2|Overall Study|Withdrawal by Subject|0
2657034|NCT00679783|9175076|P1|Overall Study|Withdrawal by Subject|0
2657035|NCT00679783|9175070|P7|Overall Study|Lack of Efficacy|0
2657036|NCT00679783|9175071|P6|Overall Study|Lack of Efficacy|0
2657037|NCT00679783|9175072|P5|Overall Study|Lack of Efficacy|0
2657038|NCT00679783|9175073|P4|Overall Study|Lack of Efficacy|2
2657039|NCT00679783|9175074|P3|Overall Study|Lack of Efficacy|0
2657040|NCT00679783|9175075|P2|Overall Study|Lack of Efficacy|1
2657041|NCT00679783|9175076|P1|Overall Study|Lack of Efficacy|0
2657042|NCT00679783|9175070|P7|Overall Study|Adverse Event|1
2657043|NCT00679783|9175071|P6|Overall Study|Adverse Event|0
2657044|NCT00679783|9175072|P5|Overall Study|Adverse Event|0
2657045|NCT00679783|9175073|P4|Overall Study|Adverse Event|3
2657046|NCT00679783|9175074|P3|Overall Study|Adverse Event|0
2657047|NCT00679783|9175075|P2|Overall Study|Adverse Event|0
2657048|NCT00679783|9175076|P1|Overall Study|Adverse Event|0
2657049|NCT00679627|9175129|P2|Overall Study|Early Study Closure|405
2657050|NCT00679627|9175130|P1|Overall Study|Early Study Closure|425
2657051|NCT00679627|9175129|P2|Overall Study|Lost to Follow-up|26
2657052|NCT00679627|9175130|P1|Overall Study|Lost to Follow-up|22
2657053|NCT00679627|9175129|P2|Overall Study|Withdrawal by Subject|172
2657054|NCT00679627|9175130|P1|Overall Study|Withdrawal by Subject|168
2657055|NCT00679627|9175129|P2|Overall Study|Adverse Event|53
2657056|NCT00679627|9175130|P1|Overall Study|Adverse Event|43
2657057|NCT00679627|9175129|P2|Overall Study|Death|29
2657058|NCT00679627|9175130|P1|Overall Study|Death|41
2657059|NCT00679549|9175154|P2|Overall Study|missing outcome echocardiograms|5
2657060|NCT00679549|9175155|P1|Overall Study|missing outcome echocardiograms|4
2657061|NCT00679549|9175154|P2|Overall Study|dropout|4
2657062|NCT00679549|9175155|P1|Overall Study|dropout|2
2657063|NCT00679432|9175165|P4|Overall Study|Randomization error, return to prior Rx|0
2657064|NCT00679432|9175166|P3|Overall Study|Randomization error, return to prior Rx|3
2657065|NCT00679432|9175167|P2|Overall Study|Randomization error, return to prior Rx|0
2657066|NCT00679432|9175168|P1|Overall Study|Randomization error, return to prior Rx|0
2657067|NCT00679432|9175165|P4|Overall Study|Infectious colitis, normal histology|3
2657068|NCT00679432|9175166|P3|Overall Study|Infectious colitis, normal histology|8
2657069|NCT00679432|9175167|P2|Overall Study|Infectious colitis, normal histology|4
2657070|NCT00679432|9175168|P1|Overall Study|Infectious colitis, normal histology|5
2657071|NCT00679432|9175165|P4|Overall Study|Lack of Efficacy|8
2657072|NCT00679432|9175166|P3|Overall Study|Lack of Efficacy|14
2657073|NCT00679432|9175167|P2|Overall Study|Lack of Efficacy|9
2657074|NCT00679432|9175168|P1|Overall Study|Lack of Efficacy|13
2657075|NCT00679432|9175165|P4|Overall Study|Sponsor decision|0
2657076|NCT00679432|9175166|P3|Overall Study|Sponsor decision|0
2657077|NCT00679432|9175167|P2|Overall Study|Sponsor decision|0
2657078|NCT00679432|9175168|P1|Overall Study|Sponsor decision|1
2657079|NCT00679432|9175165|P4|Overall Study|Physician Decision|2
2657080|NCT00679432|9175166|P3|Overall Study|Physician Decision|2
2657081|NCT00679432|9175167|P2|Overall Study|Physician Decision|2
2657082|NCT00679432|9175168|P1|Overall Study|Physician Decision|3
2657083|NCT00679432|9175165|P4|Overall Study|Lost to Follow-up|2
2657084|NCT00679432|9175166|P3|Overall Study|Lost to Follow-up|4
2657085|NCT00679432|9175167|P2|Overall Study|Lost to Follow-up|5
2657086|NCT00679432|9175168|P1|Overall Study|Lost to Follow-up|1
2657087|NCT00679432|9175165|P4|Overall Study|Withdrawal by Subject|9
2657088|NCT00679432|9175166|P3|Overall Study|Withdrawal by Subject|10
2657089|NCT00679432|9175167|P2|Overall Study|Withdrawal by Subject|11
2657090|NCT00679432|9175168|P1|Overall Study|Withdrawal by Subject|8
2657091|NCT00679432|9175165|P4|Overall Study|Protocol Violation|1
2657092|NCT00679432|9175166|P3|Overall Study|Protocol Violation|2
2657093|NCT00679432|9175167|P2|Overall Study|Protocol Violation|1
2657094|NCT00679432|9175168|P1|Overall Study|Protocol Violation|1
2657095|NCT00679432|9175165|P4|Overall Study|Adverse Event|7
2657096|NCT00679432|9175166|P3|Overall Study|Adverse Event|10
2657097|NCT00679432|9175167|P2|Overall Study|Adverse Event|6
2657098|NCT00679432|9175168|P1|Overall Study|Adverse Event|5
2657099|NCT00679367|9175211|P1|Overall Study|Withdrawal by Subject|1
2657100|NCT00679367|9175211|P1|Overall Study|Lack of Efficacy|3
2657101|NCT00679367|9175211|P1|Overall Study|inability to swallow oral drugs|1
2657102|NCT00679367|9175211|P1|Overall Study|Adverse Event|7
2657103|NCT00679354|9175217|P1|Overall Study|Ineligible|1
2657104|NCT00679354|9175217|P1|Overall Study|Physician Decision|4
2657105|NCT00679354|9175217|P1|Overall Study|Lack of Efficacy|22
2657106|NCT00679354|9175217|P1|Overall Study|Death|3
2657107|NCT00679341|9175235|P2|Overall Study|Physician/patient decision to withdraw|6
2657108|NCT00679341|9175236|P1|Overall Study|Physician/patient decision to withdraw|0
2657109|NCT00679341|9175235|P2|Overall Study|Not treated|2
2657110|NCT00679341|9175236|P1|Overall Study|Not treated|0
2657111|NCT00679341|9175235|P2|Overall Study|Physician Decision|0
2657112|NCT00679341|9175236|P1|Overall Study|Physician Decision|1
2657113|NCT00679341|9175235|P2|Overall Study|Other|0
2657114|NCT00679341|9175236|P1|Overall Study|Other|1
2657115|NCT00679341|9175235|P2|Overall Study|Death|1
2657116|NCT00679341|9175236|P1|Overall Study|Death|1
2657117|NCT00679341|9175235|P2|Overall Study|Subject/guardian decision to discontinue|0
2657118|NCT00679341|9175236|P1|Overall Study|Subject/guardian decision to discontinue|3
2657119|NCT00679341|9175235|P2|Overall Study|Adverse Event|6
2657120|NCT00679341|9175236|P1|Overall Study|Adverse Event|5
2657121|NCT00679341|9175235|P2|Overall Study|Disease progression|36
2657122|NCT00679341|9175236|P1|Overall Study|Disease progression|42
2657123|NCT00679302|9175256|P2|Overall Study|Lost to Follow-up|4
2657124|NCT00679302|9175257|P1|Overall Study|Lost to Follow-up|8
2657125|NCT00679289|9175268|P3|Overall Study|Physician Decision|1
2657126|NCT00679289|9175269|P2|Overall Study|Physician Decision|0
2657127|NCT00679289|9175270|P1|Overall Study|Physician Decision|1
2657128|NCT00679289|9175268|P3|Overall Study|Adverse Event|3
2657129|NCT00679289|9175269|P2|Overall Study|Adverse Event|0
2657130|NCT00679289|9175270|P1|Overall Study|Adverse Event|0
2657131|NCT00679289|9175268|P3|Overall Study|Withdrawal by Subject|1
2657132|NCT00679289|9175269|P2|Overall Study|Withdrawal by Subject|1
2657133|NCT00679289|9175270|P1|Overall Study|Withdrawal by Subject|0
2657134|NCT00679289|9175268|P3|Overall Study|Progressive disease|18
2657135|NCT00679289|9175269|P2|Overall Study|Progressive disease|5
2657136|NCT00679289|9175270|P1|Overall Study|Progressive disease|4
2657137|NCT00679263|9175292|P3|Visit 2/Dose 1|subject not compliance|0
2657138|NCT00679263|9175293|P2|Visit 2/Dose 1|subject not compliance|1
2657139|NCT00679263|9175294|P1|Visit 2/Dose 1|subject not compliance|1
2657140|NCT00679263|9175292|P3|Visit 2/Dose 1|Adverse Event|0
2657141|NCT00679263|9175293|P2|Visit 2/Dose 1|Adverse Event|0
2657142|NCT00679263|9175294|P1|Visit 2/Dose 1|Adverse Event|1
2657143|NCT00679211|9175305|P1|Overall Study|Other|1
2657144|NCT00679211|9175305|P1|Overall Study|Transferred to extension study TDM4529g|12
2657145|NCT00679211|9175305|P1|Overall Study|Refused to undergo protocol procedures|1
2657146|NCT00679211|9175305|P1|Overall Study|Physician Decision|5
2657147|NCT00679211|9175305|P1|Overall Study|Withdrawal by Subject|2
2657148|NCT00679211|9175305|P1|Overall Study|Adverse Event|7
2657149|NCT00679211|9175305|P1|Overall Study|Progressive disease|82
2657150|NCT00679172|9175322|P5|Overall Study|Other not specified|0
2657151|NCT00679172|9175323|P4|Overall Study|Other not specified|0
2657152|NCT00679172|9175324|P3|Overall Study|Other not specified|1
2657153|NCT00679172|9175325|P2|Overall Study|Other not specified|0
2657154|NCT00679172|9175326|P1|Overall Study|Other not specified|0
2657155|NCT00679172|9175322|P5|Overall Study|Non-compliance|0
2657156|NCT00679172|9175323|P4|Overall Study|Non-compliance|1
2657157|NCT00679172|9175324|P3|Overall Study|Non-compliance|0
2657158|NCT00679172|9175325|P2|Overall Study|Non-compliance|1
2657159|NCT00679172|9175326|P1|Overall Study|Non-compliance|1
2657160|NCT00679081|9175389|P1|Overall Study|Lost to Follow-up|1
2657161|NCT00679055|9175399|P2|Overall Study|Study Terminated|1
2657162|NCT00679055|9175400|P1|Overall Study|Study Terminated|2
2657163|NCT00679055|9175399|P2|Overall Study|Other|3
2657164|NCT00679055|9175400|P1|Overall Study|Other|0
2657165|NCT00679055|9175399|P2|Overall Study|Adverse Event|1
2657166|NCT00679055|9175400|P1|Overall Study|Adverse Event|0
2657167|NCT00679029|9175410|P1|Overall Study|Lost to Follow-up|1
2657168|NCT00679029|9175410|P1|Overall Study|Withdrawal by Subject|1
2657169|NCT00679029|9175410|P1|Overall Study|Adverse Event|3
2657170|NCT00678899|9175417|P1|Overall Study|Adverse Event|1
2657171|NCT00678886|9175426|P4|Overall Study|Other|0
2657172|NCT00678886|9175427|P3|Overall Study|Other|1
2657173|NCT00678886|9175428|P2|Overall Study|Other|0
2657174|NCT00678886|9175429|P1|Overall Study|Other|0
2657175|NCT00678886|9175426|P4|Overall Study|Lost to Follow-up|2
2657176|NCT00678886|9175427|P3|Overall Study|Lost to Follow-up|3
2657177|NCT00678886|9175428|P2|Overall Study|Lost to Follow-up|0
2657178|NCT00678886|9175429|P1|Overall Study|Lost to Follow-up|0
2657179|NCT00678886|9175426|P4|Overall Study|Physician Decision|1
2657180|NCT00678886|9175427|P3|Overall Study|Physician Decision|1
2657181|NCT00678886|9175428|P2|Overall Study|Physician Decision|0
2657182|NCT00678886|9175429|P1|Overall Study|Physician Decision|0
2657183|NCT00678886|9175426|P4|Overall Study|Withdrawal by Subject|6
2657184|NCT00678886|9175427|P3|Overall Study|Withdrawal by Subject|4
2657185|NCT00678886|9175428|P2|Overall Study|Withdrawal by Subject|0
2657186|NCT00678886|9175429|P1|Overall Study|Withdrawal by Subject|0
2657187|NCT00678795|9175498|P2|Overall Study|Lack of Efficacy|1
2657188|NCT00678795|9175499|P1|Overall Study|Lack of Efficacy|1
2657189|NCT00678795|9175498|P2|Overall Study|Lost to Follow-up|1
2657190|NCT00678795|9175499|P1|Overall Study|Lost to Follow-up|0
2657191|NCT00678795|9175498|P2|Overall Study|Protocol Violation|1
2657192|NCT00678795|9175499|P1|Overall Study|Protocol Violation|0
2657193|NCT00678795|9175498|P2|Overall Study|Withdrawal by Subject|0
2657194|NCT00678795|9175499|P1|Overall Study|Withdrawal by Subject|3
2657195|NCT00678795|9175498|P2|Overall Study|Adverse Event|3
2657196|NCT00678795|9175499|P1|Overall Study|Adverse Event|7
2657197|NCT00678691|9175521|P2|Overall Study|Adverse Event|4
2657198|NCT00678691|9175522|P1|Overall Study|Adverse Event|6
2657199|NCT00678652|9175532|P4|Overall Study|Relocation|0
2657200|NCT00678652|9175533|P3|Overall Study|Relocation|0
2657201|NCT00678652|9175534|P2|Overall Study|Relocation|0
2657202|NCT00678652|9175535|P1|Overall Study|Relocation|1
2657203|NCT00678652|9175532|P4|Overall Study|Pregnancy|0
2657204|NCT00678652|9175533|P3|Overall Study|Pregnancy|1
2657205|NCT00678652|9175534|P2|Overall Study|Pregnancy|0
2657206|NCT00678652|9175535|P1|Overall Study|Pregnancy|0
2657207|NCT00678652|9175532|P4|Overall Study|Protocol Violation|0
2657208|NCT00678652|9175533|P3|Overall Study|Protocol Violation|0
2657209|NCT00678652|9175534|P2|Overall Study|Protocol Violation|0
2657210|NCT00678652|9175535|P1|Overall Study|Protocol Violation|2
2657211|NCT00678639|9175559|P2|Overall Study|Lost to Follow-up at 30 days|0
2657212|NCT00678639|9175560|P1|Overall Study|Lost to Follow-up at 30 days|2
2657213|NCT00678587|9175575|P2|Overall Study|Withdrew Consent|3
2657214|NCT00678587|9175576|P1|Overall Study|Withdrew Consent|8
2657215|NCT00678587|9175575|P2|Overall Study|Investigator Discretion|6
2657216|NCT00678587|9175576|P1|Overall Study|Investigator Discretion|2
2657217|NCT00678587|9175575|P2|Overall Study|Lost to Follow-up|5
2657218|NCT00678587|9175576|P1|Overall Study|Lost to Follow-up|3
2657219|NCT00678587|9175575|P2|Overall Study|Study Closed/Terminated|0
2657220|NCT00678587|9175576|P1|Overall Study|Study Closed/Terminated|1
2657221|NCT00678587|9175575|P2|Overall Study|Protocol Violation|1
2657222|NCT00678587|9175576|P1|Overall Study|Protocol Violation|2
2657223|NCT00678587|9175575|P2|Overall Study|Lack of Efficacy|0
2657224|NCT00678587|9175576|P1|Overall Study|Lack of Efficacy|1
2657225|NCT00678587|9175575|P2|Overall Study|Adverse Event|3
2657226|NCT00678587|9175576|P1|Overall Study|Adverse Event|3
2657227|NCT00678392|9175670|P2|Overall Study|Other|53
2657228|NCT00678392|9175671|P1|Overall Study|Other|56
2657229|NCT00678392|9175670|P2|Overall Study|Randomized But Not Treated|7
2657230|NCT00678392|9175671|P1|Overall Study|Randomized But Not Treated|2
2657231|NCT00678392|9175670|P2|Overall Study|Withdrawal by Subject|4
2657232|NCT00678392|9175671|P1|Overall Study|Withdrawal by Subject|4
2657233|NCT00678392|9175670|P2|Overall Study|Sponsor's Decision|2
2657234|NCT00678392|9175671|P1|Overall Study|Sponsor's Decision|1
2657235|NCT00678392|9175670|P2|Overall Study|Objective Progression or Relapse|8
2657236|NCT00678392|9175671|P1|Overall Study|Objective Progression or Relapse|3
2657237|NCT00678392|9175670|P2|Overall Study|Lost to Follow-up|13
2657238|NCT00678392|9175671|P1|Overall Study|Lost to Follow-up|15
2657239|NCT00678392|9175670|P2|Overall Study|Death|269
2657240|NCT00678392|9175671|P1|Overall Study|Death|280
2657241|NCT00678392|9175670|P2|Overall Study|Adverse Event|6
2657242|NCT00678392|9175671|P1|Overall Study|Adverse Event|0
2657243|NCT00678379|9175706|P3|Overall Study|Incomplete Data|3
2657244|NCT00678379|9175707|P2|Overall Study|Incomplete Data|3
2657245|NCT00678379|9175708|P1|Overall Study|Incomplete Data|4
2657246|NCT00678379|9175706|P3|Overall Study|Injection performed after tonsillectomy|1
2657247|NCT00678379|9175707|P2|Overall Study|Injection performed after tonsillectomy|0
2657248|NCT00678379|9175708|P1|Overall Study|Injection performed after tonsillectomy|2
2657249|NCT00678301|9175736|P2|Overall Study|Lost to Follow-up|1
2657250|NCT00678301|9175737|P1|Overall Study|Lost to Follow-up|3
2657251|NCT00678301|9175736|P2|Overall Study|Withdrawal by Subject|0
2657252|NCT00678301|9175737|P1|Overall Study|Withdrawal by Subject|4
2657253|NCT00678301|9175736|P2|Overall Study|Adverse Event|0
2657254|NCT00678301|9175737|P1|Overall Study|Adverse Event|1
2657255|NCT00678301|9175736|P2|Overall Study|Non-compliance with study procedures|1
2657256|NCT00678301|9175737|P1|Overall Study|Non-compliance with study procedures|0
2657257|NCT00678288|9175795|P2|Overall Study|Disease progression/recurrence/relapse|1
2657258|NCT00678288|9175796|P1|Overall Study|Disease progression/recurrence/relapse|6
2657259|NCT00678288|9175795|P2|Overall Study|Reason not reported|0
2657260|NCT00678288|9175796|P1|Overall Study|Reason not reported|1
2657261|NCT00678288|9175795|P2|Overall Study|Switch to commercial drug|1
2657262|NCT00678288|9175796|P1|Overall Study|Switch to commercial drug|0
2657263|NCT00678288|9175795|P2|Overall Study|Not compliant with study medication|1
2657264|NCT00678288|9175796|P1|Overall Study|Not compliant with study medication|0
2657265|NCT00678288|9175795|P2|Overall Study|Study terminated by the sponsor|0
2657266|NCT00678288|9175796|P1|Overall Study|Study terminated by the sponsor|2
2657267|NCT00678288|9175795|P2|Overall Study|Withdrawal by Subject|1
2657268|NCT00678288|9175796|P1|Overall Study|Withdrawal by Subject|1
2657269|NCT00678288|9175795|P2|Overall Study|Adverse Event|2
2657270|NCT00678288|9175796|P1|Overall Study|Adverse Event|0
2657271|NCT00678210|9175851|P4|Overall Study|Other|0
2657272|NCT00678210|9175852|P3|Overall Study|Other|1
2657273|NCT00678210|9175853|P2|Overall Study|Other|0
2657274|NCT00678210|9175854|P1|Overall Study|Other|1
2657275|NCT00678210|9175851|P4|Overall Study|Withdrawal by Subject|7
2657276|NCT00678210|9175852|P3|Overall Study|Withdrawal by Subject|1
2657277|NCT00678210|9175853|P2|Overall Study|Withdrawal by Subject|4
2657278|NCT00678210|9175854|P1|Overall Study|Withdrawal by Subject|3
2657279|NCT00678210|9175851|P4|Overall Study|Lost to Follow-up|1
2657280|NCT00678210|9175852|P3|Overall Study|Lost to Follow-up|0
2657281|NCT00678210|9175853|P2|Overall Study|Lost to Follow-up|2
2657282|NCT00678210|9175854|P1|Overall Study|Lost to Follow-up|4
2657283|NCT00678210|9175851|P4|Overall Study|Lack of Efficacy|9
2657284|NCT00678210|9175852|P3|Overall Study|Lack of Efficacy|1
2657285|NCT00678210|9175853|P2|Overall Study|Lack of Efficacy|3
2657286|NCT00678210|9175854|P1|Overall Study|Lack of Efficacy|2
2657287|NCT00678210|9175851|P4|Overall Study|Adverse Event|3
2657288|NCT00678210|9175852|P3|Overall Study|Adverse Event|3
2657289|NCT00678210|9175853|P2|Overall Study|Adverse Event|2
2657290|NCT00678210|9175854|P1|Overall Study|Adverse Event|1
2657291|NCT00678080|9175890|P2|Overall Study|Withdrawal by Subject|1
2657292|NCT00678080|9175891|P1|Overall Study|Withdrawal by Subject|0
2657293|NCT00678080|9175890|P2|Overall Study|Lost to Follow-up|0
2657294|NCT00678080|9175891|P1|Overall Study|Lost to Follow-up|1
2657295|NCT00678080|9175890|P2|Overall Study|Physician Decision|0
2657296|NCT00678080|9175891|P1|Overall Study|Physician Decision|2
2657297|NCT00678041|9175917|P2|Overall Study|Physician Decision|5
2657298|NCT00678041|9175918|P1|Overall Study|Physician Decision|5
2657299|NCT00677833|9175971|P4|Overall Study|Lost to Follow-up|0
2657300|NCT00677833|9175972|P3|Overall Study|Lost to Follow-up|1
2657301|NCT00677833|9175973|P2|Overall Study|Lost to Follow-up|0
2657302|NCT00677833|9175974|P1|Overall Study|Lost to Follow-up|0
2657303|NCT00677833|9175971|P4|Overall Study|Withdrawal by Subject|3
2657304|NCT00677833|9175972|P3|Overall Study|Withdrawal by Subject|1
2657305|NCT00677833|9175973|P2|Overall Study|Withdrawal by Subject|0
2657306|NCT00677833|9175974|P1|Overall Study|Withdrawal by Subject|4
2657307|NCT00677820|9176024|P2|Overall Study|Lost to Follow-up|0
2657308|NCT00677820|9176025|P1|Overall Study|Lost to Follow-up|1
2657309|NCT00677807|9176046|P3|Overall Study|Protocol Deviation|0
2657310|NCT00677807|9176047|P2|Overall Study|Protocol Deviation|3
2657311|NCT00677807|9176048|P1|Overall Study|Protocol Deviation|1
2657312|NCT00677807|9176046|P3|Overall Study|Death|1
2657313|NCT00677807|9176047|P2|Overall Study|Death|1
2657314|NCT00677807|9176048|P1|Overall Study|Death|0
2657315|NCT00677807|9176046|P3|Overall Study|Administrative problems|2
2657316|NCT00677807|9176047|P2|Overall Study|Administrative problems|1
2657317|NCT00677807|9176048|P1|Overall Study|Administrative problems|1
2657318|NCT00677807|9176046|P3|Overall Study|Lost to Follow-up|2
2657319|NCT00677807|9176047|P2|Overall Study|Lost to Follow-up|2
2657320|NCT00677807|9176048|P1|Overall Study|Lost to Follow-up|2
2657321|NCT00677807|9176046|P3|Overall Study|Withdrawal by Subject|6
2657322|NCT00677807|9176047|P2|Overall Study|Withdrawal by Subject|3
2657323|NCT00677807|9176048|P1|Overall Study|Withdrawal by Subject|10
2657324|NCT00677807|9176046|P3|Overall Study|Participant no longer needs study drug|1
2657325|NCT00677807|9176047|P2|Overall Study|Participant no longer needs study drug|0
2657326|NCT00677807|9176048|P1|Overall Study|Participant no longer needs study drug|0
2657327|NCT00677807|9176046|P3|Overall Study|Lack of Efficacy|2
2657328|NCT00677807|9176047|P2|Overall Study|Lack of Efficacy|0
2657329|NCT00677807|9176048|P1|Overall Study|Lack of Efficacy|0
2657330|NCT00677807|9176046|P3|Overall Study|Adverse Event|6
2657331|NCT00677807|9176047|P2|Overall Study|Adverse Event|1
2657332|NCT00677807|9176048|P1|Overall Study|Adverse Event|4
2657333|NCT00677534|9176094|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
2657334|NCT00677534|9176094|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
2657335|NCT00677534|9176094|P1|Washout (Weeks 1-4)|did not qualify after signing consent|1
2657336|NCT00677365|9176102|P4|Overall Study|Other reason|1
2657337|NCT00677365|9176103|P3|Overall Study|Other reason|0
2657338|NCT00677365|9176104|P2|Overall Study|Other reason|0
2657339|NCT00677365|9176105|P1|Overall Study|Other reason|0
2657340|NCT00677365|9176102|P4|Overall Study|Withdrawal by Subject|0
2657341|NCT00677365|9176103|P3|Overall Study|Withdrawal by Subject|1
2657342|NCT00677365|9176104|P2|Overall Study|Withdrawal by Subject|0
2657343|NCT00677365|9176105|P1|Overall Study|Withdrawal by Subject|0
2657344|NCT00677365|9176102|P4|Overall Study|Adverse Event|2
2657345|NCT00677365|9176103|P3|Overall Study|Adverse Event|1
2657346|NCT00677365|9176104|P2|Overall Study|Adverse Event|1
2657347|NCT00677365|9176105|P1|Overall Study|Adverse Event|2
2657348|NCT00677352|9176137|P2|Tapering Phase|Job transfer|1
2657349|NCT00677352|9176138|P1|Tapering Phase|Job transfer|0
2657350|NCT00677352|9176137|P2|Tapering Phase|Pregnancy|1
2657351|NCT00677352|9176138|P1|Tapering Phase|Pregnancy|0
2657352|NCT00677352|9176137|P2|Tapering Phase|Withdrawal by Subject|3
2657353|NCT00677352|9176138|P1|Tapering Phase|Withdrawal by Subject|5
2657354|NCT00677352|9176137|P2|Tapering Phase|Adverse Event|5
2657355|NCT00677352|9176138|P1|Tapering Phase|Adverse Event|1
2657356|NCT00677352|9176137|P2|Treatment Phase|Not treated|2
2657357|NCT00677352|9176138|P1|Treatment Phase|Not treated|0
2657358|NCT00677352|9176137|P2|Treatment Phase|Transference or work related matter|5
2657359|NCT00677352|9176138|P1|Treatment Phase|Transference or work related matter|0
2657360|NCT00677352|9176137|P2|Treatment Phase|Protocol Violation|1
2657361|NCT00677352|9176138|P1|Treatment Phase|Protocol Violation|1
2657362|NCT00677352|9176137|P2|Treatment Phase|Pregnancy|1
2657363|NCT00677352|9176138|P1|Treatment Phase|Pregnancy|0
2657364|NCT00677352|9176137|P2|Treatment Phase|Physician Decision|0
2657365|NCT00677352|9176138|P1|Treatment Phase|Physician Decision|1
2657366|NCT00677352|9176137|P2|Treatment Phase|Withdrawal by Subject|7
2657367|NCT00677352|9176138|P1|Treatment Phase|Withdrawal by Subject|7
2657368|NCT00677352|9176137|P2|Treatment Phase|Lost to Follow-up|1
2657369|NCT00677352|9176138|P1|Treatment Phase|Lost to Follow-up|0
2657370|NCT00677352|9176137|P2|Treatment Phase|Lack of Efficacy|3
2657371|NCT00677352|9176138|P1|Treatment Phase|Lack of Efficacy|2
2657372|NCT00677352|9176137|P2|Treatment Phase|Adverse Event|22
2657373|NCT00677352|9176138|P1|Treatment Phase|Adverse Event|14
2657374|NCT00677235|9176158|P2|Overall Study|Adverse Experience|0
2657375|NCT00677235|9176159|P1|Overall Study|Adverse Experience|1
2657376|NCT00677235|9176158|P2|Overall Study|Death|36
2657377|NCT00677235|9176159|P1|Overall Study|Death|37
2657378|NCT00677235|9176158|P2|Overall Study|Lost to Follow-up|1
2657379|NCT00677235|9176159|P1|Overall Study|Lost to Follow-up|2
2657380|NCT00677235|9176158|P2|Overall Study|Withdrawal by Subject|1
2657381|NCT00677235|9176159|P1|Overall Study|Withdrawal by Subject|1
2657382|NCT00677092|9176199|P1|Overall Study|Death Prior to Receiving Treatment|1
2657383|NCT00677092|9176199|P1|Overall Study|Withdrawal by Subject|3
2657384|NCT00677092|9176199|P1|Overall Study|Lost to Follow-up|1
2657385|NCT00677092|9176199|P1|Overall Study|Adverse Event|1
2657386|NCT00677014|9176216|P3|Overall Study|Unavailable or unreadable 6 month LVESV|18
2657387|NCT00677014|9176217|P2|Overall Study|Unavailable or unreadable 6 month LVESV|14
2657388|NCT00677014|9176218|P1|Overall Study|Unavailable or unreadable 6 month LVESV|18
2657389|NCT00677014|9176216|P3|Overall Study|Death|7
2657390|NCT00677014|9176217|P2|Overall Study|Death|15
2657391|NCT00677014|9176218|P1|Overall Study|Death|6
2657392|NCT00677014|9176216|P3|Overall Study|Lost to Follow-up|24
2657393|NCT00677014|9176217|P2|Overall Study|Lost to Follow-up|12
2657394|NCT00677014|9176218|P1|Overall Study|Lost to Follow-up|20
2657395|NCT00676715|9176271|P4|Overall Study|Participants Ongoing|24
2657396|NCT00676715|9176272|P3|Overall Study|Participants Ongoing|17
2657397|NCT00676715|9176273|P2|Overall Study|Participants Ongoing|29
2657398|NCT00676715|9176274|P1|Overall Study|Participants Ongoing|29
2657399|NCT00676715|9176271|P4|Overall Study|Adverse Event|0
2657400|NCT00676715|9176272|P3|Overall Study|Adverse Event|2
2657401|NCT00676715|9176273|P2|Overall Study|Adverse Event|1
2657402|NCT00676715|9176274|P1|Overall Study|Adverse Event|0
2657403|NCT00676715|9176271|P4|Overall Study|Death|0
2657404|NCT00676715|9176272|P3|Overall Study|Death|1
2657405|NCT00676715|9176273|P2|Overall Study|Death|1
2657406|NCT00676715|9176274|P1|Overall Study|Death|1
2657407|NCT00676715|9176271|P4|Overall Study|Lost to Follow-up|3
2657408|NCT00676715|9176272|P3|Overall Study|Lost to Follow-up|7
2657409|NCT00676715|9176273|P2|Overall Study|Lost to Follow-up|1
2657410|NCT00676715|9176274|P1|Overall Study|Lost to Follow-up|1
2657411|NCT00676715|9176271|P4|Overall Study|Other|3
2657412|NCT00676715|9176272|P3|Overall Study|Other|4
2657413|NCT00676715|9176273|P2|Overall Study|Other|6
2657414|NCT00676715|9176274|P1|Overall Study|Other|2
2657415|NCT00676715|9176271|P4|Overall Study|Withdrawal by Subject|10
2657416|NCT00676715|9176272|P3|Overall Study|Withdrawal by Subject|10
2657417|NCT00676715|9176273|P2|Overall Study|Withdrawal by Subject|9
2657418|NCT00676715|9176274|P1|Overall Study|Withdrawal by Subject|7
2657419|NCT00676689|9176304|P1|Overall Study|Continuing FU|49
2657420|NCT00676689|9176304|P1|Overall Study|Withdrawal by Subject|3
2657421|NCT00676689|9176304|P1|Overall Study|Physician Decision|1
2657422|NCT00676689|9176304|P1|Overall Study|Lost to Follow-up|4
2657423|NCT00676689|9176304|P1|Overall Study|Death|2
2657424|NCT00676689|9176304|P1|Overall Study|Screen Failure|2
2657425|NCT00676663|9176316|P2|Overall Study|Lost to Follow-up|3
2657426|NCT00676663|9176317|P1|Overall Study|Lost to Follow-up|1
2657427|NCT00676663|9176316|P2|Overall Study|Withdrew Consent|8
2657428|NCT00676663|9176317|P1|Overall Study|Withdrew Consent|1
2657429|NCT00676663|9176316|P2|Overall Study|Death|27
2657430|NCT00676663|9176317|P1|Overall Study|Death|43
2657431|NCT00676650|9176333|P2|Overall Study|Randomized but not treated|4
2657432|NCT00676650|9176334|P1|Overall Study|Randomized but not treated|3
2657433|NCT00676650|9176333|P2|Overall Study|Withdrawal by Subject|24
2657434|NCT00676650|9176334|P1|Overall Study|Withdrawal by Subject|48
2657435|NCT00676650|9176333|P2|Overall Study|Study terminated by sponsor|43
2657436|NCT00676650|9176334|P1|Overall Study|Study terminated by sponsor|57
2657437|NCT00676650|9176333|P2|Overall Study|Protocol Violation|1
2657438|NCT00676650|9176334|P1|Overall Study|Protocol Violation|3
2657439|NCT00676650|9176333|P2|Overall Study|Other|10
2657440|NCT00676650|9176334|P1|Overall Study|Other|14
2657441|NCT00676650|9176333|P2|Overall Study|Objective progression or relapse|140
2657442|NCT00676650|9176334|P1|Overall Study|Objective progression or relapse|189
2657443|NCT00676650|9176333|P2|Overall Study|Lost to Follow-up|1
2657444|NCT00676650|9176334|P1|Overall Study|Lost to Follow-up|0
2657445|NCT00676650|9176333|P2|Overall Study|Global deterioration of health status|31
2657446|NCT00676650|9176334|P1|Overall Study|Global deterioration of health status|66
2657447|NCT00676650|9176333|P2|Overall Study|Adverse Event|21
2657448|NCT00676650|9176334|P1|Overall Study|Adverse Event|159
2657449|NCT00676650|9176333|P2|Overall Study|Death|14
2657450|NCT00676650|9176334|P1|Overall Study|Death|45
2657451|NCT00676520|9176376|P1|Overall Study|Other Reason|18
2657452|NCT00676520|9176376|P1|Overall Study|Ineligible for Randomization to DAPT|209
2657453|NCT00676520|9176376|P1|Overall Study|Physician Decision|20
2657454|NCT00676520|9176376|P1|Overall Study|Death|159
2657455|NCT00676520|9176376|P1|Overall Study|Lost to Follow-up|162
2657456|NCT00676520|9176376|P1|Overall Study|Withdrawal by Subject|163
2657457|NCT00676494|9176433|P1|Overall Study|Withdrawal by Subject|6
2657458|NCT00676494|9176433|P1|Overall Study|Missed Visit|8
2657459|NCT00676403|9176450|P6|Overall Study|Withdrawal by Subject|1
2657460|NCT00676403|9176451|P5|Overall Study|Withdrawal by Subject|0
2657461|NCT00676403|9176452|P4|Overall Study|Withdrawal by Subject|0
2657462|NCT00676403|9176453|P3|Overall Study|Withdrawal by Subject|0
2657463|NCT00676403|9176454|P2|Overall Study|Withdrawal by Subject|0
2657464|NCT00676403|9176455|P1|Overall Study|Withdrawal by Subject|0
2657465|NCT00676403|9176450|P6|Overall Study|Reason Unspecified|1
2657466|NCT00676403|9176451|P5|Overall Study|Reason Unspecified|0
2657467|NCT00676403|9176452|P4|Overall Study|Reason Unspecified|0
2657468|NCT00676403|9176453|P3|Overall Study|Reason Unspecified|1
2657469|NCT00676403|9176454|P2|Overall Study|Reason Unspecified|0
2657470|NCT00676403|9176455|P1|Overall Study|Reason Unspecified|1
2657471|NCT00676403|9176450|P6|Overall Study|Lost to Follow-up|1
2657472|NCT00676403|9176451|P5|Overall Study|Lost to Follow-up|0
2657473|NCT00676403|9176452|P4|Overall Study|Lost to Follow-up|0
2657474|NCT00676403|9176453|P3|Overall Study|Lost to Follow-up|0
2657475|NCT00676403|9176454|P2|Overall Study|Lost to Follow-up|0
2657476|NCT00676403|9176455|P1|Overall Study|Lost to Follow-up|0
2657477|NCT00676403|9176450|P6|Overall Study|Adverse Event|2
2657478|NCT00676403|9176451|P5|Overall Study|Adverse Event|1
2657479|NCT00676403|9176452|P4|Overall Study|Adverse Event|5
2657480|NCT00676403|9176453|P3|Overall Study|Adverse Event|0
2657481|NCT00676403|9176454|P2|Overall Study|Adverse Event|2
2657482|NCT00676403|9176455|P1|Overall Study|Adverse Event|1
2657483|NCT00676338|9176598|P4|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
2657484|NCT00676338|9176599|P3|Overall Study|Lack of Efficacy-Loss of Glucose Control|5
2657485|NCT00676338|9176600|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
2657486|NCT00676338|9176601|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
2657487|NCT00676338|9176598|P4|Overall Study|Entry Criteria Not Met|1
2657488|NCT00676338|9176599|P3|Overall Study|Entry Criteria Not Met|1
2657489|NCT00676338|9176600|P2|Overall Study|Entry Criteria Not Met|2
2657490|NCT00676338|9176601|P1|Overall Study|Entry Criteria Not Met|0
2657491|NCT00676338|9176598|P4|Overall Study|Withdrawal by Subject|6
2657492|NCT00676338|9176599|P3|Overall Study|Withdrawal by Subject|12
2657493|NCT00676338|9176600|P2|Overall Study|Withdrawal by Subject|9
2657494|NCT00676338|9176601|P1|Overall Study|Withdrawal by Subject|17
2657495|NCT00676338|9176598|P4|Overall Study|Protocol Violation|5
2657496|NCT00676338|9176599|P3|Overall Study|Protocol Violation|2
2657497|NCT00676338|9176600|P2|Overall Study|Protocol Violation|9
2657498|NCT00676338|9176601|P1|Overall Study|Protocol Violation|5
2657499|NCT00676338|9176598|P4|Overall Study|Physician Decision|3
2657500|NCT00676338|9176599|P3|Overall Study|Physician Decision|2
2657501|NCT00676338|9176600|P2|Overall Study|Physician Decision|3
2657502|NCT00676338|9176601|P1|Overall Study|Physician Decision|3
2657503|NCT00676338|9176598|P4|Overall Study|Lost to Follow-up|4
2657504|NCT00676338|9176599|P3|Overall Study|Lost to Follow-up|3
2657505|NCT00676338|9176600|P2|Overall Study|Lost to Follow-up|1
2657506|NCT00676338|9176601|P1|Overall Study|Lost to Follow-up|4
2657507|NCT00676338|9176598|P4|Overall Study|Adverse Event|1
2657508|NCT00676338|9176599|P3|Overall Study|Adverse Event|5
2657509|NCT00676338|9176600|P2|Overall Study|Adverse Event|6
2657510|NCT00676338|9176601|P1|Overall Study|Adverse Event|6
2657511|NCT00676208|9176653|P2|Overall Study|Incomplete data|4
2657512|NCT00676208|9176654|P1|Overall Study|Incomplete data|2
2657513|NCT00676208|9176653|P2|Overall Study|Lost to Follow-up|2
2657514|NCT00676208|9176654|P1|Overall Study|Lost to Follow-up|0
2657515|NCT00676195|9176662|P1|Overall Study|Physician Decision|1
2657516|NCT00676195|9176662|P1|Overall Study|Adverse Event|1
2657517|NCT00676195|9176662|P1|Overall Study|Lost to Follow-up|1
2657518|NCT00676143|9176687|P2|Overall Study|Vasogenic edema recurrence|3
2657519|NCT00676143|9176688|P1|Overall Study|Vasogenic edema recurrence|1
2657520|NCT00676143|9176687|P2|Overall Study|Participant participation unknown|4
2657521|NCT00676143|9176688|P1|Overall Study|Participant participation unknown|1
2657522|NCT00676143|9176687|P2|Overall Study|Other|20
2657523|NCT00676143|9176688|P1|Overall Study|Other|11
2657524|NCT00676143|9176687|P2|Overall Study|Loss of caregiver|3
2657525|NCT00676143|9176688|P1|Overall Study|Loss of caregiver|5
2657526|NCT00676143|9176687|P2|Overall Study|Failed to return|1
2657527|NCT00676143|9176688|P1|Overall Study|Failed to return|2
2657528|NCT00676143|9176687|P2|Overall Study|Discontinuation of study by sponsor|88
2657529|NCT00676143|9176688|P1|Overall Study|Discontinuation of study by sponsor|65
2657530|NCT00676143|9176687|P2|Overall Study|Withdrawal by Subject|42
2657531|NCT00676143|9176688|P1|Overall Study|Withdrawal by Subject|24
2657532|NCT00676143|9176687|P2|Overall Study|Protocol Violation|8
2657533|NCT00676143|9176688|P1|Overall Study|Protocol Violation|4
2657534|NCT00676143|9176687|P2|Overall Study|Physician Decision|8
2657535|NCT00676143|9176688|P1|Overall Study|Physician Decision|5
2657536|NCT00676143|9176687|P2|Overall Study|Lost to Follow-up|13
2657537|NCT00676143|9176688|P1|Overall Study|Lost to Follow-up|0
2657538|NCT00676143|9176687|P2|Overall Study|Lack of Efficacy|6
2657539|NCT00676143|9176688|P1|Overall Study|Lack of Efficacy|0
2657540|NCT00676143|9176687|P2|Overall Study|Death|4
2657541|NCT00676143|9176688|P1|Overall Study|Death|4
2657542|NCT00676143|9176687|P2|Overall Study|Adverse Event|60
2657543|NCT00676143|9176688|P1|Overall Study|Adverse Event|34
2657544|NCT00676130|9176728|P2|Overall Study|Withdrawal by Subject|1
2657545|NCT00676130|9176729|P1|Overall Study|Withdrawal by Subject|0
2657546|NCT00676130|9176728|P2|Overall Study|Found ineligible|2
2657547|NCT00676130|9176729|P1|Overall Study|Found ineligible|3
2657548|NCT00676130|9176728|P2|Overall Study|Lost to Follow-up|1
2657549|NCT00676130|9176729|P1|Overall Study|Lost to Follow-up|0
2657550|NCT00676091|9176739|P2|Toddler Dose|Parent or legal guardian request|0
2657551|NCT00676091|9176740|P1|Toddler Dose|Parent or legal guardian request|1
2657552|NCT00676091|9176739|P2|Toddler Dose|Failed to return|0
2657553|NCT00676091|9176740|P1|Toddler Dose|Failed to return|2
2657554|NCT00676091|9176739|P2|After Infant Series|Failed to return|1
2657555|NCT00676091|9176740|P1|After Infant Series|Failed to return|1
2657556|NCT00676091|9176739|P2|After Infant Series|Protocol Violation|1
2657557|NCT00676091|9176740|P1|After Infant Series|Protocol Violation|0
2657558|NCT00676091|9176739|P2|After Infant Series|Adverse Event|1
2657559|NCT00676091|9176740|P1|After Infant Series|Adverse Event|0
2657560|NCT00676091|9176739|P2|Infant Series|Died prior to receiving 7vPnC|1
2657561|NCT00676091|9176740|P1|Infant Series|Died prior to receiving 7vPnC|0
2657562|NCT00676091|9176739|P2|Infant Series|Lost to Follow-up|0
2657563|NCT00676091|9176740|P1|Infant Series|Lost to Follow-up|1
2657564|NCT00676091|9176739|P2|Infant Series|Failed to return|3
2657565|NCT00676091|9176740|P1|Infant Series|Failed to return|1
2657566|NCT00676091|9176739|P2|Infant Series|Adverse Event|3
2657567|NCT00676091|9176740|P1|Infant Series|Adverse Event|2
2657568|NCT00676091|9176739|P2|Infant Series|Protocol Violation|3
2657569|NCT00676091|9176740|P1|Infant Series|Protocol Violation|6
2657570|NCT00676091|9176739|P2|Infant Series|Parent or legal guardian request|8
2657571|NCT00676091|9176740|P1|Infant Series|Parent or legal guardian request|10
2657572|NCT00676052|9176797|P6|Overall Study|Withdrawal by Subject|0
2657573|NCT00676052|9176798|P5|Overall Study|Withdrawal by Subject|0
2657574|NCT00676052|9176799|P4|Overall Study|Withdrawal by Subject|0
2657575|NCT00676052|9176800|P3|Overall Study|Withdrawal by Subject|1
2657576|NCT00676052|9176801|P2|Overall Study|Withdrawal by Subject|0
2657577|NCT00676052|9176802|P1|Overall Study|Withdrawal by Subject|1
2657578|NCT00676052|9176797|P6|Overall Study|Physician Decision|1
2657579|NCT00676052|9176798|P5|Overall Study|Physician Decision|0
2657580|NCT00676052|9176799|P4|Overall Study|Physician Decision|0
2657581|NCT00676052|9176800|P3|Overall Study|Physician Decision|1
2657582|NCT00676052|9176801|P2|Overall Study|Physician Decision|1
2657583|NCT00676052|9176802|P1|Overall Study|Physician Decision|1
2657584|NCT00676052|9176797|P6|Overall Study|Lost to Follow-up|0
2657585|NCT00676052|9176798|P5|Overall Study|Lost to Follow-up|1
2657586|NCT00676052|9176799|P4|Overall Study|Lost to Follow-up|0
2657587|NCT00676052|9176800|P3|Overall Study|Lost to Follow-up|0
2657588|NCT00676052|9176801|P2|Overall Study|Lost to Follow-up|0
2657589|NCT00676052|9176802|P1|Overall Study|Lost to Follow-up|0
2657590|NCT00676052|9176797|P6|Overall Study|Protocol Violation|2
2657591|NCT00676052|9176798|P5|Overall Study|Protocol Violation|1
2657592|NCT00676052|9176799|P4|Overall Study|Protocol Violation|2
2657593|NCT00676052|9176800|P3|Overall Study|Protocol Violation|2
2657594|NCT00676052|9176801|P2|Overall Study|Protocol Violation|3
2657595|NCT00676052|9176802|P1|Overall Study|Protocol Violation|5
2657596|NCT00676052|9176797|P6|Overall Study|Lack of Efficacy|1
2657597|NCT00676052|9176798|P5|Overall Study|Lack of Efficacy|2
2657598|NCT00676052|9176799|P4|Overall Study|Lack of Efficacy|1
2657599|NCT00676052|9176800|P3|Overall Study|Lack of Efficacy|1
2657600|NCT00676052|9176801|P2|Overall Study|Lack of Efficacy|2
2657601|NCT00676052|9176802|P1|Overall Study|Lack of Efficacy|2
2657602|NCT00676052|9176797|P6|Overall Study|Adverse Event|2
2657603|NCT00676052|9176798|P5|Overall Study|Adverse Event|2
2657604|NCT00676052|9176799|P4|Overall Study|Adverse Event|2
2657605|NCT00676052|9176800|P3|Overall Study|Adverse Event|1
2657606|NCT00676052|9176801|P2|Overall Study|Adverse Event|1
2657607|NCT00676052|9176802|P1|Overall Study|Adverse Event|0
2657608|NCT00675948|9176872|P2|Overall Study|Patient feels unable to take medication|1
2657609|NCT00675948|9176873|P1|Overall Study|Patient feels unable to take medication|0
2657610|NCT00675948|9176872|P2|Overall Study|Patient unable to comply with diaries|0
2657611|NCT00675948|9176873|P1|Overall Study|Patient unable to comply with diaries|1
2657612|NCT00675948|9176872|P2|Overall Study|Patient died|0
2657613|NCT00675948|9176873|P1|Overall Study|Patient died|1
2657614|NCT00675948|9176872|P2|Overall Study|Sponsor decision|1
2657615|NCT00675948|9176873|P1|Overall Study|Sponsor decision|0
2657616|NCT00675948|9176872|P2|Overall Study|Pain under control|0
2657617|NCT00675948|9176873|P1|Overall Study|Pain under control|1
2657618|NCT00675948|9176872|P2|Overall Study|Protocol Violation|0
2657619|NCT00675948|9176873|P1|Overall Study|Protocol Violation|1
2657620|NCT00675948|9176872|P2|Overall Study|Lost to Follow-up|0
2657621|NCT00675948|9176873|P1|Overall Study|Lost to Follow-up|2
2657622|NCT00675948|9176872|P2|Overall Study|Withdrawal by Subject|0
2657623|NCT00675948|9176873|P1|Overall Study|Withdrawal by Subject|7
2657624|NCT00675948|9176872|P2|Overall Study|Lack of Efficacy|0
2657625|NCT00675948|9176873|P1|Overall Study|Lack of Efficacy|3
2657626|NCT00675948|9176872|P2|Overall Study|Adverse Event|1
2657627|NCT00675948|9176873|P1|Overall Study|Adverse Event|23
2657628|NCT00675766|9176936|P4|Overall Study|Lost to Follow-up|26
2657629|NCT00675766|9176937|P3|Overall Study|Lost to Follow-up|21
2657630|NCT00675766|9176938|P2|Overall Study|Lost to Follow-up|5
2657631|NCT00675766|9176939|P1|Overall Study|Lost to Follow-up|6
2657632|NCT00675597|9176949|P1|Overall Study|Withdrawal by Subject|3
2657633|NCT00675506|9177003|P2|Overall Study|Schedule conflict|1
2657634|NCT00675506|9177004|P1|Overall Study|Schedule conflict|0
2657635|NCT00675506|9177003|P2|Overall Study|Declined participation|0
2657636|NCT00675506|9177004|P1|Overall Study|Declined participation|1
2657637|NCT00675506|9177003|P2|Overall Study|Disclosed history of cancer|0
2657638|NCT00675506|9177004|P1|Overall Study|Disclosed history of cancer|1
2657639|NCT00675506|9177003|P2|Overall Study|Hypersensitivity Reaction|0
2657640|NCT00675506|9177004|P1|Overall Study|Hypersensitivity Reaction|1
2657641|NCT00675506|9177003|P2|Overall Study|Elevated IGF-1|0
2657642|NCT00675506|9177004|P1|Overall Study|Elevated IGF-1|2
2657643|NCT00675506|9177003|P2|Overall Study|Elevated IGF-1 prior to treatment|0
2657644|NCT00675506|9177004|P1|Overall Study|Elevated IGF-1 prior to treatment|1
2657645|NCT00675506|9177003|P2|Overall Study|Elevated fasting glucose|1
2657646|NCT00675506|9177004|P1|Overall Study|Elevated fasting glucose|2
2657647|NCT00675506|9177003|P2|Overall Study|Lost interest|5
2657648|NCT00675506|9177004|P1|Overall Study|Lost interest|3
2657649|NCT00675506|9177003|P2|Overall Study|Lost to Follow-up|5
2657650|NCT00675506|9177004|P1|Overall Study|Lost to Follow-up|1
2657651|NCT00675441|9177020|P1|Overall Study|Death|1
2657652|NCT00675441|9177020|P1|Overall Study|Withdrawal by Subject|2
2657653|NCT00675428|9177026|P2|Overall Study|Physician Decision|0
2657654|NCT00675428|9177027|P1|Overall Study|Physician Decision|1
2657655|NCT00675428|9177026|P2|Overall Study|No Disease Response After Cycle 6|1
2657656|NCT00675428|9177027|P1|Overall Study|No Disease Response After Cycle 6|0
2657657|NCT00675428|9177026|P2|Overall Study|Disease Progression|2
2657658|NCT00675428|9177027|P1|Overall Study|Disease Progression|2
2657659|NCT00675103|9177069|P1|Overall Study|Adverse Event|1
2657660|NCT00675103|9177069|P1|Overall Study|Lack of Efficacy|2
2657661|NCT00674986|9177076|P2|Overall Study|Other reasons|8
2657662|NCT00674986|9177077|P1|Overall Study|Other reasons|4
2657663|NCT00674986|9177076|P2|Overall Study|Lost to Follow-up|53
2657664|NCT00674986|9177077|P1|Overall Study|Lost to Follow-up|25
2657665|NCT00674986|9177076|P2|Overall Study|Subject withdrew consent|19
2657666|NCT00674986|9177077|P1|Overall Study|Subject withdrew consent|12
2657667|NCT00674986|9177076|P2|Overall Study|Adverse Event|1
2657668|NCT00674986|9177077|P1|Overall Study|Adverse Event|2
2657669|NCT00674973|9177098|P2|Overall Study|Protocol Violation|1
2657670|NCT00674973|9177099|P1|Overall Study|Protocol Violation|0
2657671|NCT00674973|9177098|P2|Overall Study|Death|15
2657672|NCT00674973|9177099|P1|Overall Study|Death|19
2657673|NCT00674973|9177098|P2|Overall Study|Adverse Event|9
2657674|NCT00674973|9177099|P1|Overall Study|Adverse Event|2
2657675|NCT00674973|9177098|P2|Overall Study|Failure to Return|0
2657676|NCT00674973|9177099|P1|Overall Study|Failure to Return|1
2657677|NCT00674973|9177098|P2|Overall Study|Refused Treatment|5
2657678|NCT00674973|9177099|P1|Overall Study|Refused Treatment|1
2657679|NCT00674973|9177098|P2|Overall Study|Insufficient Therapeutic Response|72
2657680|NCT00674973|9177099|P1|Overall Study|Insufficient Therapeutic Response|77
2657681|NCT00674817|9177113|P1|Period 4|Adverse Event|1
2657682|NCT00674817|9177113|P1|Period 3|Protocol Violation|1
2657683|NCT00674817|9177113|P1|Period 3|Adverse Event|1
2657684|NCT00674817|9177113|P1|Period 1|Protocol Violation|1
2657685|NCT00674817|9177113|P1|Period 1|Withdrawal by Subject|2
2657686|NCT00674700|9177290|P3|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7
2657687|NCT00674700|9177291|P2|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10
2657688|NCT00674700|9177292|P1|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5
2657689|NCT00674700|9177290|P3|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4
2657690|NCT00674700|9177291|P2|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
2657691|NCT00674700|9177292|P1|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
2657692|NCT00674700|9177290|P3|Year 2 Follow-up Without Treatment|Adverse Event|1
2657693|NCT00674700|9177291|P2|Year 2 Follow-up Without Treatment|Adverse Event|1
2657694|NCT00674700|9177292|P1|Year 2 Follow-up Without Treatment|Adverse Event|0
2657695|NCT00674700|9177290|P3|Year 1|Any other reason not above-mentioned|6
2657696|NCT00674700|9177291|P2|Year 1|Any other reason not above-mentioned|7
2657697|NCT00674700|9177292|P1|Year 1|Any other reason not above-mentioned|7
2657698|NCT00674700|9177290|P3|Year 1|Withdrawal by Subject|6
2657699|NCT00674700|9177291|P2|Year 1|Withdrawal by Subject|7
2657700|NCT00674700|9177292|P1|Year 1|Withdrawal by Subject|7
2657701|NCT00674700|9177290|P3|Year 1|Adverse Event|5
2657702|NCT00674700|9177291|P2|Year 1|Adverse Event|20
2657703|NCT00674700|9177292|P1|Year 1|Adverse Event|17
2657704|NCT00674661|9177305|P2|Overall Study|Withdrawal by Subject|5
2657705|NCT00674661|9177306|P1|Overall Study|Withdrawal by Subject|0
2657706|NCT00674661|9177305|P2|Overall Study|Lost to Follow-up|3
2657707|NCT00674661|9177306|P1|Overall Study|Lost to Follow-up|6
2657708|NCT00674661|9177305|P2|Overall Study|Other|7
2657709|NCT00674661|9177306|P1|Overall Study|Other|5
2657710|NCT00674570|9177404|P3|Overall Study|Withdrawal by Subject|0
2657711|NCT00674570|9177405|P2|Overall Study|Withdrawal by Subject|2
2657712|NCT00674570|9177406|P1|Overall Study|Withdrawal by Subject|0
2657713|NCT00674362|9177445|P2|Open Label|Other: Subject moved to extension study|0
2657714|NCT00674362|9177446|P1|Open Label|Other: Subject moved to extension study|1
2657715|NCT00674362|9177445|P2|Open Label|Adverse Event|0
2657716|NCT00674362|9177446|P1|Open Label|Adverse Event|1
2657717|NCT00674362|9177445|P2|Double Blind|Other: Surgery|1
2657718|NCT00674362|9177446|P1|Double Blind|Other: Surgery|0
2657965|NCT00672984|9178228|P1|First Intervention|Withdrawal by Subject|1
2657719|NCT00674362|9177445|P2|Double Blind|Other: Loss of Patient Compliance|1
2657720|NCT00674362|9177446|P1|Double Blind|Other: Loss of Patient Compliance|0
2657721|NCT00674362|9177445|P2|Double Blind|Withdrawal by Subject|3
2657722|NCT00674362|9177446|P1|Double Blind|Withdrawal by Subject|4
2657723|NCT00674362|9177445|P2|Double Blind|Loss of efficacy|1
2657724|NCT00674362|9177446|P1|Double Blind|Loss of efficacy|0
2657725|NCT00674362|9177445|P2|Double Blind|Lack of Efficacy|6
2657726|NCT00674362|9177446|P1|Double Blind|Lack of Efficacy|2
2657727|NCT00674362|9177445|P2|Double Blind|Adverse Event|6
2657728|NCT00674362|9177446|P1|Double Blind|Adverse Event|6
2657729|NCT00674323|9177514|P3|Overall Study|Protocol Violation|0
2657730|NCT00674323|9177515|P2|Overall Study|Protocol Violation|0
2657731|NCT00674323|9177516|P1|Overall Study|Protocol Violation|1
2657732|NCT00674323|9177514|P3|Overall Study|Adverse Event|0
2657733|NCT00674323|9177515|P2|Overall Study|Adverse Event|1
2657734|NCT00674323|9177516|P1|Overall Study|Adverse Event|0
2657735|NCT00674154|9177567|P2|Overall Study|Did not want parathyroidectomy|2
2657736|NCT00674154|9177568|P1|Overall Study|Did not want parathyroidectomy|0
2657737|NCT00674154|9177567|P2|Overall Study|Withdrawal by Subject|1
2657738|NCT00674154|9177568|P1|Overall Study|Withdrawal by Subject|3
2657739|NCT00674128|9177576|P2|Overall Study|Withdrawal by Subject|23
2657740|NCT00674128|9177577|P1|Overall Study|Withdrawal by Subject|25
2657741|NCT00673933|9177602|P1|Overall Study|Lost to Follow-up|1
2657742|NCT00673933|9177602|P1|Overall Study|Withdrawal by Subject|2
2657743|NCT00673894|9177620|P2|First Intervention 4 Weeks|Adverse Event|0
2657744|NCT00673894|9177621|P1|First Intervention 4 Weeks|Adverse Event|1
2657745|NCT00673894|9177620|P2|First Intervention 4 Weeks|Withdrawal by Subject|0
2657746|NCT00673894|9177621|P1|First Intervention 4 Weeks|Withdrawal by Subject|1
2657747|NCT00673881|9177629|P1|Overall Study|Withdrawal by Subject|1
2657748|NCT00673816|9177643|P1|Overall Study|Withdrawal by Subject|1
2657749|NCT00673816|9177643|P1|Overall Study|Adverse Event|1
2657750|NCT00673790|9177653|P3|Overall Study|Randomization criteria not met|0
2657751|NCT00673790|9177654|P2|Overall Study|Randomization criteria not met|1
2657752|NCT00673790|9177655|P1|Overall Study|Randomization criteria not met|0
2657753|NCT00673790|9177653|P3|Overall Study|Unconfirmed pregnancy|0
2657754|NCT00673790|9177654|P2|Overall Study|Unconfirmed pregnancy|1
2657755|NCT00673790|9177655|P1|Overall Study|Unconfirmed pregnancy|0
2657756|NCT00673790|9177653|P3|Overall Study|Participated in two Nebivolol studies|1
2657757|NCT00673790|9177654|P2|Overall Study|Participated in two Nebivolol studies|0
2657758|NCT00673790|9177655|P1|Overall Study|Participated in two Nebivolol studies|0
2657759|NCT00673790|9177653|P3|Overall Study|Poor compliance|0
2657760|NCT00673790|9177654|P2|Overall Study|Poor compliance|0
2657761|NCT00673790|9177655|P1|Overall Study|Poor compliance|1
2657762|NCT00673790|9177653|P3|Overall Study|Sponsor Terminated due to PI oversight|0
2657763|NCT00673790|9177654|P2|Overall Study|Sponsor Terminated due to PI oversight|1
2657764|NCT00673790|9177655|P1|Overall Study|Sponsor Terminated due to PI oversight|0
2657765|NCT00673790|9177653|P3|Overall Study|Lost to Follow-up|5
2657766|NCT00673790|9177654|P2|Overall Study|Lost to Follow-up|6
2657767|NCT00673790|9177655|P1|Overall Study|Lost to Follow-up|6
2657768|NCT00673790|9177653|P3|Overall Study|Withdrawal by Subject|1
2657769|NCT00673790|9177654|P2|Overall Study|Withdrawal by Subject|4
2657770|NCT00673790|9177655|P1|Overall Study|Withdrawal by Subject|7
2657771|NCT00673790|9177653|P3|Overall Study|Protocol Violation|1
2657772|NCT00673790|9177654|P2|Overall Study|Protocol Violation|9
2657773|NCT00673790|9177655|P1|Overall Study|Protocol Violation|6
2657774|NCT00673790|9177653|P3|Overall Study|Lack of Efficacy|2
2657775|NCT00673790|9177654|P2|Overall Study|Lack of Efficacy|2
2657776|NCT00673790|9177655|P1|Overall Study|Lack of Efficacy|2
2657777|NCT00673790|9177653|P3|Overall Study|Adverse Event|2
2657778|NCT00673790|9177654|P2|Overall Study|Adverse Event|14
2657779|NCT00673790|9177655|P1|Overall Study|Adverse Event|23
2657780|NCT00673673|9177693|P1|Overall Study|Investigators' discretion|2
2657781|NCT00673673|9177693|P1|Overall Study|Withdrawal by Subject|3
2657782|NCT00673673|9177693|P1|Overall Study|Adverse Event|4
2657783|NCT00673673|9177693|P1|Overall Study|Progressive disease|27
2657784|NCT00673660|9177699|P1|Overall Study|Lost to Follow-up|107
2657785|NCT00673465|9177721|P12|Part 1/Period 2 (United States)|Protocol Violation|0
2657786|NCT00673465|9177722|P11|Part 1/Period 2 (United States)|Protocol Violation|0
2657787|NCT00673465|9177723|P10|Part 1/Period 2 (United States)|Protocol Violation|0
2657788|NCT00673465|9177724|P9|Part 1/Period 2 (United States)|Protocol Violation|0
2657789|NCT00673465|9177725|P8|Part 1/Period 2 (United States)|Protocol Violation|0
2657790|NCT00673465|9177726|P7|Part 1/Period 2 (United States)|Protocol Violation|0
2657791|NCT00673465|9177727|P6|Part 1/Period 2 (United States)|Protocol Violation|0
2657792|NCT00673465|9177728|P5|Part 1/Period 2 (United States)|Protocol Violation|1
2657793|NCT00673465|9177729|P4|Part 1/Period 2 (United States)|Protocol Violation|0
2657794|NCT00673465|9177730|P3|Part 1/Period 2 (United States)|Protocol Violation|0
2657795|NCT00673465|9177731|P2|Part 1/Period 2 (United States)|Protocol Violation|0
2657796|NCT00673465|9177732|P1|Part 1/Period 2 (United States)|Protocol Violation|0
2657797|NCT00673465|9177721|P12|Part 1/Period 1 (United States)|Protocol Violation|0
2657798|NCT00673465|9177722|P11|Part 1/Period 1 (United States)|Protocol Violation|0
2657799|NCT00673465|9177723|P10|Part 1/Period 1 (United States)|Protocol Violation|0
2657800|NCT00673465|9177724|P9|Part 1/Period 1 (United States)|Protocol Violation|0
2657801|NCT00673465|9177725|P8|Part 1/Period 1 (United States)|Protocol Violation|0
2657802|NCT00673465|9177726|P7|Part 1/Period 1 (United States)|Protocol Violation|0
2657803|NCT00673465|9177727|P6|Part 1/Period 1 (United States)|Protocol Violation|1
2657804|NCT00673465|9177728|P5|Part 1/Period 1 (United States)|Protocol Violation|1
2657805|NCT00673465|9177729|P4|Part 1/Period 1 (United States)|Protocol Violation|0
2657806|NCT00673465|9177730|P3|Part 1/Period 1 (United States)|Protocol Violation|0
2657807|NCT00673465|9177731|P2|Part 1/Period 1 (United States)|Protocol Violation|0
2657808|NCT00673465|9177732|P1|Part 1/Period 1 (United States)|Protocol Violation|0
2657809|NCT00673452|9177781|P2|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0
2657810|NCT00673452|9177782|P1|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1
2657811|NCT00673452|9177781|P2|Continuation Double-Blind Phase|Physician Decision|0
2657812|NCT00673452|9177782|P1|Continuation Double-Blind Phase|Physician Decision|2
2657813|NCT00673452|9177781|P2|Continuation Double-Blind Phase|Sponsor Decision|3
2657814|NCT00673452|9177782|P1|Continuation Double-Blind Phase|Sponsor Decision|0
2657815|NCT00673452|9177781|P2|Continuation Double-Blind Phase|Protocol Violation|3
2657816|NCT00673452|9177782|P1|Continuation Double-Blind Phase|Protocol Violation|2
2657817|NCT00673452|9177781|P2|Continuation Double-Blind Phase|Lack of Efficacy|5
2657818|NCT00673452|9177782|P1|Continuation Double-Blind Phase|Lack of Efficacy|2
2657819|NCT00673452|9177781|P2|Continuation Double-Blind Phase|Lost to Follow-up|5
2657820|NCT00673452|9177782|P1|Continuation Double-Blind Phase|Lost to Follow-up|4
2657821|NCT00673452|9177781|P2|Continuation Double-Blind Phase|Withdrawal by Subject|5
2657822|NCT00673452|9177782|P1|Continuation Double-Blind Phase|Withdrawal by Subject|9
2657823|NCT00673452|9177781|P2|Continuation Double-Blind Phase|Adverse Event|13
2657824|NCT00673452|9177782|P1|Continuation Double-Blind Phase|Adverse Event|5
2657825|NCT00673452|9177781|P2|Acute Double-Blind Phase|Withdrawal by Subject|13
2657826|NCT00673452|9177782|P1|Acute Double-Blind Phase|Withdrawal by Subject|16
2657827|NCT00673452|9177781|P2|Acute Double-Blind Phase|Sponsor Decision|1
2657828|NCT00673452|9177782|P1|Acute Double-Blind Phase|Sponsor Decision|0
2657829|NCT00673452|9177781|P2|Acute Double-Blind Phase|Protocol Violation|3
2657830|NCT00673452|9177782|P1|Acute Double-Blind Phase|Protocol Violation|5
2657831|NCT00673452|9177781|P2|Acute Double-Blind Phase|Physician Decision|6
2657832|NCT00673452|9177782|P1|Acute Double-Blind Phase|Physician Decision|0
2657833|NCT00673452|9177781|P2|Acute Double-Blind Phase|Lost to Follow-up|19
2657834|NCT00673452|9177782|P1|Acute Double-Blind Phase|Lost to Follow-up|16
2657835|NCT00673452|9177781|P2|Acute Double-Blind Phase|Lack of Efficacy|14
2657836|NCT00673452|9177782|P1|Acute Double-Blind Phase|Lack of Efficacy|9
2657837|NCT00673452|9177781|P2|Acute Double-Blind Phase|Adverse Event|24
2657838|NCT00673452|9177782|P1|Acute Double-Blind Phase|Adverse Event|41
2657839|NCT00673387|9177846|P8|Overall Study|Lost to Follow-up|5
2657840|NCT00673387|9177847|P7|Overall Study|Lost to Follow-up|8
2657841|NCT00673387|9177848|P6|Overall Study|Lost to Follow-up|5
2657842|NCT00673387|9177849|P5|Overall Study|Lost to Follow-up|6
2657843|NCT00673387|9177850|P4|Overall Study|Lost to Follow-up|6
2657844|NCT00673387|9177851|P3|Overall Study|Lost to Follow-up|5
2657845|NCT00673387|9177852|P2|Overall Study|Lost to Follow-up|6
2657846|NCT00673387|9177853|P1|Overall Study|Lost to Follow-up|8
2657847|NCT00673387|9177846|P8|Overall Study|Protocol Violation|3
2657848|NCT00673387|9177847|P7|Overall Study|Protocol Violation|1
2657849|NCT00673387|9177848|P6|Overall Study|Protocol Violation|1
2657850|NCT00673387|9177849|P5|Overall Study|Protocol Violation|0
2657851|NCT00673387|9177850|P4|Overall Study|Protocol Violation|2
2657852|NCT00673387|9177851|P3|Overall Study|Protocol Violation|1
2657853|NCT00673387|9177852|P2|Overall Study|Protocol Violation|0
2657854|NCT00673387|9177853|P1|Overall Study|Protocol Violation|3
2657855|NCT00673387|9177846|P8|Overall Study|Physician Decision|1
2657856|NCT00673387|9177847|P7|Overall Study|Physician Decision|1
2657857|NCT00673387|9177848|P6|Overall Study|Physician Decision|5
2657858|NCT00673387|9177849|P5|Overall Study|Physician Decision|0
2657859|NCT00673387|9177850|P4|Overall Study|Physician Decision|0
2657860|NCT00673387|9177851|P3|Overall Study|Physician Decision|0
2657861|NCT00673387|9177852|P2|Overall Study|Physician Decision|0
2657862|NCT00673387|9177853|P1|Overall Study|Physician Decision|0
2657863|NCT00673387|9177846|P8|Overall Study|Adverse Event|5
2657864|NCT00673387|9177847|P7|Overall Study|Adverse Event|5
2657865|NCT00673387|9177848|P6|Overall Study|Adverse Event|2
2657866|NCT00673387|9177849|P5|Overall Study|Adverse Event|6
2657867|NCT00673387|9177850|P4|Overall Study|Adverse Event|2
2657868|NCT00673387|9177851|P3|Overall Study|Adverse Event|5
2657869|NCT00673387|9177852|P2|Overall Study|Adverse Event|1
2657870|NCT00673387|9177853|P1|Overall Study|Adverse Event|3
2657871|NCT00673387|9177846|P8|Overall Study|Withdrawal by Subject|21
2657872|NCT00673387|9177847|P7|Overall Study|Withdrawal by Subject|15
2657873|NCT00673387|9177848|P6|Overall Study|Withdrawal by Subject|21
2657874|NCT00673387|9177849|P5|Overall Study|Withdrawal by Subject|18
2657875|NCT00673387|9177850|P4|Overall Study|Withdrawal by Subject|16
2657876|NCT00673387|9177851|P3|Overall Study|Withdrawal by Subject|20
2657877|NCT00673387|9177852|P2|Overall Study|Withdrawal by Subject|16
2657878|NCT00673387|9177853|P1|Overall Study|Withdrawal by Subject|15
2657879|NCT00673361|9178069|P1|Overall Study|Screen Failure|2
2657880|NCT00673257|9178105|P1|Overall Study|Unable to obtain specimen|1
2657881|NCT00673257|9178105|P1|Overall Study|Withdrawal by Subject|4
2657882|NCT00673231|9178114|P4|Overall Study|Study criteria,compliance,safety, other|4
2657883|NCT00673231|9178115|P3|Overall Study|Study criteria,compliance,safety, other|7
2657884|NCT00673231|9178116|P2|Overall Study|Study criteria,compliance,safety, other|5
2657885|NCT00673231|9178117|P1|Overall Study|Study criteria,compliance,safety, other|8
2657886|NCT00673231|9178114|P4|Overall Study|Death|0
2657887|NCT00673231|9178115|P3|Overall Study|Death|1
2657888|NCT00673231|9178116|P2|Overall Study|Death|0
2657889|NCT00673231|9178117|P1|Overall Study|Death|0
2657890|NCT00673231|9178114|P4|Overall Study|Lost to Follow-up|2
2657891|NCT00673231|9178115|P3|Overall Study|Lost to Follow-up|1
2657892|NCT00673231|9178116|P2|Overall Study|Lost to Follow-up|2
2657893|NCT00673231|9178117|P1|Overall Study|Lost to Follow-up|1
2657894|NCT00673231|9178114|P4|Overall Study|Adverse Event|6
2657895|NCT00673231|9178115|P3|Overall Study|Adverse Event|9
2657896|NCT00673231|9178116|P2|Overall Study|Adverse Event|5
2657897|NCT00673231|9178117|P1|Overall Study|Adverse Event|6
2657898|NCT00673231|9178114|P4|Overall Study|Withdrawal by Subject|6
2657899|NCT00673231|9178115|P3|Overall Study|Withdrawal by Subject|8
2657900|NCT00673231|9178116|P2|Overall Study|Withdrawal by Subject|10
2657901|NCT00673231|9178117|P1|Overall Study|Withdrawal by Subject|14
2657902|NCT00673179|9178149|P2|Overall Study|Toxicity/Complications|0
2657903|NCT00673179|9178150|P1|Overall Study|Toxicity/Complications|3
2657904|NCT00673049|9178199|P4|After Progression on Erlotinib|study terminated by sponsor|4
2657905|NCT00673049|9178200|P3|After Progression on Erlotinib|study terminated by sponsor|0
2657906|NCT00673049|9178201|P2|After Progression on Erlotinib|study terminated by sponsor|0
2657907|NCT00673049|9178202|P1|After Progression on Erlotinib|study terminated by sponsor|0
2657908|NCT00673049|9178199|P4|After Progression on Erlotinib|Withdrawal by Subject|5
2657909|NCT00673049|9178200|P3|After Progression on Erlotinib|Withdrawal by Subject|0
2657910|NCT00673049|9178201|P2|After Progression on Erlotinib|Withdrawal by Subject|0
2657911|NCT00673049|9178202|P1|After Progression on Erlotinib|Withdrawal by Subject|0
2657912|NCT00673049|9178199|P4|After Progression on Erlotinib|Lost to Follow-up|3
2657913|NCT00673049|9178200|P3|After Progression on Erlotinib|Lost to Follow-up|0
2657914|NCT00673049|9178201|P2|After Progression on Erlotinib|Lost to Follow-up|0
2657915|NCT00673049|9178202|P1|After Progression on Erlotinib|Lost to Follow-up|0
2657916|NCT00673049|9178199|P4|After Progression on Erlotinib|Death|71
2657917|NCT00673049|9178200|P3|After Progression on Erlotinib|Death|0
2657918|NCT00673049|9178201|P2|After Progression on Erlotinib|Death|0
2657919|NCT00673049|9178202|P1|After Progression on Erlotinib|Death|0
2657920|NCT00673049|9178199|P4|Before Progression on Erlotinib|Switched to figitumumab|0
2657921|NCT00673049|9178200|P3|Before Progression on Erlotinib|Switched to figitumumab|0
2657922|NCT00673049|9178201|P2|Before Progression on Erlotinib|Switched to figitumumab|83
2657923|NCT00673049|9178202|P1|Before Progression on Erlotinib|Switched to figitumumab|0
2657924|NCT00673049|9178199|P4|Before Progression on Erlotinib|study terminated by sponsor|0
2657925|NCT00673049|9178200|P3|Before Progression on Erlotinib|study terminated by sponsor|0
2657926|NCT00673049|9178201|P2|Before Progression on Erlotinib|study terminated by sponsor|14
2657927|NCT00673049|9178202|P1|Before Progression on Erlotinib|study terminated by sponsor|18
2657928|NCT00673049|9178199|P4|Before Progression on Erlotinib|Other|0
2657929|NCT00673049|9178200|P3|Before Progression on Erlotinib|Other|0
2657930|NCT00673049|9178201|P2|Before Progression on Erlotinib|Other|2
2657931|NCT00673049|9178202|P1|Before Progression on Erlotinib|Other|1
2657932|NCT00673049|9178199|P4|Before Progression on Erlotinib|Withdrawal by Subject|0
2657933|NCT00673049|9178200|P3|Before Progression on Erlotinib|Withdrawal by Subject|0
2657934|NCT00673049|9178201|P2|Before Progression on Erlotinib|Withdrawal by Subject|18
2657935|NCT00673049|9178202|P1|Before Progression on Erlotinib|Withdrawal by Subject|26
2657936|NCT00673049|9178199|P4|Before Progression on Erlotinib|Lost to Follow-up|0
2657937|NCT00673049|9178200|P3|Before Progression on Erlotinib|Lost to Follow-up|0
2657938|NCT00673049|9178201|P2|Before Progression on Erlotinib|Lost to Follow-up|5
2657939|NCT00673049|9178202|P1|Before Progression on Erlotinib|Lost to Follow-up|9
2657940|NCT00673049|9178199|P4|Before Progression on Erlotinib|Death|0
2657941|NCT00673049|9178200|P3|Before Progression on Erlotinib|Death|1
2657942|NCT00673049|9178201|P2|Before Progression on Erlotinib|Death|167
2657943|NCT00673049|9178202|P1|Before Progression on Erlotinib|Death|235
2657944|NCT00673049|9178199|P4|Before Progression on Erlotinib|Randomized but not treated|0
2657945|NCT00673049|9178200|P3|Before Progression on Erlotinib|Randomized but not treated|0
2657946|NCT00673049|9178201|P2|Before Progression on Erlotinib|Randomized but not treated|1
2657947|NCT00673049|9178202|P1|Before Progression on Erlotinib|Randomized but not treated|3
2657948|NCT00672984|9178226|P3|Third Intervention|Adverse Event|1
2657949|NCT00672984|9178227|P2|Third Intervention|Adverse Event|0
2657950|NCT00672984|9178228|P1|Third Intervention|Adverse Event|1
2657951|NCT00672984|9178226|P3|Second Intervention|Protocol Violation|1
2657952|NCT00672984|9178227|P2|Second Intervention|Protocol Violation|1
2657953|NCT00672984|9178228|P1|Second Intervention|Protocol Violation|0
2657954|NCT00672984|9178226|P3|Second Intervention|Withdrawal by Subject|0
2657955|NCT00672984|9178227|P2|Second Intervention|Withdrawal by Subject|3
2657956|NCT00672984|9178228|P1|Second Intervention|Withdrawal by Subject|0
2657957|NCT00672984|9178226|P3|Second Intervention|Non-compliance with facility policies|0
2657958|NCT00672984|9178227|P2|Second Intervention|Non-compliance with facility policies|2
2657959|NCT00672984|9178228|P1|Second Intervention|Non-compliance with facility policies|0
2657960|NCT00672984|9178226|P3|First Intervention|Sponsor decision|0
2657961|NCT00672984|9178227|P2|First Intervention|Sponsor decision|0
2657962|NCT00672984|9178228|P1|First Intervention|Sponsor decision|3
2657963|NCT00672984|9178226|P3|First Intervention|Withdrawal by Subject|2
2657964|NCT00672984|9178227|P2|First Intervention|Withdrawal by Subject|2
2657966|NCT00672984|9178226|P3|First Intervention|Adverse Event|0
2657967|NCT00672984|9178227|P2|First Intervention|Adverse Event|0
2657968|NCT00672984|9178228|P1|First Intervention|Adverse Event|5
2657969|NCT00672958|9178279|P2|Overall Study|Reason not specified|3
2657970|NCT00672958|9178280|P1|Overall Study|Reason not specified|0
2657971|NCT00672958|9178279|P2|Overall Study|Lost to Follow-up|17
2657972|NCT00672958|9178280|P1|Overall Study|Lost to Follow-up|22
2657973|NCT00672958|9178279|P2|Overall Study|Voluntary withdrawal|8
2657974|NCT00672958|9178280|P1|Overall Study|Voluntary withdrawal|12
2657975|NCT00672958|9178279|P2|Overall Study|Protocol deviations|5
2657976|NCT00672958|9178280|P1|Overall Study|Protocol deviations|11
2657977|NCT00672958|9178279|P2|Overall Study|Non-compliance with study drug|3
2657978|NCT00672958|9178280|P1|Overall Study|Non-compliance with study drug|2
2657979|NCT00672958|9178279|P2|Overall Study|Lack of Efficacy|11
2657980|NCT00672958|9178280|P1|Overall Study|Lack of Efficacy|6
2657981|NCT00672958|9178279|P2|Overall Study|Adverse Event|9
2657982|NCT00672958|9178280|P1|Overall Study|Adverse Event|11
2657983|NCT00672841|9178346|P2|Overall Study|Pregnancy|1
2657984|NCT00672841|9178347|P1|Overall Study|Pregnancy|0
2657985|NCT00672841|9178346|P2|Overall Study|Adverse Event|3
2657986|NCT00672841|9178347|P1|Overall Study|Adverse Event|0
2657987|NCT00672841|9178346|P2|Overall Study|Antifungal therapy, negative glucan|4
2657988|NCT00672841|9178347|P1|Overall Study|Antifungal therapy, negative glucan|0
2657989|NCT00672841|9178346|P2|Overall Study|icteric specimens|3
2657990|NCT00672841|9178347|P1|Overall Study|icteric specimens|0
2657991|NCT00672841|9178346|P2|Overall Study|Comfort care|4
2657992|NCT00672841|9178347|P1|Overall Study|Comfort care|1
2657993|NCT00672646|9178369|P3|Overall Study|Withdrawal by Subject|1
2657994|NCT00672646|9178370|P2|Overall Study|Withdrawal by Subject|0
2657995|NCT00672646|9178371|P1|Overall Study|Withdrawal by Subject|0
2657996|NCT00672646|9178369|P3|Overall Study|Lost to Follow-up|2
2657997|NCT00672646|9178370|P2|Overall Study|Lost to Follow-up|1
2657998|NCT00672646|9178371|P1|Overall Study|Lost to Follow-up|0
2657999|NCT00672633|9178396|P2|Overall Study|Withdrawal by Subject|1
2658000|NCT00672633|9178397|P1|Overall Study|Withdrawal by Subject|0
2658001|NCT00672620|9178411|P4|Overall Study|Reason not Specified|1
2658002|NCT00672620|9178412|P3|Overall Study|Reason not Specified|2
2658003|NCT00672620|9178413|P2|Overall Study|Reason not Specified|3
2658004|NCT00672620|9178414|P1|Overall Study|Reason not Specified|3
2658005|NCT00672620|9178411|P4|Overall Study|Lost to Follow-up|11
2658006|NCT00672620|9178412|P3|Overall Study|Lost to Follow-up|8
2658007|NCT00672620|9178413|P2|Overall Study|Lost to Follow-up|19
2658008|NCT00672620|9178414|P1|Overall Study|Lost to Follow-up|8
2658009|NCT00672620|9178411|P4|Overall Study|Withdrawal of Consent|6
2658010|NCT00672620|9178412|P3|Overall Study|Withdrawal of Consent|5
2658011|NCT00672620|9178413|P2|Overall Study|Withdrawal of Consent|12
2658012|NCT00672620|9178414|P1|Overall Study|Withdrawal of Consent|6
2658013|NCT00672620|9178411|P4|Overall Study|Protocol Deviations|5
2658014|NCT00672620|9178412|P3|Overall Study|Protocol Deviations|2
2658015|NCT00672620|9178413|P2|Overall Study|Protocol Deviations|7
2658016|NCT00672620|9178414|P1|Overall Study|Protocol Deviations|5
2658017|NCT00672620|9178411|P4|Overall Study|Noncompliance with Study Drug|2
2658018|NCT00672620|9178412|P3|Overall Study|Noncompliance with Study Drug|0
2658019|NCT00672620|9178413|P2|Overall Study|Noncompliance with Study Drug|4
2658020|NCT00672620|9178414|P1|Overall Study|Noncompliance with Study Drug|3
2658021|NCT00672620|9178411|P4|Overall Study|Lack of Efficacy|0
2658022|NCT00672620|9178412|P3|Overall Study|Lack of Efficacy|2
2658023|NCT00672620|9178413|P2|Overall Study|Lack of Efficacy|2
2658024|NCT00672620|9178414|P1|Overall Study|Lack of Efficacy|1
2658025|NCT00672620|9178411|P4|Overall Study|Adverse Event|17
2658026|NCT00672620|9178412|P3|Overall Study|Adverse Event|12
2658027|NCT00672620|9178413|P2|Overall Study|Adverse Event|7
2658028|NCT00672620|9178414|P1|Overall Study|Adverse Event|7
2658029|NCT00672555|9178479|P1|Overall Study|Did not want to answer questionnaire|2
2658030|NCT00672555|9178479|P1|Overall Study|Lost to Follow-up|4
2658031|NCT00672490|9178490|P2|Overall Study|No reason was provided|2
2658032|NCT00672490|9178491|P1|Overall Study|No reason was provided|6
2658033|NCT00672490|9178490|P2|Overall Study|Lost to Follow-up|5
2658034|NCT00672490|9178491|P1|Overall Study|Lost to Follow-up|1
2658035|NCT00672490|9178490|P2|Overall Study|Intolerance|2
2658036|NCT00672490|9178491|P1|Overall Study|Intolerance|0
2658037|NCT00672490|9178490|P2|Overall Study|Violation of Concomitant Medicine|0
2658038|NCT00672490|9178491|P1|Overall Study|Violation of Concomitant Medicine|1
2658039|NCT00672490|9178490|P2|Overall Study|Adverse Event|8
2658040|NCT00672490|9178491|P1|Overall Study|Adverse Event|5
2658041|NCT00672490|9178490|P2|Overall Study|Mismatch Include/Exclude Criteria|0
2658042|NCT00672490|9178491|P1|Overall Study|Mismatch Include/Exclude Criteria|1
2658043|NCT00672490|9178490|P2|Overall Study|Lack of Compliance|7
2658044|NCT00672490|9178491|P1|Overall Study|Lack of Compliance|2
2658045|NCT00672490|9178490|P2|Overall Study|Withdrawal by Subject|8
2658046|NCT00672490|9178491|P1|Overall Study|Withdrawal by Subject|8
2658047|NCT00672477|9178515|P2|Overall Study|no study drug for low GFR, health cond.|3
2658048|NCT00672477|9178516|P1|Overall Study|no study drug for low GFR, health cond.|1
2658049|NCT00672477|9178515|P2|Overall Study|Lack of Efficacy|1
2658050|NCT00672477|9178516|P1|Overall Study|Lack of Efficacy|1
2658051|NCT00672477|9178515|P2|Overall Study|Withdrawal by Subject|3
2658052|NCT00672477|9178516|P1|Overall Study|Withdrawal by Subject|5
2658053|NCT00672477|9178515|P2|Overall Study|Protocol Violation|1
2658054|NCT00672477|9178516|P1|Overall Study|Protocol Violation|1
2658055|NCT00672477|9178515|P2|Overall Study|Physician Decision|0
2658056|NCT00672477|9178516|P1|Overall Study|Physician Decision|2
2658057|NCT00672477|9178515|P2|Overall Study|Death|11
2658058|NCT00672477|9178516|P1|Overall Study|Death|7
2658059|NCT00672477|9178515|P2|Overall Study|Adverse Event|7
2658060|NCT00672477|9178516|P1|Overall Study|Adverse Event|10
2658061|NCT00672256|9178569|P1|Overall Study|PI dropped, bad data|44
2658062|NCT00672139|9178594|P2|Overall Study|hospice discharge, caregiver requests|2
2658063|NCT00672139|9178595|P1|Overall Study|hospice discharge, caregiver requests|3
2658064|NCT00672139|9178594|P2|Overall Study|Protocol Violation|1
2658065|NCT00672139|9178595|P1|Overall Study|Protocol Violation|1
2658066|NCT00672139|9178594|P2|Overall Study|Lack of Efficacy|1
2658067|NCT00672139|9178595|P1|Overall Study|Lack of Efficacy|4
2658068|NCT00672139|9178594|P2|Overall Study|Physician Decision|0
2658069|NCT00672139|9178595|P1|Overall Study|Physician Decision|2
2658070|NCT00672139|9178594|P2|Overall Study|Adverse Event|7
2658071|NCT00672139|9178595|P1|Overall Study|Adverse Event|4
2658072|NCT00672139|9178594|P2|Overall Study|Withdrawal by Subject|11
2658073|NCT00672139|9178595|P1|Overall Study|Withdrawal by Subject|2
2658074|NCT00672139|9178594|P2|Overall Study|Death|23
2658075|NCT00672139|9178595|P1|Overall Study|Death|14
2658076|NCT00671931|9178652|P5|Overall Study|Physician Decision|1
2658077|NCT00671931|9178653|P4|Overall Study|Physician Decision|2
2658078|NCT00671931|9178654|P3|Overall Study|Physician Decision|0
2658079|NCT00671931|9178655|P2|Overall Study|Physician Decision|0
2658080|NCT00671931|9178656|P1|Overall Study|Physician Decision|1
2658081|NCT00671879|9178676|P3|Overall Study|Withdrawal by Subject|6
2658082|NCT00671879|9178677|P2|Overall Study|Withdrawal by Subject|4
2658083|NCT00671879|9178678|P1|Overall Study|Withdrawal by Subject|0
2658084|NCT00671853|9178691|P2|Overall Study|Non-adherence with study procedures|4
2658085|NCT00671853|9178692|P1|Overall Study|Non-adherence with study procedures|1
2658086|NCT00671853|9178691|P2|Overall Study|Physician Decision|2
2658087|NCT00671853|9178692|P1|Overall Study|Physician Decision|0
2658088|NCT00671853|9178691|P2|Overall Study|Lost to Follow-up|8
2658089|NCT00671853|9178692|P1|Overall Study|Lost to Follow-up|8
2658090|NCT00671853|9178691|P2|Overall Study|Withdrawal by Subject|5
2658091|NCT00671853|9178692|P1|Overall Study|Withdrawal by Subject|1
2658092|NCT00671853|9178691|P2|Overall Study|Adverse Event|1
2658093|NCT00671853|9178692|P1|Overall Study|Adverse Event|7
2658094|NCT00671853|9178691|P2|Overall Study|Lack of Efficacy|7
2658095|NCT00671853|9178692|P1|Overall Study|Lack of Efficacy|3
2658096|NCT00671788|9178708|P1|Overall Study|Other|1
2658097|NCT00671788|9178708|P1|Overall Study|MD Decision|1
2658098|NCT00671788|9178708|P1|Overall Study|Ineligible|1
2658099|NCT00671788|9178708|P1|Overall Study|Refused further treatment|3
2658100|NCT00671788|9178708|P1|Overall Study|Adverse Event|8
2658101|NCT00671749|9178715|P1|Overall Study|Lost to Follow-up|1
2658102|NCT00671749|9178715|P1|Overall Study|Protocol Violation|1
2658103|NCT00671749|9178715|P1|Overall Study|Withdrawal by Subject|4
2658104|NCT00671749|9178715|P1|Overall Study|Adverse Event|2
2658105|NCT00671554|9178774|P1|Overall Study|Disease progression|3
2658106|NCT00671437|9178813|P1|Overall Study|Ineligible post-hoc|1
2658107|NCT00671437|9178813|P1|Overall Study|Adverse Event|3
2658108|NCT00671437|9178813|P1|Overall Study|Cutaneous SCC of head and neck|3
2658109|NCT00671437|9178813|P1|Overall Study|Progressive disease before C1 week 8|8
2658110|NCT00671060|9178847|P2|Overall Study|Physician Decision|1
2658111|NCT00671060|9178848|P1|Overall Study|Physician Decision|0
2658112|NCT00671060|9178847|P2|Overall Study|Protocol Violation|0
2658113|NCT00671060|9178848|P1|Overall Study|Protocol Violation|1
2658114|NCT00671034|9178857|P3|Overall Study|includes Alternative therapy, etc.|7
2658115|NCT00671034|9178858|P2|Overall Study|includes Alternative therapy, etc.|1
2658116|NCT00671034|9178859|P1|Overall Study|includes Alternative therapy, etc.|6
2658117|NCT00671034|9178857|P3|Overall Study|Refusal|5
2658118|NCT00671034|9178858|P2|Overall Study|Refusal|3
2658119|NCT00671034|9178859|P1|Overall Study|Refusal|5
2658120|NCT00671034|9178857|P3|Overall Study|VHR ALL feature|5
2658121|NCT00671034|9178858|P2|Overall Study|VHR ALL feature|3
2658122|NCT00671034|9178859|P1|Overall Study|VHR ALL feature|8
2658123|NCT00671034|9178857|P3|Overall Study|Physician Decision|5
2658124|NCT00671034|9178858|P2|Overall Study|Physician Decision|4
2658125|NCT00671034|9178859|P1|Overall Study|Physician Decision|12
2658126|NCT00671034|9178857|P3|Overall Study|Death|1
2658127|NCT00671034|9178858|P2|Overall Study|Death|2
2658128|NCT00671034|9178859|P1|Overall Study|Death|3
2658129|NCT00671034|9178857|P3|Overall Study|Adverse Event|1
2658130|NCT00671034|9178858|P2|Overall Study|Adverse Event|7
2658131|NCT00671034|9178859|P1|Overall Study|Adverse Event|5
2658132|NCT00670930|9178914|P2|Overall Study|Lost to Follow-up|0
2658133|NCT00670930|9178915|P1|Overall Study|Lost to Follow-up|1
2658134|NCT00670930|9178914|P2|Overall Study|Adminstrative Problem|1
2658135|NCT00670930|9178915|P1|Overall Study|Adminstrative Problem|0
2658136|NCT00670800|9178931|P2|Overall Study|2 controls were insulin resistant|2
2658137|NCT00670800|9178932|P1|Overall Study|2 controls were insulin resistant|0
2658138|NCT00670748|9178963|P4|Overall Study|Not off study|1
2658139|NCT00670748|9178964|P3|Overall Study|Not off study|1
2658140|NCT00670748|9178965|P2|Overall Study|Not off study|1
2658141|NCT00670748|9178966|P1|Overall Study|Not off study|2
2658142|NCT00670748|9178963|P4|Overall Study|Death during treatment|0
2658143|NCT00670748|9178964|P3|Overall Study|Death during treatment|1
2658144|NCT00670748|9178965|P2|Overall Study|Death during treatment|1
2658145|NCT00670748|9178966|P1|Overall Study|Death during treatment|1
2658146|NCT00670540|9179001|P1|Overall Study|missing information inclusion criteria|1
2658147|NCT00670540|9179001|P1|Overall Study|controls randomised for no follow up|2770
2658148|NCT00670540|9179001|P1|Overall Study|refused to participate|189
2658149|NCT00670540|9179001|P1|Overall Study|not living in France|348
2658150|NCT00670540|9179001|P1|Overall Study|ineligible|17
2658151|NCT00670488|9179021|P10|Overall Study|Withdrawal by Subject|0
2658152|NCT00670488|9179022|P9|Overall Study|Withdrawal by Subject|1
2658153|NCT00670488|9179023|P8|Overall Study|Withdrawal by Subject|0
2658154|NCT00670488|9179024|P7|Overall Study|Withdrawal by Subject|1
2658155|NCT00670488|9179025|P6|Overall Study|Withdrawal by Subject|0
2658156|NCT00670488|9179026|P5|Overall Study|Withdrawal by Subject|0
2658157|NCT00670488|9179027|P4|Overall Study|Withdrawal by Subject|1
2658158|NCT00670488|9179028|P3|Overall Study|Withdrawal by Subject|0
2658159|NCT00670488|9179029|P2|Overall Study|Withdrawal by Subject|1
2658160|NCT00670488|9179030|P1|Overall Study|Withdrawal by Subject|0
2658161|NCT00670488|9179021|P10|Overall Study|Progressive Disease|1
2658162|NCT00670488|9179022|P9|Overall Study|Progressive Disease|2
2658163|NCT00670488|9179023|P8|Overall Study|Progressive Disease|2
2658164|NCT00670488|9179024|P7|Overall Study|Progressive Disease|11
2658165|NCT00670488|9179025|P6|Overall Study|Progressive Disease|4
2658166|NCT00670488|9179026|P5|Overall Study|Progressive Disease|2
2658167|NCT00670488|9179027|P4|Overall Study|Progressive Disease|2
2658168|NCT00670488|9179028|P3|Overall Study|Progressive Disease|3
2658169|NCT00670488|9179029|P2|Overall Study|Progressive Disease|41
2658170|NCT00670488|9179030|P1|Overall Study|Progressive Disease|2
2658171|NCT00670488|9179021|P10|Overall Study|Physician Decision|0
2658172|NCT00670488|9179022|P9|Overall Study|Physician Decision|0
2658173|NCT00670488|9179023|P8|Overall Study|Physician Decision|0
2658174|NCT00670488|9179024|P7|Overall Study|Physician Decision|0
2658175|NCT00670488|9179025|P6|Overall Study|Physician Decision|0
2658176|NCT00670488|9179026|P5|Overall Study|Physician Decision|0
2658177|NCT00670488|9179027|P4|Overall Study|Physician Decision|1
2658178|NCT00670488|9179028|P3|Overall Study|Physician Decision|0
2658179|NCT00670488|9179029|P2|Overall Study|Physician Decision|9
2658180|NCT00670488|9179030|P1|Overall Study|Physician Decision|1
2658181|NCT00670488|9179021|P10|Overall Study|Adverse Event|1
2658182|NCT00670488|9179022|P9|Overall Study|Adverse Event|0
2658183|NCT00670488|9179023|P8|Overall Study|Adverse Event|1
2658184|NCT00670488|9179024|P7|Overall Study|Adverse Event|5
2658185|NCT00670488|9179025|P6|Overall Study|Adverse Event|1
2658186|NCT00670488|9179026|P5|Overall Study|Adverse Event|1
2658187|NCT00670488|9179027|P4|Overall Study|Adverse Event|3
2658188|NCT00670488|9179028|P3|Overall Study|Adverse Event|0
2658189|NCT00670488|9179029|P2|Overall Study|Adverse Event|7
2658190|NCT00670488|9179030|P1|Overall Study|Adverse Event|0
2658191|NCT00670449|9179217|P4|Overall Study|Abnormal Laboratory Value(s)|0
2658192|NCT00670449|9179218|P3|Overall Study|Abnormal Laboratory Value(s)|0
2658193|NCT00670449|9179219|P2|Overall Study|Abnormal Laboratory Value(s)|2
2658194|NCT00670449|9179220|P1|Overall Study|Abnormal Laboratory Value(s)|0
2658195|NCT00670449|9179217|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
2658196|NCT00670449|9179218|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
2658197|NCT00670449|9179219|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
2658198|NCT00670449|9179220|P1|Overall Study|Unsatisfactory Therapeutic Effect|2
2658199|NCT00670449|9179217|P4|Overall Study|Subject Withdrew Consent|1
2658200|NCT00670449|9179218|P3|Overall Study|Subject Withdrew Consent|0
2658201|NCT00670449|9179219|P2|Overall Study|Subject Withdrew Consent|2
2658202|NCT00670449|9179220|P1|Overall Study|Subject Withdrew Consent|0
2658203|NCT00670449|9179217|P4|Overall Study|Administrative Problems|1
2658204|NCT00670449|9179218|P3|Overall Study|Administrative Problems|0
2658205|NCT00670449|9179219|P2|Overall Study|Administrative Problems|2
2658206|NCT00670449|9179220|P1|Overall Study|Administrative Problems|0
2658207|NCT00670449|9179217|P4|Overall Study|Protocol Deviation|1
2658208|NCT00670449|9179218|P3|Overall Study|Protocol Deviation|0
2658209|NCT00670449|9179219|P2|Overall Study|Protocol Deviation|2
2658210|NCT00670449|9179220|P1|Overall Study|Protocol Deviation|1
2658211|NCT00670449|9179217|P4|Overall Study|Adverse Event|5
2658212|NCT00670449|9179218|P3|Overall Study|Adverse Event|8
2658213|NCT00670449|9179219|P2|Overall Study|Adverse Event|2
2658214|NCT00670449|9179220|P1|Overall Study|Adverse Event|6
2658215|NCT00670306|9179244|P1|Overall Study|incl/excl criterias did not meet|19
2658216|NCT00670306|9179244|P1|Overall Study|Lost to Follow-up|8
2658217|NCT00670306|9179244|P1|Overall Study|Physician Decision|1
2658218|NCT00670306|9179244|P1|Overall Study|Withdrawal by Subject|9
2658219|NCT00670306|9179244|P1|Overall Study|Lack of Efficacy|10
2658220|NCT00670306|9179244|P1|Overall Study|Adverse Event|8
2658221|NCT00670228|9179283|P2|Overall Study|Not meeting the selection criteria|0
2658222|NCT00670228|9179284|P1|Overall Study|Not meeting the selection criteria|2
2658223|NCT00670228|9179283|P2|Overall Study|Not treated|2
2658224|NCT00670228|9179284|P1|Overall Study|Not treated|2
2658225|NCT00670228|9179283|P2|Overall Study|Death or MACE|1
2658226|NCT00670228|9179284|P1|Overall Study|Death or MACE|0
2658227|NCT00670228|9179283|P2|Overall Study|Adverse Event|0
2658228|NCT00670228|9179284|P1|Overall Study|Adverse Event|1
2658229|NCT00670111|9179308|P3|Enrollment to One Month|Physician Decision|0
2658230|NCT00670111|9179309|P2|Enrollment to One Month|Physician Decision|0
2658231|NCT00670111|9179310|P1|Enrollment to One Month|Physician Decision|1
2658232|NCT00670111|9179308|P3|Enrollment to One Month|Ebrolled Patients but not Implanted|6
2658233|NCT00670111|9179309|P2|Enrollment to One Month|Ebrolled Patients but not Implanted|0
2658234|NCT00670111|9179310|P1|Enrollment to One Month|Ebrolled Patients but not Implanted|0
2658235|NCT00670111|9179308|P3|Enrollment to One Month|Testing Failure|13
2658236|NCT00670111|9179309|P2|Enrollment to One Month|Testing Failure|0
2658237|NCT00670111|9179310|P1|Enrollment to One Month|Testing Failure|0
2658238|NCT00670046|9179320|P2|Overall Study|Withdrawal by Subject|1
2658239|NCT00670046|9179321|P1|Overall Study|Withdrawal by Subject|0
2658240|NCT00670046|9179320|P2|Overall Study|Lost to Follow-up|1
2658241|NCT00670046|9179321|P1|Overall Study|Lost to Follow-up|1
2658242|NCT00670007|9179335|P1|Overall Study|Withdrawal by Subject|4
2658243|NCT00670007|9179335|P1|Overall Study|Adverse Event|1
2658244|NCT00670007|9179335|P1|Overall Study|Adverse event, serious fatal|1
2658245|NCT00670007|9179335|P1|Overall Study|Travel/Vacation|1
2658246|NCT00670007|9179335|P1|Overall Study|Lung transplant|1
2658247|NCT00670007|9179335|P1|Overall Study|Drug abuse|1
2658248|NCT00669955|9179362|P2|Overall Study|not compliant with study drug/visit|3
2658249|NCT00669955|9179363|P1|Overall Study|not compliant with study drug/visit|2
2658250|NCT00669955|9179362|P2|Overall Study|Investigator Sponsor Judgement|1
2658251|NCT00669955|9179363|P1|Overall Study|Investigator Sponsor Judgement|0
2658252|NCT00669955|9179362|P2|Overall Study|Protocol Violation|7
2658253|NCT00669955|9179363|P1|Overall Study|Protocol Violation|2
2658254|NCT00669955|9179362|P2|Overall Study|Lost to Follow-up|7
2658255|NCT00669955|9179363|P1|Overall Study|Lost to Follow-up|5
2658256|NCT00669955|9179362|P2|Overall Study|Withdrawal by Subject|3
2658257|NCT00669955|9179363|P1|Overall Study|Withdrawal by Subject|2
2658258|NCT00669955|9179362|P2|Overall Study|Death|1
2658259|NCT00669955|9179363|P1|Overall Study|Death|0
2658260|NCT00669955|9179362|P2|Overall Study|Adverse Event|5
2658261|NCT00669955|9179363|P1|Overall Study|Adverse Event|3
2658262|NCT00669942|9179393|P12|Parts 2 and 3|Protocol Violation|0
2658263|NCT00669942|9179394|P11|Parts 2 and 3|Protocol Violation|0
2658264|NCT00669942|9179395|P10|Parts 2 and 3|Protocol Violation|0
2658265|NCT00669942|9179396|P9|Parts 2 and 3|Protocol Violation|0
2658266|NCT00669942|9179397|P8|Parts 2 and 3|Protocol Violation|0
2658267|NCT00669942|9179398|P7|Parts 2 and 3|Protocol Violation|0
2658268|NCT00669942|9179399|P6|Parts 2 and 3|Protocol Violation|1
2658269|NCT00669942|9179400|P5|Parts 2 and 3|Protocol Violation|0
2658270|NCT00669942|9179401|P4|Parts 2 and 3|Protocol Violation|0
2658271|NCT00669942|9179402|P3|Parts 2 and 3|Protocol Violation|0
2658272|NCT00669942|9179403|P2|Parts 2 and 3|Protocol Violation|0
2658273|NCT00669942|9179404|P1|Parts 2 and 3|Protocol Violation|0
2658274|NCT00669942|9179393|P12|Parts 2 and 3|Withdrawal by Subject|0
2658275|NCT00669942|9179394|P11|Parts 2 and 3|Withdrawal by Subject|0
2658276|NCT00669942|9179395|P10|Parts 2 and 3|Withdrawal by Subject|0
2658277|NCT00669942|9179396|P9|Parts 2 and 3|Withdrawal by Subject|2
2658278|NCT00669942|9179397|P8|Parts 2 and 3|Withdrawal by Subject|0
2658279|NCT00669942|9179398|P7|Parts 2 and 3|Withdrawal by Subject|0
2658280|NCT00669942|9179399|P6|Parts 2 and 3|Withdrawal by Subject|1
2658281|NCT00669942|9179400|P5|Parts 2 and 3|Withdrawal by Subject|0
2658282|NCT00669942|9179401|P4|Parts 2 and 3|Withdrawal by Subject|0
2658283|NCT00669942|9179402|P3|Parts 2 and 3|Withdrawal by Subject|0
2658284|NCT00669942|9179403|P2|Parts 2 and 3|Withdrawal by Subject|0
2658285|NCT00669942|9179404|P1|Parts 2 and 3|Withdrawal by Subject|0
2658286|NCT00669942|9179393|P12|Parts 2 and 3|Adverse Event|0
2658287|NCT00669942|9179394|P11|Parts 2 and 3|Adverse Event|0
2658288|NCT00669942|9179395|P10|Parts 2 and 3|Adverse Event|0
2658289|NCT00669942|9179396|P9|Parts 2 and 3|Adverse Event|1
2658290|NCT00669942|9179397|P8|Parts 2 and 3|Adverse Event|2
2658291|NCT00669942|9179398|P7|Parts 2 and 3|Adverse Event|0
2658292|NCT00669942|9179399|P6|Parts 2 and 3|Adverse Event|0
2658293|NCT00669942|9179400|P5|Parts 2 and 3|Adverse Event|0
2658294|NCT00669942|9179401|P4|Parts 2 and 3|Adverse Event|0
2658295|NCT00669942|9179402|P3|Parts 2 and 3|Adverse Event|0
2658296|NCT00669942|9179403|P2|Parts 2 and 3|Adverse Event|0
2658297|NCT00669942|9179404|P1|Parts 2 and 3|Adverse Event|0
2658298|NCT00669903|9179487|P4|Overall Study|Protocol Violation|0
2658299|NCT00669903|9179488|P3|Overall Study|Protocol Violation|0
2658300|NCT00669903|9179489|P2|Overall Study|Protocol Violation|1
2658301|NCT00669903|9179490|P1|Overall Study|Protocol Violation|0
2658302|NCT00669903|9179487|P4|Overall Study|Lost to Follow-up|1
2658303|NCT00669903|9179488|P3|Overall Study|Lost to Follow-up|0
2658304|NCT00669903|9179489|P2|Overall Study|Lost to Follow-up|1
2658305|NCT00669903|9179490|P1|Overall Study|Lost to Follow-up|1
2658306|NCT00669903|9179487|P4|Overall Study|Withdrawal by Subject|2
2658307|NCT00669903|9179488|P3|Overall Study|Withdrawal by Subject|2
2658308|NCT00669903|9179489|P2|Overall Study|Withdrawal by Subject|2
2658309|NCT00669903|9179490|P1|Overall Study|Withdrawal by Subject|0
2658310|NCT00669903|9179487|P4|Overall Study|Adverse Event|1
2658311|NCT00669903|9179488|P3|Overall Study|Adverse Event|3
2658312|NCT00669903|9179489|P2|Overall Study|Adverse Event|1
2658313|NCT00669903|9179490|P1|Overall Study|Adverse Event|0
2658314|NCT00669877|9179520|P1|Overall Study|Disease Progression/Death|4
2658315|NCT00669864|9179525|P1|Overall Study|Other|2
2658316|NCT00669864|9179525|P1|Overall Study|Withdrawal by Subject|3
2658317|NCT00669864|9179525|P1|Overall Study|Protocol Violation|2
2658318|NCT00669864|9179525|P1|Overall Study|Lost to Follow-up|2
2658319|NCT00669669|9179539|P1|Overall Study|To late to start treatment|1
2658320|NCT00669617|9179544|P5|Period 3|Lost to Follow-up|0
2658321|NCT00669617|9179545|P4|Period 3|Lost to Follow-up|0
2658322|NCT00669617|9179546|P3|Period 3|Lost to Follow-up|0
2658323|NCT00669617|9179547|P2|Period 3|Lost to Follow-up|0
2658324|NCT00669617|9179548|P1|Period 3|Lost to Follow-up|1
2658325|NCT00669617|9179544|P5|Period 1|Protocol Deviation|1
2658326|NCT00669617|9179545|P4|Period 1|Protocol Deviation|0
2658327|NCT00669617|9179546|P3|Period 1|Protocol Deviation|0
2658328|NCT00669617|9179547|P2|Period 1|Protocol Deviation|0
2658329|NCT00669617|9179548|P1|Period 1|Protocol Deviation|0
2658330|NCT00669617|9179544|P5|Period 1|Withdrawal by Subject|0
2658331|NCT00669617|9179545|P4|Period 1|Withdrawal by Subject|0
2658332|NCT00669617|9179546|P3|Period 1|Withdrawal by Subject|1
2658333|NCT00669617|9179547|P2|Period 1|Withdrawal by Subject|0
2658334|NCT00669617|9179548|P1|Period 1|Withdrawal by Subject|0
2658335|NCT00669396|9179596|P2|Overall Study|Lost to Follow-up|12
2658336|NCT00669396|9179597|P1|Overall Study|Lost to Follow-up|10
2658337|NCT00669331|9179624|P2|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
2658338|NCT00669331|9179625|P1|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
2658339|NCT00669331|9179624|P2|Blinded Treatment Period|Physician Decision|3
2658340|NCT00669331|9179625|P1|Blinded Treatment Period|Physician Decision|3
2658341|NCT00669331|9179624|P2|Blinded Treatment Period|Death|2
2658342|NCT00669331|9179625|P1|Blinded Treatment Period|Death|0
2658343|NCT00669331|9179624|P2|Blinded Treatment Period|Lost to Follow-up|2
2658344|NCT00669331|9179625|P1|Blinded Treatment Period|Lost to Follow-up|3
2658345|NCT00669331|9179624|P2|Blinded Treatment Period|Withdrawal by Subject|19
2658346|NCT00669331|9179625|P1|Blinded Treatment Period|Withdrawal by Subject|17
2658347|NCT00669331|9179624|P2|Blinded Treatment Period|Protocol Violation|1
2658348|NCT00669331|9179625|P1|Blinded Treatment Period|Protocol Violation|1
2658349|NCT00669331|9179624|P2|Blinded Treatment Period|Adverse Event|10
2658350|NCT00669331|9179625|P1|Blinded Treatment Period|Adverse Event|16
2658351|NCT00669331|9179624|P2|Randomisation to First Dose|Randomised in error|10
2658352|NCT00669331|9179625|P1|Randomisation to First Dose|Randomised in error|3
2658353|NCT00669331|9179624|P2|Randomisation to First Dose|Sponsor decision|1
2658354|NCT00669331|9179625|P1|Randomisation to First Dose|Sponsor decision|0
2658355|NCT00669331|9179624|P2|Randomisation to First Dose|Death|0
2658356|NCT00669331|9179625|P1|Randomisation to First Dose|Death|1
2658357|NCT00669331|9179624|P2|Randomisation to First Dose|Lost to Follow-up|0
2658358|NCT00669331|9179625|P1|Randomisation to First Dose|Lost to Follow-up|2
2658359|NCT00669331|9179624|P2|Randomisation to First Dose|Withdrawal by Subject|2
2658360|NCT00669331|9179625|P1|Randomisation to First Dose|Withdrawal by Subject|3
2658361|NCT00669331|9179624|P2|Randomisation to First Dose|Protocol Violation|0
2658362|NCT00669331|9179625|P1|Randomisation to First Dose|Protocol Violation|1
2658363|NCT00669331|9179624|P2|Randomisation to First Dose|Adverse Event|0
2658364|NCT00669331|9179625|P1|Randomisation to First Dose|Adverse Event|1
2658365|NCT00669318|9179667|P1|Overall Study|Withdrawal by Subject|2
2658366|NCT00669240|9179684|P1|Overall Study|Enrolled but no dosing record|1
2658367|NCT00669240|9179684|P1|Overall Study|Enrolled but not treated|15
2658368|NCT00669240|9179684|P1|Overall Study|Other|19
2658369|NCT00669240|9179684|P1|Overall Study|Adverse Event|21
2658370|NCT00669240|9179684|P1|Overall Study|Lost to Follow-up|34
2658371|NCT00669240|9179684|P1|Overall Study|Withdrawal by Subject|42
2658372|NCT00669240|9179684|P1|Overall Study|Lack of Efficacy|33
2658373|NCT00669162|9179733|P1|Overall Study|Withdrawal by Subject|1
2658374|NCT00669110|9179739|P2|Overall Study|Withdrawal by Subject|2
2658375|NCT00669110|9179740|P1|Overall Study|Withdrawal by Subject|0
2658376|NCT00669110|9179739|P2|Overall Study|Protocol Violation|5
2658377|NCT00669110|9179740|P1|Overall Study|Protocol Violation|0
2658378|NCT00669110|9179739|P2|Overall Study|Lost to Follow-up|0
2658379|NCT00669110|9179740|P1|Overall Study|Lost to Follow-up|1
2658380|NCT00669110|9179739|P2|Overall Study|Physician Decision|1
2658381|NCT00669110|9179740|P1|Overall Study|Physician Decision|0
2658382|NCT00669110|9179739|P2|Overall Study|Caregiver request|2
2658383|NCT00669110|9179740|P1|Overall Study|Caregiver request|3
2658384|NCT00669110|9179739|P2|Overall Study|Adverse Event|3
2658385|NCT00669110|9179740|P1|Overall Study|Adverse Event|4
2658386|NCT00669071|9179776|P1|Overall Study|Final visit 40 days out of window|1
2658387|NCT00669071|9179776|P1|Overall Study|Lost to Follow-up|3
2658388|NCT00669032|9179797|P2|Overall Study|No fulfilment of the selection criteria|5
2658389|NCT00669032|9179798|P1|Overall Study|No fulfilment of the selection criteria|5
2658390|NCT00669032|9179797|P2|Overall Study|Physician Decision|1
2658391|NCT00669032|9179798|P1|Overall Study|Physician Decision|1
2658392|NCT00669032|9179797|P2|Overall Study|Adverse Event|16
2658393|NCT00669032|9179798|P1|Overall Study|Adverse Event|12
2658394|NCT00669032|9179797|P2|Overall Study|Withdrawal by Subject|13
2658395|NCT00669032|9179798|P1|Overall Study|Withdrawal by Subject|12
2658396|NCT00669032|9179797|P2|Overall Study|Lack of Efficacy|19
2658397|NCT00669032|9179798|P1|Overall Study|Lack of Efficacy|8
2658398|NCT00669032|9179797|P2|Overall Study|Lost to Follow-up|5
2658399|NCT00669032|9179798|P1|Overall Study|Lost to Follow-up|6
2658400|NCT00668863|9179844|P1|Overall Study|Physician Decision|1
2658401|NCT00668863|9179844|P1|Overall Study|Subject’s work scheduling problem|1
2658402|NCT00668863|9179844|P1|Overall Study|Surgery|1
2658403|NCT00668863|9179844|P1|Overall Study|Withdrawal by Subject|1
2658404|NCT00668863|9179844|P1|Overall Study|Global Deterioration of Health Status|4
2658405|NCT00668863|9179844|P1|Overall Study|Study Terminated by Sponsor|8
2658406|NCT00668863|9179844|P1|Overall Study|Adverse Event|13
2658407|NCT00668863|9179844|P1|Overall Study|Objective Progression or Relapse|42
2658408|NCT00668746|9179876|P2|Overall Study|Lost to Follow-up|1
2658409|NCT00668746|9179877|P1|Overall Study|Lost to Follow-up|2
2658410|NCT00668733|9179897|P2|Overall Study|Withdrawal by Subject|4
2658411|NCT00668733|9179898|P1|Overall Study|Withdrawal by Subject|0
2658412|NCT00668733|9179897|P2|Overall Study|Lost to Follow-up|3
2658413|NCT00668733|9179898|P1|Overall Study|Lost to Follow-up|2
2658414|NCT00668395|9179943|P3|Overall Study|Physician Decision|0
2658415|NCT00668395|9179944|P2|Overall Study|Physician Decision|1
2658416|NCT00668395|9179945|P1|Overall Study|Physician Decision|1
2658417|NCT00668395|9179943|P3|Overall Study|Adverse Event|0
2658418|NCT00668395|9179944|P2|Overall Study|Adverse Event|1
2658419|NCT00668395|9179945|P1|Overall Study|Adverse Event|1
2658420|NCT00668395|9179943|P3|Overall Study|Withdrawal by Subject|1
2658421|NCT00668395|9179944|P2|Overall Study|Withdrawal by Subject|4
2658422|NCT00668395|9179945|P1|Overall Study|Withdrawal by Subject|4
2658423|NCT00668317|9179957|P1|Overall Study|Adverse Event|2
2658424|NCT00668200|9179972|P1|Overall Study|Lost to Follow-up|1
2658425|NCT00668200|9179972|P1|Overall Study|Withdrawal by Subject|2
2658426|NCT00668148|9179978|P1|Overall Study|Withdrawal of Consent|2
2658427|NCT00668148|9179978|P1|Overall Study|Progressive Disease Before Treatment|2
2658428|NCT00668148|9179978|P1|Overall Study|Subject Non-compliance|1
2658429|NCT00668148|9179978|P1|Overall Study|Adverse Event|5
2658430|NCT00667992|9180017|P2|Third Intervention 100 Mcg Twice Daily|Adverse Event|1
2658431|NCT00667992|9180018|P1|Third Intervention 100 Mcg Twice Daily|Adverse Event|0
2658432|NCT00667992|9180017|P2|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
2658433|NCT00667992|9180018|P1|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1
2658434|NCT00667992|9180017|P2|Wash-out|Withdrawal by Subject|0
2658435|NCT00667992|9180018|P1|Wash-out|Withdrawal by Subject|1
2658436|NCT00667992|9180017|P2|Wash-out|Failure to wash-out|2
2658437|NCT00667992|9180018|P1|Wash-out|Failure to wash-out|2
2658438|NCT00667992|9180017|P2|Wash-out|Not within one doubling dilution|3
2658439|NCT00667992|9180018|P1|Wash-out|Not within one doubling dilution|4
2658440|NCT00667992|9180017|P2|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1
2658441|NCT00667992|9180018|P1|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0
2658442|NCT00667992|9180017|P2|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3
2658443|NCT00667992|9180018|P1|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2
2658444|NCT00667992|9180017|P2|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0
2658445|NCT00667992|9180018|P1|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1
2658446|NCT00667992|9180017|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
2658447|NCT00667992|9180018|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
2658448|NCT00667992|9180017|P2|First Intervention 100 Mcg Twice Daily|Pregnancy|0
2658449|NCT00667992|9180018|P1|First Intervention 100 Mcg Twice Daily|Pregnancy|1
2658450|NCT00667992|9180017|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
2658451|NCT00667992|9180018|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
2658452|NCT00667992|9180017|P2|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
2658453|NCT00667992|9180018|P1|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2
2658454|NCT00667992|9180017|P2|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3
2658455|NCT00667992|9180018|P1|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2
2658456|NCT00667875|9180075|P3|Overall Study|Withdrawal by Subject|7
2658457|NCT00667875|9180076|P2|Overall Study|Withdrawal by Subject|9
2658458|NCT00667875|9180077|P1|Overall Study|Withdrawal by Subject|10
2658459|NCT00667875|9180075|P3|Overall Study|Adverse Event|6
2658460|NCT00667875|9180076|P2|Overall Study|Adverse Event|2
2658461|NCT00667875|9180077|P1|Overall Study|Adverse Event|0
2658462|NCT00667810|9180111|P4|Overall Study|Other|0
2658463|NCT00667810|9180112|P3|Overall Study|Other|5
2658464|NCT00667810|9180113|P2|Overall Study|Other|6
2658465|NCT00667810|9180114|P1|Overall Study|Other|6
2658466|NCT00667810|9180111|P4|Overall Study|Vasogenic Edema Recurrence|0
2658467|NCT00667810|9180112|P3|Overall Study|Vasogenic Edema Recurrence|0
2658468|NCT00667810|9180113|P2|Overall Study|Vasogenic Edema Recurrence|3
2658469|NCT00667810|9180114|P1|Overall Study|Vasogenic Edema Recurrence|0
2658470|NCT00667810|9180111|P4|Overall Study|Loss of Caregiver|0
2658471|NCT00667810|9180112|P3|Overall Study|Loss of Caregiver|3
2658472|NCT00667810|9180113|P2|Overall Study|Loss of Caregiver|1
2658473|NCT00667810|9180114|P1|Overall Study|Loss of Caregiver|0
2658474|NCT00667810|9180111|P4|Overall Study|Failed to Return|0
2658475|NCT00667810|9180112|P3|Overall Study|Failed to Return|2
2658476|NCT00667810|9180113|P2|Overall Study|Failed to Return|0
2658477|NCT00667810|9180114|P1|Overall Study|Failed to Return|0
2658478|NCT00667810|9180111|P4|Overall Study|Discontinuation of Study by Sponsor|0
2658479|NCT00667810|9180112|P3|Overall Study|Discontinuation of Study by Sponsor|155
2658480|NCT00667810|9180113|P2|Overall Study|Discontinuation of Study by Sponsor|118
2658481|NCT00667810|9180114|P1|Overall Study|Discontinuation of Study by Sponsor|130
2658482|NCT00667810|9180111|P4|Overall Study|Withdrawal by Subject|1
2658483|NCT00667810|9180112|P3|Overall Study|Withdrawal by Subject|29
2658484|NCT00667810|9180113|P2|Overall Study|Withdrawal by Subject|20
2658485|NCT00667810|9180114|P1|Overall Study|Withdrawal by Subject|14
2658486|NCT00667810|9180111|P4|Overall Study|Protocol Violation|0
2658487|NCT00667810|9180112|P3|Overall Study|Protocol Violation|0
2658488|NCT00667810|9180113|P2|Overall Study|Protocol Violation|2
2658489|NCT00667810|9180114|P1|Overall Study|Protocol Violation|0
2658490|NCT00667810|9180111|P4|Overall Study|Physician Decision|0
2658491|NCT00667810|9180112|P3|Overall Study|Physician Decision|2
2658492|NCT00667810|9180113|P2|Overall Study|Physician Decision|1
2658493|NCT00667810|9180114|P1|Overall Study|Physician Decision|1
2658494|NCT00667810|9180111|P4|Overall Study|Lost to Follow-up|0
2658495|NCT00667810|9180112|P3|Overall Study|Lost to Follow-up|2
2658496|NCT00667810|9180113|P2|Overall Study|Lost to Follow-up|4
2658497|NCT00667810|9180114|P1|Overall Study|Lost to Follow-up|1
2658498|NCT00667810|9180111|P4|Overall Study|Lack of Efficacy|0
2658499|NCT00667810|9180112|P3|Overall Study|Lack of Efficacy|2
2658500|NCT00667810|9180113|P2|Overall Study|Lack of Efficacy|0
2658501|NCT00667810|9180114|P1|Overall Study|Lack of Efficacy|1
2658502|NCT00667810|9180111|P4|Overall Study|Death|0
2658503|NCT00667810|9180112|P3|Overall Study|Death|3
2658504|NCT00667810|9180113|P2|Overall Study|Death|1
2658505|NCT00667810|9180114|P1|Overall Study|Death|1
2658506|NCT00667810|9180111|P4|Overall Study|Adverse Event|1
2658507|NCT00667810|9180112|P3|Overall Study|Adverse Event|19
2658508|NCT00667810|9180113|P2|Overall Study|Adverse Event|14
2658509|NCT00667810|9180114|P1|Overall Study|Adverse Event|13
2658510|NCT00667732|9180190|P3|Randomization (24 Weeks)|Withdrawal by Subject|0
2658511|NCT00667732|9180191|P2|Randomization (24 Weeks)|Withdrawal by Subject|1
2658512|NCT00667732|9180192|P1|Randomization (24 Weeks)|Withdrawal by Subject|0
2658513|NCT00667732|9180190|P3|Run -In (8 Weeks)|Withdrawal by Subject|0
2658514|NCT00667732|9180191|P2|Run -In (8 Weeks)|Withdrawal by Subject|0
2658515|NCT00667732|9180192|P1|Run -In (8 Weeks)|Withdrawal by Subject|3
2658516|NCT00667732|9180190|P3|Run -In (8 Weeks)|Adverse Event|0
2658517|NCT00667732|9180191|P2|Run -In (8 Weeks)|Adverse Event|0
2658518|NCT00667732|9180192|P1|Run -In (8 Weeks)|Adverse Event|4
2658519|NCT00667602|9180228|P3|Overall Study|Protocol Violation|0
2658520|NCT00667602|9180229|P2|Overall Study|Protocol Violation|1
2658521|NCT00667602|9180230|P1|Overall Study|Protocol Violation|0
2658522|NCT00667602|9180228|P3|Overall Study|Administrative reason|2
2658523|NCT00667602|9180229|P2|Overall Study|Administrative reason|0
2658524|NCT00667602|9180230|P1|Overall Study|Administrative reason|0
2658525|NCT00667602|9180228|P3|Overall Study|Lost to Follow-up|6
2658526|NCT00667602|9180229|P2|Overall Study|Lost to Follow-up|5
2658527|NCT00667602|9180230|P1|Overall Study|Lost to Follow-up|4
2658528|NCT00667602|9180228|P3|Overall Study|Withdrawal by Subject|10
2658529|NCT00667602|9180229|P2|Overall Study|Withdrawal by Subject|9
2658530|NCT00667602|9180230|P1|Overall Study|Withdrawal by Subject|4
2658531|NCT00667576|9180298|P5|Overall Study|Missed Visit|0
2658532|NCT00667576|9180299|P4|Overall Study|Missed Visit|1
2658533|NCT00667576|9180300|P3|Overall Study|Missed Visit|0
2658534|NCT00667576|9180301|P2|Overall Study|Missed Visit|0
2658535|NCT00667576|9180302|P1|Overall Study|Missed Visit|0
2658536|NCT00667576|9180298|P5|Overall Study|Physician Decision|0
2658537|NCT00667576|9180299|P4|Overall Study|Physician Decision|1
2658538|NCT00667576|9180300|P3|Overall Study|Physician Decision|0
2658539|NCT00667576|9180301|P2|Overall Study|Physician Decision|0
2658540|NCT00667576|9180302|P1|Overall Study|Physician Decision|0
2658541|NCT00667576|9180298|P5|Overall Study|Protocol Violation|0
2658542|NCT00667576|9180299|P4|Overall Study|Protocol Violation|1
2658543|NCT00667576|9180300|P3|Overall Study|Protocol Violation|0
2658544|NCT00667576|9180301|P2|Overall Study|Protocol Violation|0
2658545|NCT00667576|9180302|P1|Overall Study|Protocol Violation|0
2658546|NCT00667576|9180298|P5|Overall Study|Lost to Follow-up|0
2658547|NCT00667576|9180299|P4|Overall Study|Lost to Follow-up|0
2658548|NCT00667576|9180300|P3|Overall Study|Lost to Follow-up|1
2658549|NCT00667576|9180301|P2|Overall Study|Lost to Follow-up|0
2658550|NCT00667576|9180302|P1|Overall Study|Lost to Follow-up|0
2658551|NCT00667576|9180298|P5|Overall Study|Adverse Event|0
2658552|NCT00667576|9180299|P4|Overall Study|Adverse Event|0
2658553|NCT00667576|9180300|P3|Overall Study|Adverse Event|0
2658554|NCT00667576|9180301|P2|Overall Study|Adverse Event|1
2658555|NCT00667576|9180302|P1|Overall Study|Adverse Event|1
2658556|NCT00667576|9180298|P5|Overall Study|Withdrawal by Subject|1
2658557|NCT00667576|9180299|P4|Overall Study|Withdrawal by Subject|1
2658558|NCT00667576|9180300|P3|Overall Study|Withdrawal by Subject|1
2658559|NCT00667576|9180301|P2|Overall Study|Withdrawal by Subject|0
2658560|NCT00667576|9180302|P1|Overall Study|Withdrawal by Subject|1
2658561|NCT00667563|9180349|P1|Overall Study|Protocol Violation|24
2658562|NCT00667459|9180369|P2|Overall Study|Lost to Follow-up|43
2658563|NCT00667459|9180370|P1|Overall Study|Lost to Follow-up|8
2658564|NCT00667459|9180369|P2|Overall Study|Death|2
2658565|NCT00667459|9180370|P1|Overall Study|Death|0
2658566|NCT00667446|9180412|P2|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1
2658567|NCT00667446|9180413|P1|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0
2658568|NCT00667446|9180412|P2|Treatment Period (36 Months)|Therapeutic Failure|1
2658569|NCT00667446|9180413|P1|Treatment Period (36 Months)|Therapeutic Failure|1
2658570|NCT00667446|9180412|P2|Treatment Period (36 Months)|Protocol Violation|1
2658571|NCT00667446|9180413|P1|Treatment Period (36 Months)|Protocol Violation|1
2658572|NCT00667446|9180412|P2|Treatment Period (36 Months)|Lost to Follow-up|0
2658573|NCT00667446|9180413|P1|Treatment Period (36 Months)|Lost to Follow-up|1
2658574|NCT00667446|9180412|P2|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0
2658575|NCT00667446|9180413|P1|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3
2658576|NCT00667446|9180412|P2|Treatment Period (36 Months)|Withdrawal by Subject|4
2658577|NCT00667446|9180413|P1|Treatment Period (36 Months)|Withdrawal by Subject|0
2658578|NCT00667446|9180412|P2|Treatment Period (36 Months)|Personal reasons|2
2658579|NCT00667446|9180413|P1|Treatment Period (36 Months)|Personal reasons|2
2658580|NCT00667446|9180412|P2|Treatment Period (36 Months)|Other|2
2658581|NCT00667446|9180413|P1|Treatment Period (36 Months)|Other|2
2658582|NCT00667446|9180412|P2|Treatment Period (36 Months)|Ready to enter puberty based on age|15
2658583|NCT00667446|9180413|P1|Treatment Period (36 Months)|Ready to enter puberty based on age|13
2658584|NCT00667420|9180435|P1|Overall Study|Withdrawal by Subject|2
2658585|NCT00667420|9180435|P1|Overall Study|Physician Decision|1
2658586|NCT00667420|9180435|P1|Overall Study|Lack of Efficacy|5
2658587|NCT00667420|9180435|P1|Overall Study|Adverse Event|2
2658588|NCT00667394|9180445|P2|Overall Study|Progressive disease|0
2658589|NCT00667394|9180446|P1|Overall Study|Progressive disease|1
2658590|NCT00667394|9180445|P2|Overall Study|Adverse Event|0
2658591|NCT00667394|9180446|P1|Overall Study|Adverse Event|3
2658592|NCT00667368|9180473|P2|Overall Study|Discontinued early|17
2658593|NCT00667368|9180474|P1|Overall Study|Discontinued early|24
2658594|NCT00667368|9180473|P2|Overall Study|Lost to Follow-up|155
2658595|NCT00667368|9180474|P1|Overall Study|Lost to Follow-up|176
2658596|NCT00667355|9180482|P1|Overall Study|Other reason was not specified|5
2658597|NCT00667355|9180482|P1|Overall Study|Lost to Follow-up|1
2658598|NCT00667355|9180482|P1|Overall Study|Adverse Event|5
2658599|NCT00667342|9180507|P3|Overall Study|Ineligible|1
2658600|NCT00667342|9180508|P2|Overall Study|Ineligible|0
2658601|NCT00667342|9180509|P1|Overall Study|Ineligible|0
2658602|NCT00667342|9180507|P3|Overall Study|Adverse Event|1
2658603|NCT00667342|9180508|P2|Overall Study|Adverse Event|0
2658604|NCT00667342|9180509|P1|Overall Study|Adverse Event|0
2658605|NCT00667342|9180507|P3|Overall Study|Relapse or tumor progression|7
2658606|NCT00667342|9180508|P2|Overall Study|Relapse or tumor progression|0
2658607|NCT00667342|9180509|P1|Overall Study|Relapse or tumor progression|9
2658608|NCT00667342|9180507|P3|Overall Study|Physician Decision|0
2658609|NCT00667342|9180508|P2|Overall Study|Physician Decision|0
2658610|NCT00667342|9180509|P1|Overall Study|Physician Decision|3
2658611|NCT00667342|9180507|P3|Overall Study|Withdrawal by Subject|0
2658612|NCT00667342|9180508|P2|Overall Study|Withdrawal by Subject|0
2658613|NCT00667342|9180509|P1|Overall Study|Withdrawal by Subject|1
2658614|NCT00667342|9180507|P3|Overall Study|Protocol Violation|0
2658615|NCT00667342|9180508|P2|Overall Study|Protocol Violation|0
2658616|NCT00667342|9180509|P1|Overall Study|Protocol Violation|1
2658617|NCT00667277|9180547|P1|Overall Study|Withdrawal by Subject|2
2658618|NCT00667251|9180554|P2|Overall Study|Symptomatic progression|2
2658619|NCT00667251|9180555|P1|Overall Study|Symptomatic progression|1
2658620|NCT00667251|9180554|P2|Overall Study|Intercurrent Illness|3
2658621|NCT00667251|9180555|P1|Overall Study|Intercurrent Illness|4
2658622|NCT00667251|9180554|P2|Overall Study|Other/missing|84
2658623|NCT00667251|9180555|P1|Overall Study|Other/missing|46
2658624|NCT00667251|9180554|P2|Overall Study|Withdrawal by Subject|2
2658625|NCT00667251|9180555|P1|Overall Study|Withdrawal by Subject|6
2658626|NCT00667251|9180554|P2|Overall Study|Adverse Event|4
2658627|NCT00667251|9180555|P1|Overall Study|Adverse Event|13
2658628|NCT00667225|9180581|P2|Overall Study|Lost to Follow-up|1
2658629|NCT00667225|9180582|P1|Overall Study|Lost to Follow-up|0
2658630|NCT00667225|9180581|P2|Overall Study|Subject had no more lesions to treat.|0
2658631|NCT00667225|9180582|P1|Overall Study|Subject had no more lesions to treat.|1
2658632|NCT00667095|9180603|P2|Overall Study|Withdrawal by Subject|1
2658633|NCT00667095|9180604|P1|Overall Study|Withdrawal by Subject|0
2658634|NCT00667017|9180620|P1|Overall Study|Withdrawal by Subject|1
2658635|NCT00666965|9180640|P4|Overall Study|Withdrawal by Subject|2
2658636|NCT00666965|9180641|P3|Overall Study|Withdrawal by Subject|0
2658637|NCT00666965|9180642|P2|Overall Study|Withdrawal by Subject|0
2658638|NCT00666965|9180643|P1|Overall Study|Withdrawal by Subject|0
2658639|NCT00666965|9180640|P4|Overall Study|Discontinuation criteria|2
2658640|NCT00666965|9180641|P3|Overall Study|Discontinuation criteria|1
2658641|NCT00666965|9180642|P2|Overall Study|Discontinuation criteria|1
2658642|NCT00666965|9180643|P1|Overall Study|Discontinuation criteria|2
2658643|NCT00666965|9180640|P4|Overall Study|Protocol Violation|2
2658644|NCT00666965|9180641|P3|Overall Study|Protocol Violation|0
2658645|NCT00666965|9180642|P2|Overall Study|Protocol Violation|0
2658646|NCT00666965|9180643|P1|Overall Study|Protocol Violation|0
2658647|NCT00666965|9180640|P4|Overall Study|Lack of Efficacy|0
2658648|NCT00666965|9180641|P3|Overall Study|Lack of Efficacy|0
2658649|NCT00666965|9180642|P2|Overall Study|Lack of Efficacy|1
2658650|NCT00666965|9180643|P1|Overall Study|Lack of Efficacy|1
2658651|NCT00666965|9180640|P4|Overall Study|Adverse Event|9
2658652|NCT00666965|9180641|P3|Overall Study|Adverse Event|1
2658653|NCT00666965|9180642|P2|Overall Study|Adverse Event|2
2658654|NCT00666965|9180643|P1|Overall Study|Adverse Event|0
2658655|NCT00666926|9180673|P16|Overall Study|Death|0
2658656|NCT00666926|9180674|P15|Overall Study|Death|0
2658657|NCT00666926|9180675|P14|Overall Study|Death|0
2658658|NCT00666926|9180676|P13|Overall Study|Death|0
2658659|NCT00666926|9180677|P12|Overall Study|Death|1
2658660|NCT00666926|9180678|P11|Overall Study|Death|0
2658661|NCT00666926|9180679|P10|Overall Study|Death|0
2658662|NCT00666926|9180680|P9|Overall Study|Death|0
2658663|NCT00666926|9180681|P8|Overall Study|Death|0
2658664|NCT00666926|9180682|P7|Overall Study|Death|0
2658665|NCT00666926|9180683|P6|Overall Study|Death|0
2658666|NCT00666926|9180684|P5|Overall Study|Death|0
2658667|NCT00666926|9180685|P4|Overall Study|Death|0
2658668|NCT00666926|9180686|P3|Overall Study|Death|0
2658669|NCT00666926|9180687|P2|Overall Study|Death|0
2658670|NCT00666926|9180688|P1|Overall Study|Death|0
2658671|NCT00666926|9180673|P16|Overall Study|Withdrawal by Subject|3
2658672|NCT00666926|9180674|P15|Overall Study|Withdrawal by Subject|3
2658673|NCT00666926|9180675|P14|Overall Study|Withdrawal by Subject|1
2658674|NCT00666926|9180676|P13|Overall Study|Withdrawal by Subject|0
2658675|NCT00666926|9180677|P12|Overall Study|Withdrawal by Subject|3
2658676|NCT00666926|9180678|P11|Overall Study|Withdrawal by Subject|0
2658677|NCT00666926|9180679|P10|Overall Study|Withdrawal by Subject|3
2658678|NCT00666926|9180680|P9|Overall Study|Withdrawal by Subject|0
2658679|NCT00666926|9180681|P8|Overall Study|Withdrawal by Subject|1
2658680|NCT00666926|9180682|P7|Overall Study|Withdrawal by Subject|0
2658681|NCT00666926|9180683|P6|Overall Study|Withdrawal by Subject|0
2658682|NCT00666926|9180684|P5|Overall Study|Withdrawal by Subject|0
2658683|NCT00666926|9180685|P4|Overall Study|Withdrawal by Subject|0
2658684|NCT00666926|9180686|P3|Overall Study|Withdrawal by Subject|0
2658685|NCT00666926|9180687|P2|Overall Study|Withdrawal by Subject|0
2658686|NCT00666926|9180688|P1|Overall Study|Withdrawal by Subject|0
2658687|NCT00666926|9180673|P16|Overall Study|Other|4
2658688|NCT00666926|9180674|P15|Overall Study|Other|4
2658689|NCT00666926|9180675|P14|Overall Study|Other|2
2658690|NCT00666926|9180676|P13|Overall Study|Other|3
2658691|NCT00666926|9180677|P12|Overall Study|Other|26
2658692|NCT00666926|9180678|P11|Overall Study|Other|3
2658693|NCT00666926|9180679|P10|Overall Study|Other|5
2658694|NCT00666926|9180680|P9|Overall Study|Other|3
2658695|NCT00666926|9180681|P8|Overall Study|Other|0
2658696|NCT00666926|9180682|P7|Overall Study|Other|4
2658697|NCT00666926|9180683|P6|Overall Study|Other|3
2658698|NCT00666926|9180684|P5|Overall Study|Other|3
2658699|NCT00666926|9180685|P4|Overall Study|Other|3
2658700|NCT00666926|9180686|P3|Overall Study|Other|3
2658701|NCT00666926|9180687|P2|Overall Study|Other|4
2658702|NCT00666926|9180688|P1|Overall Study|Other|2
2658703|NCT00666926|9180673|P16|Overall Study|Lost to Follow-up|0
2658704|NCT00666926|9180674|P15|Overall Study|Lost to Follow-up|0
2658705|NCT00666926|9180675|P14|Overall Study|Lost to Follow-up|0
2658706|NCT00666926|9180676|P13|Overall Study|Lost to Follow-up|0
2658707|NCT00666926|9180677|P12|Overall Study|Lost to Follow-up|0
2658708|NCT00666926|9180678|P11|Overall Study|Lost to Follow-up|0
2658709|NCT00666926|9180679|P10|Overall Study|Lost to Follow-up|0
2658710|NCT00666926|9180680|P9|Overall Study|Lost to Follow-up|0
2658711|NCT00666926|9180681|P8|Overall Study|Lost to Follow-up|0
2658712|NCT00666926|9180682|P7|Overall Study|Lost to Follow-up|0
2658713|NCT00666926|9180683|P6|Overall Study|Lost to Follow-up|0
2658714|NCT00666926|9180684|P5|Overall Study|Lost to Follow-up|0
2658715|NCT00666926|9180685|P4|Overall Study|Lost to Follow-up|1
2658716|NCT00666926|9180686|P3|Overall Study|Lost to Follow-up|0
2658717|NCT00666926|9180687|P2|Overall Study|Lost to Follow-up|0
2658718|NCT00666926|9180688|P1|Overall Study|Lost to Follow-up|0
2658719|NCT00666926|9180673|P16|Overall Study|Lack of Efficacy|0
2658720|NCT00666926|9180674|P15|Overall Study|Lack of Efficacy|0
2658721|NCT00666926|9180675|P14|Overall Study|Lack of Efficacy|0
2658722|NCT00666926|9180676|P13|Overall Study|Lack of Efficacy|0
2658723|NCT00666926|9180677|P12|Overall Study|Lack of Efficacy|1
2658724|NCT00666926|9180678|P11|Overall Study|Lack of Efficacy|0
2658725|NCT00666926|9180679|P10|Overall Study|Lack of Efficacy|0
2658726|NCT00666926|9180680|P9|Overall Study|Lack of Efficacy|0
2658727|NCT00666926|9180681|P8|Overall Study|Lack of Efficacy|0
2658728|NCT00666926|9180682|P7|Overall Study|Lack of Efficacy|0
2658729|NCT00666926|9180683|P6|Overall Study|Lack of Efficacy|1
2658730|NCT00666926|9180684|P5|Overall Study|Lack of Efficacy|0
2658731|NCT00666926|9180685|P4|Overall Study|Lack of Efficacy|0
2658732|NCT00666926|9180686|P3|Overall Study|Lack of Efficacy|0
2658733|NCT00666926|9180687|P2|Overall Study|Lack of Efficacy|0
2658734|NCT00666926|9180688|P1|Overall Study|Lack of Efficacy|0
2658735|NCT00666926|9180673|P16|Overall Study|Laboratory abnormality|1
2658736|NCT00666926|9180674|P15|Overall Study|Laboratory abnormality|0
2658737|NCT00666926|9180675|P14|Overall Study|Laboratory abnormality|0
2658738|NCT00666926|9180676|P13|Overall Study|Laboratory abnormality|0
2658739|NCT00666926|9180677|P12|Overall Study|Laboratory abnormality|0
2658740|NCT00666926|9180678|P11|Overall Study|Laboratory abnormality|1
2658741|NCT00666926|9180679|P10|Overall Study|Laboratory abnormality|0
2658742|NCT00666926|9180680|P9|Overall Study|Laboratory abnormality|0
2658743|NCT00666926|9180681|P8|Overall Study|Laboratory abnormality|0
2658744|NCT00666926|9180682|P7|Overall Study|Laboratory abnormality|0
2658745|NCT00666926|9180683|P6|Overall Study|Laboratory abnormality|0
2658746|NCT00666926|9180684|P5|Overall Study|Laboratory abnormality|0
2658747|NCT00666926|9180685|P4|Overall Study|Laboratory abnormality|0
2658748|NCT00666926|9180686|P3|Overall Study|Laboratory abnormality|0
2658749|NCT00666926|9180687|P2|Overall Study|Laboratory abnormality|0
2658750|NCT00666926|9180688|P1|Overall Study|Laboratory abnormality|0
2658751|NCT00666926|9180673|P16|Overall Study|Adverse Event|0
2658752|NCT00666926|9180674|P15|Overall Study|Adverse Event|0
2658753|NCT00666926|9180675|P14|Overall Study|Adverse Event|1
2658754|NCT00666926|9180676|P13|Overall Study|Adverse Event|0
2658755|NCT00666926|9180677|P12|Overall Study|Adverse Event|2
2658756|NCT00666926|9180678|P11|Overall Study|Adverse Event|2
2658757|NCT00666926|9180679|P10|Overall Study|Adverse Event|2
2658758|NCT00666926|9180680|P9|Overall Study|Adverse Event|0
2658759|NCT00666926|9180681|P8|Overall Study|Adverse Event|0
2658760|NCT00666926|9180682|P7|Overall Study|Adverse Event|0
2658761|NCT00666926|9180683|P6|Overall Study|Adverse Event|0
2658762|NCT00666926|9180684|P5|Overall Study|Adverse Event|0
2658763|NCT00666926|9180685|P4|Overall Study|Adverse Event|0
2658764|NCT00666926|9180686|P3|Overall Study|Adverse Event|0
2658765|NCT00666926|9180687|P2|Overall Study|Adverse Event|0
2658766|NCT00666926|9180688|P1|Overall Study|Adverse Event|0
2658767|NCT00666835|9180997|P2|Overall Study|Physician Decision|2
2658768|NCT00666835|9180998|P1|Overall Study|Physician Decision|1
2658769|NCT00666835|9180997|P2|Overall Study|Planned operation|0
2658770|NCT00666835|9180998|P1|Overall Study|Planned operation|2
2658771|NCT00666835|9180997|P2|Overall Study|Hemoglobulin concentration|3
2658772|NCT00666835|9180998|P1|Overall Study|Hemoglobulin concentration|4
2658773|NCT00666835|9180997|P2|Overall Study|Kidney Transplantation (NTX)|2
2658774|NCT00666835|9180998|P1|Overall Study|Kidney Transplantation (NTX)|10
2658775|NCT00666835|9180997|P2|Overall Study|Death|4
2658776|NCT00666835|9180998|P1|Overall Study|Death|15
2658777|NCT00666835|9180997|P2|Overall Study|Protocol Violation|0
2658778|NCT00666835|9180998|P1|Overall Study|Protocol Violation|2
2658779|NCT00666835|9180997|P2|Overall Study|Adverse Event|6
2658780|NCT00666835|9180998|P1|Overall Study|Adverse Event|7
2658781|NCT00666835|9180997|P2|Overall Study|Incl./excl. not fulfilled|2
2658782|NCT00666835|9180998|P1|Overall Study|Incl./excl. not fulfilled|7
2658783|NCT00666835|9180997|P2|Overall Study|Lack of Efficacy|1
2658784|NCT00666835|9180998|P1|Overall Study|Lack of Efficacy|0
2658785|NCT00666835|9180997|P2|Overall Study|Withdrawal by Subject|2
2658786|NCT00666835|9180998|P1|Overall Study|Withdrawal by Subject|5
2658787|NCT00666757|9181008|P2|Overall Study|Sponsor decision|1
2658788|NCT00666757|9181009|P1|Overall Study|Sponsor decision|0
2658789|NCT00666757|9181008|P2|Overall Study|Physician Decision|2
2658790|NCT00666757|9181009|P1|Overall Study|Physician Decision|0
2658791|NCT00666757|9181008|P2|Overall Study|Lack of Efficacy|6
2658792|NCT00666757|9181009|P1|Overall Study|Lack of Efficacy|3
2658793|NCT00666757|9181008|P2|Overall Study|Withdrawal by Subject|17
2658794|NCT00666757|9181009|P1|Overall Study|Withdrawal by Subject|13
2658795|NCT00666757|9181008|P2|Overall Study|Adverse Event|12
2658796|NCT00666757|9181009|P1|Overall Study|Adverse Event|22
2658797|NCT00666757|9181008|P2|Overall Study|Protocol Violation|24
2658798|NCT00666757|9181009|P1|Overall Study|Protocol Violation|23
2658799|NCT00666757|9181008|P2|Overall Study|Lost to Follow-up|35
2658800|NCT00666757|9181009|P1|Overall Study|Lost to Follow-up|39
2658801|NCT00666718|9181068|P2|Overall Study|Physician Decision|2
2658802|NCT00666718|9181069|P1|Overall Study|Physician Decision|0
2658803|NCT00666718|9181068|P2|Overall Study|Withdrawal by Subject|12
2658804|NCT00666718|9181069|P1|Overall Study|Withdrawal by Subject|7
2658805|NCT00666718|9181068|P2|Overall Study|Protocol Violation|3
2658806|NCT00666718|9181069|P1|Overall Study|Protocol Violation|1
2658807|NCT00666718|9181068|P2|Overall Study|Entry Criteria Not Met|0
2658808|NCT00666718|9181069|P1|Overall Study|Entry Criteria Not Met|2
2658809|NCT00666718|9181068|P2|Overall Study|Lost to Follow-up|0
2658810|NCT00666718|9181069|P1|Overall Study|Lost to Follow-up|1
2658811|NCT00666718|9181068|P2|Overall Study|Death|0
2658812|NCT00666718|9181069|P1|Overall Study|Death|1
2658813|NCT00666718|9181068|P2|Overall Study|Adverse Event|1
2658814|NCT00666718|9181069|P1|Overall Study|Adverse Event|0
2658815|NCT00666705|9181095|P1|Overall Study|Withdrawal by Subject|1
2658816|NCT00666679|9181114|P2|Second Intervention|Death|1
2658817|NCT00666679|9181115|P1|Second Intervention|Death|0
2658818|NCT00666679|9181114|P2|Second Intervention|Adverse Event|0
2658819|NCT00666679|9181115|P1|Second Intervention|Adverse Event|1
2658820|NCT00666679|9181114|P2|Washout Period of 1 Week|Protocol Violation|1
2658821|NCT00666679|9181115|P1|Washout Period of 1 Week|Protocol Violation|0
2658822|NCT00666679|9181114|P2|Washout Period of 1 Week|Lost to Follow-up|1
2658823|NCT00666679|9181115|P1|Washout Period of 1 Week|Lost to Follow-up|0
2658824|NCT00666679|9181114|P2|First Intervention|Randomized did not start treatment|1
2658825|NCT00666679|9181115|P1|First Intervention|Randomized did not start treatment|1
2658826|NCT00666679|9181114|P2|First Intervention|Withdrawal by Subject|0
2658827|NCT00666679|9181115|P1|First Intervention|Withdrawal by Subject|1
2658828|NCT00666679|9181114|P2|First Intervention|Protocol Violation|0
2658829|NCT00666679|9181115|P1|First Intervention|Protocol Violation|1
2658830|NCT00666679|9181114|P2|First Intervention|Lost to Follow-up|0
2658831|NCT00666679|9181115|P1|First Intervention|Lost to Follow-up|1
2658832|NCT00666588|9181145|P4|Overall Study|inevaluable|0
2658833|NCT00666588|9181146|P3|Overall Study|inevaluable|0
2658834|NCT00666588|9181147|P2|Overall Study|inevaluable|0
2658835|NCT00666588|9181148|P1|Overall Study|inevaluable|2
2658836|NCT00666588|9181145|P4|Overall Study|ineligible|2
2658837|NCT00666588|9181146|P3|Overall Study|ineligible|0
2658838|NCT00666588|9181147|P2|Overall Study|ineligible|0
2658839|NCT00666588|9181148|P1|Overall Study|ineligible|2
2658840|NCT00666562|9181181|P3|Overall Study|Concomitant Medication|0
2658841|NCT00666562|9181182|P2|Overall Study|Concomitant Medication|1
2658842|NCT00666562|9181183|P1|Overall Study|Concomitant Medication|0
2658843|NCT00666562|9181181|P3|Overall Study|Withdrawal by Subject|0
2658844|NCT00666562|9181182|P2|Overall Study|Withdrawal by Subject|1
2658845|NCT00666562|9181183|P1|Overall Study|Withdrawal by Subject|0
2658846|NCT00666536|9181230|P2|Overall Study|Lost to Follow-up|3
2658847|NCT00666536|9181231|P1|Overall Study|Lost to Follow-up|4
2658848|NCT00666536|9181230|P2|Overall Study|Withdrawal by Subject|9
2658849|NCT00666536|9181231|P1|Overall Study|Withdrawal by Subject|10
2658850|NCT00666536|9181230|P2|Overall Study|Protocol deviation(s)|6
2658851|NCT00666536|9181231|P1|Overall Study|Protocol deviation(s)|8
2658852|NCT00666536|9181230|P2|Overall Study|Unsatisfactory therapeutic effect|0
2658853|NCT00666536|9181231|P1|Overall Study|Unsatisfactory therapeutic effect|2
2658854|NCT00666536|9181230|P2|Overall Study|Adverse Event|19
2658855|NCT00666536|9181231|P1|Overall Study|Adverse Event|9
2658856|NCT00666458|9181249|P2|Overall Study|Medical history of anemia|0
2658857|NCT00666458|9181250|P1|Overall Study|Medical history of anemia|1
2658858|NCT00666458|9181249|P2|Overall Study|Safety reasons|0
2658859|NCT00666458|9181250|P1|Overall Study|Safety reasons|1
2658860|NCT00666458|9181249|P2|Overall Study|Severe non-compliance to the protocol|1
2658861|NCT00666458|9181250|P1|Overall Study|Severe non-compliance to the protocol|1
2658862|NCT00666458|9181249|P2|Overall Study|Study specific discontinuation criteria|7
2658863|NCT00666458|9181250|P1|Overall Study|Study specific discontinuation criteria|14
2658864|NCT00666458|9181249|P2|Overall Study|Incorrect enrollment|1
2658865|NCT00666458|9181250|P1|Overall Study|Incorrect enrollment|7
2658866|NCT00666458|9181249|P2|Overall Study|Administrative reason by sponsor|1
2658867|NCT00666458|9181250|P1|Overall Study|Administrative reason by sponsor|1
2658868|NCT00666458|9181249|P2|Overall Study|Lost to Follow-up|3
2658869|NCT00666458|9181250|P1|Overall Study|Lost to Follow-up|0
2658870|NCT00666458|9181249|P2|Overall Study|Withdrawal by Subject|4
2658871|NCT00666458|9181250|P1|Overall Study|Withdrawal by Subject|5
2658872|NCT00666458|9181249|P2|Overall Study|Adverse Event|7
2658873|NCT00666458|9181250|P1|Overall Study|Adverse Event|8
2658874|NCT00666328|9181338|P1|Overall Study|No longer met eligibility criteria|1
2658875|NCT00666328|9181338|P1|Overall Study|Lost to Follow-up|2
2658876|NCT00666328|9181338|P1|Overall Study|Death|2
2658877|NCT00666276|9181351|P1|Overall Study|Protocol Violation|34
2658878|NCT00666263|9181375|P2|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1
2658879|NCT00666263|9181376|P1|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0
2658880|NCT00666263|9181375|P2|Study Part 4 (Cross-over Period 2)|Adverse Event|0
2658881|NCT00666263|9181376|P1|Study Part 4 (Cross-over Period 2)|Adverse Event|1
2658882|NCT00666263|9181375|P2|Study Part 1 (Stabilization Phase 1)|Adverse Event|1
2658883|NCT00666263|9181376|P1|Study Part 1 (Stabilization Phase 1)|Adverse Event|0
2658884|NCT00666224|9181520|P2|Open-Label|Undefined/Unknown|1
2658885|NCT00666224|9181521|P1|Open-Label|Undefined/Unknown|1
2658886|NCT00666224|9181520|P2|Open-Label|Noncompliance|1
2658887|NCT00666224|9181521|P1|Open-Label|Noncompliance|2
2658888|NCT00666224|9181520|P2|Open-Label|Pregnancy|5
2658889|NCT00666224|9181521|P1|Open-Label|Pregnancy|1
2658890|NCT00666224|9181520|P2|Open-Label|Physician Decision|5
2658891|NCT00666224|9181521|P1|Open-Label|Physician Decision|7
2658892|NCT00666224|9181520|P2|Open-Label|Withdrawal by Subject|25
2658893|NCT00666224|9181521|P1|Open-Label|Withdrawal by Subject|12
2658894|NCT00666224|9181520|P2|Open-Label|Lost to Follow-up|5
2658895|NCT00666224|9181521|P1|Open-Label|Lost to Follow-up|4
2658896|NCT00666224|9181520|P2|Open-Label|Adverse Event|43
2658897|NCT00666224|9181521|P1|Open-Label|Adverse Event|8
2658898|NCT00666224|9181520|P2|Double-Blind|Undefined/Unknown|1
2658899|NCT00666224|9181521|P1|Double-Blind|Undefined/Unknown|4
2658900|NCT00666224|9181520|P2|Double-Blind|Death|0
2658901|NCT00666224|9181521|P1|Double-Blind|Death|1
2658902|NCT00666224|9181520|P2|Double-Blind|Noncompliance|0
2658903|NCT00666224|9181521|P1|Double-Blind|Noncompliance|1
2658904|NCT00666224|9181520|P2|Double-Blind|Pregnancy|2
2658905|NCT00666224|9181521|P1|Double-Blind|Pregnancy|3
2658906|NCT00666224|9181520|P2|Double-Blind|Sponsor decision|0
2658907|NCT00666224|9181521|P1|Double-Blind|Sponsor decision|1
2658908|NCT00666224|9181520|P2|Double-Blind|Physician Decision|3
2658909|NCT00666224|9181521|P1|Double-Blind|Physician Decision|0
2658910|NCT00666224|9181520|P2|Double-Blind|Withdrawal by Subject|14
2658911|NCT00666224|9181521|P1|Double-Blind|Withdrawal by Subject|18
2658912|NCT00666224|9181520|P2|Double-Blind|Lost to Follow-up|2
2658913|NCT00666224|9181521|P1|Double-Blind|Lost to Follow-up|2
2658914|NCT00666224|9181520|P2|Double-Blind|Adverse Event|5
2658915|NCT00666224|9181521|P1|Double-Blind|Adverse Event|15
2658916|NCT00666211|9181540|P2|Overall Study|Physician Decision|1
2658917|NCT00666211|9181541|P1|Overall Study|Physician Decision|0
2658918|NCT00666211|9181540|P2|Overall Study|off tx for other complicating disease|1
2658919|NCT00666211|9181541|P1|Overall Study|off tx for other complicating disease|0
2658920|NCT00666211|9181540|P2|Overall Study|Death|2
2658921|NCT00666211|9181541|P1|Overall Study|Death|0
2658922|NCT00666211|9181540|P2|Overall Study|hospital admission|5
2658923|NCT00666211|9181541|P1|Overall Study|hospital admission|0
2658924|NCT00666211|9181540|P2|Overall Study|toxicity|2
2658925|NCT00666211|9181541|P1|Overall Study|toxicity|0
2658926|NCT00666211|9181540|P2|Overall Study|Lost to Follow-up|0
2658927|NCT00666211|9181541|P1|Overall Study|Lost to Follow-up|2
2658928|NCT00666211|9181540|P2|Overall Study|disease progression|8
2658929|NCT00666211|9181541|P1|Overall Study|disease progression|1
2658930|NCT00666211|9181540|P2|Overall Study|patient non-compliant|6
2658931|NCT00666211|9181541|P1|Overall Study|patient non-compliant|6
2658932|NCT00666211|9181540|P2|Overall Study|went off medication, no more pain|0
2658933|NCT00666211|9181541|P1|Overall Study|went off medication, no more pain|1
2658934|NCT00666211|9181540|P2|Overall Study|Withdrawal by Subject|13
2658935|NCT00666211|9181541|P1|Overall Study|Withdrawal by Subject|10
2658936|NCT00666198|9181559|P1|Overall Study|No Drug Administration|4
2658937|NCT00666198|9181559|P1|Overall Study|Safety Not Assessable|6
2658938|NCT00666198|9181559|P1|Overall Study|No Visit After First Day of Treatment|13
2658939|NCT00666198|9181559|P1|Overall Study|Protocol Violation|10
2658940|NCT00665925|9181587|P4|Overall Study|Due to exclusion criteria|0
2658941|NCT00665925|9181588|P3|Overall Study|Due to exclusion criteria|0
2658942|NCT00665925|9181589|P2|Overall Study|Due to exclusion criteria|0
2658943|NCT00665925|9181590|P1|Overall Study|Due to exclusion criteria|1
2658944|NCT00665925|9181587|P4|Overall Study|Enrolled by mistake|1
2658945|NCT00665925|9181588|P3|Overall Study|Enrolled by mistake|0
2658946|NCT00665925|9181589|P2|Overall Study|Enrolled by mistake|0
2658947|NCT00665925|9181590|P1|Overall Study|Enrolled by mistake|0
2658948|NCT00665925|9181587|P4|Overall Study|Adverse Event|5
2658949|NCT00665925|9181588|P3|Overall Study|Adverse Event|10
2658950|NCT00665925|9181589|P2|Overall Study|Adverse Event|5
2658951|NCT00665925|9181590|P1|Overall Study|Adverse Event|1
2658952|NCT00665925|9181587|P4|Overall Study|Severe Non-Compliance to Protocol|1
2658953|NCT00665925|9181588|P3|Overall Study|Severe Non-Compliance to Protocol|1
2658954|NCT00665925|9181589|P2|Overall Study|Severe Non-Compliance to Protocol|0
2658955|NCT00665925|9181590|P1|Overall Study|Severe Non-Compliance to Protocol|0
2658956|NCT00665925|9181587|P4|Overall Study|Physician Decision|2
2658957|NCT00665925|9181588|P3|Overall Study|Physician Decision|1
2658958|NCT00665925|9181589|P2|Overall Study|Physician Decision|0
2658959|NCT00665925|9181590|P1|Overall Study|Physician Decision|0
2658960|NCT00665925|9181587|P4|Overall Study|Withdrawal by Subject|2
2658961|NCT00665925|9181588|P3|Overall Study|Withdrawal by Subject|3
2658962|NCT00665925|9181589|P2|Overall Study|Withdrawal by Subject|2
2658963|NCT00665925|9181590|P1|Overall Study|Withdrawal by Subject|2
2658964|NCT00665925|9181587|P4|Overall Study|Lost to Follow-up|2
2658965|NCT00665925|9181588|P3|Overall Study|Lost to Follow-up|2
2658966|NCT00665925|9181589|P2|Overall Study|Lost to Follow-up|2
2658967|NCT00665925|9181590|P1|Overall Study|Lost to Follow-up|1
2658968|NCT00665925|9181587|P4|Overall Study|Lack of Efficacy|8
2658969|NCT00665925|9181588|P3|Overall Study|Lack of Efficacy|9
2658970|NCT00665925|9181589|P2|Overall Study|Lack of Efficacy|8
2658971|NCT00665925|9181590|P1|Overall Study|Lack of Efficacy|10
2658972|NCT00665847|9182001|P1|Overall Study|Switch to Commercial Medication|1
2658973|NCT00665847|9182001|P1|Overall Study|Subject ineligible to continue the trial|1
2658974|NCT00665847|9182001|P1|Overall Study|Resistance to TMC125|1
2658975|NCT00665847|9182001|P1|Overall Study|Subject reached a virologic endpoint|4
2658976|NCT00665847|9182001|P1|Overall Study|Subject non-compliant|8
2658977|NCT00665847|9182001|P1|Overall Study|Withdrawal by Subject|2
2658978|NCT00665847|9182001|P1|Overall Study|Adverse Event|8
2658979|NCT00665652|9182018|P1|Overall Study|No longer met inclusion criteria.|1
2658980|NCT00665652|9182018|P1|Overall Study|Death|1
2658981|NCT00665652|9182018|P1|Overall Study|Adverse Event|4
2658982|NCT00665626|9182024|P2|Overall Study|Death|0
2658983|NCT00665626|9182025|P1|Overall Study|Death|1
2658984|NCT00665626|9182024|P2|Overall Study|Unably to comply with dosing regimen|1
2658985|NCT00665626|9182025|P1|Overall Study|Unably to comply with dosing regimen|0
2658986|NCT00665626|9182024|P2|Overall Study|Did not fulfil inclusion criteria|1
2658987|NCT00665626|9182025|P1|Overall Study|Did not fulfil inclusion criteria|0
2658988|NCT00665626|9182024|P2|Overall Study|Due to exclusion criteria|1
2658989|NCT00665626|9182025|P1|Overall Study|Due to exclusion criteria|0
2658990|NCT00665626|9182024|P2|Overall Study|Adverse Event|9
2658991|NCT00665626|9182025|P1|Overall Study|Adverse Event|1
2658992|NCT00665626|9182024|P2|Overall Study|Protocol Violation|2
2658993|NCT00665626|9182025|P1|Overall Study|Protocol Violation|0
2658994|NCT00665626|9182024|P2|Overall Study|Withdrawal by Subject|1
2658995|NCT00665626|9182025|P1|Overall Study|Withdrawal by Subject|0
2658996|NCT00665626|9182024|P2|Overall Study|Lost to Follow-up|2
2658997|NCT00665626|9182025|P1|Overall Study|Lost to Follow-up|0
2658998|NCT00665626|9182024|P2|Overall Study|Lack of Efficacy|5
2658999|NCT00665626|9182025|P1|Overall Study|Lack of Efficacy|8
2659000|NCT00665561|9182093|P2|Overall Study|Withdrawn due to pregnancy|1
2659001|NCT00665561|9182094|P1|Overall Study|Withdrawn due to pregnancy|0
2659002|NCT00665561|9182093|P2|Overall Study|Site closed|0
2659003|NCT00665561|9182094|P1|Overall Study|Site closed|8
2659004|NCT00665561|9182093|P2|Overall Study|Other|108
2659005|NCT00665561|9182094|P1|Overall Study|Other|123
2659006|NCT00665561|9182093|P2|Overall Study|Withdrawal by Subject|65
2659007|NCT00665561|9182094|P1|Overall Study|Withdrawal by Subject|74
2659008|NCT00665561|9182093|P2|Overall Study|Lost to Follow-up|264
2659009|NCT00665561|9182094|P1|Overall Study|Lost to Follow-up|203
2659010|NCT00665561|9182093|P2|Overall Study|Does not meet entrance criteria|21
2659011|NCT00665561|9182094|P1|Overall Study|Does not meet entrance criteria|19
2659012|NCT00665561|9182093|P2|Overall Study|Death recorded on subject summary pages|75
2659013|NCT00665561|9182094|P1|Overall Study|Death recorded on subject summary pages|75
2659014|NCT00665444|9182144|P1|Overall Study|Study Terminated by Study Sponsor|1
2659015|NCT00665444|9182144|P1|Overall Study|Physician Decision|1
2659016|NCT00665431|9182156|P3|Overall Study|Other|2
2659017|NCT00665431|9182157|P2|Overall Study|Other|7
2659018|NCT00665431|9182158|P1|Overall Study|Other|4
2659019|NCT00665431|9182156|P3|Overall Study|Lost to Follow-up|1
2659020|NCT00665431|9182157|P2|Overall Study|Lost to Follow-up|3
2659021|NCT00665431|9182158|P1|Overall Study|Lost to Follow-up|3
2659022|NCT00665431|9182156|P3|Overall Study|Withdrawal by Subject|15
2659023|NCT00665431|9182157|P2|Overall Study|Withdrawal by Subject|25
2659024|NCT00665431|9182158|P1|Overall Study|Withdrawal by Subject|17
2659025|NCT00665431|9182156|P3|Overall Study|Adverse Event|6
2659026|NCT00665431|9182157|P2|Overall Study|Adverse Event|22
2659027|NCT00665431|9182158|P1|Overall Study|Adverse Event|16
2659028|NCT00665366|9182201|P2|Overall Study|Other reasons|1
2659029|NCT00665366|9182202|P1|Overall Study|Other reasons|4
2659030|NCT00665366|9182201|P2|Overall Study|No longer meets study criteria|1
2659031|NCT00665366|9182202|P1|Overall Study|No longer meets study criteria|0
2659032|NCT00665366|9182201|P2|Overall Study|Pregnancy|0
2659033|NCT00665366|9182202|P1|Overall Study|Pregnancy|1
2659034|NCT00665366|9182201|P2|Overall Study|Poor compliance/noncompliance|5
2659035|NCT00665366|9182202|P1|Overall Study|Poor compliance/noncompliance|3
2659036|NCT00665366|9182201|P2|Overall Study|Lost to Follow-up|5
2659037|NCT00665366|9182202|P1|Overall Study|Lost to Follow-up|3
2659038|NCT00665366|9182201|P2|Overall Study|Withdrawal by Subject|14
2659039|NCT00665366|9182202|P1|Overall Study|Withdrawal by Subject|11
2659040|NCT00665366|9182201|P2|Overall Study|Adverse Event|23
2659041|NCT00665366|9182202|P1|Overall Study|Adverse Event|25
2659042|NCT00665366|9182201|P2|Overall Study|Lack of Efficacy|10
2659043|NCT00665366|9182202|P1|Overall Study|Lack of Efficacy|11
2659044|NCT00665353|9182230|P1|Study Step 2|Lack of Efficacy|12
2659045|NCT00665353|9182230|P1|Study Step 2|Lost to Follow-up|2
2659046|NCT00665353|9182230|P1|Study Step 1|Withdrawal by Subject|2
2659047|NCT00665353|9182230|P1|Study Step 1|Adverse Event|1
2659048|NCT00665002|9182247|P1|Overall Study|Cytogenetic resistance|1
2659049|NCT00665002|9182247|P1|Overall Study|Progression/relapse during treatment|11
2659050|NCT00664859|9182255|P3|Overall Study|Other|2
2659051|NCT00664859|9182256|P2|Overall Study|Other|1
2659052|NCT00664859|9182257|P1|Overall Study|Other|0
2659053|NCT00664859|9182255|P3|Overall Study|Lost to Follow-up|1
2659054|NCT00664859|9182256|P2|Overall Study|Lost to Follow-up|2
2659055|NCT00664859|9182257|P1|Overall Study|Lost to Follow-up|2
2659056|NCT00664859|9182255|P3|Overall Study|Withdrawal by Subject|3
2659057|NCT00664859|9182256|P2|Overall Study|Withdrawal by Subject|1
2659058|NCT00664859|9182257|P1|Overall Study|Withdrawal by Subject|4
2659059|NCT00664859|9182255|P3|Overall Study|Laboratory abnormality|4
2659060|NCT00664859|9182256|P2|Overall Study|Laboratory abnormality|1
2659061|NCT00664859|9182257|P1|Overall Study|Laboratory abnormality|2
2659062|NCT00664859|9182255|P3|Overall Study|Noncompliance with protocol|4
2659063|NCT00664859|9182256|P2|Overall Study|Noncompliance with protocol|0
2659064|NCT00664859|9182257|P1|Overall Study|Noncompliance with protocol|1
2659065|NCT00664859|9182255|P3|Overall Study|DB Study (LCP-AtorFen-2001) AE|4
2659066|NCT00664859|9182256|P2|Overall Study|DB Study (LCP-AtorFen-2001) AE|4
2659067|NCT00664859|9182257|P1|Overall Study|DB Study (LCP-AtorFen-2001) AE|6
2659068|NCT00664859|9182255|P3|Overall Study|Adverse Event|3
2659069|NCT00664859|9182256|P2|Overall Study|Adverse Event|1
2659070|NCT00664859|9182257|P1|Overall Study|Adverse Event|2
2659071|NCT00664742|9182277|P1|Overall Study|Lost to Follow-up|92
2659072|NCT00664742|9182277|P1|Overall Study|Withdrawal by Subject|31
2659073|NCT00664742|9182277|P1|Overall Study|Withdrawn due to adverse events|3
2659074|NCT00664560|9182285|P3|Overall Study|Other|5
2659075|NCT00664560|9182286|P2|Overall Study|Other|4
2659076|NCT00664560|9182287|P1|Overall Study|Other|11
2659077|NCT00664560|9182285|P3|Overall Study|Lost to Follow-up|0
2659078|NCT00664560|9182286|P2|Overall Study|Lost to Follow-up|2
2659079|NCT00664560|9182287|P1|Overall Study|Lost to Follow-up|0
2659080|NCT00664560|9182285|P3|Overall Study|Withdrawal by Subject|7
2659081|NCT00664560|9182286|P2|Overall Study|Withdrawal by Subject|13
2659082|NCT00664560|9182287|P1|Overall Study|Withdrawal by Subject|9
2659083|NCT00664560|9182285|P3|Overall Study|Adverse Event|7
2659084|NCT00664560|9182286|P2|Overall Study|Adverse Event|16
2659085|NCT00664560|9182287|P1|Overall Study|Adverse Event|19
2659086|NCT00664534|9182330|P2|Overall Study|Sponsor decision|6
2659087|NCT00664534|9182331|P1|Overall Study|Sponsor decision|8
2659088|NCT00664534|9182330|P2|Overall Study|Physician Decision|0
2659089|NCT00664534|9182331|P1|Overall Study|Physician Decision|8
2659090|NCT00664534|9182330|P2|Overall Study|Withdrawal by Subject|6
2659091|NCT00664534|9182331|P1|Overall Study|Withdrawal by Subject|7
2659092|NCT00664534|9182330|P2|Overall Study|Protocol Violation|8
2659093|NCT00664534|9182331|P1|Overall Study|Protocol Violation|10
2659094|NCT00664534|9182330|P2|Overall Study|Lost to Follow-up|10
2659095|NCT00664534|9182331|P1|Overall Study|Lost to Follow-up|6
2659096|NCT00664534|9182330|P2|Overall Study|Adverse Event|3
2659097|NCT00664534|9182331|P1|Overall Study|Adverse Event|2
2659098|NCT00664521|9182359|P2|Overall Study|Other|0
2659099|NCT00664521|9182360|P1|Overall Study|Other|1
2659100|NCT00664521|9182359|P2|Overall Study|Lost to Follow-up|0
2659101|NCT00664521|9182360|P1|Overall Study|Lost to Follow-up|1
2659102|NCT00664521|9182359|P2|Overall Study|Adverse Event|1
2659103|NCT00664521|9182360|P1|Overall Study|Adverse Event|4
2659104|NCT00664326|9182386|P1|Overall Study|Disease Progression/Recurrence/Relapse|24
2659105|NCT00664326|9182386|P1|Overall Study|Death|2
2659106|NCT00664326|9182386|P1|Overall Study|Other Reasons|3
2659107|NCT00664326|9182386|P1|Overall Study|Physician Decision|1
2659108|NCT00664326|9182386|P1|Overall Study|Withdrawal by Subject|1
2659109|NCT00664326|9182386|P1|Overall Study|Noncompliance with study medication|3
2659110|NCT00664326|9182386|P1|Overall Study|Adverse Event|14
2659111|NCT00664209|9182405|P1|Study Treatment Period|Withdrawal by Subject|2
2659112|NCT00664209|9182405|P1|Study Treatment Period|Physician Decision|4
2659113|NCT00664209|9182405|P1|Motor Fluctuations Screen|Negative for motor fluctuation|7
2659114|NCT00664105|9182413|P1|Overall Study|Disease progression|7
2659115|NCT00664105|9182413|P1|Overall Study|Adverse Event|9
2659116|NCT00664105|9182413|P1|Overall Study|Withdrawal by Subject|5
2659117|NCT00664105|9182413|P1|Overall Study|Death|3
2659118|NCT00664066|9182420|P1|Overall Study|Study terminated|3
2659119|NCT00663962|9182426|P2|Overall Study|somnolence|0
2659120|NCT00663962|9182427|P1|Overall Study|somnolence|1
2659121|NCT00663923|9182433|P1|Overall Study|Lost to Follow-up|2
2659122|NCT00663858|9182450|P3|Overall Study|Other|4
2659123|NCT00663858|9182451|P2|Overall Study|Other|2
2659124|NCT00663858|9182452|P1|Overall Study|Other|8
2659125|NCT00663858|9182450|P3|Overall Study|Protocol Violation|4
2659126|NCT00663858|9182451|P2|Overall Study|Protocol Violation|3
2659127|NCT00663858|9182452|P1|Overall Study|Protocol Violation|5
2659128|NCT00663858|9182450|P3|Overall Study|Withdrawal by Subject|3
2659129|NCT00663858|9182451|P2|Overall Study|Withdrawal by Subject|3
2659130|NCT00663858|9182452|P1|Overall Study|Withdrawal by Subject|7
2659131|NCT00663858|9182450|P3|Overall Study|Lack of Efficacy|3
2659132|NCT00663858|9182451|P2|Overall Study|Lack of Efficacy|1
2659133|NCT00663858|9182452|P1|Overall Study|Lack of Efficacy|5
2659134|NCT00663858|9182450|P3|Overall Study|Adverse Event|6
2659135|NCT00663858|9182451|P2|Overall Study|Adverse Event|1
2659136|NCT00663858|9182452|P1|Overall Study|Adverse Event|9
2659137|NCT00663702|9182490|P2|Overall Study|Lack of Efficacy|3
2659138|NCT00663702|9182491|P1|Overall Study|Lack of Efficacy|3
2659139|NCT00663702|9182490|P2|Overall Study|Death|1
2659140|NCT00663702|9182491|P1|Overall Study|Death|1
2659141|NCT00663702|9182490|P2|Overall Study|Lost to Follow-up|0
2659142|NCT00663702|9182491|P1|Overall Study|Lost to Follow-up|3
2659143|NCT00663702|9182490|P2|Overall Study|Pregnancy|1
2659144|NCT00663702|9182491|P1|Overall Study|Pregnancy|0
2659145|NCT00663702|9182490|P2|Overall Study|Withdrawal by Subject|1
2659146|NCT00663702|9182491|P1|Overall Study|Withdrawal by Subject|3
2659147|NCT00663702|9182490|P2|Overall Study|Adverse Event|4
2659148|NCT00663702|9182491|P1|Overall Study|Adverse Event|8
2659149|NCT00663260|9182527|P3|Overall Study|non-compliance, not met criteria, etc.|3
2659150|NCT00663260|9182528|P2|Overall Study|non-compliance, not met criteria, etc.|2
2659151|NCT00663260|9182529|P1|Overall Study|non-compliance, not met criteria, etc.|3
2659152|NCT00663260|9182527|P3|Overall Study|Lost to Follow-up|0
2659153|NCT00663260|9182528|P2|Overall Study|Lost to Follow-up|1
2659154|NCT00663260|9182529|P1|Overall Study|Lost to Follow-up|0
2659155|NCT00663260|9182527|P3|Overall Study|Death|1
2659156|NCT00663260|9182528|P2|Overall Study|Death|0
2659157|NCT00663260|9182529|P1|Overall Study|Death|1
2659158|NCT00663260|9182527|P3|Overall Study|Withdrawal by Subject|6
2659159|NCT00663260|9182528|P2|Overall Study|Withdrawal by Subject|1
2659160|NCT00663260|9182529|P1|Overall Study|Withdrawal by Subject|3
2659161|NCT00663260|9182527|P3|Overall Study|Adverse Event|6
2659162|NCT00663260|9182528|P2|Overall Study|Adverse Event|7
2659163|NCT00663260|9182529|P1|Overall Study|Adverse Event|12
2659164|NCT00663260|9182527|P3|Overall Study|Lack of Efficacy|0
2659165|NCT00663260|9182528|P2|Overall Study|Lack of Efficacy|0
2659166|NCT00663260|9182529|P1|Overall Study|Lack of Efficacy|2
2659167|NCT00663234|9182543|P1|Overall Study|Not willing to adhere to requirements|1
2659168|NCT00663208|9182576|P7|Follow-up Period|Other reason|1
2659169|NCT00663208|9182577|P6|Follow-up Period|Other reason|0
2659170|NCT00663208|9182578|P5|Follow-up Period|Other reason|0
2659171|NCT00663208|9182579|P4|Follow-up Period|Other reason|0
2659172|NCT00663208|9182580|P3|Follow-up Period|Other reason|0
2659173|NCT00663208|9182581|P2|Follow-up Period|Other reason|0
2659174|NCT00663208|9182582|P1|Follow-up Period|Other reason|1
2659175|NCT00663208|9182576|P7|Follow-up Period|Lost to Follow-up|0
2659176|NCT00663208|9182577|P6|Follow-up Period|Lost to Follow-up|0
2659177|NCT00663208|9182578|P5|Follow-up Period|Lost to Follow-up|0
2659178|NCT00663208|9182579|P4|Follow-up Period|Lost to Follow-up|2
2659179|NCT00663208|9182580|P3|Follow-up Period|Lost to Follow-up|3
2659180|NCT00663208|9182581|P2|Follow-up Period|Lost to Follow-up|0
2659181|NCT00663208|9182582|P1|Follow-up Period|Lost to Follow-up|2
2659182|NCT00663208|9182576|P7|Treatment Period|Lost to Follow-up|0
2659183|NCT00663208|9182577|P6|Treatment Period|Lost to Follow-up|0
2659184|NCT00663208|9182578|P5|Treatment Period|Lost to Follow-up|0
2659185|NCT00663208|9182579|P4|Treatment Period|Lost to Follow-up|0
2659186|NCT00663208|9182580|P3|Treatment Period|Lost to Follow-up|0
2659187|NCT00663208|9182581|P2|Treatment Period|Lost to Follow-up|1
2659188|NCT00663208|9182582|P1|Treatment Period|Lost to Follow-up|0
2659189|NCT00663117|9182760|P2|Overall Study|Lack of Efficacy|0
2659190|NCT00663117|9182761|P1|Overall Study|Lack of Efficacy|1
2659191|NCT00663052|9182775|P2|Overall Study|Other|1
2659192|NCT00663052|9182776|P1|Overall Study|Other|0
2659193|NCT00663052|9182775|P2|Overall Study|Unsatisfactory Response - Efficacy|1
2659194|NCT00663052|9182776|P1|Overall Study|Unsatisfactory Response - Efficacy|1
2659195|NCT00663052|9182775|P2|Overall Study|Withdrawal by Subject|5
2659196|NCT00663052|9182776|P1|Overall Study|Withdrawal by Subject|2
2659197|NCT00663052|9182775|P2|Overall Study|Protocol Violation|0
2659198|NCT00663052|9182776|P1|Overall Study|Protocol Violation|1
2659199|NCT00663052|9182775|P2|Overall Study|Discontinuation of Study by Sponsor|0
2659200|NCT00663052|9182776|P1|Overall Study|Discontinuation of Study by Sponsor|2
2659201|NCT00663052|9182775|P2|Overall Study|Adverse Event|3
2659202|NCT00663052|9182776|P1|Overall Study|Adverse Event|6
2659203|NCT00663026|9182882|P3|Overall Study|Withdrawal by Subject|1
2659204|NCT00663026|9182883|P2|Overall Study|Withdrawal by Subject|0
2659205|NCT00663026|9182884|P1|Overall Study|Withdrawal by Subject|0
2659206|NCT00663026|9182882|P3|Overall Study|Caregiver Request|0
2659207|NCT00663026|9182883|P2|Overall Study|Caregiver Request|2
2659208|NCT00663026|9182884|P1|Overall Study|Caregiver Request|0
2659209|NCT00663026|9182882|P3|Overall Study|Adverse Event|3
2659210|NCT00663026|9182883|P2|Overall Study|Adverse Event|2
2659211|NCT00663026|9182884|P1|Overall Study|Adverse Event|0
2659212|NCT00663026|9182882|P3|Overall Study|Other|0
2659213|NCT00663026|9182883|P2|Overall Study|Other|2
2659214|NCT00663026|9182884|P1|Overall Study|Other|1
2659215|NCT00663026|9182882|P3|Overall Study|Lost to Follow-up|0
2659216|NCT00663026|9182883|P2|Overall Study|Lost to Follow-up|0
2659217|NCT00663026|9182884|P1|Overall Study|Lost to Follow-up|1
2659218|NCT00662909|9182907|P3|Overall Study|Eligibility criterion not met|1
2659219|NCT00662909|9182908|P2|Overall Study|Eligibility criterion not met|1
2659220|NCT00662909|9182909|P1|Overall Study|Eligibility criterion not met|0
2659221|NCT00662909|9182907|P3|Overall Study|Physician Decision|2
2659222|NCT00662909|9182908|P2|Overall Study|Physician Decision|1
2659223|NCT00662909|9182909|P1|Overall Study|Physician Decision|1
2659224|NCT00662909|9182907|P3|Overall Study|Non-compliance with study procedures|2
2659225|NCT00662909|9182908|P2|Overall Study|Non-compliance with study procedures|3
2659226|NCT00662909|9182909|P1|Overall Study|Non-compliance with study procedures|3
2659227|NCT00662909|9182907|P3|Overall Study|Randomized- never received study drug|0
2659228|NCT00662909|9182908|P2|Overall Study|Randomized- never received study drug|0
2659229|NCT00662909|9182909|P1|Overall Study|Randomized- never received study drug|1
2659230|NCT00662909|9182907|P3|Overall Study|Protocol Violation|5
2659231|NCT00662909|9182908|P2|Overall Study|Protocol Violation|4
2659232|NCT00662909|9182909|P1|Overall Study|Protocol Violation|7
2659233|NCT00662909|9182907|P3|Overall Study|Lost to Follow-up|3
2659234|NCT00662909|9182908|P2|Overall Study|Lost to Follow-up|9
2659235|NCT00662909|9182909|P1|Overall Study|Lost to Follow-up|2
2659236|NCT00662909|9182907|P3|Overall Study|Withdrawal by Subject|16
2659237|NCT00662909|9182908|P2|Overall Study|Withdrawal by Subject|22
2659238|NCT00662909|9182909|P1|Overall Study|Withdrawal by Subject|29
2659239|NCT00662909|9182907|P3|Overall Study|Lack of Efficacy|5
2659240|NCT00662909|9182908|P2|Overall Study|Lack of Efficacy|1
2659241|NCT00662909|9182909|P1|Overall Study|Lack of Efficacy|9
2659242|NCT00662909|9182907|P3|Overall Study|Adverse Event|19
2659243|NCT00662909|9182908|P2|Overall Study|Adverse Event|18
2659244|NCT00662909|9182909|P1|Overall Study|Adverse Event|17
2659245|NCT00662857|9183007|P2|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0
2659246|NCT00662857|9183008|P1|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1
2659247|NCT00662857|9183007|P2|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1
2659248|NCT00662857|9183008|P1|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0
2659249|NCT00662857|9183007|P2|Washout 1 (3 - 14 Days)|Physician Decision|1
2659250|NCT00662857|9183008|P1|Washout 1 (3 - 14 Days)|Physician Decision|0
2659251|NCT00662831|9183023|P2|Overall Study|Adverse Event|16
2659252|NCT00662831|9183024|P1|Overall Study|Adverse Event|23
2659253|NCT00662831|9183023|P2|Overall Study|Protocol Violation|4
2659254|NCT00662831|9183024|P1|Overall Study|Protocol Violation|8
2659255|NCT00662831|9183023|P2|Overall Study|Other|31
2659256|NCT00662831|9183024|P1|Overall Study|Other|62
2659257|NCT00662831|9183023|P2|Overall Study|Withdrawal by Subject|1
2659258|NCT00662831|9183024|P1|Overall Study|Withdrawal by Subject|2
2659259|NCT00662831|9183023|P2|Overall Study|Lost to Follow-up|0
2659260|NCT00662831|9183024|P1|Overall Study|Lost to Follow-up|1
2659261|NCT00662831|9183023|P2|Overall Study|Lack of Efficacy|6
2659262|NCT00662831|9183024|P1|Overall Study|Lack of Efficacy|6
2659263|NCT00662831|9183023|P2|Overall Study|Death|1
2659264|NCT00662831|9183024|P1|Overall Study|Death|4
2659265|NCT00662649|9183104|P5|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
2659266|NCT00662649|9183105|P4|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
2659267|NCT00662649|9183106|P3|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0
2659268|NCT00662649|9183107|P2|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
2659269|NCT00662649|9183108|P1|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
2659270|NCT00662649|9183104|P5|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
2659271|NCT00662649|9183105|P4|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
2659272|NCT00662649|9183106|P3|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
2659273|NCT00662649|9183107|P2|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1
2659274|NCT00662649|9183108|P1|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
2659275|NCT00662649|9183104|P5|Extension Study (Month 24 to 60)|Subject withdrew consent|9
2659276|NCT00662649|9183105|P4|Extension Study (Month 24 to 60)|Subject withdrew consent|15
2659277|NCT00662649|9183106|P3|Extension Study (Month 24 to 60)|Subject withdrew consent|0
2659278|NCT00662649|9183107|P2|Extension Study (Month 24 to 60)|Subject withdrew consent|23
2659279|NCT00662649|9183108|P1|Extension Study (Month 24 to 60)|Subject withdrew consent|19
2659356|NCT00662558|9183148|P2|Overall Study|Lost to Follow-up|10
2659280|NCT00662649|9183104|P5|Extension Study (Month 24 to 60)|Protocol Violation|0
2659281|NCT00662649|9183105|P4|Extension Study (Month 24 to 60)|Protocol Violation|0
2659282|NCT00662649|9183106|P3|Extension Study (Month 24 to 60)|Protocol Violation|0
2659283|NCT00662649|9183107|P2|Extension Study (Month 24 to 60)|Protocol Violation|1
2659284|NCT00662649|9183108|P1|Extension Study (Month 24 to 60)|Protocol Violation|1
2659285|NCT00662649|9183104|P5|Extension Study (Month 24 to 60)|Lost to Follow-up|1
2659286|NCT00662649|9183105|P4|Extension Study (Month 24 to 60)|Lost to Follow-up|1
2659287|NCT00662649|9183106|P3|Extension Study (Month 24 to 60)|Lost to Follow-up|0
2659288|NCT00662649|9183107|P2|Extension Study (Month 24 to 60)|Lost to Follow-up|0
2659289|NCT00662649|9183108|P1|Extension Study (Month 24 to 60)|Lost to Follow-up|2
2659290|NCT00662649|9183104|P5|Extension Study (Month 24 to 60)|Adverse Event|10
2659291|NCT00662649|9183105|P4|Extension Study (Month 24 to 60)|Adverse Event|6
2659292|NCT00662649|9183106|P3|Extension Study (Month 24 to 60)|Adverse Event|0
2659293|NCT00662649|9183107|P2|Extension Study (Month 24 to 60)|Adverse Event|9
2659294|NCT00662649|9183108|P1|Extension Study (Month 24 to 60)|Adverse Event|6
2659295|NCT00662649|9183104|P5|Extension Study (Month 24 to 60)|Administrative problems|0
2659296|NCT00662649|9183105|P4|Extension Study (Month 24 to 60)|Administrative problems|1
2659297|NCT00662649|9183106|P3|Extension Study (Month 24 to 60)|Administrative problems|0
2659298|NCT00662649|9183107|P2|Extension Study (Month 24 to 60)|Administrative problems|0
2659299|NCT00662649|9183108|P1|Extension Study (Month 24 to 60)|Administrative problems|0
2659300|NCT00662649|9183104|P5|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
2659301|NCT00662649|9183105|P4|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
2659302|NCT00662649|9183106|P3|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0
2659303|NCT00662649|9183107|P2|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
2659304|NCT00662649|9183108|P1|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
2659305|NCT00662649|9183104|P5|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3
2659306|NCT00662649|9183105|P4|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8
2659307|NCT00662649|9183106|P3|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0
2659308|NCT00662649|9183107|P2|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5
2659309|NCT00662649|9183108|P1|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10
2659310|NCT00662649|9183104|P5|Core Study (24 Months)|Death|0
2659311|NCT00662649|9183105|P4|Core Study (24 Months)|Death|0
2659312|NCT00662649|9183106|P3|Core Study (24 Months)|Death|2
2659313|NCT00662649|9183107|P2|Core Study (24 Months)|Death|0
2659314|NCT00662649|9183108|P1|Core Study (24 Months)|Death|1
2659315|NCT00662649|9183104|P5|Core Study (24 Months)|Abnormal test procedure result(s)|0
2659316|NCT00662649|9183105|P4|Core Study (24 Months)|Abnormal test procedure result(s)|0
2659317|NCT00662649|9183106|P3|Core Study (24 Months)|Abnormal test procedure result(s)|1
2659318|NCT00662649|9183107|P2|Core Study (24 Months)|Abnormal test procedure result(s)|1
2659319|NCT00662649|9183108|P1|Core Study (24 Months)|Abnormal test procedure result(s)|2
2659320|NCT00662649|9183104|P5|Core Study (24 Months)|Protocol Violation|0
2659321|NCT00662649|9183105|P4|Core Study (24 Months)|Protocol Violation|0
2659322|NCT00662649|9183106|P3|Core Study (24 Months)|Protocol Violation|4
2659323|NCT00662649|9183107|P2|Core Study (24 Months)|Protocol Violation|5
2659324|NCT00662649|9183108|P1|Core Study (24 Months)|Protocol Violation|5
2659325|NCT00662649|9183104|P5|Core Study (24 Months)|Lost to Follow-up|0
2659326|NCT00662649|9183105|P4|Core Study (24 Months)|Lost to Follow-up|0
2659327|NCT00662649|9183106|P3|Core Study (24 Months)|Lost to Follow-up|7
2659328|NCT00662649|9183107|P2|Core Study (24 Months)|Lost to Follow-up|5
2659329|NCT00662649|9183108|P1|Core Study (24 Months)|Lost to Follow-up|3
2659330|NCT00662649|9183104|P5|Core Study (24 Months)|Abnormal laboratory value(s)|0
2659331|NCT00662649|9183105|P4|Core Study (24 Months)|Abnormal laboratory value(s)|0
2659332|NCT00662649|9183106|P3|Core Study (24 Months)|Abnormal laboratory value(s)|1
2659333|NCT00662649|9183107|P2|Core Study (24 Months)|Abnormal laboratory value(s)|9
2659334|NCT00662649|9183108|P1|Core Study (24 Months)|Abnormal laboratory value(s)|20
2659335|NCT00662649|9183104|P5|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
2659336|NCT00662649|9183105|P4|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
2659337|NCT00662649|9183106|P3|Core Study (24 Months)|Unsatisfactory therapeutic effect|25
2659338|NCT00662649|9183107|P2|Core Study (24 Months)|Unsatisfactory therapeutic effect|6
2659339|NCT00662649|9183108|P1|Core Study (24 Months)|Unsatisfactory therapeutic effect|13
2659340|NCT00662649|9183104|P5|Core Study (24 Months)|Adverse Event|0
2659341|NCT00662649|9183105|P4|Core Study (24 Months)|Adverse Event|0
2659342|NCT00662649|9183106|P3|Core Study (24 Months)|Adverse Event|18
2659343|NCT00662649|9183107|P2|Core Study (24 Months)|Adverse Event|13
2659344|NCT00662649|9183108|P1|Core Study (24 Months)|Adverse Event|22
2659345|NCT00662649|9183104|P5|Core Study (24 Months)|Withdrawal by Subject|0
2659346|NCT00662649|9183105|P4|Core Study (24 Months)|Withdrawal by Subject|0
2659347|NCT00662649|9183106|P3|Core Study (24 Months)|Withdrawal by Subject|28
2659348|NCT00662649|9183107|P2|Core Study (24 Months)|Withdrawal by Subject|17
2659349|NCT00662649|9183108|P1|Core Study (24 Months)|Withdrawal by Subject|31
2659350|NCT00662558|9183148|P2|Overall Study|Randomized But Did Not Receive Treatment|8
2659351|NCT00662558|9183149|P1|Overall Study|Randomized But Did Not Receive Treatment|2
2659352|NCT00662558|9183148|P2|Overall Study|Withdrawal by Subject|12
2659353|NCT00662558|9183149|P1|Overall Study|Withdrawal by Subject|7
2659354|NCT00662558|9183148|P2|Overall Study|Other|14
2659355|NCT00662558|9183149|P1|Overall Study|Other|9
2659357|NCT00662558|9183149|P1|Overall Study|Lost to Follow-up|13
2659358|NCT00662558|9183148|P2|Overall Study|Lack of Efficacy|7
2659359|NCT00662558|9183149|P1|Overall Study|Lack of Efficacy|4
2659360|NCT00662558|9183148|P2|Overall Study|Adverse Event|59
2659361|NCT00662558|9183149|P1|Overall Study|Adverse Event|21
2659362|NCT00662532|9183200|P2|Overall Study|Lost to Follow-up|1
2659363|NCT00662532|9183201|P1|Overall Study|Lost to Follow-up|0
2659364|NCT00662532|9183200|P2|Overall Study|Adverse Event|1
2659365|NCT00662532|9183201|P1|Overall Study|Adverse Event|0
2659366|NCT00662363|9183216|P2|Overall Study|Protocol Violation|1
2659367|NCT00662363|9183217|P1|Overall Study|Protocol Violation|1
2659368|NCT00662363|9183216|P2|Overall Study|Discharged early from rehab|1
2659369|NCT00662363|9183217|P1|Overall Study|Discharged early from rehab|4
2659370|NCT00662363|9183216|P2|Overall Study|Adverse Event|3
2659371|NCT00662363|9183217|P1|Overall Study|Adverse Event|0
2659372|NCT00662363|9183216|P2|Overall Study|Withdrawal by Subject|5
2659373|NCT00662363|9183217|P1|Overall Study|Withdrawal by Subject|6
2659374|NCT00662311|9183228|P3|Overall Study|Respiratory Infection|0
2659375|NCT00662311|9183229|P2|Overall Study|Respiratory Infection|0
2659376|NCT00662311|9183230|P1|Overall Study|Respiratory Infection|1
2659377|NCT00662259|9183265|P2|Overall Study|Adverse Event|0
2659378|NCT00662259|9183266|P1|Overall Study|Adverse Event|2
2659379|NCT00662129|9183308|P1|Overall Study|Ineligible|1
2659380|NCT00662129|9183308|P1|Overall Study|Cancel prior to beginning treatment|1
2659381|NCT00662129|9183308|P1|Overall Study|Protocol Violation|1
2659382|NCT00662038|9183318|P1|Overall Study|Continued treatment|5
2659383|NCT00662038|9183318|P1|Overall Study|Adverse Event|358
2659384|NCT00662038|9183318|P1|Overall Study|Death|95
2659385|NCT00662038|9183318|P1|Overall Study|Lost to Follow-up|1
2659386|NCT00662038|9183318|P1|Overall Study|Lung transplantation|44
2659387|NCT00662038|9183318|P1|Overall Study|Physician Decision|19
2659388|NCT00662038|9183318|P1|Overall Study|Sponsor decision|1
2659389|NCT00662038|9183318|P1|Overall Study|Withdrawal by Subject|83
2659390|NCT00662038|9183318|P1|Overall Study|Withdrawn consent|22
2659391|NCT00662038|9183318|P1|Overall Study|Reason not specified|3
2659392|NCT00662025|9183322|P1|Overall Study|Domestic circumstances|1
2659393|NCT00662025|9183322|P1|Overall Study|Target lesion cannot be evaluated|1
2659394|NCT00662025|9183322|P1|Overall Study|Results of other clinical study|2
2659395|NCT00662025|9183322|P1|Overall Study|Withdrawal by Subject|1
2659396|NCT00662025|9183322|P1|Overall Study|Adverse Event|7
2659397|NCT00662025|9183322|P1|Overall Study|Objective progression or relapse|51
2659398|NCT00662012|9183342|P1|Overall Study|Withdrawal by Subject|1
2659399|NCT00662012|9183342|P1|Overall Study|Death|1
2659400|NCT00662012|9183342|P1|Overall Study|Lost to Follow-up|85
2659401|NCT00661999|9183350|P3|Overall Study|Other Medical Problems|9
2659402|NCT00661999|9183351|P2|Overall Study|Other Medical Problems|4
2659403|NCT00661999|9183352|P1|Overall Study|Other Medical Problems|4
2659404|NCT00661999|9183350|P3|Overall Study|Alternative Treatment|0
2659405|NCT00661999|9183351|P2|Overall Study|Alternative Treatment|0
2659406|NCT00661999|9183352|P1|Overall Study|Alternative Treatment|1
2659407|NCT00661999|9183350|P3|Overall Study|Withdrawal by Subject|14
2659408|NCT00661999|9183351|P2|Overall Study|Withdrawal by Subject|23
2659409|NCT00661999|9183352|P1|Overall Study|Withdrawal by Subject|30
2659410|NCT00661999|9183350|P3|Overall Study|Other Reasons|23
2659411|NCT00661999|9183351|P2|Overall Study|Other Reasons|12
2659412|NCT00661999|9183352|P1|Overall Study|Other Reasons|5
2659413|NCT00661999|9183350|P3|Overall Study|Death|3
2659414|NCT00661999|9183351|P2|Overall Study|Death|6
2659415|NCT00661999|9183352|P1|Overall Study|Death|8
2659416|NCT00661999|9183350|P3|Overall Study|Adverse Event|8
2659417|NCT00661999|9183351|P2|Overall Study|Adverse Event|5
2659418|NCT00661999|9183352|P1|Overall Study|Adverse Event|11
2659419|NCT00661830|9183429|P2|Overall Study|Other reason|5
2659420|NCT00661830|9183430|P1|Overall Study|Other reason|1
2659421|NCT00661830|9183429|P2|Overall Study|Withdrawal by Subject|1
2659422|NCT00661830|9183430|P1|Overall Study|Withdrawal by Subject|1
2659423|NCT00661830|9183429|P2|Overall Study|Lost to Follow-up|3
2659424|NCT00661830|9183430|P1|Overall Study|Lost to Follow-up|1
2659425|NCT00661830|9183429|P2|Overall Study|Death|33
2659426|NCT00661830|9183430|P1|Overall Study|Death|37
2659427|NCT00661778|9183442|P1|Overall Study|Withdrawal of Consent|1
2659428|NCT00661778|9183442|P1|Overall Study|Protocol Violation|2
2659429|NCT00661778|9183442|P1|Overall Study|Reason not Specified|6
2659430|NCT00661778|9183442|P1|Overall Study|Adverse Event|18
2659431|NCT00661778|9183442|P1|Overall Study|Disease Progression|23
2659432|NCT00661726|9183449|P1|Overall Study|Adverse Event|1
2659433|NCT00661713|9183472|P8|Overall Study|Inappropriate Enrollment|0
2659434|NCT00661713|9183473|P7|Overall Study|Inappropriate Enrollment|1
2659435|NCT00661713|9183474|P6|Overall Study|Inappropriate Enrollment|0
2659436|NCT00661713|9183475|P5|Overall Study|Inappropriate Enrollment|0
2659437|NCT00661713|9183476|P4|Overall Study|Inappropriate Enrollment|0
2659438|NCT00661713|9183477|P3|Overall Study|Inappropriate Enrollment|0
2659439|NCT00661713|9183478|P2|Overall Study|Inappropriate Enrollment|0
2659440|NCT00661713|9183479|P1|Overall Study|Inappropriate Enrollment|0
2659441|NCT00661713|9183472|P8|Overall Study|Adverse Event|0
2659442|NCT00661713|9183473|P7|Overall Study|Adverse Event|1
2659443|NCT00661713|9183474|P6|Overall Study|Adverse Event|0
2659444|NCT00661713|9183475|P5|Overall Study|Adverse Event|0
2659445|NCT00661713|9183476|P4|Overall Study|Adverse Event|0
2659446|NCT00661713|9183477|P3|Overall Study|Adverse Event|0
2659447|NCT00661713|9183478|P2|Overall Study|Adverse Event|0
2659448|NCT00661713|9183479|P1|Overall Study|Adverse Event|0
2659449|NCT00661713|9183472|P8|Overall Study|Administrative Reason|0
2659450|NCT00661713|9183473|P7|Overall Study|Administrative Reason|1
2659451|NCT00661713|9183474|P6|Overall Study|Administrative Reason|2
2659452|NCT00661713|9183475|P5|Overall Study|Administrative Reason|2
2659453|NCT00661713|9183476|P4|Overall Study|Administrative Reason|2
2659454|NCT00661713|9183477|P3|Overall Study|Administrative Reason|0
2659455|NCT00661713|9183478|P2|Overall Study|Administrative Reason|1
2659456|NCT00661713|9183479|P1|Overall Study|Administrative Reason|0
2659457|NCT00661713|9183472|P8|Overall Study|Lost to Follow-up|1
2659458|NCT00661713|9183473|P7|Overall Study|Lost to Follow-up|14
2659459|NCT00661713|9183474|P6|Overall Study|Lost to Follow-up|7
2659460|NCT00661713|9183475|P5|Overall Study|Lost to Follow-up|5
2659461|NCT00661713|9183476|P4|Overall Study|Lost to Follow-up|2
2659462|NCT00661713|9183477|P3|Overall Study|Lost to Follow-up|2
2659463|NCT00661713|9183478|P2|Overall Study|Lost to Follow-up|7
2659464|NCT00661713|9183479|P1|Overall Study|Lost to Follow-up|2
2659465|NCT00661713|9183472|P8|Overall Study|Withdrawal by Subject|9
2659466|NCT00661713|9183473|P7|Overall Study|Withdrawal by Subject|45
2659467|NCT00661713|9183474|P6|Overall Study|Withdrawal by Subject|26
2659468|NCT00661713|9183475|P5|Overall Study|Withdrawal by Subject|12
2659469|NCT00661713|9183476|P4|Overall Study|Withdrawal by Subject|21
2659470|NCT00661713|9183477|P3|Overall Study|Withdrawal by Subject|12
2659471|NCT00661713|9183478|P2|Overall Study|Withdrawal by Subject|25
2659472|NCT00661713|9183479|P1|Overall Study|Withdrawal by Subject|11
2659473|NCT00661713|9183472|P8|Overall Study|Protocol Violation|1
2659474|NCT00661713|9183473|P7|Overall Study|Protocol Violation|2
2659475|NCT00661713|9183474|P6|Overall Study|Protocol Violation|2
2659476|NCT00661713|9183475|P5|Overall Study|Protocol Violation|0
2659477|NCT00661713|9183476|P4|Overall Study|Protocol Violation|3
2659478|NCT00661713|9183477|P3|Overall Study|Protocol Violation|3
2659479|NCT00661713|9183478|P2|Overall Study|Protocol Violation|6
2659480|NCT00661713|9183479|P1|Overall Study|Protocol Violation|1
2659481|NCT00661713|9183472|P8|Overall Study|Unable to Classify|0
2659482|NCT00661713|9183473|P7|Overall Study|Unable to Classify|0
2659483|NCT00661713|9183474|P6|Overall Study|Unable to Classify|0
2659484|NCT00661713|9183475|P5|Overall Study|Unable to Classify|0
2659485|NCT00661713|9183476|P4|Overall Study|Unable to Classify|0
2659486|NCT00661713|9183477|P3|Overall Study|Unable to Classify|0
2659487|NCT00661713|9183478|P2|Overall Study|Unable to Classify|0
2659488|NCT00661713|9183479|P1|Overall Study|Unable to Classify|1
2659489|NCT00661713|9183472|P8|Overall Study|Death|0
2659490|NCT00661713|9183473|P7|Overall Study|Death|0
2659491|NCT00661713|9183474|P6|Overall Study|Death|0
2659492|NCT00661713|9183475|P5|Overall Study|Death|1
2659493|NCT00661713|9183476|P4|Overall Study|Death|0
2659494|NCT00661713|9183477|P3|Overall Study|Death|0
2659495|NCT00661713|9183478|P2|Overall Study|Death|0
2659496|NCT00661713|9183479|P1|Overall Study|Death|1
2659497|NCT00661687|9183571|P1|Overall Study|Adverse Event|2
2659498|NCT00661687|9183571|P1|Overall Study|Physician Decision|1
2659499|NCT00661687|9183571|P1|Overall Study|Inability to maintain wearing schedule|3
2659500|NCT00661687|9183571|P1|Overall Study|Positive slit lamp findings|4
2659501|NCT00661687|9183571|P1|Overall Study|Study related symptoms and complaints|5
2659502|NCT00661661|9183599|P2|Overall Study|Not assigned treatment|0
2659503|NCT00661661|9183600|P1|Overall Study|Not assigned treatment|1
2659504|NCT00661661|9183599|P2|Overall Study|Other|7
2659505|NCT00661661|9183600|P1|Overall Study|Other|22
2659506|NCT00661661|9183599|P2|Overall Study|Withdrawal by Subject|5
2659507|NCT00661661|9183600|P1|Overall Study|Withdrawal by Subject|15
2659508|NCT00661661|9183599|P2|Overall Study|Lost to Follow-up|1
2659509|NCT00661661|9183600|P1|Overall Study|Lost to Follow-up|0
2659510|NCT00661661|9183599|P2|Overall Study|Lack of Efficacy|2
2659511|NCT00661661|9183600|P1|Overall Study|Lack of Efficacy|3
2659512|NCT00661661|9183599|P2|Overall Study|Adverse Event|24
2659513|NCT00661661|9183600|P1|Overall Study|Adverse Event|99
2659514|NCT00661622|9183676|P2|Overall Study|Protocol Violation|0
2659515|NCT00661622|9183677|P1|Overall Study|Protocol Violation|1
2659516|NCT00661609|9183691|P1|Overall Study|Disease progression|3
2659517|NCT00661609|9183691|P1|Overall Study|Survival follow up stage discontinued|11
2659518|NCT00661609|9183691|P1|Overall Study|PI Decision|1
2659519|NCT00661609|9183691|P1|Overall Study|Withdrawal by Subject|2
2659520|NCT00661609|9183691|P1|Overall Study|Death|20
2659521|NCT00661609|9183691|P1|Overall Study|Adverse Event|4
2659522|NCT00661531|9183758|P1|Overall Study|Withdrawal by Subject|3
2659523|NCT00661505|9183763|P1|Overall Study|Other|2
2659524|NCT00661505|9183763|P1|Overall Study|Lost to Follow-up|3
2659525|NCT00661505|9183763|P1|Overall Study|Withdrawal by Subject|8
2659526|NCT00661505|9183763|P1|Overall Study|Protocol Violation|14
2659527|NCT00661505|9183763|P1|Overall Study|Adverse Event|3
2659528|NCT00661492|9183791|P2|Overall Study|Other|0
2659529|NCT00661492|9183792|P1|Overall Study|Other|1
2659530|NCT00661492|9183791|P2|Overall Study|Lost to Follow-up|1
2659531|NCT00661492|9183792|P1|Overall Study|Lost to Follow-up|0
2659532|NCT00661492|9183791|P2|Overall Study|Investigator Request|0
2659533|NCT00661492|9183792|P1|Overall Study|Investigator Request|1
2659534|NCT00661492|9183791|P2|Overall Study|Patient Request|1
2659535|NCT00661492|9183792|P1|Overall Study|Patient Request|6
2659536|NCT00661492|9183791|P2|Overall Study|Disease Progression|14
2659537|NCT00661492|9183792|P1|Overall Study|Disease Progression|44
2659538|NCT00661492|9183791|P2|Overall Study|Adverse Event|13
2659539|NCT00661492|9183792|P1|Overall Study|Adverse Event|16
2659540|NCT00661427|9183838|P2|Overall Study|Patient not treated|2
2659541|NCT00661427|9183839|P1|Overall Study|Patient not treated|0
2659542|NCT00661427|9183838|P2|Overall Study|Adverse Event|5
2659543|NCT00661427|9183839|P1|Overall Study|Adverse Event|5
2659544|NCT00661388|9183847|P1|Overall Study|Administrative reasons|1
2659545|NCT00661388|9183847|P1|Overall Study|Dialysis initiation|1
2659546|NCT00661388|9183847|P1|Overall Study|Renal transplantation|1
2659547|NCT00661388|9183847|P1|Overall Study|Protocol Violation|7
2659548|NCT00661388|9183847|P1|Overall Study|Adverse Event|14
2659549|NCT00661362|9183870|P2|Overall Study|Metformin dose haven't decreasd to 2.5 g|0
2659550|NCT00661362|9183871|P1|Overall Study|Metformin dose haven't decreasd to 2.5 g|1
2659551|NCT00661362|9183870|P2|Overall Study|Safety reasons|0
2659552|NCT00661362|9183871|P1|Overall Study|Safety reasons|1
2659553|NCT00661362|9183870|P2|Overall Study|Severe non-compliance to protocol|1
2659554|NCT00661362|9183871|P1|Overall Study|Severe non-compliance to protocol|0
2659555|NCT00661362|9183870|P2|Overall Study|Lost to Follow-up|1
2659556|NCT00661362|9183871|P1|Overall Study|Lost to Follow-up|3
2659557|NCT00661362|9183870|P2|Overall Study|Withdrawal by Subject|23
2659558|NCT00661362|9183871|P1|Overall Study|Withdrawal by Subject|13
2659559|NCT00661362|9183870|P2|Overall Study|Study specific discontinuation criteria|11
2659560|NCT00661362|9183871|P1|Overall Study|Study specific discontinuation criteria|4
2659561|NCT00661362|9183870|P2|Overall Study|Incorrect enrollment|0
2659562|NCT00661362|9183871|P1|Overall Study|Incorrect enrollment|2
2659563|NCT00661362|9183870|P2|Overall Study|Adverse Event|4
2659564|NCT00661362|9183871|P1|Overall Study|Adverse Event|5
2659565|NCT00661271|9183889|P2|Overall Study|Lost to Follow-up|25
2659566|NCT00661271|9183890|P1|Overall Study|Lost to Follow-up|28
2659567|NCT00661258|9183900|P2|Overall Study|caught by police and in detox center|1
2659568|NCT00661258|9183901|P1|Overall Study|caught by police and in detox center|2
2659569|NCT00661258|9183900|P2|Overall Study|Death|0
2659570|NCT00661258|9183901|P1|Overall Study|Death|1
2659571|NCT00661193|9183911|P2|Overall Study|Not protocol specified|0
2659572|NCT00661193|9183912|P1|Overall Study|Not protocol specified|1
2659573|NCT00661193|9183911|P2|Overall Study|Progression|24
2659574|NCT00661193|9183912|P1|Overall Study|Progression|27
2659575|NCT00661193|9183911|P2|Overall Study|Withdrawal by Subject|1
2659576|NCT00661193|9183912|P1|Overall Study|Withdrawal by Subject|3
2659577|NCT00661193|9183911|P2|Overall Study|Adverse Event|1
2659578|NCT00661193|9183912|P1|Overall Study|Adverse Event|2
2659579|NCT00661089|9184137|P2|Overall Study|death at 8 weeks due to new stroke|1
2659580|NCT00661089|9184138|P1|Overall Study|death at 8 weeks due to new stroke|0
2659581|NCT00661089|9184137|P2|Overall Study|1 subject withdrawal|1
2659582|NCT00661089|9184138|P1|Overall Study|1 subject withdrawal|0
2659583|NCT00660907|9184186|P2|Overall Study|Various|8
2659584|NCT00660907|9184187|P1|Overall Study|Various|11
2659585|NCT00660907|9184186|P2|Overall Study|Death|3
2659586|NCT00660907|9184187|P1|Overall Study|Death|1
2659587|NCT00660907|9184186|P2|Overall Study|Safety|0
2659588|NCT00660907|9184187|P1|Overall Study|Safety|1
2659589|NCT00660907|9184186|P2|Overall Study|Poor/Non-Compliance|1
2659590|NCT00660907|9184187|P1|Overall Study|Poor/Non-Compliance|5
2659591|NCT00660907|9184186|P2|Overall Study|Lost to Follow-up|3
2659592|NCT00660907|9184187|P1|Overall Study|Lost to Follow-up|3
2659593|NCT00660907|9184186|P2|Overall Study|Withdrawal by Subject|32
2659594|NCT00660907|9184187|P1|Overall Study|Withdrawal by Subject|23
2659595|NCT00660907|9184186|P2|Overall Study|Subject No Longer Meets Study Criteria|27
2659596|NCT00660907|9184187|P1|Overall Study|Subject No Longer Meets Study Criteria|6
2659597|NCT00660907|9184186|P2|Overall Study|Adverse Event|19
2659598|NCT00660907|9184187|P1|Overall Study|Adverse Event|33
2659599|NCT00660907|9184186|P2|Overall Study|Incorrect Enrollment|1
2659600|NCT00660907|9184187|P1|Overall Study|Incorrect Enrollment|1
2659601|NCT00660829|9184201|P2|Overall Study|Other|4
2659602|NCT00660829|9184202|P1|Overall Study|Other|9
2659603|NCT00660829|9184201|P2|Overall Study|Lost to Follow-up|2
2659604|NCT00660829|9184202|P1|Overall Study|Lost to Follow-up|3
2659605|NCT00660829|9184201|P2|Overall Study|Withdrawal by Subject|2
2659606|NCT00660829|9184202|P1|Overall Study|Withdrawal by Subject|1
2659607|NCT00660829|9184201|P2|Overall Study|Non-Compliance|4
2659608|NCT00660829|9184202|P1|Overall Study|Non-Compliance|0
2659609|NCT00660829|9184201|P2|Overall Study|Lack of Efficacy|3
2659610|NCT00660829|9184202|P1|Overall Study|Lack of Efficacy|2
2659611|NCT00660829|9184201|P2|Overall Study|Adverse Event|4
2659612|NCT00660829|9184202|P1|Overall Study|Adverse Event|3
2659613|NCT00660816|9184220|P2|Overall Study|Complicating Disease|1
2659614|NCT00660816|9184221|P1|Overall Study|Complicating Disease|0
2659615|NCT00660816|9184220|P2|Overall Study|Disease Progression|12
2659616|NCT00660816|9184221|P1|Overall Study|Disease Progression|16
2659617|NCT00660816|9184220|P2|Overall Study|Protocol Violation|0
2659618|NCT00660816|9184221|P1|Overall Study|Protocol Violation|1
2659619|NCT00660816|9184220|P2|Overall Study|Physician Decision|2
2659620|NCT00660816|9184221|P1|Overall Study|Physician Decision|0
2659621|NCT00660816|9184220|P2|Overall Study|Lack of Efficacy|0
2659622|NCT00660816|9184221|P1|Overall Study|Lack of Efficacy|1
2659623|NCT00660816|9184220|P2|Overall Study|Death|2
2659624|NCT00660816|9184221|P1|Overall Study|Death|0
2659625|NCT00660816|9184220|P2|Overall Study|Withdrawal by Subject|0
2659626|NCT00660816|9184221|P1|Overall Study|Withdrawal by Subject|1
2659627|NCT00660816|9184220|P2|Overall Study|Adverse Event|2
2659628|NCT00660816|9184221|P1|Overall Study|Adverse Event|1
2659629|NCT00660790|9184233|P1|3 Months to 2 Years|Withdrawal by Subject|17
2659630|NCT00660790|9184233|P1|Baseline to 3 Months|Withdrawal by Subject|2
2659631|NCT00660790|9184233|P1|Baseline to 3 Months|Death|1
2659632|NCT00660699|9184237|P1|Overall Study|Withdrawal by Subject|2
2659633|NCT00660660|9184253|P2|Overall Study|New medication after randomization|0
2659634|NCT00660660|9184254|P1|Overall Study|New medication after randomization|1
2659635|NCT00660660|9184253|P2|Overall Study|Incorrect enrollment and other|1
2659636|NCT00660660|9184254|P1|Overall Study|Incorrect enrollment and other|0
2659637|NCT00660660|9184253|P2|Overall Study|Withdrawal by Subject|0
2659638|NCT00660660|9184254|P1|Overall Study|Withdrawal by Subject|3
2659639|NCT00660660|9184253|P2|Overall Study|Lack of Efficacy|2
2659640|NCT00660660|9184254|P1|Overall Study|Lack of Efficacy|0
2659641|NCT00660660|9184253|P2|Overall Study|Lost to Follow-up|6
2659642|NCT00660660|9184254|P1|Overall Study|Lost to Follow-up|0
2659643|NCT00660660|9184253|P2|Overall Study|Adverse Event|0
2659644|NCT00660660|9184254|P1|Overall Study|Adverse Event|1
2659645|NCT00660595|9184354|P2|Overall Study|Non Specified reasons|0
2659646|NCT00660595|9184355|P1|Overall Study|Non Specified reasons|5
2659647|NCT00660595|9184354|P2|Overall Study|Participant left hospital|0
2659648|NCT00660595|9184355|P1|Overall Study|Participant left hospital|1
2659649|NCT00660595|9184354|P2|Overall Study|Did not consent to participate in study|8
2659650|NCT00660595|9184355|P1|Overall Study|Did not consent to participate in study|12
2659651|NCT00660595|9184354|P2|Overall Study|Lost to Follow-up|1
2659652|NCT00660595|9184355|P1|Overall Study|Lost to Follow-up|0
2659653|NCT00660400|9184416|P1|Overall Study|Withdrawal by Subject|1
2659654|NCT00660400|9184416|P1|Overall Study|Intracranial hemorrhage|1
2659655|NCT00660400|9184416|P1|Overall Study|Suboptimal organ function|1
2659656|NCT00660400|9184416|P1|Overall Study|Lack of insurance approval|1
2659657|NCT00660387|9184425|P2|Overall Study|Protocol Violation|0
2659658|NCT00660387|9184426|P1|Overall Study|Protocol Violation|1
2659659|NCT00660387|9184425|P2|Overall Study|Lack of Efficacy|1
2659660|NCT00660387|9184426|P1|Overall Study|Lack of Efficacy|0
2659661|NCT00660387|9184425|P2|Overall Study|Adverse Event|2
2659662|NCT00660387|9184426|P1|Overall Study|Adverse Event|1
2659663|NCT00660348|9184480|P2|Overall Study|Withdrawal by Subject|0
2659664|NCT00660348|9184481|P1|Overall Study|Withdrawal by Subject|1
2659665|NCT00660309|9184489|P2|Overall Study|Withdrawal by Subject|3
2659666|NCT00660309|9184490|P1|Overall Study|Withdrawal by Subject|0
2659667|NCT00660309|9184489|P2|Overall Study|Adverse Event|0
2659668|NCT00660309|9184490|P1|Overall Study|Adverse Event|2
2659669|NCT00660192|9184531|P2|Overall Study|Lost to Follow-up|3
2659670|NCT00660192|9184532|P1|Overall Study|Lost to Follow-up|2
2659671|NCT00660179|9184543|P3|Overall Study|Incorrect randomization|0
2659672|NCT00660179|9184544|P2|Overall Study|Incorrect randomization|0
2659673|NCT00660179|9184545|P1|Overall Study|Incorrect randomization|1
2659674|NCT00660179|9184543|P3|Overall Study|Administrative reason|1
2659675|NCT00660179|9184544|P2|Overall Study|Administrative reason|0
2659676|NCT00660179|9184545|P1|Overall Study|Administrative reason|0
2659677|NCT00660179|9184543|P3|Overall Study|Lost to Follow-up|2
2659678|NCT00660179|9184544|P2|Overall Study|Lost to Follow-up|5
2659679|NCT00660179|9184545|P1|Overall Study|Lost to Follow-up|7
2659680|NCT00660179|9184543|P3|Overall Study|Withdrawal of consent|4
2659681|NCT00660179|9184544|P2|Overall Study|Withdrawal of consent|6
2659682|NCT00660179|9184545|P1|Overall Study|Withdrawal of consent|4
2659683|NCT00660179|9184543|P3|Overall Study|Death|34
2659684|NCT00660179|9184544|P2|Overall Study|Death|47
2659685|NCT00660179|9184545|P1|Overall Study|Death|44
2659686|NCT00660023|9184590|P1|Overall Study|Other Screening Failure|9
2659687|NCT00660023|9184590|P1|Overall Study|Missed Pregnancy Test|1
2659688|NCT00660023|9184590|P1|Overall Study|Withdrawal by Subject|1
2659689|NCT00660023|9184590|P1|Overall Study|Renal Transplantation|3
2659690|NCT00660023|9184590|P1|Overall Study|Blood Transfusion|5
2659691|NCT00660023|9184590|P1|Overall Study|Death|8
2659692|NCT00660023|9184590|P1|Overall Study|Adverse Event|2
2659693|NCT00660010|9184601|P1|Overall Study|Noncompliance with visit schedule|3
2659694|NCT00660010|9184601|P1|Overall Study|Adverse Event|1
2659695|NCT00660010|9184601|P1|Overall Study|Lost to Follow-up|3
2659696|NCT00660010|9184601|P1|Overall Study|Withdrawal by Subject|2
2659697|NCT00659984|9184615|P1|Overall Study|Adverse Event|1
2659698|NCT00659880|9184635|P1|Overall Study|Lost to Follow-up|5
2659699|NCT00659815|9184648|P2|Overall Study|Withdrawal by Subject|1
2659700|NCT00659815|9184649|P1|Overall Study|Withdrawal by Subject|1
2659701|NCT00659815|9184648|P2|Overall Study|Inability to maintain wearing schedule|2
2659702|NCT00659815|9184649|P1|Overall Study|Inability to maintain wearing schedule|1
2659703|NCT00659815|9184648|P2|Overall Study|Study related symptoms and complaints|1
2659704|NCT00659815|9184649|P1|Overall Study|Study related symptoms and complaints|2
2659705|NCT00659607|9184709|P1|Overall Study|Inconsistent BP measuring date|2
2659706|NCT00659607|9184709|P1|Overall Study|No recorded efficacy data|15
2659707|NCT00659607|9184709|P1|Overall Study|‘Unable to evaluate’ for the final asses|67
2659708|NCT00659607|9184709|P1|Overall Study|Unknown measuring date of blood pressure|85
2659709|NCT00659607|9184709|P1|Overall Study|No blood pressure recorded|147
2659710|NCT00659581|9184727|P1|Overall Study|Other|6393
2659711|NCT00659581|9184727|P1|Overall Study|Lack of Efficacy|1183
2659712|NCT00659581|9184727|P1|Overall Study|Adverse Event|1006
2659713|NCT00659529|9184739|P1|Overall Study|Screen failure|9
2659714|NCT00659529|9184739|P1|Overall Study|Protocol Violation|3
2659715|NCT00659529|9184739|P1|Overall Study|Withdrawal by Subject|4
2659716|NCT00659490|9184746|P3|Overall Study|Lost to Follow-up|1
2659717|NCT00659490|9184747|P2|Overall Study|Lost to Follow-up|0
2659718|NCT00659490|9184748|P1|Overall Study|Lost to Follow-up|2
2659719|NCT00659438|9184821|P2|Overall Study|Lost to Follow-up|0
2659720|NCT00659438|9184822|P1|Overall Study|Lost to Follow-up|1
2659721|NCT00659438|9184821|P2|Overall Study|Death|6
2659722|NCT00659438|9184822|P1|Overall Study|Death|11
2659723|NCT00659438|9184821|P2|Overall Study|Withdrawal by Subject|2
2659724|NCT00659438|9184822|P1|Overall Study|Withdrawal by Subject|2
2659725|NCT00659425|9184854|P10|Overall Study|Other|6
2659726|NCT00659425|9184855|P9|Overall Study|Other|0
2659727|NCT00659425|9184856|P8|Overall Study|Other|2
2659728|NCT00659425|9184857|P7|Overall Study|Other|3
2659729|NCT00659425|9184858|P6|Overall Study|Other|0
2659730|NCT00659425|9184859|P5|Overall Study|Other|4
2659731|NCT00659425|9184860|P4|Overall Study|Other|2
2659732|NCT00659425|9184861|P3|Overall Study|Other|1
2659733|NCT00659425|9184862|P2|Overall Study|Other|1
2659734|NCT00659425|9184863|P1|Overall Study|Other|0
2659735|NCT00659425|9184854|P10|Overall Study|Investigator Discretion|0
2659736|NCT00659425|9184855|P9|Overall Study|Investigator Discretion|0
2659737|NCT00659425|9184856|P8|Overall Study|Investigator Discretion|3
2659738|NCT00659425|9184857|P7|Overall Study|Investigator Discretion|0
2659739|NCT00659425|9184858|P6|Overall Study|Investigator Discretion|1
2659740|NCT00659425|9184859|P5|Overall Study|Investigator Discretion|0
2659741|NCT00659425|9184860|P4|Overall Study|Investigator Discretion|0
2659742|NCT00659425|9184861|P3|Overall Study|Investigator Discretion|0
2659743|NCT00659425|9184862|P2|Overall Study|Investigator Discretion|0
2659744|NCT00659425|9184863|P1|Overall Study|Investigator Discretion|0
2659745|NCT00659425|9184854|P10|Overall Study|Adverse Event|4
2659746|NCT00659425|9184855|P9|Overall Study|Adverse Event|1
2659747|NCT00659425|9184856|P8|Overall Study|Adverse Event|3
2659748|NCT00659425|9184857|P7|Overall Study|Adverse Event|0
2659749|NCT00659425|9184858|P6|Overall Study|Adverse Event|1
2659750|NCT00659425|9184859|P5|Overall Study|Adverse Event|0
2659751|NCT00659425|9184860|P4|Overall Study|Adverse Event|0
2659752|NCT00659425|9184861|P3|Overall Study|Adverse Event|0
2659753|NCT00659425|9184862|P2|Overall Study|Adverse Event|0
2659754|NCT00659425|9184863|P1|Overall Study|Adverse Event|0
2659755|NCT00659425|9184854|P10|Overall Study|Death|0
2659756|NCT00659425|9184855|P9|Overall Study|Death|0
2659757|NCT00659425|9184856|P8|Overall Study|Death|0
2659758|NCT00659425|9184857|P7|Overall Study|Death|1
2659759|NCT00659425|9184858|P6|Overall Study|Death|0
2659760|NCT00659425|9184859|P5|Overall Study|Death|0
2659761|NCT00659425|9184860|P4|Overall Study|Death|1
2659762|NCT00659425|9184861|P3|Overall Study|Death|0
2659763|NCT00659425|9184862|P2|Overall Study|Death|0
2659764|NCT00659425|9184863|P1|Overall Study|Death|0
2659765|NCT00659425|9184854|P10|Overall Study|Disease progression|3
2659766|NCT00659425|9184855|P9|Overall Study|Disease progression|5
2659767|NCT00659425|9184856|P8|Overall Study|Disease progression|3
2659768|NCT00659425|9184857|P7|Overall Study|Disease progression|4
2659769|NCT00659425|9184858|P6|Overall Study|Disease progression|2
2659770|NCT00659425|9184859|P5|Overall Study|Disease progression|0
2659771|NCT00659425|9184860|P4|Overall Study|Disease progression|1
2659772|NCT00659425|9184861|P3|Overall Study|Disease progression|0
2659773|NCT00659425|9184862|P2|Overall Study|Disease progression|0
2659774|NCT00659425|9184863|P1|Overall Study|Disease progression|1
2659775|NCT00659373|9185094|P2|Overall Study|Assessment Missed|2
2659776|NCT00659373|9185095|P1|Overall Study|Assessment Missed|2
2659777|NCT00659373|9185094|P2|Overall Study|Withdrawal by Subject|5
2659778|NCT00659373|9185095|P1|Overall Study|Withdrawal by Subject|3
2659779|NCT00659334|9185117|P7|Overall Study|Screen Failure|1
2659780|NCT00659334|9185118|P6|Overall Study|Screen Failure|0
2659781|NCT00659334|9185119|P5|Overall Study|Screen Failure|0
2659782|NCT00659334|9185120|P4|Overall Study|Screen Failure|0
2659783|NCT00659334|9185121|P3|Overall Study|Screen Failure|0
2659784|NCT00659334|9185122|P2|Overall Study|Screen Failure|5
2659785|NCT00659334|9185123|P1|Overall Study|Screen Failure|8
2659786|NCT00659269|9185150|P2|Overall Study|Physician Decision|1
2659787|NCT00659269|9185151|P1|Overall Study|Physician Decision|1
2659788|NCT00659230|9185181|P2|Overall Study|Did not return post-randomization|3
2659789|NCT00659230|9185182|P1|Overall Study|Did not return post-randomization|2
2659790|NCT00659230|9185181|P2|Overall Study|Lost source documentation|4
2659791|NCT00659230|9185182|P1|Overall Study|Lost source documentation|5
2659792|NCT00659230|9185181|P2|Overall Study|Lost to Follow-up|5
2659793|NCT00659230|9185182|P1|Overall Study|Lost to Follow-up|2
2659794|NCT00659061|9185205|P2|Overall Study|Migration due to political unrest|15
2659795|NCT00659061|9185206|P1|Overall Study|Migration due to political unrest|21
2659796|NCT00658996|9185224|P2|Second Intervention|Positive slit lamp finding|1
2659797|NCT00658996|9185225|P1|Second Intervention|Positive slit lamp finding|0
2659798|NCT00658996|9185224|P2|Second Intervention|Developed a stye on upper lid|0
2659799|NCT00658996|9185225|P1|Second Intervention|Developed a stye on upper lid|1
2659800|NCT00658996|9185224|P2|Crossover Period|Ineligible|1
2659801|NCT00658996|9185225|P1|Crossover Period|Ineligible|1
2659802|NCT00658996|9185224|P2|Crossover Period|Physician Decision|0
2659803|NCT00658996|9185225|P1|Crossover Period|Physician Decision|1
2659804|NCT00658996|9185224|P2|First Intervention|Lack of lenses|1
2659805|NCT00658996|9185225|P1|First Intervention|Lack of lenses|0
2659806|NCT00658996|9185224|P2|First Intervention|Positive slit lamp finding|0
2659807|NCT00658996|9185225|P1|First Intervention|Positive slit lamp finding|1
2659808|NCT00658879|9185235|P1|Overall Study|Protocol Violation|1
2659809|NCT00658814|9185252|P2|Maintenance Therapy|Not eligible|0
2659810|NCT00658814|9185253|P1|Maintenance Therapy|Not eligible|1
2659811|NCT00658814|9185252|P2|Maintenance Therapy|Not protocol specified|0
2659812|NCT00658814|9185253|P1|Maintenance Therapy|Not protocol specified|1
2659813|NCT00658814|9185252|P2|Maintenance Therapy|Adverse Event|1
2659814|NCT00658814|9185253|P1|Maintenance Therapy|Adverse Event|1
2659815|NCT00658814|9185252|P2|Consolidation Therapy|Not eligible|2
2659816|NCT00658814|9185253|P1|Consolidation Therapy|Not eligible|2
2659817|NCT00658814|9185252|P2|Consolidation Therapy|Not protocol specified|1
2659818|NCT00658814|9185253|P1|Consolidation Therapy|Not protocol specified|0
2659819|NCT00658814|9185252|P2|Remission Induction Chemotherapy|Not eligible|2
2659820|NCT00658814|9185253|P1|Remission Induction Chemotherapy|Not eligible|1
2659821|NCT00658814|9185252|P2|Remission Induction Chemotherapy|Not protocol specified|4
2659822|NCT00658814|9185253|P1|Remission Induction Chemotherapy|Not protocol specified|2
2659823|NCT00658814|9185252|P2|Remission Induction Chemotherapy|Death|4
2659824|NCT00658814|9185253|P1|Remission Induction Chemotherapy|Death|1
2659825|NCT00658814|9185252|P2|Remission Induction Chemotherapy|Progression/Relapse|1
2659826|NCT00658814|9185253|P1|Remission Induction Chemotherapy|Progression/Relapse|0
2659827|NCT00658814|9185252|P2|Remission Induction Chemotherapy|Withdrawal by Subject|4
2659828|NCT00658814|9185253|P1|Remission Induction Chemotherapy|Withdrawal by Subject|3
2659829|NCT00658814|9185252|P2|Remission Induction Chemotherapy|Adverse Event|3
2659830|NCT00658814|9185253|P1|Remission Induction Chemotherapy|Adverse Event|1
2659831|NCT00658788|9185267|P1|Overall Study|Treatment Discontinuation|32
2659832|NCT00658788|9185267|P1|Overall Study|Lost to Follow-up|18
2659833|NCT00658788|9185267|P1|Overall Study|Withdrawal by Subject|13
2659834|NCT00658788|9185267|P1|Overall Study|Adverse Event|11
2659835|NCT00658775|9185322|P2|Overall Study|Other|8
2659836|NCT00658775|9185323|P1|Overall Study|Other|7
2659837|NCT00658775|9185322|P2|Overall Study|Withdrawal of consent|7
2659838|NCT00658775|9185323|P1|Overall Study|Withdrawal of consent|8
2659839|NCT00658775|9185322|P2|Overall Study|Withdrawal by Subject|4
2659840|NCT00658775|9185323|P1|Overall Study|Withdrawal by Subject|6
2659841|NCT00658775|9185322|P2|Overall Study|Lost to Follow-up|18
2659842|NCT00658775|9185323|P1|Overall Study|Lost to Follow-up|17
2659843|NCT00658775|9185322|P2|Overall Study|Adverse Event|6
2659844|NCT00658775|9185323|P1|Overall Study|Adverse Event|4
2659845|NCT00658723|9185346|P3|Overall Study|Withdrawal by Subject|1
2659846|NCT00658723|9185347|P2|Overall Study|Withdrawal by Subject|0
2659847|NCT00658723|9185348|P1|Overall Study|Withdrawal by Subject|1
2659848|NCT00658723|9185346|P3|Overall Study|Scheduling Issue|0
2659849|NCT00658723|9185347|P2|Overall Study|Scheduling Issue|1
2659850|NCT00658723|9185348|P1|Overall Study|Scheduling Issue|1
2659851|NCT00658723|9185346|P3|Overall Study|Death|4
2659852|NCT00658723|9185347|P2|Overall Study|Death|1
2659853|NCT00658723|9185348|P1|Overall Study|Death|2
2659854|NCT00658723|9185346|P3|Overall Study|Lost to Follow-up|2
2659855|NCT00658723|9185347|P2|Overall Study|Lost to Follow-up|2
2659856|NCT00658723|9185348|P1|Overall Study|Lost to Follow-up|0
2659857|NCT00658684|9185386|P4|Overall Study|Pregnancy|0
2659858|NCT00658684|9185387|P3|Overall Study|Pregnancy|0
2659859|NCT00658684|9185388|P2|Overall Study|Pregnancy|1
2659860|NCT00658684|9185389|P1|Overall Study|Pregnancy|1
2659861|NCT00658684|9185386|P4|Overall Study|Protocol Violation|0
2659862|NCT00658684|9185387|P3|Overall Study|Protocol Violation|0
2659863|NCT00658684|9185388|P2|Overall Study|Protocol Violation|1
2659864|NCT00658684|9185389|P1|Overall Study|Protocol Violation|1
2659865|NCT00658684|9185386|P4|Overall Study|Lack of Efficacy|0
2659866|NCT00658684|9185387|P3|Overall Study|Lack of Efficacy|0
2659867|NCT00658684|9185388|P2|Overall Study|Lack of Efficacy|1
2659868|NCT00658684|9185389|P1|Overall Study|Lack of Efficacy|1
2659869|NCT00658684|9185386|P4|Overall Study|Withdrawal by Subject|1
2659870|NCT00658684|9185387|P3|Overall Study|Withdrawal by Subject|1
2659871|NCT00658684|9185388|P2|Overall Study|Withdrawal by Subject|4
2659872|NCT00658684|9185389|P1|Overall Study|Withdrawal by Subject|6
2659873|NCT00658684|9185386|P4|Overall Study|Adverse Event|0
2659874|NCT00658684|9185387|P3|Overall Study|Adverse Event|2
2659875|NCT00658684|9185388|P2|Overall Study|Adverse Event|8
2659876|NCT00658684|9185389|P1|Overall Study|Adverse Event|10
2659877|NCT00658658|9185444|P5|Overall Study|Other|1
2659878|NCT00658658|9185445|P4|Overall Study|Other|0
2659879|NCT00658658|9185446|P3|Overall Study|Other|0
2659880|NCT00658658|9185447|P2|Overall Study|Other|0
2659881|NCT00658658|9185448|P1|Overall Study|Other|0
2659882|NCT00658658|9185444|P5|Overall Study|Protocol-specified Criteria|0
2659883|NCT00658658|9185445|P4|Overall Study|Protocol-specified Criteria|0
2659884|NCT00658658|9185446|P3|Overall Study|Protocol-specified Criteria|0
2659885|NCT00658658|9185447|P2|Overall Study|Protocol-specified Criteria|0
2659886|NCT00658658|9185448|P1|Overall Study|Protocol-specified Criteria|1
2659887|NCT00658658|9185444|P5|Overall Study|Disease Progression|3
2659888|NCT00658658|9185445|P4|Overall Study|Disease Progression|1
2659889|NCT00658658|9185446|P3|Overall Study|Disease Progression|0
2659890|NCT00658658|9185447|P2|Overall Study|Disease Progression|1
2659891|NCT00658658|9185448|P1|Overall Study|Disease Progression|0
2659892|NCT00658658|9185444|P5|Overall Study|Death|1
2659893|NCT00658658|9185445|P4|Overall Study|Death|1
2659894|NCT00658658|9185446|P3|Overall Study|Death|0
2659895|NCT00658658|9185447|P2|Overall Study|Death|0
2659896|NCT00658658|9185448|P1|Overall Study|Death|4
2659897|NCT00658658|9185444|P5|Overall Study|Withdrawal by Subject|0
2659898|NCT00658658|9185445|P4|Overall Study|Withdrawal by Subject|0
2659899|NCT00658658|9185446|P3|Overall Study|Withdrawal by Subject|0
2659900|NCT00658658|9185447|P2|Overall Study|Withdrawal by Subject|1
2659901|NCT00658658|9185448|P1|Overall Study|Withdrawal by Subject|0
2659902|NCT00658632|9185507|P2|Overall Study|Other|8
2659903|NCT00658632|9185508|P1|Overall Study|Other|7
2659904|NCT00658632|9185507|P2|Overall Study|Pregnancy|1
2659905|NCT00658632|9185508|P1|Overall Study|Pregnancy|1
2659906|NCT00658632|9185507|P2|Overall Study|Withdrawal of consent|14
2659907|NCT00658632|9185508|P1|Overall Study|Withdrawal of consent|8
2659908|NCT00658632|9185507|P2|Overall Study|Lack of Efficacy|1
2659909|NCT00658632|9185508|P1|Overall Study|Lack of Efficacy|0
2659910|NCT00658632|9185507|P2|Overall Study|Withdrawal by Subject|7
2659911|NCT00658632|9185508|P1|Overall Study|Withdrawal by Subject|10
2659912|NCT00658632|9185507|P2|Overall Study|Lost to Follow-up|23
2659913|NCT00658632|9185508|P1|Overall Study|Lost to Follow-up|25
2659914|NCT00658632|9185507|P2|Overall Study|Adverse Event|11
2659915|NCT00658632|9185508|P1|Overall Study|Adverse Event|13
2659916|NCT00658606|9185549|P2|Overall Study|Lack of Compliance|3
2659917|NCT00658606|9185550|P1|Overall Study|Lack of Compliance|0
2659918|NCT00658606|9185549|P2|Overall Study|Withdrawal by Subject|16
2659919|NCT00658606|9185550|P1|Overall Study|Withdrawal by Subject|7
2659920|NCT00658606|9185549|P2|Overall Study|Lost to Follow-up|0
2659921|NCT00658606|9185550|P1|Overall Study|Lost to Follow-up|1
2659922|NCT00658606|9185549|P2|Overall Study|Lack of Efficacy|3
2659923|NCT00658606|9185550|P1|Overall Study|Lack of Efficacy|6
2659924|NCT00658606|9185549|P2|Overall Study|Adverse Event|1
2659925|NCT00658606|9185550|P1|Overall Study|Adverse Event|2
2659926|NCT00658567|9185579|P3|Overall Study|At Discretion of Sponsor|1
2659927|NCT00658567|9185580|P2|Overall Study|At Discretion of Sponsor|1
2659928|NCT00658567|9185581|P1|Overall Study|At Discretion of Sponsor|1
2659929|NCT00658567|9185579|P3|Overall Study|Physician Decision|0
2659930|NCT00658567|9185580|P2|Overall Study|Physician Decision|1
2659931|NCT00658567|9185581|P1|Overall Study|Physician Decision|0
2659932|NCT00658567|9185579|P3|Overall Study|Voluntary Withdrawal of Consent|2
2659933|NCT00658567|9185580|P2|Overall Study|Voluntary Withdrawal of Consent|0
2659934|NCT00658567|9185581|P1|Overall Study|Voluntary Withdrawal of Consent|2
2659935|NCT00658567|9185579|P3|Overall Study|Adverse Event|3
2659936|NCT00658567|9185580|P2|Overall Study|Adverse Event|2
2659937|NCT00658567|9185581|P1|Overall Study|Adverse Event|5
2659938|NCT00658541|9185592|P2|Washout Period of 7 Days|Withdrawal by Subject|1
2659939|NCT00658541|9185593|P1|Washout Period of 7 Days|Withdrawal by Subject|0
2659940|NCT00658541|9185592|P2|Washout Period of 7 Days|Withdrawal by Subject|1
2659941|NCT00658541|9185593|P1|Washout Period of 7 Days|Withdrawal by Subject|1
2659942|NCT00658528|9185605|P2|Overall Study|Other|4
2659943|NCT00658528|9185606|P1|Overall Study|Other|8
2659944|NCT00658528|9185605|P2|Overall Study|Withdrawal of consent|6
2659945|NCT00658528|9185606|P1|Overall Study|Withdrawal of consent|5
2659946|NCT00658528|9185605|P2|Overall Study|Withdrawal by Subject|6
2659947|NCT00658528|9185606|P1|Overall Study|Withdrawal by Subject|8
2659948|NCT00658528|9185605|P2|Overall Study|Lost to Follow-up|22
2659949|NCT00658528|9185606|P1|Overall Study|Lost to Follow-up|14
2659950|NCT00658528|9185605|P2|Overall Study|Adverse Event|7
2659951|NCT00658528|9185606|P1|Overall Study|Adverse Event|5
2659952|NCT00658359|9185646|P3|Overall Study|Lack of Efficacy|0
2659953|NCT00658359|9185647|P2|Overall Study|Lack of Efficacy|1
2659954|NCT00658359|9185648|P1|Overall Study|Lack of Efficacy|0
2659955|NCT00658359|9185646|P3|Overall Study|Lost to Follow-up|4
2659956|NCT00658359|9185647|P2|Overall Study|Lost to Follow-up|2
2659957|NCT00658359|9185648|P1|Overall Study|Lost to Follow-up|2
2659958|NCT00658359|9185646|P3|Overall Study|Withdrawal by Subject|2
2659959|NCT00658359|9185647|P2|Overall Study|Withdrawal by Subject|4
2659960|NCT00658359|9185648|P1|Overall Study|Withdrawal by Subject|7
2659961|NCT00658359|9185646|P3|Overall Study|Includes protocol Amendments 3 and 4|29
2659962|NCT00658359|9185647|P2|Overall Study|Includes protocol Amendments 3 and 4|31
2659963|NCT00658359|9185648|P1|Overall Study|Includes protocol Amendments 3 and 4|2
2659964|NCT00658359|9185646|P3|Overall Study|Protocol Violation|0
2659965|NCT00658359|9185647|P2|Overall Study|Protocol Violation|0
2659966|NCT00658359|9185648|P1|Overall Study|Protocol Violation|1
2659967|NCT00658359|9185646|P3|Overall Study|Adverse Event|9
2659968|NCT00658359|9185647|P2|Overall Study|Adverse Event|6
2659969|NCT00658359|9185648|P1|Overall Study|Adverse Event|13
2659970|NCT00658359|9185646|P3|Overall Study|Death|2
2659971|NCT00658359|9185647|P2|Overall Study|Death|1
2659972|NCT00658359|9185648|P1|Overall Study|Death|3
2659973|NCT00658333|9185736|P2|Overall Study|Adverse Event|1
2659974|NCT00658333|9185737|P1|Overall Study|Adverse Event|2
2659975|NCT00658320|9185747|P2|Extension Study: After Month 24|Subject withdrew consent|0
2659976|NCT00658320|9185748|P1|Extension Study: After Month 24|Subject withdrew consent|2
2659977|NCT00658320|9185747|P2|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7
2659978|NCT00658320|9185748|P1|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3
2659979|NCT00658320|9185747|P2|Extension Study: Month 12 to Month 24|Subject withdrew consent|0
2659980|NCT00658320|9185748|P1|Extension Study: Month 12 to Month 24|Subject withdrew consent|3
2659981|NCT00658320|9185747|P2|Core Study: 12 Months|Subject withdrew consent|3
2659982|NCT00658320|9185748|P1|Core Study: 12 Months|Subject withdrew consent|5
2659983|NCT00657709|9185791|P5|Overall Study|Protocol Violation|2
2659984|NCT00657709|9185792|P4|Overall Study|Protocol Violation|1
2659985|NCT00657709|9185793|P3|Overall Study|Protocol Violation|0
2659986|NCT00657709|9185794|P2|Overall Study|Protocol Violation|2
2659987|NCT00657709|9185795|P1|Overall Study|Protocol Violation|0
2659988|NCT00657709|9185791|P5|Overall Study|Lost to Follow-up|21
2659989|NCT00657709|9185792|P4|Overall Study|Lost to Follow-up|1
2659990|NCT00657709|9185793|P3|Overall Study|Lost to Follow-up|7
2659991|NCT00657709|9185794|P2|Overall Study|Lost to Follow-up|9
2659992|NCT00657709|9185795|P1|Overall Study|Lost to Follow-up|9
2659993|NCT00657709|9185791|P5|Overall Study|Withdrawal by Subject|9
2659994|NCT00657709|9185792|P4|Overall Study|Withdrawal by Subject|5
2659995|NCT00657709|9185793|P3|Overall Study|Withdrawal by Subject|15
2659996|NCT00657709|9185794|P2|Overall Study|Withdrawal by Subject|15
2659997|NCT00657709|9185795|P1|Overall Study|Withdrawal by Subject|7
2659998|NCT00657709|9185791|P5|Overall Study|AE or Death|1
2659999|NCT00657709|9185792|P4|Overall Study|AE or Death|7
2660000|NCT00657709|9185793|P3|Overall Study|AE or Death|6
2660001|NCT00657709|9185794|P2|Overall Study|AE or Death|7
2660002|NCT00657709|9185795|P1|Overall Study|AE or Death|7
2660003|NCT00657618|9185844|P1|Overall Study|didn't start due to schedule conflicts|1
2660004|NCT00657618|9185844|P1|Overall Study|negative for leishmaniasis|2
2660005|NCT00657618|9185844|P1|Overall Study|Withdrawal by Subject|8
2660006|NCT00657618|9185844|P1|Overall Study|Adverse Event|32
2660007|NCT00657553|9185856|P2|Overall Study|low accrual, no analysis run|5
2660008|NCT00657553|9185857|P1|Overall Study|low accrual, no analysis run|5
2660009|NCT00657540|9185865|P2|Overall Study|Lost to Follow-up|4
2660010|NCT00657540|9185866|P1|Overall Study|Lost to Follow-up|1
2660011|NCT00657371|9185880|P1|Overall Study|Pre-existing medical condition|4
2660012|NCT00657371|9185880|P1|Overall Study|Device- related reasons|13
2660013|NCT00657371|9185880|P1|Overall Study|Protocol Violation|2
2660014|NCT00657371|9185880|P1|Overall Study|Unable to intubate the cecum|5
2660015|NCT00657371|9185880|P1|Overall Study|Poor bowel preparation|15
2660016|NCT00657358|9185885|P1|Overall Study|Lack of Efficacy|6
2660017|NCT00657267|9185897|P1|Overall Study|Adverse Event|9
2660018|NCT00657267|9185897|P1|Overall Study|Progressive disease|45
2660019|NCT00657150|9185907|P2|Treatment|Other|15
2660020|NCT00657150|9185908|P1|Treatment|Other|13
2660021|NCT00657150|9185907|P2|Treatment|Withdrawal by Subject|20
2660022|NCT00657150|9185908|P1|Treatment|Withdrawal by Subject|23
2660023|NCT00657150|9185907|P2|Treatment|Lost to Follow-up|0
2660024|NCT00657150|9185908|P1|Treatment|Lost to Follow-up|1
2660025|NCT00657150|9185907|P2|Treatment|Non-compliant with protocol|9
2660026|NCT00657150|9185908|P1|Treatment|Non-compliant with protocol|10
2660027|NCT00657150|9185907|P2|Treatment|Adverse Event|53
2660028|NCT00657150|9185908|P1|Treatment|Adverse Event|60
2660029|NCT00657150|9185907|P2|Overall Study|Other|38
2660030|NCT00657150|9185908|P1|Overall Study|Other|38
2660031|NCT00657150|9185907|P2|Overall Study|Withdrawal by Subject|36
2660032|NCT00657150|9185908|P1|Overall Study|Withdrawal by Subject|51
2660033|NCT00657150|9185907|P2|Overall Study|Lost to Follow-up|0
2660034|NCT00657150|9185908|P1|Overall Study|Lost to Follow-up|2
2660035|NCT00657150|9185907|P2|Overall Study|Non-compliant with protocol|9
2660036|NCT00657150|9185908|P1|Overall Study|Non-compliant with protocol|5
2660037|NCT00657150|9185907|P2|Overall Study|Adverse Event|10
2660038|NCT00657150|9185908|P1|Overall Study|Adverse Event|19
2660039|NCT00657046|9185939|P3|Overall Study|Surgery|1
2660040|NCT00657046|9185940|P2|Overall Study|Surgery|0
2660041|NCT00657046|9185941|P1|Overall Study|Surgery|0
2660042|NCT00657046|9185939|P3|Overall Study|Death|1
2660043|NCT00657046|9185940|P2|Overall Study|Death|0
2660044|NCT00657046|9185941|P1|Overall Study|Death|0
2660045|NCT00657046|9185939|P3|Overall Study|Withdrawal by Subject|0
2660046|NCT00657046|9185940|P2|Overall Study|Withdrawal by Subject|0
2660047|NCT00657046|9185941|P1|Overall Study|Withdrawal by Subject|1
2660048|NCT00657046|9185939|P3|Overall Study|Protocol Violation|0
2660049|NCT00657046|9185940|P2|Overall Study|Protocol Violation|2
2660050|NCT00657046|9185941|P1|Overall Study|Protocol Violation|2
2660051|NCT00657046|9185939|P3|Overall Study|Adverse Event|0
2660052|NCT00657046|9185940|P2|Overall Study|Adverse Event|1
2660053|NCT00657046|9185941|P1|Overall Study|Adverse Event|1
2660054|NCT00657020|9185973|P2|PERIOD 1|Adverse Event|1
2660055|NCT00657020|9185974|P1|PERIOD 1|Adverse Event|0
2660056|NCT00656851|9186024|P2|Overall Study|Withdrawal by Subject|4
2660057|NCT00656851|9186025|P1|Overall Study|Withdrawal by Subject|0
2660058|NCT00656799|9186047|P1|Overall Study|Death|2
2660059|NCT00656669|9186069|P1|AC (Cycles 6-9)|Did not start segment 3|1
2660060|NCT00656669|9186069|P1|AC (Cycles 6-9)|Adverse Event|1
2660061|NCT00656669|9186069|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2
2660062|NCT00656669|9186069|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4
2660063|NCT00656617|9186108|P1|Overall Study|Move to different clinical trial|2
2660064|NCT00656617|9186108|P1|Overall Study|Insurance Issues|2
2660065|NCT00656617|9186108|P1|Overall Study|Death|2
2660066|NCT00656617|9186108|P1|Overall Study|Adverse Event|1
2660067|NCT00656513|9186117|P3|Overall Study|Missing baseline form|5
2660068|NCT00656513|9186118|P2|Overall Study|Missing baseline form|5
2660069|NCT00656513|9186119|P1|Overall Study|Missing baseline form|0
2660070|NCT00656513|9186117|P3|Overall Study|Treatment completed outside of timeframe|1
2660071|NCT00656513|9186118|P2|Overall Study|Treatment completed outside of timeframe|3
2660072|NCT00656513|9186119|P1|Overall Study|Treatment completed outside of timeframe|0
2660073|NCT00656513|9186117|P3|Overall Study|Incomplete treatment|0
2660074|NCT00656513|9186118|P2|Overall Study|Incomplete treatment|0
2660075|NCT00656513|9186119|P1|Overall Study|Incomplete treatment|3
2660076|NCT00656513|9186117|P3|Overall Study|Missing data|9
2660077|NCT00656513|9186118|P2|Overall Study|Missing data|11
2660078|NCT00656513|9186119|P1|Overall Study|Missing data|0
2660079|NCT00656513|9186117|P3|Overall Study|Death|1
2660080|NCT00656513|9186118|P2|Overall Study|Death|0
2660081|NCT00656513|9186119|P1|Overall Study|Death|0
2660082|NCT00656513|9186117|P3|Overall Study|Withdrawal by Subject|4
2660083|NCT00656513|9186118|P2|Overall Study|Withdrawal by Subject|11
2660084|NCT00656513|9186119|P1|Overall Study|Withdrawal by Subject|0
2660085|NCT00656513|9186117|P3|Overall Study|Protocol Violation|2
2660086|NCT00656513|9186118|P2|Overall Study|Protocol Violation|0
2660087|NCT00656513|9186119|P1|Overall Study|Protocol Violation|1
2660088|NCT00656474|9186166|P1|Overall Study|Other Reason|1
2660089|NCT00656370|9186184|P1|Overall Study|Alternates|3
2660090|NCT00656370|9186184|P1|Overall Study|Screen Failures|7
2660091|NCT00656292|9186213|P2|Overall Study|Screen failure|2
2660092|NCT00656292|9186214|P1|Overall Study|Screen failure|1
2660093|NCT00656292|9186213|P2|Overall Study|Withdrawal by Subject|3
2660094|NCT00656292|9186214|P1|Overall Study|Withdrawal by Subject|2
2660095|NCT00656175|9186241|P2|Overall Study|Transportation issues|1
2660096|NCT00656175|9186242|P1|Overall Study|Transportation issues|0
2660097|NCT00656175|9186241|P2|Overall Study|Adverse Event|0
2660098|NCT00656175|9186242|P1|Overall Study|Adverse Event|1
2660099|NCT00656136|9186250|P2|Overall Study|Unknown and others|4
2660100|NCT00656136|9186251|P1|Overall Study|Unknown and others|4
2660101|NCT00656136|9186250|P2|Overall Study|Patient refused to take study medication|10
2660102|NCT00656136|9186251|P1|Overall Study|Patient refused to take study medication|7
2660103|NCT00656136|9186250|P2|Overall Study|Protocol Violation|3
2660104|NCT00656136|9186251|P1|Overall Study|Protocol Violation|2
2660105|NCT00656136|9186250|P2|Overall Study|Other Adverse Event|51
2660106|NCT00656136|9186251|P1|Overall Study|Other Adverse Event|5
2660107|NCT00656136|9186250|P2|Overall Study|Progressive disease|322
2660108|NCT00656136|9186251|P1|Overall Study|Progressive disease|177
2660109|NCT00656084|9186261|P1|Overall Study|Investigator Request|1
2660110|NCT00656084|9186261|P1|Overall Study|Patient Request|1
2660111|NCT00656084|9186261|P1|Overall Study|Withdrawal by Subject|1
2660112|NCT00656084|9186261|P1|Overall Study|Adverse Event|4
2660113|NCT00656058|9186268|P1|Overall Study|Withdrawal by Subject|4
2660114|NCT00656058|9186268|P1|Overall Study|Withdrawal by Subject|2
2660115|NCT00656019|9186281|P4|Overall Study|Lost to Follow-up|0
2660116|NCT00656019|9186282|P3|Overall Study|Lost to Follow-up|0
2660117|NCT00656019|9186283|P2|Overall Study|Lost to Follow-up|1
2660118|NCT00656019|9186284|P1|Overall Study|Lost to Follow-up|2
2660119|NCT00656019|9186281|P4|Overall Study|Withdrawal by Subject|0
2660120|NCT00656019|9186282|P3|Overall Study|Withdrawal by Subject|0
2660121|NCT00656019|9186283|P2|Overall Study|Withdrawal by Subject|0
2660122|NCT00656019|9186284|P1|Overall Study|Withdrawal by Subject|2
2660123|NCT00656019|9186281|P4|Overall Study|Not Eligible|0
2660124|NCT00656019|9186282|P3|Overall Study|Not Eligible|0
2660125|NCT00656019|9186283|P2|Overall Study|Not Eligible|0
2660126|NCT00656019|9186284|P1|Overall Study|Not Eligible|10
2660127|NCT00655928|9186296|P2|Overall Study|Physician Decision|1
2660128|NCT00655928|9186297|P1|Overall Study|Physician Decision|1
2660129|NCT00655928|9186296|P2|Overall Study|Withdrawal by Subject|1
2660130|NCT00655928|9186297|P1|Overall Study|Withdrawal by Subject|2
2660131|NCT00655889|9186303|P1|Overall Study|Protocol Violation|1
2660132|NCT00655889|9186303|P1|Overall Study|Inadequate cell growth|1
2660133|NCT00655876|9186310|P2|Overall Study|Protocol Violation|7
2660134|NCT00655876|9186311|P1|Overall Study|Protocol Violation|9
2660135|NCT00655863|9186330|P3|Overall Study|Lost to Follow-up|1
2660136|NCT00655863|9186331|P2|Overall Study|Lost to Follow-up|0
2660137|NCT00655863|9186332|P1|Overall Study|Lost to Follow-up|0
2660138|NCT00655850|9186391|P1|Overall Study|Withdrawal by Subject|1
2660139|NCT00655850|9186391|P1|Overall Study|Death|2
2660140|NCT00655824|9186398|P1|Overall Study|Deterioration of Trial Disease|2
2660141|NCT00655824|9186398|P1|Overall Study|Withdrawal by Subject|4
2660142|NCT00655824|9186398|P1|Overall Study|Protocol Violation|1
2660143|NCT00655824|9186398|P1|Overall Study|Early Termination of Study by Sponsor|74
2660144|NCT00655824|9186398|P1|Overall Study|Adverse Event|3
2660145|NCT00655746|9186446|P1|Overall Study|Withdrawal by Subject|1
2660146|NCT00655733|9186465|P2|Overall Study|Physician Decision|1
2660147|NCT00655733|9186466|P1|Overall Study|Physician Decision|0
2660148|NCT00655733|9186465|P2|Overall Study|Withdrawal by Subject|3
2660149|NCT00655733|9186466|P1|Overall Study|Withdrawal by Subject|3
2660150|NCT00655733|9186465|P2|Overall Study|Adverse Event|2
2660151|NCT00655733|9186466|P1|Overall Study|Adverse Event|2
2660152|NCT00655733|9186465|P2|Overall Study|Lost to Follow-up|2
2660153|NCT00655733|9186466|P1|Overall Study|Lost to Follow-up|2
2660154|NCT00655668|9186499|P1|Overall Study|Withdrawal by Subject|2
2660155|NCT00655668|9186499|P1|Overall Study|New Lymphoma Treatment Started|4
2660156|NCT00655668|9186499|P1|Overall Study|Other|1
2660157|NCT00655668|9186499|P1|Overall Study|Study Terminated|9
2660158|NCT00655668|9186499|P1|Overall Study|Disease Progression|27
2660159|NCT00655668|9186499|P1|Overall Study|Death|5
2660160|NCT00655668|9186499|P1|Overall Study|Adverse Event|6
2660161|NCT00655629|9186526|P2|Overall Study|consent withdrawn|4
2660162|NCT00655629|9186527|P1|Overall Study|consent withdrawn|6
2660163|NCT00655629|9186526|P2|Overall Study|Protocol Violation|3
2660164|NCT00655629|9186527|P1|Overall Study|Protocol Violation|5
2660165|NCT00655629|9186526|P2|Overall Study|Lost to Follow-up|3
2660166|NCT00655629|9186527|P1|Overall Study|Lost to Follow-up|4
2660167|NCT00655629|9186526|P2|Overall Study|Lack of Efficacy|12
2660168|NCT00655629|9186527|P1|Overall Study|Lack of Efficacy|2
2660169|NCT00655629|9186526|P2|Overall Study|Adverse Event|1
2660170|NCT00655629|9186527|P1|Overall Study|Adverse Event|4
2660171|NCT00655564|9186563|P1|Overall Study|Desired Alternate Therapy|1
2660172|NCT00655564|9186563|P1|Overall Study|Lost to Follow-up|1
2660173|NCT00655564|9186563|P1|Overall Study|Adverse Event|1
2660174|NCT00655551|9186571|P3|Period 4 (up to 7 Days)|Adverse Event|0
2660175|NCT00655551|9186572|P2|Period 4 (up to 7 Days)|Adverse Event|2
2660176|NCT00655551|9186573|P1|Period 4 (up to 7 Days)|Adverse Event|0
2660177|NCT00655551|9186571|P3|Period 3 (up to 7 Days)|Adverse Event|4
2660178|NCT00655551|9186572|P2|Period 3 (up to 7 Days)|Adverse Event|0
2660179|NCT00655551|9186573|P1|Period 3 (up to 7 Days)|Adverse Event|0
2660180|NCT00655551|9186571|P3|Period 2 (up to 7 Days)|Adverse Event|0
2660181|NCT00655551|9186572|P2|Period 2 (up to 7 Days)|Adverse Event|1
2660182|NCT00655551|9186573|P1|Period 2 (up to 7 Days)|Adverse Event|0
2660183|NCT00655551|9186571|P3|All Periods Combined|Adverse Event|4
2660184|NCT00655551|9186572|P2|All Periods Combined|Adverse Event|3
2660185|NCT00655551|9186573|P1|All Periods Combined|Adverse Event|0
2660186|NCT00655486|9186610|P1|Overall Study|Other: Abnormal electrocardiogram (ECG)|1
2660187|NCT00655486|9186610|P1|Overall Study|Other: Could not tolerate BID dosing|1
2660188|NCT00655486|9186610|P1|Overall Study|Other: Pregnancy|1
2660189|NCT00655486|9186610|P1|Overall Study|Unsatisfactory compliance|2
2660190|NCT00655486|9186610|P1|Overall Study|Protocol Violation|1
2660191|NCT00655486|9186610|P1|Overall Study|Withdrawal by Subject|4
2660192|NCT00655486|9186610|P1|Overall Study|Lack of Efficacy|8
2660193|NCT00655486|9186610|P1|Overall Study|Adverse Event|10
2660194|NCT00655356|9186638|P2|Overall Study|Other Reason|0
2660195|NCT00655356|9186639|P1|Overall Study|Other Reason|1
2660196|NCT00655356|9186638|P2|Overall Study|Protocol Violation|1
2660197|NCT00655356|9186639|P1|Overall Study|Protocol Violation|2
2660198|NCT00655356|9186638|P2|Overall Study|Adverse Event|1
2660199|NCT00655356|9186639|P1|Overall Study|Adverse Event|1
2660200|NCT00655356|9186638|P2|Overall Study|Sponsor Request|4
2660201|NCT00655356|9186639|P1|Overall Study|Sponsor Request|10
2660202|NCT00655356|9186638|P2|Overall Study|Withdrawal by Subject|4
2660203|NCT00655356|9186639|P1|Overall Study|Withdrawal by Subject|3
2660204|NCT00654940|9186703|P2|Period 1|Intolerable Pain Level|0
2660205|NCT00654940|9186704|P1|Period 1|Intolerable Pain Level|1
2660206|NCT00654940|9186703|P2|Period 1|Adverse Event|1
2660207|NCT00654940|9186704|P1|Period 1|Adverse Event|0
2660208|NCT00654901|9186728|P4|Overall Study|Withdrawal by Subject|0
2660209|NCT00654901|9186729|P3|Overall Study|Withdrawal by Subject|1
2660210|NCT00654901|9186730|P2|Overall Study|Withdrawal by Subject|0
2660211|NCT00654901|9186731|P1|Overall Study|Withdrawal by Subject|3
2660212|NCT00654901|9186728|P4|Overall Study|Lost to Follow-up|0
2660213|NCT00654901|9186729|P3|Overall Study|Lost to Follow-up|1
2660214|NCT00654901|9186730|P2|Overall Study|Lost to Follow-up|0
2660215|NCT00654901|9186731|P1|Overall Study|Lost to Follow-up|1
2660216|NCT00654875|9186751|P2|Overall Study|Administrative Problems|0
2660217|NCT00654875|9186752|P1|Overall Study|Administrative Problems|1
2660218|NCT00654875|9186751|P2|Overall Study|Abnormal Test Procedure Result(s)|0
2660219|NCT00654875|9186752|P1|Overall Study|Abnormal Test Procedure Result(s)|1
2660220|NCT00654875|9186751|P2|Overall Study|Lost to Follow-up|3
2660221|NCT00654875|9186752|P1|Overall Study|Lost to Follow-up|1
2660222|NCT00654875|9186751|P2|Overall Study|Lack of Efficacy|2
2660223|NCT00654875|9186752|P1|Overall Study|Lack of Efficacy|2
2660224|NCT00654875|9186751|P2|Overall Study|Protocol Violation|3
2660225|NCT00654875|9186752|P1|Overall Study|Protocol Violation|3
2660226|NCT00654875|9186751|P2|Overall Study|Withdrawal by Subject|4
2660227|NCT00654875|9186752|P1|Overall Study|Withdrawal by Subject|4
2660228|NCT00654875|9186751|P2|Overall Study|Adverse Event|5
2660229|NCT00654875|9186752|P1|Overall Study|Adverse Event|5
2660230|NCT00654745|9186785|P1|Overall Study|poor ABPM, noncompliance, lab MAs|3
2660231|NCT00654745|9186785|P1|Overall Study|Withdrawal by Subject|10
2660232|NCT00654745|9186785|P1|Overall Study|Protocol Violation|11
2660233|NCT00654745|9186785|P1|Overall Study|Lost to Follow-up|7
2660234|NCT00654745|9186785|P1|Overall Study|Adverse Event|12
2660235|NCT00654732|9186825|P2|Overall Study|Adverse Event|6
2660236|NCT00654732|9186826|P1|Overall Study|Adverse Event|4
2660237|NCT00654641|9186839|P2|Overall Study|Lost to Follow-up|3
2660238|NCT00654641|9186840|P1|Overall Study|Lost to Follow-up|2
2660239|NCT00654628|9186846|P1|6 –Week Extension Period (Single Site)|Lost to Follow-up|1
2660240|NCT00654628|9186846|P1|6 –Week Extension Period (Single Site)|Adverse Event|4
2660241|NCT00654628|9186846|P1|6-week Active Treatment Period|Out of window period|1
2660242|NCT00654628|9186846|P1|6-week Active Treatment Period|Transferred to branch hospital|1
2660243|NCT00654628|9186846|P1|6-week Active Treatment Period|Lost to Follow-up|10
2660244|NCT00654628|9186846|P1|6-week Active Treatment Period|Adverse Event|9
2660245|NCT00654498|9186895|P2|Overall Study|Other reason not defined above|5
2660246|NCT00654498|9186896|P1|Overall Study|Other reason not defined above|4
2660247|NCT00654498|9186895|P2|Overall Study|Withdrawal by Subject|0
2660248|NCT00654498|9186896|P1|Overall Study|Withdrawal by Subject|1
2660249|NCT00654498|9186895|P2|Overall Study|Lost to Follow-up|5
2660250|NCT00654498|9186896|P1|Overall Study|Lost to Follow-up|1
2660251|NCT00654498|9186895|P2|Overall Study|Protocol Violation|1
2660252|NCT00654498|9186896|P1|Overall Study|Protocol Violation|1
2660253|NCT00654498|9186895|P2|Overall Study|Adverse Event|1
2660254|NCT00654498|9186896|P1|Overall Study|Adverse Event|6
2660255|NCT00654498|9186895|P2|Overall Study|Not Treated|0
2660256|NCT00654498|9186896|P1|Overall Study|Not Treated|1
2660257|NCT00654420|9186928|P4|Phase II|Missing Disposition Record|0
2660258|NCT00654420|9186929|P3|Phase II|Missing Disposition Record|1
2660259|NCT00654420|9186930|P2|Phase II|Missing Disposition Record|0
2660260|NCT00654420|9186931|P1|Phase II|Missing Disposition Record|0
2660261|NCT00654420|9186928|P4|Phase II|Withdrawal by Subject|1
2660262|NCT00654420|9186929|P3|Phase II|Withdrawal by Subject|4
2660263|NCT00654420|9186930|P2|Phase II|Withdrawal by Subject|0
2660264|NCT00654420|9186931|P1|Phase II|Withdrawal by Subject|0
2660265|NCT00654420|9186928|P4|Phase II|Progressive Disease|29
2660266|NCT00654420|9186929|P3|Phase II|Progressive Disease|29
2660267|NCT00654420|9186930|P2|Phase II|Progressive Disease|0
2660268|NCT00654420|9186931|P1|Phase II|Progressive Disease|0
2660269|NCT00654420|9186928|P4|Phase II|Physician Decision|4
2660270|NCT00654420|9186929|P3|Phase II|Physician Decision|0
2660271|NCT00654420|9186930|P2|Phase II|Physician Decision|0
2660272|NCT00654420|9186931|P1|Phase II|Physician Decision|0
2660273|NCT00654420|9186928|P4|Phase II|Lost to Follow-up|1
2660274|NCT00654420|9186929|P3|Phase II|Lost to Follow-up|0
2660275|NCT00654420|9186930|P2|Phase II|Lost to Follow-up|0
2660276|NCT00654420|9186931|P1|Phase II|Lost to Follow-up|0
2660277|NCT00654420|9186928|P4|Phase II|Adverse Event|3
2660278|NCT00654420|9186929|P3|Phase II|Adverse Event|3
2660279|NCT00654420|9186930|P2|Phase II|Adverse Event|0
2660280|NCT00654420|9186931|P1|Phase II|Adverse Event|0
2660281|NCT00654420|9186928|P4|Phase I (Dose Escalation)|Progressive Disease|0
2660282|NCT00654420|9186929|P3|Phase I (Dose Escalation)|Progressive Disease|0
2660283|NCT00654420|9186930|P2|Phase I (Dose Escalation)|Progressive Disease|15
2660284|NCT00654420|9186931|P1|Phase I (Dose Escalation)|Progressive Disease|4
2660285|NCT00654420|9186928|P4|Phase I (Dose Escalation)|Adverse Event|0
2660286|NCT00654420|9186929|P3|Phase I (Dose Escalation)|Adverse Event|0
2660287|NCT00654420|9186930|P2|Phase I (Dose Escalation)|Adverse Event|1
2660288|NCT00654420|9186931|P1|Phase I (Dose Escalation)|Adverse Event|0
2660289|NCT00654381|9186957|P6|Extension Stage|Closure of the trial site|1
2660290|NCT00654381|9186958|P5|Extension Stage|Closure of the trial site|1
2660291|NCT00654381|9186959|P4|Extension Stage|Closure of the trial site|0
2660292|NCT00654381|9186960|P3|Extension Stage|Closure of the trial site|0
2660293|NCT00654381|9186961|P2|Extension Stage|Closure of the trial site|0
2660294|NCT00654381|9186962|P1|Extension Stage|Closure of the trial site|0
2660295|NCT00654381|9186957|P6|Extension Stage|Withdrawal by Subject|1
2660296|NCT00654381|9186958|P5|Extension Stage|Withdrawal by Subject|1
2660297|NCT00654381|9186959|P4|Extension Stage|Withdrawal by Subject|1
2660298|NCT00654381|9186960|P3|Extension Stage|Withdrawal by Subject|1
2660299|NCT00654381|9186961|P2|Extension Stage|Withdrawal by Subject|0
2660300|NCT00654381|9186962|P1|Extension Stage|Withdrawal by Subject|0
2660301|NCT00654381|9186957|P6|Extension Stage|Lack of Efficacy|0
2660302|NCT00654381|9186958|P5|Extension Stage|Lack of Efficacy|0
2660303|NCT00654381|9186959|P4|Extension Stage|Lack of Efficacy|0
2660304|NCT00654381|9186960|P3|Extension Stage|Lack of Efficacy|1
2660305|NCT00654381|9186961|P2|Extension Stage|Lack of Efficacy|0
2660306|NCT00654381|9186962|P1|Extension Stage|Lack of Efficacy|0
2660307|NCT00654381|9186957|P6|Extension Stage|Protocol Violation|0
2660308|NCT00654381|9186958|P5|Extension Stage|Protocol Violation|0
2660309|NCT00654381|9186959|P4|Extension Stage|Protocol Violation|1
2660310|NCT00654381|9186960|P3|Extension Stage|Protocol Violation|0
2660311|NCT00654381|9186961|P2|Extension Stage|Protocol Violation|0
2660312|NCT00654381|9186962|P1|Extension Stage|Protocol Violation|0
2660313|NCT00654381|9186957|P6|Extension Stage|Adverse Event|1
2660314|NCT00654381|9186958|P5|Extension Stage|Adverse Event|1
2660315|NCT00654381|9186959|P4|Extension Stage|Adverse Event|7
2660316|NCT00654381|9186960|P3|Extension Stage|Adverse Event|9
2660317|NCT00654381|9186961|P2|Extension Stage|Adverse Event|2
2660318|NCT00654381|9186962|P1|Extension Stage|Adverse Event|1
2660319|NCT00654381|9186957|P6|2nd Stage|Investigator's decision|0
2660320|NCT00654381|9186958|P5|2nd Stage|Investigator's decision|0
2660321|NCT00654381|9186959|P4|2nd Stage|Investigator's decision|1
2660322|NCT00654381|9186960|P3|2nd Stage|Investigator's decision|1
2660323|NCT00654381|9186961|P2|2nd Stage|Investigator's decision|0
2660324|NCT00654381|9186962|P1|2nd Stage|Investigator's decision|0
2660325|NCT00654381|9186957|P6|2nd Stage|Withdrawal by Subject|1
2660326|NCT00654381|9186958|P5|2nd Stage|Withdrawal by Subject|1
2660327|NCT00654381|9186959|P4|2nd Stage|Withdrawal by Subject|0
2660328|NCT00654381|9186960|P3|2nd Stage|Withdrawal by Subject|0
2660329|NCT00654381|9186961|P2|2nd Stage|Withdrawal by Subject|0
2660330|NCT00654381|9186962|P1|2nd Stage|Withdrawal by Subject|0
2660331|NCT00654381|9186957|P6|2nd Stage|Adverse Event|2
2660332|NCT00654381|9186958|P5|2nd Stage|Adverse Event|7
2660333|NCT00654381|9186959|P4|2nd Stage|Adverse Event|3
2660334|NCT00654381|9186960|P3|2nd Stage|Adverse Event|2
2660335|NCT00654381|9186961|P2|2nd Stage|Adverse Event|0
2660336|NCT00654381|9186962|P1|2nd Stage|Adverse Event|2
2660337|NCT00654381|9186957|P6|1st Stage|Investigator's decision|0
2660338|NCT00654381|9186958|P5|1st Stage|Investigator's decision|0
2660339|NCT00654381|9186959|P4|1st Stage|Investigator's decision|1
2660340|NCT00654381|9186960|P3|1st Stage|Investigator's decision|0
2660341|NCT00654381|9186961|P2|1st Stage|Investigator's decision|0
2660342|NCT00654381|9186962|P1|1st Stage|Investigator's decision|0
2660343|NCT00654381|9186957|P6|1st Stage|Withdrawal by Subject|1
2660344|NCT00654381|9186958|P5|1st Stage|Withdrawal by Subject|0
2660345|NCT00654381|9186959|P4|1st Stage|Withdrawal by Subject|1
2660346|NCT00654381|9186960|P3|1st Stage|Withdrawal by Subject|0
2660347|NCT00654381|9186961|P2|1st Stage|Withdrawal by Subject|0
2660348|NCT00654381|9186962|P1|1st Stage|Withdrawal by Subject|0
2660349|NCT00654381|9186957|P6|1st Stage|Adverse Event|1
2660350|NCT00654381|9186958|P5|1st Stage|Adverse Event|2
2660351|NCT00654381|9186959|P4|1st Stage|Adverse Event|3
2660352|NCT00654381|9186960|P3|1st Stage|Adverse Event|3
2660353|NCT00654381|9186961|P2|1st Stage|Adverse Event|3
2660354|NCT00654381|9186962|P1|1st Stage|Adverse Event|3
2660355|NCT00654368|9186999|P3|Overall Study|Adverse Event|6
2660356|NCT00654368|9187000|P2|Overall Study|Adverse Event|9
2660357|NCT00654368|9187001|P1|Overall Study|Adverse Event|14
2660358|NCT00654368|9186999|P3|Overall Study|Other|3
2660359|NCT00654368|9187000|P2|Overall Study|Other|2
2660360|NCT00654368|9187001|P1|Overall Study|Other|0
2660361|NCT00654368|9186999|P3|Overall Study|Pregnancy|2
2660362|NCT00654368|9187000|P2|Overall Study|Pregnancy|0
2660363|NCT00654368|9187001|P1|Overall Study|Pregnancy|0
2660364|NCT00654368|9186999|P3|Overall Study|Death|0
2660365|NCT00654368|9187000|P2|Overall Study|Death|0
2660366|NCT00654368|9187001|P1|Overall Study|Death|1
2660367|NCT00654368|9186999|P3|Overall Study|Physician Decision|2
2660368|NCT00654368|9187000|P2|Overall Study|Physician Decision|0
2660369|NCT00654368|9187001|P1|Overall Study|Physician Decision|0
2660370|NCT00654368|9186999|P3|Overall Study|Requirement for alternative therapy|1
2660371|NCT00654368|9187000|P2|Overall Study|Requirement for alternative therapy|1
2660372|NCT00654368|9187001|P1|Overall Study|Requirement for alternative therapy|1
2660373|NCT00654368|9186999|P3|Overall Study|Disease progression|13
2660374|NCT00654368|9187000|P2|Overall Study|Disease progression|31
2660375|NCT00654368|9187001|P1|Overall Study|Disease progression|21
2660376|NCT00654368|9186999|P3|Overall Study|Withdrawal by Subject|2
2660377|NCT00654368|9187000|P2|Overall Study|Withdrawal by Subject|2
2660378|NCT00654368|9187001|P1|Overall Study|Withdrawal by Subject|5
2660379|NCT00654368|9186999|P3|Overall Study|Non-compliance|2
2660380|NCT00654368|9187000|P2|Overall Study|Non-compliance|1
2660381|NCT00654368|9187001|P1|Overall Study|Non-compliance|2
2660382|NCT00654368|9186999|P3|Overall Study|Protocol deviation|1
2660383|NCT00654368|9187000|P2|Overall Study|Protocol deviation|2
2660384|NCT00654368|9187001|P1|Overall Study|Protocol deviation|3
2660385|NCT00654368|9186999|P3|Overall Study|Ineligibility determined|0
2660386|NCT00654368|9187000|P2|Overall Study|Ineligibility determined|0
2660387|NCT00654368|9187001|P1|Overall Study|Ineligibility determined|6
2660388|NCT00654355|9187034|P2|Overall Study|Lost to Follow-up|2
2660389|NCT00654355|9187035|P1|Overall Study|Lost to Follow-up|2
2660390|NCT00654238|9187066|P1|Overall Study|Screen Failures|4
2660391|NCT00654186|9187071|P1|Overall Study|Withdrawal by Subject|5
2660392|NCT00654095|9187096|P1|Overall Study|Did not meet inclusion criteria|1
2660393|NCT00654095|9187096|P1|Overall Study|Adverse reaction did not improve (5)|4
2660394|NCT00654095|9187096|P1|Overall Study|Elevated alanine aminotransferase (4)|7
2660395|NCT00654095|9187096|P1|Overall Study|Withdrawal by Subject|5
2660396|NCT00654095|9187096|P1|Overall Study|Adverse Event|11
2660397|NCT00654095|9187096|P1|Overall Study|Elevated alanine aminotransferase (3)|1
2660398|NCT00654095|9187096|P1|Overall Study|Elevated triglyceride level (2)|1
2660399|NCT00654095|9187096|P1|Overall Study|Drop in low density lipoprotein (1)|2
2660400|NCT00654004|9187119|P2|Overall Study|Lost to Follow-up|0
2660401|NCT00654004|9187120|P1|Overall Study|Lost to Follow-up|1
2660402|NCT00653991|9187136|P2|6 Month Follow-up|Participant would not respond|141
2660403|NCT00653991|9187137|P1|6 Month Follow-up|Participant would not respond|133
2660404|NCT00653991|9187136|P2|3 Month Follow-up|Participant would not respond|157
2660405|NCT00653991|9187137|P1|3 Month Follow-up|Participant would not respond|150
2660406|NCT00653939|9187149|P2|Overall Study|Other|6
2660407|NCT00653939|9187150|P1|Overall Study|Other|2
2660408|NCT00653939|9187149|P2|Overall Study|Disease Progression|3
2660409|NCT00653939|9187150|P1|Overall Study|Disease Progression|2
2660410|NCT00653939|9187149|P2|Overall Study|Physician Decision|0
2660411|NCT00653939|9187150|P1|Overall Study|Physician Decision|4
2660412|NCT00653939|9187149|P2|Overall Study|Withdrawal by Subject|3
2660413|NCT00653939|9187150|P1|Overall Study|Withdrawal by Subject|3
2660414|NCT00653939|9187149|P2|Overall Study|Adverse Event|3
2660415|NCT00653939|9187150|P1|Overall Study|Adverse Event|1
2660416|NCT00653523|9187175|P1|Overall Study|Adverse reaction did not improve (4)|1
2660417|NCT00653523|9187175|P1|Overall Study|Elevated alanine aminotransferase (3)|2
2660418|NCT00653523|9187175|P1|Overall Study|Withdrawal by Subject|6
2660419|NCT00653523|9187175|P1|Overall Study|Adverse Event|7
2660420|NCT00653523|9187175|P1|Overall Study|Elevated creatine phosphokinase (2)|1
2660421|NCT00653523|9187175|P1|Overall Study|Drop in low density lipoprotein (1)|2
2660422|NCT00653328|9187179|P1|Overall Study|Drug manufacturer no longing making drug|2
2660423|NCT00653328|9187179|P1|Overall Study|Disease progression|10
2660424|NCT00653328|9187179|P1|Overall Study|Adverse Event|2
2660425|NCT00653328|9187179|P1|Overall Study|Withdrawal by Subject|1
2660426|NCT00653263|9187186|P1|Overall Study|Physician Decision|1
2660427|NCT00653263|9187186|P1|Overall Study|Withdrawal by Subject|1
2660428|NCT00653224|9187194|P2|Overall Study|Other|4
2660429|NCT00653224|9187195|P1|Overall Study|Other|2
2660430|NCT00653224|9187194|P2|Overall Study|Lost to Follow-up|0
2660431|NCT00653224|9187195|P1|Overall Study|Lost to Follow-up|1
2660432|NCT00653224|9187194|P2|Overall Study|Loss of efficacy|0
2660433|NCT00653224|9187195|P1|Overall Study|Loss of efficacy|1
2660434|NCT00653224|9187194|P2|Overall Study|Lack of Efficacy|2
2660435|NCT00653224|9187195|P1|Overall Study|Lack of Efficacy|1
2660436|NCT00653224|9187194|P2|Overall Study|Adverse Event|1
2660437|NCT00653224|9187195|P1|Overall Study|Adverse Event|2
2660438|NCT00653159|9187381|P2|Overall Study|Lost to Follow-up|2
2660439|NCT00653159|9187382|P1|Overall Study|Lost to Follow-up|1
2660440|NCT00653159|9187381|P2|Overall Study|Adverse Event|1
2660441|NCT00653159|9187382|P1|Overall Study|Adverse Event|4
2660442|NCT00653068|9187409|P1|Overall Study|Ineligible|2
2660443|NCT00653068|9187409|P1|Overall Study|Withdrawal by Subject|1
2660444|NCT00653068|9187409|P1|Overall Study|Physician Decision|4
2660445|NCT00653068|9187409|P1|Overall Study|Lack of Efficacy|34
2660446|NCT00653068|9187409|P1|Overall Study|Death|9
2660447|NCT00652951|9187423|P3|Booster Phase|Other|0
2660448|NCT00652951|9187424|P2|Booster Phase|Other|0
2660449|NCT00652951|9187425|P1|Booster Phase|Other|1
2660450|NCT00652951|9187423|P3|Booster Phase|Adverse event, non-fatal|0
2660451|NCT00652951|9187424|P2|Booster Phase|Adverse event, non-fatal|1
2660452|NCT00652951|9187425|P1|Booster Phase|Adverse event, non-fatal|0
2660453|NCT00652938|9187562|P3|Overall Study|fear of blood sampling|0
2660454|NCT00652938|9187563|P2|Overall Study|fear of blood sampling|1
2660455|NCT00652938|9187564|P1|Overall Study|fear of blood sampling|0
2660456|NCT00652938|9187562|P3|Overall Study|Lost to Follow-up|2
2660457|NCT00652938|9187563|P2|Overall Study|Lost to Follow-up|0
2660458|NCT00652938|9187564|P1|Overall Study|Lost to Follow-up|0
2660459|NCT00652938|9187562|P3|Overall Study|Withdrawal by Subject|1
2660460|NCT00652938|9187563|P2|Overall Study|Withdrawal by Subject|6
2660461|NCT00652938|9187564|P1|Overall Study|Withdrawal by Subject|0
2660462|NCT00652938|9187562|P3|Overall Study|Adverse Event|2
2660463|NCT00652938|9187563|P2|Overall Study|Adverse Event|0
2660464|NCT00652938|9187564|P1|Overall Study|Adverse Event|1
2660465|NCT00652899|9187629|P1|Overall Study|Treating physician decision|1
2660466|NCT00652899|9187629|P1|Overall Study|Death|1
2660467|NCT00652834|9187639|P1|Overall Study|Lost to Follow-up|2
2660468|NCT00652834|9187639|P1|Overall Study|Withdrawal by Subject|3
2660469|NCT00652743|9187646|P3|Months 36-42|Other|8
2660470|NCT00652743|9187647|P2|Months 36-42|Other|2
2660471|NCT00652743|9187648|P1|Months 36-42|Other|4
2660472|NCT00652743|9187646|P3|Months 36-42|Migrated/moved from study area|0
2660473|NCT00652743|9187647|P2|Months 36-42|Migrated/moved from study area|0
2660474|NCT00652743|9187648|P1|Months 36-42|Migrated/moved from study area|1
2660475|NCT00652743|9187646|P3|Months 36-42|Lost to Follow-up|0
2660476|NCT00652743|9187647|P2|Months 36-42|Lost to Follow-up|1
2660477|NCT00652743|9187648|P1|Months 36-42|Lost to Follow-up|0
2660478|NCT00652743|9187646|P3|Months 36-42|Withdrawal by Subject|0
2660479|NCT00652743|9187647|P2|Months 36-42|Withdrawal by Subject|1
2660480|NCT00652743|9187648|P1|Months 36-42|Withdrawal by Subject|1
2660481|NCT00652743|9187646|P3|Months 36-42|Serious Adverse Events|1
2660482|NCT00652743|9187647|P2|Months 36-42|Serious Adverse Events|1
2660483|NCT00652743|9187648|P1|Months 36-42|Serious Adverse Events|0
2660484|NCT00652743|9187646|P3|Months 24-30|Other|11
2660485|NCT00652743|9187647|P2|Months 24-30|Other|1
2660486|NCT00652743|9187648|P1|Months 24-30|Other|5
2660487|NCT00652743|9187646|P3|Months 12-18|Lost to Follow-up|7
2660488|NCT00652743|9187647|P2|Months 12-18|Lost to Follow-up|2
2660489|NCT00652743|9187648|P1|Months 12-18|Lost to Follow-up|1
2660490|NCT00652626|9187730|P7|Extension Phase|Death|1
2660491|NCT00652626|9187731|P6|Extension Phase|Death|1
2660492|NCT00652626|9187732|P5|Extension Phase|Death|0
2660493|NCT00652626|9187733|P4|Extension Phase|Death|0
2660494|NCT00652626|9187734|P3|Extension Phase|Death|0
2660495|NCT00652626|9187735|P2|Extension Phase|Death|0
2660496|NCT00652626|9187736|P1|Extension Phase|Death|0
2660497|NCT00652626|9187730|P7|Extension Phase|Physician Decision|1
2660498|NCT00652626|9187731|P6|Extension Phase|Physician Decision|1
2660499|NCT00652626|9187732|P5|Extension Phase|Physician Decision|0
2660500|NCT00652626|9187733|P4|Extension Phase|Physician Decision|0
2660501|NCT00652626|9187734|P3|Extension Phase|Physician Decision|0
2660502|NCT00652626|9187735|P2|Extension Phase|Physician Decision|0
2660503|NCT00652626|9187736|P1|Extension Phase|Physician Decision|0
2660504|NCT00652626|9187730|P7|Extension Phase|No Longer Receiving Clinical Benefit|0
2660505|NCT00652626|9187731|P6|Extension Phase|No Longer Receiving Clinical Benefit|6
2660506|NCT00652626|9187732|P5|Extension Phase|No Longer Receiving Clinical Benefit|0
2660507|NCT00652626|9187733|P4|Extension Phase|No Longer Receiving Clinical Benefit|0
2660508|NCT00652626|9187734|P3|Extension Phase|No Longer Receiving Clinical Benefit|0
2660509|NCT00652626|9187735|P2|Extension Phase|No Longer Receiving Clinical Benefit|0
2660510|NCT00652626|9187736|P1|Extension Phase|No Longer Receiving Clinical Benefit|0
2660511|NCT00652626|9187730|P7|Extension Phase|Adverse Event|1
2660512|NCT00652626|9187731|P6|Extension Phase|Adverse Event|2
2660513|NCT00652626|9187732|P5|Extension Phase|Adverse Event|0
2660514|NCT00652626|9187733|P4|Extension Phase|Adverse Event|0
2660515|NCT00652626|9187734|P3|Extension Phase|Adverse Event|0
2660516|NCT00652626|9187735|P2|Extension Phase|Adverse Event|0
2660517|NCT00652626|9187736|P1|Extension Phase|Adverse Event|0
2660518|NCT00652626|9187730|P7|Extension Phase|Withdrawal by Subject|0
2660519|NCT00652626|9187731|P6|Extension Phase|Withdrawal by Subject|2
2660520|NCT00652626|9187732|P5|Extension Phase|Withdrawal by Subject|0
2660521|NCT00652626|9187733|P4|Extension Phase|Withdrawal by Subject|0
2660522|NCT00652626|9187734|P3|Extension Phase|Withdrawal by Subject|0
2660523|NCT00652626|9187735|P2|Extension Phase|Withdrawal by Subject|0
2660524|NCT00652626|9187736|P1|Extension Phase|Withdrawal by Subject|0
2660525|NCT00652626|9187730|P7|Initial Treatment Phase|Lost to Follow-up|0
2660526|NCT00652626|9187731|P6|Initial Treatment Phase|Lost to Follow-up|0
2660527|NCT00652626|9187732|P5|Initial Treatment Phase|Lost to Follow-up|1
2660528|NCT00652626|9187733|P4|Initial Treatment Phase|Lost to Follow-up|0
2660529|NCT00652626|9187734|P3|Initial Treatment Phase|Lost to Follow-up|0
2660530|NCT00652626|9187735|P2|Initial Treatment Phase|Lost to Follow-up|0
2660531|NCT00652626|9187736|P1|Initial Treatment Phase|Lost to Follow-up|0
2660532|NCT00652626|9187730|P7|Initial Treatment Phase|Sponsor Request|0
2660533|NCT00652626|9187731|P6|Initial Treatment Phase|Sponsor Request|0
2660534|NCT00652626|9187732|P5|Initial Treatment Phase|Sponsor Request|0
2660535|NCT00652626|9187733|P4|Initial Treatment Phase|Sponsor Request|0
2660536|NCT00652626|9187734|P3|Initial Treatment Phase|Sponsor Request|1
2660537|NCT00652626|9187735|P2|Initial Treatment Phase|Sponsor Request|0
2660538|NCT00652626|9187736|P1|Initial Treatment Phase|Sponsor Request|0
2660539|NCT00652626|9187730|P7|Initial Treatment Phase|Physician Decision|0
2660540|NCT00652626|9187731|P6|Initial Treatment Phase|Physician Decision|0
2660541|NCT00652626|9187732|P5|Initial Treatment Phase|Physician Decision|1
2660542|NCT00652626|9187733|P4|Initial Treatment Phase|Physician Decision|0
2660543|NCT00652626|9187734|P3|Initial Treatment Phase|Physician Decision|0
2660544|NCT00652626|9187735|P2|Initial Treatment Phase|Physician Decision|0
2660545|NCT00652626|9187736|P1|Initial Treatment Phase|Physician Decision|0
2660546|NCT00652626|9187730|P7|Initial Treatment Phase|Protocol Violation|0
2660547|NCT00652626|9187731|P6|Initial Treatment Phase|Protocol Violation|0
2660548|NCT00652626|9187732|P5|Initial Treatment Phase|Protocol Violation|0
2660549|NCT00652626|9187733|P4|Initial Treatment Phase|Protocol Violation|1
2660550|NCT00652626|9187734|P3|Initial Treatment Phase|Protocol Violation|0
2660551|NCT00652626|9187735|P2|Initial Treatment Phase|Protocol Violation|0
2660552|NCT00652626|9187736|P1|Initial Treatment Phase|Protocol Violation|0
2660553|NCT00652626|9187730|P7|Initial Treatment Phase|Adverse Event|0
2660554|NCT00652626|9187731|P6|Initial Treatment Phase|Adverse Event|0
2660555|NCT00652626|9187732|P5|Initial Treatment Phase|Adverse Event|1
2660556|NCT00652626|9187733|P4|Initial Treatment Phase|Adverse Event|0
2660557|NCT00652626|9187734|P3|Initial Treatment Phase|Adverse Event|0
2660558|NCT00652626|9187735|P2|Initial Treatment Phase|Adverse Event|0
2660559|NCT00652626|9187736|P1|Initial Treatment Phase|Adverse Event|0
2660560|NCT00652366|9187805|P5|Overall Study|Other|0
2660561|NCT00652366|9187806|P4|Overall Study|Other|4
2660562|NCT00652366|9187807|P3|Overall Study|Other|3
2660563|NCT00652366|9187808|P2|Overall Study|Other|2
2660564|NCT00652366|9187809|P1|Overall Study|Other|5
2660565|NCT00652366|9187805|P5|Overall Study|Refused treatment|5
2660566|NCT00652366|9187806|P4|Overall Study|Refused treatment|17
2660567|NCT00652366|9187807|P3|Overall Study|Refused treatment|6
2660568|NCT00652366|9187808|P2|Overall Study|Refused treatment|7
2660569|NCT00652366|9187809|P1|Overall Study|Refused treatment|3
2660570|NCT00652366|9187805|P5|Overall Study|Protocol Violation|0
2660571|NCT00652366|9187806|P4|Overall Study|Protocol Violation|0
2660572|NCT00652366|9187807|P3|Overall Study|Protocol Violation|0
2660573|NCT00652366|9187808|P2|Overall Study|Protocol Violation|0
2660574|NCT00652366|9187809|P1|Overall Study|Protocol Violation|1
2660575|NCT00652366|9187805|P5|Overall Study|Violation of Selection Criteria|0
2660576|NCT00652366|9187806|P4|Overall Study|Violation of Selection Criteria|0
2660577|NCT00652366|9187807|P3|Overall Study|Violation of Selection Criteria|1
2660578|NCT00652366|9187808|P2|Overall Study|Violation of Selection Criteria|0
2660579|NCT00652366|9187809|P1|Overall Study|Violation of Selection Criteria|0
2660580|NCT00652366|9187805|P5|Overall Study|Lack of Efficacy|13
2660581|NCT00652366|9187806|P4|Overall Study|Lack of Efficacy|133
2660582|NCT00652366|9187807|P3|Overall Study|Lack of Efficacy|53
2660583|NCT00652366|9187808|P2|Overall Study|Lack of Efficacy|58
2660584|NCT00652366|9187809|P1|Overall Study|Lack of Efficacy|84
2660585|NCT00652366|9187805|P5|Overall Study|Death|5
2660586|NCT00652366|9187806|P4|Overall Study|Death|8
2660587|NCT00652366|9187807|P3|Overall Study|Death|1
2660588|NCT00652366|9187808|P2|Overall Study|Death|4
2660589|NCT00652366|9187809|P1|Overall Study|Death|5
2660590|NCT00652366|9187805|P5|Overall Study|Adverse Event|13
2660591|NCT00652366|9187806|P4|Overall Study|Adverse Event|17
2660592|NCT00652366|9187807|P3|Overall Study|Adverse Event|7
2660593|NCT00652366|9187808|P2|Overall Study|Adverse Event|4
2660594|NCT00652366|9187809|P1|Overall Study|Adverse Event|8
2660595|NCT00652340|9187844|P2|Overall Study|Had not progressed.|3
2660596|NCT00652340|9187845|P1|Overall Study|Had not progressed.|4
2660597|NCT00652327|9187855|P2|Overall Study|Lost to Follow-up|3
2660598|NCT00652327|9187856|P1|Overall Study|Lost to Follow-up|0
2660599|NCT00652327|9187855|P2|Overall Study|Adverse Event|2
2660600|NCT00652327|9187856|P1|Overall Study|Adverse Event|0
2660601|NCT00652093|9187898|P6|Overall Study|Physician Decision|0
2660602|NCT00652093|9187899|P5|Overall Study|Physician Decision|1
2660603|NCT00652093|9187900|P4|Overall Study|Physician Decision|0
2660604|NCT00652093|9187901|P3|Overall Study|Physician Decision|0
2660605|NCT00652093|9187902|P2|Overall Study|Physician Decision|0
2660606|NCT00652093|9187903|P1|Overall Study|Physician Decision|0
2660607|NCT00652093|9187898|P6|Overall Study|Withdrawal by Subject|0
2660608|NCT00652093|9187899|P5|Overall Study|Withdrawal by Subject|1
2660609|NCT00652093|9187900|P4|Overall Study|Withdrawal by Subject|0
2660610|NCT00652093|9187901|P3|Overall Study|Withdrawal by Subject|1
2660611|NCT00652093|9187902|P2|Overall Study|Withdrawal by Subject|0
2660612|NCT00652093|9187903|P1|Overall Study|Withdrawal by Subject|0
2660613|NCT00652028|9187993|P4|Overall Study|Physician Decision|0
2660614|NCT00652028|9187994|P3|Overall Study|Physician Decision|1
2660615|NCT00652028|9187995|P2|Overall Study|Physician Decision|0
2660616|NCT00652028|9187996|P1|Overall Study|Physician Decision|0
2660617|NCT00652028|9187993|P4|Overall Study|No Longer Meets Entry Criteria|0
2660618|NCT00652028|9187994|P3|Overall Study|No Longer Meets Entry Criteria|0
2660619|NCT00652028|9187995|P2|Overall Study|No Longer Meets Entry Criteria|1
2660620|NCT00652028|9187996|P1|Overall Study|No Longer Meets Entry Criteria|0
2660621|NCT00652028|9187993|P4|Overall Study|Adverse Event|0
2660622|NCT00652028|9187994|P3|Overall Study|Adverse Event|0
2660623|NCT00652028|9187995|P2|Overall Study|Adverse Event|0
2660624|NCT00652028|9187996|P1|Overall Study|Adverse Event|1
2660625|NCT00651937|9188040|P2|Overall Study|Withdrawal by Subject|1
2660626|NCT00651937|9188041|P1|Overall Study|Withdrawal by Subject|4
2660627|NCT00651924|9188051|P2|Overall Study|Withdrawal by Subject|5
2660628|NCT00651924|9188052|P1|Overall Study|Withdrawal by Subject|0
2660629|NCT00651924|9188051|P2|Overall Study|Withdrawal by PI|2
2660630|NCT00651924|9188052|P1|Overall Study|Withdrawal by PI|0
2660631|NCT00651820|9188058|P1|Overall Study|Lost to Follow-up|2
2660632|NCT00651755|9188090|P2|Cycle 2 (Second 21 Days)|Not Evaluable|1
2660633|NCT00651755|9188091|P1|Cycle 2 (Second 21 Days)|Not Evaluable|0
2660634|NCT00651755|9188090|P2|Cycle 1 (First 21 Days)|Withdrawal by Subject|0
2660635|NCT00651755|9188091|P1|Cycle 1 (First 21 Days)|Withdrawal by Subject|1
2660636|NCT00651664|9188117|P10|Overall Study|Reason not Specified|0
2660637|NCT00651664|9188118|P9|Overall Study|Reason not Specified|0
2660638|NCT00651664|9188119|P8|Overall Study|Reason not Specified|0
2660639|NCT00651664|9188120|P7|Overall Study|Reason not Specified|1
2660640|NCT00651664|9188121|P6|Overall Study|Reason not Specified|0
2660641|NCT00651664|9188122|P5|Overall Study|Reason not Specified|0
2660642|NCT00651664|9188123|P4|Overall Study|Reason not Specified|0
2660643|NCT00651664|9188124|P3|Overall Study|Reason not Specified|0
2660644|NCT00651664|9188125|P2|Overall Study|Reason not Specified|0
2660645|NCT00651664|9188126|P1|Overall Study|Reason not Specified|0
2660646|NCT00651664|9188117|P10|Overall Study|Symptomatic Deterioration|0
2660647|NCT00651664|9188118|P9|Overall Study|Symptomatic Deterioration|1
2660648|NCT00651664|9188119|P8|Overall Study|Symptomatic Deterioration|0
2660649|NCT00651664|9188120|P7|Overall Study|Symptomatic Deterioration|1
2660650|NCT00651664|9188121|P6|Overall Study|Symptomatic Deterioration|0
2660651|NCT00651664|9188122|P5|Overall Study|Symptomatic Deterioration|0
2660652|NCT00651664|9188123|P4|Overall Study|Symptomatic Deterioration|1
2660653|NCT00651664|9188124|P3|Overall Study|Symptomatic Deterioration|0
2660654|NCT00651664|9188125|P2|Overall Study|Symptomatic Deterioration|0
2660655|NCT00651664|9188126|P1|Overall Study|Symptomatic Deterioration|0
2660656|NCT00651664|9188117|P10|Overall Study|Patient Declined Further Treatment|1
2660657|NCT00651664|9188118|P9|Overall Study|Patient Declined Further Treatment|0
2660658|NCT00651664|9188119|P8|Overall Study|Patient Declined Further Treatment|0
2660659|NCT00651664|9188120|P7|Overall Study|Patient Declined Further Treatment|0
2660660|NCT00651664|9188121|P6|Overall Study|Patient Declined Further Treatment|1
2660661|NCT00651664|9188122|P5|Overall Study|Patient Declined Further Treatment|1
2660662|NCT00651664|9188123|P4|Overall Study|Patient Declined Further Treatment|1
2660663|NCT00651664|9188124|P3|Overall Study|Patient Declined Further Treatment|0
2660664|NCT00651664|9188125|P2|Overall Study|Patient Declined Further Treatment|0
2660665|NCT00651664|9188126|P1|Overall Study|Patient Declined Further Treatment|0
2660666|NCT00651664|9188117|P10|Overall Study|Progressive Disease|5
2660667|NCT00651664|9188118|P9|Overall Study|Progressive Disease|5
2660668|NCT00651664|9188119|P8|Overall Study|Progressive Disease|6
2660669|NCT00651664|9188120|P7|Overall Study|Progressive Disease|3
2660670|NCT00651664|9188121|P6|Overall Study|Progressive Disease|1
2660671|NCT00651664|9188122|P5|Overall Study|Progressive Disease|4
2660672|NCT00651664|9188123|P4|Overall Study|Progressive Disease|12
2660673|NCT00651664|9188124|P3|Overall Study|Progressive Disease|3
2660674|NCT00651664|9188125|P2|Overall Study|Progressive Disease|3
2660675|NCT00651664|9188126|P1|Overall Study|Progressive Disease|3
2660676|NCT00651664|9188117|P10|Overall Study|Unsatisfactory Therapeutic Response|1
2660677|NCT00651664|9188118|P9|Overall Study|Unsatisfactory Therapeutic Response|0
2660678|NCT00651664|9188119|P8|Overall Study|Unsatisfactory Therapeutic Response|1
2660679|NCT00651664|9188120|P7|Overall Study|Unsatisfactory Therapeutic Response|0
2660680|NCT00651664|9188121|P6|Overall Study|Unsatisfactory Therapeutic Response|1
2660681|NCT00651664|9188122|P5|Overall Study|Unsatisfactory Therapeutic Response|1
2660682|NCT00651664|9188123|P4|Overall Study|Unsatisfactory Therapeutic Response|0
2660683|NCT00651664|9188124|P3|Overall Study|Unsatisfactory Therapeutic Response|0
2660684|NCT00651664|9188125|P2|Overall Study|Unsatisfactory Therapeutic Response|0
2660685|NCT00651664|9188126|P1|Overall Study|Unsatisfactory Therapeutic Response|0
2660686|NCT00651664|9188117|P10|Overall Study|Occurrence of Adverse Event(s)|0
2660687|NCT00651664|9188118|P9|Overall Study|Occurrence of Adverse Event(s)|1
2660688|NCT00651664|9188119|P8|Overall Study|Occurrence of Adverse Event(s)|0
2660689|NCT00651664|9188120|P7|Overall Study|Occurrence of Adverse Event(s)|1
2660690|NCT00651664|9188121|P6|Overall Study|Occurrence of Adverse Event(s)|0
2660691|NCT00651664|9188122|P5|Overall Study|Occurrence of Adverse Event(s)|0
2660692|NCT00651664|9188123|P4|Overall Study|Occurrence of Adverse Event(s)|0
2660693|NCT00651664|9188124|P3|Overall Study|Occurrence of Adverse Event(s)|0
2660694|NCT00651664|9188125|P2|Overall Study|Occurrence of Adverse Event(s)|0
2660695|NCT00651664|9188126|P1|Overall Study|Occurrence of Adverse Event(s)|0
2660696|NCT00651313|9188298|P2|Overall Study|Adminstrative Discontinuation|3
2660697|NCT00651313|9188299|P1|Overall Study|Adminstrative Discontinuation|2
2660698|NCT00651313|9188298|P2|Overall Study|Lost to Follow-up|1
2660699|NCT00651313|9188299|P1|Overall Study|Lost to Follow-up|1
2660700|NCT00651313|9188298|P2|Overall Study|Withdrawal by Subject|1
2660701|NCT00651313|9188299|P1|Overall Study|Withdrawal by Subject|3
2660702|NCT00651313|9188298|P2|Overall Study|Adverse Event|1
2660703|NCT00651313|9188299|P1|Overall Study|Adverse Event|0
2660704|NCT00651261|9188307|P2|Overall Study|Never treated|3
2660705|NCT00651261|9188308|P1|Overall Study|Never treated|5
2660706|NCT00651261|9188307|P2|Overall Study|Other disease or participant decisions|23
2660707|NCT00651261|9188308|P1|Overall Study|Other disease or participant decisions|23
2660708|NCT00651261|9188307|P2|Overall Study|Alternative therapy|107
2660709|NCT00651261|9188308|P1|Overall Study|Alternative therapy|109
2660710|NCT00651261|9188307|P2|Overall Study|Disease progression|58
2660711|NCT00651261|9188308|P1|Overall Study|Disease progression|58
2660712|NCT00651261|9188307|P2|Overall Study|Induction failure|35
2660713|NCT00651261|9188308|P1|Overall Study|Induction failure|24
2660714|NCT00651261|9188307|P2|Overall Study|Withdrawal by Subject|40
2660715|NCT00651261|9188308|P1|Overall Study|Withdrawal by Subject|22
2660716|NCT00651261|9188307|P2|Overall Study|Death|18
2660717|NCT00651261|9188308|P1|Overall Study|Death|18
2660718|NCT00651261|9188307|P2|Overall Study|Adverse Event|22
2660719|NCT00651261|9188308|P1|Overall Study|Adverse Event|32
2660720|NCT00651183|9188324|P2|Overall Study|missing|0
2660721|NCT00651183|9188325|P1|Overall Study|missing|1
2660722|NCT00651183|9188324|P2|Overall Study|Other reasons|2
2660723|NCT00651183|9188325|P1|Overall Study|Other reasons|4
2660724|NCT00651183|9188324|P2|Overall Study|Lost to Follow-up|1
2660725|NCT00651183|9188325|P1|Overall Study|Lost to Follow-up|3
2660726|NCT00651183|9188324|P2|Overall Study|Withdrawal by Subject|3
2660727|NCT00651183|9188325|P1|Overall Study|Withdrawal by Subject|6
2660728|NCT00651183|9188324|P2|Overall Study|Tolerability insufficient +Patients wish|1
2660729|NCT00651183|9188325|P1|Overall Study|Tolerability insufficient +Patients wish|0
2660730|NCT00651183|9188324|P2|Overall Study|Tolerability insufficient|2
2660731|NCT00651183|9188325|P1|Overall Study|Tolerability insufficient|5
2660732|NCT00651183|9188324|P2|Overall Study|Efficacy insufficient + patients wish|1
2660733|NCT00651183|9188325|P1|Overall Study|Efficacy insufficient + patients wish|0
2660734|NCT00651183|9188324|P2|Overall Study|Lack of Efficacy|0
2660735|NCT00651183|9188325|P1|Overall Study|Lack of Efficacy|1
2660736|NCT00651157|9188337|P1|Overall Study|Protocol Violation|1
2660737|NCT00651157|9188337|P1|Overall Study|Death|1
2660738|NCT00651118|9188347|P4|Overall Study|Withdrawal by Subject|1
2660739|NCT00651118|9188348|P3|Overall Study|Withdrawal by Subject|1
2660740|NCT00651118|9188349|P2|Overall Study|Withdrawal by Subject|1
2660741|NCT00651118|9188350|P1|Overall Study|Withdrawal by Subject|0
2660742|NCT00651118|9188347|P4|Overall Study|administrative|1
2660743|NCT00651118|9188348|P3|Overall Study|administrative|2
2660744|NCT00651118|9188349|P2|Overall Study|administrative|4
2660745|NCT00651118|9188350|P1|Overall Study|administrative|1
2660746|NCT00651118|9188347|P4|Overall Study|Lost to Follow-up|2
2660747|NCT00651118|9188348|P3|Overall Study|Lost to Follow-up|1
2660748|NCT00651118|9188349|P2|Overall Study|Lost to Follow-up|0
2660749|NCT00651118|9188350|P1|Overall Study|Lost to Follow-up|2
2660750|NCT00651118|9188347|P4|Overall Study|Protocol Violation|2
2660751|NCT00651118|9188348|P3|Overall Study|Protocol Violation|6
2660752|NCT00651118|9188349|P2|Overall Study|Protocol Violation|2
2660753|NCT00651118|9188350|P1|Overall Study|Protocol Violation|2
2660754|NCT00651118|9188347|P4|Overall Study|Adverse Event|1
2660755|NCT00651118|9188348|P3|Overall Study|Adverse Event|1
2660756|NCT00651118|9188349|P2|Overall Study|Adverse Event|0
2660757|NCT00651118|9188350|P1|Overall Study|Adverse Event|4
2660758|NCT00650845|9188419|P2|Overall Study|Protocol Violation|13
2660759|NCT00650845|9188420|P1|Overall Study|Protocol Violation|0
2660760|NCT00650845|9188419|P2|Overall Study|Withdrawal by Subject|0
2660761|NCT00650845|9188420|P1|Overall Study|Withdrawal by Subject|5
2660762|NCT00650806|9188440|P4|Overall Study|Other|0
2660763|NCT00650806|9188441|P3|Overall Study|Other|2
2660764|NCT00650806|9188442|P2|Overall Study|Other|1
2660765|NCT00650806|9188443|P1|Overall Study|Other|1
2660766|NCT00650806|9188440|P4|Overall Study|Study terminated by sponsor|4
2660767|NCT00650806|9188441|P3|Overall Study|Study terminated by sponsor|5
2660768|NCT00650806|9188442|P2|Overall Study|Study terminated by sponsor|3
2660769|NCT00650806|9188443|P1|Overall Study|Study terminated by sponsor|2
2660770|NCT00650806|9188440|P4|Overall Study|Noncompliance with study drug regimen|0
2660771|NCT00650806|9188441|P3|Overall Study|Noncompliance with study drug regimen|0
2660772|NCT00650806|9188442|P2|Overall Study|Noncompliance with study drug regimen|1
2660773|NCT00650806|9188443|P1|Overall Study|Noncompliance with study drug regimen|1
2660774|NCT00650806|9188440|P4|Overall Study|Withdrawal by Subject|6
2660775|NCT00650806|9188441|P3|Overall Study|Withdrawal by Subject|8
2660776|NCT00650806|9188442|P2|Overall Study|Withdrawal by Subject|5
2660777|NCT00650806|9188443|P1|Overall Study|Withdrawal by Subject|7
2660778|NCT00650806|9188440|P4|Overall Study|Pregnancy|1
2660779|NCT00650806|9188441|P3|Overall Study|Pregnancy|0
2660780|NCT00650806|9188442|P2|Overall Study|Pregnancy|0
2660781|NCT00650806|9188443|P1|Overall Study|Pregnancy|0
2660782|NCT00650806|9188440|P4|Overall Study|Protocol Violation|1
2660783|NCT00650806|9188441|P3|Overall Study|Protocol Violation|0
2660784|NCT00650806|9188442|P2|Overall Study|Protocol Violation|0
2660785|NCT00650806|9188443|P1|Overall Study|Protocol Violation|0
2660786|NCT00650806|9188440|P4|Overall Study|Lost to Follow-up|10
2660787|NCT00650806|9188441|P3|Overall Study|Lost to Follow-up|11
2660788|NCT00650806|9188442|P2|Overall Study|Lost to Follow-up|6
2660789|NCT00650806|9188443|P1|Overall Study|Lost to Follow-up|7
2660790|NCT00650806|9188440|P4|Overall Study|Adverse Event|4
2660791|NCT00650806|9188441|P3|Overall Study|Adverse Event|3
2660792|NCT00650806|9188442|P2|Overall Study|Adverse Event|5
2660793|NCT00650806|9188443|P1|Overall Study|Adverse Event|0
2660794|NCT00650767|9188485|P4|Overall Study|Other|0
2660795|NCT00650767|9188486|P3|Overall Study|Other|0
2660796|NCT00650767|9188487|P2|Overall Study|Other|1
2660797|NCT00650767|9188488|P1|Overall Study|Other|1
2660798|NCT00650767|9188485|P4|Overall Study|Lost to Follow-up|0
2660799|NCT00650767|9188486|P3|Overall Study|Lost to Follow-up|1
2660800|NCT00650767|9188487|P2|Overall Study|Lost to Follow-up|1
2660801|NCT00650767|9188488|P1|Overall Study|Lost to Follow-up|1
2660802|NCT00650767|9188485|P4|Overall Study|Withdrawal by Subject|3
2660803|NCT00650767|9188486|P3|Overall Study|Withdrawal by Subject|3
2660804|NCT00650767|9188487|P2|Overall Study|Withdrawal by Subject|4
2660805|NCT00650767|9188488|P1|Overall Study|Withdrawal by Subject|2
2660806|NCT00650767|9188485|P4|Overall Study|Death|0
2660807|NCT00650767|9188486|P3|Overall Study|Death|0
2660808|NCT00650767|9188487|P2|Overall Study|Death|0
2660809|NCT00650767|9188488|P1|Overall Study|Death|1
2660810|NCT00650767|9188485|P4|Overall Study|Adverse Event|8
2660811|NCT00650767|9188486|P3|Overall Study|Adverse Event|10
2660812|NCT00650767|9188487|P2|Overall Study|Adverse Event|3
2660813|NCT00650767|9188488|P1|Overall Study|Adverse Event|0
2660814|NCT00650585|9188992|P2|Overall Study|Excluded/ruled ineligible|129
2660815|NCT00650585|9188993|P1|Overall Study|Excluded/ruled ineligible|357
2660816|NCT00650585|9188992|P2|Overall Study|No parental consent|866
2660817|NCT00650585|9188993|P1|Overall Study|No parental consent|935
2660818|NCT00650585|9188992|P2|Overall Study|Lost to Follow-up|482
2660819|NCT00650585|9188993|P1|Overall Study|Lost to Follow-up|505
2660820|NCT00650104|9189037|P1|Overall Study|Sponsor Terminated Dosing|1
2660821|NCT00650104|9189037|P1|Overall Study|Non-compliance|2
2660822|NCT00650104|9189037|P1|Overall Study|Lost to Follow-up|1
2660823|NCT00650104|9189037|P1|Overall Study|Physician Decision|7
2660824|NCT00650104|9189037|P1|Overall Study|Withdrawal by Subject|11
2660825|NCT00650104|9189037|P1|Overall Study|Death|2
2660826|NCT00650104|9189037|P1|Overall Study|Adverse Event|17
2660827|NCT00650091|9189052|P3|Amended Study Design|Other|0
2660828|NCT00650091|9189053|P2|Amended Study Design|Other|3
2660829|NCT00650091|9189054|P1|Amended Study Design|Other|1
2660830|NCT00650091|9189052|P3|Amended Study Design|Lung transplantation|0
2660831|NCT00650091|9189053|P2|Amended Study Design|Lung transplantation|2
2660832|NCT00650091|9189054|P1|Amended Study Design|Lung transplantation|4
2660833|NCT00650091|9189052|P3|Amended Study Design|Adverse Event|0
2660834|NCT00650091|9189053|P2|Amended Study Design|Adverse Event|4
2660835|NCT00650091|9189054|P1|Amended Study Design|Adverse Event|1
2660836|NCT00650091|9189052|P3|Amended Study Design|Physician Decision|0
2660837|NCT00650091|9189053|P2|Amended Study Design|Physician Decision|0
2660838|NCT00650091|9189054|P1|Amended Study Design|Physician Decision|5
2660839|NCT00650091|9189052|P3|Amended Study Design|Withdrawal by Subject|0
2660840|NCT00650091|9189053|P2|Amended Study Design|Withdrawal by Subject|11
2660841|NCT00650091|9189054|P1|Amended Study Design|Withdrawal by Subject|12
2660842|NCT00649428|9189097|P2|Overall Study|Physician Decision|1
2660843|NCT00649428|9189098|P1|Overall Study|Physician Decision|0
2660844|NCT00649428|9189097|P2|Overall Study|Protocol Violation|2
2660845|NCT00649428|9189098|P1|Overall Study|Protocol Violation|6
2660846|NCT00649428|9189097|P2|Overall Study|Insufficient manufacturing yield|1
2660847|NCT00649428|9189098|P1|Overall Study|Insufficient manufacturing yield|5
2660848|NCT00649428|9189097|P2|Overall Study|Lost to Follow-up|3
2660849|NCT00649428|9189098|P1|Overall Study|Lost to Follow-up|1
2660850|NCT00649428|9189097|P2|Overall Study|Withdrawal by Subject|6
2660851|NCT00649428|9189098|P1|Overall Study|Withdrawal by Subject|6
2660852|NCT00649428|9189097|P2|Overall Study|Adverse Event|2
2660853|NCT00649428|9189098|P1|Overall Study|Adverse Event|2
2660854|NCT00649389|9189114|P4|Overall Study|Other|6
2660855|NCT00649389|9189115|P3|Overall Study|Other|1
2660856|NCT00649389|9189116|P2|Overall Study|Other|9
2660857|NCT00649389|9189117|P1|Overall Study|Other|3
2660858|NCT00649389|9189114|P4|Overall Study|Withdrawal by Subject|23
2660859|NCT00649389|9189115|P3|Overall Study|Withdrawal by Subject|19
2660860|NCT00649389|9189116|P2|Overall Study|Withdrawal by Subject|21
2660861|NCT00649389|9189117|P1|Overall Study|Withdrawal by Subject|20
2660862|NCT00649389|9189114|P4|Overall Study|Protocol Violation|8
2660863|NCT00649389|9189115|P3|Overall Study|Protocol Violation|9
2660864|NCT00649389|9189116|P2|Overall Study|Protocol Violation|13
2660865|NCT00649389|9189117|P1|Overall Study|Protocol Violation|11
2660866|NCT00649389|9189114|P4|Overall Study|Lost to Follow-up|26
2660867|NCT00649389|9189115|P3|Overall Study|Lost to Follow-up|21
2660868|NCT00649389|9189116|P2|Overall Study|Lost to Follow-up|17
2660869|NCT00649389|9189117|P1|Overall Study|Lost to Follow-up|15
2660870|NCT00649389|9189114|P4|Overall Study|Adverse Event|48
2660871|NCT00649389|9189115|P3|Overall Study|Adverse Event|38
2660872|NCT00649389|9189116|P2|Overall Study|Adverse Event|46
2660873|NCT00649389|9189117|P1|Overall Study|Adverse Event|22
2660874|NCT00649220|9189139|P1|Overall Study|Withdrawal by Subject|1
2660875|NCT00649220|9189139|P1|Overall Study|Adverse Event|2
2660876|NCT00648895|9189160|P2|Overall Study|Lack of Efficacy|1
2660877|NCT00648895|9189161|P1|Overall Study|Lack of Efficacy|0
2660878|NCT00648739|9189167|P7|Overall Study|Follow-up Visits Not Completed|0
2660879|NCT00648739|9189168|P6|Overall Study|Follow-up Visits Not Completed|0
2660880|NCT00648739|9189169|P5|Overall Study|Follow-up Visits Not Completed|0
2660881|NCT00648739|9189170|P4|Overall Study|Follow-up Visits Not Completed|0
2660882|NCT00648739|9189171|P3|Overall Study|Follow-up Visits Not Completed|0
2660883|NCT00648739|9189172|P2|Overall Study|Follow-up Visits Not Completed|1
2660884|NCT00648739|9189173|P1|Overall Study|Follow-up Visits Not Completed|0
2660885|NCT00648739|9189167|P7|Overall Study|Positive Human Anti-human Antibody|0
2660886|NCT00648739|9189168|P6|Overall Study|Positive Human Anti-human Antibody|0
2660887|NCT00648739|9189169|P5|Overall Study|Positive Human Anti-human Antibody|0
2660888|NCT00648739|9189170|P4|Overall Study|Positive Human Anti-human Antibody|0
2660889|NCT00648739|9189171|P3|Overall Study|Positive Human Anti-human Antibody|1
2660890|NCT00648739|9189172|P2|Overall Study|Positive Human Anti-human Antibody|0
2660891|NCT00648739|9189173|P1|Overall Study|Positive Human Anti-human Antibody|0
2660892|NCT00648739|9189167|P7|Overall Study|Death|0
2660893|NCT00648739|9189168|P6|Overall Study|Death|0
2660894|NCT00648739|9189169|P5|Overall Study|Death|0
2660895|NCT00648739|9189170|P4|Overall Study|Death|0
2660896|NCT00648739|9189171|P3|Overall Study|Death|0
2660897|NCT00648739|9189172|P2|Overall Study|Death|1
2660898|NCT00648739|9189173|P1|Overall Study|Death|0
2660899|NCT00648739|9189167|P7|Overall Study|Investigator Considered it Advisable|1
2660900|NCT00648739|9189168|P6|Overall Study|Investigator Considered it Advisable|1
2660901|NCT00648739|9189169|P5|Overall Study|Investigator Considered it Advisable|0
2660902|NCT00648739|9189170|P4|Overall Study|Investigator Considered it Advisable|0
2660903|NCT00648739|9189171|P3|Overall Study|Investigator Considered it Advisable|0
2660904|NCT00648739|9189172|P2|Overall Study|Investigator Considered it Advisable|0
2660905|NCT00648739|9189173|P1|Overall Study|Investigator Considered it Advisable|0
2660906|NCT00648739|9189167|P7|Overall Study|Lack of Efficacy|0
2660907|NCT00648739|9189168|P6|Overall Study|Lack of Efficacy|2
2660908|NCT00648739|9189169|P5|Overall Study|Lack of Efficacy|1
2660909|NCT00648739|9189170|P4|Overall Study|Lack of Efficacy|0
2660910|NCT00648739|9189171|P3|Overall Study|Lack of Efficacy|0
2660911|NCT00648739|9189172|P2|Overall Study|Lack of Efficacy|0
2660912|NCT00648739|9189173|P1|Overall Study|Lack of Efficacy|0
2660913|NCT00648739|9189167|P7|Overall Study|Withdrawal by Subject|0
2660914|NCT00648739|9189168|P6|Overall Study|Withdrawal by Subject|2
2660915|NCT00648739|9189169|P5|Overall Study|Withdrawal by Subject|0
2660916|NCT00648739|9189170|P4|Overall Study|Withdrawal by Subject|0
2660917|NCT00648739|9189171|P3|Overall Study|Withdrawal by Subject|1
2660918|NCT00648739|9189172|P2|Overall Study|Withdrawal by Subject|0
2660919|NCT00648739|9189173|P1|Overall Study|Withdrawal by Subject|1
2660920|NCT00648739|9189167|P7|Overall Study|Adverse Event|0
2660921|NCT00648739|9189168|P6|Overall Study|Adverse Event|0
2660922|NCT00648739|9189169|P5|Overall Study|Adverse Event|1
2660923|NCT00648739|9189170|P4|Overall Study|Adverse Event|2
2660924|NCT00648739|9189171|P3|Overall Study|Adverse Event|1
2660925|NCT00648739|9189172|P2|Overall Study|Adverse Event|0
2660926|NCT00648739|9189173|P1|Overall Study|Adverse Event|1
2660927|NCT00648167|9189507|P1|Overall Study|unable to swallow tablets|1
2660928|NCT00648167|9189507|P1|Overall Study|Adverse Event|6
2660929|NCT00648037|9189527|P1|Overall Study|Other|1
2660930|NCT00648037|9189527|P1|Overall Study|Relapse|2
2660931|NCT00648037|9189527|P1|Overall Study|Adverse Event|11
2660932|NCT00648037|9189527|P1|Overall Study|Withdrawal by Subject|1
2660933|NCT00648037|9189527|P1|Overall Study|Not Treated|1
2660934|NCT00647699|9189546|P2|Overall Study|Withdrawal by Subject|8
2660935|NCT00647699|9189547|P1|Overall Study|Withdrawal by Subject|3
2660936|NCT00647699|9189546|P2|Overall Study|Lost to Follow-up|4
2660937|NCT00647699|9189547|P1|Overall Study|Lost to Follow-up|5
2660938|NCT00647556|9189555|P2|Overall Study|Surgery for pre-existing neck pain|0
2660939|NCT00647556|9189556|P1|Overall Study|Surgery for pre-existing neck pain|1
2660940|NCT00647556|9189555|P2|Overall Study|Withdrawal by Subject|0
2660941|NCT00647556|9189556|P1|Overall Study|Withdrawal by Subject|1
2660942|NCT00647556|9189555|P2|Overall Study|Protocol Violation|1
2660943|NCT00647556|9189556|P1|Overall Study|Protocol Violation|0
2660944|NCT00647556|9189555|P2|Overall Study|Lost to Follow-up|0
2660945|NCT00647556|9189556|P1|Overall Study|Lost to Follow-up|1
2660946|NCT00647556|9189555|P2|Overall Study|Adverse Event|1
2660947|NCT00647556|9189556|P1|Overall Study|Adverse Event|0
2660948|NCT00647426|9189570|P1|Overall Study|Withdrawal by Subject|2
2660949|NCT00647348|9189592|P2|Overall Study|Lost to Follow-up|6
2660950|NCT00647348|9189593|P1|Overall Study|Lost to Follow-up|3
2660951|NCT00647270|9189618|P3|Period 2, Placebo Switched to Adalimumab|Other|0
2660952|NCT00647270|9189619|P2|Period 2, Placebo Switched to Adalimumab|Other|6
2660953|NCT00647270|9189620|P1|Period 2, Placebo Switched to Adalimumab|Other|2
2660954|NCT00647270|9189618|P3|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4
2660955|NCT00647270|9189619|P2|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
2660956|NCT00647270|9189620|P1|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
2660957|NCT00647270|9189618|P3|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
2660958|NCT00647270|9189619|P2|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
2660959|NCT00647270|9189620|P1|Period 2, Placebo Switched to Adalimumab|Adverse Event|1
2660960|NCT00647270|9189618|P3|Period 1, Placebo-control (12 Weeks)|Other|8
2660961|NCT00647270|9189619|P2|Period 1, Placebo-control (12 Weeks)|Other|4
2660962|NCT00647270|9189620|P1|Period 1, Placebo-control (12 Weeks)|Other|4
2660963|NCT00647270|9189618|P3|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7
2660964|NCT00647270|9189619|P2|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1
2660965|NCT00647270|9189620|P1|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2
2660966|NCT00647270|9189618|P3|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
2660967|NCT00647270|9189619|P2|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
2660968|NCT00647270|9189620|P1|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0
2660969|NCT00647270|9189618|P3|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
2660970|NCT00647270|9189619|P2|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
2660971|NCT00647270|9189620|P1|Period 1, Placebo-control (12 Weeks)|Adverse Event|2
2660972|NCT00646958|9189646|P3|Overall Study|Did not receive study drug|2
2660973|NCT00646958|9189647|P2|Overall Study|Did not receive study drug|0
2660974|NCT00646958|9189648|P1|Overall Study|Did not receive study drug|2
2660975|NCT00646958|9189646|P3|Overall Study|Withdrawal by Subject|0
2660976|NCT00646958|9189647|P2|Overall Study|Withdrawal by Subject|2
2660977|NCT00646958|9189648|P1|Overall Study|Withdrawal by Subject|1
2660978|NCT00646958|9189646|P3|Overall Study|Abnormal screening lab tests|0
2660979|NCT00646958|9189647|P2|Overall Study|Abnormal screening lab tests|1
2660980|NCT00646958|9189648|P1|Overall Study|Abnormal screening lab tests|1
2660981|NCT00646958|9189646|P3|Overall Study|Protocol Violation|0
2660982|NCT00646958|9189647|P2|Overall Study|Protocol Violation|1
2660983|NCT00646958|9189648|P1|Overall Study|Protocol Violation|1
2660984|NCT00646958|9189646|P3|Overall Study|Lost to Follow-up|7
2660985|NCT00646958|9189647|P2|Overall Study|Lost to Follow-up|5
2660986|NCT00646958|9189648|P1|Overall Study|Lost to Follow-up|1
2660987|NCT00646958|9189646|P3|Overall Study|Adverse Event|0
2660988|NCT00646958|9189647|P2|Overall Study|Adverse Event|0
2660989|NCT00646958|9189648|P1|Overall Study|Adverse Event|4
2660990|NCT00646958|9189646|P3|Overall Study|Lack of Efficacy|0
2660991|NCT00646958|9189647|P2|Overall Study|Lack of Efficacy|0
2660992|NCT00646958|9189648|P1|Overall Study|Lack of Efficacy|1
2660993|NCT00646906|9189663|P7|Crossover Period 2|Physician Decision|1
2660994|NCT00646906|9189664|P6|Crossover Period 2|Physician Decision|0
2660995|NCT00646906|9189665|P5|Crossover Period 2|Physician Decision|0
2660996|NCT00646906|9189666|P4|Crossover Period 2|Physician Decision|0
2660997|NCT00646906|9189667|P3|Crossover Period 2|Physician Decision|0
2660998|NCT00646906|9189668|P2|Crossover Period 2|Physician Decision|0
2660999|NCT00646906|9189669|P1|Crossover Period 2|Physician Decision|0
2661000|NCT00646906|9189663|P7|Crossover Period 2|Withdrawal by Subject|0
2661001|NCT00646906|9189664|P6|Crossover Period 2|Withdrawal by Subject|0
2661002|NCT00646906|9189665|P5|Crossover Period 2|Withdrawal by Subject|0
2661003|NCT00646906|9189666|P4|Crossover Period 2|Withdrawal by Subject|1
2661004|NCT00646906|9189667|P3|Crossover Period 2|Withdrawal by Subject|2
2661005|NCT00646906|9189668|P2|Crossover Period 2|Withdrawal by Subject|1
2661006|NCT00646906|9189669|P1|Crossover Period 2|Withdrawal by Subject|0
2661007|NCT00646906|9189663|P7|Crossover Period 1|Withdrawal by Subject|0
2661008|NCT00646906|9189664|P6|Crossover Period 1|Withdrawal by Subject|1
2661009|NCT00646906|9189665|P5|Crossover Period 1|Withdrawal by Subject|0
2661010|NCT00646906|9189666|P4|Crossover Period 1|Withdrawal by Subject|0
2661011|NCT00646906|9189667|P3|Crossover Period 1|Withdrawal by Subject|0
2661012|NCT00646906|9189668|P2|Crossover Period 1|Withdrawal by Subject|0
2661013|NCT00646906|9189669|P1|Crossover Period 1|Withdrawal by Subject|1
2661014|NCT00646776|9189688|P2|Overall Study|Investigator discretion|4
2661015|NCT00646776|9189689|P1|Overall Study|Investigator discretion|0
2661016|NCT00646776|9189688|P2|Overall Study|Adverse Event|9
2661017|NCT00646776|9189689|P1|Overall Study|Adverse Event|1
2661018|NCT00646399|9189787|P2|Overall Study|Other Reason|11
2661019|NCT00646399|9189788|P1|Overall Study|Other Reason|11
2661020|NCT00646399|9189787|P2|Overall Study|Withdrawal by Subject|10
2661021|NCT00646399|9189788|P1|Overall Study|Withdrawal by Subject|9
2661022|NCT00646399|9189787|P2|Overall Study|Death|53
2661023|NCT00646399|9189788|P1|Overall Study|Death|63
2661024|NCT00646282|9189796|P2|Overall Study|Protocol terminated|4
2661025|NCT00646282|9189797|P1|Overall Study|Protocol terminated|4
2661026|NCT00646113|9189803|P1|Overall Study|Adverse Event|3
2661027|NCT00646113|9189803|P1|Overall Study|Lost to Follow-up|5
2661028|NCT00645944|9189824|P2|Received Medication|Protocol Violation|1
2661029|NCT00645944|9189825|P1|Received Medication|Protocol Violation|2
2661030|NCT00645944|9189824|P2|Received Medication|Lost to Follow-up|0
2661031|NCT00645944|9189825|P1|Received Medication|Lost to Follow-up|1
2661032|NCT00645944|9189824|P2|Received Medication|Withdrawal by Subject|1
2661033|NCT00645944|9189825|P1|Received Medication|Withdrawal by Subject|1
2661034|NCT00645944|9189824|P2|Received Medication|Adverse Event|1
2661035|NCT00645944|9189825|P1|Received Medication|Adverse Event|2
2661036|NCT00645944|9189824|P2|Randomized|Withdrawal by Subject|2
2661037|NCT00645944|9189825|P1|Randomized|Withdrawal by Subject|1
2661038|NCT00645853|9189833|P2|Overall Study|recall of ICF, planned operation, death|4
2661039|NCT00645853|9189834|P1|Overall Study|recall of ICF, planned operation, death|7
2661040|NCT00645853|9189833|P2|Overall Study|Discontinuation criteria|2
2661041|NCT00645853|9189834|P1|Overall Study|Discontinuation criteria|2
2661042|NCT00645853|9189833|P2|Overall Study|Protocol Violation|2
2661043|NCT00645853|9189834|P1|Overall Study|Protocol Violation|0
2661044|NCT00645853|9189833|P2|Overall Study|Withdrawal by Subject|2
2661045|NCT00645853|9189834|P1|Overall Study|Withdrawal by Subject|5
2661046|NCT00645853|9189833|P2|Overall Study|AZ study closure in Hungary|40
2661047|NCT00645853|9189834|P1|Overall Study|AZ study closure in Hungary|60
2661048|NCT00645853|9189833|P2|Overall Study|Adverse Event|7
2661049|NCT00645853|9189834|P1|Overall Study|Adverse Event|18
2661050|NCT00645840|9189852|P1|Overall Study|Protocol Violation|3
2661051|NCT00645788|9189870|P4|Overall Study|Pulmonary exacerbation|9
2661052|NCT00645788|9189871|P3|Overall Study|Pulmonary exacerbation|11
2661053|NCT00645788|9189872|P2|Overall Study|Pulmonary exacerbation|16
2661054|NCT00645788|9189873|P1|Overall Study|Pulmonary exacerbation|13
2661055|NCT00645788|9189870|P4|Overall Study|Withdrawal by Subject|2
2661056|NCT00645788|9189871|P3|Overall Study|Withdrawal by Subject|0
2661057|NCT00645788|9189872|P2|Overall Study|Withdrawal by Subject|1
2661058|NCT00645788|9189873|P1|Overall Study|Withdrawal by Subject|0
2661059|NCT00645788|9189870|P4|Overall Study|Protocol Violation|0
2661060|NCT00645788|9189871|P3|Overall Study|Protocol Violation|2
2661061|NCT00645788|9189872|P2|Overall Study|Protocol Violation|0
2661062|NCT00645788|9189873|P1|Overall Study|Protocol Violation|1
2661063|NCT00645788|9189870|P4|Overall Study|Lost to Follow-up|0
2661064|NCT00645788|9189871|P3|Overall Study|Lost to Follow-up|0
2661065|NCT00645788|9189872|P2|Overall Study|Lost to Follow-up|0
2661066|NCT00645788|9189873|P1|Overall Study|Lost to Follow-up|1
2661067|NCT00645788|9189870|P4|Overall Study|Adverse Event|3
2661068|NCT00645788|9189871|P3|Overall Study|Adverse Event|5
2661069|NCT00645788|9189872|P2|Overall Study|Adverse Event|9
2661070|NCT00645788|9189873|P1|Overall Study|Adverse Event|4
2661071|NCT00645788|9189870|P4|Overall Study|Did not receive study drug|0
2661072|NCT00645788|9189871|P3|Overall Study|Did not receive study drug|0
2661073|NCT00645788|9189872|P2|Overall Study|Did not receive study drug|1
2661074|NCT00645788|9189873|P1|Overall Study|Did not receive study drug|1
2661075|NCT00645671|9189951|P2|Overall Study|Physician Decision|1
2661076|NCT00645671|9189952|P1|Overall Study|Physician Decision|0
2661077|NCT00645671|9189951|P2|Overall Study|Adverse Event|1
2661078|NCT00645671|9189952|P1|Overall Study|Adverse Event|0
2661079|NCT00645671|9189951|P2|Overall Study|Withdrawal by Subject|4
2661080|NCT00645671|9189952|P1|Overall Study|Withdrawal by Subject|0
2661081|NCT00645671|9189951|P2|Overall Study|Protocol Violation|0
2661082|NCT00645671|9189952|P1|Overall Study|Protocol Violation|1
2661083|NCT00645593|9189966|P2|Overall Study|Later found to be ineligible|0
2661084|NCT00645593|9189967|P1|Overall Study|Later found to be ineligible|1
2661085|NCT00645567|9189979|P1|Overall Study|Adverse Event|1
2661086|NCT00645528|9189987|P1|Overall Study|Did not show up for Visit 2|7
2661087|NCT00645411|9190009|P4|Overall Study|Unable to classify|4
2661088|NCT00645411|9190010|P3|Overall Study|Unable to classify|3
2661089|NCT00645411|9190011|P2|Overall Study|Unable to classify|0
2661090|NCT00645411|9190012|P1|Overall Study|Unable to classify|0
2661091|NCT00645411|9190009|P4|Overall Study|Inappropriate enrollment|1
2661092|NCT00645411|9190010|P3|Overall Study|Inappropriate enrollment|4
2661093|NCT00645411|9190011|P2|Overall Study|Inappropriate enrollment|0
2661094|NCT00645411|9190012|P1|Overall Study|Inappropriate enrollment|0
2661095|NCT00645411|9190009|P4|Overall Study|Protocol Violation|0
2661096|NCT00645411|9190010|P3|Overall Study|Protocol Violation|1
2661097|NCT00645411|9190011|P2|Overall Study|Protocol Violation|0
2661098|NCT00645411|9190012|P1|Overall Study|Protocol Violation|1
2661099|NCT00645411|9190009|P4|Overall Study|Lost to Follow-up|75
2661100|NCT00645411|9190010|P3|Overall Study|Lost to Follow-up|124
2661101|NCT00645411|9190011|P2|Overall Study|Lost to Follow-up|5
2661102|NCT00645411|9190012|P1|Overall Study|Lost to Follow-up|10
2661103|NCT00645411|9190009|P4|Overall Study|Withdrawal by Subject|21
2661104|NCT00645411|9190010|P3|Overall Study|Withdrawal by Subject|19
2661105|NCT00645411|9190011|P2|Overall Study|Withdrawal by Subject|1
2661106|NCT00645411|9190012|P1|Overall Study|Withdrawal by Subject|2
2661107|NCT00645411|9190009|P4|Overall Study|Adverse Event|2
2661108|NCT00645411|9190010|P3|Overall Study|Adverse Event|0
2661109|NCT00645411|9190011|P2|Overall Study|Adverse Event|0
2661110|NCT00645411|9190012|P1|Overall Study|Adverse Event|0
2661111|NCT00645164|9190054|P1|Overall Study|Protocol Violation|1
2661112|NCT00645164|9190054|P1|Overall Study|Withdrawal by Subject|4
2661113|NCT00645164|9190054|P1|Overall Study|Lost to Follow-up|2
2661114|NCT00645099|9190060|P2|Overall Study|Other|5
2661115|NCT00645099|9190061|P1|Overall Study|Other|9
2661116|NCT00645099|9190060|P2|Overall Study|Adverse Event|5
2661117|NCT00645099|9190061|P1|Overall Study|Adverse Event|11
2661118|NCT00645099|9190060|P2|Overall Study|Lost to Follow-up|4
2661119|NCT00645099|9190061|P1|Overall Study|Lost to Follow-up|6
2661120|NCT00645099|9190060|P2|Overall Study|Withdrawal by Subject|22
2661121|NCT00645099|9190061|P1|Overall Study|Withdrawal by Subject|30
2661122|NCT00645099|9190060|P2|Overall Study|Lack of Efficacy|6
2661123|NCT00645099|9190061|P1|Overall Study|Lack of Efficacy|15
2661124|NCT00644995|9190130|P2|Overall Study|Refused|0
2661125|NCT00644995|9190131|P1|Overall Study|Refused|1
2661126|NCT00644995|9190130|P2|Overall Study|Lost to Follow-up|4
2661127|NCT00644995|9190131|P1|Overall Study|Lost to Follow-up|1
2661128|NCT00644969|9190151|P2|Post Treatment Phase|Other|0
2661129|NCT00644969|9190152|P1|Post Treatment Phase|Other|1
2661130|NCT00644969|9190151|P2|Post Treatment Phase|Lost to Follow-up|1
2661131|NCT00644969|9190152|P1|Post Treatment Phase|Lost to Follow-up|4
2661132|NCT00644969|9190151|P2|Post Treatment Phase|Withdrawal by Subject|2
2661133|NCT00644969|9190152|P1|Post Treatment Phase|Withdrawal by Subject|4
2661134|NCT00644969|9190151|P2|Post Treatment Phase|Death|0
2661135|NCT00644969|9190152|P1|Post Treatment Phase|Death|1
2661136|NCT00644969|9190151|P2|Treatment Phase|Other|1
2661137|NCT00644969|9190152|P1|Treatment Phase|Other|4
2661138|NCT00644969|9190151|P2|Treatment Phase|Lost to Follow-up|2
2661139|NCT00644969|9190152|P1|Treatment Phase|Lost to Follow-up|2
2661140|NCT00644969|9190151|P2|Treatment Phase|Withdrawal by Subject|0
2661141|NCT00644969|9190152|P1|Treatment Phase|Withdrawal by Subject|4
2661142|NCT00644969|9190151|P2|Treatment Phase|Adverse Event|0
2661143|NCT00644969|9190152|P1|Treatment Phase|Adverse Event|3
2661144|NCT00644969|9190151|P2|Treatment Phase|Randomized, not treated|0
2661145|NCT00644969|9190152|P1|Treatment Phase|Randomized, not treated|1
2661146|NCT00644917|9190198|P1|Overall Study|Withdrawal by Subject|2
2661147|NCT00644787|9190206|P3|Period 2: Double Blind Phase|Worsening of symptoms|1
2661148|NCT00644787|9190207|P2|Period 2: Double Blind Phase|Worsening of symptoms|0
2661149|NCT00644787|9190208|P1|Period 2: Double Blind Phase|Worsening of symptoms|0
2661150|NCT00644787|9190206|P3|Period 2: Double Blind Phase|Worsening of underlying disease|2
2661151|NCT00644787|9190207|P2|Period 2: Double Blind Phase|Worsening of underlying disease|6
2661152|NCT00644787|9190208|P1|Period 2: Double Blind Phase|Worsening of underlying disease|0
2661153|NCT00644787|9190206|P3|Period 2: Double Blind Phase|Withdrawal by Subject|0
2661154|NCT00644787|9190207|P2|Period 2: Double Blind Phase|Withdrawal by Subject|1
2661155|NCT00644787|9190208|P1|Period 2: Double Blind Phase|Withdrawal by Subject|0
2661156|NCT00644787|9190206|P3|Period 2: Double Blind Phase|Adverse Event|4
2661157|NCT00644787|9190207|P2|Period 2: Double Blind Phase|Adverse Event|2
2661158|NCT00644787|9190208|P1|Period 2: Double Blind Phase|Adverse Event|0
2661159|NCT00644787|9190206|P3|Period 1: Titration Phase|Participant was judged as ineligible|0
2661160|NCT00644787|9190207|P2|Period 1: Titration Phase|Participant was judged as ineligible|0
2661161|NCT00644787|9190208|P1|Period 1: Titration Phase|Participant was judged as ineligible|3
2661162|NCT00644787|9190206|P3|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
2661163|NCT00644787|9190207|P2|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
2661164|NCT00644787|9190208|P1|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3
2661165|NCT00644787|9190206|P3|Period 1: Titration Phase|Worsening of symptoms|0
2661166|NCT00644787|9190207|P2|Period 1: Titration Phase|Worsening of symptoms|0
2661167|NCT00644787|9190208|P1|Period 1: Titration Phase|Worsening of symptoms|1
2661168|NCT00644787|9190206|P3|Period 1: Titration Phase|Worsening of complications|0
2661169|NCT00644787|9190207|P2|Period 1: Titration Phase|Worsening of complications|0
2661170|NCT00644787|9190208|P1|Period 1: Titration Phase|Worsening of complications|1
2661171|NCT00644787|9190206|P3|Period 1: Titration Phase|Worsening of underlying disease|0
2661172|NCT00644787|9190207|P2|Period 1: Titration Phase|Worsening of underlying disease|0
2661173|NCT00644787|9190208|P1|Period 1: Titration Phase|Worsening of underlying disease|5
2661174|NCT00644787|9190206|P3|Period 1: Titration Phase|Physician Decision|0
2661175|NCT00644787|9190207|P2|Period 1: Titration Phase|Physician Decision|0
2661176|NCT00644787|9190208|P1|Period 1: Titration Phase|Physician Decision|1
2661177|NCT00644787|9190206|P3|Period 1: Titration Phase|Withdrawal by Subject|0
2661178|NCT00644787|9190207|P2|Period 1: Titration Phase|Withdrawal by Subject|0
2661179|NCT00644787|9190208|P1|Period 1: Titration Phase|Withdrawal by Subject|2
2661180|NCT00644787|9190206|P3|Period 1: Titration Phase|Adverse Event|0
2661181|NCT00644787|9190207|P2|Period 1: Titration Phase|Adverse Event|0
2661182|NCT00644787|9190208|P1|Period 1: Titration Phase|Adverse Event|11
2661183|NCT00644423|9190252|P2|Overall Study|Lost to Follow-up|1
2661184|NCT00644423|9190253|P1|Overall Study|Lost to Follow-up|1
2661185|NCT00644358|9190271|P1|Overall Study|Other Unspecified|11
2661186|NCT00644358|9190271|P1|Overall Study|Noncompliance|14
2661187|NCT00644358|9190271|P1|Overall Study|Protocol Violation|5
2661188|NCT00644358|9190271|P1|Overall Study|Lack of Effectiveness|39
2661189|NCT00644358|9190271|P1|Overall Study|Consent Withdrawal|64
2661190|NCT00644358|9190271|P1|Overall Study|Lost to Follow-up|105
2661191|NCT00644358|9190271|P1|Overall Study|Adverse Event|124
2661192|NCT00644332|9190278|P1|Overall Study|Could Not Attend Scheduled Visits|1
2661193|NCT00644332|9190278|P1|Overall Study|Did Not Meet Eligibility Requirements|1
2661194|NCT00644332|9190278|P1|Overall Study|Completion Status Unknown|2
2661195|NCT00644332|9190278|P1|Overall Study|Withdrawal by Subject|6
2661196|NCT00644332|9190278|P1|Overall Study|Adverse Event|11
2661197|NCT00644228|9190304|P2|Maintenance|On Treatment|40
2661198|NCT00644228|9190305|P1|Maintenance|On Treatment|26
2661199|NCT00644228|9190304|P2|Maintenance|Not Protocol-Specified|15
2661200|NCT00644228|9190305|P1|Maintenance|Not Protocol-Specified|14
2661201|NCT00644228|9190304|P2|Maintenance|Death|3
2661202|NCT00644228|9190305|P1|Maintenance|Death|3
2661203|NCT00644228|9190304|P2|Maintenance|Progression/Relapse|42
2661204|NCT00644228|9190305|P1|Maintenance|Progression/Relapse|67
2661205|NCT00644228|9190304|P2|Maintenance|Withdrawal by Subject|4
2661206|NCT00644228|9190305|P1|Maintenance|Withdrawal by Subject|6
2661207|NCT00644228|9190304|P2|Maintenance|Adverse Event|31
2661208|NCT00644228|9190305|P1|Maintenance|Adverse Event|27
2661209|NCT00644228|9190304|P2|Induction Therapy|Not Protocol-Specified|28
2661210|NCT00644228|9190305|P1|Induction Therapy|Not Protocol-Specified|24
2661211|NCT00644228|9190304|P2|Induction Therapy|Death|7
2661212|NCT00644228|9190305|P1|Induction Therapy|Death|3
2661213|NCT00644228|9190304|P2|Induction Therapy|Progression/Relapse|12
2661214|NCT00644228|9190305|P1|Induction Therapy|Progression/Relapse|24
2661215|NCT00644228|9190304|P2|Induction Therapy|Withdrawal by Subject|3
2661216|NCT00644228|9190305|P1|Induction Therapy|Withdrawal by Subject|10
2661217|NCT00644228|9190304|P2|Induction Therapy|Adverse Event|55
2661218|NCT00644228|9190305|P1|Induction Therapy|Adverse Event|22
2661219|NCT00644228|9190304|P2|Randomization & Eligibility|Invalid Consent|1
2661220|NCT00644228|9190305|P1|Randomization & Eligibility|Invalid Consent|0
2661221|NCT00644228|9190304|P2|Randomization & Eligibility|Withdrew Consent prior to therapy start|0
2661222|NCT00644228|9190305|P1|Randomization & Eligibility|Withdrew Consent prior to therapy start|1
2661223|NCT00644228|9190304|P2|Randomization & Eligibility|Ineligible|21
2661224|NCT00644228|9190305|P1|Randomization & Eligibility|Ineligible|31
2661225|NCT00644059|9190334|P3|Overall Study|Unable to classify|3
2661226|NCT00644059|9190335|P2|Overall Study|Unable to classify|2
2661227|NCT00644059|9190336|P1|Overall Study|Unable to classify|6
2661228|NCT00644059|9190334|P3|Overall Study|Protocol Deviation/violation|15
2661229|NCT00644059|9190335|P2|Overall Study|Protocol Deviation/violation|19
2661230|NCT00644059|9190336|P1|Overall Study|Protocol Deviation/violation|20
2661231|NCT00644059|9190334|P3|Overall Study|Inappropriate Enrollment|0
2661232|NCT00644059|9190335|P2|Overall Study|Inappropriate Enrollment|3
2661233|NCT00644059|9190336|P1|Overall Study|Inappropriate Enrollment|1
2661234|NCT00644059|9190334|P3|Overall Study|Adverse Event|1
2661235|NCT00644059|9190335|P2|Overall Study|Adverse Event|5
2661236|NCT00644059|9190336|P1|Overall Study|Adverse Event|8
2661237|NCT00644059|9190334|P3|Overall Study|Withdrawal by Subject|30
2661238|NCT00644059|9190335|P2|Overall Study|Withdrawal by Subject|60
2661239|NCT00644059|9190336|P1|Overall Study|Withdrawal by Subject|52
2661240|NCT00644059|9190334|P3|Overall Study|Lost to Follow-up|16
2661241|NCT00644059|9190335|P2|Overall Study|Lost to Follow-up|34
2661242|NCT00644059|9190336|P1|Overall Study|Lost to Follow-up|37
2661243|NCT00643916|9190426|P6|Overall Study|Not Vaccinated|0
2661244|NCT00643916|9190427|P5|Overall Study|Not Vaccinated|2
2661245|NCT00643916|9190428|P4|Overall Study|Not Vaccinated|0
2661246|NCT00643916|9190429|P3|Overall Study|Not Vaccinated|3
2661247|NCT00643916|9190430|P2|Overall Study|Not Vaccinated|2
2661248|NCT00643916|9190431|P1|Overall Study|Not Vaccinated|2
2661249|NCT00643916|9190426|P6|Overall Study|Withdrawal by Subject|1
2661250|NCT00643916|9190427|P5|Overall Study|Withdrawal by Subject|0
2661251|NCT00643916|9190428|P4|Overall Study|Withdrawal by Subject|1
2661252|NCT00643916|9190429|P3|Overall Study|Withdrawal by Subject|2
2661253|NCT00643916|9190430|P2|Overall Study|Withdrawal by Subject|2
2661254|NCT00643916|9190431|P1|Overall Study|Withdrawal by Subject|2
2661255|NCT00643916|9190426|P6|Overall Study|Lost to Follow-up|0
2661256|NCT00643916|9190427|P5|Overall Study|Lost to Follow-up|0
2661257|NCT00643916|9190428|P4|Overall Study|Lost to Follow-up|0
2661258|NCT00643916|9190429|P3|Overall Study|Lost to Follow-up|0
2661259|NCT00643916|9190430|P2|Overall Study|Lost to Follow-up|1
2661260|NCT00643916|9190431|P1|Overall Study|Lost to Follow-up|0
2661261|NCT00643916|9190426|P6|Overall Study|Protocol Violation|0
2661262|NCT00643916|9190427|P5|Overall Study|Protocol Violation|0
2661263|NCT00643916|9190428|P4|Overall Study|Protocol Violation|1
2661264|NCT00643916|9190429|P3|Overall Study|Protocol Violation|1
2661265|NCT00643916|9190430|P2|Overall Study|Protocol Violation|1
2661266|NCT00643916|9190431|P1|Overall Study|Protocol Violation|0
2661267|NCT00643851|9190460|P3|Overall Study|Non-compl., not met criteria, etc.|6
2661268|NCT00643851|9190461|P2|Overall Study|Non-compl., not met criteria, etc.|4
2661269|NCT00643851|9190462|P1|Overall Study|Non-compl., not met criteria, etc.|3
2661270|NCT00643851|9190460|P3|Overall Study|Withdrawal by Subject|9
2661271|NCT00643851|9190461|P2|Overall Study|Withdrawal by Subject|15
2661272|NCT00643851|9190462|P1|Overall Study|Withdrawal by Subject|8
2661273|NCT00643851|9190460|P3|Overall Study|Lost to Follow-up|9
2661274|NCT00643851|9190461|P2|Overall Study|Lost to Follow-up|6
2661275|NCT00643851|9190462|P1|Overall Study|Lost to Follow-up|4
2661276|NCT00643851|9190460|P3|Overall Study|Adverse Event|6
2661277|NCT00643851|9190461|P2|Overall Study|Adverse Event|6
2661278|NCT00643851|9190462|P1|Overall Study|Adverse Event|2
2661279|NCT00643851|9190460|P3|Overall Study|Lack of Efficacy|0
2661280|NCT00643851|9190461|P2|Overall Study|Lack of Efficacy|1
2661281|NCT00643851|9190462|P1|Overall Study|Lack of Efficacy|0
2661282|NCT00643851|9190460|P3|Overall Study|Death|0
2661283|NCT00643851|9190461|P2|Overall Study|Death|1
2661284|NCT00643851|9190462|P1|Overall Study|Death|0
2661285|NCT00643760|9190490|P5|Overall Study|Withdrawal by Subject|1
2661286|NCT00643760|9190491|P4|Overall Study|Withdrawal by Subject|4
2661287|NCT00643760|9190492|P3|Overall Study|Withdrawal by Subject|2
2661288|NCT00643760|9190493|P2|Overall Study|Withdrawal by Subject|1
2661289|NCT00643760|9190494|P1|Overall Study|Withdrawal by Subject|3
2661290|NCT00643760|9190490|P5|Overall Study|Investigator Discretion|0
2661291|NCT00643760|9190491|P4|Overall Study|Investigator Discretion|2
2661292|NCT00643760|9190492|P3|Overall Study|Investigator Discretion|0
2661293|NCT00643760|9190493|P2|Overall Study|Investigator Discretion|0
2661294|NCT00643760|9190494|P1|Overall Study|Investigator Discretion|0
2661295|NCT00643760|9190490|P5|Overall Study|Lost to Follow-up|3
2661296|NCT00643760|9190491|P4|Overall Study|Lost to Follow-up|3
2661297|NCT00643760|9190492|P3|Overall Study|Lost to Follow-up|1
2661298|NCT00643760|9190493|P2|Overall Study|Lost to Follow-up|2
2661299|NCT00643760|9190494|P1|Overall Study|Lost to Follow-up|6
2661300|NCT00643760|9190490|P5|Overall Study|Protocol Violation|6
2661301|NCT00643760|9190491|P4|Overall Study|Protocol Violation|4
2661302|NCT00643760|9190492|P3|Overall Study|Protocol Violation|4
2661303|NCT00643760|9190493|P2|Overall Study|Protocol Violation|6
2661304|NCT00643760|9190494|P1|Overall Study|Protocol Violation|7
2661305|NCT00643760|9190490|P5|Overall Study|Lack of Efficacy|3
2661306|NCT00643760|9190491|P4|Overall Study|Lack of Efficacy|4
2661307|NCT00643760|9190492|P3|Overall Study|Lack of Efficacy|0
2661308|NCT00643760|9190493|P2|Overall Study|Lack of Efficacy|1
2661309|NCT00643760|9190494|P1|Overall Study|Lack of Efficacy|3
2661310|NCT00643760|9190490|P5|Overall Study|Adverse Event|6
2661311|NCT00643760|9190491|P4|Overall Study|Adverse Event|21
2661312|NCT00643760|9190492|P3|Overall Study|Adverse Event|12
2661313|NCT00643760|9190493|P2|Overall Study|Adverse Event|5
2661314|NCT00643760|9190494|P1|Overall Study|Adverse Event|11
2661315|NCT00643682|9190598|P2|Overall Study|did not keep appointment|509
2661316|NCT00643682|9190599|P1|Overall Study|did not keep appointment|522
2661317|NCT00643604|9190611|P1|Overall Study|Death|1
2661318|NCT00643565|9190639|P2|Overall Study|Adverse Event|8
2661319|NCT00643565|9190640|P1|Overall Study|Adverse Event|5
2661320|NCT00643565|9190639|P2|Overall Study|Administrative|16
2661321|NCT00643565|9190640|P1|Overall Study|Administrative|22
2661322|NCT00643565|9190639|P2|Overall Study|Did Not Cooperate|1
2661323|NCT00643565|9190640|P1|Overall Study|Did Not Cooperate|0
2661324|NCT00643565|9190639|P2|Overall Study|Protocol Violation|0
2661325|NCT00643565|9190640|P1|Overall Study|Protocol Violation|3
2661326|NCT00643565|9190639|P2|Overall Study|Progression of Disease|14
2661327|NCT00643565|9190640|P1|Overall Study|Progression of Disease|18
2661328|NCT00643565|9190639|P2|Overall Study|Recurrence of Disease|1
2661329|NCT00643565|9190640|P1|Overall Study|Recurrence of Disease|2
2661330|NCT00643565|9190639|P2|Overall Study|Refused Treatment / Did Not Cooperate|1
2661331|NCT00643565|9190640|P1|Overall Study|Refused Treatment / Did Not Cooperate|0
2661332|NCT00643565|9190639|P2|Overall Study|Other|8
2661333|NCT00643565|9190640|P1|Overall Study|Other|7
2661334|NCT00643565|9190639|P2|Overall Study|Lost to Follow-up|6
2661335|NCT00643565|9190640|P1|Overall Study|Lost to Follow-up|0
2661336|NCT00643565|9190639|P2|Overall Study|Withdrawal by Subject|1
2661337|NCT00643565|9190640|P1|Overall Study|Withdrawal by Subject|4
2661338|NCT00643565|9190639|P2|Overall Study|Death|11
2661339|NCT00643565|9190640|P1|Overall Study|Death|12
2661340|NCT00643487|9190662|P1|Overall Study|Technical difficulty|3
2661341|NCT00643448|9190669|P3|Overall Study|QTcF>550 ms|0
2661342|NCT00643448|9190670|P2|Overall Study|QTcF>550 ms|3
2661343|NCT00643448|9190671|P1|Overall Study|QTcF>550 ms|0
2661344|NCT00643448|9190669|P3|Overall Study|Adverse Event|2
2661345|NCT00643448|9190670|P2|Overall Study|Adverse Event|2
2661346|NCT00643448|9190671|P1|Overall Study|Adverse Event|2
2661347|NCT00643448|9190669|P3|Overall Study|Lack of Efficacy|4
2661348|NCT00643448|9190670|P2|Overall Study|Lack of Efficacy|0
2661349|NCT00643448|9190671|P1|Overall Study|Lack of Efficacy|2
2661350|NCT00643279|9190688|P2|Overall Study|Physician Decision|1
2661351|NCT00643279|9190689|P1|Overall Study|Physician Decision|0
2661352|NCT00643279|9190688|P2|Overall Study|Lost to Follow-up|1
2661353|NCT00643279|9190689|P1|Overall Study|Lost to Follow-up|0
2661354|NCT00643279|9190688|P2|Overall Study|Withdrawal by Subject|0
2661355|NCT00643279|9190689|P1|Overall Study|Withdrawal by Subject|3
2661356|NCT00643279|9190688|P2|Overall Study|Death|11
2661357|NCT00643279|9190689|P1|Overall Study|Death|13
2661358|NCT00643201|9190711|P2|Completed Study Follow Up|non-specified|0
2661359|NCT00643201|9190712|P1|Completed Study Follow Up|non-specified|1
2661360|NCT00643201|9190711|P2|Completed Study Follow Up|Lost to Follow-up|16
2661361|NCT00643201|9190712|P1|Completed Study Follow Up|Lost to Follow-up|18
2661362|NCT00643201|9190711|P2|Completed Study Follow Up|Withdrawal by Subject|29
2661363|NCT00643201|9190712|P1|Completed Study Follow Up|Withdrawal by Subject|23
2661364|NCT00643201|9190711|P2|Completed Study Follow Up|Death|34
2661365|NCT00643201|9190712|P1|Completed Study Follow Up|Death|28
2661366|NCT00643201|9190711|P2|Randomized, Completed 6 Months of Study|Other|107
2661367|NCT00643201|9190712|P1|Randomized, Completed 6 Months of Study|Other|107
2661368|NCT00643201|9190711|P2|Randomized, Completed 6 Months of Study|Administrative reason|1
2661369|NCT00643201|9190712|P1|Randomized, Completed 6 Months of Study|Administrative reason|1
2661370|NCT00643201|9190711|P2|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9
2661371|NCT00643201|9190712|P1|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13
2661372|NCT00643201|9190711|P2|Randomized, Completed 6 Months of Study|Pregnancy|2
2661373|NCT00643201|9190712|P1|Randomized, Completed 6 Months of Study|Pregnancy|3
2661374|NCT00643201|9190711|P2|Randomized, Completed 6 Months of Study|Poor or non-compliance|23
2661375|NCT00643201|9190712|P1|Randomized, Completed 6 Months of Study|Poor or non-compliance|20
2661376|NCT00643201|9190711|P2|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
2661377|NCT00643201|9190712|P1|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
2661378|NCT00643201|9190711|P2|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
2661379|NCT00643201|9190712|P1|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
2661380|NCT00643201|9190711|P2|Randomized, Completed 6 Months of Study|Adverse Event|182
2661381|NCT00643201|9190712|P1|Randomized, Completed 6 Months of Study|Adverse Event|150
2661382|NCT00643201|9190711|P2|Randomized, Completed 6 Months of Study|Death|26
2661383|NCT00643201|9190712|P1|Randomized, Completed 6 Months of Study|Death|20
2661384|NCT00643162|9190760|P2|Overall Study|Withdrawal by Subject|1
2661385|NCT00643162|9190761|P1|Overall Study|Withdrawal by Subject|1
2661386|NCT00643123|9190773|P2|Overall Study|Withdrawal by Subject|1
2661387|NCT00643123|9190774|P1|Overall Study|Withdrawal by Subject|1
2661388|NCT00643123|9190773|P2|Overall Study|Lost to Follow-up|0
2661389|NCT00643123|9190774|P1|Overall Study|Lost to Follow-up|4
2661390|NCT00643006|9190806|P2|Overall Study|Lost to Follow-up|4
2661391|NCT00643006|9190807|P1|Overall Study|Lost to Follow-up|5
2661392|NCT00642993|9190817|P2|Overall Study|Administrative|0
2661393|NCT00642993|9190818|P1|Overall Study|Administrative|1
2661394|NCT00642993|9190817|P2|Overall Study|Did not meet protocol eligibility|1
2661395|NCT00642993|9190818|P1|Overall Study|Did not meet protocol eligibility|0
2661396|NCT00642993|9190817|P2|Overall Study|Protocol Violation|4
2661397|NCT00642993|9190818|P1|Overall Study|Protocol Violation|1
2661398|NCT00642993|9190817|P2|Overall Study|Withdrew - reason unrelated to treatment|3
2661399|NCT00642993|9190818|P1|Overall Study|Withdrew - reason unrelated to treatment|11
2661400|NCT00642993|9190817|P2|Overall Study|Lost to Follow-up|4
2661401|NCT00642993|9190818|P1|Overall Study|Lost to Follow-up|8
2661402|NCT00642993|9190817|P2|Overall Study|Adverse Event|4
2661403|NCT00642993|9190818|P1|Overall Study|Adverse Event|85
2661404|NCT00642902|9190836|P4|Overall Study|Other|4
2661405|NCT00642902|9190837|P3|Overall Study|Other|1
2661406|NCT00642902|9190838|P2|Overall Study|Other|5
2661407|NCT00642902|9190839|P1|Overall Study|Other|1
2661408|NCT00642902|9190836|P4|Overall Study|Randomized, but not treated|0
2661409|NCT00642902|9190837|P3|Overall Study|Randomized, but not treated|1
2661410|NCT00642902|9190838|P2|Overall Study|Randomized, but not treated|0
2661411|NCT00642902|9190839|P1|Overall Study|Randomized, but not treated|0
2661412|NCT00642902|9190836|P4|Overall Study|Premature termination of clinical trial|35
2661413|NCT00642902|9190837|P3|Overall Study|Premature termination of clinical trial|35
2661414|NCT00642902|9190838|P2|Overall Study|Premature termination of clinical trial|32
2661415|NCT00642902|9190839|P1|Overall Study|Premature termination of clinical trial|37
2661416|NCT00642902|9190836|P4|Overall Study|Death|0
2661417|NCT00642902|9190837|P3|Overall Study|Death|0
2661418|NCT00642902|9190838|P2|Overall Study|Death|0
2661419|NCT00642902|9190839|P1|Overall Study|Death|1
2661420|NCT00642902|9190836|P4|Overall Study|Lack of Efficacy|0
2661421|NCT00642902|9190837|P3|Overall Study|Lack of Efficacy|3
2661422|NCT00642902|9190838|P2|Overall Study|Lack of Efficacy|3
2661423|NCT00642902|9190839|P1|Overall Study|Lack of Efficacy|0
2661424|NCT00642902|9190836|P4|Overall Study|Lost to Follow-up|0
2661425|NCT00642902|9190837|P3|Overall Study|Lost to Follow-up|0
2661426|NCT00642902|9190838|P2|Overall Study|Lost to Follow-up|1
2661427|NCT00642902|9190839|P1|Overall Study|Lost to Follow-up|1
2661428|NCT00642902|9190836|P4|Overall Study|Adverse Event|1
2661429|NCT00642902|9190837|P3|Overall Study|Adverse Event|3
2661430|NCT00642902|9190838|P2|Overall Study|Adverse Event|1
2661431|NCT00642902|9190839|P1|Overall Study|Adverse Event|0
2661432|NCT00642850|9190861|P1|Overall Study|Other reasons|7
2661433|NCT00642850|9190861|P1|Overall Study|Blood transfusion|6
2661434|NCT00642850|9190861|P1|Overall Study|Kidney transplantation|8
2661435|NCT00642850|9190861|P1|Overall Study|Protocol Violation|2
2661436|NCT00642850|9190861|P1|Overall Study|Lack of Efficacy|1
2661437|NCT00642850|9190861|P1|Overall Study|Adverse Event|2
2661438|NCT00642850|9190861|P1|Overall Study|Death|7
2661439|NCT00642811|9190877|P6|Overall Study|Other|0
2661440|NCT00642811|9190878|P5|Overall Study|Other|0
2661441|NCT00642811|9190879|P4|Overall Study|Other|1
2661442|NCT00642811|9190880|P3|Overall Study|Other|0
2661443|NCT00642811|9190881|P2|Overall Study|Other|1
2661444|NCT00642811|9190882|P1|Overall Study|Other|0
2661445|NCT00642811|9190877|P6|Overall Study|Severe Non-compliance to protocol|0
2661446|NCT00642811|9190878|P5|Overall Study|Severe Non-compliance to protocol|0
2661447|NCT00642811|9190879|P4|Overall Study|Severe Non-compliance to protocol|0
2661448|NCT00642811|9190880|P3|Overall Study|Severe Non-compliance to protocol|0
2661449|NCT00642811|9190881|P2|Overall Study|Severe Non-compliance to protocol|0
2661450|NCT00642811|9190882|P1|Overall Study|Severe Non-compliance to protocol|1
2661451|NCT00642811|9190877|P6|Overall Study|Developement of discontinuation criteria|0
2661452|NCT00642811|9190878|P5|Overall Study|Developement of discontinuation criteria|1
2661453|NCT00642811|9190879|P4|Overall Study|Developement of discontinuation criteria|0
2661454|NCT00642811|9190880|P3|Overall Study|Developement of discontinuation criteria|0
2661455|NCT00642811|9190881|P2|Overall Study|Developement of discontinuation criteria|0
2661456|NCT00642811|9190882|P1|Overall Study|Developement of discontinuation criteria|0
2661457|NCT00642811|9190877|P6|Overall Study|Adverse Event|1
2661458|NCT00642811|9190878|P5|Overall Study|Adverse Event|0
2661459|NCT00642811|9190879|P4|Overall Study|Adverse Event|0
2661460|NCT00642811|9190880|P3|Overall Study|Adverse Event|0
2661461|NCT00642811|9190881|P2|Overall Study|Adverse Event|3
2661462|NCT00642811|9190882|P1|Overall Study|Adverse Event|2
2661463|NCT00642772|9190904|P1|Overall Study|Withdrawal by Subject|7
2661464|NCT00642772|9190904|P1|Overall Study|Lost to Follow-up|3
2661465|NCT00642759|9190908|P1|Overall Study|Protocol Violation|1
2661466|NCT00642746|9190917|P2|Overall Study|Patient unevaluable|0
2661467|NCT00642746|9190918|P1|Overall Study|Patient unevaluable|1
2661468|NCT00642707|9190932|P4|Overall Study|Withdrawal by Subject|0
2661469|NCT00642707|9190933|P3|Overall Study|Withdrawal by Subject|0
2661470|NCT00642707|9190934|P2|Overall Study|Withdrawal by Subject|0
2661471|NCT00642707|9190935|P1|Overall Study|Withdrawal by Subject|1
2661472|NCT00642707|9190932|P4|Overall Study|Adverse Event|2
2661473|NCT00642707|9190933|P3|Overall Study|Adverse Event|0
2661474|NCT00642707|9190934|P2|Overall Study|Adverse Event|0
2661475|NCT00642707|9190935|P1|Overall Study|Adverse Event|0
2661476|NCT00642668|9190970|P1|Overall Study|Blood Transfusion|2
2661477|NCT00642668|9190970|P1|Overall Study|Dialysis Initiation|5
2661478|NCT00642668|9190970|P1|Overall Study|Failure to Return|1
2661479|NCT00642668|9190970|P1|Overall Study|Insufficient Therapeutic Response|1
2661480|NCT00642668|9190970|P1|Overall Study|Death|2
2661481|NCT00642668|9190970|P1|Overall Study|Adverse Event|2
2661482|NCT00642668|9190970|P1|Overall Study|Lost to Follow-up|1
2661483|NCT00642642|9190978|P1|Treatment & Follow Up|Lost to Follow-up|10
2661484|NCT00642642|9190978|P1|Treatment & Follow Up|Withdrawal by Subject|5
2661485|NCT00642642|9190978|P1|Treatment & Follow Up|Adverse Event|2
2661486|NCT00642616|9190995|P4|Overall Study|Physician Decision|1
2661487|NCT00642616|9190996|P3|Overall Study|Physician Decision|1
2661488|NCT00642616|9190997|P2|Overall Study|Physician Decision|0
2661489|NCT00642616|9190998|P1|Overall Study|Physician Decision|0
2661490|NCT00642616|9190995|P4|Overall Study|Protocol Violation|0
2661491|NCT00642616|9190996|P3|Overall Study|Protocol Violation|2
2661492|NCT00642616|9190997|P2|Overall Study|Protocol Violation|0
2661493|NCT00642616|9190998|P1|Overall Study|Protocol Violation|0
2661494|NCT00642616|9190995|P4|Overall Study|Withdrawal by Subject|1
2661495|NCT00642616|9190996|P3|Overall Study|Withdrawal by Subject|1
2661496|NCT00642616|9190997|P2|Overall Study|Withdrawal by Subject|1
2661497|NCT00642616|9190998|P1|Overall Study|Withdrawal by Subject|0
2661498|NCT00642616|9190995|P4|Overall Study|Study Terminated by Sponsor|5
2661499|NCT00642616|9190996|P3|Overall Study|Study Terminated by Sponsor|4
2661500|NCT00642616|9190997|P2|Overall Study|Study Terminated by Sponsor|6
2661501|NCT00642616|9190998|P1|Overall Study|Study Terminated by Sponsor|7
2661502|NCT00642616|9190995|P4|Overall Study|Adverse Event|0
2661503|NCT00642616|9190996|P3|Overall Study|Adverse Event|1
2661504|NCT00642616|9190997|P2|Overall Study|Adverse Event|0
2661505|NCT00642616|9190998|P1|Overall Study|Adverse Event|2
2661506|NCT00642473|9191031|P2|Overall Study|Other|2
2661507|NCT00642473|9191032|P1|Overall Study|Other|2
2661508|NCT00642473|9191031|P2|Overall Study|Progression or death|4
2661509|NCT00642473|9191032|P1|Overall Study|Progression or death|2
2661510|NCT00642473|9191031|P2|Overall Study|Withdrawal by Subject|5
2661511|NCT00642473|9191032|P1|Overall Study|Withdrawal by Subject|0
2661512|NCT00642460|9191046|P6|Part III: Open-Label Up to Week 260|Refused treatment|3
2661513|NCT00642460|9191047|P5|Part III: Open-Label Up to Week 260|Refused treatment|8
2661514|NCT00642460|9191048|P4|Part III: Open-Label Up to Week 260|Refused treatment|0
2661515|NCT00642460|9191049|P3|Part III: Open-Label Up to Week 260|Refused treatment|0
2661516|NCT00642460|9191050|P2|Part III: Open-Label Up to Week 260|Refused treatment|0
2661517|NCT00642460|9191051|P1|Part III: Open-Label Up to Week 260|Refused treatment|0
2661518|NCT00642460|9191046|P6|Part III: Open-Label Up to Week 260|Administrative reason|1
2661519|NCT00642460|9191047|P5|Part III: Open-Label Up to Week 260|Administrative reason|0
2661520|NCT00642460|9191048|P4|Part III: Open-Label Up to Week 260|Administrative reason|0
2661521|NCT00642460|9191049|P3|Part III: Open-Label Up to Week 260|Administrative reason|0
2661522|NCT00642460|9191050|P2|Part III: Open-Label Up to Week 260|Administrative reason|0
2661523|NCT00642460|9191051|P1|Part III: Open-Label Up to Week 260|Administrative reason|0
2661524|NCT00642460|9191046|P6|Part III: Open-Label Up to Week 260|Death|3
2661525|NCT00642460|9191047|P5|Part III: Open-Label Up to Week 260|Death|0
2661526|NCT00642460|9191048|P4|Part III: Open-Label Up to Week 260|Death|0
2661527|NCT00642460|9191049|P3|Part III: Open-Label Up to Week 260|Death|0
2661528|NCT00642460|9191050|P2|Part III: Open-Label Up to Week 260|Death|0
2661529|NCT00642460|9191051|P1|Part III: Open-Label Up to Week 260|Death|0
2661530|NCT00642460|9191046|P6|Part III: Open-Label Up to Week 260|Other|2
2661531|NCT00642460|9191047|P5|Part III: Open-Label Up to Week 260|Other|2
2661532|NCT00642460|9191048|P4|Part III: Open-Label Up to Week 260|Other|0
2661533|NCT00642460|9191049|P3|Part III: Open-Label Up to Week 260|Other|0
2661534|NCT00642460|9191050|P2|Part III: Open-Label Up to Week 260|Other|0
2661535|NCT00642460|9191051|P1|Part III: Open-Label Up to Week 260|Other|0
2661536|NCT00642460|9191046|P6|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
2661537|NCT00642460|9191047|P5|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
2661538|NCT00642460|9191048|P4|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
2661539|NCT00642460|9191049|P3|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
2661540|NCT00642460|9191050|P2|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
2661541|NCT00642460|9191051|P1|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
2661542|NCT00642460|9191046|P6|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1
2661543|NCT00642460|9191047|P5|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4
2661544|NCT00642460|9191048|P4|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
2661545|NCT00642460|9191049|P3|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
2661546|NCT00642460|9191050|P2|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
2661547|NCT00642460|9191051|P1|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
2661548|NCT00642460|9191046|P6|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4
2661549|NCT00642460|9191047|P5|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3
2661550|NCT00642460|9191048|P4|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
2661551|NCT00642460|9191049|P3|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
2661552|NCT00642460|9191050|P2|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
2661553|NCT00642460|9191051|P1|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
2661554|NCT00642460|9191046|P6|Part III: Open-Label Up to Week 260|Adverse Event|6
2661555|NCT00642460|9191047|P5|Part III: Open-Label Up to Week 260|Adverse Event|7
2661556|NCT00642460|9191048|P4|Part III: Open-Label Up to Week 260|Adverse Event|0
2661557|NCT00642460|9191049|P3|Part III: Open-Label Up to Week 260|Adverse Event|0
2661558|NCT00642460|9191050|P2|Part III: Open-Label Up to Week 260|Adverse Event|0
2661559|NCT00642460|9191051|P1|Part III: Open-Label Up to Week 260|Adverse Event|0
2661560|NCT00642460|9191046|P6|Part II: Open-Label Up to Week 92|Administrative reasons|0
2661561|NCT00642460|9191047|P5|Part II: Open-Label Up to Week 92|Administrative reasons|0
2661562|NCT00642460|9191048|P4|Part II: Open-Label Up to Week 92|Administrative reasons|1
2661563|NCT00642460|9191049|P3|Part II: Open-Label Up to Week 92|Administrative reasons|0
2661564|NCT00642460|9191050|P2|Part II: Open-Label Up to Week 92|Administrative reasons|0
2661565|NCT00642460|9191051|P1|Part II: Open-Label Up to Week 92|Administrative reasons|0
2661566|NCT00642460|9191046|P6|Part II: Open-Label Up to Week 92|Failure to return|0
2661567|NCT00642460|9191047|P5|Part II: Open-Label Up to Week 92|Failure to return|0
2661568|NCT00642460|9191048|P4|Part II: Open-Label Up to Week 92|Failure to return|0
2661569|NCT00642460|9191049|P3|Part II: Open-Label Up to Week 92|Failure to return|0
2661570|NCT00642460|9191050|P2|Part II: Open-Label Up to Week 92|Failure to return|1
2661571|NCT00642460|9191051|P1|Part II: Open-Label Up to Week 92|Failure to return|0
2661572|NCT00642460|9191046|P6|Part II: Open-Label Up to Week 92|Refused treatment|0
2661573|NCT00642460|9191047|P5|Part II: Open-Label Up to Week 92|Refused treatment|0
2661574|NCT00642460|9191048|P4|Part II: Open-Label Up to Week 92|Refused treatment|0
2661575|NCT00642460|9191049|P3|Part II: Open-Label Up to Week 92|Refused treatment|0
2661576|NCT00642460|9191050|P2|Part II: Open-Label Up to Week 92|Refused treatment|1
2661577|NCT00642460|9191051|P1|Part II: Open-Label Up to Week 92|Refused treatment|3
2661578|NCT00642460|9191046|P6|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
2661579|NCT00642460|9191047|P5|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
2661580|NCT00642460|9191048|P4|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
2661581|NCT00642460|9191049|P3|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
2661582|NCT00642460|9191050|P2|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3
2661583|NCT00642460|9191051|P1|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2
2661584|NCT00642460|9191046|P6|Part II: Open-Label Up to Week 92|Death|0
2661585|NCT00642460|9191047|P5|Part II: Open-Label Up to Week 92|Death|0
2661586|NCT00642460|9191048|P4|Part II: Open-Label Up to Week 92|Death|2
2661587|NCT00642460|9191049|P3|Part II: Open-Label Up to Week 92|Death|0
2661588|NCT00642460|9191050|P2|Part II: Open-Label Up to Week 92|Death|1
2661589|NCT00642460|9191051|P1|Part II: Open-Label Up to Week 92|Death|0
2661590|NCT00642460|9191046|P6|Part II: Open-Label Up to Week 92|Adverse Event|0
2661591|NCT00642460|9191047|P5|Part II: Open-Label Up to Week 92|Adverse Event|0
2661592|NCT00642460|9191048|P4|Part II: Open-Label Up to Week 92|Adverse Event|0
2661593|NCT00642460|9191049|P3|Part II: Open-Label Up to Week 92|Adverse Event|0
2661594|NCT00642460|9191050|P2|Part II: Open-Label Up to Week 92|Adverse Event|2
2661595|NCT00642460|9191051|P1|Part II: Open-Label Up to Week 92|Adverse Event|4
2661596|NCT00642460|9191046|P6|Part I: 12 Week Double-Blind|Refused Treatment|0
2661597|NCT00642460|9191047|P5|Part I: 12 Week Double-Blind|Refused Treatment|0
2661598|NCT00642460|9191048|P4|Part I: 12 Week Double-Blind|Refused Treatment|0
2661599|NCT00642460|9191049|P3|Part I: 12 Week Double-Blind|Refused Treatment|0
2661600|NCT00642460|9191050|P2|Part I: 12 Week Double-Blind|Refused Treatment|0
2661601|NCT00642460|9191051|P1|Part I: 12 Week Double-Blind|Refused Treatment|1
2661602|NCT00642460|9191046|P6|Part I: 12 Week Double-Blind|Adverse Event|0
2661603|NCT00642460|9191047|P5|Part I: 12 Week Double-Blind|Adverse Event|0
2661604|NCT00642460|9191048|P4|Part I: 12 Week Double-Blind|Adverse Event|0
2661605|NCT00642460|9191049|P3|Part I: 12 Week Double-Blind|Adverse Event|1
2661606|NCT00642460|9191050|P2|Part I: 12 Week Double-Blind|Adverse Event|1
2661607|NCT00642460|9191051|P1|Part I: 12 Week Double-Blind|Adverse Event|0
2661608|NCT00642369|9191126|P2|Overall Study|Lack of Efficacy|2
2661609|NCT00642369|9191127|P1|Overall Study|Lack of Efficacy|2
2661610|NCT00642369|9191126|P2|Overall Study|misdiagnosis|1
2661611|NCT00642369|9191127|P1|Overall Study|misdiagnosis|0
2661612|NCT00642369|9191126|P2|Overall Study|Withdrawal by Subject|0
2661613|NCT00642369|9191127|P1|Overall Study|Withdrawal by Subject|1
2661614|NCT00642369|9191126|P2|Overall Study|Adverse Event|3
2661615|NCT00642369|9191127|P1|Overall Study|Adverse Event|2
2661616|NCT00642356|9191137|P2|Overall Study|Lack of Efficacy|0
2661617|NCT00642356|9191138|P1|Overall Study|Lack of Efficacy|1
2661618|NCT00642356|9191137|P2|Overall Study|Protocol Violation|3
2661619|NCT00642356|9191138|P1|Overall Study|Protocol Violation|0
2661620|NCT00642356|9191137|P2|Overall Study|Adverse Event|0
2661621|NCT00642356|9191138|P1|Overall Study|Adverse Event|1
2661622|NCT00642304|9191146|P1|Overall Study|Transplantation|1
2661623|NCT00642304|9191146|P1|Overall Study|Erythropoiesis Stimulating Agent Use.|1
2661624|NCT00642304|9191146|P1|Overall Study|Blood transfusion|2
2661625|NCT00642304|9191146|P1|Overall Study|Death|1
2661626|NCT00642304|9191146|P1|Overall Study|Adverse Event|1
2661627|NCT00642278|9191162|P7|Overall Study|Other|0
2661628|NCT00642278|9191163|P6|Overall Study|Other|1
2661629|NCT00642278|9191164|P5|Overall Study|Other|0
2661630|NCT00642278|9191165|P4|Overall Study|Other|1
2661631|NCT00642278|9191166|P3|Overall Study|Other|0
2661632|NCT00642278|9191167|P2|Overall Study|Other|1
2661633|NCT00642278|9191168|P1|Overall Study|Other|2
2661634|NCT00642278|9191162|P7|Overall Study|Noncompliance with study drug regimen|0
2661635|NCT00642278|9191163|P6|Overall Study|Noncompliance with study drug regimen|0
2661636|NCT00642278|9191164|P5|Overall Study|Noncompliance with study drug regimen|0
2661637|NCT00642278|9191165|P4|Overall Study|Noncompliance with study drug regimen|1
2661638|NCT00642278|9191166|P3|Overall Study|Noncompliance with study drug regimen|0
2661639|NCT00642278|9191167|P2|Overall Study|Noncompliance with study drug regimen|0
2661640|NCT00642278|9191168|P1|Overall Study|Noncompliance with study drug regimen|0
2661641|NCT00642278|9191162|P7|Overall Study|Withdrawal by Subject|2
2661642|NCT00642278|9191163|P6|Overall Study|Withdrawal by Subject|2
2661643|NCT00642278|9191164|P5|Overall Study|Withdrawal by Subject|6
2661644|NCT00642278|9191165|P4|Overall Study|Withdrawal by Subject|3
2661645|NCT00642278|9191166|P3|Overall Study|Withdrawal by Subject|1
2661646|NCT00642278|9191167|P2|Overall Study|Withdrawal by Subject|1
2661647|NCT00642278|9191168|P1|Overall Study|Withdrawal by Subject|1
2661648|NCT00642278|9191162|P7|Overall Study|Protocol Violation|2
2661649|NCT00642278|9191163|P6|Overall Study|Protocol Violation|1
2661650|NCT00642278|9191164|P5|Overall Study|Protocol Violation|0
2661651|NCT00642278|9191165|P4|Overall Study|Protocol Violation|1
2661652|NCT00642278|9191166|P3|Overall Study|Protocol Violation|1
2661653|NCT00642278|9191167|P2|Overall Study|Protocol Violation|0
2661654|NCT00642278|9191168|P1|Overall Study|Protocol Violation|0
2661655|NCT00642278|9191162|P7|Overall Study|Physician Decision|0
2661656|NCT00642278|9191163|P6|Overall Study|Physician Decision|0
2661657|NCT00642278|9191164|P5|Overall Study|Physician Decision|0
2661658|NCT00642278|9191165|P4|Overall Study|Physician Decision|1
2661659|NCT00642278|9191166|P3|Overall Study|Physician Decision|0
2661660|NCT00642278|9191167|P2|Overall Study|Physician Decision|0
2661661|NCT00642278|9191168|P1|Overall Study|Physician Decision|0
2661662|NCT00642278|9191162|P7|Overall Study|Lost to Follow-up|1
2661663|NCT00642278|9191163|P6|Overall Study|Lost to Follow-up|1
2661664|NCT00642278|9191164|P5|Overall Study|Lost to Follow-up|0
2661665|NCT00642278|9191165|P4|Overall Study|Lost to Follow-up|1
2661666|NCT00642278|9191166|P3|Overall Study|Lost to Follow-up|0
2661667|NCT00642278|9191167|P2|Overall Study|Lost to Follow-up|1
2661668|NCT00642278|9191168|P1|Overall Study|Lost to Follow-up|5
2661669|NCT00642278|9191162|P7|Overall Study|Lack of Efficacy|0
2661670|NCT00642278|9191163|P6|Overall Study|Lack of Efficacy|0
2661671|NCT00642278|9191164|P5|Overall Study|Lack of Efficacy|0
2661672|NCT00642278|9191165|P4|Overall Study|Lack of Efficacy|0
2661673|NCT00642278|9191166|P3|Overall Study|Lack of Efficacy|0
2661674|NCT00642278|9191167|P2|Overall Study|Lack of Efficacy|1
2661675|NCT00642278|9191168|P1|Overall Study|Lack of Efficacy|0
2661676|NCT00642278|9191162|P7|Overall Study|Adverse Event|0
2661677|NCT00642278|9191163|P6|Overall Study|Adverse Event|2
2661678|NCT00642278|9191164|P5|Overall Study|Adverse Event|2
2661679|NCT00642278|9191165|P4|Overall Study|Adverse Event|1
2661680|NCT00642278|9191166|P3|Overall Study|Adverse Event|3
2661681|NCT00642278|9191167|P2|Overall Study|Adverse Event|1
2661682|NCT00642278|9191168|P1|Overall Study|Adverse Event|2
2661683|NCT00642174|9191221|P2|Period 1 - Initial Drug|Entry Criteria Not Met|1
2661684|NCT00642174|9191222|P1|Period 1 - Initial Drug|Entry Criteria Not Met|0
2661685|NCT00642018|9191238|P2|Overall Study|Entry Criteria Not Met|1
2661686|NCT00642018|9191239|P1|Overall Study|Entry Criteria Not Met|0
2661687|NCT00642018|9191238|P2|Overall Study|Death|3
2661688|NCT00642018|9191239|P1|Overall Study|Death|0
2661689|NCT00642018|9191238|P2|Overall Study|Protocol Violation|1
2661690|NCT00642018|9191239|P1|Overall Study|Protocol Violation|0
2661691|NCT00642018|9191238|P2|Overall Study|Physician Decision|10
2661692|NCT00642018|9191239|P1|Overall Study|Physician Decision|0
2661693|NCT00642018|9191238|P2|Overall Study|Progressive Disease|18
2661694|NCT00642018|9191239|P1|Overall Study|Progressive Disease|13
2661695|NCT00642018|9191238|P2|Overall Study|Withdrawal by Subject|10
2661696|NCT00642018|9191239|P1|Overall Study|Withdrawal by Subject|4
2661697|NCT00642018|9191238|P2|Overall Study|Adverse Event|36
2661698|NCT00642018|9191239|P1|Overall Study|Adverse Event|11
2661699|NCT00641719|9191306|P2|Overall Study|Reason Not Specified|2
2661700|NCT00641719|9191307|P1|Overall Study|Reason Not Specified|1
2661701|NCT00641719|9191306|P2|Overall Study|Withdrawal by Subject|4
2661702|NCT00641719|9191307|P1|Overall Study|Withdrawal by Subject|4
2661703|NCT00641719|9191306|P2|Overall Study|Adverse Event|29
2661704|NCT00641719|9191307|P1|Overall Study|Adverse Event|24
2661705|NCT00641719|9191306|P2|Overall Study|Lack of Efficacy|2
2661706|NCT00641719|9191307|P1|Overall Study|Lack of Efficacy|1
2661707|NCT00641706|9191331|P2|Overall Study|Lead Investigator Decision|1
2661708|NCT00641706|9191332|P1|Overall Study|Lead Investigator Decision|0
2661709|NCT00641706|9191331|P2|Overall Study|Clinical Decline|0
2661710|NCT00641706|9191332|P1|Overall Study|Clinical Decline|1
2661711|NCT00641706|9191331|P2|Overall Study|Withdrawal by Subject|1
2661712|NCT00641706|9191332|P1|Overall Study|Withdrawal by Subject|6
2661713|NCT00641706|9191331|P2|Overall Study|Adverse Event|1
2661714|NCT00641706|9191332|P1|Overall Study|Adverse Event|2
2661715|NCT00641667|9191344|P1|Overall Study|Worsening of underlying disease|3
2661716|NCT00641667|9191344|P1|Overall Study|Physician Decision|1
2661717|NCT00641667|9191344|P1|Overall Study|Adverse Event|1
2661718|NCT00641667|9191344|P1|Overall Study|Withdrawal by Subject|1
2661719|NCT00641537|9191372|P8|24-Week Supplemental Follow-up Period|Other|1
2661720|NCT00641537|9191373|P7|24-Week Supplemental Follow-up Period|Other|1
2661721|NCT00641537|9191374|P6|24-Week Supplemental Follow-up Period|Other|0
2661722|NCT00641537|9191375|P5|24-Week Supplemental Follow-up Period|Other|3
2661723|NCT00641537|9191376|P4|24-Week Supplemental Follow-up Period|Other|1
2661724|NCT00641537|9191377|P3|24-Week Supplemental Follow-up Period|Other|2
2661725|NCT00641537|9191378|P2|24-Week Supplemental Follow-up Period|Other|2
2661726|NCT00641537|9191379|P1|24-Week Supplemental Follow-up Period|Other|0
2661727|NCT00641537|9191372|P8|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
2661728|NCT00641537|9191373|P7|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
2661729|NCT00641537|9191374|P6|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
2661730|NCT00641537|9191375|P5|24-Week Supplemental Follow-up Period|Lost to Follow-up|2
2661731|NCT00641537|9191376|P4|24-Week Supplemental Follow-up Period|Lost to Follow-up|3
2661732|NCT00641537|9191377|P3|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
2661733|NCT00641537|9191378|P2|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
2661734|NCT00641537|9191379|P1|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
2661735|NCT00641537|9191372|P8|96-week Period|Other|6
2661736|NCT00641537|9191373|P7|96-week Period|Other|4
2661737|NCT00641537|9191374|P6|96-week Period|Other|6
2661738|NCT00641537|9191375|P5|96-week Period|Other|12
2661739|NCT00641537|9191376|P4|96-week Period|Other|9
2661740|NCT00641537|9191377|P3|96-week Period|Other|14
2661741|NCT00641537|9191378|P2|96-week Period|Other|7
2661742|NCT00641537|9191379|P1|96-week Period|Other|4
2661743|NCT00641537|9191372|P8|96-week Period|Death|0
2661744|NCT00641537|9191373|P7|96-week Period|Death|0
2661745|NCT00641537|9191374|P6|96-week Period|Death|0
2661746|NCT00641537|9191375|P5|96-week Period|Death|0
2661747|NCT00641537|9191376|P4|96-week Period|Death|0
2661748|NCT00641537|9191377|P3|96-week Period|Death|1
2661749|NCT00641537|9191378|P2|96-week Period|Death|0
2661750|NCT00641537|9191379|P1|96-week Period|Death|2
2661751|NCT00641537|9191372|P8|96-week Period|Protocol Violation|0
2661752|NCT00641537|9191373|P7|96-week Period|Protocol Violation|0
2661753|NCT00641537|9191374|P6|96-week Period|Protocol Violation|1
2661754|NCT00641537|9191375|P5|96-week Period|Protocol Violation|0
2661755|NCT00641537|9191376|P4|96-week Period|Protocol Violation|1
2661756|NCT00641537|9191377|P3|96-week Period|Protocol Violation|0
2661757|NCT00641537|9191378|P2|96-week Period|Protocol Violation|1
2661758|NCT00641537|9191379|P1|96-week Period|Protocol Violation|0
2661759|NCT00641537|9191372|P8|96-week Period|Lost to Follow-up|0
2661760|NCT00641537|9191373|P7|96-week Period|Lost to Follow-up|1
2661761|NCT00641537|9191374|P6|96-week Period|Lost to Follow-up|0
2661762|NCT00641537|9191375|P5|96-week Period|Lost to Follow-up|4
2661763|NCT00641537|9191376|P4|96-week Period|Lost to Follow-up|2
2661764|NCT00641537|9191377|P3|96-week Period|Lost to Follow-up|2
2661765|NCT00641537|9191378|P2|96-week Period|Lost to Follow-up|1
2661766|NCT00641537|9191379|P1|96-week Period|Lost to Follow-up|3
2661767|NCT00641537|9191372|P8|96-week Period|Adverse Event|0
2661768|NCT00641537|9191373|P7|96-week Period|Adverse Event|0
2661769|NCT00641537|9191374|P6|96-week Period|Adverse Event|0
2661770|NCT00641537|9191375|P5|96-week Period|Adverse Event|2
2661771|NCT00641537|9191376|P4|96-week Period|Adverse Event|0
2661772|NCT00641537|9191377|P3|96-week Period|Adverse Event|3
2661773|NCT00641537|9191378|P2|96-week Period|Adverse Event|1
2661774|NCT00641537|9191379|P1|96-week Period|Adverse Event|0
2661775|NCT00641147|9191434|P2|Completed 16 Months.|Lost to Follow-up|0
2661776|NCT00641147|9191435|P1|Completed 16 Months.|Lost to Follow-up|1
2661777|NCT00641147|9191434|P2|Completed 16 Months.|Physician Decision|0
2661778|NCT00641147|9191435|P1|Completed 16 Months.|Physician Decision|1
2661779|NCT00641147|9191434|P2|Completed 12 Months.|Withdrawal by Subject|1
2661780|NCT00641147|9191435|P1|Completed 12 Months.|Withdrawal by Subject|0
2661781|NCT00641147|9191434|P2|Completed 12 Months.|Physician Decision|1
2661782|NCT00641147|9191435|P1|Completed 12 Months.|Physician Decision|1
2661783|NCT00641147|9191434|P2|Completed 8 Months.|Withdrawal by Subject|1
2661784|NCT00641147|9191435|P1|Completed 8 Months.|Withdrawal by Subject|0
2661785|NCT00641147|9191434|P2|Completed 8 Months.|non compliance|0
2661786|NCT00641147|9191435|P1|Completed 8 Months.|non compliance|1
2661787|NCT00641147|9191434|P2|Completed 8 Months.|Physician Decision|1
2661788|NCT00641147|9191435|P1|Completed 8 Months.|Physician Decision|2
2661789|NCT00641147|9191434|P2|Completed 4 Months.|Adverse Event|0
2661790|NCT00641147|9191435|P1|Completed 4 Months.|Adverse Event|1
2661791|NCT00641147|9191434|P2|Completed 4 Months.|Physician Decision|0
2661792|NCT00641147|9191435|P1|Completed 4 Months.|Physician Decision|1
2661793|NCT00641056|9191488|P2|Overall Study|Sponsor Decision|2
2661794|NCT00641056|9191489|P1|Overall Study|Sponsor Decision|1
2661795|NCT00641056|9191488|P2|Overall Study|Subject Decision|19
2661796|NCT00641056|9191489|P1|Overall Study|Subject Decision|6
2661797|NCT00641056|9191488|P2|Overall Study|Entry Criteria Not Met|0
2661798|NCT00641056|9191489|P1|Overall Study|Entry Criteria Not Met|3
2661799|NCT00641056|9191488|P2|Overall Study|Protocol Violation|0
2661800|NCT00641056|9191489|P1|Overall Study|Protocol Violation|2
2661801|NCT00641056|9191488|P2|Overall Study|Physician Decision|1
2661802|NCT00641056|9191489|P1|Overall Study|Physician Decision|3
2661803|NCT00641056|9191488|P2|Overall Study|Lost to Follow-up|1
2661804|NCT00641056|9191489|P1|Overall Study|Lost to Follow-up|2
2661805|NCT00641056|9191488|P2|Overall Study|Adverse Event|2
2661806|NCT00641056|9191489|P1|Overall Study|Adverse Event|12
2661807|NCT00641043|9191517|P2|Overall Study|Other incl. lack of efficacy|2
2661808|NCT00641043|9191518|P1|Overall Study|Other incl. lack of efficacy|4
2661809|NCT00641043|9191517|P2|Overall Study|Withdrawal by Subject|4
2661810|NCT00641043|9191518|P1|Overall Study|Withdrawal by Subject|4
2661811|NCT00641043|9191517|P2|Overall Study|Lost to Follow-up|2
2661812|NCT00641043|9191518|P1|Overall Study|Lost to Follow-up|3
2661813|NCT00641043|9191517|P2|Overall Study|Protocol Violation|3
2661814|NCT00641043|9191518|P1|Overall Study|Protocol Violation|2
2661815|NCT00641043|9191517|P2|Overall Study|Adverse Event|4
2661816|NCT00641043|9191518|P1|Overall Study|Adverse Event|6
2661817|NCT00640926|9191555|P3|Overall Study|Withdrawal by Subject|1
2661818|NCT00640926|9191556|P2|Overall Study|Withdrawal by Subject|0
2661819|NCT00640926|9191557|P1|Overall Study|Withdrawal by Subject|1
2661820|NCT00640926|9191555|P3|Overall Study|Lost to Follow-up|2
2661821|NCT00640926|9191556|P2|Overall Study|Lost to Follow-up|1
2661822|NCT00640926|9191557|P1|Overall Study|Lost to Follow-up|3
2661823|NCT00640926|9191555|P3|Overall Study|Protocol Violation|2
2661824|NCT00640926|9191556|P2|Overall Study|Protocol Violation|0
2661825|NCT00640926|9191557|P1|Overall Study|Protocol Violation|2
2661826|NCT00640926|9191555|P3|Overall Study|Lack of Efficacy|1
2661827|NCT00640926|9191556|P2|Overall Study|Lack of Efficacy|2
2661828|NCT00640926|9191557|P1|Overall Study|Lack of Efficacy|0
2661829|NCT00640926|9191555|P3|Overall Study|Adverse Event|2
2661830|NCT00640926|9191556|P2|Overall Study|Adverse Event|3
2661831|NCT00640926|9191557|P1|Overall Study|Adverse Event|2
2661832|NCT00640835|9191570|P2|Overall Study|Other Reason|4
2661833|NCT00640835|9191571|P1|Overall Study|Other Reason|19
2661834|NCT00640835|9191570|P2|Overall Study|Lost to Follow-up|13
2661835|NCT00640835|9191571|P1|Overall Study|Lost to Follow-up|17
2661836|NCT00640835|9191570|P2|Overall Study|Protocol Violation|2
2661837|NCT00640835|9191571|P1|Overall Study|Protocol Violation|2
2661838|NCT00640835|9191570|P2|Overall Study|Sponsor's Decision|7
2661839|NCT00640835|9191571|P1|Overall Study|Sponsor's Decision|11
2661840|NCT00640835|9191570|P2|Overall Study|Physician Decision|14
2661841|NCT00640835|9191571|P1|Overall Study|Physician Decision|10
2661842|NCT00640835|9191570|P2|Overall Study|Withdrawal by Subject|14
2661843|NCT00640835|9191571|P1|Overall Study|Withdrawal by Subject|12
2661844|NCT00640835|9191570|P2|Overall Study|Adverse Event|3
2661845|NCT00640835|9191571|P1|Overall Study|Adverse Event|5
2661846|NCT00640614|9191635|P2|Overall Study|Lost to Follow-up|0
2661847|NCT00640614|9191636|P1|Overall Study|Lost to Follow-up|1
2661848|NCT00640601|9191678|P1|Overall Study|treatment naive, combination therapy|10
2661849|NCT00640601|9191678|P1|Overall Study|Physician Decision|8
2661850|NCT00640601|9191678|P1|Overall Study|Lost to Follow-up|9
2661851|NCT00640601|9191678|P1|Overall Study|Lack of Efficacy|16
2661852|NCT00640601|9191678|P1|Overall Study|Protocol Violation|6
2661853|NCT00640601|9191678|P1|Overall Study|Withdrawal by Subject|20
2661854|NCT00640601|9191678|P1|Overall Study|Adverse Event|43
2661855|NCT00640562|9191694|P2|Overall Study|Glycosylated Hemoglobin >8|0
2661856|NCT00640562|9191695|P1|Overall Study|Glycosylated Hemoglobin >8|1
2661857|NCT00640562|9191694|P2|Overall Study|Low study drug dose|1
2661858|NCT00640562|9191695|P1|Overall Study|Low study drug dose|0
2661859|NCT00640562|9191694|P2|Overall Study|Past use of Seroquel -stopped due to AE|1
2661860|NCT00640562|9191695|P1|Overall Study|Past use of Seroquel -stopped due to AE|0
2661861|NCT00640562|9191694|P2|Overall Study|Known risperidone intolerance|1
2661862|NCT00640562|9191695|P1|Overall Study|Known risperidone intolerance|0
2661863|NCT00640562|9191694|P2|Overall Study|Withdrawal by Subject|10
2661864|NCT00640562|9191695|P1|Overall Study|Withdrawal by Subject|6
2661865|NCT00640562|9191694|P2|Overall Study|Protocol Violation|4
2661866|NCT00640562|9191695|P1|Overall Study|Protocol Violation|2
2661867|NCT00640562|9191694|P2|Overall Study|Lack of Efficacy|4
2661868|NCT00640562|9191695|P1|Overall Study|Lack of Efficacy|1
2661869|NCT00640562|9191694|P2|Overall Study|Adverse Event|5
2661870|NCT00640562|9191695|P1|Overall Study|Adverse Event|8
2661871|NCT00640510|9191723|P2|Overall Study|Physician Decision|1
2661872|NCT00640510|9191724|P1|Overall Study|Physician Decision|0
2661873|NCT00640510|9191723|P2|Overall Study|Protocol Violation|0
2661874|NCT00640510|9191724|P1|Overall Study|Protocol Violation|1
2661875|NCT00640510|9191723|P2|Overall Study|Lack of Efficacy|1
2661876|NCT00640510|9191724|P1|Overall Study|Lack of Efficacy|0
2661877|NCT00640393|9191736|P3|Part 2|Adverse Event|0
2661878|NCT00640393|9191737|P2|Part 2|Adverse Event|1
2661879|NCT00640393|9191738|P1|Part 2|Adverse Event|0
2661880|NCT00640393|9191736|P3|Part 2|Non-adherence|0
2661881|NCT00640393|9191737|P2|Part 2|Non-adherence|1
2661882|NCT00640393|9191738|P1|Part 2|Non-adherence|0
2661883|NCT00640393|9191736|P3|Part 2|Withdrawal by Subject|1
2661884|NCT00640393|9191737|P2|Part 2|Withdrawal by Subject|6
2661885|NCT00640393|9191738|P1|Part 2|Withdrawal by Subject|0
2661886|NCT00640393|9191736|P3|Part 2|Lost to Follow-up|2
2661887|NCT00640393|9191737|P2|Part 2|Lost to Follow-up|2
2661888|NCT00640393|9191738|P1|Part 2|Lost to Follow-up|0
2661889|NCT00640393|9191736|P3|Randomization|Never randomized by site|0
2661890|NCT00640393|9191737|P2|Randomization|Never randomized by site|0
2661891|NCT00640393|9191738|P1|Randomization|Never randomized by site|2
2661892|NCT00640393|9191736|P3|Randomization|Withdrawn per protocol|0
2661893|NCT00640393|9191737|P2|Randomization|Withdrawn per protocol|0
2661894|NCT00640393|9191738|P1|Randomization|Withdrawn per protocol|17
2661895|NCT00640393|9191736|P3|Part 1|Withdrawal by Subject|0
2661896|NCT00640393|9191737|P2|Part 1|Withdrawal by Subject|0
2661897|NCT00640393|9191738|P1|Part 1|Withdrawal by Subject|3
2661898|NCT00640393|9191736|P3|Part 1|Lost to Follow-up|0
2661899|NCT00640393|9191737|P2|Part 1|Lost to Follow-up|0
2661900|NCT00640393|9191738|P1|Part 1|Lost to Follow-up|2
2661901|NCT00640341|9191803|P3|Overall Study|Adverse event and positive slit lamp|0
2661902|NCT00640341|9191804|P2|Overall Study|Adverse event and positive slit lamp|0
2661903|NCT00640341|9191805|P1|Overall Study|Adverse event and positive slit lamp|1
2661904|NCT00640341|9191803|P3|Overall Study|Ineligable at Baseline|2
2661905|NCT00640341|9191804|P2|Overall Study|Ineligable at Baseline|3
2661906|NCT00640341|9191805|P1|Overall Study|Ineligable at Baseline|5
2661907|NCT00640341|9191803|P3|Overall Study|Poor fit/Uncomfortable|0
2661908|NCT00640341|9191804|P2|Overall Study|Poor fit/Uncomfortable|0
2661909|NCT00640341|9191805|P1|Overall Study|Poor fit/Uncomfortable|4
2661910|NCT00640341|9191803|P3|Overall Study|Unacceptable Lens Movement|0
2661911|NCT00640341|9191804|P2|Overall Study|Unacceptable Lens Movement|0
2661912|NCT00640341|9191805|P1|Overall Study|Unacceptable Lens Movement|1
2661913|NCT00640341|9191803|P3|Overall Study|Withdrawal by Subject|1
2661914|NCT00640341|9191804|P2|Overall Study|Withdrawal by Subject|0
2661915|NCT00640341|9191805|P1|Overall Study|Withdrawal by Subject|4
2661916|NCT00640341|9191803|P3|Overall Study|Lost to Follow-up|0
2661917|NCT00640341|9191804|P2|Overall Study|Lost to Follow-up|0
2661918|NCT00640341|9191805|P1|Overall Study|Lost to Follow-up|2
2661919|NCT00640341|9191803|P3|Overall Study|Failure to Follow Subject Instructions|0
2661920|NCT00640341|9191804|P2|Overall Study|Failure to Follow Subject Instructions|0
2661921|NCT00640341|9191805|P1|Overall Study|Failure to Follow Subject Instructions|1
2661922|NCT00640341|9191803|P3|Overall Study|Inability to Maintain Wearing Schedule|0
2661923|NCT00640341|9191804|P2|Overall Study|Inability to Maintain Wearing Schedule|1
2661924|NCT00640341|9191805|P1|Overall Study|Inability to Maintain Wearing Schedule|1
2661925|NCT00640341|9191803|P3|Overall Study|Study Related Symptoms/Complaints|2
2661926|NCT00640341|9191804|P2|Overall Study|Study Related Symptoms/Complaints|1
2661927|NCT00640341|9191805|P1|Overall Study|Study Related Symptoms/Complaints|2
2661928|NCT00640341|9191803|P3|Overall Study|Positive Slit Lamp Findings|1
2661929|NCT00640341|9191804|P2|Overall Study|Positive Slit Lamp Findings|0
2661930|NCT00640341|9191805|P1|Overall Study|Positive Slit Lamp Findings|0
2661931|NCT00640341|9191803|P3|Overall Study|Adverse Event|1
2661932|NCT00640341|9191804|P2|Overall Study|Adverse Event|0
2661933|NCT00640341|9191805|P1|Overall Study|Adverse Event|0
2661934|NCT00640328|9191825|P6|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
2661935|NCT00640328|9191826|P5|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
2661936|NCT00640328|9191827|P4|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
2661937|NCT00640328|9191828|P3|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
2661938|NCT00640328|9191829|P2|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
2661939|NCT00640328|9191830|P1|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
2661940|NCT00640328|9191825|P6|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
2661941|NCT00640328|9191826|P5|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
2661942|NCT00640328|9191827|P4|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
2661943|NCT00640328|9191828|P3|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1
2661944|NCT00640328|9191829|P2|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
2661945|NCT00640328|9191830|P1|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
2661946|NCT00640328|9191825|P6|Second Treatment Period (Weeks 24-48)|Adverse Event|0
2661947|NCT00640328|9191826|P5|Second Treatment Period (Weeks 24-48)|Adverse Event|1
2661948|NCT00640328|9191827|P4|Second Treatment Period (Weeks 24-48)|Adverse Event|0
2661949|NCT00640328|9191828|P3|Second Treatment Period (Weeks 24-48)|Adverse Event|0
2661950|NCT00640328|9191829|P2|Second Treatment Period (Weeks 24-48)|Adverse Event|0
2661951|NCT00640328|9191830|P1|Second Treatment Period (Weeks 24-48)|Adverse Event|0
2661952|NCT00640328|9191825|P6|First Treatment Period (Weeks 0-24)|Adverse Event|0
2661953|NCT00640328|9191826|P5|First Treatment Period (Weeks 0-24)|Adverse Event|0
2661954|NCT00640328|9191827|P4|First Treatment Period (Weeks 0-24)|Adverse Event|0
2661955|NCT00640328|9191828|P3|First Treatment Period (Weeks 0-24)|Adverse Event|0
2661956|NCT00640328|9191829|P2|First Treatment Period (Weeks 0-24)|Adverse Event|1
2661957|NCT00640328|9191830|P1|First Treatment Period (Weeks 0-24)|Adverse Event|0
2661958|NCT00640315|9191996|P2|Overall Study|Withdrawal by Subject|1
2661959|NCT00640315|9191997|P1|Overall Study|Withdrawal by Subject|0
2661960|NCT00640289|9192123|P1|Overall Study|Missing status|5
2661961|NCT00640289|9192123|P1|Overall Study|Transferred to another center|1
2661962|NCT00640289|9192123|P1|Overall Study|Data collected under different amendment|2
2661963|NCT00640289|9192123|P1|Overall Study|Lost to Follow-up|1
2661964|NCT00640289|9192123|P1|Overall Study|Withdrawal by Subject|1
2661965|NCT00640289|9192123|P1|Overall Study|Death|3
2661966|NCT00640224|9192235|P4|Overall Study|Headaches|0
2661967|NCT00640224|9192236|P3|Overall Study|Headaches|0
2661968|NCT00640224|9192237|P2|Overall Study|Headaches|1
2661969|NCT00640224|9192238|P1|Overall Study|Headaches|0
2661970|NCT00640224|9192235|P4|Overall Study|Withdrawal by Subject|0
2661971|NCT00640224|9192236|P3|Overall Study|Withdrawal by Subject|0
2661972|NCT00640224|9192237|P2|Overall Study|Withdrawal by Subject|0
2661973|NCT00640224|9192238|P1|Overall Study|Withdrawal by Subject|1
2661974|NCT00640224|9192235|P4|Overall Study|Lost to Follow-up|0
2661975|NCT00640224|9192236|P3|Overall Study|Lost to Follow-up|0
2661976|NCT00640224|9192237|P2|Overall Study|Lost to Follow-up|2
2661977|NCT00640224|9192238|P1|Overall Study|Lost to Follow-up|5
2661978|NCT00640146|9192338|P2|Overall Study|Randomized but not treated|3
2661979|NCT00640146|9192339|P1|Overall Study|Randomized but not treated|1
2661980|NCT00640146|9192338|P2|Overall Study|Withdrawal by Subject|1
2661981|NCT00640146|9192339|P1|Overall Study|Withdrawal by Subject|1
2661982|NCT00640146|9192338|P2|Overall Study|Lack of Efficacy|1
2661983|NCT00640146|9192339|P1|Overall Study|Lack of Efficacy|0
2661984|NCT00640146|9192338|P2|Overall Study|Lost to Follow-up|1
2661985|NCT00640146|9192339|P1|Overall Study|Lost to Follow-up|0
2661986|NCT00640146|9192338|P2|Overall Study|Adverse Event|0
2661987|NCT00640146|9192339|P1|Overall Study|Adverse Event|2
2661988|NCT00640133|9192351|P2|Open Label Phase (Month 4-12)|Adverse Event|0
2661989|NCT00640133|9192352|P1|Open Label Phase (Month 4-12)|Adverse Event|1
2661990|NCT00640133|9192351|P2|Open Label Phase (Month 4-12)|Withdrawal by Subject|0
2661991|NCT00640133|9192352|P1|Open Label Phase (Month 4-12)|Withdrawal by Subject|1
2661992|NCT00640133|9192351|P2|Open Label Phase (Month 4-12)|Lack of Efficacy|0
2661993|NCT00640133|9192352|P1|Open Label Phase (Month 4-12)|Lack of Efficacy|1
2661994|NCT00640042|9192372|P1|Enrollment|Did not receive study drug|83
2661995|NCT00640016|9192388|P4|Overall Study|Adverse Event|1
2661996|NCT00640016|9192389|P3|Overall Study|Adverse Event|0
2661997|NCT00640016|9192390|P2|Overall Study|Adverse Event|0
2661998|NCT00640016|9192391|P1|Overall Study|Adverse Event|0
2661999|NCT00640016|9192388|P4|Overall Study|Study termination|2
2662000|NCT00640016|9192389|P3|Overall Study|Study termination|3
2662001|NCT00640016|9192390|P2|Overall Study|Study termination|1
2662002|NCT00640016|9192391|P1|Overall Study|Study termination|2
2662003|NCT00640016|9192388|P4|Overall Study|Withdrawal by Subject|0
2662004|NCT00640016|9192389|P3|Overall Study|Withdrawal by Subject|0
2662005|NCT00640016|9192390|P2|Overall Study|Withdrawal by Subject|1
2662006|NCT00640016|9192391|P1|Overall Study|Withdrawal by Subject|0
2662007|NCT00639769|9192443|P1|Overall Study|Withdrawal by Subject|4
2662008|NCT00639769|9192443|P1|Overall Study|Disease progression|26
2662009|NCT00639769|9192443|P1|Overall Study|Lack of Efficacy|1
2662010|NCT00639769|9192443|P1|Overall Study|Adverse Event|7
2662011|NCT00639769|9192443|P1|Overall Study|Death|2
2662012|NCT00639678|9192460|P4|Overall Study|Lack of Compliance|0
2662013|NCT00639678|9192461|P3|Overall Study|Lack of Compliance|1
2662014|NCT00639678|9192462|P2|Overall Study|Lack of Compliance|0
2662015|NCT00639678|9192463|P1|Overall Study|Lack of Compliance|0
2662016|NCT00639678|9192460|P4|Overall Study|Adverse Event|0
2662017|NCT00639678|9192461|P3|Overall Study|Adverse Event|0
2662018|NCT00639678|9192462|P2|Overall Study|Adverse Event|1
2662019|NCT00639678|9192463|P1|Overall Study|Adverse Event|0
2662020|NCT00639678|9192460|P4|Overall Study|Lost to Follow-up|0
2662021|NCT00639678|9192461|P3|Overall Study|Lost to Follow-up|6
2662022|NCT00639678|9192462|P2|Overall Study|Lost to Follow-up|0
2662023|NCT00639678|9192463|P1|Overall Study|Lost to Follow-up|1
2662024|NCT00639678|9192460|P4|Overall Study|Withdrawal by Subject|0
2662025|NCT00639678|9192461|P3|Overall Study|Withdrawal by Subject|4
2662026|NCT00639678|9192462|P2|Overall Study|Withdrawal by Subject|0
2662027|NCT00639678|9192463|P1|Overall Study|Withdrawal by Subject|3
2662028|NCT00639509|9192528|P1|Overall Study|Death|1
2662029|NCT00639457|9192536|P2|Overall Study|Withdrawal by Subject|3
2662030|NCT00639457|9192537|P1|Overall Study|Withdrawal by Subject|2
2662031|NCT00639379|9192596|P2|Period 1 - 2 Weeks|lens issue|0
2662032|NCT00639379|9192597|P1|Period 1 - 2 Weeks|lens issue|3
2662033|NCT00639379|9192596|P2|Period 1 - 2 Weeks|Lost to Follow-up|0
2662034|NCT00639379|9192597|P1|Period 1 - 2 Weeks|Lost to Follow-up|2
2662035|NCT00639223|9192613|P2|Overall Study|Lost to Follow-up|2
2662036|NCT00639223|9192614|P1|Overall Study|Lost to Follow-up|0
2662037|NCT00639002|9192654|P1|Overall Study|Lack of Efficacy|1
2662038|NCT00639002|9192654|P1|Overall Study|Physician Decision|6
2662039|NCT00639002|9192654|P1|Overall Study|Disease progression|3
2662040|NCT00639002|9192654|P1|Overall Study|Protocol Violation|1
2662041|NCT00639002|9192654|P1|Overall Study|Adverse Event|1
2662042|NCT00639002|9192654|P1|Overall Study|Death|1
2662043|NCT00638989|9192663|P3|Overall Study|Lost to Follow-up|1
2662044|NCT00638989|9192664|P2|Overall Study|Lost to Follow-up|0
2662045|NCT00638989|9192665|P1|Overall Study|Lost to Follow-up|0
2662046|NCT00638963|9192705|P2|Overall Study|Withdrawal by Subject|0
2662047|NCT00638963|9192706|P1|Overall Study|Withdrawal by Subject|1
2662048|NCT00638846|9192747|P2|Overall Study|lens issue|3
2662049|NCT00638846|9192748|P1|Overall Study|lens issue|1
2662050|NCT00638846|9192747|P2|Overall Study|Lost to Follow-up|2
2662051|NCT00638846|9192748|P1|Overall Study|Lost to Follow-up|3
2662052|NCT00638846|9192747|P2|Overall Study|Adverse Event|1
2662053|NCT00638846|9192748|P1|Overall Study|Adverse Event|0
2662054|NCT00638690|9192792|P2|Overall Study|Lost to Follow-up|2
2662055|NCT00638690|9192793|P1|Overall Study|Lost to Follow-up|4
2662056|NCT00638690|9192792|P2|Overall Study|Withdrawal by Subject|5
2662057|NCT00638690|9192793|P1|Overall Study|Withdrawal by Subject|22
2662058|NCT00638690|9192792|P2|Overall Study|Death|335
2662059|NCT00638690|9192793|P1|Overall Study|Death|655
2662060|NCT00638508|9192813|P2|Overall Study|Physician Decision|2
2662061|NCT00638508|9192814|P1|Overall Study|Physician Decision|5
2662062|NCT00638456|9192860|P2|Overall Study|Withdrawal by Subject|2
2662063|NCT00638456|9192861|P1|Overall Study|Withdrawal by Subject|6
2662064|NCT00638443|9192871|P2|First Intervention|Adverse Event|1
2662065|NCT00638443|9192872|P1|First Intervention|Adverse Event|2
2662066|NCT00638404|9192902|P2|Overall Study|Physician Decision|0
2662067|NCT00638404|9192903|P1|Overall Study|Physician Decision|8
2662068|NCT00638378|9192915|P1|Overall Study|Physician Decision|4
2662069|NCT00638378|9192915|P1|Overall Study|Disease progression|15
2662070|NCT00638378|9192915|P1|Overall Study|Adverse Event|1
2662071|NCT00638378|9192915|P1|Overall Study|Death|2
2662072|NCT00638235|9192955|P9|Overall Study|Lost to Follow-up|18
2662073|NCT00638235|9192956|P8|Overall Study|Lost to Follow-up|1
2662074|NCT00638235|9192957|P7|Overall Study|Lost to Follow-up|0
2662075|NCT00638235|9192958|P6|Overall Study|Lost to Follow-up|26
2662076|NCT00638235|9192959|P5|Overall Study|Lost to Follow-up|13
2662077|NCT00638235|9192960|P4|Overall Study|Lost to Follow-up|10
2662078|NCT00638235|9192961|P3|Overall Study|Lost to Follow-up|18
2662079|NCT00638235|9192962|P2|Overall Study|Lost to Follow-up|3
2662080|NCT00638235|9192963|P1|Overall Study|Lost to Follow-up|31
2662081|NCT00638183|9193373|P1|Overall Study|Other reason not defined above|27
2662082|NCT00638183|9193373|P1|Overall Study|Lost to Follow-up|46
2662083|NCT00638183|9193373|P1|Overall Study|Physician Decision|9
2662084|NCT00638183|9193373|P1|Overall Study|Lack of Efficacy|14
2662085|NCT00638183|9193373|P1|Overall Study|Adverse Event|23
2662086|NCT00638157|9193382|P2|Overall Study|Randomized, not treated|0
2662087|NCT00638157|9193383|P1|Overall Study|Randomized, not treated|2
2662088|NCT00638157|9193382|P2|Overall Study|Other|2
2662089|NCT00638157|9193383|P1|Overall Study|Other|1
2662090|NCT00638157|9193382|P2|Overall Study|Physician Decision|0
2662091|NCT00638157|9193383|P1|Overall Study|Physician Decision|1
2662092|NCT00638157|9193382|P2|Overall Study|Lost to Follow-up|0
2662093|NCT00638157|9193383|P1|Overall Study|Lost to Follow-up|1
2662094|NCT00638157|9193382|P2|Overall Study|Microbiological failure|0
2662095|NCT00638157|9193383|P1|Overall Study|Microbiological failure|1
2662096|NCT00638157|9193382|P2|Overall Study|Clinical (symptomatic) failure|1
2662097|NCT00638157|9193383|P1|Overall Study|Clinical (symptomatic) failure|1
2662098|NCT00638157|9193382|P2|Overall Study|Adverse Event|1
2662099|NCT00638157|9193383|P1|Overall Study|Adverse Event|0
2662100|NCT00638027|9193393|P2|Overall Study|Adverse Event|2
2662101|NCT00638027|9193394|P1|Overall Study|Adverse Event|0
2662102|NCT00637806|9193441|P4|Extension Phase|Study Discontinued|1
2662103|NCT00637806|9193442|P3|Extension Phase|Study Discontinued|0
2662104|NCT00637806|9193443|P2|Extension Phase|Study Discontinued|0
2662105|NCT00637806|9193444|P1|Extension Phase|Study Discontinued|0
2662106|NCT00637806|9193441|P4|Double-blind Phase|Study Discontinued|0
2662107|NCT00637806|9193442|P3|Double-blind Phase|Study Discontinued|1
2662108|NCT00637806|9193443|P2|Double-blind Phase|Study Discontinued|0
2662109|NCT00637806|9193444|P1|Double-blind Phase|Study Discontinued|2
2662110|NCT00637728|9193479|P3|Double-blind Phase|Study Discontinued|0
2662111|NCT00637728|9193480|P2|Double-blind Phase|Study Discontinued|1
2662112|NCT00637728|9193481|P1|Double-blind Phase|Study Discontinued|1
2662113|NCT00637728|9193479|P3|Double-blind Phase|Non-compliance|0
2662114|NCT00637728|9193480|P2|Double-blind Phase|Non-compliance|0
2662115|NCT00637728|9193481|P1|Double-blind Phase|Non-compliance|2
2662116|NCT00637728|9193479|P3|Double-blind Phase|Adverse Event|0
2662117|NCT00637728|9193480|P2|Double-blind Phase|Adverse Event|0
2662118|NCT00637728|9193481|P1|Double-blind Phase|Adverse Event|1
2662119|NCT00637572|9193496|P2|Overall Study|Illicit Drug Use|0
2662120|NCT00637572|9193497|P1|Overall Study|Illicit Drug Use|1
2662121|NCT00637572|9193496|P2|Overall Study|Withdrawal by Subject|2
2662122|NCT00637572|9193497|P1|Overall Study|Withdrawal by Subject|0
2662123|NCT00637572|9193496|P2|Overall Study|Physician Decision|1
2662124|NCT00637572|9193497|P1|Overall Study|Physician Decision|1
2662125|NCT00637572|9193496|P2|Overall Study|Lost to Follow-up|1
2662126|NCT00637572|9193497|P1|Overall Study|Lost to Follow-up|0
2662127|NCT00637572|9193496|P2|Overall Study|Death|1
2662128|NCT00637572|9193497|P1|Overall Study|Death|0
2662129|NCT00637572|9193496|P2|Overall Study|Adverse Event|2
2662130|NCT00637572|9193497|P1|Overall Study|Adverse Event|1
2662131|NCT00637416|9193536|P2|Overall Study|Unable to take study drug|1
2662132|NCT00637416|9193537|P1|Overall Study|Unable to take study drug|0
2662133|NCT00637416|9193536|P2|Overall Study|Lost to Follow-up|1
2662134|NCT00637416|9193537|P1|Overall Study|Lost to Follow-up|1
2662135|NCT00637377|9193547|P4|Overall Study|Other (no further information available)|5
2662136|NCT00637377|9193548|P3|Overall Study|Other (no further information available)|10
2662137|NCT00637377|9193549|P2|Overall Study|Other (no further information available)|6
2662138|NCT00637377|9193550|P1|Overall Study|Other (no further information available)|7
2662139|NCT00637377|9193547|P4|Overall Study|Withdrawal by Subject|11
2662140|NCT00637377|9193548|P3|Overall Study|Withdrawal by Subject|13
2662141|NCT00637377|9193549|P2|Overall Study|Withdrawal by Subject|15
2662142|NCT00637377|9193550|P1|Overall Study|Withdrawal by Subject|11
2662143|NCT00637377|9193547|P4|Overall Study|Protocol Violation|0
2662144|NCT00637377|9193548|P3|Overall Study|Protocol Violation|1
2662145|NCT00637377|9193549|P2|Overall Study|Protocol Violation|1
2662146|NCT00637377|9193550|P1|Overall Study|Protocol Violation|2
2662147|NCT00637377|9193547|P4|Overall Study|Lost to Follow-up|2
2662148|NCT00637377|9193548|P3|Overall Study|Lost to Follow-up|2
2662149|NCT00637377|9193549|P2|Overall Study|Lost to Follow-up|1
2662150|NCT00637377|9193550|P1|Overall Study|Lost to Follow-up|4
2662151|NCT00637377|9193547|P4|Overall Study|Lack of Efficacy|1
2662152|NCT00637377|9193548|P3|Overall Study|Lack of Efficacy|1
2662153|NCT00637377|9193549|P2|Overall Study|Lack of Efficacy|0
2662154|NCT00637377|9193550|P1|Overall Study|Lack of Efficacy|0
2662155|NCT00637377|9193547|P4|Overall Study|Death|1
2662156|NCT00637377|9193548|P3|Overall Study|Death|2
2662157|NCT00637377|9193549|P2|Overall Study|Death|3
2662158|NCT00637377|9193550|P1|Overall Study|Death|1
2662159|NCT00637377|9193547|P4|Overall Study|Adverse Event|9
2662160|NCT00637377|9193548|P3|Overall Study|Adverse Event|8
2662161|NCT00637377|9193549|P2|Overall Study|Adverse Event|6
2662162|NCT00637377|9193550|P1|Overall Study|Adverse Event|2
2662163|NCT00637273|9193599|P3|Overall Study|Loss of Glucose Control|1
2662164|NCT00637273|9193600|P2|Overall Study|Loss of Glucose Control|1
2662165|NCT00637273|9193601|P1|Overall Study|Loss of Glucose Control|1
2662166|NCT00637273|9193599|P3|Overall Study|Administrative|0
2662167|NCT00637273|9193600|P2|Overall Study|Administrative|0
2662168|NCT00637273|9193601|P1|Overall Study|Administrative|2
2662169|NCT00637273|9193599|P3|Overall Study|Investigator Decision|1
2662170|NCT00637273|9193600|P2|Overall Study|Investigator Decision|3
2662171|NCT00637273|9193601|P1|Overall Study|Investigator Decision|1
2662172|NCT00637273|9193599|P3|Overall Study|Withdrawal of Consent|18
2662173|NCT00637273|9193600|P2|Overall Study|Withdrawal of Consent|6
2662174|NCT00637273|9193601|P1|Overall Study|Withdrawal of Consent|18
2662175|NCT00637273|9193599|P3|Overall Study|Protocol Violation|1
2662176|NCT00637273|9193600|P2|Overall Study|Protocol Violation|4
2662177|NCT00637273|9193601|P1|Overall Study|Protocol Violation|2
2662178|NCT00637273|9193599|P3|Overall Study|Lost to Follow-up|13
2662179|NCT00637273|9193600|P2|Overall Study|Lost to Follow-up|9
2662180|NCT00637273|9193601|P1|Overall Study|Lost to Follow-up|8
2662181|NCT00637273|9193599|P3|Overall Study|Adverse Event|7
2662182|NCT00637273|9193600|P2|Overall Study|Adverse Event|5
2662183|NCT00637273|9193601|P1|Overall Study|Adverse Event|11
2662184|NCT00637195|9193659|P2|Overall Study|Withdrawal by Subject|1
2662185|NCT00637195|9193660|P1|Overall Study|Withdrawal by Subject|0
2662186|NCT00637195|9193659|P2|Overall Study|Other|0
2662187|NCT00637195|9193660|P1|Overall Study|Other|2
2662188|NCT00637195|9193659|P2|Overall Study|Lost to Follow-up|0
2662189|NCT00637195|9193660|P1|Overall Study|Lost to Follow-up|1
2662190|NCT00637156|9193696|P2|Overall Study|Lost to Follow-up|16
2662191|NCT00637156|9193697|P1|Overall Study|Lost to Follow-up|10
2662192|NCT00637156|9193696|P2|Overall Study|Death|1
2662193|NCT00637156|9193697|P1|Overall Study|Death|0
2662194|NCT00637156|9193696|P2|Overall Study|Withdrawal by Subject|7
2662195|NCT00637156|9193697|P1|Overall Study|Withdrawal by Subject|0
2662196|NCT00637000|9193739|P2|Overall Study|Withdrawal by Subject|3
2662197|NCT00637000|9193740|P1|Overall Study|Withdrawal by Subject|4
2662198|NCT00636987|9193780|P1|Overall Study|5 year visit window not complete|69
2662199|NCT00636987|9193780|P1|Overall Study|Lost to Follow-up|63
2662200|NCT00636987|9193780|P1|Overall Study|Explanted|13
2662201|NCT00636987|9193780|P1|Overall Study|Death|44
2662202|NCT00636961|9193790|P2|Period 2|Adverse Event|0
2662203|NCT00636961|9193791|P1|Period 2|Adverse Event|1
2662204|NCT00636961|9193790|P2|Period 1|Administrative problems|1
2662205|NCT00636961|9193791|P1|Period 1|Administrative problems|1
2662206|NCT00636818|9193805|P1|Overall Study|Withdrawal by Subject|4
2662207|NCT00636818|9193805|P1|Overall Study|Protocol Violation|1
2662208|NCT00636818|9193805|P1|Overall Study|Entry Criteria Exclusion|3
2662209|NCT00636818|9193805|P1|Overall Study|Lost to Follow-up|2
2662210|NCT00636818|9193805|P1|Overall Study|Adverse Event|1
2662211|NCT00636792|9193830|P1|Overall Study|Other|3
2662212|NCT00636792|9193830|P1|Overall Study|Withdrawal by Subject|3
2662213|NCT00636792|9193830|P1|Overall Study|Progressive Disease|4
2662214|NCT00636792|9193830|P1|Overall Study|Physician Decision|7
2662215|NCT00636792|9193830|P1|Overall Study|Adverse Event|16
2662216|NCT00636675|9193846|P2|Overall Study|Withdrawal by Subject|10
2662217|NCT00636675|9193847|P1|Overall Study|Withdrawal by Subject|19
2662218|NCT00636675|9193846|P2|Overall Study|Lost to Follow-up|31
2662219|NCT00636675|9193847|P1|Overall Study|Lost to Follow-up|121
2662220|NCT00636636|9193890|P2|Overall Study|Withdrawal by Subject|9
2662221|NCT00636636|9193891|P1|Overall Study|Withdrawal by Subject|4
2662222|NCT00636636|9193890|P2|Overall Study|Death|1
2662223|NCT00636636|9193891|P1|Overall Study|Death|0
2662224|NCT00636636|9193890|P2|Overall Study|Lost to Follow-up|1
2662225|NCT00636636|9193891|P1|Overall Study|Lost to Follow-up|0
2662226|NCT00636636|9193890|P2|Overall Study|Protocol Violation|2
2662227|NCT00636636|9193891|P1|Overall Study|Protocol Violation|2
2662228|NCT00636636|9193890|P2|Overall Study|Lack of Efficacy|12
2662229|NCT00636636|9193891|P1|Overall Study|Lack of Efficacy|7
2662230|NCT00636636|9193890|P2|Overall Study|Adverse Event|8
2662231|NCT00636636|9193891|P1|Overall Study|Adverse Event|19
2662232|NCT00636636|9193890|P2|Overall Study|Other reason|6
2662233|NCT00636636|9193891|P1|Overall Study|Other reason|4
2662234|NCT00636610|9193907|P2|Overall Study|Reason for discontinuation not available|2
2662235|NCT00636610|9193908|P1|Overall Study|Reason for discontinuation not available|3
2662236|NCT00636610|9193907|P2|Overall Study|Disease progression - clinical|3
2662237|NCT00636610|9193908|P1|Overall Study|Disease progression - clinical|8
2662238|NCT00636610|9193907|P2|Overall Study|Disease progression - radiographic|51
2662239|NCT00636610|9193908|P1|Overall Study|Disease progression - radiographic|41
2662240|NCT00636610|9193907|P2|Overall Study|Subject decision to withdraw|11
2662241|NCT00636610|9193908|P1|Overall Study|Subject decision to withdraw|15
2662242|NCT00636610|9193907|P2|Overall Study|Physician decision to withdraw patient|9
2662243|NCT00636610|9193908|P1|Overall Study|Physician decision to withdraw patient|15
2662244|NCT00636610|9193907|P2|Overall Study|Death|3
2662245|NCT00636610|9193908|P1|Overall Study|Death|6
2662246|NCT00636610|9193907|P2|Overall Study|Adverse Event|4
2662247|NCT00636610|9193908|P1|Overall Study|Adverse Event|4
2662248|NCT00636506|9193918|P1|Overall Study|Procedure aborted|1
2662249|NCT00636506|9193918|P1|Overall Study|Withdrawal by Subject|6
2662250|NCT00636506|9193918|P1|Overall Study|Explanted|1
2662251|NCT00636506|9193918|P1|Overall Study|Lost to Follow-up|8
2662252|NCT00636441|9193965|P7|Overall Study|Screen Failure|17
2662253|NCT00636441|9193966|P6|Overall Study|Screen Failure|0
2662254|NCT00636441|9193967|P5|Overall Study|Screen Failure|0
2662255|NCT00636441|9193968|P4|Overall Study|Screen Failure|0
2662256|NCT00636441|9193969|P3|Overall Study|Screen Failure|0
2662257|NCT00636441|9193970|P2|Overall Study|Screen Failure|0
2662258|NCT00636441|9193971|P1|Overall Study|Screen Failure|0
2662259|NCT00636441|9193965|P7|Overall Study|Late, ineligible|1
2662260|NCT00636441|9193966|P6|Overall Study|Late, ineligible|0
2662261|NCT00636441|9193967|P5|Overall Study|Late, ineligible|0
2662262|NCT00636441|9193968|P4|Overall Study|Late, ineligible|0
2662263|NCT00636441|9193969|P3|Overall Study|Late, ineligible|0
2662264|NCT00636441|9193970|P2|Overall Study|Late, ineligible|0
2662265|NCT00636441|9193971|P1|Overall Study|Late, ineligible|0
2662266|NCT00636441|9193965|P7|Overall Study|Adverse Event|0
2662267|NCT00636441|9193966|P6|Overall Study|Adverse Event|1
2662268|NCT00636441|9193967|P5|Overall Study|Adverse Event|0
2662269|NCT00636441|9193968|P4|Overall Study|Adverse Event|0
2662270|NCT00636441|9193969|P3|Overall Study|Adverse Event|1
2662271|NCT00636441|9193970|P2|Overall Study|Adverse Event|1
2662272|NCT00636441|9193971|P1|Overall Study|Adverse Event|0
2662273|NCT00636363|9194014|P3|Overall Study|Withdrawal by Subject|2
2662274|NCT00636363|9194015|P2|Overall Study|Withdrawal by Subject|3
2662275|NCT00636363|9194016|P1|Overall Study|Withdrawal by Subject|1
2662276|NCT00636363|9194014|P3|Overall Study|Lost to Follow-up|2
2662277|NCT00636363|9194015|P2|Overall Study|Lost to Follow-up|4
2662278|NCT00636363|9194016|P1|Overall Study|Lost to Follow-up|3
2662279|NCT00636363|9194014|P3|Overall Study|Protocol Violation|0
2662280|NCT00636363|9194015|P2|Overall Study|Protocol Violation|3
2662281|NCT00636363|9194016|P1|Overall Study|Protocol Violation|0
2662282|NCT00636363|9194014|P3|Overall Study|Lack of motivation|1
2662283|NCT00636363|9194015|P2|Overall Study|Lack of motivation|0
2662284|NCT00636363|9194016|P1|Overall Study|Lack of motivation|1
2662285|NCT00636363|9194014|P3|Overall Study|Missed > 1 visit|3
2662286|NCT00636363|9194015|P2|Overall Study|Missed > 1 visit|1
2662287|NCT00636363|9194016|P1|Overall Study|Missed > 1 visit|0
2662288|NCT00636363|9194014|P3|Overall Study|Met ineligibility criteria|3
2662289|NCT00636363|9194015|P2|Overall Study|Met ineligibility criteria|0
2662290|NCT00636363|9194016|P1|Overall Study|Met ineligibility criteria|0
2662291|NCT00636363|9194014|P3|Overall Study|Study related symptoms/complaints|4
2662292|NCT00636363|9194015|P2|Overall Study|Study related symptoms/complaints|7
2662293|NCT00636363|9194016|P1|Overall Study|Study related symptoms/complaints|8
2662294|NCT00636363|9194014|P3|Overall Study|Positive slit lamp finding|1
2662295|NCT00636363|9194015|P2|Overall Study|Positive slit lamp finding|2
2662296|NCT00636363|9194016|P1|Overall Study|Positive slit lamp finding|0
2662297|NCT00636363|9194014|P3|Overall Study|Adverse Event|1
2662298|NCT00636363|9194015|P2|Overall Study|Adverse Event|0
2662299|NCT00636363|9194016|P1|Overall Study|Adverse Event|0
2662300|NCT00636363|9194014|P3|Overall Study|Conjunctivitis|1
2662301|NCT00636363|9194015|P2|Overall Study|Conjunctivitis|0
2662302|NCT00636363|9194016|P1|Overall Study|Conjunctivitis|0
2662303|NCT00636207|9194037|P7|Overall Study|Withdrawal by Subject|0
2662304|NCT00636207|9194038|P6|Overall Study|Withdrawal by Subject|0
2662305|NCT00636207|9194039|P5|Overall Study|Withdrawal by Subject|1
2662306|NCT00636207|9194040|P4|Overall Study|Withdrawal by Subject|0
2662307|NCT00636207|9194041|P3|Overall Study|Withdrawal by Subject|0
2662308|NCT00636207|9194042|P2|Overall Study|Withdrawal by Subject|1
2662309|NCT00636207|9194043|P1|Overall Study|Withdrawal by Subject|0
2662310|NCT00636207|9194037|P7|Overall Study|Adverse Event|0
2662311|NCT00636207|9194038|P6|Overall Study|Adverse Event|0
2662312|NCT00636207|9194039|P5|Overall Study|Adverse Event|0
2662313|NCT00636207|9194040|P4|Overall Study|Adverse Event|0
2662314|NCT00636207|9194041|P3|Overall Study|Adverse Event|0
2662315|NCT00636207|9194042|P2|Overall Study|Adverse Event|0
2662316|NCT00636207|9194043|P1|Overall Study|Adverse Event|1
2662317|NCT00636194|9194107|P2|Overall Study|Protocol Violation|0
2662318|NCT00636194|9194108|P1|Overall Study|Protocol Violation|2
2662319|NCT00636194|9194107|P2|Overall Study|Study related symptoms and complaints|0
2662320|NCT00636194|9194108|P1|Overall Study|Study related symptoms and complaints|1
2662321|NCT00636181|9194121|P3|Overall Study|Withdrawal by Subject|10
2662322|NCT00636181|9194122|P2|Overall Study|Withdrawal by Subject|6
2662323|NCT00636181|9194123|P1|Overall Study|Withdrawal by Subject|8
2662324|NCT00636168|9194151|P2|Long Term Follow-Up|Death|9
2662325|NCT00636168|9194152|P1|Long Term Follow-Up|Death|8
2662326|NCT00636168|9194151|P2|Long Term Follow-Up|Participant withdrew consent|2
2662327|NCT00636168|9194152|P1|Long Term Follow-Up|Participant withdrew consent|0
2662328|NCT00636168|9194151|P2|Long Term Follow-Up|Lost to Follow-up|3
2662329|NCT00636168|9194152|P1|Long Term Follow-Up|Lost to Follow-up|3
2662330|NCT00636168|9194151|P2|Treated With Study Drug|Other reason|3
2662331|NCT00636168|9194152|P1|Treated With Study Drug|Other reason|1
2662332|NCT00636168|9194151|P2|Treated With Study Drug|No longer meets study criteria|0
2662333|NCT00636168|9194152|P1|Treated With Study Drug|No longer meets study criteria|1
2662334|NCT00636168|9194151|P2|Treated With Study Drug|Pregnancy|0
2662335|NCT00636168|9194152|P1|Treated With Study Drug|Pregnancy|1
2662336|NCT00636168|9194151|P2|Treated With Study Drug|Death|0
2662337|NCT00636168|9194152|P1|Treated With Study Drug|Death|3
2662338|NCT00636168|9194151|P2|Treated With Study Drug|Poor/non-compliance|3
2662339|NCT00636168|9194152|P1|Treated With Study Drug|Poor/non-compliance|1
2662340|NCT00636168|9194151|P2|Treated With Study Drug|Participant withdrew consent|21
2662341|NCT00636168|9194152|P1|Treated With Study Drug|Participant withdrew consent|16
2662342|NCT00636168|9194151|P2|Treated With Study Drug|Adverse Event|22
2662343|NCT00636168|9194152|P1|Treated With Study Drug|Adverse Event|250
2662344|NCT00636168|9194151|P2|Treated With Study Drug|Recurrence of disease|282
2662345|NCT00636168|9194152|P1|Treated With Study Drug|Recurrence of disease|135
2662346|NCT00636168|9194151|P2|Randomized to Study Drug|No longer meets study criteria|0
2662347|NCT00636168|9194152|P1|Randomized to Study Drug|No longer meets study criteria|1
2662348|NCT00636168|9194151|P2|Randomized to Study Drug|Adverse Event|0
2662349|NCT00636168|9194152|P1|Randomized to Study Drug|Adverse Event|1
2662350|NCT00636168|9194151|P2|Randomized to Study Drug|Withdrawal by Subject|2
2662351|NCT00636168|9194152|P1|Randomized to Study Drug|Withdrawal by Subject|2
2662352|NCT00636155|9194180|P1|Overall Study|Physician Decision|5
2662353|NCT00636155|9194180|P1|Overall Study|Stem cell transplant|1
2662354|NCT00636155|9194180|P1|Overall Study|Withdrawal by Subject|3
2662355|NCT00636155|9194180|P1|Overall Study|Lack of Efficacy|1
2662356|NCT00636155|9194180|P1|Overall Study|Adverse Event|8
2662357|NCT00635999|9194222|P3|Overall Study|Withdrawal by Subject|1
2662358|NCT00635999|9194223|P2|Overall Study|Withdrawal by Subject|2
2662359|NCT00635999|9194224|P1|Overall Study|Withdrawal by Subject|4
2662360|NCT00635882|9194241|P6|Overall Study|Protocol Violation|0
2662361|NCT00635882|9194242|P5|Overall Study|Protocol Violation|0
2662362|NCT00635882|9194243|P4|Overall Study|Protocol Violation|0
2662363|NCT00635882|9194244|P3|Overall Study|Protocol Violation|0
2662364|NCT00635882|9194245|P2|Overall Study|Protocol Violation|0
2662365|NCT00635882|9194246|P1|Overall Study|Protocol Violation|1
2662366|NCT00635804|9194376|P8|Overall Study|Withdrawal by Subject|0
2662367|NCT00635804|9194377|P7|Overall Study|Withdrawal by Subject|0
2662368|NCT00635804|9194378|P6|Overall Study|Withdrawal by Subject|0
2662369|NCT00635804|9194379|P5|Overall Study|Withdrawal by Subject|0
2662370|NCT00635804|9194380|P4|Overall Study|Withdrawal by Subject|0
2662371|NCT00635804|9194381|P3|Overall Study|Withdrawal by Subject|0
2662372|NCT00635804|9194382|P2|Overall Study|Withdrawal by Subject|0
2662373|NCT00635804|9194383|P1|Overall Study|Withdrawal by Subject|1
2662374|NCT00635804|9194376|P8|Overall Study|Adverse Event|0
2662375|NCT00635804|9194377|P7|Overall Study|Adverse Event|0
2662376|NCT00635804|9194378|P6|Overall Study|Adverse Event|1
2662377|NCT00635804|9194379|P5|Overall Study|Adverse Event|0
2662378|NCT00635804|9194380|P4|Overall Study|Adverse Event|0
2662379|NCT00635804|9194381|P3|Overall Study|Adverse Event|0
2662380|NCT00635804|9194382|P2|Overall Study|Adverse Event|0
2662381|NCT00635804|9194383|P1|Overall Study|Adverse Event|0
2662382|NCT00635778|9194487|P7|Overall Study|Progressive disease|4
2662383|NCT00635778|9194488|P6|Overall Study|Progressive disease|14
2662384|NCT00635778|9194489|P5|Overall Study|Progressive disease|5
2662385|NCT00635778|9194490|P4|Overall Study|Progressive disease|4
2662386|NCT00635778|9194491|P3|Overall Study|Progressive disease|3
2662387|NCT00635778|9194492|P2|Overall Study|Progressive disease|3
2662388|NCT00635778|9194493|P1|Overall Study|Progressive disease|0
2662389|NCT00635778|9194487|P7|Overall Study|Withdrawal by Subject|1
2662390|NCT00635778|9194488|P6|Overall Study|Withdrawal by Subject|1
2662391|NCT00635778|9194489|P5|Overall Study|Withdrawal by Subject|0
2662392|NCT00635778|9194490|P4|Overall Study|Withdrawal by Subject|1
2662393|NCT00635778|9194491|P3|Overall Study|Withdrawal by Subject|0
2662394|NCT00635778|9194492|P2|Overall Study|Withdrawal by Subject|0
2662395|NCT00635778|9194493|P1|Overall Study|Withdrawal by Subject|0
2662396|NCT00635778|9194487|P7|Overall Study|Adverse Event|1
2662397|NCT00635778|9194488|P6|Overall Study|Adverse Event|6
2662398|NCT00635778|9194489|P5|Overall Study|Adverse Event|3
2662399|NCT00635778|9194490|P4|Overall Study|Adverse Event|3
2662400|NCT00635778|9194491|P3|Overall Study|Adverse Event|0
2662401|NCT00635778|9194492|P2|Overall Study|Adverse Event|0
2662402|NCT00635778|9194493|P1|Overall Study|Adverse Event|1
2662403|NCT00635661|9194564|P1|Overall Study|Withdrawal by Subject|4
2662404|NCT00635648|9194568|P1|Overall Study|Other reason|2
2662405|NCT00635648|9194568|P1|Overall Study|Noncompliance with protocol|1
2662406|NCT00635648|9194568|P1|Overall Study|No improvement after 7-10 days treatment|4
2662407|NCT00635648|9194568|P1|Overall Study|Use of other antifungal agent needed|1
2662408|NCT00635648|9194568|P1|Overall Study|Rapid progression of baseline disease|4
2662409|NCT00635648|9194568|P1|Overall Study|Physician Decision|4
2662410|NCT00635648|9194568|P1|Overall Study|Withdrawal by Subject|9
2662411|NCT00635648|9194568|P1|Overall Study|Adverse Event|12
2662412|NCT00635570|9194590|P2|Overall Study|Early termination(No sexual activity)|1
2662413|NCT00635570|9194591|P1|Overall Study|Early termination(No sexual activity)|1
2662414|NCT00635570|9194590|P2|Overall Study|Did not complete survey|1
2662415|NCT00635570|9194591|P1|Overall Study|Did not complete survey|2
2662416|NCT00635570|9194590|P2|Overall Study|Physician Decision|0
2662417|NCT00635570|9194591|P1|Overall Study|Physician Decision|1
2662418|NCT00635570|9194590|P2|Overall Study|Adverse Event|0
2662419|NCT00635570|9194591|P1|Overall Study|Adverse Event|2
2662420|NCT00635570|9194590|P2|Overall Study|Withdrawal by Subject|1
2662421|NCT00635570|9194591|P1|Overall Study|Withdrawal by Subject|1
2662422|NCT00635570|9194590|P2|Overall Study|Lost to Follow-up|8
2662423|NCT00635570|9194591|P1|Overall Study|Lost to Follow-up|8
2662424|NCT00635492|9194605|P2|Overall Study|Withdrawal by Subject|45
2662425|NCT00635492|9194606|P1|Overall Study|Withdrawal by Subject|82
2662426|NCT00635492|9194605|P2|Overall Study|Sponsor decision|3
2662427|NCT00635492|9194606|P1|Overall Study|Sponsor decision|2
2662428|NCT00635492|9194605|P2|Overall Study|Physician Decision|22
2662429|NCT00635492|9194606|P1|Overall Study|Physician Decision|32
2662430|NCT00635492|9194605|P2|Overall Study|Lost to Follow-up|172
2662431|NCT00635492|9194606|P1|Overall Study|Lost to Follow-up|151
2662432|NCT00635492|9194605|P2|Overall Study|Death|40
2662433|NCT00635492|9194606|P1|Overall Study|Death|12
2662434|NCT00635427|9194679|P5|Overall Study|Withdrawal Of Consent|2
2662435|NCT00635427|9194680|P4|Overall Study|Withdrawal Of Consent|2
2662436|NCT00635427|9194681|P3|Overall Study|Withdrawal Of Consent|0
2662437|NCT00635427|9194682|P2|Overall Study|Withdrawal Of Consent|0
2662438|NCT00635427|9194683|P1|Overall Study|Withdrawal Of Consent|0
2662439|NCT00635427|9194679|P5|Overall Study|Termination Of Study By Sponsor|6
2662440|NCT00635427|9194680|P4|Overall Study|Termination Of Study By Sponsor|6
2662441|NCT00635427|9194681|P3|Overall Study|Termination Of Study By Sponsor|10
2662442|NCT00635427|9194682|P2|Overall Study|Termination Of Study By Sponsor|6
2662443|NCT00635427|9194683|P1|Overall Study|Termination Of Study By Sponsor|12
2662444|NCT00635427|9194679|P5|Overall Study|Death|0
2662445|NCT00635427|9194680|P4|Overall Study|Death|1
2662446|NCT00635427|9194681|P3|Overall Study|Death|0
2662447|NCT00635427|9194682|P2|Overall Study|Death|0
2662448|NCT00635427|9194683|P1|Overall Study|Death|0
2662449|NCT00635427|9194679|P5|Overall Study|Refusal Of Required DiagnosticEvaluation|0
2662450|NCT00635427|9194680|P4|Overall Study|Refusal Of Required DiagnosticEvaluation|0
2662451|NCT00635427|9194681|P3|Overall Study|Refusal Of Required DiagnosticEvaluation|1
2662452|NCT00635427|9194682|P2|Overall Study|Refusal Of Required DiagnosticEvaluation|0
2662453|NCT00635427|9194683|P1|Overall Study|Refusal Of Required DiagnosticEvaluation|0
2662454|NCT00635349|9194722|P2|Overall Study|Adverse Event|9
2662455|NCT00635349|9194723|P1|Overall Study|Adverse Event|11
2662456|NCT00635349|9194722|P2|Overall Study|Lost to Follow-up|3
2662457|NCT00635349|9194723|P1|Overall Study|Lost to Follow-up|4
2662458|NCT00635349|9194722|P2|Overall Study|Withdrawal by Subject|8
2662459|NCT00635349|9194723|P1|Overall Study|Withdrawal by Subject|3
2662460|NCT00635349|9194722|P2|Overall Study|Protocol Violation|22
2662461|NCT00635349|9194723|P1|Overall Study|Protocol Violation|18
2662462|NCT00635349|9194722|P2|Overall Study|Other|6
2662463|NCT00635349|9194723|P1|Overall Study|Other|8
2662464|NCT00635219|9194777|P5|Overall Study|Administrative or Other Reasons|1
2662465|NCT00635219|9194778|P4|Overall Study|Administrative or Other Reasons|0
2662466|NCT00635219|9194779|P3|Overall Study|Administrative or Other Reasons|1
2662467|NCT00635219|9194780|P2|Overall Study|Administrative or Other Reasons|1
2662468|NCT00635219|9194781|P1|Overall Study|Administrative or Other Reasons|0
2662469|NCT00635219|9194777|P5|Overall Study|Lost to Follow-up|3
2662470|NCT00635219|9194778|P4|Overall Study|Lost to Follow-up|0
2662471|NCT00635219|9194779|P3|Overall Study|Lost to Follow-up|2
2662472|NCT00635219|9194780|P2|Overall Study|Lost to Follow-up|0
2662473|NCT00635219|9194781|P1|Overall Study|Lost to Follow-up|0
2662474|NCT00635219|9194777|P5|Overall Study|Withdrawal of Consent|8
2662475|NCT00635219|9194778|P4|Overall Study|Withdrawal of Consent|11
2662476|NCT00635219|9194779|P3|Overall Study|Withdrawal of Consent|8
2662477|NCT00635219|9194780|P2|Overall Study|Withdrawal of Consent|6
2662478|NCT00635219|9194781|P1|Overall Study|Withdrawal of Consent|8
2662479|NCT00635219|9194777|P5|Overall Study|Protocol Violation|4
2662480|NCT00635219|9194778|P4|Overall Study|Protocol Violation|2
2662481|NCT00635219|9194779|P3|Overall Study|Protocol Violation|3
2662482|NCT00635219|9194780|P2|Overall Study|Protocol Violation|2
2662483|NCT00635219|9194781|P1|Overall Study|Protocol Violation|0
2662484|NCT00635219|9194777|P5|Overall Study|Non-compliance With Study Product|1
2662485|NCT00635219|9194778|P4|Overall Study|Non-compliance With Study Product|2
2662486|NCT00635219|9194779|P3|Overall Study|Non-compliance With Study Product|0
2662487|NCT00635219|9194780|P2|Overall Study|Non-compliance With Study Product|0
2662488|NCT00635219|9194781|P1|Overall Study|Non-compliance With Study Product|0
2662489|NCT00635219|9194777|P5|Overall Study|Lack of Efficacy|6
2662490|NCT00635219|9194778|P4|Overall Study|Lack of Efficacy|4
2662491|NCT00635219|9194779|P3|Overall Study|Lack of Efficacy|3
2662492|NCT00635219|9194780|P2|Overall Study|Lack of Efficacy|6
2662493|NCT00635219|9194781|P1|Overall Study|Lack of Efficacy|5
2662494|NCT00635219|9194777|P5|Overall Study|Adverse Event|19
2662495|NCT00635219|9194778|P4|Overall Study|Adverse Event|15
2662496|NCT00635219|9194779|P3|Overall Study|Adverse Event|18
2662497|NCT00635219|9194780|P2|Overall Study|Adverse Event|10
2662498|NCT00635219|9194781|P1|Overall Study|Adverse Event|12
2662499|NCT00635154|9194844|P1|Overall Study|Still on treatment|21
2662500|NCT00635154|9194844|P1|Overall Study|Other|4
2662501|NCT00635154|9194844|P1|Overall Study|Alternative Treatment|8
2662502|NCT00635102|9194887|P2|Overall Study|Withdrawal by Subject|8
2662503|NCT00635102|9194888|P1|Overall Study|Withdrawal by Subject|7
2662504|NCT00635089|9194982|P1|Overall Study|Other|31
2662505|NCT00635089|9194982|P1|Overall Study|Lost to Follow-up|8
2662506|NCT00635089|9194982|P1|Overall Study|Protocol Deviation|4
2662507|NCT00635089|9194982|P1|Overall Study|Lack of Efficacy|28
2662508|NCT00635089|9194982|P1|Overall Study|Adverse Event|7
2662509|NCT00635050|9195009|P1|Overall Study|Withdrawal by Subject|1
2662510|NCT00635024|9195016|P1|Overall Study|Adverse Event|1
2662511|NCT00634933|9195027|P5|Part B: Week 24 to Week 52|Other|1
2662512|NCT00634933|9195028|P4|Part B: Week 24 to Week 52|Other|0
2662513|NCT00634933|9195029|P3|Part B: Week 24 to Week 52|Other|5
2662514|NCT00634933|9195030|P2|Part B: Week 24 to Week 52|Other|0
2662515|NCT00634933|9195031|P1|Part B: Week 24 to Week 52|Other|0
2662516|NCT00634933|9195027|P5|Part B: Week 24 to Week 52|Lack of Efficacy|0
2662517|NCT00634933|9195028|P4|Part B: Week 24 to Week 52|Lack of Efficacy|0
2662518|NCT00634933|9195029|P3|Part B: Week 24 to Week 52|Lack of Efficacy|1
2662519|NCT00634933|9195030|P2|Part B: Week 24 to Week 52|Lack of Efficacy|1
2662520|NCT00634933|9195031|P1|Part B: Week 24 to Week 52|Lack of Efficacy|0
2662521|NCT00634933|9195027|P5|Part B: Week 24 to Week 52|Withdrawal by Subject|1
2662522|NCT00634933|9195028|P4|Part B: Week 24 to Week 52|Withdrawal by Subject|2
2662523|NCT00634933|9195029|P3|Part B: Week 24 to Week 52|Withdrawal by Subject|0
2662524|NCT00634933|9195030|P2|Part B: Week 24 to Week 52|Withdrawal by Subject|0
2662525|NCT00634933|9195031|P1|Part B: Week 24 to Week 52|Withdrawal by Subject|0
2662526|NCT00634933|9195027|P5|Part B: Week 24 to Week 52|Protocol Violation|1
2662527|NCT00634933|9195028|P4|Part B: Week 24 to Week 52|Protocol Violation|0
2662528|NCT00634933|9195029|P3|Part B: Week 24 to Week 52|Protocol Violation|0
2662529|NCT00634933|9195030|P2|Part B: Week 24 to Week 52|Protocol Violation|0
2662530|NCT00634933|9195031|P1|Part B: Week 24 to Week 52|Protocol Violation|0
2662531|NCT00634933|9195027|P5|Part B: Week 24 to Week 52|Physician Decision|0
2662532|NCT00634933|9195028|P4|Part B: Week 24 to Week 52|Physician Decision|0
2662533|NCT00634933|9195029|P3|Part B: Week 24 to Week 52|Physician Decision|1
2662534|NCT00634933|9195030|P2|Part B: Week 24 to Week 52|Physician Decision|1
2662535|NCT00634933|9195031|P1|Part B: Week 24 to Week 52|Physician Decision|0
2662536|NCT00634933|9195027|P5|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7
2662537|NCT00634933|9195028|P4|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3
2662538|NCT00634933|9195029|P3|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14
2662539|NCT00634933|9195030|P2|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11
2662540|NCT00634933|9195031|P1|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0
2662541|NCT00634933|9195027|P5|Part B: Week 24 to Week 52|Adverse Event|0
2662542|NCT00634933|9195028|P4|Part B: Week 24 to Week 52|Adverse Event|1
2662543|NCT00634933|9195029|P3|Part B: Week 24 to Week 52|Adverse Event|1
2662544|NCT00634933|9195030|P2|Part B: Week 24 to Week 52|Adverse Event|1
2662545|NCT00634933|9195031|P1|Part B: Week 24 to Week 52|Adverse Event|0
2662546|NCT00634933|9195027|P5|Between Part A and Part B|Physician Decision|0
2662547|NCT00634933|9195028|P4|Between Part A and Part B|Physician Decision|0
2662548|NCT00634933|9195029|P3|Between Part A and Part B|Physician Decision|0
2662549|NCT00634933|9195030|P2|Between Part A and Part B|Physician Decision|1
2662550|NCT00634933|9195031|P1|Between Part A and Part B|Physician Decision|0
2662551|NCT00634933|9195027|P5|Part A: Baseline to Week 24|Other|0
2662552|NCT00634933|9195028|P4|Part A: Baseline to Week 24|Other|0
2662553|NCT00634933|9195029|P3|Part A: Baseline to Week 24|Other|5
2662554|NCT00634933|9195030|P2|Part A: Baseline to Week 24|Other|8
2662555|NCT00634933|9195031|P1|Part A: Baseline to Week 24|Other|1
2662556|NCT00634933|9195027|P5|Part A: Baseline to Week 24|Lack of Efficacy|0
2662557|NCT00634933|9195028|P4|Part A: Baseline to Week 24|Lack of Efficacy|0
2662558|NCT00634933|9195029|P3|Part A: Baseline to Week 24|Lack of Efficacy|0
2662559|NCT00634933|9195030|P2|Part A: Baseline to Week 24|Lack of Efficacy|1
2662560|NCT00634933|9195031|P1|Part A: Baseline to Week 24|Lack of Efficacy|3
2662561|NCT00634933|9195027|P5|Part A: Baseline to Week 24|Withdrawal by Subject|0
2662562|NCT00634933|9195028|P4|Part A: Baseline to Week 24|Withdrawal by Subject|0
2662563|NCT00634933|9195029|P3|Part A: Baseline to Week 24|Withdrawal by Subject|3
2662564|NCT00634933|9195030|P2|Part A: Baseline to Week 24|Withdrawal by Subject|3
2662565|NCT00634933|9195031|P1|Part A: Baseline to Week 24|Withdrawal by Subject|0
2662566|NCT00634933|9195027|P5|Part A: Baseline to Week 24|Lost to Follow-up|0
2662567|NCT00634933|9195028|P4|Part A: Baseline to Week 24|Lost to Follow-up|0
2662568|NCT00634933|9195029|P3|Part A: Baseline to Week 24|Lost to Follow-up|1
2662569|NCT00634933|9195030|P2|Part A: Baseline to Week 24|Lost to Follow-up|1
2662570|NCT00634933|9195031|P1|Part A: Baseline to Week 24|Lost to Follow-up|0
2662571|NCT00634933|9195027|P5|Part A: Baseline to Week 24|Investigator Request|0
2662572|NCT00634933|9195028|P4|Part A: Baseline to Week 24|Investigator Request|0
2662573|NCT00634933|9195029|P3|Part A: Baseline to Week 24|Investigator Request|1
2662574|NCT00634933|9195030|P2|Part A: Baseline to Week 24|Investigator Request|1
2662575|NCT00634933|9195031|P1|Part A: Baseline to Week 24|Investigator Request|1
2662576|NCT00634933|9195027|P5|Part A: Baseline to Week 24|Failed to Return|0
2662577|NCT00634933|9195028|P4|Part A: Baseline to Week 24|Failed to Return|0
2662578|NCT00634933|9195029|P3|Part A: Baseline to Week 24|Failed to Return|0
2662579|NCT00634933|9195030|P2|Part A: Baseline to Week 24|Failed to Return|0
2662580|NCT00634933|9195031|P1|Part A: Baseline to Week 24|Failed to Return|1
2662581|NCT00634933|9195027|P5|Part A: Baseline to Week 24|Death|0
2662582|NCT00634933|9195028|P4|Part A: Baseline to Week 24|Death|0
2662583|NCT00634933|9195029|P3|Part A: Baseline to Week 24|Death|0
2662584|NCT00634933|9195030|P2|Part A: Baseline to Week 24|Death|0
2662585|NCT00634933|9195031|P1|Part A: Baseline to Week 24|Death|1
2662586|NCT00634933|9195027|P5|Part A: Baseline to Week 24|Adverse Event|0
2662587|NCT00634933|9195028|P4|Part A: Baseline to Week 24|Adverse Event|0
2662588|NCT00634933|9195029|P3|Part A: Baseline to Week 24|Adverse Event|8
2662589|NCT00634933|9195030|P2|Part A: Baseline to Week 24|Adverse Event|4
2662590|NCT00634933|9195031|P1|Part A: Baseline to Week 24|Adverse Event|4
2662591|NCT00634920|9195100|P3|Period 2 - Post-Randomization|Patients did not receive study drug|0
2662592|NCT00634920|9195101|P2|Period 2 - Post-Randomization|Patients did not receive study drug|0
2662593|NCT00634920|9195102|P1|Period 2 - Post-Randomization|Patients did not receive study drug|2
2662594|NCT00634920|9195100|P3|Period 2 - Post-Randomization|consent withdrawal, non compliance|0
2662595|NCT00634920|9195101|P2|Period 2 - Post-Randomization|consent withdrawal, non compliance|13
2662596|NCT00634920|9195102|P1|Period 2 - Post-Randomization|consent withdrawal, non compliance|9
2662597|NCT00634920|9195100|P3|Period 2 - Post-Randomization|Death|0
2662598|NCT00634920|9195101|P2|Period 2 - Post-Randomization|Death|5
2662599|NCT00634920|9195102|P1|Period 2 - Post-Randomization|Death|2
2662600|NCT00634920|9195100|P3|Period 2 - Post-Randomization|Rejection|0
2662601|NCT00634920|9195101|P2|Period 2 - Post-Randomization|Rejection|5
2662602|NCT00634920|9195102|P1|Period 2 - Post-Randomization|Rejection|11
2662603|NCT00634920|9195100|P3|Period 2 - Post-Randomization|Adverse Event|0
2662604|NCT00634920|9195101|P2|Period 2 - Post-Randomization|Adverse Event|9
2662605|NCT00634920|9195102|P1|Period 2 - Post-Randomization|Adverse Event|37
2662606|NCT00634920|9195100|P3|Period 1 - Pre-Randomization|Other issues|6
2662607|NCT00634920|9195101|P2|Period 1 - Pre-Randomization|Other issues|0
2662608|NCT00634920|9195102|P1|Period 1 - Pre-Randomization|Other issues|0
2662609|NCT00634920|9195100|P3|Period 1 - Pre-Randomization|Non-Compliance|3
2662610|NCT00634920|9195101|P2|Period 1 - Pre-Randomization|Non-Compliance|0
2662611|NCT00634920|9195102|P1|Period 1 - Pre-Randomization|Non-Compliance|0
2662612|NCT00634920|9195100|P3|Period 1 - Pre-Randomization|Withdrawal by Subject|21
2662613|NCT00634920|9195101|P2|Period 1 - Pre-Randomization|Withdrawal by Subject|0
2662614|NCT00634920|9195102|P1|Period 1 - Pre-Randomization|Withdrawal by Subject|0
2662615|NCT00634920|9195100|P3|Period 1 - Pre-Randomization|Rejections|55
2662616|NCT00634920|9195101|P2|Period 1 - Pre-Randomization|Rejections|0
2662617|NCT00634920|9195102|P1|Period 1 - Pre-Randomization|Rejections|0
2662618|NCT00634920|9195100|P3|Period 1 - Pre-Randomization|Wound healing problems|16
2662619|NCT00634920|9195101|P2|Period 1 - Pre-Randomization|Wound healing problems|0
2662620|NCT00634920|9195102|P1|Period 1 - Pre-Randomization|Wound healing problems|0
2662621|NCT00634920|9195100|P3|Period 1 - Pre-Randomization|Adverse Event|36
2662622|NCT00634920|9195101|P2|Period 1 - Pre-Randomization|Adverse Event|0
2662623|NCT00634920|9195102|P1|Period 1 - Pre-Randomization|Adverse Event|0
2662624|NCT00634907|9195146|P2|Overall Study|Withdrawal by Subject|8
2662625|NCT00634907|9195147|P1|Overall Study|Withdrawal by Subject|11
2662626|NCT00634907|9195146|P2|Overall Study|Physician Decision|9
2662627|NCT00634907|9195147|P1|Overall Study|Physician Decision|3
2662628|NCT00634907|9195146|P2|Overall Study|Withdrawal by Subject|0
2662629|NCT00634907|9195147|P1|Overall Study|Withdrawal by Subject|3
2662630|NCT00634842|9195171|P2|Overall Study|Subject off study drug for too long|1
2662631|NCT00634842|9195172|P1|Overall Study|Subject off study drug for too long|0
2662632|NCT00634842|9195171|P2|Overall Study|No wish to keep taking Avandia|1
2662633|NCT00634842|9195172|P1|Overall Study|No wish to keep taking Avandia|0
2662634|NCT00634842|9195171|P2|Overall Study|No need of study drug to treat diabetes|1
2662635|NCT00634842|9195172|P1|Overall Study|No need of study drug to treat diabetes|0
2662636|NCT00634842|9195171|P2|Overall Study|Discontinued due to injection|2
2662637|NCT00634842|9195172|P1|Overall Study|Discontinued due to injection|0
2662638|NCT00634842|9195171|P2|Overall Study|Lack of time and intolerance to drug|1
2662639|NCT00634842|9195172|P1|Overall Study|Lack of time and intolerance to drug|0
2662640|NCT00634842|9195171|P2|Overall Study|Withdrawal by Subject|3
2662641|NCT00634842|9195172|P1|Overall Study|Withdrawal by Subject|1
2662642|NCT00634842|9195171|P2|Overall Study|Physician Decision|0
2662643|NCT00634842|9195172|P1|Overall Study|Physician Decision|1
2662644|NCT00634842|9195171|P2|Overall Study|Lost to Follow-up|2
2662645|NCT00634842|9195172|P1|Overall Study|Lost to Follow-up|1
2662646|NCT00634842|9195171|P2|Overall Study|Inclusion criteria were not met|0
2662647|NCT00634842|9195172|P1|Overall Study|Inclusion criteria were not met|1
2662648|NCT00634842|9195171|P2|Overall Study|Move to another state|0
2662649|NCT00634842|9195172|P1|Overall Study|Move to another state|1
2662650|NCT00634842|9195171|P2|Overall Study|Protocol Violation|4
2662651|NCT00634842|9195172|P1|Overall Study|Protocol Violation|8
2662652|NCT00634842|9195171|P2|Overall Study|Adverse Event|3
2662653|NCT00634842|9195172|P1|Overall Study|Adverse Event|2
2662654|NCT00634751|9195188|P4|Pancreatic and Bilial Tract Cancer|Death|1
2662655|NCT00634751|9195189|P3|Pancreatic and Bilial Tract Cancer|Death|1
2662656|NCT00634751|9195190|P2|Pancreatic and Bilial Tract Cancer|Death|0
2662657|NCT00634751|9195191|P1|Pancreatic and Bilial Tract Cancer|Death|0
2662658|NCT00634751|9195188|P4|Phase I: 400mg Sorafenib BID+2DOC|Death|0
2662659|NCT00634751|9195189|P3|Phase I: 400mg Sorafenib BID+2DOC|Death|0
2662660|NCT00634751|9195190|P2|Phase I: 400mg Sorafenib BID+2DOC|Death|1
2662661|NCT00634751|9195191|P1|Phase I: 400mg Sorafenib BID+2DOC|Death|0
2662662|NCT00634751|9195188|P4|Phase I: 200mg Sorafenib+2DOC|Death|0
2662663|NCT00634751|9195189|P3|Phase I: 200mg Sorafenib+2DOC|Death|0
2662664|NCT00634751|9195190|P2|Phase I: 200mg Sorafenib+2DOC|Death|0
2662665|NCT00634751|9195191|P1|Phase I: 200mg Sorafenib+2DOC|Death|1
2662666|NCT00634647|9195209|P1|Overall Study|declined to participate before treatment|1
2662667|NCT00634647|9195209|P1|Overall Study|refused further treatment|3
2662668|NCT00634647|9195209|P1|Overall Study|death on study|3
2662669|NCT00634569|9195229|P2|Overall Study|Physician Decision|1
2662670|NCT00634569|9195230|P1|Overall Study|Physician Decision|0
2662671|NCT00634569|9195229|P2|Overall Study|Withdrawal by Subject|4
2662672|NCT00634569|9195230|P1|Overall Study|Withdrawal by Subject|0
2662673|NCT00634543|9195244|P2|Overall Study|Lost to Follow-up|1
2662674|NCT00634543|9195245|P1|Overall Study|Lost to Follow-up|0
2662675|NCT00634543|9195244|P2|Overall Study|Withdrawal by Subject|4
2662676|NCT00634543|9195245|P1|Overall Study|Withdrawal by Subject|4
2662677|NCT00634543|9195244|P2|Overall Study|Adverse Event|11
2662678|NCT00634543|9195245|P1|Overall Study|Adverse Event|11
2662679|NCT00634543|9195244|P2|Overall Study|Protocol Violation|3
2662680|NCT00634543|9195245|P1|Overall Study|Protocol Violation|3
2662681|NCT00634543|9195244|P2|Overall Study|Other|2
2662682|NCT00634543|9195245|P1|Overall Study|Other|1
2662683|NCT00634504|9195263|P2|Overall Study|Protocol Violation|0
2662684|NCT00634504|9195264|P1|Overall Study|Protocol Violation|1
2662685|NCT00634244|9195323|P3|Overall Study|Other complicating disease|0
2662686|NCT00634244|9195324|P2|Overall Study|Other complicating disease|1
2662687|NCT00634244|9195325|P1|Overall Study|Other complicating disease|0
2662688|NCT00634244|9195323|P3|Overall Study|Disease progression/relapse|0
2662689|NCT00634244|9195324|P2|Overall Study|Disease progression/relapse|1
2662690|NCT00634244|9195325|P1|Overall Study|Disease progression/relapse|0
2662691|NCT00634244|9195323|P3|Overall Study|Physician Decision|0
2662692|NCT00634244|9195324|P2|Overall Study|Physician Decision|1
2662693|NCT00634244|9195325|P1|Overall Study|Physician Decision|0
2662694|NCT00634244|9195323|P3|Overall Study|Withdrawal by Subject|0
2662695|NCT00634244|9195324|P2|Overall Study|Withdrawal by Subject|1
2662696|NCT00634244|9195325|P1|Overall Study|Withdrawal by Subject|0
2662697|NCT00634244|9195323|P3|Overall Study|Adverse Event|0
2662698|NCT00634244|9195324|P2|Overall Study|Adverse Event|2
2662699|NCT00634244|9195325|P1|Overall Study|Adverse Event|0
2662700|NCT00634244|9195323|P3|Overall Study|Death|0
2662701|NCT00634244|9195324|P2|Overall Study|Death|6
2662702|NCT00634244|9195325|P1|Overall Study|Death|1
2662703|NCT00634244|9195323|P3|Overall Study|Never started treatment|0
2662704|NCT00634244|9195324|P2|Overall Study|Never started treatment|1
2662705|NCT00634244|9195325|P1|Overall Study|Never started treatment|0
2662706|NCT00634179|9195336|P1|Phase II: Maintenance|Diagnosis changed after re-review|1
2662707|NCT00634114|9195355|P3|Overall Study|Other reason|1
2662708|NCT00634114|9195356|P2|Overall Study|Other reason|1
2662709|NCT00634114|9195357|P1|Overall Study|Other reason|1
2662710|NCT00634114|9195355|P3|Overall Study|Difficult to continue|1
2662711|NCT00634114|9195356|P2|Overall Study|Difficult to continue|1
2662712|NCT00634114|9195357|P1|Overall Study|Difficult to continue|3
2662713|NCT00634114|9195355|P3|Overall Study|Recurrence of reflux esophagitis|21
2662714|NCT00634114|9195356|P2|Overall Study|Recurrence of reflux esophagitis|15
2662715|NCT00634114|9195357|P1|Overall Study|Recurrence of reflux esophagitis|5
2662716|NCT00634114|9195355|P3|Overall Study|Incorrect enrolment|0
2662717|NCT00634114|9195356|P2|Overall Study|Incorrect enrolment|1
2662718|NCT00634114|9195357|P1|Overall Study|Incorrect enrolment|0
2662719|NCT00634114|9195355|P3|Overall Study|Pregnancy|0
2662720|NCT00634114|9195356|P2|Overall Study|Pregnancy|0
2662721|NCT00634114|9195357|P1|Overall Study|Pregnancy|1
2662722|NCT00634114|9195355|P3|Overall Study|Protocol Violation|1
2662723|NCT00634114|9195356|P2|Overall Study|Protocol Violation|3
2662724|NCT00634114|9195357|P1|Overall Study|Protocol Violation|3
2662725|NCT00634114|9195355|P3|Overall Study|Lost to Follow-up|1
2662726|NCT00634114|9195356|P2|Overall Study|Lost to Follow-up|0
2662727|NCT00634114|9195357|P1|Overall Study|Lost to Follow-up|0
2662728|NCT00634114|9195355|P3|Overall Study|Withdrawal by Subject|11
2662729|NCT00634114|9195356|P2|Overall Study|Withdrawal by Subject|6
2662730|NCT00634114|9195357|P1|Overall Study|Withdrawal by Subject|9
2662731|NCT00634114|9195355|P3|Overall Study|Adverse Event|3
2662732|NCT00634114|9195356|P2|Overall Study|Adverse Event|8
2662733|NCT00634114|9195357|P1|Overall Study|Adverse Event|6
2662734|NCT00634088|9195375|P4|Time Period 3: Dose Level 3|Progressive disease|0
2662735|NCT00634088|9195376|P3|Time Period 3: Dose Level 3|Progressive disease|1
2662736|NCT00634088|9195377|P2|Time Period 3: Dose Level 3|Progressive disease|0
2662737|NCT00634088|9195378|P1|Time Period 3: Dose Level 3|Progressive disease|0
2662738|NCT00634088|9195375|P4|Time Period 2: Dose Level 2|Progressive disease|0
2662739|NCT00634088|9195376|P3|Time Period 2: Dose Level 2|Progressive disease|0
2662740|NCT00634088|9195377|P2|Time Period 2: Dose Level 2|Progressive disease|1
2662741|NCT00634088|9195378|P1|Time Period 2: Dose Level 2|Progressive disease|0
2662742|NCT00634088|9195375|P4|Time Period 2: Dose Level 2|Adverse Event|0
2662743|NCT00634088|9195376|P3|Time Period 2: Dose Level 2|Adverse Event|0
2662744|NCT00634088|9195377|P2|Time Period 2: Dose Level 2|Adverse Event|2
2662745|NCT00634088|9195378|P1|Time Period 2: Dose Level 2|Adverse Event|0
2662746|NCT00634088|9195375|P4|Time Period 1: Dose Level 1|Adverse Event|0
2662747|NCT00634088|9195376|P3|Time Period 1: Dose Level 1|Adverse Event|0
2662748|NCT00634088|9195377|P2|Time Period 1: Dose Level 1|Adverse Event|0
2662749|NCT00634088|9195378|P1|Time Period 1: Dose Level 1|Adverse Event|3
2662750|NCT00634088|9195375|P4|Time Period 1: Dose Level 1|Physician Decision|0
2662751|NCT00634088|9195376|P3|Time Period 1: Dose Level 1|Physician Decision|0
2662752|NCT00634088|9195377|P2|Time Period 1: Dose Level 1|Physician Decision|0
2662753|NCT00634088|9195378|P1|Time Period 1: Dose Level 1|Physician Decision|1
2662754|NCT00634088|9195375|P4|Time Period 1: Dose Level 1|Disease progression|0
2662755|NCT00634088|9195376|P3|Time Period 1: Dose Level 1|Disease progression|0
2662756|NCT00634088|9195377|P2|Time Period 1: Dose Level 1|Disease progression|0
2662757|NCT00634088|9195378|P1|Time Period 1: Dose Level 1|Disease progression|2
2662758|NCT00634049|9195429|P1|Overall Study|Screening failure|1
2662759|NCT00634049|9195429|P1|Overall Study|Died prior to receiving study drug|1
2662760|NCT00634049|9195429|P1|Overall Study|Never received study drug|1
2662761|NCT00634036|9195508|P2|Overall Study|Withdrawal by Subject|1
2662762|NCT00634036|9195509|P1|Overall Study|Withdrawal by Subject|1
2662763|NCT00634036|9195508|P2|Overall Study|Lost to Follow-up|1
2662764|NCT00634036|9195509|P1|Overall Study|Lost to Follow-up|1
2662765|NCT00634010|9195523|P2|Overall Study|Non-Compliant|1
2662766|NCT00634010|9195524|P1|Overall Study|Non-Compliant|1
2662767|NCT00634010|9195523|P2|Overall Study|Disease Progression|1
2662768|NCT00634010|9195524|P1|Overall Study|Disease Progression|1
2662769|NCT00634010|9195523|P2|Overall Study|Physician Decision|1
2662770|NCT00634010|9195524|P1|Overall Study|Physician Decision|1
2662771|NCT00634010|9195523|P2|Overall Study|Withdrawal by Subject|6
2662772|NCT00634010|9195524|P1|Overall Study|Withdrawal by Subject|5
2662773|NCT00634010|9195523|P2|Overall Study|Adverse Event|5
2662774|NCT00634010|9195524|P1|Overall Study|Adverse Event|2
2662775|NCT00633984|9195532|P2|Overall Study|Hospitalized|0
2662776|NCT00633984|9195533|P1|Overall Study|Hospitalized|1
2662777|NCT00633984|9195532|P2|Overall Study|Withdrawal by Subject|7
2662778|NCT00633984|9195533|P1|Overall Study|Withdrawal by Subject|8
2662779|NCT00633984|9195532|P2|Overall Study|Lost to Follow-up|6
2662780|NCT00633984|9195533|P1|Overall Study|Lost to Follow-up|0
2662781|NCT00633945|9195541|P1|Overall Study|Physician Decision|2
2662782|NCT00633932|9195557|P3|Overall Study|Moved Away|0
2662783|NCT00633932|9195558|P2|Overall Study|Moved Away|0
2662784|NCT00633932|9195559|P1|Overall Study|Moved Away|1
2662785|NCT00633932|9195557|P3|Overall Study|Doctor's judgement|0
2662786|NCT00633932|9195558|P2|Overall Study|Doctor's judgement|0
2662787|NCT00633932|9195559|P1|Overall Study|Doctor's judgement|1
2662788|NCT00633932|9195557|P3|Overall Study|Physician Decision|1
2662789|NCT00633932|9195558|P2|Overall Study|Physician Decision|0
2662790|NCT00633932|9195559|P1|Overall Study|Physician Decision|0
2662791|NCT00633932|9195557|P3|Overall Study|Protocol Violation|3
2662792|NCT00633932|9195558|P2|Overall Study|Protocol Violation|2
2662793|NCT00633932|9195559|P1|Overall Study|Protocol Violation|5
2662794|NCT00633932|9195557|P3|Overall Study|Lost to Follow-up|2
2662795|NCT00633932|9195558|P2|Overall Study|Lost to Follow-up|0
2662796|NCT00633932|9195559|P1|Overall Study|Lost to Follow-up|1
2662797|NCT00633932|9195557|P3|Overall Study|Withdrawal by Subject|1
2662798|NCT00633932|9195558|P2|Overall Study|Withdrawal by Subject|9
2662799|NCT00633932|9195559|P1|Overall Study|Withdrawal by Subject|3
2662800|NCT00633932|9195557|P3|Overall Study|Adverse Event|4
2662801|NCT00633932|9195558|P2|Overall Study|Adverse Event|3
2662802|NCT00633932|9195559|P1|Overall Study|Adverse Event|1
2662803|NCT00633893|9195590|P3|Overall Study|Other|31
2662804|NCT00633893|9195591|P2|Overall Study|Other|33
2662805|NCT00633893|9195592|P1|Overall Study|Other|28
2662806|NCT00633893|9195590|P3|Overall Study|Not meet/no longer meets criteria|4
2662807|NCT00633893|9195591|P2|Overall Study|Not meet/no longer meets criteria|6
2662808|NCT00633893|9195592|P1|Overall Study|Not meet/no longer meets criteria|4
2662809|NCT00633893|9195590|P3|Overall Study|Pregnancy|1
2662810|NCT00633893|9195591|P2|Overall Study|Pregnancy|1
2662811|NCT00633893|9195592|P1|Overall Study|Pregnancy|2
2662812|NCT00633893|9195590|P3|Overall Study|Poor/non-compliance|3
2662813|NCT00633893|9195591|P2|Overall Study|Poor/non-compliance|12
2662814|NCT00633893|9195592|P1|Overall Study|Poor/non-compliance|5
2662815|NCT00633893|9195590|P3|Overall Study|Lost to Follow-up|8
2662816|NCT00633893|9195591|P2|Overall Study|Lost to Follow-up|4
2662817|NCT00633893|9195592|P1|Overall Study|Lost to Follow-up|2
2662818|NCT00633893|9195590|P3|Overall Study|Withdrawal by Subject|6
2662819|NCT00633893|9195591|P2|Overall Study|Withdrawal by Subject|12
2662820|NCT00633893|9195592|P1|Overall Study|Withdrawal by Subject|7
2662821|NCT00633893|9195590|P3|Overall Study|Adverse Event|126
2662822|NCT00633893|9195591|P2|Overall Study|Adverse Event|58
2662823|NCT00633893|9195592|P1|Overall Study|Adverse Event|65
2662824|NCT00633893|9195590|P3|Overall Study|Death|9
2662825|NCT00633893|9195591|P2|Overall Study|Death|3
2662826|NCT00633893|9195592|P1|Overall Study|Death|1
2662827|NCT00633880|9195666|P3|Open Label Titration|Withdrawal by Subject|0
2662828|NCT00633880|9195667|P2|Open Label Titration|Withdrawal by Subject|0
2662829|NCT00633880|9195668|P1|Open Label Titration|Withdrawal by Subject|4
2662830|NCT00633880|9195666|P3|Open Label Titration|Physician Decision|0
2662831|NCT00633880|9195667|P2|Open Label Titration|Physician Decision|0
2662832|NCT00633880|9195668|P1|Open Label Titration|Physician Decision|1
2662833|NCT00633880|9195666|P3|Open Label Titration|Protocol Violation|0
2662834|NCT00633880|9195667|P2|Open Label Titration|Protocol Violation|0
2662835|NCT00633880|9195668|P1|Open Label Titration|Protocol Violation|6
2662836|NCT00633880|9195666|P3|Open Label Titration|Treatment Failure|0
2662837|NCT00633880|9195667|P2|Open Label Titration|Treatment Failure|0
2662838|NCT00633880|9195668|P1|Open Label Titration|Treatment Failure|55
2662839|NCT00633880|9195666|P3|Open Label Titration|Adverse Event|0
2662840|NCT00633880|9195667|P2|Open Label Titration|Adverse Event|0
2662841|NCT00633880|9195668|P1|Open Label Titration|Adverse Event|13
2662842|NCT00633880|9195666|P3|Open Label Titration|Lack of Efficacy|0
2662843|NCT00633880|9195667|P2|Open Label Titration|Lack of Efficacy|0
2662844|NCT00633880|9195668|P1|Open Label Titration|Lack of Efficacy|1
2662845|NCT00633750|9195704|P1|Overall Study|Withdrawal by Subject|3
2662846|NCT00633750|9195704|P1|Overall Study|Adverse Event|2
2662847|NCT00633594|9195713|P3|Overall Study|Disease Progression|1
2662848|NCT00633594|9195714|P2|Overall Study|Disease Progression|0
2662849|NCT00633594|9195715|P1|Overall Study|Disease Progression|0
2662850|NCT00633594|9195713|P3|Overall Study|Death|2
2662851|NCT00633594|9195714|P2|Overall Study|Death|1
2662852|NCT00633594|9195715|P1|Overall Study|Death|0
2662853|NCT00633594|9195713|P3|Overall Study|Adverse Event|7
2662854|NCT00633594|9195714|P2|Overall Study|Adverse Event|4
2662855|NCT00633594|9195715|P1|Overall Study|Adverse Event|0
2662856|NCT00633477|9195744|P2|Overall Study|Randomized but not treated|0
2662857|NCT00633477|9195745|P1|Overall Study|Randomized but not treated|1
2662858|NCT00633477|9195744|P2|Overall Study|Death|0
2662859|NCT00633477|9195745|P1|Overall Study|Death|1
2662860|NCT00633464|9195761|P2|Overall Study|Never Treated (Randomized in error)|1
2662861|NCT00633464|9195762|P1|Overall Study|Never Treated (Randomized in error)|0
2662862|NCT00633464|9195761|P2|Overall Study|Never Treated (Not met study criteria)|1
2662863|NCT00633464|9195762|P1|Overall Study|Never Treated (Not met study criteria)|0
2662864|NCT00633360|9195797|P2|Overall Study|Protocol Violation|1
2662865|NCT00633360|9195798|P1|Overall Study|Protocol Violation|0
2662866|NCT00633360|9195797|P2|Overall Study|Adverse Event|1
2662867|NCT00633360|9195798|P1|Overall Study|Adverse Event|3
2662868|NCT00633360|9195797|P2|Overall Study|Lost to Follow-up|1
2662869|NCT00633360|9195798|P1|Overall Study|Lost to Follow-up|1
2662870|NCT00633243|9195821|P2|Overall Study|Couldn't tolerate side-effects|1
2662871|NCT00633243|9195822|P1|Overall Study|Couldn't tolerate side-effects|1
2662872|NCT00633243|9195821|P2|Overall Study|Mental Health--Depression|1
2662873|NCT00633243|9195822|P1|Overall Study|Mental Health--Depression|0
2662874|NCT00633243|9195821|P2|Overall Study|Not comfortable with self-injecting|1
2662875|NCT00633243|9195822|P1|Overall Study|Not comfortable with self-injecting|0
2662876|NCT00633243|9195821|P2|Overall Study|Homeless--no refrigeration for meds|1
2662877|NCT00633243|9195822|P1|Overall Study|Homeless--no refrigeration for meds|0
2662878|NCT00633243|9195821|P2|Overall Study|incarceration|2
2662879|NCT00633243|9195822|P1|Overall Study|incarceration|0
2662880|NCT00633243|9195821|P2|Overall Study|Withdrawal by Subject|1
2662881|NCT00633243|9195822|P1|Overall Study|Withdrawal by Subject|0
2662882|NCT00633217|9195830|P2|Overall Study|Withdrew Consent|3
2662883|NCT00633217|9195831|P1|Overall Study|Withdrew Consent|3
2662884|NCT00633217|9195830|P2|Overall Study|Investigator Discretion|0
2662885|NCT00633217|9195831|P1|Overall Study|Investigator Discretion|2
2662886|NCT00633217|9195830|P2|Overall Study|Lost to Follow-up|2
2662887|NCT00633217|9195831|P1|Overall Study|Lost to Follow-up|2
2662888|NCT00633217|9195830|P2|Overall Study|Protocol Violation|7
2662889|NCT00633217|9195831|P1|Overall Study|Protocol Violation|3
2662890|NCT00633217|9195830|P2|Overall Study|Lack of Efficacy|2
2662891|NCT00633217|9195831|P1|Overall Study|Lack of Efficacy|0
2662892|NCT00633217|9195830|P2|Overall Study|Adverse Event|9
2662893|NCT00633217|9195831|P1|Overall Study|Adverse Event|5
2662894|NCT00633152|9195843|P2|Overall Study|Miscellaneous Other|2
2662895|NCT00633152|9195844|P1|Overall Study|Miscellaneous Other|3
2662896|NCT00633152|9195843|P2|Overall Study|Lost to Follow-up|1
2662897|NCT00633152|9195844|P1|Overall Study|Lost to Follow-up|4
2662898|NCT00633152|9195843|P2|Overall Study|Withdrawal by Subject|1
2662899|NCT00633152|9195844|P1|Overall Study|Withdrawal by Subject|1
2662900|NCT00633152|9195843|P2|Overall Study|Randomized, did not receive study drug|2
2662901|NCT00633152|9195844|P1|Overall Study|Randomized, did not receive study drug|5
2662902|NCT00633152|9195843|P2|Overall Study|Adverse Event|0
2662903|NCT00633152|9195844|P1|Overall Study|Adverse Event|1
2662904|NCT00633139|9195855|P3|Overall Study|Withdrawal by Subject|0
2662905|NCT00633139|9195856|P2|Overall Study|Withdrawal by Subject|1
2662906|NCT00633139|9195857|P1|Overall Study|Withdrawal by Subject|0
2662907|NCT00633139|9195855|P3|Overall Study|Non compliance|1
2662908|NCT00633139|9195856|P2|Overall Study|Non compliance|0
2662909|NCT00633139|9195857|P1|Overall Study|Non compliance|0
2662910|NCT00633126|9195871|P1|Overall Study|Did not receive full dose|1
2662911|NCT00633074|9195885|P2|Overall Study|Adverse Event|0
2662912|NCT00633074|9195886|P1|Overall Study|Adverse Event|1
2662913|NCT00633061|9195916|P2|Overall Study|Study closed|0
2662914|NCT00633061|9195917|P1|Overall Study|Study closed|86
2662915|NCT00633022|9195928|P3|Overall Study|Physician Decision|0
2662916|NCT00633022|9195929|P2|Overall Study|Physician Decision|1
2662917|NCT00633022|9195930|P1|Overall Study|Physician Decision|0
2662918|NCT00633022|9195928|P3|Overall Study|Adverse Event|5
2662919|NCT00633022|9195929|P2|Overall Study|Adverse Event|0
2662920|NCT00633022|9195930|P1|Overall Study|Adverse Event|1
2662921|NCT00632931|9195992|P3|Part 2|Withdrawal by Subject|3
2662922|NCT00632931|9195993|P2|Part 2|Withdrawal by Subject|0
2662923|NCT00632931|9195994|P1|Part 2|Withdrawal by Subject|0
2662924|NCT00632931|9195992|P3|Part 2|Lack of Efficacy|17
2662925|NCT00632931|9195993|P2|Part 2|Lack of Efficacy|0
2662926|NCT00632931|9195994|P1|Part 2|Lack of Efficacy|0
2662927|NCT00632931|9195992|P3|Part 2|Death|1
2662928|NCT00632931|9195993|P2|Part 2|Death|0
2662929|NCT00632931|9195994|P1|Part 2|Death|0
2662930|NCT00632931|9195992|P3|Part 2|Adverse Event|3
2662931|NCT00632931|9195993|P2|Part 2|Adverse Event|0
2662932|NCT00632931|9195994|P1|Part 2|Adverse Event|0
2662933|NCT00632931|9195992|P3|Part 1, Period 1|Withdrawal by Subject|0
2662934|NCT00632931|9195993|P2|Part 1, Period 1|Withdrawal by Subject|0
2662935|NCT00632931|9195994|P1|Part 1, Period 1|Withdrawal by Subject|1
2662936|NCT00632931|9195992|P3|Part 1, Period 1|Protocol Violation|0
2662937|NCT00632931|9195993|P2|Part 1, Period 1|Protocol Violation|0
2662938|NCT00632931|9195994|P1|Part 1, Period 1|Protocol Violation|1
2662939|NCT00632827|9196013|P1|Overall Study|Lost to Follow-up|1
2662940|NCT00632827|9196013|P1|Overall Study|Adverse Event|5
2662941|NCT00632827|9196013|P1|Overall Study|Death|2
2662942|NCT00632827|9196013|P1|Overall Study|Excluded after GVD (Not evaluable)|2
2662943|NCT00632749|9196071|P14|Overall Study|Reason other than those specified above|2
2662944|NCT00632749|9196072|P13|Overall Study|Reason other than those specified above|0
2662945|NCT00632749|9196073|P12|Overall Study|Reason other than those specified above|1
2662946|NCT00632749|9196074|P11|Overall Study|Reason other than those specified above|2
2662947|NCT00632749|9196075|P10|Overall Study|Reason other than those specified above|0
2662948|NCT00632749|9196076|P9|Overall Study|Reason other than those specified above|0
2662949|NCT00632749|9196077|P8|Overall Study|Reason other than those specified above|0
2662950|NCT00632749|9196078|P7|Overall Study|Reason other than those specified above|1
2662951|NCT00632749|9196079|P6|Overall Study|Reason other than those specified above|0
2662952|NCT00632749|9196080|P5|Overall Study|Reason other than those specified above|1
2662953|NCT00632749|9196081|P4|Overall Study|Reason other than those specified above|0
2662954|NCT00632749|9196082|P3|Overall Study|Reason other than those specified above|0
2662955|NCT00632749|9196083|P2|Overall Study|Reason other than those specified above|2
2662956|NCT00632749|9196084|P1|Overall Study|Reason other than those specified above|0
2662957|NCT00632749|9196071|P14|Overall Study|Refuse to continue medication|0
2662958|NCT00632749|9196072|P13|Overall Study|Refuse to continue medication|0
2662959|NCT00632749|9196073|P12|Overall Study|Refuse to continue medication|0
2662960|NCT00632749|9196074|P11|Overall Study|Refuse to continue medication|0
2662961|NCT00632749|9196075|P10|Overall Study|Refuse to continue medication|1
2662962|NCT00632749|9196076|P9|Overall Study|Refuse to continue medication|0
2662963|NCT00632749|9196077|P8|Overall Study|Refuse to continue medication|0
2662964|NCT00632749|9196078|P7|Overall Study|Refuse to continue medication|0
2662965|NCT00632749|9196079|P6|Overall Study|Refuse to continue medication|0
2662966|NCT00632749|9196080|P5|Overall Study|Refuse to continue medication|0
2662967|NCT00632749|9196081|P4|Overall Study|Refuse to continue medication|1
2662968|NCT00632749|9196082|P3|Overall Study|Refuse to continue medication|0
2662969|NCT00632749|9196083|P2|Overall Study|Refuse to continue medication|0
2662970|NCT00632749|9196084|P1|Overall Study|Refuse to continue medication|0
2662971|NCT00632749|9196071|P14|Overall Study|Other Adverse event|0
2662972|NCT00632749|9196072|P13|Overall Study|Other Adverse event|1
2662973|NCT00632749|9196073|P12|Overall Study|Other Adverse event|0
2662974|NCT00632749|9196074|P11|Overall Study|Other Adverse event|1
2662975|NCT00632749|9196075|P10|Overall Study|Other Adverse event|0
2662976|NCT00632749|9196076|P9|Overall Study|Other Adverse event|2
2662977|NCT00632749|9196077|P8|Overall Study|Other Adverse event|2
2662978|NCT00632749|9196078|P7|Overall Study|Other Adverse event|1
2662979|NCT00632749|9196079|P6|Overall Study|Other Adverse event|4
2662980|NCT00632749|9196080|P5|Overall Study|Other Adverse event|2
2662981|NCT00632749|9196081|P4|Overall Study|Other Adverse event|1
2662982|NCT00632749|9196082|P3|Overall Study|Other Adverse event|1
2662983|NCT00632749|9196083|P2|Overall Study|Other Adverse event|1
2662984|NCT00632749|9196084|P1|Overall Study|Other Adverse event|1
2662985|NCT00632749|9196071|P14|Overall Study|Progressive disease|4
2662986|NCT00632749|9196072|P13|Overall Study|Progressive disease|2
2662987|NCT00632749|9196073|P12|Overall Study|Progressive disease|3
2662988|NCT00632749|9196074|P11|Overall Study|Progressive disease|4
2662989|NCT00632749|9196075|P10|Overall Study|Progressive disease|2
2662990|NCT00632749|9196076|P9|Overall Study|Progressive disease|3
2662991|NCT00632749|9196077|P8|Overall Study|Progressive disease|2
2662992|NCT00632749|9196078|P7|Overall Study|Progressive disease|3
2662993|NCT00632749|9196079|P6|Overall Study|Progressive disease|4
2662994|NCT00632749|9196080|P5|Overall Study|Progressive disease|4
2662995|NCT00632749|9196081|P4|Overall Study|Progressive disease|2
2662996|NCT00632749|9196082|P3|Overall Study|Progressive disease|2
2662997|NCT00632749|9196083|P2|Overall Study|Progressive disease|2
2662998|NCT00632749|9196084|P1|Overall Study|Progressive disease|3
2662999|NCT00632736|9196378|P1|Overall Study|Other|16
2663000|NCT00632736|9196378|P1|Overall Study|Non-compliance|10
2663001|NCT00632736|9196378|P1|Overall Study|Sponsor terminated study|5
2663002|NCT00632736|9196378|P1|Overall Study|Lack of Efficacy|5
2663003|NCT00632736|9196378|P1|Overall Study|Withdrawal by Subject|99
2663004|NCT00632736|9196378|P1|Overall Study|Protocol Violation|14
2663005|NCT00632736|9196378|P1|Overall Study|Lost to Follow-up|15
2663006|NCT00632736|9196378|P1|Overall Study|Adverse Event|104
2663007|NCT00632541|9196413|P1|Overall Study|Adverse Event|7
2663008|NCT00632502|9196422|P2|Overall Study|Randomized not treated|0
2663009|NCT00632502|9196423|P1|Overall Study|Randomized not treated|3
2663010|NCT00632502|9196422|P2|Overall Study|Adverse Event|1
2663011|NCT00632502|9196423|P1|Overall Study|Adverse Event|0
2663012|NCT00632463|9196467|P3|Overall Study|Adverse Event|0
2663013|NCT00632463|9196468|P2|Overall Study|Adverse Event|1
2663014|NCT00632463|9196469|P1|Overall Study|Adverse Event|0
2663015|NCT00632424|9196486|P1|Overall Study|Study Drug Toxicity|1
2663016|NCT00632424|9196486|P1|Overall Study|Disease Progression|17
2663017|NCT00632359|9196517|P1|Overall Study|Withdrawal by Subject|2
2663018|NCT00632229|9196530|P2|Overall Study|Undisclosed reasons within the first wee|1
2663019|NCT00632229|9196531|P1|Overall Study|Undisclosed reasons within the first wee|0
2663020|NCT00632229|9196530|P2|Overall Study|Lack of Efficacy|2
2663021|NCT00632229|9196531|P1|Overall Study|Lack of Efficacy|0
2663022|NCT00632229|9196530|P2|Overall Study|Lost to Follow-up|3
2663023|NCT00632229|9196531|P1|Overall Study|Lost to Follow-up|0
2663024|NCT00632229|9196530|P2|Overall Study|Adverse Event|0
2663025|NCT00632229|9196531|P1|Overall Study|Adverse Event|6
2663026|NCT00632203|9196541|P2|Overall Study|Did not start study treatment|0
2663027|NCT00632203|9196542|P1|Overall Study|Did not start study treatment|1
2663028|NCT00632125|9196560|P1|Overall Study|Moved to other dialysis unit, etc.|102
2663029|NCT00632125|9196560|P1|Overall Study|Development of uncontrolled hypertension|5
2663030|NCT00632125|9196560|P1|Overall Study|Non-compliance|8
2663031|NCT00632125|9196560|P1|Overall Study|Need for systemic immunosuppressive medi|8
2663032|NCT00632125|9196560|P1|Overall Study|Renal transplantation|17
2663033|NCT00632125|9196560|P1|Overall Study|Adverse Event|36
2663034|NCT00632125|9196560|P1|Overall Study|Withdrawal by Subject|44
2663035|NCT00632125|9196560|P1|Overall Study|Death|82
2663036|NCT00632099|9196566|P2|Overall Study|Lost to Follow-up|3
2663037|NCT00632099|9196567|P1|Overall Study|Lost to Follow-up|3
2663038|NCT00632021|9196575|P2|Overall Study|Withdrawal/death|7
2663039|NCT00632021|9196576|P1|Overall Study|Withdrawal/death|4
2663040|NCT00631969|9196586|P2|Overall Study|No Drug Exposure|2
2663041|NCT00631969|9196587|P1|Overall Study|No Drug Exposure|2
2663042|NCT00631969|9196586|P2|Overall Study|Noncompliant With Study Medication|1
2663043|NCT00631969|9196587|P1|Overall Study|Noncompliant With Study Medication|0
2663044|NCT00631969|9196586|P2|Overall Study|Consent Withdrawn|7
2663045|NCT00631969|9196587|P1|Overall Study|Consent Withdrawn|5
2663046|NCT00631969|9196586|P2|Overall Study|Protocol Violation|1
2663047|NCT00631969|9196587|P1|Overall Study|Protocol Violation|1
2663048|NCT00631969|9196586|P2|Overall Study|Lost to Follow-up|1
2663049|NCT00631969|9196587|P1|Overall Study|Lost to Follow-up|2
2663050|NCT00631969|9196586|P2|Overall Study|Lack of Efficacy|8
2663051|NCT00631969|9196587|P1|Overall Study|Lack of Efficacy|2
2663052|NCT00631969|9196586|P2|Overall Study|Adverse Event|1
2663053|NCT00631969|9196587|P1|Overall Study|Adverse Event|3
2663054|NCT00631917|9196633|P2|Overall Study|Death|0
2663055|NCT00631917|9196634|P1|Overall Study|Death|1
2663056|NCT00631917|9196633|P2|Overall Study|Administrative problems|0
2663057|NCT00631917|9196634|P1|Overall Study|Administrative problems|2
2663058|NCT00631917|9196633|P2|Overall Study|Lost to Follow-up|7
2663059|NCT00631917|9196634|P1|Overall Study|Lost to Follow-up|7
2663060|NCT00631917|9196633|P2|Overall Study|Subject withdrew consent|33
2663061|NCT00631917|9196634|P1|Overall Study|Subject withdrew consent|25
2663062|NCT00631917|9196633|P2|Overall Study|Protocol deviation|5
2663063|NCT00631917|9196634|P1|Overall Study|Protocol deviation|6
2663064|NCT00631917|9196633|P2|Overall Study|No longer required study drug|1
2663065|NCT00631917|9196634|P1|Overall Study|No longer required study drug|0
2663066|NCT00631917|9196633|P2|Overall Study|Unsatisfactory therapeutic effect|14
2663067|NCT00631917|9196634|P1|Overall Study|Unsatisfactory therapeutic effect|8
2663068|NCT00631917|9196633|P2|Overall Study|Abnormal test procedure result(s)|2
2663069|NCT00631917|9196634|P1|Overall Study|Abnormal test procedure result(s)|3
2663070|NCT00631917|9196633|P2|Overall Study|Abnormal laboratory value(s)|1
2663071|NCT00631917|9196634|P1|Overall Study|Abnormal laboratory value(s)|2
2663072|NCT00631917|9196633|P2|Overall Study|Adverse Event|45
2663073|NCT00631917|9196634|P1|Overall Study|Adverse Event|34
2663074|NCT00631696|9196661|P2|Overall Study|Adverse Event|0
2663075|NCT00631696|9196662|P1|Overall Study|Adverse Event|5
2663076|NCT00631696|9196661|P2|Overall Study|Study terminated by sponsor|3
2663077|NCT00631696|9196662|P1|Overall Study|Study terminated by sponsor|3
2663078|NCT00631696|9196661|P2|Overall Study|Protocol Violation|9
2663079|NCT00631696|9196662|P1|Overall Study|Protocol Violation|9
2663080|NCT00631696|9196661|P2|Overall Study|Other|8
2663081|NCT00631696|9196662|P1|Overall Study|Other|8
2663082|NCT00631696|9196661|P2|Overall Study|Withdrawal by Subject|9
2663083|NCT00631696|9196662|P1|Overall Study|Withdrawal by Subject|2
2663084|NCT00631696|9196661|P2|Overall Study|Lost to Follow-up|10
2663085|NCT00631696|9196662|P1|Overall Study|Lost to Follow-up|7
2663086|NCT00631696|9196661|P2|Overall Study|Follow up after database release date|0
2663087|NCT00631696|9196662|P1|Overall Study|Follow up after database release date|1
2663088|NCT00631696|9196661|P2|Overall Study|Discontinued after database release date|0
2663089|NCT00631696|9196662|P1|Overall Study|Discontinued after database release date|1
2663090|NCT00631696|9196661|P2|Overall Study|Entered, not randomized to treatment|1
2663091|NCT00631696|9196662|P1|Overall Study|Entered, not randomized to treatment|1
2663092|NCT00631657|9196705|P3|7-Day Discontinuation Period|Other|0
2663093|NCT00631657|9196706|P2|7-Day Discontinuation Period|Other|0
2663094|NCT00631657|9196707|P1|7-Day Discontinuation Period|Other|1
2663095|NCT00631657|9196705|P3|7-Day Discontinuation Period|Not Treated|1
2663096|NCT00631657|9196706|P2|7-Day Discontinuation Period|Not Treated|1
2663097|NCT00631657|9196707|P1|7-Day Discontinuation Period|Not Treated|1
2663098|NCT00631657|9196705|P3|6-Month Treatment Period|Not Treated|1
2663099|NCT00631657|9196706|P2|6-Month Treatment Period|Not Treated|0
2663100|NCT00631657|9196707|P1|6-Month Treatment Period|Not Treated|2
2663101|NCT00631657|9196705|P3|6-Month Treatment Period|Other|4
2663102|NCT00631657|9196706|P2|6-Month Treatment Period|Other|0
2663103|NCT00631657|9196707|P1|6-Month Treatment Period|Other|16
2663104|NCT00631657|9196705|P3|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6
2663105|NCT00631657|9196706|P2|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0
2663106|NCT00631657|9196707|P1|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21
2663107|NCT00631657|9196705|P3|6-Month Treatment Period|Lost to Follow-up|2
2663108|NCT00631657|9196706|P2|6-Month Treatment Period|Lost to Follow-up|0
2663109|NCT00631657|9196707|P1|6-Month Treatment Period|Lost to Follow-up|7
2663110|NCT00631657|9196705|P3|6-Month Treatment Period|Lack of Efficacy|25
2663111|NCT00631657|9196706|P2|6-Month Treatment Period|Lack of Efficacy|0
2663112|NCT00631657|9196707|P1|6-Month Treatment Period|Lack of Efficacy|34
2663113|NCT00631657|9196705|P3|6-Month Treatment Period|Withdrawal by Subject|5
2663114|NCT00631657|9196706|P2|6-Month Treatment Period|Withdrawal by Subject|0
2663115|NCT00631657|9196707|P1|6-Month Treatment Period|Withdrawal by Subject|14
2663116|NCT00631657|9196705|P3|6-Month Treatment Period|Adverse Event|7
2663117|NCT00631657|9196706|P2|6-Month Treatment Period|Adverse Event|0
2663118|NCT00631657|9196707|P1|6-Month Treatment Period|Adverse Event|47
2663119|NCT00631540|9196756|P1|Overall Study|Core Lab Data Unavailable|3
2663120|NCT00631540|9196756|P1|Overall Study|Lost to Follow-up|2
2663121|NCT00631540|9196756|P1|Overall Study|Death|4
2663122|NCT00631540|9196756|P1|Overall Study|Withdrawal by Subject|5
2663123|NCT00631488|9196768|P3|Overall Study|Protocol Violation|1
2663124|NCT00631488|9196769|P2|Overall Study|Protocol Violation|0
2663125|NCT00631488|9196770|P1|Overall Study|Protocol Violation|0
2663126|NCT00631488|9196768|P3|Overall Study|Physician Decision|1
2663127|NCT00631488|9196769|P2|Overall Study|Physician Decision|0
2663128|NCT00631488|9196770|P1|Overall Study|Physician Decision|1
2663129|NCT00631488|9196768|P3|Overall Study|Lost to Follow-up|0
2663130|NCT00631488|9196769|P2|Overall Study|Lost to Follow-up|2
2663131|NCT00631488|9196770|P1|Overall Study|Lost to Follow-up|2
2663132|NCT00631488|9196768|P3|Overall Study|Adverse Event|0
2663133|NCT00631488|9196769|P2|Overall Study|Adverse Event|0
2663134|NCT00631488|9196770|P1|Overall Study|Adverse Event|1
2663135|NCT00631475|9196790|P1|Overall Study|Preparation for lung transplant|8
2663136|NCT00631475|9196790|P1|Overall Study|Withdrew consent|5
2663137|NCT00631475|9196790|P1|Overall Study|Adverse Event|14
2663138|NCT00631475|9196790|P1|Overall Study|Death|18
2663139|NCT00631410|9196809|P2|Overall Study|Surgery|0
2663140|NCT00631410|9196810|P1|Overall Study|Surgery|1
2663141|NCT00631410|9196809|P2|Overall Study|Objective Progression or Relapse|3
2663142|NCT00631410|9196810|P1|Overall Study|Objective Progression or Relapse|4
2663143|NCT00631410|9196809|P2|Overall Study|Adverse Event|3
2663144|NCT00631410|9196810|P1|Overall Study|Adverse Event|1
2663145|NCT00631371|9196829|P2|Overall Study|Death|239
2663146|NCT00631371|9196830|P1|Overall Study|Death|263
2663147|NCT00631371|9196829|P2|Overall Study|Discontinuation of study by Sponsor|76
2663148|NCT00631371|9196830|P1|Overall Study|Discontinuation of study by Sponsor|70
2663149|NCT00631371|9196829|P2|Overall Study|subject request|45
2663150|NCT00631371|9196830|P1|Overall Study|subject request|38
2663151|NCT00631371|9196829|P2|Overall Study|Other reason|12
2663152|NCT00631371|9196830|P1|Overall Study|Other reason|5
2663153|NCT00631371|9196829|P2|Overall Study|Lost to Follow-up|19
2663154|NCT00631371|9196830|P1|Overall Study|Lost to Follow-up|24
2663155|NCT00631189|9196863|P4|Treatment Phase|patient did not take pravastatin|0
2663156|NCT00631189|9196864|P3|Treatment Phase|patient did not take pravastatin|1
2663157|NCT00631189|9196865|P2|Treatment Phase|patient did not take pravastatin|0
2663158|NCT00631189|9196866|P1|Treatment Phase|patient did not take pravastatin|0
2663159|NCT00631189|9196863|P4|Treatment Phase|Pregnancy|0
2663160|NCT00631189|9196864|P3|Treatment Phase|Pregnancy|1
2663161|NCT00631189|9196865|P2|Treatment Phase|Pregnancy|0
2663162|NCT00631189|9196866|P1|Treatment Phase|Pregnancy|0
2663163|NCT00631189|9196863|P4|Treatment Phase|Lost to Follow-up|0
2663164|NCT00631189|9196864|P3|Treatment Phase|Lost to Follow-up|0
2663165|NCT00631189|9196865|P2|Treatment Phase|Lost to Follow-up|1
2663166|NCT00631189|9196866|P1|Treatment Phase|Lost to Follow-up|0
2663167|NCT00631189|9196863|P4|Treatment Phase|Adverse Event|4
2663168|NCT00631189|9196864|P3|Treatment Phase|Adverse Event|2
2663169|NCT00631189|9196865|P2|Treatment Phase|Adverse Event|3
2663170|NCT00631189|9196866|P1|Treatment Phase|Adverse Event|0
2663171|NCT00631189|9196863|P4|Treatment Phase|Protocol Violation|2
2663172|NCT00631189|9196864|P3|Treatment Phase|Protocol Violation|6
2663173|NCT00631189|9196865|P2|Treatment Phase|Protocol Violation|1
2663174|NCT00631189|9196866|P1|Treatment Phase|Protocol Violation|0
2663175|NCT00631189|9196863|P4|Treatment Phase|Withdrawal by Subject|1
2663176|NCT00631189|9196864|P3|Treatment Phase|Withdrawal by Subject|1
2663177|NCT00631189|9196865|P2|Treatment Phase|Withdrawal by Subject|2
2663178|NCT00631189|9196866|P1|Treatment Phase|Withdrawal by Subject|0
2663179|NCT00631189|9196863|P4|Initial Phase|Withdrawal by Subject|0
2663180|NCT00631189|9196864|P3|Initial Phase|Withdrawal by Subject|0
2663181|NCT00631189|9196865|P2|Initial Phase|Withdrawal by Subject|0
2663182|NCT00631189|9196866|P1|Initial Phase|Withdrawal by Subject|4
2663183|NCT00631189|9196863|P4|Initial Phase|Protocol Violation|0
2663184|NCT00631189|9196864|P3|Initial Phase|Protocol Violation|0
2663185|NCT00631189|9196865|P2|Initial Phase|Protocol Violation|0
2663186|NCT00631189|9196866|P1|Initial Phase|Protocol Violation|347
2663187|NCT00631137|9196910|P2|Overall Study|Withdrawal by Subject|0
2663188|NCT00631137|9196911|P1|Overall Study|Withdrawal by Subject|1
2663189|NCT00631020|9196929|P1|Overall Study|Incarcerated|1
2663190|NCT00631020|9196929|P1|Overall Study|Lost to Follow-up|7
2663191|NCT00631007|9196944|P6|Overall Study|Other|0
2663192|NCT00631007|9196945|P5|Overall Study|Other|1
2663193|NCT00631007|9196946|P4|Overall Study|Other|0
2663194|NCT00631007|9196947|P3|Overall Study|Other|0
2663195|NCT00631007|9196948|P2|Overall Study|Other|1
2663196|NCT00631007|9196949|P1|Overall Study|Other|2
2663197|NCT00631007|9196944|P6|Overall Study|Withdrawal by Subject|3
2663198|NCT00631007|9196945|P5|Overall Study|Withdrawal by Subject|1
2663199|NCT00631007|9196946|P4|Overall Study|Withdrawal by Subject|2
2663200|NCT00631007|9196947|P3|Overall Study|Withdrawal by Subject|2
2663201|NCT00631007|9196948|P2|Overall Study|Withdrawal by Subject|5
2663202|NCT00631007|9196949|P1|Overall Study|Withdrawal by Subject|4
2663203|NCT00631007|9196944|P6|Overall Study|Persistent Hyperglycemia|5
2663204|NCT00631007|9196945|P5|Overall Study|Persistent Hyperglycemia|2
2663205|NCT00631007|9196946|P4|Overall Study|Persistent Hyperglycemia|1
2663206|NCT00631007|9196947|P3|Overall Study|Persistent Hyperglycemia|5
2663207|NCT00631007|9196948|P2|Overall Study|Persistent Hyperglycemia|2
2663208|NCT00631007|9196949|P1|Overall Study|Persistent Hyperglycemia|2
2663209|NCT00631007|9196944|P6|Overall Study|Physician Decision|2
2663210|NCT00631007|9196945|P5|Overall Study|Physician Decision|0
2663211|NCT00631007|9196946|P4|Overall Study|Physician Decision|0
2663212|NCT00631007|9196947|P3|Overall Study|Physician Decision|1
2663213|NCT00631007|9196948|P2|Overall Study|Physician Decision|0
2663214|NCT00631007|9196949|P1|Overall Study|Physician Decision|1
2663215|NCT00631007|9196944|P6|Overall Study|Lost to Follow-up|3
2663216|NCT00631007|9196945|P5|Overall Study|Lost to Follow-up|5
2663217|NCT00631007|9196946|P4|Overall Study|Lost to Follow-up|4
2663218|NCT00631007|9196947|P3|Overall Study|Lost to Follow-up|2
2663219|NCT00631007|9196948|P2|Overall Study|Lost to Follow-up|1
2663220|NCT00631007|9196949|P1|Overall Study|Lost to Follow-up|2
2663221|NCT00631007|9196944|P6|Overall Study|Adverse Event|2
2663222|NCT00631007|9196945|P5|Overall Study|Adverse Event|3
2663223|NCT00631007|9196946|P4|Overall Study|Adverse Event|2
2663224|NCT00631007|9196947|P3|Overall Study|Adverse Event|0
2663225|NCT00631007|9196948|P2|Overall Study|Adverse Event|2
2663226|NCT00631007|9196949|P1|Overall Study|Adverse Event|0
2663227|NCT00630994|9196969|P1|Overall Study|Other|1
2663228|NCT00630994|9196969|P1|Overall Study|Lack of Efficacy|1
2663229|NCT00630994|9196969|P1|Overall Study|Disease Progression|1
2663230|NCT00630994|9196969|P1|Overall Study|Adverse Event|1
2663231|NCT00630916|9196999|P1|Overall Study|Lack of Efficacy|3
2663232|NCT00630916|9196999|P1|Overall Study|Physician Decision|47
2663233|NCT00630916|9196999|P1|Overall Study|Protocol Violation|7
2663234|NCT00630916|9196999|P1|Overall Study|Withdrawal by Subject|30
2663235|NCT00630916|9196999|P1|Overall Study|Lost to Follow-up|5
2663236|NCT00630916|9196999|P1|Overall Study|Explant|8
2663237|NCT00630916|9196999|P1|Overall Study|Death|110
2663238|NCT00630877|9197009|P3|Overall Study|Personal reasons|1
2663239|NCT00630877|9197010|P2|Overall Study|Personal reasons|0
2663240|NCT00630877|9197011|P1|Overall Study|Personal reasons|0
2663241|NCT00630877|9197009|P3|Overall Study|Protocol violation|1
2663242|NCT00630877|9197010|P2|Overall Study|Protocol violation|0
2663243|NCT00630877|9197011|P1|Overall Study|Protocol violation|1
2663244|NCT00630877|9197009|P3|Overall Study|Noncompliance|1
2663245|NCT00630877|9197010|P2|Overall Study|Noncompliance|3
2663246|NCT00630877|9197011|P1|Overall Study|Noncompliance|2
2663247|NCT00630877|9197009|P3|Overall Study|Lost to Follow-up|0
2663248|NCT00630877|9197010|P2|Overall Study|Lost to Follow-up|0
2663249|NCT00630877|9197011|P1|Overall Study|Lost to Follow-up|2
2663250|NCT00630877|9197009|P3|Overall Study|Withdrawal by Subject|0
2663251|NCT00630877|9197010|P2|Overall Study|Withdrawal by Subject|4
2663252|NCT00630877|9197011|P1|Overall Study|Withdrawal by Subject|3
2663253|NCT00630877|9197009|P3|Overall Study|Adverse Event|7
2663254|NCT00630877|9197010|P2|Overall Study|Adverse Event|8
2663255|NCT00630877|9197011|P1|Overall Study|Adverse Event|11
2663256|NCT00630864|9197029|P1|Part 2 (After Week 6 up to Month 12)|Liver transplant|2
2663257|NCT00630864|9197029|P1|Part 1 (up to Week 6)|Adverse Event|1
2663258|NCT00630838|9197068|P2|Overall Study|Lost to Follow-up|1
2663259|NCT00630838|9197069|P1|Overall Study|Lost to Follow-up|0
2663260|NCT00630838|9197068|P2|Overall Study|Death|1
2663261|NCT00630838|9197069|P1|Overall Study|Death|0
2663262|NCT00630825|9197081|P4|Overall Study|Withdrawal by Subject|3
2663263|NCT00630825|9197082|P3|Overall Study|Withdrawal by Subject|2
2663264|NCT00630825|9197083|P2|Overall Study|Withdrawal by Subject|2
2663265|NCT00630825|9197084|P1|Overall Study|Withdrawal by Subject|2
2663266|NCT00630825|9197081|P4|Overall Study|Physician Decision|0
2663267|NCT00630825|9197082|P3|Overall Study|Physician Decision|0
2663268|NCT00630825|9197083|P2|Overall Study|Physician Decision|0
2663269|NCT00630825|9197084|P1|Overall Study|Physician Decision|1
2663270|NCT00630825|9197081|P4|Overall Study|Lost to Follow-up|1
2663271|NCT00630825|9197082|P3|Overall Study|Lost to Follow-up|1
2663272|NCT00630825|9197083|P2|Overall Study|Lost to Follow-up|1
2663273|NCT00630825|9197084|P1|Overall Study|Lost to Follow-up|1
2663274|NCT00630825|9197081|P4|Overall Study|Entry Criteria Not Met|1
2663275|NCT00630825|9197082|P3|Overall Study|Entry Criteria Not Met|2
2663276|NCT00630825|9197083|P2|Overall Study|Entry Criteria Not Met|0
2663277|NCT00630825|9197084|P1|Overall Study|Entry Criteria Not Met|1
2663278|NCT00630825|9197081|P4|Overall Study|Adverse Event|1
2663279|NCT00630825|9197082|P3|Overall Study|Adverse Event|3
2663280|NCT00630825|9197083|P2|Overall Study|Adverse Event|4
2663281|NCT00630825|9197084|P1|Overall Study|Adverse Event|4
2663282|NCT00630786|9197156|P3|Overall Study|Other|0
2663283|NCT00630786|9197157|P2|Overall Study|Other|0
2663284|NCT00630786|9197158|P1|Overall Study|Other|1
2663285|NCT00630786|9197156|P3|Overall Study|Lost to Follow-up|0
2663286|NCT00630786|9197157|P2|Overall Study|Lost to Follow-up|1
2663287|NCT00630786|9197158|P1|Overall Study|Lost to Follow-up|0
2663288|NCT00630786|9197156|P3|Overall Study|Withdrawal by Subject|1
2663289|NCT00630786|9197157|P2|Overall Study|Withdrawal by Subject|1
2663290|NCT00630786|9197158|P1|Overall Study|Withdrawal by Subject|0
2663291|NCT00630786|9197156|P3|Overall Study|Physician Decision|1
2663292|NCT00630786|9197157|P2|Overall Study|Physician Decision|0
2663293|NCT00630786|9197158|P1|Overall Study|Physician Decision|0
2663294|NCT00630747|9197177|P1|Overall Study|Returned to country of origin|1
2663295|NCT00630747|9197177|P1|Overall Study|Transferred to Study TKT031NPU|7
2663296|NCT00630747|9197177|P1|Overall Study|Death|1
2663297|NCT00630539|9197230|P4|Overall Study|Withdrawal by Subject|1
2663298|NCT00630539|9197231|P3|Overall Study|Withdrawal by Subject|0
2663299|NCT00630539|9197232|P2|Overall Study|Withdrawal by Subject|1
2663300|NCT00630539|9197233|P1|Overall Study|Withdrawal by Subject|0
2663301|NCT00630539|9197230|P4|Overall Study|Adverse Event|2
2663302|NCT00630539|9197231|P3|Overall Study|Adverse Event|1
2663303|NCT00630539|9197232|P2|Overall Study|Adverse Event|3
2663304|NCT00630539|9197233|P1|Overall Study|Adverse Event|1
2663305|NCT00630396|9197329|P1|Overall Study|Lost to Follow-up|3
2663306|NCT00630396|9197329|P1|Overall Study|Death|4
2663307|NCT00630344|9197335|P1|Overall Study|Other|1
2663308|NCT00630344|9197335|P1|Overall Study|Intercurrent Illness|1
2663309|NCT00630344|9197335|P1|Overall Study|Withdrawal by Subject|1
2663310|NCT00630344|9197335|P1|Overall Study|Physician Decision|9
2663311|NCT00630344|9197335|P1|Overall Study|Progressive Disease|19
2663312|NCT00630344|9197335|P1|Overall Study|Adverse Event|5
2663313|NCT00630331|9197347|P3|Overall Study|Protocol Violation|6
2663314|NCT00630331|9197348|P2|Overall Study|Protocol Violation|5
2663315|NCT00630331|9197349|P1|Overall Study|Protocol Violation|4
2663316|NCT00630331|9197347|P3|Overall Study|Unable to classify|3
2663317|NCT00630331|9197348|P2|Overall Study|Unable to classify|4
2663318|NCT00630331|9197349|P1|Overall Study|Unable to classify|9
2663319|NCT00630331|9197347|P3|Overall Study|Inappropriate enrollment|3
2663320|NCT00630331|9197348|P2|Overall Study|Inappropriate enrollment|6
2663321|NCT00630331|9197349|P1|Overall Study|Inappropriate enrollment|3
2663322|NCT00630331|9197347|P3|Overall Study|Lost to Follow-up|170
2663323|NCT00630331|9197348|P2|Overall Study|Lost to Follow-up|143
2663324|NCT00630331|9197349|P1|Overall Study|Lost to Follow-up|175
2663325|NCT00630331|9197347|P3|Overall Study|Withdrawal by Subject|5
2663326|NCT00630331|9197348|P2|Overall Study|Withdrawal by Subject|7
2663327|NCT00630331|9197349|P1|Overall Study|Withdrawal by Subject|12
2663328|NCT00630331|9197347|P3|Overall Study|Adverse Event|0
2663329|NCT00630331|9197348|P2|Overall Study|Adverse Event|0
2663330|NCT00630331|9197349|P1|Overall Study|Adverse Event|1
2663331|NCT00630331|9197347|P3|Overall Study|Death|1
2663332|NCT00630331|9197348|P2|Overall Study|Death|1
2663333|NCT00630331|9197349|P1|Overall Study|Death|2
2663334|NCT00630305|9197390|P1|Overall Study|Inability to insert contact lens|1
2663335|NCT00630305|9197390|P1|Overall Study|Withdrawal by Subject|1
2663336|NCT00630292|9197412|P1|Overall Study|Withdrawal by Subject|1
2663337|NCT00630058|9197418|P2|Overall Study|stopping criteria|2
2663338|NCT00630058|9197419|P1|Overall Study|stopping criteria|3
2663339|NCT00630058|9197418|P2|Overall Study|Withdrawal by Subject|1
2663340|NCT00630058|9197419|P1|Overall Study|Withdrawal by Subject|0
2663341|NCT00630058|9197418|P2|Overall Study|Adverse Event|1
2663342|NCT00630058|9197419|P1|Overall Study|Adverse Event|1
2663343|NCT00629772|9197450|P2|Second Intervention Week 14 - Week 26|Lack of Efficacy|1
2663344|NCT00629772|9197451|P1|Second Intervention Week 14 - Week 26|Lack of Efficacy|0
2663345|NCT00629772|9197450|P2|Second Intervention Week 14 - Week 26|Adverse Event|1
2663346|NCT00629772|9197451|P1|Second Intervention Week 14 - Week 26|Adverse Event|1
2663347|NCT00629707|9197471|P2|Overall Study|Physician Decision|1
2663348|NCT00629707|9197472|P1|Overall Study|Physician Decision|0
2663349|NCT00629707|9197471|P2|Overall Study|Withdrawal by Subject|1
2663350|NCT00629707|9197472|P1|Overall Study|Withdrawal by Subject|0
2663351|NCT00629265|9197492|P2|Overall Study|Unknown Reason|2
2663352|NCT00629265|9197493|P1|Overall Study|Unknown Reason|2
2663353|NCT00629265|9197492|P2|Overall Study|Unrelated Medical Complications|1
2663354|NCT00629265|9197493|P1|Overall Study|Unrelated Medical Complications|3
2663355|NCT00629265|9197492|P2|Overall Study|Needed Esophageal Dilation|1
2663356|NCT00629265|9197493|P1|Overall Study|Needed Esophageal Dilation|4
2663357|NCT00629265|9197492|P2|Overall Study|Other CA Requiring Treatment|3
2663358|NCT00629265|9197493|P1|Overall Study|Other CA Requiring Treatment|1
2663359|NCT00629265|9197492|P2|Overall Study|HNC Recurrence|0
2663360|NCT00629265|9197493|P1|Overall Study|HNC Recurrence|4
2663361|NCT00629265|9197492|P2|Overall Study|Adverse Event|0
2663362|NCT00629265|9197493|P1|Overall Study|Adverse Event|2
2663363|NCT00629265|9197492|P2|Overall Study|Death|0
2663364|NCT00629265|9197493|P1|Overall Study|Death|1
2663365|NCT00629265|9197492|P2|Overall Study|Withdrawal by Subject|8
2663366|NCT00629265|9197493|P1|Overall Study|Withdrawal by Subject|11
2663367|NCT00629265|9197492|P2|Overall Study|Lost to Follow-up|5
2663368|NCT00629265|9197493|P1|Overall Study|Lost to Follow-up|4
2663369|NCT00629239|9197503|P2|Overall Study|Physician Decision|0
2663370|NCT00629239|9197504|P1|Overall Study|Physician Decision|1
2663371|NCT00629239|9197503|P2|Overall Study|Adverse Event|4
2663372|NCT00629239|9197504|P1|Overall Study|Adverse Event|7
2663373|NCT00629083|9197557|P2|Overall Study|Refused to return for 12 month visit|0
2663374|NCT00629083|9197558|P1|Overall Study|Refused to return for 12 month visit|1
2663375|NCT00629083|9197557|P2|Overall Study|Moved out of country/state|1
2663376|NCT00629083|9197558|P1|Overall Study|Moved out of country/state|2
2663377|NCT00629083|9197557|P2|Overall Study|Lost to Follow-up|8
2663378|NCT00629083|9197558|P1|Overall Study|Lost to Follow-up|12
2663379|NCT00629083|9197557|P2|Overall Study|Withdrawal by Subject|2
2663380|NCT00629083|9197558|P1|Overall Study|Withdrawal by Subject|10
2663381|NCT00629083|9197557|P2|Overall Study|Lack of Efficacy|1
2663382|NCT00629083|9197558|P1|Overall Study|Lack of Efficacy|3
2663383|NCT00629083|9197557|P2|Overall Study|Adverse Event|2
2663384|NCT00629083|9197558|P1|Overall Study|Adverse Event|0
2663385|NCT00628927|9197589|P2|Overall Study|Equipment failure|0
2663386|NCT00628927|9197590|P1|Overall Study|Equipment failure|1
2663387|NCT00628927|9197589|P2|Overall Study|Lost to Follow-up|0
2663388|NCT00628927|9197590|P1|Overall Study|Lost to Follow-up|1
2663389|NCT00628927|9197589|P2|Overall Study|Problems performing blood draw|0
2663390|NCT00628927|9197590|P1|Overall Study|Problems performing blood draw|6
2663391|NCT00628862|9197635|P3|Overall Study|COPD Exacerbation|0
2663392|NCT00628862|9197636|P2|Overall Study|COPD Exacerbation|1
2663393|NCT00628862|9197637|P1|Overall Study|COPD Exacerbation|0
2663394|NCT00628862|9197635|P3|Overall Study|Protocol Violation|0
2663395|NCT00628862|9197636|P2|Overall Study|Protocol Violation|0
2663396|NCT00628862|9197637|P1|Overall Study|Protocol Violation|1
2663397|NCT00628862|9197635|P3|Overall Study|Lost to Follow-up|1
2663398|NCT00628862|9197636|P2|Overall Study|Lost to Follow-up|2
2663399|NCT00628862|9197637|P1|Overall Study|Lost to Follow-up|0
2663400|NCT00628862|9197635|P3|Overall Study|Withdrawal by Subject|11
2663401|NCT00628862|9197636|P2|Overall Study|Withdrawal by Subject|6
2663402|NCT00628862|9197637|P1|Overall Study|Withdrawal by Subject|4
2663403|NCT00628862|9197635|P3|Overall Study|Adverse Event|10
2663404|NCT00628862|9197636|P2|Overall Study|Adverse Event|8
2663405|NCT00628862|9197637|P1|Overall Study|Adverse Event|6
2663406|NCT00628758|9197683|P2|Overall Study|Treatment Failure|2
2663407|NCT00628758|9197684|P1|Overall Study|Treatment Failure|0
2663408|NCT00628758|9197683|P2|Overall Study|Investigator Moved|0
2663409|NCT00628758|9197684|P1|Overall Study|Investigator Moved|3
2663410|NCT00628758|9197683|P2|Overall Study|Pregnancy|2
2663411|NCT00628758|9197684|P1|Overall Study|Pregnancy|2
2663412|NCT00628758|9197683|P2|Overall Study|Lost to Follow-up|31
2663413|NCT00628758|9197684|P1|Overall Study|Lost to Follow-up|25
2663414|NCT00628758|9197683|P2|Overall Study|Protocol Violation|1
2663415|NCT00628758|9197684|P1|Overall Study|Protocol Violation|5
2663416|NCT00628758|9197683|P2|Overall Study|Death|0
2663417|NCT00628758|9197684|P1|Overall Study|Death|1
2663418|NCT00628758|9197683|P2|Overall Study|Withdrawal by Subject|3
2663419|NCT00628758|9197684|P1|Overall Study|Withdrawal by Subject|6
2663420|NCT00628758|9197683|P2|Overall Study|Adverse Event|3
2663421|NCT00628758|9197684|P1|Overall Study|Adverse Event|2
2663422|NCT00628446|9197728|P1|Overall Study|Protocol Violation|3
2663423|NCT00628446|9197728|P1|Overall Study|Withdrawal by Subject|1
2663424|NCT00628446|9197728|P1|Overall Study|Lost to Follow-up|3
2663425|NCT00628355|9197739|P2|Overall Study|Withdrawal by Subject|1
2663426|NCT00628355|9197740|P1|Overall Study|Withdrawal by Subject|1
2663427|NCT00628251|9197751|P3|Ongoing Initial Study Treatment at DCO|Other|2
2663428|NCT00628251|9197752|P2|Ongoing Initial Study Treatment at DCO|Other|0
2663429|NCT00628251|9197753|P1|Ongoing Initial Study Treatment at DCO|Other|1
2663430|NCT00628251|9197751|P3|Ongoing Initial Study Treatment at DCO|Other reason|6
2663431|NCT00628251|9197752|P2|Ongoing Initial Study Treatment at DCO|Other reason|1
2663432|NCT00628251|9197753|P1|Ongoing Initial Study Treatment at DCO|Other reason|0
2663433|NCT00628251|9197751|P3|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1
2663434|NCT00628251|9197752|P2|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2
2663435|NCT00628251|9197753|P1|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1
2663436|NCT00628251|9197751|P3|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13
2663437|NCT00628251|9197752|P2|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15
2663438|NCT00628251|9197753|P1|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19
2663439|NCT00628251|9197751|P3|Ongoing Initial Study Treatment at DCO|Adverse Event|3
2663440|NCT00628251|9197752|P2|Ongoing Initial Study Treatment at DCO|Adverse Event|2
2663441|NCT00628251|9197753|P1|Ongoing Initial Study Treatment at DCO|Adverse Event|1
2663442|NCT00628251|9197751|P3|Randomised Part|Withdrawal by Subject|1
2663443|NCT00628251|9197752|P2|Randomised Part|Withdrawal by Subject|0
2663444|NCT00628251|9197753|P1|Randomised Part|Withdrawal by Subject|0
2663445|NCT00628212|9197799|P4|Overall Study|Physician Decision|3
2663446|NCT00628212|9197800|P3|Overall Study|Physician Decision|2
2663447|NCT00628212|9197801|P2|Overall Study|Physician Decision|1
2663448|NCT00628212|9197802|P1|Overall Study|Physician Decision|1
2663449|NCT00628212|9197799|P4|Overall Study|Adverse Event|2
2663450|NCT00628212|9197800|P3|Overall Study|Adverse Event|1
2663451|NCT00628212|9197801|P2|Overall Study|Adverse Event|0
2663452|NCT00628212|9197802|P1|Overall Study|Adverse Event|2
2663453|NCT00628108|9197850|P2|Overall Study|Withdrawal by Subject|0
2663454|NCT00628108|9197851|P1|Overall Study|Withdrawal by Subject|1
2663455|NCT00628108|9197850|P2|Overall Study|Adverse Event|3
2663456|NCT00628108|9197851|P1|Overall Study|Adverse Event|0
2663457|NCT00628030|9197883|P2|Post to 6 Month Follow-up|Lost to Follow-up|30
2663458|NCT00628030|9197884|P1|Post to 6 Month Follow-up|Lost to Follow-up|32
2663459|NCT00628030|9197883|P2|Baseline to Post-Assessment|Withdrawal by Subject|0
2663460|NCT00628030|9197884|P1|Baseline to Post-Assessment|Withdrawal by Subject|5
2663461|NCT00628030|9197883|P2|Baseline to Post-Assessment|Lost to Follow-up|29
2663462|NCT00628030|9197884|P1|Baseline to Post-Assessment|Lost to Follow-up|28
2663463|NCT00627926|9197910|P3|Overall Study|Noncompliance/unspecified|17
2663464|NCT00627926|9197911|P2|Overall Study|Noncompliance/unspecified|23
2663465|NCT00627926|9197912|P1|Overall Study|Noncompliance/unspecified|8
2663466|NCT00627926|9197910|P3|Overall Study|Lack of Efficacy|38
2663467|NCT00627926|9197911|P2|Overall Study|Lack of Efficacy|40
2663468|NCT00627926|9197912|P1|Overall Study|Lack of Efficacy|118
2663469|NCT00627926|9197910|P3|Overall Study|Withdrawal by Subject|0
2663470|NCT00627926|9197911|P2|Overall Study|Withdrawal by Subject|1
2663471|NCT00627926|9197912|P1|Overall Study|Withdrawal by Subject|2
2663472|NCT00627926|9197910|P3|Overall Study|Lost to Follow-up|4
2663473|NCT00627926|9197911|P2|Overall Study|Lost to Follow-up|3
2663474|NCT00627926|9197912|P1|Overall Study|Lost to Follow-up|4
2663475|NCT00627926|9197910|P3|Overall Study|Death|0
2663476|NCT00627926|9197911|P2|Overall Study|Death|0
2663477|NCT00627926|9197912|P1|Overall Study|Death|1
2663478|NCT00627926|9197910|P3|Overall Study|Adverse Event|36
2663479|NCT00627926|9197911|P2|Overall Study|Adverse Event|37
2663480|NCT00627926|9197912|P1|Overall Study|Adverse Event|26
2663481|NCT00627705|9197964|P2|Overall Study|Lost to Follow-up|1
2663482|NCT00627705|9197965|P1|Overall Study|Lost to Follow-up|0
2663483|NCT00627705|9197964|P2|Overall Study|Withdrawal by Subject|2
2663484|NCT00627705|9197965|P1|Overall Study|Withdrawal by Subject|0
2663485|NCT00627705|9197964|P2|Overall Study|Adverse Event|0
2663486|NCT00627705|9197965|P1|Overall Study|Adverse Event|1
2663487|NCT00627705|9197964|P2|Overall Study|Unwilling to take the compound (taste)|3
2663488|NCT00627705|9197965|P1|Overall Study|Unwilling to take the compound (taste)|1
2663489|NCT00627523|9198016|P2|Overall Study|Other|0
2663490|NCT00627523|9198017|P1|Overall Study|Other|1
2663491|NCT00627523|9198016|P2|Overall Study|Withdrawal by Subject|2
2663492|NCT00627523|9198017|P1|Overall Study|Withdrawal by Subject|0
2663493|NCT00627523|9198016|P2|Overall Study|Lack of Efficacy|0
2663494|NCT00627523|9198017|P1|Overall Study|Lack of Efficacy|1
2663495|NCT00627497|9198045|P4|Overall Study|Lost to Follow-up|0
2663496|NCT00627497|9198046|P3|Overall Study|Lost to Follow-up|0
2663497|NCT00627497|9198047|P2|Overall Study|Lost to Follow-up|1
2663498|NCT00627497|9198048|P1|Overall Study|Lost to Follow-up|1
2663499|NCT00627458|9198109|P3|Overall Study|Lost to Follow-up|0
2663500|NCT00627458|9198110|P2|Overall Study|Lost to Follow-up|1
2663501|NCT00627458|9198111|P1|Overall Study|Lost to Follow-up|1
2663502|NCT00627458|9198109|P3|Overall Study|Withdrawal by Subject|5
2663503|NCT00627458|9198110|P2|Overall Study|Withdrawal by Subject|6
2663504|NCT00627458|9198111|P1|Overall Study|Withdrawal by Subject|2
2663505|NCT00627458|9198109|P3|Overall Study|Migrated from study area|1
2663506|NCT00627458|9198110|P2|Overall Study|Migrated from study area|0
2663507|NCT00627458|9198111|P1|Overall Study|Migrated from study area|1
2663508|NCT00627445|9198186|P2|Overall Study|Other|8
2663509|NCT00627445|9198187|P1|Overall Study|Other|6
2663510|NCT00627445|9198186|P2|Overall Study|Lack of Efficacy|1
2663511|NCT00627445|9198187|P1|Overall Study|Lack of Efficacy|0
2663512|NCT00627445|9198186|P2|Overall Study|Adverse Event|3
2663513|NCT00627445|9198187|P1|Overall Study|Adverse Event|3
2663514|NCT00627393|9198230|P2|Per-Protocol Analysis|Withdrawal by patient/family/physician|10
2663515|NCT00627393|9198231|P1|Per-Protocol Analysis|Withdrawal by patient/family/physician|4
2663516|NCT00627393|9198230|P2|Per-Protocol Analysis|Received unstimulated/no granulocytes|3
2663517|NCT00627393|9198231|P1|Per-Protocol Analysis|Received unstimulated/no granulocytes|6
2663518|NCT00627393|9198230|P2|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5
2663519|NCT00627393|9198231|P1|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4
2663520|NCT00627393|9198230|P2|Intention-To-Treat Analysis|Adjudication indeterminate|3
2663521|NCT00627393|9198231|P1|Intention-To-Treat Analysis|Adjudication indeterminate|5
2663522|NCT00627094|9198267|P2|Overall Study|Other reason|0
2663523|NCT00627094|9198268|P1|Overall Study|Other reason|1
2663524|NCT00627094|9198267|P2|Overall Study|ulcer healed|7
2663525|NCT00627094|9198268|P1|Overall Study|ulcer healed|1
2663526|NCT00627094|9198267|P2|Overall Study|Withdrawal by Subject|1
2663527|NCT00627094|9198268|P1|Overall Study|Withdrawal by Subject|1
2663528|NCT00627094|9198267|P2|Overall Study|Lost to Follow-up|0
2663529|NCT00627094|9198268|P1|Overall Study|Lost to Follow-up|1
2663530|NCT00627094|9198267|P2|Overall Study|Adverse Event|7
2663531|NCT00627094|9198268|P1|Overall Study|Adverse Event|8
2663532|NCT00627042|9198280|P1|Overall Study|Withdrawal by Subject|2
2663533|NCT00627016|9198292|P2|Overall Study|Pregnancy|0
2663534|NCT00627016|9198293|P1|Overall Study|Pregnancy|1
2663535|NCT00627016|9198292|P2|Overall Study|Placed on Excluded Drugs|0
2663536|NCT00627016|9198293|P1|Overall Study|Placed on Excluded Drugs|1
2663537|NCT00627016|9198292|P2|Overall Study|Lack of Efficacy|0
2663538|NCT00627016|9198293|P1|Overall Study|Lack of Efficacy|1
2663539|NCT00627016|9198292|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
2663540|NCT00627016|9198293|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
2663541|NCT00627016|9198292|P2|Overall Study|Withdrawal by Subject|1
2663542|NCT00627016|9198293|P1|Overall Study|Withdrawal by Subject|2
2663543|NCT00627016|9198292|P2|Overall Study|Lost to Follow-up|1
2663544|NCT00627016|9198293|P1|Overall Study|Lost to Follow-up|0
2663545|NCT00627016|9198292|P2|Overall Study|Protocol Violation|2
2663546|NCT00627016|9198293|P1|Overall Study|Protocol Violation|0
2663547|NCT00627016|9198292|P2|Overall Study|Adverse Event|1
2663548|NCT00627016|9198293|P1|Overall Study|Adverse Event|1
2663549|NCT00626925|9198305|P2|Overall Study|Time constraints|1
2663550|NCT00626925|9198306|P1|Overall Study|Time constraints|3
2663551|NCT00626925|9198305|P2|Overall Study|Lack of Efficacy|4
2663552|NCT00626925|9198306|P1|Overall Study|Lack of Efficacy|1
2663553|NCT00626925|9198305|P2|Overall Study|Adverse effect|2
2663554|NCT00626925|9198306|P1|Overall Study|Adverse effect|6
2663555|NCT00626925|9198305|P2|Overall Study|relapse|0
2663556|NCT00626925|9198306|P1|Overall Study|relapse|1
2663557|NCT00626925|9198305|P2|Overall Study|Lost to Follow-up|2
2663558|NCT00626925|9198306|P1|Overall Study|Lost to Follow-up|1
2663559|NCT00626821|9198353|P1|Overall Study|other/unknown reason|104
2663560|NCT00626821|9198353|P1|Overall Study|Product dysfunction|21
2663561|NCT00626821|9198353|P1|Overall Study|Physician Decision|9
2663562|NCT00626821|9198353|P1|Overall Study|Withdrawal by Subject|10
2663563|NCT00626821|9198353|P1|Overall Study|Protocol Violation|33
2663564|NCT00626821|9198353|P1|Overall Study|Adverse Event|44
2663565|NCT00626795|9198433|P3|Blinded Treatment|Missing reason for withdrawal|5
2663566|NCT00626795|9198434|P2|Blinded Treatment|Missing reason for withdrawal|3
2663567|NCT00626795|9198435|P1|Blinded Treatment|Missing reason for withdrawal|5
2663568|NCT00626795|9198433|P3|Blinded Treatment|Other reasons|2
2663569|NCT00626795|9198434|P2|Blinded Treatment|Other reasons|0
2663570|NCT00626795|9198435|P1|Blinded Treatment|Other reasons|2
2663571|NCT00626795|9198433|P3|Blinded Treatment|Withdrawal by Subject|0
2663572|NCT00626795|9198434|P2|Blinded Treatment|Withdrawal by Subject|1
2663573|NCT00626795|9198435|P1|Blinded Treatment|Withdrawal by Subject|1
2663574|NCT00626795|9198433|P3|Blinded Treatment|Protocol Violation|1
2663575|NCT00626795|9198434|P2|Blinded Treatment|Protocol Violation|1
2663576|NCT00626795|9198435|P1|Blinded Treatment|Protocol Violation|0
2663577|NCT00626795|9198433|P3|Blinded Treatment|Unacceptable adverse event|1
2663578|NCT00626795|9198434|P2|Blinded Treatment|Unacceptable adverse event|0
2663579|NCT00626795|9198435|P1|Blinded Treatment|Unacceptable adverse event|0
2663580|NCT00626795|9198433|P3|Blinded Treatment|Lack of Efficacy|0
2663581|NCT00626795|9198434|P2|Blinded Treatment|Lack of Efficacy|0
2663582|NCT00626795|9198435|P1|Blinded Treatment|Lack of Efficacy|2
2663583|NCT00626795|9198433|P3|Open-label TD1414 Cream TID Treatment|Adverse Event|0
2663584|NCT00626795|9198434|P2|Open-label TD1414 Cream TID Treatment|Adverse Event|1
2663585|NCT00626795|9198435|P1|Open-label TD1414 Cream TID Treatment|Adverse Event|0
2663586|NCT00626639|9198486|P2|Overall Study|Occurrence of grade 3 oral mucositis|2
2663587|NCT00626639|9198487|P1|Overall Study|Occurrence of grade 3 oral mucositis|2
2663588|NCT00626561|9198533|P1|Overall Study|Disease Progression|2
2663589|NCT00626561|9198533|P1|Overall Study|Withdrawal by Subject|2
2663590|NCT00626548|9198539|P2|Overall Study|Other termination reason|613
2663591|NCT00626548|9198540|P1|Overall Study|Other termination reason|493
2663592|NCT00626548|9198539|P2|Overall Study|Lost to Follow-up|2
2663593|NCT00626548|9198540|P1|Overall Study|Lost to Follow-up|2
2663594|NCT00626548|9198539|P2|Overall Study|Protocol Violation|11
2663595|NCT00626548|9198540|P1|Overall Study|Protocol Violation|4
2663596|NCT00626548|9198539|P2|Overall Study|Withdrawal by Subject|46
2663597|NCT00626548|9198540|P1|Overall Study|Withdrawal by Subject|42
2663598|NCT00626548|9198539|P2|Overall Study|Adverse Event|44
2663599|NCT00626548|9198540|P1|Overall Study|Adverse Event|164
2663600|NCT00626522|9198554|P6|Overall Study|Non-fulfilment of in/exclusion criteria|0
2663601|NCT00626522|9198555|P5|Overall Study|Non-fulfilment of in/exclusion criteria|0
2663602|NCT00626522|9198556|P4|Overall Study|Non-fulfilment of in/exclusion criteria|1
2663603|NCT00626522|9198557|P3|Overall Study|Non-fulfilment of in/exclusion criteria|1
2663604|NCT00626522|9198558|P2|Overall Study|Non-fulfilment of in/exclusion criteria|0
2663605|NCT00626522|9198559|P1|Overall Study|Non-fulfilment of in/exclusion criteria|1
2663606|NCT00626522|9198554|P6|Overall Study|Inconsistent reason reported|0
2663607|NCT00626522|9198555|P5|Overall Study|Inconsistent reason reported|0
2663608|NCT00626522|9198556|P4|Overall Study|Inconsistent reason reported|0
2663609|NCT00626522|9198557|P3|Overall Study|Inconsistent reason reported|0
2663610|NCT00626522|9198558|P2|Overall Study|Inconsistent reason reported|0
2663611|NCT00626522|9198559|P1|Overall Study|Inconsistent reason reported|1
2663612|NCT00626522|9198554|P6|Overall Study|Lost to Follow-up|0
2663613|NCT00626522|9198555|P5|Overall Study|Lost to Follow-up|0
2663614|NCT00626522|9198556|P4|Overall Study|Lost to Follow-up|0
2663615|NCT00626522|9198557|P3|Overall Study|Lost to Follow-up|0
2663616|NCT00626522|9198558|P2|Overall Study|Lost to Follow-up|1
2663617|NCT00626522|9198559|P1|Overall Study|Lost to Follow-up|0
2663618|NCT00626522|9198554|P6|Overall Study|COPD exacerbation|0
2663619|NCT00626522|9198555|P5|Overall Study|COPD exacerbation|1
2663620|NCT00626522|9198556|P4|Overall Study|COPD exacerbation|1
2663621|NCT00626522|9198557|P3|Overall Study|COPD exacerbation|0
2663622|NCT00626522|9198558|P2|Overall Study|COPD exacerbation|0
2663623|NCT00626522|9198559|P1|Overall Study|COPD exacerbation|0
2663624|NCT00626522|9198554|P6|Overall Study|Withdrawal by Subject|1
2663625|NCT00626522|9198555|P5|Overall Study|Withdrawal by Subject|4
2663626|NCT00626522|9198556|P4|Overall Study|Withdrawal by Subject|0
2663627|NCT00626522|9198557|P3|Overall Study|Withdrawal by Subject|5
2663628|NCT00626522|9198558|P2|Overall Study|Withdrawal by Subject|5
2663629|NCT00626522|9198559|P1|Overall Study|Withdrawal by Subject|2
2663630|NCT00626522|9198554|P6|Overall Study|Adverse Event|1
2663631|NCT00626522|9198555|P5|Overall Study|Adverse Event|1
2663632|NCT00626522|9198556|P4|Overall Study|Adverse Event|0
2663633|NCT00626522|9198557|P3|Overall Study|Adverse Event|2
2663634|NCT00626522|9198558|P2|Overall Study|Adverse Event|1
2663635|NCT00626522|9198559|P1|Overall Study|Adverse Event|2
2663636|NCT00626522|9198554|P6|Overall Study|Protocol Violation|0
2663637|NCT00626522|9198555|P5|Overall Study|Protocol Violation|1
2663638|NCT00626522|9198556|P4|Overall Study|Protocol Violation|0
2663639|NCT00626522|9198557|P3|Overall Study|Protocol Violation|0
2663640|NCT00626522|9198558|P2|Overall Study|Protocol Violation|0
2663641|NCT00626522|9198559|P1|Overall Study|Protocol Violation|0
2663642|NCT00626405|9198622|P2|Overall Study|Withdrawal by Subject|1
2663643|NCT00626405|9198623|P1|Overall Study|Withdrawal by Subject|0
2663644|NCT00626405|9198622|P2|Overall Study|Deemed Ineligible|0
2663645|NCT00626405|9198623|P1|Overall Study|Deemed Ineligible|1
2663646|NCT00626392|9198639|P6|Coadministration Period|Other|1
2663647|NCT00626392|9198640|P5|Coadministration Period|Other|1
2663648|NCT00626392|9198641|P4|Coadministration Period|Other|1
2663649|NCT00626392|9198642|P3|Coadministration Period|Other|3
2663650|NCT00626392|9198643|P2|Coadministration Period|Other|2
2663651|NCT00626392|9198644|P1|Coadministration Period|Other|0
2663652|NCT00626392|9198639|P6|Coadministration Period|Protocol Violation|0
2663653|NCT00626392|9198640|P5|Coadministration Period|Protocol Violation|1
2663654|NCT00626392|9198641|P4|Coadministration Period|Protocol Violation|1
2663655|NCT00626392|9198642|P3|Coadministration Period|Protocol Violation|0
2663656|NCT00626392|9198643|P2|Coadministration Period|Protocol Violation|1
2663657|NCT00626392|9198644|P1|Coadministration Period|Protocol Violation|0
2663658|NCT00626392|9198639|P6|Coadministration Period|Withdrawal by Subject|1
2663659|NCT00626392|9198640|P5|Coadministration Period|Withdrawal by Subject|0
2663660|NCT00626392|9198641|P4|Coadministration Period|Withdrawal by Subject|1
2663661|NCT00626392|9198642|P3|Coadministration Period|Withdrawal by Subject|0
2663662|NCT00626392|9198643|P2|Coadministration Period|Withdrawal by Subject|1
2663663|NCT00626392|9198644|P1|Coadministration Period|Withdrawal by Subject|1
2663664|NCT00626392|9198639|P6|Coadministration Period|Adverse Event|4
2663665|NCT00626392|9198640|P5|Coadministration Period|Adverse Event|3
2663666|NCT00626392|9198641|P4|Coadministration Period|Adverse Event|4
2663667|NCT00626392|9198642|P3|Coadministration Period|Adverse Event|7
2663668|NCT00626392|9198643|P2|Coadministration Period|Adverse Event|1
2663669|NCT00626392|9198644|P1|Coadministration Period|Adverse Event|3
2663670|NCT00626392|9198639|P6|Run-in Period|Noncompliance|0
2663671|NCT00626392|9198640|P5|Run-in Period|Noncompliance|0
2663672|NCT00626392|9198641|P4|Run-in Period|Noncompliance|0
2663673|NCT00626392|9198642|P3|Run-in Period|Noncompliance|1
2663674|NCT00626392|9198643|P2|Run-in Period|Noncompliance|0
2663675|NCT00626392|9198644|P1|Run-in Period|Noncompliance|1
2663676|NCT00626392|9198639|P6|Run-in Period|Withdrawal by Subject|1
2663677|NCT00626392|9198640|P5|Run-in Period|Withdrawal by Subject|3
2663678|NCT00626392|9198641|P4|Run-in Period|Withdrawal by Subject|1
2663679|NCT00626392|9198642|P3|Run-in Period|Withdrawal by Subject|1
2663680|NCT00626392|9198643|P2|Run-in Period|Withdrawal by Subject|1
2663681|NCT00626392|9198644|P1|Run-in Period|Withdrawal by Subject|0
2663682|NCT00626392|9198639|P6|Run-in Period|Adverse Event|0
2663683|NCT00626392|9198640|P5|Run-in Period|Adverse Event|1
2663684|NCT00626392|9198641|P4|Run-in Period|Adverse Event|0
2663685|NCT00626392|9198642|P3|Run-in Period|Adverse Event|1
2663686|NCT00626392|9198643|P2|Run-in Period|Adverse Event|0
2663687|NCT00626392|9198644|P1|Run-in Period|Adverse Event|0
2663688|NCT00626327|9198672|P3|Overall Study|Protocol Violation|26
2663689|NCT00626327|9198673|P2|Overall Study|Protocol Violation|4
2663690|NCT00626327|9198674|P1|Overall Study|Protocol Violation|26
2663691|NCT00626327|9198672|P3|Overall Study|Administrative Reason|6
2663692|NCT00626327|9198673|P2|Overall Study|Administrative Reason|0
2663693|NCT00626327|9198674|P1|Overall Study|Administrative Reason|2
2663694|NCT00626327|9198672|P3|Overall Study|Inappropriate enrollment|3
2663695|NCT00626327|9198673|P2|Overall Study|Inappropriate enrollment|5
2663696|NCT00626327|9198674|P1|Overall Study|Inappropriate enrollment|4
2663697|NCT00626327|9198672|P3|Overall Study|Lost to Follow-up|23
2663698|NCT00626327|9198673|P2|Overall Study|Lost to Follow-up|21
2663699|NCT00626327|9198674|P1|Overall Study|Lost to Follow-up|24
2663700|NCT00626327|9198672|P3|Overall Study|Adverse Event|0
2663701|NCT00626327|9198673|P2|Overall Study|Adverse Event|0
2663702|NCT00626327|9198674|P1|Overall Study|Adverse Event|1
2663703|NCT00626327|9198672|P3|Overall Study|Withdrawal by Subject|30
2663704|NCT00626327|9198673|P2|Overall Study|Withdrawal by Subject|29
2663705|NCT00626327|9198674|P1|Overall Study|Withdrawal by Subject|21
2663706|NCT00626275|9198700|P8|Part B|Withdrawal by Subject|1
2663707|NCT00626275|9198701|P7|Part B|Withdrawal by Subject|0
2663708|NCT00626275|9198702|P6|Part B|Withdrawal by Subject|0
2663709|NCT00626275|9198703|P5|Part B|Withdrawal by Subject|0
2663710|NCT00626275|9198704|P4|Part B|Withdrawal by Subject|0
2663711|NCT00626275|9198705|P3|Part B|Withdrawal by Subject|0
2663712|NCT00626275|9198706|P2|Part B|Withdrawal by Subject|0
2663713|NCT00626275|9198707|P1|Part B|Withdrawal by Subject|0
2663714|NCT00626275|9198700|P8|Part B|Lost to Follow-up|0
2663715|NCT00626275|9198701|P7|Part B|Lost to Follow-up|1
2663716|NCT00626275|9198702|P6|Part B|Lost to Follow-up|0
2663717|NCT00626275|9198703|P5|Part B|Lost to Follow-up|0
2663718|NCT00626275|9198704|P4|Part B|Lost to Follow-up|0
2663719|NCT00626275|9198705|P3|Part B|Lost to Follow-up|0
2663720|NCT00626275|9198706|P2|Part B|Lost to Follow-up|0
2663721|NCT00626275|9198707|P1|Part B|Lost to Follow-up|0
2663722|NCT00626275|9198700|P8|Part A - Treatment Period 1|Withdrawal by Subject|0
2663723|NCT00626275|9198701|P7|Part A - Treatment Period 1|Withdrawal by Subject|0
2663724|NCT00626275|9198702|P6|Part A - Treatment Period 1|Withdrawal by Subject|0
2663725|NCT00626275|9198703|P5|Part A - Treatment Period 1|Withdrawal by Subject|0
2663726|NCT00626275|9198704|P4|Part A - Treatment Period 1|Withdrawal by Subject|0
2663727|NCT00626275|9198705|P3|Part A - Treatment Period 1|Withdrawal by Subject|1
2663728|NCT00626275|9198706|P2|Part A - Treatment Period 1|Withdrawal by Subject|0
2663729|NCT00626275|9198707|P1|Part A - Treatment Period 1|Withdrawal by Subject|0
2663730|NCT00626275|9198700|P8|Part A - Treatment Period 1|Adverse Event|0
2663731|NCT00626275|9198701|P7|Part A - Treatment Period 1|Adverse Event|0
2663732|NCT00626275|9198702|P6|Part A - Treatment Period 1|Adverse Event|0
2663733|NCT00626275|9198703|P5|Part A - Treatment Period 1|Adverse Event|0
2663734|NCT00626275|9198704|P4|Part A - Treatment Period 1|Adverse Event|0
2663735|NCT00626275|9198705|P3|Part A - Treatment Period 1|Adverse Event|0
2663736|NCT00626275|9198706|P2|Part A - Treatment Period 1|Adverse Event|0
2663737|NCT00626275|9198707|P1|Part A - Treatment Period 1|Adverse Event|1
2663738|NCT00626093|9198751|P1|Overall Study|One of the required devices not implante|6
2663739|NCT00626093|9198751|P1|Overall Study|Protocol Violation|1
2663740|NCT00626093|9198751|P1|Overall Study|Withdrawal by Subject|6
2663741|NCT00626093|9198751|P1|Overall Study|Physician Decision|4
2663742|NCT00626093|9198751|P1|Overall Study|Death|1
2663743|NCT00626093|9198751|P1|Overall Study|Lost to Follow-up|5
2663744|NCT00626028|9198758|P2|Overall Study|Inclusion/Exclusion Criteria|6
2663745|NCT00626028|9198759|P1|Overall Study|Inclusion/Exclusion Criteria|3
2663746|NCT00626028|9198758|P2|Overall Study|Physician Decision|1
2663747|NCT00626028|9198759|P1|Overall Study|Physician Decision|2
2663748|NCT00626028|9198758|P2|Overall Study|Device Failure|1
2663749|NCT00626028|9198759|P1|Overall Study|Device Failure|0
2663750|NCT00626028|9198758|P2|Overall Study|Adverse Event|1
2663751|NCT00626028|9198759|P1|Overall Study|Adverse Event|1
2663752|NCT00625872|9198783|P2|Overall Study|Randomized but not treated|1
2663753|NCT00625872|9198784|P1|Overall Study|Randomized but not treated|0
2663754|NCT00625872|9198783|P2|Overall Study|Terminated by sponsor|5
2663755|NCT00625872|9198784|P1|Overall Study|Terminated by sponsor|2
2663756|NCT00625872|9198783|P2|Overall Study|Does not meet inclusion criteria|0
2663757|NCT00625872|9198784|P1|Overall Study|Does not meet inclusion criteria|1
2663758|NCT00625872|9198783|P2|Overall Study|Withdrawal by Subject|0
2663759|NCT00625872|9198784|P1|Overall Study|Withdrawal by Subject|1
2663760|NCT00625846|9198898|P4|Overall Study|Withdrawal by Subject|2
2663761|NCT00625846|9198899|P3|Overall Study|Withdrawal by Subject|1
2663762|NCT00625846|9198900|P2|Overall Study|Withdrawal by Subject|0
2663763|NCT00625846|9198901|P1|Overall Study|Withdrawal by Subject|2
2663764|NCT00625820|9198927|P1|Overall Study|Withdrawal by Subject|1
2663765|NCT00625807|9198935|P2|Overall Study|schedule conflict|8
2663766|NCT00625807|9198936|P1|Overall Study|schedule conflict|2
2663767|NCT00625742|9198952|P1|Overall Study|Ineligible|1
2663768|NCT00625742|9198952|P1|Overall Study|Lost to Follow-up|4
2663769|NCT00625742|9198952|P1|Overall Study|Adverse Event|4
2663770|NCT00625742|9198952|P1|Overall Study|Withdrawal by Subject|1
2663771|NCT00625742|9198952|P1|Overall Study|Disease Progression|2
2663772|NCT00625586|9198971|P1|Overall Study|Adverse Event|1
2663773|NCT00625443|9198984|P3|Overall Study|Other|1
2663774|NCT00625443|9198985|P2|Overall Study|Other|1
2663775|NCT00625443|9198986|P1|Overall Study|Other|0
2663776|NCT00625443|9198984|P3|Overall Study|Physician Decision|2
2663777|NCT00625443|9198985|P2|Overall Study|Physician Decision|4
2663778|NCT00625443|9198986|P1|Overall Study|Physician Decision|0
2663779|NCT00625443|9198984|P3|Overall Study|Withdrawal by Subject|2
2663780|NCT00625443|9198985|P2|Overall Study|Withdrawal by Subject|1
2663781|NCT00625443|9198986|P1|Overall Study|Withdrawal by Subject|0
2663782|NCT00625443|9198984|P3|Overall Study|Platelet count increase >=500,000/mm3|0
2663783|NCT00625443|9198985|P2|Overall Study|Platelet count increase >=500,000/mm3|0
2663784|NCT00625443|9198986|P1|Overall Study|Platelet count increase >=500,000/mm3|1
2663785|NCT00625443|9198984|P3|Overall Study|Non-compliance with protocol|0
2663786|NCT00625443|9198985|P2|Overall Study|Non-compliance with protocol|1
2663787|NCT00625443|9198986|P1|Overall Study|Non-compliance with protocol|0
2663788|NCT00625443|9198984|P3|Overall Study|Adverse Event|0
2663789|NCT00625443|9198985|P2|Overall Study|Adverse Event|4
2663790|NCT00625443|9198986|P1|Overall Study|Adverse Event|1
2663791|NCT00625365|9199066|P1|Overall Study|VSD|1
2663792|NCT00625365|9199066|P1|Overall Study|No IV access|5
2663793|NCT00625365|9199066|P1|Overall Study|Withdrawal by Subject|1
2663794|NCT00625183|9199072|P1|Overall Study|Disease Progression|1
2663795|NCT00625131|9199083|P3|Overall Study|Withdrawal by Subject|5
2663796|NCT00625131|9199084|P2|Overall Study|Withdrawal by Subject|0
2663797|NCT00625131|9199085|P1|Overall Study|Withdrawal by Subject|1
2663798|NCT00625131|9199083|P3|Overall Study|Lost to Follow-up|0
2663799|NCT00625131|9199084|P2|Overall Study|Lost to Follow-up|2
2663800|NCT00625131|9199085|P1|Overall Study|Lost to Follow-up|3
2663801|NCT00624832|9199114|P4|Overall Study|Abnormal Laboratory Value|0
2663802|NCT00624832|9199115|P3|Overall Study|Abnormal Laboratory Value|0
2663803|NCT00624832|9199116|P2|Overall Study|Abnormal Laboratory Value|0
2663804|NCT00624832|9199117|P1|Overall Study|Abnormal Laboratory Value|2
2663805|NCT00624832|9199114|P4|Overall Study|Adverse Event|1
2663806|NCT00624832|9199115|P3|Overall Study|Adverse Event|0
2663807|NCT00624832|9199116|P2|Overall Study|Adverse Event|1
2663808|NCT00624832|9199117|P1|Overall Study|Adverse Event|0
2663809|NCT00624819|9199133|P4|Follow-up Period: Year 4|Lost to Follow-up|0
2663810|NCT00624819|9199134|P3|Follow-up Period: Year 4|Lost to Follow-up|0
2663811|NCT00624819|9199135|P2|Follow-up Period: Year 4|Lost to Follow-up|1
2663812|NCT00624819|9199136|P1|Follow-up Period: Year 4|Lost to Follow-up|1
2663813|NCT00624819|9199133|P4|Follow-up Period: Year 4|Parents decision|0
2663814|NCT00624819|9199134|P3|Follow-up Period: Year 4|Parents decision|1
2663815|NCT00624819|9199135|P2|Follow-up Period: Year 4|Parents decision|0
2663816|NCT00624819|9199136|P1|Follow-up Period: Year 4|Parents decision|0
2663817|NCT00624780|9199313|P6|Follow-up (Week 26)|Other|0
2663818|NCT00624780|9199314|P5|Follow-up (Week 26)|Other|0
2663819|NCT00624780|9199315|P4|Follow-up (Week 26)|Other|0
2663820|NCT00624780|9199316|P3|Follow-up (Week 26)|Other|0
2663821|NCT00624780|9199317|P2|Follow-up (Week 26)|Other|1
2663822|NCT00624780|9199318|P1|Follow-up (Week 26)|Other|1
2663823|NCT00624780|9199313|P6|Follow-up (Week 26)|Withdrawal by Subject|0
2663824|NCT00624780|9199314|P5|Follow-up (Week 26)|Withdrawal by Subject|0
2663825|NCT00624780|9199315|P4|Follow-up (Week 26)|Withdrawal by Subject|0
2663826|NCT00624780|9199316|P3|Follow-up (Week 26)|Withdrawal by Subject|0
2663827|NCT00624780|9199317|P2|Follow-up (Week 26)|Withdrawal by Subject|0
2663828|NCT00624780|9199318|P1|Follow-up (Week 26)|Withdrawal by Subject|1
2663829|NCT00624780|9199313|P6|Follow-up (Week 26)|Lost to Follow-up|0
2663830|NCT00624780|9199314|P5|Follow-up (Week 26)|Lost to Follow-up|1
2663831|NCT00624780|9199315|P4|Follow-up (Week 26)|Lost to Follow-up|0
2663832|NCT00624780|9199316|P3|Follow-up (Week 26)|Lost to Follow-up|1
2663833|NCT00624780|9199317|P2|Follow-up (Week 26)|Lost to Follow-up|0
2663834|NCT00624780|9199318|P1|Follow-up (Week 26)|Lost to Follow-up|0
2663835|NCT00624780|9199313|P6|Follow-up (Week 26)|Adverse Event|0
2663836|NCT00624780|9199314|P5|Follow-up (Week 26)|Adverse Event|1
2663837|NCT00624780|9199315|P4|Follow-up (Week 26)|Adverse Event|0
2663838|NCT00624780|9199316|P3|Follow-up (Week 26)|Adverse Event|0
2663839|NCT00624780|9199317|P2|Follow-up (Week 26)|Adverse Event|0
2663840|NCT00624780|9199318|P1|Follow-up (Week 26)|Adverse Event|0
2663841|NCT00624780|9199313|P6|Follow-up (Week 26)|Death|0
2663842|NCT00624780|9199314|P5|Follow-up (Week 26)|Death|0
2663843|NCT00624780|9199315|P4|Follow-up (Week 26)|Death|0
2663844|NCT00624780|9199316|P3|Follow-up (Week 26)|Death|1
2663845|NCT00624780|9199317|P2|Follow-up (Week 26)|Death|0
2663846|NCT00624780|9199318|P1|Follow-up (Week 26)|Death|0
2663847|NCT00624780|9199313|P6|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
2663848|NCT00624780|9199314|P5|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
2663849|NCT00624780|9199315|P4|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
2663850|NCT00624780|9199316|P3|Treatment Discontinuation (Week 25)|Lost to Follow-up|1
2663851|NCT00624780|9199317|P2|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
2663852|NCT00624780|9199318|P1|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
2663853|NCT00624780|9199313|P6|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
2663854|NCT00624780|9199314|P5|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
2663855|NCT00624780|9199315|P4|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
2663856|NCT00624780|9199316|P3|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
2663857|NCT00624780|9199317|P2|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
2663858|NCT00624780|9199318|P1|Treatment Discontinuation (Week 25)|Lack of Efficacy|1
2663859|NCT00624780|9199313|P6|Treatment Discontinuation (Week 25)|Adverse Event|1
2663860|NCT00624780|9199314|P5|Treatment Discontinuation (Week 25)|Adverse Event|0
2663861|NCT00624780|9199315|P4|Treatment Discontinuation (Week 25)|Adverse Event|1
2663862|NCT00624780|9199316|P3|Treatment Discontinuation (Week 25)|Adverse Event|2
2663863|NCT00624780|9199317|P2|Treatment Discontinuation (Week 25)|Adverse Event|0
2663864|NCT00624780|9199318|P1|Treatment Discontinuation (Week 25)|Adverse Event|1
2663865|NCT00624780|9199313|P6|Fixed Dosing (Week 13 to Week 24)|Other|3
2663866|NCT00624780|9199314|P5|Fixed Dosing (Week 13 to Week 24)|Other|4
2663867|NCT00624780|9199315|P4|Fixed Dosing (Week 13 to Week 24)|Other|1
2663868|NCT00624780|9199316|P3|Fixed Dosing (Week 13 to Week 24)|Other|4
2663869|NCT00624780|9199317|P2|Fixed Dosing (Week 13 to Week 24)|Other|3
2663870|NCT00624780|9199318|P1|Fixed Dosing (Week 13 to Week 24)|Other|5
2663871|NCT00624780|9199313|P6|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
2663872|NCT00624780|9199314|P5|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
2663873|NCT00624780|9199315|P4|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
2663874|NCT00624780|9199316|P3|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
2663875|NCT00624780|9199317|P2|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
2663876|NCT00624780|9199318|P1|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
2663877|NCT00624780|9199313|P6|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
2663878|NCT00624780|9199314|P5|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
2663879|NCT00624780|9199315|P4|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
2663880|NCT00624780|9199316|P3|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
2663881|NCT00624780|9199317|P2|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
2663882|NCT00624780|9199318|P1|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
2663883|NCT00624780|9199313|P6|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
2663884|NCT00624780|9199314|P5|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
2663885|NCT00624780|9199315|P4|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
2663886|NCT00624780|9199316|P3|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
2663887|NCT00624780|9199317|P2|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1
2663888|NCT00624780|9199318|P1|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
2663889|NCT00624780|9199313|P6|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1
2663890|NCT00624780|9199314|P5|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3
2663891|NCT00624780|9199315|P4|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2
2663892|NCT00624780|9199316|P3|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
2663893|NCT00624780|9199317|P2|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4
2663894|NCT00624780|9199318|P1|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
2663895|NCT00624780|9199313|P6|Treatment Optimization (Up to Week 12)|Other|0
2663896|NCT00624780|9199314|P5|Treatment Optimization (Up to Week 12)|Other|9
2663897|NCT00624780|9199315|P4|Treatment Optimization (Up to Week 12)|Other|2
2663898|NCT00624780|9199316|P3|Treatment Optimization (Up to Week 12)|Other|8
2663899|NCT00624780|9199317|P2|Treatment Optimization (Up to Week 12)|Other|4
2663900|NCT00624780|9199318|P1|Treatment Optimization (Up to Week 12)|Other|10
2663901|NCT00624780|9199313|P6|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
2663902|NCT00624780|9199314|P5|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
2663903|NCT00624780|9199315|P4|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
2663904|NCT00624780|9199316|P3|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7
2663905|NCT00624780|9199317|P2|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2
2663906|NCT00624780|9199318|P1|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
2663907|NCT00624780|9199313|P6|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
2663908|NCT00624780|9199314|P5|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
2663909|NCT00624780|9199315|P4|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
2663910|NCT00624780|9199316|P3|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
2663911|NCT00624780|9199317|P2|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
2663912|NCT00624780|9199318|P1|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
2663913|NCT00624780|9199313|P6|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1
2663914|NCT00624780|9199314|P5|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9
2663915|NCT00624780|9199315|P4|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
2663916|NCT00624780|9199316|P3|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10
2663917|NCT00624780|9199317|P2|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2
2663918|NCT00624780|9199318|P1|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
2663919|NCT00624780|9199313|P6|Treatment Optimization (Up to Week 12)|Adverse Event|5
2663920|NCT00624780|9199314|P5|Treatment Optimization (Up to Week 12)|Adverse Event|9
2663921|NCT00624780|9199315|P4|Treatment Optimization (Up to Week 12)|Adverse Event|3
2663922|NCT00624780|9199316|P3|Treatment Optimization (Up to Week 12)|Adverse Event|15
2663923|NCT00624780|9199317|P2|Treatment Optimization (Up to Week 12)|Adverse Event|5
2663924|NCT00624780|9199318|P1|Treatment Optimization (Up to Week 12)|Adverse Event|7
2663925|NCT00624585|9199509|P1|Overall Study|Adverse Event|3
2663926|NCT00624585|9199509|P1|Overall Study|Disease Progression|6
2663927|NCT00624585|9199509|P1|Overall Study|Death|3
2663928|NCT00624520|9199539|P2|Overall Study|Death|1
2663929|NCT00624520|9199540|P1|Overall Study|Death|0
2663930|NCT00624520|9199539|P2|Overall Study|Withdrawal by Subject|7
2663931|NCT00624520|9199540|P1|Overall Study|Withdrawal by Subject|12
2663932|NCT00624468|9199567|P4|Safety Follow-up (SFU) Period|Other|1
2663933|NCT00624468|9199568|P3|Safety Follow-up (SFU) Period|Other|1
2663934|NCT00624468|9199569|P2|Safety Follow-up (SFU) Period|Other|0
2663935|NCT00624468|9199570|P1|Safety Follow-up (SFU) Period|Other|0
2663936|NCT00624468|9199567|P4|Safety Follow-up (SFU) Period|Lost to Follow-up|2
2663937|NCT00624468|9199568|P3|Safety Follow-up (SFU) Period|Lost to Follow-up|1
2663938|NCT00624468|9199569|P2|Safety Follow-up (SFU) Period|Lost to Follow-up|0
2663939|NCT00624468|9199570|P1|Safety Follow-up (SFU) Period|Lost to Follow-up|0
2663940|NCT00624468|9199567|P4|Double-blind Period|Withdrew Prematurely|0
2663941|NCT00624468|9199568|P3|Double-blind Period|Withdrew Prematurely|0
2663942|NCT00624468|9199569|P2|Double-blind Period|Withdrew Prematurely|1
2663943|NCT00624468|9199570|P1|Double-blind Period|Withdrew Prematurely|1
2663944|NCT00624468|9199567|P4|Double-blind Period|Early Termination Initiated by Sponsor|0
2663945|NCT00624468|9199568|P3|Double-blind Period|Early Termination Initiated by Sponsor|0
2663946|NCT00624468|9199569|P2|Double-blind Period|Early Termination Initiated by Sponsor|12
2663947|NCT00624468|9199570|P1|Double-blind Period|Early Termination Initiated by Sponsor|13
2663948|NCT00624377|9199637|P1|Overall Study|Non-evaluable population|84
2663949|NCT00624377|9199637|P1|Overall Study|Other|91
2663950|NCT00624377|9199637|P1|Overall Study|Adverse Event|14
2663951|NCT00624377|9199637|P1|Overall Study|Withdrawal by Subject|100
2663952|NCT00624377|9199637|P1|Overall Study|Lost to Follow-up|355
2663953|NCT00624338|9199651|P3|Overall Study|Randomized but not treated|3
2663954|NCT00624338|9199652|P2|Overall Study|Randomized but not treated|1
2663955|NCT00624338|9199653|P1|Overall Study|Randomized but not treated|2
2663956|NCT00624338|9199651|P3|Overall Study|Other|9
2663957|NCT00624338|9199652|P2|Overall Study|Other|5
2663958|NCT00624338|9199653|P1|Overall Study|Other|15
2663959|NCT00624338|9199651|P3|Overall Study|Termination of 150 mg group by Sponsor|0
2663960|NCT00624338|9199652|P2|Overall Study|Termination of 150 mg group by Sponsor|55
2663961|NCT00624338|9199653|P1|Overall Study|Termination of 150 mg group by Sponsor|0
2663962|NCT00624338|9199651|P3|Overall Study|Immunoglobulin less than 3gram per liter|0
2663963|NCT00624338|9199652|P2|Overall Study|Immunoglobulin less than 3gram per liter|0
2663964|NCT00624338|9199653|P1|Overall Study|Immunoglobulin less than 3gram per liter|1
2663965|NCT00624338|9199651|P3|Overall Study|Death|0
2663966|NCT00624338|9199652|P2|Overall Study|Death|2
2663967|NCT00624338|9199653|P1|Overall Study|Death|0
2663968|NCT00624338|9199651|P3|Overall Study|Protocol Violation|2
2663969|NCT00624338|9199652|P2|Overall Study|Protocol Violation|3
2663970|NCT00624338|9199653|P1|Overall Study|Protocol Violation|3
2663971|NCT00624338|9199651|P3|Overall Study|Lack of Efficacy|14
2663972|NCT00624338|9199652|P2|Overall Study|Lack of Efficacy|3
2663973|NCT00624338|9199653|P1|Overall Study|Lack of Efficacy|11
2663974|NCT00624338|9199651|P3|Overall Study|Lost to Follow-up|0
2663975|NCT00624338|9199652|P2|Overall Study|Lost to Follow-up|0
2663976|NCT00624338|9199653|P1|Overall Study|Lost to Follow-up|1
2663977|NCT00624338|9199651|P3|Overall Study|Adverse Event|18
2663978|NCT00624338|9199652|P2|Overall Study|Adverse Event|14
2663979|NCT00624338|9199653|P1|Overall Study|Adverse Event|14
2663980|NCT00624286|9199675|P2|Overall Study|Death|1
2663981|NCT00624286|9199676|P1|Overall Study|Death|0
2663982|NCT00624286|9199675|P2|Overall Study|Abnormal test procedure result(s)|1
2663983|NCT00624286|9199676|P1|Overall Study|Abnormal test procedure result(s)|0
2663984|NCT00624286|9199675|P2|Overall Study|Not stated|1
2663985|NCT00624286|9199676|P1|Overall Study|Not stated|0
2663986|NCT00624286|9199675|P2|Overall Study|Lack of Efficacy|6
2663987|NCT00624286|9199676|P1|Overall Study|Lack of Efficacy|1
2663988|NCT00624286|9199675|P2|Overall Study|Administrative problems|0
2663989|NCT00624286|9199676|P1|Overall Study|Administrative problems|3
2663990|NCT00624286|9199675|P2|Overall Study|Lost to Follow-up|2
2663991|NCT00624286|9199676|P1|Overall Study|Lost to Follow-up|3
2663992|NCT00624286|9199675|P2|Overall Study|Withdrawal by Subject|4
2663993|NCT00624286|9199676|P1|Overall Study|Withdrawal by Subject|5
2663994|NCT00624286|9199675|P2|Overall Study|Adverse Event|3
2663995|NCT00624286|9199676|P1|Overall Study|Adverse Event|6
2663996|NCT00624286|9199675|P2|Overall Study|Protocol Deviation|9
2663997|NCT00624286|9199676|P1|Overall Study|Protocol Deviation|7
2663998|NCT00624065|9199729|P2|Overall Study|Met protocol-defined stopping criteria|9
2663999|NCT00624065|9199730|P1|Overall Study|Met protocol-defined stopping criteria|4
2664000|NCT00624065|9199729|P2|Overall Study|Lack of Efficacy|3
2664001|NCT00624065|9199730|P1|Overall Study|Lack of Efficacy|0
2664002|NCT00624065|9199729|P2|Overall Study|Consent withdrawn|5
2664003|NCT00624065|9199730|P1|Overall Study|Consent withdrawn|6
2664004|NCT00624065|9199729|P2|Overall Study|Lost to Follow-up|1
2664005|NCT00624065|9199730|P1|Overall Study|Lost to Follow-up|4
2664006|NCT00624065|9199729|P2|Overall Study|Adverse Event|6
2664007|NCT00624065|9199730|P1|Overall Study|Adverse Event|5
2664008|NCT00624052|9199742|P4|Overall Study|Changed job/ran out if meds|0
2664009|NCT00624052|9199743|P3|Overall Study|Changed job/ran out if meds|0
2664010|NCT00624052|9199744|P2|Overall Study|Changed job/ran out if meds|2
2664011|NCT00624052|9199745|P1|Overall Study|Changed job/ran out if meds|0
2664012|NCT00624052|9199742|P4|Overall Study|Consent withdrawn|0
2664013|NCT00624052|9199743|P3|Overall Study|Consent withdrawn|1
2664014|NCT00624052|9199744|P2|Overall Study|Consent withdrawn|1
2664015|NCT00624052|9199745|P1|Overall Study|Consent withdrawn|3
2664016|NCT00624052|9199742|P4|Overall Study|Non compliant with the protocol|1
2664017|NCT00624052|9199743|P3|Overall Study|Non compliant with the protocol|1
2664018|NCT00624052|9199744|P2|Overall Study|Non compliant with the protocol|1
2664019|NCT00624052|9199745|P1|Overall Study|Non compliant with the protocol|2
2664020|NCT00624052|9199742|P4|Overall Study|Lost to Follow-up|0
2664021|NCT00624052|9199743|P3|Overall Study|Lost to Follow-up|1
2664022|NCT00624052|9199744|P2|Overall Study|Lost to Follow-up|3
2664023|NCT00624052|9199745|P1|Overall Study|Lost to Follow-up|2
2664024|NCT00624052|9199742|P4|Overall Study|Lack of Efficacy|0
2664025|NCT00624052|9199743|P3|Overall Study|Lack of Efficacy|0
2664026|NCT00624052|9199744|P2|Overall Study|Lack of Efficacy|1
2664027|NCT00624052|9199745|P1|Overall Study|Lack of Efficacy|1
2664028|NCT00624052|9199742|P4|Overall Study|Adverse Event|3
2664029|NCT00624052|9199743|P3|Overall Study|Adverse Event|0
2664030|NCT00624052|9199744|P2|Overall Study|Adverse Event|6
2664031|NCT00624052|9199745|P1|Overall Study|Adverse Event|7
2664032|NCT00623935|9199822|P1|Overall Study|Patient Declined Transplant|1
2664033|NCT00623935|9199822|P1|Overall Study|Death|1
2664034|NCT00623831|9199829|P2|Overall Study|Progressive Disease|1
2664035|NCT00623831|9199830|P1|Overall Study|Progressive Disease|0
2664036|NCT00623831|9199829|P2|Overall Study|Withdrawal by Subject|0
2664037|NCT00623831|9199830|P1|Overall Study|Withdrawal by Subject|1
2664038|NCT00623805|9199842|P2|Overall Study|Reason not Specified|6
2664039|NCT00623805|9199843|P1|Overall Study|Reason not Specified|3
2664040|NCT00623805|9199842|P2|Overall Study|Protocol Violation|1
2664041|NCT00623805|9199843|P1|Overall Study|Protocol Violation|1
2664042|NCT00623805|9199842|P2|Overall Study|Lost to Follow-up|2
2664043|NCT00623805|9199843|P1|Overall Study|Lost to Follow-up|2
2664044|NCT00623805|9199842|P2|Overall Study|Lack of Efficacy|7
2664045|NCT00623805|9199843|P1|Overall Study|Lack of Efficacy|3
2664046|NCT00623805|9199842|P2|Overall Study|Death|0
2664047|NCT00623805|9199843|P1|Overall Study|Death|2
2664048|NCT00623805|9199842|P2|Overall Study|Adverse Event|6
2664049|NCT00623805|9199843|P1|Overall Study|Adverse Event|9
2664050|NCT00623779|9199860|P3|Overall Study|Criteria from CSR|1
2664051|NCT00623779|9199861|P2|Overall Study|Criteria from CSR|0
2664052|NCT00623779|9199862|P1|Overall Study|Criteria from CSR|2
2664053|NCT00623779|9199860|P3|Overall Study|Adverse Event|0
2664054|NCT00623779|9199861|P2|Overall Study|Adverse Event|3
2664055|NCT00623779|9199862|P1|Overall Study|Adverse Event|1
2664056|NCT00623766|9199911|P2|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0
2664057|NCT00623766|9199912|P1|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1
2664058|NCT00623766|9199911|P2|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2
2664059|NCT00623766|9199912|P1|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1
2664060|NCT00623766|9199911|P2|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0
2664061|NCT00623766|9199912|P1|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4
2664062|NCT00623766|9199911|P2|Maintenance Phase (Week 24 to Year 2)|Disease progression|0
2664063|NCT00623766|9199912|P1|Maintenance Phase (Week 24 to Year 2)|Disease progression|4
2664064|NCT00623766|9199911|P2|Induction Phase (Day 1 to Week 24)|Off treatment|16
2664065|NCT00623766|9199912|P1|Induction Phase (Day 1 to Week 24)|Off treatment|36
2664066|NCT00623727|9199936|P2|Open Label Follow-up|Participant convenience|1
2664067|NCT00623727|9199937|P1|Open Label Follow-up|Participant convenience|0
2664068|NCT00623727|9199936|P2|Open Label Follow-up|Study termination|6
2664069|NCT00623727|9199937|P1|Open Label Follow-up|Study termination|0
2664070|NCT00623727|9199936|P2|Open Label Follow-up|Withdrawal by Subject|1
2664071|NCT00623727|9199937|P1|Open Label Follow-up|Withdrawal by Subject|0
2664072|NCT00623727|9199936|P2|Double Blind (DB)|Protocol Violation|2
2664073|NCT00623727|9199937|P1|Double Blind (DB)|Protocol Violation|2
2664074|NCT00623727|9199936|P2|Double Blind (DB)|Lost to Follow-up|1
2664075|NCT00623727|9199937|P1|Double Blind (DB)|Lost to Follow-up|1
2664076|NCT00623727|9199936|P2|Double Blind (DB)|Termination of the double-blind period|21
2664077|NCT00623727|9199937|P1|Double Blind (DB)|Termination of the double-blind period|22
2664078|NCT00623727|9199936|P2|Double Blind (DB)|Lack of Efficacy|2
2664079|NCT00623727|9199937|P1|Double Blind (DB)|Lack of Efficacy|2
2664080|NCT00623727|9199936|P2|Double Blind (DB)|Withdrawal by Subject|2
2664081|NCT00623727|9199937|P1|Double Blind (DB)|Withdrawal by Subject|8
2664082|NCT00623727|9199936|P2|Double Blind (DB)|Physician Decision|1
2664083|NCT00623727|9199937|P1|Double Blind (DB)|Physician Decision|0
2664084|NCT00623727|9199936|P2|Double Blind (DB)|Adverse Event|3
2664085|NCT00623727|9199937|P1|Double Blind (DB)|Adverse Event|1
2664086|NCT00623623|9199992|P2|Overall Study|Previous enrolment into this study|1
2664087|NCT00623623|9199993|P1|Overall Study|Previous enrolment into this study|1
2664088|NCT00623597|9200049|P2|Overall Study|Failed to return|0
2664089|NCT00623597|9200050|P1|Overall Study|Failed to return|1
2664090|NCT00623545|9200113|P1|Overall Study|Withdrawal by Subject|4
2664091|NCT00623545|9200113|P1|Overall Study|Adverse Event|6
2664092|NCT00623480|9200133|P2|Overall Study|Site closed by sponsor|1
2664093|NCT00623480|9200134|P1|Overall Study|Site closed by sponsor|0
2664094|NCT00623480|9200133|P2|Overall Study|Protocol Violation|1
2664095|NCT00623480|9200134|P1|Overall Study|Protocol Violation|0
2664096|NCT00623480|9200133|P2|Overall Study|Non-compliant with study medication|0
2664097|NCT00623480|9200134|P1|Overall Study|Non-compliant with study medication|4
2664098|NCT00623480|9200133|P2|Overall Study|Lack of Efficacy|0
2664099|NCT00623480|9200134|P1|Overall Study|Lack of Efficacy|1
2664100|NCT00623480|9200133|P2|Overall Study|Withdrawal by Subject|4
2664101|NCT00623480|9200134|P1|Overall Study|Withdrawal by Subject|2
2664102|NCT00623480|9200133|P2|Overall Study|Lost to Follow-up|1
2664103|NCT00623480|9200134|P1|Overall Study|Lost to Follow-up|0
2664104|NCT00623467|9200146|P1|Overall Study|Withdrawal by Subject|2
2664105|NCT00623467|9200146|P1|Overall Study|Protocol Violation|4
2664106|NCT00623467|9200146|P1|Overall Study|Lost to Follow-up|1
2664107|NCT00623428|9200216|P2|Follow-up Period|Death|1
2664108|NCT00623428|9200217|P1|Follow-up Period|Death|0
2664109|NCT00623428|9200216|P2|Follow-up Period|Reason not specified|1
2664110|NCT00623428|9200217|P1|Follow-up Period|Reason not specified|1
2664111|NCT00623428|9200216|P2|Follow-up Period|Did not cooperate|3
2664112|NCT00623428|9200217|P1|Follow-up Period|Did not cooperate|0
2664113|NCT00623428|9200216|P2|Follow-up Period|HCV-RNA detectable at end of treatment|1
2664114|NCT00623428|9200217|P1|Follow-up Period|HCV-RNA detectable at end of treatment|2
2664115|NCT00623428|9200216|P2|Follow-up Period|Patient withdrew consent|4
2664116|NCT00623428|9200217|P1|Follow-up Period|Patient withdrew consent|5
2664117|NCT00623428|9200216|P2|Follow-up Period|Failure to return|2
2664118|NCT00623428|9200217|P1|Follow-up Period|Failure to return|10
2664119|NCT00623428|9200216|P2|Follow-up Period|Relapse post-treatment|3
2664120|NCT00623428|9200217|P1|Follow-up Period|Relapse post-treatment|11
2664121|NCT00623428|9200216|P2|Treatment Period|Withdrawal by Subject|1
2664122|NCT00623428|9200217|P1|Treatment Period|Withdrawal by Subject|0
2664123|NCT00623428|9200216|P2|Treatment Period|Other|1
2664124|NCT00623428|9200217|P1|Treatment Period|Other|0
2664125|NCT00623428|9200216|P2|Treatment Period|Insufficient therapeutic response|2
2664126|NCT00623428|9200217|P1|Treatment Period|Insufficient therapeutic response|0
2664127|NCT00623428|9200216|P2|Treatment Period|Did not cooperate / refused treatment|13
2664128|NCT00623428|9200217|P1|Treatment Period|Did not cooperate / refused treatment|0
2664129|NCT00623428|9200216|P2|Treatment Period|Death|1
2664130|NCT00623428|9200217|P1|Treatment Period|Death|0
2664131|NCT00623428|9200216|P2|Treatment Period|Adverse event/intercurrent illness|9
2664132|NCT00623428|9200217|P1|Treatment Period|Adverse event/intercurrent illness|0
2664133|NCT00623233|9200235|P1|Overall Study|Withdrawal by Subject|3
2664134|NCT00623233|9200235|P1|Overall Study|Lost to Follow-up|1
2664135|NCT00623233|9200235|P1|Overall Study|Physician Decision|10
2664136|NCT00623233|9200235|P1|Overall Study|Adverse Event|10
2664137|NCT00623194|9200242|P1|Overall Study|Unclassified|1
2664138|NCT00623194|9200242|P1|Overall Study|Protocol Violation|3
2664139|NCT00623194|9200242|P1|Overall Study|Lack of Efficacy|1
2664140|NCT00623103|9200279|P2|Overall Study|Protocol deviation|1
2664141|NCT00623103|9200280|P1|Overall Study|Protocol deviation|2
2664142|NCT00623103|9200279|P2|Overall Study|Death|11
2664143|NCT00623103|9200280|P1|Overall Study|Death|11
2664144|NCT00623103|9200279|P2|Overall Study|Administrative problems|4
2664145|NCT00623103|9200280|P1|Overall Study|Administrative problems|2
2664146|NCT00623103|9200279|P2|Overall Study|Lost to Follow-up|1
2664147|NCT00623103|9200280|P1|Overall Study|Lost to Follow-up|4
2664148|NCT00623103|9200279|P2|Overall Study|Withdrawal by Subject|24
2664149|NCT00623103|9200280|P1|Overall Study|Withdrawal by Subject|18
2664150|NCT00623103|9200279|P2|Overall Study|Unsatisfactory therapeutic effect|12
2664151|NCT00623103|9200280|P1|Overall Study|Unsatisfactory therapeutic effect|4
2664152|NCT00623103|9200279|P2|Overall Study|Adverse Event|60
2664153|NCT00623103|9200280|P1|Overall Study|Adverse Event|70
2664154|NCT00622908|9200308|P2|Overall Study|Termination by study sponser|1
2664155|NCT00622908|9200309|P1|Overall Study|Termination by study sponser|0
2664156|NCT00622908|9200308|P2|Overall Study|Refusal|1
2664157|NCT00622908|9200309|P1|Overall Study|Refusal|0
2664158|NCT00622908|9200308|P2|Overall Study|Lost to Follow-up|0
2664159|NCT00622908|9200309|P1|Overall Study|Lost to Follow-up|1
2664160|NCT00622908|9200308|P2|Overall Study|Lack of Efficacy|7
2664161|NCT00622908|9200309|P1|Overall Study|Lack of Efficacy|1
2664162|NCT00622908|9200308|P2|Overall Study|Adverse Event|1
2664163|NCT00622908|9200309|P1|Overall Study|Adverse Event|0
2664164|NCT00622908|9200308|P2|Overall Study|Protocol Violation|0
2664165|NCT00622908|9200309|P1|Overall Study|Protocol Violation|1
2664166|NCT00622869|9200339|P3|Overall Study|Missing|1
2664167|NCT00622869|9200340|P2|Overall Study|Missing|1
2664168|NCT00622869|9200341|P1|Overall Study|Missing|0
2664169|NCT00622869|9200339|P3|Overall Study|Graft Loss|2
2664170|NCT00622869|9200340|P2|Overall Study|Graft Loss|3
2664171|NCT00622869|9200341|P1|Overall Study|Graft Loss|5
2664172|NCT00622869|9200339|P3|Overall Study|Lost to Follow-up|2
2664173|NCT00622869|9200340|P2|Overall Study|Lost to Follow-up|4
2664174|NCT00622869|9200341|P1|Overall Study|Lost to Follow-up|2
2664175|NCT00622869|9200339|P3|Overall Study|Death|10
2664176|NCT00622869|9200340|P2|Overall Study|Death|15
2664177|NCT00622869|9200341|P1|Overall Study|Death|12
2664178|NCT00622869|9200339|P3|Overall Study|Administrative Problems|13
2664179|NCT00622869|9200340|P2|Overall Study|Administrative Problems|17
2664180|NCT00622869|9200341|P1|Overall Study|Administrative Problems|11
2664181|NCT00622869|9200339|P3|Overall Study|Subject Withdrew Consent|11
2664182|NCT00622869|9200340|P2|Overall Study|Subject Withdrew Consent|17
2664183|NCT00622869|9200341|P1|Overall Study|Subject Withdrew Consent|13
2664184|NCT00622739|9200360|P2|Overall Study|Lost to Follow-up|1
2664185|NCT00622739|9200361|P1|Overall Study|Lost to Follow-up|0
2664186|NCT00622739|9200360|P2|Overall Study|Withdrawal by Subject|1
2664187|NCT00622739|9200361|P1|Overall Study|Withdrawal by Subject|0
2664188|NCT00622739|9200360|P2|Overall Study|Lack of Efficacy|2
2664189|NCT00622739|9200361|P1|Overall Study|Lack of Efficacy|0
2664190|NCT00622739|9200360|P2|Overall Study|Adverse Event|2
2664191|NCT00622739|9200361|P1|Overall Study|Adverse Event|1
2664192|NCT00622739|9200360|P2|Overall Study|Physician Decision|0
2664193|NCT00622739|9200361|P1|Overall Study|Physician Decision|1
2664194|NCT00622726|9200379|P2|August, 2010 to April, 2013|Death|5
2664195|NCT00622726|9200380|P1|August, 2010 to April, 2013|Death|1
2664196|NCT00622726|9200379|P2|March, 2008 to August, 2010|Death|2
2664197|NCT00622726|9200380|P1|March, 2008 to August, 2010|Death|5
2664198|NCT00622713|9200390|P1|Overall Study|Did not meet eligibility criteria|1
2664199|NCT00622713|9200390|P1|Overall Study|Subject no longer required study drug|1
2664200|NCT00622713|9200390|P1|Overall Study|Death|2
2664201|NCT00622713|9200390|P1|Overall Study|Lost to Follow-up|5
2664202|NCT00622713|9200390|P1|Overall Study|Withdrawal by Subject|11
2664203|NCT00622713|9200390|P1|Overall Study|Administrative problems|4
2664204|NCT00622713|9200390|P1|Overall Study|Adverse Event|35
2664205|NCT00622700|9200401|P7|Extension Treatment Period|Other than specified above|1
2664206|NCT00622700|9200402|P6|Extension Treatment Period|Other than specified above|1
2664207|NCT00622700|9200403|P5|Extension Treatment Period|Other than specified above|0
2664208|NCT00622700|9200404|P4|Extension Treatment Period|Other than specified above|0
2664209|NCT00622700|9200405|P3|Extension Treatment Period|Other than specified above|0
2664210|NCT00622700|9200406|P2|Extension Treatment Period|Other than specified above|0
2664211|NCT00622700|9200407|P1|Extension Treatment Period|Other than specified above|0
2664212|NCT00622700|9200401|P7|Extension Treatment Period|Missing|0
2664213|NCT00622700|9200402|P6|Extension Treatment Period|Missing|1
2664214|NCT00622700|9200403|P5|Extension Treatment Period|Missing|3
2664215|NCT00622700|9200404|P4|Extension Treatment Period|Missing|2
2664216|NCT00622700|9200405|P3|Extension Treatment Period|Missing|0
2664217|NCT00622700|9200406|P2|Extension Treatment Period|Missing|0
2664218|NCT00622700|9200407|P1|Extension Treatment Period|Missing|0
2664219|NCT00622700|9200401|P7|Extension Treatment Period|Withdrawal by Subject|10
2664220|NCT00622700|9200402|P6|Extension Treatment Period|Withdrawal by Subject|6
2664221|NCT00622700|9200403|P5|Extension Treatment Period|Withdrawal by Subject|16
2664222|NCT00622700|9200404|P4|Extension Treatment Period|Withdrawal by Subject|11
2664223|NCT00622700|9200405|P3|Extension Treatment Period|Withdrawal by Subject|0
2664224|NCT00622700|9200406|P2|Extension Treatment Period|Withdrawal by Subject|0
2664225|NCT00622700|9200407|P1|Extension Treatment Period|Withdrawal by Subject|0
2664226|NCT00622700|9200401|P7|Extension Treatment Period|Progressive Disease|2
2664227|NCT00622700|9200402|P6|Extension Treatment Period|Progressive Disease|0
2664228|NCT00622700|9200403|P5|Extension Treatment Period|Progressive Disease|2
2664229|NCT00622700|9200404|P4|Extension Treatment Period|Progressive Disease|1
2664230|NCT00622700|9200405|P3|Extension Treatment Period|Progressive Disease|0
2664231|NCT00622700|9200406|P2|Extension Treatment Period|Progressive Disease|0
2664232|NCT00622700|9200407|P1|Extension Treatment Period|Progressive Disease|0
2664233|NCT00622700|9200401|P7|Extension Treatment Period|Lost to Follow-up|0
2664234|NCT00622700|9200402|P6|Extension Treatment Period|Lost to Follow-up|0
2664235|NCT00622700|9200403|P5|Extension Treatment Period|Lost to Follow-up|1
2664236|NCT00622700|9200404|P4|Extension Treatment Period|Lost to Follow-up|0
2664237|NCT00622700|9200405|P3|Extension Treatment Period|Lost to Follow-up|0
2664238|NCT00622700|9200406|P2|Extension Treatment Period|Lost to Follow-up|0
2664239|NCT00622700|9200407|P1|Extension Treatment Period|Lost to Follow-up|0
2664240|NCT00622700|9200401|P7|Extension Treatment Period|Protocol Violation|0
2664241|NCT00622700|9200402|P6|Extension Treatment Period|Protocol Violation|2
2664242|NCT00622700|9200403|P5|Extension Treatment Period|Protocol Violation|0
2664243|NCT00622700|9200404|P4|Extension Treatment Period|Protocol Violation|0
2664244|NCT00622700|9200405|P3|Extension Treatment Period|Protocol Violation|0
2664245|NCT00622700|9200406|P2|Extension Treatment Period|Protocol Violation|0
2664246|NCT00622700|9200407|P1|Extension Treatment Period|Protocol Violation|0
2664247|NCT00622700|9200401|P7|Extension Treatment Period|Lack of Efficacy|9
2664248|NCT00622700|9200402|P6|Extension Treatment Period|Lack of Efficacy|1
2664249|NCT00622700|9200403|P5|Extension Treatment Period|Lack of Efficacy|8
2664250|NCT00622700|9200404|P4|Extension Treatment Period|Lack of Efficacy|2
2664251|NCT00622700|9200405|P3|Extension Treatment Period|Lack of Efficacy|0
2664252|NCT00622700|9200406|P2|Extension Treatment Period|Lack of Efficacy|0
2664253|NCT00622700|9200407|P1|Extension Treatment Period|Lack of Efficacy|0
2664254|NCT00622700|9200401|P7|Extension Treatment Period|Adverse Event|8
2664255|NCT00622700|9200402|P6|Extension Treatment Period|Adverse Event|6
2664256|NCT00622700|9200403|P5|Extension Treatment Period|Adverse Event|9
2664257|NCT00622700|9200404|P4|Extension Treatment Period|Adverse Event|5
2664258|NCT00622700|9200405|P3|Extension Treatment Period|Adverse Event|0
2664259|NCT00622700|9200406|P2|Extension Treatment Period|Adverse Event|0
2664260|NCT00622700|9200407|P1|Extension Treatment Period|Adverse Event|0
2664261|NCT00622700|9200401|P7|Core Treatment Period|Other than specified above|0
2664262|NCT00622700|9200402|P6|Core Treatment Period|Other than specified above|0
2664263|NCT00622700|9200403|P5|Core Treatment Period|Other than specified above|0
2664264|NCT00622700|9200404|P4|Core Treatment Period|Other than specified above|0
2664265|NCT00622700|9200405|P3|Core Treatment Period|Other than specified above|5
2664266|NCT00622700|9200406|P2|Core Treatment Period|Other than specified above|2
2664267|NCT00622700|9200407|P1|Core Treatment Period|Other than specified above|2
2664268|NCT00622700|9200401|P7|Core Treatment Period|Withdrawal by Subject|0
2664269|NCT00622700|9200402|P6|Core Treatment Period|Withdrawal by Subject|0
2664270|NCT00622700|9200403|P5|Core Treatment Period|Withdrawal by Subject|0
2664271|NCT00622700|9200404|P4|Core Treatment Period|Withdrawal by Subject|0
2664272|NCT00622700|9200405|P3|Core Treatment Period|Withdrawal by Subject|15
2664273|NCT00622700|9200406|P2|Core Treatment Period|Withdrawal by Subject|18
2664274|NCT00622700|9200407|P1|Core Treatment Period|Withdrawal by Subject|12
2664275|NCT00622700|9200401|P7|Core Treatment Period|Progressive Disease|0
2664276|NCT00622700|9200402|P6|Core Treatment Period|Progressive Disease|0
2664277|NCT00622700|9200403|P5|Core Treatment Period|Progressive Disease|0
2664278|NCT00622700|9200404|P4|Core Treatment Period|Progressive Disease|0
2664279|NCT00622700|9200405|P3|Core Treatment Period|Progressive Disease|0
2664280|NCT00622700|9200406|P2|Core Treatment Period|Progressive Disease|1
2664281|NCT00622700|9200407|P1|Core Treatment Period|Progressive Disease|3
2664282|NCT00622700|9200401|P7|Core Treatment Period|Death|0
2664283|NCT00622700|9200402|P6|Core Treatment Period|Death|0
2664284|NCT00622700|9200403|P5|Core Treatment Period|Death|0
2664285|NCT00622700|9200404|P4|Core Treatment Period|Death|0
2664286|NCT00622700|9200405|P3|Core Treatment Period|Death|0
2664287|NCT00622700|9200406|P2|Core Treatment Period|Death|0
2664288|NCT00622700|9200407|P1|Core Treatment Period|Death|1
2664289|NCT00622700|9200401|P7|Core Treatment Period|Lost to Follow-up|0
2664290|NCT00622700|9200402|P6|Core Treatment Period|Lost to Follow-up|0
2664291|NCT00622700|9200403|P5|Core Treatment Period|Lost to Follow-up|0
2664292|NCT00622700|9200404|P4|Core Treatment Period|Lost to Follow-up|0
2664293|NCT00622700|9200405|P3|Core Treatment Period|Lost to Follow-up|1
2664294|NCT00622700|9200406|P2|Core Treatment Period|Lost to Follow-up|1
2664295|NCT00622700|9200407|P1|Core Treatment Period|Lost to Follow-up|1
2664296|NCT00622700|9200401|P7|Core Treatment Period|Lack of Efficacy|0
2664297|NCT00622700|9200402|P6|Core Treatment Period|Lack of Efficacy|0
2664298|NCT00622700|9200403|P5|Core Treatment Period|Lack of Efficacy|0
2664299|NCT00622700|9200404|P4|Core Treatment Period|Lack of Efficacy|0
2664300|NCT00622700|9200405|P3|Core Treatment Period|Lack of Efficacy|12
2664301|NCT00622700|9200406|P2|Core Treatment Period|Lack of Efficacy|6
2664302|NCT00622700|9200407|P1|Core Treatment Period|Lack of Efficacy|19
2664303|NCT00622700|9200401|P7|Core Treatment Period|Adverse Event|0
2664304|NCT00622700|9200402|P6|Core Treatment Period|Adverse Event|0
2664305|NCT00622700|9200403|P5|Core Treatment Period|Adverse Event|0
2664306|NCT00622700|9200404|P4|Core Treatment Period|Adverse Event|0
2664307|NCT00622700|9200405|P3|Core Treatment Period|Adverse Event|18
2664308|NCT00622700|9200406|P2|Core Treatment Period|Adverse Event|25
2664309|NCT00622700|9200407|P1|Core Treatment Period|Adverse Event|18
2664310|NCT00622700|9200401|P7|Core Treatment Period|Randomized but Not Treated|0
2664311|NCT00622700|9200402|P6|Core Treatment Period|Randomized but Not Treated|0
2664312|NCT00622700|9200403|P5|Core Treatment Period|Randomized but Not Treated|0
2664313|NCT00622700|9200404|P4|Core Treatment Period|Randomized but Not Treated|0
2664314|NCT00622700|9200405|P3|Core Treatment Period|Randomized but Not Treated|2
2664315|NCT00622700|9200406|P2|Core Treatment Period|Randomized but Not Treated|2
2664316|NCT00622700|9200407|P1|Core Treatment Period|Randomized but Not Treated|0
2664317|NCT00622635|9200466|P6|Treatment Period 3|Withdrawal by Subject|0
2664318|NCT00622635|9200467|P5|Treatment Period 3|Withdrawal by Subject|0
2664319|NCT00622635|9200468|P4|Treatment Period 3|Withdrawal by Subject|1
2664320|NCT00622635|9200469|P3|Treatment Period 3|Withdrawal by Subject|0
2664321|NCT00622635|9200470|P2|Treatment Period 3|Withdrawal by Subject|0
2664322|NCT00622635|9200471|P1|Treatment Period 3|Withdrawal by Subject|0
2664323|NCT00622635|9200466|P6|Treatment Period 3|Adverse Event|0
2664324|NCT00622635|9200467|P5|Treatment Period 3|Adverse Event|0
2664325|NCT00622635|9200468|P4|Treatment Period 3|Adverse Event|2
2664326|NCT00622635|9200469|P3|Treatment Period 3|Adverse Event|0
2664327|NCT00622635|9200470|P2|Treatment Period 3|Adverse Event|0
2664328|NCT00622635|9200471|P1|Treatment Period 3|Adverse Event|0
2664329|NCT00622635|9200466|P6|Treatment Period 2|Adverse Event|0
2664330|NCT00622635|9200467|P5|Treatment Period 2|Adverse Event|0
2664331|NCT00622635|9200468|P4|Treatment Period 2|Adverse Event|0
2664332|NCT00622635|9200469|P3|Treatment Period 2|Adverse Event|0
2664333|NCT00622635|9200470|P2|Treatment Period 2|Adverse Event|0
2664334|NCT00622635|9200471|P1|Treatment Period 2|Adverse Event|1
2664335|NCT00622635|9200466|P6|Treatment Period 1|Abnormal test procedure result(s)|0
2664336|NCT00622635|9200467|P5|Treatment Period 1|Abnormal test procedure result(s)|1
2664337|NCT00622635|9200468|P4|Treatment Period 1|Abnormal test procedure result(s)|0
2664338|NCT00622635|9200469|P3|Treatment Period 1|Abnormal test procedure result(s)|0
2664339|NCT00622635|9200470|P2|Treatment Period 1|Abnormal test procedure result(s)|0
2664340|NCT00622635|9200471|P1|Treatment Period 1|Abnormal test procedure result(s)|0
2664341|NCT00622635|9200466|P6|Treatment Period 1|Withdrawal by Subject|0
2664342|NCT00622635|9200467|P5|Treatment Period 1|Withdrawal by Subject|0
2664343|NCT00622635|9200468|P4|Treatment Period 1|Withdrawal by Subject|0
2664344|NCT00622635|9200469|P3|Treatment Period 1|Withdrawal by Subject|0
2664345|NCT00622635|9200470|P2|Treatment Period 1|Withdrawal by Subject|1
2664346|NCT00622635|9200471|P1|Treatment Period 1|Withdrawal by Subject|0
2664347|NCT00622635|9200466|P6|Treatment Period 1|Adverse Event|0
2664348|NCT00622635|9200467|P5|Treatment Period 1|Adverse Event|0
2664349|NCT00622635|9200468|P4|Treatment Period 1|Adverse Event|0
2664350|NCT00622635|9200469|P3|Treatment Period 1|Adverse Event|1
2664351|NCT00622635|9200470|P2|Treatment Period 1|Adverse Event|0
2664352|NCT00622635|9200471|P1|Treatment Period 1|Adverse Event|0
2664353|NCT00622440|9200554|P2|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1
2664354|NCT00622440|9200555|P1|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0
2664355|NCT00622440|9200554|P2|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1
2664356|NCT00622440|9200555|P1|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0
2664357|NCT00622440|9200554|P2|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5
2664358|NCT00622440|9200555|P1|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3
2664359|NCT00622440|9200554|P2|Baseline - Week 12 (Treatment)|Received cream but did not return|1
2664360|NCT00622440|9200555|P1|Baseline - Week 12 (Treatment)|Received cream but did not return|4
2664361|NCT00622401|9200581|P3|Overall Study|Disease progression prior to treatment|0
2664362|NCT00622401|9200582|P2|Overall Study|Disease progression prior to treatment|2
2664363|NCT00622401|9200583|P1|Overall Study|Disease progression prior to treatment|3
2664364|NCT00622388|9200590|P1|Overall Study|Insurance Expired|1
2664365|NCT00622388|9200590|P1|Overall Study|Withdrew Consent|1
2664366|NCT00622388|9200590|P1|Overall Study|Took Prohibited Medication|2
2664367|NCT00622388|9200590|P1|Overall Study|Received Alternate Anticancer Therapy|8
2664368|NCT00622388|9200590|P1|Overall Study|Death|3
2664369|NCT00622388|9200590|P1|Overall Study|Participant Refusal|1
2664370|NCT00622388|9200590|P1|Overall Study|Protocol Violation|3
2664371|NCT00622388|9200590|P1|Overall Study|Adverse Event|6
2664372|NCT00622388|9200590|P1|Overall Study|Disease Progression|47
2664373|NCT00622336|9200608|P1|Extension Phase|Other|9
2664374|NCT00622336|9200608|P1|Extension Phase|Lost to Follow-up|1
2664375|NCT00622336|9200608|P1|Extension Phase|Withdrawal by Subject|1
2664376|NCT00622336|9200608|P1|Extension Phase|Lack of therapeutic effect|2
2664377|NCT00622336|9200608|P1|Extension Phase|Progressive Disease|6
2664378|NCT00622336|9200608|P1|Extension Phase|Adverse Event|2
2664379|NCT00622336|9200608|P1|Treatment Phase|Lost to Follow-up|2
2664380|NCT00622336|9200608|P1|Treatment Phase|Withdrawal by Subject|13
2664381|NCT00622336|9200608|P1|Treatment Phase|Lack of therapeutic effect|13
2664382|NCT00622336|9200608|P1|Treatment Phase|Death|14
2664383|NCT00622336|9200608|P1|Treatment Phase|Other|40
2664384|NCT00622336|9200608|P1|Treatment Phase|Adverse Event|46
2664385|NCT00622336|9200608|P1|Treatment Phase|Progression of Disease|181
2664386|NCT00622284|9200619|P2|Overall Study|Other reason (not specified)|24
2664387|NCT00622284|9200620|P1|Overall Study|Other reason (not specified)|33
2664388|NCT00622284|9200619|P2|Overall Study|Withdrawal by Subject|24
2664389|NCT00622284|9200620|P1|Overall Study|Withdrawal by Subject|27
2664390|NCT00622284|9200619|P2|Overall Study|Lost to Follow-up|13
2664391|NCT00622284|9200620|P1|Overall Study|Lost to Follow-up|11
2664392|NCT00622284|9200619|P2|Overall Study|Protocol Violation|5
2664393|NCT00622284|9200620|P1|Overall Study|Protocol Violation|12
2664394|NCT00622284|9200619|P2|Overall Study|Adverse Event|90
2664395|NCT00622284|9200620|P1|Overall Study|Adverse Event|61
2664396|NCT00622284|9200619|P2|Overall Study|Lack of Efficacy|15
2664397|NCT00622284|9200620|P1|Overall Study|Lack of Efficacy|45
2664398|NCT00622180|9200682|P2|Overall Study|Lost to Follow-up|2
2664399|NCT00622180|9200683|P1|Overall Study|Lost to Follow-up|1
2664400|NCT00622167|9200689|P1|Overall Study|Did not meet angiographic criteria|20
2664401|NCT00621985|9200693|P1|Dexamethasone Admission|Adverse Event|1
2664402|NCT00621959|9200701|P2|Overall Study|Other|3
2664403|NCT00621959|9200702|P1|Overall Study|Other|1
2664404|NCT00621959|9200701|P2|Overall Study|Withdrawal by Subject|1
2664405|NCT00621959|9200702|P1|Overall Study|Withdrawal by Subject|1
2664406|NCT00621959|9200701|P2|Overall Study|Lost to Follow-up|2
2664407|NCT00621959|9200702|P1|Overall Study|Lost to Follow-up|0
2664408|NCT00621959|9200701|P2|Overall Study|Lack of Efficacy|1
2664409|NCT00621959|9200702|P1|Overall Study|Lack of Efficacy|1
2664410|NCT00621959|9200701|P2|Overall Study|Adverse Event|2
2664411|NCT00621959|9200702|P1|Overall Study|Adverse Event|4
2664412|NCT00621855|9200741|P5|Overall Study|Patients did not receive study drug|2
2664413|NCT00621855|9200742|P4|Overall Study|Patients did not receive study drug|4
2664414|NCT00621855|9200743|P3|Overall Study|Patients did not receive study drug|5
2664415|NCT00621855|9200744|P2|Overall Study|Patients did not receive study drug|3
2664416|NCT00621855|9200745|P1|Overall Study|Patients did not receive study drug|3
2664417|NCT00621855|9200741|P5|Overall Study|Other|4
2664418|NCT00621855|9200742|P4|Overall Study|Other|5
2664419|NCT00621855|9200743|P3|Overall Study|Other|6
2664420|NCT00621855|9200744|P2|Overall Study|Other|7
2664421|NCT00621855|9200745|P1|Overall Study|Other|9
2664422|NCT00621855|9200741|P5|Overall Study|Withdrawal by Subject|9
2664423|NCT00621855|9200742|P4|Overall Study|Withdrawal by Subject|13
2664424|NCT00621855|9200743|P3|Overall Study|Withdrawal by Subject|13
2664425|NCT00621855|9200744|P2|Overall Study|Withdrawal by Subject|11
2664426|NCT00621855|9200745|P1|Overall Study|Withdrawal by Subject|16
2664427|NCT00621855|9200741|P5|Overall Study|Protocol Violation|8
2664428|NCT00621855|9200742|P4|Overall Study|Protocol Violation|7
2664429|NCT00621855|9200743|P3|Overall Study|Protocol Violation|6
2664430|NCT00621855|9200744|P2|Overall Study|Protocol Violation|8
2664431|NCT00621855|9200745|P1|Overall Study|Protocol Violation|16
2664432|NCT00621855|9200741|P5|Overall Study|Lost to Follow-up|1
2664433|NCT00621855|9200742|P4|Overall Study|Lost to Follow-up|4
2664434|NCT00621855|9200743|P3|Overall Study|Lost to Follow-up|3
2664435|NCT00621855|9200744|P2|Overall Study|Lost to Follow-up|1
2664436|NCT00621855|9200745|P1|Overall Study|Lost to Follow-up|0
2664437|NCT00621855|9200741|P5|Overall Study|Adverse Event|31
2664438|NCT00621855|9200742|P4|Overall Study|Adverse Event|34
2664439|NCT00621855|9200743|P3|Overall Study|Adverse Event|48
2664440|NCT00621855|9200744|P2|Overall Study|Adverse Event|31
2664441|NCT00621855|9200745|P1|Overall Study|Adverse Event|32
2664442|NCT00621842|9200787|P1|Overall Study|Lack of Efficacy|2
2664443|NCT00621842|9200787|P1|Overall Study|Protocol Violation|4
2664444|NCT00621842|9200787|P1|Overall Study|Withdrawal by Subject|7
2664445|NCT00621842|9200787|P1|Overall Study|Adverse Event|6
2664446|NCT00621777|9200804|P2|Randomized Phase|Death|1
2664447|NCT00621777|9200805|P1|Randomized Phase|Death|0
2664448|NCT00621777|9200804|P2|Randomized Phase|administrative|3
2664449|NCT00621777|9200805|P1|Randomized Phase|administrative|0
2664450|NCT00621777|9200804|P2|Randomized Phase|Withdrawal by Subject|9
2664451|NCT00621777|9200805|P1|Randomized Phase|Withdrawal by Subject|1
2664452|NCT00621777|9200804|P2|Randomized Phase|Lost to Follow-up|3
2664453|NCT00621777|9200805|P1|Randomized Phase|Lost to Follow-up|3
2664454|NCT00621777|9200804|P2|Randomized Phase|Adverse Event|3
2664455|NCT00621777|9200805|P1|Randomized Phase|Adverse Event|3
2664456|NCT00621777|9200804|P2|Open Phase|Lost to Follow-up|0
2664457|NCT00621777|9200805|P1|Open Phase|Lost to Follow-up|10
2664458|NCT00621777|9200804|P2|Open Phase|administrative|0
2664459|NCT00621777|9200805|P1|Open Phase|administrative|13
2664460|NCT00621777|9200804|P2|Open Phase|Withdrawal by Subject|0
2664461|NCT00621777|9200805|P1|Open Phase|Withdrawal by Subject|17
2664462|NCT00621777|9200804|P2|Open Phase|Did not abstain during open phase|0
2664463|NCT00621777|9200805|P1|Open Phase|Did not abstain during open phase|56
2664464|NCT00621777|9200804|P2|Open Phase|Adverse Event|0
2664465|NCT00621777|9200805|P1|Open Phase|Adverse Event|20
2664466|NCT00621764|9200820|P4|Overall Study|Protocol Violation|1
2664467|NCT00621764|9200821|P3|Overall Study|Protocol Violation|0
2664468|NCT00621764|9200822|P2|Overall Study|Protocol Violation|0
2664469|NCT00621764|9200823|P1|Overall Study|Protocol Violation|0
2664470|NCT00621621|9200869|P2|Overall Study|Subjects were exited at EP study|0
2664471|NCT00621621|9200870|P1|Overall Study|Subjects were exited at EP study|30
2664472|NCT00621582|9200878|P1|Overall Study|issues not identified by investigators|18
2664473|NCT00621582|9200878|P1|Overall Study|Lost to Follow-up|24
2664474|NCT00621582|9200878|P1|Overall Study|Protocol Violation|57
2664475|NCT00621582|9200878|P1|Overall Study|Adverse Event|7
2664476|NCT00621543|9200885|P1|Overall Study|Lost to Follow-up|23
2664477|NCT00621517|9200909|P2|Overall Study|Adverse Event|0
2664478|NCT00621517|9200910|P1|Overall Study|Adverse Event|1
2664479|NCT00621517|9200909|P2|Overall Study|Withdrawal by Subject|4
2664480|NCT00621517|9200910|P1|Overall Study|Withdrawal by Subject|3
2664481|NCT00621517|9200909|P2|Overall Study|Lost to Follow-up|3
2664482|NCT00621517|9200910|P1|Overall Study|Lost to Follow-up|3
2664483|NCT00621504|9200922|P2|Overall Study|Death|6
2664484|NCT00621504|9200923|P1|Overall Study|Death|6
2664485|NCT00621504|9200922|P2|Overall Study|Other|0
2664486|NCT00621504|9200923|P1|Overall Study|Other|1
2664487|NCT00621504|9200922|P2|Overall Study|Lost to Follow-up|10
2664488|NCT00621504|9200923|P1|Overall Study|Lost to Follow-up|8
2664489|NCT00621504|9200922|P2|Overall Study|Withdrew consent|6
2664490|NCT00621504|9200923|P1|Overall Study|Withdrew consent|9
2664491|NCT00621504|9200922|P2|Overall Study|At the request of sponsor/investigator|0
2664492|NCT00621504|9200923|P1|Overall Study|At the request of sponsor/investigator|1
2664493|NCT00621504|9200922|P2|Overall Study|Adverse Event|3
2664494|NCT00621504|9200923|P1|Overall Study|Adverse Event|1
2664495|NCT00621322|9200957|P6|Overall Study|Migrated/moved from study area|2
2664496|NCT00621322|9200958|P5|Overall Study|Migrated/moved from study area|0
2664497|NCT00621322|9200959|P4|Overall Study|Migrated/moved from study area|1
2664498|NCT00621322|9200960|P3|Overall Study|Migrated/moved from study area|1
2664499|NCT00621322|9200961|P2|Overall Study|Migrated/moved from study area|0
2664500|NCT00621322|9200962|P1|Overall Study|Migrated/moved from study area|1
2664501|NCT00621322|9200957|P6|Overall Study|Withdrawal by Subject|2
2664502|NCT00621322|9200958|P5|Overall Study|Withdrawal by Subject|0
2664503|NCT00621322|9200959|P4|Overall Study|Withdrawal by Subject|1
2664504|NCT00621322|9200960|P3|Overall Study|Withdrawal by Subject|0
2664505|NCT00621322|9200961|P2|Overall Study|Withdrawal by Subject|0
2664506|NCT00621322|9200962|P1|Overall Study|Withdrawal by Subject|0
2664507|NCT00621322|9200957|P6|Overall Study|Physician Decision|0
2664508|NCT00621322|9200958|P5|Overall Study|Physician Decision|0
2664509|NCT00621322|9200959|P4|Overall Study|Physician Decision|1
2664510|NCT00621322|9200960|P3|Overall Study|Physician Decision|1
2664511|NCT00621322|9200961|P2|Overall Study|Physician Decision|0
2664512|NCT00621322|9200962|P1|Overall Study|Physician Decision|0
2664513|NCT00621322|9200957|P6|Overall Study|Lost to Follow-up|0
2664514|NCT00621322|9200958|P5|Overall Study|Lost to Follow-up|1
2664515|NCT00621322|9200959|P4|Overall Study|Lost to Follow-up|0
2664516|NCT00621322|9200960|P3|Overall Study|Lost to Follow-up|0
2664517|NCT00621322|9200961|P2|Overall Study|Lost to Follow-up|0
2664518|NCT00621322|9200962|P1|Overall Study|Lost to Follow-up|0
2664519|NCT00621309|9201042|P6|Overall Study|Withdrawal by Subject|1
2664520|NCT00621309|9201043|P5|Overall Study|Withdrawal by Subject|1
2664521|NCT00621309|9201044|P4|Overall Study|Withdrawal by Subject|1
2664522|NCT00621309|9201045|P3|Overall Study|Withdrawal by Subject|1
2664523|NCT00621309|9201046|P2|Overall Study|Withdrawal by Subject|0
2664524|NCT00621309|9201047|P1|Overall Study|Withdrawal by Subject|2
2664525|NCT00621296|9201053|P1|Overall Study|Stopping Criteria|3
2664526|NCT00621296|9201053|P1|Overall Study|Unmatch Criteria|1
2664527|NCT00621296|9201053|P1|Overall Study|Physician Decision|7
2664528|NCT00621296|9201053|P1|Overall Study|Lack of Efficacy|1
2664529|NCT00621296|9201053|P1|Overall Study|Adverse Event|2
2664530|NCT00621257|9201062|P5|Overall Study|Withdrawal by Subject|1
2664531|NCT00621257|9201063|P4|Overall Study|Withdrawal by Subject|1
2664532|NCT00621257|9201064|P3|Overall Study|Withdrawal by Subject|0
2664533|NCT00621257|9201065|P2|Overall Study|Withdrawal by Subject|0
2664534|NCT00621257|9201066|P1|Overall Study|Withdrawal by Subject|0
2664535|NCT00621257|9201062|P5|Overall Study|Physician Decision|1
2664536|NCT00621257|9201063|P4|Overall Study|Physician Decision|1
2664537|NCT00621257|9201064|P3|Overall Study|Physician Decision|0
2664538|NCT00621257|9201065|P2|Overall Study|Physician Decision|2
2664539|NCT00621257|9201066|P1|Overall Study|Physician Decision|0
2664540|NCT00621257|9201062|P5|Overall Study|Adverse Event|0
2664541|NCT00621257|9201063|P4|Overall Study|Adverse Event|0
2664542|NCT00621257|9201064|P3|Overall Study|Adverse Event|1
2664543|NCT00621257|9201065|P2|Overall Study|Adverse Event|1
2664544|NCT00621257|9201066|P1|Overall Study|Adverse Event|0
2664545|NCT00621257|9201062|P5|Overall Study|Lost to Follow-up|7
2664546|NCT00621257|9201063|P4|Overall Study|Lost to Follow-up|4
2664547|NCT00621257|9201064|P3|Overall Study|Lost to Follow-up|2
2664548|NCT00621257|9201065|P2|Overall Study|Lost to Follow-up|0
2664549|NCT00621257|9201066|P1|Overall Study|Lost to Follow-up|4
2664550|NCT00621244|9201082|P4|Overall Study|Administrative problems|2
2664551|NCT00621244|9201083|P3|Overall Study|Administrative problems|0
2664552|NCT00621244|9201084|P2|Overall Study|Administrative problems|1
2664553|NCT00621244|9201085|P1|Overall Study|Administrative problems|5
2664554|NCT00621244|9201082|P4|Overall Study|Adverse Event|2
2664555|NCT00621244|9201083|P3|Overall Study|Adverse Event|9
2664556|NCT00621244|9201084|P2|Overall Study|Adverse Event|7
2664557|NCT00621244|9201085|P1|Overall Study|Adverse Event|27
2664558|NCT00621244|9201082|P4|Overall Study|Death|1
2664559|NCT00621244|9201083|P3|Overall Study|Death|1
2664560|NCT00621244|9201084|P2|Overall Study|Death|3
2664561|NCT00621244|9201085|P1|Overall Study|Death|3
2664562|NCT00621244|9201082|P4|Overall Study|Disease progression|15
2664563|NCT00621244|9201083|P3|Overall Study|Disease progression|20
2664564|NCT00621244|9201084|P2|Overall Study|Disease progression|20
2664565|NCT00621244|9201085|P1|Overall Study|Disease progression|44
2664566|NCT00621244|9201082|P4|Overall Study|Withdrawal by Subject|3
2664567|NCT00621244|9201083|P3|Overall Study|Withdrawal by Subject|3
2664568|NCT00621244|9201084|P2|Overall Study|Withdrawal by Subject|3
2664569|NCT00621244|9201085|P1|Overall Study|Withdrawal by Subject|7
2664570|NCT00621192|9201189|P4|Overall Study|Final Assessments not Completed|1
2664571|NCT00621192|9201190|P3|Overall Study|Final Assessments not Completed|3
2664572|NCT00621192|9201191|P2|Overall Study|Final Assessments not Completed|0
2664573|NCT00621192|9201192|P1|Overall Study|Final Assessments not Completed|0
2664574|NCT00621192|9201189|P4|Overall Study|Death|0
2664575|NCT00621192|9201190|P3|Overall Study|Death|0
2664576|NCT00621192|9201191|P2|Overall Study|Death|5
2664577|NCT00621192|9201192|P1|Overall Study|Death|2
2664578|NCT00621192|9201189|P4|Overall Study|Adverse Event|1
2664579|NCT00621192|9201190|P3|Overall Study|Adverse Event|0
2664580|NCT00621192|9201191|P2|Overall Study|Adverse Event|1
2664581|NCT00621192|9201192|P1|Overall Study|Adverse Event|0
2664582|NCT00621192|9201189|P4|Overall Study|Protocol Violation|1
2664583|NCT00621192|9201190|P3|Overall Study|Protocol Violation|0
2664584|NCT00621192|9201191|P2|Overall Study|Protocol Violation|0
2664585|NCT00621192|9201192|P1|Overall Study|Protocol Violation|1
2664586|NCT00621192|9201189|P4|Overall Study|Physician Decision|0
2664587|NCT00621192|9201190|P3|Overall Study|Physician Decision|0
2664588|NCT00621192|9201191|P2|Overall Study|Physician Decision|3
2664589|NCT00621192|9201192|P1|Overall Study|Physician Decision|1
2664590|NCT00621192|9201189|P4|Overall Study|Withdrawal by Subject|0
2664591|NCT00621192|9201190|P3|Overall Study|Withdrawal by Subject|2
2664592|NCT00621192|9201191|P2|Overall Study|Withdrawal by Subject|0
2664593|NCT00621192|9201192|P1|Overall Study|Withdrawal by Subject|0
2664594|NCT00621153|9201216|P2|Overall Study|Withdrawal by Subject|5
2664595|NCT00621153|9201217|P1|Overall Study|Withdrawal by Subject|4
2664596|NCT00621153|9201216|P2|Overall Study|Lost to Follow-up|1
2664597|NCT00621153|9201217|P1|Overall Study|Lost to Follow-up|5
2664598|NCT00621153|9201216|P2|Overall Study|Adverse Event|2
2664599|NCT00621153|9201217|P1|Overall Study|Adverse Event|3
2664600|NCT00621153|9201216|P2|Overall Study|Safety Reason|7
2664601|NCT00621153|9201217|P1|Overall Study|Safety Reason|8
2664602|NCT00621140|9201225|P2|Overall Study|Other incl. lack of efficacy|5
2664603|NCT00621140|9201226|P1|Overall Study|Other incl. lack of efficacy|6
2664604|NCT00621140|9201225|P2|Overall Study|Withdrawal by Subject|6
2664605|NCT00621140|9201226|P1|Overall Study|Withdrawal by Subject|4
2664606|NCT00621140|9201225|P2|Overall Study|Lost to Follow-up|2
2664607|NCT00621140|9201226|P1|Overall Study|Lost to Follow-up|1
2664608|NCT00621140|9201225|P2|Overall Study|Adverse Event|5
2664609|NCT00621140|9201226|P1|Overall Study|Adverse Event|4
2664610|NCT00621023|9201273|P1|Overall Study|Follow up discontinued|1
2664611|NCT00621023|9201273|P1|Overall Study|Death|5
2664612|NCT00620854|9201290|P6|Washout 1|Withdrawal by Subject|0
2664613|NCT00620854|9201291|P5|Washout 1|Withdrawal by Subject|0
2664614|NCT00620854|9201292|P4|Washout 1|Withdrawal by Subject|1
2664615|NCT00620854|9201293|P3|Washout 1|Withdrawal by Subject|1
2664616|NCT00620854|9201294|P2|Washout 1|Withdrawal by Subject|0
2664617|NCT00620854|9201295|P1|Washout 1|Withdrawal by Subject|0
2664618|NCT00620815|9201326|P3|Overall Study|Protocol Violation|1
2664619|NCT00620815|9201327|P2|Overall Study|Protocol Violation|2
2664620|NCT00620815|9201328|P1|Overall Study|Protocol Violation|1
2664621|NCT00620815|9201326|P3|Overall Study|Inappropriate enrolment|1
2664622|NCT00620815|9201327|P2|Overall Study|Inappropriate enrolment|0
2664623|NCT00620815|9201328|P1|Overall Study|Inappropriate enrolment|0
2664624|NCT00620815|9201326|P3|Overall Study|Lost to Follow-up|3
2664625|NCT00620815|9201327|P2|Overall Study|Lost to Follow-up|6
2664626|NCT00620815|9201328|P1|Overall Study|Lost to Follow-up|1
2664627|NCT00620815|9201326|P3|Overall Study|Withdrawal by Subject|0
2664628|NCT00620815|9201327|P2|Overall Study|Withdrawal by Subject|2
2664629|NCT00620815|9201328|P1|Overall Study|Withdrawal by Subject|1
2664630|NCT00620815|9201326|P3|Overall Study|Adverse Event|2
2664631|NCT00620815|9201327|P2|Overall Study|Adverse Event|1
2664632|NCT00620815|9201328|P1|Overall Study|Adverse Event|1
2664633|NCT00620776|9201368|P2|Overall Study|Withdrawal by Subject|2
2664634|NCT00620776|9201369|P1|Overall Study|Withdrawal by Subject|3
2664635|NCT00620776|9201368|P2|Overall Study|Lost to Follow-up|5
2664636|NCT00620776|9201369|P1|Overall Study|Lost to Follow-up|2
2664637|NCT00620776|9201368|P2|Overall Study|Lack of Efficacy|1
2664638|NCT00620776|9201369|P1|Overall Study|Lack of Efficacy|2
2664639|NCT00620776|9201368|P2|Overall Study|Adverse Event|3
2664640|NCT00620776|9201369|P1|Overall Study|Adverse Event|2
2664641|NCT00620776|9201368|P2|Overall Study|Did not receive treatment|5
2664642|NCT00620776|9201369|P1|Overall Study|Did not receive treatment|3
2664643|NCT00620763|9201397|P2|Period: Second Intervention|Withdrawal by Subject|0
2664644|NCT00620763|9201398|P1|Period: Second Intervention|Withdrawal by Subject|1
2664645|NCT00620763|9201397|P2|Period: First Intervention|Protocol Violation|3
2664646|NCT00620763|9201398|P1|Period: First Intervention|Protocol Violation|0
2664647|NCT00620763|9201397|P2|Period: First Intervention|Withdrawal by Subject|2
2664648|NCT00620763|9201398|P1|Period: First Intervention|Withdrawal by Subject|0
2664649|NCT00620750|9201404|P1|Overall Study|Lost to Follow-up|25
2664650|NCT00620659|9201419|P6|Treatment Period 3|Withdrawal by Subject|0
2664651|NCT00620659|9201420|P5|Treatment Period 3|Withdrawal by Subject|0
2664652|NCT00620659|9201421|P4|Treatment Period 3|Withdrawal by Subject|1
2664653|NCT00620659|9201422|P3|Treatment Period 3|Withdrawal by Subject|0
2664654|NCT00620659|9201423|P2|Treatment Period 3|Withdrawal by Subject|0
2664655|NCT00620659|9201424|P1|Treatment Period 3|Withdrawal by Subject|0
2664656|NCT00620659|9201419|P6|Treatment Period 3|Adverse Event|0
2664657|NCT00620659|9201420|P5|Treatment Period 3|Adverse Event|0
2664658|NCT00620659|9201421|P4|Treatment Period 3|Adverse Event|0
2664659|NCT00620659|9201422|P3|Treatment Period 3|Adverse Event|0
2664660|NCT00620659|9201423|P2|Treatment Period 3|Adverse Event|2
2664661|NCT00620659|9201424|P1|Treatment Period 3|Adverse Event|0
2664662|NCT00620659|9201419|P6|Placebo Washout Period 2|Adverse Event|0
2664663|NCT00620659|9201420|P5|Placebo Washout Period 2|Adverse Event|0
2664664|NCT00620659|9201421|P4|Placebo Washout Period 2|Adverse Event|0
2664665|NCT00620659|9201422|P3|Placebo Washout Period 2|Adverse Event|0
2664666|NCT00620659|9201423|P2|Placebo Washout Period 2|Adverse Event|0
2664667|NCT00620659|9201424|P1|Placebo Washout Period 2|Adverse Event|2
2664668|NCT00620659|9201419|P6|Treatment Period 2|Withdrawal by Subject|0
2664669|NCT00620659|9201420|P5|Treatment Period 2|Withdrawal by Subject|3
2664670|NCT00620659|9201421|P4|Treatment Period 2|Withdrawal by Subject|0
2664671|NCT00620659|9201422|P3|Treatment Period 2|Withdrawal by Subject|1
2664672|NCT00620659|9201423|P2|Treatment Period 2|Withdrawal by Subject|0
2664673|NCT00620659|9201424|P1|Treatment Period 2|Withdrawal by Subject|0
2664674|NCT00620659|9201419|P6|Treatment Period 2|Adverse Event|0
2664675|NCT00620659|9201420|P5|Treatment Period 2|Adverse Event|2
2664676|NCT00620659|9201421|P4|Treatment Period 2|Adverse Event|0
2664677|NCT00620659|9201422|P3|Treatment Period 2|Adverse Event|0
2664678|NCT00620659|9201423|P2|Treatment Period 2|Adverse Event|3
2664679|NCT00620659|9201424|P1|Treatment Period 2|Adverse Event|0
2664680|NCT00620659|9201419|P6|Placebo Washout Period 1|Withdrawal by Subject|0
2664681|NCT00620659|9201420|P5|Placebo Washout Period 1|Withdrawal by Subject|0
2664682|NCT00620659|9201421|P4|Placebo Washout Period 1|Withdrawal by Subject|1
2664683|NCT00620659|9201422|P3|Placebo Washout Period 1|Withdrawal by Subject|0
2664684|NCT00620659|9201423|P2|Placebo Washout Period 1|Withdrawal by Subject|0
2664685|NCT00620659|9201424|P1|Placebo Washout Period 1|Withdrawal by Subject|0
2664686|NCT00620659|9201419|P6|Treatment Period 1|Withdrawal by Subject|0
2664687|NCT00620659|9201420|P5|Treatment Period 1|Withdrawal by Subject|1
2664688|NCT00620659|9201421|P4|Treatment Period 1|Withdrawal by Subject|0
2664689|NCT00620659|9201422|P3|Treatment Period 1|Withdrawal by Subject|1
2664690|NCT00620659|9201423|P2|Treatment Period 1|Withdrawal by Subject|0
2664691|NCT00620659|9201424|P1|Treatment Period 1|Withdrawal by Subject|1
2664692|NCT00620659|9201419|P6|Treatment Period 1|Protocol Violation|0
2664693|NCT00620659|9201420|P5|Treatment Period 1|Protocol Violation|0
2664694|NCT00620659|9201421|P4|Treatment Period 1|Protocol Violation|0
2664695|NCT00620659|9201422|P3|Treatment Period 1|Protocol Violation|0
2664696|NCT00620659|9201423|P2|Treatment Period 1|Protocol Violation|0
2664697|NCT00620659|9201424|P1|Treatment Period 1|Protocol Violation|1
2664698|NCT00620659|9201419|P6|Treatment Period 1|Adverse Event|0
2664699|NCT00620659|9201420|P5|Treatment Period 1|Adverse Event|0
2664700|NCT00620659|9201421|P4|Treatment Period 1|Adverse Event|3
2664701|NCT00620659|9201422|P3|Treatment Period 1|Adverse Event|0
2664702|NCT00620659|9201423|P2|Treatment Period 1|Adverse Event|0
2664703|NCT00620659|9201424|P1|Treatment Period 1|Adverse Event|1
2664704|NCT00620555|9201442|P1|Overall Study|Visit failure against planned|1
2664705|NCT00620555|9201442|P1|Overall Study|Choice of other treatment|1
2664706|NCT00620555|9201442|P1|Overall Study|Withdrawal by Subject|1
2664707|NCT00620555|9201442|P1|Overall Study|Lack of Efficacy|12
2664708|NCT00620555|9201442|P1|Overall Study|Protocol Violation|2
2664709|NCT00620555|9201442|P1|Overall Study|Adverse Event|4
2664710|NCT00620542|9201451|P4|Part B (2 Year Core Study)|IVUS not available|2
2664711|NCT00620542|9201452|P3|Part B (2 Year Core Study)|IVUS not available|3
2664712|NCT00620542|9201453|P2|Part B (2 Year Core Study)|IVUS not available|0
2664713|NCT00620542|9201454|P1|Part B (2 Year Core Study)|IVUS not available|0
2664714|NCT00620542|9201451|P4|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
2664715|NCT00620542|9201452|P3|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
2664716|NCT00620542|9201453|P2|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
2664799|NCT00620282|9201577|P3|Overall Study|Adverse Event|0
2664717|NCT00620542|9201454|P1|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
2664718|NCT00620542|9201451|P4|Part B (2 Year Core Study)|Safety reasons|3
2664719|NCT00620542|9201452|P3|Part B (2 Year Core Study)|Safety reasons|2
2664720|NCT00620542|9201453|P2|Part B (2 Year Core Study)|Safety reasons|0
2664721|NCT00620542|9201454|P1|Part B (2 Year Core Study)|Safety reasons|0
2664722|NCT00620542|9201451|P4|Part B (2 Year Core Study)|Protocol Violation|16
2664723|NCT00620542|9201452|P3|Part B (2 Year Core Study)|Protocol Violation|13
2664724|NCT00620542|9201453|P2|Part B (2 Year Core Study)|Protocol Violation|0
2664725|NCT00620542|9201454|P1|Part B (2 Year Core Study)|Protocol Violation|0
2664726|NCT00620542|9201451|P4|Part B (2 Year Core Study)|Lost to Follow-up|9
2664727|NCT00620542|9201452|P3|Part B (2 Year Core Study)|Lost to Follow-up|20
2664728|NCT00620542|9201453|P2|Part B (2 Year Core Study)|Lost to Follow-up|0
2664729|NCT00620542|9201454|P1|Part B (2 Year Core Study)|Lost to Follow-up|0
2664730|NCT00620542|9201451|P4|Part B (2 Year Core Study)|Withdrawal by Subject|54
2664731|NCT00620542|9201452|P3|Part B (2 Year Core Study)|Withdrawal by Subject|55
2664732|NCT00620542|9201453|P2|Part B (2 Year Core Study)|Withdrawal by Subject|0
2664733|NCT00620542|9201454|P1|Part B (2 Year Core Study)|Withdrawal by Subject|0
2664734|NCT00620542|9201451|P4|Part B (2 Year Core Study)|Protocol Violation|5
2664735|NCT00620542|9201452|P3|Part B (2 Year Core Study)|Protocol Violation|3
2664736|NCT00620542|9201453|P2|Part B (2 Year Core Study)|Protocol Violation|0
2664737|NCT00620542|9201454|P1|Part B (2 Year Core Study)|Protocol Violation|0
2664738|NCT00620542|9201451|P4|Part B (2 Year Core Study)|Adverse Event|49
2664739|NCT00620542|9201452|P3|Part B (2 Year Core Study)|Adverse Event|46
2664740|NCT00620542|9201453|P2|Part B (2 Year Core Study)|Adverse Event|0
2664741|NCT00620542|9201454|P1|Part B (2 Year Core Study)|Adverse Event|0
2664742|NCT00620542|9201451|P4|Part A (Run-in - 2 Weeks)|IVUS not available|0
2664743|NCT00620542|9201452|P3|Part A (Run-in - 2 Weeks)|IVUS not available|0
2664744|NCT00620542|9201453|P2|Part A (Run-in - 2 Weeks)|IVUS not available|4
2664745|NCT00620542|9201454|P1|Part A (Run-in - 2 Weeks)|IVUS not available|4
2664746|NCT00620542|9201451|P4|Part A (Run-in - 2 Weeks)|Safety reasons|0
2664747|NCT00620542|9201452|P3|Part A (Run-in - 2 Weeks)|Safety reasons|0
2664748|NCT00620542|9201453|P2|Part A (Run-in - 2 Weeks)|Safety reasons|1
2664749|NCT00620542|9201454|P1|Part A (Run-in - 2 Weeks)|Safety reasons|0
2664750|NCT00620542|9201451|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
2664751|NCT00620542|9201452|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
2664752|NCT00620542|9201453|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|1
2664753|NCT00620542|9201454|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|0
2664754|NCT00620542|9201451|P4|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
2664755|NCT00620542|9201452|P3|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
2664756|NCT00620542|9201453|P2|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6
2664757|NCT00620542|9201454|P1|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7
2664758|NCT00620542|9201451|P4|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
2664759|NCT00620542|9201452|P3|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
2664760|NCT00620542|9201453|P2|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40
2664761|NCT00620542|9201454|P1|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43
2664762|NCT00620542|9201451|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
2664763|NCT00620542|9201452|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
2664764|NCT00620542|9201453|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|409
2664765|NCT00620542|9201454|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|406
2664766|NCT00620542|9201451|P4|Part A (Run-in - 2 Weeks)|Adverse Event|0
2664767|NCT00620542|9201452|P3|Part A (Run-in - 2 Weeks)|Adverse Event|0
2664768|NCT00620542|9201453|P2|Part A (Run-in - 2 Weeks)|Adverse Event|15
2664769|NCT00620542|9201454|P1|Part A (Run-in - 2 Weeks)|Adverse Event|12
2664770|NCT00620464|9201519|P2|Overall Study|Used prohibited medication|0
2664771|NCT00620464|9201520|P1|Overall Study|Used prohibited medication|1
2664772|NCT00620464|9201519|P2|Overall Study|Personal|2
2664773|NCT00620464|9201520|P1|Overall Study|Personal|2
2664774|NCT00620464|9201519|P2|Overall Study|Planning Pregnancy|4
2664775|NCT00620464|9201520|P1|Overall Study|Planning Pregnancy|1
2664776|NCT00620464|9201519|P2|Overall Study|Lost to Follow-up|1
2664777|NCT00620464|9201520|P1|Overall Study|Lost to Follow-up|1
2664778|NCT00620464|9201519|P2|Overall Study|Adverse Event|17
2664779|NCT00620464|9201520|P1|Overall Study|Adverse Event|15
2664780|NCT00620373|9201539|P1|Overall Study|Unverified cancer status|33
2664781|NCT00620321|9201557|P2|Overall Study|Withdrawal by Subject|1
2664782|NCT00620321|9201558|P1|Overall Study|Withdrawal by Subject|1
2664783|NCT00620321|9201557|P2|Overall Study|Sponsor Decision|1
2664784|NCT00620321|9201558|P1|Overall Study|Sponsor Decision|0
2664785|NCT00620321|9201557|P2|Overall Study|Progressive Disease|5
2664786|NCT00620321|9201558|P1|Overall Study|Progressive Disease|5
2664787|NCT00620321|9201557|P2|Overall Study|Physician Decision|7
2664788|NCT00620321|9201558|P1|Overall Study|Physician Decision|0
2664789|NCT00620321|9201557|P2|Overall Study|Death|1
2664790|NCT00620321|9201558|P1|Overall Study|Death|1
2664791|NCT00620321|9201557|P2|Overall Study|Adverse Event|1
2664792|NCT00620321|9201558|P1|Overall Study|Adverse Event|1
2664793|NCT00620282|9201577|P3|Overall Study|Withdrawal by Subject|0
2664794|NCT00620282|9201578|P2|Overall Study|Withdrawal by Subject|1
2664795|NCT00620282|9201579|P1|Overall Study|Withdrawal by Subject|0
2664796|NCT00620282|9201577|P3|Overall Study|Arterial line unable to be placed|1
2664797|NCT00620282|9201578|P2|Overall Study|Arterial line unable to be placed|0
2664798|NCT00620282|9201579|P1|Overall Study|Arterial line unable to be placed|0
2664800|NCT00620282|9201578|P2|Overall Study|Adverse Event|1
2664801|NCT00620282|9201579|P1|Overall Study|Adverse Event|0
2664802|NCT00620113|9201643|P4|Overall Study|Withdrawal by Subject|5
2664803|NCT00620113|9201644|P3|Overall Study|Withdrawal by Subject|3
2664804|NCT00620113|9201645|P2|Overall Study|Withdrawal by Subject|1
2664805|NCT00620113|9201646|P1|Overall Study|Withdrawal by Subject|5
2664806|NCT00620113|9201643|P4|Overall Study|Protocol Violation|0
2664807|NCT00620113|9201644|P3|Overall Study|Protocol Violation|0
2664808|NCT00620113|9201645|P2|Overall Study|Protocol Violation|1
2664809|NCT00620113|9201646|P1|Overall Study|Protocol Violation|2
2664810|NCT00620113|9201643|P4|Overall Study|Physician Decision|2
2664811|NCT00620113|9201644|P3|Overall Study|Physician Decision|0
2664812|NCT00620113|9201645|P2|Overall Study|Physician Decision|0
2664813|NCT00620113|9201646|P1|Overall Study|Physician Decision|1
2664814|NCT00620113|9201643|P4|Overall Study|Lack of Efficacy|2
2664815|NCT00620113|9201644|P3|Overall Study|Lack of Efficacy|0
2664816|NCT00620113|9201645|P2|Overall Study|Lack of Efficacy|3
2664817|NCT00620113|9201646|P1|Overall Study|Lack of Efficacy|2
2664818|NCT00620113|9201643|P4|Overall Study|Adverse Event|1
2664819|NCT00620113|9201644|P3|Overall Study|Adverse Event|2
2664820|NCT00620113|9201645|P2|Overall Study|Adverse Event|2
2664821|NCT00620113|9201646|P1|Overall Study|Adverse Event|3
2664822|NCT00620074|9201696|P1|Overall Study|Adverse Event|1
2664823|NCT00620035|9201719|P1|Overall Study|Other Reason|38
2664824|NCT00620035|9201719|P1|Overall Study|Withdrawal of Informed Consent|1
2664825|NCT00620035|9201719|P1|Overall Study|Adverse Event|106
2664826|NCT00620022|9201729|P2|Treatment Period 2|Adverse Event|2
2664827|NCT00620022|9201730|P1|Treatment Period 2|Adverse Event|2
2664828|NCT00620022|9201729|P2|Treatment Period 1|Subject withdrew consent|0
2664829|NCT00620022|9201730|P1|Treatment Period 1|Subject withdrew consent|1
2664830|NCT00620022|9201729|P2|Treatment Period 1|Adverse Event|6
2664831|NCT00620022|9201730|P1|Treatment Period 1|Adverse Event|4
2664832|NCT00619983|9201742|P4|Test Drug Alone|Failure of daily diary device|2
2664833|NCT00619983|9201743|P3|Test Drug Alone|Failure of daily diary device|2
2664834|NCT00619983|9201744|P2|Test Drug Alone|Failure of daily diary device|1
2664835|NCT00619983|9201745|P1|Test Drug Alone|Failure of daily diary device|1
2664836|NCT00619983|9201742|P4|Test Drug Alone|Withdrawal by Subject|1
2664837|NCT00619983|9201743|P3|Test Drug Alone|Withdrawal by Subject|0
2664838|NCT00619983|9201744|P2|Test Drug Alone|Withdrawal by Subject|0
2664839|NCT00619983|9201745|P1|Test Drug Alone|Withdrawal by Subject|1
2664840|NCT00619957|9201772|P2|Month 48 Open-Label|Withdrawal by Subject|9
2664841|NCT00619957|9201773|P1|Month 48 Open-Label|Withdrawal by Subject|6
2664842|NCT00619957|9201772|P2|Month 48 Open-Label|Lost to Follow-up|4
2664843|NCT00619957|9201773|P1|Month 48 Open-Label|Lost to Follow-up|2
2664844|NCT00619957|9201772|P2|Month 48 Open-Label|Adverse Event|4
2664845|NCT00619957|9201773|P1|Month 48 Open-Label|Adverse Event|4
2664846|NCT00619957|9201772|P2|Month 24 Double-Blind|Did not take any study medication|1
2664847|NCT00619957|9201773|P1|Month 24 Double-Blind|Did not take any study medication|0
2664848|NCT00619957|9201772|P2|Month 24 Double-Blind|Lost to Follow-up|0
2664849|NCT00619957|9201773|P1|Month 24 Double-Blind|Lost to Follow-up|1
2664850|NCT00619957|9201772|P2|Month 24 Double-Blind|Withdrawal by Subject|9
2664851|NCT00619957|9201773|P1|Month 24 Double-Blind|Withdrawal by Subject|7
2664852|NCT00619957|9201772|P2|Month 24 Double-Blind|Protocol Violation|0
2664853|NCT00619957|9201773|P1|Month 24 Double-Blind|Protocol Violation|1
2664854|NCT00619957|9201772|P2|Month 24 Double-Blind|Adverse Event|7
2664855|NCT00619957|9201773|P1|Month 24 Double-Blind|Adverse Event|9
2664856|NCT00619918|9201855|P2|Overall Study|Left before receiving first dose|8
2664857|NCT00619918|9201856|P1|Overall Study|Left before receiving first dose|5
2664858|NCT00619918|9201855|P2|Overall Study|Transfer to outside facility|3
2664859|NCT00619918|9201856|P1|Overall Study|Transfer to outside facility|3
2664860|NCT00619918|9201855|P2|Overall Study|Physician Decision|8
2664861|NCT00619918|9201856|P1|Overall Study|Physician Decision|8
2664862|NCT00619918|9201855|P2|Overall Study|Withdrawal by Subject|3
2664863|NCT00619918|9201856|P1|Overall Study|Withdrawal by Subject|4
2664864|NCT00619892|9201866|P2|Overall Study|Intercurrent illness|1
2664865|NCT00619892|9201867|P1|Overall Study|Intercurrent illness|0
2664866|NCT00619892|9201866|P2|Overall Study|Lost to Follow-up|1
2664867|NCT00619892|9201867|P1|Overall Study|Lost to Follow-up|0
2664868|NCT00619892|9201866|P2|Overall Study|Adverse Event|0
2664869|NCT00619892|9201867|P1|Overall Study|Adverse Event|3
2664870|NCT00619866|9201878|P5|Weeks 13 - 24|Lost to Follow-up|0
2664871|NCT00619866|9201879|P4|Weeks 13 - 24|Lost to Follow-up|0
2664872|NCT00619866|9201880|P3|Weeks 13 - 24|Lost to Follow-up|0
2664873|NCT00619866|9201881|P2|Weeks 13 - 24|Lost to Follow-up|3
2664874|NCT00619866|9201882|P1|Weeks 13 - 24|Lost to Follow-up|0
2664875|NCT00619866|9201878|P5|Weeks 13 - 24|Non-compliance|0
2664876|NCT00619866|9201879|P4|Weeks 13 - 24|Non-compliance|0
2664877|NCT00619866|9201880|P3|Weeks 13 - 24|Non-compliance|1
2664878|NCT00619866|9201881|P2|Weeks 13 - 24|Non-compliance|1
2664879|NCT00619866|9201882|P1|Weeks 13 - 24|Non-compliance|0
2664880|NCT00619866|9201878|P5|Weeks 13 - 24|Withdrawal by Subject|2
2664881|NCT00619866|9201879|P4|Weeks 13 - 24|Withdrawal by Subject|2
2664882|NCT00619866|9201880|P3|Weeks 13 - 24|Withdrawal by Subject|2
2664883|NCT00619866|9201881|P2|Weeks 13 - 24|Withdrawal by Subject|3
2664884|NCT00619866|9201882|P1|Weeks 13 - 24|Withdrawal by Subject|0
2664885|NCT00619866|9201878|P5|Weeks 13 - 24|Protocol Deviation|0
2664886|NCT00619866|9201879|P4|Weeks 13 - 24|Protocol Deviation|1
2664887|NCT00619866|9201880|P3|Weeks 13 - 24|Protocol Deviation|0
2664888|NCT00619866|9201881|P2|Weeks 13 - 24|Protocol Deviation|0
2664889|NCT00619866|9201882|P1|Weeks 13 - 24|Protocol Deviation|0
2664890|NCT00619866|9201878|P5|Weeks 13 - 24|Adverse Event|0
2664891|NCT00619866|9201879|P4|Weeks 13 - 24|Adverse Event|1
2664892|NCT00619866|9201880|P3|Weeks 13 - 24|Adverse Event|2
2664893|NCT00619866|9201881|P2|Weeks 13 - 24|Adverse Event|0
2664894|NCT00619866|9201882|P1|Weeks 13 - 24|Adverse Event|0
2664895|NCT00619866|9201878|P5|Weeks 1 - 12|Sponsor Decision|0
2664896|NCT00619866|9201879|P4|Weeks 1 - 12|Sponsor Decision|0
2664897|NCT00619866|9201880|P3|Weeks 1 - 12|Sponsor Decision|0
2664898|NCT00619866|9201881|P2|Weeks 1 - 12|Sponsor Decision|1
2664899|NCT00619866|9201882|P1|Weeks 1 - 12|Sponsor Decision|0
2664900|NCT00619866|9201878|P5|Weeks 1 - 12|Lost to Follow-up|0
2664901|NCT00619866|9201879|P4|Weeks 1 - 12|Lost to Follow-up|0
2664902|NCT00619866|9201880|P3|Weeks 1 - 12|Lost to Follow-up|2
2664903|NCT00619866|9201881|P2|Weeks 1 - 12|Lost to Follow-up|0
2664904|NCT00619866|9201882|P1|Weeks 1 - 12|Lost to Follow-up|4
2664905|NCT00619866|9201878|P5|Weeks 1 - 12|Lack of Efficacy|0
2664906|NCT00619866|9201879|P4|Weeks 1 - 12|Lack of Efficacy|0
2664907|NCT00619866|9201880|P3|Weeks 1 - 12|Lack of Efficacy|1
2664908|NCT00619866|9201881|P2|Weeks 1 - 12|Lack of Efficacy|2
2664909|NCT00619866|9201882|P1|Weeks 1 - 12|Lack of Efficacy|3
2664910|NCT00619866|9201878|P5|Weeks 1 - 12|Withdrawal by Subject|0
2664911|NCT00619866|9201879|P4|Weeks 1 - 12|Withdrawal by Subject|0
2664912|NCT00619866|9201880|P3|Weeks 1 - 12|Withdrawal by Subject|4
2664913|NCT00619866|9201881|P2|Weeks 1 - 12|Withdrawal by Subject|2
2664914|NCT00619866|9201882|P1|Weeks 1 - 12|Withdrawal by Subject|7
2664915|NCT00619866|9201878|P5|Weeks 1 - 12|Non-compliance|0
2664916|NCT00619866|9201879|P4|Weeks 1 - 12|Non-compliance|0
2664917|NCT00619866|9201880|P3|Weeks 1 - 12|Non-compliance|1
2664918|NCT00619866|9201881|P2|Weeks 1 - 12|Non-compliance|0
2664919|NCT00619866|9201882|P1|Weeks 1 - 12|Non-compliance|0
2664920|NCT00619866|9201878|P5|Weeks 1 - 12|Adverse Event|0
2664921|NCT00619866|9201879|P4|Weeks 1 - 12|Adverse Event|0
2664922|NCT00619866|9201880|P3|Weeks 1 - 12|Adverse Event|2
2664923|NCT00619866|9201881|P2|Weeks 1 - 12|Adverse Event|1
2664924|NCT00619866|9201882|P1|Weeks 1 - 12|Adverse Event|0
2664925|NCT00619827|9201969|P2|Overall Study|Withdrawal by Subject|2
2664926|NCT00619827|9201970|P1|Overall Study|Withdrawal by Subject|2
2664927|NCT00619827|9201969|P2|Overall Study|Adverse Event|2
2664928|NCT00619827|9201970|P1|Overall Study|Adverse Event|1
2664929|NCT00619801|9201978|P2|Overall Study|Loss of efficacy|1
2664930|NCT00619801|9201979|P1|Overall Study|Loss of efficacy|0
2664931|NCT00619801|9201978|P2|Overall Study|Withdrawal by Subject|1
2664932|NCT00619801|9201979|P1|Overall Study|Withdrawal by Subject|1
2664933|NCT00619801|9201978|P2|Overall Study|Lack of Efficacy|1
2664934|NCT00619801|9201979|P1|Overall Study|Lack of Efficacy|0
2664935|NCT00619645|9202036|P1|Overall Study|Adverse Event|1
2664936|NCT00619619|9202050|P8|Overall Study|Adverse Event|2
2664937|NCT00619619|9202051|P7|Overall Study|Adverse Event|0
2664938|NCT00619619|9202052|P6|Overall Study|Adverse Event|0
2664939|NCT00619619|9202053|P5|Overall Study|Adverse Event|2
2664940|NCT00619619|9202054|P4|Overall Study|Adverse Event|0
2664941|NCT00619619|9202055|P3|Overall Study|Adverse Event|0
2664942|NCT00619619|9202056|P2|Overall Study|Adverse Event|0
2664943|NCT00619619|9202057|P1|Overall Study|Adverse Event|0
2664944|NCT00619619|9202050|P8|Overall Study|Protocol Violation|1
2664945|NCT00619619|9202051|P7|Overall Study|Protocol Violation|1
2664946|NCT00619619|9202052|P6|Overall Study|Protocol Violation|0
2664947|NCT00619619|9202053|P5|Overall Study|Protocol Violation|0
2664948|NCT00619619|9202054|P4|Overall Study|Protocol Violation|1
2664949|NCT00619619|9202055|P3|Overall Study|Protocol Violation|0
2664950|NCT00619619|9202056|P2|Overall Study|Protocol Violation|0
2664951|NCT00619619|9202057|P1|Overall Study|Protocol Violation|0
2664952|NCT00619619|9202050|P8|Overall Study|Physician Decision|0
2664953|NCT00619619|9202051|P7|Overall Study|Physician Decision|0
2664954|NCT00619619|9202052|P6|Overall Study|Physician Decision|0
2664955|NCT00619619|9202053|P5|Overall Study|Physician Decision|0
2664956|NCT00619619|9202054|P4|Overall Study|Physician Decision|0
2664957|NCT00619619|9202055|P3|Overall Study|Physician Decision|1
2664958|NCT00619619|9202056|P2|Overall Study|Physician Decision|0
2664959|NCT00619619|9202057|P1|Overall Study|Physician Decision|0
2664960|NCT00619515|9202142|P1|Overall Study|Study Termination by IRB|73
2664961|NCT00619502|9202156|P2|Overall Study|Lost to Follow-up|10
2664962|NCT00619502|9202157|P1|Overall Study|Lost to Follow-up|8
2664963|NCT00619489|9202169|P2|Overall Study|Rolled over to Study C13008 (NCT00790933|15
2664964|NCT00619489|9202170|P1|Overall Study|Rolled over to Study C13008 (NCT00790933|22
2664965|NCT00619489|9202169|P2|Overall Study|Lack of Efficacy|11
2664966|NCT00619489|9202170|P1|Overall Study|Lack of Efficacy|0
2664967|NCT00619489|9202169|P2|Overall Study|Withdrawal by Subject|1
2664968|NCT00619489|9202170|P1|Overall Study|Withdrawal by Subject|1
2664969|NCT00619489|9202169|P2|Overall Study|Adverse Event|7
2664970|NCT00619489|9202170|P1|Overall Study|Adverse Event|0
2664971|NCT00619476|9202192|P4|Overall Study|Withdrawal by Subject|4
2664972|NCT00619476|9202193|P3|Overall Study|Withdrawal by Subject|5
2664973|NCT00619476|9202194|P2|Overall Study|Withdrawal by Subject|7
2664974|NCT00619476|9202195|P1|Overall Study|Withdrawal by Subject|5
2664975|NCT00619476|9202192|P4|Overall Study|Investigator Discretion|0
2664976|NCT00619476|9202193|P3|Overall Study|Investigator Discretion|2
2664977|NCT00619476|9202194|P2|Overall Study|Investigator Discretion|2
2664978|NCT00619476|9202195|P1|Overall Study|Investigator Discretion|2
2664979|NCT00619476|9202192|P4|Overall Study|Lost to Follow-up|1
2664980|NCT00619476|9202193|P3|Overall Study|Lost to Follow-up|0
2664981|NCT00619476|9202194|P2|Overall Study|Lost to Follow-up|2
2664982|NCT00619476|9202195|P1|Overall Study|Lost to Follow-up|1
2664983|NCT00619476|9202192|P4|Overall Study|Protocol Violation|9
2664984|NCT00619476|9202193|P3|Overall Study|Protocol Violation|4
2664985|NCT00619476|9202194|P2|Overall Study|Protocol Violation|4
2664986|NCT00619476|9202195|P1|Overall Study|Protocol Violation|5
2664987|NCT00619476|9202192|P4|Overall Study|Lack of Efficacy|4
2664988|NCT00619476|9202193|P3|Overall Study|Lack of Efficacy|1
2664989|NCT00619476|9202194|P2|Overall Study|Lack of Efficacy|1
2664990|NCT00619476|9202195|P1|Overall Study|Lack of Efficacy|6
2664991|NCT00619476|9202192|P4|Overall Study|Adverse Event|16
2664992|NCT00619476|9202193|P3|Overall Study|Adverse Event|12
2664993|NCT00619476|9202194|P2|Overall Study|Adverse Event|6
2664994|NCT00619476|9202195|P1|Overall Study|Adverse Event|12
2664995|NCT00619385|9202280|P3|Overall Study|Other|1
2664996|NCT00619385|9202281|P2|Overall Study|Other|2
2664997|NCT00619385|9202282|P1|Overall Study|Other|1
2664998|NCT00619385|9202280|P3|Overall Study|Adverse Event|3
2664999|NCT00619385|9202281|P2|Overall Study|Adverse Event|0
2665000|NCT00619385|9202282|P1|Overall Study|Adverse Event|0
2665001|NCT00619359|9202297|P2|Overall Study|Progressive Disease|1
2665002|NCT00619359|9202298|P1|Overall Study|Progressive Disease|3
2665003|NCT00619359|9202297|P2|Overall Study|Withdrawal by Subject|20
2665004|NCT00619359|9202298|P1|Overall Study|Withdrawal by Subject|19
2665005|NCT00619359|9202297|P2|Overall Study|Protocol Violation|1
2665006|NCT00619359|9202298|P1|Overall Study|Protocol Violation|1
2665007|NCT00619359|9202297|P2|Overall Study|Physician Decision|7
2665008|NCT00619359|9202298|P1|Overall Study|Physician Decision|0
2665009|NCT00619359|9202297|P2|Overall Study|Lost to Follow-up|16
2665010|NCT00619359|9202298|P1|Overall Study|Lost to Follow-up|12
2665011|NCT00619359|9202297|P2|Overall Study|Adverse Event|36
2665012|NCT00619359|9202298|P1|Overall Study|Adverse Event|32
2665013|NCT00619307|9202310|P2|Overall Study|MS attack plus steroids|1
2665014|NCT00619307|9202311|P1|Overall Study|MS attack plus steroids|0
2665015|NCT00619307|9202310|P2|Overall Study|Severe migraine|1
2665016|NCT00619307|9202311|P1|Overall Study|Severe migraine|0
2665017|NCT00619307|9202310|P2|Overall Study|Withdrew consent|0
2665018|NCT00619307|9202311|P1|Overall Study|Withdrew consent|1
2665019|NCT00619307|9202310|P2|Overall Study|Protocol Violation|0
2665020|NCT00619307|9202311|P1|Overall Study|Protocol Violation|3
2665021|NCT00619307|9202310|P2|Overall Study|Lost to Follow-up|1
2665022|NCT00619307|9202311|P1|Overall Study|Lost to Follow-up|0
2665023|NCT00619307|9202310|P2|Overall Study|Adverse Event|1
2665024|NCT00619307|9202311|P1|Overall Study|Adverse Event|0
2665025|NCT00619229|9202348|P2|Overall Study|Investigator planned Cataract Operation|0
2665026|NCT00619229|9202349|P1|Overall Study|Investigator planned Cataract Operation|1
2665027|NCT00619229|9202348|P2|Overall Study|Termination of the Study by the Sponsor|1
2665028|NCT00619229|9202349|P1|Overall Study|Termination of the Study by the Sponsor|1
2665029|NCT00619229|9202348|P2|Overall Study|Lost to Follow-up|0
2665030|NCT00619229|9202349|P1|Overall Study|Lost to Follow-up|1
2665031|NCT00619229|9202348|P2|Overall Study|Withdrawal by Subject|1
2665032|NCT00619229|9202349|P1|Overall Study|Withdrawal by Subject|1
2665033|NCT00619177|9202388|P1|Overall Study|Not specified reasons|6
2665034|NCT00619177|9202388|P1|Overall Study|Missing termination information|481
2665035|NCT00619177|9202388|P1|Overall Study|Lack of Efficacy|1
2665036|NCT00619177|9202388|P1|Overall Study|Lost to Follow-up|2
2665037|NCT00619177|9202388|P1|Overall Study|Adverse Event|18
2665038|NCT00619151|9202398|P2|Overall Study|Study terminated prior to followup|0
2665039|NCT00619151|9202399|P1|Overall Study|Study terminated prior to followup|1
2665040|NCT00619112|9202409|P2|Overall Study|Adverse Event|2
2665041|NCT00619112|9202410|P1|Overall Study|Adverse Event|1
2665042|NCT00619099|9202431|P2|Overall Study|Physician Decision|6
2665043|NCT00619099|9202432|P1|Overall Study|Physician Decision|9
2665044|NCT00619099|9202431|P2|Overall Study|Withdrawal by Subject|2
2665045|NCT00619099|9202432|P1|Overall Study|Withdrawal by Subject|10
2665046|NCT00619099|9202431|P2|Overall Study|Emergence of Clinically Significant Lab|2
2665047|NCT00619099|9202432|P1|Overall Study|Emergence of Clinically Significant Lab|1
2665048|NCT00619099|9202431|P2|Overall Study|Adverse Event|3
2665049|NCT00619099|9202432|P1|Overall Study|Adverse Event|4
2665050|NCT00619099|9202431|P2|Overall Study|Allogeneic Bone Marrow Transplantation|1
2665051|NCT00619099|9202432|P1|Overall Study|Allogeneic Bone Marrow Transplantation|2
2665052|NCT00619099|9202431|P2|Overall Study|Progressive Disease|5
2665053|NCT00619099|9202432|P1|Overall Study|Progressive Disease|7
2665054|NCT00618995|9202454|P4|Period 4|Adverse Event|0
2665055|NCT00618995|9202455|P3|Period 4|Adverse Event|0
2665056|NCT00618995|9202456|P2|Period 4|Adverse Event|0
2665057|NCT00618995|9202457|P1|Period 4|Adverse Event|1
2665058|NCT00618995|9202454|P4|Period 2|Protocol Violation|0
2665059|NCT00618995|9202455|P3|Period 2|Protocol Violation|1
2665060|NCT00618995|9202456|P2|Period 2|Protocol Violation|0
2665061|NCT00618995|9202457|P1|Period 2|Protocol Violation|0
2665062|NCT00618995|9202454|P4|Period 1|Protocol Violation|0
2665063|NCT00618995|9202455|P3|Period 1|Protocol Violation|1
2665064|NCT00618995|9202456|P2|Period 1|Protocol Violation|1
2665065|NCT00618995|9202457|P1|Period 1|Protocol Violation|0
2665066|NCT00618995|9202454|P4|Period 1|Adverse Event|0
2665067|NCT00618995|9202455|P3|Period 1|Adverse Event|1
2665068|NCT00618995|9202456|P2|Period 1|Adverse Event|0
2665069|NCT00618995|9202457|P1|Period 1|Adverse Event|0
2665070|NCT00618982|9202471|P1|Overall Study|ongoing, still treated with study med.|25
2665071|NCT00618982|9202471|P1|Overall Study|Protocol Violation|1
2665072|NCT00618982|9202471|P1|Overall Study|Withdrawal by Subject|1
2665073|NCT00618982|9202471|P1|Overall Study|Adverse Event|23
2665074|NCT00618956|9202494|P2|Overall Study|did not meet criteria, non-compliance|1
2665075|NCT00618956|9202495|P1|Overall Study|did not meet criteria, non-compliance|2
2665076|NCT00618956|9202494|P2|Overall Study|Protocol Violation|2
2665077|NCT00618956|9202495|P1|Overall Study|Protocol Violation|2
2665078|NCT00618956|9202494|P2|Overall Study|Lost to Follow-up|5
2665079|NCT00618956|9202495|P1|Overall Study|Lost to Follow-up|4
2665080|NCT00618956|9202494|P2|Overall Study|Withdrawal by Subject|7
2665081|NCT00618956|9202495|P1|Overall Study|Withdrawal by Subject|5
2665082|NCT00618956|9202494|P2|Overall Study|Lack of Efficacy|1
2665083|NCT00618956|9202495|P1|Overall Study|Lack of Efficacy|2
2665084|NCT00618956|9202494|P2|Overall Study|Adverse Event|34
2665085|NCT00618956|9202495|P1|Overall Study|Adverse Event|10
2665086|NCT00618826|9202520|P1|Overall Study|Adverse Event|1
2665087|NCT00618813|9202525|P1|Overall Study|Withdrawal by Subject|1
2665088|NCT00618813|9202525|P1|Overall Study|Physician Decision|2
2665089|NCT00618813|9202525|P1|Overall Study|Lack of Efficacy|1
2665090|NCT00618787|9202535|P2|Overall Study|Lost to Follow-up|0
2665091|NCT00618787|9202536|P1|Overall Study|Lost to Follow-up|1
2665092|NCT00618787|9202535|P2|Overall Study|Withdrawal by Subject|1
2665093|NCT00618787|9202536|P1|Overall Study|Withdrawal by Subject|2
2665094|NCT00618787|9202535|P2|Overall Study|Adverse Event|1
2665095|NCT00618787|9202536|P1|Overall Study|Adverse Event|0
2665096|NCT00618774|9202544|P2|Overall Study|Withdrawal by Subject|0
2665097|NCT00618774|9202545|P1|Overall Study|Withdrawal by Subject|1
2665098|NCT00618774|9202544|P2|Overall Study|Adverse Event|3
2665099|NCT00618774|9202545|P1|Overall Study|Adverse Event|5
2665100|NCT00618748|9202578|P3|Overall Study|Withdrawal by Subject|5
2665101|NCT00618748|9202579|P2|Overall Study|Withdrawal by Subject|1
2665102|NCT00618748|9202580|P1|Overall Study|Withdrawal by Subject|4
2665103|NCT00618748|9202578|P3|Overall Study|Physician Decision|1
2665104|NCT00618748|9202579|P2|Overall Study|Physician Decision|1
2665105|NCT00618748|9202580|P1|Overall Study|Physician Decision|3
2665106|NCT00618748|9202578|P3|Overall Study|Adverse Event|8
2665107|NCT00618748|9202579|P2|Overall Study|Adverse Event|3
2665108|NCT00618748|9202580|P1|Overall Study|Adverse Event|4
2665109|NCT00618722|9202625|P4|Overall Study|Miscellaneous Reasons|1
2665110|NCT00618722|9202626|P3|Overall Study|Miscellaneous Reasons|1
2665111|NCT00618722|9202627|P2|Overall Study|Miscellaneous Reasons|0
2665112|NCT00618722|9202628|P1|Overall Study|Miscellaneous Reasons|0
2665113|NCT00618722|9202625|P4|Overall Study|Lost to Follow-up|2
2665114|NCT00618722|9202626|P3|Overall Study|Lost to Follow-up|0
2665115|NCT00618722|9202627|P2|Overall Study|Lost to Follow-up|0
2665116|NCT00618722|9202628|P1|Overall Study|Lost to Follow-up|2
2665117|NCT00618722|9202625|P4|Overall Study|Inability to Complete Study Procedure|0
2665118|NCT00618722|9202626|P3|Overall Study|Inability to Complete Study Procedure|0
2665119|NCT00618722|9202627|P2|Overall Study|Inability to Complete Study Procedure|1
2665120|NCT00618722|9202628|P1|Overall Study|Inability to Complete Study Procedure|0
2665121|NCT00618722|9202625|P4|Overall Study|Patient Request|1
2665122|NCT00618722|9202626|P3|Overall Study|Patient Request|1
2665123|NCT00618722|9202627|P2|Overall Study|Patient Request|1
2665124|NCT00618722|9202628|P1|Overall Study|Patient Request|1
2665125|NCT00618722|9202625|P4|Overall Study|Refusal of Treatment|0
2665126|NCT00618722|9202626|P3|Overall Study|Refusal of Treatment|1
2665127|NCT00618722|9202627|P2|Overall Study|Refusal of Treatment|0
2665128|NCT00618722|9202628|P1|Overall Study|Refusal of Treatment|0
2665129|NCT00618618|9202666|P4|Overall Study|Death|0
2665130|NCT00618618|9202667|P3|Overall Study|Death|0
2665131|NCT00618618|9202668|P2|Overall Study|Death|1
2665132|NCT00618618|9202669|P1|Overall Study|Death|0
2665133|NCT00618618|9202666|P4|Overall Study|Did Not Meet Entry Criteria|0
2665134|NCT00618618|9202667|P3|Overall Study|Did Not Meet Entry Criteria|1
2665135|NCT00618618|9202668|P2|Overall Study|Did Not Meet Entry Criteria|0
2665136|NCT00618618|9202669|P1|Overall Study|Did Not Meet Entry Criteria|0
2665137|NCT00618618|9202666|P4|Overall Study|Non-compliance|0
2665138|NCT00618618|9202667|P3|Overall Study|Non-compliance|0
2665139|NCT00618618|9202668|P2|Overall Study|Non-compliance|1
2665140|NCT00618618|9202669|P1|Overall Study|Non-compliance|1
2665141|NCT00618618|9202666|P4|Overall Study|Lost to Follow-up|1
2665142|NCT00618618|9202667|P3|Overall Study|Lost to Follow-up|0
2665143|NCT00618618|9202668|P2|Overall Study|Lost to Follow-up|0
2665144|NCT00618618|9202669|P1|Overall Study|Lost to Follow-up|3
2665145|NCT00618618|9202666|P4|Overall Study|Inability to Complete Study Procedures|0
2665146|NCT00618618|9202667|P3|Overall Study|Inability to Complete Study Procedures|0
2665147|NCT00618618|9202668|P2|Overall Study|Inability to Complete Study Procedures|1
2665148|NCT00618618|9202669|P1|Overall Study|Inability to Complete Study Procedures|0
2665149|NCT00618618|9202666|P4|Overall Study|Patient Request|0
2665150|NCT00618618|9202667|P3|Overall Study|Patient Request|2
2665151|NCT00618618|9202668|P2|Overall Study|Patient Request|0
2665152|NCT00618618|9202669|P1|Overall Study|Patient Request|0
2665153|NCT00618514|9202728|P3|Overall Study|Lost to Follow-up|4
2665154|NCT00618514|9202729|P2|Overall Study|Lost to Follow-up|12
2665155|NCT00618514|9202730|P1|Overall Study|Lost to Follow-up|11
2665156|NCT00618449|9202750|P2|Overall Study|Lost to Follow-up|110
2665157|NCT00618449|9202751|P1|Overall Study|Lost to Follow-up|98
2665158|NCT00618410|9202770|P2|Washout Period (2 Weeks)|Physician Decision|1
2665159|NCT00618410|9202771|P1|Washout Period (2 Weeks)|Physician Decision|0
2665160|NCT00618371|9202787|P1|Overall Study|Withdrawal by Subject|2
2665161|NCT00618072|9202820|P3|Overall Study|Physician Decision|1
2665162|NCT00618072|9202821|P2|Overall Study|Physician Decision|1
2665163|NCT00618072|9202822|P1|Overall Study|Physician Decision|0
2665164|NCT00618072|9202820|P3|Overall Study|Lost to Follow-up|3
2665165|NCT00618072|9202821|P2|Overall Study|Lost to Follow-up|0
2665166|NCT00618072|9202822|P1|Overall Study|Lost to Follow-up|2
2665167|NCT00617929|9202878|P1|Overall Study|Physician Decision|1
2665168|NCT00617903|9202890|P2|Overall Study|noncompliance|1
2665169|NCT00617903|9202891|P1|Overall Study|noncompliance|0
2665170|NCT00617903|9202890|P2|Overall Study|Adverse Event|1
2665171|NCT00617903|9202891|P1|Overall Study|Adverse Event|0
2665172|NCT00617903|9202890|P2|Overall Study|Lack of Efficacy|1
2665173|NCT00617903|9202891|P1|Overall Study|Lack of Efficacy|0
2665174|NCT00617903|9202890|P2|Overall Study|Lost to Follow-up|1
2665175|NCT00617903|9202891|P1|Overall Study|Lost to Follow-up|1
2665176|NCT00617903|9202890|P2|Overall Study|Withdrawal by Subject|3
2665177|NCT00617903|9202891|P1|Overall Study|Withdrawal by Subject|2
2665178|NCT00617890|9202937|P4|Overall Study|Not treated|1
2665179|NCT00617890|9202938|P3|Overall Study|Not treated|1
2665180|NCT00617890|9202939|P2|Overall Study|Not treated|0
2665181|NCT00617890|9202940|P1|Overall Study|Not treated|1
2665182|NCT00617890|9202937|P4|Overall Study|Adverse Event|8
2665183|NCT00617890|9202938|P3|Overall Study|Adverse Event|3
2665184|NCT00617890|9202939|P2|Overall Study|Adverse Event|0
2665185|NCT00617890|9202940|P1|Overall Study|Adverse Event|1
2665186|NCT00617890|9202937|P4|Overall Study|Protocol Violation|0
2665187|NCT00617890|9202938|P3|Overall Study|Protocol Violation|0
2665188|NCT00617890|9202939|P2|Overall Study|Protocol Violation|1
2665189|NCT00617890|9202940|P1|Overall Study|Protocol Violation|2
2665190|NCT00617890|9202937|P4|Overall Study|Withdrawal by Subject|2
2665191|NCT00617890|9202938|P3|Overall Study|Withdrawal by Subject|0
2665192|NCT00617890|9202939|P2|Overall Study|Withdrawal by Subject|1
2665193|NCT00617890|9202940|P1|Overall Study|Withdrawal by Subject|4
2665194|NCT00617890|9202937|P4|Overall Study|Lost to Follow-up|2
2665195|NCT00617890|9202938|P3|Overall Study|Lost to Follow-up|1
2665196|NCT00617890|9202939|P2|Overall Study|Lost to Follow-up|0
2665197|NCT00617890|9202940|P1|Overall Study|Lost to Follow-up|0
2665198|NCT00617890|9202937|P4|Overall Study|Lack of Efficacy|97
2665199|NCT00617890|9202938|P3|Overall Study|Lack of Efficacy|30
2665200|NCT00617890|9202939|P2|Overall Study|Lack of Efficacy|26
2665201|NCT00617890|9202940|P1|Overall Study|Lack of Efficacy|23
2665202|NCT00617890|9202937|P4|Overall Study|Treatment ongoing at data cut-off|5
2665203|NCT00617890|9202938|P3|Overall Study|Treatment ongoing at data cut-off|0
2665204|NCT00617890|9202939|P2|Overall Study|Treatment ongoing at data cut-off|0
2665205|NCT00617890|9202940|P1|Overall Study|Treatment ongoing at data cut-off|0
2665206|NCT00617851|9202976|P4|Overall Study|Unable to classify|0
2665207|NCT00617851|9202977|P3|Overall Study|Unable to classify|1
2665208|NCT00617851|9202978|P2|Overall Study|Unable to classify|0
2665209|NCT00617851|9202979|P1|Overall Study|Unable to classify|1
2665210|NCT00617851|9202976|P4|Overall Study|Inappropriate Enrollment|1
2665211|NCT00617851|9202977|P3|Overall Study|Inappropriate Enrollment|1
2665212|NCT00617851|9202978|P2|Overall Study|Inappropriate Enrollment|4
2665213|NCT00617851|9202979|P1|Overall Study|Inappropriate Enrollment|5
2665214|NCT00617851|9202976|P4|Overall Study|Lost to Follow-up|19
2665215|NCT00617851|9202977|P3|Overall Study|Lost to Follow-up|31
2665216|NCT00617851|9202978|P2|Overall Study|Lost to Follow-up|29
2665217|NCT00617851|9202979|P1|Overall Study|Lost to Follow-up|27
2665218|NCT00617851|9202976|P4|Overall Study|Withdrawal by Subject|4
2665219|NCT00617851|9202977|P3|Overall Study|Withdrawal by Subject|12
2665220|NCT00617851|9202978|P2|Overall Study|Withdrawal by Subject|7
2665221|NCT00617851|9202979|P1|Overall Study|Withdrawal by Subject|14
2665222|NCT00617851|9202976|P4|Overall Study|Death|1
2665223|NCT00617851|9202977|P3|Overall Study|Death|0
2665224|NCT00617851|9202978|P2|Overall Study|Death|0
2665225|NCT00617851|9202979|P1|Overall Study|Death|0
2665226|NCT00617773|9203017|P1|Overall Study|Protocol Violation|1
2665227|NCT00617773|9203017|P1|Overall Study|Progressive disease|19
2665228|NCT00617773|9203017|P1|Overall Study|Death|1
2665229|NCT00617773|9203017|P1|Overall Study|Withdrawal by Subject|1
2665230|NCT00617773|9203017|P1|Overall Study|Lack of compliance with the protocol|1
2665231|NCT00617773|9203017|P1|Overall Study|Physician Decision|1
2665232|NCT00617734|9203034|P2|Overall Study|Lost to Follow-up|1
2665233|NCT00617734|9203035|P1|Overall Study|Lost to Follow-up|0
2665234|NCT00617734|9203034|P2|Overall Study|Found Ineligible After Randomization|4
2665235|NCT00617734|9203035|P1|Overall Study|Found Ineligible After Randomization|1
2665236|NCT00617734|9203034|P2|Overall Study|Protocol Violation|0
2665237|NCT00617734|9203035|P1|Overall Study|Protocol Violation|1
2665238|NCT00617734|9203034|P2|Overall Study|Adverse Event|1
2665239|NCT00617734|9203035|P1|Overall Study|Adverse Event|4
2665240|NCT00617734|9203034|P2|Overall Study|Withdrew Consent|0
2665241|NCT00617734|9203035|P1|Overall Study|Withdrew Consent|2
2665242|NCT00617708|9203056|P3|Overall Study|Not eligible|5
2665243|NCT00617708|9203057|P2|Overall Study|Not eligible|3
2665244|NCT00617708|9203058|P1|Overall Study|Not eligible|1
2665245|NCT00617708|9203056|P3|Overall Study|Not protocol specified|2
2665246|NCT00617708|9203057|P2|Overall Study|Not protocol specified|4
2665247|NCT00617708|9203058|P1|Overall Study|Not protocol specified|1
2665248|NCT00617708|9203056|P3|Overall Study|Progression/Relapse|36
2665249|NCT00617708|9203057|P2|Overall Study|Progression/Relapse|40
2665250|NCT00617708|9203058|P1|Overall Study|Progression/Relapse|7
2665251|NCT00617708|9203056|P3|Overall Study|Death|5
2665252|NCT00617708|9203057|P2|Overall Study|Death|6
2665253|NCT00617708|9203058|P1|Overall Study|Death|0
2665254|NCT00617708|9203056|P3|Overall Study|Withdrawal by Subject|7
2665255|NCT00617708|9203057|P2|Overall Study|Withdrawal by Subject|1
2665256|NCT00617708|9203058|P1|Overall Study|Withdrawal by Subject|1
2665257|NCT00617708|9203056|P3|Overall Study|Adverse Event|9
2665258|NCT00617708|9203057|P2|Overall Study|Adverse Event|6
2665259|NCT00617708|9203058|P1|Overall Study|Adverse Event|0
2665260|NCT00617669|9203075|P2|Overall Study|Patients randomized but not treated|3
2665261|NCT00617669|9203076|P1|Overall Study|Patients randomized but not treated|2
2665262|NCT00617669|9203075|P2|Overall Study|Reason not otherwise captured, eg; death|290
2665263|NCT00617669|9203076|P1|Overall Study|Reason not otherwise captured, eg; death|265
2665264|NCT00617669|9203075|P2|Overall Study|Protocol Violation|3
2665265|NCT00617669|9203076|P1|Overall Study|Protocol Violation|2
2665266|NCT00617669|9203075|P2|Overall Study|Adverse Event|76
2665267|NCT00617669|9203076|P1|Overall Study|Adverse Event|87
2665268|NCT00617669|9203075|P2|Overall Study|Lost to Follow-up|2
2665269|NCT00617669|9203076|P1|Overall Study|Lost to Follow-up|3
2665270|NCT00617669|9203075|P2|Overall Study|Withdrawal by Subject|77
2665271|NCT00617669|9203076|P1|Overall Study|Withdrawal by Subject|71
2665272|NCT00617604|9203098|P2|Overall Study|Randomized but Never Received Study Drug|3
2665273|NCT00617604|9203099|P1|Overall Study|Randomized but Never Received Study Drug|3
2665274|NCT00617604|9203098|P2|Overall Study|Withdrawal by Subject|6
2665275|NCT00617604|9203099|P1|Overall Study|Withdrawal by Subject|4
2665276|NCT00617604|9203098|P2|Overall Study|Miscellaneous Reasons|10
2665277|NCT00617604|9203099|P1|Overall Study|Miscellaneous Reasons|8
2665278|NCT00617604|9203098|P2|Overall Study|Lost to Follow-up|0
2665279|NCT00617604|9203099|P1|Overall Study|Lost to Follow-up|1
2665280|NCT00617604|9203098|P2|Overall Study|Death|1
2665281|NCT00617604|9203099|P1|Overall Study|Death|2
2665282|NCT00617591|9203143|P1|Overall Study|Withdrew consent during Maintenance|6
2665283|NCT00617591|9203143|P1|Overall Study|Withdrew consent during Induction|4
2665284|NCT00617461|9203159|P2|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2
2665285|NCT00617461|9203160|P1|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1
2665286|NCT00617461|9203159|P2|6-Day Down-Titration Period|Withdrawal by Subject|0
2665287|NCT00617461|9203160|P1|6-Day Down-Titration Period|Withdrawal by Subject|1
2665288|NCT00617461|9203159|P2|Second Treatment Intervention Period|Lack of Efficacy|3
2665289|NCT00617461|9203160|P1|Second Treatment Intervention Period|Lack of Efficacy|0
2665290|NCT00617461|9203159|P2|Second Treatment Intervention Period|Adverse Event|1
2665291|NCT00617461|9203160|P1|Second Treatment Intervention Period|Adverse Event|0
2665292|NCT00617461|9203159|P2|4-Day Crossover Period|Withdrawal by Subject|0
2665293|NCT00617461|9203160|P1|4-Day Crossover Period|Withdrawal by Subject|1
2665294|NCT00617461|9203159|P2|First Treatment Intervention Period|Withdrawal by Subject|0
2665295|NCT00617461|9203160|P1|First Treatment Intervention Period|Withdrawal by Subject|4
2665296|NCT00617461|9203159|P2|First Treatment Intervention Period|Investigator Discretion|1
2665297|NCT00617461|9203160|P1|First Treatment Intervention Period|Investigator Discretion|1
2665298|NCT00617461|9203159|P2|First Treatment Intervention Period|Lost to Follow-up|1
2665299|NCT00617461|9203160|P1|First Treatment Intervention Period|Lost to Follow-up|0
2665300|NCT00617461|9203159|P2|First Treatment Intervention Period|Protocol Violation|1
2665301|NCT00617461|9203160|P1|First Treatment Intervention Period|Protocol Violation|2
2665302|NCT00617461|9203159|P2|First Treatment Intervention Period|Lack of Efficacy|0
2665303|NCT00617461|9203160|P1|First Treatment Intervention Period|Lack of Efficacy|1
2665304|NCT00617461|9203159|P2|First Treatment Intervention Period|Adverse Event|0
2665305|NCT00617461|9203160|P1|First Treatment Intervention Period|Adverse Event|2
2665306|NCT00617409|9203216|P3|Overall Study|Alternative Therapy|0
2665307|NCT00617409|9203217|P2|Overall Study|Alternative Therapy|2
2665308|NCT00617409|9203218|P1|Overall Study|Alternative Therapy|1
2665309|NCT00617409|9203216|P3|Overall Study|Death|4
2665310|NCT00617409|9203217|P2|Overall Study|Death|5
2665311|NCT00617409|9203218|P1|Overall Study|Death|3
2665312|NCT00617409|9203216|P3|Overall Study|Disease Progression|18
2665313|NCT00617409|9203217|P2|Overall Study|Disease Progression|8
2665314|NCT00617409|9203218|P1|Overall Study|Disease Progression|8
2665315|NCT00617409|9203216|P3|Overall Study|Adverse Event|3
2665316|NCT00617409|9203217|P2|Overall Study|Adverse Event|2
2665317|NCT00617409|9203218|P1|Overall Study|Adverse Event|0
2665318|NCT00617409|9203216|P3|Overall Study|Withdrawal by Subject|2
2665319|NCT00617409|9203217|P2|Overall Study|Withdrawal by Subject|1
2665320|NCT00617409|9203218|P1|Overall Study|Withdrawal by Subject|4
2665321|NCT00617357|9203233|P1|Overall Study|Physician Decision|1
2665322|NCT00617357|9203233|P1|Overall Study|Withdrawal by Subject|1
2665323|NCT00617357|9203233|P1|Overall Study|insurance concerns|2
2665324|NCT00617357|9203233|P1|Overall Study|Death|5
2665325|NCT00617357|9203233|P1|Overall Study|Lost to Follow-up|7
2665326|NCT00617344|9203246|P3|Overall Study|Withdrawal by Subject|2
2665327|NCT00617344|9203247|P2|Overall Study|Withdrawal by Subject|9
2665328|NCT00617344|9203248|P1|Overall Study|Withdrawal by Subject|8
2665329|NCT00617344|9203246|P3|Overall Study|Lost to Follow-up|1
2665330|NCT00617344|9203247|P2|Overall Study|Lost to Follow-up|4
2665331|NCT00617344|9203248|P1|Overall Study|Lost to Follow-up|5
2665332|NCT00617344|9203246|P3|Overall Study|Protocol Violation|5
2665333|NCT00617344|9203247|P2|Overall Study|Protocol Violation|8
2665334|NCT00617344|9203248|P1|Overall Study|Protocol Violation|10
2665335|NCT00617344|9203246|P3|Overall Study|Other Adverse Event|0
2665336|NCT00617344|9203247|P2|Overall Study|Other Adverse Event|1
2665337|NCT00617344|9203248|P1|Overall Study|Other Adverse Event|1
2665338|NCT00617344|9203246|P3|Overall Study|Serious adverse event|0
2665339|NCT00617344|9203247|P2|Overall Study|Serious adverse event|0
2665340|NCT00617344|9203248|P1|Overall Study|Serious adverse event|1
2665341|NCT00617305|9203276|P3|Overall Study|Withdrawal by Subject|0
2665342|NCT00617305|9203277|P2|Overall Study|Withdrawal by Subject|0
2665343|NCT00617305|9203278|P1|Overall Study|Withdrawal by Subject|1
2665344|NCT00617305|9203276|P3|Overall Study|Protocol Violation|1
2665345|NCT00617305|9203277|P2|Overall Study|Protocol Violation|0
2665346|NCT00617305|9203278|P1|Overall Study|Protocol Violation|1
2665347|NCT00617305|9203276|P3|Overall Study|Physician Decision|0
2665348|NCT00617305|9203277|P2|Overall Study|Physician Decision|0
2665349|NCT00617305|9203278|P1|Overall Study|Physician Decision|1
2665350|NCT00617305|9203276|P3|Overall Study|Death|0
2665351|NCT00617305|9203277|P2|Overall Study|Death|0
2665352|NCT00617305|9203278|P1|Overall Study|Death|1
2665353|NCT00617305|9203276|P3|Overall Study|Adverse Event|0
2665354|NCT00617305|9203277|P2|Overall Study|Adverse Event|0
2665355|NCT00617305|9203278|P1|Overall Study|Adverse Event|4
2665356|NCT00617279|9203334|P2|Overall Study|Death|2
2665357|NCT00617279|9203335|P1|Overall Study|Death|1
2665358|NCT00617279|9203334|P2|Overall Study|Lost to Follow-up|0
2665359|NCT00617279|9203335|P1|Overall Study|Lost to Follow-up|1
2665360|NCT00617279|9203334|P2|Overall Study|Graft abandonment|0
2665361|NCT00617279|9203335|P1|Overall Study|Graft abandonment|2
2665362|NCT00617279|9203334|P2|Overall Study|Study terminated by Sponsor|15
2665363|NCT00617279|9203335|P1|Overall Study|Study terminated by Sponsor|10
2665364|NCT00617240|9203391|P2|Overall Study|Lack of Efficacy|0
2665365|NCT00617240|9203392|P1|Overall Study|Lack of Efficacy|1
2665366|NCT00617201|9203412|P2|Overall Study|Lost to Follow-up|13
2665367|NCT00617201|9203413|P1|Overall Study|Lost to Follow-up|9
2665368|NCT00617123|9203441|P2|Study Treatment Period|Noncompliance with Protocol|1
2665369|NCT00617123|9203442|P1|Study Treatment Period|Noncompliance with Protocol|0
2665370|NCT00617123|9203441|P2|Study Treatment Period|Did Not Meet Protocol Eligibility|0
2665371|NCT00617123|9203442|P1|Study Treatment Period|Did Not Meet Protocol Eligibility|2
2665372|NCT00617123|9203441|P2|Study Treatment Period|Adverse Event|3
2665373|NCT00617123|9203442|P1|Study Treatment Period|Adverse Event|7
2665374|NCT00617123|9203441|P2|Study Treatment Period|Withdrawal by Subject|12
2665375|NCT00617123|9203442|P1|Study Treatment Period|Withdrawal by Subject|8
2665376|NCT00617123|9203441|P2|Referral Screening Period|Adverse Event|1
2665377|NCT00617123|9203442|P1|Referral Screening Period|Adverse Event|0
2665378|NCT00617123|9203441|P2|Referral Screening Period|Did Not Wish To Continue|1
2665379|NCT00617123|9203442|P1|Referral Screening Period|Did Not Wish To Continue|3
2665380|NCT00617123|9203441|P2|Referral Screening Period|Did Not Meet Protocol Eligibility|24
2665381|NCT00617123|9203442|P1|Referral Screening Period|Did Not Meet Protocol Eligibility|36
2665382|NCT00617084|9203473|P2|Overall Study|Missed 12 Months visit|19
2665383|NCT00617084|9203474|P1|Overall Study|Missed 12 Months visit|16
2665384|NCT00617084|9203473|P2|Overall Study|Withdrawal by Subject|7
2665385|NCT00617084|9203474|P1|Overall Study|Withdrawal by Subject|5
2665386|NCT00616967|9203527|P3|Overall Study|Withdrawal by Subject|1
2665387|NCT00616967|9203528|P2|Overall Study|Withdrawal by Subject|0
2665388|NCT00616967|9203529|P1|Overall Study|Withdrawal by Subject|0
2665389|NCT00616941|9203554|P3|Overall Study|Vaccination Suspended|3
2665390|NCT00616941|9203555|P2|Overall Study|Vaccination Suspended|0
2665391|NCT00616941|9203556|P1|Overall Study|Vaccination Suspended|0
2665392|NCT00616941|9203554|P3|Overall Study|Unrelated Medical Illness/Complication|0
2665393|NCT00616941|9203555|P2|Overall Study|Unrelated Medical Illness/Complication|2
2665394|NCT00616941|9203556|P1|Overall Study|Unrelated Medical Illness/Complication|0
2665395|NCT00616941|9203554|P3|Overall Study|Subject Non-compliance|1
2665396|NCT00616941|9203555|P2|Overall Study|Subject Non-compliance|0
2665397|NCT00616941|9203556|P1|Overall Study|Subject Non-compliance|0
2665398|NCT00616941|9203554|P3|Overall Study|Adverse Event|1
2665399|NCT00616941|9203555|P2|Overall Study|Adverse Event|1
2665400|NCT00616941|9203556|P1|Overall Study|Adverse Event|0
2665401|NCT00616941|9203554|P3|Overall Study|Progressive Disease|1
2665402|NCT00616941|9203555|P2|Overall Study|Progressive Disease|2
2665403|NCT00616941|9203556|P1|Overall Study|Progressive Disease|1
2665404|NCT00616928|9203583|P4|Overall Study|Lost to Follow-up|0
2665405|NCT00616928|9203584|P3|Overall Study|Lost to Follow-up|0
2665406|NCT00616928|9203585|P2|Overall Study|Lost to Follow-up|7
2665407|NCT00616928|9203586|P1|Overall Study|Lost to Follow-up|5
2665408|NCT00616928|9203583|P4|Overall Study|Other|5
2665409|NCT00616928|9203584|P3|Overall Study|Other|15
2665410|NCT00616928|9203585|P2|Overall Study|Other|8
2665411|NCT00616928|9203586|P1|Overall Study|Other|51
2665412|NCT00616928|9203583|P4|Overall Study|Adverse Event|2
2665413|NCT00616928|9203584|P3|Overall Study|Adverse Event|2
2665414|NCT00616928|9203585|P2|Overall Study|Adverse Event|3
2665415|NCT00616928|9203586|P1|Overall Study|Adverse Event|6
2665416|NCT00616902|9203650|P2|Overall Study|Termination of study|6
2665417|NCT00616902|9203651|P1|Overall Study|Termination of study|6
2665418|NCT00616759|9203694|P2|Overall Study|Withdrawal by Subject|2
2665419|NCT00616759|9203695|P1|Overall Study|Withdrawal by Subject|1
2665420|NCT00616759|9203694|P2|Overall Study|Physician Decision|0
2665421|NCT00616759|9203695|P1|Overall Study|Physician Decision|2
2665422|NCT00616655|9203704|P3|Overall Study|Other|5
2665423|NCT00616655|9203705|P2|Overall Study|Other|6
2665424|NCT00616655|9203706|P1|Overall Study|Other|6
2665425|NCT00616655|9203704|P3|Overall Study|Does not meet in/ex criteria|2
2665426|NCT00616655|9203705|P2|Overall Study|Does not meet in/ex criteria|0
2665427|NCT00616655|9203706|P1|Overall Study|Does not meet in/ex criteria|0
2665428|NCT00616655|9203704|P3|Overall Study|Withdrawal by Subject|11
2665429|NCT00616655|9203705|P2|Overall Study|Withdrawal by Subject|7
2665430|NCT00616655|9203706|P1|Overall Study|Withdrawal by Subject|9
2665431|NCT00616655|9203704|P3|Overall Study|Protocol Violation|3
2665432|NCT00616655|9203705|P2|Overall Study|Protocol Violation|4
2665433|NCT00616655|9203706|P1|Overall Study|Protocol Violation|2
2665434|NCT00616655|9203704|P3|Overall Study|Lost to Follow-up|10
2665435|NCT00616655|9203705|P2|Overall Study|Lost to Follow-up|12
2665436|NCT00616655|9203706|P1|Overall Study|Lost to Follow-up|3
2665437|NCT00616655|9203704|P3|Overall Study|Lack of Efficacy|5
2665438|NCT00616655|9203705|P2|Overall Study|Lack of Efficacy|5
2665439|NCT00616655|9203706|P1|Overall Study|Lack of Efficacy|5
2665440|NCT00616655|9203704|P3|Overall Study|Adverse Event|12
2665441|NCT00616655|9203705|P2|Overall Study|Adverse Event|7
2665442|NCT00616655|9203706|P1|Overall Study|Adverse Event|10
2665443|NCT00616642|9203746|P2|Overall Study|Withdrawal by Subject|1
2665444|NCT00616642|9203747|P1|Overall Study|Withdrawal by Subject|0
2665445|NCT00616629|9203758|P5|Overall Study|AV-block|0
2665446|NCT00616629|9203759|P4|Overall Study|AV-block|0
2665447|NCT00616629|9203760|P3|Overall Study|AV-block|0
2665448|NCT00616629|9203761|P2|Overall Study|AV-block|0
2665449|NCT00616629|9203762|P1|Overall Study|AV-block|1
2665450|NCT00616629|9203758|P5|Overall Study|Protocol Violation|0
2665451|NCT00616629|9203759|P4|Overall Study|Protocol Violation|0
2665452|NCT00616629|9203760|P3|Overall Study|Protocol Violation|1
2665453|NCT00616629|9203761|P2|Overall Study|Protocol Violation|2
2665454|NCT00616629|9203762|P1|Overall Study|Protocol Violation|1
2665455|NCT00616603|9203807|P3|Overall Study|Physician Decision|2
2665456|NCT00616603|9203808|P2|Overall Study|Physician Decision|0
2665457|NCT00616603|9203809|P1|Overall Study|Physician Decision|2
2665458|NCT00616434|9203832|P2|Overall Study|Protocol deviation|1
2665459|NCT00616434|9203833|P1|Overall Study|Protocol deviation|0
2665460|NCT00616434|9203832|P2|Overall Study|Withdrawal by Subject|1
2665461|NCT00616434|9203833|P1|Overall Study|Withdrawal by Subject|1
2665462|NCT00616434|9203832|P2|Overall Study|Physician Decision|4
2665463|NCT00616434|9203833|P1|Overall Study|Physician Decision|0
2665464|NCT00616434|9203832|P2|Overall Study|Adverse Event|2
2665465|NCT00616434|9203833|P1|Overall Study|Adverse Event|5
2665466|NCT00616421|9203846|P3|Overall Study|Unable to classify|0
2665467|NCT00616421|9203847|P2|Overall Study|Unable to classify|0
2665468|NCT00616421|9203848|P1|Overall Study|Unable to classify|1
2665469|NCT00616421|9203846|P3|Overall Study|Protocol Violation|2
2665470|NCT00616421|9203847|P2|Overall Study|Protocol Violation|1
2665471|NCT00616421|9203848|P1|Overall Study|Protocol Violation|0
2665472|NCT00616421|9203846|P3|Overall Study|Administrative reason|0
2665473|NCT00616421|9203847|P2|Overall Study|Administrative reason|0
2665474|NCT00616421|9203848|P1|Overall Study|Administrative reason|1
2665475|NCT00616421|9203846|P3|Overall Study|Inappropriate enrollment|1
2665476|NCT00616421|9203847|P2|Overall Study|Inappropriate enrollment|0
2665477|NCT00616421|9203848|P1|Overall Study|Inappropriate enrollment|3
2665478|NCT00616421|9203846|P3|Overall Study|Lost to Follow-up|30
2665479|NCT00616421|9203847|P2|Overall Study|Lost to Follow-up|26
2665480|NCT00616421|9203848|P1|Overall Study|Lost to Follow-up|12
2665481|NCT00616421|9203846|P3|Overall Study|Withdrawal by Subject|8
2665482|NCT00616421|9203847|P2|Overall Study|Withdrawal by Subject|11
2665483|NCT00616421|9203848|P1|Overall Study|Withdrawal by Subject|9
2665484|NCT00616239|9203889|P1|Overall Study|Withdrawal by Subject|2
2665485|NCT00616018|9203919|P1|Overall Study|Protocol Violation|3
2665486|NCT00615992|9203924|P1|Overall Study|Protocol Violation|67
2665487|NCT00615914|9203950|P1|Overall Study|Irregularly enrolled patients|10
2665488|NCT00615914|9203950|P1|Overall Study|No treatment|2
2665489|NCT00615914|9203950|P1|Overall Study|No data was collected.|65
2665490|NCT00615914|9203950|P1|Overall Study|Physician Decision|4
2665491|NCT00615914|9203950|P1|Overall Study|Withdrawal by Subject|16
2665492|NCT00615914|9203950|P1|Overall Study|Lost to Follow-up|187
2665493|NCT00615914|9203950|P1|Overall Study|Lack of Efficacy|59
2665494|NCT00615914|9203950|P1|Overall Study|Death|20
2665495|NCT00615914|9203950|P1|Overall Study|Adverse Event|274
2665496|NCT00615901|9203957|P1|Overall Study|Adverse Event|7
2665497|NCT00615901|9203957|P1|Overall Study|Withdrawal by Subject|2
2665498|NCT00615836|9203965|P5|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
2665499|NCT00615836|9203966|P4|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
2665500|NCT00615836|9203967|P3|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
2665501|NCT00615836|9203968|P2|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
2665502|NCT00615836|9203969|P1|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65
2665503|NCT00615836|9203965|P5|Extension Study (FE992026 CS31)|Not reported|0
2665504|NCT00615836|9203966|P4|Extension Study (FE992026 CS31)|Not reported|4
2665505|NCT00615836|9203967|P3|Extension Study (FE992026 CS31)|Not reported|1
2665506|NCT00615836|9203968|P2|Extension Study (FE992026 CS31)|Not reported|4
2665507|NCT00615836|9203969|P1|Extension Study (FE992026 CS31)|Not reported|6
2665508|NCT00615836|9203965|P5|Extension Study (FE992026 CS31)|Other|0
2665509|NCT00615836|9203966|P4|Extension Study (FE992026 CS31)|Other|8
2665510|NCT00615836|9203967|P3|Extension Study (FE992026 CS31)|Other|8
2665511|NCT00615836|9203968|P2|Extension Study (FE992026 CS31)|Other|7
2665512|NCT00615836|9203969|P1|Extension Study (FE992026 CS31)|Other|10
2665513|NCT00615836|9203965|P5|Extension Study (FE992026 CS31)|Lost to Follow-up|0
2665514|NCT00615836|9203966|P4|Extension Study (FE992026 CS31)|Lost to Follow-up|10
2665515|NCT00615836|9203967|P3|Extension Study (FE992026 CS31)|Lost to Follow-up|5
2665516|NCT00615836|9203968|P2|Extension Study (FE992026 CS31)|Lost to Follow-up|14
2665517|NCT00615836|9203969|P1|Extension Study (FE992026 CS31)|Lost to Follow-up|10
2665518|NCT00615836|9203965|P5|Extension Study (FE992026 CS31)|Withdrawal by Subject|0
2665519|NCT00615836|9203966|P4|Extension Study (FE992026 CS31)|Withdrawal by Subject|43
2665520|NCT00615836|9203967|P3|Extension Study (FE992026 CS31)|Withdrawal by Subject|38
2665521|NCT00615836|9203968|P2|Extension Study (FE992026 CS31)|Withdrawal by Subject|42
2665522|NCT00615836|9203969|P1|Extension Study (FE992026 CS31)|Withdrawal by Subject|37
2665523|NCT00615836|9203965|P5|Extension Study (FE992026 CS31)|Protocol Violation|0
2665524|NCT00615836|9203966|P4|Extension Study (FE992026 CS31)|Protocol Violation|3
2665525|NCT00615836|9203967|P3|Extension Study (FE992026 CS31)|Protocol Violation|2
2665526|NCT00615836|9203968|P2|Extension Study (FE992026 CS31)|Protocol Violation|5
2665527|NCT00615836|9203969|P1|Extension Study (FE992026 CS31)|Protocol Violation|4
2665528|NCT00615836|9203965|P5|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
2665529|NCT00615836|9203966|P4|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
2665530|NCT00615836|9203967|P3|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
2665531|NCT00615836|9203968|P2|Extension Study (FE992026 CS31)|Use of exclusionary medication|2
2665532|NCT00615836|9203969|P1|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
2665533|NCT00615836|9203965|P5|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
2665534|NCT00615836|9203966|P4|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
2665535|NCT00615836|9203967|P3|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
2665536|NCT00615836|9203968|P2|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
2665537|NCT00615836|9203969|P1|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1
2665538|NCT00615836|9203965|P5|Extension Study (FE992026 CS31)|Adverse Event|0
2665539|NCT00615836|9203966|P4|Extension Study (FE992026 CS31)|Adverse Event|13
2665540|NCT00615836|9203967|P3|Extension Study (FE992026 CS31)|Adverse Event|15
2665541|NCT00615836|9203968|P2|Extension Study (FE992026 CS31)|Adverse Event|12
2665542|NCT00615836|9203969|P1|Extension Study (FE992026 CS31)|Adverse Event|7
2665543|NCT00615719|9204029|P1|Overall Study|Physician Decision|5
2665544|NCT00615550|9204043|P2|Overall Study|Lost to Follow-up|1
2665545|NCT00615550|9204044|P1|Overall Study|Lost to Follow-up|6
2665546|NCT00615459|9204067|P4|Period III|Unsatisfactory therapeutic effect|0
2665547|NCT00615459|9204068|P3|Period III|Unsatisfactory therapeutic effect|0
2665548|NCT00615459|9204069|P2|Period III|Unsatisfactory therapeutic effect|1
2665549|NCT00615459|9204070|P1|Period III|Unsatisfactory therapeutic effect|0
2665550|NCT00615459|9204067|P4|Period III|Administrative problems|0
2665551|NCT00615459|9204068|P3|Period III|Administrative problems|1
2665552|NCT00615459|9204069|P2|Period III|Administrative problems|1
2665553|NCT00615459|9204070|P1|Period III|Administrative problems|0
2665554|NCT00615459|9204067|P4|Period III|Adverse Event|0
2665555|NCT00615459|9204068|P3|Period III|Adverse Event|0
2665556|NCT00615459|9204069|P2|Period III|Adverse Event|1
2665557|NCT00615459|9204070|P1|Period III|Adverse Event|0
2665558|NCT00615459|9204067|P4|Period II|Lost to Follow-up|1
2665559|NCT00615459|9204068|P3|Period II|Lost to Follow-up|0
2665560|NCT00615459|9204069|P2|Period II|Lost to Follow-up|0
2665561|NCT00615459|9204070|P1|Period II|Lost to Follow-up|0
2665562|NCT00615459|9204067|P4|Period II|Adverse Event|0
2665563|NCT00615459|9204068|P3|Period II|Adverse Event|0
2665564|NCT00615459|9204069|P2|Period II|Adverse Event|0
2665565|NCT00615459|9204070|P1|Period II|Adverse Event|1
2665566|NCT00615459|9204067|P4|Period I|Abnormal test procedure results|0
2665567|NCT00615459|9204068|P3|Period I|Abnormal test procedure results|1
2665568|NCT00615459|9204069|P2|Period I|Abnormal test procedure results|1
2665569|NCT00615459|9204070|P1|Period I|Abnormal test procedure results|1
2665570|NCT00615459|9204067|P4|Period I|Subject withdrew consent|1
2665571|NCT00615459|9204068|P3|Period I|Subject withdrew consent|0
2665572|NCT00615459|9204069|P2|Period I|Subject withdrew consent|0
2665573|NCT00615459|9204070|P1|Period I|Subject withdrew consent|1
2665574|NCT00615459|9204067|P4|Period I|Adverse Event|0
2665575|NCT00615459|9204068|P3|Period I|Adverse Event|1
2665576|NCT00615459|9204069|P2|Period I|Adverse Event|0
2665577|NCT00615459|9204070|P1|Period I|Adverse Event|2
2665578|NCT00615290|9204116|P1|Overall Study|Other|2
2665579|NCT00615290|9204116|P1|Overall Study|Withdrawal by Subject|1
2665580|NCT00615290|9204116|P1|Overall Study|Lost to Follow-up|3
2665581|NCT00615290|9204116|P1|Overall Study|Adverse Event|2
2665582|NCT00615264|9204130|P2|Overall Study|Dermal Hypersensitivity|3
2665583|NCT00615264|9204131|P1|Overall Study|Dermal Hypersensitivity|0
2665584|NCT00615264|9204130|P2|Overall Study|Not defined|4
2665585|NCT00615264|9204131|P1|Overall Study|Not defined|7
2665586|NCT00615264|9204130|P2|Overall Study|Protocol Violation|7
2665587|NCT00615264|9204131|P1|Overall Study|Protocol Violation|11
2665588|NCT00615264|9204130|P2|Overall Study|Death|1
2665589|NCT00615264|9204131|P1|Overall Study|Death|1
2665590|NCT00615264|9204130|P2|Overall Study|Adverse Event|5
2665591|NCT00615264|9204131|P1|Overall Study|Adverse Event|8
2665592|NCT00615264|9204130|P2|Overall Study|Lost to Follow-up|13
2665593|NCT00615264|9204131|P1|Overall Study|Lost to Follow-up|6
2665594|NCT00615264|9204130|P2|Overall Study|Withdrawal by Subject|19
2665595|NCT00615264|9204131|P1|Overall Study|Withdrawal by Subject|17
2665596|NCT00615199|9204143|P4|Overall Study|Withdrawal by Subject|0
2665597|NCT00615199|9204144|P3|Overall Study|Withdrawal by Subject|0
2665598|NCT00615199|9204145|P2|Overall Study|Withdrawal by Subject|1
2665599|NCT00615199|9204146|P1|Overall Study|Withdrawal by Subject|2
2665600|NCT00615199|9204143|P4|Overall Study|Other|1
2665601|NCT00615199|9204144|P3|Overall Study|Other|0
2665602|NCT00615199|9204145|P2|Overall Study|Other|0
2665603|NCT00615199|9204146|P1|Overall Study|Other|0
2665604|NCT00615199|9204143|P4|Overall Study|Lost to Follow-up|0
2665605|NCT00615199|9204144|P3|Overall Study|Lost to Follow-up|0
2665606|NCT00615199|9204145|P2|Overall Study|Lost to Follow-up|0
2665607|NCT00615199|9204146|P1|Overall Study|Lost to Follow-up|1
2665608|NCT00615199|9204143|P4|Overall Study|Lack of Efficacy|1
2665609|NCT00615199|9204144|P3|Overall Study|Lack of Efficacy|0
2665610|NCT00615199|9204145|P2|Overall Study|Lack of Efficacy|0
2665611|NCT00615199|9204146|P1|Overall Study|Lack of Efficacy|2
2665612|NCT00615199|9204143|P4|Overall Study|Adverse Event|0
2665613|NCT00615199|9204144|P3|Overall Study|Adverse Event|1
2665614|NCT00615199|9204145|P2|Overall Study|Adverse Event|1
2665615|NCT00615199|9204146|P1|Overall Study|Adverse Event|3
2665616|NCT00615108|9204180|P1|Overall Study|Lost to Follow-up|15
2665617|NCT00615108|9204180|P1|Overall Study|Other|370
2665618|NCT00615108|9204180|P1|Overall Study|Adverse Event|122
2665619|NCT00615069|9204195|P1|Overall Study|Withdrawal by Subject|4
2665620|NCT00615069|9204195|P1|Overall Study|Physician Decision|2
2665621|NCT00615069|9204195|P1|Overall Study|Death|10
2665622|NCT00615056|9204204|P4|Overall Study|Randomized but not treated|0
2665623|NCT00615056|9204205|P3|Overall Study|Randomized but not treated|0
2665624|NCT00615056|9204206|P2|Overall Study|Randomized but not treated|0
2665625|NCT00615056|9204207|P1|Overall Study|Randomized but not treated|3
2665626|NCT00615056|9204204|P4|Overall Study|Discontinued by Sponsor|0
2665627|NCT00615056|9204205|P3|Overall Study|Discontinued by Sponsor|0
2665628|NCT00615056|9204206|P2|Overall Study|Discontinued by Sponsor|0
2665629|NCT00615056|9204207|P1|Overall Study|Discontinued by Sponsor|1
2665630|NCT00615056|9204204|P4|Overall Study|Withdrawal by Subject|0
2665631|NCT00615056|9204205|P3|Overall Study|Withdrawal by Subject|1
2665632|NCT00615056|9204206|P2|Overall Study|Withdrawal by Subject|1
2665633|NCT00615056|9204207|P1|Overall Study|Withdrawal by Subject|0
2665634|NCT00615056|9204204|P4|Overall Study|Objective progression or relapse|0
2665635|NCT00615056|9204205|P3|Overall Study|Objective progression or relapse|0
2665636|NCT00615056|9204206|P2|Overall Study|Objective progression or relapse|2
2665637|NCT00615056|9204207|P1|Overall Study|Objective progression or relapse|0
2665638|NCT00615056|9204204|P4|Overall Study|Other|7
2665639|NCT00615056|9204205|P3|Overall Study|Other|10
2665640|NCT00615056|9204206|P2|Overall Study|Other|15
2665641|NCT00615056|9204207|P1|Overall Study|Other|13
2665642|NCT00615056|9204204|P4|Overall Study|Lost to Follow-up|5
2665643|NCT00615056|9204205|P3|Overall Study|Lost to Follow-up|4
2665644|NCT00615056|9204206|P2|Overall Study|Lost to Follow-up|2
2665645|NCT00615056|9204207|P1|Overall Study|Lost to Follow-up|1
2665646|NCT00615056|9204204|P4|Overall Study|Death|23
2665647|NCT00615056|9204205|P3|Overall Study|Death|21
2665648|NCT00615056|9204206|P2|Overall Study|Death|31
2665649|NCT00615056|9204207|P1|Overall Study|Death|31
2665650|NCT00615030|9204237|P12|Period III|Administrative problems|0
2665651|NCT00615030|9204238|P11|Period III|Administrative problems|0
2665652|NCT00615030|9204239|P10|Period III|Administrative problems|0
2665653|NCT00615030|9204240|P9|Period III|Administrative problems|0
2665654|NCT00615030|9204241|P8|Period III|Administrative problems|0
2665655|NCT00615030|9204242|P7|Period III|Administrative problems|0
2665656|NCT00615030|9204243|P6|Period III|Administrative problems|0
2665657|NCT00615030|9204244|P5|Period III|Administrative problems|0
2665658|NCT00615030|9204245|P4|Period III|Administrative problems|1
2665659|NCT00615030|9204246|P3|Period III|Administrative problems|0
2665660|NCT00615030|9204247|P2|Period III|Administrative problems|0
2665661|NCT00615030|9204248|P1|Period III|Administrative problems|1
2665662|NCT00615030|9204237|P12|Period II|Subject withdrew consent|0
2665663|NCT00615030|9204238|P11|Period II|Subject withdrew consent|0
2665664|NCT00615030|9204239|P10|Period II|Subject withdrew consent|0
2665665|NCT00615030|9204240|P9|Period II|Subject withdrew consent|0
2665666|NCT00615030|9204241|P8|Period II|Subject withdrew consent|0
2665667|NCT00615030|9204242|P7|Period II|Subject withdrew consent|1
2665668|NCT00615030|9204243|P6|Period II|Subject withdrew consent|0
2665669|NCT00615030|9204244|P5|Period II|Subject withdrew consent|0
2665670|NCT00615030|9204245|P4|Period II|Subject withdrew consent|1
2665671|NCT00615030|9204246|P3|Period II|Subject withdrew consent|0
2665672|NCT00615030|9204247|P2|Period II|Subject withdrew consent|0
2665673|NCT00615030|9204248|P1|Period II|Subject withdrew consent|0
2665674|NCT00615030|9204237|P12|Period II|Adverse Event|0
2665675|NCT00615030|9204238|P11|Period II|Adverse Event|0
2665676|NCT00615030|9204239|P10|Period II|Adverse Event|0
2665677|NCT00615030|9204240|P9|Period II|Adverse Event|1
2665678|NCT00615030|9204241|P8|Period II|Adverse Event|0
2665679|NCT00615030|9204242|P7|Period II|Adverse Event|0
2665680|NCT00615030|9204243|P6|Period II|Adverse Event|0
2665681|NCT00615030|9204244|P5|Period II|Adverse Event|0
2665682|NCT00615030|9204245|P4|Period II|Adverse Event|0
2665683|NCT00615030|9204246|P3|Period II|Adverse Event|1
2665684|NCT00615030|9204247|P2|Period II|Adverse Event|0
2665685|NCT00615030|9204248|P1|Period II|Adverse Event|0
2665686|NCT00615030|9204237|P12|Period I|Abnormal laboratory value(s)|0
2665687|NCT00615030|9204238|P11|Period I|Abnormal laboratory value(s)|0
2665688|NCT00615030|9204239|P10|Period I|Abnormal laboratory value(s)|0
2665689|NCT00615030|9204240|P9|Period I|Abnormal laboratory value(s)|0
2665690|NCT00615030|9204241|P8|Period I|Abnormal laboratory value(s)|0
2665691|NCT00615030|9204242|P7|Period I|Abnormal laboratory value(s)|0
2665692|NCT00615030|9204243|P6|Period I|Abnormal laboratory value(s)|1
2665693|NCT00615030|9204244|P5|Period I|Abnormal laboratory value(s)|0
2665694|NCT00615030|9204245|P4|Period I|Abnormal laboratory value(s)|0
2665695|NCT00615030|9204246|P3|Period I|Abnormal laboratory value(s)|0
2665696|NCT00615030|9204247|P2|Period I|Abnormal laboratory value(s)|0
2665697|NCT00615030|9204248|P1|Period I|Abnormal laboratory value(s)|0
2665698|NCT00615030|9204237|P12|Period I|Subject withdrew consent|1
2665699|NCT00615030|9204238|P11|Period I|Subject withdrew consent|1
2665700|NCT00615030|9204239|P10|Period I|Subject withdrew consent|0
2665701|NCT00615030|9204240|P9|Period I|Subject withdrew consent|1
2665702|NCT00615030|9204241|P8|Period I|Subject withdrew consent|0
2665703|NCT00615030|9204242|P7|Period I|Subject withdrew consent|0
2665704|NCT00615030|9204243|P6|Period I|Subject withdrew consent|0
2665705|NCT00615030|9204244|P5|Period I|Subject withdrew consent|0
2665706|NCT00615030|9204245|P4|Period I|Subject withdrew consent|0
2665707|NCT00615030|9204246|P3|Period I|Subject withdrew consent|0
2665708|NCT00615030|9204247|P2|Period I|Subject withdrew consent|0
2665709|NCT00615030|9204248|P1|Period I|Subject withdrew consent|0
2665710|NCT00615030|9204237|P12|Period I|Protocol deviation|0
2665711|NCT00615030|9204238|P11|Period I|Protocol deviation|0
2665712|NCT00615030|9204239|P10|Period I|Protocol deviation|0
2665713|NCT00615030|9204240|P9|Period I|Protocol deviation|0
2665714|NCT00615030|9204241|P8|Period I|Protocol deviation|0
2665715|NCT00615030|9204242|P7|Period I|Protocol deviation|0
2665716|NCT00615030|9204243|P6|Period I|Protocol deviation|0
2665717|NCT00615030|9204244|P5|Period I|Protocol deviation|0
2665718|NCT00615030|9204245|P4|Period I|Protocol deviation|0
2665719|NCT00615030|9204246|P3|Period I|Protocol deviation|0
2665720|NCT00615030|9204247|P2|Period I|Protocol deviation|0
2665721|NCT00615030|9204248|P1|Period I|Protocol deviation|1
2665722|NCT00615030|9204237|P12|Period I|Administrative problem|0
2665723|NCT00615030|9204238|P11|Period I|Administrative problem|0
2665724|NCT00615030|9204239|P10|Period I|Administrative problem|0
2665725|NCT00615030|9204240|P9|Period I|Administrative problem|0
2665726|NCT00615030|9204241|P8|Period I|Administrative problem|0
2665727|NCT00615030|9204242|P7|Period I|Administrative problem|0
2665728|NCT00615030|9204243|P6|Period I|Administrative problem|0
2665729|NCT00615030|9204244|P5|Period I|Administrative problem|1
2665730|NCT00615030|9204245|P4|Period I|Administrative problem|0
2665731|NCT00615030|9204246|P3|Period I|Administrative problem|0
2665732|NCT00615030|9204247|P2|Period I|Administrative problem|0
2665733|NCT00615030|9204248|P1|Period I|Administrative problem|0
2665734|NCT00615017|9204268|P6|Overall Study|Physician discontinued drug|1
2665735|NCT00615017|9204269|P5|Overall Study|Physician discontinued drug|0
2665736|NCT00615017|9204270|P4|Overall Study|Physician discontinued drug|0
2665737|NCT00615017|9204271|P3|Overall Study|Physician discontinued drug|0
2665738|NCT00615017|9204272|P2|Overall Study|Physician discontinued drug|0
2665739|NCT00615017|9204273|P1|Overall Study|Physician discontinued drug|0
2665740|NCT00615017|9204268|P6|Overall Study|Transferred out of Intensive Care Unit|0
2665741|NCT00615017|9204269|P5|Overall Study|Transferred out of Intensive Care Unit|0
2665742|NCT00615017|9204270|P4|Overall Study|Transferred out of Intensive Care Unit|1
2665743|NCT00615017|9204271|P3|Overall Study|Transferred out of Intensive Care Unit|0
2665744|NCT00615017|9204272|P2|Overall Study|Transferred out of Intensive Care Unit|0
2665745|NCT00615017|9204273|P1|Overall Study|Transferred out of Intensive Care Unit|0
2665746|NCT00615017|9204268|P6|Overall Study|Sepsis resolved|0
2665747|NCT00615017|9204269|P5|Overall Study|Sepsis resolved|0
2665748|NCT00615017|9204270|P4|Overall Study|Sepsis resolved|0
2665749|NCT00615017|9204271|P3|Overall Study|Sepsis resolved|1
2665750|NCT00615017|9204272|P2|Overall Study|Sepsis resolved|0
2665751|NCT00615017|9204273|P1|Overall Study|Sepsis resolved|0
2665752|NCT00615017|9204268|P6|Overall Study|Death|1
2665753|NCT00615017|9204269|P5|Overall Study|Death|1
2665754|NCT00615017|9204270|P4|Overall Study|Death|0
2665755|NCT00615017|9204271|P3|Overall Study|Death|2
2665756|NCT00615017|9204272|P2|Overall Study|Death|0
2665757|NCT00615017|9204273|P1|Overall Study|Death|0
2665758|NCT00615017|9204268|P6|Overall Study|Adverse Event|1
2665759|NCT00615017|9204269|P5|Overall Study|Adverse Event|0
2665760|NCT00615017|9204270|P4|Overall Study|Adverse Event|0
2665761|NCT00615017|9204271|P3|Overall Study|Adverse Event|2
2665762|NCT00615017|9204272|P2|Overall Study|Adverse Event|1
2665763|NCT00615017|9204273|P1|Overall Study|Adverse Event|0
2665764|NCT00614991|9204431|P6|Overall Study|Adverse Event|0
2665765|NCT00614991|9204432|P5|Overall Study|Adverse Event|1
2665766|NCT00614991|9204433|P4|Overall Study|Adverse Event|0
2665767|NCT00614991|9204434|P3|Overall Study|Adverse Event|0
2665768|NCT00614991|9204435|P2|Overall Study|Adverse Event|3
2665769|NCT00614991|9204436|P1|Overall Study|Adverse Event|3
2665770|NCT00614939|9204470|P2|Overall Study|Hospitalized due to kidney transplant|0
2665771|NCT00614939|9204471|P1|Overall Study|Hospitalized due to kidney transplant|1
2665772|NCT00614939|9204470|P2|Overall Study|Poor/non-compliance|0
2665773|NCT00614939|9204471|P1|Overall Study|Poor/non-compliance|4
2665774|NCT00614939|9204470|P2|Overall Study|Death|3
2665775|NCT00614939|9204471|P1|Overall Study|Death|4
2665776|NCT00614939|9204470|P2|Overall Study|Incorrect enrollment|2
2665777|NCT00614939|9204471|P1|Overall Study|Incorrect enrollment|1
2665778|NCT00614939|9204470|P2|Overall Study|Adverse Event|5
2665779|NCT00614939|9204471|P1|Overall Study|Adverse Event|2
2665780|NCT00614939|9204470|P2|Overall Study|Study specific discontinuation criteris|16
2665781|NCT00614939|9204471|P1|Overall Study|Study specific discontinuation criteris|13
2665782|NCT00614939|9204470|P2|Overall Study|Withdrawal by Subject|17
2665783|NCT00614939|9204471|P1|Overall Study|Withdrawal by Subject|10
2665784|NCT00614926|9204505|P2|Overall Study|Adverse Event|0
2665785|NCT00614926|9204506|P1|Overall Study|Adverse Event|3
2665786|NCT00614926|9204505|P2|Overall Study|Burden of travel|0
2665787|NCT00614926|9204506|P1|Overall Study|Burden of travel|1
2665788|NCT00614874|9204519|P1|Overall Study|Withdrawal by Subject|1
2665789|NCT00614874|9204519|P1|Overall Study|Protocol Violation|1
2665790|NCT00614822|9204526|P1|Overall Study|Adverse Event|3
2665791|NCT00614744|9204535|P2|Overall Study|Incomplete for Behavior Issues|2
2665792|NCT00614744|9204536|P1|Overall Study|Incomplete for Behavior Issues|0
2665793|NCT00614744|9204535|P2|Overall Study|Lost to Follow-up|4
2665794|NCT00614744|9204536|P1|Overall Study|Lost to Follow-up|5
2665795|NCT00614614|9204562|P5|Booster Vaccination Phase|Other|1
2665796|NCT00614614|9204563|P4|Booster Vaccination Phase|Other|2
2665797|NCT00614614|9204564|P3|Booster Vaccination Phase|Other|3
2665798|NCT00614614|9204565|P2|Booster Vaccination Phase|Other|1
2665799|NCT00614614|9204566|P1|Booster Vaccination Phase|Other|0
2665800|NCT00614614|9204562|P5|Booster Vaccination Phase|Protocol Violation|0
2665801|NCT00614614|9204563|P4|Booster Vaccination Phase|Protocol Violation|3
2665802|NCT00614614|9204564|P3|Booster Vaccination Phase|Protocol Violation|2
2665803|NCT00614614|9204565|P2|Booster Vaccination Phase|Protocol Violation|0
2665804|NCT00614614|9204566|P1|Booster Vaccination Phase|Protocol Violation|0
2665805|NCT00614614|9204562|P5|Booster Vaccination Phase|Lost to Follow-up|8
2665806|NCT00614614|9204563|P4|Booster Vaccination Phase|Lost to Follow-up|10
2665807|NCT00614614|9204564|P3|Booster Vaccination Phase|Lost to Follow-up|17
2665808|NCT00614614|9204565|P2|Booster Vaccination Phase|Lost to Follow-up|5
2665809|NCT00614614|9204566|P1|Booster Vaccination Phase|Lost to Follow-up|0
2665810|NCT00614614|9204562|P5|Booster Vaccination Phase|Withdrawal by Subject|4
2665811|NCT00614614|9204563|P4|Booster Vaccination Phase|Withdrawal by Subject|3
2665812|NCT00614614|9204564|P3|Booster Vaccination Phase|Withdrawal by Subject|4
2665813|NCT00614614|9204565|P2|Booster Vaccination Phase|Withdrawal by Subject|0
2665814|NCT00614614|9204566|P1|Booster Vaccination Phase|Withdrawal by Subject|0
2665815|NCT00614614|9204562|P5|Booster Vaccination Phase|Adverse Event|0
2665816|NCT00614614|9204563|P4|Booster Vaccination Phase|Adverse Event|1
2665817|NCT00614614|9204564|P3|Booster Vaccination Phase|Adverse Event|1
2665818|NCT00614614|9204565|P2|Booster Vaccination Phase|Adverse Event|0
2665819|NCT00614614|9204566|P1|Booster Vaccination Phase|Adverse Event|0
2665820|NCT00614614|9204562|P5|Primary Vaccination Phase|Other|0
2665821|NCT00614614|9204563|P4|Primary Vaccination Phase|Other|0
2665822|NCT00614614|9204564|P3|Primary Vaccination Phase|Other|0
2665823|NCT00614614|9204565|P2|Primary Vaccination Phase|Other|0
2665824|NCT00614614|9204566|P1|Primary Vaccination Phase|Other|4
2665825|NCT00614614|9204562|P5|Primary Vaccination Phase|Protocol Violation|0
2665826|NCT00614614|9204563|P4|Primary Vaccination Phase|Protocol Violation|0
2665827|NCT00614614|9204564|P3|Primary Vaccination Phase|Protocol Violation|0
2665828|NCT00614614|9204565|P2|Primary Vaccination Phase|Protocol Violation|3
2665829|NCT00614614|9204566|P1|Primary Vaccination Phase|Protocol Violation|9
2665830|NCT00614614|9204562|P5|Primary Vaccination Phase|Lost to Follow-up|0
2665831|NCT00614614|9204563|P4|Primary Vaccination Phase|Lost to Follow-up|0
2665832|NCT00614614|9204564|P3|Primary Vaccination Phase|Lost to Follow-up|0
2665833|NCT00614614|9204565|P2|Primary Vaccination Phase|Lost to Follow-up|8
2665834|NCT00614614|9204566|P1|Primary Vaccination Phase|Lost to Follow-up|26
2665835|NCT00614614|9204562|P5|Primary Vaccination Phase|Withdrawal by Subject|0
2665836|NCT00614614|9204563|P4|Primary Vaccination Phase|Withdrawal by Subject|0
2665837|NCT00614614|9204564|P3|Primary Vaccination Phase|Withdrawal by Subject|0
2665838|NCT00614614|9204565|P2|Primary Vaccination Phase|Withdrawal by Subject|6
2665839|NCT00614614|9204566|P1|Primary Vaccination Phase|Withdrawal by Subject|45
2665840|NCT00614614|9204562|P5|Primary Vaccination Phase|Adverse Event|0
2665841|NCT00614614|9204563|P4|Primary Vaccination Phase|Adverse Event|0
2665842|NCT00614614|9204564|P3|Primary Vaccination Phase|Adverse Event|0
2665843|NCT00614614|9204565|P2|Primary Vaccination Phase|Adverse Event|0
2665844|NCT00614614|9204566|P1|Primary Vaccination Phase|Adverse Event|6
2665845|NCT00614575|9204689|P1|Overall Study|No treatment|1
2665846|NCT00614575|9204689|P1|Overall Study|Irregularly enrolled patients|23
2665847|NCT00614575|9204689|P1|Overall Study|No data were collected.|18
2665848|NCT00614575|9204689|P1|Overall Study|Physician Decision|2
2665849|NCT00614575|9204689|P1|Overall Study|Death|3
2665850|NCT00614575|9204689|P1|Overall Study|Withdrawal by Subject|6
2665851|NCT00614575|9204689|P1|Overall Study|Lack of Efficacy|14
2665852|NCT00614575|9204689|P1|Overall Study|Lost to Follow-up|55
2665853|NCT00614575|9204689|P1|Overall Study|Adverse Event|106
2665854|NCT00614523|9204700|P2|Overall Study|Administrative Decision|46
2665855|NCT00614523|9204701|P1|Overall Study|Administrative Decision|23
2665856|NCT00614523|9204700|P2|Overall Study|Disease Progression|8
2665857|NCT00614523|9204701|P1|Overall Study|Disease Progression|0
2665858|NCT00614523|9204700|P2|Overall Study|Ineligibility Determined|2
2665859|NCT00614523|9204701|P1|Overall Study|Ineligibility Determined|1
2665860|NCT00614523|9204700|P2|Overall Study|Other|11
2665861|NCT00614523|9204701|P1|Overall Study|Other|6
2665862|NCT00614523|9204700|P2|Overall Study|Withdrawal by Subject|22
2665863|NCT00614523|9204701|P1|Overall Study|Withdrawal by Subject|12
2665864|NCT00614523|9204700|P2|Overall Study|Protocol Violation|2
2665865|NCT00614523|9204701|P1|Overall Study|Protocol Violation|3
2665866|NCT00614523|9204700|P2|Overall Study|Lost to Follow-up|1
2665867|NCT00614523|9204701|P1|Overall Study|Lost to Follow-up|0
2665868|NCT00614523|9204700|P2|Overall Study|Lack of Efficacy|11
2665869|NCT00614523|9204701|P1|Overall Study|Lack of Efficacy|9
2665870|NCT00614523|9204700|P2|Overall Study|Death|8
2665871|NCT00614523|9204701|P1|Overall Study|Death|5
2665872|NCT00614523|9204700|P2|Overall Study|Adverse Event|20
2665873|NCT00614523|9204701|P1|Overall Study|Adverse Event|4
2665874|NCT00614393|9204766|P5|Overall Study|Not Treated|2
2665875|NCT00614393|9204767|P4|Overall Study|Not Treated|0
2665876|NCT00614393|9204768|P3|Overall Study|Not Treated|0
2665877|NCT00614393|9204769|P2|Overall Study|Not Treated|0
2665878|NCT00614393|9204770|P1|Overall Study|Not Treated|0
2665879|NCT00614393|9204766|P5|Overall Study|Other|2
2665880|NCT00614393|9204767|P4|Overall Study|Other|4
2665881|NCT00614393|9204768|P3|Overall Study|Other|0
2665882|NCT00614393|9204769|P2|Overall Study|Other|0
2665883|NCT00614393|9204770|P1|Overall Study|Other|4
2665884|NCT00614393|9204766|P5|Overall Study|Withdrawal by Subject|13
2665885|NCT00614393|9204767|P4|Overall Study|Withdrawal by Subject|16
2665886|NCT00614393|9204768|P3|Overall Study|Withdrawal by Subject|1
2665887|NCT00614393|9204769|P2|Overall Study|Withdrawal by Subject|1
2665888|NCT00614393|9204770|P1|Overall Study|Withdrawal by Subject|20
2665889|NCT00614393|9204766|P5|Overall Study|Terminated by Sponsor|1
2665890|NCT00614393|9204767|P4|Overall Study|Terminated by Sponsor|0
2665891|NCT00614393|9204768|P3|Overall Study|Terminated by Sponsor|0
2665892|NCT00614393|9204769|P2|Overall Study|Terminated by Sponsor|0
2665893|NCT00614393|9204770|P1|Overall Study|Terminated by Sponsor|0
2665894|NCT00614393|9204766|P5|Overall Study|Protocol Violation|0
2665895|NCT00614393|9204767|P4|Overall Study|Protocol Violation|0
2665896|NCT00614393|9204768|P3|Overall Study|Protocol Violation|0
2665897|NCT00614393|9204769|P2|Overall Study|Protocol Violation|0
2665898|NCT00614393|9204770|P1|Overall Study|Protocol Violation|1
2665899|NCT00614393|9204766|P5|Overall Study|Progressive Disease|130
2665900|NCT00614393|9204767|P4|Overall Study|Progressive Disease|138
2665901|NCT00614393|9204768|P3|Overall Study|Progressive Disease|5
2665902|NCT00614393|9204769|P2|Overall Study|Progressive Disease|5
2665903|NCT00614393|9204770|P1|Overall Study|Progressive Disease|118
2665904|NCT00614393|9204766|P5|Overall Study|Physician Decision|9
2665905|NCT00614393|9204767|P4|Overall Study|Physician Decision|8
2665906|NCT00614393|9204768|P3|Overall Study|Physician Decision|1
2665907|NCT00614393|9204769|P2|Overall Study|Physician Decision|0
2665908|NCT00614393|9204770|P1|Overall Study|Physician Decision|17
2665909|NCT00614393|9204766|P5|Overall Study|Lost to Follow-up|2
2665910|NCT00614393|9204767|P4|Overall Study|Lost to Follow-up|1
2665911|NCT00614393|9204768|P3|Overall Study|Lost to Follow-up|0
2665912|NCT00614393|9204769|P2|Overall Study|Lost to Follow-up|0
2665913|NCT00614393|9204770|P1|Overall Study|Lost to Follow-up|0
2665914|NCT00614393|9204766|P5|Overall Study|Adverse Event|21
2665915|NCT00614393|9204767|P4|Overall Study|Adverse Event|13
2665916|NCT00614393|9204768|P3|Overall Study|Adverse Event|3
2665917|NCT00614393|9204769|P2|Overall Study|Adverse Event|2
2665918|NCT00614393|9204770|P1|Overall Study|Adverse Event|20
2665919|NCT00614380|9204816|P4|Overall Study|Consent withdrawn|0
2665920|NCT00614380|9204817|P3|Overall Study|Consent withdrawn|0
2665921|NCT00614380|9204818|P2|Overall Study|Consent withdrawn|1
2665922|NCT00614380|9204819|P1|Overall Study|Consent withdrawn|3
2665923|NCT00614380|9204816|P4|Overall Study|Non compliant with the protocol|2
2665924|NCT00614380|9204817|P3|Overall Study|Non compliant with the protocol|1
2665925|NCT00614380|9204818|P2|Overall Study|Non compliant with the protocol|2
2665926|NCT00614380|9204819|P1|Overall Study|Non compliant with the protocol|12
2665927|NCT00614380|9204816|P4|Overall Study|Lost to Follow-up|0
2665928|NCT00614380|9204817|P3|Overall Study|Lost to Follow-up|0
2665929|NCT00614380|9204818|P2|Overall Study|Lost to Follow-up|1
2665930|NCT00614380|9204819|P1|Overall Study|Lost to Follow-up|6
2665931|NCT00614380|9204816|P4|Overall Study|Adverse Event|0
2665932|NCT00614380|9204817|P3|Overall Study|Adverse Event|0
2665933|NCT00614380|9204818|P2|Overall Study|Adverse Event|4
2665934|NCT00614380|9204819|P1|Overall Study|Adverse Event|14
2665935|NCT00614120|9204886|P4|Overall Study|Lost to Follow-up|4
2665936|NCT00614120|9204887|P3|Overall Study|Lost to Follow-up|3
2665937|NCT00614120|9204888|P2|Overall Study|Lost to Follow-up|2
2665938|NCT00614120|9204889|P1|Overall Study|Lost to Follow-up|1
2665939|NCT00614120|9204886|P4|Overall Study|Taken inhibition medication eg Prandin|1
2665940|NCT00614120|9204887|P3|Overall Study|Taken inhibition medication eg Prandin|1
2665941|NCT00614120|9204888|P2|Overall Study|Taken inhibition medication eg Prandin|0
2665942|NCT00614120|9204889|P1|Overall Study|Taken inhibition medication eg Prandin|0
2665943|NCT00614120|9204886|P4|Overall Study|Late syphilis, latent|0
2665944|NCT00614120|9204887|P3|Overall Study|Late syphilis, latent|0
2665945|NCT00614120|9204888|P2|Overall Study|Late syphilis, latent|0
2665946|NCT00614120|9204889|P1|Overall Study|Late syphilis, latent|1
2665947|NCT00614120|9204886|P4|Overall Study|Lack of trial product|0
2665948|NCT00614120|9204887|P3|Overall Study|Lack of trial product|2
2665949|NCT00614120|9204888|P2|Overall Study|Lack of trial product|3
2665950|NCT00614120|9204889|P1|Overall Study|Lack of trial product|3
2665951|NCT00614120|9204886|P4|Overall Study|Hypoglycaemia|1
2665952|NCT00614120|9204887|P3|Overall Study|Hypoglycaemia|0
2665953|NCT00614120|9204888|P2|Overall Study|Hypoglycaemia|0
2665954|NCT00614120|9204889|P1|Overall Study|Hypoglycaemia|0
2665955|NCT00614120|9204886|P4|Overall Study|hCG positive (not pregnant)|0
2665956|NCT00614120|9204887|P3|Overall Study|hCG positive (not pregnant)|1
2665957|NCT00614120|9204888|P2|Overall Study|hCG positive (not pregnant)|0
2665958|NCT00614120|9204889|P1|Overall Study|hCG positive (not pregnant)|0
2665959|NCT00614120|9204886|P4|Overall Study|Did not meet trial criteria|1
2665960|NCT00614120|9204887|P3|Overall Study|Did not meet trial criteria|1
2665961|NCT00614120|9204888|P2|Overall Study|Did not meet trial criteria|1
2665962|NCT00614120|9204889|P1|Overall Study|Did not meet trial criteria|0
2665963|NCT00614120|9204886|P4|Overall Study|Withdrawal by Subject|3
2665964|NCT00614120|9204887|P3|Overall Study|Withdrawal by Subject|16
2665965|NCT00614120|9204888|P2|Overall Study|Withdrawal by Subject|10
2665966|NCT00614120|9204889|P1|Overall Study|Withdrawal by Subject|9
2665967|NCT00614120|9204886|P4|Overall Study|Withdrawal criteria|0
2665968|NCT00614120|9204887|P3|Overall Study|Withdrawal criteria|0
2665969|NCT00614120|9204888|P2|Overall Study|Withdrawal criteria|0
2665970|NCT00614120|9204889|P1|Overall Study|Withdrawal criteria|1
2665971|NCT00614120|9204886|P4|Overall Study|Protocol Violation|1
2665972|NCT00614120|9204887|P3|Overall Study|Protocol Violation|3
2665973|NCT00614120|9204888|P2|Overall Study|Protocol Violation|5
2665974|NCT00614120|9204889|P1|Overall Study|Protocol Violation|2
2665975|NCT00614120|9204886|P4|Overall Study|Lack of Efficacy|2
2665976|NCT00614120|9204887|P3|Overall Study|Lack of Efficacy|2
2665977|NCT00614120|9204888|P2|Overall Study|Lack of Efficacy|3
2665978|NCT00614120|9204889|P1|Overall Study|Lack of Efficacy|3
2665979|NCT00614120|9204886|P4|Overall Study|Adverse Event|3
2665980|NCT00614120|9204887|P3|Overall Study|Adverse Event|30
2665981|NCT00614120|9204888|P2|Overall Study|Adverse Event|22
2665982|NCT00614120|9204889|P1|Overall Study|Adverse Event|9
2665983|NCT00614055|9204930|P3|Overall Study|Unclassified|2
2665984|NCT00614055|9204931|P2|Overall Study|Unclassified|4
2665985|NCT00614055|9204932|P1|Overall Study|Unclassified|1
2665986|NCT00614055|9204930|P3|Overall Study|Lack of Efficacy|2
2665987|NCT00614055|9204931|P2|Overall Study|Lack of Efficacy|0
2665988|NCT00614055|9204932|P1|Overall Study|Lack of Efficacy|0
2665989|NCT00614055|9204930|P3|Overall Study|Protocol Violation|1
2665990|NCT00614055|9204931|P2|Overall Study|Protocol Violation|2
2665991|NCT00614055|9204932|P1|Overall Study|Protocol Violation|2
2665992|NCT00614055|9204930|P3|Overall Study|Adverse Event|0
2665993|NCT00614055|9204931|P2|Overall Study|Adverse Event|0
2665994|NCT00614055|9204932|P1|Overall Study|Adverse Event|1
2665995|NCT00613951|9204979|P3|Overall Study|Unclassified|2
2665996|NCT00613951|9204980|P2|Overall Study|Unclassified|3
2665997|NCT00613951|9204981|P1|Overall Study|Unclassified|5
2665998|NCT00613951|9204979|P3|Overall Study|Protocol Violation|1
2665999|NCT00613951|9204980|P2|Overall Study|Protocol Violation|1
2666000|NCT00613951|9204981|P1|Overall Study|Protocol Violation|1
2666001|NCT00613951|9204979|P3|Overall Study|Lack of Efficacy|1
2666002|NCT00613951|9204980|P2|Overall Study|Lack of Efficacy|1
2666003|NCT00613951|9204981|P1|Overall Study|Lack of Efficacy|0
2666004|NCT00613951|9204979|P3|Overall Study|Adverse Event|1
2666005|NCT00613951|9204980|P2|Overall Study|Adverse Event|0
2666006|NCT00613951|9204981|P1|Overall Study|Adverse Event|1
2666007|NCT00613938|9205026|P4|Overall Study|Other|3
2666008|NCT00613938|9205027|P3|Overall Study|Other|1
2666009|NCT00613938|9205028|P2|Overall Study|Other|2
2666010|NCT00613938|9205029|P1|Overall Study|Other|1
2666011|NCT00613938|9205026|P4|Overall Study|Lack of Efficacy|9
2666012|NCT00613938|9205027|P3|Overall Study|Lack of Efficacy|5
2666013|NCT00613938|9205028|P2|Overall Study|Lack of Efficacy|18
2666014|NCT00613938|9205029|P1|Overall Study|Lack of Efficacy|16
2666015|NCT00613938|9205026|P4|Overall Study|Adverse Event|5
2666016|NCT00613938|9205027|P3|Overall Study|Adverse Event|8
2666017|NCT00613938|9205028|P2|Overall Study|Adverse Event|4
2666018|NCT00613938|9205029|P1|Overall Study|Adverse Event|1
2666019|NCT00613938|9205026|P4|Overall Study|Withdrawal by Subject|9
2666020|NCT00613938|9205027|P3|Overall Study|Withdrawal by Subject|9
2666021|NCT00613938|9205028|P2|Overall Study|Withdrawal by Subject|4
2666022|NCT00613938|9205029|P1|Overall Study|Withdrawal by Subject|2
2666023|NCT00613925|9205061|P2|Overall Study|1 did not tolerate outpatient biopsy|1
2666024|NCT00613925|9205062|P1|Overall Study|1 did not tolerate outpatient biopsy|0
2666025|NCT00613834|9205072|P2|Overall Study|Withdrawal by Subject|3
2666026|NCT00613834|9205073|P1|Overall Study|Withdrawal by Subject|0
2666027|NCT00613821|9205085|P2|Overall Study|Physician Decision|1
2666028|NCT00613821|9205086|P1|Overall Study|Physician Decision|1
2666029|NCT00613821|9205085|P2|Overall Study|Withdrawal by Subject|0
2666030|NCT00613821|9205086|P1|Overall Study|Withdrawal by Subject|1
2666031|NCT00613730|9205092|P1|Overall Study|Administrative decision|1
2666032|NCT00613730|9205092|P1|Overall Study|Disease progression|2
2666033|NCT00613626|9205101|P3|Overall Study|Ineligible|0
2666034|NCT00613626|9205102|P2|Overall Study|Ineligible|1
2666035|NCT00613626|9205103|P1|Overall Study|Ineligible|0
2666036|NCT00613574|9205119|P1|Overall Study|Other|1
2666037|NCT00613574|9205119|P1|Overall Study|Lost to Follow-up|2
2666038|NCT00613574|9205119|P1|Overall Study|Adverse Event|3
2666039|NCT00613509|9205131|P2|Cycle 1|Other administrative reason|1
2666040|NCT00613509|9205132|P1|Cycle 1|Other administrative reason|0
2666041|NCT00613509|9205131|P2|Cycle 1|Unacceptable Toxicity|0
2666042|NCT00613509|9205132|P1|Cycle 1|Unacceptable Toxicity|1
2666043|NCT00613509|9205131|P2|Cycle 1|Disease Progression|6
2666044|NCT00613509|9205132|P1|Cycle 1|Disease Progression|2
2666045|NCT00613509|9205131|P2|Cycle 1|Adverse Event|1
2666046|NCT00613509|9205132|P1|Cycle 1|Adverse Event|2
2666047|NCT00613366|9205178|P2|Overall Study|Withdrawal by Subject|2
2666048|NCT00613366|9205179|P1|Overall Study|Withdrawal by Subject|3
2666049|NCT00613327|9205187|P1|Overall Study|Other|47
2666050|NCT00613327|9205187|P1|Overall Study|Protocol Violation|2
2666051|NCT00613327|9205187|P1|Overall Study|Withdrawal by Subject|6
2666052|NCT00613327|9205187|P1|Overall Study|Lost to Follow-up|8
2666053|NCT00613327|9205187|P1|Overall Study|Adverse Event|38
2666054|NCT00613314|9205206|P1|Overall Study|Other reason not defined above|90
2666055|NCT00613314|9205206|P1|Overall Study|Lost to Follow-up|46
2666056|NCT00613314|9205206|P1|Overall Study|Protocol Violation|14
2666057|NCT00613314|9205206|P1|Overall Study|Adverse Event|5
2666058|NCT00613301|9205214|P1|Overall Study|Irregularly enrolled patients|12
2666059|NCT00613301|9205214|P1|Overall Study|No data was collected|53
2666060|NCT00613301|9205214|P1|Overall Study|Physician Decision|2
2666061|NCT00613301|9205214|P1|Overall Study|Lack of Efficacy|13
2666062|NCT00613301|9205214|P1|Overall Study|Death|6
2666063|NCT00613301|9205214|P1|Overall Study|Withdrawal by Subject|5
2666064|NCT00613301|9205214|P1|Overall Study|Lost to Follow-up|88
2666065|NCT00613301|9205214|P1|Overall Study|Adverse Event|49
2666066|NCT00613106|9205223|P2|Overall Study|misc|3
2666067|NCT00613106|9205224|P1|Overall Study|misc|4
2666068|NCT00613106|9205223|P2|Overall Study|Lost to Follow-up|2
2666069|NCT00613106|9205224|P1|Overall Study|Lost to Follow-up|7
2666070|NCT00613106|9205223|P2|Overall Study|Withdrawal by Subject|3
2666071|NCT00613106|9205224|P1|Overall Study|Withdrawal by Subject|6
2666072|NCT00613106|9205223|P2|Overall Study|Adverse Event|1
2666073|NCT00613106|9205224|P1|Overall Study|Adverse Event|3
2666074|NCT00613080|9205230|P1|Overall Study|Ineligible / no protocol treatment|11
2666075|NCT00613015|9205265|P6|Overall Study|Lost to Follow-up|3
2666076|NCT00613015|9205266|P5|Overall Study|Lost to Follow-up|2
2666077|NCT00613015|9205267|P4|Overall Study|Lost to Follow-up|3
2666078|NCT00613015|9205268|P3|Overall Study|Lost to Follow-up|3
2666079|NCT00613015|9205269|P2|Overall Study|Lost to Follow-up|1
2666080|NCT00613015|9205270|P1|Overall Study|Lost to Follow-up|0
2666081|NCT00612807|9205306|P2|Overall Study|Withdrawal by Subject|0
2666082|NCT00612807|9205307|P1|Overall Study|Withdrawal by Subject|2
2666083|NCT00612690|9205342|P2|Overall Study|Withdrawal by Site|0
2666084|NCT00612690|9205343|P1|Overall Study|Withdrawal by Site|11
2666085|NCT00612690|9205342|P2|Overall Study|Withdrawal by Subject|20
2666086|NCT00612690|9205343|P1|Overall Study|Withdrawal by Subject|32
2666087|NCT00612690|9205342|P2|Overall Study|Lost to Follow-up|98
2666088|NCT00612690|9205343|P1|Overall Study|Lost to Follow-up|72
2666089|NCT00612677|9205351|P1|Overall Study|study closed before treatment started|1
2666090|NCT00612534|9205419|P4|Overall Study|Other Reason|0
2666091|NCT00612534|9205420|P3|Overall Study|Other Reason|0
2666092|NCT00612534|9205421|P2|Overall Study|Other Reason|1
2666093|NCT00612534|9205422|P1|Overall Study|Other Reason|0
2666094|NCT00612534|9205419|P4|Overall Study|Lack of Efficacy|16
2666095|NCT00612534|9205420|P3|Overall Study|Lack of Efficacy|5
2666096|NCT00612534|9205421|P2|Overall Study|Lack of Efficacy|12
2666097|NCT00612534|9205422|P1|Overall Study|Lack of Efficacy|13
2666098|NCT00612534|9205419|P4|Overall Study|Adverse Event|1
2666099|NCT00612534|9205420|P3|Overall Study|Adverse Event|2
2666100|NCT00612534|9205421|P2|Overall Study|Adverse Event|4
2666101|NCT00612534|9205422|P1|Overall Study|Adverse Event|0
2666102|NCT00612508|9205434|P2|Overall Study|Withdrawal by Subject|4
2666103|NCT00612508|9205435|P1|Overall Study|Withdrawal by Subject|3
2666104|NCT00612456|9205446|P3|Overall Study|Withdrawal by Subject|0
2666105|NCT00612456|9205447|P2|Overall Study|Withdrawal by Subject|1
2666106|NCT00612456|9205448|P1|Overall Study|Withdrawal by Subject|0
2666107|NCT00612456|9205446|P3|Overall Study|Lack of Efficacy|0
2666108|NCT00612456|9205447|P2|Overall Study|Lack of Efficacy|1
2666109|NCT00612456|9205448|P1|Overall Study|Lack of Efficacy|1
2666110|NCT00612456|9205446|P3|Overall Study|Adverse Event|0
2666111|NCT00612456|9205447|P2|Overall Study|Adverse Event|0
2666112|NCT00612456|9205448|P1|Overall Study|Adverse Event|1
2666113|NCT00612352|9205511|P2|Overall Study|didn't return calls/show up on test date|1
2666114|NCT00612352|9205512|P1|Overall Study|didn't return calls/show up on test date|4
2666115|NCT00612352|9205511|P2|Overall Study|moved out of state|0
2666116|NCT00612352|9205512|P1|Overall Study|moved out of state|1
2666117|NCT00612352|9205511|P2|Overall Study|Withdrawal by Subject|5
2666118|NCT00612352|9205512|P1|Overall Study|Withdrawal by Subject|3
2666119|NCT00612352|9205511|P2|Overall Study|Adverse Event|0
2666120|NCT00612352|9205512|P1|Overall Study|Adverse Event|1
2666121|NCT00612313|9205632|P2|Overall Study|Lost to Follow-up|4
2666122|NCT00612313|9205633|P1|Overall Study|Lost to Follow-up|11
2666123|NCT00612313|9205632|P2|Overall Study|Withdrawal by Subject|9
2666124|NCT00612313|9205633|P1|Overall Study|Withdrawal by Subject|6
2666125|NCT00612105|9205675|P2|Period Title 3: 3-Week Taper Phase|Other|0
2666126|NCT00612105|9205676|P1|Period Title 3: 3-Week Taper Phase|Other|1
2666127|NCT00612105|9205675|P2|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0
2666128|NCT00612105|9205676|P1|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1
2666129|NCT00612105|9205675|P2|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
2666130|NCT00612105|9205676|P1|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
2666131|NCT00612105|9205675|P2|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1
2666132|NCT00612105|9205676|P1|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9
2666133|NCT00612105|9205675|P2|Period Title 1: 6-Week Titration Phase|Other|1
2666134|NCT00612105|9205676|P1|Period Title 1: 6-Week Titration Phase|Other|0
2666135|NCT00612105|9205675|P2|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0
2666136|NCT00612105|9205676|P1|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5
2666137|NCT00612105|9205675|P2|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1
2666138|NCT00612105|9205676|P1|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3
2666139|NCT00612105|9205675|P2|Period Title 1: 6-Week Titration Phase|Protocol Violation|0
2666140|NCT00612105|9205676|P1|Period Title 1: 6-Week Titration Phase|Protocol Violation|1
2666141|NCT00612105|9205675|P2|Period Title 1: 6-Week Titration Phase|Physician Decision|1
2666142|NCT00612105|9205676|P1|Period Title 1: 6-Week Titration Phase|Physician Decision|1
2666143|NCT00612105|9205675|P2|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0
2666144|NCT00612105|9205676|P1|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2
2666145|NCT00612105|9205675|P2|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1
2666146|NCT00612105|9205676|P1|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6
2666147|NCT00612105|9205675|P2|Period Title 1: 6-Week Titration Phase|Adverse Event|1
2666148|NCT00612105|9205676|P1|Period Title 1: 6-Week Titration Phase|Adverse Event|18
2666149|NCT00612066|9205726|P1|Overall Study|Adverse Event|1
2666150|NCT00612040|9205733|P3|Overall Study|Unclassified|5
2666151|NCT00612040|9205734|P2|Overall Study|Unclassified|2
2666152|NCT00612040|9205735|P1|Overall Study|Unclassified|2
2666153|NCT00612040|9205733|P3|Overall Study|Lack of Efficacy|0
2666154|NCT00612040|9205734|P2|Overall Study|Lack of Efficacy|1
2666155|NCT00612040|9205735|P1|Overall Study|Lack of Efficacy|2
2666156|NCT00612040|9205733|P3|Overall Study|Protocol Violation|1
2666157|NCT00612040|9205734|P2|Overall Study|Protocol Violation|2
2666158|NCT00612040|9205735|P1|Overall Study|Protocol Violation|1
2666159|NCT00612040|9205733|P3|Overall Study|Adverse Event|1
2666160|NCT00612040|9205734|P2|Overall Study|Adverse Event|2
2666161|NCT00612040|9205735|P1|Overall Study|Adverse Event|0
2666162|NCT00611923|9205781|P2|Overall Study|Withdrawal by Subject|2
2666163|NCT00611923|9205782|P1|Overall Study|Withdrawal by Subject|2
2666164|NCT00611884|9205827|P4|Overall Study|Unclassified|3
2666165|NCT00611884|9205828|P3|Overall Study|Unclassified|2
2666166|NCT00611884|9205829|P2|Overall Study|Unclassified|4
2666167|NCT00611884|9205830|P1|Overall Study|Unclassified|7
2666168|NCT00611884|9205827|P4|Overall Study|Lack of Efficacy|0
2666169|NCT00611884|9205828|P3|Overall Study|Lack of Efficacy|0
2666170|NCT00611884|9205829|P2|Overall Study|Lack of Efficacy|1
2666171|NCT00611884|9205830|P1|Overall Study|Lack of Efficacy|0
2666172|NCT00611884|9205827|P4|Overall Study|Non-Compliance|2
2666173|NCT00611884|9205828|P3|Overall Study|Non-Compliance|2
2666174|NCT00611884|9205829|P2|Overall Study|Non-Compliance|4
2666175|NCT00611884|9205830|P1|Overall Study|Non-Compliance|1
2666176|NCT00611884|9205827|P4|Overall Study|Adverse Event|1
2666177|NCT00611884|9205828|P3|Overall Study|Adverse Event|0
2666178|NCT00611884|9205829|P2|Overall Study|Adverse Event|0
2666179|NCT00611884|9205830|P1|Overall Study|Adverse Event|1
2666180|NCT00611858|9205884|P1|Overall Study|Withdrawal by Subject|2
2666181|NCT00611858|9205884|P1|Overall Study|Adverse Event|2
2666182|NCT00611806|9205896|P2|Overall Study|Lost to Follow-up|0
2666183|NCT00611806|9205897|P1|Overall Study|Lost to Follow-up|6
2666184|NCT00611806|9205896|P2|Overall Study|Adverse Event|1
2666185|NCT00611806|9205897|P1|Overall Study|Adverse Event|2
2666186|NCT00611806|9205896|P2|Overall Study|Withdrawal by Subject|2
2666187|NCT00611806|9205897|P1|Overall Study|Withdrawal by Subject|8
2666188|NCT00611767|9205911|P2|Overall Study|Physician Decision|0
2666189|NCT00611767|9205912|P1|Overall Study|Physician Decision|1
2666190|NCT00611767|9205911|P2|Overall Study|didn't like the medication|1
2666191|NCT00611767|9205912|P1|Overall Study|didn't like the medication|1
2666192|NCT00611767|9205911|P2|Overall Study|Thiopental not available|0
2666193|NCT00611767|9205912|P1|Overall Study|Thiopental not available|3
2666194|NCT00611767|9205911|P2|Overall Study|Withdrawal by Subject|1
2666195|NCT00611767|9205912|P1|Overall Study|Withdrawal by Subject|4
2666196|NCT00611715|9206074|P2|Overall Study|two patients are still on treatment|0
2666197|NCT00611715|9206075|P1|Overall Study|two patients are still on treatment|2
2666198|NCT00611715|9206074|P2|Overall Study|Death|0
2666199|NCT00611715|9206075|P1|Overall Study|Death|1
2666200|NCT00611715|9206074|P2|Overall Study|Adverse Event|1
2666201|NCT00611715|9206075|P1|Overall Study|Adverse Event|9
2666202|NCT00611715|9206074|P2|Overall Study|Withdrawal by Subject|1
2666203|NCT00611715|9206075|P1|Overall Study|Withdrawal by Subject|5
2666204|NCT00611715|9206074|P2|Overall Study|Disease Progression|4
2666205|NCT00611715|9206075|P1|Overall Study|Disease Progression|24
2666206|NCT00611559|9206095|P3|Overall Study|Protocol Violation|1
2666207|NCT00611559|9206096|P2|Overall Study|Protocol Violation|0
2666208|NCT00611559|9206097|P1|Overall Study|Protocol Violation|1
2666209|NCT00611559|9206095|P3|Overall Study|Lost to Follow-up|0
2666210|NCT00611559|9206096|P2|Overall Study|Lost to Follow-up|1
2666211|NCT00611559|9206097|P1|Overall Study|Lost to Follow-up|0
2666212|NCT00611533|9206156|P2|Second Intervention (6 Weeks)|Adverse Event|2
2666213|NCT00611533|9206157|P1|Second Intervention (6 Weeks)|Adverse Event|0
2666214|NCT00611533|9206156|P2|First Intervention (6 Weeks)|Adverse Event|1
2666215|NCT00611533|9206157|P1|First Intervention (6 Weeks)|Adverse Event|0
2666216|NCT00611533|9206156|P2|First Intervention (6 Weeks)|Never started study|1
2666217|NCT00611533|9206157|P1|First Intervention (6 Weeks)|Never started study|0
2666218|NCT00611455|9206191|P3|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49
2666219|NCT00611455|9206192|P2|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
2666220|NCT00611455|9206193|P1|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
2666221|NCT00611455|9206191|P3|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13
2666222|NCT00611455|9206192|P2|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
2666223|NCT00611455|9206193|P1|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
2666224|NCT00611455|9206191|P3|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80
2666225|NCT00611455|9206192|P2|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
2666226|NCT00611455|9206193|P1|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
2666227|NCT00611455|9206191|P3|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23
2666228|NCT00611455|9206192|P2|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
2666229|NCT00611455|9206193|P1|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
2666230|NCT00611455|9206191|P3|Follow-up Period (Approximately 2 Years)|Protocol Violation|4
2666231|NCT00611455|9206192|P2|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
2666232|NCT00611455|9206193|P1|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
2666233|NCT00611455|9206191|P3|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12
2666234|NCT00611455|9206192|P2|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
2666235|NCT00611455|9206193|P1|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
2666236|NCT00611455|9206191|P3|Follow-up Period (Approximately 2 Years)|Adverse Event|30
2666237|NCT00611455|9206192|P2|Follow-up Period (Approximately 2 Years)|Adverse Event|0
2666238|NCT00611455|9206193|P1|Follow-up Period (Approximately 2 Years)|Adverse Event|0
2666239|NCT00611455|9206191|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
2666240|NCT00611455|9206192|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18
2666241|NCT00611455|9206193|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
2666242|NCT00611455|9206191|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
2666243|NCT00611455|9206192|P2|OL Treatment Period (120 Weeks)|Physician Decision|5
2666244|NCT00611455|9206193|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
2666245|NCT00611455|9206191|P3|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
2666246|NCT00611455|9206192|P2|OL Treatment Period (120 Weeks)|Lost to Follow-up|5
2666247|NCT00611455|9206193|P1|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
2666248|NCT00611455|9206191|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
2666249|NCT00611455|9206192|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110
2666250|NCT00611455|9206193|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
2666251|NCT00611455|9206191|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
2666252|NCT00611455|9206192|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12
2666253|NCT00611455|9206193|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
2666254|NCT00611455|9206191|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
2666255|NCT00611455|9206192|P2|OL Treatment Period (120 Weeks)|Protocol Violation|3
2666256|NCT00611455|9206193|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
2666257|NCT00611455|9206191|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
2666258|NCT00611455|9206192|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|9
2666259|NCT00611455|9206193|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
2666260|NCT00611455|9206191|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
2666261|NCT00611455|9206192|P2|OL Treatment Period (120 Weeks)|Adverse Event|17
2666262|NCT00611455|9206193|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
2666263|NCT00611455|9206191|P3|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
2666264|NCT00611455|9206192|P2|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
2666265|NCT00611455|9206193|P1|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1
2666266|NCT00611455|9206191|P3|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0
2666267|NCT00611455|9206192|P2|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
2666268|NCT00611455|9206193|P1|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
2666269|NCT00611455|9206191|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
2666270|NCT00611455|9206192|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3
2666271|NCT00611455|9206193|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2
2666272|NCT00611455|9206191|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
2666273|NCT00611455|9206192|P2|DB Treatment Period (24 Weeks)|Protocol Violation|1
2666274|NCT00611455|9206193|P1|DB Treatment Period (24 Weeks)|Protocol Violation|4
2666275|NCT00611455|9206191|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
2666276|NCT00611455|9206192|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
2666277|NCT00611455|9206193|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|2
2666278|NCT00611455|9206191|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
2666279|NCT00611455|9206192|P2|DB Treatment Period (24 Weeks)|Adverse Event|8
2666280|NCT00611455|9206193|P1|DB Treatment Period (24 Weeks)|Adverse Event|2
2666281|NCT00611247|9206373|P2|Overall Study|Lack of Efficacy|16
2666282|NCT00611247|9206374|P1|Overall Study|Lack of Efficacy|1
2666283|NCT00611247|9206373|P2|Overall Study|Death|5
2666284|NCT00611247|9206374|P1|Overall Study|Death|1
2666285|NCT00611130|9206386|P2|Overall Study|Death|0
2666286|NCT00611130|9206387|P1|Overall Study|Death|1
2666287|NCT00611130|9206386|P2|Overall Study|Adverse Event|0
2666288|NCT00611130|9206387|P1|Overall Study|Adverse Event|1
2666289|NCT00611130|9206386|P2|Overall Study|Administrative|1
2666290|NCT00611130|9206387|P1|Overall Study|Administrative|1
2666291|NCT00611130|9206386|P2|Overall Study|Incarceration|2
2666292|NCT00611130|9206387|P1|Overall Study|Incarceration|3
2666293|NCT00611130|9206386|P2|Overall Study|Other|4
2666294|NCT00611130|9206387|P1|Overall Study|Other|5
2666295|NCT00611130|9206386|P2|Overall Study|Withdrawal by Subject|5
2666296|NCT00611130|9206387|P1|Overall Study|Withdrawal by Subject|6
2666297|NCT00611130|9206386|P2|Overall Study|Protocol noncompliance|6
2666298|NCT00611130|9206387|P1|Overall Study|Protocol noncompliance|7
2666299|NCT00611130|9206386|P2|Overall Study|Lost to Follow-up|29
2666300|NCT00611130|9206387|P1|Overall Study|Lost to Follow-up|25
2666301|NCT00611026|9206397|P3|Double-blind Treatment Period|Other|18
2666302|NCT00611026|9206398|P2|Double-blind Treatment Period|Other|20
2666303|NCT00611026|9206399|P1|Double-blind Treatment Period|Other|13
2666304|NCT00611026|9206397|P3|Double-blind Treatment Period|Withdrawal by Subject|16
2666305|NCT00611026|9206398|P2|Double-blind Treatment Period|Withdrawal by Subject|19
2666306|NCT00611026|9206399|P1|Double-blind Treatment Period|Withdrawal by Subject|7
2666307|NCT00611026|9206397|P3|Double-blind Treatment Period|Lost to Follow-up|14
2666308|NCT00611026|9206398|P2|Double-blind Treatment Period|Lost to Follow-up|11
2666309|NCT00611026|9206399|P1|Double-blind Treatment Period|Lost to Follow-up|6
2666310|NCT00611026|9206397|P3|Double-blind Treatment Period|Lack of Efficacy|4
2666311|NCT00611026|9206398|P2|Double-blind Treatment Period|Lack of Efficacy|10
2666312|NCT00611026|9206399|P1|Double-blind Treatment Period|Lack of Efficacy|11
2666313|NCT00611026|9206397|P3|Double-blind Treatment Period|Adverse Event|46
2666314|NCT00611026|9206398|P2|Double-blind Treatment Period|Adverse Event|28
2666315|NCT00611026|9206399|P1|Double-blind Treatment Period|Adverse Event|9
2666316|NCT00611026|9206397|P3|Double-blind Treatment Period|Death|0
2666317|NCT00611026|9206398|P2|Double-blind Treatment Period|Death|0
2666318|NCT00611026|9206399|P1|Double-blind Treatment Period|Death|1
2666319|NCT00611026|9206397|P3|Randomized to Double-blind Treatment|Not treated|3
2666320|NCT00611026|9206398|P2|Randomized to Double-blind Treatment|Not treated|1
2666321|NCT00611026|9206399|P1|Randomized to Double-blind Treatment|Not treated|2
2666322|NCT00610857|9206476|P1|Overall Study|Not evaluable for response|2
2666323|NCT00610714|9206520|P2|Overall Study|Study completion at 120 PFS events|2
2666324|NCT00610714|9206521|P1|Overall Study|Study completion at 120 PFS events|2
2666325|NCT00610714|9206520|P2|Overall Study|Withdrawal by Subject|3
2666326|NCT00610714|9206521|P1|Overall Study|Withdrawal by Subject|9
2666327|NCT00610714|9206520|P2|Overall Study|Death|18
2666328|NCT00610714|9206521|P1|Overall Study|Death|12
2666329|NCT00610714|9206520|P2|Overall Study|Adverse Event|1
2666330|NCT00610714|9206521|P1|Overall Study|Adverse Event|3
2666331|NCT00610675|9206559|P1|Overall Study|Other reason (not specified)|25
2666332|NCT00610675|9206559|P1|Overall Study|Lost to Follow-up|31
2666333|NCT00610675|9206559|P1|Overall Study|Lack of Compliance|7
2666334|NCT00610675|9206559|P1|Overall Study|Reasons unrelated to trial|27
2666335|NCT00610675|9206559|P1|Overall Study|Withdrawal by Subject|28
2666336|NCT00610675|9206559|P1|Overall Study|Insufficient Effect|31
2666337|NCT00610675|9206559|P1|Overall Study|Adverse Event|67
2666338|NCT00610675|9206559|P1|Overall Study|Untreated|4
2666339|NCT00610649|9206581|P11|Overall Study|Withdrawal by Subject|0
2666340|NCT00610649|9206582|P10|Overall Study|Withdrawal by Subject|1
2666341|NCT00610649|9206583|P9|Overall Study|Withdrawal by Subject|0
2666342|NCT00610649|9206584|P8|Overall Study|Withdrawal by Subject|0
2666343|NCT00610649|9206585|P7|Overall Study|Withdrawal by Subject|0
2666344|NCT00610649|9206586|P6|Overall Study|Withdrawal by Subject|0
2666345|NCT00610649|9206587|P5|Overall Study|Withdrawal by Subject|0
2666346|NCT00610649|9206588|P4|Overall Study|Withdrawal by Subject|0
2666347|NCT00610649|9206589|P3|Overall Study|Withdrawal by Subject|0
2666348|NCT00610649|9206590|P2|Overall Study|Withdrawal by Subject|0
2666349|NCT00610649|9206591|P1|Overall Study|Withdrawal by Subject|0
2666350|NCT00610649|9206581|P11|Overall Study|Family Emergency|0
2666351|NCT00610649|9206582|P10|Overall Study|Family Emergency|0
2666352|NCT00610649|9206583|P9|Overall Study|Family Emergency|0
2666353|NCT00610649|9206584|P8|Overall Study|Family Emergency|0
2666354|NCT00610649|9206585|P7|Overall Study|Family Emergency|0
2666355|NCT00610649|9206586|P6|Overall Study|Family Emergency|0
2666356|NCT00610649|9206587|P5|Overall Study|Family Emergency|0
2666357|NCT00610649|9206588|P4|Overall Study|Family Emergency|0
2666358|NCT00610649|9206589|P3|Overall Study|Family Emergency|0
2666359|NCT00610649|9206590|P2|Overall Study|Family Emergency|1
2666360|NCT00610649|9206591|P1|Overall Study|Family Emergency|0
2666361|NCT00610649|9206581|P11|Overall Study|Adverse Event|1
2666362|NCT00610649|9206582|P10|Overall Study|Adverse Event|0
2666363|NCT00610649|9206583|P9|Overall Study|Adverse Event|0
2666364|NCT00610649|9206584|P8|Overall Study|Adverse Event|0
2666365|NCT00610649|9206585|P7|Overall Study|Adverse Event|0
2666366|NCT00610649|9206586|P6|Overall Study|Adverse Event|0
2666367|NCT00610649|9206587|P5|Overall Study|Adverse Event|0
2666368|NCT00610649|9206588|P4|Overall Study|Adverse Event|0
2666369|NCT00610649|9206589|P3|Overall Study|Adverse Event|0
2666370|NCT00610649|9206590|P2|Overall Study|Adverse Event|0
2666371|NCT00610649|9206591|P1|Overall Study|Adverse Event|1
2666372|NCT00610441|9206677|P4|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
2666373|NCT00610441|9206678|P3|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
2666374|NCT00610441|9206679|P2|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
2666375|NCT00610441|9206680|P1|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1
2666376|NCT00610441|9206677|P4|Treatment Period 2 - 3 Weeks|Adverse Event|1
2666377|NCT00610441|9206678|P3|Treatment Period 2 - 3 Weeks|Adverse Event|0
2666378|NCT00610441|9206679|P2|Treatment Period 2 - 3 Weeks|Adverse Event|0
2666379|NCT00610441|9206680|P1|Treatment Period 2 - 3 Weeks|Adverse Event|0
2666380|NCT00610441|9206677|P4|Treatment Period 2 - 3 Weeks|Other|1
2666381|NCT00610441|9206678|P3|Treatment Period 2 - 3 Weeks|Other|0
2666382|NCT00610441|9206679|P2|Treatment Period 2 - 3 Weeks|Other|1
2666383|NCT00610441|9206680|P1|Treatment Period 2 - 3 Weeks|Other|1
2666384|NCT00610441|9206677|P4|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
2666385|NCT00610441|9206678|P3|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
2666386|NCT00610441|9206679|P2|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1
2666387|NCT00610441|9206680|P1|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
2666388|NCT00610441|9206677|P4|Placebo Washout Period - 2 Weeks|Adverse Event|0
2666389|NCT00610441|9206678|P3|Placebo Washout Period - 2 Weeks|Adverse Event|2
2666390|NCT00610441|9206679|P2|Placebo Washout Period - 2 Weeks|Adverse Event|0
2666391|NCT00610441|9206680|P1|Placebo Washout Period - 2 Weeks|Adverse Event|0
2666392|NCT00610441|9206677|P4|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
2666393|NCT00610441|9206678|P3|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
2666394|NCT00610441|9206679|P2|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0
2666395|NCT00610441|9206680|P1|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
2666396|NCT00610441|9206677|P4|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0
2666397|NCT00610441|9206678|P3|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
2666398|NCT00610441|9206679|P2|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
2666399|NCT00610441|9206680|P1|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
2666400|NCT00610441|9206677|P4|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
2666401|NCT00610441|9206678|P3|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1
2666402|NCT00610441|9206679|P2|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
2666403|NCT00610441|9206680|P1|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
2666404|NCT00610441|9206677|P4|Treatment Period 1 - 3 Weeks|Adverse Event|1
2666405|NCT00610441|9206678|P3|Treatment Period 1 - 3 Weeks|Adverse Event|4
2666406|NCT00610441|9206679|P2|Treatment Period 1 - 3 Weeks|Adverse Event|1
2666407|NCT00610441|9206680|P1|Treatment Period 1 - 3 Weeks|Adverse Event|1
2666408|NCT00610363|9206789|P2|Overall Study|Other than specified above|1
2666409|NCT00610363|9206790|P1|Overall Study|Other than specified above|1
2666410|NCT00610363|9206789|P2|Overall Study|Withdrawal by Subject|0
2666411|NCT00610363|9206790|P1|Overall Study|Withdrawal by Subject|1
2666412|NCT00610363|9206789|P2|Overall Study|Lost to Follow-up|0
2666413|NCT00610363|9206790|P1|Overall Study|Lost to Follow-up|4
2666414|NCT00610363|9206789|P2|Overall Study|Lack of Efficacy|0
2666415|NCT00610363|9206790|P1|Overall Study|Lack of Efficacy|2
2666416|NCT00610363|9206789|P2|Overall Study|Adverse Event|1
2666417|NCT00610363|9206790|P1|Overall Study|Adverse Event|3
2666418|NCT00610363|9206789|P2|Overall Study|Non-compliance with protocol|1
2666419|NCT00610363|9206790|P1|Overall Study|Non-compliance with protocol|0
2666420|NCT00610207|9206815|P1|Overall Study|Lost to Follow-up|3
2666421|NCT00610168|9206822|P2|Overall Study|Withdrawal by Subject|0
2666422|NCT00610168|9206823|P1|Overall Study|Withdrawal by Subject|2
2666423|NCT00610155|9206842|P6|Period 3|Adverse Event|0
2666424|NCT00610155|9206843|P5|Period 3|Adverse Event|0
2666425|NCT00610155|9206844|P4|Period 3|Adverse Event|0
2666426|NCT00610155|9206845|P3|Period 3|Adverse Event|0
2666427|NCT00610155|9206846|P2|Period 3|Adverse Event|0
2666428|NCT00610155|9206847|P1|Period 3|Adverse Event|1
2666429|NCT00610155|9206842|P6|Period 1|Withdrawal by Subject|0
2666430|NCT00610155|9206843|P5|Period 1|Withdrawal by Subject|0
2666431|NCT00610155|9206844|P4|Period 1|Withdrawal by Subject|0
2666432|NCT00610155|9206845|P3|Period 1|Withdrawal by Subject|1
2666433|NCT00610155|9206846|P2|Period 1|Withdrawal by Subject|0
2666434|NCT00610155|9206847|P1|Period 1|Withdrawal by Subject|0
2666435|NCT00610129|9206894|P1|Overall Study|Not treated since patients ineligible|3
2666436|NCT00609986|9206900|P2|Overall Study|Did not receive transplant or treatment|3
2666437|NCT00609986|9206901|P1|Overall Study|Did not receive transplant or treatment|8
2666438|NCT00609973|9206915|P2|Overall Study|Withdrawal by Subject|1
2666439|NCT00609973|9206916|P1|Overall Study|Withdrawal by Subject|0
2666440|NCT00609973|9206915|P2|Overall Study|Lost to Follow-up|1
2666441|NCT00609973|9206916|P1|Overall Study|Lost to Follow-up|2
2666442|NCT00609973|9206915|P2|Overall Study|Protocol Violation|3
2666443|NCT00609973|9206916|P1|Overall Study|Protocol Violation|4
2666444|NCT00609973|9206915|P2|Overall Study|Adverse Event|1
2666445|NCT00609973|9206916|P1|Overall Study|Adverse Event|2
2666446|NCT00609947|9206924|P1|Overall Study|Death|1
2666447|NCT00609869|9206929|P1|Overall Study|Mantle cell: not evaluable|4
2666448|NCT00609869|9206929|P1|Overall Study|Rituximab reaction prior to lenalidomide|1
2666449|NCT00609869|9206929|P1|Overall Study|Hepatitis B infection|1
2666450|NCT00609869|9206929|P1|Overall Study|Severe tumor flare reaction|1
2666451|NCT00609869|9206929|P1|Overall Study|Seizures|1
2666452|NCT00609869|9206929|P1|Overall Study|Withdrawal by Subject|1
2666453|NCT00609869|9206929|P1|Overall Study|Severe hematologic toxicity|1
2666454|NCT00609869|9206929|P1|Overall Study|Withdrawn, ischemic stroke|1
2666455|NCT00609765|9206948|P1|Overall Study|Study ended prior to 12 months|1
2666456|NCT00609674|9206962|P2|Overall Study|Withdrew consent|1
2666457|NCT00609674|9206963|P1|Overall Study|Withdrew consent|2
2666458|NCT00609674|9206962|P2|Overall Study|Lost to Follow-up|0
2666459|NCT00609674|9206963|P1|Overall Study|Lost to Follow-up|1
2666460|NCT00609674|9206962|P2|Overall Study|Protocol Violation|5
2666461|NCT00609674|9206963|P1|Overall Study|Protocol Violation|3
2666462|NCT00609674|9206962|P2|Overall Study|Adverse Event|1
2666463|NCT00609674|9206963|P1|Overall Study|Adverse Event|1
2666464|NCT00609622|9206999|P2|Overall Study|Global deterioration of health status|2
2666465|NCT00609622|9207000|P1|Overall Study|Global deterioration of health status|6
2666466|NCT00609622|9206999|P2|Overall Study|Other|14
2666467|NCT00609622|9207000|P1|Overall Study|Other|7
2666468|NCT00609622|9206999|P2|Overall Study|Study terminated by sponsor|3
2666469|NCT00609622|9207000|P1|Overall Study|Study terminated by sponsor|16
2666470|NCT00609622|9206999|P2|Overall Study|Objective progression or relapse|41
2666471|NCT00609622|9207000|P1|Overall Study|Objective progression or relapse|47
2666472|NCT00609622|9206999|P2|Overall Study|Protocol Violation|1
2666473|NCT00609622|9207000|P1|Overall Study|Protocol Violation|1
2666474|NCT00609622|9206999|P2|Overall Study|Death|4
2666475|NCT00609622|9207000|P1|Overall Study|Death|1
2666476|NCT00609622|9206999|P2|Overall Study|Withdrawal by Subject|20
2666477|NCT00609622|9207000|P1|Overall Study|Withdrawal by Subject|4
2666478|NCT00609622|9206999|P2|Overall Study|Adverse Event|10
2666479|NCT00609622|9207000|P1|Overall Study|Adverse Event|14
2666480|NCT00609609|9207022|P2|Overall Study|Progression|2
2666481|NCT00609609|9207023|P1|Overall Study|Progression|4
2666482|NCT00609609|9207022|P2|Overall Study|Withdrawal by Subject|0
2666483|NCT00609609|9207023|P1|Overall Study|Withdrawal by Subject|2
2666484|NCT00609518|9207035|P2|Overall Study|Death from Adverse Event|2
2666485|NCT00609518|9207036|P1|Overall Study|Death from Adverse Event|2
2666486|NCT00609518|9207035|P2|Overall Study|Physician Decision|3
2666487|NCT00609518|9207036|P1|Overall Study|Physician Decision|1
2666488|NCT00609518|9207035|P2|Overall Study|Lost to Follow-up|0
2666489|NCT00609518|9207036|P1|Overall Study|Lost to Follow-up|3
2666490|NCT00609518|9207035|P2|Overall Study|Withdrawal by Subject|3
2666491|NCT00609518|9207036|P1|Overall Study|Withdrawal by Subject|5
2666492|NCT00609518|9207035|P2|Overall Study|Death from Study Disease|32
2666493|NCT00609518|9207036|P1|Overall Study|Death from Study Disease|32
2666494|NCT00609492|9207051|P3|Overall Study|Lost to Follow-up|4
2666495|NCT00609492|9207052|P2|Overall Study|Lost to Follow-up|1
2666496|NCT00609492|9207053|P1|Overall Study|Lost to Follow-up|1
2666497|NCT00609492|9207051|P3|Overall Study|Withdrawal by Subject|3
2666498|NCT00609492|9207052|P2|Overall Study|Withdrawal by Subject|2
2666499|NCT00609492|9207053|P1|Overall Study|Withdrawal by Subject|0
2666500|NCT00609466|9207138|P3|Overall Study|Lack of Efficacy|2
2666501|NCT00609466|9207139|P2|Overall Study|Lack of Efficacy|2
2666502|NCT00609466|9207140|P1|Overall Study|Lack of Efficacy|0
2666503|NCT00609466|9207138|P3|Overall Study|Adverse Event|1
2666504|NCT00609466|9207139|P2|Overall Study|Adverse Event|3
2666505|NCT00609466|9207140|P1|Overall Study|Adverse Event|2
2666506|NCT00609466|9207138|P3|Overall Study|Withdrawal by Subject|1
2666507|NCT00609466|9207139|P2|Overall Study|Withdrawal by Subject|1
2666508|NCT00609466|9207140|P1|Overall Study|Withdrawal by Subject|0
2666509|NCT00609362|9207168|P2|Overall Study|Adverse Event|0
2666510|NCT00609362|9207169|P1|Overall Study|Adverse Event|1
2666511|NCT00609362|9207168|P2|Overall Study|Withdrawal by Subject|1
2666512|NCT00609362|9207169|P1|Overall Study|Withdrawal by Subject|2
2666513|NCT00609336|9207179|P1|Overall Study|LA or Met at Surgery|9
2666514|NCT00609336|9207179|P1|Overall Study|Death|1
2666515|NCT00609336|9207179|P1|Overall Study|Protocol Violation|3
2666516|NCT00609245|9207230|P1|Overall Study|Adverse Event|1
2666517|NCT00609167|9207238|P2|Overall Study|Stem Cell Transplant|6
2666518|NCT00609167|9207239|P1|Overall Study|Stem Cell Transplant|0
2666519|NCT00609167|9207238|P2|Overall Study|Disease Progression|0
2666520|NCT00609167|9207239|P1|Overall Study|Disease Progression|1
2666521|NCT00609167|9207238|P2|Overall Study|Adverse Event|1
2666522|NCT00609167|9207239|P1|Overall Study|Adverse Event|5
2666523|NCT00609167|9207238|P2|Overall Study|Lack of Efficacy|0
2666524|NCT00609167|9207239|P1|Overall Study|Lack of Efficacy|1
2666525|NCT00609167|9207238|P2|Overall Study|Withdrawal by Subject|0
2666526|NCT00609167|9207239|P1|Overall Study|Withdrawal by Subject|1
2666527|NCT00608985|9207270|P4|Overall Study|Lost to Follow-up|0
2666528|NCT00608985|9207271|P3|Overall Study|Lost to Follow-up|0
2666529|NCT00608985|9207272|P2|Overall Study|Lost to Follow-up|1
2666530|NCT00608985|9207273|P1|Overall Study|Lost to Follow-up|2
2666531|NCT00608985|9207270|P4|Overall Study|Withdrawal of Consent|1
2666532|NCT00608985|9207271|P3|Overall Study|Withdrawal of Consent|1
2666533|NCT00608985|9207272|P2|Overall Study|Withdrawal of Consent|1
2666534|NCT00608985|9207273|P1|Overall Study|Withdrawal of Consent|5
2666535|NCT00608985|9207270|P4|Overall Study|Administrative/Other|2
2666536|NCT00608985|9207271|P3|Overall Study|Administrative/Other|1
2666537|NCT00608985|9207272|P2|Overall Study|Administrative/Other|4
2666538|NCT00608985|9207273|P1|Overall Study|Administrative/Other|7
2666539|NCT00608985|9207270|P4|Overall Study|Adverse Event|6
2666540|NCT00608985|9207271|P3|Overall Study|Adverse Event|4
2666541|NCT00608985|9207272|P2|Overall Study|Adverse Event|7
2666542|NCT00608985|9207273|P1|Overall Study|Adverse Event|2
2666543|NCT00608959|9207305|P1|Part 1|Did not meet eligibility criteria|1
2666544|NCT00608907|9207318|P3|Overall Study|Progressive Disease|0
2666545|NCT00608907|9207319|P2|Overall Study|Progressive Disease|0
2666546|NCT00608907|9207320|P1|Overall Study|Progressive Disease|1
2666547|NCT00608907|9207318|P3|Overall Study|Withdrawal by Subject|0
2666548|NCT00608907|9207319|P2|Overall Study|Withdrawal by Subject|0
2666549|NCT00608907|9207320|P1|Overall Study|Withdrawal by Subject|4
2666550|NCT00608907|9207318|P3|Overall Study|Death|0
2666551|NCT00608907|9207319|P2|Overall Study|Death|0
2666552|NCT00608907|9207320|P1|Overall Study|Death|1
2666553|NCT00608907|9207318|P3|Overall Study|Adverse Event|1
2666554|NCT00608907|9207319|P2|Overall Study|Adverse Event|0
2666555|NCT00608907|9207320|P1|Overall Study|Adverse Event|6
2666556|NCT00608894|9207330|P2|Overall Study|Withdrawal by Subject|2
2666557|NCT00608894|9207331|P1|Overall Study|Withdrawal by Subject|0
2666558|NCT00608881|9207343|P2|Overall Study|Institutionalized|2
2666559|NCT00608881|9207344|P1|Overall Study|Institutionalized|1
2666560|NCT00608881|9207343|P2|Overall Study|Physician Decision|5
2666561|NCT00608881|9207344|P1|Overall Study|Physician Decision|5
2666562|NCT00608881|9207343|P2|Overall Study|Withdrawal by Subject|29
2666563|NCT00608881|9207344|P1|Overall Study|Withdrawal by Subject|18
2666564|NCT00608881|9207343|P2|Overall Study|Lost to Follow-up|14
2666565|NCT00608881|9207344|P1|Overall Study|Lost to Follow-up|28
2666566|NCT00608881|9207343|P2|Overall Study|Adverse Event|3
2666567|NCT00608881|9207344|P1|Overall Study|Adverse Event|5
2666568|NCT00608881|9207343|P2|Overall Study|Death|13
2666569|NCT00608881|9207344|P1|Overall Study|Death|22
2666570|NCT00608868|9207378|P1|Overall Study|Physician Decision|2
2666571|NCT00608868|9207378|P1|Overall Study|Adverse Event|1
2666572|NCT00608868|9207378|P1|Overall Study|Lost to Follow-up|2
2666573|NCT00608868|9207378|P1|Overall Study|Protocol Violation|3
2666574|NCT00608868|9207378|P1|Overall Study|Withdrawal by Subject|7
2666575|NCT00608842|9207389|P4|Overall Study|Lost to Follow-up|0
2666576|NCT00608842|9207390|P3|Overall Study|Lost to Follow-up|0
2666577|NCT00608842|9207391|P2|Overall Study|Lost to Follow-up|0
2666578|NCT00608842|9207392|P1|Overall Study|Lost to Follow-up|1
2666579|NCT00608842|9207389|P4|Overall Study|Participant's Request|1
2666580|NCT00608842|9207390|P3|Overall Study|Participant's Request|2
2666581|NCT00608842|9207391|P2|Overall Study|Participant's Request|1
2666582|NCT00608842|9207392|P1|Overall Study|Participant's Request|0
2666583|NCT00608829|9207426|P1|Overall Study|Subject refuses to follow up or return.|5
2666584|NCT00608829|9207426|P1|Overall Study|Withdrawal by Subject|4
2666585|NCT00608829|9207426|P1|Overall Study|Death|6
2666586|NCT00608582|9207452|P2|Overall Study|Early stage Design Change|3
2666587|NCT00608582|9207453|P1|Overall Study|Early stage Design Change|0
2666588|NCT00608582|9207452|P2|Overall Study|Illicit Drug Use|0
2666589|NCT00608582|9207453|P1|Overall Study|Illicit Drug Use|1
2666590|NCT00608582|9207452|P2|Overall Study|No Best Response in Phase 1 located|1
2666591|NCT00608582|9207453|P1|Overall Study|No Best Response in Phase 1 located|1
2666592|NCT00608582|9207452|P2|Overall Study|Lost to Follow-up|0
2666593|NCT00608582|9207453|P1|Overall Study|Lost to Follow-up|2
2666594|NCT00608569|9207463|P2|Overall Study|Unable to adhere with study requirements|1
2666595|NCT00608569|9207464|P1|Overall Study|Unable to adhere with study requirements|0
2666596|NCT00608569|9207463|P2|Overall Study|Adverse Event|0
2666597|NCT00608569|9207464|P1|Overall Study|Adverse Event|1
2666598|NCT00608569|9207463|P2|Overall Study|Withdrawal by Subject|0
2666599|NCT00608569|9207464|P1|Overall Study|Withdrawal by Subject|1
2666600|NCT00608569|9207463|P2|Overall Study|Lost to Follow-up|5
2666601|NCT00608569|9207464|P1|Overall Study|Lost to Follow-up|4
2666602|NCT00608569|9207463|P2|Overall Study|Death|3
2666603|NCT00608569|9207464|P1|Overall Study|Death|4
2666604|NCT00608543|9207484|P1|Overall Study|Adverse Event|4
2666605|NCT00608530|9207497|P4|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
2666606|NCT00608530|9207498|P3|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1
2666607|NCT00608530|9207499|P2|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
2666608|NCT00608530|9207500|P1|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
2666609|NCT00608530|9207497|P4|Study 2 Nurse-delivered Treatments|Time demands of study|1
2666610|NCT00608530|9207498|P3|Study 2 Nurse-delivered Treatments|Time demands of study|4
2666611|NCT00608530|9207499|P2|Study 2 Nurse-delivered Treatments|Time demands of study|0
2666612|NCT00608530|9207500|P1|Study 2 Nurse-delivered Treatments|Time demands of study|0
2666613|NCT00608530|9207497|P4|Study 2 Nurse-delivered Treatments|Protocol Violation|0
2666614|NCT00608530|9207498|P3|Study 2 Nurse-delivered Treatments|Protocol Violation|2
2666615|NCT00608530|9207499|P2|Study 2 Nurse-delivered Treatments|Protocol Violation|0
2666616|NCT00608530|9207500|P1|Study 2 Nurse-delivered Treatments|Protocol Violation|0
2666704|NCT00607919|9207940|P1|Acute Phase|Lack of Efficacy|1
2666617|NCT00608530|9207497|P4|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3
2666618|NCT00608530|9207498|P3|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2
2666619|NCT00608530|9207499|P2|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
2666620|NCT00608530|9207500|P1|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
2666621|NCT00608530|9207497|P4|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
2666622|NCT00608530|9207498|P3|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
2666623|NCT00608530|9207499|P2|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
2666624|NCT00608530|9207500|P1|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
2666625|NCT00608530|9207497|P4|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
2666626|NCT00608530|9207498|P3|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
2666627|NCT00608530|9207499|P2|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5
2666628|NCT00608530|9207500|P1|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11
2666629|NCT00608517|9207521|P3|Overall Study|Death|0
2666630|NCT00608517|9207522|P2|Overall Study|Death|0
2666631|NCT00608517|9207523|P1|Overall Study|Death|1
2666632|NCT00608426|9207703|P2|Overall Study|refused, health issues, wrong address|348
2666633|NCT00608426|9207704|P1|Overall Study|refused, health issues, wrong address|319
2666634|NCT00608426|9207703|P2|Overall Study|Lost to Follow-up|521
2666635|NCT00608426|9207704|P1|Overall Study|Lost to Follow-up|485
2666636|NCT00608426|9207703|P2|Overall Study|Death|36
2666637|NCT00608426|9207704|P1|Overall Study|Death|32
2666638|NCT00608322|9207716|P2|Overall Study|Death|1
2666639|NCT00608322|9207717|P1|Overall Study|Death|2
2666640|NCT00608244|9207723|P1|Overall Study|Low trough levels|1
2666641|NCT00608244|9207723|P1|Overall Study|Adverse Event|1
2666642|NCT00608205|9207734|P2|Overall Study|Patient non-compliant|1
2666643|NCT00608205|9207735|P1|Overall Study|Patient non-compliant|0
2666644|NCT00608205|9207734|P2|Overall Study|Adverse Event|2
2666645|NCT00608205|9207735|P1|Overall Study|Adverse Event|3
2666646|NCT00608023|9207852|P3|Overall Study|Unknown reason|0
2666647|NCT00608023|9207853|P2|Overall Study|Unknown reason|3
2666648|NCT00608023|9207854|P1|Overall Study|Unknown reason|0
2666649|NCT00608023|9207852|P3|Overall Study|Protocol Violation|1
2666650|NCT00608023|9207853|P2|Overall Study|Protocol Violation|3
2666651|NCT00608023|9207854|P1|Overall Study|Protocol Violation|1
2666652|NCT00608023|9207852|P3|Overall Study|Lost to Follow-up|1
2666653|NCT00608023|9207853|P2|Overall Study|Lost to Follow-up|2
2666654|NCT00608023|9207854|P1|Overall Study|Lost to Follow-up|2
2666655|NCT00608023|9207852|P3|Overall Study|Adverse Event|5
2666656|NCT00608023|9207853|P2|Overall Study|Adverse Event|4
2666657|NCT00608023|9207854|P1|Overall Study|Adverse Event|1
2666658|NCT00608023|9207852|P3|Overall Study|Withdrawal by Subject|7
2666659|NCT00608023|9207853|P2|Overall Study|Withdrawal by Subject|10
2666660|NCT00608023|9207854|P1|Overall Study|Withdrawal by Subject|8
2666661|NCT00607997|9207878|P4|Overall Study|Other without explanation|1
2666662|NCT00607997|9207879|P3|Overall Study|Other without explanation|4
2666663|NCT00607997|9207880|P2|Overall Study|Other without explanation|0
2666664|NCT00607997|9207881|P1|Overall Study|Other without explanation|2
2666665|NCT00607997|9207878|P4|Overall Study|Relapse, recurrent illness|0
2666666|NCT00607997|9207879|P3|Overall Study|Relapse, recurrent illness|2
2666667|NCT00607997|9207880|P2|Overall Study|Relapse, recurrent illness|0
2666668|NCT00607997|9207881|P1|Overall Study|Relapse, recurrent illness|4
2666669|NCT00607997|9207878|P4|Overall Study|Physician Decision|0
2666670|NCT00607997|9207879|P3|Overall Study|Physician Decision|0
2666671|NCT00607997|9207880|P2|Overall Study|Physician Decision|1
2666672|NCT00607997|9207881|P1|Overall Study|Physician Decision|4
2666673|NCT00607997|9207878|P4|Overall Study|Adverse Event|0
2666674|NCT00607997|9207879|P3|Overall Study|Adverse Event|2
2666675|NCT00607997|9207880|P2|Overall Study|Adverse Event|1
2666676|NCT00607997|9207881|P1|Overall Study|Adverse Event|3
2666677|NCT00607997|9207878|P4|Overall Study|Death|5
2666678|NCT00607997|9207879|P3|Overall Study|Death|2
2666679|NCT00607997|9207880|P2|Overall Study|Death|5
2666680|NCT00607997|9207881|P1|Overall Study|Death|8
2666681|NCT00607997|9207878|P4|Overall Study|Lack of Efficacy|10
2666682|NCT00607997|9207879|P3|Overall Study|Lack of Efficacy|14
2666683|NCT00607997|9207880|P2|Overall Study|Lack of Efficacy|20
2666684|NCT00607997|9207881|P1|Overall Study|Lack of Efficacy|6
2666685|NCT00607919|9207939|P2|Open-Label Phase|Parent/Caregiver Decision|2
2666686|NCT00607919|9207940|P1|Open-Label Phase|Parent/Caregiver Decision|1
2666687|NCT00607919|9207939|P2|Open-Label Phase|Withdrawal by Subject|2
2666688|NCT00607919|9207940|P1|Open-Label Phase|Withdrawal by Subject|2
2666689|NCT00607919|9207939|P2|Open-Label Phase|Protocol Violation|2
2666690|NCT00607919|9207940|P1|Open-Label Phase|Protocol Violation|2
2666691|NCT00607919|9207939|P2|Open-Label Phase|Lost to Follow-up|1
2666692|NCT00607919|9207940|P1|Open-Label Phase|Lost to Follow-up|4
2666693|NCT00607919|9207939|P2|Open-Label Phase|Adverse Event|5
2666694|NCT00607919|9207940|P1|Open-Label Phase|Adverse Event|1
2666695|NCT00607919|9207939|P2|Acute Phase|Withdrawal by Subject|3
2666696|NCT00607919|9207940|P1|Acute Phase|Withdrawal by Subject|3
2666697|NCT00607919|9207939|P2|Acute Phase|Protocol Violation|1
2666698|NCT00607919|9207940|P1|Acute Phase|Protocol Violation|5
2666699|NCT00607919|9207939|P2|Acute Phase|Parent/Caregiver Decision|4
2666700|NCT00607919|9207940|P1|Acute Phase|Parent/Caregiver Decision|6
2666701|NCT00607919|9207939|P2|Acute Phase|Lost to Follow-up|3
2666702|NCT00607919|9207940|P1|Acute Phase|Lost to Follow-up|9
2666703|NCT00607919|9207939|P2|Acute Phase|Lack of Efficacy|2
2666705|NCT00607919|9207939|P2|Acute Phase|Entry Criteria Not Met|1
2666706|NCT00607919|9207940|P1|Acute Phase|Entry Criteria Not Met|1
2666707|NCT00607919|9207939|P2|Acute Phase|Adverse Event|2
2666708|NCT00607919|9207940|P1|Acute Phase|Adverse Event|9
2666709|NCT00607893|9207998|P2|Overall Study|Withdrew due to hypertensive urgency|1
2666710|NCT00607893|9207999|P1|Overall Study|Withdrew due to hypertensive urgency|1
2666711|NCT00607893|9207998|P2|Overall Study|Declined to be treated|0
2666712|NCT00607893|9207999|P1|Overall Study|Declined to be treated|1
2666713|NCT00607893|9207998|P2|Overall Study|withdrew could not tolerate CPAP|1
2666714|NCT00607893|9207999|P1|Overall Study|withdrew could not tolerate CPAP|0
2666715|NCT00607893|9207998|P2|Overall Study|Withdrew due to osteomyelitis surgery|1
2666716|NCT00607893|9207999|P1|Overall Study|Withdrew due to osteomyelitis surgery|0
2666717|NCT00607893|9207998|P2|Overall Study|withdrew due to loss of interest|1
2666718|NCT00607893|9207999|P1|Overall Study|withdrew due to loss of interest|0
2666719|NCT00607893|9207998|P2|Overall Study|Lost to Follow-up|0
2666720|NCT00607893|9207999|P1|Overall Study|Lost to Follow-up|4
2666721|NCT00607880|9208027|P2|Overall Study|Unable to place port due to occlusion|0
2666722|NCT00607880|9208028|P1|Overall Study|Unable to place port due to occlusion|1
2666723|NCT00607789|9208078|P2|Overall Study|Withdrawal by Subject|0
2666724|NCT00607789|9208079|P1|Overall Study|Withdrawal by Subject|1
2666725|NCT00607789|9208078|P2|Overall Study|Lost to Follow-up|5
2666726|NCT00607789|9208079|P1|Overall Study|Lost to Follow-up|0
2666727|NCT00607789|9208078|P2|Overall Study|Inadequate adherence|0
2666728|NCT00607789|9208079|P1|Overall Study|Inadequate adherence|3
2666729|NCT00607789|9208078|P2|Overall Study|Lack of Efficacy|1
2666730|NCT00607789|9208079|P1|Overall Study|Lack of Efficacy|0
2666731|NCT00607789|9208078|P2|Overall Study|Adverse Event|0
2666732|NCT00607789|9208079|P1|Overall Study|Adverse Event|3
2666733|NCT00607724|9208094|P7|Stage 2: Expanded Cohort|Withdrawal by Subject|0
2666734|NCT00607724|9208095|P6|Stage 2: Expanded Cohort|Withdrawal by Subject|0
2666735|NCT00607724|9208096|P5|Stage 2: Expanded Cohort|Withdrawal by Subject|0
2666736|NCT00607724|9208097|P4|Stage 2: Expanded Cohort|Withdrawal by Subject|1
2666737|NCT00607724|9208098|P3|Stage 2: Expanded Cohort|Withdrawal by Subject|0
2666738|NCT00607724|9208099|P2|Stage 2: Expanded Cohort|Withdrawal by Subject|0
2666739|NCT00607724|9208100|P1|Stage 2: Expanded Cohort|Withdrawal by Subject|0
2666740|NCT00607724|9208094|P7|Stage 2: Expanded Cohort|Physician Decision|0
2666741|NCT00607724|9208095|P6|Stage 2: Expanded Cohort|Physician Decision|1
2666742|NCT00607724|9208096|P5|Stage 2: Expanded Cohort|Physician Decision|1
2666743|NCT00607724|9208097|P4|Stage 2: Expanded Cohort|Physician Decision|0
2666744|NCT00607724|9208098|P3|Stage 2: Expanded Cohort|Physician Decision|0
2666745|NCT00607724|9208099|P2|Stage 2: Expanded Cohort|Physician Decision|0
2666746|NCT00607724|9208100|P1|Stage 2: Expanded Cohort|Physician Decision|0
2666747|NCT00607724|9208094|P7|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|10
2666748|NCT00607724|9208095|P6|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|11
2666749|NCT00607724|9208096|P5|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|8
2666750|NCT00607724|9208097|P4|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|4
2666751|NCT00607724|9208098|P3|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
2666752|NCT00607724|9208099|P2|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
2666753|NCT00607724|9208100|P1|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
2666754|NCT00607724|9208094|P7|Stage 2: Expanded Cohort|Adverse Event|1
2666755|NCT00607724|9208095|P6|Stage 2: Expanded Cohort|Adverse Event|0
2666756|NCT00607724|9208096|P5|Stage 2: Expanded Cohort|Adverse Event|0
2666757|NCT00607724|9208097|P4|Stage 2: Expanded Cohort|Adverse Event|0
2666758|NCT00607724|9208098|P3|Stage 2: Expanded Cohort|Adverse Event|0
2666759|NCT00607724|9208099|P2|Stage 2: Expanded Cohort|Adverse Event|0
2666760|NCT00607724|9208100|P1|Stage 2: Expanded Cohort|Adverse Event|0
2666761|NCT00607724|9208094|P7|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
2666762|NCT00607724|9208095|P6|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
2666763|NCT00607724|9208096|P5|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
2666764|NCT00607724|9208097|P4|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
2666765|NCT00607724|9208098|P3|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|4
2666766|NCT00607724|9208099|P2|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|8
2666767|NCT00607724|9208100|P1|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|7
2666768|NCT00607386|9208263|P1|Overall Study|Physician Decision|1
2666769|NCT00607373|9208278|P2|Follow-up Period|Withdrawal by Subject|3
2666770|NCT00607373|9208279|P1|Follow-up Period|Withdrawal by Subject|1
2666771|NCT00607373|9208278|P2|Follow-up Period|Protocol Violation|1
2666772|NCT00607373|9208279|P1|Follow-up Period|Protocol Violation|0
2666773|NCT00607373|9208278|P2|Follow-up Period|Other|1
2666774|NCT00607373|9208279|P1|Follow-up Period|Other|0
2666775|NCT00607373|9208278|P2|Treatment Period|Withdrawal by Subject|1
2666776|NCT00607373|9208279|P1|Treatment Period|Withdrawal by Subject|0
2666777|NCT00607373|9208278|P2|Treatment Period|Physician Decision|1
2666778|NCT00607373|9208279|P1|Treatment Period|Physician Decision|0
2666779|NCT00607373|9208278|P2|Treatment Period|Adverse Event|4
2666780|NCT00607373|9208279|P1|Treatment Period|Adverse Event|0
2666781|NCT00607087|9208381|P3|Period 3|Adverse Event|0
2666782|NCT00607087|9208382|P2|Period 3|Adverse Event|1
2666783|NCT00607087|9208383|P1|Period 3|Adverse Event|0
2666784|NCT00607087|9208381|P3|Period 3|Withdrawal by Subject|0
2666785|NCT00607087|9208382|P2|Period 3|Withdrawal by Subject|1
2666786|NCT00607087|9208383|P1|Period 3|Withdrawal by Subject|2
2666787|NCT00607087|9208381|P3|Period 2|Poor compliance to protocol|1
2666788|NCT00607087|9208382|P2|Period 2|Poor compliance to protocol|0
2666789|NCT00607087|9208383|P1|Period 2|Poor compliance to protocol|0
2666790|NCT00607087|9208381|P3|Period 2|Adverse Event|3
2666791|NCT00607087|9208382|P2|Period 2|Adverse Event|1
2666792|NCT00607087|9208383|P1|Period 2|Adverse Event|0
2666793|NCT00607087|9208381|P3|Period 2|Other reason|0
2666794|NCT00607087|9208382|P2|Period 2|Other reason|1
2666795|NCT00607087|9208383|P1|Period 2|Other reason|1
2666796|NCT00607087|9208381|P3|Period 2|Withdrawal by Subject|1
2666797|NCT00607087|9208382|P2|Period 2|Withdrawal by Subject|1
2666798|NCT00607087|9208383|P1|Period 2|Withdrawal by Subject|0
2666799|NCT00607087|9208381|P3|Period 1|Other reason|2
2666800|NCT00607087|9208382|P2|Period 1|Other reason|4
2666801|NCT00607087|9208383|P1|Period 1|Other reason|0
2666802|NCT00607087|9208381|P3|Period 1|Lost to Follow-up|0
2666803|NCT00607087|9208382|P2|Period 1|Lost to Follow-up|0
2666804|NCT00607087|9208383|P1|Period 1|Lost to Follow-up|1
2666805|NCT00607087|9208381|P3|Period 1|Poor compliance to protocol|0
2666806|NCT00607087|9208382|P2|Period 1|Poor compliance to protocol|0
2666807|NCT00607087|9208383|P1|Period 1|Poor compliance to protocol|1
2666808|NCT00607087|9208381|P3|Period 1|Adverse Event|0
2666809|NCT00607087|9208382|P2|Period 1|Adverse Event|0
2666810|NCT00607087|9208383|P1|Period 1|Adverse Event|3
2666811|NCT00607087|9208381|P3|Period 1|Withdrawal by Subject|3
2666812|NCT00607087|9208382|P2|Period 1|Withdrawal by Subject|2
2666813|NCT00607087|9208383|P1|Period 1|Withdrawal by Subject|7
2666814|NCT00607087|9208381|P3|Overall Study|Lost to Follow-up|0
2666815|NCT00607087|9208382|P2|Overall Study|Lost to Follow-up|0
2666816|NCT00607087|9208383|P1|Overall Study|Lost to Follow-up|1
2666817|NCT00607087|9208381|P3|Overall Study|Poor compliance to protocol|1
2666818|NCT00607087|9208382|P2|Overall Study|Poor compliance to protocol|0
2666819|NCT00607087|9208383|P1|Overall Study|Poor compliance to protocol|1
2666820|NCT00607087|9208381|P3|Overall Study|Other reason|2
2666821|NCT00607087|9208382|P2|Overall Study|Other reason|5
2666822|NCT00607087|9208383|P1|Overall Study|Other reason|1
2666823|NCT00607087|9208381|P3|Overall Study|Adverse Event|3
2666824|NCT00607087|9208382|P2|Overall Study|Adverse Event|2
2666825|NCT00607087|9208383|P1|Overall Study|Adverse Event|3
2666826|NCT00607087|9208381|P3|Overall Study|Withdrawal by Subject|4
2666827|NCT00607087|9208382|P2|Overall Study|Withdrawal by Subject|4
2666828|NCT00607087|9208383|P1|Overall Study|Withdrawal by Subject|9
2666829|NCT00607048|9208441|P6|Overall Study|Other|1
2666830|NCT00607048|9208442|P5|Overall Study|Other|0
2666831|NCT00607048|9208443|P4|Overall Study|Other|0
2666832|NCT00607048|9208444|P3|Overall Study|Other|0
2666833|NCT00607048|9208445|P2|Overall Study|Other|1
2666834|NCT00607048|9208446|P1|Overall Study|Other|1
2666835|NCT00607048|9208441|P6|Overall Study|Withdrawal by Subject|2
2666836|NCT00607048|9208442|P5|Overall Study|Withdrawal by Subject|0
2666837|NCT00607048|9208443|P4|Overall Study|Withdrawal by Subject|1
2666838|NCT00607048|9208444|P3|Overall Study|Withdrawal by Subject|0
2666839|NCT00607048|9208445|P2|Overall Study|Withdrawal by Subject|0
2666840|NCT00607048|9208446|P1|Overall Study|Withdrawal by Subject|0
2666841|NCT00607048|9208441|P6|Overall Study|Objective disease progression - relapse|2
2666842|NCT00607048|9208442|P5|Overall Study|Objective disease progression - relapse|2
2666843|NCT00607048|9208443|P4|Overall Study|Objective disease progression - relapse|2
2666844|NCT00607048|9208444|P3|Overall Study|Objective disease progression - relapse|4
2666845|NCT00607048|9208445|P2|Overall Study|Objective disease progression - relapse|2
2666846|NCT00607048|9208446|P1|Overall Study|Objective disease progression - relapse|1
2666847|NCT00607048|9208441|P6|Overall Study|Global deterioration of health|0
2666848|NCT00607048|9208442|P5|Overall Study|Global deterioration of health|0
2666849|NCT00607048|9208443|P4|Overall Study|Global deterioration of health|0
2666850|NCT00607048|9208444|P3|Overall Study|Global deterioration of health|0
2666851|NCT00607048|9208445|P2|Overall Study|Global deterioration of health|0
2666852|NCT00607048|9208446|P1|Overall Study|Global deterioration of health|1
2666853|NCT00607048|9208441|P6|Overall Study|Adverse Event|0
2666854|NCT00607048|9208442|P5|Overall Study|Adverse Event|4
2666855|NCT00607048|9208443|P4|Overall Study|Adverse Event|0
2666856|NCT00607048|9208444|P3|Overall Study|Adverse Event|0
2666857|NCT00607048|9208445|P2|Overall Study|Adverse Event|1
2666858|NCT00607048|9208446|P1|Overall Study|Adverse Event|0
2666859|NCT00607022|9208531|P3|Overall Study|Withdrawal by Subject|0
2666860|NCT00607022|9208532|P2|Overall Study|Withdrawal by Subject|0
2666861|NCT00607022|9208533|P1|Overall Study|Withdrawal by Subject|1
2666862|NCT00606931|9208550|P1|Overall Study|Withdrawal by Subject|3
2666863|NCT00606905|9208558|P2|Overall Study|Withdrew|5
2666864|NCT00606905|9208559|P1|Overall Study|Withdrew|5
2666865|NCT00606905|9208558|P2|Overall Study|Non-Index Pregnancy|4
2666866|NCT00606905|9208559|P1|Overall Study|Non-Index Pregnancy|1
2666867|NCT00606905|9208558|P2|Overall Study|No Pregnancy|6
2666868|NCT00606905|9208559|P1|Overall Study|No Pregnancy|9
2666869|NCT00606892|9208565|P2|First Intervention|Protocol Violation|4
2666870|NCT00606892|9208566|P1|First Intervention|Protocol Violation|1
2666871|NCT00606801|9208600|P2|Intervention|Protocol Violation|3
2666872|NCT00606801|9208601|P1|Intervention|Protocol Violation|3
2666873|NCT00606684|9208629|P7|Double-Blind Treatment Period|Withdrawal by Subject|0
2666874|NCT00606684|9208630|P6|Double-Blind Treatment Period|Withdrawal by Subject|2
2666875|NCT00606684|9208631|P5|Double-Blind Treatment Period|Withdrawal by Subject|1
2666876|NCT00606684|9208632|P4|Double-Blind Treatment Period|Withdrawal by Subject|2
2666877|NCT00606684|9208633|P3|Double-Blind Treatment Period|Withdrawal by Subject|1
2666878|NCT00606684|9208634|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
2666879|NCT00606684|9208635|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
2666880|NCT00606684|9208629|P7|Double-Blind Treatment Period|Physician Decision|2
2666881|NCT00606684|9208630|P6|Double-Blind Treatment Period|Physician Decision|1
2666882|NCT00606684|9208631|P5|Double-Blind Treatment Period|Physician Decision|3
2666883|NCT00606684|9208632|P4|Double-Blind Treatment Period|Physician Decision|0
2666884|NCT00606684|9208633|P3|Double-Blind Treatment Period|Physician Decision|1
2666885|NCT00606684|9208634|P2|Double-Blind Treatment Period|Physician Decision|5
2666886|NCT00606684|9208635|P1|Double-Blind Treatment Period|Physician Decision|0
2666887|NCT00606684|9208629|P7|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
2666888|NCT00606684|9208630|P6|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3
2666889|NCT00606684|9208631|P5|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
2666890|NCT00606684|9208632|P4|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
2666891|NCT00606684|9208633|P3|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
2666892|NCT00606684|9208634|P2|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
2666893|NCT00606684|9208635|P1|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0
2666894|NCT00606684|9208629|P7|Double-Blind Treatment Period|Protocol Violation|4
2666895|NCT00606684|9208630|P6|Double-Blind Treatment Period|Protocol Violation|3
2666896|NCT00606684|9208631|P5|Double-Blind Treatment Period|Protocol Violation|0
2666897|NCT00606684|9208632|P4|Double-Blind Treatment Period|Protocol Violation|3
2666898|NCT00606684|9208633|P3|Double-Blind Treatment Period|Protocol Violation|5
2666899|NCT00606684|9208634|P2|Double-Blind Treatment Period|Protocol Violation|5
2666900|NCT00606684|9208635|P1|Double-Blind Treatment Period|Protocol Violation|0
2666901|NCT00606684|9208629|P7|Double-Blind Treatment Period|Lack of Efficacy|0
2666902|NCT00606684|9208630|P6|Double-Blind Treatment Period|Lack of Efficacy|0
2666903|NCT00606684|9208631|P5|Double-Blind Treatment Period|Lack of Efficacy|1
2666904|NCT00606684|9208632|P4|Double-Blind Treatment Period|Lack of Efficacy|0
2666905|NCT00606684|9208633|P3|Double-Blind Treatment Period|Lack of Efficacy|0
2666906|NCT00606684|9208634|P2|Double-Blind Treatment Period|Lack of Efficacy|1
2666907|NCT00606684|9208635|P1|Double-Blind Treatment Period|Lack of Efficacy|0
2666908|NCT00606684|9208629|P7|Double-Blind Treatment Period|Adverse Event|1
2666909|NCT00606684|9208630|P6|Double-Blind Treatment Period|Adverse Event|0
2666910|NCT00606684|9208631|P5|Double-Blind Treatment Period|Adverse Event|2
2666911|NCT00606684|9208632|P4|Double-Blind Treatment Period|Adverse Event|4
2666912|NCT00606684|9208633|P3|Double-Blind Treatment Period|Adverse Event|2
2666913|NCT00606684|9208634|P2|Double-Blind Treatment Period|Adverse Event|3
2666914|NCT00606684|9208635|P1|Double-Blind Treatment Period|Adverse Event|0
2666915|NCT00606684|9208629|P7|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
2666916|NCT00606684|9208630|P6|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
2666917|NCT00606684|9208631|P5|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
2666918|NCT00606684|9208632|P4|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
2666919|NCT00606684|9208633|P3|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
2666920|NCT00606684|9208634|P2|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
2666921|NCT00606684|9208635|P1|2-week Single-Blind Run-in Period|Received Study Medication in Error|1
2666922|NCT00606684|9208629|P7|2-week Single-Blind Run-in Period|Adverse Event|0
2666923|NCT00606684|9208630|P6|2-week Single-Blind Run-in Period|Adverse Event|0
2666924|NCT00606684|9208631|P5|2-week Single-Blind Run-in Period|Adverse Event|0
2666925|NCT00606684|9208632|P4|2-week Single-Blind Run-in Period|Adverse Event|0
2666926|NCT00606684|9208633|P3|2-week Single-Blind Run-in Period|Adverse Event|0
2666927|NCT00606684|9208634|P2|2-week Single-Blind Run-in Period|Adverse Event|0
2666928|NCT00606684|9208635|P1|2-week Single-Blind Run-in Period|Adverse Event|2
2666929|NCT00606684|9208629|P7|2-week Single-Blind Run-in Period|Lost to Follow-up|0
2666930|NCT00606684|9208630|P6|2-week Single-Blind Run-in Period|Lost to Follow-up|0
2666931|NCT00606684|9208631|P5|2-week Single-Blind Run-in Period|Lost to Follow-up|0
2666932|NCT00606684|9208632|P4|2-week Single-Blind Run-in Period|Lost to Follow-up|0
2666933|NCT00606684|9208633|P3|2-week Single-Blind Run-in Period|Lost to Follow-up|0
2666934|NCT00606684|9208634|P2|2-week Single-Blind Run-in Period|Lost to Follow-up|0
2666935|NCT00606684|9208635|P1|2-week Single-Blind Run-in Period|Lost to Follow-up|5
2666936|NCT00606684|9208629|P7|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
2666937|NCT00606684|9208630|P6|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
2666938|NCT00606684|9208631|P5|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
2666939|NCT00606684|9208632|P4|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
2666940|NCT00606684|9208633|P3|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
2666941|NCT00606684|9208634|P2|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
2666942|NCT00606684|9208635|P1|2-week Single-Blind Run-in Period|Withdrawal by Subject|15
2666943|NCT00606684|9208629|P7|2-week Single-Blind Run-in Period|Physician Decision|0
2666944|NCT00606684|9208630|P6|2-week Single-Blind Run-in Period|Physician Decision|0
2666945|NCT00606684|9208631|P5|2-week Single-Blind Run-in Period|Physician Decision|0
2666946|NCT00606684|9208632|P4|2-week Single-Blind Run-in Period|Physician Decision|0
2666947|NCT00606684|9208633|P3|2-week Single-Blind Run-in Period|Physician Decision|0
2666948|NCT00606684|9208634|P2|2-week Single-Blind Run-in Period|Physician Decision|0
2666949|NCT00606684|9208635|P1|2-week Single-Blind Run-in Period|Physician Decision|18
2666950|NCT00606684|9208629|P7|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
2666951|NCT00606684|9208630|P6|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
2666952|NCT00606684|9208631|P5|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
2666953|NCT00606684|9208632|P4|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
2666954|NCT00606684|9208633|P3|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
2666955|NCT00606684|9208634|P2|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
2666956|NCT00606684|9208635|P1|2-week Single-Blind Run-in Period|Study Closed/Terminated|32
2666957|NCT00606684|9208629|P7|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
2666958|NCT00606684|9208630|P6|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
2666959|NCT00606684|9208631|P5|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
2666960|NCT00606684|9208632|P4|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
2666961|NCT00606684|9208633|P3|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
2666962|NCT00606684|9208634|P2|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
2666963|NCT00606684|9208635|P1|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173
2666964|NCT00606632|9208667|P1|Overall Study|Miscellaneous reasons|9
2666965|NCT00606632|9208667|P1|Overall Study|Withdrawal by Subject|13
2666966|NCT00606593|9208680|P10|Overall Study|Administrative/Other|0
2666967|NCT00606593|9208681|P9|Overall Study|Administrative/Other|0
2666968|NCT00606593|9208682|P8|Overall Study|Administrative/Other|0
2666969|NCT00606593|9208683|P7|Overall Study|Administrative/Other|0
2666970|NCT00606593|9208684|P6|Overall Study|Administrative/Other|0
2666971|NCT00606593|9208685|P5|Overall Study|Administrative/Other|0
2666972|NCT00606593|9208686|P4|Overall Study|Administrative/Other|0
2666973|NCT00606593|9208687|P3|Overall Study|Administrative/Other|1
2666974|NCT00606593|9208688|P2|Overall Study|Administrative/Other|0
2666975|NCT00606593|9208689|P1|Overall Study|Administrative/Other|0
2666976|NCT00606593|9208680|P10|Overall Study|Withdrawal of consent|0
2666977|NCT00606593|9208681|P9|Overall Study|Withdrawal of consent|0
2666978|NCT00606593|9208682|P8|Overall Study|Withdrawal of consent|0
2666979|NCT00606593|9208683|P7|Overall Study|Withdrawal of consent|0
2666980|NCT00606593|9208684|P6|Overall Study|Withdrawal of consent|0
2666981|NCT00606593|9208685|P5|Overall Study|Withdrawal of consent|0
2666982|NCT00606593|9208686|P4|Overall Study|Withdrawal of consent|0
2666983|NCT00606593|9208687|P3|Overall Study|Withdrawal of consent|1
2666984|NCT00606593|9208688|P2|Overall Study|Withdrawal of consent|0
2666985|NCT00606593|9208689|P1|Overall Study|Withdrawal of consent|1
2666986|NCT00606593|9208680|P10|Overall Study|Adverse Event|0
2666987|NCT00606593|9208681|P9|Overall Study|Adverse Event|1
2666988|NCT00606593|9208682|P8|Overall Study|Adverse Event|2
2666989|NCT00606593|9208683|P7|Overall Study|Adverse Event|1
2666990|NCT00606593|9208684|P6|Overall Study|Adverse Event|0
2666991|NCT00606593|9208685|P5|Overall Study|Adverse Event|1
2666992|NCT00606593|9208686|P4|Overall Study|Adverse Event|1
2666993|NCT00606593|9208687|P3|Overall Study|Adverse Event|0
2666994|NCT00606593|9208688|P2|Overall Study|Adverse Event|0
2666995|NCT00606593|9208689|P1|Overall Study|Adverse Event|0
2666996|NCT00606580|9208710|P3|Overall Study|Withdrawal by Subject|0
2666997|NCT00606580|9208711|P2|Overall Study|Withdrawal by Subject|1
2666998|NCT00606580|9208712|P1|Overall Study|Withdrawal by Subject|0
2666999|NCT00606580|9208710|P3|Overall Study|Withdrawal by investigator|6
2667000|NCT00606580|9208711|P2|Overall Study|Withdrawal by investigator|1
2667001|NCT00606580|9208712|P1|Overall Study|Withdrawal by investigator|0
2667002|NCT00606580|9208710|P3|Overall Study|Clinical failures|12
2667003|NCT00606580|9208711|P2|Overall Study|Clinical failures|0
2667004|NCT00606580|9208712|P1|Overall Study|Clinical failures|1
2667005|NCT00606580|9208710|P3|Overall Study|Lost to Follow-up|4
2667006|NCT00606580|9208711|P2|Overall Study|Lost to Follow-up|1
2667007|NCT00606580|9208712|P1|Overall Study|Lost to Follow-up|1
2667008|NCT00606502|9208778|P2|Treatment|Treatment ongoing at time of data cutoff|3
2667009|NCT00606502|9208779|P1|Treatment|Treatment ongoing at time of data cutoff|0
2667010|NCT00606502|9208778|P2|Randomization|Randomized but not treated|0
2667011|NCT00606502|9208779|P1|Randomization|Randomized but not treated|3
2667012|NCT00606320|9208800|P1|Overall Study|Progression to depressive phase|4
2667013|NCT00606320|9208800|P1|Overall Study|Withdrawal by Subject|10
2667014|NCT00606320|9208800|P1|Overall Study|Protocol Violation|8
2667015|NCT00606320|9208800|P1|Overall Study|Physician Decision|7
2667016|NCT00606320|9208800|P1|Overall Study|Lack of Efficacy|5
2667017|NCT00606320|9208800|P1|Overall Study|Adverse Event|3
2667018|NCT00606307|9208805|P1|Overall Study|QTc prolongation|1
2667019|NCT00606307|9208805|P1|Overall Study|Disease progression|6
2667020|NCT00606307|9208805|P1|Overall Study|Withdrawal by Subject|2
2667021|NCT00606307|9208805|P1|Overall Study|Adverse Event|2
2667022|NCT00606281|9208813|P2|Overall Study|Change of residence or other commitments|1
2667023|NCT00606281|9208814|P1|Overall Study|Change of residence or other commitments|1
2667024|NCT00606281|9208813|P2|Overall Study|Progression to depressive phase|1
2667025|NCT00606281|9208814|P1|Overall Study|Progression to depressive phase|1
2667026|NCT00606281|9208813|P2|Overall Study|Withdrawal by Subject|13
2667027|NCT00606281|9208814|P1|Overall Study|Withdrawal by Subject|11
2667028|NCT00606281|9208813|P2|Overall Study|Protocol Violation|3
2667029|NCT00606281|9208814|P1|Overall Study|Protocol Violation|3
2667030|NCT00606281|9208813|P2|Overall Study|Physician Decision|1
2667031|NCT00606281|9208814|P1|Overall Study|Physician Decision|0
2667032|NCT00606281|9208813|P2|Overall Study|Lack of Efficacy|35
2667033|NCT00606281|9208814|P1|Overall Study|Lack of Efficacy|28
2667034|NCT00606281|9208813|P2|Overall Study|Death|0
2667035|NCT00606281|9208814|P1|Overall Study|Death|1
2667036|NCT00606281|9208813|P2|Overall Study|Adverse Event|12
2667037|NCT00606281|9208814|P1|Overall Study|Adverse Event|11
2667038|NCT00606229|9208822|P1|Overall Study|change of residence or other commitments|2
2667039|NCT00606229|9208822|P1|Overall Study|does not meet inclusion criterion 1-3|4
2667040|NCT00606229|9208822|P1|Overall Study|Withdrawal by Subject|4
2667041|NCT00606229|9208822|P1|Overall Study|Lack of Efficacy|1
2667042|NCT00606229|9208822|P1|Overall Study|Adverse Event|11
2667043|NCT00606177|9208829|P2|Overall Study|Change of residence or other commitments|1
2667044|NCT00606177|9208830|P1|Overall Study|Change of residence or other commitments|1
2667045|NCT00606177|9208829|P2|Overall Study|Diabetic blood glucose level/ High HbA1c|1
2667046|NCT00606177|9208830|P1|Overall Study|Diabetic blood glucose level/ High HbA1c|1
2667047|NCT00606177|9208829|P2|Overall Study|Progression to depressive phase|1
2667048|NCT00606177|9208830|P1|Overall Study|Progression to depressive phase|6
2667049|NCT00606177|9208829|P2|Overall Study|Withdrawal by Subject|6
2667050|NCT00606177|9208830|P1|Overall Study|Withdrawal by Subject|5
2667051|NCT00606177|9208829|P2|Overall Study|Protocol Violation|4
2667052|NCT00606177|9208830|P1|Overall Study|Protocol Violation|1
2667053|NCT00606177|9208829|P2|Overall Study|Physician Decision|0
2667054|NCT00606177|9208830|P1|Overall Study|Physician Decision|1
2667055|NCT00606177|9208829|P2|Overall Study|Lack of Efficacy|7
2667056|NCT00606177|9208830|P1|Overall Study|Lack of Efficacy|3
2667057|NCT00606177|9208829|P2|Overall Study|Adverse Event|5
2667058|NCT00606177|9208830|P1|Overall Study|Adverse Event|9
2667059|NCT00606086|9208857|P2|Overall Study|Randomized, not treated|2
2667060|NCT00606086|9208858|P1|Overall Study|Randomized, not treated|1
2667061|NCT00606086|9208857|P2|Overall Study|Non-compliance|1
2667062|NCT00606086|9208858|P1|Overall Study|Non-compliance|0
2667063|NCT00606086|9208857|P2|Overall Study|Withdrawal by Subject|3
2667064|NCT00606086|9208858|P1|Overall Study|Withdrawal by Subject|5
2667065|NCT00606086|9208857|P2|Overall Study|Protocol Violation|0
2667066|NCT00606086|9208858|P1|Overall Study|Protocol Violation|1
2667067|NCT00606086|9208857|P2|Overall Study|Lost to Follow-up|8
2667068|NCT00606086|9208858|P1|Overall Study|Lost to Follow-up|4
2667069|NCT00606086|9208857|P2|Overall Study|Adverse Event|1
2667070|NCT00606086|9208858|P1|Overall Study|Adverse Event|1
2667071|NCT00606034|9208868|P1|Overall Study|incarceration|1
2667072|NCT00606021|9208876|P3|Maintenance Phase|Lost to Follow-up|2
2667073|NCT00606021|9208877|P2|Maintenance Phase|Lost to Follow-up|5
2667074|NCT00606021|9208878|P1|Maintenance Phase|Lost to Follow-up|0
2667075|NCT00606021|9208876|P3|Maintenance Phase|Physician Decision|0
2667076|NCT00606021|9208877|P2|Maintenance Phase|Physician Decision|1
2667077|NCT00606021|9208878|P1|Maintenance Phase|Physician Decision|0
2667078|NCT00606021|9208876|P3|Maintenance Phase|Death|15
2667079|NCT00606021|9208877|P2|Maintenance Phase|Death|17
2667080|NCT00606021|9208878|P1|Maintenance Phase|Death|0
2667081|NCT00606021|9208876|P3|Induction Phase|Lost to Follow-up|0
2667082|NCT00606021|9208877|P2|Induction Phase|Lost to Follow-up|0
2667083|NCT00606021|9208878|P1|Induction Phase|Lost to Follow-up|10
2667084|NCT00606021|9208876|P3|Induction Phase|Withdrawal by Subject|0
2667085|NCT00606021|9208877|P2|Induction Phase|Withdrawal by Subject|0
2667086|NCT00606021|9208878|P1|Induction Phase|Withdrawal by Subject|2
2667087|NCT00606021|9208876|P3|Induction Phase|Physician Decision|0
2667088|NCT00606021|9208877|P2|Induction Phase|Physician Decision|0
2667089|NCT00606021|9208878|P1|Induction Phase|Physician Decision|2
2667090|NCT00606021|9208876|P3|Induction Phase|Death|0
2667091|NCT00606021|9208877|P2|Induction Phase|Death|0
2667092|NCT00606021|9208878|P1|Induction Phase|Death|73
2667093|NCT00606008|9208896|P1|Overall Study|Withdrawal by Subject|4
2667094|NCT00606008|9208896|P1|Overall Study|Adverse Event|1
2667095|NCT00605917|9208910|P1|Overall Study|Protocol Violation|79
2667096|NCT00605865|9208962|P1|Overall Study|Protocol Violation|115
2667097|NCT00605839|9209004|P3|Overall Study|Protocol Violation|0
2667098|NCT00605839|9209005|P2|Overall Study|Protocol Violation|0
2667099|NCT00605839|9209006|P1|Overall Study|Protocol Violation|1
2667100|NCT00605813|9209014|P1|Overall Study|Protocol Violation|25
2667101|NCT00605722|9209027|P1|Overall Study|Failure to return|1
2667102|NCT00605722|9209027|P1|Overall Study|Insufficient therapeutic response|44
2667103|NCT00605722|9209027|P1|Overall Study|Adverse Event|6
2667104|NCT00605657|9209048|P1|Overall Study|Protocol Violation|1
2667105|NCT00605657|9209048|P1|Overall Study|Adverse Event|1
2667106|NCT00605566|9209053|P1|Overall Study|Poor compliance in run-in period|1
2667107|NCT00605566|9209053|P1|Overall Study|Clinical deterioration|1
2667108|NCT00605566|9209053|P1|Overall Study|Adverse Event|1
2667109|NCT00605540|9209061|P1|Overall Study|Lost to Follow-up|23
2667110|NCT00605540|9209061|P1|Overall Study|Death|15
2667111|NCT00605475|9209079|P10|Overall Study|Withdrawal by Subject|1
2667112|NCT00605475|9209080|P9|Overall Study|Withdrawal by Subject|0
2667113|NCT00605475|9209081|P8|Overall Study|Withdrawal by Subject|0
2667114|NCT00605475|9209082|P7|Overall Study|Withdrawal by Subject|0
2667115|NCT00605475|9209083|P6|Overall Study|Withdrawal by Subject|2
2667116|NCT00605475|9209084|P5|Overall Study|Withdrawal by Subject|0
2667117|NCT00605475|9209085|P4|Overall Study|Withdrawal by Subject|0
2667118|NCT00605475|9209086|P3|Overall Study|Withdrawal by Subject|0
2667119|NCT00605475|9209087|P2|Overall Study|Withdrawal by Subject|0
2667120|NCT00605475|9209088|P1|Overall Study|Withdrawal by Subject|0
2667121|NCT00605475|9209079|P10|Overall Study|Protocol Violation|0
2667122|NCT00605475|9209080|P9|Overall Study|Protocol Violation|0
2667123|NCT00605475|9209081|P8|Overall Study|Protocol Violation|0
2667124|NCT00605475|9209082|P7|Overall Study|Protocol Violation|0
2667125|NCT00605475|9209083|P6|Overall Study|Protocol Violation|0
2667126|NCT00605475|9209084|P5|Overall Study|Protocol Violation|1
2667127|NCT00605475|9209085|P4|Overall Study|Protocol Violation|0
2667128|NCT00605475|9209086|P3|Overall Study|Protocol Violation|0
2667129|NCT00605475|9209087|P2|Overall Study|Protocol Violation|0
2667130|NCT00605475|9209088|P1|Overall Study|Protocol Violation|0
2667131|NCT00605475|9209079|P10|Overall Study|Lost to Follow-up|1
2667132|NCT00605475|9209080|P9|Overall Study|Lost to Follow-up|1
2667133|NCT00605475|9209081|P8|Overall Study|Lost to Follow-up|0
2667134|NCT00605475|9209082|P7|Overall Study|Lost to Follow-up|0
2667135|NCT00605475|9209083|P6|Overall Study|Lost to Follow-up|0
2667136|NCT00605475|9209084|P5|Overall Study|Lost to Follow-up|0
2667137|NCT00605475|9209085|P4|Overall Study|Lost to Follow-up|0
2667138|NCT00605475|9209086|P3|Overall Study|Lost to Follow-up|0
2667139|NCT00605475|9209087|P2|Overall Study|Lost to Follow-up|0
2667140|NCT00605475|9209088|P1|Overall Study|Lost to Follow-up|0
2667141|NCT00605475|9209079|P10|Overall Study|Administrative problems|0
2667142|NCT00605475|9209080|P9|Overall Study|Administrative problems|0
2667143|NCT00605475|9209081|P8|Overall Study|Administrative problems|0
2667144|NCT00605475|9209082|P7|Overall Study|Administrative problems|1
2667145|NCT00605475|9209083|P6|Overall Study|Administrative problems|0
2667146|NCT00605475|9209084|P5|Overall Study|Administrative problems|0
2667147|NCT00605475|9209085|P4|Overall Study|Administrative problems|0
2667148|NCT00605475|9209086|P3|Overall Study|Administrative problems|0
2667149|NCT00605475|9209087|P2|Overall Study|Administrative problems|0
2667150|NCT00605475|9209088|P1|Overall Study|Administrative problems|0
2667151|NCT00605475|9209079|P10|Overall Study|Abnormal Laboratory Values|0
2667152|NCT00605475|9209080|P9|Overall Study|Abnormal Laboratory Values|1
2667153|NCT00605475|9209081|P8|Overall Study|Abnormal Laboratory Values|0
2667154|NCT00605475|9209082|P7|Overall Study|Abnormal Laboratory Values|0
2667155|NCT00605475|9209083|P6|Overall Study|Abnormal Laboratory Values|0
2667156|NCT00605475|9209084|P5|Overall Study|Abnormal Laboratory Values|0
2667157|NCT00605475|9209085|P4|Overall Study|Abnormal Laboratory Values|0
2667158|NCT00605475|9209086|P3|Overall Study|Abnormal Laboratory Values|0
2667159|NCT00605475|9209087|P2|Overall Study|Abnormal Laboratory Values|0
2667160|NCT00605475|9209088|P1|Overall Study|Abnormal Laboratory Values|0
2667161|NCT00605345|9209265|P2|Overall Study|Protocol Violation|2
2667162|NCT00605345|9209266|P1|Overall Study|Protocol Violation|0
2667163|NCT00605345|9209265|P2|Overall Study|Adverse Event|1
2667164|NCT00605345|9209266|P1|Overall Study|Adverse Event|0
2667165|NCT00605345|9209265|P2|Overall Study|Withdrawal by Subject|0
2667166|NCT00605345|9209266|P1|Overall Study|Withdrawal by Subject|1
2667167|NCT00605319|9209282|P1|Overall Study|Adverse Event|6
2667168|NCT00605306|9209294|P2|Overall Study|Adverse Event|1
2667169|NCT00605306|9209295|P1|Overall Study|Adverse Event|0
2667170|NCT00605293|9209309|P2|Overall Study|Principal Investigator Decision|1
2667171|NCT00605293|9209310|P1|Overall Study|Principal Investigator Decision|0
2667172|NCT00605293|9209309|P2|Overall Study|Dialysis Out of Centre for 3 Months|1
2667173|NCT00605293|9209310|P1|Overall Study|Dialysis Out of Centre for 3 Months|0
2667174|NCT00605293|9209309|P2|Overall Study|Incorrect Epoetin Beta Administration|0
2667175|NCT00605293|9209310|P1|Overall Study|Incorrect Epoetin Beta Administration|1
2667176|NCT00605293|9209309|P2|Overall Study|Renal Transplantation|1
2667177|NCT00605293|9209310|P1|Overall Study|Renal Transplantation|3
2667178|NCT00605293|9209309|P2|Overall Study|Blood Transfusion|1
2667179|NCT00605293|9209310|P1|Overall Study|Blood Transfusion|7
2667180|NCT00605293|9209309|P2|Overall Study|Holidays Dialysis Out|0
2667181|NCT00605293|9209310|P1|Overall Study|Holidays Dialysis Out|1
2667182|NCT00605293|9209309|P2|Overall Study|Adverse Event|0
2667183|NCT00605293|9209310|P1|Overall Study|Adverse Event|1
2667184|NCT00605293|9209309|P2|Overall Study|Insufficient Therapeutic Response|0
2667185|NCT00605293|9209310|P1|Overall Study|Insufficient Therapeutic Response|2
2667186|NCT00605293|9209309|P2|Overall Study|Death|1
2667187|NCT00605293|9209310|P1|Overall Study|Death|2
2667188|NCT00605280|9209330|P4|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
2667189|NCT00605280|9209331|P3|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
2667190|NCT00605280|9209332|P2|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
2667191|NCT00605280|9209333|P1|Year 3 Extension|Lost to Follow-up or Patient non-comply|2
2667192|NCT00605280|9209330|P4|Year 3 Extension|Other|0
2667193|NCT00605280|9209331|P3|Year 3 Extension|Other|0
2667194|NCT00605280|9209332|P2|Year 3 Extension|Other|0
2667195|NCT00605280|9209333|P1|Year 3 Extension|Other|2
2667196|NCT00605280|9209330|P4|Year 3 Extension|Withdrawal by Subject|5
2667197|NCT00605280|9209331|P3|Year 3 Extension|Withdrawal by Subject|0
2667198|NCT00605280|9209332|P2|Year 3 Extension|Withdrawal by Subject|0
2667199|NCT00605280|9209333|P1|Year 3 Extension|Withdrawal by Subject|2
2667200|NCT00605280|9209330|P4|Year 3 Extension|Physician Decision|2
2667201|NCT00605280|9209331|P3|Year 3 Extension|Physician Decision|0
2667202|NCT00605280|9209332|P2|Year 3 Extension|Physician Decision|0
2667203|NCT00605280|9209333|P1|Year 3 Extension|Physician Decision|0
2667204|NCT00605280|9209330|P4|Year 3 Extension|Adverse Event|2
2667205|NCT00605280|9209331|P3|Year 3 Extension|Adverse Event|0
2667206|NCT00605280|9209332|P2|Year 3 Extension|Adverse Event|0
2667207|NCT00605280|9209333|P1|Year 3 Extension|Adverse Event|2
2667208|NCT00605280|9209330|P4|Year 2|Lost to Follow-up or Patient non-comply|2
2667209|NCT00605280|9209331|P3|Year 2|Lost to Follow-up or Patient non-comply|0
2667210|NCT00605280|9209332|P2|Year 2|Lost to Follow-up or Patient non-comply|0
2667211|NCT00605280|9209333|P1|Year 2|Lost to Follow-up or Patient non-comply|4
2667212|NCT00605280|9209330|P4|Year 2|Other|1
2667213|NCT00605280|9209331|P3|Year 2|Other|0
2667214|NCT00605280|9209332|P2|Year 2|Other|0
2667215|NCT00605280|9209333|P1|Year 2|Other|1
2667216|NCT00605280|9209330|P4|Year 2|Withdrawal by Subject|4
2667217|NCT00605280|9209331|P3|Year 2|Withdrawal by Subject|0
2667218|NCT00605280|9209332|P2|Year 2|Withdrawal by Subject|0
2667219|NCT00605280|9209333|P1|Year 2|Withdrawal by Subject|4
2667220|NCT00605280|9209330|P4|Year 2|Physician Decision|11
2667221|NCT00605280|9209331|P3|Year 2|Physician Decision|4
2667222|NCT00605280|9209332|P2|Year 2|Physician Decision|6
2667223|NCT00605280|9209333|P1|Year 2|Physician Decision|11
2667224|NCT00605280|9209330|P4|Year 2|Adverse Event|4
2667225|NCT00605280|9209331|P3|Year 2|Adverse Event|2
2667226|NCT00605280|9209332|P2|Year 2|Adverse Event|0
2667227|NCT00605280|9209333|P1|Year 2|Adverse Event|4
2667228|NCT00605280|9209330|P4|Year 1|Lost to Follow-up or Patient non-comply|2
2667229|NCT00605280|9209331|P3|Year 1|Lost to Follow-up or Patient non-comply|0
2667230|NCT00605280|9209332|P2|Year 1|Lost to Follow-up or Patient non-comply|1
2667231|NCT00605280|9209333|P1|Year 1|Lost to Follow-up or Patient non-comply|5
2667232|NCT00605280|9209330|P4|Year 1|Other|1
2667233|NCT00605280|9209331|P3|Year 1|Other|0
2667234|NCT00605280|9209332|P2|Year 1|Other|1
2667235|NCT00605280|9209333|P1|Year 1|Other|2
2667236|NCT00605280|9209330|P4|Year 1|Withdrawal by Subject|4
2667237|NCT00605280|9209331|P3|Year 1|Withdrawal by Subject|0
2667238|NCT00605280|9209332|P2|Year 1|Withdrawal by Subject|4
2667239|NCT00605280|9209333|P1|Year 1|Withdrawal by Subject|2
2667240|NCT00605280|9209330|P4|Year 1|Physician Decision|6
2667241|NCT00605280|9209331|P3|Year 1|Physician Decision|0
2667242|NCT00605280|9209332|P2|Year 1|Physician Decision|4
2667243|NCT00605280|9209333|P1|Year 1|Physician Decision|7
2667244|NCT00605280|9209330|P4|Year 1|Adverse Event|5
2667245|NCT00605280|9209331|P3|Year 1|Adverse Event|1
2667246|NCT00605280|9209332|P2|Year 1|Adverse Event|1
2667247|NCT00605280|9209333|P1|Year 1|Adverse Event|3
2667248|NCT00605280|9209330|P4|Year 1|Protocol Violation|1
2667249|NCT00605280|9209331|P3|Year 1|Protocol Violation|0
2667250|NCT00605280|9209332|P2|Year 1|Protocol Violation|0
2667251|NCT00605280|9209333|P1|Year 1|Protocol Violation|0
2667252|NCT00605267|9209367|P2|Overall Study|Withdrawal by Subject|3
2667253|NCT00605267|9209368|P1|Overall Study|Withdrawal by Subject|2
2667254|NCT00605267|9209367|P2|Overall Study|Lack of Efficacy|5
2667255|NCT00605267|9209368|P1|Overall Study|Lack of Efficacy|1
2667256|NCT00605267|9209367|P2|Overall Study|Adverse Event|1
2667257|NCT00605267|9209368|P1|Overall Study|Adverse Event|0
2667258|NCT00605189|9209416|P3|Overall Study|Other|0
2667259|NCT00605189|9209417|P2|Overall Study|Other|2
2667260|NCT00605189|9209418|P1|Overall Study|Other|2
2667261|NCT00605189|9209416|P3|Overall Study|Adverse Event|0
2667262|NCT00605189|9209417|P2|Overall Study|Adverse Event|0
2667263|NCT00605189|9209418|P1|Overall Study|Adverse Event|1
2667264|NCT00605176|9209429|P3|Overall Study|Other (not due to AE)|0
2667265|NCT00605176|9209430|P2|Overall Study|Other (not due to AE)|1
2667266|NCT00605176|9209431|P1|Overall Study|Other (not due to AE)|1
2667267|NCT00605176|9209429|P3|Overall Study|Use of concomitant therapy|1
2667268|NCT00605176|9209430|P2|Overall Study|Use of concomitant therapy|0
2667269|NCT00605176|9209431|P1|Overall Study|Use of concomitant therapy|1
2667270|NCT00605176|9209429|P3|Overall Study|Non-complicance with study procedures|0
2667271|NCT00605176|9209430|P2|Overall Study|Non-complicance with study procedures|0
2667272|NCT00605176|9209431|P1|Overall Study|Non-complicance with study procedures|1
2667273|NCT00605176|9209429|P3|Overall Study|Lost to Follow-up|1
2667274|NCT00605176|9209430|P2|Overall Study|Lost to Follow-up|2
2667275|NCT00605176|9209431|P1|Overall Study|Lost to Follow-up|2
2667276|NCT00605176|9209429|P3|Overall Study|Withdrawal by Subject|4
2667277|NCT00605176|9209430|P2|Overall Study|Withdrawal by Subject|2
2667278|NCT00605176|9209431|P1|Overall Study|Withdrawal by Subject|4
2667279|NCT00605176|9209429|P3|Overall Study|Adverse Event|3
2667280|NCT00605176|9209430|P2|Overall Study|Adverse Event|1
2667281|NCT00605176|9209431|P1|Overall Study|Adverse Event|2
2667282|NCT00605085|9209455|P2|Overall Study|administrative reasons|8
2667283|NCT00605085|9209456|P1|Overall Study|administrative reasons|18
2667284|NCT00605085|9209455|P2|Overall Study|Lost to Follow-up|5
2667285|NCT00605085|9209456|P1|Overall Study|Lost to Follow-up|10
2667286|NCT00605085|9209455|P2|Overall Study|Protocol Violation|2
2667287|NCT00605085|9209456|P1|Overall Study|Protocol Violation|3
2667288|NCT00605085|9209455|P2|Overall Study|Pregnancy|0
2667289|NCT00605085|9209456|P1|Overall Study|Pregnancy|2
2667290|NCT00605085|9209455|P2|Overall Study|Adverse Event|5
2667291|NCT00605085|9209456|P1|Overall Study|Adverse Event|9
2667292|NCT00605085|9209455|P2|Overall Study|Withdrawal by Subject|5
2667293|NCT00605085|9209456|P1|Overall Study|Withdrawal by Subject|8
2667294|NCT00605033|9209489|P2|Overall Study|Protocol Violation|1
2667295|NCT00605033|9209490|P1|Overall Study|Protocol Violation|1
2667296|NCT00605033|9209489|P2|Overall Study|Withdrawal by Subject|4
2667297|NCT00605033|9209490|P1|Overall Study|Withdrawal by Subject|3
2667298|NCT00605033|9209489|P2|Overall Study|Lost to Follow-up|1
2667299|NCT00605033|9209490|P1|Overall Study|Lost to Follow-up|1
2667300|NCT00605033|9209489|P2|Overall Study|Adverse Event|2
2667301|NCT00605033|9209490|P1|Overall Study|Adverse Event|2
2667302|NCT00604825|9209534|P4|Overall Study|Exclusion criterion met|1
2667303|NCT00604825|9209535|P3|Overall Study|Exclusion criterion met|0
2667304|NCT00604825|9209536|P2|Overall Study|Exclusion criterion met|0
2667305|NCT00604825|9209537|P1|Overall Study|Exclusion criterion met|0
2667306|NCT00604825|9209534|P4|Overall Study|Physician Decision|1
2667307|NCT00604825|9209535|P3|Overall Study|Physician Decision|0
2667308|NCT00604825|9209536|P2|Overall Study|Physician Decision|0
2667309|NCT00604825|9209537|P1|Overall Study|Physician Decision|0
2667310|NCT00604825|9209534|P4|Overall Study|Did not meet eligibility criteria|0
2667311|NCT00604825|9209535|P3|Overall Study|Did not meet eligibility criteria|2
2667312|NCT00604825|9209536|P2|Overall Study|Did not meet eligibility criteria|0
2667313|NCT00604825|9209537|P1|Overall Study|Did not meet eligibility criteria|0
2667314|NCT00604825|9209534|P4|Overall Study|Lack of Efficacy|0
2667315|NCT00604825|9209535|P3|Overall Study|Lack of Efficacy|1
2667316|NCT00604825|9209536|P2|Overall Study|Lack of Efficacy|2
2667317|NCT00604825|9209537|P1|Overall Study|Lack of Efficacy|3
2667318|NCT00604825|9209534|P4|Overall Study|Withdrawal by Subject|5
2667319|NCT00604825|9209535|P3|Overall Study|Withdrawal by Subject|5
2667320|NCT00604825|9209536|P2|Overall Study|Withdrawal by Subject|3
2667321|NCT00604825|9209537|P1|Overall Study|Withdrawal by Subject|4
2667322|NCT00604825|9209534|P4|Overall Study|Protocol Violation|0
2667323|NCT00604825|9209535|P3|Overall Study|Protocol Violation|0
2667324|NCT00604825|9209536|P2|Overall Study|Protocol Violation|1
2667325|NCT00604825|9209537|P1|Overall Study|Protocol Violation|0
2667326|NCT00604825|9209534|P4|Overall Study|Lost to Follow-up|0
2667327|NCT00604825|9209535|P3|Overall Study|Lost to Follow-up|1
2667328|NCT00604825|9209536|P2|Overall Study|Lost to Follow-up|3
2667329|NCT00604825|9209537|P1|Overall Study|Lost to Follow-up|0
2667330|NCT00604825|9209534|P4|Overall Study|Adverse Event|4
2667331|NCT00604825|9209535|P3|Overall Study|Adverse Event|7
2667332|NCT00604825|9209536|P2|Overall Study|Adverse Event|6
2667333|NCT00604825|9209537|P1|Overall Study|Adverse Event|2
2667334|NCT00604786|9209765|P2|Overall Study|Lost to Follow-up|0
2667335|NCT00604786|9209766|P1|Overall Study|Lost to Follow-up|2
2667336|NCT00604721|9209772|P1|Overall Study|Withdrawal by Subject|1
2667337|NCT00604721|9209772|P1|Overall Study|Physician Decision|1
2667338|NCT00604708|9209780|P2|Overall Study|Adverse Event|6
2667339|NCT00604708|9209781|P1|Overall Study|Adverse Event|6
2667340|NCT00604708|9209780|P2|Overall Study|administrative reasons|11
2667341|NCT00604708|9209781|P1|Overall Study|administrative reasons|9
2667342|NCT00604708|9209780|P2|Overall Study|Lost to Follow-up|5
2667343|NCT00604708|9209781|P1|Overall Study|Lost to Follow-up|5
2667344|NCT00604708|9209780|P2|Overall Study|Protocol Violation|8
2667345|NCT00604708|9209781|P1|Overall Study|Protocol Violation|2
2667346|NCT00604708|9209780|P2|Overall Study|Withdrawal by Subject|10
2667347|NCT00604708|9209781|P1|Overall Study|Withdrawal by Subject|9
2667348|NCT00604695|9209791|P2|Overall Study|Did not receive first bolus.|4
2667349|NCT00604695|9209792|P1|Overall Study|Did not receive first bolus.|0
2667350|NCT00604669|9209814|P1|Overall Study|lack of information in chart|7
2667351|NCT00604565|9209820|P2|Overall Study|Study terminated|3
2667352|NCT00604565|9209821|P1|Overall Study|Study terminated|0
2667353|NCT00604500|9209840|P1|Overall Study|Did not meet protocol eligibility|1
2667354|NCT00604500|9209840|P1|Overall Study|Administrative|1
2667355|NCT00604500|9209840|P1|Overall Study|Withdrawal by Subject|4
2667356|NCT00604500|9209840|P1|Overall Study|Treatment Failure|1
2667357|NCT00604500|9209840|P1|Overall Study|Protocol Violation|2
2667358|NCT00604500|9209840|P1|Overall Study|Adverse Event|2
2667359|NCT00604383|9209854|P2|Overall Study|Physician Decision|3
2667360|NCT00604383|9209855|P1|Overall Study|Physician Decision|0
2667361|NCT00604383|9209854|P2|Overall Study|Adverse Event|9
2667362|NCT00604383|9209855|P1|Overall Study|Adverse Event|16
2667363|NCT00604383|9209854|P2|Overall Study|Death|22
2667364|NCT00604383|9209855|P1|Overall Study|Death|14
2667365|NCT00604383|9209854|P2|Overall Study|Lost to Follow-up|19
2667366|NCT00604383|9209855|P1|Overall Study|Lost to Follow-up|24
2667367|NCT00604383|9209854|P2|Overall Study|Withdrawal by Subject|31
2667368|NCT00604383|9209855|P1|Overall Study|Withdrawal by Subject|33
2667369|NCT00604279|9209871|P2|Overall Study|Other|4
2667370|NCT00604279|9209872|P1|Overall Study|Other|8
2667371|NCT00604279|9209871|P2|Overall Study|Adverse Event|5
2667372|NCT00604279|9209872|P1|Overall Study|Adverse Event|4
2667373|NCT00604279|9209871|P2|Overall Study|Withdrawal by Subject|5
2667374|NCT00604279|9209872|P1|Overall Study|Withdrawal by Subject|16
2667375|NCT00604279|9209871|P2|Overall Study|Protocol Violation|1
2667376|NCT00604279|9209872|P1|Overall Study|Protocol Violation|3
2667377|NCT00604279|9209871|P2|Overall Study|Pregnancy|0
2667378|NCT00604279|9209872|P1|Overall Study|Pregnancy|2
2667379|NCT00604279|9209871|P2|Overall Study|Lost to Follow-up|14
2667380|NCT00604279|9209872|P1|Overall Study|Lost to Follow-up|9
2667381|NCT00604279|9209871|P2|Overall Study|Lack of Efficacy|9
2667382|NCT00604279|9209872|P1|Overall Study|Lack of Efficacy|22
2667383|NCT00604214|9209888|P2|Day 91 to Day 180|Withdrawal by Subject|1
2667384|NCT00604214|9209889|P1|Day 91 to Day 180|Withdrawal by Subject|1
2667385|NCT00604214|9209888|P2|Day 91 to Day 180|Lost to Follow-up|8
2667386|NCT00604214|9209889|P1|Day 91 to Day 180|Lost to Follow-up|6
2667387|NCT00604214|9209888|P2|Day 91 to Day 180|Death|23
2667388|NCT00604214|9209889|P1|Day 91 to Day 180|Death|19
2667389|NCT00604214|9209888|P2|Day 29 to Day 90|Withdrawal by Subject|6
2667390|NCT00604214|9209889|P1|Day 29 to Day 90|Withdrawal by Subject|0
2667391|NCT00604214|9209888|P2|Day 29 to Day 90|Lost to Follow-up|6
2667392|NCT00604214|9209889|P1|Day 29 to Day 90|Lost to Follow-up|4
2667393|NCT00604214|9209888|P2|Day 29 to Day 90|Death|67
2667394|NCT00604214|9209889|P1|Day 29 to Day 90|Death|64
2667395|NCT00604214|9209888|P2|Baseline to Day 28|Withdrawal by Subject|7
2667396|NCT00604214|9209889|P1|Baseline to Day 28|Withdrawal by Subject|3
2667397|NCT00604214|9209888|P2|Baseline to Day 28|Lost to Follow-up|4
2667398|NCT00604214|9209889|P1|Baseline to Day 28|Lost to Follow-up|2
2667399|NCT00604214|9209888|P2|Baseline to Day 28|Death|202
2667400|NCT00604214|9209889|P1|Baseline to Day 28|Death|223
2667401|NCT00604188|9209921|P2|Overall Study|Did not receive study drug|1
2667402|NCT00604188|9209922|P1|Overall Study|Did not receive study drug|0
2667403|NCT00604188|9209921|P2|Overall Study|Non-compliance with protocol|4
2667404|NCT00604188|9209922|P1|Overall Study|Non-compliance with protocol|4
2667405|NCT00604188|9209921|P2|Overall Study|Withdrawal by Subject|1
2667406|NCT00604188|9209922|P1|Overall Study|Withdrawal by Subject|5
2667407|NCT00604188|9209921|P2|Overall Study|Lost to Follow-up|15
2667408|NCT00604188|9209922|P1|Overall Study|Lost to Follow-up|17
2667409|NCT00604188|9209921|P2|Overall Study|Adverse Event|4
2667410|NCT00604188|9209922|P1|Overall Study|Adverse Event|1
2667411|NCT00604175|9209945|P3|Week 29 Through Week 72|Non-adherence to study requirements|1
2667412|NCT00604175|9209946|P2|Week 29 Through Week 72|Non-adherence to study requirements|0
2667413|NCT00604175|9209947|P1|Week 29 Through Week 72|Non-adherence to study requirements|0
2667414|NCT00604175|9209945|P3|Week 29 Through Week 72|Site closure|0
2667415|NCT00604175|9209946|P2|Week 29 Through Week 72|Site closure|1
2667416|NCT00604175|9209947|P1|Week 29 Through Week 72|Site closure|0
2667417|NCT00604175|9209945|P3|Week 29 Through Week 72|Lost to Follow-up|2
2667418|NCT00604175|9209946|P2|Week 29 Through Week 72|Lost to Follow-up|6
2667419|NCT00604175|9209947|P1|Week 29 Through Week 72|Lost to Follow-up|12
2667420|NCT00604175|9209945|P3|Week 29 Through Week 72|Death|1
2667421|NCT00604175|9209946|P2|Week 29 Through Week 72|Death|0
2667422|NCT00604175|9209947|P1|Week 29 Through Week 72|Death|0
2667423|NCT00604175|9209945|P3|Entry Through Week 28|Did not start intervention|1
2667424|NCT00604175|9209946|P2|Entry Through Week 28|Did not start intervention|0
2667425|NCT00604175|9209947|P1|Entry Through Week 28|Did not start intervention|2
2667426|NCT00604175|9209945|P3|Entry Through Week 28|Ineligible|0
2667427|NCT00604175|9209946|P2|Entry Through Week 28|Ineligible|0
2667428|NCT00604175|9209947|P1|Entry Through Week 28|Ineligible|1
2667429|NCT00604175|9209945|P3|Entry Through Week 28|Lost to Follow-up|0
2667430|NCT00604175|9209946|P2|Entry Through Week 28|Lost to Follow-up|3
2667431|NCT00604175|9209947|P1|Entry Through Week 28|Lost to Follow-up|4
2667432|NCT00604175|9209945|P3|Entry Through Week 28|Withdrawal by Subject|0
2667433|NCT00604175|9209946|P2|Entry Through Week 28|Withdrawal by Subject|0
2667434|NCT00604175|9209947|P1|Entry Through Week 28|Withdrawal by Subject|1
2667435|NCT00604175|9209945|P3|Entry Through Week 28|Death|0
2667436|NCT00604175|9209946|P2|Entry Through Week 28|Death|0
2667437|NCT00604175|9209947|P1|Entry Through Week 28|Death|2
2667438|NCT00604162|9210000|P1|Overall Study|Withdrawal by Subject|1
2667439|NCT00604162|9210000|P1|Overall Study|Physician Decision|3
2667440|NCT00603980|9210042|P1|Main Study|14th subject completed trial|1
2667441|NCT00603980|9210042|P1|Study Qualification|Inconsistent data reporting|13
2667442|NCT00603980|9210042|P1|Study Qualification|Protocol Violation|3
2667443|NCT00603915|9210158|P1|Overall Study|Physician Decision|1
2667444|NCT00603837|9210188|P2|Overall Study|Physician Decision|0
2667445|NCT00603837|9210189|P1|Overall Study|Physician Decision|3
2667446|NCT00603798|9210198|P3|Overall Study|Not due to AE|4
2667447|NCT00603798|9210199|P2|Overall Study|Not due to AE|1
2667448|NCT00603798|9210200|P1|Overall Study|Not due to AE|1
2667449|NCT00603798|9210198|P3|Overall Study|Non-compliance with study procedures|0
2667450|NCT00603798|9210199|P2|Overall Study|Non-compliance with study procedures|1
2667451|NCT00603798|9210200|P1|Overall Study|Non-compliance with study procedures|0
2667452|NCT00603798|9210198|P3|Overall Study|Lost to Follow-up|1
2667453|NCT00603798|9210199|P2|Overall Study|Lost to Follow-up|0
2667454|NCT00603798|9210200|P1|Overall Study|Lost to Follow-up|1
2667455|NCT00603798|9210198|P3|Overall Study|Withdrawal by Subject|4
2667456|NCT00603798|9210199|P2|Overall Study|Withdrawal by Subject|3
2667457|NCT00603798|9210200|P1|Overall Study|Withdrawal by Subject|4
2667458|NCT00603798|9210198|P3|Overall Study|Adverse Event|1
2667459|NCT00603798|9210199|P2|Overall Study|Adverse Event|2
2667460|NCT00603798|9210200|P1|Overall Study|Adverse Event|4
2667461|NCT00603746|9210223|P6|Overall Study|Withdrawal by Subject|1
2667462|NCT00603746|9210224|P5|Overall Study|Withdrawal by Subject|3
2667463|NCT00603746|9210225|P4|Overall Study|Withdrawal by Subject|1
2667464|NCT00603746|9210226|P3|Overall Study|Withdrawal by Subject|0
2667465|NCT00603746|9210227|P2|Overall Study|Withdrawal by Subject|0
2667466|NCT00603746|9210228|P1|Overall Study|Withdrawal by Subject|1
2667467|NCT00603746|9210223|P6|Overall Study|Physician Decision|0
2667468|NCT00603746|9210224|P5|Overall Study|Physician Decision|1
2667469|NCT00603746|9210225|P4|Overall Study|Physician Decision|0
2667470|NCT00603746|9210226|P3|Overall Study|Physician Decision|0
2667471|NCT00603746|9210227|P2|Overall Study|Physician Decision|0
2667472|NCT00603746|9210228|P1|Overall Study|Physician Decision|1
2667473|NCT00603746|9210223|P6|Overall Study|Lost to Follow-up|0
2667474|NCT00603746|9210224|P5|Overall Study|Lost to Follow-up|0
2667475|NCT00603746|9210225|P4|Overall Study|Lost to Follow-up|0
2667476|NCT00603746|9210226|P3|Overall Study|Lost to Follow-up|1
2667477|NCT00603746|9210227|P2|Overall Study|Lost to Follow-up|1
2667478|NCT00603746|9210228|P1|Overall Study|Lost to Follow-up|0
2667479|NCT00603746|9210223|P6|Overall Study|Protocol Violation|0
2667480|NCT00603746|9210224|P5|Overall Study|Protocol Violation|1
2667481|NCT00603746|9210225|P4|Overall Study|Protocol Violation|0
2667482|NCT00603746|9210226|P3|Overall Study|Protocol Violation|1
2667483|NCT00603746|9210227|P2|Overall Study|Protocol Violation|3
2667484|NCT00603746|9210228|P1|Overall Study|Protocol Violation|0
2667485|NCT00603746|9210223|P6|Overall Study|Lack of Efficacy|8
2667486|NCT00603746|9210224|P5|Overall Study|Lack of Efficacy|12
2667487|NCT00603746|9210225|P4|Overall Study|Lack of Efficacy|11
2667488|NCT00603746|9210226|P3|Overall Study|Lack of Efficacy|6
2667489|NCT00603746|9210227|P2|Overall Study|Lack of Efficacy|11
2667490|NCT00603746|9210228|P1|Overall Study|Lack of Efficacy|34
2667491|NCT00603746|9210223|P6|Overall Study|Adverse Event|4
2667492|NCT00603746|9210224|P5|Overall Study|Adverse Event|0
2667493|NCT00603746|9210225|P4|Overall Study|Adverse Event|1
2667494|NCT00603746|9210226|P3|Overall Study|Adverse Event|0
2667495|NCT00603746|9210227|P2|Overall Study|Adverse Event|3
2667496|NCT00603746|9210228|P1|Overall Study|Adverse Event|2
2667497|NCT00603733|9210376|P2|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5
2667498|NCT00603733|9210377|P1|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3
2667499|NCT00603733|9210376|P2|Maintenance Phase ITT|Physician Decision|1
2667500|NCT00603733|9210377|P1|Maintenance Phase ITT|Physician Decision|0
2667501|NCT00603733|9210376|P2|Maintenance Phase ITT|Lack of Efficacy|2
2667502|NCT00603733|9210377|P1|Maintenance Phase ITT|Lack of Efficacy|2
2667503|NCT00603733|9210376|P2|Maintenance Phase ITT|Lost to Follow-up|1
2667504|NCT00603733|9210377|P1|Maintenance Phase ITT|Lost to Follow-up|0
2667505|NCT00603733|9210376|P2|Maintenance Phase ITT|Protocol Violation|1
2667506|NCT00603733|9210377|P1|Maintenance Phase ITT|Protocol Violation|1
2667507|NCT00603733|9210376|P2|Maintenance Phase ITT|Withdrawal by Subject|0
2667508|NCT00603733|9210377|P1|Maintenance Phase ITT|Withdrawal by Subject|1
2667509|NCT00603733|9210376|P2|Maintenance Phase ITT|Adverse Event|6
2667510|NCT00603733|9210377|P1|Maintenance Phase ITT|Adverse Event|3
2667511|NCT00603733|9210376|P2|Run-In Phase - 4 Weeks|Lack of Efficacy|1
2667512|NCT00603733|9210377|P1|Run-In Phase - 4 Weeks|Lack of Efficacy|2
2667513|NCT00603733|9210376|P2|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10
2667514|NCT00603733|9210377|P1|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5
2667515|NCT00603733|9210376|P2|Run-In Phase - 4 Weeks|Lost to Follow-up|0
2667516|NCT00603733|9210377|P1|Run-In Phase - 4 Weeks|Lost to Follow-up|1
2667517|NCT00603733|9210376|P2|Run-In Phase - 4 Weeks|Withdrawal by Subject|1
2667518|NCT00603733|9210377|P1|Run-In Phase - 4 Weeks|Withdrawal by Subject|4
2667519|NCT00603733|9210376|P2|Run-In Phase - 4 Weeks|Adverse Event|1
2667520|NCT00603733|9210377|P1|Run-In Phase - 4 Weeks|Adverse Event|2
2667521|NCT00603733|9210376|P2|Active Phase ITT|Subject moved, site closed|1
2667522|NCT00603733|9210377|P1|Active Phase ITT|Subject moved, site closed|1
2667523|NCT00603733|9210376|P2|Active Phase ITT|Lack of Efficacy|2
2667524|NCT00603733|9210377|P1|Active Phase ITT|Lack of Efficacy|1
2667525|NCT00603733|9210376|P2|Active Phase ITT|Did not meet inclusion/exclusion|3
2667526|NCT00603733|9210377|P1|Active Phase ITT|Did not meet inclusion/exclusion|1
2667527|NCT00603733|9210376|P2|Active Phase ITT|Lost to Follow-up|1
2667528|NCT00603733|9210377|P1|Active Phase ITT|Lost to Follow-up|0
2667529|NCT00603733|9210376|P2|Active Phase ITT|Withdrawal by Subject|3
2667530|NCT00603733|9210377|P1|Active Phase ITT|Withdrawal by Subject|0
2667531|NCT00603733|9210376|P2|Active Phase ITT|Adverse Event|7
2667532|NCT00603733|9210377|P1|Active Phase ITT|Adverse Event|8
2667533|NCT00603590|9210427|P2|Overall Study|Cardiovascular event|1
2667534|NCT00603590|9210428|P1|Overall Study|Cardiovascular event|0
2667535|NCT00603590|9210427|P2|Overall Study|Lost to Follow-up|4
2667536|NCT00603590|9210428|P1|Overall Study|Lost to Follow-up|8
2667537|NCT00603590|9210427|P2|Overall Study|Adverse Event|0
2667538|NCT00603590|9210428|P1|Overall Study|Adverse Event|2
2667539|NCT00603590|9210427|P2|Overall Study|Patient discontinued study drug|15
2667540|NCT00603590|9210428|P1|Overall Study|Patient discontinued study drug|22
2667541|NCT00603590|9210427|P2|Overall Study|Refused blood test|1
2667542|NCT00603590|9210428|P1|Overall Study|Refused blood test|5
2667543|NCT00603590|9210427|P2|Overall Study|Did not attend study clinic|30
2667544|NCT00603590|9210428|P1|Overall Study|Did not attend study clinic|39
2667545|NCT00603538|9210452|P3|Overall Study|Objective progression or relapse|0
2667546|NCT00603538|9210453|P2|Overall Study|Objective progression or relapse|0
2667547|NCT00603538|9210454|P1|Overall Study|Objective progression or relapse|3
2667548|NCT00603538|9210452|P3|Overall Study|Adverse Event|2
2667549|NCT00603538|9210453|P2|Overall Study|Adverse Event|4
2667550|NCT00603538|9210454|P1|Overall Study|Adverse Event|0
2667551|NCT00603525|9210494|P3|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111
2667552|NCT00603525|9210495|P2|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
2667553|NCT00603525|9210496|P1|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
2667554|NCT00603525|9210494|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
2667555|NCT00603525|9210495|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8
2667556|NCT00603525|9210496|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
2667557|NCT00603525|9210494|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
2667558|NCT00603525|9210495|P2|OL Treatment Period (120 Weeks)|Physician Decision|2
2667559|NCT00603525|9210496|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
2667560|NCT00603525|9210494|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
2667561|NCT00603525|9210495|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71
2667562|NCT00603525|9210496|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
2667563|NCT00603525|9210494|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
2667564|NCT00603525|9210495|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5
2667565|NCT00603525|9210496|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
2667566|NCT00603525|9210494|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
2667567|NCT00603525|9210495|P2|OL Treatment Period (120 Weeks)|Protocol Violation|1
2667568|NCT00603525|9210496|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
2667569|NCT00603525|9210494|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
2667570|NCT00603525|9210495|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|13
2667571|NCT00603525|9210496|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
2667572|NCT00603525|9210494|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
2667573|NCT00603525|9210495|P2|OL Treatment Period (120 Weeks)|Adverse Event|12
2667574|NCT00603525|9210496|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
2667575|NCT00603525|9210494|P3|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
2667576|NCT00603525|9210495|P2|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1
2667577|NCT00603525|9210496|P1|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
2667578|NCT00603525|9210494|P3|DB Treatment Period (24 Weeks)|Physician Decision|0
2667579|NCT00603525|9210495|P2|DB Treatment Period (24 Weeks)|Physician Decision|1
2667580|NCT00603525|9210496|P1|DB Treatment Period (24 Weeks)|Physician Decision|0
2667581|NCT00603525|9210494|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
2667582|NCT00603525|9210495|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6
2667583|NCT00603525|9210496|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5
2667584|NCT00603525|9210494|P3|DB Treatment Period (24 Weeks)|Lost to Follow-up|0
2667585|NCT00603525|9210495|P2|DB Treatment Period (24 Weeks)|Lost to Follow-up|3
2667586|NCT00603525|9210496|P1|DB Treatment Period (24 Weeks)|Lost to Follow-up|1
2667587|NCT00603525|9210494|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
2667588|NCT00603525|9210495|P2|DB Treatment Period (24 Weeks)|Protocol Violation|2
2667589|NCT00603525|9210496|P1|DB Treatment Period (24 Weeks)|Protocol Violation|1
2667590|NCT00603525|9210494|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
2667591|NCT00603525|9210495|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
2667592|NCT00603525|9210496|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|7
2667593|NCT00603525|9210494|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
2667594|NCT00603525|9210495|P2|DB Treatment Period (24 Weeks)|Adverse Event|9
2667595|NCT00603525|9210496|P1|DB Treatment Period (24 Weeks)|Adverse Event|3
2667596|NCT00603512|9210628|P5|Overall Study|Randomized but not treated|0
2667597|NCT00603512|9210629|P4|Overall Study|Randomized but not treated|2
2667598|NCT00603512|9210630|P3|Overall Study|Randomized but not treated|1
2667599|NCT00603512|9210631|P2|Overall Study|Randomized but not treated|1
2667600|NCT00603512|9210632|P1|Overall Study|Randomized but not treated|0
2667601|NCT00603512|9210628|P5|Overall Study|Withdrawal by Subject|1
2667602|NCT00603512|9210629|P4|Overall Study|Withdrawal by Subject|0
2667603|NCT00603512|9210630|P3|Overall Study|Withdrawal by Subject|0
2667604|NCT00603512|9210631|P2|Overall Study|Withdrawal by Subject|0
2667605|NCT00603512|9210632|P1|Overall Study|Withdrawal by Subject|0
2667606|NCT00603512|9210628|P5|Overall Study|Other|1
2667607|NCT00603512|9210629|P4|Overall Study|Other|1
2667608|NCT00603512|9210630|P3|Overall Study|Other|0
2667609|NCT00603512|9210631|P2|Overall Study|Other|1
2667610|NCT00603512|9210632|P1|Overall Study|Other|2
2667611|NCT00603512|9210628|P5|Overall Study|Lack of Efficacy|1
2667612|NCT00603512|9210629|P4|Overall Study|Lack of Efficacy|0
2667613|NCT00603512|9210630|P3|Overall Study|Lack of Efficacy|0
2667614|NCT00603512|9210631|P2|Overall Study|Lack of Efficacy|1
2667615|NCT00603512|9210632|P1|Overall Study|Lack of Efficacy|0
2667616|NCT00603512|9210628|P5|Overall Study|Adverse Event|2
2667617|NCT00603512|9210629|P4|Overall Study|Adverse Event|4
2667618|NCT00603512|9210630|P3|Overall Study|Adverse Event|4
2667619|NCT00603512|9210631|P2|Overall Study|Adverse Event|2
2667620|NCT00603512|9210632|P1|Overall Study|Adverse Event|0
2667621|NCT00603473|9210774|P1|Overall Study|Protocol Violation|1
2667622|NCT00603473|9210774|P1|Overall Study|Lack of Efficacy|4
2667623|NCT00603473|9210774|P1|Overall Study|Adverse Event|4
2667624|NCT00603447|9210787|P7|Overall Study|Withdrew Consent|1
2667625|NCT00603447|9210788|P6|Overall Study|Withdrew Consent|0
2667626|NCT00603447|9210789|P5|Overall Study|Withdrew Consent|1
2667627|NCT00603447|9210790|P4|Overall Study|Withdrew Consent|0
2667628|NCT00603447|9210791|P3|Overall Study|Withdrew Consent|0
2667629|NCT00603447|9210792|P2|Overall Study|Withdrew Consent|2
2667630|NCT00603447|9210793|P1|Overall Study|Withdrew Consent|0
2667631|NCT00603447|9210787|P7|Overall Study|Other|13
2667632|NCT00603447|9210788|P6|Overall Study|Other|0
2667633|NCT00603447|9210789|P5|Overall Study|Other|3
2667634|NCT00603447|9210790|P4|Overall Study|Other|0
2667635|NCT00603447|9210791|P3|Overall Study|Other|1
2667636|NCT00603447|9210792|P2|Overall Study|Other|0
2667637|NCT00603447|9210793|P1|Overall Study|Other|0
2667638|NCT00603447|9210787|P7|Overall Study|Adverse Event|10
2667639|NCT00603447|9210788|P6|Overall Study|Adverse Event|2
2667640|NCT00603447|9210789|P5|Overall Study|Adverse Event|1
2667641|NCT00603447|9210790|P4|Overall Study|Adverse Event|2
2667642|NCT00603447|9210791|P3|Overall Study|Adverse Event|1
2667643|NCT00603447|9210792|P2|Overall Study|Adverse Event|1
2667644|NCT00603447|9210793|P1|Overall Study|Adverse Event|0
2667645|NCT00603382|9210832|P6|Overall Study|Withdrawal by Subject|1
2667646|NCT00603382|9210833|P5|Overall Study|Withdrawal by Subject|0
2667647|NCT00603382|9210834|P4|Overall Study|Withdrawal by Subject|1
2667648|NCT00603382|9210835|P3|Overall Study|Withdrawal by Subject|1
2667649|NCT00603382|9210836|P2|Overall Study|Withdrawal by Subject|3
2667650|NCT00603382|9210837|P1|Overall Study|Withdrawal by Subject|3
2667651|NCT00603382|9210832|P6|Overall Study|Physician Decision|3
2667652|NCT00603382|9210833|P5|Overall Study|Physician Decision|1
2667653|NCT00603382|9210834|P4|Overall Study|Physician Decision|0
2667654|NCT00603382|9210835|P3|Overall Study|Physician Decision|2
2667655|NCT00603382|9210836|P2|Overall Study|Physician Decision|0
2667656|NCT00603382|9210837|P1|Overall Study|Physician Decision|0
2667657|NCT00603382|9210832|P6|Overall Study|Lost to Follow-up|1
2667658|NCT00603382|9210833|P5|Overall Study|Lost to Follow-up|0
2667659|NCT00603382|9210834|P4|Overall Study|Lost to Follow-up|1
2667660|NCT00603382|9210835|P3|Overall Study|Lost to Follow-up|1
2667661|NCT00603382|9210836|P2|Overall Study|Lost to Follow-up|1
2667662|NCT00603382|9210837|P1|Overall Study|Lost to Follow-up|0
2667663|NCT00603382|9210832|P6|Overall Study|Protocol Violation|0
2667664|NCT00603382|9210833|P5|Overall Study|Protocol Violation|1
2667665|NCT00603382|9210834|P4|Overall Study|Protocol Violation|2
2667666|NCT00603382|9210835|P3|Overall Study|Protocol Violation|1
2667667|NCT00603382|9210836|P2|Overall Study|Protocol Violation|0
2667668|NCT00603382|9210837|P1|Overall Study|Protocol Violation|1
2667669|NCT00603382|9210832|P6|Overall Study|Lack of Efficacy|11
2667670|NCT00603382|9210833|P5|Overall Study|Lack of Efficacy|6
2667671|NCT00603382|9210834|P4|Overall Study|Lack of Efficacy|6
2667672|NCT00603382|9210835|P3|Overall Study|Lack of Efficacy|3
2667673|NCT00603382|9210836|P2|Overall Study|Lack of Efficacy|9
2667674|NCT00603382|9210837|P1|Overall Study|Lack of Efficacy|14
2667675|NCT00603382|9210832|P6|Overall Study|Adverse Event|2
2667676|NCT00603382|9210833|P5|Overall Study|Adverse Event|1
2667677|NCT00603382|9210834|P4|Overall Study|Adverse Event|2
2667678|NCT00603382|9210835|P3|Overall Study|Adverse Event|1
2667679|NCT00603382|9210836|P2|Overall Study|Adverse Event|1
2667680|NCT00603382|9210837|P1|Overall Study|Adverse Event|0
2667681|NCT00603304|9210985|P2|Overall Study|Patient Decision|0
2667682|NCT00603304|9210986|P1|Overall Study|Patient Decision|2
2667683|NCT00603304|9210985|P2|Overall Study|Other|0
2667684|NCT00603304|9210986|P1|Overall Study|Other|2
2667685|NCT00603304|9210985|P2|Overall Study|Moved Away|2
2667686|NCT00603304|9210986|P1|Overall Study|Moved Away|0
2667687|NCT00603304|9210985|P2|Overall Study|Non-Compliant|1
2667688|NCT00603304|9210986|P1|Overall Study|Non-Compliant|0
2667689|NCT00603304|9210985|P2|Overall Study|Exclusionary Medication|3
2667690|NCT00603304|9210986|P1|Overall Study|Exclusionary Medication|2
2667691|NCT00603304|9210985|P2|Overall Study|Crossed Over to Open Label Therapy|3
2667692|NCT00603304|9210986|P1|Overall Study|Crossed Over to Open Label Therapy|3
2667693|NCT00603304|9210985|P2|Overall Study|Unacceptable Treatment Toxicity|8
2667694|NCT00603304|9210986|P1|Overall Study|Unacceptable Treatment Toxicity|5
2667695|NCT00603304|9210985|P2|Overall Study|Adverse Event|2
2667696|NCT00603304|9210986|P1|Overall Study|Adverse Event|4
2667697|NCT00603304|9210985|P2|Overall Study|Protocol Violation|0
2667698|NCT00603304|9210986|P1|Overall Study|Protocol Violation|1
2667699|NCT00603304|9210985|P2|Overall Study|Withdrawal by Subject|5
2667700|NCT00603304|9210986|P1|Overall Study|Withdrawal by Subject|8
2667701|NCT00603304|9210985|P2|Overall Study|Lost to Follow-up|7
2667702|NCT00603304|9210986|P1|Overall Study|Lost to Follow-up|5
2667703|NCT00603278|9211042|P6|Overall Study|Lost to Follow-up|0
2667704|NCT00603278|9211043|P5|Overall Study|Lost to Follow-up|1
2667705|NCT00603278|9211044|P4|Overall Study|Lost to Follow-up|0
2667706|NCT00603278|9211045|P3|Overall Study|Lost to Follow-up|0
2667707|NCT00603278|9211046|P2|Overall Study|Lost to Follow-up|0
2667708|NCT00603278|9211047|P1|Overall Study|Lost to Follow-up|1
2667709|NCT00603278|9211042|P6|Overall Study|Physician Decision|1
2667710|NCT00603278|9211043|P5|Overall Study|Physician Decision|2
2667711|NCT00603278|9211044|P4|Overall Study|Physician Decision|0
2667712|NCT00603278|9211045|P3|Overall Study|Physician Decision|0
2667713|NCT00603278|9211046|P2|Overall Study|Physician Decision|1
2667714|NCT00603278|9211047|P1|Overall Study|Physician Decision|0
2667715|NCT00603278|9211042|P6|Overall Study|Protocol Violation|1
2667716|NCT00603278|9211043|P5|Overall Study|Protocol Violation|0
2667717|NCT00603278|9211044|P4|Overall Study|Protocol Violation|1
2667718|NCT00603278|9211045|P3|Overall Study|Protocol Violation|1
2667719|NCT00603278|9211046|P2|Overall Study|Protocol Violation|0
2667720|NCT00603278|9211047|P1|Overall Study|Protocol Violation|3
2667721|NCT00603278|9211042|P6|Overall Study|Withdrawal by Subject|2
2667722|NCT00603278|9211043|P5|Overall Study|Withdrawal by Subject|1
2667723|NCT00603278|9211044|P4|Overall Study|Withdrawal by Subject|2
2667724|NCT00603278|9211045|P3|Overall Study|Withdrawal by Subject|1
2667725|NCT00603278|9211046|P2|Overall Study|Withdrawal by Subject|3
2667726|NCT00603278|9211047|P1|Overall Study|Withdrawal by Subject|2
2667727|NCT00603278|9211042|P6|Overall Study|Adverse Event|1
2667728|NCT00603278|9211043|P5|Overall Study|Adverse Event|2
2667729|NCT00603278|9211044|P4|Overall Study|Adverse Event|0
2667730|NCT00603278|9211045|P3|Overall Study|Adverse Event|1
2667731|NCT00603278|9211046|P2|Overall Study|Adverse Event|3
2667732|NCT00603278|9211047|P1|Overall Study|Adverse Event|0
2667733|NCT00603278|9211042|P6|Overall Study|Lack of Efficacy|14
2667734|NCT00603278|9211043|P5|Overall Study|Lack of Efficacy|7
2667735|NCT00603278|9211044|P4|Overall Study|Lack of Efficacy|8
2667736|NCT00603278|9211045|P3|Overall Study|Lack of Efficacy|11
2667737|NCT00603278|9211046|P2|Overall Study|Lack of Efficacy|10
2667738|NCT00603278|9211047|P1|Overall Study|Lack of Efficacy|35
2667739|NCT00603265|9211196|P3|Overall Study|Protocol Violation|0
2667740|NCT00603265|9211197|P2|Overall Study|Protocol Violation|0
2667741|NCT00603265|9211198|P1|Overall Study|Protocol Violation|1
2667742|NCT00603265|9211196|P3|Overall Study|Participant Left Country, No Responses|0
2667743|NCT00603265|9211197|P2|Overall Study|Participant Left Country, No Responses|1
2667744|NCT00603265|9211198|P1|Overall Study|Participant Left Country, No Responses|0
2667745|NCT00603265|9211196|P3|Overall Study|Out of Town, Ran Out of Study Drug|0
2667746|NCT00603265|9211197|P2|Overall Study|Out of Town, Ran Out of Study Drug|1
2667747|NCT00603265|9211198|P1|Overall Study|Out of Town, Ran Out of Study Drug|0
2667748|NCT00603265|9211196|P3|Overall Study|Lost to Follow-up|0
2667749|NCT00603265|9211197|P2|Overall Study|Lost to Follow-up|1
2667750|NCT00603265|9211198|P1|Overall Study|Lost to Follow-up|0
2667751|NCT00603265|9211196|P3|Overall Study|Lack of Efficacy|3
2667752|NCT00603265|9211197|P2|Overall Study|Lack of Efficacy|0
2667753|NCT00603265|9211198|P1|Overall Study|Lack of Efficacy|3
2667754|NCT00603265|9211196|P3|Overall Study|Withdrawal by Subject|1
2667755|NCT00603265|9211197|P2|Overall Study|Withdrawal by Subject|2
2667756|NCT00603265|9211198|P1|Overall Study|Withdrawal by Subject|1
2667757|NCT00603265|9211196|P3|Overall Study|Adverse Event|1
2667758|NCT00603265|9211197|P2|Overall Study|Adverse Event|11
2667759|NCT00603265|9211198|P1|Overall Study|Adverse Event|2
2667760|NCT00603239|9211226|P2|Overall Study|Subject decision|1
2667761|NCT00603239|9211227|P1|Overall Study|Subject decision|2
2667762|NCT00603239|9211226|P2|Overall Study|Protocol Violation|0
2667763|NCT00603239|9211227|P1|Overall Study|Protocol Violation|2
2667764|NCT00603239|9211226|P2|Overall Study|Physician Decision|0
2667765|NCT00603239|9211227|P1|Overall Study|Physician Decision|2
2667766|NCT00603239|9211226|P2|Overall Study|Lost to Follow-up|1
2667767|NCT00603239|9211227|P1|Overall Study|Lost to Follow-up|2
2667768|NCT00603239|9211226|P2|Overall Study|Loss of glucose control|0
2667769|NCT00603239|9211227|P1|Overall Study|Loss of glucose control|3
2667770|NCT00603239|9211226|P2|Overall Study|Entry criteria not met|1
2667771|NCT00603239|9211227|P1|Overall Study|Entry criteria not met|0
2667772|NCT00603239|9211226|P2|Overall Study|Adverse Event|1
2667773|NCT00603239|9211227|P1|Overall Study|Adverse Event|4
2667774|NCT00602979|9211288|P5|Overall Study|Failed Intubation|0
2667775|NCT00602979|9211289|P4|Overall Study|Failed Intubation|1
2667776|NCT00602979|9211290|P3|Overall Study|Failed Intubation|0
2667777|NCT00602979|9211291|P2|Overall Study|Failed Intubation|1
2667778|NCT00602979|9211292|P1|Overall Study|Failed Intubation|0
2667779|NCT00602979|9211288|P5|Overall Study|Lost to Follow-up|3
2667780|NCT00602979|9211289|P4|Overall Study|Lost to Follow-up|2
2667781|NCT00602979|9211290|P3|Overall Study|Lost to Follow-up|3
2667782|NCT00602979|9211291|P2|Overall Study|Lost to Follow-up|2
2667783|NCT00602979|9211292|P1|Overall Study|Lost to Follow-up|3
2667784|NCT00602927|9211342|P2|Period 3: 13 Days|MRI data quality|2
2667785|NCT00602927|9211343|P1|Period 3: 13 Days|MRI data quality|2
2667786|NCT00602927|9211342|P2|Period 3: 13 Days|Protocol Violation|1
2667787|NCT00602927|9211343|P1|Period 3: 13 Days|Protocol Violation|0
2667788|NCT00602927|9211342|P2|Period 2: 14 Days|Protocol Violation|2
2667789|NCT00602927|9211343|P1|Period 2: 14 Days|Protocol Violation|0
2667790|NCT00602927|9211342|P2|Period 1: 13 Days|Claustrophobia|1
2667791|NCT00602927|9211343|P1|Period 1: 13 Days|Claustrophobia|0
2667792|NCT00602927|9211342|P2|Period 1: 13 Days|Time|0
2667793|NCT00602927|9211343|P1|Period 1: 13 Days|Time|1
2667794|NCT00602927|9211342|P2|Period 1: 13 Days|MRI scanner technical issue|0
2667795|NCT00602927|9211343|P1|Period 1: 13 Days|MRI scanner technical issue|1
2667796|NCT00602927|9211342|P2|Period 1: 13 Days|Protocol Violation|4
2667797|NCT00602927|9211343|P1|Period 1: 13 Days|Protocol Violation|2
2667798|NCT00602797|9211360|P1|Overall Study|Adverse Event|1
2667799|NCT00602667|9211378|P3|Overall Study|Progressive disease prior to therapy|1
2667800|NCT00602667|9211379|P2|Overall Study|Progressive disease prior to therapy|0
2667801|NCT00602667|9211380|P1|Overall Study|Progressive disease prior to therapy|0
2667802|NCT00602667|9211378|P3|Overall Study|Progressive disease|45
2667803|NCT00602667|9211379|P2|Overall Study|Progressive disease|48
2667804|NCT00602667|9211380|P1|Overall Study|Progressive disease|13
2667805|NCT00602667|9211378|P3|Overall Study|Physician Decision|8
2667806|NCT00602667|9211379|P2|Overall Study|Physician Decision|3
2667807|NCT00602667|9211380|P1|Overall Study|Physician Decision|2
2667808|NCT00602667|9211378|P3|Overall Study|Second malignancy|0
2667809|NCT00602667|9211379|P2|Overall Study|Second malignancy|1
2667810|NCT00602667|9211380|P1|Overall Study|Second malignancy|0
2667811|NCT00602667|9211378|P3|Overall Study|Excessive toxicity|0
2667812|NCT00602667|9211379|P2|Overall Study|Excessive toxicity|1
2667813|NCT00602667|9211380|P1|Overall Study|Excessive toxicity|1
2667814|NCT00602667|9211378|P3|Overall Study|Family request|6
2667815|NCT00602667|9211379|P2|Overall Study|Family request|25
2667816|NCT00602667|9211380|P1|Overall Study|Family request|3
2667817|NCT00602667|9211378|P3|Overall Study|Death|1
2667818|NCT00602667|9211379|P2|Overall Study|Death|1
2667819|NCT00602667|9211380|P1|Overall Study|Death|0
2667820|NCT00602667|9211378|P3|Overall Study|Still on Therapy|2
2667821|NCT00602667|9211379|P2|Overall Study|Still on Therapy|2
2667822|NCT00602667|9211380|P1|Overall Study|Still on Therapy|0
2667823|NCT00602641|9211559|P2|Overall Study|Other|1
2667824|NCT00602641|9211560|P1|Overall Study|Other|3
2667825|NCT00602641|9211559|P2|Overall Study|Administrative Closure|1
2667826|NCT00602641|9211560|P1|Overall Study|Administrative Closure|1
2667827|NCT00602641|9211559|P2|Overall Study|Physician Decision|4
2667828|NCT00602641|9211560|P1|Overall Study|Physician Decision|5
2667829|NCT00602641|9211559|P2|Overall Study|Other Complicating Disease|2
2667830|NCT00602641|9211560|P1|Overall Study|Other Complicating Disease|5
2667831|NCT00602641|9211559|P2|Overall Study|Alternative therapy|2
2667832|NCT00602641|9211560|P1|Overall Study|Alternative therapy|5
2667833|NCT00602641|9211559|P2|Overall Study|Withdrawal by Subject|12
2667834|NCT00602641|9211560|P1|Overall Study|Withdrawal by Subject|15
2667835|NCT00602641|9211559|P2|Overall Study|Death|5
2667836|NCT00602641|9211560|P1|Overall Study|Death|6
2667837|NCT00602641|9211559|P2|Overall Study|Disease progression|55
2667838|NCT00602641|9211560|P1|Overall Study|Disease progression|38
2667839|NCT00602641|9211559|P2|Overall Study|Adverse Event|53
2667840|NCT00602641|9211560|P1|Overall Study|Adverse Event|62
2667841|NCT00602641|9211559|P2|Overall Study|Still on treatment at time of analysis|15
2667842|NCT00602641|9211560|P1|Overall Study|Still on treatment at time of analysis|8
2667843|NCT00602641|9211559|P2|Overall Study|Never started protocol therapy|2
2667844|NCT00602641|9211560|P1|Overall Study|Never started protocol therapy|6
2667845|NCT00602537|9211574|P2|Follow Up Study Comparison|Withdrawal by Subject|2
2667846|NCT00602537|9211575|P1|Follow Up Study Comparison|Withdrawal by Subject|2
2667847|NCT00602537|9211574|P2|Follow Up Study Comparison|Lost to Follow-up|1
2667848|NCT00602537|9211575|P1|Follow Up Study Comparison|Lost to Follow-up|8
2667849|NCT00602537|9211574|P2|Follow Up Study Comparison|Adverse Event|0
2667850|NCT00602537|9211575|P1|Follow Up Study Comparison|Adverse Event|1
2667851|NCT00602537|9211574|P2|12 Week Double Blind Comparison|Withdrawal by Subject|13
2667852|NCT00602537|9211575|P1|12 Week Double Blind Comparison|Withdrawal by Subject|3
2667853|NCT00602537|9211574|P2|12 Week Double Blind Comparison|Lost to Follow-up|6
2667854|NCT00602537|9211575|P1|12 Week Double Blind Comparison|Lost to Follow-up|5
2667855|NCT00602537|9211574|P2|12 Week Double Blind Comparison|Lack of Efficacy|23
2667856|NCT00602537|9211575|P1|12 Week Double Blind Comparison|Lack of Efficacy|13
2667857|NCT00602537|9211574|P2|12 Week Double Blind Comparison|Adverse Event|5
2667858|NCT00602537|9211575|P1|12 Week Double Blind Comparison|Adverse Event|2
2667859|NCT00602472|9211585|P2|Overall Study|Other incl. lack of efficacy|2
2667860|NCT00602472|9211586|P1|Overall Study|Other incl. lack of efficacy|4
2667861|NCT00602472|9211585|P2|Overall Study|Withdrawal by Subject|14
2667862|NCT00602472|9211586|P1|Overall Study|Withdrawal by Subject|8
2667863|NCT00602472|9211585|P2|Overall Study|Protocol Violation|19
2667864|NCT00602472|9211586|P1|Overall Study|Protocol Violation|4
2667865|NCT00602472|9211585|P2|Overall Study|Adverse Event|23
2667866|NCT00602472|9211586|P1|Overall Study|Adverse Event|5
2667867|NCT00602420|9211651|P2|Overall Study|Adverse Event|0
2667868|NCT00602420|9211652|P1|Overall Study|Adverse Event|1
2667869|NCT00602420|9211651|P2|Overall Study|Withdrawal by Subject|17
2667870|NCT00602420|9211652|P1|Overall Study|Withdrawal by Subject|18
2667871|NCT00602420|9211651|P2|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3
2667872|NCT00602420|9211652|P1|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5
2667873|NCT00602420|9211651|P2|Overall Study|Death|4
2667874|NCT00602420|9211652|P1|Overall Study|Death|1
2667875|NCT00601900|9211760|P2|Overall Study|Withdrawal by Subject|3
2667876|NCT00601900|9211761|P1|Overall Study|Withdrawal by Subject|0
2667877|NCT00601835|9211777|P2|Overall Study|Relocate|2
2667878|NCT00601835|9211778|P1|Overall Study|Relocate|12
2667879|NCT00601835|9211777|P2|Overall Study|Adverse Event|1
2667880|NCT00601835|9211778|P1|Overall Study|Adverse Event|1
2667881|NCT00601835|9211777|P2|Overall Study|Lost to Follow-up|5
2667882|NCT00601835|9211778|P1|Overall Study|Lost to Follow-up|37
2667883|NCT00601835|9211777|P2|Overall Study|Physician Decision|0
2667884|NCT00601835|9211778|P1|Overall Study|Physician Decision|1
2667885|NCT00601835|9211777|P2|Overall Study|Withdrawal by Subject|6
2667886|NCT00601835|9211778|P1|Overall Study|Withdrawal by Subject|9
2667887|NCT00601705|9211867|P1|Overall Study|Withdrawal by Subject|1
2667888|NCT00601640|9211879|P3|Overall Study|change in eligibility status|1
2667889|NCT00601640|9211880|P2|Overall Study|change in eligibility status|1
2667890|NCT00601640|9211881|P1|Overall Study|change in eligibility status|0
2667891|NCT00601640|9211879|P3|Overall Study|intercurrent illness|0
2667892|NCT00601640|9211880|P2|Overall Study|intercurrent illness|0
2667893|NCT00601640|9211881|P1|Overall Study|intercurrent illness|1
2667894|NCT00601640|9211879|P3|Overall Study|Adverse Event|2
2667895|NCT00601640|9211880|P2|Overall Study|Adverse Event|4
2667896|NCT00601640|9211881|P1|Overall Study|Adverse Event|0
2667897|NCT00601640|9211879|P3|Overall Study|Death|0
2667898|NCT00601640|9211880|P2|Overall Study|Death|0
2667899|NCT00601640|9211881|P1|Overall Study|Death|1
2667900|NCT00601640|9211879|P3|Overall Study|Withdrawal by Subject|7
2667901|NCT00601640|9211880|P2|Overall Study|Withdrawal by Subject|0
2667902|NCT00601640|9211881|P1|Overall Study|Withdrawal by Subject|3
2667903|NCT00601523|9211906|P2|Overall Study|Other|1
2667904|NCT00601523|9211907|P1|Overall Study|Other|9
2667905|NCT00601523|9211906|P2|Overall Study|Withdrawal by Subject|9
2667906|NCT00601523|9211907|P1|Overall Study|Withdrawal by Subject|18
2667907|NCT00601523|9211906|P2|Overall Study|Lost to Follow-up|1
2667908|NCT00601523|9211907|P1|Overall Study|Lost to Follow-up|0
2667909|NCT00601523|9211906|P2|Overall Study|Protocol Violation|1
2667910|NCT00601523|9211907|P1|Overall Study|Protocol Violation|5
2667911|NCT00601523|9211906|P2|Overall Study|Lack of Efficacy|0
2667912|NCT00601523|9211907|P1|Overall Study|Lack of Efficacy|3
2667913|NCT00601523|9211906|P2|Overall Study|Adverse Event|14
2667914|NCT00601523|9211907|P1|Overall Study|Adverse Event|42
2667915|NCT00601458|9211942|P3|Overall Study|Early Termination|1
2667916|NCT00601458|9211943|P2|Overall Study|Early Termination|1
2667917|NCT00601458|9211944|P1|Overall Study|Early Termination|0
2667918|NCT00601458|9211942|P3|Overall Study|Protocol Violation|1
2667919|NCT00601458|9211943|P2|Overall Study|Protocol Violation|2
2667920|NCT00601458|9211944|P1|Overall Study|Protocol Violation|3
2667921|NCT00601458|9211942|P3|Overall Study|Incomplete Data|0
2667922|NCT00601458|9211943|P2|Overall Study|Incomplete Data|2
2667923|NCT00601458|9211944|P1|Overall Study|Incomplete Data|0
2667924|NCT00601458|9211942|P3|Overall Study|Dosing Error|0
2667925|NCT00601458|9211943|P2|Overall Study|Dosing Error|0
2667926|NCT00601458|9211944|P1|Overall Study|Dosing Error|1
2667927|NCT00601419|9211955|P1|Overall Study|Missed Visits|1
2667928|NCT00601419|9211955|P1|Overall Study|Lost to Follow-up|3
2667929|NCT00601354|9211985|P2|Overall Study|Lost to Follow-up|5
2667930|NCT00601354|9211986|P1|Overall Study|Lost to Follow-up|4
2667931|NCT00601250|9211998|P2|Overall Study|Other incl. lack of efficacy|9
2667932|NCT00601250|9211999|P1|Overall Study|Other incl. lack of efficacy|2
2667933|NCT00601250|9211998|P2|Overall Study|Withdrawal by Subject|13
2667934|NCT00601250|9211999|P1|Overall Study|Withdrawal by Subject|4
2667935|NCT00601250|9211998|P2|Overall Study|Lost to Follow-up|6
2667936|NCT00601250|9211999|P1|Overall Study|Lost to Follow-up|2
2667937|NCT00601250|9211998|P2|Overall Study|Protocol Violation|2
2667938|NCT00601250|9211999|P1|Overall Study|Protocol Violation|3
2667939|NCT00601250|9211998|P2|Overall Study|Adverse Event|9
2667940|NCT00601250|9211999|P1|Overall Study|Adverse Event|3
2667941|NCT00601172|9212035|P2|Overall Study|Did not meet continuation criteria|20
2667942|NCT00601172|9212036|P1|Overall Study|Did not meet continuation criteria|19
2667943|NCT00601172|9212035|P2|Overall Study|Withdrawal by Subject|27
2667944|NCT00601172|9212036|P1|Overall Study|Withdrawal by Subject|35
2667945|NCT00601172|9212035|P2|Overall Study|Physician Decision|28
2667946|NCT00601172|9212036|P1|Overall Study|Physician Decision|27
2667947|NCT00601172|9212035|P2|Overall Study|Lost to Follow-up|3
2667948|NCT00601172|9212036|P1|Overall Study|Lost to Follow-up|4
2667949|NCT00601172|9212035|P2|Overall Study|Protocol Violation|5
2667950|NCT00601172|9212036|P1|Overall Study|Protocol Violation|2
2667951|NCT00601172|9212035|P2|Overall Study|Lack of Efficacy|12
2667952|NCT00601172|9212036|P1|Overall Study|Lack of Efficacy|11
2667953|NCT00601172|9212035|P2|Overall Study|Adverse Event|32
2667954|NCT00601172|9212036|P1|Overall Study|Adverse Event|43
2667955|NCT00601107|9212093|P4|Overall Study|Undefined|0
2667956|NCT00601107|9212094|P3|Overall Study|Undefined|1
2667957|NCT00601107|9212095|P2|Overall Study|Undefined|0
2667958|NCT00601107|9212096|P1|Overall Study|Undefined|1
2667959|NCT00601107|9212093|P4|Overall Study|Worsening of Psoriasis|4
2667960|NCT00601107|9212094|P3|Overall Study|Worsening of Psoriasis|1
2667961|NCT00601107|9212095|P2|Overall Study|Worsening of Psoriasis|1
2667962|NCT00601107|9212096|P1|Overall Study|Worsening of Psoriasis|4
2667963|NCT00601107|9212093|P4|Overall Study|Serum Calcium >11.5 milligram/deciliter|1
2667964|NCT00601107|9212094|P3|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
2667965|NCT00601107|9212095|P2|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
2667966|NCT00601107|9212096|P1|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
2667967|NCT00601107|9212093|P4|Overall Study|Lost to Follow-up|3
2667968|NCT00601107|9212094|P3|Overall Study|Lost to Follow-up|0
2667969|NCT00601107|9212095|P2|Overall Study|Lost to Follow-up|3
2667970|NCT00601107|9212096|P1|Overall Study|Lost to Follow-up|3
2667971|NCT00601107|9212093|P4|Overall Study|Withdrawal by Subject|4
2667972|NCT00601107|9212094|P3|Overall Study|Withdrawal by Subject|7
2667973|NCT00601107|9212095|P2|Overall Study|Withdrawal by Subject|4
2667974|NCT00601107|9212096|P1|Overall Study|Withdrawal by Subject|5
2667975|NCT00601107|9212093|P4|Overall Study|Adverse Event|0
2667976|NCT00601107|9212094|P3|Overall Study|Adverse Event|3
2667977|NCT00601107|9212095|P2|Overall Study|Adverse Event|1
2667978|NCT00601107|9212096|P1|Overall Study|Adverse Event|0
2667979|NCT00600938|9212116|P4|Extension Study|Death|0
2667980|NCT00600938|9212117|P3|Extension Study|Death|0
2667981|NCT00600938|9212118|P2|Extension Study|Death|0
2667982|NCT00600938|9212119|P1|Extension Study|Death|1
2667983|NCT00600938|9212116|P4|Extension Study|Lost to Follow-up|0
2667984|NCT00600938|9212117|P3|Extension Study|Lost to Follow-up|2
2667985|NCT00600938|9212118|P2|Extension Study|Lost to Follow-up|1
2667986|NCT00600938|9212119|P1|Extension Study|Lost to Follow-up|1
2667987|NCT00600938|9212116|P4|Extension Study|Withdrawal by Subject|0
2667988|NCT00600938|9212117|P3|Extension Study|Withdrawal by Subject|3
2667989|NCT00600938|9212118|P2|Extension Study|Withdrawal by Subject|2
2667990|NCT00600938|9212119|P1|Extension Study|Withdrawal by Subject|2
2668146|NCT00600171|9212459|P4|Overall Study|Protocol Violation|1
2667991|NCT00600938|9212116|P4|Extension Study|Unsatisfactory therapeutic effect|0
2667992|NCT00600938|9212117|P3|Extension Study|Unsatisfactory therapeutic effect|1
2667993|NCT00600938|9212118|P2|Extension Study|Unsatisfactory therapeutic effect|1
2667994|NCT00600938|9212119|P1|Extension Study|Unsatisfactory therapeutic effect|4
2667995|NCT00600938|9212116|P4|Extension Study|Abnormal test procedure results|1
2667996|NCT00600938|9212117|P3|Extension Study|Abnormal test procedure results|1
2667997|NCT00600938|9212118|P2|Extension Study|Abnormal test procedure results|1
2667998|NCT00600938|9212119|P1|Extension Study|Abnormal test procedure results|0
2667999|NCT00600938|9212116|P4|Extension Study|Adverse Event|0
2668000|NCT00600938|9212117|P3|Extension Study|Adverse Event|2
2668001|NCT00600938|9212118|P2|Extension Study|Adverse Event|0
2668002|NCT00600938|9212119|P1|Extension Study|Adverse Event|1
2668003|NCT00600938|9212116|P4|Core Study|Protocol Violation|0
2668004|NCT00600938|9212117|P3|Core Study|Protocol Violation|0
2668005|NCT00600938|9212118|P2|Core Study|Protocol Violation|2
2668006|NCT00600938|9212119|P1|Core Study|Protocol Violation|1
2668007|NCT00600938|9212116|P4|Core Study|Death|0
2668008|NCT00600938|9212117|P3|Core Study|Death|0
2668009|NCT00600938|9212118|P2|Core Study|Death|1
2668010|NCT00600938|9212119|P1|Core Study|Death|1
2668011|NCT00600938|9212116|P4|Core Study|Lost to Follow-up|0
2668012|NCT00600938|9212117|P3|Core Study|Lost to Follow-up|0
2668013|NCT00600938|9212118|P2|Core Study|Lost to Follow-up|2
2668014|NCT00600938|9212119|P1|Core Study|Lost to Follow-up|3
2668015|NCT00600938|9212116|P4|Core Study|Patient withdrew consent|0
2668016|NCT00600938|9212117|P3|Core Study|Patient withdrew consent|0
2668017|NCT00600938|9212118|P2|Core Study|Patient withdrew consent|12
2668018|NCT00600938|9212119|P1|Core Study|Patient withdrew consent|7
2668019|NCT00600938|9212116|P4|Core Study|Unsatisfactory therapeutic effect|0
2668020|NCT00600938|9212117|P3|Core Study|Unsatisfactory therapeutic effect|0
2668021|NCT00600938|9212118|P2|Core Study|Unsatisfactory therapeutic effect|2
2668022|NCT00600938|9212119|P1|Core Study|Unsatisfactory therapeutic effect|1
2668023|NCT00600938|9212116|P4|Core Study|Abnormal test procedure result(s)|0
2668024|NCT00600938|9212117|P3|Core Study|Abnormal test procedure result(s)|0
2668025|NCT00600938|9212118|P2|Core Study|Abnormal test procedure result(s)|2
2668026|NCT00600938|9212119|P1|Core Study|Abnormal test procedure result(s)|3
2668027|NCT00600886|9212183|P2|Extension - After Crossover (CAS)|Death|0
2668028|NCT00600886|9212184|P1|Extension - After Crossover (CAS)|Death|1
2668029|NCT00600886|9212183|P2|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0
2668030|NCT00600886|9212184|P1|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3
2668031|NCT00600886|9212183|P2|Extension - After Crossover (CAS)|Subject no longer requires study drug|0
2668032|NCT00600886|9212184|P1|Extension - After Crossover (CAS)|Subject no longer requires study drug|3
2668033|NCT00600886|9212183|P2|Extension - After Crossover (CAS)|Administrative Problems|4
2668034|NCT00600886|9212184|P1|Extension - After Crossover (CAS)|Administrative Problems|4
2668035|NCT00600886|9212183|P2|Extension - After Crossover (CAS)|Lack of Efficacy|4
2668036|NCT00600886|9212184|P1|Extension - After Crossover (CAS)|Lack of Efficacy|13
2668037|NCT00600886|9212183|P2|Extension - After Crossover (CAS)|Withdrawal by Subject|4
2668038|NCT00600886|9212184|P1|Extension - After Crossover (CAS)|Withdrawal by Subject|19
2668039|NCT00600886|9212183|P2|Extension - After Crossover (CAS)|Adverse Event|1
2668040|NCT00600886|9212184|P1|Extension - After Crossover (CAS)|Adverse Event|19
2668041|NCT00600886|9212183|P2|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0
2668042|NCT00600886|9212184|P1|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6
2668043|NCT00600886|9212183|P2|Extension - Same Treatment (FAS)|Death|1
2668044|NCT00600886|9212184|P1|Extension - Same Treatment (FAS)|Death|1
2668045|NCT00600886|9212183|P2|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0
2668046|NCT00600886|9212184|P1|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4
2668047|NCT00600886|9212183|P2|Extension - Same Treatment (FAS)|Adverse Event|1
2668048|NCT00600886|9212184|P1|Extension - Same Treatment (FAS)|Adverse Event|4
2668049|NCT00600886|9212183|P2|Extension - Same Treatment (FAS)|Lost to Follow-up|1
2668050|NCT00600886|9212184|P1|Extension - Same Treatment (FAS)|Lost to Follow-up|3
2668051|NCT00600886|9212183|P2|Extension - Same Treatment (FAS)|Administrative Problems|3
2668052|NCT00600886|9212184|P1|Extension - Same Treatment (FAS)|Administrative Problems|9
2668053|NCT00600886|9212183|P2|Extension - Same Treatment (FAS)|Lack of Efficacy|3
2668054|NCT00600886|9212184|P1|Extension - Same Treatment (FAS)|Lack of Efficacy|3
2668055|NCT00600886|9212183|P2|Extension - Same Treatment (FAS)|Withdrawal by Subject|2
2668056|NCT00600886|9212184|P1|Extension - Same Treatment (FAS)|Withdrawal by Subject|16
2668057|NCT00600886|9212183|P2|Core Phase - Full Analysis Set (FAS)|Death|1
2668058|NCT00600886|9212184|P1|Core Phase - Full Analysis Set (FAS)|Death|0
2668059|NCT00600886|9212183|P2|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0
2668060|NCT00600886|9212184|P1|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1
2668061|NCT00600886|9212183|P2|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0
2668062|NCT00600886|9212184|P1|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1
2668063|NCT00600886|9212183|P2|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0
2668064|NCT00600886|9212184|P1|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2
2668065|NCT00600886|9212183|P2|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3
2668066|NCT00600886|9212184|P1|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5
2668067|NCT00600886|9212183|P2|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8
2668147|NCT00600171|9212460|P3|Overall Study|Protocol Violation|0
2668068|NCT00600886|9212184|P1|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5
2668069|NCT00600886|9212183|P2|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8
2668070|NCT00600886|9212184|P1|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7
2668071|NCT00600886|9212183|P2|Core Phase - Full Analysis Set (FAS)|Adverse Event|6
2668072|NCT00600886|9212184|P1|Core Phase - Full Analysis Set (FAS)|Adverse Event|14
2668073|NCT00600821|9212248|P2|Overall Study|Other|3
2668074|NCT00600821|9212249|P1|Overall Study|Other|2
2668075|NCT00600821|9212248|P2|Overall Study|Randomized but not treated|1
2668076|NCT00600821|9212249|P1|Overall Study|Randomized but not treated|0
2668077|NCT00600821|9212248|P2|Overall Study|Objective progression or relapse|1
2668078|NCT00600821|9212249|P1|Overall Study|Objective progression or relapse|0
2668079|NCT00600821|9212248|P2|Overall Study|Terminated by sponsor|6
2668080|NCT00600821|9212249|P1|Overall Study|Terminated by sponsor|8
2668081|NCT00600821|9212248|P2|Overall Study|Withdrawal by Subject|1
2668082|NCT00600821|9212249|P1|Overall Study|Withdrawal by Subject|1
2668083|NCT00600821|9212248|P2|Overall Study|Lost to Follow-up|2
2668084|NCT00600821|9212249|P1|Overall Study|Lost to Follow-up|2
2668085|NCT00600821|9212248|P2|Overall Study|Death|46
2668086|NCT00600821|9212249|P1|Overall Study|Death|45
2668087|NCT00600756|9212277|P2|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
2668088|NCT00600756|9212278|P1|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
2668089|NCT00600756|9212277|P2|Overall Study Analysis After 12 Months|Lost to Follow-up|13
2668090|NCT00600756|9212278|P1|Overall Study Analysis After 12 Months|Lost to Follow-up|16
2668091|NCT00600756|9212277|P2|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20
2668092|NCT00600756|9212278|P1|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16
2668093|NCT00600756|9212277|P2|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20
2668094|NCT00600756|9212278|P1|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17
2668095|NCT00600756|9212277|P2|Overall Study Analysis After 12 Months|Incorrect enrollment|29
2668096|NCT00600756|9212278|P1|Overall Study Analysis After 12 Months|Incorrect enrollment|21
2668097|NCT00600756|9212277|P2|Overall Study Analysis After 12 Months|Withdrawal by Subject|41
2668098|NCT00600756|9212278|P1|Overall Study Analysis After 12 Months|Withdrawal by Subject|51
2668099|NCT00600756|9212277|P2|Overall Study Analysis After 12 Months|Adverse Event|44
2668100|NCT00600756|9212278|P1|Overall Study Analysis After 12 Months|Adverse Event|53
2668101|NCT00600756|9212277|P2|Analysis After 6 Months|Study-specific discontinuation criteria|3
2668102|NCT00600756|9212278|P1|Analysis After 6 Months|Study-specific discontinuation criteria|6
2668103|NCT00600756|9212277|P2|Analysis After 6 Months|Lost to Follow-up|8
2668104|NCT00600756|9212278|P1|Analysis After 6 Months|Lost to Follow-up|10
2668105|NCT00600756|9212277|P2|Analysis After 6 Months|Severe non-compliance to protocol|11
2668106|NCT00600756|9212278|P1|Analysis After 6 Months|Severe non-compliance to protocol|11
2668107|NCT00600756|9212277|P2|Analysis After 6 Months|worsening symptom, lack of efficacy|14
2668108|NCT00600756|9212278|P1|Analysis After 6 Months|worsening symptom, lack of efficacy|11
2668109|NCT00600756|9212277|P2|Analysis After 6 Months|Incorrect Enrollment|21
2668110|NCT00600756|9212278|P1|Analysis After 6 Months|Incorrect Enrollment|12
2668111|NCT00600756|9212277|P2|Analysis After 6 Months|Withdrawal by Subject|30
2668112|NCT00600756|9212278|P1|Analysis After 6 Months|Withdrawal by Subject|38
2668113|NCT00600756|9212277|P2|Analysis After 6 Months|Adverse Event|33
2668114|NCT00600756|9212278|P1|Analysis After 6 Months|Adverse Event|43
2668115|NCT00600613|9212387|P1|Overall Study|Protocol Deviation|1
2668116|NCT00600353|9212393|P2|Overall Study|History of prepartive regimen|1
2668117|NCT00600353|9212394|P1|Overall Study|History of prepartive regimen|0
2668118|NCT00600353|9212393|P2|Overall Study|history of malignancy within 5 years|0
2668119|NCT00600353|9212394|P1|Overall Study|history of malignancy within 5 years|1
2668120|NCT00600171|9212457|P6|Overall Study|Lost to Follow-up|0
2668121|NCT00600171|9212458|P5|Overall Study|Lost to Follow-up|0
2668122|NCT00600171|9212459|P4|Overall Study|Lost to Follow-up|1
2668123|NCT00600171|9212460|P3|Overall Study|Lost to Follow-up|0
2668124|NCT00600171|9212461|P2|Overall Study|Lost to Follow-up|0
2668125|NCT00600171|9212462|P1|Overall Study|Lost to Follow-up|0
2668126|NCT00600171|9212457|P6|Overall Study|Physician Decision|2
2668127|NCT00600171|9212458|P5|Overall Study|Physician Decision|0
2668128|NCT00600171|9212459|P4|Overall Study|Physician Decision|1
2668129|NCT00600171|9212460|P3|Overall Study|Physician Decision|0
2668130|NCT00600171|9212461|P2|Overall Study|Physician Decision|1
2668131|NCT00600171|9212462|P1|Overall Study|Physician Decision|0
2668132|NCT00600171|9212457|P6|Overall Study|Withdrawal by Subject|1
2668133|NCT00600171|9212458|P5|Overall Study|Withdrawal by Subject|1
2668134|NCT00600171|9212459|P4|Overall Study|Withdrawal by Subject|1
2668135|NCT00600171|9212460|P3|Overall Study|Withdrawal by Subject|0
2668136|NCT00600171|9212461|P2|Overall Study|Withdrawal by Subject|0
2668137|NCT00600171|9212462|P1|Overall Study|Withdrawal by Subject|3
2668138|NCT00600171|9212457|P6|Overall Study|Met Protocol-defined Stopping Criteria|2
2668139|NCT00600171|9212458|P5|Overall Study|Met Protocol-defined Stopping Criteria|2
2668140|NCT00600171|9212459|P4|Overall Study|Met Protocol-defined Stopping Criteria|3
2668141|NCT00600171|9212460|P3|Overall Study|Met Protocol-defined Stopping Criteria|7
2668142|NCT00600171|9212461|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
2668143|NCT00600171|9212462|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
2668144|NCT00600171|9212457|P6|Overall Study|Protocol Violation|0
2668145|NCT00600171|9212458|P5|Overall Study|Protocol Violation|0
2668148|NCT00600171|9212461|P2|Overall Study|Protocol Violation|2
2668149|NCT00600171|9212462|P1|Overall Study|Protocol Violation|1
2668150|NCT00600171|9212457|P6|Overall Study|Lack of Efficacy|0
2668151|NCT00600171|9212458|P5|Overall Study|Lack of Efficacy|4
2668152|NCT00600171|9212459|P4|Overall Study|Lack of Efficacy|5
2668153|NCT00600171|9212460|P3|Overall Study|Lack of Efficacy|3
2668154|NCT00600171|9212461|P2|Overall Study|Lack of Efficacy|12
2668155|NCT00600171|9212462|P1|Overall Study|Lack of Efficacy|9
2668156|NCT00600171|9212457|P6|Overall Study|Adverse Event|0
2668157|NCT00600171|9212458|P5|Overall Study|Adverse Event|1
2668158|NCT00600171|9212459|P4|Overall Study|Adverse Event|0
2668159|NCT00600171|9212460|P3|Overall Study|Adverse Event|0
2668160|NCT00600171|9212461|P2|Overall Study|Adverse Event|1
2668161|NCT00600171|9212462|P1|Overall Study|Adverse Event|0
2668162|NCT00600119|9212536|P6|Follow-up Period|Other|0
2668163|NCT00600119|9212537|P5|Follow-up Period|Other|0
2668164|NCT00600119|9212538|P4|Follow-up Period|Other|0
2668165|NCT00600119|9212539|P3|Follow-up Period|Other|0
2668166|NCT00600119|9212540|P2|Follow-up Period|Other|0
2668167|NCT00600119|9212541|P1|Follow-up Period|Other|1
2668168|NCT00600119|9212536|P6|Follow-up Period|Adverse Event|1
2668169|NCT00600119|9212537|P5|Follow-up Period|Adverse Event|0
2668170|NCT00600119|9212538|P4|Follow-up Period|Adverse Event|0
2668171|NCT00600119|9212539|P3|Follow-up Period|Adverse Event|0
2668172|NCT00600119|9212540|P2|Follow-up Period|Adverse Event|0
2668173|NCT00600119|9212541|P1|Follow-up Period|Adverse Event|0
2668174|NCT00600119|9212536|P6|Double-blind Treatment Period|Adverse Event|10
2668175|NCT00600119|9212537|P5|Double-blind Treatment Period|Adverse Event|2
2668176|NCT00600119|9212538|P4|Double-blind Treatment Period|Adverse Event|1
2668177|NCT00600119|9212539|P3|Double-blind Treatment Period|Adverse Event|0
2668178|NCT00600119|9212540|P2|Double-blind Treatment Period|Adverse Event|1
2668179|NCT00600119|9212541|P1|Double-blind Treatment Period|Adverse Event|1
2668180|NCT00600119|9212536|P6|Double-blind Treatment Period|Lost to Follow-up|0
2668181|NCT00600119|9212537|P5|Double-blind Treatment Period|Lost to Follow-up|0
2668182|NCT00600119|9212538|P4|Double-blind Treatment Period|Lost to Follow-up|0
2668183|NCT00600119|9212539|P3|Double-blind Treatment Period|Lost to Follow-up|0
2668184|NCT00600119|9212540|P2|Double-blind Treatment Period|Lost to Follow-up|1
2668185|NCT00600119|9212541|P1|Double-blind Treatment Period|Lost to Follow-up|0
2668186|NCT00600119|9212536|P6|Double-blind Treatment Period|Physician Decision|0
2668187|NCT00600119|9212537|P5|Double-blind Treatment Period|Physician Decision|0
2668188|NCT00600119|9212538|P4|Double-blind Treatment Period|Physician Decision|0
2668189|NCT00600119|9212539|P3|Double-blind Treatment Period|Physician Decision|0
2668190|NCT00600119|9212540|P2|Double-blind Treatment Period|Physician Decision|0
2668191|NCT00600119|9212541|P1|Double-blind Treatment Period|Physician Decision|2
2668192|NCT00600119|9212536|P6|Double-blind Treatment Period|Sponsor Decision|0
2668193|NCT00600119|9212537|P5|Double-blind Treatment Period|Sponsor Decision|1
2668194|NCT00600119|9212538|P4|Double-blind Treatment Period|Sponsor Decision|0
2668195|NCT00600119|9212539|P3|Double-blind Treatment Period|Sponsor Decision|0
2668196|NCT00600119|9212540|P2|Double-blind Treatment Period|Sponsor Decision|1
2668197|NCT00600119|9212541|P1|Double-blind Treatment Period|Sponsor Decision|0
2668198|NCT00600119|9212536|P6|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
2668199|NCT00600119|9212537|P5|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
2668200|NCT00600119|9212538|P4|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
2668201|NCT00600119|9212539|P3|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
2668202|NCT00600119|9212540|P2|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1
2668203|NCT00600119|9212541|P1|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
2668204|NCT00600119|9212536|P6|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
2668205|NCT00600119|9212537|P5|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
2668206|NCT00600119|9212538|P4|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
2668207|NCT00600119|9212539|P3|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
2668208|NCT00600119|9212540|P2|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
2668209|NCT00600119|9212541|P1|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
2668210|NCT00600119|9212536|P6|Double-blind Treatment Period|Other|1
2668211|NCT00600119|9212537|P5|Double-blind Treatment Period|Other|2
2668212|NCT00600119|9212538|P4|Double-blind Treatment Period|Other|0
2668213|NCT00600119|9212539|P3|Double-blind Treatment Period|Other|0
2668214|NCT00600119|9212540|P2|Double-blind Treatment Period|Other|0
2668215|NCT00600119|9212541|P1|Double-blind Treatment Period|Other|0
2668216|NCT00600119|9212536|P6|Double-blind Treatment Period|Withdrawal by Subject|3
2668217|NCT00600119|9212537|P5|Double-blind Treatment Period|Withdrawal by Subject|0
2668218|NCT00600119|9212538|P4|Double-blind Treatment Period|Withdrawal by Subject|1
2668219|NCT00600119|9212539|P3|Double-blind Treatment Period|Withdrawal by Subject|0
2668220|NCT00600119|9212540|P2|Double-blind Treatment Period|Withdrawal by Subject|0
2668221|NCT00600119|9212541|P1|Double-blind Treatment Period|Withdrawal by Subject|2
2668222|NCT00600119|9212536|P6|Single-blind Placebo run-in Period|Withdrawal by Subject|0
2668223|NCT00600119|9212537|P5|Single-blind Placebo run-in Period|Withdrawal by Subject|0
2668224|NCT00600119|9212538|P4|Single-blind Placebo run-in Period|Withdrawal by Subject|0
2668225|NCT00600119|9212539|P3|Single-blind Placebo run-in Period|Withdrawal by Subject|0
2668226|NCT00600119|9212540|P2|Single-blind Placebo run-in Period|Withdrawal by Subject|1
2668227|NCT00600119|9212541|P1|Single-blind Placebo run-in Period|Withdrawal by Subject|2
2668228|NCT00600119|9212536|P6|Single-blind Placebo run-in Period|Adverse Event|1
2668229|NCT00600119|9212537|P5|Single-blind Placebo run-in Period|Adverse Event|0
2668230|NCT00600119|9212538|P4|Single-blind Placebo run-in Period|Adverse Event|1
2668231|NCT00600119|9212539|P3|Single-blind Placebo run-in Period|Adverse Event|0
2668232|NCT00600119|9212540|P2|Single-blind Placebo run-in Period|Adverse Event|0
2668233|NCT00600119|9212541|P1|Single-blind Placebo run-in Period|Adverse Event|0
2668234|NCT00600119|9212536|P6|Single-blind Placebo run-in Period|Lost to Follow-up|0
2668235|NCT00600119|9212537|P5|Single-blind Placebo run-in Period|Lost to Follow-up|0
2668236|NCT00600119|9212538|P4|Single-blind Placebo run-in Period|Lost to Follow-up|0
2668237|NCT00600119|9212539|P3|Single-blind Placebo run-in Period|Lost to Follow-up|0
2668238|NCT00600119|9212540|P2|Single-blind Placebo run-in Period|Lost to Follow-up|0
2668239|NCT00600119|9212541|P1|Single-blind Placebo run-in Period|Lost to Follow-up|1
2668240|NCT00600119|9212536|P6|Single-blind Placebo run-in Period|Sponsor Decision|0
2668241|NCT00600119|9212537|P5|Single-blind Placebo run-in Period|Sponsor Decision|1
2668242|NCT00600119|9212538|P4|Single-blind Placebo run-in Period|Sponsor Decision|0
2668243|NCT00600119|9212539|P3|Single-blind Placebo run-in Period|Sponsor Decision|1
2668244|NCT00600119|9212540|P2|Single-blind Placebo run-in Period|Sponsor Decision|0
2668245|NCT00600119|9212541|P1|Single-blind Placebo run-in Period|Sponsor Decision|0
2668246|NCT00600119|9212536|P6|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
2668247|NCT00600119|9212537|P5|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
2668248|NCT00600119|9212538|P4|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
2668249|NCT00600119|9212539|P3|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
2668250|NCT00600119|9212540|P2|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
2668251|NCT00600119|9212541|P1|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
2668252|NCT00600119|9212536|P6|Single-blind Placebo run-in Period|Other - Not specified|1
2668253|NCT00600119|9212537|P5|Single-blind Placebo run-in Period|Other - Not specified|1
2668254|NCT00600119|9212538|P4|Single-blind Placebo run-in Period|Other - Not specified|0
2668255|NCT00600119|9212539|P3|Single-blind Placebo run-in Period|Other - Not specified|0
2668256|NCT00600119|9212540|P2|Single-blind Placebo run-in Period|Other - Not specified|0
2668257|NCT00600119|9212541|P1|Single-blind Placebo run-in Period|Other - Not specified|1
2668258|NCT00600106|9212575|P2|Overall Study|Withdrawal by Subject|1
2668259|NCT00600106|9212576|P1|Overall Study|Withdrawal by Subject|1
2668260|NCT00600067|9212623|P2|Overall Study|Lack of Efficacy|0
2668261|NCT00600067|9212624|P1|Overall Study|Lack of Efficacy|1
2668262|NCT00600067|9212623|P2|Overall Study|protocol non-compliance|3
2668263|NCT00600067|9212624|P1|Overall Study|protocol non-compliance|0
2668264|NCT00600067|9212623|P2|Overall Study|Lost to Follow-up|3
2668265|NCT00600067|9212624|P1|Overall Study|Lost to Follow-up|2
2668266|NCT00600067|9212623|P2|Overall Study|Adverse Event|1
2668267|NCT00600067|9212624|P1|Overall Study|Adverse Event|0
2668268|NCT00600028|9212634|P2|Second Intervention (12 Weeks)|Adverse Event|2
2668269|NCT00600028|9212635|P1|Second Intervention (12 Weeks)|Adverse Event|0
2668270|NCT00600028|9212634|P2|First Intervention (12 Weeks)|Adverse Event|1
2668271|NCT00600028|9212635|P1|First Intervention (12 Weeks)|Adverse Event|0
2668272|NCT00600028|9212634|P2|First Intervention (12 Weeks)|Withdrawal by Subject|0
2668273|NCT00600028|9212635|P1|First Intervention (12 Weeks)|Withdrawal by Subject|1
2668274|NCT00599924|9212665|P7|Overall Study|Other|2
2668275|NCT00599924|9212666|P6|Overall Study|Other|0
2668276|NCT00599924|9212667|P5|Overall Study|Other|2
2668277|NCT00599924|9212668|P4|Overall Study|Other|1
2668278|NCT00599924|9212669|P3|Overall Study|Other|0
2668279|NCT00599924|9212670|P2|Overall Study|Other|0
2668280|NCT00599924|9212671|P1|Overall Study|Other|0
2668281|NCT00599924|9212665|P7|Overall Study|Withdrawal by Subject|0
2668282|NCT00599924|9212666|P6|Overall Study|Withdrawal by Subject|0
2668283|NCT00599924|9212667|P5|Overall Study|Withdrawal by Subject|1
2668284|NCT00599924|9212668|P4|Overall Study|Withdrawal by Subject|0
2668285|NCT00599924|9212669|P3|Overall Study|Withdrawal by Subject|1
2668286|NCT00599924|9212670|P2|Overall Study|Withdrawal by Subject|0
2668287|NCT00599924|9212671|P1|Overall Study|Withdrawal by Subject|0
2668288|NCT00599924|9212665|P7|Overall Study|Protocol Violation|0
2668289|NCT00599924|9212666|P6|Overall Study|Protocol Violation|0
2668290|NCT00599924|9212667|P5|Overall Study|Protocol Violation|0
2668291|NCT00599924|9212668|P4|Overall Study|Protocol Violation|1
2668292|NCT00599924|9212669|P3|Overall Study|Protocol Violation|0
2668293|NCT00599924|9212670|P2|Overall Study|Protocol Violation|0
2668294|NCT00599924|9212671|P1|Overall Study|Protocol Violation|0
2668295|NCT00599924|9212665|P7|Overall Study|Death|1
2668296|NCT00599924|9212666|P6|Overall Study|Death|2
2668297|NCT00599924|9212667|P5|Overall Study|Death|0
2668298|NCT00599924|9212668|P4|Overall Study|Death|2
2668299|NCT00599924|9212669|P3|Overall Study|Death|0
2668300|NCT00599924|9212670|P2|Overall Study|Death|0
2668301|NCT00599924|9212671|P1|Overall Study|Death|0
2668302|NCT00599924|9212665|P7|Overall Study|Adverse Event|2
2668303|NCT00599924|9212666|P6|Overall Study|Adverse Event|0
2668304|NCT00599924|9212667|P5|Overall Study|Adverse Event|0
2668305|NCT00599924|9212668|P4|Overall Study|Adverse Event|2
2668306|NCT00599924|9212669|P3|Overall Study|Adverse Event|0
2668307|NCT00599924|9212670|P2|Overall Study|Adverse Event|0
2668308|NCT00599924|9212671|P1|Overall Study|Adverse Event|0
2668309|NCT00599924|9212665|P7|Overall Study|Lack of Efficacy|0
2668310|NCT00599924|9212666|P6|Overall Study|Lack of Efficacy|2
2668311|NCT00599924|9212667|P5|Overall Study|Lack of Efficacy|3
2668312|NCT00599924|9212668|P4|Overall Study|Lack of Efficacy|2
2668313|NCT00599924|9212669|P3|Overall Study|Lack of Efficacy|1
2668314|NCT00599924|9212670|P2|Overall Study|Lack of Efficacy|5
2668315|NCT00599924|9212671|P1|Overall Study|Lack of Efficacy|3
2668316|NCT00599755|9212775|P1|Overall Study|No data available|1
2668317|NCT00599755|9212775|P1|Overall Study|Other Reason|2
2668318|NCT00599755|9212775|P1|Overall Study|Progression of Disease|3
2668319|NCT00599755|9212775|P1|Overall Study|Withdrawal by Subject|2
2668320|NCT00599755|9212775|P1|Overall Study|Adverse Event|11
2668321|NCT00599521|9212786|P2|Overall Study|Pregnancy|2
2668322|NCT00599521|9212787|P1|Overall Study|Pregnancy|0
2668323|NCT00599521|9212786|P2|Overall Study|Lost to Follow-up|23
2668324|NCT00599521|9212787|P1|Overall Study|Lost to Follow-up|23
2668325|NCT00599521|9212786|P2|Overall Study|Protocol Violation|1
2668326|NCT00599521|9212787|P1|Overall Study|Protocol Violation|1
2668327|NCT00599521|9212786|P2|Overall Study|Withdrawal by Subject|34
2668328|NCT00599521|9212787|P1|Overall Study|Withdrawal by Subject|28
2668329|NCT00599521|9212786|P2|Overall Study|Adverse Event|1
2668330|NCT00599521|9212787|P1|Overall Study|Adverse Event|4
2668331|NCT00599521|9212786|P2|Overall Study|Lack of Efficacy|8
2668332|NCT00599521|9212787|P1|Overall Study|Lack of Efficacy|4
2668333|NCT00599339|9212801|P1|Overall Study|Study Termination Status Unknown|12
2668334|NCT00599339|9212801|P1|Overall Study|No valid data consent|36
2668335|NCT00599339|9212801|P1|Overall Study|Lost to Follow-up|221
2668336|NCT00599339|9212801|P1|Overall Study|Other Reason|179
2668337|NCT00599339|9212801|P1|Overall Study|Withdrawal by Subject|137
2668338|NCT00599339|9212801|P1|Overall Study|Adverse Event|79
2668339|NCT00599326|9212903|P1|Overall Study|Noncompliant|1
2668340|NCT00599326|9212903|P1|Overall Study|Lost to Follow-up|1
2668341|NCT00599313|9212908|P1|Overall Study|Ineligible|1
2668342|NCT00599313|9212908|P1|Overall Study|Patient Request|4
2668343|NCT00599313|9212908|P1|Overall Study|Disease Progression|12
2668344|NCT00599313|9212908|P1|Overall Study|Adverse Event|19
2668345|NCT00599196|9212950|P1|Overall Study|Other: Inv Switched Dopamine Agonist|1
2668346|NCT00599196|9212950|P1|Overall Study|Other: Patient Stopped Due To Moving|1
2668347|NCT00599196|9212950|P1|Overall Study|Other: Pt Moved To Australia|1
2668348|NCT00599196|9212950|P1|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1
2668349|NCT00599196|9212950|P1|Overall Study|Other: Spouse Withdrew Consent|1
2668350|NCT00599196|9212950|P1|Overall Study|Other: Patient Leaving For Israel|1
2668351|NCT00599196|9212950|P1|Overall Study|Lost to Follow-up|17
2668352|NCT00599196|9212950|P1|Overall Study|Study ended per sponsor|197
2668353|NCT00599196|9212950|P1|Overall Study|Subject withdrew consent|43
2668354|NCT00599196|9212950|P1|Overall Study|Unsatisfactory compliance of subject|3
2668355|NCT00599196|9212950|P1|Overall Study|Adverse Event|93
2668356|NCT00599196|9212950|P1|Overall Study|Lack of Efficacy|22
2668357|NCT00599027|9212981|P2|Overall Study|Treatment Failure|1
2668358|NCT00599027|9212982|P1|Overall Study|Treatment Failure|0
2668359|NCT00599027|9212981|P2|Overall Study|Adverse Event|1
2668360|NCT00599027|9212982|P1|Overall Study|Adverse Event|0
2668361|NCT00599027|9212981|P2|Overall Study|Withdrawal by Subject|1
2668362|NCT00599027|9212982|P1|Overall Study|Withdrawal by Subject|1
2668363|NCT00598871|9212995|P2|Overall Study|Adverse Event|1
2668364|NCT00598871|9212996|P1|Overall Study|Adverse Event|0
2668365|NCT00598832|9213006|P2|Overall Study|Non compliance|0
2668366|NCT00598832|9213007|P1|Overall Study|Non compliance|1
2668367|NCT00598832|9213006|P2|Overall Study|Physician Decision|4
2668368|NCT00598832|9213007|P1|Overall Study|Physician Decision|1
2668369|NCT00598832|9213006|P2|Overall Study|Pregnancy|2
2668370|NCT00598832|9213007|P1|Overall Study|Pregnancy|2
2668371|NCT00598832|9213006|P2|Overall Study|Lost to Follow-up|29
2668372|NCT00598832|9213007|P1|Overall Study|Lost to Follow-up|24
2668373|NCT00598832|9213006|P2|Overall Study|Protocol Violation|2
2668374|NCT00598832|9213007|P1|Overall Study|Protocol Violation|0
2668375|NCT00598832|9213006|P2|Overall Study|Withdrawal by Subject|36
2668376|NCT00598832|9213007|P1|Overall Study|Withdrawal by Subject|25
2668377|NCT00598832|9213006|P2|Overall Study|Adverse Event|2
2668378|NCT00598832|9213007|P1|Overall Study|Adverse Event|6
2668379|NCT00598832|9213006|P2|Overall Study|Lack of Efficacy|7
2668380|NCT00598832|9213007|P1|Overall Study|Lack of Efficacy|3
2668381|NCT00598702|9213060|P8|Overall Study|Dose limiting toxicity|0
2668382|NCT00598702|9213061|P7|Overall Study|Dose limiting toxicity|0
2668383|NCT00598702|9213062|P6|Overall Study|Dose limiting toxicity|1
2668384|NCT00598702|9213063|P5|Overall Study|Dose limiting toxicity|1
2668385|NCT00598702|9213064|P4|Overall Study|Dose limiting toxicity|1
2668386|NCT00598702|9213065|P3|Overall Study|Dose limiting toxicity|0
2668387|NCT00598702|9213066|P2|Overall Study|Dose limiting toxicity|0
2668388|NCT00598702|9213067|P1|Overall Study|Dose limiting toxicity|0
2668389|NCT00598702|9213060|P8|Overall Study|Physician Decision|0
2668390|NCT00598702|9213061|P7|Overall Study|Physician Decision|0
2668391|NCT00598702|9213062|P6|Overall Study|Physician Decision|0
2668392|NCT00598702|9213063|P5|Overall Study|Physician Decision|1
2668393|NCT00598702|9213064|P4|Overall Study|Physician Decision|0
2668394|NCT00598702|9213065|P3|Overall Study|Physician Decision|0
2668395|NCT00598702|9213066|P2|Overall Study|Physician Decision|0
2668396|NCT00598702|9213067|P1|Overall Study|Physician Decision|0
2668397|NCT00598702|9213060|P8|Overall Study|Withdrawal by Subject|0
2668398|NCT00598702|9213061|P7|Overall Study|Withdrawal by Subject|0
2668399|NCT00598702|9213062|P6|Overall Study|Withdrawal by Subject|0
2668400|NCT00598702|9213063|P5|Overall Study|Withdrawal by Subject|1
2668401|NCT00598702|9213064|P4|Overall Study|Withdrawal by Subject|1
2668402|NCT00598702|9213065|P3|Overall Study|Withdrawal by Subject|0
2668403|NCT00598702|9213066|P2|Overall Study|Withdrawal by Subject|0
2668404|NCT00598702|9213067|P1|Overall Study|Withdrawal by Subject|0
2668405|NCT00598702|9213060|P8|Overall Study|Adverse Event|0
2668406|NCT00598702|9213061|P7|Overall Study|Adverse Event|0
2668407|NCT00598702|9213062|P6|Overall Study|Adverse Event|0
2668408|NCT00598702|9213063|P5|Overall Study|Adverse Event|0
2668409|NCT00598702|9213064|P4|Overall Study|Adverse Event|1
2668410|NCT00598702|9213065|P3|Overall Study|Adverse Event|0
2668411|NCT00598702|9213066|P2|Overall Study|Adverse Event|0
2668412|NCT00598702|9213067|P1|Overall Study|Adverse Event|0
2668413|NCT00598702|9213060|P8|Overall Study|Early discharge from hospital|0
2668414|NCT00598702|9213061|P7|Overall Study|Early discharge from hospital|1
2668415|NCT00598702|9213062|P6|Overall Study|Early discharge from hospital|10
2668416|NCT00598702|9213063|P5|Overall Study|Early discharge from hospital|0
2668417|NCT00598702|9213064|P4|Overall Study|Early discharge from hospital|5
2668418|NCT00598702|9213065|P3|Overall Study|Early discharge from hospital|2
2668419|NCT00598702|9213066|P2|Overall Study|Early discharge from hospital|0
2668420|NCT00598702|9213067|P1|Overall Study|Early discharge from hospital|0
2668421|NCT00598702|9213060|P8|Overall Study|Other|0
2668422|NCT00598702|9213061|P7|Overall Study|Other|0
2668423|NCT00598702|9213062|P6|Overall Study|Other|1
2668424|NCT00598702|9213063|P5|Overall Study|Other|0
2668425|NCT00598702|9213064|P4|Overall Study|Other|0
2668426|NCT00598702|9213065|P3|Overall Study|Other|0
2668427|NCT00598702|9213066|P2|Overall Study|Other|2
2668428|NCT00598702|9213067|P1|Overall Study|Other|0
2668429|NCT00598650|9213143|P1|Overall Study|Physician Decision|2
2668430|NCT00598650|9213143|P1|Overall Study|Prohibited Concomitant Medication|2
2668431|NCT00598650|9213143|P1|Overall Study|Not eligible|1
2668432|NCT00598650|9213143|P1|Overall Study|No treatment for 3 weeks|1
2668433|NCT00598650|9213143|P1|Overall Study|Adverse Event|18
2668434|NCT00598650|9213143|P1|Overall Study|Withdrawal by Subject|3
2668435|NCT00598585|9213152|P2|Overall Study|Lost to Follow-up|0
2668436|NCT00598585|9213153|P1|Overall Study|Lost to Follow-up|1
2668437|NCT00598559|9213162|P3|Overall Study|Subject unable/unwilling to attend visit|0
2668438|NCT00598559|9213163|P2|Overall Study|Subject unable/unwilling to attend visit|7
2668439|NCT00598559|9213164|P1|Overall Study|Subject unable/unwilling to attend visit|4
2668440|NCT00598559|9213162|P3|Overall Study|Early discharge from hospital|3
2668441|NCT00598559|9213163|P2|Overall Study|Early discharge from hospital|12
2668442|NCT00598559|9213164|P1|Overall Study|Early discharge from hospital|9
2668443|NCT00598559|9213162|P3|Overall Study|Protocol Non-compliance|0
2668444|NCT00598559|9213163|P2|Overall Study|Protocol Non-compliance|0
2668445|NCT00598559|9213164|P1|Overall Study|Protocol Non-compliance|1
2668446|NCT00598559|9213162|P3|Overall Study|Withdrawal by Subject|0
2668447|NCT00598559|9213163|P2|Overall Study|Withdrawal by Subject|2
2668448|NCT00598559|9213164|P1|Overall Study|Withdrawal by Subject|2
2668449|NCT00598559|9213162|P3|Overall Study|Adverse Event|0
2668450|NCT00598559|9213163|P2|Overall Study|Adverse Event|7
2668451|NCT00598559|9213164|P1|Overall Study|Adverse Event|11
2668452|NCT00598442|9213191|P3|Overall Study|Started dialysis|0
2668453|NCT00598442|9213192|P2|Overall Study|Started dialysis|0
2668454|NCT00598442|9213193|P1|Overall Study|Started dialysis|1
2668455|NCT00598442|9213191|P3|Overall Study|Site closed by sponsor|1
2668456|NCT00598442|9213192|P2|Overall Study|Site closed by sponsor|2
2668457|NCT00598442|9213193|P1|Overall Study|Site closed by sponsor|5
2668458|NCT00598442|9213191|P3|Overall Study|Renal transplant|1
2668459|NCT00598442|9213192|P2|Overall Study|Renal transplant|0
2668460|NCT00598442|9213193|P1|Overall Study|Renal transplant|0
2668461|NCT00598442|9213191|P3|Overall Study|Relocation|0
2668462|NCT00598442|9213192|P2|Overall Study|Relocation|4
2668463|NCT00598442|9213193|P1|Overall Study|Relocation|1
2668464|NCT00598442|9213191|P3|Overall Study|Noncompliance|1
2668465|NCT00598442|9213192|P2|Overall Study|Noncompliance|2
2668466|NCT00598442|9213193|P1|Overall Study|Noncompliance|0
2668467|NCT00598442|9213191|P3|Overall Study|Withdrawal by Subject|6
2668468|NCT00598442|9213192|P2|Overall Study|Withdrawal by Subject|16
2668469|NCT00598442|9213193|P1|Overall Study|Withdrawal by Subject|8
2668470|NCT00598442|9213191|P3|Overall Study|Physician Decision|1
2668471|NCT00598442|9213192|P2|Overall Study|Physician Decision|1
2668472|NCT00598442|9213193|P1|Overall Study|Physician Decision|2
2668473|NCT00598442|9213191|P3|Overall Study|Lost to Follow-up|3
2668474|NCT00598442|9213192|P2|Overall Study|Lost to Follow-up|3
2668475|NCT00598442|9213193|P1|Overall Study|Lost to Follow-up|4
2668476|NCT00598442|9213191|P3|Overall Study|Death|11
2668477|NCT00598442|9213192|P2|Overall Study|Death|11
2668478|NCT00598442|9213193|P1|Overall Study|Death|19
2668479|NCT00598442|9213191|P3|Overall Study|Adverse Event|0
2668480|NCT00598442|9213192|P2|Overall Study|Adverse Event|0
2668481|NCT00598442|9213193|P1|Overall Study|Adverse Event|3
2668482|NCT00598273|9213210|P3|Overall Study|Started dialysis|5
2668483|NCT00598273|9213211|P2|Overall Study|Started dialysis|4
2668484|NCT00598273|9213212|P1|Overall Study|Started dialysis|6
2668485|NCT00598273|9213210|P3|Overall Study|Site elected to close|0
2668486|NCT00598273|9213211|P2|Overall Study|Site elected to close|0
2668487|NCT00598273|9213212|P1|Overall Study|Site elected to close|1
2668488|NCT00598273|9213210|P3|Overall Study|Renal transplant|1
2668489|NCT00598273|9213211|P2|Overall Study|Renal transplant|0
2668490|NCT00598273|9213212|P1|Overall Study|Renal transplant|1
2668491|NCT00598273|9213210|P3|Overall Study|Relocation|4
2668492|NCT00598273|9213211|P2|Overall Study|Relocation|2
2668493|NCT00598273|9213212|P1|Overall Study|Relocation|0
2668494|NCT00598273|9213210|P3|Overall Study|Noncompliance|3
2668495|NCT00598273|9213211|P2|Overall Study|Noncompliance|2
2668496|NCT00598273|9213212|P1|Overall Study|Noncompliance|3
2668497|NCT00598273|9213210|P3|Overall Study|Withdrawal by Subject|10
2668498|NCT00598273|9213211|P2|Overall Study|Withdrawal by Subject|10
2668499|NCT00598273|9213212|P1|Overall Study|Withdrawal by Subject|12
2668500|NCT00598273|9213210|P3|Overall Study|Physician Decision|1
2668501|NCT00598273|9213211|P2|Overall Study|Physician Decision|0
2668502|NCT00598273|9213212|P1|Overall Study|Physician Decision|0
2668503|NCT00598273|9213210|P3|Overall Study|Lost to Follow-up|5
2668504|NCT00598273|9213211|P2|Overall Study|Lost to Follow-up|3
2668505|NCT00598273|9213212|P1|Overall Study|Lost to Follow-up|8
2668506|NCT00598273|9213210|P3|Overall Study|Death|8
2668507|NCT00598273|9213211|P2|Overall Study|Death|12
2668508|NCT00598273|9213212|P1|Overall Study|Death|6
2668509|NCT00598273|9213210|P3|Overall Study|Adverse Event|2
2668510|NCT00598273|9213211|P2|Overall Study|Adverse Event|5
2668511|NCT00598273|9213212|P1|Overall Study|Adverse Event|4
2668512|NCT00598078|9213226|P2|Period 2 (Day 2)|Adverse Event|0
2668513|NCT00598078|9213227|P1|Period 2 (Day 2)|Adverse Event|1
2668514|NCT00597766|9213309|P3|Follow-up 2, Week 8|Lost to Follow-up|1
2668515|NCT00597766|9213310|P2|Follow-up 2, Week 8|Lost to Follow-up|0
2668516|NCT00597766|9213311|P1|Follow-up 2, Week 8|Lost to Follow-up|0
2668517|NCT00597766|9213309|P3|Follow-up 1, Week 4|Withdrawal by Subject|0
2668518|NCT00597766|9213310|P2|Follow-up 1, Week 4|Withdrawal by Subject|0
2668519|NCT00597766|9213311|P1|Follow-up 1, Week 4|Withdrawal by Subject|1
2668520|NCT00597753|9213330|P2|Overall Study|Site elected to close|4
2668521|NCT00597753|9213331|P1|Overall Study|Site elected to close|2
2668522|NCT00597753|9213330|P2|Overall Study|Site closed by sponsor|7
2668523|NCT00597753|9213331|P1|Overall Study|Site closed by sponsor|19
2668524|NCT00597753|9213330|P2|Overall Study|Renal transplant|3
2668525|NCT00597753|9213331|P1|Overall Study|Renal transplant|10
2668526|NCT00597753|9213330|P2|Overall Study|Relocation|6
2668527|NCT00597753|9213331|P1|Overall Study|Relocation|17
2668528|NCT00597753|9213330|P2|Overall Study|Noncompliance|1
2668529|NCT00597753|9213331|P1|Overall Study|Noncompliance|2
2668530|NCT00597753|9213330|P2|Overall Study|Never dosed|0
2668531|NCT00597753|9213331|P1|Overall Study|Never dosed|2
2668532|NCT00597753|9213330|P2|Overall Study|Discontinued Dialysis|1
2668533|NCT00597753|9213331|P1|Overall Study|Discontinued Dialysis|0
2668534|NCT00597753|9213330|P2|Overall Study|Withdrawal by Subject|12
2668535|NCT00597753|9213331|P1|Overall Study|Withdrawal by Subject|35
2668536|NCT00597753|9213330|P2|Overall Study|Pregnancy|0
2668537|NCT00597753|9213331|P1|Overall Study|Pregnancy|1
2668538|NCT00597753|9213330|P2|Overall Study|Physician Decision|1
2668539|NCT00597753|9213331|P1|Overall Study|Physician Decision|5
2668540|NCT00597753|9213330|P2|Overall Study|Lost to Follow-up|3
2668541|NCT00597753|9213331|P1|Overall Study|Lost to Follow-up|10
2668542|NCT00597753|9213330|P2|Overall Study|Lack of Efficacy|0
2668543|NCT00597753|9213331|P1|Overall Study|Lack of Efficacy|2
2668544|NCT00597753|9213330|P2|Overall Study|Death|29
2668545|NCT00597753|9213331|P1|Overall Study|Death|55
2668546|NCT00597753|9213330|P2|Overall Study|Adverse Event|2
2668547|NCT00597753|9213331|P1|Overall Study|Adverse Event|6
2668548|NCT00597714|9213365|P3|Overall Study|Recipient death|10
2668549|NCT00597714|9213366|P2|Overall Study|Recipient death|0
2668550|NCT00597714|9213367|P1|Overall Study|Recipient death|0
2668551|NCT00597714|9213365|P3|Overall Study|Death|0
2668552|NCT00597714|9213366|P2|Overall Study|Death|46
2668553|NCT00597714|9213367|P1|Overall Study|Death|56
2668554|NCT00597701|9213379|P2|Overall Study|Did not start intervention (pharmacy er)|2
2668555|NCT00597701|9213380|P1|Overall Study|Did not start intervention (pharmacy er)|0
2668556|NCT00597701|9213379|P2|Overall Study|Physician Decision|0
2668557|NCT00597701|9213380|P1|Overall Study|Physician Decision|2
2668558|NCT00597701|9213379|P2|Overall Study|Death|1
2668559|NCT00597701|9213380|P1|Overall Study|Death|0
2668560|NCT00597701|9213379|P2|Overall Study|Withdrawal by Subject|5
2668561|NCT00597701|9213380|P1|Overall Study|Withdrawal by Subject|5
2668562|NCT00597584|9213402|P2|Overall Study|Renal transplant|7
2668563|NCT00597584|9213403|P1|Overall Study|Renal transplant|9
2668564|NCT00597584|9213402|P2|Overall Study|Relocation|6
2668565|NCT00597584|9213403|P1|Overall Study|Relocation|8
2668566|NCT00597584|9213402|P2|Overall Study|Never dosed|0
2668567|NCT00597584|9213403|P1|Overall Study|Never dosed|1
2668568|NCT00597584|9213402|P2|Overall Study|Lost ability to consent|1
2668569|NCT00597584|9213403|P1|Overall Study|Lost ability to consent|1
2668570|NCT00597584|9213402|P2|Overall Study|Discontinued Dialysis|1
2668571|NCT00597584|9213403|P1|Overall Study|Discontinued Dialysis|0
2668572|NCT00597584|9213402|P2|Overall Study|Withdrawal by Subject|12
2668573|NCT00597584|9213403|P1|Overall Study|Withdrawal by Subject|44
2668574|NCT00597584|9213402|P2|Overall Study|Pregnancy|0
2668575|NCT00597584|9213403|P1|Overall Study|Pregnancy|2
2668576|NCT00597584|9213402|P2|Overall Study|Physician Decision|0
2668577|NCT00597584|9213403|P1|Overall Study|Physician Decision|3
2668578|NCT00597584|9213402|P2|Overall Study|Lost to Follow-up|4
2668579|NCT00597584|9213403|P1|Overall Study|Lost to Follow-up|2
2668580|NCT00597584|9213402|P2|Overall Study|Lack of Efficacy|0
2668581|NCT00597584|9213403|P1|Overall Study|Lack of Efficacy|1
2668582|NCT00597584|9213402|P2|Overall Study|Death|30
2668583|NCT00597584|9213403|P1|Overall Study|Death|53
2668584|NCT00597584|9213402|P2|Overall Study|Adverse Event|2
2668585|NCT00597584|9213403|P1|Overall Study|Adverse Event|4
2668586|NCT00597519|9213428|P1|Overall Study|Death|1
2668587|NCT00597506|9213432|P1|Overall Study|Subject is being followed for survival|1
2668588|NCT00597376|9213482|P2|Overall Study|Adverse Event|1
2668589|NCT00597376|9213483|P1|Overall Study|Adverse Event|4
2668590|NCT00597376|9213482|P2|Overall Study|Withdrawal by Subject|3
2668591|NCT00597376|9213483|P1|Overall Study|Withdrawal by Subject|4
2668592|NCT00597207|9213524|P2|Overall Study|Lost to Follow-up|7
2668593|NCT00597207|9213525|P1|Overall Study|Lost to Follow-up|5
2668594|NCT00597116|9213533|P2|Overall Study|Progressive disease|6
2668595|NCT00597116|9213534|P1|Overall Study|Progressive disease|11
2668596|NCT00597116|9213533|P2|Overall Study|Lost to Follow-up|0
2668597|NCT00597116|9213534|P1|Overall Study|Lost to Follow-up|1
2668598|NCT00597116|9213533|P2|Overall Study|Death|1
2668599|NCT00597116|9213534|P1|Overall Study|Death|0
2668600|NCT00597116|9213533|P2|Overall Study|Physician Decision|1
2668601|NCT00597116|9213534|P1|Overall Study|Physician Decision|0
2668602|NCT00597116|9213533|P2|Overall Study|Withdrawal by Subject|2
2668603|NCT00597116|9213534|P1|Overall Study|Withdrawal by Subject|0
2668604|NCT00597116|9213533|P2|Overall Study|Adverse Event|1
2668605|NCT00597116|9213534|P1|Overall Study|Adverse Event|2
2668606|NCT00597012|9213560|P2|Overall Study|Lost to Follow-up|2
2668607|NCT00597012|9213561|P1|Overall Study|Lost to Follow-up|0
2668608|NCT00597012|9213560|P2|Overall Study|Ineligible|0
2668609|NCT00597012|9213561|P1|Overall Study|Ineligible|2
2668610|NCT00597012|9213560|P2|Overall Study|Withdrawal by Subject|4
2668611|NCT00597012|9213561|P1|Overall Study|Withdrawal by Subject|7
2668612|NCT00597012|9213560|P2|Overall Study|Underwent Total Knee Replacement (TKR)|1
2668613|NCT00597012|9213561|P1|Overall Study|Underwent Total Knee Replacement (TKR)|3
2668614|NCT00597012|9213560|P2|Overall Study|Death|1
2668615|NCT00597012|9213561|P1|Overall Study|Death|1
2668616|NCT00596960|9213573|P2|Overall Study|No alcohol use data|1
2668617|NCT00596960|9213574|P1|Overall Study|No alcohol use data|0
2668618|NCT00596960|9213573|P2|Overall Study|Protocol Violation|1
2668619|NCT00596960|9213574|P1|Overall Study|Protocol Violation|0
2668620|NCT00596960|9213573|P2|Overall Study|Physician Decision|0
2668621|NCT00596960|9213574|P1|Overall Study|Physician Decision|1
2668622|NCT00596960|9213573|P2|Overall Study|Incarcerated|0
2668623|NCT00596960|9213574|P1|Overall Study|Incarcerated|2
2668624|NCT00596960|9213573|P2|Overall Study|Withdrawal by Subject|0
2668625|NCT00596960|9213574|P1|Overall Study|Withdrawal by Subject|1
2668626|NCT00596960|9213573|P2|Overall Study|Lost to Follow-up|5
2668627|NCT00596960|9213574|P1|Overall Study|Lost to Follow-up|6
2668628|NCT00596960|9213573|P2|Overall Study|Death|2
2668629|NCT00596960|9213574|P1|Overall Study|Death|1
2668630|NCT00596947|9213586|P2|Overall Study|Lost to Follow-up|0
2668631|NCT00596947|9213587|P1|Overall Study|Lost to Follow-up|1
2668632|NCT00596947|9213586|P2|Overall Study|study halted due to low enrollment|3
2668633|NCT00596947|9213587|P1|Overall Study|study halted due to low enrollment|5
2668634|NCT00596934|9213627|P1|Overall Study|Withdrawal by Subject|1
2668635|NCT00596934|9213627|P1|Overall Study|Protocol Violation|1
2668636|NCT00596830|9213640|P2|Overall Study|Randomized but not treated|7
2668637|NCT00596830|9213641|P1|Overall Study|Randomized but not treated|3
2668638|NCT00596830|9213640|P2|Overall Study|Follow-up was discontinued|0
2668639|NCT00596830|9213641|P1|Overall Study|Follow-up was discontinued|1
2668640|NCT00596830|9213640|P2|Overall Study|Study terminated by sponsor|62
2668641|NCT00596830|9213641|P1|Overall Study|Study terminated by sponsor|51
2668642|NCT00596830|9213640|P2|Overall Study|Withdrawal by Subject|12
2668643|NCT00596830|9213641|P1|Overall Study|Withdrawal by Subject|22
2668644|NCT00596830|9213640|P2|Overall Study|Lost to Follow-up|11
2668645|NCT00596830|9213641|P1|Overall Study|Lost to Follow-up|7
2668646|NCT00596830|9213640|P2|Overall Study|Death|247
2668647|NCT00596830|9213641|P1|Overall Study|Death|258
2668648|NCT00596817|9213667|P2|Double-blind Period|Other Reasons|18
2668649|NCT00596817|9213668|P1|Double-blind Period|Other Reasons|10
2668650|NCT00596817|9213667|P2|Double-blind Period|Lost to Follow-up|2
2668651|NCT00596817|9213668|P1|Double-blind Period|Lost to Follow-up|0
2668652|NCT00596817|9213667|P2|Double-blind Period|Withdrawal of Consent|3
2668653|NCT00596817|9213668|P1|Double-blind Period|Withdrawal of Consent|7
2668654|NCT00596817|9213667|P2|Double-blind Period|Protocol Violation|8
2668655|NCT00596817|9213668|P1|Double-blind Period|Protocol Violation|11
2668656|NCT00596817|9213667|P2|Double-blind Period|Non-compliance With Study Product|4
2668657|NCT00596817|9213668|P1|Double-blind Period|Non-compliance With Study Product|3
2668658|NCT00596817|9213667|P2|Double-blind Period|Lack of Efficacy|28
2668659|NCT00596817|9213668|P1|Double-blind Period|Lack of Efficacy|52
2668660|NCT00596817|9213667|P2|Double-blind Period|Adverse Event|16
2668661|NCT00596817|9213668|P1|Double-blind Period|Adverse Event|5
2668662|NCT00596817|9213667|P2|Open-label Period to Double-blind Period|Other Reasons|14
2668663|NCT00596817|9213668|P1|Open-label Period to Double-blind Period|Other Reasons|0
2668664|NCT00596817|9213667|P2|Open-label Period to Double-blind Period|Not Eligible|49
2668665|NCT00596817|9213668|P1|Open-label Period to Double-blind Period|Not Eligible|0
2668666|NCT00596817|9213667|P2|Open-label Period to Double-blind Period|Lack of Efficacy|24
2668667|NCT00596817|9213668|P1|Open-label Period to Double-blind Period|Lack of Efficacy|0
2668668|NCT00596817|9213667|P2|Open-label Period to Double-blind Period|Adverse Event|5
2668669|NCT00596817|9213668|P1|Open-label Period to Double-blind Period|Adverse Event|0
2668670|NCT00596817|9213667|P2|Open-label Period|Other Reasons|65
2668671|NCT00596817|9213668|P1|Open-label Period|Other Reasons|0
2668672|NCT00596817|9213667|P2|Open-label Period|Lack of Efficacy|33
2668673|NCT00596817|9213668|P1|Open-label Period|Lack of Efficacy|0
2668674|NCT00596817|9213667|P2|Open-label Period|Adverse Event|49
2668675|NCT00596817|9213668|P1|Open-label Period|Adverse Event|0
2668676|NCT00596752|9213693|P2|Overall Study|Protocol Violation|0
2668677|NCT00596752|9213694|P1|Overall Study|Protocol Violation|1
2668678|NCT00596752|9213693|P2|Overall Study|Lack of Efficacy|7
2668679|NCT00596752|9213694|P1|Overall Study|Lack of Efficacy|4
2668680|NCT00596752|9213693|P2|Overall Study|Unsatisfactory Compliance|6
2668681|NCT00596752|9213694|P1|Overall Study|Unsatisfactory Compliance|9
2668682|NCT00596752|9213693|P2|Overall Study|Withdrawal by Subject|9
2668683|NCT00596752|9213694|P1|Overall Study|Withdrawal by Subject|12
2668684|NCT00596752|9213693|P2|Overall Study|Lost to Follow-up|38
2668685|NCT00596752|9213694|P1|Overall Study|Lost to Follow-up|22
2668686|NCT00596752|9213693|P2|Overall Study|Adverse Event|34
2668687|NCT00596752|9213694|P1|Overall Study|Adverse Event|34
2668688|NCT00596752|9213693|P2|Overall Study|Other Reason|49
2668689|NCT00596752|9213694|P1|Overall Study|Other Reason|44
2668690|NCT00596687|9213724|P2|Overall Study|cancelled surgery|1
2668691|NCT00596687|9213725|P1|Overall Study|cancelled surgery|1
2668692|NCT00596687|9213724|P2|Overall Study|Withdrawal by Subject|1
2668693|NCT00596687|9213725|P1|Overall Study|Withdrawal by Subject|3
2668694|NCT00596687|9213724|P2|Overall Study|continuous insulin infusion during TPN|1
2668695|NCT00596687|9213725|P1|Overall Study|continuous insulin infusion during TPN|2
2668696|NCT00596687|9213724|P2|Overall Study|< 24 hours of insulin treatment|6
2668697|NCT00596687|9213725|P1|Overall Study|< 24 hours of insulin treatment|8
2668698|NCT00596635|9213736|P3|Overall Study|Could not provide urine specimen|2
2668699|NCT00596635|9213737|P2|Overall Study|Could not provide urine specimen|2
2668700|NCT00596635|9213738|P1|Overall Study|Could not provide urine specimen|1
2668701|NCT00596635|9213736|P3|Overall Study|Hip fracture|3
2668702|NCT00596635|9213737|P2|Overall Study|Hip fracture|3
2668703|NCT00596635|9213738|P1|Overall Study|Hip fracture|2
2668704|NCT00596635|9213736|P3|Overall Study|Treatment for symptomatic UTI|3
2668705|NCT00596635|9213737|P2|Overall Study|Treatment for symptomatic UTI|6
2668706|NCT00596635|9213738|P1|Overall Study|Treatment for symptomatic UTI|4
2668707|NCT00596635|9213736|P3|Overall Study|Lost to Follow-up|0
2668708|NCT00596635|9213737|P2|Overall Study|Lost to Follow-up|2
2668709|NCT00596635|9213738|P1|Overall Study|Lost to Follow-up|0
2668710|NCT00596466|9213764|P1|Overall Study|Enrolled, not treated|2
2668711|NCT00596466|9213764|P1|Overall Study|Unpecified|2
2668712|NCT00596466|9213764|P1|Overall Study|Protocol Violation|2
2668713|NCT00596466|9213764|P1|Overall Study|Withdrawal by Subject|2
2668714|NCT00596466|9213764|P1|Overall Study|Adverse Event|4
2668715|NCT00596466|9213764|P1|Overall Study|Lack of Efficacy|5
2668716|NCT00596427|9213794|P2|Overall Study|Protocol Violation|0
2668717|NCT00596427|9213795|P1|Overall Study|Protocol Violation|1
2668718|NCT00596427|9213794|P2|Overall Study|Increased Fasting Triacylglycerol level|0
2668719|NCT00596427|9213795|P1|Overall Study|Increased Fasting Triacylglycerol level|1
2668720|NCT00596427|9213794|P2|Overall Study|Withdrawal by Subject|2
2668721|NCT00596427|9213795|P1|Overall Study|Withdrawal by Subject|2
2668722|NCT00596362|9213823|P1|Overall Study|Progressive Disease|1
2668723|NCT00596011|9213859|P2|Overall Study|Adverse Event|7
2668724|NCT00596011|9213860|P1|Overall Study|Adverse Event|11
2668725|NCT00596011|9213859|P2|Overall Study|Withdrawal by Subject|3
2668726|NCT00596011|9213860|P1|Overall Study|Withdrawal by Subject|2
2668727|NCT00595959|9213876|P1|Overall Study|Lost to Follow-up|1
2668728|NCT00595959|9213876|P1|Overall Study|Withdrawal by Subject|1
2668729|NCT00595920|9213910|P1|Overall Study|The OLTERMS study was discontinued by th|116
2668730|NCT00595868|9213921|P2|Overall Study|Lost to Follow-up|50
2668731|NCT00595868|9213922|P1|Overall Study|Lost to Follow-up|45
2668732|NCT00595764|9213945|P2|Overall Study|Withdrawal by Subject|0
2668733|NCT00595764|9213946|P1|Overall Study|Withdrawal by Subject|4
2668734|NCT00595764|9213945|P2|Overall Study|Missed 3 PM visits|7
2668735|NCT00595764|9213946|P1|Overall Study|Missed 3 PM visits|1
2668736|NCT00595764|9213945|P2|Overall Study|Missed Medication >1 week|17
2668737|NCT00595764|9213946|P1|Overall Study|Missed Medication >1 week|10
2668738|NCT00595764|9213945|P2|Overall Study|Protocol Violation|19
2668739|NCT00595764|9213946|P1|Overall Study|Protocol Violation|24
2668740|NCT00595621|9213962|P2|Randomization and Study|Withdrawal by Subject|1
2668741|NCT00595621|9213963|P1|Randomization and Study|Withdrawal by Subject|0
2668742|NCT00595621|9213962|P2|Randomization and Study|Adverse Event|0
2668743|NCT00595621|9213963|P1|Randomization and Study|Adverse Event|2
2668744|NCT00595621|9213962|P2|Open Label Run in|Withdrawal by Subject|0
2668745|NCT00595621|9213963|P1|Open Label Run in|Withdrawal by Subject|1
2668746|NCT00595621|9213962|P2|Open Label Run in|Physician Decision|0
2668747|NCT00595621|9213963|P1|Open Label Run in|Physician Decision|1
2668748|NCT00595621|9213962|P2|Open Label Run in|Adverse Event|0
2668749|NCT00595621|9213963|P1|Open Label Run in|Adverse Event|1
2668750|NCT00595582|9213980|P1|Overall Study|Physician Decision|5
2668751|NCT00595582|9213980|P1|Overall Study|Adverse Event|2
2668752|NCT00595582|9213980|P1|Overall Study|Lost to Follow-up|1
2668753|NCT00595582|9213980|P1|Overall Study|Pilot study that PI terminated|2
2668754|NCT00595517|9214006|P1|Overall Study|No intention to attend regularly|1
2668755|NCT00595517|9214006|P1|Overall Study|usage of prohibited treatment|1
2668756|NCT00595517|9214006|P1|Overall Study|Recurrence of ulcer|5
2668757|NCT00595517|9214006|P1|Overall Study|Protocol Violation|2
2668758|NCT00595517|9214006|P1|Overall Study|Withdrawal by Subject|4
2668759|NCT00595517|9214006|P1|Overall Study|Adverse Event|6
2668760|NCT00595504|9214015|P2|Overall Study|Physician Decision|0
2668761|NCT00595504|9214016|P1|Overall Study|Physician Decision|1
2668762|NCT00595504|9214015|P2|Overall Study|Withdrawal by Subject|3
2668763|NCT00595504|9214016|P1|Overall Study|Withdrawal by Subject|1
2668764|NCT00595478|9214028|P2|36-week Follow-up Period|Withdrawal by Subject|4
2668765|NCT00595478|9214029|P1|36-week Follow-up Period|Withdrawal by Subject|4
2668766|NCT00595478|9214028|P2|36-week Follow-up Period|Lost to Follow-up|4
2668767|NCT00595478|9214029|P1|36-week Follow-up Period|Lost to Follow-up|5
2668768|NCT00595465|9214040|P3|Overall Study|administrative reason|1
2668769|NCT00595465|9214041|P2|Overall Study|administrative reason|0
2668770|NCT00595465|9214042|P1|Overall Study|administrative reason|0
2668771|NCT00595465|9214040|P3|Overall Study|Lost to Follow-up|2
2668772|NCT00595465|9214041|P2|Overall Study|Lost to Follow-up|0
2668773|NCT00595465|9214042|P1|Overall Study|Lost to Follow-up|0
2668774|NCT00595465|9214040|P3|Overall Study|Protocol Violation|0
2668775|NCT00595465|9214041|P2|Overall Study|Protocol Violation|1
2668776|NCT00595465|9214042|P1|Overall Study|Protocol Violation|2
2668777|NCT00595465|9214040|P3|Overall Study|Pregnancy|1
2668778|NCT00595465|9214041|P2|Overall Study|Pregnancy|0
2668779|NCT00595465|9214042|P1|Overall Study|Pregnancy|0
2668780|NCT00595465|9214040|P3|Overall Study|Adverse Event|3
2668781|NCT00595465|9214041|P2|Overall Study|Adverse Event|3
2668782|NCT00595465|9214042|P1|Overall Study|Adverse Event|4
2668783|NCT00595413|9214054|P4|Overall Study|Other|0
2668784|NCT00595413|9214055|P3|Overall Study|Other|5
2668785|NCT00595413|9214056|P2|Overall Study|Other|1
2668786|NCT00595413|9214057|P1|Overall Study|Other|5
2668787|NCT00595413|9214054|P4|Overall Study|Death|0
2668788|NCT00595413|9214055|P3|Overall Study|Death|1
2668789|NCT00595413|9214056|P2|Overall Study|Death|0
2668790|NCT00595413|9214057|P1|Overall Study|Death|0
2668791|NCT00595413|9214054|P4|Overall Study|Lost to Follow-up|3
2668792|NCT00595413|9214055|P3|Overall Study|Lost to Follow-up|1
2668793|NCT00595413|9214056|P2|Overall Study|Lost to Follow-up|2
2668794|NCT00595413|9214057|P1|Overall Study|Lost to Follow-up|2
2668795|NCT00595413|9214054|P4|Overall Study|Adverse Event|1
2668796|NCT00595413|9214055|P3|Overall Study|Adverse Event|1
2668797|NCT00595413|9214056|P2|Overall Study|Adverse Event|2
2668798|NCT00595413|9214057|P1|Overall Study|Adverse Event|0
2668799|NCT00595335|9214098|P2|Six Months to Twelve Months|Disease Progression|0
2668800|NCT00595335|9214099|P1|Six Months to Twelve Months|Disease Progression|1
2668801|NCT00595335|9214098|P2|Six Months to Twelve Months|Withdrawal by Subject|1
2668802|NCT00595335|9214099|P1|Six Months to Twelve Months|Withdrawal by Subject|0
2668803|NCT00595335|9214098|P2|Baseline to Six Months|Adverse Event|0
2668804|NCT00595335|9214099|P1|Baseline to Six Months|Adverse Event|1
2668805|NCT00595335|9214098|P2|Baseline to Six Months|Disease Progression|1
2668806|NCT00595335|9214099|P1|Baseline to Six Months|Disease Progression|1
2668807|NCT00595335|9214098|P2|Baseline to Six Months|Withdrawal by Subject|1
2668808|NCT00595335|9214099|P1|Baseline to Six Months|Withdrawal by Subject|0
2668809|NCT00595309|9214119|P1|Overall Study|personal reason|1
2668810|NCT00595309|9214119|P1|Overall Study|acute infection after V0|1
2668811|NCT00595309|9214119|P1|Overall Study|planned vaccination against yellow fever|1
2668812|NCT00595309|9214119|P1|Overall Study|Lost to Follow-up|1
2668813|NCT00595127|9214168|P1|Overall Study|joined another trial|1
2668814|NCT00595127|9214168|P1|Overall Study|Relapsed|3
2668815|NCT00595127|9214168|P1|Overall Study|Death|6
2668816|NCT00595075|9214189|P2|Overall Study|Withdrawal by Subject|0
2668817|NCT00595075|9214190|P1|Overall Study|Withdrawal by Subject|1
2668818|NCT00594958|9214211|P3|Overall Study|administrative|2
2668819|NCT00594958|9214212|P2|Overall Study|administrative|0
2668820|NCT00594958|9214213|P1|Overall Study|administrative|3
2668821|NCT00594958|9214211|P3|Overall Study|Lost to Follow-up|3
2668822|NCT00594958|9214212|P2|Overall Study|Lost to Follow-up|0
2668823|NCT00594958|9214213|P1|Overall Study|Lost to Follow-up|5
2668824|NCT00594958|9214211|P3|Overall Study|Protocol Violation|2
2668825|NCT00594958|9214212|P2|Overall Study|Protocol Violation|0
2668826|NCT00594958|9214213|P1|Overall Study|Protocol Violation|1
2668827|NCT00594958|9214211|P3|Overall Study|Pregnancy|0
2668828|NCT00594958|9214212|P2|Overall Study|Pregnancy|2
2668829|NCT00594958|9214213|P1|Overall Study|Pregnancy|0
2668830|NCT00594958|9214211|P3|Overall Study|Adverse Event|2
2668831|NCT00594958|9214212|P2|Overall Study|Adverse Event|1
2668832|NCT00594958|9214213|P1|Overall Study|Adverse Event|4
2668833|NCT00594958|9214211|P3|Overall Study|Withdrawal by Subject|1
2668834|NCT00594958|9214212|P2|Overall Study|Withdrawal by Subject|0
2668835|NCT00594958|9214213|P1|Overall Study|Withdrawal by Subject|1
2668836|NCT00594906|9214234|P2|Overall Study|Death|1
2668837|NCT00594906|9214235|P1|Overall Study|Death|0
2668838|NCT00594906|9214234|P2|Overall Study|Physician Decision|1
2668839|NCT00594906|9214235|P1|Overall Study|Physician Decision|0
2668840|NCT00594906|9214234|P2|Overall Study|Physician Decision|0
2668841|NCT00594906|9214235|P1|Overall Study|Physician Decision|1
2668842|NCT00594880|9214243|P2|Overall Study|Lost to Follow-up|0
2668843|NCT00594880|9214244|P1|Overall Study|Lost to Follow-up|1
2668844|NCT00594880|9214243|P2|Overall Study|Withdrawal by Subject|1
2668845|NCT00594880|9214244|P1|Overall Study|Withdrawal by Subject|1
2668846|NCT00594854|9214256|P2|Overall Study|Study terminated|10
2668847|NCT00594854|9214257|P1|Overall Study|Study terminated|7
2668848|NCT00594815|9214267|P1|Overall Study|Toxicity|4
2668849|NCT00594815|9214267|P1|Overall Study|Withdrawal by Subject|2
2668850|NCT00594815|9214267|P1|Overall Study|Never Treated|3
2668851|NCT00594659|9214292|P3|Overall Study|Lost to Follow-up|7
2668852|NCT00594659|9214293|P2|Overall Study|Lost to Follow-up|9
2668853|NCT00594659|9214294|P1|Overall Study|Lost to Follow-up|13
2668854|NCT00594646|9214305|P1|Overall Study|Lost to Follow-up|15
2668855|NCT00594646|9214305|P1|Overall Study|Withdrawal by Subject|1
2668856|NCT00594568|9214313|P3|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18
2668857|NCT00594568|9214314|P2|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22
2668858|NCT00594568|9214315|P1|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25
2668859|NCT00594568|9214313|P3|Safety Follow Up (SFU)-Optional|Caregiver Decision|9
2668860|NCT00594568|9214314|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|16
2668861|NCT00594568|9214315|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|17
2668862|NCT00594568|9214313|P3|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
2668863|NCT00594568|9214314|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
2668864|NCT00594568|9214315|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
2668865|NCT00594568|9214313|P3|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13
2668866|NCT00594568|9214314|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15
2668867|NCT00594568|9214315|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12
2668868|NCT00594568|9214313|P3|Safety Follow Up (SFU)-Optional|Adverse Event|0
2668869|NCT00594568|9214314|P2|Safety Follow Up (SFU)-Optional|Adverse Event|0
2668870|NCT00594568|9214315|P1|Safety Follow Up (SFU)-Optional|Adverse Event|5
2668871|NCT00594568|9214313|P3|Safety Follow Up (SFU)-Optional|Death|0
2668872|NCT00594568|9214314|P2|Safety Follow Up (SFU)-Optional|Death|1
2668873|NCT00594568|9214315|P1|Safety Follow Up (SFU)-Optional|Death|0
2668874|NCT00594568|9214313|P3|Delayed Start|Sponsor Decision|59
2668875|NCT00594568|9214314|P2|Delayed Start|Sponsor Decision|66
2668876|NCT00594568|9214315|P1|Delayed Start|Sponsor Decision|77
2668877|NCT00594568|9214313|P3|Delayed Start|Caregiver Decision|2
2668878|NCT00594568|9214314|P2|Delayed Start|Caregiver Decision|6
2668879|NCT00594568|9214315|P1|Delayed Start|Caregiver Decision|5
2668880|NCT00594568|9214313|P3|Delayed Start|Lost to Follow-up|1
2668881|NCT00594568|9214314|P2|Delayed Start|Lost to Follow-up|0
2668882|NCT00594568|9214315|P1|Delayed Start|Lost to Follow-up|0
2668883|NCT00594568|9214313|P3|Delayed Start|Physician Decision|1
2668884|NCT00594568|9214314|P2|Delayed Start|Physician Decision|0
2668885|NCT00594568|9214315|P1|Delayed Start|Physician Decision|0
2668886|NCT00594568|9214313|P3|Delayed Start|Withdrawal by Subject|0
2668887|NCT00594568|9214314|P2|Delayed Start|Withdrawal by Subject|3
2668888|NCT00594568|9214315|P1|Delayed Start|Withdrawal by Subject|4
2668889|NCT00594568|9214313|P3|Delayed Start|Adverse Event|2
2668890|NCT00594568|9214314|P2|Delayed Start|Adverse Event|2
2668891|NCT00594568|9214315|P1|Delayed Start|Adverse Event|12
2668892|NCT00594568|9214313|P3|Delayed Start|Death|1
2668893|NCT00594568|9214314|P2|Delayed Start|Death|0
2668894|NCT00594568|9214315|P1|Delayed Start|Death|0
2668895|NCT00594568|9214313|P3|Initial Treatment|Entry criteria exclusion|1
2668896|NCT00594568|9214314|P2|Initial Treatment|Entry criteria exclusion|1
2668897|NCT00594568|9214315|P1|Initial Treatment|Entry criteria exclusion|0
2668898|NCT00594568|9214313|P3|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6
2668899|NCT00594568|9214314|P2|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
2668900|NCT00594568|9214315|P1|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
2668901|NCT00594568|9214313|P3|Initial Treatment|Caregiver decision|36
2668902|NCT00594568|9214314|P2|Initial Treatment|Caregiver decision|36
2668903|NCT00594568|9214315|P1|Initial Treatment|Caregiver decision|21
2668904|NCT00594568|9214313|P3|Initial Treatment|Sponsor decision|147
2668905|NCT00594568|9214314|P2|Initial Treatment|Sponsor decision|142
2668906|NCT00594568|9214315|P1|Initial Treatment|Sponsor decision|193
2668907|NCT00594568|9214313|P3|Initial Treatment|Withdrawal by Subject|46
2668908|NCT00594568|9214314|P2|Initial Treatment|Withdrawal by Subject|31
2668909|NCT00594568|9214315|P1|Initial Treatment|Withdrawal by Subject|25
2668910|NCT00594568|9214313|P3|Initial Treatment|Protocol Violation|5
2668911|NCT00594568|9214314|P2|Initial Treatment|Protocol Violation|2
2668912|NCT00594568|9214315|P1|Initial Treatment|Protocol Violation|2
2668913|NCT00594568|9214313|P3|Initial Treatment|Physician Decision|4
2668914|NCT00594568|9214314|P2|Initial Treatment|Physician Decision|2
2668915|NCT00594568|9214315|P1|Initial Treatment|Physician Decision|3
2668916|NCT00594568|9214313|P3|Initial Treatment|Lost to Follow-up|4
2668917|NCT00594568|9214314|P2|Initial Treatment|Lost to Follow-up|1
2668918|NCT00594568|9214315|P1|Initial Treatment|Lost to Follow-up|4
2668919|NCT00594568|9214313|P3|Initial Treatment|Death|15
2668920|NCT00594568|9214314|P2|Initial Treatment|Death|11
2668921|NCT00594568|9214315|P1|Initial Treatment|Death|6
2668922|NCT00594568|9214313|P3|Initial Treatment|Adverse Event|144
2668923|NCT00594568|9214314|P2|Initial Treatment|Adverse Event|121
2668924|NCT00594568|9214315|P1|Initial Treatment|Adverse Event|51
2668925|NCT00594516|9214403|P3|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2
2669005|NCT00594204|9214600|P1|Overall Study|Lost to Follow-up|9
2668926|NCT00594516|9214404|P2|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
2668927|NCT00594516|9214405|P1|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
2668928|NCT00594516|9214403|P3|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
2668929|NCT00594516|9214404|P2|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
2668930|NCT00594516|9214405|P1|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0
2668931|NCT00594516|9214403|P3|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2
2668932|NCT00594516|9214404|P2|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3
2668933|NCT00594516|9214405|P1|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0
2668934|NCT00594516|9214403|P3|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
2668935|NCT00594516|9214404|P2|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
2668936|NCT00594516|9214405|P1|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0
2668937|NCT00594516|9214403|P3|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
2668938|NCT00594516|9214404|P2|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
2668939|NCT00594516|9214405|P1|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6
2668940|NCT00594516|9214403|P3|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
2668941|NCT00594516|9214404|P2|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
2668942|NCT00594516|9214405|P1|Open Label (OL): Tapentadol IR|Lack of Efficacy|1
2668943|NCT00594516|9214403|P3|Open Label (OL): Tapentadol IR|Adverse Event|0
2668944|NCT00594516|9214404|P2|Open Label (OL): Tapentadol IR|Adverse Event|0
2668945|NCT00594516|9214405|P1|Open Label (OL): Tapentadol IR|Adverse Event|16
2668946|NCT00594516|9214403|P3|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
2668947|NCT00594516|9214404|P2|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
2668948|NCT00594516|9214405|P1|Open Label (OL): Tapentadol IR|Lost to Follow-up|2
2668949|NCT00594516|9214403|P3|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
2668950|NCT00594516|9214404|P2|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
2668951|NCT00594516|9214405|P1|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4
2668952|NCT00594464|9214413|P1|Overall Study|Delay in operation|2
2668953|NCT00594464|9214413|P1|Overall Study|Withdrawal by Subject|1
2668954|NCT00594399|9214542|P3|Rerandomization Arm 1 Only|Withdrawal by Subject|0
2668955|NCT00594399|9214543|P2|Rerandomization Arm 1 Only|Withdrawal by Subject|3
2668956|NCT00594399|9214544|P1|Rerandomization Arm 1 Only|Withdrawal by Subject|0
2668957|NCT00594399|9214542|P3|Rerandomization Arm 1 Only|Death|0
2668958|NCT00594399|9214543|P2|Rerandomization Arm 1 Only|Death|1
2668959|NCT00594399|9214544|P1|Rerandomization Arm 1 Only|Death|2
2668960|NCT00594399|9214542|P3|Initial 3 Month Counseling|Family illness|0
2668961|NCT00594399|9214543|P2|Initial 3 Month Counseling|Family illness|0
2668962|NCT00594399|9214544|P1|Initial 3 Month Counseling|Family illness|1
2668963|NCT00594399|9214542|P3|Initial 3 Month Counseling|Moved|0
2668964|NCT00594399|9214543|P2|Initial 3 Month Counseling|Moved|0
2668965|NCT00594399|9214544|P1|Initial 3 Month Counseling|Moved|1
2668966|NCT00594399|9214542|P3|Initial 3 Month Counseling|Pain|0
2668967|NCT00594399|9214543|P2|Initial 3 Month Counseling|Pain|0
2668968|NCT00594399|9214544|P1|Initial 3 Month Counseling|Pain|2
2668969|NCT00594399|9214542|P3|Initial 3 Month Counseling|Too busy|0
2668970|NCT00594399|9214543|P2|Initial 3 Month Counseling|Too busy|1
2668971|NCT00594399|9214544|P1|Initial 3 Month Counseling|Too busy|7
2668972|NCT00594399|9214542|P3|Initial 3 Month Counseling|Personal issues|0
2668973|NCT00594399|9214543|P2|Initial 3 Month Counseling|Personal issues|0
2668974|NCT00594399|9214544|P1|Initial 3 Month Counseling|Personal issues|2
2668975|NCT00594399|9214542|P3|Initial 3 Month Counseling|Lack of Interest|0
2668976|NCT00594399|9214543|P2|Initial 3 Month Counseling|Lack of Interest|3
2668977|NCT00594399|9214544|P1|Initial 3 Month Counseling|Lack of Interest|3
2668978|NCT00594399|9214542|P3|Initial 3 Month Counseling|Not ready to exercise|0
2668979|NCT00594399|9214543|P2|Initial 3 Month Counseling|Not ready to exercise|0
2668980|NCT00594399|9214544|P1|Initial 3 Month Counseling|Not ready to exercise|1
2668981|NCT00594386|9214566|P1|Overall Study|Other: Loss of drivers license|1
2668982|NCT00594386|9214566|P1|Overall Study|Other: Patient wants prescription Neupro|1
2668983|NCT00594386|9214566|P1|Overall Study|Other: Site terminated participation|1
2668984|NCT00594386|9214566|P1|Overall Study|Other: Sponsor closure of study|1
2668985|NCT00594386|9214566|P1|Overall Study|Other: Study terminated per investigator|2
2668986|NCT00594386|9214566|P1|Overall Study|Other: Subject admitted to nursing home|1
2668987|NCT00594386|9214566|P1|Overall Study|Other: Subject moved to Seattle|1
2668988|NCT00594386|9214566|P1|Overall Study|Other: Patient went off patch (hospital)|1
2668989|NCT00594386|9214566|P1|Overall Study|Lost to Follow-up|6
2668990|NCT00594386|9214566|P1|Overall Study|Study ended per sponsor|115
2668991|NCT00594386|9214566|P1|Overall Study|Subject withdrew consent|35
2668992|NCT00594386|9214566|P1|Overall Study|Unsatisfactory compliance of subject|11
2668993|NCT00594386|9214566|P1|Overall Study|Adverse Event|68
2668994|NCT00594386|9214566|P1|Overall Study|Lack of Efficacy|12
2668995|NCT00594386|9214566|P1|Overall Study|Major protocol violation|2
2668996|NCT00594204|9214599|P2|Overall Study|Randomized but not treated|1
2668997|NCT00594204|9214600|P1|Overall Study|Randomized but not treated|4
2668998|NCT00594204|9214599|P2|Overall Study|Lack of Efficacy|4
2668999|NCT00594204|9214600|P1|Overall Study|Lack of Efficacy|3
2669000|NCT00594204|9214599|P2|Overall Study|Other|3
2669001|NCT00594204|9214600|P1|Overall Study|Other|4
2669002|NCT00594204|9214599|P2|Overall Study|Withdrawal by Subject|29
2669003|NCT00594204|9214600|P1|Overall Study|Withdrawal by Subject|23
2669004|NCT00594204|9214599|P2|Overall Study|Lost to Follow-up|5
2669006|NCT00594204|9214599|P2|Overall Study|Adverse Event|3
2669007|NCT00594204|9214600|P1|Overall Study|Adverse Event|15
2669008|NCT00594178|9214610|P1|Overall Study|Physician Decision|5
2669009|NCT00594165|9214615|P1|Overall Study|Other: Site terminated participation|2
2669010|NCT00594165|9214615|P1|Overall Study|Other: Subject enrolled in other trial|1
2669011|NCT00594165|9214615|P1|Overall Study|Other: House bound; can't get to clinic|1
2669012|NCT00594165|9214615|P1|Overall Study|Other: Brain surgery controlled symptoms|1
2669013|NCT00594165|9214615|P1|Overall Study|Other: Subject moving|3
2669014|NCT00594165|9214615|P1|Overall Study|Other: PI discretion|5
2669015|NCT00594165|9214615|P1|Overall Study|Lost to Follow-up|4
2669016|NCT00594165|9214615|P1|Overall Study|Study ended per sponsor|102
2669017|NCT00594165|9214615|P1|Overall Study|Subject withdrew consent|27
2669018|NCT00594165|9214615|P1|Overall Study|Unsatisfactory compliance of subject|6
2669019|NCT00594165|9214615|P1|Overall Study|Adverse Event|52
2669020|NCT00594165|9214615|P1|Overall Study|Lack of Efficacy|12
2669021|NCT00594165|9214615|P1|Overall Study|Major protocol violation|1
2669022|NCT00594100|9214621|P1|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4
2669023|NCT00594100|9214621|P1|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6
2669024|NCT00594100|9214621|P1|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2
2669025|NCT00594100|9214621|P1|Procedure|Technical Failure|9
2669026|NCT00594035|9214637|P2|Overall Study|Subject couldn't return due to job|1
2669027|NCT00594035|9214638|P1|Overall Study|Subject couldn't return due to job|0
2669028|NCT00594035|9214637|P2|Overall Study|Subject transferred to nursing home|1
2669029|NCT00594035|9214638|P1|Overall Study|Subject transferred to nursing home|0
2669030|NCT00594035|9214637|P2|Overall Study|Withdrawal by Subject|0
2669031|NCT00594035|9214638|P1|Overall Study|Withdrawal by Subject|1
2669032|NCT00594035|9214637|P2|Overall Study|Lost to Follow-up|1
2669033|NCT00594035|9214638|P1|Overall Study|Lost to Follow-up|1
2669034|NCT00593957|9214668|P3|Overall Study|Physician Decision|2
2669035|NCT00593957|9214669|P2|Overall Study|Physician Decision|1
2669036|NCT00593957|9214670|P1|Overall Study|Physician Decision|0
2669037|NCT00593918|9214694|P2|Overall Study|Withdrawal by Subject|24
2669038|NCT00593918|9214695|P1|Overall Study|Withdrawal by Subject|5
2669039|NCT00593840|9214708|P1|Overall Study|Withdrawal by Subject|1
2669040|NCT00593827|9214720|P2|Overall Study|On Active Treatment/Pending|2
2669041|NCT00593827|9214721|P1|Overall Study|On Active Treatment/Pending|0
2669042|NCT00593814|9214745|P2|Overall Study|Physician Decision|0
2669043|NCT00593814|9214746|P1|Overall Study|Physician Decision|3
2669044|NCT00593814|9214745|P2|Overall Study|Lost to Follow-up|0
2669045|NCT00593814|9214746|P1|Overall Study|Lost to Follow-up|7
2669046|NCT00593814|9214745|P2|Overall Study|Withdrawal by Subject|0
2669047|NCT00593814|9214746|P1|Overall Study|Withdrawal by Subject|7
2669048|NCT00593814|9214745|P2|Overall Study|Death|0
2669049|NCT00593814|9214746|P1|Overall Study|Death|7
2669050|NCT00593736|9214758|P4|Treatment Period and Placebo Run-out|Various|0
2669051|NCT00593736|9214759|P3|Treatment Period and Placebo Run-out|Various|1
2669052|NCT00593736|9214760|P2|Treatment Period and Placebo Run-out|Various|1
2669053|NCT00593736|9214761|P1|Treatment Period and Placebo Run-out|Various|1
2669054|NCT00593736|9214758|P4|Treatment Period and Placebo Run-out|Withdrawal by Subject|3
2669055|NCT00593736|9214759|P3|Treatment Period and Placebo Run-out|Withdrawal by Subject|1
2669056|NCT00593736|9214760|P2|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
2669057|NCT00593736|9214761|P1|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
2669058|NCT00593736|9214758|P4|Treatment Period and Placebo Run-out|Protocol Violation|1
2669059|NCT00593736|9214759|P3|Treatment Period and Placebo Run-out|Protocol Violation|1
2669060|NCT00593736|9214760|P2|Treatment Period and Placebo Run-out|Protocol Violation|0
2669061|NCT00593736|9214761|P1|Treatment Period and Placebo Run-out|Protocol Violation|0
2669062|NCT00593736|9214758|P4|Treatment Period and Placebo Run-out|Lost to Follow-up|0
2669063|NCT00593736|9214759|P3|Treatment Period and Placebo Run-out|Lost to Follow-up|2
2669064|NCT00593736|9214760|P2|Treatment Period and Placebo Run-out|Lost to Follow-up|1
2669065|NCT00593736|9214761|P1|Treatment Period and Placebo Run-out|Lost to Follow-up|2
2669066|NCT00593736|9214758|P4|Screening Period and Placebo Run-in|Various|25
2669067|NCT00593736|9214759|P3|Screening Period and Placebo Run-in|Various|0
2669068|NCT00593736|9214760|P2|Screening Period and Placebo Run-in|Various|0
2669069|NCT00593736|9214761|P1|Screening Period and Placebo Run-in|Various|0
2669070|NCT00593736|9214758|P4|Screening Period and Placebo Run-in|Did Not Meet Criteria|322
2669071|NCT00593736|9214759|P3|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
2669072|NCT00593736|9214760|P2|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
2669073|NCT00593736|9214761|P1|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
2669074|NCT00593736|9214758|P4|Screening Period and Placebo Run-in|Study Termination|15
2669075|NCT00593736|9214759|P3|Screening Period and Placebo Run-in|Study Termination|0
2669076|NCT00593736|9214760|P2|Screening Period and Placebo Run-in|Study Termination|0
2669077|NCT00593736|9214761|P1|Screening Period and Placebo Run-in|Study Termination|0
2669078|NCT00593736|9214758|P4|Screening Period and Placebo Run-in|Withdrawal by Subject|43
2669079|NCT00593736|9214759|P3|Screening Period and Placebo Run-in|Withdrawal by Subject|0
2669080|NCT00593736|9214760|P2|Screening Period and Placebo Run-in|Withdrawal by Subject|0
2669081|NCT00593736|9214761|P1|Screening Period and Placebo Run-in|Withdrawal by Subject|0
2669082|NCT00593736|9214758|P4|Screening Period and Placebo Run-in|Lost to Follow-up|9
2669083|NCT00593736|9214759|P3|Screening Period and Placebo Run-in|Lost to Follow-up|0
2669084|NCT00593736|9214760|P2|Screening Period and Placebo Run-in|Lost to Follow-up|0
2669085|NCT00593736|9214761|P1|Screening Period and Placebo Run-in|Lost to Follow-up|0
2669086|NCT00593736|9214758|P4|Screening Period and Placebo Run-in|Adverse Event|3
2669087|NCT00593736|9214759|P3|Screening Period and Placebo Run-in|Adverse Event|0
2669088|NCT00593736|9214760|P2|Screening Period and Placebo Run-in|Adverse Event|0
2669089|NCT00593736|9214761|P1|Screening Period and Placebo Run-in|Adverse Event|0
2669090|NCT00593684|9215009|P2|Overall Study|Death|1
2669091|NCT00593684|9215010|P1|Overall Study|Death|2
2669092|NCT00593606|9215036|P1|Overall Study|Screen Failure|3
2669093|NCT00593606|9215036|P1|Overall Study|Run-In Failure|5
2669094|NCT00593606|9215036|P1|Overall Study|Lost to Follow-up|2
2669095|NCT00593606|9215036|P1|Overall Study|Protocol Violation|3
2669096|NCT00593606|9215036|P1|Overall Study|Withdrawal by Subject|1
2669097|NCT00593606|9215036|P1|Overall Study|Adverse Event|13
2669098|NCT00593554|9215134|P2|Overall Study|Disease Progression|2
2669099|NCT00593554|9215135|P1|Overall Study|Disease Progression|1
2669100|NCT00593554|9215134|P2|Overall Study|Withdrawal by Subject|0
2669101|NCT00593554|9215135|P1|Overall Study|Withdrawal by Subject|1
2669102|NCT00593554|9215134|P2|Overall Study|Physician Decision|1
2669103|NCT00593554|9215135|P1|Overall Study|Physician Decision|0
2669104|NCT00593554|9215134|P2|Overall Study|Death|2
2669105|NCT00593554|9215135|P1|Overall Study|Death|1
2669106|NCT00593385|9215230|P1|Overall Study|Withdrawal by Subject|9
2669107|NCT00593385|9215230|P1|Overall Study|Lost to Follow-up|17
2669108|NCT00593385|9215230|P1|Overall Study|Death|14
2669109|NCT00593333|9215291|P2|Overall Study|Lost to Follow-up|11
2669110|NCT00593333|9215292|P1|Overall Study|Lost to Follow-up|10
2669111|NCT00593112|9215315|P2|Overall Study|Withdrawal by Subject|0
2669112|NCT00593112|9215316|P1|Overall Study|Withdrawal by Subject|5
2669113|NCT00593112|9215315|P2|Overall Study|Unreadable Scan|0
2669114|NCT00593112|9215316|P1|Overall Study|Unreadable Scan|1
2669115|NCT00593112|9215315|P2|Overall Study|Abnormal Scan|0
2669116|NCT00593112|9215316|P1|Overall Study|Abnormal Scan|1
2669117|NCT00593112|9215315|P2|Overall Study|Scan Anxiety|0
2669118|NCT00593112|9215316|P1|Overall Study|Scan Anxiety|3
2669119|NCT00592904|9215343|P4|Overall Study|Other|0
2669120|NCT00592904|9215344|P3|Overall Study|Other|0
2669121|NCT00592904|9215345|P2|Overall Study|Other|3
2669122|NCT00592904|9215346|P1|Overall Study|Other|3
2669123|NCT00592904|9215343|P4|Overall Study|Physician Decision|0
2669124|NCT00592904|9215344|P3|Overall Study|Physician Decision|1
2669125|NCT00592904|9215345|P2|Overall Study|Physician Decision|3
2669126|NCT00592904|9215346|P1|Overall Study|Physician Decision|0
2669127|NCT00592904|9215343|P4|Overall Study|Lack of Efficacy|3
2669128|NCT00592904|9215344|P3|Overall Study|Lack of Efficacy|2
2669129|NCT00592904|9215345|P2|Overall Study|Lack of Efficacy|7
2669130|NCT00592904|9215346|P1|Overall Study|Lack of Efficacy|2
2669131|NCT00592904|9215343|P4|Overall Study|Withdrawal by Subject|2
2669132|NCT00592904|9215344|P3|Overall Study|Withdrawal by Subject|1
2669133|NCT00592904|9215345|P2|Overall Study|Withdrawal by Subject|16
2669134|NCT00592904|9215346|P1|Overall Study|Withdrawal by Subject|4
2669135|NCT00592904|9215343|P4|Overall Study|Protocol Violation|1
2669136|NCT00592904|9215344|P3|Overall Study|Protocol Violation|0
2669137|NCT00592904|9215345|P2|Overall Study|Protocol Violation|1
2669138|NCT00592904|9215346|P1|Overall Study|Protocol Violation|1
2669139|NCT00592904|9215343|P4|Overall Study|Adverse Event|5
2669140|NCT00592904|9215344|P3|Overall Study|Adverse Event|13
2669141|NCT00592904|9215345|P2|Overall Study|Adverse Event|25
2669142|NCT00592904|9215346|P1|Overall Study|Adverse Event|15
2669143|NCT00592852|9215372|P1|Overall Study|Withdrawal by Subject|1
2669144|NCT00592852|9215372|P1|Overall Study|Found ineligible|1
2669145|NCT00592852|9215372|P1|Overall Study|Adverse Event|3
2669146|NCT00592852|9215372|P1|Overall Study|Non-compliance|1
2669147|NCT00592839|9215380|P3|Overall Study|Lost to Follow-up|1
2669148|NCT00592839|9215381|P2|Overall Study|Lost to Follow-up|1
2669149|NCT00592839|9215382|P1|Overall Study|Lost to Follow-up|0
2669150|NCT00592839|9215380|P3|Overall Study|Adverse Event|0
2669151|NCT00592839|9215381|P2|Overall Study|Adverse Event|1
2669152|NCT00592839|9215382|P1|Overall Study|Adverse Event|0
2669153|NCT00592839|9215380|P3|Overall Study|Protocol Violation|2
2669154|NCT00592839|9215381|P2|Overall Study|Protocol Violation|1
2669155|NCT00592839|9215382|P1|Overall Study|Protocol Violation|1
2669156|NCT00592839|9215380|P3|Overall Study|Withdrawal by Subject|3
2669157|NCT00592839|9215381|P2|Overall Study|Withdrawal by Subject|1
2669158|NCT00592839|9215382|P1|Overall Study|Withdrawal by Subject|1
2669159|NCT00592774|9215410|P5|Overall Study|Other|2
2669160|NCT00592774|9215411|P4|Overall Study|Other|0
2669161|NCT00592774|9215412|P3|Overall Study|Other|1
2669162|NCT00592774|9215413|P2|Overall Study|Other|1
2669163|NCT00592774|9215414|P1|Overall Study|Other|0
2669164|NCT00592774|9215410|P5|Overall Study|Physician Decision|1
2669165|NCT00592774|9215411|P4|Overall Study|Physician Decision|0
2669166|NCT00592774|9215412|P3|Overall Study|Physician Decision|1
2669167|NCT00592774|9215413|P2|Overall Study|Physician Decision|1
2669168|NCT00592774|9215414|P1|Overall Study|Physician Decision|0
2669169|NCT00592774|9215410|P5|Overall Study|Lack of Efficacy|2
2669170|NCT00592774|9215411|P4|Overall Study|Lack of Efficacy|0
2669171|NCT00592774|9215412|P3|Overall Study|Lack of Efficacy|0
2669172|NCT00592774|9215413|P2|Overall Study|Lack of Efficacy|3
2669173|NCT00592774|9215414|P1|Overall Study|Lack of Efficacy|3
2669174|NCT00592774|9215410|P5|Overall Study|Withdrawal by Subject|0
2669175|NCT00592774|9215411|P4|Overall Study|Withdrawal by Subject|0
2669176|NCT00592774|9215412|P3|Overall Study|Withdrawal by Subject|0
2669177|NCT00592774|9215413|P2|Overall Study|Withdrawal by Subject|7
2669178|NCT00592774|9215414|P1|Overall Study|Withdrawal by Subject|3
2669179|NCT00592774|9215410|P5|Overall Study|Protocol Violation|1
2669180|NCT00592774|9215411|P4|Overall Study|Protocol Violation|0
2669181|NCT00592774|9215412|P3|Overall Study|Protocol Violation|0
2669182|NCT00592774|9215413|P2|Overall Study|Protocol Violation|1
2669183|NCT00592774|9215414|P1|Overall Study|Protocol Violation|0
2669184|NCT00592774|9215410|P5|Overall Study|Adverse Event|8
2669185|NCT00592774|9215411|P4|Overall Study|Adverse Event|14
2669186|NCT00592774|9215412|P3|Overall Study|Adverse Event|2
2669187|NCT00592774|9215413|P2|Overall Study|Adverse Event|19
2669188|NCT00592774|9215414|P1|Overall Study|Adverse Event|5
2669189|NCT00592683|9215486|P2|Overall Study|Lost to Follow-up|1
2669190|NCT00592683|9215487|P1|Overall Study|Lost to Follow-up|0
2669191|NCT00592683|9215486|P2|Overall Study|Other|0
2669192|NCT00592683|9215487|P1|Overall Study|Other|1
2669193|NCT00592683|9215486|P2|Overall Study|Study drug expired|0
2669194|NCT00592683|9215487|P1|Overall Study|Study drug expired|1
2669195|NCT00592683|9215486|P2|Overall Study|Protocol Violation|0
2669196|NCT00592683|9215487|P1|Overall Study|Protocol Violation|1
2669197|NCT00592683|9215486|P2|Overall Study|Adverse Event|2
2669198|NCT00592683|9215487|P1|Overall Study|Adverse Event|0
2669199|NCT00592683|9215486|P2|Overall Study|Withdrawal by Subject|0
2669200|NCT00592683|9215487|P1|Overall Study|Withdrawal by Subject|1
2669201|NCT00592683|9215486|P2|Overall Study|Found ineligible|1
2669202|NCT00592683|9215487|P1|Overall Study|Found ineligible|0
2669203|NCT00592631|9215497|P2|Overall Study|Lost to Follow-up|2
2669204|NCT00592631|9215498|P1|Overall Study|Lost to Follow-up|0
2669205|NCT00592553|9215507|P3|Overall Study|Protocol Noncompliance|0
2669206|NCT00592553|9215508|P2|Overall Study|Protocol Noncompliance|0
2669207|NCT00592553|9215509|P1|Overall Study|Protocol Noncompliance|1
2669208|NCT00592384|9215626|P2|Overall Study|Withdrawal by Subject|6
2669209|NCT00592384|9215627|P1|Overall Study|Withdrawal by Subject|5
2669210|NCT00592358|9215635|P1|Overall Study|Inability to swallow pills|1
2669211|NCT00592358|9215635|P1|Overall Study|Lack of Efficacy|2
2669212|NCT00592358|9215635|P1|Overall Study|Adverse Event|1
2669213|NCT00592358|9215635|P1|Overall Study|Withdrawal by Subject|2
2669214|NCT00592319|9215642|P2|Overall Study|Lost to Follow-up|3
2669215|NCT00592319|9215643|P1|Overall Study|Lost to Follow-up|0
2669216|NCT00592072|9215718|P2|Wash Out Period|Lost to Follow-up|1
2669217|NCT00592072|9215719|P1|Wash Out Period|Lost to Follow-up|1
2669218|NCT00592007|9215741|P1|Overall Study|patient ineligible (out of lab range)|1
2669219|NCT00592007|9215741|P1|Overall Study|Withdrawal by Subject|1
2669220|NCT00591864|9215753|P1|Overall Study|Incomplete Imaging|5
2669221|NCT00591851|9215759|P1|Overall Study|Progressive Disease|1
2669222|NCT00591851|9215759|P1|Overall Study|Adverse Event|2
2669223|NCT00591851|9215759|P1|Overall Study|Withdrawal by Subject|3
2669224|NCT00591838|9215768|P5|Overall Study|Withdrawal by Subject|0
2669225|NCT00591838|9215769|P4|Overall Study|Withdrawal by Subject|1
2669226|NCT00591838|9215770|P3|Overall Study|Withdrawal by Subject|0
2669227|NCT00591838|9215771|P2|Overall Study|Withdrawal by Subject|0
2669228|NCT00591838|9215772|P1|Overall Study|Withdrawal by Subject|0
2669229|NCT00591786|9215836|P10|Overall Study|Withdrawal of Informed Consent|0
2669230|NCT00591786|9215837|P9|Overall Study|Withdrawal of Informed Consent|0
2669231|NCT00591786|9215838|P8|Overall Study|Withdrawal of Informed Consent|0
2669232|NCT00591786|9215839|P7|Overall Study|Withdrawal of Informed Consent|0
2669233|NCT00591786|9215840|P6|Overall Study|Withdrawal of Informed Consent|0
2669234|NCT00591786|9215841|P5|Overall Study|Withdrawal of Informed Consent|0
2669235|NCT00591786|9215842|P4|Overall Study|Withdrawal of Informed Consent|0
2669236|NCT00591786|9215843|P3|Overall Study|Withdrawal of Informed Consent|1
2669237|NCT00591786|9215844|P2|Overall Study|Withdrawal of Informed Consent|0
2669238|NCT00591786|9215845|P1|Overall Study|Withdrawal of Informed Consent|0
2669239|NCT00591773|9215890|P3|Overall Study|Other|4
2669240|NCT00591773|9215891|P2|Overall Study|Other|1
2669241|NCT00591773|9215892|P1|Overall Study|Other|1
2669242|NCT00591773|9215890|P3|Overall Study|Lack of Efficacy|2
2669243|NCT00591773|9215891|P2|Overall Study|Lack of Efficacy|2
2669244|NCT00591773|9215892|P1|Overall Study|Lack of Efficacy|1
2669245|NCT00591773|9215890|P3|Overall Study|Withdrawal by Subject|3
2669246|NCT00591773|9215891|P2|Overall Study|Withdrawal by Subject|5
2669247|NCT00591773|9215892|P1|Overall Study|Withdrawal by Subject|2
2669248|NCT00591773|9215890|P3|Overall Study|Lost to Follow-up|1
2669249|NCT00591773|9215891|P2|Overall Study|Lost to Follow-up|4
2669250|NCT00591773|9215892|P1|Overall Study|Lost to Follow-up|1
2669251|NCT00591773|9215890|P3|Overall Study|Protocol Violation|0
2669252|NCT00591773|9215891|P2|Overall Study|Protocol Violation|3
2669253|NCT00591773|9215892|P1|Overall Study|Protocol Violation|2
2669254|NCT00591773|9215890|P3|Overall Study|Adverse Event|6
2669255|NCT00591773|9215891|P2|Overall Study|Adverse Event|9
2669256|NCT00591773|9215892|P1|Overall Study|Adverse Event|9
2669257|NCT00591734|9215951|P1|Overall Study|Intercurrent Illness|8
2669258|NCT00591734|9215951|P1|Overall Study|Physician Decision|5
2669259|NCT00591734|9215951|P1|Overall Study|Adverse Event|5
2669260|NCT00591734|9215951|P1|Overall Study|Lack of Efficacy|35
2669261|NCT00591721|9215957|P2|Overall Study|Intervention not received|8
2669262|NCT00591721|9215958|P1|Overall Study|Intervention not received|10
2669263|NCT00591721|9215957|P2|Overall Study|Lost to Follow-up|4
2669264|NCT00591721|9215958|P1|Overall Study|Lost to Follow-up|1
2669265|NCT00591721|9215957|P2|Overall Study|Withdrawal by Subject|10
2669266|NCT00591721|9215958|P1|Overall Study|Withdrawal by Subject|10
2669267|NCT00591591|9215966|P2|Overall Study|Lack of Efficacy|2
2669268|NCT00591591|9215967|P1|Overall Study|Lack of Efficacy|10
2669269|NCT00591591|9215966|P2|Overall Study|Withdrawal by Subject|37
2669270|NCT00591591|9215967|P1|Overall Study|Withdrawal by Subject|1
2669271|NCT00591578|9215984|P3|Open-Label Extension Phase|Other|0
2669272|NCT00591578|9215985|P2|Open-Label Extension Phase|Other|0
2669273|NCT00591578|9215986|P1|Open-Label Extension Phase|Other|1
2669274|NCT00591578|9215984|P3|Open-Label Extension Phase|Withdrawal by Subject|0
2669275|NCT00591578|9215985|P2|Open-Label Extension Phase|Withdrawal by Subject|1
2669276|NCT00591578|9215986|P1|Open-Label Extension Phase|Withdrawal by Subject|1
2669277|NCT00591578|9215984|P3|Open-Label Extension Phase|Lost to Follow-up|0
2669278|NCT00591578|9215985|P2|Open-Label Extension Phase|Lost to Follow-up|4
2669279|NCT00591578|9215986|P1|Open-Label Extension Phase|Lost to Follow-up|1
2669280|NCT00591578|9215984|P3|Open-Label Extension Phase|Adverse Event|0
2669281|NCT00591578|9215985|P2|Open-Label Extension Phase|Adverse Event|5
2669282|NCT00591578|9215986|P1|Open-Label Extension Phase|Adverse Event|3
2669283|NCT00591578|9215984|P3|Double-Blind Treatment Phase|Other|4
2669284|NCT00591578|9215985|P2|Double-Blind Treatment Phase|Other|9
2669285|NCT00591578|9215986|P1|Double-Blind Treatment Phase|Other|4
2669286|NCT00591578|9215984|P3|Double-Blind Treatment Phase|Lack of Efficacy|25
2669287|NCT00591578|9215985|P2|Double-Blind Treatment Phase|Lack of Efficacy|9
2669288|NCT00591578|9215986|P1|Double-Blind Treatment Phase|Lack of Efficacy|16
2669289|NCT00591578|9215984|P3|Double-Blind Treatment Phase|Pregnancy|0
2669290|NCT00591578|9215985|P2|Double-Blind Treatment Phase|Pregnancy|0
2669291|NCT00591578|9215986|P1|Double-Blind Treatment Phase|Pregnancy|1
2669292|NCT00591578|9215984|P3|Double-Blind Treatment Phase|Withdrawal by Subject|22
2669293|NCT00591578|9215985|P2|Double-Blind Treatment Phase|Withdrawal by Subject|22
2669294|NCT00591578|9215986|P1|Double-Blind Treatment Phase|Withdrawal by Subject|22
2669295|NCT00591578|9215984|P3|Double-Blind Treatment Phase|Lost to Follow-up|11
2669296|NCT00591578|9215985|P2|Double-Blind Treatment Phase|Lost to Follow-up|12
2669297|NCT00591578|9215986|P1|Double-Blind Treatment Phase|Lost to Follow-up|12
2669298|NCT00591578|9215984|P3|Double-Blind Treatment Phase|Protocol Violation|3
2669299|NCT00591578|9215985|P2|Double-Blind Treatment Phase|Protocol Violation|2
2669300|NCT00591578|9215986|P1|Double-Blind Treatment Phase|Protocol Violation|3
2669301|NCT00591578|9215984|P3|Double-Blind Treatment Phase|Adverse Event|19
2669302|NCT00591578|9215985|P2|Double-Blind Treatment Phase|Adverse Event|26
2669303|NCT00591578|9215986|P1|Double-Blind Treatment Phase|Adverse Event|20
2669304|NCT00591565|9216037|P1|Overall Study|lost follow up, withdrawn|5
2669305|NCT00591409|9216051|P10|Overall Study|Not Treated|1
2669306|NCT00591409|9216052|P9|Overall Study|Not Treated|0
2669307|NCT00591409|9216053|P8|Overall Study|Not Treated|0
2669308|NCT00591409|9216054|P7|Overall Study|Not Treated|0
2669309|NCT00591409|9216055|P6|Overall Study|Not Treated|0
2669310|NCT00591409|9216056|P5|Overall Study|Not Treated|1
2669311|NCT00591409|9216057|P4|Overall Study|Not Treated|0
2669312|NCT00591409|9216058|P3|Overall Study|Not Treated|0
2669313|NCT00591409|9216059|P2|Overall Study|Not Treated|0
2669314|NCT00591409|9216060|P1|Overall Study|Not Treated|0
2669315|NCT00591370|9216102|P1|Overall Study|Not Treated|2
2669316|NCT00591344|9216110|P2|Overall Study|Did not want to come off medication|1
2669317|NCT00591344|9216111|P1|Overall Study|Did not want to come off medication|0
2669318|NCT00591344|9216110|P2|Overall Study|Lost to Follow-up|1
2669319|NCT00591344|9216111|P1|Overall Study|Lost to Follow-up|0
2669320|NCT00591344|9216110|P2|Overall Study|Death|1
2669321|NCT00591344|9216111|P1|Overall Study|Death|0
2669322|NCT00591344|9216110|P2|Overall Study|Underwent DBS|2
2669323|NCT00591344|9216111|P1|Overall Study|Underwent DBS|2
2669324|NCT00591344|9216110|P2|Overall Study|Medical complications|3
2669325|NCT00591344|9216111|P1|Overall Study|Medical complications|1
2669326|NCT00591344|9216110|P2|Overall Study|Moved out of state|0
2669327|NCT00591344|9216111|P1|Overall Study|Moved out of state|1
2669328|NCT00591344|9216110|P2|Overall Study|Transportation issues|0
2669329|NCT00591344|9216111|P1|Overall Study|Transportation issues|1
2669330|NCT00591266|9216137|P3|Overall Study|Other|5
2669331|NCT00591266|9216138|P2|Overall Study|Other|4
2669332|NCT00591266|9216139|P1|Overall Study|Other|1
2669333|NCT00591266|9216137|P3|Overall Study|Lack of Efficacy|0
2669334|NCT00591266|9216138|P2|Overall Study|Lack of Efficacy|2
2669335|NCT00591266|9216139|P1|Overall Study|Lack of Efficacy|0
2669336|NCT00591266|9216137|P3|Overall Study|Withdrawal by Subject|5
2669337|NCT00591266|9216138|P2|Overall Study|Withdrawal by Subject|2
2669338|NCT00591266|9216139|P1|Overall Study|Withdrawal by Subject|6
2669339|NCT00591266|9216137|P3|Overall Study|Protocol Violation|1
2669340|NCT00591266|9216138|P2|Overall Study|Protocol Violation|0
2669341|NCT00591266|9216139|P1|Overall Study|Protocol Violation|0
2669342|NCT00591266|9216137|P3|Overall Study|Lost to Follow-up|0
2669343|NCT00591266|9216138|P2|Overall Study|Lost to Follow-up|1
2669344|NCT00591266|9216139|P1|Overall Study|Lost to Follow-up|0
2669345|NCT00591266|9216137|P3|Overall Study|Adverse Event|3
2669346|NCT00591266|9216138|P2|Overall Study|Adverse Event|2
2669347|NCT00591266|9216139|P1|Overall Study|Adverse Event|2
2669348|NCT00591253|9216192|P3|Overall Study|Other|3
2669349|NCT00591253|9216193|P2|Overall Study|Other|5
2669350|NCT00591253|9216194|P1|Overall Study|Other|5
2669351|NCT00591253|9216192|P3|Overall Study|Lack of Efficacy|3
2669352|NCT00591253|9216193|P2|Overall Study|Lack of Efficacy|0
2669353|NCT00591253|9216194|P1|Overall Study|Lack of Efficacy|1
2669354|NCT00591253|9216192|P3|Overall Study|Withdrawal by Subject|6
2669355|NCT00591253|9216193|P2|Overall Study|Withdrawal by Subject|7
2669356|NCT00591253|9216194|P1|Overall Study|Withdrawal by Subject|1
2669357|NCT00591253|9216192|P3|Overall Study|Lost to Follow-up|0
2669358|NCT00591253|9216193|P2|Overall Study|Lost to Follow-up|4
2669359|NCT00591253|9216194|P1|Overall Study|Lost to Follow-up|2
2669360|NCT00591253|9216192|P3|Overall Study|Protocol Violation|2
2669361|NCT00591253|9216193|P2|Overall Study|Protocol Violation|2
2669362|NCT00591253|9216194|P1|Overall Study|Protocol Violation|2
2669363|NCT00591253|9216192|P3|Overall Study|Adverse Event|1
2669364|NCT00591253|9216193|P2|Overall Study|Adverse Event|3
2669365|NCT00591253|9216194|P1|Overall Study|Adverse Event|3
2669366|NCT00591214|9216262|P1|Overall Study|Withdrawal by Subject|1
2669367|NCT00591214|9216262|P1|Overall Study|Physician Decision|7
2669368|NCT00591149|9216271|P1|Overall Study|Withdrawal by Subject|1
2669369|NCT00591149|9216271|P1|Overall Study|Adverse Event|4
2669370|NCT00591006|9216287|P24|Overall Study|Adverse Event|0
2669371|NCT00591006|9216288|P23|Overall Study|Adverse Event|1
2669372|NCT00591006|9216289|P22|Overall Study|Adverse Event|0
2669373|NCT00591006|9216290|P21|Overall Study|Adverse Event|0
2669374|NCT00591006|9216291|P20|Overall Study|Adverse Event|0
2669375|NCT00591006|9216292|P19|Overall Study|Adverse Event|0
2669376|NCT00591006|9216293|P18|Overall Study|Adverse Event|0
2669377|NCT00591006|9216294|P17|Overall Study|Adverse Event|0
2669378|NCT00591006|9216295|P16|Overall Study|Adverse Event|0
2669379|NCT00591006|9216296|P15|Overall Study|Adverse Event|0
2669380|NCT00591006|9216297|P14|Overall Study|Adverse Event|0
2669381|NCT00591006|9216298|P13|Overall Study|Adverse Event|0
2669382|NCT00591006|9216299|P12|Overall Study|Adverse Event|0
2669383|NCT00591006|9216300|P11|Overall Study|Adverse Event|0
2669384|NCT00591006|9216301|P10|Overall Study|Adverse Event|0
2669385|NCT00591006|9216302|P9|Overall Study|Adverse Event|0
2669386|NCT00591006|9216303|P8|Overall Study|Adverse Event|0
2669387|NCT00591006|9216304|P7|Overall Study|Adverse Event|0
2669388|NCT00591006|9216305|P6|Overall Study|Adverse Event|0
2669389|NCT00591006|9216306|P5|Overall Study|Adverse Event|0
2669390|NCT00591006|9216307|P4|Overall Study|Adverse Event|0
2669391|NCT00591006|9216308|P3|Overall Study|Adverse Event|0
2669392|NCT00591006|9216309|P2|Overall Study|Adverse Event|0
2669393|NCT00591006|9216310|P1|Overall Study|Adverse Event|0
2669394|NCT00591006|9216287|P24|Overall Study|Withdrawal by Subject|1
2669395|NCT00591006|9216288|P23|Overall Study|Withdrawal by Subject|0
2669396|NCT00591006|9216289|P22|Overall Study|Withdrawal by Subject|0
2669397|NCT00591006|9216290|P21|Overall Study|Withdrawal by Subject|0
2669398|NCT00591006|9216291|P20|Overall Study|Withdrawal by Subject|0
2669399|NCT00591006|9216292|P19|Overall Study|Withdrawal by Subject|0
2669400|NCT00591006|9216293|P18|Overall Study|Withdrawal by Subject|0
2669401|NCT00591006|9216294|P17|Overall Study|Withdrawal by Subject|0
2669402|NCT00591006|9216295|P16|Overall Study|Withdrawal by Subject|1
2669403|NCT00591006|9216296|P15|Overall Study|Withdrawal by Subject|0
2669404|NCT00591006|9216297|P14|Overall Study|Withdrawal by Subject|0
2669405|NCT00591006|9216298|P13|Overall Study|Withdrawal by Subject|0
2669406|NCT00591006|9216299|P12|Overall Study|Withdrawal by Subject|0
2669407|NCT00591006|9216300|P11|Overall Study|Withdrawal by Subject|0
2669408|NCT00591006|9216301|P10|Overall Study|Withdrawal by Subject|0
2669409|NCT00591006|9216302|P9|Overall Study|Withdrawal by Subject|0
2669410|NCT00591006|9216303|P8|Overall Study|Withdrawal by Subject|0
2669411|NCT00591006|9216304|P7|Overall Study|Withdrawal by Subject|0
2669412|NCT00591006|9216305|P6|Overall Study|Withdrawal by Subject|0
2669413|NCT00591006|9216306|P5|Overall Study|Withdrawal by Subject|0
2669414|NCT00591006|9216307|P4|Overall Study|Withdrawal by Subject|0
2669415|NCT00591006|9216308|P3|Overall Study|Withdrawal by Subject|0
2669416|NCT00591006|9216309|P2|Overall Study|Withdrawal by Subject|0
2669417|NCT00591006|9216310|P1|Overall Study|Withdrawal by Subject|0
2669418|NCT00590980|9216328|P1|Overall Study|Did not meet all inclusion criteria|10
2669419|NCT00590967|9216334|P2|Overall Study|Did not receive chemo per protocol|0
2669420|NCT00590967|9216335|P1|Overall Study|Did not receive chemo per protocol|1
2669421|NCT00590967|9216334|P2|Overall Study|Did not sign consent form|1
2669422|NCT00590967|9216335|P1|Overall Study|Did not sign consent form|0
2669423|NCT00590967|9216334|P2|Overall Study|Non-compliant|2
2669424|NCT00590967|9216335|P1|Overall Study|Non-compliant|0
2669425|NCT00590967|9216334|P2|Overall Study|Poor performance status|1
2669426|NCT00590967|9216335|P1|Overall Study|Poor performance status|0
2669427|NCT00590967|9216334|P2|Overall Study|Ineligible|0
2669428|NCT00590967|9216335|P1|Overall Study|Ineligible|1
2669429|NCT00590967|9216334|P2|Overall Study|Withdrawal by Subject|1
2669430|NCT00590967|9216335|P1|Overall Study|Withdrawal by Subject|1
2669431|NCT00590902|9216347|P1|Overall Study|Death|1
2669432|NCT00590824|9216380|P4|Overall Study|Adverse Event|1
2669433|NCT00590824|9216381|P3|Overall Study|Adverse Event|0
2669434|NCT00590824|9216382|P2|Overall Study|Adverse Event|0
2669435|NCT00590824|9216383|P1|Overall Study|Adverse Event|0
2669436|NCT00590824|9216380|P4|Overall Study|Disease could not be resected|0
2669437|NCT00590824|9216381|P3|Overall Study|Disease could not be resected|1
2669438|NCT00590824|9216382|P2|Overall Study|Disease could not be resected|2
2669439|NCT00590824|9216383|P1|Overall Study|Disease could not be resected|0
2669440|NCT00590759|9216409|P1|Overall Study|Lost to Follow-up|28
2669441|NCT00590759|9216409|P1|Overall Study|Death|52
2669442|NCT00590720|9216416|P2|Overall Study|Withdrawal by Subject|1
2669443|NCT00590720|9216417|P1|Overall Study|Withdrawal by Subject|0
2669444|NCT00590720|9216416|P2|Overall Study|Lost to Follow-up|0
2669445|NCT00590720|9216417|P1|Overall Study|Lost to Follow-up|1
2669446|NCT00590590|9216479|P3|Overall Study|Did not complete study|0
2669447|NCT00590590|9216480|P2|Overall Study|Did not complete study|1
2669448|NCT00590590|9216481|P1|Overall Study|Did not complete study|0
2669449|NCT00590590|9216479|P3|Overall Study|Did not complete due to study closure|1
2669450|NCT00590590|9216480|P2|Overall Study|Did not complete due to study closure|1
2669451|NCT00590590|9216481|P1|Overall Study|Did not complete due to study closure|1
2669452|NCT00590590|9216479|P3|Overall Study|Withdrawal by Subject|1
2669453|NCT00590590|9216480|P2|Overall Study|Withdrawal by Subject|1
2669454|NCT00590590|9216481|P1|Overall Study|Withdrawal by Subject|0
2669455|NCT00590590|9216479|P3|Overall Study|Lost to Follow-up|2
2669456|NCT00590590|9216480|P2|Overall Study|Lost to Follow-up|1
2669457|NCT00590590|9216481|P1|Overall Study|Lost to Follow-up|4
2669458|NCT00590590|9216479|P3|Overall Study|Protocol Violation|2
2669459|NCT00590590|9216480|P2|Overall Study|Protocol Violation|0
2669460|NCT00590590|9216481|P1|Overall Study|Protocol Violation|0
2669461|NCT00590590|9216479|P3|Overall Study|Adverse Event|0
2669462|NCT00590590|9216480|P2|Overall Study|Adverse Event|0
2669463|NCT00590590|9216481|P1|Overall Study|Adverse Event|1
2669464|NCT00590590|9216479|P3|Overall Study|Lack of Efficacy|0
2669465|NCT00590590|9216480|P2|Overall Study|Lack of Efficacy|2
2669466|NCT00590590|9216481|P1|Overall Study|Lack of Efficacy|1
2669467|NCT00590577|9216508|P4|Overall Study|Various reasons|2
2669468|NCT00590577|9216509|P3|Overall Study|Various reasons|1
2669469|NCT00590577|9216510|P2|Overall Study|Various reasons|3
2669470|NCT00590577|9216511|P1|Overall Study|Various reasons|1
2669471|NCT00590577|9216508|P4|Overall Study|Pregnancy|0
2669472|NCT00590577|9216509|P3|Overall Study|Pregnancy|0
2669473|NCT00590577|9216510|P2|Overall Study|Pregnancy|1
2669474|NCT00590577|9216511|P1|Overall Study|Pregnancy|0
2669475|NCT00590577|9216508|P4|Overall Study|Lost to Follow-up|9
2669476|NCT00590577|9216509|P3|Overall Study|Lost to Follow-up|6
2669477|NCT00590577|9216510|P2|Overall Study|Lost to Follow-up|6
2669478|NCT00590577|9216511|P1|Overall Study|Lost to Follow-up|12
2669479|NCT00590577|9216508|P4|Overall Study|Adverse Event|11
2669480|NCT00590577|9216509|P3|Overall Study|Adverse Event|13
2669481|NCT00590577|9216510|P2|Overall Study|Adverse Event|10
2669482|NCT00590577|9216511|P1|Overall Study|Adverse Event|10
2669483|NCT00590577|9216508|P4|Overall Study|Withdrawal by Subject|26
2669484|NCT00590577|9216509|P3|Overall Study|Withdrawal by Subject|30
2669485|NCT00590577|9216510|P2|Overall Study|Withdrawal by Subject|28
2669486|NCT00590577|9216511|P1|Overall Study|Withdrawal by Subject|23
2669487|NCT00590577|9216508|P4|Overall Study|Lack of Efficacy|45
2669488|NCT00590577|9216509|P3|Overall Study|Lack of Efficacy|23
2669489|NCT00590577|9216510|P2|Overall Study|Lack of Efficacy|28
2669490|NCT00590577|9216511|P1|Overall Study|Lack of Efficacy|31
2669491|NCT00590564|9216529|P1|Overall Study|Patient Non-compliance|6
2669492|NCT00590564|9216529|P1|Overall Study|Patient Found to be Ineligible|1
2669493|NCT00590564|9216529|P1|Overall Study|Protocol Violation|1
2669494|NCT00590564|9216529|P1|Overall Study|Lost to Follow-up|6
2669495|NCT00590564|9216529|P1|Overall Study|Withdrawal by Subject|4
2669496|NCT00590538|9216533|P1|Overall Study|Study terminated before completed|2
2669497|NCT00590317|9216579|P2|Overall Study|Lack of Efficacy|5
2669498|NCT00590317|9216580|P1|Overall Study|Lack of Efficacy|1
2669499|NCT00590135|9216610|P1|Overall Study|Primary endpoint measure not obtainable|59
2669500|NCT00590044|9216620|P2|Overall Study|Protocol Violation|0
2669501|NCT00590044|9216621|P1|Overall Study|Protocol Violation|1
2669502|NCT00590044|9216620|P2|Overall Study|wrong insulin arm assigned|0
2669503|NCT00590044|9216621|P1|Overall Study|wrong insulin arm assigned|1
2669504|NCT00590044|9216620|P2|Overall Study|Withdrawal by Subject|2
2669505|NCT00590044|9216621|P1|Overall Study|Withdrawal by Subject|2
2669506|NCT00590031|9216633|P1|Overall Study|Admin Hold|1
2669507|NCT00590031|9216633|P1|Overall Study|Metastatic Disease|1
2669508|NCT00590031|9216633|P1|Overall Study|Withdrawal by Subject|1
2669509|NCT00590031|9216633|P1|Overall Study|Adverse Event|3
2669510|NCT00589979|9216660|P3|Double-Blind Treatment Period 3|Withdrawal by Subject|1
2669511|NCT00589979|9216661|P2|Double-Blind Treatment Period 3|Withdrawal by Subject|0
2669512|NCT00589979|9216662|P1|Double-Blind Treatment Period 3|Withdrawal by Subject|0
2669513|NCT00589979|9216660|P3|Double-Blind Treatment Period 3|Protocol Violation|0
2669514|NCT00589979|9216661|P2|Double-Blind Treatment Period 3|Protocol Violation|1
2669515|NCT00589979|9216662|P1|Double-Blind Treatment Period 3|Protocol Violation|0
2669516|NCT00589979|9216660|P3|Double-Blind Treatment Period 2|Other|1
2669517|NCT00589979|9216661|P2|Double-Blind Treatment Period 2|Other|0
2669518|NCT00589979|9216662|P1|Double-Blind Treatment Period 2|Other|0
2669519|NCT00589979|9216660|P3|Double-Blind Treatment Period 2|Withdrawal by Subject|1
2669520|NCT00589979|9216661|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|0
2669521|NCT00589979|9216662|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
2669522|NCT00589979|9216660|P3|Double-Blind Treatment Period 2|Adverse Event|0
2669523|NCT00589979|9216661|P2|Double-Blind Treatment Period 2|Adverse Event|1
2669524|NCT00589979|9216662|P1|Double-Blind Treatment Period 2|Adverse Event|0
2669525|NCT00589979|9216660|P3|Double-Blind Treatment Period 1|Withdrawal by Subject|1
2669526|NCT00589979|9216661|P2|Double-Blind Treatment Period 1|Withdrawal by Subject|0
2669527|NCT00589979|9216662|P1|Double-Blind Treatment Period 1|Withdrawal by Subject|0
2669528|NCT00589979|9216660|P3|Double-Blind Treatment Period 1|Protocol Violation|1
2669529|NCT00589979|9216661|P2|Double-Blind Treatment Period 1|Protocol Violation|1
2669530|NCT00589979|9216662|P1|Double-Blind Treatment Period 1|Protocol Violation|0
2669531|NCT00589979|9216660|P3|Double-Blind Treatment Period 1|Adverse Event|0
2669532|NCT00589979|9216661|P2|Double-Blind Treatment Period 1|Adverse Event|1
2669533|NCT00589979|9216662|P1|Double-Blind Treatment Period 1|Adverse Event|0
2669534|NCT00589979|9216660|P3|Run-In Period|Informed Consent Withdrawn|0
2669535|NCT00589979|9216661|P2|Run-In Period|Informed Consent Withdrawn|0
2669536|NCT00589979|9216662|P1|Run-In Period|Informed Consent Withdrawn|4
2669537|NCT00589979|9216660|P3|Run-In Period|Withdrawal by Subject|0
2669538|NCT00589979|9216661|P2|Run-In Period|Withdrawal by Subject|0
2669539|NCT00589979|9216662|P1|Run-In Period|Withdrawal by Subject|10
2669540|NCT00589979|9216660|P3|Run-In Period|Did not qualify for randomization|0
2669541|NCT00589979|9216661|P2|Run-In Period|Did not qualify for randomization|0
2669542|NCT00589979|9216662|P1|Run-In Period|Did not qualify for randomization|54
2669543|NCT00589979|9216660|P3|Run-In Period|Protocol Violation|0
2669544|NCT00589979|9216661|P2|Run-In Period|Protocol Violation|0
2669545|NCT00589979|9216662|P1|Run-In Period|Protocol Violation|3
2669546|NCT00589979|9216660|P3|Run-In Period|Adverse Event|0
2669547|NCT00589979|9216661|P2|Run-In Period|Adverse Event|0
2669548|NCT00589979|9216662|P1|Run-In Period|Adverse Event|5
2669549|NCT00589914|9216701|P2|Overall Study|Other|17
2669550|NCT00589914|9216702|P1|Overall Study|Other|22
2669551|NCT00589914|9216701|P2|Overall Study|Withdrawal by Subject|49
2669552|NCT00589914|9216702|P1|Overall Study|Withdrawal by Subject|55
2669553|NCT00589914|9216701|P2|Overall Study|Pregnancy|0
2669554|NCT00589914|9216702|P1|Overall Study|Pregnancy|1
2669555|NCT00589914|9216701|P2|Overall Study|Lost to Follow-up|18
2669556|NCT00589914|9216702|P1|Overall Study|Lost to Follow-up|11
2669557|NCT00589914|9216701|P2|Overall Study|Lack of Efficacy|43
2669558|NCT00589914|9216702|P1|Overall Study|Lack of Efficacy|40
2669559|NCT00589914|9216701|P2|Overall Study|Death|0
2669560|NCT00589914|9216702|P1|Overall Study|Death|2
2669561|NCT00589914|9216701|P2|Overall Study|Adverse Event|10
2669562|NCT00589914|9216702|P1|Overall Study|Adverse Event|19
2669563|NCT00589797|9216758|P2|Overall Study|Non-Randomized Training Subjects|6
2669564|NCT00589797|9216759|P1|Overall Study|Non-Randomized Training Subjects|46
2669565|NCT00589797|9216758|P2|Overall Study|Withdrawal by Subject|5
2669566|NCT00589797|9216759|P1|Overall Study|Withdrawal by Subject|6
2669567|NCT00589797|9216758|P2|Overall Study|Physician Decision|3
2669568|NCT00589797|9216759|P1|Overall Study|Physician Decision|8
2669569|NCT00589797|9216758|P2|Overall Study|Lost to Follow-up|9
2669570|NCT00589797|9216759|P1|Overall Study|Lost to Follow-up|12
2669571|NCT00589797|9216758|P2|Overall Study|Death|0
2669572|NCT00589797|9216759|P1|Overall Study|Death|1
2669573|NCT00589784|9216783|P2|Overall Study|Adverse Event|4
2669574|NCT00589784|9216784|P1|Overall Study|Adverse Event|0
2669575|NCT00589784|9216783|P2|Overall Study|Patient inevaluable|0
2669576|NCT00589784|9216784|P1|Overall Study|Patient inevaluable|1
2669577|NCT00589784|9216783|P2|Overall Study|Withdrawal by Subject|6
2669578|NCT00589784|9216784|P1|Overall Study|Withdrawal by Subject|0
2669579|NCT00589693|9216791|P2|Overall Study|Protocol Violation|1
2669580|NCT00589693|9216792|P1|Overall Study|Protocol Violation|1
2669581|NCT00589693|9216791|P2|Overall Study|Physician Decision|1
2669582|NCT00589693|9216792|P1|Overall Study|Physician Decision|0
2669583|NCT00589693|9216791|P2|Overall Study|Lost to Follow-up|0
2669584|NCT00589693|9216792|P1|Overall Study|Lost to Follow-up|1
2669585|NCT00589693|9216791|P2|Overall Study|Lack of Efficacy|1
2669586|NCT00589693|9216792|P1|Overall Study|Lack of Efficacy|0
2669587|NCT00589693|9216791|P2|Overall Study|Death|16
2669588|NCT00589693|9216792|P1|Overall Study|Death|26
2669589|NCT00589693|9216791|P2|Overall Study|Adverse Event|4
2669590|NCT00589693|9216792|P1|Overall Study|Adverse Event|4
2669591|NCT00589693|9216791|P2|Overall Study|randomized in error|6
2669592|NCT00589693|9216792|P1|Overall Study|randomized in error|12
2669593|NCT00589667|9216806|P1|Overall Study|Withdrawal by Subject|1
2669594|NCT00589667|9216806|P1|Overall Study|Adverse Event|2
2669595|NCT00589628|9216813|P2|Overall Study|Lost to Follow-up|1
2669596|NCT00589628|9216814|P1|Overall Study|Lost to Follow-up|0
2669597|NCT00589602|9216820|P1|Overall Study|Did not collect enough CD34+ cells|1
2669598|NCT00589472|9216855|P1|Overall Study|Adverse Event|1
2669599|NCT00589303|9216878|P2|Overall Study|Withdrawal by Subject|1
2669600|NCT00589303|9216879|P1|Overall Study|Withdrawal by Subject|2
2669601|NCT00589290|9216885|P1|Overall Study|Withdrawal by Subject|1
2669602|NCT00589121|9216908|P2|Overall Study|No protocol treatment received|1
2669603|NCT00589121|9216909|P1|Overall Study|No protocol treatment received|0
2669604|NCT00589121|9216908|P2|Overall Study|Protocol Violation|6
2669605|NCT00589121|9216909|P1|Overall Study|Protocol Violation|2
2669606|NCT00589108|9216931|P3|Overall Study|Death|4
2669607|NCT00589108|9216932|P2|Overall Study|Death|3
2669608|NCT00589108|9216933|P1|Overall Study|Death|3
2669609|NCT00589108|9216931|P3|Overall Study|Lost to Follow-up|1
2669610|NCT00589108|9216932|P2|Overall Study|Lost to Follow-up|1
2669611|NCT00589108|9216933|P1|Overall Study|Lost to Follow-up|1
2669612|NCT00588952|9216969|P2|Overall Study|Withdrawal by Subject|5
2669613|NCT00588952|9216970|P1|Overall Study|Withdrawal by Subject|3
2669614|NCT00588952|9216969|P2|Overall Study|Adverse Event|2
2669615|NCT00588952|9216970|P1|Overall Study|Adverse Event|0
2669616|NCT00588861|9216998|P2|10 Years|Incomplete due to study termination|114
2669617|NCT00588861|9216999|P1|10 Years|Incomplete due to study termination|107
2669618|NCT00588861|9216998|P2|8 Years|Patients did not return for follow-up|114
2669619|NCT00588861|9216999|P1|8 Years|Patients did not return for follow-up|105
2669620|NCT00588861|9216998|P2|6 Years|Patients did not return for follow-up|109
2669621|NCT00588861|9216999|P1|6 Years|Patients did not return for follow-up|104
2669622|NCT00588861|9216998|P2|4 Years|Patients did not return for follow-up|103
2669623|NCT00588861|9216999|P1|4 Years|Patients did not return for follow-up|91
2669624|NCT00588861|9216998|P2|2 Years|Patients did not return for follow-up|87
2669625|NCT00588861|9216999|P1|2 Years|Patients did not return for follow-up|92
2669626|NCT00588861|9216998|P2|1 Year|Patients did not return for follow-up|82
2669627|NCT00588861|9216999|P1|1 Year|Patients did not return for follow-up|89
2669628|NCT00588861|9216998|P2|6 Months|Patients did not return for follow-up|73
2669629|NCT00588861|9216999|P1|6 Months|Patients did not return for follow-up|98
2669630|NCT00588861|9216998|P2|Pre-Operative|Patients Did Not Complete Preop Data|86
2669631|NCT00588861|9216999|P1|Pre-Operative|Patients Did Not Complete Preop Data|95
2669632|NCT00588848|9217009|P2|Overall Study|Physician Decision|3
2669633|NCT00588848|9217010|P1|Overall Study|Physician Decision|0
2669634|NCT00588822|9217020|P1|Overall Study|progression of disease|8
2669635|NCT00588770|9217040|P2|Overall Study|Patient non-compliance|2
2669636|NCT00588770|9217041|P1|Overall Study|Patient non-compliance|2
2669637|NCT00588770|9217040|P2|Overall Study|Physician discretion|0
2669638|NCT00588770|9217041|P1|Overall Study|Physician discretion|2
2669639|NCT00588770|9217040|P2|Overall Study|Lack of Efficacy|10
2669640|NCT00588770|9217041|P1|Overall Study|Lack of Efficacy|8
2669641|NCT00588770|9217040|P2|Overall Study|Not start protocol therapy|9
2669642|NCT00588770|9217041|P1|Overall Study|Not start protocol therapy|0
2669643|NCT00588770|9217040|P2|Overall Study|Other complicating disease|2
2669644|NCT00588770|9217041|P1|Overall Study|Other complicating disease|3
2669645|NCT00588770|9217040|P2|Overall Study|Alternative therapy|4
2669646|NCT00588770|9217041|P1|Overall Study|Alternative therapy|2
2669647|NCT00588770|9217040|P2|Overall Study|Withdrawal by Subject|25
2669648|NCT00588770|9217041|P1|Overall Study|Withdrawal by Subject|15
2669649|NCT00588770|9217040|P2|Overall Study|Death|22
2669650|NCT00588770|9217041|P1|Overall Study|Death|13
2669651|NCT00588770|9217040|P2|Overall Study|Adverse Event|58
2669652|NCT00588770|9217041|P1|Overall Study|Adverse Event|29
2669653|NCT00588770|9217040|P2|Overall Study|Disease progression|68
2669654|NCT00588770|9217041|P1|Overall Study|Disease progression|85
2669655|NCT00588731|9217053|P2|Overall Study|Withdrawal by Subject|2
2669656|NCT00588731|9217054|P1|Overall Study|Withdrawal by Subject|3
2669657|NCT00588692|9217064|P2|Overall Study|Death|0
2669658|NCT00588692|9217065|P1|Overall Study|Death|1
2669659|NCT00588692|9217064|P2|Overall Study|Cancer|0
2669660|NCT00588692|9217065|P1|Overall Study|Cancer|1
2669661|NCT00588692|9217064|P2|Overall Study|Severe Peptic Ulcer Disease|0
2669662|NCT00588692|9217065|P1|Overall Study|Severe Peptic Ulcer Disease|1
2669663|NCT00588692|9217064|P2|Overall Study|Hip Surgery|1
2669664|NCT00588692|9217065|P1|Overall Study|Hip Surgery|0
2669665|NCT00588692|9217064|P2|Overall Study|Withdrawal by Subject|2
2669666|NCT00588692|9217065|P1|Overall Study|Withdrawal by Subject|4
2669667|NCT00588666|9217101|P1|Overall Study|Adverse Event|4
2669668|NCT00588640|9217106|P1|Overall Study|Ineligible Patient|1
2669669|NCT00588640|9217106|P1|Overall Study|Physician Decision|1
2669670|NCT00588445|9217125|P1|Overall Study|Not Treated|10
2669671|NCT00588445|9217125|P1|Overall Study|Disease Progression|1
2669672|NCT00588445|9217125|P1|Overall Study|Withdrawal by Subject|3
2669673|NCT00588445|9217125|P1|Overall Study|Protocol Violation|1
2669674|NCT00588354|9217149|P2|Baseline to 4 Weeks|Lost to Follow-up|1
2669675|NCT00588354|9217150|P1|Baseline to 4 Weeks|Lost to Follow-up|0
2669676|NCT00588354|9217149|P2|Baseline to 2 Weeks|Lack of Efficacy|0
2669677|NCT00588354|9217150|P1|Baseline to 2 Weeks|Lack of Efficacy|1
2669678|NCT00588354|9217149|P2|Baseline to 2 Weeks|Adverse Event|0
2669679|NCT00588354|9217150|P1|Baseline to 2 Weeks|Adverse Event|1
2669680|NCT00588341|9217170|P1|Overall Study|Patient ineligible|1
2669681|NCT00588341|9217170|P1|Overall Study|Not treated due to metastatic disease|1
2669682|NCT00588341|9217170|P1|Overall Study|Withdrawal by Subject|3
2669683|NCT00588237|9217174|P1|Overall Study|Patien not treated|1
2669684|NCT00588237|9217174|P1|Overall Study|Evaluable for toxicity only|3
2669685|NCT00588146|9217197|P2|First Intervention (Baseline to 6 mo)|Adverse Event|3
2669686|NCT00588146|9217198|P1|First Intervention (Baseline to 6 mo)|Adverse Event|4
2669687|NCT00588094|9217204|P1|Overall Study|Progression of Disease|2
2669688|NCT00588094|9217204|P1|Overall Study|Adverse Event|3
2669689|NCT00587990|9217211|P3|Overall Study|Death|1
2669690|NCT00587990|9217212|P2|Overall Study|Death|0
2669691|NCT00587990|9217213|P1|Overall Study|Death|0
2669692|NCT00587964|9217256|P1|Overall Study|Progression of Disease|4
2669693|NCT00587964|9217256|P1|Overall Study|Patient did not receive intervention|5
2669694|NCT00587964|9217256|P1|Overall Study|Patient found to be ineligible|1
2669695|NCT00587964|9217256|P1|Overall Study|Lost to Follow-up|1
2669696|NCT00587964|9217256|P1|Overall Study|Withdrawal by Subject|1
2669697|NCT00587860|9217262|P2|Overall Study|Withdrawal by Subject|3
2669698|NCT00587860|9217263|P1|Overall Study|Withdrawal by Subject|3
2669699|NCT00587860|9217262|P2|Overall Study|Lost to Follow-up|2
2669700|NCT00587860|9217263|P1|Overall Study|Lost to Follow-up|2
2669701|NCT00587847|9217283|P1|Overall Study|Adverse Event|2
2669702|NCT00587847|9217283|P1|Overall Study|Lack of Efficacy|5
2669703|NCT00587795|9217306|P2|Overall Study|Withdrawal by Subject|0
2669704|NCT00587795|9217307|P1|Overall Study|Withdrawal by Subject|1
2669705|NCT00587639|9217361|P1|Overall Study|Withdrawal by Subject|1
2669706|NCT00587587|9217368|P2|Overall Study|Lost to Follow-up|1
2669707|NCT00587587|9217369|P1|Overall Study|Lost to Follow-up|6
2669708|NCT00587457|9217423|P3|Overall Study|Development of neutralizing Abs|1
2669709|NCT00587457|9217424|P2|Overall Study|Development of neutralizing Abs|0
2669710|NCT00587457|9217425|P1|Overall Study|Development of neutralizing Abs|0
2669711|NCT00587457|9217423|P3|Overall Study|Undefined|1
2669712|NCT00587457|9217424|P2|Overall Study|Undefined|0
2669713|NCT00587457|9217425|P1|Overall Study|Undefined|0
2669714|NCT00587457|9217423|P3|Overall Study|Initiation of alternative therapy|0
2669715|NCT00587457|9217424|P2|Overall Study|Initiation of alternative therapy|1
2669716|NCT00587457|9217425|P1|Overall Study|Initiation of alternative therapy|0
2669717|NCT00587457|9217423|P3|Overall Study|Disease progression|2
2669718|NCT00587457|9217424|P2|Overall Study|Disease progression|0
2669719|NCT00587457|9217425|P1|Overall Study|Disease progression|2
2669720|NCT00587457|9217423|P3|Overall Study|Adverse Event|1
2669721|NCT00587457|9217424|P2|Overall Study|Adverse Event|2
2669722|NCT00587457|9217425|P1|Overall Study|Adverse Event|1
2669723|NCT00587431|9217462|P2|Overall Study|Withdrawal by Subject|1
2669724|NCT00587431|9217463|P1|Overall Study|Withdrawal by Subject|0
2669725|NCT00587431|9217462|P2|Overall Study|Adverse Event|0
2669726|NCT00587431|9217463|P1|Overall Study|Adverse Event|1
2669727|NCT00587288|9217474|P2|Overall Study|Protocol Violation|0
2669728|NCT00587288|9217475|P1|Overall Study|Protocol Violation|1
2669729|NCT00587288|9217474|P2|Overall Study|Lack of Efficacy|8
2669730|NCT00587288|9217475|P1|Overall Study|Lack of Efficacy|2
2669731|NCT00587288|9217474|P2|Overall Study|Adverse Event|1
2669732|NCT00587288|9217475|P1|Overall Study|Adverse Event|0
2669733|NCT00587223|9217493|P1|Overall Study|Adverse Event|1
2669734|NCT00587171|9217510|P2|Overall Study|Lost to Follow-up|1
2669735|NCT00587171|9217511|P1|Overall Study|Lost to Follow-up|1
2669736|NCT00587158|9217541|P2|Overall Study|Subject did not want to take study med|1
2669737|NCT00587158|9217542|P1|Overall Study|Subject did not want to take study med|0
2669738|NCT00587158|9217541|P2|Overall Study|Death|1
2669739|NCT00587158|9217542|P1|Overall Study|Death|0
2669740|NCT00587158|9217541|P2|Overall Study|Lost to Follow-up|2
2669741|NCT00587158|9217542|P1|Overall Study|Lost to Follow-up|1
2669742|NCT00587158|9217541|P2|Overall Study|Physician Decision|1
2669743|NCT00587158|9217542|P1|Overall Study|Physician Decision|0
2669744|NCT00587158|9217541|P2|Overall Study|Did not want to do 24 hr urine collect.|3
2669745|NCT00587158|9217542|P1|Overall Study|Did not want to do 24 hr urine collect.|4
2669746|NCT00587054|9217595|P1|Overall Study|Patient not treated|9
2669747|NCT00586924|9217621|P6|Overall Study|Other|6
2669748|NCT00586924|9217622|P5|Overall Study|Other|1
2669749|NCT00586924|9217623|P4|Overall Study|Other|1
2669750|NCT00586924|9217624|P3|Overall Study|Other|1
2669751|NCT00586924|9217625|P2|Overall Study|Other|0
2669752|NCT00586924|9217626|P1|Overall Study|Other|1
2669753|NCT00586924|9217621|P6|Overall Study|Complete response|2
2669754|NCT00586924|9217622|P5|Overall Study|Complete response|2
2669755|NCT00586924|9217623|P4|Overall Study|Complete response|0
2669756|NCT00586924|9217624|P3|Overall Study|Complete response|0
2669757|NCT00586924|9217625|P2|Overall Study|Complete response|1
2669758|NCT00586924|9217626|P1|Overall Study|Complete response|0
2669759|NCT00586924|9217621|P6|Overall Study|Development of neutralizing antibodies|22
2669760|NCT00586924|9217622|P5|Overall Study|Development of neutralizing antibodies|0
2669761|NCT00586924|9217623|P4|Overall Study|Development of neutralizing antibodies|0
2669762|NCT00586924|9217624|P3|Overall Study|Development of neutralizing antibodies|2
2669763|NCT00586924|9217625|P2|Overall Study|Development of neutralizing antibodies|2
2669764|NCT00586924|9217626|P1|Overall Study|Development of neutralizing antibodies|2
2669765|NCT00586924|9217621|P6|Overall Study|Disease progression|0
2669766|NCT00586924|9217622|P5|Overall Study|Disease progression|1
2669767|NCT00586924|9217623|P4|Overall Study|Disease progression|1
2669768|NCT00586924|9217624|P3|Overall Study|Disease progression|0
2669769|NCT00586924|9217625|P2|Overall Study|Disease progression|0
2669770|NCT00586924|9217626|P1|Overall Study|Disease progression|0
2669771|NCT00586924|9217621|P6|Overall Study|Initiation of alternative cancer therapy|1
2669772|NCT00586924|9217622|P5|Overall Study|Initiation of alternative cancer therapy|0
2669773|NCT00586924|9217623|P4|Overall Study|Initiation of alternative cancer therapy|0
2669774|NCT00586924|9217624|P3|Overall Study|Initiation of alternative cancer therapy|0
2669775|NCT00586924|9217625|P2|Overall Study|Initiation of alternative cancer therapy|0
2669776|NCT00586924|9217626|P1|Overall Study|Initiation of alternative cancer therapy|0
2669777|NCT00586924|9217621|P6|Overall Study|Adverse event/serious adverse event|2
2669778|NCT00586924|9217622|P5|Overall Study|Adverse event/serious adverse event|0
2669779|NCT00586924|9217623|P4|Overall Study|Adverse event/serious adverse event|1
2669780|NCT00586924|9217624|P3|Overall Study|Adverse event/serious adverse event|0
2669781|NCT00586924|9217625|P2|Overall Study|Adverse event/serious adverse event|0
2669782|NCT00586924|9217626|P1|Overall Study|Adverse event/serious adverse event|0
2669783|NCT00586898|9217826|P1|Overall Study|Evaluable for Toxicity Only|5
2669784|NCT00586898|9217826|P1|Overall Study|Patiemt Non-compliance|1
2669785|NCT00586898|9217826|P1|Overall Study|Adverse Event|1
2669786|NCT00586846|9217830|P1|Overall Study|Evaluable for Toxicity Only|4
2669787|NCT00586846|9217830|P1|Overall Study|Death|1
2669788|NCT00586846|9217830|P1|Overall Study|Physician Decision|1
2669789|NCT00586820|9217836|P2|Overall Study|Unsuccessful PCI|0
2669790|NCT00586820|9217837|P1|Overall Study|Unsuccessful PCI|1
2669791|NCT00586703|9217868|P1|Overall Study|Death|12
2669792|NCT00586690|9217875|P2|Overall Study|Lab can't accommodate|0
2669793|NCT00586690|9217876|P1|Overall Study|Lab can't accommodate|1
2669794|NCT00586690|9217875|P2|Overall Study|Lack of Efficacy|0
2669795|NCT00586690|9217876|P1|Overall Study|Lack of Efficacy|2
2669796|NCT00586690|9217875|P2|Overall Study|Adverse Event|0
2669797|NCT00586690|9217876|P1|Overall Study|Adverse Event|1
2669798|NCT00586690|9217875|P2|Overall Study|Disease Progression|0
2669799|NCT00586690|9217876|P1|Overall Study|Disease Progression|10
2669800|NCT00586690|9217875|P2|Overall Study|Death|0
2669801|NCT00586690|9217876|P1|Overall Study|Death|2
2669802|NCT00586664|9217886|P3|Overall Study|Exclusion criteria met|0
2669803|NCT00586664|9217887|P2|Overall Study|Exclusion criteria met|0
2669804|NCT00586664|9217888|P1|Overall Study|Exclusion criteria met|2
2669805|NCT00586664|9217886|P3|Overall Study|Withdrawal by Subject|1
2669806|NCT00586664|9217887|P2|Overall Study|Withdrawal by Subject|7
2669807|NCT00586664|9217888|P1|Overall Study|Withdrawal by Subject|3
2669808|NCT00586625|9217934|P2|Overall Study|Subject unable to return for visit|0
2669809|NCT00586625|9217935|P1|Overall Study|Subject unable to return for visit|2
2669810|NCT00586625|9217934|P2|Overall Study|Subject non-compliance|1
2669811|NCT00586625|9217935|P1|Overall Study|Subject non-compliance|0
2669812|NCT00586625|9217934|P2|Overall Study|Withdrawal by Subject|10
2669813|NCT00586625|9217935|P1|Overall Study|Withdrawal by Subject|32
2669814|NCT00586625|9217934|P2|Overall Study|Protocol Violation|0
2669815|NCT00586625|9217935|P1|Overall Study|Protocol Violation|3
2669816|NCT00586625|9217934|P2|Overall Study|Adverse Event|6
2669817|NCT00586625|9217935|P1|Overall Study|Adverse Event|6
2669818|NCT00586612|9217943|P2|Booster Phase|Lost to Follow-up|1
2669819|NCT00586612|9217944|P1|Booster Phase|Lost to Follow-up|3
2669820|NCT00586612|9217943|P2|Primary Phase|Withdrawal by Subject|2
2669821|NCT00586612|9217944|P1|Primary Phase|Withdrawal by Subject|0
2669822|NCT00586612|9217943|P2|Primary Phase|Lost to Follow-up|1
2669823|NCT00586612|9217944|P1|Primary Phase|Lost to Follow-up|0
2669824|NCT00586612|9217943|P2|Primary Phase|Protocol Violation|0
2669825|NCT00586612|9217944|P1|Primary Phase|Protocol Violation|1
2669826|NCT00586521|9218014|P1|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1
2669827|NCT00586495|9218021|P1|Follow-up|Switch to commercial drug|10
2669828|NCT00586495|9218021|P1|Follow-up|Protocol driven decision point|37
2669829|NCT00586495|9218021|P1|Follow-up|Withdrawal by Subject|4
2669830|NCT00586495|9218021|P1|Follow-up|Lost to Follow-up|1
2669831|NCT00586495|9218021|P1|Follow-up|Death|40
2669832|NCT00586495|9218021|P1|Treatment Period|Switch to commercial drug|10
2669833|NCT00586495|9218021|P1|Treatment Period|Disease progression, recurrence/relapse|71
2669834|NCT00586495|9218021|P1|Treatment Period|Withdrawal by Subject|1
2669835|NCT00586495|9218021|P1|Treatment Period|Protocol Violation|1
2669836|NCT00586495|9218021|P1|Treatment Period|Death|1
2669837|NCT00586495|9218021|P1|Treatment Period|Adverse Event|11
2669838|NCT00586469|9218050|P2|Overall Study|Adverse Event|1
2669839|NCT00586469|9218051|P1|Overall Study|Adverse Event|0
2669840|NCT00586339|9218078|P3|Overall Study|Lost to Follow-up|1
2669841|NCT00586339|9218079|P2|Overall Study|Lost to Follow-up|2
2669842|NCT00586339|9218080|P1|Overall Study|Lost to Follow-up|3
2669843|NCT00586339|9218078|P3|Overall Study|Migrated/moved from study area|4
2669844|NCT00586339|9218079|P2|Overall Study|Migrated/moved from study area|2
2669845|NCT00586339|9218080|P1|Overall Study|Migrated/moved from study area|3
2669846|NCT00586339|9218078|P3|Overall Study|Withdrawal by Subject|1
2669847|NCT00586339|9218079|P2|Overall Study|Withdrawal by Subject|3
2669848|NCT00586339|9218080|P1|Overall Study|Withdrawal by Subject|1
2669849|NCT00586326|9218181|P1|Treated Through 5-yr Follow Up-Treated|Other|2
2669850|NCT00586326|9218181|P1|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14
2669851|NCT00586326|9218181|P1|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5
2669852|NCT00586326|9218181|P1|Treated Through 5-yr Follow Up-Treated|Medical Reason|2
2669853|NCT00586326|9218181|P1|Treated Through 5-yr Follow Up-Treated|Death|2
2669854|NCT00586326|9218181|P1|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1
2669855|NCT00586326|9218181|P1|Device Placed toTreatment-ITT|Physician Decision|1
2669856|NCT00586326|9218181|P1|Device Placed toTreatment-ITT|Positive Margins|3
2669857|NCT00586326|9218181|P1|Device Placed toTreatment-ITT|Microinvasion|1
2669858|NCT00586326|9218181|P1|Device Placed toTreatment-ITT|Cavity Conformance|6
2669859|NCT00586326|9218181|P1|Device Placed toTreatment-ITT|Skin Distance|7
2669860|NCT00586326|9218181|P1|Enrollment to Device Placement-Enrolled|Other|1
2669861|NCT00586326|9218181|P1|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1
2669862|NCT00586326|9218181|P1|Enrollment to Device Placement-Enrolled|Physician Decision|1
2669863|NCT00586326|9218181|P1|Enrollment to Device Placement-Enrolled|Microinvasion|2
2669864|NCT00586326|9218181|P1|Enrollment to Device Placement-Enrolled|Cavity Conformance|4
2669865|NCT00586326|9218181|P1|Enrollment to Device Placement-Enrolled|Skin Distance|6
2669866|NCT00586313|9218192|P1|Overall Study|Lack of Efficacy|2
2669867|NCT00586157|9218228|P2|Second Intervention|Adverse Event|1
2669868|NCT00586157|9218229|P1|Second Intervention|Adverse Event|0
2669869|NCT00586157|9218228|P2|Second Intervention|Worsening behavior|0
2669870|NCT00586157|9218229|P1|Second Intervention|Worsening behavior|1
2669871|NCT00586157|9218228|P2|Second Intervention|Withdrawal by Subject|0
2669872|NCT00586157|9218229|P1|Second Intervention|Withdrawal by Subject|1
2669873|NCT00586157|9218228|P2|First Intervention|Worsening behavior|0
2669874|NCT00586157|9218229|P1|First Intervention|Worsening behavior|1
2669875|NCT00586105|9218239|P1|Overall Study|Reason not reported|1
2669876|NCT00586105|9218239|P1|Overall Study|Switched to commercial drug|9
2669877|NCT00586105|9218239|P1|Overall Study|Disease progression|19
2669878|NCT00586105|9218239|P1|Overall Study|Withdrawal by Subject|3
2669879|NCT00586105|9218239|P1|Overall Study|Protocol Violation|1
2669880|NCT00586105|9218239|P1|Overall Study|Death|2
2669881|NCT00586105|9218239|P1|Overall Study|Adverse Event|4
2669882|NCT00586066|9218254|P2|Overall Study|Withdrawal of consent|2
2669883|NCT00586066|9218255|P1|Overall Study|Withdrawal of consent|4
2669884|NCT00586066|9218254|P2|Overall Study|Physician Decision|0
2669885|NCT00586066|9218255|P1|Overall Study|Physician Decision|1
2669886|NCT00586066|9218254|P2|Overall Study|Adverse Event|2
2669887|NCT00586066|9218255|P1|Overall Study|Adverse Event|2
2669888|NCT00586066|9218254|P2|Overall Study|Lack of Efficacy|3
2669889|NCT00586066|9218255|P1|Overall Study|Lack of Efficacy|5
2669890|NCT00586066|9218254|P2|Overall Study|Lost to Follow-up|3
2669891|NCT00586066|9218255|P1|Overall Study|Lost to Follow-up|6
2669892|NCT00585975|9218312|P2|Overall Study|Enrollment met/over-enrolled|9
2669893|NCT00585975|9218313|P1|Overall Study|Enrollment met/over-enrolled|10
2669894|NCT00585975|9218312|P2|Overall Study|Lost to Follow-up|1
2669895|NCT00585975|9218313|P1|Overall Study|Lost to Follow-up|2
2669896|NCT00585975|9218312|P2|Overall Study|Withdrawal by Subject|3
2669897|NCT00585975|9218313|P1|Overall Study|Withdrawal by Subject|3
2669898|NCT00585923|9218323|P2|Overall Study|Physician decided not to continue|33
2669899|NCT00585923|9218324|P1|Overall Study|Physician decided not to continue|31
2669900|NCT00585689|9218355|P1|Overall Study|Death|1
2669901|NCT00585689|9218355|P1|Overall Study|Patient had unresectable disease|1
2669902|NCT00585689|9218355|P1|Overall Study|Patient Declined Surgery|1
2669903|NCT00585689|9218355|P1|Overall Study|Adverse Event|1
2669904|NCT00585689|9218355|P1|Overall Study|Received different ABI-007 schedule|3
2669905|NCT00585585|9218414|P1|Overall Study|Adverse Event|1
2669906|NCT00585546|9218418|P1|Clenbuterol Treatment - up to 12 Months|Adverse Event|3
2669907|NCT00585546|9218418|P1|Clenbuterol Treatment - up to 12 Months|Death|1
2669908|NCT00585533|9218432|P1|Overall Study|objective or symptomatic progression|9
2669909|NCT00585468|9218441|P2|First Intervention|Withdrawal by Subject|1
2669910|NCT00585468|9218442|P1|First Intervention|Withdrawal by Subject|1
2669911|NCT00585351|9218474|P8|Enrollment Period (Intervention)|Unknown if alive or deceased|0
2669912|NCT00585351|9218475|P7|Enrollment Period (Intervention)|Unknown if alive or deceased|0
2669913|NCT00585351|9218476|P6|Enrollment Period (Intervention)|Unknown if alive or deceased|2
2669914|NCT00585351|9218477|P5|Enrollment Period (Intervention)|Unknown if alive or deceased|1
2669915|NCT00585351|9218478|P4|Enrollment Period (Intervention)|Unknown if alive or deceased|0
2669916|NCT00585351|9218479|P3|Enrollment Period (Intervention)|Unknown if alive or deceased|0
2669917|NCT00585351|9218480|P2|Enrollment Period (Intervention)|Unknown if alive or deceased|0
2669918|NCT00585351|9218481|P1|Enrollment Period (Intervention)|Unknown if alive or deceased|0
2669919|NCT00585351|9218474|P8|Enrollment Period (Intervention)|Death|0
2669920|NCT00585351|9218475|P7|Enrollment Period (Intervention)|Death|1
2669921|NCT00585351|9218476|P6|Enrollment Period (Intervention)|Death|0
2669922|NCT00585351|9218477|P5|Enrollment Period (Intervention)|Death|1
2669923|NCT00585351|9218478|P4|Enrollment Period (Intervention)|Death|0
2669924|NCT00585351|9218479|P3|Enrollment Period (Intervention)|Death|0
2669925|NCT00585351|9218480|P2|Enrollment Period (Intervention)|Death|0
2669926|NCT00585351|9218481|P1|Enrollment Period (Intervention)|Death|0
2669927|NCT00585351|9218474|P8|Enrollment Period (Intervention)|Lost to Follow-up|1
2669928|NCT00585351|9218475|P7|Enrollment Period (Intervention)|Lost to Follow-up|1
2669929|NCT00585351|9218476|P6|Enrollment Period (Intervention)|Lost to Follow-up|0
2669930|NCT00585351|9218477|P5|Enrollment Period (Intervention)|Lost to Follow-up|0
2669931|NCT00585351|9218478|P4|Enrollment Period (Intervention)|Lost to Follow-up|0
2669932|NCT00585351|9218479|P3|Enrollment Period (Intervention)|Lost to Follow-up|0
2669933|NCT00585351|9218480|P2|Enrollment Period (Intervention)|Lost to Follow-up|0
2669934|NCT00585351|9218481|P1|Enrollment Period (Intervention)|Lost to Follow-up|0
2669935|NCT00585351|9218474|P8|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
2669936|NCT00585351|9218475|P7|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
2669937|NCT00585351|9218476|P6|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
2669938|NCT00585351|9218477|P5|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
2669939|NCT00585351|9218478|P4|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
2669940|NCT00585351|9218479|P3|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
2669941|NCT00585351|9218480|P2|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
2669942|NCT00585351|9218481|P1|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
2669943|NCT00585351|9218474|P8|Notification Period (Informed Consent)|No study medication on flight|0
2669944|NCT00585351|9218475|P7|Notification Period (Informed Consent)|No study medication on flight|0
2669945|NCT00585351|9218476|P6|Notification Period (Informed Consent)|No study medication on flight|0
2669946|NCT00585351|9218477|P5|Notification Period (Informed Consent)|No study medication on flight|0
2669947|NCT00585351|9218478|P4|Notification Period (Informed Consent)|No study medication on flight|0
2669948|NCT00585351|9218479|P3|Notification Period (Informed Consent)|No study medication on flight|0
2669949|NCT00585351|9218480|P2|Notification Period (Informed Consent)|No study medication on flight|1
2669950|NCT00585351|9218481|P1|Notification Period (Informed Consent)|No study medication on flight|0
2669951|NCT00585351|9218474|P8|Notification Period (Informed Consent)|Flight aborted|0
2669952|NCT00585351|9218475|P7|Notification Period (Informed Consent)|Flight aborted|0
2669953|NCT00585351|9218476|P6|Notification Period (Informed Consent)|Flight aborted|0
2669954|NCT00585351|9218477|P5|Notification Period (Informed Consent)|Flight aborted|0
2669955|NCT00585351|9218478|P4|Notification Period (Informed Consent)|Flight aborted|0
2669956|NCT00585351|9218479|P3|Notification Period (Informed Consent)|Flight aborted|0
2669957|NCT00585351|9218480|P2|Notification Period (Informed Consent)|Flight aborted|1
2669958|NCT00585351|9218481|P1|Notification Period (Informed Consent)|Flight aborted|2
2669959|NCT00585351|9218474|P8|Notification Period (Informed Consent)|Physician Decision|0
2669960|NCT00585351|9218475|P7|Notification Period (Informed Consent)|Physician Decision|0
2669961|NCT00585351|9218476|P6|Notification Period (Informed Consent)|Physician Decision|0
2669962|NCT00585351|9218477|P5|Notification Period (Informed Consent)|Physician Decision|0
2669963|NCT00585351|9218478|P4|Notification Period (Informed Consent)|Physician Decision|0
2669964|NCT00585351|9218479|P3|Notification Period (Informed Consent)|Physician Decision|0
2669965|NCT00585351|9218480|P2|Notification Period (Informed Consent)|Physician Decision|2
2669966|NCT00585351|9218481|P1|Notification Period (Informed Consent)|Physician Decision|0
2669967|NCT00585325|9218497|P2|Overall Study|Withdrawal by Subject|1
2669968|NCT00585325|9218498|P1|Overall Study|Withdrawal by Subject|1
2669969|NCT00585312|9218506|P2|Overall Study|Study terminated by the sponsor|31
2669970|NCT00585312|9218507|P1|Overall Study|Study terminated by the sponsor|34
2669971|NCT00585312|9218506|P2|Overall Study|Withdrawal by Subject|1
2669972|NCT00585312|9218507|P1|Overall Study|Withdrawal by Subject|5
2669973|NCT00585312|9218506|P2|Overall Study|Reason not specified|0
2669974|NCT00585312|9218507|P1|Overall Study|Reason not specified|2
2669975|NCT00585312|9218506|P2|Overall Study|Lost to Follow-up|1
2669976|NCT00585312|9218507|P1|Overall Study|Lost to Follow-up|1
2669977|NCT00585312|9218506|P2|Overall Study|Lack of Efficacy|11
2669978|NCT00585312|9218507|P1|Overall Study|Lack of Efficacy|6
2669979|NCT00585312|9218506|P2|Overall Study|Adverse Event|0
2669980|NCT00585312|9218507|P1|Overall Study|Adverse Event|3
2669981|NCT00585286|9218519|P1|Overall Study|Lost to Follow-up|1
2669982|NCT00585221|9218535|P1|Overall Study|Protocol Violation|8
2669983|NCT00585169|9218545|P1|Overall Study|Withdrawal by Subject|1
2669984|NCT00585078|9218555|P1|Overall Study|Death|1
2669985|NCT00585078|9218555|P1|Overall Study|Adverse Event|10
2669986|NCT00585078|9218555|P1|Overall Study|Disease Progression|24
2669987|NCT00585078|9218555|P1|Overall Study|Poor performance status|1
2669988|NCT00585078|9218555|P1|Overall Study|Withdrawal by Subject|4
2669989|NCT00585052|9218562|P1|Overall Study|Withdrawal by Subject|1
2669990|NCT00585039|9218569|P2|Overall Study|medication spilled|0
2669991|NCT00585039|9218570|P1|Overall Study|medication spilled|2
2669992|NCT00584987|9218599|P4|Overall Study|Adverse Event|1
2669993|NCT00584987|9218600|P3|Overall Study|Adverse Event|0
2669994|NCT00584987|9218601|P2|Overall Study|Adverse Event|0
2669995|NCT00584987|9218602|P1|Overall Study|Adverse Event|0
2669996|NCT00584987|9218599|P4|Overall Study|Protocol Violation|0
2669997|NCT00584987|9218600|P3|Overall Study|Protocol Violation|1
2669998|NCT00584987|9218601|P2|Overall Study|Protocol Violation|1
2669999|NCT00584987|9218602|P1|Overall Study|Protocol Violation|1
2670000|NCT00584909|9218654|P1|Overall Study|Adverse Event|4
2670001|NCT00584844|9218664|P1|Overall Study|Screen Failure|20
2670002|NCT00584844|9218664|P1|Overall Study|Withdrawal by Subject|59
2670003|NCT00584805|9218714|P1|Overall Study|Screen failures|2
2670004|NCT00584805|9218714|P1|Overall Study|Lost to follow up|3
2670005|NCT00584805|9218714|P1|Overall Study|Non-compliance|1
2670006|NCT00584805|9218714|P1|Overall Study|Withdrawal by Subject|18
2670007|NCT00584805|9218714|P1|Overall Study|Relocation|36
2670008|NCT00584805|9218714|P1|Overall Study|No longer at risk of exposure|39
2670009|NCT00584740|9218727|P2|Overall Study|Lost to Follow-up|1
2670010|NCT00584740|9218728|P1|Overall Study|Lost to Follow-up|0
2670011|NCT00584740|9218727|P2|Overall Study|Withdrawal by Subject|2
2670012|NCT00584740|9218728|P1|Overall Study|Withdrawal by Subject|3
2670013|NCT00584740|9218727|P2|Overall Study|Lack of Efficacy|2
2670014|NCT00584740|9218728|P1|Overall Study|Lack of Efficacy|8
2670015|NCT00584740|9218727|P2|Overall Study|Adverse Event|1
2670016|NCT00584740|9218728|P1|Overall Study|Adverse Event|1
2670017|NCT00584727|9218746|P6|Third Intervention|Protocol Violation|2
2670018|NCT00584727|9218747|P5|Third Intervention|Protocol Violation|4
2670019|NCT00584727|9218748|P4|Third Intervention|Protocol Violation|0
2670020|NCT00584727|9218749|P3|Third Intervention|Protocol Violation|1
2670021|NCT00584727|9218750|P2|Third Intervention|Protocol Violation|0
2670022|NCT00584727|9218751|P1|Third Intervention|Protocol Violation|0
2670023|NCT00584727|9218746|P6|First Intervention|Discontinuation|0
2670024|NCT00584727|9218747|P5|First Intervention|Discontinuation|0
2670025|NCT00584727|9218748|P4|First Intervention|Discontinuation|0
2670026|NCT00584727|9218749|P3|First Intervention|Discontinuation|1
2670027|NCT00584727|9218750|P2|First Intervention|Discontinuation|0
2670028|NCT00584727|9218751|P1|First Intervention|Discontinuation|0
2670029|NCT00584454|9218789|P1|Overall Study|Clinical Hold|2
2670030|NCT00584454|9218789|P1|Overall Study|Relocation|1
2670031|NCT00584454|9218789|P1|Overall Study|Adverse Event|1
2670032|NCT00584415|9218793|P1|Overall Study|Adverse Event|7
2670033|NCT00584194|9218816|P1|Overall Study|Other|135
2670034|NCT00584012|9218829|P1|Overall Study|Withdrawal by Subject|1
2670035|NCT00583947|9218835|P2|Cross-over Period|Other|1
2670036|NCT00583947|9218836|P1|Cross-over Period|Other|1
2670037|NCT00583947|9218835|P2|Cross-over Period|Did not meet-no longer met entry criteri|1
2670038|NCT00583947|9218836|P1|Cross-over Period|Did not meet-no longer met entry criteri|0
2670039|NCT00583947|9218835|P2|Cross-over Period|Withdrawal by Subject|0
2670040|NCT00583947|9218836|P1|Cross-over Period|Withdrawal by Subject|2
2670041|NCT00583947|9218835|P2|Cross-over Period|Adverse Event|0
2670042|NCT00583947|9218836|P1|Cross-over Period|Adverse Event|2
2670043|NCT00583791|9218957|P1|Overall Study|Death|6
2670044|NCT00583791|9218957|P1|Overall Study|Other|67
2670045|NCT00583596|9219012|P1|Overall Study|Outside f-up window|26
2670046|NCT00583596|9219012|P1|Overall Study|Not consented|15
2670047|NCT00583596|9219012|P1|Overall Study|Data not complete|1
2670048|NCT00583596|9219012|P1|Overall Study|Lost to Follow-up|94
2670049|NCT00583596|9219012|P1|Overall Study|Withdrawal by Subject|6
2670050|NCT00583596|9219012|P1|Overall Study|Death|2
2670051|NCT00583596|9219012|P1|Overall Study|Excluded due to Hurricane Katrina|30
2670052|NCT00583596|9219012|P1|Overall Study|Lost to Follow-up|110
2670053|NCT00583557|9219017|P1|Overall Study|Did not receive belimumab in LBRA99|2
2670054|NCT00583557|9219017|P1|Overall Study|Other|5
2670055|NCT00583557|9219017|P1|Overall Study|Lack of Compliance|5
2670056|NCT00583557|9219017|P1|Overall Study|Lack of Efficacy|31
2670057|NCT00583557|9219017|P1|Overall Study|Adverse Event|9
2670058|NCT00583557|9219017|P1|Overall Study|Withdrawal by Subject|18
2670059|NCT00583453|9219048|P2|Overall Study|discontinued intervention|2
2670060|NCT00583453|9219049|P1|Overall Study|discontinued intervention|0
2670061|NCT00583362|9219086|P1|Overall Study|Withdrawal by Subject|57
2670062|NCT00583362|9219086|P1|Overall Study|Protocol Violation|2
2670063|NCT00583362|9219086|P1|Overall Study|Physician Decision|19
2670064|NCT00583362|9219086|P1|Overall Study|Sponsor request due to missed doses|1
2670065|NCT00583362|9219086|P1|Overall Study|Behavioral problems and non-compliance|1
2670066|NCT00583362|9219086|P1|Overall Study|Misunderstanding of protocol|1
2670067|NCT00583362|9219086|P1|Overall Study|Missed visits due to staff changes|1
2670068|NCT00583362|9219086|P1|Overall Study|Subject moved out of the country/state|2
2670069|NCT00583362|9219086|P1|Overall Study|Subject not dosed in LBSL99|1
2670070|NCT00583362|9219086|P1|Overall Study|Current site closed|7
2670071|NCT00583362|9219086|P1|Overall Study|Miscommunication of visit window|5
2670072|NCT00583362|9219086|P1|Overall Study|Pregnancy|7
2670073|NCT00583362|9219086|P1|Overall Study|Non-compliance with study drug|28
2670074|NCT00583362|9219086|P1|Overall Study|Lost to Follow-up|4
2670075|NCT00583362|9219086|P1|Overall Study|Lack of Efficacy|22
2670076|NCT00583362|9219086|P1|Overall Study|Adverse Event|44
2670077|NCT00583219|9219110|P1|Phase 2|Withdrawal by Subject|1
2670078|NCT00583115|9219127|P1|Overall Study|Death|1
2670079|NCT00583102|9219132|P1|Overall Study|Adverse Event|3
2670080|NCT00582972|9219145|P1|Overall Study|Protocol Violation|2
2670081|NCT00582933|9219154|P1|Overall Study|Physician Decision|3
2670082|NCT00582907|9219158|P4|2nd Course|Lack of Efficacy|0
2670083|NCT00582907|9219159|P3|2nd Course|Lack of Efficacy|0
2670084|NCT00582907|9219160|P2|2nd Course|Lack of Efficacy|0
2670085|NCT00582907|9219161|P1|2nd Course|Lack of Efficacy|1
2670086|NCT00582907|9219158|P4|1st Course|Lost to Follow-up|1
2670087|NCT00582907|9219159|P3|1st Course|Lost to Follow-up|0
2670088|NCT00582907|9219160|P2|1st Course|Lost to Follow-up|0
2670089|NCT00582907|9219161|P1|1st Course|Lost to Follow-up|0
2670090|NCT00582907|9219158|P4|1st Course|Withdrawal by Subject|0
2670091|NCT00582907|9219159|P3|1st Course|Withdrawal by Subject|0
2670092|NCT00582907|9219160|P2|1st Course|Withdrawal by Subject|0
2670093|NCT00582907|9219161|P1|1st Course|Withdrawal by Subject|1
2670094|NCT00582816|9219200|P1|Overall Study|Engraftment Failure|3
2670095|NCT00582790|9219210|P1|Overall Study|Rapid progression of disease|1
2670096|NCT00582738|9219219|P2|Overall Study|Withdrawal by Subject|3
2670097|NCT00582738|9219220|P1|Overall Study|Withdrawal by Subject|0
2670098|NCT00582738|9219219|P2|Overall Study|Protocol Violation|1
2670099|NCT00582738|9219220|P1|Overall Study|Protocol Violation|1
2670100|NCT00582738|9219219|P2|Overall Study|Other|0
2670101|NCT00582738|9219220|P1|Overall Study|Other|1
2670102|NCT00582738|9219219|P2|Overall Study|Graft Lost|1
2670103|NCT00582738|9219220|P1|Overall Study|Graft Lost|0
2670104|NCT00582738|9219219|P2|Overall Study|Adverse Event|5
2670105|NCT00582738|9219220|P1|Overall Study|Adverse Event|0
2670106|NCT00582738|9219219|P2|Overall Study|Administrative Problems|8
2670107|NCT00582738|9219220|P1|Overall Study|Administrative Problems|7
2670108|NCT00582712|9219244|P1|Overall Study|Complicating disease requiring treatment|1
2670109|NCT00582712|9219244|P1|Overall Study|Withdrawal by Subject|1
2670110|NCT00582712|9219244|P1|Overall Study|Lack of Efficacy|1
2670111|NCT00582712|9219244|P1|Overall Study|Adverse Event|1
2670112|NCT00582608|9219259|P1|Overall Study|Lack of accrual|4
2670113|NCT00582608|9219259|P1|Overall Study|Patient Ineligible|1
2670114|NCT00582608|9219259|P1|Overall Study|Not Treated|7
2670115|NCT00582556|9219266|P3|Overall Study|Physician Decision|1
2670116|NCT00582556|9219267|P2|Overall Study|Physician Decision|0
2670117|NCT00582556|9219268|P1|Overall Study|Physician Decision|0
2670118|NCT00582556|9219266|P3|Overall Study|Withdrawal by Subject|1
2670119|NCT00582556|9219267|P2|Overall Study|Withdrawal by Subject|1
2670120|NCT00582556|9219268|P1|Overall Study|Withdrawal by Subject|0
2670121|NCT00582491|9219296|P2|Overall Study|Withdrawal by Subject|0
2670122|NCT00582491|9219297|P1|Overall Study|Withdrawal by Subject|1
2670123|NCT00582426|9219321|P2|Overall Study|Use of illicit drugs|0
2670124|NCT00582426|9219322|P1|Overall Study|Use of illicit drugs|1
2670125|NCT00582426|9219321|P2|Overall Study|Disease Progression|2
2670126|NCT00582426|9219322|P1|Overall Study|Disease Progression|2
2670127|NCT00582426|9219321|P2|Overall Study|Withdrawal by Subject|2
2670128|NCT00582426|9219322|P1|Overall Study|Withdrawal by Subject|3
2670129|NCT00582426|9219321|P2|Overall Study|Death|3
2670130|NCT00582426|9219322|P1|Overall Study|Death|4
2670131|NCT00582426|9219321|P2|Overall Study|Protocol Violation|2
2670132|NCT00582426|9219322|P1|Overall Study|Protocol Violation|6
2670133|NCT00582426|9219321|P2|Overall Study|Adverse Event|2
2670134|NCT00582426|9219322|P1|Overall Study|Adverse Event|4
2670135|NCT00582426|9219321|P2|Overall Study|Lost to Follow-up|2
2670136|NCT00582426|9219322|P1|Overall Study|Lost to Follow-up|0
2670137|NCT00582309|9219369|P3|Overall Study|Protocol Violation|2
2670138|NCT00582309|9219370|P2|Overall Study|Protocol Violation|0
2670139|NCT00582309|9219371|P1|Overall Study|Protocol Violation|0
2670140|NCT00582166|9219384|P1|Overall Study|Ineligible pathology|1
2670141|NCT00582166|9219384|P1|Overall Study|Death|1
2670142|NCT00582114|9219394|P2|Overall Study|Stopped by data safety monitoring board|20
2670143|NCT00582114|9219395|P1|Overall Study|Stopped by data safety monitoring board|19
2670144|NCT00582114|9219394|P2|Overall Study|Physician Decision|6
2670145|NCT00582114|9219395|P1|Overall Study|Physician Decision|0
2670146|NCT00582114|9219394|P2|Overall Study|Adverse Event|1
2670147|NCT00582114|9219395|P1|Overall Study|Adverse Event|1
2670148|NCT00582114|9219394|P2|Overall Study|Withdrawal by Subject|16
2670149|NCT00582114|9219395|P1|Overall Study|Withdrawal by Subject|8
2670150|NCT00582114|9219394|P2|Overall Study|Lost to Follow-up|6
2670151|NCT00582114|9219395|P1|Overall Study|Lost to Follow-up|7
2670152|NCT00582114|9219394|P2|Overall Study|Kidney Transplant|1
2670153|NCT00582114|9219395|P1|Overall Study|Kidney Transplant|3
2670154|NCT00582114|9219394|P2|Overall Study|Death|4
2670155|NCT00582114|9219395|P1|Overall Study|Death|4
2670156|NCT00582036|9219410|P2|Overall Study|Withdrawal by Subject|1
2670157|NCT00582036|9219411|P1|Overall Study|Withdrawal by Subject|0
2670158|NCT00582010|9219419|P2|Overall Study|Death|1
2670159|NCT00582010|9219420|P1|Overall Study|Death|0
2670160|NCT00581945|9219449|P2|Overall Study|Death|0
2670161|NCT00581945|9219450|P1|Overall Study|Death|1
2670162|NCT00581945|9219449|P2|Overall Study|Withdrawal by Subject|6
2670163|NCT00581945|9219450|P1|Overall Study|Withdrawal by Subject|2
2670164|NCT00581945|9219449|P2|Overall Study|Unsatisfactory therapeutic effect|0
2670165|NCT00581945|9219450|P1|Overall Study|Unsatisfactory therapeutic effect|2
2670166|NCT00581945|9219449|P2|Overall Study|Adverse Event|4
2670167|NCT00581945|9219450|P1|Overall Study|Adverse Event|4
2670168|NCT00581919|9219466|P1|Overall Study|Withdrawal by Subject|1
2670169|NCT00581919|9219466|P1|Overall Study|Started Non-Protocol Therapy|2
2670170|NCT00581919|9219466|P1|Overall Study|Other Complicating Disease|1
2670171|NCT00581919|9219466|P1|Overall Study|Physician Decision|1
2670172|NCT00581919|9219466|P1|Overall Study|Disease Progression|10
2670173|NCT00581919|9219466|P1|Overall Study|Death|1
2670174|NCT00581919|9219466|P1|Overall Study|Adverse Event|8
2670175|NCT00581828|9219485|P1|Overall Study|Protocol Violation|1
2670176|NCT00581776|9219489|P1|Overall Study|Disease progression or no response|3
2670177|NCT00581555|9219507|P2|Overall Study|Other reasons|4
2670178|NCT00581555|9219508|P1|Overall Study|Other reasons|16
2670179|NCT00581555|9219507|P2|Overall Study|Lost to Follow-up|2
2670180|NCT00581555|9219508|P1|Overall Study|Lost to Follow-up|2
2670181|NCT00581555|9219507|P2|Overall Study|Withdrawal by Subject|9
2670182|NCT00581555|9219508|P1|Overall Study|Withdrawal by Subject|18
2670183|NCT00581555|9219507|P2|Overall Study|Physician Decision|2
2670184|NCT00581555|9219508|P1|Overall Study|Physician Decision|3
2670185|NCT00581555|9219507|P2|Overall Study|Adverse Event|3
2670186|NCT00581555|9219508|P1|Overall Study|Adverse Event|4
2670187|NCT00581542|9219532|P2|Overall Study|Lost to Follow-up|21
2670188|NCT00581542|9219533|P1|Overall Study|Lost to Follow-up|9
2670189|NCT00581542|9219532|P2|Overall Study|they met an exclusion criteria|2
2670190|NCT00581542|9219533|P1|Overall Study|they met an exclusion criteria|2
2670191|NCT00581360|9219587|P1|Overall Study|Withdrawal by Subject|1
2670192|NCT00581308|9219606|P1|Month 12|Other|1
2670193|NCT00581308|9219606|P1|Month 12|Device Removed|1
2670194|NCT00581308|9219606|P1|Month 12|Withdrawal by Subject|3
2670195|NCT00581308|9219606|P1|Month 12|Lost to Follow-up|14
2670196|NCT00581308|9219606|P1|Month 12|Death|1
2670197|NCT00581308|9219606|P1|Month 6|Withdrawal by Subject|2
2670198|NCT00581308|9219606|P1|Month 6|Lost to Follow-up|1
2670199|NCT00581308|9219606|P1|Month 1|Uknown|1
2670200|NCT00581308|9219606|P1|Month 1|Device Removed|2
2670201|NCT00581308|9219606|P1|Month 1|Withdrawal by Subject|2
2670202|NCT00581308|9219606|P1|Month 1|Lost to Follow-up|3
2670203|NCT00581308|9219606|P1|Pre Discharge|Device Removed|1
2670204|NCT00581308|9219606|P1|Pre Discharge|Lost to Follow-up|1
2670205|NCT00581113|9219637|P2|Overall Study|Withdrawal by Subject|1
2670206|NCT00581113|9219638|P1|Overall Study|Withdrawal by Subject|0
2670207|NCT00581100|9219648|P2|Overall Study|Other|0
2670208|NCT00581100|9219649|P1|Overall Study|Other|3
2670209|NCT00581100|9219648|P2|Overall Study|Withdrawal by Subject|4
2670210|NCT00581100|9219649|P1|Overall Study|Withdrawal by Subject|1
2670211|NCT00581100|9219648|P2|Overall Study|Adverse Event|1
2670212|NCT00581100|9219649|P1|Overall Study|Adverse Event|2
2670213|NCT00581100|9219648|P2|Overall Study|Death|0
2670214|NCT00581100|9219649|P1|Overall Study|Death|1
2670215|NCT00580983|9219702|P1|Overall Study|Did not complete 12 mon post RT studies|7
2670216|NCT00580970|9219709|P1|Treatment (Lovastatin)|Death|1
2670217|NCT00580970|9219709|P1|Treatment (Lovastatin)|Development of metastatic second primary|1
2670218|NCT00580970|9219709|P1|Treatment (Lovastatin)|Physician Decision|4
2670219|NCT00580970|9219709|P1|Treatment (Lovastatin)|Intolerance of Lovastatin|7
2670220|NCT00580970|9219709|P1|Treatment (Lovastatin)|Non-compliance|6
2670221|NCT00580970|9219709|P1|Pre-treatment|Non-compliance|1
2670222|NCT00580866|9219724|P2|Overall Study|Lost to Follow-up|2
2670223|NCT00580866|9219725|P1|Overall Study|Lost to Follow-up|2
2670224|NCT00580840|9219749|P4|Double-Blind|Other: Forbidden Medication|0
2670225|NCT00580840|9219750|P3|Double-Blind|Other: Forbidden Medication|1
2670226|NCT00580840|9219751|P2|Double-Blind|Other: Forbidden Medication|0
2670227|NCT00580840|9219752|P1|Double-Blind|Other: Forbidden Medication|0
2670228|NCT00580840|9219749|P4|Double-Blind|Other: Discontinued Methotrexate|0
2670229|NCT00580840|9219750|P3|Double-Blind|Other: Discontinued Methotrexate|0
2670230|NCT00580840|9219751|P2|Double-Blind|Other: Discontinued Methotrexate|1
2670231|NCT00580840|9219752|P1|Double-Blind|Other: Discontinued Methotrexate|0
2670232|NCT00580840|9219749|P4|Double-Blind|Withdrawal by Subject|2
2670233|NCT00580840|9219750|P3|Double-Blind|Withdrawal by Subject|2
2670234|NCT00580840|9219751|P2|Double-Blind|Withdrawal by Subject|1
2670235|NCT00580840|9219752|P1|Double-Blind|Withdrawal by Subject|0
2670236|NCT00580840|9219749|P4|Double-Blind|Lost to Follow-up|2
2670237|NCT00580840|9219750|P3|Double-Blind|Lost to Follow-up|0
2670238|NCT00580840|9219751|P2|Double-Blind|Lost to Follow-up|1
2670239|NCT00580840|9219752|P1|Double-Blind|Lost to Follow-up|0
2670240|NCT00580840|9219749|P4|Double-Blind|Loss of Efficacy|10
2670241|NCT00580840|9219750|P3|Double-Blind|Loss of Efficacy|2
2670242|NCT00580840|9219751|P2|Double-Blind|Loss of Efficacy|1
2670243|NCT00580840|9219752|P1|Double-Blind|Loss of Efficacy|0
2670244|NCT00580840|9219749|P4|Double-Blind|Adverse Event|1
2670245|NCT00580840|9219750|P3|Double-Blind|Adverse Event|4
2670246|NCT00580840|9219751|P2|Double-Blind|Adverse Event|3
2670247|NCT00580840|9219752|P1|Double-Blind|Adverse Event|0
2670248|NCT00580840|9219749|P4|Run-in|Other: Exclusionary Lab Value|0
2670249|NCT00580840|9219750|P3|Run-in|Other: Exclusionary Lab Value|0
2670250|NCT00580840|9219751|P2|Run-in|Other: Exclusionary Lab Value|0
2670251|NCT00580840|9219752|P1|Run-in|Other: Exclusionary Lab Value|1
2670252|NCT00580840|9219749|P4|Run-in|Other: Did Not Meet Joint Count Criteria|0
2670253|NCT00580840|9219750|P3|Run-in|Other: Did Not Meet Joint Count Criteria|0
2670254|NCT00580840|9219751|P2|Run-in|Other: Did Not Meet Joint Count Criteria|0
2670255|NCT00580840|9219752|P1|Run-in|Other: Did Not Meet Joint Count Criteria|1
2670256|NCT00580840|9219749|P4|Run-in|Other: Per Sponsor Request|0
2670257|NCT00580840|9219750|P3|Run-in|Other: Per Sponsor Request|0
2670258|NCT00580840|9219751|P2|Run-in|Other: Per Sponsor Request|0
2670259|NCT00580840|9219752|P1|Run-in|Other: Per Sponsor Request|2
2670260|NCT00580840|9219749|P4|Run-in|Withdrawal by Subject|0
2670261|NCT00580840|9219750|P3|Run-in|Withdrawal by Subject|0
2670262|NCT00580840|9219751|P2|Run-in|Withdrawal by Subject|0
2670263|NCT00580840|9219752|P1|Run-in|Withdrawal by Subject|5
2670264|NCT00580840|9219749|P4|Run-in|Lost to Follow-up|0
2670265|NCT00580840|9219750|P3|Run-in|Lost to Follow-up|0
2670266|NCT00580840|9219751|P2|Run-in|Lost to Follow-up|0
2670267|NCT00580840|9219752|P1|Run-in|Lost to Follow-up|4
2670268|NCT00580840|9219749|P4|Run-in|Loss of Efficacy|0
2670269|NCT00580840|9219750|P3|Run-in|Loss of Efficacy|0
2670270|NCT00580840|9219751|P2|Run-in|Loss of Efficacy|0
2670271|NCT00580840|9219752|P1|Run-in|Loss of Efficacy|1
2670272|NCT00580840|9219749|P4|Run-in|Lack of Efficacy|0
2670273|NCT00580840|9219750|P3|Run-in|Lack of Efficacy|0
2670274|NCT00580840|9219751|P2|Run-in|Lack of Efficacy|0
2670275|NCT00580840|9219752|P1|Run-in|Lack of Efficacy|93
2670276|NCT00580840|9219749|P4|Run-in|Adverse Event|0
2670277|NCT00580840|9219750|P3|Run-in|Adverse Event|0
2670278|NCT00580840|9219751|P2|Run-in|Adverse Event|0
2670279|NCT00580840|9219752|P1|Run-in|Adverse Event|17
2670280|NCT00580801|9219860|P3|Overall Study|Travel|0
2670281|NCT00580801|9219861|P2|Overall Study|Travel|0
2670282|NCT00580801|9219862|P1|Overall Study|Travel|1
2670283|NCT00580801|9219860|P3|Overall Study|Participant non-compliant|1
2670284|NCT00580801|9219861|P2|Overall Study|Participant non-compliant|0
2670285|NCT00580801|9219862|P1|Overall Study|Participant non-compliant|0
2670286|NCT00580801|9219860|P3|Overall Study|Reached a virologic endpoint|2
2670287|NCT00580801|9219861|P2|Overall Study|Reached a virologic endpoint|1
2670288|NCT00580801|9219862|P1|Overall Study|Reached a virologic endpoint|0
2670289|NCT00580801|9219860|P3|Overall Study|Lost to Follow-up|0
2670290|NCT00580801|9219861|P2|Overall Study|Lost to Follow-up|0
2670291|NCT00580801|9219862|P1|Overall Study|Lost to Follow-up|2
2670292|NCT00580801|9219860|P3|Overall Study|Adverse Event|0
2670293|NCT00580801|9219861|P2|Overall Study|Adverse Event|0
2670294|NCT00580801|9219862|P1|Overall Study|Adverse Event|2
2670295|NCT00580801|9219860|P3|Overall Study|Physician Decision|0
2670296|NCT00580801|9219861|P2|Overall Study|Physician Decision|0
2670297|NCT00580801|9219862|P1|Overall Study|Physician Decision|1
2670298|NCT00580788|9219901|P4|Overall Study|Adverse Event|1
2670299|NCT00580788|9219902|P3|Overall Study|Adverse Event|0
2670300|NCT00580788|9219903|P2|Overall Study|Adverse Event|0
2670301|NCT00580788|9219904|P1|Overall Study|Adverse Event|0
2670302|NCT00580723|9219962|P1|Overall Study|Lost to Follow-up|5
2670303|NCT00580723|9219962|P1|Overall Study|Did not want to participate in extension|3
2670304|NCT00580606|9220005|P2|Open Label (OL)|Needed Prohibited Medication|1
2670305|NCT00580606|9220006|P1|Open Label (OL)|Needed Prohibited Medication|0
2670306|NCT00580606|9220005|P2|Open Label (OL)|Physician Decision|1
2670307|NCT00580606|9220006|P1|Open Label (OL)|Physician Decision|1
2670308|NCT00580606|9220005|P2|Open Label (OL)|Non-compliance|0
2670309|NCT00580606|9220006|P1|Open Label (OL)|Non-compliance|2
2670310|NCT00580606|9220005|P2|Open Label (OL)|Pregnancy|1
2670311|NCT00580606|9220006|P1|Open Label (OL)|Pregnancy|0
2670312|NCT00580606|9220005|P2|Open Label (OL)|Lost to Follow-up|1
2670313|NCT00580606|9220006|P1|Open Label (OL)|Lost to Follow-up|0
2670314|NCT00580606|9220005|P2|Open Label (OL)|Dosing Symptoms|1
2670315|NCT00580606|9220006|P1|Open Label (OL)|Dosing Symptoms|0
2670316|NCT00580606|9220005|P2|Open Label (OL)|Withdrawal by Subject|6
2670317|NCT00580606|9220006|P1|Open Label (OL)|Withdrawal by Subject|4
2670318|NCT00580606|9220005|P2|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1
2670319|NCT00580606|9220006|P1|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2
2670320|NCT00580047|9220087|P3|Overall Study|Withdrawal by Subject|0
2670321|NCT00580047|9220088|P2|Overall Study|Withdrawal by Subject|0
2670322|NCT00580047|9220089|P1|Overall Study|Withdrawal by Subject|1
2670323|NCT00580047|9220087|P3|Overall Study|Withdrawal by Subject|2
2670324|NCT00580047|9220088|P2|Overall Study|Withdrawal by Subject|1
2670325|NCT00580047|9220089|P1|Overall Study|Withdrawal by Subject|1
2670326|NCT00580047|9220087|P3|Overall Study|Lost to Follow-up|0
2670327|NCT00580047|9220088|P2|Overall Study|Lost to Follow-up|1
2670328|NCT00580047|9220089|P1|Overall Study|Lost to Follow-up|1
2670329|NCT00580034|9220100|P2|Overall Study|Toxicity|0
2670330|NCT00580034|9220101|P1|Overall Study|Toxicity|10
2670331|NCT00579982|9220107|P1|Overall Study|Protocol Violation|4
2670332|NCT00579982|9220107|P1|Overall Study|Adverse Event|4
2670333|NCT00579826|9220141|P2|Overall Study|Withdrawal by Subject|3
2670334|NCT00579826|9220142|P1|Overall Study|Withdrawal by Subject|5
2670335|NCT00579670|9220176|P5|Overall Study|Withdrawal by Subject|0
2670336|NCT00579670|9220177|P4|Overall Study|Withdrawal by Subject|0
2670337|NCT00579670|9220178|P3|Overall Study|Withdrawal by Subject|1
2670338|NCT00579670|9220179|P2|Overall Study|Withdrawal by Subject|0
2670339|NCT00579670|9220180|P1|Overall Study|Withdrawal by Subject|0
2670340|NCT00579670|9220176|P5|Overall Study|Other|0
2670341|NCT00579670|9220177|P4|Overall Study|Other|2
2670342|NCT00579670|9220178|P3|Overall Study|Other|1
2670343|NCT00579670|9220179|P2|Overall Study|Other|0
2670344|NCT00579670|9220180|P1|Overall Study|Other|0
2670345|NCT00579670|9220176|P5|Overall Study|Lost to Follow-up|0
2670346|NCT00579670|9220177|P4|Overall Study|Lost to Follow-up|4
2670347|NCT00579670|9220178|P3|Overall Study|Lost to Follow-up|0
2670348|NCT00579670|9220179|P2|Overall Study|Lost to Follow-up|1
2670349|NCT00579670|9220180|P1|Overall Study|Lost to Follow-up|0
2670350|NCT00579670|9220176|P5|Overall Study|Lack of Efficacy|0
2670351|NCT00579670|9220177|P4|Overall Study|Lack of Efficacy|14
2670352|NCT00579670|9220178|P3|Overall Study|Lack of Efficacy|1
2670353|NCT00579670|9220179|P2|Overall Study|Lack of Efficacy|0
2670354|NCT00579670|9220180|P1|Overall Study|Lack of Efficacy|0
2670355|NCT00579670|9220176|P5|Overall Study|Adverse Event|0
2670356|NCT00579670|9220177|P4|Overall Study|Adverse Event|2
2670357|NCT00579670|9220178|P3|Overall Study|Adverse Event|1
2670358|NCT00579670|9220179|P2|Overall Study|Adverse Event|0
2670359|NCT00579670|9220180|P1|Overall Study|Adverse Event|1
2670360|NCT00579670|9220176|P5|Overall Study|Death|0
2670361|NCT00579670|9220177|P4|Overall Study|Death|0
2670362|NCT00579670|9220178|P3|Overall Study|Death|0
2670363|NCT00579670|9220179|P2|Overall Study|Death|0
2670364|NCT00579670|9220180|P1|Overall Study|Death|1
2670365|NCT00579527|9220392|P1|Overall Study|Death|4
2670366|NCT00579501|9220404|P1|Overall Study|Radiation therapy before surgery|1
2670367|NCT00579501|9220404|P1|Overall Study|Secondary lesion|1
2670368|NCT00579501|9220404|P1|Overall Study|toxicity|1
2670369|NCT00579501|9220404|P1|Overall Study|End of neoadjuvant therapy|25
2670370|NCT00579501|9220404|P1|Overall Study|Death|1
2670371|NCT00579345|9220432|P8|Overall Study|Death|0
2670372|NCT00579345|9220433|P7|Overall Study|Death|0
2670373|NCT00579345|9220434|P6|Overall Study|Death|0
2670374|NCT00579345|9220435|P5|Overall Study|Death|0
2670375|NCT00579345|9220436|P4|Overall Study|Death|1
2670376|NCT00579345|9220437|P3|Overall Study|Death|1
2670377|NCT00579345|9220438|P2|Overall Study|Death|1
2670378|NCT00579345|9220439|P1|Overall Study|Death|1
2670379|NCT00579345|9220432|P8|Overall Study|Protocol Violation|1
2670380|NCT00579345|9220433|P7|Overall Study|Protocol Violation|0
2670381|NCT00579345|9220434|P6|Overall Study|Protocol Violation|0
2670382|NCT00579345|9220435|P5|Overall Study|Protocol Violation|0
2670383|NCT00579345|9220436|P4|Overall Study|Protocol Violation|0
2670384|NCT00579345|9220437|P3|Overall Study|Protocol Violation|0
2670385|NCT00579345|9220438|P2|Overall Study|Protocol Violation|0
2670386|NCT00579345|9220439|P1|Overall Study|Protocol Violation|1
2670387|NCT00579345|9220432|P8|Overall Study|Adverse Event|0
2670388|NCT00579345|9220433|P7|Overall Study|Adverse Event|0
2670389|NCT00579345|9220434|P6|Overall Study|Adverse Event|0
2670390|NCT00579345|9220435|P5|Overall Study|Adverse Event|0
2670391|NCT00579345|9220436|P4|Overall Study|Adverse Event|0
2670392|NCT00579345|9220437|P3|Overall Study|Adverse Event|1
2670393|NCT00579345|9220438|P2|Overall Study|Adverse Event|0
2670394|NCT00579345|9220439|P1|Overall Study|Adverse Event|0
2670395|NCT00579345|9220432|P8|Overall Study|Lost to Follow-up|0
2670396|NCT00579345|9220433|P7|Overall Study|Lost to Follow-up|0
2670397|NCT00579345|9220434|P6|Overall Study|Lost to Follow-up|0
2670398|NCT00579345|9220435|P5|Overall Study|Lost to Follow-up|0
2670399|NCT00579345|9220436|P4|Overall Study|Lost to Follow-up|0
2670400|NCT00579345|9220437|P3|Overall Study|Lost to Follow-up|0
2670401|NCT00579345|9220438|P2|Overall Study|Lost to Follow-up|0
2670402|NCT00579345|9220439|P1|Overall Study|Lost to Follow-up|1
2670403|NCT00579345|9220432|P8|Overall Study|Withdrawal by Subject|1
2670404|NCT00579345|9220433|P7|Overall Study|Withdrawal by Subject|0
2670405|NCT00579345|9220434|P6|Overall Study|Withdrawal by Subject|0
2670406|NCT00579345|9220435|P5|Overall Study|Withdrawal by Subject|0
2670407|NCT00579345|9220436|P4|Overall Study|Withdrawal by Subject|0
2670408|NCT00579345|9220437|P3|Overall Study|Withdrawal by Subject|0
2670409|NCT00579345|9220438|P2|Overall Study|Withdrawal by Subject|0
2670410|NCT00579345|9220439|P1|Overall Study|Withdrawal by Subject|2
2670411|NCT00579254|9220471|P1|Overall Study|Discontinued when study terminated|73
2670412|NCT00579254|9220471|P1|Overall Study|Lost to Follow-up|39
2670413|NCT00579098|9220495|P2|Overall Study|AF returned after ablation|2
2670414|NCT00579098|9220496|P1|Overall Study|AF returned after ablation|3
2670415|NCT00579098|9220495|P2|Overall Study|Withdrawal by Subject|3
2670416|NCT00579098|9220496|P1|Overall Study|Withdrawal by Subject|2
2670417|NCT00579098|9220495|P2|Overall Study|Adverse Event|3
2670418|NCT00579098|9220496|P1|Overall Study|Adverse Event|2
2670419|NCT00579098|9220495|P2|Overall Study|Lost to Follow-up|0
2670420|NCT00579098|9220496|P1|Overall Study|Lost to Follow-up|2
2670421|NCT00579059|9220512|P2|Overall Study|Study Canceled at 1 Year|10
2670422|NCT00579059|9220513|P1|Overall Study|Study Canceled at 1 Year|21
2670423|NCT00578942|9220587|P1|Overall Study|Lost to Follow-up|1
2670424|NCT00578877|9220626|P2|Overall Study|did not provide follow-up data|17
2670425|NCT00578877|9220627|P1|Overall Study|did not provide follow-up data|12
2670426|NCT00578877|9220626|P2|Overall Study|early discontinue|101
2670427|NCT00578877|9220627|P1|Overall Study|early discontinue|61
2670428|NCT00578877|9220626|P2|Overall Study|Lost to Follow-up|10
2670429|NCT00578877|9220627|P1|Overall Study|Lost to Follow-up|8
2670430|NCT00578864|9220635|P2|Overall Study|Death|0
2670431|NCT00578864|9220636|P1|Overall Study|Death|1
2670432|NCT00578812|9220652|P2|Overall Study|Not treated|7
2670433|NCT00578812|9220653|P1|Overall Study|Not treated|6
2670434|NCT00578786|9220692|P3|Overall Study|Qualified but Not Enrolled in Extension|0
2670435|NCT00578786|9220693|P2|Overall Study|Qualified but Not Enrolled in Extension|3
2670436|NCT00578786|9220694|P1|Overall Study|Qualified but Not Enrolled in Extension|0
2670437|NCT00578786|9220692|P3|Overall Study|Not Otherwise Specified|1
2670438|NCT00578786|9220693|P2|Overall Study|Not Otherwise Specified|4
2670439|NCT00578786|9220694|P1|Overall Study|Not Otherwise Specified|0
2670440|NCT00578786|9220692|P3|Overall Study|Pregnancy|0
2670441|NCT00578786|9220693|P2|Overall Study|Pregnancy|1
2670442|NCT00578786|9220694|P1|Overall Study|Pregnancy|0
2670443|NCT00578786|9220692|P3|Overall Study|Lost to Follow-up|0
2670444|NCT00578786|9220693|P2|Overall Study|Lost to Follow-up|4
2670445|NCT00578786|9220694|P1|Overall Study|Lost to Follow-up|0
2670446|NCT00578786|9220692|P3|Overall Study|Sponsor Decision|1
2670447|NCT00578786|9220693|P2|Overall Study|Sponsor Decision|0
2670448|NCT00578786|9220694|P1|Overall Study|Sponsor Decision|0
2670449|NCT00578786|9220692|P3|Overall Study|Physician Decision|1
2670450|NCT00578786|9220693|P2|Overall Study|Physician Decision|0
2670451|NCT00578786|9220694|P1|Overall Study|Physician Decision|1
2670452|NCT00578786|9220692|P3|Overall Study|Protocol Violation|1
2670453|NCT00578786|9220693|P2|Overall Study|Protocol Violation|3
2670454|NCT00578786|9220694|P1|Overall Study|Protocol Violation|0
2670455|NCT00578786|9220692|P3|Overall Study|Withdrawal by Subject|5
2670456|NCT00578786|9220693|P2|Overall Study|Withdrawal by Subject|8
2670457|NCT00578786|9220694|P1|Overall Study|Withdrawal by Subject|7
2670458|NCT00578786|9220692|P3|Overall Study|Early Escape from Prior Study|2
2670459|NCT00578786|9220693|P2|Overall Study|Early Escape from Prior Study|1
2670460|NCT00578786|9220694|P1|Overall Study|Early Escape from Prior Study|2
2670461|NCT00578786|9220692|P3|Overall Study|Lack of Efficacy|2
2670462|NCT00578786|9220693|P2|Overall Study|Lack of Efficacy|5
2670463|NCT00578786|9220694|P1|Overall Study|Lack of Efficacy|2
2670464|NCT00578786|9220692|P3|Overall Study|Adverse Event|17
2670465|NCT00578786|9220693|P2|Overall Study|Adverse Event|37
2670466|NCT00578786|9220694|P1|Overall Study|Adverse Event|27
2670467|NCT00578643|9220795|P1|Overall Study|Lost to Follow-up|1
2670468|NCT00578643|9220795|P1|Overall Study|Death|1
2670469|NCT00578565|9220811|P1|Overall Study|Adverse Event|3
2670470|NCT00578448|9220841|P1|1 Year Long Term Extension (LTE)|Adverse Event|1
2670471|NCT00578448|9220841|P1|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1
2670472|NCT00578448|9220841|P1|Day 1 up to 3 Years of Planned Study|Adverse Event|1
2670473|NCT00578448|9220841|P1|Day 1 up to 3 Years of Planned Study|Death|1
2670474|NCT00578318|9220905|P2|Overall Study|Physician Decision|0
2670475|NCT00578318|9220906|P1|Overall Study|Physician Decision|1
2670476|NCT00578318|9220905|P2|Overall Study|Lost to Follow-up|0
2670477|NCT00578318|9220906|P1|Overall Study|Lost to Follow-up|2
2670478|NCT00578227|9220988|P3|Overall Study|Withdrawal by Subject|3
2670479|NCT00578227|9220989|P2|Overall Study|Withdrawal by Subject|1
2670480|NCT00578227|9220990|P1|Overall Study|Withdrawal by Subject|5
2670481|NCT00578227|9220988|P3|Overall Study|Lost to Follow-up|1
2670482|NCT00578227|9220989|P2|Overall Study|Lost to Follow-up|1
2670483|NCT00578227|9220990|P1|Overall Study|Lost to Follow-up|0
2670484|NCT00578175|9221115|P3|Overall Study|Other reasons|23
2670485|NCT00578175|9221116|P2|Overall Study|Other reasons|42
2670486|NCT00578175|9221117|P1|Overall Study|Other reasons|70
2670487|NCT00578175|9221115|P3|Overall Study|Adverse Event|1
2670488|NCT00578175|9221116|P2|Overall Study|Adverse Event|1
2670489|NCT00578175|9221117|P1|Overall Study|Adverse Event|0
2670490|NCT00578136|9221196|P2|Overall Study|Not given intervention|1
2670491|NCT00578136|9221197|P1|Overall Study|Not given intervention|1
2670492|NCT00577889|9221215|P3|Overall Study|Withdrawal by Subject|0
2670493|NCT00577889|9221216|P2|Overall Study|Withdrawal by Subject|0
2670494|NCT00577889|9221217|P1|Overall Study|Withdrawal by Subject|1
2670495|NCT00577863|9221236|P2|Overall Study|Did Not Receive at Least One Injection|1
2670496|NCT00577863|9221237|P1|Overall Study|Did Not Receive at Least One Injection|0
2670497|NCT00577863|9221236|P2|Overall Study|Sponsor Decision|7
2670498|NCT00577863|9221237|P1|Overall Study|Sponsor Decision|2
2670499|NCT00577863|9221236|P2|Overall Study|Withdrawal by Subject|2
2670500|NCT00577863|9221237|P1|Overall Study|Withdrawal by Subject|0
2670501|NCT00577863|9221236|P2|Overall Study|Entry Criteria Exclusion|0
2670502|NCT00577863|9221237|P1|Overall Study|Entry Criteria Exclusion|1
2670503|NCT00577863|9221236|P2|Overall Study|Lost to Follow-up|2
2670504|NCT00577863|9221237|P1|Overall Study|Lost to Follow-up|2
2670505|NCT00577863|9221236|P2|Overall Study|Death|0
2670506|NCT00577863|9221237|P1|Overall Study|Death|1
2670507|NCT00577863|9221236|P2|Overall Study|Adverse Event|2
2670508|NCT00577863|9221237|P1|Overall Study|Adverse Event|4
2670509|NCT00577824|9221279|P3|Overall Study|Protocol Violation|0
2670510|NCT00577824|9221280|P2|Overall Study|Protocol Violation|1
2670511|NCT00577824|9221281|P1|Overall Study|Protocol Violation|1
2670512|NCT00577824|9221279|P3|Overall Study|Patient decision|1
2670513|NCT00577824|9221280|P2|Overall Study|Patient decision|1
2670514|NCT00577824|9221281|P1|Overall Study|Patient decision|0
2670515|NCT00577824|9221279|P3|Overall Study|Adverse Event|1
2670516|NCT00577824|9221280|P2|Overall Study|Adverse Event|18
2670517|NCT00577824|9221281|P1|Overall Study|Adverse Event|6
2670518|NCT00577772|9221339|P2|Overall Study|Lost to Follow-up|1
2670519|NCT00577772|9221340|P1|Overall Study|Lost to Follow-up|0
2670520|NCT00577720|9221350|P4|Overall Study|Withdrawal by Subject|2
2670521|NCT00577720|9221351|P3|Overall Study|Withdrawal by Subject|0
2670522|NCT00577720|9221352|P2|Overall Study|Withdrawal by Subject|0
2670523|NCT00577720|9221353|P1|Overall Study|Withdrawal by Subject|2
2670524|NCT00577720|9221350|P4|Overall Study|Protocol Violation|1
2670525|NCT00577720|9221351|P3|Overall Study|Protocol Violation|0
2670526|NCT00577720|9221352|P2|Overall Study|Protocol Violation|0
2670527|NCT00577720|9221353|P1|Overall Study|Protocol Violation|0
2670528|NCT00577720|9221350|P4|Overall Study|Lost to Follow-up|0
2670529|NCT00577720|9221351|P3|Overall Study|Lost to Follow-up|1
2670530|NCT00577720|9221352|P2|Overall Study|Lost to Follow-up|0
2670531|NCT00577720|9221353|P1|Overall Study|Lost to Follow-up|0
2670532|NCT00577720|9221350|P4|Overall Study|Adverse Event|4
2670533|NCT00577720|9221351|P3|Overall Study|Adverse Event|0
2670534|NCT00577720|9221352|P2|Overall Study|Adverse Event|1
2670535|NCT00577720|9221353|P1|Overall Study|Adverse Event|2
2670536|NCT00577707|9221371|P1|Overall Study|Withdrawal by Subject|3
2670537|NCT00577655|9221379|P2|Overall Study|Lost to Follow-up|1
2670538|NCT00577655|9221380|P1|Overall Study|Lost to Follow-up|1
2670539|NCT00577655|9221379|P2|Overall Study|Protocol Violation|1
2670540|NCT00577655|9221380|P1|Overall Study|Protocol Violation|0
2670541|NCT00577655|9221379|P2|Overall Study|Patient Request|2
2670542|NCT00577655|9221380|P1|Overall Study|Patient Request|0
2670543|NCT00577642|9221418|P1|Overall Study|Clinical Disease Progression|1
2670544|NCT00577629|9221422|P1|Long Term Follow-Up|Physician Decision|1
2670545|NCT00577629|9221422|P1|Long Term Follow-Up|Withdrawal by Subject|4
2670546|NCT00577629|9221422|P1|Long Term Follow-Up|Lost to Follow-up|5
2670547|NCT00577629|9221422|P1|Long Term Follow-Up|Death|15
2670548|NCT00577629|9221422|P1|Treatment Period|Death|1
2670549|NCT00577473|9221449|P2|Overall Study|Lack of Efficacy|7
2670550|NCT00577473|9221450|P1|Overall Study|Lack of Efficacy|8
2670551|NCT00577473|9221449|P2|Overall Study|Physician Decision|2
2670552|NCT00577473|9221450|P1|Overall Study|Physician Decision|2
2670553|NCT00577473|9221449|P2|Overall Study|Withdrawal by Subject|6
2670554|NCT00577473|9221450|P1|Overall Study|Withdrawal by Subject|2
2670555|NCT00577473|9221449|P2|Overall Study|Adverse Event|5
2670556|NCT00577473|9221450|P1|Overall Study|Adverse Event|8
2670557|NCT00577473|9221449|P2|Overall Study|Protocol Violation|4
2670558|NCT00577473|9221450|P1|Overall Study|Protocol Violation|1
2670559|NCT00577460|9221481|P3|Overall Study|Other|2
2670560|NCT00577460|9221482|P2|Overall Study|Other|3
2670561|NCT00577460|9221483|P1|Overall Study|Other|0
2670562|NCT00577460|9221481|P3|Overall Study|Withdrawal by Subject|6
2670563|NCT00577460|9221482|P2|Overall Study|Withdrawal by Subject|5
2670564|NCT00577460|9221483|P1|Overall Study|Withdrawal by Subject|5
2670565|NCT00577460|9221481|P3|Overall Study|Lost to Follow-up|4
2670566|NCT00577460|9221482|P2|Overall Study|Lost to Follow-up|3
2670567|NCT00577460|9221483|P1|Overall Study|Lost to Follow-up|0
2670568|NCT00577460|9221481|P3|Overall Study|Protocol Violation|1
2670569|NCT00577460|9221482|P2|Overall Study|Protocol Violation|1
2670570|NCT00577460|9221483|P1|Overall Study|Protocol Violation|0
2670571|NCT00577460|9221481|P3|Overall Study|Adverse Event|14
2670572|NCT00577460|9221482|P2|Overall Study|Adverse Event|7
2670573|NCT00577460|9221483|P1|Overall Study|Adverse Event|11
2670574|NCT00577408|9221592|P2|Overall Study|Psychiatric hospitalization|1
2670575|NCT00577408|9221593|P1|Overall Study|Psychiatric hospitalization|0
2670576|NCT00577408|9221592|P2|Overall Study|Death|1
2670577|NCT00577408|9221593|P1|Overall Study|Death|0
2670578|NCT00577408|9221592|P2|Overall Study|Scheduling Issues|3
2670579|NCT00577408|9221593|P1|Overall Study|Scheduling Issues|0
2670580|NCT00577408|9221592|P2|Overall Study|Moved out of state|1
2670581|NCT00577408|9221593|P1|Overall Study|Moved out of state|0
2670582|NCT00577408|9221592|P2|Overall Study|Refused Oral Naltrexone|1
2670583|NCT00577408|9221593|P1|Overall Study|Refused Oral Naltrexone|0
2670584|NCT00577408|9221592|P2|Overall Study|Non-compliance with study meds|3
2670585|NCT00577408|9221593|P1|Overall Study|Non-compliance with study meds|0
2670586|NCT00577408|9221592|P2|Overall Study|Continued opioid use|2
2670587|NCT00577408|9221593|P1|Overall Study|Continued opioid use|3
2670588|NCT00577408|9221592|P2|Overall Study|Stopped attending study visits|11
2670589|NCT00577408|9221593|P1|Overall Study|Stopped attending study visits|9
2670590|NCT00577395|9221601|P2|Overall Study|Study was terminated early by Sponsor|6
2670591|NCT00577395|9221602|P1|Overall Study|Study was terminated early by Sponsor|7
2670592|NCT00577382|9221612|P2|Overall Study|Lost to Follow-up|2
2670593|NCT00577382|9221613|P1|Overall Study|Lost to Follow-up|2
2670594|NCT00577382|9221612|P2|Overall Study|Death|1
2670595|NCT00577382|9221613|P1|Overall Study|Death|1
2670596|NCT00577382|9221612|P2|Overall Study|Intercurrent Illness|2
2670597|NCT00577382|9221613|P1|Overall Study|Intercurrent Illness|1
2670598|NCT00577382|9221612|P2|Overall Study|Progressive Disease|19
2670599|NCT00577382|9221613|P1|Overall Study|Progressive Disease|17
2670600|NCT00577382|9221612|P2|Overall Study|Withdrawal by Subject|1
2670601|NCT00577382|9221613|P1|Overall Study|Withdrawal by Subject|0
2670602|NCT00577382|9221612|P2|Overall Study|Adverse Event|6
2670603|NCT00577382|9221613|P1|Overall Study|Adverse Event|0
2670604|NCT00577122|9221756|P2|Overall Study|Alternative Therapy|1
2670605|NCT00577122|9221757|P1|Overall Study|Alternative Therapy|0
2670606|NCT00577122|9221756|P2|Overall Study|Prog, refract disease during active trt|5
2670607|NCT00577122|9221757|P1|Overall Study|Prog, refract disease during active trt|8
2670608|NCT00577122|9221756|P2|Overall Study|Progression, relapse during active trt|8
2670609|NCT00577122|9221757|P1|Overall Study|Progression, relapse during active trt|6
2670610|NCT00577122|9221756|P2|Overall Study|Adverse Event|2
2670611|NCT00577122|9221757|P1|Overall Study|Adverse Event|0
2670612|NCT00577096|9221771|P2|Short Term Participation|Death|1
2670613|NCT00577096|9221772|P1|Short Term Participation|Death|1
2670614|NCT00577096|9221771|P2|Short Term Participation|Withdrawal by Subject|5
2670615|NCT00577096|9221772|P1|Short Term Participation|Withdrawal by Subject|3
2670616|NCT00577096|9221771|P2|Short Term Participation|withdrew from multiple myeloma treatment|2
2670617|NCT00577096|9221772|P1|Short Term Participation|withdrew from multiple myeloma treatment|3
2670618|NCT00577031|9221811|P1|Overall Study|Death|6
2670619|NCT00577031|9221811|P1|Overall Study|Medical decision|14
2670620|NCT00577031|9221811|P1|Overall Study|Need for surgery|17
2670621|NCT00577031|9221811|P1|Overall Study|Participant non-compliance|5
2670622|NCT00577031|9221811|P1|Overall Study|Participant withdrew consent|13
2670623|NCT00577031|9221811|P1|Overall Study|Protocol Violation|5
2670624|NCT00577031|9221811|P1|Overall Study|Progression of disease|93
2670625|NCT00577031|9221811|P1|Overall Study|Adverse Event|52
2670626|NCT00577005|9221832|P2|Overall Study|Withdrawal by Subject|1
2670627|NCT00577005|9221833|P1|Overall Study|Withdrawal by Subject|2
2670628|NCT00577005|9221832|P2|Overall Study|Lost to Follow-up|2
2670629|NCT00577005|9221833|P1|Overall Study|Lost to Follow-up|3
2670630|NCT00576927|9221847|P1|Sleep Hygiene With the Placebo|Withdrawal by Subject|1
2670631|NCT00576927|9221847|P1|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1
2670632|NCT00576927|9221847|P1|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1
2670633|NCT00576927|9221847|P1|Sleep Hygiene Behavioral Intervention|Death|1
2670634|NCT00576927|9221847|P1|Sleep Hygiene Behavioral Intervention|Responded to intervention|4
2670635|NCT00576927|9221847|P1|Baseline|Withdrawal by Subject|3
2670636|NCT00576927|9221847|P1|Baseline|Medication Change by PCP of subject|1
2670637|NCT00576927|9221847|P1|Baseline|Physician Decision|9
2670638|NCT00576927|9221847|P1|Clinical Assessment|Physician Decision|1
2670639|NCT00576927|9221847|P1|Clinical Assessment|Withdrawal by Subject|10
2670640|NCT00576927|9221847|P1|Clinical Assessment|Death|1
2670641|NCT00576927|9221847|P1|Clinical Assessment|Lack of Efficacy|24
2670642|NCT00576901|9221859|P1|Overall Study|Protocol Violation|1
2670643|NCT00576901|9221859|P1|Overall Study|Disease course|1
2670644|NCT00576901|9221859|P1|Overall Study|Withdrawal by Subject|1
2670645|NCT00576836|9221867|P2|Overall Study|Physician Decision|1
2670646|NCT00576836|9221868|P1|Overall Study|Physician Decision|0
2670647|NCT00576836|9221867|P2|Overall Study|Death|1
2670648|NCT00576836|9221868|P1|Overall Study|Death|0
2670649|NCT00576823|9221883|P3|40-week Safety Extension Phase|Lack of Efficacy|0
2670650|NCT00576823|9221884|P2|40-week Safety Extension Phase|Lack of Efficacy|0
2670651|NCT00576823|9221885|P1|40-week Safety Extension Phase|Lack of Efficacy|1
2670652|NCT00576823|9221883|P3|12-week Efficacy Phase|Parentʼs schedule issue|0
2670653|NCT00576823|9221884|P2|12-week Efficacy Phase|Parentʼs schedule issue|0
2670654|NCT00576823|9221885|P1|12-week Efficacy Phase|Parentʼs schedule issue|1
2670655|NCT00576758|9221901|P2|Follow-up Period|Withdrew consent|1
2670656|NCT00576758|9221902|P1|Follow-up Period|Withdrew consent|2
2670657|NCT00576758|9221901|P2|Follow-up Period|Insufficient therapeutic response|5
2670658|NCT00576758|9221902|P1|Follow-up Period|Insufficient therapeutic response|16
2670659|NCT00576758|9221901|P2|Follow-up Period|Death|3
2670660|NCT00576758|9221902|P1|Follow-up Period|Death|3
2670661|NCT00576758|9221901|P2|Follow-up Period|Administrative/Other|8
2670662|NCT00576758|9221902|P1|Follow-up Period|Administrative/Other|6
2670663|NCT00576758|9221901|P2|Extension Treatment Period|Administrative/Other|1
2670664|NCT00576758|9221902|P1|Extension Treatment Period|Administrative/Other|3
2670665|NCT00576758|9221901|P2|Extension Treatment Period|Insufficient therapeutic response|33
2670666|NCT00576758|9221902|P1|Extension Treatment Period|Insufficient therapeutic response|30
2670667|NCT00576758|9221901|P2|Extension Treatment Period|Refused treatment/did not cooperate|1
2670668|NCT00576758|9221902|P1|Extension Treatment Period|Refused treatment/did not cooperate|2
2670669|NCT00576758|9221901|P2|Extension Treatment Period|Death|1
2670670|NCT00576758|9221902|P1|Extension Treatment Period|Death|1
2670671|NCT00576758|9221901|P2|Extension Treatment Period|Adverse event or Intercurrent illness|7
2670672|NCT00576758|9221902|P1|Extension Treatment Period|Adverse event or Intercurrent illness|6
2670673|NCT00576758|9221901|P2|Induction Treatment Period|Withdrew consent|0
2670674|NCT00576758|9221902|P1|Induction Treatment Period|Withdrew consent|1
2670675|NCT00576758|9221901|P2|Induction Treatment Period|Refused treatment/ Did not Cooperate|1
2670676|NCT00576758|9221902|P1|Induction Treatment Period|Refused treatment/ Did not Cooperate|0
2670677|NCT00576758|9221901|P2|Induction Treatment Period|Death|0
2670678|NCT00576758|9221902|P1|Induction Treatment Period|Death|1
2670679|NCT00576758|9221901|P2|Induction Treatment Period|Violation of selection criteria at entry|1
2670680|NCT00576758|9221902|P1|Induction Treatment Period|Violation of selection criteria at entry|1
2670681|NCT00576758|9221901|P2|Induction Treatment Period|Insufficient therapeutic response|0
2670682|NCT00576758|9221902|P1|Induction Treatment Period|Insufficient therapeutic response|2
2670683|NCT00576758|9221901|P2|Induction Treatment Period|Adverse event or Intercurrent illness|3
2670684|NCT00576758|9221902|P1|Induction Treatment Period|Adverse event or Intercurrent illness|3
2670685|NCT00576732|9221948|P6|OPEN LABEL|Protocol Violation|0
2670686|NCT00576732|9221949|P5|OPEN LABEL|Protocol Violation|1
2670687|NCT00576732|9221950|P4|OPEN LABEL|Protocol Violation|2
2670688|NCT00576732|9221951|P3|OPEN LABEL|Protocol Violation|0
2670689|NCT00576732|9221952|P2|OPEN LABEL|Protocol Violation|0
2670690|NCT00576732|9221953|P1|OPEN LABEL|Protocol Violation|0
2670691|NCT00576732|9221948|P6|OPEN LABEL|Lack of Efficacy|3
2670692|NCT00576732|9221949|P5|OPEN LABEL|Lack of Efficacy|2
2670693|NCT00576732|9221950|P4|OPEN LABEL|Lack of Efficacy|2
2670694|NCT00576732|9221951|P3|OPEN LABEL|Lack of Efficacy|0
2670695|NCT00576732|9221952|P2|OPEN LABEL|Lack of Efficacy|0
2670696|NCT00576732|9221953|P1|OPEN LABEL|Lack of Efficacy|0
2670697|NCT00576732|9221948|P6|OPEN LABEL|OTHER|2
2670698|NCT00576732|9221949|P5|OPEN LABEL|OTHER|0
2670699|NCT00576732|9221950|P4|OPEN LABEL|OTHER|0
2670700|NCT00576732|9221951|P3|OPEN LABEL|OTHER|0
2670701|NCT00576732|9221952|P2|OPEN LABEL|OTHER|0
2670702|NCT00576732|9221953|P1|OPEN LABEL|OTHER|0
2670703|NCT00576732|9221948|P6|OPEN LABEL|Withdrawal by Subject|1
2670704|NCT00576732|9221949|P5|OPEN LABEL|Withdrawal by Subject|0
2670705|NCT00576732|9221950|P4|OPEN LABEL|Withdrawal by Subject|1
2670706|NCT00576732|9221951|P3|OPEN LABEL|Withdrawal by Subject|0
2670707|NCT00576732|9221952|P2|OPEN LABEL|Withdrawal by Subject|0
2670708|NCT00576732|9221953|P1|OPEN LABEL|Withdrawal by Subject|0
2670709|NCT00576732|9221948|P6|OPEN LABEL|Lost to Follow-up|1
2670710|NCT00576732|9221949|P5|OPEN LABEL|Lost to Follow-up|1
2670711|NCT00576732|9221950|P4|OPEN LABEL|Lost to Follow-up|2
2670712|NCT00576732|9221951|P3|OPEN LABEL|Lost to Follow-up|0
2670713|NCT00576732|9221952|P2|OPEN LABEL|Lost to Follow-up|0
2670714|NCT00576732|9221953|P1|OPEN LABEL|Lost to Follow-up|0
2670715|NCT00576732|9221948|P6|OPEN LABEL|Adverse Event|1
2670716|NCT00576732|9221949|P5|OPEN LABEL|Adverse Event|0
2670717|NCT00576732|9221950|P4|OPEN LABEL|Adverse Event|4
2670718|NCT00576732|9221951|P3|OPEN LABEL|Adverse Event|0
2670719|NCT00576732|9221952|P2|OPEN LABEL|Adverse Event|0
2670720|NCT00576732|9221953|P1|OPEN LABEL|Adverse Event|0
2670721|NCT00576732|9221948|P6|DOUBLE BLIND|Protocol Violation|0
2670722|NCT00576732|9221949|P5|DOUBLE BLIND|Protocol Violation|0
2670723|NCT00576732|9221950|P4|DOUBLE BLIND|Protocol Violation|0
2670724|NCT00576732|9221951|P3|DOUBLE BLIND|Protocol Violation|0
2670725|NCT00576732|9221952|P2|DOUBLE BLIND|Protocol Violation|0
2670726|NCT00576732|9221953|P1|DOUBLE BLIND|Protocol Violation|1
2670727|NCT00576732|9221948|P6|DOUBLE BLIND|Lack of Efficacy|0
2670728|NCT00576732|9221949|P5|DOUBLE BLIND|Lack of Efficacy|0
2670729|NCT00576732|9221950|P4|DOUBLE BLIND|Lack of Efficacy|0
2670730|NCT00576732|9221951|P3|DOUBLE BLIND|Lack of Efficacy|0
2670731|NCT00576732|9221952|P2|DOUBLE BLIND|Lack of Efficacy|1
2670732|NCT00576732|9221953|P1|DOUBLE BLIND|Lack of Efficacy|6
2670733|NCT00576732|9221948|P6|DOUBLE BLIND|OTHER|0
2670734|NCT00576732|9221949|P5|DOUBLE BLIND|OTHER|0
2670735|NCT00576732|9221950|P4|DOUBLE BLIND|OTHER|0
2670736|NCT00576732|9221951|P3|DOUBLE BLIND|OTHER|1
2670737|NCT00576732|9221952|P2|DOUBLE BLIND|OTHER|2
2670738|NCT00576732|9221953|P1|DOUBLE BLIND|OTHER|0
2670739|NCT00576732|9221948|P6|DOUBLE BLIND|Withdrawal by Subject|0
2670740|NCT00576732|9221949|P5|DOUBLE BLIND|Withdrawal by Subject|0
2670741|NCT00576732|9221950|P4|DOUBLE BLIND|Withdrawal by Subject|0
2670742|NCT00576732|9221951|P3|DOUBLE BLIND|Withdrawal by Subject|3
2670743|NCT00576732|9221952|P2|DOUBLE BLIND|Withdrawal by Subject|1
2670744|NCT00576732|9221953|P1|DOUBLE BLIND|Withdrawal by Subject|1
2670745|NCT00576732|9221948|P6|DOUBLE BLIND|Lost to Follow-up|0
2670746|NCT00576732|9221949|P5|DOUBLE BLIND|Lost to Follow-up|0
2670747|NCT00576732|9221950|P4|DOUBLE BLIND|Lost to Follow-up|0
2670748|NCT00576732|9221951|P3|DOUBLE BLIND|Lost to Follow-up|1
2670749|NCT00576732|9221952|P2|DOUBLE BLIND|Lost to Follow-up|1
2670750|NCT00576732|9221953|P1|DOUBLE BLIND|Lost to Follow-up|0
2670751|NCT00576732|9221948|P6|DOUBLE BLIND|Adverse Event|0
2670752|NCT00576732|9221949|P5|DOUBLE BLIND|Adverse Event|0
2670753|NCT00576732|9221950|P4|DOUBLE BLIND|Adverse Event|0
2670754|NCT00576732|9221951|P3|DOUBLE BLIND|Adverse Event|1
2670755|NCT00576732|9221952|P2|DOUBLE BLIND|Adverse Event|0
2670756|NCT00576732|9221953|P1|DOUBLE BLIND|Adverse Event|0
2670757|NCT00576693|9221985|P2|Overall Study|Withdrawal by Subject|13
2670758|NCT00576693|9221986|P1|Overall Study|Withdrawal by Subject|3
2670759|NCT00576693|9221985|P2|Overall Study|Lost to Follow-up|11
2670760|NCT00576693|9221986|P1|Overall Study|Lost to Follow-up|7
2670761|NCT00576628|9221992|P1|Overall Study|Dialysis|15
2670762|NCT00576628|9221992|P1|Overall Study|Transplantation|1
2670763|NCT00576628|9221992|P1|Overall Study|The patient move into other town|1
2670764|NCT00576628|9221992|P1|Overall Study|Progression of Renal Failure|1
2670765|NCT00576628|9221992|P1|Overall Study|Progression of Kidney Disease|1
2670766|NCT00576628|9221992|P1|Overall Study|RBC transfusion|1
2670767|NCT00576628|9221992|P1|Overall Study|Pregnancy|1
2670768|NCT00576628|9221992|P1|Overall Study|Refused Treatment|8
2670769|NCT00576628|9221992|P1|Overall Study|Failure to return|1
2670770|NCT00576628|9221992|P1|Overall Study|Death|2
2670771|NCT00576628|9221992|P1|Overall Study|Adverse Event|11
2670772|NCT00576576|9222012|P1|Overall Study|Protocol Violation|1
2670773|NCT00576576|9222012|P1|Overall Study|Lost to Follow-up|6
2670774|NCT00576472|9222046|P15|MPH Home Maintenance Phase|Lost to Follow-up|3
2670775|NCT00576472|9222047|P14|MPH Home Maintenance Phase|Lost to Follow-up|0
2670776|NCT00576472|9222048|P13|MPH Home Maintenance Phase|Lost to Follow-up|0
2670777|NCT00576472|9222049|P12|MPH Home Maintenance Phase|Lost to Follow-up|0
2670778|NCT00576472|9222050|P11|MPH Home Maintenance Phase|Lost to Follow-up|0
2670779|NCT00576472|9222051|P10|MPH Home Maintenance Phase|Lost to Follow-up|0
2670780|NCT00576472|9222052|P9|MPH Home Maintenance Phase|Lost to Follow-up|0
2670781|NCT00576472|9222053|P8|MPH Home Maintenance Phase|Lost to Follow-up|0
2670782|NCT00576472|9222054|P7|MPH Home Maintenance Phase|Lost to Follow-up|0
2670783|NCT00576472|9222055|P6|MPH Home Maintenance Phase|Lost to Follow-up|0
2670784|NCT00576472|9222056|P5|MPH Home Maintenance Phase|Lost to Follow-up|0
2670785|NCT00576472|9222057|P4|MPH Home Maintenance Phase|Lost to Follow-up|0
2670786|NCT00576472|9222058|P3|MPH Home Maintenance Phase|Lost to Follow-up|0
2670787|NCT00576472|9222059|P2|MPH Home Maintenance Phase|Lost to Follow-up|0
2670788|NCT00576472|9222060|P1|MPH Home Maintenance Phase|Lost to Follow-up|0
2670789|NCT00576472|9222046|P15|MPH Home Maintenance Phase|Medical reasons|6
2670790|NCT00576472|9222047|P14|MPH Home Maintenance Phase|Medical reasons|0
2670791|NCT00576472|9222048|P13|MPH Home Maintenance Phase|Medical reasons|0
2670792|NCT00576472|9222049|P12|MPH Home Maintenance Phase|Medical reasons|0
2670793|NCT00576472|9222050|P11|MPH Home Maintenance Phase|Medical reasons|0
2670794|NCT00576472|9222051|P10|MPH Home Maintenance Phase|Medical reasons|0
2670795|NCT00576472|9222052|P9|MPH Home Maintenance Phase|Medical reasons|0
2670796|NCT00576472|9222053|P8|MPH Home Maintenance Phase|Medical reasons|0
2670797|NCT00576472|9222054|P7|MPH Home Maintenance Phase|Medical reasons|0
2670798|NCT00576472|9222055|P6|MPH Home Maintenance Phase|Medical reasons|0
2670799|NCT00576472|9222056|P5|MPH Home Maintenance Phase|Medical reasons|0
2670800|NCT00576472|9222057|P4|MPH Home Maintenance Phase|Medical reasons|0
2670801|NCT00576472|9222058|P3|MPH Home Maintenance Phase|Medical reasons|0
2670802|NCT00576472|9222059|P2|MPH Home Maintenance Phase|Medical reasons|0
2670803|NCT00576472|9222060|P1|MPH Home Maintenance Phase|Medical reasons|0
2670804|NCT00576472|9222046|P15|MPH Home Maintenance Phase|Withdrawal by Subject|6
2670805|NCT00576472|9222047|P14|MPH Home Maintenance Phase|Withdrawal by Subject|0
2670806|NCT00576472|9222048|P13|MPH Home Maintenance Phase|Withdrawal by Subject|0
2670807|NCT00576472|9222049|P12|MPH Home Maintenance Phase|Withdrawal by Subject|0
2670808|NCT00576472|9222050|P11|MPH Home Maintenance Phase|Withdrawal by Subject|0
2670809|NCT00576472|9222051|P10|MPH Home Maintenance Phase|Withdrawal by Subject|0
2670810|NCT00576472|9222052|P9|MPH Home Maintenance Phase|Withdrawal by Subject|0
2670811|NCT00576472|9222053|P8|MPH Home Maintenance Phase|Withdrawal by Subject|0
2670812|NCT00576472|9222054|P7|MPH Home Maintenance Phase|Withdrawal by Subject|0
2670813|NCT00576472|9222055|P6|MPH Home Maintenance Phase|Withdrawal by Subject|0
2670814|NCT00576472|9222056|P5|MPH Home Maintenance Phase|Withdrawal by Subject|0
2670815|NCT00576472|9222057|P4|MPH Home Maintenance Phase|Withdrawal by Subject|0
2670816|NCT00576472|9222058|P3|MPH Home Maintenance Phase|Withdrawal by Subject|0
2670817|NCT00576472|9222059|P2|MPH Home Maintenance Phase|Withdrawal by Subject|0
2670818|NCT00576472|9222060|P1|MPH Home Maintenance Phase|Withdrawal by Subject|0
2670819|NCT00576472|9222046|P15|MPH Home Maintenance Phase|Side effects|8
2670820|NCT00576472|9222047|P14|MPH Home Maintenance Phase|Side effects|0
2670821|NCT00576472|9222048|P13|MPH Home Maintenance Phase|Side effects|0
2670822|NCT00576472|9222049|P12|MPH Home Maintenance Phase|Side effects|0
2670823|NCT00576472|9222050|P11|MPH Home Maintenance Phase|Side effects|0
2670824|NCT00576472|9222051|P10|MPH Home Maintenance Phase|Side effects|0
2670825|NCT00576472|9222052|P9|MPH Home Maintenance Phase|Side effects|0
2670826|NCT00576472|9222053|P8|MPH Home Maintenance Phase|Side effects|0
2670827|NCT00576472|9222054|P7|MPH Home Maintenance Phase|Side effects|0
2670828|NCT00576472|9222055|P6|MPH Home Maintenance Phase|Side effects|0
2670829|NCT00576472|9222056|P5|MPH Home Maintenance Phase|Side effects|0
2670830|NCT00576472|9222057|P4|MPH Home Maintenance Phase|Side effects|0
2670831|NCT00576472|9222058|P3|MPH Home Maintenance Phase|Side effects|0
2670832|NCT00576472|9222059|P2|MPH Home Maintenance Phase|Side effects|0
2670833|NCT00576472|9222060|P1|MPH Home Maintenance Phase|Side effects|0
2670834|NCT00576472|9222046|P15|MPH Home Maintenance Phase|Insufficient data|0
2670835|NCT00576472|9222047|P14|MPH Home Maintenance Phase|Insufficient data|4
2670836|NCT00576472|9222048|P13|MPH Home Maintenance Phase|Insufficient data|0
2670837|NCT00576472|9222049|P12|MPH Home Maintenance Phase|Insufficient data|0
2670838|NCT00576472|9222050|P11|MPH Home Maintenance Phase|Insufficient data|0
2670839|NCT00576472|9222051|P10|MPH Home Maintenance Phase|Insufficient data|0
2670840|NCT00576472|9222052|P9|MPH Home Maintenance Phase|Insufficient data|0
2670841|NCT00576472|9222053|P8|MPH Home Maintenance Phase|Insufficient data|0
2670842|NCT00576472|9222054|P7|MPH Home Maintenance Phase|Insufficient data|0
2670843|NCT00576472|9222055|P6|MPH Home Maintenance Phase|Insufficient data|0
2670844|NCT00576472|9222056|P5|MPH Home Maintenance Phase|Insufficient data|0
2670845|NCT00576472|9222057|P4|MPH Home Maintenance Phase|Insufficient data|0
2670846|NCT00576472|9222058|P3|MPH Home Maintenance Phase|Insufficient data|0
2670847|NCT00576472|9222059|P2|MPH Home Maintenance Phase|Insufficient data|0
2670848|NCT00576472|9222060|P1|MPH Home Maintenance Phase|Insufficient data|0
2670849|NCT00576472|9222046|P15|MPH Home Maintenance Phase|Declined to participate|0
2670850|NCT00576472|9222047|P14|MPH Home Maintenance Phase|Declined to participate|7
2670851|NCT00576472|9222048|P13|MPH Home Maintenance Phase|Declined to participate|0
2670852|NCT00576472|9222049|P12|MPH Home Maintenance Phase|Declined to participate|0
2670853|NCT00576472|9222050|P11|MPH Home Maintenance Phase|Declined to participate|0
2670854|NCT00576472|9222051|P10|MPH Home Maintenance Phase|Declined to participate|0
2670855|NCT00576472|9222052|P9|MPH Home Maintenance Phase|Declined to participate|0
2670856|NCT00576472|9222053|P8|MPH Home Maintenance Phase|Declined to participate|0
2670857|NCT00576472|9222054|P7|MPH Home Maintenance Phase|Declined to participate|0
2670858|NCT00576472|9222055|P6|MPH Home Maintenance Phase|Declined to participate|0
2670859|NCT00576472|9222056|P5|MPH Home Maintenance Phase|Declined to participate|0
2670860|NCT00576472|9222057|P4|MPH Home Maintenance Phase|Declined to participate|0
2670861|NCT00576472|9222058|P3|MPH Home Maintenance Phase|Declined to participate|0
2670862|NCT00576472|9222059|P2|MPH Home Maintenance Phase|Declined to participate|0
2670863|NCT00576472|9222060|P1|MPH Home Maintenance Phase|Declined to participate|0
2670864|NCT00576472|9222046|P15|MPH Home Maintenance Phase|Did not meet response criteria|0
2670865|NCT00576472|9222047|P14|MPH Home Maintenance Phase|Did not meet response criteria|16
2670866|NCT00576472|9222048|P13|MPH Home Maintenance Phase|Did not meet response criteria|0
2670867|NCT00576472|9222049|P12|MPH Home Maintenance Phase|Did not meet response criteria|0
2670868|NCT00576472|9222050|P11|MPH Home Maintenance Phase|Did not meet response criteria|0
2670869|NCT00576472|9222051|P10|MPH Home Maintenance Phase|Did not meet response criteria|0
2670870|NCT00576472|9222052|P9|MPH Home Maintenance Phase|Did not meet response criteria|0
2670871|NCT00576472|9222053|P8|MPH Home Maintenance Phase|Did not meet response criteria|0
2670872|NCT00576472|9222054|P7|MPH Home Maintenance Phase|Did not meet response criteria|0
2670873|NCT00576472|9222055|P6|MPH Home Maintenance Phase|Did not meet response criteria|0
2670874|NCT00576472|9222056|P5|MPH Home Maintenance Phase|Did not meet response criteria|0
2670875|NCT00576472|9222057|P4|MPH Home Maintenance Phase|Did not meet response criteria|0
2670876|NCT00576472|9222058|P3|MPH Home Maintenance Phase|Did not meet response criteria|0
2670877|NCT00576472|9222059|P2|MPH Home Maintenance Phase|Did not meet response criteria|0
2670878|NCT00576472|9222060|P1|MPH Home Maintenance Phase|Did not meet response criteria|0
2670879|NCT00576472|9222046|P15|MPH Cross Over Phase|Did not complete cross over phase|0
2670880|NCT00576472|9222047|P14|MPH Cross Over Phase|Did not complete cross over phase|0
2670881|NCT00576472|9222048|P13|MPH Cross Over Phase|Did not complete cross over phase|0
2670882|NCT00576472|9222049|P12|MPH Cross Over Phase|Did not complete cross over phase|1
2670883|NCT00576472|9222050|P11|MPH Cross Over Phase|Did not complete cross over phase|1
2670884|NCT00576472|9222051|P10|MPH Cross Over Phase|Did not complete cross over phase|0
2670885|NCT00576472|9222052|P9|MPH Cross Over Phase|Did not complete cross over phase|2
2670886|NCT00576472|9222053|P8|MPH Cross Over Phase|Did not complete cross over phase|0
2670887|NCT00576472|9222054|P7|MPH Cross Over Phase|Did not complete cross over phase|0
2670888|NCT00576472|9222055|P6|MPH Cross Over Phase|Did not complete cross over phase|0
2670889|NCT00576472|9222056|P5|MPH Cross Over Phase|Did not complete cross over phase|0
2670890|NCT00576472|9222057|P4|MPH Cross Over Phase|Did not complete cross over phase|0
2670891|NCT00576472|9222058|P3|MPH Cross Over Phase|Did not complete cross over phase|0
2670892|NCT00576472|9222059|P2|MPH Cross Over Phase|Did not complete cross over phase|0
2670893|NCT00576472|9222060|P1|MPH Cross Over Phase|Did not complete cross over phase|0
2670894|NCT00576472|9222046|P15|MPH Cross Over Phase|Physician Decision|0
2670895|NCT00576472|9222047|P14|MPH Cross Over Phase|Physician Decision|0
2670896|NCT00576472|9222048|P13|MPH Cross Over Phase|Physician Decision|0
2670897|NCT00576472|9222049|P12|MPH Cross Over Phase|Physician Decision|0
2670898|NCT00576472|9222050|P11|MPH Cross Over Phase|Physician Decision|0
2670899|NCT00576472|9222051|P10|MPH Cross Over Phase|Physician Decision|0
2670900|NCT00576472|9222052|P9|MPH Cross Over Phase|Physician Decision|0
2670901|NCT00576472|9222053|P8|MPH Cross Over Phase|Physician Decision|0
2670902|NCT00576472|9222054|P7|MPH Cross Over Phase|Physician Decision|4
2670903|NCT00576472|9222055|P6|MPH Cross Over Phase|Physician Decision|0
2670904|NCT00576472|9222056|P5|MPH Cross Over Phase|Physician Decision|0
2670905|NCT00576472|9222057|P4|MPH Cross Over Phase|Physician Decision|0
2670906|NCT00576472|9222058|P3|MPH Cross Over Phase|Physician Decision|0
2670907|NCT00576472|9222059|P2|MPH Cross Over Phase|Physician Decision|0
2670908|NCT00576472|9222060|P1|MPH Cross Over Phase|Physician Decision|0
2670909|NCT00576472|9222046|P15|MPH Cross Over Phase|Ineligible due to disease|0
2670910|NCT00576472|9222047|P14|MPH Cross Over Phase|Ineligible due to disease|0
2670911|NCT00576472|9222048|P13|MPH Cross Over Phase|Ineligible due to disease|0
2670912|NCT00576472|9222049|P12|MPH Cross Over Phase|Ineligible due to disease|0
2670913|NCT00576472|9222050|P11|MPH Cross Over Phase|Ineligible due to disease|0
2670914|NCT00576472|9222051|P10|MPH Cross Over Phase|Ineligible due to disease|0
2670915|NCT00576472|9222052|P9|MPH Cross Over Phase|Ineligible due to disease|0
2670916|NCT00576472|9222053|P8|MPH Cross Over Phase|Ineligible due to disease|0
2670917|NCT00576472|9222054|P7|MPH Cross Over Phase|Ineligible due to disease|2
2670918|NCT00576472|9222055|P6|MPH Cross Over Phase|Ineligible due to disease|0
2670919|NCT00576472|9222056|P5|MPH Cross Over Phase|Ineligible due to disease|0
2670920|NCT00576472|9222057|P4|MPH Cross Over Phase|Ineligible due to disease|0
2670921|NCT00576472|9222058|P3|MPH Cross Over Phase|Ineligible due to disease|0
2670922|NCT00576472|9222059|P2|MPH Cross Over Phase|Ineligible due to disease|0
2670923|NCT00576472|9222060|P1|MPH Cross Over Phase|Ineligible due to disease|0
2670924|NCT00576472|9222046|P15|MPH Cross Over Phase|Withdrawal by Subject|0
2670925|NCT00576472|9222047|P14|MPH Cross Over Phase|Withdrawal by Subject|0
2670926|NCT00576472|9222048|P13|MPH Cross Over Phase|Withdrawal by Subject|0
2670927|NCT00576472|9222049|P12|MPH Cross Over Phase|Withdrawal by Subject|0
2670928|NCT00576472|9222050|P11|MPH Cross Over Phase|Withdrawal by Subject|0
2670929|NCT00576472|9222051|P10|MPH Cross Over Phase|Withdrawal by Subject|0
2670930|NCT00576472|9222052|P9|MPH Cross Over Phase|Withdrawal by Subject|0
2670931|NCT00576472|9222053|P8|MPH Cross Over Phase|Withdrawal by Subject|0
2670932|NCT00576472|9222054|P7|MPH Cross Over Phase|Withdrawal by Subject|6
2670933|NCT00576472|9222055|P6|MPH Cross Over Phase|Withdrawal by Subject|0
2670934|NCT00576472|9222056|P5|MPH Cross Over Phase|Withdrawal by Subject|0
2670935|NCT00576472|9222057|P4|MPH Cross Over Phase|Withdrawal by Subject|0
2670936|NCT00576472|9222058|P3|MPH Cross Over Phase|Withdrawal by Subject|0
2670937|NCT00576472|9222059|P2|MPH Cross Over Phase|Withdrawal by Subject|0
2670938|NCT00576472|9222060|P1|MPH Cross Over Phase|Withdrawal by Subject|0
2670939|NCT00576472|9222046|P15|MPH In-Lab Phase|Psychiatric exclusion|0
2670940|NCT00576472|9222047|P14|MPH In-Lab Phase|Psychiatric exclusion|0
2670941|NCT00576472|9222048|P13|MPH In-Lab Phase|Psychiatric exclusion|0
2670942|NCT00576472|9222049|P12|MPH In-Lab Phase|Psychiatric exclusion|0
2670943|NCT00576472|9222050|P11|MPH In-Lab Phase|Psychiatric exclusion|0
2670944|NCT00576472|9222051|P10|MPH In-Lab Phase|Psychiatric exclusion|0
2670945|NCT00576472|9222052|P9|MPH In-Lab Phase|Psychiatric exclusion|0
2670946|NCT00576472|9222053|P8|MPH In-Lab Phase|Psychiatric exclusion|0
2670947|NCT00576472|9222054|P7|MPH In-Lab Phase|Psychiatric exclusion|0
2670948|NCT00576472|9222055|P6|MPH In-Lab Phase|Psychiatric exclusion|0
2670949|NCT00576472|9222056|P5|MPH In-Lab Phase|Psychiatric exclusion|0
2670950|NCT00576472|9222057|P4|MPH In-Lab Phase|Psychiatric exclusion|10
2670951|NCT00576472|9222058|P3|MPH In-Lab Phase|Psychiatric exclusion|0
2670952|NCT00576472|9222059|P2|MPH In-Lab Phase|Psychiatric exclusion|0
2670953|NCT00576472|9222060|P1|MPH In-Lab Phase|Psychiatric exclusion|0
2670954|NCT00576472|9222046|P15|MPH In-Lab Phase|No attention/academic problems|0
2670955|NCT00576472|9222047|P14|MPH In-Lab Phase|No attention/academic problems|0
2670956|NCT00576472|9222048|P13|MPH In-Lab Phase|No attention/academic problems|0
2670957|NCT00576472|9222049|P12|MPH In-Lab Phase|No attention/academic problems|0
2670958|NCT00576472|9222050|P11|MPH In-Lab Phase|No attention/academic problems|0
2670959|NCT00576472|9222051|P10|MPH In-Lab Phase|No attention/academic problems|0
2670960|NCT00576472|9222052|P9|MPH In-Lab Phase|No attention/academic problems|0
2670961|NCT00576472|9222053|P8|MPH In-Lab Phase|No attention/academic problems|0
2670962|NCT00576472|9222054|P7|MPH In-Lab Phase|No attention/academic problems|0
2670963|NCT00576472|9222055|P6|MPH In-Lab Phase|No attention/academic problems|0
2670964|NCT00576472|9222056|P5|MPH In-Lab Phase|No attention/academic problems|0
2670965|NCT00576472|9222057|P4|MPH In-Lab Phase|No attention/academic problems|245
2670966|NCT00576472|9222058|P3|MPH In-Lab Phase|No attention/academic problems|0
2670967|NCT00576472|9222059|P2|MPH In-Lab Phase|No attention/academic problems|0
2670968|NCT00576472|9222060|P1|MPH In-Lab Phase|No attention/academic problems|0
2670969|NCT00576472|9222046|P15|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
2670970|NCT00576472|9222047|P14|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
2670971|NCT00576472|9222048|P13|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
2670972|NCT00576472|9222049|P12|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
2670973|NCT00576472|9222050|P11|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
2670974|NCT00576472|9222051|P10|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
2670975|NCT00576472|9222052|P9|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
2670976|NCT00576472|9222053|P8|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
2670977|NCT00576472|9222054|P7|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
2670978|NCT00576472|9222055|P6|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
2670979|NCT00576472|9222056|P5|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
2670980|NCT00576472|9222057|P4|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4
2670981|NCT00576472|9222058|P3|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
2670982|NCT00576472|9222059|P2|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
2670983|NCT00576472|9222060|P1|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
2670984|NCT00576472|9222046|P15|MPH In-Lab Phase|Lost to Follow-up|0
2670985|NCT00576472|9222047|P14|MPH In-Lab Phase|Lost to Follow-up|0
2670986|NCT00576472|9222048|P13|MPH In-Lab Phase|Lost to Follow-up|0
2670987|NCT00576472|9222049|P12|MPH In-Lab Phase|Lost to Follow-up|0
2670988|NCT00576472|9222050|P11|MPH In-Lab Phase|Lost to Follow-up|0
2670989|NCT00576472|9222051|P10|MPH In-Lab Phase|Lost to Follow-up|0
2670990|NCT00576472|9222052|P9|MPH In-Lab Phase|Lost to Follow-up|0
2670991|NCT00576472|9222053|P8|MPH In-Lab Phase|Lost to Follow-up|0
2670992|NCT00576472|9222054|P7|MPH In-Lab Phase|Lost to Follow-up|0
2670993|NCT00576472|9222055|P6|MPH In-Lab Phase|Lost to Follow-up|0
2670994|NCT00576472|9222056|P5|MPH In-Lab Phase|Lost to Follow-up|0
2670995|NCT00576472|9222057|P4|MPH In-Lab Phase|Lost to Follow-up|1
2670996|NCT00576472|9222058|P3|MPH In-Lab Phase|Lost to Follow-up|0
2670997|NCT00576472|9222059|P2|MPH In-Lab Phase|Lost to Follow-up|0
2670998|NCT00576472|9222060|P1|MPH In-Lab Phase|Lost to Follow-up|0
2670999|NCT00576472|9222046|P15|MPH In-Lab Phase|Declined participation in medication pha|0
2671000|NCT00576472|9222047|P14|MPH In-Lab Phase|Declined participation in medication pha|0
2671001|NCT00576472|9222048|P13|MPH In-Lab Phase|Declined participation in medication pha|0
2671002|NCT00576472|9222049|P12|MPH In-Lab Phase|Declined participation in medication pha|0
2671003|NCT00576472|9222050|P11|MPH In-Lab Phase|Declined participation in medication pha|0
2671004|NCT00576472|9222051|P10|MPH In-Lab Phase|Declined participation in medication pha|0
2671005|NCT00576472|9222052|P9|MPH In-Lab Phase|Declined participation in medication pha|0
2671006|NCT00576472|9222053|P8|MPH In-Lab Phase|Declined participation in medication pha|0
2671007|NCT00576472|9222054|P7|MPH In-Lab Phase|Declined participation in medication pha|0
2671008|NCT00576472|9222055|P6|MPH In-Lab Phase|Declined participation in medication pha|0
2671009|NCT00576472|9222056|P5|MPH In-Lab Phase|Declined participation in medication pha|0
2671010|NCT00576472|9222057|P4|MPH In-Lab Phase|Declined participation in medication pha|75
2671011|NCT00576472|9222058|P3|MPH In-Lab Phase|Declined participation in medication pha|0
2671012|NCT00576472|9222059|P2|MPH In-Lab Phase|Declined participation in medication pha|0
2671013|NCT00576472|9222060|P1|MPH In-Lab Phase|Declined participation in medication pha|0
2671014|NCT00576420|9222153|P3|Overall Study|Death|1
2671015|NCT00576420|9222154|P2|Overall Study|Death|0
2671016|NCT00576420|9222155|P1|Overall Study|Death|0
2671017|NCT00576407|9222320|P1|Overall Study|Physician Decision|1
2671018|NCT00576407|9222320|P1|Overall Study|Death|7
2671019|NCT00576381|9222332|P1|Overall Study|Adverse Event|4
2671020|NCT00576381|9222332|P1|Overall Study|Reoperation|3
2671021|NCT00576316|9222336|P1|Overall Study|Protocol Violation|9
2671022|NCT00576316|9222336|P1|Overall Study|Withdrawal by Subject|2
2671023|NCT00576316|9222336|P1|Overall Study|Adverse Event|9
2671024|NCT00576303|9222341|P1|Long Term Safety Period|Early withdrawal|16
2671025|NCT00576303|9222341|P1|Efficacy Evaluation Period|Early withdrawal|5
2671026|NCT00576303|9222341|P1|Dose Titration Period|Early withdrawal|17
2671027|NCT00576199|9222359|P1|Overall Study|Reason Unspecified|2
2671028|NCT00576199|9222359|P1|Overall Study|Refused Treatment|2
2671029|NCT00576199|9222359|P1|Overall Study|Insufficient Therapeutic Response|14
2671030|NCT00576199|9222359|P1|Overall Study|Adverse Event|12
2671031|NCT00576056|9222372|P1|Overall Study|Physician Decision|1
2671032|NCT00576056|9222372|P1|Overall Study|did not meet eligibility criteria|8
2671033|NCT00576056|9222372|P1|Overall Study|Withdrawal by Subject|2
2671034|NCT00576056|9222372|P1|Overall Study|Lack of Efficacy|1
2671035|NCT00576056|9222372|P1|Overall Study|Death|1
2671036|NCT00576056|9222372|P1|Overall Study|Adverse Event|1
2671037|NCT00575666|9222388|P2|Overall Study|Physician Decision|1
2671038|NCT00575666|9222389|P1|Overall Study|Physician Decision|1
2671039|NCT00575666|9222388|P2|Overall Study|Withdrawal by Subject|2
2671040|NCT00575666|9222389|P1|Overall Study|Withdrawal by Subject|3
2671041|NCT00575588|9222429|P2|Overall Study|Impossible to determine HbA1c|1
2671042|NCT00575588|9222430|P1|Overall Study|Impossible to determine HbA1c|0
2671043|NCT00575588|9222429|P2|Overall Study|Patient moved|3
2671044|NCT00575588|9222430|P1|Overall Study|Patient moved|1
2671045|NCT00575588|9222429|P2|Overall Study|Elevated triglyceride|0
2671046|NCT00575588|9222430|P1|Overall Study|Elevated triglyceride|1
2671047|NCT00575588|9222429|P2|Overall Study|Safety reasons|1
2671048|NCT00575588|9222430|P1|Overall Study|Safety reasons|2
2671049|NCT00575588|9222429|P2|Overall Study|Severe non-compliance to protocol|7
2671050|NCT00575588|9222430|P1|Overall Study|Severe non-compliance to protocol|5
2671051|NCT00575588|9222429|P2|Overall Study|Study specific discontinuation criteria|218
2671052|NCT00575588|9222430|P1|Overall Study|Study specific discontinuation criteria|203
2671053|NCT00575588|9222429|P2|Overall Study|Incorrect enrollment|4
2671054|NCT00575588|9222430|P1|Overall Study|Incorrect enrollment|8
2671055|NCT00575588|9222429|P2|Overall Study|Death|2
2671056|NCT00575588|9222430|P1|Overall Study|Death|4
2671057|NCT00575588|9222429|P2|Overall Study|Lost to Follow-up|3
2671058|NCT00575588|9222430|P1|Overall Study|Lost to Follow-up|1
2671059|NCT00575588|9222429|P2|Overall Study|Withdrawal by Subject|31
2671060|NCT00575588|9222430|P1|Overall Study|Withdrawal by Subject|27
2671061|NCT00575588|9222429|P2|Overall Study|Adverse Event|13
2671062|NCT00575588|9222430|P1|Overall Study|Adverse Event|11
2671063|NCT00575510|9222453|P3|Overall Study|Pregnancy|1
2671064|NCT00575510|9222454|P2|Overall Study|Pregnancy|0
2671065|NCT00575510|9222455|P1|Overall Study|Pregnancy|0
2671066|NCT00575510|9222453|P3|Overall Study|Clinic Called Patient|7
2671067|NCT00575510|9222454|P2|Overall Study|Clinic Called Patient|7
2671068|NCT00575510|9222455|P1|Overall Study|Clinic Called Patient|7
2671069|NCT00575510|9222453|P3|Overall Study|Withdrawal by Subject|0
2671070|NCT00575510|9222454|P2|Overall Study|Withdrawal by Subject|0
2671071|NCT00575510|9222455|P1|Overall Study|Withdrawal by Subject|1
2671072|NCT00575510|9222453|P3|Overall Study|Lost to Follow-up|9
2671073|NCT00575510|9222454|P2|Overall Study|Lost to Follow-up|6
2671074|NCT00575510|9222455|P1|Overall Study|Lost to Follow-up|4
2671075|NCT00575380|9222468|P2|Overall Study|Various|2
2671076|NCT00575380|9222469|P1|Overall Study|Various|0
2671077|NCT00575380|9222468|P2|Overall Study|Adverse Event|1
2671078|NCT00575380|9222469|P1|Overall Study|Adverse Event|0
2671079|NCT00575380|9222468|P2|Overall Study|Withdrawal by Subject|0
2671080|NCT00575380|9222469|P1|Overall Study|Withdrawal by Subject|1
2671081|NCT00575094|9222611|P1|Overall Study|Withdrawal by Subject|1
2671082|NCT00575094|9222611|P1|Overall Study|Adverse Event|2
2671083|NCT00575042|9222615|P1|Overall Study|Lost to Follow-up|1
2671084|NCT00575042|9222615|P1|Overall Study|Adverse Event|2
2671085|NCT00574951|9222666|P1|Overall Study|Ineligible - improper prior treatment|1
2671086|NCT00574912|9222674|P1|Overall Study|Physician Decision|2
2671087|NCT00574912|9222674|P1|Overall Study|scheduling conflicts|3
2671088|NCT00574912|9222674|P1|Overall Study|Could not place IV lines.|3
2671089|NCT00574873|9222688|P2|Overall Study|Extension Study|0
2671090|NCT00574873|9222689|P1|Overall Study|Extension Study|126
2671091|NCT00574873|9222688|P2|Overall Study|Blank, site closed per local regulations|2
2671092|NCT00574873|9222689|P1|Overall Study|Blank, site closed per local regulations|2
2671093|NCT00574873|9222688|P2|Overall Study|Discontinuation of study by sponsor|199
2671094|NCT00574873|9222689|P1|Overall Study|Discontinuation of study by sponsor|5
2671095|NCT00574873|9222688|P2|Overall Study|Other|4
2671096|NCT00574873|9222689|P1|Overall Study|Other|40
2671097|NCT00574873|9222688|P2|Overall Study|Lost to Follow-up|5
2671098|NCT00574873|9222689|P1|Overall Study|Lost to Follow-up|14
2671099|NCT00574873|9222688|P2|Overall Study|Death|14
2671100|NCT00574873|9222689|P1|Overall Study|Death|15
2671101|NCT00574873|9222688|P2|Overall Study|Investigator request|8
2671102|NCT00574873|9222689|P1|Overall Study|Investigator request|18
2671103|NCT00574873|9222688|P2|Overall Study|Withdrawal by Subject|19
2671104|NCT00574873|9222689|P1|Overall Study|Withdrawal by Subject|18
2671105|NCT00574847|9222707|P2|Overall Study|Did not receive medication (declined)|5
2671106|NCT00574847|9222708|P1|Overall Study|Did not receive medication (declined)|2
2671107|NCT00574847|9222707|P2|Overall Study|Physician Decision|0
2671108|NCT00574847|9222708|P1|Overall Study|Physician Decision|1
2671109|NCT00574847|9222707|P2|Overall Study|Withdrawal by Subject|2
2671110|NCT00574847|9222708|P1|Overall Study|Withdrawal by Subject|2
2671111|NCT00574847|9222707|P2|Overall Study|Death|0
2671112|NCT00574847|9222708|P1|Overall Study|Death|1
2671113|NCT00574847|9222707|P2|Overall Study|Adverse Event|0
2671114|NCT00574847|9222708|P1|Overall Study|Adverse Event|2
2671115|NCT00574795|9222753|P1|Toddler Dose|Withdrawal by Subject|1
2671116|NCT00574795|9222753|P1|After Infant Series|Adverse Event|2
2671117|NCT00574795|9222753|P1|After Infant Series|Withdrawal by Subject|1
2671118|NCT00574795|9222753|P1|Infant Series|Adverse Event|1
2671119|NCT00574795|9222753|P1|Infant Series|Protocol Violation|2
2671120|NCT00574795|9222753|P1|Infant Series|Withdrawal by Subject|2
2671121|NCT00574405|9222836|P2|Overall Study|Withdrawal by Subject|2
2671122|NCT00574405|9222837|P1|Overall Study|Withdrawal by Subject|3
2671123|NCT00574288|9222857|P7|Overall Study|Other|0
2671124|NCT00574288|9222858|P6|Overall Study|Other|0
2671125|NCT00574288|9222859|P5|Overall Study|Other|0
2671126|NCT00574288|9222860|P4|Overall Study|Other|0
2671127|NCT00574288|9222861|P3|Overall Study|Other|0
2671128|NCT00574288|9222862|P2|Overall Study|Other|1
2671129|NCT00574288|9222863|P1|Overall Study|Other|1
2671130|NCT00574288|9222857|P7|Overall Study|Progressive Disease|0
2671131|NCT00574288|9222858|P6|Overall Study|Progressive Disease|0
2671132|NCT00574288|9222859|P5|Overall Study|Progressive Disease|1
2671133|NCT00574288|9222860|P4|Overall Study|Progressive Disease|2
2671134|NCT00574288|9222861|P3|Overall Study|Progressive Disease|3
2671135|NCT00574288|9222862|P2|Overall Study|Progressive Disease|2
2671136|NCT00574288|9222863|P1|Overall Study|Progressive Disease|17
2671137|NCT00574288|9222857|P7|Overall Study|Study Terminated By Sponsor|5
2671138|NCT00574288|9222858|P6|Overall Study|Study Terminated By Sponsor|0
2671139|NCT00574288|9222859|P5|Overall Study|Study Terminated By Sponsor|0
2671140|NCT00574288|9222860|P4|Overall Study|Study Terminated By Sponsor|0
2671141|NCT00574288|9222861|P3|Overall Study|Study Terminated By Sponsor|0
2671142|NCT00574288|9222862|P2|Overall Study|Study Terminated By Sponsor|0
2671143|NCT00574288|9222863|P1|Overall Study|Study Terminated By Sponsor|0
2671144|NCT00574288|9222857|P7|Overall Study|Lost to Follow-up|2
2671145|NCT00574288|9222858|P6|Overall Study|Lost to Follow-up|1
2671146|NCT00574288|9222859|P5|Overall Study|Lost to Follow-up|0
2671147|NCT00574288|9222860|P4|Overall Study|Lost to Follow-up|0
2671148|NCT00574288|9222861|P3|Overall Study|Lost to Follow-up|0
2671149|NCT00574288|9222862|P2|Overall Study|Lost to Follow-up|0
2671150|NCT00574288|9222863|P1|Overall Study|Lost to Follow-up|0
2671151|NCT00574288|9222857|P7|Overall Study|Death|21
2671152|NCT00574288|9222858|P6|Overall Study|Death|25
2671153|NCT00574288|9222859|P5|Overall Study|Death|0
2671154|NCT00574288|9222860|P4|Overall Study|Death|0
2671155|NCT00574288|9222861|P3|Overall Study|Death|0
2671156|NCT00574288|9222862|P2|Overall Study|Death|0
2671157|NCT00574288|9222863|P1|Overall Study|Death|0
2671158|NCT00574288|9222857|P7|Overall Study|Adverse Event|0
2671159|NCT00574288|9222858|P6|Overall Study|Adverse Event|0
2671160|NCT00574288|9222859|P5|Overall Study|Adverse Event|1
2671161|NCT00574288|9222860|P4|Overall Study|Adverse Event|0
2671162|NCT00574288|9222861|P3|Overall Study|Adverse Event|0
2671163|NCT00574288|9222862|P2|Overall Study|Adverse Event|0
2671164|NCT00574288|9222863|P1|Overall Study|Adverse Event|2
2671165|NCT00574275|9222901|P2|Overall Study|Operation for curative intent|1
2671166|NCT00574275|9222902|P1|Overall Study|Operation for curative intent|0
2671167|NCT00574275|9222901|P2|Overall Study|Insurance change|1
2671168|NCT00574275|9222902|P1|Overall Study|Insurance change|0
2671169|NCT00574275|9222901|P2|Overall Study|Patient and Investigator decision|1
2671170|NCT00574275|9222902|P1|Overall Study|Patient and Investigator decision|0
2671171|NCT00574275|9222901|P2|Overall Study|Protocol Violation|1
2671172|NCT00574275|9222902|P1|Overall Study|Protocol Violation|0
2671173|NCT00574275|9222901|P2|Overall Study|Physician Decision|1
2671174|NCT00574275|9222902|P1|Overall Study|Physician Decision|1
2671175|NCT00574275|9222901|P2|Overall Study|Error calculating tumor measurement|0
2671176|NCT00574275|9222902|P1|Overall Study|Error calculating tumor measurement|1
2671177|NCT00574275|9222901|P2|Overall Study|Withdrawal by Subject|17
2671178|NCT00574275|9222902|P1|Overall Study|Withdrawal by Subject|15
2671179|NCT00574275|9222901|P2|Overall Study|Study stopped based on DMC decision|23
2671180|NCT00574275|9222902|P1|Overall Study|Study stopped based on DMC decision|62
2671181|NCT00574275|9222901|P2|Overall Study|Lost to Follow-up|1
2671182|NCT00574275|9222902|P1|Overall Study|Lost to Follow-up|2
2671183|NCT00574275|9222901|P2|Overall Study|Disease progression|146
2671184|NCT00574275|9222902|P1|Overall Study|Disease progression|160
2671185|NCT00574275|9222901|P2|Overall Study|Adverse Event|76
2671186|NCT00574275|9222902|P1|Overall Study|Adverse Event|32
2671187|NCT00574275|9222901|P2|Overall Study|Randomized but not treated|3
2671188|NCT00574275|9222902|P1|Overall Study|Randomized but not treated|2
2671189|NCT00574249|9222920|P2|Overall Study|PPD test taken twice|1
2671190|NCT00574249|9222921|P1|Overall Study|PPD test taken twice|0
2671191|NCT00574249|9222920|P2|Overall Study|Excluded by company|1
2671192|NCT00574249|9222921|P1|Overall Study|Excluded by company|0
2671193|NCT00574249|9222920|P2|Overall Study|Pregnancy|0
2671194|NCT00574249|9222921|P1|Overall Study|Pregnancy|1
2671195|NCT00574249|9222920|P2|Overall Study|Physician Decision|0
2671196|NCT00574249|9222921|P1|Overall Study|Physician Decision|1
2671197|NCT00574249|9222920|P2|Overall Study|Withdrawal by Subject|0
2671198|NCT00574249|9222921|P1|Overall Study|Withdrawal by Subject|3
2671199|NCT00574249|9222920|P2|Overall Study|History of carcinoma|0
2671200|NCT00574249|9222921|P1|Overall Study|History of carcinoma|1
2671201|NCT00574249|9222920|P2|Overall Study|Protocol Violation|2
2671202|NCT00574249|9222921|P1|Overall Study|Protocol Violation|5
2671203|NCT00574249|9222920|P2|Overall Study|Lost to Follow-up|3
2671204|NCT00574249|9222921|P1|Overall Study|Lost to Follow-up|4
2671205|NCT00574249|9222920|P2|Overall Study|Lack of Efficacy|3
2671206|NCT00574249|9222921|P1|Overall Study|Lack of Efficacy|5
2671207|NCT00574249|9222920|P2|Overall Study|Adverse Event|18
2671208|NCT00574249|9222921|P1|Overall Study|Adverse Event|6
2671209|NCT00574145|9222972|P2|Overall Study|Withdrawal by Subject|1
2671210|NCT00574145|9222973|P1|Overall Study|Withdrawal by Subject|2
2671211|NCT00574119|9222983|P1|Overall Study|Physician Decision|1
2671212|NCT00574119|9222983|P1|Overall Study|Withdrawal by Subject|1
2671213|NCT00574119|9222983|P1|Overall Study|Protocol Violation|1
2671214|NCT00574119|9222983|P1|Overall Study|Adverse Event|1
2671215|NCT00574080|9222997|P2|Overall Study|Death|10
2671216|NCT00574080|9222998|P1|Overall Study|Death|10
2671217|NCT00573937|9223067|P2|Overall Study|Study Terminated|1
2671218|NCT00573937|9223068|P1|Overall Study|Study Terminated|0
2671219|NCT00573859|9223082|P1|Smoking Versus Abstinence|Scheduling conflicts|12
2671220|NCT00573859|9223082|P1|Medication Versus Placebo|Scheduling conflicts|12
2671221|NCT00573833|9223088|P1|Overall Study|Not Treated|2
2671222|NCT00573794|9223095|P1|Overall Study|Other|46
2671223|NCT00573794|9223095|P1|Overall Study|Lack of Efficacy|94
2671224|NCT00573794|9223095|P1|Overall Study|Protocol Violation|6
2671225|NCT00573794|9223095|P1|Overall Study|Lost to Follow-up|13
2671226|NCT00573794|9223095|P1|Overall Study|Withdrew Consent|90
2671227|NCT00573794|9223095|P1|Overall Study|Adverse Event|81
2671228|NCT00573768|9223126|P3|Overall Study|Lost to Follow-up|1
2671229|NCT00573768|9223127|P2|Overall Study|Lost to Follow-up|0
2671230|NCT00573768|9223128|P1|Overall Study|Lost to Follow-up|0
2671231|NCT00573768|9223126|P3|Overall Study|Withdrawal by Subject|0
2671232|NCT00573768|9223127|P2|Overall Study|Withdrawal by Subject|1
2671233|NCT00573768|9223128|P1|Overall Study|Withdrawal by Subject|0
2671234|NCT00573768|9223126|P3|Overall Study|Protocol Violation|1
2671235|NCT00573768|9223127|P2|Overall Study|Protocol Violation|0
2671236|NCT00573768|9223128|P1|Overall Study|Protocol Violation|1
2671237|NCT00573768|9223126|P3|Overall Study|Adverse Event|2
2671238|NCT00573768|9223127|P2|Overall Study|Adverse Event|1
2671239|NCT00573768|9223128|P1|Overall Study|Adverse Event|1
2671240|NCT00573755|9223138|P2|Overall Study|Still receiving treatment|0
2671241|NCT00573755|9223139|P1|Overall Study|Still receiving treatment|1
2671242|NCT00573534|9223155|P1|Overall Study|oppositional behavior|3
2671243|NCT00573469|9223196|P3|Overall Study|Other|3
2671244|NCT00573469|9223197|P2|Overall Study|Other|1
2671245|NCT00573469|9223198|P1|Overall Study|Other|5
2671246|NCT00573469|9223196|P3|Overall Study|Withdrawal by Subject|0
2671247|NCT00573469|9223197|P2|Overall Study|Withdrawal by Subject|2
2671248|NCT00573469|9223198|P1|Overall Study|Withdrawal by Subject|0
2671249|NCT00573469|9223196|P3|Overall Study|Adverse Event|1
2671250|NCT00573469|9223197|P2|Overall Study|Adverse Event|1
2671251|NCT00573469|9223198|P1|Overall Study|Adverse Event|1
2671252|NCT00573443|9223221|P3|Open-Label Extension Phase|Other|0
2671253|NCT00573443|9223222|P2|Open-Label Extension Phase|Other|0
2671254|NCT00573443|9223223|P1|Open-Label Extension Phase|Other|2
2671255|NCT00573443|9223221|P3|Open-Label Extension Phase|Protocol Violation|0
2671256|NCT00573443|9223222|P2|Open-Label Extension Phase|Protocol Violation|0
2671257|NCT00573443|9223223|P1|Open-Label Extension Phase|Protocol Violation|2
2671258|NCT00573443|9223221|P3|Open-Label Extension Phase|Withdrawal by Subject|0
2671259|NCT00573443|9223222|P2|Open-Label Extension Phase|Withdrawal by Subject|0
2671260|NCT00573443|9223223|P1|Open-Label Extension Phase|Withdrawal by Subject|3
2671261|NCT00573443|9223221|P3|Open-Label Extension Phase|Serious Adverse Event|0
2671262|NCT00573443|9223222|P2|Open-Label Extension Phase|Serious Adverse Event|0
2671263|NCT00573443|9223223|P1|Open-Label Extension Phase|Serious Adverse Event|5
2671264|NCT00573443|9223221|P3|Open-Label Extension Phase|Adverse Event|0
2671265|NCT00573443|9223222|P2|Open-Label Extension Phase|Adverse Event|0
2671266|NCT00573443|9223223|P1|Open-Label Extension Phase|Adverse Event|3
2671267|NCT00573443|9223221|P3|Open-Label Extension Phase|Exacerbation of MS symptoms|0
2671268|NCT00573443|9223222|P2|Open-Label Extension Phase|Exacerbation of MS symptoms|0
2671269|NCT00573443|9223223|P1|Open-Label Extension Phase|Exacerbation of MS symptoms|2
2671270|NCT00573443|9223221|P3|Open-Label Extension Phase|Lost to Follow-up|0
2671271|NCT00573443|9223222|P2|Open-Label Extension Phase|Lost to Follow-up|0
2671272|NCT00573443|9223223|P1|Open-Label Extension Phase|Lost to Follow-up|1
2671273|NCT00573443|9223221|P3|Double-Blind Phase|Other|3
2671274|NCT00573443|9223222|P2|Double-Blind Phase|Other|2
2671275|NCT00573443|9223223|P1|Double-Blind Phase|Other|0
2671276|NCT00573443|9223221|P3|Double-Blind Phase|Protocol Violation|1
2671277|NCT00573443|9223222|P2|Double-Blind Phase|Protocol Violation|2
2671278|NCT00573443|9223223|P1|Double-Blind Phase|Protocol Violation|0
2671279|NCT00573443|9223221|P3|Double-Blind Phase|Withdrawal by Subject|7
2671280|NCT00573443|9223222|P2|Double-Blind Phase|Withdrawal by Subject|2
2671281|NCT00573443|9223223|P1|Double-Blind Phase|Withdrawal by Subject|2
2671282|NCT00573443|9223221|P3|Double-Blind Phase|Medication refusal due to AE|0
2671283|NCT00573443|9223222|P2|Double-Blind Phase|Medication refusal due to AE|2
2671284|NCT00573443|9223223|P1|Double-Blind Phase|Medication refusal due to AE|2
2671285|NCT00573443|9223221|P3|Double-Blind Phase|Serious Adverse Event (AE)|1
2671286|NCT00573443|9223222|P2|Double-Blind Phase|Serious Adverse Event (AE)|3
2671287|NCT00573443|9223223|P1|Double-Blind Phase|Serious Adverse Event (AE)|2
2671288|NCT00573443|9223221|P3|Double-Blind Phase|Adverse Event|0
2671289|NCT00573443|9223222|P2|Double-Blind Phase|Adverse Event|5
2671290|NCT00573443|9223223|P1|Double-Blind Phase|Adverse Event|1
2671291|NCT00573443|9223221|P3|Double-Blind Phase|Exacerbation of MS symptoms|1
2671292|NCT00573443|9223222|P2|Double-Blind Phase|Exacerbation of MS symptoms|0
2671293|NCT00573443|9223223|P1|Double-Blind Phase|Exacerbation of MS symptoms|1
2671294|NCT00573443|9223221|P3|Double-Blind Phase|Lost to Follow-up|2
2671295|NCT00573443|9223222|P2|Double-Blind Phase|Lost to Follow-up|3
2671296|NCT00573443|9223223|P1|Double-Blind Phase|Lost to Follow-up|1
2671297|NCT00573430|9223253|P3|Overall Study|Eligibility criteria not fulfilled|3
2671298|NCT00573430|9223254|P2|Overall Study|Eligibility criteria not fulfilled|0
2671299|NCT00573430|9223255|P1|Overall Study|Eligibility criteria not fulfilled|0
2671300|NCT00573430|9223253|P3|Overall Study|Protocol Violation|1
2671301|NCT00573430|9223254|P2|Overall Study|Protocol Violation|1
2671302|NCT00573430|9223255|P1|Overall Study|Protocol Violation|0
2671303|NCT00573430|9223253|P3|Overall Study|Withdrawal by Subject|1
2671304|NCT00573430|9223254|P2|Overall Study|Withdrawal by Subject|0
2671305|NCT00573430|9223255|P1|Overall Study|Withdrawal by Subject|1
2671306|NCT00573430|9223253|P3|Overall Study|Adverse Event|2
2671307|NCT00573430|9223254|P2|Overall Study|Adverse Event|0
2671308|NCT00573430|9223255|P1|Overall Study|Adverse Event|0
2671309|NCT00573430|9223253|P3|Overall Study|Incorrect enrollment of randomization|3
2671310|NCT00573430|9223254|P2|Overall Study|Incorrect enrollment of randomization|4
2671311|NCT00573430|9223255|P1|Overall Study|Incorrect enrollment of randomization|0
2671312|NCT00573391|9223277|P2|Overall Study|Death|0
2671313|NCT00573391|9223278|P1|Overall Study|Death|1
2671314|NCT00573391|9223277|P2|Overall Study|study stopped|2
2671315|NCT00573391|9223278|P1|Overall Study|study stopped|2
2671316|NCT00573313|9223288|P4|Overall Study|Protocol Violation|0
2671317|NCT00573313|9223289|P3|Overall Study|Protocol Violation|6
2671318|NCT00573313|9223290|P2|Overall Study|Protocol Violation|0
2671319|NCT00573313|9223291|P1|Overall Study|Protocol Violation|5
2671320|NCT00573248|9223341|P2|Overall Study|scheduling conflicts|11
2671321|NCT00573248|9223342|P1|Overall Study|scheduling conflicts|15
2671322|NCT00573183|9223356|P2|Overall Study|Other|2
2671323|NCT00573183|9223357|P1|Overall Study|Other|5
2671324|NCT00573183|9223356|P2|Overall Study|Incarceration|8
2671325|NCT00573183|9223357|P1|Overall Study|Incarceration|5
2671326|NCT00573183|9223356|P2|Overall Study|Adverse Event|0
2671327|NCT00573183|9223357|P1|Overall Study|Adverse Event|2
2671328|NCT00573183|9223356|P2|Overall Study|Death|1
2671329|NCT00573183|9223357|P1|Overall Study|Death|0
2671330|NCT00573183|9223356|P2|Overall Study|Withdrawal by Subject|2
2671331|NCT00573183|9223357|P1|Overall Study|Withdrawal by Subject|8
2671332|NCT00573183|9223356|P2|Overall Study|Lost to Follow-up|50
2671333|NCT00573183|9223357|P1|Overall Study|Lost to Follow-up|52
2671334|NCT00573170|9223365|P6|Third Treatment Period|Lost to Follow-up|2
2671335|NCT00573170|9223366|P5|Third Treatment Period|Lost to Follow-up|0
2671336|NCT00573170|9223367|P4|Third Treatment Period|Lost to Follow-up|0
2671337|NCT00573170|9223368|P3|Third Treatment Period|Lost to Follow-up|0
2671338|NCT00573170|9223369|P2|Third Treatment Period|Lost to Follow-up|0
2671339|NCT00573170|9223370|P1|Third Treatment Period|Lost to Follow-up|0
2671340|NCT00573170|9223365|P6|Third Treatment Period|Withdrawal by Subject|0
2671341|NCT00573170|9223366|P5|Third Treatment Period|Withdrawal by Subject|0
2671342|NCT00573170|9223367|P4|Third Treatment Period|Withdrawal by Subject|0
2671343|NCT00573170|9223368|P3|Third Treatment Period|Withdrawal by Subject|0
2671344|NCT00573170|9223369|P2|Third Treatment Period|Withdrawal by Subject|0
2671345|NCT00573170|9223370|P1|Third Treatment Period|Withdrawal by Subject|1
2671346|NCT00573170|9223365|P6|Second Washout Period|Other|2
2671347|NCT00573170|9223366|P5|Second Washout Period|Other|6
2671348|NCT00573170|9223367|P4|Second Washout Period|Other|4
2671349|NCT00573170|9223368|P3|Second Washout Period|Other|1
2671350|NCT00573170|9223369|P2|Second Washout Period|Other|2
2671351|NCT00573170|9223370|P1|Second Washout Period|Other|1
2671352|NCT00573170|9223365|P6|Second Washout Period|Lost to Follow-up|0
2671353|NCT00573170|9223366|P5|Second Washout Period|Lost to Follow-up|0
2671354|NCT00573170|9223367|P4|Second Washout Period|Lost to Follow-up|1
2671355|NCT00573170|9223368|P3|Second Washout Period|Lost to Follow-up|0
2671356|NCT00573170|9223369|P2|Second Washout Period|Lost to Follow-up|0
2671357|NCT00573170|9223370|P1|Second Washout Period|Lost to Follow-up|0
2671358|NCT00573170|9223365|P6|Second Washout Period|Withdrawal by Subject|0
2671359|NCT00573170|9223366|P5|Second Washout Period|Withdrawal by Subject|1
2671360|NCT00573170|9223367|P4|Second Washout Period|Withdrawal by Subject|0
2671361|NCT00573170|9223368|P3|Second Washout Period|Withdrawal by Subject|2
2671362|NCT00573170|9223369|P2|Second Washout Period|Withdrawal by Subject|1
2671363|NCT00573170|9223370|P1|Second Washout Period|Withdrawal by Subject|1
2671364|NCT00573170|9223365|P6|Second Washout Period|Protocol Violation|0
2671365|NCT00573170|9223366|P5|Second Washout Period|Protocol Violation|0
2671366|NCT00573170|9223367|P4|Second Washout Period|Protocol Violation|0
2671367|NCT00573170|9223368|P3|Second Washout Period|Protocol Violation|1
2671368|NCT00573170|9223369|P2|Second Washout Period|Protocol Violation|1
2671369|NCT00573170|9223370|P1|Second Washout Period|Protocol Violation|2
2671370|NCT00573170|9223365|P6|Second Washout Period|Adverse Event|0
2671371|NCT00573170|9223366|P5|Second Washout Period|Adverse Event|1
2671372|NCT00573170|9223367|P4|Second Washout Period|Adverse Event|0
2671373|NCT00573170|9223368|P3|Second Washout Period|Adverse Event|0
2671374|NCT00573170|9223369|P2|Second Washout Period|Adverse Event|0
2671375|NCT00573170|9223370|P1|Second Washout Period|Adverse Event|1
2671376|NCT00573170|9223365|P6|First Washout Period|Other|0
2671377|NCT00573170|9223366|P5|First Washout Period|Other|0
2671378|NCT00573170|9223367|P4|First Washout Period|Other|1
2671379|NCT00573170|9223368|P3|First Washout Period|Other|1
2671380|NCT00573170|9223369|P2|First Washout Period|Other|0
2671381|NCT00573170|9223370|P1|First Washout Period|Other|4
2671382|NCT00573170|9223365|P6|First Washout Period|Withdrawal by Subject|3
2671383|NCT00573170|9223366|P5|First Washout Period|Withdrawal by Subject|3
2671384|NCT00573170|9223367|P4|First Washout Period|Withdrawal by Subject|2
2671385|NCT00573170|9223368|P3|First Washout Period|Withdrawal by Subject|0
2671386|NCT00573170|9223369|P2|First Washout Period|Withdrawal by Subject|0
2671387|NCT00573170|9223370|P1|First Washout Period|Withdrawal by Subject|2
2671388|NCT00573170|9223365|P6|First Washout Period|Lost to Follow-up|2
2671389|NCT00573170|9223366|P5|First Washout Period|Lost to Follow-up|0
2671390|NCT00573170|9223367|P4|First Washout Period|Lost to Follow-up|2
2671391|NCT00573170|9223368|P3|First Washout Period|Lost to Follow-up|0
2671392|NCT00573170|9223369|P2|First Washout Period|Lost to Follow-up|1
2671393|NCT00573170|9223370|P1|First Washout Period|Lost to Follow-up|1
2671394|NCT00573170|9223365|P6|First Washout Period|Lack of Efficacy|1
2671395|NCT00573170|9223366|P5|First Washout Period|Lack of Efficacy|0
2671396|NCT00573170|9223367|P4|First Washout Period|Lack of Efficacy|0
2671397|NCT00573170|9223368|P3|First Washout Period|Lack of Efficacy|0
2671398|NCT00573170|9223369|P2|First Washout Period|Lack of Efficacy|0
2671399|NCT00573170|9223370|P1|First Washout Period|Lack of Efficacy|0
2671400|NCT00573170|9223365|P6|First Washout Period|Adverse Event|1
2671401|NCT00573170|9223366|P5|First Washout Period|Adverse Event|0
2671402|NCT00573170|9223367|P4|First Washout Period|Adverse Event|0
2671403|NCT00573170|9223368|P3|First Washout Period|Adverse Event|0
2671404|NCT00573170|9223369|P2|First Washout Period|Adverse Event|1
2671405|NCT00573170|9223370|P1|First Washout Period|Adverse Event|1
2671406|NCT00573170|9223365|P6|First Treatment Period|Did Not Treat Attack 1|0
2671407|NCT00573170|9223366|P5|First Treatment Period|Did Not Treat Attack 1|1
2671408|NCT00573170|9223367|P4|First Treatment Period|Did Not Treat Attack 1|0
2671409|NCT00573170|9223368|P3|First Treatment Period|Did Not Treat Attack 1|0
2671410|NCT00573170|9223369|P2|First Treatment Period|Did Not Treat Attack 1|0
2671411|NCT00573170|9223370|P1|First Treatment Period|Did Not Treat Attack 1|0
2671412|NCT00573157|9223446|P2|Overall Study|Other|1
2671413|NCT00573157|9223447|P1|Overall Study|Other|1
2671414|NCT00573157|9223446|P2|Overall Study|Adverse Event|1
2671415|NCT00573157|9223447|P1|Overall Study|Adverse Event|3
2671416|NCT00573144|9223459|P2|Overall Study|Withdrawal by Subject|3
2671417|NCT00573144|9223460|P1|Overall Study|Withdrawal by Subject|2
2671418|NCT00573131|9223472|P2|Overall Study|Withdrawal by Subject|8
2671419|NCT00573131|9223473|P1|Overall Study|Withdrawal by Subject|10
2671420|NCT00573066|9223479|P1|Overall Study|Postoperative bleeding|1
2671421|NCT00573066|9223479|P1|Overall Study|IV malfunction|1
2671422|NCT00573066|9223479|P1|Overall Study|Exclusion criteria|18
2671423|NCT00572910|9223523|P11|Overall Study|Withdrawal by Subject|1
2671424|NCT00572910|9223524|P10|Overall Study|Withdrawal by Subject|2
2671425|NCT00572910|9223525|P9|Overall Study|Withdrawal by Subject|2
2671426|NCT00572910|9223526|P8|Overall Study|Withdrawal by Subject|2
2671427|NCT00572910|9223527|P7|Overall Study|Withdrawal by Subject|0
2671428|NCT00572910|9223528|P6|Overall Study|Withdrawal by Subject|3
2671429|NCT00572910|9223529|P5|Overall Study|Withdrawal by Subject|1
2671430|NCT00572910|9223530|P4|Overall Study|Withdrawal by Subject|0
2671431|NCT00572910|9223531|P3|Overall Study|Withdrawal by Subject|1
2671432|NCT00572910|9223532|P2|Overall Study|Withdrawal by Subject|0
2671433|NCT00572910|9223533|P1|Overall Study|Withdrawal by Subject|3
2671434|NCT00572910|9223523|P11|Overall Study|Lost to Follow-up|0
2671435|NCT00572910|9223524|P10|Overall Study|Lost to Follow-up|1
2671436|NCT00572910|9223525|P9|Overall Study|Lost to Follow-up|0
2671437|NCT00572910|9223526|P8|Overall Study|Lost to Follow-up|0
2671438|NCT00572910|9223527|P7|Overall Study|Lost to Follow-up|0
2671439|NCT00572910|9223528|P6|Overall Study|Lost to Follow-up|0
2671440|NCT00572910|9223529|P5|Overall Study|Lost to Follow-up|1
2671441|NCT00572910|9223530|P4|Overall Study|Lost to Follow-up|2
2671442|NCT00572910|9223531|P3|Overall Study|Lost to Follow-up|1
2671443|NCT00572910|9223532|P2|Overall Study|Lost to Follow-up|1
2671444|NCT00572910|9223533|P1|Overall Study|Lost to Follow-up|0
2671445|NCT00572910|9223523|P11|Overall Study|Adverse Event|2
2671446|NCT00572910|9223524|P10|Overall Study|Adverse Event|3
2671447|NCT00572910|9223525|P9|Overall Study|Adverse Event|1
2671448|NCT00572910|9223526|P8|Overall Study|Adverse Event|2
2671449|NCT00572910|9223527|P7|Overall Study|Adverse Event|4
2671450|NCT00572910|9223528|P6|Overall Study|Adverse Event|0
2671451|NCT00572910|9223529|P5|Overall Study|Adverse Event|0
2671452|NCT00572910|9223530|P4|Overall Study|Adverse Event|2
2671453|NCT00572910|9223531|P3|Overall Study|Adverse Event|0
2671454|NCT00572910|9223532|P2|Overall Study|Adverse Event|2
2671455|NCT00572910|9223533|P1|Overall Study|Adverse Event|1
2671456|NCT00572832|9223600|P2|Overall Study|Pregnancy|1
2671457|NCT00572832|9223601|P1|Overall Study|Pregnancy|0
2671458|NCT00572832|9223600|P2|Overall Study|Lost to Follow-up|11
2671459|NCT00572832|9223601|P1|Overall Study|Lost to Follow-up|0
2671460|NCT00572728|9223607|P1|Overall Study|Pathology missing|1
2671461|NCT00572728|9223607|P1|Overall Study|FLT2 after second chemotherapy initiated|7
2671462|NCT00572728|9223607|P1|Overall Study|Second chemotherapy not initiated|1
2671463|NCT00572728|9223607|P1|Overall Study|FLT2 not completed|5
2671464|NCT00572728|9223607|P1|Overall Study|First Chemotherapy not initiated|2
2671465|NCT00572728|9223607|P1|Overall Study|FLT1 not completed|4
2671466|NCT00572728|9223607|P1|Overall Study|Offstudy due to complicating disease|1
2671467|NCT00572728|9223607|P1|Overall Study|Enrolled under Amendment 4|5
2671468|NCT00572728|9223607|P1|Overall Study|Ineligible|3
2671469|NCT00572728|9223607|P1|Overall Study|Withdrawal by Subject|10
2671470|NCT00572624|9223621|P2|Overall Study|Health issues unrelated to the study|0
2671471|NCT00572624|9223622|P1|Overall Study|Health issues unrelated to the study|1
2671472|NCT00572624|9223621|P2|Overall Study|Problem with vascular access|0
2671473|NCT00572624|9223622|P1|Overall Study|Problem with vascular access|1
2671474|NCT00572624|9223621|P2|Overall Study|Refused to do the stress test|0
2671475|NCT00572624|9223622|P1|Overall Study|Refused to do the stress test|1
2671476|NCT00572624|9223621|P2|Overall Study|Admitted to being a smoker|0
2671477|NCT00572624|9223622|P1|Overall Study|Admitted to being a smoker|1
2671478|NCT00572624|9223621|P2|Overall Study|Started a new job-- no time for study|0
2671479|NCT00572624|9223622|P1|Overall Study|Started a new job-- no time for study|1
2671480|NCT00572624|9223621|P2|Overall Study|Medication change|0
2671481|NCT00572624|9223622|P1|Overall Study|Medication change|1
2671482|NCT00572624|9223621|P2|Overall Study|Wanted to do a different diet program|0
2671483|NCT00572624|9223622|P1|Overall Study|Wanted to do a different diet program|1
2671484|NCT00572624|9223621|P2|Overall Study|Lost to Follow-up|4
2671485|NCT00572624|9223622|P1|Overall Study|Lost to Follow-up|10
2671486|NCT00572572|9223650|P2|Overall Study|Withdrawal by Subject|6
2671487|NCT00572572|9223651|P1|Overall Study|Withdrawal by Subject|3
2671488|NCT00572533|9223669|P2|Overall Study|Transfer out of Facility|1
2671489|NCT00572533|9223670|P1|Overall Study|Transfer out of Facility|0
2671490|NCT00572533|9223669|P2|Overall Study|Social Issues|0
2671491|NCT00572533|9223670|P1|Overall Study|Social Issues|1
2671492|NCT00572533|9223669|P2|Overall Study|Received Kidney Transplant|1
2671493|NCT00572533|9223670|P1|Overall Study|Received Kidney Transplant|2
2671494|NCT00572533|9223669|P2|Overall Study|Death|1
2671495|NCT00572533|9223670|P1|Overall Study|Death|4
2671496|NCT00572195|9223714|P1|Overall Study|Lost to Follow-up|5
2671497|NCT00572195|9223714|P1|Overall Study|Adverse Event|4
2671498|NCT00572195|9223714|P1|Overall Study|Death|9
2671499|NCT00572195|9223714|P1|Overall Study|Withdrawal by Subject|50
2671500|NCT00572156|9223726|P4|Overall Study|Sponsor Decision|19
2671501|NCT00572156|9223727|P3|Overall Study|Sponsor Decision|17
2671502|NCT00572156|9223728|P2|Overall Study|Sponsor Decision|16
2671503|NCT00572156|9223729|P1|Overall Study|Sponsor Decision|20
2671504|NCT00572156|9223726|P4|Overall Study|Patient/Parent Decision|3
2671505|NCT00572156|9223727|P3|Overall Study|Patient/Parent Decision|4
2671506|NCT00572156|9223728|P2|Overall Study|Patient/Parent Decision|6
2671507|NCT00572156|9223729|P1|Overall Study|Patient/Parent Decision|1
2671508|NCT00572156|9223726|P4|Overall Study|Protocol Violation|2
2671509|NCT00572156|9223727|P3|Overall Study|Protocol Violation|0
2671510|NCT00572156|9223728|P2|Overall Study|Protocol Violation|2
2671511|NCT00572156|9223729|P1|Overall Study|Protocol Violation|1
2671512|NCT00572156|9223726|P4|Overall Study|Lost to Follow-up|0
2671513|NCT00572156|9223727|P3|Overall Study|Lost to Follow-up|1
2671514|NCT00572156|9223728|P2|Overall Study|Lost to Follow-up|1
2671515|NCT00572156|9223729|P1|Overall Study|Lost to Follow-up|1
2671516|NCT00572156|9223726|P4|Overall Study|Adverse Event|1
2671517|NCT00572156|9223727|P3|Overall Study|Adverse Event|5
2671518|NCT00572156|9223728|P2|Overall Study|Adverse Event|1
2671519|NCT00572156|9223729|P1|Overall Study|Adverse Event|3
2671520|NCT00572039|9223800|P2|Overall Study|Ill|1
2671521|NCT00572039|9223801|P1|Overall Study|Ill|5
2671522|NCT00572039|9223800|P2|Overall Study|Death|3
2671523|NCT00572039|9223801|P1|Overall Study|Death|2
2671524|NCT00572039|9223800|P2|Overall Study|Withdrawal by Subject|6
2671525|NCT00572039|9223801|P1|Overall Study|Withdrawal by Subject|9
2671526|NCT00571948|9223833|P2|Overall Study|Parent were afraid of blood colection|5
2671527|NCT00571948|9223834|P1|Overall Study|Parent were afraid of blood colection|2
2671528|NCT00571948|9223833|P2|Overall Study|infant refused study meal|4
2671529|NCT00571948|9223834|P1|Overall Study|infant refused study meal|3
2671530|NCT00571948|9223833|P2|Overall Study|Protocol Violation|3
2671531|NCT00571948|9223834|P1|Overall Study|Protocol Violation|3
2671532|NCT00571948|9223833|P2|Overall Study|Withdrawal by Subject|2
2671533|NCT00571948|9223834|P1|Overall Study|Withdrawal by Subject|1
2671534|NCT00571948|9223833|P2|Overall Study|Lost to Follow-up|0
2671535|NCT00571948|9223834|P1|Overall Study|Lost to Follow-up|2
2671536|NCT00571922|9223842|P2|Overall Study|Completion unknown|36
2671537|NCT00571922|9223843|P1|Overall Study|Completion unknown|36
2671538|NCT00571701|9223853|P2|Second Intervention 12 Months|Withdrawal by Subject|0
2671539|NCT00571701|9223854|P1|Second Intervention 12 Months|Withdrawal by Subject|3
2671540|NCT00571701|9223853|P2|Second Intervention 12 Months|Adverse Event|1
2671541|NCT00571701|9223854|P1|Second Intervention 12 Months|Adverse Event|0
2671542|NCT00571701|9223853|P2|First Intervention 12 Months|Death|0
2671543|NCT00571701|9223854|P1|First Intervention 12 Months|Death|1
2671544|NCT00571701|9223853|P2|First Intervention 12 Months|Withdrawal by Subject|1
2671545|NCT00571701|9223854|P1|First Intervention 12 Months|Withdrawal by Subject|2
2671546|NCT00571688|9223880|P2|Overall Study|subject moved out of the area|0
2671547|NCT00571688|9223881|P1|Overall Study|subject moved out of the area|1
2671548|NCT00571688|9223880|P2|Overall Study|subject did not tolerate Consta|0
2671549|NCT00571688|9223881|P1|Overall Study|subject did not tolerate Consta|1
2671550|NCT00571688|9223880|P2|Overall Study|Lost to Follow-up|6
2671551|NCT00571688|9223881|P1|Overall Study|Lost to Follow-up|3
2671552|NCT00571662|9223887|P1|Overall Study|Adverse Event|5
2671553|NCT00571662|9223887|P1|Overall Study|psychiatric instability|1
2671554|NCT00571662|9223887|P1|Overall Study|Withdrawal by Subject|2
2671555|NCT00571649|9223898|P2|Follow-up Period|Protocol Violation|12
2671556|NCT00571649|9223899|P1|Follow-up Period|Protocol Violation|5
2671557|NCT00571649|9223898|P2|Follow-up Period|Patient convenience|121
2671558|NCT00571649|9223899|P1|Follow-up Period|Patient convenience|136
2671559|NCT00571649|9223898|P2|Follow-up Period|Lost to Follow-up|92
2671560|NCT00571649|9223899|P1|Follow-up Period|Lost to Follow-up|95
2671561|NCT00571649|9223898|P2|Follow-up Period|Physician Decision|13
2671562|NCT00571649|9223899|P1|Follow-up Period|Physician Decision|7
2671563|NCT00571649|9223898|P2|Follow-up Period|Death|133
2671564|NCT00571649|9223899|P1|Follow-up Period|Death|132
2671565|NCT00571649|9223898|P2|Follow-up Period|Withdrawal by Subject|115
2671566|NCT00571649|9223899|P1|Follow-up Period|Withdrawal by Subject|119
2671567|NCT00571649|9223898|P2|Follow-up Period|Clinical endpoint reached|2
2671568|NCT00571649|9223899|P1|Follow-up Period|Clinical endpoint reached|5
2671569|NCT00571649|9223898|P2|Follow-up Period|Adverse Event|40
2671570|NCT00571649|9223899|P1|Follow-up Period|Adverse Event|46
2671571|NCT00571649|9223898|P2|Treatment Period|Technical problems|5
2671572|NCT00571649|9223899|P1|Treatment Period|Technical problems|3
2671573|NCT00571649|9223898|P2|Treatment Period|Protocol Violation|92
2671574|NCT00571649|9223899|P1|Treatment Period|Protocol Violation|90
2671575|NCT00571649|9223898|P2|Treatment Period|Patient convenience|13
2671576|NCT00571649|9223899|P1|Treatment Period|Patient convenience|11
2671577|NCT00571649|9223898|P2|Treatment Period|Non-compliant with study medication|89
2671578|NCT00571649|9223899|P1|Treatment Period|Non-compliant with study medication|88
2671579|NCT00571649|9223898|P2|Treatment Period|Lost to Follow-up|41
2671580|NCT00571649|9223899|P1|Treatment Period|Lost to Follow-up|43
2671581|NCT00571649|9223898|P2|Treatment Period|Physician Decision|9
2671582|NCT00571649|9223899|P1|Treatment Period|Physician Decision|8
2671583|NCT00571649|9223898|P2|Treatment Period|Death|59
2671584|NCT00571649|9223899|P1|Treatment Period|Death|76
2671585|NCT00571649|9223898|P2|Treatment Period|Withdrawal by Subject|255
2671586|NCT00571649|9223899|P1|Treatment Period|Withdrawal by Subject|285
2671587|NCT00571649|9223898|P2|Treatment Period|Clinical endpoint reached|56
2671588|NCT00571649|9223899|P1|Treatment Period|Clinical endpoint reached|50
2671589|NCT00571649|9223898|P2|Treatment Period|Adverse Event|385
2671590|NCT00571649|9223899|P1|Treatment Period|Adverse Event|438
2671591|NCT00571103|9223997|P1|Overall Study|Lost to Follow-up|1
2671592|NCT00571103|9223997|P1|Overall Study|Withdrawal by Subject|1
2671593|NCT00571064|9224002|P1|Overall Study|Other|2
2671594|NCT00571064|9224002|P1|Overall Study|Withdrawal by Subject|2
2671595|NCT00571064|9224002|P1|Overall Study|Protocol Violation|4
2671596|NCT00571064|9224002|P1|Overall Study|Adverse Event|13
2671597|NCT00571038|9224017|P2|Overall Study|Moved out of state|2
2671598|NCT00571038|9224018|P1|Overall Study|Moved out of state|2
2671599|NCT00571038|9224017|P2|Overall Study|Withdrawal by Subject|3
2671600|NCT00571038|9224018|P1|Overall Study|Withdrawal by Subject|1
2671601|NCT00571038|9224017|P2|Overall Study|Death|5
2671602|NCT00571038|9224018|P1|Overall Study|Death|7
2671603|NCT00571038|9224017|P2|Overall Study|Lost to Follow-up|4
2671604|NCT00571038|9224018|P1|Overall Study|Lost to Follow-up|1
2671605|NCT00570921|9224073|P1|Overall Study|Physician Decision|1
2671606|NCT00570921|9224073|P1|Overall Study|Protocol Violation|1
2671607|NCT00570908|9224079|P1|Overall Study|Withdrawal by Subject|2
2671608|NCT00570908|9224079|P1|Overall Study|Adverse Event|5
2671609|NCT00570778|9224083|P4|Overall Study|Subject no longer requires study drug|0
2671610|NCT00570778|9224084|P3|Overall Study|Subject no longer requires study drug|0
2671611|NCT00570778|9224085|P2|Overall Study|Subject no longer requires study drug|1
2671612|NCT00570778|9224086|P1|Overall Study|Subject no longer requires study drug|0
2671613|NCT00570778|9224083|P4|Overall Study|Lost to Follow-up|0
2671614|NCT00570778|9224084|P3|Overall Study|Lost to Follow-up|1
2671615|NCT00570778|9224085|P2|Overall Study|Lost to Follow-up|0
2671616|NCT00570778|9224086|P1|Overall Study|Lost to Follow-up|0
2671617|NCT00570778|9224083|P4|Overall Study|Unsatisfactory therapeutic effect|0
2671618|NCT00570778|9224084|P3|Overall Study|Unsatisfactory therapeutic effect|0
2671619|NCT00570778|9224085|P2|Overall Study|Unsatisfactory therapeutic effect|0
2671620|NCT00570778|9224086|P1|Overall Study|Unsatisfactory therapeutic effect|1
2671621|NCT00570778|9224083|P4|Overall Study|Abnormal test procedure|0
2671622|NCT00570778|9224084|P3|Overall Study|Abnormal test procedure|0
2671623|NCT00570778|9224085|P2|Overall Study|Abnormal test procedure|0
2671624|NCT00570778|9224086|P1|Overall Study|Abnormal test procedure|1
2671625|NCT00570778|9224083|P4|Overall Study|Subject withdrew consent|1
2671626|NCT00570778|9224084|P3|Overall Study|Subject withdrew consent|0
2671627|NCT00570778|9224085|P2|Overall Study|Subject withdrew consent|1
2671628|NCT00570778|9224086|P1|Overall Study|Subject withdrew consent|0
2671629|NCT00570778|9224083|P4|Overall Study|Adverse Event|1
2671630|NCT00570778|9224084|P3|Overall Study|Adverse Event|4
2671631|NCT00570778|9224085|P2|Overall Study|Adverse Event|1
2671632|NCT00570778|9224086|P1|Overall Study|Adverse Event|0
2671633|NCT00570778|9224083|P4|Overall Study|Protocol deviation|2
2671634|NCT00570778|9224084|P3|Overall Study|Protocol deviation|2
2671635|NCT00570778|9224085|P2|Overall Study|Protocol deviation|1
2671636|NCT00570778|9224086|P1|Overall Study|Protocol deviation|2
2671637|NCT00570739|9224127|P4|Overall Study|Other|3
2671638|NCT00570739|9224128|P3|Overall Study|Other|5
2671639|NCT00570739|9224129|P2|Overall Study|Other|2
2671640|NCT00570739|9224130|P1|Overall Study|Other|0
2671641|NCT00570739|9224127|P4|Overall Study|Met discontinuation criteria|1
2671642|NCT00570739|9224128|P3|Overall Study|Met discontinuation criteria|1
2671643|NCT00570739|9224129|P2|Overall Study|Met discontinuation criteria|0
2671644|NCT00570739|9224130|P1|Overall Study|Met discontinuation criteria|1
2671645|NCT00570739|9224127|P4|Overall Study|Required restricted medication|0
2671646|NCT00570739|9224128|P3|Overall Study|Required restricted medication|1
2671647|NCT00570739|9224129|P2|Overall Study|Required restricted medication|0
2671648|NCT00570739|9224130|P1|Overall Study|Required restricted medication|0
2671649|NCT00570739|9224127|P4|Overall Study|Withdrawal by Subject|5
2671650|NCT00570739|9224128|P3|Overall Study|Withdrawal by Subject|3
2671651|NCT00570739|9224129|P2|Overall Study|Withdrawal by Subject|7
2671652|NCT00570739|9224130|P1|Overall Study|Withdrawal by Subject|7
2671653|NCT00570739|9224127|P4|Overall Study|Physician Decision|0
2671654|NCT00570739|9224128|P3|Overall Study|Physician Decision|0
2671655|NCT00570739|9224129|P2|Overall Study|Physician Decision|1
2671656|NCT00570739|9224130|P1|Overall Study|Physician Decision|1
2671657|NCT00570739|9224127|P4|Overall Study|Lost to Follow-up|1
2671658|NCT00570739|9224128|P3|Overall Study|Lost to Follow-up|4
2671659|NCT00570739|9224129|P2|Overall Study|Lost to Follow-up|5
2671660|NCT00570739|9224130|P1|Overall Study|Lost to Follow-up|4
2671661|NCT00570739|9224127|P4|Overall Study|Adverse Event|2
2671662|NCT00570739|9224128|P3|Overall Study|Adverse Event|2
2671663|NCT00570739|9224129|P2|Overall Study|Adverse Event|6
2671664|NCT00570739|9224130|P1|Overall Study|Adverse Event|8
2671665|NCT00570713|9224282|P2|Overall Study|Discontinuation of Study by the Sponsor|7
2671666|NCT00570713|9224283|P1|Overall Study|Discontinuation of Study by the Sponsor|10
2671667|NCT00570713|9224282|P2|Overall Study|Withdrawal by Subject|3
2671668|NCT00570713|9224283|P1|Overall Study|Withdrawal by Subject|3
2671669|NCT00570713|9224282|P2|Overall Study|Physician Decision|2
2671670|NCT00570713|9224283|P1|Overall Study|Physician Decision|2
2671671|NCT00570713|9224282|P2|Overall Study|Lack of Efficacy|49
2671672|NCT00570713|9224283|P1|Overall Study|Lack of Efficacy|40
2671673|NCT00570713|9224282|P2|Overall Study|Death|7
2671674|NCT00570713|9224283|P1|Overall Study|Death|7
2671675|NCT00570713|9224282|P2|Overall Study|Adverse Event|9
2671676|NCT00570713|9224283|P1|Overall Study|Adverse Event|16
2671677|NCT00570687|9224301|P10|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2671678|NCT00570687|9224302|P9|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2671679|NCT00570687|9224303|P8|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2671680|NCT00570687|9224304|P7|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1
2671681|NCT00570687|9224305|P6|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2671682|NCT00570687|9224306|P5|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2671683|NCT00570687|9224307|P4|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2671684|NCT00570687|9224308|P3|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2671685|NCT00570687|9224309|P2|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2671686|NCT00570687|9224310|P1|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2671687|NCT00570687|9224301|P10|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2671688|NCT00570687|9224302|P9|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1
2671689|NCT00570687|9224303|P8|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2671690|NCT00570687|9224304|P7|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2671691|NCT00570687|9224305|P6|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2671692|NCT00570687|9224306|P5|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2671693|NCT00570687|9224307|P4|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2671694|NCT00570687|9224308|P3|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2671695|NCT00570687|9224309|P2|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2671696|NCT00570687|9224310|P1|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2671697|NCT00570687|9224301|P10|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
2671698|NCT00570687|9224302|P9|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
2671699|NCT00570687|9224303|P8|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
2671700|NCT00570687|9224304|P7|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
2671701|NCT00570687|9224305|P6|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
2671702|NCT00570687|9224306|P5|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
2671703|NCT00570687|9224307|P4|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2671704|NCT00570687|9224308|P3|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2671705|NCT00570687|9224309|P2|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2671706|NCT00570687|9224310|P1|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
2671707|NCT00570674|9224336|P7|Overall Study|Withdrawal by Subject|0
2671708|NCT00570674|9224337|P6|Overall Study|Withdrawal by Subject|0
2671709|NCT00570674|9224338|P5|Overall Study|Withdrawal by Subject|0
2671710|NCT00570674|9224339|P4|Overall Study|Withdrawal by Subject|0
2671711|NCT00570674|9224340|P3|Overall Study|Withdrawal by Subject|1
2671712|NCT00570674|9224341|P2|Overall Study|Withdrawal by Subject|0
2671713|NCT00570674|9224342|P1|Overall Study|Withdrawal by Subject|0
2671714|NCT00570505|9224365|P1|Overall Study|Other loss to follow-up|4
2671715|NCT00570505|9224365|P1|Overall Study|Lost to Follow-up|23
2671716|NCT00570505|9224365|P1|Overall Study|Withdrawal by Subject|7
2671717|NCT00570505|9224365|P1|Overall Study|Adverse Event|7
2671718|NCT00570492|9224378|P3|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
2671719|NCT00570492|9224379|P2|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3
2671720|NCT00570492|9224380|P1|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
2671721|NCT00570492|9224378|P3|52-week Double-blind Treatment Period|Lack of Efficacy|0
2671722|NCT00570492|9224379|P2|52-week Double-blind Treatment Period|Lack of Efficacy|3
2671723|NCT00570492|9224380|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
2671724|NCT00570492|9224378|P3|52-week Double-blind Treatment Period|Physician Decision|4
2671725|NCT00570492|9224379|P2|52-week Double-blind Treatment Period|Physician Decision|2
2671726|NCT00570492|9224380|P1|52-week Double-blind Treatment Period|Physician Decision|0
2671727|NCT00570492|9224378|P3|52-week Double-blind Treatment Period|Adverse Event|5
2671728|NCT00570492|9224379|P2|52-week Double-blind Treatment Period|Adverse Event|5
2671729|NCT00570492|9224380|P1|52-week Double-blind Treatment Period|Adverse Event|0
2671730|NCT00570492|9224378|P3|52-week Double-blind Treatment Period|Lost to Follow-up|7
2671731|NCT00570492|9224379|P2|52-week Double-blind Treatment Period|Lost to Follow-up|5
2671732|NCT00570492|9224380|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
2671733|NCT00570492|9224378|P3|52-week Double-blind Treatment Period|Protocol Violation|15
2671734|NCT00570492|9224379|P2|52-week Double-blind Treatment Period|Protocol Violation|12
2671735|NCT00570492|9224380|P1|52-week Double-blind Treatment Period|Protocol Violation|0
2671736|NCT00570492|9224378|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|20
2671737|NCT00570492|9224379|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|20
2671738|NCT00570492|9224380|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
2671739|NCT00570492|9224378|P3|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
2671740|NCT00570492|9224379|P2|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
2671741|NCT00570492|9224380|P1|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1
2671742|NCT00570492|9224378|P3|16-week Single-blind Baseline Period|Adverse Event|0
2671743|NCT00570492|9224379|P2|16-week Single-blind Baseline Period|Adverse Event|0
2671744|NCT00570492|9224380|P1|16-week Single-blind Baseline Period|Adverse Event|1
2671745|NCT00570492|9224378|P3|16-week Single-blind Baseline Period|Lost to Follow-up|0
2671746|NCT00570492|9224379|P2|16-week Single-blind Baseline Period|Lost to Follow-up|0
2671747|NCT00570492|9224380|P1|16-week Single-blind Baseline Period|Lost to Follow-up|2
2671748|NCT00570492|9224378|P3|16-week Single-blind Baseline Period|Protocol Violation|0
2671749|NCT00570492|9224379|P2|16-week Single-blind Baseline Period|Protocol Violation|0
2671750|NCT00570492|9224380|P1|16-week Single-blind Baseline Period|Protocol Violation|15
2671751|NCT00570492|9224378|P3|16-week Single-blind Baseline Period|Withdrawal by Subject|0
2671752|NCT00570492|9224379|P2|16-week Single-blind Baseline Period|Withdrawal by Subject|0
2671753|NCT00570492|9224380|P1|16-week Single-blind Baseline Period|Withdrawal by Subject|56
2671754|NCT00570492|9224378|P3|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
2671755|NCT00570492|9224379|P2|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
2671756|NCT00570492|9224380|P1|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263
2671757|NCT00570492|9224378|P3|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
2671758|NCT00570492|9224379|P2|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
2671759|NCT00570492|9224380|P1|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98
2671760|NCT00570401|9224418|P1|Overall Study|Adverse Event|2
2671761|NCT00570323|9224452|P2|Complete Study After Start|Physician Decision|0
2671762|NCT00570323|9224453|P1|Complete Study After Start|Physician Decision|1
2671763|NCT00570323|9224452|P2|Complete Study After Start|Withdrawal by Subject|0
2671764|NCT00570323|9224453|P1|Complete Study After Start|Withdrawal by Subject|2
2671765|NCT00570323|9224452|P2|Complete Study After Start|Lost to Follow-up|1
2671766|NCT00570323|9224453|P1|Complete Study After Start|Lost to Follow-up|0
2671767|NCT00570323|9224452|P2|Started Treatment After Randomization|Physician Decision|0
2671768|NCT00570323|9224453|P1|Started Treatment After Randomization|Physician Decision|1
2671769|NCT00570323|9224452|P2|Started Treatment After Randomization|Protocol Violation|0
2671770|NCT00570323|9224453|P1|Started Treatment After Randomization|Protocol Violation|1
2671771|NCT00570323|9224452|P2|Started Treatment After Randomization|Withdrawal by Subject|1
2671772|NCT00570323|9224453|P1|Started Treatment After Randomization|Withdrawal by Subject|0
2671773|NCT00570310|9224465|P2|Overall Study|Lack of Efficacy|4
2671774|NCT00570310|9224466|P1|Overall Study|Lack of Efficacy|1
2671775|NCT00570310|9224465|P2|Overall Study|Adverse Event|2
2671776|NCT00570310|9224466|P1|Overall Study|Adverse Event|1
2671777|NCT00570232|9224485|P1|Overall Study|discontinued due to noncompliance|2
2671778|NCT00570232|9224485|P1|Overall Study|discontinued due to recurrence|8
2671779|NCT00570232|9224485|P1|Overall Study|discontinued due to medical condition|3
2671780|NCT00570232|9224485|P1|Overall Study|Adverse Event|10
2671781|NCT00570141|9224491|P1|Overall Study|Lost to Follow-up|1
2671782|NCT00570141|9224491|P1|Overall Study|Missed visits|1
2671783|NCT00570141|9224491|P1|Overall Study|Adverse Event|1
2671784|NCT00570063|9224507|P2|Overall Study|Sponsor's Decision|3
2671785|NCT00570063|9224508|P1|Overall Study|Sponsor's Decision|7
2671786|NCT00570063|9224507|P2|Overall Study|Withdrawal by Subject|3
2671787|NCT00570063|9224508|P1|Overall Study|Withdrawal by Subject|4
2671788|NCT00570063|9224507|P2|Overall Study|Lack of Efficacy|1
2671789|NCT00570063|9224508|P1|Overall Study|Lack of Efficacy|0
2671790|NCT00570063|9224507|P2|Overall Study|Adverse Event|1
2671791|NCT00570063|9224508|P1|Overall Study|Adverse Event|4
2671792|NCT00570037|9224574|P2|Overall Study|Could not reach for 6-8 week contact|69
2671793|NCT00570037|9224575|P1|Overall Study|Could not reach for 6-8 week contact|44
2671794|NCT00569946|9224585|P1|Overall Study|Global Deterioration of Health Status|1
2671795|NCT00569946|9224585|P1|Overall Study|Objective Progression or Relapse|42
2671796|NCT00569946|9224585|P1|Overall Study|Adverse Event|16
2671797|NCT00569803|9224617|P8|Overall Study|Withdrawal by Subject|1
2671798|NCT00569803|9224618|P7|Overall Study|Withdrawal by Subject|0
2671799|NCT00569803|9224619|P6|Overall Study|Withdrawal by Subject|0
2671800|NCT00569803|9224620|P5|Overall Study|Withdrawal by Subject|0
2671801|NCT00569803|9224621|P4|Overall Study|Withdrawal by Subject|0
2671802|NCT00569803|9224622|P3|Overall Study|Withdrawal by Subject|0
2671803|NCT00569803|9224623|P2|Overall Study|Withdrawal by Subject|0
2671804|NCT00569803|9224624|P1|Overall Study|Withdrawal by Subject|0
2671805|NCT00569803|9224617|P8|Overall Study|injection syringe leaked during dosing|0
2671806|NCT00569803|9224618|P7|Overall Study|injection syringe leaked during dosing|0
2671807|NCT00569803|9224619|P6|Overall Study|injection syringe leaked during dosing|0
2671808|NCT00569803|9224620|P5|Overall Study|injection syringe leaked during dosing|0
2671809|NCT00569803|9224621|P4|Overall Study|injection syringe leaked during dosing|1
2671810|NCT00569803|9224622|P3|Overall Study|injection syringe leaked during dosing|0
2671811|NCT00569803|9224623|P2|Overall Study|injection syringe leaked during dosing|0
2671812|NCT00569803|9224624|P1|Overall Study|injection syringe leaked during dosing|0
2671813|NCT00569803|9224617|P8|Overall Study|Lost to Follow-up|0
2671814|NCT00569803|9224618|P7|Overall Study|Lost to Follow-up|0
2671815|NCT00569803|9224619|P6|Overall Study|Lost to Follow-up|0
2671816|NCT00569803|9224620|P5|Overall Study|Lost to Follow-up|0
2671817|NCT00569803|9224621|P4|Overall Study|Lost to Follow-up|0
2671818|NCT00569803|9224622|P3|Overall Study|Lost to Follow-up|0
2671819|NCT00569803|9224623|P2|Overall Study|Lost to Follow-up|0
2671820|NCT00569803|9224624|P1|Overall Study|Lost to Follow-up|1
2671821|NCT00569777|9224751|P2|Overall Study|pregnant|0
2671822|NCT00569777|9224752|P1|Overall Study|pregnant|1
2671823|NCT00569777|9224751|P2|Overall Study|did not meet exclusion criteria|2
2671824|NCT00569777|9224752|P1|Overall Study|did not meet exclusion criteria|1
2671825|NCT00569777|9224751|P2|Overall Study|scheduled eye surgery|1
2671826|NCT00569777|9224752|P1|Overall Study|scheduled eye surgery|0
2671827|NCT00569777|9224751|P2|Overall Study|Lost to Follow-up|0
2671828|NCT00569777|9224752|P1|Overall Study|Lost to Follow-up|1
2671829|NCT00569777|9224751|P2|Overall Study|Adverse Event|0
2671830|NCT00569777|9224752|P1|Overall Study|Adverse Event|3
2671831|NCT00569777|9224751|P2|Overall Study|Withdrawal by Subject|0
2671832|NCT00569777|9224752|P1|Overall Study|Withdrawal by Subject|4
2671833|NCT00569582|9224803|P1|Overall Study|Subject was non-compliant.|1
2671834|NCT00569582|9224803|P1|Overall Study|Subject was too ill to travel.|1
2671835|NCT00569582|9224803|P1|Overall Study|Adverse Event|7
2671836|NCT00569582|9224803|P1|Overall Study|Death|2
2671837|NCT00569582|9224803|P1|Overall Study|Withdrawal by Subject|5
2671838|NCT00569374|9224819|P1|Overall Study|Withdrawal by Subject|4
2671839|NCT00569270|9224838|P2|Period: First Intervention|Protocol Violation|1
2671840|NCT00569270|9224839|P1|Period: First Intervention|Protocol Violation|0
2671841|NCT00569231|9224874|P1|Overall Study|Non-compliance|2
2671842|NCT00569231|9224874|P1|Overall Study|Car accident injury|1
2671843|NCT00569231|9224874|P1|Overall Study|Withdrawal by Subject|1
2671844|NCT00569231|9224874|P1|Overall Study|Airfare expense|2
2671845|NCT00569231|9224874|P1|Overall Study|Study unrelated surgery|1
2671846|NCT00569166|9224912|P3|Overall Study|Lost to Follow-up|1
2671847|NCT00569166|9224913|P2|Overall Study|Lost to Follow-up|1
2671848|NCT00569166|9224914|P1|Overall Study|Lost to Follow-up|2
2671849|NCT00569166|9224912|P3|Overall Study|Withdrawal by Subject|3
2671850|NCT00569166|9224913|P2|Overall Study|Withdrawal by Subject|5
2671851|NCT00569166|9224914|P1|Overall Study|Withdrawal by Subject|7
2671852|NCT00569127|9224948|P2|Overall Study|Still on Treatment|3
2671853|NCT00569127|9224949|P1|Overall Study|Still on Treatment|7
2671854|NCT00569127|9224948|P2|Overall Study|Not Eligible|11
2671855|NCT00569127|9224949|P1|Overall Study|Not Eligible|14
2671856|NCT00569127|9224948|P2|Overall Study|Lost to Follow-up|3
2671857|NCT00569127|9224949|P1|Overall Study|Lost to Follow-up|0
2671858|NCT00569127|9224948|P2|Overall Study|Other|19
2671859|NCT00569127|9224949|P1|Overall Study|Other|20
2671860|NCT00569127|9224948|P2|Overall Study|Death|3
2671861|NCT00569127|9224949|P1|Overall Study|Death|4
2671862|NCT00569127|9224948|P2|Overall Study|Progression|100
2671863|NCT00569127|9224949|P1|Overall Study|Progression|99
2671864|NCT00569127|9224948|P2|Overall Study|Withdrawal by Subject|27
2671865|NCT00569127|9224949|P1|Overall Study|Withdrawal by Subject|13
2671866|NCT00569127|9224948|P2|Overall Study|Adverse Event|47
2671867|NCT00569127|9224949|P1|Overall Study|Adverse Event|57
2671868|NCT00568958|9224984|P2|Follow-Up|Adverse Event|0
2671869|NCT00568958|9224985|P1|Follow-Up|Adverse Event|1
2671870|NCT00568958|9224984|P2|Follow-Up|Family Emergency|0
2671871|NCT00568958|9224985|P1|Follow-Up|Family Emergency|1
2671872|NCT00568958|9224984|P2|Follow-Up|Physician Decision|1
2671873|NCT00568958|9224985|P1|Follow-Up|Physician Decision|1
2671874|NCT00568958|9224984|P2|Follow-Up|Withdrawal by Subject|6
2671875|NCT00568958|9224985|P1|Follow-Up|Withdrawal by Subject|6
2671876|NCT00568958|9224984|P2|Allocation|Physician Decision|0
2671877|NCT00568958|9224985|P1|Allocation|Physician Decision|2
2671878|NCT00568958|9224984|P2|Allocation|Withdrawal by Subject|3
2671879|NCT00568958|9224985|P1|Allocation|Withdrawal by Subject|7
2671880|NCT00568776|9225032|P4|Overall Study|Miscellaeneous|4
2671881|NCT00568776|9225033|P3|Overall Study|Miscellaeneous|1
2671882|NCT00568776|9225034|P2|Overall Study|Miscellaeneous|3
2671883|NCT00568776|9225035|P1|Overall Study|Miscellaeneous|3
2671884|NCT00568776|9225032|P4|Overall Study|Sponsor Decision|42
2671885|NCT00568776|9225033|P3|Overall Study|Sponsor Decision|41
2671886|NCT00568776|9225034|P2|Overall Study|Sponsor Decision|2
2671887|NCT00568776|9225035|P1|Overall Study|Sponsor Decision|2
2671888|NCT00568776|9225032|P4|Overall Study|Loss of Caregiver|2
2671889|NCT00568776|9225033|P3|Overall Study|Loss of Caregiver|1
2671890|NCT00568776|9225034|P2|Overall Study|Loss of Caregiver|2
2671891|NCT00568776|9225035|P1|Overall Study|Loss of Caregiver|0
2671892|NCT00568776|9225032|P4|Overall Study|Withdrawal by Subject|7
2671893|NCT00568776|9225033|P3|Overall Study|Withdrawal by Subject|13
2671894|NCT00568776|9225034|P2|Overall Study|Withdrawal by Subject|15
2671895|NCT00568776|9225035|P1|Overall Study|Withdrawal by Subject|13
2671896|NCT00568776|9225032|P4|Overall Study|Protocol Violation|1
2671897|NCT00568776|9225033|P3|Overall Study|Protocol Violation|1
2671898|NCT00568776|9225034|P2|Overall Study|Protocol Violation|0
2671899|NCT00568776|9225035|P1|Overall Study|Protocol Violation|1
2671900|NCT00568776|9225032|P4|Overall Study|Lost to Follow-up|1
2671901|NCT00568776|9225033|P3|Overall Study|Lost to Follow-up|1
2671902|NCT00568776|9225034|P2|Overall Study|Lost to Follow-up|1
2671903|NCT00568776|9225035|P1|Overall Study|Lost to Follow-up|1
2671904|NCT00568776|9225032|P4|Overall Study|Lack of Efficacy|4
2671905|NCT00568776|9225033|P3|Overall Study|Lack of Efficacy|2
2671906|NCT00568776|9225034|P2|Overall Study|Lack of Efficacy|2
2671907|NCT00568776|9225035|P1|Overall Study|Lack of Efficacy|2
2671908|NCT00568776|9225032|P4|Overall Study|Physician Decision|0
2671909|NCT00568776|9225033|P3|Overall Study|Physician Decision|0
2671910|NCT00568776|9225034|P2|Overall Study|Physician Decision|2
2671911|NCT00568776|9225035|P1|Overall Study|Physician Decision|0
2671912|NCT00568776|9225032|P4|Overall Study|Death|3
2671913|NCT00568776|9225033|P3|Overall Study|Death|4
2671914|NCT00568776|9225034|P2|Overall Study|Death|1
2671915|NCT00568776|9225035|P1|Overall Study|Death|0
2671916|NCT00568776|9225032|P4|Overall Study|Adverse Event|8
2671917|NCT00568776|9225033|P3|Overall Study|Adverse Event|10
2671918|NCT00568776|9225034|P2|Overall Study|Adverse Event|8
2671919|NCT00568776|9225035|P1|Overall Study|Adverse Event|8
2671920|NCT00568685|9225084|P3|Overall Study|Protocol Violation|0
2671921|NCT00568685|9225085|P2|Overall Study|Protocol Violation|0
2671922|NCT00568685|9225086|P1|Overall Study|Protocol Violation|1
2671923|NCT00568685|9225084|P3|Overall Study|Withdrawal by Subject|2
2671924|NCT00568685|9225085|P2|Overall Study|Withdrawal by Subject|2
2671925|NCT00568685|9225086|P1|Overall Study|Withdrawal by Subject|7
2671926|NCT00568685|9225084|P3|Overall Study|Adverse Event|3
2671927|NCT00568685|9225085|P2|Overall Study|Adverse Event|3
2671928|NCT00568685|9225086|P1|Overall Study|Adverse Event|2
2671929|NCT00568555|9225143|P2|Overall Study|Withdrawal by Subject|1
2671930|NCT00568555|9225144|P1|Overall Study|Withdrawal by Subject|1
2671931|NCT00568451|9225162|P4|Overall Study|Disease Progression|7
2671932|NCT00568451|9225163|P3|Overall Study|Disease Progression|2
2671933|NCT00568451|9225164|P2|Overall Study|Disease Progression|0
2671934|NCT00568451|9225165|P1|Overall Study|Disease Progression|0
2671935|NCT00568399|9225181|P1|Overall Study|Withdrawal by Subject|8
2671936|NCT00568399|9225181|P1|Overall Study|Adverse Event|5
2671937|NCT00568399|9225181|P1|Overall Study|Death|2
2671938|NCT00568334|9225196|P2|Overall Study|Lost to Follow-up|0
2671939|NCT00568334|9225197|P1|Overall Study|Lost to Follow-up|1
2671940|NCT00568334|9225196|P2|Overall Study|Withdrawal by Subject|1
2671941|NCT00568334|9225197|P1|Overall Study|Withdrawal by Subject|0
2671942|NCT00568178|9225223|P6|Open Label Extension|Withdrawal by Subject|4
2671943|NCT00568178|9225224|P5|Open Label Extension|Withdrawal by Subject|4
2671944|NCT00568178|9225225|P4|Open Label Extension|Withdrawal by Subject|0
2671945|NCT00568178|9225226|P3|Open Label Extension|Withdrawal by Subject|0
2671946|NCT00568178|9225227|P2|Open Label Extension|Withdrawal by Subject|0
2671947|NCT00568178|9225228|P1|Open Label Extension|Withdrawal by Subject|0
2671948|NCT00568178|9225223|P6|Open Label Extension|Termination of Trial|47
2671949|NCT00568178|9225224|P5|Open Label Extension|Termination of Trial|45
2671950|NCT00568178|9225225|P4|Open Label Extension|Termination of Trial|0
2671951|NCT00568178|9225226|P3|Open Label Extension|Termination of Trial|0
2671952|NCT00568178|9225227|P2|Open Label Extension|Termination of Trial|0
2671953|NCT00568178|9225228|P1|Open Label Extension|Termination of Trial|0
2671954|NCT00568178|9225223|P6|Open Label Extension|Progressive Disease|1
2671955|NCT00568178|9225224|P5|Open Label Extension|Progressive Disease|3
2671956|NCT00568178|9225225|P4|Open Label Extension|Progressive Disease|0
2671957|NCT00568178|9225226|P3|Open Label Extension|Progressive Disease|0
2671958|NCT00568178|9225227|P2|Open Label Extension|Progressive Disease|0
2671959|NCT00568178|9225228|P1|Open Label Extension|Progressive Disease|0
2671960|NCT00568178|9225223|P6|Open Label Extension|Pregnancy|1
2671961|NCT00568178|9225224|P5|Open Label Extension|Pregnancy|0
2671962|NCT00568178|9225225|P4|Open Label Extension|Pregnancy|0
2671963|NCT00568178|9225226|P3|Open Label Extension|Pregnancy|0
2671964|NCT00568178|9225227|P2|Open Label Extension|Pregnancy|0
2671965|NCT00568178|9225228|P1|Open Label Extension|Pregnancy|0
2671966|NCT00568178|9225223|P6|Open Label Extension|Physician Decision|8
2671967|NCT00568178|9225224|P5|Open Label Extension|Physician Decision|9
2671968|NCT00568178|9225225|P4|Open Label Extension|Physician Decision|0
2671969|NCT00568178|9225226|P3|Open Label Extension|Physician Decision|0
2671970|NCT00568178|9225227|P2|Open Label Extension|Physician Decision|0
2671971|NCT00568178|9225228|P1|Open Label Extension|Physician Decision|0
2671972|NCT00568178|9225223|P6|Open Label Extension|Lost to Follow-up|11
2671973|NCT00568178|9225224|P5|Open Label Extension|Lost to Follow-up|6
2671974|NCT00568178|9225225|P4|Open Label Extension|Lost to Follow-up|0
2671975|NCT00568178|9225226|P3|Open Label Extension|Lost to Follow-up|0
2671976|NCT00568178|9225227|P2|Open Label Extension|Lost to Follow-up|0
2671977|NCT00568178|9225228|P1|Open Label Extension|Lost to Follow-up|0
2671978|NCT00568178|9225223|P6|Open Label Extension|Protocol Violation|0
2671979|NCT00568178|9225224|P5|Open Label Extension|Protocol Violation|1
2671980|NCT00568178|9225225|P4|Open Label Extension|Protocol Violation|0
2671981|NCT00568178|9225226|P3|Open Label Extension|Protocol Violation|0
2671982|NCT00568178|9225227|P2|Open Label Extension|Protocol Violation|0
2671983|NCT00568178|9225228|P1|Open Label Extension|Protocol Violation|0
2671984|NCT00568178|9225223|P6|Open Label Extension|Adverse Event|8
2671985|NCT00568178|9225224|P5|Open Label Extension|Adverse Event|11
2671986|NCT00568178|9225225|P4|Open Label Extension|Adverse Event|0
2671987|NCT00568178|9225226|P3|Open Label Extension|Adverse Event|0
2671988|NCT00568178|9225227|P2|Open Label Extension|Adverse Event|0
2671989|NCT00568178|9225228|P1|Open Label Extension|Adverse Event|0
2671990|NCT00568178|9225223|P6|Double Blind Base Study|Progressive Disease|0
2671991|NCT00568178|9225224|P5|Double Blind Base Study|Progressive Disease|0
2671992|NCT00568178|9225225|P4|Double Blind Base Study|Progressive Disease|1
2671993|NCT00568178|9225226|P3|Double Blind Base Study|Progressive Disease|0
2671994|NCT00568178|9225227|P2|Double Blind Base Study|Progressive Disease|0
2671995|NCT00568178|9225228|P1|Double Blind Base Study|Progressive Disease|0
2671996|NCT00568178|9225223|P6|Double Blind Base Study|Withdrawal by Subject|0
2671997|NCT00568178|9225224|P5|Double Blind Base Study|Withdrawal by Subject|0
2671998|NCT00568178|9225225|P4|Double Blind Base Study|Withdrawal by Subject|0
2671999|NCT00568178|9225226|P3|Double Blind Base Study|Withdrawal by Subject|0
2672000|NCT00568178|9225227|P2|Double Blind Base Study|Withdrawal by Subject|1
2672001|NCT00568178|9225228|P1|Double Blind Base Study|Withdrawal by Subject|1
2672002|NCT00568178|9225223|P6|Double Blind Base Study|Protocol Violation|0
2672003|NCT00568178|9225224|P5|Double Blind Base Study|Protocol Violation|0
2672004|NCT00568178|9225225|P4|Double Blind Base Study|Protocol Violation|0
2672005|NCT00568178|9225226|P3|Double Blind Base Study|Protocol Violation|0
2672006|NCT00568178|9225227|P2|Double Blind Base Study|Protocol Violation|2
2672007|NCT00568178|9225228|P1|Double Blind Base Study|Protocol Violation|3
2672008|NCT00568178|9225223|P6|Double Blind Base Study|Physician Decision|0
2672009|NCT00568178|9225224|P5|Double Blind Base Study|Physician Decision|0
2672010|NCT00568178|9225225|P4|Double Blind Base Study|Physician Decision|1
2672011|NCT00568178|9225226|P3|Double Blind Base Study|Physician Decision|0
2672012|NCT00568178|9225227|P2|Double Blind Base Study|Physician Decision|1
2672013|NCT00568178|9225228|P1|Double Blind Base Study|Physician Decision|1
2672014|NCT00568178|9225223|P6|Double Blind Base Study|Lost to Follow-up|0
2672015|NCT00568178|9225224|P5|Double Blind Base Study|Lost to Follow-up|0
2672016|NCT00568178|9225225|P4|Double Blind Base Study|Lost to Follow-up|1
2672017|NCT00568178|9225226|P3|Double Blind Base Study|Lost to Follow-up|0
2672018|NCT00568178|9225227|P2|Double Blind Base Study|Lost to Follow-up|0
2672019|NCT00568178|9225228|P1|Double Blind Base Study|Lost to Follow-up|1
2672020|NCT00568178|9225223|P6|Double Blind Base Study|Adverse Event|0
2672021|NCT00568178|9225224|P5|Double Blind Base Study|Adverse Event|0
2672022|NCT00568178|9225225|P4|Double Blind Base Study|Adverse Event|2
2672023|NCT00568178|9225226|P3|Double Blind Base Study|Adverse Event|1
2672024|NCT00568178|9225227|P2|Double Blind Base Study|Adverse Event|2
2672025|NCT00568178|9225228|P1|Double Blind Base Study|Adverse Event|0
2672026|NCT00568061|9225261|P2|Overall Study|Adverse Event|1
2672027|NCT00568061|9225262|P1|Overall Study|Adverse Event|0
2672028|NCT00568061|9225261|P2|Overall Study|Inclusion / exclusion criteria|1
2672029|NCT00568061|9225262|P1|Overall Study|Inclusion / exclusion criteria|5
2672030|NCT00567996|9225325|P3|Overall Study|Patient's inability to use the device|0
2672031|NCT00567996|9225326|P2|Overall Study|Patient's inability to use the device|1
2672032|NCT00567996|9225327|P1|Overall Study|Patient's inability to use the device|0
2672033|NCT00567996|9225325|P3|Overall Study|Death|2
2672034|NCT00567996|9225326|P2|Overall Study|Death|0
2672035|NCT00567996|9225327|P1|Overall Study|Death|1
2672036|NCT00567996|9225325|P3|Overall Study|Administrative problems|0
2672037|NCT00567996|9225326|P2|Overall Study|Administrative problems|1
2672038|NCT00567996|9225327|P1|Overall Study|Administrative problems|1
2672039|NCT00567996|9225325|P3|Overall Study|Unsatisfactory therapeutic effect|15
2672040|NCT00567996|9225326|P2|Overall Study|Unsatisfactory therapeutic effect|2
2672041|NCT00567996|9225327|P1|Overall Study|Unsatisfactory therapeutic effect|1
2672042|NCT00567996|9225325|P3|Overall Study|Lost to Follow-up|2
2672043|NCT00567996|9225326|P2|Overall Study|Lost to Follow-up|5
2672044|NCT00567996|9225327|P1|Overall Study|Lost to Follow-up|2
2672045|NCT00567996|9225325|P3|Overall Study|Abnormal test procedure result(s)|1
2672046|NCT00567996|9225326|P2|Overall Study|Abnormal test procedure result(s)|1
2672047|NCT00567996|9225327|P1|Overall Study|Abnormal test procedure result(s)|2
2672048|NCT00567996|9225325|P3|Overall Study|Abnormal Lab value(s)|2
2672049|NCT00567996|9225326|P2|Overall Study|Abnormal Lab value(s)|1
2672050|NCT00567996|9225327|P1|Overall Study|Abnormal Lab value(s)|2
2672051|NCT00567996|9225325|P3|Overall Study|Withdrawal by Subject|22
2672052|NCT00567996|9225326|P2|Overall Study|Withdrawal by Subject|12
2672053|NCT00567996|9225327|P1|Overall Study|Withdrawal by Subject|8
2672054|NCT00567996|9225325|P3|Overall Study|Protocol Deviation|13
2672055|NCT00567996|9225326|P2|Overall Study|Protocol Deviation|11
2672056|NCT00567996|9225327|P1|Overall Study|Protocol Deviation|9
2672057|NCT00567996|9225325|P3|Overall Study|Adverse Event|13
2672058|NCT00567996|9225326|P2|Overall Study|Adverse Event|16
2672059|NCT00567996|9225327|P1|Overall Study|Adverse Event|18
2672060|NCT00567892|9225343|P4|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
2672061|NCT00567892|9225344|P3|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
2672062|NCT00567892|9225345|P2|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
2672063|NCT00567892|9225346|P1|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
2672064|NCT00567892|9225343|P4|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4
2672065|NCT00567892|9225344|P3|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
2672066|NCT00567892|9225345|P2|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
2672067|NCT00567892|9225346|P1|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
2672068|NCT00567879|9225364|P6|Overall Study|Disease progression|3
2672069|NCT00567879|9225365|P5|Overall Study|Disease progression|11
2672070|NCT00567879|9225366|P4|Overall Study|Disease progression|5
2672071|NCT00567879|9225367|P3|Overall Study|Disease progression|15
2672072|NCT00567879|9225368|P2|Overall Study|Disease progression|7
2672073|NCT00567879|9225369|P1|Overall Study|Disease progression|5
2672074|NCT00567879|9225364|P6|Overall Study|New cancer therapy|0
2672075|NCT00567879|9225365|P5|Overall Study|New cancer therapy|0
2672076|NCT00567879|9225366|P4|Overall Study|New cancer therapy|0
2672077|NCT00567879|9225367|P3|Overall Study|New cancer therapy|1
2672078|NCT00567879|9225368|P2|Overall Study|New cancer therapy|0
2672079|NCT00567879|9225369|P1|Overall Study|New cancer therapy|0
2672080|NCT00567879|9225364|P6|Overall Study|Withdrawal by Subject|0
2672081|NCT00567879|9225365|P5|Overall Study|Withdrawal by Subject|0
2672082|NCT00567879|9225366|P4|Overall Study|Withdrawal by Subject|1
2672083|NCT00567879|9225367|P3|Overall Study|Withdrawal by Subject|3
2672084|NCT00567879|9225368|P2|Overall Study|Withdrawal by Subject|0
2672085|NCT00567879|9225369|P1|Overall Study|Withdrawal by Subject|0
2672086|NCT00567879|9225364|P6|Overall Study|Abnormal test procedure(s)|0
2672087|NCT00567879|9225365|P5|Overall Study|Abnormal test procedure(s)|0
2672088|NCT00567879|9225366|P4|Overall Study|Abnormal test procedure(s)|0
2672089|NCT00567879|9225367|P3|Overall Study|Abnormal test procedure(s)|1
2672090|NCT00567879|9225368|P2|Overall Study|Abnormal test procedure(s)|0
2672091|NCT00567879|9225369|P1|Overall Study|Abnormal test procedure(s)|0
2672092|NCT00567879|9225364|P6|Overall Study|Adverse Event|0
2672093|NCT00567879|9225365|P5|Overall Study|Adverse Event|1
2672094|NCT00567879|9225366|P4|Overall Study|Adverse Event|0
2672095|NCT00567879|9225367|P3|Overall Study|Adverse Event|1
2672096|NCT00567879|9225368|P2|Overall Study|Adverse Event|0
2672097|NCT00567879|9225369|P1|Overall Study|Adverse Event|2
2672098|NCT00567593|9225436|P1|Overall Study|Physician Decision|1
2672099|NCT00567593|9225436|P1|Overall Study|Adverse Event|1
2672100|NCT00567567|9225443|P3|Overall Study|Unable adequate stem cell for transplant|2
2672101|NCT00567567|9225444|P2|Overall Study|Unable adequate stem cell for transplant|0
2672102|NCT00567567|9225445|P1|Overall Study|Unable adequate stem cell for transplant|0
2672103|NCT00567567|9225443|P3|Overall Study|Enrolled another COG therapeutic study|0
2672104|NCT00567567|9225444|P2|Overall Study|Enrolled another COG therapeutic study|80
2672105|NCT00567567|9225445|P1|Overall Study|Enrolled another COG therapeutic study|99
2672106|NCT00567567|9225443|P3|Overall Study|Refusal by patient/parent/guardian|122
2672107|NCT00567567|9225444|P2|Overall Study|Refusal by patient/parent/guardian|16
2672108|NCT00567567|9225445|P1|Overall Study|Refusal by patient/parent/guardian|9
2672109|NCT00567567|9225443|P3|Overall Study|Ineligible|9
2672110|NCT00567567|9225444|P2|Overall Study|Ineligible|0
2672111|NCT00567567|9225445|P1|Overall Study|Ineligible|4
2672112|NCT00567567|9225443|P3|Overall Study|Withdrawal by Subject|2
2672113|NCT00567567|9225444|P2|Overall Study|Withdrawal by Subject|0
2672114|NCT00567567|9225445|P1|Overall Study|Withdrawal by Subject|0
2672115|NCT00567567|9225443|P3|Overall Study|Physician Decision|84
2672116|NCT00567567|9225444|P2|Overall Study|Physician Decision|18
2672117|NCT00567567|9225445|P1|Overall Study|Physician Decision|16
2672118|NCT00567567|9225443|P3|Overall Study|Lost to Follow-up|1
2672119|NCT00567567|9225444|P2|Overall Study|Lost to Follow-up|0
2672120|NCT00567567|9225445|P1|Overall Study|Lost to Follow-up|0
2672121|NCT00567567|9225443|P3|Overall Study|Lack of Efficacy|48
2672122|NCT00567567|9225444|P2|Overall Study|Lack of Efficacy|17
2672123|NCT00567567|9225445|P1|Overall Study|Lack of Efficacy|16
2672124|NCT00567567|9225443|P3|Overall Study|Death|5
2672125|NCT00567567|9225444|P2|Overall Study|Death|1
2672126|NCT00567567|9225445|P1|Overall Study|Death|8
2672127|NCT00567567|9225443|P3|Overall Study|Adverse Event|5
2672128|NCT00567567|9225444|P2|Overall Study|Adverse Event|2
2672129|NCT00567567|9225445|P1|Overall Study|Adverse Event|0
2672130|NCT00567541|9225493|P2|Overall Study|Adverse Event|1
2672131|NCT00567541|9225494|P1|Overall Study|Adverse Event|0
2672132|NCT00567502|9225504|P4|Overall Study|Never Initiated Treatment|72
2672133|NCT00567502|9225505|P3|Overall Study|Never Initiated Treatment|0
2672134|NCT00567502|9225506|P2|Overall Study|Never Initiated Treatment|0
2672135|NCT00567502|9225507|P1|Overall Study|Never Initiated Treatment|0
2672136|NCT00567502|9225504|P4|Overall Study|Sponsor request|1
2672137|NCT00567502|9225505|P3|Overall Study|Sponsor request|30
2672138|NCT00567502|9225506|P2|Overall Study|Sponsor request|0
2672139|NCT00567502|9225507|P1|Overall Study|Sponsor request|9
2672140|NCT00567502|9225504|P4|Overall Study|Participant request|1
2672141|NCT00567502|9225505|P3|Overall Study|Participant request|33
2672142|NCT00567502|9225506|P2|Overall Study|Participant request|1
2672143|NCT00567502|9225507|P1|Overall Study|Participant request|12
2672144|NCT00567502|9225504|P4|Overall Study|Other|6
2672145|NCT00567502|9225505|P3|Overall Study|Other|134
2672146|NCT00567502|9225506|P2|Overall Study|Other|2
2672147|NCT00567502|9225507|P1|Overall Study|Other|64
2672148|NCT00567502|9225504|P4|Overall Study|Death|5
2672149|NCT00567502|9225505|P3|Overall Study|Death|360
2672150|NCT00567502|9225506|P2|Overall Study|Death|16
2672151|NCT00567502|9225507|P1|Overall Study|Death|65
2672152|NCT00567502|9225504|P4|Overall Study|Lost to Follow-up|2
2672153|NCT00567502|9225505|P3|Overall Study|Lost to Follow-up|351
2672154|NCT00567502|9225506|P2|Overall Study|Lost to Follow-up|14
2672155|NCT00567502|9225507|P1|Overall Study|Lost to Follow-up|91
2672156|NCT00567489|9225544|P2|Overall Study|Other|0
2672157|NCT00567489|9225545|P1|Overall Study|Other|1
2672158|NCT00567489|9225544|P2|Overall Study|Renal Transplantation|3
2672159|NCT00567489|9225545|P1|Overall Study|Renal Transplantation|0
2672160|NCT00567489|9225544|P2|Overall Study|Withdrawal by Subject|2
2672161|NCT00567489|9225545|P1|Overall Study|Withdrawal by Subject|0
2672162|NCT00567489|9225544|P2|Overall Study|Physician Decision|4
2672163|NCT00567489|9225545|P1|Overall Study|Physician Decision|0
2672164|NCT00567489|9225544|P2|Overall Study|Adverse Event|14
2672165|NCT00567489|9225545|P1|Overall Study|Adverse Event|6
2672166|NCT00567476|9225595|P2|Overall Study|Non-adherence to protocol|1
2672167|NCT00567476|9225596|P1|Overall Study|Non-adherence to protocol|0
2672168|NCT00567476|9225595|P2|Overall Study|Medical Decision|1
2672169|NCT00567476|9225596|P1|Overall Study|Medical Decision|0
2672170|NCT00567476|9225595|P2|Overall Study|Administrative issues|0
2672171|NCT00567476|9225596|P1|Overall Study|Administrative issues|1
2672172|NCT00567476|9225595|P2|Overall Study|Lost to Follow-up|1
2672173|NCT00567476|9225596|P1|Overall Study|Lost to Follow-up|0
2672174|NCT00567476|9225595|P2|Overall Study|Protocol Violation|1
2672175|NCT00567476|9225596|P1|Overall Study|Protocol Violation|4
2672176|NCT00567476|9225595|P2|Overall Study|Pregnancy|0
2672177|NCT00567476|9225596|P1|Overall Study|Pregnancy|1
2672178|NCT00567476|9225595|P2|Overall Study|Adverse Event|0
2672179|NCT00567476|9225596|P1|Overall Study|Adverse Event|2
2672180|NCT00567398|9225622|P2|Overall Study|Other|0
2672181|NCT00567398|9225623|P1|Overall Study|Other|1
2672182|NCT00567398|9225622|P2|Overall Study|Renal Transplantation|3
2672183|NCT00567398|9225623|P1|Overall Study|Renal Transplantation|0
2672184|NCT00567398|9225622|P2|Overall Study|Withdrawal by Subject|2
2672185|NCT00567398|9225623|P1|Overall Study|Withdrawal by Subject|0
2672186|NCT00567398|9225622|P2|Overall Study|Physician Decision|4
2672187|NCT00567398|9225623|P1|Overall Study|Physician Decision|0
2672188|NCT00567398|9225622|P2|Overall Study|Adverse Event|14
2672189|NCT00567398|9225623|P1|Overall Study|Adverse Event|6
2672190|NCT00567359|9225671|P1|Overall Study|Withdrawal by Subject|1
2672191|NCT00567268|9225696|P1|Overall Study|"Safety Evaluation Not Assessable"|1
2672192|NCT00567268|9225696|P1|Overall Study|No Drug Administration|4
2672193|NCT00567268|9225696|P1|Overall Study|No Visit After First Day of Treatment|2
2672194|NCT00567268|9225696|P1|Overall Study|Lost to Follow-up|36
2672195|NCT00567268|9225696|P1|Overall Study|Protocol Violation|7
2672196|NCT00567255|9225747|P2|Overall Study|Drug noncompliance,moved,other|15
2672197|NCT00567255|9225748|P1|Overall Study|Drug noncompliance,moved,other|25
2672198|NCT00567255|9225747|P2|Overall Study|Pregnancy|0
2672199|NCT00567255|9225748|P1|Overall Study|Pregnancy|6
2672200|NCT00567255|9225747|P2|Overall Study|Protocol Violation|8
2672201|NCT00567255|9225748|P1|Overall Study|Protocol Violation|20
2672202|NCT00567255|9225747|P2|Overall Study|Lack of Efficacy|33
2672203|NCT00567255|9225748|P1|Overall Study|Lack of Efficacy|19
2672204|NCT00567255|9225747|P2|Overall Study|Withdrawal by Subject|56
2672205|NCT00567255|9225748|P1|Overall Study|Withdrawal by Subject|75
2672206|NCT00567255|9225747|P2|Overall Study|Lost to Follow-up|48
2672207|NCT00567255|9225748|P1|Overall Study|Lost to Follow-up|77
2672208|NCT00567255|9225747|P2|Overall Study|Adverse Event|68
2672209|NCT00567255|9225748|P1|Overall Study|Adverse Event|241
2672210|NCT00567190|9225811|P2|Overall Study|Withdrew Consent or Lost to Follow-up|53
2672211|NCT00567190|9225812|P1|Overall Study|Withdrew Consent or Lost to Follow-up|48
2672212|NCT00567190|9225811|P2|Overall Study|Death|280
2672213|NCT00567190|9225812|P1|Overall Study|Death|235
2672214|NCT00567164|9225863|P3|Overall Study|Missing|0
2672215|NCT00567164|9225864|P2|Overall Study|Missing|0
2672216|NCT00567164|9225865|P1|Overall Study|Missing|1
2672217|NCT00567164|9225863|P3|Overall Study|Primary Reason coded as 'Other'|16
2672218|NCT00567164|9225864|P2|Overall Study|Primary Reason coded as 'Other'|8
2672219|NCT00567164|9225865|P1|Overall Study|Primary Reason coded as 'Other'|37
2672220|NCT00567164|9225863|P3|Overall Study|Pregnancy|6
2672221|NCT00567164|9225864|P2|Overall Study|Pregnancy|4
2672222|NCT00567164|9225865|P1|Overall Study|Pregnancy|20
2672223|NCT00567164|9225863|P3|Overall Study|Lost to Follow-up|21
2672224|NCT00567164|9225864|P2|Overall Study|Lost to Follow-up|23
2672225|NCT00567164|9225865|P1|Overall Study|Lost to Follow-up|202
2672226|NCT00567164|9225863|P3|Overall Study|Death|1
2672227|NCT00567164|9225864|P2|Overall Study|Death|0
2672228|NCT00567164|9225865|P1|Overall Study|Death|0
2672229|NCT00567164|9225863|P3|Overall Study|Adverse Event|9
2672230|NCT00567164|9225864|P2|Overall Study|Adverse Event|13
2672231|NCT00567164|9225865|P1|Overall Study|Adverse Event|92
2672232|NCT00567164|9225863|P3|Overall Study|Protocol Violation|2
2672233|NCT00567164|9225864|P2|Overall Study|Protocol Violation|4
2672234|NCT00567164|9225865|P1|Overall Study|Protocol Violation|23
2672235|NCT00567164|9225863|P3|Overall Study|Withdrawal by Subject|17
2672236|NCT00567164|9225864|P2|Overall Study|Withdrawal by Subject|21
2672237|NCT00567164|9225865|P1|Overall Study|Withdrawal by Subject|171
2672238|NCT00567112|9225937|P3|Washout Period 3 (3 Days)|Protocol Violation|0
2672239|NCT00567112|9225938|P2|Washout Period 3 (3 Days)|Protocol Violation|0
2672240|NCT00567112|9225939|P1|Washout Period 3 (3 Days)|Protocol Violation|1
2672241|NCT00567112|9225937|P3|Washout Period 3 (3 Days)|Lost to Follow-up|0
2672242|NCT00567112|9225938|P2|Washout Period 3 (3 Days)|Lost to Follow-up|0
2672243|NCT00567112|9225939|P1|Washout Period 3 (3 Days)|Lost to Follow-up|2
2672244|NCT00567112|9225937|P3|Treatment Period 2 (3 Days)|Protocol Violation|0
2672245|NCT00567112|9225938|P2|Treatment Period 2 (3 Days)|Protocol Violation|1
2672246|NCT00567112|9225939|P1|Treatment Period 2 (3 Days)|Protocol Violation|0
2672247|NCT00566995|9225970|P1|Overall Study|Withdrew consent|3
2672248|NCT00566995|9225970|P1|Overall Study|Toxicity|4
2672249|NCT00566982|9225985|P2|Overall Study|Other-family problems & doctor's request|2
2672250|NCT00566982|9225986|P1|Overall Study|Other-family problems & doctor's request|0
2672251|NCT00566982|9225985|P2|Overall Study|Lost to Follow-up|1
2672252|NCT00566982|9225986|P1|Overall Study|Lost to Follow-up|0
2672253|NCT00566982|9225985|P2|Overall Study|Protocol Violation|4
2672254|NCT00566982|9225986|P1|Overall Study|Protocol Violation|1
2672255|NCT00566982|9225985|P2|Overall Study|Withdrawal by Subject|14
2672256|NCT00566982|9225986|P1|Overall Study|Withdrawal by Subject|1
2672257|NCT00566982|9225985|P2|Overall Study|Adverse Event|48
2672258|NCT00566982|9225986|P1|Overall Study|Adverse Event|6
2672259|NCT00566852|9226051|P2|Overall Study|Missing reason not reported|20
2672260|NCT00566852|9226052|P1|Overall Study|Missing reason not reported|16
2672261|NCT00566852|9226051|P2|Overall Study|Missing reason not specified|2
2672262|NCT00566852|9226052|P1|Overall Study|Missing reason not specified|1
2672263|NCT00566852|9226051|P2|Overall Study|Not tested due to disability|12
2672264|NCT00566852|9226052|P1|Overall Study|Not tested due to disability|6
2672265|NCT00566852|9226051|P2|Overall Study|Patient refusal|37
2672266|NCT00566852|9226052|P1|Overall Study|Patient refusal|37
2672267|NCT00566852|9226051|P2|Overall Study|Withdrawal by Subject|25
2672268|NCT00566852|9226052|P1|Overall Study|Withdrawal by Subject|30
2672269|NCT00566852|9226051|P2|Overall Study|Death|78
2672270|NCT00566852|9226052|P1|Overall Study|Death|95
2672271|NCT00566852|9226051|P2|Overall Study|Protocol Violation|24
2672272|NCT00566852|9226052|P1|Overall Study|Protocol Violation|22
2672273|NCT00566735|9226083|P2|Overall Study|Switched into a manic episode|1
2672274|NCT00566735|9226084|P1|Overall Study|Switched into a manic episode|0
2672275|NCT00566735|9226083|P2|Overall Study|Refused neuropsychological testing|5
2672276|NCT00566735|9226084|P1|Overall Study|Refused neuropsychological testing|2
2672277|NCT00566735|9226083|P2|Overall Study|Withdrawal by Subject|1
2672278|NCT00566735|9226084|P1|Overall Study|Withdrawal by Subject|0
2672279|NCT00566722|9226097|P3|Overall Study|Noncompliant with drug administration|1
2672280|NCT00566722|9226098|P2|Overall Study|Noncompliant with drug administration|0
2672281|NCT00566722|9226099|P1|Overall Study|Noncompliant with drug administration|0
2672282|NCT00566722|9226097|P3|Overall Study|Serious adverse event|0
2672283|NCT00566722|9226098|P2|Overall Study|Serious adverse event|1
2672284|NCT00566722|9226099|P1|Overall Study|Serious adverse event|0
2672285|NCT00566722|9226097|P3|Overall Study|Did not meet exclusion criteria|2
2672286|NCT00566722|9226098|P2|Overall Study|Did not meet exclusion criteria|0
2672287|NCT00566722|9226099|P1|Overall Study|Did not meet exclusion criteria|0
2672288|NCT00566722|9226097|P3|Overall Study|Lack of Efficacy|4
2672289|NCT00566722|9226098|P2|Overall Study|Lack of Efficacy|2
2672290|NCT00566722|9226099|P1|Overall Study|Lack of Efficacy|1
2672291|NCT00566722|9226097|P3|Overall Study|Lost to Follow-up|1
2672292|NCT00566722|9226098|P2|Overall Study|Lost to Follow-up|1
2672293|NCT00566722|9226099|P1|Overall Study|Lost to Follow-up|1
2672294|NCT00566722|9226097|P3|Overall Study|Withdrawal by Subject|1
2672295|NCT00566722|9226098|P2|Overall Study|Withdrawal by Subject|0
2672296|NCT00566722|9226099|P1|Overall Study|Withdrawal by Subject|0
2672297|NCT00566722|9226097|P3|Overall Study|Adverse Event|0
2672298|NCT00566722|9226098|P2|Overall Study|Adverse Event|1
2672299|NCT00566722|9226099|P1|Overall Study|Adverse Event|0
2672300|NCT00566709|9226145|P2|Overall Study|Protocol Violation|0
2672301|NCT00566709|9226146|P1|Overall Study|Protocol Violation|5
2672302|NCT00566696|9226162|P1|Overall Study|Non-Patient Donors|37
2672303|NCT00566696|9226162|P1|Overall Study|Physician Decision|1
2672304|NCT00566696|9226162|P1|Overall Study|Health Status Change|1
2672305|NCT00566696|9226162|P1|Overall Study|Muromonab not available|1
2672306|NCT00566696|9226162|P1|Overall Study|Met Exclusion Criteria|2
2672307|NCT00566631|9226172|P1|Part 2: Extension Phase|Other|5
2672308|NCT00566631|9226172|P1|Part 2: Extension Phase|Death|1
2672309|NCT00566631|9226172|P1|Part 2: Extension Phase|Lost to Follow-up|6
2672310|NCT00566631|9226172|P1|Part 2: Extension Phase|Adverse Event|11
2672311|NCT00566631|9226172|P1|Part 2: Extension Phase|Withdrawal by Subject|34
2672312|NCT00566631|9226172|P1|Part 2: Extension Phase|Lack of Efficacy|25
2672313|NCT00566631|9226172|P1|Between Treatment and Extension Phase|Participants not willing to participate|95
2672314|NCT00566631|9226172|P1|Part 1: Core Treatment Phase|Met exclusion criteria|1
2672315|NCT00566631|9226172|P1|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1
2672316|NCT00566631|9226172|P1|Part 1: Core Treatment Phase|Withdrawal by Subject|26
2672317|NCT00566631|9226172|P1|Part 1: Core Treatment Phase|Lost to Follow-up|4
2672318|NCT00566631|9226172|P1|Part 1: Core Treatment Phase|Adverse Event|9
2672319|NCT00566631|9226172|P1|Part 1: Core Treatment Phase|Physician Decision|1
2672320|NCT00566631|9226172|P1|Part 1: Core Treatment Phase|Lack of Efficacy|18
2672321|NCT00566527|9226199|P3|Overall Study|Withdrawal by Subject|43
2672322|NCT00566527|9226200|P2|Overall Study|Withdrawal by Subject|43
2672323|NCT00566527|9226201|P1|Overall Study|Withdrawal by Subject|6
2672324|NCT00566527|9226199|P3|Overall Study|Lost to Follow-up|4
2672325|NCT00566527|9226200|P2|Overall Study|Lost to Follow-up|4
2672326|NCT00566527|9226201|P1|Overall Study|Lost to Follow-up|3
2672327|NCT00566527|9226199|P3|Overall Study|Physician Decision|20
2672328|NCT00566527|9226200|P2|Overall Study|Physician Decision|8
2672329|NCT00566527|9226201|P1|Overall Study|Physician Decision|3
2672330|NCT00566527|9226199|P3|Overall Study|Adverse Event|1
2672331|NCT00566527|9226200|P2|Overall Study|Adverse Event|0
2672332|NCT00566527|9226201|P1|Overall Study|Adverse Event|2
2672333|NCT00566527|9226199|P3|Overall Study|Reason not provided|10
2672334|NCT00566527|9226200|P2|Overall Study|Reason not provided|11
2672335|NCT00566527|9226201|P1|Overall Study|Reason not provided|3
2672336|NCT00566254|9226262|P2|Overall Study|Other|2
2672337|NCT00566254|9226263|P1|Overall Study|Other|0
2672338|NCT00566254|9226262|P2|Overall Study|Lack of Efficacy|6
2672339|NCT00566254|9226263|P1|Overall Study|Lack of Efficacy|5
2672340|NCT00566254|9226262|P2|Overall Study|Withdrawal by Subject|2
2672341|NCT00566254|9226263|P1|Overall Study|Withdrawal by Subject|1
2672342|NCT00566254|9226262|P2|Overall Study|Protocol Violation|3
2672343|NCT00566254|9226263|P1|Overall Study|Protocol Violation|1
2672344|NCT00566254|9226262|P2|Overall Study|Adverse Event|1
2672345|NCT00566254|9226263|P1|Overall Study|Adverse Event|3
2672346|NCT00566228|9226277|P2|Overall Study|progressed before infusion could occur|1
2672347|NCT00566228|9226278|P1|Overall Study|progressed before infusion could occur|0
2672348|NCT00566228|9226277|P2|Overall Study|Unable to collect sufficient CD34 cells|2
2672349|NCT00566228|9226278|P1|Overall Study|Unable to collect sufficient CD34 cells|3
2672350|NCT00566228|9226277|P2|Overall Study|Attempt to mobilize stem cells failed|2
2672351|NCT00566228|9226278|P1|Overall Study|Attempt to mobilize stem cells failed|2
2672352|NCT00566228|9226277|P2|Overall Study|Withdrawal by Subject|0
2672353|NCT00566228|9226278|P1|Overall Study|Withdrawal by Subject|1
2672354|NCT00566111|9226311|P2|Overall Study|Adverse Event|2
2672355|NCT00566111|9226312|P1|Overall Study|Adverse Event|0
2672356|NCT00566098|9226326|P1|Administration of ASCT+MILs|Lack of Efficacy|8
2672357|NCT00566098|9226326|P1|Administration of ASCT+MILs|Death|10
2672358|NCT00566098|9226326|P1|Generation of MILs Product|Relapsed|1
2672359|NCT00566098|9226326|P1|Collection of MILs|Relapsed|1
2672360|NCT00566098|9226326|P1|Collection of MILs|Withdrawal by Subject|1
2672361|NCT00566020|9226336|P2|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1
2672362|NCT00566020|9226337|P1|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0
2672363|NCT00566020|9226336|P2|46-week Long-term Administration Phase|Lost to Follow-up|2
2672364|NCT00566020|9226337|P1|46-week Long-term Administration Phase|Lost to Follow-up|0
2672365|NCT00566020|9226336|P2|46-week Long-term Administration Phase|Physician Decision|7
2672366|NCT00566020|9226337|P1|46-week Long-term Administration Phase|Physician Decision|0
2672367|NCT00566020|9226336|P2|46-week Long-term Administration Phase|Adverse Event|7
2672368|NCT00566020|9226337|P1|46-week Long-term Administration Phase|Adverse Event|0
2672369|NCT00566020|9226336|P2|6-week Dosage Adjustment Phase|Lack of Efficacy|0
2672370|NCT00566020|9226337|P1|6-week Dosage Adjustment Phase|Lack of Efficacy|2
2672371|NCT00566020|9226336|P2|6-week Dosage Adjustment Phase|Adverse Event|0
2672372|NCT00566020|9226337|P1|6-week Dosage Adjustment Phase|Adverse Event|5
2672373|NCT00565812|9226426|P3|Overall Study|Physician Decision|0
2672374|NCT00565812|9226427|P2|Overall Study|Physician Decision|0
2672375|NCT00565812|9226428|P1|Overall Study|Physician Decision|2
2672376|NCT00565812|9226426|P3|Overall Study|Follow-up Visit Not Completed|1
2672377|NCT00565812|9226427|P2|Overall Study|Follow-up Visit Not Completed|0
2672378|NCT00565812|9226428|P1|Overall Study|Follow-up Visit Not Completed|2
2672379|NCT00565812|9226426|P3|Overall Study|Low Compliance|1
2672380|NCT00565812|9226427|P2|Overall Study|Low Compliance|0
2672381|NCT00565812|9226428|P1|Overall Study|Low Compliance|1
2672382|NCT00565812|9226426|P3|Overall Study|Surgical Intervention|2
2672383|NCT00565812|9226427|P2|Overall Study|Surgical Intervention|1
2672384|NCT00565812|9226428|P1|Overall Study|Surgical Intervention|0
2672385|NCT00565812|9226426|P3|Overall Study|Research Site Closure|8
2672386|NCT00565812|9226427|P2|Overall Study|Research Site Closure|1
2672387|NCT00565812|9226428|P1|Overall Study|Research Site Closure|6
2672388|NCT00565812|9226426|P3|Overall Study|Domestic Reasons|3
2672389|NCT00565812|9226427|P2|Overall Study|Domestic Reasons|1
2672390|NCT00565812|9226428|P1|Overall Study|Domestic Reasons|7
2672391|NCT00565812|9226426|P3|Overall Study|Sponsor Decision|1
2672392|NCT00565812|9226427|P2|Overall Study|Sponsor Decision|5
2672393|NCT00565812|9226428|P1|Overall Study|Sponsor Decision|1
2672394|NCT00565812|9226426|P3|Overall Study|Relocated Out of Area|9
2672395|NCT00565812|9226427|P2|Overall Study|Relocated Out of Area|8
2672396|NCT00565812|9226428|P1|Overall Study|Relocated Out of Area|5
2672397|NCT00565812|9226426|P3|Overall Study|Jury Duty|0
2672398|NCT00565812|9226427|P2|Overall Study|Jury Duty|0
2672399|NCT00565812|9226428|P1|Overall Study|Jury Duty|1
2672400|NCT00565812|9226426|P3|Overall Study|Adverse Event|40
2672401|NCT00565812|9226427|P2|Overall Study|Adverse Event|54
2672402|NCT00565812|9226428|P1|Overall Study|Adverse Event|41
2672403|NCT00565812|9226426|P3|Overall Study|Protocol Violation|4
2672404|NCT00565812|9226427|P2|Overall Study|Protocol Violation|6
2672405|NCT00565812|9226428|P1|Overall Study|Protocol Violation|2
2672406|NCT00565812|9226426|P3|Overall Study|Work Schedule|1
2672407|NCT00565812|9226427|P2|Overall Study|Work Schedule|3
2672408|NCT00565812|9226428|P1|Overall Study|Work Schedule|5
2672409|NCT00565812|9226426|P3|Overall Study|Withdrawal by Subject|48
2672410|NCT00565812|9226427|P2|Overall Study|Withdrawal by Subject|47
2672411|NCT00565812|9226428|P1|Overall Study|Withdrawal by Subject|58
2672412|NCT00565812|9226426|P3|Overall Study|Lost to Follow-up|8
2672413|NCT00565812|9226427|P2|Overall Study|Lost to Follow-up|8
2672414|NCT00565812|9226428|P1|Overall Study|Lost to Follow-up|10
2672415|NCT00565812|9226426|P3|Overall Study|Did not Meet Entrance Criteria|1
2672416|NCT00565812|9226427|P2|Overall Study|Did not Meet Entrance Criteria|0
2672417|NCT00565812|9226428|P1|Overall Study|Did not Meet Entrance Criteria|1
2672418|NCT00565812|9226426|P3|Overall Study|Death|3
2672419|NCT00565812|9226427|P2|Overall Study|Death|1
2672420|NCT00565812|9226428|P1|Overall Study|Death|2
2672421|NCT00565773|9226565|P1|Overall Study|Physician Decision|1
2672422|NCT00565773|9226565|P1|Overall Study|Withdrawal by Subject|1
2672423|NCT00565747|9226577|P2|Overall Study|No embryo transfer|73
2672424|NCT00565747|9226578|P1|Overall Study|No embryo transfer|67
2672425|NCT00565721|9226588|P1|Overall Study|Other reasons|6
2672426|NCT00565721|9226588|P1|Overall Study|Physician Decision|2
2672427|NCT00565721|9226588|P1|Overall Study|Technical Problems|1
2672428|NCT00565721|9226588|P1|Overall Study|Lost to Follow-up|6
2672429|NCT00565721|9226588|P1|Overall Study|Screen Failure|2
2672430|NCT00565617|9226637|P1|Overall Study|Withdrawal by Subject|1
2672431|NCT00565604|9226641|P1|Overall Study|Lost to Follow-up|2
2672432|NCT00565604|9226641|P1|Overall Study|Failure to treat|2
2672433|NCT00565448|9226687|P2|Overall Study|Withdrawal by Subject|0
2672434|NCT00565448|9226688|P1|Overall Study|Withdrawal by Subject|1
2672435|NCT00565448|9226687|P2|Overall Study|Disease progression|0
2672436|NCT00565448|9226688|P1|Overall Study|Disease progression|1
2672437|NCT00565448|9226687|P2|Overall Study|Adverse Event|2
2672438|NCT00565448|9226688|P1|Overall Study|Adverse Event|1
2672439|NCT00565409|9226699|P4|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43
2672440|NCT00565409|9226700|P3|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11
2672441|NCT00565409|9226701|P2|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4
2672442|NCT00565409|9226702|P1|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0
2672443|NCT00565409|9226699|P4|Period 2 Double-Blind|Other|9
2672444|NCT00565409|9226700|P3|Period 2 Double-Blind|Other|5
2672445|NCT00565409|9226701|P2|Period 2 Double-Blind|Other|4
2672446|NCT00565409|9226702|P1|Period 2 Double-Blind|Other|0
2672447|NCT00565409|9226699|P4|Period 2 Double-Blind|Lost to Follow-up|0
2672448|NCT00565409|9226700|P3|Period 2 Double-Blind|Lost to Follow-up|1
2672449|NCT00565409|9226701|P2|Period 2 Double-Blind|Lost to Follow-up|0
2672450|NCT00565409|9226702|P1|Period 2 Double-Blind|Lost to Follow-up|0
2672451|NCT00565409|9226699|P4|Period 2 Double-Blind|Protocol Violation|2
2672452|NCT00565409|9226700|P3|Period 2 Double-Blind|Protocol Violation|6
2672453|NCT00565409|9226701|P2|Period 2 Double-Blind|Protocol Violation|4
2672454|NCT00565409|9226702|P1|Period 2 Double-Blind|Protocol Violation|0
2672455|NCT00565409|9226699|P4|Period 2 Double-Blind|Death|0
2672456|NCT00565409|9226700|P3|Period 2 Double-Blind|Death|0
2672457|NCT00565409|9226701|P2|Period 2 Double-Blind|Death|2
2672458|NCT00565409|9226702|P1|Period 2 Double-Blind|Death|0
2672459|NCT00565409|9226699|P4|Period 2 Double-Blind|Adverse Event|5
2672460|NCT00565409|9226700|P3|Period 2 Double-Blind|Adverse Event|4
2672461|NCT00565409|9226701|P2|Period 2 Double-Blind|Adverse Event|7
2672462|NCT00565409|9226702|P1|Period 2 Double-Blind|Adverse Event|0
2672463|NCT00565409|9226699|P4|After Period 1, Prior to Period 2|did not meet criteria|0
2672464|NCT00565409|9226700|P3|After Period 1, Prior to Period 2|did not meet criteria|0
2672465|NCT00565409|9226701|P2|After Period 1, Prior to Period 2|did not meet criteria|0
2672466|NCT00565409|9226702|P1|After Period 1, Prior to Period 2|did not meet criteria|152
2672467|NCT00565409|9226699|P4|Period 1 Open Label|no conclusion of participation record|0
2672468|NCT00565409|9226700|P3|Period 1 Open Label|no conclusion of participation record|0
2672469|NCT00565409|9226701|P2|Period 1 Open Label|no conclusion of participation record|0
2672470|NCT00565409|9226702|P1|Period 1 Open Label|no conclusion of participation record|1
2672471|NCT00565409|9226699|P4|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
2672472|NCT00565409|9226700|P3|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
2672473|NCT00565409|9226701|P2|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
2672474|NCT00565409|9226702|P1|Period 1 Open Label|Unsatisfactory Response-Efficacy|22
2672475|NCT00565409|9226699|P4|Period 1 Open Label|Protocol Violation|0
2672476|NCT00565409|9226700|P3|Period 1 Open Label|Protocol Violation|0
2672477|NCT00565409|9226701|P2|Period 1 Open Label|Protocol Violation|0
2672478|NCT00565409|9226702|P1|Period 1 Open Label|Protocol Violation|14
2672479|NCT00565409|9226699|P4|Period 1 Open Label|Other|0
2672480|NCT00565409|9226700|P3|Period 1 Open Label|Other|0
2672481|NCT00565409|9226701|P2|Period 1 Open Label|Other|0
2672482|NCT00565409|9226702|P1|Period 1 Open Label|Other|21
2672483|NCT00565409|9226699|P4|Period 1 Open Label|Lost to Follow-up|0
2672484|NCT00565409|9226700|P3|Period 1 Open Label|Lost to Follow-up|0
2672485|NCT00565409|9226701|P2|Period 1 Open Label|Lost to Follow-up|0
2672486|NCT00565409|9226702|P1|Period 1 Open Label|Lost to Follow-up|1
2672487|NCT00565409|9226699|P4|Period 1 Open Label|Death|0
2672488|NCT00565409|9226700|P3|Period 1 Open Label|Death|0
2672489|NCT00565409|9226701|P2|Period 1 Open Label|Death|0
2672490|NCT00565409|9226702|P1|Period 1 Open Label|Death|2
2672491|NCT00565409|9226699|P4|Period 1 Open Label|Adverse Event|0
2672492|NCT00565409|9226700|P3|Period 1 Open Label|Adverse Event|0
2672493|NCT00565409|9226701|P2|Period 1 Open Label|Adverse Event|0
2672494|NCT00565409|9226702|P1|Period 1 Open Label|Adverse Event|17
2672495|NCT00565136|9226838|P1|Overall Study|Protocol Violation|1
2672496|NCT00565136|9226838|P1|Overall Study|Withdrawal by Subject|1
2672497|NCT00565136|9226838|P1|Overall Study|Lost to Follow-up|1
2672498|NCT00565058|9226879|P2|Overall Study|Adverse Event|0
2672499|NCT00565058|9226880|P1|Overall Study|Adverse Event|1
2672500|NCT00564902|9226927|P3|Overall Study|Death|0
2672501|NCT00564902|9226928|P2|Overall Study|Death|1
2672502|NCT00564902|9226929|P1|Overall Study|Death|1
2672503|NCT00564902|9226927|P3|Overall Study|Withdrawal by Subject|4
2672504|NCT00564902|9226928|P2|Overall Study|Withdrawal by Subject|3
2672505|NCT00564902|9226929|P1|Overall Study|Withdrawal by Subject|0
2672506|NCT00564889|9226961|P1|Overall Study|Other, not specified|4
2672507|NCT00564889|9226961|P1|Overall Study|Disease progression|3
2672508|NCT00564889|9226961|P1|Overall Study|Alternative treatment|3
2672509|NCT00564889|9226961|P1|Overall Study|Adverse Event|12
2672510|NCT00564889|9226961|P1|Overall Study|Death|7
2672511|NCT00564850|9226976|P1|Overall Study|Protocol Violation|2
2672512|NCT00564733|9226994|P1|Overall Study|Ineligible|5
2672513|NCT00564733|9226994|P1|Overall Study|Withdrawal by Subject|4
2672514|NCT00564629|9227028|P2|Overall Study|Vomited within 2 hours of receiving drug|9
2672515|NCT00564629|9227029|P1|Overall Study|Vomited within 2 hours of receiving drug|15
2672516|NCT00564486|9227054|P4|Overall Study|Lost to Follow-up|2
2672517|NCT00564486|9227055|P3|Overall Study|Lost to Follow-up|2
2672518|NCT00564486|9227056|P2|Overall Study|Lost to Follow-up|0
2672519|NCT00564486|9227057|P1|Overall Study|Lost to Follow-up|3
2672520|NCT00564486|9227054|P4|Overall Study|Subject refused to have blood drawn|0
2672521|NCT00564486|9227055|P3|Overall Study|Subject refused to have blood drawn|1
2672522|NCT00564486|9227056|P2|Overall Study|Subject refused to have blood drawn|0
2672523|NCT00564486|9227057|P1|Overall Study|Subject refused to have blood drawn|0
2672524|NCT00564486|9227054|P4|Overall Study|Withdrawal by Subject|5
2672525|NCT00564486|9227055|P3|Overall Study|Withdrawal by Subject|0
2672526|NCT00564486|9227056|P2|Overall Study|Withdrawal by Subject|0
2672527|NCT00564486|9227057|P1|Overall Study|Withdrawal by Subject|4
2672528|NCT00564486|9227054|P4|Overall Study|Adverse Event|0
2672529|NCT00564486|9227055|P3|Overall Study|Adverse Event|0
2672530|NCT00564486|9227056|P2|Overall Study|Adverse Event|1
2672531|NCT00564486|9227057|P1|Overall Study|Adverse Event|0
2672532|NCT00564395|9227106|P2|First Intervention (10 Days)|Trouble with the CGM tracing|2
2672533|NCT00564395|9227107|P1|First Intervention (10 Days)|Trouble with the CGM tracing|1
2672534|NCT00564395|9227106|P2|First Intervention (10 Days)|Withdrawal by Subject|0
2672535|NCT00564395|9227107|P1|First Intervention (10 Days)|Withdrawal by Subject|1
2672536|NCT00564278|9227115|P2|Overall Study|Withdrawal by Subject|7
2672537|NCT00564278|9227116|P1|Overall Study|Withdrawal by Subject|11
2672538|NCT00564278|9227115|P2|Overall Study|Physician Decision|2
2672539|NCT00564278|9227116|P1|Overall Study|Physician Decision|1
2672540|NCT00564278|9227115|P2|Overall Study|Lost to Follow-up|33
2672541|NCT00564278|9227116|P1|Overall Study|Lost to Follow-up|35
2672542|NCT00564070|9227138|P2|Overall Study|Worsening depression, referred to care|0
2672543|NCT00564070|9227139|P1|Overall Study|Worsening depression, referred to care|3
2672544|NCT00564070|9227138|P2|Overall Study|Lost to Follow-up|7
2672545|NCT00564070|9227139|P1|Overall Study|Lost to Follow-up|9
2672546|NCT00564018|9227166|P3|Overall Study|Withdrawal by Subject|1
2672547|NCT00564018|9227167|P2|Overall Study|Withdrawal by Subject|3
2672548|NCT00564018|9227168|P1|Overall Study|Withdrawal by Subject|2
2672549|NCT00563797|9227181|P2|Overall Study|Lost to Follow-up|2
2672550|NCT00563797|9227182|P1|Overall Study|Lost to Follow-up|7
2672551|NCT00563784|9227194|P1|Overall Study|Screen Failures|20
2672552|NCT00563784|9227194|P1|Overall Study|Withdrawal by Subject|2
2672553|NCT00563706|9227208|P9|DB Treatment Period (Day 1 up to Day 28)|Other|2
2672554|NCT00563706|9227209|P8|DB Treatment Period (Day 1 up to Day 28)|Other|1
2672555|NCT00563706|9227210|P7|DB Treatment Period (Day 1 up to Day 28)|Other|0
2672556|NCT00563706|9227211|P6|DB Treatment Period (Day 1 up to Day 28)|Other|0
2672557|NCT00563706|9227212|P5|DB Treatment Period (Day 1 up to Day 28)|Other|0
2672558|NCT00563706|9227213|P4|DB Treatment Period (Day 1 up to Day 28)|Other|0
2672559|NCT00563706|9227214|P3|DB Treatment Period (Day 1 up to Day 28)|Other|0
2672560|NCT00563706|9227215|P2|DB Treatment Period (Day 1 up to Day 28)|Other|0
2672561|NCT00563706|9227216|P1|DB Treatment Period (Day 1 up to Day 28)|Other|0
2672562|NCT00563706|9227208|P9|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
2672563|NCT00563706|9227209|P8|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1
2672564|NCT00563706|9227210|P7|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
2672565|NCT00563706|9227211|P6|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
2672566|NCT00563706|9227212|P5|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
2672567|NCT00563706|9227213|P4|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
2672568|NCT00563706|9227214|P3|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
2672569|NCT00563706|9227215|P2|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
2672570|NCT00563706|9227216|P1|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2
2672571|NCT00563706|9227208|P9|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
2672572|NCT00563706|9227209|P8|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6
2672573|NCT00563706|9227210|P7|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1
2672574|NCT00563706|9227211|P6|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
2672575|NCT00563706|9227212|P5|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4
2672576|NCT00563706|9227213|P4|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5
2672577|NCT00563706|9227214|P3|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2
2672578|NCT00563706|9227215|P2|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
2672579|NCT00563706|9227216|P1|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9
2672580|NCT00563706|9227208|P9|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
2672581|NCT00563706|9227209|P8|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5
2672582|NCT00563706|9227210|P7|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
2672583|NCT00563706|9227211|P6|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
2672584|NCT00563706|9227212|P5|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
2672585|NCT00563706|9227213|P4|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4
2672586|NCT00563706|9227214|P3|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
2672587|NCT00563706|9227215|P2|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
2672588|NCT00563706|9227216|P1|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
2672589|NCT00563706|9227208|P9|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5
2672590|NCT00563706|9227209|P8|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
2672591|NCT00563706|9227210|P7|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
2672592|NCT00563706|9227211|P6|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
2672593|NCT00563706|9227212|P5|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
2672594|NCT00563706|9227213|P4|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
2672595|NCT00563706|9227214|P3|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
2672596|NCT00563706|9227215|P2|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
2672597|NCT00563706|9227216|P1|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4
2672598|NCT00563381|9227334|P2|Overall Study|Individual different reasons|34
2672599|NCT00563381|9227335|P1|Overall Study|Individual different reasons|24
2672600|NCT00563381|9227334|P2|Overall Study|Lack of Efficacy|24
2672601|NCT00563381|9227335|P1|Overall Study|Lack of Efficacy|32
2672602|NCT00563381|9227334|P2|Overall Study|Withdrawal by Subject|209
2672603|NCT00563381|9227335|P1|Overall Study|Withdrawal by Subject|192
2672604|NCT00563381|9227334|P2|Overall Study|Lost to Follow-up|15
2672605|NCT00563381|9227335|P1|Overall Study|Lost to Follow-up|7
2672606|NCT00563381|9227334|P2|Overall Study|Protocol Violation|74
2672607|NCT00563381|9227335|P1|Overall Study|Protocol Violation|66
2672608|NCT00563381|9227334|P2|Overall Study|Adverse Event|292
2672609|NCT00563381|9227335|P1|Overall Study|Adverse Event|264
2672610|NCT00563368|9227408|P7|Overall Study|Other|0
2672611|NCT00563368|9227409|P6|Overall Study|Other|4
2672612|NCT00563368|9227410|P5|Overall Study|Other|4
2672613|NCT00563368|9227411|P4|Overall Study|Other|4
2672614|NCT00563368|9227412|P3|Overall Study|Other|3
2672615|NCT00563368|9227413|P2|Overall Study|Other|5
2672616|NCT00563368|9227414|P1|Overall Study|Other|5
2672617|NCT00563368|9227408|P7|Overall Study|requirement for restricted medication|0
2672618|NCT00563368|9227409|P6|Overall Study|requirement for restricted medication|0
2672619|NCT00563368|9227410|P5|Overall Study|requirement for restricted medication|0
2672620|NCT00563368|9227411|P4|Overall Study|requirement for restricted medication|0
2672621|NCT00563368|9227412|P3|Overall Study|requirement for restricted medication|2
2672622|NCT00563368|9227413|P2|Overall Study|requirement for restricted medication|0
2672623|NCT00563368|9227414|P1|Overall Study|requirement for restricted medication|0
2672624|NCT00563368|9227408|P7|Overall Study|Pregnancy|0
2672625|NCT00563368|9227409|P6|Overall Study|Pregnancy|2
2672626|NCT00563368|9227410|P5|Overall Study|Pregnancy|1
2672627|NCT00563368|9227411|P4|Overall Study|Pregnancy|2
2672628|NCT00563368|9227412|P3|Overall Study|Pregnancy|1
2672629|NCT00563368|9227413|P2|Overall Study|Pregnancy|0
2672630|NCT00563368|9227414|P1|Overall Study|Pregnancy|1
2672631|NCT00563368|9227408|P7|Overall Study|protocol non-compliance|3
2672632|NCT00563368|9227409|P6|Overall Study|protocol non-compliance|1
2672633|NCT00563368|9227410|P5|Overall Study|protocol non-compliance|0
2672634|NCT00563368|9227411|P4|Overall Study|protocol non-compliance|1
2672635|NCT00563368|9227412|P3|Overall Study|protocol non-compliance|2
2672636|NCT00563368|9227413|P2|Overall Study|protocol non-compliance|1
2672637|NCT00563368|9227414|P1|Overall Study|protocol non-compliance|1
2672638|NCT00563368|9227408|P7|Overall Study|Withdrawal by Subject|4
2672639|NCT00563368|9227409|P6|Overall Study|Withdrawal by Subject|5
2672640|NCT00563368|9227410|P5|Overall Study|Withdrawal by Subject|8
2672641|NCT00563368|9227411|P4|Overall Study|Withdrawal by Subject|7
2672642|NCT00563368|9227412|P3|Overall Study|Withdrawal by Subject|5
2672643|NCT00563368|9227413|P2|Overall Study|Withdrawal by Subject|6
2672644|NCT00563368|9227414|P1|Overall Study|Withdrawal by Subject|11
2672645|NCT00563368|9227408|P7|Overall Study|Adverse Event|17
2672646|NCT00563368|9227409|P6|Overall Study|Adverse Event|10
2672647|NCT00563368|9227410|P5|Overall Study|Adverse Event|6
2672648|NCT00563368|9227411|P4|Overall Study|Adverse Event|9
2672649|NCT00563368|9227412|P3|Overall Study|Adverse Event|5
2672650|NCT00563368|9227413|P2|Overall Study|Adverse Event|4
2672651|NCT00563368|9227414|P1|Overall Study|Adverse Event|3
2672652|NCT00563368|9227408|P7|Overall Study|Lost to Follow-up|9
2672653|NCT00563368|9227409|P6|Overall Study|Lost to Follow-up|8
2672654|NCT00563368|9227410|P5|Overall Study|Lost to Follow-up|9
2672655|NCT00563368|9227411|P4|Overall Study|Lost to Follow-up|6
2672656|NCT00563368|9227412|P3|Overall Study|Lost to Follow-up|12
2672657|NCT00563368|9227413|P2|Overall Study|Lost to Follow-up|14
2672658|NCT00563368|9227414|P1|Overall Study|Lost to Follow-up|14
2672659|NCT00563316|9227437|P1|Overall Study|Other|1
2672660|NCT00563316|9227437|P1|Overall Study|On-going in study as of 16 July 2009.|5
2672661|NCT00563316|9227437|P1|Overall Study|Death|1
2672662|NCT00563316|9227437|P1|Overall Study|Lost to Follow-up|2
2672663|NCT00563316|9227437|P1|Overall Study|Physician Decision|1
2672664|NCT00563316|9227437|P1|Overall Study|Adverse Event|2
2672665|NCT00563186|9227462|P2|Overall Study|Incomplete data|1
2672666|NCT00563186|9227463|P1|Overall Study|Incomplete data|1
2672667|NCT00563186|9227462|P2|Overall Study|LOS<48 hours|74
2672668|NCT00563186|9227463|P1|Overall Study|LOS<48 hours|97
2672669|NCT00562965|9227474|P2|Overall Study|Other|1
2672670|NCT00562965|9227475|P1|Overall Study|Other|0
2672671|NCT00562965|9227474|P2|Overall Study|Lost to Follow-up|0
2672672|NCT00562965|9227475|P1|Overall Study|Lost to Follow-up|1
2672673|NCT00562965|9227474|P2|Overall Study|Death|4
2672674|NCT00562965|9227475|P1|Overall Study|Death|2
2672675|NCT00562965|9227474|P2|Overall Study|Withdrawal by Subject|1
2672676|NCT00562965|9227475|P1|Overall Study|Withdrawal by Subject|0
2672677|NCT00562861|9227496|P2|Overall Study|Lost to Follow-up|3
2672678|NCT00562861|9227497|P1|Overall Study|Lost to Follow-up|7
2672679|NCT00562861|9227496|P2|Overall Study|noncompliance, moved|2
2672680|NCT00562861|9227497|P1|Overall Study|noncompliance, moved|7
2672681|NCT00562861|9227496|P2|Overall Study|Lack of Efficacy|5
2672682|NCT00562861|9227497|P1|Overall Study|Lack of Efficacy|5
2672683|NCT00562861|9227496|P2|Overall Study|Adverse Event|1
2672684|NCT00562861|9227497|P1|Overall Study|Adverse Event|1
2672685|NCT00562718|9227503|P1|Overall Study|not stated|1
2672686|NCT00562718|9227503|P1|Overall Study|Lack of Efficacy|2
2672687|NCT00562718|9227503|P1|Overall Study|Adverse Event|4
2672688|NCT00562718|9227503|P1|Overall Study|Withdrawal by Subject|3
2672689|NCT00562718|9227503|P1|Overall Study|Death|1
2672690|NCT00562627|9227512|P3|Overall Study|Protocol Violation|1
2672691|NCT00562627|9227513|P2|Overall Study|Protocol Violation|1
2672692|NCT00562627|9227514|P1|Overall Study|Protocol Violation|1
2672693|NCT00562588|9227530|P2|Overall Study|Other|2
2672694|NCT00562588|9227531|P1|Overall Study|Other|0
2672695|NCT00562588|9227530|P2|Overall Study|Withdrawal by Subject|9
2672696|NCT00562588|9227531|P1|Overall Study|Withdrawal by Subject|10
2672697|NCT00562588|9227530|P2|Overall Study|Lost to Follow-up|4
2672698|NCT00562588|9227531|P1|Overall Study|Lost to Follow-up|12
2672699|NCT00562588|9227530|P2|Overall Study|Protocol Violation|26
2672700|NCT00562588|9227531|P1|Overall Study|Protocol Violation|30
2672701|NCT00562588|9227530|P2|Overall Study|Adverse Event|58
2672702|NCT00562588|9227531|P1|Overall Study|Adverse Event|40
2672703|NCT00562484|9227561|P2|Overall Study|Reason not provided or not specified|12
2672704|NCT00562484|9227562|P1|Overall Study|Reason not provided or not specified|25
2672705|NCT00562484|9227561|P2|Overall Study|Lost to Follow-up|71
2672706|NCT00562484|9227562|P1|Overall Study|Lost to Follow-up|132
2672707|NCT00562484|9227561|P2|Overall Study|Moved away from the study area|9
2672708|NCT00562484|9227562|P1|Overall Study|Moved away from the study area|20
2672709|NCT00562484|9227561|P2|Overall Study|Withdrawal by Subject|9
2672710|NCT00562484|9227562|P1|Overall Study|Withdrawal by Subject|12
2672711|NCT00562484|9227561|P2|Overall Study|Protocol Violation|2
2672712|NCT00562484|9227562|P1|Overall Study|Protocol Violation|11
2672713|NCT00562484|9227561|P2|Overall Study|Adverse Event|1
2672714|NCT00562484|9227562|P1|Overall Study|Adverse Event|6
2672715|NCT00562354|9227594|P2|Overall Study|Lost to Follow-up|1
2672716|NCT00562354|9227595|P1|Overall Study|Lost to Follow-up|0
2672717|NCT00562354|9227594|P2|Overall Study|Physician Decision|1
2672718|NCT00562354|9227595|P1|Overall Study|Physician Decision|0
2672719|NCT00562302|9227661|P2|Overall Study|Not stated|4
2672720|NCT00562302|9227662|P1|Overall Study|Not stated|1
2672721|NCT00562302|9227661|P2|Overall Study|Lung resection prior to study completion|7
2672722|NCT00562302|9227662|P1|Overall Study|Lung resection prior to study completion|7
2672723|NCT00562302|9227661|P2|Overall Study|Death|2
2672724|NCT00562302|9227662|P1|Overall Study|Death|1
2672725|NCT00562302|9227661|P2|Overall Study|Withdrawal by Subject|8
2672726|NCT00562302|9227662|P1|Overall Study|Withdrawal by Subject|7
2672727|NCT00562302|9227661|P2|Overall Study|Non-compliance|2
2672728|NCT00562302|9227662|P1|Overall Study|Non-compliance|1
2672729|NCT00562302|9227661|P2|Overall Study|Adverse Event|6
2672730|NCT00562302|9227662|P1|Overall Study|Adverse Event|0
2672731|NCT00562302|9227661|P2|Overall Study|Lost to Follow-up|3
2672732|NCT00562302|9227662|P1|Overall Study|Lost to Follow-up|3
2672733|NCT00562159|9227684|P2|Overall Study|Did not meet protocol eligibility|1
2672734|NCT00562159|9227685|P1|Overall Study|Did not meet protocol eligibility|1
2672735|NCT00562159|9227684|P2|Overall Study|Protocol Violation|12
2672736|NCT00562159|9227685|P1|Overall Study|Protocol Violation|12
2672737|NCT00562159|9227684|P2|Overall Study|Withdrawal by Subject|8
2672738|NCT00562159|9227685|P1|Overall Study|Withdrawal by Subject|9
2672739|NCT00562159|9227684|P2|Overall Study|Lost to Follow-up|4
2672740|NCT00562159|9227685|P1|Overall Study|Lost to Follow-up|5
2672741|NCT00562159|9227684|P2|Overall Study|Adverse Event|8
2672742|NCT00562159|9227685|P1|Overall Study|Adverse Event|11
2672743|NCT00562120|9227697|P4|First Intervention Period|Randomized but not Treated|0
2672744|NCT00562120|9227698|P3|First Intervention Period|Randomized but not Treated|0
2672745|NCT00562120|9227699|P2|First Intervention Period|Randomized but not Treated|0
2672746|NCT00562120|9227700|P1|First Intervention Period|Randomized but not Treated|1
2672747|NCT00562120|9227697|P4|First Intervention Period|Adverse Event|0
2672748|NCT00562120|9227698|P3|First Intervention Period|Adverse Event|0
2672749|NCT00562120|9227699|P2|First Intervention Period|Adverse Event|0
2672750|NCT00562120|9227700|P1|First Intervention Period|Adverse Event|1
2672751|NCT00562094|9227732|P1|Overall Study|Lost to Follow-up|62
2672752|NCT00561977|9227747|P3|Overall Study|Pregnancy|1
2672753|NCT00561977|9227748|P2|Overall Study|Pregnancy|1
2672754|NCT00561977|9227749|P1|Overall Study|Pregnancy|0
2672755|NCT00561977|9227747|P3|Overall Study|Withdrawal by Subject|1
2672756|NCT00561977|9227748|P2|Overall Study|Withdrawal by Subject|2
2672757|NCT00561977|9227749|P1|Overall Study|Withdrawal by Subject|0
2672758|NCT00561951|9227775|P3|Overall Study|Adverse Event Occured Before Treatment|1
2672759|NCT00561951|9227776|P2|Overall Study|Adverse Event Occured Before Treatment|2
2672760|NCT00561951|9227777|P1|Overall Study|Adverse Event Occured Before Treatment|1
2672761|NCT00561951|9227775|P3|Overall Study|Meet Withdrawal Criterion|1
2672762|NCT00561951|9227776|P2|Overall Study|Meet Withdrawal Criterion|1
2672763|NCT00561951|9227777|P1|Overall Study|Meet Withdrawal Criterion|0
2672764|NCT00561951|9227775|P3|Overall Study|Pregnancy|0
2672765|NCT00561951|9227776|P2|Overall Study|Pregnancy|1
2672766|NCT00561951|9227777|P1|Overall Study|Pregnancy|0
2672767|NCT00561951|9227775|P3|Overall Study|Physician Decision|0
2672768|NCT00561951|9227776|P2|Overall Study|Physician Decision|0
2672769|NCT00561951|9227777|P1|Overall Study|Physician Decision|1
2672770|NCT00561951|9227775|P3|Overall Study|Protocol Violation|4
2672771|NCT00561951|9227776|P2|Overall Study|Protocol Violation|3
2672772|NCT00561951|9227777|P1|Overall Study|Protocol Violation|4
2672773|NCT00561951|9227775|P3|Overall Study|Withdrawal by Subject|10
2672774|NCT00561951|9227776|P2|Overall Study|Withdrawal by Subject|9
2672775|NCT00561951|9227777|P1|Overall Study|Withdrawal by Subject|10
2672776|NCT00561951|9227775|P3|Overall Study|Lost to Follow-up|0
2672777|NCT00561951|9227776|P2|Overall Study|Lost to Follow-up|1
2672778|NCT00561951|9227777|P1|Overall Study|Lost to Follow-up|1
2672779|NCT00561951|9227775|P3|Overall Study|Lack of Efficacy|2
2672780|NCT00561951|9227776|P2|Overall Study|Lack of Efficacy|3
2672781|NCT00561951|9227777|P1|Overall Study|Lack of Efficacy|5
2672782|NCT00561951|9227775|P3|Overall Study|Adverse Event|14
2672783|NCT00561951|9227776|P2|Overall Study|Adverse Event|14
2672784|NCT00561951|9227777|P1|Overall Study|Adverse Event|11
2672785|NCT00561925|9227833|P5|Open-Label Extension Period|Declined entry into extension period|50
2672786|NCT00561925|9227834|P4|Open-Label Extension Period|Declined entry into extension period|43
2672787|NCT00561925|9227835|P3|Open-Label Extension Period|Declined entry into extension period|0
2672788|NCT00561925|9227836|P2|Open-Label Extension Period|Declined entry into extension period|0
2672789|NCT00561925|9227837|P1|Open-Label Extension Period|Declined entry into extension period|0
2672790|NCT00561925|9227833|P5|144-week Double-blind, Double-dummy|Other|0
2672791|NCT00561925|9227834|P4|144-week Double-blind, Double-dummy|Other|0
2672792|NCT00561925|9227835|P3|144-week Double-blind, Double-dummy|Other|11
2672793|NCT00561925|9227836|P2|144-week Double-blind, Double-dummy|Other|8
2672794|NCT00561925|9227837|P1|144-week Double-blind, Double-dummy|Other|0
2672795|NCT00561925|9227833|P5|144-week Double-blind, Double-dummy|Not treated with study drug|0
2672796|NCT00561925|9227834|P4|144-week Double-blind, Double-dummy|Not treated with study drug|0
2672797|NCT00561925|9227835|P3|144-week Double-blind, Double-dummy|Not treated with study drug|0
2672798|NCT00561925|9227836|P2|144-week Double-blind, Double-dummy|Not treated with study drug|2
2672799|NCT00561925|9227837|P1|144-week Double-blind, Double-dummy|Not treated with study drug|0
2672800|NCT00561925|9227833|P5|144-week Double-blind, Double-dummy|Death|0
2672801|NCT00561925|9227834|P4|144-week Double-blind, Double-dummy|Death|0
2672802|NCT00561925|9227835|P3|144-week Double-blind, Double-dummy|Death|3
2672803|NCT00561925|9227836|P2|144-week Double-blind, Double-dummy|Death|6
2672804|NCT00561925|9227837|P1|144-week Double-blind, Double-dummy|Death|0
2672805|NCT00561925|9227833|P5|144-week Double-blind, Double-dummy|Pregnancy|0
2672806|NCT00561925|9227834|P4|144-week Double-blind, Double-dummy|Pregnancy|0
2672807|NCT00561925|9227835|P3|144-week Double-blind, Double-dummy|Pregnancy|9
2672808|NCT00561925|9227836|P2|144-week Double-blind, Double-dummy|Pregnancy|1
2672809|NCT00561925|9227837|P1|144-week Double-blind, Double-dummy|Pregnancy|0
2672810|NCT00561925|9227833|P5|144-week Double-blind, Double-dummy|Lack of Efficacy|0
2672811|NCT00561925|9227834|P4|144-week Double-blind, Double-dummy|Lack of Efficacy|0
2672812|NCT00561925|9227835|P3|144-week Double-blind, Double-dummy|Lack of Efficacy|33
2672813|NCT00561925|9227836|P2|144-week Double-blind, Double-dummy|Lack of Efficacy|36
2672814|NCT00561925|9227837|P1|144-week Double-blind, Double-dummy|Lack of Efficacy|0
2672815|NCT00561925|9227833|P5|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
2672816|NCT00561925|9227834|P4|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
2672817|NCT00561925|9227835|P3|144-week Double-blind, Double-dummy|Withdrawal by Subject|7
2672818|NCT00561925|9227836|P2|144-week Double-blind, Double-dummy|Withdrawal by Subject|19
2672819|NCT00561925|9227837|P1|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
2672820|NCT00561925|9227833|P5|144-week Double-blind, Double-dummy|Lost to Follow-up|0
2672821|NCT00561925|9227834|P4|144-week Double-blind, Double-dummy|Lost to Follow-up|0
2672822|NCT00561925|9227835|P3|144-week Double-blind, Double-dummy|Lost to Follow-up|12
2672823|NCT00561925|9227836|P2|144-week Double-blind, Double-dummy|Lost to Follow-up|15
2672824|NCT00561925|9227837|P1|144-week Double-blind, Double-dummy|Lost to Follow-up|0
2672825|NCT00561925|9227833|P5|144-week Double-blind, Double-dummy|Protocol Violation|0
2672826|NCT00561925|9227834|P4|144-week Double-blind, Double-dummy|Protocol Violation|0
2672827|NCT00561925|9227835|P3|144-week Double-blind, Double-dummy|Protocol Violation|9
2672828|NCT00561925|9227836|P2|144-week Double-blind, Double-dummy|Protocol Violation|15
2672829|NCT00561925|9227837|P1|144-week Double-blind, Double-dummy|Protocol Violation|0
2672830|NCT00561925|9227833|P5|144-week Double-blind, Double-dummy|Adverse Event|0
2672831|NCT00561925|9227834|P4|144-week Double-blind, Double-dummy|Adverse Event|0
2672832|NCT00561925|9227835|P3|144-week Double-blind, Double-dummy|Adverse Event|43
2672833|NCT00561925|9227836|P2|144-week Double-blind, Double-dummy|Adverse Event|48
2672834|NCT00561925|9227837|P1|144-week Double-blind, Double-dummy|Adverse Event|0
2672835|NCT00561925|9227833|P5|14 Day Lead-In Period|Other|0
2672836|NCT00561925|9227834|P4|14 Day Lead-In Period|Other|0
2672837|NCT00561925|9227835|P3|14 Day Lead-In Period|Other|0
2672838|NCT00561925|9227836|P2|14 Day Lead-In Period|Other|0
2672839|NCT00561925|9227837|P1|14 Day Lead-In Period|Other|5
2672840|NCT00561925|9227833|P5|14 Day Lead-In Period|Withdrawal by Subject|0
2672841|NCT00561925|9227834|P4|14 Day Lead-In Period|Withdrawal by Subject|0
2672842|NCT00561925|9227835|P3|14 Day Lead-In Period|Withdrawal by Subject|0
2672843|NCT00561925|9227836|P2|14 Day Lead-In Period|Withdrawal by Subject|0
2672844|NCT00561925|9227837|P1|14 Day Lead-In Period|Withdrawal by Subject|4
2672845|NCT00561925|9227833|P5|14 Day Lead-In Period|Lost to Follow-up|0
2672846|NCT00561925|9227834|P4|14 Day Lead-In Period|Lost to Follow-up|0
2672847|NCT00561925|9227835|P3|14 Day Lead-In Period|Lost to Follow-up|0
2672848|NCT00561925|9227836|P2|14 Day Lead-In Period|Lost to Follow-up|0
2672849|NCT00561925|9227837|P1|14 Day Lead-In Period|Lost to Follow-up|4
2672850|NCT00561925|9227833|P5|14 Day Lead-In Period|In/Exclusion criteria|0
2672851|NCT00561925|9227834|P4|14 Day Lead-In Period|In/Exclusion criteria|0
2672852|NCT00561925|9227835|P3|14 Day Lead-In Period|In/Exclusion criteria|0
2672853|NCT00561925|9227836|P2|14 Day Lead-In Period|In/Exclusion criteria|0
2672854|NCT00561925|9227837|P1|14 Day Lead-In Period|In/Exclusion criteria|4
2672855|NCT00561925|9227833|P5|14 Day Lead-In Period|Adverse Event|0
2672856|NCT00561925|9227834|P4|14 Day Lead-In Period|Adverse Event|0
2672857|NCT00561925|9227835|P3|14 Day Lead-In Period|Adverse Event|0
2672858|NCT00561925|9227836|P2|14 Day Lead-In Period|Adverse Event|0
2672859|NCT00561925|9227837|P1|14 Day Lead-In Period|Adverse Event|38
2672860|NCT00561912|9227886|P1|Overall Study|ineligible|1
2672861|NCT00561821|9227898|P4|Overall Study|Adverse Event|1
2672862|NCT00561821|9227899|P3|Overall Study|Adverse Event|1
2672863|NCT00561821|9227900|P2|Overall Study|Adverse Event|3
2672864|NCT00561821|9227901|P1|Overall Study|Adverse Event|2
2672865|NCT00561821|9227898|P4|Overall Study|Other (reason not specified)|0
2672866|NCT00561821|9227899|P3|Overall Study|Other (reason not specified)|0
2672867|NCT00561821|9227900|P2|Overall Study|Other (reason not specified)|1
2672868|NCT00561821|9227901|P1|Overall Study|Other (reason not specified)|1
2672869|NCT00561821|9227898|P4|Overall Study|Reasons not related to trial|0
2672870|NCT00561821|9227899|P3|Overall Study|Reasons not related to trial|0
2672871|NCT00561821|9227900|P2|Overall Study|Reasons not related to trial|1
2672872|NCT00561821|9227901|P1|Overall Study|Reasons not related to trial|2
2672873|NCT00561821|9227898|P4|Overall Study|Withdrawal by Subject|2
2672874|NCT00561821|9227899|P3|Overall Study|Withdrawal by Subject|0
2672875|NCT00561821|9227900|P2|Overall Study|Withdrawal by Subject|1
2672876|NCT00561821|9227901|P1|Overall Study|Withdrawal by Subject|0
2672877|NCT00561821|9227898|P4|Overall Study|Not treated|0
2672878|NCT00561821|9227899|P3|Overall Study|Not treated|1
2672879|NCT00561821|9227900|P2|Overall Study|Not treated|0
2672880|NCT00561821|9227901|P1|Overall Study|Not treated|0
2672881|NCT00561795|9227977|P4|Overall Study|Physician Decision|0
2672882|NCT00561795|9227978|P3|Overall Study|Physician Decision|0
2672883|NCT00561795|9227979|P2|Overall Study|Physician Decision|0
2672884|NCT00561795|9227980|P1|Overall Study|Physician Decision|1
2672885|NCT00561795|9227977|P4|Overall Study|Study Closed/Terminated|0
2672886|NCT00561795|9227978|P3|Overall Study|Study Closed/Terminated|0
2672887|NCT00561795|9227979|P2|Overall Study|Study Closed/Terminated|3
2672888|NCT00561795|9227980|P1|Overall Study|Study Closed/Terminated|0
2672889|NCT00561795|9227977|P4|Overall Study|Adverse Event|0
2672890|NCT00561795|9227978|P3|Overall Study|Adverse Event|0
2672891|NCT00561795|9227979|P2|Overall Study|Adverse Event|3
2672892|NCT00561795|9227980|P1|Overall Study|Adverse Event|3
2672893|NCT00561730|9228000|P1|Overall Study|Not specified reasons|1
2672894|NCT00561730|9228000|P1|Overall Study|Lost to Follow-up|5
2672895|NCT00561730|9228000|P1|Overall Study|Handling of the drug|1
2672896|NCT00561730|9228000|P1|Overall Study|Adverse Event|2
2672897|NCT00561678|9228016|P2|Overall Study|anesthesia provider refusal|0
2672898|NCT00561678|9228017|P1|Overall Study|anesthesia provider refusal|1
2672899|NCT00561678|9228016|P2|Overall Study|surgery rescheduled to different site|2
2672900|NCT00561678|9228017|P1|Overall Study|surgery rescheduled to different site|2
2672901|NCT00561678|9228016|P2|Overall Study|surgery cancelled|1
2672902|NCT00561678|9228017|P1|Overall Study|surgery cancelled|1
2672903|NCT00561678|9228016|P2|Overall Study|Withdrawal by Subject|3
2672904|NCT00561678|9228017|P1|Overall Study|Withdrawal by Subject|4
2672905|NCT00561652|9228035|P2|Overall Study|Withdrawal by Subject|1
2672906|NCT00561652|9228036|P1|Overall Study|Withdrawal by Subject|0
2672907|NCT00561574|9228119|P2|Overall Study|Other|7
2672908|NCT00561574|9228120|P1|Overall Study|Other|5
2672909|NCT00561574|9228119|P2|Overall Study|Lost to Follow-up|0
2672910|NCT00561574|9228120|P1|Overall Study|Lost to Follow-up|1
2672911|NCT00561574|9228119|P2|Overall Study|Reason Unrelated to Trial|2
2672912|NCT00561574|9228120|P1|Overall Study|Reason Unrelated to Trial|6
2672913|NCT00561574|9228119|P2|Overall Study|Withdrawal by Subject|4
2672914|NCT00561574|9228120|P1|Overall Study|Withdrawal by Subject|4
2672915|NCT00561574|9228119|P2|Overall Study|Lack of Efficacy|21
2672916|NCT00561574|9228120|P1|Overall Study|Lack of Efficacy|11
2672917|NCT00561574|9228119|P2|Overall Study|Adverse Event|24
2672918|NCT00561574|9228120|P1|Overall Study|Adverse Event|21
2672919|NCT00561470|9228146|P2|Overall Study|Ongoing Treatment|14
2672920|NCT00561470|9228147|P1|Overall Study|Ongoing Treatment|11
2672921|NCT00561470|9228146|P2|Overall Study|Planning surgery|1
2672922|NCT00561470|9228147|P1|Overall Study|Planning surgery|1
2672923|NCT00561470|9228146|P2|Overall Study|Missed visit window|4
2672924|NCT00561470|9228147|P1|Overall Study|Missed visit window|1
2672925|NCT00561470|9228146|P2|Overall Study|Randomized but not treated|5
2672926|NCT00561470|9228147|P1|Overall Study|Randomized but not treated|5
2672927|NCT00561470|9228146|P2|Overall Study|Unauthorized procedure|1
2672928|NCT00561470|9228147|P1|Overall Study|Unauthorized procedure|3
2672929|NCT00561470|9228146|P2|Overall Study|Metastatic surgery|12
2672930|NCT00561470|9228147|P1|Overall Study|Metastatic surgery|10
2672931|NCT00561470|9228146|P2|Overall Study|Subject request|77
2672932|NCT00561470|9228147|P1|Overall Study|Subject request|43
2672933|NCT00561470|9228146|P2|Overall Study|Consent Withdrawn|6
2672934|NCT00561470|9228147|P1|Overall Study|Consent Withdrawn|2
2672935|NCT00561470|9228146|P2|Overall Study|Physician Decision|20
2672936|NCT00561470|9228147|P1|Overall Study|Physician Decision|21
2672937|NCT00561470|9228146|P2|Overall Study|Lost to Follow-up|0
2672938|NCT00561470|9228147|P1|Overall Study|Lost to Follow-up|2
2672939|NCT00561470|9228146|P2|Overall Study|poor compliance to protocol|4
2672940|NCT00561470|9228147|P1|Overall Study|poor compliance to protocol|4
2672941|NCT00561470|9228146|P2|Overall Study|Disease progression|305
2672942|NCT00561470|9228147|P1|Overall Study|Disease progression|437
2672943|NCT00561470|9228146|P2|Overall Study|Adverse Event|163
2672944|NCT00561470|9228147|P1|Overall Study|Adverse Event|74
2672945|NCT00561392|9228183|P1|Overall Study|Administrative problems|4
2672946|NCT00561392|9228183|P1|Overall Study|Withdrawal by Subject|8
2672947|NCT00561392|9228183|P1|Overall Study|Protocol Violation|1
2672948|NCT00561392|9228183|P1|Overall Study|Lack of Efficacy|2
2672949|NCT00561392|9228183|P1|Overall Study|Adverse Event|38
2672950|NCT00561353|9228205|P10|Overall Study|Withdrawal by Subject|0
2672951|NCT00561353|9228206|P9|Overall Study|Withdrawal by Subject|0
2672952|NCT00561353|9228207|P8|Overall Study|Withdrawal by Subject|0
2672953|NCT00561353|9228208|P7|Overall Study|Withdrawal by Subject|0
2672954|NCT00561353|9228209|P6|Overall Study|Withdrawal by Subject|0
2672955|NCT00561353|9228210|P5|Overall Study|Withdrawal by Subject|0
2672956|NCT00561353|9228211|P4|Overall Study|Withdrawal by Subject|0
2672957|NCT00561353|9228212|P3|Overall Study|Withdrawal by Subject|0
2672958|NCT00561353|9228213|P2|Overall Study|Withdrawal by Subject|2
2672959|NCT00561353|9228214|P1|Overall Study|Withdrawal by Subject|0
2672960|NCT00561353|9228205|P10|Overall Study|Lost to Follow-up|0
2672961|NCT00561353|9228206|P9|Overall Study|Lost to Follow-up|0
2672962|NCT00561353|9228207|P8|Overall Study|Lost to Follow-up|0
2672963|NCT00561353|9228208|P7|Overall Study|Lost to Follow-up|0
2672964|NCT00561353|9228209|P6|Overall Study|Lost to Follow-up|0
2672965|NCT00561353|9228210|P5|Overall Study|Lost to Follow-up|0
2672966|NCT00561353|9228211|P4|Overall Study|Lost to Follow-up|0
2672967|NCT00561353|9228212|P3|Overall Study|Lost to Follow-up|1
2672968|NCT00561353|9228213|P2|Overall Study|Lost to Follow-up|0
2672969|NCT00561353|9228214|P1|Overall Study|Lost to Follow-up|2
2672970|NCT00561353|9228205|P10|Overall Study|Adverse Event|1
2672971|NCT00561353|9228206|P9|Overall Study|Adverse Event|0
2672972|NCT00561353|9228207|P8|Overall Study|Adverse Event|0
2672973|NCT00561353|9228208|P7|Overall Study|Adverse Event|1
2672974|NCT00561353|9228209|P6|Overall Study|Adverse Event|0
2672975|NCT00561353|9228210|P5|Overall Study|Adverse Event|0
2672976|NCT00561353|9228211|P4|Overall Study|Adverse Event|2
2672977|NCT00561353|9228212|P3|Overall Study|Adverse Event|0
2672978|NCT00561353|9228213|P2|Overall Study|Adverse Event|0
2672979|NCT00561353|9228214|P1|Overall Study|Adverse Event|0
2672980|NCT00561353|9228205|P10|Overall Study|Other|0
2672981|NCT00561353|9228206|P9|Overall Study|Other|0
2672982|NCT00561353|9228207|P8|Overall Study|Other|0
2672983|NCT00561353|9228208|P7|Overall Study|Other|0
2672984|NCT00561353|9228209|P6|Overall Study|Other|2
2672985|NCT00561353|9228210|P5|Overall Study|Other|0
2672986|NCT00561353|9228211|P4|Overall Study|Other|0
2672987|NCT00561353|9228212|P3|Overall Study|Other|1
2672988|NCT00561353|9228213|P2|Overall Study|Other|0
2672989|NCT00561353|9228214|P1|Overall Study|Other|1
2672990|NCT00561353|9228205|P10|Overall Study|Subject ineligible to continue the trial|1
2672991|NCT00561353|9228206|P9|Overall Study|Subject ineligible to continue the trial|2
2672992|NCT00561353|9228207|P8|Overall Study|Subject ineligible to continue the trial|0
2672993|NCT00561353|9228208|P7|Overall Study|Subject ineligible to continue the trial|1
2672994|NCT00561353|9228209|P6|Overall Study|Subject ineligible to continue the trial|1
2672995|NCT00561353|9228210|P5|Overall Study|Subject ineligible to continue the trial|0
2672996|NCT00561353|9228211|P4|Overall Study|Subject ineligible to continue the trial|0
2672997|NCT00561353|9228212|P3|Overall Study|Subject ineligible to continue the trial|0
2672998|NCT00561353|9228213|P2|Overall Study|Subject ineligible to continue the trial|0
2672999|NCT00561353|9228214|P1|Overall Study|Subject ineligible to continue the trial|0
2673000|NCT00561353|9228205|P10|Overall Study|Subject reached a virologic endpoint|0
2673001|NCT00561353|9228206|P9|Overall Study|Subject reached a virologic endpoint|5
2673002|NCT00561353|9228207|P8|Overall Study|Subject reached a virologic endpoint|4
2673003|NCT00561353|9228208|P7|Overall Study|Subject reached a virologic endpoint|4
2673004|NCT00561353|9228209|P6|Overall Study|Subject reached a virologic endpoint|3
2673005|NCT00561353|9228210|P5|Overall Study|Subject reached a virologic endpoint|1
2673006|NCT00561353|9228211|P4|Overall Study|Subject reached a virologic endpoint|4
2673007|NCT00561353|9228212|P3|Overall Study|Subject reached a virologic endpoint|1
2673008|NCT00561353|9228213|P2|Overall Study|Subject reached a virologic endpoint|1
2673009|NCT00561353|9228214|P1|Overall Study|Subject reached a virologic endpoint|2
2673010|NCT00561340|9228369|P2|Overall Study|refused to drink pediasure|0
2673011|NCT00561340|9228370|P1|Overall Study|refused to drink pediasure|6
2673012|NCT00561080|9228390|P3|12-month Post Last Dose Follow-up|Lost to Follow-up|0
2673013|NCT00561080|9228391|P2|12-month Post Last Dose Follow-up|Lost to Follow-up|0
2673014|NCT00561080|9228392|P1|12-month Post Last Dose Follow-up|Lost to Follow-up|2
2673015|NCT00561080|9228390|P3|12-month Post Last Dose Follow-up|Withdrawal by Subject|5
2673016|NCT00561080|9228391|P2|12-month Post Last Dose Follow-up|Withdrawal by Subject|6
2673017|NCT00561080|9228392|P1|12-month Post Last Dose Follow-up|Withdrawal by Subject|2
2673018|NCT00561080|9228390|P3|12-month Post Last Dose Follow-up|Protocol Violation|4
2673019|NCT00561080|9228391|P2|12-month Post Last Dose Follow-up|Protocol Violation|0
2673020|NCT00561080|9228392|P1|12-month Post Last Dose Follow-up|Protocol Violation|0
2673021|NCT00561080|9228390|P3|12-month Post Last Dose Follow-up|Adverse Event|1
2673022|NCT00561080|9228391|P2|12-month Post Last Dose Follow-up|Adverse Event|3
2673023|NCT00561080|9228392|P1|12-month Post Last Dose Follow-up|Adverse Event|3
2673024|NCT00561080|9228390|P3|Vaccination Period (up to Month 4)|Other|1
2673025|NCT00561080|9228391|P2|Vaccination Period (up to Month 4)|Other|2
2673026|NCT00561080|9228392|P1|Vaccination Period (up to Month 4)|Other|0
2673027|NCT00561080|9228390|P3|Vaccination Period (up to Month 4)|Lost to Follow-up|0
2673028|NCT00561080|9228391|P2|Vaccination Period (up to Month 4)|Lost to Follow-up|1
2673029|NCT00561080|9228392|P1|Vaccination Period (up to Month 4)|Lost to Follow-up|0
2673030|NCT00561080|9228390|P3|Vaccination Period (up to Month 4)|Withdrawal by Subject|13
2673031|NCT00561080|9228391|P2|Vaccination Period (up to Month 4)|Withdrawal by Subject|16
2673032|NCT00561080|9228392|P1|Vaccination Period (up to Month 4)|Withdrawal by Subject|3
2673033|NCT00561080|9228390|P3|Vaccination Period (up to Month 4)|Protocol Violation|3
2673034|NCT00561080|9228391|P2|Vaccination Period (up to Month 4)|Protocol Violation|1
2673035|NCT00561080|9228392|P1|Vaccination Period (up to Month 4)|Protocol Violation|0
2673036|NCT00561080|9228390|P3|Vaccination Period (up to Month 4)|Definitive Contra-indication|3
2673037|NCT00561080|9228391|P2|Vaccination Period (up to Month 4)|Definitive Contra-indication|2
2673038|NCT00561080|9228392|P1|Vaccination Period (up to Month 4)|Definitive Contra-indication|0
2673039|NCT00561080|9228390|P3|Vaccination Period (up to Month 4)|Adverse Event|6
2673040|NCT00561080|9228391|P2|Vaccination Period (up to Month 4)|Adverse Event|4
2673041|NCT00561080|9228392|P1|Vaccination Period (up to Month 4)|Adverse Event|0
2673042|NCT00561015|9228469|P6|Overall Study|Participant non-compliance|0
2673043|NCT00561015|9228470|P5|Overall Study|Participant non-compliance|0
2673044|NCT00561015|9228471|P4|Overall Study|Participant non-compliance|0
2673045|NCT00561015|9228472|P3|Overall Study|Participant non-compliance|0
2673046|NCT00561015|9228473|P2|Overall Study|Participant non-compliance|0
2673047|NCT00561015|9228474|P1|Overall Study|Participant non-compliance|2
2673048|NCT00561015|9228469|P6|Overall Study|Lost to Follow-up|3
2673049|NCT00561015|9228470|P5|Overall Study|Lost to Follow-up|0
2673050|NCT00561015|9228471|P4|Overall Study|Lost to Follow-up|1
2673051|NCT00561015|9228472|P3|Overall Study|Lost to Follow-up|0
2673052|NCT00561015|9228473|P2|Overall Study|Lost to Follow-up|0
2673053|NCT00561015|9228474|P1|Overall Study|Lost to Follow-up|2
2673054|NCT00561015|9228469|P6|Overall Study|Adverse Event|0
2673055|NCT00561015|9228470|P5|Overall Study|Adverse Event|1
2673056|NCT00561015|9228471|P4|Overall Study|Adverse Event|0
2673057|NCT00561015|9228472|P3|Overall Study|Adverse Event|0
2673058|NCT00561015|9228473|P2|Overall Study|Adverse Event|0
2673059|NCT00561015|9228474|P1|Overall Study|Adverse Event|0
2673060|NCT00560950|9228565|P2|Overall Study|Lost to Follow-up|0
2673061|NCT00560950|9228566|P1|Overall Study|Lost to Follow-up|1
2673062|NCT00560937|9228604|P2|Overall Study|Physician Decision|1
2673063|NCT00560937|9228605|P1|Overall Study|Physician Decision|1
2673064|NCT00560937|9228604|P2|Overall Study|Withdrawal by Subject|1
2673065|NCT00560937|9228605|P1|Overall Study|Withdrawal by Subject|0
2673066|NCT00560885|9228621|P1|Overall Study|Withdrawal by Subject|1
2673067|NCT00560885|9228621|P1|Overall Study|Death|7
2673068|NCT00560833|9228646|P5|Overall Study|Never received drug|1
2673069|NCT00560833|9228647|P4|Overall Study|Never received drug|0
2673070|NCT00560833|9228648|P3|Overall Study|Never received drug|0
2673071|NCT00560833|9228649|P2|Overall Study|Never received drug|1
2673072|NCT00560833|9228650|P1|Overall Study|Never received drug|0
2673073|NCT00560833|9228646|P5|Overall Study|Other|0
2673074|NCT00560833|9228647|P4|Overall Study|Other|0
2673075|NCT00560833|9228648|P3|Overall Study|Other|3
2673076|NCT00560833|9228649|P2|Overall Study|Other|1
2673077|NCT00560833|9228650|P1|Overall Study|Other|1
2673078|NCT00560833|9228646|P5|Overall Study|Participant uncooperative|2
2673079|NCT00560833|9228647|P4|Overall Study|Participant uncooperative|4
2673080|NCT00560833|9228648|P3|Overall Study|Participant uncooperative|4
2673081|NCT00560833|9228649|P2|Overall Study|Participant uncooperative|5
2673082|NCT00560833|9228650|P1|Overall Study|Participant uncooperative|5
2673083|NCT00560833|9228646|P5|Overall Study|Lack of Efficacy|4
2673084|NCT00560833|9228647|P4|Overall Study|Lack of Efficacy|4
2673085|NCT00560833|9228648|P3|Overall Study|Lack of Efficacy|6
2673086|NCT00560833|9228649|P2|Overall Study|Lack of Efficacy|9
2673087|NCT00560833|9228650|P1|Overall Study|Lack of Efficacy|22
2673088|NCT00560833|9228646|P5|Overall Study|Lost to Follow-up|0
2673089|NCT00560833|9228647|P4|Overall Study|Lost to Follow-up|0
2673090|NCT00560833|9228648|P3|Overall Study|Lost to Follow-up|1
2673091|NCT00560833|9228649|P2|Overall Study|Lost to Follow-up|0
2673092|NCT00560833|9228650|P1|Overall Study|Lost to Follow-up|0
2673093|NCT00560833|9228646|P5|Overall Study|Adverse Event|35
2673094|NCT00560833|9228647|P4|Overall Study|Adverse Event|23
2673095|NCT00560833|9228648|P3|Overall Study|Adverse Event|25
2673096|NCT00560833|9228649|P2|Overall Study|Adverse Event|10
2673097|NCT00560833|9228650|P1|Overall Study|Adverse Event|16
2673098|NCT00560794|9228682|P1|Overall Study|Received Bone Marrow Transplant|6
2673099|NCT00560794|9228682|P1|Overall Study|Hematological Relapse|1
2673100|NCT00560794|9228682|P1|Overall Study|Minimal Residual Disease Relapse|1
2673101|NCT00560794|9228682|P1|Overall Study|Patient was not Compliant|1
2673102|NCT00560794|9228682|P1|Overall Study|Adverse Event|2
2673103|NCT00560755|9228699|P1|Overall Study|Physician Decision|2
2673104|NCT00560755|9228699|P1|Overall Study|Adverse Event|8
2673105|NCT00560755|9228699|P1|Overall Study|Lost to Follow-up|9
2673106|NCT00560755|9228699|P1|Overall Study|Withdrawal by Subject|26
2673107|NCT00560755|9228699|P1|Overall Study|Protocol Violation|15
2673108|NCT00560703|9228720|P2|Overall Study|non-compliance|1
2673109|NCT00560703|9228721|P1|Overall Study|non-compliance|0
2673110|NCT00560703|9228720|P2|Overall Study|Withdrawal by Subject|1
2673111|NCT00560703|9228721|P1|Overall Study|Withdrawal by Subject|0
2673112|NCT00560703|9228720|P2|Overall Study|Protocol Violation|2
2673113|NCT00560703|9228721|P1|Overall Study|Protocol Violation|0
2673114|NCT00560703|9228720|P2|Overall Study|Adverse Event|2
2673115|NCT00560703|9228721|P1|Overall Study|Adverse Event|0
2673116|NCT00560573|9228744|P6|Overall Study|Enrolled, not treated|0
2673117|NCT00560573|9228745|P5|Overall Study|Enrolled, not treated|1
2673118|NCT00560573|9228746|P4|Overall Study|Enrolled, not treated|0
2673119|NCT00560573|9228747|P3|Overall Study|Enrolled, not treated|0
2673120|NCT00560573|9228748|P2|Overall Study|Enrolled, not treated|0
2673121|NCT00560573|9228749|P1|Overall Study|Enrolled, not treated|0
2673122|NCT00560573|9228744|P6|Overall Study|Other|3
2673123|NCT00560573|9228745|P5|Overall Study|Other|3
2673124|NCT00560573|9228746|P4|Overall Study|Other|3
2673125|NCT00560573|9228747|P3|Overall Study|Other|2
2673126|NCT00560573|9228748|P2|Overall Study|Other|2
2673127|NCT00560573|9228749|P1|Overall Study|Other|2
2673128|NCT00560573|9228744|P6|Overall Study|Withdrawal by Subject|0
2673129|NCT00560573|9228745|P5|Overall Study|Withdrawal by Subject|1
2673130|NCT00560573|9228746|P4|Overall Study|Withdrawal by Subject|1
2673131|NCT00560573|9228747|P3|Overall Study|Withdrawal by Subject|0
2673132|NCT00560573|9228748|P2|Overall Study|Withdrawal by Subject|0
2673133|NCT00560573|9228749|P1|Overall Study|Withdrawal by Subject|0
2673134|NCT00560573|9228744|P6|Overall Study|Lost to Follow-up|0
2673135|NCT00560573|9228745|P5|Overall Study|Lost to Follow-up|1
2673136|NCT00560573|9228746|P4|Overall Study|Lost to Follow-up|1
2673137|NCT00560573|9228747|P3|Overall Study|Lost to Follow-up|0
2673138|NCT00560573|9228748|P2|Overall Study|Lost to Follow-up|0
2673139|NCT00560573|9228749|P1|Overall Study|Lost to Follow-up|0
2673140|NCT00560573|9228744|P6|Overall Study|Death|10
2673141|NCT00560573|9228745|P5|Overall Study|Death|1
2673142|NCT00560573|9228746|P4|Overall Study|Death|5
2673143|NCT00560573|9228747|P3|Overall Study|Death|4
2673144|NCT00560573|9228748|P2|Overall Study|Death|1
2673145|NCT00560573|9228749|P1|Overall Study|Death|4
2673146|NCT00560508|9228826|P2|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
2673147|NCT00560508|9228827|P1|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
2673148|NCT00560508|9228826|P2|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3
2673149|NCT00560508|9228827|P1|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0
2673150|NCT00560508|9228826|P2|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
2673151|NCT00560508|9228827|P1|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
2673152|NCT00560508|9228826|P2|52-week Open-label Period Pramipexole ER|Adverse Event|6
2673153|NCT00560508|9228827|P1|52-week Open-label Period Pramipexole ER|Adverse Event|6
2673154|NCT00560508|9228826|P2|12 Week Double-blind Period|Withdrawal by Subject|1
2673155|NCT00560508|9228827|P1|12 Week Double-blind Period|Withdrawal by Subject|1
2673156|NCT00560508|9228826|P2|12 Week Double-blind Period|Protocol Violation|0
2673157|NCT00560508|9228827|P1|12 Week Double-blind Period|Protocol Violation|1
2673158|NCT00560508|9228826|P2|12 Week Double-blind Period|Adverse Event|2
2673159|NCT00560508|9228827|P1|12 Week Double-blind Period|Adverse Event|3
2673160|NCT00560417|9228886|P2|Overall Study|Withdrawal by Subject|3
2673161|NCT00560417|9228887|P1|Overall Study|Withdrawal by Subject|3
2673162|NCT00560417|9228886|P2|Overall Study|Sponsor Decision|0
2673163|NCT00560417|9228887|P1|Overall Study|Sponsor Decision|2
2673164|NCT00560417|9228886|P2|Overall Study|Protocol Violation|5
2673165|NCT00560417|9228887|P1|Overall Study|Protocol Violation|6
2673166|NCT00560417|9228886|P2|Overall Study|Physician Decision|6
2673167|NCT00560417|9228887|P1|Overall Study|Physician Decision|2
2673168|NCT00560417|9228886|P2|Overall Study|Lost to Follow-up|1
2673169|NCT00560417|9228887|P1|Overall Study|Lost to Follow-up|0
2673170|NCT00560417|9228886|P2|Overall Study|Entry Criteria Not Met|0
2673171|NCT00560417|9228887|P1|Overall Study|Entry Criteria Not Met|1
2673172|NCT00560417|9228886|P2|Overall Study|Adverse Event|2
2673173|NCT00560417|9228887|P1|Overall Study|Adverse Event|3
2673174|NCT00560404|9228915|P2|Overall Study|Other withdrawal reason|5
2673175|NCT00560404|9228916|P1|Overall Study|Other withdrawal reason|13
2673176|NCT00560404|9228915|P2|Overall Study|Failure to return|2
2673177|NCT00560404|9228916|P1|Overall Study|Failure to return|1
2673178|NCT00560404|9228915|P2|Overall Study|Withdrew Consent|0
2673179|NCT00560404|9228916|P1|Overall Study|Withdrew Consent|4
2673180|NCT00560404|9228915|P2|Overall Study|Administrative Reasons|1
2673181|NCT00560404|9228916|P1|Overall Study|Administrative Reasons|1
2673182|NCT00560404|9228915|P2|Overall Study|Protocol Violation|7
2673183|NCT00560404|9228916|P1|Overall Study|Protocol Violation|12
2673184|NCT00560404|9228915|P2|Overall Study|Death|3
2673185|NCT00560404|9228916|P1|Overall Study|Death|3
2673186|NCT00560404|9228915|P2|Overall Study|Adverse Event|3
2673187|NCT00560404|9228916|P1|Overall Study|Adverse Event|2
2673188|NCT00560391|9228963|P5|Overall Study|Still on treatment|2
2673189|NCT00560391|9228964|P4|Overall Study|Still on treatment|1
2673190|NCT00560391|9228965|P3|Overall Study|Still on treatment|0
2673191|NCT00560391|9228966|P2|Overall Study|Still on treatment|0
2673192|NCT00560391|9228967|P1|Overall Study|Still on treatment|0
2673193|NCT00560352|9229023|P3|Overall Study|Maximum clinical benefit|0
2673194|NCT00560352|9229024|P2|Overall Study|Maximum clinical benefit|0
2673195|NCT00560352|9229025|P1|Overall Study|Maximum clinical benefit|1
2673196|NCT00560352|9229023|P3|Overall Study|Withdrawal by Subject|1
2673197|NCT00560352|9229024|P2|Overall Study|Withdrawal by Subject|1
2673198|NCT00560352|9229025|P1|Overall Study|Withdrawal by Subject|1
2673199|NCT00560352|9229023|P3|Overall Study|Disease progression|1
2673200|NCT00560352|9229024|P2|Overall Study|Disease progression|1
2673201|NCT00560352|9229025|P1|Overall Study|Disease progression|0
2673202|NCT00560352|9229023|P3|Overall Study|Study drug toxicity|1
2673203|NCT00560352|9229024|P2|Overall Study|Study drug toxicity|0
2673204|NCT00560352|9229025|P1|Overall Study|Study drug toxicity|3
2673205|NCT00560352|9229023|P3|Overall Study|Adverse event unrelated to study drug|1
2673206|NCT00560352|9229024|P2|Overall Study|Adverse event unrelated to study drug|1
2673207|NCT00560352|9229025|P1|Overall Study|Adverse event unrelated to study drug|2
2673208|NCT00560313|9229042|P1|Overall Study|Protocol Violation|1
2673209|NCT00560313|9229042|P1|Overall Study|Lost to Follow-up|1
2673210|NCT00560313|9229042|P1|Overall Study|Withdrawal by Subject|2
2673211|NCT00560313|9229042|P1|Overall Study|Adverse Events or Death|2
2673212|NCT00560235|9229069|P3|Phase 2|Ongoing at Date of Cut-Off|1
2673213|NCT00560235|9229070|P2|Phase 2|Ongoing at Date of Cut-Off|0
2673214|NCT00560235|9229071|P1|Phase 2|Ongoing at Date of Cut-Off|0
2673215|NCT00560235|9229069|P3|Phase 2|Discontinued|96
2673216|NCT00560235|9229070|P2|Phase 2|Discontinued|0
2673217|NCT00560235|9229071|P1|Phase 2|Discontinued|0
2673218|NCT00560235|9229069|P3|Phase 1B|Discontinued|0
2673219|NCT00560235|9229070|P2|Phase 1B|Discontinued|19
2673220|NCT00560235|9229071|P1|Phase 1B|Discontinued|0
2673221|NCT00560235|9229069|P3|Phase 1|Discontinued|0
2673222|NCT00560235|9229070|P2|Phase 1|Discontinued|0
2673223|NCT00560235|9229071|P1|Phase 1|Discontinued|8
2673224|NCT00560105|9229102|P2|Overall Study|musculoskeletal chest discomfort with us|2
2673225|NCT00560105|9229103|P1|Overall Study|musculoskeletal chest discomfort with us|1
2673226|NCT00560066|9229117|P2|Overall Study|Missing primary reason|2
2673227|NCT00560066|9229118|P1|Overall Study|Missing primary reason|0
2673228|NCT00560066|9229117|P2|Overall Study|Administrative reason|5
2673229|NCT00560066|9229118|P1|Overall Study|Administrative reason|0
2673230|NCT00560066|9229117|P2|Overall Study|Protocol Violation|1
2673231|NCT00560066|9229118|P1|Overall Study|Protocol Violation|0
2673232|NCT00560066|9229117|P2|Overall Study|Lost to Follow-up|10
2673233|NCT00560066|9229118|P1|Overall Study|Lost to Follow-up|4
2673234|NCT00560066|9229117|P2|Overall Study|Withdrawal by Subject|3
2673235|NCT00560066|9229118|P1|Overall Study|Withdrawal by Subject|0
2673236|NCT00560066|9229117|P2|Overall Study|Death|1
2673237|NCT00560066|9229118|P1|Overall Study|Death|2
2673238|NCT00559988|9229150|P2|Overall Study|ICD device explanted|17
2673239|NCT00559988|9229151|P1|Overall Study|ICD device explanted|10
2673240|NCT00559988|9229150|P2|Overall Study|Lost to Follow-up|56
2673241|NCT00559988|9229151|P1|Overall Study|Lost to Follow-up|42
2673242|NCT00559988|9229150|P2|Overall Study|Withdrawal by Subject|139
2673243|NCT00559988|9229151|P1|Overall Study|Withdrawal by Subject|152
2673244|NCT00559988|9229150|P2|Overall Study|Death|140
2673245|NCT00559988|9229151|P1|Overall Study|Death|147
2673246|NCT00559962|9229181|P8|Overall Study|Inclusion/exclusion criteria not met|0
2673247|NCT00559962|9229182|P7|Overall Study|Inclusion/exclusion criteria not met|1
2673248|NCT00559962|9229183|P6|Overall Study|Inclusion/exclusion criteria not met|0
2673249|NCT00559962|9229184|P5|Overall Study|Inclusion/exclusion criteria not met|0
2673250|NCT00559962|9229185|P4|Overall Study|Inclusion/exclusion criteria not met|0
2673251|NCT00559962|9229186|P3|Overall Study|Inclusion/exclusion criteria not met|0
2673252|NCT00559962|9229187|P2|Overall Study|Inclusion/exclusion criteria not met|0
2673253|NCT00559962|9229188|P1|Overall Study|Inclusion/exclusion criteria not met|0
2673254|NCT00559962|9229181|P8|Overall Study|Withdrawal by Subject|2
2673255|NCT00559962|9229182|P7|Overall Study|Withdrawal by Subject|0
2673256|NCT00559962|9229183|P6|Overall Study|Withdrawal by Subject|1
2673257|NCT00559962|9229184|P5|Overall Study|Withdrawal by Subject|3
2673258|NCT00559962|9229185|P4|Overall Study|Withdrawal by Subject|0
2673259|NCT00559962|9229186|P3|Overall Study|Withdrawal by Subject|2
2673260|NCT00559962|9229187|P2|Overall Study|Withdrawal by Subject|1
2673261|NCT00559962|9229188|P1|Overall Study|Withdrawal by Subject|1
2673262|NCT00559962|9229181|P8|Overall Study|Lost to Follow-up|0
2673263|NCT00559962|9229182|P7|Overall Study|Lost to Follow-up|0
2673264|NCT00559962|9229183|P6|Overall Study|Lost to Follow-up|0
2673265|NCT00559962|9229184|P5|Overall Study|Lost to Follow-up|0
2673266|NCT00559962|9229185|P4|Overall Study|Lost to Follow-up|0
2673267|NCT00559962|9229186|P3|Overall Study|Lost to Follow-up|0
2673268|NCT00559962|9229187|P2|Overall Study|Lost to Follow-up|1
2673269|NCT00559962|9229188|P1|Overall Study|Lost to Follow-up|0
2673270|NCT00559962|9229181|P8|Overall Study|Adverse Event|2
2673271|NCT00559962|9229182|P7|Overall Study|Adverse Event|4
2673272|NCT00559962|9229183|P6|Overall Study|Adverse Event|4
2673273|NCT00559962|9229184|P5|Overall Study|Adverse Event|11
2673274|NCT00559962|9229185|P4|Overall Study|Adverse Event|5
2673275|NCT00559962|9229186|P3|Overall Study|Adverse Event|8
2673276|NCT00559962|9229187|P2|Overall Study|Adverse Event|7
2673277|NCT00559962|9229188|P1|Overall Study|Adverse Event|1
2673278|NCT00559949|9229208|P1|Overall Study|No disease evaluation per protocol|1
2673279|NCT00559949|9229208|P1|Overall Study|Withdrawal by Subject|4
2673280|NCT00559949|9229208|P1|Overall Study|Adverse Event|1
2673281|NCT00559949|9229208|P1|Overall Study|Progressive Disease during cycle 1|1
2673282|NCT00559845|9229224|P1|Overall Study|Premature Surgery-Investigator Decision|1
2673283|NCT00559845|9229224|P1|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1
2673284|NCT00559845|9229224|P1|Overall Study|Adverse Event|3
2673285|NCT00559845|9229224|P1|Overall Study|Disease Progression|1
2673286|NCT00559845|9229224|P1|Overall Study|Withdrew Consent|1
2673287|NCT00559754|9229233|P1|Overall Study|Withdrawal by Subject|2
2673288|NCT00559754|9229233|P1|Overall Study|Investigator criteria|2
2673289|NCT00559754|9229233|P1|Overall Study|Protocol Violation|1
2673290|NCT00559754|9229233|P1|Overall Study|Adverse Event|5
2673291|NCT00559754|9229233|P1|Overall Study|Disease progression|1
2673292|NCT00559637|9229257|P1|Overall Study|Inclusion or exclusion criteria violated|2
2673293|NCT00559637|9229257|P1|Overall Study|Change of home|1
2673294|NCT00559637|9229257|P1|Overall Study|Change of center|1
2673295|NCT00559637|9229257|P1|Overall Study|Delayed administration of C.E.R.A|1
2673296|NCT00559637|9229257|P1|Overall Study|Participation in another study|1
2673297|NCT00559637|9229257|P1|Overall Study|Suspected lung cancer|1
2673298|NCT00559637|9229257|P1|Overall Study|Started requiring dialysis after month 7|2
2673299|NCT00559637|9229257|P1|Overall Study|Insufficient response|3
2673300|NCT00559637|9229257|P1|Overall Study|Failure to return|6
2673301|NCT00559637|9229257|P1|Overall Study|Withdrawal criteria fulfilled|4
2673302|NCT00559637|9229257|P1|Overall Study|Protocol Violation|6
2673303|NCT00559637|9229257|P1|Overall Study|Withdrawal by Subject|4
2673304|NCT00559637|9229257|P1|Overall Study|Adverse Event|22
2673305|NCT00559585|9229270|P2|Open Label LT Period Main + Sub-Study|no end of study status page|0
2673306|NCT00559585|9229271|P1|Open Label LT Period Main + Sub-Study|no end of study status page|1
2673307|NCT00559585|9229270|P2|Open Label LT Period Main + Sub-Study|non-specified|0
2673308|NCT00559585|9229271|P1|Open Label LT Period Main + Sub-Study|non-specified|71
2673309|NCT00559585|9229270|P2|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0
2673310|NCT00559585|9229271|P1|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8
2673311|NCT00559585|9229270|P2|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0
2673312|NCT00559585|9229271|P1|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89
2673313|NCT00559585|9229270|P2|Open Label LT Period Main + Sub-Study|No longer met criteria|0
2673314|NCT00559585|9229271|P1|Open Label LT Period Main + Sub-Study|No longer met criteria|1
2673315|NCT00559585|9229270|P2|Open Label LT Period Main + Sub-Study|Death|0
2673316|NCT00559585|9229271|P1|Open Label LT Period Main + Sub-Study|Death|20
2673317|NCT00559585|9229270|P2|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0
2673318|NCT00559585|9229271|P1|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9
2673319|NCT00559585|9229270|P2|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0
2673320|NCT00559585|9229271|P1|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32
2673321|NCT00559585|9229270|P2|Open Label LT Period Main + Sub-Study|Pregnancy|0
2673322|NCT00559585|9229271|P1|Open Label LT Period Main + Sub-Study|Pregnancy|16
2673323|NCT00559585|9229270|P2|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0
2673324|NCT00559585|9229271|P1|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81
2673325|NCT00559585|9229270|P2|Open Label LT Period Main + Sub-Study|Adverse Event|0
2673326|NCT00559585|9229271|P1|Open Label LT Period Main + Sub-Study|Adverse Event|100
2673327|NCT00559585|9229270|P2|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
2673328|NCT00559585|9229271|P1|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
2673329|NCT00559585|9229270|P2|Double Blind ST Period Main Study|Ongoing Infection Risk|0
2673330|NCT00559585|9229271|P1|Double Blind ST Period Main Study|Ongoing Infection Risk|1
2673331|NCT00559585|9229270|P2|Double Blind ST Period Main Study|Investigator Decision|1
2673332|NCT00559585|9229271|P1|Double Blind ST Period Main Study|Investigator Decision|0
2673333|NCT00559585|9229270|P2|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1
2673334|NCT00559585|9229271|P1|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0
2673335|NCT00559585|9229270|P2|Double Blind ST Period Main Study|Participant Weight Gain|0
2673336|NCT00559585|9229271|P1|Double Blind ST Period Main Study|Participant Weight Gain|1
2673337|NCT00559585|9229270|P2|Double Blind ST Period Main Study|Early Discontinuation|1
2673338|NCT00559585|9229271|P1|Double Blind ST Period Main Study|Early Discontinuation|0
2673339|NCT00559585|9229270|P2|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1
2673340|NCT00559585|9229271|P1|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0
2673341|NCT00559585|9229270|P2|Double Blind ST Period Main Study|Incomplete Breast Exam|1
2673342|NCT00559585|9229271|P1|Double Blind ST Period Main Study|Incomplete Breast Exam|0
2673343|NCT00559585|9229270|P2|Double Blind ST Period Main Study|Missed Doses|1
2673344|NCT00559585|9229271|P1|Double Blind ST Period Main Study|Missed Doses|0
2673345|NCT00559585|9229270|P2|Double Blind ST Period Main Study|Poor/Non-Compliance|0
2673346|NCT00559585|9229271|P1|Double Blind ST Period Main Study|Poor/Non-Compliance|3
2673347|NCT00559585|9229270|P2|Double Blind ST Period Main Study|Lack of Efficacy|1
2673348|NCT00559585|9229271|P1|Double Blind ST Period Main Study|Lack of Efficacy|6
2673349|NCT00559585|9229270|P2|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1
2673350|NCT00559585|9229271|P1|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2
2673351|NCT00559585|9229270|P2|Double Blind ST Period Main Study|Death|1
2673352|NCT00559585|9229271|P1|Double Blind ST Period Main Study|Death|1
2673353|NCT00559585|9229270|P2|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0
2673354|NCT00559585|9229271|P1|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1
2673355|NCT00559585|9229270|P2|Double Blind ST Period Main Study|Lost to Follow-up|6
2673356|NCT00559585|9229271|P1|Double Blind ST Period Main Study|Lost to Follow-up|0
2673357|NCT00559585|9229270|P2|Double Blind ST Period Main Study|Withdrawal by Subject|5
2673358|NCT00559585|9229271|P1|Double Blind ST Period Main Study|Withdrawal by Subject|11
2673359|NCT00559585|9229270|P2|Double Blind ST Period Main Study|Adverse Event|25
2673360|NCT00559585|9229271|P1|Double Blind ST Period Main Study|Adverse Event|17
2673361|NCT00559507|9229331|P1|Overall Study|Not treated, patient ineligible|3
2673362|NCT00559377|9229350|P1|Overall Study|Withdrawal by Subject|9
2673363|NCT00559364|9229360|P2|Overall Study|Inclusion/exclusion criteria failure|0
2673364|NCT00559364|9229361|P1|Overall Study|Inclusion/exclusion criteria failure|1
2673365|NCT00559273|9229373|P2|Evaluation Period (8 Weeks)|Physician Decision|1
2673366|NCT00559273|9229374|P1|Evaluation Period (8 Weeks)|Physician Decision|0
2673367|NCT00559273|9229373|P2|Evaluation Period (8 Weeks)|Withdrawal by Subject|0
2673368|NCT00559273|9229374|P1|Evaluation Period (8 Weeks)|Withdrawal by Subject|2
2673369|NCT00559273|9229373|P2|Evaluation Period (8 Weeks)|Adverse Event|1
2673370|NCT00559273|9229374|P1|Evaluation Period (8 Weeks)|Adverse Event|0
2673371|NCT00559273|9229373|P2|Evaluation Period (8 Weeks)|Death|3
2673372|NCT00559273|9229374|P1|Evaluation Period (8 Weeks)|Death|1
2673373|NCT00559273|9229373|P2|Correction Period (20 Weeks)|Did not received study treatment|0
2673374|NCT00559273|9229374|P1|Correction Period (20 Weeks)|Did not received study treatment|2
2673375|NCT00559273|9229373|P2|Correction Period (20 Weeks)|Participant treated by another center|1
2673376|NCT00559273|9229374|P1|Correction Period (20 Weeks)|Participant treated by another center|0
2673377|NCT00559273|9229373|P2|Correction Period (20 Weeks)|Withdrawal by Subject|6
2673378|NCT00559273|9229374|P1|Correction Period (20 Weeks)|Withdrawal by Subject|2
2673379|NCT00559273|9229373|P2|Correction Period (20 Weeks)|Adverse Event|1
2673380|NCT00559273|9229374|P1|Correction Period (20 Weeks)|Adverse Event|2
2673381|NCT00559273|9229373|P2|Correction Period (20 Weeks)|Death|4
2673382|NCT00559273|9229374|P1|Correction Period (20 Weeks)|Death|3
2673383|NCT00559104|9229396|P2|Overall Study|Lack of Efficacy|0
2673384|NCT00559104|9229397|P1|Overall Study|Lack of Efficacy|9
2673385|NCT00558896|9229418|P7|Overall Study|Continues on treatment|6
2673386|NCT00558896|9229419|P6|Overall Study|Continues on treatment|25
2673387|NCT00558896|9229420|P5|Overall Study|Continues on treatment|9
2673388|NCT00558896|9229421|P4|Overall Study|Continues on treatment|1
2673389|NCT00558896|9229422|P3|Overall Study|Continues on treatment|0
2673390|NCT00558896|9229423|P2|Overall Study|Continues on treatment|1
2673391|NCT00558896|9229424|P1|Overall Study|Continues on treatment|10
2673392|NCT00558896|9229418|P7|Overall Study|Physician discretion|3
2673393|NCT00558896|9229419|P6|Overall Study|Physician discretion|3
2673394|NCT00558896|9229420|P5|Overall Study|Physician discretion|1
2673395|NCT00558896|9229421|P4|Overall Study|Physician discretion|2
2673396|NCT00558896|9229422|P3|Overall Study|Physician discretion|1
2673397|NCT00558896|9229423|P2|Overall Study|Physician discretion|2
2673398|NCT00558896|9229424|P1|Overall Study|Physician discretion|3
2673399|NCT00558896|9229418|P7|Overall Study|Alternative Treatment|1
2673400|NCT00558896|9229419|P6|Overall Study|Alternative Treatment|7
2673401|NCT00558896|9229420|P5|Overall Study|Alternative Treatment|6
2673402|NCT00558896|9229421|P4|Overall Study|Alternative Treatment|2
2673403|NCT00558896|9229422|P3|Overall Study|Alternative Treatment|0
2673404|NCT00558896|9229423|P2|Overall Study|Alternative Treatment|2
2673405|NCT00558896|9229424|P1|Overall Study|Alternative Treatment|2
2673406|NCT00558896|9229418|P7|Overall Study|Withdrawal by Subject|5
2673407|NCT00558896|9229419|P6|Overall Study|Withdrawal by Subject|5
2673408|NCT00558896|9229420|P5|Overall Study|Withdrawal by Subject|1
2673409|NCT00558896|9229421|P4|Overall Study|Withdrawal by Subject|1
2673410|NCT00558896|9229422|P3|Overall Study|Withdrawal by Subject|1
2673411|NCT00558896|9229423|P2|Overall Study|Withdrawal by Subject|1
2673412|NCT00558896|9229424|P1|Overall Study|Withdrawal by Subject|2
2673413|NCT00558896|9229418|P7|Overall Study|Death|6
2673414|NCT00558896|9229419|P6|Overall Study|Death|2
2673415|NCT00558896|9229420|P5|Overall Study|Death|2
2673416|NCT00558896|9229421|P4|Overall Study|Death|3
2673417|NCT00558896|9229422|P3|Overall Study|Death|2
2673418|NCT00558896|9229423|P2|Overall Study|Death|0
2673419|NCT00558896|9229424|P1|Overall Study|Death|3
2673420|NCT00558896|9229418|P7|Overall Study|Adverse Event|3
2673421|NCT00558896|9229419|P6|Overall Study|Adverse Event|10
2673422|NCT00558896|9229420|P5|Overall Study|Adverse Event|4
2673423|NCT00558896|9229421|P4|Overall Study|Adverse Event|3
2673424|NCT00558896|9229422|P3|Overall Study|Adverse Event|1
2673425|NCT00558896|9229423|P2|Overall Study|Adverse Event|1
2673426|NCT00558896|9229424|P1|Overall Study|Adverse Event|1
2673427|NCT00558831|9229526|P1|Overall Study|Lost to Follow-up|1
2673428|NCT00558753|9229583|P2|Overall Study|Lost to Follow-up|7
2673429|NCT00558753|9229584|P1|Overall Study|Lost to Follow-up|5
2673430|NCT00558701|9229596|P2|Overall Study|Protocol Deviations|4
2673431|NCT00558701|9229597|P1|Overall Study|Protocol Deviations|1
2673432|NCT00558636|9229605|P2|Follow-up|Premature termination of the study|7
2673433|NCT00558636|9229606|P1|Follow-up|Premature termination of the study|12
2673434|NCT00558636|9229605|P2|Treatment|Disease progression|5
2673435|NCT00558636|9229606|P1|Treatment|Disease progression|1
2673436|NCT00558636|9229605|P2|Treatment|Premature termination of the study|37
2673437|NCT00558636|9229606|P1|Treatment|Premature termination of the study|35
2673438|NCT00558636|9229605|P2|Treatment|Withdrawal by Subject|0
2673439|NCT00558636|9229606|P1|Treatment|Withdrawal by Subject|2
2673440|NCT00558636|9229605|P2|Treatment|Adverse Event|2
2673441|NCT00558636|9229606|P1|Treatment|Adverse Event|9
2673442|NCT00558558|9229706|P1|Overall Study|Lack of Efficacy|4
2673443|NCT00558558|9229706|P1|Overall Study|Withdrawal by Subject|1
2673444|NCT00558558|9229706|P1|Overall Study|Unable to swallow|1
2673445|NCT00558519|9229710|P1|Overall Study|Never received treatment|1
2673446|NCT00558519|9229710|P1|Overall Study|Insufficient data|1
2673447|NCT00558519|9229710|P1|Overall Study|Ineligible|1
2673448|NCT00558519|9229710|P1|Overall Study|Ph+|20
2673449|NCT00558467|9229720|P2|Overall Study|Patient moving out of state|1
2673450|NCT00558467|9229721|P1|Overall Study|Patient moving out of state|0
2673451|NCT00558467|9229720|P2|Overall Study|Lack of Efficacy|1
2673452|NCT00558467|9229721|P1|Overall Study|Lack of Efficacy|0
2673453|NCT00558467|9229720|P2|Overall Study|Adverse Event|2
2673454|NCT00558467|9229721|P1|Overall Study|Adverse Event|1
2673455|NCT00558428|9229781|P4|Overall Study|Other|1
2673456|NCT00558428|9229782|P3|Overall Study|Other|0
2673457|NCT00558428|9229783|P2|Overall Study|Other|0
2673458|NCT00558428|9229784|P1|Overall Study|Other|3
2673459|NCT00558428|9229781|P4|Overall Study|Consent withdrawn|1
2673460|NCT00558428|9229782|P3|Overall Study|Consent withdrawn|0
2673461|NCT00558428|9229783|P2|Overall Study|Consent withdrawn|1
2673462|NCT00558428|9229784|P1|Overall Study|Consent withdrawn|2
2673463|NCT00558428|9229781|P4|Overall Study|Non compliant with protocol|3
2673464|NCT00558428|9229782|P3|Overall Study|Non compliant with protocol|0
2673465|NCT00558428|9229783|P2|Overall Study|Non compliant with protocol|0
2673466|NCT00558428|9229784|P1|Overall Study|Non compliant with protocol|1
2673467|NCT00558428|9229781|P4|Overall Study|Lack of Efficacy|2
2673468|NCT00558428|9229782|P3|Overall Study|Lack of Efficacy|1
2673469|NCT00558428|9229783|P2|Overall Study|Lack of Efficacy|0
2673470|NCT00558428|9229784|P1|Overall Study|Lack of Efficacy|0
2673471|NCT00558428|9229781|P4|Overall Study|Lost to Follow-up|0
2673472|NCT00558428|9229782|P3|Overall Study|Lost to Follow-up|0
2673473|NCT00558428|9229783|P2|Overall Study|Lost to Follow-up|1
2673474|NCT00558428|9229784|P1|Overall Study|Lost to Follow-up|0
2673475|NCT00558428|9229781|P4|Overall Study|Adverse Event|4
2673476|NCT00558428|9229782|P3|Overall Study|Adverse Event|3
2673477|NCT00558428|9229783|P2|Overall Study|Adverse Event|22
2673478|NCT00558428|9229784|P1|Overall Study|Adverse Event|6
2673479|NCT00558363|9229824|P2|Overall Study|Hospitalized; Unable to Continue|1
2673480|NCT00558363|9229825|P1|Overall Study|Hospitalized; Unable to Continue|0
2673481|NCT00558363|9229824|P2|Overall Study|Randomized in Error|2
2673482|NCT00558363|9229825|P1|Overall Study|Randomized in Error|1
2673483|NCT00558363|9229824|P2|Overall Study|Met Protocol-defined Stopping Criteria|16
2673484|NCT00558363|9229825|P1|Overall Study|Met Protocol-defined Stopping Criteria|32
2673485|NCT00558363|9229824|P2|Overall Study|Lost to Follow-up|1
2673486|NCT00558363|9229825|P1|Overall Study|Lost to Follow-up|0
2673487|NCT00558363|9229824|P2|Overall Study|Protocol Violation|1
2673488|NCT00558363|9229825|P1|Overall Study|Protocol Violation|2
2673489|NCT00558363|9229824|P2|Overall Study|Lack of Efficacy|2
2673490|NCT00558363|9229825|P1|Overall Study|Lack of Efficacy|2
2673491|NCT00558363|9229824|P2|Overall Study|Adverse Event|5
2673492|NCT00558363|9229825|P1|Overall Study|Adverse Event|5
2673493|NCT00558363|9229824|P2|Overall Study|Withdrawal by Subject|4
2673494|NCT00558363|9229825|P1|Overall Study|Withdrawal by Subject|11
2673495|NCT00558363|9229824|P2|Overall Study|Physician Decision|4
2673496|NCT00558363|9229825|P1|Overall Study|Physician Decision|18
2673497|NCT00558285|9229880|P5|Overall Study|Protocol deviation|0
2673498|NCT00558285|9229881|P4|Overall Study|Protocol deviation|1
2673499|NCT00558285|9229882|P3|Overall Study|Protocol deviation|0
2673500|NCT00558285|9229883|P2|Overall Study|Protocol deviation|1
2673501|NCT00558285|9229884|P1|Overall Study|Protocol deviation|1
2673502|NCT00558285|9229880|P5|Overall Study|Administrative problems|1
2673503|NCT00558285|9229881|P4|Overall Study|Administrative problems|1
2673504|NCT00558285|9229882|P3|Overall Study|Administrative problems|0
2673505|NCT00558285|9229883|P2|Overall Study|Administrative problems|0
2673506|NCT00558285|9229884|P1|Overall Study|Administrative problems|0
2673507|NCT00558285|9229880|P5|Overall Study|Lost to Follow-up|0
2673508|NCT00558285|9229881|P4|Overall Study|Lost to Follow-up|0
2673509|NCT00558285|9229882|P3|Overall Study|Lost to Follow-up|0
2673510|NCT00558285|9229883|P2|Overall Study|Lost to Follow-up|1
2673511|NCT00558285|9229884|P1|Overall Study|Lost to Follow-up|1
2673512|NCT00558285|9229880|P5|Overall Study|Subject withdrew consent|1
2673513|NCT00558285|9229881|P4|Overall Study|Subject withdrew consent|1
2673514|NCT00558285|9229882|P3|Overall Study|Subject withdrew consent|1
2673515|NCT00558285|9229883|P2|Overall Study|Subject withdrew consent|0
2673516|NCT00558285|9229884|P1|Overall Study|Subject withdrew consent|2
2673517|NCT00558285|9229880|P5|Overall Study|Abnormal test procedure result(s)|0
2673518|NCT00558285|9229881|P4|Overall Study|Abnormal test procedure result(s)|0
2673519|NCT00558285|9229882|P3|Overall Study|Abnormal test procedure result(s)|0
2673520|NCT00558285|9229883|P2|Overall Study|Abnormal test procedure result(s)|0
2673521|NCT00558285|9229884|P1|Overall Study|Abnormal test procedure result(s)|1
2673522|NCT00558285|9229880|P5|Overall Study|Adverse Event|2
2673523|NCT00558285|9229881|P4|Overall Study|Adverse Event|1
2673524|NCT00558285|9229882|P3|Overall Study|Adverse Event|4
2673525|NCT00558285|9229883|P2|Overall Study|Adverse Event|1
2673526|NCT00558285|9229884|P1|Overall Study|Adverse Event|1
2673527|NCT00558272|9229928|P2|Overall Study|Withdrawal by Subject|1
2673528|NCT00558272|9229929|P1|Overall Study|Withdrawal by Subject|0
2673529|NCT00558272|9229928|P2|Overall Study|Incorrectly enrolled|0
2673530|NCT00558272|9229929|P1|Overall Study|Incorrectly enrolled|1
2673531|NCT00558272|9229928|P2|Overall Study|AZ study team decision|1
2673532|NCT00558272|9229929|P1|Overall Study|AZ study team decision|0
2673533|NCT00558272|9229928|P2|Overall Study|Dev. of study specific discon. criteria|0
2673534|NCT00558272|9229929|P1|Overall Study|Dev. of study specific discon. criteria|1
2673535|NCT00558272|9229928|P2|Overall Study|Death|0
2673536|NCT00558272|9229929|P1|Overall Study|Death|1
2673537|NCT00558272|9229928|P2|Overall Study|Adverse Event|0
2673538|NCT00558272|9229929|P1|Overall Study|Adverse Event|10
2673539|NCT00558259|9229969|P2|Overall Study|Withdrawal by Subject|13
2673540|NCT00558259|9229970|P1|Overall Study|Withdrawal by Subject|12
2673541|NCT00558259|9229969|P2|Overall Study|Protocol Violation|5
2673542|NCT00558259|9229970|P1|Overall Study|Protocol Violation|9
2673543|NCT00558259|9229969|P2|Overall Study|Adverse Event|81
2673544|NCT00558259|9229970|P1|Overall Study|Adverse Event|50
2673545|NCT00558103|9230010|P6|Monotherapy Extension Phase|Disease Progression|8
2673546|NCT00558103|9230011|P5|Monotherapy Extension Phase|Disease Progression|0
2673547|NCT00558103|9230012|P4|Monotherapy Extension Phase|Disease Progression|0
2673548|NCT00558103|9230013|P3|Monotherapy Extension Phase|Disease Progression|0
2673549|NCT00558103|9230014|P2|Monotherapy Extension Phase|Disease Progression|0
2673550|NCT00558103|9230015|P1|Monotherapy Extension Phase|Disease Progression|0
2673551|NCT00558103|9230010|P6|Monotherapy Extension Phase|Protocol Violation|1
2673552|NCT00558103|9230011|P5|Monotherapy Extension Phase|Protocol Violation|0
2673553|NCT00558103|9230012|P4|Monotherapy Extension Phase|Protocol Violation|0
2673554|NCT00558103|9230013|P3|Monotherapy Extension Phase|Protocol Violation|0
2673555|NCT00558103|9230014|P2|Monotherapy Extension Phase|Protocol Violation|0
2673556|NCT00558103|9230015|P1|Monotherapy Extension Phase|Protocol Violation|0
2673557|NCT00558103|9230010|P6|Randomized Treatment Phase|Adverse Event|0
2673558|NCT00558103|9230011|P5|Randomized Treatment Phase|Adverse Event|1
2673559|NCT00558103|9230012|P4|Randomized Treatment Phase|Adverse Event|1
2673560|NCT00558103|9230013|P3|Randomized Treatment Phase|Adverse Event|0
2673561|NCT00558103|9230014|P2|Randomized Treatment Phase|Adverse Event|0
2673562|NCT00558103|9230015|P1|Randomized Treatment Phase|Adverse Event|0
2673563|NCT00558103|9230010|P6|Randomized Treatment Phase|Disease Progression|0
2673564|NCT00558103|9230011|P5|Randomized Treatment Phase|Disease Progression|0
2673565|NCT00558103|9230012|P4|Randomized Treatment Phase|Disease Progression|0
2673566|NCT00558103|9230013|P3|Randomized Treatment Phase|Disease Progression|1
2673567|NCT00558103|9230014|P2|Randomized Treatment Phase|Disease Progression|0
2673568|NCT00558103|9230015|P1|Randomized Treatment Phase|Disease Progression|1
2673569|NCT00558103|9230010|P6|Randomized Treatment Phase|Withdrawal by Subject|0
2673570|NCT00558103|9230011|P5|Randomized Treatment Phase|Withdrawal by Subject|1
2673571|NCT00558103|9230012|P4|Randomized Treatment Phase|Withdrawal by Subject|0
2673572|NCT00558103|9230013|P3|Randomized Treatment Phase|Withdrawal by Subject|0
2673573|NCT00558103|9230014|P2|Randomized Treatment Phase|Withdrawal by Subject|2
2673574|NCT00558103|9230015|P1|Randomized Treatment Phase|Withdrawal by Subject|2
2673575|NCT00558103|9230010|P6|Randomized Treatment Phase|Lost to Follow-up|0
2673576|NCT00558103|9230011|P5|Randomized Treatment Phase|Lost to Follow-up|3
2673577|NCT00558103|9230012|P4|Randomized Treatment Phase|Lost to Follow-up|1
2673578|NCT00558103|9230013|P3|Randomized Treatment Phase|Lost to Follow-up|2
2673579|NCT00558103|9230014|P2|Randomized Treatment Phase|Lost to Follow-up|2
2673580|NCT00558103|9230015|P1|Randomized Treatment Phase|Lost to Follow-up|2
2673581|NCT00558064|9230045|P2|Overall Study|No visit within allowance period|0
2673582|NCT00558064|9230046|P1|Overall Study|No visit within allowance period|1
2673583|NCT00558064|9230045|P2|Overall Study|Withdrawal by Subject|1
2673584|NCT00558064|9230046|P1|Overall Study|Withdrawal by Subject|0
2673585|NCT00558064|9230045|P2|Overall Study|Lost to Follow-up|1
2673586|NCT00558064|9230046|P1|Overall Study|Lost to Follow-up|0
2673587|NCT00558064|9230045|P2|Overall Study|Protocol Violation|0
2673588|NCT00558064|9230046|P1|Overall Study|Protocol Violation|1
2673589|NCT00558064|9230045|P2|Overall Study|Lack of Efficacy|1
2673590|NCT00558064|9230046|P1|Overall Study|Lack of Efficacy|0
2673591|NCT00558064|9230045|P2|Overall Study|Adverse Event|2
2673592|NCT00558064|9230046|P1|Overall Study|Adverse Event|3
2673593|NCT00558025|9230068|P2|Overall Study|Protocol Violation|0
2673594|NCT00558025|9230069|P1|Overall Study|Protocol Violation|1
2673595|NCT00558025|9230068|P2|Overall Study|Withdrawal by Subject|2
2673596|NCT00558025|9230069|P1|Overall Study|Withdrawal by Subject|2
2673597|NCT00558025|9230068|P2|Overall Study|Adverse Event|1
2673598|NCT00558025|9230069|P1|Overall Study|Adverse Event|1
2673599|NCT00557856|9230116|P9|Part 2: Exploratory Phase|global deterioration of health status|1
2673600|NCT00557856|9230117|P8|Part 2: Exploratory Phase|global deterioration of health status|0
2673601|NCT00557856|9230118|P7|Part 2: Exploratory Phase|global deterioration of health status|0
2673602|NCT00557856|9230119|P6|Part 2: Exploratory Phase|global deterioration of health status|0
2673603|NCT00557856|9230120|P5|Part 2: Exploratory Phase|global deterioration of health status|0
2673604|NCT00557856|9230121|P4|Part 2: Exploratory Phase|global deterioration of health status|0
2673605|NCT00557856|9230122|P3|Part 2: Exploratory Phase|global deterioration of health status|0
2673606|NCT00557856|9230123|P2|Part 2: Exploratory Phase|global deterioration of health status|0
2673607|NCT00557856|9230124|P1|Part 2: Exploratory Phase|global deterioration of health status|0
2673608|NCT00557856|9230116|P9|Part 2: Exploratory Phase|Death|2
2673609|NCT00557856|9230117|P8|Part 2: Exploratory Phase|Death|0
2673610|NCT00557856|9230118|P7|Part 2: Exploratory Phase|Death|0
2673611|NCT00557856|9230119|P6|Part 2: Exploratory Phase|Death|0
2673612|NCT00557856|9230120|P5|Part 2: Exploratory Phase|Death|0
2673613|NCT00557856|9230121|P4|Part 2: Exploratory Phase|Death|0
2673614|NCT00557856|9230122|P3|Part 2: Exploratory Phase|Death|0
2673615|NCT00557856|9230123|P2|Part 2: Exploratory Phase|Death|0
2673616|NCT00557856|9230124|P1|Part 2: Exploratory Phase|Death|0
2673617|NCT00557856|9230116|P9|Part 2: Exploratory Phase|Other|1
2673618|NCT00557856|9230117|P8|Part 2: Exploratory Phase|Other|0
2673619|NCT00557856|9230118|P7|Part 2: Exploratory Phase|Other|0
2673620|NCT00557856|9230119|P6|Part 2: Exploratory Phase|Other|0
2673621|NCT00557856|9230120|P5|Part 2: Exploratory Phase|Other|0
2673622|NCT00557856|9230121|P4|Part 2: Exploratory Phase|Other|0
2673623|NCT00557856|9230122|P3|Part 2: Exploratory Phase|Other|0
2673624|NCT00557856|9230123|P2|Part 2: Exploratory Phase|Other|0
2673625|NCT00557856|9230124|P1|Part 2: Exploratory Phase|Other|0
2673626|NCT00557856|9230116|P9|Part 2: Exploratory Phase|Adverse Event|4
2673627|NCT00557856|9230117|P8|Part 2: Exploratory Phase|Adverse Event|0
2673628|NCT00557856|9230118|P7|Part 2: Exploratory Phase|Adverse Event|0
2673629|NCT00557856|9230119|P6|Part 2: Exploratory Phase|Adverse Event|0
2673630|NCT00557856|9230120|P5|Part 2: Exploratory Phase|Adverse Event|0
2673631|NCT00557856|9230121|P4|Part 2: Exploratory Phase|Adverse Event|0
2673632|NCT00557856|9230122|P3|Part 2: Exploratory Phase|Adverse Event|0
2673633|NCT00557856|9230123|P2|Part 2: Exploratory Phase|Adverse Event|0
2673634|NCT00557856|9230124|P1|Part 2: Exploratory Phase|Adverse Event|0
2673635|NCT00557856|9230116|P9|Part 2: Exploratory Phase|Withdrawal by Subject|1
2673636|NCT00557856|9230117|P8|Part 2: Exploratory Phase|Withdrawal by Subject|0
2673637|NCT00557856|9230118|P7|Part 2: Exploratory Phase|Withdrawal by Subject|0
2673638|NCT00557856|9230119|P6|Part 2: Exploratory Phase|Withdrawal by Subject|0
2673639|NCT00557856|9230120|P5|Part 2: Exploratory Phase|Withdrawal by Subject|0
2673640|NCT00557856|9230121|P4|Part 2: Exploratory Phase|Withdrawal by Subject|0
2673641|NCT00557856|9230122|P3|Part 2: Exploratory Phase|Withdrawal by Subject|0
2673642|NCT00557856|9230123|P2|Part 2: Exploratory Phase|Withdrawal by Subject|0
2673643|NCT00557856|9230124|P1|Part 2: Exploratory Phase|Withdrawal by Subject|0
2673644|NCT00557856|9230116|P9|Part 2: Exploratory Phase|objective progression or relapse|15
2673645|NCT00557856|9230117|P8|Part 2: Exploratory Phase|objective progression or relapse|0
2673646|NCT00557856|9230118|P7|Part 2: Exploratory Phase|objective progression or relapse|0
2673647|NCT00557856|9230119|P6|Part 2: Exploratory Phase|objective progression or relapse|0
2673648|NCT00557856|9230120|P5|Part 2: Exploratory Phase|objective progression or relapse|0
2673649|NCT00557856|9230121|P4|Part 2: Exploratory Phase|objective progression or relapse|0
2673650|NCT00557856|9230122|P3|Part 2: Exploratory Phase|objective progression or relapse|0
2673651|NCT00557856|9230123|P2|Part 2: Exploratory Phase|objective progression or relapse|0
2673652|NCT00557856|9230124|P1|Part 2: Exploratory Phase|objective progression or relapse|0
2673653|NCT00557856|9230116|P9|Part 1: Dose Escalation Phase|randomized but not treated|0
2673654|NCT00557856|9230117|P8|Part 1: Dose Escalation Phase|randomized but not treated|0
2673655|NCT00557856|9230118|P7|Part 1: Dose Escalation Phase|randomized but not treated|0
2673656|NCT00557856|9230119|P6|Part 1: Dose Escalation Phase|randomized but not treated|0
2673657|NCT00557856|9230120|P5|Part 1: Dose Escalation Phase|randomized but not treated|0
2673658|NCT00557856|9230121|P4|Part 1: Dose Escalation Phase|randomized but not treated|0
2673659|NCT00557856|9230122|P3|Part 1: Dose Escalation Phase|randomized but not treated|0
2673660|NCT00557856|9230123|P2|Part 1: Dose Escalation Phase|randomized but not treated|0
2673661|NCT00557856|9230124|P1|Part 1: Dose Escalation Phase|randomized but not treated|2
2673662|NCT00557856|9230116|P9|Part 1: Dose Escalation Phase|global deterioration of health status|0
2673663|NCT00557856|9230117|P8|Part 1: Dose Escalation Phase|global deterioration of health status|0
2673664|NCT00557856|9230118|P7|Part 1: Dose Escalation Phase|global deterioration of health status|1
2673665|NCT00557856|9230119|P6|Part 1: Dose Escalation Phase|global deterioration of health status|2
2673666|NCT00557856|9230120|P5|Part 1: Dose Escalation Phase|global deterioration of health status|0
2673667|NCT00557856|9230121|P4|Part 1: Dose Escalation Phase|global deterioration of health status|0
2673668|NCT00557856|9230122|P3|Part 1: Dose Escalation Phase|global deterioration of health status|0
2673669|NCT00557856|9230123|P2|Part 1: Dose Escalation Phase|global deterioration of health status|0
2673670|NCT00557856|9230124|P1|Part 1: Dose Escalation Phase|global deterioration of health status|0
2673671|NCT00557856|9230116|P9|Part 1: Dose Escalation Phase|Death|0
2673672|NCT00557856|9230117|P8|Part 1: Dose Escalation Phase|Death|0
2673673|NCT00557856|9230118|P7|Part 1: Dose Escalation Phase|Death|0
2673674|NCT00557856|9230119|P6|Part 1: Dose Escalation Phase|Death|1
2673675|NCT00557856|9230120|P5|Part 1: Dose Escalation Phase|Death|0
2673676|NCT00557856|9230121|P4|Part 1: Dose Escalation Phase|Death|0
2673677|NCT00557856|9230122|P3|Part 1: Dose Escalation Phase|Death|0
2673678|NCT00557856|9230123|P2|Part 1: Dose Escalation Phase|Death|0
2673679|NCT00557856|9230124|P1|Part 1: Dose Escalation Phase|Death|0
2673680|NCT00557856|9230116|P9|Part 1: Dose Escalation Phase|Other|0
2673681|NCT00557856|9230117|P8|Part 1: Dose Escalation Phase|Other|1
2673682|NCT00557856|9230118|P7|Part 1: Dose Escalation Phase|Other|0
2673683|NCT00557856|9230119|P6|Part 1: Dose Escalation Phase|Other|0
2673684|NCT00557856|9230120|P5|Part 1: Dose Escalation Phase|Other|0
2673685|NCT00557856|9230121|P4|Part 1: Dose Escalation Phase|Other|1
2673686|NCT00557856|9230122|P3|Part 1: Dose Escalation Phase|Other|1
2673687|NCT00557856|9230123|P2|Part 1: Dose Escalation Phase|Other|0
2673688|NCT00557856|9230124|P1|Part 1: Dose Escalation Phase|Other|0
2673689|NCT00557856|9230116|P9|Part 1: Dose Escalation Phase|Adverse Event|0
2673690|NCT00557856|9230117|P8|Part 1: Dose Escalation Phase|Adverse Event|2
2673691|NCT00557856|9230118|P7|Part 1: Dose Escalation Phase|Adverse Event|1
2673692|NCT00557856|9230119|P6|Part 1: Dose Escalation Phase|Adverse Event|3
2673693|NCT00557856|9230120|P5|Part 1: Dose Escalation Phase|Adverse Event|1
2673694|NCT00557856|9230121|P4|Part 1: Dose Escalation Phase|Adverse Event|1
2673695|NCT00557856|9230122|P3|Part 1: Dose Escalation Phase|Adverse Event|1
2673696|NCT00557856|9230123|P2|Part 1: Dose Escalation Phase|Adverse Event|0
2673697|NCT00557856|9230124|P1|Part 1: Dose Escalation Phase|Adverse Event|1
2673698|NCT00557856|9230116|P9|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
2673699|NCT00557856|9230117|P8|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
2673700|NCT00557856|9230118|P7|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
2673701|NCT00557856|9230119|P6|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
2673702|NCT00557856|9230120|P5|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
2673703|NCT00557856|9230121|P4|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
2673704|NCT00557856|9230122|P3|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
2673705|NCT00557856|9230123|P2|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
2673706|NCT00557856|9230124|P1|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
2673707|NCT00557856|9230116|P9|Part 1: Dose Escalation Phase|objective progression or relapse|0
2673708|NCT00557856|9230117|P8|Part 1: Dose Escalation Phase|objective progression or relapse|3
2673709|NCT00557856|9230118|P7|Part 1: Dose Escalation Phase|objective progression or relapse|5
2673710|NCT00557856|9230119|P6|Part 1: Dose Escalation Phase|objective progression or relapse|2
2673711|NCT00557856|9230120|P5|Part 1: Dose Escalation Phase|objective progression or relapse|3
2673712|NCT00557856|9230121|P4|Part 1: Dose Escalation Phase|objective progression or relapse|1
2673713|NCT00557856|9230122|P3|Part 1: Dose Escalation Phase|objective progression or relapse|3
2673714|NCT00557856|9230123|P2|Part 1: Dose Escalation Phase|objective progression or relapse|5
2673715|NCT00557856|9230124|P1|Part 1: Dose Escalation Phase|objective progression or relapse|3
2673716|NCT00557830|9230323|P3|Screening Treatment Phase|Unable to tolerate standard dose|0
2673717|NCT00557830|9230324|P2|Screening Treatment Phase|Unable to tolerate standard dose|0
2673718|NCT00557830|9230325|P1|Screening Treatment Phase|Unable to tolerate standard dose|3
2673719|NCT00557830|9230323|P3|Screening Treatment Phase|Adverse Event|0
2673720|NCT00557830|9230324|P2|Screening Treatment Phase|Adverse Event|0
2673721|NCT00557830|9230325|P1|Screening Treatment Phase|Adverse Event|2
2673722|NCT00557830|9230323|P3|Screening Treatment Phase|Withdrawal by Subject|0
2673723|NCT00557830|9230324|P2|Screening Treatment Phase|Withdrawal by Subject|0
2673724|NCT00557830|9230325|P1|Screening Treatment Phase|Withdrawal by Subject|1
2673725|NCT00557622|9230347|P2|12-Week Treatment Phase|Lost to Follow-up|1
2673726|NCT00557622|9230348|P1|12-Week Treatment Phase|Lost to Follow-up|0
2673727|NCT00557622|9230347|P2|4-Week Run-in Phase|Protocol-defined stopping criteria|0
2673728|NCT00557622|9230348|P1|4-Week Run-in Phase|Protocol-defined stopping criteria|1
2673729|NCT00557622|9230347|P2|4-Week Run-in Phase|Withdrawal by Subject|0
2673730|NCT00557622|9230348|P1|4-Week Run-in Phase|Withdrawal by Subject|1
2673731|NCT00557505|9230377|P9|Overall Study|Withdrawal by Subject|1
2673732|NCT00557505|9230378|P8|Overall Study|Withdrawal by Subject|0
2673733|NCT00557505|9230379|P7|Overall Study|Withdrawal by Subject|0
2673734|NCT00557505|9230380|P6|Overall Study|Withdrawal by Subject|0
2673735|NCT00557505|9230381|P5|Overall Study|Withdrawal by Subject|0
2673736|NCT00557505|9230382|P4|Overall Study|Withdrawal by Subject|1
2673737|NCT00557505|9230383|P3|Overall Study|Withdrawal by Subject|0
2673738|NCT00557505|9230384|P2|Overall Study|Withdrawal by Subject|0
2673739|NCT00557505|9230385|P1|Overall Study|Withdrawal by Subject|0
2673740|NCT00557505|9230377|P9|Overall Study|Objective progression or relapse|15
2673741|NCT00557505|9230378|P8|Overall Study|Objective progression or relapse|5
2673742|NCT00557505|9230379|P7|Overall Study|Objective progression or relapse|2
2673743|NCT00557505|9230380|P6|Overall Study|Objective progression or relapse|3
2673744|NCT00557505|9230381|P5|Overall Study|Objective progression or relapse|2
2673745|NCT00557505|9230382|P4|Overall Study|Objective progression or relapse|2
2673746|NCT00557505|9230383|P3|Overall Study|Objective progression or relapse|3
2673747|NCT00557505|9230384|P2|Overall Study|Objective progression or relapse|3
2673748|NCT00557505|9230385|P1|Overall Study|Objective progression or relapse|2
2673749|NCT00557505|9230377|P9|Overall Study|Global deterioration of health|0
2673750|NCT00557505|9230378|P8|Overall Study|Global deterioration of health|0
2673751|NCT00557505|9230379|P7|Overall Study|Global deterioration of health|0
2673752|NCT00557505|9230380|P6|Overall Study|Global deterioration of health|0
2673753|NCT00557505|9230381|P5|Overall Study|Global deterioration of health|0
2673754|NCT00557505|9230382|P4|Overall Study|Global deterioration of health|0
2673755|NCT00557505|9230383|P3|Overall Study|Global deterioration of health|0
2673756|NCT00557505|9230384|P2|Overall Study|Global deterioration of health|0
2673757|NCT00557505|9230385|P1|Overall Study|Global deterioration of health|1
2673758|NCT00557505|9230377|P9|Overall Study|Adverse Event|0
2673759|NCT00557505|9230378|P8|Overall Study|Adverse Event|0
2673760|NCT00557505|9230379|P7|Overall Study|Adverse Event|1
2673761|NCT00557505|9230380|P6|Overall Study|Adverse Event|0
2673762|NCT00557505|9230381|P5|Overall Study|Adverse Event|0
2673763|NCT00557505|9230382|P4|Overall Study|Adverse Event|0
2673764|NCT00557505|9230383|P3|Overall Study|Adverse Event|1
2673765|NCT00557505|9230384|P2|Overall Study|Adverse Event|0
2673766|NCT00557505|9230385|P1|Overall Study|Adverse Event|0
2673767|NCT00557505|9230377|P9|Overall Study|Death|1
2673768|NCT00557505|9230378|P8|Overall Study|Death|0
2673769|NCT00557505|9230379|P7|Overall Study|Death|0
2673770|NCT00557505|9230380|P6|Overall Study|Death|0
2673771|NCT00557505|9230381|P5|Overall Study|Death|0
2673772|NCT00557505|9230382|P4|Overall Study|Death|0
2673773|NCT00557505|9230383|P3|Overall Study|Death|0
2673774|NCT00557505|9230384|P2|Overall Study|Death|0
2673775|NCT00557505|9230385|P1|Overall Study|Death|0
2673776|NCT00557492|9230549|P1|Overall Study|Change in health insurance|1
2673777|NCT00557466|9230567|P6|Overall Study|Lost to Follow-up|0
2673778|NCT00557466|9230568|P5|Overall Study|Lost to Follow-up|0
2673779|NCT00557466|9230569|P4|Overall Study|Lost to Follow-up|1
2673780|NCT00557466|9230570|P3|Overall Study|Lost to Follow-up|0
2673781|NCT00557466|9230571|P2|Overall Study|Lost to Follow-up|0
2673782|NCT00557466|9230572|P1|Overall Study|Lost to Follow-up|0
2673783|NCT00557466|9230567|P6|Overall Study|Abnormal test procedure results|0
2673784|NCT00557466|9230568|P5|Overall Study|Abnormal test procedure results|0
2673785|NCT00557466|9230569|P4|Overall Study|Abnormal test procedure results|0
2673786|NCT00557466|9230570|P3|Overall Study|Abnormal test procedure results|1
2673787|NCT00557466|9230571|P2|Overall Study|Abnormal test procedure results|0
2673788|NCT00557466|9230572|P1|Overall Study|Abnormal test procedure results|0
2673789|NCT00557466|9230567|P6|Overall Study|Administrative problems|0
2673790|NCT00557466|9230568|P5|Overall Study|Administrative problems|0
2673791|NCT00557466|9230569|P4|Overall Study|Administrative problems|0
2673792|NCT00557466|9230570|P3|Overall Study|Administrative problems|1
2673793|NCT00557466|9230571|P2|Overall Study|Administrative problems|1
2673794|NCT00557466|9230572|P1|Overall Study|Administrative problems|0
2673795|NCT00557466|9230567|P6|Overall Study|Subject withdrew consent|2
2673796|NCT00557466|9230568|P5|Overall Study|Subject withdrew consent|1
2673797|NCT00557466|9230569|P4|Overall Study|Subject withdrew consent|0
2673798|NCT00557466|9230570|P3|Overall Study|Subject withdrew consent|0
2673799|NCT00557466|9230571|P2|Overall Study|Subject withdrew consent|0
2673800|NCT00557466|9230572|P1|Overall Study|Subject withdrew consent|0
2673801|NCT00557466|9230567|P6|Overall Study|Protocol deviation|0
2673802|NCT00557466|9230568|P5|Overall Study|Protocol deviation|0
2673803|NCT00557466|9230569|P4|Overall Study|Protocol deviation|2
2673804|NCT00557466|9230570|P3|Overall Study|Protocol deviation|0
2673805|NCT00557466|9230571|P2|Overall Study|Protocol deviation|1
2673806|NCT00557466|9230572|P1|Overall Study|Protocol deviation|0
2673807|NCT00557466|9230567|P6|Overall Study|Abnormal laboratory value(s)|0
2673808|NCT00557466|9230568|P5|Overall Study|Abnormal laboratory value(s)|0
2673809|NCT00557466|9230569|P4|Overall Study|Abnormal laboratory value(s)|0
2673810|NCT00557466|9230570|P3|Overall Study|Abnormal laboratory value(s)|0
2673811|NCT00557466|9230571|P2|Overall Study|Abnormal laboratory value(s)|2
2673812|NCT00557466|9230572|P1|Overall Study|Abnormal laboratory value(s)|1
2673813|NCT00557466|9230567|P6|Overall Study|Adverse Event|4
2673814|NCT00557466|9230568|P5|Overall Study|Adverse Event|2
2673815|NCT00557466|9230569|P4|Overall Study|Adverse Event|1
2673816|NCT00557466|9230570|P3|Overall Study|Adverse Event|4
2673817|NCT00557466|9230571|P2|Overall Study|Adverse Event|1
2673818|NCT00557466|9230572|P1|Overall Study|Adverse Event|3
2673819|NCT00557440|9230625|P3|Treatment Period 1|Adverse Event|1
2673820|NCT00557440|9230626|P2|Treatment Period 1|Adverse Event|0
2673821|NCT00557440|9230627|P1|Treatment Period 1|Adverse Event|0
2673822|NCT00557323|9230681|P1|Overall Study|Administrative change|2
2673823|NCT00557323|9230681|P1|Overall Study|Withdrawal by Subject|2
2673824|NCT00557323|9230681|P1|Overall Study|Death|3
2673825|NCT00557310|9230686|P1|Extension Phase (18 - 24 Months)|Protocol Violation|1
2673826|NCT00557310|9230686|P1|Extension Phase (18 - 24 Months)|Physician Decision|2
2673827|NCT00557310|9230686|P1|Extension Phase (18 - 24 Months)|Lost to Follow-up|1
2673828|NCT00557310|9230686|P1|Extension Phase (18 - 24 Months)|Adverse Event|1
2673829|NCT00557310|9230686|P1|Main Study (0 - 18 Months)|Withdrawal by Subject|1
2673830|NCT00557310|9230686|P1|Main Study (0 - 18 Months)|Adverse Event|4
2673831|NCT00557245|9230732|P3|Overall Study|Ineligible|2
2673832|NCT00557245|9230733|P2|Overall Study|Ineligible|4
2673833|NCT00557245|9230734|P1|Overall Study|Ineligible|5
2673834|NCT00557245|9230732|P3|Overall Study|Lost to Follow-up|10
2673835|NCT00557245|9230733|P2|Overall Study|Lost to Follow-up|8
2673836|NCT00557245|9230734|P1|Overall Study|Lost to Follow-up|7
2673837|NCT00557193|9230772|P6|Post Induction Therapy by Tx Assignment|Induction Failure|5
2673838|NCT00557193|9230773|P5|Post Induction Therapy by Tx Assignment|Induction Failure|0
2673839|NCT00557193|9230774|P4|Post Induction Therapy by Tx Assignment|Induction Failure|0
2673840|NCT00557193|9230775|P3|Post Induction Therapy by Tx Assignment|Induction Failure|4
2673841|NCT00557193|9230776|P2|Post Induction Therapy by Tx Assignment|Induction Failure|0
2673842|NCT00557193|9230777|P1|Post Induction Therapy by Tx Assignment|Induction Failure|0
2673843|NCT00557193|9230772|P6|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
2673844|NCT00557193|9230773|P5|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
2673845|NCT00557193|9230774|P4|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
2673846|NCT00557193|9230775|P3|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2
2673847|NCT00557193|9230776|P2|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
2673848|NCT00557193|9230777|P1|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
2673849|NCT00557193|9230772|P6|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
2673850|NCT00557193|9230773|P5|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
2673851|NCT00557193|9230774|P4|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
2673852|NCT00557193|9230775|P3|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1
2673853|NCT00557193|9230776|P2|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
2673854|NCT00557193|9230777|P1|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
2673855|NCT00557193|9230772|P6|Post Induction Therapy by Tx Assignment|Relapse|20
2673856|NCT00557193|9230773|P5|Post Induction Therapy by Tx Assignment|Relapse|1
2673857|NCT00557193|9230774|P4|Post Induction Therapy by Tx Assignment|Relapse|3
2673858|NCT00557193|9230775|P3|Post Induction Therapy by Tx Assignment|Relapse|16
2673859|NCT00557193|9230776|P2|Post Induction Therapy by Tx Assignment|Relapse|5
2673860|NCT00557193|9230777|P1|Post Induction Therapy by Tx Assignment|Relapse|0
2673861|NCT00557193|9230772|P6|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5
2673862|NCT00557193|9230773|P5|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2
2673863|NCT00557193|9230774|P4|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2
2673864|NCT00557193|9230775|P3|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0
2673865|NCT00557193|9230776|P2|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1
2673866|NCT00557193|9230777|P1|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0
2673867|NCT00557193|9230772|P6|Post Induction Therapy by Tx Assignment|Physician Decision|2
2673868|NCT00557193|9230773|P5|Post Induction Therapy by Tx Assignment|Physician Decision|2
2673869|NCT00557193|9230774|P4|Post Induction Therapy by Tx Assignment|Physician Decision|1
2673870|NCT00557193|9230775|P3|Post Induction Therapy by Tx Assignment|Physician Decision|5
2673871|NCT00557193|9230776|P2|Post Induction Therapy by Tx Assignment|Physician Decision|3
2673872|NCT00557193|9230777|P1|Post Induction Therapy by Tx Assignment|Physician Decision|0
2673873|NCT00557193|9230772|P6|Post Induction Therapy by Tx Assignment|Death|2
2673874|NCT00557193|9230773|P5|Post Induction Therapy by Tx Assignment|Death|2
2673875|NCT00557193|9230774|P4|Post Induction Therapy by Tx Assignment|Death|0
2673876|NCT00557193|9230775|P3|Post Induction Therapy by Tx Assignment|Death|2
2673877|NCT00557193|9230776|P2|Post Induction Therapy by Tx Assignment|Death|0
2673878|NCT00557193|9230777|P1|Post Induction Therapy by Tx Assignment|Death|0
2673879|NCT00557193|9230772|P6|Post Induction Therapy by Tx Assignment|Adverse Event|3
2673880|NCT00557193|9230773|P5|Post Induction Therapy by Tx Assignment|Adverse Event|0
2673881|NCT00557193|9230774|P4|Post Induction Therapy by Tx Assignment|Adverse Event|1
2673882|NCT00557193|9230775|P3|Post Induction Therapy by Tx Assignment|Adverse Event|2
2673883|NCT00557193|9230776|P2|Post Induction Therapy by Tx Assignment|Adverse Event|1
2673884|NCT00557193|9230777|P1|Post Induction Therapy by Tx Assignment|Adverse Event|0
2673885|NCT00557193|9230772|P6|Induction|Unable to receive Lestaurtinib-Not in US|0
2673886|NCT00557193|9230773|P5|Induction|Unable to receive Lestaurtinib-Not in US|0
2673887|NCT00557193|9230774|P4|Induction|Unable to receive Lestaurtinib-Not in US|0
2673888|NCT00557193|9230775|P3|Induction|Unable to receive Lestaurtinib-Not in US|0
2673889|NCT00557193|9230776|P2|Induction|Unable to receive Lestaurtinib-Not in US|0
2673890|NCT00557193|9230777|P1|Induction|Unable to receive Lestaurtinib-Not in US|2
2673891|NCT00557193|9230772|P6|Induction|Inevaluable for post Induction|0
2673892|NCT00557193|9230773|P5|Induction|Inevaluable for post Induction|0
2673893|NCT00557193|9230774|P4|Induction|Inevaluable for post Induction|0
2673894|NCT00557193|9230775|P3|Induction|Inevaluable for post Induction|0
2673895|NCT00557193|9230776|P2|Induction|Inevaluable for post Induction|0
2673896|NCT00557193|9230777|P1|Induction|Inevaluable for post Induction|2
2673897|NCT00557193|9230772|P6|Induction|Ineligible|0
2673898|NCT00557193|9230773|P5|Induction|Ineligible|0
2673899|NCT00557193|9230774|P4|Induction|Ineligible|0
2673900|NCT00557193|9230775|P3|Induction|Ineligible|0
2673901|NCT00557193|9230776|P2|Induction|Ineligible|0
2673902|NCT00557193|9230777|P1|Induction|Ineligible|8
2673903|NCT00557193|9230772|P6|Induction|Refusal of Further Protocol Therapy|0
2673904|NCT00557193|9230773|P5|Induction|Refusal of Further Protocol Therapy|0
2673905|NCT00557193|9230774|P4|Induction|Refusal of Further Protocol Therapy|0
2673906|NCT00557193|9230775|P3|Induction|Refusal of Further Protocol Therapy|0
2673907|NCT00557193|9230776|P2|Induction|Refusal of Further Protocol Therapy|0
2673908|NCT00557193|9230777|P1|Induction|Refusal of Further Protocol Therapy|2
2673909|NCT00557193|9230772|P6|Induction|Withdrawal by Subject|0
2673910|NCT00557193|9230773|P5|Induction|Withdrawal by Subject|0
2673911|NCT00557193|9230774|P4|Induction|Withdrawal by Subject|0
2673912|NCT00557193|9230775|P3|Induction|Withdrawal by Subject|0
2673913|NCT00557193|9230776|P2|Induction|Withdrawal by Subject|0
2673914|NCT00557193|9230777|P1|Induction|Withdrawal by Subject|1
2673915|NCT00557193|9230772|P6|Induction|Physician Decision|0
2673916|NCT00557193|9230773|P5|Induction|Physician Decision|0
2673917|NCT00557193|9230774|P4|Induction|Physician Decision|0
2673918|NCT00557193|9230775|P3|Induction|Physician Decision|0
2673919|NCT00557193|9230776|P2|Induction|Physician Decision|0
2673920|NCT00557193|9230777|P1|Induction|Physician Decision|3
2673921|NCT00557193|9230772|P6|Induction|Death|0
2673922|NCT00557193|9230773|P5|Induction|Death|0
2673923|NCT00557193|9230774|P4|Induction|Death|0
2673924|NCT00557193|9230775|P3|Induction|Death|0
2673925|NCT00557193|9230776|P2|Induction|Death|0
2673926|NCT00557193|9230777|P1|Induction|Death|6
2673927|NCT00557193|9230772|P6|Induction|Adverse Event|0
2673928|NCT00557193|9230773|P5|Induction|Adverse Event|0
2673929|NCT00557193|9230774|P4|Induction|Adverse Event|0
2673930|NCT00557193|9230775|P3|Induction|Adverse Event|0
2673931|NCT00557193|9230776|P2|Induction|Adverse Event|0
2673932|NCT00557193|9230777|P1|Induction|Adverse Event|2
2673933|NCT00557076|9230817|P2|Overall Study|Unblinding|1
2673934|NCT00557076|9230818|P1|Overall Study|Unblinding|0
2673935|NCT00556998|9230826|P1|Voriconazole Oral|Intolerant of oral treatment|1
2673936|NCT00556998|9230826|P1|Voriconazole Oral|Adverse Event|1
2673937|NCT00556998|9230826|P1|Voriconazole Intravenous (IV)|Other|4
2673938|NCT00556998|9230826|P1|Voriconazole Intravenous (IV)|Adverse Event|1
2673939|NCT00556933|9230861|P4|CNI Withdrawal vs. Minimization|Death|1
2673940|NCT00556933|9230862|P3|CNI Withdrawal vs. Minimization|Death|0
2673941|NCT00556933|9230863|P2|CNI Withdrawal vs. Minimization|Death|0
2673942|NCT00556933|9230864|P1|CNI Withdrawal vs. Minimization|Death|0
2673943|NCT00556933|9230861|P4|CNI Withdrawal vs. Minimization|Graft loss|0
2673944|NCT00556933|9230862|P3|CNI Withdrawal vs. Minimization|Graft loss|2
2673945|NCT00556933|9230863|P2|CNI Withdrawal vs. Minimization|Graft loss|1
2673946|NCT00556933|9230864|P1|CNI Withdrawal vs. Minimization|Graft loss|0
2673947|NCT00556933|9230861|P4|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
2673948|NCT00556933|9230862|P3|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
2673949|NCT00556933|9230863|P2|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
2673950|NCT00556933|9230864|P1|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
2673951|NCT00556933|9230861|P4|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
2673952|NCT00556933|9230862|P3|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
2673953|NCT00556933|9230863|P2|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
2673954|NCT00556933|9230864|P1|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
2673955|NCT00556933|9230861|P4|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
2673956|NCT00556933|9230862|P3|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
2673957|NCT00556933|9230863|P2|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
2673958|NCT00556933|9230864|P1|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
2673959|NCT00556933|9230861|P4|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
2673960|NCT00556933|9230862|P3|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
2673961|NCT00556933|9230863|P2|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1
2673962|NCT00556933|9230864|P1|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
2673963|NCT00556933|9230861|P4|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
2673964|NCT00556933|9230862|P3|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
2673965|NCT00556933|9230863|P2|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1
2673966|NCT00556933|9230864|P1|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
2673967|NCT00556933|9230861|P4|Single vs. Divided-dose rATG Induction|Death|0
2673968|NCT00556933|9230862|P3|Single vs. Divided-dose rATG Induction|Death|0
2673969|NCT00556933|9230863|P2|Single vs. Divided-dose rATG Induction|Death|1
2673970|NCT00556933|9230864|P1|Single vs. Divided-dose rATG Induction|Death|0
2673971|NCT00556933|9230861|P4|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
2673972|NCT00556933|9230862|P3|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
2673973|NCT00556933|9230863|P2|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
2673974|NCT00556933|9230864|P1|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0
2673975|NCT00556933|9230861|P4|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
2673976|NCT00556933|9230862|P3|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1
2673977|NCT00556933|9230863|P2|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
2673978|NCT00556933|9230864|P1|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
2673979|NCT00556933|9230861|P4|Single vs. Divided-dose rATG Induction|Protocol Violation|0
2673980|NCT00556933|9230862|P3|Single vs. Divided-dose rATG Induction|Protocol Violation|3
2673981|NCT00556933|9230863|P2|Single vs. Divided-dose rATG Induction|Protocol Violation|3
2673982|NCT00556933|9230864|P1|Single vs. Divided-dose rATG Induction|Protocol Violation|2
2673983|NCT00556894|9230921|P3|Overall Study|Withdrawal by Subject|1
2673984|NCT00556894|9230922|P2|Overall Study|Withdrawal by Subject|1
2673985|NCT00556894|9230923|P1|Overall Study|Withdrawal by Subject|1
2673986|NCT00556894|9230921|P3|Overall Study|Change in therapy|2
2673987|NCT00556894|9230922|P2|Overall Study|Change in therapy|1
2673988|NCT00556894|9230923|P1|Overall Study|Change in therapy|2
2673989|NCT00556894|9230921|P3|Overall Study|regulatory decision in Bulgaria|13
2673990|NCT00556894|9230922|P2|Overall Study|regulatory decision in Bulgaria|14
2673991|NCT00556894|9230923|P1|Overall Study|regulatory decision in Bulgaria|10
2673992|NCT00556894|9230921|P3|Overall Study|Death|0
2673993|NCT00556894|9230922|P2|Overall Study|Death|0
2673994|NCT00556894|9230923|P1|Overall Study|Death|1
2673995|NCT00556894|9230921|P3|Overall Study|Adverse Event|3
2673996|NCT00556894|9230922|P2|Overall Study|Adverse Event|3
2673997|NCT00556894|9230923|P1|Overall Study|Adverse Event|2
2673998|NCT00556712|9230933|P2|Overall Study|Ongoing at Data Cutoff|66
2673999|NCT00556712|9230934|P1|Overall Study|Ongoing at Data Cutoff|32
2674000|NCT00556712|9230933|P2|Overall Study|Other|2
2674001|NCT00556712|9230934|P1|Overall Study|Other|2
2674002|NCT00556712|9230933|P2|Overall Study|Failure to Return|3
2674003|NCT00556712|9230934|P1|Overall Study|Failure to Return|2
2674004|NCT00556712|9230933|P2|Overall Study|Refused Treatment|16
2674005|NCT00556712|9230934|P1|Overall Study|Refused Treatment|17
2674006|NCT00556712|9230933|P2|Overall Study|Protocol Violation|2
2674007|NCT00556712|9230934|P1|Overall Study|Protocol Violation|3
2674008|NCT00556712|9230933|P2|Overall Study|Progressive Disease|320
2674009|NCT00556712|9230934|P1|Overall Study|Progressive Disease|383
2674010|NCT00556712|9230933|P2|Overall Study|Death|10
2674011|NCT00556712|9230934|P1|Overall Study|Death|5
2674012|NCT00556712|9230933|P2|Overall Study|Adverse Event|19
2674013|NCT00556712|9230934|P1|Overall Study|Adverse Event|7
2674014|NCT00556673|9231012|P2|Overall Study|Protocol deviation|2
2674015|NCT00556673|9231013|P1|Overall Study|Protocol deviation|3
2674016|NCT00556439|9231149|P4|After Week 12 (Randomized Study Period)|Severe infection|0
2674017|NCT00556439|9231150|P3|After Week 12 (Randomized Study Period)|Severe infection|0
2674018|NCT00556439|9231151|P2|After Week 12 (Randomized Study Period)|Severe infection|0
2674019|NCT00556439|9231152|P1|After Week 12 (Randomized Study Period)|Severe infection|1
2674020|NCT00556439|9231149|P4|After Week 12 (Randomized Study Period)|Malignancy|1
2674021|NCT00556439|9231150|P3|After Week 12 (Randomized Study Period)|Malignancy|0
2674022|NCT00556439|9231151|P2|After Week 12 (Randomized Study Period)|Malignancy|1
2674023|NCT00556439|9231152|P1|After Week 12 (Randomized Study Period)|Malignancy|0
2674024|NCT00556439|9231149|P4|After Week 12 (Randomized Study Period)|Physician Decision|0
2674025|NCT00556439|9231150|P3|After Week 12 (Randomized Study Period)|Physician Decision|0
2674026|NCT00556439|9231151|P2|After Week 12 (Randomized Study Period)|Physician Decision|0
2674027|NCT00556439|9231152|P1|After Week 12 (Randomized Study Period)|Physician Decision|1
2674028|NCT00556439|9231149|P4|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
2674029|NCT00556439|9231150|P3|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
2674030|NCT00556439|9231151|P2|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3
2674031|NCT00556439|9231152|P1|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1
2674032|NCT00556439|9231149|P4|Study Entry to Week 12|Malignancy|0
2674033|NCT00556439|9231150|P3|Study Entry to Week 12|Malignancy|1
2674034|NCT00556439|9231151|P2|Study Entry to Week 12|Malignancy|0
2674035|NCT00556439|9231152|P1|Study Entry to Week 12|Malignancy|0
2674036|NCT00556439|9231149|P4|Study Entry to Week 12|Recurrent infection|0
2674037|NCT00556439|9231150|P3|Study Entry to Week 12|Recurrent infection|0
2674038|NCT00556439|9231151|P2|Study Entry to Week 12|Recurrent infection|0
2674039|NCT00556439|9231152|P1|Study Entry to Week 12|Recurrent infection|1
2674040|NCT00556439|9231149|P4|Study Entry to Week 12|Withdrawal by Subject|0
2674041|NCT00556439|9231150|P3|Study Entry to Week 12|Withdrawal by Subject|1
2674042|NCT00556439|9231151|P2|Study Entry to Week 12|Withdrawal by Subject|0
2674043|NCT00556439|9231152|P1|Study Entry to Week 12|Withdrawal by Subject|1
2674044|NCT00556439|9231149|P4|Study Entry to Week 12|Physician Decision|0
2674045|NCT00556439|9231150|P3|Study Entry to Week 12|Physician Decision|0
2674046|NCT00556439|9231151|P2|Study Entry to Week 12|Physician Decision|0
2674047|NCT00556439|9231152|P1|Study Entry to Week 12|Physician Decision|1
2674048|NCT00556439|9231149|P4|Study Entry to Week 12|Lack of Efficacy|0
2674049|NCT00556439|9231150|P3|Study Entry to Week 12|Lack of Efficacy|6
2674050|NCT00556439|9231151|P2|Study Entry to Week 12|Lack of Efficacy|0
2674051|NCT00556439|9231152|P1|Study Entry to Week 12|Lack of Efficacy|5
2674052|NCT00556426|9231162|P1|Overall Study|Death|6
2674053|NCT00556426|9231162|P1|Overall Study|Withdrawal by Subject|3
2674054|NCT00556374|9231184|P2|Overall Study|Lost to Follow-up|5
2674055|NCT00556374|9231185|P1|Overall Study|Lost to Follow-up|7
2674056|NCT00556374|9231184|P2|Overall Study|Death|43
2674057|NCT00556374|9231185|P1|Overall Study|Death|50
2674058|NCT00556374|9231184|P2|Overall Study|Withdrawal by Subject|172
2674059|NCT00556374|9231185|P1|Overall Study|Withdrawal by Subject|190
2674060|NCT00556322|9231205|P2|Overall Study|Death|14
2674061|NCT00556322|9231206|P1|Overall Study|Death|20
2674062|NCT00556322|9231205|P2|Overall Study|Ongoing at data cutoff|5
2674063|NCT00556322|9231206|P1|Overall Study|Ongoing at data cutoff|3
2674064|NCT00556322|9231205|P2|Overall Study|Protocol Violation|1
2674065|NCT00556322|9231206|P1|Overall Study|Protocol Violation|5
2674066|NCT00556322|9231205|P2|Overall Study|Withdrawal by Subject|7
2674067|NCT00556322|9231206|P1|Overall Study|Withdrawal by Subject|19
2674068|NCT00556322|9231205|P2|Overall Study|Lost to Follow-up|3
2674069|NCT00556322|9231206|P1|Overall Study|Lost to Follow-up|5
2674070|NCT00556322|9231205|P2|Overall Study|Other|1
2674071|NCT00556322|9231206|P1|Overall Study|Other|4
2674072|NCT00556322|9231205|P2|Overall Study|Adverse Event|4
2674073|NCT00556322|9231206|P1|Overall Study|Adverse Event|7
2674074|NCT00556322|9231205|P2|Overall Study|Insufficient therapeutic response|168
2674075|NCT00556322|9231206|P1|Overall Study|Insufficient therapeutic response|158
2674076|NCT00556166|9231254|P1|Overall Study|Withdrawal by Subject|1
2674077|NCT00556075|9231267|P3|Overall Study|Endometrial stripe not viewed on 2 tvu|0
2674078|NCT00556075|9231268|P2|Overall Study|Endometrial stripe not viewed on 2 tvu|1
2674079|NCT00556075|9231269|P1|Overall Study|Endometrial stripe not viewed on 2 tvu|0
2674080|NCT00556075|9231267|P3|Overall Study|Personal issues|0
2674081|NCT00556075|9231268|P2|Overall Study|Personal issues|1
2674082|NCT00556075|9231269|P1|Overall Study|Personal issues|4
2674083|NCT00556075|9231267|P3|Overall Study|Adverse Event|0
2674084|NCT00556075|9231268|P2|Overall Study|Adverse Event|2
2674085|NCT00556075|9231269|P1|Overall Study|Adverse Event|1
2674086|NCT00556075|9231267|P3|Overall Study|Not eligible|2
2674087|NCT00556075|9231268|P2|Overall Study|Not eligible|1
2674088|NCT00556075|9231269|P1|Overall Study|Not eligible|1
2674089|NCT00556075|9231267|P3|Overall Study|Protocol Violation|3
2674090|NCT00556075|9231268|P2|Overall Study|Protocol Violation|1
2674091|NCT00556075|9231269|P1|Overall Study|Protocol Violation|1
2674092|NCT00556075|9231267|P3|Overall Study|Withdrawal by Subject|0
2674093|NCT00556075|9231268|P2|Overall Study|Withdrawal by Subject|3
2674094|NCT00556075|9231269|P1|Overall Study|Withdrawal by Subject|3
2674095|NCT00556075|9231267|P3|Overall Study|Lost to Follow-up|3
2674096|NCT00556075|9231268|P2|Overall Study|Lost to Follow-up|0
2674097|NCT00556075|9231269|P1|Overall Study|Lost to Follow-up|3
2674098|NCT00555971|9231320|P2|Overall Study|Adverse Event|1
2674099|NCT00555971|9231321|P1|Overall Study|Adverse Event|1
2674100|NCT00555906|9231332|P5|Phase 2|Randomized but not Treated|2
2674101|NCT00555906|9231333|P4|Phase 2|Randomized but not Treated|0
2674102|NCT00555906|9231334|P3|Phase 2|Randomized but not Treated|0
2674103|NCT00555906|9231335|P2|Phase 2|Randomized but not Treated|0
2674104|NCT00555906|9231336|P1|Phase 2|Randomized but not Treated|0
2674105|NCT00555906|9231332|P5|Phase 2|Other|6
2674106|NCT00555906|9231333|P4|Phase 2|Other|0
2674107|NCT00555906|9231334|P3|Phase 2|Other|0
2674108|NCT00555906|9231335|P2|Phase 2|Other|0
2674109|NCT00555906|9231336|P1|Phase 2|Other|0
2674110|NCT00555906|9231332|P5|Phase 2|Withdrawal by Subject|2
2674111|NCT00555906|9231333|P4|Phase 2|Withdrawal by Subject|0
2674112|NCT00555906|9231334|P3|Phase 2|Withdrawal by Subject|0
2674113|NCT00555906|9231335|P2|Phase 2|Withdrawal by Subject|0
2674114|NCT00555906|9231336|P1|Phase 2|Withdrawal by Subject|0
2674115|NCT00555906|9231332|P5|Phase 2|Objective Progression or Relapse|16
2674116|NCT00555906|9231333|P4|Phase 2|Objective Progression or Relapse|0
2674117|NCT00555906|9231334|P3|Phase 2|Objective Progression or Relapse|0
2674118|NCT00555906|9231335|P2|Phase 2|Objective Progression or Relapse|0
2674119|NCT00555906|9231336|P1|Phase 2|Objective Progression or Relapse|0
2674120|NCT00555906|9231332|P5|Phase 2|Global Deterioration of Health Status|2
2674121|NCT00555906|9231333|P4|Phase 2|Global Deterioration of Health Status|0
2674122|NCT00555906|9231334|P3|Phase 2|Global Deterioration of Health Status|0
2674123|NCT00555906|9231335|P2|Phase 2|Global Deterioration of Health Status|0
2674124|NCT00555906|9231336|P1|Phase 2|Global Deterioration of Health Status|0
2674125|NCT00555906|9231332|P5|Phase 2|Adverse Event|4
2674126|NCT00555906|9231333|P4|Phase 2|Adverse Event|0
2674127|NCT00555906|9231334|P3|Phase 2|Adverse Event|0
2674128|NCT00555906|9231335|P2|Phase 2|Adverse Event|0
2674129|NCT00555906|9231336|P1|Phase 2|Adverse Event|0
2674130|NCT00555906|9231332|P5|Phase 1|Withdrawal by Subject|0
2674131|NCT00555906|9231333|P4|Phase 1|Withdrawal by Subject|1
2674132|NCT00555906|9231334|P3|Phase 1|Withdrawal by Subject|0
2674133|NCT00555906|9231335|P2|Phase 1|Withdrawal by Subject|0
2674134|NCT00555906|9231336|P1|Phase 1|Withdrawal by Subject|0
2674135|NCT00555906|9231332|P5|Phase 1|Adverse Event|0
2674136|NCT00555906|9231333|P4|Phase 1|Adverse Event|2
2674137|NCT00555906|9231334|P3|Phase 1|Adverse Event|3
2674138|NCT00555906|9231335|P2|Phase 1|Adverse Event|0
2674139|NCT00555906|9231336|P1|Phase 1|Adverse Event|0
2674140|NCT00555906|9231332|P5|Phase 1|Global Deterioration of Health Status|0
2674141|NCT00555906|9231333|P4|Phase 1|Global Deterioration of Health Status|1
2674142|NCT00555906|9231334|P3|Phase 1|Global Deterioration of Health Status|1
2674143|NCT00555906|9231335|P2|Phase 1|Global Deterioration of Health Status|1
2674144|NCT00555906|9231336|P1|Phase 1|Global Deterioration of Health Status|0
2674145|NCT00555906|9231332|P5|Phase 1|Objective Progression or Relapse|0
2674146|NCT00555906|9231333|P4|Phase 1|Objective Progression or Relapse|1
2674147|NCT00555906|9231334|P3|Phase 1|Objective Progression or Relapse|3
2674148|NCT00555906|9231335|P2|Phase 1|Objective Progression or Relapse|5
2674149|NCT00555906|9231336|P1|Phase 1|Objective Progression or Relapse|3
2674150|NCT00555672|9231458|P2|Overall Study|Participant refused|0
2674151|NCT00555672|9231459|P1|Overall Study|Participant refused|2
2674152|NCT00555672|9231458|P2|Overall Study|Other|1
2674153|NCT00555672|9231459|P1|Overall Study|Other|3
2674154|NCT00555672|9231458|P2|Overall Study|Objective progression or relapse|5
2674155|NCT00555672|9231459|P1|Overall Study|Objective progression or relapse|11
2674156|NCT00555672|9231458|P2|Overall Study|Adverse Event|2
2674157|NCT00555672|9231459|P1|Overall Study|Adverse Event|8
2674158|NCT00555672|9231458|P2|Overall Study|Death|2
2674159|NCT00555672|9231459|P1|Overall Study|Death|0
2674160|NCT00555620|9231484|P6|Overall Study|Other|3
2674161|NCT00555620|9231485|P5|Overall Study|Other|0
2674162|NCT00555620|9231486|P4|Overall Study|Other|1
2674163|NCT00555620|9231487|P3|Overall Study|Other|0
2674164|NCT00555620|9231488|P2|Overall Study|Other|0
2674165|NCT00555620|9231489|P1|Overall Study|Other|0
2674166|NCT00555620|9231484|P6|Overall Study|Participant refused treatment|1
2674167|NCT00555620|9231485|P5|Overall Study|Participant refused treatment|0
2674168|NCT00555620|9231486|P4|Overall Study|Participant refused treatment|0
2674169|NCT00555620|9231487|P3|Overall Study|Participant refused treatment|1
2674170|NCT00555620|9231488|P2|Overall Study|Participant refused treatment|1
2674171|NCT00555620|9231489|P1|Overall Study|Participant refused treatment|0
2674172|NCT00555620|9231484|P6|Overall Study|Objective progression or relapse|16
2674173|NCT00555620|9231485|P5|Overall Study|Objective progression or relapse|3
2674174|NCT00555620|9231486|P4|Overall Study|Objective progression or relapse|17
2674175|NCT00555620|9231487|P3|Overall Study|Objective progression or relapse|12
2674176|NCT00555620|9231488|P2|Overall Study|Objective progression or relapse|5
2674177|NCT00555620|9231489|P1|Overall Study|Objective progression or relapse|6
2674178|NCT00555620|9231484|P6|Overall Study|Adverse Event|1
2674179|NCT00555620|9231485|P5|Overall Study|Adverse Event|0
2674180|NCT00555620|9231486|P4|Overall Study|Adverse Event|5
2674181|NCT00555620|9231487|P3|Overall Study|Adverse Event|1
2674182|NCT00555620|9231488|P2|Overall Study|Adverse Event|0
2674183|NCT00555620|9231489|P1|Overall Study|Adverse Event|0
2674184|NCT00555620|9231484|P6|Overall Study|Study terminated by sponsor|0
2674185|NCT00555620|9231485|P5|Overall Study|Study terminated by sponsor|0
2674186|NCT00555620|9231486|P4|Overall Study|Study terminated by sponsor|0
2674187|NCT00555620|9231487|P3|Overall Study|Study terminated by sponsor|1
2674188|NCT00555620|9231488|P2|Overall Study|Study terminated by sponsor|0
2674189|NCT00555620|9231489|P1|Overall Study|Study terminated by sponsor|0
2674190|NCT00555620|9231484|P6|Overall Study|Death|1
2674191|NCT00555620|9231485|P5|Overall Study|Death|0
2674192|NCT00555620|9231486|P4|Overall Study|Death|0
2674193|NCT00555620|9231487|P3|Overall Study|Death|0
2674194|NCT00555620|9231488|P2|Overall Study|Death|1
2674195|NCT00555620|9231489|P1|Overall Study|Death|0
2674196|NCT00555568|9231613|P3|Overall Study|Lost to Follow-up|16
2674197|NCT00555568|9231614|P2|Overall Study|Lost to Follow-up|16
2674198|NCT00555568|9231615|P1|Overall Study|Lost to Follow-up|26
2674199|NCT00555477|9231637|P2|Overall Study|Physician Decision|2
2674200|NCT00555477|9231638|P1|Overall Study|Physician Decision|1
2674201|NCT00555477|9231637|P2|Overall Study|Withdrawal by Subject|2
2674202|NCT00555477|9231638|P1|Overall Study|Withdrawal by Subject|1
2674203|NCT00555477|9231637|P2|Overall Study|Adverse Event|9
2674204|NCT00555477|9231638|P1|Overall Study|Adverse Event|0
2674205|NCT00555438|9231654|P1|Between 10 Days and 30 Days Postoperativ|Death|5
2674206|NCT00555438|9231654|P1|10 Days Post-operative|Death|4
2674207|NCT00555425|9231664|P2|Overall Study|Became pregnant and transferred care|1
2674208|NCT00555425|9231665|P1|Overall Study|Became pregnant and transferred care|0
2674209|NCT00555425|9231664|P2|Overall Study|Met criteria for protective transfer|3
2674210|NCT00555425|9231665|P1|Overall Study|Met criteria for protective transfer|16
2674211|NCT00555425|9231664|P2|Overall Study|Missed 3 physician management visits|0
2674212|NCT00555425|9231665|P1|Overall Study|Missed 3 physician management visits|1
2674213|NCT00555425|9231664|P2|Overall Study|Missed Medication > 1 wk|15
2674214|NCT00555425|9231665|P1|Overall Study|Missed Medication > 1 wk|34
2674215|NCT00555321|9231701|P5|Long-term Extension Phase|Other Reason|0
2674216|NCT00555321|9231702|P4|Long-term Extension Phase|Other Reason|0
2674217|NCT00555321|9231703|P3|Long-term Extension Phase|Other Reason|2
2674218|NCT00555321|9231704|P2|Long-term Extension Phase|Other Reason|0
2674219|NCT00555321|9231705|P1|Long-term Extension Phase|Other Reason|1
2674220|NCT00555321|9231701|P5|Long-term Extension Phase|Participant did not meet study criteria|1
2674221|NCT00555321|9231702|P4|Long-term Extension Phase|Participant did not meet study criteria|0
2674222|NCT00555321|9231703|P3|Long-term Extension Phase|Participant did not meet study criteria|0
2674223|NCT00555321|9231704|P2|Long-term Extension Phase|Participant did not meet study criteria|0
2674224|NCT00555321|9231705|P1|Long-term Extension Phase|Participant did not meet study criteria|0
2674225|NCT00555321|9231701|P5|Long-term Extension Phase|Death|0
2674226|NCT00555321|9231702|P4|Long-term Extension Phase|Death|3
2674227|NCT00555321|9231703|P3|Long-term Extension Phase|Death|0
2674228|NCT00555321|9231704|P2|Long-term Extension Phase|Death|0
2674229|NCT00555321|9231705|P1|Long-term Extension Phase|Death|2
2674230|NCT00555321|9231701|P5|Long-term Extension Phase|Administrative reason by sponsor|23
2674231|NCT00555321|9231702|P4|Long-term Extension Phase|Administrative reason by sponsor|31
2674232|NCT00555321|9231703|P3|Long-term Extension Phase|Administrative reason by sponsor|18
2674233|NCT00555321|9231704|P2|Long-term Extension Phase|Administrative reason by sponsor|21
2674234|NCT00555321|9231705|P1|Long-term Extension Phase|Administrative reason by sponsor|23
2674235|NCT00555321|9231701|P5|Long-term Extension Phase|Withdrawal by Subject|2
2674236|NCT00555321|9231702|P4|Long-term Extension Phase|Withdrawal by Subject|3
2674237|NCT00555321|9231703|P3|Long-term Extension Phase|Withdrawal by Subject|2
2674238|NCT00555321|9231704|P2|Long-term Extension Phase|Withdrawal by Subject|1
2674239|NCT00555321|9231705|P1|Long-term Extension Phase|Withdrawal by Subject|2
2674240|NCT00555321|9231701|P5|Long-term Extension Phase|Adverse Event|0
2674241|NCT00555321|9231702|P4|Long-term Extension Phase|Adverse Event|1
2674242|NCT00555321|9231703|P3|Long-term Extension Phase|Adverse Event|2
2674243|NCT00555321|9231704|P2|Long-term Extension Phase|Adverse Event|5
2674244|NCT00555321|9231705|P1|Long-term Extension Phase|Adverse Event|2
2674245|NCT00555321|9231701|P5|Treatment Phase up to 12-months|Never treated|4
2674246|NCT00555321|9231702|P4|Treatment Phase up to 12-months|Never treated|0
2674247|NCT00555321|9231703|P3|Treatment Phase up to 12-months|Never treated|1
2674248|NCT00555321|9231704|P2|Treatment Phase up to 12-months|Never treated|3
2674249|NCT00555321|9231705|P1|Treatment Phase up to 12-months|Never treated|2
2674250|NCT00555321|9231701|P5|Treatment Phase up to 12-months|Other Reason|0
2674251|NCT00555321|9231702|P4|Treatment Phase up to 12-months|Other Reason|0
2674252|NCT00555321|9231703|P3|Treatment Phase up to 12-months|Other Reason|2
2674253|NCT00555321|9231704|P2|Treatment Phase up to 12-months|Other Reason|3
2674254|NCT00555321|9231705|P1|Treatment Phase up to 12-months|Other Reason|1
2674255|NCT00555321|9231701|P5|Treatment Phase up to 12-months|Lack of Efficacy|0
2674256|NCT00555321|9231702|P4|Treatment Phase up to 12-months|Lack of Efficacy|0
2674257|NCT00555321|9231703|P3|Treatment Phase up to 12-months|Lack of Efficacy|5
2674258|NCT00555321|9231704|P2|Treatment Phase up to 12-months|Lack of Efficacy|8
2674259|NCT00555321|9231705|P1|Treatment Phase up to 12-months|Lack of Efficacy|9
2674260|NCT00555321|9231701|P5|Treatment Phase up to 12-months|Death|0
2674261|NCT00555321|9231702|P4|Treatment Phase up to 12-months|Death|0
2674262|NCT00555321|9231703|P3|Treatment Phase up to 12-months|Death|4
2674263|NCT00555321|9231704|P2|Treatment Phase up to 12-months|Death|1
2674264|NCT00555321|9231705|P1|Treatment Phase up to 12-months|Death|2
2674265|NCT00555321|9231701|P5|Treatment Phase up to 12-months|Withdrawal by Subject|0
2674266|NCT00555321|9231702|P4|Treatment Phase up to 12-months|Withdrawal by Subject|0
2674267|NCT00555321|9231703|P3|Treatment Phase up to 12-months|Withdrawal by Subject|1
2674268|NCT00555321|9231704|P2|Treatment Phase up to 12-months|Withdrawal by Subject|0
2674269|NCT00555321|9231705|P1|Treatment Phase up to 12-months|Withdrawal by Subject|1
2674270|NCT00555321|9231701|P5|Treatment Phase up to 12-months|Adverse Event|18
2674271|NCT00555321|9231702|P4|Treatment Phase up to 12-months|Adverse Event|7
2674272|NCT00555321|9231703|P3|Treatment Phase up to 12-months|Adverse Event|11
2674273|NCT00555321|9231704|P2|Treatment Phase up to 12-months|Adverse Event|7
2674274|NCT00555321|9231705|P1|Treatment Phase up to 12-months|Adverse Event|6
2674275|NCT00555217|9232009|P2|Overall Study|close out sites|17
2674276|NCT00555217|9232010|P1|Overall Study|close out sites|21
2674277|NCT00555217|9232009|P2|Overall Study|Lost to Follow-up|20
2674278|NCT00555217|9232010|P1|Overall Study|Lost to Follow-up|19
2674279|NCT00555217|9232009|P2|Overall Study|Withdrawal by Subject|31
2674280|NCT00555217|9232010|P1|Overall Study|Withdrawal by Subject|35
2674281|NCT00555061|9232047|P1|Overall Study|Participant enrolled, but never treated|1
2674282|NCT00555061|9232047|P1|Overall Study|Withdrawal by Subject|2
2674283|NCT00555061|9232047|P1|Overall Study|Lost to Follow-up|2
2674284|NCT00555061|9232047|P1|Overall Study|Protocol Violation|1
2674285|NCT00555061|9232047|P1|Overall Study|Adverse Event|3
2674286|NCT00555009|9232066|P2|Overall Study|Terminated by Sponsor|5
2674287|NCT00555009|9232067|P1|Overall Study|Terminated by Sponsor|2
2674288|NCT00555009|9232066|P2|Overall Study|Withdrawal by Subject|1
2674289|NCT00555009|9232067|P1|Overall Study|Withdrawal by Subject|0
2674290|NCT00554840|9232147|P2|Overall Study|Physician Decision|1
2674291|NCT00554840|9232148|P1|Overall Study|Physician Decision|0
2674292|NCT00554801|9232166|P2|Overall Study|Withdrawal by Subject|0
2674293|NCT00554801|9232167|P1|Overall Study|Withdrawal by Subject|14
2674294|NCT00554801|9232166|P2|Overall Study|left area before completion|0
2674295|NCT00554801|9232167|P1|Overall Study|left area before completion|5
2674296|NCT00554788|9232178|P3|Overall Study|Ineligible|1
2674297|NCT00554788|9232179|P2|Overall Study|Ineligible|0
2674298|NCT00554788|9232180|P1|Overall Study|Ineligible|2
2674299|NCT00554788|9232178|P3|Overall Study|Progressive disease|3
2674300|NCT00554788|9232179|P2|Overall Study|Progressive disease|0
2674301|NCT00554788|9232180|P1|Overall Study|Progressive disease|0
2674302|NCT00554788|9232178|P3|Overall Study|Refusal of further protocol therapy|1
2674303|NCT00554788|9232179|P2|Overall Study|Refusal of further protocol therapy|1
2674304|NCT00554788|9232180|P1|Overall Study|Refusal of further protocol therapy|0
2674305|NCT00554788|9232178|P3|Overall Study|Withdrawal by Subject|1
2674306|NCT00554788|9232179|P2|Overall Study|Withdrawal by Subject|0
2674307|NCT00554788|9232180|P1|Overall Study|Withdrawal by Subject|0
2674308|NCT00554788|9232178|P3|Overall Study|Physician Decision|3
2674309|NCT00554788|9232179|P2|Overall Study|Physician Decision|1
2674310|NCT00554788|9232180|P1|Overall Study|Physician Decision|1
2674311|NCT00554788|9232178|P3|Overall Study|Lost to Follow-up|3
2674312|NCT00554788|9232179|P2|Overall Study|Lost to Follow-up|3
2674313|NCT00554788|9232180|P1|Overall Study|Lost to Follow-up|4
2674314|NCT00554788|9232178|P3|Overall Study|Adverse Event|2
2674315|NCT00554788|9232179|P2|Overall Study|Adverse Event|1
2674316|NCT00554788|9232180|P1|Overall Study|Adverse Event|0
2674317|NCT00554619|9232212|P1|Overall Study|Liver Function Test Abnormality|1
2674318|NCT00554619|9232212|P1|Overall Study|Physician Decision|1
2674319|NCT00554619|9232212|P1|Overall Study|Adverse Event|1
2674320|NCT00554515|9232224|P1|Overall Study|Misc|15
2674321|NCT00554515|9232224|P1|Overall Study|Other|1
2674322|NCT00554515|9232224|P1|Overall Study|Achieved Stable Disease|7
2674323|NCT00554515|9232224|P1|Overall Study|Death|2
2674324|NCT00554515|9232224|P1|Overall Study|Adverse Event|9
2674325|NCT00554515|9232224|P1|Overall Study|Withdrawal by Subject|11
2674326|NCT00554515|9232224|P1|Overall Study|Physician Decision|18
2674327|NCT00554515|9232224|P1|Overall Study|Disease progression|52
2674328|NCT00554515|9232224|P1|Overall Study|Withdrawal by Subject|3
2674329|NCT00554229|9232287|P2|Overall Study|Randomised but no treatment received|0
2674330|NCT00554229|9232288|P1|Overall Study|Randomised but no treatment received|1
2674331|NCT00554229|9232287|P2|Overall Study|Reason not otherwise captured, eg; death|140
2674332|NCT00554229|9232288|P1|Overall Study|Reason not otherwise captured, eg; death|119
2674333|NCT00554229|9232287|P2|Overall Study|Protocol Violation|3
2674334|NCT00554229|9232288|P1|Overall Study|Protocol Violation|3
2674335|NCT00554229|9232287|P2|Overall Study|Adverse Event|39
2674336|NCT00554229|9232288|P1|Overall Study|Adverse Event|71
2674337|NCT00554229|9232287|P2|Overall Study|Withdrawal by Subject|37
2674338|NCT00554229|9232288|P1|Overall Study|Withdrawal by Subject|29
2674339|NCT00554229|9232287|P2|Overall Study|Lost to Follow-up|6
2674340|NCT00554229|9232288|P1|Overall Study|Lost to Follow-up|3
2674341|NCT00554216|9232313|P3|Overall Study|Lack of Efficacy|0
2674342|NCT00554216|9232314|P2|Overall Study|Lack of Efficacy|3
2674343|NCT00554216|9232315|P1|Overall Study|Lack of Efficacy|15
2674344|NCT00554216|9232313|P3|Overall Study|Other|10
2674345|NCT00554216|9232314|P2|Overall Study|Other|7
2674346|NCT00554216|9232315|P1|Overall Study|Other|12
2674347|NCT00554216|9232313|P3|Overall Study|Restricted med|1
2674348|NCT00554216|9232314|P2|Overall Study|Restricted med|1
2674349|NCT00554216|9232315|P1|Overall Study|Restricted med|3
2674350|NCT00554216|9232313|P3|Overall Study|Pregnancy|14
2674351|NCT00554216|9232314|P2|Overall Study|Pregnancy|1
2674352|NCT00554216|9232315|P1|Overall Study|Pregnancy|2
2674353|NCT00554216|9232313|P3|Overall Study|Non compliance|5
2674354|NCT00554216|9232314|P2|Overall Study|Non compliance|4
2674355|NCT00554216|9232315|P1|Overall Study|Non compliance|10
2674356|NCT00554216|9232313|P3|Overall Study|Withdrawal by Subject|43
2674357|NCT00554216|9232314|P2|Overall Study|Withdrawal by Subject|31
2674358|NCT00554216|9232315|P1|Overall Study|Withdrawal by Subject|92
2674359|NCT00554216|9232313|P3|Overall Study|Adverse Event|36
2674360|NCT00554216|9232314|P2|Overall Study|Adverse Event|16
2674361|NCT00554216|9232315|P1|Overall Study|Adverse Event|16
2674362|NCT00554216|9232313|P3|Overall Study|Lost to Follow-up|63
2674363|NCT00554216|9232314|P2|Overall Study|Lost to Follow-up|31
2674364|NCT00554216|9232315|P1|Overall Study|Lost to Follow-up|92
2674365|NCT00554190|9232326|P1|Overall Study|Termination forms not completed|10
2674366|NCT00554099|9232335|P3|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
2674367|NCT00554099|9232336|P2|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
2674368|NCT00554099|9232337|P1|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4
2674369|NCT00554099|9232335|P3|Non-Treatment Phase (9 Months)|Relapse|1
2674370|NCT00554099|9232336|P2|Non-Treatment Phase (9 Months)|Relapse|1
2674371|NCT00554099|9232337|P1|Non-Treatment Phase (9 Months)|Relapse|2
2674372|NCT00554099|9232335|P3|Non-Treatment Phase (9 Months)|Lost to Follow-up|0
2674373|NCT00554099|9232336|P2|Non-Treatment Phase (9 Months)|Lost to Follow-up|2
2674374|NCT00554099|9232337|P1|Non-Treatment Phase (9 Months)|Lost to Follow-up|1
2674375|NCT00554099|9232335|P3|Treatment Period (12 Weeks)|Withdrawal by Subject|4
2674376|NCT00554099|9232336|P2|Treatment Period (12 Weeks)|Withdrawal by Subject|1
2674377|NCT00554099|9232337|P1|Treatment Period (12 Weeks)|Withdrawal by Subject|4
2674378|NCT00554099|9232335|P3|Treatment Period (12 Weeks)|Protocol Violation|2
2674379|NCT00554099|9232336|P2|Treatment Period (12 Weeks)|Protocol Violation|0
2674380|NCT00554099|9232337|P1|Treatment Period (12 Weeks)|Protocol Violation|0
2674381|NCT00554099|9232335|P3|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0
2674382|NCT00554099|9232336|P2|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2
2674383|NCT00554099|9232337|P1|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1
2674384|NCT00554099|9232335|P3|Treatment Period (12 Weeks)|Lost to Follow-up|2
2674385|NCT00554099|9232336|P2|Treatment Period (12 Weeks)|Lost to Follow-up|0
2674386|NCT00554099|9232337|P1|Treatment Period (12 Weeks)|Lost to Follow-up|1
2674387|NCT00554099|9232335|P3|Treatment Period (12 Weeks)|Physician Decision|0
2674388|NCT00554099|9232336|P2|Treatment Period (12 Weeks)|Physician Decision|0
2674389|NCT00554099|9232337|P1|Treatment Period (12 Weeks)|Physician Decision|3
2674390|NCT00554099|9232335|P3|Treatment Period (12 Weeks)|Adverse Event|1
2674391|NCT00554099|9232336|P2|Treatment Period (12 Weeks)|Adverse Event|5
2674392|NCT00554099|9232337|P1|Treatment Period (12 Weeks)|Adverse Event|3
2674393|NCT00553787|9232392|P3|Overall Study|Other|13
2674394|NCT00553787|9232393|P2|Overall Study|Other|10
2674395|NCT00553787|9232394|P1|Overall Study|Other|18
2674396|NCT00553787|9232392|P3|Overall Study|Requirement for restricted medication|5
2674397|NCT00553787|9232393|P2|Overall Study|Requirement for restricted medication|7
2674398|NCT00553787|9232394|P1|Overall Study|Requirement for restricted medication|8
2674399|NCT00553787|9232392|P3|Overall Study|non compliance|11
2674400|NCT00553787|9232393|P2|Overall Study|non compliance|0
2674401|NCT00553787|9232394|P1|Overall Study|non compliance|4
2674402|NCT00553787|9232392|P3|Overall Study|Pregnancy|2
2674403|NCT00553787|9232393|P2|Overall Study|Pregnancy|1
2674404|NCT00553787|9232394|P1|Overall Study|Pregnancy|0
2674405|NCT00553787|9232392|P3|Overall Study|Lack of Efficacy|3
2674406|NCT00553787|9232393|P2|Overall Study|Lack of Efficacy|1
2674407|NCT00553787|9232394|P1|Overall Study|Lack of Efficacy|31
2674408|NCT00553787|9232392|P3|Overall Study|Withdrawal by Subject|83
2674409|NCT00553787|9232393|P2|Overall Study|Withdrawal by Subject|40
2674410|NCT00553787|9232394|P1|Overall Study|Withdrawal by Subject|151
2674411|NCT00553787|9232392|P3|Overall Study|Lost to Follow-up|78
2674412|NCT00553787|9232393|P2|Overall Study|Lost to Follow-up|44
2674413|NCT00553787|9232394|P1|Overall Study|Lost to Follow-up|132
2674414|NCT00553787|9232392|P3|Overall Study|Adverse Event|67
2674415|NCT00553787|9232393|P2|Overall Study|Adverse Event|21
2674416|NCT00553787|9232394|P1|Overall Study|Adverse Event|34
2674417|NCT00553696|9232426|P4|Overall Study|Withdrawal by Subject|0
2674418|NCT00553696|9232427|P3|Overall Study|Withdrawal by Subject|0
2674419|NCT00553696|9232428|P2|Overall Study|Withdrawal by Subject|1
2674420|NCT00553696|9232429|P1|Overall Study|Withdrawal by Subject|0
2674421|NCT00553696|9232426|P4|Overall Study|Objective progression or relapse|0
2674422|NCT00553696|9232427|P3|Overall Study|Objective progression or relapse|6
2674423|NCT00553696|9232428|P2|Overall Study|Objective progression or relapse|9
2674424|NCT00553696|9232429|P1|Overall Study|Objective progression or relapse|2
2674425|NCT00553696|9232426|P4|Overall Study|Global deterioration of health status|0
2674426|NCT00553696|9232427|P3|Overall Study|Global deterioration of health status|0
2674427|NCT00553696|9232428|P2|Overall Study|Global deterioration of health status|2
2674428|NCT00553696|9232429|P1|Overall Study|Global deterioration of health status|0
2674429|NCT00553696|9232426|P4|Overall Study|Adverse Event|1
2674430|NCT00553696|9232427|P3|Overall Study|Adverse Event|0
2674431|NCT00553696|9232428|P2|Overall Study|Adverse Event|4
2674432|NCT00553696|9232429|P1|Overall Study|Adverse Event|2
2674433|NCT00553644|9232467|P1|Overall Study|Alternative therapy|6
2674434|NCT00553644|9232467|P1|Overall Study|Physician Decision|1
2674435|NCT00553644|9232467|P1|Overall Study|Withdrawal by Subject|4
2674436|NCT00553644|9232467|P1|Overall Study|Adverse Event|17
2674437|NCT00553631|9232476|P2|Overall Study|Lost to Follow-up|0
2674438|NCT00553631|9232477|P1|Overall Study|Lost to Follow-up|1
2674439|NCT00553631|9232476|P2|Overall Study|Withdrawal by Subject|1
2674440|NCT00553631|9232477|P1|Overall Study|Withdrawal by Subject|0
2674441|NCT00553605|9232499|P2|Overall Study|Randomized but not treated|0
2674442|NCT00553605|9232500|P1|Overall Study|Randomized but not treated|2
2674443|NCT00553605|9232499|P2|Overall Study|Did not receive full dose|0
2674444|NCT00553605|9232500|P1|Overall Study|Did not receive full dose|1
2674445|NCT00553605|9232499|P2|Overall Study|Did not meet entrance criteria|3
2674446|NCT00553605|9232500|P1|Overall Study|Did not meet entrance criteria|1
2674447|NCT00553540|9232526|P2|Overall Study|discharged after first visit|5
2674448|NCT00553540|9232527|P1|Overall Study|discharged after first visit|2
2674449|NCT00553514|9232538|P5|Overall Study|Other|1
2674450|NCT00553514|9232539|P4|Overall Study|Other|0
2674451|NCT00553514|9232540|P3|Overall Study|Other|0
2674452|NCT00553514|9232541|P2|Overall Study|Other|1
2674453|NCT00553514|9232542|P1|Overall Study|Other|1
2674454|NCT00553514|9232538|P5|Overall Study|Risk of multiple pregnancy|0
2674455|NCT00553514|9232539|P4|Overall Study|Risk of multiple pregnancy|1
2674456|NCT00553514|9232540|P3|Overall Study|Risk of multiple pregnancy|0
2674457|NCT00553514|9232541|P2|Overall Study|Risk of multiple pregnancy|2
2674458|NCT00553514|9232542|P1|Overall Study|Risk of multiple pregnancy|0
2674459|NCT00553514|9232538|P5|Overall Study|Ovarian hyperstimulation syndrome risk|0
2674460|NCT00553514|9232539|P4|Overall Study|Ovarian hyperstimulation syndrome risk|0
2674461|NCT00553514|9232540|P3|Overall Study|Ovarian hyperstimulation syndrome risk|1
2674462|NCT00553514|9232541|P2|Overall Study|Ovarian hyperstimulation syndrome risk|0
2674463|NCT00553514|9232542|P1|Overall Study|Ovarian hyperstimulation syndrome risk|3
2674464|NCT00553514|9232538|P5|Overall Study|Lack of ovarian response|6
2674465|NCT00553514|9232539|P4|Overall Study|Lack of ovarian response|5
2674466|NCT00553514|9232540|P3|Overall Study|Lack of ovarian response|5
2674467|NCT00553514|9232541|P2|Overall Study|Lack of ovarian response|5
2674468|NCT00553514|9232542|P1|Overall Study|Lack of ovarian response|4
2674469|NCT00553514|9232538|P5|Overall Study|Protocol deviation|0
2674470|NCT00553514|9232539|P4|Overall Study|Protocol deviation|1
2674471|NCT00553514|9232540|P3|Overall Study|Protocol deviation|0
2674472|NCT00553514|9232541|P2|Overall Study|Protocol deviation|0
2674473|NCT00553514|9232542|P1|Overall Study|Protocol deviation|0
2674474|NCT00553501|9232579|P1|Overall Study|Progression|1
2674475|NCT00553501|9232579|P1|Overall Study|Death|1
2674476|NCT00553501|9232579|P1|Overall Study|Adverse Event|2
2674477|NCT00553475|9232588|P3|Overall Study|Due to moving|0
2674478|NCT00553475|9232589|P2|Overall Study|Due to moving|1
2674479|NCT00553475|9232590|P1|Overall Study|Due to moving|0
2674480|NCT00553475|9232588|P3|Overall Study|Physician Decision|0
2674481|NCT00553475|9232589|P2|Overall Study|Physician Decision|0
2674482|NCT00553475|9232590|P1|Overall Study|Physician Decision|1
2674483|NCT00553475|9232588|P3|Overall Study|Withdrawal by Subject|0
2674484|NCT00553475|9232589|P2|Overall Study|Withdrawal by Subject|1
2674485|NCT00553475|9232590|P1|Overall Study|Withdrawal by Subject|1
2674486|NCT00553475|9232588|P3|Overall Study|Lack of Efficacy|0
2674487|NCT00553475|9232589|P2|Overall Study|Lack of Efficacy|1
2674488|NCT00553475|9232590|P1|Overall Study|Lack of Efficacy|7
2674489|NCT00553475|9232588|P3|Overall Study|Adverse Event|13
2674490|NCT00553475|9232589|P2|Overall Study|Adverse Event|17
2674491|NCT00553475|9232590|P1|Overall Study|Adverse Event|7
2674492|NCT00553462|9232712|P1|Overall Study|Physician Decision|1
2674493|NCT00553462|9232712|P1|Overall Study|Withdrawal by Subject|5
2674494|NCT00553462|9232712|P1|Overall Study|Progression|4
2674495|NCT00553462|9232712|P1|Overall Study|Adverse Event|4
2674496|NCT00553436|9232718|P1|Overall Study|Conversion to another procedure|1
2674497|NCT00553358|9232742|P3|Overall Study|Other: Reason Not Specified|20
2674498|NCT00553358|9232743|P2|Overall Study|Other: Reason Not Specified|4
2674499|NCT00553358|9232744|P1|Overall Study|Other: Reason Not Specified|15
2674500|NCT00553358|9232742|P3|Overall Study|Missing|1
2674501|NCT00553358|9232743|P2|Overall Study|Missing|1
2674502|NCT00553358|9232744|P1|Overall Study|Missing|1
2674503|NCT00553358|9232742|P3|Overall Study|Participant Withdrawal from Drug|3
2674504|NCT00553358|9232743|P2|Overall Study|Participant Withdrawal from Drug|0
2674505|NCT00553358|9232744|P1|Overall Study|Participant Withdrawal from Drug|0
2674506|NCT00553358|9232742|P3|Overall Study|Recurrence of Disease|1
2674507|NCT00553358|9232743|P2|Overall Study|Recurrence of Disease|4
2674508|NCT00553358|9232744|P1|Overall Study|Recurrence of Disease|3
2674509|NCT00553358|9232742|P3|Overall Study|Withdrawal by Subject|1
2674510|NCT00553358|9232743|P2|Overall Study|Withdrawal by Subject|0
2674511|NCT00553358|9232744|P1|Overall Study|Withdrawal by Subject|5
2674512|NCT00553358|9232742|P3|Overall Study|Protocol Violation|1
2674513|NCT00553358|9232743|P2|Overall Study|Protocol Violation|1
2674514|NCT00553358|9232744|P1|Overall Study|Protocol Violation|0
2674515|NCT00553358|9232742|P3|Overall Study|Lost to Follow-up|1
2674516|NCT00553358|9232743|P2|Overall Study|Lost to Follow-up|0
2674517|NCT00553358|9232744|P1|Overall Study|Lost to Follow-up|0
2674518|NCT00553358|9232742|P3|Overall Study|Adverse Event|32
2674519|NCT00553358|9232743|P2|Overall Study|Adverse Event|2
2674520|NCT00553358|9232744|P1|Overall Study|Adverse Event|29
2674521|NCT00553332|9232770|P1|Overall Study|ineligible, incorrect diagnosis|1
2674522|NCT00553319|9232782|P3|Overall Study|moved|1
2674523|NCT00553319|9232783|P2|Overall Study|moved|0
2674524|NCT00553319|9232784|P1|Overall Study|moved|1
2674525|NCT00553319|9232782|P3|Overall Study|incarceration|0
2674526|NCT00553319|9232783|P2|Overall Study|incarceration|0
2674527|NCT00553319|9232784|P1|Overall Study|incarceration|1
2674528|NCT00553319|9232782|P3|Overall Study|non-compliance|2
2674529|NCT00553319|9232783|P2|Overall Study|non-compliance|0
2674530|NCT00553319|9232784|P1|Overall Study|non-compliance|0
2674531|NCT00553319|9232782|P3|Overall Study|wanted treatment elsewhere|1
2674532|NCT00553319|9232783|P2|Overall Study|wanted treatment elsewhere|1
2674533|NCT00553319|9232784|P1|Overall Study|wanted treatment elsewhere|2
2674534|NCT00553319|9232782|P3|Overall Study|Lost to Follow-up|5
2674535|NCT00553319|9232783|P2|Overall Study|Lost to Follow-up|9
2674536|NCT00553319|9232784|P1|Overall Study|Lost to Follow-up|10
2674537|NCT00553280|9232795|P1|Overall Study|Physician Decision|1
2674538|NCT00553280|9232795|P1|Overall Study|Withdrawal by Subject|3
2674539|NCT00553280|9232795|P1|Overall Study|Lack of Efficacy|3
2674540|NCT00553280|9232795|P1|Overall Study|Adverse Event|19
2674541|NCT00553267|9232807|P3|Overall Study|Specified category|1
2674542|NCT00553267|9232808|P2|Overall Study|Specified category|2
2674543|NCT00553267|9232809|P1|Overall Study|Specified category|1
2674544|NCT00553267|9232807|P3|Overall Study|Consent withdrawn|1
2674545|NCT00553267|9232808|P2|Overall Study|Consent withdrawn|3
2674546|NCT00553267|9232809|P1|Overall Study|Consent withdrawn|2
2674547|NCT00553267|9232807|P3|Overall Study|Lost to Follow-up|1
2674548|NCT00553267|9232808|P2|Overall Study|Lost to Follow-up|0
2674549|NCT00553267|9232809|P1|Overall Study|Lost to Follow-up|0
2674550|NCT00553267|9232807|P3|Overall Study|Non compliant with protocol|2
2674551|NCT00553267|9232808|P2|Overall Study|Non compliant with protocol|3
2674552|NCT00553267|9232809|P1|Overall Study|Non compliant with protocol|3
2674553|NCT00553267|9232807|P3|Overall Study|Adverse Event|5
2674554|NCT00553267|9232808|P2|Overall Study|Adverse Event|10
2674555|NCT00553267|9232809|P1|Overall Study|Adverse Event|8
2674556|NCT00553202|9232844|P1|Overall Study|Fails to meet organ function|6
2674557|NCT00553202|9232844|P1|Overall Study|No donor identified|16
2674558|NCT00553202|9232844|P1|Overall Study|Withdrawal by Subject|1
2674559|NCT00553202|9232844|P1|Overall Study|Physician Decision|28
2674560|NCT00553202|9232844|P1|Overall Study|Lost to Follow-up|1
2674561|NCT00553202|9232844|P1|Overall Study|Death|16
2674562|NCT00553150|9232871|P4|Overall Study|Ineligible|1
2674563|NCT00553150|9232872|P3|Overall Study|Ineligible|0
2674564|NCT00553150|9232873|P2|Overall Study|Ineligible|0
2674565|NCT00553150|9232874|P1|Overall Study|Ineligible|0
2674566|NCT00553150|9232871|P4|Overall Study|Protocol Violation|1
2674567|NCT00553150|9232872|P3|Overall Study|Protocol Violation|0
2674568|NCT00553150|9232873|P2|Overall Study|Protocol Violation|0
2674569|NCT00553150|9232874|P1|Overall Study|Protocol Violation|0
2674570|NCT00553150|9232871|P4|Overall Study|Withdrawal by Subject|2
2674571|NCT00553150|9232872|P3|Overall Study|Withdrawal by Subject|0
2674572|NCT00553150|9232873|P2|Overall Study|Withdrawal by Subject|0
2674573|NCT00553150|9232874|P1|Overall Study|Withdrawal by Subject|0
2674574|NCT00552929|9232910|P10|Overall Study|Not Eligible|0
2674575|NCT00552929|9232911|P9|Overall Study|Not Eligible|0
2674576|NCT00552929|9232912|P8|Overall Study|Not Eligible|0
2674577|NCT00552929|9232913|P7|Overall Study|Not Eligible|0
2674578|NCT00552929|9232914|P6|Overall Study|Not Eligible|1
2674579|NCT00552929|9232915|P5|Overall Study|Not Eligible|0
2674580|NCT00552929|9232916|P4|Overall Study|Not Eligible|0
2674581|NCT00552929|9232917|P3|Overall Study|Not Eligible|0
2674582|NCT00552929|9232918|P2|Overall Study|Not Eligible|0
2674583|NCT00552929|9232919|P1|Overall Study|Not Eligible|0
2674584|NCT00552929|9232910|P10|Overall Study|Lost to Follow-up|0
2674585|NCT00552929|9232911|P9|Overall Study|Lost to Follow-up|1
2674586|NCT00552929|9232912|P8|Overall Study|Lost to Follow-up|0
2674587|NCT00552929|9232913|P7|Overall Study|Lost to Follow-up|0
2674588|NCT00552929|9232914|P6|Overall Study|Lost to Follow-up|0
2674589|NCT00552929|9232915|P5|Overall Study|Lost to Follow-up|0
2674590|NCT00552929|9232916|P4|Overall Study|Lost to Follow-up|0
2674591|NCT00552929|9232917|P3|Overall Study|Lost to Follow-up|0
2674592|NCT00552929|9232918|P2|Overall Study|Lost to Follow-up|0
2674593|NCT00552929|9232919|P1|Overall Study|Lost to Follow-up|0
2674594|NCT00552760|9232990|P2|Overall Study|Medication Change|0
2674595|NCT00552760|9232991|P1|Overall Study|Medication Change|1
2674596|NCT00552760|9232990|P2|Overall Study|Withdrawal by Subject|0
2674597|NCT00552760|9232991|P1|Overall Study|Withdrawal by Subject|3
2674598|NCT00552760|9232990|P2|Overall Study|Medical Condition|1
2674599|NCT00552760|9232991|P1|Overall Study|Medical Condition|1
2674600|NCT00552760|9232990|P2|Overall Study|Non-compliance|1
2674601|NCT00552760|9232991|P1|Overall Study|Non-compliance|1
2674602|NCT00552760|9232990|P2|Overall Study|Lost to Follow-up|1
2674603|NCT00552760|9232991|P1|Overall Study|Lost to Follow-up|1
2674604|NCT00552760|9232990|P2|Overall Study|Protocol Violation|1
2674605|NCT00552760|9232991|P1|Overall Study|Protocol Violation|0
2674606|NCT00552760|9232990|P2|Overall Study|Relapsed- Mixed Event|5
2674607|NCT00552760|9232991|P1|Overall Study|Relapsed- Mixed Event|3
2674608|NCT00552760|9232990|P2|Overall Study|Relapse- Manic Event|3
2674609|NCT00552760|9232991|P1|Overall Study|Relapse- Manic Event|3
2674610|NCT00552760|9232990|P2|Overall Study|Relapsed- Depressed Event|16
2674611|NCT00552760|9232991|P1|Overall Study|Relapsed- Depressed Event|10
2674612|NCT00552760|9232990|P2|Overall Study|Adverse Event|5
2674613|NCT00552760|9232991|P1|Overall Study|Adverse Event|3
2674614|NCT00552669|9233018|P2|Overall Study|Death|7
2674615|NCT00552669|9233019|P1|Overall Study|Death|3
2674616|NCT00552617|9233039|P10|Overall Study|Lost to Follow-up|0
2674617|NCT00552617|9233040|P9|Overall Study|Lost to Follow-up|2
2674618|NCT00552617|9233041|P8|Overall Study|Lost to Follow-up|0
2674619|NCT00552617|9233042|P7|Overall Study|Lost to Follow-up|0
2674620|NCT00552617|9233043|P6|Overall Study|Lost to Follow-up|2
2674621|NCT00552617|9233044|P5|Overall Study|Lost to Follow-up|0
2674622|NCT00552617|9233045|P4|Overall Study|Lost to Follow-up|1
2674623|NCT00552617|9233046|P3|Overall Study|Lost to Follow-up|0
2674624|NCT00552617|9233047|P2|Overall Study|Lost to Follow-up|0
2674625|NCT00552617|9233048|P1|Overall Study|Lost to Follow-up|0
2674626|NCT00552617|9233039|P10|Overall Study|Not Treated|1
2674627|NCT00552617|9233040|P9|Overall Study|Not Treated|0
2674628|NCT00552617|9233041|P8|Overall Study|Not Treated|0
2674629|NCT00552617|9233042|P7|Overall Study|Not Treated|0
2674630|NCT00552617|9233043|P6|Overall Study|Not Treated|0
2674631|NCT00552617|9233044|P5|Overall Study|Not Treated|0
2674632|NCT00552617|9233045|P4|Overall Study|Not Treated|0
2674633|NCT00552617|9233046|P3|Overall Study|Not Treated|1
2674634|NCT00552617|9233047|P2|Overall Study|Not Treated|0
2674635|NCT00552617|9233048|P1|Overall Study|Not Treated|0
2674636|NCT00552578|9233092|P2|Overall Study|Lost to Follow-up|1
2674637|NCT00552578|9233093|P1|Overall Study|Lost to Follow-up|1
2674638|NCT00552513|9233105|P2|Overall Study|Lost to Follow-up|1
2674639|NCT00552513|9233106|P1|Overall Study|Lost to Follow-up|5
2674640|NCT00552396|9233151|P7|Overall Study|protocol withdrawal criteria|9
2674641|NCT00552396|9233152|P6|Overall Study|protocol withdrawal criteria|3
2674642|NCT00552396|9233153|P5|Overall Study|protocol withdrawal criteria|3
2674643|NCT00552396|9233154|P4|Overall Study|protocol withdrawal criteria|6
2674644|NCT00552396|9233155|P3|Overall Study|protocol withdrawal criteria|3
2674645|NCT00552396|9233156|P2|Overall Study|protocol withdrawal criteria|3
2674646|NCT00552396|9233157|P1|Overall Study|protocol withdrawal criteria|3
2674647|NCT00552344|9233194|P1|Overall Study|Other Reason|22
2674648|NCT00552344|9233194|P1|Overall Study|SAE, fatal + AE, non-serious non-fatal|1
2674649|NCT00552344|9233194|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62
2674650|NCT00552344|9233194|P1|Overall Study|AE, non-serious non-fatal|38
2674651|NCT00552344|9233194|P1|Overall Study|SAE, non-fatal|6
2674652|NCT00552344|9233194|P1|Overall Study|Withdrawal by Subject|48
2674653|NCT00552344|9233194|P1|Overall Study|Lost to Follow-up|8
2674654|NCT00552344|9233194|P1|Overall Study|Loss of efficacy|75
2674655|NCT00552344|9233194|P1|Overall Study|Lack of Efficacy|55
2674656|NCT00552305|9233203|P1|Overall Study|Other: Subject went to rehab|1
2674657|NCT00552305|9233203|P1|Overall Study|Other: Subject incarcerated|1
2674658|NCT00552305|9233203|P1|Overall Study|Other: Subject moved from area|2
2674659|NCT00552305|9233203|P1|Overall Study|Other: Health problems, not drug related|1
2674660|NCT00552305|9233203|P1|Overall Study|Other: Subject became pregnant|1
2674661|NCT00552305|9233203|P1|Overall Study|Other: Subject underwent surgery|4
2674662|NCT00552305|9233203|P1|Overall Study|Other: Unable to attend visits|1
2674663|NCT00552305|9233203|P1|Overall Study|Other: Personal problems|1
2674664|NCT00552305|9233203|P1|Overall Study|Other: Site closed|4
2674665|NCT00552305|9233203|P1|Overall Study|LoE/WD consent/Other: cannot make visits|1
2674666|NCT00552305|9233203|P1|Overall Study|AE/Other: prohibited drug required|1
2674667|NCT00552305|9233203|P1|Overall Study|Poor compliance/lost to follow-up|1
2674668|NCT00552305|9233203|P1|Overall Study|Unsatisfactory compliance|11
2674669|NCT00552305|9233203|P1|Overall Study|Adverse event (AE)/withdrew (WD) consent|2
2674670|NCT00552305|9233203|P1|Overall Study|Lack of efficacy (LoE)/adverse event|3
2674671|NCT00552305|9233203|P1|Overall Study|Lack of efficacy/withdrew consent|1
2674672|NCT00552305|9233203|P1|Overall Study|Withdrawal by Subject|44
2674673|NCT00552305|9233203|P1|Overall Study|Protocol Violation|3
2674674|NCT00552305|9233203|P1|Overall Study|Lost to Follow-up|4
2674675|NCT00552305|9233203|P1|Overall Study|Lack of Efficacy|120
2674676|NCT00552305|9233203|P1|Overall Study|Adverse Event|43
2674677|NCT00552279|9233213|P2|Overall Study|Other|1
2674678|NCT00552279|9233214|P1|Overall Study|Other|1
2674679|NCT00552279|9233213|P2|Overall Study|Lost to Follow-up|0
2674680|NCT00552279|9233214|P1|Overall Study|Lost to Follow-up|1
2674681|NCT00552279|9233213|P2|Overall Study|Withdrawal by Subject|1
2674682|NCT00552279|9233214|P1|Overall Study|Withdrawal by Subject|12
2674683|NCT00552279|9233213|P2|Overall Study|Adverse Event|1
2674684|NCT00552279|9233214|P1|Overall Study|Adverse Event|0
2674685|NCT00552240|9233240|P2|Overall Study|Other|0
2674686|NCT00552240|9233241|P1|Overall Study|Other|1
2674687|NCT00552240|9233240|P2|Overall Study|Lack of Efficacy|0
2674688|NCT00552240|9233241|P1|Overall Study|Lack of Efficacy|6
2674689|NCT00552240|9233240|P2|Overall Study|Withdrawal by Subject|2
2674690|NCT00552240|9233241|P1|Overall Study|Withdrawal by Subject|2
2674691|NCT00552240|9233240|P2|Overall Study|Lost to Follow-up|6
2674692|NCT00552240|9233241|P1|Overall Study|Lost to Follow-up|5
2674693|NCT00552240|9233240|P2|Overall Study|Protocol Violation|1
2674694|NCT00552240|9233241|P1|Overall Study|Protocol Violation|1
2674695|NCT00552240|9233240|P2|Overall Study|Adverse Event|9
2674696|NCT00552240|9233241|P1|Overall Study|Adverse Event|9
2674697|NCT00552188|9233343|P2|Overall Study|Subject returned to home country|1
2674698|NCT00552188|9233344|P1|Overall Study|Subject returned to home country|0
2674699|NCT00552188|9233343|P2|Overall Study|Withdrawal of consent|1
2674700|NCT00552188|9233344|P1|Overall Study|Withdrawal of consent|0
2674701|NCT00552188|9233343|P2|Overall Study|Lost to Follow-up|1
2674702|NCT00552188|9233344|P1|Overall Study|Lost to Follow-up|2
2674703|NCT00552188|9233343|P2|Overall Study|Adverse Event|2
2674704|NCT00552188|9233344|P1|Overall Study|Adverse Event|0
2674705|NCT00552175|9233355|P3|Overall Study|Reason Not Specified|1
2674706|NCT00552175|9233356|P2|Overall Study|Reason Not Specified|1
2674707|NCT00552175|9233357|P1|Overall Study|Reason Not Specified|3
2674708|NCT00552175|9233355|P3|Overall Study|Entry Criteria Not Met|0
2674709|NCT00552175|9233356|P2|Overall Study|Entry Criteria Not Met|1
2674710|NCT00552175|9233357|P1|Overall Study|Entry Criteria Not Met|1
2674711|NCT00552175|9233355|P3|Overall Study|Lost to Follow-up|1
2674712|NCT00552175|9233356|P2|Overall Study|Lost to Follow-up|0
2674713|NCT00552175|9233357|P1|Overall Study|Lost to Follow-up|0
2674714|NCT00552175|9233355|P3|Overall Study|Withdrawal by Subject|1
2674715|NCT00552175|9233356|P2|Overall Study|Withdrawal by Subject|2
2674716|NCT00552175|9233357|P1|Overall Study|Withdrawal by Subject|2
2674717|NCT00552175|9233355|P3|Overall Study|Adverse Event|10
2674718|NCT00552175|9233356|P2|Overall Study|Adverse Event|9
2674719|NCT00552175|9233357|P1|Overall Study|Adverse Event|9
2674720|NCT00552175|9233355|P3|Overall Study|Lack of Efficacy|1
2674721|NCT00552175|9233356|P2|Overall Study|Lack of Efficacy|0
2674722|NCT00552175|9233357|P1|Overall Study|Lack of Efficacy|2
2674723|NCT00552110|9233397|P5|Overall Study|Nonserious Adverse Event (AE)|0
2674724|NCT00552110|9233398|P4|Overall Study|Nonserious Adverse Event (AE)|1
2674725|NCT00552110|9233399|P3|Overall Study|Nonserious Adverse Event (AE)|0
2674726|NCT00552110|9233400|P2|Overall Study|Nonserious Adverse Event (AE)|0
2674727|NCT00552110|9233401|P1|Overall Study|Nonserious Adverse Event (AE)|1
2674728|NCT00552110|9233397|P5|Overall Study|Increased Blood Pressure at Visit 2|0
2674729|NCT00552110|9233398|P4|Overall Study|Increased Blood Pressure at Visit 2|1
2674730|NCT00552110|9233399|P3|Overall Study|Increased Blood Pressure at Visit 2|0
2674731|NCT00552110|9233400|P2|Overall Study|Increased Blood Pressure at Visit 2|0
2674732|NCT00552110|9233401|P1|Overall Study|Increased Blood Pressure at Visit 2|0
2674733|NCT00552110|9233397|P5|Overall Study|Delay of Study due to Relabeling|0
2674734|NCT00552110|9233398|P4|Overall Study|Delay of Study due to Relabeling|1
2674735|NCT00552110|9233399|P3|Overall Study|Delay of Study due to Relabeling|0
2674736|NCT00552110|9233400|P2|Overall Study|Delay of Study due to Relabeling|0
2674737|NCT00552110|9233401|P1|Overall Study|Delay of Study due to Relabeling|0
2674738|NCT00552110|9233397|P5|Overall Study|Use of Prohibited Medication|0
2674739|NCT00552110|9233398|P4|Overall Study|Use of Prohibited Medication|0
2674740|NCT00552110|9233399|P3|Overall Study|Use of Prohibited Medication|0
2674741|NCT00552110|9233400|P2|Overall Study|Use of Prohibited Medication|1
2674742|NCT00552110|9233401|P1|Overall Study|Use of Prohibited Medication|1
2674743|NCT00552110|9233397|P5|Overall Study|Withdrawn per Sponsor|1
2674744|NCT00552110|9233398|P4|Overall Study|Withdrawn per Sponsor|0
2674745|NCT00552110|9233399|P3|Overall Study|Withdrawn per Sponsor|0
2674746|NCT00552110|9233400|P2|Overall Study|Withdrawn per Sponsor|1
2674747|NCT00552110|9233401|P1|Overall Study|Withdrawn per Sponsor|0
2674748|NCT00552110|9233397|P5|Overall Study|Failed to Comply With Study Requirements|1
2674749|NCT00552110|9233398|P4|Overall Study|Failed to Comply With Study Requirements|0
2674750|NCT00552110|9233399|P3|Overall Study|Failed to Comply With Study Requirements|1
2674751|NCT00552110|9233400|P2|Overall Study|Failed to Comply With Study Requirements|1
2674752|NCT00552110|9233401|P1|Overall Study|Failed to Comply With Study Requirements|1
2674753|NCT00552110|9233397|P5|Overall Study|Lost to Follow-up|1
2674754|NCT00552110|9233398|P4|Overall Study|Lost to Follow-up|1
2674755|NCT00552110|9233399|P3|Overall Study|Lost to Follow-up|0
2674756|NCT00552110|9233400|P2|Overall Study|Lost to Follow-up|0
2674757|NCT00552110|9233401|P1|Overall Study|Lost to Follow-up|0
2674758|NCT00552110|9233397|P5|Overall Study|Withdrawal by Subject|2
2674759|NCT00552110|9233398|P4|Overall Study|Withdrawal by Subject|3
2674760|NCT00552110|9233399|P3|Overall Study|Withdrawal by Subject|0
2674761|NCT00552110|9233400|P2|Overall Study|Withdrawal by Subject|2
2674762|NCT00552110|9233401|P1|Overall Study|Withdrawal by Subject|0
2674763|NCT00552110|9233397|P5|Overall Study|Lack of Efficacy|4
2674764|NCT00552110|9233398|P4|Overall Study|Lack of Efficacy|1
2674765|NCT00552110|9233399|P3|Overall Study|Lack of Efficacy|0
2674766|NCT00552110|9233400|P2|Overall Study|Lack of Efficacy|0
2674767|NCT00552110|9233401|P1|Overall Study|Lack of Efficacy|1
2674768|NCT00552110|9233397|P5|Overall Study|Serious or Life-Threatening AE|0
2674769|NCT00552110|9233398|P4|Overall Study|Serious or Life-Threatening AE|0
2674770|NCT00552110|9233399|P3|Overall Study|Serious or Life-Threatening AE|1
2674771|NCT00552110|9233400|P2|Overall Study|Serious or Life-Threatening AE|0
2674772|NCT00552110|9233401|P1|Overall Study|Serious or Life-Threatening AE|0
2674773|NCT00552084|9233420|P2|Overall Study|change in anti-arrythmic drug|1
2674774|NCT00552084|9233421|P1|Overall Study|change in anti-arrythmic drug|1
2674775|NCT00552084|9233420|P2|Overall Study|Protocol Violation|0
2674776|NCT00552084|9233421|P1|Overall Study|Protocol Violation|1
2674777|NCT00552084|9233420|P2|Overall Study|Withdrawal by Subject|5
2674778|NCT00552084|9233421|P1|Overall Study|Withdrawal by Subject|4
2674779|NCT00552084|9233420|P2|Overall Study|Adverse Event|3
2674780|NCT00552084|9233421|P1|Overall Study|Adverse Event|2
2674781|NCT00552071|9233429|P2|Overall Study|Withdrawal by Subject|1
2674782|NCT00552071|9233430|P1|Overall Study|Withdrawal by Subject|0
2674783|NCT00552071|9233429|P2|Overall Study|Death|1
2674784|NCT00552071|9233430|P1|Overall Study|Death|0
2674785|NCT00552071|9233429|P2|Overall Study|Pregnancy|0
2674786|NCT00552071|9233430|P1|Overall Study|Pregnancy|1
2674787|NCT00552071|9233429|P2|Overall Study|Physician Decision|0
2674788|NCT00552071|9233430|P1|Overall Study|Physician Decision|1
2674789|NCT00552071|9233429|P2|Overall Study|Lack of Efficacy|0
2674790|NCT00552071|9233430|P1|Overall Study|Lack of Efficacy|1
2674791|NCT00552071|9233429|P2|Overall Study|Adverse Event|0
2674792|NCT00552071|9233430|P1|Overall Study|Adverse Event|1
2674793|NCT00552058|9233440|P2|Overall Study|Other: Early Roll Over|0
2674794|NCT00552058|9233441|P1|Overall Study|Other: Early Roll Over|1
2674795|NCT00552058|9233440|P2|Overall Study|Other: Sponsors Decision|1
2674796|NCT00552058|9233441|P1|Overall Study|Other: Sponsors Decision|0
2674797|NCT00552058|9233440|P2|Overall Study|Other: Randomized in error|1
2674798|NCT00552058|9233441|P1|Overall Study|Other: Randomized in error|0
2674799|NCT00552058|9233440|P2|Overall Study|Other: Positive Stool Result|1
2674800|NCT00552058|9233441|P1|Overall Study|Other: Positive Stool Result|0
2674801|NCT00552058|9233440|P2|Overall Study|Other: Low CDAI score, entry violation|1
2674802|NCT00552058|9233441|P1|Overall Study|Other: Low CDAI score, entry violation|0
2674803|NCT00552058|9233440|P2|Overall Study|Other: Crossed Over to a Follow-up Study|1
2674804|NCT00552058|9233441|P1|Overall Study|Other: Crossed Over to a Follow-up Study|0
2674805|NCT00552058|9233440|P2|Overall Study|Other: Non Compliance|2
2674806|NCT00552058|9233441|P1|Overall Study|Other: Non Compliance|1
2674807|NCT00552058|9233440|P2|Overall Study|Other: Protocol Violation|1
2674808|NCT00552058|9233441|P1|Overall Study|Other: Protocol Violation|0
2674809|NCT00552058|9233440|P2|Overall Study|Withdrawal by Subject|4
2674810|NCT00552058|9233441|P1|Overall Study|Withdrawal by Subject|4
2674811|NCT00552058|9233440|P2|Overall Study|Lost to Follow-up|0
2674812|NCT00552058|9233441|P1|Overall Study|Lost to Follow-up|1
2674813|NCT00552058|9233440|P2|Overall Study|Lack of Efficacy|5
2674814|NCT00552058|9233441|P1|Overall Study|Lack of Efficacy|1
2674815|NCT00552058|9233440|P2|Overall Study|Adverse Event|7
2674816|NCT00552058|9233441|P1|Overall Study|Adverse Event|8
2674817|NCT00552032|9233481|P2|Overall Study|Lost to Follow-up|5
2674818|NCT00552032|9233482|P1|Overall Study|Lost to Follow-up|8
2674819|NCT00552032|9233481|P2|Overall Study|Protocol Violation|12
2674820|NCT00552032|9233482|P1|Overall Study|Protocol Violation|7
2674821|NCT00552032|9233481|P2|Overall Study|Withdrawal by Subject|2
2674822|NCT00552032|9233482|P1|Overall Study|Withdrawal by Subject|2
2674823|NCT00551759|9233526|P1|Overall Study|Ineligible|1
2674824|NCT00551759|9233526|P1|Overall Study|Death|5
2674825|NCT00551759|9233526|P1|Overall Study|Adverse Event|7
2674826|NCT00551642|9233567|P2|Overall Study|Inclusion/Exclusion criteria|4
2674827|NCT00551642|9233568|P1|Overall Study|Inclusion/Exclusion criteria|4
2674828|NCT00551642|9233567|P2|Overall Study|Delivery device failure|3
2674829|NCT00551642|9233568|P1|Overall Study|Delivery device failure|1
2674830|NCT00551642|9233567|P2|Overall Study|Physician Decision|1
2674831|NCT00551642|9233568|P1|Overall Study|Physician Decision|0
2674832|NCT00551642|9233567|P2|Overall Study|Protocol Violation|11
2674833|NCT00551642|9233568|P1|Overall Study|Protocol Violation|6
2674834|NCT00551642|9233567|P2|Overall Study|Death|31
2674835|NCT00551642|9233568|P1|Overall Study|Death|33
2674836|NCT00551642|9233567|P2|Overall Study|Adverse Event|12
2674837|NCT00551642|9233568|P1|Overall Study|Adverse Event|15
2674838|NCT00551642|9233567|P2|Overall Study|Withdrawal by Subject|1
2674839|NCT00551642|9233568|P1|Overall Study|Withdrawal by Subject|2
2674840|NCT00551525|9233574|P1|Overall Study|Protocol Violation|5
2674841|NCT00551460|9233583|P1|Overall Study|Not analyzable (did not start treatment)|4
2674842|NCT00551460|9233583|P1|Overall Study|Ineligible|4
2674843|NCT00551460|9233583|P1|Overall Study|Death|7
2674844|NCT00551460|9233583|P1|Overall Study|Physician Decision|1
2674845|NCT00551460|9233583|P1|Overall Study|Withdrawal by Subject|1
2674846|NCT00551460|9233583|P1|Overall Study|Adverse Event|1
2674847|NCT00551421|9233589|P1|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1
2674848|NCT00551369|9233596|P1|Overall Study|Not treated per protocol and re|1
2674849|NCT00551369|9233596|P1|Overall Study|Withdrawal by Subject|1
2674850|NCT00551369|9233596|P1|Overall Study|Protocol Violation|5
2674851|NCT00551291|9233605|P1|Overall Study|Physician Decision|1
2674852|NCT00551213|9233613|P2|Overall Study|Not Treated|2
2674853|NCT00551213|9233614|P1|Overall Study|Not Treated|1
2674854|NCT00551213|9233613|P2|Overall Study|Withdrawal by Subject|0
2674855|NCT00551213|9233614|P1|Overall Study|Withdrawal by Subject|2
2674856|NCT00551213|9233613|P2|Overall Study|Progressive Disease|12
2674857|NCT00551213|9233614|P1|Overall Study|Progressive Disease|41
2674858|NCT00551213|9233613|P2|Overall Study|Adverse Event|3
2674859|NCT00551213|9233614|P1|Overall Study|Adverse Event|6
2674860|NCT00551161|9233658|P1|Overall Study|Withdrawal by Subject|1
2674861|NCT00551135|9233666|P4|Overall Study|Withdrawal by Subject|1
2674862|NCT00551135|9233667|P3|Overall Study|Withdrawal by Subject|3
2674863|NCT00551135|9233668|P2|Overall Study|Withdrawal by Subject|0
2674864|NCT00551135|9233669|P1|Overall Study|Withdrawal by Subject|1
2674865|NCT00551135|9233666|P4|Overall Study|Other|2
2674866|NCT00551135|9233667|P3|Overall Study|Other|1
2674867|NCT00551135|9233668|P2|Overall Study|Other|2
2674868|NCT00551135|9233669|P1|Overall Study|Other|3
2674869|NCT00551135|9233666|P4|Overall Study|Lost to Follow-up|1
2674870|NCT00551135|9233667|P3|Overall Study|Lost to Follow-up|0
2674871|NCT00551135|9233668|P2|Overall Study|Lost to Follow-up|0
2674872|NCT00551135|9233669|P1|Overall Study|Lost to Follow-up|0
2674873|NCT00551135|9233666|P4|Overall Study|Adverse Event|1
2674874|NCT00551135|9233667|P3|Overall Study|Adverse Event|1
2674875|NCT00551135|9233668|P2|Overall Study|Adverse Event|0
2674876|NCT00551135|9233669|P1|Overall Study|Adverse Event|1
2674877|NCT00551031|9233798|P5|Overall Study|Did not receive vaccine|0
2674878|NCT00551031|9233799|P4|Overall Study|Did not receive vaccine|0
2674879|NCT00551031|9233800|P3|Overall Study|Did not receive vaccine|0
2674880|NCT00551031|9233801|P2|Overall Study|Did not receive vaccine|2
2674881|NCT00551031|9233802|P1|Overall Study|Did not receive vaccine|1
2674882|NCT00551031|9233798|P5|Overall Study|Serious Adverse Event|0
2674883|NCT00551031|9233799|P4|Overall Study|Serious Adverse Event|0
2674884|NCT00551031|9233800|P3|Overall Study|Serious Adverse Event|1
2674885|NCT00551031|9233801|P2|Overall Study|Serious Adverse Event|2
2674886|NCT00551031|9233802|P1|Overall Study|Serious Adverse Event|0
2674887|NCT00551031|9233798|P5|Overall Study|Withdrawal by Subject|0
2674888|NCT00551031|9233799|P4|Overall Study|Withdrawal by Subject|2
2674889|NCT00551031|9233800|P3|Overall Study|Withdrawal by Subject|1
2674890|NCT00551031|9233801|P2|Overall Study|Withdrawal by Subject|4
2674891|NCT00551031|9233802|P1|Overall Study|Withdrawal by Subject|0
2674892|NCT00551031|9233798|P5|Overall Study|Lost to Follow-up|1
2674893|NCT00551031|9233799|P4|Overall Study|Lost to Follow-up|1
2674894|NCT00551031|9233800|P3|Overall Study|Lost to Follow-up|0
2674895|NCT00551031|9233801|P2|Overall Study|Lost to Follow-up|1
2674896|NCT00551031|9233802|P1|Overall Study|Lost to Follow-up|0
2674897|NCT00551031|9233798|P5|Overall Study|Protocol Violation|0
2674898|NCT00551031|9233799|P4|Overall Study|Protocol Violation|0
2674899|NCT00551031|9233800|P3|Overall Study|Protocol Violation|0
2674900|NCT00551031|9233801|P2|Overall Study|Protocol Violation|1
2674901|NCT00551031|9233802|P1|Overall Study|Protocol Violation|1
2674902|NCT00551031|9233798|P5|Overall Study|Adverse Event|0
2674903|NCT00551031|9233799|P4|Overall Study|Adverse Event|0
2674904|NCT00551031|9233800|P3|Overall Study|Adverse Event|0
2674905|NCT00551031|9233801|P2|Overall Study|Adverse Event|1
2674906|NCT00551031|9233802|P1|Overall Study|Adverse Event|0
2674907|NCT00550953|9233831|P2|Overall Study|Not able to visit the site|3
2674908|NCT00550953|9233832|P1|Overall Study|Not able to visit the site|2
2674909|NCT00550953|9233831|P2|Overall Study|Adverse Event|3
2674910|NCT00550953|9233832|P1|Overall Study|Adverse Event|4
2674911|NCT00550836|9233879|P2|Overall Study|Withdrawal by Subject|9
2674912|NCT00550836|9233880|P1|Overall Study|Withdrawal by Subject|3
2674913|NCT00550771|9233896|P2|Overall Study|Protocol Violation|5
2674914|NCT00550771|9233897|P1|Overall Study|Protocol Violation|4
2674915|NCT00550771|9233896|P2|Overall Study|Withdrawal by Subject|1
2674916|NCT00550771|9233897|P1|Overall Study|Withdrawal by Subject|0
2674917|NCT00550771|9233896|P2|Overall Study|Physician Decision|0
2674918|NCT00550771|9233897|P1|Overall Study|Physician Decision|2
2674919|NCT00550771|9233896|P2|Overall Study|Discontinued for study-related reasons|1
2674920|NCT00550771|9233897|P1|Overall Study|Discontinued for study-related reasons|0
2674921|NCT00550771|9233896|P2|Overall Study|Adverse Event|3
2674922|NCT00550771|9233897|P1|Overall Study|Adverse Event|11
2674923|NCT00550745|9233911|P2|Overall Study|Screen failure|0
2674924|NCT00550745|9233912|P1|Overall Study|Screen failure|1
2674925|NCT00550745|9233911|P2|Overall Study|Withdrawal by Subject|10
2674926|NCT00550745|9233912|P1|Overall Study|Withdrawal by Subject|17
2674927|NCT00550745|9233911|P2|Overall Study|Protocol Violation|2
2674928|NCT00550745|9233912|P1|Overall Study|Protocol Violation|4
2674929|NCT00550745|9233911|P2|Overall Study|Physician Decision|2
2674930|NCT00550745|9233912|P1|Overall Study|Physician Decision|0
2674931|NCT00550745|9233911|P2|Overall Study|Lost to Follow-up|30
2674932|NCT00550745|9233912|P1|Overall Study|Lost to Follow-up|45
2674933|NCT00550745|9233911|P2|Overall Study|Death|16
2674934|NCT00550745|9233912|P1|Overall Study|Death|20
2674935|NCT00550732|9233920|P1|Overall Study|Adverse Event|1
2674936|NCT00550732|9233920|P1|Overall Study|Palliative care|1
2674937|NCT00550732|9233920|P1|Overall Study|Lost to Follow-up|1
2674938|NCT00550732|9233920|P1|Overall Study|Physician Decision|2
2674939|NCT00550732|9233920|P1|Overall Study|Withdrawal by Subject|2
2674940|NCT00550732|9233920|P1|Overall Study|Death|4
2674941|NCT00550680|9233931|P1|Overall Study|Screen Failure|6
2674942|NCT00550680|9233931|P1|Overall Study|Refused Treatment|19
2674943|NCT00550680|9233931|P1|Overall Study|Protocol Violation|7
2674944|NCT00550680|9233931|P1|Overall Study|Other|10
2674945|NCT00550680|9233931|P1|Overall Study|Lack of Efficacy|1
2674946|NCT00550680|9233931|P1|Overall Study|Lost to Follow-up|3
2674947|NCT00550680|9233931|P1|Overall Study|Early Improvement|1
2674948|NCT00550680|9233931|P1|Overall Study|Death|3
2674949|NCT00550680|9233931|P1|Overall Study|Adverse Event|5
2674950|NCT00550680|9233931|P1|Overall Study|Administrative Reasons|1
2674951|NCT00550615|9233952|P4|Overall Study|Not evaluable|7
2674952|NCT00550615|9233953|P3|Overall Study|Not evaluable|2
2674953|NCT00550615|9233954|P2|Overall Study|Not evaluable|0
2674954|NCT00550615|9233955|P1|Overall Study|Not evaluable|0
2674955|NCT00550615|9233952|P4|Overall Study|Withdrawal by Subject|3
2674956|NCT00550615|9233953|P3|Overall Study|Withdrawal by Subject|2
2674957|NCT00550615|9233954|P2|Overall Study|Withdrawal by Subject|0
2674958|NCT00550615|9233955|P1|Overall Study|Withdrawal by Subject|0
2674959|NCT00550550|9233974|P2|Overall Study|Randomized But Not Treated|0
2674960|NCT00550550|9233975|P1|Overall Study|Randomized But Not Treated|1
2674961|NCT00550550|9233974|P2|Overall Study|Did Not Meet Protocol Eligibility|1
2674962|NCT00550550|9233975|P1|Overall Study|Did Not Meet Protocol Eligibility|1
2674963|NCT00550550|9233974|P2|Overall Study|Protocol Violation|14
2674964|NCT00550550|9233975|P1|Overall Study|Protocol Violation|5
2674965|NCT00550550|9233974|P2|Overall Study|Withdrawal by Subject|8
2674966|NCT00550550|9233975|P1|Overall Study|Withdrawal by Subject|10
2674967|NCT00550550|9233974|P2|Overall Study|Lost to Follow-up|0
2674968|NCT00550550|9233975|P1|Overall Study|Lost to Follow-up|4
2674969|NCT00550550|9233974|P2|Overall Study|Treatment Failure|1
2674970|NCT00550550|9233975|P1|Overall Study|Treatment Failure|0
2674971|NCT00550550|9233974|P2|Overall Study|Adverse Event|5
2674972|NCT00550550|9233975|P1|Overall Study|Adverse Event|13
2674973|NCT00550537|9233987|P1|Overall Study|Treated closer to home|4
2674974|NCT00550537|9233987|P1|Overall Study|Declining performance status|2
2674975|NCT00550537|9233987|P1|Overall Study|Other complicating ilness|3
2674976|NCT00550537|9233987|P1|Overall Study|Change in treatment plan|4
2674977|NCT00550537|9233987|P1|Overall Study|Withdrawal by Subject|7
2674978|NCT00550537|9233987|P1|Overall Study|Disease progression before|46
2674979|NCT00550537|9233987|P1|Overall Study|Adverse Event|20
2674980|NCT00550537|9233987|P1|Overall Study|Death|18
2674981|NCT00550459|9234004|P2|Overall Study|Withdrawal by Subject|1
2674982|NCT00550459|9234005|P1|Overall Study|Withdrawal by Subject|1
2674983|NCT00550459|9234004|P2|Overall Study|Adverse Event|2
2674984|NCT00550459|9234005|P1|Overall Study|Adverse Event|0
2674985|NCT00550446|9234074|P11|Post Week 12|Other|0
2674986|NCT00550446|9234075|P10|Post Week 12|Other|1
2674987|NCT00550446|9234076|P9|Post Week 12|Other|1
2674988|NCT00550446|9234077|P8|Post Week 12|Other|0
2674989|NCT00550446|9234078|P7|Post Week 12|Other|1
2674990|NCT00550446|9234079|P6|Post Week 12|Other|0
2674991|NCT00550446|9234080|P5|Post Week 12|Other|0
2674992|NCT00550446|9234081|P4|Post Week 12|Other|1
2674993|NCT00550446|9234082|P3|Post Week 12|Other|0
2674994|NCT00550446|9234083|P2|Post Week 12|Other|1
2674995|NCT00550446|9234084|P1|Post Week 12|Other|1
2674996|NCT00550446|9234074|P11|Post Week 12|Withdrawal by Subject|0
2674997|NCT00550446|9234075|P10|Post Week 12|Withdrawal by Subject|0
2674998|NCT00550446|9234076|P9|Post Week 12|Withdrawal by Subject|0
2674999|NCT00550446|9234077|P8|Post Week 12|Withdrawal by Subject|0
2675000|NCT00550446|9234078|P7|Post Week 12|Withdrawal by Subject|0
2675001|NCT00550446|9234079|P6|Post Week 12|Withdrawal by Subject|0
2675002|NCT00550446|9234080|P5|Post Week 12|Withdrawal by Subject|1
2675003|NCT00550446|9234081|P4|Post Week 12|Withdrawal by Subject|0
2675004|NCT00550446|9234082|P3|Post Week 12|Withdrawal by Subject|0
2675005|NCT00550446|9234083|P2|Post Week 12|Withdrawal by Subject|0
2675006|NCT00550446|9234084|P1|Post Week 12|Withdrawal by Subject|0
2675007|NCT00550446|9234074|P11|Post Week 12|Lost to Follow-up|0
2675008|NCT00550446|9234075|P10|Post Week 12|Lost to Follow-up|0
2675009|NCT00550446|9234076|P9|Post Week 12|Lost to Follow-up|0
2675010|NCT00550446|9234077|P8|Post Week 12|Lost to Follow-up|0
2675011|NCT00550446|9234078|P7|Post Week 12|Lost to Follow-up|1
2675012|NCT00550446|9234079|P6|Post Week 12|Lost to Follow-up|0
2675013|NCT00550446|9234080|P5|Post Week 12|Lost to Follow-up|0
2675014|NCT00550446|9234081|P4|Post Week 12|Lost to Follow-up|1
2675015|NCT00550446|9234082|P3|Post Week 12|Lost to Follow-up|1
2675016|NCT00550446|9234083|P2|Post Week 12|Lost to Follow-up|0
2675017|NCT00550446|9234084|P1|Post Week 12|Lost to Follow-up|0
2675018|NCT00550446|9234074|P11|Post Week 12|Lack of Efficacy|1
2675019|NCT00550446|9234075|P10|Post Week 12|Lack of Efficacy|2
2675020|NCT00550446|9234076|P9|Post Week 12|Lack of Efficacy|1
2675021|NCT00550446|9234077|P8|Post Week 12|Lack of Efficacy|1
2675022|NCT00550446|9234078|P7|Post Week 12|Lack of Efficacy|0
2675023|NCT00550446|9234079|P6|Post Week 12|Lack of Efficacy|0
2675024|NCT00550446|9234080|P5|Post Week 12|Lack of Efficacy|0
2675025|NCT00550446|9234081|P4|Post Week 12|Lack of Efficacy|0
2675026|NCT00550446|9234082|P3|Post Week 12|Lack of Efficacy|1
2675027|NCT00550446|9234083|P2|Post Week 12|Lack of Efficacy|0
2675028|NCT00550446|9234084|P1|Post Week 12|Lack of Efficacy|0
2675029|NCT00550446|9234074|P11|Post Week 12|Adverse Event|0
2675030|NCT00550446|9234075|P10|Post Week 12|Adverse Event|4
2675031|NCT00550446|9234076|P9|Post Week 12|Adverse Event|0
2675032|NCT00550446|9234077|P8|Post Week 12|Adverse Event|0
2675033|NCT00550446|9234078|P7|Post Week 12|Adverse Event|0
2675034|NCT00550446|9234079|P6|Post Week 12|Adverse Event|1
2675035|NCT00550446|9234080|P5|Post Week 12|Adverse Event|1
2675036|NCT00550446|9234081|P4|Post Week 12|Adverse Event|1
2675037|NCT00550446|9234082|P3|Post Week 12|Adverse Event|1
2675038|NCT00550446|9234083|P2|Post Week 12|Adverse Event|1
2675039|NCT00550446|9234084|P1|Post Week 12|Adverse Event|2
2675040|NCT00550446|9234074|P11|Up To Week 12|Randomized not treated|0
2675041|NCT00550446|9234075|P10|Up To Week 12|Randomized not treated|0
2675042|NCT00550446|9234076|P9|Up To Week 12|Randomized not treated|0
2675043|NCT00550446|9234077|P8|Up To Week 12|Randomized not treated|0
2675044|NCT00550446|9234078|P7|Up To Week 12|Randomized not treated|0
2675045|NCT00550446|9234079|P6|Up To Week 12|Randomized not treated|0
2675046|NCT00550446|9234080|P5|Up To Week 12|Randomized not treated|0
2675047|NCT00550446|9234081|P4|Up To Week 12|Randomized not treated|0
2675048|NCT00550446|9234082|P3|Up To Week 12|Randomized not treated|1
2675049|NCT00550446|9234083|P2|Up To Week 12|Randomized not treated|1
2675050|NCT00550446|9234084|P1|Up To Week 12|Randomized not treated|0
2675051|NCT00550446|9234074|P11|Up To Week 12|Other|0
2675052|NCT00550446|9234075|P10|Up To Week 12|Other|0
2675053|NCT00550446|9234076|P9|Up To Week 12|Other|0
2675054|NCT00550446|9234077|P8|Up To Week 12|Other|0
2675055|NCT00550446|9234078|P7|Up To Week 12|Other|4
2675056|NCT00550446|9234079|P6|Up To Week 12|Other|1
2675057|NCT00550446|9234080|P5|Up To Week 12|Other|0
2675058|NCT00550446|9234081|P4|Up To Week 12|Other|0
2675059|NCT00550446|9234082|P3|Up To Week 12|Other|0
2675060|NCT00550446|9234083|P2|Up To Week 12|Other|0
2675061|NCT00550446|9234084|P1|Up To Week 12|Other|3
2675062|NCT00550446|9234074|P11|Up To Week 12|Withdrawal by Subject|0
2675063|NCT00550446|9234075|P10|Up To Week 12|Withdrawal by Subject|0
2675064|NCT00550446|9234076|P9|Up To Week 12|Withdrawal by Subject|0
2675065|NCT00550446|9234077|P8|Up To Week 12|Withdrawal by Subject|0
2675066|NCT00550446|9234078|P7|Up To Week 12|Withdrawal by Subject|3
2675067|NCT00550446|9234079|P6|Up To Week 12|Withdrawal by Subject|1
2675068|NCT00550446|9234080|P5|Up To Week 12|Withdrawal by Subject|0
2675069|NCT00550446|9234081|P4|Up To Week 12|Withdrawal by Subject|2
2675070|NCT00550446|9234082|P3|Up To Week 12|Withdrawal by Subject|3
2675071|NCT00550446|9234083|P2|Up To Week 12|Withdrawal by Subject|0
2675072|NCT00550446|9234084|P1|Up To Week 12|Withdrawal by Subject|2
2675073|NCT00550446|9234074|P11|Up To Week 12|Lost to Follow-up|0
2675074|NCT00550446|9234075|P10|Up To Week 12|Lost to Follow-up|0
2675075|NCT00550446|9234076|P9|Up To Week 12|Lost to Follow-up|0
2675076|NCT00550446|9234077|P8|Up To Week 12|Lost to Follow-up|0
2675077|NCT00550446|9234078|P7|Up To Week 12|Lost to Follow-up|2
2675078|NCT00550446|9234079|P6|Up To Week 12|Lost to Follow-up|1
2675079|NCT00550446|9234080|P5|Up To Week 12|Lost to Follow-up|1
2675080|NCT00550446|9234081|P4|Up To Week 12|Lost to Follow-up|0
2675081|NCT00550446|9234082|P3|Up To Week 12|Lost to Follow-up|0
2675082|NCT00550446|9234083|P2|Up To Week 12|Lost to Follow-up|1
2675083|NCT00550446|9234084|P1|Up To Week 12|Lost to Follow-up|0
2675084|NCT00550446|9234074|P11|Up To Week 12|Lack of Efficacy|0
2675085|NCT00550446|9234075|P10|Up To Week 12|Lack of Efficacy|0
2675086|NCT00550446|9234076|P9|Up To Week 12|Lack of Efficacy|0
2675087|NCT00550446|9234077|P8|Up To Week 12|Lack of Efficacy|0
2675088|NCT00550446|9234078|P7|Up To Week 12|Lack of Efficacy|3
2675089|NCT00550446|9234079|P6|Up To Week 12|Lack of Efficacy|3
2675090|NCT00550446|9234080|P5|Up To Week 12|Lack of Efficacy|0
2675091|NCT00550446|9234081|P4|Up To Week 12|Lack of Efficacy|1
2675092|NCT00550446|9234082|P3|Up To Week 12|Lack of Efficacy|0
2675093|NCT00550446|9234083|P2|Up To Week 12|Lack of Efficacy|1
2675094|NCT00550446|9234084|P1|Up To Week 12|Lack of Efficacy|3
2675095|NCT00550446|9234074|P11|Up To Week 12|Adverse Event|0
2675096|NCT00550446|9234075|P10|Up To Week 12|Adverse Event|0
2675097|NCT00550446|9234076|P9|Up To Week 12|Adverse Event|0
2675098|NCT00550446|9234077|P8|Up To Week 12|Adverse Event|0
2675099|NCT00550446|9234078|P7|Up To Week 12|Adverse Event|1
2675100|NCT00550446|9234079|P6|Up To Week 12|Adverse Event|2
2675101|NCT00550446|9234080|P5|Up To Week 12|Adverse Event|2
2675102|NCT00550446|9234081|P4|Up To Week 12|Adverse Event|0
2675103|NCT00550446|9234082|P3|Up To Week 12|Adverse Event|0
2675104|NCT00550446|9234083|P2|Up To Week 12|Adverse Event|2
2675105|NCT00550446|9234084|P1|Up To Week 12|Adverse Event|2
2675106|NCT00550420|9234516|P1|Overall Study|Prohibited medicine|1
2675107|NCT00550420|9234516|P1|Overall Study|Exclusion criteria|1
2675108|NCT00550420|9234516|P1|Overall Study|Out of Electrocardiogram criteria|1
2675109|NCT00550420|9234516|P1|Overall Study|Caregiver's decision to withdraw|1
2675110|NCT00550420|9234516|P1|Overall Study|Unethical stop of enrollment|2
2675111|NCT00550420|9234516|P1|Overall Study|Lack of curative effect|1
2675112|NCT00550420|9234516|P1|Overall Study|Investigators opinion|1
2675113|NCT00550420|9234516|P1|Overall Study|Prolonged QT Interval Electrocardiogram|12
2675114|NCT00550420|9234516|P1|Overall Study|Missing|2
2675115|NCT00550420|9234516|P1|Overall Study|Still in study at termination|206
2675116|NCT00550420|9234516|P1|Overall Study|Withdrawal by Subject|30
2675117|NCT00550420|9234516|P1|Overall Study|Protocol Violation|11
2675118|NCT00550420|9234516|P1|Overall Study|Lost to Follow-up|8
2675119|NCT00550420|9234516|P1|Overall Study|Adverse Event|28
2675120|NCT00550407|9234539|P3|26-Week Randomized Phase|Withdrawal by Subject|3
2675121|NCT00550407|9234540|P2|26-Week Randomized Phase|Withdrawal by Subject|1
2675122|NCT00550407|9234541|P1|26-Week Randomized Phase|Withdrawal by Subject|0
2675123|NCT00550407|9234539|P3|26-Week Randomized Phase|Investigator Discretion|0
2675124|NCT00550407|9234540|P2|26-Week Randomized Phase|Investigator Discretion|1
2675125|NCT00550407|9234541|P1|26-Week Randomized Phase|Investigator Discretion|0
2675126|NCT00550407|9234539|P3|26-Week Randomized Phase|Lack of Efficacy|19
2675127|NCT00550407|9234540|P2|26-Week Randomized Phase|Lack of Efficacy|36
2675128|NCT00550407|9234541|P1|26-Week Randomized Phase|Lack of Efficacy|0
2675129|NCT00550407|9234539|P3|26-Week Randomized Phase|Adverse Event|2
2675130|NCT00550407|9234540|P2|26-Week Randomized Phase|Adverse Event|5
2675131|NCT00550407|9234541|P1|26-Week Randomized Phase|Adverse Event|0
2675132|NCT00550407|9234539|P3|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
2675133|NCT00550407|9234540|P2|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
2675134|NCT00550407|9234541|P1|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1
2675135|NCT00550407|9234539|P3|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
2675136|NCT00550407|9234540|P2|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
2675137|NCT00550407|9234541|P1|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6
2675138|NCT00550407|9234539|P3|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
2675139|NCT00550407|9234540|P2|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
2675140|NCT00550407|9234541|P1|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8
2675141|NCT00550407|9234539|P3|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
2675142|NCT00550407|9234540|P2|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
2675143|NCT00550407|9234541|P1|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1
2675144|NCT00550407|9234539|P3|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
2675145|NCT00550407|9234540|P2|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
2675146|NCT00550407|9234541|P1|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1
2675147|NCT00550407|9234539|P3|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
2675148|NCT00550407|9234540|P2|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
2675149|NCT00550407|9234541|P1|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1
2675150|NCT00550407|9234539|P3|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
2675151|NCT00550407|9234540|P2|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
2675152|NCT00550407|9234541|P1|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39
2675153|NCT00550407|9234539|P3|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
2675154|NCT00550407|9234540|P2|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
2675155|NCT00550407|9234541|P1|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55
2675156|NCT00550238|9234613|P1|Overall Study|Sponsor decision|55
2675157|NCT00550238|9234613|P1|Overall Study|Lost to Follow-up|13
2675158|NCT00550238|9234613|P1|Overall Study|Patient noncompliance|25
2675159|NCT00550238|9234613|P1|Overall Study|Physician Decision|31
2675160|NCT00550238|9234613|P1|Overall Study|Withdrawal by Subject|167
2675161|NCT00550238|9234613|P1|Overall Study|Disease progression|46
2675162|NCT00550238|9234613|P1|Overall Study|Death|34
2675163|NCT00550238|9234613|P1|Overall Study|Adverse Event|88
2675164|NCT00550173|9234620|P3|Overall Study|Lost to Follow-up|3
2675165|NCT00550173|9234621|P2|Overall Study|Lost to Follow-up|4
2675166|NCT00550173|9234622|P1|Overall Study|Lost to Follow-up|4
2675167|NCT00550173|9234620|P3|Overall Study|Sponsor Decision|1
2675168|NCT00550173|9234621|P2|Overall Study|Sponsor Decision|7
2675169|NCT00550173|9234622|P1|Overall Study|Sponsor Decision|13
2675170|NCT00550173|9234620|P3|Overall Study|Withdrawal by Subject|17
2675171|NCT00550173|9234621|P2|Overall Study|Withdrawal by Subject|12
2675172|NCT00550173|9234622|P1|Overall Study|Withdrawal by Subject|9
2675173|NCT00550173|9234620|P3|Overall Study|Physician Decision|2
2675174|NCT00550173|9234621|P2|Overall Study|Physician Decision|2
2675175|NCT00550173|9234622|P1|Overall Study|Physician Decision|1
2675176|NCT00550173|9234620|P3|Overall Study|Death|50
2675177|NCT00550173|9234621|P2|Overall Study|Death|38
2675178|NCT00550173|9234622|P1|Overall Study|Death|45
2675179|NCT00550147|9234651|P1|Quetiapine Addition Treatment Period|Moved out of state|1
2675180|NCT00550147|9234651|P1|Quetiapine Addition Treatment Period|Noncompliance|2
2675181|NCT00550147|9234651|P1|Quetiapine Addition Treatment Period|Adverse Event|3
2675182|NCT00550147|9234651|P1|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2
2675183|NCT00550147|9234651|P1|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4
2675184|NCT00550043|9234674|P5|Overall Study|Other Reasons- Unspecified|0
2675185|NCT00550043|9234675|P4|Overall Study|Other Reasons- Unspecified|1
2675186|NCT00550043|9234676|P3|Overall Study|Other Reasons- Unspecified|0
2675187|NCT00550043|9234677|P2|Overall Study|Other Reasons- Unspecified|1
2675188|NCT00550043|9234678|P1|Overall Study|Other Reasons- Unspecified|0
2675189|NCT00550043|9234674|P5|Overall Study|Subject Withdrew Consent|0
2675190|NCT00550043|9234675|P4|Overall Study|Subject Withdrew Consent|0
2675191|NCT00550043|9234676|P3|Overall Study|Subject Withdrew Consent|1
2675192|NCT00550043|9234677|P2|Overall Study|Subject Withdrew Consent|2
2675193|NCT00550043|9234678|P1|Overall Study|Subject Withdrew Consent|0
2675194|NCT00550043|9234674|P5|Overall Study|Adverse Event|1
2675195|NCT00550043|9234675|P4|Overall Study|Adverse Event|1
2675196|NCT00550043|9234676|P3|Overall Study|Adverse Event|0
2675197|NCT00550043|9234677|P2|Overall Study|Adverse Event|0
2675198|NCT00550043|9234678|P1|Overall Study|Adverse Event|0
2675199|NCT00549939|9234733|P3|40-week Open Label Treatment Period|Other|4
2675200|NCT00549939|9234734|P2|40-week Open Label Treatment Period|Other|1
2675201|NCT00549939|9234735|P1|40-week Open Label Treatment Period|Other|0
2675202|NCT00549939|9234733|P3|40-week Open Label Treatment Period|Protocol Violation|0
2675203|NCT00549939|9234734|P2|40-week Open Label Treatment Period|Protocol Violation|1
2675204|NCT00549939|9234735|P1|40-week Open Label Treatment Period|Protocol Violation|0
2675205|NCT00549939|9234733|P3|40-week Open Label Treatment Period|Lack of Efficacy|0
2675206|NCT00549939|9234734|P2|40-week Open Label Treatment Period|Lack of Efficacy|1
2675207|NCT00549939|9234735|P1|40-week Open Label Treatment Period|Lack of Efficacy|0
2675208|NCT00549939|9234733|P3|40-week Open Label Treatment Period|Adverse Event|1
2675209|NCT00549939|9234734|P2|40-week Open Label Treatment Period|Adverse Event|2
2675210|NCT00549939|9234735|P1|40-week Open Label Treatment Period|Adverse Event|0
2675211|NCT00549939|9234733|P3|12-week Double Blind Treatment Period|Too many blood draws|0
2675212|NCT00549939|9234734|P2|12-week Double Blind Treatment Period|Too many blood draws|1
2675213|NCT00549939|9234735|P1|12-week Double Blind Treatment Period|Too many blood draws|0
2675214|NCT00549939|9234733|P3|12-week Double Blind Treatment Period|Adverse Event|2
2675215|NCT00549939|9234734|P2|12-week Double Blind Treatment Period|Adverse Event|1
2675216|NCT00549939|9234735|P1|12-week Double Blind Treatment Period|Adverse Event|1
2675217|NCT00549900|9234762|P1|Overall Study|Adverse Event|1
2675218|NCT00549770|9234818|P8|Overall Study|Adverse Event|4
2675219|NCT00549770|9234819|P7|Overall Study|Adverse Event|5
2675220|NCT00549770|9234820|P6|Overall Study|Adverse Event|0
2675221|NCT00549770|9234821|P5|Overall Study|Adverse Event|1
2675222|NCT00549770|9234822|P4|Overall Study|Adverse Event|2
2675223|NCT00549770|9234823|P3|Overall Study|Adverse Event|1
2675224|NCT00549770|9234824|P2|Overall Study|Adverse Event|3
2675225|NCT00549770|9234825|P1|Overall Study|Adverse Event|1
2675226|NCT00549770|9234818|P8|Overall Study|Abnormal laboratory values|0
2675227|NCT00549770|9234819|P7|Overall Study|Abnormal laboratory values|0
2675228|NCT00549770|9234820|P6|Overall Study|Abnormal laboratory values|1
2675229|NCT00549770|9234821|P5|Overall Study|Abnormal laboratory values|0
2675230|NCT00549770|9234822|P4|Overall Study|Abnormal laboratory values|0
2675231|NCT00549770|9234823|P3|Overall Study|Abnormal laboratory values|0
2675232|NCT00549770|9234824|P2|Overall Study|Abnormal laboratory values|0
2675233|NCT00549770|9234825|P1|Overall Study|Abnormal laboratory values|0
2675234|NCT00549770|9234818|P8|Overall Study|Abnormal test procedure results|1
2675235|NCT00549770|9234819|P7|Overall Study|Abnormal test procedure results|1
2675236|NCT00549770|9234820|P6|Overall Study|Abnormal test procedure results|1
2675237|NCT00549770|9234821|P5|Overall Study|Abnormal test procedure results|0
2675238|NCT00549770|9234822|P4|Overall Study|Abnormal test procedure results|2
2675239|NCT00549770|9234823|P3|Overall Study|Abnormal test procedure results|0
2675240|NCT00549770|9234824|P2|Overall Study|Abnormal test procedure results|0
2675241|NCT00549770|9234825|P1|Overall Study|Abnormal test procedure results|0
2675242|NCT00549770|9234818|P8|Overall Study|Lack of Efficacy|8
2675243|NCT00549770|9234819|P7|Overall Study|Lack of Efficacy|3
2675244|NCT00549770|9234820|P6|Overall Study|Lack of Efficacy|1
2675245|NCT00549770|9234821|P5|Overall Study|Lack of Efficacy|5
2675246|NCT00549770|9234822|P4|Overall Study|Lack of Efficacy|3
2675247|NCT00549770|9234823|P3|Overall Study|Lack of Efficacy|2
2675248|NCT00549770|9234824|P2|Overall Study|Lack of Efficacy|0
2675249|NCT00549770|9234825|P1|Overall Study|Lack of Efficacy|1
2675250|NCT00549770|9234818|P8|Overall Study|Withdrawal by Subject|9
2675251|NCT00549770|9234819|P7|Overall Study|Withdrawal by Subject|4
2675252|NCT00549770|9234820|P6|Overall Study|Withdrawal by Subject|6
2675253|NCT00549770|9234821|P5|Overall Study|Withdrawal by Subject|6
2675254|NCT00549770|9234822|P4|Overall Study|Withdrawal by Subject|5
2675255|NCT00549770|9234823|P3|Overall Study|Withdrawal by Subject|4
2675256|NCT00549770|9234824|P2|Overall Study|Withdrawal by Subject|6
2675257|NCT00549770|9234825|P1|Overall Study|Withdrawal by Subject|4
2675258|NCT00549770|9234818|P8|Overall Study|Lost to Follow-up|0
2675259|NCT00549770|9234819|P7|Overall Study|Lost to Follow-up|0
2675260|NCT00549770|9234820|P6|Overall Study|Lost to Follow-up|2
2675261|NCT00549770|9234821|P5|Overall Study|Lost to Follow-up|3
2675262|NCT00549770|9234822|P4|Overall Study|Lost to Follow-up|2
2675263|NCT00549770|9234823|P3|Overall Study|Lost to Follow-up|2
2675264|NCT00549770|9234824|P2|Overall Study|Lost to Follow-up|0
2675265|NCT00549770|9234825|P1|Overall Study|Lost to Follow-up|0
2675266|NCT00549770|9234818|P8|Overall Study|Administrative problems|1
2675267|NCT00549770|9234819|P7|Overall Study|Administrative problems|0
2675268|NCT00549770|9234820|P6|Overall Study|Administrative problems|0
2675269|NCT00549770|9234821|P5|Overall Study|Administrative problems|0
2675270|NCT00549770|9234822|P4|Overall Study|Administrative problems|0
2675271|NCT00549770|9234823|P3|Overall Study|Administrative problems|0
2675272|NCT00549770|9234824|P2|Overall Study|Administrative problems|1
2675273|NCT00549770|9234825|P1|Overall Study|Administrative problems|0
2675274|NCT00549770|9234818|P8|Overall Study|Protocol deviation|2
2675275|NCT00549770|9234819|P7|Overall Study|Protocol deviation|1
2675276|NCT00549770|9234820|P6|Overall Study|Protocol deviation|2
2675277|NCT00549770|9234821|P5|Overall Study|Protocol deviation|2
2675278|NCT00549770|9234822|P4|Overall Study|Protocol deviation|2
2675279|NCT00549770|9234823|P3|Overall Study|Protocol deviation|1
2675280|NCT00549770|9234824|P2|Overall Study|Protocol deviation|1
2675281|NCT00549770|9234825|P1|Overall Study|Protocol deviation|1
2675282|NCT00549757|9234909|P2|Extension Period (in Average 9 Months)|Patient's request|436
2675283|NCT00549757|9234910|P1|Extension Period (in Average 9 Months)|Patient's request|421
2675284|NCT00549757|9234909|P2|Extension Period (in Average 9 Months)|Withdrawal by Subject|16
2675285|NCT00549757|9234910|P1|Extension Period (in Average 9 Months)|Withdrawal by Subject|9
2675286|NCT00549757|9234909|P2|Extension Period (in Average 9 Months)|Lost to Follow-up|47
2675287|NCT00549757|9234910|P1|Extension Period (in Average 9 Months)|Lost to Follow-up|52
2675288|NCT00549757|9234909|P2|Extension Period (in Average 9 Months)|Death|136
2675289|NCT00549757|9234910|P1|Extension Period (in Average 9 Months)|Death|143
2675290|NCT00549757|9234909|P2|Active Treatment Phase: Max. 50 Months|Missing data|9
2675291|NCT00549757|9234910|P1|Active Treatment Phase: Max. 50 Months|Missing data|8
2675375|NCT00549549|9235043|P2|Overall Study|Lost to Follow-up|0
2675292|NCT00549757|9234909|P2|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55
2675293|NCT00549757|9234910|P1|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69
2675294|NCT00549757|9234909|P2|Active Treatment Phase: Max. 50 Months|Patient's request|380
2675295|NCT00549757|9234910|P1|Active Treatment Phase: Max. 50 Months|Patient's request|353
2675296|NCT00549757|9234909|P2|Active Treatment Phase: Max. 50 Months|Death|200
2675297|NCT00549757|9234910|P1|Active Treatment Phase: Max. 50 Months|Death|188
2675298|NCT00549757|9234909|P2|Active Treatment Phase: Max. 50 Months|Administrative problems|3019
2675299|NCT00549757|9234910|P1|Active Treatment Phase: Max. 50 Months|Administrative problems|2857
2675300|NCT00549757|9234909|P2|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29
2675301|NCT00549757|9234910|P1|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41
2675302|NCT00549757|9234909|P2|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
2675303|NCT00549757|9234910|P1|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
2675304|NCT00549757|9234909|P2|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53
2675305|NCT00549757|9234910|P1|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47
2675306|NCT00549757|9234909|P2|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
2675307|NCT00549757|9234910|P1|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
2675308|NCT00549757|9234909|P2|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58
2675309|NCT00549757|9234910|P1|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98
2675310|NCT00549757|9234909|P2|Active Treatment Phase: Max. 50 Months|Adverse Event|462
2675311|NCT00549757|9234910|P1|Active Treatment Phase: Max. 50 Months|Adverse Event|590
2675312|NCT00549718|9234972|P4|Overall Study|Administrative|1
2675313|NCT00549718|9234973|P3|Overall Study|Administrative|2
2675314|NCT00549718|9234974|P2|Overall Study|Administrative|2
2675315|NCT00549718|9234975|P1|Overall Study|Administrative|2
2675316|NCT00549718|9234972|P4|Overall Study|Withdrawal by Subject|13
2675317|NCT00549718|9234973|P3|Overall Study|Withdrawal by Subject|12
2675318|NCT00549718|9234974|P2|Overall Study|Withdrawal by Subject|18
2675319|NCT00549718|9234975|P1|Overall Study|Withdrawal by Subject|9
2675320|NCT00549718|9234972|P4|Overall Study|Lost to Follow-up|6
2675321|NCT00549718|9234973|P3|Overall Study|Lost to Follow-up|0
2675322|NCT00549718|9234974|P2|Overall Study|Lost to Follow-up|2
2675323|NCT00549718|9234975|P1|Overall Study|Lost to Follow-up|4
2675324|NCT00549718|9234972|P4|Overall Study|Adverse Event|3
2675325|NCT00549718|9234973|P3|Overall Study|Adverse Event|7
2675326|NCT00549718|9234974|P2|Overall Study|Adverse Event|8
2675327|NCT00549718|9234975|P1|Overall Study|Adverse Event|6
2675328|NCT00549718|9234972|P4|Overall Study|Insufficient clinical response|32
2675329|NCT00549718|9234973|P3|Overall Study|Insufficient clinical response|18
2675330|NCT00549718|9234974|P2|Overall Study|Insufficient clinical response|7
2675331|NCT00549718|9234975|P1|Overall Study|Insufficient clinical response|20
2675332|NCT00549640|9234991|P2|Overall Study|Lost to Follow-up|4
2675333|NCT00549640|9234992|P1|Overall Study|Lost to Follow-up|7
2675334|NCT00549640|9234991|P2|Overall Study|Adverse Event|0
2675335|NCT00549640|9234992|P1|Overall Study|Adverse Event|5
2675336|NCT00549640|9234991|P2|Overall Study|Withdrawal by Subject|12
2675337|NCT00549640|9234992|P1|Overall Study|Withdrawal by Subject|6
2675338|NCT00549601|9235005|P3|Received Study Drug|Withdrawal by Subject|1
2675339|NCT00549601|9235006|P2|Received Study Drug|Withdrawal by Subject|0
2675340|NCT00549601|9235007|P1|Received Study Drug|Withdrawal by Subject|2
2675341|NCT00549601|9235005|P3|Received Study Drug|Protocol Violation|1
2675342|NCT00549601|9235006|P2|Received Study Drug|Protocol Violation|4
2675343|NCT00549601|9235007|P1|Received Study Drug|Protocol Violation|3
2675344|NCT00549601|9235005|P3|Received Study Drug|Lost to Follow-up|1
2675345|NCT00549601|9235006|P2|Received Study Drug|Lost to Follow-up|1
2675346|NCT00549601|9235007|P1|Received Study Drug|Lost to Follow-up|0
2675347|NCT00549601|9235005|P3|Received Study Drug|Death|0
2675348|NCT00549601|9235006|P2|Received Study Drug|Death|1
2675349|NCT00549601|9235007|P1|Received Study Drug|Death|0
2675350|NCT00549601|9235005|P3|Received Study Drug|Adverse Event|1
2675351|NCT00549601|9235006|P2|Received Study Drug|Adverse Event|5
2675352|NCT00549601|9235007|P1|Received Study Drug|Adverse Event|2
2675353|NCT00549601|9235005|P3|Randomized|Withdrawal by Subject|1
2675354|NCT00549601|9235006|P2|Randomized|Withdrawal by Subject|1
2675355|NCT00549601|9235007|P1|Randomized|Withdrawal by Subject|0
2675356|NCT00549601|9235005|P3|Randomized|Protocol Violation|1
2675357|NCT00549601|9235006|P2|Randomized|Protocol Violation|0
2675358|NCT00549601|9235007|P1|Randomized|Protocol Violation|0
2675359|NCT00549562|9235029|P1|Overall Study|Lack of Efficacy|1
2675360|NCT00549562|9235029|P1|Overall Study|Adverse Event|1
2675361|NCT00549549|9235041|P4|Overall Study|Randomized but not treated|1
2675362|NCT00549549|9235042|P3|Overall Study|Randomized but not treated|1
2675363|NCT00549549|9235043|P2|Overall Study|Randomized but not treated|0
2675364|NCT00549549|9235044|P1|Overall Study|Randomized but not treated|0
2675365|NCT00549549|9235041|P4|Overall Study|Other|11
2675366|NCT00549549|9235042|P3|Overall Study|Other|9
2675367|NCT00549549|9235043|P2|Overall Study|Other|9
2675368|NCT00549549|9235044|P1|Overall Study|Other|9
2675369|NCT00549549|9235041|P4|Overall Study|Withdrawal by Subject|0
2675370|NCT00549549|9235042|P3|Overall Study|Withdrawal by Subject|1
2675371|NCT00549549|9235043|P2|Overall Study|Withdrawal by Subject|4
2675372|NCT00549549|9235044|P1|Overall Study|Withdrawal by Subject|0
2675373|NCT00549549|9235041|P4|Overall Study|Lost to Follow-up|2
2675374|NCT00549549|9235042|P3|Overall Study|Lost to Follow-up|1
2675376|NCT00549549|9235044|P1|Overall Study|Lost to Follow-up|1
2675377|NCT00549549|9235041|P4|Overall Study|Lack of Efficacy|2
2675378|NCT00549549|9235042|P3|Overall Study|Lack of Efficacy|4
2675379|NCT00549549|9235043|P2|Overall Study|Lack of Efficacy|6
2675380|NCT00549549|9235044|P1|Overall Study|Lack of Efficacy|9
2675381|NCT00549549|9235041|P4|Overall Study|Adverse Event|9
2675382|NCT00549549|9235042|P3|Overall Study|Adverse Event|1
2675383|NCT00549549|9235043|P2|Overall Study|Adverse Event|3
2675384|NCT00549549|9235044|P1|Overall Study|Adverse Event|5
2675385|NCT00549445|9235112|P2|Overall Study|Sputum & Blood Samples Not Available|17
2675386|NCT00549445|9235113|P1|Overall Study|Sputum & Blood Samples Not Available|15
2675387|NCT00549328|9235132|P1|Overall Study|Use of Prohibited Medication|1
2675388|NCT00549328|9235132|P1|Overall Study|Death|1
2675389|NCT00549328|9235132|P1|Overall Study|Disease Progression|10
2675390|NCT00549328|9235132|P1|Overall Study|Adverse Event|2
2675391|NCT00549302|9235143|P3|Open-Label|Withdrawal by Subject|6
2675392|NCT00549302|9235144|P2|Open-Label|Withdrawal by Subject|0
2675393|NCT00549302|9235145|P1|Open-Label|Withdrawal by Subject|0
2675394|NCT00549302|9235143|P3|Open-Label|New drug pulmonary atrial hypertension|2
2675395|NCT00549302|9235144|P2|Open-Label|New drug pulmonary atrial hypertension|0
2675396|NCT00549302|9235145|P1|Open-Label|New drug pulmonary atrial hypertension|0
2675397|NCT00549302|9235143|P3|Open-Label|Other|3
2675398|NCT00549302|9235144|P2|Open-Label|Other|0
2675399|NCT00549302|9235145|P1|Open-Label|Other|0
2675400|NCT00549302|9235143|P3|Open-Label|Lost to Follow-up|2
2675401|NCT00549302|9235144|P2|Open-Label|Lost to Follow-up|0
2675402|NCT00549302|9235145|P1|Open-Label|Lost to Follow-up|0
2675403|NCT00549302|9235143|P3|Open-Label|Investigator Decision|5
2675404|NCT00549302|9235144|P2|Open-Label|Investigator Decision|0
2675405|NCT00549302|9235145|P1|Open-Label|Investigator Decision|0
2675406|NCT00549302|9235143|P3|Open-Label|Death|40
2675407|NCT00549302|9235144|P2|Open-Label|Death|0
2675408|NCT00549302|9235145|P1|Open-Label|Death|0
2675409|NCT00549302|9235143|P3|Open-Label|Adverse Event|11
2675410|NCT00549302|9235144|P2|Open-Label|Adverse Event|0
2675411|NCT00549302|9235145|P1|Open-Label|Adverse Event|0
2675412|NCT00549302|9235143|P3|Double-Blind|New condition or starts new therapy|0
2675413|NCT00549302|9235144|P2|Double-Blind|New condition or starts new therapy|2
2675414|NCT00549302|9235145|P1|Double-Blind|New condition or starts new therapy|0
2675415|NCT00549302|9235143|P3|Double-Blind|New Drug Pulmonary Atrial Hypertension|0
2675416|NCT00549302|9235144|P2|Double-Blind|New Drug Pulmonary Atrial Hypertension|10
2675417|NCT00549302|9235145|P1|Double-Blind|New Drug Pulmonary Atrial Hypertension|1
2675418|NCT00549302|9235143|P3|Double-Blind|Lost to Follow-up|0
2675419|NCT00549302|9235144|P2|Double-Blind|Lost to Follow-up|2
2675420|NCT00549302|9235145|P1|Double-Blind|Lost to Follow-up|1
2675421|NCT00549302|9235143|P3|Double-Blind|Sponsor Decision|0
2675422|NCT00549302|9235144|P2|Double-Blind|Sponsor Decision|1
2675423|NCT00549302|9235145|P1|Double-Blind|Sponsor Decision|0
2675424|NCT00549302|9235143|P3|Double-Blind|Investigator Decision|0
2675425|NCT00549302|9235144|P2|Double-Blind|Investigator Decision|5
2675426|NCT00549302|9235145|P1|Double-Blind|Investigator Decision|1
2675427|NCT00549302|9235143|P3|Double-Blind|Withdrawal by Subject|0
2675428|NCT00549302|9235144|P2|Double-Blind|Withdrawal by Subject|8
2675429|NCT00549302|9235145|P1|Double-Blind|Withdrawal by Subject|3
2675430|NCT00549302|9235143|P3|Double-Blind|Adverse Event|0
2675431|NCT00549302|9235144|P2|Double-Blind|Adverse Event|16
2675432|NCT00549302|9235145|P1|Double-Blind|Adverse Event|3
2675433|NCT00549302|9235143|P3|Double-Blind|Death|0
2675434|NCT00549302|9235144|P2|Double-Blind|Death|9
2675435|NCT00549302|9235145|P1|Double-Blind|Death|2
2675436|NCT00549198|9235157|P2|Overall Study|Not Exposed to Study Drug|4
2675437|NCT00549198|9235158|P1|Overall Study|Not Exposed to Study Drug|3
2675438|NCT00549198|9235157|P2|Overall Study|Pregnancy|3
2675439|NCT00549198|9235158|P1|Overall Study|Pregnancy|0
2675440|NCT00549198|9235157|P2|Overall Study|No scan facilities|2
2675441|NCT00549198|9235158|P1|Overall Study|No scan facilities|0
2675442|NCT00549198|9235157|P2|Overall Study|Participant overweight, no scan possible|0
2675443|NCT00549198|9235158|P1|Overall Study|Participant overweight, no scan possible|1
2675444|NCT00549198|9235157|P2|Overall Study|Participant planning pregnancy|0
2675445|NCT00549198|9235158|P1|Overall Study|Participant planning pregnancy|1
2675446|NCT00549198|9235157|P2|Overall Study|Prohibited Medication|2
2675447|NCT00549198|9235158|P1|Overall Study|Prohibited Medication|1
2675448|NCT00549198|9235157|P2|Overall Study|Participant moved.Week 96 visit, no scan|0
2675449|NCT00549198|9235158|P1|Overall Study|Participant moved.Week 96 visit, no scan|1
2675450|NCT00549198|9235157|P2|Overall Study|Participant not able to perform Week 96|0
2675451|NCT00549198|9235158|P1|Overall Study|Participant not able to perform Week 96|1
2675452|NCT00549198|9235157|P2|Overall Study|Participant Moved|0
2675453|NCT00549198|9235158|P1|Overall Study|Participant Moved|2
2675454|NCT00549198|9235157|P2|Overall Study|Disease Progression|0
2675455|NCT00549198|9235158|P1|Overall Study|Disease Progression|1
2675456|NCT00549198|9235157|P2|Overall Study|Withdrawal by Subject|7
2675457|NCT00549198|9235158|P1|Overall Study|Withdrawal by Subject|7
2675458|NCT00549198|9235157|P2|Overall Study|Investigator Decision|3
2675459|NCT00549198|9235158|P1|Overall Study|Investigator Decision|4
2675460|NCT00549198|9235157|P2|Overall Study|Protocol Violation|2
2675461|NCT00549198|9235158|P1|Overall Study|Protocol Violation|7
2675462|NCT00549198|9235157|P2|Overall Study|Treatment Eligibility Criteria Not Met|0
2675463|NCT00549198|9235158|P1|Overall Study|Treatment Eligibility Criteria Not Met|3
2675464|NCT00549198|9235157|P2|Overall Study|Lost to Follow-up|8
2675465|NCT00549198|9235158|P1|Overall Study|Lost to Follow-up|7
2675466|NCT00549198|9235157|P2|Overall Study|Non-compliance|4
2675467|NCT00549198|9235158|P1|Overall Study|Non-compliance|2
2675468|NCT00549198|9235157|P2|Overall Study|Protocol-defined Virological Failure|0
2675469|NCT00549198|9235158|P1|Overall Study|Protocol-defined Virological Failure|7
2675470|NCT00549198|9235157|P2|Overall Study|Insufficient Viral Load Response|2
2675471|NCT00549198|9235158|P1|Overall Study|Insufficient Viral Load Response|4
2675472|NCT00549198|9235157|P2|Overall Study|Adverse Event|26
2675473|NCT00549198|9235158|P1|Overall Study|Adverse Event|28
2675474|NCT00549055|9235295|P1|Overall Study|Very low visual acuity (VA)|1
2675475|NCT00549055|9235295|P1|Overall Study|Choroidal neovascularization|1
2675476|NCT00549055|9235295|P1|Overall Study|Growth choroidal neovascularisation|1
2675477|NCT00549055|9235295|P1|Overall Study|Vitreous hemorrhage|1
2675478|NCT00549055|9235295|P1|Overall Study|Active choroidal neovascula increased|1
2675479|NCT00549055|9235295|P1|Overall Study|Decrease of size|1
2675480|NCT00549055|9235295|P1|Overall Study|Progression to fibrosis|2
2675481|NCT00549055|9235295|P1|Overall Study|Stabilization|5
2675482|NCT00549055|9235295|P1|Overall Study|Lack of Efficacy|18
2675483|NCT00549055|9235295|P1|Overall Study|Adverse Event|4
2675484|NCT00548847|9235319|P1|Overall Study|Disease progression|7
2675485|NCT00548808|9235326|P2|Overall Study|Sponsor Decision|1
2675486|NCT00548808|9235327|P1|Overall Study|Sponsor Decision|1
2675487|NCT00548808|9235326|P2|Overall Study|Lack of Efficacy|0
2675488|NCT00548808|9235327|P1|Overall Study|Lack of Efficacy|2
2675489|NCT00548808|9235326|P2|Overall Study|Entry Criteria Not Met|2
2675490|NCT00548808|9235327|P1|Overall Study|Entry Criteria Not Met|2
2675491|NCT00548808|9235326|P2|Overall Study|Death|0
2675492|NCT00548808|9235327|P1|Overall Study|Death|2
2675493|NCT00548808|9235326|P2|Overall Study|Adverse Event|5
2675494|NCT00548808|9235327|P1|Overall Study|Adverse Event|4
2675495|NCT00548808|9235326|P2|Overall Study|Physician Decision|3
2675496|NCT00548808|9235327|P1|Overall Study|Physician Decision|6
2675497|NCT00548808|9235326|P2|Overall Study|Withdrawal by Subject|4
2675498|NCT00548808|9235327|P1|Overall Study|Withdrawal by Subject|8
2675499|NCT00548808|9235326|P2|Overall Study|Protocol Violation|8
2675500|NCT00548808|9235327|P1|Overall Study|Protocol Violation|8
2675501|NCT00548808|9235326|P2|Overall Study|Lost to Follow-up|3
2675502|NCT00548808|9235327|P1|Overall Study|Lost to Follow-up|9
2675503|NCT00548717|9235351|P2|Overall Study|Alternative treatment for GVHD|0
2675504|NCT00548717|9235352|P1|Overall Study|Alternative treatment for GVHD|1
2675505|NCT00548717|9235351|P2|Overall Study|Relapse|0
2675506|NCT00548717|9235352|P1|Overall Study|Relapse|3
2675507|NCT00548717|9235351|P2|Overall Study|Death|2
2675508|NCT00548717|9235352|P1|Overall Study|Death|5
2675509|NCT00548548|9235396|P2|Overall Study|Lost to Follow-up|18
2675510|NCT00548548|9235397|P1|Overall Study|Lost to Follow-up|17
2675511|NCT00548548|9235396|P2|Overall Study|Death|348
2675512|NCT00548548|9235397|P1|Overall Study|Death|345
2675513|NCT00548405|9235440|P3|Overall Study|Randomized but not treated|0
2675514|NCT00548405|9235441|P2|Overall Study|Randomized but not treated|0
2675515|NCT00548405|9235442|P1|Overall Study|Randomized but not treated|1
2675516|NCT00548405|9235440|P3|Overall Study|Sponsor decision|0
2675517|NCT00548405|9235441|P2|Overall Study|Sponsor decision|0
2675518|NCT00548405|9235442|P1|Overall Study|Sponsor decision|1
2675519|NCT00548405|9235440|P3|Overall Study|Death|1
2675520|NCT00548405|9235441|P2|Overall Study|Death|1
2675521|NCT00548405|9235442|P1|Overall Study|Death|0
2675522|NCT00548405|9235440|P3|Overall Study|Lost to Follow-up|2
2675523|NCT00548405|9235441|P2|Overall Study|Lost to Follow-up|1
2675524|NCT00548405|9235442|P1|Overall Study|Lost to Follow-up|1
2675525|NCT00548405|9235440|P3|Overall Study|Withdrawal by Subject|5
2675526|NCT00548405|9235441|P2|Overall Study|Withdrawal by Subject|12
2675527|NCT00548405|9235442|P1|Overall Study|Withdrawal by Subject|36
2675528|NCT00548405|9235440|P3|Overall Study|Protocol Violation|0
2675529|NCT00548405|9235441|P2|Overall Study|Protocol Violation|0
2675530|NCT00548405|9235442|P1|Overall Study|Protocol Violation|1
2675531|NCT00548405|9235440|P3|Overall Study|Pregnancy|0
2675532|NCT00548405|9235441|P2|Overall Study|Pregnancy|0
2675533|NCT00548405|9235442|P1|Overall Study|Pregnancy|1
2675534|NCT00548405|9235440|P3|Overall Study|Physician Decision|1
2675535|NCT00548405|9235441|P2|Overall Study|Physician Decision|4
2675536|NCT00548405|9235442|P1|Overall Study|Physician Decision|3
2675537|NCT00548405|9235440|P3|Overall Study|Lack of Efficacy|0
2675538|NCT00548405|9235441|P2|Overall Study|Lack of Efficacy|0
2675539|NCT00548405|9235442|P1|Overall Study|Lack of Efficacy|6
2675540|NCT00548405|9235440|P3|Overall Study|Adverse Event|0
2675541|NCT00548405|9235441|P2|Overall Study|Adverse Event|2
2675542|NCT00548405|9235442|P1|Overall Study|Adverse Event|6
2675543|NCT00548340|9235463|P3|Overall Study|Other|1
2675544|NCT00548340|9235464|P2|Overall Study|Other|1
2675545|NCT00548340|9235465|P1|Overall Study|Other|1
2675546|NCT00548340|9235463|P3|Overall Study|Withdrawal by Subject|3
2675547|NCT00548340|9235464|P2|Overall Study|Withdrawal by Subject|4
2675548|NCT00548340|9235465|P1|Overall Study|Withdrawal by Subject|2
2675549|NCT00548340|9235463|P3|Overall Study|Lost to Follow-up|0
2675550|NCT00548340|9235464|P2|Overall Study|Lost to Follow-up|1
2675551|NCT00548340|9235465|P1|Overall Study|Lost to Follow-up|1
2675552|NCT00548340|9235463|P3|Overall Study|Adverse Event|2
2675553|NCT00548340|9235464|P2|Overall Study|Adverse Event|2
2675554|NCT00548340|9235465|P1|Overall Study|Adverse Event|2
2675555|NCT00548340|9235463|P3|Overall Study|Protocol Violation|3
2675556|NCT00548340|9235464|P2|Overall Study|Protocol Violation|3
2675557|NCT00548340|9235465|P1|Overall Study|Protocol Violation|2
2675558|NCT00548327|9235484|P2|Overall Study|Adverse Event|1
2675559|NCT00548327|9235485|P1|Overall Study|Adverse Event|0
2675560|NCT00548262|9235503|P1|Overall Study|Withdrawal by Subject|1
2675561|NCT00548262|9235503|P1|Overall Study|Other|3
2675562|NCT00548262|9235503|P1|Overall Study|Lost to Follow-up|1
2675563|NCT00548262|9235503|P1|Overall Study|Lack of Efficacy|4
2675564|NCT00548262|9235503|P1|Overall Study|Adverse Event|2
2675565|NCT00548262|9235503|P1|Overall Study|Death|21
2675566|NCT00548249|9235533|P5|Overall Study|Sponsor's request|0
2675567|NCT00548249|9235534|P4|Overall Study|Sponsor's request|1
2675568|NCT00548249|9235535|P3|Overall Study|Sponsor's request|0
2675569|NCT00548249|9235536|P2|Overall Study|Sponsor's request|0
2675570|NCT00548249|9235537|P1|Overall Study|Sponsor's request|0
2675571|NCT00548249|9235533|P5|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
2675572|NCT00548249|9235534|P4|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
2675573|NCT00548249|9235535|P3|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
2675574|NCT00548249|9235536|P2|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
2675575|NCT00548249|9235537|P1|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
2675576|NCT00548249|9235533|P5|Overall Study|Withdrawal by Subject|0
2675577|NCT00548249|9235534|P4|Overall Study|Withdrawal by Subject|0
2675578|NCT00548249|9235535|P3|Overall Study|Withdrawal by Subject|0
2675579|NCT00548249|9235536|P2|Overall Study|Withdrawal by Subject|0
2675580|NCT00548249|9235537|P1|Overall Study|Withdrawal by Subject|2
2675581|NCT00548249|9235533|P5|Overall Study|Prolonged hospitalization|0
2675582|NCT00548249|9235534|P4|Overall Study|Prolonged hospitalization|1
2675583|NCT00548249|9235535|P3|Overall Study|Prolonged hospitalization|2
2675584|NCT00548249|9235536|P2|Overall Study|Prolonged hospitalization|0
2675585|NCT00548249|9235537|P1|Overall Study|Prolonged hospitalization|0
2675586|NCT00548249|9235533|P5|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0
2675587|NCT00548249|9235534|P4|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
2675588|NCT00548249|9235535|P3|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
2675589|NCT00548249|9235536|P2|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
2675590|NCT00548249|9235537|P1|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
2675591|NCT00548249|9235533|P5|Overall Study|Erythropoietin (ESA)Dose Change Required|2
2675592|NCT00548249|9235534|P4|Overall Study|Erythropoietin (ESA)Dose Change Required|2
2675593|NCT00548249|9235535|P3|Overall Study|Erythropoietin (ESA)Dose Change Required|1
2675594|NCT00548249|9235536|P2|Overall Study|Erythropoietin (ESA)Dose Change Required|0
2675595|NCT00548249|9235537|P1|Overall Study|Erythropoietin (ESA)Dose Change Required|0
2675596|NCT00548249|9235533|P5|Overall Study|Post-dialysis high TSAT or low UIBC|2
2675597|NCT00548249|9235534|P4|Overall Study|Post-dialysis high TSAT or low UIBC|3
2675598|NCT00548249|9235535|P3|Overall Study|Post-dialysis high TSAT or low UIBC|1
2675599|NCT00548249|9235536|P2|Overall Study|Post-dialysis high TSAT or low UIBC|0
2675600|NCT00548249|9235537|P1|Overall Study|Post-dialysis high TSAT or low UIBC|0
2675601|NCT00548249|9235533|P5|Overall Study|Adverse Event|1
2675602|NCT00548249|9235534|P4|Overall Study|Adverse Event|1
2675603|NCT00548249|9235535|P3|Overall Study|Adverse Event|0
2675604|NCT00548249|9235536|P2|Overall Study|Adverse Event|2
2675605|NCT00548249|9235537|P1|Overall Study|Adverse Event|2
2675606|NCT00548249|9235533|P5|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4
2675607|NCT00548249|9235534|P4|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1
2675608|NCT00548249|9235535|P3|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2
2675609|NCT00548249|9235536|P2|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
2675610|NCT00548249|9235537|P1|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
2675611|NCT00548249|9235533|P5|Overall Study|Miscellaneous|2
2675612|NCT00548249|9235534|P4|Overall Study|Miscellaneous|0
2675613|NCT00548249|9235535|P3|Overall Study|Miscellaneous|2
2675614|NCT00548249|9235536|P2|Overall Study|Miscellaneous|3
2675615|NCT00548249|9235537|P1|Overall Study|Miscellaneous|2
2675616|NCT00548249|9235533|P5|Overall Study|Protocol Violation|3
2675617|NCT00548249|9235534|P4|Overall Study|Protocol Violation|0
2675618|NCT00548249|9235535|P3|Overall Study|Protocol Violation|4
2675619|NCT00548249|9235536|P2|Overall Study|Protocol Violation|1
2675620|NCT00548249|9235537|P1|Overall Study|Protocol Violation|1
2675621|NCT00548249|9235533|P5|Overall Study|Transferrin Saturation (TSAT) <20%|2
2675622|NCT00548249|9235534|P4|Overall Study|Transferrin Saturation (TSAT) <20%|1
2675623|NCT00548249|9235535|P3|Overall Study|Transferrin Saturation (TSAT) <20%|3
2675624|NCT00548249|9235536|P2|Overall Study|Transferrin Saturation (TSAT) <20%|1
2675625|NCT00548249|9235537|P1|Overall Study|Transferrin Saturation (TSAT) <20%|5
2675626|NCT00548249|9235533|P5|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
2675627|NCT00548249|9235534|P4|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2
2675628|NCT00548249|9235535|P3|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
2675629|NCT00548249|9235536|P2|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
2675630|NCT00548249|9235537|P1|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3
2675631|NCT00548184|9235585|P1|Overall Study|Found Her2 negative|1
2675632|NCT00548184|9235585|P1|Overall Study|took other drug|1
2675633|NCT00548184|9235585|P1|Overall Study|Adverse Event|3
2675634|NCT00548145|9235633|P2|Overall Study|Physician Decision|1
2675635|NCT00548145|9235634|P1|Overall Study|Physician Decision|1
2675636|NCT00548145|9235633|P2|Overall Study|Withdrawal by Subject|2
2675637|NCT00548145|9235634|P1|Overall Study|Withdrawal by Subject|0
2675638|NCT00548145|9235633|P2|Overall Study|Death|1
2675639|NCT00548145|9235634|P1|Overall Study|Death|0
2675640|NCT00548093|9235653|P2|Overall Study|Completed post-treatment follow-up|0
2675641|NCT00548093|9235654|P1|Overall Study|Completed post-treatment follow-up|1
2675642|NCT00548093|9235653|P2|Overall Study|Withdrawal by Subject|0
2675643|NCT00548093|9235654|P1|Overall Study|Withdrawal by Subject|1
2675644|NCT00548093|9235653|P2|Overall Study|Other|1
2675645|NCT00548093|9235654|P1|Overall Study|Other|11
2675646|NCT00548093|9235653|P2|Overall Study|Objective progression or relapse|1
2675647|NCT00548093|9235654|P1|Overall Study|Objective progression or relapse|1
2675648|NCT00548093|9235653|P2|Overall Study|Lost to Follow-up|1
2675649|NCT00548093|9235654|P1|Overall Study|Lost to Follow-up|3
2675650|NCT00548093|9235653|P2|Overall Study|Death|13
2675651|NCT00548093|9235654|P1|Overall Study|Death|33
2675652|NCT00547911|9235692|P6|Overall Study|Adverse Event|0
2675653|NCT00547911|9235693|P5|Overall Study|Adverse Event|0
2675654|NCT00547911|9235694|P4|Overall Study|Adverse Event|1
2675655|NCT00547911|9235695|P3|Overall Study|Adverse Event|0
2675656|NCT00547911|9235696|P2|Overall Study|Adverse Event|0
2675657|NCT00547911|9235697|P1|Overall Study|Adverse Event|0
2675658|NCT00547703|9235728|P2|Overall Study|Lost to Follow-up|0
2675659|NCT00547703|9235729|P1|Overall Study|Lost to Follow-up|1
2675660|NCT00547534|9235754|P1|Overall Study|Disease Progression|4
2675661|NCT00547534|9235754|P1|Overall Study|Adverse Event|7
2675662|NCT00547521|9235762|P2|Long Term Extension (LTE) Study|Poor/Non-Compliance|1
2675663|NCT00547521|9235763|P1|Long Term Extension (LTE) Study|Poor/Non-Compliance|0
2675664|NCT00547521|9235762|P2|Long Term Extension (LTE) Study|Other|2
2675665|NCT00547521|9235763|P1|Long Term Extension (LTE) Study|Other|0
2675666|NCT00547521|9235762|P2|Long Term Extension (LTE) Study|Withdrawal by Subject|2
2675667|NCT00547521|9235763|P1|Long Term Extension (LTE) Study|Withdrawal by Subject|0
2675668|NCT00547521|9235762|P2|Long Term Extension (LTE) Study|Lost to Follow-up|3
2675669|NCT00547521|9235763|P1|Long Term Extension (LTE) Study|Lost to Follow-up|0
2675670|NCT00547521|9235762|P2|Long Term Extension (LTE) Study|Adverse Event|9
2675671|NCT00547521|9235763|P1|Long Term Extension (LTE) Study|Adverse Event|0
2675672|NCT00547521|9235762|P2|Long Term Extension (LTE) Study|Lack of Efficacy|14
2675673|NCT00547521|9235763|P1|Long Term Extension (LTE) Study|Lack of Efficacy|0
2675674|NCT00547521|9235762|P2|Short Term Study (4 Months)|primary endpoint evaluation not complete|1
2675675|NCT00547521|9235763|P1|Short Term Study (4 Months)|primary endpoint evaluation not complete|0
2675676|NCT00547521|9235762|P2|Short Term Study (4 Months)|Withdrawal of consent|1
2675677|NCT00547521|9235763|P1|Short Term Study (4 Months)|Withdrawal of consent|0
2675678|NCT00547521|9235762|P2|Short Term Study (4 Months)|Lack of Efficacy|2
2675679|NCT00547521|9235763|P1|Short Term Study (4 Months)|Lack of Efficacy|0
2675680|NCT00547521|9235762|P2|Short Term Study (4 Months)|Adverse Event|0
2675681|NCT00547521|9235763|P1|Short Term Study (4 Months)|Adverse Event|1
2675682|NCT00547378|9235840|P3|All Implanted Cohort|Other reasons|1
2675683|NCT00547378|9235841|P2|All Implanted Cohort|Other reasons|0
2675684|NCT00547378|9235842|P1|All Implanted Cohort|Other reasons|1
2675685|NCT00547378|9235840|P3|All Implanted Cohort|Site closure|1
2675686|NCT00547378|9235841|P2|All Implanted Cohort|Site closure|0
2675687|NCT00547378|9235842|P1|All Implanted Cohort|Site closure|2
2675688|NCT00547378|9235840|P3|All Implanted Cohort|Physician Decision|6
2675689|NCT00547378|9235841|P2|All Implanted Cohort|Physician Decision|2
2675690|NCT00547378|9235842|P1|All Implanted Cohort|Physician Decision|0
2675691|NCT00547378|9235840|P3|All Implanted Cohort|Death|4
2675692|NCT00547378|9235841|P2|All Implanted Cohort|Death|1
2675693|NCT00547378|9235842|P1|All Implanted Cohort|Death|3
2675694|NCT00547378|9235840|P3|All Implanted Cohort|Lost to Follow-up|14
2675695|NCT00547378|9235841|P2|All Implanted Cohort|Lost to Follow-up|1
2675696|NCT00547378|9235842|P1|All Implanted Cohort|Lost to Follow-up|0
2675697|NCT00547378|9235840|P3|All Implanted Cohort|Adverse Event|17
2675698|NCT00547378|9235841|P2|All Implanted Cohort|Adverse Event|10
2675699|NCT00547378|9235842|P1|All Implanted Cohort|Adverse Event|4
2675700|NCT00547378|9235840|P3|All Implanted Cohort|Withdrawal by Subject|27
2675701|NCT00547378|9235841|P2|All Implanted Cohort|Withdrawal by Subject|4
2675702|NCT00547378|9235842|P1|All Implanted Cohort|Withdrawal by Subject|5
2675703|NCT00547378|9235840|P3|Randomized Cohort|Other reasons|0
2675704|NCT00547378|9235841|P2|Randomized Cohort|Other reasons|0
2675705|NCT00547378|9235842|P1|Randomized Cohort|Other reasons|2
2675706|NCT00547378|9235840|P3|Randomized Cohort|Adverse Event|0
2675707|NCT00547378|9235841|P2|Randomized Cohort|Adverse Event|0
2675708|NCT00547378|9235842|P1|Randomized Cohort|Adverse Event|1
2675709|NCT00547378|9235840|P3|Randomized Cohort|Lost to Follow-up|0
2675710|NCT00547378|9235841|P2|Randomized Cohort|Lost to Follow-up|0
2675711|NCT00547378|9235842|P1|Randomized Cohort|Lost to Follow-up|1
2675712|NCT00547378|9235840|P3|Randomized Cohort|Death|0
2675713|NCT00547378|9235841|P2|Randomized Cohort|Death|1
2675714|NCT00547378|9235842|P1|Randomized Cohort|Death|0
2675715|NCT00547378|9235840|P3|Randomized Cohort|Withdrawal by Subject|0
2675716|NCT00547378|9235841|P2|Randomized Cohort|Withdrawal by Subject|5
2675717|NCT00547378|9235842|P1|Randomized Cohort|Withdrawal by Subject|7
2675718|NCT00547365|9235852|P1|Overall Study|death (not related to study)|4
2675719|NCT00547365|9235852|P1|Overall Study|Protocol Violation|2
2675720|NCT00547365|9235852|P1|Overall Study|Lost to Follow-up|1
2675721|NCT00547365|9235852|P1|Overall Study|Physician Decision|1
2675722|NCT00547300|9235859|P2|Overall Study|Did not Meet Entry Criteria|2
2675723|NCT00547300|9235860|P1|Overall Study|Did not Meet Entry Criteria|0
2675724|NCT00547300|9235859|P2|Overall Study|Study was Administratively Terminated|24
2675725|NCT00547300|9235860|P1|Overall Study|Study was Administratively Terminated|25
2675726|NCT00547248|9235874|P4|Overall Study|Withdrawal by Subject|1
2675727|NCT00547248|9235875|P3|Overall Study|Withdrawal by Subject|7
2675728|NCT00547248|9235876|P2|Overall Study|Withdrawal by Subject|0
2675729|NCT00547248|9235877|P1|Overall Study|Withdrawal by Subject|0
2675730|NCT00547248|9235874|P4|Overall Study|Migrated/moved from study area|0
2675731|NCT00547248|9235875|P3|Overall Study|Migrated/moved from study area|2
2675732|NCT00547248|9235876|P2|Overall Study|Migrated/moved from study area|0
2675733|NCT00547248|9235877|P1|Overall Study|Migrated/moved from study area|0
2675734|NCT00547248|9235874|P4|Overall Study|Protocol Violation|1
2675735|NCT00547248|9235875|P3|Overall Study|Protocol Violation|1
2675736|NCT00547248|9235876|P2|Overall Study|Protocol Violation|0
2675737|NCT00547248|9235877|P1|Overall Study|Protocol Violation|0
2675738|NCT00547157|9235995|P2|Overall Study|Lost to Follow-up|2
2675739|NCT00547157|9235996|P1|Overall Study|Lost to Follow-up|4
2675740|NCT00547157|9235995|P2|Overall Study|Administrative decision|2
2675741|NCT00547157|9235996|P1|Overall Study|Administrative decision|3
2675742|NCT00547157|9235995|P2|Overall Study|Withdrawal by Subject|1
2675743|NCT00547157|9235996|P1|Overall Study|Withdrawal by Subject|3
2675744|NCT00547157|9235995|P2|Overall Study|Death|18
2675745|NCT00547157|9235996|P1|Overall Study|Death|38
2675746|NCT00547157|9235995|P2|Overall Study|Other|0
2675747|NCT00547157|9235996|P1|Overall Study|Other|1
2675748|NCT00547118|9236014|P2|Overall Study|Study suspended|8
2675749|NCT00547118|9236015|P1|Overall Study|Study suspended|7
2675750|NCT00547118|9236014|P2|Overall Study|Did not qualify prior to starting drug|1
2675751|NCT00547118|9236015|P1|Overall Study|Did not qualify prior to starting drug|1
2675752|NCT00546910|9236059|P2|Overall Study|Withdrawal by Subject|0
2675753|NCT00546910|9236060|P1|Overall Study|Withdrawal by Subject|2
2675754|NCT00546910|9236059|P2|Overall Study|Physician Decision|1
2675755|NCT00546910|9236060|P1|Overall Study|Physician Decision|0
2675756|NCT00546910|9236059|P2|Overall Study|Lack of Efficacy|7
2675757|NCT00546910|9236060|P1|Overall Study|Lack of Efficacy|5
2675758|NCT00546910|9236059|P2|Overall Study|Adverse Event|3
2675759|NCT00546910|9236060|P1|Overall Study|Adverse Event|2
2675760|NCT00546871|9236126|P2|Study Extension Period|Withdrawal by Subject|1
2675761|NCT00546871|9236127|P1|Study Extension Period|Withdrawal by Subject|0
2675762|NCT00546871|9236126|P2|Study Extension Period|Protocol Violation|0
2675763|NCT00546871|9236127|P1|Study Extension Period|Protocol Violation|1
2675764|NCT00546871|9236126|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1
2675765|NCT00546871|9236127|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0
2675766|NCT00546871|9236126|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2
2675767|NCT00546871|9236127|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1
2675768|NCT00546871|9236126|P2|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0
2675769|NCT00546871|9236127|P1|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1
2675770|NCT00546819|9236232|P2|Overall Study|Withdrawal by Subject|2
2675771|NCT00546819|9236233|P1|Overall Study|Withdrawal by Subject|4
2675772|NCT00546819|9236232|P2|Overall Study|Lost to Follow-up|1
2675773|NCT00546819|9236233|P1|Overall Study|Lost to Follow-up|2
2675774|NCT00546819|9236232|P2|Overall Study|Adverse Event|3
2675775|NCT00546819|9236233|P1|Overall Study|Adverse Event|2
2675776|NCT00546754|9236245|P2|Overall Study|Missing|7
2675777|NCT00546754|9236246|P1|Overall Study|Missing|14
2675778|NCT00546754|9236245|P2|Overall Study|Patient's Decision|1
2675779|NCT00546754|9236246|P1|Overall Study|Patient's Decision|0
2675780|NCT00546754|9236245|P2|Overall Study|Elevated Creatinine and Potassium levels|1
2675781|NCT00546754|9236246|P1|Overall Study|Elevated Creatinine and Potassium levels|0
2675782|NCT00546754|9236245|P2|Overall Study|Missing Cooperation|0
2675783|NCT00546754|9236246|P1|Overall Study|Missing Cooperation|1
2675784|NCT00546754|9236245|P2|Overall Study|Suicide|0
2675785|NCT00546754|9236246|P1|Overall Study|Suicide|1
2675786|NCT00546754|9236245|P2|Overall Study|Hip Replacement|0
2675787|NCT00546754|9236246|P1|Overall Study|Hip Replacement|1
2675788|NCT00546754|9236245|P2|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0
2675789|NCT00546754|9236246|P1|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1
2675790|NCT00546754|9236245|P2|Overall Study|Dyspnea|0
2675791|NCT00546754|9236246|P1|Overall Study|Dyspnea|1
2675792|NCT00546754|9236245|P2|Overall Study|Withdrawal by Subject|7
2675793|NCT00546754|9236246|P1|Overall Study|Withdrawal by Subject|6
2675794|NCT00546754|9236245|P2|Overall Study|Protocol Violation|0
2675795|NCT00546754|9236246|P1|Overall Study|Protocol Violation|3
2675796|NCT00546754|9236245|P2|Overall Study|Lost to Follow-up|15
2675797|NCT00546754|9236246|P1|Overall Study|Lost to Follow-up|9
2675798|NCT00546754|9236245|P2|Overall Study|Lack of Efficacy|1
2675799|NCT00546754|9236246|P1|Overall Study|Lack of Efficacy|1
2675800|NCT00546754|9236245|P2|Overall Study|Adverse Event|16
2675801|NCT00546754|9236246|P1|Overall Study|Adverse Event|11
2675802|NCT00546754|9236245|P2|Overall Study|Serious Adverse Event|1
2675803|NCT00546754|9236246|P1|Overall Study|Serious Adverse Event|1
2675804|NCT00546715|9236289|P4|Overall Study|Withdrawal by Subject|0
2675805|NCT00546715|9236290|P3|Overall Study|Withdrawal by Subject|0
2675806|NCT00546715|9236291|P2|Overall Study|Withdrawal by Subject|1
2675807|NCT00546715|9236292|P1|Overall Study|Withdrawal by Subject|0
2675808|NCT00546637|9236347|P2|Overall Study|Randomized, but not treated|1
2675809|NCT00546637|9236348|P1|Overall Study|Randomized, but not treated|3
2675810|NCT00546637|9236347|P2|Overall Study|Withdrawal by Subject|9
2675811|NCT00546637|9236348|P1|Overall Study|Withdrawal by Subject|7
2675812|NCT00546637|9236347|P2|Overall Study|Other|12
2675813|NCT00546637|9236348|P1|Overall Study|Other|10
2675814|NCT00546637|9236347|P2|Overall Study|Lost to Follow-up|2
2675815|NCT00546637|9236348|P1|Overall Study|Lost to Follow-up|2
2675816|NCT00546637|9236347|P2|Overall Study|Lack of Efficacy|5
2675817|NCT00546637|9236348|P1|Overall Study|Lack of Efficacy|5
2675818|NCT00546637|9236347|P2|Overall Study|Adverse Event|20
2675819|NCT00546637|9236348|P1|Overall Study|Adverse Event|46
2675820|NCT00546572|9236422|P2|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1
2675821|NCT00546572|9236423|P1|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2
2675822|NCT00546572|9236422|P2|Vax 2 / Year 1|Adverse Event|0
2675823|NCT00546572|9236423|P1|Vax 2 / Year 1|Adverse Event|1
2675824|NCT00546572|9236422|P2|Vax 2 / Year 1|Other|1
2675825|NCT00546572|9236423|P1|Vax 2 / Year 1|Other|1
2675826|NCT00546572|9236422|P2|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59
2675827|NCT00546572|9236423|P1|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64
2675828|NCT00546572|9236422|P2|Vax 1 / Year 0|Lost to Follow-up|1
2675829|NCT00546572|9236423|P1|Vax 1 / Year 0|Lost to Follow-up|0
2675830|NCT00546572|9236422|P2|Vax 1 / Year 0|Adverse Event|1
2675831|NCT00546572|9236423|P1|Vax 1 / Year 0|Adverse Event|0
2675832|NCT00546572|9236422|P2|Vax 1 / Year 0|Death|2
2675833|NCT00546572|9236423|P1|Vax 1 / Year 0|Death|2
2675834|NCT00546572|9236422|P2|Vax 1 / Year 0|Protocol Violation|4
2675835|NCT00546572|9236423|P1|Vax 1 / Year 0|Protocol Violation|3
2675836|NCT00546572|9236422|P2|Vax 1 / Year 0|Withdrawal by Subject|2
2675837|NCT00546572|9236423|P1|Vax 1 / Year 0|Withdrawal by Subject|3
2675838|NCT00546572|9236422|P2|Vax 1 / Year 0|Randomized, not treated|1
2675839|NCT00546572|9236423|P1|Vax 1 / Year 0|Randomized, not treated|1
2675840|NCT00546481|9236467|P3|Maintenance Phase (CERA)|Other Reason|1
2675841|NCT00546481|9236468|P2|Maintenance Phase (CERA)|Other Reason|0
2675842|NCT00546481|9236469|P1|Maintenance Phase (CERA)|Other Reason|0
2675843|NCT00546481|9236467|P3|Maintenance Phase (CERA)|Kidney transplantation|1
2675844|NCT00546481|9236468|P2|Maintenance Phase (CERA)|Kidney transplantation|0
2675845|NCT00546481|9236469|P1|Maintenance Phase (CERA)|Kidney transplantation|0
2675846|NCT00546481|9236467|P3|Maintenance Phase (CERA)|Withdrawal by Subject|2
2675847|NCT00546481|9236468|P2|Maintenance Phase (CERA)|Withdrawal by Subject|0
2675848|NCT00546481|9236469|P1|Maintenance Phase (CERA)|Withdrawal by Subject|0
2675849|NCT00546481|9236467|P3|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
2675850|NCT00546481|9236468|P2|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1
2675851|NCT00546481|9236469|P1|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
2675852|NCT00546481|9236467|P3|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0
2675853|NCT00546481|9236468|P2|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
2675854|NCT00546481|9236469|P1|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
2675855|NCT00546481|9236467|P3|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
2675856|NCT00546481|9236468|P2|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
2675857|NCT00546481|9236469|P1|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2
2675858|NCT00546481|9236467|P3|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
2675859|NCT00546481|9236468|P2|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
2675860|NCT00546481|9236469|P1|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1
2675861|NCT00546481|9236467|P3|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0
2675862|NCT00546481|9236468|P2|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3
2675863|NCT00546481|9236469|P1|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1
2675864|NCT00546481|9236467|P3|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
2675865|NCT00546481|9236468|P2|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
2675866|NCT00546481|9236469|P1|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1
2675867|NCT00546377|9236507|P1|Overall Study|Adverse Event|6
2675868|NCT00546377|9236507|P1|Overall Study|Deemed ineligible|1
2675869|NCT00546364|9236515|P3|Overall Study|Sponsor decision|1
2675870|NCT00546364|9236516|P2|Overall Study|Sponsor decision|0
2675871|NCT00546364|9236517|P1|Overall Study|Sponsor decision|0
2675872|NCT00546364|9236515|P3|Overall Study|Physician Decision|1
2675873|NCT00546364|9236516|P2|Overall Study|Physician Decision|0
2675874|NCT00546364|9236517|P1|Overall Study|Physician Decision|0
2675875|NCT00546364|9236515|P3|Overall Study|Target lesions resected|0
2675876|NCT00546364|9236516|P2|Overall Study|Target lesions resected|0
2675877|NCT00546364|9236517|P1|Overall Study|Target lesions resected|1
2675878|NCT00546364|9236515|P3|Overall Study|Palliative treatment|1
2675879|NCT00546364|9236516|P2|Overall Study|Palliative treatment|0
2675880|NCT00546364|9236517|P1|Overall Study|Palliative treatment|1
2675881|NCT00546364|9236515|P3|Overall Study|Mixed response|0
2675882|NCT00546364|9236516|P2|Overall Study|Mixed response|0
2675883|NCT00546364|9236517|P1|Overall Study|Mixed response|1
2675884|NCT00546364|9236515|P3|Overall Study|Prior taxotere|0
2675885|NCT00546364|9236516|P2|Overall Study|Prior taxotere|0
2675886|NCT00546364|9236517|P1|Overall Study|Prior taxotere|1
2675887|NCT00546364|9236515|P3|Overall Study|Withdrawal by Subject|3
2675888|NCT00546364|9236516|P2|Overall Study|Withdrawal by Subject|6
2675889|NCT00546364|9236517|P1|Overall Study|Withdrawal by Subject|5
2675890|NCT00546364|9236515|P3|Overall Study|No longer meets study criteria|0
2675891|NCT00546364|9236516|P2|Overall Study|No longer meets study criteria|1
2675892|NCT00546364|9236517|P1|Overall Study|No longer meets study criteria|1
2675893|NCT00546364|9236515|P3|Overall Study|Poor compliance/noncompliance|1
2675894|NCT00546364|9236516|P2|Overall Study|Poor compliance/noncompliance|0
2675895|NCT00546364|9236517|P1|Overall Study|Poor compliance/noncompliance|0
2675896|NCT00546364|9236515|P3|Overall Study|Administrative reason by sponsor|0
2675897|NCT00546364|9236516|P2|Overall Study|Administrative reason by sponsor|0
2675898|NCT00546364|9236517|P1|Overall Study|Administrative reason by sponsor|1
2675899|NCT00546364|9236515|P3|Overall Study|Completed and off treatment|2
2675900|NCT00546364|9236516|P2|Overall Study|Completed and off treatment|0
2675901|NCT00546364|9236517|P1|Overall Study|Completed and off treatment|1
2675902|NCT00546364|9236515|P3|Overall Study|Disease progression|8
2675903|NCT00546364|9236516|P2|Overall Study|Disease progression|11
2675904|NCT00546364|9236517|P1|Overall Study|Disease progression|5
2675905|NCT00546351|9236552|P1|Overall Study|Other reasons for premature termination|17
2675906|NCT00546351|9236552|P1|Overall Study|Unsatisfactory compliance|9
2675907|NCT00546351|9236552|P1|Overall Study|Protocol Deviation|1
2675908|NCT00546351|9236552|P1|Overall Study|Lost to Follow-up|9
2675909|NCT00546351|9236552|P1|Overall Study|Withdrawal by Subject|109
2675910|NCT00546351|9236552|P1|Overall Study|Lack of Efficacy|15
2675911|NCT00546351|9236552|P1|Overall Study|Adverse Event|76
2675912|NCT00546260|9236598|P2|Overall Study|Drug not given pre diagnostic angiogr|2
2675913|NCT00546260|9236599|P1|Overall Study|Drug not given pre diagnostic angiogr|8
2675914|NCT00546117|9236621|P2|Overall Study|Inability to schedule follow-up visit|0
2675915|NCT00546117|9236622|P1|Overall Study|Inability to schedule follow-up visit|1
2675916|NCT00546117|9236621|P2|Overall Study|Withdrawal by Subject|0
2675917|NCT00546117|9236622|P1|Overall Study|Withdrawal by Subject|3
2675918|NCT00546078|9236647|P2|Overall Study|Other reason|1
2675919|NCT00546078|9236648|P1|Overall Study|Other reason|1
2675920|NCT00546078|9236647|P2|Overall Study|Withdrawal by Subject|3
2675921|NCT00546078|9236648|P1|Overall Study|Withdrawal by Subject|2
2675922|NCT00546078|9236647|P2|Overall Study|Lost to Follow-up|3
2675923|NCT00546078|9236648|P1|Overall Study|Lost to Follow-up|1
2675924|NCT00546052|9236686|P1|Overall Study|Non Compliance|7
2675925|NCT00546052|9236686|P1|Overall Study|Withdrawal by Subject|20
2675926|NCT00546052|9236686|P1|Overall Study|Protocol Violation|9
2675927|NCT00546052|9236686|P1|Overall Study|Lost to Follow-up|144
2675928|NCT00546052|9236686|P1|Overall Study|Adverse Event|47
2675929|NCT00546000|9236704|P1|Overall Study|Baseline HPA Axis Supression|2
2675930|NCT00546000|9236704|P1|Overall Study|Lost to Follow-up|1
2675931|NCT00546000|9236704|P1|Overall Study|Adverse Event|1
2675932|NCT00545948|9236723|P3|Overall Study|Not Treated|7
2675933|NCT00545948|9236724|P2|Overall Study|Not Treated|1
2675934|NCT00545948|9236725|P1|Overall Study|Not Treated|1
2675935|NCT00545844|9236735|P1|Overall Study|Withdrawal by Subject|2
2675936|NCT00545844|9236735|P1|Overall Study|Protocol Violation|1
2675937|NCT00545844|9236735|P1|Overall Study|Lost to Follow-up|9
2675938|NCT00545792|9236749|P1|Overall Study|Withdrawal by Subject|1
2675939|NCT00545779|9236754|P1|Overall Study|Failure to return|3
2675940|NCT00545779|9236754|P1|Overall Study|Adverse Event/intercurrent illness|5
2675941|NCT00545779|9236754|P1|Overall Study|Withdrawal by Subject|20
2675942|NCT00545779|9236754|P1|Overall Study|Did not cooperate|7
2675943|NCT00545779|9236754|P1|Overall Study|Other protocol violation|1
2675944|NCT00545779|9236754|P1|Overall Study|Violation of selection criteria at entry|8
2675945|NCT00545753|9236774|P3|Overall Study|Protocol Violation|4
2675946|NCT00545753|9236775|P2|Overall Study|Protocol Violation|1
2675947|NCT00545753|9236776|P1|Overall Study|Protocol Violation|3
2675948|NCT00545753|9236774|P3|Overall Study|Lost to Follow-up|12
2675949|NCT00545753|9236775|P2|Overall Study|Lost to Follow-up|3
2675950|NCT00545753|9236776|P1|Overall Study|Lost to Follow-up|13
2675951|NCT00545753|9236774|P3|Overall Study|Withdrawal by Subject|10
2675952|NCT00545753|9236775|P2|Overall Study|Withdrawal by Subject|1
2675953|NCT00545753|9236776|P1|Overall Study|Withdrawal by Subject|0
2675954|NCT00545740|9236789|P4|Overall Study|Husband against study|0
2675955|NCT00545740|9236790|P3|Overall Study|Husband against study|1
2675956|NCT00545740|9236791|P2|Overall Study|Husband against study|0
2675957|NCT00545740|9236792|P1|Overall Study|Husband against study|0
2675958|NCT00545740|9236789|P4|Overall Study|Patient difficulties|0
2675959|NCT00545740|9236790|P3|Overall Study|Patient difficulties|0
2675960|NCT00545740|9236791|P2|Overall Study|Patient difficulties|1
2675961|NCT00545740|9236792|P1|Overall Study|Patient difficulties|0
2675962|NCT00545740|9236789|P4|Overall Study|Non-adherence to visits|0
2675963|NCT00545740|9236790|P3|Overall Study|Non-adherence to visits|0
2675964|NCT00545740|9236791|P2|Overall Study|Non-adherence to visits|1
2675965|NCT00545740|9236792|P1|Overall Study|Non-adherence to visits|0
2675966|NCT00545740|9236789|P4|Overall Study|Lack of time|0
2675967|NCT00545740|9236790|P3|Overall Study|Lack of time|0
2675968|NCT00545740|9236791|P2|Overall Study|Lack of time|1
2675969|NCT00545740|9236792|P1|Overall Study|Lack of time|0
2675970|NCT00545740|9236789|P4|Overall Study|Sponsor decision|0
2675971|NCT00545740|9236790|P3|Overall Study|Sponsor decision|0
2675972|NCT00545740|9236791|P2|Overall Study|Sponsor decision|1
2675973|NCT00545740|9236792|P1|Overall Study|Sponsor decision|0
2675974|NCT00545740|9236789|P4|Overall Study|Accepted only monthly telephone calls|0
2675975|NCT00545740|9236790|P3|Overall Study|Accepted only monthly telephone calls|0
2675976|NCT00545740|9236791|P2|Overall Study|Accepted only monthly telephone calls|0
2675977|NCT00545740|9236792|P1|Overall Study|Accepted only monthly telephone calls|1
2675978|NCT00545740|9236789|P4|Overall Study|Physician Decision|0
2675979|NCT00545740|9236790|P3|Overall Study|Physician Decision|3
2675980|NCT00545740|9236791|P2|Overall Study|Physician Decision|0
2675981|NCT00545740|9236792|P1|Overall Study|Physician Decision|0
2675982|NCT00545740|9236789|P4|Overall Study|Missed visit|0
2675983|NCT00545740|9236790|P3|Overall Study|Missed visit|0
2675984|NCT00545740|9236791|P2|Overall Study|Missed visit|0
2675985|NCT00545740|9236792|P1|Overall Study|Missed visit|1
2675986|NCT00545740|9236789|P4|Overall Study|Site closure|0
2675987|NCT00545740|9236790|P3|Overall Study|Site closure|0
2675988|NCT00545740|9236791|P2|Overall Study|Site closure|0
2675989|NCT00545740|9236792|P1|Overall Study|Site closure|1
2675990|NCT00545740|9236789|P4|Overall Study|Suspected Diverticulitis Recurrence|1
2675991|NCT00545740|9236790|P3|Overall Study|Suspected Diverticulitis Recurrence|1
2675992|NCT00545740|9236791|P2|Overall Study|Suspected Diverticulitis Recurrence|1
2675993|NCT00545740|9236792|P1|Overall Study|Suspected Diverticulitis Recurrence|1
2675994|NCT00545740|9236789|P4|Overall Study|Diverticulitis attack|1
2675995|NCT00545740|9236790|P3|Overall Study|Diverticulitis attack|1
2675996|NCT00545740|9236791|P2|Overall Study|Diverticulitis attack|0
2675997|NCT00545740|9236792|P1|Overall Study|Diverticulitis attack|0
2675998|NCT00545740|9236789|P4|Overall Study|Moved|0
2675999|NCT00545740|9236790|P3|Overall Study|Moved|1
2676000|NCT00545740|9236791|P2|Overall Study|Moved|0
2676001|NCT00545740|9236792|P1|Overall Study|Moved|2
2676002|NCT00545740|9236789|P4|Overall Study|Non-compliance|0
2676003|NCT00545740|9236790|P3|Overall Study|Non-compliance|1
2676004|NCT00545740|9236791|P2|Overall Study|Non-compliance|2
2676005|NCT00545740|9236792|P1|Overall Study|Non-compliance|0
2676006|NCT00545740|9236789|P4|Overall Study|Protocol Violation|0
2676007|NCT00545740|9236790|P3|Overall Study|Protocol Violation|1
2676008|NCT00545740|9236791|P2|Overall Study|Protocol Violation|3
2676009|NCT00545740|9236792|P1|Overall Study|Protocol Violation|1
2676010|NCT00545740|9236789|P4|Overall Study|Lost to Follow-up|6
2676011|NCT00545740|9236790|P3|Overall Study|Lost to Follow-up|5
2676012|NCT00545740|9236791|P2|Overall Study|Lost to Follow-up|5
2676013|NCT00545740|9236792|P1|Overall Study|Lost to Follow-up|7
2676014|NCT00545740|9236789|P4|Overall Study|Adverse Event|9
2676015|NCT00545740|9236790|P3|Overall Study|Adverse Event|19
2676016|NCT00545740|9236791|P2|Overall Study|Adverse Event|18
2676017|NCT00545740|9236792|P1|Overall Study|Adverse Event|10
2676018|NCT00545740|9236789|P4|Overall Study|Withdrawal by Subject|18
2676019|NCT00545740|9236790|P3|Overall Study|Withdrawal by Subject|16
2676020|NCT00545740|9236791|P2|Overall Study|Withdrawal by Subject|15
2676021|NCT00545740|9236792|P1|Overall Study|Withdrawal by Subject|17
2676022|NCT00545740|9236789|P4|Overall Study|Lack of Efficacy|36
2676023|NCT00545740|9236790|P3|Overall Study|Lack of Efficacy|47
2676024|NCT00545740|9236791|P2|Overall Study|Lack of Efficacy|35
2676025|NCT00545740|9236792|P1|Overall Study|Lack of Efficacy|34
2676026|NCT00545714|9236826|P1|Maintenance Phase (36 Months)|Death|2
2676027|NCT00545714|9236826|P1|Maintenance Phase (36 Months)|Withdrawal by Subject|3
2676028|NCT00545714|9236826|P1|Maintenance Phase (36 Months)|Protocol Violation|1
2676029|NCT00545714|9236826|P1|Maintenance Phase (36 Months)|Physician Decision|1
2676030|NCT00545714|9236826|P1|Maintenance Phase (36 Months)|Disease Progression|9
2676031|NCT00545714|9236826|P1|Maintenance Phase (36 Months)|Unacceptable Toxicity|16
2676032|NCT00545714|9236826|P1|Induction Phase (6 Months)|Eligibility Criteria Violation|2
2676033|NCT00545714|9236826|P1|Induction Phase (6 Months)|Disease Progression|1
2676034|NCT00545714|9236826|P1|Induction Phase (6 Months)|Unacceptable Toxicity|6
2676035|NCT00545714|9236826|P1|Induction Phase (6 Months)|Physician Decision|3
2676036|NCT00545688|9236847|P4|Follow-Up Period|Violation of Selection Criteria at Entry|1
2676037|NCT00545688|9236848|P3|Follow-Up Period|Violation of Selection Criteria at Entry|0
2676038|NCT00545688|9236849|P2|Follow-Up Period|Violation of Selection Criteria at Entry|2
2676039|NCT00545688|9236850|P1|Follow-Up Period|Violation of Selection Criteria at Entry|0
2676040|NCT00545688|9236847|P4|Follow-Up Period|Unspecified Reason|8
2676041|NCT00545688|9236848|P3|Follow-Up Period|Unspecified Reason|6
2676042|NCT00545688|9236849|P2|Follow-Up Period|Unspecified Reason|5
2676043|NCT00545688|9236850|P1|Follow-Up Period|Unspecified Reason|2
2676044|NCT00545688|9236847|P4|Follow-Up Period|Lost to Follow-up|1
2676045|NCT00545688|9236848|P3|Follow-Up Period|Lost to Follow-up|3
2676046|NCT00545688|9236849|P2|Follow-Up Period|Lost to Follow-up|3
2676047|NCT00545688|9236850|P1|Follow-Up Period|Lost to Follow-up|3
2676048|NCT00545688|9236847|P4|Follow-Up Period|Refused Treatment|2
2676049|NCT00545688|9236848|P3|Follow-Up Period|Refused Treatment|0
2676050|NCT00545688|9236849|P2|Follow-Up Period|Refused Treatment|2
2676051|NCT00545688|9236850|P1|Follow-Up Period|Refused Treatment|6
2676052|NCT00545688|9236847|P4|Follow-Up Period|Disease Progression|9
2676053|NCT00545688|9236848|P3|Follow-Up Period|Disease Progression|9
2676054|NCT00545688|9236849|P2|Follow-Up Period|Disease Progression|5
2676055|NCT00545688|9236850|P1|Follow-Up Period|Disease Progression|6
2676056|NCT00545688|9236847|P4|Follow-Up Period|Death|6
2676057|NCT00545688|9236848|P3|Follow-Up Period|Death|2
2676058|NCT00545688|9236849|P2|Follow-Up Period|Death|2
2676059|NCT00545688|9236850|P1|Follow-Up Period|Death|4
2676060|NCT00545688|9236847|P4|Adjuvant Treatment Period|Unknown Reason|0
2676061|NCT00545688|9236848|P3|Adjuvant Treatment Period|Unknown Reason|0
2676062|NCT00545688|9236849|P2|Adjuvant Treatment Period|Unknown Reason|1
2676063|NCT00545688|9236850|P1|Adjuvant Treatment Period|Unknown Reason|0
2676064|NCT00545688|9236847|P4|Adjuvant Treatment Period|Adverse Event|2
2676065|NCT00545688|9236848|P3|Adjuvant Treatment Period|Adverse Event|2
2676066|NCT00545688|9236849|P2|Adjuvant Treatment Period|Adverse Event|3
2676067|NCT00545688|9236850|P1|Adjuvant Treatment Period|Adverse Event|0
2676068|NCT00545688|9236847|P4|Adjuvant Treatment Period|Lost to Follow-up|0
2676069|NCT00545688|9236848|P3|Adjuvant Treatment Period|Lost to Follow-up|1
2676070|NCT00545688|9236849|P2|Adjuvant Treatment Period|Lost to Follow-up|0
2676071|NCT00545688|9236850|P1|Adjuvant Treatment Period|Lost to Follow-up|1
2676072|NCT00545688|9236847|P4|Adjuvant Treatment Period|Refused Treatment|5
2676073|NCT00545688|9236848|P3|Adjuvant Treatment Period|Refused Treatment|1
2676074|NCT00545688|9236849|P2|Adjuvant Treatment Period|Refused Treatment|1
2676075|NCT00545688|9236850|P1|Adjuvant Treatment Period|Refused Treatment|1
2676076|NCT00545688|9236847|P4|Adjuvant Treatment Period|Disease Progression|7
2676077|NCT00545688|9236848|P3|Adjuvant Treatment Period|Disease Progression|0
2676078|NCT00545688|9236849|P2|Adjuvant Treatment Period|Disease Progression|3
2676079|NCT00545688|9236850|P1|Adjuvant Treatment Period|Disease Progression|3
2676080|NCT00545688|9236847|P4|Neo-Adjuvant Treatment Period|Adverse Event|2
2676081|NCT00545688|9236848|P3|Neo-Adjuvant Treatment Period|Adverse Event|2
2676082|NCT00545688|9236849|P2|Neo-Adjuvant Treatment Period|Adverse Event|0
2676083|NCT00545688|9236850|P1|Neo-Adjuvant Treatment Period|Adverse Event|0
2676084|NCT00545688|9236847|P4|Neo-Adjuvant Treatment Period|Unknown Reason|0
2676085|NCT00545688|9236848|P3|Neo-Adjuvant Treatment Period|Unknown Reason|0
2676086|NCT00545688|9236849|P2|Neo-Adjuvant Treatment Period|Unknown Reason|0
2676087|NCT00545688|9236850|P1|Neo-Adjuvant Treatment Period|Unknown Reason|1
2676088|NCT00545688|9236847|P4|Neo-Adjuvant Treatment Period|Disease Progression|2
2676089|NCT00545688|9236848|P3|Neo-Adjuvant Treatment Period|Disease Progression|7
2676090|NCT00545688|9236849|P2|Neo-Adjuvant Treatment Period|Disease Progression|1
2676091|NCT00545688|9236850|P1|Neo-Adjuvant Treatment Period|Disease Progression|0
2676092|NCT00545688|9236847|P4|Neo-Adjuvant Treatment Period|Death|0
2676093|NCT00545688|9236848|P3|Neo-Adjuvant Treatment Period|Death|0
2676094|NCT00545688|9236849|P2|Neo-Adjuvant Treatment Period|Death|1
2676095|NCT00545688|9236850|P1|Neo-Adjuvant Treatment Period|Death|0
2676096|NCT00545688|9236847|P4|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
2676097|NCT00545688|9236848|P3|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
2676098|NCT00545688|9236849|P2|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
2676099|NCT00545688|9236850|P1|Neo-Adjuvant Treatment Period|Lost to Follow-up|1
2676100|NCT00545688|9236847|P4|Neo-Adjuvant Treatment Period|Refused Treatment|1
2676101|NCT00545688|9236848|P3|Neo-Adjuvant Treatment Period|Refused Treatment|4
2676102|NCT00545688|9236849|P2|Neo-Adjuvant Treatment Period|Refused Treatment|1
2676103|NCT00545688|9236850|P1|Neo-Adjuvant Treatment Period|Refused Treatment|1
2676104|NCT00545688|9236847|P4|Neo-Adjuvant Treatment Period|Protocol Violation|1
2676105|NCT00545688|9236848|P3|Neo-Adjuvant Treatment Period|Protocol Violation|1
2676106|NCT00545688|9236849|P2|Neo-Adjuvant Treatment Period|Protocol Violation|2
2676107|NCT00545688|9236850|P1|Neo-Adjuvant Treatment Period|Protocol Violation|1
2676108|NCT00545584|9236949|P3|Overall Study|Two or more reasons for discontinuation|8
2676109|NCT00545584|9236950|P2|Overall Study|Two or more reasons for discontinuation|19
2676110|NCT00545584|9236951|P1|Overall Study|Two or more reasons for discontinuation|17
2676111|NCT00545584|9236949|P3|Overall Study|Only one reason for discontinuation|48
2676112|NCT00545584|9236950|P2|Overall Study|Only one reason for discontinuation|61
2676113|NCT00545584|9236951|P1|Overall Study|Only one reason for discontinuation|62
2676114|NCT00545571|9236962|P1|Overall Study|Kidney Transplantation|3
2676115|NCT00545571|9236962|P1|Overall Study|Early Termination of Study|24
2676116|NCT00545571|9236962|P1|Overall Study|Transfusion|12
2676117|NCT00545571|9236962|P1|Overall Study|Screen Failure|16
2676118|NCT00545571|9236962|P1|Overall Study|Refused Treatment|1
2676119|NCT00545571|9236962|P1|Overall Study|Protocol Violation|2
2676120|NCT00545571|9236962|P1|Overall Study|Lack of Efficacy|1
2676121|NCT00545571|9236962|P1|Overall Study|Death|5
2676122|NCT00545571|9236962|P1|Overall Study|Adverse Event|2
2676123|NCT00545571|9236962|P1|Overall Study|Administrative Reasons|1
2676124|NCT00545532|9236977|P2|Overall Study|Death|1
2676125|NCT00545532|9236978|P1|Overall Study|Death|0
2676126|NCT00545532|9236977|P2|Overall Study|Lost to Follow-up|6
2676127|NCT00545532|9236978|P1|Overall Study|Lost to Follow-up|5
2676128|NCT00545532|9236977|P2|Overall Study|Withdrawal by Subject|3
2676129|NCT00545532|9236978|P1|Overall Study|Withdrawal by Subject|1
2676130|NCT00545441|9237069|P2|Overall Study|Patients were not treated|3
2676131|NCT00545441|9237070|P1|Overall Study|Patients were not treated|1
2676132|NCT00545441|9237069|P2|Overall Study|Persistence or recurrence of fistula|2
2676133|NCT00545441|9237070|P1|Overall Study|Persistence or recurrence of fistula|5
2676134|NCT00545441|9237069|P2|Overall Study|Withdrawal by Subject|1
2676135|NCT00545441|9237070|P1|Overall Study|Withdrawal by Subject|1
2676136|NCT00545441|9237069|P2|Overall Study|Technical failure|1
2676137|NCT00545441|9237070|P1|Overall Study|Technical failure|0
2676138|NCT00545441|9237069|P2|Overall Study|Lost to Follow-up|5
2676139|NCT00545441|9237070|P1|Overall Study|Lost to Follow-up|9
2676140|NCT00545441|9237069|P2|Overall Study|Fistula draining at 6 months|4
2676141|NCT00545441|9237070|P1|Overall Study|Fistula draining at 6 months|2
2676142|NCT00545402|9237078|P2|Overall Study|Reason not specified|1
2676143|NCT00545402|9237079|P1|Overall Study|Reason not specified|1
2676144|NCT00545402|9237078|P2|Overall Study|Protocol Violation|0
2676145|NCT00545402|9237079|P1|Overall Study|Protocol Violation|1
2676146|NCT00545402|9237078|P2|Overall Study|Withdrawal by Subject|1
2676147|NCT00545402|9237079|P1|Overall Study|Withdrawal by Subject|0
2676148|NCT00545402|9237078|P2|Overall Study|Graft loss|4
2676149|NCT00545402|9237079|P1|Overall Study|Graft loss|2
2676150|NCT00545402|9237078|P2|Overall Study|Death|7
2676151|NCT00545402|9237079|P1|Overall Study|Death|5
2676152|NCT00545402|9237078|P2|Overall Study|Use of unauthorized immunosuppressant|7
2676153|NCT00545402|9237079|P1|Overall Study|Use of unauthorized immunosuppressant|8
2676154|NCT00545402|9237078|P2|Overall Study|Discontinuation of treatment|9
2676155|NCT00545402|9237079|P1|Overall Study|Discontinuation of treatment|17
2676156|NCT00545363|9237097|P2|Overall Study|Other|1
2676157|NCT00545363|9237098|P1|Overall Study|Other|1
2676158|NCT00545363|9237097|P2|Overall Study|Lost to Follow-up|0
2676159|NCT00545363|9237098|P1|Overall Study|Lost to Follow-up|2
2676160|NCT00545363|9237097|P2|Overall Study|Did not meet entry criteria|1
2676161|NCT00545363|9237098|P1|Overall Study|Did not meet entry criteria|1
2676162|NCT00545363|9237097|P2|Overall Study|Non-compliance|1
2676163|NCT00545363|9237098|P1|Overall Study|Non-compliance|3
2676164|NCT00545363|9237097|P2|Overall Study|Withdrawal by Subject|5
2676165|NCT00545363|9237098|P1|Overall Study|Withdrawal by Subject|6
2676166|NCT00545363|9237097|P2|Overall Study|Adverse Event|7
2676167|NCT00545363|9237098|P1|Overall Study|Adverse Event|6
2676168|NCT00545298|9237113|P3|Overall Study|Issues with Standard of Care|1
2676169|NCT00545298|9237114|P2|Overall Study|Issues with Standard of Care|0
2676170|NCT00545298|9237115|P1|Overall Study|Issues with Standard of Care|2
2676171|NCT00545272|9237132|P6|Overall Study|Lost to Follow-up|0
2676172|NCT00545272|9237133|P5|Overall Study|Lost to Follow-up|1
2676173|NCT00545272|9237134|P4|Overall Study|Lost to Follow-up|0
2676174|NCT00545272|9237135|P3|Overall Study|Lost to Follow-up|0
2676175|NCT00545272|9237136|P2|Overall Study|Lost to Follow-up|0
2676176|NCT00545272|9237137|P1|Overall Study|Lost to Follow-up|0
2676177|NCT00545272|9237132|P6|Overall Study|Abnormal test procedure result(s)|0
2676178|NCT00545272|9237133|P5|Overall Study|Abnormal test procedure result(s)|1
2676179|NCT00545272|9237134|P4|Overall Study|Abnormal test procedure result(s)|0
2676180|NCT00545272|9237135|P3|Overall Study|Abnormal test procedure result(s)|0
2676181|NCT00545272|9237136|P2|Overall Study|Abnormal test procedure result(s)|0
2676182|NCT00545272|9237137|P1|Overall Study|Abnormal test procedure result(s)|0
2676183|NCT00545272|9237132|P6|Overall Study|Abnormal laboratory value(s)|1
2676184|NCT00545272|9237133|P5|Overall Study|Abnormal laboratory value(s)|0
2676185|NCT00545272|9237134|P4|Overall Study|Abnormal laboratory value(s)|0
2676186|NCT00545272|9237135|P3|Overall Study|Abnormal laboratory value(s)|0
2676187|NCT00545272|9237136|P2|Overall Study|Abnormal laboratory value(s)|0
2676188|NCT00545272|9237137|P1|Overall Study|Abnormal laboratory value(s)|0
2676189|NCT00545272|9237132|P6|Overall Study|Adverse Event|1
2676190|NCT00545272|9237133|P5|Overall Study|Adverse Event|0
2676191|NCT00545272|9237134|P4|Overall Study|Adverse Event|0
2676192|NCT00545272|9237135|P3|Overall Study|Adverse Event|1
2676193|NCT00545272|9237136|P2|Overall Study|Adverse Event|0
2676194|NCT00545272|9237137|P1|Overall Study|Adverse Event|0
2676195|NCT00545272|9237132|P6|Overall Study|Protocol deviation|1
2676196|NCT00545272|9237133|P5|Overall Study|Protocol deviation|0
2676197|NCT00545272|9237134|P4|Overall Study|Protocol deviation|1
2676198|NCT00545272|9237135|P3|Overall Study|Protocol deviation|0
2676199|NCT00545272|9237136|P2|Overall Study|Protocol deviation|1
2676200|NCT00545272|9237137|P1|Overall Study|Protocol deviation|0
2676201|NCT00545233|9237189|P2|Overall Study|Physician Decision|1
2676202|NCT00545233|9237190|P1|Overall Study|Physician Decision|2
2676203|NCT00545233|9237189|P2|Overall Study|Insufficient response|15
2676204|NCT00545233|9237190|P1|Overall Study|Insufficient response|14
2676205|NCT00545233|9237189|P2|Overall Study|Failure to Return|6
2676206|NCT00545233|9237190|P1|Overall Study|Failure to Return|4
2676207|NCT00545233|9237189|P2|Overall Study|Refused Treatment|7
2676208|NCT00545233|9237190|P1|Overall Study|Refused Treatment|9
2676209|NCT00545233|9237189|P2|Overall Study|Protocol Violation|0
2676210|NCT00545233|9237190|P1|Overall Study|Protocol Violation|2
2676211|NCT00545233|9237189|P2|Overall Study|Violation of Selection Criteria at Entry|1
2676212|NCT00545233|9237190|P1|Overall Study|Violation of Selection Criteria at Entry|5
2676213|NCT00545233|9237189|P2|Overall Study|Adverse Event|5
2676214|NCT00545233|9237190|P1|Overall Study|Adverse Event|10
2676215|NCT00545168|9237249|P3|Overall Study|Visit for Day 21 was not done in error|2
2676216|NCT00545168|9237250|P2|Overall Study|Visit for Day 21 was not done in error|0
2676217|NCT00545168|9237251|P1|Overall Study|Visit for Day 21 was not done in error|1
2676218|NCT00545168|9237249|P3|Overall Study|Protocol Violation|1
2676219|NCT00545168|9237250|P2|Overall Study|Protocol Violation|0
2676220|NCT00545168|9237251|P1|Overall Study|Protocol Violation|1
2676221|NCT00545168|9237249|P3|Overall Study|Withdrawal by Subject|13
2676222|NCT00545168|9237250|P2|Overall Study|Withdrawal by Subject|0
2676223|NCT00545168|9237251|P1|Overall Study|Withdrawal by Subject|9
2676224|NCT00545168|9237249|P3|Overall Study|Lost to Follow-up|5
2676225|NCT00545168|9237250|P2|Overall Study|Lost to Follow-up|5
2676226|NCT00545168|9237251|P1|Overall Study|Lost to Follow-up|5
2676227|NCT00545103|9237277|P4|Overall Study|Death|0
2676228|NCT00545103|9237278|P3|Overall Study|Death|0
2676229|NCT00545103|9237279|P2|Overall Study|Death|1
2676230|NCT00545103|9237280|P1|Overall Study|Death|0
2676231|NCT00545103|9237277|P4|Overall Study|Subject met endpoint under protocol v. 1|0
2676232|NCT00545103|9237278|P3|Overall Study|Subject met endpoint under protocol v. 1|1
2676233|NCT00545103|9237279|P2|Overall Study|Subject met endpoint under protocol v. 1|0
2676234|NCT00545103|9237280|P1|Overall Study|Subject met endpoint under protocol v. 1|0
2676235|NCT00545103|9237277|P4|Overall Study|Does not want to take study drug anymore|0
2676236|NCT00545103|9237278|P3|Overall Study|Does not want to take study drug anymore|1
2676237|NCT00545103|9237279|P2|Overall Study|Does not want to take study drug anymore|0
2676238|NCT00545103|9237280|P1|Overall Study|Does not want to take study drug anymore|1
2676239|NCT00545103|9237277|P4|Overall Study|Use of prohibited medication|0
2676240|NCT00545103|9237278|P3|Overall Study|Use of prohibited medication|1
2676241|NCT00545103|9237279|P2|Overall Study|Use of prohibited medication|0
2676242|NCT00545103|9237280|P1|Overall Study|Use of prohibited medication|0
2676243|NCT00545103|9237277|P4|Overall Study|Subject moved|0
2676244|NCT00545103|9237278|P3|Overall Study|Subject moved|0
2676245|NCT00545103|9237279|P2|Overall Study|Subject moved|1
2676246|NCT00545103|9237280|P1|Overall Study|Subject moved|0
2676247|NCT00545103|9237277|P4|Overall Study|Investigator decision|0
2676248|NCT00545103|9237278|P3|Overall Study|Investigator decision|1
2676249|NCT00545103|9237279|P2|Overall Study|Investigator decision|0
2676250|NCT00545103|9237280|P1|Overall Study|Investigator decision|0
2676251|NCT00545103|9237277|P4|Overall Study|Noncompliance|0
2676252|NCT00545103|9237278|P3|Overall Study|Noncompliance|0
2676253|NCT00545103|9237279|P2|Overall Study|Noncompliance|1
2676254|NCT00545103|9237280|P1|Overall Study|Noncompliance|0
2676255|NCT00545103|9237277|P4|Overall Study|Subject's decision|0
2676256|NCT00545103|9237278|P3|Overall Study|Subject's decision|0
2676257|NCT00545103|9237279|P2|Overall Study|Subject's decision|0
2676258|NCT00545103|9237280|P1|Overall Study|Subject's decision|1
2676259|NCT00545103|9237277|P4|Overall Study|Personal reasons|0
2676260|NCT00545103|9237278|P3|Overall Study|Personal reasons|0
2676261|NCT00545103|9237279|P2|Overall Study|Personal reasons|0
2676262|NCT00545103|9237280|P1|Overall Study|Personal reasons|1
2676263|NCT00545103|9237277|P4|Overall Study|Diverticulitis crisis|1
2676264|NCT00545103|9237278|P3|Overall Study|Diverticulitis crisis|0
2676265|NCT00545103|9237279|P2|Overall Study|Diverticulitis crisis|0
2676266|NCT00545103|9237280|P1|Overall Study|Diverticulitis crisis|0
2676267|NCT00545103|9237277|P4|Overall Study|Wish to start a family|1
2676268|NCT00545103|9237278|P3|Overall Study|Wish to start a family|0
2676269|NCT00545103|9237279|P2|Overall Study|Wish to start a family|0
2676270|NCT00545103|9237280|P1|Overall Study|Wish to start a family|0
2676271|NCT00545103|9237277|P4|Overall Study|Investigational product not taken|1
2676272|NCT00545103|9237278|P3|Overall Study|Investigational product not taken|0
2676273|NCT00545103|9237279|P2|Overall Study|Investigational product not taken|0
2676274|NCT00545103|9237280|P1|Overall Study|Investigational product not taken|1
2676275|NCT00545103|9237277|P4|Overall Study|Difficult to open package|1
2676276|NCT00545103|9237278|P3|Overall Study|Difficult to open package|0
2676277|NCT00545103|9237279|P2|Overall Study|Difficult to open package|0
2676278|NCT00545103|9237280|P1|Overall Study|Difficult to open package|0
2676279|NCT00545103|9237277|P4|Overall Study|Suspected recurrence of diverticulitis|3
2676280|NCT00545103|9237278|P3|Overall Study|Suspected recurrence of diverticulitis|0
2676281|NCT00545103|9237279|P2|Overall Study|Suspected recurrence of diverticulitis|0
2676282|NCT00545103|9237280|P1|Overall Study|Suspected recurrence of diverticulitis|1
2676283|NCT00545103|9237277|P4|Overall Study|Protocol Violation|0
2676284|NCT00545103|9237278|P3|Overall Study|Protocol Violation|3
2676285|NCT00545103|9237279|P2|Overall Study|Protocol Violation|2
2676286|NCT00545103|9237280|P1|Overall Study|Protocol Violation|1
2676287|NCT00545103|9237277|P4|Overall Study|Lost to Follow-up|4
2676288|NCT00545103|9237278|P3|Overall Study|Lost to Follow-up|3
2676289|NCT00545103|9237279|P2|Overall Study|Lost to Follow-up|6
2676290|NCT00545103|9237280|P1|Overall Study|Lost to Follow-up|4
2676291|NCT00545103|9237277|P4|Overall Study|Adverse Event|10
2676292|NCT00545103|9237278|P3|Overall Study|Adverse Event|17
2676293|NCT00545103|9237279|P2|Overall Study|Adverse Event|12
2676294|NCT00545103|9237280|P1|Overall Study|Adverse Event|11
2676295|NCT00545103|9237277|P4|Overall Study|Withdrawal by Subject|22
2676296|NCT00545103|9237278|P3|Overall Study|Withdrawal by Subject|18
2676297|NCT00545103|9237279|P2|Overall Study|Withdrawal by Subject|10
2676298|NCT00545103|9237280|P1|Overall Study|Withdrawal by Subject|6
2676299|NCT00545103|9237277|P4|Overall Study|Lack of Efficacy|27
2676300|NCT00545103|9237278|P3|Overall Study|Lack of Efficacy|31
2676301|NCT00545103|9237279|P2|Overall Study|Lack of Efficacy|45
2676302|NCT00545103|9237280|P1|Overall Study|Lack of Efficacy|48
2676303|NCT00545077|9237316|P2|Overall Study|Death|8
2676304|NCT00545077|9237317|P1|Overall Study|Death|0
2676305|NCT00545077|9237316|P2|Overall Study|Adverse Event|31
2676306|NCT00545077|9237317|P1|Overall Study|Adverse Event|0
2676307|NCT00545077|9237316|P2|Overall Study|Protocol Violation|0
2676308|NCT00545077|9237317|P1|Overall Study|Protocol Violation|1
2676309|NCT00545077|9237316|P2|Overall Study|Lost to Follow-up|0
2676310|NCT00545077|9237317|P1|Overall Study|Lost to Follow-up|2
2676311|NCT00545077|9237316|P2|Overall Study|Physician Decision|3
2676312|NCT00545077|9237317|P1|Overall Study|Physician Decision|6
2676313|NCT00545077|9237316|P2|Overall Study|Withdrawal by Subject|14
2676314|NCT00545077|9237317|P1|Overall Study|Withdrawal by Subject|3
2676315|NCT00545077|9237316|P2|Overall Study|Disease Progression|98
2676316|NCT00545077|9237317|P1|Overall Study|Disease Progression|131
2676317|NCT00545077|9237316|P2|Overall Study|Treatment not received|1
2676318|NCT00545077|9237317|P1|Overall Study|Treatment not received|5
2676319|NCT00545064|9237333|P1|Overall Study|inclement weather|1
2676320|NCT00545064|9237333|P1|Overall Study|cancel all appointments, no rebooking|1
2676321|NCT00545064|9237333|P1|Overall Study|did not complete course of treatment|1
2676322|NCT00545064|9237333|P1|Overall Study|Withdrawal by Subject|2
2676323|NCT00545064|9237333|P1|Overall Study|Lost to Follow-up|3
2676324|NCT00545051|9237344|P2|Overall Study|Administrative reasons|1
2676325|NCT00545051|9237345|P1|Overall Study|Administrative reasons|0
2676326|NCT00545051|9237344|P2|Overall Study|Withdrawal by Subject|1
2676327|NCT00545051|9237345|P1|Overall Study|Withdrawal by Subject|0
2676328|NCT00545051|9237344|P2|Overall Study|Protocol Violation|0
2676329|NCT00545051|9237345|P1|Overall Study|Protocol Violation|1
2676330|NCT00545051|9237344|P2|Overall Study|Violation of inclusion/exclusion|2
2676331|NCT00545051|9237345|P1|Overall Study|Violation of inclusion/exclusion|0
2676332|NCT00545051|9237344|P2|Overall Study|Death|0
2676333|NCT00545051|9237345|P1|Overall Study|Death|1
2676334|NCT00545051|9237344|P2|Overall Study|Adverse Event|3
2676335|NCT00545051|9237345|P1|Overall Study|Adverse Event|7
2676336|NCT00544882|9237389|P3|Cycle 3: Follow-up|Pregnancy|0
2676337|NCT00544882|9237390|P2|Cycle 3: Follow-up|Pregnancy|1
2676338|NCT00544882|9237391|P1|Cycle 3: Follow-up|Pregnancy|0
2676339|NCT00544882|9237389|P3|Cycle 3: Follow-up|Noncompliance|0
2676340|NCT00544882|9237390|P2|Cycle 3: Follow-up|Noncompliance|1
2676341|NCT00544882|9237391|P1|Cycle 3: Follow-up|Noncompliance|0
2676342|NCT00544882|9237389|P3|Cycle 2: Randomized Treatment Cycle|Noncompliance|1
2676343|NCT00544882|9237390|P2|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
2676344|NCT00544882|9237391|P1|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
2676345|NCT00544882|9237389|P3|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
2676346|NCT00544882|9237390|P2|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1
2676347|NCT00544882|9237391|P1|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
2676348|NCT00544882|9237389|P3|Cycle 1: Run-in Cycle|Adverse Event|0
2676349|NCT00544882|9237390|P2|Cycle 1: Run-in Cycle|Adverse Event|0
2676350|NCT00544882|9237391|P1|Cycle 1: Run-in Cycle|Adverse Event|1
2676351|NCT00544882|9237389|P3|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
2676352|NCT00544882|9237390|P2|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
2676353|NCT00544882|9237391|P1|Cycle 1: Run-in Cycle|Withdrawal by Subject|2
2676354|NCT00544869|9237416|P3|Overall Study|Physician Decision|0
2676355|NCT00544869|9237417|P2|Overall Study|Physician Decision|0
2676356|NCT00544869|9237418|P1|Overall Study|Physician Decision|2
2676357|NCT00544869|9237416|P3|Overall Study|Lack of Efficacy|0
2676358|NCT00544869|9237417|P2|Overall Study|Lack of Efficacy|1
2676359|NCT00544869|9237418|P1|Overall Study|Lack of Efficacy|1
2676360|NCT00544869|9237416|P3|Overall Study|Adverse Event|0
2676361|NCT00544869|9237417|P2|Overall Study|Adverse Event|1
2676362|NCT00544869|9237418|P1|Overall Study|Adverse Event|6
2676363|NCT00544869|9237416|P3|Overall Study|Rsolution of congenitive symptoms|0
2676364|NCT00544869|9237417|P2|Overall Study|Rsolution of congenitive symptoms|0
2676365|NCT00544869|9237418|P1|Overall Study|Rsolution of congenitive symptoms|3
2676366|NCT00544817|9237426|P1|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1
2676367|NCT00544817|9237426|P1|Follow-up Systemic Therapy|Physician Decision|3
2676368|NCT00544817|9237426|P1|Follow-up Systemic Therapy|Lack of Efficacy|15
2676369|NCT00544817|9237426|P1|No Treatment Interval|Adverse Event|1
2676370|NCT00544817|9237426|P1|No Treatment Interval|Physician Decision|3
2676371|NCT00544817|9237426|P1|No Treatment Interval|Lack of Efficacy|8
2676372|NCT00544817|9237426|P1|Combined Modality|Intercurrent Illness - Pneumonia|1
2676373|NCT00544817|9237426|P1|Combined Modality|Adverse Event|2
2676374|NCT00544817|9237426|P1|Combined Modality|Worsening Neurologic Symptoms|2
2676375|NCT00544817|9237426|P1|Combined Modality|Lack of Efficacy|2
2676376|NCT00544648|9237475|P2|Overall Study|progression of disease|0
2676377|NCT00544648|9237476|P1|Overall Study|progression of disease|1
2676378|NCT00544648|9237475|P2|Overall Study|Adverse Event|1
2676379|NCT00544648|9237476|P1|Overall Study|Adverse Event|1
2676380|NCT00544648|9237475|P2|Overall Study|Withdrawal by Subject|0
2676381|NCT00544648|9237476|P1|Overall Study|Withdrawal by Subject|1
2676382|NCT00544557|9237490|P1|Overall Study|Other|98
2676383|NCT00544557|9237490|P1|Overall Study|Lack of Efficacy|196
2676384|NCT00544557|9237490|P1|Overall Study|Adverse Event|140
2676385|NCT00544544|9237521|P1|Overall Study|Lost to Follow-up|1
2676386|NCT00544544|9237521|P1|Overall Study|Adverse Event|1
2676387|NCT00544544|9237521|P1|Overall Study|Withdrawal by Subject|1
2676388|NCT00544440|9237528|P1|Overall Study|Other|5
2676389|NCT00544440|9237528|P1|Overall Study|Progressive Disease|47
2676390|NCT00544440|9237528|P1|Overall Study|Subject Non-compliance|1
2676391|NCT00544440|9237528|P1|Overall Study|Withdrawal by Subject|2
2676392|NCT00544440|9237528|P1|Overall Study|Adverse Event|1
2676393|NCT00544440|9237528|P1|Overall Study|Other|1
2676394|NCT00544167|9237535|P1|Overall Study|Physician Decision|8
2676395|NCT00544167|9237535|P1|Overall Study|Adverse Event|21
2676396|NCT00543985|9237561|P1|Overall Study|Withdrawal by Subject|4
2676397|NCT00543855|9237572|P4|Overall Study|Protocol Violation|0
2676398|NCT00543855|9237573|P3|Overall Study|Protocol Violation|0
2676399|NCT00543855|9237574|P2|Overall Study|Protocol Violation|0
2676400|NCT00543855|9237575|P1|Overall Study|Protocol Violation|1
2676401|NCT00543855|9237572|P4|Overall Study|Withdrawal by Subject|0
2676402|NCT00543855|9237573|P3|Overall Study|Withdrawal by Subject|2
2676403|NCT00543855|9237574|P2|Overall Study|Withdrawal by Subject|1
2676404|NCT00543855|9237575|P1|Overall Study|Withdrawal by Subject|0
2676405|NCT00543855|9237572|P4|Overall Study|Lost to Follow-up|0
2676406|NCT00543855|9237573|P3|Overall Study|Lost to Follow-up|1
2676407|NCT00543855|9237574|P2|Overall Study|Lost to Follow-up|0
2676408|NCT00543855|9237575|P1|Overall Study|Lost to Follow-up|0
2676409|NCT00543855|9237572|P4|Overall Study|Adverse Event|4
2676410|NCT00543855|9237573|P3|Overall Study|Adverse Event|3
2676411|NCT00543855|9237574|P2|Overall Study|Adverse Event|1
2676412|NCT00543855|9237575|P1|Overall Study|Adverse Event|3
2676413|NCT00543803|9237597|P1|Overall Study|Other|86
2676414|NCT00543803|9237597|P1|Overall Study|Lost to Follow-up|20
2676415|NCT00543803|9237597|P1|Overall Study|Lack of Efficacy|22
2676416|NCT00543803|9237597|P1|Overall Study|Adverse Event|14
2676417|NCT00543725|9237625|P2|Overall Study|Other|3
2676418|NCT00543725|9237626|P1|Overall Study|Other|3
2676419|NCT00543725|9237625|P2|Overall Study|Lost to Follow-up|11
2676420|NCT00543725|9237626|P1|Overall Study|Lost to Follow-up|15
2676421|NCT00543725|9237625|P2|Overall Study|Withdrawal by Subject|13
2676422|NCT00543725|9237626|P1|Overall Study|Withdrawal by Subject|4
2676423|NCT00543725|9237625|P2|Overall Study|Protocol Violation|1
2676424|NCT00543725|9237626|P1|Overall Study|Protocol Violation|0
2676425|NCT00543725|9237625|P2|Overall Study|Subject Reached A Virologic Endpoint|14
2676426|NCT00543725|9237626|P1|Overall Study|Subject Reached A Virologic Endpoint|22
2676427|NCT00543725|9237625|P2|Overall Study|Subject Ineligible To Continue The Trial|0
2676428|NCT00543725|9237626|P1|Overall Study|Subject Ineligible To Continue The Trial|2
2676429|NCT00543725|9237625|P2|Overall Study|Subject Non-Compliant|4
2676430|NCT00543725|9237626|P1|Overall Study|Subject Non-Compliant|4
2676431|NCT00543725|9237625|P2|Overall Study|Sponsor's Decision|1
2676432|NCT00543725|9237626|P1|Overall Study|Sponsor's Decision|0
2676433|NCT00543725|9237625|P2|Overall Study|Adverse Event|27
2676434|NCT00543725|9237626|P1|Overall Study|Adverse Event|18
2676435|NCT00543569|9237652|P4|Overall Study|Randomized but never received study drug|3
2676436|NCT00543569|9237653|P3|Overall Study|Randomized but never received study drug|5
2676437|NCT00543569|9237654|P2|Overall Study|Randomized but never received study drug|3
2676438|NCT00543569|9237655|P1|Overall Study|Randomized but never received study drug|3
2676439|NCT00543569|9237652|P4|Overall Study|Miscellaneous Reasons|4
2676440|NCT00543569|9237653|P3|Overall Study|Miscellaneous Reasons|11
2676441|NCT00543569|9237654|P2|Overall Study|Miscellaneous Reasons|3
2676442|NCT00543569|9237655|P1|Overall Study|Miscellaneous Reasons|7
2676443|NCT00543569|9237652|P4|Overall Study|Lost to Follow-up|1
2676444|NCT00543569|9237653|P3|Overall Study|Lost to Follow-up|1
2676445|NCT00543569|9237654|P2|Overall Study|Lost to Follow-up|0
2676446|NCT00543569|9237655|P1|Overall Study|Lost to Follow-up|0
2676447|NCT00543569|9237652|P4|Overall Study|Death|1
2676448|NCT00543569|9237653|P3|Overall Study|Death|3
2676449|NCT00543569|9237654|P2|Overall Study|Death|2
2676450|NCT00543569|9237655|P1|Overall Study|Death|2
2676451|NCT00543543|9237761|P4|Extension Study|Withdrawal by Subject|120
2676452|NCT00543543|9237762|P3|Extension Study|Withdrawal by Subject|0
2676453|NCT00543543|9237763|P2|Extension Study|Withdrawal by Subject|0
2676454|NCT00543543|9237764|P1|Extension Study|Withdrawal by Subject|0
2676455|NCT00543543|9237761|P4|Extension Study|Protocol Violation|11
2676456|NCT00543543|9237762|P3|Extension Study|Protocol Violation|0
2676457|NCT00543543|9237763|P2|Extension Study|Protocol Violation|0
2676458|NCT00543543|9237764|P1|Extension Study|Protocol Violation|0
2676459|NCT00543543|9237761|P4|Extension Study|Pregnancy|6
2676460|NCT00543543|9237762|P3|Extension Study|Pregnancy|0
2676461|NCT00543543|9237763|P2|Extension Study|Pregnancy|0
2676462|NCT00543543|9237764|P1|Extension Study|Pregnancy|0
2676463|NCT00543543|9237761|P4|Extension Study|Physician Decision|7
2676464|NCT00543543|9237762|P3|Extension Study|Physician Decision|0
2676465|NCT00543543|9237763|P2|Extension Study|Physician Decision|0
2676466|NCT00543543|9237764|P1|Extension Study|Physician Decision|0
2676467|NCT00543543|9237761|P4|Extension Study|Lost to Follow-up|77
2676468|NCT00543543|9237762|P3|Extension Study|Lost to Follow-up|0
2676469|NCT00543543|9237763|P2|Extension Study|Lost to Follow-up|0
2676470|NCT00543543|9237764|P1|Extension Study|Lost to Follow-up|0
2676471|NCT00543543|9237761|P4|Extension Study|Adverse Event|5
2676472|NCT00543543|9237762|P3|Extension Study|Adverse Event|0
2676473|NCT00543543|9237763|P2|Extension Study|Adverse Event|0
2676474|NCT00543543|9237764|P1|Extension Study|Adverse Event|0
2676475|NCT00543543|9237761|P4|Base Study|Withdrawal by Subject|503
2676476|NCT00543543|9237762|P3|Base Study|Withdrawal by Subject|5
2676477|NCT00543543|9237763|P2|Base Study|Withdrawal by Subject|482
2676478|NCT00543543|9237764|P1|Base Study|Withdrawal by Subject|7
2676479|NCT00543543|9237761|P4|Base Study|Protocol Violation|6
2676480|NCT00543543|9237762|P3|Base Study|Protocol Violation|0
2676481|NCT00543543|9237763|P2|Base Study|Protocol Violation|6
2676482|NCT00543543|9237764|P1|Base Study|Protocol Violation|0
2676483|NCT00543543|9237761|P4|Base Study|Physician Decision|7
2676484|NCT00543543|9237762|P3|Base Study|Physician Decision|0
2676485|NCT00543543|9237763|P2|Base Study|Physician Decision|4
2676486|NCT00543543|9237764|P1|Base Study|Physician Decision|0
2676487|NCT00543543|9237761|P4|Base Study|Lost to Follow-up|701
2676488|NCT00543543|9237762|P3|Base Study|Lost to Follow-up|9
2676489|NCT00543543|9237763|P2|Base Study|Lost to Follow-up|749
2676490|NCT00543543|9237764|P1|Base Study|Lost to Follow-up|12
2676491|NCT00543543|9237761|P4|Base Study|Adverse Event|5
2676492|NCT00543543|9237762|P3|Base Study|Adverse Event|0
2676493|NCT00543543|9237763|P2|Base Study|Adverse Event|11
2676494|NCT00543543|9237764|P1|Base Study|Adverse Event|1
2676495|NCT00543439|9237808|P3|Period 2|Adverse Event|1
2676496|NCT00543439|9237809|P2|Period 2|Adverse Event|1
2676497|NCT00543439|9237810|P1|Period 2|Adverse Event|0
2676498|NCT00543439|9237808|P3|Period 2|Protocol Violation|1
2676499|NCT00543439|9237809|P2|Period 2|Protocol Violation|0
2676500|NCT00543439|9237810|P1|Period 2|Protocol Violation|1
2676501|NCT00543439|9237808|P3|Period 1|Physician Decision|1
2676502|NCT00543439|9237809|P2|Period 1|Physician Decision|0
2676503|NCT00543439|9237810|P1|Period 1|Physician Decision|0
2676504|NCT00543439|9237808|P3|Period 1|Withdrawal by Subject|0
2676505|NCT00543439|9237809|P2|Period 1|Withdrawal by Subject|1
2676506|NCT00543439|9237810|P1|Period 1|Withdrawal by Subject|1
2676507|NCT00543439|9237808|P3|Period 1|Adverse Event|1
2676508|NCT00543439|9237809|P2|Period 1|Adverse Event|2
2676509|NCT00543439|9237810|P1|Period 1|Adverse Event|0
2676510|NCT00543387|9237879|P11|Crossover Participants|Study Terminated by Sponsor|1
2676511|NCT00543387|9237880|P10|Crossover Participants|Study Terminated by Sponsor|0
2676512|NCT00543387|9237881|P9|Crossover Participants|Study Terminated by Sponsor|0
2676513|NCT00543387|9237882|P8|Crossover Participants|Study Terminated by Sponsor|0
2676514|NCT00543387|9237883|P7|Crossover Participants|Study Terminated by Sponsor|0
2676515|NCT00543387|9237884|P6|Crossover Participants|Study Terminated by Sponsor|0
2676516|NCT00543387|9237885|P5|Crossover Participants|Study Terminated by Sponsor|0
2676517|NCT00543387|9237886|P4|Crossover Participants|Study Terminated by Sponsor|0
2676518|NCT00543387|9237887|P3|Crossover Participants|Study Terminated by Sponsor|0
2676519|NCT00543387|9237888|P2|Crossover Participants|Study Terminated by Sponsor|0
2676520|NCT00543387|9237889|P1|Crossover Participants|Study Terminated by Sponsor|0
2676521|NCT00543387|9237879|P11|Crossover Participants|Progressive Disease|2
2676522|NCT00543387|9237880|P10|Crossover Participants|Progressive Disease|1
2676523|NCT00543387|9237881|P9|Crossover Participants|Progressive Disease|0
2676524|NCT00543387|9237882|P8|Crossover Participants|Progressive Disease|0
2676525|NCT00543387|9237883|P7|Crossover Participants|Progressive Disease|0
2676526|NCT00543387|9237884|P6|Crossover Participants|Progressive Disease|0
2676527|NCT00543387|9237885|P5|Crossover Participants|Progressive Disease|0
2676528|NCT00543387|9237886|P4|Crossover Participants|Progressive Disease|0
2676529|NCT00543387|9237887|P3|Crossover Participants|Progressive Disease|0
2676530|NCT00543387|9237888|P2|Crossover Participants|Progressive Disease|0
2676531|NCT00543387|9237889|P1|Crossover Participants|Progressive Disease|0
2676532|NCT00543387|9237879|P11|Panel 1 + Panel 2|Withdrawal by Subject|0
2676533|NCT00543387|9237880|P10|Panel 1 + Panel 2|Withdrawal by Subject|0
2676534|NCT00543387|9237881|P9|Panel 1 + Panel 2|Withdrawal by Subject|0
2676535|NCT00543387|9237882|P8|Panel 1 + Panel 2|Withdrawal by Subject|0
2676536|NCT00543387|9237883|P7|Panel 1 + Panel 2|Withdrawal by Subject|1
2676537|NCT00543387|9237884|P6|Panel 1 + Panel 2|Withdrawal by Subject|0
2676538|NCT00543387|9237885|P5|Panel 1 + Panel 2|Withdrawal by Subject|0
2676539|NCT00543387|9237886|P4|Panel 1 + Panel 2|Withdrawal by Subject|0
2676540|NCT00543387|9237887|P3|Panel 1 + Panel 2|Withdrawal by Subject|0
2676541|NCT00543387|9237888|P2|Panel 1 + Panel 2|Withdrawal by Subject|0
2676542|NCT00543387|9237889|P1|Panel 1 + Panel 2|Withdrawal by Subject|0
2676543|NCT00543387|9237879|P11|Panel 1 + Panel 2|Progressive Disease (PD)|0
2676544|NCT00543387|9237880|P10|Panel 1 + Panel 2|Progressive Disease (PD)|0
2676545|NCT00543387|9237881|P9|Panel 1 + Panel 2|Progressive Disease (PD)|4
2676546|NCT00543387|9237882|P8|Panel 1 + Panel 2|Progressive Disease (PD)|4
2676547|NCT00543387|9237883|P7|Panel 1 + Panel 2|Progressive Disease (PD)|5
2676548|NCT00543387|9237884|P6|Panel 1 + Panel 2|Progressive Disease (PD)|3
2676549|NCT00543387|9237885|P5|Panel 1 + Panel 2|Progressive Disease (PD)|3
2676550|NCT00543387|9237886|P4|Panel 1 + Panel 2|Progressive Disease (PD)|3
2676551|NCT00543387|9237887|P3|Panel 1 + Panel 2|Progressive Disease (PD)|2
2676552|NCT00543387|9237888|P2|Panel 1 + Panel 2|Progressive Disease (PD)|2
2676553|NCT00543387|9237889|P1|Panel 1 + Panel 2|Progressive Disease (PD)|3
2676554|NCT00543387|9237879|P11|Panel 1 + Panel 2|Physician Decision|0
2676555|NCT00543387|9237880|P10|Panel 1 + Panel 2|Physician Decision|0
2676556|NCT00543387|9237881|P9|Panel 1 + Panel 2|Physician Decision|0
2676557|NCT00543387|9237882|P8|Panel 1 + Panel 2|Physician Decision|1
2676558|NCT00543387|9237883|P7|Panel 1 + Panel 2|Physician Decision|0
2676559|NCT00543387|9237884|P6|Panel 1 + Panel 2|Physician Decision|0
2676560|NCT00543387|9237885|P5|Panel 1 + Panel 2|Physician Decision|0
2676561|NCT00543387|9237886|P4|Panel 1 + Panel 2|Physician Decision|0
2676562|NCT00543387|9237887|P3|Panel 1 + Panel 2|Physician Decision|1
2676563|NCT00543387|9237888|P2|Panel 1 + Panel 2|Physician Decision|0
2676564|NCT00543387|9237889|P1|Panel 1 + Panel 2|Physician Decision|0
2676565|NCT00543387|9237879|P11|Panel 1 + Panel 2|Adverse Event|0
2676566|NCT00543387|9237880|P10|Panel 1 + Panel 2|Adverse Event|0
2676567|NCT00543387|9237881|P9|Panel 1 + Panel 2|Adverse Event|1
2676568|NCT00543387|9237882|P8|Panel 1 + Panel 2|Adverse Event|1
2676569|NCT00543387|9237883|P7|Panel 1 + Panel 2|Adverse Event|0
2676570|NCT00543387|9237884|P6|Panel 1 + Panel 2|Adverse Event|0
2676571|NCT00543387|9237885|P5|Panel 1 + Panel 2|Adverse Event|0
2676572|NCT00543387|9237886|P4|Panel 1 + Panel 2|Adverse Event|0
2676573|NCT00543387|9237887|P3|Panel 1 + Panel 2|Adverse Event|0
2676574|NCT00543387|9237888|P2|Panel 1 + Panel 2|Adverse Event|1
2676575|NCT00543387|9237889|P1|Panel 1 + Panel 2|Adverse Event|0
2676576|NCT00543309|9237927|P3|Overall Study|Physician Decision|0
2676577|NCT00543309|9237928|P2|Overall Study|Physician Decision|1
2676578|NCT00543309|9237929|P1|Overall Study|Physician Decision|0
2676579|NCT00543296|9237979|P1|Overall Study|Physician Decision|7
2676580|NCT00543140|9237986|P1|Overall Study|Conversion to different procedure|1
2676581|NCT00543140|9237986|P1|Overall Study|Subject moved|1
2676582|NCT00543140|9237986|P1|Overall Study|Death|1
2676583|NCT00543140|9237986|P1|Overall Study|SAE leading to explant of SAGB|3
2676584|NCT00543140|9237986|P1|Overall Study|Insufficient weight loss|10
2676585|NCT00543140|9237986|P1|Overall Study|Protocol Violation|10
2676586|NCT00543140|9237986|P1|Overall Study|Withdrawal by Subject|13
2676587|NCT00543140|9237986|P1|Overall Study|Lost to Follow-up|33
2676588|NCT00543062|9238024|P4|Overall Study|Protocol Violation|0
2676589|NCT00543062|9238025|P3|Overall Study|Protocol Violation|0
2676590|NCT00543062|9238026|P2|Overall Study|Protocol Violation|0
2676591|NCT00543062|9238027|P1|Overall Study|Protocol Violation|1
2676592|NCT00543062|9238024|P4|Overall Study|Adverse Event|1
2676593|NCT00543062|9238025|P3|Overall Study|Adverse Event|1
2676594|NCT00543062|9238026|P2|Overall Study|Adverse Event|1
2676595|NCT00543062|9238027|P1|Overall Study|Adverse Event|0
2676596|NCT00543062|9238024|P4|Overall Study|Withdrawal by Subject|0
2676597|NCT00543062|9238025|P3|Overall Study|Withdrawal by Subject|2
2676598|NCT00543062|9238026|P2|Overall Study|Withdrawal by Subject|0
2676599|NCT00543062|9238027|P1|Overall Study|Withdrawal by Subject|1
2676600|NCT00542997|9238049|P1|Efficacy Period|Adverse Event|3
2676601|NCT00542997|9238049|P1|Wash in / Wash Out Period|Adverse Event|3
2676602|NCT00542997|9238049|P1|Wash in / Wash Out Period|Withdrawal by Subject|2
2676603|NCT00542880|9238071|P2|Period 3|Adverse Event|2
2676604|NCT00542880|9238072|P1|Period 3|Adverse Event|0
2676605|NCT00542880|9238071|P2|Period 2|Other|1
2676606|NCT00542880|9238072|P1|Period 2|Other|0
2676607|NCT00542880|9238071|P2|Period 2|Severe non-compliance|1
2676608|NCT00542880|9238072|P1|Period 2|Severe non-compliance|0
2676609|NCT00542880|9238071|P2|Period 2|Discontinuation criteria|0
2676610|NCT00542880|9238072|P1|Period 2|Discontinuation criteria|2
2676611|NCT00542880|9238071|P2|Period 2|Eligibility not fulfilled|1
2676612|NCT00542880|9238072|P1|Period 2|Eligibility not fulfilled|0
2676613|NCT00542880|9238071|P2|Period 2|Adverse Event|7
2676614|NCT00542880|9238072|P1|Period 2|Adverse Event|5
2676615|NCT00542880|9238071|P2|Period 1|Protocol Violation|1
2676616|NCT00542880|9238072|P1|Period 1|Protocol Violation|0
2676617|NCT00542880|9238071|P2|Period 1|Withdrawal by Subject|1
2676618|NCT00542880|9238072|P1|Period 1|Withdrawal by Subject|1
2676619|NCT00542880|9238071|P2|Period 1|Development of study-specific criteria|2
2676620|NCT00542880|9238072|P1|Period 1|Development of study-specific criteria|1
2676621|NCT00542880|9238071|P2|Period 1|Adverse Event|2
2676622|NCT00542880|9238072|P1|Period 1|Adverse Event|2
2676623|NCT00542880|9238071|P2|Period 1|Eligibility criteria not fulfilled|6
2676624|NCT00542880|9238072|P1|Period 1|Eligibility criteria not fulfilled|2
2676625|NCT00542828|9238108|P1|Overall Study|Did Not Receive Thymoglobulin Treatment|2
2676626|NCT00542828|9238108|P1|Overall Study|Study Prematurely Discontinued|7
2676627|NCT00542828|9238108|P1|Overall Study|Need for Prohibited Treatment|3
2676628|NCT00542828|9238108|P1|Overall Study|Physician Decision|1
2676629|NCT00542815|9238126|P3|Overall Study|Other reasons|10
2676630|NCT00542815|9238127|P2|Overall Study|Other reasons|10
2676631|NCT00542815|9238128|P1|Overall Study|Other reasons|24
2676632|NCT00542815|9238126|P3|Overall Study|Withdrawal by Subject|8
2676633|NCT00542815|9238127|P2|Overall Study|Withdrawal by Subject|5
2676634|NCT00542815|9238128|P1|Overall Study|Withdrawal by Subject|41
2676635|NCT00542815|9238126|P3|Overall Study|Protocol Violation|2
2676636|NCT00542815|9238127|P2|Overall Study|Protocol Violation|1
2676637|NCT00542815|9238128|P1|Overall Study|Protocol Violation|1
2676638|NCT00542815|9238126|P3|Overall Study|Physician Decision|0
2676639|NCT00542815|9238127|P2|Overall Study|Physician Decision|1
2676640|NCT00542815|9238128|P1|Overall Study|Physician Decision|2
2676641|NCT00542815|9238126|P3|Overall Study|Lack of Efficacy|0
2676642|NCT00542815|9238127|P2|Overall Study|Lack of Efficacy|2
2676643|NCT00542815|9238128|P1|Overall Study|Lack of Efficacy|9
2676644|NCT00542815|9238126|P3|Overall Study|Death|3
2676645|NCT00542815|9238127|P2|Overall Study|Death|7
2676646|NCT00542815|9238128|P1|Overall Study|Death|10
2676647|NCT00542815|9238126|P3|Overall Study|Adverse Event|9
2676648|NCT00542815|9238127|P2|Overall Study|Adverse Event|6
2676649|NCT00542815|9238128|P1|Overall Study|Adverse Event|19
2676650|NCT00542789|9238141|P2|Overall Study|Recurrence of Gastric Ulcer|57
2676651|NCT00542789|9238142|P1|Overall Study|Recurrence of Gastric Ulcer|8
2676652|NCT00542789|9238141|P2|Overall Study|Protocol Violation|1
2676653|NCT00542789|9238142|P1|Overall Study|Protocol Violation|8
2676654|NCT00542789|9238141|P2|Overall Study|Withdrawal by Subject|3
2676655|NCT00542789|9238142|P1|Overall Study|Withdrawal by Subject|7
2676656|NCT00542789|9238141|P2|Overall Study|Adverse Event|17
2676657|NCT00542789|9238142|P1|Overall Study|Adverse Event|18
2676658|NCT00542425|9238242|P5|Extended 24 Weeks of Treatment|Other|1
2676659|NCT00542425|9238243|P4|Extended 24 Weeks of Treatment|Other|0
2676660|NCT00542425|9238244|P3|Extended 24 Weeks of Treatment|Other|0
2676661|NCT00542425|9238245|P2|Extended 24 Weeks of Treatment|Other|1
2676662|NCT00542425|9238246|P1|Extended 24 Weeks of Treatment|Other|1
2676663|NCT00542425|9238242|P5|Extended 24 Weeks of Treatment|Refusal of treatment|0
2676664|NCT00542425|9238243|P4|Extended 24 Weeks of Treatment|Refusal of treatment|0
2676665|NCT00542425|9238244|P3|Extended 24 Weeks of Treatment|Refusal of treatment|0
2676666|NCT00542425|9238245|P2|Extended 24 Weeks of Treatment|Refusal of treatment|1
2676667|NCT00542425|9238246|P1|Extended 24 Weeks of Treatment|Refusal of treatment|0
2676668|NCT00542425|9238242|P5|Extended 24 Weeks of Treatment|Protocol Violation|0
2676669|NCT00542425|9238243|P4|Extended 24 Weeks of Treatment|Protocol Violation|0
2676670|NCT00542425|9238244|P3|Extended 24 Weeks of Treatment|Protocol Violation|1
2676671|NCT00542425|9238245|P2|Extended 24 Weeks of Treatment|Protocol Violation|0
2676672|NCT00542425|9238246|P1|Extended 24 Weeks of Treatment|Protocol Violation|0
2676673|NCT00542425|9238242|P5|Extended 24 Weeks of Treatment|Adverse Event|0
2676674|NCT00542425|9238243|P4|Extended 24 Weeks of Treatment|Adverse Event|1
2676675|NCT00542425|9238244|P3|Extended 24 Weeks of Treatment|Adverse Event|1
2676676|NCT00542425|9238245|P2|Extended 24 Weeks of Treatment|Adverse Event|0
2676677|NCT00542425|9238246|P1|Extended 24 Weeks of Treatment|Adverse Event|0
2676678|NCT00542425|9238242|P5|Initial 24 Weeks|Other|0
2676679|NCT00542425|9238243|P4|Initial 24 Weeks|Other|0
2676680|NCT00542425|9238244|P3|Initial 24 Weeks|Other|1
2676681|NCT00542425|9238245|P2|Initial 24 Weeks|Other|2
2676682|NCT00542425|9238246|P1|Initial 24 Weeks|Other|0
2676683|NCT00542425|9238242|P5|Initial 24 Weeks|Refusal of treatment|1
2676684|NCT00542425|9238243|P4|Initial 24 Weeks|Refusal of treatment|4
2676685|NCT00542425|9238244|P3|Initial 24 Weeks|Refusal of treatment|1
2676686|NCT00542425|9238245|P2|Initial 24 Weeks|Refusal of treatment|2
2676687|NCT00542425|9238246|P1|Initial 24 Weeks|Refusal of treatment|2
2676688|NCT00542425|9238242|P5|Initial 24 Weeks|Protocol Violation|0
2676689|NCT00542425|9238243|P4|Initial 24 Weeks|Protocol Violation|1
2676690|NCT00542425|9238244|P3|Initial 24 Weeks|Protocol Violation|0
2676691|NCT00542425|9238245|P2|Initial 24 Weeks|Protocol Violation|0
2676692|NCT00542425|9238246|P1|Initial 24 Weeks|Protocol Violation|0
2676693|NCT00542425|9238242|P5|Initial 24 Weeks|Non-compliance|1
2676694|NCT00542425|9238243|P4|Initial 24 Weeks|Non-compliance|1
2676695|NCT00542425|9238244|P3|Initial 24 Weeks|Non-compliance|0
2676696|NCT00542425|9238245|P2|Initial 24 Weeks|Non-compliance|0
2676697|NCT00542425|9238246|P1|Initial 24 Weeks|Non-compliance|0
2676698|NCT00542425|9238242|P5|Initial 24 Weeks|Lost to Follow-up|0
2676699|NCT00542425|9238243|P4|Initial 24 Weeks|Lost to Follow-up|0
2676700|NCT00542425|9238244|P3|Initial 24 Weeks|Lost to Follow-up|1
2676701|NCT00542425|9238245|P2|Initial 24 Weeks|Lost to Follow-up|2
2676702|NCT00542425|9238246|P1|Initial 24 Weeks|Lost to Follow-up|2
2676703|NCT00542425|9238242|P5|Initial 24 Weeks|Inability to complete procedures|2
2676704|NCT00542425|9238243|P4|Initial 24 Weeks|Inability to complete procedures|1
2676705|NCT00542425|9238244|P3|Initial 24 Weeks|Inability to complete procedures|2
2676706|NCT00542425|9238245|P2|Initial 24 Weeks|Inability to complete procedures|3
2676707|NCT00542425|9238246|P1|Initial 24 Weeks|Inability to complete procedures|0
2676708|NCT00542425|9238242|P5|Initial 24 Weeks|Adverse Event|2
2676709|NCT00542425|9238243|P4|Initial 24 Weeks|Adverse Event|3
2676710|NCT00542425|9238244|P3|Initial 24 Weeks|Adverse Event|1
2676711|NCT00542425|9238245|P2|Initial 24 Weeks|Adverse Event|1
2676712|NCT00542425|9238246|P1|Initial 24 Weeks|Adverse Event|0
2676713|NCT00542425|9238242|P5|Initial 24 Weeks|Administrative reasons|0
2676714|NCT00542425|9238243|P4|Initial 24 Weeks|Administrative reasons|1
2676715|NCT00542425|9238244|P3|Initial 24 Weeks|Administrative reasons|1
2676716|NCT00542425|9238245|P2|Initial 24 Weeks|Administrative reasons|0
2676717|NCT00542425|9238246|P1|Initial 24 Weeks|Administrative reasons|0
2676718|NCT00542386|9238284|P6|Overall Study|Other Reasons|2
2676719|NCT00542386|9238285|P5|Overall Study|Other Reasons|4
2676720|NCT00542386|9238286|P4|Overall Study|Other Reasons|3
2676721|NCT00542386|9238287|P3|Overall Study|Other Reasons|4
2676722|NCT00542386|9238288|P2|Overall Study|Other Reasons|1
2676723|NCT00542386|9238289|P1|Overall Study|Other Reasons|4
2676724|NCT00542386|9238284|P6|Overall Study|Withdrawal by Subject|7
2676725|NCT00542386|9238285|P5|Overall Study|Withdrawal by Subject|15
2676726|NCT00542386|9238286|P4|Overall Study|Withdrawal by Subject|11
2676727|NCT00542386|9238287|P3|Overall Study|Withdrawal by Subject|10
2676728|NCT00542386|9238288|P2|Overall Study|Withdrawal by Subject|8
2676729|NCT00542386|9238289|P1|Overall Study|Withdrawal by Subject|5
2676730|NCT00542386|9238284|P6|Overall Study|Protocol Violation|4
2676731|NCT00542386|9238285|P5|Overall Study|Protocol Violation|0
2676732|NCT00542386|9238286|P4|Overall Study|Protocol Violation|0
2676733|NCT00542386|9238287|P3|Overall Study|Protocol Violation|1
2676734|NCT00542386|9238288|P2|Overall Study|Protocol Violation|0
2676735|NCT00542386|9238289|P1|Overall Study|Protocol Violation|0
2676736|NCT00542386|9238284|P6|Overall Study|Physician Decision|0
2676737|NCT00542386|9238285|P5|Overall Study|Physician Decision|0
2676738|NCT00542386|9238286|P4|Overall Study|Physician Decision|1
2676739|NCT00542386|9238287|P3|Overall Study|Physician Decision|0
2676740|NCT00542386|9238288|P2|Overall Study|Physician Decision|0
2676741|NCT00542386|9238289|P1|Overall Study|Physician Decision|1
2676742|NCT00542386|9238284|P6|Overall Study|Lack of Efficacy|31
2676743|NCT00542386|9238285|P5|Overall Study|Lack of Efficacy|7
2676744|NCT00542386|9238286|P4|Overall Study|Lack of Efficacy|13
2676745|NCT00542386|9238287|P3|Overall Study|Lack of Efficacy|10
2676746|NCT00542386|9238288|P2|Overall Study|Lack of Efficacy|12
2676747|NCT00542386|9238289|P1|Overall Study|Lack of Efficacy|32
2676748|NCT00542386|9238284|P6|Overall Study|Death|2
2676749|NCT00542386|9238285|P5|Overall Study|Death|1
2676750|NCT00542386|9238286|P4|Overall Study|Death|2
2676751|NCT00542386|9238287|P3|Overall Study|Death|1
2676752|NCT00542386|9238288|P2|Overall Study|Death|0
2676753|NCT00542386|9238289|P1|Overall Study|Death|0
2676754|NCT00542386|9238284|P6|Overall Study|Adverse Event|4
2676755|NCT00542386|9238285|P5|Overall Study|Adverse Event|13
2676756|NCT00542386|9238286|P4|Overall Study|Adverse Event|8
2676757|NCT00542386|9238287|P3|Overall Study|Adverse Event|7
2676758|NCT00542386|9238288|P2|Overall Study|Adverse Event|7
2676759|NCT00542386|9238289|P1|Overall Study|Adverse Event|1
2676760|NCT00542321|9238311|P2|Overall Study|Death|1
2676761|NCT00542321|9238312|P1|Overall Study|Death|0
2676762|NCT00542269|9238334|P3|Overall Study|Administrative problems|1
2676763|NCT00542269|9238335|P2|Overall Study|Administrative problems|1
2676764|NCT00542269|9238336|P1|Overall Study|Administrative problems|1
2676765|NCT00542269|9238334|P3|Overall Study|Withdrawal by Subject|0
2676766|NCT00542269|9238335|P2|Overall Study|Withdrawal by Subject|0
2676767|NCT00542269|9238336|P1|Overall Study|Withdrawal by Subject|1
2676768|NCT00542269|9238334|P3|Overall Study|Protocol Violation|0
2676769|NCT00542269|9238335|P2|Overall Study|Protocol Violation|1
2676770|NCT00542269|9238336|P1|Overall Study|Protocol Violation|1
2676771|NCT00542269|9238334|P3|Overall Study|Adverse Event|5
2676772|NCT00542269|9238335|P2|Overall Study|Adverse Event|4
2676773|NCT00542269|9238336|P1|Overall Study|Adverse Event|10
2676774|NCT00542191|9238365|P1|Overall Study|Death|3
2676775|NCT00542178|9238375|P8|Overall Study|did not complete year 4 follow-up|85
2676776|NCT00542178|9238376|P7|Overall Study|did not complete year 4 follow-up|87
2676777|NCT00542178|9238377|P6|Overall Study|did not complete year 4 follow-up|89
2676778|NCT00542178|9238378|P5|Overall Study|did not complete year 4 follow-up|64
2676779|NCT00542178|9238379|P4|Overall Study|did not complete year 4 follow-up|62
2676780|NCT00542178|9238380|P3|Overall Study|did not complete year 4 follow-up|74
2676781|NCT00542178|9238381|P2|Overall Study|did not complete year 4 follow-up|80
2676782|NCT00542178|9238382|P1|Overall Study|did not complete year 4 follow-up|75
2676783|NCT00541970|9238418|P4|Month 60|Protocol Violation|72
2676784|NCT00541970|9238419|P3|Month 60|Protocol Violation|82
2676785|NCT00541970|9238420|P2|Month 60|Protocol Violation|77
2676786|NCT00541970|9238421|P1|Month 60|Protocol Violation|78
2676787|NCT00541970|9238418|P4|Month 48|Lost to Follow-up|73
2676788|NCT00541970|9238419|P3|Month 48|Lost to Follow-up|68
2676789|NCT00541970|9238420|P2|Month 48|Lost to Follow-up|68
2676790|NCT00541970|9238421|P1|Month 48|Lost to Follow-up|66
2676791|NCT00541970|9238418|P4|Month 48|Other|0
2676792|NCT00541970|9238419|P3|Month 48|Other|1
2676793|NCT00541970|9238420|P2|Month 48|Other|1
2676794|NCT00541970|9238421|P1|Month 48|Other|3
2676795|NCT00541970|9238418|P4|Month 48|Withdrawal by Subject|2
2676796|NCT00541970|9238419|P3|Month 48|Withdrawal by Subject|4
2676797|NCT00541970|9238420|P2|Month 48|Withdrawal by Subject|4
2676798|NCT00541970|9238421|P1|Month 48|Withdrawal by Subject|2
2676799|NCT00541970|9238418|P4|Month 36|Protocol Violation|60
2676800|NCT00541970|9238419|P3|Month 36|Protocol Violation|66
2676801|NCT00541970|9238420|P2|Month 36|Protocol Violation|66
2676802|NCT00541970|9238421|P1|Month 36|Protocol Violation|61
2676803|NCT00541970|9238418|P4|Month 24|Protocol Violation|21
2676804|NCT00541970|9238419|P3|Month 24|Protocol Violation|31
2676805|NCT00541970|9238420|P2|Month 24|Protocol Violation|31
2676806|NCT00541970|9238421|P1|Month 24|Protocol Violation|29
2676807|NCT00541970|9238418|P4|Month 24|Adverse Event|1
2676808|NCT00541970|9238419|P3|Month 24|Adverse Event|1
2676809|NCT00541970|9238420|P2|Month 24|Adverse Event|1
2676810|NCT00541970|9238421|P1|Month 24|Adverse Event|0
2676811|NCT00541970|9238418|P4|Month 18|Protocol Violation|16
2676812|NCT00541970|9238419|P3|Month 18|Protocol Violation|24
2676813|NCT00541970|9238420|P2|Month 18|Protocol Violation|23
2676814|NCT00541970|9238421|P1|Month 18|Protocol Violation|14
2676815|NCT00541970|9238418|P4|Month 18|Adverse Event|1
2676816|NCT00541970|9238419|P3|Month 18|Adverse Event|1
2676817|NCT00541970|9238420|P2|Month 18|Adverse Event|1
2676818|NCT00541970|9238421|P1|Month 18|Adverse Event|0
2676819|NCT00541970|9238418|P4|Month 12|Protocol Violation|15
2676820|NCT00541970|9238419|P3|Month 12|Protocol Violation|20
2676821|NCT00541970|9238420|P2|Month 12|Protocol Violation|21
2676822|NCT00541970|9238421|P1|Month 12|Protocol Violation|12
2676823|NCT00541970|9238418|P4|Month 12|Adverse Event|1
2676824|NCT00541970|9238419|P3|Month 12|Adverse Event|1
2676825|NCT00541970|9238420|P2|Month 12|Adverse Event|1
2676826|NCT00541970|9238421|P1|Month 12|Adverse Event|0
2676827|NCT00541970|9238418|P4|Month 7|Protocol Violation|5
2676828|NCT00541970|9238419|P3|Month 7|Protocol Violation|11
2676829|NCT00541970|9238420|P2|Month 7|Protocol Violation|13
2676830|NCT00541970|9238421|P1|Month 7|Protocol Violation|9
2676831|NCT00541931|9238572|P2|Overall Study|Transportation Issue|1
2676832|NCT00541931|9238573|P1|Overall Study|Transportation Issue|0
2676833|NCT00541931|9238572|P2|Overall Study|Withdrawal by Subject|0
2676834|NCT00541931|9238573|P1|Overall Study|Withdrawal by Subject|1
2676835|NCT00541931|9238572|P2|Overall Study|Lost to Follow-up|3
2676836|NCT00541931|9238573|P1|Overall Study|Lost to Follow-up|3
2676837|NCT00541931|9238572|P2|Overall Study|Adverse Event|0
2676838|NCT00541931|9238573|P1|Overall Study|Adverse Event|1
2676839|NCT00541866|9238586|P5|Overall Study|Physician Decision|0
2676840|NCT00541866|9238587|P4|Overall Study|Physician Decision|1
2676841|NCT00541866|9238588|P3|Overall Study|Physician Decision|2
2676842|NCT00541866|9238589|P2|Overall Study|Physician Decision|0
2676843|NCT00541866|9238590|P1|Overall Study|Physician Decision|0
2676844|NCT00541866|9238586|P5|Overall Study|Not Reported or Other|1
2676845|NCT00541866|9238587|P4|Overall Study|Not Reported or Other|3
2676846|NCT00541866|9238588|P3|Overall Study|Not Reported or Other|3
2676847|NCT00541866|9238589|P2|Overall Study|Not Reported or Other|3
2676848|NCT00541866|9238590|P1|Overall Study|Not Reported or Other|11
2676849|NCT00541866|9238586|P5|Overall Study|Lack of Efficacy|14
2676850|NCT00541866|9238587|P4|Overall Study|Lack of Efficacy|12
2676851|NCT00541866|9238588|P3|Overall Study|Lack of Efficacy|10
2676852|NCT00541866|9238589|P2|Overall Study|Lack of Efficacy|15
2676853|NCT00541866|9238590|P1|Overall Study|Lack of Efficacy|19
2676854|NCT00541866|9238586|P5|Overall Study|Death|0
2676855|NCT00541866|9238587|P4|Overall Study|Death|0
2676856|NCT00541866|9238588|P3|Overall Study|Death|0
2676857|NCT00541866|9238589|P2|Overall Study|Death|0
2676858|NCT00541866|9238590|P1|Overall Study|Death|1
2676859|NCT00541866|9238586|P5|Overall Study|Adverse Event|0
2676860|NCT00541866|9238587|P4|Overall Study|Adverse Event|0
2676861|NCT00541866|9238588|P3|Overall Study|Adverse Event|0
2676862|NCT00541866|9238589|P2|Overall Study|Adverse Event|0
2676863|NCT00541866|9238590|P1|Overall Study|Adverse Event|3
2676864|NCT00541775|9238631|P3|Overall Study|Withdrawal by Subject and Other|2
2676865|NCT00541775|9238632|P2|Overall Study|Withdrawal by Subject and Other|0
2676866|NCT00541775|9238633|P1|Overall Study|Withdrawal by Subject and Other|5
2676867|NCT00541775|9238631|P3|Overall Study|Protocol Violation|0
2676868|NCT00541775|9238632|P2|Overall Study|Protocol Violation|0
2676869|NCT00541775|9238633|P1|Overall Study|Protocol Violation|1
2676870|NCT00541775|9238631|P3|Overall Study|Lost to Follow-up|2
2676871|NCT00541775|9238632|P2|Overall Study|Lost to Follow-up|0
2676872|NCT00541775|9238633|P1|Overall Study|Lost to Follow-up|0
2676873|NCT00541775|9238631|P3|Overall Study|Lack of Efficacy|3
2676874|NCT00541775|9238632|P2|Overall Study|Lack of Efficacy|0
2676875|NCT00541775|9238633|P1|Overall Study|Lack of Efficacy|0
2676876|NCT00541775|9238631|P3|Overall Study|Adverse Event|1
2676877|NCT00541775|9238632|P2|Overall Study|Adverse Event|2
2676878|NCT00541775|9238633|P1|Overall Study|Adverse Event|3
2676879|NCT00541658|9238659|P3|Overall Study|Took No Study Drug|0
2676880|NCT00541658|9238660|P2|Overall Study|Took No Study Drug|0
2676881|NCT00541658|9238661|P1|Overall Study|Took No Study Drug|1
2676882|NCT00541658|9238659|P3|Overall Study|Withdrawal by Subject|32
2676883|NCT00541658|9238660|P2|Overall Study|Withdrawal by Subject|32
2676884|NCT00541658|9238661|P1|Overall Study|Withdrawal by Subject|28
2676885|NCT00541658|9238659|P3|Overall Study|Protocol Violation|1
2676886|NCT00541658|9238660|P2|Overall Study|Protocol Violation|1
2676887|NCT00541658|9238661|P1|Overall Study|Protocol Violation|0
2676888|NCT00541658|9238659|P3|Overall Study|Lost to Follow-up|6
2676889|NCT00541658|9238660|P2|Overall Study|Lost to Follow-up|3
2676890|NCT00541658|9238661|P1|Overall Study|Lost to Follow-up|3
2676891|NCT00541658|9238659|P3|Overall Study|Physician Decision|4
2676892|NCT00541658|9238660|P2|Overall Study|Physician Decision|0
2676893|NCT00541658|9238661|P1|Overall Study|Physician Decision|0
2676894|NCT00541658|9238659|P3|Overall Study|Adverse Event|25
2676895|NCT00541658|9238660|P2|Overall Study|Adverse Event|37
2676896|NCT00541658|9238661|P1|Overall Study|Adverse Event|28
2676897|NCT00541450|9238824|P2|Phase B|Withdrawal by Subject|6
2676898|NCT00541450|9238825|P1|Phase B|Withdrawal by Subject|8
2676899|NCT00541450|9238824|P2|Phase B|Protocol Violation|3
2676900|NCT00541450|9238825|P1|Phase B|Protocol Violation|3
2676901|NCT00541450|9238824|P2|Phase B|Pregnancy|1
2676902|NCT00541450|9238825|P1|Phase B|Pregnancy|0
2676903|NCT00541450|9238824|P2|Phase B|Physician Decision|2
2676904|NCT00541450|9238825|P1|Phase B|Physician Decision|4
2676905|NCT00541450|9238824|P2|Phase B|Lost to Follow-up|4
2676906|NCT00541450|9238825|P1|Phase B|Lost to Follow-up|6
2676907|NCT00541450|9238824|P2|Phase B|Hyperglycemia|9
2676908|NCT00541450|9238825|P1|Phase B|Hyperglycemia|10
2676909|NCT00541450|9238824|P2|Phase B|Adverse Event|6
2676910|NCT00541450|9238825|P1|Phase B|Adverse Event|6
2676911|NCT00541450|9238824|P2|Phase A|Withdrawal by Subject|7
2676912|NCT00541450|9238825|P1|Phase A|Withdrawal by Subject|7
2676913|NCT00541450|9238824|P2|Phase A|Protocol Violation|3
2676914|NCT00541450|9238825|P1|Phase A|Protocol Violation|2
2676915|NCT00541450|9238824|P2|Phase A|Physician Decision|0
2676916|NCT00541450|9238825|P1|Phase A|Physician Decision|2
2676917|NCT00541450|9238824|P2|Phase A|Lost to Follow-up|4
2676918|NCT00541450|9238825|P1|Phase A|Lost to Follow-up|6
2676919|NCT00541450|9238824|P2|Phase A|Hyperglycemia|1
2676920|NCT00541450|9238825|P1|Phase A|Hyperglycemia|0
2676921|NCT00541450|9238824|P2|Phase A|Creatinine/CrCl -Increase in creatinine|2
2676922|NCT00541450|9238825|P1|Phase A|Creatinine/CrCl -Increase in creatinine|0
2676923|NCT00541450|9238824|P2|Phase A|Adverse Event|0
2676924|NCT00541450|9238825|P1|Phase A|Adverse Event|3
2676925|NCT00541346|9238843|P1|Follow-up|Adverse Event|1
2676926|NCT00541307|9238857|P1|Overall Study|Surgical Bypass|5
2676927|NCT00541307|9238857|P1|Overall Study|Subject returned early (outside window)|1
2676928|NCT00541307|9238857|P1|Overall Study|Lost to Follow-up|4
2676929|NCT00541307|9238857|P1|Overall Study|Withdrawal by Subject|6
2676930|NCT00541307|9238857|P1|Overall Study|Physician Decision|3
2676931|NCT00541307|9238857|P1|Overall Study|Death|5
2676932|NCT00541229|9238882|P6|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
2676933|NCT00541229|9238883|P5|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
2676934|NCT00541229|9238884|P4|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
2676935|NCT00541229|9238885|P3|Treatment Period III (Week 11)|Study Terminated by Sponsor|1
2676936|NCT00541229|9238886|P2|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
2676937|NCT00541229|9238887|P1|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
2676938|NCT00541229|9238882|P6|Treatment Period III (Week 11)|Protocol Specified Criteria|1
2676939|NCT00541229|9238883|P5|Treatment Period III (Week 11)|Protocol Specified Criteria|0
2676940|NCT00541229|9238884|P4|Treatment Period III (Week 11)|Protocol Specified Criteria|0
2676941|NCT00541229|9238885|P3|Treatment Period III (Week 11)|Protocol Specified Criteria|0
2676942|NCT00541229|9238886|P2|Treatment Period III (Week 11)|Protocol Specified Criteria|0
2676943|NCT00541229|9238887|P1|Treatment Period III (Week 11)|Protocol Specified Criteria|0
2676944|NCT00541229|9238882|P6|Treatment Period III (Week 11)|Adverse Event|0
2676945|NCT00541229|9238883|P5|Treatment Period III (Week 11)|Adverse Event|1
2676946|NCT00541229|9238884|P4|Treatment Period III (Week 11)|Adverse Event|0
2676947|NCT00541229|9238885|P3|Treatment Period III (Week 11)|Adverse Event|0
2676948|NCT00541229|9238886|P2|Treatment Period III (Week 11)|Adverse Event|0
2676949|NCT00541229|9238887|P1|Treatment Period III (Week 11)|Adverse Event|0
2676950|NCT00541229|9238882|P6|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
2676951|NCT00541229|9238883|P5|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
2676952|NCT00541229|9238884|P4|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
2676953|NCT00541229|9238885|P3|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2
2676954|NCT00541229|9238886|P2|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
2676955|NCT00541229|9238887|P1|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
2676956|NCT00541229|9238882|P6|Washout Period II (Week 7-10)|Withdrawal by Subject|0
2676957|NCT00541229|9238883|P5|Washout Period II (Week 7-10)|Withdrawal by Subject|1
2676958|NCT00541229|9238884|P4|Washout Period II (Week 7-10)|Withdrawal by Subject|0
2676959|NCT00541229|9238885|P3|Washout Period II (Week 7-10)|Withdrawal by Subject|0
2676960|NCT00541229|9238886|P2|Washout Period II (Week 7-10)|Withdrawal by Subject|0
2676961|NCT00541229|9238887|P1|Washout Period II (Week 7-10)|Withdrawal by Subject|0
2676962|NCT00541229|9238882|P6|Washout Period II (Week 7-10)|Protocol Violation|0
2676963|NCT00541229|9238883|P5|Washout Period II (Week 7-10)|Protocol Violation|0
2676964|NCT00541229|9238884|P4|Washout Period II (Week 7-10)|Protocol Violation|0
2676965|NCT00541229|9238885|P3|Washout Period II (Week 7-10)|Protocol Violation|0
2676966|NCT00541229|9238886|P2|Washout Period II (Week 7-10)|Protocol Violation|0
2676967|NCT00541229|9238887|P1|Washout Period II (Week 7-10)|Protocol Violation|1
2676968|NCT00541229|9238882|P6|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
2676969|NCT00541229|9238883|P5|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
2676970|NCT00541229|9238884|P4|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
2676971|NCT00541229|9238885|P3|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
2676972|NCT00541229|9238886|P2|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
2676973|NCT00541229|9238887|P1|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
2676974|NCT00541229|9238882|P6|Treatment Period II (Week 6)|Protocol Violation|1
2676975|NCT00541229|9238883|P5|Treatment Period II (Week 6)|Protocol Violation|1
2676976|NCT00541229|9238884|P4|Treatment Period II (Week 6)|Protocol Violation|0
2676977|NCT00541229|9238885|P3|Treatment Period II (Week 6)|Protocol Violation|0
2676978|NCT00541229|9238886|P2|Treatment Period II (Week 6)|Protocol Violation|0
2676979|NCT00541229|9238887|P1|Treatment Period II (Week 6)|Protocol Violation|0
2676980|NCT00541229|9238882|P6|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4
2676981|NCT00541229|9238883|P5|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1
2676982|NCT00541229|9238884|P4|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
2676983|NCT00541229|9238885|P3|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
2676984|NCT00541229|9238886|P2|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2
2676985|NCT00541229|9238887|P1|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
2676986|NCT00541229|9238882|P6|Washout Period I (Week 2-5)|Protocol Violation|1
2676987|NCT00541229|9238883|P5|Washout Period I (Week 2-5)|Protocol Violation|0
2676988|NCT00541229|9238884|P4|Washout Period I (Week 2-5)|Protocol Violation|0
2676989|NCT00541229|9238885|P3|Washout Period I (Week 2-5)|Protocol Violation|0
2676990|NCT00541229|9238886|P2|Washout Period I (Week 2-5)|Protocol Violation|0
2676991|NCT00541229|9238887|P1|Washout Period I (Week 2-5)|Protocol Violation|0
2676992|NCT00541229|9238882|P6|Washout Period I (Week 2-5)|Physician Decision|0
2676993|NCT00541229|9238883|P5|Washout Period I (Week 2-5)|Physician Decision|0
2676994|NCT00541229|9238884|P4|Washout Period I (Week 2-5)|Physician Decision|1
2676995|NCT00541229|9238885|P3|Washout Period I (Week 2-5)|Physician Decision|0
2676996|NCT00541229|9238886|P2|Washout Period I (Week 2-5)|Physician Decision|0
2676997|NCT00541229|9238887|P1|Washout Period I (Week 2-5)|Physician Decision|0
2676998|NCT00541229|9238882|P6|Washout Period I (Week 2-5)|Adverse Event|0
2676999|NCT00541229|9238883|P5|Washout Period I (Week 2-5)|Adverse Event|0
2677000|NCT00541229|9238884|P4|Washout Period I (Week 2-5)|Adverse Event|0
2677001|NCT00541229|9238885|P3|Washout Period I (Week 2-5)|Adverse Event|1
2677002|NCT00541229|9238886|P2|Washout Period I (Week 2-5)|Adverse Event|0
2677003|NCT00541229|9238887|P1|Washout Period I (Week 2-5)|Adverse Event|1
2677004|NCT00541229|9238882|P6|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
2677005|NCT00541229|9238883|P5|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
2677006|NCT00541229|9238884|P4|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
2677007|NCT00541229|9238885|P3|Treatment Period I (Week 1)|Study Terminated by Sponsor|2
2677008|NCT00541229|9238886|P2|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
2677009|NCT00541229|9238887|P1|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
2677010|NCT00541229|9238882|P6|Treatment Period I (Week 1)|Protocol Specified Criteria|1
2677011|NCT00541229|9238883|P5|Treatment Period I (Week 1)|Protocol Specified Criteria|0
2677012|NCT00541229|9238884|P4|Treatment Period I (Week 1)|Protocol Specified Criteria|0
2677013|NCT00541229|9238885|P3|Treatment Period I (Week 1)|Protocol Specified Criteria|0
2677014|NCT00541229|9238886|P2|Treatment Period I (Week 1)|Protocol Specified Criteria|0
2677015|NCT00541229|9238887|P1|Treatment Period I (Week 1)|Protocol Specified Criteria|0
2677016|NCT00541229|9238882|P6|Treatment Period I (Week 1)|Withdrawal by Subject|1
2677017|NCT00541229|9238883|P5|Treatment Period I (Week 1)|Withdrawal by Subject|0
2677018|NCT00541229|9238884|P4|Treatment Period I (Week 1)|Withdrawal by Subject|0
2677019|NCT00541229|9238885|P3|Treatment Period I (Week 1)|Withdrawal by Subject|0
2677020|NCT00541229|9238886|P2|Treatment Period I (Week 1)|Withdrawal by Subject|0
2677021|NCT00541229|9238887|P1|Treatment Period I (Week 1)|Withdrawal by Subject|0
2677022|NCT00541229|9238882|P6|Treatment Period I (Week 1)|Physician Decision|0
2677023|NCT00541229|9238883|P5|Treatment Period I (Week 1)|Physician Decision|0
2677024|NCT00541229|9238884|P4|Treatment Period I (Week 1)|Physician Decision|0
2677025|NCT00541229|9238885|P3|Treatment Period I (Week 1)|Physician Decision|1
2677026|NCT00541229|9238886|P2|Treatment Period I (Week 1)|Physician Decision|0
2677027|NCT00541229|9238887|P1|Treatment Period I (Week 1)|Physician Decision|0
2677028|NCT00541099|9238906|P1|Overall Study|Ineligible|3
2677029|NCT00541034|9238914|P1|Overall Study|Non-Compliance|3
2677030|NCT00540644|9238963|P2|Overall Study|Noncomplilance|0
2677031|NCT00540644|9238964|P1|Overall Study|Noncomplilance|1
2677032|NCT00540644|9238963|P2|Overall Study|Withdrawal by Subject|2
2677033|NCT00540644|9238964|P1|Overall Study|Withdrawal by Subject|2
2677034|NCT00540644|9238963|P2|Overall Study|Physician Decision|5
2677035|NCT00540644|9238964|P1|Overall Study|Physician Decision|0
2677036|NCT00540644|9238963|P2|Overall Study|Disease Progression|1
2677037|NCT00540644|9238964|P1|Overall Study|Disease Progression|3
2677038|NCT00540644|9238963|P2|Overall Study|Adverse Event|1
2677039|NCT00540644|9238964|P1|Overall Study|Adverse Event|3
2677040|NCT00540592|9238984|P10|Overall Study|Withdrawal by Subject|0
2677041|NCT00540592|9238985|P9|Overall Study|Withdrawal by Subject|0
2677042|NCT00540592|9238986|P8|Overall Study|Withdrawal by Subject|0
2677043|NCT00540592|9238987|P7|Overall Study|Withdrawal by Subject|0
2677044|NCT00540592|9238988|P6|Overall Study|Withdrawal by Subject|0
2677045|NCT00540592|9238989|P5|Overall Study|Withdrawal by Subject|0
2677046|NCT00540592|9238990|P4|Overall Study|Withdrawal by Subject|1
2677047|NCT00540592|9238991|P3|Overall Study|Withdrawal by Subject|1
2677048|NCT00540592|9238992|P2|Overall Study|Withdrawal by Subject|0
2677049|NCT00540592|9238993|P1|Overall Study|Withdrawal by Subject|0
2677050|NCT00540592|9238984|P10|Overall Study|Lost to Follow-up|0
2677051|NCT00540592|9238985|P9|Overall Study|Lost to Follow-up|0
2677052|NCT00540592|9238986|P8|Overall Study|Lost to Follow-up|0
2677053|NCT00540592|9238987|P7|Overall Study|Lost to Follow-up|0
2677054|NCT00540592|9238988|P6|Overall Study|Lost to Follow-up|0
2677055|NCT00540592|9238989|P5|Overall Study|Lost to Follow-up|0
2677056|NCT00540592|9238990|P4|Overall Study|Lost to Follow-up|0
2677057|NCT00540592|9238991|P3|Overall Study|Lost to Follow-up|0
2677058|NCT00540592|9238992|P2|Overall Study|Lost to Follow-up|0
2677059|NCT00540592|9238993|P1|Overall Study|Lost to Follow-up|2
2677060|NCT00540592|9238984|P10|Overall Study|Adverse Event|2
2677061|NCT00540592|9238985|P9|Overall Study|Adverse Event|1
2677062|NCT00540592|9238986|P8|Overall Study|Adverse Event|1
2677063|NCT00540592|9238987|P7|Overall Study|Adverse Event|0
2677064|NCT00540592|9238988|P6|Overall Study|Adverse Event|0
2677065|NCT00540592|9238989|P5|Overall Study|Adverse Event|1
2677066|NCT00540592|9238990|P4|Overall Study|Adverse Event|0
2677067|NCT00540592|9238991|P3|Overall Study|Adverse Event|0
2677068|NCT00540592|9238992|P2|Overall Study|Adverse Event|1
2677069|NCT00540592|9238993|P1|Overall Study|Adverse Event|0
2677070|NCT00540514|9239232|P2|Overall Study|Paclitaxel not available|2
2677071|NCT00540514|9239233|P1|Overall Study|Paclitaxel not available|0
2677072|NCT00540514|9239232|P2|Overall Study|Excluded prior to treatment|7
2677073|NCT00540514|9239233|P1|Overall Study|Excluded prior to treatment|7
2677074|NCT00540514|9239232|P2|Overall Study|Withdrawal by Subject|67
2677075|NCT00540514|9239233|P1|Overall Study|Withdrawal by Subject|65
2677076|NCT00540514|9239232|P2|Overall Study|Lost to Follow-up|1
2677077|NCT00540514|9239233|P1|Overall Study|Lost to Follow-up|1
2677078|NCT00540514|9239232|P2|Overall Study|Protocol Deviation|4
2677079|NCT00540514|9239233|P1|Overall Study|Protocol Deviation|3
2677080|NCT00540514|9239232|P2|Overall Study|Physician Decision|99
2677081|NCT00540514|9239233|P1|Overall Study|Physician Decision|86
2677082|NCT00540514|9239232|P2|Overall Study|Adverse Event|24
2677083|NCT00540514|9239233|P1|Overall Study|Adverse Event|20
2677084|NCT00540514|9239232|P2|Overall Study|Unacceptable Toxicity|62
2677085|NCT00540514|9239233|P1|Overall Study|Unacceptable Toxicity|61
2677086|NCT00540514|9239232|P2|Overall Study|Still on treatment|0
2677087|NCT00540514|9239233|P1|Overall Study|Still on treatment|3
2677088|NCT00540449|9239265|P2|Overall Study|Other|4
2677089|NCT00540449|9239266|P1|Overall Study|Other|1
2677090|NCT00540449|9239265|P2|Overall Study|Withdrawal by Subject|10
2677091|NCT00540449|9239266|P1|Overall Study|Withdrawal by Subject|10
2677092|NCT00540449|9239265|P2|Overall Study|Subject Reached A Virologic Endpoint|8
2677093|NCT00540449|9239266|P1|Overall Study|Subject Reached A Virologic Endpoint|32
2677094|NCT00540449|9239265|P2|Overall Study|Subject Non-Compliant|5
2677095|NCT00540449|9239266|P1|Overall Study|Subject Non-Compliant|7
2677096|NCT00540449|9239265|P2|Overall Study|Lost to Follow-up|17
2677097|NCT00540449|9239266|P1|Overall Study|Lost to Follow-up|19
2677098|NCT00540449|9239265|P2|Overall Study|Subject Ineligible To Continue The Trial|1
2677099|NCT00540449|9239266|P1|Overall Study|Subject Ineligible To Continue The Trial|2
2677100|NCT00540449|9239265|P2|Overall Study|Sponsor's Decision|1
2677101|NCT00540449|9239266|P1|Overall Study|Sponsor's Decision|1
2677102|NCT00540449|9239265|P2|Overall Study|Adverse Event|32
2677103|NCT00540449|9239266|P1|Overall Study|Adverse Event|12
2677104|NCT00540436|9239288|P1|Second 12-Week Treatment Period|Adverse Event|1
2677105|NCT00540436|9239288|P1|First 12-Week Treatment Period|Initiation of prohibited medication|1
2677106|NCT00540436|9239288|P1|First 12-Week Treatment Period|Withdrawal by Subject|1
2677107|NCT00540436|9239288|P1|First 12-Week Treatment Period|Adverse Event|1
2677108|NCT00540423|9239303|P3|Open-Label Treatment Period|Lack of Efficacy|2
2677109|NCT00540423|9239304|P2|Open-Label Treatment Period|Lack of Efficacy|0
2677110|NCT00540423|9239305|P1|Open-Label Treatment Period|Lack of Efficacy|0
2677111|NCT00540423|9239303|P3|Double-Blind Treatment Period|Adverse Event|0
2677112|NCT00540423|9239304|P2|Double-Blind Treatment Period|Adverse Event|1
2677113|NCT00540423|9239305|P1|Double-Blind Treatment Period|Adverse Event|0
2677114|NCT00540293|9239355|P1|Overall Study|Protocol violation, & subject schedule|12
2677115|NCT00540293|9239355|P1|Overall Study|Withdrawal by Subject|6
2677116|NCT00540293|9239355|P1|Overall Study|Adverse event not related to study drug|7
2677117|NCT00540293|9239355|P1|Overall Study|Adverse event related to study drug|10
2677118|NCT00540228|9239403|P5|Overall Study|Lost to Follow-up|0
2677119|NCT00540228|9239404|P4|Overall Study|Lost to Follow-up|0
2677120|NCT00540228|9239405|P3|Overall Study|Lost to Follow-up|0
2677121|NCT00540228|9239406|P2|Overall Study|Lost to Follow-up|1
2677122|NCT00540228|9239407|P1|Overall Study|Lost to Follow-up|1
2677123|NCT00540228|9239403|P5|Overall Study|Adverse Event|0
2677124|NCT00540228|9239404|P4|Overall Study|Adverse Event|0
2677125|NCT00540228|9239405|P3|Overall Study|Adverse Event|0
2677126|NCT00540228|9239406|P2|Overall Study|Adverse Event|0
2677127|NCT00540228|9239407|P1|Overall Study|Adverse Event|2
2677128|NCT00540124|9239477|P3|Overall Study|Withdrawal by Subject|0
2677129|NCT00540124|9239478|P2|Overall Study|Withdrawal by Subject|1
2677130|NCT00540124|9239479|P1|Overall Study|Withdrawal by Subject|1
2677131|NCT00540124|9239477|P3|Overall Study|Lack of Efficacy|0
2677132|NCT00540124|9239478|P2|Overall Study|Lack of Efficacy|0
2677133|NCT00540124|9239479|P1|Overall Study|Lack of Efficacy|1
2677134|NCT00540124|9239477|P3|Overall Study|Entry Criteria Not Met|0
2677135|NCT00540124|9239478|P2|Overall Study|Entry Criteria Not Met|0
2677136|NCT00540124|9239479|P1|Overall Study|Entry Criteria Not Met|2
2677137|NCT00540124|9239477|P3|Overall Study|Adverse Event|1
2677138|NCT00540124|9239478|P2|Overall Study|Adverse Event|2
2677139|NCT00540124|9239479|P1|Overall Study|Adverse Event|0
2677140|NCT00540046|9239525|P2|Overall Study|Lost to Follow-up|23
2677141|NCT00540046|9239526|P1|Overall Study|Lost to Follow-up|33
2677142|NCT00539994|9239562|P3|Overall Study|Physician Decision|1
2677143|NCT00539994|9239563|P2|Overall Study|Physician Decision|0
2677144|NCT00539994|9239564|P1|Overall Study|Physician Decision|0
2677145|NCT00539994|9239562|P3|Overall Study|Withdrawal by Subject|1
2677146|NCT00539994|9239563|P2|Overall Study|Withdrawal by Subject|0
2677147|NCT00539994|9239564|P1|Overall Study|Withdrawal by Subject|1
2677148|NCT00539994|9239562|P3|Overall Study|Lost to Follow-up|0
2677149|NCT00539994|9239563|P2|Overall Study|Lost to Follow-up|1
2677150|NCT00539994|9239564|P1|Overall Study|Lost to Follow-up|2
2677151|NCT00539864|9239614|P2|Overall Study|Withdrawal by Subject|1
2677152|NCT00539864|9239615|P1|Overall Study|Withdrawal by Subject|1
2677153|NCT00539864|9239614|P2|Overall Study|Lost to Follow-up|1
2677154|NCT00539864|9239615|P1|Overall Study|Lost to Follow-up|0
2677155|NCT00539734|9239627|P1|Overall Study|Protocol Violation|1
2677156|NCT00539591|9239653|P3|Overall Study|Disease progression|3
2677157|NCT00539591|9239654|P2|Overall Study|Disease progression|2
2677158|NCT00539591|9239655|P1|Overall Study|Disease progression|2
2677159|NCT00539591|9239653|P3|Overall Study|Toxicity|0
2677160|NCT00539591|9239654|P2|Overall Study|Toxicity|0
2677161|NCT00539591|9239655|P1|Overall Study|Toxicity|3
2677162|NCT00539513|9239807|P2|Overall Study|Lost to Follow-up|1
2677163|NCT00539513|9239808|P1|Overall Study|Lost to Follow-up|0
2677164|NCT00539513|9239807|P2|Overall Study|Withdrawal by Subject|1
2677165|NCT00539513|9239808|P1|Overall Study|Withdrawal by Subject|2
2677166|NCT00539500|9239820|P1|Overall Study|Lost to Follow-up|2
2677167|NCT00539500|9239820|P1|Overall Study|Disease Progression|1
2677168|NCT00539305|9239828|P2|Overall Study|Withdrawal by Subject|1
2677169|NCT00539305|9239829|P1|Overall Study|Withdrawal by Subject|0
2677170|NCT00539305|9239828|P2|Overall Study|Substance Use|1
2677171|NCT00539305|9239829|P1|Overall Study|Substance Use|0
2677172|NCT00539305|9239828|P2|Overall Study|Adverse Event|0
2677173|NCT00539305|9239829|P1|Overall Study|Adverse Event|1
2677174|NCT00539279|9239843|P2|6-Month Follow-Up Assessment|Lost to Follow-up|7
2677175|NCT00539279|9239844|P1|6-Month Follow-Up Assessment|Lost to Follow-up|1
2677176|NCT00539279|9239843|P2|Post-Treatment Assessment|Lost to Follow-up|9
2677177|NCT00539279|9239844|P1|Post-Treatment Assessment|Lost to Follow-up|12
2677178|NCT00539279|9239843|P2|Treatment|Death|0
2677179|NCT00539279|9239844|P1|Treatment|Death|1
2677180|NCT00539279|9239843|P2|Treatment|Withdrawal by Subject|8
2677181|NCT00539279|9239844|P1|Treatment|Withdrawal by Subject|10
2677182|NCT00539240|9239870|P3|Overall Study|Adverse Event|10
2677183|NCT00539240|9239871|P2|Overall Study|Adverse Event|1
2677184|NCT00539240|9239872|P1|Overall Study|Adverse Event|3
2677185|NCT00539240|9239870|P3|Overall Study|Lost to Follow-up|1
2677186|NCT00539240|9239871|P2|Overall Study|Lost to Follow-up|3
2677187|NCT00539240|9239872|P1|Overall Study|Lost to Follow-up|2
2677188|NCT00539240|9239870|P3|Overall Study|Protocol Violation|4
2677189|NCT00539240|9239871|P2|Overall Study|Protocol Violation|1
2677190|NCT00539240|9239872|P1|Overall Study|Protocol Violation|1
2677191|NCT00539240|9239870|P3|Overall Study|Withdrawal by Subject|0
2677192|NCT00539240|9239871|P2|Overall Study|Withdrawal by Subject|2
2677193|NCT00539240|9239872|P1|Overall Study|Withdrawal by Subject|0
2677194|NCT00539188|9239891|P2|Overall Study|Lost to Follow-up|1
2677195|NCT00539188|9239892|P1|Overall Study|Lost to Follow-up|2
2677196|NCT00539188|9239891|P2|Overall Study|Withdrawal by Subject|0
2677197|NCT00539188|9239892|P1|Overall Study|Withdrawal by Subject|1
2677198|NCT00539032|9239915|P2|Overall Study|Withdrawal by Subject|1
2677199|NCT00539032|9239916|P1|Overall Study|Withdrawal by Subject|2
2677200|NCT00539006|9239930|P4|Treatment Period 2|Other|0
2677201|NCT00539006|9239931|P3|Treatment Period 2|Other|0
2677202|NCT00539006|9239932|P2|Treatment Period 2|Other|1
2677203|NCT00539006|9239933|P1|Treatment Period 2|Other|0
2677204|NCT00539006|9239930|P4|Treatment Period 2|Protocol Violation|0
2677205|NCT00539006|9239931|P3|Treatment Period 2|Protocol Violation|0
2677206|NCT00539006|9239932|P2|Treatment Period 2|Protocol Violation|0
2677207|NCT00539006|9239933|P1|Treatment Period 2|Protocol Violation|1
2677208|NCT00539006|9239930|P4|Washout|Other|3
2677209|NCT00539006|9239931|P3|Washout|Other|2
2677210|NCT00539006|9239932|P2|Washout|Other|1
2677211|NCT00539006|9239933|P1|Washout|Other|1
2677212|NCT00539006|9239930|P4|Washout|Failed to meet continuation criteria|6
2677213|NCT00539006|9239931|P3|Washout|Failed to meet continuation criteria|14
2677214|NCT00539006|9239932|P2|Washout|Failed to meet continuation criteria|5
2677215|NCT00539006|9239933|P1|Washout|Failed to meet continuation criteria|16
2677216|NCT00539006|9239930|P4|Washout|Withdrawal by Subject|0
2677217|NCT00539006|9239931|P3|Washout|Withdrawal by Subject|0
2677218|NCT00539006|9239932|P2|Washout|Withdrawal by Subject|2
2677219|NCT00539006|9239933|P1|Washout|Withdrawal by Subject|0
2677220|NCT00539006|9239930|P4|Washout|Protocol Violation|0
2677221|NCT00539006|9239931|P3|Washout|Protocol Violation|0
2677222|NCT00539006|9239932|P2|Washout|Protocol Violation|1
2677223|NCT00539006|9239933|P1|Washout|Protocol Violation|1
2677224|NCT00539006|9239930|P4|Washout|Adverse Event|0
2677225|NCT00539006|9239931|P3|Washout|Adverse Event|0
2677226|NCT00539006|9239932|P2|Washout|Adverse Event|1
2677227|NCT00539006|9239933|P1|Washout|Adverse Event|2
2677228|NCT00539006|9239930|P4|Treatment Period 1|Lack of Efficacy|1
2677229|NCT00539006|9239931|P3|Treatment Period 1|Lack of Efficacy|0
2677230|NCT00539006|9239932|P2|Treatment Period 1|Lack of Efficacy|0
2677231|NCT00539006|9239933|P1|Treatment Period 1|Lack of Efficacy|0
2677232|NCT00539006|9239930|P4|Treatment Period 1|Protocol Violation|0
2677233|NCT00539006|9239931|P3|Treatment Period 1|Protocol Violation|1
2677234|NCT00539006|9239932|P2|Treatment Period 1|Protocol Violation|0
2677235|NCT00539006|9239933|P1|Treatment Period 1|Protocol Violation|0
2677236|NCT00539006|9239930|P4|Treatment Period 1|Lost to Follow-up|0
2677237|NCT00539006|9239931|P3|Treatment Period 1|Lost to Follow-up|1
2677238|NCT00539006|9239932|P2|Treatment Period 1|Lost to Follow-up|0
2677239|NCT00539006|9239933|P1|Treatment Period 1|Lost to Follow-up|0
2677240|NCT00539006|9239930|P4|Pre-treatment|Other|0
2677241|NCT00539006|9239931|P3|Pre-treatment|Other|0
2677242|NCT00539006|9239932|P2|Pre-treatment|Other|1
2677243|NCT00539006|9239933|P1|Pre-treatment|Other|0
2677244|NCT00538902|9239978|P3|OL Wk 24 to End (Primary D/C Reasons)|Various|22
2677245|NCT00538902|9239979|P2|OL Wk 24 to End (Primary D/C Reasons)|Various|25
2677246|NCT00538902|9239980|P1|OL Wk 24 to End (Primary D/C Reasons)|Various|18
2677247|NCT00538902|9239978|P3|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6
2677248|NCT00538902|9239979|P2|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10
2677249|NCT00538902|9239980|P1|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1
2677250|NCT00538902|9239978|P3|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25
2677251|NCT00538902|9239979|P2|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19
2677252|NCT00538902|9239980|P1|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15
2677253|NCT00538902|9239978|P3|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11
2677254|NCT00538902|9239979|P2|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10
2677255|NCT00538902|9239980|P1|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2
2677256|NCT00538902|9239978|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
2677257|NCT00538902|9239979|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
2677258|NCT00538902|9239980|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
2677259|NCT00538902|9239978|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1
2677260|NCT00538902|9239979|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
2677261|NCT00538902|9239980|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
2677262|NCT00538902|9239978|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1
2677263|NCT00538902|9239979|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
2677264|NCT00538902|9239980|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
2677265|NCT00538902|9239978|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3
2677266|NCT00538902|9239979|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2
2677267|NCT00538902|9239980|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1
2677268|NCT00538785|9240041|P2|Overall Study|Lost to Follow-up|0
2677269|NCT00538785|9240042|P1|Overall Study|Lost to Follow-up|1
2677270|NCT00538785|9240041|P2|Overall Study|Withdrawal of consent|7
2677271|NCT00538785|9240042|P1|Overall Study|Withdrawal of consent|9
2677272|NCT00538785|9240041|P2|Overall Study|Death|10
2677273|NCT00538785|9240042|P1|Overall Study|Death|9
2677274|NCT00538733|9240084|P1|Overall Study|still on therapy|1
2677275|NCT00538733|9240084|P1|Overall Study|declined to participate|2
2677276|NCT00538733|9240084|P1|Overall Study|Death|1
2677277|NCT00538733|9240084|P1|Overall Study|Adverse Event|8
2677278|NCT00538629|9240134|P1|Overall Study|Subject's untimely distrust of medicine|1
2677279|NCT00538629|9240134|P1|Overall Study|Lost to Follow-up|6
2677280|NCT00538629|9240134|P1|Overall Study|Lack of Efficacy|12
2677281|NCT00538629|9240134|P1|Overall Study|Adverse Event|2
2677282|NCT00538629|9240134|P1|Overall Study|At subject's request|1
2677283|NCT00538590|9240190|P2|Overall Study|Death|0
2677284|NCT00538590|9240191|P1|Overall Study|Death|1
2677285|NCT00538473|9240229|P2|Overall Study|Adverse Event|0
2677286|NCT00538473|9240230|P1|Overall Study|Adverse Event|1
2677287|NCT00538291|9240310|P1|Overall Study|Withdrawal by Subject|1
2677288|NCT00538291|9240310|P1|Overall Study|Adverse Event|2
2677289|NCT00537979|9240368|P2|Overall Study|Heart failure|1
2677290|NCT00537979|9240369|P1|Overall Study|Heart failure|0
2677291|NCT00537979|9240368|P2|Overall Study|Kidney transplant|3
2677292|NCT00537979|9240369|P1|Overall Study|Kidney transplant|0
2677293|NCT00537979|9240368|P2|Overall Study|Death|3
2677294|NCT00537979|9240369|P1|Overall Study|Death|0
2677295|NCT00537979|9240368|P2|Overall Study|Non-compliance with treatment/procedure|2
2677296|NCT00537979|9240369|P1|Overall Study|Non-compliance with treatment/procedure|2
2677297|NCT00537979|9240368|P2|Overall Study|Lack of Efficacy|1
2677298|NCT00537979|9240369|P1|Overall Study|Lack of Efficacy|0
2677299|NCT00537979|9240368|P2|Overall Study|Lost to Follow-up|4
2677300|NCT00537979|9240369|P1|Overall Study|Lost to Follow-up|1
2677301|NCT00537979|9240368|P2|Overall Study|Withdrawal by Subject|4
2677302|NCT00537979|9240369|P1|Overall Study|Withdrawal by Subject|1
2677303|NCT00537979|9240368|P2|Overall Study|Adverse Event|2
2677304|NCT00537979|9240369|P1|Overall Study|Adverse Event|2
2677305|NCT00537940|9240385|P2|Overall Study|Other|12
2677306|NCT00537940|9240386|P1|Overall Study|Other|10
2677307|NCT00537940|9240385|P2|Overall Study|Study terminated by sponsor|3
2677308|NCT00537940|9240386|P1|Overall Study|Study terminated by sponsor|2
2677309|NCT00537940|9240385|P2|Overall Study|Pregnancy|1
2677310|NCT00537940|9240386|P1|Overall Study|Pregnancy|1
2677311|NCT00537940|9240385|P2|Overall Study|Protocol Violation|4
2677312|NCT00537940|9240386|P1|Overall Study|Protocol Violation|6
2677313|NCT00537940|9240385|P2|Overall Study|Withdrawal by Subject|95
2677314|NCT00537940|9240386|P1|Overall Study|Withdrawal by Subject|113
2677315|NCT00537940|9240385|P2|Overall Study|Lost to Follow-up|29
2677316|NCT00537940|9240386|P1|Overall Study|Lost to Follow-up|23
2677317|NCT00537940|9240385|P2|Overall Study|Lack of Efficacy|16
2677318|NCT00537940|9240386|P1|Overall Study|Lack of Efficacy|8
2677319|NCT00537940|9240385|P2|Overall Study|Adverse Event|19
2677320|NCT00537940|9240386|P1|Overall Study|Adverse Event|20
2677321|NCT00537823|9240410|P2|Overall Study|Adverse Event|0
2677322|NCT00537823|9240411|P1|Overall Study|Adverse Event|2
2677323|NCT00537810|9240437|P4|Overall Study|Medically withdrawn|1
2677324|NCT00537810|9240438|P3|Overall Study|Medically withdrawn|0
2677325|NCT00537810|9240439|P2|Overall Study|Medically withdrawn|2
2677326|NCT00537810|9240440|P1|Overall Study|Medically withdrawn|2
2677327|NCT00537810|9240437|P4|Overall Study|Withdrawal by Subject|3
2677328|NCT00537810|9240438|P3|Overall Study|Withdrawal by Subject|4
2677329|NCT00537810|9240439|P2|Overall Study|Withdrawal by Subject|11
2677330|NCT00537810|9240440|P1|Overall Study|Withdrawal by Subject|4
2677331|NCT00537771|9240456|P2|Overall Study|Severe Non-Compliance to Protocol|2
2677332|NCT00537771|9240457|P1|Overall Study|Severe Non-Compliance to Protocol|4
2677333|NCT00537771|9240456|P2|Overall Study|Protocol Violation|6
2677334|NCT00537771|9240457|P1|Overall Study|Protocol Violation|2
2677335|NCT00537771|9240456|P2|Overall Study|Lost to Follow-up|15
2677336|NCT00537771|9240457|P1|Overall Study|Lost to Follow-up|9
2677337|NCT00537771|9240456|P2|Overall Study|Adverse Event|15
2677338|NCT00537771|9240457|P1|Overall Study|Adverse Event|8
2677339|NCT00537771|9240456|P2|Overall Study|Withdrawal by Subject|23
2677340|NCT00537771|9240457|P1|Overall Study|Withdrawal by Subject|6
2677341|NCT00537745|9240467|P1|Overall Study|Subject unable to provide Interlock info|1
2677342|NCT00537745|9240467|P1|Overall Study|Withdrawal by Subject|2
2677343|NCT00537745|9240467|P1|Overall Study|Did not meet eligibility criteria|2
2677344|NCT00537485|9240512|P2|Overall Study|Physician Decision|0
2677345|NCT00537485|9240513|P1|Overall Study|Physician Decision|1
2677346|NCT00537485|9240512|P2|Overall Study|Withdrawal by Subject|3
2677347|NCT00537485|9240513|P1|Overall Study|Withdrawal by Subject|1
2677348|NCT00537485|9240512|P2|Overall Study|Withdrawal by Subject|2
2677349|NCT00537485|9240513|P1|Overall Study|Withdrawal by Subject|3
2677350|NCT00537485|9240512|P2|Overall Study|Adverse Event|5
2677351|NCT00537485|9240513|P1|Overall Study|Adverse Event|10
2677352|NCT00537394|9240586|P3|2nd Year of Follow-up|Clinic site closure|0
2677353|NCT00537394|9240587|P2|2nd Year of Follow-up|Clinic site closure|0
2677354|NCT00537394|9240588|P1|2nd Year of Follow-up|Clinic site closure|1
2677355|NCT00537394|9240586|P3|2nd Year of Follow-up|Lost to Follow-up|2
2677356|NCT00537394|9240587|P2|2nd Year of Follow-up|Lost to Follow-up|7
2677357|NCT00537394|9240588|P1|2nd Year of Follow-up|Lost to Follow-up|6
2677358|NCT00537394|9240586|P3|2nd Year of Follow-up|Withdrawal by Subject|2
2677359|NCT00537394|9240587|P2|2nd Year of Follow-up|Withdrawal by Subject|1
2677360|NCT00537394|9240588|P1|2nd Year of Follow-up|Withdrawal by Subject|0
2677361|NCT00537394|9240586|P3|2nd Year of Follow-up|Death|2
2677362|NCT00537394|9240587|P2|2nd Year of Follow-up|Death|1
2677363|NCT00537394|9240588|P1|2nd Year of Follow-up|Death|4
2677364|NCT00537394|9240586|P3|First Year of Follow-up|Lost to Follow-up|1
2677365|NCT00537394|9240587|P2|First Year of Follow-up|Lost to Follow-up|5
2677366|NCT00537394|9240588|P1|First Year of Follow-up|Lost to Follow-up|1
2677367|NCT00537394|9240586|P3|First Year of Follow-up|Withdrawal by Subject|1
2677368|NCT00537394|9240587|P2|First Year of Follow-up|Withdrawal by Subject|6
2677369|NCT00537394|9240588|P1|First Year of Follow-up|Withdrawal by Subject|3
2677370|NCT00537394|9240586|P3|First Year of Follow-up|Severe debilitation|1
2677371|NCT00537394|9240587|P2|First Year of Follow-up|Severe debilitation|0
2677372|NCT00537394|9240588|P1|First Year of Follow-up|Severe debilitation|1
2677373|NCT00537394|9240586|P3|First Year of Follow-up|Death|0
2677374|NCT00537394|9240587|P2|First Year of Follow-up|Death|0
2677375|NCT00537394|9240588|P1|First Year of Follow-up|Death|7
2677376|NCT00537381|9240624|P2|Overall Study|Other|3
2677377|NCT00537381|9240625|P1|Overall Study|Other|5
2677378|NCT00537381|9240624|P2|Overall Study|Sponsor decision|9
2677379|NCT00537381|9240625|P1|Overall Study|Sponsor decision|14
2677380|NCT00537381|9240624|P2|Overall Study|Disease Progression|18
2677381|NCT00537381|9240625|P1|Overall Study|Disease Progression|9
2677382|NCT00537381|9240624|P2|Overall Study|Physician Decision|6
2677383|NCT00537381|9240625|P1|Overall Study|Physician Decision|7
2677384|NCT00537381|9240624|P2|Overall Study|Withdrawal by Subject|14
2677385|NCT00537381|9240625|P1|Overall Study|Withdrawal by Subject|5
2677386|NCT00537381|9240624|P2|Overall Study|Death|3
2677387|NCT00537381|9240625|P1|Overall Study|Death|3
2677388|NCT00537381|9240624|P2|Overall Study|Adverse Event|9
2677389|NCT00537381|9240625|P1|Overall Study|Adverse Event|13
2677390|NCT00537329|9240645|P1|Overall Study|Other|1
2677391|NCT00537329|9240645|P1|Overall Study|Withdrawal by Subject|4
2677392|NCT00537329|9240645|P1|Overall Study|Lost to Follow-up|6
2677393|NCT00537329|9240645|P1|Overall Study|Lack of Efficacy|2
2677394|NCT00537329|9240645|P1|Overall Study|Adverse Event|3
2677395|NCT00537329|9240645|P1|Overall Study|Death|10
2677396|NCT00537316|9240665|P7|Part 2|Administrative|1
2677397|NCT00537316|9240666|P6|Part 2|Administrative|4
2677398|NCT00537316|9240667|P5|Part 2|Administrative|1
2677399|NCT00537316|9240668|P4|Part 2|Administrative|3
2677400|NCT00537316|9240669|P3|Part 2|Administrative|24
2677401|NCT00537316|9240670|P2|Part 2|Administrative|8
2677402|NCT00537316|9240671|P1|Part 2|Administrative|16
2677403|NCT00537316|9240665|P7|Part 2|Withdrawal by Subject|0
2677404|NCT00537316|9240666|P6|Part 2|Withdrawal by Subject|0
2677405|NCT00537316|9240667|P5|Part 2|Withdrawal by Subject|0
2677406|NCT00537316|9240668|P4|Part 2|Withdrawal by Subject|0
2677407|NCT00537316|9240669|P3|Part 2|Withdrawal by Subject|4
2677408|NCT00537316|9240670|P2|Part 2|Withdrawal by Subject|1
2677409|NCT00537316|9240671|P1|Part 2|Withdrawal by Subject|5
2677410|NCT00537316|9240665|P7|Part 2|Lost to Follow-up|0
2677411|NCT00537316|9240666|P6|Part 2|Lost to Follow-up|0
2677412|NCT00537316|9240667|P5|Part 2|Lost to Follow-up|0
2677413|NCT00537316|9240668|P4|Part 2|Lost to Follow-up|0
2677414|NCT00537316|9240669|P3|Part 2|Lost to Follow-up|2
2677415|NCT00537316|9240670|P2|Part 2|Lost to Follow-up|0
2677416|NCT00537316|9240671|P1|Part 2|Lost to Follow-up|1
2677417|NCT00537316|9240665|P7|Part 2|Adverse Event|0
2677418|NCT00537316|9240666|P6|Part 2|Adverse Event|0
2677419|NCT00537316|9240667|P5|Part 2|Adverse Event|0
2677420|NCT00537316|9240668|P4|Part 2|Adverse Event|0
2677421|NCT00537316|9240669|P3|Part 2|Adverse Event|2
2677422|NCT00537316|9240670|P2|Part 2|Adverse Event|0
2677423|NCT00537316|9240671|P1|Part 2|Adverse Event|4
2677424|NCT00537316|9240665|P7|Part 2|Never entered follow-up|1
2677425|NCT00537316|9240666|P6|Part 2|Never entered follow-up|0
2677426|NCT00537316|9240667|P5|Part 2|Never entered follow-up|0
2677427|NCT00537316|9240668|P4|Part 2|Never entered follow-up|0
2677428|NCT00537316|9240669|P3|Part 2|Never entered follow-up|0
2677429|NCT00537316|9240670|P2|Part 2|Never entered follow-up|0
2677430|NCT00537316|9240671|P1|Part 2|Never entered follow-up|0
2677431|NCT00537316|9240665|P7|Part 1|Administrative|0
2677432|NCT00537316|9240666|P6|Part 1|Administrative|0
2677433|NCT00537316|9240667|P5|Part 1|Administrative|0
2677434|NCT00537316|9240668|P4|Part 1|Administrative|0
2677435|NCT00537316|9240669|P3|Part 1|Administrative|2
2677436|NCT00537316|9240670|P2|Part 1|Administrative|0
2677437|NCT00537316|9240671|P1|Part 1|Administrative|0
2677438|NCT00537316|9240665|P7|Part 1|Did not meet protocol eligibility|0
2677439|NCT00537316|9240666|P6|Part 1|Did not meet protocol eligibility|0
2677440|NCT00537316|9240667|P5|Part 1|Did not meet protocol eligibility|0
2677441|NCT00537316|9240668|P4|Part 1|Did not meet protocol eligibility|0
2677442|NCT00537316|9240669|P3|Part 1|Did not meet protocol eligibility|2
2677443|NCT00537316|9240670|P2|Part 1|Did not meet protocol eligibility|3
2677444|NCT00537316|9240671|P1|Part 1|Did not meet protocol eligibility|1
2677445|NCT00537316|9240665|P7|Part 1|Protocol Violation|0
2677446|NCT00537316|9240666|P6|Part 1|Protocol Violation|0
2677447|NCT00537316|9240667|P5|Part 1|Protocol Violation|0
2677448|NCT00537316|9240668|P4|Part 1|Protocol Violation|0
2677449|NCT00537316|9240669|P3|Part 1|Protocol Violation|1
2677450|NCT00537316|9240670|P2|Part 1|Protocol Violation|5
2677451|NCT00537316|9240671|P1|Part 1|Protocol Violation|1
2677452|NCT00537316|9240665|P7|Part 1|Withdrawal by Subject|0
2677453|NCT00537316|9240666|P6|Part 1|Withdrawal by Subject|0
2677454|NCT00537316|9240667|P5|Part 1|Withdrawal by Subject|0
2677455|NCT00537316|9240668|P4|Part 1|Withdrawal by Subject|0
2677456|NCT00537316|9240669|P3|Part 1|Withdrawal by Subject|4
2677457|NCT00537316|9240670|P2|Part 1|Withdrawal by Subject|8
2677458|NCT00537316|9240671|P1|Part 1|Withdrawal by Subject|3
2677459|NCT00537316|9240665|P7|Part 1|Lost to Follow-up|0
2677460|NCT00537316|9240666|P6|Part 1|Lost to Follow-up|0
2677461|NCT00537316|9240667|P5|Part 1|Lost to Follow-up|0
2677462|NCT00537316|9240668|P4|Part 1|Lost to Follow-up|0
2677463|NCT00537316|9240669|P3|Part 1|Lost to Follow-up|0
2677464|NCT00537316|9240670|P2|Part 1|Lost to Follow-up|0
2677465|NCT00537316|9240671|P1|Part 1|Lost to Follow-up|1
2677466|NCT00537316|9240665|P7|Part 1|Protocol defined clinical event|0
2677467|NCT00537316|9240666|P6|Part 1|Protocol defined clinical event|0
2677468|NCT00537316|9240667|P5|Part 1|Protocol defined clinical event|0
2677469|NCT00537316|9240668|P4|Part 1|Protocol defined clinical event|0
2677470|NCT00537316|9240669|P3|Part 1|Protocol defined clinical event|0
2677471|NCT00537316|9240670|P2|Part 1|Protocol defined clinical event|0
2677472|NCT00537316|9240671|P1|Part 1|Protocol defined clinical event|1
2677473|NCT00537316|9240665|P7|Part 1|Adverse Event|0
2677474|NCT00537316|9240666|P6|Part 1|Adverse Event|0
2677475|NCT00537316|9240667|P5|Part 1|Adverse Event|0
2677476|NCT00537316|9240668|P4|Part 1|Adverse Event|0
2677477|NCT00537316|9240669|P3|Part 1|Adverse Event|8
2677478|NCT00537316|9240670|P2|Part 1|Adverse Event|11
2677479|NCT00537316|9240671|P1|Part 1|Adverse Event|7
2677480|NCT00537303|9240698|P2|Overall Study|Unclassified|7
2677481|NCT00537303|9240699|P1|Overall Study|Unclassified|8
2677482|NCT00537303|9240698|P2|Overall Study|Withdrawal criteria|3
2677483|NCT00537303|9240699|P1|Overall Study|Withdrawal criteria|3
2677484|NCT00537303|9240698|P2|Overall Study|Protocol Violation|4
2677485|NCT00537303|9240699|P1|Overall Study|Protocol Violation|8
2677486|NCT00537303|9240698|P2|Overall Study|Lack of Efficacy|7
2677487|NCT00537303|9240699|P1|Overall Study|Lack of Efficacy|6
2677488|NCT00537303|9240698|P2|Overall Study|Adverse Event|4
2677489|NCT00537303|9240699|P1|Overall Study|Adverse Event|1
2677490|NCT00537277|9240720|P1|Overall Study|Non-compliance with trial procedures|15
2677491|NCT00537277|9240720|P1|Overall Study|Inability to tolerate trial medication|4
2677492|NCT00537277|9240720|P1|Overall Study|Unclassified|4
2677493|NCT00537277|9240720|P1|Overall Study|Protocol Violation|11
2677494|NCT00537277|9240720|P1|Overall Study|Lost to Follow-up|12
2677495|NCT00537277|9240720|P1|Overall Study|Lack of Efficacy|2
2677496|NCT00537277|9240720|P1|Overall Study|Adverse Event|1
2677497|NCT00537238|9240731|P2|Overall Study|Other|52
2677498|NCT00537238|9240732|P1|Overall Study|Other|44
2677499|NCT00537238|9240731|P2|Overall Study|Does not meet entrance criteria|2
2677500|NCT00537238|9240732|P1|Overall Study|Does not meet entrance criteria|0
2677501|NCT00537238|9240731|P2|Overall Study|Protocol Violation|19
2677502|NCT00537238|9240732|P1|Overall Study|Protocol Violation|15
2677503|NCT00537238|9240731|P2|Overall Study|Withdrawal by Subject|47
2677504|NCT00537238|9240732|P1|Overall Study|Withdrawal by Subject|51
2677505|NCT00537238|9240731|P2|Overall Study|Lost to Follow-up|8
2677506|NCT00537238|9240732|P1|Overall Study|Lost to Follow-up|12
2677507|NCT00537238|9240731|P2|Overall Study|Lack of Efficacy|21
2677508|NCT00537238|9240732|P1|Overall Study|Lack of Efficacy|20
2677509|NCT00537238|9240731|P2|Overall Study|Adverse Event|22
2677510|NCT00537238|9240732|P1|Overall Study|Adverse Event|31
2677511|NCT00537238|9240731|P2|Overall Study|Death|2
2677512|NCT00537238|9240732|P1|Overall Study|Death|1
2677513|NCT00537199|9240752|P1|Overall Study|Study Terminated|1
2677514|NCT00537095|9240758|P2|Overall Study|Incorrect enrolment|1
2677515|NCT00537095|9240759|P1|Overall Study|Incorrect enrolment|0
2677516|NCT00537095|9240758|P2|Overall Study|subjective disease progression|1
2677517|NCT00537095|9240759|P1|Overall Study|subjective disease progression|0
2677518|NCT00537095|9240758|P2|Overall Study|Withdrawal by Subject|2
2677519|NCT00537095|9240759|P1|Overall Study|Withdrawal by Subject|2
2677520|NCT00537095|9240758|P2|Overall Study|Death|1
2677521|NCT00537095|9240759|P1|Overall Study|Death|3
2677522|NCT00537095|9240758|P2|Overall Study|disease progression|48
2677523|NCT00537095|9240759|P1|Overall Study|disease progression|21
2677524|NCT00537095|9240758|P2|Overall Study|Adverse Event|4
2677525|NCT00537095|9240759|P1|Overall Study|Adverse Event|24
2677526|NCT00537095|9240758|P2|Overall Study|surgery|0
2677527|NCT00537095|9240759|P1|Overall Study|surgery|1
2677528|NCT00537082|9240774|P3|Overall Study|Discontinued before initiating treatment|0
2677529|NCT00537082|9240775|P2|Overall Study|Discontinued before initiating treatment|0
2677530|NCT00537082|9240776|P1|Overall Study|Discontinued before initiating treatment|3
2677531|NCT00537082|9240774|P3|Overall Study|Withdrawal by Subject|0
2677532|NCT00537082|9240775|P2|Overall Study|Withdrawal by Subject|1
2677533|NCT00537082|9240776|P1|Overall Study|Withdrawal by Subject|0
2677534|NCT00537082|9240774|P3|Overall Study|Lack of Efficacy|2
2677535|NCT00537082|9240775|P2|Overall Study|Lack of Efficacy|0
2677536|NCT00537082|9240776|P1|Overall Study|Lack of Efficacy|0
2677537|NCT00537082|9240774|P3|Overall Study|Protocol Violation|1
2677538|NCT00537082|9240775|P2|Overall Study|Protocol Violation|2
2677539|NCT00537082|9240776|P1|Overall Study|Protocol Violation|0
2677540|NCT00537082|9240774|P3|Overall Study|Adverse Event|3
2677541|NCT00537082|9240775|P2|Overall Study|Adverse Event|6
2677542|NCT00537082|9240776|P1|Overall Study|Adverse Event|6
2677543|NCT00537056|9240793|P1|Interim PET/CT|scheduling conflicts and/or exposure|5
2677544|NCT00537030|9240805|P1|Overall Study|Inevaluable|2
2677545|NCT00537030|9240805|P1|Overall Study|Ineligible|2
2677546|NCT00537030|9240805|P1|Overall Study|Disease progression/ relapse during Tx|1
2677547|NCT00537030|9240805|P1|Overall Study|≥ Grade 2 allergy|7
2677548|NCT00537030|9240805|P1|Overall Study|Withdrawal by Subject|2
2677549|NCT00537030|9240805|P1|Overall Study|Physician Decision|2
2677550|NCT00537017|9240812|P1|Follow-up Phase|Withdrawal by Subject|9
2677551|NCT00537017|9240812|P1|Treatment Phase|Protocol Violation|2
2677552|NCT00537017|9240812|P1|Treatment Phase|Withdrawal by Subject|13
2677553|NCT00537017|9240812|P1|Treatment Phase|Adverse Event|19
2677554|NCT00536991|9240823|P1|Overall Study|patient ineligible|2
2677555|NCT00536991|9240823|P1|Overall Study|Physician Decision|1
2677556|NCT00536991|9240823|P1|Overall Study|Withdrawal by Subject|10
2677557|NCT00536978|9240830|P1|Overall Study|Not eligible for Adback Infusion|22
2677558|NCT00536874|9240859|P1|Overall Study|Withdrawal by Subject|1
2677559|NCT00536874|9240859|P1|Overall Study|Death|2
2677560|NCT00536874|9240859|P1|Overall Study|Adverse Event|1
2677561|NCT00536809|9240869|P1|Phase II|Referred for surgical resection|1
2677562|NCT00536809|9240869|P1|Phase II|Adverse Event|1
2677563|NCT00536744|9240892|P2|Overall Study|PI tried alternative treatment|3
2677564|NCT00536744|9240893|P1|Overall Study|PI tried alternative treatment|1
2677565|NCT00536744|9240892|P2|Overall Study|Withdrawal by Subject|8
2677566|NCT00536744|9240893|P1|Overall Study|Withdrawal by Subject|7
2677567|NCT00536744|9240892|P2|Overall Study|Lost to Follow-up|5
2677568|NCT00536744|9240893|P1|Overall Study|Lost to Follow-up|3
2677569|NCT00536744|9240892|P2|Overall Study|Physician Decision|1
2677570|NCT00536744|9240893|P1|Overall Study|Physician Decision|3
2677571|NCT00536744|9240892|P2|Overall Study|Death|1
2677572|NCT00536744|9240893|P1|Overall Study|Death|2
2677573|NCT00536744|9240892|P2|Overall Study|Adverse Event|10
2677574|NCT00536744|9240893|P1|Overall Study|Adverse Event|13
2677575|NCT00536731|9240902|P3|Overall Study|Other|0
2677576|NCT00536731|9240903|P2|Overall Study|Other|1
2677577|NCT00536731|9240904|P1|Overall Study|Other|1
2677578|NCT00536731|9240902|P3|Overall Study|Safety reasons|1
2677579|NCT00536731|9240903|P2|Overall Study|Safety reasons|0
2677580|NCT00536731|9240904|P1|Overall Study|Safety reasons|0
2677581|NCT00536731|9240902|P3|Overall Study|Intake of prohibited conc. medication|1
2677582|NCT00536731|9240903|P2|Overall Study|Intake of prohibited conc. medication|0
2677583|NCT00536731|9240904|P1|Overall Study|Intake of prohibited conc. medication|0
2677584|NCT00536731|9240902|P3|Overall Study|Withdrawal by Subject|0
2677585|NCT00536731|9240903|P2|Overall Study|Withdrawal by Subject|2
2677586|NCT00536731|9240904|P1|Overall Study|Withdrawal by Subject|0
2677587|NCT00536731|9240902|P3|Overall Study|Adverse Event|3
2677588|NCT00536731|9240903|P2|Overall Study|Adverse Event|2
2677589|NCT00536731|9240904|P1|Overall Study|Adverse Event|3
2677590|NCT00536575|9240948|P1|Overall Study|Death|1
2677591|NCT00536575|9240948|P1|Overall Study|Withdrawal by Subject|1
2677592|NCT00536510|9240954|P2|Overall Study|Patient Discontinued for Other Reasons|2
2677593|NCT00536510|9240955|P1|Overall Study|Patient Discontinued for Other Reasons|2
2677594|NCT00536510|9240954|P2|Overall Study|Laboratory Adverse Event|1
2677595|NCT00536510|9240955|P1|Overall Study|Laboratory Adverse Event|2
2677596|NCT00536510|9240954|P2|Overall Study|Flushing with Product|0
2677597|NCT00536510|9240955|P1|Overall Study|Flushing with Product|20
2677598|NCT00536510|9240954|P2|Overall Study|Withdrawal by Subject|9
2677599|NCT00536510|9240955|P1|Overall Study|Withdrawal by Subject|16
2677600|NCT00536510|9240954|P2|Overall Study|Protocol Violation|5
2677601|NCT00536510|9240955|P1|Overall Study|Protocol Violation|4
2677602|NCT00536510|9240954|P2|Overall Study|Lost to Follow-up|8
2677603|NCT00536510|9240955|P1|Overall Study|Lost to Follow-up|11
2677604|NCT00536510|9240954|P2|Overall Study|Adverse Event|4
2677605|NCT00536510|9240955|P1|Overall Study|Adverse Event|27
2677606|NCT00536484|9240965|P2|Overall Study|Other|0
2677607|NCT00536484|9240966|P1|Overall Study|Other|4
2677608|NCT00536484|9240965|P2|Overall Study|Lack of Efficacy|5
2677609|NCT00536484|9240966|P1|Overall Study|Lack of Efficacy|16
2677610|NCT00536484|9240965|P2|Overall Study|Lost to Follow-up|6
2677611|NCT00536484|9240966|P1|Overall Study|Lost to Follow-up|8
2677612|NCT00536484|9240965|P2|Overall Study|Withdrawal by Subject|11
2677613|NCT00536484|9240966|P1|Overall Study|Withdrawal by Subject|11
2677614|NCT00536484|9240965|P2|Overall Study|Adverse Event|34
2677615|NCT00536484|9240966|P1|Overall Study|Adverse Event|21
2677616|NCT00536471|9241000|P4|Overall Study|Sponsor Decision|2
2677617|NCT00536471|9241001|P3|Overall Study|Sponsor Decision|3
2677618|NCT00536471|9241002|P2|Overall Study|Sponsor Decision|1
2677619|NCT00536471|9241003|P1|Overall Study|Sponsor Decision|0
2677620|NCT00536471|9241000|P4|Overall Study|Death|2
2677621|NCT00536471|9241001|P3|Overall Study|Death|1
2677622|NCT00536471|9241002|P2|Overall Study|Death|0
2677623|NCT00536471|9241003|P1|Overall Study|Death|0
2677624|NCT00536471|9241000|P4|Overall Study|Physician Decision|2
2677625|NCT00536471|9241001|P3|Overall Study|Physician Decision|3
2677626|NCT00536471|9241002|P2|Overall Study|Physician Decision|1
2677627|NCT00536471|9241003|P1|Overall Study|Physician Decision|11
2677628|NCT00536471|9241000|P4|Overall Study|Protocol Violation|3
2677629|NCT00536471|9241001|P3|Overall Study|Protocol Violation|2
2677630|NCT00536471|9241002|P2|Overall Study|Protocol Violation|1
2677631|NCT00536471|9241003|P1|Overall Study|Protocol Violation|8
2677632|NCT00536471|9241000|P4|Overall Study|Lack of Efficacy|9
2677633|NCT00536471|9241001|P3|Overall Study|Lack of Efficacy|11
2677634|NCT00536471|9241002|P2|Overall Study|Lack of Efficacy|18
2677635|NCT00536471|9241003|P1|Overall Study|Lack of Efficacy|17
2677636|NCT00536471|9241000|P4|Overall Study|Withdrawal by Subject|21
2677637|NCT00536471|9241001|P3|Overall Study|Withdrawal by Subject|43
2677638|NCT00536471|9241002|P2|Overall Study|Withdrawal by Subject|24
2677639|NCT00536471|9241003|P1|Overall Study|Withdrawal by Subject|40
2677640|NCT00536471|9241000|P4|Overall Study|Adverse Event|13
2677641|NCT00536471|9241001|P3|Overall Study|Adverse Event|28
2677642|NCT00536471|9241002|P2|Overall Study|Adverse Event|16
2677643|NCT00536471|9241003|P1|Overall Study|Adverse Event|32
2677644|NCT00536471|9241000|P4|Overall Study|Lost to Follow-up|22
2677645|NCT00536471|9241001|P3|Overall Study|Lost to Follow-up|48
2677646|NCT00536471|9241002|P2|Overall Study|Lost to Follow-up|23
2677647|NCT00536471|9241003|P1|Overall Study|Lost to Follow-up|48
2677648|NCT00536380|9241248|P3|Overall Study|Administrative|1
2677649|NCT00536380|9241249|P2|Overall Study|Administrative|0
2677650|NCT00536380|9241250|P1|Overall Study|Administrative|0
2677651|NCT00536380|9241248|P3|Overall Study|Did not meet protocol eligibility|1
2677652|NCT00536380|9241249|P2|Overall Study|Did not meet protocol eligibility|0
2677653|NCT00536380|9241250|P1|Overall Study|Did not meet protocol eligibility|0
2677654|NCT00536380|9241248|P3|Overall Study|Noncompliance with protocol|2
2677655|NCT00536380|9241249|P2|Overall Study|Noncompliance with protocol|2
2677656|NCT00536380|9241250|P1|Overall Study|Noncompliance with protocol|3
2677657|NCT00536380|9241248|P3|Overall Study|Withdrawal related to study drug|2
2677658|NCT00536380|9241249|P2|Overall Study|Withdrawal related to study drug|5
2677659|NCT00536380|9241250|P1|Overall Study|Withdrawal related to study drug|7
2677660|NCT00536380|9241248|P3|Overall Study|Withdrawal unrelated to study drug|1
2677661|NCT00536380|9241249|P2|Overall Study|Withdrawal unrelated to study drug|0
2677662|NCT00536380|9241250|P1|Overall Study|Withdrawal unrelated to study drug|2
2677663|NCT00536380|9241248|P3|Overall Study|Lost to Follow-up|1
2677664|NCT00536380|9241249|P2|Overall Study|Lost to Follow-up|0
2677665|NCT00536380|9241250|P1|Overall Study|Lost to Follow-up|0
2677666|NCT00536380|9241248|P3|Overall Study|Adverse Event|2
2677667|NCT00536380|9241249|P2|Overall Study|Adverse Event|2
2677668|NCT00536380|9241250|P1|Overall Study|Adverse Event|0
2677669|NCT00536263|9241274|P3|Overall Study|Did not meet protocol eligibility|2
2677670|NCT00536263|9241275|P2|Overall Study|Did not meet protocol eligibility|2
2677671|NCT00536263|9241276|P1|Overall Study|Did not meet protocol eligibility|1
2677672|NCT00536263|9241274|P3|Overall Study|Noncompliance with protocol|1
2677673|NCT00536263|9241275|P2|Overall Study|Noncompliance with protocol|0
2677674|NCT00536263|9241276|P1|Overall Study|Noncompliance with protocol|0
2677675|NCT00536263|9241274|P3|Overall Study|Subject withdrew - treatment related|2
2677676|NCT00536263|9241275|P2|Overall Study|Subject withdrew - treatment related|3
2677677|NCT00536263|9241276|P1|Overall Study|Subject withdrew - treatment related|0
2677678|NCT00536263|9241274|P3|Overall Study|Subject withdrew - not treatment related|5
2677679|NCT00536263|9241275|P2|Overall Study|Subject withdrew - not treatment related|0
2677680|NCT00536263|9241276|P1|Overall Study|Subject withdrew - not treatment related|2
2677681|NCT00536263|9241274|P3|Overall Study|Lost to Follow-up|4
2677682|NCT00536263|9241275|P2|Overall Study|Lost to Follow-up|4
2677683|NCT00536263|9241276|P1|Overall Study|Lost to Follow-up|3
2677684|NCT00536263|9241274|P3|Overall Study|Adverse Event|7
2677685|NCT00536263|9241275|P2|Overall Study|Adverse Event|5
2677686|NCT00536263|9241276|P1|Overall Study|Adverse Event|5
2677687|NCT00536198|9241316|P2|Overall Study|Protocol Violation|1
2677688|NCT00536198|9241317|P1|Overall Study|Protocol Violation|0
2677689|NCT00536198|9241316|P2|Overall Study|Pregnancy|1
2677690|NCT00536198|9241317|P1|Overall Study|Pregnancy|1
2677691|NCT00536198|9241316|P2|Overall Study|Rescue|9
2677692|NCT00536198|9241317|P1|Overall Study|Rescue|3
2677693|NCT00536198|9241316|P2|Overall Study|Adverse Event|2
2677694|NCT00536198|9241317|P1|Overall Study|Adverse Event|2
2677695|NCT00536198|9241316|P2|Overall Study|Withdrawal by Subject|12
2677696|NCT00536198|9241317|P1|Overall Study|Withdrawal by Subject|16
2677697|NCT00536198|9241316|P2|Overall Study|Lost to Follow-up|14
2677698|NCT00536198|9241317|P1|Overall Study|Lost to Follow-up|15
2677699|NCT00536120|9241356|P2|Overall Study|Missed Study Visit|1
2677700|NCT00536120|9241357|P1|Overall Study|Missed Study Visit|0
2677701|NCT00536120|9241356|P2|Overall Study|Steroid Use|2
2677702|NCT00536120|9241357|P1|Overall Study|Steroid Use|0
2677703|NCT00536120|9241356|P2|Overall Study|Sponsor Decision Due to Lab Values|0
2677704|NCT00536120|9241357|P1|Overall Study|Sponsor Decision Due to Lab Values|1
2677705|NCT00536120|9241356|P2|Overall Study|Non-compliance|0
2677706|NCT00536120|9241357|P1|Overall Study|Non-compliance|1
2677707|NCT00536120|9241356|P2|Overall Study|Positive for Anti-natalizumab Antibodies|0
2677708|NCT00536120|9241357|P1|Overall Study|Positive for Anti-natalizumab Antibodies|3
2677709|NCT00536120|9241356|P2|Overall Study|Lost to Follow-up|0
2677710|NCT00536120|9241357|P1|Overall Study|Lost to Follow-up|1
2677711|NCT00536107|9241371|P2|Overall Study|Study Termination|4
2677712|NCT00536107|9241372|P1|Overall Study|Study Termination|2
2677713|NCT00536107|9241371|P2|Overall Study|Withdrawal by Subject|1
2677714|NCT00536107|9241372|P1|Overall Study|Withdrawal by Subject|0
2677715|NCT00536107|9241371|P2|Overall Study|Incorrect enrolment|0
2677716|NCT00536107|9241372|P1|Overall Study|Incorrect enrolment|1
2677717|NCT00536107|9241371|P2|Overall Study|Death|1
2677718|NCT00536107|9241372|P1|Overall Study|Death|5
2677719|NCT00535847|9241426|P3|Overall Study|Protocol-defined Virologic Stopping Rule|0
2677720|NCT00535847|9241427|P2|Overall Study|Protocol-defined Virologic Stopping Rule|10
2677721|NCT00535847|9241428|P1|Overall Study|Protocol-defined Virologic Stopping Rule|16
2677722|NCT00535847|9241426|P3|Overall Study|Non compliance|0
2677723|NCT00535847|9241427|P2|Overall Study|Non compliance|1
2677724|NCT00535847|9241428|P1|Overall Study|Non compliance|1
2677725|NCT00535847|9241426|P3|Overall Study|Adverse Event|2
2677726|NCT00535847|9241427|P2|Overall Study|Adverse Event|3
2677727|NCT00535847|9241428|P1|Overall Study|Adverse Event|5
2677728|NCT00535730|9241663|P2|Overall Study|Withdrawal by Subject|4
2677729|NCT00535730|9241664|P1|Overall Study|Withdrawal by Subject|0
2677730|NCT00535730|9241663|P2|Overall Study|Protocol Violation|0
2677731|NCT00535730|9241664|P1|Overall Study|Protocol Violation|1
2677732|NCT00535730|9241663|P2|Overall Study|Physician Decision|1
2677733|NCT00535730|9241664|P1|Overall Study|Physician Decision|0
2677734|NCT00535730|9241663|P2|Overall Study|Lost to Follow-up|1
2677735|NCT00535730|9241664|P1|Overall Study|Lost to Follow-up|0
2677736|NCT00535730|9241663|P2|Overall Study|Adverse Event|1
2677737|NCT00535730|9241664|P1|Overall Study|Adverse Event|1
2677738|NCT00535626|9241685|P1|Overall Study|Unable to return|2
2677739|NCT00535626|9241685|P1|Overall Study|Subject terminated|31
2677740|NCT00535626|9241685|P1|Overall Study|Removal/revision of study component|8
2677741|NCT00535626|9241685|P1|Overall Study|Withdrawal by Subject|20
2677742|NCT00535626|9241685|P1|Overall Study|Lost to Follow-up|29
2677743|NCT00535626|9241685|P1|Overall Study|Death|15
2677744|NCT00535496|9241725|P4|Overall Study|Not treated with sugammadex|0
2677745|NCT00535496|9241726|P3|Overall Study|Not treated with sugammadex|0
2677746|NCT00535496|9241727|P2|Overall Study|Not treated with sugammadex|1
2677747|NCT00535496|9241728|P1|Overall Study|Not treated with sugammadex|0
2677748|NCT00535496|9241725|P4|Overall Study|Lost to Follow-up|0
2677749|NCT00535496|9241726|P3|Overall Study|Lost to Follow-up|0
2677750|NCT00535496|9241727|P2|Overall Study|Lost to Follow-up|1
2677751|NCT00535496|9241728|P1|Overall Study|Lost to Follow-up|0
2677752|NCT00535405|9241748|P5|Overall Study|Withdrawal by Subject|8
2677753|NCT00535405|9241749|P4|Overall Study|Withdrawal by Subject|10
2677754|NCT00535405|9241750|P3|Overall Study|Withdrawal by Subject|10
2677755|NCT00535405|9241751|P2|Overall Study|Withdrawal by Subject|11
2677756|NCT00535405|9241752|P1|Overall Study|Withdrawal by Subject|5
2677757|NCT00535405|9241748|P5|Overall Study|Protocol Violation|0
2677758|NCT00535405|9241749|P4|Overall Study|Protocol Violation|1
2677759|NCT00535405|9241750|P3|Overall Study|Protocol Violation|2
2677760|NCT00535405|9241751|P2|Overall Study|Protocol Violation|2
2677761|NCT00535405|9241752|P1|Overall Study|Protocol Violation|2
2677762|NCT00535405|9241748|P5|Overall Study|Physician Decision|1
2677763|NCT00535405|9241749|P4|Overall Study|Physician Decision|1
2677764|NCT00535405|9241750|P3|Overall Study|Physician Decision|0
2677765|NCT00535405|9241751|P2|Overall Study|Physician Decision|2
2677766|NCT00535405|9241752|P1|Overall Study|Physician Decision|3
2677767|NCT00535405|9241748|P5|Overall Study|Lost to Follow-up|1
2677768|NCT00535405|9241749|P4|Overall Study|Lost to Follow-up|2
2677769|NCT00535405|9241750|P3|Overall Study|Lost to Follow-up|3
2677770|NCT00535405|9241751|P2|Overall Study|Lost to Follow-up|3
2677771|NCT00535405|9241752|P1|Overall Study|Lost to Follow-up|1
2677772|NCT00535405|9241748|P5|Overall Study|Adverse Event|6
2677773|NCT00535405|9241749|P4|Overall Study|Adverse Event|8
2677774|NCT00535405|9241750|P3|Overall Study|Adverse Event|3
2677775|NCT00535405|9241751|P2|Overall Study|Adverse Event|8
2677776|NCT00535405|9241752|P1|Overall Study|Adverse Event|6
2677777|NCT00535288|9241813|P5|Overall Study|Other|1
2677778|NCT00535288|9241814|P4|Overall Study|Other|2
2677779|NCT00535288|9241815|P3|Overall Study|Other|1
2677780|NCT00535288|9241816|P2|Overall Study|Other|1
2677781|NCT00535288|9241817|P1|Overall Study|Other|2
2677782|NCT00535288|9241813|P5|Overall Study|Unwilling to cooperate|4
2677783|NCT00535288|9241814|P4|Overall Study|Unwilling to cooperate|3
2677784|NCT00535288|9241815|P3|Overall Study|Unwilling to cooperate|3
2677785|NCT00535288|9241816|P2|Overall Study|Unwilling to cooperate|6
2677786|NCT00535288|9241817|P1|Overall Study|Unwilling to cooperate|6
2677787|NCT00535288|9241813|P5|Overall Study|Lack of Efficacy|7
2677788|NCT00535288|9241814|P4|Overall Study|Lack of Efficacy|4
2677789|NCT00535288|9241815|P3|Overall Study|Lack of Efficacy|4
2677790|NCT00535288|9241816|P2|Overall Study|Lack of Efficacy|3
2677791|NCT00535288|9241817|P1|Overall Study|Lack of Efficacy|26
2677792|NCT00535288|9241813|P5|Overall Study|Lost to Follow-up|0
2677793|NCT00535288|9241814|P4|Overall Study|Lost to Follow-up|0
2677794|NCT00535288|9241815|P3|Overall Study|Lost to Follow-up|0
2677795|NCT00535288|9241816|P2|Overall Study|Lost to Follow-up|3
2677796|NCT00535288|9241817|P1|Overall Study|Lost to Follow-up|0
2677797|NCT00535288|9241813|P5|Overall Study|Adverse Event|30
2677798|NCT00535288|9241814|P4|Overall Study|Adverse Event|20
2677799|NCT00535288|9241815|P3|Overall Study|Adverse Event|25
2677800|NCT00535288|9241816|P2|Overall Study|Adverse Event|19
2677801|NCT00535288|9241817|P1|Overall Study|Adverse Event|20
2677802|NCT00535262|9241894|P1|Overall Study|No funding|3
2677803|NCT00535236|9241908|P10|Overall Study|Withdrawal by Subject|2
2677804|NCT00535236|9241909|P9|Overall Study|Withdrawal by Subject|4
2677805|NCT00535236|9241910|P8|Overall Study|Withdrawal by Subject|0
2677806|NCT00535236|9241911|P7|Overall Study|Withdrawal by Subject|5
2677807|NCT00535236|9241912|P6|Overall Study|Withdrawal by Subject|1
2677808|NCT00535236|9241913|P5|Overall Study|Withdrawal by Subject|6
2677809|NCT00535236|9241914|P4|Overall Study|Withdrawal by Subject|1
2677810|NCT00535236|9241915|P3|Overall Study|Withdrawal by Subject|2
2677811|NCT00535236|9241916|P2|Overall Study|Withdrawal by Subject|0
2677812|NCT00535236|9241917|P1|Overall Study|Withdrawal by Subject|3
2677813|NCT00535236|9241908|P10|Overall Study|Protocol Violation|0
2677814|NCT00535236|9241909|P9|Overall Study|Protocol Violation|1
2677815|NCT00535236|9241910|P8|Overall Study|Protocol Violation|0
2677816|NCT00535236|9241911|P7|Overall Study|Protocol Violation|0
2677817|NCT00535236|9241912|P6|Overall Study|Protocol Violation|0
2677818|NCT00535236|9241913|P5|Overall Study|Protocol Violation|0
2677819|NCT00535236|9241914|P4|Overall Study|Protocol Violation|0
2677820|NCT00535236|9241915|P3|Overall Study|Protocol Violation|1
2677821|NCT00535236|9241916|P2|Overall Study|Protocol Violation|0
2677822|NCT00535236|9241917|P1|Overall Study|Protocol Violation|2
2677823|NCT00535236|9241908|P10|Overall Study|Physician Decision|0
2677824|NCT00535236|9241909|P9|Overall Study|Physician Decision|0
2677825|NCT00535236|9241910|P8|Overall Study|Physician Decision|0
2677826|NCT00535236|9241911|P7|Overall Study|Physician Decision|1
2677827|NCT00535236|9241912|P6|Overall Study|Physician Decision|0
2677828|NCT00535236|9241913|P5|Overall Study|Physician Decision|1
2677829|NCT00535236|9241914|P4|Overall Study|Physician Decision|0
2677830|NCT00535236|9241915|P3|Overall Study|Physician Decision|0
2677831|NCT00535236|9241916|P2|Overall Study|Physician Decision|0
2677832|NCT00535236|9241917|P1|Overall Study|Physician Decision|0
2677833|NCT00535236|9241908|P10|Overall Study|Lost to Follow-up|1
2677834|NCT00535236|9241909|P9|Overall Study|Lost to Follow-up|6
2677835|NCT00535236|9241910|P8|Overall Study|Lost to Follow-up|0
2677836|NCT00535236|9241911|P7|Overall Study|Lost to Follow-up|0
2677837|NCT00535236|9241912|P6|Overall Study|Lost to Follow-up|0
2677838|NCT00535236|9241913|P5|Overall Study|Lost to Follow-up|2
2677839|NCT00535236|9241914|P4|Overall Study|Lost to Follow-up|0
2677840|NCT00535236|9241915|P3|Overall Study|Lost to Follow-up|0
2677841|NCT00535236|9241916|P2|Overall Study|Lost to Follow-up|2
2677842|NCT00535236|9241917|P1|Overall Study|Lost to Follow-up|1
2677843|NCT00535236|9241908|P10|Overall Study|Adverse Event|1
2677844|NCT00535236|9241909|P9|Overall Study|Adverse Event|2
2677845|NCT00535236|9241910|P8|Overall Study|Adverse Event|1
2677846|NCT00535236|9241911|P7|Overall Study|Adverse Event|5
2677847|NCT00535236|9241912|P6|Overall Study|Adverse Event|0
2677848|NCT00535236|9241913|P5|Overall Study|Adverse Event|3
2677849|NCT00535236|9241914|P4|Overall Study|Adverse Event|3
2677850|NCT00535236|9241915|P3|Overall Study|Adverse Event|9
2677851|NCT00535236|9241916|P2|Overall Study|Adverse Event|0
2677852|NCT00535236|9241917|P1|Overall Study|Adverse Event|1
2677853|NCT00535223|9241977|P2|Overall Study|Withdrawal by Subject|1
2677854|NCT00535223|9241978|P1|Overall Study|Withdrawal by Subject|4
2677855|NCT00535145|9241986|P1|Phase II|Subject non-compliance|2
2677856|NCT00535145|9241986|P1|Phase II|Withdrawal by Subject|5
2677857|NCT00535145|9241986|P1|Phase II|Lost to Follow-up|5
2677858|NCT00535145|9241986|P1|Phase II|Lack of Efficacy|1
2677859|NCT00535145|9241986|P1|Phase II|Adverse Event|2
2677860|NCT00535145|9241986|P1|Phase I|(diagnosis)|3
2677861|NCT00535145|9241986|P1|Phase I|(PI decision)|1
2677862|NCT00535145|9241986|P1|Phase I|(protocol violation)|1
2677863|NCT00535145|9241986|P1|Phase I|(eligibility)|8
2677864|NCT00535145|9241986|P1|Phase I|Withdrawal by Subject|6
2677865|NCT00535145|9241986|P1|Phase I|Lost to Follow-up|7
2677866|NCT00535145|9241986|P1|Phase I|Adverse Event|3
2677867|NCT00535132|9241998|P2|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
2677868|NCT00535132|9241999|P1|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
2677869|NCT00535132|9241998|P2|Safety Analysis Set|Did Not Receive Study Medication|2
2677870|NCT00535132|9241999|P1|Safety Analysis Set|Did Not Receive Study Medication|2
2677871|NCT00534976|9242080|P2|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0
2677872|NCT00534976|9242081|P1|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1
2677873|NCT00534976|9242080|P2|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0
2677874|NCT00534976|9242081|P1|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1
2677875|NCT00534976|9242080|P2|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1
2677876|NCT00534976|9242081|P1|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0
2677877|NCT00534638|9242161|P2|Overall Study|Other|902
2677878|NCT00534638|9242162|P1|Overall Study|Other|1685
2677879|NCT00534638|9242161|P2|Overall Study|Lost to follow-up, complete vaccination|10757
2677880|NCT00534638|9242162|P1|Overall Study|Lost to follow-up, complete vaccination|4707
2677881|NCT00534638|9242161|P2|Overall Study|Lost to follow-up,incomplete vaccination|117
2677882|NCT00534638|9242162|P1|Overall Study|Lost to follow-up,incomplete vaccination|83
2677883|NCT00534638|9242161|P2|Overall Study|Migrated/moved from study area|11
2677884|NCT00534638|9242162|P1|Overall Study|Migrated/moved from study area|13
2677885|NCT00534638|9242161|P2|Overall Study|Withdrawal by Subject|4
2677886|NCT00534638|9242162|P1|Overall Study|Withdrawal by Subject|3
2677887|NCT00534599|9242200|P2|Overall Study|Other|0
2677888|NCT00534599|9242201|P1|Overall Study|Other|7
2677889|NCT00534599|9242200|P2|Overall Study|Withdrawal by Subject|6
2677890|NCT00534599|9242201|P1|Overall Study|Withdrawal by Subject|4
2677891|NCT00534599|9242200|P2|Overall Study|Lost to Follow-up|14
2677892|NCT00534599|9242201|P1|Overall Study|Lost to Follow-up|11
2677893|NCT00534599|9242200|P2|Overall Study|Protocol Violation|3
2677894|NCT00534599|9242201|P1|Overall Study|Protocol Violation|1
2677895|NCT00534599|9242200|P2|Overall Study|Generalized anxiety disorder worsened|1
2677896|NCT00534599|9242201|P1|Overall Study|Generalized anxiety disorder worsened|0
2677897|NCT00534599|9242200|P2|Overall Study|Lack of Efficacy|1
2677898|NCT00534599|9242201|P1|Overall Study|Lack of Efficacy|0
2677899|NCT00534599|9242200|P2|Overall Study|Developed study-specific d/c criteria|0
2677900|NCT00534599|9242201|P1|Overall Study|Developed study-specific d/c criteria|5
2677901|NCT00534599|9242200|P2|Overall Study|Mis-randomization|2
2677902|NCT00534599|9242201|P1|Overall Study|Mis-randomization|2
2677903|NCT00534599|9242200|P2|Overall Study|Incorrect enrollment|1
2677904|NCT00534599|9242201|P1|Overall Study|Incorrect enrollment|2
2677905|NCT00534599|9242200|P2|Overall Study|Adverse Event|4
2677906|NCT00534599|9242201|P1|Overall Study|Adverse Event|25
2677907|NCT00534495|9242237|P3|Long Term Ext. Phase Week 24-month 21|non compliance|2
2677908|NCT00534495|9242238|P2|Long Term Ext. Phase Week 24-month 21|non compliance|0
2677909|NCT00534495|9242239|P1|Long Term Ext. Phase Week 24-month 21|non compliance|0
2677910|NCT00534495|9242237|P3|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3
2677911|NCT00534495|9242238|P2|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
2677912|NCT00534495|9242239|P1|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
2677913|NCT00534495|9242237|P3|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5
2677914|NCT00534495|9242238|P2|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
2677915|NCT00534495|9242239|P1|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
2677916|NCT00534495|9242237|P3|Long Term Ext. Phase Week 24-month 21|Adverse Event|1
2677917|NCT00534495|9242238|P2|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
2677918|NCT00534495|9242239|P1|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
2677919|NCT00534495|9242237|P3|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0
2677920|NCT00534495|9242238|P2|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
2677921|NCT00534495|9242239|P1|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
2677922|NCT00534495|9242237|P3|All Active Treatment Phase Week 4-24|Lost to Follow-up|0
2677923|NCT00534495|9242238|P2|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
2677924|NCT00534495|9242239|P1|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
2677925|NCT00534495|9242237|P3|All Active Treatment Phase Week 4-24|Lack of Efficacy|0
2677926|NCT00534495|9242238|P2|All Active Treatment Phase Week 4-24|Lack of Efficacy|7
2677927|NCT00534495|9242239|P1|All Active Treatment Phase Week 4-24|Lack of Efficacy|1
2677928|NCT00534495|9242237|P3|All Active Treatment Phase Week 4-24|Adverse Event|0
2677929|NCT00534495|9242238|P2|All Active Treatment Phase Week 4-24|Adverse Event|0
2677930|NCT00534495|9242239|P1|All Active Treatment Phase Week 4-24|Adverse Event|1
2677931|NCT00534495|9242237|P3|Double Blind Placebo Phase Week 0-4|randomized in error|0
2677932|NCT00534495|9242238|P2|Double Blind Placebo Phase Week 0-4|randomized in error|1
2677933|NCT00534495|9242239|P1|Double Blind Placebo Phase Week 0-4|randomized in error|0
2677934|NCT00534404|9242277|P3|Overall Study|Lost to Follow-up|201
2677935|NCT00534404|9242278|P2|Overall Study|Lost to Follow-up|138
2677936|NCT00534404|9242279|P1|Overall Study|Lost to Follow-up|170
2677937|NCT00534404|9242277|P3|Overall Study|Removed by study staff|1
2677938|NCT00534404|9242278|P2|Overall Study|Removed by study staff|3
2677939|NCT00534404|9242279|P1|Overall Study|Removed by study staff|2
2677940|NCT00534404|9242277|P3|Overall Study|Withdrawal by Subject|38
2677941|NCT00534404|9242278|P2|Overall Study|Withdrawal by Subject|2
2677942|NCT00534404|9242279|P1|Overall Study|Withdrawal by Subject|8
2677943|NCT00534404|9242277|P3|Overall Study|Death|2
2677944|NCT00534404|9242278|P2|Overall Study|Death|0
2677945|NCT00534404|9242279|P1|Overall Study|Death|0
2677946|NCT00534352|9242310|P1|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1
2677947|NCT00534352|9242310|P1|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2
2677948|NCT00534352|9242310|P1|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1
2677949|NCT00534352|9242310|P1|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1
2677950|NCT00534352|9242310|P1|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1
2677951|NCT00534352|9242310|P1|Treatment A: TMC125 + TDF/FTC|Physician Decision|1
2677952|NCT00534313|9242354|P4|Long-term Period|Other|2
2677953|NCT00534313|9242355|P3|Long-term Period|Other|2
2677954|NCT00534313|9242356|P2|Long-term Period|Other|2
2677955|NCT00534313|9242357|P1|Long-term Period|Other|1
2677956|NCT00534313|9242354|P4|Long-term Period|Administrative reason by sponsor|18
2677957|NCT00534313|9242355|P3|Long-term Period|Administrative reason by sponsor|26
2677958|NCT00534313|9242356|P2|Long-term Period|Administrative reason by sponsor|15
2677959|NCT00534313|9242357|P1|Long-term Period|Administrative reason by sponsor|17
2677960|NCT00534313|9242354|P4|Long-term Period|Poor compliance/noncompliance|0
2677961|NCT00534313|9242355|P3|Long-term Period|Poor compliance/noncompliance|1
2677962|NCT00534313|9242356|P2|Long-term Period|Poor compliance/noncompliance|1
2677963|NCT00534313|9242357|P1|Long-term Period|Poor compliance/noncompliance|0
2677964|NCT00534313|9242354|P4|Long-term Period|No longer meets study criteria|0
2677965|NCT00534313|9242355|P3|Long-term Period|No longer meets study criteria|0
2677966|NCT00534313|9242356|P2|Long-term Period|No longer meets study criteria|1
2677967|NCT00534313|9242357|P1|Long-term Period|No longer meets study criteria|0
2677968|NCT00534313|9242354|P4|Long-term Period|Withdrawal by Subject|0
2677969|NCT00534313|9242355|P3|Long-term Period|Withdrawal by Subject|0
2677970|NCT00534313|9242356|P2|Long-term Period|Withdrawal by Subject|2
2677971|NCT00534313|9242357|P1|Long-term Period|Withdrawal by Subject|2
2677972|NCT00534313|9242354|P4|Long-term Period|Lost to Follow-up|0
2677973|NCT00534313|9242355|P3|Long-term Period|Lost to Follow-up|0
2677974|NCT00534313|9242356|P2|Long-term Period|Lost to Follow-up|2
2677975|NCT00534313|9242357|P1|Long-term Period|Lost to Follow-up|1
2677976|NCT00534313|9242354|P4|Long-term Period|Lack of Efficacy|12
2677977|NCT00534313|9242355|P3|Long-term Period|Lack of Efficacy|14
2677978|NCT00534313|9242356|P2|Long-term Period|Lack of Efficacy|10
2677979|NCT00534313|9242357|P1|Long-term Period|Lack of Efficacy|14
2677980|NCT00534313|9242354|P4|Long-term Period|Adverse Event|1
2677981|NCT00534313|9242355|P3|Long-term Period|Adverse Event|0
2677982|NCT00534313|9242356|P2|Long-term Period|Adverse Event|1
2677983|NCT00534313|9242357|P1|Long-term Period|Adverse Event|2
2677984|NCT00534313|9242354|P4|Short-term Period|Pregnancy|0
2677985|NCT00534313|9242355|P3|Short-term Period|Pregnancy|1
2677986|NCT00534313|9242356|P2|Short-term Period|Pregnancy|0
2677987|NCT00534313|9242357|P1|Short-term Period|Pregnancy|0
2677988|NCT00534313|9242354|P4|Short-term Period|Participant withdrew consent|2
2677989|NCT00534313|9242355|P3|Short-term Period|Participant withdrew consent|0
2677990|NCT00534313|9242356|P2|Short-term Period|Participant withdrew consent|0
2677991|NCT00534313|9242357|P1|Short-term Period|Participant withdrew consent|2
2677992|NCT00534313|9242354|P4|Short-term Period|Participant not meeting study criteria|1
2677993|NCT00534313|9242355|P3|Short-term Period|Participant not meeting study criteria|0
2677994|NCT00534313|9242356|P2|Short-term Period|Participant not meeting study criteria|0
2677995|NCT00534313|9242357|P1|Short-term Period|Participant not meeting study criteria|0
2677996|NCT00534313|9242354|P4|Short-term Period|Lack of Efficacy|3
2677997|NCT00534313|9242355|P3|Short-term Period|Lack of Efficacy|0
2677998|NCT00534313|9242356|P2|Short-term Period|Lack of Efficacy|4
2677999|NCT00534313|9242357|P1|Short-term Period|Lack of Efficacy|3
2678000|NCT00534313|9242354|P4|Short-term Period|Adverse Event|3
2678001|NCT00534313|9242355|P3|Short-term Period|Adverse Event|1
2678002|NCT00534313|9242356|P2|Short-term Period|Adverse Event|2
2678003|NCT00534313|9242357|P1|Short-term Period|Adverse Event|1
2678004|NCT00534248|9242452|P2|Overall Study|Withdrawal by Subject|255
2678005|NCT00534248|9242453|P1|Overall Study|Withdrawal by Subject|263
2678006|NCT00534248|9242452|P2|Overall Study|Protocol Violation|4
2678007|NCT00534248|9242453|P1|Overall Study|Protocol Violation|3
2678008|NCT00534248|9242452|P2|Overall Study|Physician Decision|7
2678009|NCT00534248|9242453|P1|Overall Study|Physician Decision|10
2678010|NCT00534248|9242452|P2|Overall Study|Other protocol specified criteria|3
2678011|NCT00534248|9242453|P1|Overall Study|Other protocol specified criteria|13
2678012|NCT00534248|9242452|P2|Overall Study|Lost to Follow-up|375
2678013|NCT00534248|9242453|P1|Overall Study|Lost to Follow-up|353
2678014|NCT00534248|9242452|P2|Overall Study|Adverse Event|29
2678015|NCT00534248|9242453|P1|Overall Study|Adverse Event|19
2678016|NCT00534105|9242610|P2|Overall Study|Lost to Follow-up|39
2678017|NCT00534105|9242611|P1|Overall Study|Lost to Follow-up|23
2678018|NCT00534092|9242625|P2|Overall Study|personal reasons/family concerns|0
2678019|NCT00534092|9242626|P1|Overall Study|personal reasons/family concerns|1
2678020|NCT00534092|9242625|P2|Overall Study|Lost to Follow-up|0
2678021|NCT00534092|9242626|P1|Overall Study|Lost to Follow-up|1
2678022|NCT00533949|9242664|P4|Overall Study|Withdrawal by Subject|1
2678023|NCT00533949|9242665|P3|Overall Study|Withdrawal by Subject|1
2678024|NCT00533949|9242666|P2|Overall Study|Withdrawal by Subject|2
2678025|NCT00533949|9242667|P1|Overall Study|Withdrawal by Subject|3
2678026|NCT00533949|9242664|P4|Overall Study|Protocol Violation|9
2678027|NCT00533949|9242665|P3|Overall Study|Protocol Violation|9
2678028|NCT00533949|9242666|P2|Overall Study|Protocol Violation|12
2678029|NCT00533949|9242667|P1|Overall Study|Protocol Violation|12
2678030|NCT00533897|9242708|P8|Long Term Extension (LTE)|Other|6
2678031|NCT00533897|9242709|P7|Long Term Extension (LTE)|Other|1
2678032|NCT00533897|9242710|P6|Long Term Extension (LTE)|Other|0
2678033|NCT00533897|9242711|P5|Long Term Extension (LTE)|Other|0
2678034|NCT00533897|9242712|P4|Long Term Extension (LTE)|Other|0
2678035|NCT00533897|9242713|P3|Long Term Extension (LTE)|Other|0
2678036|NCT00533897|9242714|P2|Long Term Extension (LTE)|Other|0
2678037|NCT00533897|9242715|P1|Long Term Extension (LTE)|Other|0
2678038|NCT00533897|9242708|P8|Long Term Extension (LTE)|Lost to Follow-up|1
2678039|NCT00533897|9242709|P7|Long Term Extension (LTE)|Lost to Follow-up|1
2678040|NCT00533897|9242710|P6|Long Term Extension (LTE)|Lost to Follow-up|0
2678041|NCT00533897|9242711|P5|Long Term Extension (LTE)|Lost to Follow-up|0
2678042|NCT00533897|9242712|P4|Long Term Extension (LTE)|Lost to Follow-up|0
2678043|NCT00533897|9242713|P3|Long Term Extension (LTE)|Lost to Follow-up|0
2678044|NCT00533897|9242714|P2|Long Term Extension (LTE)|Lost to Follow-up|0
2678045|NCT00533897|9242715|P1|Long Term Extension (LTE)|Lost to Follow-up|0
2678046|NCT00533897|9242708|P8|Long Term Extension (LTE)|Pregnancy|2
2678047|NCT00533897|9242709|P7|Long Term Extension (LTE)|Pregnancy|0
2678048|NCT00533897|9242710|P6|Long Term Extension (LTE)|Pregnancy|0
2678049|NCT00533897|9242711|P5|Long Term Extension (LTE)|Pregnancy|0
2678050|NCT00533897|9242712|P4|Long Term Extension (LTE)|Pregnancy|0
2678051|NCT00533897|9242713|P3|Long Term Extension (LTE)|Pregnancy|0
2678052|NCT00533897|9242714|P2|Long Term Extension (LTE)|Pregnancy|0
2678053|NCT00533897|9242715|P1|Long Term Extension (LTE)|Pregnancy|0
2678054|NCT00533897|9242708|P8|Long Term Extension (LTE)|Adverse Event|5
2678055|NCT00533897|9242709|P7|Long Term Extension (LTE)|Adverse Event|2
2678056|NCT00533897|9242710|P6|Long Term Extension (LTE)|Adverse Event|0
2678057|NCT00533897|9242711|P5|Long Term Extension (LTE)|Adverse Event|0
2678058|NCT00533897|9242712|P4|Long Term Extension (LTE)|Adverse Event|0
2678059|NCT00533897|9242713|P3|Long Term Extension (LTE)|Adverse Event|0
2678060|NCT00533897|9242714|P2|Long Term Extension (LTE)|Adverse Event|0
2678061|NCT00533897|9242715|P1|Long Term Extension (LTE)|Adverse Event|0
2678062|NCT00533897|9242708|P8|Long Term Extension (LTE)|Poor/Non-compliance|0
2678063|NCT00533897|9242709|P7|Long Term Extension (LTE)|Poor/Non-compliance|1
2678064|NCT00533897|9242710|P6|Long Term Extension (LTE)|Poor/Non-compliance|0
2678065|NCT00533897|9242711|P5|Long Term Extension (LTE)|Poor/Non-compliance|0
2678066|NCT00533897|9242712|P4|Long Term Extension (LTE)|Poor/Non-compliance|0
2678067|NCT00533897|9242713|P3|Long Term Extension (LTE)|Poor/Non-compliance|0
2678068|NCT00533897|9242714|P2|Long Term Extension (LTE)|Poor/Non-compliance|0
2678069|NCT00533897|9242715|P1|Long Term Extension (LTE)|Poor/Non-compliance|0
2678070|NCT00533897|9242708|P8|Long Term Extension (LTE)|Lack of Efficacy|3
2678071|NCT00533897|9242709|P7|Long Term Extension (LTE)|Lack of Efficacy|5
2678072|NCT00533897|9242710|P6|Long Term Extension (LTE)|Lack of Efficacy|0
2678073|NCT00533897|9242711|P5|Long Term Extension (LTE)|Lack of Efficacy|0
2678074|NCT00533897|9242712|P4|Long Term Extension (LTE)|Lack of Efficacy|0
2678075|NCT00533897|9242713|P3|Long Term Extension (LTE)|Lack of Efficacy|0
2678076|NCT00533897|9242714|P2|Long Term Extension (LTE)|Lack of Efficacy|0
2678077|NCT00533897|9242715|P1|Long Term Extension (LTE)|Lack of Efficacy|0
2678078|NCT00533897|9242708|P8|Long Term Extension (LTE)|Death|3
2678079|NCT00533897|9242709|P7|Long Term Extension (LTE)|Death|1
2678080|NCT00533897|9242710|P6|Long Term Extension (LTE)|Death|0
2678081|NCT00533897|9242711|P5|Long Term Extension (LTE)|Death|0
2678082|NCT00533897|9242712|P4|Long Term Extension (LTE)|Death|0
2678083|NCT00533897|9242713|P3|Long Term Extension (LTE)|Death|0
2678084|NCT00533897|9242714|P2|Long Term Extension (LTE)|Death|0
2678085|NCT00533897|9242715|P1|Long Term Extension (LTE)|Death|0
2678086|NCT00533897|9242708|P8|Long Term Extension (LTE)|Participant Withdrew Consent|5
2678087|NCT00533897|9242709|P7|Long Term Extension (LTE)|Participant Withdrew Consent|2
2678088|NCT00533897|9242710|P6|Long Term Extension (LTE)|Participant Withdrew Consent|0
2678089|NCT00533897|9242711|P5|Long Term Extension (LTE)|Participant Withdrew Consent|0
2678090|NCT00533897|9242712|P4|Long Term Extension (LTE)|Participant Withdrew Consent|0
2678091|NCT00533897|9242713|P3|Long Term Extension (LTE)|Participant Withdrew Consent|0
2678092|NCT00533897|9242714|P2|Long Term Extension (LTE)|Participant Withdrew Consent|0
2678093|NCT00533897|9242715|P1|Long Term Extension (LTE)|Participant Withdrew Consent|0
2678094|NCT00533897|9242708|P8|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
2678095|NCT00533897|9242709|P7|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
2678096|NCT00533897|9242710|P6|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1
2678097|NCT00533897|9242711|P5|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
2678098|NCT00533897|9242712|P4|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
2678099|NCT00533897|9242713|P3|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
2678100|NCT00533897|9242714|P2|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
2678101|NCT00533897|9242715|P1|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
2678102|NCT00533897|9242708|P8|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
2678103|NCT00533897|9242709|P7|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
2678104|NCT00533897|9242710|P6|Re-introduction (RI) Period 3|Participant Withdrew Consent|1
2678105|NCT00533897|9242711|P5|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
2678106|NCT00533897|9242712|P4|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
2678107|NCT00533897|9242713|P3|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
2678108|NCT00533897|9242714|P2|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
2678109|NCT00533897|9242715|P1|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
2678110|NCT00533897|9242708|P8|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
2678111|NCT00533897|9242709|P7|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
2678112|NCT00533897|9242710|P6|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
2678113|NCT00533897|9242711|P5|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
2678114|NCT00533897|9242712|P4|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
2678115|NCT00533897|9242713|P3|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1
2678116|NCT00533897|9242714|P2|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
2678117|NCT00533897|9242715|P1|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
2678118|NCT00533897|9242708|P8|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
2678119|NCT00533897|9242709|P7|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
2678120|NCT00533897|9242710|P6|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
2678121|NCT00533897|9242711|P5|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
2678122|NCT00533897|9242712|P4|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
2678123|NCT00533897|9242713|P3|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2
2678124|NCT00533897|9242714|P2|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1
2678125|NCT00533897|9242715|P1|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
2678126|NCT00533897|9242708|P8|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
2678127|NCT00533897|9242709|P7|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
2678128|NCT00533897|9242710|P6|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
2678129|NCT00533897|9242711|P5|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
2678130|NCT00533897|9242712|P4|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
2678131|NCT00533897|9242713|P3|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
2678132|NCT00533897|9242714|P2|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
2678133|NCT00533897|9242715|P1|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1
2678134|NCT00533897|9242708|P8|Lead-in (LI) Period 1|Lack of Efficacy|0
2678135|NCT00533897|9242709|P7|Lead-in (LI) Period 1|Lack of Efficacy|0
2678136|NCT00533897|9242710|P6|Lead-in (LI) Period 1|Lack of Efficacy|0
2678137|NCT00533897|9242711|P5|Lead-in (LI) Period 1|Lack of Efficacy|0
2678138|NCT00533897|9242712|P4|Lead-in (LI) Period 1|Lack of Efficacy|0
2678139|NCT00533897|9242713|P3|Lead-in (LI) Period 1|Lack of Efficacy|0
2678140|NCT00533897|9242714|P2|Lead-in (LI) Period 1|Lack of Efficacy|0
2678141|NCT00533897|9242715|P1|Lead-in (LI) Period 1|Lack of Efficacy|3
2678142|NCT00533897|9242708|P8|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
2678143|NCT00533897|9242709|P7|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
2678144|NCT00533897|9242710|P6|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
2678145|NCT00533897|9242711|P5|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
2678146|NCT00533897|9242712|P4|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
2678147|NCT00533897|9242713|P3|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
2678148|NCT00533897|9242714|P2|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
2678149|NCT00533897|9242715|P1|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2
2678150|NCT00533897|9242708|P8|Lead-in (LI) Period 1|Lost to Follow-up|0
2678151|NCT00533897|9242709|P7|Lead-in (LI) Period 1|Lost to Follow-up|0
2678152|NCT00533897|9242710|P6|Lead-in (LI) Period 1|Lost to Follow-up|0
2678153|NCT00533897|9242711|P5|Lead-in (LI) Period 1|Lost to Follow-up|0
2678154|NCT00533897|9242712|P4|Lead-in (LI) Period 1|Lost to Follow-up|0
2678155|NCT00533897|9242713|P3|Lead-in (LI) Period 1|Lost to Follow-up|0
2678156|NCT00533897|9242714|P2|Lead-in (LI) Period 1|Lost to Follow-up|0
2678157|NCT00533897|9242715|P1|Lead-in (LI) Period 1|Lost to Follow-up|1
2678158|NCT00533897|9242708|P8|Lead-in (LI) Period 1|Participant Withdrew Consent|0
2678159|NCT00533897|9242709|P7|Lead-in (LI) Period 1|Participant Withdrew Consent|0
2678160|NCT00533897|9242710|P6|Lead-in (LI) Period 1|Participant Withdrew Consent|0
2678161|NCT00533897|9242711|P5|Lead-in (LI) Period 1|Participant Withdrew Consent|0
2678162|NCT00533897|9242712|P4|Lead-in (LI) Period 1|Participant Withdrew Consent|0
2678163|NCT00533897|9242713|P3|Lead-in (LI) Period 1|Participant Withdrew Consent|0
2678164|NCT00533897|9242714|P2|Lead-in (LI) Period 1|Participant Withdrew Consent|0
2678165|NCT00533897|9242715|P1|Lead-in (LI) Period 1|Participant Withdrew Consent|2
2678166|NCT00533897|9242708|P8|Lead-in (LI) Period 1|Adverse Event|0
2678167|NCT00533897|9242709|P7|Lead-in (LI) Period 1|Adverse Event|0
2678168|NCT00533897|9242710|P6|Lead-in (LI) Period 1|Adverse Event|0
2678169|NCT00533897|9242711|P5|Lead-in (LI) Period 1|Adverse Event|0
2678170|NCT00533897|9242712|P4|Lead-in (LI) Period 1|Adverse Event|0
2678171|NCT00533897|9242713|P3|Lead-in (LI) Period 1|Adverse Event|0
2678172|NCT00533897|9242714|P2|Lead-in (LI) Period 1|Adverse Event|0
2678173|NCT00533897|9242715|P1|Lead-in (LI) Period 1|Adverse Event|1
2678174|NCT00533845|9242855|P2|Overall Study|Physician Decision|0
2678175|NCT00533845|9242856|P1|Overall Study|Physician Decision|1
2678176|NCT00533702|9242864|P2|Overall Study|Found ineligible after randomization|1
2678177|NCT00533702|9242865|P1|Overall Study|Found ineligible after randomization|2
2678178|NCT00533702|9242864|P2|Overall Study|Withdrawal by Subject|1
2678179|NCT00533702|9242865|P1|Overall Study|Withdrawal by Subject|3
2678180|NCT00533507|9242896|P1|Overall Study|Withdrawal by Subject|1
2678181|NCT00533273|9242941|P2|Open-label|Withdrawal by Subject|0
2678182|NCT00533273|9242942|P1|Open-label|Withdrawal by Subject|6
2678183|NCT00533273|9242941|P2|Double-blind|Withdrew consent|2
2678184|NCT00533273|9242942|P1|Double-blind|Withdrew consent|0
2678185|NCT00532948|9242993|P3|Overall Study|Failure to return|0
2678186|NCT00532948|9242994|P2|Overall Study|Failure to return|1
2678187|NCT00532948|9242995|P1|Overall Study|Failure to return|0
2678188|NCT00532948|9242993|P3|Overall Study|Violation of selection criteria at entry|0
2678189|NCT00532948|9242994|P2|Overall Study|Violation of selection criteria at entry|1
2678190|NCT00532948|9242995|P1|Overall Study|Violation of selection criteria at entry|0
2678191|NCT00532948|9242993|P3|Overall Study|Death|4
2678192|NCT00532948|9242994|P2|Overall Study|Death|3
2678193|NCT00532948|9242995|P1|Overall Study|Death|3
2678194|NCT00532948|9242993|P3|Overall Study|Protocol Violation|0
2678195|NCT00532948|9242994|P2|Overall Study|Protocol Violation|0
2678196|NCT00532948|9242995|P1|Overall Study|Protocol Violation|1
2678197|NCT00532935|9243027|P2|Overall Study|Protocol Specific Criteria|15
2678198|NCT00532935|9243028|P1|Overall Study|Protocol Specific Criteria|11
2678199|NCT00532935|9243027|P2|Overall Study|Withdrawal by Subject|9
2678200|NCT00532935|9243028|P1|Overall Study|Withdrawal by Subject|10
2678201|NCT00532935|9243027|P2|Overall Study|Protocol Violation|2
2678202|NCT00532935|9243028|P1|Overall Study|Protocol Violation|4
2678203|NCT00532935|9243027|P2|Overall Study|Pregnancy|0
2678204|NCT00532935|9243028|P1|Overall Study|Pregnancy|1
2678205|NCT00532935|9243027|P2|Overall Study|Physician Decision|5
2678206|NCT00532935|9243028|P1|Overall Study|Physician Decision|4
2678207|NCT00532935|9243027|P2|Overall Study|Lost to Follow-up|6
2678208|NCT00532935|9243028|P1|Overall Study|Lost to Follow-up|10
2678209|NCT00532935|9243027|P2|Overall Study|Lack of Efficacy|3
2678210|NCT00532935|9243028|P1|Overall Study|Lack of Efficacy|0
2678211|NCT00532935|9243027|P2|Overall Study|Adverse Event|12
2678212|NCT00532935|9243028|P1|Overall Study|Adverse Event|11
2678213|NCT00532883|9243046|P4|Overall Study|Early Study Termination|4
2678214|NCT00532883|9243047|P3|Overall Study|Early Study Termination|1
2678215|NCT00532883|9243048|P2|Overall Study|Early Study Termination|4
2678216|NCT00532883|9243049|P1|Overall Study|Early Study Termination|4
2678217|NCT00532883|9243046|P4|Overall Study|Subject was Nonadherent|0
2678218|NCT00532883|9243047|P3|Overall Study|Subject was Nonadherent|1
2678219|NCT00532883|9243048|P2|Overall Study|Subject was Nonadherent|1
2678220|NCT00532883|9243049|P1|Overall Study|Subject was Nonadherent|0
2678221|NCT00532883|9243046|P4|Overall Study|Withdrawal by Subject|0
2678222|NCT00532883|9243047|P3|Overall Study|Withdrawal by Subject|1
2678223|NCT00532883|9243048|P2|Overall Study|Withdrawal by Subject|1
2678224|NCT00532883|9243049|P1|Overall Study|Withdrawal by Subject|0
2678225|NCT00532883|9243046|P4|Overall Study|Lost to Follow-up|0
2678226|NCT00532883|9243047|P3|Overall Study|Lost to Follow-up|1
2678227|NCT00532883|9243048|P2|Overall Study|Lost to Follow-up|1
2678228|NCT00532883|9243049|P1|Overall Study|Lost to Follow-up|1
2678229|NCT00532883|9243046|P4|Overall Study|Adverse Event|1
2678230|NCT00532883|9243047|P3|Overall Study|Adverse Event|0
2678231|NCT00532883|9243048|P2|Overall Study|Adverse Event|0
2678232|NCT00532883|9243049|P1|Overall Study|Adverse Event|1
2678233|NCT00532779|9243062|P3|Overall Study|Drug noncompliance, moved, other|29
2678234|NCT00532779|9243063|P2|Overall Study|Drug noncompliance, moved, other|23
2678235|NCT00532779|9243064|P1|Overall Study|Drug noncompliance, moved, other|14
2678236|NCT00532779|9243062|P3|Overall Study|Death|0
2678237|NCT00532779|9243063|P2|Overall Study|Death|1
2678238|NCT00532779|9243064|P1|Overall Study|Death|0
2678239|NCT00532779|9243062|P3|Overall Study|Pregnancy|3
2678240|NCT00532779|9243063|P2|Overall Study|Pregnancy|5
2678241|NCT00532779|9243064|P1|Overall Study|Pregnancy|2
2678242|NCT00532779|9243062|P3|Overall Study|Protocol Violation|7
2678243|NCT00532779|9243063|P2|Overall Study|Protocol Violation|9
2678244|NCT00532779|9243064|P1|Overall Study|Protocol Violation|5
2678245|NCT00532779|9243062|P3|Overall Study|Lack of Efficacy|40
2678246|NCT00532779|9243063|P2|Overall Study|Lack of Efficacy|12
2678247|NCT00532779|9243064|P1|Overall Study|Lack of Efficacy|12
2678248|NCT00532779|9243062|P3|Overall Study|Withdrawal by Subject|90
2678249|NCT00532779|9243063|P2|Overall Study|Withdrawal by Subject|60
2678250|NCT00532779|9243064|P1|Overall Study|Withdrawal by Subject|63
2678251|NCT00532779|9243062|P3|Overall Study|Lost to Follow-up|66
2678252|NCT00532779|9243063|P2|Overall Study|Lost to Follow-up|65
2678253|NCT00532779|9243064|P1|Overall Study|Lost to Follow-up|76
2678254|NCT00532779|9243062|P3|Overall Study|Adverse Event|56
2678255|NCT00532779|9243063|P2|Overall Study|Adverse Event|112
2678256|NCT00532779|9243064|P1|Overall Study|Adverse Event|122
2678257|NCT00532493|9243125|P2|Overall Study|Contraindicative Medication|0
2678258|NCT00532493|9243126|P1|Overall Study|Contraindicative Medication|1
2678259|NCT00532493|9243125|P2|Overall Study|Subject Moved Away|1
2678260|NCT00532493|9243126|P1|Overall Study|Subject Moved Away|3
2678261|NCT00532493|9243125|P2|Overall Study|Protocol Deviation|0
2678262|NCT00532493|9243126|P1|Overall Study|Protocol Deviation|1
2678263|NCT00532493|9243125|P2|Overall Study|Adverse Event|5
2678264|NCT00532493|9243126|P1|Overall Study|Adverse Event|6
2678265|NCT00532493|9243125|P2|Overall Study|Physician Decision|6
2678266|NCT00532493|9243126|P1|Overall Study|Physician Decision|1
2678267|NCT00532493|9243125|P2|Overall Study|Withdrawal by Subject|9
2678268|NCT00532493|9243126|P1|Overall Study|Withdrawal by Subject|7
2678269|NCT00532493|9243125|P2|Overall Study|Lost to Follow-up|7
2678270|NCT00532493|9243126|P1|Overall Study|Lost to Follow-up|10
2678271|NCT00532493|9243125|P2|Overall Study|Death|1
2678272|NCT00532493|9243126|P1|Overall Study|Death|1
2678273|NCT00532441|9243160|P2|Overall Study|Death|0
2678274|NCT00532441|9243161|P1|Overall Study|Death|1
2678275|NCT00532298|9243176|P6|Overall Study|Lost to Follow-up|1
2678276|NCT00532298|9243177|P5|Overall Study|Lost to Follow-up|0
2678277|NCT00532298|9243178|P4|Overall Study|Lost to Follow-up|0
2678278|NCT00532298|9243179|P3|Overall Study|Lost to Follow-up|1
2678279|NCT00532298|9243180|P2|Overall Study|Lost to Follow-up|1
2678280|NCT00532298|9243181|P1|Overall Study|Lost to Follow-up|1
2678281|NCT00532298|9243176|P6|Overall Study|Adverse Event|1
2678282|NCT00532298|9243177|P5|Overall Study|Adverse Event|1
2678283|NCT00532298|9243178|P4|Overall Study|Adverse Event|0
2678284|NCT00532298|9243179|P3|Overall Study|Adverse Event|0
2678285|NCT00532298|9243180|P2|Overall Study|Adverse Event|0
2678286|NCT00532298|9243181|P1|Overall Study|Adverse Event|1
2678287|NCT00532259|9243261|P1|Overall Study|Protocol Violation|1
2678288|NCT00532259|9243261|P1|Overall Study|Physician Decision|3
2678289|NCT00532259|9243261|P1|Overall Study|Lost to Follow-up|3
2678290|NCT00532259|9243261|P1|Overall Study|Lack of Efficacy|21
2678291|NCT00532259|9243261|P1|Overall Study|Death|1
2678292|NCT00532259|9243261|P1|Overall Study|Adverse Event|1
2678293|NCT00532259|9243261|P1|Overall Study|Withdrawal by Subject|2
2678294|NCT00532155|9243268|P2|Overall Study|Did not receive study medication|6
2678295|NCT00532155|9243269|P1|Overall Study|Did not receive study medication|2
2678296|NCT00532155|9243268|P2|Overall Study|Study termination stop further treatment|0
2678297|NCT00532155|9243269|P1|Overall Study|Study termination stop further treatment|4
2678298|NCT00532155|9243268|P2|Overall Study|Study terminated by sponsor|0
2678299|NCT00532155|9243269|P1|Overall Study|Study terminated by sponsor|1
2678300|NCT00532155|9243268|P2|Overall Study|Study stopped|0
2678301|NCT00532155|9243269|P1|Overall Study|Study stopped|1
2678302|NCT00532155|9243268|P2|Overall Study|Had brain metastasis, was mis-randomized|0
2678303|NCT00532155|9243269|P1|Overall Study|Had brain metastasis, was mis-randomized|1
2678304|NCT00532155|9243268|P2|Overall Study|Progressive disease (by incorrect scan)|1
2678305|NCT00532155|9243269|P1|Overall Study|Progressive disease (by incorrect scan)|0
2678306|NCT00532155|9243268|P2|Overall Study|Promotor ended study|0
2678307|NCT00532155|9243269|P1|Overall Study|Promotor ended study|1
2678308|NCT00532155|9243268|P2|Overall Study|Occurence of a secondary cancer|1
2678309|NCT00532155|9243269|P1|Overall Study|Occurence of a secondary cancer|0
2678310|NCT00532155|9243268|P2|Overall Study|Occurence of a second cancer|1
2678311|NCT00532155|9243269|P1|Overall Study|Occurence of a second cancer|0
2678312|NCT00532155|9243268|P2|Overall Study|Pre-existing brain metastasis (by MRI)|0
2678313|NCT00532155|9243269|P1|Overall Study|Pre-existing brain metastasis (by MRI)|1
2678314|NCT00532155|9243268|P2|Overall Study|Moved|0
2678315|NCT00532155|9243269|P1|Overall Study|Moved|1
2678316|NCT00532155|9243268|P2|Overall Study|Consent withdrawn|7
2678317|NCT00532155|9243269|P1|Overall Study|Consent withdrawn|5
2678318|NCT00532155|9243268|P2|Overall Study|Withdrawal by Subject|44
2678319|NCT00532155|9243269|P1|Overall Study|Withdrawal by Subject|23
2678320|NCT00532155|9243268|P2|Overall Study|Physician Decision|15
2678321|NCT00532155|9243269|P1|Overall Study|Physician Decision|16
2678322|NCT00532155|9243268|P2|Overall Study|Lost to Follow-up|0
2678323|NCT00532155|9243269|P1|Overall Study|Lost to Follow-up|2
2678324|NCT00532155|9243268|P2|Overall Study|Protocol Violation|3
2678325|NCT00532155|9243269|P1|Overall Study|Protocol Violation|1
2678326|NCT00532155|9243268|P2|Overall Study|Lack of Efficacy|255
2678327|NCT00532155|9243269|P1|Overall Study|Lack of Efficacy|332
2678328|NCT00532155|9243268|P2|Overall Study|Adverse Event|123
2678329|NCT00532155|9243269|P1|Overall Study|Adverse Event|66
2678330|NCT00532129|9243283|P1|Follow-up Period|Other|6
2678331|NCT00532129|9243283|P1|Follow-up Period|Lost to Follow-up|1
2678332|NCT00532129|9243283|P1|Follow-up Period|Disease progression|57
2678333|NCT00532129|9243283|P1|Follow-up Period|Adverse event/Serious adverse event|1
2678334|NCT00532129|9243283|P1|Treatment Period|Other|5
2678335|NCT00532129|9243283|P1|Treatment Period|Protocol Violation|1
2678336|NCT00532129|9243283|P1|Treatment Period|Disease progression|3
2678337|NCT00532129|9243283|P1|Treatment Period|Physician Decision|15
2678338|NCT00532129|9243283|P1|Treatment Period|Adverse event/Serious adverse event|25
2678339|NCT00531960|9243303|P2|Overall Study|Other|10
2678340|NCT00531960|9243304|P1|Overall Study|Other|4
2678341|NCT00531960|9243303|P2|Overall Study|Refused Treatment|6
2678342|NCT00531960|9243304|P1|Overall Study|Refused Treatment|5
2678343|NCT00531960|9243303|P2|Overall Study|Violation of Selection Criteria|0
2678344|NCT00531960|9243304|P1|Overall Study|Violation of Selection Criteria|2
2678345|NCT00531960|9243303|P2|Overall Study|Lack of Efficacy|41
2678346|NCT00531960|9243304|P1|Overall Study|Lack of Efficacy|42
2678347|NCT00531960|9243303|P2|Overall Study|Death|2
2678348|NCT00531960|9243304|P1|Overall Study|Death|3
2678349|NCT00531960|9243303|P2|Overall Study|Adverse Event|4
2678350|NCT00531960|9243304|P1|Overall Study|Adverse Event|5
2678351|NCT00531947|9243322|P2|Overall Study|Other (e.g., Lack of Efficacy)|5
2678352|NCT00531947|9243323|P1|Overall Study|Other (e.g., Lack of Efficacy)|5
2678353|NCT00531947|9243322|P2|Overall Study|Non-Compliance|7
2678354|NCT00531947|9243323|P1|Overall Study|Non-Compliance|4
2678355|NCT00531947|9243322|P2|Overall Study|Protocol Violation|1
2678356|NCT00531947|9243323|P1|Overall Study|Protocol Violation|2
2678357|NCT00531947|9243322|P2|Overall Study|Withdrawal by Subject|19
2678358|NCT00531947|9243323|P1|Overall Study|Withdrawal by Subject|14
2678359|NCT00531947|9243322|P2|Overall Study|Lost to Follow-up|9
2678360|NCT00531947|9243323|P1|Overall Study|Lost to Follow-up|12
2678361|NCT00531947|9243322|P2|Overall Study|Adverse Event|10
2678362|NCT00531947|9243323|P1|Overall Study|Adverse Event|5
2678363|NCT00531934|9243367|P2|Overall Study|Other|2
2678364|NCT00531934|9243368|P1|Overall Study|Other|2
2678365|NCT00531934|9243367|P2|Overall Study|Withdrawal by Subject|1
2678366|NCT00531934|9243368|P1|Overall Study|Withdrawal by Subject|1
2678367|NCT00531934|9243367|P2|Overall Study|Death|10
2678368|NCT00531934|9243368|P1|Overall Study|Death|7
2678369|NCT00531934|9243367|P2|Overall Study|Progression|42
2678370|NCT00531934|9243368|P1|Overall Study|Progression|52
2678371|NCT00531934|9243367|P2|Overall Study|Adverse Event|8
2678372|NCT00531934|9243368|P1|Overall Study|Adverse Event|4
2678373|NCT00531752|9243496|P4|Second Double-blind Intervention Period|Lost to Follow-up|1
2678374|NCT00531752|9243497|P3|Second Double-blind Intervention Period|Lost to Follow-up|0
2678375|NCT00531752|9243498|P2|Second Double-blind Intervention Period|Lost to Follow-up|0
2678376|NCT00531752|9243499|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
2678377|NCT00531752|9243496|P4|Second Double-blind Intervention Period|Withdrawal by Subject|1
2678378|NCT00531752|9243497|P3|Second Double-blind Intervention Period|Withdrawal by Subject|0
2678379|NCT00531752|9243498|P2|Second Double-blind Intervention Period|Withdrawal by Subject|0
2678380|NCT00531752|9243499|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
2678381|NCT00531752|9243496|P4|Second Double-blind Intervention Period|Other|0
2678382|NCT00531752|9243497|P3|Second Double-blind Intervention Period|Other|0
2678383|NCT00531752|9243498|P2|Second Double-blind Intervention Period|Other|1
2678384|NCT00531752|9243499|P1|Second Double-blind Intervention Period|Other|1
2678385|NCT00531752|9243496|P4|Second Double-blind Intervention Period|Adverse Event|0
2678386|NCT00531752|9243497|P3|Second Double-blind Intervention Period|Adverse Event|0
2678387|NCT00531752|9243498|P2|Second Double-blind Intervention Period|Adverse Event|1
2678388|NCT00531752|9243499|P1|Second Double-blind Intervention Period|Adverse Event|1
2678389|NCT00531752|9243496|P4|First Double-blind Intervention Period|Randomized but not treated|0
2678390|NCT00531752|9243497|P3|First Double-blind Intervention Period|Randomized but not treated|0
2678391|NCT00531752|9243498|P2|First Double-blind Intervention Period|Randomized but not treated|0
2678392|NCT00531752|9243499|P1|First Double-blind Intervention Period|Randomized but not treated|1
2678393|NCT00531752|9243496|P4|First Double-blind Intervention Period|Lost to Follow-up|1
2678394|NCT00531752|9243497|P3|First Double-blind Intervention Period|Lost to Follow-up|1
2678395|NCT00531752|9243498|P2|First Double-blind Intervention Period|Lost to Follow-up|0
2678396|NCT00531752|9243499|P1|First Double-blind Intervention Period|Lost to Follow-up|0
2678397|NCT00531752|9243496|P4|First Double-blind Intervention Period|Withdrawal by Subject|1
2678398|NCT00531752|9243497|P3|First Double-blind Intervention Period|Withdrawal by Subject|1
2678399|NCT00531752|9243498|P2|First Double-blind Intervention Period|Withdrawal by Subject|0
2678400|NCT00531752|9243499|P1|First Double-blind Intervention Period|Withdrawal by Subject|2
2678401|NCT00531752|9243496|P4|First Double-blind Intervention Period|Other|0
2678402|NCT00531752|9243497|P3|First Double-blind Intervention Period|Other|4
2678403|NCT00531752|9243498|P2|First Double-blind Intervention Period|Other|4
2678404|NCT00531752|9243499|P1|First Double-blind Intervention Period|Other|1
2678405|NCT00531752|9243496|P4|First Double-blind Intervention Period|Adverse Event|1
2678406|NCT00531752|9243497|P3|First Double-blind Intervention Period|Adverse Event|1
2678407|NCT00531752|9243498|P2|First Double-blind Intervention Period|Adverse Event|0
2678408|NCT00531752|9243499|P1|First Double-blind Intervention Period|Adverse Event|2
2678409|NCT00531479|9243610|P2|Overall Study|Did not receive treatment|3
2678410|NCT00531479|9243611|P1|Overall Study|Did not receive treatment|2
2678411|NCT00531479|9243610|P2|Overall Study|Withdrawal by Subject|6
2678412|NCT00531479|9243611|P1|Overall Study|Withdrawal by Subject|6
2678413|NCT00531479|9243610|P2|Overall Study|Other|1
2678414|NCT00531479|9243611|P1|Overall Study|Other|0
2678415|NCT00531479|9243610|P2|Overall Study|Lost to Follow-up|2
2678416|NCT00531479|9243611|P1|Overall Study|Lost to Follow-up|0
2678417|NCT00531479|9243610|P2|Overall Study|Death|71
2678418|NCT00531479|9243611|P1|Overall Study|Death|68
2678419|NCT00531427|9243642|P2|Overall Study|Administrative|9
2678420|NCT00531427|9243643|P1|Overall Study|Administrative|4
2678421|NCT00531427|9243642|P2|Overall Study|Lack of Efficacy|39
2678422|NCT00531427|9243643|P1|Overall Study|Lack of Efficacy|14
2678423|NCT00531427|9243642|P2|Overall Study|Lost to Follow-up|3
2678424|NCT00531427|9243643|P1|Overall Study|Lost to Follow-up|4
2678425|NCT00531427|9243642|P2|Overall Study|Adverse Event|30
2678426|NCT00531427|9243643|P1|Overall Study|Adverse Event|44
2678427|NCT00531427|9243642|P2|Overall Study|Withdrawal by Subject|13
2678428|NCT00531427|9243643|P1|Overall Study|Withdrawal by Subject|7
2678429|NCT00531284|9243671|P17|Overall Study|Other|0
2678430|NCT00531284|9243672|P16|Overall Study|Other|0
2678431|NCT00531284|9243673|P15|Overall Study|Other|1
2678432|NCT00531284|9243674|P14|Overall Study|Other|0
2678433|NCT00531284|9243675|P13|Overall Study|Other|0
2678434|NCT00531284|9243676|P12|Overall Study|Other|2
2678435|NCT00531284|9243677|P11|Overall Study|Other|0
2678436|NCT00531284|9243678|P10|Overall Study|Other|1
2678437|NCT00531284|9243679|P9|Overall Study|Other|2
2678438|NCT00531284|9243680|P8|Overall Study|Other|0
2678439|NCT00531284|9243681|P7|Overall Study|Other|0
2678440|NCT00531284|9243682|P6|Overall Study|Other|1
2678441|NCT00531284|9243683|P5|Overall Study|Other|2
2678442|NCT00531284|9243684|P4|Overall Study|Other|10
2678443|NCT00531284|9243685|P3|Overall Study|Other|0
2678444|NCT00531284|9243686|P2|Overall Study|Other|0
2678445|NCT00531284|9243687|P1|Overall Study|Other|1
2678446|NCT00531284|9243671|P17|Overall Study|Withdrawal by Subject|1
2678447|NCT00531284|9243672|P16|Overall Study|Withdrawal by Subject|1
2678448|NCT00531284|9243673|P15|Overall Study|Withdrawal by Subject|0
2678449|NCT00531284|9243674|P14|Overall Study|Withdrawal by Subject|1
2678450|NCT00531284|9243675|P13|Overall Study|Withdrawal by Subject|0
2678451|NCT00531284|9243676|P12|Overall Study|Withdrawal by Subject|3
2678452|NCT00531284|9243677|P11|Overall Study|Withdrawal by Subject|0
2678453|NCT00531284|9243678|P10|Overall Study|Withdrawal by Subject|0
2678454|NCT00531284|9243679|P9|Overall Study|Withdrawal by Subject|0
2678455|NCT00531284|9243680|P8|Overall Study|Withdrawal by Subject|0
2678456|NCT00531284|9243681|P7|Overall Study|Withdrawal by Subject|0
2678457|NCT00531284|9243682|P6|Overall Study|Withdrawal by Subject|0
2678458|NCT00531284|9243683|P5|Overall Study|Withdrawal by Subject|0
2678459|NCT00531284|9243684|P4|Overall Study|Withdrawal by Subject|4
2678460|NCT00531284|9243685|P3|Overall Study|Withdrawal by Subject|0
2678461|NCT00531284|9243686|P2|Overall Study|Withdrawal by Subject|0
2678462|NCT00531284|9243687|P1|Overall Study|Withdrawal by Subject|1
2678463|NCT00531284|9243671|P17|Overall Study|Adverse Event|2
2678464|NCT00531284|9243672|P16|Overall Study|Adverse Event|0
2678465|NCT00531284|9243673|P15|Overall Study|Adverse Event|1
2678466|NCT00531284|9243674|P14|Overall Study|Adverse Event|1
2678467|NCT00531284|9243675|P13|Overall Study|Adverse Event|0
2678468|NCT00531284|9243676|P12|Overall Study|Adverse Event|5
2678469|NCT00531284|9243677|P11|Overall Study|Adverse Event|0
2678470|NCT00531284|9243678|P10|Overall Study|Adverse Event|0
2678471|NCT00531284|9243679|P9|Overall Study|Adverse Event|3
2678472|NCT00531284|9243680|P8|Overall Study|Adverse Event|2
2678473|NCT00531284|9243681|P7|Overall Study|Adverse Event|3
2678474|NCT00531284|9243682|P6|Overall Study|Adverse Event|2
2678475|NCT00531284|9243683|P5|Overall Study|Adverse Event|0
2678476|NCT00531284|9243684|P4|Overall Study|Adverse Event|7
2678477|NCT00531284|9243685|P3|Overall Study|Adverse Event|1
2678478|NCT00531284|9243686|P2|Overall Study|Adverse Event|1
2678479|NCT00531284|9243687|P1|Overall Study|Adverse Event|0
2678480|NCT00531284|9243671|P17|Overall Study|Progressive Disease|5
2678481|NCT00531284|9243672|P16|Overall Study|Progressive Disease|11
2678482|NCT00531284|9243673|P15|Overall Study|Progressive Disease|2
2678483|NCT00531284|9243674|P14|Overall Study|Progressive Disease|1
2678484|NCT00531284|9243675|P13|Overall Study|Progressive Disease|2
2678485|NCT00531284|9243676|P12|Overall Study|Progressive Disease|14
2678486|NCT00531284|9243677|P11|Overall Study|Progressive Disease|3
2678487|NCT00531284|9243678|P10|Overall Study|Progressive Disease|3
2678488|NCT00531284|9243679|P9|Overall Study|Progressive Disease|6
2678489|NCT00531284|9243680|P8|Overall Study|Progressive Disease|8
2678490|NCT00531284|9243681|P7|Overall Study|Progressive Disease|3
2678491|NCT00531284|9243682|P6|Overall Study|Progressive Disease|4
2678492|NCT00531284|9243683|P5|Overall Study|Progressive Disease|4
2678493|NCT00531284|9243684|P4|Overall Study|Progressive Disease|42
2678494|NCT00531284|9243685|P3|Overall Study|Progressive Disease|5
2678495|NCT00531284|9243686|P2|Overall Study|Progressive Disease|3
2678496|NCT00531284|9243687|P1|Overall Study|Progressive Disease|1
2678497|NCT00531206|9243837|P1|Overall Study|including non-related adverse events|8
2678498|NCT00531206|9243837|P1|Overall Study|Lost to Follow-up|5
2678499|NCT00531206|9243837|P1|Overall Study|Lack of Efficacy|2
2678500|NCT00531206|9243837|P1|Overall Study|Adverse Event related|5
2678501|NCT00531050|9243867|P6|Part 2: Period 3|Abnormal test procedure|1
2678502|NCT00531050|9243868|P5|Part 2: Period 3|Abnormal test procedure|0
2678503|NCT00531050|9243869|P4|Part 2: Period 3|Abnormal test procedure|0
2678504|NCT00531050|9243870|P3|Part 2: Period 3|Abnormal test procedure|0
2678505|NCT00531050|9243871|P2|Part 2: Period 3|Abnormal test procedure|0
2678506|NCT00531050|9243872|P1|Part 2: Period 3|Abnormal test procedure|1
2678507|NCT00531050|9243867|P6|Part 2: Period 1|Adverse Event|1
2678508|NCT00531050|9243868|P5|Part 2: Period 1|Adverse Event|0
2678509|NCT00531050|9243869|P4|Part 2: Period 1|Adverse Event|0
2678510|NCT00531050|9243870|P3|Part 2: Period 1|Adverse Event|0
2678511|NCT00531050|9243871|P2|Part 2: Period 1|Adverse Event|0
2678512|NCT00531050|9243872|P1|Part 2: Period 1|Adverse Event|0
2678513|NCT00531050|9243867|P6|Part 1: Period 3|Adverse Event|0
2678514|NCT00531050|9243868|P5|Part 1: Period 3|Adverse Event|0
2678515|NCT00531050|9243869|P4|Part 1: Period 3|Adverse Event|0
2678516|NCT00531050|9243870|P3|Part 1: Period 3|Adverse Event|0
2678517|NCT00531050|9243871|P2|Part 1: Period 3|Adverse Event|0
2678518|NCT00531050|9243872|P1|Part 1: Period 3|Adverse Event|1
2678519|NCT00531050|9243867|P6|Part 1: Period 1|Protocol Deviation|0
2678520|NCT00531050|9243868|P5|Part 1: Period 1|Protocol Deviation|0
2678521|NCT00531050|9243869|P4|Part 1: Period 1|Protocol Deviation|1
2678522|NCT00531050|9243870|P3|Part 1: Period 1|Protocol Deviation|0
2678523|NCT00531050|9243871|P2|Part 1: Period 1|Protocol Deviation|0
2678524|NCT00531050|9243872|P1|Part 1: Period 1|Protocol Deviation|0
2678525|NCT00531050|9243867|P6|Part 1: Period 1|Adverse Event|0
2678526|NCT00531050|9243868|P5|Part 1: Period 1|Adverse Event|0
2678527|NCT00531050|9243869|P4|Part 1: Period 1|Adverse Event|0
2678528|NCT00531050|9243870|P3|Part 1: Period 1|Adverse Event|0
2678529|NCT00531050|9243871|P2|Part 1: Period 1|Adverse Event|1
2678530|NCT00531050|9243872|P1|Part 1: Period 1|Adverse Event|0
2678531|NCT00531011|9243901|P2|Overall Study|Physician Decision|3
2678532|NCT00531011|9243902|P1|Overall Study|Physician Decision|0
2678533|NCT00531011|9243901|P2|Overall Study|Lost to Follow-up|0
2678534|NCT00531011|9243902|P1|Overall Study|Lost to Follow-up|1
2678535|NCT00531011|9243901|P2|Overall Study|Death|0
2678536|NCT00531011|9243902|P1|Overall Study|Death|1
2678537|NCT00531011|9243901|P2|Overall Study|Withdrawal by Subject|4
2678538|NCT00531011|9243902|P1|Overall Study|Withdrawal by Subject|2
2678539|NCT00530946|9243948|P4|Overall Study|Noncompliance|0
2678540|NCT00530946|9243949|P3|Overall Study|Noncompliance|0
2678541|NCT00530946|9243950|P2|Overall Study|Noncompliance|0
2678542|NCT00530946|9243951|P1|Overall Study|Noncompliance|1
2678543|NCT00530946|9243948|P4|Overall Study|Protocol Violation|1
2678544|NCT00530946|9243949|P3|Overall Study|Protocol Violation|0
2678545|NCT00530946|9243950|P2|Overall Study|Protocol Violation|0
2678546|NCT00530946|9243951|P1|Overall Study|Protocol Violation|0
2678547|NCT00530946|9243948|P4|Overall Study|Adverse Event|1
2678548|NCT00530946|9243949|P3|Overall Study|Adverse Event|1
2678549|NCT00530946|9243950|P2|Overall Study|Adverse Event|2
2678550|NCT00530946|9243951|P1|Overall Study|Adverse Event|1
2678551|NCT00530920|9244004|P3|Overall Study|Withdrawal by Subject|1
2678552|NCT00530920|9244005|P2|Overall Study|Withdrawal by Subject|0
2678553|NCT00530920|9244006|P1|Overall Study|Withdrawal by Subject|0
2678554|NCT00530920|9244004|P3|Overall Study|Adverse Event|3
2678555|NCT00530920|9244005|P2|Overall Study|Adverse Event|0
2678556|NCT00530920|9244006|P1|Overall Study|Adverse Event|0
2678557|NCT00530920|9244004|P3|Overall Study|Randomized but not treated|0
2678558|NCT00530920|9244005|P2|Overall Study|Randomized but not treated|2
2678559|NCT00530920|9244006|P1|Overall Study|Randomized but not treated|0
2678560|NCT00530894|9244066|P4|Overall Study|Alive and censored prior to 1 year|0
2678561|NCT00530894|9244067|P3|Overall Study|Alive and censored prior to 1 year|0
2678562|NCT00530894|9244068|P2|Overall Study|Alive and censored prior to 1 year|0
2678563|NCT00530894|9244069|P1|Overall Study|Alive and censored prior to 1 year|2
2678564|NCT00530894|9244066|P4|Overall Study|Withdrawal by Subject|5
2678565|NCT00530894|9244067|P3|Overall Study|Withdrawal by Subject|0
2678566|NCT00530894|9244068|P2|Overall Study|Withdrawal by Subject|23
2678567|NCT00530894|9244069|P1|Overall Study|Withdrawal by Subject|1
2678568|NCT00530894|9244066|P4|Overall Study|Lost to Follow-up|0
2678569|NCT00530894|9244067|P3|Overall Study|Lost to Follow-up|0
2678570|NCT00530894|9244068|P2|Overall Study|Lost to Follow-up|3
2678571|NCT00530894|9244069|P1|Overall Study|Lost to Follow-up|1
2678572|NCT00530894|9244066|P4|Overall Study|Death|89
2678573|NCT00530894|9244067|P3|Overall Study|Death|55
2678574|NCT00530894|9244068|P2|Overall Study|Death|89
2678575|NCT00530894|9244069|P1|Overall Study|Death|84
2678576|NCT00530855|9244097|P1|Overall Study|Other reason for premature termination|17
2678577|NCT00530855|9244097|P1|Overall Study|Lost to Follow-up|9
2678578|NCT00530855|9244097|P1|Overall Study|Unsatisfactory compliance of subject|11
2678579|NCT00530855|9244097|P1|Overall Study|Protocol Violation|3
2678580|NCT00530855|9244097|P1|Overall Study|Non Fatal Non Serious AE|12
2678581|NCT00530855|9244097|P1|Overall Study|Non Fatal Serious AE|7
2678582|NCT00530855|9244097|P1|Overall Study|Fatal Serious AE|3
2678583|NCT00530855|9244097|P1|Overall Study|Withdrawal by Subject|30
2678584|NCT00530855|9244097|P1|Overall Study|Lack of Efficacy|20
2678585|NCT00530842|9244106|P2|Period 2|Individual different reasons|0
2678586|NCT00530842|9244107|P1|Period 2|Individual different reasons|2
2678587|NCT00530842|9244106|P2|Period 2|Withdrawal by Subject|2
2678588|NCT00530842|9244107|P1|Period 2|Withdrawal by Subject|1
2678589|NCT00530842|9244106|P2|Period 2|Protocol Violation|0
2678590|NCT00530842|9244107|P1|Period 2|Protocol Violation|1
2678591|NCT00530842|9244106|P2|Period 2|Lost to Follow-up|4
2678592|NCT00530842|9244107|P1|Period 2|Lost to Follow-up|0
2678593|NCT00530842|9244106|P2|Period 2|Lack of Efficacy|0
2678594|NCT00530842|9244107|P1|Period 2|Lack of Efficacy|1
2678595|NCT00530842|9244106|P2|Period 2|Adverse Event|3
2678596|NCT00530842|9244107|P1|Period 2|Adverse Event|3
2678597|NCT00530842|9244106|P2|Period 1|Individual different reasons|3
2678598|NCT00530842|9244107|P1|Period 1|Individual different reasons|2
2678599|NCT00530842|9244106|P2|Period 1|Withdrawal by Subject|3
2678600|NCT00530842|9244107|P1|Period 1|Withdrawal by Subject|2
2678601|NCT00530842|9244106|P2|Period 1|Protocol Violation|1
2678602|NCT00530842|9244107|P1|Period 1|Protocol Violation|2
2678603|NCT00530842|9244106|P2|Period 1|Lack of Efficacy|1
2678604|NCT00530842|9244107|P1|Period 1|Lack of Efficacy|1
2678605|NCT00530842|9244106|P2|Period 1|Adverse Event|3
2678606|NCT00530842|9244107|P1|Period 1|Adverse Event|7
2678607|NCT00530842|9244106|P2|Overall Study|Individual different reasons|3
2678608|NCT00530842|9244107|P1|Overall Study|Individual different reasons|4
2678609|NCT00530842|9244106|P2|Overall Study|Withdrawal by Subject|5
2678610|NCT00530842|9244107|P1|Overall Study|Withdrawal by Subject|4
2678611|NCT00530842|9244106|P2|Overall Study|Protocol Violation|2
2678612|NCT00530842|9244107|P1|Overall Study|Protocol Violation|3
2678613|NCT00530842|9244106|P2|Overall Study|Lost to Follow-up|4
2678614|NCT00530842|9244107|P1|Overall Study|Lost to Follow-up|0
2678615|NCT00530842|9244106|P2|Overall Study|Lack of Efficacy|1
2678616|NCT00530842|9244107|P1|Overall Study|Lack of Efficacy|2
2678617|NCT00530842|9244106|P2|Overall Study|Adverse Event|6
2678618|NCT00530842|9244107|P1|Overall Study|Adverse Event|10
2678619|NCT00530816|9244234|P3|Overall Study|Withdrawal by Subject|6
2678620|NCT00530816|9244235|P2|Overall Study|Withdrawal by Subject|2
2678621|NCT00530816|9244236|P1|Overall Study|Withdrawal by Subject|1
2678622|NCT00530816|9244234|P3|Overall Study|Other|4
2678623|NCT00530816|9244235|P2|Overall Study|Other|3
2678624|NCT00530816|9244236|P1|Overall Study|Other|3
2678625|NCT00530816|9244234|P3|Overall Study|Adverse Event|7
2678626|NCT00530816|9244235|P2|Overall Study|Adverse Event|13
2678627|NCT00530816|9244236|P1|Overall Study|Adverse Event|6
2678628|NCT00530816|9244234|P3|Overall Study|Progressive Disease|24
2678629|NCT00530816|9244235|P2|Overall Study|Progressive Disease|24
2678630|NCT00530816|9244236|P1|Overall Study|Progressive Disease|16
2678631|NCT00530790|9244279|P1|Overall Study|Physician Decision|1
2678632|NCT00530790|9244279|P1|Overall Study|Withdrawal by Subject|2
2678633|NCT00530790|9244279|P1|Overall Study|Adverse Event|2
2678634|NCT00530777|9244301|P2|Overall Study|Unable to adhere to visit schedule|1
2678635|NCT00530777|9244302|P1|Overall Study|Unable to adhere to visit schedule|5
2678636|NCT00530777|9244301|P2|Overall Study|Withdrawal by Subject|1
2678637|NCT00530777|9244302|P1|Overall Study|Withdrawal by Subject|0
2678638|NCT00530777|9244301|P2|Overall Study|Physician Decision|0
2678639|NCT00530777|9244302|P1|Overall Study|Physician Decision|1
2678640|NCT00530777|9244301|P2|Overall Study|Death|2
2678641|NCT00530777|9244302|P1|Overall Study|Death|1
2678642|NCT00530777|9244301|P2|Overall Study|Lost to Follow-up|1
2678643|NCT00530777|9244302|P1|Overall Study|Lost to Follow-up|0
2678644|NCT00530712|9244359|P1|12 Month Follow-up Visit|Death|9
2678645|NCT00530712|9244359|P1|12 Month Follow-up Visit|Lost to Follow-up|7
2678646|NCT00530712|9244359|P1|12 Month Follow-up Visit|Missed Visit|3
2678647|NCT00530712|9244359|P1|12 Month Follow-up Visit|Withdrawal by Subject|5
2678648|NCT00530712|9244359|P1|6 Month Follow-up Visit|Death|2
2678649|NCT00530712|9244359|P1|6 Month Follow-up Visit|Lost to Follow-up|3
2678650|NCT00530712|9244359|P1|6 Month Follow-up Visit|Missed Visit|3
2678651|NCT00530712|9244359|P1|6 Month Follow-up Visit|Withdrawal by Subject|4
2678652|NCT00530712|9244359|P1|30 Day Follow-up Visit|Missed Visit|5
2678653|NCT00530712|9244359|P1|30 Day Follow-up Visit|Withdrawal by Subject|2
2678654|NCT00530504|9244380|P1|Overall Study|Exited study due to other reasons|33
2678655|NCT00530504|9244380|P1|Overall Study|Withdrawal by Subject|39
2678656|NCT00530504|9244380|P1|Overall Study|Lost to Follow-up|26
2678657|NCT00530504|9244380|P1|Overall Study|Death|54
2678658|NCT00530439|9244386|P2|Overall Study|Severe malformation/abortion|3
2678659|NCT00530439|9244387|P1|Overall Study|Severe malformation/abortion|0
2678660|NCT00530439|9244386|P2|Overall Study|Twin pregnancy|2
2678661|NCT00530439|9244387|P1|Overall Study|Twin pregnancy|0
2678662|NCT00530439|9244386|P2|Overall Study|Misclassification|0
2678663|NCT00530439|9244387|P1|Overall Study|Misclassification|2
2678664|NCT00530439|9244386|P2|Overall Study|Missed abortion|4
2678665|NCT00530439|9244387|P1|Overall Study|Missed abortion|1
2678666|NCT00530439|9244386|P2|Overall Study|Withdraw|14
2678667|NCT00530439|9244387|P1|Overall Study|Withdraw|18
2678668|NCT00530439|9244386|P2|Overall Study|GDM|3
2678669|NCT00530439|9244387|P1|Overall Study|GDM|9
2678670|NCT00530348|9244395|P2|Overall Study|Noncompliance with inclusion criterion 3|1
2678671|NCT00530348|9244396|P1|Overall Study|Noncompliance with inclusion criterion 3|0
2678672|NCT00530348|9244395|P2|Overall Study|Randomised in error|0
2678673|NCT00530348|9244396|P1|Overall Study|Randomised in error|1
2678674|NCT00530348|9244395|P2|Overall Study|Withdrawal by Subject|12
2678675|NCT00530348|9244396|P1|Overall Study|Withdrawal by Subject|12
2678676|NCT00530348|9244395|P2|Overall Study|Pregnancy|0
2678677|NCT00530348|9244396|P1|Overall Study|Pregnancy|1
2678678|NCT00530348|9244395|P2|Overall Study|Physician Decision|2
2678679|NCT00530348|9244396|P1|Overall Study|Physician Decision|1
2678680|NCT00530348|9244395|P2|Overall Study|Lost to Follow-up|2
2678681|NCT00530348|9244396|P1|Overall Study|Lost to Follow-up|0
2678682|NCT00530348|9244395|P2|Overall Study|Lack of Efficacy|0
2678683|NCT00530348|9244396|P1|Overall Study|Lack of Efficacy|2
2678684|NCT00530348|9244395|P2|Overall Study|Death|1
2678685|NCT00530348|9244396|P1|Overall Study|Death|0
2678686|NCT00530348|9244395|P2|Overall Study|Adverse Event|1
2678687|NCT00530348|9244396|P1|Overall Study|Adverse Event|5
2678688|NCT00530335|9244412|P1|Overall Study|Physician Decision|1
2678689|NCT00530335|9244412|P1|Overall Study|Withdrawal by Subject|1
2678690|NCT00530335|9244412|P1|Overall Study|Protocol Violation|1
2678691|NCT00530335|9244412|P1|Overall Study|Adverse Event|3
2678692|NCT00530270|9244429|P2|Overall Study|Protocol Violation|0
2678693|NCT00530270|9244430|P1|Overall Study|Protocol Violation|1
2678694|NCT00530257|9244444|P1|Overall Study|Lost to Follow-up|1
2678695|NCT00530218|9244472|P1|Overall Study|Death|12
2678696|NCT00530218|9244472|P1|Overall Study|CMV Not Detected|13
2678697|NCT00530088|9244479|P1|Overall Study|Other Not Specified|2
2678698|NCT00530088|9244479|P1|Overall Study|Physician Decision|4
2678699|NCT00530088|9244479|P1|Overall Study|Disease Progression|4
2678700|NCT00530075|9244484|P1|Overall Study|Withdrawal by Subject|1
2678701|NCT00530075|9244484|P1|Overall Study|Protocol Violation|1
2678702|NCT00530075|9244484|P1|Overall Study|Lack of Efficacy|3
2678703|NCT00530075|9244484|P1|Overall Study|Death|1
2678704|NCT00530075|9244484|P1|Overall Study|Adverse Event|1
2678705|NCT00530023|9244497|P2|Overall Study|Withdrawal by Subject|1
2678706|NCT00530023|9244498|P1|Overall Study|Withdrawal by Subject|0
2678707|NCT00529958|9244515|P3|5-Year Follow-up|Withdrawal by Subject|0
2678708|NCT00529958|9244516|P2|5-Year Follow-up|Withdrawal by Subject|0
2678709|NCT00529958|9244517|P1|5-Year Follow-up|Withdrawal by Subject|1
2678710|NCT00529958|9244515|P3|5-Year Follow-up|Lost to Follow-up|1
2678711|NCT00529958|9244516|P2|5-Year Follow-up|Lost to Follow-up|3
2678712|NCT00529958|9244517|P1|5-Year Follow-up|Lost to Follow-up|2
2678713|NCT00529958|9244515|P3|2-Year Follow-up|Withdrawal by Subject|0
2678714|NCT00529958|9244516|P2|2-Year Follow-up|Withdrawal by Subject|0
2678715|NCT00529958|9244517|P1|2-Year Follow-up|Withdrawal by Subject|3
2678716|NCT00529958|9244515|P3|2-Year Follow-up|Lost to Follow-up|2
2678717|NCT00529958|9244516|P2|2-Year Follow-up|Lost to Follow-up|2
2678718|NCT00529958|9244517|P1|2-Year Follow-up|Lost to Follow-up|1
2678719|NCT00529802|9244558|P1|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2
2678720|NCT00529802|9244558|P1|Evaluable for Primary Endpoint|Lost to Follow-up|1
2678721|NCT00529802|9244558|P1|Evaluable for Primary Endpoint|Lack of Efficacy|1
2678722|NCT00529802|9244558|P1|Evaluable for Primary Endpoint|Death|1
2678723|NCT00529802|9244558|P1|Evaluable for Primary Endpoint|Adverse Event|2
2678724|NCT00529802|9244558|P1|Evaluable for Primary Endpoint|Worsening performance status|2
2678725|NCT00529802|9244558|P1|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3
2678726|NCT00529789|9244564|P1|Study Period IV|Lost to Follow-up|3
2678727|NCT00529789|9244564|P1|Study Period IV|Lack of Efficacy|1
2678728|NCT00529789|9244564|P1|Study Period IV|Adverse Event|1
2678729|NCT00529789|9244564|P1|Study Period IV|Parent/Caregiver Decision|1
2678730|NCT00529789|9244564|P1|Study Period II/III|Lost to Follow-up|3
2678731|NCT00529789|9244564|P1|Study Period II/III|Physician Decision|3
2678732|NCT00529789|9244564|P1|Study Period II/III|Protocol Violation|3
2678733|NCT00529789|9244564|P1|Study Period II/III|Withdrawal by Subject|1
2678734|NCT00529789|9244564|P1|Study Period II/III|Lack of Efficacy|2
2678735|NCT00529789|9244564|P1|Study Period II/III|Adverse Event|3
2678736|NCT00529789|9244564|P1|Study Period II/III|Parent/Caregiver Decision|9
2678737|NCT00529763|9244589|P3|Overall Study|Patient Withdrew Consent|2
2678738|NCT00529763|9244590|P2|Overall Study|Patient Withdrew Consent|3
2678739|NCT00529763|9244591|P1|Overall Study|Patient Withdrew Consent|2
2678740|NCT00529763|9244589|P3|Overall Study|Study Drug Toxicity|1
2678741|NCT00529763|9244590|P2|Overall Study|Study Drug Toxicity|6
2678742|NCT00529763|9244591|P1|Overall Study|Study Drug Toxicity|1
2678743|NCT00529763|9244589|P3|Overall Study|Stem Cell Transplant|0
2678744|NCT00529763|9244590|P2|Overall Study|Stem Cell Transplant|3
2678745|NCT00529763|9244591|P1|Overall Study|Stem Cell Transplant|0
2678746|NCT00529763|9244589|P3|Overall Study|Lost to Follow-up|1
2678747|NCT00529763|9244590|P2|Overall Study|Lost to Follow-up|1
2678748|NCT00529763|9244591|P1|Overall Study|Lost to Follow-up|0
2678749|NCT00529763|9244589|P3|Overall Study|Disease Progression|1
2678750|NCT00529763|9244590|P2|Overall Study|Disease Progression|16
2678751|NCT00529763|9244591|P1|Overall Study|Disease Progression|6
2678752|NCT00529763|9244589|P3|Overall Study|Death|1
2678753|NCT00529763|9244590|P2|Overall Study|Death|1
2678754|NCT00529763|9244591|P1|Overall Study|Death|0
2678755|NCT00529763|9244589|P3|Overall Study|Adverse Event Unrelated to Study Drug|1
2678756|NCT00529763|9244590|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
2678757|NCT00529763|9244591|P1|Overall Study|Adverse Event Unrelated to Study Drug|1
2678758|NCT00529659|9244629|P2|Overall Study|Withdrawal by Subject|6
2678759|NCT00529659|9244630|P1|Overall Study|Withdrawal by Subject|1
2678760|NCT00529659|9244629|P2|Overall Study|Protocol Violation|6
2678761|NCT00529659|9244630|P1|Overall Study|Protocol Violation|2
2678762|NCT00529659|9244629|P2|Overall Study|Physician Decision|2
2678763|NCT00529659|9244630|P1|Overall Study|Physician Decision|0
2678764|NCT00529659|9244629|P2|Overall Study|Lost to Follow-up|2
2678765|NCT00529659|9244630|P1|Overall Study|Lost to Follow-up|0
2678766|NCT00529659|9244629|P2|Overall Study|Adverse Event|7
2678767|NCT00529659|9244630|P1|Overall Study|Adverse Event|8
2678768|NCT00529633|9244648|P2|Overall Study|Withdrawal by Subject|1
2678769|NCT00529633|9244649|P1|Overall Study|Withdrawal by Subject|1
2678770|NCT00529568|9244661|P3|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19
2678771|NCT00529568|9244662|P2|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17
2678772|NCT00529568|9244663|P1|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0
2678773|NCT00529568|9244661|P3|Double-bilnd Antiviral Treatment Phase|Physician Decision|8
2678774|NCT00529568|9244662|P2|Double-bilnd Antiviral Treatment Phase|Physician Decision|5
2678775|NCT00529568|9244663|P1|Double-bilnd Antiviral Treatment Phase|Physician Decision|0
2678776|NCT00529568|9244661|P3|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48
2678777|NCT00529568|9244662|P2|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15
2678778|NCT00529568|9244663|P1|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0
2678779|NCT00529568|9244661|P3|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
2678780|NCT00529568|9244662|P2|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1
2678781|NCT00529568|9244663|P1|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
2678782|NCT00529568|9244661|P3|Double-bilnd Antiviral Treatment Phase|Adverse Event|27
2678783|NCT00529568|9244662|P2|Double-bilnd Antiviral Treatment Phase|Adverse Event|10
2678784|NCT00529568|9244663|P1|Double-bilnd Antiviral Treatment Phase|Adverse Event|0
2678785|NCT00529568|9244661|P3|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
2678786|NCT00529568|9244662|P2|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
2678787|NCT00529568|9244663|P1|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3
2678788|NCT00529568|9244661|P3|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
2678789|NCT00529568|9244662|P2|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
2678790|NCT00529568|9244663|P1|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13
2678791|NCT00529568|9244661|P3|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
2678792|NCT00529568|9244662|P2|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
2678793|NCT00529568|9244663|P1|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8
2678794|NCT00529568|9244661|P3|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
2678795|NCT00529568|9244662|P2|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
2678796|NCT00529568|9244663|P1|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5
2678797|NCT00529568|9244661|P3|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
2678798|NCT00529568|9244662|P2|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
2678799|NCT00529568|9244663|P1|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12
2678800|NCT00529568|9244661|P3|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
2678801|NCT00529568|9244662|P2|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
2678802|NCT00529568|9244663|P1|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5
2678803|NCT00529542|9244726|P2|Overall Study|Lost to Follow-up|1
2678804|NCT00529542|9244727|P1|Overall Study|Lost to Follow-up|0
2678805|NCT00529542|9244726|P2|Overall Study|Withdrawal by Subject|0
2678806|NCT00529542|9244727|P1|Overall Study|Withdrawal by Subject|1
2678807|NCT00529529|9244770|P3|Overall Study|Administrative problems|3
2678808|NCT00529529|9244771|P2|Overall Study|Administrative problems|0
2678809|NCT00529529|9244772|P1|Overall Study|Administrative problems|1
2678810|NCT00529529|9244770|P3|Overall Study|Abnormal test procedure result(s)|0
2678811|NCT00529529|9244771|P2|Overall Study|Abnormal test procedure result(s)|0
2678812|NCT00529529|9244772|P1|Overall Study|Abnormal test procedure result(s)|1
2678813|NCT00529529|9244770|P3|Overall Study|Death|0
2678814|NCT00529529|9244771|P2|Overall Study|Death|0
2678815|NCT00529529|9244772|P1|Overall Study|Death|2
2678816|NCT00529529|9244770|P3|Overall Study|Unsatisfactory therapeutic effect|2
2678817|NCT00529529|9244771|P2|Overall Study|Unsatisfactory therapeutic effect|2
2678818|NCT00529529|9244772|P1|Overall Study|Unsatisfactory therapeutic effect|2
2678819|NCT00529529|9244770|P3|Overall Study|Lost to Follow-up|1
2678820|NCT00529529|9244771|P2|Overall Study|Lost to Follow-up|3
2678821|NCT00529529|9244772|P1|Overall Study|Lost to Follow-up|5
2678822|NCT00529529|9244770|P3|Overall Study|Protocol deviation|5
2678823|NCT00529529|9244771|P2|Overall Study|Protocol deviation|12
2678824|NCT00529529|9244772|P1|Overall Study|Protocol deviation|8
2678825|NCT00529529|9244770|P3|Overall Study|Subject withdrew consent|12
2678826|NCT00529529|9244771|P2|Overall Study|Subject withdrew consent|9
2678827|NCT00529529|9244772|P1|Overall Study|Subject withdrew consent|12
2678828|NCT00529529|9244770|P3|Overall Study|Adverse Event|8
2678829|NCT00529529|9244771|P2|Overall Study|Adverse Event|17
2678830|NCT00529529|9244772|P1|Overall Study|Adverse Event|12
2678831|NCT00529516|9244831|P3|Overall Study|Lost to Follow-up|1
2678832|NCT00529516|9244832|P2|Overall Study|Lost to Follow-up|0
2678833|NCT00529516|9244833|P1|Overall Study|Lost to Follow-up|0
2678834|NCT00529516|9244831|P3|Overall Study|Withdrawal by Subject|0
2678835|NCT00529516|9244832|P2|Overall Study|Withdrawal by Subject|1
2678836|NCT00529516|9244833|P1|Overall Study|Withdrawal by Subject|1
2678837|NCT00529516|9244831|P3|Overall Study|Adverse Event|0
2678838|NCT00529516|9244832|P2|Overall Study|Adverse Event|1
2678839|NCT00529516|9244833|P1|Overall Study|Adverse Event|2
2678840|NCT00529451|9244918|P4|Overall Study|Administrative problems|2
2678841|NCT00529451|9244919|P3|Overall Study|Administrative problems|0
2678842|NCT00529451|9244920|P2|Overall Study|Administrative problems|1
2678843|NCT00529451|9244921|P1|Overall Study|Administrative problems|1
2678844|NCT00529451|9244918|P4|Overall Study|Protocol deviation|1
2678845|NCT00529451|9244919|P3|Overall Study|Protocol deviation|4
2678846|NCT00529451|9244920|P2|Overall Study|Protocol deviation|1
2678847|NCT00529451|9244921|P1|Overall Study|Protocol deviation|1
2678848|NCT00529451|9244918|P4|Overall Study|Lost to Follow-up|4
2678849|NCT00529451|9244919|P3|Overall Study|Lost to Follow-up|4
2678850|NCT00529451|9244920|P2|Overall Study|Lost to Follow-up|7
2678851|NCT00529451|9244921|P1|Overall Study|Lost to Follow-up|4
2678852|NCT00529451|9244918|P4|Overall Study|Unsatisfactory therapeutic response|4
2678853|NCT00529451|9244919|P3|Overall Study|Unsatisfactory therapeutic response|5
2678854|NCT00529451|9244920|P2|Overall Study|Unsatisfactory therapeutic response|2
2678855|NCT00529451|9244921|P1|Overall Study|Unsatisfactory therapeutic response|6
2678856|NCT00529451|9244918|P4|Overall Study|Adverse Event|8
2678857|NCT00529451|9244919|P3|Overall Study|Adverse Event|14
2678858|NCT00529451|9244920|P2|Overall Study|Adverse Event|16
2678859|NCT00529451|9244921|P1|Overall Study|Adverse Event|9
2678860|NCT00529451|9244918|P4|Overall Study|Subject withdrew consent|12
2678861|NCT00529451|9244919|P3|Overall Study|Subject withdrew consent|13
2678862|NCT00529451|9244920|P2|Overall Study|Subject withdrew consent|21
2678863|NCT00529451|9244921|P1|Overall Study|Subject withdrew consent|16
2678864|NCT00529399|9244948|P3|Overall Study|Non-compliant|0
2678865|NCT00529399|9244949|P2|Overall Study|Non-compliant|1
2678866|NCT00529399|9244950|P1|Overall Study|Non-compliant|0
2678867|NCT00529399|9244948|P3|Overall Study|Withdrawal by Subject|1
2678868|NCT00529399|9244949|P2|Overall Study|Withdrawal by Subject|0
2678869|NCT00529399|9244950|P1|Overall Study|Withdrawal by Subject|1
2678870|NCT00529399|9244948|P3|Overall Study|Lost to Follow-up|1
2678871|NCT00529399|9244949|P2|Overall Study|Lost to Follow-up|0
2678872|NCT00529399|9244950|P1|Overall Study|Lost to Follow-up|1
2678873|NCT00529386|9244958|P1|Overall Study|Lost to Follow-up|1
2678874|NCT00529373|9244964|P2|Second Extension Study|Status Missing|5
2678875|NCT00529373|9244965|P1|Second Extension Study|Status Missing|5
2678876|NCT00529373|9244964|P2|Second Extension Study|Withdrawal by Subject|75
2678877|NCT00529373|9244965|P1|Second Extension Study|Withdrawal by Subject|97
2678878|NCT00529373|9244964|P2|Second Extension Study|Protocol Violation|1
2678879|NCT00529373|9244965|P1|Second Extension Study|Protocol Violation|2
2678880|NCT00529373|9244964|P2|Second Extension Study|Physician Decision|26
2678881|NCT00529373|9244965|P1|Second Extension Study|Physician Decision|63
2678882|NCT00529373|9244964|P2|Second Extension Study|Other|12
2678883|NCT00529373|9244965|P1|Second Extension Study|Other|7
2678884|NCT00529373|9244964|P2|Second Extension Study|Lost to Follow-up|12
2678885|NCT00529373|9244965|P1|Second Extension Study|Lost to Follow-up|18
2678886|NCT00529373|9244964|P2|Second Extension Study|Lack of Efficacy|15
2678887|NCT00529373|9244965|P1|Second Extension Study|Lack of Efficacy|7
2678888|NCT00529373|9244964|P2|Second Extension Study|Adverse Event|51
2678889|NCT00529373|9244965|P1|Second Extension Study|Adverse Event|101
2678890|NCT00529373|9244964|P2|First Extension Study|Did not cont. into 2nd Ext (unknown)|25
2678891|NCT00529373|9244965|P1|First Extension Study|Did not cont. into 2nd Ext (unknown)|32
2678892|NCT00529373|9244964|P2|First Extension Study|Did not cont. into 2nd Ext (verified)|281
2678893|NCT00529373|9244965|P1|First Extension Study|Did not cont. into 2nd Ext (verified)|256
2678894|NCT00529373|9244964|P2|First Extension Study|Discontinued after 5 years completion|346
2678895|NCT00529373|9244965|P1|First Extension Study|Discontinued after 5 years completion|208
2678896|NCT00529373|9244964|P2|First Extension Study|Disposition record non-existing|1
2678897|NCT00529373|9244965|P1|First Extension Study|Disposition record non-existing|0
2678898|NCT00529373|9244964|P2|First Extension Study|Withdrawal by Subject|287
2678899|NCT00529373|9244965|P1|First Extension Study|Withdrawal by Subject|296
2678900|NCT00529373|9244964|P2|First Extension Study|Protocol Violation|13
2678901|NCT00529373|9244965|P1|First Extension Study|Protocol Violation|16
2678902|NCT00529373|9244964|P2|First Extension Study|Physician Decision|45
2678903|NCT00529373|9244965|P1|First Extension Study|Physician Decision|50
2678904|NCT00529373|9244964|P2|First Extension Study|Other|47
2678905|NCT00529373|9244965|P1|First Extension Study|Other|27
2678906|NCT00529373|9244964|P2|First Extension Study|Lost to Follow-up|37
2678907|NCT00529373|9244965|P1|First Extension Study|Lost to Follow-up|41
2678908|NCT00529373|9244964|P2|First Extension Study|Lack of Efficacy|427
2678909|NCT00529373|9244965|P1|First Extension Study|Lack of Efficacy|65
2678910|NCT00529373|9244964|P2|First Extension Study|Adverse Event|142
2678911|NCT00529373|9244965|P1|First Extension Study|Adverse Event|162
2678912|NCT00529373|9244964|P2|Base Study|Did not continue into Extension|2238
2678913|NCT00529373|9244965|P1|Base Study|Did not continue into Extension|1795
2678914|NCT00529373|9244964|P2|Base Study|Withdrawal by Subject|967
2678915|NCT00529373|9244965|P1|Base Study|Withdrawal by Subject|1062
2678916|NCT00529373|9244964|P2|Base Study|Protocol Violation|38
2678917|NCT00529373|9244965|P1|Base Study|Protocol Violation|48
2678918|NCT00529373|9244964|P2|Base Study|Physician Decision|52
2678919|NCT00529373|9244965|P1|Base Study|Physician Decision|60
2678920|NCT00529373|9244964|P2|Base Study|Other Protocol Specified Criteria|20
2678921|NCT00529373|9244965|P1|Base Study|Other Protocol Specified Criteria|19
2678922|NCT00529373|9244964|P2|Base Study|Lost to Follow-up|208
2678923|NCT00529373|9244965|P1|Base Study|Lost to Follow-up|221
2678924|NCT00529373|9244964|P2|Base Study|Lack of Efficacy|75
2678925|NCT00529373|9244965|P1|Base Study|Lack of Efficacy|16
2678926|NCT00529373|9244964|P2|Base Study|Adverse Event|470
2678927|NCT00529373|9244965|P1|Base Study|Adverse Event|525
2678928|NCT00529308|9245159|P2|Overall Study|Withdrawal by Subject|1
2678929|NCT00529308|9245160|P1|Overall Study|Withdrawal by Subject|1
2678930|NCT00529243|9245189|P1|Overall Study|Relocated|1
2678931|NCT00529243|9245189|P1|Overall Study|Death|1
2678932|NCT00529243|9245189|P1|Overall Study|Adverse Event|1
2678933|NCT00529217|9245194|P1|Overall Study|Unable to adhere to study schedule|2
2678934|NCT00529217|9245194|P1|Overall Study|Lack of Efficacy|2
2678935|NCT00529152|9245230|P1|Overall Study|Lost to Follow-up|1
2678936|NCT00529152|9245230|P1|Overall Study|Withdrawal by Subject|2
2678937|NCT00529152|9245230|P1|Overall Study|Adverse Event|2
2678938|NCT00529100|9245254|P2|Overall Study|Participant Ineligibility|1
2678939|NCT00529100|9245255|P1|Overall Study|Participant Ineligibility|0
2678940|NCT00529100|9245254|P2|Overall Study|Withdrawal by Subject|1
2678941|NCT00529100|9245255|P1|Overall Study|Withdrawal by Subject|0
2678942|NCT00529100|9245254|P2|Overall Study|Progressive Disease|1
2678943|NCT00529100|9245255|P1|Overall Study|Progressive Disease|0
2678944|NCT00529100|9245254|P2|Overall Study|Protocol Violation|1
2678945|NCT00529100|9245255|P1|Overall Study|Protocol Violation|0
2678946|NCT00529100|9245254|P2|Overall Study|Adverse Event|5
2678947|NCT00529100|9245255|P1|Overall Study|Adverse Event|0
2678948|NCT00529087|9245272|P3|Overall Study|Protocol deviation|2
2678949|NCT00529087|9245273|P2|Overall Study|Protocol deviation|1
2678950|NCT00529087|9245274|P1|Overall Study|Protocol deviation|1
2678951|NCT00529087|9245272|P3|Overall Study|Withdrawal by Subject|3
2678952|NCT00529087|9245273|P2|Overall Study|Withdrawal by Subject|3
2678953|NCT00529087|9245274|P1|Overall Study|Withdrawal by Subject|3
2678954|NCT00529087|9245272|P3|Overall Study|Protocol Violation|6
2678955|NCT00529087|9245273|P2|Overall Study|Protocol Violation|7
2678956|NCT00529087|9245274|P1|Overall Study|Protocol Violation|8
2678957|NCT00529087|9245272|P3|Overall Study|Lost to Follow-up|1
2678958|NCT00529087|9245273|P2|Overall Study|Lost to Follow-up|4
2678959|NCT00529087|9245274|P1|Overall Study|Lost to Follow-up|6
2678960|NCT00529087|9245272|P3|Overall Study|Adverse Event|4
2678961|NCT00529087|9245273|P2|Overall Study|Adverse Event|13
2678962|NCT00529087|9245274|P1|Overall Study|Adverse Event|10
2678963|NCT00529035|9245338|P1|Overall Study|Withdrawal by Subject|1
2678964|NCT00528970|9245352|P3|Overall Study|Randomized but not treated|1
2678965|NCT00528970|9245353|P2|Overall Study|Randomized but not treated|0
2678966|NCT00528970|9245354|P1|Overall Study|Randomized but not treated|0
2678967|NCT00528970|9245352|P3|Overall Study|Withdrawal by Subject|5
2678968|NCT00528970|9245353|P2|Overall Study|Withdrawal by Subject|3
2678969|NCT00528970|9245354|P1|Overall Study|Withdrawal by Subject|4
2678970|NCT00528970|9245352|P3|Overall Study|Lack of Efficacy|1
2678971|NCT00528970|9245353|P2|Overall Study|Lack of Efficacy|0
2678972|NCT00528970|9245354|P1|Overall Study|Lack of Efficacy|0
2678973|NCT00528970|9245352|P3|Overall Study|Protocol Violation|4
2678974|NCT00528970|9245353|P2|Overall Study|Protocol Violation|1
2678975|NCT00528970|9245354|P1|Overall Study|Protocol Violation|2
2678976|NCT00528970|9245352|P3|Overall Study|Other than specified|3
2678977|NCT00528970|9245353|P2|Overall Study|Other than specified|3
2678978|NCT00528970|9245354|P1|Overall Study|Other than specified|2
2678979|NCT00528970|9245352|P3|Overall Study|Lost to Follow-up|1
2678980|NCT00528970|9245353|P2|Overall Study|Lost to Follow-up|0
2678981|NCT00528970|9245354|P1|Overall Study|Lost to Follow-up|0
2678982|NCT00528970|9245352|P3|Overall Study|Adverse Event|5
2678983|NCT00528970|9245353|P2|Overall Study|Adverse Event|8
2678984|NCT00528970|9245354|P1|Overall Study|Adverse Event|6
2678985|NCT00528957|9245373|P2|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
2678986|NCT00528957|9245374|P1|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
2678987|NCT00528957|9245373|P2|Long-Term Extension (Week 336 and On)|Withdrew Consent|1
2678988|NCT00528957|9245374|P1|Long-Term Extension (Week 336 and On)|Withdrew Consent|2
2678989|NCT00528957|9245373|P2|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5
2678990|NCT00528957|9245374|P1|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3
2678991|NCT00528957|9245373|P2|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10
2678992|NCT00528957|9245374|P1|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4
2678993|NCT00528957|9245373|P2|Third Extension (Week 240 to Week 336)|Withdrew Consent|1
2678994|NCT00528957|9245374|P1|Third Extension (Week 240 to Week 336)|Withdrew Consent|0
2678995|NCT00528957|9245373|P2|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1
2678996|NCT00528957|9245374|P1|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0
2678997|NCT00528957|9245373|P2|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
2678998|NCT00528957|9245374|P1|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
2678999|NCT00528957|9245373|P2|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3
2679000|NCT00528957|9245374|P1|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0
2679001|NCT00528957|9245373|P2|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4
2679002|NCT00528957|9245374|P1|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5
2679003|NCT00528957|9245373|P2|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0
2679004|NCT00528957|9245374|P1|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3
2679005|NCT00528957|9245373|P2|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3
2679006|NCT00528957|9245374|P1|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4
2679007|NCT00528957|9245373|P2|First Extension (Week 48 to Week 144)|Withdrew Consent|1
2679008|NCT00528957|9245374|P1|First Extension (Week 48 to Week 144)|Withdrew Consent|0
2679009|NCT00528957|9245373|P2|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0
2679010|NCT00528957|9245374|P1|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1
2679011|NCT00528957|9245373|P2|First Extension (Week 48 to Week 144)|Investigator's Discretion|0
2679012|NCT00528957|9245374|P1|First Extension (Week 48 to Week 144)|Investigator's Discretion|2
2679013|NCT00528957|9245373|P2|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0
2679014|NCT00528957|9245374|P1|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2
2679015|NCT00528957|9245373|P2|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1
2679016|NCT00528957|9245374|P1|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2
2679017|NCT00528931|9245515|P1|Overall Study|Lost to Follow-up|1
2679018|NCT00528879|9245527|P4|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0
2679019|NCT00528879|9245528|P3|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
2679020|NCT00528879|9245529|P2|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
2679021|NCT00528879|9245530|P1|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
2679022|NCT00528879|9245527|P4|Long-term Period (Weeks 24 to 102)|Pregnancy|0
2679023|NCT00528879|9245528|P3|Long-term Period (Weeks 24 to 102)|Pregnancy|0
2679024|NCT00528879|9245529|P2|Long-term Period (Weeks 24 to 102)|Pregnancy|0
2679025|NCT00528879|9245530|P1|Long-term Period (Weeks 24 to 102)|Pregnancy|1
2679026|NCT00528879|9245527|P4|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2
2679027|NCT00528879|9245528|P3|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1
2679028|NCT00528879|9245529|P2|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5
2679029|NCT00528879|9245530|P1|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0
2679030|NCT00528879|9245527|P4|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7
2679031|NCT00528879|9245528|P3|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3
2679032|NCT00528879|9245529|P2|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5
2679033|NCT00528879|9245530|P1|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4
2679034|NCT00528879|9245527|P4|Long-term Period (Weeks 24 to 102)|Death|0
2679035|NCT00528879|9245528|P3|Long-term Period (Weeks 24 to 102)|Death|0
2679036|NCT00528879|9245529|P2|Long-term Period (Weeks 24 to 102)|Death|1
2679037|NCT00528879|9245530|P1|Long-term Period (Weeks 24 to 102)|Death|0
2679038|NCT00528879|9245527|P4|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
2679039|NCT00528879|9245528|P3|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8
2679040|NCT00528879|9245529|P2|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6
2679041|NCT00528879|9245530|P1|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
2679042|NCT00528879|9245527|P4|Long-term Period (Weeks 24 to 102)|Adverse Event|2
2679043|NCT00528879|9245528|P3|Long-term Period (Weeks 24 to 102)|Adverse Event|3
2679044|NCT00528879|9245529|P2|Long-term Period (Weeks 24 to 102)|Adverse Event|4
2679045|NCT00528879|9245530|P1|Long-term Period (Weeks 24 to 102)|Adverse Event|5
2679046|NCT00528879|9245527|P4|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9
2679047|NCT00528879|9245528|P3|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17
2679048|NCT00528879|9245529|P2|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16
2679049|NCT00528879|9245530|P1|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27
2679050|NCT00528879|9245527|P4|Short-term Period (Day 1 to Week 24)|Other|1
2679051|NCT00528879|9245528|P3|Short-term Period (Day 1 to Week 24)|Other|1
2679052|NCT00528879|9245529|P2|Short-term Period (Day 1 to Week 24)|Other|0
2679053|NCT00528879|9245530|P1|Short-term Period (Day 1 to Week 24)|Other|0
2679054|NCT00528879|9245527|P4|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
2679055|NCT00528879|9245528|P3|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0
2679056|NCT00528879|9245529|P2|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
2679057|NCT00528879|9245530|P1|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
2679058|NCT00528879|9245527|P4|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
2679059|NCT00528879|9245528|P3|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
2679060|NCT00528879|9245529|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3
2679061|NCT00528879|9245530|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
2679062|NCT00528879|9245527|P4|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
2679063|NCT00528879|9245528|P3|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2
2679064|NCT00528879|9245529|P2|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
2679065|NCT00528879|9245530|P1|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
2679066|NCT00528879|9245527|P4|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
2679067|NCT00528879|9245528|P3|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
2679068|NCT00528879|9245529|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
2679069|NCT00528879|9245530|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
2679070|NCT00528879|9245527|P4|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3
2679071|NCT00528879|9245528|P3|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
2679072|NCT00528879|9245529|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
2679073|NCT00528879|9245530|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7
2679074|NCT00528879|9245527|P4|Short-term Period (Day 1 to Week 24)|Adverse Event|4
2679075|NCT00528879|9245528|P3|Short-term Period (Day 1 to Week 24)|Adverse Event|2
2679076|NCT00528879|9245529|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|4
2679077|NCT00528879|9245530|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|4
2679078|NCT00528879|9245527|P4|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
2679079|NCT00528879|9245528|P3|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1
2679080|NCT00528879|9245529|P2|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
2679081|NCT00528879|9245530|P1|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3
2679082|NCT00528866|9245596|P1|Overall Study|Protocol Violation|6
2679083|NCT00528840|9245609|P1|Overall Study|Other|2
2679084|NCT00528840|9245609|P1|Overall Study|Administrative Reasons|1
2679085|NCT00528840|9245609|P1|Overall Study|Death|2
2679086|NCT00528840|9245609|P1|Overall Study|Withdrawal by Subject|17
2679087|NCT00528840|9245609|P1|Overall Study|Adverse Event|1
2679088|NCT00528840|9245609|P1|Overall Study|Lost to Follow-up|10
2679089|NCT00528801|9245623|P2|Overall Study|Administrative Reasons|1
2679090|NCT00528801|9245624|P1|Overall Study|Administrative Reasons|0
2679091|NCT00528801|9245623|P2|Overall Study|Lost to Follow-up|4
2679092|NCT00528801|9245624|P1|Overall Study|Lost to Follow-up|15
2679093|NCT00528801|9245623|P2|Overall Study|Protocol Violation|5
2679094|NCT00528801|9245624|P1|Overall Study|Protocol Violation|11
2679095|NCT00528801|9245623|P2|Overall Study|Withdrawal by Subject|1
2679096|NCT00528801|9245624|P1|Overall Study|Withdrawal by Subject|1
2679097|NCT00528775|9245638|P1|Overall Study|Other not specified|1
2679098|NCT00528645|9245646|P1|Overall Study|Adverse Event|3
2679099|NCT00528606|9245655|P2|Overall Study|Other|0
2679100|NCT00528606|9245656|P1|Overall Study|Other|2
2679101|NCT00528606|9245655|P2|Overall Study|Adverse Event|0
2679102|NCT00528606|9245656|P1|Overall Study|Adverse Event|3
2679103|NCT00528606|9245655|P2|Overall Study|Lost to Follow-up|1
2679104|NCT00528606|9245656|P1|Overall Study|Lost to Follow-up|4
2679105|NCT00528606|9245655|P2|Overall Study|Withdrew consent|3
2679106|NCT00528606|9245656|P1|Overall Study|Withdrew consent|4
2679107|NCT00528567|9245689|P2|Overall Study|Administrative/Other|75
2679108|NCT00528567|9245690|P1|Overall Study|Administrative/Other|22
2679109|NCT00528567|9245689|P2|Overall Study|Other Protocol Violation|21
2679110|NCT00528567|9245690|P1|Overall Study|Other Protocol Violation|5
2679111|NCT00528567|9245689|P2|Overall Study|Failure to Return|4
2679112|NCT00528567|9245690|P1|Overall Study|Failure to Return|1
2679113|NCT00528567|9245689|P2|Overall Study|Refused Treatment/Did Not Cooperate|42
2679114|NCT00528567|9245690|P1|Overall Study|Refused Treatment/Did Not Cooperate|52
2679115|NCT00528567|9245689|P2|Overall Study|Withdrew Consent|55
2679116|NCT00528567|9245690|P1|Overall Study|Withdrew Consent|59
2679117|NCT00528567|9245689|P2|Overall Study|Violation Criteria at Entry|17
2679118|NCT00528567|9245690|P1|Overall Study|Violation Criteria at Entry|3
2679119|NCT00528567|9245689|P2|Overall Study|Adverse Event/Intermittent Illness|29
2679120|NCT00528567|9245690|P1|Overall Study|Adverse Event/Intermittent Illness|255
2679121|NCT00528567|9245689|P2|Overall Study|Breast Cancer Recurrence/2nd Primary|60
2679122|NCT00528567|9245690|P1|Overall Study|Breast Cancer Recurrence/2nd Primary|30
2679123|NCT00528567|9245689|P2|Overall Study|Death|5
2679124|NCT00528567|9245690|P1|Overall Study|Death|4
2679125|NCT00528528|9245757|P4|Overall Study|Ongoing participant|0
2679126|NCT00528528|9245758|P3|Overall Study|Ongoing participant|1
2679127|NCT00528528|9245759|P2|Overall Study|Ongoing participant|0
2679128|NCT00528528|9245760|P1|Overall Study|Ongoing participant|0
2679129|NCT00528528|9245757|P4|Overall Study|Withdrawal by Subject|1
2679130|NCT00528528|9245758|P3|Overall Study|Withdrawal by Subject|1
2679131|NCT00528528|9245759|P2|Overall Study|Withdrawal by Subject|2
2679132|NCT00528528|9245760|P1|Overall Study|Withdrawal by Subject|3
2679133|NCT00528528|9245757|P4|Overall Study|Other|0
2679134|NCT00528528|9245758|P3|Overall Study|Other|0
2679135|NCT00528528|9245759|P2|Overall Study|Other|1
2679136|NCT00528528|9245760|P1|Overall Study|Other|0
2679137|NCT00528528|9245757|P4|Overall Study|Ineligible to continue the trial|1
2679138|NCT00528528|9245758|P3|Overall Study|Ineligible to continue the trial|0
2679139|NCT00528528|9245759|P2|Overall Study|Ineligible to continue the trial|0
2679140|NCT00528528|9245760|P1|Overall Study|Ineligible to continue the trial|0
2679141|NCT00528528|9245757|P4|Overall Study|Lost to Follow-up|1
2679142|NCT00528528|9245758|P3|Overall Study|Lost to Follow-up|1
2679143|NCT00528528|9245759|P2|Overall Study|Lost to Follow-up|0
2679144|NCT00528528|9245760|P1|Overall Study|Lost to Follow-up|0
2679145|NCT00528424|9245798|P1|Overall Study|Other|12
2679146|NCT00528424|9245798|P1|Overall Study|Administrative reason|2
2679147|NCT00528424|9245798|P1|Overall Study|Withdrew consent|2
2679148|NCT00528424|9245798|P1|Overall Study|Lost to Follow-up|13
2679149|NCT00528411|9245813|P3|Overall Study|Prior commitment medication|0
2679150|NCT00528411|9245814|P2|Overall Study|Prior commitment medication|1
2679151|NCT00528411|9245815|P1|Overall Study|Prior commitment medication|0
2679152|NCT00528411|9245813|P3|Overall Study|Severe non-compliance to protocol|0
2679153|NCT00528411|9245814|P2|Overall Study|Severe non-compliance to protocol|1
2679154|NCT00528411|9245815|P1|Overall Study|Severe non-compliance to protocol|0
2679155|NCT00528411|9245813|P3|Overall Study|Incorrect Enrolment|0
2679156|NCT00528411|9245814|P2|Overall Study|Incorrect Enrolment|1
2679157|NCT00528411|9245815|P1|Overall Study|Incorrect Enrolment|1
2679158|NCT00528411|9245813|P3|Overall Study|Adverse Event|1
2679159|NCT00528411|9245814|P2|Overall Study|Adverse Event|0
2679160|NCT00528411|9245815|P1|Overall Study|Adverse Event|4
2679161|NCT00528372|9245952|P9|Long-term (LT) Period (Weeks 24-102)|Other|0
2679162|NCT00528372|9245953|P8|Long-term (LT) Period (Weeks 24-102)|Other|1
2679163|NCT00528372|9245954|P7|Long-term (LT) Period (Weeks 24-102)|Other|3
2679164|NCT00528372|9245955|P6|Long-term (LT) Period (Weeks 24-102)|Other|0
2679165|NCT00528372|9245956|P5|Long-term (LT) Period (Weeks 24-102)|Other|3
2679166|NCT00528372|9245957|P4|Long-term (LT) Period (Weeks 24-102)|Other|2
2679167|NCT00528372|9245958|P3|Long-term (LT) Period (Weeks 24-102)|Other|1
2679168|NCT00528372|9245959|P2|Long-term (LT) Period (Weeks 24-102)|Other|2
2679169|NCT00528372|9245960|P1|Long-term (LT) Period (Weeks 24-102)|Other|2
2679170|NCT00528372|9245952|P9|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
2679171|NCT00528372|9245953|P8|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
2679172|NCT00528372|9245954|P7|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
2679173|NCT00528372|9245955|P6|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
2679174|NCT00528372|9245956|P5|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
2679175|NCT00528372|9245957|P4|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
2679176|NCT00528372|9245958|P3|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
2679177|NCT00528372|9245959|P2|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
2679178|NCT00528372|9245960|P1|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
2679179|NCT00528372|9245952|P9|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
2679180|NCT00528372|9245953|P8|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
2679181|NCT00528372|9245954|P7|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
2679182|NCT00528372|9245955|P6|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1
2679183|NCT00528372|9245956|P5|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2
2679184|NCT00528372|9245957|P4|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
2679185|NCT00528372|9245958|P3|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
2679186|NCT00528372|9245959|P2|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
2679187|NCT00528372|9245960|P1|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
2679188|NCT00528372|9245952|P9|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
2679189|NCT00528372|9245953|P8|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
2679190|NCT00528372|9245954|P7|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
2679191|NCT00528372|9245955|P6|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
2679192|NCT00528372|9245956|P5|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
2679193|NCT00528372|9245957|P4|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
2679194|NCT00528372|9245958|P3|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
2679195|NCT00528372|9245959|P2|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
2679196|NCT00528372|9245960|P1|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
2679197|NCT00528372|9245952|P9|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
2679198|NCT00528372|9245953|P8|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
2679199|NCT00528372|9245954|P7|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
2679200|NCT00528372|9245955|P6|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4
2679201|NCT00528372|9245956|P5|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0
2679202|NCT00528372|9245957|P4|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
2679203|NCT00528372|9245958|P3|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
2679204|NCT00528372|9245959|P2|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
2679205|NCT00528372|9245960|P1|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
2679206|NCT00528372|9245952|P9|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
2679207|NCT00528372|9245953|P8|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2
2679208|NCT00528372|9245954|P7|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
2679209|NCT00528372|9245955|P6|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0
2679210|NCT00528372|9245956|P5|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7
2679211|NCT00528372|9245957|P4|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
2679212|NCT00528372|9245958|P3|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
2679213|NCT00528372|9245959|P2|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
2679214|NCT00528372|9245960|P1|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
2679215|NCT00528372|9245952|P9|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
2679216|NCT00528372|9245953|P8|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
2679217|NCT00528372|9245954|P7|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4
2679218|NCT00528372|9245955|P6|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
2679219|NCT00528372|9245956|P5|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2
2679220|NCT00528372|9245957|P4|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
2679221|NCT00528372|9245958|P3|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
2679222|NCT00528372|9245959|P2|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
2679223|NCT00528372|9245960|P1|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
2679224|NCT00528372|9245952|P9|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
2679225|NCT00528372|9245953|P8|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
2679226|NCT00528372|9245954|P7|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2
2679227|NCT00528372|9245955|P6|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
2679228|NCT00528372|9245956|P5|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
2679229|NCT00528372|9245957|P4|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
2679230|NCT00528372|9245958|P3|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1
2679231|NCT00528372|9245959|P2|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
2679232|NCT00528372|9245960|P1|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
2679233|NCT00528372|9245952|P9|Short-term (ST) Period (Day 1-Week 24)|Other|0
2679234|NCT00528372|9245953|P8|Short-term (ST) Period (Day 1-Week 24)|Other|1
2679235|NCT00528372|9245954|P7|Short-term (ST) Period (Day 1-Week 24)|Other|0
2679236|NCT00528372|9245955|P6|Short-term (ST) Period (Day 1-Week 24)|Other|0
2679237|NCT00528372|9245956|P5|Short-term (ST) Period (Day 1-Week 24)|Other|0
2679238|NCT00528372|9245957|P4|Short-term (ST) Period (Day 1-Week 24)|Other|1
2679239|NCT00528372|9245958|P3|Short-term (ST) Period (Day 1-Week 24)|Other|0
2679240|NCT00528372|9245959|P2|Short-term (ST) Period (Day 1-Week 24)|Other|0
2679241|NCT00528372|9245960|P1|Short-term (ST) Period (Day 1-Week 24)|Other|3
2679242|NCT00528372|9245952|P9|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
2679243|NCT00528372|9245953|P8|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
2679244|NCT00528372|9245954|P7|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
2679245|NCT00528372|9245955|P6|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
2679246|NCT00528372|9245956|P5|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
2679247|NCT00528372|9245957|P4|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
2679248|NCT00528372|9245958|P3|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
2679249|NCT00528372|9245959|P2|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
2679250|NCT00528372|9245960|P1|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
2679251|NCT00528372|9245952|P9|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
2679252|NCT00528372|9245953|P8|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
2679253|NCT00528372|9245954|P7|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
2679254|NCT00528372|9245955|P6|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1
2679255|NCT00528372|9245956|P5|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
2679256|NCT00528372|9245957|P4|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2
2679257|NCT00528372|9245958|P3|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
2679258|NCT00528372|9245959|P2|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
2679259|NCT00528372|9245960|P1|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
2679260|NCT00528372|9245952|P9|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
2679261|NCT00528372|9245953|P8|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
2679262|NCT00528372|9245954|P7|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
2679263|NCT00528372|9245955|P6|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
2679264|NCT00528372|9245956|P5|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
2679265|NCT00528372|9245957|P4|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
2679266|NCT00528372|9245958|P3|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
2679267|NCT00528372|9245959|P2|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
2679268|NCT00528372|9245960|P1|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5
2679269|NCT00528372|9245952|P9|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
2679270|NCT00528372|9245953|P8|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
2679271|NCT00528372|9245954|P7|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
2679272|NCT00528372|9245955|P6|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
2679273|NCT00528372|9245956|P5|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
2679274|NCT00528372|9245957|P4|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
2679275|NCT00528372|9245958|P3|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7
2679276|NCT00528372|9245959|P2|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
2679277|NCT00528372|9245960|P1|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
2679278|NCT00528372|9245952|P9|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
2679279|NCT00528372|9245953|P8|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
2679280|NCT00528372|9245954|P7|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
2679281|NCT00528372|9245955|P6|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
2679282|NCT00528372|9245956|P5|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
2679283|NCT00528372|9245957|P4|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6
2679284|NCT00528372|9245958|P3|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
2679285|NCT00528372|9245959|P2|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
2679286|NCT00528372|9245960|P1|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
2679287|NCT00528372|9245952|P9|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
2679288|NCT00528372|9245953|P8|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
2679289|NCT00528372|9245954|P7|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
2679290|NCT00528372|9245955|P6|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
2679291|NCT00528372|9245956|P5|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
2679292|NCT00528372|9245957|P4|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
2679293|NCT00528372|9245958|P3|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
2679294|NCT00528372|9245959|P2|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
2679295|NCT00528372|9245960|P1|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2
2679296|NCT00528112|9246092|P2|Extension Phase|Protocol Violation|2
2679297|NCT00528112|9246093|P1|Extension Phase|Protocol Violation|0
2679298|NCT00528112|9246092|P2|Extension Phase|Adverse Event|36
2679299|NCT00528112|9246093|P1|Extension Phase|Adverse Event|0
2679300|NCT00528112|9246092|P2|Extension Phase|Death|1
2679301|NCT00528112|9246093|P1|Extension Phase|Death|0
2679302|NCT00528112|9246092|P2|Extension Phase|Lost to Follow-up|12
2679303|NCT00528112|9246093|P1|Extension Phase|Lost to Follow-up|0
2679304|NCT00528112|9246092|P2|Extension Phase|Pregnancy|3
2679305|NCT00528112|9246093|P1|Extension Phase|Pregnancy|0
2679306|NCT00528112|9246092|P2|Extension Phase|Other reasons|100
2679307|NCT00528112|9246093|P1|Extension Phase|Other reasons|0
2679308|NCT00528112|9246092|P2|Extension Phase|Withdrawal by Subject|3
2679309|NCT00528112|9246093|P1|Extension Phase|Withdrawal by Subject|0
2679310|NCT00528112|9246092|P2|Treatment up to 3 Years|Other reasons|186
2679311|NCT00528112|9246093|P1|Treatment up to 3 Years|Other reasons|186
2679312|NCT00528112|9246092|P2|Treatment up to 3 Years|Pregnancy|10
2679313|NCT00528112|9246093|P1|Treatment up to 3 Years|Pregnancy|9
2679314|NCT00528112|9246092|P2|Treatment up to 3 Years|Lost to Follow-up|61
2679315|NCT00528112|9246093|P1|Treatment up to 3 Years|Lost to Follow-up|63
2679316|NCT00528112|9246092|P2|Treatment up to 3 Years|Death|1
2679317|NCT00528112|9246093|P1|Treatment up to 3 Years|Death|0
2679318|NCT00528112|9246092|P2|Treatment up to 3 Years|Protocol Violation|16
2679319|NCT00528112|9246093|P1|Treatment up to 3 Years|Protocol Violation|16
2679320|NCT00528112|9246092|P2|Treatment up to 3 Years|Withdrawal by Subject|31
2679321|NCT00528112|9246093|P1|Treatment up to 3 Years|Withdrawal by Subject|26
2679322|NCT00528112|9246092|P2|Treatment up to 3 Years|Adverse Event|278
2679323|NCT00528112|9246093|P1|Treatment up to 3 Years|Adverse Event|313
2679324|NCT00528021|9246151|P4|Overall Study|Lack of Efficacy|9
2679325|NCT00528021|9246152|P3|Overall Study|Lack of Efficacy|7
2679326|NCT00528021|9246153|P2|Overall Study|Lack of Efficacy|13
2679327|NCT00528021|9246154|P1|Overall Study|Lack of Efficacy|17
2679328|NCT00527982|9246166|P2|Overall Study|Physician Decision|0
2679329|NCT00527982|9246167|P1|Overall Study|Physician Decision|1
2679330|NCT00527904|9246208|P1|Overall Study|misc|22
2679331|NCT00527904|9246208|P1|Overall Study|Lost to Follow-up|8
2679332|NCT00527904|9246208|P1|Overall Study|Withdrawal by Subject|21
2679333|NCT00527904|9246208|P1|Overall Study|Adverse Event|45
2679334|NCT00527826|9246227|P2|Overall Study|Participant moved away|1
2679335|NCT00527826|9246228|P1|Overall Study|Participant moved away|0
2679336|NCT00527826|9246227|P2|Overall Study|Additional Intake of Viani forte|1
2679337|NCT00527826|9246228|P1|Overall Study|Additional Intake of Viani forte|0
2679338|NCT00527826|9246227|P2|Overall Study|Alpha-1 Antitrypsin Deficiency|1
2679339|NCT00527826|9246228|P1|Overall Study|Alpha-1 Antitrypsin Deficiency|0
2679340|NCT00527826|9246227|P2|Overall Study|Inclusion Criteria Not Met|3
2679341|NCT00527826|9246228|P1|Overall Study|Inclusion Criteria Not Met|3
2679342|NCT00527826|9246227|P2|Overall Study|Withdrawal by Subject|8
2679343|NCT00527826|9246228|P1|Overall Study|Withdrawal by Subject|5
2679344|NCT00527826|9246227|P2|Overall Study|Lost to Follow-up|2
2679345|NCT00527826|9246228|P1|Overall Study|Lost to Follow-up|3
2679346|NCT00527826|9246227|P2|Overall Study|Adverse Event|10
2679347|NCT00527826|9246228|P1|Overall Study|Adverse Event|10
2679348|NCT00527787|9246277|P2|Overall Study|misc|2
2679349|NCT00527787|9246278|P1|Overall Study|misc|5
2679350|NCT00527787|9246277|P2|Overall Study|Duodenal Ulcer|10
2679351|NCT00527787|9246278|P1|Overall Study|Duodenal Ulcer|1
2679352|NCT00527787|9246277|P2|Overall Study|Lost to Follow-up|2
2679353|NCT00527787|9246278|P1|Overall Study|Lost to Follow-up|5
2679354|NCT00527787|9246277|P2|Overall Study|Withdrawal by Subject|25
2679355|NCT00527787|9246278|P1|Overall Study|Withdrawal by Subject|13
2679356|NCT00527787|9246277|P2|Overall Study|Adverse Event|24
2679357|NCT00527787|9246278|P1|Overall Study|Adverse Event|14
2679358|NCT00527748|9246300|P1|Overall Study|Other|3
2679359|NCT00527735|9246307|P3|Overall Study|Completed treatment during maintenance|1
2679360|NCT00527735|9246308|P2|Overall Study|Completed treatment during maintenance|2
2679361|NCT00527735|9246309|P1|Overall Study|Completed treatment during maintenance|2
2679362|NCT00527735|9246307|P3|Overall Study|Poor compliance or noncompliance|1
2679363|NCT00527735|9246308|P2|Overall Study|Poor compliance or noncompliance|1
2679364|NCT00527735|9246309|P1|Overall Study|Poor compliance or noncompliance|0
2679365|NCT00527735|9246307|P3|Overall Study|Lost to Follow-up|3
2679366|NCT00527735|9246308|P2|Overall Study|Lost to Follow-up|0
2679367|NCT00527735|9246309|P1|Overall Study|Lost to Follow-up|0
2679368|NCT00527735|9246307|P3|Overall Study|No longer met study criteria|1
2679369|NCT00527735|9246308|P2|Overall Study|No longer met study criteria|2
2679370|NCT00527735|9246309|P1|Overall Study|No longer met study criteria|2
2679371|NCT00527735|9246307|P3|Overall Study|Withdrawal by Subject|3
2679372|NCT00527735|9246308|P2|Overall Study|Withdrawal by Subject|4
2679373|NCT00527735|9246309|P1|Overall Study|Withdrawal by Subject|5
2679374|NCT00527735|9246307|P3|Overall Study|Not identified|5
2679375|NCT00527735|9246308|P2|Overall Study|Not identified|5
2679376|NCT00527735|9246309|P1|Overall Study|Not identified|5
2679377|NCT00527735|9246307|P3|Overall Study|Adverse Event|7
2679378|NCT00527735|9246308|P2|Overall Study|Adverse Event|6
2679379|NCT00527735|9246309|P1|Overall Study|Adverse Event|10
2679380|NCT00527735|9246307|P3|Overall Study|Completed treatment in treatment phase|18
2679381|NCT00527735|9246308|P2|Overall Study|Completed treatment in treatment phase|13
2679382|NCT00527735|9246309|P1|Overall Study|Completed treatment in treatment phase|14
2679383|NCT00527735|9246307|P3|Overall Study|Death|15
2679384|NCT00527735|9246308|P2|Overall Study|Death|13
2679385|NCT00527735|9246309|P1|Overall Study|Death|23
2679386|NCT00527735|9246307|P3|Overall Study|Disease progression|53
2679387|NCT00527735|9246308|P2|Overall Study|Disease progression|61
2679388|NCT00527735|9246309|P1|Overall Study|Disease progression|47
2679389|NCT00527618|9246395|P2|Week 15-18 (Second Intervention)|Withdrawal by Subject|1
2679390|NCT00527618|9246396|P1|Week 15-18 (Second Intervention)|Withdrawal by Subject|0
2679391|NCT00527618|9246395|P2|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1
2679392|NCT00527618|9246396|P1|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0
2679393|NCT00527618|9246395|P2|Week 15-18 (Second Intervention)|Lost to Follow-up|1
2679394|NCT00527618|9246396|P1|Week 15-18 (Second Intervention)|Lost to Follow-up|0
2679395|NCT00527618|9246395|P2|Week 13-14 (Washout)|Lost to Follow-up|0
2679396|NCT00527618|9246396|P1|Week 13-14 (Washout)|Lost to Follow-up|1
2679397|NCT00527618|9246395|P2|Week 1-12 (First Intervention)|Adverse Event|1
2679398|NCT00527618|9246396|P1|Week 1-12 (First Intervention)|Adverse Event|0
2679399|NCT00527618|9246395|P2|Week 1-12 (First Intervention)|Lost to Follow-up|1
2679400|NCT00527618|9246396|P1|Week 1-12 (First Intervention)|Lost to Follow-up|3
2679401|NCT00527605|9246411|P2|Overall Study|Protocol Violation|2
2679402|NCT00527605|9246412|P1|Overall Study|Protocol Violation|1
2679403|NCT00527605|9246411|P2|Overall Study|Lost to Follow-up|2
2679404|NCT00527605|9246412|P1|Overall Study|Lost to Follow-up|6
2679405|NCT00527605|9246411|P2|Overall Study|Withdrawal by Subject|7
2679406|NCT00527605|9246412|P1|Overall Study|Withdrawal by Subject|3
2679407|NCT00527605|9246411|P2|Overall Study|Adverse Event|0
2679408|NCT00527605|9246412|P1|Overall Study|Adverse Event|3
2679409|NCT00527514|9246463|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1
2679410|NCT00527514|9246463|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1
2679411|NCT00527514|9246463|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1
2679412|NCT00527514|9246463|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1
2679413|NCT00527514|9246463|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1
2679414|NCT00527514|9246463|P1|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2
2679415|NCT00527514|9246463|P1|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1
2679416|NCT00527488|9246479|P4|Overall Study|Withdrawn prior to dosing|0
2679417|NCT00527488|9246480|P3|Overall Study|Withdrawn prior to dosing|1
2679418|NCT00527488|9246481|P2|Overall Study|Withdrawn prior to dosing|1
2679419|NCT00527488|9246482|P1|Overall Study|Withdrawn prior to dosing|0
2679420|NCT00527423|9246565|P1|Overall Study|Death|9
2679421|NCT00527423|9246565|P1|Overall Study|OTHER|4
2679422|NCT00527423|9246565|P1|Overall Study|Lost to Follow-up|4
2679423|NCT00527423|9246565|P1|Overall Study|Withdrawal by Subject|10
2679424|NCT00527423|9246565|P1|Overall Study|Physician Decision|4
2679425|NCT00527423|9246565|P1|Overall Study|Adverse Event|5
2679426|NCT00527423|9246565|P1|Overall Study|Protocol Violation|1
2679427|NCT00527397|9246571|P1|Overall Study|Study terminated by sponsor|13
2679428|NCT00527397|9246571|P1|Overall Study|Withdrawal by Subject|6
2679429|NCT00527397|9246571|P1|Overall Study|Protocol Violation|1
2679430|NCT00527397|9246571|P1|Overall Study|Lack of Efficacy|1
2679431|NCT00527397|9246571|P1|Overall Study|Adverse Event|3
2679432|NCT00527332|9246597|P2|Overall Study|Withdrew consent|1
2679433|NCT00527332|9246598|P1|Overall Study|Withdrew consent|5
2679434|NCT00527332|9246597|P2|Overall Study|Protocol Violation|8
2679435|NCT00527332|9246598|P1|Overall Study|Protocol Violation|4
2679436|NCT00527319|9246607|P3|Overall Study|Adverse Event|1
2679437|NCT00527319|9246608|P2|Overall Study|Adverse Event|0
2679438|NCT00527319|9246609|P1|Overall Study|Adverse Event|0
2679439|NCT00527319|9246607|P3|Overall Study|Intercurrent Medical Illness|3
2679440|NCT00527319|9246608|P2|Overall Study|Intercurrent Medical Illness|1
2679441|NCT00527319|9246609|P1|Overall Study|Intercurrent Medical Illness|0
2679442|NCT00527319|9246607|P3|Overall Study|Death|1
2679443|NCT00527319|9246608|P2|Overall Study|Death|3
2679444|NCT00527319|9246609|P1|Overall Study|Death|0
2679445|NCT00527319|9246607|P3|Overall Study|Lost to Follow-up|0
2679446|NCT00527319|9246608|P2|Overall Study|Lost to Follow-up|0
2679447|NCT00527319|9246609|P1|Overall Study|Lost to Follow-up|1
2679448|NCT00527319|9246607|P3|Overall Study|Withdrawal by Subject|1
2679449|NCT00527319|9246608|P2|Overall Study|Withdrawal by Subject|0
2679450|NCT00527319|9246609|P1|Overall Study|Withdrawal by Subject|5
2679451|NCT00527111|9246639|P2|Overall Study|Other|2
2679452|NCT00527111|9246640|P1|Overall Study|Other|2
2679453|NCT00527111|9246639|P2|Overall Study|Patient Request|5
2679454|NCT00527111|9246640|P1|Overall Study|Patient Request|2
2679455|NCT00527111|9246639|P2|Overall Study|Investigator Request|1
2679456|NCT00527111|9246640|P1|Overall Study|Investigator Request|2
2679457|NCT00527111|9246639|P2|Overall Study|Death|1
2679458|NCT00527111|9246640|P1|Overall Study|Death|0
2679459|NCT00527111|9246639|P2|Overall Study|Adverse Event|13
2679460|NCT00527111|9246640|P1|Overall Study|Adverse Event|14
2679461|NCT00527072|9246662|P1|Overall Study|Withdrawal by Subject|7
2679462|NCT00527072|9246662|P1|Overall Study|Protocol Violation|2
2679463|NCT00527072|9246662|P1|Overall Study|Lost to Follow-up|3
2679464|NCT00527072|9246662|P1|Overall Study|Lack of Efficacy|11
2679465|NCT00527072|9246662|P1|Overall Study|Adverse Event|13
2679466|NCT00526994|9246671|P3|Overall Study|incarcerated, impaired, incomplete|3
2679467|NCT00526994|9246672|P2|Overall Study|incarcerated, impaired, incomplete|3
2679468|NCT00526994|9246673|P1|Overall Study|incarcerated, impaired, incomplete|4
2679469|NCT00526994|9246671|P3|Overall Study|Withdrawal by Subject|5
2679470|NCT00526994|9246672|P2|Overall Study|Withdrawal by Subject|7
2679471|NCT00526994|9246673|P1|Overall Study|Withdrawal by Subject|2
2679472|NCT00526994|9246671|P3|Overall Study|Death|3
2679473|NCT00526994|9246672|P2|Overall Study|Death|3
2679474|NCT00526994|9246673|P1|Overall Study|Death|4
2679475|NCT00526994|9246671|P3|Overall Study|Lost to Follow-up|96
2679476|NCT00526994|9246672|P2|Overall Study|Lost to Follow-up|108
2679477|NCT00526994|9246673|P1|Overall Study|Lost to Follow-up|98
2679478|NCT00526890|9246690|P1|Overall Study|Adverse Event|2
2679479|NCT00526799|9246702|P2|Overall Study|Intercurrent Complicating Disease|1
2679480|NCT00526799|9246703|P1|Overall Study|Intercurrent Complicating Disease|0
2679481|NCT00526799|9246702|P2|Overall Study|Withdrawal by Subject|0
2679482|NCT00526799|9246703|P1|Overall Study|Withdrawal by Subject|1
2679483|NCT00526669|9246711|P2|Combined Treatment Phase|Death|2
2679484|NCT00526669|9246712|P1|Combined Treatment Phase|Death|0
2679485|NCT00526669|9246711|P2|Combined Treatment Phase|Sponsor Terminated Study|2
2679486|NCT00526669|9246712|P1|Combined Treatment Phase|Sponsor Terminated Study|0
2679487|NCT00526669|9246711|P2|Combined Treatment Phase|Withdrawal by Subject|2
2679488|NCT00526669|9246712|P1|Combined Treatment Phase|Withdrawal by Subject|0
2679489|NCT00526669|9246711|P2|Combined Treatment Phase|Lost to Follow-up|2
2679490|NCT00526669|9246712|P1|Combined Treatment Phase|Lost to Follow-up|0
2679491|NCT00526656|9246741|P1|Overall Study|Refused surgery|1
2679492|NCT00526656|9246741|P1|Overall Study|Death|1
2679493|NCT00526630|9246747|P2|Second Intervention Period - 12 Weeks|Withdrawn|1
2679494|NCT00526630|9246748|P1|Second Intervention Period - 12 Weeks|Withdrawn|2
2679495|NCT00526630|9246747|P2|First Intervention Period - 12 Weeks|Withdrawn|3
2679496|NCT00526630|9246748|P1|First Intervention Period - 12 Weeks|Withdrawn|0
2679497|NCT00526331|9246860|P1|Overall Study|Sponsor Termination|55
2679498|NCT00526227|9246868|P1|Overall Study|Death|1
2679499|NCT00526227|9246868|P1|Overall Study|Device not implanted|1
2679500|NCT00526162|9246879|P1|Overall Study|Device not implanted|3
2679501|NCT00526110|9246912|P2|Overall Study|Poor Tolerance|5
2679502|NCT00526110|9246913|P1|Overall Study|Poor Tolerance|0
2679503|NCT00526110|9246912|P2|Overall Study|Withdrawal by Subject|2
2679504|NCT00526110|9246913|P1|Overall Study|Withdrawal by Subject|0
2679505|NCT00526110|9246912|P2|Overall Study|Maximal Response|6
2679506|NCT00526110|9246913|P1|Overall Study|Maximal Response|0
2679507|NCT00526110|9246912|P2|Overall Study|Disease Progression|19
2679508|NCT00526110|9246913|P1|Overall Study|Disease Progression|0
2679509|NCT00526110|9246912|P2|Overall Study|Adverse Event|9
2679510|NCT00526110|9246913|P1|Overall Study|Adverse Event|2
2679511|NCT00526097|9246922|P2|Overall Study|Other|1
2679512|NCT00526097|9246923|P1|Overall Study|Other|2
2679513|NCT00526097|9246922|P2|Overall Study|Withdrawal by Subject|1
2679514|NCT00526097|9246923|P1|Overall Study|Withdrawal by Subject|3
2679515|NCT00526097|9246922|P2|Overall Study|Protocol Violation|10
2679516|NCT00526097|9246923|P1|Overall Study|Protocol Violation|4
2679517|NCT00526097|9246922|P2|Overall Study|Adverse Event|44
2679518|NCT00526097|9246923|P1|Overall Study|Adverse Event|6
2679519|NCT00526071|9247099|P1|Overall Study|Lack of Response to Study Drug|4
2679520|NCT00526071|9247099|P1|Overall Study|Withdrawal by Subject|1
2679521|NCT00526071|9247099|P1|Overall Study|Adverse Event|1
2679522|NCT00525915|9247125|P2|Overall Study|Unrelated illness|0
2679523|NCT00525915|9247126|P1|Overall Study|Unrelated illness|1
2679524|NCT00525915|9247125|P2|Overall Study|Refused Surgery|2
2679525|NCT00525915|9247126|P1|Overall Study|Refused Surgery|1
2679526|NCT00525915|9247125|P2|Overall Study|Withdrawal by Subject|0
2679527|NCT00525915|9247126|P1|Overall Study|Withdrawal by Subject|1
2679528|NCT00525915|9247125|P2|Overall Study|Disease Progression|6
2679529|NCT00525915|9247126|P1|Overall Study|Disease Progression|5
2679530|NCT00525915|9247125|P2|Overall Study|Non-Compliance|1
2679531|NCT00525915|9247126|P1|Overall Study|Non-Compliance|0
2679532|NCT00525902|9247132|P1|Overall Study|Lack of Efficacy|1
2679533|NCT00525824|9247156|P4|Overall Study|Other|1
2679534|NCT00525824|9247157|P3|Overall Study|Other|3
2679535|NCT00525824|9247158|P2|Overall Study|Other|3
2679536|NCT00525824|9247159|P1|Overall Study|Other|1
2679537|NCT00525824|9247156|P4|Overall Study|Safety reasons|0
2679538|NCT00525824|9247157|P3|Overall Study|Safety reasons|1
2679539|NCT00525824|9247158|P2|Overall Study|Safety reasons|0
2679540|NCT00525824|9247159|P1|Overall Study|Safety reasons|1
2679541|NCT00525824|9247156|P4|Overall Study|Severe non-compliance|1
2679542|NCT00525824|9247157|P3|Overall Study|Severe non-compliance|1
2679543|NCT00525824|9247158|P2|Overall Study|Severe non-compliance|1
2679544|NCT00525824|9247159|P1|Overall Study|Severe non-compliance|0
2679545|NCT00525824|9247156|P4|Overall Study|Incorrect enrolment/mis-randomisation|2
2679546|NCT00525824|9247157|P3|Overall Study|Incorrect enrolment/mis-randomisation|1
2679547|NCT00525824|9247158|P2|Overall Study|Incorrect enrolment/mis-randomisation|2
2679548|NCT00525824|9247159|P1|Overall Study|Incorrect enrolment/mis-randomisation|1
2679549|NCT00525824|9247156|P4|Overall Study|Lost to Follow-up|0
2679550|NCT00525824|9247157|P3|Overall Study|Lost to Follow-up|4
2679551|NCT00525824|9247158|P2|Overall Study|Lost to Follow-up|2
2679552|NCT00525824|9247159|P1|Overall Study|Lost to Follow-up|4
2679553|NCT00525824|9247156|P4|Overall Study|Withdrawal by Subject|4
2679554|NCT00525824|9247157|P3|Overall Study|Withdrawal by Subject|3
2679555|NCT00525824|9247158|P2|Overall Study|Withdrawal by Subject|9
2679556|NCT00525824|9247159|P1|Overall Study|Withdrawal by Subject|5
2679557|NCT00525824|9247156|P4|Overall Study|Adverse Event|7
2679558|NCT00525824|9247157|P3|Overall Study|Adverse Event|6
2679559|NCT00525824|9247158|P2|Overall Study|Adverse Event|11
2679560|NCT00525824|9247159|P1|Overall Study|Adverse Event|7
2679561|NCT00525785|9247232|P1|Overall Study|Physician Decision|1
2679562|NCT00525785|9247232|P1|Overall Study|Lack of Efficacy|1
2679563|NCT00525785|9247232|P1|Overall Study|Withdrawal by Subject|1
2679564|NCT00525590|9247256|P1|Overall Study|Other|13
2679565|NCT00525590|9247256|P1|Overall Study|Death|9
2679566|NCT00525590|9247256|P1|Overall Study|Lost to Follow-up|1
2679567|NCT00525590|9247256|P1|Overall Study|Withdrawal by Subject|16
2679568|NCT00525590|9247256|P1|Overall Study|Physician Decision|3
2679569|NCT00525590|9247256|P1|Overall Study|Adverse Event|3
2679570|NCT00525512|9247284|P4|Open-Label Phase|Other reason (not specified)|5
2679571|NCT00525512|9247285|P3|Open-Label Phase|Other reason (not specified)|4
2679572|NCT00525512|9247286|P2|Open-Label Phase|Other reason (not specified)|0
2679573|NCT00525512|9247287|P1|Open-Label Phase|Other reason (not specified)|0
2679574|NCT00525512|9247284|P4|Open-Label Phase|Lost to Follow-up|0
2679575|NCT00525512|9247285|P3|Open-Label Phase|Lost to Follow-up|1
2679576|NCT00525512|9247286|P2|Open-Label Phase|Lost to Follow-up|0
2679577|NCT00525512|9247287|P1|Open-Label Phase|Lost to Follow-up|0
2679578|NCT00525512|9247284|P4|Open-Label Phase|Adverse Event|0
2679579|NCT00525512|9247285|P3|Open-Label Phase|Adverse Event|1
2679580|NCT00525512|9247286|P2|Open-Label Phase|Adverse Event|0
2679581|NCT00525512|9247287|P1|Open-Label Phase|Adverse Event|0
2679582|NCT00525512|9247284|P4|Double-Blind Phase|Other reason (not specified)|0
2679583|NCT00525512|9247285|P3|Double-Blind Phase|Other reason (not specified)|0
2679584|NCT00525512|9247286|P2|Double-Blind Phase|Other reason (not specified)|13
2679585|NCT00525512|9247287|P1|Double-Blind Phase|Other reason (not specified)|12
2679586|NCT00525512|9247284|P4|Double-Blind Phase|Lack of Efficacy|0
2679587|NCT00525512|9247285|P3|Double-Blind Phase|Lack of Efficacy|0
2679588|NCT00525512|9247286|P2|Double-Blind Phase|Lack of Efficacy|5
2679589|NCT00525512|9247287|P1|Double-Blind Phase|Lack of Efficacy|13
2679590|NCT00525512|9247284|P4|Double-Blind Phase|Withdrawal by Subject|0
2679591|NCT00525512|9247285|P3|Double-Blind Phase|Withdrawal by Subject|0
2679592|NCT00525512|9247286|P2|Double-Blind Phase|Withdrawal by Subject|12
2679593|NCT00525512|9247287|P1|Double-Blind Phase|Withdrawal by Subject|17
2679594|NCT00525512|9247284|P4|Double-Blind Phase|Lost to Follow-up|0
2679595|NCT00525512|9247285|P3|Double-Blind Phase|Lost to Follow-up|0
2679596|NCT00525512|9247286|P2|Double-Blind Phase|Lost to Follow-up|7
2679597|NCT00525512|9247287|P1|Double-Blind Phase|Lost to Follow-up|3
2679598|NCT00525512|9247284|P4|Double-Blind Phase|Protocol Violation|0
2679599|NCT00525512|9247285|P3|Double-Blind Phase|Protocol Violation|0
2679600|NCT00525512|9247286|P2|Double-Blind Phase|Protocol Violation|1
2679601|NCT00525512|9247287|P1|Double-Blind Phase|Protocol Violation|3
2679602|NCT00525512|9247284|P4|Double-Blind Phase|Adverse Event|0
2679603|NCT00525512|9247285|P3|Double-Blind Phase|Adverse Event|0
2679604|NCT00525512|9247286|P2|Double-Blind Phase|Adverse Event|28
2679605|NCT00525512|9247287|P1|Double-Blind Phase|Adverse Event|48
2679606|NCT00525499|9247429|P4|Overall Study|Protocol Violation|0
2679607|NCT00525499|9247430|P3|Overall Study|Protocol Violation|1
2679608|NCT00525499|9247431|P2|Overall Study|Protocol Violation|1
2679609|NCT00525499|9247432|P1|Overall Study|Protocol Violation|0
2679610|NCT00525499|9247429|P4|Overall Study|Withdrawal by Subject|2
2679611|NCT00525499|9247430|P3|Overall Study|Withdrawal by Subject|5
2679612|NCT00525499|9247431|P2|Overall Study|Withdrawal by Subject|1
2679613|NCT00525499|9247432|P1|Overall Study|Withdrawal by Subject|5
2679614|NCT00525499|9247429|P4|Overall Study|Adverse Event|1
2679615|NCT00525499|9247430|P3|Overall Study|Adverse Event|0
2679616|NCT00525499|9247431|P2|Overall Study|Adverse Event|1
2679617|NCT00525499|9247432|P1|Overall Study|Adverse Event|0
2679618|NCT00525499|9247429|P4|Overall Study|Lost to Follow-up|4
2679619|NCT00525499|9247430|P3|Overall Study|Lost to Follow-up|1
2679620|NCT00525499|9247431|P2|Overall Study|Lost to Follow-up|4
2679621|NCT00525499|9247432|P1|Overall Study|Lost to Follow-up|2
2679622|NCT00525265|9247459|P2|Overall Study|Protocol Violation|0
2679623|NCT00525265|9247460|P1|Overall Study|Protocol Violation|1
2679624|NCT00525161|9247517|P1|Overall Study|Adverse Event|1
2679625|NCT00525148|9247527|P4|Overall Study|Other than stated|3
2679626|NCT00525148|9247528|P3|Overall Study|Other than stated|0
2679627|NCT00525148|9247529|P2|Overall Study|Other than stated|1
2679628|NCT00525148|9247530|P1|Overall Study|Other than stated|2
2679629|NCT00525148|9247527|P4|Overall Study|Refused continuation of study medication|1
2679630|NCT00525148|9247528|P3|Overall Study|Refused continuation of study medication|0
2679631|NCT00525148|9247529|P2|Overall Study|Refused continuation of study medication|2
2679632|NCT00525148|9247530|P1|Overall Study|Refused continuation of study medication|0
2679633|NCT00525148|9247527|P4|Overall Study|Progressive disease|49
2679634|NCT00525148|9247528|P3|Overall Study|Progressive disease|6
2679635|NCT00525148|9247529|P2|Overall Study|Progressive disease|30
2679636|NCT00525148|9247530|P1|Overall Study|Progressive disease|18
2679637|NCT00525148|9247527|P4|Overall Study|Other Adverse Event|8
2679638|NCT00525148|9247528|P3|Overall Study|Other Adverse Event|1
2679639|NCT00525148|9247529|P2|Overall Study|Other Adverse Event|5
2679640|NCT00525148|9247530|P1|Overall Study|Other Adverse Event|3
2679641|NCT00525044|9247558|P2|Overall Study|Lost to Follow-up|1
2679642|NCT00525044|9247559|P1|Overall Study|Lost to Follow-up|0
2679643|NCT00525031|9247575|P2|Overall Study|Disease Progression|1
2679644|NCT00525031|9247576|P1|Overall Study|Disease Progression|1
2679645|NCT00524771|9247590|P2|Overall Study|Protocol Violation|585
2679646|NCT00524771|9247591|P1|Overall Study|Protocol Violation|220
2679647|NCT00524745|9247605|P4|Overall Study|subject withdrawal or lost to follow up|22
2679648|NCT00524745|9247606|P3|Overall Study|subject withdrawal or lost to follow up|29
2679649|NCT00524745|9247607|P2|Overall Study|subject withdrawal or lost to follow up|13
2679650|NCT00524745|9247608|P1|Overall Study|subject withdrawal or lost to follow up|34
2679651|NCT00524680|9247634|P4|Overall Study|Withdrawal by Subject|1
2679652|NCT00524680|9247635|P3|Overall Study|Withdrawal by Subject|1
2679653|NCT00524680|9247636|P2|Overall Study|Withdrawal by Subject|0
2679654|NCT00524680|9247637|P1|Overall Study|Withdrawal by Subject|1
2679655|NCT00524680|9247634|P4|Overall Study|Other|3
2679656|NCT00524680|9247635|P3|Overall Study|Other|2
2679657|NCT00524680|9247636|P2|Overall Study|Other|1
2679658|NCT00524680|9247637|P1|Overall Study|Other|0
2679659|NCT00524680|9247634|P4|Overall Study|Adverse Event|1
2679660|NCT00524680|9247635|P3|Overall Study|Adverse Event|0
2679661|NCT00524680|9247636|P2|Overall Study|Adverse Event|0
2679662|NCT00524680|9247637|P1|Overall Study|Adverse Event|2
2679663|NCT00524680|9247634|P4|Overall Study|progression|1
2679664|NCT00524680|9247635|P3|Overall Study|progression|0
2679665|NCT00524680|9247636|P2|Overall Study|progression|0
2679666|NCT00524680|9247637|P1|Overall Study|progression|0
2679667|NCT00524589|9247659|P1|Overall Study|Disease Progression|16
2679668|NCT00524589|9247659|P1|Overall Study|Withdrawal by Subject|2
2679669|NCT00524485|9247710|P1|Overall Study|Withdrawal by Subject|5
2679670|NCT00524459|9247739|P1|Overall Study|Other|1
2679671|NCT00524459|9247739|P1|Overall Study|Withdrawal by Subject|1
2679672|NCT00524420|9247749|P2|Overall Study|Lack of Efficacy|0
2679673|NCT00524420|9247750|P1|Overall Study|Lack of Efficacy|1
2679674|NCT00524368|9247768|P2|Overall Study|Other|2
2679675|NCT00524368|9247769|P1|Overall Study|Other|3
2679676|NCT00524368|9247768|P2|Overall Study|Ineligible to Continue the study|5
2679677|NCT00524368|9247769|P1|Overall Study|Ineligible to Continue the study|2
2679678|NCT00524368|9247768|P2|Overall Study|Sponsor's Decision|0
2679679|NCT00524368|9247769|P1|Overall Study|Sponsor's Decision|2
2679680|NCT00524368|9247768|P2|Overall Study|Reached a Virologic Endpoint|2
2679681|NCT00524368|9247769|P1|Overall Study|Reached a Virologic Endpoint|3
2679682|NCT00524368|9247768|P2|Overall Study|Non-compliant|9
2679683|NCT00524368|9247769|P1|Overall Study|Non-compliant|8
2679684|NCT00524368|9247768|P2|Overall Study|Withdrawal by Subject|5
2679685|NCT00524368|9247769|P1|Overall Study|Withdrawal by Subject|4
2679686|NCT00524368|9247768|P2|Overall Study|Lost to Follow-up|13
2679687|NCT00524368|9247769|P1|Overall Study|Lost to Follow-up|9
2679688|NCT00524368|9247768|P2|Overall Study|Adverse Event|12
2679689|NCT00524368|9247769|P1|Overall Study|Adverse Event|10
2679690|NCT00524316|9247803|P1|Overall Study|Disease Progression|7
2679691|NCT00524316|9247803|P1|Overall Study|Adverse Event|7
2679692|NCT00524316|9247803|P1|Overall Study|Withdrawal by Subject|2
2679693|NCT00524303|9247815|P3|Overall Study|Completed 5 years|1
2679694|NCT00524303|9247816|P2|Overall Study|Completed 5 years|0
2679695|NCT00524303|9247817|P1|Overall Study|Completed 5 years|0
2679696|NCT00524303|9247815|P3|Overall Study|Physician Decision|1
2679697|NCT00524303|9247816|P2|Overall Study|Physician Decision|0
2679698|NCT00524303|9247817|P1|Overall Study|Physician Decision|0
2679699|NCT00524303|9247815|P3|Overall Study|Sponsor Request|1
2679700|NCT00524303|9247816|P2|Overall Study|Sponsor Request|0
2679701|NCT00524303|9247817|P1|Overall Study|Sponsor Request|0
2679702|NCT00524303|9247815|P3|Overall Study|Disease Recurrence|0
2679703|NCT00524303|9247816|P2|Overall Study|Disease Recurrence|1
2679704|NCT00524303|9247817|P1|Overall Study|Disease Recurrence|0
2679705|NCT00524303|9247815|P3|Overall Study|Disease Progression|1
2679706|NCT00524303|9247816|P2|Overall Study|Disease Progression|4
2679707|NCT00524303|9247817|P1|Overall Study|Disease Progression|0
2679708|NCT00524303|9247815|P3|Overall Study|Worsening Peripheral Neuropathy|0
2679709|NCT00524303|9247816|P2|Overall Study|Worsening Peripheral Neuropathy|0
2679710|NCT00524303|9247817|P1|Overall Study|Worsening Peripheral Neuropathy|1
2679711|NCT00524303|9247815|P3|Overall Study|Did not Complete Study Dosing|0
2679712|NCT00524303|9247816|P2|Overall Study|Did not Complete Study Dosing|0
2679713|NCT00524303|9247817|P1|Overall Study|Did not Complete Study Dosing|1
2679714|NCT00524303|9247815|P3|Overall Study|Adverse Event|3
2679715|NCT00524303|9247816|P2|Overall Study|Adverse Event|2
2679716|NCT00524303|9247817|P1|Overall Study|Adverse Event|1
2679717|NCT00524303|9247815|P3|Overall Study|Death|3
2679718|NCT00524303|9247816|P2|Overall Study|Death|2
2679719|NCT00524303|9247817|P1|Overall Study|Death|0
2679720|NCT00524303|9247815|P3|Overall Study|Withdrawal by Subject|4
2679721|NCT00524303|9247816|P2|Overall Study|Withdrawal by Subject|0
2679722|NCT00524303|9247817|P1|Overall Study|Withdrawal by Subject|3
2679723|NCT00524303|9247815|P3|Overall Study|Protocol Violation|1
2679724|NCT00524303|9247816|P2|Overall Study|Protocol Violation|1
2679725|NCT00524303|9247817|P1|Overall Study|Protocol Violation|0
2679726|NCT00524303|9247815|P3|Overall Study|Lost to Follow-up|3
2679727|NCT00524303|9247816|P2|Overall Study|Lost to Follow-up|0
2679728|NCT00524303|9247817|P1|Overall Study|Lost to Follow-up|6
2679729|NCT00524173|9247869|P2|Overall Study|Had not reached endpoint at study close|1
2679730|NCT00524173|9247870|P1|Overall Study|Had not reached endpoint at study close|4
2679731|NCT00524173|9247869|P2|Overall Study|Death|0
2679732|NCT00524173|9247870|P1|Overall Study|Death|1
2679733|NCT00524173|9247869|P2|Overall Study|Lost to Follow-up|1
2679734|NCT00524173|9247870|P1|Overall Study|Lost to Follow-up|0
2679735|NCT00524134|9247882|P1|Overall Study|Physician Decision|1
2679736|NCT00524134|9247882|P1|Overall Study|Withdrawal by Subject|1
2679737|NCT00524121|9247889|P1|Overall Study|Not treated (changed mind)|1
2679738|NCT00524121|9247889|P1|Overall Study|Not treated (became ineligible)|4
2679739|NCT00524121|9247889|P1|Overall Study|Death|1
2679740|NCT00524121|9247889|P1|Overall Study|Other|1
2679741|NCT00524121|9247889|P1|Overall Study|Patient refused|2
2679742|NCT00524121|9247889|P1|Overall Study|Adverse Event|4
2679743|NCT00524121|9247889|P1|Overall Study|Disease progression|6
2679744|NCT00524043|9247909|P3|Overall Study|Various (eg, incarceration)|0
2679745|NCT00524043|9247910|P2|Overall Study|Various (eg, incarceration)|1
2679746|NCT00524043|9247911|P1|Overall Study|Various (eg, incarceration)|2
2679747|NCT00524043|9247909|P3|Overall Study|Lost to Follow-up|3
2679748|NCT00524043|9247910|P2|Overall Study|Lost to Follow-up|5
2679749|NCT00524043|9247911|P1|Overall Study|Lost to Follow-up|3
2679750|NCT00524043|9247909|P3|Overall Study|Adverse Event|7
2679751|NCT00524043|9247910|P2|Overall Study|Adverse Event|2
2679752|NCT00524043|9247911|P1|Overall Study|Adverse Event|5
2679753|NCT00524043|9247909|P3|Overall Study|Withdrawal by Subject|7
2679754|NCT00524043|9247910|P2|Overall Study|Withdrawal by Subject|7
2679755|NCT00524043|9247911|P1|Overall Study|Withdrawal by Subject|5
2679756|NCT00524043|9247909|P3|Overall Study|Lack of Efficacy|14
2679757|NCT00524043|9247910|P2|Overall Study|Lack of Efficacy|13
2679758|NCT00524043|9247911|P1|Overall Study|Lack of Efficacy|15
2679759|NCT00524030|9247933|P2|Overall Study|Death|1
2679760|NCT00524030|9247934|P1|Overall Study|Death|0
2679761|NCT00524030|9247933|P2|Overall Study|Adverse Event|21
2679762|NCT00524030|9247934|P1|Overall Study|Adverse Event|3
2679763|NCT00524030|9247933|P2|Overall Study|Pregnancy|0
2679764|NCT00524030|9247934|P1|Overall Study|Pregnancy|1
2679765|NCT00524030|9247933|P2|Overall Study|Protocol Violation|1
2679766|NCT00524030|9247934|P1|Overall Study|Protocol Violation|0
2679767|NCT00524030|9247933|P2|Overall Study|Noncompliance/Investigator discretion|2
2679768|NCT00524030|9247934|P1|Overall Study|Noncompliance/Investigator discretion|0
2679769|NCT00524030|9247933|P2|Overall Study|Withdrawal by Subject|8
2679770|NCT00524030|9247934|P1|Overall Study|Withdrawal by Subject|3
2679771|NCT00524030|9247933|P2|Overall Study|Lost to Follow-up|2
2679772|NCT00524030|9247934|P1|Overall Study|Lost to Follow-up|0
2679773|NCT00524030|9247933|P2|Overall Study|Lack of Efficacy|24
2679774|NCT00524030|9247934|P1|Overall Study|Lack of Efficacy|10
2679775|NCT00523991|9247973|P2|Overall Study|Other reason (not specified)|0
2679776|NCT00523991|9247974|P1|Overall Study|Other reason (not specified)|3
2679777|NCT00523991|9247973|P2|Overall Study|Withdrawal by Subject|17
2679778|NCT00523991|9247974|P1|Overall Study|Withdrawal by Subject|7
2679779|NCT00523991|9247973|P2|Overall Study|Lost to Follow-up|1
2679780|NCT00523991|9247974|P1|Overall Study|Lost to Follow-up|4
2679781|NCT00523991|9247973|P2|Overall Study|Protocol Violation|4
2679782|NCT00523991|9247974|P1|Overall Study|Protocol Violation|1
2679783|NCT00523991|9247973|P2|Overall Study|Adverse Event|5
2679784|NCT00523991|9247974|P1|Overall Study|Adverse Event|6
2679785|NCT00523978|9248254|P2|Overall Study|Death|0
2679786|NCT00523978|9248255|P1|Overall Study|Death|1
2679787|NCT00523978|9248254|P2|Overall Study|Screen Failures|1
2679788|NCT00523978|9248255|P1|Overall Study|Screen Failures|5
2679789|NCT00523978|9248254|P2|Overall Study|Withdrawal by Subject|7
2679790|NCT00523978|9248255|P1|Overall Study|Withdrawal by Subject|3
2679791|NCT00523848|9248277|P1|Overall Study|Other, unspecified|4
2679792|NCT00523848|9248277|P1|Overall Study|Disease Progression|5
2679793|NCT00523848|9248277|P1|Overall Study|NOT TREATED (Became ineligible)|2
2679794|NCT00523848|9248277|P1|Overall Study|Withdrawal by Subject|2
2679795|NCT00523848|9248277|P1|Overall Study|Adverse Event|11
2679796|NCT00523744|9248287|P1|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1
2679797|NCT00523744|9248287|P1|Phase 2 - Amlodipine+Valsartan|Adverse Event|2
2679798|NCT00523744|9248287|P1|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1
2679799|NCT00523744|9248287|P1|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2
2679800|NCT00523744|9248287|P1|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1
2679801|NCT00523744|9248287|P1|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2
2679802|NCT00523718|9248306|P2|Overall Study|Protocol Violation|0
2679803|NCT00523718|9248307|P1|Overall Study|Protocol Violation|2
2679804|NCT00523718|9248306|P2|Overall Study|Withdrawal by Subject|0
2679805|NCT00523718|9248307|P1|Overall Study|Withdrawal by Subject|1
2679806|NCT00523705|9248321|P2|Overall Study|No time for study.|1
2679807|NCT00523705|9248322|P1|Overall Study|No time for study.|0
2679808|NCT00523640|9248334|P1|Overall Study|Death|1
2679809|NCT00523549|9248351|P2|Overall Study|Lost to Follow-up|5
2679810|NCT00523549|9248352|P1|Overall Study|Lost to Follow-up|3
2679811|NCT00523549|9248351|P2|Overall Study|Patient withdrew consent|6
2679812|NCT00523549|9248352|P1|Overall Study|Patient withdrew consent|7
2679813|NCT00523549|9248351|P2|Overall Study|Protocol Deviation|1
2679814|NCT00523549|9248352|P1|Overall Study|Protocol Deviation|3
2679815|NCT00523549|9248351|P2|Overall Study|Unsatisfactory therapeutic effect|1
2679816|NCT00523549|9248352|P1|Overall Study|Unsatisfactory therapeutic effect|0
2679817|NCT00523549|9248351|P2|Overall Study|Adverse Event|3
2679818|NCT00523549|9248352|P1|Overall Study|Adverse Event|6
2679819|NCT00523419|9248370|P1|Overall Study|Death due to Adverse Event|2
2679820|NCT00523419|9248370|P1|Overall Study|Death due to Study Disease|4
2679821|NCT00523419|9248370|P1|Overall Study|Progressive Disease|22
2679822|NCT00523419|9248370|P1|Overall Study|Physician Decision|2
2679823|NCT00523419|9248370|P1|Overall Study|Withdrawal by Subject|1
2679824|NCT00523419|9248370|P1|Overall Study|Adverse Event|1
2679825|NCT00523367|9248380|P1|Overall Study|4 Withdrawn by PI|4
2679826|NCT00523367|9248380|P1|Overall Study|19 screen failures|19
2679827|NCT00523341|9248386|P2|Overall Study|Disease Progression|0
2679828|NCT00523341|9248387|P1|Overall Study|Disease Progression|1
2679829|NCT00523341|9248386|P2|Overall Study|Ineligibility Determined|4
2679830|NCT00523341|9248387|P1|Overall Study|Ineligibility Determined|3
2679831|NCT00523341|9248386|P2|Overall Study|Protocol Deviation|5
2679832|NCT00523341|9248387|P1|Overall Study|Protocol Deviation|6
2679833|NCT00523341|9248386|P2|Overall Study|Requirement for Alternative Therapy|14
2679834|NCT00523341|9248387|P1|Overall Study|Requirement for Alternative Therapy|4
2679835|NCT00523341|9248386|P2|Overall Study|Physician Decision|13
2679836|NCT00523341|9248387|P1|Overall Study|Physician Decision|14
2679837|NCT00523341|9248386|P2|Overall Study|Non-compliance|13
2679838|NCT00523341|9248387|P1|Overall Study|Non-compliance|20
2679839|NCT00523341|9248386|P2|Overall Study|Lost to Follow-up|61
2679840|NCT00523341|9248387|P1|Overall Study|Lost to Follow-up|73
2679841|NCT00523341|9248386|P2|Overall Study|Death|110
2679842|NCT00523341|9248387|P1|Overall Study|Death|101
2679843|NCT00523341|9248386|P2|Overall Study|Adverse Event|155
2679844|NCT00523341|9248387|P1|Overall Study|Adverse Event|122
2679845|NCT00523341|9248386|P2|Overall Study|Other|198
2679846|NCT00523341|9248387|P1|Overall Study|Other|181
2679847|NCT00523341|9248386|P2|Overall Study|Withdrawal by Subject|427
2679848|NCT00523341|9248387|P1|Overall Study|Withdrawal by Subject|399
2679849|NCT00522951|9248504|P2|Period 2|residual contrast medium|1
2679850|NCT00522951|9248505|P1|Period 2|residual contrast medium|1
2679851|NCT00522951|9248504|P2|Period 2|Withdrawal by Subject|0
2679852|NCT00522951|9248505|P1|Period 2|Withdrawal by Subject|1
2679853|NCT00522951|9248504|P2|Washout Period|Death|1
2679854|NCT00522951|9248505|P1|Washout Period|Death|0
2679855|NCT00522951|9248504|P2|Washout Period|Adverse Event|1
2679856|NCT00522951|9248505|P1|Washout Period|Adverse Event|0
2679857|NCT00522951|9248504|P2|Period 1|body motion|1
2679858|NCT00522951|9248505|P1|Period 1|body motion|0
2679859|NCT00522873|9248560|P2|Overall Study|Never Received Medication|0
2679860|NCT00522873|9248561|P1|Overall Study|Never Received Medication|1
2679861|NCT00522873|9248560|P2|Overall Study|Medication Errors|1
2679862|NCT00522873|9248561|P1|Overall Study|Medication Errors|1
2679863|NCT00522873|9248560|P2|Overall Study|Personal Reasons|1
2679864|NCT00522873|9248561|P1|Overall Study|Personal Reasons|8
2679865|NCT00522873|9248560|P2|Overall Study|Lost to Follow-up|3
2679866|NCT00522873|9248561|P1|Overall Study|Lost to Follow-up|11
2679867|NCT00522873|9248560|P2|Overall Study|Protocol Violation|4
2679868|NCT00522873|9248561|P1|Overall Study|Protocol Violation|14
2679869|NCT00522873|9248560|P2|Overall Study|Withdrawal by Subject|9
2679870|NCT00522873|9248561|P1|Overall Study|Withdrawal by Subject|20
2679871|NCT00522873|9248560|P2|Overall Study|Adverse Event|26
2679872|NCT00522873|9248561|P1|Overall Study|Adverse Event|41
2679873|NCT00522626|9248574|P1|Overall Study|Lost to Follow-up|7
2679874|NCT00522548|9248580|P2|Overall Study|Withdrawal by Subject|2
2679875|NCT00522548|9248581|P1|Overall Study|Withdrawal by Subject|0
2679876|NCT00522548|9248580|P2|Overall Study|Adverse Event|2
2679877|NCT00522548|9248581|P1|Overall Study|Adverse Event|2
2679878|NCT00522457|9248609|P1|Overall Study|Adverse Event|2
2679879|NCT00522457|9248609|P1|Overall Study|Due to disease progression|16
2679880|NCT00522431|9248615|P1|Overall Study|Other/unknown|1
2679881|NCT00522431|9248615|P1|Overall Study|Subject non-compliance|1
2679882|NCT00522431|9248615|P1|Overall Study|Withdrawal by Subject|2
2679883|NCT00522431|9248615|P1|Overall Study|Protocol Violation|2
2679884|NCT00522431|9248615|P1|Overall Study|Adverse Event|5
2679885|NCT00522418|9248622|P2|Overall Study|Lack of Efficacy|1
2679886|NCT00522418|9248623|P1|Overall Study|Lack of Efficacy|0
2679887|NCT00522418|9248622|P2|Overall Study|Consent Withdraw|2
2679888|NCT00522418|9248623|P1|Overall Study|Consent Withdraw|1
2679889|NCT00522418|9248622|P2|Overall Study|Reason Not Specified|1
2679890|NCT00522418|9248623|P1|Overall Study|Reason Not Specified|3
2679891|NCT00522418|9248622|P2|Overall Study|Noncompliance|2
2679892|NCT00522418|9248623|P1|Overall Study|Noncompliance|2
2679893|NCT00522418|9248622|P2|Overall Study|Early Study Termination|47
2679894|NCT00522418|9248623|P1|Overall Study|Early Study Termination|46
2679895|NCT00522418|9248622|P2|Overall Study|Local IRB Consent Violation|5
2679896|NCT00522418|9248623|P1|Overall Study|Local IRB Consent Violation|5
2679897|NCT00522392|9248671|P2|Overall Study|Non-compliance|1
2679898|NCT00522392|9248672|P1|Overall Study|Non-compliance|0
2679899|NCT00522392|9248671|P2|Overall Study|Physician Decision|1
2679900|NCT00522392|9248672|P1|Overall Study|Physician Decision|0
2679901|NCT00522392|9248671|P2|Overall Study|Withdrawal by Subject|1
2679902|NCT00522392|9248672|P1|Overall Study|Withdrawal by Subject|1
2679903|NCT00522392|9248671|P2|Overall Study|Adverse Event|7
2679904|NCT00522392|9248672|P1|Overall Study|Adverse Event|7
2679905|NCT00522392|9248671|P2|Overall Study|Disease progression|3
2679906|NCT00522392|9248672|P1|Overall Study|Disease progression|0
2679907|NCT00522379|9248689|P5|Overall Study|Subject Withdrawal|0
2679908|NCT00522379|9248690|P4|Overall Study|Subject Withdrawal|1
2679909|NCT00522379|9248691|P3|Overall Study|Subject Withdrawal|0
2679910|NCT00522379|9248692|P2|Overall Study|Subject Withdrawal|0
2679911|NCT00522379|9248693|P1|Overall Study|Subject Withdrawal|0
2679912|NCT00522379|9248689|P5|Overall Study|Site Closed|0
2679913|NCT00522379|9248690|P4|Overall Study|Site Closed|1
2679914|NCT00522379|9248691|P3|Overall Study|Site Closed|0
2679915|NCT00522379|9248692|P2|Overall Study|Site Closed|0
2679916|NCT00522379|9248693|P1|Overall Study|Site Closed|0
2679917|NCT00522379|9248689|P5|Overall Study|Family Problem|0
2679918|NCT00522379|9248690|P4|Overall Study|Family Problem|0
2679919|NCT00522379|9248691|P3|Overall Study|Family Problem|1
2679920|NCT00522379|9248692|P2|Overall Study|Family Problem|0
2679921|NCT00522379|9248693|P1|Overall Study|Family Problem|0
2679922|NCT00522379|9248689|P5|Overall Study|Sponsor Request|0
2679923|NCT00522379|9248690|P4|Overall Study|Sponsor Request|0
2679924|NCT00522379|9248691|P3|Overall Study|Sponsor Request|0
2679925|NCT00522379|9248692|P2|Overall Study|Sponsor Request|1
2679926|NCT00522379|9248693|P1|Overall Study|Sponsor Request|0
2679927|NCT00522379|9248689|P5|Overall Study|Subject Moved|0
2679928|NCT00522379|9248690|P4|Overall Study|Subject Moved|0
2679929|NCT00522379|9248691|P3|Overall Study|Subject Moved|0
2679930|NCT00522379|9248692|P2|Overall Study|Subject Moved|1
2679931|NCT00522379|9248693|P1|Overall Study|Subject Moved|1
2679932|NCT00522379|9248689|P5|Overall Study|Dispensing error|0
2679933|NCT00522379|9248690|P4|Overall Study|Dispensing error|1
2679934|NCT00522379|9248691|P3|Overall Study|Dispensing error|0
2679935|NCT00522379|9248692|P2|Overall Study|Dispensing error|0
2679936|NCT00522379|9248693|P1|Overall Study|Dispensing error|1
2679937|NCT00522379|9248689|P5|Overall Study|Randomization error|1
2679938|NCT00522379|9248690|P4|Overall Study|Randomization error|0
2679939|NCT00522379|9248691|P3|Overall Study|Randomization error|0
2679940|NCT00522379|9248692|P2|Overall Study|Randomization error|0
2679941|NCT00522379|9248693|P1|Overall Study|Randomization error|0
2679942|NCT00522379|9248689|P5|Overall Study|Lost to Follow-up|2
2679943|NCT00522379|9248690|P4|Overall Study|Lost to Follow-up|2
2679944|NCT00522379|9248691|P3|Overall Study|Lost to Follow-up|4
2679945|NCT00522379|9248692|P2|Overall Study|Lost to Follow-up|0
2679946|NCT00522379|9248693|P1|Overall Study|Lost to Follow-up|1
2679947|NCT00522379|9248689|P5|Overall Study|Unsatisfactory Subject Compliance|0
2679948|NCT00522379|9248690|P4|Overall Study|Unsatisfactory Subject Compliance|0
2679949|NCT00522379|9248691|P3|Overall Study|Unsatisfactory Subject Compliance|0
2679950|NCT00522379|9248692|P2|Overall Study|Unsatisfactory Subject Compliance|2
2679951|NCT00522379|9248693|P1|Overall Study|Unsatisfactory Subject Compliance|1
2679952|NCT00522379|9248689|P5|Overall Study|Protocol Violation|0
2679953|NCT00522379|9248690|P4|Overall Study|Protocol Violation|0
2679954|NCT00522379|9248691|P3|Overall Study|Protocol Violation|2
2679955|NCT00522379|9248692|P2|Overall Study|Protocol Violation|1
2679956|NCT00522379|9248693|P1|Overall Study|Protocol Violation|1
2679957|NCT00522379|9248689|P5|Overall Study|Withdrawal by Subject|0
2679958|NCT00522379|9248690|P4|Overall Study|Withdrawal by Subject|2
2679959|NCT00522379|9248691|P3|Overall Study|Withdrawal by Subject|1
2679960|NCT00522379|9248692|P2|Overall Study|Withdrawal by Subject|3
2679961|NCT00522379|9248693|P1|Overall Study|Withdrawal by Subject|2
2679962|NCT00522379|9248689|P5|Overall Study|Lack of Efficacy|7
2679963|NCT00522379|9248690|P4|Overall Study|Lack of Efficacy|2
2679964|NCT00522379|9248691|P3|Overall Study|Lack of Efficacy|2
2679965|NCT00522379|9248692|P2|Overall Study|Lack of Efficacy|0
2679966|NCT00522379|9248693|P1|Overall Study|Lack of Efficacy|3
2679967|NCT00522379|9248689|P5|Overall Study|Adverse Event|17
2679968|NCT00522379|9248690|P4|Overall Study|Adverse Event|5
2679969|NCT00522379|9248691|P3|Overall Study|Adverse Event|12
2679970|NCT00522379|9248692|P2|Overall Study|Adverse Event|15
2679971|NCT00522379|9248693|P1|Overall Study|Adverse Event|12
2679972|NCT00522301|9248795|P1|Overall Study|Adverse Event|5
2679973|NCT00522301|9248795|P1|Overall Study|Withdrawal by Subject|1
2679974|NCT00522275|9248799|P1|Overall Study|Other: Subject had surgery for epilepsy|2
2679975|NCT00522275|9248799|P1|Overall Study|Other: Subject ran out of medication|1
2679976|NCT00522275|9248799|P1|Overall Study|Other: Sponsor request|2
2679977|NCT00522275|9248799|P1|Overall Study|Other: Travel to / from site difficulty|3
2679978|NCT00522275|9248799|P1|Overall Study|Other: Site / clinic closed|4
2679979|NCT00522275|9248799|P1|Overall Study|Other: Subject arrested|1
2679980|NCT00522275|9248799|P1|Overall Study|Other: Subject relocated|2
2679981|NCT00522275|9248799|P1|Overall Study|Other: Subject is pregnant|2
2679982|NCT00522275|9248799|P1|Overall Study|Other: Subject wants to become pregnant|2
2679983|NCT00522275|9248799|P1|Overall Study|Lost to Follow-up|8
2679984|NCT00522275|9248799|P1|Overall Study|Unsatisfactory compliance|11
2679985|NCT00522275|9248799|P1|Overall Study|Protocol deviation|1
2679986|NCT00522275|9248799|P1|Overall Study|Subject withdrew consent|16
2679987|NCT00522275|9248799|P1|Overall Study|Lack of Efficacy|80
2679988|NCT00522275|9248799|P1|Overall Study|Adverse Event|35
2679989|NCT00522041|9248820|P2|Overall Study|Did not receive treatment|1
2679990|NCT00522041|9248821|P1|Overall Study|Did not receive treatment|0
2679991|NCT00522041|9248820|P2|Overall Study|Voluntary withdrawal|4
2679992|NCT00522041|9248821|P1|Overall Study|Voluntary withdrawal|5
2679993|NCT00522041|9248820|P2|Overall Study|Lost to Follow-up|4
2679994|NCT00522041|9248821|P1|Overall Study|Lost to Follow-up|1
2679995|NCT00522041|9248820|P2|Overall Study|Protocol Violation|0
2679996|NCT00522041|9248821|P1|Overall Study|Protocol Violation|2
2679997|NCT00522041|9248820|P2|Overall Study|Adverse Event|3
2679998|NCT00522041|9248821|P1|Overall Study|Adverse Event|9
2679999|NCT00521599|9248880|P3|Overall Study|Did not meet protocol eligibility|1
2680000|NCT00521599|9248881|P2|Overall Study|Did not meet protocol eligibility|2
2680001|NCT00521599|9248882|P1|Overall Study|Did not meet protocol eligibility|2
2680002|NCT00521599|9248880|P3|Overall Study|Protocol Violation|2
2680003|NCT00521599|9248881|P2|Overall Study|Protocol Violation|4
2680004|NCT00521599|9248882|P1|Overall Study|Protocol Violation|2
2680005|NCT00521599|9248880|P3|Overall Study|Withdrawal by subject treatment related|2
2680006|NCT00521599|9248881|P2|Overall Study|Withdrawal by subject treatment related|1
2680007|NCT00521599|9248882|P1|Overall Study|Withdrawal by subject treatment related|3
2680008|NCT00521599|9248880|P3|Overall Study|Withdrawal by Subject|1
2680009|NCT00521599|9248881|P2|Overall Study|Withdrawal by Subject|5
2680010|NCT00521599|9248882|P1|Overall Study|Withdrawal by Subject|3
2680011|NCT00521599|9248880|P3|Overall Study|Lost to Follow-up|2
2680012|NCT00521599|9248881|P2|Overall Study|Lost to Follow-up|1
2680013|NCT00521599|9248882|P1|Overall Study|Lost to Follow-up|2
2680014|NCT00521599|9248880|P3|Overall Study|Treatment Failure|22
2680015|NCT00521599|9248881|P2|Overall Study|Treatment Failure|9
2680016|NCT00521599|9248882|P1|Overall Study|Treatment Failure|8
2680017|NCT00521599|9248880|P3|Overall Study|Adverse Event|6
2680018|NCT00521599|9248881|P2|Overall Study|Adverse Event|7
2680019|NCT00521599|9248882|P1|Overall Study|Adverse Event|5
2680020|NCT00521586|9248893|P2|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7
2680021|NCT00521586|9248894|P1|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2
2680022|NCT00521586|9248893|P2|Revaccination With 13vPnC (Year 5)|Failed to return|4
2680023|NCT00521586|9248894|P1|Revaccination With 13vPnC (Year 5)|Failed to return|1
2680024|NCT00521586|9248893|P2|Revaccination With 13vPnC (Year 5)|Subject request|1
2680025|NCT00521586|9248894|P1|Revaccination With 13vPnC (Year 5)|Subject request|0
2680026|NCT00521586|9248893|P2|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57
2680027|NCT00521586|9248894|P1|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54
2680028|NCT00521586|9248893|P2|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22
2680029|NCT00521586|9248894|P1|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18
2680030|NCT00521586|9248893|P2|Follow-up (From 6-month[Year 0]-Year 5)|Other|26
2680031|NCT00521586|9248894|P1|Follow-up (From 6-month[Year 0]-Year 5)|Other|22
2680032|NCT00521586|9248893|P2|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56
2680033|NCT00521586|9248894|P1|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55
2680034|NCT00521586|9248893|P2|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
2680035|NCT00521586|9248894|P1|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
2680036|NCT00521586|9248893|P2|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3
2680037|NCT00521586|9248894|P1|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7
2680038|NCT00521586|9248893|P2|Follow-up (From 6-month[Year 0]-Year 5)|Death|2
2680039|NCT00521586|9248894|P1|Follow-up (From 6-month[Year 0]-Year 5)|Death|5
2680040|NCT00521586|9248893|P2|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1
2680041|NCT00521586|9248894|P1|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5
2680042|NCT00521586|9248893|P2|Initial Vaccination (Year 0)|Failed to return|1
2680043|NCT00521586|9248894|P1|Initial Vaccination (Year 0)|Failed to return|0
2680044|NCT00521586|9248893|P2|Initial Vaccination (Year 0)|Death|0
2680045|NCT00521586|9248894|P1|Initial Vaccination (Year 0)|Death|1
2680046|NCT00521586|9248893|P2|Initial Vaccination (Year 0)|Adverse Event|1
2680047|NCT00521586|9248894|P1|Initial Vaccination (Year 0)|Adverse Event|0
2680048|NCT00521586|9248893|P2|Initial Vaccination (Year 0)|Investigator request|0
2680049|NCT00521586|9248894|P1|Initial Vaccination (Year 0)|Investigator request|2
2680050|NCT00521586|9248893|P2|Initial Vaccination (Year 0)|Other, unspecified|1
2680051|NCT00521586|9248894|P1|Initial Vaccination (Year 0)|Other, unspecified|3
2680052|NCT00521586|9248893|P2|Initial Vaccination (Year 0)|Protocol Violation|5
2680053|NCT00521586|9248894|P1|Initial Vaccination (Year 0)|Protocol Violation|2
2680054|NCT00521586|9248893|P2|Initial Vaccination (Year 0)|Lost to Follow-up|10
2680055|NCT00521586|9248894|P1|Initial Vaccination (Year 0)|Lost to Follow-up|5
2680056|NCT00521586|9248893|P2|Initial Vaccination (Year 0)|Subject request|11
2680057|NCT00521586|9248894|P1|Initial Vaccination (Year 0)|Subject request|8
2680058|NCT00521365|9248967|P1|Overall Study|Usage of not allowed drugs|6
2680059|NCT00521365|9248967|P1|Overall Study|Drug compliance|3
2680060|NCT00521365|9248967|P1|Overall Study|Protocol deviation|2
2680061|NCT00521365|9248967|P1|Overall Study|Lost to Follow-up|6
2680062|NCT00521365|9248967|P1|Overall Study|Adverse Event|3
2680063|NCT00521339|9248997|P3|Treatment Extension Phase|Death|1
2680064|NCT00521339|9248998|P2|Treatment Extension Phase|Death|0
2680065|NCT00521339|9248999|P1|Treatment Extension Phase|Death|0
2680066|NCT00521339|9248997|P3|Treatment Extension Phase|Withdrawal by Subject|2
2680067|NCT00521339|9248998|P2|Treatment Extension Phase|Withdrawal by Subject|0
2680068|NCT00521339|9248999|P1|Treatment Extension Phase|Withdrawal by Subject|0
2680069|NCT00521339|9248997|P3|Treatment Phase|Protocol Violation|0
2680070|NCT00521339|9248998|P2|Treatment Phase|Protocol Violation|0
2680071|NCT00521339|9248999|P1|Treatment Phase|Protocol Violation|1
2680072|NCT00521339|9248997|P3|Treatment Phase|Lost to Follow-up|0
2680073|NCT00521339|9248998|P2|Treatment Phase|Lost to Follow-up|0
2680074|NCT00521339|9248999|P1|Treatment Phase|Lost to Follow-up|1
2680075|NCT00521339|9248997|P3|Treatment Phase|Withdrawal by Subject|0
2680076|NCT00521339|9248998|P2|Treatment Phase|Withdrawal by Subject|0
2680077|NCT00521339|9248999|P1|Treatment Phase|Withdrawal by Subject|3
2680078|NCT00521339|9248997|P3|Treatment Phase|Lack of Efficacy|0
2680079|NCT00521339|9248998|P2|Treatment Phase|Lack of Efficacy|0
2680080|NCT00521339|9248999|P1|Treatment Phase|Lack of Efficacy|3
2680081|NCT00521339|9248997|P3|Treatment Phase|Intolerability to study drug|0
2680082|NCT00521339|9248998|P2|Treatment Phase|Intolerability to study drug|0
2680083|NCT00521339|9248999|P1|Treatment Phase|Intolerability to study drug|2
2680084|NCT00521339|9248997|P3|Treatment Phase|Adverse Event|0
2680085|NCT00521339|9248998|P2|Treatment Phase|Adverse Event|0
2680086|NCT00521339|9248999|P1|Treatment Phase|Adverse Event|2
2680087|NCT00521144|9249067|P5|Overall Study|Progressive Disease|6
2680088|NCT00521144|9249068|P4|Overall Study|Progressive Disease|0
2680089|NCT00521144|9249069|P3|Overall Study|Progressive Disease|2
2680090|NCT00521144|9249070|P2|Overall Study|Progressive Disease|2
2680091|NCT00521144|9249071|P1|Overall Study|Progressive Disease|4
2680092|NCT00521144|9249067|P5|Overall Study|Adverse Event|1
2680093|NCT00521144|9249068|P4|Overall Study|Adverse Event|0
2680094|NCT00521144|9249069|P3|Overall Study|Adverse Event|0
2680095|NCT00521144|9249070|P2|Overall Study|Adverse Event|1
2680096|NCT00521144|9249071|P1|Overall Study|Adverse Event|0
2680097|NCT00521144|9249067|P5|Overall Study|Not Treated|0
2680098|NCT00521144|9249068|P4|Overall Study|Not Treated|1
2680099|NCT00521144|9249069|P3|Overall Study|Not Treated|0
2680100|NCT00521144|9249070|P2|Overall Study|Not Treated|0
2680101|NCT00521144|9249071|P1|Overall Study|Not Treated|0
2680102|NCT00521079|9249085|P2|Overall Study|Withdrawal by Subject|3
2680103|NCT00521079|9249086|P1|Overall Study|Withdrawal by Subject|5
2680104|NCT00521079|9249085|P2|Overall Study|Lost to Follow-up|1
2680105|NCT00521079|9249086|P1|Overall Study|Lost to Follow-up|2
2680106|NCT00521079|9249085|P2|Overall Study|Adverse Event|1
2680107|NCT00521079|9249086|P1|Overall Study|Adverse Event|7
2680108|NCT00521053|9249096|P1|Observation Phase|Physician Decision|1
2680109|NCT00521053|9249096|P1|Observation Phase|Other non-study melanoma treatment|1
2680110|NCT00521053|9249096|P1|Observation Phase|Adverse Event|1
2680111|NCT00521053|9249096|P1|Observation Phase|Death|2
2680112|NCT00521053|9249096|P1|Observation Phase|Additional PV-10 via alternate protocol|8
2680113|NCT00521053|9249096|P1|Observation Phase|Disease Progression|55
2680114|NCT00521014|9249106|P1|Overall Study|Inevaluable, not treated|1
2680115|NCT00521001|9249110|P1|Overall Study|Ineligible|1
2680116|NCT00520975|9249119|P2|Overall Study|Not start protocol therapy|2
2680117|NCT00520975|9249120|P1|Overall Study|Not start protocol therapy|1
2680118|NCT00520975|9249119|P2|Overall Study|Other reasons|2
2680119|NCT00520975|9249120|P1|Overall Study|Other reasons|4
2680120|NCT00520975|9249119|P2|Overall Study|Other therapy|4
2680121|NCT00520975|9249120|P1|Overall Study|Other therapy|2
2680122|NCT00520975|9249119|P2|Overall Study|Withdrawal by Subject|5
2680123|NCT00520975|9249120|P1|Overall Study|Withdrawal by Subject|3
2680124|NCT00520975|9249119|P2|Overall Study|Death|2
2680125|NCT00520975|9249120|P1|Overall Study|Death|0
2680126|NCT00520975|9249119|P2|Overall Study|Adverse Event|10
2680127|NCT00520975|9249120|P1|Overall Study|Adverse Event|7
2680128|NCT00520975|9249119|P2|Overall Study|Disease progression|23
2680129|NCT00520975|9249120|P1|Overall Study|Disease progression|31
2680130|NCT00520936|9249152|P8|Overall Study|Protocol Violation|0
2680131|NCT00520936|9249153|P7|Overall Study|Protocol Violation|1
2680132|NCT00520936|9249154|P6|Overall Study|Protocol Violation|0
2680133|NCT00520936|9249155|P5|Overall Study|Protocol Violation|1
2680134|NCT00520936|9249156|P4|Overall Study|Protocol Violation|0
2680135|NCT00520936|9249157|P3|Overall Study|Protocol Violation|1
2680136|NCT00520936|9249158|P2|Overall Study|Protocol Violation|1
2680137|NCT00520936|9249159|P1|Overall Study|Protocol Violation|0
2680138|NCT00520936|9249152|P8|Overall Study|Death|0
2680139|NCT00520936|9249153|P7|Overall Study|Death|1
2680140|NCT00520936|9249154|P6|Overall Study|Death|0
2680141|NCT00520936|9249155|P5|Overall Study|Death|0
2680142|NCT00520936|9249156|P4|Overall Study|Death|0
2680143|NCT00520936|9249157|P3|Overall Study|Death|0
2680144|NCT00520936|9249158|P2|Overall Study|Death|0
2680145|NCT00520936|9249159|P1|Overall Study|Death|0
2680146|NCT00520936|9249152|P8|Overall Study|Toxicity Requiring Removal from Study|0
2680147|NCT00520936|9249153|P7|Overall Study|Toxicity Requiring Removal from Study|2
2680148|NCT00520936|9249154|P6|Overall Study|Toxicity Requiring Removal from Study|0
2680149|NCT00520936|9249155|P5|Overall Study|Toxicity Requiring Removal from Study|0
2680150|NCT00520936|9249156|P4|Overall Study|Toxicity Requiring Removal from Study|0
2680151|NCT00520936|9249157|P3|Overall Study|Toxicity Requiring Removal from Study|0
2680152|NCT00520936|9249158|P2|Overall Study|Toxicity Requiring Removal from Study|1
2680153|NCT00520936|9249159|P1|Overall Study|Toxicity Requiring Removal from Study|0
2680154|NCT00520936|9249152|P8|Overall Study|Withdrawal by Subject|1
2680155|NCT00520936|9249153|P7|Overall Study|Withdrawal by Subject|0
2680156|NCT00520936|9249154|P6|Overall Study|Withdrawal by Subject|0
2680157|NCT00520936|9249155|P5|Overall Study|Withdrawal by Subject|0
2680158|NCT00520936|9249156|P4|Overall Study|Withdrawal by Subject|0
2680159|NCT00520936|9249157|P3|Overall Study|Withdrawal by Subject|0
2680160|NCT00520936|9249158|P2|Overall Study|Withdrawal by Subject|0
2680161|NCT00520936|9249159|P1|Overall Study|Withdrawal by Subject|0
2680162|NCT00520936|9249152|P8|Overall Study|Physician Decision|0
2680163|NCT00520936|9249153|P7|Overall Study|Physician Decision|0
2680164|NCT00520936|9249154|P6|Overall Study|Physician Decision|0
2680165|NCT00520936|9249155|P5|Overall Study|Physician Decision|0
2680166|NCT00520936|9249156|P4|Overall Study|Physician Decision|0
2680167|NCT00520936|9249157|P3|Overall Study|Physician Decision|1
2680168|NCT00520936|9249158|P2|Overall Study|Physician Decision|2
2680169|NCT00520936|9249159|P1|Overall Study|Physician Decision|0
2680170|NCT00520845|9249214|P1|Overall Study|Alternative Therapy|1
2680171|NCT00520845|9249214|P1|Overall Study|Withdrawal by Subject|1
2680172|NCT00520845|9249214|P1|Overall Study|Disease Progression, relapse|13
2680173|NCT00520845|9249214|P1|Overall Study|Adverse Event|4
2680174|NCT00520845|9249214|P1|Overall Study|Death|3
2680175|NCT00520767|9249222|P1|Overall Study|Death|2
2680176|NCT00520741|9249228|P2|Overall Study|Other reasons for premature termination|6
2680177|NCT00520741|9249229|P1|Overall Study|Other reasons for premature termination|0
2680178|NCT00520741|9249228|P2|Overall Study|Lost to Follow-up|4
2680179|NCT00520741|9249229|P1|Overall Study|Lost to Follow-up|4
2680180|NCT00520741|9249228|P2|Overall Study|Unsatisfactory compliance of subject|3
2680181|NCT00520741|9249229|P1|Overall Study|Unsatisfactory compliance of subject|4
2680182|NCT00520741|9249228|P2|Overall Study|Protocol Violation|15
2680183|NCT00520741|9249229|P1|Overall Study|Protocol Violation|2
2680184|NCT00520741|9249228|P2|Overall Study|Withdrawal by Subject|11
2680185|NCT00520741|9249229|P1|Overall Study|Withdrawal by Subject|0
2680186|NCT00520741|9249228|P2|Overall Study|Lack of Efficacy|30
2680187|NCT00520741|9249229|P1|Overall Study|Lack of Efficacy|11
2680188|NCT00520741|9249228|P2|Overall Study|Adverse Event|56
2680189|NCT00520741|9249229|P1|Overall Study|Adverse Event|16
2680190|NCT00520676|9249247|P2|Overall Study|Withdrawal by Subject|11
2680191|NCT00520676|9249248|P1|Overall Study|Withdrawal by Subject|7
2680192|NCT00520676|9249247|P2|Overall Study|Physician Decision|1
2680193|NCT00520676|9249248|P1|Overall Study|Physician Decision|4
2680194|NCT00520676|9249247|P2|Overall Study|Lost to Follow-up|10
2680195|NCT00520676|9249248|P1|Overall Study|Lost to Follow-up|6
2680196|NCT00520676|9249247|P2|Overall Study|Death|81
2680197|NCT00520676|9249248|P1|Overall Study|Death|84
2680198|NCT00520572|9249274|P6|Overall Study|Did not receive Treatment|0
2680199|NCT00520572|9249275|P5|Overall Study|Did not receive Treatment|0
2680200|NCT00520572|9249276|P4|Overall Study|Did not receive Treatment|0
2680201|NCT00520572|9249277|P3|Overall Study|Did not receive Treatment|1
2680202|NCT00520572|9249278|P2|Overall Study|Did not receive Treatment|0
2680203|NCT00520572|9249279|P1|Overall Study|Did not receive Treatment|1
2680204|NCT00520572|9249274|P6|Overall Study|Long break in taking Medication|0
2680205|NCT00520572|9249275|P5|Overall Study|Long break in taking Medication|0
2680206|NCT00520572|9249276|P4|Overall Study|Long break in taking Medication|1
2680207|NCT00520572|9249277|P3|Overall Study|Long break in taking Medication|0
2680208|NCT00520572|9249278|P2|Overall Study|Long break in taking Medication|0
2680209|NCT00520572|9249279|P1|Overall Study|Long break in taking Medication|0
2680210|NCT00520572|9249274|P6|Overall Study|Oral corticotherapy for acute urticaria|0
2680211|NCT00520572|9249275|P5|Overall Study|Oral corticotherapy for acute urticaria|0
2680212|NCT00520572|9249276|P4|Overall Study|Oral corticotherapy for acute urticaria|0
2680213|NCT00520572|9249277|P3|Overall Study|Oral corticotherapy for acute urticaria|0
2680214|NCT00520572|9249278|P2|Overall Study|Oral corticotherapy for acute urticaria|1
2680215|NCT00520572|9249279|P1|Overall Study|Oral corticotherapy for acute urticaria|0
2680216|NCT00520572|9249274|P6|Overall Study|Incorrect enrollment|0
2680217|NCT00520572|9249275|P5|Overall Study|Incorrect enrollment|1
2680218|NCT00520572|9249276|P4|Overall Study|Incorrect enrollment|0
2680219|NCT00520572|9249277|P3|Overall Study|Incorrect enrollment|1
2680220|NCT00520572|9249278|P2|Overall Study|Incorrect enrollment|0
2680221|NCT00520572|9249279|P1|Overall Study|Incorrect enrollment|1
2680222|NCT00520572|9249274|P6|Overall Study|Lost to Follow-up|0
2680223|NCT00520572|9249275|P5|Overall Study|Lost to Follow-up|1
2680224|NCT00520572|9249276|P4|Overall Study|Lost to Follow-up|0
2680225|NCT00520572|9249277|P3|Overall Study|Lost to Follow-up|0
2680226|NCT00520572|9249278|P2|Overall Study|Lost to Follow-up|0
2680227|NCT00520572|9249279|P1|Overall Study|Lost to Follow-up|0
2680228|NCT00520572|9249274|P6|Overall Study|Lack of Efficacy|0
2680229|NCT00520572|9249275|P5|Overall Study|Lack of Efficacy|1
2680230|NCT00520572|9249276|P4|Overall Study|Lack of Efficacy|2
2680231|NCT00520572|9249277|P3|Overall Study|Lack of Efficacy|1
2680232|NCT00520572|9249278|P2|Overall Study|Lack of Efficacy|1
2680233|NCT00520572|9249279|P1|Overall Study|Lack of Efficacy|1
2680234|NCT00520572|9249274|P6|Overall Study|Protocol Violation|0
2680235|NCT00520572|9249275|P5|Overall Study|Protocol Violation|0
2680236|NCT00520572|9249276|P4|Overall Study|Protocol Violation|0
2680237|NCT00520572|9249277|P3|Overall Study|Protocol Violation|1
2680238|NCT00520572|9249278|P2|Overall Study|Protocol Violation|0
2680239|NCT00520572|9249279|P1|Overall Study|Protocol Violation|0
2680240|NCT00520572|9249274|P6|Overall Study|Withdrawal by Subject|0
2680241|NCT00520572|9249275|P5|Overall Study|Withdrawal by Subject|2
2680242|NCT00520572|9249276|P4|Overall Study|Withdrawal by Subject|2
2680243|NCT00520572|9249277|P3|Overall Study|Withdrawal by Subject|5
2680244|NCT00520572|9249278|P2|Overall Study|Withdrawal by Subject|9
2680245|NCT00520572|9249279|P1|Overall Study|Withdrawal by Subject|0
2680246|NCT00520572|9249274|P6|Overall Study|Adverse Event|2
2680247|NCT00520572|9249275|P5|Overall Study|Adverse Event|7
2680248|NCT00520572|9249276|P4|Overall Study|Adverse Event|9
2680249|NCT00520572|9249277|P3|Overall Study|Adverse Event|6
2680250|NCT00520572|9249278|P2|Overall Study|Adverse Event|3
2680251|NCT00520572|9249279|P1|Overall Study|Adverse Event|9
2680252|NCT00520546|9249317|P1|Overall Study|failed radiopharmaceut. synthesis of FEC|5
2680253|NCT00520546|9249317|P1|Overall Study|Withdrawal by Subject|1
2680254|NCT00520494|9249332|P1|Overall Study|Withdrawal by Subject|1
2680255|NCT00520481|9249357|P2|Overall Study|Withdrawal by Subject|0
2680256|NCT00520481|9249358|P1|Overall Study|Withdrawal by Subject|3
2680257|NCT00520481|9249357|P2|Overall Study|Adverse Event|1
2680258|NCT00520481|9249358|P1|Overall Study|Adverse Event|4
2680259|NCT00520403|9249382|P1|Bevacizumab Monotherapy|Symptomatic progression of cancer|1
2680260|NCT00520403|9249382|P1|Bevacizumab Monotherapy|Radiological progression of cancer|1
2680261|NCT00520403|9249382|P1|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1
2680262|NCT00520403|9249382|P1|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1
2680263|NCT00520403|9249382|P1|Bevacizumab + IFN/Vinblastine|Death|2
2680264|NCT00520403|9249382|P1|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4
2680265|NCT00520403|9249382|P1|Bevacizumab + IFN/Vinblastine|Adverse Event|4
2680266|NCT00520403|9249382|P1|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6
2680267|NCT00520351|9249391|P2|First Intervention|Withdrawal by Subject|1
2680268|NCT00520351|9249392|P1|First Intervention|Withdrawal by Subject|1
2680269|NCT00520299|9249407|P3|Overall Study|Progressive disease|4
2680270|NCT00520299|9249408|P2|Overall Study|Progressive disease|3
2680271|NCT00520299|9249409|P1|Overall Study|Progressive disease|0
2680272|NCT00520299|9249407|P3|Overall Study|Withdrawal by Subject|2
2680273|NCT00520299|9249408|P2|Overall Study|Withdrawal by Subject|0
2680274|NCT00520299|9249409|P1|Overall Study|Withdrawal by Subject|0
2680275|NCT00520130|9249464|P2|Overall Study|Physician Decision|1
2680276|NCT00520130|9249465|P1|Overall Study|Physician Decision|1
2680277|NCT00520130|9249464|P2|Overall Study|Disease progression on study|0
2680278|NCT00520130|9249465|P1|Overall Study|Disease progression on study|4
2680279|NCT00520039|9249507|P2|Overall Study|Exclusion criteria met at first visit|5
2680280|NCT00520039|9249508|P1|Overall Study|Exclusion criteria met at first visit|7
2680281|NCT00520013|9249521|P3|Overall Study|Physician Decision|3
2680282|NCT00520013|9249522|P2|Overall Study|Physician Decision|0
2680283|NCT00520013|9249523|P1|Overall Study|Physician Decision|0
2680284|NCT00520013|9249521|P3|Overall Study|Death|0
2680285|NCT00520013|9249522|P2|Overall Study|Death|1
2680286|NCT00520013|9249523|P1|Overall Study|Death|0
2680287|NCT00520013|9249521|P3|Overall Study|Clinical Progression|0
2680288|NCT00520013|9249522|P2|Overall Study|Clinical Progression|1
2680289|NCT00520013|9249523|P1|Overall Study|Clinical Progression|3
2680290|NCT00520013|9249521|P3|Overall Study|Progressive Disease|0
2680291|NCT00520013|9249522|P2|Overall Study|Progressive Disease|3
2680292|NCT00520013|9249523|P1|Overall Study|Progressive Disease|7
2680293|NCT00520013|9249521|P3|Overall Study|Adverse Event|7
2680294|NCT00520013|9249522|P2|Overall Study|Adverse Event|10
2680295|NCT00520013|9249523|P1|Overall Study|Adverse Event|2
2680296|NCT00520013|9249521|P3|Overall Study|Withdrawal by Subject|1
2680297|NCT00520013|9249522|P2|Overall Study|Withdrawal by Subject|0
2680298|NCT00520013|9249523|P1|Overall Study|Withdrawal by Subject|0
2680299|NCT00519896|9249533|P1|Overall Study|Adverse Event|1
2680300|NCT00519896|9249533|P1|Overall Study|Protocol Violation|1
2680301|NCT00519831|9249539|P1|Overall Study|Adverse Event|3
2680302|NCT00519779|9249556|P2|Overall Study|Withdrawal by Subject|1
2680303|NCT00519779|9249557|P1|Overall Study|Withdrawal by Subject|0
2680304|NCT00519649|9249573|P1|Overall Study|Withdrawal by Subject|1
2680305|NCT00519636|9249586|P4|Post Study Period|Subject randomized in error|1
2680306|NCT00519636|9249587|P3|Post Study Period|Subject randomized in error|0
2680307|NCT00519636|9249588|P2|Post Study Period|Subject randomized in error|0
2680308|NCT00519636|9249589|P1|Post Study Period|Subject randomized in error|0
2680309|NCT00519636|9249586|P4|Treatment Period 2|Subject misrandomized|1
2680310|NCT00519636|9249587|P3|Treatment Period 2|Subject misrandomized|0
2680311|NCT00519636|9249588|P2|Treatment Period 2|Subject misrandomized|0
2680312|NCT00519636|9249589|P1|Treatment Period 2|Subject misrandomized|0
2680313|NCT00519636|9249586|P4|Treatment Period 2|Per doctors request|0
2680314|NCT00519636|9249587|P3|Treatment Period 2|Per doctors request|1
2680315|NCT00519636|9249588|P2|Treatment Period 2|Per doctors request|0
2680316|NCT00519636|9249589|P1|Treatment Period 2|Per doctors request|0
2680317|NCT00519636|9249586|P4|Treatment Period 2|Subject randomized in error|0
2680318|NCT00519636|9249587|P3|Treatment Period 2|Subject randomized in error|0
2680319|NCT00519636|9249588|P2|Treatment Period 2|Subject randomized in error|1
2680320|NCT00519636|9249589|P1|Treatment Period 2|Subject randomized in error|0
2680321|NCT00519636|9249586|P4|Treatment Period 2|Failed To Meet Continuation Criteria|1
2680406|NCT00519376|9249698|P3|Treatment Period 4|Lost to Follow-up|1
2680322|NCT00519636|9249587|P3|Treatment Period 2|Failed To Meet Continuation Criteria|0
2680323|NCT00519636|9249588|P2|Treatment Period 2|Failed To Meet Continuation Criteria|0
2680324|NCT00519636|9249589|P1|Treatment Period 2|Failed To Meet Continuation Criteria|0
2680325|NCT00519636|9249586|P4|Washout Period|Prohibited medications|0
2680326|NCT00519636|9249587|P3|Washout Period|Prohibited medications|1
2680327|NCT00519636|9249588|P2|Washout Period|Prohibited medications|0
2680328|NCT00519636|9249589|P1|Washout Period|Prohibited medications|0
2680329|NCT00519636|9249586|P4|Washout Period|Subject randomized in error|0
2680330|NCT00519636|9249587|P3|Washout Period|Subject randomized in error|1
2680331|NCT00519636|9249588|P2|Washout Period|Subject randomized in error|0
2680332|NCT00519636|9249589|P1|Washout Period|Subject randomized in error|0
2680333|NCT00519636|9249586|P4|Washout Period|Per doctors request|0
2680334|NCT00519636|9249587|P3|Washout Period|Per doctors request|0
2680335|NCT00519636|9249588|P2|Washout Period|Per doctors request|1
2680336|NCT00519636|9249589|P1|Washout Period|Per doctors request|0
2680337|NCT00519636|9249586|P4|Washout Period|Non-compliant|0
2680338|NCT00519636|9249587|P3|Washout Period|Non-compliant|0
2680339|NCT00519636|9249588|P2|Washout Period|Non-compliant|1
2680340|NCT00519636|9249589|P1|Washout Period|Non-compliant|0
2680341|NCT00519636|9249586|P4|Washout Period|Participating in study at another site|0
2680342|NCT00519636|9249587|P3|Washout Period|Participating in study at another site|0
2680343|NCT00519636|9249588|P2|Washout Period|Participating in study at another site|0
2680344|NCT00519636|9249589|P1|Washout Period|Participating in study at another site|1
2680345|NCT00519636|9249586|P4|Washout Period|Out of pollen area > 48 hours|0
2680346|NCT00519636|9249587|P3|Washout Period|Out of pollen area > 48 hours|0
2680347|NCT00519636|9249588|P2|Washout Period|Out of pollen area > 48 hours|0
2680348|NCT00519636|9249589|P1|Washout Period|Out of pollen area > 48 hours|1
2680349|NCT00519636|9249586|P4|Washout Period|Failed to meet continuation criteria|3
2680350|NCT00519636|9249587|P3|Washout Period|Failed to meet continuation criteria|9
2680351|NCT00519636|9249588|P2|Washout Period|Failed to meet continuation criteria|11
2680352|NCT00519636|9249589|P1|Washout Period|Failed to meet continuation criteria|14
2680353|NCT00519636|9249586|P4|Washout Period|Withdrawal by Subject|0
2680354|NCT00519636|9249587|P3|Washout Period|Withdrawal by Subject|1
2680355|NCT00519636|9249588|P2|Washout Period|Withdrawal by Subject|0
2680356|NCT00519636|9249589|P1|Washout Period|Withdrawal by Subject|1
2680357|NCT00519636|9249586|P4|Washout Period|Protocol Violation|2
2680358|NCT00519636|9249587|P3|Washout Period|Protocol Violation|1
2680359|NCT00519636|9249588|P2|Washout Period|Protocol Violation|0
2680360|NCT00519636|9249589|P1|Washout Period|Protocol Violation|0
2680361|NCT00519636|9249586|P4|Washout Period|Lost to Follow-up|0
2680362|NCT00519636|9249587|P3|Washout Period|Lost to Follow-up|0
2680363|NCT00519636|9249588|P2|Washout Period|Lost to Follow-up|0
2680364|NCT00519636|9249589|P1|Washout Period|Lost to Follow-up|1
2680365|NCT00519636|9249586|P4|Washout Period|Adverse Event|0
2680366|NCT00519636|9249587|P3|Washout Period|Adverse Event|1
2680367|NCT00519636|9249588|P2|Washout Period|Adverse Event|1
2680368|NCT00519636|9249589|P1|Washout Period|Adverse Event|2
2680369|NCT00519636|9249586|P4|Treatment Period 1|Sponsor request due to missed visit|0
2680370|NCT00519636|9249587|P3|Treatment Period 1|Sponsor request due to missed visit|0
2680371|NCT00519636|9249588|P2|Treatment Period 1|Sponsor request due to missed visit|0
2680372|NCT00519636|9249589|P1|Treatment Period 1|Sponsor request due to missed visit|1
2680373|NCT00519636|9249586|P4|Treatment Period 1|Adverse Event|0
2680374|NCT00519636|9249587|P3|Treatment Period 1|Adverse Event|1
2680375|NCT00519636|9249588|P2|Treatment Period 1|Adverse Event|0
2680376|NCT00519636|9249589|P1|Treatment Period 1|Adverse Event|1
2680377|NCT00519623|9249619|P1|Overall Study|Adverse Event|1
2680378|NCT00519532|9249653|P1|Overall Study|Lost to Follow-up|2
2680379|NCT00519532|9249653|P1|Overall Study|Withdrawal by Subject|5
2680380|NCT00519532|9249653|P1|Overall Study|Adverse Event|11
2680381|NCT00519428|9249663|P3|Overall Study|unstated|2
2680382|NCT00519428|9249664|P2|Overall Study|unstated|3
2680383|NCT00519428|9249665|P1|Overall Study|unstated|1
2680384|NCT00519428|9249663|P3|Overall Study|Withdrawal by Subject|7
2680385|NCT00519428|9249664|P2|Overall Study|Withdrawal by Subject|3
2680386|NCT00519428|9249665|P1|Overall Study|Withdrawal by Subject|8
2680387|NCT00519428|9249663|P3|Overall Study|Lost to Follow-up|6
2680388|NCT00519428|9249664|P2|Overall Study|Lost to Follow-up|7
2680389|NCT00519428|9249665|P1|Overall Study|Lost to Follow-up|7
2680390|NCT00519428|9249663|P3|Overall Study|Adverse Event|10
2680391|NCT00519428|9249664|P2|Overall Study|Adverse Event|2
2680392|NCT00519428|9249665|P1|Overall Study|Adverse Event|5
2680393|NCT00519376|9249685|P16|Treatment Period 4|Lost to Follow-up|0
2680394|NCT00519376|9249686|P15|Treatment Period 4|Lost to Follow-up|0
2680395|NCT00519376|9249687|P14|Treatment Period 4|Lost to Follow-up|0
2680396|NCT00519376|9249688|P13|Treatment Period 4|Lost to Follow-up|0
2680397|NCT00519376|9249689|P12|Treatment Period 4|Lost to Follow-up|0
2680398|NCT00519376|9249690|P11|Treatment Period 4|Lost to Follow-up|0
2680399|NCT00519376|9249691|P10|Treatment Period 4|Lost to Follow-up|0
2680400|NCT00519376|9249692|P9|Treatment Period 4|Lost to Follow-up|0
2680401|NCT00519376|9249693|P8|Treatment Period 4|Lost to Follow-up|0
2680402|NCT00519376|9249694|P7|Treatment Period 4|Lost to Follow-up|0
2680403|NCT00519376|9249695|P6|Treatment Period 4|Lost to Follow-up|0
2680404|NCT00519376|9249696|P5|Treatment Period 4|Lost to Follow-up|0
2680405|NCT00519376|9249697|P4|Treatment Period 4|Lost to Follow-up|0
2680407|NCT00519376|9249699|P2|Treatment Period 4|Lost to Follow-up|0
2680408|NCT00519376|9249700|P1|Treatment Period 4|Lost to Follow-up|0
2680409|NCT00519376|9249685|P16|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
2680410|NCT00519376|9249686|P15|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
2680411|NCT00519376|9249687|P14|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
2680412|NCT00519376|9249688|P13|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1
2680413|NCT00519376|9249689|P12|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
2680414|NCT00519376|9249690|P11|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
2680415|NCT00519376|9249691|P10|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
2680416|NCT00519376|9249692|P9|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
2680417|NCT00519376|9249693|P8|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
2680418|NCT00519376|9249694|P7|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
2680419|NCT00519376|9249695|P6|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
2680420|NCT00519376|9249696|P5|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
2680421|NCT00519376|9249697|P4|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
2680422|NCT00519376|9249698|P3|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
2680423|NCT00519376|9249699|P2|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
2680424|NCT00519376|9249700|P1|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
2680425|NCT00519285|9249824|P2|Overall Study|Treatment ongoing|2
2680426|NCT00519285|9249825|P1|Overall Study|Treatment ongoing|1
2680427|NCT00519285|9249824|P2|Overall Study|Not treated|7
2680428|NCT00519285|9249825|P1|Overall Study|Not treated|8
2680429|NCT00519285|9249824|P2|Overall Study|Reason unspecified|8
2680430|NCT00519285|9249825|P1|Overall Study|Reason unspecified|5
2680431|NCT00519285|9249824|P2|Overall Study|Poor compliance to protocol|7
2680432|NCT00519285|9249825|P1|Overall Study|Poor compliance to protocol|5
2680433|NCT00519285|9249824|P2|Overall Study|Consent withdrawn|5
2680434|NCT00519285|9249825|P1|Overall Study|Consent withdrawn|4
2680435|NCT00519285|9249824|P2|Overall Study|Participant's request|84
2680436|NCT00519285|9249825|P1|Overall Study|Participant's request|53
2680437|NCT00519285|9249824|P2|Overall Study|Physician Decision|47
2680438|NCT00519285|9249825|P1|Overall Study|Physician Decision|75
2680439|NCT00519285|9249824|P2|Overall Study|Disease progression|186
2680440|NCT00519285|9249825|P1|Overall Study|Disease progression|334
2680441|NCT00519285|9249824|P2|Overall Study|Adverse Event|266
2680442|NCT00519285|9249825|P1|Overall Study|Adverse Event|127
2680443|NCT00519194|9249851|P1|Overall Study|Lost to Follow-up|3
2680444|NCT00519194|9249851|P1|Overall Study|Death|9
2680445|NCT00519194|9249851|P1|Overall Study|Withdrawal by Subject|9
2680446|NCT00519077|9249866|P1|Overall Study|Other|2
2680447|NCT00519077|9249866|P1|Overall Study|Death|6
2680448|NCT00518986|9249873|P2|Overall Study|Non-Specific|1
2680449|NCT00518986|9249874|P1|Overall Study|Non-Specific|2
2680450|NCT00518986|9249873|P2|Overall Study|Withdrawal by Subject|4
2680451|NCT00518986|9249874|P1|Overall Study|Withdrawal by Subject|4
2680452|NCT00518986|9249873|P2|Overall Study|Protocol Violation|7
2680453|NCT00518986|9249874|P1|Overall Study|Protocol Violation|5
2680454|NCT00518986|9249873|P2|Overall Study|Physician Decision|3
2680455|NCT00518986|9249874|P1|Overall Study|Physician Decision|0
2680456|NCT00518986|9249873|P2|Overall Study|Lost to Follow-up|2
2680457|NCT00518986|9249874|P1|Overall Study|Lost to Follow-up|3
2680458|NCT00518986|9249873|P2|Overall Study|Lack of Efficacy|2
2680459|NCT00518986|9249874|P1|Overall Study|Lack of Efficacy|0
2680460|NCT00518986|9249873|P2|Overall Study|Adverse Event|7
2680461|NCT00518986|9249874|P1|Overall Study|Adverse Event|12
2680462|NCT00518973|9250000|P2|Overall Study|Withdrawal by Subject|2
2680463|NCT00518973|9250001|P1|Overall Study|Withdrawal by Subject|3
2680464|NCT00518882|9250017|P2|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25
2680465|NCT00518882|9250018|P1|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18
2680466|NCT00518882|9250017|P2|Open-Label Extension, Week 26-78|Subject decision|0
2680467|NCT00518882|9250018|P1|Open-Label Extension, Week 26-78|Subject decision|2
2680468|NCT00518882|9250017|P2|Open-Label Extension, Week 26-78|Exclusion criteria|0
2680469|NCT00518882|9250018|P1|Open-Label Extension, Week 26-78|Exclusion criteria|2
2680470|NCT00518882|9250017|P2|Open-Label Extension, Week 26-78|Decreased kidney function|0
2680471|NCT00518882|9250018|P1|Open-Label Extension, Week 26-78|Decreased kidney function|1
2680472|NCT00518882|9250017|P2|Open-Label Extension, Week 26-78|Creatine increased|0
2680473|NCT00518882|9250018|P1|Open-Label Extension, Week 26-78|Creatine increased|1
2680474|NCT00518882|9250017|P2|Open-Label Extension, Week 26-78|Change in treatment|1
2680475|NCT00518882|9250018|P1|Open-Label Extension, Week 26-78|Change in treatment|1
2680476|NCT00518882|9250017|P2|Open-Label Extension, Week 26-78|Consent withdrawn|1
2680477|NCT00518882|9250018|P1|Open-Label Extension, Week 26-78|Consent withdrawn|2
2680478|NCT00518882|9250017|P2|Open-Label Extension, Week 26-78|Lost to follow up|1
2680479|NCT00518882|9250018|P1|Open-Label Extension, Week 26-78|Lost to follow up|1
2680480|NCT00518882|9250017|P2|Open-Label Extension, Week 26-78|Hypoglycaemia|1
2680481|NCT00518882|9250018|P1|Open-Label Extension, Week 26-78|Hypoglycaemia|0
2680482|NCT00518882|9250017|P2|Open-Label Extension, Week 26-78|Withdrawel criteria|2
2680483|NCT00518882|9250018|P1|Open-Label Extension, Week 26-78|Withdrawel criteria|1
2680484|NCT00518882|9250017|P2|Open-Label Extension, Week 26-78|Protocol Violation|4
2680485|NCT00518882|9250018|P1|Open-Label Extension, Week 26-78|Protocol Violation|3
2680486|NCT00518882|9250017|P2|Open-Label Extension, Week 26-78|Lack of Efficacy|5
2680570|NCT00518336|9250301|P2|Year 8|Could not attend in time|1
2680487|NCT00518882|9250018|P1|Open-Label Extension, Week 26-78|Lack of Efficacy|6
2680488|NCT00518882|9250017|P2|Open-Label Extension, Week 26-78|Adverse Event|9
2680489|NCT00518882|9250018|P1|Open-Label Extension, Week 26-78|Adverse Event|3
2680490|NCT00518882|9250017|P2|Double-Blind, Week 0-26|Mutual consent|1
2680491|NCT00518882|9250018|P1|Double-Blind, Week 0-26|Mutual consent|0
2680492|NCT00518882|9250017|P2|Double-Blind, Week 0-26|Hypoglycaemia|2
2680493|NCT00518882|9250018|P1|Double-Blind, Week 0-26|Hypoglycaemia|0
2680494|NCT00518882|9250017|P2|Double-Blind, Week 0-26|Fear of hypoglycaemia|1
2680495|NCT00518882|9250018|P1|Double-Blind, Week 0-26|Fear of hypoglycaemia|0
2680496|NCT00518882|9250017|P2|Double-Blind, Week 0-26|Loss of trust|1
2680497|NCT00518882|9250018|P1|Double-Blind, Week 0-26|Loss of trust|0
2680498|NCT00518882|9250017|P2|Double-Blind, Week 0-26|Withdrawal of consent|3
2680499|NCT00518882|9250018|P1|Double-Blind, Week 0-26|Withdrawal of consent|1
2680500|NCT00518882|9250017|P2|Double-Blind, Week 0-26|Subject decision|1
2680501|NCT00518882|9250018|P1|Double-Blind, Week 0-26|Subject decision|1
2680502|NCT00518882|9250017|P2|Double-Blind, Week 0-26|Lost to follow up|1
2680503|NCT00518882|9250018|P1|Double-Blind, Week 0-26|Lost to follow up|2
2680504|NCT00518882|9250017|P2|Double-Blind, Week 0-26|Withdrawal criteria|1
2680505|NCT00518882|9250018|P1|Double-Blind, Week 0-26|Withdrawal criteria|1
2680506|NCT00518882|9250017|P2|Double-Blind, Week 0-26|Protocol Violation|3
2680507|NCT00518882|9250018|P1|Double-Blind, Week 0-26|Protocol Violation|4
2680508|NCT00518882|9250017|P2|Double-Blind, Week 0-26|Lack of Efficacy|0
2680509|NCT00518882|9250018|P1|Double-Blind, Week 0-26|Lack of Efficacy|1
2680510|NCT00518882|9250017|P2|Double-Blind, Week 0-26|Adverse Event|31
2680511|NCT00518882|9250018|P1|Double-Blind, Week 0-26|Adverse Event|23
2680512|NCT00518687|9250199|P2|Overall Study|Withdrawal by Subject|110
2680513|NCT00518687|9250200|P1|Overall Study|Withdrawal by Subject|110
2680514|NCT00518687|9250199|P2|Overall Study|Study terminated by sponsor|918
2680515|NCT00518687|9250200|P1|Overall Study|Study terminated by sponsor|930
2680516|NCT00518687|9250199|P2|Overall Study|Protocol Violation|10
2680517|NCT00518687|9250200|P1|Overall Study|Protocol Violation|8
2680518|NCT00518687|9250199|P2|Overall Study|Progressive disease|2
2680519|NCT00518687|9250200|P1|Overall Study|Progressive disease|2
2680520|NCT00518687|9250199|P2|Overall Study|Physician Decision|48
2680521|NCT00518687|9250200|P1|Overall Study|Physician Decision|42
2680522|NCT00518687|9250199|P2|Overall Study|Lost to Follow-up|155
2680523|NCT00518687|9250200|P1|Overall Study|Lost to Follow-up|144
2680524|NCT00518687|9250199|P2|Overall Study|Adverse Event|177
2680525|NCT00518687|9250200|P1|Overall Study|Adverse Event|201
2680526|NCT00518622|9250220|P8|Overall Study|Study medication taken incorrectly|0
2680527|NCT00518622|9250221|P7|Overall Study|Study medication taken incorrectly|0
2680528|NCT00518622|9250222|P6|Overall Study|Study medication taken incorrectly|0
2680529|NCT00518622|9250223|P5|Overall Study|Study medication taken incorrectly|0
2680530|NCT00518622|9250224|P4|Overall Study|Study medication taken incorrectly|0
2680531|NCT00518622|9250225|P3|Overall Study|Study medication taken incorrectly|0
2680532|NCT00518622|9250226|P2|Overall Study|Study medication taken incorrectly|1
2680533|NCT00518622|9250227|P1|Overall Study|Study medication taken incorrectly|0
2680534|NCT00518622|9250220|P8|Overall Study|Lost to Follow-up|0
2680535|NCT00518622|9250221|P7|Overall Study|Lost to Follow-up|0
2680536|NCT00518622|9250222|P6|Overall Study|Lost to Follow-up|0
2680537|NCT00518622|9250223|P5|Overall Study|Lost to Follow-up|0
2680538|NCT00518622|9250224|P4|Overall Study|Lost to Follow-up|0
2680539|NCT00518622|9250225|P3|Overall Study|Lost to Follow-up|1
2680540|NCT00518622|9250226|P2|Overall Study|Lost to Follow-up|0
2680541|NCT00518622|9250227|P1|Overall Study|Lost to Follow-up|0
2680542|NCT00518531|9250255|P2|Treatment Period 2|Non-compliance|2
2680543|NCT00518531|9250256|P1|Treatment Period 2|Non-compliance|1
2680544|NCT00518531|9250255|P2|Treatment Period 2|Protocol-specified criteria|1
2680545|NCT00518531|9250256|P1|Treatment Period 2|Protocol-specified criteria|0
2680546|NCT00518531|9250255|P2|Treatment Period 2|Adverse Event|7
2680547|NCT00518531|9250256|P1|Treatment Period 2|Adverse Event|1
2680548|NCT00518531|9250255|P2|Treatment Period 2|Complete out of scheduled visit window|2
2680549|NCT00518531|9250256|P1|Treatment Period 2|Complete out of scheduled visit window|1
2680550|NCT00518531|9250255|P2|Treatment Period 2|Withdrawal by Subject|8
2680551|NCT00518531|9250256|P1|Treatment Period 2|Withdrawal by Subject|0
2680552|NCT00518531|9250255|P2|Treatment Period 1|Early crossover|3
2680553|NCT00518531|9250256|P1|Treatment Period 1|Early crossover|1
2680554|NCT00518531|9250255|P2|Treatment Period 1|Withdrawal by Subject|6
2680555|NCT00518531|9250256|P1|Treatment Period 1|Withdrawal by Subject|4
2680556|NCT00518531|9250255|P2|Treatment Period 1|Protocol Violation|0
2680557|NCT00518531|9250256|P1|Treatment Period 1|Protocol Violation|2
2680558|NCT00518531|9250255|P2|Treatment Period 1|Physician Decision|0
2680559|NCT00518531|9250256|P1|Treatment Period 1|Physician Decision|1
2680560|NCT00518531|9250255|P2|Treatment Period 1|Lost to Follow-up|3
2680561|NCT00518531|9250256|P1|Treatment Period 1|Lost to Follow-up|5
2680562|NCT00518531|9250255|P2|Treatment Period 1|Adverse Event|0
2680563|NCT00518531|9250256|P1|Treatment Period 1|Adverse Event|5
2680564|NCT00518336|9250301|P2|Year 9|Personal reasons|0
2680565|NCT00518336|9250302|P1|Year 9|Personal reasons|1
2680566|NCT00518336|9250301|P2|Year 9|Lost to Follow-up|0
2680567|NCT00518336|9250302|P1|Year 9|Lost to Follow-up|3
2680568|NCT00518336|9250301|P2|Year 9|Migrated/moved from study area|1
2680569|NCT00518336|9250302|P1|Year 9|Migrated/moved from study area|1
2680571|NCT00518336|9250302|P1|Year 8|Could not attend in time|0
2680572|NCT00518336|9250301|P2|Year 8|Lost to Follow-up|1
2680573|NCT00518336|9250302|P1|Year 8|Lost to Follow-up|1
2680574|NCT00518336|9250301|P2|Year 7|Could not attend in time|3
2680575|NCT00518336|9250302|P1|Year 7|Could not attend in time|0
2680576|NCT00518336|9250301|P2|Year 7|Lost to Follow-up|0
2680577|NCT00518336|9250302|P1|Year 7|Lost to Follow-up|2
2680578|NCT00518323|9250468|P4|Overall Study|Prohibited medication and others|0
2680579|NCT00518323|9250469|P3|Overall Study|Prohibited medication and others|1
2680580|NCT00518323|9250470|P2|Overall Study|Prohibited medication and others|1
2680581|NCT00518323|9250471|P1|Overall Study|Prohibited medication and others|3
2680582|NCT00518323|9250468|P4|Overall Study|Adverse Event|0
2680583|NCT00518323|9250469|P3|Overall Study|Adverse Event|1
2680584|NCT00518323|9250470|P2|Overall Study|Adverse Event|1
2680585|NCT00518323|9250471|P1|Overall Study|Adverse Event|1
2680586|NCT00518323|9250468|P4|Overall Study|Lost to Follow-up|3
2680587|NCT00518323|9250469|P3|Overall Study|Lost to Follow-up|1
2680588|NCT00518323|9250470|P2|Overall Study|Lost to Follow-up|2
2680589|NCT00518323|9250471|P1|Overall Study|Lost to Follow-up|0
2680590|NCT00518323|9250468|P4|Overall Study|Withdrawal by Subject|2
2680591|NCT00518323|9250469|P3|Overall Study|Withdrawal by Subject|4
2680592|NCT00518323|9250470|P2|Overall Study|Withdrawal by Subject|2
2680593|NCT00518323|9250471|P1|Overall Study|Withdrawal by Subject|1
2680594|NCT00518323|9250468|P4|Overall Study|Lack of Efficacy|20
2680595|NCT00518323|9250469|P3|Overall Study|Lack of Efficacy|4
2680596|NCT00518323|9250470|P2|Overall Study|Lack of Efficacy|2
2680597|NCT00518323|9250471|P1|Overall Study|Lack of Efficacy|14
2680598|NCT00518284|9250501|P4|Overall Study|Study Termination|2
2680599|NCT00518284|9250502|P3|Overall Study|Study Termination|1
2680600|NCT00518284|9250503|P2|Overall Study|Study Termination|2
2680601|NCT00518284|9250504|P1|Overall Study|Study Termination|0
2680602|NCT00518284|9250501|P4|Overall Study|Adverse Event|0
2680603|NCT00518284|9250502|P3|Overall Study|Adverse Event|0
2680604|NCT00518284|9250503|P2|Overall Study|Adverse Event|1
2680605|NCT00518284|9250504|P1|Overall Study|Adverse Event|0
2680606|NCT00518206|9250560|P2|Overall Study|Completion Status Unknown|0
2680607|NCT00518206|9250561|P1|Overall Study|Completion Status Unknown|1
2680608|NCT00518206|9250560|P2|Overall Study|Reason Unknown|0
2680609|NCT00518206|9250561|P1|Overall Study|Reason Unknown|1
2680610|NCT00518206|9250560|P2|Overall Study|Drug Supply Issue|0
2680611|NCT00518206|9250561|P1|Overall Study|Drug Supply Issue|1
2680612|NCT00518206|9250560|P2|Overall Study|Withdrawal by Subject|0
2680613|NCT00518206|9250561|P1|Overall Study|Withdrawal by Subject|2
2680614|NCT00518206|9250560|P2|Overall Study|Disease Progression Requiring Therapy|6
2680615|NCT00518206|9250561|P1|Overall Study|Disease Progression Requiring Therapy|6
2680616|NCT00518180|9250578|P3|Overall Study|Adverse Event|0
2680617|NCT00518180|9250579|P2|Overall Study|Adverse Event|0
2680618|NCT00518180|9250580|P1|Overall Study|Adverse Event|1
2680619|NCT00518180|9250578|P3|Overall Study|Unable to classify|0
2680620|NCT00518180|9250579|P2|Overall Study|Unable to classify|2
2680621|NCT00518180|9250580|P1|Overall Study|Unable to classify|0
2680622|NCT00518180|9250578|P3|Overall Study|Protocol Violation|4
2680623|NCT00518180|9250579|P2|Overall Study|Protocol Violation|7
2680624|NCT00518180|9250580|P1|Overall Study|Protocol Violation|5
2680625|NCT00518180|9250578|P3|Overall Study|Administrative reason|2
2680626|NCT00518180|9250579|P2|Overall Study|Administrative reason|2
2680627|NCT00518180|9250580|P1|Overall Study|Administrative reason|0
2680628|NCT00518180|9250578|P3|Overall Study|Lost to Follow-up|34
2680629|NCT00518180|9250579|P2|Overall Study|Lost to Follow-up|28
2680630|NCT00518180|9250580|P1|Overall Study|Lost to Follow-up|30
2680631|NCT00518180|9250578|P3|Overall Study|Withdrawal by Subject|42
2680632|NCT00518180|9250579|P2|Overall Study|Withdrawal by Subject|30
2680633|NCT00518180|9250580|P1|Overall Study|Withdrawal by Subject|29
2680634|NCT00518115|9250636|P10|Overall Study|Moved Out of State|1
2680635|NCT00518115|9250637|P9|Overall Study|Moved Out of State|0
2680636|NCT00518115|9250638|P8|Overall Study|Moved Out of State|0
2680637|NCT00518115|9250639|P7|Overall Study|Moved Out of State|0
2680638|NCT00518115|9250640|P6|Overall Study|Moved Out of State|0
2680639|NCT00518115|9250641|P5|Overall Study|Moved Out of State|0
2680640|NCT00518115|9250642|P4|Overall Study|Moved Out of State|0
2680641|NCT00518115|9250643|P3|Overall Study|Moved Out of State|0
2680642|NCT00518115|9250644|P2|Overall Study|Moved Out of State|0
2680643|NCT00518115|9250645|P1|Overall Study|Moved Out of State|0
2680644|NCT00518115|9250636|P10|Overall Study|Withdrew Consent|0
2680645|NCT00518115|9250637|P9|Overall Study|Withdrew Consent|0
2680646|NCT00518115|9250638|P8|Overall Study|Withdrew Consent|0
2680647|NCT00518115|9250639|P7|Overall Study|Withdrew Consent|0
2680648|NCT00518115|9250640|P6|Overall Study|Withdrew Consent|1
2680649|NCT00518115|9250641|P5|Overall Study|Withdrew Consent|0
2680650|NCT00518115|9250642|P4|Overall Study|Withdrew Consent|0
2680651|NCT00518115|9250643|P3|Overall Study|Withdrew Consent|0
2680652|NCT00518115|9250644|P2|Overall Study|Withdrew Consent|0
2680653|NCT00518115|9250645|P1|Overall Study|Withdrew Consent|0
2680654|NCT00518115|9250636|P10|Overall Study|Family Emergency; Had to Go to England|0
2680655|NCT00518115|9250637|P9|Overall Study|Family Emergency; Had to Go to England|0
2680656|NCT00518115|9250638|P8|Overall Study|Family Emergency; Had to Go to England|0
2680657|NCT00518115|9250639|P7|Overall Study|Family Emergency; Had to Go to England|0
2680658|NCT00518115|9250640|P6|Overall Study|Family Emergency; Had to Go to England|0
2680659|NCT00518115|9250641|P5|Overall Study|Family Emergency; Had to Go to England|1
2680660|NCT00518115|9250642|P4|Overall Study|Family Emergency; Had to Go to England|0
2680661|NCT00518115|9250643|P3|Overall Study|Family Emergency; Had to Go to England|0
2680662|NCT00518115|9250644|P2|Overall Study|Family Emergency; Had to Go to England|0
2680663|NCT00518115|9250645|P1|Overall Study|Family Emergency; Had to Go to England|0
2680664|NCT00518115|9250636|P10|Overall Study|Violation of Exclusion Criteria|0
2680665|NCT00518115|9250637|P9|Overall Study|Violation of Exclusion Criteria|0
2680666|NCT00518115|9250638|P8|Overall Study|Violation of Exclusion Criteria|0
2680667|NCT00518115|9250639|P7|Overall Study|Violation of Exclusion Criteria|1
2680668|NCT00518115|9250640|P6|Overall Study|Violation of Exclusion Criteria|0
2680669|NCT00518115|9250641|P5|Overall Study|Violation of Exclusion Criteria|0
2680670|NCT00518115|9250642|P4|Overall Study|Violation of Exclusion Criteria|1
2680671|NCT00518115|9250643|P3|Overall Study|Violation of Exclusion Criteria|0
2680672|NCT00518115|9250644|P2|Overall Study|Violation of Exclusion Criteria|0
2680673|NCT00518115|9250645|P1|Overall Study|Violation of Exclusion Criteria|0
2680674|NCT00518115|9250636|P10|Overall Study|Wrong Monotherapy Administered|0
2680675|NCT00518115|9250637|P9|Overall Study|Wrong Monotherapy Administered|0
2680676|NCT00518115|9250638|P8|Overall Study|Wrong Monotherapy Administered|0
2680677|NCT00518115|9250639|P7|Overall Study|Wrong Monotherapy Administered|1
2680678|NCT00518115|9250640|P6|Overall Study|Wrong Monotherapy Administered|0
2680679|NCT00518115|9250641|P5|Overall Study|Wrong Monotherapy Administered|0
2680680|NCT00518115|9250642|P4|Overall Study|Wrong Monotherapy Administered|0
2680681|NCT00518115|9250643|P3|Overall Study|Wrong Monotherapy Administered|1
2680682|NCT00518115|9250644|P2|Overall Study|Wrong Monotherapy Administered|0
2680683|NCT00518115|9250645|P1|Overall Study|Wrong Monotherapy Administered|0
2680684|NCT00518115|9250636|P10|Overall Study|Different Monotherapy Diabetic Drug|0
2680685|NCT00518115|9250637|P9|Overall Study|Different Monotherapy Diabetic Drug|1
2680686|NCT00518115|9250638|P8|Overall Study|Different Monotherapy Diabetic Drug|0
2680687|NCT00518115|9250639|P7|Overall Study|Different Monotherapy Diabetic Drug|0
2680688|NCT00518115|9250640|P6|Overall Study|Different Monotherapy Diabetic Drug|0
2680689|NCT00518115|9250641|P5|Overall Study|Different Monotherapy Diabetic Drug|0
2680690|NCT00518115|9250642|P4|Overall Study|Different Monotherapy Diabetic Drug|0
2680691|NCT00518115|9250643|P3|Overall Study|Different Monotherapy Diabetic Drug|1
2680692|NCT00518115|9250644|P2|Overall Study|Different Monotherapy Diabetic Drug|0
2680693|NCT00518115|9250645|P1|Overall Study|Different Monotherapy Diabetic Drug|0
2680694|NCT00518115|9250636|P10|Overall Study|Physician Prescribed Antidiabetic Drug|0
2680695|NCT00518115|9250637|P9|Overall Study|Physician Prescribed Antidiabetic Drug|0
2680696|NCT00518115|9250638|P8|Overall Study|Physician Prescribed Antidiabetic Drug|0
2680697|NCT00518115|9250639|P7|Overall Study|Physician Prescribed Antidiabetic Drug|0
2680698|NCT00518115|9250640|P6|Overall Study|Physician Prescribed Antidiabetic Drug|0
2680699|NCT00518115|9250641|P5|Overall Study|Physician Prescribed Antidiabetic Drug|0
2680700|NCT00518115|9250642|P4|Overall Study|Physician Prescribed Antidiabetic Drug|0
2680701|NCT00518115|9250643|P3|Overall Study|Physician Prescribed Antidiabetic Drug|0
2680702|NCT00518115|9250644|P2|Overall Study|Physician Prescribed Antidiabetic Drug|0
2680703|NCT00518115|9250645|P1|Overall Study|Physician Prescribed Antidiabetic Drug|1
2680704|NCT00518115|9250636|P10|Overall Study|Treatment Eligibility Criteria Not Met|0
2680705|NCT00518115|9250637|P9|Overall Study|Treatment Eligibility Criteria Not Met|0
2680706|NCT00518115|9250638|P8|Overall Study|Treatment Eligibility Criteria Not Met|0
2680707|NCT00518115|9250639|P7|Overall Study|Treatment Eligibility Criteria Not Met|0
2680708|NCT00518115|9250640|P6|Overall Study|Treatment Eligibility Criteria Not Met|4
2680709|NCT00518115|9250641|P5|Overall Study|Treatment Eligibility Criteria Not Met|0
2680710|NCT00518115|9250642|P4|Overall Study|Treatment Eligibility Criteria Not Met|0
2680711|NCT00518115|9250643|P3|Overall Study|Treatment Eligibility Criteria Not Met|0
2680712|NCT00518115|9250644|P2|Overall Study|Treatment Eligibility Criteria Not Met|1
2680713|NCT00518115|9250645|P1|Overall Study|Treatment Eligibility Criteria Not Met|1
2680714|NCT00518115|9250636|P10|Overall Study|Non-Compliance|1
2680715|NCT00518115|9250637|P9|Overall Study|Non-Compliance|0
2680716|NCT00518115|9250638|P8|Overall Study|Non-Compliance|1
2680717|NCT00518115|9250639|P7|Overall Study|Non-Compliance|1
2680718|NCT00518115|9250640|P6|Overall Study|Non-Compliance|1
2680719|NCT00518115|9250641|P5|Overall Study|Non-Compliance|1
2680720|NCT00518115|9250642|P4|Overall Study|Non-Compliance|0
2680721|NCT00518115|9250643|P3|Overall Study|Non-Compliance|1
2680722|NCT00518115|9250644|P2|Overall Study|Non-Compliance|0
2680723|NCT00518115|9250645|P1|Overall Study|Non-Compliance|1
2680724|NCT00518115|9250636|P10|Overall Study|Lack of Efficacy|0
2680725|NCT00518115|9250637|P9|Overall Study|Lack of Efficacy|0
2680726|NCT00518115|9250638|P8|Overall Study|Lack of Efficacy|1
2680727|NCT00518115|9250639|P7|Overall Study|Lack of Efficacy|0
2680728|NCT00518115|9250640|P6|Overall Study|Lack of Efficacy|0
2680729|NCT00518115|9250641|P5|Overall Study|Lack of Efficacy|0
2680730|NCT00518115|9250642|P4|Overall Study|Lack of Efficacy|1
2680731|NCT00518115|9250643|P3|Overall Study|Lack of Efficacy|1
2680732|NCT00518115|9250644|P2|Overall Study|Lack of Efficacy|0
2680733|NCT00518115|9250645|P1|Overall Study|Lack of Efficacy|1
2680734|NCT00518115|9250636|P10|Overall Study|Withdrawal by Subject|3
2680735|NCT00518115|9250637|P9|Overall Study|Withdrawal by Subject|1
2680736|NCT00518115|9250638|P8|Overall Study|Withdrawal by Subject|2
2680737|NCT00518115|9250639|P7|Overall Study|Withdrawal by Subject|0
2680738|NCT00518115|9250640|P6|Overall Study|Withdrawal by Subject|1
2680739|NCT00518115|9250641|P5|Overall Study|Withdrawal by Subject|2
2680740|NCT00518115|9250642|P4|Overall Study|Withdrawal by Subject|0
2680741|NCT00518115|9250643|P3|Overall Study|Withdrawal by Subject|5
2680742|NCT00518115|9250644|P2|Overall Study|Withdrawal by Subject|1
2680743|NCT00518115|9250645|P1|Overall Study|Withdrawal by Subject|1
2680744|NCT00518115|9250636|P10|Overall Study|Protocol Violation|0
2680745|NCT00518115|9250637|P9|Overall Study|Protocol Violation|0
2680746|NCT00518115|9250638|P8|Overall Study|Protocol Violation|0
2680747|NCT00518115|9250639|P7|Overall Study|Protocol Violation|0
2680748|NCT00518115|9250640|P6|Overall Study|Protocol Violation|0
2680749|NCT00518115|9250641|P5|Overall Study|Protocol Violation|0
2680750|NCT00518115|9250642|P4|Overall Study|Protocol Violation|0
2680751|NCT00518115|9250643|P3|Overall Study|Protocol Violation|1
2680752|NCT00518115|9250644|P2|Overall Study|Protocol Violation|3
2680753|NCT00518115|9250645|P1|Overall Study|Protocol Violation|1
2680754|NCT00518115|9250636|P10|Overall Study|Lost to Follow-up|1
2680755|NCT00518115|9250637|P9|Overall Study|Lost to Follow-up|1
2680756|NCT00518115|9250638|P8|Overall Study|Lost to Follow-up|1
2680757|NCT00518115|9250639|P7|Overall Study|Lost to Follow-up|0
2680758|NCT00518115|9250640|P6|Overall Study|Lost to Follow-up|3
2680759|NCT00518115|9250641|P5|Overall Study|Lost to Follow-up|1
2680760|NCT00518115|9250642|P4|Overall Study|Lost to Follow-up|3
2680761|NCT00518115|9250643|P3|Overall Study|Lost to Follow-up|2
2680762|NCT00518115|9250644|P2|Overall Study|Lost to Follow-up|0
2680763|NCT00518115|9250645|P1|Overall Study|Lost to Follow-up|0
2680764|NCT00518115|9250636|P10|Overall Study|Adverse Event|9
2680765|NCT00518115|9250637|P9|Overall Study|Adverse Event|2
2680766|NCT00518115|9250638|P8|Overall Study|Adverse Event|10
2680767|NCT00518115|9250639|P7|Overall Study|Adverse Event|5
2680768|NCT00518115|9250640|P6|Overall Study|Adverse Event|5
2680769|NCT00518115|9250641|P5|Overall Study|Adverse Event|5
2680770|NCT00518115|9250642|P4|Overall Study|Adverse Event|6
2680771|NCT00518115|9250643|P3|Overall Study|Adverse Event|5
2680772|NCT00518115|9250644|P2|Overall Study|Adverse Event|1
2680773|NCT00518115|9250645|P1|Overall Study|Adverse Event|6
2680774|NCT00518011|9250820|P2|Overall Study|Withdrawal by Subject|0
2680775|NCT00518011|9250821|P1|Overall Study|Withdrawal by Subject|1
2680776|NCT00518011|9250820|P2|Overall Study|Other Reasons|2
2680777|NCT00518011|9250821|P1|Overall Study|Other Reasons|3
2680778|NCT00518011|9250820|P2|Overall Study|Disease Progression|2
2680779|NCT00518011|9250821|P1|Overall Study|Disease Progression|2
2680780|NCT00518011|9250820|P2|Overall Study|Adverse Event|3
2680781|NCT00518011|9250821|P1|Overall Study|Adverse Event|2
2680782|NCT00518011|9250820|P2|Overall Study|Death|1
2680783|NCT00518011|9250821|P1|Overall Study|Death|1
2680784|NCT00517933|9250843|P2|Period 2|Underwent lung transplant|2
2680785|NCT00517933|9250844|P1|Period 2|Underwent lung transplant|0
2680786|NCT00517933|9250843|P2|Period 2|Withdrawal by Subject|3
2680787|NCT00517933|9250844|P1|Period 2|Withdrawal by Subject|1
2680788|NCT00517933|9250843|P2|Period 2|Physician Decision|0
2680789|NCT00517933|9250844|P1|Period 2|Physician Decision|1
2680790|NCT00517933|9250843|P2|Period 2|Adverse Event|4
2680791|NCT00517933|9250844|P1|Period 2|Adverse Event|2
2680792|NCT00517933|9250843|P2|Period 2|Death|4
2680793|NCT00517933|9250844|P1|Period 2|Death|2
2680794|NCT00517933|9250843|P2|Period 1|Underwent lung transplant|1
2680795|NCT00517933|9250844|P1|Period 1|Underwent lung transplant|0
2680796|NCT00517933|9250843|P2|Period 1|Lost to Follow-up|0
2680797|NCT00517933|9250844|P1|Period 1|Lost to Follow-up|2
2680798|NCT00517933|9250843|P2|Period 1|Adverse Event|4
2680799|NCT00517933|9250844|P1|Period 1|Adverse Event|4
2680800|NCT00517933|9250843|P2|Period 1|Death|1
2680801|NCT00517933|9250844|P1|Period 1|Death|2
2680802|NCT00517881|9250908|P1|Overall Study|Renal transplantation|2
2680803|NCT00517881|9250908|P1|Overall Study|Adverse Event|1
2680804|NCT00517881|9250908|P1|Overall Study|Protocol Violation|2
2680805|NCT00517829|9250920|P2|Overall Study|Other|1
2680806|NCT00517829|9250921|P1|Overall Study|Other|3
2680807|NCT00517829|9250920|P2|Overall Study|Investigator Request|3
2680808|NCT00517829|9250921|P1|Overall Study|Investigator Request|5
2680809|NCT00517829|9250920|P2|Overall Study|Patient Request|5
2680810|NCT00517829|9250921|P1|Overall Study|Patient Request|6
2680811|NCT00517829|9250920|P2|Overall Study|Disease Progression|32
2680812|NCT00517829|9250921|P1|Overall Study|Disease Progression|39
2680813|NCT00517829|9250920|P2|Overall Study|Adverse Event|34
2680814|NCT00517829|9250921|P1|Overall Study|Adverse Event|22
2680815|NCT00517751|9250935|P1|Overall Study|Missing|3
2680816|NCT00517751|9250935|P1|Overall Study|Patient not due for visit|76
2680817|NCT00517751|9250935|P1|Overall Study|patient not over due|6
2680818|NCT00517751|9250935|P1|Overall Study|Lost to Follow-up|4
2680819|NCT00517751|9250935|P1|Overall Study|Withdrawal by Subject|37
2680820|NCT00517751|9250935|P1|Overall Study|Death|3
2680821|NCT00517699|9250958|P1|Overall Study|Study terminated by Sponsor|2
2680822|NCT00517699|9250958|P1|Overall Study|Administrative error|1
2680823|NCT00517699|9250958|P1|Overall Study|Lack of Efficacy|1
2680824|NCT00517699|9250958|P1|Overall Study|Withdrawal by Subject|1
2680825|NCT00517634|9250966|P6|Second Treatment Period|Withdrawal by Subject|0
2680826|NCT00517634|9250967|P5|Second Treatment Period|Withdrawal by Subject|1
2680827|NCT00517634|9250968|P4|Second Treatment Period|Withdrawal by Subject|0
2680828|NCT00517634|9250969|P3|Second Treatment Period|Withdrawal by Subject|0
2680829|NCT00517634|9250970|P2|Second Treatment Period|Withdrawal by Subject|0
2680830|NCT00517634|9250971|P1|Second Treatment Period|Withdrawal by Subject|0
2680831|NCT00517413|9251073|P1|Overall Study|Other-Reasons|23
2680832|NCT00517413|9251073|P1|Overall Study|Failure to return|1
2680833|NCT00517413|9251073|P1|Overall Study|Withdrawal by Subject|2
2680834|NCT00517413|9251073|P1|Overall Study|Protocol Violation|15
2680835|NCT00517413|9251073|P1|Overall Study|Death|13
2680836|NCT00517413|9251073|P1|Overall Study|Adverse Event|7
2680837|NCT00517361|9251094|P1|Overall Study|The study was terminated|5
2680838|NCT00517361|9251094|P1|Overall Study|Death|6
2680839|NCT00517296|9251103|P2|Overall Study|Withdrawal by Subject|0
2680840|NCT00517296|9251104|P1|Overall Study|Withdrawal by Subject|1
2680841|NCT00517192|9251116|P2|Overall Study|Early termination of the trial|18
2680842|NCT00517192|9251117|P1|Overall Study|Early termination of the trial|16
2680843|NCT00517192|9251116|P2|Overall Study|Withdrawal by Subject|0
2680844|NCT00517192|9251117|P1|Overall Study|Withdrawal by Subject|1
2680845|NCT00517192|9251116|P2|Overall Study|Lost to Follow-up|1
2680846|NCT00517192|9251117|P1|Overall Study|Lost to Follow-up|1
2680847|NCT00517192|9251116|P2|Overall Study|Adverse Event|1
2680848|NCT00517192|9251117|P1|Overall Study|Adverse Event|1
2680849|NCT00516906|9251224|P2|Overall Study|Final Dressing Removal Data not captured|2
2680850|NCT00516906|9251225|P1|Overall Study|Final Dressing Removal Data not captured|6
2680851|NCT00516893|9251235|P1|Overall Study|Received Medication From Another Study|1
2680852|NCT00516893|9251235|P1|Overall Study|Pregnancy|1
2680853|NCT00516893|9251235|P1|Overall Study|Relocated|1
2680854|NCT00516893|9251235|P1|Overall Study|Persistent Antibodies per Protocol|6
2680855|NCT00516893|9251235|P1|Overall Study|Death|1
2680856|NCT00516893|9251235|P1|Overall Study|Noncompliance|2
2680857|NCT00516893|9251235|P1|Overall Study|Withdrawal by Subject|2
2680858|NCT00516893|9251235|P1|Overall Study|Adverse Event|3
2680859|NCT00516893|9251235|P1|Overall Study|Lost to Follow-up|4
2680860|NCT00516737|9251244|P2|Overall Study|Lack of Qualifying Event|6
2680861|NCT00516737|9251245|P1|Overall Study|Lack of Qualifying Event|9
2680862|NCT00516737|9251244|P2|Overall Study|Withdrawal by Subject|1
2680863|NCT00516737|9251245|P1|Overall Study|Withdrawal by Subject|0
2680864|NCT00516737|9251244|P2|Overall Study|Physician Decision|1
2680865|NCT00516737|9251245|P1|Overall Study|Physician Decision|0
2680866|NCT00516737|9251244|P2|Overall Study|Lost to Follow-up|0
2680867|NCT00516737|9251245|P1|Overall Study|Lost to Follow-up|2
2680868|NCT00516386|9251284|P1|Overall Study|Lost to Follow-up|2
2680869|NCT00516386|9251284|P1|Overall Study|not interested in the study|4
2680870|NCT00516321|9251291|P3|Double-blind (DB) Antiviral Treatment|Physician Decision|0
2680871|NCT00516321|9251292|P2|Double-blind (DB) Antiviral Treatment|Physician Decision|2
2680872|NCT00516321|9251293|P1|Double-blind (DB) Antiviral Treatment|Physician Decision|0
2680873|NCT00516321|9251291|P3|Double-blind (DB) Antiviral Treatment|Protocol Violation|1
2680874|NCT00516321|9251292|P2|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
2680875|NCT00516321|9251293|P1|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
2680876|NCT00516321|9251291|P3|Double-blind (DB) Antiviral Treatment|Adverse Event|13
2680877|NCT00516321|9251292|P2|Double-blind (DB) Antiviral Treatment|Adverse Event|8
2680878|NCT00516321|9251293|P1|Double-blind (DB) Antiviral Treatment|Adverse Event|0
2680879|NCT00516321|9251291|P3|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18
2680880|NCT00516321|9251292|P2|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13
2680881|NCT00516321|9251293|P1|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0
2680882|NCT00516321|9251291|P3|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22
2680883|NCT00516321|9251292|P2|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12
2680884|NCT00516321|9251293|P1|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0
2680885|NCT00516321|9251291|P3|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
2680886|NCT00516321|9251292|P2|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
2680887|NCT00516321|9251293|P1|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3
2680888|NCT00516321|9251291|P3|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
2680889|NCT00516321|9251292|P2|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
2680890|NCT00516321|9251293|P1|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7
2680891|NCT00516321|9251291|P3|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
2680892|NCT00516321|9251292|P2|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
2680893|NCT00516321|9251293|P1|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2
2680894|NCT00516321|9251291|P3|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
2680895|NCT00516321|9251292|P2|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
2680896|NCT00516321|9251293|P1|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1
2680897|NCT00516321|9251291|P3|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
2680898|NCT00516321|9251292|P2|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
2680899|NCT00516321|9251293|P1|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9
2680900|NCT00516321|9251291|P3|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
2680901|NCT00516321|9251292|P2|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
2680902|NCT00516321|9251293|P1|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11
2680903|NCT00516295|9251344|P3|Overall Study|Ineligible|0
2680904|NCT00516295|9251345|P2|Overall Study|Ineligible|0
2680905|NCT00516295|9251346|P1|Overall Study|Ineligible|1
2680906|NCT00516295|9251344|P3|Overall Study|Lack of Efficacy|0
2680907|NCT00516295|9251345|P2|Overall Study|Lack of Efficacy|0
2680908|NCT00516295|9251346|P1|Overall Study|Lack of Efficacy|2
2680909|NCT00516269|9251359|P2|Overall Study|Protocol Violation|1
2680910|NCT00516269|9251360|P1|Overall Study|Protocol Violation|0
2680911|NCT00516269|9251359|P2|Overall Study|Lost to Follow-up|1
2680912|NCT00516269|9251360|P1|Overall Study|Lost to Follow-up|0
2680913|NCT00516269|9251359|P2|Overall Study|Adverse Event|1
2680914|NCT00516269|9251360|P1|Overall Study|Adverse Event|2
2680915|NCT00516139|9251381|P1|Overall Study|Lack of Efficacy|1
2680916|NCT00516139|9251381|P1|Overall Study|Withdrawal by Subject|8
2680917|NCT00516139|9251381|P1|Overall Study|Protocol Violation|1
2680918|NCT00516139|9251381|P1|Overall Study|Lost to Follow-up|1
2680919|NCT00516139|9251381|P1|Overall Study|Adverse Event|27
2680920|NCT00516074|9251412|P2|Overall Study|Loss of Glucose Control|0
2680921|NCT00516074|9251413|P1|Overall Study|Loss of Glucose Control|2
2680922|NCT00516074|9251412|P2|Overall Study|Subject Decision|2
2680923|NCT00516074|9251413|P1|Overall Study|Subject Decision|4
2680924|NCT00516074|9251412|P2|Overall Study|Adverse Event|1
2680925|NCT00516074|9251413|P1|Overall Study|Adverse Event|0
2680926|NCT00516048|9251431|P3|Overall Study|Subject Decision|0
2680927|NCT00516048|9251432|P2|Overall Study|Subject Decision|2
2680928|NCT00516048|9251433|P1|Overall Study|Subject Decision|0
2680929|NCT00516048|9251431|P3|Overall Study|Death|1
2680930|NCT00516048|9251432|P2|Overall Study|Death|0
2680931|NCT00516048|9251433|P1|Overall Study|Death|0
2680932|NCT00515827|9251468|P2|Second Intervention (12 Weeks)|Consent withdraw|0
2680933|NCT00515827|9251469|P1|Second Intervention (12 Weeks)|Consent withdraw|1
2680934|NCT00515827|9251468|P2|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
2680935|NCT00515827|9251469|P1|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
2680936|NCT00515671|9251527|P2|Overall Study|incarcerated|2
2680937|NCT00515671|9251528|P1|Overall Study|incarcerated|1
2680938|NCT00515671|9251527|P2|Overall Study|Withdrawal by Subject|5
2680939|NCT00515671|9251528|P1|Overall Study|Withdrawal by Subject|3
2680940|NCT00515671|9251527|P2|Overall Study|Lost to Follow-up|10
2680941|NCT00515671|9251528|P1|Overall Study|Lost to Follow-up|13
2680942|NCT00515619|9251536|P1|Overall Study|Other: Subject interested in other AED|1
2680943|NCT00515619|9251536|P1|Overall Study|Other: Drug available on license|1
2680944|NCT00515619|9251536|P1|Overall Study|Other: Request from sponsor|1
2680945|NCT00515619|9251536|P1|Overall Study|Other: Subject became pregnant|1
2680946|NCT00515619|9251536|P1|Overall Study|Other: Investigator decision|1
2680947|NCT00515619|9251536|P1|Overall Study|Other: Subject moved to another country|1
2680948|NCT00515619|9251536|P1|Overall Study|Other: Subject required surgery|1
2680949|NCT00515619|9251536|P1|Overall Study|Other: Subject cannot attend visits|2
2680950|NCT00515619|9251536|P1|Overall Study|Other: Site discontinuing trials|2
2680951|NCT00515619|9251536|P1|Overall Study|Unsatisfactory compliance|6
2680952|NCT00515619|9251536|P1|Overall Study|Lost to Follow-up|4
2680953|NCT00515619|9251536|P1|Overall Study|Protocol Violation|3
2680954|NCT00515619|9251536|P1|Overall Study|Withdrawal by Subject|66
2680955|NCT00515619|9251536|P1|Overall Study|Lack of Efficacy|92
2680956|NCT00515619|9251536|P1|Overall Study|Adverse Event|34
2680957|NCT00515541|9251548|P4|Overall Study|Withdrawal by Subject|2
2680958|NCT00515541|9251549|P3|Overall Study|Withdrawal by Subject|0
2680959|NCT00515541|9251550|P2|Overall Study|Withdrawal by Subject|2
2680960|NCT00515541|9251551|P1|Overall Study|Withdrawal by Subject|0
2680961|NCT00515541|9251548|P4|Overall Study|No show for appointments|2
2680962|NCT00515541|9251549|P3|Overall Study|No show for appointments|0
2680963|NCT00515541|9251550|P2|Overall Study|No show for appointments|1
2680964|NCT00515541|9251551|P1|Overall Study|No show for appointments|0
2680965|NCT00515541|9251548|P4|Overall Study|Physician Decision|1
2680966|NCT00515541|9251549|P3|Overall Study|Physician Decision|0
2680967|NCT00515541|9251550|P2|Overall Study|Physician Decision|2
2680968|NCT00515541|9251551|P1|Overall Study|Physician Decision|0
2680969|NCT00515502|9251573|P12|Treatment Period 2|Adverse Event|0
2680970|NCT00515502|9251574|P11|Treatment Period 2|Adverse Event|0
2680971|NCT00515502|9251575|P10|Treatment Period 2|Adverse Event|0
2680972|NCT00515502|9251576|P9|Treatment Period 2|Adverse Event|0
2680973|NCT00515502|9251577|P8|Treatment Period 2|Adverse Event|0
2680974|NCT00515502|9251578|P7|Treatment Period 2|Adverse Event|0
2680975|NCT00515502|9251579|P6|Treatment Period 2|Adverse Event|0
2680976|NCT00515502|9251580|P5|Treatment Period 2|Adverse Event|0
2680977|NCT00515502|9251581|P4|Treatment Period 2|Adverse Event|0
2680978|NCT00515502|9251582|P3|Treatment Period 2|Adverse Event|0
2680979|NCT00515502|9251583|P2|Treatment Period 2|Adverse Event|1
2680980|NCT00515502|9251584|P1|Treatment Period 2|Adverse Event|0
2680981|NCT00515502|9251573|P12|Treatment Period 1|Adverse Event|1
2680982|NCT00515502|9251574|P11|Treatment Period 1|Adverse Event|0
2680983|NCT00515502|9251575|P10|Treatment Period 1|Adverse Event|0
2680984|NCT00515502|9251576|P9|Treatment Period 1|Adverse Event|1
2680985|NCT00515502|9251577|P8|Treatment Period 1|Adverse Event|0
2680986|NCT00515502|9251578|P7|Treatment Period 1|Adverse Event|1
2680987|NCT00515502|9251579|P6|Treatment Period 1|Adverse Event|0
2680988|NCT00515502|9251580|P5|Treatment Period 1|Adverse Event|0
2680989|NCT00515502|9251581|P4|Treatment Period 1|Adverse Event|0
2680990|NCT00515502|9251582|P3|Treatment Period 1|Adverse Event|0
2680991|NCT00515502|9251583|P2|Treatment Period 1|Adverse Event|0
2680992|NCT00515502|9251584|P1|Treatment Period 1|Adverse Event|0
2680993|NCT00515463|9251744|P2|Overall Study|Other|1
2680994|NCT00515463|9251745|P1|Overall Study|Other|0
2680995|NCT00515463|9251744|P2|Overall Study|Lost to Follow-up|5
2680996|NCT00515463|9251745|P1|Overall Study|Lost to Follow-up|6
2680997|NCT00515463|9251744|P2|Overall Study|Withdrawal by Subject|4
2680998|NCT00515463|9251745|P1|Overall Study|Withdrawal by Subject|3
2680999|NCT00515463|9251744|P2|Overall Study|Adverse Event|2
2681000|NCT00515463|9251745|P1|Overall Study|Adverse Event|1
2681001|NCT00515463|9251744|P2|Overall Study|Physician Decision|2
2681002|NCT00515463|9251745|P1|Overall Study|Physician Decision|4
2681003|NCT00515294|9251944|P4|Overall Study|Caffeine amount inaccurate|0
2681004|NCT00515294|9251945|P3|Overall Study|Caffeine amount inaccurate|7
2681005|NCT00515294|9251946|P2|Overall Study|Caffeine amount inaccurate|0
2681006|NCT00515294|9251947|P1|Overall Study|Caffeine amount inaccurate|5
2681007|NCT00515294|9251944|P4|Overall Study|Driver simulator problems|3
2681008|NCT00515294|9251945|P3|Overall Study|Driver simulator problems|1
2681009|NCT00515294|9251946|P2|Overall Study|Driver simulator problems|1
2681010|NCT00515294|9251947|P1|Overall Study|Driver simulator problems|1
2681011|NCT00515294|9251944|P4|Overall Study|Lost to Follow-up|1
2681012|NCT00515294|9251945|P3|Overall Study|Lost to Follow-up|3
2681013|NCT00515294|9251946|P2|Overall Study|Lost to Follow-up|2
2681014|NCT00515294|9251947|P1|Overall Study|Lost to Follow-up|3
2681015|NCT00515216|9251961|P1|Overall Study|Withdrawal by Subject|1
2681016|NCT00515112|9252023|P2|Overall Study|The study was terminated|2
2681017|NCT00515112|9252024|P1|Overall Study|The study was terminated|3
2681018|NCT00515112|9252023|P2|Overall Study|Death|1
2681019|NCT00515112|9252024|P1|Overall Study|Death|0
2681020|NCT00515099|9252034|P2|Overall Study|IRB Recommendation|0
2681021|NCT00515099|9252035|P1|Overall Study|IRB Recommendation|1
2681022|NCT00515099|9252034|P2|Overall Study|Withdrawal by Subject|0
2681023|NCT00515099|9252035|P1|Overall Study|Withdrawal by Subject|2
2681024|NCT00515099|9252034|P2|Overall Study|Lost to Follow-up|4
2681025|NCT00515099|9252035|P1|Overall Study|Lost to Follow-up|0
2681026|NCT00515086|9252057|P4|Overall Study|Death|0
2681027|NCT00515086|9252058|P3|Overall Study|Death|0
2681028|NCT00515086|9252059|P2|Overall Study|Death|0
2681029|NCT00515086|9252060|P1|Overall Study|Death|2
2681030|NCT00515086|9252057|P4|Overall Study|Study drug no longer required|0
2681031|NCT00515086|9252058|P3|Overall Study|Study drug no longer required|0
2681032|NCT00515086|9252059|P2|Overall Study|Study drug no longer required|1
2681033|NCT00515086|9252060|P1|Overall Study|Study drug no longer required|0
2681034|NCT00515086|9252057|P4|Overall Study|Lost to Follow-up|0
2681035|NCT00515086|9252058|P3|Overall Study|Lost to Follow-up|0
2681036|NCT00515086|9252059|P2|Overall Study|Lost to Follow-up|0
2681037|NCT00515086|9252060|P1|Overall Study|Lost to Follow-up|1
2681038|NCT00515086|9252057|P4|Overall Study|Unsatisfactory therapeutic effect|2
2681039|NCT00515086|9252058|P3|Overall Study|Unsatisfactory therapeutic effect|3
2681040|NCT00515086|9252059|P2|Overall Study|Unsatisfactory therapeutic effect|3
2681041|NCT00515086|9252060|P1|Overall Study|Unsatisfactory therapeutic effect|18
2681042|NCT00515086|9252057|P4|Overall Study|Withdrawal by Subject|1
2681043|NCT00515086|9252058|P3|Overall Study|Withdrawal by Subject|0
2681044|NCT00515086|9252059|P2|Overall Study|Withdrawal by Subject|0
2681045|NCT00515086|9252060|P1|Overall Study|Withdrawal by Subject|1
2681046|NCT00515086|9252057|P4|Overall Study|Administrative|0
2681047|NCT00515086|9252058|P3|Overall Study|Administrative|0
2681048|NCT00515086|9252059|P2|Overall Study|Administrative|1
2681049|NCT00515086|9252060|P1|Overall Study|Administrative|1
2681050|NCT00515086|9252057|P4|Overall Study|Adverse Event|3
2681051|NCT00515086|9252058|P3|Overall Study|Adverse Event|2
2681052|NCT00515086|9252059|P2|Overall Study|Adverse Event|1
2681053|NCT00515086|9252060|P1|Overall Study|Adverse Event|1
2681054|NCT00515073|9252087|P1|Overall Study|Physician Decision|1
2681055|NCT00515073|9252087|P1|Overall Study|Withdrawal by Subject|1
2681056|NCT00515034|9252095|P4|Overall Study|Other|1
2681057|NCT00515034|9252096|P3|Overall Study|Other|2
2681058|NCT00515034|9252097|P2|Overall Study|Other|0
2681059|NCT00515034|9252098|P1|Overall Study|Other|1
2681060|NCT00515034|9252095|P4|Overall Study|Physician Decision|1
2681061|NCT00515034|9252096|P3|Overall Study|Physician Decision|1
2681062|NCT00515034|9252097|P2|Overall Study|Physician Decision|0
2681063|NCT00515034|9252098|P1|Overall Study|Physician Decision|0
2681064|NCT00515034|9252095|P4|Overall Study|Withdrawal by Subject|0
2681065|NCT00515034|9252096|P3|Overall Study|Withdrawal by Subject|3
2681066|NCT00515034|9252097|P2|Overall Study|Withdrawal by Subject|0
2681067|NCT00515034|9252098|P1|Overall Study|Withdrawal by Subject|1
2681068|NCT00515034|9252095|P4|Overall Study|Death|3
2681069|NCT00515034|9252096|P3|Overall Study|Death|1
2681070|NCT00515034|9252097|P2|Overall Study|Death|2
2681071|NCT00515034|9252098|P1|Overall Study|Death|4
2681072|NCT00515034|9252095|P4|Overall Study|Adverse Event|0
2681073|NCT00515034|9252096|P3|Overall Study|Adverse Event|1
2681074|NCT00515034|9252097|P2|Overall Study|Adverse Event|0
2681075|NCT00515034|9252098|P1|Overall Study|Adverse Event|2
2681076|NCT00515008|9252129|P2|Overall Study|Scheduling conflict|0
2681077|NCT00515008|9252130|P1|Overall Study|Scheduling conflict|1
2681078|NCT00515008|9252129|P2|Overall Study|Left the Boston Area|1
2681079|NCT00515008|9252130|P1|Overall Study|Left the Boston Area|1
2681080|NCT00515008|9252129|P2|Overall Study|Declined|3
2681081|NCT00515008|9252130|P1|Overall Study|Declined|0
2681082|NCT00515008|9252129|P2|Overall Study|Lost to Follow-up|0
2681083|NCT00515008|9252130|P1|Overall Study|Lost to Follow-up|1
2681084|NCT00514943|9252154|P2|Stage 2|Other than stated above|2
2681085|NCT00514943|9252155|P1|Stage 2|Other than stated above|0
2681086|NCT00514943|9252154|P2|Stage 2|Patient refused to continue study meds|0
2681087|NCT00514943|9252155|P1|Stage 2|Patient refused to continue study meds|2
2681088|NCT00514943|9252154|P2|Stage 2|Other Adverse Event|10
2681089|NCT00514943|9252155|P1|Stage 2|Other Adverse Event|3
2681090|NCT00514943|9252154|P2|Stage 2|Progressive disease|24
2681091|NCT00514943|9252155|P1|Stage 2|Progressive disease|27
2681092|NCT00514943|9252154|P2|Stage 1|Other than stated above|7
2681093|NCT00514943|9252155|P1|Stage 1|Other than stated above|1
2681094|NCT00514943|9252154|P2|Stage 1|Patient refused to continue study meds|3
2681095|NCT00514943|9252155|P1|Stage 1|Patient refused to continue study meds|8
2681096|NCT00514943|9252154|P2|Stage 1|Not treated|2
2681097|NCT00514943|9252155|P1|Stage 1|Not treated|1
2681098|NCT00514943|9252154|P2|Stage 1|Other Adverse Event|6
2681099|NCT00514943|9252155|P1|Stage 1|Other Adverse Event|16
2681100|NCT00514943|9252154|P2|Stage 1|Progressive disease|8
2681101|NCT00514943|9252155|P1|Stage 1|Progressive disease|4
2681102|NCT00514917|9252213|P2|Overall Study|Undefined|5
2681103|NCT00514917|9252214|P1|Overall Study|Undefined|11
2681104|NCT00514917|9252213|P2|Overall Study|Discontinued due to study closure|81
2681105|NCT00514917|9252214|P1|Overall Study|Discontinued due to study closure|88
2681106|NCT00514917|9252213|P2|Overall Study|Withdrawal by Subject|16
2681107|NCT00514917|9252214|P1|Overall Study|Withdrawal by Subject|18
2681108|NCT00514917|9252213|P2|Overall Study|Lost to Follow-up|3
2681109|NCT00514917|9252214|P1|Overall Study|Lost to Follow-up|4
2681110|NCT00514917|9252213|P2|Overall Study|Protocol Violation|0
2681111|NCT00514917|9252214|P1|Overall Study|Protocol Violation|1
2681112|NCT00514917|9252213|P2|Overall Study|Death|10
2681113|NCT00514917|9252214|P1|Overall Study|Death|4
2681114|NCT00514904|9252242|P2|Overall Study|Lost to Follow-up|3
2681115|NCT00514904|9252243|P1|Overall Study|Lost to Follow-up|21
2681116|NCT00514904|9252242|P2|Overall Study|Withdrawal by Subject|2
2681117|NCT00514904|9252243|P1|Overall Study|Withdrawal by Subject|3
2681118|NCT00514813|9252308|P4|Overall Study|Death|2
2681119|NCT00514813|9252309|P3|Overall Study|Death|3
2681120|NCT00514813|9252310|P2|Overall Study|Death|2
2681121|NCT00514813|9252311|P1|Overall Study|Death|0
2681122|NCT00514813|9252308|P4|Overall Study|Kidney transplant|0
2681123|NCT00514813|9252309|P3|Overall Study|Kidney transplant|2
2681124|NCT00514813|9252310|P2|Overall Study|Kidney transplant|6
2681125|NCT00514813|9252311|P1|Overall Study|Kidney transplant|0
2681126|NCT00514813|9252308|P4|Overall Study|Lack of Efficacy|0
2681127|NCT00514813|9252309|P3|Overall Study|Lack of Efficacy|0
2681128|NCT00514813|9252310|P2|Overall Study|Lack of Efficacy|1
2681129|NCT00514813|9252311|P1|Overall Study|Lack of Efficacy|0
2681130|NCT00514813|9252308|P4|Overall Study|Withdrawal by Subject|0
2681131|NCT00514813|9252309|P3|Overall Study|Withdrawal by Subject|0
2681132|NCT00514813|9252310|P2|Overall Study|Withdrawal by Subject|1
2681133|NCT00514813|9252311|P1|Overall Study|Withdrawal by Subject|0
2681134|NCT00514813|9252308|P4|Overall Study|Protocol Violation|0
2681135|NCT00514813|9252309|P3|Overall Study|Protocol Violation|0
2681136|NCT00514813|9252310|P2|Overall Study|Protocol Violation|0
2681137|NCT00514813|9252311|P1|Overall Study|Protocol Violation|1
2681138|NCT00514813|9252308|P4|Overall Study|Adverse Event|0
2681139|NCT00514813|9252309|P3|Overall Study|Adverse Event|2
2681140|NCT00514813|9252310|P2|Overall Study|Adverse Event|2
2681141|NCT00514813|9252311|P1|Overall Study|Adverse Event|0
2681142|NCT00514813|9252308|P4|Overall Study|Study terminated|2
2681143|NCT00514813|9252309|P3|Overall Study|Study terminated|40
2681144|NCT00514813|9252310|P2|Overall Study|Study terminated|74
2681145|NCT00514813|9252311|P1|Overall Study|Study terminated|14
2681146|NCT00514735|9252331|P2|Overall Study|Lost to Follow-up|1
2681147|NCT00514735|9252332|P1|Overall Study|Lost to Follow-up|0
2681148|NCT00514735|9252331|P2|Overall Study|Death|0
2681149|NCT00514735|9252332|P1|Overall Study|Death|1
2681150|NCT00514735|9252331|P2|Overall Study|Withdrawal by Subject|5
2681151|NCT00514735|9252332|P1|Overall Study|Withdrawal by Subject|13
2681152|NCT00514683|9252368|P5|Overall Study|Reason other than listed above|1
2681153|NCT00514683|9252369|P4|Overall Study|Reason other than listed above|0
2681154|NCT00514683|9252370|P3|Overall Study|Reason other than listed above|2
2681155|NCT00514683|9252371|P2|Overall Study|Reason other than listed above|1
2681156|NCT00514683|9252372|P1|Overall Study|Reason other than listed above|0
2681157|NCT00514683|9252368|P5|Overall Study|Withdrawal by Subject|4
2681158|NCT00514683|9252369|P4|Overall Study|Withdrawal by Subject|0
2681159|NCT00514683|9252370|P3|Overall Study|Withdrawal by Subject|1
2681160|NCT00514683|9252371|P2|Overall Study|Withdrawal by Subject|2
2681161|NCT00514683|9252372|P1|Overall Study|Withdrawal by Subject|2
2681162|NCT00514683|9252368|P5|Overall Study|Protocol Violation|0
2681163|NCT00514683|9252369|P4|Overall Study|Protocol Violation|1
2681164|NCT00514683|9252370|P3|Overall Study|Protocol Violation|0
2681165|NCT00514683|9252371|P2|Overall Study|Protocol Violation|1
2681166|NCT00514683|9252372|P1|Overall Study|Protocol Violation|1
2681167|NCT00514683|9252368|P5|Overall Study|Adverse Event|27
2681168|NCT00514683|9252369|P4|Overall Study|Adverse Event|13
2681169|NCT00514683|9252370|P3|Overall Study|Adverse Event|15
2681170|NCT00514683|9252371|P2|Overall Study|Adverse Event|20
2681171|NCT00514683|9252372|P1|Overall Study|Adverse Event|21
2681172|NCT00514683|9252368|P5|Overall Study|Not treated|1
2681173|NCT00514683|9252369|P4|Overall Study|Not treated|0
2681174|NCT00514683|9252370|P3|Overall Study|Not treated|0
2681175|NCT00514683|9252371|P2|Overall Study|Not treated|1
2681176|NCT00514683|9252372|P1|Overall Study|Not treated|2
2681177|NCT00514514|9252571|P3|Extension - 4 Years|Adverse Event|3
2681178|NCT00514514|9252572|P2|Extension - 4 Years|Adverse Event|6
2681179|NCT00514514|9252573|P1|Extension - 4 Years|Adverse Event|9
2681180|NCT00514514|9252571|P3|Extension - 4 Years|Death|6
2681181|NCT00514514|9252572|P2|Extension - 4 Years|Death|3
2681182|NCT00514514|9252573|P1|Extension - 4 Years|Death|8
2681183|NCT00514514|9252571|P3|Extension - 4 Years|Administrative problems|1
2681184|NCT00514514|9252572|P2|Extension - 4 Years|Administrative problems|1
2681185|NCT00514514|9252573|P1|Extension - 4 Years|Administrative problems|3
2681186|NCT00514514|9252571|P3|Extension - 4 Years|Lost to Follow-up|9
2681187|NCT00514514|9252572|P2|Extension - 4 Years|Lost to Follow-up|10
2681188|NCT00514514|9252573|P1|Extension - 4 Years|Lost to Follow-up|12
2681189|NCT00514514|9252571|P3|Extension - 4 Years|Withdrawal by Subject|2
2681190|NCT00514514|9252572|P2|Extension - 4 Years|Withdrawal by Subject|2
2681191|NCT00514514|9252573|P1|Extension - 4 Years|Withdrawal by Subject|5
2681192|NCT00514514|9252571|P3|Randomized - 9 Month|Adverse Event|27
2681193|NCT00514514|9252572|P2|Randomized - 9 Month|Adverse Event|44
2681194|NCT00514514|9252573|P1|Randomized - 9 Month|Adverse Event|25
2681195|NCT00514514|9252571|P3|Randomized - 9 Month|Abnormal laboratory values|1
2681196|NCT00514514|9252572|P2|Randomized - 9 Month|Abnormal laboratory values|3
2681197|NCT00514514|9252573|P1|Randomized - 9 Month|Abnormal laboratory values|0
2681198|NCT00514514|9252571|P3|Randomized - 9 Month|Lack of Efficacy|1
2681199|NCT00514514|9252572|P2|Randomized - 9 Month|Lack of Efficacy|3
2681200|NCT00514514|9252573|P1|Randomized - 9 Month|Lack of Efficacy|2
2681201|NCT00514514|9252571|P3|Randomized - 9 Month|Protocol Violation|0
2681202|NCT00514514|9252572|P2|Randomized - 9 Month|Protocol Violation|1
2681203|NCT00514514|9252573|P1|Randomized - 9 Month|Protocol Violation|1
2681204|NCT00514514|9252571|P3|Randomized - 9 Month|Withdrawal by Subject|5
2681205|NCT00514514|9252572|P2|Randomized - 9 Month|Withdrawal by Subject|7
2681206|NCT00514514|9252573|P1|Randomized - 9 Month|Withdrawal by Subject|7
2681207|NCT00514514|9252571|P3|Randomized - 9 Month|Administrative problems|2
2681208|NCT00514514|9252572|P2|Randomized - 9 Month|Administrative problems|1
2681209|NCT00514514|9252573|P1|Randomized - 9 Month|Administrative problems|1
2681210|NCT00514514|9252571|P3|Randomized - 9 Month|Death|2
2681211|NCT00514514|9252572|P2|Randomized - 9 Month|Death|2
2681212|NCT00514514|9252573|P1|Randomized - 9 Month|Death|3
2681213|NCT00514514|9252571|P3|Pre-phase|Withdrawal by Subject|0
2681214|NCT00514514|9252572|P2|Pre-phase|Withdrawal by Subject|0
2681215|NCT00514514|9252573|P1|Pre-phase|Withdrawal by Subject|66
2681216|NCT00514514|9252571|P3|Pre-phase|Adverse Event|0
2681217|NCT00514514|9252572|P2|Pre-phase|Adverse Event|0
2681218|NCT00514514|9252573|P1|Pre-phase|Adverse Event|137
2681219|NCT00514514|9252571|P3|Pre-phase|Lack of Efficacy|0
2681220|NCT00514514|9252572|P2|Pre-phase|Lack of Efficacy|0
2681221|NCT00514514|9252573|P1|Pre-phase|Lack of Efficacy|35
2681222|NCT00514514|9252571|P3|Pre-phase|abnormal lab values|0
2681223|NCT00514514|9252572|P2|Pre-phase|abnormal lab values|0
2681224|NCT00514514|9252573|P1|Pre-phase|abnormal lab values|23
2681225|NCT00514514|9252571|P3|Pre-phase|Lost to Follow-up|0
2681226|NCT00514514|9252572|P2|Pre-phase|Lost to Follow-up|0
2681227|NCT00514514|9252573|P1|Pre-phase|Lost to Follow-up|2
2681228|NCT00514514|9252571|P3|Pre-phase|abnormal test procedure results|0
2681229|NCT00514514|9252572|P2|Pre-phase|abnormal test procedure results|0
2681230|NCT00514514|9252573|P1|Pre-phase|abnormal test procedure results|15
2681231|NCT00514514|9252571|P3|Pre-phase|condition no longer requires study drug|0
2681232|NCT00514514|9252572|P2|Pre-phase|condition no longer requires study drug|0
2681233|NCT00514514|9252573|P1|Pre-phase|condition no longer requires study drug|7
2681234|NCT00514514|9252571|P3|Pre-phase|Protocol Violation|0
2681235|NCT00514514|9252572|P2|Pre-phase|Protocol Violation|0
2681236|NCT00514514|9252573|P1|Pre-phase|Protocol Violation|6
2681237|NCT00514514|9252571|P3|Pre-phase|administrative problems|0
2681238|NCT00514514|9252572|P2|Pre-phase|administrative problems|0
2681239|NCT00514514|9252573|P1|Pre-phase|administrative problems|2
2681240|NCT00514514|9252571|P3|Pre-phase|Death|0
2681241|NCT00514514|9252572|P2|Pre-phase|Death|0
2681242|NCT00514514|9252573|P1|Pre-phase|Death|10
2681243|NCT00514449|9252625|P2|Overall Study|Lost to Follow-up|0
2681244|NCT00514449|9252626|P1|Overall Study|Lost to Follow-up|1
2681245|NCT00514449|9252625|P2|Overall Study|Protocol Violation|2
2681246|NCT00514449|9252626|P1|Overall Study|Protocol Violation|1
2681247|NCT00514449|9252625|P2|Overall Study|Withdrawal by Subject|2
2681248|NCT00514449|9252626|P1|Overall Study|Withdrawal by Subject|1
2681249|NCT00514020|9252650|P1|Overall Study|"patients moved to the no tx group"|6
2681250|NCT00514020|9252650|P1|Overall Study|patient went to radiation treatment|1
2681251|NCT00514020|9252650|P1|Overall Study|other complicating disease|2
2681252|NCT00514020|9252650|P1|Overall Study|disease progression|9
2681253|NCT00514020|9252650|P1|Overall Study|Physician Decision|1
2681254|NCT00514020|9252650|P1|Overall Study|Withdrawal by Subject|3
2681255|NCT00514020|9252650|P1|Overall Study|Adverse Event|6
2681256|NCT00513708|9252704|P3|Overall Study|Lost to Follow-up|4
2681257|NCT00513708|9252705|P2|Overall Study|Lost to Follow-up|4
2681258|NCT00513708|9252706|P1|Overall Study|Lost to Follow-up|4
2681259|NCT00513695|9252720|P1|Overall Study|Progression prior to surgery|3
2681260|NCT00513695|9252720|P1|Overall Study|Discontinued therapy|2
2681261|NCT00513682|9252729|P1|Washout Phase|Adverse Event|2
2681262|NCT00513604|9252759|P5|Overall Study|Death during treatment|0
2681263|NCT00513604|9252760|P4|Overall Study|Death during treatment|0
2681264|NCT00513604|9252761|P3|Overall Study|Death during treatment|2
2681265|NCT00513604|9252762|P2|Overall Study|Death during treatment|3
2681266|NCT00513604|9252763|P1|Overall Study|Death during treatment|0
2681267|NCT00513604|9252759|P5|Overall Study|Not treated|0
2681268|NCT00513604|9252760|P4|Overall Study|Not treated|0
2681269|NCT00513604|9252761|P3|Overall Study|Not treated|1
2681270|NCT00513604|9252762|P2|Overall Study|Not treated|0
2681271|NCT00513604|9252763|P1|Overall Study|Not treated|2
2681272|NCT00513500|9252797|P2|Overall Study|Hospitalized|14
2681273|NCT00513500|9252798|P1|Overall Study|Hospitalized|4
2681274|NCT00513500|9252797|P2|Overall Study|Death|1
2681275|NCT00513500|9252798|P1|Overall Study|Death|2
2681276|NCT00513500|9252797|P2|Overall Study|Lost to Follow-up|39
2681277|NCT00513500|9252798|P1|Overall Study|Lost to Follow-up|35
2681278|NCT00513474|9252810|P2|Overall Study|Participant Withdrew Consent|0
2681279|NCT00513474|9252811|P1|Overall Study|Participant Withdrew Consent|1
2681280|NCT00513474|9252810|P2|Overall Study|Death|9
2681281|NCT00513474|9252811|P1|Overall Study|Death|6
2681282|NCT00513409|9252867|P2|Overall Study|Visit 3 not done|2
2681283|NCT00513409|9252868|P1|Overall Study|Visit 3 not done|1
2681284|NCT00513409|9252867|P2|Overall Study|Physician Decision|0
2681285|NCT00513409|9252868|P1|Overall Study|Physician Decision|1
2681286|NCT00513409|9252867|P2|Overall Study|Lost to Follow-up|1
2681287|NCT00513409|9252868|P1|Overall Study|Lost to Follow-up|0
2681288|NCT00513409|9252867|P2|Overall Study|Withdrawal by Subject|2
2681289|NCT00513409|9252868|P1|Overall Study|Withdrawal by Subject|0
2681290|NCT00513409|9252867|P2|Overall Study|Adverse Event|1
2681291|NCT00513409|9252868|P1|Overall Study|Adverse Event|0
2681292|NCT00513357|9252924|P2|Overall Study|Disease Progression|1
2681293|NCT00513357|9252925|P1|Overall Study|Disease Progression|2
2681294|NCT00513357|9252924|P2|Overall Study|Withdrawal by Subject|4
2681295|NCT00513357|9252925|P1|Overall Study|Withdrawal by Subject|5
2681296|NCT00513357|9252924|P2|Overall Study|Death|0
2681297|NCT00513357|9252925|P1|Overall Study|Death|2
2681298|NCT00513357|9252924|P2|Overall Study|Adverse Event|2
2681299|NCT00513357|9252925|P1|Overall Study|Adverse Event|4
2681300|NCT00513357|9252924|P2|Overall Study|did not receive allocated placebo|3
2681301|NCT00513357|9252925|P1|Overall Study|did not receive allocated placebo|2
2681302|NCT00513305|9252944|P2|Overall Study|Sponsor Decision|2
2681303|NCT00513305|9252945|P1|Overall Study|Sponsor Decision|0
2681304|NCT00513305|9252944|P2|Overall Study|Persistent hypocellularity|1
2681305|NCT00513305|9252945|P1|Overall Study|Persistent hypocellularity|0
2681306|NCT00513305|9252944|P2|Overall Study|Physician Decision|0
2681307|NCT00513305|9252945|P1|Overall Study|Physician Decision|1
2681308|NCT00513305|9252944|P2|Overall Study|Hematologic counts did not recover|0
2681309|NCT00513305|9252945|P1|Overall Study|Hematologic counts did not recover|1
2681310|NCT00513305|9252944|P2|Overall Study|Eligible for stem cell transplant|0
2681311|NCT00513305|9252945|P1|Overall Study|Eligible for stem cell transplant|1
2681312|NCT00513305|9252944|P2|Overall Study|Disease progression|5
2681313|NCT00513305|9252945|P1|Overall Study|Disease progression|8
2681314|NCT00513305|9252944|P2|Overall Study|Withdrawal by Subject|2
2681315|NCT00513305|9252945|P1|Overall Study|Withdrawal by Subject|1
2681316|NCT00513305|9252944|P2|Overall Study|Lack of Efficacy|13
2681317|NCT00513305|9252945|P1|Overall Study|Lack of Efficacy|8
2681318|NCT00513305|9252944|P2|Overall Study|Death (through Consolidation Treatment)|2
2681319|NCT00513305|9252945|P1|Overall Study|Death (through Consolidation Treatment)|2
2681320|NCT00513305|9252944|P2|Overall Study|Adverse Event|2
2681321|NCT00513305|9252945|P1|Overall Study|Adverse Event|6
2681322|NCT00513240|9252988|P2|Overall Study|Withdrawal by Subject|4
2681323|NCT00513240|9252989|P1|Overall Study|Withdrawal by Subject|7
2681324|NCT00513240|9252988|P2|Overall Study|Death|3
2681325|NCT00513240|9252989|P1|Overall Study|Death|3
2681326|NCT00513240|9252988|P2|Overall Study|Did not have intended surgery|0
2681327|NCT00513240|9252989|P1|Overall Study|Did not have intended surgery|3
2681328|NCT00513071|9253002|P1|Overall Study|Physician Decision|3
2681329|NCT00513071|9253002|P1|Overall Study|Withdrawal by Subject|1
2681330|NCT00513071|9253002|P1|Overall Study|Adverse Event|1
2681331|NCT00513019|9253014|P2|Overall Study|Withdrawal by Subject|5
2681332|NCT00513019|9253015|P1|Overall Study|Withdrawal by Subject|4
2681333|NCT00513019|9253014|P2|Overall Study|Adverse Event|0
2681334|NCT00513019|9253015|P1|Overall Study|Adverse Event|1
2681335|NCT00512902|9253021|P1|Overall Study|Lost to Follow-up|1
2681336|NCT00512902|9253021|P1|Overall Study|Adverse Event|7
2681337|NCT00512798|9253036|P2|Overall Study|Withdrawal by Subject|0
2681338|NCT00512798|9253037|P1|Overall Study|Withdrawal by Subject|3
2681339|NCT00512798|9253036|P2|Overall Study|Progression of disease|20
2681340|NCT00512798|9253037|P1|Overall Study|Progression of disease|14
2681341|NCT00512798|9253036|P2|Overall Study|Adverse Event|4
2681342|NCT00512798|9253037|P1|Overall Study|Adverse Event|2
2681343|NCT00512798|9253036|P2|Overall Study|Death|3
2681344|NCT00512798|9253037|P1|Overall Study|Death|0
2681345|NCT00512707|9253048|P2|Overall Study|Unable to tolerate the smell of the gel|0
2681346|NCT00512707|9253049|P1|Overall Study|Unable to tolerate the smell of the gel|1
2681347|NCT00512707|9253048|P2|Overall Study|Developed a hematocrit exceeding 0.54|0
2681348|NCT00512707|9253049|P1|Overall Study|Developed a hematocrit exceeding 0.54|2
2681349|NCT00512707|9253048|P2|Overall Study|Developed skin irritation|1
2681350|NCT00512707|9253049|P1|Overall Study|Developed skin irritation|2
2681351|NCT00512707|9253048|P2|Overall Study|Lost to Follow-up|11
2681352|NCT00512707|9253049|P1|Overall Study|Lost to Follow-up|5
2681353|NCT00512252|9253099|P3|Overall Study|Death|1
2681354|NCT00512252|9253100|P2|Overall Study|Death|0
2681355|NCT00512252|9253101|P1|Overall Study|Death|0
2681356|NCT00512252|9253099|P3|Overall Study|Protocol Violation|1
2681357|NCT00512252|9253100|P2|Overall Study|Protocol Violation|0
2681358|NCT00512252|9253101|P1|Overall Study|Protocol Violation|0
2681359|NCT00512252|9253099|P3|Overall Study|Lost to Follow-up|1
2681360|NCT00512252|9253100|P2|Overall Study|Lost to Follow-up|0
2681361|NCT00512252|9253101|P1|Overall Study|Lost to Follow-up|0
2681362|NCT00512148|9253129|P1|Primay Study Period|Withdrawal by Subject|1
2681363|NCT00512096|9253135|P1|Overall Study|Lack of Efficacy|3
2681364|NCT00512096|9253135|P1|Overall Study|Withdrawal by Subject|2
2681365|NCT00512096|9253135|P1|Overall Study|Adverse Event|2
2681366|NCT00511901|9253163|P2|Overall Study|Withdrawal by Subject|3
2681367|NCT00511901|9253164|P1|Overall Study|Withdrawal by Subject|1
2681368|NCT00511875|9253186|P2|Overall Study|Missing variables|0
2681369|NCT00511875|9253187|P1|Overall Study|Missing variables|1
2681370|NCT00511875|9253186|P2|Overall Study|Lost to Follow-up|0
2681371|NCT00511875|9253187|P1|Overall Study|Lost to Follow-up|4
2681372|NCT00511836|9253227|P2|Double-blind Period|Lost to Follow-up|0
2681373|NCT00511836|9253228|P1|Double-blind Period|Lost to Follow-up|1
2681374|NCT00511810|9253245|P2|Overall Study|Refused second scn|1
2681375|NCT00511810|9253246|P1|Overall Study|Refused second scn|0
2681376|NCT00511810|9253245|P2|Overall Study|Lack of Efficacy|2
2681377|NCT00511810|9253246|P1|Overall Study|Lack of Efficacy|0
2681378|NCT00511810|9253245|P2|Overall Study|Lost to Follow-up|2
2681379|NCT00511810|9253246|P1|Overall Study|Lost to Follow-up|1
2681380|NCT00511797|9253256|P4|Overall Study|Other (moving etc)|2
2681381|NCT00511797|9253257|P3|Overall Study|Other (moving etc)|1
2681382|NCT00511797|9253258|P2|Overall Study|Other (moving etc)|0
2681383|NCT00511797|9253259|P1|Overall Study|Other (moving etc)|1
2681384|NCT00511797|9253256|P4|Overall Study|Partially missing diary|0
2681385|NCT00511797|9253257|P3|Overall Study|Partially missing diary|1
2681386|NCT00511797|9253258|P2|Overall Study|Partially missing diary|0
2681387|NCT00511797|9253259|P1|Overall Study|Partially missing diary|0
2681388|NCT00511797|9253256|P4|Overall Study|Study drug not taken|1
2681389|NCT00511797|9253257|P3|Overall Study|Study drug not taken|0
2681390|NCT00511797|9253258|P2|Overall Study|Study drug not taken|1
2681391|NCT00511797|9253259|P1|Overall Study|Study drug not taken|0
2681392|NCT00511797|9253256|P4|Overall Study|Never dispensed|3
2681393|NCT00511797|9253257|P3|Overall Study|Never dispensed|1
2681394|NCT00511797|9253258|P2|Overall Study|Never dispensed|0
2681395|NCT00511797|9253259|P1|Overall Study|Never dispensed|1
2681396|NCT00511797|9253256|P4|Overall Study|Withdrawal by Subject|2
2681397|NCT00511797|9253257|P3|Overall Study|Withdrawal by Subject|4
2681398|NCT00511797|9253258|P2|Overall Study|Withdrawal by Subject|3
2681399|NCT00511797|9253259|P1|Overall Study|Withdrawal by Subject|3
2681400|NCT00511797|9253256|P4|Overall Study|Protocol Violation|3
2681401|NCT00511797|9253257|P3|Overall Study|Protocol Violation|2
2681402|NCT00511797|9253258|P2|Overall Study|Protocol Violation|2
2681403|NCT00511797|9253259|P1|Overall Study|Protocol Violation|0
2681404|NCT00511797|9253256|P4|Overall Study|Pregnancy|1
2681405|NCT00511797|9253257|P3|Overall Study|Pregnancy|0
2681406|NCT00511797|9253258|P2|Overall Study|Pregnancy|0
2681407|NCT00511797|9253259|P1|Overall Study|Pregnancy|0
2681408|NCT00511797|9253256|P4|Overall Study|Lost to Follow-up|1
2681409|NCT00511797|9253257|P3|Overall Study|Lost to Follow-up|0
2681410|NCT00511797|9253258|P2|Overall Study|Lost to Follow-up|0
2681411|NCT00511797|9253259|P1|Overall Study|Lost to Follow-up|1
2681412|NCT00511797|9253256|P4|Overall Study|Adverse Event|2
2681413|NCT00511797|9253257|P3|Overall Study|Adverse Event|2
2681414|NCT00511797|9253258|P2|Overall Study|Adverse Event|2
2681415|NCT00511797|9253259|P1|Overall Study|Adverse Event|1
2681416|NCT00511667|9253378|P2|Overall Study|Other|1
2681417|NCT00511667|9253379|P1|Overall Study|Other|2
2681418|NCT00511667|9253378|P2|Overall Study|Site terminated|1
2681419|NCT00511667|9253379|P1|Overall Study|Site terminated|6
2681420|NCT00511667|9253378|P2|Overall Study|Withdrawal by Subject|0
2681421|NCT00511667|9253379|P1|Overall Study|Withdrawal by Subject|2
2681422|NCT00511667|9253378|P2|Overall Study|Protocol Violation|1
2681423|NCT00511667|9253379|P1|Overall Study|Protocol Violation|1
2681424|NCT00511667|9253378|P2|Overall Study|Adverse Event|0
2681425|NCT00511667|9253379|P1|Overall Study|Adverse Event|1
2681426|NCT00511472|9253414|P2|Overall Study|Not reported|2
2681427|NCT00511472|9253415|P1|Overall Study|Not reported|2
2681428|NCT00511472|9253414|P2|Overall Study|Laboratory Adverse Event|2
2681429|NCT00511472|9253415|P1|Overall Study|Laboratory Adverse Event|0
2681430|NCT00511472|9253414|P2|Overall Study|Clinical Adverse Event|2
2681431|NCT00511472|9253415|P1|Overall Study|Clinical Adverse Event|1
2681432|NCT00511433|9253434|P2|Overall Study|Other Reason|1
2681433|NCT00511433|9253435|P1|Overall Study|Other Reason|1
2681434|NCT00511433|9253434|P2|Overall Study|Adverse Event|0
2681435|NCT00511433|9253435|P1|Overall Study|Adverse Event|5
2681436|NCT00511355|9253475|P2|Overall Study|Other reason pre-treatment|1
2681437|NCT00511355|9253476|P1|Overall Study|Other reason pre-treatment|0
2681438|NCT00511355|9253475|P2|Overall Study|Withdrawal of informed consent|1
2681439|NCT00511355|9253476|P1|Overall Study|Withdrawal of informed consent|0
2681440|NCT00511355|9253475|P2|Overall Study|Pre-treatment (serious) adverse event|1
2681441|NCT00511355|9253476|P1|Overall Study|Pre-treatment (serious) adverse event|0
2681442|NCT00511355|9253475|P2|Overall Study|Other Reason|1
2681443|NCT00511355|9253476|P1|Overall Study|Other Reason|0
2681444|NCT00511355|9253475|P2|Overall Study|Lost to Follow-up|1
2681445|NCT00511355|9253476|P1|Overall Study|Lost to Follow-up|2
2681446|NCT00511355|9253475|P2|Overall Study|Pregnancy Wish|0
2681447|NCT00511355|9253476|P1|Overall Study|Pregnancy Wish|1
2681448|NCT00511355|9253475|P2|Overall Study|Adverse Event|4
2681449|NCT00511355|9253476|P1|Overall Study|Adverse Event|4
2681450|NCT00511342|9253576|P2|Overall Study|Other Reason|2
2681451|NCT00511342|9253577|P1|Overall Study|Other Reason|2
2681452|NCT00511342|9253576|P2|Overall Study|Lost to Follow-up|5
2681453|NCT00511342|9253577|P1|Overall Study|Lost to Follow-up|1
2681454|NCT00511342|9253576|P2|Overall Study|Pregnancy wish|1
2681455|NCT00511342|9253577|P1|Overall Study|Pregnancy wish|0
2681456|NCT00511342|9253576|P2|Overall Study|Pregnancy|1
2681457|NCT00511342|9253577|P1|Overall Study|Pregnancy|0
2681458|NCT00511342|9253576|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|12
2681459|NCT00511342|9253577|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|8
2681460|NCT00511342|9253576|P2|Overall Study|Unacceptable vaginal bleeding|1
2681461|NCT00511342|9253577|P1|Overall Study|Unacceptable vaginal bleeding|2
2681462|NCT00511238|9253608|P2|Overall Study|various reasons|14
2681463|NCT00511238|9253609|P1|Overall Study|various reasons|4
2681464|NCT00511238|9253608|P2|Overall Study|Progressive Disease|157
2681465|NCT00511238|9253609|P1|Overall Study|Progressive Disease|23
2681466|NCT00511238|9253608|P2|Overall Study|Withdrawal by Subject|22
2681467|NCT00511238|9253609|P1|Overall Study|Withdrawal by Subject|2
2681468|NCT00511238|9253608|P2|Overall Study|Adverse Event|33
2681469|NCT00511238|9253609|P1|Overall Study|Adverse Event|13
2681470|NCT00511199|9253628|P2|Overall Study|Other Reason|37
2681471|NCT00511199|9253629|P1|Overall Study|Other Reason|78
2681472|NCT00511199|9253628|P2|Overall Study|Lost to Follow-up|17
2681473|NCT00511199|9253629|P1|Overall Study|Lost to Follow-up|40
2681474|NCT00511199|9253628|P2|Overall Study|Pregnancy Wish|8
2681475|NCT00511199|9253629|P1|Overall Study|Pregnancy Wish|16
2681476|NCT00511199|9253628|P2|Overall Study|Pregnancy|3
2681477|NCT00511199|9253629|P1|Overall Study|Pregnancy|6
2681478|NCT00511199|9253628|P2|Overall Study|Withdrawal of Informed Consent|4
2681479|NCT00511199|9253629|P1|Overall Study|Withdrawal of Informed Consent|19
2681480|NCT00511199|9253628|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|52
2681481|NCT00511199|9253629|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|227
2681482|NCT00511199|9253628|P2|Overall Study|Unacceptable Vaginal Bleeding|4
2681483|NCT00511199|9253629|P1|Overall Study|Unacceptable Vaginal Bleeding|63
2681484|NCT00511147|9253658|P1|Overall Study|Required platelet transfusion|1
2681485|NCT00511147|9253658|P1|Overall Study|Disease progression|5
2681486|NCT00511147|9253658|P1|Overall Study|Withdrawal by Subject|1
2681487|NCT00511134|9253667|P2|Overall Study|Withdrawal by Subject|2
2681488|NCT00511134|9253668|P1|Overall Study|Withdrawal by Subject|0
2681489|NCT00511108|9253680|P4|Overall Study|Withdrawal by Subject|2
2681490|NCT00511108|9253681|P3|Overall Study|Withdrawal by Subject|3
2681491|NCT00511108|9253682|P2|Overall Study|Withdrawal by Subject|0
2681492|NCT00511108|9253683|P1|Overall Study|Withdrawal by Subject|4
2681493|NCT00511108|9253680|P4|Overall Study|Physician Decision|1
2681494|NCT00511108|9253681|P3|Overall Study|Physician Decision|0
2681495|NCT00511108|9253682|P2|Overall Study|Physician Decision|0
2681496|NCT00511108|9253683|P1|Overall Study|Physician Decision|0
2681497|NCT00511108|9253680|P4|Overall Study|Lost to Follow-up|0
2681498|NCT00511108|9253681|P3|Overall Study|Lost to Follow-up|1
2681499|NCT00511108|9253682|P2|Overall Study|Lost to Follow-up|2
2681500|NCT00511108|9253683|P1|Overall Study|Lost to Follow-up|0
2681501|NCT00511108|9253680|P4|Overall Study|Adverse Event|2
2681502|NCT00511108|9253681|P3|Overall Study|Adverse Event|1
2681503|NCT00511108|9253682|P2|Overall Study|Adverse Event|0
2681504|NCT00511108|9253683|P1|Overall Study|Adverse Event|2
2681505|NCT00511004|9253714|P3|Overall Study|Lost to Follow-up|4
2681506|NCT00511004|9253715|P2|Overall Study|Lost to Follow-up|0
2681507|NCT00511004|9253716|P1|Overall Study|Lost to Follow-up|0
2681508|NCT00510952|9253735|P2|Overall Study|Did Not Receive Study Drug|0
2681509|NCT00510952|9253736|P1|Overall Study|Did Not Receive Study Drug|2
2681510|NCT00510952|9253735|P2|Overall Study|Withdrawal by Subject|7
2681511|NCT00510952|9253736|P1|Overall Study|Withdrawal by Subject|6
2681512|NCT00510952|9253735|P2|Overall Study|Sponsor Decision|0
2681513|NCT00510952|9253736|P1|Overall Study|Sponsor Decision|1
2681514|NCT00510952|9253735|P2|Overall Study|Protocol Violation|4
2681515|NCT00510952|9253736|P1|Overall Study|Protocol Violation|7
2681516|NCT00510952|9253735|P2|Overall Study|Physician Decision|1
2681517|NCT00510952|9253736|P1|Overall Study|Physician Decision|1
2681518|NCT00510952|9253735|P2|Overall Study|Lost to Follow-up|3
2681519|NCT00510952|9253736|P1|Overall Study|Lost to Follow-up|5
2681520|NCT00510952|9253735|P2|Overall Study|Entry Criteria Not Met|1
2681521|NCT00510952|9253736|P1|Overall Study|Entry Criteria Not Met|3
2681522|NCT00510952|9253735|P2|Overall Study|Adverse Event|0
2681523|NCT00510952|9253736|P1|Overall Study|Adverse Event|1
2681524|NCT00510887|9253762|P1|Overall Study|Lost to Follow-up|1
2681525|NCT00510874|9253778|P7|Overall Study|Lost to Follow-up|1
2681526|NCT00510874|9253779|P6|Overall Study|Lost to Follow-up|0
2681527|NCT00510874|9253780|P5|Overall Study|Lost to Follow-up|4
2681528|NCT00510874|9253781|P4|Overall Study|Lost to Follow-up|3
2681529|NCT00510874|9253782|P3|Overall Study|Lost to Follow-up|1
2681530|NCT00510874|9253783|P2|Overall Study|Lost to Follow-up|3
2681531|NCT00510874|9253784|P1|Overall Study|Lost to Follow-up|2
2681532|NCT00510874|9253778|P7|Overall Study|Withdrawal by Subject|0
2681533|NCT00510874|9253779|P6|Overall Study|Withdrawal by Subject|0
2681534|NCT00510874|9253780|P5|Overall Study|Withdrawal by Subject|3
2681535|NCT00510874|9253781|P4|Overall Study|Withdrawal by Subject|0
2681536|NCT00510874|9253782|P3|Overall Study|Withdrawal by Subject|0
2681537|NCT00510874|9253783|P2|Overall Study|Withdrawal by Subject|1
2681538|NCT00510874|9253784|P1|Overall Study|Withdrawal by Subject|1
2681539|NCT00510835|9253887|P3|Overall Study|Withdrawal by Subject|2
2681540|NCT00510835|9253888|P2|Overall Study|Withdrawal by Subject|2
2681541|NCT00510835|9253889|P1|Overall Study|Withdrawal by Subject|6
2681542|NCT00510783|9253915|P2|Overall Study|Protocol Violation|1
2681543|NCT00510783|9253916|P1|Overall Study|Protocol Violation|0
2681544|NCT00510783|9253915|P2|Overall Study|Withdrawal by Subject|3
2681545|NCT00510783|9253916|P1|Overall Study|Withdrawal by Subject|2
2681546|NCT00510783|9253915|P2|Overall Study|Lost to Follow-up|25
2681547|NCT00510783|9253916|P1|Overall Study|Lost to Follow-up|29
2681548|NCT00510718|9253933|P2|Multiple Dose Period: 12 Weeks|Other|1
2681549|NCT00510718|9253934|P1|Multiple Dose Period: 12 Weeks|Other|1
2681550|NCT00510718|9253933|P2|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3
2681551|NCT00510718|9253934|P1|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1
2681552|NCT00510718|9253933|P2|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3
2681553|NCT00510718|9253934|P1|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1
2681554|NCT00510718|9253933|P2|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11
2681555|NCT00510718|9253934|P1|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8
2681556|NCT00510718|9253933|P2|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6
2681557|NCT00510718|9253934|P1|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3
2681558|NCT00510718|9253933|P2|Multiple Dose Period: 12 Weeks|Adverse Event|8
2681559|NCT00510718|9253934|P1|Multiple Dose Period: 12 Weeks|Adverse Event|1
2681560|NCT00510692|9254060|P2|Overall Study|Withdrawal by Subject|0
2681561|NCT00510692|9254061|P1|Overall Study|Withdrawal by Subject|1
2681562|NCT00510692|9254060|P2|Overall Study|Adverse Event|3
2681563|NCT00510692|9254061|P1|Overall Study|Adverse Event|1
2681564|NCT00510653|9254075|P1|Overall Study|Monetary|3
2681565|NCT00510653|9254075|P1|Overall Study|Withdrawal by Subject|8
2681566|NCT00510510|9254082|P3|Overall Study|Protocol Violation|4
2681567|NCT00510510|9254083|P2|Overall Study|Protocol Violation|3
2681568|NCT00510510|9254084|P1|Overall Study|Protocol Violation|0
2681569|NCT00510510|9254082|P3|Overall Study|Lost to Follow-up|1
2681570|NCT00510510|9254083|P2|Overall Study|Lost to Follow-up|0
2681571|NCT00510510|9254084|P1|Overall Study|Lost to Follow-up|0
2681572|NCT00510510|9254082|P3|Overall Study|Withdrawal by Subject|3
2681573|NCT00510510|9254083|P2|Overall Study|Withdrawal by Subject|2
2681574|NCT00510510|9254084|P1|Overall Study|Withdrawal by Subject|1
2681575|NCT00510510|9254082|P3|Overall Study|Subjects no longer requires study drug|2
2681576|NCT00510510|9254083|P2|Overall Study|Subjects no longer requires study drug|0
2681577|NCT00510510|9254084|P1|Overall Study|Subjects no longer requires study drug|0
2681578|NCT00510510|9254082|P3|Overall Study|Lack of Efficacy|1
2681579|NCT00510510|9254083|P2|Overall Study|Lack of Efficacy|1
2681580|NCT00510510|9254084|P1|Overall Study|Lack of Efficacy|0
2681581|NCT00510510|9254082|P3|Overall Study|Adverse Event|6
2681582|NCT00510510|9254083|P2|Overall Study|Adverse Event|3
2681583|NCT00510510|9254084|P1|Overall Study|Adverse Event|4
2681584|NCT00510484|9254102|P2|Wash-out Period|Adverse Event|1
2681585|NCT00510484|9254103|P1|Wash-out Period|Adverse Event|0
2681586|NCT00510458|9254123|P1|Overall Study|Revision|2
2681587|NCT00510458|9254123|P1|Overall Study|Withdrawal by Subject|3
2681588|NCT00510458|9254123|P1|Overall Study|Lost to Follow-up|6
2681589|NCT00510458|9254123|P1|Overall Study|Terminated|14
2681590|NCT00510458|9254123|P1|Overall Study|Death|1
2681591|NCT00510458|9254123|P1|Overall Study|5 year not evaluable/missed|21
2681592|NCT00510289|9254136|P1|Overall Study|Progressed prior to starting drug|2
2681593|NCT00510289|9254136|P1|Overall Study|Lost to Follow-up|1
2681594|NCT00510289|9254136|P1|Overall Study|Refused bone marrow biopsy|2
2681595|NCT00510289|9254136|P1|Overall Study|Withdrawal by Subject|7
2681596|NCT00510276|9254146|P2|Extension Open-Label Phase|Subject Decision|9
2681597|NCT00510276|9254147|P1|Extension Open-Label Phase|Subject Decision|7
2681598|NCT00510276|9254146|P2|Extension Open-Label Phase|Sponsor Decision|0
2681599|NCT00510276|9254147|P1|Extension Open-Label Phase|Sponsor Decision|1
2681600|NCT00510276|9254146|P2|Extension Open-Label Phase|Protocol Violation|1
2681601|NCT00510276|9254147|P1|Extension Open-Label Phase|Protocol Violation|0
2681602|NCT00510276|9254146|P2|Extension Open-Label Phase|Physician Decision|3
2681603|NCT00510276|9254147|P1|Extension Open-Label Phase|Physician Decision|2
2681604|NCT00510276|9254146|P2|Extension Open-Label Phase|Lost to Follow-up|10
2681605|NCT00510276|9254147|P1|Extension Open-Label Phase|Lost to Follow-up|12
2681606|NCT00510276|9254146|P2|Extension Open-Label Phase|Lack of Efficacy|7
2681607|NCT00510276|9254147|P1|Extension Open-Label Phase|Lack of Efficacy|2
2681608|NCT00510276|9254146|P2|Extension Open-Label Phase|Adverse Event|18
2681609|NCT00510276|9254147|P1|Extension Open-Label Phase|Adverse Event|9
2681610|NCT00510276|9254146|P2|Acute Double-Blind Phase|Subject Decision|28
2681611|NCT00510276|9254147|P1|Acute Double-Blind Phase|Subject Decision|26
2681612|NCT00510276|9254146|P2|Acute Double-Blind Phase|Sponsor Decision|1
2681613|NCT00510276|9254147|P1|Acute Double-Blind Phase|Sponsor Decision|2
2681614|NCT00510276|9254146|P2|Acute Double-Blind Phase|Protocol Violation|3
2681615|NCT00510276|9254147|P1|Acute Double-Blind Phase|Protocol Violation|4
2681616|NCT00510276|9254146|P2|Acute Double-Blind Phase|Physician Decision|3
2681617|NCT00510276|9254147|P1|Acute Double-Blind Phase|Physician Decision|0
2681618|NCT00510276|9254146|P2|Acute Double-Blind Phase|Lost to Follow-up|49
2681619|NCT00510276|9254147|P1|Acute Double-Blind Phase|Lost to Follow-up|48
2681620|NCT00510276|9254146|P2|Acute Double-Blind Phase|Lack of Efficacy|4
2681621|NCT00510276|9254147|P1|Acute Double-Blind Phase|Lack of Efficacy|3
2681622|NCT00510276|9254146|P2|Acute Double-Blind Phase|Entry Criteria Not Met|1
2681623|NCT00510276|9254147|P1|Acute Double-Blind Phase|Entry Criteria Not Met|1
2681624|NCT00510276|9254146|P2|Acute Double-Blind Phase|Adverse Event|6
2681625|NCT00510276|9254147|P1|Acute Double-Blind Phase|Adverse Event|21
2681626|NCT00510198|9254241|P2|Overall Study|Withdrawal by Subject|4
2681627|NCT00510198|9254242|P1|Overall Study|Withdrawal by Subject|5
2681628|NCT00510146|9254256|P2|Open-Label Treatment|Sponsor Decision|0
2681629|NCT00510146|9254257|P1|Open-Label Treatment|Sponsor Decision|2
2681630|NCT00510146|9254256|P2|Open-Label Treatment|Clinical Relapse|1
2681631|NCT00510146|9254257|P1|Open-Label Treatment|Clinical Relapse|1
2681632|NCT00510146|9254256|P2|Open-Label Treatment|Withdrawal by Subject|12
2681633|NCT00510146|9254257|P1|Open-Label Treatment|Withdrawal by Subject|24
2681634|NCT00510146|9254256|P2|Open-Label Treatment|Protocol Violation|2
2681635|NCT00510146|9254257|P1|Open-Label Treatment|Protocol Violation|4
2681636|NCT00510146|9254256|P2|Open-Label Treatment|Physician Decision|1
2681637|NCT00510146|9254257|P1|Open-Label Treatment|Physician Decision|3
2681638|NCT00510146|9254256|P2|Open-Label Treatment|Lost to Follow-up|1
2681639|NCT00510146|9254257|P1|Open-Label Treatment|Lost to Follow-up|10
2681640|NCT00510146|9254256|P2|Open-Label Treatment|Lack of Efficacy|0
2681641|NCT00510146|9254257|P1|Open-Label Treatment|Lack of Efficacy|4
2681642|NCT00510146|9254256|P2|Open-Label Treatment|Death|1
2681643|NCT00510146|9254257|P1|Open-Label Treatment|Death|1
2681644|NCT00510146|9254256|P2|Open-Label Treatment|Adverse Event|8
2681645|NCT00510146|9254257|P1|Open-Label Treatment|Adverse Event|22
2681646|NCT00510146|9254256|P2|Double-Blind Treatment|Entry Criteria Not Met|0
2681647|NCT00510146|9254257|P1|Double-Blind Treatment|Entry Criteria Not Met|3
2681648|NCT00510146|9254256|P2|Double-Blind Treatment|Clinical Relapse|1
2681649|NCT00510146|9254257|P1|Double-Blind Treatment|Clinical Relapse|0
2681650|NCT00510146|9254256|P2|Double-Blind Treatment|Withdrawal by Subject|13
2681651|NCT00510146|9254257|P1|Double-Blind Treatment|Withdrawal by Subject|27
2681652|NCT00510146|9254256|P2|Double-Blind Treatment|Protocol Violation|2
2681653|NCT00510146|9254257|P1|Double-Blind Treatment|Protocol Violation|1
2681654|NCT00510146|9254256|P2|Double-Blind Treatment|Physician Decision|0
2681655|NCT00510146|9254257|P1|Double-Blind Treatment|Physician Decision|6
2681656|NCT00510146|9254256|P2|Double-Blind Treatment|Lost to Follow-up|7
2681657|NCT00510146|9254257|P1|Double-Blind Treatment|Lost to Follow-up|3
2681658|NCT00510146|9254256|P2|Double-Blind Treatment|Lack of Efficacy|13
2681659|NCT00510146|9254257|P1|Double-Blind Treatment|Lack of Efficacy|6
2681660|NCT00510146|9254256|P2|Double-Blind Treatment|Adverse Event|13
2681661|NCT00510146|9254257|P1|Double-Blind Treatment|Adverse Event|30
2681662|NCT00510068|9254346|P2|Open-label Period|Abnormal laboratory value (s)|0
2681663|NCT00510068|9254347|P1|Open-label Period|Abnormal laboratory value (s)|1
2681664|NCT00510068|9254346|P2|Open-label Period|Protocol Violation|0
2681665|NCT00510068|9254347|P1|Open-label Period|Protocol Violation|2
2681666|NCT00510068|9254346|P2|Open-label Period|New cancer therapy|0
2681667|NCT00510068|9254347|P1|Open-label Period|New cancer therapy|7
2681668|NCT00510068|9254346|P2|Open-label Period|Death|0
2681669|NCT00510068|9254347|P1|Open-label Period|Death|7
2681670|NCT00510068|9254346|P2|Open-label Period|Administrative problems|0
2681671|NCT00510068|9254347|P1|Open-label Period|Administrative problems|17
2681672|NCT00510068|9254346|P2|Open-label Period|Withdrawal by Subject|0
2681673|NCT00510068|9254347|P1|Open-label Period|Withdrawal by Subject|21
2681674|NCT00510068|9254346|P2|Open-label Period|Adverse Event|0
2681675|NCT00510068|9254347|P1|Open-label Period|Adverse Event|46
2681676|NCT00510068|9254346|P2|Open-label Period|Disease Progression|0
2681677|NCT00510068|9254347|P1|Open-label Period|Disease Progression|124
2681678|NCT00510068|9254346|P2|Double-blind Period|Protocol Violation|0
2681679|NCT00510068|9254347|P1|Double-blind Period|Protocol Violation|6
2681680|NCT00510068|9254346|P2|Double-blind Period|Lost to Follow-up|0
2681681|NCT00510068|9254347|P1|Double-blind Period|Lost to Follow-up|1
2681682|NCT00510068|9254346|P2|Double-blind Period|Abnormal test result (s)|0
2681683|NCT00510068|9254347|P1|Double-blind Period|Abnormal test result (s)|1
2681684|NCT00510068|9254346|P2|Double-blind Period|Death|3
2681685|NCT00510068|9254347|P1|Double-blind Period|Death|4
2681686|NCT00510068|9254346|P2|Double-blind Period|Withdrawal by Subject|6
2681687|NCT00510068|9254347|P1|Double-blind Period|Withdrawal by Subject|8
2681688|NCT00510068|9254346|P2|Double-blind Period|Adverse Event|7
2681689|NCT00510068|9254347|P1|Double-blind Period|Adverse Event|37
2681690|NCT00510068|9254346|P2|Double-blind Period|Final primary analysis|18
2681691|NCT00510068|9254347|P1|Double-blind Period|Final primary analysis|52
2681692|NCT00510068|9254346|P2|Double-blind Period|Disease progression|169
2681693|NCT00510068|9254347|P1|Double-blind Period|Disease progression|98
2681694|NCT00509925|9254388|P2|Overall Study|Personal reasons|1
2681695|NCT00509925|9254389|P1|Overall Study|Personal reasons|0
2681696|NCT00509899|9254437|P8|Overall Study|Lack of Efficacy|0
2681697|NCT00509899|9254438|P7|Overall Study|Lack of Efficacy|0
2681698|NCT00509899|9254439|P6|Overall Study|Lack of Efficacy|1
2681699|NCT00509899|9254440|P5|Overall Study|Lack of Efficacy|0
2681700|NCT00509899|9254441|P4|Overall Study|Lack of Efficacy|0
2681701|NCT00509899|9254442|P3|Overall Study|Lack of Efficacy|2
2681702|NCT00509899|9254443|P2|Overall Study|Lack of Efficacy|0
2681703|NCT00509899|9254444|P1|Overall Study|Lack of Efficacy|1
2681704|NCT00509899|9254437|P8|Overall Study|Death|1
2681705|NCT00509899|9254438|P7|Overall Study|Death|1
2681706|NCT00509899|9254439|P6|Overall Study|Death|1
2681707|NCT00509899|9254440|P5|Overall Study|Death|1
2681708|NCT00509899|9254441|P4|Overall Study|Death|0
2681709|NCT00509899|9254442|P3|Overall Study|Death|3
2681710|NCT00509899|9254443|P2|Overall Study|Death|2
2681711|NCT00509899|9254444|P1|Overall Study|Death|2
2681712|NCT00509899|9254437|P8|Overall Study|Intercurrent Illness|0
2681713|NCT00509899|9254438|P7|Overall Study|Intercurrent Illness|0
2681714|NCT00509899|9254439|P6|Overall Study|Intercurrent Illness|1
2681715|NCT00509899|9254440|P5|Overall Study|Intercurrent Illness|0
2681716|NCT00509899|9254441|P4|Overall Study|Intercurrent Illness|1
2681717|NCT00509899|9254442|P3|Overall Study|Intercurrent Illness|0
2681718|NCT00509899|9254443|P2|Overall Study|Intercurrent Illness|0
2681719|NCT00509899|9254444|P1|Overall Study|Intercurrent Illness|1
2681720|NCT00509899|9254437|P8|Overall Study|Physician Decision|0
2681721|NCT00509899|9254438|P7|Overall Study|Physician Decision|0
2681722|NCT00509899|9254439|P6|Overall Study|Physician Decision|4
2681723|NCT00509899|9254440|P5|Overall Study|Physician Decision|1
2681724|NCT00509899|9254441|P4|Overall Study|Physician Decision|0
2681725|NCT00509899|9254442|P3|Overall Study|Physician Decision|7
2681726|NCT00509899|9254443|P2|Overall Study|Physician Decision|2
2681727|NCT00509899|9254444|P1|Overall Study|Physician Decision|4
2681728|NCT00509899|9254437|P8|Overall Study|Withdrawal by Subject|0
2681729|NCT00509899|9254438|P7|Overall Study|Withdrawal by Subject|0
2681730|NCT00509899|9254439|P6|Overall Study|Withdrawal by Subject|2
2681731|NCT00509899|9254440|P5|Overall Study|Withdrawal by Subject|3
2681732|NCT00509899|9254441|P4|Overall Study|Withdrawal by Subject|0
2681733|NCT00509899|9254442|P3|Overall Study|Withdrawal by Subject|3
2681734|NCT00509899|9254443|P2|Overall Study|Withdrawal by Subject|2
2681735|NCT00509899|9254444|P1|Overall Study|Withdrawal by Subject|6
2681736|NCT00509899|9254437|P8|Overall Study|Unacceptable Toxicity|0
2681737|NCT00509899|9254438|P7|Overall Study|Unacceptable Toxicity|0
2681738|NCT00509899|9254439|P6|Overall Study|Unacceptable Toxicity|0
2681739|NCT00509899|9254440|P5|Overall Study|Unacceptable Toxicity|0
2681740|NCT00509899|9254441|P4|Overall Study|Unacceptable Toxicity|2
2681741|NCT00509899|9254442|P3|Overall Study|Unacceptable Toxicity|0
2681742|NCT00509899|9254443|P2|Overall Study|Unacceptable Toxicity|0
2681743|NCT00509899|9254444|P1|Overall Study|Unacceptable Toxicity|1
2681744|NCT00509899|9254437|P8|Overall Study|Progressive disease|0
2681745|NCT00509899|9254438|P7|Overall Study|Progressive disease|0
2681746|NCT00509899|9254439|P6|Overall Study|Progressive disease|1
2681747|NCT00509899|9254440|P5|Overall Study|Progressive disease|0
2681748|NCT00509899|9254441|P4|Overall Study|Progressive disease|1
2681749|NCT00509899|9254442|P3|Overall Study|Progressive disease|5
2681750|NCT00509899|9254443|P2|Overall Study|Progressive disease|3
2681751|NCT00509899|9254444|P1|Overall Study|Progressive disease|1
2681752|NCT00509821|9254501|P2|Study Period 1 (Induction)|Progressive Disease|1
2681753|NCT00509821|9254502|P1|Study Period 1 (Induction)|Progressive Disease|0
2681754|NCT00509821|9254501|P2|Study Period 1 (Induction)|Adverse Event|2
2681755|NCT00509821|9254502|P1|Study Period 1 (Induction)|Adverse Event|0
2681756|NCT00509821|9254501|P2|Study Period 1 (Induction)|Death|1
2681757|NCT00509821|9254502|P1|Study Period 1 (Induction)|Death|0
2681758|NCT00509795|9254520|P4|Overall Study|Withdrawal by Subject|8
2681759|NCT00509795|9254521|P3|Overall Study|Withdrawal by Subject|7
2681760|NCT00509795|9254522|P2|Overall Study|Withdrawal by Subject|5
2681761|NCT00509795|9254523|P1|Overall Study|Withdrawal by Subject|10
2681762|NCT00509795|9254520|P4|Overall Study|Protocol Violation|1
2681763|NCT00509795|9254521|P3|Overall Study|Protocol Violation|3
2681764|NCT00509795|9254522|P2|Overall Study|Protocol Violation|0
2681765|NCT00509795|9254523|P1|Overall Study|Protocol Violation|3
2681766|NCT00509795|9254520|P4|Overall Study|OTHER|1
2681767|NCT00509795|9254521|P3|Overall Study|OTHER|4
2681768|NCT00509795|9254522|P2|Overall Study|OTHER|0
2681769|NCT00509795|9254523|P1|Overall Study|OTHER|1
2681770|NCT00509795|9254520|P4|Overall Study|Lost to Follow-up|4
2681771|NCT00509795|9254521|P3|Overall Study|Lost to Follow-up|4
2681772|NCT00509795|9254522|P2|Overall Study|Lost to Follow-up|2
2681773|NCT00509795|9254523|P1|Overall Study|Lost to Follow-up|1
2681774|NCT00509795|9254520|P4|Overall Study|Lack of Efficacy|2
2681775|NCT00509795|9254521|P3|Overall Study|Lack of Efficacy|2
2681776|NCT00509795|9254522|P2|Overall Study|Lack of Efficacy|0
2681777|NCT00509795|9254523|P1|Overall Study|Lack of Efficacy|0
2681778|NCT00509795|9254520|P4|Overall Study|Death|7
2681779|NCT00509795|9254521|P3|Overall Study|Death|2
2681780|NCT00509795|9254522|P2|Overall Study|Death|1
2681781|NCT00509795|9254523|P1|Overall Study|Death|3
2681782|NCT00509795|9254520|P4|Overall Study|Adverse Event|4
2681783|NCT00509795|9254521|P3|Overall Study|Adverse Event|5
2681784|NCT00509795|9254522|P2|Overall Study|Adverse Event|3
2681785|NCT00509795|9254523|P1|Overall Study|Adverse Event|4
2681786|NCT00509769|9254554|P1|Overall Study|Use of prohibited therapies during study|1
2681787|NCT00509769|9254554|P1|Overall Study|Physician Decision|8
2681788|NCT00509769|9254554|P1|Overall Study|Patient’s decision|1
2681789|NCT00509769|9254554|P1|Overall Study|Adverse Event|4
2681790|NCT00509769|9254554|P1|Overall Study|Progressive disease|77
2681791|NCT00509600|9254573|P1|Overall Study|Adverse Event|1
2681792|NCT00509366|9254652|P5|Overall Study|Not Treated (Screen Failure)|0
2681793|NCT00509366|9254653|P4|Overall Study|Not Treated (Screen Failure)|0
2681794|NCT00509366|9254654|P3|Overall Study|Not Treated (Screen Failure)|1
2681795|NCT00509366|9254655|P2|Overall Study|Not Treated (Screen Failure)|1
2681796|NCT00509366|9254656|P1|Overall Study|Not Treated (Screen Failure)|1
2681797|NCT00509262|9254680|P2|Overall Study|Withdrawal by Subject|11
2681798|NCT00509262|9254681|P1|Overall Study|Withdrawal by Subject|24
2681799|NCT00509262|9254680|P2|Overall Study|Protocol Violation|2
2681800|NCT00509262|9254681|P1|Overall Study|Protocol Violation|2
2681801|NCT00509262|9254680|P2|Overall Study|Physician Decision|3
2681802|NCT00509262|9254681|P1|Overall Study|Physician Decision|1
2681803|NCT00509262|9254680|P2|Overall Study|Lost to Follow-up|6
2681804|NCT00509262|9254681|P1|Overall Study|Lost to Follow-up|1
2681805|NCT00509262|9254680|P2|Overall Study|Lack of Efficacy|0
2681806|NCT00509262|9254681|P1|Overall Study|Lack of Efficacy|1
2681807|NCT00509262|9254680|P2|Overall Study|Other|2
2681808|NCT00509262|9254681|P1|Overall Study|Other|2
2681809|NCT00509262|9254680|P2|Overall Study|Adverse Event|18
2681810|NCT00509262|9254681|P1|Overall Study|Adverse Event|16
2681811|NCT00509236|9254699|P2|Overall Study|Scheduled Kidney Transplant|0
2681812|NCT00509236|9254700|P1|Overall Study|Scheduled Kidney Transplant|1
2681813|NCT00509236|9254699|P2|Overall Study|Excluded Medication|1
2681814|NCT00509236|9254700|P1|Overall Study|Excluded Medication|1
2681815|NCT00509236|9254699|P2|Overall Study|Protocol Violation|0
2681816|NCT00509236|9254700|P1|Overall Study|Protocol Violation|3
2681817|NCT00509236|9254699|P2|Overall Study|Withdrawal by Subject|10
2681818|NCT00509236|9254700|P1|Overall Study|Withdrawal by Subject|5
2681819|NCT00509236|9254699|P2|Overall Study|Adverse Event|9
2681820|NCT00509236|9254700|P1|Overall Study|Adverse Event|7
2681821|NCT00509223|9254715|P2|Overall Study|Did not meet revised inclusion criteria|62
2681822|NCT00509223|9254716|P1|Overall Study|Did not meet revised inclusion criteria|56
2681823|NCT00509223|9254715|P2|Overall Study|Including: subject change of address|2
2681824|NCT00509223|9254716|P1|Overall Study|Including: subject change of address|5
2681825|NCT00509223|9254715|P2|Overall Study|Withdrawal by Subject|6
2681826|NCT00509223|9254716|P1|Overall Study|Withdrawal by Subject|25
2681827|NCT00509223|9254715|P2|Overall Study|Adverse Event|1
2681828|NCT00509223|9254716|P1|Overall Study|Adverse Event|1
2681829|NCT00509223|9254715|P2|Overall Study|Lost to Follow-up|1
2681830|NCT00509223|9254716|P1|Overall Study|Lost to Follow-up|1
2681831|NCT00509106|9254739|P2|Overall Study|Death|6
2681832|NCT00509106|9254740|P1|Overall Study|Death|6
2681833|NCT00509106|9254739|P2|Overall Study|Other|0
2681834|NCT00509106|9254740|P1|Overall Study|Other|1
2681835|NCT00509106|9254739|P2|Overall Study|Lost to Follow-up|10
2681836|NCT00509106|9254740|P1|Overall Study|Lost to Follow-up|16
2681837|NCT00509106|9254739|P2|Overall Study|Withdrew consent|8
2681838|NCT00509106|9254740|P1|Overall Study|Withdrew consent|4
2681839|NCT00509106|9254739|P2|Overall Study|At the request of sponsor/investigator|2
2681840|NCT00509106|9254740|P1|Overall Study|At the request of sponsor/investigator|1
2681841|NCT00509106|9254739|P2|Overall Study|Noncompliance|1
2681842|NCT00509106|9254740|P1|Overall Study|Noncompliance|0
2681843|NCT00509106|9254739|P2|Overall Study|Adverse Event|2
2681844|NCT00509106|9254740|P1|Overall Study|Adverse Event|3
2681845|NCT00509093|9254746|P1|Overall Study|Physician Decision|1
2681846|NCT00509093|9254746|P1|Overall Study|Withdrawal by Subject|3
2681847|NCT00509093|9254746|P1|Overall Study|Transformed into MDS|1
2681848|NCT00509093|9254746|P1|Overall Study|Disease Progression|9
2681849|NCT00509093|9254746|P1|Overall Study|Adverse Event|10
2681850|NCT00509067|9254756|P2|Overall Study|Protocol Violation|3
2681851|NCT00509067|9254757|P1|Overall Study|Protocol Violation|0
2681852|NCT00509067|9254756|P2|Overall Study|Adverse Event|1
2681853|NCT00509067|9254757|P1|Overall Study|Adverse Event|3
2681854|NCT00509067|9254756|P2|Overall Study|Lost to Follow-up|1
2681855|NCT00509067|9254757|P1|Overall Study|Lost to Follow-up|1
2681856|NCT00509028|9254776|P2|Overall Study|Non-compliance|1
2681857|NCT00509028|9254777|P1|Overall Study|Non-compliance|2
2681858|NCT00509028|9254776|P2|Overall Study|Protocol Violation|2
2681859|NCT00509028|9254777|P1|Overall Study|Protocol Violation|4
2681860|NCT00509028|9254776|P2|Overall Study|Lost to Follow-up|1
2681861|NCT00509028|9254777|P1|Overall Study|Lost to Follow-up|0
2681862|NCT00509028|9254776|P2|Overall Study|Withdrawal by Subject|3
2681863|NCT00509028|9254777|P1|Overall Study|Withdrawal by Subject|4
2681864|NCT00509028|9254776|P2|Overall Study|Adverse Event|0
2681865|NCT00509028|9254777|P1|Overall Study|Adverse Event|2
2681866|NCT00508924|9254817|P4|Overall Study|Protocol Violation|1
2681867|NCT00508924|9254818|P3|Overall Study|Protocol Violation|1
2681868|NCT00508924|9254819|P2|Overall Study|Protocol Violation|0
2681869|NCT00508924|9254820|P1|Overall Study|Protocol Violation|0
2681870|NCT00508872|9254834|P1|Overall Study|Physician Decision|1
2681871|NCT00508872|9254834|P1|Overall Study|Lost to Follow-up|1
2681872|NCT00508820|9254840|P2|Overall Study|Protocol-specified Criteria|12
2681873|NCT00508820|9254841|P1|Overall Study|Protocol-specified Criteria|3
2681874|NCT00508820|9254840|P2|Overall Study|Requirement for alternative therapy|15
2681875|NCT00508820|9254841|P1|Overall Study|Requirement for alternative therapy|7
2681876|NCT00508820|9254840|P2|Overall Study|Noncompliance|0
2681877|NCT00508820|9254841|P1|Overall Study|Noncompliance|1
2681878|NCT00508820|9254840|P2|Overall Study|Other|2
2681879|NCT00508820|9254841|P1|Overall Study|Other|11
2681880|NCT00508820|9254840|P2|Overall Study|Withdrawal by Subject|12
2681881|NCT00508820|9254841|P1|Overall Study|Withdrawal by Subject|10
2681882|NCT00508820|9254840|P2|Overall Study|Protocol Violation|0
2681883|NCT00508820|9254841|P1|Overall Study|Protocol Violation|2
2681884|NCT00508820|9254840|P2|Overall Study|Pregnancy|2
2681885|NCT00508820|9254841|P1|Overall Study|Pregnancy|0
2681886|NCT00508820|9254840|P2|Overall Study|Physician Decision|2
2681887|NCT00508820|9254841|P1|Overall Study|Physician Decision|8
2681888|NCT00508820|9254840|P2|Overall Study|Lost to Follow-up|1
2681889|NCT00508820|9254841|P1|Overall Study|Lost to Follow-up|1
2681890|NCT00508820|9254840|P2|Overall Study|Death|8
2681891|NCT00508820|9254841|P1|Overall Study|Death|6
2681892|NCT00508820|9254840|P2|Overall Study|Adverse Event|10
2681893|NCT00508820|9254841|P1|Overall Study|Adverse Event|6
2681894|NCT00508755|9254851|P1|Overall Study|Withdrawal by Subject|1
2681895|NCT00508742|9254859|P2|Period 3: Toddler Dose|Other|4
2681896|NCT00508742|9254860|P1|Period 3: Toddler Dose|Other|5
2681897|NCT00508742|9254859|P2|Period 3: Toddler Dose|Parent/Legal Guardian Request|8
2681898|NCT00508742|9254860|P1|Period 3: Toddler Dose|Parent/Legal Guardian Request|17
2681899|NCT00508742|9254859|P2|Period 3: Toddler Dose|Lost to Follow-up|3
2681900|NCT00508742|9254860|P1|Period 3: Toddler Dose|Lost to Follow-up|2
2681901|NCT00508742|9254859|P2|Period 3: Toddler Dose|Adverse Event|0
2681902|NCT00508742|9254860|P1|Period 3: Toddler Dose|Adverse Event|1
2681903|NCT00508742|9254859|P2|Period 2: After Infant Series|Other|1
2681904|NCT00508742|9254860|P1|Period 2: After Infant Series|Other|2
2681905|NCT00508742|9254859|P2|Period 2: After Infant Series|Failed to Return|0
2681906|NCT00508742|9254860|P1|Period 2: After Infant Series|Failed to Return|1
2681907|NCT00508742|9254859|P2|Period 2: After Infant Series|Parent/Legal Guardian Request|3
2681908|NCT00508742|9254860|P1|Period 2: After Infant Series|Parent/Legal Guardian Request|0
2681909|NCT00508742|9254859|P2|Period 2: After Infant Series|Protocol Violation|0
2681910|NCT00508742|9254860|P1|Period 2: After Infant Series|Protocol Violation|1
2681911|NCT00508742|9254859|P2|Period 2: After Infant Series|Lost to Follow-up|1
2681912|NCT00508742|9254860|P1|Period 2: After Infant Series|Lost to Follow-up|1
2681913|NCT00508742|9254859|P2|Period 2: After Infant Series|Adverse Event|6
2681914|NCT00508742|9254860|P1|Period 2: After Infant Series|Adverse Event|2
2681915|NCT00508742|9254859|P2|Period 1: Infant Series|Other|1
2681916|NCT00508742|9254860|P1|Period 1: Infant Series|Other|4
2681917|NCT00508742|9254859|P2|Period 1: Infant Series|Physician Decision|0
2681918|NCT00508742|9254860|P1|Period 1: Infant Series|Physician Decision|1
2681919|NCT00508742|9254859|P2|Period 1: Infant Series|Parent/Legal Guardian Request|40
2681920|NCT00508742|9254860|P1|Period 1: Infant Series|Parent/Legal Guardian Request|31
2681921|NCT00508742|9254859|P2|Period 1: Infant Series|Protocol Violation|0
2681922|NCT00508742|9254860|P1|Period 1: Infant Series|Protocol Violation|1
2681923|NCT00508742|9254859|P2|Period 1: Infant Series|Adverse Event|4
2681924|NCT00508742|9254860|P1|Period 1: Infant Series|Adverse Event|5
2681925|NCT00508651|9254885|P2|Overall Study|Withdrawal by Subject|1
2681926|NCT00508651|9254886|P1|Overall Study|Withdrawal by Subject|1
2681927|NCT00508651|9254885|P2|Overall Study|Lost to Follow-up|1
2681928|NCT00508651|9254886|P1|Overall Study|Lost to Follow-up|3
2681929|NCT00508482|9254967|P3|at the 4th Week of Follow-up|Lost to Follow-up|1
2681930|NCT00508482|9254968|P2|at the 4th Week of Follow-up|Lost to Follow-up|6
2681931|NCT00508482|9254969|P1|at the 4th Week of Follow-up|Lost to Follow-up|20
2681932|NCT00508482|9254967|P3|Over 4 Weeks of Treatment|Lost to Follow-up|16
2681933|NCT00508482|9254968|P2|Over 4 Weeks of Treatment|Lost to Follow-up|10
2681934|NCT00508482|9254969|P1|Over 4 Weeks of Treatment|Lost to Follow-up|12
2681935|NCT00508482|9254967|P3|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|4
2681936|NCT00508482|9254968|P2|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|7
2681937|NCT00508482|9254969|P1|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|9
2681938|NCT00508404|9255013|P1|Overall Study|Other - Not Specified|3
2681939|NCT00508404|9255013|P1|Overall Study|Lost to Follow-up|2
2681940|NCT00508404|9255013|P1|Overall Study|Protocol-specified Criteria|2
2681941|NCT00508404|9255013|P1|Overall Study|Withdrawal by Subject|3
2681942|NCT00508404|9255013|P1|Overall Study|Physician Decision|2
2681943|NCT00508404|9255013|P1|Overall Study|Death|16
2681944|NCT00508404|9255013|P1|Overall Study|Adverse Event|2
2681945|NCT00508404|9255013|P1|Overall Study|Ongoing at Data Cut-off|12
2681946|NCT00508391|9255040|P2|Second Treatment|Withdrawal by Subject|0
2681947|NCT00508391|9255041|P1|Second Treatment|Withdrawal by Subject|2
2681948|NCT00508391|9255040|P2|First Treatment|Withdrawal by Subject|3
2681949|NCT00508391|9255041|P1|First Treatment|Withdrawal by Subject|6
2681950|NCT00508274|9255061|P1|Overall Study|Withdrawal by Subject|1
2681951|NCT00508274|9255061|P1|Overall Study|Adverse Event|1
2681952|NCT00508261|9255074|P4|Overall Study|Lost to Follow-up|1
2681953|NCT00508261|9255075|P3|Overall Study|Lost to Follow-up|1
2681954|NCT00508261|9255076|P2|Overall Study|Lost to Follow-up|1
2681955|NCT00508261|9255077|P1|Overall Study|Lost to Follow-up|0
2681956|NCT00508261|9255074|P4|Overall Study|Migrated/ moved from study area|0
2681957|NCT00508261|9255075|P3|Overall Study|Migrated/ moved from study area|0
2681958|NCT00508261|9255076|P2|Overall Study|Migrated/ moved from study area|1
2681959|NCT00508261|9255077|P1|Overall Study|Migrated/ moved from study area|0
2681960|NCT00508261|9255074|P4|Overall Study|Withdrawal by Subject|0
2681961|NCT00508261|9255075|P3|Overall Study|Withdrawal by Subject|4
2681962|NCT00508261|9255076|P2|Overall Study|Withdrawal by Subject|4
2681963|NCT00508261|9255077|P1|Overall Study|Withdrawal by Subject|3
2681964|NCT00508261|9255074|P4|Overall Study|Serious Adverse Event|0
2681965|NCT00508261|9255075|P3|Overall Study|Serious Adverse Event|0
2681966|NCT00508261|9255076|P2|Overall Study|Serious Adverse Event|1
2681967|NCT00508261|9255077|P1|Overall Study|Serious Adverse Event|0
2681968|NCT00508261|9255074|P4|Overall Study|Other|0
2681969|NCT00508261|9255075|P3|Overall Study|Other|1
2681970|NCT00508261|9255076|P2|Overall Study|Other|1
2681971|NCT00508261|9255077|P1|Overall Study|Other|0
2681972|NCT00508157|9255217|P2|Overall Study|Other known cause|1
2681973|NCT00508157|9255218|P1|Overall Study|Other known cause|0
2681974|NCT00508157|9255217|P2|Overall Study|Subject no longer met study criteria|1
2681975|NCT00508157|9255218|P1|Overall Study|Subject no longer met study criteria|0
2681976|NCT00508157|9255217|P2|Overall Study|Lost to Follow-up|0
2681977|NCT00508157|9255218|P1|Overall Study|Lost to Follow-up|1
2681978|NCT00508157|9255217|P2|Overall Study|Subject Withdrew Consent|0
2681979|NCT00508157|9255218|P1|Overall Study|Subject Withdrew Consent|1
2681980|NCT00508157|9255217|P2|Overall Study|Adverse Event|1
2681981|NCT00508157|9255218|P1|Overall Study|Adverse Event|0
2681982|NCT00508144|9255240|P1|Overall Study|Death|5
2681983|NCT00508144|9255240|P1|Overall Study|Not eligible|6
2681984|NCT00508027|9255279|P1|Dose Level 2|Withdrawal by Subject|2
2681985|NCT00508027|9255279|P1|Dose Level 2|Lost to Follow-up|2
2681986|NCT00508027|9255279|P1|Dose Level 1|Physician Decision|2
2681987|NCT00508027|9255279|P1|Dose Level 1|Withdrawal by Subject|2
2681988|NCT00508027|9255279|P1|Dose Level 1|Lost to Follow-up|4
2681989|NCT00508001|9255320|P3|Overall Study|Withdrawal by Subject|1
2681990|NCT00508001|9255321|P2|Overall Study|Withdrawal by Subject|4
2681991|NCT00508001|9255322|P1|Overall Study|Withdrawal by Subject|4
2681992|NCT00508001|9255320|P3|Overall Study|Death|1
2681993|NCT00508001|9255321|P2|Overall Study|Death|1
2681994|NCT00508001|9255322|P1|Overall Study|Death|0
2681995|NCT00508001|9255320|P3|Overall Study|condition under investigation worsened|1
2681996|NCT00508001|9255321|P2|Overall Study|condition under investigation worsened|7
2681997|NCT00508001|9255322|P1|Overall Study|condition under investigation worsened|13
2681998|NCT00508001|9255320|P3|Overall Study|Adverse Event|4
2681999|NCT00508001|9255321|P2|Overall Study|Adverse Event|0
2682000|NCT00508001|9255322|P1|Overall Study|Adverse Event|2
2682001|NCT00507819|9255339|P2|Washout (6 Weeks)|Withdrawal by Subject|0
2682002|NCT00507819|9255340|P1|Washout (6 Weeks)|Withdrawal by Subject|1
2682003|NCT00507689|9255359|P2|Randomized Period|Withdrawal by Subject|1
2682004|NCT00507689|9255360|P1|Randomized Period|Withdrawal by Subject|0
2682005|NCT00507689|9255359|P2|Randomized Period|Adverse Event|1
2682006|NCT00507689|9255360|P1|Randomized Period|Adverse Event|1
2682007|NCT00507689|9255359|P2|Pre-Randomization Period|Withdrawal by Subject|0
2682008|NCT00507689|9255360|P1|Pre-Randomization Period|Withdrawal by Subject|1
2682009|NCT00507689|9255359|P2|Pre-Randomization Period|Physician Decision|0
2682010|NCT00507689|9255360|P1|Pre-Randomization Period|Physician Decision|1
2682011|NCT00507689|9255359|P2|Pre-Randomization Period|Adverse Event|0
2682012|NCT00507689|9255360|P1|Pre-Randomization Period|Adverse Event|1
2682013|NCT00507546|9255392|P2|Overall Study|Physician Decision|1
2682014|NCT00507546|9255393|P1|Overall Study|Physician Decision|0
2682015|NCT00507546|9255392|P2|Overall Study|Protocol Violation|0
2682016|NCT00507546|9255393|P1|Overall Study|Protocol Violation|1
2682017|NCT00507546|9255392|P2|Overall Study|Withdrawal by Subject|0
2682018|NCT00507546|9255393|P1|Overall Study|Withdrawal by Subject|1
2682019|NCT00507507|9255403|P2|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16
2682020|NCT00507507|9255404|P1|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9
2682021|NCT00507507|9255403|P2|24-week Treatment-free Follow-up Period|Adverse Event|1
2682022|NCT00507507|9255404|P1|24-week Treatment-free Follow-up Period|Adverse Event|0
2682023|NCT00507507|9255403|P2|24-week Treatment-free Follow-up Period|Physician Decision|0
2682024|NCT00507507|9255404|P1|24-week Treatment-free Follow-up Period|Physician Decision|1
2682025|NCT00507507|9255403|P2|Treatment Period|Withdrawal by Subject|47
2682026|NCT00507507|9255404|P1|Treatment Period|Withdrawal by Subject|46
2682027|NCT00507507|9255403|P2|Treatment Period|Adverse Event|1
2682028|NCT00507507|9255404|P1|Treatment Period|Adverse Event|1
2682029|NCT00507507|9255403|P2|Treatment Period|Protocol Violation|2
2682030|NCT00507507|9255404|P1|Treatment Period|Protocol Violation|1
2682031|NCT00507507|9255403|P2|Treatment Period|Physician Decision|1
2682032|NCT00507507|9255404|P1|Treatment Period|Physician Decision|4
2682033|NCT00507507|9255403|P2|Treatment Period|Lost to Follow-up|2
2682034|NCT00507507|9255404|P1|Treatment Period|Lost to Follow-up|0
2682035|NCT00507455|9255439|P3|Overall Study|Other - miscellaneous reason|1
2682036|NCT00507455|9255440|P2|Overall Study|Other - miscellaneous reason|0
2682037|NCT00507455|9255441|P1|Overall Study|Other - miscellaneous reason|1
2682038|NCT00507455|9255439|P3|Overall Study|Lack of Efficacy|0
2682039|NCT00507455|9255440|P2|Overall Study|Lack of Efficacy|1
2682040|NCT00507455|9255441|P1|Overall Study|Lack of Efficacy|0
2682041|NCT00507455|9255439|P3|Overall Study|Lost to Follow-up|2
2682042|NCT00507455|9255440|P2|Overall Study|Lost to Follow-up|0
2682043|NCT00507455|9255441|P1|Overall Study|Lost to Follow-up|2
2682044|NCT00507455|9255439|P3|Overall Study|Protocol Violation|1
2682045|NCT00507455|9255440|P2|Overall Study|Protocol Violation|1
2682046|NCT00507455|9255441|P1|Overall Study|Protocol Violation|4
2682047|NCT00507455|9255439|P3|Overall Study|Withdrawal by Subject|2
2682048|NCT00507455|9255440|P2|Overall Study|Withdrawal by Subject|1
2682049|NCT00507455|9255441|P1|Overall Study|Withdrawal by Subject|2
2682050|NCT00507455|9255439|P3|Overall Study|Adverse Event|6
2682051|NCT00507455|9255440|P2|Overall Study|Adverse Event|3
2682052|NCT00507455|9255441|P1|Overall Study|Adverse Event|3
2682053|NCT00507442|9255504|P4|Overall Study|Other|2
2682054|NCT00507442|9255505|P3|Overall Study|Other|2
2682055|NCT00507442|9255506|P2|Overall Study|Other|5
2682056|NCT00507442|9255507|P1|Overall Study|Other|2
2682057|NCT00507442|9255504|P4|Overall Study|Withdrawal by Subject|1
2682058|NCT00507442|9255505|P3|Overall Study|Withdrawal by Subject|2
2682059|NCT00507442|9255506|P2|Overall Study|Withdrawal by Subject|4
2682060|NCT00507442|9255507|P1|Overall Study|Withdrawal by Subject|4
2682061|NCT00507442|9255504|P4|Overall Study|Progressive Disease|0
2682062|NCT00507442|9255505|P3|Overall Study|Progressive Disease|2
2682063|NCT00507442|9255506|P2|Overall Study|Progressive Disease|4
2682064|NCT00507442|9255507|P1|Overall Study|Progressive Disease|2
2682065|NCT00507442|9255504|P4|Overall Study|Physician Decision|1
2682066|NCT00507442|9255505|P3|Overall Study|Physician Decision|4
2682067|NCT00507442|9255506|P2|Overall Study|Physician Decision|2
2682068|NCT00507442|9255507|P1|Overall Study|Physician Decision|0
2682069|NCT00507442|9255504|P4|Overall Study|Lost to Follow-up|0
2682070|NCT00507442|9255505|P3|Overall Study|Lost to Follow-up|1
2682071|NCT00507442|9255506|P2|Overall Study|Lost to Follow-up|0
2682072|NCT00507442|9255507|P1|Overall Study|Lost to Follow-up|0
2682073|NCT00507442|9255504|P4|Overall Study|Protocol Violation|0
2682074|NCT00507442|9255505|P3|Overall Study|Protocol Violation|0
2682075|NCT00507442|9255506|P2|Overall Study|Protocol Violation|1
2682076|NCT00507442|9255507|P1|Overall Study|Protocol Violation|0
2682077|NCT00507442|9255504|P4|Overall Study|Adverse Event|1
2682078|NCT00507442|9255505|P3|Overall Study|Adverse Event|4
2682079|NCT00507442|9255506|P2|Overall Study|Adverse Event|11
2682080|NCT00507442|9255507|P1|Overall Study|Adverse Event|8
2682081|NCT00507429|9255559|P2|Maintenance Phase|Progressive Disease|0
2682082|NCT00507429|9255560|P1|Maintenance Phase|Progressive Disease|14
2682083|NCT00507429|9255559|P2|Treatment Phase|Other|3
2682084|NCT00507429|9255560|P1|Treatment Phase|Other|6
2682085|NCT00507429|9255559|P2|Treatment Phase|Physician Decision|2
2682086|NCT00507429|9255560|P1|Treatment Phase|Physician Decision|4
2682087|NCT00507429|9255559|P2|Treatment Phase|Withdrawal by Subject|3
2682088|NCT00507429|9255560|P1|Treatment Phase|Withdrawal by Subject|3
2682089|NCT00507429|9255559|P2|Treatment Phase|Adverse Event|5
2682090|NCT00507429|9255560|P1|Treatment Phase|Adverse Event|12
2682091|NCT00507429|9255559|P2|Treatment Phase|Disease Progression|5
2682092|NCT00507429|9255560|P1|Treatment Phase|Disease Progression|12
2682093|NCT00507416|9255571|P3|Overall Study|Did not Receive Study Treatment|4
2682094|NCT00507416|9255572|P2|Overall Study|Did not Receive Study Treatment|9
2682095|NCT00507416|9255573|P1|Overall Study|Did not Receive Study Treatment|3
2682096|NCT00507416|9255571|P3|Overall Study|Other|13
2682097|NCT00507416|9255572|P2|Overall Study|Other|16
2682098|NCT00507416|9255573|P1|Overall Study|Other|11
2682099|NCT00507416|9255571|P3|Overall Study|Patient declined further treatment|11
2682100|NCT00507416|9255572|P2|Overall Study|Patient declined further treatment|14
2682101|NCT00507416|9255573|P1|Overall Study|Patient declined further treatment|18
2682102|NCT00507416|9255571|P3|Overall Study|Progressive Disease|13
2682103|NCT00507416|9255572|P2|Overall Study|Progressive Disease|10
2682104|NCT00507416|9255573|P1|Overall Study|Progressive Disease|20
2682105|NCT00507416|9255571|P3|Overall Study|Lack ofEfficacy / Physician Decision|8
2682106|NCT00507416|9255572|P2|Overall Study|Lack ofEfficacy / Physician Decision|7
2682107|NCT00507416|9255573|P1|Overall Study|Lack ofEfficacy / Physician Decision|7
2682108|NCT00507416|9255571|P3|Overall Study|Protocol Violation|0
2682109|NCT00507416|9255572|P2|Overall Study|Protocol Violation|2
2682110|NCT00507416|9255573|P1|Overall Study|Protocol Violation|1
2682111|NCT00507416|9255571|P3|Overall Study|Adverse Event|65
2682112|NCT00507416|9255572|P2|Overall Study|Adverse Event|67
2682113|NCT00507416|9255573|P1|Overall Study|Adverse Event|58
2682114|NCT00507130|9255615|P4|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
2682115|NCT00507130|9255616|P3|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
2682116|NCT00507130|9255617|P2|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
2682117|NCT00507130|9255618|P1|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1
2682118|NCT00507130|9255615|P4|Overall Study|Lost to Follow-up|1
2682119|NCT00507130|9255616|P3|Overall Study|Lost to Follow-up|1
2682120|NCT00507130|9255617|P2|Overall Study|Lost to Follow-up|0
2682121|NCT00507130|9255618|P1|Overall Study|Lost to Follow-up|0
2682122|NCT00506948|9255660|P1|Overall Study|Physician Decision|1
2682123|NCT00506948|9255660|P1|Overall Study|Adverse Event|5
2682124|NCT00506948|9255660|P1|Overall Study|Death|4
2682125|NCT00506922|9255669|P5|Overall Study|Withdrawal by Subject|1
2682126|NCT00506922|9255670|P4|Overall Study|Withdrawal by Subject|0
2682127|NCT00506922|9255671|P3|Overall Study|Withdrawal by Subject|0
2682128|NCT00506922|9255672|P2|Overall Study|Withdrawal by Subject|0
2682129|NCT00506922|9255673|P1|Overall Study|Withdrawal by Subject|0
2682130|NCT00506922|9255669|P5|Overall Study|Physician Decision|0
2682131|NCT00506922|9255670|P4|Overall Study|Physician Decision|2
2682132|NCT00506922|9255671|P3|Overall Study|Physician Decision|0
2682133|NCT00506922|9255672|P2|Overall Study|Physician Decision|0
2682134|NCT00506922|9255673|P1|Overall Study|Physician Decision|0
2682135|NCT00506883|9255700|P3|Overall Study|Other|1
2682136|NCT00506883|9255701|P2|Overall Study|Other|1
2682137|NCT00506883|9255702|P1|Overall Study|Other|5
2682138|NCT00506883|9255700|P3|Overall Study|Lack of Efficacy|1
2682139|NCT00506883|9255701|P2|Overall Study|Lack of Efficacy|1
2682140|NCT00506883|9255702|P1|Overall Study|Lack of Efficacy|0
2682141|NCT00506883|9255700|P3|Overall Study|Withdrawal by Subject|1
2682142|NCT00506883|9255701|P2|Overall Study|Withdrawal by Subject|0
2682143|NCT00506883|9255702|P1|Overall Study|Withdrawal by Subject|1
2682144|NCT00506883|9255700|P3|Overall Study|Lost to Follow-up|1
2682145|NCT00506883|9255701|P2|Overall Study|Lost to Follow-up|1
2682146|NCT00506883|9255702|P1|Overall Study|Lost to Follow-up|1
2682147|NCT00506831|9255715|P1|Overall Study|Withdrawal by Subject|1
2682148|NCT00506831|9255715|P1|Overall Study|Death|1
2682149|NCT00506753|9255728|P2|Overall Study|Lost to Follow-up|15
2682150|NCT00506753|9255729|P1|Overall Study|Lost to Follow-up|21
2682151|NCT00506662|9255767|P2|Overall Study|Not recorded|6
2682152|NCT00506662|9255768|P1|Overall Study|Not recorded|4
2682153|NCT00506662|9255767|P2|Overall Study|Trial terminated|16
2682154|NCT00506662|9255768|P1|Overall Study|Trial terminated|10
2682155|NCT00506662|9255767|P2|Overall Study|Protocol Violation|4
2682156|NCT00506662|9255768|P1|Overall Study|Protocol Violation|2
2682157|NCT00506662|9255767|P2|Overall Study|Lack of Efficacy|0
2682158|NCT00506662|9255768|P1|Overall Study|Lack of Efficacy|1
2682159|NCT00506662|9255767|P2|Overall Study|Adverse Event|2
2682160|NCT00506662|9255768|P1|Overall Study|Adverse Event|0
2682161|NCT00506493|9255802|P1|Overall Study|Withdrawal by Subject|5
2682162|NCT00506493|9255802|P1|Overall Study|Death|6
2682163|NCT00506454|9255811|P2|Overall Study|Withdrawal by Subject|1
2682164|NCT00506454|9255812|P1|Overall Study|Withdrawal by Subject|1
2682165|NCT00506441|9255818|P2|Period 2; Double-blind Period|Other Reason|1
2682166|NCT00506441|9255819|P1|Period 2; Double-blind Period|Other Reason|1
2682167|NCT00506441|9255818|P2|Period 2; Double-blind Period|Withdrawal by Subject|0
2682168|NCT00506441|9255819|P1|Period 2; Double-blind Period|Withdrawal by Subject|1
2682169|NCT00506441|9255818|P2|Period 2; Double-blind Period|Physician Decision|1
2682170|NCT00506441|9255819|P1|Period 2; Double-blind Period|Physician Decision|1
2682171|NCT00506441|9255818|P2|Period 2; Double-blind Period|Lack of Efficacy|2
2682172|NCT00506441|9255819|P1|Period 2; Double-blind Period|Lack of Efficacy|0
2682173|NCT00506441|9255818|P2|Period 2; Double-blind Period|Adverse Event|1
2682174|NCT00506441|9255819|P1|Period 2; Double-blind Period|Adverse Event|0
2682175|NCT00506441|9255818|P2|Period 1; Open-label Period|Other Reasons|0
2682176|NCT00506441|9255819|P1|Period 1; Open-label Period|Other Reasons|13
2682177|NCT00506441|9255818|P2|Period 1; Open-label Period|Withdrawal by Subject|0
2682178|NCT00506441|9255819|P1|Period 1; Open-label Period|Withdrawal by Subject|13
2682179|NCT00506441|9255818|P2|Period 1; Open-label Period|Protocol Violation|0
2682180|NCT00506441|9255819|P1|Period 1; Open-label Period|Protocol Violation|9
2682181|NCT00506441|9255818|P2|Period 1; Open-label Period|Physician Decision|0
2682182|NCT00506441|9255819|P1|Period 1; Open-label Period|Physician Decision|5
2682183|NCT00506441|9255818|P2|Period 1; Open-label Period|Lost to Follow-up|0
2682184|NCT00506441|9255819|P1|Period 1; Open-label Period|Lost to Follow-up|2
2682185|NCT00506441|9255818|P2|Period 1; Open-label Period|Lack of Efficacy|0
2682186|NCT00506441|9255819|P1|Period 1; Open-label Period|Lack of Efficacy|13
2682187|NCT00506441|9255818|P2|Period 1; Open-label Period|Adverse Event|0
2682188|NCT00506441|9255819|P1|Period 1; Open-label Period|Adverse Event|21
2682189|NCT00506415|9255827|P4|Extended Open Label (Maximum 48 Weeks)|Death|7
2682190|NCT00506415|9255828|P3|Extended Open Label (Maximum 48 Weeks)|Death|0
2682191|NCT00506415|9255829|P2|Extended Open Label (Maximum 48 Weeks)|Death|0
2682192|NCT00506415|9255830|P1|Extended Open Label (Maximum 48 Weeks)|Death|0
2682193|NCT00506415|9255827|P4|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6
2682194|NCT00506415|9255828|P3|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
2682195|NCT00506415|9255829|P2|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
2682196|NCT00506415|9255830|P1|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
2682197|NCT00506415|9255827|P4|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5
2682198|NCT00506415|9255828|P3|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
2682199|NCT00506415|9255829|P2|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
2682200|NCT00506415|9255830|P1|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
2682201|NCT00506415|9255827|P4|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14
2682202|NCT00506415|9255828|P3|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
2682203|NCT00506415|9255829|P2|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
2682204|NCT00506415|9255830|P1|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
2682205|NCT00506415|9255827|P4|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8
2682206|NCT00506415|9255828|P3|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
2682207|NCT00506415|9255829|P2|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
2682208|NCT00506415|9255830|P1|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
2682209|NCT00506415|9255827|P4|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18
2682210|NCT00506415|9255828|P3|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
2682211|NCT00506415|9255829|P2|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
2682212|NCT00506415|9255830|P1|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
2682213|NCT00506415|9255827|P4|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4
2682214|NCT00506415|9255828|P3|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
2682215|NCT00506415|9255829|P2|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
2682216|NCT00506415|9255830|P1|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
2682217|NCT00506415|9255827|P4|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
2682218|NCT00506415|9255828|P3|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1
2682219|NCT00506415|9255829|P2|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
2682220|NCT00506415|9255830|P1|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
2682221|NCT00506415|9255827|P4|Double Blind (Maximum 48 Weeks )|Administrative problems|0
2682222|NCT00506415|9255828|P3|Double Blind (Maximum 48 Weeks )|Administrative problems|2
2682223|NCT00506415|9255829|P2|Double Blind (Maximum 48 Weeks )|Administrative problems|3
2682224|NCT00506415|9255830|P1|Double Blind (Maximum 48 Weeks )|Administrative problems|0
2682225|NCT00506415|9255827|P4|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
2682226|NCT00506415|9255828|P3|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17
2682227|NCT00506415|9255829|P2|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20
2682228|NCT00506415|9255830|P1|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
2682229|NCT00506415|9255827|P4|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
2682230|NCT00506415|9255828|P3|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6
2682231|NCT00506415|9255829|P2|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4
2682232|NCT00506415|9255830|P1|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
2682233|NCT00506415|9255827|P4|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
2682234|NCT00506415|9255828|P3|Double Blind (Maximum 48 Weeks )|Protocol Violation|3
2682235|NCT00506415|9255829|P2|Double Blind (Maximum 48 Weeks )|Protocol Violation|5
2682236|NCT00506415|9255830|P1|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
2682237|NCT00506415|9255827|P4|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
2682238|NCT00506415|9255828|P3|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
2682239|NCT00506415|9255829|P2|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
2682240|NCT00506415|9255830|P1|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
2682241|NCT00506415|9255827|P4|Double Blind (Maximum 48 Weeks )|Death|0
2682242|NCT00506415|9255828|P3|Double Blind (Maximum 48 Weeks )|Death|3
2682243|NCT00506415|9255829|P2|Double Blind (Maximum 48 Weeks )|Death|5
2682244|NCT00506415|9255830|P1|Double Blind (Maximum 48 Weeks )|Death|0
2682245|NCT00506415|9255827|P4|Double Blind (Maximum 48 Weeks )|Adverse Event|0
2682246|NCT00506415|9255828|P3|Double Blind (Maximum 48 Weeks )|Adverse Event|28
2682247|NCT00506415|9255829|P2|Double Blind (Maximum 48 Weeks )|Adverse Event|33
2682248|NCT00506415|9255830|P1|Double Blind (Maximum 48 Weeks )|Adverse Event|0
2682249|NCT00506415|9255827|P4|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
2682250|NCT00506415|9255828|P3|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
2682251|NCT00506415|9255829|P2|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
2682252|NCT00506415|9255830|P1|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28
2682253|NCT00506415|9255827|P4|Initial Open Label (Maximum 48 Weeks)|Death|0
2682254|NCT00506415|9255828|P3|Initial Open Label (Maximum 48 Weeks)|Death|0
2682255|NCT00506415|9255829|P2|Initial Open Label (Maximum 48 Weeks)|Death|0
2682256|NCT00506415|9255830|P1|Initial Open Label (Maximum 48 Weeks)|Death|22
2682257|NCT00506415|9255827|P4|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
2682258|NCT00506415|9255828|P3|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
2682259|NCT00506415|9255829|P2|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
2682260|NCT00506415|9255830|P1|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7
2682261|NCT00506415|9255827|P4|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
2682262|NCT00506415|9255828|P3|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
2682263|NCT00506415|9255829|P2|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
2682264|NCT00506415|9255830|P1|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22
2682265|NCT00506415|9255827|P4|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
2682266|NCT00506415|9255828|P3|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
2682267|NCT00506415|9255829|P2|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
2682268|NCT00506415|9255830|P1|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88
2682269|NCT00506415|9255827|P4|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
2682270|NCT00506415|9255828|P3|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
2682271|NCT00506415|9255829|P2|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
2682272|NCT00506415|9255830|P1|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58
2682273|NCT00506415|9255827|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
2682274|NCT00506415|9255828|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
2682275|NCT00506415|9255829|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
2682276|NCT00506415|9255830|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1
2682277|NCT00506415|9255827|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
2682278|NCT00506415|9255828|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
2682279|NCT00506415|9255829|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
2682280|NCT00506415|9255830|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1
2682281|NCT00506415|9255827|P4|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
2682282|NCT00506415|9255828|P3|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
2682283|NCT00506415|9255829|P2|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
2682284|NCT00506415|9255830|P1|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272
2682285|NCT00506389|9255855|P3|In-treatment Period|Randomized but not treated|1
2682286|NCT00506389|9255856|P2|In-treatment Period|Randomized but not treated|1
2682287|NCT00506389|9255857|P1|In-treatment Period|Randomized but not treated|4
2682288|NCT00506389|9255855|P3|In-treatment Period|Adverse Event|2
2682289|NCT00506389|9255856|P2|In-treatment Period|Adverse Event|5
2682290|NCT00506389|9255857|P1|In-treatment Period|Adverse Event|11
2682291|NCT00506389|9255855|P3|In-treatment Period|Lack of Efficacy|0
2682292|NCT00506389|9255856|P2|In-treatment Period|Lack of Efficacy|2
2682293|NCT00506389|9255857|P1|In-treatment Period|Lack of Efficacy|0
2682294|NCT00506389|9255855|P3|In-treatment Period|Withdrawal by Subject|4
2682295|NCT00506389|9255856|P2|In-treatment Period|Withdrawal by Subject|3
2682296|NCT00506389|9255857|P1|In-treatment Period|Withdrawal by Subject|3
2682297|NCT00506389|9255855|P3|In-treatment Period|Reasons not related to trial|0
2682298|NCT00506389|9255856|P2|In-treatment Period|Reasons not related to trial|1
2682299|NCT00506389|9255857|P1|In-treatment Period|Reasons not related to trial|4
2682300|NCT00506389|9255855|P3|In-treatment Period|Lack of compliance|0
2682301|NCT00506389|9255856|P2|In-treatment Period|Lack of compliance|0
2682302|NCT00506389|9255857|P1|In-treatment Period|Lack of compliance|1
2682303|NCT00506389|9255855|P3|In-treatment Period|Lost to Follow-up|1
2682304|NCT00506389|9255856|P2|In-treatment Period|Lost to Follow-up|0
2682305|NCT00506389|9255857|P1|In-treatment Period|Lost to Follow-up|0
2682306|NCT00506389|9255855|P3|In-treatment Period|Other|4
2682307|NCT00506389|9255856|P2|In-treatment Period|Other|3
2682308|NCT00506389|9255857|P1|In-treatment Period|Other|3
2682309|NCT00506350|9255883|P9|Overall Study|Other|2
2682310|NCT00506350|9255884|P8|Overall Study|Other|2
2682311|NCT00506350|9255885|P7|Overall Study|Other|0
2682312|NCT00506350|9255886|P6|Overall Study|Other|0
2682313|NCT00506350|9255887|P5|Overall Study|Other|3
2682314|NCT00506350|9255888|P4|Overall Study|Other|0
2682315|NCT00506350|9255889|P3|Overall Study|Other|3
2682316|NCT00506350|9255890|P2|Overall Study|Other|1
2682317|NCT00506350|9255891|P1|Overall Study|Other|1
2682318|NCT00506350|9255883|P9|Overall Study|Medical Reason|0
2682319|NCT00506350|9255884|P8|Overall Study|Medical Reason|0
2682320|NCT00506350|9255885|P7|Overall Study|Medical Reason|0
2682321|NCT00506350|9255886|P6|Overall Study|Medical Reason|0
2682322|NCT00506350|9255887|P5|Overall Study|Medical Reason|1
2682323|NCT00506350|9255888|P4|Overall Study|Medical Reason|0
2682324|NCT00506350|9255889|P3|Overall Study|Medical Reason|0
2682325|NCT00506350|9255890|P2|Overall Study|Medical Reason|0
2682326|NCT00506350|9255891|P1|Overall Study|Medical Reason|0
2682327|NCT00506350|9255883|P9|Overall Study|Lost to Follow-up|2
2682328|NCT00506350|9255884|P8|Overall Study|Lost to Follow-up|0
2682329|NCT00506350|9255885|P7|Overall Study|Lost to Follow-up|0
2682330|NCT00506350|9255886|P6|Overall Study|Lost to Follow-up|1
2682331|NCT00506350|9255887|P5|Overall Study|Lost to Follow-up|2
2682332|NCT00506350|9255888|P4|Overall Study|Lost to Follow-up|1
2682333|NCT00506350|9255889|P3|Overall Study|Lost to Follow-up|1
2682334|NCT00506350|9255890|P2|Overall Study|Lost to Follow-up|1
2682335|NCT00506350|9255891|P1|Overall Study|Lost to Follow-up|1
2682336|NCT00506350|9255883|P9|Overall Study|Withdrawal by Subject|0
2682337|NCT00506350|9255884|P8|Overall Study|Withdrawal by Subject|2
2682338|NCT00506350|9255885|P7|Overall Study|Withdrawal by Subject|1
2682339|NCT00506350|9255886|P6|Overall Study|Withdrawal by Subject|1
2682340|NCT00506350|9255887|P5|Overall Study|Withdrawal by Subject|4
2682341|NCT00506350|9255888|P4|Overall Study|Withdrawal by Subject|1
2682342|NCT00506350|9255889|P3|Overall Study|Withdrawal by Subject|1
2682343|NCT00506350|9255890|P2|Overall Study|Withdrawal by Subject|1
2682344|NCT00506350|9255891|P1|Overall Study|Withdrawal by Subject|0
2682345|NCT00506350|9255883|P9|Overall Study|Protocol Violation|0
2682346|NCT00506350|9255884|P8|Overall Study|Protocol Violation|0
2682347|NCT00506350|9255885|P7|Overall Study|Protocol Violation|1
2682348|NCT00506350|9255886|P6|Overall Study|Protocol Violation|0
2682349|NCT00506350|9255887|P5|Overall Study|Protocol Violation|0
2682350|NCT00506350|9255888|P4|Overall Study|Protocol Violation|0
2682351|NCT00506350|9255889|P3|Overall Study|Protocol Violation|1
2682352|NCT00506350|9255890|P2|Overall Study|Protocol Violation|0
2682353|NCT00506350|9255891|P1|Overall Study|Protocol Violation|0
2682354|NCT00506350|9255883|P9|Overall Study|Adverse Event|1
2682355|NCT00506350|9255884|P8|Overall Study|Adverse Event|1
2682356|NCT00506350|9255885|P7|Overall Study|Adverse Event|0
2682357|NCT00506350|9255886|P6|Overall Study|Adverse Event|0
2682358|NCT00506350|9255887|P5|Overall Study|Adverse Event|0
2682359|NCT00506350|9255888|P4|Overall Study|Adverse Event|0
2682360|NCT00506350|9255889|P3|Overall Study|Adverse Event|0
2682361|NCT00506350|9255890|P2|Overall Study|Adverse Event|0
2682362|NCT00506350|9255891|P1|Overall Study|Adverse Event|0
2682363|NCT00506350|9255883|P9|Overall Study|Serious Adverse Event|0
2682364|NCT00506350|9255884|P8|Overall Study|Serious Adverse Event|0
2682365|NCT00506350|9255885|P7|Overall Study|Serious Adverse Event|0
2682366|NCT00506350|9255886|P6|Overall Study|Serious Adverse Event|0
2682367|NCT00506350|9255887|P5|Overall Study|Serious Adverse Event|0
2682368|NCT00506350|9255888|P4|Overall Study|Serious Adverse Event|0
2682369|NCT00506350|9255889|P3|Overall Study|Serious Adverse Event|0
2682370|NCT00506350|9255890|P2|Overall Study|Serious Adverse Event|0
2682371|NCT00506350|9255891|P1|Overall Study|Serious Adverse Event|1
2682372|NCT00506285|9256038|P2|6-month Open Label Phase|Withdrawal by Subject|5
2682373|NCT00506285|9256039|P1|6-month Open Label Phase|Withdrawal by Subject|9
2682374|NCT00506285|9256038|P2|6-month Open Label Phase|Lost to Follow-up|7
2682375|NCT00506285|9256039|P1|6-month Open Label Phase|Lost to Follow-up|1
2682376|NCT00506285|9256038|P2|Double Blind Cross-Over Phase|Lost to Follow-up|2
2682377|NCT00506285|9256039|P1|Double Blind Cross-Over Phase|Lost to Follow-up|5
2682378|NCT00506285|9256038|P2|Double Blind Cross-Over Phase|Withdrawal by Subject|3
2682379|NCT00506285|9256039|P1|Double Blind Cross-Over Phase|Withdrawal by Subject|4
2682380|NCT00506285|9256038|P2|3 Week Screening Phase|Withdrawal by Subject|10
2682381|NCT00506285|9256039|P1|3 Week Screening Phase|Withdrawal by Subject|17
2682382|NCT00506142|9256054|P2|Overall Study|New health condition|0
2682383|NCT00506142|9256055|P1|Overall Study|New health condition|1
2682384|NCT00506142|9256054|P2|Overall Study|Physician Decision|0
2682385|NCT00506142|9256055|P1|Overall Study|Physician Decision|1
2682386|NCT00506142|9256054|P2|Overall Study|Withdrawal by Subject|5
2682387|NCT00506142|9256055|P1|Overall Study|Withdrawal by Subject|4
2682388|NCT00506142|9256054|P2|Overall Study|Lack of Efficacy|7
2682389|NCT00506142|9256055|P1|Overall Study|Lack of Efficacy|21
2682390|NCT00506142|9256054|P2|Overall Study|Adverse Event|7
2682391|NCT00506142|9256055|P1|Overall Study|Adverse Event|8
2682392|NCT00506077|9256063|P2|Treatment Period 2|Withdrawal by Subject|0
2682393|NCT00506077|9256064|P1|Treatment Period 2|Withdrawal by Subject|1
2682394|NCT00506077|9256063|P2|Treatment Period 2|Adverse Event|1
2682395|NCT00506077|9256064|P1|Treatment Period 2|Adverse Event|0
2682396|NCT00506077|9256063|P2|Treatment Period 1|Withdrawal by Subject|0
2682397|NCT00506077|9256064|P1|Treatment Period 1|Withdrawal by Subject|2
2682398|NCT00506077|9256063|P2|Treatment Period 1|Lost to Follow-up|2
2682399|NCT00506077|9256064|P1|Treatment Period 1|Lost to Follow-up|0
2682400|NCT00506077|9256063|P2|Treatment Period 1|Adverse Event|1
2682401|NCT00506077|9256064|P1|Treatment Period 1|Adverse Event|2
2682402|NCT00505934|9256106|P1|Overall Study|Other: IV dose needed to be changed|1
2682403|NCT00505934|9256106|P1|Overall Study|Other: Unable to obtain IV & PK samples|1
2682404|NCT00505934|9256106|P1|Overall Study|Adverse Event|1
2682405|NCT00505921|9256112|P1|Overall Study|Failed to Mobilize|8
2682406|NCT00505921|9256112|P1|Overall Study|Ineligible|1
2682407|NCT00505778|9256129|P2|Overall Study|Took No Study Drug|2
2682408|NCT00505778|9256130|P1|Overall Study|Took No Study Drug|2
2682409|NCT00505778|9256129|P2|Overall Study|Relapse|65
2682410|NCT00505778|9256130|P1|Overall Study|Relapse|65
2682411|NCT00505778|9256129|P2|Overall Study|Withdrawal by Subject|14
2682412|NCT00505778|9256130|P1|Overall Study|Withdrawal by Subject|29
2682413|NCT00505778|9256129|P2|Overall Study|Protocol Violation|9
2682414|NCT00505778|9256130|P1|Overall Study|Protocol Violation|7
2682415|NCT00505778|9256129|P2|Overall Study|Unable to Meet Protocol Criteria|1
2682416|NCT00505778|9256130|P1|Overall Study|Unable to Meet Protocol Criteria|4
2682417|NCT00505778|9256129|P2|Overall Study|Lost to Follow-up|23
2682418|NCT00505778|9256130|P1|Overall Study|Lost to Follow-up|17
2682419|NCT00505778|9256129|P2|Overall Study|Physician Decision|14
2682420|NCT00505778|9256130|P1|Overall Study|Physician Decision|8
2682421|NCT00505778|9256129|P2|Overall Study|Adverse Event|7
2682422|NCT00505778|9256130|P1|Overall Study|Adverse Event|2
2682423|NCT00505765|9256149|P3|Overall Study|Noncompliance|3
2682424|NCT00505765|9256150|P2|Overall Study|Noncompliance|1
2682425|NCT00505765|9256151|P1|Overall Study|Noncompliance|0
2682426|NCT00505765|9256149|P3|Overall Study|Adverse Event|0
2682427|NCT00505765|9256150|P2|Overall Study|Adverse Event|2
2682428|NCT00505765|9256151|P1|Overall Study|Adverse Event|1
2682429|NCT00505765|9256149|P3|Overall Study|Withdrawal by Subject|0
2682430|NCT00505765|9256150|P2|Overall Study|Withdrawal by Subject|0
2682431|NCT00505765|9256151|P1|Overall Study|Withdrawal by Subject|1
2682432|NCT00505752|9256178|P4|Overall Study|Other|2
2682433|NCT00505752|9256179|P3|Overall Study|Other|1
2682434|NCT00505752|9256180|P2|Overall Study|Other|2
2682435|NCT00505752|9256181|P1|Overall Study|Other|1
2682436|NCT00505752|9256178|P4|Overall Study|All embryos/blastocysts discarded|1
2682437|NCT00505752|9256179|P3|Overall Study|All embryos/blastocysts discarded|1
2682438|NCT00505752|9256180|P2|Overall Study|All embryos/blastocysts discarded|0
2682439|NCT00505752|9256181|P1|Overall Study|All embryos/blastocysts discarded|0
2682440|NCT00505752|9256178|P4|Overall Study|No Fertilization|1
2682441|NCT00505752|9256179|P3|Overall Study|No Fertilization|2
2682442|NCT00505752|9256180|P2|Overall Study|No Fertilization|1
2682443|NCT00505752|9256181|P1|Overall Study|No Fertilization|1
2682444|NCT00505752|9256178|P4|Overall Study|No oocytes retrieved|1
2682445|NCT00505752|9256179|P3|Overall Study|No oocytes retrieved|0
2682446|NCT00505752|9256180|P2|Overall Study|No oocytes retrieved|2
2682447|NCT00505752|9256181|P1|Overall Study|No oocytes retrieved|0
2682448|NCT00505752|9256178|P4|Overall Study|Ovarian hyperstimulation syndrome risk|1
2682449|NCT00505752|9256179|P3|Overall Study|Ovarian hyperstimulation syndrome risk|3
2682450|NCT00505752|9256180|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
2682451|NCT00505752|9256181|P1|Overall Study|Ovarian hyperstimulation syndrome risk|1
2682452|NCT00505752|9256178|P4|Overall Study|Lack of ovarian response|0
2682453|NCT00505752|9256179|P3|Overall Study|Lack of ovarian response|0
2682454|NCT00505752|9256180|P2|Overall Study|Lack of ovarian response|3
2682455|NCT00505752|9256181|P1|Overall Study|Lack of ovarian response|1
2682456|NCT00505752|9256178|P4|Overall Study|Lost to Follow-up|0
2682457|NCT00505752|9256179|P3|Overall Study|Lost to Follow-up|0
2682458|NCT00505752|9256180|P2|Overall Study|Lost to Follow-up|0
2682459|NCT00505752|9256181|P1|Overall Study|Lost to Follow-up|1
2682460|NCT00505752|9256178|P4|Overall Study|Adverse Event|0
2682461|NCT00505752|9256179|P3|Overall Study|Adverse Event|1
2682462|NCT00505752|9256180|P2|Overall Study|Adverse Event|0
2682463|NCT00505752|9256181|P1|Overall Study|Adverse Event|1
2682464|NCT00505687|9256195|P1|Overall Study|Other: As Per Sponsor|8
2682465|NCT00505687|9256195|P1|Overall Study|Other: Disease Progression|1
2682466|NCT00505687|9256195|P1|Overall Study|Other: Neupro Given In Hospital|1
2682467|NCT00505687|9256195|P1|Overall Study|Other: Patches Would Not Stick D/T Sweat|1
2682468|NCT00505687|9256195|P1|Overall Study|Other: Prolonged Hospitalization|1
2682469|NCT00505687|9256195|P1|Overall Study|Other: Scheduled DBS Surgery|1
2682470|NCT00505687|9256195|P1|Overall Study|Other: Underwent Implantation Of DBS|1
2682471|NCT00505687|9256195|P1|Overall Study|Lost to Follow-up|1
2682472|NCT00505687|9256195|P1|Overall Study|Subject withdrew consent|15
2682473|NCT00505687|9256195|P1|Overall Study|Adverse Event|48
2682474|NCT00505687|9256195|P1|Overall Study|Lack of Efficacy|15
2682475|NCT00505687|9256195|P1|Overall Study|Important protocol violation|2
2682476|NCT00505661|9256201|P1|Overall Study|Not Eligible|4
2682477|NCT00505622|9256212|P3|Overall Study|Study termination by sponsor|90
2682478|NCT00505622|9256213|P2|Overall Study|Study termination by sponsor|98
2682479|NCT00505622|9256214|P1|Overall Study|Study termination by sponsor|115
2682480|NCT00505622|9256212|P3|Overall Study|Withdrawal by Subject|2
2682481|NCT00505622|9256213|P2|Overall Study|Withdrawal by Subject|3
2682482|NCT00505622|9256214|P1|Overall Study|Withdrawal by Subject|0
2682483|NCT00505622|9256212|P3|Overall Study|Protocol Violation|0
2682484|NCT00505622|9256213|P2|Overall Study|Protocol Violation|1
2682485|NCT00505622|9256214|P1|Overall Study|Protocol Violation|1
2682486|NCT00505622|9256212|P3|Overall Study|Adverse Event|4
2682487|NCT00505622|9256213|P2|Overall Study|Adverse Event|6
2682488|NCT00505622|9256214|P1|Overall Study|Adverse Event|5
2682489|NCT00505414|9256239|P5|Maintenance Phase|underlying disease and therapy required|0
2682490|NCT00505414|9256240|P4|Maintenance Phase|underlying disease and therapy required|0
2682491|NCT00505414|9256241|P3|Maintenance Phase|underlying disease and therapy required|2
2682492|NCT00505414|9256242|P2|Maintenance Phase|underlying disease and therapy required|2
2682493|NCT00505414|9256243|P1|Maintenance Phase|underlying disease and therapy required|0
2682494|NCT00505414|9256239|P5|Maintenance Phase|Withdrawal by Subject|0
2682495|NCT00505414|9256240|P4|Maintenance Phase|Withdrawal by Subject|0
2682496|NCT00505414|9256241|P3|Maintenance Phase|Withdrawal by Subject|1
2682497|NCT00505414|9256242|P2|Maintenance Phase|Withdrawal by Subject|0
2682498|NCT00505414|9256243|P1|Maintenance Phase|Withdrawal by Subject|0
2682499|NCT00505414|9256239|P5|Maintenance Phase|Lack of Efficacy|0
2682500|NCT00505414|9256240|P4|Maintenance Phase|Lack of Efficacy|0
2682501|NCT00505414|9256241|P3|Maintenance Phase|Lack of Efficacy|1
2682502|NCT00505414|9256242|P2|Maintenance Phase|Lack of Efficacy|1
2682503|NCT00505414|9256243|P1|Maintenance Phase|Lack of Efficacy|2
2682504|NCT00505414|9256239|P5|Maintenance Phase|Death|0
2682505|NCT00505414|9256240|P4|Maintenance Phase|Death|0
2682506|NCT00505414|9256241|P3|Maintenance Phase|Death|1
2682507|NCT00505414|9256242|P2|Maintenance Phase|Death|0
2682508|NCT00505414|9256243|P1|Maintenance Phase|Death|2
2682509|NCT00505414|9256239|P5|Maintenance Phase|Adverse Event|0
2682510|NCT00505414|9256240|P4|Maintenance Phase|Adverse Event|0
2682511|NCT00505414|9256241|P3|Maintenance Phase|Adverse Event|3
2682512|NCT00505414|9256242|P2|Maintenance Phase|Adverse Event|2
2682513|NCT00505414|9256243|P1|Maintenance Phase|Adverse Event|2
2682514|NCT00505414|9256239|P5|Titration Phase|Underlying disease and therapy required|3
2682515|NCT00505414|9256240|P4|Titration Phase|Underlying disease and therapy required|7
2682516|NCT00505414|9256241|P3|Titration Phase|Underlying disease and therapy required|0
2682517|NCT00505414|9256242|P2|Titration Phase|Underlying disease and therapy required|0
2682518|NCT00505414|9256243|P1|Titration Phase|Underlying disease and therapy required|0
2682519|NCT00505414|9256239|P5|Titration Phase|Withdrawal by Subject|4
2682520|NCT00505414|9256240|P4|Titration Phase|Withdrawal by Subject|3
2682521|NCT00505414|9256241|P3|Titration Phase|Withdrawal by Subject|0
2682522|NCT00505414|9256242|P2|Titration Phase|Withdrawal by Subject|0
2682523|NCT00505414|9256243|P1|Titration Phase|Withdrawal by Subject|0
2682524|NCT00505414|9256239|P5|Titration Phase|Protocol Violation|1
2682525|NCT00505414|9256240|P4|Titration Phase|Protocol Violation|0
2682526|NCT00505414|9256241|P3|Titration Phase|Protocol Violation|0
2682527|NCT00505414|9256242|P2|Titration Phase|Protocol Violation|0
2682528|NCT00505414|9256243|P1|Titration Phase|Protocol Violation|0
2682529|NCT00505414|9256239|P5|Titration Phase|Lack of Efficacy|1
2682530|NCT00505414|9256240|P4|Titration Phase|Lack of Efficacy|10
2682531|NCT00505414|9256241|P3|Titration Phase|Lack of Efficacy|0
2682532|NCT00505414|9256242|P2|Titration Phase|Lack of Efficacy|0
2682533|NCT00505414|9256243|P1|Titration Phase|Lack of Efficacy|0
2682534|NCT00505414|9256239|P5|Titration Phase|Death|0
2682535|NCT00505414|9256240|P4|Titration Phase|Death|2
2682536|NCT00505414|9256241|P3|Titration Phase|Death|0
2682537|NCT00505414|9256242|P2|Titration Phase|Death|0
2682538|NCT00505414|9256243|P1|Titration Phase|Death|0
2682539|NCT00505414|9256239|P5|Titration Phase|Adverse Event|3
2682540|NCT00505414|9256240|P4|Titration Phase|Adverse Event|8
2682541|NCT00505414|9256241|P3|Titration Phase|Adverse Event|0
2682542|NCT00505414|9256242|P2|Titration Phase|Adverse Event|0
2682543|NCT00505414|9256243|P1|Titration Phase|Adverse Event|0
2682544|NCT00505375|9256260|P2|Overall Study|Travel issues|1
2682545|NCT00505375|9256261|P1|Overall Study|Travel issues|0
2682546|NCT00505375|9256260|P2|Overall Study|Pregnancy|0
2682547|NCT00505375|9256261|P1|Overall Study|Pregnancy|1
2682548|NCT00505375|9256260|P2|Overall Study|Lost to Follow-up|2
2682549|NCT00505375|9256261|P1|Overall Study|Lost to Follow-up|0
2682550|NCT00505375|9256260|P2|Overall Study|Withdrawal by Subject|2
2682551|NCT00505375|9256261|P1|Overall Study|Withdrawal by Subject|2
2682552|NCT00505375|9256260|P2|Overall Study|Death|0
2682553|NCT00505375|9256261|P1|Overall Study|Death|1
2682554|NCT00505284|9256283|P5|Overall Study|Other|4
2682555|NCT00505284|9256284|P4|Overall Study|Other|4
2682556|NCT00505284|9256285|P3|Overall Study|Other|0
2682557|NCT00505284|9256286|P2|Overall Study|Other|0
2682558|NCT00505284|9256287|P1|Overall Study|Other|5
2682559|NCT00505284|9256283|P5|Overall Study|Physician Decision|0
2682560|NCT00505284|9256284|P4|Overall Study|Physician Decision|0
2682561|NCT00505284|9256285|P3|Overall Study|Physician Decision|0
2682562|NCT00505284|9256286|P2|Overall Study|Physician Decision|1
2682563|NCT00505284|9256287|P1|Overall Study|Physician Decision|0
2682564|NCT00505284|9256283|P5|Overall Study|Lack of Efficacy|1
2682565|NCT00505284|9256284|P4|Overall Study|Lack of Efficacy|1
2682566|NCT00505284|9256285|P3|Overall Study|Lack of Efficacy|1
2682567|NCT00505284|9256286|P2|Overall Study|Lack of Efficacy|1
2682568|NCT00505284|9256287|P1|Overall Study|Lack of Efficacy|0
2682569|NCT00505284|9256283|P5|Overall Study|Withdrawal by Subject|6
2682570|NCT00505284|9256284|P4|Overall Study|Withdrawal by Subject|0
2682571|NCT00505284|9256285|P3|Overall Study|Withdrawal by Subject|1
2682572|NCT00505284|9256286|P2|Overall Study|Withdrawal by Subject|6
2682573|NCT00505284|9256287|P1|Overall Study|Withdrawal by Subject|2
2682574|NCT00505284|9256283|P5|Overall Study|Protocol Violation|0
2682575|NCT00505284|9256284|P4|Overall Study|Protocol Violation|0
2682576|NCT00505284|9256285|P3|Overall Study|Protocol Violation|1
2682577|NCT00505284|9256286|P2|Overall Study|Protocol Violation|1
2682578|NCT00505284|9256287|P1|Overall Study|Protocol Violation|0
2682579|NCT00505284|9256283|P5|Overall Study|Adverse Event|22
2682580|NCT00505284|9256284|P4|Overall Study|Adverse Event|14
2682581|NCT00505284|9256285|P3|Overall Study|Adverse Event|9
2682582|NCT00505284|9256286|P2|Overall Study|Adverse Event|7
2682583|NCT00505284|9256287|P1|Overall Study|Adverse Event|3
2682584|NCT00505076|9256357|P3|Overall Study|Withdrawal by Subject|2
2682585|NCT00505076|9256358|P2|Overall Study|Withdrawal by Subject|1
2682586|NCT00505076|9256359|P1|Overall Study|Withdrawal by Subject|0
2682587|NCT00505076|9256357|P3|Overall Study|Protocol Violation|2
2682588|NCT00505076|9256358|P2|Overall Study|Protocol Violation|1
2682589|NCT00505076|9256359|P1|Overall Study|Protocol Violation|2
2682590|NCT00505076|9256357|P3|Overall Study|Adverse Event|1
2682591|NCT00505076|9256358|P2|Overall Study|Adverse Event|0
2682592|NCT00505076|9256359|P1|Overall Study|Adverse Event|1
2682593|NCT00504881|9256388|P2|Overall Study|AE of unknown type|0
2682594|NCT00504881|9256389|P1|Overall Study|AE of unknown type|1
2682595|NCT00504881|9256388|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2
2682596|NCT00504881|9256389|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
2682597|NCT00504881|9256388|P2|Overall Study|AE, non-serious non-fatal|14
2682598|NCT00504881|9256389|P1|Overall Study|AE, non-serious non-fatal|4
2682599|NCT00504881|9256388|P2|Overall Study|SAE, non-fatal|6
2682600|NCT00504881|9256389|P1|Overall Study|SAE, non-fatal|2
2682601|NCT00504881|9256388|P2|Overall Study|AE, serious fatal|1
2682602|NCT00504881|9256389|P1|Overall Study|AE, serious fatal|0
2682603|NCT00504881|9256388|P2|Overall Study|Safety Visit not performed|1
2682604|NCT00504881|9256389|P1|Overall Study|Safety Visit not performed|0
2682605|NCT00504881|9256388|P2|Overall Study|No Birth Control|1
2682606|NCT00504881|9256389|P1|Overall Study|No Birth Control|0
2682607|NCT00504881|9256388|P2|Overall Study|Non-Compliance|0
2682608|NCT00504881|9256389|P1|Overall Study|Non-Compliance|1
2682609|NCT00504881|9256388|P2|Overall Study|Withdrawal by Subject|4
2682610|NCT00504881|9256389|P1|Overall Study|Withdrawal by Subject|1
2682611|NCT00504881|9256388|P2|Overall Study|Lost to Follow-up|2
2682612|NCT00504881|9256389|P1|Overall Study|Lost to Follow-up|0
2682613|NCT00504881|9256388|P2|Overall Study|Lack of Efficacy|5
2682614|NCT00504881|9256389|P1|Overall Study|Lack of Efficacy|1
2682615|NCT00504829|9256442|P3|Overall Study|Protocol Violation|10
2682616|NCT00504829|9256443|P2|Overall Study|Protocol Violation|4
2682617|NCT00504829|9256444|P1|Overall Study|Protocol Violation|6
2682618|NCT00504777|9256453|P1|Overall Study|Adverse Event|1
2682619|NCT00504725|9256466|P2|Overall Study|Protocol Violation|0
2682620|NCT00504725|9256467|P1|Overall Study|Protocol Violation|1
2682621|NCT00504595|9256490|P4|Overall Study|Other|0
2682622|NCT00504595|9256491|P3|Overall Study|Other|2
2682623|NCT00504595|9256492|P2|Overall Study|Other|0
2682624|NCT00504595|9256493|P1|Overall Study|Other|0
2682625|NCT00504595|9256490|P4|Overall Study|Lack of Efficacy|0
2682626|NCT00504595|9256491|P3|Overall Study|Lack of Efficacy|0
2682627|NCT00504595|9256492|P2|Overall Study|Lack of Efficacy|0
2682628|NCT00504595|9256493|P1|Overall Study|Lack of Efficacy|1
2682629|NCT00504556|9256510|P5|Overall Study|not in safety analysis set|1
2682630|NCT00504556|9256511|P4|Overall Study|not in safety analysis set|0
2682631|NCT00504556|9256512|P3|Overall Study|not in safety analysis set|1
2682632|NCT00504556|9256513|P2|Overall Study|not in safety analysis set|1
2682633|NCT00504556|9256514|P1|Overall Study|not in safety analysis set|0
2682634|NCT00504556|9256510|P5|Overall Study|Other|0
2682635|NCT00504556|9256511|P4|Overall Study|Other|3
2682636|NCT00504556|9256512|P3|Overall Study|Other|2
2682637|NCT00504556|9256513|P2|Overall Study|Other|2
2682638|NCT00504556|9256514|P1|Overall Study|Other|2
2682639|NCT00504556|9256510|P5|Overall Study|data monitor committee decision|0
2682640|NCT00504556|9256511|P4|Overall Study|data monitor committee decision|100
2682641|NCT00504556|9256512|P3|Overall Study|data monitor committee decision|0
2682642|NCT00504556|9256513|P2|Overall Study|data monitor committee decision|0
2682643|NCT00504556|9256514|P1|Overall Study|data monitor committee decision|0
2682644|NCT00504556|9256510|P5|Overall Study|did not meet entry criteria|0
2682645|NCT00504556|9256511|P4|Overall Study|did not meet entry criteria|1
2682646|NCT00504556|9256512|P3|Overall Study|did not meet entry criteria|1
2682647|NCT00504556|9256513|P2|Overall Study|did not meet entry criteria|0
2682648|NCT00504556|9256514|P1|Overall Study|did not meet entry criteria|2
2682649|NCT00504556|9256510|P5|Overall Study|administrative reasons|2
2682650|NCT00504556|9256511|P4|Overall Study|administrative reasons|1
2682651|NCT00504556|9256512|P3|Overall Study|administrative reasons|2
2682652|NCT00504556|9256513|P2|Overall Study|administrative reasons|2
2682653|NCT00504556|9256514|P1|Overall Study|administrative reasons|0
2682654|NCT00504556|9256510|P5|Overall Study|Withdrawal by Subject|12
2682655|NCT00504556|9256511|P4|Overall Study|Withdrawal by Subject|8
2682656|NCT00504556|9256512|P3|Overall Study|Withdrawal by Subject|7
2682657|NCT00504556|9256513|P2|Overall Study|Withdrawal by Subject|16
2682658|NCT00504556|9256514|P1|Overall Study|Withdrawal by Subject|16
2682659|NCT00504556|9256510|P5|Overall Study|Lost to Follow-up|1
2682660|NCT00504556|9256511|P4|Overall Study|Lost to Follow-up|1
2682661|NCT00504556|9256512|P3|Overall Study|Lost to Follow-up|1
2682662|NCT00504556|9256513|P2|Overall Study|Lost to Follow-up|0
2682663|NCT00504556|9256514|P1|Overall Study|Lost to Follow-up|0
2682664|NCT00504556|9256510|P5|Overall Study|Protocol Violation|2
2682665|NCT00504556|9256511|P4|Overall Study|Protocol Violation|1
2682666|NCT00504556|9256512|P3|Overall Study|Protocol Violation|2
2682667|NCT00504556|9256513|P2|Overall Study|Protocol Violation|3
2682668|NCT00504556|9256514|P1|Overall Study|Protocol Violation|1
2682669|NCT00504556|9256510|P5|Overall Study|Death|2
2682670|NCT00504556|9256511|P4|Overall Study|Death|0
2682671|NCT00504556|9256512|P3|Overall Study|Death|1
2682672|NCT00504556|9256513|P2|Overall Study|Death|3
2682673|NCT00504556|9256514|P1|Overall Study|Death|3
2682674|NCT00504556|9256510|P5|Overall Study|Adverse Event|5
2682675|NCT00504556|9256511|P4|Overall Study|Adverse Event|13
2682676|NCT00504556|9256512|P3|Overall Study|Adverse Event|14
2682677|NCT00504556|9256513|P2|Overall Study|Adverse Event|11
2682678|NCT00504556|9256514|P1|Overall Study|Adverse Event|11
2682679|NCT00504426|9256582|P4|Overall Study|Withdrawal by Subject|0
2682680|NCT00504426|9256583|P3|Overall Study|Withdrawal by Subject|0
2682681|NCT00504426|9256584|P2|Overall Study|Withdrawal by Subject|0
2682682|NCT00504426|9256585|P1|Overall Study|Withdrawal by Subject|2
2682683|NCT00504426|9256582|P4|Overall Study|Protocol Violation|0
2682684|NCT00504426|9256583|P3|Overall Study|Protocol Violation|2
2682685|NCT00504426|9256584|P2|Overall Study|Protocol Violation|1
2682686|NCT00504426|9256585|P1|Overall Study|Protocol Violation|1
2682687|NCT00504426|9256582|P4|Overall Study|Adverse Event|0
2682688|NCT00504426|9256583|P3|Overall Study|Adverse Event|2
2682689|NCT00504426|9256584|P2|Overall Study|Adverse Event|0
2682690|NCT00504426|9256585|P1|Overall Study|Adverse Event|0
2682691|NCT00504348|9256599|P1|Overall Study|Physician Decision|1
2682692|NCT00504348|9256599|P1|Overall Study|Lack of Efficacy|4
2682693|NCT00504348|9256599|P1|Overall Study|Adverse Event|3
2682694|NCT00504309|9256610|P6|Overall Study|Withdrawal by Subject|0
2682695|NCT00504309|9256611|P5|Overall Study|Withdrawal by Subject|0
2682696|NCT00504309|9256612|P4|Overall Study|Withdrawal by Subject|0
2682697|NCT00504309|9256613|P3|Overall Study|Withdrawal by Subject|1
2682698|NCT00504309|9256614|P2|Overall Study|Withdrawal by Subject|0
2682699|NCT00504309|9256615|P1|Overall Study|Withdrawal by Subject|0
2682700|NCT00504309|9256610|P6|Overall Study|Death|0
2682701|NCT00504309|9256611|P5|Overall Study|Death|1
2682702|NCT00504309|9256612|P4|Overall Study|Death|0
2682703|NCT00504309|9256613|P3|Overall Study|Death|0
2682704|NCT00504309|9256614|P2|Overall Study|Death|0
2682705|NCT00504309|9256615|P1|Overall Study|Death|0
2682706|NCT00504257|9256653|P1|Overall Study|ineligible histology|2
2682707|NCT00504257|9256653|P1|Overall Study|Withdrawal by Subject|2
2682708|NCT00504231|9256665|P4|Overall Study|Discrepant chart documentation re route|0
2682709|NCT00504231|9256666|P3|Overall Study|Discrepant chart documentation re route|1
2682710|NCT00504231|9256667|P2|Overall Study|Discrepant chart documentation re route|0
2682711|NCT00504231|9256668|P1|Overall Study|Discrepant chart documentation re route|0
2682712|NCT00504166|9256688|P2|Overall Study|Lost to Follow-up|3
2682713|NCT00504166|9256689|P1|Overall Study|Lost to Follow-up|1
2682714|NCT00504166|9256688|P2|Overall Study|Physician Decision|1
2682715|NCT00504166|9256689|P1|Overall Study|Physician Decision|1
2682716|NCT00504166|9256688|P2|Overall Study|Withdrawal by Subject|6
2682717|NCT00504166|9256689|P1|Overall Study|Withdrawal by Subject|3
2682718|NCT00504166|9256688|P2|Overall Study|Adverse Event|4
2682719|NCT00504166|9256689|P1|Overall Study|Adverse Event|1
2682720|NCT00504153|9256695|P1|Overall Study|Death|1
2682721|NCT00504153|9256695|P1|Overall Study|Adverse Event|4
2682722|NCT00504153|9256695|P1|Overall Study|Withdrawal by Subject|1
2682723|NCT00504075|9256703|P1|Overall Study|Required other therapeutic intervention|1
2682724|NCT00504075|9256703|P1|Overall Study|Withdrawal by Subject|1
2682725|NCT00504075|9256703|P1|Overall Study|Lost to Follow-up|5
2682726|NCT00504075|9256703|P1|Overall Study|Adverse Event|1
2682727|NCT00503997|9256713|P1|Overall Study|Withdrawal by Subject|1
2682728|NCT00503997|9256713|P1|Overall Study|Death|1
2682729|NCT00503997|9256713|P1|Overall Study|Adverse Event|5
2682730|NCT00503997|9256713|P1|Overall Study|disease progression|1
2682731|NCT00503984|9256719|P6|Overall Study|Death|0
2682732|NCT00503984|9256720|P5|Overall Study|Death|1
2682733|NCT00503984|9256721|P4|Overall Study|Death|0
2682734|NCT00503984|9256722|P3|Overall Study|Death|0
2682735|NCT00503984|9256723|P2|Overall Study|Death|0
2682736|NCT00503984|9256724|P1|Overall Study|Death|0
2682737|NCT00503984|9256719|P6|Overall Study|Adverse Event|0
2682738|NCT00503984|9256720|P5|Overall Study|Adverse Event|0
2682739|NCT00503984|9256721|P4|Overall Study|Adverse Event|0
2682740|NCT00503984|9256722|P3|Overall Study|Adverse Event|0
2682741|NCT00503984|9256723|P2|Overall Study|Adverse Event|1
2682742|NCT00503984|9256724|P1|Overall Study|Adverse Event|0
2682743|NCT00503984|9256719|P6|Overall Study|Protocol Violation|0
2682744|NCT00503984|9256720|P5|Overall Study|Protocol Violation|0
2682745|NCT00503984|9256721|P4|Overall Study|Protocol Violation|0
2682746|NCT00503984|9256722|P3|Overall Study|Protocol Violation|0
2682747|NCT00503984|9256723|P2|Overall Study|Protocol Violation|1
2682748|NCT00503984|9256724|P1|Overall Study|Protocol Violation|0
2682749|NCT00503906|9256750|P1|Overall Study|Withdrawal by Subject|1
2682750|NCT00503841|9256772|P1|Overall Study|All screen failures|44
2682751|NCT00503776|9256783|P4|Overall Study|Physician Decision|1
2682752|NCT00503776|9256784|P3|Overall Study|Physician Decision|1
2682753|NCT00503776|9256785|P2|Overall Study|Physician Decision|0
2682754|NCT00503776|9256786|P1|Overall Study|Physician Decision|0
2682755|NCT00503776|9256783|P4|Overall Study|Withdrawal by Subject|1
2682756|NCT00503776|9256784|P3|Overall Study|Withdrawal by Subject|1
2682757|NCT00503776|9256785|P2|Overall Study|Withdrawal by Subject|0
2682758|NCT00503776|9256786|P1|Overall Study|Withdrawal by Subject|1
2682759|NCT00503698|9256819|P2|Overall Study|Not exposed to trial drug|6
2682760|NCT00503698|9256820|P1|Overall Study|Not exposed to trial drug|11
2682761|NCT00503698|9256819|P2|Overall Study|Unclassified|32
2682762|NCT00503698|9256820|P1|Overall Study|Unclassified|48
2682763|NCT00503698|9256819|P2|Overall Study|Critically ill|0
2682764|NCT00503698|9256820|P1|Overall Study|Critically ill|2
2682765|NCT00503698|9256819|P2|Overall Study|Move to nonparticipating dialysis center|1
2682766|NCT00503698|9256820|P1|Overall Study|Move to nonparticipating dialysis center|2
2682767|NCT00503698|9256819|P2|Overall Study|Switch to peritoneal or home dialysis|2
2682768|NCT00503698|9256820|P1|Overall Study|Switch to peritoneal or home dialysis|2
2682769|NCT00503698|9256819|P2|Overall Study|Any condition in exclusion criteria|6
2682770|NCT00503698|9256820|P1|Overall Study|Any condition in exclusion criteria|4
2682771|NCT00503698|9256819|P2|Overall Study|Pregnancy/intention to become pregnant|0
2682772|NCT00503698|9256820|P1|Overall Study|Pregnancy/intention to become pregnant|1
2682773|NCT00503698|9256819|P2|Overall Study|End hemodialysis due to renal transplant|4
2682774|NCT00503698|9256820|P1|Overall Study|End hemodialysis due to renal transplant|10
2682775|NCT00503698|9256819|P2|Overall Study|Trial terminated|253
2682776|NCT00503698|9256820|P1|Overall Study|Trial terminated|216
2682777|NCT00503698|9256819|P2|Overall Study|Lack of Efficacy|4
2682778|NCT00503698|9256820|P1|Overall Study|Lack of Efficacy|3
2682779|NCT00503698|9256819|P2|Overall Study|Death|0
2682780|NCT00503698|9256820|P1|Overall Study|Death|1
2682781|NCT00503698|9256819|P2|Overall Study|Adverse Event|41
2682782|NCT00503698|9256820|P1|Overall Study|Adverse Event|52
2682783|NCT00503698|9256819|P2|Overall Study|Protocol Violation|6
2682784|NCT00503698|9256820|P1|Overall Study|Protocol Violation|5
2682785|NCT00503685|9256837|P3|Overall Study|Eligibility Criteria Not Met|0
2682786|NCT00503685|9256838|P2|Overall Study|Eligibility Criteria Not Met|1
2682787|NCT00503685|9256839|P1|Overall Study|Eligibility Criteria Not Met|0
2682788|NCT00503685|9256837|P3|Overall Study|Protocol Violation|0
2682789|NCT00503685|9256838|P2|Overall Study|Protocol Violation|1
2682790|NCT00503685|9256839|P1|Overall Study|Protocol Violation|0
2682791|NCT00503685|9256837|P3|Overall Study|Withdrawal by Subject|0
2682792|NCT00503685|9256838|P2|Overall Study|Withdrawal by Subject|1
2682793|NCT00503685|9256839|P1|Overall Study|Withdrawal by Subject|0
2682794|NCT00503685|9256837|P3|Overall Study|Adverse Event|2
2682795|NCT00503685|9256838|P2|Overall Study|Adverse Event|0
2682796|NCT00503685|9256839|P1|Overall Study|Adverse Event|0
2682797|NCT00503425|9256881|P1|Overall Study|Missing Data/Unknown|4
2682798|NCT00503425|9256881|P1|Overall Study|Death|3
2682799|NCT00503425|9256881|P1|Overall Study|Lost to Follow-up|3
2682800|NCT00503425|9256881|P1|Overall Study|Withdrawal by Subject|8
2682801|NCT00503425|9256881|P1|Overall Study|Lack of Efficacy|25
2682802|NCT00503425|9256881|P1|Overall Study|Adverse Event|5
2682803|NCT00503425|9256881|P1|Overall Study|Participant files lost|6
2682804|NCT00503399|9256891|P2|Overall Study|Lost to Follow-up|2
2682805|NCT00503399|9256892|P1|Overall Study|Lost to Follow-up|0
2682806|NCT00503399|9256891|P2|Overall Study|Adverse Event|3
2682807|NCT00503399|9256892|P1|Overall Study|Adverse Event|0
2682808|NCT00503399|9256891|P2|Overall Study|Withdrawal by Subject|2
2682809|NCT00503399|9256892|P1|Overall Study|Withdrawal by Subject|4
2682810|NCT00503399|9256891|P2|Overall Study|Protocol Violation|0
2682811|NCT00503399|9256892|P1|Overall Study|Protocol Violation|1
2682812|NCT00503399|9256891|P2|Overall Study|Death|1
2682813|NCT00503399|9256892|P1|Overall Study|Death|2
2682814|NCT00503308|9256916|P2|Overall Study|Protocol Violation|1
2682815|NCT00503308|9256917|P1|Overall Study|Protocol Violation|2
2682816|NCT00503139|9256923|P1|Overall Study|Protocol Violation|4
2682817|NCT00503139|9256923|P1|Overall Study|Case Report Forms were not collected|4
2682818|NCT00503009|9256971|P3|Overall Study|Physician Decision|1
2682819|NCT00503009|9256972|P2|Overall Study|Physician Decision|1
2682820|NCT00503009|9256973|P1|Overall Study|Physician Decision|0
2682821|NCT00503009|9256971|P3|Overall Study|Withdrawal by Subject|1
2682822|NCT00503009|9256972|P2|Overall Study|Withdrawal by Subject|1
2682823|NCT00503009|9256973|P1|Overall Study|Withdrawal by Subject|0
2682824|NCT00503009|9256971|P3|Overall Study|Protocol Violation|1
2682825|NCT00503009|9256972|P2|Overall Study|Protocol Violation|0
2682826|NCT00503009|9256973|P1|Overall Study|Protocol Violation|1
2682827|NCT00502996|9256990|P1|Overall Study|Adverse Event|2
2682828|NCT00502996|9256990|P1|Overall Study|Withdrawal Informed Consent|6
2682829|NCT00502996|9256990|P1|Overall Study|Treatment failure|25
2682830|NCT00502996|9256990|P1|Overall Study|Protocol Violation|2
2682831|NCT00502996|9256990|P1|Overall Study|Lost to Follow-up|9
2682832|NCT00502840|9257058|P1|Overall Study|Other|20
2682833|NCT00502840|9257058|P1|Overall Study|Administrative problems|1
2682834|NCT00502840|9257058|P1|Overall Study|Lost to Follow-up|6
2682835|NCT00502840|9257058|P1|Overall Study|Withdrawal by Subject|5
2682836|NCT00502840|9257058|P1|Overall Study|Protocol Violation|4
2682837|NCT00502840|9257058|P1|Overall Study|Lack of Efficacy|11
2682838|NCT00502840|9257058|P1|Overall Study|Additional or changed therapy|48
2682839|NCT00502840|9257058|P1|Overall Study|Adverse Event|5
2682840|NCT00502801|9257086|P1|End of Therapy to Test of Cure|OTHER|2
2682841|NCT00502801|9257086|P1|End of Therapy to Test of Cure|Death|3
2682842|NCT00502801|9257086|P1|End of Therapy to Test of Cure|Lost to Follow-up|2
2682843|NCT00502801|9257086|P1|End of Therapy to Test of Cure|Withdrawal by Subject|1
2682844|NCT00502801|9257086|P1|Treatment Period|OTHER|30
2682845|NCT00502801|9257086|P1|Treatment Period|Death|14
2682846|NCT00502801|9257086|P1|Treatment Period|Adverse Event|7
2682847|NCT00502801|9257086|P1|Treatment Period|Withdrawal by Subject|3
2682848|NCT00502775|9257094|P3|Overall Study|Subject took disallowed drug|1
2682849|NCT00502775|9257095|P2|Overall Study|Subject took disallowed drug|0
2682850|NCT00502775|9257096|P1|Overall Study|Subject took disallowed drug|0
2682851|NCT00502775|9257094|P3|Overall Study|Subject in jail|0
2682852|NCT00502775|9257095|P2|Overall Study|Subject in jail|1
2682853|NCT00502775|9257096|P1|Overall Study|Subject in jail|0
2682854|NCT00502775|9257094|P3|Overall Study|Declining pollen counts|1
2682855|NCT00502775|9257095|P2|Overall Study|Declining pollen counts|1
2682856|NCT00502775|9257096|P1|Overall Study|Declining pollen counts|0
2682857|NCT00502775|9257094|P3|Overall Study|Outside pollen area more than 48 hours|0
2682858|NCT00502775|9257095|P2|Overall Study|Outside pollen area more than 48 hours|1
2682859|NCT00502775|9257096|P1|Overall Study|Outside pollen area more than 48 hours|0
2682860|NCT00502775|9257094|P3|Overall Study|Non-compliance|2
2682861|NCT00502775|9257095|P2|Overall Study|Non-compliance|2
2682862|NCT00502775|9257096|P1|Overall Study|Non-compliance|0
2682863|NCT00502775|9257094|P3|Overall Study|Randomized in error|1
2682864|NCT00502775|9257095|P2|Overall Study|Randomized in error|1
2682865|NCT00502775|9257096|P1|Overall Study|Randomized in error|0
2682866|NCT00502775|9257094|P3|Overall Study|Logpad compliance <80%|0
2682867|NCT00502775|9257095|P2|Overall Study|Logpad compliance <80%|0
2682868|NCT00502775|9257096|P1|Overall Study|Logpad compliance <80%|1
2682869|NCT00502775|9257094|P3|Overall Study|Subject unable to swallow capsule|1
2682870|NCT00502775|9257095|P2|Overall Study|Subject unable to swallow capsule|0
2682871|NCT00502775|9257096|P1|Overall Study|Subject unable to swallow capsule|1
2682872|NCT00502775|9257094|P3|Overall Study|Non-compliance with eDiary|1
2682873|NCT00502775|9257095|P2|Overall Study|Non-compliance with eDiary|1
2682874|NCT00502775|9257096|P1|Overall Study|Non-compliance with eDiary|4
2682875|NCT00502775|9257094|P3|Overall Study|Sponsor Terminated Study|1
2682876|NCT00502775|9257095|P2|Overall Study|Sponsor Terminated Study|0
2682877|NCT00502775|9257096|P1|Overall Study|Sponsor Terminated Study|1
2682878|NCT00502775|9257094|P3|Overall Study|Withdrawal by Subject|2
2682879|NCT00502775|9257095|P2|Overall Study|Withdrawal by Subject|1
2682880|NCT00502775|9257096|P1|Overall Study|Withdrawal by Subject|1
2682881|NCT00502775|9257094|P3|Overall Study|Protocol Violation|2
2682882|NCT00502775|9257095|P2|Overall Study|Protocol Violation|5
2682883|NCT00502775|9257096|P1|Overall Study|Protocol Violation|1
2682884|NCT00502775|9257094|P3|Overall Study|Adverse Event|1
2682885|NCT00502775|9257095|P2|Overall Study|Adverse Event|2
2682886|NCT00502775|9257096|P1|Overall Study|Adverse Event|1
2682887|NCT00502697|9257139|P2|Overall Study|did not meet assignment criteria|2
2682888|NCT00502697|9257140|P1|Overall Study|did not meet assignment criteria|4
2682889|NCT00502697|9257139|P2|Overall Study|found not to meet eligibility criteria|4
2682890|NCT00502697|9257140|P1|Overall Study|found not to meet eligibility criteria|3
2682891|NCT00502697|9257139|P2|Overall Study|disenrolled due to pregnancy loss|5
2682892|NCT00502697|9257140|P1|Overall Study|disenrolled due to pregnancy loss|3
2682893|NCT00502697|9257139|P2|Overall Study|Withdrawal by Subject|1
2682894|NCT00502697|9257140|P1|Overall Study|Withdrawal by Subject|3
2682895|NCT00502671|9257148|P1|Overall Study|Adverse Event|19
2682896|NCT00502671|9257148|P1|Overall Study|Protocol Violation|16
2682897|NCT00502671|9257148|P1|Overall Study|Lost to Follow-up|7
2682898|NCT00502671|9257148|P1|Overall Study|Personal Reasons|22
2682899|NCT00502671|9257148|P1|Overall Study|Disease Progression|13
2682900|NCT00502593|9257165|P12|Overall Study|Lost to Follow-up|0
2682901|NCT00502593|9257166|P11|Overall Study|Lost to Follow-up|1
2682902|NCT00502593|9257167|P10|Overall Study|Lost to Follow-up|0
2682903|NCT00502593|9257168|P9|Overall Study|Lost to Follow-up|3
2682904|NCT00502593|9257169|P8|Overall Study|Lost to Follow-up|0
2682905|NCT00502593|9257170|P7|Overall Study|Lost to Follow-up|0
2682906|NCT00502593|9257171|P6|Overall Study|Lost to Follow-up|0
2682907|NCT00502593|9257172|P5|Overall Study|Lost to Follow-up|0
2682908|NCT00502593|9257173|P4|Overall Study|Lost to Follow-up|1
2682909|NCT00502593|9257174|P3|Overall Study|Lost to Follow-up|1
2682910|NCT00502593|9257175|P2|Overall Study|Lost to Follow-up|1
2682911|NCT00502593|9257176|P1|Overall Study|Lost to Follow-up|2
2682912|NCT00502593|9257165|P12|Overall Study|Withdrawal by Subject|0
2682913|NCT00502593|9257166|P11|Overall Study|Withdrawal by Subject|1
2682914|NCT00502593|9257167|P10|Overall Study|Withdrawal by Subject|0
2682915|NCT00502593|9257168|P9|Overall Study|Withdrawal by Subject|3
2682916|NCT00502593|9257169|P8|Overall Study|Withdrawal by Subject|0
2682917|NCT00502593|9257170|P7|Overall Study|Withdrawal by Subject|3
2682918|NCT00502593|9257171|P6|Overall Study|Withdrawal by Subject|0
2682919|NCT00502593|9257172|P5|Overall Study|Withdrawal by Subject|2
2682920|NCT00502593|9257173|P4|Overall Study|Withdrawal by Subject|2
2682921|NCT00502593|9257174|P3|Overall Study|Withdrawal by Subject|6
2682922|NCT00502593|9257175|P2|Overall Study|Withdrawal by Subject|0
2682923|NCT00502593|9257176|P1|Overall Study|Withdrawal by Subject|0
2682924|NCT00502593|9257165|P12|Overall Study|Withdrawn unspecified reason|0
2682925|NCT00502593|9257166|P11|Overall Study|Withdrawn unspecified reason|0
2682926|NCT00502593|9257167|P10|Overall Study|Withdrawn unspecified reason|0
2682927|NCT00502593|9257168|P9|Overall Study|Withdrawn unspecified reason|0
2682928|NCT00502593|9257169|P8|Overall Study|Withdrawn unspecified reason|0
2682929|NCT00502593|9257170|P7|Overall Study|Withdrawn unspecified reason|2
2682930|NCT00502593|9257171|P6|Overall Study|Withdrawn unspecified reason|0
2682931|NCT00502593|9257172|P5|Overall Study|Withdrawn unspecified reason|2
2682932|NCT00502593|9257173|P4|Overall Study|Withdrawn unspecified reason|1
2682933|NCT00502593|9257174|P3|Overall Study|Withdrawn unspecified reason|3
2682934|NCT00502593|9257175|P2|Overall Study|Withdrawn unspecified reason|1
2682935|NCT00502593|9257176|P1|Overall Study|Withdrawn unspecified reason|1
2682936|NCT00502320|9257692|P2|Overall Study|Adverse Event|5
2682937|NCT00502320|9257693|P1|Overall Study|Adverse Event|3
2682938|NCT00502320|9257692|P2|Overall Study|Screen Failure|1
2682939|NCT00502320|9257693|P1|Overall Study|Screen Failure|0
2682940|NCT00502320|9257692|P2|Overall Study|No longer met criteria|0
2682941|NCT00502320|9257693|P1|Overall Study|No longer met criteria|1
2682942|NCT00502320|9257692|P2|Overall Study|Withdrew Consent|0
2682943|NCT00502320|9257693|P1|Overall Study|Withdrew Consent|1
2682944|NCT00502320|9257692|P2|Overall Study|Lost to Follow-up|1
2682945|NCT00502320|9257693|P1|Overall Study|Lost to Follow-up|1
2682946|NCT00502242|9257705|P2|Overall Study|Withdrawal by Subject|7
2682947|NCT00502242|9257706|P1|Overall Study|Withdrawal by Subject|6
2682948|NCT00502242|9257705|P2|Overall Study|Protocol Violation|1
2682949|NCT00502242|9257706|P1|Overall Study|Protocol Violation|3
2682950|NCT00502242|9257705|P2|Overall Study|Other - Unspecified|14
2682951|NCT00502242|9257706|P1|Overall Study|Other - Unspecified|8
2682952|NCT00502242|9257705|P2|Overall Study|Physician Decision|3
2682953|NCT00502242|9257706|P1|Overall Study|Physician Decision|2
2682954|NCT00502242|9257705|P2|Overall Study|Adverse Event|20
2682955|NCT00502242|9257706|P1|Overall Study|Adverse Event|31
2682956|NCT00502242|9257705|P2|Overall Study|Lack of Efficacy|11
2682957|NCT00502242|9257706|P1|Overall Study|Lack of Efficacy|1
2682958|NCT00502203|9257770|P1|Overall Study|Inevaluable|1
2682959|NCT00501969|9257779|P1|Overall Study|Other: Sponsor Termination/Commercial RX|1
2682960|NCT00501969|9257779|P1|Overall Study|Other: Admin Request from the Sponsor|3
2682961|NCT00501969|9257779|P1|Overall Study|Other: As Required by Local EC|2
2682962|NCT00501969|9257779|P1|Overall Study|Other: DX Changed - Parkinsons to PSNP|1
2682963|NCT00501969|9257779|P1|Overall Study|Other: Pat Pending Surgery for PD|1
2682964|NCT00501969|9257779|P1|Overall Study|Other: Patient is Going to Have DBS|1
2682965|NCT00501969|9257779|P1|Overall Study|Other: Patients + Investigator Agreement|1
2682966|NCT00501969|9257779|P1|Overall Study|Other: Severe Dementia Unable Sign PIC|1
2682967|NCT00501969|9257779|P1|Overall Study|Other: Sponsor Stopped Study|12
2682968|NCT00501969|9257779|P1|Overall Study|Other: Sponsor Termination at Site|1
2682969|NCT00501969|9257779|P1|Overall Study|Other: Sponsors Request|10
2682970|NCT00501969|9257779|P1|Overall Study|Other: Tired Of Clinical Trial Process|1
2682971|NCT00501969|9257779|P1|Overall Study|Lost to Follow-up|4
2682972|NCT00501969|9257779|P1|Overall Study|Subject withdrew consent|51
2682973|NCT00501969|9257779|P1|Overall Study|Unsatisfactory compliance of subject|7
2682974|NCT00501969|9257779|P1|Overall Study|Adverse Event|76
2682975|NCT00501969|9257779|P1|Overall Study|Lack of Efficacy|29
2682976|NCT00501969|9257779|P1|Overall Study|Major Protocol Violation|4
2682977|NCT00501852|9257811|P1|Overall Study|Withdrawal by Subject|2
2682978|NCT00501852|9257811|P1|Overall Study|Adverse Event|3
2682979|NCT00501644|9257831|P1|Overall Study|Withdrawal by Subject|1
2682980|NCT00501644|9257831|P1|Overall Study|Adverse Event|4
2682981|NCT00501540|9257860|P1|Overall Study|Death|5
2682982|NCT00501293|9257872|P2|Maintenance Period|Application site reaction|0
2682983|NCT00501293|9257873|P1|Maintenance Period|Application site reaction|1
2682984|NCT00501293|9257872|P2|Maintenance Period|Would not wear patch|0
2682985|NCT00501293|9257873|P1|Maintenance Period|Would not wear patch|1
2682986|NCT00501293|9257872|P2|Maintenance Period|Went into rehabilitation|0
2682987|NCT00501293|9257873|P1|Maintenance Period|Went into rehabilitation|1
2682988|NCT00501293|9257872|P2|Maintenance Period|Noncompliant with study medication|0
2682989|NCT00501293|9257873|P1|Maintenance Period|Noncompliant with study medication|5
2682990|NCT00501293|9257872|P2|Maintenance Period|Lack of Efficacy|1
2682991|NCT00501293|9257873|P1|Maintenance Period|Lack of Efficacy|4
2682992|NCT00501293|9257872|P2|Maintenance Period|Protocol Violation|1
2682993|NCT00501293|9257873|P1|Maintenance Period|Protocol Violation|2
2682994|NCT00501293|9257872|P2|Maintenance Period|Adverse Event|6
2682995|NCT00501293|9257873|P1|Maintenance Period|Adverse Event|6
2682996|NCT00501293|9257872|P2|Maintenance Period|Lost to Follow-up|7
2682997|NCT00501293|9257873|P1|Maintenance Period|Lost to Follow-up|12
2682998|NCT00501293|9257872|P2|Maintenance Period|Withdrawal by Subject|13
2682999|NCT00501293|9257873|P1|Maintenance Period|Withdrawal by Subject|14
2683000|NCT00501293|9257872|P2|Optimization Period|Enrolled in error|0
2683001|NCT00501293|9257873|P1|Optimization Period|Enrolled in error|1
2683002|NCT00501228|9257900|P1|Overall Study|Withdrawal by Subject|1
2683003|NCT00501085|9257904|P1|Overall Study|Other loss to follow-up|32
2683004|NCT00501085|9257904|P1|Overall Study|Study closed by sponsor|109
2683005|NCT00501085|9257904|P1|Overall Study|Non-Compliance|24
2683006|NCT00501085|9257904|P1|Overall Study|Adverse Event|4
2683007|NCT00501085|9257904|P1|Overall Study|Explantation Surgery|26
2683008|NCT00501085|9257904|P1|Overall Study|Revision Surgery|7
2683009|NCT00501085|9257904|P1|Overall Study|Subject Decision|1
2683010|NCT00501085|9257904|P1|Overall Study|Withdrawal by Subject|34
2683011|NCT00501085|9257904|P1|Overall Study|Lost to Follow-up|195
2683012|NCT00501059|9257914|P2|Overall Study|Not treated|17
2683013|NCT00501059|9257915|P1|Overall Study|Not treated|25
2683014|NCT00501059|9257914|P2|Overall Study|Lost to Follow-up|198
2683015|NCT00501059|9257915|P1|Overall Study|Lost to Follow-up|210
2683016|NCT00501059|9257914|P2|Overall Study|Adverse Event|122
2683017|NCT00501059|9257915|P1|Overall Study|Adverse Event|129
2683018|NCT00501059|9257914|P2|Overall Study|Reason not given|1
2683019|NCT00501059|9257915|P1|Overall Study|Reason not given|3
2683020|NCT00501059|9257914|P2|Overall Study|Non-compliant with study treatment|16
2683021|NCT00501059|9257915|P1|Overall Study|Non-compliant with study treatment|23
2683022|NCT00501059|9257914|P2|Overall Study|Consent withdrawn by subject|873
2683023|NCT00501059|9257915|P1|Overall Study|Consent withdrawn by subject|817
2683024|NCT00501059|9257914|P2|Overall Study|Insufficient therapeutic effect|5
2683025|NCT00501059|9257915|P1|Overall Study|Insufficient therapeutic effect|4
2683026|NCT00501059|9257914|P2|Overall Study|Clinical endpoint reached|123
2683027|NCT00501059|9257915|P1|Overall Study|Clinical endpoint reached|110
2683028|NCT00501059|9257914|P2|Overall Study|Missing end-of-study page|92
2683029|NCT00501059|9257915|P1|Overall Study|Missing end-of-study page|91
2683030|NCT00501059|9257914|P2|Overall Study|Other|239
2683031|NCT00501059|9257915|P1|Overall Study|Other|236
2683032|NCT00501059|9257914|P2|Overall Study|Death|137
2683033|NCT00501059|9257915|P1|Overall Study|Death|140
2683034|NCT00501059|9257914|P2|Overall Study|Protocol Violation|69
2683035|NCT00501059|9257915|P1|Overall Study|Protocol Violation|80
2683036|NCT00501046|9257939|P2|Overall Study|Reaching endpoints,Noncompliance,etc|137
2683037|NCT00501046|9257940|P1|Overall Study|Reaching endpoints,Noncompliance,etc|119
2683038|NCT00501046|9257939|P2|Overall Study|Withdrawal by Subject|83
2683039|NCT00501046|9257940|P1|Overall Study|Withdrawal by Subject|84
2683040|NCT00501046|9257939|P2|Overall Study|Protocol Violation|1
2683041|NCT00501046|9257940|P1|Overall Study|Protocol Violation|2
2683042|NCT00501046|9257939|P2|Overall Study|Pregnancy|3
2683043|NCT00501046|9257940|P1|Overall Study|Pregnancy|0
2683044|NCT00501046|9257939|P2|Overall Study|Physician Decision|2
2683045|NCT00501046|9257940|P1|Overall Study|Physician Decision|7
2683046|NCT00501046|9257939|P2|Overall Study|Lost to Follow-up|13
2683047|NCT00501046|9257940|P1|Overall Study|Lost to Follow-up|14
2683048|NCT00501046|9257939|P2|Overall Study|Death|30
2683049|NCT00501046|9257940|P1|Overall Study|Death|23
2683050|NCT00501046|9257939|P2|Overall Study|Adverse Event|25
2683051|NCT00501046|9257940|P1|Overall Study|Adverse Event|21
2683052|NCT00501007|9257946|P2|Overall Study|Inclusion criteria not met.|25
2683053|NCT00501007|9257947|P1|Overall Study|Inclusion criteria not met.|29
2683054|NCT00500903|9257956|P3|Overall Study|Reason Not Specified|2
2683055|NCT00500903|9257957|P2|Overall Study|Reason Not Specified|0
2683056|NCT00500903|9257958|P1|Overall Study|Reason Not Specified|10
2683057|NCT00500903|9257956|P3|Overall Study|Symptomatic Deterioration|0
2683058|NCT00500903|9257957|P2|Overall Study|Symptomatic Deterioration|0
2683059|NCT00500903|9257958|P1|Overall Study|Symptomatic Deterioration|2
2683060|NCT00500903|9257956|P3|Overall Study|Patient Declined Further Treatment|3
2683061|NCT00500903|9257957|P2|Overall Study|Patient Declined Further Treatment|0
2683062|NCT00500903|9257958|P1|Overall Study|Patient Declined Further Treatment|0
2683063|NCT00500903|9257956|P3|Overall Study|Progressive Disease|15
2683064|NCT00500903|9257957|P2|Overall Study|Progressive Disease|2
2683065|NCT00500903|9257958|P1|Overall Study|Progressive Disease|41
2683066|NCT00500903|9257956|P3|Overall Study|Unsatisfactory Therapeutic Response|0
2683067|NCT00500903|9257957|P2|Overall Study|Unsatisfactory Therapeutic Response|0
2683068|NCT00500903|9257958|P1|Overall Study|Unsatisfactory Therapeutic Response|2
2683069|NCT00500903|9257956|P3|Overall Study|Occurrence of Adverse Event(s)|0
2683070|NCT00500903|9257957|P2|Overall Study|Occurrence of Adverse Event(s)|0
2683071|NCT00500903|9257958|P1|Overall Study|Occurrence of Adverse Event(s)|10
2683072|NCT00500760|9258154|P2|Overall Study|Other|2
2683073|NCT00500760|9258155|P1|Overall Study|Other|1
2683074|NCT00500760|9258154|P2|Overall Study|Lost to Follow-up|0
2683075|NCT00500760|9258155|P1|Overall Study|Lost to Follow-up|3
2683076|NCT00500760|9258154|P2|Overall Study|Administrative decision|0
2683077|NCT00500760|9258155|P1|Overall Study|Administrative decision|2
2683078|NCT00500760|9258154|P2|Overall Study|Withdrawal by Subject|7
2683079|NCT00500760|9258155|P1|Overall Study|Withdrawal by Subject|5
2683080|NCT00500760|9258154|P2|Overall Study|Death|15
2683081|NCT00500760|9258155|P1|Overall Study|Death|32
2683082|NCT00500682|9258175|P2|Overall Study|Reaching endpoints, Noncompliance, etc|144
2683083|NCT00500682|9258176|P1|Overall Study|Reaching endpoints, Noncompliance, etc|144
2683084|NCT00500682|9258175|P2|Overall Study|Withdrawal by Subject|74
2683085|NCT00500682|9258176|P1|Overall Study|Withdrawal by Subject|80
2683086|NCT00500682|9258175|P2|Overall Study|Protocol Violation|3
2683087|NCT00500682|9258176|P1|Overall Study|Protocol Violation|1
2683088|NCT00500682|9258175|P2|Overall Study|Pregnancy|0
2683089|NCT00500682|9258176|P1|Overall Study|Pregnancy|2
2683090|NCT00500682|9258175|P2|Overall Study|Physician Decision|10
2683091|NCT00500682|9258176|P1|Overall Study|Physician Decision|6
2683092|NCT00500682|9258175|P2|Overall Study|Lost to Follow-up|11
2683093|NCT00500682|9258176|P1|Overall Study|Lost to Follow-up|11
2683094|NCT00500682|9258175|P2|Overall Study|Death|16
2683095|NCT00500682|9258176|P1|Overall Study|Death|25
2683096|NCT00500682|9258175|P2|Overall Study|Adverse Event|29
2683097|NCT00500682|9258176|P1|Overall Study|Adverse Event|37
2683098|NCT00500539|9258210|P1|Follow-up Period (16 Weeks)|Missing|3
2683099|NCT00500539|9258210|P1|Follow-up Period (16 Weeks)|Protocol Deviation|1
2683100|NCT00500539|9258210|P1|Follow-up Period (16 Weeks)|Death|1
2683101|NCT00500539|9258210|P1|Follow-up Period (16 Weeks)|Administrative problems|1
2683102|NCT00500539|9258210|P1|Follow-up Period (16 Weeks)|Lost to Follow-up|3
2683103|NCT00500539|9258210|P1|Follow-up Period (16 Weeks)|Subject withdrew consent|2
2683104|NCT00500539|9258210|P1|Follow-up Period (16 Weeks)|Adverse Event|1
2683105|NCT00500539|9258210|P1|Treatment Period (24 Weeks)|Protocol Deviation|5
2683106|NCT00500539|9258210|P1|Treatment Period (24 Weeks)|Administrative problems|2
2683107|NCT00500539|9258210|P1|Treatment Period (24 Weeks)|Lost to Follow-up|2
2683108|NCT00500539|9258210|P1|Treatment Period (24 Weeks)|Subject withdrew consent|1
2683109|NCT00500539|9258210|P1|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1
2683110|NCT00500539|9258210|P1|Treatment Period (24 Weeks)|Adverse Event|4
2683111|NCT00500370|9258236|P2|Overall Study|Subject Decision|17
2683112|NCT00500370|9258237|P1|Overall Study|Subject Decision|10
2683113|NCT00500370|9258236|P2|Overall Study|Sponsor Decision|0
2683114|NCT00500370|9258237|P1|Overall Study|Sponsor Decision|2
2683115|NCT00500370|9258236|P2|Overall Study|Protocol Violation|4
2683116|NCT00500370|9258237|P1|Overall Study|Protocol Violation|2
2683117|NCT00500370|9258236|P2|Overall Study|Lost to Follow-up|10
2683118|NCT00500370|9258237|P1|Overall Study|Lost to Follow-up|10
2683119|NCT00500370|9258236|P2|Overall Study|Adverse Event|3
2683120|NCT00500370|9258237|P1|Overall Study|Adverse Event|9
2683121|NCT00500357|9258273|P1|Overall Study|Death|1
2683122|NCT00500331|9258299|P7|Overall Study|Protocol violated|0
2683123|NCT00500331|9258300|P6|Overall Study|Protocol violated|0
2683124|NCT00500331|9258301|P5|Overall Study|Protocol violated|0
2683125|NCT00500331|9258302|P4|Overall Study|Protocol violated|1
2683126|NCT00500331|9258303|P3|Overall Study|Protocol violated|0
2683127|NCT00500331|9258304|P2|Overall Study|Protocol violated|0
2683128|NCT00500331|9258305|P1|Overall Study|Protocol violated|0
2683129|NCT00500331|9258299|P7|Overall Study|State ban of biological samples export|0
2683130|NCT00500331|9258300|P6|Overall Study|State ban of biological samples export|0
2683131|NCT00500331|9258301|P5|Overall Study|State ban of biological samples export|0
2683132|NCT00500331|9258302|P4|Overall Study|State ban of biological samples export|1
2683133|NCT00500331|9258303|P3|Overall Study|State ban of biological samples export|0
2683134|NCT00500331|9258304|P2|Overall Study|State ban of biological samples export|0
2683135|NCT00500331|9258305|P1|Overall Study|State ban of biological samples export|0
2683136|NCT00500331|9258299|P7|Overall Study|Diabetologist nurse in the study|0
2683137|NCT00500331|9258300|P6|Overall Study|Diabetologist nurse in the study|0
2683138|NCT00500331|9258301|P5|Overall Study|Diabetologist nurse in the study|0
2683139|NCT00500331|9258302|P4|Overall Study|Diabetologist nurse in the study|0
2683140|NCT00500331|9258303|P3|Overall Study|Diabetologist nurse in the study|1
2683141|NCT00500331|9258304|P2|Overall Study|Diabetologist nurse in the study|0
2683142|NCT00500331|9258305|P1|Overall Study|Diabetologist nurse in the study|0
2683143|NCT00500331|9258299|P7|Overall Study|Participant was randomized by mistake|0
2683144|NCT00500331|9258300|P6|Overall Study|Participant was randomized by mistake|0
2683145|NCT00500331|9258301|P5|Overall Study|Participant was randomized by mistake|0
2683146|NCT00500331|9258302|P4|Overall Study|Participant was randomized by mistake|0
2683147|NCT00500331|9258303|P3|Overall Study|Participant was randomized by mistake|0
2683148|NCT00500331|9258304|P2|Overall Study|Participant was randomized by mistake|0
2683149|NCT00500331|9258305|P1|Overall Study|Participant was randomized by mistake|1
2683150|NCT00500331|9258299|P7|Overall Study|Sponsor decided to withdraw participant|0
2683151|NCT00500331|9258300|P6|Overall Study|Sponsor decided to withdraw participant|0
2683152|NCT00500331|9258301|P5|Overall Study|Sponsor decided to withdraw participant|0
2683153|NCT00500331|9258302|P4|Overall Study|Sponsor decided to withdraw participant|0
2683154|NCT00500331|9258303|P3|Overall Study|Sponsor decided to withdraw participant|0
2683155|NCT00500331|9258304|P2|Overall Study|Sponsor decided to withdraw participant|0
2683156|NCT00500331|9258305|P1|Overall Study|Sponsor decided to withdraw participant|1
2683157|NCT00500331|9258299|P7|Overall Study|Exclusion citeria not met on Visit 4|0
2683158|NCT00500331|9258300|P6|Overall Study|Exclusion citeria not met on Visit 4|0
2683159|NCT00500331|9258301|P5|Overall Study|Exclusion citeria not met on Visit 4|0
2683160|NCT00500331|9258302|P4|Overall Study|Exclusion citeria not met on Visit 4|0
2683161|NCT00500331|9258303|P3|Overall Study|Exclusion citeria not met on Visit 4|0
2683162|NCT00500331|9258304|P2|Overall Study|Exclusion citeria not met on Visit 4|0
2683163|NCT00500331|9258305|P1|Overall Study|Exclusion citeria not met on Visit 4|1
2683164|NCT00500331|9258299|P7|Overall Study|Didn't return for continuation of study|0
2683165|NCT00500331|9258300|P6|Overall Study|Didn't return for continuation of study|0
2683166|NCT00500331|9258301|P5|Overall Study|Didn't return for continuation of study|0
2683167|NCT00500331|9258302|P4|Overall Study|Didn't return for continuation of study|0
2683168|NCT00500331|9258303|P3|Overall Study|Didn't return for continuation of study|0
2683169|NCT00500331|9258304|P2|Overall Study|Didn't return for continuation of study|0
2683170|NCT00500331|9258305|P1|Overall Study|Didn't return for continuation of study|1
2683171|NCT00500331|9258299|P7|Overall Study|Increased serum creatinine from Baseline|0
2683172|NCT00500331|9258300|P6|Overall Study|Increased serum creatinine from Baseline|1
2683173|NCT00500331|9258301|P5|Overall Study|Increased serum creatinine from Baseline|0
2683174|NCT00500331|9258302|P4|Overall Study|Increased serum creatinine from Baseline|0
2683175|NCT00500331|9258303|P3|Overall Study|Increased serum creatinine from Baseline|0
2683176|NCT00500331|9258304|P2|Overall Study|Increased serum creatinine from Baseline|0
2683177|NCT00500331|9258305|P1|Overall Study|Increased serum creatinine from Baseline|0
2683178|NCT00500331|9258299|P7|Overall Study|Liver function test abnormality|0
2683179|NCT00500331|9258300|P6|Overall Study|Liver function test abnormality|0
2683180|NCT00500331|9258301|P5|Overall Study|Liver function test abnormality|0
2683181|NCT00500331|9258302|P4|Overall Study|Liver function test abnormality|0
2683182|NCT00500331|9258303|P3|Overall Study|Liver function test abnormality|1
2683183|NCT00500331|9258304|P2|Overall Study|Liver function test abnormality|0
2683184|NCT00500331|9258305|P1|Overall Study|Liver function test abnormality|0
2683185|NCT00500331|9258299|P7|Overall Study|Lack of Efficacy|0
2683186|NCT00500331|9258300|P6|Overall Study|Lack of Efficacy|0
2683187|NCT00500331|9258301|P5|Overall Study|Lack of Efficacy|0
2683188|NCT00500331|9258302|P4|Overall Study|Lack of Efficacy|0
2683189|NCT00500331|9258303|P3|Overall Study|Lack of Efficacy|0
2683190|NCT00500331|9258304|P2|Overall Study|Lack of Efficacy|1
2683191|NCT00500331|9258305|P1|Overall Study|Lack of Efficacy|3
2683192|NCT00500331|9258299|P7|Overall Study|Withdrawal by Subject|1
2683193|NCT00500331|9258300|P6|Overall Study|Withdrawal by Subject|1
2683194|NCT00500331|9258301|P5|Overall Study|Withdrawal by Subject|0
2683195|NCT00500331|9258302|P4|Overall Study|Withdrawal by Subject|5
2683196|NCT00500331|9258303|P3|Overall Study|Withdrawal by Subject|1
2683197|NCT00500331|9258304|P2|Overall Study|Withdrawal by Subject|0
2683198|NCT00500331|9258305|P1|Overall Study|Withdrawal by Subject|4
2683199|NCT00500331|9258299|P7|Overall Study|Protocol Violation|1
2683200|NCT00500331|9258300|P6|Overall Study|Protocol Violation|1
2683201|NCT00500331|9258301|P5|Overall Study|Protocol Violation|1
2683202|NCT00500331|9258302|P4|Overall Study|Protocol Violation|0
2683203|NCT00500331|9258303|P3|Overall Study|Protocol Violation|1
2683204|NCT00500331|9258304|P2|Overall Study|Protocol Violation|1
2683205|NCT00500331|9258305|P1|Overall Study|Protocol Violation|3
2683206|NCT00500331|9258299|P7|Overall Study|Lost to Follow-up|0
2683207|NCT00500331|9258300|P6|Overall Study|Lost to Follow-up|0
2683208|NCT00500331|9258301|P5|Overall Study|Lost to Follow-up|1
2683209|NCT00500331|9258302|P4|Overall Study|Lost to Follow-up|2
2683210|NCT00500331|9258303|P3|Overall Study|Lost to Follow-up|1
2683211|NCT00500331|9258304|P2|Overall Study|Lost to Follow-up|1
2683212|NCT00500331|9258305|P1|Overall Study|Lost to Follow-up|1
2683213|NCT00500331|9258299|P7|Overall Study|Adverse Event|0
2683214|NCT00500331|9258300|P6|Overall Study|Adverse Event|2
2683215|NCT00500331|9258301|P5|Overall Study|Adverse Event|2
2683216|NCT00500331|9258302|P4|Overall Study|Adverse Event|1
2683217|NCT00500331|9258303|P3|Overall Study|Adverse Event|0
2683218|NCT00500331|9258304|P2|Overall Study|Adverse Event|2
2683219|NCT00500331|9258305|P1|Overall Study|Adverse Event|0
2683220|NCT00500318|9258442|P2|Overall Study|Other Reason|1
2683221|NCT00500318|9258443|P1|Overall Study|Other Reason|0
2683222|NCT00500318|9258442|P2|Overall Study|Lack of Efficacy|3
2683223|NCT00500318|9258443|P1|Overall Study|Lack of Efficacy|0
2683224|NCT00500318|9258442|P2|Overall Study|Withdrawal by Subject|2
2683225|NCT00500318|9258443|P1|Overall Study|Withdrawal by Subject|1
2683226|NCT00500318|9258442|P2|Overall Study|Protocol Violation|3
2683227|NCT00500318|9258443|P1|Overall Study|Protocol Violation|1
2683228|NCT00500318|9258442|P2|Overall Study|Adverse Event|8
2683229|NCT00500318|9258443|P1|Overall Study|Adverse Event|3
2683230|NCT00500292|9258460|P3|Overall Study|Other|4
2683231|NCT00500292|9258461|P2|Overall Study|Other|1
2683232|NCT00500292|9258462|P1|Overall Study|Other|1
2683233|NCT00500292|9258460|P3|Overall Study|Withdrawal by Subject|0
2683234|NCT00500292|9258461|P2|Overall Study|Withdrawal by Subject|1
2683235|NCT00500292|9258462|P1|Overall Study|Withdrawal by Subject|0
2683236|NCT00500292|9258460|P3|Overall Study|Condition under investigation worsened|19
2683237|NCT00500292|9258461|P2|Overall Study|Condition under investigation worsened|23
2683238|NCT00500292|9258462|P1|Overall Study|Condition under investigation worsened|21
2683239|NCT00500292|9258460|P3|Overall Study|Adverse Event|4
2683240|NCT00500292|9258461|P2|Overall Study|Adverse Event|6
2683241|NCT00500292|9258462|P1|Overall Study|Adverse Event|3
2683242|NCT00500149|9258483|P2|Second Intervention (Cross-over Phase)|Lost to Follow-up|0
2683243|NCT00500149|9258484|P1|Second Intervention (Cross-over Phase)|Lost to Follow-up|2
2683244|NCT00500149|9258483|P2|First Intervention (Cross-over Phase)|Protocol Violation|0
2683245|NCT00500149|9258484|P1|First Intervention (Cross-over Phase)|Protocol Violation|1
2683246|NCT00500149|9258483|P2|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
2683247|NCT00500149|9258484|P1|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
2683248|NCT00500149|9258483|P2|First Intervention (Cross-over Phase)|Adverse Event|1
2683249|NCT00500149|9258484|P1|First Intervention (Cross-over Phase)|Adverse Event|0
2683250|NCT00500149|9258483|P2|Enrolled (Dose-optimization Phase)|Protocol Violation|0
2683251|NCT00500149|9258484|P1|Enrolled (Dose-optimization Phase)|Protocol Violation|1
2683252|NCT00500149|9258483|P2|Enrolled (Dose-optimization Phase)|Adverse Event|0
2683253|NCT00500149|9258484|P1|Enrolled (Dose-optimization Phase)|Adverse Event|8
2683254|NCT00500149|9258483|P2|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0
2683255|NCT00500149|9258484|P1|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3
2683256|NCT00500110|9258492|P1|Overall Study|Withdrawal by Subject|3
2683257|NCT00500071|9258496|P1|30-day Safety Follow-up|Lost to Follow-up|17
2683258|NCT00500071|9258496|P1|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4
2683259|NCT00500071|9258496|P1|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1
2683260|NCT00500071|9258496|P1|Dose-optimization and Maintenance Phase|Lack of Efficacy|2
2683261|NCT00500071|9258496|P1|Dose-optimization and Maintenance Phase|Protocol Violation|2
2683262|NCT00500071|9258496|P1|Dose-optimization and Maintenance Phase|Adverse Event|13
2683263|NCT00500071|9258496|P1|Screening and Washout Phase|Protocol Violation|1
2683264|NCT00499889|9258519|P1|Overall Study|Infection prior to treatment|1
2683265|NCT00499863|9258527|P2|Overall Study|Lost to Follow-up|1
2683266|NCT00499863|9258528|P1|Overall Study|Lost to Follow-up|1
2683267|NCT00499863|9258527|P2|Overall Study|Sponsor decision|2
2683268|NCT00499863|9258528|P1|Overall Study|Sponsor decision|2
2683269|NCT00499863|9258527|P2|Overall Study|Adverse Event|2
2683270|NCT00499863|9258528|P1|Overall Study|Adverse Event|8
2683271|NCT00499863|9258527|P2|Overall Study|Withdrawal by Subject|4
2683272|NCT00499863|9258528|P1|Overall Study|Withdrawal by Subject|6
2683273|NCT00499863|9258527|P2|Overall Study|Protocol Violation|7
2683274|NCT00499863|9258528|P1|Overall Study|Protocol Violation|12
2683275|NCT00499863|9258527|P2|Overall Study|Lack of Efficacy|27
2683276|NCT00499863|9258528|P1|Overall Study|Lack of Efficacy|21
2683277|NCT00500266|9258556|P1|Overall Study|Assigned, not treated|4
2683278|NCT00500266|9258556|P1|Overall Study|Withdrawal by Subject|3
2683279|NCT00500266|9258556|P1|Overall Study|Lost to Follow-up|3
2683280|NCT00500266|9258556|P1|Overall Study|Death|3
2683281|NCT00499746|9258563|P1|Phase 1(6-9 One Day Sessions)|Unable to determine|1
2683282|NCT00499746|9258563|P1|Phase 1(6-9 One Day Sessions)|Investigator decision|1
2683283|NCT00499746|9258563|P1|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3
2683284|NCT00499746|9258563|P1|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7
2683285|NCT00499694|9258632|P1|Overall Study|Patient never received treatment.|1
2683286|NCT00499681|9258641|P2|Overall Study|disease progression|1
2683287|NCT00499681|9258642|P1|Overall Study|disease progression|0
2683288|NCT00499681|9258641|P2|Overall Study|toxicity|1
2683289|NCT00499681|9258642|P1|Overall Study|toxicity|0
2683290|NCT00499616|9258669|P4|Overall Study|Patient/Parent Refusal|0
2683291|NCT00499616|9258670|P3|Overall Study|Patient/Parent Refusal|3
2683292|NCT00499616|9258671|P2|Overall Study|Patient/Parent Refusal|5
2683293|NCT00499616|9258672|P1|Overall Study|Patient/Parent Refusal|1
2683294|NCT00499616|9258669|P4|Overall Study|Not evaluable|41
2683295|NCT00499616|9258670|P3|Overall Study|Not evaluable|0
2683296|NCT00499616|9258671|P2|Overall Study|Not evaluable|0
2683297|NCT00499616|9258672|P1|Overall Study|Not evaluable|0
2683298|NCT00499616|9258669|P4|Overall Study|Ineligible|15
2683299|NCT00499616|9258670|P3|Overall Study|Ineligible|0
2683300|NCT00499616|9258671|P2|Overall Study|Ineligible|2
2683301|NCT00499616|9258672|P1|Overall Study|Ineligible|1
2683302|NCT00499616|9258669|P4|Overall Study|Withdrawal by Subject|0
2683303|NCT00499616|9258670|P3|Overall Study|Withdrawal by Subject|1
2683304|NCT00499616|9258671|P2|Overall Study|Withdrawal by Subject|0
2683305|NCT00499616|9258672|P1|Overall Study|Withdrawal by Subject|1
2683306|NCT00499616|9258669|P4|Overall Study|Physician Decision|0
2683307|NCT00499616|9258670|P3|Overall Study|Physician Decision|9
2683308|NCT00499616|9258671|P2|Overall Study|Physician Decision|16
2683309|NCT00499616|9258672|P1|Overall Study|Physician Decision|6
2683310|NCT00499616|9258669|P4|Overall Study|Lost to Follow-up|0
2683311|NCT00499616|9258670|P3|Overall Study|Lost to Follow-up|1
2683312|NCT00499616|9258671|P2|Overall Study|Lost to Follow-up|0
2683313|NCT00499616|9258672|P1|Overall Study|Lost to Follow-up|0
2683314|NCT00499616|9258669|P4|Overall Study|Lack of Efficacy|0
2683315|NCT00499616|9258670|P3|Overall Study|Lack of Efficacy|19
2683316|NCT00499616|9258671|P2|Overall Study|Lack of Efficacy|0
2683317|NCT00499616|9258672|P1|Overall Study|Lack of Efficacy|5
2683318|NCT00499616|9258669|P4|Overall Study|Death|1
2683319|NCT00499616|9258670|P3|Overall Study|Death|3
2683320|NCT00499616|9258671|P2|Overall Study|Death|5
2683321|NCT00499616|9258672|P1|Overall Study|Death|1
2683322|NCT00499603|9258717|P2|Overall Study|Adverse Event|1
2683323|NCT00499603|9258718|P1|Overall Study|Adverse Event|0
2683324|NCT00499590|9258731|P3|Overall Study|Not treated|1
2683325|NCT00499590|9258732|P2|Overall Study|Not treated|0
2683326|NCT00499590|9258733|P1|Overall Study|Not treated|1
2683327|NCT00499590|9258731|P3|Overall Study|Study Terminated|112
2683328|NCT00499590|9258732|P2|Overall Study|Study Terminated|112
2683329|NCT00499590|9258733|P1|Overall Study|Study Terminated|112
2683330|NCT00499486|9258744|P1|Overall Study|Withdrawal by Subject|16
2683331|NCT00499460|9258771|P2|Intervention 2 (30 Days)|Withdrawal by Subject|1
2683332|NCT00499460|9258772|P1|Intervention 2 (30 Days)|Withdrawal by Subject|0
2683333|NCT00499460|9258771|P2|Intervention 1 (30 Days)|Fainting upon Blood Draw|0
2683334|NCT00499460|9258772|P1|Intervention 1 (30 Days)|Fainting upon Blood Draw|1
2683335|NCT00499460|9258771|P2|Intervention 1 (30 Days)|Withdrawal by Subject|0
2683336|NCT00499460|9258772|P1|Intervention 1 (30 Days)|Withdrawal by Subject|1
2683337|NCT00499369|9258805|P5|Overall Study|Ineligible|0
2683338|NCT00499369|9258806|P4|Overall Study|Ineligible|1
2683339|NCT00499369|9258807|P3|Overall Study|Ineligible|1
2683340|NCT00499369|9258808|P2|Overall Study|Ineligible|2
2683341|NCT00499369|9258809|P1|Overall Study|Ineligible|2
2683342|NCT00499369|9258805|P5|Overall Study|Not protocol specified|0
2683343|NCT00499369|9258806|P4|Overall Study|Not protocol specified|1
2683344|NCT00499369|9258807|P3|Overall Study|Not protocol specified|3
2683345|NCT00499369|9258808|P2|Overall Study|Not protocol specified|0
2683346|NCT00499369|9258809|P1|Overall Study|Not protocol specified|2
2683347|NCT00499369|9258805|P5|Overall Study|Death|0
2683348|NCT00499369|9258806|P4|Overall Study|Death|0
2683349|NCT00499369|9258807|P3|Overall Study|Death|0
2683350|NCT00499369|9258808|P2|Overall Study|Death|1
2683351|NCT00499369|9258809|P1|Overall Study|Death|0
2683352|NCT00499369|9258805|P5|Overall Study|Progression|10
2683353|NCT00499369|9258806|P4|Overall Study|Progression|6
2683354|NCT00499369|9258807|P3|Overall Study|Progression|9
2683355|NCT00499369|9258808|P2|Overall Study|Progression|12
2683356|NCT00499369|9258809|P1|Overall Study|Progression|10
2683357|NCT00499369|9258805|P5|Overall Study|Withdrawal by Subject|0
2683358|NCT00499369|9258806|P4|Overall Study|Withdrawal by Subject|0
2683359|NCT00499369|9258807|P3|Overall Study|Withdrawal by Subject|1
2683360|NCT00499369|9258808|P2|Overall Study|Withdrawal by Subject|1
2683361|NCT00499369|9258809|P1|Overall Study|Withdrawal by Subject|0
2683362|NCT00499369|9258805|P5|Overall Study|Adverse Event|2
2683363|NCT00499369|9258806|P4|Overall Study|Adverse Event|1
2683364|NCT00499369|9258807|P3|Overall Study|Adverse Event|3
2683365|NCT00499369|9258808|P2|Overall Study|Adverse Event|2
2683366|NCT00499369|9258809|P1|Overall Study|Adverse Event|2
2683367|NCT00499252|9258845|P1|Overall Study|<no further label>|3
2683368|NCT00499252|9258845|P1|Overall Study|Ineligible|4
2683369|NCT00499252|9258845|P1|Overall Study|Refused further treatment|2
2683370|NCT00499252|9258845|P1|Overall Study|Adverse Event|3
2683371|NCT00499122|9258855|P1|Overall Study|Withdrawal by Subject|2
2683372|NCT00499083|9258898|P1|Overall Study|Not evaluable|3
2683373|NCT00499031|9258905|P1|Overall Study|Never treated|1
2683374|NCT00499031|9258905|P1|Overall Study|Required test not done|1
2683375|NCT00499031|9258905|P1|Overall Study|Improper pre-protocol treatment|1
2683376|NCT00498797|9258928|P2|Overall Study|Other|1
2683377|NCT00498797|9258929|P1|Overall Study|Other|3
2683378|NCT00498797|9258928|P2|Overall Study|Condition under investigation worsened|21
2683379|NCT00498797|9258929|P1|Overall Study|Condition under investigation worsened|19
2683380|NCT00498797|9258928|P2|Overall Study|Adverse Event|5
2683381|NCT00498797|9258929|P1|Overall Study|Adverse Event|12
2683382|NCT00498797|9258928|P2|Overall Study|Withdrawal by Subject|2
2683383|NCT00498797|9258929|P1|Overall Study|Withdrawal by Subject|4
2683384|NCT00498602|9259013|P7|Overall Study|Other|0
2683385|NCT00498602|9259014|P6|Overall Study|Other|3
2683386|NCT00498602|9259015|P5|Overall Study|Other|0
2683387|NCT00498602|9259016|P4|Overall Study|Other|0
2683388|NCT00498602|9259017|P3|Overall Study|Other|1
2683389|NCT00498602|9259018|P2|Overall Study|Other|3
2683390|NCT00498602|9259019|P1|Overall Study|Other|2
2683391|NCT00498602|9259013|P7|Overall Study|Subject Request|1
2683392|NCT00498602|9259014|P6|Overall Study|Subject Request|4
2683393|NCT00498602|9259015|P5|Overall Study|Subject Request|1
2683394|NCT00498602|9259016|P4|Overall Study|Subject Request|1
2683395|NCT00498602|9259017|P3|Overall Study|Subject Request|1
2683396|NCT00498602|9259018|P2|Overall Study|Subject Request|0
2683397|NCT00498602|9259019|P1|Overall Study|Subject Request|3
2683398|NCT00498602|9259013|P7|Overall Study|Investigator Request|0
2683399|NCT00498602|9259014|P6|Overall Study|Investigator Request|0
2683400|NCT00498602|9259015|P5|Overall Study|Investigator Request|0
2683401|NCT00498602|9259016|P4|Overall Study|Investigator Request|0
2683402|NCT00498602|9259017|P3|Overall Study|Investigator Request|1
2683403|NCT00498602|9259018|P2|Overall Study|Investigator Request|0
2683404|NCT00498602|9259019|P1|Overall Study|Investigator Request|0
2683405|NCT00498602|9259013|P7|Overall Study|Caregiver Request|0
2683406|NCT00498602|9259014|P6|Overall Study|Caregiver Request|2
2683407|NCT00498602|9259015|P5|Overall Study|Caregiver Request|1
2683408|NCT00498602|9259016|P4|Overall Study|Caregiver Request|0
2683409|NCT00498602|9259017|P3|Overall Study|Caregiver Request|2
2683410|NCT00498602|9259018|P2|Overall Study|Caregiver Request|2
2683411|NCT00498602|9259019|P1|Overall Study|Caregiver Request|2
2683412|NCT00498602|9259013|P7|Overall Study|AE not related to Study Drug|1
2683413|NCT00498602|9259014|P6|Overall Study|AE not related to Study Drug|2
2683414|NCT00498602|9259015|P5|Overall Study|AE not related to Study Drug|2
2683415|NCT00498602|9259016|P4|Overall Study|AE not related to Study Drug|0
2683416|NCT00498602|9259017|P3|Overall Study|AE not related to Study Drug|0
2683417|NCT00498602|9259018|P2|Overall Study|AE not related to Study Drug|3
2683418|NCT00498602|9259019|P1|Overall Study|AE not related to Study Drug|1
2683419|NCT00498602|9259013|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
2683420|NCT00498602|9259014|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
2683421|NCT00498602|9259015|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
2683422|NCT00498602|9259016|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
2683423|NCT00498602|9259017|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
2683424|NCT00498602|9259018|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
2683425|NCT00498602|9259019|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
2683426|NCT00498602|9259013|P7|Overall Study|Lost to Follow-up|0
2683427|NCT00498602|9259014|P6|Overall Study|Lost to Follow-up|0
2683428|NCT00498602|9259015|P5|Overall Study|Lost to Follow-up|0
2683429|NCT00498602|9259016|P4|Overall Study|Lost to Follow-up|2
2683430|NCT00498602|9259017|P3|Overall Study|Lost to Follow-up|0
2683431|NCT00498602|9259018|P2|Overall Study|Lost to Follow-up|2
2683432|NCT00498602|9259019|P1|Overall Study|Lost to Follow-up|0
2683433|NCT00498602|9259013|P7|Overall Study|Lack of Efficacy|0
2683434|NCT00498602|9259014|P6|Overall Study|Lack of Efficacy|0
2683435|NCT00498602|9259015|P5|Overall Study|Lack of Efficacy|0
2683436|NCT00498602|9259016|P4|Overall Study|Lack of Efficacy|0
2683437|NCT00498602|9259017|P3|Overall Study|Lack of Efficacy|0
2683438|NCT00498602|9259018|P2|Overall Study|Lack of Efficacy|0
2683439|NCT00498602|9259019|P1|Overall Study|Lack of Efficacy|1
2683440|NCT00498602|9259013|P7|Overall Study|Death|0
2683441|NCT00498602|9259014|P6|Overall Study|Death|1
2683442|NCT00498602|9259015|P5|Overall Study|Death|0
2683443|NCT00498602|9259016|P4|Overall Study|Death|0
2683444|NCT00498602|9259017|P3|Overall Study|Death|0
2683445|NCT00498602|9259018|P2|Overall Study|Death|0
2683446|NCT00498602|9259019|P1|Overall Study|Death|0
2683447|NCT00498485|9259067|P2|Overall Study|Adverse Event|5
2683448|NCT00498485|9259068|P1|Overall Study|Adverse Event|1
2683449|NCT00498433|9259079|P3|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
2683450|NCT00498433|9259080|P2|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
2683451|NCT00498433|9259081|P1|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1
2683452|NCT00498433|9259079|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
2683453|NCT00498433|9259080|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
2683454|NCT00498433|9259081|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15
2683455|NCT00498433|9259079|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
2683456|NCT00498433|9259080|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
2683457|NCT00498433|9259081|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2
2683458|NCT00498433|9259079|P3|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
2683459|NCT00498433|9259080|P2|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
2683460|NCT00498433|9259081|P1|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2
2683461|NCT00498368|9259126|P2|Overall Study|Withdrawal by Subject|2
2683462|NCT00498368|9259127|P1|Overall Study|Withdrawal by Subject|3
2683463|NCT00498355|9259139|P1|Overall Study|Lost to Follow-up|1
2683464|NCT00498186|9259147|P1|Overall Study|Other|10
2683465|NCT00498186|9259147|P1|Overall Study|Lost to Follow-up|3
2683466|NCT00498186|9259147|P1|Overall Study|Withdrawal by Subject|18
2683467|NCT00498186|9259147|P1|Overall Study|Unsatisfactory compliance of subject|12
2683468|NCT00498186|9259147|P1|Overall Study|Adverse Event|89
2683469|NCT00498186|9259147|P1|Overall Study|Lack of Efficacy|31
2683470|NCT00498186|9259147|P1|Overall Study|Protocol Violation|10
2683471|NCT00498173|9259154|P3|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0
2683472|NCT00498173|9259155|P2|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1
2683473|NCT00498173|9259156|P1|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2
2683474|NCT00497874|9259186|P2|Overall Study|Unable to schedule|24
2683475|NCT00497874|9259187|P1|Overall Study|Unable to schedule|37
2683476|NCT00497874|9259186|P2|Overall Study|Unable to contact|67
2683477|NCT00497874|9259187|P1|Overall Study|Unable to contact|52
2683478|NCT00497874|9259186|P2|Overall Study|Death|4
2683479|NCT00497874|9259187|P1|Overall Study|Death|2
2683480|NCT00497874|9259186|P2|Overall Study|Illness|4
2683481|NCT00497874|9259187|P1|Overall Study|Illness|8
2683482|NCT00497874|9259186|P2|Overall Study|Withdrawal by Subject|17
2683483|NCT00497874|9259187|P1|Overall Study|Withdrawal by Subject|48
2683484|NCT00497796|9259205|P2|Overall Study|Not applicable (randomized not treated)|4
2683485|NCT00497796|9259206|P1|Overall Study|Not applicable (randomized not treated)|0
2683486|NCT00497796|9259205|P2|Overall Study|Lost to Follow-up|1
2683487|NCT00497796|9259206|P1|Overall Study|Lost to Follow-up|0
2683488|NCT00497796|9259205|P2|Overall Study|Investigator/sponsor discretion|34
2683489|NCT00497796|9259206|P1|Overall Study|Investigator/sponsor discretion|31
2683490|NCT00497796|9259205|P2|Overall Study|Consent withdrawn|3
2683491|NCT00497796|9259206|P1|Overall Study|Consent withdrawn|10
2683492|NCT00497796|9259205|P2|Overall Study|CMV infection or disease treatment|4
2683493|NCT00497796|9259206|P1|Overall Study|CMV infection or disease treatment|30
2683494|NCT00497796|9259205|P2|Overall Study|Adverse event (related)|4
2683495|NCT00497796|9259206|P1|Overall Study|Adverse event (related)|5
2683496|NCT00497796|9259205|P2|Overall Study|Adverse event (not related)|9
2683497|NCT00497796|9259206|P1|Overall Study|Adverse event (not related)|9
2683498|NCT00497198|9259293|P2|Overall Study|Withdrawal by Subject|1
2683499|NCT00497198|9259294|P1|Overall Study|Withdrawal by Subject|0
2683500|NCT00497198|9259293|P2|Overall Study|Physician Decision|2
2683501|NCT00497198|9259294|P1|Overall Study|Physician Decision|1
2683502|NCT00497198|9259293|P2|Overall Study|Adverse Event|2
2683503|NCT00497198|9259294|P1|Overall Study|Adverse Event|4
2683504|NCT00497146|9259310|P2|Long-term Follow-up Period|Other|1
2683505|NCT00497146|9259311|P1|Long-term Follow-up Period|Other|0
2683506|NCT00497146|9259310|P2|Long-term Follow-up Period|Lost to Follow-up|1
2683507|NCT00497146|9259311|P1|Long-term Follow-up Period|Lost to Follow-up|5
2683508|NCT00497146|9259310|P2|Long-term Follow-up Period|Withdrawal by Subject|2
2683509|NCT00497146|9259311|P1|Long-term Follow-up Period|Withdrawal by Subject|8
2683510|NCT00497146|9259310|P2|Long-term Follow-up Period|Adverse Event|2
2683511|NCT00497146|9259311|P1|Long-term Follow-up Period|Adverse Event|2
2683512|NCT00497146|9259310|P2|Treatment Period|Other Reason|3
2683513|NCT00497146|9259311|P1|Treatment Period|Other Reason|2
2683514|NCT00497146|9259310|P2|Treatment Period|Unable to dose reduce per protocol|1
2683515|NCT00497146|9259311|P1|Treatment Period|Unable to dose reduce per protocol|4
2683516|NCT00497146|9259310|P2|Treatment Period|Change in RAAS inhibitor therapy|2
2683517|NCT00497146|9259311|P1|Treatment Period|Change in RAAS inhibitor therapy|5
2683518|NCT00497146|9259310|P2|Treatment Period|Required dialysis|1
2683519|NCT00497146|9259311|P1|Treatment Period|Required dialysis|4
2683520|NCT00497146|9259310|P2|Treatment Period|Lost to Follow-up|3
2683521|NCT00497146|9259311|P1|Treatment Period|Lost to Follow-up|1
2683522|NCT00497146|9259310|P2|Treatment Period|Withdrawal by Subject|9
2683523|NCT00497146|9259311|P1|Treatment Period|Withdrawal by Subject|5
2683524|NCT00497146|9259310|P2|Treatment Period|Adverse Event|2
2683525|NCT00497146|9259311|P1|Treatment Period|Adverse Event|6
2683526|NCT00496964|9259379|P2|Overall Study|Withdrawal by Subject|1
2683527|NCT00496964|9259380|P1|Overall Study|Withdrawal by Subject|0
2683528|NCT00496873|9259398|P1|Overall Study|Withdrawal by Subject|3
2683529|NCT00496873|9259398|P1|Overall Study|Death|2
2683530|NCT00496873|9259398|P1|Overall Study|Ineligible|2
2683531|NCT00496834|9259431|P2|Overall Study|Blood Pressure control failure|1
2683532|NCT00496834|9259432|P1|Overall Study|Blood Pressure control failure|2
2683533|NCT00496834|9259431|P2|Overall Study|Lost to Follow-up|0
2683534|NCT00496834|9259432|P1|Overall Study|Lost to Follow-up|2
2683535|NCT00496834|9259431|P2|Overall Study|IP administration violation|0
2683536|NCT00496834|9259432|P1|Overall Study|IP administration violation|2
2683537|NCT00496834|9259431|P2|Overall Study|Adverse Event|3
2683538|NCT00496834|9259432|P1|Overall Study|Adverse Event|5
2683539|NCT00496834|9259431|P2|Overall Study|Inclusion/exclusion criteria not met|2
2683540|NCT00496834|9259432|P1|Overall Study|Inclusion/exclusion criteria not met|3
2683541|NCT00496834|9259431|P2|Overall Study|Contraindicated medication administered|1
2683542|NCT00496834|9259432|P1|Overall Study|Contraindicated medication administered|0
2683543|NCT00496834|9259431|P2|Overall Study|Withdrawal by Subject|6
2683544|NCT00496834|9259432|P1|Overall Study|Withdrawal by Subject|4
2683545|NCT00496782|9259451|P2|Overall Study|Protocol Violation|2
2683546|NCT00496782|9259452|P1|Overall Study|Protocol Violation|1
2683547|NCT00496769|9259486|P3|Open Label|>=1 reason assigned per patient|1011
2683548|NCT00496769|9259487|P2|Open Label|>=1 reason assigned per patient|0
2683549|NCT00496769|9259488|P1|Open Label|>=1 reason assigned per patient|0
2683550|NCT00496769|9259486|P3|Double Blind|>=1 reason assigned per patient|0
2683551|NCT00496769|9259487|P2|Double Blind|>=1 reason assigned per patient|649
2683552|NCT00496769|9259488|P1|Double Blind|>=1 reason assigned per patient|558
2683553|NCT00496730|9259518|P2|Overall Study|Withdrawal by Subject|2
2683554|NCT00496730|9259519|P1|Overall Study|Withdrawal by Subject|2
2683555|NCT00496730|9259518|P2|Overall Study|Lost to Follow-up|3
2683556|NCT00496730|9259519|P1|Overall Study|Lost to Follow-up|4
2683557|NCT00496626|9259531|P2|Overall Study|Relocated|1
2683558|NCT00496626|9259532|P1|Overall Study|Relocated|0
2683559|NCT00496626|9259531|P2|Overall Study|Withdrawal by Subject|4
2683560|NCT00496626|9259532|P1|Overall Study|Withdrawal by Subject|5
2683561|NCT00496626|9259531|P2|Overall Study|Protocol Violation|0
2683562|NCT00496626|9259532|P1|Overall Study|Protocol Violation|1
2683563|NCT00496626|9259531|P2|Overall Study|Lost to Follow-up|1
2683564|NCT00496626|9259532|P1|Overall Study|Lost to Follow-up|0
2683565|NCT00496587|9259544|P1|Overall Study|Complications unrelated|2
2683566|NCT00496587|9259544|P1|Overall Study|Death|1
2683567|NCT00496587|9259544|P1|Overall Study|Withdrawal by Subject|2
2683568|NCT00496587|9259544|P1|Overall Study|Progressive Disease|24
2683569|NCT00496587|9259544|P1|Overall Study|Adverse Event|2
2683570|NCT00496483|9259550|P1|Overall Study|Lack of Efficacy|1
2683571|NCT00496483|9259550|P1|Overall Study|Adverse Event|2
2683572|NCT00496483|9259550|P1|Overall Study|Not dosed|9
2683573|NCT00496470|9259567|P2|Overall Study|Other reason|2
2683574|NCT00496470|9259568|P1|Overall Study|Other reason|0
2683575|NCT00496470|9259567|P2|Overall Study|Incorrectly enrolled|5
2683576|NCT00496470|9259568|P1|Overall Study|Incorrectly enrolled|13
2683577|NCT00496470|9259567|P2|Overall Study|Withdrawal by Subject|12
2683578|NCT00496470|9259568|P1|Overall Study|Withdrawal by Subject|5
2683579|NCT00496470|9259567|P2|Overall Study|Adverse Event|10
2683580|NCT00496470|9259568|P1|Overall Study|Adverse Event|8
2683581|NCT00496366|9259654|P1|Overall Study|Death|1
2683582|NCT00496197|9259685|P1|Overall Study|Protocol Violation|8
2683583|NCT00496197|9259685|P1|Overall Study|Other|14
2683584|NCT00496197|9259685|P1|Overall Study|Pathogen not isolated baseline specimen|4
2683585|NCT00496197|9259685|P1|Overall Study|Withdrawal by Subject|11
2683586|NCT00496197|9259685|P1|Overall Study|Lost to Follow-up|11
2683587|NCT00496197|9259685|P1|Overall Study|Insufficient bacteriological response|10
2683588|NCT00496197|9259685|P1|Overall Study|Insufficient clinical response|3
2683589|NCT00496197|9259685|P1|Overall Study|Does not meet entrance criteria|5
2683590|NCT00496197|9259685|P1|Overall Study|Adverse Event|13
2683591|NCT00496197|9259685|P1|Overall Study|Discontinued study due to death|43
2683592|NCT00496080|9259712|P1|Overall Study|Physician Decision|6
2683593|NCT00496080|9259712|P1|Overall Study|Withdrawal by Subject|5
2683594|NCT00496080|9259712|P1|Overall Study|Surgical re-intervention|7
2683595|NCT00496080|9259712|P1|Overall Study|Lost to Follow-up|9
2683596|NCT00496054|9259722|P1|Overall Study|Lost to Follow-up|7
2683597|NCT00496054|9259722|P1|Overall Study|Adverse Event|1
2683598|NCT00496015|9259754|P5|Overall Study|Other|0
2683599|NCT00496015|9259755|P4|Overall Study|Other|1
2683600|NCT00496015|9259756|P3|Overall Study|Other|0
2683601|NCT00496015|9259757|P2|Overall Study|Other|0
2683602|NCT00496015|9259758|P1|Overall Study|Other|1
2683603|NCT00495820|9259882|P2|Overall Study|Adverse Event|1
2683604|NCT00495820|9259883|P1|Overall Study|Adverse Event|1
2683605|NCT00495794|9259895|P2|Overall Study|Pharmacist did not activate patient|0
2683606|NCT00495794|9259896|P1|Overall Study|Pharmacist did not activate patient|522
2683607|NCT00495755|9259906|P1|Overall Study|Adverse Event|3
2683608|NCT00495677|9259927|P7|Stage 1 (25 Days)|Adverse Event|0
2683609|NCT00495677|9259928|P6|Stage 1 (25 Days)|Adverse Event|0
2683610|NCT00495677|9259929|P5|Stage 1 (25 Days)|Adverse Event|0
2683611|NCT00495677|9259930|P4|Stage 1 (25 Days)|Adverse Event|0
2683612|NCT00495677|9259931|P3|Stage 1 (25 Days)|Adverse Event|1
2683613|NCT00495677|9259932|P2|Stage 1 (25 Days)|Adverse Event|0
2683614|NCT00495677|9259933|P1|Stage 1 (25 Days)|Adverse Event|0
2683615|NCT00495625|9259988|P1|Overall Study|Did not complete at least 1 42 day cycle|10
2683616|NCT00495612|9259999|P2|Overall Study|Subject's Decision to Withdraw|0
2683617|NCT00495612|9260000|P1|Overall Study|Subject's Decision to Withdraw|3
2683618|NCT00495612|9259999|P2|Overall Study|Lost to Follow-up|0
2683619|NCT00495612|9260000|P1|Overall Study|Lost to Follow-up|1
2683620|NCT00495586|9260018|P2|Overall Study|Withdrawal by Subject|4
2683621|NCT00495586|9260019|P1|Overall Study|Withdrawal by Subject|4
2683622|NCT00495521|9260029|P2|Overall Study|Physician Decision|1
2683623|NCT00495521|9260030|P1|Overall Study|Physician Decision|0
2683624|NCT00495495|9260060|P1|Overall Study|Protocol Violation|99
2683625|NCT00495469|9260080|P7|Overall Study|ST depression at randomisation in ECG|0
2683626|NCT00495469|9260081|P6|Overall Study|ST depression at randomisation in ECG|0
2683627|NCT00495469|9260082|P5|Overall Study|ST depression at randomisation in ECG|0
2683628|NCT00495469|9260083|P4|Overall Study|ST depression at randomisation in ECG|0
2683629|NCT00495469|9260084|P3|Overall Study|ST depression at randomisation in ECG|0
2683630|NCT00495469|9260085|P2|Overall Study|ST depression at randomisation in ECG|1
2683631|NCT00495469|9260086|P1|Overall Study|ST depression at randomisation in ECG|0
2683632|NCT00495469|9260080|P7|Overall Study|Liver function test abnormality|0
2683633|NCT00495469|9260081|P6|Overall Study|Liver function test abnormality|0
2683634|NCT00495469|9260082|P5|Overall Study|Liver function test abnormality|0
2683635|NCT00495469|9260083|P4|Overall Study|Liver function test abnormality|0
2683636|NCT00495469|9260084|P3|Overall Study|Liver function test abnormality|0
2683637|NCT00495469|9260085|P2|Overall Study|Liver function test abnormality|1
2683638|NCT00495469|9260086|P1|Overall Study|Liver function test abnormality|0
2683639|NCT00495469|9260080|P7|Overall Study|Lack of Efficacy|1
2683640|NCT00495469|9260081|P6|Overall Study|Lack of Efficacy|0
2683641|NCT00495469|9260082|P5|Overall Study|Lack of Efficacy|0
2683642|NCT00495469|9260083|P4|Overall Study|Lack of Efficacy|0
2683643|NCT00495469|9260084|P3|Overall Study|Lack of Efficacy|0
2683644|NCT00495469|9260085|P2|Overall Study|Lack of Efficacy|0
2683645|NCT00495469|9260086|P1|Overall Study|Lack of Efficacy|0
2683646|NCT00495469|9260080|P7|Overall Study|Withdrawal by Subject|3
2683647|NCT00495469|9260081|P6|Overall Study|Withdrawal by Subject|2
2683648|NCT00495469|9260082|P5|Overall Study|Withdrawal by Subject|3
2683649|NCT00495469|9260083|P4|Overall Study|Withdrawal by Subject|3
2683650|NCT00495469|9260084|P3|Overall Study|Withdrawal by Subject|1
2683651|NCT00495469|9260085|P2|Overall Study|Withdrawal by Subject|3
2683652|NCT00495469|9260086|P1|Overall Study|Withdrawal by Subject|5
2683653|NCT00495469|9260080|P7|Overall Study|Protocol Violation|0
2683654|NCT00495469|9260081|P6|Overall Study|Protocol Violation|2
2683655|NCT00495469|9260082|P5|Overall Study|Protocol Violation|1
2683656|NCT00495469|9260083|P4|Overall Study|Protocol Violation|0
2683657|NCT00495469|9260084|P3|Overall Study|Protocol Violation|0
2683658|NCT00495469|9260085|P2|Overall Study|Protocol Violation|0
2683659|NCT00495469|9260086|P1|Overall Study|Protocol Violation|0
2683660|NCT00495469|9260080|P7|Overall Study|Lost to Follow-up|0
2683661|NCT00495469|9260081|P6|Overall Study|Lost to Follow-up|0
2683662|NCT00495469|9260082|P5|Overall Study|Lost to Follow-up|0
2683663|NCT00495469|9260083|P4|Overall Study|Lost to Follow-up|1
2683664|NCT00495469|9260084|P3|Overall Study|Lost to Follow-up|3
2683665|NCT00495469|9260085|P2|Overall Study|Lost to Follow-up|1
2683666|NCT00495469|9260086|P1|Overall Study|Lost to Follow-up|1
2683667|NCT00495469|9260080|P7|Overall Study|Adverse Event|1
2683668|NCT00495469|9260081|P6|Overall Study|Adverse Event|1
2683669|NCT00495469|9260082|P5|Overall Study|Adverse Event|1
2683670|NCT00495469|9260083|P4|Overall Study|Adverse Event|0
2683671|NCT00495469|9260084|P3|Overall Study|Adverse Event|3
2683672|NCT00495469|9260085|P2|Overall Study|Adverse Event|1
2683673|NCT00495469|9260086|P1|Overall Study|Adverse Event|0
2683674|NCT00495391|9260230|P2|Overall Study|Withdrawal by Subject|3
2683675|NCT00495391|9260231|P1|Overall Study|Withdrawal by Subject|2
2683676|NCT00495391|9260230|P2|Overall Study|Lack of Efficacy|18
2683677|NCT00495391|9260231|P1|Overall Study|Lack of Efficacy|34
2683678|NCT00495170|9260254|P1|Overall Study|Inappropriate staging|8
2683679|NCT00495170|9260254|P1|Overall Study|Withdrawal by Subject|3
2683680|NCT00495170|9260254|P1|Overall Study|Lost to Follow-up|9
2683681|NCT00495131|9260273|P2|Overall Study|Withdrawal by Subject|0
2683682|NCT00495131|9260274|P1|Overall Study|Withdrawal by Subject|1
2683683|NCT00495131|9260273|P2|Overall Study|Lost to Follow-up|2
2683684|NCT00495131|9260274|P1|Overall Study|Lost to Follow-up|0
2683685|NCT00495131|9260273|P2|Overall Study|Lack of Efficacy|2
2683686|NCT00495131|9260274|P1|Overall Study|Lack of Efficacy|0
2683687|NCT00495131|9260273|P2|Overall Study|Adverse Event|2
2683688|NCT00495131|9260274|P1|Overall Study|Adverse Event|6
2683689|NCT00495040|9260291|P1|Overall Study|Withdrawal by Subject|3
2683690|NCT00494871|9260306|P2|Follow-up (FU) Period|Clinical Endpoint Reached|2
2683691|NCT00494871|9260307|P1|Follow-up (FU) Period|Clinical Endpoint Reached|3
2683692|NCT00494871|9260306|P2|Follow-up (FU) Period|Withdrawal by Subject|5
2683693|NCT00494871|9260307|P1|Follow-up (FU) Period|Withdrawal by Subject|5
2683694|NCT00494871|9260306|P2|Follow-up (FU) Period|Protocol Violation|0
2683695|NCT00494871|9260307|P1|Follow-up (FU) Period|Protocol Violation|1
2683696|NCT00494871|9260306|P2|Follow-up (FU) Period|Physician Decision|1
2683697|NCT00494871|9260307|P1|Follow-up (FU) Period|Physician Decision|0
2683698|NCT00494871|9260306|P2|Follow-up (FU) Period|Lost to Follow-up|2
2683699|NCT00494871|9260307|P1|Follow-up (FU) Period|Lost to Follow-up|6
2683700|NCT00494871|9260306|P2|Follow-up (FU) Period|Death|12
2683701|NCT00494871|9260307|P1|Follow-up (FU) Period|Death|13
2683702|NCT00494871|9260306|P2|Follow-up (FU) Period|Adverse Event|1
2683703|NCT00494871|9260307|P1|Follow-up (FU) Period|Adverse Event|1
2683704|NCT00494871|9260306|P2|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
2683705|NCT00494871|9260307|P1|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
2683706|NCT00494871|9260306|P2|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
2683707|NCT00494871|9260307|P1|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
2683708|NCT00494871|9260306|P2|Double-blind (DB) Treatment Period|Site Closed by Investigator|2
2683709|NCT00494871|9260307|P1|Double-blind (DB) Treatment Period|Site Closed by Investigator|1
2683710|NCT00494871|9260306|P2|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8
2683711|NCT00494871|9260307|P1|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12
2683712|NCT00494871|9260306|P2|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1
2683713|NCT00494871|9260307|P1|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3
2683714|NCT00494871|9260306|P2|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28
2683715|NCT00494871|9260307|P1|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18
2683716|NCT00494871|9260306|P2|Double-blind (DB) Treatment Period|Protocol Violation|9
2683717|NCT00494871|9260307|P1|Double-blind (DB) Treatment Period|Protocol Violation|9
2683718|NCT00494871|9260306|P2|Double-blind (DB) Treatment Period|Lost to Follow-up|1
2683719|NCT00494871|9260307|P1|Double-blind (DB) Treatment Period|Lost to Follow-up|4
2683720|NCT00494871|9260306|P2|Double-blind (DB) Treatment Period|Physician Decision|13
2683721|NCT00494871|9260307|P1|Double-blind (DB) Treatment Period|Physician Decision|4
2683722|NCT00494871|9260306|P2|Double-blind (DB) Treatment Period|Death|3
2683723|NCT00494871|9260307|P1|Double-blind (DB) Treatment Period|Death|8
2683724|NCT00494871|9260306|P2|Double-blind (DB) Treatment Period|Withdrawal by Subject|35
2683725|NCT00494871|9260307|P1|Double-blind (DB) Treatment Period|Withdrawal by Subject|26
2683726|NCT00494871|9260306|P2|Double-blind (DB) Treatment Period|Adverse Event|70
2683727|NCT00494871|9260307|P1|Double-blind (DB) Treatment Period|Adverse Event|73
2683728|NCT00494780|9260348|P2|Overall Study|Insurance Issues|1
2683729|NCT00494780|9260349|P1|Overall Study|Insurance Issues|0
2683730|NCT00494780|9260348|P2|Overall Study|Residual Tumour Mass|1
2683731|NCT00494780|9260349|P1|Overall Study|Residual Tumour Mass|0
2683732|NCT00494780|9260348|P2|Overall Study|Non-compliance|0
2683733|NCT00494780|9260349|P1|Overall Study|Non-compliance|1
2683734|NCT00494780|9260348|P2|Overall Study|New Treatment|2
2683735|NCT00494780|9260349|P1|Overall Study|New Treatment|2
2683736|NCT00494780|9260348|P2|Overall Study|Progression of Study Disease|8
2683737|NCT00494780|9260349|P1|Overall Study|Progression of Study Disease|7
2683738|NCT00494780|9260348|P2|Overall Study|Withdrew before Dosed|1
2683739|NCT00494780|9260349|P1|Overall Study|Withdrew before Dosed|0
2683740|NCT00494780|9260348|P2|Overall Study|Adverse Event|0
2683741|NCT00494780|9260349|P1|Overall Study|Adverse Event|1
2683742|NCT00494676|9260387|P2|Second Intervention|Withdrawal by Subject|1
2683743|NCT00494676|9260388|P1|Second Intervention|Withdrawal by Subject|1
2683744|NCT00494676|9260387|P2|First Intervention|Withdrawal by Subject|3
2683745|NCT00494676|9260388|P1|First Intervention|Withdrawal by Subject|1
2683746|NCT00494676|9260387|P2|Allocation|Withdrawal by Subject|4
2683747|NCT00494676|9260388|P1|Allocation|Withdrawal by Subject|2
2683748|NCT00494507|9260403|P4|Open-Label Phase|Worsening Disease|2
2683749|NCT00494507|9260404|P3|Open-Label Phase|Worsening Disease|0
2683750|NCT00494507|9260405|P2|Open-Label Phase|Worsening Disease|0
2683751|NCT00494507|9260406|P1|Open-Label Phase|Worsening Disease|0
2683752|NCT00494507|9260403|P4|Open-Label Phase|Adverse Event|3
2683753|NCT00494507|9260404|P3|Open-Label Phase|Adverse Event|5
2683754|NCT00494507|9260405|P2|Open-Label Phase|Adverse Event|1
2683755|NCT00494507|9260406|P1|Open-Label Phase|Adverse Event|0
2683756|NCT00494507|9260403|P4|Double-Blind Phase|Negative DNA test|1
2683757|NCT00494507|9260404|P3|Double-Blind Phase|Negative DNA test|0
2683758|NCT00494507|9260405|P2|Double-Blind Phase|Negative DNA test|0
2683759|NCT00494507|9260406|P1|Double-Blind Phase|Negative DNA test|0
2683760|NCT00494507|9260403|P4|Double-Blind Phase|Subject Non-compliance|0
2683761|NCT00494507|9260404|P3|Double-Blind Phase|Subject Non-compliance|1
2683762|NCT00494507|9260405|P2|Double-Blind Phase|Subject Non-compliance|0
2683763|NCT00494507|9260406|P1|Double-Blind Phase|Subject Non-compliance|0
2683764|NCT00494507|9260403|P4|Double-Blind Phase|Withdrawal by Subject|0
2683765|NCT00494507|9260404|P3|Double-Blind Phase|Withdrawal by Subject|0
2683766|NCT00494507|9260405|P2|Double-Blind Phase|Withdrawal by Subject|0
2683767|NCT00494507|9260406|P1|Double-Blind Phase|Withdrawal by Subject|1
2683768|NCT00494507|9260403|P4|Double-Blind Phase|Adverse Event|0
2683769|NCT00494507|9260404|P3|Double-Blind Phase|Adverse Event|1
2683770|NCT00494507|9260405|P2|Double-Blind Phase|Adverse Event|0
2683771|NCT00494507|9260406|P1|Double-Blind Phase|Adverse Event|2
2683772|NCT00494481|9260473|P2|Overall Study|Never received IP|0
2683773|NCT00494481|9260474|P1|Overall Study|Never received IP|2
2683774|NCT00494481|9260473|P2|Overall Study|Other|0
2683775|NCT00494481|9260474|P1|Overall Study|Other|1
2683776|NCT00494481|9260473|P2|Overall Study|Adverse Event|11
2683777|NCT00494481|9260474|P1|Overall Study|Adverse Event|15
2683778|NCT00494481|9260473|P2|Overall Study|Condition under investigation worsened|13
2683779|NCT00494481|9260474|P1|Overall Study|Condition under investigation worsened|11
2683780|NCT00494442|9260482|P2|Overall Study|Intercurrent illness|1
2683781|NCT00494442|9260483|P1|Overall Study|Intercurrent illness|0
2683782|NCT00494442|9260482|P2|Overall Study|Non-compliance|1
2683783|NCT00494442|9260483|P1|Overall Study|Non-compliance|0
2683784|NCT00494442|9260482|P2|Overall Study|Physician Decision|1
2683785|NCT00494442|9260483|P1|Overall Study|Physician Decision|0
2683786|NCT00494442|9260482|P2|Overall Study|Adverse Event|2
2683787|NCT00494442|9260483|P1|Overall Study|Adverse Event|0
2683788|NCT00494442|9260482|P2|Overall Study|Lack of Efficacy|10
2683789|NCT00494442|9260483|P1|Overall Study|Lack of Efficacy|16
2683790|NCT00494442|9260482|P2|Overall Study|Death|1
2683791|NCT00494442|9260483|P1|Overall Study|Death|1
2683792|NCT00494299|9260499|P2|Overall Study|Protocol Driven Decision Point|22
2683793|NCT00494299|9260500|P1|Overall Study|Protocol Driven Decision Point|11
2683794|NCT00494299|9260499|P2|Overall Study|Site Closed by Sponsor|0
2683795|NCT00494299|9260500|P1|Overall Study|Site Closed by Sponsor|6
2683796|NCT00494299|9260499|P2|Overall Study|Participant Did Not Take Study Drug|2
2683797|NCT00494299|9260500|P1|Overall Study|Participant Did Not Take Study Drug|0
2683798|NCT00494299|9260499|P2|Overall Study|Disease Progression, Recurrence/Relapse|185
2683799|NCT00494299|9260500|P1|Overall Study|Disease Progression, Recurrence/Relapse|109
2683800|NCT00494299|9260499|P2|Overall Study|Withdrawal by Subject|3
2683801|NCT00494299|9260500|P1|Overall Study|Withdrawal by Subject|8
2683802|NCT00494299|9260499|P2|Overall Study|Protocol Violation|2
2683803|NCT00494299|9260500|P1|Overall Study|Protocol Violation|1
2683804|NCT00494299|9260499|P2|Overall Study|Physician Decision|2
2683805|NCT00494299|9260500|P1|Overall Study|Physician Decision|0
2683806|NCT00494299|9260499|P2|Overall Study|Lost to Follow-up|0
2683807|NCT00494299|9260500|P1|Overall Study|Lost to Follow-up|1
2683808|NCT00494299|9260499|P2|Overall Study|Adverse Event|13
2683809|NCT00494299|9260500|P1|Overall Study|Adverse Event|93
2683810|NCT00494234|9260512|P2|Overall Study|Death|1
2683811|NCT00494234|9260513|P1|Overall Study|Death|2
2683812|NCT00494234|9260512|P2|Overall Study|Withdrawal by Subject|0
2683813|NCT00494234|9260513|P1|Overall Study|Withdrawal by Subject|1
2683814|NCT00494234|9260512|P2|Overall Study|Lack of Efficacy|9
2683815|NCT00494234|9260513|P1|Overall Study|Lack of Efficacy|12
2683816|NCT00494221|9260532|P3|Overall Study|Withdrawal by Subject|0
2683817|NCT00494221|9260533|P2|Overall Study|Withdrawal by Subject|2
2683818|NCT00494221|9260534|P1|Overall Study|Withdrawal by Subject|1
2683819|NCT00494221|9260532|P3|Overall Study|Death|14
2683820|NCT00494221|9260533|P2|Overall Study|Death|9
2683821|NCT00494221|9260534|P1|Overall Study|Death|15
2683822|NCT00494091|9260575|P2|Overall Study|Withdrawal by Subject|7
2683823|NCT00494091|9260576|P1|Overall Study|Withdrawal by Subject|0
2683824|NCT00494091|9260575|P2|Overall Study|Other|11
2683825|NCT00494091|9260576|P1|Overall Study|Other|1
2683826|NCT00494091|9260575|P2|Overall Study|Lost to Follow-up|4
2683827|NCT00494091|9260576|P1|Overall Study|Lost to Follow-up|0
2683828|NCT00494091|9260575|P2|Overall Study|Death|54
2683829|NCT00494091|9260576|P1|Overall Study|Death|5
2683830|NCT00494026|9260598|P1|Overall Study|Sponsor Decision|4
2683831|NCT00494013|9260608|P2|Overall Study|Sponsor Decision|1
2683832|NCT00494013|9260609|P1|Overall Study|Sponsor Decision|0
2683833|NCT00494013|9260608|P2|Overall Study|Withdrawal by Subject|14
2683834|NCT00494013|9260609|P1|Overall Study|Withdrawal by Subject|13
2683835|NCT00494013|9260608|P2|Overall Study|Protocol Violation|5
2683836|NCT00494013|9260609|P1|Overall Study|Protocol Violation|8
2683837|NCT00494013|9260608|P2|Overall Study|Physician Decision|5
2683838|NCT00494013|9260609|P1|Overall Study|Physician Decision|3
2683839|NCT00494013|9260608|P2|Overall Study|Lost to Follow-up|6
2683840|NCT00494013|9260609|P1|Overall Study|Lost to Follow-up|5
2683841|NCT00494013|9260608|P2|Overall Study|Entry Criteria Not Met|4
2683842|NCT00494013|9260609|P1|Overall Study|Entry Criteria Not Met|1
2683843|NCT00494013|9260608|P2|Overall Study|Adverse Event|1
2683844|NCT00494013|9260609|P1|Overall Study|Adverse Event|0
2683845|NCT00493974|9260639|P2|Overall Study|Lost to Follow-up|6
2683846|NCT00493974|9260640|P1|Overall Study|Lost to Follow-up|4
2683847|NCT00493974|9260639|P2|Overall Study|Withdrawal by Subject|6
2683848|NCT00493974|9260640|P1|Overall Study|Withdrawal by Subject|8
2683849|NCT00493974|9260639|P2|Overall Study|Death|2
2683850|NCT00493974|9260640|P1|Overall Study|Death|1
2683851|NCT00493779|9260667|P1|Overall Study|Logistical issue at site|1
2683852|NCT00493649|9260674|P1|Overall Study|Other|13
2683853|NCT00493649|9260674|P1|Overall Study|Lost to Follow-up|1
2683854|NCT00493649|9260674|P1|Overall Study|Disease Progression|1
2683855|NCT00493649|9260674|P1|Overall Study|Investigator Request|2
2683856|NCT00493649|9260674|P1|Overall Study|Patient Request|21
2683857|NCT00493649|9260674|P1|Overall Study|Adverse Event|44
2683858|NCT00493636|9260687|P2|Overall Study|Mis-randomization|1
2683859|NCT00493636|9260688|P1|Overall Study|Mis-randomization|1
2683860|NCT00493636|9260687|P2|Overall Study|Disease progression/recurrence/relapse|1
2683861|NCT00493636|9260688|P1|Overall Study|Disease progression/recurrence/relapse|0
2683862|NCT00493636|9260687|P2|Overall Study|Withdrawal by Subject|0
2683863|NCT00493636|9260688|P1|Overall Study|Withdrawal by Subject|1
2683864|NCT00493454|9260702|P1|Overall Study|Withdrawal by Subject|1
2683865|NCT00493311|9260708|P2|Overall Study|Need for rescue medication|2
2683866|NCT00493311|9260709|P1|Overall Study|Need for rescue medication|2
2683867|NCT00493285|9260729|P6|Overall Study|Lost to Follow-up|0
2683868|NCT00493285|9260730|P5|Overall Study|Lost to Follow-up|1
2683869|NCT00493285|9260731|P4|Overall Study|Lost to Follow-up|0
2683870|NCT00493285|9260732|P3|Overall Study|Lost to Follow-up|0
2683871|NCT00493285|9260733|P2|Overall Study|Lost to Follow-up|0
2683872|NCT00493285|9260734|P1|Overall Study|Lost to Follow-up|0
2683873|NCT00493246|9260966|P8|Overall Study|Lost to Follow-up|0
2683874|NCT00493246|9260967|P7|Overall Study|Lost to Follow-up|1
2683875|NCT00493246|9260968|P6|Overall Study|Lost to Follow-up|0
2683876|NCT00493246|9260969|P5|Overall Study|Lost to Follow-up|0
2683877|NCT00493246|9260970|P4|Overall Study|Lost to Follow-up|0
2683878|NCT00493246|9260971|P3|Overall Study|Lost to Follow-up|0
2683879|NCT00493246|9260972|P2|Overall Study|Lost to Follow-up|0
2683880|NCT00493246|9260973|P1|Overall Study|Lost to Follow-up|0
2683881|NCT00493246|9260966|P8|Overall Study|No access to draw blood|0
2683882|NCT00493246|9260967|P7|Overall Study|No access to draw blood|0
2683883|NCT00493246|9260968|P6|Overall Study|No access to draw blood|1
2683884|NCT00493246|9260969|P5|Overall Study|No access to draw blood|0
2683885|NCT00493246|9260970|P4|Overall Study|No access to draw blood|0
2683886|NCT00493246|9260971|P3|Overall Study|No access to draw blood|0
2683887|NCT00493246|9260972|P2|Overall Study|No access to draw blood|0
2683888|NCT00493246|9260973|P1|Overall Study|No access to draw blood|0
2683889|NCT00493246|9260966|P8|Overall Study|Withdrawal by Subject|0
2683890|NCT00493246|9260967|P7|Overall Study|Withdrawal by Subject|0
2683891|NCT00493246|9260968|P6|Overall Study|Withdrawal by Subject|0
2683892|NCT00493246|9260969|P5|Overall Study|Withdrawal by Subject|1
2683893|NCT00493246|9260970|P4|Overall Study|Withdrawal by Subject|0
2683894|NCT00493246|9260971|P3|Overall Study|Withdrawal by Subject|0
2683895|NCT00493246|9260972|P2|Overall Study|Withdrawal by Subject|0
2683896|NCT00493246|9260973|P1|Overall Study|Withdrawal by Subject|0
2683897|NCT00493220|9261037|P6|Third Intervention|Withdrawal by Subject|0
2683898|NCT00493220|9261038|P5|Third Intervention|Withdrawal by Subject|0
2683899|NCT00493220|9261039|P4|Third Intervention|Withdrawal by Subject|0
2683900|NCT00493220|9261040|P3|Third Intervention|Withdrawal by Subject|0
2683901|NCT00493220|9261041|P2|Third Intervention|Withdrawal by Subject|0
2683902|NCT00493220|9261042|P1|Third Intervention|Withdrawal by Subject|1
2683903|NCT00493038|9261070|P2|Follow-up|Lost to Follow-up|0
2683904|NCT00493038|9261071|P1|Follow-up|Lost to Follow-up|1
2683905|NCT00493038|9261070|P2|Treatment|Other|1
2683906|NCT00493038|9261071|P1|Treatment|Other|0
2683907|NCT00493038|9261070|P2|Treatment|Withdrawal by Subject|12
2683908|NCT00493038|9261071|P1|Treatment|Withdrawal by Subject|11
2683909|NCT00493038|9261070|P2|Treatment|Lost to Follow-up|3
2683910|NCT00493038|9261071|P1|Treatment|Lost to Follow-up|5
2683911|NCT00493038|9261070|P2|Treatment|Adverse Event|4
2683912|NCT00493038|9261071|P1|Treatment|Adverse Event|8
2683913|NCT00493025|9261085|P1|Overall Study|Physician Decision|19
2683914|NCT00493012|9261096|P2|Overall Study|Lost to Follow-up|17
2683915|NCT00493012|9261097|P1|Overall Study|Lost to Follow-up|18
2683916|NCT00492921|9261140|P3|Overall Study|Death|1
2683917|NCT00492921|9261141|P2|Overall Study|Death|0
2683918|NCT00492921|9261142|P1|Overall Study|Death|1
2683919|NCT00492856|9261153|P4|Post-consolidation|Observation Arm|0
2683920|NCT00492856|9261154|P3|Post-consolidation|Observation Arm|27
2683921|NCT00492856|9261155|P2|Post-consolidation|Observation Arm|0
2683922|NCT00492856|9261156|P1|Post-consolidation|Observation Arm|0
2683923|NCT00492856|9261153|P4|Post-consolidation|Lost to Follow-up|0
2683924|NCT00492856|9261154|P3|Post-consolidation|Lost to Follow-up|0
2683925|NCT00492856|9261155|P2|Post-consolidation|Lost to Follow-up|2
2683926|NCT00492856|9261156|P1|Post-consolidation|Lost to Follow-up|0
2683927|NCT00492856|9261153|P4|Post-consolidation|Not protocol specified|0
2683928|NCT00492856|9261154|P3|Post-consolidation|Not protocol specified|0
2683929|NCT00492856|9261155|P2|Post-consolidation|Not protocol specified|1
2683930|NCT00492856|9261156|P1|Post-consolidation|Not protocol specified|0
2683931|NCT00492856|9261153|P4|Post-consolidation|Death|0
2683932|NCT00492856|9261154|P3|Post-consolidation|Death|0
2683933|NCT00492856|9261155|P2|Post-consolidation|Death|1
2683934|NCT00492856|9261156|P1|Post-consolidation|Death|0
2683935|NCT00492856|9261153|P4|Post-consolidation|Withdrawal by Subject|0
2683936|NCT00492856|9261154|P3|Post-consolidation|Withdrawal by Subject|0
2683937|NCT00492856|9261155|P2|Post-consolidation|Withdrawal by Subject|4
2683938|NCT00492856|9261156|P1|Post-consolidation|Withdrawal by Subject|0
2683939|NCT00492856|9261153|P4|Post-consolidation|Adverse Event|1
2683940|NCT00492856|9261154|P3|Post-consolidation|Adverse Event|0
2683941|NCT00492856|9261155|P2|Post-consolidation|Adverse Event|4
2683942|NCT00492856|9261156|P1|Post-consolidation|Adverse Event|0
2683943|NCT00492856|9261153|P4|Consolidation|Lost to Follow-up|0
2683944|NCT00492856|9261154|P3|Consolidation|Lost to Follow-up|0
2683945|NCT00492856|9261155|P2|Consolidation|Lost to Follow-up|0
2683946|NCT00492856|9261156|P1|Consolidation|Lost to Follow-up|1
2683947|NCT00492856|9261153|P4|Consolidation|Not protocol specified|0
2683948|NCT00492856|9261154|P3|Consolidation|Not protocol specified|0
2683949|NCT00492856|9261155|P2|Consolidation|Not protocol specified|0
2683950|NCT00492856|9261156|P1|Consolidation|Not protocol specified|2
2683951|NCT00492856|9261153|P4|Consolidation|Adverse Event|0
2683952|NCT00492856|9261154|P3|Consolidation|Adverse Event|0
2683953|NCT00492856|9261155|P2|Consolidation|Adverse Event|0
2683954|NCT00492856|9261156|P1|Consolidation|Adverse Event|6
2683955|NCT00492856|9261153|P4|Induction|Death|0
2683956|NCT00492856|9261154|P3|Induction|Death|0
2683957|NCT00492856|9261155|P2|Induction|Death|0
2683958|NCT00492856|9261156|P1|Induction|Death|3
2683959|NCT00492856|9261153|P4|Induction|Withdrawal by Subject|0
2683960|NCT00492856|9261154|P3|Induction|Withdrawal by Subject|0
2683961|NCT00492856|9261155|P2|Induction|Withdrawal by Subject|0
2683962|NCT00492856|9261156|P1|Induction|Withdrawal by Subject|1
2683963|NCT00492856|9261153|P4|Induction|Adverse Event|0
2683964|NCT00492856|9261154|P3|Induction|Adverse Event|0
2683965|NCT00492856|9261155|P2|Induction|Adverse Event|0
2683966|NCT00492856|9261156|P1|Induction|Adverse Event|2
2683967|NCT00492752|9261170|P4|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
2683968|NCT00492752|9261171|P3|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
2683969|NCT00492752|9261172|P2|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
2683970|NCT00492752|9261173|P1|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1
2683971|NCT00492752|9261170|P4|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
2683972|NCT00492752|9261171|P3|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
2683973|NCT00492752|9261172|P2|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6
2683974|NCT00492752|9261173|P1|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
2683975|NCT00492752|9261170|P4|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1
2683976|NCT00492752|9261171|P3|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
2683977|NCT00492752|9261172|P2|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
2683978|NCT00492752|9261173|P1|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
2683979|NCT00492752|9261170|P4|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2
2683980|NCT00492752|9261171|P3|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
2683981|NCT00492752|9261172|P2|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1
2683982|NCT00492752|9261173|P1|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
2683983|NCT00492752|9261170|P4|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
2683984|NCT00492752|9261171|P3|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
2683985|NCT00492752|9261172|P2|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1
2683986|NCT00492752|9261173|P1|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2
2683987|NCT00492752|9261170|P4|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0
2683988|NCT00492752|9261171|P3|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2
2683989|NCT00492752|9261172|P2|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1
2683990|NCT00492752|9261173|P1|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8
2683991|NCT00492752|9261170|P4|Follow-up and/or Open Label Sorafenib|Death|1
2683992|NCT00492752|9261171|P3|Follow-up and/or Open Label Sorafenib|Death|45
2683993|NCT00492752|9261172|P2|Follow-up and/or Open Label Sorafenib|Death|5
2683994|NCT00492752|9261173|P1|Follow-up and/or Open Label Sorafenib|Death|75
2683995|NCT00492752|9261170|P4|Follow-up and/or Open Label Sorafenib|Adverse Event|2
2683996|NCT00492752|9261171|P3|Follow-up and/or Open Label Sorafenib|Adverse Event|0
2683997|NCT00492752|9261172|P2|Follow-up and/or Open Label Sorafenib|Adverse Event|2
2683998|NCT00492752|9261173|P1|Follow-up and/or Open Label Sorafenib|Adverse Event|0
2683999|NCT00492752|9261170|P4|Double Blind Treatment|Protocol Violation|0
2684000|NCT00492752|9261171|P3|Double Blind Treatment|Protocol Violation|1
2684001|NCT00492752|9261172|P2|Double Blind Treatment|Protocol Violation|0
2684002|NCT00492752|9261173|P1|Double Blind Treatment|Protocol Violation|0
2684003|NCT00492752|9261170|P4|Double Blind Treatment|Adverse Event|0
2684004|NCT00492752|9261171|P3|Double Blind Treatment|Adverse Event|0
2684005|NCT00492752|9261172|P2|Double Blind Treatment|Adverse Event|0
2684006|NCT00492752|9261173|P1|Double Blind Treatment|Adverse Event|1
2684007|NCT00492752|9261170|P4|Double Blind Treatment|Death|0
2684008|NCT00492752|9261171|P3|Double Blind Treatment|Death|2
2684009|NCT00492752|9261172|P2|Double Blind Treatment|Death|0
2684010|NCT00492752|9261173|P1|Double Blind Treatment|Death|13
2684011|NCT00492726|9261208|P2|Overall Study|Non compliant with study medication|3
2684012|NCT00492726|9261209|P1|Overall Study|Non compliant with study medication|0
2684013|NCT00492726|9261208|P2|Overall Study|Withdrawal by Subject|3
2684014|NCT00492726|9261209|P1|Overall Study|Withdrawal by Subject|6
2684015|NCT00492726|9261208|P2|Overall Study|Physician Decision|1
2684016|NCT00492726|9261209|P1|Overall Study|Physician Decision|0
2684017|NCT00492726|9261208|P2|Overall Study|Lost to Follow-up|19
2684018|NCT00492726|9261209|P1|Overall Study|Lost to Follow-up|27
2684019|NCT00492726|9261208|P2|Overall Study|Lack of Efficacy|2
2684020|NCT00492726|9261209|P1|Overall Study|Lack of Efficacy|0
2684021|NCT00492726|9261208|P2|Overall Study|Death|2
2684022|NCT00492726|9261209|P1|Overall Study|Death|7
2684023|NCT00492726|9261208|P2|Overall Study|Adverse Event|6
2684024|NCT00492726|9261209|P1|Overall Study|Adverse Event|10
2684025|NCT00492648|9261235|P2|Month 30 (109671 Study)|Protocol Violation|1
2684026|NCT00492648|9261236|P1|Month 30 (109671 Study)|Protocol Violation|0
2684027|NCT00492557|9261283|P2|Overall Study|Lost to Follow-up|1
2684028|NCT00492557|9261284|P1|Overall Study|Lost to Follow-up|0
2684029|NCT00492557|9261283|P2|Overall Study|Failed to return|0
2684030|NCT00492557|9261284|P1|Overall Study|Failed to return|1
2684031|NCT00492557|9261283|P2|Overall Study|Adverse Event|0
2684032|NCT00492557|9261284|P1|Overall Study|Adverse Event|1
2684033|NCT00492557|9261283|P2|Overall Study|Death|1
2684034|NCT00492557|9261284|P1|Overall Study|Death|1
2684035|NCT00492557|9261283|P2|Overall Study|Other|2
2684036|NCT00492557|9261284|P1|Overall Study|Other|2
2684037|NCT00492557|9261283|P2|Overall Study|Protocol Violation|8
2684038|NCT00492557|9261284|P1|Overall Study|Protocol Violation|7
2684039|NCT00492557|9261283|P2|Overall Study|Subject request|11
2684040|NCT00492557|9261284|P1|Overall Study|Subject request|12
2684041|NCT00492531|9261314|P2|Overall Study|Withdrawn(More than one reason selected)|23
2684042|NCT00492531|9261315|P1|Overall Study|Withdrawn(More than one reason selected)|22
2684043|NCT00492297|9261388|P1|Survival Only Follow-up|Study terminated by sponsor|12
2684044|NCT00492297|9261388|P1|Survival Only Follow-up|Lack of Efficacy|1
2684045|NCT00492297|9261388|P1|Survival Only Follow-up|Death|46
2684046|NCT00492297|9261388|P1|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2
2684047|NCT00492297|9261388|P1|Active Follow-up 30(+4) Days Duration|Death|17
2684048|NCT00492297|9261388|P1|Treatment|Study terminated by sponsor|3
2684049|NCT00492297|9261388|P1|Treatment|Death|2
2684050|NCT00492284|9261406|P4|Overall Study|Withdrawal by Subject|2
2684051|NCT00492284|9261407|P3|Overall Study|Withdrawal by Subject|0
2684052|NCT00492284|9261408|P2|Overall Study|Withdrawal by Subject|0
2684053|NCT00492284|9261409|P1|Overall Study|Withdrawal by Subject|1
2684054|NCT00492284|9261406|P4|Overall Study|Death|5
2684055|NCT00492284|9261407|P3|Overall Study|Death|2
2684056|NCT00492284|9261408|P2|Overall Study|Death|3
2684057|NCT00492284|9261409|P1|Overall Study|Death|0
2684058|NCT00492284|9261406|P4|Overall Study|Lost to Follow-up|1
2684059|NCT00492284|9261407|P3|Overall Study|Lost to Follow-up|3
2684060|NCT00492284|9261408|P2|Overall Study|Lost to Follow-up|0
2684061|NCT00492284|9261409|P1|Overall Study|Lost to Follow-up|0
2684062|NCT00492284|9261406|P4|Overall Study|Adverse Event|2
2684063|NCT00492284|9261407|P3|Overall Study|Adverse Event|1
2684064|NCT00492284|9261408|P2|Overall Study|Adverse Event|1
2684065|NCT00492284|9261409|P1|Overall Study|Adverse Event|0
2684066|NCT00492232|9261453|P2|Open-Label Treatment|Withdrawal by Subject|0
2684067|NCT00492232|9261454|P1|Open-Label Treatment|Withdrawal by Subject|1
2684068|NCT00492232|9261453|P2|Double-Blind Treatment|Randomized not treated|0
2684069|NCT00492232|9261454|P1|Double-Blind Treatment|Randomized not treated|1
2684070|NCT00492232|9261453|P2|Double-Blind Treatment|Other|5
2684071|NCT00492232|9261454|P1|Double-Blind Treatment|Other|6
2684072|NCT00492232|9261453|P2|Double-Blind Treatment|Lack of Efficacy|0
2684073|NCT00492232|9261454|P1|Double-Blind Treatment|Lack of Efficacy|1
2684074|NCT00492232|9261453|P2|Double-Blind Treatment|Withdrawal by Subject|8
2684075|NCT00492232|9261454|P1|Double-Blind Treatment|Withdrawal by Subject|4
2684076|NCT00492232|9261453|P2|Double-Blind Treatment|Lost to Follow-up|3
2684077|NCT00492232|9261454|P1|Double-Blind Treatment|Lost to Follow-up|2
2684078|NCT00492232|9261453|P2|Double-Blind Treatment|Protocol Violation|7
2684079|NCT00492232|9261454|P1|Double-Blind Treatment|Protocol Violation|3
2684080|NCT00492232|9261453|P2|Double-Blind Treatment|Adverse Event|2
2684081|NCT00492232|9261454|P1|Double-Blind Treatment|Adverse Event|1
2684082|NCT00492232|9261453|P2|Placebo Run-in|Missing|2
2684083|NCT00492232|9261454|P1|Placebo Run-in|Missing|0
2684084|NCT00492232|9261453|P2|Placebo Run-in|Other|6
2684085|NCT00492232|9261454|P1|Placebo Run-in|Other|0
2684086|NCT00492232|9261453|P2|Placebo Run-in|Entrance criteria not met|45
2684087|NCT00492232|9261454|P1|Placebo Run-in|Entrance criteria not met|0
2684088|NCT00492232|9261453|P2|Placebo Run-in|Pregnancy|1
2684089|NCT00492232|9261454|P1|Placebo Run-in|Pregnancy|0
2684090|NCT00492232|9261453|P2|Placebo Run-in|Withdrawal by Subject|8
2684091|NCT00492232|9261454|P1|Placebo Run-in|Withdrawal by Subject|0
2684092|NCT00492232|9261453|P2|Placebo Run-in|Lost to Follow-up|3
2684093|NCT00492232|9261454|P1|Placebo Run-in|Lost to Follow-up|0
2684094|NCT00492232|9261453|P2|Placebo Run-in|Protocol Violation|3
2684095|NCT00492232|9261454|P1|Placebo Run-in|Protocol Violation|0
2684096|NCT00492232|9261453|P2|Placebo Run-in|Adverse Event|2
2684097|NCT00492232|9261454|P1|Placebo Run-in|Adverse Event|0
2684098|NCT00492115|9261495|P2|Overall Study|Withdrawal by Subject|4
2684099|NCT00492115|9261496|P1|Overall Study|Withdrawal by Subject|3
2684100|NCT00492063|9261517|P4|Overall Study|Protocol Violation|1
2684101|NCT00492063|9261518|P3|Overall Study|Protocol Violation|0
2684102|NCT00492063|9261519|P2|Overall Study|Protocol Violation|0
2684103|NCT00492063|9261520|P1|Overall Study|Protocol Violation|0
2684104|NCT00492063|9261517|P4|Overall Study|Lost to Follow-up|3
2684105|NCT00492063|9261518|P3|Overall Study|Lost to Follow-up|5
2684106|NCT00492063|9261519|P2|Overall Study|Lost to Follow-up|11
2684107|NCT00492063|9261520|P1|Overall Study|Lost to Follow-up|6
2684108|NCT00492063|9261517|P4|Overall Study|Withdrawal by Subject|4
2684109|NCT00492063|9261518|P3|Overall Study|Withdrawal by Subject|5
2684110|NCT00492063|9261519|P2|Overall Study|Withdrawal by Subject|3
2684111|NCT00492063|9261520|P1|Overall Study|Withdrawal by Subject|4
2684112|NCT00492063|9261517|P4|Overall Study|Death|2
2684113|NCT00492063|9261518|P3|Overall Study|Death|1
2684114|NCT00492063|9261519|P2|Overall Study|Death|0
2684115|NCT00492063|9261520|P1|Overall Study|Death|0
2684116|NCT00492024|9261544|P2|Follow up|Lost to Follow-up|1
2684117|NCT00492024|9261545|P1|Follow up|Lost to Follow-up|1
2684118|NCT00492024|9261544|P2|Follow up|Lack of Efficacy|1
2684119|NCT00492024|9261545|P1|Follow up|Lack of Efficacy|0
2684120|NCT00492024|9261544|P2|Treatment|Withdrawal by Subject|0
2684121|NCT00492024|9261545|P1|Treatment|Withdrawal by Subject|2
2684122|NCT00492024|9261544|P2|Treatment|Lost to Follow-up|1
2684123|NCT00492024|9261545|P1|Treatment|Lost to Follow-up|3
2684124|NCT00492024|9261544|P2|Treatment|Lack of Efficacy|20
2684125|NCT00492024|9261545|P1|Treatment|Lack of Efficacy|21
2684126|NCT00492024|9261544|P2|Treatment|Adverse Event|1
2684127|NCT00492024|9261545|P1|Treatment|Adverse Event|3
2684128|NCT00491894|9261561|P1|Overall Study|Other-Intake of prohibited medication|1
2684129|NCT00491894|9261561|P1|Overall Study|Protocol Violation|2
2684130|NCT00491894|9261561|P1|Overall Study|Physician Decision|2
2684131|NCT00491894|9261561|P1|Overall Study|Other-Failed to meet any criteria|2
2684132|NCT00491894|9261561|P1|Overall Study|Lack of Efficacy|2
2684133|NCT00491894|9261561|P1|Overall Study|Lost to Follow-up|3
2684134|NCT00491894|9261561|P1|Overall Study|Death|3
2684135|NCT00491894|9261561|P1|Overall Study|Withdrawal by Subject|5
2684136|NCT00491894|9261561|P1|Overall Study|Adverse Event|14
2684137|NCT00491764|9261588|P6|Overall Study|Administrative|0
2684138|NCT00491764|9261589|P5|Overall Study|Administrative|0
2684139|NCT00491764|9261590|P4|Overall Study|Administrative|1
2684140|NCT00491764|9261591|P3|Overall Study|Administrative|2
2684141|NCT00491764|9261592|P2|Overall Study|Administrative|0
2684142|NCT00491764|9261593|P1|Overall Study|Administrative|1
2684143|NCT00491764|9261588|P6|Overall Study|Did not Meet Protocol Eligibility|1
2684144|NCT00491764|9261589|P5|Overall Study|Did not Meet Protocol Eligibility|1
2684145|NCT00491764|9261590|P4|Overall Study|Did not Meet Protocol Eligibility|0
2684146|NCT00491764|9261591|P3|Overall Study|Did not Meet Protocol Eligibility|1
2684147|NCT00491764|9261592|P2|Overall Study|Did not Meet Protocol Eligibility|1
2684148|NCT00491764|9261593|P1|Overall Study|Did not Meet Protocol Eligibility|0
2684149|NCT00491764|9261588|P6|Overall Study|Non Compliance with the Protocol|0
2684150|NCT00491764|9261589|P5|Overall Study|Non Compliance with the Protocol|0
2684151|NCT00491764|9261590|P4|Overall Study|Non Compliance with the Protocol|0
2684152|NCT00491764|9261591|P3|Overall Study|Non Compliance with the Protocol|0
2684153|NCT00491764|9261592|P2|Overall Study|Non Compliance with the Protocol|0
2684154|NCT00491764|9261593|P1|Overall Study|Non Compliance with the Protocol|1
2684155|NCT00491764|9261588|P6|Overall Study|Withdrawal by Subject|4
2684156|NCT00491764|9261589|P5|Overall Study|Withdrawal by Subject|2
2684157|NCT00491764|9261590|P4|Overall Study|Withdrawal by Subject|2
2684158|NCT00491764|9261591|P3|Overall Study|Withdrawal by Subject|1
2684159|NCT00491764|9261592|P2|Overall Study|Withdrawal by Subject|3
2684160|NCT00491764|9261593|P1|Overall Study|Withdrawal by Subject|2
2684161|NCT00491764|9261588|P6|Overall Study|Lost to Follow-up|3
2684162|NCT00491764|9261589|P5|Overall Study|Lost to Follow-up|0
2684163|NCT00491764|9261590|P4|Overall Study|Lost to Follow-up|1
2684164|NCT00491764|9261591|P3|Overall Study|Lost to Follow-up|0
2684165|NCT00491764|9261592|P2|Overall Study|Lost to Follow-up|1
2684166|NCT00491764|9261593|P1|Overall Study|Lost to Follow-up|0
2684167|NCT00491764|9261588|P6|Overall Study|Adverse Event|1
2684168|NCT00491764|9261589|P5|Overall Study|Adverse Event|0
2684169|NCT00491764|9261590|P4|Overall Study|Adverse Event|4
2684170|NCT00491764|9261591|P3|Overall Study|Adverse Event|4
2684171|NCT00491764|9261592|P2|Overall Study|Adverse Event|2
2684172|NCT00491764|9261593|P1|Overall Study|Adverse Event|1
2684173|NCT00491608|9261641|P1|Overall Study|Withdrawal by Subject|1
2684174|NCT00491608|9261641|P1|Overall Study|Death|2
2684175|NCT00491556|9261652|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1
2684176|NCT00491556|9261653|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0
2684177|NCT00491556|9261652|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1
2684178|NCT00491556|9261653|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0
2684179|NCT00491556|9261652|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0
2684180|NCT00491556|9261653|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2
2684181|NCT00491556|9261652|P2|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0
2684182|NCT00491556|9261653|P1|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2
2684183|NCT00491556|9261652|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0
2684184|NCT00491556|9261653|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2
2684185|NCT00491556|9261652|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0
2684186|NCT00491556|9261653|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5
2684187|NCT00491556|9261652|P2|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0
2684188|NCT00491556|9261653|P1|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2
2684189|NCT00491556|9261652|P2|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0
2684190|NCT00491556|9261653|P1|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5
2684191|NCT00491556|9261652|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1
2684192|NCT00491556|9261653|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2
2684193|NCT00491556|9261652|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0
2684194|NCT00491556|9261653|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2
2684195|NCT00491556|9261652|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
2684196|NCT00491556|9261653|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
2684197|NCT00491556|9261652|P2|Entry-Week (WK) 48: EXP/Standard Care|Other|0
2684198|NCT00491556|9261653|P1|Entry-Week (WK) 48: EXP/Standard Care|Other|3
2684199|NCT00491556|9261652|P2|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0
2684200|NCT00491556|9261653|P1|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3
2684201|NCT00491556|9261652|P2|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0
2684202|NCT00491556|9261653|P1|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2
2684203|NCT00491556|9261652|P2|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0
2684204|NCT00491556|9261653|P1|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2
2684205|NCT00491556|9261652|P2|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0
2684206|NCT00491556|9261653|P1|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11
2684207|NCT00491556|9261652|P2|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0
2684208|NCT00491556|9261653|P1|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2
2684209|NCT00491556|9261652|P2|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0
2684210|NCT00491556|9261653|P1|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1
2684211|NCT00491556|9261652|P2|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0
2684212|NCT00491556|9261653|P1|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1
2684213|NCT00491556|9261652|P2|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0
2684214|NCT00491556|9261653|P1|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1
2684215|NCT00491530|9261712|P3|Overall Study|Use of Prohibited Medication|1
2684216|NCT00491530|9261713|P2|Overall Study|Use of Prohibited Medication|0
2684217|NCT00491530|9261714|P1|Overall Study|Use of Prohibited Medication|0
2684218|NCT00491530|9261712|P3|Overall Study|Patient Request|0
2684219|NCT00491530|9261713|P2|Overall Study|Patient Request|1
2684220|NCT00491530|9261714|P1|Overall Study|Patient Request|0
2684221|NCT00491530|9261712|P3|Overall Study|Investigator Discretion|0
2684222|NCT00491530|9261713|P2|Overall Study|Investigator Discretion|1
2684223|NCT00491530|9261714|P1|Overall Study|Investigator Discretion|0
2684224|NCT00491530|9261712|P3|Overall Study|Lack of Efficacy|0
2684225|NCT00491530|9261713|P2|Overall Study|Lack of Efficacy|1
2684226|NCT00491530|9261714|P1|Overall Study|Lack of Efficacy|0
2684227|NCT00491530|9261712|P3|Overall Study|Lost to Follow-up|2
2684228|NCT00491530|9261713|P2|Overall Study|Lost to Follow-up|2
2684229|NCT00491530|9261714|P1|Overall Study|Lost to Follow-up|3
2684230|NCT00491530|9261712|P3|Overall Study|Withdrawal by Subject|0
2684231|NCT00491530|9261713|P2|Overall Study|Withdrawal by Subject|0
2684232|NCT00491530|9261714|P1|Overall Study|Withdrawal by Subject|3
2684233|NCT00491530|9261712|P3|Overall Study|Adverse Event|2
2684234|NCT00491530|9261713|P2|Overall Study|Adverse Event|1
2684235|NCT00491530|9261714|P1|Overall Study|Adverse Event|6
2684236|NCT00491504|9261744|P4|Overall Study|Protocol Violation|2
2684237|NCT00491504|9261745|P3|Overall Study|Protocol Violation|3
2684238|NCT00491504|9261746|P2|Overall Study|Protocol Violation|0
2684239|NCT00491504|9261747|P1|Overall Study|Protocol Violation|0
2684240|NCT00491504|9261744|P4|Overall Study|Withdrawal by Subject|2
2684241|NCT00491504|9261745|P3|Overall Study|Withdrawal by Subject|1
2684242|NCT00491504|9261746|P2|Overall Study|Withdrawal by Subject|0
2684243|NCT00491504|9261747|P1|Overall Study|Withdrawal by Subject|0
2684244|NCT00491504|9261744|P4|Overall Study|Adverse Event|0
2684245|NCT00491504|9261745|P3|Overall Study|Adverse Event|0
2684246|NCT00491504|9261746|P2|Overall Study|Adverse Event|1
2684247|NCT00491504|9261747|P1|Overall Study|Adverse Event|0
2684248|NCT00491400|9261757|P2|Overall Study|Withdrawal by Subject|4
2684249|NCT00491400|9261758|P1|Overall Study|Withdrawal by Subject|5
2684250|NCT00491387|9261766|P1|Overall Study|study terminated|20
2684251|NCT00491322|9261781|P2|Overall Study|Pregnancy|1
2684252|NCT00491322|9261782|P1|Overall Study|Pregnancy|0
2684253|NCT00491322|9261781|P2|Overall Study|Protocol Violation|0
2684254|NCT00491322|9261782|P1|Overall Study|Protocol Violation|1
2684255|NCT00491179|9261801|P2|Overall Study|Withdrawal by Subject|1
2684256|NCT00491179|9261802|P1|Overall Study|Withdrawal by Subject|2
2684257|NCT00491179|9261801|P2|Overall Study|Adverse Event|1
2684258|NCT00491179|9261802|P1|Overall Study|Adverse Event|5
2684259|NCT00491075|9261810|P1|Overall Study|Physician Decision|1
2684260|NCT00491075|9261810|P1|Overall Study|Withdrawal by Subject|1
2684261|NCT00490971|9261816|P5|Maintenance|Other|3
2684262|NCT00490971|9261817|P4|Maintenance|Other|9
2684263|NCT00490971|9261818|P3|Maintenance|Other|11
2684264|NCT00490971|9261819|P2|Maintenance|Other|0
2684265|NCT00490971|9261820|P1|Maintenance|Other|0
2684266|NCT00490971|9261816|P5|Maintenance|Withdrawal by Subject|18
2684267|NCT00490971|9261817|P4|Maintenance|Withdrawal by Subject|28
2684268|NCT00490971|9261818|P3|Maintenance|Withdrawal by Subject|26
2684269|NCT00490971|9261819|P2|Maintenance|Withdrawal by Subject|0
2684270|NCT00490971|9261820|P1|Maintenance|Withdrawal by Subject|0
2684271|NCT00490971|9261816|P5|Maintenance|Protocol Violation|1
2684272|NCT00490971|9261817|P4|Maintenance|Protocol Violation|1
2684273|NCT00490971|9261818|P3|Maintenance|Protocol Violation|4
2684274|NCT00490971|9261819|P2|Maintenance|Protocol Violation|0
2684275|NCT00490971|9261820|P1|Maintenance|Protocol Violation|0
2684276|NCT00490971|9261816|P5|Maintenance|Pregnancy|0
2684277|NCT00490971|9261817|P4|Maintenance|Pregnancy|0
2684278|NCT00490971|9261818|P3|Maintenance|Pregnancy|1
2684279|NCT00490971|9261819|P2|Maintenance|Pregnancy|0
2684280|NCT00490971|9261820|P1|Maintenance|Pregnancy|0
2684281|NCT00490971|9261816|P5|Maintenance|Lost to Follow-up|10
2684282|NCT00490971|9261817|P4|Maintenance|Lost to Follow-up|8
2684283|NCT00490971|9261818|P3|Maintenance|Lost to Follow-up|5
2684284|NCT00490971|9261819|P2|Maintenance|Lost to Follow-up|0
2684285|NCT00490971|9261820|P1|Maintenance|Lost to Follow-up|0
2684286|NCT00490971|9261816|P5|Maintenance|Death|0
2684287|NCT00490971|9261817|P4|Maintenance|Death|2
2684288|NCT00490971|9261818|P3|Maintenance|Death|0
2684289|NCT00490971|9261819|P2|Maintenance|Death|0
2684290|NCT00490971|9261820|P1|Maintenance|Death|0
2684291|NCT00490971|9261816|P5|Maintenance|Adverse Event|7
2684292|NCT00490971|9261817|P4|Maintenance|Adverse Event|5
2684293|NCT00490971|9261818|P3|Maintenance|Adverse Event|4
2684294|NCT00490971|9261819|P2|Maintenance|Adverse Event|0
2684295|NCT00490971|9261820|P1|Maintenance|Adverse Event|0
2684296|NCT00490971|9261816|P5|Acute/Continuation|Other|0
2684297|NCT00490971|9261817|P4|Acute/Continuation|Other|0
2684298|NCT00490971|9261818|P3|Acute/Continuation|Other|0
2684299|NCT00490971|9261819|P2|Acute/Continuation|Other|4
2684300|NCT00490971|9261820|P1|Acute/Continuation|Other|11
2684301|NCT00490971|9261816|P5|Acute/Continuation|Withdrawal by Subject|0
2684302|NCT00490971|9261817|P4|Acute/Continuation|Withdrawal by Subject|0
2684303|NCT00490971|9261818|P3|Acute/Continuation|Withdrawal by Subject|0
2684304|NCT00490971|9261819|P2|Acute/Continuation|Withdrawal by Subject|24
2684305|NCT00490971|9261820|P1|Acute/Continuation|Withdrawal by Subject|92
2684306|NCT00490971|9261816|P5|Acute/Continuation|Protocol Violation|0
2684307|NCT00490971|9261817|P4|Acute/Continuation|Protocol Violation|0
2684308|NCT00490971|9261818|P3|Acute/Continuation|Protocol Violation|0
2684309|NCT00490971|9261819|P2|Acute/Continuation|Protocol Violation|2
2684310|NCT00490971|9261820|P1|Acute/Continuation|Protocol Violation|10
2684311|NCT00490971|9261816|P5|Acute/Continuation|Lost to Follow-up|0
2684312|NCT00490971|9261817|P4|Acute/Continuation|Lost to Follow-up|0
2684313|NCT00490971|9261818|P3|Acute/Continuation|Lost to Follow-up|0
2684314|NCT00490971|9261819|P2|Acute/Continuation|Lost to Follow-up|7
2684315|NCT00490971|9261820|P1|Acute/Continuation|Lost to Follow-up|23
2684316|NCT00490971|9261816|P5|Acute/Continuation|Lack of Efficacy|0
2684317|NCT00490971|9261817|P4|Acute/Continuation|Lack of Efficacy|0
2684318|NCT00490971|9261818|P3|Acute/Continuation|Lack of Efficacy|0
2684319|NCT00490971|9261819|P2|Acute/Continuation|Lack of Efficacy|12
2684320|NCT00490971|9261820|P1|Acute/Continuation|Lack of Efficacy|106
2684321|NCT00490971|9261816|P5|Acute/Continuation|Death|0
2684322|NCT00490971|9261817|P4|Acute/Continuation|Death|0
2684323|NCT00490971|9261818|P3|Acute/Continuation|Death|0
2684324|NCT00490971|9261819|P2|Acute/Continuation|Death|0
2684325|NCT00490971|9261820|P1|Acute/Continuation|Death|2
2684326|NCT00490971|9261816|P5|Acute/Continuation|Adverse Event|0
2684327|NCT00490971|9261817|P4|Acute/Continuation|Adverse Event|0
2684328|NCT00490971|9261818|P3|Acute/Continuation|Adverse Event|0
2684329|NCT00490971|9261819|P2|Acute/Continuation|Adverse Event|13
2684330|NCT00490971|9261820|P1|Acute/Continuation|Adverse Event|62
2684331|NCT00490945|9261867|P5|Overall Study|Adverse Event|0
2684332|NCT00490945|9261868|P4|Overall Study|Adverse Event|0
2684333|NCT00490945|9261869|P3|Overall Study|Adverse Event|0
2684334|NCT00490945|9261870|P2|Overall Study|Adverse Event|1
2684335|NCT00490945|9261871|P1|Overall Study|Adverse Event|0
2684336|NCT00490919|9261907|P3|Double-blind Phase|Administrative|6
2684337|NCT00490919|9261908|P2|Double-blind Phase|Administrative|6
2684338|NCT00490919|9261909|P1|Double-blind Phase|Administrative|0
2684339|NCT00490919|9261907|P3|Double-blind Phase|Lack of Efficacy|36
2684340|NCT00490919|9261908|P2|Double-blind Phase|Lack of Efficacy|22
2684341|NCT00490919|9261909|P1|Double-blind Phase|Lack of Efficacy|0
2684342|NCT00490919|9261907|P3|Double-blind Phase|Lost to Follow-up|11
2684343|NCT00490919|9261908|P2|Double-blind Phase|Lost to Follow-up|8
2684344|NCT00490919|9261909|P1|Double-blind Phase|Lost to Follow-up|0
2684345|NCT00490919|9261907|P3|Double-blind Phase|Withdrawal by Subject|11
2684346|NCT00490919|9261908|P2|Double-blind Phase|Withdrawal by Subject|10
2684347|NCT00490919|9261909|P1|Double-blind Phase|Withdrawal by Subject|0
2684348|NCT00490919|9261907|P3|Double-blind Phase|Adverse Event|20
2684349|NCT00490919|9261908|P2|Double-blind Phase|Adverse Event|40
2684350|NCT00490919|9261909|P1|Double-blind Phase|Adverse Event|0
2684351|NCT00490919|9261907|P3|Open-label Run-in Period|Confirmed or suspected diversion|0
2684352|NCT00490919|9261908|P2|Open-label Run-in Period|Confirmed or suspected diversion|0
2684353|NCT00490919|9261909|P1|Open-label Run-in Period|Confirmed or suspected diversion|3
2684354|NCT00490919|9261907|P3|Open-label Run-in Period|Administrative|0
2684355|NCT00490919|9261908|P2|Open-label Run-in Period|Administrative|0
2684356|NCT00490919|9261909|P1|Open-label Run-in Period|Administrative|40
2684357|NCT00490919|9261907|P3|Open-label Run-in Period|Lack of Efficacy|0
2684358|NCT00490919|9261908|P2|Open-label Run-in Period|Lack of Efficacy|0
2684359|NCT00490919|9261909|P1|Open-label Run-in Period|Lack of Efficacy|143
2684360|NCT00490919|9261907|P3|Open-label Run-in Period|Lost to Follow-up|0
2684361|NCT00490919|9261908|P2|Open-label Run-in Period|Lost to Follow-up|0
2684362|NCT00490919|9261909|P1|Open-label Run-in Period|Lost to Follow-up|21
2684363|NCT00490919|9261907|P3|Open-label Run-in Period|Withdrawal by Subject|0
2684364|NCT00490919|9261908|P2|Open-label Run-in Period|Withdrawal by Subject|0
2684365|NCT00490919|9261909|P1|Open-label Run-in Period|Withdrawal by Subject|37
2684366|NCT00490919|9261907|P3|Open-label Run-in Period|Adverse Event|0
2684367|NCT00490919|9261908|P2|Open-label Run-in Period|Adverse Event|0
2684368|NCT00490919|9261909|P1|Open-label Run-in Period|Adverse Event|239
2684369|NCT00490841|9261920|P1|Overall Study|30 day f/u, only non-study stent used|3
2684370|NCT00490841|9261920|P1|Overall Study|Lost to Follow-up|1
2684371|NCT00490841|9261920|P1|Overall Study|Withdrawal by Subject|4
2684372|NCT00490841|9261920|P1|Overall Study|Death|5
2684373|NCT00490815|9261942|P2|Overall Study|Death|3
2684374|NCT00490815|9261943|P1|Overall Study|Death|1
2684375|NCT00490815|9261942|P2|Overall Study|Lost to Follow-up|3
2684376|NCT00490815|9261943|P1|Overall Study|Lost to Follow-up|1
2684377|NCT00490815|9261942|P2|Overall Study|Withdrawal by Subject|0
2684378|NCT00490815|9261943|P1|Overall Study|Withdrawal by Subject|4
2684379|NCT00490815|9261942|P2|Overall Study|Adverse Event|3
2684380|NCT00490815|9261943|P1|Overall Study|Adverse Event|2
2684381|NCT00490724|9261971|P3|Period II|Treatment Discontinuation|3
2684382|NCT00490724|9261972|P2|Period II|Treatment Discontinuation|1
2684383|NCT00490724|9261973|P1|Period II|Treatment Discontinuation|3
2684384|NCT00490724|9261971|P3|Period I|Physician Decision|1
2684385|NCT00490724|9261972|P2|Period I|Physician Decision|0
2684386|NCT00490724|9261973|P1|Period I|Physician Decision|0
2684387|NCT00490698|9262038|P1|Overall Study|Physician Decision|2
2684388|NCT00490698|9262038|P1|Overall Study|Disease Progression|7
2684389|NCT00490698|9262038|P1|Overall Study|Withdrawal by Subject|1
2684390|NCT00490646|9262044|P2|Overall Study|Never Treated (withdrew consent)|1
2684391|NCT00490646|9262045|P1|Overall Study|Never Treated (withdrew consent)|0
2684392|NCT00490646|9262044|P2|Overall Study|Never Treated (had an adverse event)|0
2684393|NCT00490646|9262045|P1|Overall Study|Never Treated (had an adverse event)|1
2684394|NCT00490646|9262044|P2|Overall Study|Still on trastuzumab monotherapy|1
2684395|NCT00490646|9262045|P1|Overall Study|Still on trastuzumab monotherapy|1
2684396|NCT00490568|9262065|P1|Overall Study|Participant withdrawal due to surgery|1
2684397|NCT00490568|9262065|P1|Overall Study|Participant died|1
2684398|NCT00490568|9262065|P1|Overall Study|Efficacy related|3
2684399|NCT00490568|9262065|P1|Overall Study|Non-Compliance|7
2684400|NCT00490568|9262065|P1|Overall Study|Investigator decision|3
2684401|NCT00490568|9262065|P1|Overall Study|Unmet inclusion-exclusion criteria|5
2684402|NCT00490568|9262065|P1|Overall Study|Disease progression|4
2684403|NCT00490568|9262065|P1|Overall Study|Legal representative withdrew consent|1
2684404|NCT00490568|9262065|P1|Overall Study|Participant refused follow-up|9
2684405|NCT00490568|9262065|P1|Overall Study|Abnormal ECG|25
2684406|NCT00490568|9262065|P1|Overall Study|Caregiver related|20
2684407|NCT00490568|9262065|P1|Overall Study|Exclusion criteria met|1
2684408|NCT00490568|9262065|P1|Overall Study|Other|1
2684409|NCT00490568|9262065|P1|Overall Study|Still in the study at termination|974
2684410|NCT00490568|9262065|P1|Overall Study|Withdrawal by Subject|135
2684411|NCT00490568|9262065|P1|Overall Study|Protocol Violation|45
2684412|NCT00490568|9262065|P1|Overall Study|Lost to Follow-up|13
2684413|NCT00490568|9262065|P1|Overall Study|Adverse Event|116
2684414|NCT00490555|9262089|P4|Overall Study|noncompliant with drug administration|0
2684415|NCT00490555|9262090|P3|Overall Study|noncompliant with drug administration|2
2684416|NCT00490555|9262091|P2|Overall Study|noncompliant with drug administration|0
2684417|NCT00490555|9262092|P1|Overall Study|noncompliant with drug administration|0
2684418|NCT00490542|9262120|P2|Overall Study|Lack of Efficacy|1
2684419|NCT00490542|9262121|P1|Overall Study|Lack of Efficacy|1
2684420|NCT00490542|9262120|P2|Overall Study|Adverse Event|3
2684421|NCT00490542|9262121|P1|Overall Study|Adverse Event|3
2684422|NCT00490542|9262120|P2|Overall Study|Lost to Follow-up|0
2684423|NCT00490542|9262121|P1|Overall Study|Lost to Follow-up|3
2684424|NCT00490529|9262127|P1|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1
2684425|NCT00490529|9262127|P1|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1
2684426|NCT00490529|9262127|P1|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1
2684427|NCT00490529|9262127|P1|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1
2684428|NCT00490529|9262127|P1|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4
2684429|NCT00490529|9262127|P1|Completed Pre-CpG-MCL Vaccine Procedures|Death|4
2684430|NCT00490490|9262135|P1|Completed Assessment for TTP|Lost to Follow-up|2
2684431|NCT00490490|9262135|P1|Completed Assessment for TTP|Withdrawal by Subject|1
2684432|NCT00490451|9262152|P2|Overall Study|Progressive Disease|34
2684433|NCT00490451|9262153|P1|Overall Study|Progressive Disease|53
2684434|NCT00490451|9262152|P2|Overall Study|Protocol Violation|0
2684435|NCT00490451|9262153|P1|Overall Study|Protocol Violation|1
2684436|NCT00490451|9262152|P2|Overall Study|Investigator Decision|0
2684437|NCT00490451|9262153|P1|Overall Study|Investigator Decision|1
2684438|NCT00490451|9262152|P2|Overall Study|Withdrawal by Subject|0
2684439|NCT00490451|9262153|P1|Overall Study|Withdrawal by Subject|2
2684440|NCT00490451|9262152|P2|Overall Study|Death|1
2684441|NCT00490451|9262153|P1|Overall Study|Death|3
2684442|NCT00490451|9262152|P2|Overall Study|Adverse Event|3
2684443|NCT00490451|9262153|P1|Overall Study|Adverse Event|3
2684444|NCT00490139|9262195|P4|Overall Study|Participant Withdrew Consent|116
2684445|NCT00490139|9262196|P3|Overall Study|Participant Withdrew Consent|208
2684446|NCT00490139|9262197|P2|Overall Study|Participant Withdrew Consent|110
2684447|NCT00490139|9262198|P1|Overall Study|Participant Withdrew Consent|146
2684448|NCT00490139|9262195|P4|Overall Study|Lost to Follow-up|56
2684449|NCT00490139|9262196|P3|Overall Study|Lost to Follow-up|58
2684450|NCT00490139|9262197|P2|Overall Study|Lost to Follow-up|46
2684451|NCT00490139|9262198|P1|Overall Study|Lost to Follow-up|56
2684452|NCT00490139|9262195|P4|Overall Study|Death|135
2684453|NCT00490139|9262196|P3|Overall Study|Death|168
2684454|NCT00490139|9262197|P2|Overall Study|Death|119
2684455|NCT00490139|9262198|P1|Overall Study|Death|106
2684456|NCT00490061|9262233|P1|Overall Study|Physician Decision|1
2684457|NCT00490035|9262242|P4|Overall Study|AE of unknown type|0
2684458|NCT00490035|9262243|P3|Overall Study|AE of unknown type|2
2684459|NCT00490035|9262244|P2|Overall Study|AE of unknown type|0
2684460|NCT00490035|9262245|P1|Overall Study|AE of unknown type|0
2684461|NCT00490035|9262242|P4|Overall Study|Serious adverse event (SAE), non-fatal|0
2684462|NCT00490035|9262243|P3|Overall Study|Serious adverse event (SAE), non-fatal|1
2684463|NCT00490035|9262244|P2|Overall Study|Serious adverse event (SAE), non-fatal|0
2684464|NCT00490035|9262245|P1|Overall Study|Serious adverse event (SAE), non-fatal|0
2684465|NCT00490035|9262242|P4|Overall Study|AE, serious fatal|0
2684466|NCT00490035|9262243|P3|Overall Study|AE, serious fatal|0
2684467|NCT00490035|9262244|P2|Overall Study|AE, serious fatal|0
2684468|NCT00490035|9262245|P1|Overall Study|AE, serious fatal|1
2684469|NCT00490035|9262242|P4|Overall Study|Other reason|1
2684470|NCT00490035|9262243|P3|Overall Study|Other reason|3
2684471|NCT00490035|9262244|P2|Overall Study|Other reason|1
2684472|NCT00490035|9262245|P1|Overall Study|Other reason|0
2684473|NCT00490035|9262242|P4|Overall Study|Withdrawal by Subject|0
2684474|NCT00490035|9262243|P3|Overall Study|Withdrawal by Subject|1
2684475|NCT00490035|9262244|P2|Overall Study|Withdrawal by Subject|1
2684476|NCT00490035|9262245|P1|Overall Study|Withdrawal by Subject|2
2684477|NCT00490035|9262242|P4|Overall Study|Lost to Follow-up|0
2684478|NCT00490035|9262243|P3|Overall Study|Lost to Follow-up|1
2684479|NCT00490035|9262244|P2|Overall Study|Lost to Follow-up|0
2684480|NCT00490035|9262245|P1|Overall Study|Lost to Follow-up|2
2684481|NCT00490035|9262242|P4|Overall Study|AE, non-serious non-fatal|5
2684482|NCT00490035|9262243|P3|Overall Study|AE, non-serious non-fatal|4
2684483|NCT00490035|9262244|P2|Overall Study|AE, non-serious non-fatal|4
2684484|NCT00490035|9262245|P1|Overall Study|AE, non-serious non-fatal|3
2684485|NCT00490022|9262345|P2|Overall Study|Subject failed to disclose concommitant|1
2684486|NCT00490022|9262346|P1|Overall Study|Subject failed to disclose concommitant|0
2684487|NCT00490022|9262345|P2|Overall Study|Withdrawal by Subject|0
2684488|NCT00490022|9262346|P1|Overall Study|Withdrawal by Subject|1
2684489|NCT00490022|9262345|P2|Overall Study|Adverse Event|2
2684490|NCT00490022|9262346|P1|Overall Study|Adverse Event|0
2684491|NCT00489970|9262363|P3|Persistence Year 9|Other|2
2684492|NCT00489970|9262364|P2|Persistence Year 9|Other|0
2684493|NCT00489970|9262365|P1|Persistence Year 9|Other|1
2684494|NCT00489970|9262363|P3|Persistence Year 9|Lost to Follow-up|3
2684495|NCT00489970|9262364|P2|Persistence Year 9|Lost to Follow-up|2
2684496|NCT00489970|9262365|P1|Persistence Year 9|Lost to Follow-up|2
2684497|NCT00489918|9262469|P5|Overall Study|Physician Decision|0
2684498|NCT00489918|9262470|P4|Overall Study|Physician Decision|0
2684499|NCT00489918|9262471|P3|Overall Study|Physician Decision|1
2684500|NCT00489918|9262472|P2|Overall Study|Physician Decision|0
2684501|NCT00489918|9262473|P1|Overall Study|Physician Decision|0
2684502|NCT00489918|9262469|P5|Overall Study|Lost to Follow-up|0
2684503|NCT00489918|9262470|P4|Overall Study|Lost to Follow-up|1
2684504|NCT00489918|9262471|P3|Overall Study|Lost to Follow-up|1
2684505|NCT00489918|9262472|P2|Overall Study|Lost to Follow-up|0
2684506|NCT00489918|9262473|P1|Overall Study|Lost to Follow-up|0
2684507|NCT00489918|9262469|P5|Overall Study|Adverse Event|0
2684508|NCT00489918|9262470|P4|Overall Study|Adverse Event|0
2684509|NCT00489918|9262471|P3|Overall Study|Adverse Event|1
2684510|NCT00489918|9262472|P2|Overall Study|Adverse Event|1
2684511|NCT00489918|9262473|P1|Overall Study|Adverse Event|0
2684512|NCT00489918|9262469|P5|Overall Study|Withdrawal by Subject|1
2684513|NCT00489918|9262470|P4|Overall Study|Withdrawal by Subject|0
2684514|NCT00489918|9262471|P3|Overall Study|Withdrawal by Subject|1
2684515|NCT00489918|9262472|P2|Overall Study|Withdrawal by Subject|1
2684516|NCT00489918|9262473|P1|Overall Study|Withdrawal by Subject|2
2684517|NCT00489853|9262522|P3|Treatment Period 3|Study specific discontinuation criteria|0
2684518|NCT00489853|9262523|P2|Treatment Period 3|Study specific discontinuation criteria|1
2684519|NCT00489853|9262524|P1|Treatment Period 3|Study specific discontinuation criteria|0
2684520|NCT00489853|9262522|P3|Wash-out Period 2|Study specific discontinuation criteria|2
2684521|NCT00489853|9262523|P2|Wash-out Period 2|Study specific discontinuation criteria|2
2684522|NCT00489853|9262524|P1|Wash-out Period 2|Study specific discontinuation criteria|3
2684523|NCT00489853|9262522|P3|Wash-out Period 2|Adverse Event|0
2684524|NCT00489853|9262523|P2|Wash-out Period 2|Adverse Event|1
2684525|NCT00489853|9262524|P1|Wash-out Period 2|Adverse Event|1
2684526|NCT00489853|9262522|P3|Wash-out Period 1|Study-specific discontinuation criteria|4
2684527|NCT00489853|9262523|P2|Wash-out Period 1|Study-specific discontinuation criteria|1
2684528|NCT00489853|9262524|P1|Wash-out Period 1|Study-specific discontinuation criteria|0
2684529|NCT00489853|9262522|P3|Wash-out Period 1|Protocol Violation|1
2684530|NCT00489853|9262523|P2|Wash-out Period 1|Protocol Violation|1
2684531|NCT00489853|9262524|P1|Wash-out Period 1|Protocol Violation|0
2684532|NCT00489853|9262522|P3|Wash-out Period 1|Adverse Event|1
2684533|NCT00489853|9262523|P2|Wash-out Period 1|Adverse Event|1
2684534|NCT00489853|9262524|P1|Wash-out Period 1|Adverse Event|0
2684535|NCT00489853|9262522|P3|Wash-out Period 1|Withdrawal by Subject|0
2684536|NCT00489853|9262523|P2|Wash-out Period 1|Withdrawal by Subject|0
2684537|NCT00489853|9262524|P1|Wash-out Period 1|Withdrawal by Subject|1
2684538|NCT00489827|9262621|P2|Overall Study|Intraoperative exclusion criteria|1
2684539|NCT00489827|9262622|P1|Overall Study|Intraoperative exclusion criteria|1
2684540|NCT00489827|9262621|P2|Overall Study|Intraoperative exclusion criteria|1
2684541|NCT00489827|9262622|P1|Overall Study|Intraoperative exclusion criteria|1
2684542|NCT00489736|9262646|P2|Overall Study|Not coded/ Not pre-specified|8
2684543|NCT00489736|9262647|P1|Overall Study|Not coded/ Not pre-specified|5
2684544|NCT00489736|9262646|P2|Overall Study|Poor compliance|2
2684545|NCT00489736|9262647|P1|Overall Study|Poor compliance|6
2684546|NCT00489736|9262646|P2|Overall Study|Adverse Event|45
2684547|NCT00489736|9262647|P1|Overall Study|Adverse Event|32
2684548|NCT00489736|9262646|P2|Overall Study|Lack of Efficacy|14
2684549|NCT00489736|9262647|P1|Overall Study|Lack of Efficacy|53
2684550|NCT00489554|9262657|P1|Overall Study|Lost to Follow-up|1
2684551|NCT00489554|9262657|P1|Overall Study|Withdrawal by Subject|1
2684552|NCT00489554|9262657|P1|Overall Study|Adverse Event|2
2684553|NCT00489541|9262677|P2|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5
2684554|NCT00489541|9262678|P1|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4
2684555|NCT00489541|9262677|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12
2684556|NCT00489541|9262678|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23
2684557|NCT00489541|9262677|P2|12-Month Clinical Follow-up|Death|2
2684558|NCT00489541|9262678|P1|12-Month Clinical Follow-up|Death|3
2684559|NCT00489541|9262677|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|0
2684560|NCT00489541|9262678|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|2
2684561|NCT00489541|9262677|P2|12-Month Clinical Follow-up|Lost to Follow-up|0
2684562|NCT00489541|9262678|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
2684563|NCT00489541|9262677|P2|12-Month Clinical Follow-up|Withdrawal by Subject|3
2684564|NCT00489541|9262678|P1|12-Month Clinical Follow-up|Withdrawal by Subject|2
2684565|NCT00489489|9262689|P3|Overall Study|Other than above|0
2684566|NCT00489489|9262690|P2|Overall Study|Other than above|1
2684567|NCT00489489|9262691|P1|Overall Study|Other than above|0
2684568|NCT00489489|9262689|P3|Overall Study|Participant did not wish to continue|0
2684569|NCT00489489|9262690|P2|Overall Study|Participant did not wish to continue|1
2684570|NCT00489489|9262691|P1|Overall Study|Participant did not wish to continue|1
2684571|NCT00489489|9262689|P3|Overall Study|Progressive disease|0
2684572|NCT00489489|9262690|P2|Overall Study|Progressive disease|1
2684573|NCT00489489|9262691|P1|Overall Study|Progressive disease|0
2684574|NCT00489489|9262689|P3|Overall Study|Protocol Violation|1
2684575|NCT00489489|9262690|P2|Overall Study|Protocol Violation|0
2684576|NCT00489489|9262691|P1|Overall Study|Protocol Violation|1
2684577|NCT00489489|9262689|P3|Overall Study|Adverse Event|1
2684578|NCT00489489|9262690|P2|Overall Study|Adverse Event|1
2684579|NCT00489489|9262691|P1|Overall Study|Adverse Event|1
2684580|NCT00489489|9262689|P3|Overall Study|Not treated due to protocol violation|1
2684581|NCT00489489|9262690|P2|Overall Study|Not treated due to protocol violation|1
2684582|NCT00489489|9262691|P1|Overall Study|Not treated due to protocol violation|0
2684583|NCT00489476|9262723|P4|Overall Study|Lost to Follow-up|0
2684584|NCT00489476|9262724|P3|Overall Study|Lost to Follow-up|0
2684585|NCT00489476|9262725|P2|Overall Study|Lost to Follow-up|1
2684586|NCT00489476|9262726|P1|Overall Study|Lost to Follow-up|0
2684587|NCT00489424|9262747|P3|Overall Study|Administrative problems|1
2684588|NCT00489424|9262748|P2|Overall Study|Administrative problems|2
2684589|NCT00489424|9262749|P1|Overall Study|Administrative problems|0
2684590|NCT00489424|9262747|P3|Overall Study|Lack of Efficacy|0
2684591|NCT00489424|9262748|P2|Overall Study|Lack of Efficacy|0
2684592|NCT00489424|9262749|P1|Overall Study|Lack of Efficacy|1
2684593|NCT00489424|9262747|P3|Overall Study|Adverse Event|4
2684594|NCT00489424|9262748|P2|Overall Study|Adverse Event|3
2684595|NCT00489424|9262749|P1|Overall Study|Adverse Event|3
2684596|NCT00489411|9262780|P2|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
2684597|NCT00489411|9262781|P1|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
2684598|NCT00489411|9262780|P2|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12
2684599|NCT00489411|9262781|P1|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11
2684600|NCT00489411|9262780|P2|Initial Treatment Period (Weeks 1-5)|Incomplete data|5
2684601|NCT00489411|9262781|P1|Initial Treatment Period (Weeks 1-5)|Incomplete data|1
2684602|NCT00489411|9262780|P2|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12
2684603|NCT00489411|9262781|P1|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21
2684604|NCT00489411|9262780|P2|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5
2684605|NCT00489411|9262781|P1|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6
2684606|NCT00489359|9262795|P2|Overall Study|Adverse Event|16
2684607|NCT00489359|9262796|P1|Overall Study|Adverse Event|0
2684608|NCT00489359|9262795|P2|Overall Study|Withdrawal by Subject|5
2684609|NCT00489359|9262796|P1|Overall Study|Withdrawal by Subject|1
2684610|NCT00489359|9262795|P2|Overall Study|Lost to Follow-up|0
2684611|NCT00489359|9262796|P1|Overall Study|Lost to Follow-up|1
2684612|NCT00489359|9262795|P2|Overall Study|Progressive Disease|6
2684613|NCT00489359|9262796|P1|Overall Study|Progressive Disease|5
2684614|NCT00489359|9262795|P2|Overall Study|Death|2
2684615|NCT00489359|9262796|P1|Overall Study|Death|0
2684616|NCT00489255|9262872|P2|Period 3: Days 57 to 84|Lost to Follow-up|1
2684617|NCT00489255|9262873|P1|Period 3: Days 57 to 84|Lost to Follow-up|0
2684618|NCT00489255|9262872|P2|Period 3: Days 57 to 84|Withdrawal by Subject|0
2684619|NCT00489255|9262873|P1|Period 3: Days 57 to 84|Withdrawal by Subject|1
2684620|NCT00489255|9262872|P2|Period 3: Days 57 to 84|Adverse Event|3
2684621|NCT00489255|9262873|P1|Period 3: Days 57 to 84|Adverse Event|3
2684622|NCT00489255|9262872|P2|Period 2: Days 29 to 56|Withdrawal by Subject|3
2684623|NCT00489255|9262873|P1|Period 2: Days 29 to 56|Withdrawal by Subject|0
2684624|NCT00489255|9262872|P2|Period 2: Days 29 to 56|Adverse Event|1
2684625|NCT00489255|9262873|P1|Period 2: Days 29 to 56|Adverse Event|3
2684626|NCT00489255|9262872|P2|Period 1: Days 1 to 28|Noncompliance|0
2684627|NCT00489255|9262873|P1|Period 1: Days 1 to 28|Noncompliance|2
2684628|NCT00489255|9262872|P2|Period 1: Days 1 to 28|Physician Decision|4
2684629|NCT00489255|9262873|P1|Period 1: Days 1 to 28|Physician Decision|1
2684630|NCT00489255|9262872|P2|Period 1: Days 1 to 28|Withdrawal by Subject|0
2684631|NCT00489255|9262873|P1|Period 1: Days 1 to 28|Withdrawal by Subject|5
2684632|NCT00489255|9262872|P2|Period 1: Days 1 to 28|Adverse Event|8
2684633|NCT00489255|9262873|P1|Period 1: Days 1 to 28|Adverse Event|21
2684634|NCT00489255|9262872|P2|Screening and Initial Randomization|Discontinued prior to taking study drug|3
2684635|NCT00489255|9262873|P1|Screening and Initial Randomization|Discontinued prior to taking study drug|9
2684636|NCT00489216|9262921|P1|Overall Study|Adverse Event|1
2684637|NCT00488982|9262934|P3|Course 1|Adverse Event|6
2684638|NCT00488982|9262935|P2|Course 1|Adverse Event|0
2684639|NCT00488982|9262936|P1|Course 1|Adverse Event|0
2684640|NCT00488982|9262934|P3|Course 1|nonprotocol therapy|2
2684641|NCT00488982|9262935|P2|Course 1|nonprotocol therapy|2
2684642|NCT00488982|9262936|P1|Course 1|nonprotocol therapy|0
2684643|NCT00488982|9262934|P3|Course 1|Withdrawal by Subject|2
2684644|NCT00488982|9262935|P2|Course 1|Withdrawal by Subject|8
2684645|NCT00488982|9262936|P1|Course 1|Withdrawal by Subject|0
2684646|NCT00488982|9262934|P3|Course 1|Physician Decision|4
2684647|NCT00488982|9262935|P2|Course 1|Physician Decision|2
2684648|NCT00488982|9262936|P1|Course 1|Physician Decision|0
2684649|NCT00488826|9262959|P3|Overall Study|Protocol Deviations|1
2684650|NCT00488826|9262960|P2|Overall Study|Protocol Deviations|1
2684651|NCT00488826|9262961|P1|Overall Study|Protocol Deviations|2
2684652|NCT00488826|9262959|P3|Overall Study|Lost to Follow-up|0
2684653|NCT00488826|9262960|P2|Overall Study|Lost to Follow-up|1
2684654|NCT00488826|9262961|P1|Overall Study|Lost to Follow-up|5
2684655|NCT00488826|9262959|P3|Overall Study|Adverse Event|4
2684656|NCT00488826|9262960|P2|Overall Study|Adverse Event|15
2684657|NCT00488826|9262961|P1|Overall Study|Adverse Event|9
2684658|NCT00488826|9262959|P3|Overall Study|Protocol Violation|2
2684659|NCT00488826|9262960|P2|Overall Study|Protocol Violation|0
2684660|NCT00488826|9262961|P1|Overall Study|Protocol Violation|0
2684661|NCT00488826|9262959|P3|Overall Study|Withdrawal by Subject|19
2684662|NCT00488826|9262960|P2|Overall Study|Withdrawal by Subject|35
2684663|NCT00488826|9262961|P1|Overall Study|Withdrawal by Subject|40
2684664|NCT00488774|9262976|P4|Overall Study|Lost to Follow-up|1
2684665|NCT00488774|9262977|P3|Overall Study|Lost to Follow-up|1
2684666|NCT00488774|9262978|P2|Overall Study|Lost to Follow-up|0
2684667|NCT00488774|9262979|P1|Overall Study|Lost to Follow-up|0
2684668|NCT00488774|9262976|P4|Overall Study|Other|2
2684669|NCT00488774|9262977|P3|Overall Study|Other|2
2684670|NCT00488774|9262978|P2|Overall Study|Other|3
2684671|NCT00488774|9262979|P1|Overall Study|Other|6
2684672|NCT00488774|9262976|P4|Overall Study|Withdrawal of consent|0
2684673|NCT00488774|9262977|P3|Overall Study|Withdrawal of consent|2
2684674|NCT00488774|9262978|P2|Overall Study|Withdrawal of consent|2
2684675|NCT00488774|9262979|P1|Overall Study|Withdrawal of consent|2
2684676|NCT00488683|9262996|P3|Overall Study|Unable to Classify|0
2684677|NCT00488683|9262997|P2|Overall Study|Unable to Classify|0
2684678|NCT00488683|9262998|P1|Overall Study|Unable to Classify|1
2684679|NCT00488683|9262996|P3|Overall Study|Protocol Violation|0
2684680|NCT00488683|9262997|P2|Overall Study|Protocol Violation|1
2684681|NCT00488683|9262998|P1|Overall Study|Protocol Violation|5
2684682|NCT00488683|9262996|P3|Overall Study|Lost to Follow-up|0
2684683|NCT00488683|9262997|P2|Overall Study|Lost to Follow-up|3
2684684|NCT00488683|9262998|P1|Overall Study|Lost to Follow-up|5
2684685|NCT00488683|9262996|P3|Overall Study|Withdrawal by Subject|2
2684686|NCT00488683|9262997|P2|Overall Study|Withdrawal by Subject|2
2684687|NCT00488683|9262998|P1|Overall Study|Withdrawal by Subject|1
2684688|NCT00488644|9263057|P1|Overall Study|Not Evaluable|1
2684689|NCT00488644|9263057|P1|Overall Study|Not Eligible|1
2684690|NCT00488631|9263067|P10|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
2684691|NCT00488631|9263068|P9|Open Label Study Extension (Week 54-228)|Unspecified reasons|87
2684692|NCT00488631|9263069|P8|Open Label Study Extension (Week 54-228)|Unspecified reasons|14
2684693|NCT00488631|9263070|P7|Open Label Study Extension (Week 54-228)|Unspecified reasons|63
2684694|NCT00488631|9263071|P6|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
2684695|NCT00488631|9263072|P5|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
2684696|NCT00488631|9263073|P4|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
2684697|NCT00488631|9263074|P3|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
2684698|NCT00488631|9263075|P2|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
2684699|NCT00488631|9263076|P1|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
2684700|NCT00488631|9263067|P10|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
2684701|NCT00488631|9263068|P9|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6
2684702|NCT00488631|9263069|P8|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
2684703|NCT00488631|9263070|P7|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2
2684704|NCT00488631|9263071|P6|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
2684705|NCT00488631|9263072|P5|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
2684706|NCT00488631|9263073|P4|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
2684707|NCT00488631|9263074|P3|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
2684708|NCT00488631|9263075|P2|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
2684709|NCT00488631|9263076|P1|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
2684710|NCT00488631|9263067|P10|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3
2684711|NCT00488631|9263068|P9|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34
2684712|NCT00488631|9263069|P8|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
2684713|NCT00488631|9263070|P7|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
2684714|NCT00488631|9263071|P6|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
2684715|NCT00488631|9263072|P5|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
2684716|NCT00488631|9263073|P4|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
2684717|NCT00488631|9263074|P3|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
2684718|NCT00488631|9263075|P2|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
2684719|NCT00488631|9263076|P1|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
2684720|NCT00488631|9263067|P10|Open Label Study Extension (Week 54-228)|Death|0
2684721|NCT00488631|9263068|P9|Open Label Study Extension (Week 54-228)|Death|1
2684722|NCT00488631|9263069|P8|Open Label Study Extension (Week 54-228)|Death|0
2684723|NCT00488631|9263070|P7|Open Label Study Extension (Week 54-228)|Death|0
2684724|NCT00488631|9263071|P6|Open Label Study Extension (Week 54-228)|Death|0
2684725|NCT00488631|9263072|P5|Open Label Study Extension (Week 54-228)|Death|0
2684726|NCT00488631|9263073|P4|Open Label Study Extension (Week 54-228)|Death|0
2684727|NCT00488631|9263074|P3|Open Label Study Extension (Week 54-228)|Death|0
2684728|NCT00488631|9263075|P2|Open Label Study Extension (Week 54-228)|Death|0
2684729|NCT00488631|9263076|P1|Open Label Study Extension (Week 54-228)|Death|0
2684730|NCT00488631|9263067|P10|Open Label Study Extension (Week 54-228)|Adverse Event|0
2684731|NCT00488631|9263068|P9|Open Label Study Extension (Week 54-228)|Adverse Event|54
2684732|NCT00488631|9263069|P8|Open Label Study Extension (Week 54-228)|Adverse Event|8
2684733|NCT00488631|9263070|P7|Open Label Study Extension (Week 54-228)|Adverse Event|10
2684734|NCT00488631|9263071|P6|Open Label Study Extension (Week 54-228)|Adverse Event|0
2684735|NCT00488631|9263072|P5|Open Label Study Extension (Week 54-228)|Adverse Event|0
2684736|NCT00488631|9263073|P4|Open Label Study Extension (Week 54-228)|Adverse Event|0
2684737|NCT00488631|9263074|P3|Open Label Study Extension (Week 54-228)|Adverse Event|0
2684738|NCT00488631|9263075|P2|Open Label Study Extension (Week 54-228)|Adverse Event|0
2684739|NCT00488631|9263076|P1|Open Label Study Extension (Week 54-228)|Adverse Event|0
2684740|NCT00488631|9263067|P10|Double Blind Period (Week 0-54)|Other|0
2684741|NCT00488631|9263068|P9|Double Blind Period (Week 0-54)|Other|0
2684742|NCT00488631|9263069|P8|Double Blind Period (Week 0-54)|Other|0
2684743|NCT00488631|9263070|P7|Double Blind Period (Week 0-54)|Other|0
2684744|NCT00488631|9263071|P6|Double Blind Period (Week 0-54)|Other|34
2684745|NCT00488631|9263072|P5|Double Blind Period (Week 0-54)|Other|14
2684746|NCT00488631|9263073|P4|Double Blind Period (Week 0-54)|Other|11
2684747|NCT00488631|9263074|P3|Double Blind Period (Week 0-54)|Other|10
2684748|NCT00488631|9263075|P2|Double Blind Period (Week 0-54)|Other|12
2684749|NCT00488631|9263076|P1|Double Blind Period (Week 0-54)|Other|6
2684750|NCT00488631|9263067|P10|Double Blind Period (Week 0-54)|Lost to Follow-up|0
2684751|NCT00488631|9263068|P9|Double Blind Period (Week 0-54)|Lost to Follow-up|0
2684752|NCT00488631|9263069|P8|Double Blind Period (Week 0-54)|Lost to Follow-up|0
2684753|NCT00488631|9263070|P7|Double Blind Period (Week 0-54)|Lost to Follow-up|0
2684754|NCT00488631|9263071|P6|Double Blind Period (Week 0-54)|Lost to Follow-up|7
2684755|NCT00488631|9263072|P5|Double Blind Period (Week 0-54)|Lost to Follow-up|3
2684756|NCT00488631|9263073|P4|Double Blind Period (Week 0-54)|Lost to Follow-up|0
2684757|NCT00488631|9263074|P3|Double Blind Period (Week 0-54)|Lost to Follow-up|1
2684758|NCT00488631|9263075|P2|Double Blind Period (Week 0-54)|Lost to Follow-up|2
2684759|NCT00488631|9263076|P1|Double Blind Period (Week 0-54)|Lost to Follow-up|1
2684760|NCT00488631|9263067|P10|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
2684761|NCT00488631|9263068|P9|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
2684762|NCT00488631|9263069|P8|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
2684763|NCT00488631|9263070|P7|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
2684764|NCT00488631|9263071|P6|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124
2684765|NCT00488631|9263072|P5|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56
2684766|NCT00488631|9263073|P4|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18
2684767|NCT00488631|9263074|P3|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22
2684768|NCT00488631|9263075|P2|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17
2684769|NCT00488631|9263076|P1|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19
2684770|NCT00488631|9263067|P10|Double Blind Period (Week 0-54)|Death|0
2684771|NCT00488631|9263068|P9|Double Blind Period (Week 0-54)|Death|0
2684772|NCT00488631|9263069|P8|Double Blind Period (Week 0-54)|Death|0
2684773|NCT00488631|9263070|P7|Double Blind Period (Week 0-54)|Death|0
2684774|NCT00488631|9263071|P6|Double Blind Period (Week 0-54)|Death|1
2684775|NCT00488631|9263072|P5|Double Blind Period (Week 0-54)|Death|0
2684776|NCT00488631|9263073|P4|Double Blind Period (Week 0-54)|Death|0
2684777|NCT00488631|9263074|P3|Double Blind Period (Week 0-54)|Death|0
2684778|NCT00488631|9263075|P2|Double Blind Period (Week 0-54)|Death|0
2684779|NCT00488631|9263076|P1|Double Blind Period (Week 0-54)|Death|0
2684780|NCT00488631|9263067|P10|Double Blind Period (Week 0-54)|Adverse Event|0
2684781|NCT00488631|9263068|P9|Double Blind Period (Week 0-54)|Adverse Event|0
2684782|NCT00488631|9263069|P8|Double Blind Period (Week 0-54)|Adverse Event|0
2684783|NCT00488631|9263070|P7|Double Blind Period (Week 0-54)|Adverse Event|0
2684784|NCT00488631|9263071|P6|Double Blind Period (Week 0-54)|Adverse Event|50
2684785|NCT00488631|9263072|P5|Double Blind Period (Week 0-54)|Adverse Event|30
2684786|NCT00488631|9263073|P4|Double Blind Period (Week 0-54)|Adverse Event|12
2684787|NCT00488631|9263074|P3|Double Blind Period (Week 0-54)|Adverse Event|12
2684788|NCT00488631|9263075|P2|Double Blind Period (Week 0-54)|Adverse Event|12
2684789|NCT00488631|9263076|P1|Double Blind Period (Week 0-54)|Adverse Event|17
2684790|NCT00488618|9263113|P2|Overall Study|Lost to Follow-up|0
2684791|NCT00488618|9263114|P1|Overall Study|Lost to Follow-up|1
2684792|NCT00488618|9263113|P2|Overall Study|Withdrawal of Consent|13
2684793|NCT00488618|9263114|P1|Overall Study|Withdrawal of Consent|15
2684794|NCT00488618|9263113|P2|Overall Study|Protocol Violation|2
2684795|NCT00488618|9263114|P1|Overall Study|Protocol Violation|0
2684796|NCT00488618|9263113|P2|Overall Study|Insufficient Therapeutic Response|11
2684797|NCT00488618|9263114|P1|Overall Study|Insufficient Therapeutic Response|18
2684798|NCT00488618|9263113|P2|Overall Study|Adverse Event|17
2684799|NCT00488618|9263114|P1|Overall Study|Adverse Event|13
2684800|NCT00488592|9263122|P1|Overall Study|Enrolled but not treated|1
2684801|NCT00488592|9263122|P1|Overall Study|Disease progression|1
2684802|NCT00488592|9263122|P1|Overall Study|Withdrawal by Subject|1
2684803|NCT00488514|9263126|P1|Overall Study|Increased use of concomitant medication|1
2684804|NCT00488514|9263126|P1|Overall Study|Increase in number of migraines|2
2684805|NCT00488514|9263126|P1|Overall Study|Participant had too few migraines|5
2684806|NCT00488514|9263126|P1|Overall Study|Investigator decision|1
2684807|NCT00488514|9263126|P1|Overall Study|Withdrawn per medical monitor decision|2
2684808|NCT00488514|9263126|P1|Overall Study|Postive drug screen|1
2684809|NCT00488514|9263126|P1|Overall Study|Did not meet criteria for treatment|30
2684810|NCT00488514|9263126|P1|Overall Study|Lack of Efficacy|28
2684811|NCT00488514|9263126|P1|Overall Study|Withdrawal by Subject|106
2684812|NCT00488514|9263126|P1|Overall Study|Protocol Violation|32
2684813|NCT00488514|9263126|P1|Overall Study|Lost to Follow-up|44
2684814|NCT00488514|9263126|P1|Overall Study|Adverse Event|41
2684815|NCT00488475|9263214|P1|Overall Study|Other|1754
2684816|NCT00488345|9263243|P3|Overall Study|Parent/legal guardian request|1
2684817|NCT00488345|9263244|P2|Overall Study|Parent/legal guardian request|1
2684818|NCT00488345|9263245|P1|Overall Study|Parent/legal guardian request|0
2684819|NCT00488345|9263243|P3|Overall Study|Surgical team recommendation|0
2684820|NCT00488345|9263244|P2|Overall Study|Surgical team recommendation|1
2684821|NCT00488345|9263245|P1|Overall Study|Surgical team recommendation|0
2684822|NCT00488345|9263243|P3|Overall Study|Institutional Review Board review|1
2684823|NCT00488345|9263244|P2|Overall Study|Institutional Review Board review|0
2684824|NCT00488345|9263245|P1|Overall Study|Institutional Review Board review|0
2684825|NCT00488345|9263243|P3|Overall Study|Unable to administer antibiotics at home|0
2684826|NCT00488345|9263244|P2|Overall Study|Unable to administer antibiotics at home|1
2684827|NCT00488345|9263245|P1|Overall Study|Unable to administer antibiotics at home|0
2684828|NCT00488345|9263243|P3|Overall Study|Adverse Event|1
2684829|NCT00488345|9263244|P2|Overall Study|Adverse Event|1
2684830|NCT00488345|9263245|P1|Overall Study|Adverse Event|0
2684831|NCT00488319|9263271|P3|Overall Study|Other reasons for withdrawal|12
2684832|NCT00488319|9263272|P2|Overall Study|Other reasons for withdrawal|4
2684833|NCT00488319|9263273|P1|Overall Study|Other reasons for withdrawal|0
2684834|NCT00488319|9263271|P3|Overall Study|Withdrawal by Subject|44
2684835|NCT00488319|9263272|P2|Overall Study|Withdrawal by Subject|20
2684836|NCT00488319|9263273|P1|Overall Study|Withdrawal by Subject|5
2684837|NCT00488319|9263271|P3|Overall Study|Lost to Follow-up|16
2684838|NCT00488319|9263272|P2|Overall Study|Lost to Follow-up|5
2684839|NCT00488319|9263273|P1|Overall Study|Lost to Follow-up|3
2684840|NCT00488319|9263271|P3|Overall Study|Lack of Efficacy|27
2684841|NCT00488319|9263272|P2|Overall Study|Lack of Efficacy|12
2684842|NCT00488319|9263273|P1|Overall Study|Lack of Efficacy|6
2684843|NCT00488319|9263271|P3|Overall Study|Adverse Event|23
2684844|NCT00488319|9263272|P2|Overall Study|Adverse Event|2
2684845|NCT00488319|9263273|P1|Overall Study|Adverse Event|1
2684846|NCT00488293|9263360|P2|Overall Study|Misrandomization/Other Unspecified|1
2684847|NCT00488293|9263361|P1|Overall Study|Misrandomization/Other Unspecified|1
2684848|NCT00488293|9263360|P2|Overall Study|Death|1
2684849|NCT00488293|9263361|P1|Overall Study|Death|2
2684850|NCT00488293|9263360|P2|Overall Study|Withdrawal by Subject|3
2684851|NCT00488293|9263361|P1|Overall Study|Withdrawal by Subject|5
2684852|NCT00488293|9263360|P2|Overall Study|Lost to Follow-up|25
2684853|NCT00488293|9263361|P1|Overall Study|Lost to Follow-up|28
2684854|NCT00488033|9263406|P2|Overall Study|Withdrawal by Subject|0
2684855|NCT00488033|9263407|P1|Overall Study|Withdrawal by Subject|1
2684856|NCT00487981|9263423|P1|Overall Study|Hypothyroidism diagnosis|1
2684857|NCT00487942|9263431|P4|Overall Study|Withdrawal by Subject|0
2684858|NCT00487942|9263432|P3|Overall Study|Withdrawal by Subject|2
2684859|NCT00487942|9263433|P2|Overall Study|Withdrawal by Subject|1
2684860|NCT00487942|9263434|P1|Overall Study|Withdrawal by Subject|0
2684861|NCT00487942|9263431|P4|Overall Study|Protocol Violation|0
2684862|NCT00487942|9263432|P3|Overall Study|Protocol Violation|0
2684863|NCT00487942|9263433|P2|Overall Study|Protocol Violation|1
2684864|NCT00487942|9263434|P1|Overall Study|Protocol Violation|1
2684865|NCT00487942|9263431|P4|Overall Study|Lost to Follow-up|1
2684866|NCT00487942|9263432|P3|Overall Study|Lost to Follow-up|0
2684867|NCT00487942|9263433|P2|Overall Study|Lost to Follow-up|0
2684868|NCT00487942|9263434|P1|Overall Study|Lost to Follow-up|1
2684869|NCT00487942|9263431|P4|Overall Study|Adverse Event|1
2684870|NCT00487942|9263432|P3|Overall Study|Adverse Event|1
2684871|NCT00487942|9263433|P2|Overall Study|Adverse Event|1
2684872|NCT00487942|9263434|P1|Overall Study|Adverse Event|1
2684873|NCT00487825|9263818|P2|Overall Study|Other|2
2684874|NCT00487825|9263819|P1|Overall Study|Other|3
2684875|NCT00487825|9263818|P2|Overall Study|Lack of Efficacy|1
2684876|NCT00487825|9263819|P1|Overall Study|Lack of Efficacy|1
2684877|NCT00487825|9263818|P2|Overall Study|Adverse Event|2
2684878|NCT00487825|9263819|P1|Overall Study|Adverse Event|2
2684879|NCT00487747|9263831|P1|Overall Study|Lack of Efficacy|1
2684880|NCT00487747|9263831|P1|Overall Study|Lost to Follow-up|9
2684881|NCT00487747|9263831|P1|Overall Study|Adverse Event|1
2684882|NCT00487695|9263848|P2|Second Procedure|Withdrawal by Subject|2
2684883|NCT00487695|9263849|P1|Second Procedure|Withdrawal by Subject|1
2684884|NCT00487695|9263848|P2|Second Procedure|active wheezing|1
2684885|NCT00487695|9263849|P1|Second Procedure|active wheezing|0
2684886|NCT00487695|9263848|P2|First Procedure|esophageal stricture found (excl crit)|0
2684887|NCT00487695|9263849|P1|First Procedure|esophageal stricture found (excl crit)|1
2684888|NCT00487695|9263848|P2|First Procedure|active wheezing (did not have procedure)|0
2684889|NCT00487695|9263849|P1|First Procedure|active wheezing (did not have procedure)|1
2684890|NCT00487695|9263848|P2|First Procedure|invasive cancer on EGD (excl criteria)|0
2684891|NCT00487695|9263849|P1|First Procedure|invasive cancer on EGD (excl criteria)|1
2684892|NCT00487578|9263877|P2|Overall Study|Lost to Follow-up|1
2684893|NCT00487578|9263878|P1|Overall Study|Lost to Follow-up|0
2684894|NCT00487578|9263877|P2|Overall Study|Lack of Efficacy|1
2684895|NCT00487578|9263878|P1|Overall Study|Lack of Efficacy|0
2684896|NCT00487578|9263877|P2|Overall Study|Adverse Event|2
2684897|NCT00487578|9263878|P1|Overall Study|Adverse Event|1
2684898|NCT00487552|9263898|P1|Overall Study|Stent not placed|1
2684899|NCT00487552|9263898|P1|Overall Study|Death due to progressive malignancy|2
2684900|NCT00487552|9263898|P1|Overall Study|Unsuccessful magnet placements|3
2684901|NCT00487539|9263907|P4|Overall Study|Other|2
2684902|NCT00487539|9263908|P3|Overall Study|Other|2
2684903|NCT00487539|9263909|P2|Overall Study|Other|1
2684904|NCT00487539|9263910|P1|Overall Study|Other|3
2684905|NCT00487539|9263907|P4|Overall Study|Unsatisfactory therapeutic effect|1
2684906|NCT00487539|9263908|P3|Overall Study|Unsatisfactory therapeutic effect|0
2684907|NCT00487539|9263909|P2|Overall Study|Unsatisfactory therapeutic effect|0
2684908|NCT00487539|9263910|P1|Overall Study|Unsatisfactory therapeutic effect|1
2684909|NCT00487539|9263907|P4|Overall Study|Adverse Event|1
2684910|NCT00487539|9263908|P3|Overall Study|Adverse Event|1
2684911|NCT00487539|9263909|P2|Overall Study|Adverse Event|2
2684912|NCT00487539|9263910|P1|Overall Study|Adverse Event|3
2684913|NCT00487435|9263944|P1|Overall Study|Other|83
2684914|NCT00487435|9263944|P1|Overall Study|Study Medication Non-Compliant|32
2684915|NCT00487435|9263944|P1|Overall Study|Resolution Of Pain|1
2684916|NCT00487435|9263944|P1|Overall Study|Withdrawal by Subject|132
2684917|NCT00487435|9263944|P1|Overall Study|Pregnancy|2
2684918|NCT00487435|9263944|P1|Overall Study|Lost to Follow-up|54
2684919|NCT00487435|9263944|P1|Overall Study|Lack of Efficacy|33
2684920|NCT00487435|9263944|P1|Overall Study|Death|2
2684921|NCT00487435|9263944|P1|Overall Study|Adverse Event|146
2684922|NCT00487279|9263957|P2|Overall Study|Withdrawal by Subject|2
2684923|NCT00487279|9263958|P1|Overall Study|Withdrawal by Subject|0
2684924|NCT00487279|9263957|P2|Overall Study|Death|0
2684925|NCT00487279|9263958|P1|Overall Study|Death|1
2684926|NCT00487240|9263968|P2|Overall Study|Physician Decision|0
2684927|NCT00487240|9263969|P1|Overall Study|Physician Decision|2
2684928|NCT00487240|9263968|P2|Overall Study|Sponsor Decision|1
2684929|NCT00487240|9263969|P1|Overall Study|Sponsor Decision|2
2684930|NCT00487240|9263968|P2|Overall Study|Entry Criteria Not Met|4
2684931|NCT00487240|9263969|P1|Overall Study|Entry Criteria Not Met|3
2684932|NCT00487240|9263968|P2|Overall Study|Protocol Violation|5
2684933|NCT00487240|9263969|P1|Overall Study|Protocol Violation|5
2684934|NCT00487240|9263968|P2|Overall Study|Adverse Event|4
2684935|NCT00487240|9263969|P1|Overall Study|Adverse Event|0
2684936|NCT00487240|9263968|P2|Overall Study|Lost to Follow-up|6
2684937|NCT00487240|9263969|P1|Overall Study|Lost to Follow-up|7
2684938|NCT00487240|9263968|P2|Overall Study|Withdrawal by Subject|6
2684939|NCT00487240|9263969|P1|Overall Study|Withdrawal by Subject|12
2684940|NCT00487188|9263997|P3|Maintenance Phase|Administrative|1
2684941|NCT00487188|9263998|P2|Maintenance Phase|Administrative|0
2684942|NCT00487188|9263999|P1|Maintenance Phase|Administrative|0
2684943|NCT00487188|9263997|P3|Maintenance Phase|Lost to Follow-up|0
2684944|NCT00487188|9263998|P2|Maintenance Phase|Lost to Follow-up|0
2684945|NCT00487188|9263999|P1|Maintenance Phase|Lost to Follow-up|1
2684946|NCT00487188|9263997|P3|Maintenance Phase|Death|0
2684947|NCT00487188|9263998|P2|Maintenance Phase|Death|0
2684948|NCT00487188|9263999|P1|Maintenance Phase|Death|1
2684949|NCT00487188|9263997|P3|Maintenance Phase|Adverse Event|0
2684950|NCT00487188|9263998|P2|Maintenance Phase|Adverse Event|0
2684951|NCT00487188|9263999|P1|Maintenance Phase|Adverse Event|1
2684952|NCT00487188|9263997|P3|Induction Phase|Administrative|0
2684953|NCT00487188|9263998|P2|Induction Phase|Administrative|1
2684954|NCT00487188|9263999|P1|Induction Phase|Administrative|0
2684955|NCT00487188|9263997|P3|Induction Phase|Lost to Follow-up|0
2684956|NCT00487188|9263998|P2|Induction Phase|Lost to Follow-up|2
2684957|NCT00487188|9263999|P1|Induction Phase|Lost to Follow-up|2
2684958|NCT00487188|9263997|P3|Induction Phase|Refused Treatment|0
2684959|NCT00487188|9263998|P2|Induction Phase|Refused Treatment|2
2684960|NCT00487188|9263999|P1|Induction Phase|Refused Treatment|1
2684961|NCT00487188|9263997|P3|Induction Phase|Protocol Violation|0
2684962|NCT00487188|9263998|P2|Induction Phase|Protocol Violation|0
2684963|NCT00487188|9263999|P1|Induction Phase|Protocol Violation|1
2684964|NCT00487188|9263997|P3|Induction Phase|Lack of Efficacy|0
2684965|NCT00487188|9263998|P2|Induction Phase|Lack of Efficacy|1
2684966|NCT00487188|9263999|P1|Induction Phase|Lack of Efficacy|0
2684967|NCT00487188|9263997|P3|Induction Phase|Adverse Event|0
2684968|NCT00487188|9263998|P2|Induction Phase|Adverse Event|0
2684969|NCT00487188|9263999|P1|Induction Phase|Adverse Event|5
2684970|NCT00487188|9263997|P3|Induction Phase|Abnormality of Laboratory Test|0
2684971|NCT00487188|9263998|P2|Induction Phase|Abnormality of Laboratory Test|1
2684972|NCT00487188|9263999|P1|Induction Phase|Abnormality of Laboratory Test|0
2684973|NCT00487162|9264038|P2|Overall Study|Withdrawal by Subject|3
2684974|NCT00487162|9264039|P1|Overall Study|Withdrawal by Subject|2
2684975|NCT00487162|9264038|P2|Overall Study|Physician Decision|1
2684976|NCT00487162|9264039|P1|Overall Study|Physician Decision|0
2684977|NCT00487162|9264038|P2|Overall Study|Adverse Event|1
2684978|NCT00487162|9264039|P1|Overall Study|Adverse Event|0
2684979|NCT00487084|9264050|P3|Overall Study|Did not receive intervention|5
2684980|NCT00487084|9264051|P2|Overall Study|Did not receive intervention|3
2684981|NCT00487084|9264052|P1|Overall Study|Did not receive intervention|4
2684982|NCT00486954|9264073|P5|Randomized Part|Sponsor Terminated Study|13
2684983|NCT00486954|9264074|P4|Randomized Part|Sponsor Terminated Study|19
2684984|NCT00486954|9264075|P3|Randomized Part|Sponsor Terminated Study|0
2684985|NCT00486954|9264076|P2|Randomized Part|Sponsor Terminated Study|0
2684986|NCT00486954|9264077|P1|Randomized Part|Sponsor Terminated Study|0
2684987|NCT00486954|9264073|P5|Randomized Part|Withdrawal by Subject|0
2684988|NCT00486954|9264074|P4|Randomized Part|Withdrawal by Subject|1
2684989|NCT00486954|9264075|P3|Randomized Part|Withdrawal by Subject|0
2684990|NCT00486954|9264076|P2|Randomized Part|Withdrawal by Subject|0
2684991|NCT00486954|9264077|P1|Randomized Part|Withdrawal by Subject|0
2684992|NCT00486954|9264073|P5|Randomized Part|Lost to Follow-up|1
2684993|NCT00486954|9264074|P4|Randomized Part|Lost to Follow-up|0
2684994|NCT00486954|9264075|P3|Randomized Part|Lost to Follow-up|0
2684995|NCT00486954|9264076|P2|Randomized Part|Lost to Follow-up|0
2684996|NCT00486954|9264077|P1|Randomized Part|Lost to Follow-up|0
2684997|NCT00486954|9264073|P5|Pilot Part|Disease Progression|0
2684998|NCT00486954|9264074|P4|Pilot Part|Disease Progression|0
2684999|NCT00486954|9264075|P3|Pilot Part|Disease Progression|1
2685000|NCT00486954|9264076|P2|Pilot Part|Disease Progression|0
2685001|NCT00486954|9264077|P1|Pilot Part|Disease Progression|2
2685002|NCT00486954|9264073|P5|Pilot Part|Adverse Event|0
2685003|NCT00486954|9264074|P4|Pilot Part|Adverse Event|0
2685004|NCT00486954|9264075|P3|Pilot Part|Adverse Event|5
2685005|NCT00486954|9264076|P2|Pilot Part|Adverse Event|0
2685006|NCT00486954|9264077|P1|Pilot Part|Adverse Event|4
2685007|NCT00486902|9264175|P2|Overall Study|No toradol due to hemmorhage or allergy|1
2685008|NCT00486902|9264176|P1|Overall Study|No toradol due to hemmorhage or allergy|3
2685009|NCT00486902|9264175|P2|Overall Study|Did not meet inclusion criteria|0
2685010|NCT00486902|9264176|P1|Overall Study|Did not meet inclusion criteria|1
2685011|NCT00486902|9264175|P2|Overall Study|spinal anesthetic protocal violation|1
2685012|NCT00486902|9264176|P1|Overall Study|spinal anesthetic protocal violation|1
2685013|NCT00486902|9264175|P2|Overall Study|decision for postpartum tubal ligation|1
2685014|NCT00486902|9264176|P1|Overall Study|decision for postpartum tubal ligation|3
2685015|NCT00486902|9264175|P2|Overall Study|Withdrawal by Subject|2
2685016|NCT00486902|9264176|P1|Overall Study|Withdrawal by Subject|1
2685017|NCT00486837|9264243|P2|Overall Study|No sputum, devise issues, exacerbation|4
2685018|NCT00486837|9264244|P1|Overall Study|No sputum, devise issues, exacerbation|3
2685019|NCT00486837|9264243|P2|Overall Study|Protocol Violation|2
2685020|NCT00486837|9264244|P1|Overall Study|Protocol Violation|4
2685021|NCT00486837|9264243|P2|Overall Study|Adverse Event|1
2685022|NCT00486837|9264244|P1|Overall Study|Adverse Event|1
2685023|NCT00486837|9264243|P2|Overall Study|Withdrawal by Subject|0
2685024|NCT00486837|9264244|P1|Overall Study|Withdrawal by Subject|1
2685025|NCT00486811|9264284|P3|Overall Study|All other|7
2685026|NCT00486811|9264285|P2|Overall Study|All other|11
2685027|NCT00486811|9264286|P1|Overall Study|All other|18
2685028|NCT00486811|9264284|P3|Overall Study|Study drug non-compliant|3
2685029|NCT00486811|9264285|P2|Overall Study|Study drug non-compliant|6
2685030|NCT00486811|9264286|P1|Overall Study|Study drug non-compliant|5
2685031|NCT00486811|9264284|P3|Overall Study|Withdrawal by Subject|58
2685032|NCT00486811|9264285|P2|Overall Study|Withdrawal by Subject|44
2685033|NCT00486811|9264286|P1|Overall Study|Withdrawal by Subject|33
2685034|NCT00486811|9264284|P3|Overall Study|Lost to Follow-up|4
2685035|NCT00486811|9264285|P2|Overall Study|Lost to Follow-up|6
2685036|NCT00486811|9264286|P1|Overall Study|Lost to Follow-up|4
2685037|NCT00486811|9264284|P3|Overall Study|Lack of Efficacy|7
2685038|NCT00486811|9264285|P2|Overall Study|Lack of Efficacy|14
2685039|NCT00486811|9264286|P1|Overall Study|Lack of Efficacy|34
2685040|NCT00486811|9264284|P3|Overall Study|Adverse Event|135
2685041|NCT00486811|9264285|P2|Overall Study|Adverse Event|60
2685042|NCT00486811|9264286|P1|Overall Study|Adverse Event|28
2685043|NCT00486759|9264329|P2|Safety Follow-up|Adverse event/intercurrent illness|0
2685044|NCT00486759|9264330|P1|Safety Follow-up|Adverse event/intercurrent illness|4
2685045|NCT00486759|9264329|P2|Safety Follow-up|Refused treatment/did not cooperate|4
2685046|NCT00486759|9264330|P1|Safety Follow-up|Refused treatment/did not cooperate|6
2685047|NCT00486759|9264329|P2|Safety Follow-up|Administrative/not specified|6
2685048|NCT00486759|9264330|P1|Safety Follow-up|Administrative/not specified|8
2685049|NCT00486759|9264329|P2|Safety Follow-up|Failure to return|6
2685050|NCT00486759|9264330|P1|Safety Follow-up|Failure to return|9
2685051|NCT00486759|9264329|P2|Safety Follow-up|Withdrew consent|23
2685052|NCT00486759|9264330|P1|Safety Follow-up|Withdrew consent|32
2685053|NCT00486759|9264329|P2|Safety Follow-up|Death|29
2685054|NCT00486759|9264330|P1|Safety Follow-up|Death|40
2685055|NCT00486759|9264329|P2|Safety Follow-up|Insufficient therapeutic response|50
2685056|NCT00486759|9264330|P1|Safety Follow-up|Insufficient therapeutic response|40
2685057|NCT00486759|9264329|P2|Treatment|Failure to return|1
2685058|NCT00486759|9264330|P1|Treatment|Failure to return|1
2685059|NCT00486759|9264329|P2|Treatment|Other protocol violation|5
2685060|NCT00486759|9264330|P1|Treatment|Other protocol violation|1
2685061|NCT00486759|9264329|P2|Treatment|Violation of selection criteria at entry|3
2685062|NCT00486759|9264330|P1|Treatment|Violation of selection criteria at entry|3
2685063|NCT00486759|9264329|P2|Treatment|Refused treatment|7
2685064|NCT00486759|9264330|P1|Treatment|Refused treatment|10
2685065|NCT00486759|9264329|P2|Treatment|Administrative/reason not specified|21
2685066|NCT00486759|9264330|P1|Treatment|Administrative/reason not specified|17
2685067|NCT00486759|9264329|P2|Treatment|Withdrew consent|12
2685068|NCT00486759|9264330|P1|Treatment|Withdrew consent|15
2685069|NCT00486759|9264329|P2|Treatment|Death|10
2685070|NCT00486759|9264330|P1|Treatment|Death|17
2685071|NCT00486759|9264329|P2|Treatment|Insufficient therapeutic response|39
2685072|NCT00486759|9264330|P1|Treatment|Insufficient therapeutic response|37
2685073|NCT00486759|9264329|P2|Treatment|Adverse event/intercurrent illness|39
2685074|NCT00486759|9264330|P1|Treatment|Adverse event/intercurrent illness|86
2685075|NCT00486720|9264342|P2|Overall Study|Progressive Disease|1
2685076|NCT00486720|9264343|P1|Overall Study|Progressive Disease|0
2685077|NCT00486720|9264342|P2|Overall Study|Withdrawal by Subject|1
2685078|NCT00486720|9264343|P1|Overall Study|Withdrawal by Subject|3
2685079|NCT00486720|9264342|P2|Overall Study|Protocol Violation|0
2685080|NCT00486720|9264343|P1|Overall Study|Protocol Violation|1
2685081|NCT00486720|9264342|P2|Overall Study|Physician Decision|2
2685082|NCT00486720|9264343|P1|Overall Study|Physician Decision|1
2685083|NCT00486720|9264342|P2|Overall Study|Lack of Efficacy|6
2685084|NCT00486720|9264343|P1|Overall Study|Lack of Efficacy|4
2685085|NCT00486720|9264342|P2|Overall Study|Adverse Event|2
2685086|NCT00486720|9264343|P1|Overall Study|Adverse Event|1
2685087|NCT00486603|9264378|P5|Overall Study|Physician Decision|0
2685088|NCT00486603|9264379|P4|Overall Study|Physician Decision|0
2685089|NCT00486603|9264380|P3|Overall Study|Physician Decision|0
2685090|NCT00486603|9264381|P2|Overall Study|Physician Decision|1
2685091|NCT00486603|9264382|P1|Overall Study|Physician Decision|0
2685092|NCT00486603|9264378|P5|Overall Study|Withdrawal by Subject|0
2685093|NCT00486603|9264379|P4|Overall Study|Withdrawal by Subject|0
2685094|NCT00486603|9264380|P3|Overall Study|Withdrawal by Subject|0
2685095|NCT00486603|9264381|P2|Overall Study|Withdrawal by Subject|0
2685096|NCT00486603|9264382|P1|Overall Study|Withdrawal by Subject|1
2685097|NCT00486434|9264430|P2|Overall Study|Personal reasons|6
2685098|NCT00486434|9264431|P1|Overall Study|Personal reasons|5
2685099|NCT00486434|9264430|P2|Overall Study|Death|2
2685100|NCT00486434|9264431|P1|Overall Study|Death|1
2685101|NCT00486434|9264430|P2|Overall Study|Lost to Follow-up|3
2685102|NCT00486434|9264431|P1|Overall Study|Lost to Follow-up|2
2685103|NCT00486434|9264430|P2|Overall Study|Lack of Efficacy|19
2685104|NCT00486434|9264431|P1|Overall Study|Lack of Efficacy|12
2685105|NCT00486434|9264430|P2|Overall Study|Protocol Violation|21
2685106|NCT00486434|9264431|P1|Overall Study|Protocol Violation|22
2685107|NCT00486434|9264430|P2|Overall Study|Adverse Event|44
2685108|NCT00486434|9264431|P1|Overall Study|Adverse Event|118
2685109|NCT00486434|9264430|P2|Overall Study|Withdrawal by Subject|39
2685110|NCT00486434|9264431|P1|Overall Study|Withdrawal by Subject|34
2685111|NCT00486330|9264450|P1|Overall Study|Adverse Event|2
2685112|NCT00486291|9264456|P2|Overall Study|requirement for restricted medication|3
2685113|NCT00486291|9264457|P1|Overall Study|requirement for restricted medication|0
2685114|NCT00486291|9264456|P2|Overall Study|protocol non-compliance|15
2685115|NCT00486291|9264457|P1|Overall Study|protocol non-compliance|10
2685116|NCT00486291|9264456|P2|Overall Study|Lost to Follow-up|7
2685117|NCT00486291|9264457|P1|Overall Study|Lost to Follow-up|3
2685118|NCT00486291|9264456|P2|Overall Study|Adverse Event|4
2685119|NCT00486291|9264457|P1|Overall Study|Adverse Event|3
2685120|NCT00486278|9264465|P1|Overall Study|Physician Decision|2
2685121|NCT00486278|9264465|P1|Overall Study|Withdrawal by Subject|2
2685122|NCT00486278|9264465|P1|Overall Study|Adverse Event|5
2685123|NCT00486265|9264599|P1|Overall Study|Lack of Efficacy|8
2685124|NCT00486265|9264599|P1|Overall Study|Adverse Event|1
2685125|NCT00486252|9264603|P1|Overall Study|Other|18
2685126|NCT00486252|9264603|P1|Overall Study|Lost to Follow-up|24
2685127|NCT00486252|9264603|P1|Overall Study|Lack of Efficacy|9
2685128|NCT00486252|9264603|P1|Overall Study|Adverse Event|7
2685129|NCT00486226|9264618|P1|Overall Study|Lost to Follow-up|8
2685130|NCT00486226|9264618|P1|Overall Study|Withdrawal by Subject|1
2685131|NCT00486226|9264618|P1|Overall Study|Adverse Event|1
2685132|NCT00486226|9264618|P1|Overall Study|Death|3
2685133|NCT00486044|9264628|P2|Overall Study|Lost to Follow-up|1
2685134|NCT00486044|9264629|P1|Overall Study|Lost to Follow-up|0
2685135|NCT00486044|9264628|P2|Overall Study|Adverse Event|1
2685136|NCT00486044|9264629|P1|Overall Study|Adverse Event|0
2685137|NCT00486044|9264628|P2|Overall Study|Withdrawal by Subject|1
2685138|NCT00486044|9264629|P1|Overall Study|Withdrawal by Subject|2
2685139|NCT00485758|9264723|P2|Overall Study|Study Terminated by Sponsor|0
2685140|NCT00485758|9264724|P1|Overall Study|Study Terminated by Sponsor|3
2685141|NCT00485758|9264723|P2|Overall Study|Withdrawal by Subject|27
2685142|NCT00485758|9264724|P1|Overall Study|Withdrawal by Subject|32
2685143|NCT00485758|9264723|P2|Overall Study|Protocol Violation|2
2685144|NCT00485758|9264724|P1|Overall Study|Protocol Violation|11
2685145|NCT00485758|9264723|P2|Overall Study|Physician Decision|3
2685146|NCT00485758|9264724|P1|Overall Study|Physician Decision|3
2685147|NCT00485758|9264723|P2|Overall Study|Lost to Follow-up|1
2685148|NCT00485758|9264724|P1|Overall Study|Lost to Follow-up|5
2685149|NCT00485758|9264723|P2|Overall Study|Death|1
2685150|NCT00485758|9264724|P1|Overall Study|Death|0
2685151|NCT00485758|9264723|P2|Overall Study|Adverse Event|31
2685152|NCT00485758|9264724|P1|Overall Study|Adverse Event|102
2685153|NCT00485732|9264736|P2|Overall Study|Lost to Follow-up|2
2685154|NCT00485732|9264737|P1|Overall Study|Lost to Follow-up|2
2685155|NCT00485732|9264736|P2|Overall Study|Withdrawal by Subject|4
2685156|NCT00485732|9264737|P1|Overall Study|Withdrawal by Subject|5
2685157|NCT00485732|9264736|P2|Overall Study|Protocol Violation|3
2685158|NCT00485732|9264737|P1|Overall Study|Protocol Violation|1
2685159|NCT00485472|9264775|P2|Overall Study|Lost to Follow-up|1
2685160|NCT00485472|9264776|P1|Overall Study|Lost to Follow-up|0
2685161|NCT00485472|9264775|P2|Overall Study|Other|1
2685162|NCT00485472|9264776|P1|Overall Study|Other|2
2685163|NCT00485472|9264775|P2|Overall Study|Protocol Violation|1
2685164|NCT00485472|9264776|P1|Overall Study|Protocol Violation|0
2685165|NCT00485472|9264775|P2|Overall Study|Withdrawal by Subject|0
2685166|NCT00485472|9264776|P1|Overall Study|Withdrawal by Subject|1
2685167|NCT00485472|9264775|P2|Overall Study|Lack of Efficacy|4
2685168|NCT00485472|9264776|P1|Overall Study|Lack of Efficacy|5
2685169|NCT00485472|9264775|P2|Overall Study|Adverse Event|5
2685170|NCT00485472|9264776|P1|Overall Study|Adverse Event|8
2685171|NCT00485303|9264813|P1|Overall Study|Treatment ongoing at cutoff date|2
2685172|NCT00485303|9264813|P1|Overall Study|Initiation of new anti-cancer treatment|2
2685173|NCT00485303|9264813|P1|Overall Study|Other|3
2685174|NCT00485303|9264813|P1|Overall Study|Progressive Disease|44
2685175|NCT00485303|9264813|P1|Overall Study|Adverse Event|5
2685176|NCT00485264|9264831|P6|Overall Study|Other Reason|0
2685177|NCT00485264|9264832|P5|Overall Study|Other Reason|0
2685178|NCT00485264|9264833|P4|Overall Study|Other Reason|0
2685179|NCT00485264|9264834|P3|Overall Study|Other Reason|0
2685180|NCT00485264|9264835|P2|Overall Study|Other Reason|0
2685181|NCT00485264|9264836|P1|Overall Study|Other Reason|3
2685182|NCT00485264|9264831|P6|Overall Study|Lost to Follow-up|1
2685183|NCT00485264|9264832|P5|Overall Study|Lost to Follow-up|0
2685184|NCT00485264|9264833|P4|Overall Study|Lost to Follow-up|0
2685185|NCT00485264|9264834|P3|Overall Study|Lost to Follow-up|1
2685186|NCT00485264|9264835|P2|Overall Study|Lost to Follow-up|1
2685187|NCT00485264|9264836|P1|Overall Study|Lost to Follow-up|2
2685188|NCT00485264|9264831|P6|Overall Study|Non-Compliant|0
2685189|NCT00485264|9264832|P5|Overall Study|Non-Compliant|1
2685190|NCT00485264|9264833|P4|Overall Study|Non-Compliant|0
2685191|NCT00485264|9264834|P3|Overall Study|Non-Compliant|1
2685192|NCT00485264|9264835|P2|Overall Study|Non-Compliant|2
2685193|NCT00485264|9264836|P1|Overall Study|Non-Compliant|17
2685194|NCT00485264|9264831|P6|Overall Study|Not Able to Attend Clinic|2
2685195|NCT00485264|9264832|P5|Overall Study|Not Able to Attend Clinic|1
2685196|NCT00485264|9264833|P4|Overall Study|Not Able to Attend Clinic|1
2685197|NCT00485264|9264834|P3|Overall Study|Not Able to Attend Clinic|0
2685198|NCT00485264|9264835|P2|Overall Study|Not Able to Attend Clinic|0
2685199|NCT00485264|9264836|P1|Overall Study|Not Able to Attend Clinic|5
2685200|NCT00485264|9264831|P6|Overall Study|Intolerance/Unable to Tolerate Dose|0
2685201|NCT00485264|9264832|P5|Overall Study|Intolerance/Unable to Tolerate Dose|0
2685202|NCT00485264|9264833|P4|Overall Study|Intolerance/Unable to Tolerate Dose|0
2685203|NCT00485264|9264834|P3|Overall Study|Intolerance/Unable to Tolerate Dose|1
2685204|NCT00485264|9264835|P2|Overall Study|Intolerance/Unable to Tolerate Dose|0
2685205|NCT00485264|9264836|P1|Overall Study|Intolerance/Unable to Tolerate Dose|0
2685206|NCT00485264|9264831|P6|Overall Study|Physician Decision|0
2685207|NCT00485264|9264832|P5|Overall Study|Physician Decision|0
2685208|NCT00485264|9264833|P4|Overall Study|Physician Decision|0
2685209|NCT00485264|9264834|P3|Overall Study|Physician Decision|0
2685210|NCT00485264|9264835|P2|Overall Study|Physician Decision|2
2685211|NCT00485264|9264836|P1|Overall Study|Physician Decision|0
2685212|NCT00485264|9264831|P6|Overall Study|Guardian Consent Withdrawn|0
2685213|NCT00485264|9264832|P5|Overall Study|Guardian Consent Withdrawn|1
2685214|NCT00485264|9264833|P4|Overall Study|Guardian Consent Withdrawn|0
2685215|NCT00485264|9264834|P3|Overall Study|Guardian Consent Withdrawn|0
2685216|NCT00485264|9264835|P2|Overall Study|Guardian Consent Withdrawn|0
2685217|NCT00485264|9264836|P1|Overall Study|Guardian Consent Withdrawn|1
2685218|NCT00485264|9264831|P6|Overall Study|Lack of Efficacy|0
2685219|NCT00485264|9264832|P5|Overall Study|Lack of Efficacy|0
2685220|NCT00485264|9264833|P4|Overall Study|Lack of Efficacy|0
2685221|NCT00485264|9264834|P3|Overall Study|Lack of Efficacy|0
2685222|NCT00485264|9264835|P2|Overall Study|Lack of Efficacy|1
2685223|NCT00485264|9264836|P1|Overall Study|Lack of Efficacy|0
2685224|NCT00485264|9264831|P6|Overall Study|Number/Volume/Timing of Study Meds|0
2685225|NCT00485264|9264832|P5|Overall Study|Number/Volume/Timing of Study Meds|0
2685226|NCT00485264|9264833|P4|Overall Study|Number/Volume/Timing of Study Meds|0
2685227|NCT00485264|9264834|P3|Overall Study|Number/Volume/Timing of Study Meds|1
2685228|NCT00485264|9264835|P2|Overall Study|Number/Volume/Timing of Study Meds|1
2685229|NCT00485264|9264836|P1|Overall Study|Number/Volume/Timing of Study Meds|2
2685230|NCT00485264|9264831|P6|Overall Study|Disallowed Medication|1
2685231|NCT00485264|9264832|P5|Overall Study|Disallowed Medication|0
2685232|NCT00485264|9264833|P4|Overall Study|Disallowed Medication|0
2685233|NCT00485264|9264834|P3|Overall Study|Disallowed Medication|0
2685234|NCT00485264|9264835|P2|Overall Study|Disallowed Medication|0
2685235|NCT00485264|9264836|P1|Overall Study|Disallowed Medication|0
2685236|NCT00485264|9264831|P6|Overall Study|Pregnancy|0
2685237|NCT00485264|9264832|P5|Overall Study|Pregnancy|0
2685238|NCT00485264|9264833|P4|Overall Study|Pregnancy|0
2685239|NCT00485264|9264834|P3|Overall Study|Pregnancy|0
2685240|NCT00485264|9264835|P2|Overall Study|Pregnancy|0
2685241|NCT00485264|9264836|P1|Overall Study|Pregnancy|4
2685242|NCT00485264|9264831|P6|Overall Study|Adverse Event|3
2685243|NCT00485264|9264832|P5|Overall Study|Adverse Event|1
2685244|NCT00485264|9264833|P4|Overall Study|Adverse Event|3
2685245|NCT00485264|9264834|P3|Overall Study|Adverse Event|2
2685246|NCT00485264|9264835|P2|Overall Study|Adverse Event|0
2685247|NCT00485264|9264836|P1|Overall Study|Adverse Event|1
2685248|NCT00485264|9264831|P6|Overall Study|Death|0
2685249|NCT00485264|9264832|P5|Overall Study|Death|1
2685250|NCT00485264|9264833|P4|Overall Study|Death|0
2685251|NCT00485264|9264834|P3|Overall Study|Death|0
2685252|NCT00485264|9264835|P2|Overall Study|Death|0
2685253|NCT00485264|9264836|P1|Overall Study|Death|1
2685254|NCT00485264|9264831|P6|Overall Study|Enrolled But Not Given Treatment|0
2685255|NCT00485264|9264832|P5|Overall Study|Enrolled But Not Given Treatment|1
2685256|NCT00485264|9264833|P4|Overall Study|Enrolled But Not Given Treatment|0
2685257|NCT00485264|9264834|P3|Overall Study|Enrolled But Not Given Treatment|0
2685258|NCT00485264|9264835|P2|Overall Study|Enrolled But Not Given Treatment|0
2685259|NCT00485264|9264836|P1|Overall Study|Enrolled But Not Given Treatment|0
2685260|NCT00485173|9264924|P2|Overall Study|Lost to Follow-up|61
2685261|NCT00485173|9264925|P1|Overall Study|Lost to Follow-up|32
2685262|NCT00485173|9264924|P2|Overall Study|Death|3
2685263|NCT00485173|9264925|P1|Overall Study|Death|4
2685264|NCT00485134|9264973|P8|Overall Study|Pregnancy|0
2685265|NCT00485134|9264974|P7|Overall Study|Pregnancy|1
2685266|NCT00485134|9264975|P6|Overall Study|Pregnancy|0
2685267|NCT00485134|9264976|P5|Overall Study|Pregnancy|0
2685268|NCT00485134|9264977|P4|Overall Study|Pregnancy|0
2685269|NCT00485134|9264978|P3|Overall Study|Pregnancy|0
2685270|NCT00485134|9264979|P2|Overall Study|Pregnancy|0
2685271|NCT00485134|9264980|P1|Overall Study|Pregnancy|0
2685272|NCT00485134|9264973|P8|Overall Study|Unable to comply with study schedule|1
2685273|NCT00485134|9264974|P7|Overall Study|Unable to comply with study schedule|0
2685274|NCT00485134|9264975|P6|Overall Study|Unable to comply with study schedule|0
2685275|NCT00485134|9264976|P5|Overall Study|Unable to comply with study schedule|0
2685276|NCT00485134|9264977|P4|Overall Study|Unable to comply with study schedule|0
2685277|NCT00485134|9264978|P3|Overall Study|Unable to comply with study schedule|0
2685278|NCT00485134|9264979|P2|Overall Study|Unable to comply with study schedule|0
2685279|NCT00485134|9264980|P1|Overall Study|Unable to comply with study schedule|0
2685280|NCT00485134|9264973|P8|Overall Study|Non-compliance|0
2685281|NCT00485134|9264974|P7|Overall Study|Non-compliance|2
2685282|NCT00485134|9264975|P6|Overall Study|Non-compliance|2
2685283|NCT00485134|9264976|P5|Overall Study|Non-compliance|1
2685284|NCT00485134|9264977|P4|Overall Study|Non-compliance|0
2685285|NCT00485134|9264978|P3|Overall Study|Non-compliance|0
2685286|NCT00485134|9264979|P2|Overall Study|Non-compliance|0
2685287|NCT00485134|9264980|P1|Overall Study|Non-compliance|0
2685288|NCT00485134|9264973|P8|Overall Study|Positive drug test|0
2685289|NCT00485134|9264974|P7|Overall Study|Positive drug test|0
2685290|NCT00485134|9264975|P6|Overall Study|Positive drug test|1
2685291|NCT00485134|9264976|P5|Overall Study|Positive drug test|2
2685292|NCT00485134|9264977|P4|Overall Study|Positive drug test|0
2685293|NCT00485134|9264978|P3|Overall Study|Positive drug test|0
2685294|NCT00485134|9264979|P2|Overall Study|Positive drug test|0
2685295|NCT00485134|9264980|P1|Overall Study|Positive drug test|0
2685296|NCT00485134|9264973|P8|Overall Study|Withdrew for adverse event|0
2685297|NCT00485134|9264974|P7|Overall Study|Withdrew for adverse event|0
2685298|NCT00485134|9264975|P6|Overall Study|Withdrew for adverse event|0
2685299|NCT00485134|9264976|P5|Overall Study|Withdrew for adverse event|0
2685300|NCT00485134|9264977|P4|Overall Study|Withdrew for adverse event|0
2685301|NCT00485134|9264978|P3|Overall Study|Withdrew for adverse event|1
2685302|NCT00485134|9264979|P2|Overall Study|Withdrew for adverse event|0
2685303|NCT00485134|9264980|P1|Overall Study|Withdrew for adverse event|0
2685304|NCT00485134|9264973|P8|Overall Study|Change in health status|0
2685305|NCT00485134|9264974|P7|Overall Study|Change in health status|0
2685306|NCT00485134|9264975|P6|Overall Study|Change in health status|1
2685307|NCT00485134|9264976|P5|Overall Study|Change in health status|0
2685308|NCT00485134|9264977|P4|Overall Study|Change in health status|1
2685309|NCT00485134|9264978|P3|Overall Study|Change in health status|2
2685310|NCT00485134|9264979|P2|Overall Study|Change in health status|1
2685311|NCT00485134|9264980|P1|Overall Study|Change in health status|0
2685312|NCT00485134|9264973|P8|Overall Study|Withdrawal by Subject|0
2685313|NCT00485134|9264974|P7|Overall Study|Withdrawal by Subject|0
2685314|NCT00485134|9264975|P6|Overall Study|Withdrawal by Subject|0
2685315|NCT00485134|9264976|P5|Overall Study|Withdrawal by Subject|0
2685316|NCT00485134|9264977|P4|Overall Study|Withdrawal by Subject|0
2685317|NCT00485134|9264978|P3|Overall Study|Withdrawal by Subject|0
2685318|NCT00485134|9264979|P2|Overall Study|Withdrawal by Subject|1
2685319|NCT00485134|9264980|P1|Overall Study|Withdrawal by Subject|0
2685320|NCT00485134|9264973|P8|Overall Study|Lost to Follow-up|0
2685321|NCT00485134|9264974|P7|Overall Study|Lost to Follow-up|0
2685322|NCT00485134|9264975|P6|Overall Study|Lost to Follow-up|0
2685323|NCT00485134|9264976|P5|Overall Study|Lost to Follow-up|0
2685324|NCT00485134|9264977|P4|Overall Study|Lost to Follow-up|0
2685325|NCT00485134|9264978|P3|Overall Study|Lost to Follow-up|0
2685326|NCT00485134|9264979|P2|Overall Study|Lost to Follow-up|0
2685327|NCT00485134|9264980|P1|Overall Study|Lost to Follow-up|1
2685328|NCT00485069|9265002|P2|Overall Study|Withdrawal by Subject|6
2685329|NCT00485069|9265003|P1|Overall Study|Withdrawal by Subject|6
2685330|NCT00485069|9265002|P2|Overall Study|Protocol Violation|1
2685331|NCT00485069|9265003|P1|Overall Study|Protocol Violation|0
2685332|NCT00485069|9265002|P2|Overall Study|Lack of Efficacy|1
2685333|NCT00485069|9265003|P1|Overall Study|Lack of Efficacy|2
2685334|NCT00485069|9265002|P2|Overall Study|Adverse Event|4
2685335|NCT00485069|9265003|P1|Overall Study|Adverse Event|10
2685336|NCT00484939|9265048|P2|Overall Study|Reason Not Specified|6
2685337|NCT00484939|9265049|P1|Overall Study|Reason Not Specified|11
2685338|NCT00484939|9265048|P2|Overall Study|Screen Failure|2
2685339|NCT00484939|9265049|P1|Overall Study|Screen Failure|2
2685340|NCT00484939|9265048|P2|Overall Study|Disease progression|88
2685341|NCT00484939|9265049|P1|Overall Study|Disease progression|67
2685342|NCT00484939|9265048|P2|Overall Study|Discretion of Investigator or Sponsor|3
2685343|NCT00484939|9265049|P1|Overall Study|Discretion of Investigator or Sponsor|7
2685344|NCT00484939|9265048|P2|Overall Study|Lost to Follow-up|3
2685345|NCT00484939|9265049|P1|Overall Study|Lost to Follow-up|0
2685346|NCT00484939|9265048|P2|Overall Study|Protocol Violation|3
2685347|NCT00484939|9265049|P1|Overall Study|Protocol Violation|3
2685348|NCT00484939|9265048|P2|Overall Study|Patient Withdrew Consent|10
2685349|NCT00484939|9265049|P1|Overall Study|Patient Withdrew Consent|19
2685350|NCT00484939|9265048|P2|Overall Study|Adverse Event|12
2685351|NCT00484939|9265049|P1|Overall Study|Adverse Event|22
2685352|NCT00484939|9265048|P2|Overall Study|Death|13
2685353|NCT00484939|9265049|P1|Overall Study|Death|9
2685354|NCT00484679|9265076|P1|Overall Study|Withdrawal by Subject|3
2685355|NCT00484419|9265083|P3|Overall Study|sponsor decision, randomized in error|2
2685356|NCT00484419|9265084|P2|Overall Study|sponsor decision, randomized in error|0
2685357|NCT00484419|9265085|P1|Overall Study|sponsor decision, randomized in error|0
2685358|NCT00484419|9265083|P3|Overall Study|subject relocated|0
2685359|NCT00484419|9265084|P2|Overall Study|subject relocated|1
2685360|NCT00484419|9265085|P1|Overall Study|subject relocated|0
2685361|NCT00484419|9265083|P3|Overall Study|subject unable to receive medication|0
2685362|NCT00484419|9265084|P2|Overall Study|subject unable to receive medication|0
2685363|NCT00484419|9265085|P1|Overall Study|subject unable to receive medication|1
2685364|NCT00484419|9265083|P3|Overall Study|Physician Decision|1
2685365|NCT00484419|9265084|P2|Overall Study|Physician Decision|1
2685366|NCT00484419|9265085|P1|Overall Study|Physician Decision|1
2685367|NCT00484419|9265083|P3|Overall Study|required restricted medication|1
2685368|NCT00484419|9265084|P2|Overall Study|required restricted medication|0
2685369|NCT00484419|9265085|P1|Overall Study|required restricted medication|1
2685370|NCT00484419|9265083|P3|Overall Study|subject met discontinuation criteria|4
2685371|NCT00484419|9265084|P2|Overall Study|subject met discontinuation criteria|2
2685372|NCT00484419|9265085|P1|Overall Study|subject met discontinuation criteria|2
2685373|NCT00484419|9265083|P3|Overall Study|Withdrawal by Subject|1
2685374|NCT00484419|9265084|P2|Overall Study|Withdrawal by Subject|1
2685375|NCT00484419|9265085|P1|Overall Study|Withdrawal by Subject|3
2685376|NCT00484419|9265083|P3|Overall Study|Lost to Follow-up|2
2685377|NCT00484419|9265084|P2|Overall Study|Lost to Follow-up|0
2685378|NCT00484419|9265085|P1|Overall Study|Lost to Follow-up|1
2685379|NCT00484419|9265083|P3|Overall Study|Adverse Event|0
2685380|NCT00484419|9265084|P2|Overall Study|Adverse Event|0
2685381|NCT00484419|9265085|P1|Overall Study|Adverse Event|3
2685382|NCT00484315|9265169|P2|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2
2685383|NCT00484315|9265170|P1|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3
2685384|NCT00484315|9265169|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11
2685385|NCT00484315|9265170|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25
2685386|NCT00484315|9265169|P2|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2
2685387|NCT00484315|9265170|P1|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3
2685388|NCT00484315|9265169|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|4
2685389|NCT00484315|9265170|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|13
2685390|NCT00484315|9265169|P2|12-Month Clinical Follow-up|Lost to Follow-up|1
2685391|NCT00484315|9265170|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
2685392|NCT00484315|9265169|P2|12-Month Clinical Follow-up|Withdrawal by Subject|0
2685393|NCT00484315|9265170|P1|12-Month Clinical Follow-up|Withdrawal by Subject|4
2685394|NCT00484315|9265169|P2|12-Month Clinical Follow-up|Death|2
2685395|NCT00484315|9265170|P1|12-Month Clinical Follow-up|Death|6
2685396|NCT00484289|9265181|P3|Post Marketing Phase|Adverse Event|0
2685397|NCT00484289|9265182|P2|Post Marketing Phase|Adverse Event|1
2685398|NCT00484289|9265183|P1|Post Marketing Phase|Adverse Event|0
2685399|NCT00484289|9265181|P3|Long Term Phase|Other Reason|1
2685400|NCT00484289|9265182|P2|Long Term Phase|Other Reason|5
2685401|NCT00484289|9265183|P1|Long Term Phase|Other Reason|0
2685402|NCT00484289|9265181|P3|Long Term Phase|Inadequate response|4
2685403|NCT00484289|9265182|P2|Long Term Phase|Inadequate response|7
2685404|NCT00484289|9265183|P1|Long Term Phase|Inadequate response|2
2685405|NCT00484289|9265181|P3|Long Term Phase|Withdrawal by Subject|6
2685406|NCT00484289|9265182|P2|Long Term Phase|Withdrawal by Subject|7
2685407|NCT00484289|9265183|P1|Long Term Phase|Withdrawal by Subject|0
2685408|NCT00484289|9265181|P3|Long Term Phase|Adverse Event|5
2685409|NCT00484289|9265182|P2|Long Term Phase|Adverse Event|17
2685410|NCT00484289|9265183|P1|Long Term Phase|Adverse Event|1
2685411|NCT00484185|9265255|P1|Overall Study|Death|2
2685412|NCT00484185|9265255|P1|Overall Study|Randomized but not treated|5
2685413|NCT00484185|9265255|P1|Overall Study|Other|20
2685414|NCT00484185|9265255|P1|Overall Study|Lost to Follow-up|44
2685415|NCT00484159|9265277|P3|Overall Study|Lost to Follow-up|0
2685416|NCT00484159|9265278|P2|Overall Study|Lost to Follow-up|1
2685417|NCT00484159|9265279|P1|Overall Study|Lost to Follow-up|1
2685418|NCT00484094|9265290|P1|Overall Study|Other|3
2685419|NCT00484094|9265290|P1|Overall Study|Discontinued|39
2685420|NCT00483938|9265306|P7|Overall Study|Other|32
2685421|NCT00483938|9265307|P6|Overall Study|Other|4
2685422|NCT00483938|9265308|P5|Overall Study|Other|0
2685423|NCT00483938|9265309|P4|Overall Study|Other|4
2685424|NCT00483938|9265310|P3|Overall Study|Other|0
2685425|NCT00483938|9265311|P2|Overall Study|Other|9
2685426|NCT00483938|9265312|P1|Overall Study|Other|3
2685427|NCT00483938|9265306|P7|Overall Study|Death|0
2685428|NCT00483938|9265307|P6|Overall Study|Death|0
2685429|NCT00483938|9265308|P5|Overall Study|Death|0
2685430|NCT00483938|9265309|P4|Overall Study|Death|0
2685431|NCT00483938|9265310|P3|Overall Study|Death|0
2685432|NCT00483938|9265311|P2|Overall Study|Death|2
2685433|NCT00483938|9265312|P1|Overall Study|Death|0
2685434|NCT00483938|9265306|P7|Overall Study|Lost to Follow-up|3
2685435|NCT00483938|9265307|P6|Overall Study|Lost to Follow-up|1
2685436|NCT00483938|9265308|P5|Overall Study|Lost to Follow-up|1
2685437|NCT00483938|9265309|P4|Overall Study|Lost to Follow-up|2
2685438|NCT00483938|9265310|P3|Overall Study|Lost to Follow-up|0
2685439|NCT00483938|9265311|P2|Overall Study|Lost to Follow-up|2
2685440|NCT00483938|9265312|P1|Overall Study|Lost to Follow-up|1
2685441|NCT00483938|9265306|P7|Overall Study|Withdrawal by Subject|2
2685442|NCT00483938|9265307|P6|Overall Study|Withdrawal by Subject|3
2685443|NCT00483938|9265308|P5|Overall Study|Withdrawal by Subject|1
2685444|NCT00483938|9265309|P4|Overall Study|Withdrawal by Subject|0
2685445|NCT00483938|9265310|P3|Overall Study|Withdrawal by Subject|0
2685446|NCT00483938|9265311|P2|Overall Study|Withdrawal by Subject|6
2685447|NCT00483938|9265312|P1|Overall Study|Withdrawal by Subject|1
2685448|NCT00483938|9265306|P7|Overall Study|Protocol Violation|3
2685449|NCT00483938|9265307|P6|Overall Study|Protocol Violation|0
2685450|NCT00483938|9265308|P5|Overall Study|Protocol Violation|0
2685451|NCT00483938|9265309|P4|Overall Study|Protocol Violation|0
2685452|NCT00483938|9265310|P3|Overall Study|Protocol Violation|0
2685453|NCT00483938|9265311|P2|Overall Study|Protocol Violation|0
2685454|NCT00483938|9265312|P1|Overall Study|Protocol Violation|0
2685455|NCT00483756|9265336|P3|Overall Study|Randomized, Not Treated|4
2685456|NCT00483756|9265337|P2|Overall Study|Randomized, Not Treated|4
2685457|NCT00483756|9265338|P1|Overall Study|Randomized, Not Treated|1
2685458|NCT00483756|9265336|P3|Overall Study|Other|3
2685459|NCT00483756|9265337|P2|Overall Study|Other|4
2685460|NCT00483756|9265338|P1|Overall Study|Other|2
2685461|NCT00483756|9265336|P3|Overall Study|Withdrawal by Subject|4
2685462|NCT00483756|9265337|P2|Overall Study|Withdrawal by Subject|3
2685463|NCT00483756|9265338|P1|Overall Study|Withdrawal by Subject|5
2685464|NCT00483756|9265336|P3|Overall Study|Lost to Follow-up|0
2685465|NCT00483756|9265337|P2|Overall Study|Lost to Follow-up|1
2685466|NCT00483756|9265338|P1|Overall Study|Lost to Follow-up|3
2685467|NCT00483756|9265336|P3|Overall Study|Lack of Efficacy|0
2685468|NCT00483756|9265337|P2|Overall Study|Lack of Efficacy|0
2685469|NCT00483756|9265338|P1|Overall Study|Lack of Efficacy|1
2685470|NCT00483756|9265336|P3|Overall Study|Adverse Event|40
2685471|NCT00483756|9265337|P2|Overall Study|Adverse Event|38
2685472|NCT00483756|9265338|P1|Overall Study|Adverse Event|19
2685473|NCT00483756|9265336|P3|Overall Study|Death|1
2685474|NCT00483756|9265337|P2|Overall Study|Death|0
2685475|NCT00483756|9265338|P1|Overall Study|Death|2
2685476|NCT00483717|9265402|P2|Overall Study|Withdrawal by Subject|0
2685477|NCT00483717|9265403|P1|Overall Study|Withdrawal by Subject|1
2685478|NCT00483717|9265402|P2|Overall Study|Lost to Follow-up|0
2685479|NCT00483717|9265403|P1|Overall Study|Lost to Follow-up|1
2685480|NCT00483717|9265402|P2|Overall Study|No treatment for migraine|13
2685481|NCT00483717|9265403|P1|Overall Study|No treatment for migraine|16
2685482|NCT00483717|9265402|P2|Overall Study|Time of dosing missing|1
2685483|NCT00483717|9265403|P1|Overall Study|Time of dosing missing|1
2685484|NCT00483717|9265402|P2|Overall Study|Protocol Violation|7
2685485|NCT00483717|9265403|P1|Overall Study|Protocol Violation|5
2685486|NCT00483704|9265426|P3|Treatment|Physician Decision|4
2685487|NCT00483704|9265427|P2|Treatment|Physician Decision|1
2685488|NCT00483704|9265428|P1|Treatment|Physician Decision|0
2685489|NCT00483704|9265426|P3|Treatment|Pregnancy|0
2685490|NCT00483704|9265427|P2|Treatment|Pregnancy|1
2685491|NCT00483704|9265428|P1|Treatment|Pregnancy|0
2685492|NCT00483704|9265426|P3|Treatment|Lack of Efficacy|1
2685493|NCT00483704|9265427|P2|Treatment|Lack of Efficacy|1
2685494|NCT00483704|9265428|P1|Treatment|Lack of Efficacy|1
2685495|NCT00483704|9265426|P3|Treatment|Lost to Follow-up|5
2685496|NCT00483704|9265427|P2|Treatment|Lost to Follow-up|7
2685497|NCT00483704|9265428|P1|Treatment|Lost to Follow-up|2
2685498|NCT00483704|9265426|P3|Treatment|Protocol Violation|5
2685499|NCT00483704|9265427|P2|Treatment|Protocol Violation|3
2685500|NCT00483704|9265428|P1|Treatment|Protocol Violation|6
2685501|NCT00483704|9265426|P3|Treatment|Withdrawal by Subject|21
2685502|NCT00483704|9265427|P2|Treatment|Withdrawal by Subject|12
2685503|NCT00483704|9265428|P1|Treatment|Withdrawal by Subject|16
2685504|NCT00483704|9265426|P3|Treatment|Adverse Event|4
2685505|NCT00483704|9265427|P2|Treatment|Adverse Event|5
2685506|NCT00483704|9265428|P1|Treatment|Adverse Event|3
2685507|NCT00483704|9265426|P3|Treatment|Lack of qualifying migraines|116
2685508|NCT00483704|9265427|P2|Treatment|Lack of qualifying migraines|99
2685509|NCT00483704|9265428|P1|Treatment|Lack of qualifying migraines|101
2685510|NCT00483704|9265426|P3|Randomization|Lack of qualifying migraines|31
2685511|NCT00483704|9265427|P2|Randomization|Lack of qualifying migraines|25
2685512|NCT00483704|9265428|P1|Randomization|Lack of qualifying migraines|21
2685513|NCT00483704|9265426|P3|Randomization|Progressive disease|1
2685514|NCT00483704|9265427|P2|Randomization|Progressive disease|0
2685515|NCT00483704|9265428|P1|Randomization|Progressive disease|0
2685516|NCT00483704|9265426|P3|Randomization|Physician Decision|0
2685517|NCT00483704|9265427|P2|Randomization|Physician Decision|4
2685518|NCT00483704|9265428|P1|Randomization|Physician Decision|2
2685519|NCT00483704|9265426|P3|Randomization|Pregnancy|0
2685520|NCT00483704|9265427|P2|Randomization|Pregnancy|0
2685521|NCT00483704|9265428|P1|Randomization|Pregnancy|1
2685522|NCT00483704|9265426|P3|Randomization|Lost to Follow-up|19
2685523|NCT00483704|9265427|P2|Randomization|Lost to Follow-up|14
2685524|NCT00483704|9265428|P1|Randomization|Lost to Follow-up|14
2685525|NCT00483704|9265426|P3|Randomization|Protocol Violation|22
2685526|NCT00483704|9265427|P2|Randomization|Protocol Violation|25
2685527|NCT00483704|9265428|P1|Randomization|Protocol Violation|14
2685528|NCT00483704|9265426|P3|Randomization|Withdrawal by Subject|18
2685529|NCT00483704|9265427|P2|Randomization|Withdrawal by Subject|28
2685530|NCT00483704|9265428|P1|Randomization|Withdrawal by Subject|19
2685531|NCT00483652|9265474|P2|Double-blind Treatment Period|Withdrawal due to AE before study began|0
2685532|NCT00483652|9265475|P1|Double-blind Treatment Period|Withdrawal due to AE before study began|1
2685533|NCT00483652|9265474|P2|Double-blind Treatment Period|Protocol inclusion deviation|0
2685534|NCT00483652|9265475|P1|Double-blind Treatment Period|Protocol inclusion deviation|1
2685535|NCT00483652|9265474|P2|Double-blind Treatment Period|Adverse Event|4
2685536|NCT00483652|9265475|P1|Double-blind Treatment Period|Adverse Event|3
2685537|NCT00483652|9265474|P2|Double-blind Treatment Period|Protocol Violation|1
2685538|NCT00483652|9265475|P1|Double-blind Treatment Period|Protocol Violation|2
2685539|NCT00483574|9265485|P2|Overall Study|Withdrawal by Subject|0
2685540|NCT00483574|9265486|P1|Overall Study|Withdrawal by Subject|52
2685541|NCT00483574|9265485|P2|Overall Study|Lost to Follow-up|4
2685542|NCT00483574|9265486|P1|Overall Study|Lost to Follow-up|16
2685543|NCT00483574|9265485|P2|Overall Study|Protocol Violation|9
2685544|NCT00483574|9265486|P1|Overall Study|Protocol Violation|28
2685545|NCT00483574|9265485|P2|Overall Study|Adverse Event|0
2685546|NCT00483574|9265486|P1|Overall Study|Adverse Event|6
2685547|NCT00483548|9265501|P2|Overall Study|Withdrawal by Subject|2
2685548|NCT00483548|9265502|P1|Overall Study|Withdrawal by Subject|5
2685549|NCT00483548|9265501|P2|Overall Study|Lost to Follow-up|4
2685550|NCT00483548|9265502|P1|Overall Study|Lost to Follow-up|3
2685551|NCT00483548|9265501|P2|Overall Study|Non-compliance with medication|0
2685552|NCT00483548|9265502|P1|Overall Study|Non-compliance with medication|2
2685553|NCT00483548|9265501|P2|Overall Study|Unable to comply with protocol schedule|0
2685554|NCT00483548|9265502|P1|Overall Study|Unable to comply with protocol schedule|1
2685555|NCT00483548|9265501|P2|Overall Study|Protocol required discontinuation|6
2685556|NCT00483548|9265502|P1|Overall Study|Protocol required discontinuation|6
2685557|NCT00483548|9265501|P2|Overall Study|Pregnancy|0
2685558|NCT00483548|9265502|P1|Overall Study|Pregnancy|1
2685559|NCT00483548|9265501|P2|Overall Study|Protocol Violation|7
2685560|NCT00483548|9265502|P1|Overall Study|Protocol Violation|11
2685561|NCT00483548|9265501|P2|Overall Study|Lack of Efficacy|8
2685562|NCT00483548|9265502|P1|Overall Study|Lack of Efficacy|4
2685563|NCT00483548|9265501|P2|Overall Study|Laboratory abnormality|2
2685564|NCT00483548|9265502|P1|Overall Study|Laboratory abnormality|1
2685565|NCT00483548|9265501|P2|Overall Study|Adverse Event|14
2685566|NCT00483548|9265502|P1|Overall Study|Adverse Event|25
2685567|NCT00483548|9265501|P2|Overall Study|Randomized; not treated with study drug|3
2685568|NCT00483548|9265502|P1|Overall Study|Randomized; not treated with study drug|1
2685569|NCT00483405|9265560|P1|Overall Study|Other complicating disease|1
2685570|NCT00483405|9265560|P1|Overall Study|Withdrawal by Subject|2
2685571|NCT00483405|9265560|P1|Overall Study|Death|3
2685572|NCT00483405|9265560|P1|Overall Study|Lack of Efficacy|14
2685573|NCT00483405|9265560|P1|Overall Study|Adverse Event|8
2685574|NCT00483379|9265569|P2|Treatment Period|Withdrawal by Subject|0
2685575|NCT00483379|9265570|P1|Treatment Period|Withdrawal by Subject|1
2685576|NCT00483379|9265569|P2|Treatment Period|Adverse Event|0
2685577|NCT00483379|9265570|P1|Treatment Period|Adverse Event|1
2685578|NCT00483327|9265606|P1|Overall Study|Patient Non Compliance|2
2685579|NCT00483327|9265606|P1|Overall Study|Lost to Follow-up|4
2685580|NCT00483327|9265606|P1|Overall Study|Withdrawal by Subject|3
2685581|NCT00483327|9265606|P1|Overall Study|Adverse Event|1
2685582|NCT00483184|9265638|P3|Overall Study|Protocol Violation|1
2685583|NCT00483184|9265639|P2|Overall Study|Protocol Violation|0
2685584|NCT00483184|9265640|P1|Overall Study|Protocol Violation|1
2685585|NCT00483184|9265638|P3|Overall Study|Adverse Event|2
2685586|NCT00483184|9265639|P2|Overall Study|Adverse Event|2
2685587|NCT00483184|9265640|P1|Overall Study|Adverse Event|1
2685588|NCT00483184|9265638|P3|Overall Study|Lost to Follow-up|0
2685589|NCT00483184|9265639|P2|Overall Study|Lost to Follow-up|0
2685590|NCT00483184|9265640|P1|Overall Study|Lost to Follow-up|1
2685591|NCT00483184|9265638|P3|Overall Study|Withdrawal by Subject|0
2685592|NCT00483184|9265639|P2|Overall Study|Withdrawal by Subject|2
2685593|NCT00483184|9265640|P1|Overall Study|Withdrawal by Subject|2
2685594|NCT00483119|9265650|P2|Overall Study|Physician Decision|0
2685595|NCT00483119|9265651|P1|Overall Study|Physician Decision|1
2685596|NCT00483119|9265650|P2|Overall Study|Adverse Event|1
2685597|NCT00483119|9265651|P1|Overall Study|Adverse Event|0
2685598|NCT00483041|9265665|P2|Overall Study|ABNORMAL LAB DATA AT SCREENING|1
2685599|NCT00483041|9265666|P1|Overall Study|ABNORMAL LAB DATA AT SCREENING|0
2685600|NCT00483002|9265696|P1|Overall Study|Other|967
2685601|NCT00483002|9265696|P1|Overall Study|Other|2
2685602|NCT00483002|9265696|P1|Overall Study|Lost to Follow-up|962
2685603|NCT00483002|9265696|P1|Overall Study|Lack of Efficacy|555
2685604|NCT00483002|9265696|P1|Overall Study|Adverse Event|68
2685605|NCT00482729|9265721|P2|Overall Study|Withdrawal by Subject|69
2685606|NCT00482729|9265722|P1|Overall Study|Withdrawal by Subject|67
2685607|NCT00482729|9265721|P2|Overall Study|Protocol Violation|18
2685608|NCT00482729|9265722|P1|Overall Study|Protocol Violation|10
2685609|NCT00482729|9265721|P2|Overall Study|Pregnancy|2
2685610|NCT00482729|9265722|P1|Overall Study|Pregnancy|4
2685611|NCT00482729|9265721|P2|Overall Study|Physician Decision|7
2685612|NCT00482729|9265722|P1|Overall Study|Physician Decision|10
2685613|NCT00482729|9265721|P2|Overall Study|Lost to Follow-up|66
2685614|NCT00482729|9265722|P1|Overall Study|Lost to Follow-up|86
2685615|NCT00482729|9265721|P2|Overall Study|Lack of Efficacy|16
2685616|NCT00482729|9265722|P1|Overall Study|Lack of Efficacy|4
2685617|NCT00482729|9265721|P2|Overall Study|Hyperglycemia Criteria|5
2685618|NCT00482729|9265722|P1|Overall Study|Hyperglycemia Criteria|7
2685619|NCT00482729|9265721|P2|Overall Study|Creatinine/Creatinine Clearance Criteria|2
2685620|NCT00482729|9265722|P1|Overall Study|Creatinine/Creatinine Clearance Criteria|0
2685621|NCT00482729|9265721|P2|Overall Study|Adverse Event|33
2685622|NCT00482729|9265722|P1|Overall Study|Adverse Event|29
2685623|NCT00482703|9265738|P2|Overall Study|Poor compliance|0
2685624|NCT00482703|9265739|P1|Overall Study|Poor compliance|1
2685625|NCT00482612|9265810|P4|Follow-up Period|Reasons not related to trial|3
2685626|NCT00482612|9265811|P3|Follow-up Period|Reasons not related to trial|1
2685627|NCT00482612|9265812|P2|Follow-up Period|Reasons not related to trial|0
2685628|NCT00482612|9265813|P1|Follow-up Period|Reasons not related to trial|1
2685629|NCT00482612|9265810|P4|Follow-up Period|Withdrawal by Subject|2
2685630|NCT00482612|9265811|P3|Follow-up Period|Withdrawal by Subject|7
2685631|NCT00482612|9265812|P2|Follow-up Period|Withdrawal by Subject|5
2685632|NCT00482612|9265813|P1|Follow-up Period|Withdrawal by Subject|3
2685633|NCT00482612|9265810|P4|Follow-up Period|Lack of Efficacy|0
2685634|NCT00482612|9265811|P3|Follow-up Period|Lack of Efficacy|1
2685635|NCT00482612|9265812|P2|Follow-up Period|Lack of Efficacy|0
2685636|NCT00482612|9265813|P1|Follow-up Period|Lack of Efficacy|2
2685637|NCT00482612|9265810|P4|Follow-up Period|Adverse Event|0
2685638|NCT00482612|9265811|P3|Follow-up Period|Adverse Event|9
2685639|NCT00482612|9265812|P2|Follow-up Period|Adverse Event|7
2685640|NCT00482612|9265813|P1|Follow-up Period|Adverse Event|4
2685641|NCT00482612|9265810|P4|Follow-up Period|Lost to Follow-up|1
2685642|NCT00482612|9265811|P3|Follow-up Period|Lost to Follow-up|2
2685643|NCT00482612|9265812|P2|Follow-up Period|Lost to Follow-up|4
2685644|NCT00482612|9265813|P1|Follow-up Period|Lost to Follow-up|0
2685645|NCT00482612|9265810|P4|Follow-up Period|Lack of compliance|0
2685646|NCT00482612|9265811|P3|Follow-up Period|Lack of compliance|1
2685647|NCT00482612|9265812|P2|Follow-up Period|Lack of compliance|0
2685648|NCT00482612|9265813|P1|Follow-up Period|Lack of compliance|0
2685649|NCT00482612|9265810|P4|Follow-up Period|Other|2
2685650|NCT00482612|9265811|P3|Follow-up Period|Other|1
2685651|NCT00482612|9265812|P2|Follow-up Period|Other|2
2685652|NCT00482612|9265813|P1|Follow-up Period|Other|4
2685653|NCT00482612|9265810|P4|In-treatment Period|No study medication administered|0
2685654|NCT00482612|9265811|P3|In-treatment Period|No study medication administered|1
2685655|NCT00482612|9265812|P2|In-treatment Period|No study medication administered|0
2685656|NCT00482612|9265813|P1|In-treatment Period|No study medication administered|0
2685657|NCT00482391|9265862|P1|Overall Study|Death|1
2685658|NCT00482391|9265862|P1|Overall Study|Adverse Event|1
2685659|NCT00482391|9265862|P1|Overall Study|Withdrawal by Subject|1
2685660|NCT00482274|9265867|P1|Overall Study|Adverse Event|1
2685661|NCT00482170|9265877|P2|Overall Study|Unspecified reason|2
2685662|NCT00482170|9265878|P1|Overall Study|Unspecified reason|0
2685663|NCT00482170|9265877|P2|Overall Study|Lost to Follow-up|0
2685664|NCT00482170|9265878|P1|Overall Study|Lost to Follow-up|2
2685665|NCT00482170|9265877|P2|Overall Study|Protocol Violation|3
2685666|NCT00482170|9265878|P1|Overall Study|Protocol Violation|2
2685667|NCT00482170|9265877|P2|Overall Study|Withdrawal by Subject|1
2685668|NCT00482170|9265878|P1|Overall Study|Withdrawal by Subject|6
2685669|NCT00482170|9265877|P2|Overall Study|Adverse Event|14
2685670|NCT00482170|9265878|P1|Overall Study|Adverse Event|5
2685671|NCT00482053|9265996|P1|Inter-treatment Period|Disease progression|1
2685672|NCT00482014|9266010|P4|Overall Study|Sponsor Decision|1
2685673|NCT00482014|9266011|P3|Overall Study|Sponsor Decision|1
2685674|NCT00482014|9266012|P2|Overall Study|Sponsor Decision|2
2685675|NCT00482014|9266013|P1|Overall Study|Sponsor Decision|1
2685676|NCT00482014|9266010|P4|Overall Study|Lack of Efficacy|6
2685677|NCT00482014|9266011|P3|Overall Study|Lack of Efficacy|4
2685678|NCT00482014|9266012|P2|Overall Study|Lack of Efficacy|0
2685679|NCT00482014|9266013|P1|Overall Study|Lack of Efficacy|1
2685680|NCT00482014|9266010|P4|Overall Study|Death|4
2685681|NCT00482014|9266011|P3|Overall Study|Death|1
2685682|NCT00482014|9266012|P2|Overall Study|Death|2
2685683|NCT00482014|9266013|P1|Overall Study|Death|1
2685684|NCT00482014|9266010|P4|Overall Study|Adverse Event|8
2685685|NCT00482014|9266011|P3|Overall Study|Adverse Event|2
2685686|NCT00482014|9266012|P2|Overall Study|Adverse Event|0
2685687|NCT00482014|9266013|P1|Overall Study|Adverse Event|3
2685688|NCT00482014|9266010|P4|Overall Study|Withdrawal by Subject|4
2685689|NCT00482014|9266011|P3|Overall Study|Withdrawal by Subject|3
2685690|NCT00482014|9266012|P2|Overall Study|Withdrawal by Subject|2
2685691|NCT00482014|9266013|P1|Overall Study|Withdrawal by Subject|1
2685692|NCT00482001|9266037|P2|Overall Study|Protocol Violation|1
2685693|NCT00482001|9266038|P1|Overall Study|Protocol Violation|1
2685694|NCT00481988|9266058|P2|Overall Study|Withdrawal by Subject|1
2685695|NCT00481988|9266059|P1|Overall Study|Withdrawal by Subject|1
2685696|NCT00481871|9266072|P5|Overall Study|Progressive Disease - pt withdrew|0
2685697|NCT00481871|9266073|P4|Overall Study|Progressive Disease - pt withdrew|0
2685698|NCT00481871|9266074|P3|Overall Study|Progressive Disease - pt withdrew|1
2685699|NCT00481871|9266075|P2|Overall Study|Progressive Disease - pt withdrew|0
2685700|NCT00481871|9266076|P1|Overall Study|Progressive Disease - pt withdrew|0
2685701|NCT00481832|9266101|P1|Inter-transplant Period|Lack of allogeneic donor|5
2685702|NCT00481832|9266101|P1|Inter-transplant Period|Disease relapse|11
2685703|NCT00481832|9266101|P1|Inter-transplant Period|Physician Decision|4
2685704|NCT00481832|9266101|P1|Inter-transplant Period|Death|3
2685705|NCT00481832|9266101|P1|Inter-transplant Period|Adverse Event|4
2685706|NCT00481832|9266101|P1|Enrollment|Unable to collect enough stem cells|2
2685707|NCT00481832|9266101|P1|Enrollment|Physician Decision|8
2685708|NCT00481767|9266116|P2|Overall Study|Lost to Follow-up|10
2685709|NCT00481767|9266117|P1|Overall Study|Lost to Follow-up|16
2685710|NCT00481767|9266116|P2|Overall Study|Withdrawal by Subject|11
2685711|NCT00481767|9266117|P1|Overall Study|Withdrawal by Subject|16
2685712|NCT00481676|9266151|P2|Overall Study|Administrative problem|0
2685713|NCT00481676|9266152|P1|Overall Study|Administrative problem|1
2685714|NCT00481676|9266151|P2|Overall Study|Unsatisfactory therapeutic effect|4
2685715|NCT00481676|9266152|P1|Overall Study|Unsatisfactory therapeutic effect|1
2685716|NCT00481676|9266151|P2|Overall Study|Adverse Event|1
2685717|NCT00481676|9266152|P1|Overall Study|Adverse Event|0
2685718|NCT00481247|9266204|P2|Overall Study|Did not receive treatment|2
2685719|NCT00481247|9266205|P1|Overall Study|Did not receive treatment|1
2685720|NCT00481247|9266204|P2|Overall Study|Varied|15
2685721|NCT00481247|9266205|P1|Overall Study|Varied|6
2685722|NCT00481247|9266204|P2|Overall Study|Administrative reason by sponsor|162
2685723|NCT00481247|9266205|P1|Overall Study|Administrative reason by sponsor|157
2685724|NCT00481247|9266204|P2|Overall Study|Poor compliance/noncompliance|7
2685725|NCT00481247|9266205|P1|Overall Study|Poor compliance/noncompliance|1
2685726|NCT00481247|9266204|P2|Overall Study|Lost to Follow-up|2
2685727|NCT00481247|9266205|P1|Overall Study|Lost to Follow-up|1
2685728|NCT00481247|9266204|P2|Overall Study|Pregnancy|1
2685729|NCT00481247|9266205|P1|Overall Study|Pregnancy|2
2685730|NCT00481247|9266204|P2|Overall Study|Withdrawal by Subject|13
2685731|NCT00481247|9266205|P1|Overall Study|Withdrawal by Subject|8
2685732|NCT00481247|9266204|P2|Overall Study|AE unrelated to study drug|4
2685733|NCT00481247|9266205|P1|Overall Study|AE unrelated to study drug|13
2685734|NCT00481247|9266204|P2|Overall Study|Treatment failure|14
2685735|NCT00481247|9266205|P1|Overall Study|Treatment failure|10
2685736|NCT00481247|9266204|P2|Overall Study|Intolerance|17
2685737|NCT00481247|9266205|P1|Overall Study|Intolerance|42
2685738|NCT00481247|9266204|P2|Overall Study|Disease progression|22
2685739|NCT00481247|9266205|P1|Overall Study|Disease progression|18
2685740|NCT00481247|9266204|P2|Overall Study|Death|1
2685741|NCT00481247|9266205|P1|Overall Study|Death|0
2685742|NCT00481195|9266229|P2|Overall Study|Miscellaneous|2
2685743|NCT00481195|9266230|P1|Overall Study|Miscellaneous|2
2685744|NCT00481195|9266229|P2|Overall Study|Withdrawal by Subject|9
2685745|NCT00481195|9266230|P1|Overall Study|Withdrawal by Subject|3
2685746|NCT00481195|9266229|P2|Overall Study|Protocol Violation|7
2685747|NCT00481195|9266230|P1|Overall Study|Protocol Violation|10
2685748|NCT00481195|9266229|P2|Overall Study|Physician Decision|1
2685749|NCT00481195|9266230|P1|Overall Study|Physician Decision|3
2685750|NCT00481195|9266229|P2|Overall Study|Lost to Follow-up|6
2685751|NCT00481195|9266230|P1|Overall Study|Lost to Follow-up|4
2685752|NCT00481195|9266229|P2|Overall Study|Lack of Efficacy|3
2685753|NCT00481195|9266230|P1|Overall Study|Lack of Efficacy|1
2685754|NCT00481195|9266229|P2|Overall Study|Adverse Event|11
2685755|NCT00481195|9266230|P1|Overall Study|Adverse Event|16
2685756|NCT00481078|9266316|P2|Overall Study|Brain metastasis|1
2685757|NCT00481078|9266317|P1|Overall Study|Brain metastasis|0
2685758|NCT00481078|9266316|P2|Overall Study|Received other treatment|1
2685759|NCT00481078|9266317|P1|Overall Study|Received other treatment|2
2685760|NCT00481078|9266316|P2|Overall Study|Information not available|0
2685761|NCT00481078|9266317|P1|Overall Study|Information not available|1
2685762|NCT00481078|9266316|P2|Overall Study|Withdrawal by Subject|1
2685763|NCT00481078|9266317|P1|Overall Study|Withdrawal by Subject|7
2685764|NCT00481078|9266316|P2|Overall Study|Intercurrent illness|0
2685765|NCT00481078|9266317|P1|Overall Study|Intercurrent illness|1
2685766|NCT00481078|9266316|P2|Overall Study|Death|3
2685767|NCT00481078|9266317|P1|Overall Study|Death|5
2685768|NCT00481078|9266316|P2|Overall Study|Adverse Event|3
2685769|NCT00481078|9266317|P1|Overall Study|Adverse Event|15
2685770|NCT00481078|9266316|P2|Overall Study|Progression of disease|11
2685771|NCT00481078|9266317|P1|Overall Study|Progression of disease|11
2685772|NCT00481065|9266335|P8|Overall Study|Unable to classify|0
2685773|NCT00481065|9266336|P7|Overall Study|Unable to classify|0
2685774|NCT00481065|9266337|P6|Overall Study|Unable to classify|0
2685775|NCT00481065|9266338|P5|Overall Study|Unable to classify|1
2685776|NCT00481065|9266339|P4|Overall Study|Unable to classify|0
2685777|NCT00481065|9266340|P3|Overall Study|Unable to classify|2
2685778|NCT00481065|9266341|P2|Overall Study|Unable to classify|1
2685779|NCT00481065|9266342|P1|Overall Study|Unable to classify|0
2685780|NCT00481065|9266335|P8|Overall Study|Protocol Violation|2
2685781|NCT00481065|9266336|P7|Overall Study|Protocol Violation|3
2685782|NCT00481065|9266337|P6|Overall Study|Protocol Violation|6
2685783|NCT00481065|9266338|P5|Overall Study|Protocol Violation|2
2685784|NCT00481065|9266339|P4|Overall Study|Protocol Violation|1
2685785|NCT00481065|9266340|P3|Overall Study|Protocol Violation|1
2685786|NCT00481065|9266341|P2|Overall Study|Protocol Violation|1
2685787|NCT00481065|9266342|P1|Overall Study|Protocol Violation|2
2685788|NCT00481065|9266335|P8|Overall Study|Administrative reason|0
2685789|NCT00481065|9266336|P7|Overall Study|Administrative reason|1
2685790|NCT00481065|9266337|P6|Overall Study|Administrative reason|2
2685791|NCT00481065|9266338|P5|Overall Study|Administrative reason|0
2685792|NCT00481065|9266339|P4|Overall Study|Administrative reason|0
2685793|NCT00481065|9266340|P3|Overall Study|Administrative reason|0
2685794|NCT00481065|9266341|P2|Overall Study|Administrative reason|0
2685795|NCT00481065|9266342|P1|Overall Study|Administrative reason|0
2685796|NCT00481065|9266335|P8|Overall Study|Inappropriate enrollment|1
2685797|NCT00481065|9266336|P7|Overall Study|Inappropriate enrollment|0
2685798|NCT00481065|9266337|P6|Overall Study|Inappropriate enrollment|1
2685799|NCT00481065|9266338|P5|Overall Study|Inappropriate enrollment|2
2685800|NCT00481065|9266339|P4|Overall Study|Inappropriate enrollment|0
2685801|NCT00481065|9266340|P3|Overall Study|Inappropriate enrollment|2
2685802|NCT00481065|9266341|P2|Overall Study|Inappropriate enrollment|0
2685803|NCT00481065|9266342|P1|Overall Study|Inappropriate enrollment|4
2685804|NCT00481065|9266335|P8|Overall Study|Lost to Follow-up|5
2685805|NCT00481065|9266336|P7|Overall Study|Lost to Follow-up|2
2685806|NCT00481065|9266337|P6|Overall Study|Lost to Follow-up|3
2685807|NCT00481065|9266338|P5|Overall Study|Lost to Follow-up|3
2685808|NCT00481065|9266339|P4|Overall Study|Lost to Follow-up|3
2685809|NCT00481065|9266340|P3|Overall Study|Lost to Follow-up|4
2685810|NCT00481065|9266341|P2|Overall Study|Lost to Follow-up|2
2685811|NCT00481065|9266342|P1|Overall Study|Lost to Follow-up|4
2685812|NCT00481065|9266335|P8|Overall Study|Withdrawal by Subject|10
2685813|NCT00481065|9266336|P7|Overall Study|Withdrawal by Subject|9
2685814|NCT00481065|9266337|P6|Overall Study|Withdrawal by Subject|12
2685815|NCT00481065|9266338|P5|Overall Study|Withdrawal by Subject|13
2685816|NCT00481065|9266339|P4|Overall Study|Withdrawal by Subject|11
2685817|NCT00481065|9266340|P3|Overall Study|Withdrawal by Subject|7
2685818|NCT00481065|9266341|P2|Overall Study|Withdrawal by Subject|12
2685819|NCT00481065|9266342|P1|Overall Study|Withdrawal by Subject|11
2685820|NCT00481065|9266335|P8|Overall Study|Adverse event or death|1
2685821|NCT00481065|9266336|P7|Overall Study|Adverse event or death|1
2685822|NCT00481065|9266337|P6|Overall Study|Adverse event or death|0
2685823|NCT00481065|9266338|P5|Overall Study|Adverse event or death|2
2685824|NCT00481065|9266339|P4|Overall Study|Adverse event or death|0
2685825|NCT00481065|9266340|P3|Overall Study|Adverse event or death|3
2685826|NCT00481065|9266341|P2|Overall Study|Adverse event or death|1
2685827|NCT00481065|9266342|P1|Overall Study|Adverse event or death|1
2685828|NCT00480857|9266432|P1|Overall Study|Lack of Efficacy|2
2685829|NCT00480779|9266442|P2|Overall Study|Job and Health-related|3
2685830|NCT00480779|9266443|P1|Overall Study|Job and Health-related|0
2685831|NCT00480779|9266442|P2|Overall Study|Other|0
2685832|NCT00480779|9266443|P1|Overall Study|Other|2
2685833|NCT00480636|9266480|P1|Overall Study|Lost to follow-up; subsequently died|1
2685834|NCT00480636|9266480|P1|Overall Study|Other|2
2685835|NCT00480636|9266480|P1|Overall Study|Lost to Follow-up|4
2685836|NCT00480636|9266480|P1|Overall Study|Death|12
2685837|NCT00480532|9266492|P4|Overall Study|Protocol Violation|0
2685838|NCT00480532|9266493|P3|Overall Study|Protocol Violation|1
2685839|NCT00480532|9266494|P2|Overall Study|Protocol Violation|0
2685840|NCT00480532|9266495|P1|Overall Study|Protocol Violation|0
2685841|NCT00480532|9266492|P4|Overall Study|Withdrawal by Subject|1
2685842|NCT00480532|9266493|P3|Overall Study|Withdrawal by Subject|3
2685843|NCT00480532|9266494|P2|Overall Study|Withdrawal by Subject|4
2685844|NCT00480532|9266495|P1|Overall Study|Withdrawal by Subject|2
2685845|NCT00480493|9266515|P2|Overall Study|moved|7
2685846|NCT00480493|9266516|P1|Overall Study|moved|2
2685847|NCT00480441|9266528|P3|Randomization|Lost to Follow-up|2
2685848|NCT00480441|9266529|P2|Randomization|Lost to Follow-up|7
2685849|NCT00480441|9266530|P1|Randomization|Lost to Follow-up|0
2685850|NCT00480441|9266528|P3|Baseline Functional MRI|physical contraindication|0
2685851|NCT00480441|9266529|P2|Baseline Functional MRI|physical contraindication|0
2685852|NCT00480441|9266530|P1|Baseline Functional MRI|physical contraindication|4
2685853|NCT00480441|9266528|P3|Baseline Functional MRI|Lost to Follow-up|0
2685854|NCT00480441|9266529|P2|Baseline Functional MRI|Lost to Follow-up|0
2685855|NCT00480441|9266530|P1|Baseline Functional MRI|Lost to Follow-up|4
2685856|NCT00480441|9266528|P3|Baseline Functional MRI|Functional MRI data not usable|0
2685857|NCT00480441|9266529|P2|Baseline Functional MRI|Functional MRI data not usable|0
2685858|NCT00480441|9266530|P1|Baseline Functional MRI|Functional MRI data not usable|4
2685859|NCT00480441|9266528|P3|Screening|Not Eligible|0
2685860|NCT00480441|9266529|P2|Screening|Not Eligible|0
2685861|NCT00480441|9266530|P1|Screening|Not Eligible|37
2685862|NCT00480324|9266539|P2|Overall Study|Subject’s mother pregnant|1
2685863|NCT00480324|9266540|P1|Overall Study|Subject’s mother pregnant|0
2685864|NCT00480324|9266539|P2|Overall Study|Lost to Follow-up|8
2685865|NCT00480324|9266540|P1|Overall Study|Lost to Follow-up|17
2685866|NCT00480324|9266539|P2|Overall Study|Withdrawal by Subject|5
2685867|NCT00480324|9266540|P1|Overall Study|Withdrawal by Subject|14
2685868|NCT00480324|9266539|P2|Overall Study|Protocol Violation|1
2685869|NCT00480324|9266540|P1|Overall Study|Protocol Violation|0
2685870|NCT00480324|9266539|P2|Overall Study|Adverse Event|1
2685871|NCT00480324|9266540|P1|Overall Study|Adverse Event|1
2685872|NCT00480077|9266568|P2|Overall Study|early exit|11
2685873|NCT00480077|9266569|P1|Overall Study|early exit|12
2685874|NCT00480077|9266568|P2|Overall Study|Death|15
2685875|NCT00480077|9266569|P1|Overall Study|Death|19
2685876|NCT00480025|9266577|P2|Overall Study|SAE including intercurrent illness|42
2685877|NCT00480025|9266578|P1|Overall Study|SAE including intercurrent illness|76
2685878|NCT00480025|9266577|P2|Overall Study|Other|29
2685879|NCT00480025|9266578|P1|Overall Study|Other|70
2685880|NCT00480025|9266577|P2|Overall Study|Adverse Event|12
2685881|NCT00480025|9266578|P1|Overall Study|Adverse Event|44
2685882|NCT00480025|9266577|P2|Overall Study|Disease Progression / Recurrence|224
2685883|NCT00480025|9266578|P1|Overall Study|Disease Progression / Recurrence|449
2685884|NCT00480025|9266577|P2|Overall Study|Patients remaining ongoing at Data Lock|55
2685885|NCT00480025|9266578|P1|Overall Study|Patients remaining ongoing at Data Lock|101
2685886|NCT00480025|9266577|P2|Overall Study|Protocol Violation|7
2685887|NCT00480025|9266578|P1|Overall Study|Protocol Violation|12
2685888|NCT00479882|9266650|P4|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
2685889|NCT00479882|9266651|P3|Crossover: Period III (Weeks 13-20)|Protocol Violation|1
2685890|NCT00479882|9266652|P2|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
2685891|NCT00479882|9266653|P1|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
2685892|NCT00479882|9266650|P4|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
2685893|NCT00479882|9266651|P3|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1
2685894|NCT00479882|9266652|P2|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
2685895|NCT00479882|9266653|P1|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
2685896|NCT00479882|9266650|P4|Crossover: Period III (Weeks 13-20)|Participant moved|0
2685897|NCT00479882|9266651|P3|Crossover: Period III (Weeks 13-20)|Participant moved|1
2685898|NCT00479882|9266652|P2|Crossover: Period III (Weeks 13-20)|Participant moved|2
2685899|NCT00479882|9266653|P1|Crossover: Period III (Weeks 13-20)|Participant moved|1
2685900|NCT00479882|9266650|P4|Crossover: Period III (Weeks 13-20)|Other|2
2685901|NCT00479882|9266651|P3|Crossover: Period III (Weeks 13-20)|Other|2
2685902|NCT00479882|9266652|P2|Crossover: Period III (Weeks 13-20)|Other|0
2685903|NCT00479882|9266653|P1|Crossover: Period III (Weeks 13-20)|Other|5
2685904|NCT00479882|9266650|P4|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
2685905|NCT00479882|9266651|P3|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
2685906|NCT00479882|9266652|P2|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2
2685907|NCT00479882|9266653|P1|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
2685908|NCT00479882|9266650|P4|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
2685909|NCT00479882|9266651|P3|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
2685910|NCT00479882|9266652|P2|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1
2685911|NCT00479882|9266653|P1|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3
2685912|NCT00479882|9266650|P4|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10
2685913|NCT00479882|9266651|P3|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
2685914|NCT00479882|9266652|P2|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13
2685915|NCT00479882|9266653|P1|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
2685916|NCT00479882|9266650|P4|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
2685917|NCT00479882|9266651|P3|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5
2685918|NCT00479882|9266652|P2|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
2685919|NCT00479882|9266653|P1|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2
2685920|NCT00479882|9266650|P4|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25
2685921|NCT00479882|9266651|P3|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30
2685922|NCT00479882|9266652|P2|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33
2685923|NCT00479882|9266653|P1|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24
2685924|NCT00479882|9266650|P4|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1
2685925|NCT00479882|9266651|P3|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2
2685926|NCT00479882|9266652|P2|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4
2685927|NCT00479882|9266653|P1|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0
2685928|NCT00479882|9266650|P4|Precrossover: Periods I/II (Weeks 1-12)|Other|5
2685929|NCT00479882|9266651|P3|Precrossover: Periods I/II (Weeks 1-12)|Other|9
2685930|NCT00479882|9266652|P2|Precrossover: Periods I/II (Weeks 1-12)|Other|6
2685931|NCT00479882|9266653|P1|Precrossover: Periods I/II (Weeks 1-12)|Other|4
2685932|NCT00479882|9266650|P4|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11
2685933|NCT00479882|9266651|P3|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
2685934|NCT00479882|9266652|P2|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
2685935|NCT00479882|9266653|P1|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12
2685936|NCT00479882|9266650|P4|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
2685937|NCT00479882|9266651|P3|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
2685938|NCT00479882|9266652|P2|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
2685939|NCT00479882|9266653|P1|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0
2685940|NCT00479882|9266650|P4|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87
2685941|NCT00479882|9266651|P3|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98
2685942|NCT00479882|9266652|P2|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99
2685943|NCT00479882|9266653|P1|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96
2685944|NCT00479856|9266783|P1|Overall Study|Physician Decision|1
2685945|NCT00479856|9266783|P1|Overall Study|Withdrawal by Subject|1
2685946|NCT00479856|9266783|P1|Overall Study|Adverse Event|1
2685947|NCT00479765|9266792|P1|Overall Study|study terminated|4
2685948|NCT00479713|9266798|P2|Overall Study|Withdrawal by Subject|1
2685949|NCT00479713|9266799|P1|Overall Study|Withdrawal by Subject|4
2685950|NCT00479713|9266798|P2|Overall Study|Protocol Violation|1
2685951|NCT00479713|9266799|P1|Overall Study|Protocol Violation|0
2685952|NCT00479713|9266798|P2|Overall Study|Lost to Follow-up|1
2685953|NCT00479713|9266799|P1|Overall Study|Lost to Follow-up|0
2685954|NCT00479713|9266798|P2|Overall Study|Death|0
2685955|NCT00479713|9266799|P1|Overall Study|Death|1
2685956|NCT00479713|9266798|P2|Overall Study|Adverse Event|6
2685957|NCT00479713|9266799|P1|Overall Study|Adverse Event|8
2685958|NCT00479674|9266823|P1|Overall Study|none provided|3
2685959|NCT00479674|9266823|P1|Overall Study|Physician Decision|14
2685960|NCT00479674|9266823|P1|Overall Study|Withdrawal by Subject|6
2685961|NCT00479674|9266823|P1|Overall Study|Adverse Event|18
2685962|NCT00479557|9266838|P7|Overall Study|Other|0
2685963|NCT00479557|9266839|P6|Overall Study|Other|3
2685964|NCT00479557|9266840|P5|Overall Study|Other|0
2685965|NCT00479557|9266841|P4|Overall Study|Other|0
2685966|NCT00479557|9266842|P3|Overall Study|Other|1
2685967|NCT00479557|9266843|P2|Overall Study|Other|3
2685968|NCT00479557|9266844|P1|Overall Study|Other|2
2685969|NCT00479557|9266838|P7|Overall Study|Subject Request|1
2685970|NCT00479557|9266839|P6|Overall Study|Subject Request|4
2685971|NCT00479557|9266840|P5|Overall Study|Subject Request|1
2685972|NCT00479557|9266841|P4|Overall Study|Subject Request|1
2685973|NCT00479557|9266842|P3|Overall Study|Subject Request|1
2685974|NCT00479557|9266843|P2|Overall Study|Subject Request|0
2685975|NCT00479557|9266844|P1|Overall Study|Subject Request|3
2685976|NCT00479557|9266838|P7|Overall Study|Investigator Request|0
2685977|NCT00479557|9266839|P6|Overall Study|Investigator Request|0
2685978|NCT00479557|9266840|P5|Overall Study|Investigator Request|0
2685979|NCT00479557|9266841|P4|Overall Study|Investigator Request|0
2685980|NCT00479557|9266842|P3|Overall Study|Investigator Request|1
2685981|NCT00479557|9266843|P2|Overall Study|Investigator Request|0
2685982|NCT00479557|9266844|P1|Overall Study|Investigator Request|0
2685983|NCT00479557|9266838|P7|Overall Study|Caregiver Request|0
2685984|NCT00479557|9266839|P6|Overall Study|Caregiver Request|2
2685985|NCT00479557|9266840|P5|Overall Study|Caregiver Request|1
2685986|NCT00479557|9266841|P4|Overall Study|Caregiver Request|0
2685987|NCT00479557|9266842|P3|Overall Study|Caregiver Request|2
2685988|NCT00479557|9266843|P2|Overall Study|Caregiver Request|2
2685989|NCT00479557|9266844|P1|Overall Study|Caregiver Request|2
2685990|NCT00479557|9266838|P7|Overall Study|AE not related to Study Drug|1
2685991|NCT00479557|9266839|P6|Overall Study|AE not related to Study Drug|2
2685992|NCT00479557|9266840|P5|Overall Study|AE not related to Study Drug|2
2685993|NCT00479557|9266841|P4|Overall Study|AE not related to Study Drug|0
2685994|NCT00479557|9266842|P3|Overall Study|AE not related to Study Drug|0
2685995|NCT00479557|9266843|P2|Overall Study|AE not related to Study Drug|3
2685996|NCT00479557|9266844|P1|Overall Study|AE not related to Study Drug|1
2685997|NCT00479557|9266838|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
2685998|NCT00479557|9266839|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
2685999|NCT00479557|9266840|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
2686000|NCT00479557|9266841|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
2686001|NCT00479557|9266842|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
2686002|NCT00479557|9266843|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
2686003|NCT00479557|9266844|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
2686004|NCT00479557|9266838|P7|Overall Study|Lost to Follow-up|0
2686005|NCT00479557|9266839|P6|Overall Study|Lost to Follow-up|0
2686006|NCT00479557|9266840|P5|Overall Study|Lost to Follow-up|0
2686007|NCT00479557|9266841|P4|Overall Study|Lost to Follow-up|2
2686008|NCT00479557|9266842|P3|Overall Study|Lost to Follow-up|0
2686009|NCT00479557|9266843|P2|Overall Study|Lost to Follow-up|2
2686010|NCT00479557|9266844|P1|Overall Study|Lost to Follow-up|0
2686011|NCT00479557|9266838|P7|Overall Study|Lack of Efficacy|0
2686012|NCT00479557|9266839|P6|Overall Study|Lack of Efficacy|0
2686013|NCT00479557|9266840|P5|Overall Study|Lack of Efficacy|0
2686014|NCT00479557|9266841|P4|Overall Study|Lack of Efficacy|0
2686015|NCT00479557|9266842|P3|Overall Study|Lack of Efficacy|0
2686016|NCT00479557|9266843|P2|Overall Study|Lack of Efficacy|0
2686017|NCT00479557|9266844|P1|Overall Study|Lack of Efficacy|1
2686018|NCT00479557|9266838|P7|Overall Study|Death|0
2686019|NCT00479557|9266839|P6|Overall Study|Death|1
2686020|NCT00479557|9266840|P5|Overall Study|Death|0
2686021|NCT00479557|9266841|P4|Overall Study|Death|0
2686022|NCT00479557|9266842|P3|Overall Study|Death|0
2686023|NCT00479557|9266843|P2|Overall Study|Death|0
2686024|NCT00479557|9266844|P1|Overall Study|Death|0
2686025|NCT00479466|9266887|P6|Overall Study|Withdrawal by Subject|1
2686026|NCT00479466|9266888|P5|Overall Study|Withdrawal by Subject|3
2686027|NCT00479466|9266889|P4|Overall Study|Withdrawal by Subject|2
2686028|NCT00479466|9266890|P3|Overall Study|Withdrawal by Subject|0
2686029|NCT00479466|9266891|P2|Overall Study|Withdrawal by Subject|5
2686030|NCT00479466|9266892|P1|Overall Study|Withdrawal by Subject|3
2686031|NCT00479466|9266887|P6|Overall Study|Protocol Violation|0
2686032|NCT00479466|9266888|P5|Overall Study|Protocol Violation|0
2686033|NCT00479466|9266889|P4|Overall Study|Protocol Violation|0
2686034|NCT00479466|9266890|P3|Overall Study|Protocol Violation|0
2686035|NCT00479466|9266891|P2|Overall Study|Protocol Violation|0
2686036|NCT00479466|9266892|P1|Overall Study|Protocol Violation|1
2686037|NCT00479466|9266887|P6|Overall Study|Pregnancy|0
2686038|NCT00479466|9266888|P5|Overall Study|Pregnancy|1
2686039|NCT00479466|9266889|P4|Overall Study|Pregnancy|0
2686040|NCT00479466|9266890|P3|Overall Study|Pregnancy|0
2686041|NCT00479466|9266891|P2|Overall Study|Pregnancy|0
2686042|NCT00479466|9266892|P1|Overall Study|Pregnancy|0
2686043|NCT00479466|9266887|P6|Overall Study|Physician Decision|0
2686044|NCT00479466|9266888|P5|Overall Study|Physician Decision|0
2686045|NCT00479466|9266889|P4|Overall Study|Physician Decision|0
2686046|NCT00479466|9266890|P3|Overall Study|Physician Decision|1
2686047|NCT00479466|9266891|P2|Overall Study|Physician Decision|1
2686048|NCT00479466|9266892|P1|Overall Study|Physician Decision|2
2686049|NCT00479466|9266887|P6|Overall Study|Lost to Follow-up|2
2686050|NCT00479466|9266888|P5|Overall Study|Lost to Follow-up|2
2686051|NCT00479466|9266889|P4|Overall Study|Lost to Follow-up|0
2686052|NCT00479466|9266890|P3|Overall Study|Lost to Follow-up|1
2686053|NCT00479466|9266891|P2|Overall Study|Lost to Follow-up|1
2686054|NCT00479466|9266892|P1|Overall Study|Lost to Follow-up|0
2686055|NCT00479466|9266887|P6|Overall Study|Lack of Efficacy|0
2686056|NCT00479466|9266888|P5|Overall Study|Lack of Efficacy|0
2686057|NCT00479466|9266889|P4|Overall Study|Lack of Efficacy|0
2686058|NCT00479466|9266890|P3|Overall Study|Lack of Efficacy|1
2686059|NCT00479466|9266891|P2|Overall Study|Lack of Efficacy|0
2686060|NCT00479466|9266892|P1|Overall Study|Lack of Efficacy|2
2686061|NCT00479466|9266887|P6|Overall Study|Hyperglycemia|1
2686062|NCT00479466|9266888|P5|Overall Study|Hyperglycemia|0
2686063|NCT00479466|9266889|P4|Overall Study|Hyperglycemia|0
2686064|NCT00479466|9266890|P3|Overall Study|Hyperglycemia|0
2686065|NCT00479466|9266891|P2|Overall Study|Hyperglycemia|0
2686066|NCT00479466|9266892|P1|Overall Study|Hyperglycemia|0
2686067|NCT00479466|9266887|P6|Overall Study|Adverse Event|0
2686068|NCT00479466|9266888|P5|Overall Study|Adverse Event|2
2686069|NCT00479466|9266889|P4|Overall Study|Adverse Event|1
2686070|NCT00479466|9266890|P3|Overall Study|Adverse Event|0
2686071|NCT00479466|9266891|P2|Overall Study|Adverse Event|1
2686072|NCT00479466|9266892|P1|Overall Study|Adverse Event|5
2686073|NCT00479401|9266921|P3|Overall Study|Exclusion criteria, relocation|0
2686074|NCT00479401|9266922|P2|Overall Study|Exclusion criteria, relocation|3
2686075|NCT00479401|9266923|P1|Overall Study|Exclusion criteria, relocation|4
2686076|NCT00479401|9266921|P3|Overall Study|Withdrawal by Subject|2
2686077|NCT00479401|9266922|P2|Overall Study|Withdrawal by Subject|10
2686078|NCT00479401|9266923|P1|Overall Study|Withdrawal by Subject|16
2686079|NCT00479401|9266921|P3|Overall Study|Lost to Follow-up|1
2686080|NCT00479401|9266922|P2|Overall Study|Lost to Follow-up|1
2686081|NCT00479401|9266923|P1|Overall Study|Lost to Follow-up|1
2686082|NCT00479401|9266921|P3|Overall Study|Protocol Violation|1
2686083|NCT00479401|9266922|P2|Overall Study|Protocol Violation|1
2686084|NCT00479401|9266923|P1|Overall Study|Protocol Violation|2
2686085|NCT00479401|9266921|P3|Overall Study|Lack of Efficacy|4
2686086|NCT00479401|9266922|P2|Overall Study|Lack of Efficacy|2
2686087|NCT00479401|9266923|P1|Overall Study|Lack of Efficacy|2
2686088|NCT00479401|9266921|P3|Overall Study|Adverse Event|4
2686089|NCT00479401|9266922|P2|Overall Study|Adverse Event|20
2686090|NCT00479401|9266923|P1|Overall Study|Adverse Event|24
2686091|NCT00479388|9266978|P2|Overall Study|Withdrawal by Subject|17
2686092|NCT00479388|9266979|P1|Overall Study|Withdrawal by Subject|32
2686093|NCT00479388|9266978|P2|Overall Study|Protocol Violation|9
2686094|NCT00479388|9266979|P1|Overall Study|Protocol Violation|10
2686095|NCT00479388|9266978|P2|Overall Study|Lost to Follow-up|2
2686096|NCT00479388|9266979|P1|Overall Study|Lost to Follow-up|0
2686097|NCT00479388|9266978|P2|Overall Study|Adverse Event|45
2686098|NCT00479388|9266979|P1|Overall Study|Adverse Event|90
2686099|NCT00479336|9266993|P4|Overall Study|Resolution of all hepatic edema findings|0
2686100|NCT00479336|9266994|P3|Overall Study|Resolution of all hepatic edema findings|0
2686101|NCT00479336|9266995|P2|Overall Study|Resolution of all hepatic edema findings|1
2686102|NCT00479336|9266996|P1|Overall Study|Resolution of all hepatic edema findings|1
2686103|NCT00479336|9266993|P4|Overall Study|Physician Decision|2
2686104|NCT00479336|9266994|P3|Overall Study|Physician Decision|0
2686105|NCT00479336|9266995|P2|Overall Study|Physician Decision|1
2686106|NCT00479336|9266996|P1|Overall Study|Physician Decision|0
2686107|NCT00479336|9266993|P4|Overall Study|Withdrawal by Subject|0
2686108|NCT00479336|9266994|P3|Overall Study|Withdrawal by Subject|0
2686109|NCT00479336|9266995|P2|Overall Study|Withdrawal by Subject|2
2686110|NCT00479336|9266996|P1|Overall Study|Withdrawal by Subject|1
2686111|NCT00479336|9266993|P4|Overall Study|Protocol Violation|0
2686112|NCT00479336|9266994|P3|Overall Study|Protocol Violation|0
2686113|NCT00479336|9266995|P2|Overall Study|Protocol Violation|1
2686114|NCT00479336|9266996|P1|Overall Study|Protocol Violation|0
2686115|NCT00479336|9266993|P4|Overall Study|Lack of Efficacy|0
2686116|NCT00479336|9266994|P3|Overall Study|Lack of Efficacy|0
2686117|NCT00479336|9266995|P2|Overall Study|Lack of Efficacy|0
2686118|NCT00479336|9266996|P1|Overall Study|Lack of Efficacy|1
2686119|NCT00479336|9266993|P4|Overall Study|Adverse Event|3
2686120|NCT00479336|9266994|P3|Overall Study|Adverse Event|1
2686121|NCT00479336|9266995|P2|Overall Study|Adverse Event|1
2686122|NCT00479336|9266996|P1|Overall Study|Adverse Event|1
2686123|NCT00479232|9267019|P6|Overall Study|Withdrew Consent|3
2686124|NCT00479232|9267020|P5|Overall Study|Withdrew Consent|1
2686125|NCT00479232|9267021|P4|Overall Study|Withdrew Consent|0
2686126|NCT00479232|9267022|P3|Overall Study|Withdrew Consent|6
2686127|NCT00479232|9267023|P2|Overall Study|Withdrew Consent|2
2686128|NCT00479232|9267024|P1|Overall Study|Withdrew Consent|0
2686129|NCT00479232|9267019|P6|Overall Study|Progressive Disease|12
2686130|NCT00479232|9267020|P5|Overall Study|Progressive Disease|3
2686131|NCT00479232|9267021|P4|Overall Study|Progressive Disease|3
2686132|NCT00479232|9267022|P3|Overall Study|Progressive Disease|12
2686133|NCT00479232|9267023|P2|Overall Study|Progressive Disease|1
2686134|NCT00479232|9267024|P1|Overall Study|Progressive Disease|3
2686135|NCT00479232|9267019|P6|Overall Study|Physician Decision|1
2686136|NCT00479232|9267020|P5|Overall Study|Physician Decision|0
2686137|NCT00479232|9267021|P4|Overall Study|Physician Decision|0
2686138|NCT00479232|9267022|P3|Overall Study|Physician Decision|2
2686139|NCT00479232|9267023|P2|Overall Study|Physician Decision|0
2686140|NCT00479232|9267024|P1|Overall Study|Physician Decision|0
2686141|NCT00479232|9267019|P6|Overall Study|Lack of Efficacy|4
2686142|NCT00479232|9267020|P5|Overall Study|Lack of Efficacy|0
2686143|NCT00479232|9267021|P4|Overall Study|Lack of Efficacy|0
2686144|NCT00479232|9267022|P3|Overall Study|Lack of Efficacy|2
2686145|NCT00479232|9267023|P2|Overall Study|Lack of Efficacy|0
2686146|NCT00479232|9267024|P1|Overall Study|Lack of Efficacy|0
2686147|NCT00479232|9267019|P6|Overall Study|Deviation from Protocol|0
2686148|NCT00479232|9267020|P5|Overall Study|Deviation from Protocol|0
2686149|NCT00479232|9267021|P4|Overall Study|Deviation from Protocol|0
2686150|NCT00479232|9267022|P3|Overall Study|Deviation from Protocol|1
2686151|NCT00479232|9267023|P2|Overall Study|Deviation from Protocol|0
2686152|NCT00479232|9267024|P1|Overall Study|Deviation from Protocol|0
2686153|NCT00479232|9267019|P6|Overall Study|Adverse Event|10
2686154|NCT00479232|9267020|P5|Overall Study|Adverse Event|0
2686155|NCT00479232|9267021|P4|Overall Study|Adverse Event|0
2686156|NCT00479232|9267022|P3|Overall Study|Adverse Event|5
2686157|NCT00479232|9267023|P2|Overall Study|Adverse Event|0
2686158|NCT00479232|9267024|P1|Overall Study|Adverse Event|0
2686159|NCT00478933|9267077|P1|Overall Study|Inadequate data available|53
2686160|NCT00478933|9267077|P1|Overall Study|Informed consent not verified|3
2686161|NCT00478933|9267077|P1|Overall Study|Protocol Violation|22
2686162|NCT00478881|9267103|P2|Overall Study|Non-Compliance with Study Medication|2
2686163|NCT00478881|9267104|P1|Overall Study|Non-Compliance with Study Medication|0
2686164|NCT00478881|9267103|P2|Overall Study|Withdrawal by Subject|2
2686165|NCT00478881|9267104|P1|Overall Study|Withdrawal by Subject|6
2686166|NCT00478881|9267103|P2|Overall Study|Protocol Violation|2
2686167|NCT00478881|9267104|P1|Overall Study|Protocol Violation|2
2686168|NCT00478881|9267103|P2|Overall Study|Lost to Follow-up|1
2686169|NCT00478881|9267104|P1|Overall Study|Lost to Follow-up|0
2686170|NCT00478881|9267103|P2|Overall Study|Lack of Efficacy|3
2686171|NCT00478881|9267104|P1|Overall Study|Lack of Efficacy|0
2686172|NCT00478881|9267103|P2|Overall Study|Adverse Event|12
2686173|NCT00478881|9267104|P1|Overall Study|Adverse Event|31
2686174|NCT00478777|9267128|P1|Overall Study|Not treated with lenalidomide|6
2686175|NCT00478777|9267128|P1|Overall Study|End of therapy|2
2686176|NCT00478777|9267128|P1|Overall Study|Lymphocytes infusion|1
2686177|NCT00478777|9267128|P1|Overall Study|Lack of compliance|1
2686178|NCT00478777|9267128|P1|Overall Study|Intolerance of therapy|1
2686179|NCT00478777|9267128|P1|Overall Study|Physician Decision|1
2686180|NCT00478777|9267128|P1|Overall Study|Lost to Follow-up|3
2686181|NCT00478777|9267128|P1|Overall Study|Protocol Violation|3
2686182|NCT00478777|9267128|P1|Overall Study|Death|3
2686183|NCT00478777|9267128|P1|Overall Study|Withdrawal by Subject|4
2686184|NCT00478777|9267128|P1|Overall Study|Lack of Efficacy|23
2686185|NCT00478777|9267128|P1|Overall Study|Adverse Event|29
2686186|NCT00478673|9267135|P1|12-Months Post-Procedure|Visit Not Required by Protocol|6
2686187|NCT00478673|9267135|P1|12-Months Post-Procedure|Missed Visit|25
2686188|NCT00478673|9267135|P1|12-Months Post-Procedure|Withdrawal by Subject|6
2686189|NCT00478673|9267135|P1|12-Months Post-Procedure|Lost to Follow-up|4
2686190|NCT00478673|9267135|P1|12-Months Post-Procedure|Death|23
2686191|NCT00478673|9267135|P1|30-Days Post-Procedure|Missed Visit|7
2686192|NCT00478673|9267135|P1|30-Days Post-Procedure|Withdrawal by Subject|1
2686193|NCT00478673|9267135|P1|30-Days Post-Procedure|Death|2
2686194|NCT00478647|9267140|P1|Overall Study|Withdrawal by Subject|1
2686195|NCT00478647|9267140|P1|Overall Study|Adverse Event|1
2686196|NCT00478608|9267148|P1|Overall Study|Protocol Violation|3
2686197|NCT00478608|9267148|P1|Overall Study|Withdrawal by Subject|2
2686198|NCT00478608|9267148|P1|Overall Study|Serious Adverse Event|14
2686199|NCT00478608|9267148|P1|Overall Study|Adverse Event|1
2686200|NCT00478426|9267181|P1|Overall Study|Withdrawal by Subject|1
2686201|NCT00478257|9267200|P2|Overall Study|Withdrawal by Subject|3
2686202|NCT00478257|9267201|P1|Overall Study|Withdrawal by Subject|8
2686203|NCT00478244|9267207|P1|Overall Study|Did not receive transplant|1
2686204|NCT00478231|9267220|P1|Overall Study|Randomized, not treated|3
2686205|NCT00478231|9267220|P1|Overall Study|Adverse Event|5
2686206|NCT00478231|9267220|P1|Overall Study|Other|9
2686207|NCT00478231|9267220|P1|Overall Study|Withdrawal by Subject|6
2686208|NCT00478231|9267220|P1|Overall Study|Lost to Follow-up|7
2686209|NCT00478231|9267220|P1|Overall Study|Lack of Efficacy|47
2686210|NCT00478231|9267220|P1|Overall Study|Death|7
2686211|NCT00478205|9267256|P2|Overall Study|Other|12
2686212|NCT00478205|9267257|P1|Overall Study|Other|24
2686213|NCT00478205|9267256|P2|Overall Study|Lack of Efficacy|0
2686214|NCT00478205|9267257|P1|Overall Study|Lack of Efficacy|1
2686215|NCT00478205|9267256|P2|Overall Study|Withdrawal by Subject|22
2686216|NCT00478205|9267257|P1|Overall Study|Withdrawal by Subject|61
2686217|NCT00478205|9267256|P2|Overall Study|Request of Investigator or Sponsor|5
2686218|NCT00478205|9267257|P1|Overall Study|Request of Investigator or Sponsor|4
2686219|NCT00478205|9267256|P2|Overall Study|Protocol Violation|5
2686220|NCT00478205|9267257|P1|Overall Study|Protocol Violation|15
2686221|NCT00478205|9267256|P2|Overall Study|Medication Non-compliance|4
2686222|NCT00478205|9267257|P1|Overall Study|Medication Non-compliance|9
2686223|NCT00478205|9267256|P2|Overall Study|Adverse Event|39
2686224|NCT00478205|9267257|P1|Overall Study|Adverse Event|182
2686225|NCT00478140|9267301|P1|Overall Study|Clinical Disease Progression|1
2686226|NCT00478023|9267333|P5|Overall Study|Lack of pain, Technical difficulties|3
2686227|NCT00478023|9267334|P4|Overall Study|Lack of pain, Technical difficulties|6
2686228|NCT00478023|9267335|P3|Overall Study|Lack of pain, Technical difficulties|5
2686229|NCT00478023|9267336|P2|Overall Study|Lack of pain, Technical difficulties|3
2686230|NCT00478023|9267337|P1|Overall Study|Lack of pain, Technical difficulties|7
2686231|NCT00478023|9267333|P5|Overall Study|Withdrawal by Subject|5
2686232|NCT00478023|9267334|P4|Overall Study|Withdrawal by Subject|4
2686233|NCT00478023|9267335|P3|Overall Study|Withdrawal by Subject|2
2686234|NCT00478023|9267336|P2|Overall Study|Withdrawal by Subject|3
2686235|NCT00478023|9267337|P1|Overall Study|Withdrawal by Subject|2
2686236|NCT00478023|9267333|P5|Overall Study|Lost to Follow-up|0
2686237|NCT00478023|9267334|P4|Overall Study|Lost to Follow-up|1
2686238|NCT00478023|9267335|P3|Overall Study|Lost to Follow-up|1
2686239|NCT00478023|9267336|P2|Overall Study|Lost to Follow-up|1
2686240|NCT00478023|9267337|P1|Overall Study|Lost to Follow-up|3
2686241|NCT00478023|9267333|P5|Overall Study|Lack of Efficacy|41
2686242|NCT00478023|9267334|P4|Overall Study|Lack of Efficacy|5
2686243|NCT00478023|9267335|P3|Overall Study|Lack of Efficacy|4
2686244|NCT00478023|9267336|P2|Overall Study|Lack of Efficacy|10
2686245|NCT00478023|9267337|P1|Overall Study|Lack of Efficacy|11
2686246|NCT00478023|9267333|P5|Overall Study|Death|0
2686247|NCT00478023|9267334|P4|Overall Study|Death|0
2686248|NCT00478023|9267335|P3|Overall Study|Death|0
2686249|NCT00478023|9267336|P2|Overall Study|Death|0
2686250|NCT00478023|9267337|P1|Overall Study|Death|1
2686251|NCT00478023|9267333|P5|Overall Study|Adverse Event|6
2686252|NCT00478023|9267334|P4|Overall Study|Adverse Event|14
2686253|NCT00478023|9267335|P3|Overall Study|Adverse Event|8
2686254|NCT00478023|9267336|P2|Overall Study|Adverse Event|7
2686255|NCT00478023|9267337|P1|Overall Study|Adverse Event|11
2686256|NCT00477971|9267356|P2|Overall Study|Alternative treatment|1
2686257|NCT00477971|9267357|P1|Overall Study|Alternative treatment|3
2686258|NCT00477971|9267356|P2|Overall Study|Death|4
2686259|NCT00477971|9267357|P1|Overall Study|Death|2
2686260|NCT00477971|9267356|P2|Overall Study|Adverse Event|0
2686261|NCT00477971|9267357|P1|Overall Study|Adverse Event|3
2686262|NCT00477971|9267356|P2|Overall Study|Withdrawal by Subject|1
2686263|NCT00477971|9267357|P1|Overall Study|Withdrawal by Subject|3
2686264|NCT00477971|9267356|P2|Overall Study|Disease progression|0
2686265|NCT00477971|9267357|P1|Overall Study|Disease progression|6
2686266|NCT00477750|9267369|P1|Overall Study|Currently Receiving Treatment|11
2686267|NCT00477672|9267385|P3|Overall Study|Discretion of Sponsor|0
2686268|NCT00477672|9267386|P2|Overall Study|Discretion of Sponsor|2
2686269|NCT00477672|9267387|P1|Overall Study|Discretion of Sponsor|1
2686270|NCT00477672|9267385|P3|Overall Study|Consent withdrawn|10
2686271|NCT00477672|9267386|P2|Overall Study|Consent withdrawn|5
2686272|NCT00477672|9267387|P1|Overall Study|Consent withdrawn|2
2686273|NCT00477672|9267385|P3|Overall Study|Protocol noncompliance|0
2686274|NCT00477672|9267386|P2|Overall Study|Protocol noncompliance|2
2686275|NCT00477672|9267387|P1|Overall Study|Protocol noncompliance|0
2686276|NCT00477672|9267385|P3|Overall Study|Physician Decision|0
2686277|NCT00477672|9267386|P2|Overall Study|Physician Decision|0
2686278|NCT00477672|9267387|P1|Overall Study|Physician Decision|1
2686279|NCT00477672|9267385|P3|Overall Study|Disease progression|0
2686280|NCT00477672|9267386|P2|Overall Study|Disease progression|1
2686281|NCT00477672|9267387|P1|Overall Study|Disease progression|0
2686282|NCT00477672|9267385|P3|Overall Study|Death|0
2686283|NCT00477672|9267386|P2|Overall Study|Death|1
2686284|NCT00477672|9267387|P1|Overall Study|Death|0
2686285|NCT00477672|9267385|P3|Overall Study|Adverse Event|6
2686286|NCT00477672|9267386|P2|Overall Study|Adverse Event|5
2686287|NCT00477672|9267387|P1|Overall Study|Adverse Event|3
2686288|NCT00477633|9267398|P1|Overall Study|Various (Moving, Enrollment closed)|75
2686289|NCT00477633|9267398|P1|Overall Study|Protocol Violation|25
2686290|NCT00477633|9267398|P1|Overall Study|Withdrawal by Subject|149
2686291|NCT00477633|9267398|P1|Overall Study|Lost to Follow-up|271
2686292|NCT00477633|9267398|P1|Overall Study|Pregnancy|23
2686293|NCT00477633|9267398|P1|Overall Study|Adverse Event|143
2686294|NCT00477633|9267398|P1|Overall Study|Did not receive treatment|23
2686295|NCT00477607|9267406|P2|Overall Study|Lost to Follow-up|7
2686296|NCT00477607|9267407|P1|Overall Study|Lost to Follow-up|7
2686297|NCT00477594|9267419|P2|Follow-up Period|Other|0
2686298|NCT00477594|9267420|P1|Follow-up Period|Other|1
2686299|NCT00477594|9267419|P2|Follow-up Period|Withdrawal by Subject|1
2686300|NCT00477594|9267420|P1|Follow-up Period|Withdrawal by Subject|2
2686301|NCT00477594|9267419|P2|Year 3|Withdrawal by Subject|0
2686302|NCT00477594|9267420|P1|Year 3|Withdrawal by Subject|1
2686303|NCT00477594|9267419|P2|Year 3|Adverse Event|0
2686304|NCT00477594|9267420|P1|Year 3|Adverse Event|1
2686305|NCT00477594|9267419|P2|Year 1 and Year 2|Other|0
2686306|NCT00477594|9267420|P1|Year 1 and Year 2|Other|1
2686307|NCT00477594|9267419|P2|Year 1 and Year 2|Withdrawal by Subject|1
2686308|NCT00477594|9267420|P1|Year 1 and Year 2|Withdrawal by Subject|2
2686309|NCT00477594|9267419|P2|Year 1 and Year 2|Physician Decision|1
2686310|NCT00477594|9267420|P1|Year 1 and Year 2|Physician Decision|2
2686311|NCT00477594|9267419|P2|Year 1 and Year 2|Adverse Event|2
2686312|NCT00477594|9267420|P1|Year 1 and Year 2|Adverse Event|4
2686313|NCT00477490|9267481|P9|Part II: Extension Week 5 up to Day 169|Not reported|0
2686314|NCT00477490|9267482|P8|Part II: Extension Week 5 up to Day 169|Not reported|0
2686315|NCT00477490|9267483|P7|Part II: Extension Week 5 up to Day 169|Not reported|0
2686316|NCT00477490|9267484|P6|Part II: Extension Week 5 up to Day 169|Not reported|0
2686317|NCT00477490|9267485|P5|Part II: Extension Week 5 up to Day 169|Not reported|1
2686318|NCT00477490|9267486|P4|Part II: Extension Week 5 up to Day 169|Not reported|0
2686319|NCT00477490|9267487|P3|Part II: Extension Week 5 up to Day 169|Not reported|1
2686320|NCT00477490|9267488|P2|Part II: Extension Week 5 up to Day 169|Not reported|3
2686321|NCT00477490|9267489|P1|Part II: Extension Week 5 up to Day 169|Not reported|0
2686322|NCT00477490|9267481|P9|Part II: Extension Week 5 up to Day 169|Other, not specified|1
2686323|NCT00477490|9267482|P8|Part II: Extension Week 5 up to Day 169|Other, not specified|0
2686324|NCT00477490|9267483|P7|Part II: Extension Week 5 up to Day 169|Other, not specified|1
2686325|NCT00477490|9267484|P6|Part II: Extension Week 5 up to Day 169|Other, not specified|1
2686326|NCT00477490|9267485|P5|Part II: Extension Week 5 up to Day 169|Other, not specified|2
2686327|NCT00477490|9267486|P4|Part II: Extension Week 5 up to Day 169|Other, not specified|4
2686328|NCT00477490|9267487|P3|Part II: Extension Week 5 up to Day 169|Other, not specified|2
2686329|NCT00477490|9267488|P2|Part II: Extension Week 5 up to Day 169|Other, not specified|4
2686330|NCT00477490|9267489|P1|Part II: Extension Week 5 up to Day 169|Other, not specified|0
2686331|NCT00477490|9267481|P9|Part II: Extension Week 5 up to Day 169|Excluded medication|0
2686332|NCT00477490|9267482|P8|Part II: Extension Week 5 up to Day 169|Excluded medication|0
2686333|NCT00477490|9267483|P7|Part II: Extension Week 5 up to Day 169|Excluded medication|0
2686334|NCT00477490|9267484|P6|Part II: Extension Week 5 up to Day 169|Excluded medication|0
2686335|NCT00477490|9267485|P5|Part II: Extension Week 5 up to Day 169|Excluded medication|0
2686336|NCT00477490|9267486|P4|Part II: Extension Week 5 up to Day 169|Excluded medication|0
2686337|NCT00477490|9267487|P3|Part II: Extension Week 5 up to Day 169|Excluded medication|0
2686338|NCT00477490|9267488|P2|Part II: Extension Week 5 up to Day 169|Excluded medication|1
2686339|NCT00477490|9267489|P1|Part II: Extension Week 5 up to Day 169|Excluded medication|0
2686340|NCT00477490|9267481|P9|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
2686341|NCT00477490|9267482|P8|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
2686342|NCT00477490|9267483|P7|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
2686343|NCT00477490|9267484|P6|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
2686344|NCT00477490|9267485|P5|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
2686345|NCT00477490|9267486|P4|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
2686346|NCT00477490|9267487|P3|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
2686347|NCT00477490|9267488|P2|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
2686348|NCT00477490|9267489|P1|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
2686349|NCT00477490|9267481|P9|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
2686350|NCT00477490|9267482|P8|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
2686351|NCT00477490|9267483|P7|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1
2686352|NCT00477490|9267484|P6|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
2686353|NCT00477490|9267485|P5|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5
2686354|NCT00477490|9267486|P4|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
2686355|NCT00477490|9267487|P3|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2
2686356|NCT00477490|9267488|P2|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3
2686357|NCT00477490|9267489|P1|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
2686358|NCT00477490|9267481|P9|Part II: Extension Week 5 up to Day 169|Adverse Event|4
2686359|NCT00477490|9267482|P8|Part II: Extension Week 5 up to Day 169|Adverse Event|1
2686360|NCT00477490|9267483|P7|Part II: Extension Week 5 up to Day 169|Adverse Event|1
2686361|NCT00477490|9267484|P6|Part II: Extension Week 5 up to Day 169|Adverse Event|1
2686362|NCT00477490|9267485|P5|Part II: Extension Week 5 up to Day 169|Adverse Event|1
2686363|NCT00477490|9267486|P4|Part II: Extension Week 5 up to Day 169|Adverse Event|1
2686364|NCT00477490|9267487|P3|Part II: Extension Week 5 up to Day 169|Adverse Event|3
2686365|NCT00477490|9267488|P2|Part II: Extension Week 5 up to Day 169|Adverse Event|2
2686366|NCT00477490|9267489|P1|Part II: Extension Week 5 up to Day 169|Adverse Event|0
2686367|NCT00477490|9267481|P9|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
2686368|NCT00477490|9267482|P8|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3
2686369|NCT00477490|9267483|P7|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
2686370|NCT00477490|9267484|P6|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4
2686371|NCT00477490|9267485|P5|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10
2686372|NCT00477490|9267486|P4|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
2686373|NCT00477490|9267487|P3|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
2686374|NCT00477490|9267488|P2|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15
2686375|NCT00477490|9267489|P1|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0
2686376|NCT00477490|9267481|P9|Part I: 4 Week Efficacy|Not Reported|0
2686377|NCT00477490|9267482|P8|Part I: 4 Week Efficacy|Not Reported|0
2686378|NCT00477490|9267483|P7|Part I: 4 Week Efficacy|Not Reported|0
2686379|NCT00477490|9267484|P6|Part I: 4 Week Efficacy|Not Reported|0
2686380|NCT00477490|9267485|P5|Part I: 4 Week Efficacy|Not Reported|1
2686381|NCT00477490|9267486|P4|Part I: 4 Week Efficacy|Not Reported|0
2686382|NCT00477490|9267487|P3|Part I: 4 Week Efficacy|Not Reported|3
2686383|NCT00477490|9267488|P2|Part I: 4 Week Efficacy|Not Reported|2
2686384|NCT00477490|9267489|P1|Part I: 4 Week Efficacy|Not Reported|1
2686385|NCT00477490|9267481|P9|Part I: 4 Week Efficacy|Other, not specified|0
2686386|NCT00477490|9267482|P8|Part I: 4 Week Efficacy|Other, not specified|0
2686387|NCT00477490|9267483|P7|Part I: 4 Week Efficacy|Other, not specified|0
2686388|NCT00477490|9267484|P6|Part I: 4 Week Efficacy|Other, not specified|0
2686389|NCT00477490|9267485|P5|Part I: 4 Week Efficacy|Other, not specified|1
2686390|NCT00477490|9267486|P4|Part I: 4 Week Efficacy|Other, not specified|1
2686391|NCT00477490|9267487|P3|Part I: 4 Week Efficacy|Other, not specified|0
2686392|NCT00477490|9267488|P2|Part I: 4 Week Efficacy|Other, not specified|4
2686393|NCT00477490|9267489|P1|Part I: 4 Week Efficacy|Other, not specified|2
2686394|NCT00477490|9267481|P9|Part I: 4 Week Efficacy|Lost to Follow-up|0
2686395|NCT00477490|9267482|P8|Part I: 4 Week Efficacy|Lost to Follow-up|0
2686396|NCT00477490|9267483|P7|Part I: 4 Week Efficacy|Lost to Follow-up|0
2686397|NCT00477490|9267484|P6|Part I: 4 Week Efficacy|Lost to Follow-up|0
2686398|NCT00477490|9267485|P5|Part I: 4 Week Efficacy|Lost to Follow-up|3
2686399|NCT00477490|9267486|P4|Part I: 4 Week Efficacy|Lost to Follow-up|5
2686400|NCT00477490|9267487|P3|Part I: 4 Week Efficacy|Lost to Follow-up|1
2686401|NCT00477490|9267488|P2|Part I: 4 Week Efficacy|Lost to Follow-up|4
2686402|NCT00477490|9267489|P1|Part I: 4 Week Efficacy|Lost to Follow-up|2
2686403|NCT00477490|9267481|P9|Part I: 4 Week Efficacy|Withdrawal by Subject|0
2686404|NCT00477490|9267482|P8|Part I: 4 Week Efficacy|Withdrawal by Subject|0
2686405|NCT00477490|9267483|P7|Part I: 4 Week Efficacy|Withdrawal by Subject|0
2686406|NCT00477490|9267484|P6|Part I: 4 Week Efficacy|Withdrawal by Subject|0
2686407|NCT00477490|9267485|P5|Part I: 4 Week Efficacy|Withdrawal by Subject|9
2686408|NCT00477490|9267486|P4|Part I: 4 Week Efficacy|Withdrawal by Subject|4
2686409|NCT00477490|9267487|P3|Part I: 4 Week Efficacy|Withdrawal by Subject|6
2686410|NCT00477490|9267488|P2|Part I: 4 Week Efficacy|Withdrawal by Subject|5
2686411|NCT00477490|9267489|P1|Part I: 4 Week Efficacy|Withdrawal by Subject|6
2686412|NCT00477490|9267481|P9|Part I: 4 Week Efficacy|Protocol Violation|0
2686413|NCT00477490|9267482|P8|Part I: 4 Week Efficacy|Protocol Violation|0
2686414|NCT00477490|9267483|P7|Part I: 4 Week Efficacy|Protocol Violation|0
2686415|NCT00477490|9267484|P6|Part I: 4 Week Efficacy|Protocol Violation|0
2686416|NCT00477490|9267485|P5|Part I: 4 Week Efficacy|Protocol Violation|1
2686417|NCT00477490|9267486|P4|Part I: 4 Week Efficacy|Protocol Violation|0
2686418|NCT00477490|9267487|P3|Part I: 4 Week Efficacy|Protocol Violation|0
2686419|NCT00477490|9267488|P2|Part I: 4 Week Efficacy|Protocol Violation|0
2686420|NCT00477490|9267489|P1|Part I: 4 Week Efficacy|Protocol Violation|2
2686421|NCT00477490|9267481|P9|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
2686422|NCT00477490|9267482|P8|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
2686423|NCT00477490|9267483|P7|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
2686424|NCT00477490|9267484|P6|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
2686425|NCT00477490|9267485|P5|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4
2686426|NCT00477490|9267486|P4|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5
2686427|NCT00477490|9267487|P3|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
2686428|NCT00477490|9267488|P2|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
2686429|NCT00477490|9267489|P1|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1
2686430|NCT00477490|9267481|P9|Part I: 4 Week Efficacy|Adverse Event|0
2686431|NCT00477490|9267482|P8|Part I: 4 Week Efficacy|Adverse Event|0
2686432|NCT00477490|9267483|P7|Part I: 4 Week Efficacy|Adverse Event|0
2686433|NCT00477490|9267484|P6|Part I: 4 Week Efficacy|Adverse Event|0
2686434|NCT00477490|9267485|P5|Part I: 4 Week Efficacy|Adverse Event|6
2686435|NCT00477490|9267486|P4|Part I: 4 Week Efficacy|Adverse Event|5
2686436|NCT00477490|9267487|P3|Part I: 4 Week Efficacy|Adverse Event|0
2686437|NCT00477490|9267488|P2|Part I: 4 Week Efficacy|Adverse Event|4
2686438|NCT00477490|9267489|P1|Part I: 4 Week Efficacy|Adverse Event|1
2686439|NCT00477464|9267573|P1|Overall Study|Completion of protocol-defined follow-up|14
2686440|NCT00477464|9267573|P1|Overall Study|Death|36
2686441|NCT00477464|9267573|P1|Overall Study|Lost to Follow-up|1
2686442|NCT00477386|9267617|P2|Overall Study|Withdrawal by Subject|0
2686443|NCT00477386|9267618|P1|Overall Study|Withdrawal by Subject|1
2686444|NCT00477386|9267617|P2|Overall Study|Physician Decision|0
2686445|NCT00477386|9267618|P1|Overall Study|Physician Decision|1
2686446|NCT00477386|9267617|P2|Overall Study|Other|2
2686447|NCT00477386|9267618|P1|Overall Study|Other|1
2686448|NCT00477386|9267617|P2|Overall Study|Disease progression, refractory|3
2686449|NCT00477386|9267618|P1|Overall Study|Disease progression, refractory|1
2686450|NCT00477386|9267617|P2|Overall Study|Disease progression, relapse|4
2686451|NCT00477386|9267618|P1|Overall Study|Disease progression, relapse|3
2686452|NCT00477386|9267617|P2|Overall Study|Adverse Event|8
2686453|NCT00477386|9267618|P1|Overall Study|Adverse Event|4
2686454|NCT00477334|9267628|P2|Overall Study|Protocol Violation|1
2686455|NCT00477334|9267629|P1|Overall Study|Protocol Violation|7
2686456|NCT00477334|9267628|P2|Overall Study|Administrative Problems|15
2686457|NCT00477334|9267629|P1|Overall Study|Administrative Problems|39
2686458|NCT00477334|9267628|P2|Overall Study|Lost to Follow-up|4
2686459|NCT00477334|9267629|P1|Overall Study|Lost to Follow-up|15
2686460|NCT00477334|9267628|P2|Overall Study|Withdrawal by Subject|1
2686461|NCT00477334|9267629|P1|Overall Study|Withdrawal by Subject|2
2686462|NCT00477334|9267628|P2|Overall Study|Adverse Event|2
2686463|NCT00477334|9267629|P1|Overall Study|Adverse Event|1
2686464|NCT00477334|9267628|P2|Overall Study|Discontinued prior to taking study drug|53
2686465|NCT00477334|9267629|P1|Overall Study|Discontinued prior to taking study drug|106
2686466|NCT00477295|9267655|P2|Overall Study|Other|3
2686467|NCT00477295|9267656|P1|Overall Study|Other|4
2686468|NCT00477295|9267655|P2|Overall Study|Lost to Follow-up|11
2686469|NCT00477295|9267656|P1|Overall Study|Lost to Follow-up|21
2686470|NCT00477295|9267655|P2|Overall Study|Physician Decision|5
2686471|NCT00477295|9267656|P1|Overall Study|Physician Decision|4
2686472|NCT00477295|9267655|P2|Overall Study|Protocol Violation|8
2686473|NCT00477295|9267656|P1|Overall Study|Protocol Violation|3
2686474|NCT00477295|9267655|P2|Overall Study|Lack of Efficacy|23
2686475|NCT00477295|9267656|P1|Overall Study|Lack of Efficacy|23
2686476|NCT00477295|9267655|P2|Overall Study|Withdrawal by Subject|24
2686477|NCT00477295|9267656|P1|Overall Study|Withdrawal by Subject|35
2686478|NCT00477295|9267655|P2|Overall Study|Adverse Event|35
2686479|NCT00477295|9267656|P1|Overall Study|Adverse Event|31
2686480|NCT00477269|9267684|P3|Open Label Extension|Death|4
2686481|NCT00477269|9267685|P2|Open Label Extension|Death|0
2686482|NCT00477269|9267686|P1|Open Label Extension|Death|0
2686483|NCT00477269|9267684|P3|Open Label Extension|Adminiatrative problems|2
2686484|NCT00477269|9267685|P2|Open Label Extension|Adminiatrative problems|0
2686485|NCT00477269|9267686|P1|Open Label Extension|Adminiatrative problems|0
2686486|NCT00477269|9267684|P3|Open Label Extension|unsatisfactory therapeutic effects|2
2686487|NCT00477269|9267685|P2|Open Label Extension|unsatisfactory therapeutic effects|0
2686488|NCT00477269|9267686|P1|Open Label Extension|unsatisfactory therapeutic effects|0
2686489|NCT00477269|9267684|P3|Open Label Extension|Abnormal laboratory values|1
2686490|NCT00477269|9267685|P2|Open Label Extension|Abnormal laboratory values|0
2686491|NCT00477269|9267686|P1|Open Label Extension|Abnormal laboratory values|0
2686492|NCT00477269|9267684|P3|Open Label Extension|Adverse Event|4
2686493|NCT00477269|9267685|P2|Open Label Extension|Adverse Event|0
2686494|NCT00477269|9267686|P1|Open Label Extension|Adverse Event|0
2686495|NCT00477269|9267684|P3|Core Study|Withdrawn Consent|0
2686496|NCT00477269|9267685|P2|Core Study|Withdrawn Consent|1
2686497|NCT00477269|9267686|P1|Core Study|Withdrawn Consent|0
2686498|NCT00477269|9267684|P3|Core Study|Death|0
2686499|NCT00477269|9267685|P2|Core Study|Death|3
2686500|NCT00477269|9267686|P1|Core Study|Death|3
2686501|NCT00477269|9267684|P3|Core Study|Adverse Event|0
2686502|NCT00477269|9267685|P2|Core Study|Adverse Event|4
2686503|NCT00477269|9267686|P1|Core Study|Adverse Event|6
2686504|NCT00477165|9267765|P2|Overall Study|Adverse Event|2
2686505|NCT00477165|9267766|P1|Overall Study|Adverse Event|7
2686506|NCT00477152|9267778|P1|Overall Study|Adverse Event|1
2686507|NCT00477152|9267778|P1|Overall Study|Parent withdrew consent|2
2686508|NCT00476996|9267794|P4|OLE Phase (From Week 48)|Early termination of the study|578
2686509|NCT00476996|9267795|P3|OLE Phase (From Week 48)|Early termination of the study|0
2686510|NCT00476996|9267796|P2|OLE Phase (From Week 48)|Early termination of the study|0
2686511|NCT00476996|9267797|P1|OLE Phase (From Week 48)|Early termination of the study|0
2686512|NCT00476996|9267794|P4|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4
2686513|NCT00476996|9267795|P3|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
2686514|NCT00476996|9267796|P2|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
2686515|NCT00476996|9267797|P1|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
2686516|NCT00476996|9267794|P4|OLE Phase (From Week 48)|Lost to Follow-up|4
2686517|NCT00476996|9267795|P3|OLE Phase (From Week 48)|Lost to Follow-up|0
2686518|NCT00476996|9267796|P2|OLE Phase (From Week 48)|Lost to Follow-up|0
2686519|NCT00476996|9267797|P1|OLE Phase (From Week 48)|Lost to Follow-up|0
2686520|NCT00476996|9267794|P4|OLE Phase (From Week 48)|Lack of Efficacy|13
2686521|NCT00476996|9267795|P3|OLE Phase (From Week 48)|Lack of Efficacy|0
2686522|NCT00476996|9267796|P2|OLE Phase (From Week 48)|Lack of Efficacy|0
2686523|NCT00476996|9267797|P1|OLE Phase (From Week 48)|Lack of Efficacy|0
2686524|NCT00476996|9267794|P4|OLE Phase (From Week 48)|Death|7
2686525|NCT00476996|9267795|P3|OLE Phase (From Week 48)|Death|0
2686526|NCT00476996|9267796|P2|OLE Phase (From Week 48)|Death|0
2686527|NCT00476996|9267797|P1|OLE Phase (From Week 48)|Death|0
2686528|NCT00476996|9267794|P4|OLE Phase (From Week 48)|Adverse Event|8
2686529|NCT00476996|9267795|P3|OLE Phase (From Week 48)|Adverse Event|0
2686530|NCT00476996|9267796|P2|OLE Phase (From Week 48)|Adverse Event|0
2686531|NCT00476996|9267797|P1|OLE Phase (From Week 48)|Adverse Event|0
2686532|NCT00476996|9267794|P4|OLE Phase (From Week 48)|Withdrawal by Subject|50
2686533|NCT00476996|9267795|P3|OLE Phase (From Week 48)|Withdrawal by Subject|0
2686534|NCT00476996|9267796|P2|OLE Phase (From Week 48)|Withdrawal by Subject|0
2686535|NCT00476996|9267797|P1|OLE Phase (From Week 48)|Withdrawal by Subject|0
2686536|NCT00476996|9267794|P4|Blinded Treatment Phase (up to Week 48)|Adverse Event|0
2686537|NCT00476996|9267795|P3|Blinded Treatment Phase (up to Week 48)|Adverse Event|7
2686538|NCT00476996|9267796|P2|Blinded Treatment Phase (up to Week 48)|Adverse Event|13
2686539|NCT00476996|9267797|P1|Blinded Treatment Phase (up to Week 48)|Adverse Event|11
2686540|NCT00476996|9267794|P4|Blinded Treatment Phase (up to Week 48)|Death|0
2686541|NCT00476996|9267795|P3|Blinded Treatment Phase (up to Week 48)|Death|1
2686542|NCT00476996|9267796|P2|Blinded Treatment Phase (up to Week 48)|Death|1
2686543|NCT00476996|9267797|P1|Blinded Treatment Phase (up to Week 48)|Death|2
2686544|NCT00476996|9267794|P4|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0
2686545|NCT00476996|9267795|P3|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6
2686546|NCT00476996|9267796|P2|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5
2686547|NCT00476996|9267797|P1|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22
2686548|NCT00476996|9267794|P4|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0
2686549|NCT00476996|9267795|P3|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3
2686550|NCT00476996|9267796|P2|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4
2686551|NCT00476996|9267797|P1|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0
2686552|NCT00476996|9267794|P4|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
2686553|NCT00476996|9267795|P3|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
2686554|NCT00476996|9267796|P2|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2
2686555|NCT00476996|9267797|P1|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
2686556|NCT00476996|9267794|P4|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0
2686557|NCT00476996|9267795|P3|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21
2686558|NCT00476996|9267796|P2|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20
2686559|NCT00476996|9267797|P1|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24
2686560|NCT00476996|9267794|P4|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0
2686561|NCT00476996|9267795|P3|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0
2686562|NCT00476996|9267796|P2|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3
2686563|NCT00476996|9267797|P1|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1
2686564|NCT00476996|9267794|P4|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0
2686565|NCT00476996|9267795|P3|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7
2686566|NCT00476996|9267796|P2|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7
2686567|NCT00476996|9267797|P1|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12
2686568|NCT00476957|9267829|P2|Overall Study|Lost to Follow-up|193
2686569|NCT00476957|9267830|P1|Overall Study|Lost to Follow-up|176
2686570|NCT00476593|9267894|P4|Overall Study|Lost to Follow-up|22
2686571|NCT00476593|9267895|P3|Overall Study|Lost to Follow-up|8
2686572|NCT00476593|9267896|P2|Overall Study|Lost to Follow-up|2
2686573|NCT00476593|9267897|P1|Overall Study|Lost to Follow-up|10
2686574|NCT00476476|9267909|P2|Overall Study|Progressive Disease|17
2686575|NCT00476476|9267910|P1|Overall Study|Progressive Disease|0
2686576|NCT00476476|9267909|P2|Overall Study|Adverse Event|7
2686577|NCT00476476|9267910|P1|Overall Study|Adverse Event|2
2686578|NCT00476229|9267928|P1|Overall Study|Progressive shortness of breath|1
2686579|NCT00476151|9267934|P2|Overall Study|Physician Decision|2
2686580|NCT00476151|9267935|P1|Overall Study|Physician Decision|0
2686581|NCT00476151|9267934|P2|Overall Study|Withdrawal by Subject|0
2686582|NCT00476151|9267935|P1|Overall Study|Withdrawal by Subject|2
2686583|NCT00476151|9267934|P2|Overall Study|Protocol Violation|3
2686584|NCT00476151|9267935|P1|Overall Study|Protocol Violation|1
2686585|NCT00476151|9267934|P2|Overall Study|Adverse Event|2
2686586|NCT00476151|9267935|P1|Overall Study|Adverse Event|0
2686587|NCT00476086|9267941|P1|Overall Study|Progressive Disease|4
2686588|NCT00476086|9267941|P1|Overall Study|Alternative therapy|1
2686589|NCT00476047|9267947|P1|Overall Study|Lost to Follow-up|1
2686590|NCT00476008|9267973|P2|Overall Study|Death|0
2686591|NCT00476008|9267974|P1|Overall Study|Death|1
2686592|NCT00476008|9267973|P2|Overall Study|Withdrawal by Subject|1
2686593|NCT00476008|9267974|P1|Overall Study|Withdrawal by Subject|0
2686594|NCT00476008|9267973|P2|Overall Study|Physician Decision: Medication Noncompli|1
2686595|NCT00476008|9267974|P1|Overall Study|Physician Decision: Medication Noncompli|2
2686596|NCT00476008|9267973|P2|Overall Study|Placebo concerns|2
2686597|NCT00476008|9267974|P1|Overall Study|Placebo concerns|2
2686598|NCT00476008|9267973|P2|Overall Study|Adverse Event|4
2686599|NCT00476008|9267974|P1|Overall Study|Adverse Event|4
2686600|NCT00475982|9268000|P2|Overall Study|surgery rescheduled|3
2686601|NCT00475982|9268001|P1|Overall Study|surgery rescheduled|7
2686602|NCT00475865|9268049|P3|Overall Study|Other than above|0
2686603|NCT00475865|9268050|P2|Overall Study|Other than above|1
2686604|NCT00475865|9268051|P1|Overall Study|Other than above|0
2686605|NCT00475865|9268049|P3|Overall Study|Participant did not wish to continue|0
2686606|NCT00475865|9268050|P2|Overall Study|Participant did not wish to continue|0
2686607|NCT00475865|9268051|P1|Overall Study|Participant did not wish to continue|1
2686608|NCT00475865|9268049|P3|Overall Study|Progressive disease|2
2686609|NCT00475865|9268050|P2|Overall Study|Progressive disease|1
2686610|NCT00475865|9268051|P1|Overall Study|Progressive disease|0
2686611|NCT00475865|9268049|P3|Overall Study|Lack of Efficacy|0
2686612|NCT00475865|9268050|P2|Overall Study|Lack of Efficacy|0
2686613|NCT00475865|9268051|P1|Overall Study|Lack of Efficacy|1
2686614|NCT00475865|9268049|P3|Overall Study|Adverse Event|4
2686615|NCT00475865|9268050|P2|Overall Study|Adverse Event|3
2686616|NCT00475865|9268051|P1|Overall Study|Adverse Event|0
2686617|NCT00475852|9268081|P2|Overall Study|Lost to Follow-up|68
2686618|NCT00475852|9268082|P1|Overall Study|Lost to Follow-up|54
2686619|NCT00475852|9268081|P2|Overall Study|Withdrawal by Subject|24
2686620|NCT00475852|9268082|P1|Overall Study|Withdrawal by Subject|19
2686621|NCT00475852|9268081|P2|Overall Study|Death|456
2686622|NCT00475852|9268082|P1|Overall Study|Death|444
2686623|NCT00475735|9268133|P6|Treatment Period 2|Withdrawal by Subject|0
2686624|NCT00475735|9268134|P5|Treatment Period 2|Withdrawal by Subject|1
2686625|NCT00475735|9268135|P4|Treatment Period 2|Withdrawal by Subject|0
2686626|NCT00475735|9268136|P3|Treatment Period 2|Withdrawal by Subject|0
2686627|NCT00475735|9268137|P2|Treatment Period 2|Withdrawal by Subject|0
2686628|NCT00475735|9268138|P1|Treatment Period 2|Withdrawal by Subject|0
2686629|NCT00475735|9268133|P6|Treatment Period 2|Lack of Efficacy|1
2686630|NCT00475735|9268134|P5|Treatment Period 2|Lack of Efficacy|0
2686631|NCT00475735|9268135|P4|Treatment Period 2|Lack of Efficacy|0
2686632|NCT00475735|9268136|P3|Treatment Period 2|Lack of Efficacy|0
2686633|NCT00475735|9268137|P2|Treatment Period 2|Lack of Efficacy|0
2686634|NCT00475735|9268138|P1|Treatment Period 2|Lack of Efficacy|0
2686635|NCT00475735|9268133|P6|Treatment Period 2|Adverse Event|0
2686636|NCT00475735|9268134|P5|Treatment Period 2|Adverse Event|0
2686637|NCT00475735|9268135|P4|Treatment Period 2|Adverse Event|2
2686638|NCT00475735|9268136|P3|Treatment Period 2|Adverse Event|0
2686639|NCT00475735|9268137|P2|Treatment Period 2|Adverse Event|1
2686640|NCT00475735|9268138|P1|Treatment Period 2|Adverse Event|0
2686641|NCT00475735|9268133|P6|Treatment Washout|Protocol Violation|0
2686642|NCT00475735|9268134|P5|Treatment Washout|Protocol Violation|0
2686643|NCT00475735|9268135|P4|Treatment Washout|Protocol Violation|0
2686644|NCT00475735|9268136|P3|Treatment Washout|Protocol Violation|0
2686645|NCT00475735|9268137|P2|Treatment Washout|Protocol Violation|1
2686646|NCT00475735|9268138|P1|Treatment Washout|Protocol Violation|0
2686647|NCT00475735|9268133|P6|Treatment Washout|Lost to Follow-up|0
2686648|NCT00475735|9268134|P5|Treatment Washout|Lost to Follow-up|0
2686649|NCT00475735|9268135|P4|Treatment Washout|Lost to Follow-up|0
2686650|NCT00475735|9268136|P3|Treatment Washout|Lost to Follow-up|0
2686651|NCT00475735|9268137|P2|Treatment Washout|Lost to Follow-up|1
2686652|NCT00475735|9268138|P1|Treatment Washout|Lost to Follow-up|0
2686653|NCT00475735|9268133|P6|Treatment Period 1|DC due to no efficacy but Continuing|0
2686654|NCT00475735|9268134|P5|Treatment Period 1|DC due to no efficacy but Continuing|0
2686655|NCT00475735|9268135|P4|Treatment Period 1|DC due to no efficacy but Continuing|0
2686656|NCT00475735|9268136|P3|Treatment Period 1|DC due to no efficacy but Continuing|0
2686657|NCT00475735|9268137|P2|Treatment Period 1|DC due to no efficacy but Continuing|1
2686658|NCT00475735|9268138|P1|Treatment Period 1|DC due to no efficacy but Continuing|0
2686659|NCT00475735|9268133|P6|Treatment Period 1|DC due to AE but continuing|2
2686660|NCT00475735|9268134|P5|Treatment Period 1|DC due to AE but continuing|2
2686661|NCT00475735|9268135|P4|Treatment Period 1|DC due to AE but continuing|1
2686662|NCT00475735|9268136|P3|Treatment Period 1|DC due to AE but continuing|0
2686663|NCT00475735|9268137|P2|Treatment Period 1|DC due to AE but continuing|0
2686664|NCT00475735|9268138|P1|Treatment Period 1|DC due to AE but continuing|0
2686665|NCT00475735|9268133|P6|Treatment Period 1|Withdrawal by Subject|0
2686666|NCT00475735|9268134|P5|Treatment Period 1|Withdrawal by Subject|0
2686667|NCT00475735|9268135|P4|Treatment Period 1|Withdrawal by Subject|0
2686668|NCT00475735|9268136|P3|Treatment Period 1|Withdrawal by Subject|0
2686669|NCT00475735|9268137|P2|Treatment Period 1|Withdrawal by Subject|1
2686670|NCT00475735|9268138|P1|Treatment Period 1|Withdrawal by Subject|1
2686671|NCT00475735|9268133|P6|Treatment Period 1|Protocol Violation|0
2686672|NCT00475735|9268134|P5|Treatment Period 1|Protocol Violation|0
2686673|NCT00475735|9268135|P4|Treatment Period 1|Protocol Violation|1
2686674|NCT00475735|9268136|P3|Treatment Period 1|Protocol Violation|0
2686675|NCT00475735|9268137|P2|Treatment Period 1|Protocol Violation|0
2686676|NCT00475735|9268138|P1|Treatment Period 1|Protocol Violation|0
2686677|NCT00475735|9268133|P6|Treatment Period 1|Lost to Follow-up|1
2686678|NCT00475735|9268134|P5|Treatment Period 1|Lost to Follow-up|0
2686679|NCT00475735|9268135|P4|Treatment Period 1|Lost to Follow-up|0
2686680|NCT00475735|9268136|P3|Treatment Period 1|Lost to Follow-up|0
2686681|NCT00475735|9268137|P2|Treatment Period 1|Lost to Follow-up|0
2686682|NCT00475735|9268138|P1|Treatment Period 1|Lost to Follow-up|0
2686683|NCT00475735|9268133|P6|Treatment Period 1|Lack of Efficacy|0
2686684|NCT00475735|9268134|P5|Treatment Period 1|Lack of Efficacy|0
2686685|NCT00475735|9268135|P4|Treatment Period 1|Lack of Efficacy|0
2686686|NCT00475735|9268136|P3|Treatment Period 1|Lack of Efficacy|0
2686687|NCT00475735|9268137|P2|Treatment Period 1|Lack of Efficacy|0
2686688|NCT00475735|9268138|P1|Treatment Period 1|Lack of Efficacy|1
2686689|NCT00475735|9268133|P6|Treatment Period 1|Adverse Event|0
2686690|NCT00475735|9268134|P5|Treatment Period 1|Adverse Event|0
2686691|NCT00475735|9268135|P4|Treatment Period 1|Adverse Event|0
2686692|NCT00475735|9268136|P3|Treatment Period 1|Adverse Event|0
2686693|NCT00475735|9268137|P2|Treatment Period 1|Adverse Event|0
2686694|NCT00475735|9268138|P1|Treatment Period 1|Adverse Event|2
2686695|NCT00475722|9268151|P2|Overall Study|Protocol Violation|0
2686696|NCT00475722|9268152|P1|Overall Study|Protocol Violation|3
2686697|NCT00475722|9268151|P2|Overall Study|Withdrawal by Subject|12
2686698|NCT00475722|9268152|P1|Overall Study|Withdrawal by Subject|12
2686699|NCT00475709|9268158|P1|Overall Study|Lost to Follow-up|21
2686700|NCT00475709|9268158|P1|Overall Study|Device Explant|6
2686701|NCT00475709|9268158|P1|Overall Study|Death|41
2686702|NCT00475709|9268158|P1|Overall Study|Did not meet eligibility criteria|8
2686703|NCT00475670|9268166|P2|Overall Study|Other|3
2686704|NCT00475670|9268167|P1|Overall Study|Other|0
2686705|NCT00475670|9268166|P2|Overall Study|Failure to Return|1
2686706|NCT00475670|9268167|P1|Overall Study|Failure to Return|0
2686707|NCT00475670|9268166|P2|Overall Study|Refused treatment|2
2686708|NCT00475670|9268167|P1|Overall Study|Refused treatment|0
2686709|NCT00475670|9268166|P2|Overall Study|Lack of Efficacy|34
2686710|NCT00475670|9268167|P1|Overall Study|Lack of Efficacy|3
2686711|NCT00475670|9268166|P2|Overall Study|Death|1
2686712|NCT00475670|9268167|P1|Overall Study|Death|0
2686713|NCT00475657|9268191|P1|Overall Study|Sponsor's Decision|3
2686714|NCT00475657|9268191|P1|Overall Study|Death|1
2686715|NCT00475644|9268199|P1|Overall Study|Protocol Violation|13
2686716|NCT00475423|9268264|P1|Overall Study|Lost to Follow-up|7
2686717|NCT00475423|9268264|P1|Overall Study|Reason not specified|1
2686718|NCT00475423|9268264|P1|Overall Study|Death|1
2686719|NCT00475423|9268264|P1|Overall Study|Lack of Efficacy|8
2686720|NCT00475423|9268264|P1|Overall Study|Withdrawal by Subject|6
2686721|NCT00475423|9268264|P1|Overall Study|Adverse Event|4
2686722|NCT00475423|9268264|P1|Overall Study|Protocol Violation|5
2686723|NCT00475306|9268310|P4|Overall Study|Protocol Violation|1
2686724|NCT00475306|9268311|P3|Overall Study|Protocol Violation|0
2686725|NCT00475306|9268312|P2|Overall Study|Protocol Violation|1
2686726|NCT00475306|9268313|P1|Overall Study|Protocol Violation|1
2686727|NCT00475228|9268344|P2|Overall Study|Lost to Follow-up|17
2686728|NCT00475228|9268345|P1|Overall Study|Lost to Follow-up|17
2686729|NCT00475176|9268384|P1|Overall Study|Protocol Violation|1
2686730|NCT00475176|9268384|P1|Overall Study|Withdrawal by Subject|1
2686731|NCT00475176|9268384|P1|Overall Study|Adverse Event|2
2686732|NCT00475033|9268424|P2|Toddler Dose|Lost to Follow-up|0
2686733|NCT00475033|9268425|P1|Toddler Dose|Lost to Follow-up|1
2686734|NCT00475033|9268424|P2|Toddler Dose|Failed to return|0
2686735|NCT00475033|9268425|P1|Toddler Dose|Failed to return|1
2686736|NCT00475033|9268424|P2|Toddler Dose|Parent or legal guardian request|0
2686737|NCT00475033|9268425|P1|Toddler Dose|Parent or legal guardian request|2
2686738|NCT00475033|9268424|P2|After the Infant Series|Other|1
2686739|NCT00475033|9268425|P1|After the Infant Series|Other|0
2686740|NCT00475033|9268424|P2|After the Infant Series|Lost to Follow-up|0
2686741|NCT00475033|9268425|P1|After the Infant Series|Lost to Follow-up|1
2686742|NCT00475033|9268424|P2|After the Infant Series|Protocol Violation|0
2686743|NCT00475033|9268425|P1|After the Infant Series|Protocol Violation|1
2686744|NCT00475033|9268424|P2|After the Infant Series|Failed to return|1
2686745|NCT00475033|9268425|P1|After the Infant Series|Failed to return|2
2686746|NCT00475033|9268424|P2|After the Infant Series|Parent or legal guardian request|2
2686747|NCT00475033|9268425|P1|After the Infant Series|Parent or legal guardian request|2
2686748|NCT00475033|9268424|P2|After the Infant Series|Adverse Event|4
2686749|NCT00475033|9268425|P1|After the Infant Series|Adverse Event|0
2686750|NCT00475033|9268424|P2|Infant Series|Adverse Event|2
2686751|NCT00475033|9268425|P1|Infant Series|Adverse Event|0
2686752|NCT00475033|9268424|P2|Infant Series|Lost to Follow-up|0
2686753|NCT00475033|9268425|P1|Infant Series|Lost to Follow-up|2
2686754|NCT00475033|9268424|P2|Infant Series|Protocol Violation|2
2686755|NCT00475033|9268425|P1|Infant Series|Protocol Violation|1
2686756|NCT00475033|9268424|P2|Infant Series|Parent or legal guardian request|5
2686757|NCT00475033|9268425|P1|Infant Series|Parent or legal guardian request|1
2686758|NCT00475033|9268424|P2|Infant Series|Failed to return|4
2686759|NCT00475033|9268425|P1|Infant Series|Failed to return|3
2686760|NCT00475020|9268473|P1|Overall Study|Donor not able to donate the last minute|1
2686761|NCT00475020|9268473|P1|Overall Study|Insurance Denial|1
2686762|NCT00475020|9268473|P1|Overall Study|Physician Decision|3
2686763|NCT00474994|9268478|P1|Overall Study|Patient found to be ineligible|1
2686764|NCT00474994|9268478|P1|Overall Study|Patient evaluable for toxicity only|3
2686765|NCT00474994|9268478|P1|Overall Study|Patient Not treated|1
2686766|NCT00474968|9268484|P2|Overall Study|Sample not collected|1
2686767|NCT00474968|9268485|P1|Overall Study|Sample not collected|1
2686768|NCT00474968|9268484|P2|Overall Study|Protocol Violation|8
2686769|NCT00474968|9268485|P1|Overall Study|Protocol Violation|9
2686770|NCT00474968|9268484|P2|Overall Study|Withdrawal by Subject|7
2686771|NCT00474968|9268485|P1|Overall Study|Withdrawal by Subject|8
2686772|NCT00474955|9268495|P1|Overall Study|Personal reasons|5
2686773|NCT00474955|9268495|P1|Overall Study|Drug unavailability|1
2686774|NCT00474955|9268495|P1|Overall Study|Adverse Event|2
2686775|NCT00474929|9268511|P5|Overall Study|Physician Decision|0
2686776|NCT00474929|9268512|P4|Overall Study|Physician Decision|2
2686777|NCT00474929|9268513|P3|Overall Study|Physician Decision|1
2686778|NCT00474929|9268514|P2|Overall Study|Physician Decision|0
2686779|NCT00474929|9268515|P1|Overall Study|Physician Decision|0
2686780|NCT00474929|9268511|P5|Overall Study|Unrelated medical condition|0
2686781|NCT00474929|9268512|P4|Overall Study|Unrelated medical condition|0
2686782|NCT00474929|9268513|P3|Overall Study|Unrelated medical condition|1
2686783|NCT00474929|9268514|P2|Overall Study|Unrelated medical condition|0
2686784|NCT00474929|9268515|P1|Overall Study|Unrelated medical condition|0
2686785|NCT00474929|9268511|P5|Overall Study|Withdrawal by Subject|0
2686786|NCT00474929|9268512|P4|Overall Study|Withdrawal by Subject|0
2686787|NCT00474929|9268513|P3|Overall Study|Withdrawal by Subject|0
2686788|NCT00474929|9268514|P2|Overall Study|Withdrawal by Subject|1
2686789|NCT00474929|9268515|P1|Overall Study|Withdrawal by Subject|0
2686790|NCT00474903|9268532|P3|Overall Study|Protocol Violation|2
2686791|NCT00474903|9268533|P2|Overall Study|Protocol Violation|5
2686792|NCT00474903|9268534|P1|Overall Study|Protocol Violation|1
2686793|NCT00474812|9268556|P1|Overall Study|No Initiation of treatment|2
2686794|NCT00474812|9268556|P1|Overall Study|Withdrawal by Subject|5
2686795|NCT00474786|9268566|P2|Overall Study|Other|0
2686796|NCT00474786|9268567|P1|Overall Study|Other|5
2686797|NCT00474786|9268566|P2|Overall Study|Withdrawal by Subject|15
2686798|NCT00474786|9268567|P1|Overall Study|Withdrawal by Subject|15
2686799|NCT00474786|9268566|P2|Overall Study|Protocol Violation|0
2686800|NCT00474786|9268567|P1|Overall Study|Protocol Violation|2
2686801|NCT00474786|9268566|P2|Overall Study|Lost to Follow-up|7
2686802|NCT00474786|9268567|P1|Overall Study|Lost to Follow-up|4
2686803|NCT00474786|9268566|P2|Overall Study|Discontinuation of Study by Sponsor|59
2686804|NCT00474786|9268567|P1|Overall Study|Discontinuation of Study by Sponsor|42
2686805|NCT00474786|9268566|P2|Overall Study|Death|170
2686806|NCT00474786|9268567|P1|Overall Study|Death|189
2686807|NCT00474786|9268566|P2|Overall Study|Investigator Request|1
2686808|NCT00474786|9268567|P1|Overall Study|Investigator Request|2
2686809|NCT00474786|9268566|P2|Overall Study|Not Meeting Study Criteria|1
2686810|NCT00474786|9268567|P1|Overall Study|Not Meeting Study Criteria|0
2686811|NCT00474760|9268592|P7|Overall Study|Terminated by sponsor|2
2686812|NCT00474760|9268593|P6|Overall Study|Terminated by sponsor|0
2686813|NCT00474760|9268594|P5|Overall Study|Terminated by sponsor|0
2686814|NCT00474760|9268595|P4|Overall Study|Terminated by sponsor|0
2686815|NCT00474760|9268596|P3|Overall Study|Terminated by sponsor|0
2686816|NCT00474760|9268597|P2|Overall Study|Terminated by sponsor|0
2686817|NCT00474760|9268598|P1|Overall Study|Terminated by sponsor|0
2686818|NCT00474760|9268592|P7|Overall Study|Progressive disease|7
2686819|NCT00474760|9268593|P6|Overall Study|Progressive disease|20
2686820|NCT00474760|9268594|P5|Overall Study|Progressive disease|8
2686821|NCT00474760|9268595|P4|Overall Study|Progressive disease|2
2686822|NCT00474760|9268596|P3|Overall Study|Progressive disease|3
2686823|NCT00474760|9268597|P2|Overall Study|Progressive disease|2
2686824|NCT00474760|9268598|P1|Overall Study|Progressive disease|3
2686825|NCT00474760|9268592|P7|Overall Study|Other|0
2686826|NCT00474760|9268593|P6|Overall Study|Other|0
2686827|NCT00474760|9268594|P5|Overall Study|Other|1
2686828|NCT00474760|9268595|P4|Overall Study|Other|0
2686829|NCT00474760|9268596|P3|Overall Study|Other|0
2686830|NCT00474760|9268597|P2|Overall Study|Other|1
2686831|NCT00474760|9268598|P1|Overall Study|Other|0
2686832|NCT00474760|9268592|P7|Overall Study|Withdrawal by Subject|1
2686833|NCT00474760|9268593|P6|Overall Study|Withdrawal by Subject|1
2686834|NCT00474760|9268594|P5|Overall Study|Withdrawal by Subject|0
2686835|NCT00474760|9268595|P4|Overall Study|Withdrawal by Subject|1
2686836|NCT00474760|9268596|P3|Overall Study|Withdrawal by Subject|0
2686837|NCT00474760|9268597|P2|Overall Study|Withdrawal by Subject|0
2686838|NCT00474760|9268598|P1|Overall Study|Withdrawal by Subject|0
2686839|NCT00474760|9268592|P7|Overall Study|Laboratory abnormality|0
2686840|NCT00474760|9268593|P6|Overall Study|Laboratory abnormality|1
2686841|NCT00474760|9268594|P5|Overall Study|Laboratory abnormality|0
2686842|NCT00474760|9268595|P4|Overall Study|Laboratory abnormality|0
2686843|NCT00474760|9268596|P3|Overall Study|Laboratory abnormality|0
2686844|NCT00474760|9268597|P2|Overall Study|Laboratory abnormality|0
2686845|NCT00474760|9268598|P1|Overall Study|Laboratory abnormality|0
2686846|NCT00474760|9268592|P7|Overall Study|Adverse Event|0
2686847|NCT00474760|9268593|P6|Overall Study|Adverse Event|7
2686848|NCT00474760|9268594|P5|Overall Study|Adverse Event|1
2686849|NCT00474760|9268595|P4|Overall Study|Adverse Event|0
2686850|NCT00474760|9268596|P3|Overall Study|Adverse Event|0
2686851|NCT00474760|9268597|P2|Overall Study|Adverse Event|0
2686852|NCT00474760|9268598|P1|Overall Study|Adverse Event|0
2686853|NCT00474760|9268592|P7|Overall Study|Death|0
2686854|NCT00474760|9268593|P6|Overall Study|Death|0
2686855|NCT00474760|9268594|P5|Overall Study|Death|2
2686856|NCT00474760|9268595|P4|Overall Study|Death|0
2686857|NCT00474760|9268596|P3|Overall Study|Death|0
2686858|NCT00474760|9268597|P2|Overall Study|Death|0
2686859|NCT00474760|9268598|P1|Overall Study|Death|0
2686860|NCT00474708|9268705|P2|Overall Study|Physician Decision|6
2686861|NCT00474708|9268706|P1|Overall Study|Physician Decision|9
2686862|NCT00474708|9268705|P2|Overall Study|Lost to Follow-up|9
2686863|NCT00474708|9268706|P1|Overall Study|Lost to Follow-up|18
2686864|NCT00474708|9268705|P2|Overall Study|Lack of compliance|4
2686865|NCT00474708|9268706|P1|Overall Study|Lack of compliance|12
2686866|NCT00474708|9268705|P2|Overall Study|Withdrawal by Subject|0
2686867|NCT00474708|9268706|P1|Overall Study|Withdrawal by Subject|7
2686868|NCT00474708|9268705|P2|Overall Study|Suicide ideation/behavior|1
2686869|NCT00474708|9268706|P1|Overall Study|Suicide ideation/behavior|0
2686870|NCT00474708|9268705|P2|Overall Study|Lack of Efficacy|5
2686871|NCT00474708|9268706|P1|Overall Study|Lack of Efficacy|11
2686872|NCT00474630|9268716|P2|Overall Study|Drug noncompliance, other|4
2686873|NCT00474630|9268717|P1|Overall Study|Drug noncompliance, other|11
2686874|NCT00474630|9268716|P2|Overall Study|Lack of Efficacy|6
2686875|NCT00474630|9268717|P1|Overall Study|Lack of Efficacy|5
2686876|NCT00474630|9268716|P2|Overall Study|Protocol Violation|4
2686877|NCT00474630|9268717|P1|Overall Study|Protocol Violation|3
2686878|NCT00474630|9268716|P2|Overall Study|Withdrawal by Subject|15
2686879|NCT00474630|9268717|P1|Overall Study|Withdrawal by Subject|21
2686880|NCT00474630|9268716|P2|Overall Study|Lost to Follow-up|15
2686881|NCT00474630|9268717|P1|Overall Study|Lost to Follow-up|22
2686882|NCT00474630|9268716|P2|Overall Study|Adverse Event|26
2686883|NCT00474630|9268717|P1|Overall Study|Adverse Event|98
2686884|NCT00474539|9268810|P2|Toddler Dose|Protocol Violation|0
2686885|NCT00474539|9268811|P1|Toddler Dose|Protocol Violation|1
2686886|NCT00474539|9268810|P2|After Infant Series|Withdrawal by Subject|0
2686887|NCT00474539|9268811|P1|After Infant Series|Withdrawal by Subject|1
2686888|NCT00474539|9268810|P2|After Infant Series|Lost to Follow-up|0
2686889|NCT00474539|9268811|P1|After Infant Series|Lost to Follow-up|3
2686890|NCT00474539|9268810|P2|Infant Series|Protocol Violation|1
2686891|NCT00474539|9268811|P1|Infant Series|Protocol Violation|0
2686892|NCT00474539|9268810|P2|Infant Series|Lost to Follow-up|1
2686893|NCT00474539|9268811|P1|Infant Series|Lost to Follow-up|2
2686894|NCT00474539|9268810|P2|Infant Series|Randomization error|0
2686895|NCT00474539|9268811|P1|Infant Series|Randomization error|5
2686896|NCT00474539|9268810|P2|Infant Series|Withdrawal by Subject|4
2686897|NCT00474539|9268811|P1|Infant Series|Withdrawal by Subject|3
2686898|NCT00474526|9268876|P17|Overall Study|Withdrawal by Subject|1
2686899|NCT00474526|9268877|P16|Overall Study|Withdrawal by Subject|1
2686900|NCT00474526|9268878|P15|Overall Study|Withdrawal by Subject|22
2686901|NCT00474526|9268879|P14|Overall Study|Withdrawal by Subject|37
2686902|NCT00474526|9268880|P13|Overall Study|Withdrawal by Subject|4
2686903|NCT00474526|9268881|P12|Overall Study|Withdrawal by Subject|4
2686904|NCT00474526|9268882|P11|Overall Study|Withdrawal by Subject|5
2686905|NCT00474526|9268883|P10|Overall Study|Withdrawal by Subject|13
2686906|NCT00474526|9268884|P9|Overall Study|Withdrawal by Subject|4
2686907|NCT00474526|9268885|P8|Overall Study|Withdrawal by Subject|4
2686908|NCT00474526|9268886|P7|Overall Study|Withdrawal by Subject|12
2686909|NCT00474526|9268887|P6|Overall Study|Withdrawal by Subject|6
2686910|NCT00474526|9268888|P5|Overall Study|Withdrawal by Subject|38
2686911|NCT00474526|9268889|P4|Overall Study|Withdrawal by Subject|52
2686912|NCT00474526|9268890|P3|Overall Study|Withdrawal by Subject|21
2686913|NCT00474526|9268891|P2|Overall Study|Withdrawal by Subject|24
2686914|NCT00474526|9268892|P1|Overall Study|Withdrawal by Subject|9
2686915|NCT00474526|9268876|P17|Overall Study|UNABLE TO CLASSIFY|1
2686916|NCT00474526|9268877|P16|Overall Study|UNABLE TO CLASSIFY|6
2686917|NCT00474526|9268878|P15|Overall Study|UNABLE TO CLASSIFY|12
2686918|NCT00474526|9268879|P14|Overall Study|UNABLE TO CLASSIFY|20
2686919|NCT00474526|9268880|P13|Overall Study|UNABLE TO CLASSIFY|0
2686920|NCT00474526|9268881|P12|Overall Study|UNABLE TO CLASSIFY|0
2686921|NCT00474526|9268882|P11|Overall Study|UNABLE TO CLASSIFY|0
2686922|NCT00474526|9268883|P10|Overall Study|UNABLE TO CLASSIFY|3
2686923|NCT00474526|9268884|P9|Overall Study|UNABLE TO CLASSIFY|0
2686924|NCT00474526|9268885|P8|Overall Study|UNABLE TO CLASSIFY|1
2686925|NCT00474526|9268886|P7|Overall Study|UNABLE TO CLASSIFY|0
2686926|NCT00474526|9268887|P6|Overall Study|UNABLE TO CLASSIFY|2
2686927|NCT00474526|9268888|P5|Overall Study|UNABLE TO CLASSIFY|3
2686928|NCT00474526|9268889|P4|Overall Study|UNABLE TO CLASSIFY|1
2686929|NCT00474526|9268890|P3|Overall Study|UNABLE TO CLASSIFY|0
2686930|NCT00474526|9268891|P2|Overall Study|UNABLE TO CLASSIFY|0
2686931|NCT00474526|9268892|P1|Overall Study|UNABLE TO CLASSIFY|1
2686932|NCT00474526|9268876|P17|Overall Study|Protocol Violation|2
2686933|NCT00474526|9268877|P16|Overall Study|Protocol Violation|6
2686934|NCT00474526|9268878|P15|Overall Study|Protocol Violation|9
2686935|NCT00474526|9268879|P14|Overall Study|Protocol Violation|19
2686936|NCT00474526|9268880|P13|Overall Study|Protocol Violation|4
2686937|NCT00474526|9268881|P12|Overall Study|Protocol Violation|2
2686938|NCT00474526|9268882|P11|Overall Study|Protocol Violation|2
2686939|NCT00474526|9268883|P10|Overall Study|Protocol Violation|4
2686940|NCT00474526|9268884|P9|Overall Study|Protocol Violation|0
2686941|NCT00474526|9268885|P8|Overall Study|Protocol Violation|0
2686942|NCT00474526|9268886|P7|Overall Study|Protocol Violation|3
2686943|NCT00474526|9268887|P6|Overall Study|Protocol Violation|1
2686944|NCT00474526|9268888|P5|Overall Study|Protocol Violation|3
2686945|NCT00474526|9268889|P4|Overall Study|Protocol Violation|12
2686946|NCT00474526|9268890|P3|Overall Study|Protocol Violation|4
2686947|NCT00474526|9268891|P2|Overall Study|Protocol Violation|6
2686948|NCT00474526|9268892|P1|Overall Study|Protocol Violation|2
2686949|NCT00474526|9268876|P17|Overall Study|Lost to Follow-up|5
2686950|NCT00474526|9268877|P16|Overall Study|Lost to Follow-up|4
2686951|NCT00474526|9268878|P15|Overall Study|Lost to Follow-up|29
2686952|NCT00474526|9268879|P14|Overall Study|Lost to Follow-up|74
2686953|NCT00474526|9268880|P13|Overall Study|Lost to Follow-up|6
2686954|NCT00474526|9268881|P12|Overall Study|Lost to Follow-up|4
2686955|NCT00474526|9268882|P11|Overall Study|Lost to Follow-up|2
2686956|NCT00474526|9268883|P10|Overall Study|Lost to Follow-up|6
2686957|NCT00474526|9268884|P9|Overall Study|Lost to Follow-up|0
2686958|NCT00474526|9268885|P8|Overall Study|Lost to Follow-up|1
2686959|NCT00474526|9268886|P7|Overall Study|Lost to Follow-up|8
2686960|NCT00474526|9268887|P6|Overall Study|Lost to Follow-up|5
2686961|NCT00474526|9268888|P5|Overall Study|Lost to Follow-up|11
2686962|NCT00474526|9268889|P4|Overall Study|Lost to Follow-up|29
2686963|NCT00474526|9268890|P3|Overall Study|Lost to Follow-up|13
2686964|NCT00474526|9268891|P2|Overall Study|Lost to Follow-up|6
2686965|NCT00474526|9268892|P1|Overall Study|Lost to Follow-up|8
2686966|NCT00474526|9268876|P17|Overall Study|INAPPROPRIATE ENROLLMENT|0
2686967|NCT00474526|9268877|P16|Overall Study|INAPPROPRIATE ENROLLMENT|0
2686968|NCT00474526|9268878|P15|Overall Study|INAPPROPRIATE ENROLLMENT|2
2686969|NCT00474526|9268879|P14|Overall Study|INAPPROPRIATE ENROLLMENT|2
2686970|NCT00474526|9268880|P13|Overall Study|INAPPROPRIATE ENROLLMENT|0
2686971|NCT00474526|9268881|P12|Overall Study|INAPPROPRIATE ENROLLMENT|0
2686972|NCT00474526|9268882|P11|Overall Study|INAPPROPRIATE ENROLLMENT|0
2686973|NCT00474526|9268883|P10|Overall Study|INAPPROPRIATE ENROLLMENT|0
2686974|NCT00474526|9268884|P9|Overall Study|INAPPROPRIATE ENROLLMENT|0
2686975|NCT00474526|9268885|P8|Overall Study|INAPPROPRIATE ENROLLMENT|0
2686976|NCT00474526|9268886|P7|Overall Study|INAPPROPRIATE ENROLLMENT|0
2686977|NCT00474526|9268887|P6|Overall Study|INAPPROPRIATE ENROLLMENT|0
2686978|NCT00474526|9268888|P5|Overall Study|INAPPROPRIATE ENROLLMENT|2
2686979|NCT00474526|9268889|P4|Overall Study|INAPPROPRIATE ENROLLMENT|1
2686980|NCT00474526|9268890|P3|Overall Study|INAPPROPRIATE ENROLLMENT|0
2686981|NCT00474526|9268891|P2|Overall Study|INAPPROPRIATE ENROLLMENT|1
2686982|NCT00474526|9268892|P1|Overall Study|INAPPROPRIATE ENROLLMENT|0
2686983|NCT00474526|9268876|P17|Overall Study|Death|0
2686984|NCT00474526|9268877|P16|Overall Study|Death|0
2686985|NCT00474526|9268878|P15|Overall Study|Death|0
2686986|NCT00474526|9268879|P14|Overall Study|Death|3
2686987|NCT00474526|9268880|P13|Overall Study|Death|0
2686988|NCT00474526|9268881|P12|Overall Study|Death|0
2686989|NCT00474526|9268882|P11|Overall Study|Death|0
2686990|NCT00474526|9268883|P10|Overall Study|Death|0
2686991|NCT00474526|9268884|P9|Overall Study|Death|0
2686992|NCT00474526|9268885|P8|Overall Study|Death|0
2686993|NCT00474526|9268886|P7|Overall Study|Death|0
2686994|NCT00474526|9268887|P6|Overall Study|Death|0
2686995|NCT00474526|9268888|P5|Overall Study|Death|0
2686996|NCT00474526|9268889|P4|Overall Study|Death|0
2686997|NCT00474526|9268890|P3|Overall Study|Death|0
2686998|NCT00474526|9268891|P2|Overall Study|Death|0
2686999|NCT00474526|9268892|P1|Overall Study|Death|0
2687000|NCT00474526|9268876|P17|Overall Study|Adverse Event|0
2687001|NCT00474526|9268877|P16|Overall Study|Adverse Event|1
2687002|NCT00474526|9268878|P15|Overall Study|Adverse Event|1
2687003|NCT00474526|9268879|P14|Overall Study|Adverse Event|0
2687004|NCT00474526|9268880|P13|Overall Study|Adverse Event|0
2687005|NCT00474526|9268881|P12|Overall Study|Adverse Event|0
2687006|NCT00474526|9268882|P11|Overall Study|Adverse Event|0
2687007|NCT00474526|9268883|P10|Overall Study|Adverse Event|0
2687008|NCT00474526|9268884|P9|Overall Study|Adverse Event|0
2687009|NCT00474526|9268885|P8|Overall Study|Adverse Event|0
2687010|NCT00474526|9268886|P7|Overall Study|Adverse Event|1
2687011|NCT00474526|9268887|P6|Overall Study|Adverse Event|1
2687012|NCT00474526|9268888|P5|Overall Study|Adverse Event|2
2687013|NCT00474526|9268889|P4|Overall Study|Adverse Event|4
2687014|NCT00474526|9268890|P3|Overall Study|Adverse Event|2
2687015|NCT00474526|9268891|P2|Overall Study|Adverse Event|0
2687016|NCT00474526|9268892|P1|Overall Study|Adverse Event|2
2687017|NCT00474526|9268876|P17|Overall Study|ADMINISTRATIVE REASON|0
2687018|NCT00474526|9268877|P16|Overall Study|ADMINISTRATIVE REASON|0
2687019|NCT00474526|9268878|P15|Overall Study|ADMINISTRATIVE REASON|2
2687020|NCT00474526|9268879|P14|Overall Study|ADMINISTRATIVE REASON|1
2687021|NCT00474526|9268880|P13|Overall Study|ADMINISTRATIVE REASON|1
2687022|NCT00474526|9268881|P12|Overall Study|ADMINISTRATIVE REASON|1
2687023|NCT00474526|9268882|P11|Overall Study|ADMINISTRATIVE REASON|1
2687024|NCT00474526|9268883|P10|Overall Study|ADMINISTRATIVE REASON|1
2687025|NCT00474526|9268884|P9|Overall Study|ADMINISTRATIVE REASON|2
2687026|NCT00474526|9268885|P8|Overall Study|ADMINISTRATIVE REASON|0
2687027|NCT00474526|9268886|P7|Overall Study|ADMINISTRATIVE REASON|1
2687028|NCT00474526|9268887|P6|Overall Study|ADMINISTRATIVE REASON|1
2687029|NCT00474526|9268888|P5|Overall Study|ADMINISTRATIVE REASON|9
2687030|NCT00474526|9268889|P4|Overall Study|ADMINISTRATIVE REASON|20
2687031|NCT00474526|9268890|P3|Overall Study|ADMINISTRATIVE REASON|9
2687032|NCT00474526|9268891|P2|Overall Study|ADMINISTRATIVE REASON|9
2687033|NCT00474526|9268892|P1|Overall Study|ADMINISTRATIVE REASON|11
2687034|NCT00474487|9269057|P4|Overall Study|Death|0
2687035|NCT00474487|9269058|P3|Overall Study|Death|0
2687036|NCT00474487|9269059|P2|Overall Study|Death|1
2687037|NCT00474487|9269060|P1|Overall Study|Death|0
2687038|NCT00474487|9269057|P4|Overall Study|Inappropriate enrollment|0
2687039|NCT00474487|9269058|P3|Overall Study|Inappropriate enrollment|7
2687040|NCT00474487|9269059|P2|Overall Study|Inappropriate enrollment|0
2687041|NCT00474487|9269060|P1|Overall Study|Inappropriate enrollment|4
2687042|NCT00474487|9269057|P4|Overall Study|Lost to Follow-up|0
2687043|NCT00474487|9269058|P3|Overall Study|Lost to Follow-up|7
2687044|NCT00474487|9269059|P2|Overall Study|Lost to Follow-up|1
2687045|NCT00474487|9269060|P1|Overall Study|Lost to Follow-up|20
2687046|NCT00474487|9269057|P4|Overall Study|Withdrawal by Subject|0
2687047|NCT00474487|9269058|P3|Overall Study|Withdrawal by Subject|0
2687048|NCT00474487|9269059|P2|Overall Study|Withdrawal by Subject|0
2687049|NCT00474487|9269060|P1|Overall Study|Withdrawal by Subject|6
2687050|NCT00474383|9269080|P2|Extension|Progressive Disease|5
2687051|NCT00474383|9269081|P1|Extension|Progressive Disease|0
2687052|NCT00474383|9269080|P2|Between Main Study and Extension|Did Not Enter Extension Phase|0
2687053|NCT00474383|9269081|P1|Between Main Study and Extension|Did Not Enter Extension Phase|6
2687054|NCT00474383|9269080|P2|Main Study|Other|0
2687055|NCT00474383|9269081|P1|Main Study|Other|1
2687056|NCT00474383|9269080|P2|Main Study|Progressive Disease|0
2687057|NCT00474383|9269081|P1|Main Study|Progressive Disease|23
2687058|NCT00474383|9269080|P2|Main Study|Symptomatic Deterioration|0
2687059|NCT00474383|9269081|P1|Main Study|Symptomatic Deterioration|1
2687060|NCT00474383|9269080|P2|Main Study|Adverse Event|0
2687061|NCT00474383|9269081|P1|Main Study|Adverse Event|11
2687062|NCT00474266|9269096|P4|Overall Study|Withdrawal by Subject|7
2687063|NCT00474266|9269097|P3|Overall Study|Withdrawal by Subject|4
2687064|NCT00474266|9269098|P2|Overall Study|Withdrawal by Subject|20
2687065|NCT00474266|9269099|P1|Overall Study|Withdrawal by Subject|7
2687066|NCT00474253|9269203|P2|Overall Study|Discharged prior to study completion|1
2687067|NCT00474253|9269204|P1|Overall Study|Discharged prior to study completion|0
2687068|NCT00474253|9269203|P2|Overall Study|Lost to Follow-up|0
2687069|NCT00474253|9269204|P1|Overall Study|Lost to Follow-up|1
2687070|NCT00474253|9269203|P2|Overall Study|Withdrew due to surgery-related issues|3
2687071|NCT00474253|9269204|P1|Overall Study|Withdrew due to surgery-related issues|0
2687072|NCT00474253|9269203|P2|Overall Study|Withdrew consent|0
2687073|NCT00474253|9269204|P1|Overall Study|Withdrew consent|2
2687074|NCT00474240|9269228|P6|Overall Study|Removed due to lab value|1
2687075|NCT00474240|9269229|P5|Overall Study|Removed due to lab value|0
2687076|NCT00474240|9269230|P4|Overall Study|Removed due to lab value|0
2687077|NCT00474240|9269231|P3|Overall Study|Removed due to lab value|0
2687078|NCT00474240|9269232|P2|Overall Study|Removed due to lab value|0
2687079|NCT00474240|9269233|P1|Overall Study|Removed due to lab value|0
2687080|NCT00474240|9269228|P6|Overall Study|Adverse Event|16
2687081|NCT00474240|9269229|P5|Overall Study|Adverse Event|5
2687082|NCT00474240|9269230|P4|Overall Study|Adverse Event|14
2687083|NCT00474240|9269231|P3|Overall Study|Adverse Event|9
2687084|NCT00474240|9269232|P2|Overall Study|Adverse Event|0
2687085|NCT00474240|9269233|P1|Overall Study|Adverse Event|0
2687086|NCT00474240|9269228|P6|Overall Study|Withdrawal by Subject|1
2687087|NCT00474240|9269229|P5|Overall Study|Withdrawal by Subject|3
2687088|NCT00474240|9269230|P4|Overall Study|Withdrawal by Subject|2
2687089|NCT00474240|9269231|P3|Overall Study|Withdrawal by Subject|0
2687090|NCT00474240|9269232|P2|Overall Study|Withdrawal by Subject|1
2687091|NCT00474240|9269233|P1|Overall Study|Withdrawal by Subject|1
2687092|NCT00474188|9269258|P1|Overall Study|Study discontinued by sponsor|5
2687093|NCT00474188|9269258|P1|Overall Study|Withdrawal by Subject|1
2687094|NCT00474175|9269268|P3|Overall Study|Administrative|0
2687095|NCT00474175|9269269|P2|Overall Study|Administrative|1
2687096|NCT00474175|9269270|P1|Overall Study|Administrative|0
2687097|NCT00474175|9269268|P3|Overall Study|Protocol Violation|1
2687098|NCT00474175|9269269|P2|Overall Study|Protocol Violation|2
2687099|NCT00474175|9269270|P1|Overall Study|Protocol Violation|0
2687100|NCT00474175|9269268|P3|Overall Study|Ineligible|1
2687101|NCT00474175|9269269|P2|Overall Study|Ineligible|3
2687102|NCT00474175|9269270|P1|Overall Study|Ineligible|1
2687103|NCT00474175|9269268|P3|Overall Study|Withdrawal by Subject|1
2687104|NCT00474175|9269269|P2|Overall Study|Withdrawal by Subject|1
2687105|NCT00474175|9269270|P1|Overall Study|Withdrawal by Subject|0
2687106|NCT00474175|9269268|P3|Overall Study|Lack of Efficacy|1
2687107|NCT00474175|9269269|P2|Overall Study|Lack of Efficacy|0
2687108|NCT00474175|9269270|P1|Overall Study|Lack of Efficacy|0
2687109|NCT00474058|9269334|P2|Overall Study|Other|0
2687110|NCT00474058|9269335|P1|Overall Study|Other|2
2687111|NCT00474058|9269334|P2|Overall Study|Withdrawal by Subject|7
2687112|NCT00474058|9269335|P1|Overall Study|Withdrawal by Subject|11
2687113|NCT00474058|9269334|P2|Overall Study|Lack of Efficacy|4
2687114|NCT00474058|9269335|P1|Overall Study|Lack of Efficacy|0
2687115|NCT00474058|9269334|P2|Overall Study|Adverse Event|6
2687116|NCT00474058|9269335|P1|Overall Study|Adverse Event|11
2687117|NCT00474045|9269349|P2|Overall Study|Withdrawal criteria|50
2687118|NCT00474045|9269350|P1|Overall Study|Withdrawal criteria|60
2687119|NCT00474045|9269349|P2|Overall Study|Withdrawal by Subject|18
2687120|NCT00474045|9269350|P1|Overall Study|Withdrawal by Subject|16
2687121|NCT00474045|9269349|P2|Overall Study|Protocol Violation|12
2687122|NCT00474045|9269350|P1|Overall Study|Protocol Violation|10
2687123|NCT00474045|9269349|P2|Overall Study|Lost to Follow-up|1
2687124|NCT00474045|9269350|P1|Overall Study|Lost to Follow-up|1
2687125|NCT00474045|9269349|P2|Overall Study|Lack of Efficacy|9
2687126|NCT00474045|9269350|P1|Overall Study|Lack of Efficacy|0
2687127|NCT00474045|9269349|P2|Overall Study|Unclassified|3
2687128|NCT00474045|9269350|P1|Overall Study|Unclassified|1
2687129|NCT00474045|9269349|P2|Overall Study|Adverse Event|8
2687130|NCT00474045|9269350|P1|Overall Study|Adverse Event|18
2687131|NCT00473889|9269450|P2|Overall Study|Withdrawal by Subject|0
2687132|NCT00473889|9269451|P1|Overall Study|Withdrawal by Subject|5
2687133|NCT00473889|9269450|P2|Overall Study|Trial Terminated|6
2687134|NCT00473889|9269451|P1|Overall Study|Trial Terminated|3
2687135|NCT00473889|9269450|P2|Overall Study|Physician Decision|5
2687136|NCT00473889|9269451|P1|Overall Study|Physician Decision|10
2687137|NCT00473889|9269450|P2|Overall Study|Lost to Follow-up|1
2687138|NCT00473889|9269451|P1|Overall Study|Lost to Follow-up|2
2687139|NCT00473889|9269450|P2|Overall Study|Lack of Efficacy|29
2687140|NCT00473889|9269451|P1|Overall Study|Lack of Efficacy|28
2687141|NCT00473889|9269450|P2|Overall Study|Protocol Violation|2
2687142|NCT00473889|9269451|P1|Overall Study|Protocol Violation|4
2687143|NCT00473889|9269450|P2|Overall Study|Adverse Event|17
2687144|NCT00473889|9269451|P1|Overall Study|Adverse Event|30
2687145|NCT00473889|9269450|P2|Overall Study|Did not receive study medication|4
2687146|NCT00473889|9269451|P1|Overall Study|Did not receive study medication|1
2687147|NCT00473876|9269463|P2|Overall Study|Lost to Follow-up|1
2687148|NCT00473876|9269464|P1|Overall Study|Lost to Follow-up|3
2687149|NCT00473824|9269483|P2|Overall Study|Withdrawal by physician|0
2687150|NCT00473824|9269484|P1|Overall Study|Withdrawal by physician|1
2687151|NCT00473824|9269483|P2|Overall Study|Lost to Follow-up|0
2687152|NCT00473824|9269484|P1|Overall Study|Lost to Follow-up|1
2687153|NCT00473824|9269483|P2|Overall Study|Death|0
2687154|NCT00473824|9269484|P1|Overall Study|Death|1
2687155|NCT00473824|9269483|P2|Overall Study|Adverse Event|0
2687156|NCT00473824|9269484|P1|Overall Study|Adverse Event|1
2687157|NCT00473824|9269483|P2|Overall Study|Virologic Breakthrough|0
2687158|NCT00473824|9269484|P1|Overall Study|Virologic Breakthrough|1
2687159|NCT00473746|9269495|P5|Period 2 (Phase 2)|Reason not specified|3
2687160|NCT00473746|9269496|P4|Period 2 (Phase 2)|Reason not specified|0
2687161|NCT00473746|9269497|P3|Period 2 (Phase 2)|Reason not specified|0
2687162|NCT00473746|9269498|P2|Period 2 (Phase 2)|Reason not specified|0
2687163|NCT00473746|9269499|P1|Period 2 (Phase 2)|Reason not specified|0
2687164|NCT00473746|9269495|P5|Period 2 (Phase 2)|Progressive Disease|20
2687165|NCT00473746|9269496|P4|Period 2 (Phase 2)|Progressive Disease|0
2687166|NCT00473746|9269497|P3|Period 2 (Phase 2)|Progressive Disease|0
2687167|NCT00473746|9269498|P2|Period 2 (Phase 2)|Progressive Disease|0
2687168|NCT00473746|9269499|P1|Period 2 (Phase 2)|Progressive Disease|0
2687169|NCT00473746|9269495|P5|Period 2 (Phase 2)|Death|1
2687170|NCT00473746|9269496|P4|Period 2 (Phase 2)|Death|0
2687171|NCT00473746|9269497|P3|Period 2 (Phase 2)|Death|0
2687172|NCT00473746|9269498|P2|Period 2 (Phase 2)|Death|0
2687173|NCT00473746|9269499|P1|Period 2 (Phase 2)|Death|0
2687174|NCT00473746|9269495|P5|Period 2 (Phase 2)|Adverse Event|3
2687175|NCT00473746|9269496|P4|Period 2 (Phase 2)|Adverse Event|0
2687176|NCT00473746|9269497|P3|Period 2 (Phase 2)|Adverse Event|0
2687177|NCT00473746|9269498|P2|Period 2 (Phase 2)|Adverse Event|0
2687178|NCT00473746|9269499|P1|Period 2 (Phase 2)|Adverse Event|0
2687179|NCT00473746|9269495|P5|Period 1 (Phase 1)|Reason not specified|0
2687180|NCT00473746|9269496|P4|Period 1 (Phase 1)|Reason not specified|0
2687181|NCT00473746|9269497|P3|Period 1 (Phase 1)|Reason not specified|0
2687182|NCT00473746|9269498|P2|Period 1 (Phase 1)|Reason not specified|1
2687183|NCT00473746|9269499|P1|Period 1 (Phase 1)|Reason not specified|0
2687184|NCT00473746|9269495|P5|Period 1 (Phase 1)|Symptomatic Deterioration|0
2687185|NCT00473746|9269496|P4|Period 1 (Phase 1)|Symptomatic Deterioration|0
2687186|NCT00473746|9269497|P3|Period 1 (Phase 1)|Symptomatic Deterioration|0
2687187|NCT00473746|9269498|P2|Period 1 (Phase 1)|Symptomatic Deterioration|1
2687188|NCT00473746|9269499|P1|Period 1 (Phase 1)|Symptomatic Deterioration|0
2687189|NCT00473746|9269495|P5|Period 1 (Phase 1)|Progressive Disease|0
2687190|NCT00473746|9269496|P4|Period 1 (Phase 1)|Progressive Disease|10
2687191|NCT00473746|9269497|P3|Period 1 (Phase 1)|Progressive Disease|6
2687192|NCT00473746|9269498|P2|Period 1 (Phase 1)|Progressive Disease|6
2687193|NCT00473746|9269499|P1|Period 1 (Phase 1)|Progressive Disease|5
2687194|NCT00473746|9269495|P5|Period 1 (Phase 1)|Withdrawal by Subject|0
2687195|NCT00473746|9269496|P4|Period 1 (Phase 1)|Withdrawal by Subject|0
2687196|NCT00473746|9269497|P3|Period 1 (Phase 1)|Withdrawal by Subject|0
2687197|NCT00473746|9269498|P2|Period 1 (Phase 1)|Withdrawal by Subject|1
2687198|NCT00473746|9269499|P1|Period 1 (Phase 1)|Withdrawal by Subject|0
2687199|NCT00473746|9269495|P5|Period 1 (Phase 1)|Adverse Event|0
2687200|NCT00473746|9269496|P4|Period 1 (Phase 1)|Adverse Event|0
2687201|NCT00473746|9269497|P3|Period 1 (Phase 1)|Adverse Event|0
2687202|NCT00473746|9269498|P2|Period 1 (Phase 1)|Adverse Event|0
2687203|NCT00473746|9269499|P1|Period 1 (Phase 1)|Adverse Event|1
2687204|NCT00473694|9269548|P4|Overall Study|Lost to Follow-up|1
2687205|NCT00473694|9269549|P3|Overall Study|Lost to Follow-up|0
2687206|NCT00473694|9269550|P2|Overall Study|Lost to Follow-up|0
2687207|NCT00473694|9269551|P1|Overall Study|Lost to Follow-up|0
2687208|NCT00473694|9269548|P4|Overall Study|Participants did not receive treatment|6
2687209|NCT00473694|9269549|P3|Overall Study|Participants did not receive treatment|5
2687210|NCT00473694|9269550|P2|Overall Study|Participants did not receive treatment|3
2687211|NCT00473694|9269551|P1|Overall Study|Participants did not receive treatment|11
2687212|NCT00473694|9269548|P4|Overall Study|Adverse Event|0
2687213|NCT00473694|9269549|P3|Overall Study|Adverse Event|0
2687214|NCT00473694|9269550|P2|Overall Study|Adverse Event|1
2687215|NCT00473694|9269551|P1|Overall Study|Adverse Event|0
2687216|NCT00473668|9269592|P3|Overall Study|Other|4
2687217|NCT00473668|9269593|P2|Overall Study|Other|3
2687218|NCT00473668|9269594|P1|Overall Study|Other|2
2687219|NCT00473668|9269592|P3|Overall Study|Lost to Follow-up|6
2687220|NCT00473668|9269593|P2|Overall Study|Lost to Follow-up|4
2687221|NCT00473668|9269594|P1|Overall Study|Lost to Follow-up|0
2687222|NCT00473668|9269592|P3|Overall Study|Migrated/moved from study area|0
2687223|NCT00473668|9269593|P2|Overall Study|Migrated/moved from study area|2
2687224|NCT00473668|9269594|P1|Overall Study|Migrated/moved from study area|3
2687225|NCT00473668|9269592|P3|Overall Study|Withdrawal by Subject|0
2687226|NCT00473668|9269593|P2|Overall Study|Withdrawal by Subject|2
2687227|NCT00473668|9269594|P1|Overall Study|Withdrawal by Subject|0
2687228|NCT00473655|9269647|P3|Overall Study|Lost to Follow-up|8
2687229|NCT00473655|9269648|P2|Overall Study|Lost to Follow-up|5
2687230|NCT00473655|9269649|P1|Overall Study|Lost to Follow-up|9
2687231|NCT00473590|9269696|P2|Overall Study|Other|1
2687232|NCT00473590|9269697|P1|Overall Study|Other|0
2687233|NCT00473590|9269696|P2|Overall Study|Withdrawal by Subject|3
2687234|NCT00473590|9269697|P1|Overall Study|Withdrawal by Subject|5
2687235|NCT00473590|9269696|P2|Overall Study|Physician Decision|4
2687236|NCT00473590|9269697|P1|Overall Study|Physician Decision|2
2687237|NCT00473590|9269696|P2|Overall Study|Non–protocol-specified therapy|5
2687238|NCT00473590|9269697|P1|Overall Study|Non–protocol-specified therapy|7
2687239|NCT00473590|9269696|P2|Overall Study|Progression not resulting in death|20
2687240|NCT00473590|9269697|P1|Overall Study|Progression not resulting in death|24
2687241|NCT00473590|9269696|P2|Overall Study|Death|2
2687242|NCT00473590|9269697|P1|Overall Study|Death|4
2687243|NCT00473590|9269696|P2|Overall Study|Adverse Event|3
2687244|NCT00473590|9269697|P1|Overall Study|Adverse Event|3
2687245|NCT00473564|9269713|P1|Overall Study|robot surgery aborted in OR|23
2687246|NCT00473512|9269723|P5|Period 2 (Phase 2)|Other|0
2687247|NCT00473512|9269724|P4|Period 2 (Phase 2)|Other|3
2687248|NCT00473512|9269725|P3|Period 2 (Phase 2)|Other|0
2687249|NCT00473512|9269726|P2|Period 2 (Phase 2)|Other|0
2687250|NCT00473512|9269727|P1|Period 2 (Phase 2)|Other|1
2687251|NCT00473512|9269723|P5|Period 2 (Phase 2)|Symptomatic Deterioration|0
2687252|NCT00473512|9269724|P4|Period 2 (Phase 2)|Symptomatic Deterioration|1
2687253|NCT00473512|9269725|P3|Period 2 (Phase 2)|Symptomatic Deterioration|0
2687254|NCT00473512|9269726|P2|Period 2 (Phase 2)|Symptomatic Deterioration|0
2687255|NCT00473512|9269727|P1|Period 2 (Phase 2)|Symptomatic Deterioration|0
2687256|NCT00473512|9269723|P5|Period 2 (Phase 2)|Disease Progression|1
2687257|NCT00473512|9269724|P4|Period 2 (Phase 2)|Disease Progression|17
2687258|NCT00473512|9269725|P3|Period 2 (Phase 2)|Disease Progression|2
2687259|NCT00473512|9269726|P2|Period 2 (Phase 2)|Disease Progression|2
2687260|NCT00473512|9269727|P1|Period 2 (Phase 2)|Disease Progression|0
2687261|NCT00473512|9269723|P5|Period 2 (Phase 2)|Death|1
2687262|NCT00473512|9269724|P4|Period 2 (Phase 2)|Death|1
2687263|NCT00473512|9269725|P3|Period 2 (Phase 2)|Death|0
2687264|NCT00473512|9269726|P2|Period 2 (Phase 2)|Death|0
2687265|NCT00473512|9269727|P1|Period 2 (Phase 2)|Death|0
2687266|NCT00473512|9269723|P5|Period 2 (Phase 2)|Adverse Event|0
2687267|NCT00473512|9269724|P4|Period 2 (Phase 2)|Adverse Event|1
2687268|NCT00473512|9269725|P3|Period 2 (Phase 2)|Adverse Event|0
2687269|NCT00473512|9269726|P2|Period 2 (Phase 2)|Adverse Event|0
2687270|NCT00473512|9269727|P1|Period 2 (Phase 2)|Adverse Event|0
2687271|NCT00473512|9269723|P5|Period 1 (Phase 1)|Other|0
2687272|NCT00473512|9269724|P4|Period 1 (Phase 1)|Other|1
2687273|NCT00473512|9269725|P3|Period 1 (Phase 1)|Other|0
2687274|NCT00473512|9269726|P2|Period 1 (Phase 1)|Other|0
2687275|NCT00473512|9269727|P1|Period 1 (Phase 1)|Other|0
2687276|NCT00473512|9269723|P5|Period 1 (Phase 1)|Disease Progression|1
2687277|NCT00473512|9269724|P4|Period 1 (Phase 1)|Disease Progression|10
2687278|NCT00473512|9269725|P3|Period 1 (Phase 1)|Disease Progression|0
2687279|NCT00473512|9269726|P2|Period 1 (Phase 1)|Disease Progression|1
2687280|NCT00473512|9269727|P1|Period 1 (Phase 1)|Disease Progression|1
2687281|NCT00473512|9269723|P5|Period 1 (Phase 1)|Death|0
2687282|NCT00473512|9269724|P4|Period 1 (Phase 1)|Death|1
2687283|NCT00473512|9269725|P3|Period 1 (Phase 1)|Death|0
2687284|NCT00473512|9269726|P2|Period 1 (Phase 1)|Death|0
2687285|NCT00473512|9269727|P1|Period 1 (Phase 1)|Death|0
2687286|NCT00473512|9269723|P5|Period 1 (Phase 1)|Adverse Event|0
2687287|NCT00473512|9269724|P4|Period 1 (Phase 1)|Adverse Event|5
2687288|NCT00473512|9269725|P3|Period 1 (Phase 1)|Adverse Event|0
2687289|NCT00473512|9269726|P2|Period 1 (Phase 1)|Adverse Event|0
2687290|NCT00473512|9269727|P1|Period 1 (Phase 1)|Adverse Event|0
2687291|NCT00473434|9269785|P1|Overall Study|No longer required|1
2687292|NCT00473434|9269785|P1|Overall Study|Switching to trial medication|1
2687293|NCT00473434|9269785|P1|Overall Study|Ceased in favor of Paliperidone|1
2687294|NCT00473434|9269785|P1|Overall Study|Reason not specified|6
2687295|NCT00473434|9269785|P1|Overall Study|Safety evaluation|1
2687296|NCT00473434|9269785|P1|Overall Study|Patient was selling medication to others|1
2687297|NCT00473434|9269785|P1|Overall Study|Adverse Event|3
2687298|NCT00473434|9269785|P1|Overall Study|Lack of Efficacy|3
2687299|NCT00473434|9269785|P1|Overall Study|Compliance|3
2687300|NCT00473434|9269785|P1|Overall Study|Withdrawal by Subject|9
2687301|NCT00473434|9269785|P1|Overall Study|Physician Decision|3
2687302|NCT00473382|9269850|P3|Open-label Extension Through Month 60|Subject Required Other Intervention|0
2687303|NCT00473382|9269851|P2|Open-label Extension Through Month 60|Subject Required Other Intervention|1
2687304|NCT00473382|9269852|P1|Open-label Extension Through Month 60|Subject Required Other Intervention|2
2687305|NCT00473382|9269850|P3|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|69
2687306|NCT00473382|9269851|P2|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|70
2687307|NCT00473382|9269852|P1|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|75
2687308|NCT00473382|9269850|P3|Open-label Extension Through Month 60|Subject's Decision|6
2687309|NCT00473382|9269851|P2|Open-label Extension Through Month 60|Subject's Decision|1
2687310|NCT00473382|9269852|P1|Open-label Extension Through Month 60|Subject's Decision|7
2687311|NCT00473382|9269850|P3|Open-label Extension Through Month 60|Lost to Follow-up|1
2687312|NCT00473382|9269851|P2|Open-label Extension Through Month 60|Lost to Follow-up|3
2687313|NCT00473382|9269852|P1|Open-label Extension Through Month 60|Lost to Follow-up|1
2687314|NCT00473382|9269850|P3|Open-label Extension Through Month 60|Death|4
2687315|NCT00473382|9269851|P2|Open-label Extension Through Month 60|Death|7
2687316|NCT00473382|9269852|P1|Open-label Extension Through Month 60|Death|1
2687317|NCT00473382|9269850|P3|Open-label Extension Through Month 60|Adverse Event|2
2687318|NCT00473382|9269851|P2|Open-label Extension Through Month 60|Adverse Event|0
2687319|NCT00473382|9269852|P1|Open-label Extension Through Month 60|Adverse Event|0
2687320|NCT00473382|9269850|P3|Open-label Extension Through Month 48|Subject Required Other Intervention|0
2687321|NCT00473382|9269851|P2|Open-label Extension Through Month 48|Subject Required Other Intervention|1
2687322|NCT00473382|9269852|P1|Open-label Extension Through Month 48|Subject Required Other Intervention|2
2687323|NCT00473382|9269850|P3|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|36
2687324|NCT00473382|9269851|P2|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|34
2687325|NCT00473382|9269852|P1|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|41
2687326|NCT00473382|9269850|P3|Open-label Extension Through Month 48|Subject's Decision|6
2687327|NCT00473382|9269851|P2|Open-label Extension Through Month 48|Subject's Decision|1
2687328|NCT00473382|9269852|P1|Open-label Extension Through Month 48|Subject's Decision|5
2687329|NCT00473382|9269850|P3|Open-label Extension Through Month 48|Lost to Follow-up|1
2687330|NCT00473382|9269851|P2|Open-label Extension Through Month 48|Lost to Follow-up|2
2687331|NCT00473382|9269852|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
2687332|NCT00473382|9269850|P3|Open-label Extension Through Month 48|Death|3
2687333|NCT00473382|9269851|P2|Open-label Extension Through Month 48|Death|3
2687334|NCT00473382|9269852|P1|Open-label Extension Through Month 48|Death|1
2687335|NCT00473382|9269850|P3|Open-label Extension Through Month 48|Adverse Event|1
2687336|NCT00473382|9269851|P2|Open-label Extension Through Month 48|Adverse Event|0
2687337|NCT00473382|9269852|P1|Open-label Extension Through Month 48|Adverse Event|0
2687338|NCT00473382|9269850|P3|Core Study|Subject's decision|10
2687339|NCT00473382|9269851|P2|Core Study|Subject's decision|11
2687340|NCT00473382|9269852|P1|Core Study|Subject's decision|12
2687341|NCT00473382|9269850|P3|Core Study|Subject needed other treatment|2
2687342|NCT00473382|9269851|P2|Core Study|Subject needed other treatment|3
2687343|NCT00473382|9269852|P1|Core Study|Subject needed other treatment|1
2687344|NCT00473382|9269850|P3|Core Study|Subject non-compliance|1
2687345|NCT00473382|9269851|P2|Core Study|Subject non-compliance|2
2687346|NCT00473382|9269852|P1|Core Study|Subject non-compliance|5
2687347|NCT00473382|9269850|P3|Core Study|Physician Decision|2
2687348|NCT00473382|9269851|P2|Core Study|Physician Decision|2
2687349|NCT00473382|9269852|P1|Core Study|Physician Decision|1
2687350|NCT00473382|9269850|P3|Core Study|Lost to Follow-up|3
2687351|NCT00473382|9269851|P2|Core Study|Lost to Follow-up|3
2687352|NCT00473382|9269852|P1|Core Study|Lost to Follow-up|3
2687353|NCT00473382|9269850|P3|Core Study|Death|10
2687354|NCT00473382|9269851|P2|Core Study|Death|5
2687355|NCT00473382|9269852|P1|Core Study|Death|3
2687356|NCT00473382|9269850|P3|Core Study|Adverse Event|1
2687357|NCT00473382|9269851|P2|Core Study|Adverse Event|1
2687358|NCT00473382|9269852|P1|Core Study|Adverse Event|3
2687359|NCT00473330|9269910|P3|Open-label Extension Through Month 60|Subject Required Other Therapy|1
2687360|NCT00473330|9269911|P2|Open-label Extension Through Month 60|Subject Required Other Therapy|0
2687361|NCT00473330|9269912|P1|Open-label Extension Through Month 60|Subject Required Other Therapy|1
2687362|NCT00473330|9269910|P3|Open-label Extension Through Month 60|Subject Non-compliance|0
2687363|NCT00473330|9269911|P2|Open-label Extension Through Month 60|Subject Non-compliance|1
2687364|NCT00473330|9269912|P1|Open-label Extension Through Month 60|Subject Non-compliance|2
2687365|NCT00473330|9269910|P3|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|62
2687366|NCT00473330|9269911|P2|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|71
2687367|NCT00473330|9269912|P1|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|77
2687368|NCT00473330|9269910|P3|Open-label Extension Through Month 60|Subject's Decision|4
2687369|NCT00473330|9269911|P2|Open-label Extension Through Month 60|Subject's Decision|3
2687370|NCT00473330|9269912|P1|Open-label Extension Through Month 60|Subject's Decision|1
2687371|NCT00473330|9269910|P3|Open-label Extension Through Month 60|Physician's Decision|3
2687372|NCT00473330|9269911|P2|Open-label Extension Through Month 60|Physician's Decision|1
2687373|NCT00473330|9269912|P1|Open-label Extension Through Month 60|Physician's Decision|2
2687374|NCT00473330|9269910|P3|Open-label Extension Through Month 60|Lost to Follow-up|4
2687375|NCT00473330|9269911|P2|Open-label Extension Through Month 60|Lost to Follow-up|0
2687376|NCT00473330|9269912|P1|Open-label Extension Through Month 60|Lost to Follow-up|3
2687377|NCT00473330|9269910|P3|Open-label Extension Through Month 60|Death|1
2687378|NCT00473330|9269911|P2|Open-label Extension Through Month 60|Death|2
2687379|NCT00473330|9269912|P1|Open-label Extension Through Month 60|Death|2
2687380|NCT00473330|9269910|P3|Open-label Extension Through Month 60|Adverse Event|2
2687381|NCT00473330|9269911|P2|Open-label Extension Through Month 60|Adverse Event|0
2687382|NCT00473330|9269912|P1|Open-label Extension Through Month 60|Adverse Event|0
2687383|NCT00473330|9269910|P3|Open-label Extension Through Month 48|Subject Required Other Therapy|1
2687384|NCT00473330|9269911|P2|Open-label Extension Through Month 48|Subject Required Other Therapy|0
2687385|NCT00473330|9269912|P1|Open-label Extension Through Month 48|Subject Required Other Therapy|0
2687386|NCT00473330|9269910|P3|Open-label Extension Through Month 48|Subject Non-compliance|0
2687387|NCT00473330|9269911|P2|Open-label Extension Through Month 48|Subject Non-compliance|1
2687388|NCT00473330|9269912|P1|Open-label Extension Through Month 48|Subject Non-compliance|2
2687389|NCT00473330|9269910|P3|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|16
2687390|NCT00473330|9269911|P2|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|15
2687391|NCT00473330|9269912|P1|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|18
2687392|NCT00473330|9269910|P3|Open-label Extension Through Month 48|Subject's Decision|3
2687393|NCT00473330|9269911|P2|Open-label Extension Through Month 48|Subject's Decision|3
2687394|NCT00473330|9269912|P1|Open-label Extension Through Month 48|Subject's Decision|1
2687395|NCT00473330|9269910|P3|Open-label Extension Through Month 48|Physician's Decision|3
2687396|NCT00473330|9269911|P2|Open-label Extension Through Month 48|Physician's Decision|1
2687397|NCT00473330|9269912|P1|Open-label Extension Through Month 48|Physician's Decision|2
2687398|NCT00473330|9269910|P3|Open-label Extension Through Month 48|Lost to Follow-up|2
2687399|NCT00473330|9269911|P2|Open-label Extension Through Month 48|Lost to Follow-up|0
2687400|NCT00473330|9269912|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
2687401|NCT00473330|9269910|P3|Open-label Extension Through Month 48|Death|0
2687402|NCT00473330|9269911|P2|Open-label Extension Through Month 48|Death|0
2687403|NCT00473330|9269912|P1|Open-label Extension Through Month 48|Death|2
2687404|NCT00473330|9269910|P3|Open-label Extension Through Month 48|Adverse Event|2
2687405|NCT00473330|9269911|P2|Open-label Extension Through Month 48|Adverse Event|0
2687406|NCT00473330|9269912|P1|Open-label Extension Through Month 48|Adverse Event|0
2687407|NCT00473330|9269910|P3|Core Study|Subject's Decision|19
2687408|NCT00473330|9269911|P2|Core Study|Subject's Decision|8
2687409|NCT00473330|9269912|P1|Core Study|Subject's Decision|9
2687410|NCT00473330|9269910|P3|Core Study|Subject Required Other Therapy|3
2687411|NCT00473330|9269911|P2|Core Study|Subject Required Other Therapy|1
2687412|NCT00473330|9269912|P1|Core Study|Subject Required Other Therapy|0
2687413|NCT00473330|9269910|P3|Core Study|Subject Non-compliance|1
2687414|NCT00473330|9269911|P2|Core Study|Subject Non-compliance|2
2687415|NCT00473330|9269912|P1|Core Study|Subject Non-compliance|1
2687416|NCT00473330|9269910|P3|Core Study|Physician Decision|3
2687417|NCT00473330|9269911|P2|Core Study|Physician Decision|1
2687418|NCT00473330|9269912|P1|Core Study|Physician Decision|2
2687419|NCT00473330|9269910|P3|Core Study|Lost to Follow-up|10
2687420|NCT00473330|9269911|P2|Core Study|Lost to Follow-up|5
2687421|NCT00473330|9269912|P1|Core Study|Lost to Follow-up|5
2687422|NCT00473330|9269910|P3|Core Study|Death|4
2687423|NCT00473330|9269911|P2|Core Study|Death|4
2687424|NCT00473330|9269912|P1|Core Study|Death|6
2687425|NCT00473330|9269910|P3|Core Study|Adverse Event|1
2687426|NCT00473330|9269911|P2|Core Study|Adverse Event|4
2687427|NCT00473330|9269912|P1|Core Study|Adverse Event|4
2687428|NCT00473265|9269967|P1|Overall Study|Off treatment early|15
2687429|NCT00473265|9269967|P1|Overall Study|Unrelated adverse event|5
2687430|NCT00473083|9269979|P3|Overall Study|Adverse Event|0
2687431|NCT00473083|9269980|P2|Overall Study|Adverse Event|0
2687432|NCT00473083|9269981|P1|Overall Study|Adverse Event|1
2687433|NCT00472641|9270056|P1|Overall Study|Lost to Follow-up|1
2687434|NCT00472641|9270056|P1|Overall Study|Adverse Event|3
2687435|NCT00472641|9270056|P1|Overall Study|Lack of Efficacy|3
2687436|NCT00472446|9270076|P4|Overall Study|Questionnaires not returned|4
2687437|NCT00472446|9270077|P3|Overall Study|Questionnaires not returned|6
2687438|NCT00472446|9270078|P2|Overall Study|Questionnaires not returned|6
2687439|NCT00472446|9270079|P1|Overall Study|Questionnaires not returned|5
2687440|NCT00472446|9270076|P4|Overall Study|Reintervention|1
2687441|NCT00472446|9270077|P3|Overall Study|Reintervention|1
2687442|NCT00472446|9270078|P2|Overall Study|Reintervention|0
2687443|NCT00472446|9270079|P1|Overall Study|Reintervention|0
2687444|NCT00472446|9270076|P4|Overall Study|Protocol Violation|1
2687445|NCT00472446|9270077|P3|Overall Study|Protocol Violation|0
2687446|NCT00472446|9270078|P2|Overall Study|Protocol Violation|0
2687447|NCT00472446|9270079|P1|Overall Study|Protocol Violation|0
2687448|NCT00472420|9270109|P1|Follow-up Period|Protocol Violation|1
2687449|NCT00472420|9270109|P1|Follow-up Period|Lost to Follow-up|2
2687450|NCT00472420|9270109|P1|Follow-up Period|Physician Decision|9
2687451|NCT00472420|9270109|P1|Follow-up Period|Death|5
2687452|NCT00472420|9270109|P1|Induction Treatment Period|Death|3
2687453|NCT00472420|9270109|P1|Induction Treatment Period|Non-compliance|1
2687454|NCT00472420|9270109|P1|Induction Treatment Period|Adverse Event|3
2687455|NCT00472420|9270109|P1|Induction Treatment Period|Physician Decision|9
2687456|NCT00472303|9270117|P3|Maintenance Phase|Other|0
2687457|NCT00472303|9270118|P2|Maintenance Phase|Other|1
2687458|NCT00472303|9270119|P1|Maintenance Phase|Other|1
2687459|NCT00472303|9270117|P3|Maintenance Phase|Resolution of pain|1
2687460|NCT00472303|9270118|P2|Maintenance Phase|Resolution of pain|0
2687461|NCT00472303|9270119|P1|Maintenance Phase|Resolution of pain|0
2687462|NCT00472303|9270117|P3|Maintenance Phase|Trial medication non-compliant|1
2687463|NCT00472303|9270118|P2|Maintenance Phase|Trial medication non-compliant|0
2687464|NCT00472303|9270119|P1|Maintenance Phase|Trial medication non-compliant|0
2687465|NCT00472303|9270117|P3|Maintenance Phase|Withdrawal by Subject|3
2687466|NCT00472303|9270118|P2|Maintenance Phase|Withdrawal by Subject|7
2687467|NCT00472303|9270119|P1|Maintenance Phase|Withdrawal by Subject|6
2687468|NCT00472303|9270117|P3|Maintenance Phase|Lack of Efficacy|4
2687469|NCT00472303|9270118|P2|Maintenance Phase|Lack of Efficacy|2
2687470|NCT00472303|9270119|P1|Maintenance Phase|Lack of Efficacy|2
2687471|NCT00472303|9270117|P3|Maintenance Phase|Death|2
2687472|NCT00472303|9270118|P2|Maintenance Phase|Death|0
2687473|NCT00472303|9270119|P1|Maintenance Phase|Death|3
2687474|NCT00472303|9270117|P3|Maintenance Phase|Adverse Event|6
2687475|NCT00472303|9270118|P2|Maintenance Phase|Adverse Event|6
2687476|NCT00472303|9270119|P1|Maintenance Phase|Adverse Event|5
2687477|NCT00472303|9270117|P3|Discontinuations After Titration Phase|Other|0
2687478|NCT00472303|9270118|P2|Discontinuations After Titration Phase|Other|0
2687479|NCT00472303|9270119|P1|Discontinuations After Titration Phase|Other|5
2687480|NCT00472303|9270117|P3|Discontinuations After Titration Phase|Trial Medication non-compliant|0
2687481|NCT00472303|9270118|P2|Discontinuations After Titration Phase|Trial Medication non-compliant|1
2687482|NCT00472303|9270119|P1|Discontinuations After Titration Phase|Trial Medication non-compliant|0
2687483|NCT00472303|9270117|P3|Discontinuations After Titration Phase|Withdrawal by Subject|0
2687484|NCT00472303|9270118|P2|Discontinuations After Titration Phase|Withdrawal by Subject|2
2687485|NCT00472303|9270119|P1|Discontinuations After Titration Phase|Withdrawal by Subject|2
2687486|NCT00472303|9270117|P3|Discontinuations After Titration Phase|Lack of Efficacy|0
2687487|NCT00472303|9270118|P2|Discontinuations After Titration Phase|Lack of Efficacy|17
2687488|NCT00472303|9270119|P1|Discontinuations After Titration Phase|Lack of Efficacy|48
2687489|NCT00472303|9270117|P3|Discontinuations After Titration Phase|Adverse Event|0
2687490|NCT00472303|9270118|P2|Discontinuations After Titration Phase|Adverse Event|0
2687491|NCT00472303|9270119|P1|Discontinuations After Titration Phase|Adverse Event|6
2687492|NCT00472303|9270117|P3|Titration Phase|Other|0
2687493|NCT00472303|9270118|P2|Titration Phase|Other|1
2687494|NCT00472303|9270119|P1|Titration Phase|Other|3
2687495|NCT00472303|9270117|P3|Titration Phase|Trial Medication non-compliant|0
2687496|NCT00472303|9270118|P2|Titration Phase|Trial Medication non-compliant|1
2687497|NCT00472303|9270119|P1|Titration Phase|Trial Medication non-compliant|4
2687498|NCT00472303|9270117|P3|Titration Phase|Withdrawal by Subject|0
2687499|NCT00472303|9270118|P2|Titration Phase|Withdrawal by Subject|13
2687500|NCT00472303|9270119|P1|Titration Phase|Withdrawal by Subject|16
2687501|NCT00472303|9270117|P3|Titration Phase|Lack of Efficacy|0
2687502|NCT00472303|9270118|P2|Titration Phase|Lack of Efficacy|0
2687503|NCT00472303|9270119|P1|Titration Phase|Lack of Efficacy|10
2687504|NCT00472303|9270117|P3|Titration Phase|Death|0
2687505|NCT00472303|9270118|P2|Titration Phase|Death|2
2687506|NCT00472303|9270119|P1|Titration Phase|Death|4
2687507|NCT00472303|9270117|P3|Titration Phase|Adverse Event|0
2687508|NCT00472303|9270118|P2|Titration Phase|Adverse Event|12
2687509|NCT00472303|9270119|P1|Titration Phase|Adverse Event|22
2687510|NCT00472290|9270182|P1|Overall Study|Requirement for alternative therapy|7
2687511|NCT00472290|9270182|P1|Overall Study|Adverse Event|6
2687512|NCT00472290|9270182|P1|Overall Study|Withdrawal by Subject|5
2687513|NCT00472290|9270182|P1|Overall Study|Disease Progression|4
2687514|NCT00472290|9270182|P1|Overall Study|Lack of Efficacy|1
2687515|NCT00472290|9270182|P1|Overall Study|Lost to Follow-up|1
2687516|NCT00472290|9270182|P1|Overall Study|Death|3
2687517|NCT00472290|9270182|P1|Overall Study|Administrative Decision|37
2687518|NCT00472290|9270182|P1|Overall Study|Protocol Specified Criteria|7
2687519|NCT00472290|9270182|P1|Overall Study|Progression of Therapy-Related MDS|1
2687520|NCT00472199|9270194|P2|Overall Study|patient was asymptomatic|0
2687521|NCT00472199|9270195|P1|Overall Study|patient was asymptomatic|1
2687522|NCT00472199|9270194|P2|Overall Study|personal reason|1
2687523|NCT00472199|9270195|P1|Overall Study|personal reason|0
2687524|NCT00472199|9270194|P2|Overall Study|Withdrawal by Subject|5
2687525|NCT00472199|9270195|P1|Overall Study|Withdrawal by Subject|6
2687526|NCT00472199|9270194|P2|Overall Study|Protocol Violation|2
2687527|NCT00472199|9270195|P1|Overall Study|Protocol Violation|3
2687528|NCT00472199|9270194|P2|Overall Study|Lost to Follow-up|4
2687529|NCT00472199|9270195|P1|Overall Study|Lost to Follow-up|2
2687530|NCT00472199|9270194|P2|Overall Study|Lack of Efficacy|25
2687531|NCT00472199|9270195|P1|Overall Study|Lack of Efficacy|4
2687532|NCT00472199|9270194|P2|Overall Study|Adverse Event|23
2687533|NCT00472199|9270195|P1|Overall Study|Adverse Event|19
2687534|NCT00472082|9270261|P1|Overall Study|Study prematurely terminated|5
2687535|NCT00472030|9270283|P2|Overall Study|Physician Decision|0
2687536|NCT00472030|9270284|P1|Overall Study|Physician Decision|1
2687537|NCT00471822|9270300|P1|Overall Study|Protocol Violation|2
2687538|NCT00471718|9270308|P1|Overall Study|Withdrawal by Subject|1
2687539|NCT00471718|9270308|P1|Overall Study|disease progression|22
2687540|NCT00471718|9270308|P1|Overall Study|other complicating disease|1
2687541|NCT00471718|9270308|P1|Overall Study|Adverse Event|3
2687542|NCT00471536|9270336|P1|Overall Study|Withdrawal by Subject|1
2687543|NCT00471497|9270348|P3|Overall Study|Sub optimal response or treat. failure|0
2687544|NCT00471497|9270349|P2|Overall Study|Sub optimal response or treat. failure|3
2687545|NCT00471497|9270350|P1|Overall Study|Sub optimal response or treat. failure|8
2687546|NCT00471497|9270348|P3|Overall Study|Protocol Violation|5
2687547|NCT00471497|9270349|P2|Overall Study|Protocol Violation|3
2687548|NCT00471497|9270350|P1|Overall Study|Protocol Violation|3
2687549|NCT00471497|9270348|P3|Overall Study|Disease Progression|2
2687550|NCT00471497|9270349|P2|Overall Study|Disease Progression|2
2687551|NCT00471497|9270350|P1|Overall Study|Disease Progression|8
2687552|NCT00471497|9270348|P3|Overall Study|Death|0
2687553|NCT00471497|9270349|P2|Overall Study|Death|2
2687554|NCT00471497|9270350|P1|Overall Study|Death|0
2687555|NCT00471497|9270348|P3|Overall Study|Lost to Follow-up|1
2687556|NCT00471497|9270349|P2|Overall Study|Lost to Follow-up|2
2687557|NCT00471497|9270350|P1|Overall Study|Lost to Follow-up|1
2687558|NCT00471497|9270348|P3|Overall Study|Withdrawal by Subject|5
2687559|NCT00471497|9270349|P2|Overall Study|Withdrawal by Subject|5
2687560|NCT00471497|9270350|P1|Overall Study|Withdrawal by Subject|3
2687561|NCT00471497|9270348|P3|Overall Study|Condition no longer requires study drug|0
2687562|NCT00471497|9270349|P2|Overall Study|Condition no longer requires study drug|1
2687563|NCT00471497|9270350|P1|Overall Study|Condition no longer requires study drug|0
2687564|NCT00471497|9270348|P3|Overall Study|Abnormal Test Procedure|1
2687565|NCT00471497|9270349|P2|Overall Study|Abnormal Test Procedure|0
2687566|NCT00471497|9270350|P1|Overall Study|Abnormal Test Procedure|1
2687567|NCT00471497|9270348|P3|Overall Study|Abnormal Laboratory Value|4
2687568|NCT00471497|9270349|P2|Overall Study|Abnormal Laboratory Value|6
2687569|NCT00471497|9270350|P1|Overall Study|Abnormal Laboratory Value|3
2687570|NCT00471497|9270348|P3|Overall Study|Adverse Event|22
2687571|NCT00471497|9270349|P2|Overall Study|Adverse Event|11
2687572|NCT00471497|9270350|P1|Overall Study|Adverse Event|19
2687573|NCT00471445|9270360|P2|Overall Study|Protocol Violation|1
2687574|NCT00471445|9270361|P1|Overall Study|Protocol Violation|0
2687575|NCT00471445|9270360|P2|Overall Study|Ineligible|0
2687576|NCT00471445|9270361|P1|Overall Study|Ineligible|1
2687577|NCT00471445|9270360|P2|Overall Study|Withdrawal by Subject|1
2687578|NCT00471445|9270361|P1|Overall Study|Withdrawal by Subject|1
2687579|NCT00471354|9270374|P1|Overall Study|Patient/Caregiver Decision|12
2687580|NCT00471354|9270374|P1|Overall Study|Lack of Efficacy|5
2687581|NCT00471354|9270374|P1|Overall Study|Lost to Follow-up|3
2687582|NCT00471354|9270374|P1|Overall Study|Sponsor Decision|1
2687583|NCT00471354|9270374|P1|Overall Study|Physician Decision|4
2687584|NCT00471354|9270374|P1|Overall Study|Withdrawal by Subject|1
2687585|NCT00471354|9270374|P1|Overall Study|Protocol Violation|12
2687586|NCT00471354|9270374|P1|Overall Study|Adverse Event|13
2687587|NCT00471354|9270374|P1|Overall Study|Protocol Entry Criteria Not Met|1
2687588|NCT00471328|9270386|P2|Extension Phase|Administrative Problem|0
2687589|NCT00471328|9270387|P1|Extension Phase|Administrative Problem|1
2687590|NCT00471328|9270386|P2|Extension Phase|New cancer Therapy|0
2687591|NCT00471328|9270387|P1|Extension Phase|New cancer Therapy|1
2687592|NCT00471328|9270386|P2|Extension Phase|Disease Progression|44
2687593|NCT00471328|9270387|P1|Extension Phase|Disease Progression|32
2687594|NCT00471328|9270386|P2|Extension Phase|Treatment duration as per protocol|1
2687595|NCT00471328|9270387|P1|Extension Phase|Treatment duration as per protocol|0
2687596|NCT00471328|9270386|P2|Extension Phase|Protocol Deviation|1
2687597|NCT00471328|9270387|P1|Extension Phase|Protocol Deviation|3
2687598|NCT00471328|9270386|P2|Extension Phase|Death|7
2687599|NCT00471328|9270387|P1|Extension Phase|Death|1
2687600|NCT00471328|9270386|P2|Extension Phase|Withdrawal by Subject|2
2687601|NCT00471328|9270387|P1|Extension Phase|Withdrawal by Subject|0
2687602|NCT00471328|9270386|P2|Extension Phase|Adverse Event|12
2687603|NCT00471328|9270387|P1|Extension Phase|Adverse Event|3
2687604|NCT00471328|9270386|P2|Core Phase|Protocol Deviation|1
2687605|NCT00471328|9270387|P1|Core Phase|Protocol Deviation|0
2687606|NCT00471328|9270386|P2|Core Phase|Administrative Problem|1
2687607|NCT00471328|9270387|P1|Core Phase|Administrative Problem|0
2687608|NCT00471328|9270386|P2|Core Phase|Disease Progression|53
2687609|NCT00471328|9270387|P1|Core Phase|Disease Progression|78
2687610|NCT00471328|9270386|P2|Core Phase|Abnormal laboratory value|0
2687611|NCT00471328|9270387|P1|Core Phase|Abnormal laboratory value|1
2687612|NCT00471328|9270386|P2|Core Phase|Withdrawal by Subject|2
2687613|NCT00471328|9270387|P1|Core Phase|Withdrawal by Subject|2
2687614|NCT00471328|9270386|P2|Core Phase|Death|4
2687615|NCT00471328|9270387|P1|Core Phase|Death|8
2687616|NCT00471328|9270386|P2|Core Phase|Adverse Event|6
2687617|NCT00471328|9270387|P1|Core Phase|Adverse Event|18
2687618|NCT00471315|9270406|P1|Overall Study|Withdrawal by Subject|1
2687619|NCT00471315|9270406|P1|Overall Study|Adverse Event|7
2687620|NCT00471276|9270411|P1|Overall Study|Refused treatment|6
2687621|NCT00471276|9270411|P1|Overall Study|Other|3
2687622|NCT00471276|9270411|P1|Overall Study|Global deterioration of health status|1
2687623|NCT00471276|9270411|P1|Overall Study|Objective progression or relapse|54
2687624|NCT00471276|9270411|P1|Overall Study|Protocol Violation|1
2687625|NCT00471276|9270411|P1|Overall Study|Adverse Event|16
2687626|NCT00471276|9270411|P1|Overall Study|Death|2
2687627|NCT00471237|9270441|P7|Overall Study|Participant's decision|0
2687628|NCT00471237|9270442|P6|Overall Study|Participant's decision|1
2687629|NCT00471237|9270443|P5|Overall Study|Participant's decision|0
2687630|NCT00471237|9270444|P4|Overall Study|Participant's decision|0
2687631|NCT00471237|9270445|P3|Overall Study|Participant's decision|0
2687632|NCT00471237|9270446|P2|Overall Study|Participant's decision|0
2687633|NCT00471237|9270447|P1|Overall Study|Participant's decision|0
2687634|NCT00471237|9270441|P7|Overall Study|Participant shifted residence|0
2687635|NCT00471237|9270442|P6|Overall Study|Participant shifted residence|0
2687636|NCT00471237|9270443|P5|Overall Study|Participant shifted residence|1
2687637|NCT00471237|9270444|P4|Overall Study|Participant shifted residence|0
2687638|NCT00471237|9270445|P3|Overall Study|Participant shifted residence|0
2687639|NCT00471237|9270446|P2|Overall Study|Participant shifted residence|0
2687640|NCT00471237|9270447|P1|Overall Study|Participant shifted residence|0
2687641|NCT00471237|9270441|P7|Overall Study|Administration of prohibited medicine|0
2687642|NCT00471237|9270442|P6|Overall Study|Administration of prohibited medicine|0
2687643|NCT00471237|9270443|P5|Overall Study|Administration of prohibited medicine|1
2687644|NCT00471237|9270444|P4|Overall Study|Administration of prohibited medicine|0
2687645|NCT00471237|9270445|P3|Overall Study|Administration of prohibited medicine|0
2687646|NCT00471237|9270446|P2|Overall Study|Administration of prohibited medicine|0
2687647|NCT00471237|9270447|P1|Overall Study|Administration of prohibited medicine|0
2687648|NCT00471237|9270441|P7|Overall Study|Participant lost medication|0
2687649|NCT00471237|9270442|P6|Overall Study|Participant lost medication|0
2687650|NCT00471237|9270443|P5|Overall Study|Participant lost medication|1
2687651|NCT00471237|9270444|P4|Overall Study|Participant lost medication|0
2687652|NCT00471237|9270445|P3|Overall Study|Participant lost medication|0
2687653|NCT00471237|9270446|P2|Overall Study|Participant lost medication|0
2687654|NCT00471237|9270447|P1|Overall Study|Participant lost medication|0
2687655|NCT00471237|9270441|P7|Overall Study|High parathyroid hormone|0
2687656|NCT00471237|9270442|P6|Overall Study|High parathyroid hormone|0
2687657|NCT00471237|9270443|P5|Overall Study|High parathyroid hormone|0
2687658|NCT00471237|9270444|P4|Overall Study|High parathyroid hormone|0
2687659|NCT00471237|9270445|P3|Overall Study|High parathyroid hormone|1
2687660|NCT00471237|9270446|P2|Overall Study|High parathyroid hormone|0
2687661|NCT00471237|9270447|P1|Overall Study|High parathyroid hormone|0
2687662|NCT00471237|9270441|P7|Overall Study|Participant planned to travel to abraod|0
2687663|NCT00471237|9270442|P6|Overall Study|Participant planned to travel to abraod|1
2687664|NCT00471237|9270443|P5|Overall Study|Participant planned to travel to abraod|0
2687665|NCT00471237|9270444|P4|Overall Study|Participant planned to travel to abraod|0
2687666|NCT00471237|9270445|P3|Overall Study|Participant planned to travel to abraod|0
2687667|NCT00471237|9270446|P2|Overall Study|Participant planned to travel to abraod|0
2687668|NCT00471237|9270447|P1|Overall Study|Participant planned to travel to abraod|1
2687669|NCT00471237|9270441|P7|Overall Study|Early stopping due to non-efficacy|0
2687670|NCT00471237|9270442|P6|Overall Study|Early stopping due to non-efficacy|0
2687671|NCT00471237|9270443|P5|Overall Study|Early stopping due to non-efficacy|1
2687672|NCT00471237|9270444|P4|Overall Study|Early stopping due to non-efficacy|0
2687673|NCT00471237|9270445|P3|Overall Study|Early stopping due to non-efficacy|0
2687674|NCT00471237|9270446|P2|Overall Study|Early stopping due to non-efficacy|0
2687675|NCT00471237|9270447|P1|Overall Study|Early stopping due to non-efficacy|1
2687676|NCT00471237|9270441|P7|Overall Study|Met serum creatinine withdrawal criteria|0
2687677|NCT00471237|9270442|P6|Overall Study|Met serum creatinine withdrawal criteria|0
2687678|NCT00471237|9270443|P5|Overall Study|Met serum creatinine withdrawal criteria|0
2687679|NCT00471237|9270444|P4|Overall Study|Met serum creatinine withdrawal criteria|2
2687680|NCT00471237|9270445|P3|Overall Study|Met serum creatinine withdrawal criteria|2
2687681|NCT00471237|9270446|P2|Overall Study|Met serum creatinine withdrawal criteria|0
2687682|NCT00471237|9270447|P1|Overall Study|Met serum creatinine withdrawal criteria|1
2687683|NCT00471237|9270441|P7|Overall Study|Non-compliance|0
2687684|NCT00471237|9270442|P6|Overall Study|Non-compliance|0
2687685|NCT00471237|9270443|P5|Overall Study|Non-compliance|0
2687686|NCT00471237|9270444|P4|Overall Study|Non-compliance|1
2687687|NCT00471237|9270445|P3|Overall Study|Non-compliance|0
2687688|NCT00471237|9270446|P2|Overall Study|Non-compliance|1
2687689|NCT00471237|9270447|P1|Overall Study|Non-compliance|0
2687690|NCT00471237|9270441|P7|Overall Study|Sponsor terminated study|0
2687691|NCT00471237|9270442|P6|Overall Study|Sponsor terminated study|24
2687692|NCT00471237|9270443|P5|Overall Study|Sponsor terminated study|18
2687693|NCT00471237|9270444|P4|Overall Study|Sponsor terminated study|22
2687694|NCT00471237|9270445|P3|Overall Study|Sponsor terminated study|19
2687695|NCT00471237|9270446|P2|Overall Study|Sponsor terminated study|23
2687696|NCT00471237|9270447|P1|Overall Study|Sponsor terminated study|20
2687697|NCT00471237|9270441|P7|Overall Study|Withdrawal by Subject|2
2687698|NCT00471237|9270442|P6|Overall Study|Withdrawal by Subject|4
2687699|NCT00471237|9270443|P5|Overall Study|Withdrawal by Subject|7
2687700|NCT00471237|9270444|P4|Overall Study|Withdrawal by Subject|8
2687701|NCT00471237|9270445|P3|Overall Study|Withdrawal by Subject|5
2687702|NCT00471237|9270446|P2|Overall Study|Withdrawal by Subject|6
2687703|NCT00471237|9270447|P1|Overall Study|Withdrawal by Subject|8
2687704|NCT00471237|9270441|P7|Overall Study|Protocol Violation|1
2687705|NCT00471237|9270442|P6|Overall Study|Protocol Violation|4
2687706|NCT00471237|9270443|P5|Overall Study|Protocol Violation|2
2687707|NCT00471237|9270444|P4|Overall Study|Protocol Violation|2
2687708|NCT00471237|9270445|P3|Overall Study|Protocol Violation|3
2687709|NCT00471237|9270446|P2|Overall Study|Protocol Violation|6
2687710|NCT00471237|9270447|P1|Overall Study|Protocol Violation|3
2687711|NCT00471237|9270441|P7|Overall Study|Lost to Follow-up|0
2687712|NCT00471237|9270442|P6|Overall Study|Lost to Follow-up|0
2687713|NCT00471237|9270443|P5|Overall Study|Lost to Follow-up|3
2687714|NCT00471237|9270444|P4|Overall Study|Lost to Follow-up|2
2687715|NCT00471237|9270445|P3|Overall Study|Lost to Follow-up|0
2687716|NCT00471237|9270446|P2|Overall Study|Lost to Follow-up|1
2687717|NCT00471237|9270447|P1|Overall Study|Lost to Follow-up|1
2687718|NCT00471237|9270441|P7|Overall Study|Adverse Event|0
2687719|NCT00471237|9270442|P6|Overall Study|Adverse Event|5
2687720|NCT00471237|9270443|P5|Overall Study|Adverse Event|7
2687721|NCT00471237|9270444|P4|Overall Study|Adverse Event|8
2687722|NCT00471237|9270445|P3|Overall Study|Adverse Event|4
2687723|NCT00471237|9270446|P2|Overall Study|Adverse Event|5
2687724|NCT00471237|9270447|P1|Overall Study|Adverse Event|6
2687725|NCT00471146|9270597|P2|Overall Study|Other|5
2687726|NCT00471146|9270598|P1|Overall Study|Other|4
2687727|NCT00471146|9270597|P2|Overall Study|Randomized but not treated|8
2687728|NCT00471146|9270598|P1|Overall Study|Randomized but not treated|9
2687729|NCT00471146|9270597|P2|Overall Study|Global deterioration of health status|14
2687730|NCT00471146|9270598|P1|Overall Study|Global deterioration of health status|12
2687731|NCT00471146|9270597|P2|Overall Study|Objective progression or relapse|87
2687732|NCT00471146|9270598|P1|Overall Study|Objective progression or relapse|84
2687733|NCT00471146|9270597|P2|Overall Study|Protocol Violation|2
2687734|NCT00471146|9270598|P1|Overall Study|Protocol Violation|2
2687735|NCT00471146|9270597|P2|Overall Study|Lost to Follow-up|2
2687736|NCT00471146|9270598|P1|Overall Study|Lost to Follow-up|4
2687737|NCT00471146|9270597|P2|Overall Study|Death|12
2687738|NCT00471146|9270598|P1|Overall Study|Death|11
2687739|NCT00471146|9270597|P2|Overall Study|Withdrawal by Subject|11
2687740|NCT00471146|9270598|P1|Overall Study|Withdrawal by Subject|14
2687741|NCT00471146|9270597|P2|Overall Study|Adverse Event|33
2687742|NCT00471146|9270598|P1|Overall Study|Adverse Event|32
2687743|NCT00471107|9270623|P3|Overall Study|Technical problems/data loss|3
2687744|NCT00471107|9270624|P2|Overall Study|Technical problems/data loss|1
2687745|NCT00471107|9270625|P1|Overall Study|Technical problems/data loss|3
2687746|NCT00471081|9270635|P2|Extended Safety Follow-Up|Missing confirmed|1
2687747|NCT00471081|9270636|P1|Extended Safety Follow-Up|Missing confirmed|0
2687748|NCT00471081|9270635|P2|Extended Safety Follow-Up|Lost to Follow-up|8
2687749|NCT00471081|9270636|P1|Extended Safety Follow-Up|Lost to Follow-up|1
2687750|NCT00471081|9270635|P2|Extended Safety Follow-Up|Withdrawal by Subject|4
2687751|NCT00471081|9270636|P1|Extended Safety Follow-Up|Withdrawal by Subject|1
2687752|NCT00471081|9270635|P2|Active Phase|Lost health plan/insurance|8
2687753|NCT00471081|9270636|P1|Active Phase|Lost health plan/insurance|1
2687754|NCT00471081|9270635|P2|Active Phase|Lost to Follow-up|1
2687755|NCT00471081|9270636|P1|Active Phase|Lost to Follow-up|0
2687756|NCT00471081|9270635|P2|Active Phase|Withdrawal by Subject|3
2687757|NCT00471081|9270636|P1|Active Phase|Withdrawal by Subject|0
2687758|NCT00471081|9270635|P2|Active Phase|Protocol Violation|1
2687759|NCT00471081|9270636|P1|Active Phase|Protocol Violation|1
2687760|NCT00470847|9270682|P1|Overall Study|Pt still receiving treatment|1
2687761|NCT00470834|9270695|P2|Extension Period (24 Months)|Disease Progression|1
2687762|NCT00470834|9270696|P1|Extension Period (24 Months)|Disease Progression|0
2687763|NCT00470834|9270695|P2|Extension Period (24 Months)|Non-compliance|1
2687764|NCT00470834|9270696|P1|Extension Period (24 Months)|Non-compliance|0
2687765|NCT00470834|9270695|P2|Extension Period (24 Months)|Lost to Follow-up|1
2687766|NCT00470834|9270696|P1|Extension Period (24 Months)|Lost to Follow-up|0
2687767|NCT00470834|9270695|P2|Extension Period (24 Months)|Sponsor Terminated Study|1
2687768|NCT00470834|9270696|P1|Extension Period (24 Months)|Sponsor Terminated Study|0
2687769|NCT00470834|9270695|P2|Extension Period (24 Months)|Physician Decision|3
2687770|NCT00470834|9270696|P1|Extension Period (24 Months)|Physician Decision|4
2687771|NCT00470834|9270695|P2|Extension Period (24 Months)|Withdrawal by Subject|5
2687772|NCT00470834|9270696|P1|Extension Period (24 Months)|Withdrawal by Subject|2
2687773|NCT00470834|9270695|P2|Extension Period (24 Months)|Adverse Event|4
2687774|NCT00470834|9270696|P1|Extension Period (24 Months)|Adverse Event|3
2687775|NCT00470834|9270695|P2|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7
2687776|NCT00470834|9270696|P1|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6
2687777|NCT00470834|9270695|P2|Treatment Period (18 Months)|Lack of Efficacy|0
2687778|NCT00470834|9270696|P1|Treatment Period (18 Months)|Lack of Efficacy|1
2687779|NCT00470834|9270695|P2|Treatment Period (18 Months)|Non-compliance|0
2687780|NCT00470834|9270696|P1|Treatment Period (18 Months)|Non-compliance|1
2687781|NCT00470834|9270695|P2|Treatment Period (18 Months)|Lost to Follow-up|0
2687782|NCT00470834|9270696|P1|Treatment Period (18 Months)|Lost to Follow-up|1
2687783|NCT00470834|9270695|P2|Treatment Period (18 Months)|Sponsor Terminated Study|1
2687784|NCT00470834|9270696|P1|Treatment Period (18 Months)|Sponsor Terminated Study|1
2687785|NCT00470834|9270695|P2|Treatment Period (18 Months)|Protocol Violation|1
2687786|NCT00470834|9270696|P1|Treatment Period (18 Months)|Protocol Violation|3
2687787|NCT00470834|9270695|P2|Treatment Period (18 Months)|Physician Decision|4
2687788|NCT00470834|9270696|P1|Treatment Period (18 Months)|Physician Decision|4
2687789|NCT00470834|9270695|P2|Treatment Period (18 Months)|Withdrawal by Subject|5
2687790|NCT00470834|9270696|P1|Treatment Period (18 Months)|Withdrawal by Subject|4
2687791|NCT00470834|9270695|P2|Treatment Period (18 Months)|Adverse Event|6
2687792|NCT00470834|9270696|P1|Treatment Period (18 Months)|Adverse Event|7
2687793|NCT00470834|9270695|P2|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14
2687794|NCT00470834|9270696|P1|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16
2687795|NCT00470626|9270710|P1|Overall Study|Withdrawal by Subject|7
2687796|NCT00470626|9270710|P1|Overall Study|Lost to Follow-up|10
2687797|NCT00470535|9270752|P1|Overall Study|Other|2
2687798|NCT00470535|9270752|P1|Overall Study|Death|1
2687799|NCT00470535|9270752|P1|Overall Study|Adverse Event|1
2687800|NCT00470535|9270752|P1|Overall Study|Withdrawal by Subject|1
2687801|NCT00470535|9270752|P1|Overall Study|Disease Progression|13
2687802|NCT00470470|9270761|P1|Overall Study|Not treated|1
2687803|NCT00470470|9270761|P1|Overall Study|Death|2
2687804|NCT00470470|9270761|P1|Overall Study|Adverse Event|2
2687805|NCT00470418|9270768|P2|Overall Study|Withdrawal by Subject|0
2687806|NCT00470418|9270769|P1|Overall Study|Withdrawal by Subject|1
2687807|NCT00470366|9270790|P1|Overall Study|Poor compliance|1
2687808|NCT00470366|9270790|P1|Overall Study|Adverse Event|3
2687809|NCT00470275|9270801|P1|Overall Study|Withdrawal by Subject|2
2687810|NCT00470275|9270801|P1|Overall Study|Lack of Efficacy|7
2687811|NCT00470275|9270801|P1|Overall Study|Death|1
2687812|NCT00470262|9270807|P2|Overall Study|Withdrawal by Subject|0
2687813|NCT00470262|9270808|P1|Overall Study|Withdrawal by Subject|2
2687814|NCT00470184|9270816|P1|Overall Study|recurrence|1
2687815|NCT00470184|9270816|P1|Overall Study|other|5
2687816|NCT00470184|9270816|P1|Overall Study|Withdrawal by Subject|4
2687817|NCT00470184|9270816|P1|Overall Study|Adverse Event|3
2687818|NCT00470184|9270816|P1|Overall Study|disease Progression|4
2687819|NCT00470184|9270816|P1|Overall Study|Not treated (other)|1
2687820|NCT00470184|9270816|P1|Overall Study|Not Treated(became ineligible)|4
2687821|NCT00470158|9270828|P5|Overall Study|Protocol Violation|0
2687822|NCT00470158|9270829|P4|Overall Study|Protocol Violation|0
2687823|NCT00470158|9270830|P3|Overall Study|Protocol Violation|0
2687824|NCT00470158|9270831|P2|Overall Study|Protocol Violation|0
2687825|NCT00470158|9270832|P1|Overall Study|Protocol Violation|1
2687826|NCT00470158|9270828|P5|Overall Study|Lost to Follow-up|4
2687827|NCT00470158|9270829|P4|Overall Study|Lost to Follow-up|5
2687828|NCT00470158|9270830|P3|Overall Study|Lost to Follow-up|8
2687829|NCT00470158|9270831|P2|Overall Study|Lost to Follow-up|8
2687830|NCT00470158|9270832|P1|Overall Study|Lost to Follow-up|7
2687831|NCT00470158|9270828|P5|Overall Study|Death|2
2687832|NCT00470158|9270829|P4|Overall Study|Death|0
2687833|NCT00470158|9270830|P3|Overall Study|Death|0
2687834|NCT00470158|9270831|P2|Overall Study|Death|0
2687835|NCT00470158|9270832|P1|Overall Study|Death|0
2687836|NCT00470093|9270865|P1|Overall Study|Adverse Event|2
2687837|NCT00470067|9270872|P1|Overall Study|Disease Progression|6
2687838|NCT00470067|9270872|P1|Overall Study|Death|1
2687839|NCT00470054|9270876|P1|Overall Study|Ineligible|1
2687840|NCT00469898|9270892|P1|Overall Study|Decreased performance status|1
2687841|NCT00469898|9270892|P1|Overall Study|Disease progression|9
2687842|NCT00469898|9270892|P1|Overall Study|Death|4
2687843|NCT00469898|9270892|P1|Overall Study|Withdrawal by Subject|4
2687844|NCT00469898|9270892|P1|Overall Study|Adverse Event|7
2687845|NCT00469859|9270901|P2|Overall Study|Inevaluable|2
2687846|NCT00469859|9270902|P1|Overall Study|Inevaluable|0
2687847|NCT00469833|9270910|P1|Overall Study|No IV access|2
2687848|NCT00469612|9270922|P2|Overall Study|Study terminated before data collected|0
2687849|NCT00469612|9270923|P1|Overall Study|Study terminated before data collected|2
2687850|NCT00469456|9270950|P2|Overall Study|Withdrawal by Subject|1
2687851|NCT00469456|9270951|P1|Overall Study|Withdrawal by Subject|4
2687852|NCT00469456|9270950|P2|Overall Study|Protocol Violation|0
2687853|NCT00469456|9270951|P1|Overall Study|Protocol Violation|1
2687854|NCT00469456|9270950|P2|Overall Study|Adverse Event|3
2687855|NCT00469456|9270951|P1|Overall Study|Adverse Event|4
2687856|NCT00469209|9270980|P3|Overall Study|Adverse Event|1
2687857|NCT00469209|9270981|P2|Overall Study|Adverse Event|0
2687858|NCT00469209|9270982|P1|Overall Study|Adverse Event|1
2687859|NCT00469092|9270992|P2|Overall Study|Use of Corticosteroid|0
2687860|NCT00469092|9270993|P1|Overall Study|Use of Corticosteroid|1
2687861|NCT00469092|9270992|P2|Overall Study|Abnormal lab value|0
2687862|NCT00469092|9270993|P1|Overall Study|Abnormal lab value|1
2687863|NCT00469092|9270992|P2|Overall Study|Hypoglycaemic Episodes|1
2687864|NCT00469092|9270993|P1|Overall Study|Hypoglycaemic Episodes|1
2687865|NCT00469092|9270992|P2|Overall Study|Use of lipid lowering drug|0
2687866|NCT00469092|9270993|P1|Overall Study|Use of lipid lowering drug|1
2687867|NCT00469092|9270992|P2|Overall Study|Contraindication metformin/glimepiride|0
2687868|NCT00469092|9270993|P1|Overall Study|Contraindication metformin/glimepiride|1
2687869|NCT00469092|9270992|P2|Overall Study|Incorrectly Randomised|3
2687870|NCT00469092|9270993|P1|Overall Study|Incorrectly Randomised|4
2687871|NCT00469092|9270992|P2|Overall Study|Withdrawal Criteria|4
2687872|NCT00469092|9270993|P1|Overall Study|Withdrawal Criteria|3
2687873|NCT00469092|9270992|P2|Overall Study|Withdrawal by Subject|4
2687874|NCT00469092|9270993|P1|Overall Study|Withdrawal by Subject|4
2687875|NCT00469092|9270992|P2|Overall Study|Protocol Violation|3
2687876|NCT00469092|9270993|P1|Overall Study|Protocol Violation|3
2687877|NCT00469092|9270992|P2|Overall Study|Lost to Follow-up|2
2687878|NCT00469092|9270993|P1|Overall Study|Lost to Follow-up|1
2687879|NCT00469092|9270992|P2|Overall Study|Lack of Efficacy|0
2687880|NCT00469092|9270993|P1|Overall Study|Lack of Efficacy|1
2687881|NCT00469092|9270992|P2|Overall Study|Adverse Event|4
2687882|NCT00469092|9270993|P1|Overall Study|Adverse Event|5
2687883|NCT00469079|9271012|P3|Overall Study|Ineligible|0
2687884|NCT00469079|9271013|P2|Overall Study|Ineligible|1
2687885|NCT00469079|9271014|P1|Overall Study|Ineligible|0
2687886|NCT00469079|9271012|P3|Overall Study|Withdrawal by Subject|2
2687887|NCT00469079|9271013|P2|Overall Study|Withdrawal by Subject|2
2687888|NCT00469079|9271014|P1|Overall Study|Withdrawal by Subject|1
2687889|NCT00469079|9271012|P3|Overall Study|Lost to Follow-up|10
2687890|NCT00469079|9271013|P2|Overall Study|Lost to Follow-up|8
2687891|NCT00469079|9271014|P1|Overall Study|Lost to Follow-up|4
2687892|NCT00469079|9271012|P3|Overall Study|Adverse Event|2
2687893|NCT00469079|9271013|P2|Overall Study|Adverse Event|3
2687894|NCT00469079|9271014|P1|Overall Study|Adverse Event|1
2687895|NCT00469079|9271012|P3|Overall Study|Lack of Efficacy|5
2687896|NCT00469079|9271013|P2|Overall Study|Lack of Efficacy|8
2687897|NCT00469079|9271014|P1|Overall Study|Lack of Efficacy|3
2687898|NCT00468910|9271033|P2|Overall Study|Medical Contraindication|1
2687899|NCT00468910|9271034|P1|Overall Study|Medical Contraindication|0
2687900|NCT00468910|9271033|P2|Overall Study|Withdrawal by Subject|1
2687901|NCT00468910|9271034|P1|Overall Study|Withdrawal by Subject|2
2687902|NCT00468910|9271033|P2|Overall Study|Lost to Follow-up|1
2687903|NCT00468910|9271034|P1|Overall Study|Lost to Follow-up|2
2687904|NCT00468858|9271053|P3|Overall Study|Other|1
2687905|NCT00468858|9271054|P2|Overall Study|Other|0
2687906|NCT00468858|9271055|P1|Overall Study|Other|0
2687907|NCT00468858|9271053|P3|Overall Study|Lost to Follow-up|5
2687908|NCT00468858|9271054|P2|Overall Study|Lost to Follow-up|2
2687909|NCT00468858|9271055|P1|Overall Study|Lost to Follow-up|1
2687910|NCT00468858|9271053|P3|Overall Study|Relocation|3
2687911|NCT00468858|9271054|P2|Overall Study|Relocation|3
2687912|NCT00468858|9271055|P1|Overall Study|Relocation|1
2687913|NCT00468858|9271053|P3|Overall Study|Withdrawal by Subject|5
2687914|NCT00468858|9271054|P2|Overall Study|Withdrawal by Subject|4
2687915|NCT00468858|9271055|P1|Overall Study|Withdrawal by Subject|7
2687916|NCT00468858|9271053|P3|Overall Study|Adverse Event|0
2687917|NCT00468858|9271054|P2|Overall Study|Adverse Event|1
2687918|NCT00468858|9271055|P1|Overall Study|Adverse Event|0
2687919|NCT00468845|9271176|P3|Overall Study|Randomized, not treated|2
2687920|NCT00468845|9271177|P2|Overall Study|Randomized, not treated|4
2687921|NCT00468845|9271178|P1|Overall Study|Randomized, not treated|1
2687922|NCT00468845|9271176|P3|Overall Study|No longer willing to participate|10
2687923|NCT00468845|9271177|P2|Overall Study|No longer willing to participate|6
2687924|NCT00468845|9271178|P1|Overall Study|No longer willing to participate|5
2687925|NCT00468845|9271176|P3|Overall Study|Other|5
2687926|NCT00468845|9271177|P2|Overall Study|Other|9
2687927|NCT00468845|9271178|P1|Overall Study|Other|4
2687928|NCT00468845|9271176|P3|Overall Study|Lost to Follow-up|2
2687929|NCT00468845|9271177|P2|Overall Study|Lost to Follow-up|1
2687930|NCT00468845|9271178|P1|Overall Study|Lost to Follow-up|2
2687931|NCT00468845|9271176|P3|Overall Study|Adverse Event|11
2687932|NCT00468845|9271177|P2|Overall Study|Adverse Event|14
2687933|NCT00468845|9271178|P1|Overall Study|Adverse Event|9
2687934|NCT00468819|9271315|P3|Overall Study|Drop-outs (Treatment never received)|0
2687935|NCT00468819|9271316|P2|Overall Study|Drop-outs (Treatment never received)|0
2687936|NCT00468819|9271317|P1|Overall Study|Drop-outs (Treatment never received)|2
2687937|NCT00468819|9271315|P3|Overall Study|Lost to Follow-up|1
2687938|NCT00468819|9271316|P2|Overall Study|Lost to Follow-up|0
2687939|NCT00468819|9271317|P1|Overall Study|Lost to Follow-up|0
2687940|NCT00468819|9271315|P3|Overall Study|Withdrawal by Subject|1
2687941|NCT00468819|9271316|P2|Overall Study|Withdrawal by Subject|0
2687942|NCT00468819|9271317|P1|Overall Study|Withdrawal by Subject|4
2687943|NCT00468728|9271397|P2|Follow-up|mITT failure|31
2687944|NCT00468728|9271398|P1|Follow-up|mITT failure|34
2687945|NCT00468728|9271397|P2|Treatment|criteria for mITT population|11
2687946|NCT00468728|9271398|P1|Treatment|criteria for mITT population|4
2687947|NCT00468676|9271410|P2|Overall Study|Death|1
2687948|NCT00468676|9271411|P1|Overall Study|Death|2
2687949|NCT00468676|9271410|P2|Overall Study|Lost to Follow-up|11
2687950|NCT00468676|9271411|P1|Overall Study|Lost to Follow-up|14
2687951|NCT00468650|9271428|P1|Overall Study|Protocol Violation|1
2687952|NCT00468650|9271428|P1|Overall Study|Withdrawal by Subject|2
2687953|NCT00468650|9271428|P1|Overall Study|Lost to Follow-up|4
2687954|NCT00468585|9271476|P4|Overall Study|Withdrawal by Subject|1
2687955|NCT00468585|9271477|P3|Overall Study|Withdrawal by Subject|2
2687956|NCT00468585|9271478|P2|Overall Study|Withdrawal by Subject|0
2687957|NCT00468585|9271479|P1|Overall Study|Withdrawal by Subject|0
2687958|NCT00468585|9271476|P4|Overall Study|Adverse Event|0
2687959|NCT00468585|9271477|P3|Overall Study|Adverse Event|1
2687960|NCT00468585|9271478|P2|Overall Study|Adverse Event|0
2687961|NCT00468585|9271479|P1|Overall Study|Adverse Event|0
2687962|NCT00468585|9271476|P4|Overall Study|Patient found to be ineligible|0
2687963|NCT00468585|9271477|P3|Overall Study|Patient found to be ineligible|1
2687964|NCT00468585|9271478|P2|Overall Study|Patient found to be ineligible|0
2687965|NCT00468585|9271479|P1|Overall Study|Patient found to be ineligible|0
2687966|NCT00468585|9271476|P4|Overall Study|Patient not treated|0
2687967|NCT00468585|9271477|P3|Overall Study|Patient not treated|1
2687968|NCT00468585|9271478|P2|Overall Study|Patient not treated|0
2687969|NCT00468585|9271479|P1|Overall Study|Patient not treated|1
2687970|NCT00468559|9271491|P3|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
2687971|NCT00468559|9271492|P2|Double-blind, Treatment-withdrawal Phase|Adverse Event|2
2687972|NCT00468559|9271493|P1|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
2687973|NCT00468559|9271491|P3|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17
2687974|NCT00468559|9271492|P2|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8
2687975|NCT00468559|9271493|P1|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0
2687976|NCT00468559|9271491|P3|Open-label Treatment Phase|Withdrawal by Subject|0
2687977|NCT00468559|9271492|P2|Open-label Treatment Phase|Withdrawal by Subject|0
2687978|NCT00468559|9271493|P1|Open-label Treatment Phase|Withdrawal by Subject|4
2687979|NCT00468559|9271491|P3|Open-label Treatment Phase|Lack of Efficacy|0
2687980|NCT00468559|9271492|P2|Open-label Treatment Phase|Lack of Efficacy|0
2687981|NCT00468559|9271493|P1|Open-label Treatment Phase|Lack of Efficacy|9
2687982|NCT00468559|9271491|P3|Open-label Treatment Phase|Adverse Event|0
2687983|NCT00468559|9271492|P2|Open-label Treatment Phase|Adverse Event|0
2687984|NCT00468559|9271493|P1|Open-label Treatment Phase|Adverse Event|5
2687985|NCT00468546|9271521|P2|Week 24 to Week 104 Analysis|Other|14
2687986|NCT00468546|9271522|P1|Week 24 to Week 104 Analysis|Other|17
2687987|NCT00468546|9271521|P2|Week 24 to Week 104 Analysis|Movement into re-treatment study|183
2687988|NCT00468546|9271522|P1|Week 24 to Week 104 Analysis|Movement into re-treatment study|77
2687989|NCT00468546|9271521|P2|Week 24 to Week 104 Analysis|Failure to return|2
2687990|NCT00468546|9271522|P1|Week 24 to Week 104 Analysis|Failure to return|1
2687991|NCT00468546|9271521|P2|Week 24 to Week 104 Analysis|Refused treatment|7
2687992|NCT00468546|9271522|P1|Week 24 to Week 104 Analysis|Refused treatment|4
2687993|NCT00468546|9271521|P2|Week 24 to Week 104 Analysis|Protocol Violation|2
2687994|NCT00468546|9271522|P1|Week 24 to Week 104 Analysis|Protocol Violation|0
2687995|NCT00468546|9271521|P2|Week 24 to Week 104 Analysis|Lack of Efficacy|12
2687996|NCT00468546|9271522|P1|Week 24 to Week 104 Analysis|Lack of Efficacy|3
2687997|NCT00468546|9271521|P2|Week 24 to Week 104 Analysis|Death|0
2687998|NCT00468546|9271522|P1|Week 24 to Week 104 Analysis|Death|1
2687999|NCT00468546|9271521|P2|Week 24 to Week 104 Analysis|Adverse Event|5
2688000|NCT00468546|9271522|P1|Week 24 to Week 104 Analysis|Adverse Event|2
2688001|NCT00468546|9271521|P2|Week 24 Analysis|Participant unblinded (clinical hold)|0
2688002|NCT00468546|9271522|P1|Week 24 Analysis|Participant unblinded (clinical hold)|1
2688003|NCT00468546|9271521|P2|Week 24 Analysis|Went onto rescue therapy|0
2688004|NCT00468546|9271522|P1|Week 24 Analysis|Went onto rescue therapy|1
2688005|NCT00468546|9271521|P2|Week 24 Analysis|Due to clinical hold|0
2688006|NCT00468546|9271522|P1|Week 24 Analysis|Due to clinical hold|1
2688007|NCT00468546|9271521|P2|Week 24 Analysis|Incorrect diagnosis and treatment|1
2688008|NCT00468546|9271522|P1|Week 24 Analysis|Incorrect diagnosis and treatment|0
2688009|NCT00468546|9271521|P2|Week 24 Analysis|Rescue therapy|0
2688010|NCT00468546|9271522|P1|Week 24 Analysis|Rescue therapy|2
2688011|NCT00468546|9271521|P2|Week 24 Analysis|Failure to return|4
2688012|NCT00468546|9271522|P1|Week 24 Analysis|Failure to return|3
2688013|NCT00468546|9271521|P2|Week 24 Analysis|Adverse Event|8
2688014|NCT00468546|9271522|P1|Week 24 Analysis|Adverse Event|1
2688015|NCT00468546|9271521|P2|Week 24 Analysis|Refused treatment|5
2688016|NCT00468546|9271522|P1|Week 24 Analysis|Refused treatment|5
2688017|NCT00468546|9271521|P2|Week 24 Analysis|Lack of Efficacy|37
2688018|NCT00468546|9271522|P1|Week 24 Analysis|Lack of Efficacy|83
2688019|NCT00468481|9271552|P2|Overall Study|Other|0
2688020|NCT00468481|9271553|P1|Overall Study|Other|6
2688021|NCT00468481|9271552|P2|Overall Study|Non-Compliance|0
2688022|NCT00468481|9271553|P1|Overall Study|Non-Compliance|5
2688023|NCT00468481|9271552|P2|Overall Study|Moved out of area|1
2688024|NCT00468481|9271553|P1|Overall Study|Moved out of area|4
2688025|NCT00468481|9271552|P2|Overall Study|Egg Donor|0
2688026|NCT00468481|9271553|P1|Overall Study|Egg Donor|1
2688027|NCT00468481|9271552|P2|Overall Study|Prohibited Medication|1
2688028|NCT00468481|9271553|P1|Overall Study|Prohibited Medication|1
2688029|NCT00468481|9271552|P2|Overall Study|susp/diag malignant/premalignant disease|0
2688030|NCT00468481|9271553|P1|Overall Study|susp/diag malignant/premalignant disease|1
2688031|NCT00468481|9271552|P2|Overall Study|Withdrawal by Subject|3
2688032|NCT00468481|9271553|P1|Overall Study|Withdrawal by Subject|12
2688033|NCT00468481|9271552|P2|Overall Study|Protocol Violation|8
2688034|NCT00468481|9271553|P1|Overall Study|Protocol Violation|18
2688035|NCT00468481|9271552|P2|Overall Study|Pregnancy|0
2688036|NCT00468481|9271553|P1|Overall Study|Pregnancy|2
2688037|NCT00468481|9271552|P2|Overall Study|Lost to Follow-up|8
2688038|NCT00468481|9271553|P1|Overall Study|Lost to Follow-up|25
2688039|NCT00468481|9271552|P2|Overall Study|Adverse Event|3
2688040|NCT00468481|9271553|P1|Overall Study|Adverse Event|13
2688041|NCT00468312|9271653|P2|Overall Study|Did not meet protocol eligibility|1
2688042|NCT00468312|9271654|P1|Overall Study|Did not meet protocol eligibility|0
2688043|NCT00468312|9271653|P2|Overall Study|Protocol Violation|1
2688044|NCT00468312|9271654|P1|Overall Study|Protocol Violation|2
2688045|NCT00468312|9271653|P2|Overall Study|Withdrawal by Subject|1
2688046|NCT00468312|9271654|P1|Overall Study|Withdrawal by Subject|0
2688047|NCT00468312|9271653|P2|Overall Study|Lack of Efficacy|1
2688048|NCT00468312|9271654|P1|Overall Study|Lack of Efficacy|0
2688049|NCT00468312|9271653|P2|Overall Study|Adverse Event|1
2688050|NCT00468312|9271654|P1|Overall Study|Adverse Event|2
2688051|NCT00468299|9271670|P2|Overall Study|Withdrawal by Subject|1
2688052|NCT00468299|9271671|P1|Overall Study|Withdrawal by Subject|0
2688053|NCT00468286|9271681|P2|Overall Study|Physician Decision|1
2688054|NCT00468286|9271682|P1|Overall Study|Physician Decision|0
2688055|NCT00468286|9271681|P2|Overall Study|Withdrawal by Subject|3
2688056|NCT00468286|9271682|P1|Overall Study|Withdrawal by Subject|4
2688057|NCT00468286|9271681|P2|Overall Study|Protocol Violation|2
2688058|NCT00468286|9271682|P1|Overall Study|Protocol Violation|2
2688059|NCT00468286|9271681|P2|Overall Study|Adverse Event|6
2688060|NCT00468286|9271682|P1|Overall Study|Adverse Event|1
2688061|NCT00468169|9271714|P2|Overall Study|Withdrawal by Subject|0
2688062|NCT00468169|9271715|P1|Overall Study|Withdrawal by Subject|1
2688063|NCT00468143|9271731|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|3
2688064|NCT00468143|9271732|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|3
2688065|NCT00468143|9271731|P2|First Intervention (3 Weeks)|Withdrawal by Subject|4
2688066|NCT00468143|9271732|P1|First Intervention (3 Weeks)|Withdrawal by Subject|3
2688067|NCT00468104|9271746|P2|Second Intervention|discarded for malposition of chest tube|2
2688068|NCT00468104|9271747|P1|Second Intervention|discarded for malposition of chest tube|0
2688069|NCT00468104|9271746|P2|Second Intervention|Withdrawal by Subject|2
2688070|NCT00468104|9271747|P1|Second Intervention|Withdrawal by Subject|5
2688071|NCT00468104|9271746|P2|First Intervention|trapped lung|0
2688072|NCT00468104|9271747|P1|First Intervention|trapped lung|1
2688073|NCT00468104|9271746|P2|First Intervention|associated prolonged pneumothorax|0
2688074|NCT00468104|9271747|P1|First Intervention|associated prolonged pneumothorax|1
2688075|NCT00468104|9271746|P2|First Intervention|large lung mass with minimal effusion|0
2688076|NCT00468104|9271747|P1|First Intervention|large lung mass with minimal effusion|1
2688077|NCT00468104|9271746|P2|First Intervention|malposition/blocked chest tube tube|0
2688078|NCT00468104|9271747|P1|First Intervention|malposition/blocked chest tube tube|2
2688079|NCT00468104|9271746|P2|First Intervention|died within 3 weeks|0
2688080|NCT00468104|9271747|P1|First Intervention|died within 3 weeks|1
2688081|NCT00468104|9271746|P2|First Intervention|bleeding at chest tube site--first dose|0
2688082|NCT00468104|9271747|P1|First Intervention|bleeding at chest tube site--first dose|1
2688083|NCT00468104|9271746|P2|First Intervention|Protocol Violation|1
2688084|NCT00468104|9271747|P1|First Intervention|Protocol Violation|2
2688085|NCT00468052|9271764|P2|Overall Study|Protocol Violation|8
2688086|NCT00468052|9271765|P1|Overall Study|Protocol Violation|7
2688087|NCT00467961|9271783|P1|Overall Study|Disease Progression|2
2688088|NCT00467961|9271783|P1|Overall Study|Technical Failures|5
2688089|NCT00467896|9271787|P1|Overall Study|Patient had no improvement|1
2688090|NCT00467896|9271787|P1|Overall Study|Started inhaled Remodulin|1
2688091|NCT00467896|9271787|P1|Overall Study|Started intravenous prostacyclin|1
2688092|NCT00467896|9271787|P1|Overall Study|Mainly used Prodose not I-neb® device|1
2688093|NCT00467896|9271787|P1|Overall Study|Patient weaned off iloprost|1
2688094|NCT00467896|9271787|P1|Overall Study|Patient had atrial septostomy|1
2688095|NCT00467896|9271787|P1|Overall Study|Patient received transplant|2
2688096|NCT00467896|9271787|P1|Overall Study|Changed therapy|2
2688097|NCT00467896|9271787|P1|Overall Study|Non-compliance|3
2688098|NCT00467896|9271787|P1|Overall Study|Serious Adverse Event|13
2688099|NCT00467896|9271787|P1|Overall Study|Adverse Event|7
2688100|NCT00467896|9271787|P1|Overall Study|Consent Withdrawal|18
2688101|NCT00467870|9271813|P6|Overall Study|Other/Unknown|0
2688102|NCT00467870|9271814|P5|Overall Study|Other/Unknown|4
2688103|NCT00467870|9271815|P4|Overall Study|Other/Unknown|5
2688104|NCT00467870|9271816|P3|Overall Study|Other/Unknown|1
2688105|NCT00467870|9271817|P2|Overall Study|Other/Unknown|5
2688106|NCT00467870|9271818|P1|Overall Study|Other/Unknown|8
2688107|NCT00467870|9271813|P6|Overall Study|Subject Non-compliance|0
2688108|NCT00467870|9271814|P5|Overall Study|Subject Non-compliance|5
2688109|NCT00467870|9271815|P4|Overall Study|Subject Non-compliance|1
2688110|NCT00467870|9271816|P3|Overall Study|Subject Non-compliance|0
2688111|NCT00467870|9271817|P2|Overall Study|Subject Non-compliance|4
2688112|NCT00467870|9271818|P1|Overall Study|Subject Non-compliance|3
2688113|NCT00467870|9271813|P6|Overall Study|Lost to Follow-up|0
2688114|NCT00467870|9271814|P5|Overall Study|Lost to Follow-up|3
2688115|NCT00467870|9271815|P4|Overall Study|Lost to Follow-up|1
2688116|NCT00467870|9271816|P3|Overall Study|Lost to Follow-up|1
2688117|NCT00467870|9271817|P2|Overall Study|Lost to Follow-up|3
2688118|NCT00467870|9271818|P1|Overall Study|Lost to Follow-up|5
2688119|NCT00467870|9271813|P6|Overall Study|Withdrawal by Subject|1
2688120|NCT00467870|9271814|P5|Overall Study|Withdrawal by Subject|10
2688121|NCT00467870|9271815|P4|Overall Study|Withdrawal by Subject|9
2688122|NCT00467870|9271816|P3|Overall Study|Withdrawal by Subject|0
2688123|NCT00467870|9271817|P2|Overall Study|Withdrawal by Subject|21
2688124|NCT00467870|9271818|P1|Overall Study|Withdrawal by Subject|14
2688125|NCT00467870|9271813|P6|Overall Study|Protocol Violation|0
2688126|NCT00467870|9271814|P5|Overall Study|Protocol Violation|0
2688127|NCT00467870|9271815|P4|Overall Study|Protocol Violation|2
2688128|NCT00467870|9271816|P3|Overall Study|Protocol Violation|1
2688129|NCT00467870|9271817|P2|Overall Study|Protocol Violation|1
2688130|NCT00467870|9271818|P1|Overall Study|Protocol Violation|2
2688131|NCT00467870|9271813|P6|Overall Study|Adverse Event|1
2688132|NCT00467870|9271814|P5|Overall Study|Adverse Event|15
2688133|NCT00467870|9271815|P4|Overall Study|Adverse Event|15
2688134|NCT00467870|9271816|P3|Overall Study|Adverse Event|1
2688135|NCT00467870|9271817|P2|Overall Study|Adverse Event|9
2688136|NCT00467870|9271818|P1|Overall Study|Adverse Event|13
2688137|NCT00467857|9271861|P2|Overall Study|Discontinuation reason missing|3
2688138|NCT00467857|9271862|P1|Overall Study|Discontinuation reason missing|0
2688139|NCT00467857|9271861|P2|Overall Study|Did not meet inclusion/exclusion criteri|2
2688140|NCT00467857|9271862|P1|Overall Study|Did not meet inclusion/exclusion criteri|0
2688141|NCT00467857|9271861|P2|Overall Study|Emergency care required|1
2688142|NCT00467857|9271862|P1|Overall Study|Emergency care required|0
2688143|NCT00467857|9271861|P2|Overall Study|Discharged from court service|1
2688144|NCT00467857|9271862|P1|Overall Study|Discharged from court service|0
2688145|NCT00467857|9271861|P2|Overall Study|Death|1
2688146|NCT00467857|9271862|P1|Overall Study|Death|0
2688147|NCT00467857|9271861|P2|Overall Study|Withdrew consent|0
2688148|NCT00467857|9271862|P1|Overall Study|Withdrew consent|2
2688149|NCT00467857|9271861|P2|Overall Study|Adverse Event|0
2688150|NCT00467857|9271862|P1|Overall Study|Adverse Event|1
2688151|NCT00467831|9271910|P1|Overall Study|Withdrawal by Subject|1
2688152|NCT00467831|9271910|P1|Overall Study|Death|2
2688153|NCT00467779|9271929|P15|Stage 3|Unspecified Reason|5
2688154|NCT00467779|9271930|P14|Stage 3|Unspecified Reason|0
2688155|NCT00467779|9271931|P13|Stage 3|Unspecified Reason|0
2688156|NCT00467779|9271932|P12|Stage 3|Unspecified Reason|0
2688157|NCT00467779|9271933|P11|Stage 3|Unspecified Reason|0
2688158|NCT00467779|9271934|P10|Stage 3|Unspecified Reason|0
2688159|NCT00467779|9271935|P9|Stage 3|Unspecified Reason|0
2688160|NCT00467779|9271936|P8|Stage 3|Unspecified Reason|0
2688161|NCT00467779|9271937|P7|Stage 3|Unspecified Reason|0
2688162|NCT00467779|9271938|P6|Stage 3|Unspecified Reason|0
2688163|NCT00467779|9271939|P5|Stage 3|Unspecified Reason|0
2688164|NCT00467779|9271940|P4|Stage 3|Unspecified Reason|0
2688165|NCT00467779|9271941|P3|Stage 3|Unspecified Reason|0
2688166|NCT00467779|9271942|P2|Stage 3|Unspecified Reason|0
2688167|NCT00467779|9271943|P1|Stage 3|Unspecified Reason|0
2688168|NCT00467779|9271929|P15|Stage 3|Disease Progression|9
2688169|NCT00467779|9271930|P14|Stage 3|Disease Progression|0
2688170|NCT00467779|9271931|P13|Stage 3|Disease Progression|0
2688171|NCT00467779|9271932|P12|Stage 3|Disease Progression|0
2688172|NCT00467779|9271933|P11|Stage 3|Disease Progression|0
2688173|NCT00467779|9271934|P10|Stage 3|Disease Progression|0
2688174|NCT00467779|9271935|P9|Stage 3|Disease Progression|0
2688175|NCT00467779|9271936|P8|Stage 3|Disease Progression|0
2688176|NCT00467779|9271937|P7|Stage 3|Disease Progression|0
2688177|NCT00467779|9271938|P6|Stage 3|Disease Progression|0
2688178|NCT00467779|9271939|P5|Stage 3|Disease Progression|0
2688179|NCT00467779|9271940|P4|Stage 3|Disease Progression|0
2688180|NCT00467779|9271941|P3|Stage 3|Disease Progression|0
2688181|NCT00467779|9271942|P2|Stage 3|Disease Progression|0
2688182|NCT00467779|9271943|P1|Stage 3|Disease Progression|0
2688183|NCT00467779|9271929|P15|Stage 3|Death|1
2688184|NCT00467779|9271930|P14|Stage 3|Death|0
2688185|NCT00467779|9271931|P13|Stage 3|Death|0
2688186|NCT00467779|9271932|P12|Stage 3|Death|0
2688187|NCT00467779|9271933|P11|Stage 3|Death|0
2688188|NCT00467779|9271934|P10|Stage 3|Death|0
2688189|NCT00467779|9271935|P9|Stage 3|Death|0
2688190|NCT00467779|9271936|P8|Stage 3|Death|0
2688191|NCT00467779|9271937|P7|Stage 3|Death|0
2688192|NCT00467779|9271938|P6|Stage 3|Death|0
2688193|NCT00467779|9271939|P5|Stage 3|Death|0
2688194|NCT00467779|9271940|P4|Stage 3|Death|0
2688195|NCT00467779|9271941|P3|Stage 3|Death|0
2688196|NCT00467779|9271942|P2|Stage 3|Death|0
2688197|NCT00467779|9271943|P1|Stage 3|Death|0
2688198|NCT00467779|9271929|P15|Stage 3|Adverse Event|2
2688199|NCT00467779|9271930|P14|Stage 3|Adverse Event|0
2688200|NCT00467779|9271931|P13|Stage 3|Adverse Event|0
2688201|NCT00467779|9271932|P12|Stage 3|Adverse Event|0
2688202|NCT00467779|9271933|P11|Stage 3|Adverse Event|0
2688203|NCT00467779|9271934|P10|Stage 3|Adverse Event|0
2688204|NCT00467779|9271935|P9|Stage 3|Adverse Event|0
2688205|NCT00467779|9271936|P8|Stage 3|Adverse Event|0
2688206|NCT00467779|9271937|P7|Stage 3|Adverse Event|0
2688207|NCT00467779|9271938|P6|Stage 3|Adverse Event|0
2688208|NCT00467779|9271939|P5|Stage 3|Adverse Event|0
2688209|NCT00467779|9271940|P4|Stage 3|Adverse Event|0
2688210|NCT00467779|9271941|P3|Stage 3|Adverse Event|0
2688211|NCT00467779|9271942|P2|Stage 3|Adverse Event|0
2688212|NCT00467779|9271943|P1|Stage 3|Adverse Event|0
2688213|NCT00467779|9271929|P15|Stage 2A|Withdrawal by Subject|0
2688214|NCT00467779|9271930|P14|Stage 2A|Withdrawal by Subject|1
2688215|NCT00467779|9271931|P13|Stage 2A|Withdrawal by Subject|0
2688216|NCT00467779|9271932|P12|Stage 2A|Withdrawal by Subject|0
2688217|NCT00467779|9271933|P11|Stage 2A|Withdrawal by Subject|0
2688218|NCT00467779|9271934|P10|Stage 2A|Withdrawal by Subject|0
2688219|NCT00467779|9271935|P9|Stage 2A|Withdrawal by Subject|0
2688220|NCT00467779|9271936|P8|Stage 2A|Withdrawal by Subject|0
2688221|NCT00467779|9271937|P7|Stage 2A|Withdrawal by Subject|0
2688222|NCT00467779|9271938|P6|Stage 2A|Withdrawal by Subject|0
2688223|NCT00467779|9271939|P5|Stage 2A|Withdrawal by Subject|0
2688224|NCT00467779|9271940|P4|Stage 2A|Withdrawal by Subject|0
2688225|NCT00467779|9271941|P3|Stage 2A|Withdrawal by Subject|0
2688226|NCT00467779|9271942|P2|Stage 2A|Withdrawal by Subject|0
2688227|NCT00467779|9271943|P1|Stage 2A|Withdrawal by Subject|0
2688228|NCT00467779|9271929|P15|Stage 2A|Unspecified Reason|0
2688229|NCT00467779|9271930|P14|Stage 2A|Unspecified Reason|7
2688230|NCT00467779|9271931|P13|Stage 2A|Unspecified Reason|0
2688231|NCT00467779|9271932|P12|Stage 2A|Unspecified Reason|0
2688232|NCT00467779|9271933|P11|Stage 2A|Unspecified Reason|0
2688233|NCT00467779|9271934|P10|Stage 2A|Unspecified Reason|0
2688234|NCT00467779|9271935|P9|Stage 2A|Unspecified Reason|0
2688235|NCT00467779|9271936|P8|Stage 2A|Unspecified Reason|0
2688236|NCT00467779|9271937|P7|Stage 2A|Unspecified Reason|0
2688237|NCT00467779|9271938|P6|Stage 2A|Unspecified Reason|0
2688238|NCT00467779|9271939|P5|Stage 2A|Unspecified Reason|0
2688239|NCT00467779|9271940|P4|Stage 2A|Unspecified Reason|0
2688240|NCT00467779|9271941|P3|Stage 2A|Unspecified Reason|0
2688241|NCT00467779|9271942|P2|Stage 2A|Unspecified Reason|0
2688242|NCT00467779|9271943|P1|Stage 2A|Unspecified Reason|0
2688243|NCT00467779|9271929|P15|Stage 2A|Disease Progression|0
2688244|NCT00467779|9271930|P14|Stage 2A|Disease Progression|10
2688245|NCT00467779|9271931|P13|Stage 2A|Disease Progression|0
2688246|NCT00467779|9271932|P12|Stage 2A|Disease Progression|0
2688247|NCT00467779|9271933|P11|Stage 2A|Disease Progression|0
2688248|NCT00467779|9271934|P10|Stage 2A|Disease Progression|0
2688249|NCT00467779|9271935|P9|Stage 2A|Disease Progression|0
2688250|NCT00467779|9271936|P8|Stage 2A|Disease Progression|0
2688251|NCT00467779|9271937|P7|Stage 2A|Disease Progression|0
2688252|NCT00467779|9271938|P6|Stage 2A|Disease Progression|0
2688253|NCT00467779|9271939|P5|Stage 2A|Disease Progression|0
2688254|NCT00467779|9271940|P4|Stage 2A|Disease Progression|0
2688255|NCT00467779|9271941|P3|Stage 2A|Disease Progression|0
2688256|NCT00467779|9271942|P2|Stage 2A|Disease Progression|0
2688257|NCT00467779|9271943|P1|Stage 2A|Disease Progression|0
2688258|NCT00467779|9271929|P15|Stage 2A|Death|0
2688259|NCT00467779|9271930|P14|Stage 2A|Death|1
2688260|NCT00467779|9271931|P13|Stage 2A|Death|0
2688261|NCT00467779|9271932|P12|Stage 2A|Death|0
2688262|NCT00467779|9271933|P11|Stage 2A|Death|0
2688263|NCT00467779|9271934|P10|Stage 2A|Death|0
2688264|NCT00467779|9271935|P9|Stage 2A|Death|0
2688265|NCT00467779|9271936|P8|Stage 2A|Death|0
2688266|NCT00467779|9271937|P7|Stage 2A|Death|0
2688267|NCT00467779|9271938|P6|Stage 2A|Death|0
2688268|NCT00467779|9271939|P5|Stage 2A|Death|0
2688269|NCT00467779|9271940|P4|Stage 2A|Death|0
2688270|NCT00467779|9271941|P3|Stage 2A|Death|0
2688271|NCT00467779|9271942|P2|Stage 2A|Death|0
2688272|NCT00467779|9271943|P1|Stage 2A|Death|0
2688273|NCT00467779|9271929|P15|Stage 2A|Adverse Event|0
2688274|NCT00467779|9271930|P14|Stage 2A|Adverse Event|2
2688275|NCT00467779|9271931|P13|Stage 2A|Adverse Event|0
2688276|NCT00467779|9271932|P12|Stage 2A|Adverse Event|0
2688277|NCT00467779|9271933|P11|Stage 2A|Adverse Event|0
2688278|NCT00467779|9271934|P10|Stage 2A|Adverse Event|0
2688279|NCT00467779|9271935|P9|Stage 2A|Adverse Event|0
2688280|NCT00467779|9271936|P8|Stage 2A|Adverse Event|0
2688281|NCT00467779|9271937|P7|Stage 2A|Adverse Event|0
2688282|NCT00467779|9271938|P6|Stage 2A|Adverse Event|0
2688283|NCT00467779|9271939|P5|Stage 2A|Adverse Event|0
2688284|NCT00467779|9271940|P4|Stage 2A|Adverse Event|0
2688285|NCT00467779|9271941|P3|Stage 2A|Adverse Event|0
2688286|NCT00467779|9271942|P2|Stage 2A|Adverse Event|0
2688287|NCT00467779|9271943|P1|Stage 2A|Adverse Event|0
2688288|NCT00467779|9271929|P15|Stage 2|Unspecified Reason|0
2688289|NCT00467779|9271930|P14|Stage 2|Unspecified Reason|0
2688290|NCT00467779|9271931|P13|Stage 2|Unspecified Reason|0
2688291|NCT00467779|9271932|P12|Stage 2|Unspecified Reason|0
2688292|NCT00467779|9271933|P11|Stage 2|Unspecified Reason|0
2688293|NCT00467779|9271934|P10|Stage 2|Unspecified Reason|0
2688294|NCT00467779|9271935|P9|Stage 2|Unspecified Reason|3
2688295|NCT00467779|9271936|P8|Stage 2|Unspecified Reason|0
2688296|NCT00467779|9271937|P7|Stage 2|Unspecified Reason|0
2688297|NCT00467779|9271938|P6|Stage 2|Unspecified Reason|0
2688298|NCT00467779|9271939|P5|Stage 2|Unspecified Reason|0
2688299|NCT00467779|9271940|P4|Stage 2|Unspecified Reason|0
2688300|NCT00467779|9271941|P3|Stage 2|Unspecified Reason|0
2688301|NCT00467779|9271942|P2|Stage 2|Unspecified Reason|0
2688302|NCT00467779|9271943|P1|Stage 2|Unspecified Reason|0
2688303|NCT00467779|9271929|P15|Stage 2|Disease Progression|0
2688304|NCT00467779|9271930|P14|Stage 2|Disease Progression|0
2688305|NCT00467779|9271931|P13|Stage 2|Disease Progression|0
2688306|NCT00467779|9271932|P12|Stage 2|Disease Progression|0
2688307|NCT00467779|9271933|P11|Stage 2|Disease Progression|0
2688308|NCT00467779|9271934|P10|Stage 2|Disease Progression|0
2688309|NCT00467779|9271935|P9|Stage 2|Disease Progression|16
2688310|NCT00467779|9271936|P8|Stage 2|Disease Progression|0
2688311|NCT00467779|9271937|P7|Stage 2|Disease Progression|0
2688312|NCT00467779|9271938|P6|Stage 2|Disease Progression|0
2688313|NCT00467779|9271939|P5|Stage 2|Disease Progression|0
2688314|NCT00467779|9271940|P4|Stage 2|Disease Progression|0
2688315|NCT00467779|9271941|P3|Stage 2|Disease Progression|0
2688316|NCT00467779|9271942|P2|Stage 2|Disease Progression|0
2688317|NCT00467779|9271943|P1|Stage 2|Disease Progression|0
2688318|NCT00467779|9271929|P15|Stage 2|Death|0
2688319|NCT00467779|9271930|P14|Stage 2|Death|0
2688320|NCT00467779|9271931|P13|Stage 2|Death|0
2688321|NCT00467779|9271932|P12|Stage 2|Death|0
2688322|NCT00467779|9271933|P11|Stage 2|Death|0
2688323|NCT00467779|9271934|P10|Stage 2|Death|0
2688324|NCT00467779|9271935|P9|Stage 2|Death|1
2688325|NCT00467779|9271936|P8|Stage 2|Death|0
2688326|NCT00467779|9271937|P7|Stage 2|Death|0
2688327|NCT00467779|9271938|P6|Stage 2|Death|0
2688328|NCT00467779|9271939|P5|Stage 2|Death|0
2688329|NCT00467779|9271940|P4|Stage 2|Death|0
2688330|NCT00467779|9271941|P3|Stage 2|Death|0
2688331|NCT00467779|9271942|P2|Stage 2|Death|0
2688332|NCT00467779|9271943|P1|Stage 2|Death|0
2688333|NCT00467779|9271929|P15|Stage 2|Adverse Event|0
2688334|NCT00467779|9271930|P14|Stage 2|Adverse Event|0
2688335|NCT00467779|9271931|P13|Stage 2|Adverse Event|0
2688336|NCT00467779|9271932|P12|Stage 2|Adverse Event|0
2688337|NCT00467779|9271933|P11|Stage 2|Adverse Event|0
2688338|NCT00467779|9271934|P10|Stage 2|Adverse Event|0
2688339|NCT00467779|9271935|P9|Stage 2|Adverse Event|1
2688340|NCT00467779|9271936|P8|Stage 2|Adverse Event|0
2688341|NCT00467779|9271937|P7|Stage 2|Adverse Event|0
2688342|NCT00467779|9271938|P6|Stage 2|Adverse Event|0
2688343|NCT00467779|9271939|P5|Stage 2|Adverse Event|0
2688344|NCT00467779|9271940|P4|Stage 2|Adverse Event|0
2688345|NCT00467779|9271941|P3|Stage 2|Adverse Event|0
2688346|NCT00467779|9271942|P2|Stage 2|Adverse Event|0
2688347|NCT00467779|9271943|P1|Stage 2|Adverse Event|0
2688348|NCT00467779|9271929|P15|Stage 1A|Unspecified Reason|0
2688349|NCT00467779|9271930|P14|Stage 1A|Unspecified Reason|0
2688350|NCT00467779|9271931|P13|Stage 1A|Unspecified Reason|1
2688351|NCT00467779|9271932|P12|Stage 1A|Unspecified Reason|1
2688352|NCT00467779|9271933|P11|Stage 1A|Unspecified Reason|0
2688353|NCT00467779|9271934|P10|Stage 1A|Unspecified Reason|0
2688354|NCT00467779|9271935|P9|Stage 1A|Unspecified Reason|0
2688355|NCT00467779|9271936|P8|Stage 1A|Unspecified Reason|0
2688356|NCT00467779|9271937|P7|Stage 1A|Unspecified Reason|0
2688357|NCT00467779|9271938|P6|Stage 1A|Unspecified Reason|0
2688358|NCT00467779|9271939|P5|Stage 1A|Unspecified Reason|0
2688359|NCT00467779|9271940|P4|Stage 1A|Unspecified Reason|0
2688360|NCT00467779|9271941|P3|Stage 1A|Unspecified Reason|0
2688361|NCT00467779|9271942|P2|Stage 1A|Unspecified Reason|0
2688362|NCT00467779|9271943|P1|Stage 1A|Unspecified Reason|0
2688363|NCT00467779|9271929|P15|Stage 1A|Withdrawal by Subject|0
2688364|NCT00467779|9271930|P14|Stage 1A|Withdrawal by Subject|0
2688365|NCT00467779|9271931|P13|Stage 1A|Withdrawal by Subject|1
2688366|NCT00467779|9271932|P12|Stage 1A|Withdrawal by Subject|1
2688367|NCT00467779|9271933|P11|Stage 1A|Withdrawal by Subject|1
2688368|NCT00467779|9271934|P10|Stage 1A|Withdrawal by Subject|0
2688369|NCT00467779|9271935|P9|Stage 1A|Withdrawal by Subject|0
2688370|NCT00467779|9271936|P8|Stage 1A|Withdrawal by Subject|0
2688371|NCT00467779|9271937|P7|Stage 1A|Withdrawal by Subject|0
2688372|NCT00467779|9271938|P6|Stage 1A|Withdrawal by Subject|0
2688373|NCT00467779|9271939|P5|Stage 1A|Withdrawal by Subject|0
2688374|NCT00467779|9271940|P4|Stage 1A|Withdrawal by Subject|0
2688375|NCT00467779|9271941|P3|Stage 1A|Withdrawal by Subject|0
2688376|NCT00467779|9271942|P2|Stage 1A|Withdrawal by Subject|0
2688377|NCT00467779|9271943|P1|Stage 1A|Withdrawal by Subject|0
2688378|NCT00467779|9271929|P15|Stage 1A|Physician Decision|0
2688379|NCT00467779|9271930|P14|Stage 1A|Physician Decision|0
2688380|NCT00467779|9271931|P13|Stage 1A|Physician Decision|0
2688381|NCT00467779|9271932|P12|Stage 1A|Physician Decision|0
2688382|NCT00467779|9271933|P11|Stage 1A|Physician Decision|0
2688383|NCT00467779|9271934|P10|Stage 1A|Physician Decision|1
2688384|NCT00467779|9271935|P9|Stage 1A|Physician Decision|0
2688385|NCT00467779|9271936|P8|Stage 1A|Physician Decision|0
2688386|NCT00467779|9271937|P7|Stage 1A|Physician Decision|0
2688387|NCT00467779|9271938|P6|Stage 1A|Physician Decision|0
2688388|NCT00467779|9271939|P5|Stage 1A|Physician Decision|0
2688389|NCT00467779|9271940|P4|Stage 1A|Physician Decision|0
2688390|NCT00467779|9271941|P3|Stage 1A|Physician Decision|0
2688391|NCT00467779|9271942|P2|Stage 1A|Physician Decision|0
2688392|NCT00467779|9271943|P1|Stage 1A|Physician Decision|0
2688393|NCT00467779|9271929|P15|Stage 1A|Disease Progression|0
2688394|NCT00467779|9271930|P14|Stage 1A|Disease Progression|0
2688395|NCT00467779|9271931|P13|Stage 1A|Disease Progression|2
2688396|NCT00467779|9271932|P12|Stage 1A|Disease Progression|5
2688397|NCT00467779|9271933|P11|Stage 1A|Disease Progression|2
2688398|NCT00467779|9271934|P10|Stage 1A|Disease Progression|2
2688399|NCT00467779|9271935|P9|Stage 1A|Disease Progression|0
2688400|NCT00467779|9271936|P8|Stage 1A|Disease Progression|0
2688401|NCT00467779|9271937|P7|Stage 1A|Disease Progression|0
2688402|NCT00467779|9271938|P6|Stage 1A|Disease Progression|0
2688403|NCT00467779|9271939|P5|Stage 1A|Disease Progression|0
2688404|NCT00467779|9271940|P4|Stage 1A|Disease Progression|0
2688405|NCT00467779|9271941|P3|Stage 1A|Disease Progression|0
2688406|NCT00467779|9271942|P2|Stage 1A|Disease Progression|0
2688407|NCT00467779|9271943|P1|Stage 1A|Disease Progression|0
2688408|NCT00467779|9271929|P15|Stage 1A|Death|0
2688409|NCT00467779|9271930|P14|Stage 1A|Death|0
2688410|NCT00467779|9271931|P13|Stage 1A|Death|1
2688411|NCT00467779|9271932|P12|Stage 1A|Death|1
2688412|NCT00467779|9271933|P11|Stage 1A|Death|0
2688413|NCT00467779|9271934|P10|Stage 1A|Death|0
2688414|NCT00467779|9271935|P9|Stage 1A|Death|0
2688415|NCT00467779|9271936|P8|Stage 1A|Death|0
2688416|NCT00467779|9271937|P7|Stage 1A|Death|0
2688417|NCT00467779|9271938|P6|Stage 1A|Death|0
2688418|NCT00467779|9271939|P5|Stage 1A|Death|0
2688419|NCT00467779|9271940|P4|Stage 1A|Death|0
2688420|NCT00467779|9271941|P3|Stage 1A|Death|0
2688421|NCT00467779|9271942|P2|Stage 1A|Death|0
2688422|NCT00467779|9271943|P1|Stage 1A|Death|0
2688423|NCT00467779|9271929|P15|Stage 1A|Adverse Event|0
2688424|NCT00467779|9271930|P14|Stage 1A|Adverse Event|0
2688425|NCT00467779|9271931|P13|Stage 1A|Adverse Event|1
2688426|NCT00467779|9271932|P12|Stage 1A|Adverse Event|0
2688427|NCT00467779|9271933|P11|Stage 1A|Adverse Event|0
2688428|NCT00467779|9271934|P10|Stage 1A|Adverse Event|0
2688429|NCT00467779|9271935|P9|Stage 1A|Adverse Event|0
2688430|NCT00467779|9271936|P8|Stage 1A|Adverse Event|0
2688431|NCT00467779|9271937|P7|Stage 1A|Adverse Event|0
2688432|NCT00467779|9271938|P6|Stage 1A|Adverse Event|0
2688433|NCT00467779|9271939|P5|Stage 1A|Adverse Event|0
2688434|NCT00467779|9271940|P4|Stage 1A|Adverse Event|0
2688435|NCT00467779|9271941|P3|Stage 1A|Adverse Event|0
2688436|NCT00467779|9271942|P2|Stage 1A|Adverse Event|0
2688437|NCT00467779|9271943|P1|Stage 1A|Adverse Event|0
2688438|NCT00467779|9271929|P15|Stage 1|Withdrawal by Subject|0
2688439|NCT00467779|9271930|P14|Stage 1|Withdrawal by Subject|0
2688440|NCT00467779|9271931|P13|Stage 1|Withdrawal by Subject|0
2688441|NCT00467779|9271932|P12|Stage 1|Withdrawal by Subject|0
2688442|NCT00467779|9271933|P11|Stage 1|Withdrawal by Subject|0
2688443|NCT00467779|9271934|P10|Stage 1|Withdrawal by Subject|0
2688444|NCT00467779|9271935|P9|Stage 1|Withdrawal by Subject|0
2688445|NCT00467779|9271936|P8|Stage 1|Withdrawal by Subject|1
2688446|NCT00467779|9271937|P7|Stage 1|Withdrawal by Subject|1
2688447|NCT00467779|9271938|P6|Stage 1|Withdrawal by Subject|0
2688448|NCT00467779|9271939|P5|Stage 1|Withdrawal by Subject|0
2688449|NCT00467779|9271940|P4|Stage 1|Withdrawal by Subject|0
2688450|NCT00467779|9271941|P3|Stage 1|Withdrawal by Subject|0
2688451|NCT00467779|9271942|P2|Stage 1|Withdrawal by Subject|0
2688452|NCT00467779|9271943|P1|Stage 1|Withdrawal by Subject|0
2688453|NCT00467779|9271929|P15|Stage 1|Physician Decision|0
2688454|NCT00467779|9271930|P14|Stage 1|Physician Decision|0
2688455|NCT00467779|9271931|P13|Stage 1|Physician Decision|0
2688456|NCT00467779|9271932|P12|Stage 1|Physician Decision|0
2688457|NCT00467779|9271933|P11|Stage 1|Physician Decision|0
2688458|NCT00467779|9271934|P10|Stage 1|Physician Decision|0
2688459|NCT00467779|9271935|P9|Stage 1|Physician Decision|0
2688460|NCT00467779|9271936|P8|Stage 1|Physician Decision|0
2688461|NCT00467779|9271937|P7|Stage 1|Physician Decision|0
2688462|NCT00467779|9271938|P6|Stage 1|Physician Decision|0
2688463|NCT00467779|9271939|P5|Stage 1|Physician Decision|0
2688464|NCT00467779|9271940|P4|Stage 1|Physician Decision|0
2688465|NCT00467779|9271941|P3|Stage 1|Physician Decision|0
2688466|NCT00467779|9271942|P2|Stage 1|Physician Decision|1
2688467|NCT00467779|9271943|P1|Stage 1|Physician Decision|0
2688468|NCT00467779|9271929|P15|Stage 1|Unspecified Reason|0
2688469|NCT00467779|9271930|P14|Stage 1|Unspecified Reason|0
2688470|NCT00467779|9271931|P13|Stage 1|Unspecified Reason|0
2688471|NCT00467779|9271932|P12|Stage 1|Unspecified Reason|0
2688472|NCT00467779|9271933|P11|Stage 1|Unspecified Reason|0
2688473|NCT00467779|9271934|P10|Stage 1|Unspecified Reason|0
2688474|NCT00467779|9271935|P9|Stage 1|Unspecified Reason|0
2688475|NCT00467779|9271936|P8|Stage 1|Unspecified Reason|0
2688476|NCT00467779|9271937|P7|Stage 1|Unspecified Reason|0
2688477|NCT00467779|9271938|P6|Stage 1|Unspecified Reason|2
2688478|NCT00467779|9271939|P5|Stage 1|Unspecified Reason|1
2688479|NCT00467779|9271940|P4|Stage 1|Unspecified Reason|0
2688480|NCT00467779|9271941|P3|Stage 1|Unspecified Reason|1
2688481|NCT00467779|9271942|P2|Stage 1|Unspecified Reason|0
2688482|NCT00467779|9271943|P1|Stage 1|Unspecified Reason|1
2688483|NCT00467779|9271929|P15|Stage 1|Disease Progression|0
2688484|NCT00467779|9271930|P14|Stage 1|Disease Progression|0
2688485|NCT00467779|9271931|P13|Stage 1|Disease Progression|0
2688486|NCT00467779|9271932|P12|Stage 1|Disease Progression|0
2688487|NCT00467779|9271933|P11|Stage 1|Disease Progression|0
2688488|NCT00467779|9271934|P10|Stage 1|Disease Progression|0
2688489|NCT00467779|9271935|P9|Stage 1|Disease Progression|0
2688490|NCT00467779|9271936|P8|Stage 1|Disease Progression|5
2688491|NCT00467779|9271937|P7|Stage 1|Disease Progression|4
2688492|NCT00467779|9271938|P6|Stage 1|Disease Progression|2
2688493|NCT00467779|9271939|P5|Stage 1|Disease Progression|2
2688494|NCT00467779|9271940|P4|Stage 1|Disease Progression|3
2688495|NCT00467779|9271941|P3|Stage 1|Disease Progression|2
2688496|NCT00467779|9271942|P2|Stage 1|Disease Progression|2
2688497|NCT00467779|9271943|P1|Stage 1|Disease Progression|2
2688498|NCT00467779|9271929|P15|Stage 1|Adverse Event|0
2688499|NCT00467779|9271930|P14|Stage 1|Adverse Event|0
2688500|NCT00467779|9271931|P13|Stage 1|Adverse Event|0
2688501|NCT00467779|9271932|P12|Stage 1|Adverse Event|0
2688502|NCT00467779|9271933|P11|Stage 1|Adverse Event|0
2688503|NCT00467779|9271934|P10|Stage 1|Adverse Event|0
2688504|NCT00467779|9271935|P9|Stage 1|Adverse Event|0
2688505|NCT00467779|9271936|P8|Stage 1|Adverse Event|1
2688506|NCT00467779|9271937|P7|Stage 1|Adverse Event|2
2688507|NCT00467779|9271938|P6|Stage 1|Adverse Event|1
2688508|NCT00467779|9271939|P5|Stage 1|Adverse Event|0
2688509|NCT00467779|9271940|P4|Stage 1|Adverse Event|0
2688510|NCT00467779|9271941|P3|Stage 1|Adverse Event|0
2688511|NCT00467779|9271942|P2|Stage 1|Adverse Event|0
2688512|NCT00467779|9271943|P1|Stage 1|Adverse Event|1
2688513|NCT00467753|9272117|P2|Overall Study|Adverse Event|0
2688514|NCT00467753|9272118|P1|Overall Study|Adverse Event|2
2688515|NCT00467753|9272117|P2|Overall Study|Lost to Follow-up|2
2688516|NCT00467753|9272118|P1|Overall Study|Lost to Follow-up|1
2688517|NCT00467740|9272129|P5|Overall Study|Lack of Efficacy|0
2688518|NCT00467740|9272130|P4|Overall Study|Lack of Efficacy|0
2688519|NCT00467740|9272131|P3|Overall Study|Lack of Efficacy|0
2688520|NCT00467740|9272132|P2|Overall Study|Lack of Efficacy|1
2688521|NCT00467740|9272133|P1|Overall Study|Lack of Efficacy|0
2688522|NCT00467740|9272129|P5|Overall Study|Withdrawal by Subject|0
2688523|NCT00467740|9272130|P4|Overall Study|Withdrawal by Subject|1
2688524|NCT00467740|9272131|P3|Overall Study|Withdrawal by Subject|0
2688525|NCT00467740|9272132|P2|Overall Study|Withdrawal by Subject|1
2688526|NCT00467740|9272133|P1|Overall Study|Withdrawal by Subject|1
2688527|NCT00467740|9272129|P5|Overall Study|Lost to Follow-up|0
2688528|NCT00467740|9272130|P4|Overall Study|Lost to Follow-up|0
2688529|NCT00467740|9272131|P3|Overall Study|Lost to Follow-up|0
2688530|NCT00467740|9272132|P2|Overall Study|Lost to Follow-up|1
2688531|NCT00467740|9272133|P1|Overall Study|Lost to Follow-up|0
2688532|NCT00467740|9272129|P5|Overall Study|Protocol Violation|0
2688533|NCT00467740|9272130|P4|Overall Study|Protocol Violation|0
2688534|NCT00467740|9272131|P3|Overall Study|Protocol Violation|1
2688535|NCT00467740|9272132|P2|Overall Study|Protocol Violation|0
2688536|NCT00467740|9272133|P1|Overall Study|Protocol Violation|0
2688537|NCT00467740|9272129|P5|Overall Study|Adverse Event|0
2688538|NCT00467740|9272130|P4|Overall Study|Adverse Event|0
2688539|NCT00467740|9272131|P3|Overall Study|Adverse Event|1
2688540|NCT00467740|9272132|P2|Overall Study|Adverse Event|0
2688541|NCT00467740|9272133|P1|Overall Study|Adverse Event|0
2688542|NCT00467649|9272322|P6|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1
2688543|NCT00467649|9272323|P5|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
2688544|NCT00467649|9272324|P4|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
2688545|NCT00467649|9272325|P3|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
2688546|NCT00467649|9272326|P2|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
2688547|NCT00467649|9272327|P1|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
2688548|NCT00467649|9272322|P6|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
2688549|NCT00467649|9272323|P5|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
2688550|NCT00467649|9272324|P4|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1
2688551|NCT00467649|9272325|P3|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
2688552|NCT00467649|9272326|P2|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
2688553|NCT00467649|9272327|P1|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
2688554|NCT00467649|9272322|P6|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
2688555|NCT00467649|9272323|P5|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
2688556|NCT00467649|9272324|P4|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1
2688557|NCT00467649|9272325|P3|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
2688558|NCT00467649|9272326|P2|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
2688559|NCT00467649|9272327|P1|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
2688560|NCT00467649|9272322|P6|Phase 1 (Randomized Population)|Withdrawal of Consent|0
2688561|NCT00467649|9272323|P5|Phase 1 (Randomized Population)|Withdrawal of Consent|0
2688562|NCT00467649|9272324|P4|Phase 1 (Randomized Population)|Withdrawal of Consent|0
2688563|NCT00467649|9272325|P3|Phase 1 (Randomized Population)|Withdrawal of Consent|0
2688564|NCT00467649|9272326|P2|Phase 1 (Randomized Population)|Withdrawal of Consent|2
2688565|NCT00467649|9272327|P1|Phase 1 (Randomized Population)|Withdrawal of Consent|4
2688566|NCT00467649|9272322|P6|Phase 1 (Randomized Population)|Lost to Follow-up|0
2688567|NCT00467649|9272323|P5|Phase 1 (Randomized Population)|Lost to Follow-up|0
2688568|NCT00467649|9272324|P4|Phase 1 (Randomized Population)|Lost to Follow-up|0
2688569|NCT00467649|9272325|P3|Phase 1 (Randomized Population)|Lost to Follow-up|0
2688570|NCT00467649|9272326|P2|Phase 1 (Randomized Population)|Lost to Follow-up|4
2688571|NCT00467649|9272327|P1|Phase 1 (Randomized Population)|Lost to Follow-up|2
2688572|NCT00467649|9272322|P6|Phase 1 (Randomized Population)|Investigator Decision|0
2688573|NCT00467649|9272323|P5|Phase 1 (Randomized Population)|Investigator Decision|0
2688574|NCT00467649|9272324|P4|Phase 1 (Randomized Population)|Investigator Decision|0
2688575|NCT00467649|9272325|P3|Phase 1 (Randomized Population)|Investigator Decision|0
2688576|NCT00467649|9272326|P2|Phase 1 (Randomized Population)|Investigator Decision|0
2688577|NCT00467649|9272327|P1|Phase 1 (Randomized Population)|Investigator Decision|1
2688578|NCT00467649|9272322|P6|Phase 1 (Randomized Population)|Adverse Event|0
2688579|NCT00467649|9272323|P5|Phase 1 (Randomized Population)|Adverse Event|0
2688580|NCT00467649|9272324|P4|Phase 1 (Randomized Population)|Adverse Event|0
2688581|NCT00467649|9272325|P3|Phase 1 (Randomized Population)|Adverse Event|0
2688582|NCT00467649|9272326|P2|Phase 1 (Randomized Population)|Adverse Event|0
2688583|NCT00467649|9272327|P1|Phase 1 (Randomized Population)|Adverse Event|2
2688584|NCT00467610|9272367|P1|Overall Study|Withdrawal by Subject|1
2688585|NCT00467597|9272378|P2|Overall Study|Withdrawal by Subject|0
2688586|NCT00467597|9272379|P1|Overall Study|Withdrawal by Subject|2
2688587|NCT00467584|9272392|P3|Overall Study|Withdrawal by Subject|1
2688588|NCT00467584|9272393|P2|Overall Study|Withdrawal by Subject|5
2688589|NCT00467584|9272394|P1|Overall Study|Withdrawal by Subject|4
2688590|NCT00467558|9272404|P2|Overall Study|Lost to Follow-up|0
2688591|NCT00467558|9272405|P1|Overall Study|Lost to Follow-up|2
2688592|NCT00467519|9272415|P2|Overall Study|Withdrawal by Subject|10
2688593|NCT00467519|9272416|P1|Overall Study|Withdrawal by Subject|4
2688594|NCT00467519|9272415|P2|Overall Study|Lost to Follow-up|9
2688595|NCT00467519|9272416|P1|Overall Study|Lost to Follow-up|2
2688596|NCT00467519|9272415|P2|Overall Study|Protocol Violation|4
2688597|NCT00467519|9272416|P1|Overall Study|Protocol Violation|8
2688598|NCT00467363|9272445|P2|Overall Study|Lost to Follow-up|70
2688599|NCT00467363|9272446|P1|Overall Study|Lost to Follow-up|80
2688600|NCT00467285|9272493|P2|Overall Study|Lost to Follow-up|4
2688601|NCT00467285|9272494|P1|Overall Study|Lost to Follow-up|4
2688602|NCT00467259|9272514|P2|Overall Study|Site Closed|1
2688603|NCT00467259|9272515|P1|Overall Study|Site Closed|2
2688604|NCT00467259|9272514|P2|Overall Study|Lost to Follow-up|34
2688605|NCT00467259|9272515|P1|Overall Study|Lost to Follow-up|14
2688606|NCT00467259|9272514|P2|Overall Study|Physician Decision|2
2688607|NCT00467259|9272515|P1|Overall Study|Physician Decision|0
2688608|NCT00467259|9272514|P2|Overall Study|Withdrawal by Subject|108
2688609|NCT00467259|9272515|P1|Overall Study|Withdrawal by Subject|34
2688610|NCT00467259|9272514|P2|Overall Study|Protocol Violation|7
2688611|NCT00467259|9272515|P1|Overall Study|Protocol Violation|1
2688612|NCT00467259|9272514|P2|Overall Study|Adverse Event|90
2688613|NCT00467259|9272515|P1|Overall Study|Adverse Event|24
2688614|NCT00467051|9272532|P1|Overall Study|Adverse Event|2
2688615|NCT00466947|9272559|P2|Study End Analysis Period|Other – Unconformity in team’s treatment|1
2688616|NCT00466947|9272560|P1|Study End Analysis Period|Other – Unconformity in team’s treatment|0
2688617|NCT00466947|9272559|P2|Study End Analysis Period|Other – Subject without a legal guardian|0
2688618|NCT00466947|9272560|P1|Study End Analysis Period|Other – Subject without a legal guardian|1
2688619|NCT00466947|9272559|P2|Study End Analysis Period|Other – Forbidden vaccination|10
2688620|NCT00466947|9272560|P1|Study End Analysis Period|Other – Forbidden vaccination|21
2688621|NCT00466947|9272559|P2|Study End Analysis Period|Withdrawal by Subject|1267
2688622|NCT00466947|9272560|P1|Study End Analysis Period|Withdrawal by Subject|1264
2688623|NCT00466947|9272559|P2|Study End Analysis Period|Protocol Violation|17
2688624|NCT00466947|9272560|P1|Study End Analysis Period|Protocol Violation|9
2688625|NCT00466947|9272559|P2|Study End Analysis Period|Physician Decision|29
2688626|NCT00466947|9272560|P1|Study End Analysis Period|Physician Decision|29
2688627|NCT00466947|9272559|P2|Study End Analysis Period|Lost to Follow-up|1167
2688628|NCT00466947|9272560|P1|Study End Analysis Period|Lost to Follow-up|1137
2688629|NCT00466947|9272559|P2|Study End Analysis Period|Adverse Event|43
2688630|NCT00466947|9272560|P1|Study End Analysis Period|Adverse Event|35
2688631|NCT00466947|9272559|P2|Primary Outcome Analysis Period|Other: study still ongoing|11863
2688632|NCT00466947|9272560|P1|Primary Outcome Analysis Period|Other: study still ongoing|11875
2688633|NCT00466726|9272751|P1|Overall Study|Not evaluable for response|14
2688634|NCT00466687|9272757|P1|Overall Study|Disease progression|29
2688635|NCT00466687|9272757|P1|Overall Study|Withdrawal by Subject|1
2688636|NCT00466687|9272757|P1|Overall Study|Other complicating illness|3
2688637|NCT00466687|9272757|P1|Overall Study|Adverse Event|1
2688638|NCT00466505|9272789|P1|Overall Study|Adverse Event|4
2688639|NCT00466505|9272789|P1|Overall Study|disease progression|13
2688640|NCT00466193|9272839|P2|Overall Study|Patient refused Visit 4 procedures|0
2688641|NCT00466193|9272840|P1|Overall Study|Patient refused Visit 4 procedures|1
2688642|NCT00466193|9272839|P2|Overall Study|Withdrawal by Subject|2
2688643|NCT00466193|9272840|P1|Overall Study|Withdrawal by Subject|7
2688644|NCT00466193|9272839|P2|Overall Study|Protocol Violation|1
2688645|NCT00466193|9272840|P1|Overall Study|Protocol Violation|1
2688646|NCT00466193|9272839|P2|Overall Study|Physician Decision|0
2688647|NCT00466193|9272840|P1|Overall Study|Physician Decision|1
2688648|NCT00466193|9272839|P2|Overall Study|Lost to Follow-up|4
2688649|NCT00466193|9272840|P1|Overall Study|Lost to Follow-up|2
2688650|NCT00466193|9272839|P2|Overall Study|Adverse Event|1
2688651|NCT00466193|9272840|P1|Overall Study|Adverse Event|0
2688652|NCT00466167|9272867|P3|Overall Study|Not treated|0
2688653|NCT00466167|9272868|P2|Overall Study|Not treated|0
2688654|NCT00466167|9272869|P1|Overall Study|Not treated|1
2688655|NCT00466167|9272867|P3|Overall Study|patient did not meet inclusion criteria|1
2688656|NCT00466167|9272868|P2|Overall Study|patient did not meet inclusion criteria|0
2688657|NCT00466167|9272869|P1|Overall Study|patient did not meet inclusion criteria|1
2688658|NCT00466167|9272867|P3|Overall Study|Withdrawal by Subject|6
2688659|NCT00466167|9272868|P2|Overall Study|Withdrawal by Subject|1
2688660|NCT00466167|9272869|P1|Overall Study|Withdrawal by Subject|4
2688661|NCT00466167|9272867|P3|Overall Study|Lost to Follow-up|2
2688662|NCT00466167|9272868|P2|Overall Study|Lost to Follow-up|2
2688663|NCT00466167|9272869|P1|Overall Study|Lost to Follow-up|3
2688664|NCT00466167|9272867|P3|Overall Study|Protocol Violation|2
2688665|NCT00466167|9272868|P2|Overall Study|Protocol Violation|1
2688666|NCT00466167|9272869|P1|Overall Study|Protocol Violation|1
2688667|NCT00466167|9272867|P3|Overall Study|Lack of Efficacy|3
2688668|NCT00466167|9272868|P2|Overall Study|Lack of Efficacy|0
2688669|NCT00466167|9272869|P1|Overall Study|Lack of Efficacy|2
2688670|NCT00466167|9272867|P3|Overall Study|Adverse Event|7
2688671|NCT00466167|9272868|P2|Overall Study|Adverse Event|8
2688672|NCT00466167|9272869|P1|Overall Study|Adverse Event|8
2688673|NCT00465985|9272930|P2|Part III - Open-label Treatment Period|Adverse Event|0
2688674|NCT00465985|9272931|P1|Part III - Open-label Treatment Period|Adverse Event|1
2688675|NCT00465985|9272930|P2|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
2688676|NCT00465985|9272931|P1|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1
2688677|NCT00465985|9272930|P2|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12
2688678|NCT00465985|9272931|P1|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0
2688679|NCT00465985|9272930|P2|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
2688680|NCT00465985|9272931|P1|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4
2688681|NCT00465972|9272954|P2|Overall Study|Withdrawal by Subject|1
2688682|NCT00465972|9272955|P1|Overall Study|Withdrawal by Subject|2
2688683|NCT00465894|9272965|P2|Treatment For 12 Weeks|Withdrawal by Subject|1
2688684|NCT00465894|9272966|P1|Treatment For 12 Weeks|Withdrawal by Subject|0
2688685|NCT00465894|9272965|P2|Treatment For 12 Weeks|Family Issues|1
2688686|NCT00465894|9272966|P1|Treatment For 12 Weeks|Family Issues|1
2688687|NCT00465894|9272965|P2|Treatment For 12 Weeks|Lost to Follow-up|1
2688688|NCT00465894|9272966|P1|Treatment For 12 Weeks|Lost to Follow-up|4
2688689|NCT00465816|9272999|P3|Overall Study|Lost to Follow-up|2
2688690|NCT00465816|9273000|P2|Overall Study|Lost to Follow-up|0
2688691|NCT00465816|9273001|P1|Overall Study|Lost to Follow-up|0
2688692|NCT00465738|9273064|P2|Overall Study|Other|5
2688693|NCT00465738|9273065|P1|Overall Study|Other|2
2688694|NCT00465738|9273064|P2|Overall Study|Withdrawal by Subject|0
2688695|NCT00465738|9273065|P1|Overall Study|Withdrawal by Subject|2
2688696|NCT00465738|9273064|P2|Overall Study|Adverse Event|1
2688697|NCT00465738|9273065|P1|Overall Study|Adverse Event|0
2688698|NCT00465738|9273064|P2|Overall Study|Lost to Follow-up|0
2688699|NCT00465738|9273065|P1|Overall Study|Lost to Follow-up|2
2688700|NCT00465647|9273159|P4|Overall Study|"The other reasons included loss of IV"|2
2688701|NCT00465647|9273160|P3|Overall Study|"The other reasons included loss of IV"|3
2688702|NCT00465647|9273161|P2|Overall Study|"The other reasons included loss of IV"|4
2688703|NCT00465647|9273162|P1|Overall Study|"The other reasons included loss of IV"|8
2688704|NCT00465647|9273159|P4|Overall Study|Withdrawal by Subject|7
2688705|NCT00465647|9273160|P3|Overall Study|Withdrawal by Subject|2
2688706|NCT00465647|9273161|P2|Overall Study|Withdrawal by Subject|2
2688707|NCT00465647|9273162|P1|Overall Study|Withdrawal by Subject|1
2688708|NCT00465647|9273159|P4|Overall Study|Adverse Event|2
2688709|NCT00465647|9273160|P3|Overall Study|Adverse Event|3
2688710|NCT00465647|9273161|P2|Overall Study|Adverse Event|0
2688711|NCT00465647|9273162|P1|Overall Study|Adverse Event|2
2688712|NCT00465647|9273159|P4|Overall Study|Administrative|2
2688713|NCT00465647|9273160|P3|Overall Study|Administrative|3
2688714|NCT00465647|9273161|P2|Overall Study|Administrative|2
2688715|NCT00465647|9273162|P1|Overall Study|Administrative|2
2688716|NCT00465569|9273210|P2|Overall Study|persistent eczema during dose escalation|0
2688717|NCT00465569|9273211|P1|Overall Study|persistent eczema during dose escalation|1
2688718|NCT00465361|9273234|P1|Baseline Assessment|Personal Issues/Scheduling|4
2688719|NCT00465270|9273240|P2|Overall Study|Investigator request|4
2688720|NCT00465270|9273241|P1|Overall Study|Investigator request|3
2688721|NCT00465270|9273240|P2|Overall Study|Lost to Follow-up|67
2688722|NCT00465270|9273241|P1|Overall Study|Lost to Follow-up|60
2688723|NCT00465270|9273240|P2|Overall Study|Withdrawal by Subject|78
2688724|NCT00465270|9273241|P1|Overall Study|Withdrawal by Subject|34
2688725|NCT00465270|9273240|P2|Overall Study|Death|11
2688726|NCT00465270|9273241|P1|Overall Study|Death|7
2688727|NCT00465179|9273250|P1|Overall Study|Progression of Disease|47
2688728|NCT00465179|9273250|P1|Overall Study|Withdrawal by Subject|2
2688729|NCT00465179|9273250|P1|Overall Study|Adverse Event|4
2688730|NCT00465101|9273256|P1|Overall Study|Withdrew consent prior to procedure|3
2688731|NCT00465101|9273256|P1|Overall Study|Physician Decision|1
2688732|NCT00465101|9273256|P1|Overall Study|Withdrawal by Subject|25
2688733|NCT00465101|9273256|P1|Overall Study|Death|3
2688734|NCT00465101|9273256|P1|Overall Study|Unable to obtain IRB approval|1
2688735|NCT00465101|9273256|P1|Overall Study|Site closed due to IRB expiration|1
2688736|NCT00465101|9273256|P1|Overall Study|Patient postponed procedure|1
2688737|NCT00465101|9273256|P1|Overall Study|Pt. Insurance not accepted at center|2
2688738|NCT00465101|9273256|P1|Overall Study|Other|6
2688739|NCT00465101|9273256|P1|Overall Study|Lost to Follow-up|5
2688740|NCT00465101|9273256|P1|Overall Study|Did not meet study criteria|4
2688741|NCT00465101|9273256|P1|Overall Study|Change in health precluded follow up|4
2688742|NCT00465101|9273256|P1|Overall Study|Aborted Proc./Treatment Not Attempted|3
2688743|NCT00464945|9273326|P2|Toddler Dose|Lost to Follow-up|1
2688744|NCT00464945|9273327|P1|Toddler Dose|Lost to Follow-up|0
2688745|NCT00464945|9273326|P2|After Infant Series|Withdrawal by Subject|2
2688746|NCT00464945|9273327|P1|After Infant Series|Withdrawal by Subject|0
2688747|NCT00464945|9273326|P2|Infant Series|Lost to Follow-up|0
2688748|NCT00464945|9273327|P1|Infant Series|Lost to Follow-up|1
2688749|NCT00464945|9273326|P2|Infant Series|Protocol Violation|0
2688750|NCT00464945|9273327|P1|Infant Series|Protocol Violation|1
2688751|NCT00464945|9273326|P2|Infant Series|Withdrawal by parent/guardian request|1
2688752|NCT00464945|9273327|P1|Infant Series|Withdrawal by parent/guardian request|2
2688753|NCT00464815|9273357|P2|Overall Study|Withdrawal by Subject|3
2688754|NCT00464815|9273358|P1|Overall Study|Withdrawal by Subject|6
2688755|NCT00464737|9273391|P3|Overall Study|Other: Subject's disability per sponsor|1
2688756|NCT00464737|9273392|P2|Overall Study|Other: Subject's disability per sponsor|0
2688757|NCT00464737|9273393|P1|Overall Study|Other: Subject's disability per sponsor|0
2688758|NCT00464737|9273391|P3|Overall Study|Other: Personal family reasons|1
2688759|NCT00464737|9273392|P2|Overall Study|Other: Personal family reasons|0
2688760|NCT00464737|9273393|P1|Overall Study|Other: Personal family reasons|0
2688761|NCT00464737|9273391|P3|Overall Study|Other: Study demands too great|0
2688762|NCT00464737|9273392|P2|Overall Study|Other: Study demands too great|1
2688763|NCT00464737|9273393|P1|Overall Study|Other: Study demands too great|0
2688764|NCT00464737|9273391|P3|Overall Study|Other: Subject left town; family illness|0
2688765|NCT00464737|9273392|P2|Overall Study|Other: Subject left town; family illness|0
2688766|NCT00464737|9273393|P1|Overall Study|Other: Subject left town; family illness|1
2688767|NCT00464737|9273391|P3|Overall Study|Other: Subject's schedule doesn't permit|0
2688768|NCT00464737|9273392|P2|Overall Study|Other: Subject's schedule doesn't permit|0
2688769|NCT00464737|9273393|P1|Overall Study|Other: Subject's schedule doesn't permit|1
2688770|NCT00464737|9273391|P3|Overall Study|Lost to Follow-up|5
2688771|NCT00464737|9273392|P2|Overall Study|Lost to Follow-up|2
2688772|NCT00464737|9273393|P1|Overall Study|Lost to Follow-up|5
2688773|NCT00464737|9273391|P3|Overall Study|Non-compliance|1
2688774|NCT00464737|9273392|P2|Overall Study|Non-compliance|1
2688775|NCT00464737|9273393|P1|Overall Study|Non-compliance|0
2688776|NCT00464737|9273391|P3|Overall Study|Protocol Violation|5
2688777|NCT00464737|9273392|P2|Overall Study|Protocol Violation|1
2688778|NCT00464737|9273393|P1|Overall Study|Protocol Violation|1
2688779|NCT00464737|9273391|P3|Overall Study|Withdrawal by Subject|5
2688780|NCT00464737|9273392|P2|Overall Study|Withdrawal by Subject|3
2688781|NCT00464737|9273393|P1|Overall Study|Withdrawal by Subject|5
2688782|NCT00464737|9273391|P3|Overall Study|Lack of Efficacy|4
2688783|NCT00464737|9273392|P2|Overall Study|Lack of Efficacy|7
2688784|NCT00464737|9273393|P1|Overall Study|Lack of Efficacy|7
2688785|NCT00464737|9273391|P3|Overall Study|Adverse Event|33
2688786|NCT00464737|9273392|P2|Overall Study|Adverse Event|17
2688787|NCT00464737|9273393|P1|Overall Study|Adverse Event|12
2688788|NCT00464672|9273473|P6|Overall Study|Lost to Follow-up|0
2688789|NCT00464672|9273474|P5|Overall Study|Lost to Follow-up|1
2688790|NCT00464672|9273475|P4|Overall Study|Lost to Follow-up|0
2688791|NCT00464672|9273476|P3|Overall Study|Lost to Follow-up|0
2688792|NCT00464672|9273477|P2|Overall Study|Lost to Follow-up|10
2688793|NCT00464672|9273478|P1|Overall Study|Lost to Follow-up|25
2688794|NCT00464672|9273473|P6|Overall Study|withdrawal of consent|4
2688795|NCT00464672|9273474|P5|Overall Study|withdrawal of consent|9
2688796|NCT00464672|9273475|P4|Overall Study|withdrawal of consent|1
2688797|NCT00464672|9273476|P3|Overall Study|withdrawal of consent|0
2688798|NCT00464672|9273477|P2|Overall Study|withdrawal of consent|0
2688799|NCT00464672|9273478|P1|Overall Study|withdrawal of consent|0
2688800|NCT00464620|9273557|P3|Overall Study|Use of prohibited concomitant medication|2
2688801|NCT00464620|9273558|P2|Overall Study|Use of prohibited concomitant medication|0
2688802|NCT00464620|9273559|P1|Overall Study|Use of prohibited concomitant medication|0
2688803|NCT00464620|9273557|P3|Overall Study|Ineligible sarcoma subtype|2
2688804|NCT00464620|9273558|P2|Overall Study|Ineligible sarcoma subtype|2
2688805|NCT00464620|9273559|P1|Overall Study|Ineligible sarcoma subtype|0
2688806|NCT00464620|9273557|P3|Overall Study|Withdrawal by Subject|3
2688807|NCT00464620|9273558|P2|Overall Study|Withdrawal by Subject|0
2688808|NCT00464620|9273559|P1|Overall Study|Withdrawal by Subject|1
2688809|NCT00464620|9273557|P3|Overall Study|Physician Decision|0
2688810|NCT00464620|9273558|P2|Overall Study|Physician Decision|0
2688811|NCT00464620|9273559|P1|Overall Study|Physician Decision|1
2688812|NCT00464568|9273586|P1|Overall Study|Adverse Event|2
2688813|NCT00464542|9273659|P1|Pre-treatment|Withdrawal by Subject|2
2688814|NCT00464490|9273666|P2|Overall Study|Physician Decision|11
2688815|NCT00464490|9273667|P1|Overall Study|Physician Decision|11
2688816|NCT00464334|9273714|P11|Overall Study|Withdrawal by Subject|0
2688817|NCT00464334|9273715|P10|Overall Study|Withdrawal by Subject|0
2688818|NCT00464334|9273716|P9|Overall Study|Withdrawal by Subject|3
2688819|NCT00464334|9273717|P8|Overall Study|Withdrawal by Subject|1
2688820|NCT00464334|9273718|P7|Overall Study|Withdrawal by Subject|2
2688821|NCT00464334|9273719|P6|Overall Study|Withdrawal by Subject|2
2688822|NCT00464334|9273720|P5|Overall Study|Withdrawal by Subject|2
2688823|NCT00464334|9273721|P4|Overall Study|Withdrawal by Subject|2
2688824|NCT00464334|9273722|P3|Overall Study|Withdrawal by Subject|4
2688825|NCT00464334|9273723|P2|Overall Study|Withdrawal by Subject|7
2688826|NCT00464334|9273724|P1|Overall Study|Withdrawal by Subject|1
2688827|NCT00464334|9273714|P11|Overall Study|Study Terminated by Sponsor|0
2688828|NCT00464334|9273715|P10|Overall Study|Study Terminated by Sponsor|0
2688829|NCT00464334|9273716|P9|Overall Study|Study Terminated by Sponsor|0
2688830|NCT00464334|9273717|P8|Overall Study|Study Terminated by Sponsor|0
2688831|NCT00464334|9273718|P7|Overall Study|Study Terminated by Sponsor|0
2688832|NCT00464334|9273719|P6|Overall Study|Study Terminated by Sponsor|0
2688833|NCT00464334|9273720|P5|Overall Study|Study Terminated by Sponsor|0
2688834|NCT00464334|9273721|P4|Overall Study|Study Terminated by Sponsor|1
2688835|NCT00464334|9273722|P3|Overall Study|Study Terminated by Sponsor|0
2688836|NCT00464334|9273723|P2|Overall Study|Study Terminated by Sponsor|0
2688837|NCT00464334|9273724|P1|Overall Study|Study Terminated by Sponsor|0
2688838|NCT00464334|9273714|P11|Overall Study|Progressive Disease|0
2688839|NCT00464334|9273715|P10|Overall Study|Progressive Disease|0
2688840|NCT00464334|9273716|P9|Overall Study|Progressive Disease|1
2688841|NCT00464334|9273717|P8|Overall Study|Progressive Disease|0
2688842|NCT00464334|9273718|P7|Overall Study|Progressive Disease|0
2688843|NCT00464334|9273719|P6|Overall Study|Progressive Disease|1
2688844|NCT00464334|9273720|P5|Overall Study|Progressive Disease|0
2688845|NCT00464334|9273721|P4|Overall Study|Progressive Disease|0
2688846|NCT00464334|9273722|P3|Overall Study|Progressive Disease|0
2688847|NCT00464334|9273723|P2|Overall Study|Progressive Disease|0
2688848|NCT00464334|9273724|P1|Overall Study|Progressive Disease|0
2688849|NCT00464334|9273714|P11|Overall Study|Lost to Follow-up|2
2688850|NCT00464334|9273715|P10|Overall Study|Lost to Follow-up|0
2688851|NCT00464334|9273716|P9|Overall Study|Lost to Follow-up|0
2688852|NCT00464334|9273717|P8|Overall Study|Lost to Follow-up|0
2688853|NCT00464334|9273718|P7|Overall Study|Lost to Follow-up|1
2688854|NCT00464334|9273719|P6|Overall Study|Lost to Follow-up|0
2688855|NCT00464334|9273720|P5|Overall Study|Lost to Follow-up|1
2688856|NCT00464334|9273721|P4|Overall Study|Lost to Follow-up|0
2688857|NCT00464334|9273722|P3|Overall Study|Lost to Follow-up|1
2688858|NCT00464334|9273723|P2|Overall Study|Lost to Follow-up|0
2688859|NCT00464334|9273724|P1|Overall Study|Lost to Follow-up|0
2688860|NCT00464334|9273714|P11|Overall Study|Lack of Efficacy|0
2688861|NCT00464334|9273715|P10|Overall Study|Lack of Efficacy|0
2688862|NCT00464334|9273716|P9|Overall Study|Lack of Efficacy|0
2688863|NCT00464334|9273717|P8|Overall Study|Lack of Efficacy|0
2688864|NCT00464334|9273718|P7|Overall Study|Lack of Efficacy|0
2688865|NCT00464334|9273719|P6|Overall Study|Lack of Efficacy|0
2688866|NCT00464334|9273720|P5|Overall Study|Lack of Efficacy|0
2688867|NCT00464334|9273721|P4|Overall Study|Lack of Efficacy|0
2688868|NCT00464334|9273722|P3|Overall Study|Lack of Efficacy|0
2688869|NCT00464334|9273723|P2|Overall Study|Lack of Efficacy|1
2688870|NCT00464334|9273724|P1|Overall Study|Lack of Efficacy|0
2688871|NCT00464334|9273714|P11|Overall Study|Adverse Event|2
2688872|NCT00464334|9273715|P10|Overall Study|Adverse Event|1
2688873|NCT00464334|9273716|P9|Overall Study|Adverse Event|2
2688874|NCT00464334|9273717|P8|Overall Study|Adverse Event|0
2688875|NCT00464334|9273718|P7|Overall Study|Adverse Event|0
2688876|NCT00464334|9273719|P6|Overall Study|Adverse Event|1
2688877|NCT00464334|9273720|P5|Overall Study|Adverse Event|1
2688878|NCT00464334|9273721|P4|Overall Study|Adverse Event|1
2688879|NCT00464334|9273722|P3|Overall Study|Adverse Event|0
2688880|NCT00464334|9273723|P2|Overall Study|Adverse Event|0
2688881|NCT00464334|9273724|P1|Overall Study|Adverse Event|0
2688882|NCT00464308|9273784|P3|Overall Study|Physician Decision|0
2688883|NCT00464308|9273785|P2|Overall Study|Physician Decision|0
2688884|NCT00464308|9273786|P1|Overall Study|Physician Decision|1
2688885|NCT00464308|9273784|P3|Overall Study|Patient discontinued and other reasons|23
2688886|NCT00464308|9273785|P2|Overall Study|Patient discontinued and other reasons|17
2688887|NCT00464308|9273786|P1|Overall Study|Patient discontinued and other reasons|17
2688888|NCT00464308|9273784|P3|Overall Study|Lost to Follow-up|20
2688889|NCT00464308|9273785|P2|Overall Study|Lost to Follow-up|19
2688890|NCT00464308|9273786|P1|Overall Study|Lost to Follow-up|29
2688891|NCT00464308|9273784|P3|Overall Study|Adverse Event|16
2688892|NCT00464308|9273785|P2|Overall Study|Adverse Event|27
2688893|NCT00464308|9273786|P1|Overall Study|Adverse Event|22
2688894|NCT00464269|9273816|P4|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
2688895|NCT00464269|9273817|P3|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
2688896|NCT00464269|9273818|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
2688897|NCT00464269|9273819|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
2688898|NCT00464269|9273816|P4|Overall Study|AE, non-serious non-fatal|4
2688899|NCT00464269|9273817|P3|Overall Study|AE, non-serious non-fatal|3
2688900|NCT00464269|9273818|P2|Overall Study|AE, non-serious non-fatal|8
2688901|NCT00464269|9273819|P1|Overall Study|AE, non-serious non-fatal|2
2688902|NCT00464269|9273816|P4|Overall Study|SAE, non-fatal|1
2688903|NCT00464269|9273817|P3|Overall Study|SAE, non-fatal|0
2688904|NCT00464269|9273818|P2|Overall Study|SAE, non-fatal|0
2688905|NCT00464269|9273819|P1|Overall Study|SAE, non-fatal|0
2688906|NCT00464269|9273816|P4|Overall Study|AE, serious fatal|1
2688907|NCT00464269|9273817|P3|Overall Study|AE, serious fatal|1
2688908|NCT00464269|9273818|P2|Overall Study|AE, serious fatal|0
2688909|NCT00464269|9273819|P1|Overall Study|AE, serious fatal|0
2688910|NCT00464269|9273816|P4|Overall Study|Other reason|1
2688911|NCT00464269|9273817|P3|Overall Study|Other reason|1
2688912|NCT00464269|9273818|P2|Overall Study|Other reason|3
2688913|NCT00464269|9273819|P1|Overall Study|Other reason|3
2688914|NCT00464269|9273816|P4|Overall Study|Withdrawal by Subject|1
2688915|NCT00464269|9273817|P3|Overall Study|Withdrawal by Subject|1
2688916|NCT00464269|9273818|P2|Overall Study|Withdrawal by Subject|2
2688917|NCT00464269|9273819|P1|Overall Study|Withdrawal by Subject|0
2688918|NCT00464269|9273816|P4|Overall Study|Lost to Follow-up|1
2688919|NCT00464269|9273817|P3|Overall Study|Lost to Follow-up|0
2688920|NCT00464269|9273818|P2|Overall Study|Lost to Follow-up|4
2688921|NCT00464269|9273819|P1|Overall Study|Lost to Follow-up|0
2688922|NCT00464269|9273816|P4|Overall Study|Lack of Efficacy|0
2688923|NCT00464269|9273817|P3|Overall Study|Lack of Efficacy|0
2688924|NCT00464269|9273818|P2|Overall Study|Lack of Efficacy|0
2688925|NCT00464269|9273819|P1|Overall Study|Lack of Efficacy|1
2688926|NCT00464087|9273957|P3|Overall Study|No PCI per inclusion criteria|29
2688927|NCT00464087|9273958|P2|Overall Study|No PCI per inclusion criteria|0
2688928|NCT00464087|9273959|P1|Overall Study|No PCI per inclusion criteria|0
2688929|NCT00463866|9273977|P2|Overall Study|Other|22
2688930|NCT00463866|9273978|P1|Overall Study|Other|22
2688931|NCT00463866|9273977|P2|Overall Study|Mis-Randomization of subject|1
2688932|NCT00463866|9273978|P1|Overall Study|Mis-Randomization of subject|0
2688933|NCT00463866|9273977|P2|Overall Study|Safety Reason|3
2688934|NCT00463866|9273978|P1|Overall Study|Safety Reason|1
2688935|NCT00463866|9273977|P2|Overall Study|Severe Non-Compliance to Protocol|21
2688936|NCT00463866|9273978|P1|Overall Study|Severe Non-Compliance to Protocol|25
2688937|NCT00463866|9273977|P2|Overall Study|Incorrect Enrolment|66
2688938|NCT00463866|9273978|P1|Overall Study|Incorrect Enrolment|64
2688939|NCT00463866|9273977|P2|Overall Study|Lost to Follow-up|55
2688940|NCT00463866|9273978|P1|Overall Study|Lost to Follow-up|46
2688941|NCT00463866|9273977|P2|Overall Study|Withdrawal by Subject|79
2688942|NCT00463866|9273978|P1|Overall Study|Withdrawal by Subject|81
2688943|NCT00463866|9273977|P2|Overall Study|Adverse Event|93
2688944|NCT00463866|9273978|P1|Overall Study|Adverse Event|70
2688945|NCT00463840|9273998|P1|Overall Study|Adverse Event|3
2688946|NCT00463840|9273998|P1|Overall Study|Withdrawal by Subject|2
2688947|NCT00463840|9273998|P1|Overall Study|Disease progression|7
2688948|NCT00463801|9274003|P1|Overall Study|No longer require therapy|1
2688949|NCT00463801|9274003|P1|Overall Study|Lost to Follow-up|5
2688950|NCT00463801|9274003|P1|Overall Study|Adverse Event|4
2688951|NCT00463801|9274003|P1|Overall Study|Lack of Efficacy|2
2688952|NCT00463801|9274003|P1|Overall Study|Protocol Violation|1
2688953|NCT00463788|9274009|P2|Overall Study|Randomized but not treated|1
2688954|NCT00463788|9274010|P1|Overall Study|Randomized but not treated|1
2688955|NCT00463788|9274009|P2|Overall Study|Other|0
2688956|NCT00463788|9274010|P1|Overall Study|Other|3
2688957|NCT00463788|9274009|P2|Overall Study|Protocol Violation|1
2688958|NCT00463788|9274010|P1|Overall Study|Protocol Violation|0
2688959|NCT00463788|9274009|P2|Overall Study|Lost to Follow-up|0
2688960|NCT00463788|9274010|P1|Overall Study|Lost to Follow-up|1
2688961|NCT00463788|9274009|P2|Overall Study|Symptomatic Deterioration|3
2688962|NCT00463788|9274010|P1|Overall Study|Symptomatic Deterioration|2
2688963|NCT00463788|9274009|P2|Overall Study|Death|3
2688964|NCT00463788|9274010|P1|Overall Study|Death|4
2688965|NCT00463788|9274009|P2|Overall Study|Withdrawal by Subject|2
2688966|NCT00463788|9274010|P1|Overall Study|Withdrawal by Subject|6
2688967|NCT00463788|9274009|P2|Overall Study|Adverse Event|2
2688968|NCT00463788|9274010|P1|Overall Study|Adverse Event|6
2688969|NCT00463788|9274009|P2|Overall Study|Progressive Disease|42
2688970|NCT00463788|9274010|P1|Overall Study|Progressive Disease|86
2688971|NCT00463684|9274025|P1|Overall Study|Lost to Follow-up|3
2688972|NCT00463684|9274025|P1|Overall Study|Withdrawal by Subject|1
2688973|NCT00463606|9274043|P3|Overall Study|Protocol Violation|1
2688974|NCT00463606|9274044|P2|Overall Study|Protocol Violation|0
2688975|NCT00463606|9274045|P1|Overall Study|Protocol Violation|0
2688976|NCT00463606|9274043|P3|Overall Study|Participation in another ABT-335 trial|0
2688977|NCT00463606|9274044|P2|Overall Study|Participation in another ABT-335 trial|0
2688978|NCT00463606|9274045|P1|Overall Study|Participation in another ABT-335 trial|1
2688979|NCT00463606|9274043|P3|Overall Study|Patient randomized in error|0
2688980|NCT00463606|9274044|P2|Overall Study|Patient randomized in error|0
2688981|NCT00463606|9274045|P1|Overall Study|Patient randomized in error|1
2688982|NCT00463606|9274043|P3|Overall Study|Coordinator error|0
2688983|NCT00463606|9274044|P2|Overall Study|Coordinator error|0
2688984|NCT00463606|9274045|P1|Overall Study|Coordinator error|1
2688985|NCT00463606|9274043|P3|Overall Study|Exclusion criteria violation|0
2688986|NCT00463606|9274044|P2|Overall Study|Exclusion criteria violation|0
2688987|NCT00463606|9274045|P1|Overall Study|Exclusion criteria violation|2
2688988|NCT00463606|9274043|P3|Overall Study|Sponsor request|0
2688989|NCT00463606|9274044|P2|Overall Study|Sponsor request|1
2688990|NCT00463606|9274045|P1|Overall Study|Sponsor request|0
2688991|NCT00463606|9274043|P3|Overall Study|Physician Decision|0
2688992|NCT00463606|9274044|P2|Overall Study|Physician Decision|1
2688993|NCT00463606|9274045|P1|Overall Study|Physician Decision|0
2688994|NCT00463606|9274043|P3|Overall Study|Subject moved out of town|0
2688995|NCT00463606|9274044|P2|Overall Study|Subject moved out of town|0
2688996|NCT00463606|9274045|P1|Overall Study|Subject moved out of town|1
2688997|NCT00463606|9274043|P3|Overall Study|Subject noncompliance|0
2688998|NCT00463606|9274044|P2|Overall Study|Subject noncompliance|1
2688999|NCT00463606|9274045|P1|Overall Study|Subject noncompliance|1
2689000|NCT00463606|9274043|P3|Overall Study|Lost to Follow-up|3
2689001|NCT00463606|9274044|P2|Overall Study|Lost to Follow-up|2
2689002|NCT00463606|9274045|P1|Overall Study|Lost to Follow-up|2
2689003|NCT00463606|9274043|P3|Overall Study|Withdrawal by Subject|5
2689004|NCT00463606|9274044|P2|Overall Study|Withdrawal by Subject|11
2689005|NCT00463606|9274045|P1|Overall Study|Withdrawal by Subject|11
2689006|NCT00463606|9274043|P3|Overall Study|Adverse Event|11
2689007|NCT00463606|9274044|P2|Overall Study|Adverse Event|18
2689008|NCT00463606|9274045|P1|Overall Study|Adverse Event|21
2689009|NCT00463580|9274070|P2|Overall Study|Medical/psychiatric complications|2
2689010|NCT00463580|9274071|P1|Overall Study|Medical/psychiatric complications|0
2689011|NCT00463580|9274070|P2|Overall Study|Schedule conflict|0
2689012|NCT00463580|9274071|P1|Overall Study|Schedule conflict|2
2689013|NCT00463580|9274070|P2|Overall Study|Lost to Follow-up|0
2689014|NCT00463580|9274071|P1|Overall Study|Lost to Follow-up|1
2689015|NCT00463567|9274104|P7|Overall Study|Death|0
2689016|NCT00463567|9274105|P6|Overall Study|Death|0
2689017|NCT00463567|9274106|P5|Overall Study|Death|0
2689018|NCT00463567|9274107|P4|Overall Study|Death|0
2689019|NCT00463567|9274108|P3|Overall Study|Death|2
2689020|NCT00463567|9274109|P2|Overall Study|Death|0
2689021|NCT00463567|9274110|P1|Overall Study|Death|1
2689022|NCT00463567|9274104|P7|Overall Study|Abnormal test procedure result(s)|0
2689023|NCT00463567|9274105|P6|Overall Study|Abnormal test procedure result(s)|2
2689024|NCT00463567|9274106|P5|Overall Study|Abnormal test procedure result(s)|0
2689025|NCT00463567|9274107|P4|Overall Study|Abnormal test procedure result(s)|2
2689026|NCT00463567|9274108|P3|Overall Study|Abnormal test procedure result(s)|6
2689027|NCT00463567|9274109|P2|Overall Study|Abnormal test procedure result(s)|1
2689028|NCT00463567|9274110|P1|Overall Study|Abnormal test procedure result(s)|1
2689029|NCT00463567|9274104|P7|Overall Study|Abnormal lab value(s)|0
2689030|NCT00463567|9274105|P6|Overall Study|Abnormal lab value(s)|0
2689031|NCT00463567|9274106|P5|Overall Study|Abnormal lab value(s)|1
2689032|NCT00463567|9274107|P4|Overall Study|Abnormal lab value(s)|1
2689033|NCT00463567|9274108|P3|Overall Study|Abnormal lab value(s)|2
2689034|NCT00463567|9274109|P2|Overall Study|Abnormal lab value(s)|1
2689035|NCT00463567|9274110|P1|Overall Study|Abnormal lab value(s)|1
2689036|NCT00463567|9274104|P7|Overall Study|Lack of Efficacy|1
2689037|NCT00463567|9274105|P6|Overall Study|Lack of Efficacy|0
2689038|NCT00463567|9274106|P5|Overall Study|Lack of Efficacy|1
2689039|NCT00463567|9274107|P4|Overall Study|Lack of Efficacy|17
2689040|NCT00463567|9274108|P3|Overall Study|Lack of Efficacy|9
2689041|NCT00463567|9274109|P2|Overall Study|Lack of Efficacy|9
2689042|NCT00463567|9274110|P1|Overall Study|Lack of Efficacy|4
2689043|NCT00463567|9274104|P7|Overall Study|Administrative problems|2
2689044|NCT00463567|9274105|P6|Overall Study|Administrative problems|2
2689045|NCT00463567|9274106|P5|Overall Study|Administrative problems|3
2689046|NCT00463567|9274107|P4|Overall Study|Administrative problems|9
2689047|NCT00463567|9274108|P3|Overall Study|Administrative problems|6
2689048|NCT00463567|9274109|P2|Overall Study|Administrative problems|3
2689049|NCT00463567|9274110|P1|Overall Study|Administrative problems|5
2689050|NCT00463567|9274104|P7|Overall Study|Lost to Follow-up|1
2689051|NCT00463567|9274105|P6|Overall Study|Lost to Follow-up|1
2689052|NCT00463567|9274106|P5|Overall Study|Lost to Follow-up|1
2689053|NCT00463567|9274107|P4|Overall Study|Lost to Follow-up|8
2689054|NCT00463567|9274108|P3|Overall Study|Lost to Follow-up|13
2689055|NCT00463567|9274109|P2|Overall Study|Lost to Follow-up|6
2689056|NCT00463567|9274110|P1|Overall Study|Lost to Follow-up|12
2689057|NCT00463567|9274104|P7|Overall Study|Protocol Deviation|2
2689058|NCT00463567|9274105|P6|Overall Study|Protocol Deviation|1
2689059|NCT00463567|9274106|P5|Overall Study|Protocol Deviation|1
2689060|NCT00463567|9274107|P4|Overall Study|Protocol Deviation|11
2689061|NCT00463567|9274108|P3|Overall Study|Protocol Deviation|14
2689062|NCT00463567|9274109|P2|Overall Study|Protocol Deviation|9
2689063|NCT00463567|9274110|P1|Overall Study|Protocol Deviation|13
2689064|NCT00463567|9274104|P7|Overall Study|Withdrawal by Subject|1
2689065|NCT00463567|9274105|P6|Overall Study|Withdrawal by Subject|5
2689066|NCT00463567|9274106|P5|Overall Study|Withdrawal by Subject|6
2689067|NCT00463567|9274107|P4|Overall Study|Withdrawal by Subject|37
2689068|NCT00463567|9274108|P3|Overall Study|Withdrawal by Subject|20
2689069|NCT00463567|9274109|P2|Overall Study|Withdrawal by Subject|22
2689070|NCT00463567|9274110|P1|Overall Study|Withdrawal by Subject|29
2689071|NCT00463567|9274104|P7|Overall Study|Adverse Event|4
2689072|NCT00463567|9274105|P6|Overall Study|Adverse Event|10
2689073|NCT00463567|9274106|P5|Overall Study|Adverse Event|10
2689074|NCT00463567|9274107|P4|Overall Study|Adverse Event|46
2689075|NCT00463567|9274108|P3|Overall Study|Adverse Event|17
2689076|NCT00463567|9274109|P2|Overall Study|Adverse Event|26
2689077|NCT00463567|9274110|P1|Overall Study|Adverse Event|29
2689078|NCT00463476|9274143|P2|Overall Study|Lost to Follow-up|1
2689079|NCT00463476|9274144|P1|Overall Study|Lost to Follow-up|1
2689080|NCT00463476|9274143|P2|Overall Study|Withdrawal by Subject|2
2689081|NCT00463476|9274144|P1|Overall Study|Withdrawal by Subject|1
2689082|NCT00463385|9274233|P4|Overall Study|1 participant received commercial drug|0
2689083|NCT00463385|9274234|P3|Overall Study|1 participant received commercial drug|0
2689084|NCT00463385|9274235|P2|Overall Study|1 participant received commercial drug|1
2689085|NCT00463385|9274236|P1|Overall Study|1 participant received commercial drug|0
2689086|NCT00463385|9274233|P4|Overall Study|Missing|2
2689087|NCT00463385|9274234|P3|Overall Study|Missing|0
2689088|NCT00463385|9274235|P2|Overall Study|Missing|0
2689089|NCT00463385|9274236|P1|Overall Study|Missing|2
2689090|NCT00463385|9274233|P4|Overall Study|Death|0
2689091|NCT00463385|9274234|P3|Overall Study|Death|2
2689092|NCT00463385|9274235|P2|Overall Study|Death|1
2689093|NCT00463385|9274236|P1|Overall Study|Death|2
2689094|NCT00463385|9274233|P4|Overall Study|Lost to Follow-up|1
2689095|NCT00463385|9274234|P3|Overall Study|Lost to Follow-up|0
2689096|NCT00463385|9274235|P2|Overall Study|Lost to Follow-up|0
2689097|NCT00463385|9274236|P1|Overall Study|Lost to Follow-up|0
2689098|NCT00463385|9274233|P4|Overall Study|Withdrawal by Subject|4
2689099|NCT00463385|9274234|P3|Overall Study|Withdrawal by Subject|3
2689100|NCT00463385|9274235|P2|Overall Study|Withdrawal by Subject|3
2689101|NCT00463385|9274236|P1|Overall Study|Withdrawal by Subject|3
2689102|NCT00463385|9274233|P4|Overall Study|Lack of Efficacy|9
2689103|NCT00463385|9274234|P3|Overall Study|Lack of Efficacy|7
2689104|NCT00463385|9274235|P2|Overall Study|Lack of Efficacy|6
2689105|NCT00463385|9274236|P1|Overall Study|Lack of Efficacy|6
2689106|NCT00463385|9274233|P4|Overall Study|Adverse Event|2
2689107|NCT00463385|9274234|P3|Overall Study|Adverse Event|4
2689108|NCT00463385|9274235|P2|Overall Study|Adverse Event|8
2689109|NCT00463385|9274236|P1|Overall Study|Adverse Event|5
2689110|NCT00463385|9274233|P4|Overall Study|Other|4
2689111|NCT00463385|9274234|P3|Overall Study|Other|6
2689112|NCT00463385|9274235|P2|Overall Study|Other|3
2689113|NCT00463385|9274236|P1|Overall Study|Other|4
2689114|NCT00463346|9274288|P2|Overall Study|Withdrawal by Subject|3
2689115|NCT00463346|9274289|P1|Overall Study|Withdrawal by Subject|3
2689116|NCT00463229|9274299|P2|Overall Study|Death|3
2689117|NCT00463229|9274300|P1|Overall Study|Death|4
2689118|NCT00463229|9274299|P2|Overall Study|Lost to Follow-up|7
2689119|NCT00463229|9274300|P1|Overall Study|Lost to Follow-up|5
2689120|NCT00463060|9274320|P1|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1
2689121|NCT00463060|9274320|P1|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5
2689122|NCT00463047|9274334|P2|Double-Blind Treatment Period 2|Non-compliance with procedures|0
2689123|NCT00463047|9274335|P1|Double-Blind Treatment Period 2|Non-compliance with procedures|1
2689124|NCT00463047|9274334|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|1
2689125|NCT00463047|9274335|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
2689126|NCT00463047|9274334|P2|Double-Blind Treatment Period 2|Adverse Event|1
2689127|NCT00463047|9274335|P1|Double-Blind Treatment Period 2|Adverse Event|0
2689128|NCT00463047|9274334|P2|Double-Blind Treatment Period 1|Other|0
2689129|NCT00463047|9274335|P1|Double-Blind Treatment Period 1|Other|1
2689130|NCT00463047|9274334|P2|Double-Blind Treatment Period 1|Non-compliance with procedures|0
2689131|NCT00463047|9274335|P1|Double-Blind Treatment Period 1|Non-compliance with procedures|1
2689132|NCT00463047|9274334|P2|Double-Blind Treatment Period 1|Protocol Violation|2
2689133|NCT00463047|9274335|P1|Double-Blind Treatment Period 1|Protocol Violation|1
2689134|NCT00463047|9274334|P2|Double-Blind Treatment Period 1|Adverse Event|2
2689135|NCT00463047|9274335|P1|Double-Blind Treatment Period 1|Adverse Event|0
2689136|NCT00463047|9274334|P2|Titration Period 2|Other|2
2689137|NCT00463047|9274335|P1|Titration Period 2|Other|3
2689138|NCT00463047|9274334|P2|Titration Period 2|Non-compliance procedures|1
2689139|NCT00463047|9274335|P1|Titration Period 2|Non-compliance procedures|4
2689140|NCT00463047|9274334|P2|Titration Period 2|Non-compliance study medication|2
2689141|NCT00463047|9274335|P1|Titration Period 2|Non-compliance study medication|4
2689142|NCT00463047|9274334|P2|Titration Period 2|Lost to Follow-up|2
2689143|NCT00463047|9274335|P1|Titration Period 2|Lost to Follow-up|1
2689144|NCT00463047|9274334|P2|Titration Period 2|Protocol Violation|3
2689145|NCT00463047|9274335|P1|Titration Period 2|Protocol Violation|2
2689146|NCT00463047|9274334|P2|Titration Period 2|Withdrawal by Subject|0
2689147|NCT00463047|9274335|P1|Titration Period 2|Withdrawal by Subject|1
2689148|NCT00463047|9274334|P2|Titration Period 2|Lack of Efficacy|4
2689149|NCT00463047|9274335|P1|Titration Period 2|Lack of Efficacy|6
2689150|NCT00463047|9274334|P2|Titration Period 2|Adverse Event|9
2689151|NCT00463047|9274335|P1|Titration Period 2|Adverse Event|9
2689152|NCT00463047|9274334|P2|Titration Period 1|Other|2
2689153|NCT00463047|9274335|P1|Titration Period 1|Other|0
2689154|NCT00463047|9274334|P2|Titration Period 1|Non-compliance procedures|10
2689155|NCT00463047|9274335|P1|Titration Period 1|Non-compliance procedures|4
2689156|NCT00463047|9274334|P2|Titration Period 1|Withdrawal by Subject|5
2689157|NCT00463047|9274335|P1|Titration Period 1|Withdrawal by Subject|3
2689158|NCT00463047|9274334|P2|Titration Period 1|Protocol Violation|5
2689159|NCT00463047|9274335|P1|Titration Period 1|Protocol Violation|5
2689160|NCT00463047|9274334|P2|Titration Period 1|Non-compliance with study medication|5
2689161|NCT00463047|9274335|P1|Titration Period 1|Non-compliance with study medication|3
2689162|NCT00463047|9274334|P2|Titration Period 1|Lost to Follow-up|0
2689163|NCT00463047|9274335|P1|Titration Period 1|Lost to Follow-up|2
2689164|NCT00463047|9274334|P2|Titration Period 1|Lack of Efficacy|4
2689165|NCT00463047|9274335|P1|Titration Period 1|Lack of Efficacy|10
2689166|NCT00463047|9274334|P2|Titration Period 1|Adverse Event|8
2689167|NCT00463047|9274335|P1|Titration Period 1|Adverse Event|10
2689168|NCT00462982|9274420|P1|Overall Study|Patient Not Treated|2
2689169|NCT00462982|9274420|P1|Overall Study|Adverse Event|1
2689170|NCT00462943|9274427|P3|Overall Study|Withdrawal by Subject|0
2689171|NCT00462943|9274428|P2|Overall Study|Withdrawal by Subject|1
2689172|NCT00462943|9274429|P1|Overall Study|Withdrawal by Subject|0
2689173|NCT00462943|9274427|P3|Overall Study|Physician Decision|0
2689174|NCT00462943|9274428|P2|Overall Study|Physician Decision|0
2689175|NCT00462943|9274429|P1|Overall Study|Physician Decision|1
2689176|NCT00462943|9274427|P3|Overall Study|Transplant - not specified|1
2689177|NCT00462943|9274428|P2|Overall Study|Transplant - not specified|0
2689178|NCT00462943|9274429|P1|Overall Study|Transplant - not specified|1
2689179|NCT00462943|9274427|P3|Overall Study|Required Lymphocyte Infusion|0
2689180|NCT00462943|9274428|P2|Overall Study|Required Lymphocyte Infusion|0
2689181|NCT00462943|9274429|P1|Overall Study|Required Lymphocyte Infusion|1
2689182|NCT00462943|9274427|P3|Overall Study|Bone Marrow Transplant|0
2689183|NCT00462943|9274428|P2|Overall Study|Bone Marrow Transplant|0
2689184|NCT00462943|9274429|P1|Overall Study|Bone Marrow Transplant|1
2689185|NCT00462943|9274427|P3|Overall Study|Stem Cell Transplant|0
2689186|NCT00462943|9274428|P2|Overall Study|Stem Cell Transplant|1
2689187|NCT00462943|9274429|P1|Overall Study|Stem Cell Transplant|1
2689188|NCT00462943|9274427|P3|Overall Study|Death|7
2689189|NCT00462943|9274428|P2|Overall Study|Death|2
2689190|NCT00462943|9274429|P1|Overall Study|Death|5
2689191|NCT00462943|9274427|P3|Overall Study|Disease Progression|9
2689192|NCT00462943|9274428|P2|Overall Study|Disease Progression|15
2689193|NCT00462943|9274429|P1|Overall Study|Disease Progression|15
2689194|NCT00462943|9274427|P3|Overall Study|Request of Patient, PI, Sponsor or RA|4
2689195|NCT00462943|9274428|P2|Overall Study|Request of Patient, PI, Sponsor or RA|2
2689196|NCT00462943|9274429|P1|Overall Study|Request of Patient, PI, Sponsor or RA|8
2689197|NCT00462943|9274427|P3|Overall Study|Protocol Violation|0
2689198|NCT00462943|9274428|P2|Overall Study|Protocol Violation|0
2689199|NCT00462943|9274429|P1|Overall Study|Protocol Violation|1
2689200|NCT00462943|9274427|P3|Overall Study|Adverse Event|1
2689201|NCT00462943|9274428|P2|Overall Study|Adverse Event|4
2689202|NCT00462943|9274429|P1|Overall Study|Adverse Event|6
2689203|NCT00462943|9274427|P3|Overall Study|Failure to achieve a response|1
2689204|NCT00462943|9274428|P2|Overall Study|Failure to achieve a response|5
2689205|NCT00462943|9274429|P1|Overall Study|Failure to achieve a response|5
2689206|NCT00462904|9274521|P1|Overall Study|Lost to Follow-up|1
2689207|NCT00462865|9274526|P1|Overall Study|Adverse Event|1
2689208|NCT00462826|9274546|P1|Overall Study|Never treated|1
2689209|NCT00462826|9274546|P1|Overall Study|Ineligible - wrong primary|2
2689210|NCT00462826|9274546|P1|Overall Study|Ineligible - wrong cell type|1
2689211|NCT00462826|9274546|P1|Overall Study|Ineligible - second primary|1
2689212|NCT00462761|9274559|P1|Overall Study|Other|1
2689213|NCT00462761|9274559|P1|Overall Study|Death|12
2689214|NCT00462761|9274559|P1|Overall Study|Disease progression|43
2689215|NCT00462761|9274559|P1|Overall Study|Physician Decision|5
2689216|NCT00462761|9274559|P1|Overall Study|Withdrawal by Subject|9
2689217|NCT00462761|9274559|P1|Overall Study|Adverse Event|6
2689218|NCT00462748|9274634|P3|Overall Study|Discontinued after 41 days Rx|0
2689219|NCT00462748|9274635|P2|Overall Study|Discontinued after 41 days Rx|0
2689220|NCT00462748|9274636|P1|Overall Study|Discontinued after 41 days Rx|1
2689221|NCT00462748|9274634|P3|Overall Study|Lost to Follow-up|1
2689222|NCT00462748|9274635|P2|Overall Study|Lost to Follow-up|1
2689223|NCT00462748|9274636|P1|Overall Study|Lost to Follow-up|1
2689224|NCT00462748|9274634|P3|Overall Study|Withdrew consent|0
2689225|NCT00462748|9274635|P2|Overall Study|Withdrew consent|3
2689226|NCT00462748|9274636|P1|Overall Study|Withdrew consent|3
2689227|NCT00462748|9274634|P3|Overall Study|Protocol Violation|1
2689228|NCT00462748|9274635|P2|Overall Study|Protocol Violation|2
2689229|NCT00462748|9274636|P1|Overall Study|Protocol Violation|0
2689230|NCT00462748|9274634|P3|Overall Study|Adverse Event|9
2689231|NCT00462748|9274635|P2|Overall Study|Adverse Event|5
2689232|NCT00462748|9274636|P1|Overall Study|Adverse Event|7
2689233|NCT00462709|9274689|P1|Overall Study|Withdrew to start treatment with Cetor|1
2689234|NCT00462709|9274689|P1|Overall Study|Physician Decision|1
2689235|NCT00462709|9274689|P1|Overall Study|Logistical reasons|2
2689236|NCT00462709|9274689|P1|Overall Study|Death|2
2689237|NCT00462709|9274689|P1|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3
2689238|NCT00462709|9274689|P1|Overall Study|Withdrawal by Subject|8
2689239|NCT00462709|9274689|P1|Overall Study|Lost to Follow-up|10
2689240|NCT00462709|9274689|P1|Overall Study|Transitioned to commercial C1INH-nf|40
2689241|NCT00462670|9274698|P2|Overall Study|Resolution of signs and symptoms|2
2689242|NCT00462670|9274699|P1|Overall Study|Resolution of signs and symptoms|0
2689243|NCT00462670|9274698|P2|Overall Study|Protocol Violation|0
2689244|NCT00462670|9274699|P1|Overall Study|Protocol Violation|1
2689245|NCT00462670|9274698|P2|Overall Study|Lack of Efficacy|0
2689246|NCT00462670|9274699|P1|Overall Study|Lack of Efficacy|1
2689247|NCT00462670|9274698|P2|Overall Study|Adverse Event|5
2689248|NCT00462670|9274699|P1|Overall Study|Adverse Event|3
2689249|NCT00462501|9274736|P1|Overall Study|Adverse Event|2
2689250|NCT00462501|9274736|P1|Overall Study|Not treated|3
2689251|NCT00462462|9274742|P2|Overall Study|Physician Decision|1
2689252|NCT00462462|9274743|P1|Overall Study|Physician Decision|0
2689253|NCT00462384|9274771|P1|Overall Study|Other|4
2689254|NCT00462384|9274771|P1|Overall Study|Withdrawal by Subject|1
2689255|NCT00462384|9274771|P1|Overall Study|Death|2
2689256|NCT00462384|9274771|P1|Overall Study|Adverse Event|2
2689257|NCT00462345|9274779|P1|Overall Study|Did not complete second course|1
2689258|NCT00462345|9274779|P1|Overall Study|Withdrawal by Subject|2
2689259|NCT00462306|9274814|P2|Overall Study|insufficient data|13
2689260|NCT00462306|9274815|P1|Overall Study|insufficient data|0
2689261|NCT00461981|9274946|P2|Overall Study|Withdrawal by Subject|3
2689262|NCT00461981|9274947|P1|Overall Study|Withdrawal by Subject|2
2689263|NCT00461981|9274946|P2|Overall Study|Lost to Follow-up|6
2689264|NCT00461981|9274947|P1|Overall Study|Lost to Follow-up|9
2689265|NCT00461812|9275063|P1|Overall Study|study terminated|10
2689266|NCT00461786|9275068|P1|Overall Study|Inevaluable (Never Treated)|1
2689267|NCT00461786|9275068|P1|Overall Study|Entry Criteria Not Met|2
2689268|NCT00461708|9275113|P2|Overall Study|Death|1
2689269|NCT00461708|9275114|P1|Overall Study|Death|8
2689270|NCT00461708|9275113|P2|Overall Study|Other|4
2689271|NCT00461708|9275114|P1|Overall Study|Other|4
2689272|NCT00461708|9275113|P2|Overall Study|Withdrawal by Subject|2
2689273|NCT00461708|9275114|P1|Overall Study|Withdrawal by Subject|8
2689274|NCT00461708|9275113|P2|Overall Study|Physician Decision|4
2689275|NCT00461708|9275114|P1|Overall Study|Physician Decision|10
2689276|NCT00461708|9275113|P2|Overall Study|Lack of Efficacy|20
2689277|NCT00461708|9275114|P1|Overall Study|Lack of Efficacy|68
2689278|NCT00461708|9275113|P2|Overall Study|Adverse Event|7
2689279|NCT00461708|9275114|P1|Overall Study|Adverse Event|17
2689280|NCT00461682|9275140|P1|Overall Study|Protocol Violation|1
2689281|NCT00461630|9275168|P2|Overall Study|Lost to Follow-up|95
2689282|NCT00461630|9275169|P1|Overall Study|Lost to Follow-up|108
2689283|NCT00461630|9275168|P2|Overall Study|Death|732
2689284|NCT00461630|9275169|P1|Overall Study|Death|798
2689285|NCT00461552|9275208|P2|Overall Study|Drug Dispensing error|2
2689286|NCT00461552|9275209|P1|Overall Study|Drug Dispensing error|0
2689287|NCT00461500|9275232|P2|Overall Study|Lost to Follow-up|2
2689288|NCT00461500|9275233|P1|Overall Study|Lost to Follow-up|2
2689289|NCT00461500|9275232|P2|Overall Study|No Longer Willing to Take Part in Study|0
2689290|NCT00461500|9275233|P1|Overall Study|No Longer Willing to Take Part in Study|1
2689291|NCT00461500|9275232|P2|Overall Study|Drug Treatment Misuse|0
2689292|NCT00461500|9275233|P1|Overall Study|Drug Treatment Misuse|1
2689293|NCT00461500|9275232|P2|Overall Study|Study Stopped|2
2689294|NCT00461500|9275233|P1|Overall Study|Study Stopped|1
2689295|NCT00461500|9275232|P2|Overall Study|Expired Drug Treatment|1
2689296|NCT00461500|9275233|P1|Overall Study|Expired Drug Treatment|1
2689297|NCT00461500|9275232|P2|Overall Study|Lack of Efficacy|1
2689298|NCT00461500|9275233|P1|Overall Study|Lack of Efficacy|0
2689299|NCT00461500|9275232|P2|Overall Study|Adverse Event|0
2689300|NCT00461500|9275233|P1|Overall Study|Adverse Event|1
2689301|NCT00461305|9275276|P2|Continued Treatment|Other (missing drug etc)|0
2689302|NCT00461305|9275277|P1|Continued Treatment|Other (missing drug etc)|2
2689303|NCT00461305|9275276|P2|Continued Treatment|Partially missing diary|0
2689304|NCT00461305|9275277|P1|Continued Treatment|Partially missing diary|2
2689305|NCT00461305|9275276|P2|Continued Treatment|Withdrawal by Subject|0
2689306|NCT00461305|9275277|P1|Continued Treatment|Withdrawal by Subject|48
2689307|NCT00461305|9275276|P2|Continued Treatment|Protocol Violation|0
2689308|NCT00461305|9275277|P1|Continued Treatment|Protocol Violation|13
2689309|NCT00461305|9275276|P2|Continued Treatment|Lost to Follow-up|0
2689310|NCT00461305|9275277|P1|Continued Treatment|Lost to Follow-up|4
2689311|NCT00461305|9275276|P2|Continued Treatment|Adverse Event|0
2689312|NCT00461305|9275277|P1|Continued Treatment|Adverse Event|26
2689313|NCT00461305|9275276|P2|Treatment|Other (missing drug etc)|0
2689314|NCT00461305|9275277|P1|Treatment|Other (missing drug etc)|2
2689315|NCT00461305|9275276|P2|Treatment|Partially missing diary|0
2689316|NCT00461305|9275277|P1|Treatment|Partially missing diary|2
2689317|NCT00461305|9275276|P2|Treatment|Study drug not taken|0
2689318|NCT00461305|9275277|P1|Treatment|Study drug not taken|1
2689319|NCT00461305|9275276|P2|Treatment|Never dispensed|0
2689320|NCT00461305|9275277|P1|Treatment|Never dispensed|5
2689321|NCT00461305|9275276|P2|Treatment|Withdrawal by Subject|2
2689322|NCT00461305|9275277|P1|Treatment|Withdrawal by Subject|48
2689323|NCT00461305|9275276|P2|Treatment|Protocol Violation|2
2689324|NCT00461305|9275277|P1|Treatment|Protocol Violation|13
2689325|NCT00461305|9275276|P2|Treatment|Lost to Follow-up|2
2689326|NCT00461305|9275277|P1|Treatment|Lost to Follow-up|4
2689327|NCT00461305|9275276|P2|Treatment|Adverse Event|3
2689328|NCT00461305|9275277|P1|Treatment|Adverse Event|26
2689329|NCT00461253|9275361|P2|Overall Study|administrative|7773
2689330|NCT00461253|9275362|P1|Overall Study|administrative|773
2689331|NCT00461253|9275361|P2|Overall Study|no response|11789
2689332|NCT00461253|9275362|P1|Overall Study|no response|2609
2689333|NCT00461253|9275361|P2|Overall Study|Protocol Violation|236
2689334|NCT00461253|9275362|P1|Overall Study|Protocol Violation|613
2689335|NCT00461253|9275361|P2|Overall Study|Death|0
2689336|NCT00461253|9275362|P1|Overall Study|Death|985
2689337|NCT00461175|9275370|P2|Overall Study|Protocol Violation|365
2689338|NCT00461175|9275371|P1|Overall Study|Protocol Violation|522
2689339|NCT00461123|9275381|P2|Overall Study|Withdrawal by Subject|3
2689340|NCT00461123|9275382|P1|Overall Study|Withdrawal by Subject|1
2689341|NCT00461123|9275381|P2|Overall Study|Protocol Violation|2
2689342|NCT00461123|9275382|P1|Overall Study|Protocol Violation|3
2689343|NCT00461123|9275381|P2|Overall Study|Lost to Follow-up|1
2689344|NCT00461123|9275382|P1|Overall Study|Lost to Follow-up|1
2689345|NCT00461123|9275381|P2|Overall Study|Adverse Event|0
2689346|NCT00461123|9275382|P1|Overall Study|Adverse Event|1
2689347|NCT00461032|9275427|P2|Overall Study|Other|5
2689348|NCT00461032|9275428|P1|Overall Study|Other|7
2689349|NCT00461032|9275427|P2|Overall Study|Patient Moved or Relocated|1
2689350|NCT00461032|9275428|P1|Overall Study|Patient Moved or Relocated|2
2689351|NCT00461032|9275427|P2|Overall Study|Withdrawal by Subject|15
2689352|NCT00461032|9275428|P1|Overall Study|Withdrawal by Subject|7
2689353|NCT00461032|9275427|P2|Overall Study|Protocol Violation|4
2689354|NCT00461032|9275428|P1|Overall Study|Protocol Violation|4
2689355|NCT00461032|9275427|P2|Overall Study|Lost to Follow-up|12
2689356|NCT00461032|9275428|P1|Overall Study|Lost to Follow-up|7
2689357|NCT00461032|9275427|P2|Overall Study|Lack of Efficacy|1
2689358|NCT00461032|9275428|P1|Overall Study|Lack of Efficacy|5
2689359|NCT00461032|9275427|P2|Overall Study|Adverse Event|6
2689360|NCT00461032|9275428|P1|Overall Study|Adverse Event|5
2689361|NCT00460811|9275454|P5|Overall Study|Lost to Follow-up|6
2689362|NCT00460811|9275455|P4|Overall Study|Lost to Follow-up|3
2689363|NCT00460811|9275456|P3|Overall Study|Lost to Follow-up|5
2689364|NCT00460811|9275457|P2|Overall Study|Lost to Follow-up|2
2689365|NCT00460811|9275458|P1|Overall Study|Lost to Follow-up|3
2689366|NCT00460811|9275454|P5|Overall Study|Physician Decision|0
2689367|NCT00460811|9275455|P4|Overall Study|Physician Decision|0
2689368|NCT00460811|9275456|P3|Overall Study|Physician Decision|0
2689369|NCT00460811|9275457|P2|Overall Study|Physician Decision|0
2689370|NCT00460811|9275458|P1|Overall Study|Physician Decision|1
2689371|NCT00460811|9275454|P5|Overall Study|Withdrawal by Subject|11
2689372|NCT00460811|9275455|P4|Overall Study|Withdrawal by Subject|3
2689373|NCT00460811|9275456|P3|Overall Study|Withdrawal by Subject|6
2689374|NCT00460811|9275457|P2|Overall Study|Withdrawal by Subject|7
2689375|NCT00460811|9275458|P1|Overall Study|Withdrawal by Subject|7
2689376|NCT00460811|9275454|P5|Overall Study|Noncompliance|1
2689377|NCT00460811|9275455|P4|Overall Study|Noncompliance|2
2689378|NCT00460811|9275456|P3|Overall Study|Noncompliance|0
2689379|NCT00460811|9275457|P2|Overall Study|Noncompliance|0
2689380|NCT00460811|9275458|P1|Overall Study|Noncompliance|1
2689381|NCT00460811|9275454|P5|Overall Study|Adverse Event|2
2689382|NCT00460811|9275455|P4|Overall Study|Adverse Event|10
2689383|NCT00460811|9275456|P3|Overall Study|Adverse Event|3
2689384|NCT00460811|9275457|P2|Overall Study|Adverse Event|6
2689385|NCT00460811|9275458|P1|Overall Study|Adverse Event|4
2689386|NCT00460798|9275500|P1|Overall Study|Missing/Incomplete Dosing Information|27
2689387|NCT00460798|9275500|P1|Overall Study|Ongoing at Date of Cut-Off|82
2689388|NCT00460798|9275500|P1|Overall Study|Other|27
2689389|NCT00460798|9275500|P1|Overall Study|Progressive Disease|99
2689390|NCT00460798|9275500|P1|Overall Study|Lost to Follow-up|19
2689391|NCT00460798|9275500|P1|Overall Study|Adverse Event|27
2689392|NCT00460798|9275500|P1|Overall Study|Death|59
2689393|NCT00460746|9275508|P1|Overall Study|Lost to Follow-up|1
2689394|NCT00460746|9275508|P1|Overall Study|Adverse Event|1
2689395|NCT00460655|9275523|P4|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1
2689396|NCT00460655|9275524|P3|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
2689397|NCT00460655|9275525|P2|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
2689398|NCT00460655|9275526|P1|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
2689399|NCT00460655|9275523|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2
2689400|NCT00460655|9275524|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6
2689401|NCT00460655|9275525|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
2689402|NCT00460655|9275526|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
2689403|NCT00460655|9275523|P4|Open-Label Phase (36 Weeks)|Adverse Event|6
2689404|NCT00460655|9275524|P3|Open-Label Phase (36 Weeks)|Adverse Event|1
2689405|NCT00460655|9275525|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
2689406|NCT00460655|9275526|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
2689407|NCT00460655|9275523|P4|Double-Blind Phase (12 Weeks)|Protocol Violation|0
2689408|NCT00460655|9275524|P3|Double-Blind Phase (12 Weeks)|Protocol Violation|0
2689409|NCT00460655|9275525|P2|Double-Blind Phase (12 Weeks)|Protocol Violation|1
2689410|NCT00460655|9275526|P1|Double-Blind Phase (12 Weeks)|Protocol Violation|0
2689411|NCT00460655|9275523|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
2689412|NCT00460655|9275524|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
2689413|NCT00460655|9275525|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
2689414|NCT00460655|9275526|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3
2689415|NCT00460655|9275523|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
2689416|NCT00460655|9275524|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
2689417|NCT00460655|9275525|P2|Double-Blind Phase (12 Weeks)|Adverse Event|0
2689418|NCT00460655|9275526|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
2689419|NCT00460603|9275570|P12|Phase 2|Randomized, but not treated|0
2689420|NCT00460603|9275571|P11|Phase 2|Randomized, but not treated|0
2689421|NCT00460603|9275572|P10|Phase 2|Randomized, but not treated|3
2689422|NCT00460603|9275573|P9|Phase 2|Randomized, but not treated|0
2689423|NCT00460603|9275574|P8|Phase 2|Randomized, but not treated|0
2689424|NCT00460603|9275575|P7|Phase 2|Randomized, but not treated|0
2689425|NCT00460603|9275576|P6|Phase 2|Randomized, but not treated|0
2689426|NCT00460603|9275577|P5|Phase 2|Randomized, but not treated|0
2689427|NCT00460603|9275578|P4|Phase 2|Randomized, but not treated|0
2689428|NCT00460603|9275579|P3|Phase 2|Randomized, but not treated|0
2689429|NCT00460603|9275580|P2|Phase 2|Randomized, but not treated|0
2689430|NCT00460603|9275581|P1|Phase 2|Randomized, but not treated|0
2689431|NCT00460603|9275570|P12|Phase 2|Withdrawal by Subject|5
2689432|NCT00460603|9275571|P11|Phase 2|Withdrawal by Subject|4
2689433|NCT00460603|9275572|P10|Phase 2|Withdrawal by Subject|5
2689434|NCT00460603|9275573|P9|Phase 2|Withdrawal by Subject|0
2689435|NCT00460603|9275574|P8|Phase 2|Withdrawal by Subject|0
2689436|NCT00460603|9275575|P7|Phase 2|Withdrawal by Subject|0
2689437|NCT00460603|9275576|P6|Phase 2|Withdrawal by Subject|0
2689438|NCT00460603|9275577|P5|Phase 2|Withdrawal by Subject|0
2689439|NCT00460603|9275578|P4|Phase 2|Withdrawal by Subject|0
2689440|NCT00460603|9275579|P3|Phase 2|Withdrawal by Subject|0
2689441|NCT00460603|9275580|P2|Phase 2|Withdrawal by Subject|0
2689442|NCT00460603|9275581|P1|Phase 2|Withdrawal by Subject|0
2689443|NCT00460603|9275570|P12|Phase 2|Global Deterioration of Health Status|0
2689444|NCT00460603|9275571|P11|Phase 2|Global Deterioration of Health Status|1
2689445|NCT00460603|9275572|P10|Phase 2|Global Deterioration of Health Status|0
2689446|NCT00460603|9275573|P9|Phase 2|Global Deterioration of Health Status|0
2689447|NCT00460603|9275574|P8|Phase 2|Global Deterioration of Health Status|0
2689448|NCT00460603|9275575|P7|Phase 2|Global Deterioration of Health Status|0
2689449|NCT00460603|9275576|P6|Phase 2|Global Deterioration of Health Status|0
2689450|NCT00460603|9275577|P5|Phase 2|Global Deterioration of Health Status|0
2689451|NCT00460603|9275578|P4|Phase 2|Global Deterioration of Health Status|0
2689452|NCT00460603|9275579|P3|Phase 2|Global Deterioration of Health Status|0
2689453|NCT00460603|9275580|P2|Phase 2|Global Deterioration of Health Status|0
2689454|NCT00460603|9275581|P1|Phase 2|Global Deterioration of Health Status|0
2689455|NCT00460603|9275570|P12|Phase 2|Objective Progression or Relapse|17
2689456|NCT00460603|9275571|P11|Phase 2|Objective Progression or Relapse|10
2689457|NCT00460603|9275572|P10|Phase 2|Objective Progression or Relapse|9
2689458|NCT00460603|9275573|P9|Phase 2|Objective Progression or Relapse|0
2689459|NCT00460603|9275574|P8|Phase 2|Objective Progression or Relapse|0
2689460|NCT00460603|9275575|P7|Phase 2|Objective Progression or Relapse|0
2689461|NCT00460603|9275576|P6|Phase 2|Objective Progression or Relapse|0
2689462|NCT00460603|9275577|P5|Phase 2|Objective Progression or Relapse|0
2689463|NCT00460603|9275578|P4|Phase 2|Objective Progression or Relapse|0
2689464|NCT00460603|9275579|P3|Phase 2|Objective Progression or Relapse|0
2689465|NCT00460603|9275580|P2|Phase 2|Objective Progression or Relapse|0
2689466|NCT00460603|9275581|P1|Phase 2|Objective Progression or Relapse|0
2689467|NCT00460603|9275570|P12|Phase 2|Other|7
2689468|NCT00460603|9275571|P11|Phase 2|Other|16
2689469|NCT00460603|9275572|P10|Phase 2|Other|6
2689470|NCT00460603|9275573|P9|Phase 2|Other|0
2689471|NCT00460603|9275574|P8|Phase 2|Other|0
2689472|NCT00460603|9275575|P7|Phase 2|Other|0
2689473|NCT00460603|9275576|P6|Phase 2|Other|0
2689474|NCT00460603|9275577|P5|Phase 2|Other|0
2689475|NCT00460603|9275578|P4|Phase 2|Other|0
2689476|NCT00460603|9275579|P3|Phase 2|Other|0
2689477|NCT00460603|9275580|P2|Phase 2|Other|0
2689478|NCT00460603|9275581|P1|Phase 2|Other|0
2689479|NCT00460603|9275570|P12|Phase 2|Lost to Follow-up|0
2689480|NCT00460603|9275571|P11|Phase 2|Lost to Follow-up|0
2689481|NCT00460603|9275572|P10|Phase 2|Lost to Follow-up|1
2689482|NCT00460603|9275573|P9|Phase 2|Lost to Follow-up|0
2689483|NCT00460603|9275574|P8|Phase 2|Lost to Follow-up|0
2689484|NCT00460603|9275575|P7|Phase 2|Lost to Follow-up|0
2689485|NCT00460603|9275576|P6|Phase 2|Lost to Follow-up|0
2689486|NCT00460603|9275577|P5|Phase 2|Lost to Follow-up|0
2689487|NCT00460603|9275578|P4|Phase 2|Lost to Follow-up|0
2689488|NCT00460603|9275579|P3|Phase 2|Lost to Follow-up|0
2689489|NCT00460603|9275580|P2|Phase 2|Lost to Follow-up|0
2689490|NCT00460603|9275581|P1|Phase 2|Lost to Follow-up|0
2689491|NCT00460603|9275570|P12|Phase 2|Protocol Violation|0
2689492|NCT00460603|9275571|P11|Phase 2|Protocol Violation|1
2689493|NCT00460603|9275572|P10|Phase 2|Protocol Violation|1
2689494|NCT00460603|9275573|P9|Phase 2|Protocol Violation|0
2689495|NCT00460603|9275574|P8|Phase 2|Protocol Violation|0
2689496|NCT00460603|9275575|P7|Phase 2|Protocol Violation|0
2689497|NCT00460603|9275576|P6|Phase 2|Protocol Violation|0
2689498|NCT00460603|9275577|P5|Phase 2|Protocol Violation|0
2689499|NCT00460603|9275578|P4|Phase 2|Protocol Violation|0
2689500|NCT00460603|9275579|P3|Phase 2|Protocol Violation|0
2689501|NCT00460603|9275580|P2|Phase 2|Protocol Violation|0
2689502|NCT00460603|9275581|P1|Phase 2|Protocol Violation|0
2689503|NCT00460603|9275570|P12|Phase 2|Death|2
2689504|NCT00460603|9275571|P11|Phase 2|Death|2
2689505|NCT00460603|9275572|P10|Phase 2|Death|4
2689506|NCT00460603|9275573|P9|Phase 2|Death|0
2689507|NCT00460603|9275574|P8|Phase 2|Death|0
2689508|NCT00460603|9275575|P7|Phase 2|Death|0
2689509|NCT00460603|9275576|P6|Phase 2|Death|0
2689510|NCT00460603|9275577|P5|Phase 2|Death|0
2689511|NCT00460603|9275578|P4|Phase 2|Death|0
2689512|NCT00460603|9275579|P3|Phase 2|Death|0
2689513|NCT00460603|9275580|P2|Phase 2|Death|0
2689514|NCT00460603|9275581|P1|Phase 2|Death|0
2689515|NCT00460603|9275570|P12|Phase 2|Adverse Event|10
2689516|NCT00460603|9275571|P11|Phase 2|Adverse Event|9
2689517|NCT00460603|9275572|P10|Phase 2|Adverse Event|12
2689518|NCT00460603|9275573|P9|Phase 2|Adverse Event|0
2689519|NCT00460603|9275574|P8|Phase 2|Adverse Event|0
2689520|NCT00460603|9275575|P7|Phase 2|Adverse Event|0
2689521|NCT00460603|9275576|P6|Phase 2|Adverse Event|0
2689522|NCT00460603|9275577|P5|Phase 2|Adverse Event|0
2689523|NCT00460603|9275578|P4|Phase 2|Adverse Event|0
2689524|NCT00460603|9275579|P3|Phase 2|Adverse Event|0
2689525|NCT00460603|9275580|P2|Phase 2|Adverse Event|0
2689526|NCT00460603|9275581|P1|Phase 2|Adverse Event|0
2689527|NCT00460603|9275570|P12|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
2689528|NCT00460603|9275571|P11|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
2689529|NCT00460603|9275572|P10|Phase 2|Ongoing in study A4061008 (NCT00828919)|1
2689530|NCT00460603|9275573|P9|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
2689531|NCT00460603|9275574|P8|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
2689532|NCT00460603|9275575|P7|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
2689533|NCT00460603|9275576|P6|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
2689534|NCT00460603|9275577|P5|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
2689535|NCT00460603|9275578|P4|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
2689536|NCT00460603|9275579|P3|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
2689537|NCT00460603|9275580|P2|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
2689538|NCT00460603|9275581|P1|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
2689539|NCT00460603|9275570|P12|Phase 1|Other|0
2689540|NCT00460603|9275571|P11|Phase 1|Other|0
2689541|NCT00460603|9275572|P10|Phase 1|Other|0
2689542|NCT00460603|9275573|P9|Phase 1|Other|0
2689543|NCT00460603|9275574|P8|Phase 1|Other|1
2689544|NCT00460603|9275575|P7|Phase 1|Other|0
2689545|NCT00460603|9275576|P6|Phase 1|Other|2
2689546|NCT00460603|9275577|P5|Phase 1|Other|1
2689547|NCT00460603|9275578|P4|Phase 1|Other|1
2689548|NCT00460603|9275579|P3|Phase 1|Other|1
2689549|NCT00460603|9275580|P2|Phase 1|Other|3
2689550|NCT00460603|9275581|P1|Phase 1|Other|0
2689551|NCT00460603|9275570|P12|Phase 1|Withdrawal by Subject|0
2689552|NCT00460603|9275571|P11|Phase 1|Withdrawal by Subject|0
2689553|NCT00460603|9275572|P10|Phase 1|Withdrawal by Subject|0
2689554|NCT00460603|9275573|P9|Phase 1|Withdrawal by Subject|2
2689555|NCT00460603|9275574|P8|Phase 1|Withdrawal by Subject|0
2689556|NCT00460603|9275575|P7|Phase 1|Withdrawal by Subject|1
2689557|NCT00460603|9275576|P6|Phase 1|Withdrawal by Subject|0
2689558|NCT00460603|9275577|P5|Phase 1|Withdrawal by Subject|3
2689559|NCT00460603|9275578|P4|Phase 1|Withdrawal by Subject|1
2689560|NCT00460603|9275579|P3|Phase 1|Withdrawal by Subject|1
2689561|NCT00460603|9275580|P2|Phase 1|Withdrawal by Subject|2
2689562|NCT00460603|9275581|P1|Phase 1|Withdrawal by Subject|1
2689563|NCT00460603|9275570|P12|Phase 1|Lack of Efficacy|0
2689564|NCT00460603|9275571|P11|Phase 1|Lack of Efficacy|0
2689565|NCT00460603|9275572|P10|Phase 1|Lack of Efficacy|0
2689566|NCT00460603|9275573|P9|Phase 1|Lack of Efficacy|11
2689567|NCT00460603|9275574|P8|Phase 1|Lack of Efficacy|2
2689568|NCT00460603|9275575|P7|Phase 1|Lack of Efficacy|2
2689569|NCT00460603|9275576|P6|Phase 1|Lack of Efficacy|2
2689570|NCT00460603|9275577|P5|Phase 1|Lack of Efficacy|2
2689571|NCT00460603|9275578|P4|Phase 1|Lack of Efficacy|2
2689572|NCT00460603|9275579|P3|Phase 1|Lack of Efficacy|1
2689573|NCT00460603|9275580|P2|Phase 1|Lack of Efficacy|0
2689574|NCT00460603|9275581|P1|Phase 1|Lack of Efficacy|1
2689575|NCT00460603|9275570|P12|Phase 1|Adverse Event|0
2689576|NCT00460603|9275571|P11|Phase 1|Adverse Event|0
2689577|NCT00460603|9275572|P10|Phase 1|Adverse Event|0
2689578|NCT00460603|9275573|P9|Phase 1|Adverse Event|4
2689579|NCT00460603|9275574|P8|Phase 1|Adverse Event|0
2689580|NCT00460603|9275575|P7|Phase 1|Adverse Event|3
2689581|NCT00460603|9275576|P6|Phase 1|Adverse Event|0
2689582|NCT00460603|9275577|P5|Phase 1|Adverse Event|0
2689583|NCT00460603|9275578|P4|Phase 1|Adverse Event|2
2689584|NCT00460603|9275579|P3|Phase 1|Adverse Event|1
2689585|NCT00460603|9275580|P2|Phase 1|Adverse Event|1
2689586|NCT00460603|9275581|P1|Phase 1|Adverse Event|3
2689587|NCT00460603|9275570|P12|Phase 1|Death|0
2689588|NCT00460603|9275571|P11|Phase 1|Death|0
2689589|NCT00460603|9275572|P10|Phase 1|Death|0
2689590|NCT00460603|9275573|P9|Phase 1|Death|1
2689591|NCT00460603|9275574|P8|Phase 1|Death|0
2689592|NCT00460603|9275575|P7|Phase 1|Death|0
2689593|NCT00460603|9275576|P6|Phase 1|Death|0
2689594|NCT00460603|9275577|P5|Phase 1|Death|0
2689595|NCT00460603|9275578|P4|Phase 1|Death|2
2689596|NCT00460603|9275579|P3|Phase 1|Death|0
2689597|NCT00460603|9275580|P2|Phase 1|Death|0
2689598|NCT00460603|9275581|P1|Phase 1|Death|1
2689599|NCT00460577|9275675|P2|Overall Study|Protocol Violation|6
2689600|NCT00460577|9275676|P1|Overall Study|Protocol Violation|2
2689601|NCT00460564|9275694|P8|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
2689602|NCT00460564|9275695|P7|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
2689603|NCT00460564|9275696|P6|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
2689604|NCT00460564|9275697|P5|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1
2689605|NCT00460564|9275698|P4|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
2689606|NCT00460564|9275699|P3|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
2689607|NCT00460564|9275700|P2|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
2689608|NCT00460564|9275701|P1|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
2689609|NCT00460564|9275694|P8|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
2689610|NCT00460564|9275695|P7|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
2689611|NCT00460564|9275696|P6|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1
2689612|NCT00460564|9275697|P5|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5
2689613|NCT00460564|9275698|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
2689614|NCT00460564|9275699|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
2689615|NCT00460564|9275700|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
2689616|NCT00460564|9275701|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
2689617|NCT00460564|9275694|P8|Open-Label Phase (36 Weeks)|Adverse Event|0
2689618|NCT00460564|9275695|P7|Open-Label Phase (36 Weeks)|Adverse Event|2
2689619|NCT00460564|9275696|P6|Open-Label Phase (36 Weeks)|Adverse Event|5
2689620|NCT00460564|9275697|P5|Open-Label Phase (36 Weeks)|Adverse Event|3
2689621|NCT00460564|9275698|P4|Open-Label Phase (36 Weeks)|Adverse Event|0
2689622|NCT00460564|9275699|P3|Open-Label Phase (36 Weeks)|Adverse Event|0
2689623|NCT00460564|9275700|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
2689624|NCT00460564|9275701|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
2689625|NCT00460564|9275694|P8|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
2689626|NCT00460564|9275695|P7|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
2689627|NCT00460564|9275696|P6|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
2689628|NCT00460564|9275697|P5|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
2689629|NCT00460564|9275698|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
2689630|NCT00460564|9275699|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
2689631|NCT00460564|9275700|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
2689632|NCT00460564|9275701|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1
2689633|NCT00460564|9275694|P8|Double-Blind Phase (12 Weeks)|Adverse Event|0
2689634|NCT00460564|9275695|P7|Double-Blind Phase (12 Weeks)|Adverse Event|0
2689635|NCT00460564|9275696|P6|Double-Blind Phase (12 Weeks)|Adverse Event|0
2689636|NCT00460564|9275697|P5|Double-Blind Phase (12 Weeks)|Adverse Event|0
2689637|NCT00460564|9275698|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
2689638|NCT00460564|9275699|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
2689639|NCT00460564|9275700|P2|Double-Blind Phase (12 Weeks)|Adverse Event|1
2689640|NCT00460564|9275701|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
2689641|NCT00460434|9275845|P2|Overall Study|Lost to Follow-up|7
2689642|NCT00460434|9275846|P1|Overall Study|Lost to Follow-up|3
2689643|NCT00460408|9275925|P4|Overall Study|Other|0
2689644|NCT00460408|9275926|P3|Overall Study|Other|0
2689645|NCT00460408|9275927|P2|Overall Study|Other|2
2689646|NCT00460408|9275928|P1|Overall Study|Other|12
2689647|NCT00460408|9275925|P4|Overall Study|Insufficient clinical response|0
2689648|NCT00460408|9275926|P3|Overall Study|Insufficient clinical response|5
2689649|NCT00460408|9275927|P2|Overall Study|Insufficient clinical response|1
2689650|NCT00460408|9275928|P1|Overall Study|Insufficient clinical response|5
2689651|NCT00460408|9275925|P4|Overall Study|Withdrawal by Subject|0
2689652|NCT00460408|9275926|P3|Overall Study|Withdrawal by Subject|0
2689653|NCT00460408|9275927|P2|Overall Study|Withdrawal by Subject|0
2689654|NCT00460408|9275928|P1|Overall Study|Withdrawal by Subject|31
2689655|NCT00460408|9275925|P4|Overall Study|Lost to Follow-up|0
2689656|NCT00460408|9275926|P3|Overall Study|Lost to Follow-up|1
2689657|NCT00460408|9275927|P2|Overall Study|Lost to Follow-up|0
2689658|NCT00460408|9275928|P1|Overall Study|Lost to Follow-up|11
2689659|NCT00460408|9275925|P4|Overall Study|Death|0
2689660|NCT00460408|9275926|P3|Overall Study|Death|0
2689661|NCT00460408|9275927|P2|Overall Study|Death|0
2689662|NCT00460408|9275928|P1|Overall Study|Death|7
2689663|NCT00460408|9275925|P4|Overall Study|Adverse Event|0
2689664|NCT00460408|9275926|P3|Overall Study|Adverse Event|0
2689665|NCT00460408|9275927|P2|Overall Study|Adverse Event|0
2689666|NCT00460408|9275928|P1|Overall Study|Adverse Event|1
2689667|NCT00460265|9275965|P2|Overall Study|Ongoing|47
2689668|NCT00460265|9275966|P1|Overall Study|Ongoing|60
2689669|NCT00460265|9275965|P2|Overall Study|Withdrawal by Subject|25
2689670|NCT00460265|9275966|P1|Overall Study|Withdrawal by Subject|10
2689671|NCT00460265|9275965|P2|Overall Study|Physician Decision|2
2689672|NCT00460265|9275966|P1|Overall Study|Physician Decision|1
2689673|NCT00460265|9275965|P2|Overall Study|Lost to Follow-up|15
2689674|NCT00460265|9275966|P1|Overall Study|Lost to Follow-up|14
2689675|NCT00460239|9275982|P9|Overall Study|Withdrawal by Subject|0
2689676|NCT00460239|9275983|P8|Overall Study|Withdrawal by Subject|0
2689677|NCT00460239|9275984|P7|Overall Study|Withdrawal by Subject|0
2689678|NCT00460239|9275985|P6|Overall Study|Withdrawal by Subject|1
2689679|NCT00460239|9275986|P5|Overall Study|Withdrawal by Subject|0
2689680|NCT00460239|9275987|P4|Overall Study|Withdrawal by Subject|0
2689681|NCT00460239|9275988|P3|Overall Study|Withdrawal by Subject|0
2689682|NCT00460239|9275989|P2|Overall Study|Withdrawal by Subject|0
2689683|NCT00460239|9275990|P1|Overall Study|Withdrawal by Subject|0
2689684|NCT00460239|9275982|P9|Overall Study|Physician Decision|0
2689685|NCT00460239|9275983|P8|Overall Study|Physician Decision|0
2689686|NCT00460239|9275984|P7|Overall Study|Physician Decision|0
2689687|NCT00460239|9275985|P6|Overall Study|Physician Decision|2
2689688|NCT00460239|9275986|P5|Overall Study|Physician Decision|0
2689689|NCT00460239|9275987|P4|Overall Study|Physician Decision|0
2689690|NCT00460239|9275988|P3|Overall Study|Physician Decision|0
2689691|NCT00460239|9275989|P2|Overall Study|Physician Decision|1
2689692|NCT00460239|9275990|P1|Overall Study|Physician Decision|0
2689693|NCT00460109|9276059|P1|Overall Study|Death|1
2689694|NCT00460031|9276067|P1|Overall Study|Death|1
2689695|NCT00460031|9276067|P1|Overall Study|Withdrawal by Subject|5
2689696|NCT00460031|9276067|P1|Overall Study|Adverse Event|5
2689697|NCT00459979|9276075|P1|Overall Study|Protocol Violation|1
2689698|NCT00459979|9276075|P1|Overall Study|Withdrawal by Subject|1
2689699|NCT00459953|9276087|P2|Overall Study|not analyzed-household member in study|1
2689700|NCT00459953|9276088|P1|Overall Study|not analyzed-household member in study|1
2689701|NCT00459875|9276094|P1|Overall Study|Adverse Event|2
2689702|NCT00459875|9276094|P1|Overall Study|Ineligible participant|1
2689703|NCT00459706|9276130|P2|Overall Study|Other|1
2689704|NCT00459706|9276131|P1|Overall Study|Other|0
2689705|NCT00459706|9276130|P2|Overall Study|Failed to Return|0
2689706|NCT00459706|9276131|P1|Overall Study|Failed to Return|1
2689707|NCT00459706|9276130|P2|Overall Study|Protocol Violation|1
2689708|NCT00459706|9276131|P1|Overall Study|Protocol Violation|2
2689709|NCT00459706|9276130|P2|Overall Study|Discontinuation of Study by Sponsor|0
2689710|NCT00459706|9276131|P1|Overall Study|Discontinuation of Study by Sponsor|1
2689711|NCT00459706|9276130|P2|Overall Study|Physician Decision|0
2689712|NCT00459706|9276131|P1|Overall Study|Physician Decision|2
2689713|NCT00459706|9276130|P2|Overall Study|Withdrawal by Subject|6
2689714|NCT00459706|9276131|P1|Overall Study|Withdrawal by Subject|1
2689715|NCT00459706|9276130|P2|Overall Study|Adverse Event|13
2689716|NCT00459706|9276131|P1|Overall Study|Adverse Event|19
2689717|NCT00459667|9276274|P3|Overall Study|No treatment administered|1
2689718|NCT00459667|9276275|P2|Overall Study|No treatment administered|3
2689719|NCT00459667|9276276|P1|Overall Study|No treatment administered|6
2689720|NCT00459667|9276274|P3|Overall Study|Other reason (incl. 2 missing subjects)|1
2689721|NCT00459667|9276275|P2|Overall Study|Other reason (incl. 2 missing subjects)|15
2689722|NCT00459667|9276276|P1|Overall Study|Other reason (incl. 2 missing subjects)|12
2689723|NCT00459667|9276274|P3|Overall Study|Other disease modifying treatment|1
2689724|NCT00459667|9276275|P2|Overall Study|Other disease modifying treatment|2
2689725|NCT00459667|9276276|P1|Overall Study|Other disease modifying treatment|1
2689726|NCT00459667|9276274|P3|Overall Study|Withdrawal by Subject|5
2689727|NCT00459667|9276275|P2|Overall Study|Withdrawal by Subject|5
2689728|NCT00459667|9276276|P1|Overall Study|Withdrawal by Subject|3
2689729|NCT00459667|9276274|P3|Overall Study|Protocol Violation|0
2689730|NCT00459667|9276275|P2|Overall Study|Protocol Violation|0
2689731|NCT00459667|9276276|P1|Overall Study|Protocol Violation|1
2689732|NCT00459667|9276274|P3|Overall Study|Pregnancy|1
2689733|NCT00459667|9276275|P2|Overall Study|Pregnancy|1
2689734|NCT00459667|9276276|P1|Overall Study|Pregnancy|1
2689735|NCT00459667|9276274|P3|Overall Study|Lost to Follow-up|3
2689736|NCT00459667|9276275|P2|Overall Study|Lost to Follow-up|9
2689737|NCT00459667|9276276|P1|Overall Study|Lost to Follow-up|5
2689738|NCT00459667|9276274|P3|Overall Study|Adverse Event|8
2689739|NCT00459667|9276275|P2|Overall Study|Adverse Event|12
2689740|NCT00459667|9276276|P1|Overall Study|Adverse Event|9
2689741|NCT00459537|9276298|P2|Overall Study|Missing|0
2689742|NCT00459537|9276299|P1|Overall Study|Missing|1
2689743|NCT00459537|9276298|P2|Overall Study|Protocol Violation|3
2689744|NCT00459537|9276299|P1|Overall Study|Protocol Violation|4
2689745|NCT00459537|9276298|P2|Overall Study|Administrative problems|0
2689746|NCT00459537|9276299|P1|Overall Study|Administrative problems|3
2689747|NCT00459537|9276298|P2|Overall Study|Lost to Follow-up|30
2689748|NCT00459537|9276299|P1|Overall Study|Lost to Follow-up|27
2689749|NCT00459537|9276298|P2|Overall Study|Withdrawal by Subject|26
2689750|NCT00459537|9276299|P1|Overall Study|Withdrawal by Subject|20
2689751|NCT00459537|9276298|P2|Overall Study|Lack of Efficacy|11
2689752|NCT00459537|9276299|P1|Overall Study|Lack of Efficacy|10
2689753|NCT00459537|9276298|P2|Overall Study|Adverse Event|6
2689754|NCT00459537|9276299|P1|Overall Study|Adverse Event|1
2689755|NCT00459355|9276334|P2|Overall Study|Subject no longer met inc criteria|18
2689756|NCT00459355|9276335|P1|Overall Study|Subject no longer met inc criteria|20
2689757|NCT00459342|9276347|P1|Overall Study|Not eligible|1
2689758|NCT00459316|9276360|P3|Step 3|Withdrawal by Subject|1
2689759|NCT00459316|9276361|P2|Step 3|Withdrawal by Subject|0
2689760|NCT00459316|9276362|P1|Step 3|Withdrawal by Subject|3
2689761|NCT00459316|9276360|P3|Steps 1 & 2|Lost to Follow-up|2
2689762|NCT00459316|9276361|P2|Steps 1 & 2|Lost to Follow-up|0
2689763|NCT00459316|9276362|P1|Steps 1 & 2|Lost to Follow-up|5
2689764|NCT00459316|9276360|P3|Steps 1 & 2|Not willing to adhere to regulations|0
2689765|NCT00459316|9276361|P2|Steps 1 & 2|Not willing to adhere to regulations|0
2689766|NCT00459316|9276362|P1|Steps 1 & 2|Not willing to adhere to regulations|1
2689767|NCT00459316|9276360|P3|Steps 1 & 2|Withdrawal by Subject|0
2689768|NCT00459316|9276361|P2|Steps 1 & 2|Withdrawal by Subject|1
2689769|NCT00459316|9276362|P1|Steps 1 & 2|Withdrawal by Subject|6
2689770|NCT00459316|9276360|P3|Steps 1 & 2|Not able to get to clinic|0
2689771|NCT00459316|9276361|P2|Steps 1 & 2|Not able to get to clinic|4
2689772|NCT00459316|9276362|P1|Steps 1 & 2|Not able to get to clinic|7
2689773|NCT00459316|9276360|P3|Steps 1 & 2|Death|0
2689774|NCT00459316|9276361|P2|Steps 1 & 2|Death|1
2689775|NCT00459316|9276362|P1|Steps 1 & 2|Death|1
2689776|NCT00459316|9276360|P3|Steps 1 & 2|Other eligibility failure|0
2689777|NCT00459316|9276361|P2|Steps 1 & 2|Other eligibility failure|1
2689778|NCT00459316|9276362|P1|Steps 1 & 2|Other eligibility failure|1
2689779|NCT00459290|9276427|P1|Overall Study|Ineligible|2
2689780|NCT00459290|9276427|P1|Overall Study|Adverse Event|3
2689781|NCT00459186|9276442|P1|PET Imaging and Assessment|Adverse Event|3
2689782|NCT00459186|9276442|P1|Single Agent RAD001|Withdrawal by Subject|1
2689783|NCT00459134|9276449|P2|Overall Study|Multiple Reasons|3
2689784|NCT00459134|9276450|P1|Overall Study|Multiple Reasons|2
2689785|NCT00459134|9276449|P2|Overall Study|Progression|0
2689786|NCT00459134|9276450|P1|Overall Study|Progression|1
2689787|NCT00459134|9276449|P2|Overall Study|Toxicity|5
2689788|NCT00459134|9276450|P1|Overall Study|Toxicity|4
2689789|NCT00459134|9276449|P2|Overall Study|Surgery|2
2689790|NCT00459134|9276450|P1|Overall Study|Surgery|1
2689791|NCT00459134|9276449|P2|Overall Study|Lost to Follow-up|7
2689792|NCT00459134|9276450|P1|Overall Study|Lost to Follow-up|6
2689793|NCT00459134|9276449|P2|Overall Study|Withdrawal by Subject|7
2689794|NCT00459134|9276450|P1|Overall Study|Withdrawal by Subject|8
2689795|NCT00459134|9276449|P2|Overall Study|Physician Decision|1
2689796|NCT00459134|9276450|P1|Overall Study|Physician Decision|1
2689797|NCT00459108|9276466|P1|Overall Study|Progression|1
2689798|NCT00459108|9276466|P1|Overall Study|Death|2
2689799|NCT00459108|9276466|P1|Overall Study|Adverse Event|3
2689800|NCT00459108|9276466|P1|Overall Study|Withdrawal by Subject|5
2689801|NCT00459056|9276476|P2|First Intervention (First Three Months)|Lost to Follow-up|1
2689802|NCT00459056|9276477|P1|First Intervention (First Three Months)|Lost to Follow-up|1
2689803|NCT00459043|9276485|P2|Overall Study|Withdrawal by Subject|0
2689804|NCT00459043|9276486|P1|Overall Study|Withdrawal by Subject|1
2689805|NCT00458705|9276513|P1|Overall Study|Not Treated|1
2689806|NCT00458705|9276513|P1|Overall Study|Adverse Event|4
2689807|NCT00458536|9276517|P1|Overall Study|Progressive disease during treatment|2
2689808|NCT00458536|9276517|P1|Overall Study|Withdrawal by Subject|1
2689809|NCT00458536|9276517|P1|Overall Study|Ineligible due to toxicity|1
2689810|NCT00458536|9276517|P1|Overall Study|Patient did not have surgery|1
2689811|NCT00458536|9276517|P1|Overall Study|Did not have renal cell carcinoma|2
2689812|NCT00458536|9276517|P1|Overall Study|No measurable disease after surgery|2
2689813|NCT00458536|9276517|P1|Overall Study|Unable to make vaccine|3
2689814|NCT00458536|9276517|P1|Overall Study|Disease progression prior to treatment|7
2689815|NCT00458393|9276548|P2|Overall Study|Sites marked other on the form.|20
2689816|NCT00458393|9276549|P1|Overall Study|Sites marked other on the form.|19
2689817|NCT00458393|9276548|P2|Overall Study|Lost to Follow-up|92
2689818|NCT00458393|9276549|P1|Overall Study|Lost to Follow-up|115
2689819|NCT00458393|9276548|P2|Overall Study|Relocated|81
2689820|NCT00458393|9276549|P1|Overall Study|Relocated|77
2689821|NCT00458393|9276548|P2|Overall Study|Physician Decision|22
2689822|NCT00458393|9276549|P1|Overall Study|Physician Decision|31
2689823|NCT00458393|9276548|P2|Overall Study|Withdrawal by Subject|80
2689824|NCT00458393|9276549|P1|Overall Study|Withdrawal by Subject|67
2689825|NCT00458341|9276597|P2|Cycle 1|Adverse Event|0
2689826|NCT00458341|9276598|P1|Cycle 1|Adverse Event|1
2689827|NCT00458302|9276638|P2|Overall Study|Other|2
2689828|NCT00458302|9276639|P1|Overall Study|Other|4
2689829|NCT00458302|9276638|P2|Overall Study|Lost to Follow-up|0
2689830|NCT00458302|9276639|P1|Overall Study|Lost to Follow-up|2
2689831|NCT00458302|9276638|P2|Overall Study|Study Termination By Sponsor|0
2689832|NCT00458302|9276639|P1|Overall Study|Study Termination By Sponsor|1
2689833|NCT00458302|9276638|P2|Overall Study|Inc/Exc Criteria Not Met|1
2689834|NCT00458302|9276639|P1|Overall Study|Inc/Exc Criteria Not Met|1
2689835|NCT00458302|9276638|P2|Overall Study|Withdrawal by Subject|4
2689836|NCT00458302|9276639|P1|Overall Study|Withdrawal by Subject|6
2689837|NCT00458302|9276638|P2|Overall Study|Protocol Violation|2
2689838|NCT00458302|9276639|P1|Overall Study|Protocol Violation|0
2689839|NCT00458302|9276638|P2|Overall Study|Pregnancy|1
2689840|NCT00458302|9276639|P1|Overall Study|Pregnancy|2
2689841|NCT00458302|9276638|P2|Overall Study|Adverse Event|14
2689842|NCT00458302|9276639|P1|Overall Study|Adverse Event|4
2689843|NCT00458211|9276684|P1|Overall Study|Protocol Violation|2
2689844|NCT00458211|9276684|P1|Overall Study|Withdrawal by Subject|2
2689845|NCT00458211|9276684|P1|Overall Study|Lack of Efficacy|12
2689846|NCT00457821|9276726|P8|Part 2|Withdrawal by Subject|1
2689847|NCT00457821|9276727|P7|Part 2|Withdrawal by Subject|0
2689848|NCT00457821|9276728|P6|Part 2|Withdrawal by Subject|0
2689849|NCT00457821|9276729|P5|Part 2|Withdrawal by Subject|0
2689850|NCT00457821|9276730|P4|Part 2|Withdrawal by Subject|0
2689851|NCT00457821|9276731|P3|Part 2|Withdrawal by Subject|0
2689852|NCT00457821|9276732|P2|Part 2|Withdrawal by Subject|0
2689853|NCT00457821|9276733|P1|Part 2|Withdrawal by Subject|0
2689854|NCT00457743|9276772|P3|Overall Study|Lack of Efficacy|3
2689855|NCT00457743|9276773|P2|Overall Study|Lack of Efficacy|23
2689856|NCT00457743|9276774|P1|Overall Study|Lack of Efficacy|3
2689857|NCT00457743|9276772|P3|Overall Study|Adverse Event|0
2689858|NCT00457743|9276773|P2|Overall Study|Adverse Event|4
2689859|NCT00457743|9276774|P1|Overall Study|Adverse Event|0
2689860|NCT00457691|9276831|P2|Overall Study|Disease progression, study terminated|196
2689861|NCT00457691|9276832|P1|Overall Study|Disease progression, study terminated|180
2689862|NCT00457691|9276831|P2|Overall Study|Subject refused (reason other than AE)|19
2689863|NCT00457691|9276832|P1|Overall Study|Subject refused (reason other than AE)|14
2689864|NCT00457691|9276831|P2|Overall Study|Study terminated by Sponsor|1
2689865|NCT00457691|9276832|P1|Overall Study|Study terminated by Sponsor|1
2689866|NCT00457691|9276831|P2|Overall Study|Lost to Follow-up|14
2689867|NCT00457691|9276832|P1|Overall Study|Lost to Follow-up|23
2689868|NCT00457691|9276831|P2|Overall Study|Protocol Violation|3
2689869|NCT00457691|9276832|P1|Overall Study|Protocol Violation|1
2689870|NCT00457691|9276831|P2|Overall Study|Death|148
2689871|NCT00457691|9276832|P1|Overall Study|Death|163
2689872|NCT00457691|9276831|P2|Overall Study|Adverse Event|1
2689873|NCT00457691|9276832|P1|Overall Study|Adverse Event|4
2689874|NCT00457665|9276854|P2|24 Months|Abnormal liver function tests|5
2689875|NCT00457665|9276855|P1|24 Months|Abnormal liver function tests|1
2689876|NCT00457665|9276854|P2|24 Months|Lipodystrophy|1
2689877|NCT00457665|9276855|P1|24 Months|Lipodystrophy|1
2689878|NCT00457665|9276854|P2|24 Months|Withdrawal by Subject|2
2689879|NCT00457665|9276855|P1|24 Months|Withdrawal by Subject|3
2689880|NCT00457665|9276854|P2|12 Months|Abnormal Liver function tests|5
2689881|NCT00457665|9276855|P1|12 Months|Abnormal Liver function tests|0
2689882|NCT00457665|9276854|P2|12 Months|Withdrawal by Subject|2
2689883|NCT00457665|9276855|P1|12 Months|Withdrawal by Subject|0
2689884|NCT00457665|9276854|P2|12 Months|Lipodystrophy|0
2689885|NCT00457665|9276855|P1|12 Months|Lipodystrophy|2
2689886|NCT00457665|9276854|P2|12 Months|High HIV viral load|1
2689887|NCT00457665|9276855|P1|12 Months|High HIV viral load|5
2689888|NCT00457665|9276854|P2|12 Months|Drug allergy|1
2689889|NCT00457665|9276855|P1|12 Months|Drug allergy|1
2689890|NCT00457639|9276861|P2|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1
2689891|NCT00457639|9276862|P1|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0
2689892|NCT00457639|9276861|P2|Intervention 1 (6 Months)|unrelated illness|2
2689893|NCT00457639|9276862|P1|Intervention 1 (6 Months)|unrelated illness|0
2689894|NCT00457639|9276861|P2|Intervention 1 (6 Months)|Lost to Follow-up|0
2689895|NCT00457639|9276862|P1|Intervention 1 (6 Months)|Lost to Follow-up|3
2689896|NCT00457418|9276870|P1|Post PK Maintenance|Lost to Follow-up|1
2689897|NCT00457418|9276870|P1|Post PK Maintenance|Withdrawal by Subject|11
2689898|NCT00457418|9276870|P1|Post PK Maintenance|Progression of Disease|6
2689899|NCT00457418|9276870|P1|Post PK Maintenance|Adverse Event|10
2689900|NCT00457418|9276870|P1|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2
2689901|NCT00457418|9276870|P1|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1
2689902|NCT00457418|9276870|P1|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2
2689903|NCT00457392|9276882|P2|Overall Study|Randomized, Not Treated|3
2689904|NCT00457392|9276883|P1|Overall Study|Randomized, Not Treated|7
2689905|NCT00457392|9276882|P2|Overall Study|Study Terminated by Sponsor|4
2689906|NCT00457392|9276883|P1|Overall Study|Study Terminated by Sponsor|1
2689907|NCT00457392|9276882|P2|Overall Study|Other|4
2689908|NCT00457392|9276883|P1|Overall Study|Other|7
2689909|NCT00457392|9276882|P2|Overall Study|Protocol Violation|3
2689910|NCT00457392|9276883|P1|Overall Study|Protocol Violation|4
2689911|NCT00457392|9276882|P2|Overall Study|Lost to Follow-up|7
2689912|NCT00457392|9276883|P1|Overall Study|Lost to Follow-up|6
2689913|NCT00457392|9276882|P2|Overall Study|Withdrawal by Subject|8
2689914|NCT00457392|9276883|P1|Overall Study|Withdrawal by Subject|14
2689915|NCT00457392|9276882|P2|Overall Study|Global Deterioration of Health Status|8
2689916|NCT00457392|9276883|P1|Overall Study|Global Deterioration of Health Status|22
2689917|NCT00457392|9276882|P2|Overall Study|Adverse Event|41
2689918|NCT00457392|9276883|P1|Overall Study|Adverse Event|84
2689919|NCT00457392|9276882|P2|Overall Study|Death|106
2689920|NCT00457392|9276883|P1|Overall Study|Death|106
2689921|NCT00457392|9276882|P2|Overall Study|Objective Progression or Relapse|296
2689922|NCT00457392|9276883|P1|Overall Study|Objective Progression or Relapse|229
2689923|NCT00457301|9276910|P2|Overall Study|Death|7
2689924|NCT00457301|9276911|P1|Overall Study|Death|5
2689925|NCT00457301|9276910|P2|Overall Study|Censored out of the study|14
2689926|NCT00457301|9276911|P1|Overall Study|Censored out of the study|15
2689927|NCT00457301|9276910|P2|Overall Study|Withdrawal by Subject|3
2689928|NCT00457301|9276911|P1|Overall Study|Withdrawal by Subject|3
2689929|NCT00457249|9276925|P2|Overall Study|Serious Adverse Events|0
2689930|NCT00457249|9276926|P1|Overall Study|Serious Adverse Events|2
2689931|NCT00457249|9276925|P2|Overall Study|Withdrawal by Subject|1
2689932|NCT00457249|9276926|P1|Overall Study|Withdrawal by Subject|3
2689933|NCT00457249|9276925|P2|Overall Study|Protocol Violation|1
2689934|NCT00457249|9276926|P1|Overall Study|Protocol Violation|4
2689935|NCT00457249|9276925|P2|Overall Study|Lost to Follow-up|0
2689936|NCT00457249|9276926|P1|Overall Study|Lost to Follow-up|3
2689937|NCT00457015|9276965|P2|Overall Study|Left study site against medical advice|1
2689938|NCT00457015|9276966|P1|Overall Study|Left study site against medical advice|0
2689939|NCT00457002|9276982|P2|Overall Study|treated for 1 day; missing status/reason|0
2689940|NCT00457002|9276983|P1|Overall Study|treated for 1 day; missing status/reason|1
2689941|NCT00457002|9276982|P2|Overall Study|non-specified|38
2689942|NCT00457002|9276983|P1|Overall Study|non-specified|29
2689943|NCT00457002|9276982|P2|Overall Study|Administrative reason by Sponsor|0
2689944|NCT00457002|9276983|P1|Overall Study|Administrative reason by Sponsor|1
2689945|NCT00457002|9276982|P2|Overall Study|No longer met criteria|37
2689946|NCT00457002|9276983|P1|Overall Study|No longer met criteria|41
2689947|NCT00457002|9276982|P2|Overall Study|Poor/Non-compliance|33
2689948|NCT00457002|9276983|P1|Overall Study|Poor/Non-compliance|46
2689949|NCT00457002|9276982|P2|Overall Study|Lost to Follow-up|71
2689950|NCT00457002|9276983|P1|Overall Study|Lost to Follow-up|72
2689951|NCT00457002|9276982|P2|Overall Study|Withdrawal by Subject|271
2689952|NCT00457002|9276983|P1|Overall Study|Withdrawal by Subject|299
2689953|NCT00457002|9276982|P2|Overall Study|Adverse Event|260
2689954|NCT00457002|9276983|P1|Overall Study|Adverse Event|284
2689955|NCT00457002|9276982|P2|Overall Study|Death|47
2689956|NCT00457002|9276983|P1|Overall Study|Death|40
2689957|NCT00456846|9277088|P2|Overall Study|Other|2
2689958|NCT00456846|9277089|P1|Overall Study|Other|0
2689959|NCT00456846|9277088|P2|Overall Study|Participant Discretion|5
2689960|NCT00456846|9277089|P1|Overall Study|Participant Discretion|1
2689961|NCT00456846|9277088|P2|Overall Study|Protocol Deviation|0
2689962|NCT00456846|9277089|P1|Overall Study|Protocol Deviation|2
2689963|NCT00456846|9277088|P2|Overall Study|Physician Decision|6
2689964|NCT00456846|9277089|P1|Overall Study|Physician Decision|11
2689965|NCT00456846|9277088|P2|Overall Study|Adverse Event|15
2689966|NCT00456846|9277089|P1|Overall Study|Adverse Event|2
2689967|NCT00456755|9277130|P2|Overall Study|Lost to Follow-up|1
2689968|NCT00456755|9277131|P1|Overall Study|Lost to Follow-up|2
2689969|NCT00456612|9277145|P1|Overall Study|Withdrawal by Subject|3
2689970|NCT00456599|9277150|P1|Overall Study|Withdrawal by Subject|2
2689971|NCT00456599|9277150|P1|Overall Study|Non-compliance|1
2689972|NCT00456521|9277173|P2|Overall Study|Drug non-compliance, moved, other|11
2689973|NCT00456521|9277174|P1|Overall Study|Drug non-compliance, moved, other|26
2689974|NCT00456521|9277173|P2|Overall Study|Pregnancy|1
2689975|NCT00456521|9277174|P1|Overall Study|Pregnancy|1
2689976|NCT00456521|9277173|P2|Overall Study|Protocol Violation|0
2689977|NCT00456521|9277174|P1|Overall Study|Protocol Violation|4
2689978|NCT00456521|9277173|P2|Overall Study|Lack of Efficacy|6
2689979|NCT00456521|9277174|P1|Overall Study|Lack of Efficacy|3
2689980|NCT00456521|9277173|P2|Overall Study|Lost to Follow-up|17
2689981|NCT00456521|9277174|P1|Overall Study|Lost to Follow-up|22
2689982|NCT00456521|9277173|P2|Overall Study|Withdrawal by Subject|24
2689983|NCT00456521|9277174|P1|Overall Study|Withdrawal by Subject|43
2689984|NCT00456521|9277173|P2|Overall Study|Adverse Event|25
2689985|NCT00456521|9277174|P1|Overall Study|Adverse Event|150
2689986|NCT00456495|9277220|P1|Overall Study|Physician Decision|2
2689987|NCT00456365|9277227|P2|Overall Study|oncologic diagnosis|1
2689988|NCT00456365|9277228|P1|Overall Study|oncologic diagnosis|1
2689989|NCT00456365|9277227|P2|Overall Study|Pregnancy|1
2689990|NCT00456365|9277228|P1|Overall Study|Pregnancy|1
2689991|NCT00456365|9277227|P2|Overall Study|Withdrawal by Subject|7
2689992|NCT00456365|9277228|P1|Overall Study|Withdrawal by Subject|4
2689993|NCT00456365|9277227|P2|Overall Study|Lost to Follow-up|3
2689994|NCT00456365|9277228|P1|Overall Study|Lost to Follow-up|1
2689995|NCT00456300|9277240|P2|Overall Study|Adverse Event|0
2689996|NCT00456300|9277241|P1|Overall Study|Adverse Event|1
2689997|NCT00456092|9277265|P5|Treatment Phase (12 Weeks)|Other|0
2689998|NCT00456092|9277266|P4|Treatment Phase (12 Weeks)|Other|0
2689999|NCT00456092|9277267|P3|Treatment Phase (12 Weeks)|Other|1
2690000|NCT00456092|9277268|P2|Treatment Phase (12 Weeks)|Other|0
2690001|NCT00456092|9277269|P1|Treatment Phase (12 Weeks)|Other|1
2690002|NCT00456092|9277265|P5|Treatment Phase (12 Weeks)|Lost to Follow-up|0
2690003|NCT00456092|9277266|P4|Treatment Phase (12 Weeks)|Lost to Follow-up|0
2690004|NCT00456092|9277267|P3|Treatment Phase (12 Weeks)|Lost to Follow-up|1
2690005|NCT00456092|9277268|P2|Treatment Phase (12 Weeks)|Lost to Follow-up|1
2690006|NCT00456092|9277269|P1|Treatment Phase (12 Weeks)|Lost to Follow-up|0
2690007|NCT00456092|9277265|P5|Treatment Phase (12 Weeks)|Withdrew Consent|0
2690008|NCT00456092|9277266|P4|Treatment Phase (12 Weeks)|Withdrew Consent|0
2690009|NCT00456092|9277267|P3|Treatment Phase (12 Weeks)|Withdrew Consent|2
2690010|NCT00456092|9277268|P2|Treatment Phase (12 Weeks)|Withdrew Consent|1
2690011|NCT00456092|9277269|P1|Treatment Phase (12 Weeks)|Withdrew Consent|0
2690012|NCT00456092|9277265|P5|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
2690013|NCT00456092|9277266|P4|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
2690014|NCT00456092|9277267|P3|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7
2690015|NCT00456092|9277268|P2|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2
2690016|NCT00456092|9277269|P1|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
2690017|NCT00456092|9277265|P5|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
2690018|NCT00456092|9277266|P4|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
2690019|NCT00456092|9277267|P3|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3
2690020|NCT00456092|9277268|P2|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3
2690021|NCT00456092|9277269|P1|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
2690022|NCT00456092|9277265|P5|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
2690023|NCT00456092|9277266|P4|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
2690024|NCT00456092|9277267|P3|Treatment Phase (12 Weeks)|Flare of Psoriasis|2
2690025|NCT00456092|9277268|P2|Treatment Phase (12 Weeks)|Flare of Psoriasis|1
2690026|NCT00456092|9277269|P1|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
2690027|NCT00456092|9277265|P5|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
2690028|NCT00456092|9277266|P4|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
2690029|NCT00456092|9277267|P3|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
2690030|NCT00456092|9277268|P2|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
2690031|NCT00456092|9277269|P1|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2
2690032|NCT00456092|9277265|P5|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
2690033|NCT00456092|9277266|P4|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
2690034|NCT00456092|9277267|P3|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
2690035|NCT00456092|9277268|P2|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2
2690036|NCT00456092|9277269|P1|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1
2690037|NCT00456092|9277265|P5|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0
2690038|NCT00456092|9277266|P4|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0
2690039|NCT00456092|9277267|P3|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2
2690040|NCT00456092|9277268|P2|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4
2690041|NCT00456092|9277269|P1|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3
2690042|NCT00456092|9277265|P5|Extension Phase|Other|1
2690043|NCT00456092|9277266|P4|Extension Phase|Other|1
2690044|NCT00456092|9277267|P3|Extension Phase|Other|0
2690045|NCT00456092|9277268|P2|Extension Phase|Other|0
2690046|NCT00456092|9277269|P1|Extension Phase|Other|2
2690047|NCT00456092|9277265|P5|Extension Phase|Lost to Follow-up|1
2690048|NCT00456092|9277266|P4|Extension Phase|Lost to Follow-up|0
2690049|NCT00456092|9277267|P3|Extension Phase|Lost to Follow-up|0
2690050|NCT00456092|9277268|P2|Extension Phase|Lost to Follow-up|1
2690051|NCT00456092|9277269|P1|Extension Phase|Lost to Follow-up|1
2690052|NCT00456092|9277265|P5|Extension Phase|Withdrew Consent|0
2690053|NCT00456092|9277266|P4|Extension Phase|Withdrew Consent|0
2690054|NCT00456092|9277267|P3|Extension Phase|Withdrew Consent|0
2690055|NCT00456092|9277268|P2|Extension Phase|Withdrew Consent|0
2690056|NCT00456092|9277269|P1|Extension Phase|Withdrew Consent|2
2690057|NCT00456092|9277265|P5|Extension Phase|Worsening / Not Responding to Study Drug|2
2690058|NCT00456092|9277266|P4|Extension Phase|Worsening / Not Responding to Study Drug|0
2690059|NCT00456092|9277267|P3|Extension Phase|Worsening / Not Responding to Study Drug|0
2690060|NCT00456092|9277268|P2|Extension Phase|Worsening / Not Responding to Study Drug|1
2690061|NCT00456092|9277269|P1|Extension Phase|Worsening / Not Responding to Study Drug|3
2690062|NCT00456092|9277265|P5|Extension Phase|Flare of Psoriatic Arthritis|1
2690063|NCT00456092|9277266|P4|Extension Phase|Flare of Psoriatic Arthritis|0
2690064|NCT00456092|9277267|P3|Extension Phase|Flare of Psoriatic Arthritis|0
2690065|NCT00456092|9277268|P2|Extension Phase|Flare of Psoriatic Arthritis|0
2690066|NCT00456092|9277269|P1|Extension Phase|Flare of Psoriatic Arthritis|1
2690067|NCT00456092|9277265|P5|Extension Phase|Grade 2 or Greater AE|2
2690068|NCT00456092|9277266|P4|Extension Phase|Grade 2 or Greater AE|0
2690069|NCT00456092|9277267|P3|Extension Phase|Grade 2 or Greater AE|0
2690070|NCT00456092|9277268|P2|Extension Phase|Grade 2 or Greater AE|2
2690071|NCT00456092|9277269|P1|Extension Phase|Grade 2 or Greater AE|2
2690072|NCT00455923|9277451|P2|Overall Study|Other|1
2690073|NCT00455923|9277452|P1|Overall Study|Other|3
2690074|NCT00455923|9277451|P2|Overall Study|Pregnancy|2
2690075|NCT00455923|9277452|P1|Overall Study|Pregnancy|0
2690076|NCT00455858|9277468|P1|Overall Study|Withdrawal|1
2690077|NCT00455858|9277468|P1|Overall Study|Well controlled FPG without insulin|1
2690078|NCT00455858|9277468|P1|Overall Study|Lack of Efficacy|1
2690079|NCT00455858|9277468|P1|Overall Study|Protocol Violation|1
2690080|NCT00455858|9277468|P1|Overall Study|Lost to Follow-up|2
2690081|NCT00455741|9277478|P2|Overall Study|Physician Decision|1
2690082|NCT00455741|9277479|P1|Overall Study|Physician Decision|0
2690083|NCT00455533|9277575|P3|Period Two: Randomized Period|Subject Withdrew Consent|1
2690084|NCT00455533|9277576|P2|Period Two: Randomized Period|Subject Withdrew Consent|2
2690085|NCT00455533|9277577|P1|Period Two: Randomized Period|Subject Withdrew Consent|0
2690086|NCT00455533|9277575|P3|Period Two: Randomized Period|Study Drug Toxicity|0
2690087|NCT00455533|9277576|P2|Period Two: Randomized Period|Study Drug Toxicity|2
2690088|NCT00455533|9277577|P1|Period Two: Randomized Period|Study Drug Toxicity|0
2690089|NCT00455533|9277575|P3|Period Two: Randomized Period|Other - need reasons|0
2690090|NCT00455533|9277576|P2|Period Two: Randomized Period|Other - need reasons|1
2690091|NCT00455533|9277577|P1|Period Two: Randomized Period|Other - need reasons|0
2690092|NCT00455533|9277575|P3|Period Two: Randomized Period|Lost to Follow-up|1
2690093|NCT00455533|9277576|P2|Period Two: Randomized Period|Lost to Follow-up|0
2690094|NCT00455533|9277577|P1|Period Two: Randomized Period|Lost to Follow-up|0
2690095|NCT00455533|9277575|P3|Period Two: Randomized Period|Disease Progression|1
2690096|NCT00455533|9277576|P2|Period Two: Randomized Period|Disease Progression|1
2690097|NCT00455533|9277577|P1|Period Two: Randomized Period|Disease Progression|0
2690098|NCT00455533|9277575|P3|Period Two: Randomized Period|Death|3
2690099|NCT00455533|9277576|P2|Period Two: Randomized Period|Death|0
2690100|NCT00455533|9277577|P1|Period Two: Randomized Period|Death|0
2690101|NCT00455533|9277575|P3|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
2690102|NCT00455533|9277576|P2|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
2690103|NCT00455533|9277577|P1|Period One: Initial Chemotherapy|Subject Withdrew Consent|2
2690104|NCT00455533|9277575|P3|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
2690105|NCT00455533|9277576|P2|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
2690106|NCT00455533|9277577|P1|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2
2690107|NCT00455533|9277575|P3|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
2690108|NCT00455533|9277576|P2|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
2690109|NCT00455533|9277577|P1|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1
2690110|NCT00455533|9277575|P3|Period One: Initial Chemotherapy|Study Drug Toxicity|0
2690111|NCT00455533|9277576|P2|Period One: Initial Chemotherapy|Study Drug Toxicity|0
2690112|NCT00455533|9277577|P1|Period One: Initial Chemotherapy|Study Drug Toxicity|2
2690113|NCT00455533|9277575|P3|Period One: Initial Chemotherapy|Other--Need Reasons|0
2690114|NCT00455533|9277576|P2|Period One: Initial Chemotherapy|Other--Need Reasons|0
2690115|NCT00455533|9277577|P1|Period One: Initial Chemotherapy|Other--Need Reasons|2
2690116|NCT00455533|9277575|P3|Period One: Initial Chemotherapy|Not Reported|0
2690117|NCT00455533|9277576|P2|Period One: Initial Chemotherapy|Not Reported|0
2690118|NCT00455533|9277577|P1|Period One: Initial Chemotherapy|Not Reported|1
2690119|NCT00455533|9277575|P3|Period One: Initial Chemotherapy|Lost to Follow-up|0
2690120|NCT00455533|9277576|P2|Period One: Initial Chemotherapy|Lost to Follow-up|0
2690121|NCT00455533|9277577|P1|Period One: Initial Chemotherapy|Lost to Follow-up|2
2690122|NCT00455533|9277575|P3|Period One: Initial Chemotherapy|Disease Progression|0
2690123|NCT00455533|9277576|P2|Period One: Initial Chemotherapy|Disease Progression|0
2690124|NCT00455533|9277577|P1|Period One: Initial Chemotherapy|Disease Progression|5
2690125|NCT00455533|9277575|P3|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
2690126|NCT00455533|9277576|P2|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
2690127|NCT00455533|9277577|P1|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1
2690128|NCT00455520|9277626|P2|Double Blind Tapentadol ER vs Placebo|All other|6
2690129|NCT00455520|9277627|P1|Double Blind Tapentadol ER vs Placebo|All other|4
2690130|NCT00455520|9277626|P2|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2
2690131|NCT00455520|9277627|P1|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4
2690132|NCT00455520|9277626|P2|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
2690133|NCT00455520|9277627|P1|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
2690134|NCT00455520|9277626|P2|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7
2690135|NCT00455520|9277627|P1|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15
2690136|NCT00455520|9277626|P2|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29
2690137|NCT00455520|9277627|P1|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8
2690138|NCT00455520|9277626|P2|Double Blind Tapentadol ER vs Placebo|Adverse Event|15
2690139|NCT00455520|9277627|P1|Double Blind Tapentadol ER vs Placebo|Adverse Event|29
2690140|NCT00455520|9277626|P2|Open Label Tapentadol Extended Release|All other|0
2690141|NCT00455520|9277627|P1|Open Label Tapentadol Extended Release|All other|33
2690142|NCT00455520|9277626|P2|Open Label Tapentadol Extended Release|Study drug non-compliant|0
2690143|NCT00455520|9277627|P1|Open Label Tapentadol Extended Release|Study drug non-compliant|13
2690144|NCT00455520|9277626|P2|Open Label Tapentadol Extended Release|Lack of Efficacy|0
2690145|NCT00455520|9277627|P1|Open Label Tapentadol Extended Release|Lack of Efficacy|23
2690146|NCT00455520|9277626|P2|Open Label Tapentadol Extended Release|Adverse Event|0
2690147|NCT00455520|9277627|P1|Open Label Tapentadol Extended Release|Adverse Event|100
2690148|NCT00455520|9277626|P2|Open Label Tapentadol Extended Release|Lost to Follow-up|0
2690149|NCT00455520|9277627|P1|Open Label Tapentadol Extended Release|Lost to Follow-up|3
2690150|NCT00455520|9277626|P2|Open Label Tapentadol Extended Release|Withdrawal by Subject|0
2690151|NCT00455520|9277627|P1|Open Label Tapentadol Extended Release|Withdrawal by Subject|24
2690152|NCT00455455|9277643|P2|Washout|Withdrawal by Subject|0
2690153|NCT00455455|9277644|P1|Washout|Withdrawal by Subject|1
2690154|NCT00455455|9277643|P2|Washout|Withdrawal by Subject|1
2690155|NCT00455455|9277644|P1|Washout|Withdrawal by Subject|0
2690156|NCT00455429|9277664|P4|Overall Study|Other|1
2690157|NCT00455429|9277665|P3|Overall Study|Other|0
2690158|NCT00455429|9277666|P2|Overall Study|Other|2
2690159|NCT00455429|9277667|P1|Overall Study|Other|0
2690160|NCT00455429|9277664|P4|Overall Study|Non-compliance|1
2690161|NCT00455429|9277665|P3|Overall Study|Non-compliance|0
2690162|NCT00455429|9277666|P2|Overall Study|Non-compliance|0
2690163|NCT00455429|9277667|P1|Overall Study|Non-compliance|0
2690164|NCT00455429|9277664|P4|Overall Study|Personal Reason|0
2690165|NCT00455429|9277665|P3|Overall Study|Personal Reason|0
2690166|NCT00455429|9277666|P2|Overall Study|Personal Reason|0
2690167|NCT00455429|9277667|P1|Overall Study|Personal Reason|1
2690168|NCT00455429|9277664|P4|Overall Study|Randomly assigned but not treated|2
2690169|NCT00455429|9277665|P3|Overall Study|Randomly assigned but not treated|0
2690170|NCT00455429|9277666|P2|Overall Study|Randomly assigned but not treated|0
2690171|NCT00455429|9277667|P1|Overall Study|Randomly assigned but not treated|0
2690172|NCT00455429|9277664|P4|Overall Study|Adverse Event|3
2690173|NCT00455429|9277665|P3|Overall Study|Adverse Event|0
2690174|NCT00455429|9277666|P2|Overall Study|Adverse Event|1
2690175|NCT00455429|9277667|P1|Overall Study|Adverse Event|0
2690176|NCT00455429|9277664|P4|Overall Study|Lack of Efficacy|1
2690177|NCT00455429|9277665|P3|Overall Study|Lack of Efficacy|0
2690178|NCT00455429|9277666|P2|Overall Study|Lack of Efficacy|1
2690179|NCT00455429|9277667|P1|Overall Study|Lack of Efficacy|0
2690180|NCT00455429|9277664|P4|Overall Study|Withdrawal by Subject|0
2690181|NCT00455429|9277665|P3|Overall Study|Withdrawal by Subject|1
2690182|NCT00455429|9277666|P2|Overall Study|Withdrawal by Subject|1
2690183|NCT00455429|9277667|P1|Overall Study|Withdrawal by Subject|0
2690184|NCT00455429|9277664|P4|Overall Study|Lost to Follow-up|3
2690185|NCT00455429|9277665|P3|Overall Study|Lost to Follow-up|0
2690186|NCT00455429|9277666|P2|Overall Study|Lost to Follow-up|0
2690187|NCT00455429|9277667|P1|Overall Study|Lost to Follow-up|1
2690188|NCT00455429|9277664|P4|Overall Study|Study Terminated by Sponsor|3
2690189|NCT00455429|9277665|P3|Overall Study|Study Terminated by Sponsor|0
2690190|NCT00455429|9277666|P2|Overall Study|Study Terminated by Sponsor|0
2690191|NCT00455429|9277667|P1|Overall Study|Study Terminated by Sponsor|0
2690192|NCT00455312|9277726|P2|Overall Study|Death|1
2690193|NCT00455312|9277727|P1|Overall Study|Death|0
2690194|NCT00455195|9277753|P2|Double-blind Study AGLU02704|Unable to commit time to study|1
2690195|NCT00455195|9277754|P1|Double-blind Study AGLU02704|Unable to commit time to study|0
2690196|NCT00455195|9277753|P2|Double-blind Study AGLU02704|Withdrawal by Subject|2
2690197|NCT00455195|9277754|P1|Double-blind Study AGLU02704|Withdrawal by Subject|2
2690198|NCT00455195|9277753|P2|Double-blind Study AGLU02704|Death|0
2690199|NCT00455195|9277754|P1|Double-blind Study AGLU02704|Death|1
2690200|NCT00455195|9277753|P2|Double-blind Study AGLU02704|Adverse Event|1
2690201|NCT00455195|9277754|P1|Double-blind Study AGLU02704|Adverse Event|2
2690202|NCT00455143|9277768|P1|Overall Study|Surgical time, staff not available|1
2690203|NCT00455143|9277768|P1|Overall Study|No longer met Inclusion Criteria|1
2690204|NCT00455143|9277768|P1|Overall Study|Staff was not avail to follow patient|2
2690205|NCT00455143|9277768|P1|Overall Study|Withdrawal by Subject|1
2690206|NCT00455143|9277768|P1|Overall Study|Physician Decision|1
2690207|NCT00455013|9277792|P3|Long Term Extension (LTE)|non-specified|1
2690208|NCT00455013|9277793|P2|Long Term Extension (LTE)|non-specified|0
2690209|NCT00455013|9277794|P1|Long Term Extension (LTE)|non-specified|0
2690210|NCT00455013|9277792|P3|Long Term Extension (LTE)|Poor non-compliance|0
2690211|NCT00455013|9277793|P2|Long Term Extension (LTE)|Poor non-compliance|1
2690212|NCT00455013|9277794|P1|Long Term Extension (LTE)|Poor non-compliance|0
2690213|NCT00455013|9277792|P3|Long Term Extension (LTE)|Subject Request or refused|3
2690214|NCT00455013|9277793|P2|Long Term Extension (LTE)|Subject Request or refused|0
2690215|NCT00455013|9277794|P1|Long Term Extension (LTE)|Subject Request or refused|0
2690216|NCT00455013|9277792|P3|Long Term Extension (LTE)|No longer met criteria|1
2690217|NCT00455013|9277793|P2|Long Term Extension (LTE)|No longer met criteria|0
2690218|NCT00455013|9277794|P1|Long Term Extension (LTE)|No longer met criteria|0
2690219|NCT00455013|9277792|P3|Long Term Extension (LTE)|Death|0
2690220|NCT00455013|9277793|P2|Long Term Extension (LTE)|Death|1
2690221|NCT00455013|9277794|P1|Long Term Extension (LTE)|Death|1
2690222|NCT00455013|9277792|P3|Long Term Extension (LTE)|Withdrawal by Subject|1
2690223|NCT00455013|9277793|P2|Long Term Extension (LTE)|Withdrawal by Subject|0
2690224|NCT00455013|9277794|P1|Long Term Extension (LTE)|Withdrawal by Subject|1
2690225|NCT00455013|9277792|P3|Long Term Extension (LTE)|Adverse Event|1
2690226|NCT00455013|9277793|P2|Long Term Extension (LTE)|Adverse Event|1
2690227|NCT00455013|9277794|P1|Long Term Extension (LTE)|Adverse Event|0
2690228|NCT00455013|9277792|P3|Short Term Period|Other|1
2690229|NCT00455013|9277793|P2|Short Term Period|Other|0
2690230|NCT00455013|9277794|P1|Short Term Period|Other|0
2690231|NCT00455013|9277792|P3|Short Term Period|Lack of Efficacy|0
2690232|NCT00455013|9277793|P2|Short Term Period|Lack of Efficacy|0
2690233|NCT00455013|9277794|P1|Short Term Period|Lack of Efficacy|4
2690234|NCT00455013|9277792|P3|Short Term Period|Withdrawal by Subject|1
2690235|NCT00455013|9277793|P2|Short Term Period|Withdrawal by Subject|0
2690236|NCT00455013|9277794|P1|Short Term Period|Withdrawal by Subject|0
2690237|NCT00455013|9277792|P3|Short Term Period|Adverse Event|0
2690238|NCT00455013|9277793|P2|Short Term Period|Adverse Event|5
2690239|NCT00455013|9277794|P1|Short Term Period|Adverse Event|2
2690240|NCT00454987|9277862|P3|Booster Period|Lost to Follow-up|0
2690241|NCT00454987|9277863|P2|Booster Period|Lost to Follow-up|0
2690242|NCT00454987|9277864|P1|Booster Period|Lost to Follow-up|1
2690243|NCT00454987|9277862|P3|Booster Period|Withdrawal by Subject|0
2690244|NCT00454987|9277863|P2|Booster Period|Withdrawal by Subject|1
2690245|NCT00454987|9277864|P1|Booster Period|Withdrawal by Subject|0
2690246|NCT00454987|9277862|P3|Booster Period|Adverse Event|0
2690247|NCT00454987|9277863|P2|Booster Period|Adverse Event|0
2690248|NCT00454987|9277864|P1|Booster Period|Adverse Event|1
2690249|NCT00454909|9277938|P3|Overall Study|Others|0
2690250|NCT00454909|9277939|P2|Overall Study|Others|0
2690251|NCT00454909|9277940|P1|Overall Study|Others|1
2690252|NCT00454909|9277938|P3|Overall Study|Lost to follow-up (complete vaccination)|1
2690253|NCT00454909|9277939|P2|Overall Study|Lost to follow-up (complete vaccination)|3
2690254|NCT00454909|9277940|P1|Overall Study|Lost to follow-up (complete vaccination)|5
2690255|NCT00454909|9277938|P3|Overall Study|Migrated/moved from study area|1
2690256|NCT00454909|9277939|P2|Overall Study|Migrated/moved from study area|0
2690257|NCT00454909|9277940|P1|Overall Study|Migrated/moved from study area|0
2690258|NCT00454909|9277938|P3|Overall Study|Withdrawal by Subject|0
2690259|NCT00454909|9277939|P2|Overall Study|Withdrawal by Subject|0
2690260|NCT00454909|9277940|P1|Overall Study|Withdrawal by Subject|1
2690261|NCT00454857|9277978|P1|Overall Study|Reason unknown|1
2690262|NCT00454857|9277978|P1|Overall Study|Other|11
2690263|NCT00454857|9277978|P1|Overall Study|Death|5
2690264|NCT00454857|9277978|P1|Overall Study|Noncompliance|6
2690265|NCT00454857|9277978|P1|Overall Study|Lost to Follow-up|16
2690266|NCT00454857|9277978|P1|Overall Study|Withdrawal by Subject|15
2690267|NCT00454818|9278003|P5|Phase 2: Randomized Double-blind|Received left ventricular assist device|2
2690268|NCT00454818|9278004|P4|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
2690269|NCT00454818|9278005|P3|Phase 2: Randomized Double-blind|Received left ventricular assist device|1
2690270|NCT00454818|9278006|P2|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
2690271|NCT00454818|9278007|P1|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
2690272|NCT00454818|9278003|P5|Phase 2: Randomized Double-blind|Received a heart transplant|1
2690273|NCT00454818|9278004|P4|Phase 2: Randomized Double-blind|Received a heart transplant|0
2690274|NCT00454818|9278005|P3|Phase 2: Randomized Double-blind|Received a heart transplant|2
2690275|NCT00454818|9278006|P2|Phase 2: Randomized Double-blind|Received a heart transplant|0
2690276|NCT00454818|9278007|P1|Phase 2: Randomized Double-blind|Received a heart transplant|0
2690277|NCT00454818|9278003|P5|Phase 2: Randomized Double-blind|Death|1
2690278|NCT00454818|9278004|P4|Phase 2: Randomized Double-blind|Death|0
2690279|NCT00454818|9278005|P3|Phase 2: Randomized Double-blind|Death|0
2690280|NCT00454818|9278006|P2|Phase 2: Randomized Double-blind|Death|1
2690281|NCT00454818|9278007|P1|Phase 2: Randomized Double-blind|Death|0
2690282|NCT00454818|9278003|P5|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
2690283|NCT00454818|9278004|P4|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
2690284|NCT00454818|9278005|P3|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
2690285|NCT00454818|9278006|P2|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
2690286|NCT00454818|9278007|P1|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
2690287|NCT00454818|9278003|P5|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
2690288|NCT00454818|9278004|P4|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
2690289|NCT00454818|9278005|P3|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
2690290|NCT00454818|9278006|P2|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
2690291|NCT00454818|9278007|P1|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
2690292|NCT00454818|9278003|P5|Phase I: Open-label Dose-escalation|Death|0
2690293|NCT00454818|9278004|P4|Phase I: Open-label Dose-escalation|Death|0
2690294|NCT00454818|9278005|P3|Phase I: Open-label Dose-escalation|Death|0
2690295|NCT00454818|9278006|P2|Phase I: Open-label Dose-escalation|Death|1
2690296|NCT00454818|9278007|P1|Phase I: Open-label Dose-escalation|Death|0
2690297|NCT00454818|9278003|P5|Phase I: Open-label Dose-escalation|Received heart transplant|0
2690298|NCT00454818|9278004|P4|Phase I: Open-label Dose-escalation|Received heart transplant|0
2690299|NCT00454818|9278005|P3|Phase I: Open-label Dose-escalation|Received heart transplant|0
2690300|NCT00454818|9278006|P2|Phase I: Open-label Dose-escalation|Received heart transplant|0
2690301|NCT00454818|9278007|P1|Phase I: Open-label Dose-escalation|Received heart transplant|1
2690302|NCT00454805|9278086|P2|Overall Study|In order to begin radiotherapy|0
2690303|NCT00454805|9278087|P1|Overall Study|In order to begin radiotherapy|1
2690304|NCT00454805|9278086|P2|Overall Study|Disease progression|19
2690305|NCT00454805|9278087|P1|Overall Study|Disease progression|16
2690306|NCT00454805|9278086|P2|Overall Study|Death|2
2690307|NCT00454805|9278087|P1|Overall Study|Death|0
2690308|NCT00454805|9278086|P2|Overall Study|Withdrawal by Subject|2
2690309|NCT00454805|9278087|P1|Overall Study|Withdrawal by Subject|9
2690310|NCT00454779|9278103|P2|Second-line Treatment Phase|Ongoing|1
2690311|NCT00454779|9278104|P1|Second-line Treatment Phase|Ongoing|0
2690312|NCT00454779|9278103|P2|Second-line Treatment Phase|Ended follow-up prior to analysis|1
2690313|NCT00454779|9278104|P1|Second-line Treatment Phase|Ended follow-up prior to analysis|0
2690314|NCT00454779|9278103|P2|Second-line Treatment Phase|Withdrawal by Subject|1
2690315|NCT00454779|9278104|P1|Second-line Treatment Phase|Withdrawal by Subject|0
2690316|NCT00454779|9278103|P2|First-line Treatment Phase|Ongoing|0
2690317|NCT00454779|9278104|P1|First-line Treatment Phase|Ongoing|1
2690318|NCT00454779|9278103|P2|First-line Treatment Phase|Ended follow-up prior to analysis|1
2690319|NCT00454779|9278104|P1|First-line Treatment Phase|Ended follow-up prior to analysis|1
2690320|NCT00454779|9278103|P2|First-line Treatment Phase|Protocol Violation|1
2690321|NCT00454779|9278104|P1|First-line Treatment Phase|Protocol Violation|0
2690322|NCT00454779|9278103|P2|First-line Treatment Phase|Lost to Follow-up|0
2690323|NCT00454779|9278104|P1|First-line Treatment Phase|Lost to Follow-up|1
2690324|NCT00454779|9278103|P2|First-line Treatment Phase|Withdrawal by Subject|4
2690325|NCT00454779|9278104|P1|First-line Treatment Phase|Withdrawal by Subject|2
2690326|NCT00454779|9278103|P2|First-line Treatment Phase|Lack of Efficacy|2
2690327|NCT00454779|9278104|P1|First-line Treatment Phase|Lack of Efficacy|0
2690328|NCT00454649|9278142|P10|Overall Study|Withdrawal by Subject|0
2690329|NCT00454649|9278143|P9|Overall Study|Withdrawal by Subject|1
2690330|NCT00454649|9278144|P8|Overall Study|Withdrawal by Subject|2
2690331|NCT00454649|9278145|P7|Overall Study|Withdrawal by Subject|0
2690332|NCT00454649|9278146|P6|Overall Study|Withdrawal by Subject|1
2690333|NCT00454649|9278147|P5|Overall Study|Withdrawal by Subject|0
2690334|NCT00454649|9278148|P4|Overall Study|Withdrawal by Subject|0
2690335|NCT00454649|9278149|P3|Overall Study|Withdrawal by Subject|0
2690336|NCT00454649|9278150|P2|Overall Study|Withdrawal by Subject|0
2690337|NCT00454649|9278151|P1|Overall Study|Withdrawal by Subject|0
2690338|NCT00454649|9278142|P10|Overall Study|Other|1
2690339|NCT00454649|9278143|P9|Overall Study|Other|3
2690340|NCT00454649|9278144|P8|Overall Study|Other|0
2690341|NCT00454649|9278145|P7|Overall Study|Other|0
2690342|NCT00454649|9278146|P6|Overall Study|Other|0
2690343|NCT00454649|9278147|P5|Overall Study|Other|0
2690344|NCT00454649|9278148|P4|Overall Study|Other|3
2690345|NCT00454649|9278149|P3|Overall Study|Other|5
2690346|NCT00454649|9278150|P2|Overall Study|Other|1
2690347|NCT00454649|9278151|P1|Overall Study|Other|1
2690348|NCT00454649|9278142|P10|Overall Study|Lost to Follow-up|0
2690349|NCT00454649|9278143|P9|Overall Study|Lost to Follow-up|0
2690350|NCT00454649|9278144|P8|Overall Study|Lost to Follow-up|0
2690351|NCT00454649|9278145|P7|Overall Study|Lost to Follow-up|1
2690352|NCT00454649|9278146|P6|Overall Study|Lost to Follow-up|0
2690353|NCT00454649|9278147|P5|Overall Study|Lost to Follow-up|0
2690354|NCT00454649|9278148|P4|Overall Study|Lost to Follow-up|0
2690355|NCT00454649|9278149|P3|Overall Study|Lost to Follow-up|1
2690356|NCT00454649|9278150|P2|Overall Study|Lost to Follow-up|0
2690357|NCT00454649|9278151|P1|Overall Study|Lost to Follow-up|0
2690358|NCT00454649|9278142|P10|Overall Study|Adverse Event|2
2690359|NCT00454649|9278143|P9|Overall Study|Adverse Event|6
2690360|NCT00454649|9278144|P8|Overall Study|Adverse Event|4
2690361|NCT00454649|9278145|P7|Overall Study|Adverse Event|3
2690362|NCT00454649|9278146|P6|Overall Study|Adverse Event|2
2690363|NCT00454649|9278147|P5|Overall Study|Adverse Event|1
2690364|NCT00454649|9278148|P4|Overall Study|Adverse Event|0
2690365|NCT00454649|9278149|P3|Overall Study|Adverse Event|3
2690366|NCT00454649|9278150|P2|Overall Study|Adverse Event|1
2690367|NCT00454649|9278151|P1|Overall Study|Adverse Event|0
2690368|NCT00454649|9278142|P10|Overall Study|Lack of Efficacy|2
2690369|NCT00454649|9278143|P9|Overall Study|Lack of Efficacy|10
2690370|NCT00454649|9278144|P8|Overall Study|Lack of Efficacy|13
2690371|NCT00454649|9278145|P7|Overall Study|Lack of Efficacy|5
2690372|NCT00454649|9278146|P6|Overall Study|Lack of Efficacy|4
2690373|NCT00454649|9278147|P5|Overall Study|Lack of Efficacy|0
2690374|NCT00454649|9278148|P4|Overall Study|Lack of Efficacy|3
2690375|NCT00454649|9278149|P3|Overall Study|Lack of Efficacy|10
2690376|NCT00454649|9278150|P2|Overall Study|Lack of Efficacy|2
2690377|NCT00454649|9278151|P1|Overall Study|Lack of Efficacy|2
2690378|NCT00454636|9278280|P4|Overall Study|Lost to Follow-up|0
2690379|NCT00454636|9278281|P3|Overall Study|Lost to Follow-up|0
2690380|NCT00454636|9278282|P2|Overall Study|Lost to Follow-up|1
2690381|NCT00454636|9278283|P1|Overall Study|Lost to Follow-up|0
2690382|NCT00454636|9278280|P4|Overall Study|Patient refusal|2
2690383|NCT00454636|9278281|P3|Overall Study|Patient refusal|3
2690384|NCT00454636|9278282|P2|Overall Study|Patient refusal|1
2690385|NCT00454636|9278283|P1|Overall Study|Patient refusal|1
2690386|NCT00454636|9278280|P4|Overall Study|Death|1
2690387|NCT00454636|9278281|P3|Overall Study|Death|1
2690388|NCT00454636|9278282|P2|Overall Study|Death|1
2690389|NCT00454636|9278283|P1|Overall Study|Death|6
2690390|NCT00454636|9278280|P4|Overall Study|Protocol Violation|3
2690391|NCT00454636|9278281|P3|Overall Study|Protocol Violation|3
2690392|NCT00454636|9278282|P2|Overall Study|Protocol Violation|2
2690393|NCT00454636|9278283|P1|Overall Study|Protocol Violation|3
2690394|NCT00454636|9278280|P4|Overall Study|Disease Progression|11
2690395|NCT00454636|9278281|P3|Overall Study|Disease Progression|4
2690396|NCT00454636|9278282|P2|Overall Study|Disease Progression|12
2690397|NCT00454636|9278283|P1|Overall Study|Disease Progression|11
2690398|NCT00454636|9278280|P4|Overall Study|Adverse Event|15
2690399|NCT00454636|9278281|P3|Overall Study|Adverse Event|9
2690400|NCT00454636|9278282|P2|Overall Study|Adverse Event|6
2690401|NCT00454636|9278283|P1|Overall Study|Adverse Event|10
2690402|NCT00454584|9278316|P6|After Controlled Period|Other|17
2690403|NCT00454584|9278317|P5|After Controlled Period|Other|5
2690404|NCT00454584|9278318|P4|After Controlled Period|Other|13
2690405|NCT00454584|9278319|P3|After Controlled Period|Other|0
2690406|NCT00454584|9278320|P2|After Controlled Period|Other|0
2690407|NCT00454584|9278321|P1|After Controlled Period|Other|0
2690408|NCT00454584|9278316|P6|After Controlled Period|Other|0
2690409|NCT00454584|9278317|P5|After Controlled Period|Other|0
2690410|NCT00454584|9278318|P4|After Controlled Period|Other|1
2690411|NCT00454584|9278319|P3|After Controlled Period|Other|0
2690412|NCT00454584|9278320|P2|After Controlled Period|Other|0
2690413|NCT00454584|9278321|P1|After Controlled Period|Other|0
2690414|NCT00454584|9278316|P6|After Controlled Period|Lost to Follow-up|6
2690415|NCT00454584|9278317|P5|After Controlled Period|Lost to Follow-up|4
2690416|NCT00454584|9278318|P4|After Controlled Period|Lost to Follow-up|2
2690417|NCT00454584|9278319|P3|After Controlled Period|Lost to Follow-up|0
2690418|NCT00454584|9278320|P2|After Controlled Period|Lost to Follow-up|0
2690419|NCT00454584|9278321|P1|After Controlled Period|Lost to Follow-up|0
2690420|NCT00454584|9278316|P6|After Controlled Period|Lack of Efficacy|0
2690421|NCT00454584|9278317|P5|After Controlled Period|Lack of Efficacy|0
2690422|NCT00454584|9278318|P4|After Controlled Period|Lack of Efficacy|1
2690423|NCT00454584|9278319|P3|After Controlled Period|Lack of Efficacy|0
2690424|NCT00454584|9278320|P2|After Controlled Period|Lack of Efficacy|0
2690425|NCT00454584|9278321|P1|After Controlled Period|Lack of Efficacy|0
2690426|NCT00454584|9278316|P6|After Controlled Period|Adverse Event|9
2690427|NCT00454584|9278317|P5|After Controlled Period|Adverse Event|3
2690428|NCT00454584|9278318|P4|After Controlled Period|Adverse Event|9
2690429|NCT00454584|9278319|P3|After Controlled Period|Adverse Event|0
2690430|NCT00454584|9278320|P2|After Controlled Period|Adverse Event|0
2690431|NCT00454584|9278321|P1|After Controlled Period|Adverse Event|0
2690432|NCT00454584|9278316|P6|Controlled Period|Other|0
2690433|NCT00454584|9278317|P5|Controlled Period|Other|0
2690434|NCT00454584|9278318|P4|Controlled Period|Other|0
2690435|NCT00454584|9278319|P3|Controlled Period|Other|2
2690436|NCT00454584|9278320|P2|Controlled Period|Other|4
2690437|NCT00454584|9278321|P1|Controlled Period|Other|5
2690438|NCT00454584|9278316|P6|Controlled Period|Lost to Follow-up|0
2690439|NCT00454584|9278317|P5|Controlled Period|Lost to Follow-up|0
2690440|NCT00454584|9278318|P4|Controlled Period|Lost to Follow-up|0
2690441|NCT00454584|9278319|P3|Controlled Period|Lost to Follow-up|2
2690442|NCT00454584|9278320|P2|Controlled Period|Lost to Follow-up|2
2690443|NCT00454584|9278321|P1|Controlled Period|Lost to Follow-up|1
2690444|NCT00454584|9278316|P6|Controlled Period|Adverse Event|0
2690445|NCT00454584|9278317|P5|Controlled Period|Adverse Event|0
2690446|NCT00454584|9278318|P4|Controlled Period|Adverse Event|0
2690447|NCT00454584|9278319|P3|Controlled Period|Adverse Event|1
2690448|NCT00454584|9278320|P2|Controlled Period|Adverse Event|2
2690449|NCT00454584|9278321|P1|Controlled Period|Adverse Event|5
2690450|NCT00454571|9278343|P2|Overall Study|Withdrawal by Subject|5
2690451|NCT00454571|9278344|P1|Overall Study|Withdrawal by Subject|10
2690452|NCT00454571|9278343|P2|Overall Study|Protocol Violation|0
2690453|NCT00454571|9278344|P1|Overall Study|Protocol Violation|1
2690454|NCT00454571|9278343|P2|Overall Study|Physician Decision|1
2690455|NCT00454571|9278344|P1|Overall Study|Physician Decision|0
2690456|NCT00454571|9278343|P2|Overall Study|Adverse Event|0
2690457|NCT00454571|9278344|P1|Overall Study|Adverse Event|2
2690458|NCT00454363|9278379|P2|Overall Study|Withdrawal prior to 12 weeks treatment|0
2690459|NCT00454363|9278380|P1|Overall Study|Withdrawal prior to 12 weeks treatment|4
2690460|NCT00454363|9278379|P2|Overall Study|Adverse Event|2
2690461|NCT00454363|9278380|P1|Overall Study|Adverse Event|1
2690462|NCT00454246|9278409|P3|Overall Study|Early termination of study|9
2690463|NCT00454246|9278410|P2|Overall Study|Early termination of study|26
2690464|NCT00454246|9278411|P1|Overall Study|Early termination of study|62
2690465|NCT00454246|9278409|P3|Overall Study|Failure to return|0
2690466|NCT00454246|9278410|P2|Overall Study|Failure to return|0
2690467|NCT00454246|9278411|P1|Overall Study|Failure to return|1
2690468|NCT00454246|9278409|P3|Overall Study|Refused Treatment|0
2690469|NCT00454246|9278410|P2|Overall Study|Refused Treatment|1
2690470|NCT00454246|9278411|P1|Overall Study|Refused Treatment|1
2690471|NCT00454246|9278409|P3|Overall Study|Protocol Violation|0
2690472|NCT00454246|9278410|P2|Overall Study|Protocol Violation|0
2690473|NCT00454246|9278411|P1|Overall Study|Protocol Violation|1
2690474|NCT00454246|9278409|P3|Overall Study|Violation of selection criteria at entry|0
2690475|NCT00454246|9278410|P2|Overall Study|Violation of selection criteria at entry|0
2690476|NCT00454246|9278411|P1|Overall Study|Violation of selection criteria at entry|6
2690477|NCT00454246|9278409|P3|Overall Study|Adverse Event|0
2690478|NCT00454246|9278410|P2|Overall Study|Adverse Event|2
2690479|NCT00454246|9278411|P1|Overall Study|Adverse Event|2
2690480|NCT00454207|9278427|P2|Overall Study|Protocol Violation|1
2690481|NCT00454207|9278428|P1|Overall Study|Protocol Violation|0
2690482|NCT00454207|9278427|P2|Overall Study|Lack of Efficacy|0
2690483|NCT00454207|9278428|P1|Overall Study|Lack of Efficacy|1
2690484|NCT00454207|9278427|P2|Overall Study|Adverse Event|1
2690485|NCT00454207|9278428|P1|Overall Study|Adverse Event|3
2690486|NCT00454194|9278473|P2|Overall Study|Other Unspecified Reason|2
2690487|NCT00454194|9278474|P1|Overall Study|Other Unspecified Reason|2
2690488|NCT00454194|9278473|P2|Overall Study|Other Medical Problems|2
2690489|NCT00454194|9278474|P1|Overall Study|Other Medical Problems|1
2690490|NCT00454194|9278473|P2|Overall Study|Withdrawal by Subject|8
2690491|NCT00454194|9278474|P1|Overall Study|Withdrawal by Subject|12
2690492|NCT00454194|9278473|P2|Overall Study|Adverse Event|2
2690493|NCT00454194|9278474|P1|Overall Study|Adverse Event|7
2690494|NCT00454181|9278492|P2|Overall Study|Withdrawal by Subject|0
2690495|NCT00454181|9278493|P1|Overall Study|Withdrawal by Subject|2
2690496|NCT00454181|9278492|P2|Overall Study|Protocol Violation|1
2690497|NCT00454181|9278493|P1|Overall Study|Protocol Violation|1
2690498|NCT00454181|9278492|P2|Overall Study|Lost to Follow-up|1
2690499|NCT00454181|9278493|P1|Overall Study|Lost to Follow-up|11
2690500|NCT00454181|9278492|P2|Overall Study|Adverse Event|1
2690501|NCT00454181|9278493|P1|Overall Study|Adverse Event|1
2690502|NCT00454142|9278509|P1|Overall Study|Withdrawal by Subject|1
2690503|NCT00454116|9278527|P3|Overall Study|Other|0
2690504|NCT00454116|9278528|P2|Overall Study|Other|2
2690505|NCT00454116|9278529|P1|Overall Study|Other|2
2690506|NCT00454116|9278527|P3|Overall Study|Withdrawal by Subject|1
2690507|NCT00454116|9278528|P2|Overall Study|Withdrawal by Subject|3
2690508|NCT00454116|9278529|P1|Overall Study|Withdrawal by Subject|3
2690509|NCT00454116|9278527|P3|Overall Study|Condition under investigation worsened|18
2690510|NCT00454116|9278528|P2|Overall Study|Condition under investigation worsened|13
2690511|NCT00454116|9278529|P1|Overall Study|Condition under investigation worsened|17
2690512|NCT00454116|9278527|P3|Overall Study|Adverse Event|9
2690513|NCT00454116|9278528|P2|Overall Study|Adverse Event|11
2690514|NCT00454116|9278529|P1|Overall Study|Adverse Event|5
2690515|NCT00454051|9278539|P2|Overall Study|Protocol Violation|1
2690516|NCT00454051|9278540|P1|Overall Study|Protocol Violation|1
2690517|NCT00454051|9278539|P2|Overall Study|Withdrawal by Subject|0
2690518|NCT00454051|9278540|P1|Overall Study|Withdrawal by Subject|1
2690519|NCT00454051|9278539|P2|Overall Study|Adverse Event|2
2690520|NCT00454051|9278540|P1|Overall Study|Adverse Event|1
2690521|NCT00453999|9278573|P3|Overall Study|Subject Request|0
2690522|NCT00453999|9278574|P2|Overall Study|Subject Request|1
2690523|NCT00453999|9278575|P1|Overall Study|Subject Request|2
2690524|NCT00453999|9278573|P3|Overall Study|Withdrawal by Subject|1
2690525|NCT00453999|9278574|P2|Overall Study|Withdrawal by Subject|1
2690526|NCT00453999|9278575|P1|Overall Study|Withdrawal by Subject|2
2690527|NCT00453999|9278573|P3|Overall Study|Lost to Follow-up|1
2690528|NCT00453999|9278574|P2|Overall Study|Lost to Follow-up|1
2690529|NCT00453999|9278575|P1|Overall Study|Lost to Follow-up|0
2690530|NCT00453999|9278573|P3|Overall Study|Adverse Event|1
2690531|NCT00453999|9278574|P2|Overall Study|Adverse Event|2
2690532|NCT00453999|9278575|P1|Overall Study|Adverse Event|1
2690533|NCT00453986|9278603|P5|Overall Study|Lost to Follow-up|0
2690534|NCT00453986|9278604|P4|Overall Study|Lost to Follow-up|2
2690535|NCT00453986|9278605|P3|Overall Study|Lost to Follow-up|6
2690536|NCT00453986|9278606|P2|Overall Study|Lost to Follow-up|5
2690537|NCT00453986|9278607|P1|Overall Study|Lost to Follow-up|6
2690538|NCT00453973|9278700|P2|Overall Study|Sponsor Decision to Terminate Study|30
2690539|NCT00453973|9278701|P1|Overall Study|Sponsor Decision to Terminate Study|35
2690540|NCT00453973|9278700|P2|Overall Study|Site closed by sponsor|0
2690541|NCT00453973|9278701|P1|Overall Study|Site closed by sponsor|3
2690542|NCT00453973|9278700|P2|Overall Study|Renal transplant|1
2690543|NCT00453973|9278701|P1|Overall Study|Renal transplant|1
2690544|NCT00453973|9278700|P2|Overall Study|Relocation|0
2690545|NCT00453973|9278701|P1|Overall Study|Relocation|1
2690546|NCT00453973|9278700|P2|Overall Study|PI Decision|2
2690547|NCT00453973|9278701|P1|Overall Study|PI Decision|0
2690548|NCT00453973|9278700|P2|Overall Study|Withdrawal by Subject|6
2690549|NCT00453973|9278701|P1|Overall Study|Withdrawal by Subject|7
2690550|NCT00453973|9278700|P2|Overall Study|Adverse Event|9
2690551|NCT00453973|9278701|P1|Overall Study|Adverse Event|4
2690552|NCT00453921|9278711|P4|Overall Study|Lost to Follow-up|0
2690553|NCT00453921|9278712|P3|Overall Study|Lost to Follow-up|1
2690554|NCT00453921|9278713|P2|Overall Study|Lost to Follow-up|0
2690555|NCT00453921|9278714|P1|Overall Study|Lost to Follow-up|0
2690556|NCT00453921|9278711|P4|Overall Study|Withdrawal by Subject|1
2690557|NCT00453921|9278712|P3|Overall Study|Withdrawal by Subject|1
2690558|NCT00453921|9278713|P2|Overall Study|Withdrawal by Subject|1
2690559|NCT00453921|9278714|P1|Overall Study|Withdrawal by Subject|1
2690560|NCT00453362|9278861|P1|Overall Study|Screening Failure|14
2690561|NCT00453362|9278861|P1|Overall Study|Progression of disease|56
2690562|NCT00453362|9278861|P1|Overall Study|Withdrawal by Subject|3
2690563|NCT00453362|9278861|P1|Overall Study|Physician Decision|2
2690564|NCT00453362|9278861|P1|Overall Study|Death|7
2690565|NCT00453362|9278861|P1|Overall Study|Adverse Event|5
2690566|NCT00453349|9278887|P2|Completed Study|Lost to follow up after study treatment|11
2690567|NCT00453349|9278888|P1|Completed Study|Lost to follow up after study treatment|2
2690568|NCT00453349|9278887|P2|Completed Study|Withdrawal by Subject|5
2690569|NCT00453349|9278888|P1|Completed Study|Withdrawal by Subject|3
2690570|NCT00453349|9278887|P2|Completed Study|Protocol Violation|1
2690571|NCT00453349|9278888|P1|Completed Study|Protocol Violation|1
2690572|NCT00453349|9278887|P2|Completed Study|Lost to Follow-up|5
2690573|NCT00453349|9278888|P1|Completed Study|Lost to Follow-up|7
2690574|NCT00453349|9278887|P2|Completed Study|Lack of Efficacy|1
2690575|NCT00453349|9278888|P1|Completed Study|Lack of Efficacy|2
2690576|NCT00453349|9278887|P2|Completed Study|Adverse Event|11
2690577|NCT00453349|9278888|P1|Completed Study|Adverse Event|12
2690578|NCT00453349|9278887|P2|Reaching of Primary Endpoint (TOC)|Missing information|11
2690579|NCT00453349|9278888|P1|Reaching of Primary Endpoint (TOC)|Missing information|10
2690580|NCT00453349|9278887|P2|Randomized|Withdrawal by Subject|5
2690581|NCT00453349|9278888|P1|Randomized|Withdrawal by Subject|3
2690582|NCT00453349|9278887|P2|Randomized|Protocol Violation|1
2690583|NCT00453349|9278888|P1|Randomized|Protocol Violation|1
2690584|NCT00453349|9278887|P2|Randomized|Lost to Follow-up|5
2690585|NCT00453349|9278888|P1|Randomized|Lost to Follow-up|7
2690586|NCT00453349|9278887|P2|Randomized|Lack of Efficacy|1
2690587|NCT00453349|9278888|P1|Randomized|Lack of Efficacy|2
2690588|NCT00453349|9278887|P2|Randomized|Adverse Event|11
2690589|NCT00453349|9278888|P1|Randomized|Adverse Event|12
2690590|NCT00453310|9278919|P1|Overall Study|Progression of Disease|10
2690591|NCT00453206|9278923|P1|Overall Study|Death|1
2690592|NCT00453180|9278933|P2|Overall Study|Adverse Event|2
2690593|NCT00453180|9278934|P1|Overall Study|Adverse Event|1
2690594|NCT00453180|9278933|P2|Overall Study|Lost to Follow-up|1
2690595|NCT00453180|9278934|P1|Overall Study|Lost to Follow-up|2
2690596|NCT00453154|9278953|P4|Double BIind Maintenance|Randomized, did not receive therapy|5
2690597|NCT00453154|9278954|P3|Double BIind Maintenance|Randomized, did not receive therapy|5
2690598|NCT00453154|9278955|P2|Double BIind Maintenance|Randomized, did not receive therapy|0
2690599|NCT00453154|9278956|P1|Double BIind Maintenance|Randomized, did not receive therapy|0
2690600|NCT00453154|9278953|P4|Double BIind Maintenance|Medical Issues|1
2690601|NCT00453154|9278954|P3|Double BIind Maintenance|Medical Issues|3
2690602|NCT00453154|9278955|P2|Double BIind Maintenance|Medical Issues|0
2690603|NCT00453154|9278956|P1|Double BIind Maintenance|Medical Issues|0
2690604|NCT00453154|9278953|P4|Double BIind Maintenance|Progression|26
2690605|NCT00453154|9278954|P3|Double BIind Maintenance|Progression|29
2690606|NCT00453154|9278955|P2|Double BIind Maintenance|Progression|0
2690607|NCT00453154|9278956|P1|Double BIind Maintenance|Progression|0
2690608|NCT00453154|9278953|P4|Double BIind Maintenance|Withdrawal by Subject|4
2690609|NCT00453154|9278954|P3|Double BIind Maintenance|Withdrawal by Subject|4
2690610|NCT00453154|9278955|P2|Double BIind Maintenance|Withdrawal by Subject|0
2690611|NCT00453154|9278956|P1|Double BIind Maintenance|Withdrawal by Subject|0
2690612|NCT00453154|9278953|P4|Double BIind Maintenance|Death|1
2690613|NCT00453154|9278954|P3|Double BIind Maintenance|Death|2
2690614|NCT00453154|9278955|P2|Double BIind Maintenance|Death|0
2690615|NCT00453154|9278956|P1|Double BIind Maintenance|Death|0
2690616|NCT00453154|9278953|P4|Double BIind Maintenance|Adverse Event|12
2690617|NCT00453154|9278954|P3|Double BIind Maintenance|Adverse Event|3
2690618|NCT00453154|9278955|P2|Double BIind Maintenance|Adverse Event|0
2690619|NCT00453154|9278956|P1|Double BIind Maintenance|Adverse Event|0
2690620|NCT00453102|9278969|P1|Overall Study|Withdrawal by Subject|2
2690621|NCT00453063|9278980|P2|Overall Study|Protocol Violation|0
2690622|NCT00453063|9278981|P1|Overall Study|Protocol Violation|1
2690623|NCT00453063|9278980|P2|Overall Study|Withdrawal by Subject|1
2690624|NCT00453063|9278981|P1|Overall Study|Withdrawal by Subject|1
2690625|NCT00453063|9278980|P2|Overall Study|Adverse Event|2
2690626|NCT00453063|9278981|P1|Overall Study|Adverse Event|1
2690627|NCT00452790|9279001|P2|Toddler Dose|Parent/legal guardian request|1
2690628|NCT00452790|9279002|P1|Toddler Dose|Parent/legal guardian request|0
2690629|NCT00452790|9279001|P2|Toddler Dose|Failed to return|1
2690630|NCT00452790|9279002|P1|Toddler Dose|Failed to return|0
2690631|NCT00452790|9279001|P2|After Infant Series|Other reasons|0
2690632|NCT00452790|9279002|P1|After Infant Series|Other reasons|1
2690633|NCT00452790|9279001|P2|After Infant Series|Failed to return|0
2690634|NCT00452790|9279002|P1|After Infant Series|Failed to return|1
2690635|NCT00452790|9279001|P2|After Infant Series|Lost to Follow-up|0
2690636|NCT00452790|9279002|P1|After Infant Series|Lost to Follow-up|4
2690637|NCT00452790|9279001|P2|After Infant Series|Parent/legal guardian request|3
2690638|NCT00452790|9279002|P1|After Infant Series|Parent/legal guardian request|1
2690639|NCT00452790|9279001|P2|After Infant Series|Adverse Event|1
2690640|NCT00452790|9279002|P1|After Infant Series|Adverse Event|4
2690641|NCT00452790|9279001|P2|After Infant Series|Investigator request|10
2690642|NCT00452790|9279002|P1|After Infant Series|Investigator request|10
2690643|NCT00452790|9279001|P2|Infant Series|Death|1
2690644|NCT00452790|9279002|P1|Infant Series|Death|0
2690645|NCT00452790|9279001|P2|Infant Series|Investigator request|1
2690646|NCT00452790|9279002|P1|Infant Series|Investigator request|0
2690647|NCT00452790|9279001|P2|Infant Series|Other reasons|2
2690648|NCT00452790|9279002|P1|Infant Series|Other reasons|1
2690649|NCT00452790|9279001|P2|Infant Series|Adverse Event|2
2690650|NCT00452790|9279002|P1|Infant Series|Adverse Event|1
2690651|NCT00452790|9279001|P2|Infant Series|Lost to Follow-up|2
2690652|NCT00452790|9279002|P1|Infant Series|Lost to Follow-up|2
2690653|NCT00452790|9279001|P2|Infant Series|Protocol Violation|3
2690654|NCT00452790|9279002|P1|Infant Series|Protocol Violation|1
2690655|NCT00452790|9279001|P2|Infant Series|Failed to return|1
2690656|NCT00452790|9279002|P1|Infant Series|Failed to return|4
2690657|NCT00452790|9279001|P2|Infant Series|Parent/legal guardian request|6
2690658|NCT00452790|9279002|P1|Infant Series|Parent/legal guardian request|8
2690659|NCT00452790|9279001|P2|Infant Series|Clinical hold - consent withdrawn|123
2690660|NCT00452790|9279002|P1|Infant Series|Clinical hold - consent withdrawn|118
2690661|NCT00452699|9279038|P2|Overall Study|Other|7
2690662|NCT00452699|9279039|P1|Overall Study|Other|12
2690663|NCT00452699|9279038|P2|Overall Study|Withdrawal by Subject|25
2690664|NCT00452699|9279039|P1|Overall Study|Withdrawal by Subject|26
2690665|NCT00452699|9279038|P2|Overall Study|Protocol Violation|25
2690666|NCT00452699|9279039|P1|Overall Study|Protocol Violation|21
2690667|NCT00452699|9279038|P2|Overall Study|Lost to Follow-up|9
2690668|NCT00452699|9279039|P1|Overall Study|Lost to Follow-up|6
2690669|NCT00452699|9279038|P2|Overall Study|Lack of Efficacy|4
2690670|NCT00452699|9279039|P1|Overall Study|Lack of Efficacy|6
2690671|NCT00452699|9279038|P2|Overall Study|Adverse Event|3
2690672|NCT00452699|9279039|P1|Overall Study|Adverse Event|10
2690673|NCT00452673|9279055|P5|Dose Expansion Period|Other|2
2690674|NCT00452673|9279056|P4|Dose Expansion Period|Other|0
2690675|NCT00452673|9279057|P3|Dose Expansion Period|Other|0
2690676|NCT00452673|9279058|P2|Dose Expansion Period|Other|0
2690677|NCT00452673|9279059|P1|Dose Expansion Period|Other|0
2690678|NCT00452673|9279055|P5|Dose Expansion Period|Disease Progression|19
2690679|NCT00452673|9279056|P4|Dose Expansion Period|Disease Progression|0
2690680|NCT00452673|9279057|P3|Dose Expansion Period|Disease Progression|0
2690681|NCT00452673|9279058|P2|Dose Expansion Period|Disease Progression|0
2690682|NCT00452673|9279059|P1|Dose Expansion Period|Disease Progression|0
2690683|NCT00452673|9279055|P5|Dose Escalation Period|Withdrawal by Subject|0
2690684|NCT00452673|9279056|P4|Dose Escalation Period|Withdrawal by Subject|1
2690685|NCT00452673|9279057|P3|Dose Escalation Period|Withdrawal by Subject|0
2690686|NCT00452673|9279058|P2|Dose Escalation Period|Withdrawal by Subject|0
2690687|NCT00452673|9279059|P1|Dose Escalation Period|Withdrawal by Subject|0
2690688|NCT00452673|9279055|P5|Dose Escalation Period|Adverse Event|0
2690689|NCT00452673|9279056|P4|Dose Escalation Period|Adverse Event|1
2690690|NCT00452673|9279057|P3|Dose Escalation Period|Adverse Event|0
2690691|NCT00452673|9279058|P2|Dose Escalation Period|Adverse Event|0
2690692|NCT00452673|9279059|P1|Dose Escalation Period|Adverse Event|0
2690693|NCT00452673|9279055|P5|Dose Escalation Period|Other|0
2690694|NCT00452673|9279056|P4|Dose Escalation Period|Other|0
2690695|NCT00452673|9279057|P3|Dose Escalation Period|Other|1
2690696|NCT00452673|9279058|P2|Dose Escalation Period|Other|0
2690697|NCT00452673|9279059|P1|Dose Escalation Period|Other|0
2690698|NCT00452673|9279055|P5|Dose Escalation Period|study drug toxicity|0
2690699|NCT00452673|9279056|P4|Dose Escalation Period|study drug toxicity|1
2690700|NCT00452673|9279057|P3|Dose Escalation Period|study drug toxicity|3
2690701|NCT00452673|9279058|P2|Dose Escalation Period|study drug toxicity|3
2690702|NCT00452673|9279059|P1|Dose Escalation Period|study drug toxicity|1
2690703|NCT00452673|9279055|P5|Dose Escalation Period|Disease Progression|0
2690704|NCT00452673|9279056|P4|Dose Escalation Period|Disease Progression|6
2690705|NCT00452673|9279057|P3|Dose Escalation Period|Disease Progression|2
2690706|NCT00452673|9279058|P2|Dose Escalation Period|Disease Progression|6
2690707|NCT00452673|9279059|P1|Dose Escalation Period|Disease Progression|6
2690708|NCT00452530|9279106|P2|Overall Study|Other|11
2690709|NCT00452530|9279107|P1|Overall Study|Other|7
2690710|NCT00452530|9279106|P2|Overall Study|No longer met study criteria|22
2690711|NCT00452530|9279107|P1|Overall Study|No longer met study criteria|18
2690712|NCT00452530|9279106|P2|Overall Study|Poor compliance/noncompliance|2
2690713|NCT00452530|9279107|P1|Overall Study|Poor compliance/noncompliance|1
2690714|NCT00452530|9279106|P2|Overall Study|Lost to Follow-up|0
2690715|NCT00452530|9279107|P1|Overall Study|Lost to Follow-up|1
2690716|NCT00452530|9279106|P2|Overall Study|Withdrawal by Subject|57
2690717|NCT00452530|9279107|P1|Overall Study|Withdrawal by Subject|68
2690718|NCT00452530|9279106|P2|Overall Study|Adverse Event|44
2690719|NCT00452530|9279107|P1|Overall Study|Adverse Event|40
2690720|NCT00452530|9279106|P2|Overall Study|Death|0
2690721|NCT00452530|9279107|P1|Overall Study|Death|1
2690722|NCT00452452|9279128|P3|Overall Study|Lost to Follow-up|0
2690723|NCT00452452|9279129|P2|Overall Study|Lost to Follow-up|0
2690724|NCT00452452|9279130|P1|Overall Study|Lost to Follow-up|1
2690725|NCT00452452|9279128|P3|Overall Study|Withdrawal by Subject|0
2690726|NCT00452452|9279129|P2|Overall Study|Withdrawal by Subject|0
2690727|NCT00452452|9279130|P1|Overall Study|Withdrawal by Subject|1
2690728|NCT00452452|9279128|P3|Overall Study|Protocol Violation|1
2690729|NCT00452452|9279129|P2|Overall Study|Protocol Violation|0
2690730|NCT00452452|9279130|P1|Overall Study|Protocol Violation|0
2690731|NCT00452400|9279175|P5|Overall Study|Other reasons not listed above|1
2690732|NCT00452400|9279176|P4|Overall Study|Other reasons not listed above|1
2690733|NCT00452400|9279177|P3|Overall Study|Other reasons not listed above|0
2690734|NCT00452400|9279178|P2|Overall Study|Other reasons not listed above|0
2690735|NCT00452400|9279179|P1|Overall Study|Other reasons not listed above|0
2690736|NCT00452400|9279175|P5|Overall Study|Lack of Efficacy|0
2690737|NCT00452400|9279176|P4|Overall Study|Lack of Efficacy|0
2690738|NCT00452400|9279177|P3|Overall Study|Lack of Efficacy|0
2690739|NCT00452400|9279178|P2|Overall Study|Lack of Efficacy|0
2690740|NCT00452400|9279179|P1|Overall Study|Lack of Efficacy|2
2690741|NCT00452400|9279175|P5|Overall Study|Withdrawal by Subject|0
2690742|NCT00452400|9279176|P4|Overall Study|Withdrawal by Subject|0
2690743|NCT00452400|9279177|P3|Overall Study|Withdrawal by Subject|1
2690744|NCT00452400|9279178|P2|Overall Study|Withdrawal by Subject|0
2690745|NCT00452400|9279179|P1|Overall Study|Withdrawal by Subject|1
2690746|NCT00452400|9279175|P5|Overall Study|Lost to Follow-up|0
2690747|NCT00452400|9279176|P4|Overall Study|Lost to Follow-up|0
2690748|NCT00452400|9279177|P3|Overall Study|Lost to Follow-up|0
2690749|NCT00452400|9279178|P2|Overall Study|Lost to Follow-up|0
2690750|NCT00452400|9279179|P1|Overall Study|Lost to Follow-up|1
2690751|NCT00452400|9279175|P5|Overall Study|Protocol Violation|0
2690752|NCT00452400|9279176|P4|Overall Study|Protocol Violation|0
2690753|NCT00452400|9279177|P3|Overall Study|Protocol Violation|1
2690754|NCT00452400|9279178|P2|Overall Study|Protocol Violation|0
2690755|NCT00452400|9279179|P1|Overall Study|Protocol Violation|0
2690756|NCT00452400|9279175|P5|Overall Study|Adverse Event|2
2690757|NCT00452400|9279176|P4|Overall Study|Adverse Event|0
2690758|NCT00452400|9279177|P3|Overall Study|Adverse Event|5
2690759|NCT00452400|9279178|P2|Overall Study|Adverse Event|1
2690760|NCT00452400|9279179|P1|Overall Study|Adverse Event|1
2690761|NCT00452361|9279366|P2|Overall Study|Premature termination|9
2690762|NCT00452361|9279367|P1|Overall Study|Premature termination|13
2690763|NCT00452361|9279366|P2|Overall Study|Withdrawal by Subject|1
2690764|NCT00452361|9279367|P1|Overall Study|Withdrawal by Subject|0
2690765|NCT00452361|9279366|P2|Overall Study|Adverse Event|0
2690766|NCT00452361|9279367|P1|Overall Study|Adverse Event|8
2690767|NCT00452348|9279411|P2|Overall Study|Other|9
2690768|NCT00452348|9279412|P1|Overall Study|Other|9
2690769|NCT00452348|9279411|P2|Overall Study|Withdrawal by Subject|21
2690770|NCT00452348|9279412|P1|Overall Study|Withdrawal by Subject|18
2690771|NCT00452348|9279411|P2|Overall Study|Protocol Violation|28
2690772|NCT00452348|9279412|P1|Overall Study|Protocol Violation|22
2690773|NCT00452348|9279411|P2|Overall Study|Lost to Follow-up|8
2690774|NCT00452348|9279412|P1|Overall Study|Lost to Follow-up|14
2690775|NCT00452348|9279411|P2|Overall Study|Lack of Efficacy|9
2690776|NCT00452348|9279412|P1|Overall Study|Lack of Efficacy|10
2690777|NCT00452348|9279411|P2|Overall Study|Adverse Event|9
2690778|NCT00452348|9279412|P1|Overall Study|Adverse Event|6
2690779|NCT00452114|9279466|P2|Overall Study|Physician Decision|3
2690780|NCT00452114|9279467|P1|Overall Study|Physician Decision|3
2690781|NCT00451958|9279483|P5|CS21A (NCT00451958)|Miscellaneous reasons|0
2690782|NCT00451958|9279484|P4|CS21A (NCT00451958)|Miscellaneous reasons|14
2690783|NCT00451958|9279485|P3|CS21A (NCT00451958)|Miscellaneous reasons|17
2690784|NCT00451958|9279486|P2|CS21A (NCT00451958)|Miscellaneous reasons|27
2690785|NCT00451958|9279487|P1|CS21A (NCT00451958)|Miscellaneous reasons|28
2690786|NCT00451958|9279483|P5|CS21A (NCT00451958)|Withdrawal by Subject|0
2690787|NCT00451958|9279484|P4|CS21A (NCT00451958)|Withdrawal by Subject|3
2690788|NCT00451958|9279485|P3|CS21A (NCT00451958)|Withdrawal by Subject|4
2690789|NCT00451958|9279486|P2|CS21A (NCT00451958)|Withdrawal by Subject|4
2690790|NCT00451958|9279487|P1|CS21A (NCT00451958)|Withdrawal by Subject|7
2690791|NCT00451958|9279483|P5|CS21A (NCT00451958)|Physician Decision|0
2690792|NCT00451958|9279484|P4|CS21A (NCT00451958)|Physician Decision|4
2690793|NCT00451958|9279485|P3|CS21A (NCT00451958)|Physician Decision|4
2690794|NCT00451958|9279486|P2|CS21A (NCT00451958)|Physician Decision|4
2690795|NCT00451958|9279487|P1|CS21A (NCT00451958)|Physician Decision|2
2690796|NCT00451958|9279483|P5|CS21A (NCT00451958)|Protocol Violation|0
2690797|NCT00451958|9279484|P4|CS21A (NCT00451958)|Protocol Violation|0
2690798|NCT00451958|9279485|P3|CS21A (NCT00451958)|Protocol Violation|2
2690799|NCT00451958|9279486|P2|CS21A (NCT00451958)|Protocol Violation|3
2690800|NCT00451958|9279487|P1|CS21A (NCT00451958)|Protocol Violation|1
2690801|NCT00451958|9279483|P5|CS21A (NCT00451958)|Lost to Follow-up|0
2690802|NCT00451958|9279484|P4|CS21A (NCT00451958)|Lost to Follow-up|1
2690803|NCT00451958|9279485|P3|CS21A (NCT00451958)|Lost to Follow-up|1
2690804|NCT00451958|9279486|P2|CS21A (NCT00451958)|Lost to Follow-up|5
2690805|NCT00451958|9279487|P1|CS21A (NCT00451958)|Lost to Follow-up|6
2690806|NCT00451958|9279483|P5|CS21A (NCT00451958)|Adverse Event|0
2690807|NCT00451958|9279484|P4|CS21A (NCT00451958)|Adverse Event|17
2690808|NCT00451958|9279485|P3|CS21A (NCT00451958)|Adverse Event|14
2690809|NCT00451958|9279486|P2|CS21A (NCT00451958)|Adverse Event|34
2690810|NCT00451958|9279487|P1|CS21A (NCT00451958)|Adverse Event|21
2690811|NCT00451906|9279517|P1|Overall Study|Did not complete final visit|4
2690812|NCT00451906|9279517|P1|Overall Study|Other Reasons|121
2690813|NCT00451906|9279517|P1|Overall Study|Termination of the study|108
2690814|NCT00451906|9279517|P1|Overall Study|Progressive disease|1328
2690815|NCT00451906|9279517|P1|Overall Study|Protocol Violation|21
2690816|NCT00451906|9279517|P1|Overall Study|Withdrawal by Subject|111
2690817|NCT00451906|9279517|P1|Overall Study|Lost to Follow-up|31
2690818|NCT00451906|9279517|P1|Overall Study|Adverse Event|515
2690819|NCT00451555|9279545|P2|Overall Study|Physician Decision|1
2690820|NCT00451555|9279546|P1|Overall Study|Physician Decision|2
2690821|NCT00451555|9279545|P2|Overall Study|Withdrawal by Subject|0
2690822|NCT00451555|9279546|P1|Overall Study|Withdrawal by Subject|6
2690823|NCT00451555|9279545|P2|Overall Study|Adverse Event|1
2690824|NCT00451555|9279546|P1|Overall Study|Adverse Event|3
2690825|NCT00451555|9279545|P2|Overall Study|Protocol Violation|2
2690826|NCT00451555|9279546|P1|Overall Study|Protocol Violation|2
2690827|NCT00451451|9279580|P4|Overall Study|Other Reasons for Not Completing Study|14
2690828|NCT00451451|9279581|P3|Overall Study|Other Reasons for Not Completing Study|17
2690829|NCT00451451|9279582|P2|Overall Study|Other Reasons for Not Completing Study|30
2690830|NCT00451451|9279583|P1|Overall Study|Other Reasons for Not Completing Study|34
2690831|NCT00451451|9279580|P4|Overall Study|Death|1
2690832|NCT00451451|9279581|P3|Overall Study|Death|0
2690833|NCT00451451|9279582|P2|Overall Study|Death|0
2690834|NCT00451451|9279583|P1|Overall Study|Death|1
2690835|NCT00451451|9279580|P4|Overall Study|Subject Non-Compliance|3
2690836|NCT00451451|9279581|P3|Overall Study|Subject Non-Compliance|3
2690837|NCT00451451|9279582|P2|Overall Study|Subject Non-Compliance|4
2690838|NCT00451451|9279583|P1|Overall Study|Subject Non-Compliance|8
2690839|NCT00451451|9279580|P4|Overall Study|Investigator Decision|2
2690840|NCT00451451|9279581|P3|Overall Study|Investigator Decision|1
2690841|NCT00451451|9279582|P2|Overall Study|Investigator Decision|2
2690842|NCT00451451|9279583|P1|Overall Study|Investigator Decision|6
2690843|NCT00451451|9279580|P4|Overall Study|Consent Withdrawn|17
2690844|NCT00451451|9279581|P3|Overall Study|Consent Withdrawn|17
2690845|NCT00451451|9279582|P2|Overall Study|Consent Withdrawn|9
2690846|NCT00451451|9279583|P1|Overall Study|Consent Withdrawn|14
2690847|NCT00451451|9279580|P4|Overall Study|Lost to Follow-up|11
2690848|NCT00451451|9279581|P3|Overall Study|Lost to Follow-up|8
2690849|NCT00451451|9279582|P2|Overall Study|Lost to Follow-up|9
2690850|NCT00451451|9279583|P1|Overall Study|Lost to Follow-up|11
2690851|NCT00451451|9279580|P4|Overall Study|Adverse Event|10
2690852|NCT00451451|9279581|P3|Overall Study|Adverse Event|26
2690853|NCT00451451|9279582|P2|Overall Study|Adverse Event|21
2690854|NCT00451451|9279583|P1|Overall Study|Adverse Event|11
2690855|NCT00451321|9279618|P8|Overall Study|Sponsor decision to amend protocol|3
2690856|NCT00451321|9279619|P7|Overall Study|Sponsor decision to amend protocol|1
2690857|NCT00451321|9279620|P6|Overall Study|Sponsor decision to amend protocol|1
2690858|NCT00451321|9279621|P5|Overall Study|Sponsor decision to amend protocol|0
2690859|NCT00451321|9279622|P4|Overall Study|Sponsor decision to amend protocol|0
2690860|NCT00451321|9279623|P3|Overall Study|Sponsor decision to amend protocol|0
2690861|NCT00451321|9279624|P2|Overall Study|Sponsor decision to amend protocol|0
2690862|NCT00451321|9279625|P1|Overall Study|Sponsor decision to amend protocol|0
2690863|NCT00451321|9279618|P8|Overall Study|Study closed/terminated|3
2690864|NCT00451321|9279619|P7|Overall Study|Study closed/terminated|5
2690865|NCT00451321|9279620|P6|Overall Study|Study closed/terminated|7
2690866|NCT00451321|9279621|P5|Overall Study|Study closed/terminated|7
2690867|NCT00451321|9279622|P4|Overall Study|Study closed/terminated|5
2690868|NCT00451321|9279623|P3|Overall Study|Study closed/terminated|17
2690869|NCT00451321|9279624|P2|Overall Study|Study closed/terminated|1
2690870|NCT00451321|9279625|P1|Overall Study|Study closed/terminated|1
2690871|NCT00451321|9279618|P8|Overall Study|Withdrawal by Subject|0
2690872|NCT00451321|9279619|P7|Overall Study|Withdrawal by Subject|0
2690873|NCT00451321|9279620|P6|Overall Study|Withdrawal by Subject|0
2690874|NCT00451321|9279621|P5|Overall Study|Withdrawal by Subject|0
2690875|NCT00451321|9279622|P4|Overall Study|Withdrawal by Subject|4
2690876|NCT00451321|9279623|P3|Overall Study|Withdrawal by Subject|0
2690877|NCT00451321|9279624|P2|Overall Study|Withdrawal by Subject|1
2690878|NCT00451321|9279625|P1|Overall Study|Withdrawal by Subject|3
2690879|NCT00451321|9279618|P8|Overall Study|Lost to Follow-up|0
2690880|NCT00451321|9279619|P7|Overall Study|Lost to Follow-up|0
2690881|NCT00451321|9279620|P6|Overall Study|Lost to Follow-up|1
2690882|NCT00451321|9279621|P5|Overall Study|Lost to Follow-up|0
2690883|NCT00451321|9279622|P4|Overall Study|Lost to Follow-up|3
2690884|NCT00451321|9279623|P3|Overall Study|Lost to Follow-up|1
2690885|NCT00451321|9279624|P2|Overall Study|Lost to Follow-up|3
2690886|NCT00451321|9279625|P1|Overall Study|Lost to Follow-up|3
2690887|NCT00451282|9279797|P2|Overall Study|Lost to Follow-up|5
2690888|NCT00451282|9279798|P1|Overall Study|Lost to Follow-up|6
2690889|NCT00451217|9279814|P4|Overall Study|Not Treated|4
2690890|NCT00451217|9279815|P3|Overall Study|Not Treated|3
2690891|NCT00451217|9279816|P2|Overall Study|Not Treated|1
2690892|NCT00451217|9279817|P1|Overall Study|Not Treated|1
2690893|NCT00451217|9279814|P4|Overall Study|Withdrawal by Subject|0
2690894|NCT00451217|9279815|P3|Overall Study|Withdrawal by Subject|0
2690895|NCT00451217|9279816|P2|Overall Study|Withdrawal by Subject|0
2690896|NCT00451217|9279817|P1|Overall Study|Withdrawal by Subject|1
2690897|NCT00451217|9279814|P4|Overall Study|Lost to Follow-up|1
2690898|NCT00451217|9279815|P3|Overall Study|Lost to Follow-up|1
2690899|NCT00451217|9279816|P2|Overall Study|Lost to Follow-up|1
2690900|NCT00451217|9279817|P1|Overall Study|Lost to Follow-up|0
2690901|NCT00451204|9279845|P2|Overall Study|Other|2
2690902|NCT00451204|9279846|P1|Overall Study|Other|1
2690903|NCT00451204|9279845|P2|Overall Study|Patient refusal|4
2690904|NCT00451204|9279846|P1|Overall Study|Patient refusal|8
2690905|NCT00451204|9279845|P2|Overall Study|Protocol Violation|0
2690906|NCT00451204|9279846|P1|Overall Study|Protocol Violation|1
2690907|NCT00451204|9279845|P2|Overall Study|Lost to Follow-up|4
2690908|NCT00451204|9279846|P1|Overall Study|Lost to Follow-up|4
2690909|NCT00451204|9279845|P2|Overall Study|Lack of Efficacy|4
2690910|NCT00451204|9279846|P1|Overall Study|Lack of Efficacy|4
2690911|NCT00451204|9279845|P2|Overall Study|Adverse Event|6
2690912|NCT00451204|9279846|P1|Overall Study|Adverse Event|4
2690913|NCT00451191|9279864|P2|Overall Study|withdrawal or received alternate tx|11
2690914|NCT00451191|9279865|P1|Overall Study|withdrawal or received alternate tx|15
2690915|NCT00450866|9279892|P2|Overall Study|Physician Decision|0
2690916|NCT00450866|9279893|P1|Overall Study|Physician Decision|1
2690917|NCT00450866|9279892|P2|Overall Study|Death|0
2690918|NCT00450866|9279893|P1|Overall Study|Death|1
2690919|NCT00450866|9279892|P2|Overall Study|Withdrawal by Subject|2
2690920|NCT00450866|9279893|P1|Overall Study|Withdrawal by Subject|5
2690921|NCT00450866|9279892|P2|Overall Study|Adverse Event|1
2690922|NCT00450866|9279893|P1|Overall Study|Adverse Event|0
2690923|NCT00450814|9279913|P11|Overall Study|Patient withdrawal prior to treatment|0
2690924|NCT00450814|9279914|P10|Overall Study|Patient withdrawal prior to treatment|1
2690925|NCT00450814|9279915|P9|Overall Study|Patient withdrawal prior to treatment|0
2690926|NCT00450814|9279916|P8|Overall Study|Patient withdrawal prior to treatment|0
2690927|NCT00450814|9279917|P7|Overall Study|Patient withdrawal prior to treatment|0
2690928|NCT00450814|9279918|P6|Overall Study|Patient withdrawal prior to treatment|0
2690929|NCT00450814|9279919|P5|Overall Study|Patient withdrawal prior to treatment|0
2690930|NCT00450814|9279920|P4|Overall Study|Patient withdrawal prior to treatment|0
2690931|NCT00450814|9279921|P3|Overall Study|Patient withdrawal prior to treatment|0
2690932|NCT00450814|9279922|P2|Overall Study|Patient withdrawal prior to treatment|0
2690933|NCT00450814|9279923|P1|Overall Study|Patient withdrawal prior to treatment|0
2690934|NCT00450814|9279913|P11|Overall Study|Failed to complete the initial therapy|0
2690935|NCT00450814|9279914|P10|Overall Study|Failed to complete the initial therapy|0
2690936|NCT00450814|9279915|P9|Overall Study|Failed to complete the initial therapy|0
2690937|NCT00450814|9279916|P8|Overall Study|Failed to complete the initial therapy|0
2690938|NCT00450814|9279917|P7|Overall Study|Failed to complete the initial therapy|0
2690939|NCT00450814|9279918|P6|Overall Study|Failed to complete the initial therapy|1
2690940|NCT00450814|9279919|P5|Overall Study|Failed to complete the initial therapy|1
2690941|NCT00450814|9279920|P4|Overall Study|Failed to complete the initial therapy|1
2690942|NCT00450814|9279921|P3|Overall Study|Failed to complete the initial therapy|0
2690943|NCT00450814|9279922|P2|Overall Study|Failed to complete the initial therapy|0
2690944|NCT00450814|9279923|P1|Overall Study|Failed to complete the initial therapy|0
2690945|NCT00450801|9279957|P1|Overall Study|Death|1
2690946|NCT00450749|9279971|P3|Overall Study|Noncompliant|0
2690947|NCT00450749|9279972|P2|Overall Study|Noncompliant|1
2690948|NCT00450749|9279973|P1|Overall Study|Noncompliant|0
2690949|NCT00450749|9279971|P3|Overall Study|Withdrawal by Subject|2
2690950|NCT00450749|9279972|P2|Overall Study|Withdrawal by Subject|0
2690951|NCT00450749|9279973|P1|Overall Study|Withdrawal by Subject|0
2690952|NCT00450723|9280011|P1|Overall Study|Physician Decision|5
2690953|NCT00450658|9280019|P2|Overall Study|misc|10
2690954|NCT00450658|9280020|P1|Overall Study|misc|21
2690955|NCT00450658|9280019|P2|Overall Study|UGI ulcer|34
2690956|NCT00450658|9280020|P1|Overall Study|UGI ulcer|33
2690957|NCT00450658|9280019|P2|Overall Study|Lost to Follow-up|5
2690958|NCT00450658|9280020|P1|Overall Study|Lost to Follow-up|22
2690959|NCT00450658|9280019|P2|Overall Study|Withdrawal by Subject|26
2690960|NCT00450658|9280020|P1|Overall Study|Withdrawal by Subject|43
2690961|NCT00450658|9280019|P2|Overall Study|Adverse Event|15
2690962|NCT00450658|9280020|P1|Overall Study|Adverse Event|24
2690963|NCT00450619|9280034|P2|Overall Study|Adverse Event|0
2690964|NCT00450619|9280035|P1|Overall Study|Adverse Event|1
2690965|NCT00450619|9280034|P2|Overall Study|did not progress; refused further trmt|1
2690966|NCT00450619|9280035|P1|Overall Study|did not progress; refused further trmt|1
2690967|NCT00450619|9280034|P2|Overall Study|refused treatment after randomization|0
2690968|NCT00450619|9280035|P1|Overall Study|refused treatment after randomization|2
2690969|NCT00450580|9280061|P2|Overall Study|Withdrawal due to pregnancy|1
2690970|NCT00450580|9280062|P1|Overall Study|Withdrawal due to pregnancy|0
2690971|NCT00450580|9280061|P2|Overall Study|Patient could not swallow Norvir|0
2690972|NCT00450580|9280062|P1|Overall Study|Patient could not swallow Norvir|1
2690973|NCT00450580|9280061|P2|Overall Study|Patient went to Brazil|0
2690974|NCT00450580|9280062|P1|Overall Study|Patient went to Brazil|1
2690975|NCT00450580|9280061|P2|Overall Study|Could not comply with scheduled visits|0
2690976|NCT00450580|9280062|P1|Overall Study|Could not comply with scheduled visits|1
2690977|NCT00450580|9280061|P2|Overall Study|Protocol-defined virologic failure|0
2690978|NCT00450580|9280062|P1|Overall Study|Protocol-defined virologic failure|1
2690979|NCT00450580|9280061|P2|Overall Study|Protocol Violation|1
2690980|NCT00450580|9280062|P1|Overall Study|Protocol Violation|1
2690981|NCT00450580|9280061|P2|Overall Study|Withdrawal by Subject|2
2690982|NCT00450580|9280062|P1|Overall Study|Withdrawal by Subject|2
2690983|NCT00450580|9280061|P2|Overall Study|Lost to Follow-up|5
2690984|NCT00450580|9280062|P1|Overall Study|Lost to Follow-up|4
2690985|NCT00450580|9280061|P2|Overall Study|Adverse Event|7
2690986|NCT00450580|9280062|P1|Overall Study|Adverse Event|5
2690987|NCT00450450|9280099|P2|Overall Study|Missing Data|0
2690988|NCT00450450|9280100|P1|Overall Study|Missing Data|2
2690989|NCT00450450|9280099|P2|Overall Study|Relapse|0
2690990|NCT00450450|9280100|P1|Overall Study|Relapse|2
2690991|NCT00450450|9280099|P2|Overall Study|Death|3
2690992|NCT00450450|9280100|P1|Overall Study|Death|1
2690993|NCT00450437|9280124|P4|Overall Study|Unable to Classify|0
2690994|NCT00450437|9280125|P3|Overall Study|Unable to Classify|1
2690995|NCT00450437|9280126|P2|Overall Study|Unable to Classify|0
2690996|NCT00450437|9280127|P1|Overall Study|Unable to Classify|1
2690997|NCT00450437|9280124|P4|Overall Study|Administrative reason|0
2690998|NCT00450437|9280125|P3|Overall Study|Administrative reason|1
2690999|NCT00450437|9280126|P2|Overall Study|Administrative reason|0
2691000|NCT00450437|9280127|P1|Overall Study|Administrative reason|0
2691001|NCT00450437|9280124|P4|Overall Study|Inappropriate enrollment|0
2691002|NCT00450437|9280125|P3|Overall Study|Inappropriate enrollment|3
2691003|NCT00450437|9280126|P2|Overall Study|Inappropriate enrollment|1
2691004|NCT00450437|9280127|P1|Overall Study|Inappropriate enrollment|4
2691005|NCT00450437|9280124|P4|Overall Study|Protocol Violation|1
2691006|NCT00450437|9280125|P3|Overall Study|Protocol Violation|0
2691007|NCT00450437|9280126|P2|Overall Study|Protocol Violation|1
2691008|NCT00450437|9280127|P1|Overall Study|Protocol Violation|0
2691009|NCT00450437|9280124|P4|Overall Study|Lost to Follow-up|9
2691010|NCT00450437|9280125|P3|Overall Study|Lost to Follow-up|19
2691011|NCT00450437|9280126|P2|Overall Study|Lost to Follow-up|12
2691012|NCT00450437|9280127|P1|Overall Study|Lost to Follow-up|31
2691013|NCT00450437|9280124|P4|Overall Study|Withdrawal by Subject|1
2691014|NCT00450437|9280125|P3|Overall Study|Withdrawal by Subject|0
2691015|NCT00450437|9280126|P2|Overall Study|Withdrawal by Subject|2
2691016|NCT00450437|9280127|P1|Overall Study|Withdrawal by Subject|10
2691017|NCT00450411|9280158|P1|Overall Study|No protocol treatment|2
2691018|NCT00450411|9280158|P1|Overall Study|Protocol Violation|6
2691019|NCT00450385|9280163|P1|Overall Study|Other|3
2691020|NCT00450385|9280163|P1|Overall Study|Physician Decision|1
2691021|NCT00450385|9280163|P1|Overall Study|Adverse Event|1
2691022|NCT00450385|9280163|P1|Overall Study|Lack of Efficacy|2
2691023|NCT00450385|9280163|P1|Overall Study|Withdrawal by Subject|2
2691024|NCT00450385|9280163|P1|Overall Study|Protocol Violation|1
2691025|NCT00450385|9280163|P1|Overall Study|Death|3
2691026|NCT00450372|9280172|P1|Overall Study|Physician Decision|1
2691027|NCT00450333|9280185|P4|Overall Study|Death|2
2691028|NCT00450333|9280186|P3|Overall Study|Death|2
2691029|NCT00450333|9280187|P2|Overall Study|Death|2
2691030|NCT00450333|9280188|P1|Overall Study|Death|3
2691031|NCT00450333|9280185|P4|Overall Study|Kidney transplant|3
2691032|NCT00450333|9280186|P3|Overall Study|Kidney transplant|1
2691033|NCT00450333|9280187|P2|Overall Study|Kidney transplant|0
2691034|NCT00450333|9280188|P1|Overall Study|Kidney transplant|1
2691035|NCT00450333|9280185|P4|Overall Study|Withdrawal by Subject|0
2691036|NCT00450333|9280186|P3|Overall Study|Withdrawal by Subject|3
2691037|NCT00450333|9280187|P2|Overall Study|Withdrawal by Subject|0
2691038|NCT00450333|9280188|P1|Overall Study|Withdrawal by Subject|1
2691039|NCT00450333|9280185|P4|Overall Study|Protocol Violation|0
2691040|NCT00450333|9280186|P3|Overall Study|Protocol Violation|1
2691041|NCT00450333|9280187|P2|Overall Study|Protocol Violation|0
2691042|NCT00450333|9280188|P1|Overall Study|Protocol Violation|1
2691043|NCT00450333|9280185|P4|Overall Study|Adverse Event|2
2691044|NCT00450333|9280186|P3|Overall Study|Adverse Event|2
2691045|NCT00450333|9280187|P2|Overall Study|Adverse Event|7
2691046|NCT00450333|9280188|P1|Overall Study|Adverse Event|1
2691047|NCT00450333|9280185|P4|Overall Study|Study terminated|21
2691048|NCT00450333|9280186|P3|Overall Study|Study terminated|16
2691049|NCT00450333|9280187|P2|Overall Study|Study terminated|54
2691050|NCT00450333|9280188|P1|Overall Study|Study terminated|47
2691051|NCT00450255|9280211|P1|Overall Study|Prior RFA ablation of liver|1
2691052|NCT00450216|9280236|P2|Overall Study|misc|20
2691053|NCT00450216|9280237|P1|Overall Study|misc|21
2691054|NCT00450216|9280236|P2|Overall Study|upper gastrointestinal (UGI) ulcer|51
2691055|NCT00450216|9280237|P1|Overall Study|upper gastrointestinal (UGI) ulcer|51
2691056|NCT00450216|9280236|P2|Overall Study|Lost to Follow-up|9
2691057|NCT00450216|9280237|P1|Overall Study|Lost to Follow-up|16
2691058|NCT00450216|9280236|P2|Overall Study|Withdrawal by Subject|26
2691059|NCT00450216|9280237|P1|Overall Study|Withdrawal by Subject|48
2691060|NCT00450216|9280236|P2|Overall Study|Adverse Event|23
2691061|NCT00450216|9280237|P1|Overall Study|Adverse Event|38
2691062|NCT00450190|9280249|P1|Overall Study|Withdrawal by Subject|2
2691063|NCT00450177|9280259|P2|Overall Study|Withdrawal by Primary Team|1
2691064|NCT00450177|9280260|P1|Overall Study|Withdrawal by Primary Team|1
2691065|NCT00450177|9280259|P2|Overall Study|Withdrawal by Subject|6
2691066|NCT00450177|9280260|P1|Overall Study|Withdrawal by Subject|1
2691067|NCT00450177|9280259|P2|Overall Study|Adverse Event|4
2691068|NCT00450177|9280260|P1|Overall Study|Adverse Event|7
2691069|NCT00450112|9280286|P2|Overall Study|Others|3
2691070|NCT00450112|9280287|P1|Overall Study|Others|2
2691071|NCT00450112|9280286|P2|Overall Study|Lost to Follow-up|1
2691072|NCT00450112|9280287|P1|Overall Study|Lost to Follow-up|2
2691073|NCT00450112|9280286|P2|Overall Study|Withdrawal by Subject|1
2691074|NCT00450112|9280287|P1|Overall Study|Withdrawal by Subject|4
2691075|NCT00450112|9280286|P2|Overall Study|Other Treatment Required|1
2691076|NCT00450112|9280287|P1|Overall Study|Other Treatment Required|5
2691077|NCT00449956|9280325|P3|Overall Study|Physician Decision|1
2691078|NCT00449956|9280326|P2|Overall Study|Physician Decision|1
2691079|NCT00449956|9280327|P1|Overall Study|Physician Decision|2
2691080|NCT00449956|9280325|P3|Overall Study|Withdrawal by Subject|0
2691081|NCT00449956|9280326|P2|Overall Study|Withdrawal by Subject|1
2691082|NCT00449956|9280327|P1|Overall Study|Withdrawal by Subject|0
2691083|NCT00449956|9280325|P3|Overall Study|Protocol Violation|1
2691084|NCT00449956|9280326|P2|Overall Study|Protocol Violation|1
2691085|NCT00449956|9280327|P1|Overall Study|Protocol Violation|1
2691086|NCT00449956|9280325|P3|Overall Study|Lack of Efficacy|1
2691087|NCT00449956|9280326|P2|Overall Study|Lack of Efficacy|0
2691088|NCT00449956|9280327|P1|Overall Study|Lack of Efficacy|0
2691089|NCT00449956|9280325|P3|Overall Study|Adverse Event|6
2691090|NCT00449956|9280326|P2|Overall Study|Adverse Event|1
2691091|NCT00449956|9280327|P1|Overall Study|Adverse Event|7
2691092|NCT00449930|9280343|P2|Overall Study|Glycemic discontinuation criteria|1
2691093|NCT00449930|9280344|P1|Overall Study|Glycemic discontinuation criteria|1
2691094|NCT00449930|9280343|P2|Overall Study|Withdrawal by Subject|23
2691095|NCT00449930|9280344|P1|Overall Study|Withdrawal by Subject|16
2691096|NCT00449930|9280343|P2|Overall Study|Protocol Violation|15
2691097|NCT00449930|9280344|P1|Overall Study|Protocol Violation|14
2691098|NCT00449930|9280343|P2|Overall Study|Physician Decision|2
2691099|NCT00449930|9280344|P1|Overall Study|Physician Decision|1
2691100|NCT00449930|9280343|P2|Overall Study|Lost to Follow-up|14
2691101|NCT00449930|9280344|P1|Overall Study|Lost to Follow-up|9
2691102|NCT00449930|9280343|P2|Overall Study|Lack of Efficacy|1
2691103|NCT00449930|9280344|P1|Overall Study|Lack of Efficacy|10
2691104|NCT00449930|9280343|P2|Overall Study|Trial Terminated ( Site Closed)|0
2691105|NCT00449930|9280344|P1|Overall Study|Trial Terminated ( Site Closed)|1
2691106|NCT00449930|9280343|P2|Overall Study|Adverse Event|19
2691107|NCT00449930|9280344|P1|Overall Study|Adverse Event|9
2691108|NCT00449865|9280360|P2|Overall Study|Study was stopped|328
2691109|NCT00449865|9280361|P1|Overall Study|Study was stopped|324
2691110|NCT00449865|9280360|P2|Overall Study|Protocol Violation|7
2691111|NCT00449865|9280361|P1|Overall Study|Protocol Violation|8
2691112|NCT00449865|9280360|P2|Overall Study|Death|40
2691113|NCT00449865|9280361|P1|Overall Study|Death|31
2691114|NCT00449865|9280360|P2|Overall Study|Physician Decision|12
2691115|NCT00449865|9280361|P1|Overall Study|Physician Decision|13
2691116|NCT00449865|9280360|P2|Overall Study|Lost to Follow-up|37
2691117|NCT00449865|9280361|P1|Overall Study|Lost to Follow-up|36
2691118|NCT00449865|9280360|P2|Overall Study|Withdrawal by Subject|110
2691119|NCT00449865|9280361|P1|Overall Study|Withdrawal by Subject|110
2691120|NCT00449787|9280369|P2|Overall Study|Did not require medication|92
2691121|NCT00449787|9280370|P1|Overall Study|Did not require medication|95
2691122|NCT00449787|9280369|P2|Overall Study|Lost to Follow-up|8
2691123|NCT00449787|9280370|P1|Overall Study|Lost to Follow-up|10
2691124|NCT00449696|9280386|P2|Overall Study|Others|0
2691125|NCT00449696|9280387|P1|Overall Study|Others|7
2691126|NCT00449696|9280386|P2|Overall Study|Lost to Follow-up|3
2691127|NCT00449696|9280387|P1|Overall Study|Lost to Follow-up|2
2691128|NCT00449696|9280386|P2|Overall Study|Withdrawal by Subject|5
2691129|NCT00449696|9280387|P1|Overall Study|Withdrawal by Subject|5
2691130|NCT00449696|9280386|P2|Overall Study|Other Treatment Required|1
2691131|NCT00449696|9280387|P1|Overall Study|Other Treatment Required|6
2691132|NCT00449670|9280411|P2|Booster Phase (Study no.109873)|Other|2
2691133|NCT00449670|9280412|P1|Booster Phase (Study no.109873)|Other|0
2691134|NCT00449670|9280411|P2|Booster Phase (Study no.109873)|Migrated/moved from study area|1
2691135|NCT00449670|9280412|P1|Booster Phase (Study no.109873)|Migrated/moved from study area|0
2691136|NCT00449670|9280411|P2|Primary Phase (Study no.109630)|Lost to Follow-up|1
2691137|NCT00449670|9280412|P1|Primary Phase (Study no.109630)|Lost to Follow-up|5
2691138|NCT00449670|9280411|P2|Primary Phase (Study no.109630)|Withdrawal by Subject|1
2691139|NCT00449670|9280412|P1|Primary Phase (Study no.109630)|Withdrawal by Subject|4
2691140|NCT00449670|9280411|P2|Primary Phase (Study no.109630)|Non-serious adverse event|0
2691141|NCT00449670|9280412|P1|Primary Phase (Study no.109630)|Non-serious adverse event|4
2691142|NCT00449670|9280411|P2|Primary Phase (Study no.109630)|Serious Adverse Event|0
2691143|NCT00449670|9280412|P1|Primary Phase (Study no.109630)|Serious Adverse Event|1
2691144|NCT00449644|9280525|P4|Overall Study|Rolled-over to treatment with TMC207|1
2691145|NCT00449644|9280526|P3|Overall Study|Rolled-over to treatment with TMC207|0
2691146|NCT00449644|9280527|P2|Overall Study|Rolled-over to treatment with TMC207|0
2691147|NCT00449644|9280528|P1|Overall Study|Rolled-over to treatment with TMC207|0
2691148|NCT00449644|9280525|P4|Overall Study|Other|0
2691149|NCT00449644|9280526|P3|Overall Study|Other|1
2691150|NCT00449644|9280527|P2|Overall Study|Other|4
2691151|NCT00449644|9280528|P1|Overall Study|Other|1
2691152|NCT00449644|9280525|P4|Overall Study|Inclusion/exclusion criteria not met|6
2691153|NCT00449644|9280526|P3|Overall Study|Inclusion/exclusion criteria not met|2
2691154|NCT00449644|9280527|P2|Overall Study|Inclusion/exclusion criteria not met|0
2691155|NCT00449644|9280528|P1|Overall Study|Inclusion/exclusion criteria not met|0
2691156|NCT00449644|9280525|P4|Overall Study|Withdrawal by Subject|7
2691157|NCT00449644|9280526|P3|Overall Study|Withdrawal by Subject|6
2691158|NCT00449644|9280527|P2|Overall Study|Withdrawal by Subject|4
2691159|NCT00449644|9280528|P1|Overall Study|Withdrawal by Subject|3
2691160|NCT00449644|9280525|P4|Overall Study|Protocol Violation|7
2691161|NCT00449644|9280526|P3|Overall Study|Protocol Violation|3
2691162|NCT00449644|9280527|P2|Overall Study|Protocol Violation|4
2691163|NCT00449644|9280528|P1|Overall Study|Protocol Violation|4
2691164|NCT00449644|9280525|P4|Overall Study|Pregnancy|2
2691165|NCT00449644|9280526|P3|Overall Study|Pregnancy|3
2691166|NCT00449644|9280527|P2|Overall Study|Pregnancy|0
2691167|NCT00449644|9280528|P1|Overall Study|Pregnancy|0
2691168|NCT00449644|9280525|P4|Overall Study|Lost to Follow-up|3
2691169|NCT00449644|9280526|P3|Overall Study|Lost to Follow-up|5
2691170|NCT00449644|9280527|P2|Overall Study|Lost to Follow-up|1
2691171|NCT00449644|9280528|P1|Overall Study|Lost to Follow-up|1
2691172|NCT00449644|9280525|P4|Overall Study|Death|1
2691173|NCT00449644|9280526|P3|Overall Study|Death|6
2691174|NCT00449644|9280527|P2|Overall Study|Death|0
2691175|NCT00449644|9280528|P1|Overall Study|Death|1
2691176|NCT00449644|9280525|P4|Overall Study|Adverse Event|5
2691177|NCT00449644|9280526|P3|Overall Study|Adverse Event|3
2691178|NCT00449644|9280527|P2|Overall Study|Adverse Event|0
2691179|NCT00449644|9280528|P1|Overall Study|Adverse Event|0
2691180|NCT00449540|9280548|P3|Treatment Phase|did not experience or treat migraine|17
2691181|NCT00449540|9280549|P2|Treatment Phase|did not experience or treat migraine|20
2691182|NCT00449540|9280550|P1|Treatment Phase|did not experience or treat migraine|0
2691183|NCT00449540|9280548|P3|Pretreatment Phase|No migraine experienced|0
2691184|NCT00449540|9280549|P2|Pretreatment Phase|No migraine experienced|0
2691185|NCT00449540|9280550|P1|Pretreatment Phase|No migraine experienced|66
2691186|NCT00449176|9280567|P3|Overall Study|all other|20
2691187|NCT00449176|9280568|P2|Overall Study|all other|19
2691188|NCT00449176|9280569|P1|Overall Study|all other|22
2691189|NCT00449176|9280567|P3|Overall Study|Study drug non-compliant|11
2691190|NCT00449176|9280568|P2|Overall Study|Study drug non-compliant|11
2691191|NCT00449176|9280569|P1|Overall Study|Study drug non-compliant|14
2691192|NCT00449176|9280567|P3|Overall Study|Lack of Efficacy|50
2691193|NCT00449176|9280568|P2|Overall Study|Lack of Efficacy|7
2691194|NCT00449176|9280569|P1|Overall Study|Lack of Efficacy|13
2691195|NCT00449176|9280567|P3|Overall Study|Adverse Event|15
2691196|NCT00449176|9280568|P2|Overall Study|Adverse Event|107
2691197|NCT00449176|9280569|P1|Overall Study|Adverse Event|51
2691198|NCT00449176|9280567|P3|Overall Study|Lost to Follow-up|12
2691199|NCT00449176|9280568|P2|Overall Study|Lost to Follow-up|8
2691200|NCT00449176|9280569|P1|Overall Study|Lost to Follow-up|13
2691201|NCT00449176|9280567|P3|Overall Study|Withdrawal by Subject|59
2691202|NCT00449176|9280568|P2|Overall Study|Withdrawal by Subject|43
2691203|NCT00449176|9280569|P1|Overall Study|Withdrawal by Subject|39
2691204|NCT00449163|9280595|P1|Overall Study|Physician Decision|3
2691205|NCT00449150|9280605|P3|Overall Study|Protocol Violation|1
2691206|NCT00449150|9280606|P2|Overall Study|Protocol Violation|2
2691207|NCT00449150|9280607|P1|Overall Study|Protocol Violation|1
2691208|NCT00449150|9280605|P3|Overall Study|Withdrawal by Subject|21
2691209|NCT00449150|9280606|P2|Overall Study|Withdrawal by Subject|18
2691210|NCT00449150|9280607|P1|Overall Study|Withdrawal by Subject|17
2691211|NCT00449150|9280605|P3|Overall Study|Other|14
2691212|NCT00449150|9280606|P2|Overall Study|Other|13
2691213|NCT00449150|9280607|P1|Overall Study|Other|16
2691214|NCT00449150|9280605|P3|Overall Study|Lack of Efficacy|2
2691215|NCT00449150|9280606|P2|Overall Study|Lack of Efficacy|2
2691216|NCT00449150|9280607|P1|Overall Study|Lack of Efficacy|1
2691217|NCT00449150|9280605|P3|Overall Study|Adverse Event|9
2691218|NCT00449150|9280606|P2|Overall Study|Adverse Event|18
2691219|NCT00449150|9280607|P1|Overall Study|Adverse Event|11
2691220|NCT00449072|9280620|P2|Overall Study|Relocation|2
2691221|NCT00449072|9280621|P1|Overall Study|Relocation|3
2691222|NCT00449072|9280620|P2|Overall Study|Sponsor decision|3
2691223|NCT00449072|9280621|P1|Overall Study|Sponsor decision|1
2691224|NCT00449072|9280620|P2|Overall Study|Non-compliance|5
2691225|NCT00449072|9280621|P1|Overall Study|Non-compliance|2
2691226|NCT00449072|9280620|P2|Overall Study|Excluded medication|2
2691227|NCT00449072|9280621|P1|Overall Study|Excluded medication|0
2691228|NCT00449072|9280620|P2|Overall Study|Not treated|1
2691229|NCT00449072|9280621|P1|Overall Study|Not treated|0
2691230|NCT00449072|9280620|P2|Overall Study|Physician Decision|0
2691231|NCT00449072|9280621|P1|Overall Study|Physician Decision|1
2691232|NCT00449072|9280620|P2|Overall Study|Lack of Efficacy|1
2691233|NCT00449072|9280621|P1|Overall Study|Lack of Efficacy|1
2691234|NCT00449072|9280620|P2|Overall Study|Withdrawal by Subject|8
2691235|NCT00449072|9280621|P1|Overall Study|Withdrawal by Subject|11
2691236|NCT00449072|9280620|P2|Overall Study|Lost to Follow-up|7
2691237|NCT00449072|9280621|P1|Overall Study|Lost to Follow-up|5
2691238|NCT00449072|9280620|P2|Overall Study|Protocol Violation|12
2691239|NCT00449072|9280621|P1|Overall Study|Protocol Violation|14
2691240|NCT00449072|9280620|P2|Overall Study|Adverse Event|1
2691241|NCT00449072|9280621|P1|Overall Study|Adverse Event|3
2691242|NCT00449033|9280658|P2|Follow-up Period|Reason Missing|113
2691243|NCT00449033|9280659|P1|Follow-up Period|Reason Missing|120
2691244|NCT00449033|9280658|P2|Follow-up Period|Lost to Follow-up|10
2691245|NCT00449033|9280659|P1|Follow-up Period|Lost to Follow-up|6
2691246|NCT00449033|9280658|P2|Follow-up Period|Death|311
2691247|NCT00449033|9280659|P1|Follow-up Period|Death|299
2691248|NCT00449033|9280658|P2|Treatment Period|Treatment Ongoing|4
2691249|NCT00449033|9280659|P1|Treatment Period|Treatment Ongoing|6
2691250|NCT00449033|9280658|P2|Treatment Period|Reason Missing|4
2691251|NCT00449033|9280659|P1|Treatment Period|Reason Missing|0
2691252|NCT00449033|9280658|P2|Treatment Period|Second Malignancy|1
2691253|NCT00449033|9280659|P1|Treatment Period|Second Malignancy|0
2691254|NCT00449033|9280658|P2|Treatment Period|Non-compliance|8
2691255|NCT00449033|9280659|P1|Treatment Period|Non-compliance|7
2691256|NCT00449033|9280658|P2|Treatment Period|Amended Protocol Criteria|18
2691257|NCT00449033|9280659|P1|Treatment Period|Amended Protocol Criteria|22
2691258|NCT00449033|9280658|P2|Treatment Period|Consent Withdrawn|20
2691259|NCT00449033|9280659|P1|Treatment Period|Consent Withdrawn|36
2691260|NCT00449033|9280658|P2|Treatment Period|Disease Progression|288
2691261|NCT00449033|9280659|P1|Treatment Period|Disease Progression|231
2691262|NCT00449033|9280658|P2|Treatment Period|Protocol Violation|7
2691263|NCT00449033|9280659|P1|Treatment Period|Protocol Violation|8
2691264|NCT00449033|9280658|P2|Treatment Period|Physician Decision|5
2691265|NCT00449033|9280659|P1|Treatment Period|Physician Decision|4
2691266|NCT00449033|9280658|P2|Treatment Period|Lost to Follow-up|2
2691267|NCT00449033|9280659|P1|Treatment Period|Lost to Follow-up|0
2691268|NCT00449033|9280658|P2|Treatment Period|Death|12
2691269|NCT00449033|9280659|P1|Treatment Period|Death|21
2691270|NCT00449033|9280658|P2|Treatment Period|Adverse Event|83
2691271|NCT00449033|9280659|P1|Treatment Period|Adverse Event|117
2691272|NCT00448916|9280697|P4|Overall Study|Protocol Violation|1
2691273|NCT00448916|9280698|P3|Overall Study|Protocol Violation|0
2691274|NCT00448916|9280699|P2|Overall Study|Protocol Violation|0
2691275|NCT00448916|9280700|P1|Overall Study|Protocol Violation|0
2691276|NCT00448916|9280697|P4|Overall Study|Lost to Follow-up|1
2691277|NCT00448916|9280698|P3|Overall Study|Lost to Follow-up|0
2691278|NCT00448916|9280699|P2|Overall Study|Lost to Follow-up|1
2691279|NCT00448916|9280700|P1|Overall Study|Lost to Follow-up|0
2691280|NCT00448916|9280697|P4|Overall Study|Other|0
2691281|NCT00448916|9280698|P3|Overall Study|Other|0
2691282|NCT00448916|9280699|P2|Overall Study|Other|0
2691283|NCT00448916|9280700|P1|Overall Study|Other|1
2691284|NCT00448916|9280697|P4|Overall Study|Withdrawal by Subject|1
2691285|NCT00448916|9280698|P3|Overall Study|Withdrawal by Subject|1
2691286|NCT00448916|9280699|P2|Overall Study|Withdrawal by Subject|3
2691287|NCT00448916|9280700|P1|Overall Study|Withdrawal by Subject|3
2691288|NCT00448916|9280697|P4|Overall Study|Lack of Efficacy|1
2691289|NCT00448916|9280698|P3|Overall Study|Lack of Efficacy|2
2691290|NCT00448916|9280699|P2|Overall Study|Lack of Efficacy|0
2691291|NCT00448916|9280700|P1|Overall Study|Lack of Efficacy|1
2691292|NCT00448916|9280697|P4|Overall Study|Adverse Event|2
2691293|NCT00448916|9280698|P3|Overall Study|Adverse Event|3
2691294|NCT00448916|9280699|P2|Overall Study|Adverse Event|2
2691295|NCT00448916|9280700|P1|Overall Study|Adverse Event|2
2691296|NCT00448864|9280774|P3|Overall Study|Protocol Violation|0
2691297|NCT00448864|9280775|P2|Overall Study|Protocol Violation|2
2691298|NCT00448864|9280776|P1|Overall Study|Protocol Violation|0
2691299|NCT00448864|9280774|P3|Overall Study|Withdrawal by Subject|0
2691300|NCT00448864|9280775|P2|Overall Study|Withdrawal by Subject|2
2691301|NCT00448864|9280776|P1|Overall Study|Withdrawal by Subject|0
2691302|NCT00448864|9280774|P3|Overall Study|Physician Decision|1
2691303|NCT00448864|9280775|P2|Overall Study|Physician Decision|0
2691304|NCT00448864|9280776|P1|Overall Study|Physician Decision|1
2691305|NCT00448864|9280774|P3|Overall Study|Lost to Follow-up|0
2691306|NCT00448864|9280775|P2|Overall Study|Lost to Follow-up|1
2691307|NCT00448864|9280776|P1|Overall Study|Lost to Follow-up|3
2691308|NCT00448864|9280774|P3|Overall Study|Death|0
2691309|NCT00448864|9280775|P2|Overall Study|Death|0
2691310|NCT00448864|9280776|P1|Overall Study|Death|1
2691311|NCT00448760|9280792|P1|Overall Study|Death|3
2691312|NCT00448747|9280801|P2|Overall Study|collapsed veins|0
2691313|NCT00448747|9280802|P1|Overall Study|collapsed veins|1
2691314|NCT00448708|9280820|P2|Overall Study|not listed|2
2691315|NCT00448708|9280821|P1|Overall Study|not listed|0
2691316|NCT00448708|9280820|P2|Overall Study|Lost to Follow-up|8
2691317|NCT00448708|9280821|P1|Overall Study|Lost to Follow-up|6
2691318|NCT00448708|9280820|P2|Overall Study|Withdrawal by Subject|4
2691319|NCT00448708|9280821|P1|Overall Study|Withdrawal by Subject|8
2691320|NCT00448708|9280820|P2|Overall Study|Death|17
2691321|NCT00448708|9280821|P1|Overall Study|Death|21
2691322|NCT00448669|9280837|P2|Overall Study|Never started drug|7
2691323|NCT00448669|9280838|P1|Overall Study|Never started drug|9
2691324|NCT00448669|9280837|P2|Overall Study|HIV-infected at enrollment|2
2691325|NCT00448669|9280838|P1|Overall Study|HIV-infected at enrollment|1
2691326|NCT00448669|9280837|P2|Overall Study|Had other reasons|6
2691327|NCT00448669|9280838|P1|Overall Study|Had other reasons|5
2691328|NCT00448669|9280837|P2|Overall Study|Death|4
2691329|NCT00448669|9280838|P1|Overall Study|Death|2
2691330|NCT00448669|9280837|P2|Overall Study|Were withdrawn by investigator|6
2691331|NCT00448669|9280838|P1|Overall Study|Were withdrawn by investigator|10
2691332|NCT00448669|9280837|P2|Overall Study|Relocated|36
2691333|NCT00448669|9280838|P1|Overall Study|Relocated|49
2691334|NCT00448669|9280837|P2|Overall Study|Withdrawal by Subject|74
2691335|NCT00448669|9280838|P1|Overall Study|Withdrawal by Subject|90
2691336|NCT00448669|9280837|P2|Overall Study|Lost to Follow-up|63
2691337|NCT00448669|9280838|P1|Overall Study|Lost to Follow-up|52
2691338|NCT00448591|9280899|P1|Overall Study|Termination of Study|70
2691339|NCT00448591|9280899|P1|Overall Study|Other|154
2691340|NCT00448591|9280899|P1|Overall Study|Treatment Regimen Completed|70
2691341|NCT00448591|9280899|P1|Overall Study|Lost to Follow-up|19
2691342|NCT00448591|9280899|P1|Overall Study|Protocol Violation|41
2691343|NCT00448591|9280899|P1|Overall Study|Adverse Event|382
2691344|NCT00448591|9280899|P1|Overall Study|Progressive Disease|1382
2691345|NCT00448591|9280899|P1|Overall Study|Withdrawal by Subject|178
2691346|NCT00448539|9280910|P2|Overall Study|Lost to Follow-up|3
2691347|NCT00448539|9280911|P1|Overall Study|Lost to Follow-up|1
2691348|NCT00448539|9280910|P2|Overall Study|Change of meds|3
2691349|NCT00448539|9280911|P1|Overall Study|Change of meds|2
2691350|NCT00448539|9280910|P2|Overall Study|Miscellaneous|1
2691351|NCT00448539|9280911|P1|Overall Study|Miscellaneous|2
2691352|NCT00448539|9280910|P2|Overall Study|Lack of Efficacy|40
2691353|NCT00448539|9280911|P1|Overall Study|Lack of Efficacy|27
2691354|NCT00448539|9280910|P2|Overall Study|Adverse Event|26
2691355|NCT00448539|9280911|P1|Overall Study|Adverse Event|9
2691356|NCT00448539|9280910|P2|Overall Study|Diary non-compliance|0
2691357|NCT00448539|9280911|P1|Overall Study|Diary non-compliance|1
2691358|NCT00448539|9280910|P2|Overall Study|Withdrawal by Subject|24
2691359|NCT00448539|9280911|P1|Overall Study|Withdrawal by Subject|20
2691360|NCT00448539|9280910|P2|Overall Study|Request of the investigator or sponsor|54
2691361|NCT00448539|9280911|P1|Overall Study|Request of the investigator or sponsor|67
2691362|NCT00448539|9280910|P2|Overall Study|Protocol Violation|0
2691363|NCT00448539|9280911|P1|Overall Study|Protocol Violation|1
2691364|NCT00448539|9280910|P2|Overall Study|Medication non-compliance|1
2691365|NCT00448539|9280911|P1|Overall Study|Medication non-compliance|4
2691366|NCT00448448|9280919|P2|Overall Study|Signed consent lost|1
2691367|NCT00448448|9280920|P1|Overall Study|Signed consent lost|0
2691368|NCT00448448|9280919|P2|Overall Study|Wrong diagnosis (n=3) or other|1
2691369|NCT00448448|9280920|P1|Overall Study|Wrong diagnosis (n=3) or other|2
2691370|NCT00448448|9280919|P2|Overall Study|Lost to Follow-up|1
2691371|NCT00448448|9280920|P1|Overall Study|Lost to Follow-up|2
2691372|NCT00448448|9280919|P2|Overall Study|On protocol when study ended|36
2691373|NCT00448448|9280920|P1|Overall Study|On protocol when study ended|83
2691374|NCT00448448|9280919|P2|Overall Study|Withdrawal by Subject|2
2691375|NCT00448448|9280920|P1|Overall Study|Withdrawal by Subject|13
2691376|NCT00448435|9280926|P2|Washout Period - 2 Weeks|Withdrawal by Subject|0
2691377|NCT00448435|9280927|P1|Washout Period - 2 Weeks|Withdrawal by Subject|1
2691378|NCT00448344|9280978|P2|Overall Study|Physician Decision|2
2691379|NCT00448344|9280979|P1|Overall Study|Physician Decision|1
2691380|NCT00448344|9280978|P2|Overall Study|Death|4
2691381|NCT00448344|9280979|P1|Overall Study|Death|3
2691382|NCT00448344|9280978|P2|Overall Study|Withdrawal by Subject|8
2691383|NCT00448344|9280979|P1|Overall Study|Withdrawal by Subject|6
2691384|NCT00448344|9280978|P2|Overall Study|Lost to Follow-up|22
2691385|NCT00448344|9280979|P1|Overall Study|Lost to Follow-up|20
2691386|NCT00448279|9280989|P2|Overall Study|Protocol Violation|1
2691387|NCT00448279|9280990|P1|Overall Study|Protocol Violation|0
2691388|NCT00448279|9280989|P2|Overall Study|Other|4
2691389|NCT00448279|9280990|P1|Overall Study|Other|6
2691390|NCT00448279|9280989|P2|Overall Study|Withdrawal by Subject|3
2691391|NCT00448279|9280990|P1|Overall Study|Withdrawal by Subject|4
2691392|NCT00448279|9280989|P2|Overall Study|Disease progression|18
2691393|NCT00448279|9280990|P1|Overall Study|Disease progression|16
2691394|NCT00448279|9280989|P2|Overall Study|Adverse Event|1
2691395|NCT00448279|9280990|P1|Overall Study|Adverse Event|1
2691396|NCT00448279|9280989|P2|Overall Study|Lost to Follow-up|2
2691397|NCT00448279|9280990|P1|Overall Study|Lost to Follow-up|2
2691398|NCT00448136|9281053|P2|Overall Study|Investigator's decision (progression)|0
2691399|NCT00448136|9281054|P1|Overall Study|Investigator's decision (progression)|1
2691400|NCT00448136|9281053|P2|Overall Study|Death|8
2691401|NCT00448136|9281054|P1|Overall Study|Death|3
2691402|NCT00448123|9281092|P2|Overall Study|Physician Decision|6
2691403|NCT00448123|9281093|P1|Overall Study|Physician Decision|6
2691404|NCT00448123|9281092|P2|Overall Study|Lost to Follow-up|6
2691405|NCT00448123|9281093|P1|Overall Study|Lost to Follow-up|9
2691406|NCT00448019|9281103|P1|Overall Study|Insurance Issues|1
2691407|NCT00448019|9281103|P1|Overall Study|Death|2
2691408|NCT00448019|9281103|P1|Overall Study|Disease progression|1
2691409|NCT00448019|9281103|P1|Overall Study|Withdrawal by Subject|3
2691410|NCT00447902|9281111|P2|Overall Study|Lack of Efficacy|1
2691411|NCT00447902|9281112|P1|Overall Study|Lack of Efficacy|2
2691412|NCT00447902|9281111|P2|Overall Study|included patients who discontinued|1
2691413|NCT00447902|9281112|P1|Overall Study|included patients who discontinued|1
2691414|NCT00447902|9281111|P2|Overall Study|Withdrawal by Subject|1
2691415|NCT00447902|9281112|P1|Overall Study|Withdrawal by Subject|0
2691416|NCT00447902|9281111|P2|Overall Study|Protocol Violation|0
2691417|NCT00447902|9281112|P1|Overall Study|Protocol Violation|1
2691418|NCT00447902|9281111|P2|Overall Study|Adverse Event|3
2691419|NCT00447902|9281112|P1|Overall Study|Adverse Event|0
2691420|NCT00447876|9281154|P2|Overall Study|Deterioration of symptomology|0
2691421|NCT00447876|9281155|P1|Overall Study|Deterioration of symptomology|1
2691422|NCT00447876|9281154|P2|Overall Study|Lost to Follow-up|0
2691423|NCT00447876|9281155|P1|Overall Study|Lost to Follow-up|1
2691424|NCT00447876|9281154|P2|Overall Study|Withdrawal by Subject|4
2691425|NCT00447876|9281155|P1|Overall Study|Withdrawal by Subject|1
2691426|NCT00447772|9281185|P1|Overall Study|Premature re-injection required|1
2691427|NCT00447772|9281185|P1|Overall Study|Chemotherapy for lung cancer|1
2691428|NCT00447772|9281185|P1|Overall Study|Incomplete documentation at visit 1|1
2691429|NCT00447772|9281185|P1|Overall Study|Patient relocated|1
2691430|NCT00447772|9281185|P1|Overall Study|Adverse Event|1
2691431|NCT00447772|9281185|P1|Overall Study|Unable to attend all study visits|2
2691432|NCT00447772|9281185|P1|Overall Study|Withdrawal by Subject|1
2691433|NCT00447772|9281185|P1|Overall Study|Lost to Follow-up|9
2691434|NCT00447772|9281185|P1|Overall Study|Discontinuation of drug therapy|1
2691435|NCT00447772|9281185|P1|Overall Study|Insufficient compliance|6
2691436|NCT00447772|9281185|P1|Overall Study|Lack of Efficacy|3
2691437|NCT00447603|9281205|P3|Filter Period|Study terminated by Sponsor|10
2691438|NCT00447603|9281206|P2|Filter Period|Study terminated by Sponsor|1
2691439|NCT00447603|9281207|P1|Filter Period|Study terminated by Sponsor|0
2691440|NCT00447603|9281205|P3|Filter Period|Screen Failure|4
2691441|NCT00447603|9281206|P2|Filter Period|Screen Failure|3
2691442|NCT00447603|9281207|P1|Filter Period|Screen Failure|0
2691443|NCT00447603|9281205|P3|Filter Period|Adverse Event|1
2691444|NCT00447603|9281206|P2|Filter Period|Adverse Event|0
2691445|NCT00447603|9281207|P1|Filter Period|Adverse Event|0
2691446|NCT00447603|9281205|P3|Screening|Study Terminated by Sponsor|0
2691447|NCT00447603|9281206|P2|Screening|Study Terminated by Sponsor|0
2691448|NCT00447603|9281207|P1|Screening|Study Terminated by Sponsor|15
2691449|NCT00447603|9281205|P3|Screening|Screen Failure|0
2691450|NCT00447603|9281206|P2|Screening|Screen Failure|0
2691451|NCT00447603|9281207|P1|Screening|Screen Failure|4
2691452|NCT00447603|9281205|P3|Screening|Protocol Violation|0
2691453|NCT00447603|9281206|P2|Screening|Protocol Violation|0
2691454|NCT00447603|9281207|P1|Screening|Protocol Violation|1
2691455|NCT00447603|9281205|P3|Screening|Withdrawal by Subject|0
2691456|NCT00447603|9281206|P2|Screening|Withdrawal by Subject|0
2691457|NCT00447603|9281207|P1|Screening|Withdrawal by Subject|1
2691458|NCT00447590|9281227|P1|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10
2691459|NCT00447590|9281227|P1|Overall Study|Lost to Follow-up|24
2691460|NCT00447590|9281227|P1|Overall Study|Withdrawal by Subject|26
2691461|NCT00447499|9281236|P1|Overall Study|Physician Decision|1
2691462|NCT00447499|9281236|P1|Overall Study|Sponsor Decision|1
2691463|NCT00447499|9281236|P1|Overall Study|Patient Decision|4
2691464|NCT00447499|9281236|P1|Overall Study|Adverse Event|1
2691465|NCT00447421|9281246|P1|Overall Study|Sponsor Decision|2
2691466|NCT00447421|9281246|P1|Overall Study|Adverse Event|3
2691467|NCT00447421|9281246|P1|Overall Study|Lack of Efficacy|1
2691468|NCT00447382|9281258|P2|Overall Study|Unclassified|5
2691469|NCT00447382|9281259|P1|Overall Study|Unclassified|2
2691470|NCT00447382|9281258|P2|Overall Study|Protocol Violation|0
2691471|NCT00447382|9281259|P1|Overall Study|Protocol Violation|2
2691472|NCT00447382|9281258|P2|Overall Study|Lack of Efficacy|0
2691473|NCT00447382|9281259|P1|Overall Study|Lack of Efficacy|1
2691474|NCT00447382|9281258|P2|Overall Study|Adverse Event|1
2691475|NCT00447382|9281259|P1|Overall Study|Adverse Event|1
2691476|NCT00447278|9281320|P2|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8
2691477|NCT00447278|9281321|P1|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11
2691478|NCT00447278|9281320|P2|Period III (Optional 6 Month Extension)|Lack of Efficacy|0
2691479|NCT00447278|9281321|P1|Period III (Optional 6 Month Extension)|Lack of Efficacy|4
2691480|NCT00447278|9281320|P2|Period III (Optional 6 Month Extension)|Physician Decision|1
2691481|NCT00447278|9281321|P1|Period III (Optional 6 Month Extension)|Physician Decision|1
2691482|NCT00447278|9281320|P2|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1
2691483|NCT00447278|9281321|P1|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4
2691484|NCT00447278|9281320|P2|Period III (Optional 6 Month Extension)|Protocol Violation|1
2691485|NCT00447278|9281321|P1|Period III (Optional 6 Month Extension)|Protocol Violation|6
2691486|NCT00447278|9281320|P2|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
2691487|NCT00447278|9281321|P1|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
2691488|NCT00447278|9281320|P2|Period III (Optional 6 Month Extension)|Adverse Event|2
2691489|NCT00447278|9281321|P1|Period III (Optional 6 Month Extension)|Adverse Event|2
2691490|NCT00447278|9281320|P2|Period II (6 Month Open-Label)|Parent/Guardian Decision|10
2691491|NCT00447278|9281321|P1|Period II (6 Month Open-Label)|Parent/Guardian Decision|9
2691492|NCT00447278|9281320|P2|Period II (6 Month Open-Label)|Lack of Efficacy|1
2691493|NCT00447278|9281321|P1|Period II (6 Month Open-Label)|Lack of Efficacy|11
2691494|NCT00447278|9281320|P2|Period II (6 Month Open-Label)|Physician Decision|1
2691495|NCT00447278|9281321|P1|Period II (6 Month Open-Label)|Physician Decision|4
2691496|NCT00447278|9281320|P2|Period II (6 Month Open-Label)|Withdrawal by Subject|3
2691497|NCT00447278|9281321|P1|Period II (6 Month Open-Label)|Withdrawal by Subject|1
2691498|NCT00447278|9281320|P2|Period II (6 Month Open-Label)|Protocol Violation|7
2691499|NCT00447278|9281321|P1|Period II (6 Month Open-Label)|Protocol Violation|10
2691500|NCT00447278|9281320|P2|Period II (6 Month Open-Label)|Lost to Follow-up|4
2691501|NCT00447278|9281321|P1|Period II (6 Month Open-Label)|Lost to Follow-up|0
2691502|NCT00447278|9281320|P2|Period II (6 Month Open-Label)|Adverse Event|3
2691503|NCT00447278|9281321|P1|Period II (6 Month Open-Label)|Adverse Event|7
2691504|NCT00447265|9281342|P2|Overall Study|Physician Decision|0
2691505|NCT00447265|9281343|P1|Overall Study|Physician Decision|1
2691506|NCT00447226|9281356|P2|Double-blind Phase|Disease Progression|3
2691507|NCT00447226|9281357|P1|Double-blind Phase|Disease Progression|4
2691508|NCT00447226|9281356|P2|12-Week Open-label Phase|Physician Decision|1
2691509|NCT00447226|9281357|P1|12-Week Open-label Phase|Physician Decision|0
2691510|NCT00447226|9281356|P2|12-Week Open-label Phase|Disease Progression|20
2691511|NCT00447226|9281357|P1|12-Week Open-label Phase|Disease Progression|0
2691512|NCT00447226|9281356|P2|12-Week Open-label Phase|Protocol Violation|1
2691513|NCT00447226|9281357|P1|12-Week Open-label Phase|Protocol Violation|0
2691514|NCT00447226|9281356|P2|12-Week Open-label Phase|Adverse Event|3
2691515|NCT00447226|9281357|P1|12-Week Open-label Phase|Adverse Event|0
2691516|NCT00447057|9281400|P4|Overall Study|Death, study drug related|0
2691517|NCT00447057|9281401|P3|Overall Study|Death, study drug related|0
2691518|NCT00447057|9281402|P2|Overall Study|Death, study drug related|1
2691519|NCT00447057|9281403|P1|Overall Study|Death, study drug related|0
2691520|NCT00447057|9281400|P4|Overall Study|Death due to adverse event|2
2691521|NCT00447057|9281401|P3|Overall Study|Death due to adverse event|1
2691522|NCT00447057|9281402|P2|Overall Study|Death due to adverse event|0
2691523|NCT00447057|9281403|P1|Overall Study|Death due to adverse event|0
2691524|NCT00447057|9281400|P4|Overall Study|Progressive disease|18
2691525|NCT00447057|9281401|P3|Overall Study|Progressive disease|13
2691526|NCT00447057|9281402|P2|Overall Study|Progressive disease|43
2691527|NCT00447057|9281403|P1|Overall Study|Progressive disease|58
2691528|NCT00447057|9281400|P4|Overall Study|Sponsor decision|0
2691529|NCT00447057|9281401|P3|Overall Study|Sponsor decision|0
2691530|NCT00447057|9281402|P2|Overall Study|Sponsor decision|1
2691531|NCT00447057|9281403|P1|Overall Study|Sponsor decision|1
2691532|NCT00447057|9281400|P4|Overall Study|Physician Decision|1
2691533|NCT00447057|9281401|P3|Overall Study|Physician Decision|3
2691534|NCT00447057|9281402|P2|Overall Study|Physician Decision|6
2691535|NCT00447057|9281403|P1|Overall Study|Physician Decision|9
2691536|NCT00447057|9281400|P4|Overall Study|Withdrawal by Subject|1
2691537|NCT00447057|9281401|P3|Overall Study|Withdrawal by Subject|1
2691538|NCT00447057|9281402|P2|Overall Study|Withdrawal by Subject|5
2691539|NCT00447057|9281403|P1|Overall Study|Withdrawal by Subject|4
2691540|NCT00447057|9281400|P4|Overall Study|Protocol Violation|0
2691541|NCT00447057|9281401|P3|Overall Study|Protocol Violation|0
2691542|NCT00447057|9281402|P2|Overall Study|Protocol Violation|1
2691543|NCT00447057|9281403|P1|Overall Study|Protocol Violation|0
2691544|NCT00447057|9281400|P4|Overall Study|Entry criteria not met|0
2691545|NCT00447057|9281401|P3|Overall Study|Entry criteria not met|0
2691546|NCT00447057|9281402|P2|Overall Study|Entry criteria not met|1
2691547|NCT00447057|9281403|P1|Overall Study|Entry criteria not met|1
2691548|NCT00447057|9281400|P4|Overall Study|Lost to Follow-up|0
2691549|NCT00447057|9281401|P3|Overall Study|Lost to Follow-up|0
2691550|NCT00447057|9281402|P2|Overall Study|Lost to Follow-up|1
2691551|NCT00447057|9281403|P1|Overall Study|Lost to Follow-up|0
2691552|NCT00447057|9281400|P4|Overall Study|Death due to study disease|1
2691553|NCT00447057|9281401|P3|Overall Study|Death due to study disease|1
2691554|NCT00447057|9281402|P2|Overall Study|Death due to study disease|4
2691555|NCT00447057|9281403|P1|Overall Study|Death due to study disease|6
2691556|NCT00447057|9281400|P4|Overall Study|Adverse Event|3
2691557|NCT00447057|9281401|P3|Overall Study|Adverse Event|0
2691558|NCT00447057|9281402|P2|Overall Study|Adverse Event|10
2691559|NCT00447057|9281403|P1|Overall Study|Adverse Event|4
2691560|NCT00447005|9281421|P1|Overall Study|Lack of Efficacy|11
2691561|NCT00447005|9281421|P1|Overall Study|Adverse Event|1
2691562|NCT00446992|9281435|P1|Overall Study|Lost to Follow-up|5
2691563|NCT00446992|9281435|P1|Overall Study|Adverse Event|11
2691564|NCT00446966|9281449|P2|Overall Study|Lost to Follow-up|7
2691565|NCT00446966|9281450|P1|Overall Study|Lost to Follow-up|10
2691566|NCT00446849|9281456|P1|Maintenance Phase|concomitant medication use|1
2691567|NCT00446849|9281456|P1|Maintenance Phase|hydrocodone use|1
2691568|NCT00446849|9281456|P1|Maintenance Phase|study closure|1
2691569|NCT00446849|9281456|P1|Maintenance Phase|antibiotic use|1
2691570|NCT00446849|9281456|P1|Maintenance Phase|prohibited medication use|2
2691571|NCT00446849|9281456|P1|Maintenance Phase|noncompliance|2
2691572|NCT00446849|9281456|P1|Maintenance Phase|Pregnancy|1
2691573|NCT00446849|9281456|P1|Maintenance Phase|Lost to Follow-up|3
2691574|NCT00446849|9281456|P1|Maintenance Phase|Consent withdrawn|5
2691575|NCT00446849|9281456|P1|Maintenance Phase|Adverse Event|6
2691576|NCT00446849|9281456|P1|Maintenance Phase|Protocol Violation|7
2691577|NCT00446849|9281456|P1|Maintenance Phase|Lack of Efficacy|40
2691578|NCT00446849|9281456|P1|Acute Phase|noncompliance|1
2691579|NCT00446849|9281456|P1|Acute Phase|Physician Decision|1
2691580|NCT00446849|9281456|P1|Acute Phase|Lost to Follow-up|2
2691581|NCT00446849|9281456|P1|Acute Phase|Consent withdrawn|4
2691582|NCT00446849|9281456|P1|Acute Phase|Protocol Violation|10
2691583|NCT00446849|9281456|P1|Acute Phase|Lack of Efficacy|64
2691584|NCT00446797|9281468|P2|Overall Study|did not meet entrance criteria|1
2691585|NCT00446797|9281469|P1|Overall Study|did not meet entrance criteria|0
2691586|NCT00446797|9281468|P2|Overall Study|subject entered at another site|1
2691587|NCT00446797|9281469|P1|Overall Study|subject entered at another site|0
2691588|NCT00446797|9281468|P2|Overall Study|Protocol Violation|3
2691589|NCT00446797|9281469|P1|Overall Study|Protocol Violation|1
2691590|NCT00446797|9281468|P2|Overall Study|Withdrawal by Subject|2
2691591|NCT00446797|9281469|P1|Overall Study|Withdrawal by Subject|2
2691592|NCT00446797|9281468|P2|Overall Study|Lost to Follow-up|3
2691593|NCT00446797|9281469|P1|Overall Study|Lost to Follow-up|5
2691594|NCT00446797|9281468|P2|Overall Study|Lack of Efficacy|2
2691595|NCT00446797|9281469|P1|Overall Study|Lack of Efficacy|0
2691596|NCT00446654|9281515|P2|Overall Study|Adverse Event|0
2691597|NCT00446654|9281516|P1|Overall Study|Adverse Event|1
2691598|NCT00446654|9281515|P2|Overall Study|Withdrawal by Subject|0
2691599|NCT00446654|9281516|P1|Overall Study|Withdrawal by Subject|1
2691600|NCT00446641|9281524|P2|Overall Study|Lost to Follow-up|1
2691601|NCT00446641|9281525|P1|Overall Study|Lost to Follow-up|1
2691602|NCT00446641|9281524|P2|Overall Study|poor compliance|6
2691603|NCT00446641|9281525|P1|Overall Study|poor compliance|8
2691604|NCT00446641|9281524|P2|Overall Study|Withdrawal by Subject|3
2691605|NCT00446641|9281525|P1|Overall Study|Withdrawal by Subject|8
2691606|NCT00446563|9281545|P2|Overall Study|Administrative problems|1
2691607|NCT00446563|9281546|P1|Overall Study|Administrative problems|0
2691608|NCT00446563|9281545|P2|Overall Study|Withdrawal by Subject|1
2691609|NCT00446563|9281546|P1|Overall Study|Withdrawal by Subject|2
2691610|NCT00446563|9281545|P2|Overall Study|Unsatisfactory therapeutic effect|3
2691611|NCT00446563|9281546|P1|Overall Study|Unsatisfactory therapeutic effect|0
2691612|NCT00446563|9281545|P2|Overall Study|Abnormal test procedure result(s)|0
2691613|NCT00446563|9281546|P1|Overall Study|Abnormal test procedure result(s)|1
2691614|NCT00446563|9281545|P2|Overall Study|Abnormal laboratory value(s)|1
2691615|NCT00446563|9281546|P1|Overall Study|Abnormal laboratory value(s)|0
2691616|NCT00446563|9281545|P2|Overall Study|Adverse Event|3
2691617|NCT00446563|9281546|P1|Overall Study|Adverse Event|4
2691618|NCT00446550|9281582|P2|Overall Study|Adverse Event|0
2691619|NCT00446550|9281583|P1|Overall Study|Adverse Event|1
2691620|NCT00446511|9281595|P4|Overall Study|Administrative Problems|1
2691621|NCT00446511|9281596|P3|Overall Study|Administrative Problems|4
2691622|NCT00446511|9281597|P2|Overall Study|Administrative Problems|0
2691623|NCT00446511|9281598|P1|Overall Study|Administrative Problems|3
2691624|NCT00446511|9281595|P4|Overall Study|Withdrawal by Subject|3
2691625|NCT00446511|9281596|P3|Overall Study|Withdrawal by Subject|0
2691626|NCT00446511|9281597|P2|Overall Study|Withdrawal by Subject|0
2691627|NCT00446511|9281598|P1|Overall Study|Withdrawal by Subject|0
2691628|NCT00446511|9281595|P4|Overall Study|Protocol Violation|1
2691629|NCT00446511|9281596|P3|Overall Study|Protocol Violation|0
2691630|NCT00446511|9281597|P2|Overall Study|Protocol Violation|0
2691631|NCT00446511|9281598|P1|Overall Study|Protocol Violation|0
2691632|NCT00446511|9281595|P4|Overall Study|Adverse Event|1
2691633|NCT00446511|9281596|P3|Overall Study|Adverse Event|3
2691634|NCT00446511|9281597|P2|Overall Study|Adverse Event|2
2691635|NCT00446511|9281598|P1|Overall Study|Adverse Event|7
2691636|NCT00446459|9281622|P1|12 Months|14 subjects to MMF + Rituximab Study|14
2691637|NCT00446459|9281622|P1|12 Months|Protocol Violation|4
2691638|NCT00446459|9281622|P1|8 Months|Protocol Violation|12
2691639|NCT00446446|9281630|P1|Overall Study|On Treatment at Time of Data Cut-off|1
2691640|NCT00446446|9281630|P1|Overall Study|Adverse Event|1
2691641|NCT00446446|9281630|P1|Overall Study|Disease Progession|2
2691642|NCT00446446|9281630|P1|Overall Study|Other|4
2691643|NCT00446446|9281630|P1|Overall Study|Withdrawal by Subject|6
2691644|NCT00446446|9281630|P1|Overall Study|Death|10
2691645|NCT00446251|9281654|P1|Overall Study|Lost to Follow-up|1
2691646|NCT00446251|9281654|P1|Overall Study|Rituximab Infusion Reaction|2
2691647|NCT00446251|9281654|P1|Overall Study|On-study Transplants|2
2691648|NCT00446199|9281664|P4|Overall Study|Move|0
2691649|NCT00446199|9281665|P3|Overall Study|Move|0
2691650|NCT00446199|9281666|P2|Overall Study|Move|1
2691651|NCT00446199|9281667|P1|Overall Study|Move|0
2691652|NCT00446199|9281664|P4|Overall Study|In-/Exclusion criterion violated|1
2691653|NCT00446199|9281665|P3|Overall Study|In-/Exclusion criterion violated|2
2691654|NCT00446199|9281666|P2|Overall Study|In-/Exclusion criterion violated|1
2691655|NCT00446199|9281667|P1|Overall Study|In-/Exclusion criterion violated|2
2691656|NCT00446199|9281664|P4|Overall Study|Lost interest in study participation|0
2691657|NCT00446199|9281665|P3|Overall Study|Lost interest in study participation|0
2691658|NCT00446199|9281666|P2|Overall Study|Lost interest in study participation|1
2691659|NCT00446199|9281667|P1|Overall Study|Lost interest in study participation|0
2691660|NCT00446199|9281664|P4|Overall Study|Hormone fear|1
2691661|NCT00446199|9281665|P3|Overall Study|Hormone fear|0
2691662|NCT00446199|9281666|P2|Overall Study|Hormone fear|0
2691663|NCT00446199|9281667|P1|Overall Study|Hormone fear|0
2691664|NCT00446199|9281664|P4|Overall Study|Non-compliant with visit schedule|2
2691665|NCT00446199|9281665|P3|Overall Study|Non-compliant with visit schedule|1
2691666|NCT00446199|9281666|P2|Overall Study|Non-compliant with visit schedule|1
2691667|NCT00446199|9281667|P1|Overall Study|Non-compliant with visit schedule|1
2691668|NCT00446199|9281664|P4|Overall Study|Non-compliant with study drug|0
2691669|NCT00446199|9281665|P3|Overall Study|Non-compliant with study drug|5
2691670|NCT00446199|9281666|P2|Overall Study|Non-compliant with study drug|0
2691671|NCT00446199|9281667|P1|Overall Study|Non-compliant with study drug|1
2691672|NCT00446199|9281664|P4|Overall Study|Lack of Efficacy|1
2691673|NCT00446199|9281665|P3|Overall Study|Lack of Efficacy|0
2691674|NCT00446199|9281666|P2|Overall Study|Lack of Efficacy|0
2691675|NCT00446199|9281667|P1|Overall Study|Lack of Efficacy|1
2691676|NCT00446199|9281664|P4|Overall Study|Randomization in Error|1
2691677|NCT00446199|9281665|P3|Overall Study|Randomization in Error|1
2691678|NCT00446199|9281666|P2|Overall Study|Randomization in Error|0
2691679|NCT00446199|9281667|P1|Overall Study|Randomization in Error|2
2691680|NCT00446199|9281664|P4|Overall Study|Site termination|1
2691681|NCT00446199|9281665|P3|Overall Study|Site termination|0
2691682|NCT00446199|9281666|P2|Overall Study|Site termination|0
2691683|NCT00446199|9281667|P1|Overall Study|Site termination|2
2691684|NCT00446199|9281664|P4|Overall Study|Withdrawal by Subject|10
2691685|NCT00446199|9281665|P3|Overall Study|Withdrawal by Subject|9
2691686|NCT00446199|9281666|P2|Overall Study|Withdrawal by Subject|5
2691687|NCT00446199|9281667|P1|Overall Study|Withdrawal by Subject|2
2691688|NCT00446199|9281664|P4|Overall Study|Protocol Violation|3
2691689|NCT00446199|9281665|P3|Overall Study|Protocol Violation|1
2691690|NCT00446199|9281666|P2|Overall Study|Protocol Violation|2
2691691|NCT00446199|9281667|P1|Overall Study|Protocol Violation|1
2691692|NCT00446199|9281664|P4|Overall Study|Lost to Follow-up|6
2691693|NCT00446199|9281665|P3|Overall Study|Lost to Follow-up|2
2691694|NCT00446199|9281666|P2|Overall Study|Lost to Follow-up|5
2691695|NCT00446199|9281667|P1|Overall Study|Lost to Follow-up|4
2691696|NCT00446199|9281664|P4|Overall Study|Adverse Event|4
2691697|NCT00446199|9281665|P3|Overall Study|Adverse Event|6
2691698|NCT00446199|9281666|P2|Overall Study|Adverse Event|4
2691699|NCT00446199|9281667|P1|Overall Study|Adverse Event|7
2691700|NCT00446134|9281760|P4|Overall Study|Reason Not Completed|2
2691701|NCT00446134|9281761|P3|Overall Study|Reason Not Completed|1
2691702|NCT00446134|9281762|P2|Overall Study|Reason Not Completed|0
2691703|NCT00446134|9281763|P1|Overall Study|Reason Not Completed|3
2691704|NCT00446134|9281760|P4|Overall Study|Adverse Event-Diarrhea|0
2691705|NCT00446134|9281761|P3|Overall Study|Adverse Event-Diarrhea|2
2691706|NCT00446134|9281762|P2|Overall Study|Adverse Event-Diarrhea|1
2691707|NCT00446134|9281763|P1|Overall Study|Adverse Event-Diarrhea|1
2691708|NCT00446134|9281760|P4|Overall Study|Physician Decision|2
2691709|NCT00446134|9281761|P3|Overall Study|Physician Decision|0
2691710|NCT00446134|9281762|P2|Overall Study|Physician Decision|0
2691711|NCT00446134|9281763|P1|Overall Study|Physician Decision|0
2691712|NCT00446134|9281760|P4|Overall Study|Withdrawal by Subject|3
2691713|NCT00446134|9281761|P3|Overall Study|Withdrawal by Subject|1
2691714|NCT00446134|9281762|P2|Overall Study|Withdrawal by Subject|3
2691715|NCT00446134|9281763|P1|Overall Study|Withdrawal by Subject|3
2691716|NCT00446134|9281760|P4|Overall Study|Lost to Follow-up|1
2691717|NCT00446134|9281761|P3|Overall Study|Lost to Follow-up|1
2691718|NCT00446134|9281762|P2|Overall Study|Lost to Follow-up|3
2691719|NCT00446134|9281763|P1|Overall Study|Lost to Follow-up|1
2691720|NCT00446134|9281760|P4|Overall Study|Protocol Violation|0
2691721|NCT00446134|9281761|P3|Overall Study|Protocol Violation|1
2691722|NCT00446134|9281762|P2|Overall Study|Protocol Violation|2
2691723|NCT00446134|9281763|P1|Overall Study|Protocol Violation|0
2691724|NCT00446134|9281760|P4|Overall Study|Lack of Efficacy|19
2691725|NCT00446134|9281761|P3|Overall Study|Lack of Efficacy|24
2691726|NCT00446134|9281762|P2|Overall Study|Lack of Efficacy|19
2691727|NCT00446134|9281763|P1|Overall Study|Lack of Efficacy|19
2691728|NCT00446134|9281760|P4|Overall Study|Adverse Event|18
2691729|NCT00446134|9281761|P3|Overall Study|Adverse Event|13
2691730|NCT00446134|9281762|P2|Overall Study|Adverse Event|17
2691731|NCT00446134|9281763|P1|Overall Study|Adverse Event|7
2691732|NCT00446095|9281790|P5|Phase I (28 Days)|Lack of Efficacy|3
2691733|NCT00446095|9281791|P4|Phase I (28 Days)|Lack of Efficacy|0
2691734|NCT00446095|9281792|P3|Phase I (28 Days)|Lack of Efficacy|0
2691735|NCT00446095|9281793|P2|Phase I (28 Days)|Lack of Efficacy|0
2691736|NCT00446095|9281794|P1|Phase I (28 Days)|Lack of Efficacy|0
2691737|NCT00446095|9281790|P5|Phase I (28 Days)|Adverse Event|0
2691738|NCT00446095|9281791|P4|Phase I (28 Days)|Adverse Event|1
2691739|NCT00446095|9281792|P3|Phase I (28 Days)|Adverse Event|0
2691740|NCT00446095|9281793|P2|Phase I (28 Days)|Adverse Event|0
2691741|NCT00446095|9281794|P1|Phase I (28 Days)|Adverse Event|0
2691742|NCT00446095|9281790|P5|Phase II (8 Weeks)|Ongoing|0
2691743|NCT00446095|9281791|P4|Phase II (8 Weeks)|Ongoing|0
2691744|NCT00446095|9281792|P3|Phase II (8 Weeks)|Ongoing|1
2691745|NCT00446095|9281793|P2|Phase II (8 Weeks)|Ongoing|0
2691746|NCT00446095|9281794|P1|Phase II (8 Weeks)|Ongoing|0
2691747|NCT00446095|9281790|P5|Phase II (8 Weeks)|Lack of Efficacy|0
2691748|NCT00446095|9281791|P4|Phase II (8 Weeks)|Lack of Efficacy|0
2691749|NCT00446095|9281792|P3|Phase II (8 Weeks)|Lack of Efficacy|1
2691750|NCT00446095|9281793|P2|Phase II (8 Weeks)|Lack of Efficacy|2
2691751|NCT00446095|9281794|P1|Phase II (8 Weeks)|Lack of Efficacy|9
2691752|NCT00446095|9281790|P5|Phase II (8 Weeks)|Physician Decision|0
2691753|NCT00446095|9281791|P4|Phase II (8 Weeks)|Physician Decision|0
2691754|NCT00446095|9281792|P3|Phase II (8 Weeks)|Physician Decision|0
2691755|NCT00446095|9281793|P2|Phase II (8 Weeks)|Physician Decision|0
2691756|NCT00446095|9281794|P1|Phase II (8 Weeks)|Physician Decision|1
2691757|NCT00446095|9281790|P5|Phase II (8 Weeks)|Withdrawal by Subject|0
2691758|NCT00446095|9281791|P4|Phase II (8 Weeks)|Withdrawal by Subject|0
2691759|NCT00446095|9281792|P3|Phase II (8 Weeks)|Withdrawal by Subject|0
2691760|NCT00446095|9281793|P2|Phase II (8 Weeks)|Withdrawal by Subject|0
2691761|NCT00446095|9281794|P1|Phase II (8 Weeks)|Withdrawal by Subject|1
2691762|NCT00446095|9281790|P5|Phase II (8 Weeks)|Adverse Event|0
2691763|NCT00446095|9281791|P4|Phase II (8 Weeks)|Adverse Event|0
2691764|NCT00446095|9281792|P3|Phase II (8 Weeks)|Adverse Event|1
2691765|NCT00446095|9281793|P2|Phase II (8 Weeks)|Adverse Event|1
2691766|NCT00446095|9281794|P1|Phase II (8 Weeks)|Adverse Event|0
2691767|NCT00446095|9281790|P5|Phase II (8 Weeks)|Lost to Follow-up|0
2691768|NCT00446095|9281791|P4|Phase II (8 Weeks)|Lost to Follow-up|0
2691769|NCT00446095|9281792|P3|Phase II (8 Weeks)|Lost to Follow-up|0
2691770|NCT00446095|9281793|P2|Phase II (8 Weeks)|Lost to Follow-up|0
2691771|NCT00446095|9281794|P1|Phase II (8 Weeks)|Lost to Follow-up|1
2691772|NCT00446030|9281817|P2|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1
2691773|NCT00446030|9281818|P1|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0
2691774|NCT00446030|9281817|P2|FOLLOW-UP (up to 2-years)|Right axilla wound|0
2691775|NCT00446030|9281818|P1|FOLLOW-UP (up to 2-years)|Right axilla wound|1
2691776|NCT00446030|9281817|P2|FOLLOW-UP (up to 2-years)|Patient concern|0
2691777|NCT00446030|9281818|P1|FOLLOW-UP (up to 2-years)|Patient concern|1
2691778|NCT00446030|9281817|P2|FOLLOW-UP (up to 2-years)|Protocol Violation|0
2691779|NCT00446030|9281818|P1|FOLLOW-UP (up to 2-years)|Protocol Violation|1
2691780|NCT00446030|9281817|P2|FOLLOW-UP (up to 2-years)|Per physician discretion|0
2691781|NCT00446030|9281818|P1|FOLLOW-UP (up to 2-years)|Per physician discretion|2
2691782|NCT00446030|9281817|P2|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0
2691783|NCT00446030|9281818|P1|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2
2691784|NCT00446030|9281817|P2|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2
2691785|NCT00446030|9281818|P1|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3
2691786|NCT00446030|9281817|P2|FOLLOW-UP (up to 2-years)|Death|2
2691787|NCT00446030|9281818|P1|FOLLOW-UP (up to 2-years)|Death|2
2691788|NCT00446030|9281817|P2|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0
2691789|NCT00446030|9281818|P1|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4
2691790|NCT00446030|9281817|P2|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0
2691791|NCT00446030|9281818|P1|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5
2691792|NCT00446030|9281817|P2|FOLLOW-UP (up to 2-years)|Subject's request|4
2691793|NCT00446030|9281818|P1|FOLLOW-UP (up to 2-years)|Subject's request|9
2691794|NCT00446030|9281817|P2|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0
2691795|NCT00446030|9281818|P1|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1
2691796|NCT00446030|9281817|P2|TREATMENT (up to 52 Weeks)|Patient concern|0
2691797|NCT00446030|9281818|P1|TREATMENT (up to 52 Weeks)|Patient concern|1
2691798|NCT00446030|9281817|P2|TREATMENT (up to 52 Weeks)|Physician Decision|0
2691799|NCT00446030|9281818|P1|TREATMENT (up to 52 Weeks)|Physician Decision|1
2691800|NCT00446030|9281817|P2|TREATMENT (up to 52 Weeks)|Protocol Violation|0
2691801|NCT00446030|9281818|P1|TREATMENT (up to 52 Weeks)|Protocol Violation|1
2691802|NCT00446030|9281817|P2|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0
2691803|NCT00446030|9281818|P1|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1
2691804|NCT00446030|9281817|P2|TREATMENT (up to 52 Weeks)|Poor compliance|0
2691805|NCT00446030|9281818|P1|TREATMENT (up to 52 Weeks)|Poor compliance|1
2691806|NCT00446030|9281817|P2|TREATMENT (up to 52 Weeks)|Subject Request|1
2691807|NCT00446030|9281818|P1|TREATMENT (up to 52 Weeks)|Subject Request|9
2691808|NCT00446030|9281817|P2|TREATMENT (up to 52 Weeks)|Adverse Event|8
2691809|NCT00446030|9281818|P1|TREATMENT (up to 52 Weeks)|Adverse Event|29
2691810|NCT00445939|9281829|P4|Period B - Week 4 - Week 8|Adverse Event|1
2691811|NCT00445939|9281830|P3|Period B - Week 4 - Week 8|Adverse Event|0
2691812|NCT00445939|9281831|P2|Period B - Week 4 - Week 8|Adverse Event|0
2691813|NCT00445939|9281832|P1|Period B - Week 4 - Week 8|Adverse Event|2
2691814|NCT00445939|9281829|P4|Period A - Week 0 - Week 4|Adverse Event|0
2691815|NCT00445939|9281830|P3|Period A - Week 0 - Week 4|Adverse Event|0
2691816|NCT00445939|9281831|P2|Period A - Week 0 - Week 4|Adverse Event|2
2691817|NCT00445939|9281832|P1|Period A - Week 0 - Week 4|Adverse Event|1
2691818|NCT00445848|9281880|P1|Overall Study|Other-Not protocol specified|5
2691819|NCT00445848|9281880|P1|Overall Study|Progression|62
2691820|NCT00445848|9281880|P1|Overall Study|Withdrawal by Subject|4
2691821|NCT00445848|9281880|P1|Overall Study|Adverse Event|14
2691822|NCT00445770|9281890|P3|Overall Study|Other|6
2691823|NCT00445770|9281891|P2|Overall Study|Other|5
2691824|NCT00445770|9281892|P1|Overall Study|Other|6
2691825|NCT00445770|9281890|P3|Overall Study|Lost to Follow-up|0
2691826|NCT00445770|9281891|P2|Overall Study|Lost to Follow-up|2
2691827|NCT00445770|9281892|P1|Overall Study|Lost to Follow-up|0
2691828|NCT00445770|9281890|P3|Overall Study|Lack of Efficacy|6
2691829|NCT00445770|9281891|P2|Overall Study|Lack of Efficacy|13
2691830|NCT00445770|9281892|P1|Overall Study|Lack of Efficacy|38
2691831|NCT00445770|9281890|P3|Overall Study|Adverse Event|19
2691832|NCT00445770|9281891|P2|Overall Study|Adverse Event|15
2691833|NCT00445770|9281892|P1|Overall Study|Adverse Event|9
2691834|NCT00445692|9281993|P1|Overall Study|Lack of Efficacy|5
2691835|NCT00445692|9281993|P1|Overall Study|Adverse Event|11
2691836|NCT00445679|9282003|P4|Overall Study|Lack of Efficacy|0
2691837|NCT00445679|9282004|P3|Overall Study|Lack of Efficacy|2
2691838|NCT00445679|9282005|P2|Overall Study|Lack of Efficacy|6
2691839|NCT00445679|9282006|P1|Overall Study|Lack of Efficacy|2
2691840|NCT00445679|9282003|P4|Overall Study|Withdrawal by Subject|18
2691841|NCT00445679|9282004|P3|Overall Study|Withdrawal by Subject|20
2691842|NCT00445679|9282005|P2|Overall Study|Withdrawal by Subject|14
2691843|NCT00445679|9282006|P1|Overall Study|Withdrawal by Subject|8
2691844|NCT00445679|9282003|P4|Overall Study|Protocol Violation|1
2691845|NCT00445679|9282004|P3|Overall Study|Protocol Violation|3
2691846|NCT00445679|9282005|P2|Overall Study|Protocol Violation|3
2691847|NCT00445679|9282006|P1|Overall Study|Protocol Violation|2
2691848|NCT00445679|9282003|P4|Overall Study|Withdrawal of Informed Consent|0
2691849|NCT00445679|9282004|P3|Overall Study|Withdrawal of Informed Consent|1
2691850|NCT00445679|9282005|P2|Overall Study|Withdrawal of Informed Consent|0
2691851|NCT00445679|9282006|P1|Overall Study|Withdrawal of Informed Consent|0
2691852|NCT00445679|9282003|P4|Overall Study|Compliance|2
2691853|NCT00445679|9282004|P3|Overall Study|Compliance|1
2691854|NCT00445679|9282005|P2|Overall Study|Compliance|2
2691855|NCT00445679|9282006|P1|Overall Study|Compliance|3
2691856|NCT00445679|9282003|P4|Overall Study|Lost to Follow-up|5
2691857|NCT00445679|9282004|P3|Overall Study|Lost to Follow-up|6
2691858|NCT00445679|9282005|P2|Overall Study|Lost to Follow-up|6
2691859|NCT00445679|9282006|P1|Overall Study|Lost to Follow-up|10
2691860|NCT00445679|9282003|P4|Overall Study|Physician Decision|0
2691861|NCT00445679|9282004|P3|Overall Study|Physician Decision|1
2691862|NCT00445679|9282005|P2|Overall Study|Physician Decision|0
2691863|NCT00445679|9282006|P1|Overall Study|Physician Decision|0
2691864|NCT00445679|9282003|P4|Overall Study|Failed to return|2
2691865|NCT00445679|9282004|P3|Overall Study|Failed to return|2
2691866|NCT00445679|9282005|P2|Overall Study|Failed to return|3
2691867|NCT00445679|9282006|P1|Overall Study|Failed to return|1
2691868|NCT00445679|9282003|P4|Overall Study|Adverse Event|19
2691869|NCT00445679|9282004|P3|Overall Study|Adverse Event|30
2691870|NCT00445679|9282005|P2|Overall Study|Adverse Event|12
2691871|NCT00445679|9282006|P1|Overall Study|Adverse Event|22
2691872|NCT00445601|9282042|P2|Overall Study|Death prior to TURBT|1
2691873|NCT00445601|9282043|P1|Overall Study|Death prior to TURBT|0
2691874|NCT00445601|9282042|P2|Overall Study|Adverse Event|0
2691875|NCT00445601|9282043|P1|Overall Study|Adverse Event|2
2691876|NCT00445601|9282042|P2|Overall Study|Drug Delivery Issue|2
2691877|NCT00445601|9282043|P1|Overall Study|Drug Delivery Issue|2
2691878|NCT00445601|9282042|P2|Overall Study|Incorrect Disease Status|6
2691879|NCT00445601|9282043|P1|Overall Study|Incorrect Disease Status|6
2691880|NCT00445601|9282042|P2|Overall Study|TURBT Complication|8
2691881|NCT00445601|9282043|P1|Overall Study|TURBT Complication|12
2691882|NCT00445601|9282042|P2|Overall Study|Withdrawal by Subject|11
2691883|NCT00445601|9282043|P1|Overall Study|Withdrawal by Subject|11
2691884|NCT00445549|9282060|P1|Overall Study|progressive disease|12
2691885|NCT00445458|9282084|P4|Overall Study|Surgery|0
2691886|NCT00445458|9282085|P3|Overall Study|Surgery|1
2691887|NCT00445458|9282086|P2|Overall Study|Surgery|0
2691888|NCT00445458|9282087|P1|Overall Study|Surgery|0
2691889|NCT00445458|9282084|P4|Overall Study|Physician Decision|1
2691890|NCT00445458|9282085|P3|Overall Study|Physician Decision|1
2691891|NCT00445458|9282086|P2|Overall Study|Physician Decision|0
2691892|NCT00445458|9282087|P1|Overall Study|Physician Decision|0
2691893|NCT00445458|9282084|P4|Overall Study|Death|0
2691894|NCT00445458|9282085|P3|Overall Study|Death|2
2691895|NCT00445458|9282086|P2|Overall Study|Death|1
2691896|NCT00445458|9282087|P1|Overall Study|Death|0
2691897|NCT00445458|9282084|P4|Overall Study|Adverse Event|0
2691898|NCT00445458|9282085|P3|Overall Study|Adverse Event|3
2691899|NCT00445458|9282086|P2|Overall Study|Adverse Event|0
2691900|NCT00445458|9282087|P1|Overall Study|Adverse Event|0
2691901|NCT00445458|9282084|P4|Overall Study|Withdrawal by Subject|0
2691902|NCT00445458|9282085|P3|Overall Study|Withdrawal by Subject|7
2691903|NCT00445458|9282086|P2|Overall Study|Withdrawal by Subject|0
2691904|NCT00445458|9282087|P1|Overall Study|Withdrawal by Subject|0
2691905|NCT00445458|9282084|P4|Overall Study|Disease Progression|27
2691906|NCT00445458|9282085|P3|Overall Study|Disease Progression|54
2691907|NCT00445458|9282086|P2|Overall Study|Disease Progression|4
2691908|NCT00445458|9282087|P1|Overall Study|Disease Progression|3
2691909|NCT00445432|9282105|P4|148 Weeks of Adalimumab Treatment|Other|9
2691910|NCT00445432|9282106|P3|148 Weeks of Adalimumab Treatment|Other|0
2691911|NCT00445432|9282107|P2|148 Weeks of Adalimumab Treatment|Other|0
2691912|NCT00445432|9282108|P1|148 Weeks of Adalimumab Treatment|Other|0
2691913|NCT00445432|9282105|P4|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3
2691914|NCT00445432|9282106|P3|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
2691915|NCT00445432|9282107|P2|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
2691916|NCT00445432|9282108|P1|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
2691917|NCT00445432|9282105|P4|148 Weeks of Adalimumab Treatment|Adverse Event|32
2691918|NCT00445432|9282106|P3|148 Weeks of Adalimumab Treatment|Adverse Event|0
2691919|NCT00445432|9282107|P2|148 Weeks of Adalimumab Treatment|Adverse Event|0
2691920|NCT00445432|9282108|P1|148 Weeks of Adalimumab Treatment|Adverse Event|0
2691921|NCT00445432|9282105|P4|Through Week 52 of NCT00445432 (M06-837)|Other|0
2691922|NCT00445432|9282106|P3|Through Week 52 of NCT00445432 (M06-837)|Other|2
2692006|NCT00444678|9282526|P1|Overall Study|Physician Decision|3
2691923|NCT00445432|9282107|P2|Through Week 52 of NCT00445432 (M06-837)|Other|1
2691924|NCT00445432|9282108|P1|Through Week 52 of NCT00445432 (M06-837)|Other|0
2691925|NCT00445432|9282105|P4|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
2691926|NCT00445432|9282106|P3|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
2691927|NCT00445432|9282107|P2|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20
2691928|NCT00445432|9282108|P1|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14
2691929|NCT00445432|9282105|P4|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
2691930|NCT00445432|9282106|P3|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2
2691931|NCT00445432|9282107|P2|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
2691932|NCT00445432|9282108|P1|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
2691933|NCT00445432|9282105|P4|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0
2691934|NCT00445432|9282106|P3|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7
2691935|NCT00445432|9282107|P2|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2
2691936|NCT00445432|9282108|P1|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1
2691937|NCT00445341|9282141|P1|Overall Study|taken off treatment too early|1
2691938|NCT00445341|9282141|P1|Overall Study|refused further treatment|1
2691939|NCT00445328|9282148|P2|Overall Study|Protocol Violation|0
2691940|NCT00445328|9282149|P1|Overall Study|Protocol Violation|1
2691941|NCT00445328|9282148|P2|Overall Study|Withdrawal by Subject|0
2691942|NCT00445328|9282149|P1|Overall Study|Withdrawal by Subject|2
2691943|NCT00445328|9282148|P2|Overall Study|Other|2
2691944|NCT00445328|9282149|P1|Overall Study|Other|0
2691945|NCT00445328|9282148|P2|Overall Study|Adverse Event|3
2691946|NCT00445328|9282149|P1|Overall Study|Adverse Event|0
2691947|NCT00445328|9282148|P2|Overall Study|Death|1
2691948|NCT00445328|9282149|P1|Overall Study|Death|0
2691949|NCT00445224|9282310|P2|Specific Exercises|Withdrawal by Subject|0
2691950|NCT00445224|9282311|P1|Specific Exercises|Withdrawal by Subject|1
2691951|NCT00445224|9282310|P2|Specific Exercises|Withdrawal by Subject|3
2691952|NCT00445224|9282311|P1|Specific Exercises|Withdrawal by Subject|3
2691953|NCT00445146|9282338|P1|Overall Study|Pregnancy|1
2691954|NCT00445146|9282338|P1|Overall Study|Protocol Violation|4
2691955|NCT00445146|9282338|P1|Overall Study|Death|9
2691956|NCT00445146|9282338|P1|Overall Study|Lost to Follow-up|13
2691957|NCT00445146|9282338|P1|Overall Study|Adverse Event|13
2691958|NCT00445146|9282338|P1|Overall Study|Investigator’s Discretion|22
2691959|NCT00445146|9282338|P1|Overall Study|Lack of Efficacy|28
2691960|NCT00445146|9282338|P1|Overall Study|Withdrew Consent|29
2691961|NCT00445003|9282360|P3|Overall Study|Dropped|2
2691962|NCT00445003|9282361|P2|Overall Study|Dropped|3
2691963|NCT00445003|9282362|P1|Overall Study|Dropped|1
2691964|NCT00445003|9282360|P3|Overall Study|Missed Visit|1
2691965|NCT00445003|9282361|P2|Overall Study|Missed Visit|5
2691966|NCT00445003|9282362|P1|Overall Study|Missed Visit|3
2691967|NCT00445003|9282360|P3|Overall Study|Death|1
2691968|NCT00445003|9282361|P2|Overall Study|Death|2
2691969|NCT00445003|9282362|P1|Overall Study|Death|1
2691970|NCT00444951|9282394|P3|Overall Study|Withdrawal by Subject|3
2691971|NCT00444951|9282395|P2|Overall Study|Withdrawal by Subject|5
2691972|NCT00444951|9282396|P1|Overall Study|Withdrawal by Subject|4
2691973|NCT00444951|9282394|P3|Overall Study|Lost to Follow-up|0
2691974|NCT00444951|9282395|P2|Overall Study|Lost to Follow-up|1
2691975|NCT00444951|9282396|P1|Overall Study|Lost to Follow-up|1
2691976|NCT00444925|9282413|P3|Double-blind Treatment Period|Other|12
2691977|NCT00444925|9282414|P2|Double-blind Treatment Period|Other|7
2691978|NCT00444925|9282415|P1|Double-blind Treatment Period|Other|7
2691979|NCT00444925|9282413|P3|Double-blind Treatment Period|Withdrawal by Subject|7
2691980|NCT00444925|9282414|P2|Double-blind Treatment Period|Withdrawal by Subject|8
2691981|NCT00444925|9282415|P1|Double-blind Treatment Period|Withdrawal by Subject|6
2691982|NCT00444925|9282413|P3|Double-blind Treatment Period|Lost to Follow-up|5
2691983|NCT00444925|9282414|P2|Double-blind Treatment Period|Lost to Follow-up|8
2691984|NCT00444925|9282415|P1|Double-blind Treatment Period|Lost to Follow-up|4
2691985|NCT00444925|9282413|P3|Double-blind Treatment Period|Lack of Efficacy|13
2691986|NCT00444925|9282414|P2|Double-blind Treatment Period|Lack of Efficacy|5
2691987|NCT00444925|9282415|P1|Double-blind Treatment Period|Lack of Efficacy|5
2691988|NCT00444925|9282413|P3|Double-blind Treatment Period|Adverse Event|44
2691989|NCT00444925|9282414|P2|Double-blind Treatment Period|Adverse Event|28
2691990|NCT00444925|9282415|P1|Double-blind Treatment Period|Adverse Event|6
2691991|NCT00444925|9282413|P3|Double-blind Treatment Period|Death|0
2691992|NCT00444925|9282414|P2|Double-blind Treatment Period|Death|0
2691993|NCT00444925|9282415|P1|Double-blind Treatment Period|Death|2
2691994|NCT00444925|9282413|P3|Randomized to Double-blind Treatment|Never returned after randomization|6
2691995|NCT00444925|9282414|P2|Randomized to Double-blind Treatment|Never returned after randomization|6
2691996|NCT00444925|9282415|P1|Randomized to Double-blind Treatment|Never returned after randomization|3
2691997|NCT00444912|9282479|P2|Overall Study|Participant Failed Mobilization|0
2691998|NCT00444912|9282480|P1|Overall Study|Participant Failed Mobilization|1
2691999|NCT00444912|9282479|P2|Overall Study|Lost to Follow-up|0
2692000|NCT00444912|9282480|P1|Overall Study|Lost to Follow-up|1
2692001|NCT00444912|9282479|P2|Overall Study|Death|2
2692002|NCT00444912|9282480|P1|Overall Study|Death|1
2692003|NCT00444795|9282521|P1|Overall Study|Treated Prior to the Contract Date|2
2692004|NCT00444795|9282521|P1|Overall Study|Not Treated|1
2692005|NCT00444678|9282526|P1|Overall Study|Withdrawal by Subject|2
2692007|NCT00444678|9282526|P1|Overall Study|Death|3
2692008|NCT00444678|9282526|P1|Overall Study|Disease Progression|12
2692009|NCT00444678|9282526|P1|Overall Study|Toxicity|11
2692010|NCT00444626|9282533|P1|Initial Treatment Period|Lost to Follow-up|9
2692011|NCT00444626|9282533|P1|Initial Treatment Period|Adverse Event|1
2692012|NCT00444626|9282533|P1|Initial Treatment Period|Withdrawal by Subject|2
2692013|NCT00444600|9282563|P4|Overall Study|Missed visit|1
2692014|NCT00444600|9282564|P3|Overall Study|Missed visit|0
2692015|NCT00444600|9282565|P2|Overall Study|Missed visit|0
2692016|NCT00444600|9282566|P1|Overall Study|Missed visit|1
2692017|NCT00444600|9282563|P4|Overall Study|Dropped|7
2692018|NCT00444600|9282564|P3|Overall Study|Dropped|7
2692019|NCT00444600|9282565|P2|Overall Study|Dropped|11
2692020|NCT00444600|9282566|P1|Overall Study|Dropped|11
2692021|NCT00444600|9282563|P4|Overall Study|Death|2
2692022|NCT00444600|9282564|P3|Overall Study|Death|3
2692023|NCT00444600|9282565|P2|Overall Study|Death|5
2692024|NCT00444600|9282566|P1|Overall Study|Death|7
2692025|NCT00444587|9282658|P2|Overall Study|Missing|5
2692026|NCT00444587|9282659|P1|Overall Study|Missing|0
2692027|NCT00444587|9282658|P2|Overall Study|Protocol Violation|0
2692028|NCT00444587|9282659|P1|Overall Study|Protocol Violation|1
2692029|NCT00444587|9282658|P2|Overall Study|Investigator decision|0
2692030|NCT00444587|9282659|P1|Overall Study|Investigator decision|3
2692031|NCT00444587|9282658|P2|Overall Study|Refused treatment/did not cooperate|1
2692032|NCT00444587|9282659|P1|Overall Study|Refused treatment/did not cooperate|4
2692033|NCT00444587|9282658|P2|Overall Study|Progression of the disease|8
2692034|NCT00444587|9282659|P1|Overall Study|Progression of the disease|73
2692035|NCT00444587|9282658|P2|Overall Study|Death|1
2692036|NCT00444587|9282659|P1|Overall Study|Death|2
2692037|NCT00444535|9282680|P1|Overall Study|Adverse Event|3
2692038|NCT00444535|9282680|P1|Overall Study|Investigator decision|2
2692039|NCT00444535|9282680|P1|Overall Study|Withdrawal by Subject|3
2692040|NCT00444535|9282680|P1|Overall Study|Treatment is ongoing|16
2692041|NCT00444457|9282691|P4|Toddler Dose|Protocol Violation|1
2692042|NCT00444457|9282692|P3|Toddler Dose|Protocol Violation|0
2692043|NCT00444457|9282693|P2|Toddler Dose|Protocol Violation|0
2692044|NCT00444457|9282694|P1|Toddler Dose|Protocol Violation|1
2692045|NCT00444457|9282691|P4|Toddler Dose|Parent or legal guardian request|1
2692046|NCT00444457|9282692|P3|Toddler Dose|Parent or legal guardian request|2
2692047|NCT00444457|9282693|P2|Toddler Dose|Parent or legal guardian request|3
2692048|NCT00444457|9282694|P1|Toddler Dose|Parent or legal guardian request|0
2692049|NCT00444457|9282691|P4|Toddler Dose|Failed to return|3
2692050|NCT00444457|9282692|P3|Toddler Dose|Failed to return|1
2692051|NCT00444457|9282693|P2|Toddler Dose|Failed to return|2
2692052|NCT00444457|9282694|P1|Toddler Dose|Failed to return|2
2692053|NCT00444457|9282691|P4|Toddler Dose|Lost to Follow-up|3
2692054|NCT00444457|9282692|P3|Toddler Dose|Lost to Follow-up|1
2692055|NCT00444457|9282693|P2|Toddler Dose|Lost to Follow-up|1
2692056|NCT00444457|9282694|P1|Toddler Dose|Lost to Follow-up|4
2692057|NCT00444457|9282691|P4|After Infant Series|Other|0
2692058|NCT00444457|9282692|P3|After Infant Series|Other|0
2692059|NCT00444457|9282693|P2|After Infant Series|Other|1
2692060|NCT00444457|9282694|P1|After Infant Series|Other|0
2692061|NCT00444457|9282691|P4|After Infant Series|Investigator request|1
2692062|NCT00444457|9282692|P3|After Infant Series|Investigator request|0
2692063|NCT00444457|9282693|P2|After Infant Series|Investigator request|0
2692064|NCT00444457|9282694|P1|After Infant Series|Investigator request|0
2692065|NCT00444457|9282691|P4|After Infant Series|Adverse Event|0
2692066|NCT00444457|9282692|P3|After Infant Series|Adverse Event|0
2692067|NCT00444457|9282693|P2|After Infant Series|Adverse Event|2
2692068|NCT00444457|9282694|P1|After Infant Series|Adverse Event|2
2692069|NCT00444457|9282691|P4|After Infant Series|Protocol Violation|2
2692070|NCT00444457|9282692|P3|After Infant Series|Protocol Violation|2
2692071|NCT00444457|9282693|P2|After Infant Series|Protocol Violation|4
2692072|NCT00444457|9282694|P1|After Infant Series|Protocol Violation|2
2692073|NCT00444457|9282691|P4|After Infant Series|Lost to Follow-up|2
2692074|NCT00444457|9282692|P3|After Infant Series|Lost to Follow-up|5
2692075|NCT00444457|9282693|P2|After Infant Series|Lost to Follow-up|5
2692076|NCT00444457|9282694|P1|After Infant Series|Lost to Follow-up|5
2692077|NCT00444457|9282691|P4|After Infant Series|Failed to return|1
2692078|NCT00444457|9282692|P3|After Infant Series|Failed to return|5
2692079|NCT00444457|9282693|P2|After Infant Series|Failed to return|6
2692080|NCT00444457|9282694|P1|After Infant Series|Failed to return|7
2692081|NCT00444457|9282691|P4|After Infant Series|Parent or legal guardian request|3
2692082|NCT00444457|9282692|P3|After Infant Series|Parent or legal guardian request|6
2692083|NCT00444457|9282693|P2|After Infant Series|Parent or legal guardian request|11
2692084|NCT00444457|9282694|P1|After Infant Series|Parent or legal guardian request|4
2692085|NCT00444457|9282691|P4|After Infant Series|Other|1
2692086|NCT00444457|9282692|P3|After Infant Series|Other|1
2692087|NCT00444457|9282693|P2|After Infant Series|Other|1
2692088|NCT00444457|9282694|P1|After Infant Series|Other|0
2692089|NCT00444457|9282691|P4|Infant Series|Death|1
2692090|NCT00444457|9282692|P3|Infant Series|Death|1
2692091|NCT00444457|9282693|P2|Infant Series|Death|1
2692092|NCT00444457|9282694|P1|Infant Series|Death|0
2692093|NCT00444457|9282691|P4|Infant Series|Adverse Event|0
2692094|NCT00444457|9282692|P3|Infant Series|Adverse Event|2
2692095|NCT00444457|9282693|P2|Infant Series|Adverse Event|2
2692096|NCT00444457|9282694|P1|Infant Series|Adverse Event|1
2692097|NCT00444457|9282691|P4|Infant Series|Other|0
2692098|NCT00444457|9282692|P3|Infant Series|Other|4
2692099|NCT00444457|9282693|P2|Infant Series|Other|2
2692100|NCT00444457|9282694|P1|Infant Series|Other|0
2692101|NCT00444457|9282691|P4|Infant Series|Investigator request|2
2692102|NCT00444457|9282692|P3|Infant Series|Investigator request|3
2692103|NCT00444457|9282693|P2|Infant Series|Investigator request|3
2692104|NCT00444457|9282694|P1|Infant Series|Investigator request|4
2692105|NCT00444457|9282691|P4|Infant Series|Failed to return|2
2692106|NCT00444457|9282692|P3|Infant Series|Failed to return|4
2692107|NCT00444457|9282693|P2|Infant Series|Failed to return|4
2692108|NCT00444457|9282694|P1|Infant Series|Failed to return|5
2692109|NCT00444457|9282691|P4|Infant Series|Protocol Violation|3
2692110|NCT00444457|9282692|P3|Infant Series|Protocol Violation|6
2692111|NCT00444457|9282693|P2|Infant Series|Protocol Violation|8
2692112|NCT00444457|9282694|P1|Infant Series|Protocol Violation|16
2692113|NCT00444457|9282691|P4|Infant Series|Lost to Follow-up|6
2692114|NCT00444457|9282692|P3|Infant Series|Lost to Follow-up|7
2692115|NCT00444457|9282693|P2|Infant Series|Lost to Follow-up|11
2692116|NCT00444457|9282694|P1|Infant Series|Lost to Follow-up|10
2692117|NCT00444457|9282691|P4|Infant Series|Parent or legal guardian request|14
2692118|NCT00444457|9282692|P3|Infant Series|Parent or legal guardian request|34
2692119|NCT00444457|9282693|P2|Infant Series|Parent or legal guardian request|29
2692120|NCT00444457|9282694|P1|Infant Series|Parent or legal guardian request|18
2692121|NCT00444457|9282691|P4|Infant Series|Other|0
2692122|NCT00444457|9282692|P3|Infant Series|Other|0
2692123|NCT00444457|9282693|P2|Infant Series|Other|1
2692124|NCT00444457|9282694|P1|Infant Series|Other|0
2692125|NCT00444275|9282759|P5|Maintenance Treatment Phase|Ineffectiveness|14
2692126|NCT00444275|9282760|P4|Maintenance Treatment Phase|Ineffectiveness|3
2692127|NCT00444275|9282761|P3|Maintenance Treatment Phase|Ineffectiveness|5
2692128|NCT00444275|9282762|P2|Maintenance Treatment Phase|Ineffectiveness|0
2692129|NCT00444275|9282763|P1|Maintenance Treatment Phase|Ineffectiveness|0
2692130|NCT00444275|9282759|P5|Maintenance Treatment Phase|Protocol Violation|87
2692131|NCT00444275|9282760|P4|Maintenance Treatment Phase|Protocol Violation|88
2692132|NCT00444275|9282761|P3|Maintenance Treatment Phase|Protocol Violation|103
2692133|NCT00444275|9282762|P2|Maintenance Treatment Phase|Protocol Violation|0
2692134|NCT00444275|9282763|P1|Maintenance Treatment Phase|Protocol Violation|0
2692135|NCT00444275|9282759|P5|Maintenance Treatment Phase|Patient's wish|20
2692136|NCT00444275|9282760|P4|Maintenance Treatment Phase|Patient's wish|9
2692137|NCT00444275|9282761|P3|Maintenance Treatment Phase|Patient's wish|19
2692138|NCT00444275|9282762|P2|Maintenance Treatment Phase|Patient's wish|0
2692139|NCT00444275|9282763|P1|Maintenance Treatment Phase|Patient's wish|0
2692140|NCT00444275|9282759|P5|Maintenance Treatment Phase|Protocol specific criteria's development|6
2692141|NCT00444275|9282760|P4|Maintenance Treatment Phase|Protocol specific criteria's development|0
2692142|NCT00444275|9282761|P3|Maintenance Treatment Phase|Protocol specific criteria's development|1
2692143|NCT00444275|9282762|P2|Maintenance Treatment Phase|Protocol specific criteria's development|0
2692144|NCT00444275|9282763|P1|Maintenance Treatment Phase|Protocol specific criteria's development|0
2692145|NCT00444275|9282759|P5|Maintenance Treatment Phase|Adverse Event|13
2692146|NCT00444275|9282760|P4|Maintenance Treatment Phase|Adverse Event|2
2692147|NCT00444275|9282761|P3|Maintenance Treatment Phase|Adverse Event|3
2692148|NCT00444275|9282762|P2|Maintenance Treatment Phase|Adverse Event|0
2692149|NCT00444275|9282763|P1|Maintenance Treatment Phase|Adverse Event|0
2692150|NCT00444275|9282759|P5|Maintenance Treatment Phase|Lost to Follow-up|10
2692151|NCT00444275|9282760|P4|Maintenance Treatment Phase|Lost to Follow-up|14
2692152|NCT00444275|9282761|P3|Maintenance Treatment Phase|Lost to Follow-up|8
2692153|NCT00444275|9282762|P2|Maintenance Treatment Phase|Lost to Follow-up|0
2692154|NCT00444275|9282763|P1|Maintenance Treatment Phase|Lost to Follow-up|0
2692155|NCT00444275|9282759|P5|Maintenance Treatment Phase|Didn'r receive the treatment|29
2692156|NCT00444275|9282760|P4|Maintenance Treatment Phase|Didn'r receive the treatment|17
2692157|NCT00444275|9282761|P3|Maintenance Treatment Phase|Didn'r receive the treatment|22
2692158|NCT00444275|9282762|P2|Maintenance Treatment Phase|Didn'r receive the treatment|0
2692159|NCT00444275|9282763|P1|Maintenance Treatment Phase|Didn'r receive the treatment|0
2692160|NCT00444145|9282813|P1|Overall Study|Screen Failures|5
2692161|NCT00444145|9282813|P1|Overall Study|non-compliant|11
2692162|NCT00444145|9282813|P1|Overall Study|Lost to Follow-up|1
2692163|NCT00444145|9282813|P1|Overall Study|Withdrawal by Subject|2
2692164|NCT00444106|9282820|P3|Overall Study|Abnormal Test Procedure Results|1
2692165|NCT00444106|9282821|P2|Overall Study|Abnormal Test Procedure Results|0
2692166|NCT00444106|9282822|P1|Overall Study|Abnormal Test Procedure Results|0
2692167|NCT00444106|9282820|P3|Overall Study|Lost to Follow-up|0
2692168|NCT00444106|9282821|P2|Overall Study|Lost to Follow-up|1
2692169|NCT00444106|9282822|P1|Overall Study|Lost to Follow-up|2
2692170|NCT00444067|9282839|P2|Overall Study|Lost to Follow-up|1
2692171|NCT00444067|9282840|P1|Overall Study|Lost to Follow-up|0
2692172|NCT00443898|9282903|P4|Overall Study|Death|0
2692173|NCT00443898|9282904|P3|Overall Study|Death|0
2692174|NCT00443898|9282905|P2|Overall Study|Death|1
2692175|NCT00443898|9282906|P1|Overall Study|Death|0
2692176|NCT00443898|9282903|P4|Overall Study|Lost to Follow-up|10
2692177|NCT00443898|9282904|P3|Overall Study|Lost to Follow-up|14
2692178|NCT00443898|9282905|P2|Overall Study|Lost to Follow-up|10
2692179|NCT00443898|9282906|P1|Overall Study|Lost to Follow-up|10
2692180|NCT00443898|9282903|P4|Overall Study|Withdrawal by Subject|6
2692181|NCT00443898|9282904|P3|Overall Study|Withdrawal by Subject|10
2692182|NCT00443898|9282905|P2|Overall Study|Withdrawal by Subject|10
2692183|NCT00443898|9282906|P1|Overall Study|Withdrawal by Subject|11
2692184|NCT00443898|9282903|P4|Overall Study|Protocol Violation|0
2692185|NCT00443898|9282904|P3|Overall Study|Protocol Violation|1
2692186|NCT00443898|9282905|P2|Overall Study|Protocol Violation|1
2692187|NCT00443898|9282906|P1|Overall Study|Protocol Violation|1
2692188|NCT00443898|9282903|P4|Overall Study|Lack of Efficacy|1
2692189|NCT00443898|9282904|P3|Overall Study|Lack of Efficacy|3
2692190|NCT00443898|9282905|P2|Overall Study|Lack of Efficacy|3
2692191|NCT00443898|9282906|P1|Overall Study|Lack of Efficacy|2
2692192|NCT00443898|9282903|P4|Overall Study|Adverse Event|1
2692193|NCT00443898|9282904|P3|Overall Study|Adverse Event|1
2692194|NCT00443898|9282905|P2|Overall Study|Adverse Event|0
2692195|NCT00443898|9282906|P1|Overall Study|Adverse Event|0
2692196|NCT00443872|9282928|P1|Overall Study|Adverse Event|8
2692197|NCT00443872|9282928|P1|Overall Study|Lost to Follow-up|2
2692198|NCT00443872|9282928|P1|Overall Study|Protocol Violation|7
2692199|NCT00443846|9282943|P2|Overall Study|Lost to Follow-up|2
2692200|NCT00443846|9282944|P1|Overall Study|Lost to Follow-up|1
2692201|NCT00443846|9282943|P2|Overall Study|Personal reason|3
2692202|NCT00443846|9282944|P1|Overall Study|Personal reason|8
2692203|NCT00443846|9282943|P2|Overall Study|Adverse Event|1
2692204|NCT00443846|9282944|P1|Overall Study|Adverse Event|0
2692205|NCT00443846|9282943|P2|Overall Study|Not vaccinated, no blood sample drawn|0
2692206|NCT00443846|9282944|P1|Overall Study|Not vaccinated, no blood sample drawn|1
2692207|NCT00443846|9282943|P2|Overall Study|Withdrawn due to intercurrent disease|0
2692208|NCT00443846|9282944|P1|Overall Study|Withdrawn due to intercurrent disease|1
2692209|NCT00443820|9282954|P4|Overall Study|Death|0
2692210|NCT00443820|9282955|P3|Overall Study|Death|1
2692211|NCT00443820|9282956|P2|Overall Study|Death|0
2692212|NCT00443820|9282957|P1|Overall Study|Death|0
2692213|NCT00443820|9282954|P4|Overall Study|Administrative problems|1
2692214|NCT00443820|9282955|P3|Overall Study|Administrative problems|0
2692215|NCT00443820|9282956|P2|Overall Study|Administrative problems|0
2692216|NCT00443820|9282957|P1|Overall Study|Administrative problems|0
2692217|NCT00443820|9282954|P4|Overall Study|Lost to Follow-up|5
2692218|NCT00443820|9282955|P3|Overall Study|Lost to Follow-up|6
2692219|NCT00443820|9282956|P2|Overall Study|Lost to Follow-up|8
2692220|NCT00443820|9282957|P1|Overall Study|Lost to Follow-up|9
2692221|NCT00443820|9282954|P4|Overall Study|Withdrawal by Subject|9
2692222|NCT00443820|9282955|P3|Overall Study|Withdrawal by Subject|8
2692223|NCT00443820|9282956|P2|Overall Study|Withdrawal by Subject|7
2692224|NCT00443820|9282957|P1|Overall Study|Withdrawal by Subject|6
2692225|NCT00443820|9282954|P4|Overall Study|Protocol Violation|1
2692226|NCT00443820|9282955|P3|Overall Study|Protocol Violation|2
2692227|NCT00443820|9282956|P2|Overall Study|Protocol Violation|1
2692228|NCT00443820|9282957|P1|Overall Study|Protocol Violation|2
2692229|NCT00443820|9282954|P4|Overall Study|Lack of Efficacy|1
2692230|NCT00443820|9282955|P3|Overall Study|Lack of Efficacy|1
2692231|NCT00443820|9282956|P2|Overall Study|Lack of Efficacy|2
2692232|NCT00443820|9282957|P1|Overall Study|Lack of Efficacy|3
2692233|NCT00443820|9282954|P4|Overall Study|Adverse Event|0
2692234|NCT00443820|9282955|P3|Overall Study|Adverse Event|0
2692235|NCT00443820|9282956|P2|Overall Study|Adverse Event|1
2692236|NCT00443820|9282957|P1|Overall Study|Adverse Event|1
2692237|NCT00443781|9282979|P1|Overall Study|PD/FAD not done|1
2692238|NCT00443781|9282979|P1|Overall Study|Insurance not covered|2
2692239|NCT00443781|9282979|P1|Overall Study|Investigator terminated participation|1
2692240|NCT00443781|9282979|P1|Overall Study|Unable to comply with study follow up|2
2692241|NCT00443781|9282979|P1|Overall Study|Withdrawal by Subject|6
2692242|NCT00443781|9282979|P1|Overall Study|Protocol Violation|1
2692243|NCT00443781|9282979|P1|Overall Study|Physician Decision|2
2692244|NCT00443781|9282979|P1|Overall Study|Lost to Follow-up|10
2692245|NCT00443755|9282985|P2|Overall Study|Withdrawal by Subject|1
2692246|NCT00443755|9282986|P1|Overall Study|Withdrawal by Subject|2
2692247|NCT00443729|9283020|P2|Overall Study|Withdrawal by Subject|1
2692248|NCT00443729|9283021|P1|Overall Study|Withdrawal by Subject|3
2692249|NCT00443729|9283020|P2|Overall Study|Protocol Violation|1
2692250|NCT00443729|9283021|P1|Overall Study|Protocol Violation|1
2692251|NCT00443729|9283020|P2|Overall Study|Physician Decision|1
2692252|NCT00443729|9283021|P1|Overall Study|Physician Decision|2
2692253|NCT00443729|9283020|P2|Overall Study|Lost to Follow-up|1
2692254|NCT00443729|9283021|P1|Overall Study|Lost to Follow-up|0
2692255|NCT00443729|9283020|P2|Overall Study|Lack of Efficacy|2
2692256|NCT00443729|9283021|P1|Overall Study|Lack of Efficacy|4
2692257|NCT00443729|9283020|P2|Overall Study|Never Treated|1
2692258|NCT00443729|9283021|P1|Overall Study|Never Treated|0
2692259|NCT00443703|9283069|P2|Overall Study|Progressive Disease|0
2692260|NCT00443703|9283070|P1|Overall Study|Progressive Disease|1
2692261|NCT00443703|9283069|P2|Overall Study|Withdrawal by Subject|6
2692262|NCT00443703|9283070|P1|Overall Study|Withdrawal by Subject|9
2692263|NCT00443703|9283069|P2|Overall Study|Protocol Violation|1
2692264|NCT00443703|9283070|P1|Overall Study|Protocol Violation|1
2692265|NCT00443703|9283069|P2|Overall Study|Physician Decision|2
2692266|NCT00443703|9283070|P1|Overall Study|Physician Decision|4
2692267|NCT00443703|9283069|P2|Overall Study|Lost to Follow-up|4
2692268|NCT00443703|9283070|P1|Overall Study|Lost to Follow-up|0
2692269|NCT00443703|9283069|P2|Overall Study|Lack of Efficacy|1
2692270|NCT00443703|9283070|P1|Overall Study|Lack of Efficacy|3
2692271|NCT00443703|9283069|P2|Overall Study|Adverse Event|3
2692272|NCT00443703|9283070|P1|Overall Study|Adverse Event|7
2692273|NCT00443703|9283069|P2|Overall Study|Never Treated|1
2692274|NCT00443703|9283070|P1|Overall Study|Never Treated|3
2692275|NCT00443651|9283122|P2|Overall Study|Pregnancy|1
2692276|NCT00443651|9283123|P1|Overall Study|Pregnancy|0
2692277|NCT00443651|9283122|P2|Overall Study|Physician Decision|4
2692278|NCT00443651|9283123|P1|Overall Study|Physician Decision|13
2692279|NCT00443651|9283122|P2|Overall Study|Patient's/Guardian's Decision|30
2692280|NCT00443651|9283123|P1|Overall Study|Patient's/Guardian's Decision|58
2692281|NCT00443651|9283122|P2|Overall Study|Lost to Follow-up|12
2692282|NCT00443651|9283123|P1|Overall Study|Lost to Follow-up|18
2692283|NCT00443651|9283122|P2|Overall Study|Adverse Event|6
2692284|NCT00443651|9283123|P1|Overall Study|Adverse Event|5
2692285|NCT00443651|9283122|P2|Overall Study|Death|5
2692286|NCT00443651|9283123|P1|Overall Study|Death|1
2692287|NCT00443599|9283143|P2|Overall Study|Cardiopulmonary bypass canceled|1
2692288|NCT00443599|9283144|P1|Overall Study|Cardiopulmonary bypass canceled|3
2692289|NCT00443599|9283143|P2|Overall Study|Death|1
2692290|NCT00443599|9283144|P1|Overall Study|Death|1
2692291|NCT00443599|9283143|P2|Overall Study|Physician Decision|1
2692292|NCT00443599|9283144|P1|Overall Study|Physician Decision|2
2692293|NCT00443560|9283178|P2|Overall Study|Multiple pregnancies or fetal demise|4
2692294|NCT00443560|9283179|P1|Overall Study|Multiple pregnancies or fetal demise|2
2692295|NCT00443560|9283178|P2|Overall Study|No intrathecal dose|26
2692296|NCT00443560|9283179|P1|Overall Study|No intrathecal dose|58
2692297|NCT00443534|9283214|P1|Overall Study|Enrolled, Not Treated|1
2692298|NCT00443534|9283214|P1|Overall Study|Other|10
2692299|NCT00443534|9283214|P1|Overall Study|Study Terminated by Sponsor|12
2692300|NCT00443534|9283214|P1|Overall Study|Withdrawal by Subject|8
2692301|NCT00443534|9283214|P1|Overall Study|Death|9
2692302|NCT00443534|9283214|P1|Overall Study|Adverse Event|16
2692303|NCT00443534|9283214|P1|Overall Study|Lack of Efficacy|67
2692304|NCT00443456|9283221|P1|Overall Study|Withdrawal by Subject|1
2692305|NCT00443456|9283221|P1|Overall Study|Move|1
2692306|NCT00443456|9283221|P1|Overall Study|Adverse Event|16
2692307|NCT00443430|9283256|P2|Overall Study|Adverse Event|1
2692308|NCT00443430|9283257|P1|Overall Study|Adverse Event|1
2692309|NCT00443430|9283256|P2|Overall Study|Lack of Efficacy|3
2692310|NCT00443430|9283257|P1|Overall Study|Lack of Efficacy|3
2692311|NCT00443261|9283271|P1|Overall Study|Death|1
2692312|NCT00443209|9283277|P2|Months 13 to 18 Treatment Period|Withdrawal by Subject|2
2692313|NCT00443209|9283278|P1|Months 13 to 18 Treatment Period|Withdrawal by Subject|7
2692314|NCT00443209|9283277|P2|Months 13 to 18 Treatment Period|Trial Terminated|43
2692315|NCT00443209|9283278|P1|Months 13 to 18 Treatment Period|Trial Terminated|87
2692316|NCT00443209|9283277|P2|Months 13 to 18 Treatment Period|Lost to Follow-up|2
2692317|NCT00443209|9283278|P1|Months 13 to 18 Treatment Period|Lost to Follow-up|2
2692318|NCT00443209|9283277|P2|Months 13 to 18 Treatment Period|Lack of Efficacy|0
2692319|NCT00443209|9283278|P1|Months 13 to 18 Treatment Period|Lack of Efficacy|1
2692320|NCT00443209|9283277|P2|Months 13 to 18 Treatment Period|Protocol Violation|0
2692321|NCT00443209|9283278|P1|Months 13 to 18 Treatment Period|Protocol Violation|1
2692322|NCT00443209|9283277|P2|Months 13 to 18 Treatment Period|Adverse Event|0
2692323|NCT00443209|9283278|P1|Months 13 to 18 Treatment Period|Adverse Event|1
2692324|NCT00443209|9283277|P2|Months 1 to 12 Treatment Period|Not Treated|43
2692325|NCT00443209|9283278|P1|Months 1 to 12 Treatment Period|Not Treated|71
2692326|NCT00443209|9283277|P2|Months 1 to 12 Treatment Period|Missing|1
2692327|NCT00443209|9283278|P1|Months 1 to 12 Treatment Period|Missing|2
2692328|NCT00443209|9283277|P2|Months 1 to 12 Treatment Period|Withdrawal by Subject|34
2692329|NCT00443209|9283278|P1|Months 1 to 12 Treatment Period|Withdrawal by Subject|95
2692330|NCT00443209|9283277|P2|Months 1 to 12 Treatment Period|Trial Terminated|23
2692331|NCT00443209|9283278|P1|Months 1 to 12 Treatment Period|Trial Terminated|43
2692332|NCT00443209|9283277|P2|Months 1 to 12 Treatment Period|Pregnancy|4
2692333|NCT00443209|9283278|P1|Months 1 to 12 Treatment Period|Pregnancy|3
2692334|NCT00443209|9283277|P2|Months 1 to 12 Treatment Period|Physician Decision|4
2692335|NCT00443209|9283278|P1|Months 1 to 12 Treatment Period|Physician Decision|8
2692336|NCT00443209|9283277|P2|Months 1 to 12 Treatment Period|Lost to Follow-up|15
2692337|NCT00443209|9283278|P1|Months 1 to 12 Treatment Period|Lost to Follow-up|36
2692338|NCT00443209|9283277|P2|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
2692339|NCT00443209|9283278|P1|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
2692340|NCT00443209|9283277|P2|Months 1 to 12 Treatment Period|Lack of Efficacy|11
2692341|NCT00443209|9283278|P1|Months 1 to 12 Treatment Period|Lack of Efficacy|50
2692342|NCT00443209|9283277|P2|Months 1 to 12 Treatment Period|Protocol Violation|7
2692343|NCT00443209|9283278|P1|Months 1 to 12 Treatment Period|Protocol Violation|14
2692344|NCT00443209|9283277|P2|Months 1 to 12 Treatment Period|Adverse Event|11
2692345|NCT00443209|9283278|P1|Months 1 to 12 Treatment Period|Adverse Event|22
2692346|NCT00443118|9283295|P3|Overall Study|Withdrawal by Subject|0
2692347|NCT00443118|9283296|P2|Overall Study|Withdrawal by Subject|0
2692348|NCT00443118|9283297|P1|Overall Study|Withdrawal by Subject|1
2692349|NCT00443118|9283295|P3|Overall Study|unknown primary outcome|0
2692350|NCT00443118|9283296|P2|Overall Study|unknown primary outcome|1
2692351|NCT00443118|9283297|P1|Overall Study|unknown primary outcome|3
2692352|NCT00443053|9283346|P2|Overall Study|Physician Decision|4
2692353|NCT00443053|9283347|P1|Overall Study|Physician Decision|0
2692354|NCT00443053|9283346|P2|Overall Study|Other|4
2692355|NCT00443053|9283347|P1|Overall Study|Other|3
2692356|NCT00443053|9283346|P2|Overall Study|Noncompliance|1
2692357|NCT00443053|9283347|P1|Overall Study|Noncompliance|2
2692358|NCT00443053|9283346|P2|Overall Study|Did Not Meet Eligibility Criteria|0
2692359|NCT00443053|9283347|P1|Overall Study|Did Not Meet Eligibility Criteria|1
2692360|NCT00443053|9283346|P2|Overall Study|Lost to Follow-up|5
2692361|NCT00443053|9283347|P1|Overall Study|Lost to Follow-up|4
2692362|NCT00443053|9283346|P2|Overall Study|Withdrawal by Subject|18
2692363|NCT00443053|9283347|P1|Overall Study|Withdrawal by Subject|9
2692364|NCT00443053|9283346|P2|Overall Study|Adverse Event|1
2692365|NCT00443053|9283347|P1|Overall Study|Adverse Event|2
2692366|NCT00443040|9283368|P3|Overall Study|Converted to an open laparotomy|1
2692367|NCT00443040|9283369|P2|Overall Study|Converted to an open laparotomy|0
2692368|NCT00443040|9283370|P1|Overall Study|Converted to an open laparotomy|3
2692369|NCT00443040|9283368|P3|Overall Study|Withdrawal by Subject|0
2692370|NCT00443040|9283369|P2|Overall Study|Withdrawal by Subject|0
2692371|NCT00443040|9283370|P1|Overall Study|Withdrawal by Subject|1
2692372|NCT00442962|9283378|P1|Overall Study|Lost to Follow-up|7
2692373|NCT00442962|9283378|P1|Overall Study|Pregnancy|1
2692374|NCT00442936|9283396|P4|Overall Study|Protocol Violation|1
2692375|NCT00442936|9283397|P3|Overall Study|Protocol Violation|1
2692376|NCT00442936|9283398|P2|Overall Study|Protocol Violation|0
2692377|NCT00442936|9283399|P1|Overall Study|Protocol Violation|1
2692378|NCT00442897|9283447|P2|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3
2692379|NCT00442897|9283448|P1|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1
2692380|NCT00442897|9283447|P2|24 Weeks Follow-up (3 Centers)|Protocol Violation|1
2692381|NCT00442897|9283448|P1|24 Weeks Follow-up (3 Centers)|Protocol Violation|2
2692382|NCT00442897|9283447|P2|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
2692383|NCT00442897|9283448|P1|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
2692384|NCT00442897|9283447|P2|24 Weeks Follow-up (3 Centers)|Adverse Event|0
2692385|NCT00442897|9283448|P1|24 Weeks Follow-up (3 Centers)|Adverse Event|1
2692386|NCT00442897|9283447|P2|Base Study (12 Week Follow-up)|Withdrawal by Subject|8
2692387|NCT00442897|9283448|P1|Base Study (12 Week Follow-up)|Withdrawal by Subject|9
2692388|NCT00442897|9283447|P2|Base Study (12 Week Follow-up)|Protocol Violation|3
2692389|NCT00442897|9283448|P1|Base Study (12 Week Follow-up)|Protocol Violation|7
2692390|NCT00442897|9283447|P2|Base Study (12 Week Follow-up)|Death|1
2692391|NCT00442897|9283448|P1|Base Study (12 Week Follow-up)|Death|0
2692392|NCT00442897|9283447|P2|Base Study (12 Week Follow-up)|Adverse Event|0
2692393|NCT00442897|9283448|P1|Base Study (12 Week Follow-up)|Adverse Event|1
2692394|NCT00442702|9283466|P2|Evaluation Period|Site closure|1
2692395|NCT00442702|9283467|P1|Evaluation Period|Site closure|0
2692396|NCT00442702|9283466|P2|Evaluation Period|Failure to return|0
2692397|NCT00442702|9283467|P1|Evaluation Period|Failure to return|1
2692398|NCT00442702|9283466|P2|Evaluation Period|Renal transplant|1
2692399|NCT00442702|9283467|P1|Evaluation Period|Renal transplant|0
2692400|NCT00442702|9283466|P2|Evaluation Period|Refused treatment|1
2692401|NCT00442702|9283467|P1|Evaluation Period|Refused treatment|1
2692402|NCT00442702|9283466|P2|Evaluation Period|Insufficient Therapeutic Response|0
2692403|NCT00442702|9283467|P1|Evaluation Period|Insufficient Therapeutic Response|1
2692404|NCT00442702|9283466|P2|Evaluation Period|Death|1
2692405|NCT00442702|9283467|P1|Evaluation Period|Death|1
2692406|NCT00442702|9283466|P2|Evaluation Period|Adverse Event|0
2692407|NCT00442702|9283467|P1|Evaluation Period|Adverse Event|1
2692408|NCT00442702|9283466|P2|Titration Period|Hospitalized in another hospital|0
2692409|NCT00442702|9283467|P1|Titration Period|Hospitalized in another hospital|1
2692410|NCT00442702|9283466|P2|Titration Period|Failure to return|0
2692411|NCT00442702|9283467|P1|Titration Period|Failure to return|1
2692412|NCT00442702|9283466|P2|Titration Period|Refused Treatment|1
2692413|NCT00442702|9283467|P1|Titration Period|Refused Treatment|4
2692414|NCT00442702|9283466|P2|Titration Period|Insufficient Therapeutic Response|0
2692415|NCT00442702|9283467|P1|Titration Period|Insufficient Therapeutic Response|1
2692416|NCT00442702|9283466|P2|Titration Period|Death|2
2692417|NCT00442702|9283467|P1|Titration Period|Death|3
2692418|NCT00442702|9283466|P2|Titration Period|Adverse Event|0
2692419|NCT00442702|9283467|P1|Titration Period|Adverse Event|2
2692420|NCT00442598|9283532|P3|Overall Study|Death|0
2692421|NCT00442598|9283533|P2|Overall Study|Death|1
2692422|NCT00442598|9283534|P1|Overall Study|Death|0
2692423|NCT00442598|9283532|P3|Overall Study|Reduced creatinine clearance|0
2692424|NCT00442598|9283533|P2|Overall Study|Reduced creatinine clearance|0
2692425|NCT00442598|9283534|P1|Overall Study|Reduced creatinine clearance|1
2692426|NCT00442598|9283532|P3|Overall Study|CA125 progression|0
2692427|NCT00442598|9283533|P2|Overall Study|CA125 progression|1
2692428|NCT00442598|9283534|P1|Overall Study|CA125 progression|0
2692429|NCT00442598|9283532|P3|Overall Study|Clinical deterioration|0
2692430|NCT00442598|9283533|P2|Overall Study|Clinical deterioration|2
2692431|NCT00442598|9283534|P1|Overall Study|Clinical deterioration|1
2692432|NCT00442598|9283532|P3|Overall Study|Tumor progression|0
2692433|NCT00442598|9283533|P2|Overall Study|Tumor progression|4
2692434|NCT00442598|9283534|P1|Overall Study|Tumor progression|3
2692435|NCT00442598|9283532|P3|Overall Study|Adverse Event|0
2692436|NCT00442598|9283533|P2|Overall Study|Adverse Event|0
2692437|NCT00442598|9283534|P1|Overall Study|Adverse Event|1
2692438|NCT00442572|9283552|P2|Overall Study|Withdrawal by Subject|1
2692439|NCT00442572|9283553|P1|Overall Study|Withdrawal by Subject|0
2692440|NCT00442572|9283552|P2|Overall Study|Lost to Follow-up|1
2692441|NCT00442572|9283553|P1|Overall Study|Lost to Follow-up|0
2692442|NCT00442572|9283552|P2|Overall Study|Relapse|1
2692443|NCT00442572|9283553|P1|Overall Study|Relapse|8
2692444|NCT00442559|9283593|P2|Overall Study|Withdrawal by Subject|0
2692445|NCT00442559|9283594|P1|Overall Study|Withdrawal by Subject|1
2692446|NCT00442559|9283593|P2|Overall Study|Protocol Violation|1
2692447|NCT00442559|9283594|P1|Overall Study|Protocol Violation|1
2692448|NCT00442559|9283593|P2|Overall Study|Lost to Follow-up|34
2692449|NCT00442559|9283594|P1|Overall Study|Lost to Follow-up|32
2692450|NCT00442546|9283609|P3|Overall Study|Randomized But Not Treated|6
2692451|NCT00442546|9283610|P2|Overall Study|Randomized But Not Treated|4
2692452|NCT00442546|9283611|P1|Overall Study|Randomized But Not Treated|5
2692453|NCT00442546|9283609|P3|Overall Study|Withdrawal by Subject|7
2692454|NCT00442546|9283610|P2|Overall Study|Withdrawal by Subject|5
2692455|NCT00442546|9283611|P1|Overall Study|Withdrawal by Subject|5
2692456|NCT00442546|9283609|P3|Overall Study|Other|6
2692457|NCT00442546|9283610|P2|Overall Study|Other|9
2692458|NCT00442546|9283611|P1|Overall Study|Other|4
2692459|NCT00442546|9283609|P3|Overall Study|Lost to Follow-up|1
2692460|NCT00442546|9283610|P2|Overall Study|Lost to Follow-up|2
2692461|NCT00442546|9283611|P1|Overall Study|Lost to Follow-up|1
2692462|NCT00442546|9283609|P3|Overall Study|Adverse Event|13
2692463|NCT00442546|9283610|P2|Overall Study|Adverse Event|17
2692464|NCT00442546|9283611|P1|Overall Study|Adverse Event|11
2692465|NCT00442468|9283740|P1|Overall Study|Did not complete all study procedures|88
2692466|NCT00442468|9283740|P1|Overall Study|Withdrawal by Subject|91
2692467|NCT00442468|9283740|P1|Overall Study|Adverse Event|4
2692468|NCT00442416|9283770|P2|Overall Study|Administrative/Other|33
2692469|NCT00442416|9283771|P1|Overall Study|Administrative/Other|27
2692470|NCT00442416|9283770|P2|Overall Study|Withdrew consent|2
2692471|NCT00442416|9283771|P1|Overall Study|Withdrew consent|1
2692472|NCT00442416|9283770|P2|Overall Study|Protocol Violation|3
2692473|NCT00442416|9283771|P1|Overall Study|Protocol Violation|2
2692474|NCT00442416|9283770|P2|Overall Study|Lack of Efficacy|0
2692475|NCT00442416|9283771|P1|Overall Study|Lack of Efficacy|2
2692476|NCT00442416|9283770|P2|Overall Study|Death|0
2692477|NCT00442416|9283771|P1|Overall Study|Death|1
2692478|NCT00442416|9283770|P2|Overall Study|Adverse Event|1
2692479|NCT00442416|9283771|P1|Overall Study|Adverse Event|4
2692480|NCT00442351|9283810|P2|Overall Study|Other|1
2692481|NCT00442351|9283811|P1|Overall Study|Other|0
2692482|NCT00442351|9283810|P2|Overall Study|Did not meet protocol eligibility|0
2692483|NCT00442351|9283811|P1|Overall Study|Did not meet protocol eligibility|1
2692484|NCT00442351|9283810|P2|Overall Study|Administrative|5
2692485|NCT00442351|9283811|P1|Overall Study|Administrative|6
2692486|NCT00442286|9283833|P2|Overall Study|Patient Injury|0
2692487|NCT00442286|9283834|P1|Overall Study|Patient Injury|1
2692488|NCT00442286|9283833|P2|Overall Study|System explanted|0
2692489|NCT00442286|9283834|P1|Overall Study|System explanted|1
2692490|NCT00442286|9283833|P2|Overall Study|Withdrawal by Subject|0
2692491|NCT00442286|9283834|P1|Overall Study|Withdrawal by Subject|2
2692492|NCT00442286|9283833|P2|Overall Study|Lost to Follow-up|0
2692493|NCT00442286|9283834|P1|Overall Study|Lost to Follow-up|1
2692494|NCT00442286|9283833|P2|Overall Study|Death|2
2692495|NCT00442286|9283834|P1|Overall Study|Death|2
2692496|NCT00442117|9283896|P2|Overall Study|Met Withdrawal Criteria|1
2692497|NCT00442117|9283897|P1|Overall Study|Met Withdrawal Criteria|2
2692498|NCT00442117|9283896|P2|Overall Study|Non compliance with protocol|5
2692499|NCT00442117|9283897|P1|Overall Study|Non compliance with protocol|3
2692500|NCT00442117|9283896|P2|Overall Study|Major Deviation|20
2692501|NCT00442117|9283897|P1|Overall Study|Major Deviation|25
2692502|NCT00442117|9283896|P2|Overall Study|Withdrawal by Subject|2
2692503|NCT00442117|9283897|P1|Overall Study|Withdrawal by Subject|2
2692504|NCT00442117|9283896|P2|Overall Study|Lost to Follow-up|2
2692505|NCT00442117|9283897|P1|Overall Study|Lost to Follow-up|1
2692506|NCT00442117|9283896|P2|Overall Study|Lack of Efficacy|6
2692507|NCT00442117|9283897|P1|Overall Study|Lack of Efficacy|2
2692508|NCT00442117|9283896|P2|Overall Study|Adverse Event|2
2692509|NCT00442117|9283897|P1|Overall Study|Adverse Event|3
2692510|NCT00441974|9283928|P1|Overall Study|Protocol Violation|7
2692511|NCT00441974|9283928|P1|Overall Study|Lost to Follow-up|80
2692512|NCT00441974|9283928|P1|Overall Study|Consent Withdrawn|35
2692513|NCT00441974|9283928|P1|Overall Study|Adverse Event|6
2692514|NCT00441792|9283944|P2|Overall Study|Lost to Follow-up|2
2692515|NCT00441792|9283945|P1|Overall Study|Lost to Follow-up|0
2692516|NCT00441727|9283985|P3|Overall Study|Various reason specified|5
2692517|NCT00441727|9283986|P2|Overall Study|Various reason specified|8
2692518|NCT00441727|9283987|P1|Overall Study|Various reason specified|6
2692519|NCT00441727|9283985|P3|Overall Study|Safety Reasons|3
2692520|NCT00441727|9283986|P2|Overall Study|Safety Reasons|1
2692521|NCT00441727|9283987|P1|Overall Study|Safety Reasons|3
2692522|NCT00441727|9283985|P3|Overall Study|Lost to Follow-up|5
2692523|NCT00441727|9283986|P2|Overall Study|Lost to Follow-up|6
2692524|NCT00441727|9283987|P1|Overall Study|Lost to Follow-up|5
2692525|NCT00441727|9283985|P3|Overall Study|Withdrawal by Subject|47
2692526|NCT00441727|9283986|P2|Overall Study|Withdrawal by Subject|34
2692527|NCT00441727|9283987|P1|Overall Study|Withdrawal by Subject|40
2692528|NCT00441727|9283985|P3|Overall Study|Lack of Efficacy|48
2692529|NCT00441727|9283986|P2|Overall Study|Lack of Efficacy|8
2692530|NCT00441727|9283987|P1|Overall Study|Lack of Efficacy|7
2692531|NCT00441727|9283985|P3|Overall Study|Adverse Event|28
2692532|NCT00441727|9283986|P2|Overall Study|Adverse Event|33
2692533|NCT00441727|9283987|P1|Overall Study|Adverse Event|26
2692534|NCT00441727|9283985|P3|Overall Study|Protocol Violation|32
2692535|NCT00441727|9283986|P2|Overall Study|Protocol Violation|28
2692536|NCT00441727|9283987|P1|Overall Study|Protocol Violation|19
2692537|NCT00441701|9284020|P10|Overall Study|Withdrawal by Subject|0
2692538|NCT00441701|9284021|P9|Overall Study|Withdrawal by Subject|0
2692539|NCT00441701|9284022|P8|Overall Study|Withdrawal by Subject|0
2692540|NCT00441701|9284023|P7|Overall Study|Withdrawal by Subject|0
2692541|NCT00441701|9284024|P6|Overall Study|Withdrawal by Subject|0
2692542|NCT00441701|9284025|P5|Overall Study|Withdrawal by Subject|0
2692543|NCT00441701|9284026|P4|Overall Study|Withdrawal by Subject|1
2692544|NCT00441701|9284027|P3|Overall Study|Withdrawal by Subject|1
2692545|NCT00441701|9284028|P2|Overall Study|Withdrawal by Subject|2
2692546|NCT00441701|9284029|P1|Overall Study|Withdrawal by Subject|0
2692547|NCT00441701|9284020|P10|Overall Study|Lack of Efficacy|0
2692548|NCT00441701|9284021|P9|Overall Study|Lack of Efficacy|0
2692549|NCT00441701|9284022|P8|Overall Study|Lack of Efficacy|0
2692550|NCT00441701|9284023|P7|Overall Study|Lack of Efficacy|0
2692551|NCT00441701|9284024|P6|Overall Study|Lack of Efficacy|1
2692552|NCT00441701|9284025|P5|Overall Study|Lack of Efficacy|0
2692553|NCT00441701|9284026|P4|Overall Study|Lack of Efficacy|2
2692554|NCT00441701|9284027|P3|Overall Study|Lack of Efficacy|2
2692555|NCT00441701|9284028|P2|Overall Study|Lack of Efficacy|0
2692556|NCT00441701|9284029|P1|Overall Study|Lack of Efficacy|2
2692557|NCT00441701|9284020|P10|Overall Study|Adverse Event|0
2692558|NCT00441701|9284021|P9|Overall Study|Adverse Event|0
2692559|NCT00441701|9284022|P8|Overall Study|Adverse Event|0
2692560|NCT00441701|9284023|P7|Overall Study|Adverse Event|0
2692561|NCT00441701|9284024|P6|Overall Study|Adverse Event|2
2692562|NCT00441701|9284025|P5|Overall Study|Adverse Event|2
2692563|NCT00441701|9284026|P4|Overall Study|Adverse Event|0
2692564|NCT00441701|9284027|P3|Overall Study|Adverse Event|1
2692565|NCT00441701|9284028|P2|Overall Study|Adverse Event|2
2692566|NCT00441701|9284029|P1|Overall Study|Adverse Event|3
2692567|NCT00441584|9284111|P1|Overall Study|Failure to meet eligibility criteria|3
2692568|NCT00441584|9284111|P1|Overall Study|Lost to Follow-up|4
2692569|NCT00441584|9284111|P1|Overall Study|Protocol Violation|5
2692570|NCT00441584|9284111|P1|Overall Study|Adverse Event|6
2692571|NCT00441584|9284111|P1|Overall Study|Withdrawal by Subject|8
2692572|NCT00441584|9284111|P1|Overall Study|Lack of Efficacy|79
2692573|NCT00441545|9284119|P2|Second Intervention|Subject moved|1
2692574|NCT00441545|9284120|P1|Second Intervention|Subject moved|0
2692575|NCT00441545|9284119|P2|Second Intervention|Subject exceeded safety criteria|0
2692576|NCT00441545|9284120|P1|Second Intervention|Subject exceeded safety criteria|1
2692577|NCT00441545|9284119|P2|Second Intervention|Lack of Efficacy|1
2692578|NCT00441545|9284120|P1|Second Intervention|Lack of Efficacy|0
2692579|NCT00441545|9284119|P2|Second Intervention|Kidney Transplant|1
2692580|NCT00441545|9284120|P1|Second Intervention|Kidney Transplant|1
2692581|NCT00441545|9284119|P2|Second Intervention|Withdrawal by Subject|1
2692582|NCT00441545|9284120|P1|Second Intervention|Withdrawal by Subject|1
2692583|NCT00441545|9284119|P2|Second Intervention|Protocol Violation|1
2692584|NCT00441545|9284120|P1|Second Intervention|Protocol Violation|4
2692585|NCT00441545|9284119|P2|Second Intervention|Adverse Event|2
2692586|NCT00441545|9284120|P1|Second Intervention|Adverse Event|5
2692587|NCT00441545|9284119|P2|First Intervention|Sponsor's request|0
2692588|NCT00441545|9284120|P1|First Intervention|Sponsor's request|1
2692589|NCT00441545|9284119|P2|First Intervention|Site error|0
2692590|NCT00441545|9284120|P1|First Intervention|Site error|1
2692591|NCT00441545|9284119|P2|First Intervention|Extended hospitalization|0
2692592|NCT00441545|9284120|P1|First Intervention|Extended hospitalization|1
2692593|NCT00441545|9284119|P2|First Intervention|Subject met an exclusionary criteria|0
2692594|NCT00441545|9284120|P1|First Intervention|Subject met an exclusionary criteria|1
2692595|NCT00441545|9284119|P2|First Intervention|Subject exceeded safety criteria|1
2692596|NCT00441545|9284120|P1|First Intervention|Subject exceeded safety criteria|0
2692597|NCT00441545|9284119|P2|First Intervention|Lack of Efficacy|0
2692598|NCT00441545|9284120|P1|First Intervention|Lack of Efficacy|2
2692599|NCT00441545|9284119|P2|First Intervention|Kidney transplant|1
2692600|NCT00441545|9284120|P1|First Intervention|Kidney transplant|1
2692601|NCT00441545|9284119|P2|First Intervention|Withdrawal by Subject|3
2692602|NCT00441545|9284120|P1|First Intervention|Withdrawal by Subject|3
2692603|NCT00441545|9284119|P2|First Intervention|Protocol Violation|2
2692604|NCT00441545|9284120|P1|First Intervention|Protocol Violation|2
2692605|NCT00441545|9284119|P2|First Intervention|Adverse Event|5
2692606|NCT00441545|9284120|P1|First Intervention|Adverse Event|6
2692607|NCT00441480|9284134|P2|Overall Study|Withdrawal by Subject|3
2692608|NCT00441480|9284135|P1|Overall Study|Withdrawal by Subject|2
2692609|NCT00441480|9284134|P2|Overall Study|Protocol Violation|1
2692610|NCT00441480|9284135|P1|Overall Study|Protocol Violation|1
2692611|NCT00441467|9284167|P1|Overall Study|Progressive disease|9
2692612|NCT00441467|9284167|P1|Overall Study|Withdrawal by Subject|3
2692613|NCT00441467|9284167|P1|Overall Study|Adverse Event|6
2692614|NCT00441441|9284175|P2|Overall Study|Other|3
2692615|NCT00441441|9284176|P1|Overall Study|Other|3
2692616|NCT00441441|9284175|P2|Overall Study|Withdrawal by Subject|2
2692617|NCT00441441|9284176|P1|Overall Study|Withdrawal by Subject|1
2692618|NCT00441441|9284175|P2|Overall Study|Exacerbation of asthma|2
2692619|NCT00441441|9284176|P1|Overall Study|Exacerbation of asthma|1
2692620|NCT00441441|9284175|P2|Overall Study|Protocol Violation|6
2692621|NCT00441441|9284176|P1|Overall Study|Protocol Violation|4
2692622|NCT00441441|9284175|P2|Overall Study|Adverse Event|1
2692623|NCT00441441|9284176|P1|Overall Study|Adverse Event|2
2692624|NCT00441363|9284236|P2|Overall Study|Other|0
2692625|NCT00441363|9284237|P1|Overall Study|Other|2
2692626|NCT00441363|9284236|P2|Overall Study|Lost to Follow-up|2
2692627|NCT00441363|9284237|P1|Overall Study|Lost to Follow-up|2
2692628|NCT00441363|9284236|P2|Overall Study|Physician Decision|7
2692629|NCT00441363|9284237|P1|Overall Study|Physician Decision|6
2692630|NCT00441363|9284236|P2|Overall Study|Withdrawal by Subject|4
2692631|NCT00441363|9284237|P1|Overall Study|Withdrawal by Subject|3
2692632|NCT00441363|9284236|P2|Overall Study|Adverse Event|2
2692633|NCT00441363|9284237|P1|Overall Study|Adverse Event|4
2692634|NCT00441337|9284249|P4|Overall Study|Did not meet inclusion criteria|0
2692635|NCT00441337|9284250|P3|Overall Study|Did not meet inclusion criteria|1
2692636|NCT00441337|9284251|P2|Overall Study|Did not meet inclusion criteria|0
2692637|NCT00441337|9284252|P1|Overall Study|Did not meet inclusion criteria|0
2692638|NCT00441337|9284249|P4|Overall Study|Sponsor Decision|2
2692639|NCT00441337|9284250|P3|Overall Study|Sponsor Decision|1
2692640|NCT00441337|9284251|P2|Overall Study|Sponsor Decision|0
2692641|NCT00441337|9284252|P1|Overall Study|Sponsor Decision|0
2692642|NCT00441337|9284249|P4|Overall Study|Lost to Follow-up|1
2692643|NCT00441337|9284250|P3|Overall Study|Lost to Follow-up|0
2692644|NCT00441337|9284251|P2|Overall Study|Lost to Follow-up|0
2692645|NCT00441337|9284252|P1|Overall Study|Lost to Follow-up|0
2692646|NCT00441337|9284249|P4|Overall Study|Disease Progression|18
2692647|NCT00441337|9284250|P3|Overall Study|Disease Progression|4
2692648|NCT00441337|9284251|P2|Overall Study|Disease Progression|6
2692649|NCT00441337|9284252|P1|Overall Study|Disease Progression|6
2692650|NCT00441272|9284365|P2|Overall Study|Study terminated prior to enrollment|25
2692651|NCT00441272|9284366|P1|Overall Study|Study terminated prior to enrollment|25
2692652|NCT00441168|9284393|P2|Follow-up Period|Other|3
2692653|NCT00441168|9284394|P1|Follow-up Period|Other|1
2692654|NCT00441168|9284393|P2|Follow-up Period|Withdrawal by Subject|0
2692655|NCT00441168|9284394|P1|Follow-up Period|Withdrawal by Subject|3
2692656|NCT00441168|9284393|P2|Follow-up Period|Lost to Follow-up|6
2692657|NCT00441168|9284394|P1|Follow-up Period|Lost to Follow-up|5
2692658|NCT00441168|9284393|P2|Follow-up Period|Death|0
2692659|NCT00441168|9284394|P1|Follow-up Period|Death|3
2692660|NCT00441168|9284393|P2|Treatment Period|refractory disease|0
2692661|NCT00441168|9284394|P1|Treatment Period|refractory disease|1
2692662|NCT00441168|9284393|P2|Treatment Period|qualified for stem-cell transplantation|0
2692663|NCT00441168|9284394|P1|Treatment Period|qualified for stem-cell transplantation|3
2692664|NCT00441168|9284393|P2|Treatment Period|Withdrawal by Subject|0
2692665|NCT00441168|9284394|P1|Treatment Period|Withdrawal by Subject|3
2692666|NCT00441168|9284393|P2|Treatment Period|Lost to Follow-up|1
2692667|NCT00441168|9284394|P1|Treatment Period|Lost to Follow-up|0
2692668|NCT00441168|9284393|P2|Treatment Period|Protocol Violation|1
2692669|NCT00441168|9284394|P1|Treatment Period|Protocol Violation|0
2692670|NCT00441168|9284393|P2|Treatment Period|Progressive Disease|2
2692671|NCT00441168|9284394|P1|Treatment Period|Progressive Disease|0
2692672|NCT00441168|9284393|P2|Treatment Period|Adverse Event|2
2692673|NCT00441168|9284394|P1|Treatment Period|Adverse Event|1
2692674|NCT00441168|9284393|P2|Treatment Period|Death|0
2692675|NCT00441168|9284394|P1|Treatment Period|Death|3
2692676|NCT00441142|9284408|P4|Overall Study|Death|1
2692677|NCT00441142|9284409|P3|Overall Study|Death|0
2692678|NCT00441142|9284410|P2|Overall Study|Death|0
2692679|NCT00441142|9284411|P1|Overall Study|Death|0
2692680|NCT00441142|9284408|P4|Overall Study|Physician Decision|1
2692681|NCT00441142|9284409|P3|Overall Study|Physician Decision|0
2692682|NCT00441142|9284410|P2|Overall Study|Physician Decision|1
2692683|NCT00441142|9284411|P1|Overall Study|Physician Decision|0
2692684|NCT00441142|9284408|P4|Overall Study|Patient still receiving active study tx|2
2692685|NCT00441142|9284409|P3|Overall Study|Patient still receiving active study tx|0
2692686|NCT00441142|9284410|P2|Overall Study|Patient still receiving active study tx|0
2692687|NCT00441142|9284411|P1|Overall Study|Patient still receiving active study tx|1
2692688|NCT00441142|9284408|P4|Overall Study|Withdrawal by Subject|10
2692689|NCT00441142|9284409|P3|Overall Study|Withdrawal by Subject|2
2692690|NCT00441142|9284410|P2|Overall Study|Withdrawal by Subject|0
2692691|NCT00441142|9284411|P1|Overall Study|Withdrawal by Subject|0
2692692|NCT00441142|9284408|P4|Overall Study|Lack of Efficacy|32
2692693|NCT00441142|9284409|P3|Overall Study|Lack of Efficacy|17
2692694|NCT00441142|9284410|P2|Overall Study|Lack of Efficacy|3
2692695|NCT00441142|9284411|P1|Overall Study|Lack of Efficacy|3
2692696|NCT00441142|9284408|P4|Overall Study|Adverse Event|22
2692697|NCT00441142|9284409|P3|Overall Study|Adverse Event|3
2692698|NCT00441142|9284410|P2|Overall Study|Adverse Event|3
2692699|NCT00441142|9284411|P1|Overall Study|Adverse Event|2
2692700|NCT00441129|9284433|P2|Overall Study|Withdrawal by Subject|14
2692701|NCT00441129|9284434|P1|Overall Study|Withdrawal by Subject|6
2692702|NCT00441116|9284446|P2|Overall Study|Did not meet Eligibility Criteria|1
2692703|NCT00441116|9284447|P1|Overall Study|Did not meet Eligibility Criteria|1
2692704|NCT00441116|9284446|P2|Overall Study|Withdrawal by Subject|0
2692705|NCT00441116|9284447|P1|Overall Study|Withdrawal by Subject|1
2692706|NCT00441116|9284446|P2|Overall Study|Adverse Event|1
2692707|NCT00441116|9284447|P1|Overall Study|Adverse Event|1
2692708|NCT00441103|9284515|P2|Overall Study|Participant decided to stop|1
2692709|NCT00441103|9284516|P1|Overall Study|Participant decided to stop|0
2692710|NCT00441103|9284515|P2|Overall Study|Participant's reason|1
2692711|NCT00441103|9284516|P1|Overall Study|Participant's reason|0
2692712|NCT00441103|9284515|P2|Overall Study|Participant decided to withdraw|0
2692713|NCT00441103|9284516|P1|Overall Study|Participant decided to withdraw|1
2692714|NCT00441103|9284515|P2|Overall Study|Non-compliant|1
2692715|NCT00441103|9284516|P1|Overall Study|Non-compliant|0
2692716|NCT00441103|9284515|P2|Overall Study|Inclusion criteria absent|0
2692717|NCT00441103|9284516|P1|Overall Study|Inclusion criteria absent|1
2692718|NCT00441103|9284515|P2|Overall Study|Participant refused MRI|0
2692719|NCT00441103|9284516|P1|Overall Study|Participant refused MRI|1
2692720|NCT00441103|9284515|P2|Overall Study|Participant unable to use Rebiject II|0
2692721|NCT00441103|9284516|P1|Overall Study|Participant unable to use Rebiject II|1
2692722|NCT00441103|9284515|P2|Overall Study|Protocol Violation|0
2692723|NCT00441103|9284516|P1|Overall Study|Protocol Violation|1
2692724|NCT00441103|9284515|P2|Overall Study|Lost to Follow-up|0
2692725|NCT00441103|9284516|P1|Overall Study|Lost to Follow-up|1
2692726|NCT00441103|9284515|P2|Overall Study|Disease Progression|0
2692727|NCT00441103|9284516|P1|Overall Study|Disease Progression|2
2692728|NCT00441103|9284515|P2|Overall Study|Death|0
2692729|NCT00441103|9284516|P1|Overall Study|Death|1
2692730|NCT00441103|9284515|P2|Overall Study|Adverse Event|1
2692731|NCT00441103|9284516|P1|Overall Study|Adverse Event|2
2692732|NCT00441090|9284532|P5|Overall Study|Lack of Efficacy|0
2692733|NCT00441090|9284533|P4|Overall Study|Lack of Efficacy|0
2692734|NCT00441090|9284534|P3|Overall Study|Lack of Efficacy|0
2692735|NCT00441090|9284535|P2|Overall Study|Lack of Efficacy|0
2692736|NCT00441090|9284536|P1|Overall Study|Lack of Efficacy|1
2692737|NCT00441090|9284532|P5|Overall Study|Withdrawal by Subject|0
2692738|NCT00441090|9284533|P4|Overall Study|Withdrawal by Subject|0
2692739|NCT00441090|9284534|P3|Overall Study|Withdrawal by Subject|1
2692740|NCT00441090|9284535|P2|Overall Study|Withdrawal by Subject|0
2692741|NCT00441090|9284536|P1|Overall Study|Withdrawal by Subject|1
2692742|NCT00441090|9284532|P5|Overall Study|Platelet increase;more than 500,000 mm^3|0
2692743|NCT00441090|9284533|P4|Overall Study|Platelet increase;more than 500,000 mm^3|2
2692744|NCT00441090|9284534|P3|Overall Study|Platelet increase;more than 500,000 mm^3|0
2692745|NCT00441090|9284535|P2|Overall Study|Platelet increase;more than 500,000 mm^3|0
2692746|NCT00441090|9284536|P1|Overall Study|Platelet increase;more than 500,000 mm^3|0
2692747|NCT00441090|9284532|P5|Overall Study|Adverse Event|0
2692748|NCT00441090|9284533|P4|Overall Study|Adverse Event|0
2692749|NCT00441090|9284534|P3|Overall Study|Adverse Event|1
2692750|NCT00441090|9284535|P2|Overall Study|Adverse Event|1
2692751|NCT00441090|9284536|P1|Overall Study|Adverse Event|0
2692752|NCT00441064|9284580|P2|Overall Study|Patient withdrew consent|2
2692753|NCT00441064|9284581|P1|Overall Study|Patient withdrew consent|5
2692754|NCT00441064|9284580|P2|Overall Study|Protocol Deviation|2
2692755|NCT00441064|9284581|P1|Overall Study|Protocol Deviation|3
2692756|NCT00441064|9284580|P2|Overall Study|Unsatisfactory therapeutic effect|0
2692757|NCT00441064|9284581|P1|Overall Study|Unsatisfactory therapeutic effect|1
2692758|NCT00441064|9284580|P2|Overall Study|Abnormal test procedure results|1
2692759|NCT00441064|9284581|P1|Overall Study|Abnormal test procedure results|0
2692760|NCT00441064|9284580|P2|Overall Study|Abnormal laboratory values|2
2692761|NCT00441064|9284581|P1|Overall Study|Abnormal laboratory values|0
2692762|NCT00441064|9284580|P2|Overall Study|Adverse Event|0
2692763|NCT00441064|9284581|P1|Overall Study|Adverse Event|1
2692764|NCT00441012|9284593|P2|Overall Study|Subject Randomized but Not Vaccinated|0
2692765|NCT00441012|9284594|P1|Overall Study|Subject Randomized but Not Vaccinated|1
2692766|NCT00441012|9284593|P2|Overall Study|Withdrawal by Subject|0
2692767|NCT00441012|9284594|P1|Overall Study|Withdrawal by Subject|4
2692768|NCT00441012|9284593|P2|Overall Study|Protocol Violation|9
2692769|NCT00441012|9284594|P1|Overall Study|Protocol Violation|10
2692770|NCT00441012|9284593|P2|Overall Study|Lost to Follow-up|3
2692771|NCT00441012|9284594|P1|Overall Study|Lost to Follow-up|3
2692772|NCT00441012|9284593|P2|Overall Study|Adverse Event|1
2692773|NCT00441012|9284594|P1|Overall Study|Adverse Event|0
2692774|NCT00440947|9284608|P5|Optional 60-Week Extension Phase|Participant Remained in Cuba|1
2692775|NCT00440947|9284609|P4|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
2692776|NCT00440947|9284610|P3|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
2692777|NCT00440947|9284611|P2|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
2692778|NCT00440947|9284612|P1|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
2692779|NCT00440947|9284608|P5|Optional 60-Week Extension Phase|Physician Decision|1
2692780|NCT00440947|9284609|P4|Optional 60-Week Extension Phase|Physician Decision|0
2692781|NCT00440947|9284610|P3|Optional 60-Week Extension Phase|Physician Decision|0
2692782|NCT00440947|9284611|P2|Optional 60-Week Extension Phase|Physician Decision|0
2692783|NCT00440947|9284612|P1|Optional 60-Week Extension Phase|Physician Decision|0
2692784|NCT00440947|9284608|P5|Optional 60-Week Extension Phase|Other|0
2692785|NCT00440947|9284609|P4|Optional 60-Week Extension Phase|Other|1
2692786|NCT00440947|9284610|P3|Optional 60-Week Extension Phase|Other|0
2692787|NCT00440947|9284611|P2|Optional 60-Week Extension Phase|Other|0
2692788|NCT00440947|9284612|P1|Optional 60-Week Extension Phase|Other|0
2692789|NCT00440947|9284608|P5|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
2692790|NCT00440947|9284609|P4|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
2692791|NCT00440947|9284610|P3|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
2692792|NCT00440947|9284611|P2|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
2692793|NCT00440947|9284612|P1|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
2692794|NCT00440947|9284608|P5|Optional 60-Week Extension Phase|Sponsor Request|1
2692795|NCT00440947|9284609|P4|Optional 60-Week Extension Phase|Sponsor Request|1
2692796|NCT00440947|9284610|P3|Optional 60-Week Extension Phase|Sponsor Request|0
2692797|NCT00440947|9284611|P2|Optional 60-Week Extension Phase|Sponsor Request|0
2692798|NCT00440947|9284612|P1|Optional 60-Week Extension Phase|Sponsor Request|0
2692799|NCT00440947|9284608|P5|Optional 60-Week Extension Phase|Participant Moved|1
2692800|NCT00440947|9284609|P4|Optional 60-Week Extension Phase|Participant Moved|1
2692801|NCT00440947|9284610|P3|Optional 60-Week Extension Phase|Participant Moved|0
2692802|NCT00440947|9284611|P2|Optional 60-Week Extension Phase|Participant Moved|0
2692803|NCT00440947|9284612|P1|Optional 60-Week Extension Phase|Participant Moved|0
2692804|NCT00440947|9284608|P5|Optional 60-Week Extension Phase|Pregnancy|0
2692805|NCT00440947|9284609|P4|Optional 60-Week Extension Phase|Pregnancy|3
2692806|NCT00440947|9284610|P3|Optional 60-Week Extension Phase|Pregnancy|0
2692807|NCT00440947|9284611|P2|Optional 60-Week Extension Phase|Pregnancy|0
2692808|NCT00440947|9284612|P1|Optional 60-Week Extension Phase|Pregnancy|0
2692809|NCT00440947|9284608|P5|Optional 60-Week Extension Phase|Withdrawal by Subject|3
2692810|NCT00440947|9284609|P4|Optional 60-Week Extension Phase|Withdrawal by Subject|4
2692811|NCT00440947|9284610|P3|Optional 60-Week Extension Phase|Withdrawal by Subject|0
2692812|NCT00440947|9284611|P2|Optional 60-Week Extension Phase|Withdrawal by Subject|0
2692813|NCT00440947|9284612|P1|Optional 60-Week Extension Phase|Withdrawal by Subject|0
2692814|NCT00440947|9284608|P5|Optional 60-Week Extension Phase|Protocol Violation|0
2692815|NCT00440947|9284609|P4|Optional 60-Week Extension Phase|Protocol Violation|1
2692816|NCT00440947|9284610|P3|Optional 60-Week Extension Phase|Protocol Violation|0
2692817|NCT00440947|9284611|P2|Optional 60-Week Extension Phase|Protocol Violation|0
2692818|NCT00440947|9284612|P1|Optional 60-Week Extension Phase|Protocol Violation|0
2692819|NCT00440947|9284608|P5|Optional 60-Week Extension Phase|Lost to Follow-up|9
2692820|NCT00440947|9284609|P4|Optional 60-Week Extension Phase|Lost to Follow-up|9
2692821|NCT00440947|9284610|P3|Optional 60-Week Extension Phase|Lost to Follow-up|0
2692822|NCT00440947|9284611|P2|Optional 60-Week Extension Phase|Lost to Follow-up|0
2692823|NCT00440947|9284612|P1|Optional 60-Week Extension Phase|Lost to Follow-up|0
2692824|NCT00440947|9284608|P5|Optional 60-Week Extension Phase|Non-compliance|1
2692825|NCT00440947|9284609|P4|Optional 60-Week Extension Phase|Non-compliance|1
2692826|NCT00440947|9284610|P3|Optional 60-Week Extension Phase|Non-compliance|0
2692827|NCT00440947|9284611|P2|Optional 60-Week Extension Phase|Non-compliance|0
2692828|NCT00440947|9284612|P1|Optional 60-Week Extension Phase|Non-compliance|0
2692829|NCT00440947|9284608|P5|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2
2692830|NCT00440947|9284609|P4|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3
2692831|NCT00440947|9284610|P3|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
2692832|NCT00440947|9284611|P2|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
2692833|NCT00440947|9284612|P1|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
2692834|NCT00440947|9284608|P5|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
2692835|NCT00440947|9284609|P4|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
2692836|NCT00440947|9284610|P3|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
2692837|NCT00440947|9284611|P2|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
2692838|NCT00440947|9284612|P1|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
2692839|NCT00440947|9284608|P5|Optional 60-Week Extension Phase|Adverse Event|3
2692840|NCT00440947|9284609|P4|Optional 60-Week Extension Phase|Adverse Event|1
2692841|NCT00440947|9284610|P3|Optional 60-Week Extension Phase|Adverse Event|0
2692842|NCT00440947|9284611|P2|Optional 60-Week Extension Phase|Adverse Event|0
2692843|NCT00440947|9284612|P1|Optional 60-Week Extension Phase|Adverse Event|0
2692844|NCT00440947|9284608|P5|48-Week Randomization Phase|Physician Decision|0
2692845|NCT00440947|9284609|P4|48-Week Randomization Phase|Physician Decision|0
2692846|NCT00440947|9284610|P3|48-Week Randomization Phase|Physician Decision|0
2692847|NCT00440947|9284611|P2|48-Week Randomization Phase|Physician Decision|2
2692848|NCT00440947|9284612|P1|48-Week Randomization Phase|Physician Decision|0
2692849|NCT00440947|9284608|P5|48-Week Randomization Phase|Trying to Get Pregnant|0
2692850|NCT00440947|9284609|P4|48-Week Randomization Phase|Trying to Get Pregnant|0
2692851|NCT00440947|9284610|P3|48-Week Randomization Phase|Trying to Get Pregnant|0
2692852|NCT00440947|9284611|P2|48-Week Randomization Phase|Trying to Get Pregnant|1
2692853|NCT00440947|9284612|P1|48-Week Randomization Phase|Trying to Get Pregnant|0
2692854|NCT00440947|9284608|P5|48-Week Randomization Phase|Incarceration|0
2692855|NCT00440947|9284609|P4|48-Week Randomization Phase|Incarceration|0
2692856|NCT00440947|9284610|P3|48-Week Randomization Phase|Incarceration|0
2692857|NCT00440947|9284611|P2|48-Week Randomization Phase|Incarceration|3
2692858|NCT00440947|9284612|P1|48-Week Randomization Phase|Incarceration|0
2692859|NCT00440947|9284608|P5|48-Week Randomization Phase|Pregnancy|0
2692860|NCT00440947|9284609|P4|48-Week Randomization Phase|Pregnancy|0
2692861|NCT00440947|9284610|P3|48-Week Randomization Phase|Pregnancy|1
2692862|NCT00440947|9284611|P2|48-Week Randomization Phase|Pregnancy|0
2692863|NCT00440947|9284612|P1|48-Week Randomization Phase|Pregnancy|0
2692864|NCT00440947|9284608|P5|48-Week Randomization Phase|Withdrawal by Subject|0
2692865|NCT00440947|9284609|P4|48-Week Randomization Phase|Withdrawal by Subject|0
2692866|NCT00440947|9284610|P3|48-Week Randomization Phase|Withdrawal by Subject|4
2692867|NCT00440947|9284611|P2|48-Week Randomization Phase|Withdrawal by Subject|2
2692868|NCT00440947|9284612|P1|48-Week Randomization Phase|Withdrawal by Subject|0
2692869|NCT00440947|9284608|P5|48-Week Randomization Phase|Protocol Violation|0
2692870|NCT00440947|9284609|P4|48-Week Randomization Phase|Protocol Violation|0
2692871|NCT00440947|9284610|P3|48-Week Randomization Phase|Protocol Violation|1
2692872|NCT00440947|9284611|P2|48-Week Randomization Phase|Protocol Violation|0
2692873|NCT00440947|9284612|P1|48-Week Randomization Phase|Protocol Violation|0
2692874|NCT00440947|9284608|P5|48-Week Randomization Phase|Lost to Follow-up|0
2692875|NCT00440947|9284609|P4|48-Week Randomization Phase|Lost to Follow-up|0
2692876|NCT00440947|9284610|P3|48-Week Randomization Phase|Lost to Follow-up|8
2692877|NCT00440947|9284611|P2|48-Week Randomization Phase|Lost to Follow-up|2
2692878|NCT00440947|9284612|P1|48-Week Randomization Phase|Lost to Follow-up|0
2692879|NCT00440947|9284608|P5|48-Week Randomization Phase|Non-compliance|0
2692880|NCT00440947|9284609|P4|48-Week Randomization Phase|Non-compliance|0
2692881|NCT00440947|9284610|P3|48-Week Randomization Phase|Non-compliance|4
2692882|NCT00440947|9284611|P2|48-Week Randomization Phase|Non-compliance|3
2692883|NCT00440947|9284612|P1|48-Week Randomization Phase|Non-compliance|0
2692884|NCT00440947|9284608|P5|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
2692885|NCT00440947|9284609|P4|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
2692886|NCT00440947|9284610|P3|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
2692887|NCT00440947|9284611|P2|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
2692888|NCT00440947|9284612|P1|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
2692889|NCT00440947|9284608|P5|48-Week Randomization Phase|Adverse Event|0
2692890|NCT00440947|9284609|P4|48-Week Randomization Phase|Adverse Event|0
2692891|NCT00440947|9284610|P3|48-Week Randomization Phase|Adverse Event|5
2692892|NCT00440947|9284611|P2|48-Week Randomization Phase|Adverse Event|2
2692893|NCT00440947|9284612|P1|48-Week Randomization Phase|Adverse Event|0
2692894|NCT00440947|9284608|P5|36-Week Induction Phase|Pregnancy|0
2692895|NCT00440947|9284609|P4|36-Week Induction Phase|Pregnancy|0
2692896|NCT00440947|9284610|P3|36-Week Induction Phase|Pregnancy|0
2692897|NCT00440947|9284611|P2|36-Week Induction Phase|Pregnancy|0
2692898|NCT00440947|9284612|P1|36-Week Induction Phase|Pregnancy|1
2692899|NCT00440947|9284608|P5|36-Week Induction Phase|Incarceration|0
2692900|NCT00440947|9284609|P4|36-Week Induction Phase|Incarceration|0
2692901|NCT00440947|9284610|P3|36-Week Induction Phase|Incarceration|0
2692902|NCT00440947|9284611|P2|36-Week Induction Phase|Incarceration|0
2692903|NCT00440947|9284612|P1|36-Week Induction Phase|Incarceration|3
2692904|NCT00440947|9284608|P5|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
2692905|NCT00440947|9284609|P4|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
2692906|NCT00440947|9284610|P3|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
2692907|NCT00440947|9284611|P2|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
2692908|NCT00440947|9284612|P1|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1
2692909|NCT00440947|9284608|P5|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
2692910|NCT00440947|9284609|P4|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
2692911|NCT00440947|9284610|P3|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
2692912|NCT00440947|9284611|P2|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
2692913|NCT00440947|9284612|P1|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1
2692914|NCT00440947|9284608|P5|36-Week Induction Phase|Took Exclusionary Medications|0
2692915|NCT00440947|9284609|P4|36-Week Induction Phase|Took Exclusionary Medications|0
2692916|NCT00440947|9284610|P3|36-Week Induction Phase|Took Exclusionary Medications|0
2692917|NCT00440947|9284611|P2|36-Week Induction Phase|Took Exclusionary Medications|0
2692918|NCT00440947|9284612|P1|36-Week Induction Phase|Took Exclusionary Medications|1
2692919|NCT00440947|9284608|P5|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
2692920|NCT00440947|9284609|P4|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
2692921|NCT00440947|9284610|P3|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
2692922|NCT00440947|9284611|P2|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
2692923|NCT00440947|9284612|P1|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1
2692924|NCT00440947|9284608|P5|36-Week Induction Phase|Withdrawal by Subject|0
2692925|NCT00440947|9284609|P4|36-Week Induction Phase|Withdrawal by Subject|0
2692926|NCT00440947|9284610|P3|36-Week Induction Phase|Withdrawal by Subject|0
2692927|NCT00440947|9284611|P2|36-Week Induction Phase|Withdrawal by Subject|0
2692928|NCT00440947|9284612|P1|36-Week Induction Phase|Withdrawal by Subject|7
2692929|NCT00440947|9284608|P5|36-Week Induction Phase|Lost to Follow-up|0
2692930|NCT00440947|9284609|P4|36-Week Induction Phase|Lost to Follow-up|0
2692931|NCT00440947|9284610|P3|36-Week Induction Phase|Lost to Follow-up|0
2692932|NCT00440947|9284611|P2|36-Week Induction Phase|Lost to Follow-up|0
2692933|NCT00440947|9284612|P1|36-Week Induction Phase|Lost to Follow-up|16
2692934|NCT00440947|9284608|P5|36-Week Induction Phase|Non-compliance|0
2692935|NCT00440947|9284609|P4|36-Week Induction Phase|Non-compliance|0
2692936|NCT00440947|9284610|P3|36-Week Induction Phase|Non-compliance|0
2692937|NCT00440947|9284611|P2|36-Week Induction Phase|Non-compliance|0
2692938|NCT00440947|9284612|P1|36-Week Induction Phase|Non-compliance|10
2692939|NCT00440947|9284608|P5|36-Week Induction Phase|Protocol-defined Virologic Failure|0
2692940|NCT00440947|9284609|P4|36-Week Induction Phase|Protocol-defined Virologic Failure|0
2692941|NCT00440947|9284610|P3|36-Week Induction Phase|Protocol-defined Virologic Failure|0
2692942|NCT00440947|9284611|P2|36-Week Induction Phase|Protocol-defined Virologic Failure|0
2692943|NCT00440947|9284612|P1|36-Week Induction Phase|Protocol-defined Virologic Failure|5
2692944|NCT00440947|9284608|P5|36-Week Induction Phase|Insufficient Viral Load Response|0
2692945|NCT00440947|9284609|P4|36-Week Induction Phase|Insufficient Viral Load Response|0
2692946|NCT00440947|9284610|P3|36-Week Induction Phase|Insufficient Viral Load Response|0
2692947|NCT00440947|9284611|P2|36-Week Induction Phase|Insufficient Viral Load Response|0
2692948|NCT00440947|9284612|P1|36-Week Induction Phase|Insufficient Viral Load Response|11
2692949|NCT00440947|9284608|P5|36-Week Induction Phase|Adverse Event|0
2692950|NCT00440947|9284609|P4|36-Week Induction Phase|Adverse Event|0
2692951|NCT00440947|9284610|P3|36-Week Induction Phase|Adverse Event|0
2692952|NCT00440947|9284611|P2|36-Week Induction Phase|Adverse Event|0
2692953|NCT00440947|9284612|P1|36-Week Induction Phase|Adverse Event|16
2692954|NCT00440726|9284687|P3|Phase 2|Adverse Event|1
2692955|NCT00440726|9284688|P2|Phase 2|Adverse Event|0
2692956|NCT00440726|9284689|P1|Phase 2|Adverse Event|0
2692957|NCT00440726|9284687|P3|Phase 2|Death|1
2692958|NCT00440726|9284688|P2|Phase 2|Death|0
2692959|NCT00440726|9284689|P1|Phase 2|Death|0
2692960|NCT00440726|9284687|P3|Phase 1|Physician Decision|0
2692961|NCT00440726|9284688|P2|Phase 1|Physician Decision|0
2692962|NCT00440726|9284689|P1|Phase 1|Physician Decision|1
2692963|NCT00440726|9284687|P3|Phase 1|Dose-Limiting Toxicity|0
2692964|NCT00440726|9284688|P2|Phase 1|Dose-Limiting Toxicity|1
2692965|NCT00440726|9284689|P1|Phase 1|Dose-Limiting Toxicity|0
2692966|NCT00440700|9284703|P3|Overall Study|Withdrawal by Subject|4
2692967|NCT00440700|9284704|P2|Overall Study|Withdrawal by Subject|8
2692968|NCT00440700|9284705|P1|Overall Study|Withdrawal by Subject|8
2692969|NCT00440557|9284728|P3|Overall Study|Patient had surgery|0
2692970|NCT00440557|9284729|P2|Overall Study|Patient had surgery|0
2692971|NCT00440557|9284730|P1|Overall Study|Patient had surgery|1
2692972|NCT00440557|9284728|P3|Overall Study|Patient transferred to nursing home|0
2692973|NCT00440557|9284729|P2|Overall Study|Patient transferred to nursing home|1
2692974|NCT00440557|9284730|P1|Overall Study|Patient transferred to nursing home|0
2692975|NCT00440557|9284728|P3|Overall Study|Principal Investigator's office closed|4
2692976|NCT00440557|9284729|P2|Overall Study|Principal Investigator's office closed|6
2692977|NCT00440557|9284730|P1|Overall Study|Principal Investigator's office closed|3
2692978|NCT00440557|9284728|P3|Overall Study|Patient moved|1
2692979|NCT00440557|9284729|P2|Overall Study|Patient moved|2
2692980|NCT00440557|9284730|P1|Overall Study|Patient moved|1
2692981|NCT00440557|9284728|P3|Overall Study|Principal Investigator decision|1
2692982|NCT00440557|9284729|P2|Overall Study|Principal Investigator decision|3
2692983|NCT00440557|9284730|P1|Overall Study|Principal Investigator decision|0
2692984|NCT00440557|9284728|P3|Overall Study|Began Dialysis|4
2692985|NCT00440557|9284729|P2|Overall Study|Began Dialysis|1
2692986|NCT00440557|9284730|P1|Overall Study|Began Dialysis|4
2692987|NCT00440557|9284728|P3|Overall Study|Death|3
2692988|NCT00440557|9284729|P2|Overall Study|Death|6
2692989|NCT00440557|9284730|P1|Overall Study|Death|2
2692990|NCT00440557|9284728|P3|Overall Study|Adverse Event|5
2692991|NCT00440557|9284729|P2|Overall Study|Adverse Event|3
2692992|NCT00440557|9284730|P1|Overall Study|Adverse Event|3
2692993|NCT00440557|9284728|P3|Overall Study|Lost to Follow-up|6
2692994|NCT00440557|9284729|P2|Overall Study|Lost to Follow-up|2
2692995|NCT00440557|9284730|P1|Overall Study|Lost to Follow-up|1
2692996|NCT00440557|9284728|P3|Overall Study|Withdrawal by Subject|11
2692997|NCT00440557|9284729|P2|Overall Study|Withdrawal by Subject|5
2692998|NCT00440557|9284730|P1|Overall Study|Withdrawal by Subject|10
2692999|NCT00440531|9284762|P3|Overall Study|see pre-assignment details|0
2693000|NCT00440531|9284763|P2|Overall Study|see pre-assignment details|0
2693001|NCT00440531|9284764|P1|Overall Study|see pre-assignment details|2
2693002|NCT00440531|9284762|P3|Overall Study|Lost to Follow-up|5
2693003|NCT00440531|9284763|P2|Overall Study|Lost to Follow-up|3
2693004|NCT00440531|9284764|P1|Overall Study|Lost to Follow-up|4
2693005|NCT00440531|9284762|P3|Overall Study|Protocol Violation|0
2693006|NCT00440531|9284763|P2|Overall Study|Protocol Violation|2
2693007|NCT00440531|9284764|P1|Overall Study|Protocol Violation|1
2693008|NCT00440531|9284762|P3|Overall Study|Withdrawal by Subject|0
2693009|NCT00440531|9284763|P2|Overall Study|Withdrawal by Subject|0
2693010|NCT00440531|9284764|P1|Overall Study|Withdrawal by Subject|2
2693011|NCT00440531|9284762|P3|Overall Study|Adverse Event|2
2693012|NCT00440531|9284763|P2|Overall Study|Adverse Event|0
2693013|NCT00440531|9284764|P1|Overall Study|Adverse Event|1
2693014|NCT00440518|9284781|P3|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0
2693015|NCT00440518|9284782|P2|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2
2693016|NCT00440518|9284783|P1|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1
2693017|NCT00440518|9284781|P3|Maintenance and Safety Follow-up Periods|Other|2
2693018|NCT00440518|9284782|P2|Maintenance and Safety Follow-up Periods|Other|0
2693019|NCT00440518|9284783|P1|Maintenance and Safety Follow-up Periods|Other|0
2693020|NCT00440518|9284781|P3|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6
2693021|NCT00440518|9284782|P2|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3
2693022|NCT00440518|9284783|P1|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0
2693023|NCT00440518|9284781|P3|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4
2693024|NCT00440518|9284782|P2|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2
2693025|NCT00440518|9284783|P1|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3
2693026|NCT00440518|9284781|P3|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
2693027|NCT00440518|9284782|P2|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
2693028|NCT00440518|9284783|P1|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0
2693029|NCT00440518|9284781|P3|Maintenance and Safety Follow-up Periods|Adverse Event|2
2693030|NCT00440518|9284782|P2|Maintenance and Safety Follow-up Periods|Adverse Event|4
2693031|NCT00440518|9284783|P1|Maintenance and Safety Follow-up Periods|Adverse Event|3
2693032|NCT00440518|9284781|P3|Randomized /Titration Period|Adverse Event|0
2693033|NCT00440518|9284782|P2|Randomized /Titration Period|Adverse Event|3
2693034|NCT00440518|9284783|P1|Randomized /Titration Period|Adverse Event|2
2693035|NCT00440518|9284781|P3|Randomized /Titration Period|Lost to Follow-up|1
2693036|NCT00440518|9284782|P2|Randomized /Titration Period|Lost to Follow-up|2
2693037|NCT00440518|9284783|P1|Randomized /Titration Period|Lost to Follow-up|2
2693038|NCT00440518|9284781|P3|Randomized /Titration Period|Other|0
2693039|NCT00440518|9284782|P2|Randomized /Titration Period|Other|0
2693040|NCT00440518|9284783|P1|Randomized /Titration Period|Other|1
2693041|NCT00440518|9284781|P3|Randomized /Titration Period|Unsatisfactory Compliance|2
2693042|NCT00440518|9284782|P2|Randomized /Titration Period|Unsatisfactory Compliance|3
2693043|NCT00440518|9284783|P1|Randomized /Titration Period|Unsatisfactory Compliance|2
2693044|NCT00440518|9284781|P3|Randomized /Titration Period|Protocol Deviation|0
2693045|NCT00440518|9284782|P2|Randomized /Titration Period|Protocol Deviation|0
2693046|NCT00440518|9284783|P1|Randomized /Titration Period|Protocol Deviation|1
2693047|NCT00440518|9284781|P3|Randomized /Titration Period|Subject Withdrew Consent|0
2693048|NCT00440518|9284782|P2|Randomized /Titration Period|Subject Withdrew Consent|1
2693049|NCT00440518|9284783|P1|Randomized /Titration Period|Subject Withdrew Consent|4
2693050|NCT00440518|9284781|P3|Randomized /Titration Period|Lack of Efficacy|1
2693051|NCT00440518|9284782|P2|Randomized /Titration Period|Lack of Efficacy|0
2693052|NCT00440518|9284783|P1|Randomized /Titration Period|Lack of Efficacy|1
2693053|NCT00440466|9284828|P3|Overall Study|Met Hemoglobin Withdrawal Criteria|4
2693054|NCT00440466|9284829|P2|Overall Study|Met Hemoglobin Withdrawal Criteria|4
2693055|NCT00440466|9284830|P1|Overall Study|Met Hemoglobin Withdrawal Criteria|0
2693056|NCT00440466|9284828|P3|Overall Study|Began Dialysis|1
2693057|NCT00440466|9284829|P2|Overall Study|Began Dialysis|0
2693058|NCT00440466|9284830|P1|Overall Study|Began Dialysis|0
2693059|NCT00440466|9284828|P3|Overall Study|Withdrawal by Subject|9
2693060|NCT00440466|9284829|P2|Overall Study|Withdrawal by Subject|5
2693061|NCT00440466|9284830|P1|Overall Study|Withdrawal by Subject|2
2693062|NCT00440466|9284828|P3|Overall Study|Protocol Violation|4
2693063|NCT00440466|9284829|P2|Overall Study|Protocol Violation|0
2693064|NCT00440466|9284830|P1|Overall Study|Protocol Violation|2
2693065|NCT00440466|9284828|P3|Overall Study|Physician Decision|1
2693066|NCT00440466|9284829|P2|Overall Study|Physician Decision|0
2693067|NCT00440466|9284830|P1|Overall Study|Physician Decision|2
2693068|NCT00440466|9284828|P3|Overall Study|Lost to Follow-up|2
2693069|NCT00440466|9284829|P2|Overall Study|Lost to Follow-up|0
2693070|NCT00440466|9284830|P1|Overall Study|Lost to Follow-up|1
2693071|NCT00440466|9284828|P3|Overall Study|Adverse Event|11
2693072|NCT00440466|9284829|P2|Overall Study|Adverse Event|4
2693073|NCT00440466|9284830|P1|Overall Study|Adverse Event|3
2693074|NCT00440466|9284828|P3|Overall Study|Death|9
2693075|NCT00440466|9284829|P2|Overall Study|Death|2
2693076|NCT00440466|9284830|P1|Overall Study|Death|3
2693077|NCT00440401|9284864|P2|Overall Study|Other|5
2693078|NCT00440401|9284865|P1|Overall Study|Other|2
2693079|NCT00440401|9284864|P2|Overall Study|Adverse Event|1
2693080|NCT00440401|9284865|P1|Overall Study|Adverse Event|2
2693081|NCT00440310|9284875|P2|Overall Study|Status Unknown|3
2693082|NCT00440310|9284876|P1|Overall Study|Status Unknown|1
2693083|NCT00440310|9284875|P2|Overall Study|Other|0
2693084|NCT00440310|9284876|P1|Overall Study|Other|1
2693085|NCT00440310|9284875|P2|Overall Study|No Reply at EOS|7
2693086|NCT00440310|9284876|P1|Overall Study|No Reply at EOS|7
2693087|NCT00440310|9284875|P2|Overall Study|Withdrawal by Subject|14
2693088|NCT00440310|9284876|P1|Overall Study|Withdrawal by Subject|15
2693089|NCT00440310|9284875|P2|Overall Study|Protocol Violation|1
2693090|NCT00440310|9284876|P1|Overall Study|Protocol Violation|0
2693091|NCT00440310|9284875|P2|Overall Study|Lost to Follow-up|5
2693092|NCT00440310|9284876|P1|Overall Study|Lost to Follow-up|4
2693093|NCT00440297|9284884|P2|Overall Study|Randomized by mistake|0
2693094|NCT00440297|9284885|P1|Overall Study|Randomized by mistake|1
2693095|NCT00440297|9284884|P2|Overall Study|Withdrawal by Subject|6
2693096|NCT00440297|9284885|P1|Overall Study|Withdrawal by Subject|1
2693097|NCT00440297|9284884|P2|Overall Study|Protocol Violation|7
2693098|NCT00440297|9284885|P1|Overall Study|Protocol Violation|11
2693099|NCT00440297|9284884|P2|Overall Study|Physician Decision|0
2693100|NCT00440297|9284885|P1|Overall Study|Physician Decision|1
2693101|NCT00440297|9284884|P2|Overall Study|Lost to Follow-up|0
2693102|NCT00440297|9284885|P1|Overall Study|Lost to Follow-up|1
2693103|NCT00440297|9284884|P2|Overall Study|Adverse Event|5
2693104|NCT00440297|9284885|P1|Overall Study|Adverse Event|8
2693105|NCT00440271|9284901|P2|Overall Study|Other|0
2693106|NCT00440271|9284902|P1|Overall Study|Other|2
2693107|NCT00440271|9284901|P2|Overall Study|Due to closure of trial|10
2693108|NCT00440271|9284902|P1|Overall Study|Due to closure of trial|8
2693109|NCT00440271|9284901|P2|Overall Study|Lack of Efficacy|1
2693110|NCT00440271|9284902|P1|Overall Study|Lack of Efficacy|0
2693111|NCT00440271|9284901|P2|Overall Study|Withdrawal by Subject|2
2693112|NCT00440271|9284902|P1|Overall Study|Withdrawal by Subject|0
2693113|NCT00440271|9284901|P2|Overall Study|Lost to Follow-up|0
2693114|NCT00440271|9284902|P1|Overall Study|Lost to Follow-up|1
2693115|NCT00440271|9284901|P2|Overall Study|Adverse Event|1
2693116|NCT00440271|9284902|P1|Overall Study|Adverse Event|0
2693117|NCT00440271|9284901|P2|Overall Study|Protocol Violation|1
2693118|NCT00440271|9284902|P1|Overall Study|Protocol Violation|1
2693119|NCT00440232|9284936|P2|Overall Study|Onset of headache within 4 hours of fast|2
2693120|NCT00440232|9284937|P1|Overall Study|Onset of headache within 4 hours of fast|2
2693121|NCT00440232|9284936|P2|Overall Study|Unable to treat within allowed time|1
2693122|NCT00440232|9284937|P1|Overall Study|Unable to treat within allowed time|0
2693123|NCT00440232|9284936|P2|Overall Study|Lost to Follow-up|1
2693124|NCT00440232|9284937|P1|Overall Study|Lost to Follow-up|1
2693125|NCT00440193|9284947|P2|Observational Period|Participant convenience|0
2693126|NCT00440193|9284948|P1|Observational Period|Participant convenience|2
2693127|NCT00440193|9284947|P2|Observational Period|Clinical endpoint reached|0
2693128|NCT00440193|9284948|P1|Observational Period|Clinical endpoint reached|1
2693129|NCT00440193|9284947|P2|Observational Period|Physician Decision|0
2693130|NCT00440193|9284948|P1|Observational Period|Physician Decision|1
2693131|NCT00440193|9284947|P2|Observational Period|Withdrawal by Subject|8
2693132|NCT00440193|9284948|P1|Observational Period|Withdrawal by Subject|11
2693133|NCT00440193|9284947|P2|Observational Period|Protocol Violation|0
2693134|NCT00440193|9284948|P1|Observational Period|Protocol Violation|1
2693135|NCT00440193|9284947|P2|Observational Period|Lost to Follow-up|8
2693136|NCT00440193|9284948|P1|Observational Period|Lost to Follow-up|12
2693137|NCT00440193|9284947|P2|Observational Period|Death|20
2693138|NCT00440193|9284948|P1|Observational Period|Death|15
2693139|NCT00440193|9284947|P2|Observational Period|Adverse Event|2
2693140|NCT00440193|9284948|P1|Observational Period|Adverse Event|2
2693141|NCT00440193|9284947|P2|Treatment Period|Site closed by investigator|2
2693142|NCT00440193|9284948|P1|Treatment Period|Site closed by investigator|0
2693143|NCT00440193|9284947|P2|Treatment Period|Participant did not receive treatment|13
2693144|NCT00440193|9284948|P1|Treatment Period|Participant did not receive treatment|7
2693145|NCT00440193|9284947|P2|Treatment Period|Participant convenience|2
2693146|NCT00440193|9284948|P1|Treatment Period|Participant convenience|5
2693147|NCT00440193|9284947|P2|Treatment Period|Technical problems|1
2693148|NCT00440193|9284948|P1|Treatment Period|Technical problems|1
2693149|NCT00440193|9284947|P2|Treatment Period|Switch to commercial drug|2
2693150|NCT00440193|9284948|P1|Treatment Period|Switch to commercial drug|0
2693151|NCT00440193|9284947|P2|Treatment Period|Protocol driven decision point|2
2693152|NCT00440193|9284948|P1|Treatment Period|Protocol driven decision point|2
2693153|NCT00440193|9284947|P2|Treatment Period|Study terminated by sponsor|94
2693154|NCT00440193|9284948|P1|Treatment Period|Study terminated by sponsor|102
2693155|NCT00440193|9284947|P2|Treatment Period|Clinical endpoint reached|25
2693156|NCT00440193|9284948|P1|Treatment Period|Clinical endpoint reached|28
2693157|NCT00440193|9284947|P2|Treatment Period|Withdrawal by Subject|77
2693158|NCT00440193|9284948|P1|Treatment Period|Withdrawal by Subject|36
2693159|NCT00440193|9284947|P2|Treatment Period|Protocol Violation|19
2693160|NCT00440193|9284948|P1|Treatment Period|Protocol Violation|16
2693161|NCT00440193|9284947|P2|Treatment Period|Physician Decision|6
2693162|NCT00440193|9284948|P1|Treatment Period|Physician Decision|3
2693163|NCT00440193|9284947|P2|Treatment Period|Lost to Follow-up|18
2693164|NCT00440193|9284948|P1|Treatment Period|Lost to Follow-up|12
2693165|NCT00440193|9284947|P2|Treatment Period|Lack of Efficacy|1
2693166|NCT00440193|9284948|P1|Treatment Period|Lack of Efficacy|0
2693167|NCT00440193|9284947|P2|Treatment Period|Death|22
2693168|NCT00440193|9284948|P1|Treatment Period|Death|19
2693169|NCT00440193|9284947|P2|Treatment Period|Adverse Event|67
2693170|NCT00440193|9284948|P1|Treatment Period|Adverse Event|74
2693171|NCT00440115|9284994|P3|Overall Study|Incarceration|1
2693172|NCT00440115|9284995|P2|Overall Study|Incarceration|2
2693173|NCT00440115|9284996|P1|Overall Study|Incarceration|0
2693174|NCT00440115|9284994|P3|Overall Study|Death|5
2693175|NCT00440115|9284995|P2|Overall Study|Death|9
2693176|NCT00440115|9284996|P1|Overall Study|Death|7
2693177|NCT00440037|9285025|P1|Overall Study|Administrative decision|3
2693178|NCT00440037|9285025|P1|Overall Study|Withdrawal by Subject|6
2693179|NCT00440011|9285035|P2|Overall Study|Withdrawal by Subject|0
2693180|NCT00440011|9285036|P1|Overall Study|Withdrawal by Subject|1
2693181|NCT00440011|9285035|P2|Overall Study|Protocol Violation|1
2693182|NCT00440011|9285036|P1|Overall Study|Protocol Violation|1
2693183|NCT00440011|9285035|P2|Overall Study|Lost to Follow-up|2
2693184|NCT00440011|9285036|P1|Overall Study|Lost to Follow-up|0
2693185|NCT00440011|9285035|P2|Overall Study|Adverse Event|0
2693186|NCT00440011|9285036|P1|Overall Study|Adverse Event|2
2693187|NCT00439777|9285063|P2|Observational Period|Technical problems|1
2693188|NCT00439777|9285064|P1|Observational Period|Technical problems|0
2693189|NCT00439777|9285063|P2|Observational Period|Lack of Efficacy|0
2693190|NCT00439777|9285064|P1|Observational Period|Lack of Efficacy|1
2693191|NCT00439777|9285063|P2|Observational Period|Protocol driven decision point|1
2693192|NCT00439777|9285064|P1|Observational Period|Protocol driven decision point|0
2693193|NCT00439777|9285063|P2|Observational Period|Study terminated by sponsor|1
2693194|NCT00439777|9285064|P1|Observational Period|Study terminated by sponsor|3
2693195|NCT00439777|9285063|P2|Observational Period|Death|20
2693196|NCT00439777|9285064|P1|Observational Period|Death|27
2693197|NCT00439777|9285063|P2|Observational Period|Lost to Follow-up|11
2693198|NCT00439777|9285064|P1|Observational Period|Lost to Follow-up|1
2693199|NCT00439777|9285063|P2|Observational Period|Withdrawal by Subject|5
2693200|NCT00439777|9285064|P1|Observational Period|Withdrawal by Subject|9
2693201|NCT00439777|9285063|P2|Observational Period|Protocol Violation|2
2693202|NCT00439777|9285064|P1|Observational Period|Protocol Violation|0
2693203|NCT00439777|9285063|P2|Treatment Period|Participant convenience|8
2693204|NCT00439777|9285064|P1|Treatment Period|Participant convenience|12
2693205|NCT00439777|9285063|P2|Treatment Period|Technical problems|1
2693206|NCT00439777|9285064|P1|Treatment Period|Technical problems|3
2693207|NCT00439777|9285063|P2|Treatment Period|Clinical endpoint reached|13
2693208|NCT00439777|9285064|P1|Treatment Period|Clinical endpoint reached|26
2693209|NCT00439777|9285063|P2|Treatment Period|Physician Decision|18
2693210|NCT00439777|9285064|P1|Treatment Period|Physician Decision|7
2693211|NCT00439777|9285063|P2|Treatment Period|Protocol driven decision point|3
2693212|NCT00439777|9285064|P1|Treatment Period|Protocol driven decision point|1
2693213|NCT00439777|9285063|P2|Treatment Period|Lost to Follow-up|10
2693214|NCT00439777|9285064|P1|Treatment Period|Lost to Follow-up|8
2693215|NCT00439777|9285063|P2|Treatment Period|Lack of Efficacy|4
2693216|NCT00439777|9285064|P1|Treatment Period|Lack of Efficacy|1
2693217|NCT00439777|9285063|P2|Treatment Period|Withdrawal by Subject|118
2693218|NCT00439777|9285064|P1|Treatment Period|Withdrawal by Subject|66
2693219|NCT00439777|9285063|P2|Treatment Period|Protocol Violation|30
2693220|NCT00439777|9285064|P1|Treatment Period|Protocol Violation|23
2693221|NCT00439777|9285063|P2|Treatment Period|Adverse Event|92
2693222|NCT00439777|9285064|P1|Treatment Period|Adverse Event|111
2693223|NCT00439777|9285063|P2|Treatment Period|Did not take study treatment|8
2693224|NCT00439777|9285064|P1|Treatment Period|Did not take study treatment|7
2693225|NCT00439777|9285063|P2|Treatment Period|Site closed by investigator|1
2693226|NCT00439777|9285064|P1|Treatment Period|Site closed by investigator|0
2693227|NCT00439777|9285063|P2|Treatment Period|Study terminated by sponsor|132
2693228|NCT00439777|9285064|P1|Treatment Period|Study terminated by sponsor|125
2693229|NCT00439777|9285063|P2|Treatment Period|Death|21
2693230|NCT00439777|9285064|P1|Treatment Period|Death|29
2693231|NCT00439738|9285102|P2|Overall Study|Abnormal Lab Values|0
2693232|NCT00439738|9285103|P1|Overall Study|Abnormal Lab Values|1
2693233|NCT00439738|9285102|P2|Overall Study|Lack of Efficacy|2
2693234|NCT00439738|9285103|P1|Overall Study|Lack of Efficacy|2
2693235|NCT00439738|9285102|P2|Overall Study|Protocol Violation|3
2693236|NCT00439738|9285103|P1|Overall Study|Protocol Violation|6
2693237|NCT00439738|9285102|P2|Overall Study|Lost to Follow-up|6
2693238|NCT00439738|9285103|P1|Overall Study|Lost to Follow-up|5
2693239|NCT00439738|9285102|P2|Overall Study|Adverse Event|4
2693240|NCT00439738|9285103|P1|Overall Study|Adverse Event|6
2693241|NCT00439738|9285102|P2|Overall Study|Withdrawal by Subject|13
2693242|NCT00439738|9285103|P1|Overall Study|Withdrawal by Subject|16
2693243|NCT00439725|9285121|P2|Observational Period|Participant convenience|0
2693244|NCT00439725|9285122|P1|Observational Period|Participant convenience|1
2693245|NCT00439725|9285121|P2|Observational Period|Technical problems|0
2693246|NCT00439725|9285122|P1|Observational Period|Technical problems|1
2693247|NCT00439725|9285121|P2|Observational Period|Clinical endpoint reached|1
2693248|NCT00439725|9285122|P1|Observational Period|Clinical endpoint reached|3
2693249|NCT00439725|9285121|P2|Observational Period|Study termination by sponsor|1
2693250|NCT00439725|9285122|P1|Observational Period|Study termination by sponsor|1
2693251|NCT00439725|9285121|P2|Observational Period|Death|2
2693252|NCT00439725|9285122|P1|Observational Period|Death|0
2693253|NCT00439725|9285121|P2|Observational Period|Lost to Follow-up|1
2693254|NCT00439725|9285122|P1|Observational Period|Lost to Follow-up|0
2693255|NCT00439725|9285121|P2|Observational Period|Withdrawal by Subject|2
2693256|NCT00439725|9285122|P1|Observational Period|Withdrawal by Subject|2
2693257|NCT00439725|9285121|P2|Treatment Period|Participant did not receive treatment|4
2693258|NCT00439725|9285122|P1|Treatment Period|Participant did not receive treatment|4
2693259|NCT00439725|9285121|P2|Treatment Period|Death|1
2693260|NCT00439725|9285122|P1|Treatment Period|Death|1
2693261|NCT00439725|9285121|P2|Treatment Period|Protocol driven decision point|1
2693262|NCT00439725|9285122|P1|Treatment Period|Protocol driven decision point|1
2693263|NCT00439725|9285121|P2|Treatment Period|Participant convenience|0
2693264|NCT00439725|9285122|P1|Treatment Period|Participant convenience|1
2693265|NCT00439725|9285121|P2|Treatment Period|Lost to Follow-up|1
2693266|NCT00439725|9285122|P1|Treatment Period|Lost to Follow-up|1
2693267|NCT00439725|9285121|P2|Treatment Period|Technical problems|0
2693268|NCT00439725|9285122|P1|Treatment Period|Technical problems|1
2693269|NCT00439725|9285121|P2|Treatment Period|Clinical endpoint reached|50
2693270|NCT00439725|9285122|P1|Treatment Period|Clinical endpoint reached|6
2693271|NCT00439725|9285121|P2|Treatment Period|Protocol Violation|1
2693272|NCT00439725|9285122|P1|Treatment Period|Protocol Violation|2
2693273|NCT00439725|9285121|P2|Treatment Period|Physician Decision|1
2693274|NCT00439725|9285122|P1|Treatment Period|Physician Decision|1
2693275|NCT00439725|9285121|P2|Treatment Period|Adverse Event|18
2693276|NCT00439725|9285122|P1|Treatment Period|Adverse Event|39
2693277|NCT00439725|9285121|P2|Treatment Period|Site closed by investigator|2
2693278|NCT00439725|9285122|P1|Treatment Period|Site closed by investigator|1
2693279|NCT00439725|9285121|P2|Treatment Period|Study terminated by sponsor|148
2693280|NCT00439725|9285122|P1|Treatment Period|Study terminated by sponsor|156
2693281|NCT00439725|9285121|P2|Treatment Period|Withdrawal by Subject|19
2693282|NCT00439725|9285122|P1|Treatment Period|Withdrawal by Subject|22
2693283|NCT00439647|9285173|P2|Overall Study|Lack of Efficacy|4
2693284|NCT00439647|9285174|P1|Overall Study|Lack of Efficacy|0
2693285|NCT00439647|9285173|P2|Overall Study|Protocol Violation|4
2693286|NCT00439647|9285174|P1|Overall Study|Protocol Violation|3
2693287|NCT00439647|9285173|P2|Overall Study|Lost to Follow-up|12
2693288|NCT00439647|9285174|P1|Overall Study|Lost to Follow-up|4
2693289|NCT00439647|9285173|P2|Overall Study|Adverse Event|11
2693290|NCT00439647|9285174|P1|Overall Study|Adverse Event|11
2693291|NCT00439647|9285173|P2|Overall Study|Death|18
2693292|NCT00439647|9285174|P1|Overall Study|Death|15
2693293|NCT00439647|9285173|P2|Overall Study|Withdrawal by Subject|22
2693294|NCT00439647|9285174|P1|Overall Study|Withdrawal by Subject|25
2693295|NCT00439569|9285211|P1|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1
2693296|NCT00439569|9285211|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3
2693297|NCT00439569|9285211|P1|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1
2693298|NCT00439556|9285225|P3|Overall Study|Patient was taken off study for non-comp|0
2693299|NCT00439556|9285226|P2|Overall Study|Patient was taken off study for non-comp|1
2693300|NCT00439556|9285227|P1|Overall Study|Patient was taken off study for non-comp|0
2693301|NCT00439517|9285240|P2|Overall Study|Subject in survival follow-up|0
2693302|NCT00439517|9285241|P1|Overall Study|Subject in survival follow-up|1
2693303|NCT00439517|9285240|P2|Overall Study|Subject on treatment|0
2693304|NCT00439517|9285241|P1|Overall Study|Subject on treatment|1
2693305|NCT00439309|9285380|P2|Follow-Up|Late response by subject|1
2693306|NCT00439309|9285381|P1|Follow-Up|Late response by subject|0
2693307|NCT00439309|9285380|P2|Follow-Up|Withdrawal by Subject|1
2693308|NCT00439309|9285381|P1|Follow-Up|Withdrawal by Subject|0
2693309|NCT00439309|9285380|P2|Follow-Up|Lost to Follow-up|0
2693310|NCT00439309|9285381|P1|Follow-Up|Lost to Follow-up|2
2693311|NCT00439309|9285380|P2|Follow-Up|Death|0
2693312|NCT00439309|9285381|P1|Follow-Up|Death|1
2693313|NCT00439270|9285400|P5|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
2693314|NCT00439270|9285401|P4|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1
2693315|NCT00439270|9285402|P3|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
2693316|NCT00439270|9285403|P2|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
2693317|NCT00439270|9285404|P1|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
2693318|NCT00439270|9285400|P5|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
2693319|NCT00439270|9285401|P4|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2
2693320|NCT00439270|9285402|P3|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
2693321|NCT00439270|9285403|P2|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
2693322|NCT00439270|9285404|P1|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
2693323|NCT00439270|9285400|P5|Phase 2 (51.6 Months)|Withdrawal by Subject|0
2693324|NCT00439270|9285401|P4|Phase 2 (51.6 Months)|Withdrawal by Subject|2
2693325|NCT00439270|9285402|P3|Phase 2 (51.6 Months)|Withdrawal by Subject|0
2693326|NCT00439270|9285403|P2|Phase 2 (51.6 Months)|Withdrawal by Subject|0
2693327|NCT00439270|9285404|P1|Phase 2 (51.6 Months)|Withdrawal by Subject|0
2693328|NCT00439270|9285400|P5|Phase 2 (51.6 Months)|No longer meets study criteria|0
2693329|NCT00439270|9285401|P4|Phase 2 (51.6 Months)|No longer meets study criteria|1
2693330|NCT00439270|9285402|P3|Phase 2 (51.6 Months)|No longer meets study criteria|0
2693331|NCT00439270|9285403|P2|Phase 2 (51.6 Months)|No longer meets study criteria|0
2693332|NCT00439270|9285404|P1|Phase 2 (51.6 Months)|No longer meets study criteria|0
2693333|NCT00439270|9285400|P5|Phase 2 (51.6 Months)|Maximum clinical benefit|0
2693334|NCT00439270|9285401|P4|Phase 2 (51.6 Months)|Maximum clinical benefit|3
2693335|NCT00439270|9285402|P3|Phase 2 (51.6 Months)|Maximum clinical benefit|0
2693336|NCT00439270|9285403|P2|Phase 2 (51.6 Months)|Maximum clinical benefit|0
2693337|NCT00439270|9285404|P1|Phase 2 (51.6 Months)|Maximum clinical benefit|0
2693338|NCT00439270|9285400|P5|Phase 2 (51.6 Months)|Study drug toxicity|0
2693339|NCT00439270|9285401|P4|Phase 2 (51.6 Months)|Study drug toxicity|6
2693340|NCT00439270|9285402|P3|Phase 2 (51.6 Months)|Study drug toxicity|0
2693341|NCT00439270|9285403|P2|Phase 2 (51.6 Months)|Study drug toxicity|0
2693342|NCT00439270|9285404|P1|Phase 2 (51.6 Months)|Study drug toxicity|0
2693343|NCT00439270|9285400|P5|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
2693344|NCT00439270|9285401|P4|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1
2693345|NCT00439270|9285402|P3|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
2693346|NCT00439270|9285403|P2|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
2693347|NCT00439270|9285404|P1|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
2693348|NCT00439270|9285400|P5|Phase 2 (51.6 Months)|Disease progression|0
2693349|NCT00439270|9285401|P4|Phase 2 (51.6 Months)|Disease progression|18
2693350|NCT00439270|9285402|P3|Phase 2 (51.6 Months)|Disease progression|0
2693351|NCT00439270|9285403|P2|Phase 2 (51.6 Months)|Disease progression|0
2693352|NCT00439270|9285404|P1|Phase 2 (51.6 Months)|Disease progression|0
2693353|NCT00439270|9285400|P5|Phase 1 (18.1 Months)|Study drug toxicity|0
2693354|NCT00439270|9285401|P4|Phase 1 (18.1 Months)|Study drug toxicity|0
2693355|NCT00439270|9285402|P3|Phase 1 (18.1 Months)|Study drug toxicity|0
2693356|NCT00439270|9285403|P2|Phase 1 (18.1 Months)|Study drug toxicity|1
2693357|NCT00439270|9285404|P1|Phase 1 (18.1 Months)|Study drug toxicity|0
2693358|NCT00439270|9285400|P5|Phase 1 (18.1 Months)|Disease progression|3
2693359|NCT00439270|9285401|P4|Phase 1 (18.1 Months)|Disease progression|0
2693360|NCT00439270|9285402|P3|Phase 1 (18.1 Months)|Disease progression|3
2693361|NCT00439270|9285403|P2|Phase 1 (18.1 Months)|Disease progression|2
2693362|NCT00439270|9285404|P1|Phase 1 (18.1 Months)|Disease progression|3
2693363|NCT00439244|9285446|P3|Overall Study|Administrative problems|0
2693364|NCT00439244|9285447|P2|Overall Study|Administrative problems|0
2693365|NCT00439244|9285448|P1|Overall Study|Administrative problems|1
2693366|NCT00439244|9285446|P3|Overall Study|Protocol Violation|0
2693367|NCT00439244|9285447|P2|Overall Study|Protocol Violation|1
2693368|NCT00439244|9285448|P1|Overall Study|Protocol Violation|0
2693369|NCT00439244|9285446|P3|Overall Study|Death|0
2693370|NCT00439244|9285447|P2|Overall Study|Death|1
2693371|NCT00439244|9285448|P1|Overall Study|Death|0
2693372|NCT00439244|9285446|P3|Overall Study|Lost to Follow-up|2
2693373|NCT00439244|9285447|P2|Overall Study|Lost to Follow-up|1
2693374|NCT00439244|9285448|P1|Overall Study|Lost to Follow-up|2
2693375|NCT00439244|9285446|P3|Overall Study|Withdrawal by Subject|2
2693376|NCT00439244|9285447|P2|Overall Study|Withdrawal by Subject|1
2693377|NCT00439244|9285448|P1|Overall Study|Withdrawal by Subject|3
2693378|NCT00439244|9285446|P3|Overall Study|Adverse Event|3
2693379|NCT00439244|9285447|P2|Overall Study|Adverse Event|2
2693380|NCT00439244|9285448|P1|Overall Study|Adverse Event|5
2693381|NCT00439231|9285468|P1|Overall Study|Lack of Efficacy|28
2693382|NCT00439218|9285472|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1
2693383|NCT00439179|9285487|P4|Overall Study|* 1 pt inelig, 1 pt numb not used|0
2693384|NCT00439179|9285488|P3|Overall Study|* 1 pt inelig, 1 pt numb not used|0
2693385|NCT00439179|9285489|P2|Overall Study|* 1 pt inelig, 1 pt numb not used|2
2693386|NCT00439179|9285490|P1|Overall Study|* 1 pt inelig, 1 pt numb not used|0
2693387|NCT00439140|9285507|P3|Treatment Cycle 2|Lost to Follow-up|0
2693388|NCT00439140|9285508|P2|Treatment Cycle 2|Lost to Follow-up|1
2693389|NCT00439140|9285509|P1|Treatment Cycle 2|Lost to Follow-up|1
2693390|NCT00439140|9285507|P3|Treatment Cycle 2|Withdrawal by Subject|0
2693391|NCT00439140|9285508|P2|Treatment Cycle 2|Withdrawal by Subject|0
2693392|NCT00439140|9285509|P1|Treatment Cycle 2|Withdrawal by Subject|1
2693393|NCT00439140|9285507|P3|Treatment Cycle 1|Withdrawal by Subject|0
2693394|NCT00439140|9285508|P2|Treatment Cycle 1|Withdrawal by Subject|1
2693395|NCT00439140|9285509|P1|Treatment Cycle 1|Withdrawal by Subject|0
2693396|NCT00439140|9285507|P3|Treatment Cycle 1|Personal reasons|0
2693397|NCT00439140|9285508|P2|Treatment Cycle 1|Personal reasons|2
2693398|NCT00439140|9285509|P1|Treatment Cycle 1|Personal reasons|0
2693399|NCT00439140|9285507|P3|Treatment Cycle 1|Lost to Follow-up|1
2693400|NCT00439140|9285508|P2|Treatment Cycle 1|Lost to Follow-up|1
2693401|NCT00439140|9285509|P1|Treatment Cycle 1|Lost to Follow-up|1
2693402|NCT00438815|9285592|P1|Overall Study|Death|1
2693403|NCT00438815|9285592|P1|Overall Study|Withdrawal by Subject|6
2693404|NCT00438815|9285592|P1|Overall Study|Lost to Follow-up|6
2693405|NCT00438815|9285592|P1|Overall Study|Transitioned to commercial C1INH-nf|6
2693406|NCT00438815|9285592|P1|Overall Study|Noncompliance with protocol requirements|9
2693407|NCT00438815|9285592|P1|Overall Study|3-month follow-up no longer required|12
2693408|NCT00438815|9285592|P1|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30
2693409|NCT00438672|9285642|P2|Overall Study|Lost to Follow-up|9
2693410|NCT00438672|9285643|P1|Overall Study|Lost to Follow-up|7
2693411|NCT00438659|9285653|P2|Overall Study|Cancel|2
2693412|NCT00438659|9285654|P1|Overall Study|Cancel|5
2693413|NCT00438659|9285653|P2|Overall Study|Discontinued Mometasone/Placebo|2
2693414|NCT00438659|9285654|P1|Overall Study|Discontinued Mometasone/Placebo|1
2693415|NCT00438633|9285678|P2|Overall Study|Lost to Follow-up|17
2693416|NCT00438633|9285679|P1|Overall Study|Lost to Follow-up|15
2693417|NCT00438633|9285678|P2|Overall Study|Withdrawal by Subject|0
2693418|NCT00438633|9285679|P1|Overall Study|Withdrawal by Subject|1
2693419|NCT00438464|9285710|P2|Overall Study|Incomplete data submission|2
2693420|NCT00438464|9285711|P1|Overall Study|Incomplete data submission|0
2693421|NCT00438464|9285710|P2|Overall Study|Terminated Early|5
2693422|NCT00438464|9285711|P1|Overall Study|Terminated Early|14
2693423|NCT00438399|9285812|P6|Overall Study|Patien stopped study at visit 4 by error|0
2693424|NCT00438399|9285813|P5|Overall Study|Patien stopped study at visit 4 by error|0
2693425|NCT00438399|9285814|P4|Overall Study|Patien stopped study at visit 4 by error|0
2693426|NCT00438399|9285815|P3|Overall Study|Patien stopped study at visit 4 by error|0
2693427|NCT00438399|9285816|P2|Overall Study|Patien stopped study at visit 4 by error|0
2693428|NCT00438399|9285817|P1|Overall Study|Patien stopped study at visit 4 by error|1
2693429|NCT00438399|9285812|P6|Overall Study|Pregnancy|1
2693430|NCT00438399|9285813|P5|Overall Study|Pregnancy|0
2693431|NCT00438399|9285814|P4|Overall Study|Pregnancy|0
2693432|NCT00438399|9285815|P3|Overall Study|Pregnancy|0
2693433|NCT00438399|9285816|P2|Overall Study|Pregnancy|0
2693434|NCT00438399|9285817|P1|Overall Study|Pregnancy|0
2693435|NCT00438399|9285812|P6|Overall Study|Subje stopped study|0
2693436|NCT00438399|9285813|P5|Overall Study|Subje stopped study|0
2693437|NCT00438399|9285814|P4|Overall Study|Subje stopped study|0
2693438|NCT00438399|9285815|P3|Overall Study|Subje stopped study|1
2693439|NCT00438399|9285816|P2|Overall Study|Subje stopped study|0
2693440|NCT00438399|9285817|P1|Overall Study|Subje stopped study|0
2693441|NCT00438399|9285812|P6|Overall Study|Protocol Violation|1
2693442|NCT00438399|9285813|P5|Overall Study|Protocol Violation|0
2693443|NCT00438399|9285814|P4|Overall Study|Protocol Violation|0
2693444|NCT00438399|9285815|P3|Overall Study|Protocol Violation|1
2693445|NCT00438399|9285816|P2|Overall Study|Protocol Violation|0
2693446|NCT00438399|9285817|P1|Overall Study|Protocol Violation|0
2693447|NCT00438399|9285812|P6|Overall Study|Withdrawal by Subject|2
2693448|NCT00438399|9285813|P5|Overall Study|Withdrawal by Subject|2
2693449|NCT00438399|9285814|P4|Overall Study|Withdrawal by Subject|2
2693450|NCT00438399|9285815|P3|Overall Study|Withdrawal by Subject|3
2693451|NCT00438399|9285816|P2|Overall Study|Withdrawal by Subject|6
2693452|NCT00438399|9285817|P1|Overall Study|Withdrawal by Subject|5
2693453|NCT00438399|9285812|P6|Overall Study|Adverse Event|1
2693454|NCT00438399|9285813|P5|Overall Study|Adverse Event|0
2693455|NCT00438399|9285814|P4|Overall Study|Adverse Event|1
2693456|NCT00438399|9285815|P3|Overall Study|Adverse Event|1
2693457|NCT00438399|9285816|P2|Overall Study|Adverse Event|0
2693458|NCT00438399|9285817|P1|Overall Study|Adverse Event|0
2693459|NCT00438399|9285812|P6|Overall Study|Lost to Follow-up|1
2693460|NCT00438399|9285813|P5|Overall Study|Lost to Follow-up|1
2693461|NCT00438399|9285814|P4|Overall Study|Lost to Follow-up|1
2693462|NCT00438399|9285815|P3|Overall Study|Lost to Follow-up|1
2693463|NCT00438399|9285816|P2|Overall Study|Lost to Follow-up|2
2693464|NCT00438399|9285817|P1|Overall Study|Lost to Follow-up|2
2693465|NCT00438360|9285828|P2|Overall Study|Other|15
2693466|NCT00438360|9285829|P1|Overall Study|Other|24
2693467|NCT00438360|9285828|P2|Overall Study|Lack of Efficacy|27
2693468|NCT00438360|9285829|P1|Overall Study|Lack of Efficacy|42
2693469|NCT00438360|9285828|P2|Overall Study|Adverse Event|1
2693470|NCT00438360|9285829|P1|Overall Study|Adverse Event|6
2693471|NCT00438256|9285843|P4|Overall Study|Excluded final Diagnosis|2
2693472|NCT00438256|9285844|P3|Overall Study|Excluded final Diagnosis|0
2693473|NCT00438256|9285845|P2|Overall Study|Excluded final Diagnosis|0
2693474|NCT00438256|9285846|P1|Overall Study|Excluded final Diagnosis|0
2693475|NCT00438256|9285843|P4|Overall Study|Ineligible for Resection|7
2693476|NCT00438256|9285844|P3|Overall Study|Ineligible for Resection|1
2693477|NCT00438256|9285845|P2|Overall Study|Ineligible for Resection|1
2693478|NCT00438256|9285846|P1|Overall Study|Ineligible for Resection|2
2693479|NCT00437983|9285896|P2|Overall Study|Withdrawal by Subject|6
2693480|NCT00437983|9285897|P1|Overall Study|Withdrawal by Subject|5
2693481|NCT00437983|9285896|P2|Overall Study|Protocol Violation|1
2693482|NCT00437983|9285897|P1|Overall Study|Protocol Violation|2
2693483|NCT00437983|9285896|P2|Overall Study|Adverse Event|6
2693484|NCT00437983|9285897|P1|Overall Study|Adverse Event|6
2693485|NCT00437658|9285910|P3|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
2693486|NCT00437658|9285911|P2|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
2693487|NCT00437658|9285912|P1|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3
2693488|NCT00437658|9285910|P3|Post-treatment Period (24 Weeks)|Lost to Follow-up|1
2693489|NCT00437658|9285911|P2|Post-treatment Period (24 Weeks)|Lost to Follow-up|0
2693490|NCT00437658|9285912|P1|Post-treatment Period (24 Weeks)|Lost to Follow-up|5
2693491|NCT00437658|9285910|P3|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
2693492|NCT00437658|9285911|P2|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
2693493|NCT00437658|9285912|P1|Post-treatment Period (24 Weeks)|Lack of Efficacy|0
2693494|NCT00437658|9285910|P3|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8
2693495|NCT00437658|9285911|P2|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6
2693496|NCT00437658|9285912|P1|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12
2693497|NCT00437658|9285910|P3|Post-treatment Period (24 Weeks)|Non-compliance|1
2693498|NCT00437658|9285911|P2|Post-treatment Period (24 Weeks)|Non-compliance|0
2693499|NCT00437658|9285912|P1|Post-treatment Period (24 Weeks)|Non-compliance|3
2693500|NCT00437658|9285910|P3|Post-treatment Period (24 Weeks)|Adverse Event|1
2693501|NCT00437658|9285911|P2|Post-treatment Period (24 Weeks)|Adverse Event|0
2693502|NCT00437658|9285912|P1|Post-treatment Period (24 Weeks)|Adverse Event|1
2693503|NCT00437658|9285910|P3|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
2693504|NCT00437658|9285911|P2|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
2693505|NCT00437658|9285912|P1|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5
2693506|NCT00437658|9285910|P3|Treatment Period (24 Weeks)|Lost to Follow-up|5
2693507|NCT00437658|9285911|P2|Treatment Period (24 Weeks)|Lost to Follow-up|4
2693508|NCT00437658|9285912|P1|Treatment Period (24 Weeks)|Lost to Follow-up|5
2693509|NCT00437658|9285910|P3|Treatment Period (24 Weeks)|Lack of Efficacy|3
2693510|NCT00437658|9285911|P2|Treatment Period (24 Weeks)|Lack of Efficacy|2
2693511|NCT00437658|9285912|P1|Treatment Period (24 Weeks)|Lack of Efficacy|4
2693512|NCT00437658|9285910|P3|Treatment Period (24 Weeks)|Withdrawal by Subject|7
2693513|NCT00437658|9285911|P2|Treatment Period (24 Weeks)|Withdrawal by Subject|7
2693514|NCT00437658|9285912|P1|Treatment Period (24 Weeks)|Withdrawal by Subject|9
2693515|NCT00437658|9285910|P3|Treatment Period (24 Weeks)|Non-compliance|4
2693516|NCT00437658|9285911|P2|Treatment Period (24 Weeks)|Non-compliance|1
2693517|NCT00437658|9285912|P1|Treatment Period (24 Weeks)|Non-compliance|1
2693518|NCT00437658|9285910|P3|Treatment Period (24 Weeks)|Adverse Event|14
2693519|NCT00437658|9285911|P2|Treatment Period (24 Weeks)|Adverse Event|7
2693520|NCT00437658|9285912|P1|Treatment Period (24 Weeks)|Adverse Event|4
2693521|NCT00437645|9286006|P2|Overall Study|Condition no longer requires study drug|1
2693522|NCT00437645|9286007|P1|Overall Study|Condition no longer requires study drug|1
2693523|NCT00437645|9286006|P2|Overall Study|Lack of Efficacy|1
2693524|NCT00437645|9286007|P1|Overall Study|Lack of Efficacy|2
2693525|NCT00437645|9286006|P2|Overall Study|Administrative problems|1
2693526|NCT00437645|9286007|P1|Overall Study|Administrative problems|2
2693527|NCT00437645|9286006|P2|Overall Study|Lost to Follow-up|3
2693528|NCT00437645|9286007|P1|Overall Study|Lost to Follow-up|2
2693529|NCT00437645|9286006|P2|Overall Study|Protocol Violation|3
2693530|NCT00437645|9286007|P1|Overall Study|Protocol Violation|3
2693531|NCT00437645|9286006|P2|Overall Study|Withdrawal by Subject|22
2693532|NCT00437645|9286007|P1|Overall Study|Withdrawal by Subject|10
2693533|NCT00437645|9286006|P2|Overall Study|Adverse Event|84
2693534|NCT00437645|9286007|P1|Overall Study|Adverse Event|15
2693535|NCT00437489|9286023|P2|Overall Study|Lost to Follow-up|1
2693536|NCT00437489|9286024|P1|Overall Study|Lost to Follow-up|0
2693537|NCT00437489|9286023|P2|Overall Study|Study terminated by sponsor|21
2693538|NCT00437489|9286024|P1|Overall Study|Study terminated by sponsor|23
2693539|NCT00437281|9286061|P20|Overall Study|Lost to Follow-up|1
2693540|NCT00437281|9286062|P19|Overall Study|Lost to Follow-up|0
2693541|NCT00437281|9286063|P18|Overall Study|Lost to Follow-up|0
2693542|NCT00437281|9286064|P17|Overall Study|Lost to Follow-up|0
2693543|NCT00437281|9286065|P16|Overall Study|Lost to Follow-up|0
2693544|NCT00437281|9286066|P15|Overall Study|Lost to Follow-up|0
2693545|NCT00437281|9286067|P14|Overall Study|Lost to Follow-up|0
2693546|NCT00437281|9286068|P13|Overall Study|Lost to Follow-up|0
2693547|NCT00437281|9286069|P12|Overall Study|Lost to Follow-up|0
2693548|NCT00437281|9286070|P11|Overall Study|Lost to Follow-up|0
2693549|NCT00437281|9286071|P10|Overall Study|Lost to Follow-up|0
2693550|NCT00437281|9286072|P9|Overall Study|Lost to Follow-up|0
2693551|NCT00437281|9286073|P8|Overall Study|Lost to Follow-up|0
2693552|NCT00437281|9286074|P7|Overall Study|Lost to Follow-up|0
2693553|NCT00437281|9286075|P6|Overall Study|Lost to Follow-up|0
2693554|NCT00437281|9286076|P5|Overall Study|Lost to Follow-up|0
2693555|NCT00437281|9286077|P4|Overall Study|Lost to Follow-up|0
2693556|NCT00437281|9286078|P3|Overall Study|Lost to Follow-up|0
2693557|NCT00437281|9286079|P2|Overall Study|Lost to Follow-up|0
2693558|NCT00437281|9286080|P1|Overall Study|Lost to Follow-up|0
2693559|NCT00437281|9286061|P20|Overall Study|Adverse Event|0
2693560|NCT00437281|9286062|P19|Overall Study|Adverse Event|1
2693561|NCT00437281|9286063|P18|Overall Study|Adverse Event|0
2693562|NCT00437281|9286064|P17|Overall Study|Adverse Event|0
2693563|NCT00437281|9286065|P16|Overall Study|Adverse Event|0
2693564|NCT00437281|9286066|P15|Overall Study|Adverse Event|1
2693565|NCT00437281|9286067|P14|Overall Study|Adverse Event|1
2693566|NCT00437281|9286068|P13|Overall Study|Adverse Event|0
2693567|NCT00437281|9286069|P12|Overall Study|Adverse Event|0
2693568|NCT00437281|9286070|P11|Overall Study|Adverse Event|0
2693569|NCT00437281|9286071|P10|Overall Study|Adverse Event|1
2693570|NCT00437281|9286072|P9|Overall Study|Adverse Event|0
2693571|NCT00437281|9286073|P8|Overall Study|Adverse Event|0
2693572|NCT00437281|9286074|P7|Overall Study|Adverse Event|0
2693573|NCT00437281|9286075|P6|Overall Study|Adverse Event|1
2693574|NCT00437281|9286076|P5|Overall Study|Adverse Event|0
2693575|NCT00437281|9286077|P4|Overall Study|Adverse Event|1
2693576|NCT00437281|9286078|P3|Overall Study|Adverse Event|0
2693577|NCT00437281|9286079|P2|Overall Study|Adverse Event|0
2693578|NCT00437281|9286080|P1|Overall Study|Adverse Event|0
2693579|NCT00437203|9286384|P10|Overall Study|Other|0
2693580|NCT00437203|9286385|P9|Overall Study|Other|0
2693581|NCT00437203|9286386|P8|Overall Study|Other|0
2693582|NCT00437203|9286387|P7|Overall Study|Other|1
2693583|NCT00437203|9286388|P6|Overall Study|Other|0
2693584|NCT00437203|9286389|P5|Overall Study|Other|0
2693585|NCT00437203|9286390|P4|Overall Study|Other|0
2693586|NCT00437203|9286391|P3|Overall Study|Other|0
2693587|NCT00437203|9286392|P2|Overall Study|Other|1
2693588|NCT00437203|9286393|P1|Overall Study|Other|0
2693589|NCT00437203|9286384|P10|Overall Study|Objective progression or relapse|2
2693590|NCT00437203|9286385|P9|Overall Study|Objective progression or relapse|2
2693591|NCT00437203|9286386|P8|Overall Study|Objective progression or relapse|1
2693592|NCT00437203|9286387|P7|Overall Study|Objective progression or relapse|6
2693593|NCT00437203|9286388|P6|Overall Study|Objective progression or relapse|3
2693594|NCT00437203|9286389|P5|Overall Study|Objective progression or relapse|3
2693595|NCT00437203|9286390|P4|Overall Study|Objective progression or relapse|3
2693596|NCT00437203|9286391|P3|Overall Study|Objective progression or relapse|2
2693597|NCT00437203|9286392|P2|Overall Study|Objective progression or relapse|6
2693598|NCT00437203|9286393|P1|Overall Study|Objective progression or relapse|5
2693599|NCT00437203|9286384|P10|Overall Study|Study terminated by sponsor|0
2693600|NCT00437203|9286385|P9|Overall Study|Study terminated by sponsor|1
2693601|NCT00437203|9286386|P8|Overall Study|Study terminated by sponsor|0
2693602|NCT00437203|9286387|P7|Overall Study|Study terminated by sponsor|0
2693603|NCT00437203|9286388|P6|Overall Study|Study terminated by sponsor|0
2693604|NCT00437203|9286389|P5|Overall Study|Study terminated by sponsor|0
2693605|NCT00437203|9286390|P4|Overall Study|Study terminated by sponsor|0
2693606|NCT00437203|9286391|P3|Overall Study|Study terminated by sponsor|0
2693607|NCT00437203|9286392|P2|Overall Study|Study terminated by sponsor|0
2693608|NCT00437203|9286393|P1|Overall Study|Study terminated by sponsor|0
2693609|NCT00437203|9286384|P10|Overall Study|Adverse Event|1
2693610|NCT00437203|9286385|P9|Overall Study|Adverse Event|0
2693611|NCT00437203|9286386|P8|Overall Study|Adverse Event|1
2693612|NCT00437203|9286387|P7|Overall Study|Adverse Event|0
2693613|NCT00437203|9286388|P6|Overall Study|Adverse Event|0
2693614|NCT00437203|9286389|P5|Overall Study|Adverse Event|0
2693615|NCT00437203|9286390|P4|Overall Study|Adverse Event|0
2693616|NCT00437203|9286391|P3|Overall Study|Adverse Event|0
2693617|NCT00437203|9286392|P2|Overall Study|Adverse Event|1
2693618|NCT00437203|9286393|P1|Overall Study|Adverse Event|1
2693619|NCT00437203|9286384|P10|Overall Study|Death|1
2693620|NCT00437203|9286385|P9|Overall Study|Death|0
2693621|NCT00437203|9286386|P8|Overall Study|Death|1
2693622|NCT00437203|9286387|P7|Overall Study|Death|0
2693623|NCT00437203|9286388|P6|Overall Study|Death|0
2693624|NCT00437203|9286389|P5|Overall Study|Death|0
2693625|NCT00437203|9286390|P4|Overall Study|Death|0
2693626|NCT00437203|9286391|P3|Overall Study|Death|1
2693627|NCT00437203|9286392|P2|Overall Study|Death|0
2693628|NCT00437203|9286393|P1|Overall Study|Death|0
2693629|NCT00437125|9286497|P1|Overall Study|Physician Decision|1
2693630|NCT00437125|9286497|P1|Overall Study|Withdrawal by Caregiver|2
2693631|NCT00437125|9286497|P1|Overall Study|Withdrawal by Subject|13
2693632|NCT00437125|9286497|P1|Overall Study|Lost to Follow-up|1
2693633|NCT00437125|9286497|P1|Overall Study|Lack of Efficacy|1
2693634|NCT00437125|9286497|P1|Overall Study|Clinical Relapse|1
2693635|NCT00437125|9286497|P1|Overall Study|Death|1
2693636|NCT00437125|9286497|P1|Overall Study|Adverse Event|12
2693637|NCT00437073|9286518|P2|Overall Study|Physician Decision|1
2693638|NCT00437073|9286519|P1|Overall Study|Physician Decision|0
2693639|NCT00437073|9286518|P2|Overall Study|Sponsor Terminated Study|0
2693640|NCT00437073|9286519|P1|Overall Study|Sponsor Terminated Study|1
2693641|NCT00437034|9286547|P1|Overall Study|Disease progression during treatment|5
2693642|NCT00437034|9286547|P1|Overall Study|Adverse Event|1
2693643|NCT00436982|9286553|P2|Overall Study|no RSA data|2
2693644|NCT00436982|9286554|P1|Overall Study|no RSA data|1
2693645|NCT00436982|9286553|P2|Overall Study|Did not receive allocated intervention|1
2693646|NCT00436982|9286554|P1|Overall Study|Did not receive allocated intervention|0
2693647|NCT00436982|9286553|P2|Overall Study|Withdrawal by Subject|1
2693648|NCT00436982|9286554|P1|Overall Study|Withdrawal by Subject|3
2693649|NCT00436956|9286625|P2|Overall Study|Not evaluable|0
2693650|NCT00436956|9286626|P1|Overall Study|Not evaluable|1
2693651|NCT00436917|9286640|P1|Overall Study|Personal conflicts of patient|1
2693652|NCT00436917|9286640|P1|Overall Study|Increased creatinine|1
2693653|NCT00436917|9286640|P1|Overall Study|Treatment for polymyalgia rheumatic|1
2693654|NCT00436917|9286640|P1|Overall Study|Lost to Follow-up|1
2693655|NCT00436917|9286640|P1|Overall Study|Death|1
2693656|NCT00436917|9286640|P1|Overall Study|Physician Decision|1
2693657|NCT00436917|9286640|P1|Overall Study|Adverse Event|2
2693658|NCT00436917|9286640|P1|Overall Study|Withdrawal by Subject|13
2693659|NCT00436852|9286666|P2|Overall Study|Ineligible|0
2693660|NCT00436852|9286667|P1|Overall Study|Ineligible|1
2693661|NCT00436852|9286666|P2|Overall Study|Withdrawal by Subject|4
2693662|NCT00436852|9286667|P1|Overall Study|Withdrawal by Subject|2
2693663|NCT00436852|9286666|P2|Overall Study|Lack of Efficacy|7
2693664|NCT00436852|9286667|P1|Overall Study|Lack of Efficacy|9
2693665|NCT00436852|9286666|P2|Overall Study|Death|34
2693666|NCT00436852|9286667|P1|Overall Study|Death|23
2693667|NCT00436826|9286686|P6|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7
2693668|NCT00436826|9286687|P5|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51
2693669|NCT00436826|9286688|P4|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
2693670|NCT00436826|9286689|P3|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
2693671|NCT00436826|9286690|P2|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
2693672|NCT00436826|9286691|P1|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
2693673|NCT00436826|9286686|P6|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
2693674|NCT00436826|9286687|P5|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
2693675|NCT00436826|9286688|P4|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|24
2693676|NCT00436826|9286689|P3|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|44
2693677|NCT00436826|9286690|P2|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
2693678|NCT00436826|9286691|P1|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
2693679|NCT00436826|9286686|P6|Double Blind Period|Other|0
2693680|NCT00436826|9286687|P5|Double Blind Period|Other|0
2693681|NCT00436826|9286688|P4|Double Blind Period|Other|0
2693682|NCT00436826|9286689|P3|Double Blind Period|Other|0
2693683|NCT00436826|9286690|P2|Double Blind Period|Other|11
2693684|NCT00436826|9286691|P1|Double Blind Period|Other|10
2693685|NCT00436826|9286686|P6|Double Blind Period|Protocol Violation|0
2693686|NCT00436826|9286687|P5|Double Blind Period|Protocol Violation|0
2693687|NCT00436826|9286688|P4|Double Blind Period|Protocol Violation|0
2693688|NCT00436826|9286689|P3|Double Blind Period|Protocol Violation|0
2693689|NCT00436826|9286690|P2|Double Blind Period|Protocol Violation|0
2693690|NCT00436826|9286691|P1|Double Blind Period|Protocol Violation|1
2693691|NCT00436826|9286686|P6|Double Blind Period|Adverse Event|0
2693692|NCT00436826|9286687|P5|Double Blind Period|Adverse Event|0
2693693|NCT00436826|9286688|P4|Double Blind Period|Adverse Event|0
2693694|NCT00436826|9286689|P3|Double Blind Period|Adverse Event|0
2693695|NCT00436826|9286690|P2|Double Blind Period|Adverse Event|0
2693696|NCT00436826|9286691|P1|Double Blind Period|Adverse Event|2
2693697|NCT00436748|9286713|P2|Overall Study|Other|0
2693698|NCT00436748|9286714|P1|Overall Study|Other|3
2693699|NCT00436748|9286713|P2|Overall Study|Protocol-specified Criteria|4
2693700|NCT00436748|9286714|P1|Overall Study|Protocol-specified Criteria|5
2693701|NCT00436748|9286713|P2|Overall Study|Lost to Follow-up|1
2693702|NCT00436748|9286714|P1|Overall Study|Lost to Follow-up|0
2693703|NCT00436748|9286713|P2|Overall Study|Administrative Decision|0
2693704|NCT00436748|9286714|P1|Overall Study|Administrative Decision|1
2693705|NCT00436748|9286713|P2|Overall Study|Consent Withdrawn|4
2693706|NCT00436748|9286714|P1|Overall Study|Consent Withdrawn|1
2693707|NCT00436748|9286713|P2|Overall Study|Adverse Event|2
2693708|NCT00436748|9286714|P1|Overall Study|Adverse Event|0
2693709|NCT00436748|9286713|P2|Overall Study|Ineligibility Determined|1
2693710|NCT00436748|9286714|P1|Overall Study|Ineligibility Determined|1
2693711|NCT00436644|9286748|P1|Overall Study|Death|1
2693712|NCT00436644|9286748|P1|Overall Study|Adverse Event|2
2693713|NCT00436618|9286758|P3|Overall Study|Still on treatment|7
2693714|NCT00436618|9286759|P2|Overall Study|Still on treatment|2
2693715|NCT00436618|9286760|P1|Overall Study|Still on treatment|1
2693716|NCT00436618|9286758|P3|Overall Study|New Primary or Other Reasons|12
2693717|NCT00436618|9286759|P2|Overall Study|New Primary or Other Reasons|2
2693718|NCT00436618|9286760|P1|Overall Study|New Primary or Other Reasons|6
2693719|NCT00436618|9286758|P3|Overall Study|Death|3
2693720|NCT00436618|9286759|P2|Overall Study|Death|2
2693721|NCT00436618|9286760|P1|Overall Study|Death|4
2693722|NCT00436618|9286758|P3|Overall Study|Other Medical Problems|7
2693723|NCT00436618|9286759|P2|Overall Study|Other Medical Problems|1
2693724|NCT00436618|9286760|P1|Overall Study|Other Medical Problems|3
2693725|NCT00436618|9286758|P3|Overall Study|Alternate Treatment|12
2693726|NCT00436618|9286759|P2|Overall Study|Alternate Treatment|4
2693727|NCT00436618|9286760|P1|Overall Study|Alternate Treatment|3
2693728|NCT00436618|9286758|P3|Overall Study|Adverse Event|9
2693729|NCT00436618|9286759|P2|Overall Study|Adverse Event|8
2693730|NCT00436618|9286760|P1|Overall Study|Adverse Event|8
2693731|NCT00436618|9286758|P3|Overall Study|Withdrawal by Subject|11
2693732|NCT00436618|9286759|P2|Overall Study|Withdrawal by Subject|8
2693733|NCT00436618|9286760|P1|Overall Study|Withdrawal by Subject|5
2693734|NCT00436605|9286777|P1|Overall Study|Protocol Violation|3
2693735|NCT00436566|9286782|P1|Overall Study|Protocol Violation|1
2693736|NCT00436566|9286782|P1|Overall Study|Withdrawal by Subject|2
2693737|NCT00436553|9286789|P3|Overall Study|Withdrawal by Subject|3
2693738|NCT00436553|9286790|P2|Overall Study|Withdrawal by Subject|6
2693739|NCT00436553|9286791|P1|Overall Study|Withdrawal by Subject|5
2693740|NCT00436553|9286789|P3|Overall Study|Protocol Violation|0
2693741|NCT00436553|9286790|P2|Overall Study|Protocol Violation|0
2693742|NCT00436553|9286791|P1|Overall Study|Protocol Violation|1
2693743|NCT00436553|9286789|P3|Overall Study|Lost to Follow-up|0
2693744|NCT00436553|9286790|P2|Overall Study|Lost to Follow-up|2
2693745|NCT00436553|9286791|P1|Overall Study|Lost to Follow-up|0
2693746|NCT00436553|9286789|P3|Overall Study|Death|3
2693747|NCT00436553|9286790|P2|Overall Study|Death|1
2693748|NCT00436553|9286791|P1|Overall Study|Death|3
2693749|NCT00436553|9286789|P3|Overall Study|Adverse Event|4
2693750|NCT00436553|9286790|P2|Overall Study|Adverse Event|3
2693751|NCT00436553|9286791|P1|Overall Study|Adverse Event|4
2693752|NCT00436501|9286812|P2|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1
2693753|NCT00436501|9286813|P1|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0
2693754|NCT00436501|9286812|P2|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2
2693755|NCT00436501|9286813|P1|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0
2693756|NCT00436436|9286849|P1|Overall Study|Death|6
2693757|NCT00436436|9286849|P1|Overall Study|Adverse Event|2
2693758|NCT00436436|9286849|P1|Overall Study|Progression|4
2693759|NCT00436345|9286860|P2|Overall Study|ICU resident beyond follow-up period|0
2693760|NCT00436345|9286861|P1|Overall Study|ICU resident beyond follow-up period|3
2693761|NCT00436332|9286914|P1|Overall Study|Never Received Treatment|3
2693762|NCT00436332|9286914|P1|Overall Study|Ineligible|2
2693763|NCT00436332|9286914|P1|Overall Study|Not Protocol Specified|6
2693764|NCT00436332|9286914|P1|Overall Study|Death|2
2693765|NCT00436332|9286914|P1|Overall Study|Progression|59
2693766|NCT00436332|9286914|P1|Overall Study|Withdrawal by Subject|2
2693767|NCT00436332|9286914|P1|Overall Study|Adverse Event|9
2693768|NCT00436215|9286921|P1|Overall Study|Small bowel obstruction|1
2693769|NCT00436215|9286921|P1|Overall Study|Refused further treatment|3
2693770|NCT00436163|9286927|P1|Overall Study|Adverse Event|1
2693771|NCT00436163|9286927|P1|Overall Study|Lost to Follow-up|2
2693772|NCT00436007|9286975|P3|Overall Study|Other|1
2693773|NCT00436007|9286976|P2|Overall Study|Other|0
2693774|NCT00436007|9286977|P1|Overall Study|Other|0
2693775|NCT00436007|9286975|P3|Overall Study|Death|3
2693776|NCT00436007|9286976|P2|Overall Study|Death|1
2693777|NCT00436007|9286977|P1|Overall Study|Death|0
2693778|NCT00436007|9286975|P3|Overall Study|Physician Decision|2
2693779|NCT00436007|9286976|P2|Overall Study|Physician Decision|0
2693780|NCT00436007|9286977|P1|Overall Study|Physician Decision|0
2693781|NCT00436007|9286975|P3|Overall Study|Lost to Follow-up|13
2693782|NCT00436007|9286976|P2|Overall Study|Lost to Follow-up|10
2693783|NCT00436007|9286977|P1|Overall Study|Lost to Follow-up|14
2693784|NCT00436007|9286975|P3|Overall Study|Withdrawal by Subject|4
2693785|NCT00436007|9286976|P2|Overall Study|Withdrawal by Subject|3
2693786|NCT00436007|9286977|P1|Overall Study|Withdrawal by Subject|5
2693787|NCT00435994|9287025|P3|Overall Study|Lost to Follow-up|0
2693788|NCT00435994|9287026|P2|Overall Study|Lost to Follow-up|0
2693789|NCT00435994|9287027|P1|Overall Study|Lost to Follow-up|7
2693790|NCT00435942|9287038|P2|Overall Study|Other|1
2693791|NCT00435942|9287039|P1|Overall Study|Other|0
2693792|NCT00435942|9287038|P2|Overall Study|Technical Failure|0
2693793|NCT00435942|9287039|P1|Overall Study|Technical Failure|3
2693794|NCT00435942|9287038|P2|Overall Study|Conversion to Open Repair|0
2693795|NCT00435942|9287039|P1|Overall Study|Conversion to Open Repair|1
2693796|NCT00435942|9287038|P2|Overall Study|Lost to Follow-up|16
2693797|NCT00435942|9287039|P1|Overall Study|Lost to Follow-up|0
2693798|NCT00435942|9287038|P2|Overall Study|Withdrawal by Subject|0
2693799|NCT00435942|9287039|P1|Overall Study|Withdrawal by Subject|2
2693800|NCT00435942|9287038|P2|Overall Study|Death|10
2693801|NCT00435942|9287039|P1|Overall Study|Death|17
2693802|NCT00435825|9287079|P4|Overall Study|Did not complete full follow-up period|5
2693803|NCT00435825|9287080|P3|Overall Study|Did not complete full follow-up period|4
2693804|NCT00435825|9287081|P2|Overall Study|Did not complete full follow-up period|6
2693805|NCT00435825|9287082|P1|Overall Study|Did not complete full follow-up period|6
2693806|NCT00435825|9287079|P4|Overall Study|Did not enter follow-up|3
2693807|NCT00435825|9287080|P3|Overall Study|Did not enter follow-up|1
2693808|NCT00435825|9287081|P2|Overall Study|Did not enter follow-up|4
2693809|NCT00435825|9287082|P1|Overall Study|Did not enter follow-up|0
2693810|NCT00435825|9287079|P4|Overall Study|Did not receive study drug|0
2693811|NCT00435825|9287080|P3|Overall Study|Did not receive study drug|2
2693812|NCT00435825|9287081|P2|Overall Study|Did not receive study drug|0
2693813|NCT00435825|9287082|P1|Overall Study|Did not receive study drug|1
2693814|NCT00435825|9287079|P4|Overall Study|Failure to return|0
2693815|NCT00435825|9287080|P3|Overall Study|Failure to return|4
2693816|NCT00435825|9287081|P2|Overall Study|Failure to return|0
2693817|NCT00435825|9287082|P1|Overall Study|Failure to return|5
2693818|NCT00435825|9287079|P4|Overall Study|Refused treatment|5
2693819|NCT00435825|9287080|P3|Overall Study|Refused treatment|0
2693820|NCT00435825|9287081|P2|Overall Study|Refused treatment|0
2693821|NCT00435825|9287082|P1|Overall Study|Refused treatment|2
2693822|NCT00435825|9287079|P4|Overall Study|Other Protocol Violation|0
2693823|NCT00435825|9287080|P3|Overall Study|Other Protocol Violation|0
2693824|NCT00435825|9287081|P2|Overall Study|Other Protocol Violation|0
2693825|NCT00435825|9287082|P1|Overall Study|Other Protocol Violation|1
2693826|NCT00435825|9287079|P4|Overall Study|Insufficient Therapeutic Response|3
2693827|NCT00435825|9287080|P3|Overall Study|Insufficient Therapeutic Response|0
2693828|NCT00435825|9287081|P2|Overall Study|Insufficient Therapeutic Response|1
2693829|NCT00435825|9287082|P1|Overall Study|Insufficient Therapeutic Response|3
2693830|NCT00435825|9287079|P4|Overall Study|Abnormality of Laboratory Test|0
2693831|NCT00435825|9287080|P3|Overall Study|Abnormality of Laboratory Test|0
2693832|NCT00435825|9287081|P2|Overall Study|Abnormality of Laboratory Test|1
2693833|NCT00435825|9287082|P1|Overall Study|Abnormality of Laboratory Test|0
2693834|NCT00435487|9287205|P2|Overall Study|Received Drug in Other Treatment Group|1
2693835|NCT00435487|9287206|P1|Overall Study|Received Drug in Other Treatment Group|0
2693836|NCT00435487|9287205|P2|Overall Study|Withdrawal by Subject Prior to Treatment|2
2693837|NCT00435487|9287206|P1|Overall Study|Withdrawal by Subject Prior to Treatment|0
2693838|NCT00435487|9287205|P2|Overall Study|Withdrawal by Subject|1
2693839|NCT00435487|9287206|P1|Overall Study|Withdrawal by Subject|2
2693840|NCT00435487|9287205|P2|Overall Study|Other|2
2693841|NCT00435487|9287206|P1|Overall Study|Other|5
2693842|NCT00435487|9287205|P2|Overall Study|Lost to Follow-up|2
2693843|NCT00435487|9287206|P1|Overall Study|Lost to Follow-up|2
2693844|NCT00435487|9287205|P2|Overall Study|Adverse Event|3
2693845|NCT00435487|9287206|P1|Overall Study|Adverse Event|0
2693846|NCT00435487|9287205|P2|Overall Study|Death|4
2693847|NCT00435487|9287206|P1|Overall Study|Death|3
2693848|NCT00435461|9287225|P3|Overall Study|Lost to Follow-up|2
2693849|NCT00435461|9287226|P2|Overall Study|Lost to Follow-up|1
2693850|NCT00435461|9287227|P1|Overall Study|Lost to Follow-up|1
2693851|NCT00435461|9287225|P3|Overall Study|Non-Compliance of diary|1
2693852|NCT00435461|9287226|P2|Overall Study|Non-Compliance of diary|0
2693853|NCT00435461|9287227|P1|Overall Study|Non-Compliance of diary|2
2693854|NCT00435461|9287225|P3|Overall Study|Adverse Event|6
2693855|NCT00435461|9287226|P2|Overall Study|Adverse Event|2
2693856|NCT00435461|9287227|P1|Overall Study|Adverse Event|1
2693857|NCT00435461|9287225|P3|Overall Study|Noncompliance with study requirements|1
2693858|NCT00435461|9287226|P2|Overall Study|Noncompliance with study requirements|1
2693859|NCT00435461|9287227|P1|Overall Study|Noncompliance with study requirements|1
2693860|NCT00435461|9287225|P3|Overall Study|Participant ended study one day early|0
2693861|NCT00435461|9287226|P2|Overall Study|Participant ended study one day early|0
2693862|NCT00435461|9287227|P1|Overall Study|Participant ended study one day early|1
2693863|NCT00435461|9287225|P3|Overall Study|Participant moved eDiary,studymedication|0
2693864|NCT00435461|9287226|P2|Overall Study|Participant moved eDiary,studymedication|0
2693865|NCT00435461|9287227|P1|Overall Study|Participant moved eDiary,studymedication|1
2693866|NCT00435461|9287225|P3|Overall Study|Pregnancy|0
2693867|NCT00435461|9287226|P2|Overall Study|Pregnancy|0
2693868|NCT00435461|9287227|P1|Overall Study|Pregnancy|2
2693869|NCT00435461|9287225|P3|Overall Study|Participant could not swallow capsule|1
2693870|NCT00435461|9287226|P2|Overall Study|Participant could not swallow capsule|0
2693871|NCT00435461|9287227|P1|Overall Study|Participant could not swallow capsule|0
2693872|NCT00435461|9287225|P3|Overall Study|Participant could not tolerate symptoms|1
2693873|NCT00435461|9287226|P2|Overall Study|Participant could not tolerate symptoms|0
2693874|NCT00435461|9287227|P1|Overall Study|Participant could not tolerate symptoms|0
2693875|NCT00435461|9287225|P3|Overall Study|Randomized in error|0
2693876|NCT00435461|9287226|P2|Overall Study|Randomized in error|0
2693877|NCT00435461|9287227|P1|Overall Study|Randomized in error|1
2693878|NCT00435461|9287225|P3|Overall Study|Withdrawal by Subject|2
2693879|NCT00435461|9287226|P2|Overall Study|Withdrawal by Subject|0
2693880|NCT00435461|9287227|P1|Overall Study|Withdrawal by Subject|1
2693881|NCT00435461|9287225|P3|Overall Study|Lack of Efficacy|0
2693882|NCT00435461|9287226|P2|Overall Study|Lack of Efficacy|1
2693883|NCT00435461|9287227|P1|Overall Study|Lack of Efficacy|2
2693884|NCT00435461|9287225|P3|Overall Study|In error, two study medications switched|0
2693885|NCT00435461|9287226|P2|Overall Study|In error, two study medications switched|0
2693886|NCT00435461|9287227|P1|Overall Study|In error, two study medications switched|1
2693887|NCT00435461|9287225|P3|Overall Study|Compliance less than 80 percent|0
2693888|NCT00435461|9287226|P2|Overall Study|Compliance less than 80 percent|0
2693889|NCT00435461|9287227|P1|Overall Study|Compliance less than 80 percent|1
2693890|NCT00435461|9287225|P3|Overall Study|Participant randomized(inadequate score)|0
2693891|NCT00435461|9287226|P2|Overall Study|Participant randomized(inadequate score)|0
2693892|NCT00435461|9287227|P1|Overall Study|Participant randomized(inadequate score)|1
2693893|NCT00435461|9287225|P3|Overall Study|Protocol Violation|10
2693894|NCT00435461|9287226|P2|Overall Study|Protocol Violation|9
2693895|NCT00435461|9287227|P1|Overall Study|Protocol Violation|6
2693896|NCT00435461|9287225|P3|Overall Study|Visit changed to EarlyWithdrawn Visit|0
2693897|NCT00435461|9287226|P2|Overall Study|Visit changed to EarlyWithdrawn Visit|0
2693898|NCT00435461|9287227|P1|Overall Study|Visit changed to EarlyWithdrawn Visit|1
2693899|NCT00435409|9287264|P3|Overall Study|Sponsor decision|0
2693900|NCT00435409|9287265|P2|Overall Study|Sponsor decision|3
2693901|NCT00435409|9287266|P1|Overall Study|Sponsor decision|0
2693902|NCT00435409|9287264|P3|Overall Study|Adverse Event|8
2693903|NCT00435409|9287265|P2|Overall Study|Adverse Event|0
2693904|NCT00435409|9287266|P1|Overall Study|Adverse Event|0
2693905|NCT00435409|9287264|P3|Overall Study|Other|1
2693906|NCT00435409|9287265|P2|Overall Study|Other|30
2693907|NCT00435409|9287266|P1|Overall Study|Other|45
2693908|NCT00435409|9287264|P3|Overall Study|Withdrawal by Subject|1
2693909|NCT00435409|9287265|P2|Overall Study|Withdrawal by Subject|7
2693910|NCT00435409|9287266|P1|Overall Study|Withdrawal by Subject|8
2693911|NCT00435409|9287264|P3|Overall Study|Global deterioration of health status|4
2693912|NCT00435409|9287265|P2|Overall Study|Global deterioration of health status|0
2693913|NCT00435409|9287266|P1|Overall Study|Global deterioration of health status|0
2693914|NCT00435409|9287264|P3|Overall Study|Objective progression or relapse|58
2693915|NCT00435409|9287265|P2|Overall Study|Objective progression or relapse|93
2693916|NCT00435409|9287266|P1|Overall Study|Objective progression or relapse|158
2693917|NCT00435409|9287264|P3|Overall Study|Death|6
2693918|NCT00435409|9287265|P2|Overall Study|Death|6
2693919|NCT00435409|9287266|P1|Overall Study|Death|8
2693920|NCT00435409|9287264|P3|Overall Study|Lost to Follow-up|0
2693921|NCT00435409|9287265|P2|Overall Study|Lost to Follow-up|2
2693922|NCT00435409|9287266|P1|Overall Study|Lost to Follow-up|1
2693923|NCT00435409|9287264|P3|Overall Study|Protocol Violation|0
2693924|NCT00435409|9287265|P2|Overall Study|Protocol Violation|2
2693925|NCT00435409|9287266|P1|Overall Study|Protocol Violation|1
2693926|NCT00435370|9287288|P2|Overall Study|Antipsychotic medication changed|2
2693927|NCT00435370|9287289|P1|Overall Study|Antipsychotic medication changed|4
2693928|NCT00435370|9287288|P2|Overall Study|Withdrawal by Subject|10
2693929|NCT00435370|9287289|P1|Overall Study|Withdrawal by Subject|10
2693930|NCT00435370|9287288|P2|Overall Study|Adverse Event|8
2693931|NCT00435370|9287289|P1|Overall Study|Adverse Event|8
2693932|NCT00435188|9287297|P2|Overall Study|Lost to Follow-up|6
2693933|NCT00435188|9287298|P1|Overall Study|Lost to Follow-up|5
2693934|NCT00435188|9287297|P2|Overall Study|Withdrawal by Subject|11
2693935|NCT00435188|9287298|P1|Overall Study|Withdrawal by Subject|16
2693936|NCT00435188|9287297|P2|Overall Study|Death|6
2693937|NCT00435188|9287298|P1|Overall Study|Death|1
2693938|NCT00435162|9287341|P6|Period 2 (2 Weeks)|Adverse Event|0
2693939|NCT00435162|9287342|P5|Period 2 (2 Weeks)|Adverse Event|0
2693940|NCT00435162|9287343|P4|Period 2 (2 Weeks)|Adverse Event|0
2693941|NCT00435162|9287344|P3|Period 2 (2 Weeks)|Adverse Event|0
2693942|NCT00435162|9287345|P2|Period 2 (2 Weeks)|Adverse Event|1
2693943|NCT00435162|9287346|P1|Period 2 (2 Weeks)|Adverse Event|0
2693944|NCT00435045|9287366|P2|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0
2693945|NCT00435045|9287367|P1|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1
2693946|NCT00435045|9287366|P2|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0
2693947|NCT00435045|9287367|P1|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1
2693948|NCT00435045|9287366|P2|Weeks 13-16 / 40mg Dose Level|Adverse Event|2
2693949|NCT00435045|9287367|P1|Weeks 13-16 / 40mg Dose Level|Adverse Event|3
2693950|NCT00435045|9287366|P2|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1
2693951|NCT00435045|9287367|P1|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0
2693952|NCT00435045|9287366|P2|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
2693953|NCT00435045|9287367|P1|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
2693954|NCT00435045|9287366|P2|Weeks 9-12 / 20mg Dose Level|Adverse Event|3
2693955|NCT00435045|9287367|P1|Weeks 9-12 / 20mg Dose Level|Adverse Event|4
2693956|NCT00435045|9287366|P2|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1
2693957|NCT00435045|9287367|P1|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0
2693958|NCT00435045|9287366|P2|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0
2693959|NCT00435045|9287367|P1|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1
2693960|NCT00435045|9287366|P2|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1
2693961|NCT00435045|9287367|P1|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2
2693962|NCT00435045|9287366|P2|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
2693963|NCT00435045|9287367|P1|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
2693964|NCT00435045|9287366|P2|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
2693965|NCT00435045|9287367|P1|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
2693966|NCT00435019|9287423|P2|Overall Study|Personal reasons for withdrawal|7
2693967|NCT00435019|9287424|P1|Overall Study|Personal reasons for withdrawal|8
2693968|NCT00435019|9287423|P2|Overall Study|Protocol Violation|1
2693969|NCT00435019|9287424|P1|Overall Study|Protocol Violation|3
2693970|NCT00435019|9287423|P2|Overall Study|Lack of Efficacy|2
2693971|NCT00435019|9287424|P1|Overall Study|Lack of Efficacy|1
2693972|NCT00435019|9287423|P2|Overall Study|Adverse Event|0
2693973|NCT00435019|9287424|P1|Overall Study|Adverse Event|1
2693974|NCT00434967|9287465|P4|Overall Study|Patient Disposition Challenges|3
2693975|NCT00434967|9287466|P3|Overall Study|Patient Disposition Challenges|0
2693976|NCT00434967|9287467|P2|Overall Study|Patient Disposition Challenges|0
2693977|NCT00434967|9287468|P1|Overall Study|Patient Disposition Challenges|2
2693978|NCT00434967|9287465|P4|Overall Study|Physician Decision|0
2693979|NCT00434967|9287466|P3|Overall Study|Physician Decision|1
2693980|NCT00434967|9287467|P2|Overall Study|Physician Decision|1
2693981|NCT00434967|9287468|P1|Overall Study|Physician Decision|1
2693982|NCT00434967|9287465|P4|Overall Study|Protocol Violation|1
2693983|NCT00434967|9287466|P3|Overall Study|Protocol Violation|0
2693984|NCT00434967|9287467|P2|Overall Study|Protocol Violation|1
2693985|NCT00434967|9287468|P1|Overall Study|Protocol Violation|0
2693986|NCT00434967|9287465|P4|Overall Study|Randomized in error|1
2693987|NCT00434967|9287466|P3|Overall Study|Randomized in error|0
2693988|NCT00434967|9287467|P2|Overall Study|Randomized in error|0
2693989|NCT00434967|9287468|P1|Overall Study|Randomized in error|0
2693990|NCT00434967|9287465|P4|Overall Study|Withdrawal by Subject|6
2693991|NCT00434967|9287466|P3|Overall Study|Withdrawal by Subject|4
2693992|NCT00434967|9287467|P2|Overall Study|Withdrawal by Subject|2
2693993|NCT00434967|9287468|P1|Overall Study|Withdrawal by Subject|2
2693994|NCT00434967|9287465|P4|Overall Study|Lost to Follow-up|0
2693995|NCT00434967|9287466|P3|Overall Study|Lost to Follow-up|1
2693996|NCT00434967|9287467|P2|Overall Study|Lost to Follow-up|0
2693997|NCT00434967|9287468|P1|Overall Study|Lost to Follow-up|0
2693998|NCT00434967|9287465|P4|Overall Study|Adverse Event|3
2693999|NCT00434967|9287466|P3|Overall Study|Adverse Event|3
2694000|NCT00434967|9287467|P2|Overall Study|Adverse Event|4
2694001|NCT00434967|9287468|P1|Overall Study|Adverse Event|2
2694002|NCT00434954|9287488|P2|Overall Study|Subject decision|22
2694003|NCT00434954|9287489|P1|Overall Study|Subject decision|8
2694004|NCT00434954|9287488|P2|Overall Study|Sponsor decision|0
2694005|NCT00434954|9287489|P1|Overall Study|Sponsor decision|1
2694006|NCT00434954|9287488|P2|Overall Study|Protocol Violation|27
2694007|NCT00434954|9287489|P1|Overall Study|Protocol Violation|36
2694008|NCT00434954|9287488|P2|Overall Study|Physician Decision|3
2694009|NCT00434954|9287489|P1|Overall Study|Physician Decision|6
2694010|NCT00434954|9287488|P2|Overall Study|Lost to Follow-up|1
2694011|NCT00434954|9287489|P1|Overall Study|Lost to Follow-up|0
2694012|NCT00434954|9287488|P2|Overall Study|Entry criteria not met|16
2694013|NCT00434954|9287489|P1|Overall Study|Entry criteria not met|14
2694014|NCT00434954|9287488|P2|Overall Study|Adverse Event|2
2694015|NCT00434954|9287489|P1|Overall Study|Adverse Event|17
2694016|NCT00434876|9287519|P2|Overall Study|Lost to Follow-up|1
2694017|NCT00434876|9287520|P1|Overall Study|Lost to Follow-up|1
2694018|NCT00434759|9287534|P2|Overall Study|family affairs|0
2694019|NCT00434759|9287535|P1|Overall Study|family affairs|2
2694020|NCT00434759|9287534|P2|Overall Study|Withdrawal by Subject|1
2694021|NCT00434759|9287535|P1|Overall Study|Withdrawal by Subject|17
2694022|NCT00434759|9287534|P2|Overall Study|Lack of Efficacy|4
2694023|NCT00434759|9287535|P1|Overall Study|Lack of Efficacy|5
2694024|NCT00434642|9287551|P2|Open-label Treatment Phase|Disease Progression Per RECIST|6
2694025|NCT00434642|9287552|P1|Open-label Treatment Phase|Disease Progression Per RECIST|0
2694026|NCT00434642|9287551|P2|Open-label Treatment Phase|Adverse Event|5
2694027|NCT00434642|9287552|P1|Open-label Treatment Phase|Adverse Event|0
2694028|NCT00434642|9287551|P2|Blinded Treatment Phase|Did not Receive Treatment|1
2694029|NCT00434642|9287552|P1|Blinded Treatment Phase|Did not Receive Treatment|4
2694030|NCT00434642|9287551|P2|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29
2694031|NCT00434642|9287552|P1|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32
2694032|NCT00434642|9287551|P2|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0
2694033|NCT00434642|9287552|P1|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3
2694034|NCT00434642|9287551|P2|Blinded Treatment Phase|Physician Decision|27
2694035|NCT00434642|9287552|P1|Blinded Treatment Phase|Physician Decision|19
2694036|NCT00434642|9287551|P2|Blinded Treatment Phase|Disease Progression Per RECIST|109
2694037|NCT00434642|9287552|P1|Blinded Treatment Phase|Disease Progression Per RECIST|168
2694038|NCT00434642|9287551|P2|Blinded Treatment Phase|Clinical Disease Progression|5
2694039|NCT00434642|9287552|P1|Blinded Treatment Phase|Clinical Disease Progression|4
2694040|NCT00434642|9287551|P2|Blinded Treatment Phase|Adverse Event|58
2694041|NCT00434642|9287552|P1|Blinded Treatment Phase|Adverse Event|12
2694042|NCT00434590|9287570|P2|Overall Study|Administrative problems|5
2694043|NCT00434590|9287571|P1|Overall Study|Administrative problems|5
2694044|NCT00434577|9287582|P5|Months 0-3|Withdrawal by Subject|1
2694045|NCT00434577|9287583|P4|Months 0-3|Withdrawal by Subject|1
2694046|NCT00434577|9287584|P3|Months 0-3|Withdrawal by Subject|1
2694047|NCT00434577|9287585|P2|Months 0-3|Withdrawal by Subject|1
2694048|NCT00434577|9287586|P1|Months 0-3|Withdrawal by Subject|2
2694049|NCT00434577|9287582|P5|Months 0-3|Protocol Violation|0
2694050|NCT00434577|9287583|P4|Months 0-3|Protocol Violation|0
2694051|NCT00434577|9287584|P3|Months 0-3|Protocol Violation|1
2694052|NCT00434577|9287585|P2|Months 0-3|Protocol Violation|0
2694053|NCT00434577|9287586|P1|Months 0-3|Protocol Violation|1
2694054|NCT00434577|9287582|P5|Months 0-3|Lost to Follow-up|2
2694055|NCT00434577|9287583|P4|Months 0-3|Lost to Follow-up|0
2694056|NCT00434577|9287584|P3|Months 0-3|Lost to Follow-up|0
2694057|NCT00434577|9287585|P2|Months 0-3|Lost to Follow-up|0
2694058|NCT00434577|9287586|P1|Months 0-3|Lost to Follow-up|0
2694059|NCT00434577|9287582|P5|Months 0-3|Adverse Event|0
2694060|NCT00434577|9287583|P4|Months 0-3|Adverse Event|0
2694061|NCT00434577|9287584|P3|Months 0-3|Adverse Event|1
2694062|NCT00434577|9287585|P2|Months 0-3|Adverse Event|1
2694063|NCT00434577|9287586|P1|Months 0-3|Adverse Event|0
2694064|NCT00434577|9287582|P5|Months 0-3|Serious Adverse Event|0
2694065|NCT00434577|9287583|P4|Months 0-3|Serious Adverse Event|0
2694066|NCT00434577|9287584|P3|Months 0-3|Serious Adverse Event|1
2694067|NCT00434577|9287585|P2|Months 0-3|Serious Adverse Event|0
2694068|NCT00434577|9287586|P1|Months 0-3|Serious Adverse Event|0
2694069|NCT00434512|9287764|P6|Overall Study|Other|0
2694070|NCT00434512|9287765|P5|Overall Study|Other|0
2694071|NCT00434512|9287766|P4|Overall Study|Other|0
2694072|NCT00434512|9287767|P3|Overall Study|Other|0
2694073|NCT00434512|9287768|P2|Overall Study|Other|1
2694074|NCT00434512|9287769|P1|Overall Study|Other|0
2694075|NCT00434512|9287764|P6|Overall Study|Migrated/moved from study area|1
2694076|NCT00434512|9287765|P5|Overall Study|Migrated/moved from study area|1
2694077|NCT00434512|9287766|P4|Overall Study|Migrated/moved from study area|1
2694078|NCT00434512|9287767|P3|Overall Study|Migrated/moved from study area|0
2694079|NCT00434512|9287768|P2|Overall Study|Migrated/moved from study area|0
2694080|NCT00434512|9287769|P1|Overall Study|Migrated/moved from study area|0
2694081|NCT00434421|9287883|P1|Overall Study|Non-compliance with study treatment|1
2694082|NCT00434421|9287883|P1|Overall Study|Withdrawal by Subject|1
2694083|NCT00434330|9287911|P6|Overall Study|Subject Not Compliant With Study|0
2694084|NCT00434330|9287912|P5|Overall Study|Subject Not Compliant With Study|0
2694085|NCT00434330|9287913|P4|Overall Study|Subject Not Compliant With Study|0
2694086|NCT00434330|9287914|P3|Overall Study|Subject Not Compliant With Study|1
2694087|NCT00434330|9287915|P2|Overall Study|Subject Not Compliant With Study|0
2694088|NCT00434330|9287916|P1|Overall Study|Subject Not Compliant With Study|0
2694089|NCT00434330|9287911|P6|Overall Study|Renal transplant|0
2694090|NCT00434330|9287912|P5|Overall Study|Renal transplant|0
2694091|NCT00434330|9287913|P4|Overall Study|Renal transplant|1
2694092|NCT00434330|9287914|P3|Overall Study|Renal transplant|0
2694093|NCT00434330|9287915|P2|Overall Study|Renal transplant|0
2694094|NCT00434330|9287916|P1|Overall Study|Renal transplant|0
2694095|NCT00434330|9287911|P6|Overall Study|Withdrawal by Subject|0
2694096|NCT00434330|9287912|P5|Overall Study|Withdrawal by Subject|0
2694097|NCT00434330|9287913|P4|Overall Study|Withdrawal by Subject|1
2694098|NCT00434330|9287914|P3|Overall Study|Withdrawal by Subject|1
2694099|NCT00434330|9287915|P2|Overall Study|Withdrawal by Subject|0
2694100|NCT00434330|9287916|P1|Overall Study|Withdrawal by Subject|0
2694101|NCT00434330|9287911|P6|Overall Study|Death|1
2694102|NCT00434330|9287912|P5|Overall Study|Death|1
2694103|NCT00434330|9287913|P4|Overall Study|Death|0
2694104|NCT00434330|9287914|P3|Overall Study|Death|0
2694105|NCT00434330|9287915|P2|Overall Study|Death|0
2694106|NCT00434330|9287916|P1|Overall Study|Death|1
2694107|NCT00434330|9287911|P6|Overall Study|Adverse Event|0
2694108|NCT00434330|9287912|P5|Overall Study|Adverse Event|0
2694109|NCT00434330|9287913|P4|Overall Study|Adverse Event|0
2694110|NCT00434330|9287914|P3|Overall Study|Adverse Event|1
2694111|NCT00434330|9287915|P2|Overall Study|Adverse Event|0
2694112|NCT00434330|9287916|P1|Overall Study|Adverse Event|0
2694113|NCT00434304|9287948|P1|Overall Study|Withdrawal by Subject|4
2694114|NCT00434304|9287948|P1|Overall Study|Lack of Efficacy|2
2694115|NCT00434304|9287948|P1|Overall Study|Adverse Event|14
2694116|NCT00434252|9287997|P2|Overall Study|Withdrawal by Subject|7
2694117|NCT00434252|9287998|P1|Overall Study|Withdrawal by Subject|3
2694118|NCT00434252|9287997|P2|Overall Study|Physician Decision|8
2694119|NCT00434252|9287998|P1|Overall Study|Physician Decision|4
2694120|NCT00434252|9287997|P2|Overall Study|Lost to Follow-up|1
2694121|NCT00434252|9287998|P1|Overall Study|Lost to Follow-up|0
2694122|NCT00434252|9287997|P2|Overall Study|Death|2
2694123|NCT00434252|9287998|P1|Overall Study|Death|1
2694124|NCT00434252|9287997|P2|Overall Study|Adverse Event|13
2694125|NCT00434252|9287998|P1|Overall Study|Adverse Event|6
2694126|NCT00434252|9287997|P2|Overall Study|Lack of Efficacy|100
2694127|NCT00434252|9287998|P1|Overall Study|Lack of Efficacy|50
2694128|NCT00434213|9288032|P1|Overall Study|Non-compliant to study schedule|1
2694129|NCT00434213|9288032|P1|Overall Study|Application site reaction|1
2694130|NCT00434213|9288032|P1|Overall Study|Unable to comply with study visit window|2
2694131|NCT00434213|9288032|P1|Overall Study|Protocol Violation|3
2694132|NCT00434213|9288032|P1|Overall Study|Withdrawal by Subject|7
2694133|NCT00434213|9288032|P1|Overall Study|Lost to Follow-up|14
2694134|NCT00434213|9288032|P1|Overall Study|Lack of Efficacy|9
2694135|NCT00434213|9288032|P1|Overall Study|Adverse Event|12
2694136|NCT00434161|9288040|P3|Overall Study|Logistical error study assessments|3
2694137|NCT00434161|9288041|P2|Overall Study|Logistical error study assessments|0
2694138|NCT00434161|9288042|P1|Overall Study|Logistical error study assessments|1
2694139|NCT00434161|9288040|P3|Overall Study|Withdrawal by Subject|3
2694140|NCT00434161|9288041|P2|Overall Study|Withdrawal by Subject|0
2694141|NCT00434161|9288042|P1|Overall Study|Withdrawal by Subject|2
2694142|NCT00434161|9288040|P3|Overall Study|Non-Compliance|0
2694143|NCT00434161|9288041|P2|Overall Study|Non-Compliance|1
2694144|NCT00434161|9288042|P1|Overall Study|Non-Compliance|1
2694145|NCT00434161|9288040|P3|Overall Study|Death|1
2694146|NCT00434161|9288041|P2|Overall Study|Death|0
2694147|NCT00434161|9288042|P1|Overall Study|Death|1
2694148|NCT00434161|9288040|P3|Overall Study|Lost to Follow-up|0
2694149|NCT00434161|9288041|P2|Overall Study|Lost to Follow-up|1
2694150|NCT00434161|9288042|P1|Overall Study|Lost to Follow-up|0
2694151|NCT00434161|9288040|P3|Overall Study|Adverse Event|4
2694152|NCT00434161|9288041|P2|Overall Study|Adverse Event|1
2694153|NCT00434161|9288042|P1|Overall Study|Adverse Event|5
2694154|NCT00434148|9288086|P2|Overall Study|Abnormal test procedure result|1
2694155|NCT00434148|9288087|P1|Overall Study|Abnormal test procedure result|0
2694156|NCT00434148|9288086|P2|Overall Study|Condition no longer requires study drug|0
2694157|NCT00434148|9288087|P1|Overall Study|Condition no longer requires study drug|1
2694158|NCT00434148|9288086|P2|Overall Study|Lost to Follow-up|1
2694159|NCT00434148|9288087|P1|Overall Study|Lost to Follow-up|0
2694160|NCT00434148|9288086|P2|Overall Study|Administrative problems|10
2694161|NCT00434148|9288087|P1|Overall Study|Administrative problems|6
2694162|NCT00434148|9288086|P2|Overall Study|Protocol Violation|0
2694163|NCT00434148|9288087|P1|Overall Study|Protocol Violation|4
2694164|NCT00434148|9288086|P2|Overall Study|Withdrawal by Subject|15
2694165|NCT00434148|9288087|P1|Overall Study|Withdrawal by Subject|15
2694166|NCT00434148|9288086|P2|Overall Study|Lack of Efficacy|28
2694167|NCT00434148|9288087|P1|Overall Study|Lack of Efficacy|25
2694168|NCT00434148|9288086|P2|Overall Study|Adverse Event|18
2694169|NCT00434148|9288087|P1|Overall Study|Adverse Event|18
2694170|NCT00434122|9288123|P2|Overall Study|Travelling of subject.|0
2694171|NCT00434122|9288124|P1|Overall Study|Travelling of subject.|1
2694172|NCT00434122|9288123|P2|Overall Study|Low follicular response.|2
2694173|NCT00434122|9288124|P1|Overall Study|Low follicular response.|1
2694174|NCT00434122|9288123|P2|Overall Study|Large follicle size|2
2694175|NCT00434122|9288124|P1|Overall Study|Large follicle size|2
2694176|NCT00434122|9288123|P2|Overall Study|Personal reasons|1
2694177|NCT00434122|9288124|P1|Overall Study|Personal reasons|1
2694178|NCT00434122|9288123|P2|Overall Study|loss of subject contact|1
2694179|NCT00434122|9288124|P1|Overall Study|loss of subject contact|1
2694180|NCT00434122|9288123|P2|Overall Study|Non-compliance with protocol|1
2694181|NCT00434122|9288124|P1|Overall Study|Non-compliance with protocol|0
2694182|NCT00434109|9288133|P1|Overall Study|had embolism, did not receive sunitinib|3
2694183|NCT00434109|9288133|P1|Overall Study|Protocol Violation|1
2694184|NCT00434109|9288133|P1|Overall Study|Adverse Event|5
2694185|NCT00434109|9288133|P1|Overall Study|Physician Decision|9
2694186|NCT00434057|9288142|P1|Overall Study|Withdrawal by Subject|1
2694187|NCT00433966|9288180|P4|Stent Intervention/Randomization|Lost to Follow-up|47
2694188|NCT00433966|9288181|P3|Stent Intervention/Randomization|Lost to Follow-up|113
2694189|NCT00433966|9288182|P2|Stent Intervention/Randomization|Lost to Follow-up|0
2694190|NCT00433966|9288183|P1|Stent Intervention/Randomization|Lost to Follow-up|0
2694191|NCT00433966|9288180|P4|Stent Intervention/Randomization|Withdrawal by Subject|15
2694192|NCT00433966|9288181|P3|Stent Intervention/Randomization|Withdrawal by Subject|41
2694193|NCT00433966|9288182|P2|Stent Intervention/Randomization|Withdrawal by Subject|0
2694194|NCT00433966|9288183|P1|Stent Intervention/Randomization|Withdrawal by Subject|0
2694195|NCT00433966|9288180|P4|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
2694196|NCT00433966|9288181|P3|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
2694197|NCT00433966|9288182|P2|Pharmacology Intervention/Randomization|Not true myocardial infarction|28
2694198|NCT00433966|9288183|P1|Pharmacology Intervention/Randomization|Not true myocardial infarction|29
2694199|NCT00433966|9288180|P4|Pharmacology Intervention/Randomization|Lost to Follow-up|0
2694200|NCT00433966|9288181|P3|Pharmacology Intervention/Randomization|Lost to Follow-up|0
2694201|NCT00433966|9288182|P2|Pharmacology Intervention/Randomization|Lost to Follow-up|103
2694202|NCT00433966|9288183|P1|Pharmacology Intervention/Randomization|Lost to Follow-up|97
2694203|NCT00433966|9288180|P4|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
2694204|NCT00433966|9288181|P3|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
2694205|NCT00433966|9288182|P2|Pharmacology Intervention/Randomization|Withdrawal by Subject|43
2694206|NCT00433966|9288183|P1|Pharmacology Intervention/Randomization|Withdrawal by Subject|40
2694207|NCT00433914|9288205|P2|Overall Study|Lost to Follow-up|1
2694208|NCT00433914|9288206|P1|Overall Study|Lost to Follow-up|0
2694209|NCT00433914|9288205|P2|Overall Study|Withdrawal by Subject|2
2694210|NCT00433914|9288206|P1|Overall Study|Withdrawal by Subject|0
2694211|NCT00433836|9288226|P2|Overall Study|Abnormal laboratory values|1
2694212|NCT00433836|9288227|P1|Overall Study|Abnormal laboratory values|0
2694213|NCT00433836|9288226|P2|Overall Study|Condition no longer requires study drug|1
2694214|NCT00433836|9288227|P1|Overall Study|Condition no longer requires study drug|0
2694215|NCT00433836|9288226|P2|Overall Study|Protocol Violation|2
2694216|NCT00433836|9288227|P1|Overall Study|Protocol Violation|0
2694217|NCT00433836|9288226|P2|Overall Study|Unsatisfactory therapeutic effect|1
2694218|NCT00433836|9288227|P1|Overall Study|Unsatisfactory therapeutic effect|1
2694219|NCT00433836|9288226|P2|Overall Study|Withdrawal by Subject|1
2694220|NCT00433836|9288227|P1|Overall Study|Withdrawal by Subject|2
2694221|NCT00433836|9288226|P2|Overall Study|Lost to Follow-up|0
2694222|NCT00433836|9288227|P1|Overall Study|Lost to Follow-up|3
2694223|NCT00433836|9288226|P2|Overall Study|Adverse Event|0
2694224|NCT00433836|9288227|P1|Overall Study|Adverse Event|7
2694225|NCT00433771|9288239|P1|Overall Study|Failure to deploy stent|1
2694226|NCT00433771|9288239|P1|Overall Study|Death|2
2694227|NCT00433771|9288239|P1|Overall Study|Treated and later found to be ineligible|2
2694228|NCT00433771|9288239|P1|Overall Study|screen fail|14
2694229|NCT00433654|9288262|P2|Overall Study|Withdrawal by Subject|2
2694230|NCT00433654|9288263|P1|Overall Study|Withdrawal by Subject|1
2694231|NCT00433654|9288262|P2|Overall Study|Subject not yet due for visit|0
2694232|NCT00433654|9288263|P1|Overall Study|Subject not yet due for visit|4
2694233|NCT00433654|9288262|P2|Overall Study|Missed visit|3
2694234|NCT00433654|9288263|P1|Overall Study|Missed visit|6
2694235|NCT00433654|9288262|P2|Overall Study|Death|0
2694236|NCT00433654|9288263|P1|Overall Study|Death|4
2694237|NCT00433537|9288309|P3|Step 2 - Maintenance Rituximab or ASCT|Other|0
2694238|NCT00433537|9288310|P2|Step 2 - Maintenance Rituximab or ASCT|Other|0
2694239|NCT00433537|9288311|P1|Step 2 - Maintenance Rituximab or ASCT|Other|1
2694240|NCT00433537|9288309|P3|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
2694241|NCT00433537|9288310|P2|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
2694242|NCT00433537|9288311|P1|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4
2694243|NCT00433537|9288309|P3|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
2694244|NCT00433537|9288310|P2|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
2694245|NCT00433537|9288311|P1|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2
2694246|NCT00433537|9288309|P3|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
2694247|NCT00433537|9288310|P2|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
2694248|NCT00433537|9288311|P1|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8
2694249|NCT00433537|9288309|P3|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
2694250|NCT00433537|9288310|P2|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
2694251|NCT00433537|9288311|P1|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1
2694252|NCT00433537|9288309|P3|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2
2694253|NCT00433537|9288310|P2|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
2694254|NCT00433537|9288311|P1|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
2694255|NCT00433537|9288309|P3|Step 1 - VcR-CVAD Induction|Adverse Event|4
2694256|NCT00433537|9288310|P2|Step 1 - VcR-CVAD Induction|Adverse Event|0
2694257|NCT00433537|9288311|P1|Step 1 - VcR-CVAD Induction|Adverse Event|0
2694258|NCT00433537|9288309|P3|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2
2694259|NCT00433537|9288310|P2|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
2694260|NCT00433537|9288311|P1|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
2694261|NCT00433537|9288309|P3|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
2694262|NCT00433537|9288310|P2|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0
2694263|NCT00433537|9288311|P1|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
2694264|NCT00433511|9288323|P3|Step 2 (Arm D)|Unknown (Missing off treatment form)|1
2694265|NCT00433511|9288324|P2|Step 2 (Arm D)|Unknown (Missing off treatment form)|0
2694266|NCT00433511|9288325|P1|Step 2 (Arm D)|Unknown (Missing off treatment form)|0
2694267|NCT00433511|9288323|P3|Step 2 (Arm D)|Insurance/drug distribution issues|4
2694268|NCT00433511|9288324|P2|Step 2 (Arm D)|Insurance/drug distribution issues|0
2694269|NCT00433511|9288325|P1|Step 2 (Arm D)|Insurance/drug distribution issues|0
2694270|NCT00433511|9288323|P3|Step 2 (Arm D)|Suspected recurrence|1
2694271|NCT00433511|9288324|P2|Step 2 (Arm D)|Suspected recurrence|0
2694272|NCT00433511|9288325|P1|Step 2 (Arm D)|Suspected recurrence|0
2694273|NCT00433511|9288323|P3|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2
2694274|NCT00433511|9288324|P2|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0
2694275|NCT00433511|9288325|P1|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0
2694276|NCT00433511|9288323|P3|Step 2 (Arm D)|Other complicating disease|3
2694277|NCT00433511|9288324|P2|Step 2 (Arm D)|Other complicating disease|0
2694278|NCT00433511|9288325|P1|Step 2 (Arm D)|Other complicating disease|0
2694279|NCT00433511|9288323|P3|Step 2 (Arm D)|Disease progression, relapse|7
2694280|NCT00433511|9288324|P2|Step 2 (Arm D)|Disease progression, relapse|0
2694281|NCT00433511|9288325|P1|Step 2 (Arm D)|Disease progression, relapse|0
2694282|NCT00433511|9288323|P3|Step 2 (Arm D)|Physician Decision|9
2694283|NCT00433511|9288324|P2|Step 2 (Arm D)|Physician Decision|0
2694284|NCT00433511|9288325|P1|Step 2 (Arm D)|Physician Decision|0
2694285|NCT00433511|9288323|P3|Step 2 (Arm D)|Never started protocol therapy|148
2694286|NCT00433511|9288324|P2|Step 2 (Arm D)|Never started protocol therapy|0
2694287|NCT00433511|9288325|P1|Step 2 (Arm D)|Never started protocol therapy|0
2694288|NCT00433511|9288323|P3|Step 2 (Arm D)|Withdrawal by Subject|181
2694289|NCT00433511|9288324|P2|Step 2 (Arm D)|Withdrawal by Subject|0
2694290|NCT00433511|9288325|P1|Step 2 (Arm D)|Withdrawal by Subject|0
2694291|NCT00433511|9288323|P3|Step 2 (Arm D)|Adverse Event|135
2694292|NCT00433511|9288324|P2|Step 2 (Arm D)|Adverse Event|0
2694293|NCT00433511|9288325|P1|Step 2 (Arm D)|Adverse Event|0
2694294|NCT00433511|9288323|P3|Step 1|Patient moved|1
2694295|NCT00433511|9288324|P2|Step 1|Patient moved|0
2694296|NCT00433511|9288325|P1|Step 1|Patient moved|0
2694297|NCT00433511|9288323|P3|Step 1|Insurance/drug distribution issues|2
2694298|NCT00433511|9288324|P2|Step 1|Insurance/drug distribution issues|1
2694299|NCT00433511|9288325|P1|Step 1|Insurance/drug distribution issues|0
2694300|NCT00433511|9288323|P3|Step 1|Suspected recurrence|0
2694301|NCT00433511|9288324|P2|Step 1|Suspected recurrence|1
2694302|NCT00433511|9288325|P1|Step 1|Suspected recurrence|0
2694303|NCT00433511|9288323|P3|Step 1|Non-breast cancer surgery/wound issues|1
2694304|NCT00433511|9288324|P2|Step 1|Non-breast cancer surgery/wound issues|4
2694305|NCT00433511|9288325|P1|Step 1|Non-breast cancer surgery/wound issues|0
2694306|NCT00433511|9288323|P3|Step 1|Other complicating disease|3
2694307|NCT00433511|9288324|P2|Step 1|Other complicating disease|6
2694308|NCT00433511|9288325|P1|Step 1|Other complicating disease|2
2694309|NCT00433511|9288323|P3|Step 1|Disease progression, relapse|3
2694310|NCT00433511|9288324|P2|Step 1|Disease progression, relapse|3
2694311|NCT00433511|9288325|P1|Step 1|Disease progression, relapse|5
2694312|NCT00433511|9288323|P3|Step 1|Alternative therapy|3
2694313|NCT00433511|9288324|P2|Step 1|Alternative therapy|1
2694314|NCT00433511|9288325|P1|Step 1|Alternative therapy|2
2694315|NCT00433511|9288323|P3|Step 1|Never started protocol therapy|66
2694316|NCT00433511|9288324|P2|Step 1|Never started protocol therapy|64
2694317|NCT00433511|9288325|P1|Step 1|Never started protocol therapy|28
2694318|NCT00433511|9288323|P3|Step 1|Physician Decision|3
2694319|NCT00433511|9288324|P2|Step 1|Physician Decision|4
2694320|NCT00433511|9288325|P1|Step 1|Physician Decision|1
2694321|NCT00433511|9288323|P3|Step 1|Death|1
2694322|NCT00433511|9288324|P2|Step 1|Death|1
2694323|NCT00433511|9288325|P1|Step 1|Death|3
2694324|NCT00433511|9288323|P3|Step 1|Withdrawal by Subject|154
2694325|NCT00433511|9288324|P2|Step 1|Withdrawal by Subject|143
2694326|NCT00433511|9288325|P1|Step 1|Withdrawal by Subject|45
2694327|NCT00433511|9288323|P3|Step 1|Adverse Event|153
2694328|NCT00433511|9288324|P2|Step 1|Adverse Event|157
2694329|NCT00433511|9288325|P1|Step 1|Adverse Event|50
2694330|NCT00433446|9288339|P1|Overall Study|Ineligible|9
2694331|NCT00433446|9288339|P1|Overall Study|Other - Not Protocol specified|3
2694332|NCT00433446|9288339|P1|Overall Study|Progression|44
2694333|NCT00433446|9288339|P1|Overall Study|Refusal Unrelated to Adverse Event|1
2694334|NCT00433446|9288339|P1|Overall Study|Adverse Event|4
2694335|NCT00433381|9288349|P2|Overall Study|Ineligible / no protocol treatment|3
2694336|NCT00433381|9288350|P1|Overall Study|Ineligible / no protocol treatment|3
2694337|NCT00433329|9288369|P1|Overall Study|Physician Decision|1
2694338|NCT00433329|9288369|P1|Overall Study|Lost to Follow-up|1
2694339|NCT00433329|9288369|P1|Overall Study|Moved out of state|1
2694340|NCT00433329|9288369|P1|Overall Study|Discontinued sildenafil|2
2694341|NCT00433329|9288369|P1|Overall Study|Withdrew consent|3
2694342|NCT00433329|9288369|P1|Overall Study|Death|4
2694343|NCT00433329|9288369|P1|Overall Study|Adverse Event|9
2694344|NCT00433290|9288375|P2|Overall Study|Lost to Follow-up|0
2694345|NCT00433290|9288376|P1|Overall Study|Lost to Follow-up|1
2694346|NCT00433290|9288375|P2|Overall Study|Entry Criteria Not Met|1
2694347|NCT00433290|9288376|P1|Overall Study|Entry Criteria Not Met|0
2694348|NCT00433290|9288375|P2|Overall Study|Physician Decision|0
2694349|NCT00433290|9288376|P1|Overall Study|Physician Decision|2
2694350|NCT00433290|9288375|P2|Overall Study|Protocol Violation|2
2694351|NCT00433290|9288376|P1|Overall Study|Protocol Violation|3
2694352|NCT00433290|9288375|P2|Overall Study|Withdrawal by Subject|2
2694353|NCT00433290|9288376|P1|Overall Study|Withdrawal by Subject|4
2694354|NCT00433290|9288375|P2|Overall Study|Lack of Efficacy|5
2694355|NCT00433290|9288376|P1|Overall Study|Lack of Efficacy|1
2694356|NCT00433290|9288375|P2|Overall Study|Adverse Event|7
2694357|NCT00433290|9288376|P1|Overall Study|Adverse Event|24
2694358|NCT00433199|9288445|P2|Open-Label Period|Administrative|1
2694359|NCT00433199|9288446|P1|Open-Label Period|Administrative|0
2694360|NCT00433199|9288445|P2|Open-Label Period|Protocol Violation|2
2694361|NCT00433199|9288446|P1|Open-Label Period|Protocol Violation|0
2694362|NCT00433199|9288445|P2|Open-Label Period|Withdrawal by Subject|7
2694363|NCT00433199|9288446|P1|Open-Label Period|Withdrawal by Subject|0
2694364|NCT00433199|9288445|P2|Open-Label Period|Lost to Follow-up|3
2694365|NCT00433199|9288446|P1|Open-Label Period|Lost to Follow-up|0
2694366|NCT00433199|9288445|P2|Open-Label Period|Lack of Efficacy|2
2694367|NCT00433199|9288446|P1|Open-Label Period|Lack of Efficacy|0
2694368|NCT00433199|9288445|P2|Open-Label Period|Adverse Event|19
2694369|NCT00433199|9288446|P1|Open-Label Period|Adverse Event|0
2694370|NCT00433199|9288445|P2|Double-Blind Period|Administrative|5
2694371|NCT00433199|9288446|P1|Double-Blind Period|Administrative|1
2694372|NCT00433199|9288445|P2|Double-Blind Period|Protocol Violation|10
2694373|NCT00433199|9288446|P1|Double-Blind Period|Protocol Violation|1
2694374|NCT00433199|9288445|P2|Double-Blind Period|Withdrawal by Subject|19
2694375|NCT00433199|9288446|P1|Double-Blind Period|Withdrawal by Subject|8
2694376|NCT00433199|9288445|P2|Double-Blind Period|Lost to Follow-up|5
2694377|NCT00433199|9288446|P1|Double-Blind Period|Lost to Follow-up|2
2694378|NCT00433199|9288445|P2|Double-Blind Period|Lack of Efficacy|2
2694379|NCT00433199|9288446|P1|Double-Blind Period|Lack of Efficacy|0
2694380|NCT00433199|9288445|P2|Double-Blind Period|Adverse Event|25
2694381|NCT00433199|9288446|P1|Double-Blind Period|Adverse Event|0
2694382|NCT00433160|9288466|P2|104 Weeks, 28-Week OL Period|Physician Decision|1
2694383|NCT00433160|9288467|P1|104 Weeks, 28-Week OL Period|Physician Decision|0
2694384|NCT00433160|9288466|P2|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2
2694385|NCT00433160|9288467|P1|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8
2694386|NCT00433160|9288466|P2|104 Weeks, 28-Week OL Period|Adverse Event|0
2694387|NCT00433160|9288467|P1|104 Weeks, 28-Week OL Period|Adverse Event|2
2694388|NCT00433160|9288466|P2|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1
2694389|NCT00433160|9288467|P1|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0
2694390|NCT00433160|9288466|P2|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0
2694391|NCT00433160|9288467|P1|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2
2694392|NCT00433160|9288466|P2|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2
2694393|NCT00433160|9288467|P1|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1
2694394|NCT00433160|9288466|P2|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1
2694395|NCT00433160|9288467|P1|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3
2694396|NCT00433160|9288466|P2|52-Week Double-Blind (DB) Period|Lack of Efficacy|2
2694397|NCT00433160|9288467|P1|52-Week Double-Blind (DB) Period|Lack of Efficacy|1
2694398|NCT00433160|9288466|P2|52-Week Double-Blind (DB) Period|Sponsor Decision|0
2694399|NCT00433160|9288467|P1|52-Week Double-Blind (DB) Period|Sponsor Decision|0
2694400|NCT00433160|9288466|P2|52-Week Double-Blind (DB) Period|Physician Decision|2
2694401|NCT00433160|9288467|P1|52-Week Double-Blind (DB) Period|Physician Decision|4
2694402|NCT00433160|9288466|P2|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1
2694403|NCT00433160|9288467|P1|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6
2694404|NCT00433160|9288466|P2|52-Week Double-Blind (DB) Period|Protocol Violation|2
2694405|NCT00433160|9288467|P1|52-Week Double-Blind (DB) Period|Protocol Violation|0
2694406|NCT00433160|9288466|P2|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1
2694407|NCT00433160|9288467|P1|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0
2694408|NCT00433160|9288466|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
2694409|NCT00433160|9288467|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
2694410|NCT00433160|9288466|P2|52-Week Double-Blind (DB) Period|Death|0
2694411|NCT00433160|9288467|P1|52-Week Double-Blind (DB) Period|Death|0
2694412|NCT00433160|9288466|P2|52-Week Double-Blind (DB) Period|Adverse Event|2
2694413|NCT00433160|9288467|P1|52-Week Double-Blind (DB) Period|Adverse Event|6
2694414|NCT00433147|9288519|P4|Overall Study|Adverse Event|0
2694415|NCT00433147|9288520|P3|Overall Study|Adverse Event|0
2694416|NCT00433147|9288521|P2|Overall Study|Adverse Event|1
2694417|NCT00433147|9288522|P1|Overall Study|Adverse Event|0
2694418|NCT00433017|9288538|P2|Overall Study|Subject no longer requires study drug|1
2694419|NCT00433017|9288539|P1|Overall Study|Subject no longer requires study drug|1
2694420|NCT00433017|9288538|P2|Overall Study|Death|2
2694421|NCT00433017|9288539|P1|Overall Study|Death|2
2694422|NCT00433017|9288538|P2|Overall Study|Protocol Violation|0
2694423|NCT00433017|9288539|P1|Overall Study|Protocol Violation|1
2694424|NCT00433017|9288538|P2|Overall Study|Administrative problems|86
2694425|NCT00433017|9288539|P1|Overall Study|Administrative problems|80
2694426|NCT00433017|9288538|P2|Overall Study|Lost to Follow-up|4
2694427|NCT00433017|9288539|P1|Overall Study|Lost to Follow-up|3
2694428|NCT00433017|9288538|P2|Overall Study|Withdrawal by Subject|5
2694429|NCT00433017|9288539|P1|Overall Study|Withdrawal by Subject|4
2694430|NCT00433017|9288538|P2|Overall Study|Adverse Event|3
2694431|NCT00433017|9288539|P1|Overall Study|Adverse Event|5
2694432|NCT00433004|9288555|P2|Overall Study|Lost to Follow-up|7
2694433|NCT00433004|9288556|P1|Overall Study|Lost to Follow-up|5
2694434|NCT00432991|9288568|P2|Overall Study|Protocol Violation|12
2694435|NCT00432991|9288569|P1|Overall Study|Protocol Violation|7
2694436|NCT00432965|9288581|P2|Overall Study|Incomplete Data|3
2694437|NCT00432965|9288582|P1|Overall Study|Incomplete Data|4
2694438|NCT00432965|9288581|P2|Overall Study|Exclusionary Methods|2
2694439|NCT00432965|9288582|P1|Overall Study|Exclusionary Methods|1
2694440|NCT00432965|9288581|P2|Overall Study|Death|4
2694441|NCT00432965|9288582|P1|Overall Study|Death|3
2694442|NCT00432965|9288581|P2|Overall Study|Adverse Event|19
2694443|NCT00432965|9288582|P1|Overall Study|Adverse Event|22
2694444|NCT00432965|9288581|P2|Overall Study|Non-compliance|0
2694445|NCT00432965|9288582|P1|Overall Study|Non-compliance|7
2694446|NCT00432965|9288581|P2|Overall Study|Lack of Efficacy|13
2694447|NCT00432965|9288582|P1|Overall Study|Lack of Efficacy|8
2694448|NCT00432965|9288581|P2|Overall Study|Physician Decision|13
2694449|NCT00432965|9288582|P1|Overall Study|Physician Decision|14
2694450|NCT00432965|9288581|P2|Overall Study|Withdrawal by Subject|13
2694451|NCT00432965|9288582|P1|Overall Study|Withdrawal by Subject|13
2694452|NCT00432965|9288581|P2|Overall Study|Lost to Follow-up|19
2694453|NCT00432965|9288582|P1|Overall Study|Lost to Follow-up|22
2694454|NCT00432835|9288590|P2|Overall Study|Adverse event: lead dislodgement.|7
2694455|NCT00432835|9288591|P1|Overall Study|Adverse event: lead dislodgement.|6
2694456|NCT00432809|9288604|P3|1 Year Follow-up|Withdrawal by Subject|1
2694457|NCT00432809|9288605|P2|1 Year Follow-up|Withdrawal by Subject|0
2694458|NCT00432809|9288606|P1|1 Year Follow-up|Withdrawal by Subject|7
2694459|NCT00432809|9288604|P3|1 Year Follow-up|Misses 9 and 12 month visit|0
2694460|NCT00432809|9288605|P2|1 Year Follow-up|Misses 9 and 12 month visit|0
2694461|NCT00432809|9288606|P1|1 Year Follow-up|Misses 9 and 12 month visit|2
2694462|NCT00432744|9288679|P2|Months 7 - 12|Too disabled to score|1
2694463|NCT00432744|9288680|P1|Months 7 - 12|Too disabled to score|0
2694464|NCT00432744|9288679|P2|Months 7 - 12|Withdrawal by Subject|0
2694465|NCT00432744|9288680|P1|Months 7 - 12|Withdrawal by Subject|1
2694466|NCT00432744|9288679|P2|Months 0-6|Too disabled to score|0
2694467|NCT00432744|9288680|P1|Months 0-6|Too disabled to score|1
2694468|NCT00432744|9288679|P2|Months 0-6|Withdrawal by Subject|4
2694469|NCT00432744|9288680|P1|Months 0-6|Withdrawal by Subject|4
2694470|NCT00432679|9288692|P2|Overall Study|Withdrawal by Subject|2
2694471|NCT00432679|9288693|P1|Overall Study|Withdrawal by Subject|3
2694472|NCT00432679|9288692|P2|Overall Study|Adverse Event|1
2694473|NCT00432679|9288693|P1|Overall Study|Adverse Event|2
2694474|NCT00432666|9288717|P2|Open-Label Extension Period|Physician Decision|0
2694475|NCT00432666|9288718|P1|Open-Label Extension Period|Physician Decision|3
2694476|NCT00432666|9288717|P2|Open-Label Extension Period|Consent withdrawn|0
2694477|NCT00432666|9288718|P1|Open-Label Extension Period|Consent withdrawn|10
2694478|NCT00432666|9288717|P2|Open-Label Extension Period|Adverse Event|0
2694479|NCT00432666|9288718|P1|Open-Label Extension Period|Adverse Event|5
2694480|NCT00432666|9288717|P2|Open-Label Extension Period|Lack of Efficacy|0
2694481|NCT00432666|9288718|P1|Open-Label Extension Period|Lack of Efficacy|6
2694482|NCT00432666|9288717|P2|Open-Label Extension Period|Withdrawal Criteria Occurred|0
2694483|NCT00432666|9288718|P1|Open-Label Extension Period|Withdrawal Criteria Occurred|1
2694484|NCT00432666|9288717|P2|Main Period|Consent Withdrawn|0
2694485|NCT00432666|9288718|P1|Main Period|Consent Withdrawn|1
2694486|NCT00432666|9288717|P2|Main Period|Adverse Event|1
2694487|NCT00432666|9288718|P1|Main Period|Adverse Event|1
2694488|NCT00432562|9288891|P2|Overall Study|Death|0
2694489|NCT00432562|9288892|P1|Overall Study|Death|3
2694490|NCT00432380|9288944|P3|Overall Study|Adverse Event|0
2694491|NCT00432380|9288945|P2|Overall Study|Adverse Event|0
2694492|NCT00432380|9288946|P1|Overall Study|Adverse Event|1
2694493|NCT00432380|9288944|P3|Overall Study|Migrated/moved from study area|1
2694494|NCT00432380|9288945|P2|Overall Study|Migrated/moved from study area|4
2694495|NCT00432380|9288946|P1|Overall Study|Migrated/moved from study area|3
2694496|NCT00432276|9288999|P2|Overall Study|Other|3
2694497|NCT00432276|9289000|P1|Overall Study|Other|2
2694498|NCT00432276|9288999|P2|Overall Study|Physician Decision|8
2694499|NCT00432276|9289000|P1|Overall Study|Physician Decision|6
2694500|NCT00432276|9288999|P2|Overall Study|Withdrawal by Subject|20
2694501|NCT00432276|9289000|P1|Overall Study|Withdrawal by Subject|25
2694502|NCT00432276|9288999|P2|Overall Study|Lost to Follow-up|2
2694503|NCT00432276|9289000|P1|Overall Study|Lost to Follow-up|6
2694504|NCT00432276|9288999|P2|Overall Study|Protocol Violation|20
2694505|NCT00432276|9289000|P1|Overall Study|Protocol Violation|25
2694506|NCT00432276|9288999|P2|Overall Study|Adverse Event|16
2694507|NCT00432276|9289000|P1|Overall Study|Adverse Event|13
2694508|NCT00432276|9288999|P2|Overall Study|Hyperglycemic Rescue|87
2694509|NCT00432276|9289000|P1|Overall Study|Hyperglycemic Rescue|44
2694510|NCT00432237|9289090|P4|Overall Study|Lack of Qualifying Event|84
2694511|NCT00432237|9289091|P3|Overall Study|Lack of Qualifying Event|69
2694512|NCT00432237|9289092|P2|Overall Study|Lack of Qualifying Event|71
2694513|NCT00432237|9289093|P1|Overall Study|Lack of Qualifying Event|38
2694514|NCT00432237|9289090|P4|Overall Study|Withdrawal by Subject|11
2694515|NCT00432237|9289091|P3|Overall Study|Withdrawal by Subject|9
2694516|NCT00432237|9289092|P2|Overall Study|Withdrawal by Subject|6
2694517|NCT00432237|9289093|P1|Overall Study|Withdrawal by Subject|5
2694518|NCT00432237|9289090|P4|Overall Study|Protocol Violation|8
2694519|NCT00432237|9289091|P3|Overall Study|Protocol Violation|11
2694520|NCT00432237|9289092|P2|Overall Study|Protocol Violation|10
2694521|NCT00432237|9289093|P1|Overall Study|Protocol Violation|13
2694522|NCT00432237|9289090|P4|Overall Study|Pregnancy|0
2694523|NCT00432237|9289091|P3|Overall Study|Pregnancy|0
2694524|NCT00432237|9289092|P2|Overall Study|Pregnancy|1
2694525|NCT00432237|9289093|P1|Overall Study|Pregnancy|0
2694526|NCT00432237|9289090|P4|Overall Study|Physician Decision|1
2694527|NCT00432237|9289091|P3|Overall Study|Physician Decision|2
2694528|NCT00432237|9289092|P2|Overall Study|Physician Decision|3
2694529|NCT00432237|9289093|P1|Overall Study|Physician Decision|1
2694530|NCT00432237|9289090|P4|Overall Study|Lost to Follow-up|18
2694531|NCT00432237|9289091|P3|Overall Study|Lost to Follow-up|18
2694532|NCT00432237|9289092|P2|Overall Study|Lost to Follow-up|10
2694533|NCT00432237|9289093|P1|Overall Study|Lost to Follow-up|10
2694534|NCT00432237|9289090|P4|Overall Study|Lack of Efficacy|1
2694535|NCT00432237|9289091|P3|Overall Study|Lack of Efficacy|0
2694536|NCT00432237|9289092|P2|Overall Study|Lack of Efficacy|0
2694537|NCT00432237|9289093|P1|Overall Study|Lack of Efficacy|0
2694538|NCT00432237|9289090|P4|Overall Study|Adverse Event|1
2694539|NCT00432237|9289091|P3|Overall Study|Adverse Event|0
2694540|NCT00432237|9289092|P2|Overall Study|Adverse Event|0
2694541|NCT00432237|9289093|P1|Overall Study|Adverse Event|0
2694542|NCT00432172|9289135|P4|Overall Study|No treatment received|1
2694543|NCT00432172|9289136|P3|Overall Study|No treatment received|0
2694544|NCT00432172|9289137|P2|Overall Study|No treatment received|2
2694545|NCT00432172|9289138|P1|Overall Study|No treatment received|2
2694546|NCT00432172|9289135|P4|Overall Study|Withdrawal by Subject|2
2694547|NCT00432172|9289136|P3|Overall Study|Withdrawal by Subject|0
2694548|NCT00432172|9289137|P2|Overall Study|Withdrawal by Subject|1
2694549|NCT00432172|9289138|P1|Overall Study|Withdrawal by Subject|0
2694550|NCT00432172|9289135|P4|Overall Study|Disease progression|1
2694551|NCT00432172|9289136|P3|Overall Study|Disease progression|5
2694552|NCT00432172|9289137|P2|Overall Study|Disease progression|2
2694553|NCT00432172|9289138|P1|Overall Study|Disease progression|0
2694554|NCT00432172|9289135|P4|Overall Study|Adverse Event|3
2694555|NCT00432172|9289136|P3|Overall Study|Adverse Event|4
2694556|NCT00432172|9289137|P2|Overall Study|Adverse Event|2
2694557|NCT00432172|9289138|P1|Overall Study|Adverse Event|4
2694558|NCT00432172|9289135|P4|Overall Study|Physician Decision|0
2694559|NCT00432172|9289136|P3|Overall Study|Physician Decision|2
2694560|NCT00432172|9289137|P2|Overall Study|Physician Decision|0
2694561|NCT00432172|9289138|P1|Overall Study|Physician Decision|0
2694562|NCT00432159|9289163|P5|Overall Study|Missing NDI and/or neuro. assessment|7
2694563|NCT00432159|9289164|P4|Overall Study|Missing NDI and/or neuro. assessment|3
2694564|NCT00432159|9289165|P3|Overall Study|Missing NDI and/or neuro. assessment|1
2694565|NCT00432159|9289166|P2|Overall Study|Missing NDI and/or neuro. assessment|24
2694566|NCT00432159|9289167|P1|Overall Study|Missing NDI and/or neuro. assessment|13
2694567|NCT00432159|9289163|P5|Overall Study|Failure|3
2694568|NCT00432159|9289164|P4|Overall Study|Failure|2
2694569|NCT00432159|9289165|P3|Overall Study|Failure|3
2694570|NCT00432159|9289166|P2|Overall Study|Failure|5
2694571|NCT00432159|9289167|P1|Overall Study|Failure|9
2694572|NCT00432159|9289163|P5|Overall Study|Death|0
2694573|NCT00432159|9289164|P4|Overall Study|Death|0
2694574|NCT00432159|9289165|P3|Overall Study|Death|0
2694575|NCT00432159|9289166|P2|Overall Study|Death|1
2694576|NCT00432159|9289167|P1|Overall Study|Death|0
2694577|NCT00432042|9289274|P3|Overall Study|Lost to Follow-up|0
2694578|NCT00432042|9289275|P2|Overall Study|Lost to Follow-up|1
2694579|NCT00432042|9289276|P1|Overall Study|Lost to Follow-up|5
2694580|NCT00432042|9289274|P3|Overall Study|Withdrawal by Subject|2
2694581|NCT00432042|9289275|P2|Overall Study|Withdrawal by Subject|0
2694582|NCT00432042|9289276|P1|Overall Study|Withdrawal by Subject|0
2694583|NCT00432042|9289274|P3|Overall Study|Protocol Violation|0
2694584|NCT00432042|9289275|P2|Overall Study|Protocol Violation|0
2694585|NCT00432042|9289276|P1|Overall Study|Protocol Violation|2
2694586|NCT00431964|9289289|P2|Overall Study|Due to Unstable Health|1
2694587|NCT00431964|9289290|P1|Overall Study|Due to Unstable Health|0
2694588|NCT00431964|9289289|P2|Overall Study|Parental Consent Withdrawn|2
2694589|NCT00431964|9289290|P1|Overall Study|Parental Consent Withdrawn|0
2694590|NCT00431964|9289289|P2|Overall Study|Withdrawal by Subject|1
2694591|NCT00431964|9289290|P1|Overall Study|Withdrawal by Subject|2
2694592|NCT00431964|9289289|P2|Overall Study|Physician Decision|2
2694593|NCT00431964|9289290|P1|Overall Study|Physician Decision|2
2694594|NCT00431964|9289289|P2|Overall Study|Lost to Follow-up|2
2694595|NCT00431964|9289290|P1|Overall Study|Lost to Follow-up|1
2694596|NCT00431964|9289289|P2|Overall Study|Adverse Event|0
2694597|NCT00431964|9289290|P1|Overall Study|Adverse Event|1
2694598|NCT00431951|9289300|P4|Overall Study|Adverse Event|0
2694599|NCT00431951|9289301|P3|Overall Study|Adverse Event|1
2694600|NCT00431951|9289302|P2|Overall Study|Adverse Event|0
2694601|NCT00431951|9289303|P1|Overall Study|Adverse Event|0
2694602|NCT00431951|9289300|P4|Overall Study|Withdrawal by Subject|0
2694603|NCT00431951|9289301|P3|Overall Study|Withdrawal by Subject|0
2694604|NCT00431951|9289302|P2|Overall Study|Withdrawal by Subject|1
2694605|NCT00431951|9289303|P1|Overall Study|Withdrawal by Subject|0
2694606|NCT00431951|9289300|P4|Overall Study|Lost to Follow-up|0
2694607|NCT00431951|9289301|P3|Overall Study|Lost to Follow-up|0
2694608|NCT00431951|9289302|P2|Overall Study|Lost to Follow-up|1
2694609|NCT00431951|9289303|P1|Overall Study|Lost to Follow-up|0
2694610|NCT00431951|9289300|P4|Overall Study|Inability to follow study procedures|2
2694611|NCT00431951|9289301|P3|Overall Study|Inability to follow study procedures|1
2694612|NCT00431951|9289302|P2|Overall Study|Inability to follow study procedures|0
2694613|NCT00431951|9289303|P1|Overall Study|Inability to follow study procedures|1
2694614|NCT00431847|9289365|P5|Overall Study|Protocol Violation|1
2694615|NCT00431847|9289366|P4|Overall Study|Protocol Violation|0
2694616|NCT00431847|9289367|P3|Overall Study|Protocol Violation|0
2694617|NCT00431847|9289368|P2|Overall Study|Protocol Violation|0
2694618|NCT00431847|9289369|P1|Overall Study|Protocol Violation|0
2694619|NCT00431847|9289365|P5|Overall Study|completion of less than two study visits|0
2694620|NCT00431847|9289366|P4|Overall Study|completion of less than two study visits|14
2694621|NCT00431847|9289367|P3|Overall Study|completion of less than two study visits|4
2694622|NCT00431847|9289368|P2|Overall Study|completion of less than two study visits|3
2694623|NCT00431847|9289369|P1|Overall Study|completion of less than two study visits|6
2694624|NCT00431834|9289443|P1|Overall Study|Lost to Follow-up|1
2694625|NCT00431834|9289443|P1|Overall Study|Missed Endpoint Visit|2
2694626|NCT00431834|9289443|P1|Overall Study|Death|3
2694627|NCT00431834|9289443|P1|Overall Study|Withdrawal by Subject|7
2694628|NCT00431496|9289459|P1|Overall Study|Protocol-specified criteria|5
2694629|NCT00431496|9289459|P1|Overall Study|Withdrawal by Subject|2
2694630|NCT00431496|9289459|P1|Overall Study|Lost to Follow-up|1
2694631|NCT00431496|9289459|P1|Overall Study|Adverse Event|3
2694632|NCT00431444|9289470|P2|Overall Study|Administrative Problems|1
2694633|NCT00431444|9289471|P1|Overall Study|Administrative Problems|0
2694634|NCT00431444|9289470|P2|Overall Study|Lost to Follow-up|0
2694635|NCT00431444|9289471|P1|Overall Study|Lost to Follow-up|1
2694636|NCT00431444|9289470|P2|Overall Study|Withdrawal by Subject|1
2694637|NCT00431444|9289471|P1|Overall Study|Withdrawal by Subject|1
2694638|NCT00431444|9289470|P2|Overall Study|Adverse Event|1
2694639|NCT00431444|9289471|P1|Overall Study|Adverse Event|2
2694640|NCT00431444|9289470|P2|Overall Study|Protocol Violation|4
2694641|NCT00431444|9289471|P1|Overall Study|Protocol Violation|1
2694642|NCT00431067|9289511|P1|Overall Study|Non-compliance,lost to follow-up|2
2694643|NCT00431067|9289511|P1|Overall Study|Progressive disease|30
2694644|NCT00431067|9289511|P1|Overall Study|Other Adverse Event|9
2694645|NCT00430989|9289536|P2|Overall Study|Not eligible|6
2694646|NCT00430989|9289537|P1|Overall Study|Not eligible|13
2694647|NCT00430989|9289536|P2|Overall Study|Protocol Violation|37
2694648|NCT00430989|9289537|P1|Overall Study|Protocol Violation|30
2694649|NCT00430989|9289536|P2|Overall Study|Withdrawal by Subject|14
2694650|NCT00430989|9289537|P1|Overall Study|Withdrawal by Subject|15
2694651|NCT00430989|9289536|P2|Overall Study|Lost to Follow-up|3
2694652|NCT00430989|9289537|P1|Overall Study|Lost to Follow-up|2
2694653|NCT00430950|9289557|P2|Overall Study|concomitant medication,etc.|7
2694654|NCT00430950|9289558|P1|Overall Study|concomitant medication,etc.|5
2694655|NCT00430950|9289557|P2|Overall Study|Withdrawal by Subject|0
2694656|NCT00430950|9289558|P1|Overall Study|Withdrawal by Subject|1
2694657|NCT00430950|9289557|P2|Overall Study|Adverse Event|6
2694658|NCT00430950|9289558|P1|Overall Study|Adverse Event|7
2694659|NCT00430937|9289572|P2|Overall Study|Unable to classify|1
2694660|NCT00430937|9289573|P1|Overall Study|Unable to classify|0
2694661|NCT00430937|9289572|P2|Overall Study|Protocol discontinuation criteria met|2
2694662|NCT00430937|9289573|P1|Overall Study|Protocol discontinuation criteria met|1
2694663|NCT00430937|9289572|P2|Overall Study|Administrative reasons|0
2694664|NCT00430937|9289573|P1|Overall Study|Administrative reasons|1
2694665|NCT00430937|9289572|P2|Overall Study|Inappropriate enrollment|1
2694666|NCT00430937|9289573|P1|Overall Study|Inappropriate enrollment|2
2694667|NCT00430937|9289572|P2|Overall Study|Lack of Efficacy|5
2694668|NCT00430937|9289573|P1|Overall Study|Lack of Efficacy|6
2694669|NCT00430937|9289572|P2|Overall Study|Protocol Violation|2
2694670|NCT00430937|9289573|P1|Overall Study|Protocol Violation|3
2694671|NCT00430937|9289572|P2|Overall Study|Withdrawal by Subject|2
2694672|NCT00430937|9289573|P1|Overall Study|Withdrawal by Subject|5
2694673|NCT00430937|9289572|P2|Overall Study|Lost to Follow-up|6
2694674|NCT00430937|9289573|P1|Overall Study|Lost to Follow-up|6
2694675|NCT00430937|9289572|P2|Overall Study|Death|1
2694676|NCT00430937|9289573|P1|Overall Study|Death|0
2694677|NCT00430937|9289572|P2|Overall Study|Adverse Event|8
2694678|NCT00430937|9289573|P1|Overall Study|Adverse Event|3
2694679|NCT00430781|9289584|P3|End-of-Study Analysis; 28 July 2011|Other|0
2694680|NCT00430781|9289585|P2|End-of-Study Analysis; 28 July 2011|Other|1
2694681|NCT00430781|9289586|P1|End-of-Study Analysis; 28 July 2011|Other|4
2694682|NCT00430781|9289584|P3|End-of-Study Analysis; 28 July 2011|Physician Decision|6
2694683|NCT00430781|9289585|P2|End-of-Study Analysis; 28 July 2011|Physician Decision|6
2694684|NCT00430781|9289586|P1|End-of-Study Analysis; 28 July 2011|Physician Decision|4
2694685|NCT00430781|9289584|P3|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
2694686|NCT00430781|9289585|P2|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5
2694687|NCT00430781|9289586|P1|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
2694688|NCT00430781|9289584|P3|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
2694689|NCT00430781|9289585|P2|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2
2694690|NCT00430781|9289586|P1|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
2694691|NCT00430781|9289584|P3|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
2694692|NCT00430781|9289585|P2|End-of-Study Analysis; 28 July 2011|Protocol Violation|1
2694693|NCT00430781|9289586|P1|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
2694694|NCT00430781|9289584|P3|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
2694695|NCT00430781|9289585|P2|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
2694696|NCT00430781|9289586|P1|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5
2694697|NCT00430781|9289584|P3|Final Analysis; 31 July 2008|Ongoing|32
2694698|NCT00430781|9289585|P2|Final Analysis; 31 July 2008|Ongoing|29
2694699|NCT00430781|9289586|P1|Final Analysis; 31 July 2008|Ongoing|0
2694700|NCT00430781|9289584|P3|Final Analysis; 31 July 2008|Other|0
2694701|NCT00430781|9289585|P2|Final Analysis; 31 July 2008|Other|1
2694702|NCT00430781|9289586|P1|Final Analysis; 31 July 2008|Other|0
2694703|NCT00430781|9289584|P3|Final Analysis; 31 July 2008|Physician Decision|6
2694704|NCT00430781|9289585|P2|Final Analysis; 31 July 2008|Physician Decision|6
2694705|NCT00430781|9289586|P1|Final Analysis; 31 July 2008|Physician Decision|0
2694706|NCT00430781|9289584|P3|Final Analysis; 31 July 2008|Withdrawal by Subject|7
2694707|NCT00430781|9289585|P2|Final Analysis; 31 July 2008|Withdrawal by Subject|2
2694708|NCT00430781|9289586|P1|Final Analysis; 31 July 2008|Withdrawal by Subject|0
2694709|NCT00430781|9289584|P3|Final Analysis; 31 July 2008|Protocol Violation|0
2694710|NCT00430781|9289585|P2|Final Analysis; 31 July 2008|Protocol Violation|1
2694711|NCT00430781|9289586|P1|Final Analysis; 31 July 2008|Protocol Violation|0
2694712|NCT00430781|9289584|P3|Final Analysis; 31 July 2008|Lost to Follow-up|3
2694713|NCT00430781|9289585|P2|Final Analysis; 31 July 2008|Lost to Follow-up|0
2694714|NCT00430781|9289586|P1|Final Analysis; 31 July 2008|Lost to Follow-up|0
2694715|NCT00430781|9289584|P3|Interim Analysis; 11 February 2008|Ongoing|25
2694716|NCT00430781|9289585|P2|Interim Analysis; 11 February 2008|Ongoing|20
2694717|NCT00430781|9289586|P1|Interim Analysis; 11 February 2008|Ongoing|23
2694718|NCT00430781|9289584|P3|Interim Analysis; 11 February 2008|Physician Decision|3
2694719|NCT00430781|9289585|P2|Interim Analysis; 11 February 2008|Physician Decision|3
2694720|NCT00430781|9289586|P1|Interim Analysis; 11 February 2008|Physician Decision|2
2694721|NCT00430781|9289584|P3|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
2694722|NCT00430781|9289585|P2|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
2694723|NCT00430781|9289586|P1|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2
2694724|NCT00430781|9289584|P3|Interim Analysis; 11 February 2008|Death|0
2694725|NCT00430781|9289585|P2|Interim Analysis; 11 February 2008|Death|1
2694726|NCT00430781|9289586|P1|Interim Analysis; 11 February 2008|Death|0
2694727|NCT00430781|9289584|P3|Interim Analysis; 11 February 2008|Disease Progression|22
2694728|NCT00430781|9289585|P2|Interim Analysis; 11 February 2008|Disease Progression|30
2694729|NCT00430781|9289586|P1|Interim Analysis; 11 February 2008|Disease Progression|16
2694730|NCT00430781|9289584|P3|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
2694731|NCT00430781|9289585|P2|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
2694732|NCT00430781|9289586|P1|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1
2694733|NCT00430781|9289584|P3|Interim Analysis; 11 February 2008|Withdrawal by Subject|2
2694734|NCT00430781|9289585|P2|Interim Analysis; 11 February 2008|Withdrawal by Subject|0
2694735|NCT00430781|9289586|P1|Interim Analysis; 11 February 2008|Withdrawal by Subject|4
2694736|NCT00430781|9289584|P3|Interim Analysis; 11 February 2008|Protocol Violation|0
2694737|NCT00430781|9289585|P2|Interim Analysis; 11 February 2008|Protocol Violation|1
2694738|NCT00430781|9289586|P1|Interim Analysis; 11 February 2008|Protocol Violation|0
2694739|NCT00430781|9289584|P3|Interim Analysis; 11 February 2008|Lost to Follow-up|1
2694740|NCT00430781|9289585|P2|Interim Analysis; 11 February 2008|Lost to Follow-up|0
2694741|NCT00430781|9289586|P1|Interim Analysis; 11 February 2008|Lost to Follow-up|1
2694742|NCT00430781|9289584|P3|Interim Analysis; 11 February 2008|Adverse Event|7
2694743|NCT00430781|9289585|P2|Interim Analysis; 11 February 2008|Adverse Event|3
2694744|NCT00430781|9289586|P1|Interim Analysis; 11 February 2008|Adverse Event|10
2694745|NCT00430755|9289628|P1|Overall Study|Withdrawal by Subject|53
2694746|NCT00430716|9289635|P3|Open Label Phase|Study terminated by sponsor|4
2694747|NCT00430716|9289636|P2|Open Label Phase|Study terminated by sponsor|5
2694748|NCT00430716|9289637|P1|Open Label Phase|Study terminated by sponsor|4
2694749|NCT00430716|9289635|P3|Open Label Phase|Protocol Violation|0
2694750|NCT00430716|9289636|P2|Open Label Phase|Protocol Violation|0
2694751|NCT00430716|9289637|P1|Open Label Phase|Protocol Violation|1
2694752|NCT00430716|9289635|P3|Open Label Phase|Other|1
2694753|NCT00430716|9289636|P2|Open Label Phase|Other|1
2694754|NCT00430716|9289637|P1|Open Label Phase|Other|3
2694755|NCT00430716|9289635|P3|Open Label Phase|No longer willing to participate|1
2694756|NCT00430716|9289636|P2|Open Label Phase|No longer willing to participate|1
2694757|NCT00430716|9289637|P1|Open Label Phase|No longer willing to participate|0
2694758|NCT00430716|9289635|P3|Open Label Phase|Lost to Follow-up|1
2694759|NCT00430716|9289636|P2|Open Label Phase|Lost to Follow-up|0
2694760|NCT00430716|9289637|P1|Open Label Phase|Lost to Follow-up|1
2694761|NCT00430716|9289635|P3|Double Blind Phase|Not met eligibility criteria|0
2694762|NCT00430716|9289636|P2|Double Blind Phase|Not met eligibility criteria|0
2694763|NCT00430716|9289637|P1|Double Blind Phase|Not met eligibility criteria|1
2694764|NCT00430716|9289635|P3|Double Blind Phase|Adverse Event|3
2694765|NCT00430716|9289636|P2|Double Blind Phase|Adverse Event|1
2694766|NCT00430716|9289637|P1|Double Blind Phase|Adverse Event|1
2694767|NCT00430716|9289635|P3|Double Blind Phase|Study terminated by sponsor|2
2694768|NCT00430716|9289636|P2|Double Blind Phase|Study terminated by sponsor|1
2694769|NCT00430716|9289637|P1|Double Blind Phase|Study terminated by sponsor|1
2694770|NCT00430716|9289635|P3|Double Blind Phase|Other|0
2694771|NCT00430716|9289636|P2|Double Blind Phase|Other|2
2694772|NCT00430716|9289637|P1|Double Blind Phase|Other|0
2694773|NCT00430716|9289635|P3|Double Blind Phase|No longer willing to participate|1
2694774|NCT00430716|9289636|P2|Double Blind Phase|No longer willing to participate|1
2694775|NCT00430716|9289637|P1|Double Blind Phase|No longer willing to participate|2
2694776|NCT00430716|9289635|P3|Double Blind Phase|Death|0
2694777|NCT00430716|9289636|P2|Double Blind Phase|Death|0
2694778|NCT00430716|9289637|P1|Double Blind Phase|Death|1
2694779|NCT00430677|9289669|P3|Long-term Extension Period|Poor compliance/noncompliance|0
2694780|NCT00430677|9289670|P2|Long-term Extension Period|Poor compliance/noncompliance|0
2694781|NCT00430677|9289671|P1|Long-term Extension Period|Poor compliance/noncompliance|1
2694782|NCT00430677|9289669|P3|Long-term Extension Period|Other|1
2694783|NCT00430677|9289670|P2|Long-term Extension Period|Other|1
2694784|NCT00430677|9289671|P1|Long-term Extension Period|Other|2
2694785|NCT00430677|9289669|P3|Long-term Extension Period|Administrative reason by sponsor|46
2694786|NCT00430677|9289670|P2|Long-term Extension Period|Administrative reason by sponsor|49
2694787|NCT00430677|9289671|P1|Long-term Extension Period|Administrative reason by sponsor|41
2694788|NCT00430677|9289669|P3|Long-term Extension Period|Pregnancy|0
2694789|NCT00430677|9289670|P2|Long-term Extension Period|Pregnancy|1
2694790|NCT00430677|9289671|P1|Long-term Extension Period|Pregnancy|1
2694791|NCT00430677|9289669|P3|Long-term Extension Period|Withdrawal by Subject|2
2694792|NCT00430677|9289670|P2|Long-term Extension Period|Withdrawal by Subject|1
2694793|NCT00430677|9289671|P1|Long-term Extension Period|Withdrawal by Subject|5
2694794|NCT00430677|9289669|P3|Long-term Extension Period|Lost to Follow-up|1
2694795|NCT00430677|9289670|P2|Long-term Extension Period|Lost to Follow-up|1
2694796|NCT00430677|9289671|P1|Long-term Extension Period|Lost to Follow-up|1
2694797|NCT00430677|9289669|P3|Long-term Extension Period|Lack of Efficacy|8
2694798|NCT00430677|9289670|P2|Long-term Extension Period|Lack of Efficacy|3
2694799|NCT00430677|9289671|P1|Long-term Extension Period|Lack of Efficacy|5
2694800|NCT00430677|9289669|P3|Long-term Extension Period|Adverse Event|5
2694801|NCT00430677|9289670|P2|Long-term Extension Period|Adverse Event|2
2694802|NCT00430677|9289671|P1|Long-term Extension Period|Adverse Event|3
2694803|NCT00430677|9289669|P3|Long-term Extension Period|Death|0
2694804|NCT00430677|9289670|P2|Long-term Extension Period|Death|0
2694805|NCT00430677|9289671|P1|Long-term Extension Period|Death|1
2694806|NCT00430677|9289669|P3|Short-term Period|Pregnancy|0
2694807|NCT00430677|9289670|P2|Short-term Period|Pregnancy|2
2694808|NCT00430677|9289671|P1|Short-term Period|Pregnancy|0
2694809|NCT00430677|9289669|P3|Short-term Period|Poor compliance/ noncompliance|0
2694810|NCT00430677|9289670|P2|Short-term Period|Poor compliance/ noncompliance|1
2694811|NCT00430677|9289671|P1|Short-term Period|Poor compliance/ noncompliance|0
2694812|NCT00430677|9289669|P3|Short-term Period|Participant no longer met study criteria|2
2694813|NCT00430677|9289670|P2|Short-term Period|Participant no longer met study criteria|1
2694814|NCT00430677|9289671|P1|Short-term Period|Participant no longer met study criteria|1
2694815|NCT00430677|9289669|P3|Short-term Period|Withdrawal by Subject|2
2694816|NCT00430677|9289670|P2|Short-term Period|Withdrawal by Subject|1
2694817|NCT00430677|9289671|P1|Short-term Period|Withdrawal by Subject|1
2694818|NCT00430677|9289669|P3|Short-term Period|Lack of Efficacy|4
2694819|NCT00430677|9289670|P2|Short-term Period|Lack of Efficacy|6
2694820|NCT00430677|9289671|P1|Short-term Period|Lack of Efficacy|5
2694821|NCT00430677|9289669|P3|Short-term Period|Adverse Event|9
2694822|NCT00430677|9289670|P2|Short-term Period|Adverse Event|13
2694823|NCT00430677|9289671|P1|Short-term Period|Adverse Event|15
2694824|NCT00430677|9289669|P3|Short-term Period|Death|5
2694825|NCT00430677|9289670|P2|Short-term Period|Death|1
2694826|NCT00430677|9289671|P1|Short-term Period|Death|1
2694827|NCT00430638|9289794|P2|Overall Study|Other|2
2694828|NCT00430638|9289795|P1|Overall Study|Other|2
2694829|NCT00430638|9289794|P2|Overall Study|Non-compliant|1
2694830|NCT00430638|9289795|P1|Overall Study|Non-compliant|2
2694831|NCT00430638|9289794|P2|Overall Study|Withdrawal by Subject|6
2694832|NCT00430638|9289795|P1|Overall Study|Withdrawal by Subject|4
2694833|NCT00430638|9289794|P2|Overall Study|Protocol Violation|4
2694834|NCT00430638|9289795|P1|Overall Study|Protocol Violation|6
2694835|NCT00430638|9289794|P2|Overall Study|Lost to Follow-up|7
2694836|NCT00430638|9289795|P1|Overall Study|Lost to Follow-up|1
2694837|NCT00430638|9289794|P2|Overall Study|Uncontrolled blood pressure|13
2694838|NCT00430638|9289795|P1|Overall Study|Uncontrolled blood pressure|48
2694839|NCT00430638|9289794|P2|Overall Study|Adverse Event|15
2694840|NCT00430638|9289795|P1|Overall Study|Adverse Event|15
2694841|NCT00430573|9289830|P1|Overall Study|Withdrawal by Subject|5
2694842|NCT00430521|9289843|P8|Overall Study|Withdrawal by Subject|2
2694843|NCT00430521|9289844|P7|Overall Study|Withdrawal by Subject|0
2694844|NCT00430521|9289845|P6|Overall Study|Withdrawal by Subject|0
2694845|NCT00430521|9289846|P5|Overall Study|Withdrawal by Subject|0
2694846|NCT00430521|9289847|P4|Overall Study|Withdrawal by Subject|3
2694847|NCT00430521|9289848|P3|Overall Study|Withdrawal by Subject|0
2694848|NCT00430521|9289849|P2|Overall Study|Withdrawal by Subject|1
2694849|NCT00430521|9289850|P1|Overall Study|Withdrawal by Subject|3
2694850|NCT00430521|9289843|P8|Overall Study|Protocol Violation|0
2694851|NCT00430521|9289844|P7|Overall Study|Protocol Violation|0
2694852|NCT00430521|9289845|P6|Overall Study|Protocol Violation|0
2694853|NCT00430521|9289846|P5|Overall Study|Protocol Violation|0
2694854|NCT00430521|9289847|P4|Overall Study|Protocol Violation|0
2694855|NCT00430521|9289848|P3|Overall Study|Protocol Violation|0
2694856|NCT00430521|9289849|P2|Overall Study|Protocol Violation|0
2694857|NCT00430521|9289850|P1|Overall Study|Protocol Violation|1
2694858|NCT00430521|9289843|P8|Overall Study|Vaccine Expired|0
2694859|NCT00430521|9289844|P7|Overall Study|Vaccine Expired|0
2694860|NCT00430521|9289845|P6|Overall Study|Vaccine Expired|1
2694861|NCT00430521|9289846|P5|Overall Study|Vaccine Expired|0
2694862|NCT00430521|9289847|P4|Overall Study|Vaccine Expired|0
2694863|NCT00430521|9289848|P3|Overall Study|Vaccine Expired|0
2694864|NCT00430521|9289849|P2|Overall Study|Vaccine Expired|0
2694865|NCT00430521|9289850|P1|Overall Study|Vaccine Expired|0
2694866|NCT00430521|9289843|P8|Overall Study|Pregnancy|0
2694867|NCT00430521|9289844|P7|Overall Study|Pregnancy|1
2694868|NCT00430521|9289845|P6|Overall Study|Pregnancy|0
2694869|NCT00430521|9289846|P5|Overall Study|Pregnancy|0
2694870|NCT00430521|9289847|P4|Overall Study|Pregnancy|0
2694871|NCT00430521|9289848|P3|Overall Study|Pregnancy|0
2694872|NCT00430521|9289849|P2|Overall Study|Pregnancy|0
2694873|NCT00430521|9289850|P1|Overall Study|Pregnancy|0
2694874|NCT00430521|9289843|P8|Overall Study|Lost to Follow-up|10
2694875|NCT00430521|9289844|P7|Overall Study|Lost to Follow-up|8
2694876|NCT00430521|9289845|P6|Overall Study|Lost to Follow-up|2
2694877|NCT00430521|9289846|P5|Overall Study|Lost to Follow-up|5
2694878|NCT00430521|9289847|P4|Overall Study|Lost to Follow-up|5
2694879|NCT00430521|9289848|P3|Overall Study|Lost to Follow-up|3
2694880|NCT00430521|9289849|P2|Overall Study|Lost to Follow-up|8
2694881|NCT00430521|9289850|P1|Overall Study|Lost to Follow-up|7
2694882|NCT00430521|9289843|P8|Overall Study|Adverse Event|0
2694883|NCT00430521|9289844|P7|Overall Study|Adverse Event|1
2694884|NCT00430521|9289845|P6|Overall Study|Adverse Event|2
2694885|NCT00430521|9289846|P5|Overall Study|Adverse Event|0
2694886|NCT00430521|9289847|P4|Overall Study|Adverse Event|0
2694887|NCT00430521|9289848|P3|Overall Study|Adverse Event|0
2694888|NCT00430521|9289849|P2|Overall Study|Adverse Event|0
2694889|NCT00430521|9289850|P1|Overall Study|Adverse Event|0
2694890|NCT00430508|9290092|P4|Overall Study|Other|0
2694891|NCT00430508|9290093|P3|Overall Study|Other|3
2694892|NCT00430508|9290094|P2|Overall Study|Other|1
2694893|NCT00430508|9290095|P1|Overall Study|Other|1
2694894|NCT00430508|9290092|P4|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
2694895|NCT00430508|9290093|P3|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2
2694896|NCT00430508|9290094|P2|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
2694897|NCT00430508|9290095|P1|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0
2694898|NCT00430508|9290092|P4|Overall Study|responder at visit 4|0
2694899|NCT00430508|9290093|P3|Overall Study|responder at visit 4|2
2694900|NCT00430508|9290094|P2|Overall Study|responder at visit 4|0
2694901|NCT00430508|9290095|P1|Overall Study|responder at visit 4|0
2694902|NCT00430508|9290092|P4|Overall Study|Withdrawal by Subject|1
2694903|NCT00430508|9290093|P3|Overall Study|Withdrawal by Subject|1
2694904|NCT00430508|9290094|P2|Overall Study|Withdrawal by Subject|1
2694905|NCT00430508|9290095|P1|Overall Study|Withdrawal by Subject|0
2694906|NCT00430508|9290092|P4|Overall Study|Adverse Event|3
2694907|NCT00430508|9290093|P3|Overall Study|Adverse Event|5
2694908|NCT00430508|9290094|P2|Overall Study|Adverse Event|3
2694909|NCT00430508|9290095|P1|Overall Study|Adverse Event|2
2694910|NCT00430495|9290133|P4|Overall Study|Randomized but not Treated|0
2694911|NCT00430495|9290134|P3|Overall Study|Randomized but not Treated|0
2694912|NCT00430495|9290135|P2|Overall Study|Randomized but not Treated|0
2694913|NCT00430495|9290136|P1|Overall Study|Randomized but not Treated|2
2694914|NCT00430495|9290133|P4|Overall Study|Other|4
2694915|NCT00430495|9290134|P3|Overall Study|Other|5
2694916|NCT00430495|9290135|P2|Overall Study|Other|2
2694917|NCT00430495|9290136|P1|Overall Study|Other|8
2694918|NCT00430495|9290133|P4|Overall Study|Disease Progression|0
2694919|NCT00430495|9290134|P3|Overall Study|Disease Progression|0
2694920|NCT00430495|9290135|P2|Overall Study|Disease Progression|1
2694921|NCT00430495|9290136|P1|Overall Study|Disease Progression|1
2694922|NCT00430495|9290133|P4|Overall Study|Protocol Violation|0
2694923|NCT00430495|9290134|P3|Overall Study|Protocol Violation|1
2694924|NCT00430495|9290135|P2|Overall Study|Protocol Violation|0
2694925|NCT00430495|9290136|P1|Overall Study|Protocol Violation|1
2694926|NCT00430495|9290133|P4|Overall Study|Lost to Follow-up|0
2694927|NCT00430495|9290134|P3|Overall Study|Lost to Follow-up|4
2694928|NCT00430495|9290135|P2|Overall Study|Lost to Follow-up|1
2694929|NCT00430495|9290136|P1|Overall Study|Lost to Follow-up|0
2694930|NCT00430495|9290133|P4|Overall Study|Death|0
2694931|NCT00430495|9290134|P3|Overall Study|Death|1
2694932|NCT00430495|9290135|P2|Overall Study|Death|0
2694933|NCT00430495|9290136|P1|Overall Study|Death|0
2694934|NCT00430495|9290133|P4|Overall Study|Adverse Event|0
2694935|NCT00430495|9290134|P3|Overall Study|Adverse Event|2
2694936|NCT00430495|9290135|P2|Overall Study|Adverse Event|3
2694937|NCT00430495|9290136|P1|Overall Study|Adverse Event|2
2694938|NCT00430482|9290176|P2|Completed Treatment|Insufficient Treatment|11
2694939|NCT00430482|9290177|P1|Completed Treatment|Insufficient Treatment|7
2694940|NCT00430352|9290185|P1|Overall Study|Other|48
2694941|NCT00430352|9290185|P1|Overall Study|Death|5
2694942|NCT00430352|9290185|P1|Overall Study|Adverse Event|16
2694943|NCT00430352|9290185|P1|Overall Study|Withdrawal by Subject|11
2694944|NCT00430352|9290185|P1|Overall Study|Disease progression|58
2694945|NCT00430300|9290203|P4|Overall Study|Other|1
2694946|NCT00430300|9290204|P3|Overall Study|Other|0
2694947|NCT00430300|9290205|P2|Overall Study|Other|0
2694948|NCT00430300|9290206|P1|Overall Study|Other|0
2694949|NCT00430300|9290203|P4|Overall Study|Laboratory abnormality|0
2694950|NCT00430300|9290204|P3|Overall Study|Laboratory abnormality|0
2694951|NCT00430300|9290205|P2|Overall Study|Laboratory abnormality|0
2694952|NCT00430300|9290206|P1|Overall Study|Laboratory abnormality|1
2694953|NCT00430300|9290203|P4|Overall Study|Withdrawal by Subject|0
2694954|NCT00430300|9290204|P3|Overall Study|Withdrawal by Subject|5
2694955|NCT00430300|9290205|P2|Overall Study|Withdrawal by Subject|0
2694956|NCT00430300|9290206|P1|Overall Study|Withdrawal by Subject|1
2694957|NCT00430300|9290203|P4|Overall Study|Adverse Event|1
2694958|NCT00430300|9290204|P3|Overall Study|Adverse Event|1
2694959|NCT00430300|9290205|P2|Overall Study|Adverse Event|2
2694960|NCT00430300|9290206|P1|Overall Study|Adverse Event|0
2694961|NCT00430248|9290311|P3|Overall Study|Reason Not Specified|11
2694962|NCT00430248|9290312|P2|Overall Study|Reason Not Specified|8
2694963|NCT00430248|9290313|P1|Overall Study|Reason Not Specified|8
2694964|NCT00430248|9290311|P3|Overall Study|Gout Flare|2
2694965|NCT00430248|9290312|P2|Overall Study|Gout Flare|7
2694966|NCT00430248|9290313|P1|Overall Study|Gout Flare|3
2694967|NCT00430248|9290311|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
2694968|NCT00430248|9290312|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
2694969|NCT00430248|9290313|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|0
2694970|NCT00430248|9290311|P3|Overall Study|Withdrawal by Subject|16
2694971|NCT00430248|9290312|P2|Overall Study|Withdrawal by Subject|20
2694972|NCT00430248|9290313|P1|Overall Study|Withdrawal by Subject|14
2694973|NCT00430248|9290311|P3|Overall Study|Therapeutic Failure|1
2694974|NCT00430248|9290312|P2|Overall Study|Therapeutic Failure|1
2694975|NCT00430248|9290313|P1|Overall Study|Therapeutic Failure|1
2694976|NCT00430248|9290311|P3|Overall Study|Lost to Follow-up|28
2694977|NCT00430248|9290312|P2|Overall Study|Lost to Follow-up|33
2694978|NCT00430248|9290313|P1|Overall Study|Lost to Follow-up|28
2694979|NCT00430248|9290311|P3|Overall Study|Personal Reasons|9
2694980|NCT00430248|9290312|P2|Overall Study|Personal Reasons|24
2694981|NCT00430248|9290313|P1|Overall Study|Personal Reasons|12
2694982|NCT00430248|9290311|P3|Overall Study|Protocol Violation|4
2694983|NCT00430248|9290312|P2|Overall Study|Protocol Violation|2
2694984|NCT00430248|9290313|P1|Overall Study|Protocol Violation|10
2694985|NCT00430248|9290311|P3|Overall Study|Adverse Event|64
2694986|NCT00430248|9290312|P2|Overall Study|Adverse Event|61
2694987|NCT00430248|9290313|P1|Overall Study|Adverse Event|49
2694988|NCT00430092|9290381|P3|Overall Study|Withdrawal by Subject|1
2694989|NCT00430092|9290382|P2|Overall Study|Withdrawal by Subject|1
2694990|NCT00430092|9290383|P1|Overall Study|Withdrawal by Subject|0
2694991|NCT00430092|9290381|P3|Overall Study|Protocol Violation|1
2694992|NCT00430092|9290382|P2|Overall Study|Protocol Violation|1
2694993|NCT00430092|9290383|P1|Overall Study|Protocol Violation|0
2694994|NCT00430092|9290381|P3|Overall Study|Lost to Follow-up|0
2694995|NCT00430092|9290382|P2|Overall Study|Lost to Follow-up|0
2694996|NCT00430092|9290383|P1|Overall Study|Lost to Follow-up|1
2694997|NCT00430092|9290381|P3|Overall Study|Lack of Efficacy|54
2694998|NCT00430092|9290382|P2|Overall Study|Lack of Efficacy|2
2694999|NCT00430092|9290383|P1|Overall Study|Lack of Efficacy|5
2695000|NCT00430092|9290381|P3|Overall Study|Adverse Event|1
2695001|NCT00430092|9290382|P2|Overall Study|Adverse Event|0
2695002|NCT00430092|9290383|P1|Overall Study|Adverse Event|0
2695003|NCT00430027|9290388|P1|Overall Study|Study terminated|8
2695004|NCT00429923|9290405|P3|Overall Study|Early Termination|0
2695005|NCT00429923|9290406|P2|Overall Study|Early Termination|1
2695006|NCT00429923|9290407|P1|Overall Study|Early Termination|0
2695007|NCT00429923|9290405|P3|Overall Study|Withdrew Consent|1
2695008|NCT00429923|9290406|P2|Overall Study|Withdrew Consent|0
2695009|NCT00429923|9290407|P1|Overall Study|Withdrew Consent|1
2695010|NCT00429923|9290405|P3|Overall Study|Lost to Follow-up|2
2695011|NCT00429923|9290406|P2|Overall Study|Lost to Follow-up|0
2695012|NCT00429923|9290407|P1|Overall Study|Lost to Follow-up|0
2695013|NCT00429923|9290405|P3|Overall Study|Lack of Efficacy|33
2695014|NCT00429923|9290406|P2|Overall Study|Lack of Efficacy|1
2695015|NCT00429923|9290407|P1|Overall Study|Lack of Efficacy|4
2695016|NCT00429923|9290405|P3|Overall Study|Adverse Event|3
2695017|NCT00429923|9290406|P2|Overall Study|Adverse Event|2
2695018|NCT00429923|9290407|P1|Overall Study|Adverse Event|0
2695019|NCT00429793|9290412|P1|Overall Study|Non-measurable|1
2695020|NCT00429793|9290412|P1|Overall Study|Never treated|1
2695021|NCT00429793|9290412|P1|Overall Study|Required test not done|1
2695022|NCT00429793|9290412|P1|Overall Study|Improper pre-protocol treatment|3
2695023|NCT00429663|9290439|P2|Overall Study|Death|0
2695024|NCT00429663|9290440|P1|Overall Study|Death|4
2695025|NCT00429663|9290439|P2|Overall Study|Withdrawal by Subject|5
2695026|NCT00429663|9290440|P1|Overall Study|Withdrawal by Subject|2
2695027|NCT00429663|9290439|P2|Overall Study|Physician Decision|3
2695028|NCT00429663|9290440|P1|Overall Study|Physician Decision|6
2695029|NCT00429663|9290439|P2|Overall Study|Lost to Follow-up|31
2695030|NCT00429663|9290440|P1|Overall Study|Lost to Follow-up|24
2695031|NCT00429572|9290454|P1|Overall Study|Disease progression|1
2695032|NCT00429494|9290466|P1|Overall Study|Death|6
2695033|NCT00429494|9290466|P1|Overall Study|Withdrawal by Subject|9
2695034|NCT00429416|9290470|P1|Overall Study|Death|1
2695035|NCT00429364|9290489|P2|Overall Study|Pregnancy|1
2695036|NCT00429364|9290490|P1|Overall Study|Pregnancy|0
2695037|NCT00429364|9290489|P2|Overall Study|Underwent aortic root surgery|18
2695038|NCT00429364|9290490|P1|Overall Study|Underwent aortic root surgery|10
2695039|NCT00429364|9290489|P2|Overall Study|Death|1
2695040|NCT00429364|9290490|P1|Overall Study|Death|0
2695041|NCT00429364|9290489|P2|Overall Study|Lost to Follow-up|6
2695042|NCT00429364|9290490|P1|Overall Study|Lost to Follow-up|7
2695043|NCT00429364|9290489|P2|Overall Study|Physician Decision|2
2695044|NCT00429364|9290490|P1|Overall Study|Physician Decision|4
2695045|NCT00429364|9290489|P2|Overall Study|Withdrawal by Subject|5
2695046|NCT00429364|9290490|P1|Overall Study|Withdrawal by Subject|11
2695047|NCT00429299|9290549|P3|Overall Study|Withdrawal by Subject|3
2695048|NCT00429299|9290550|P2|Overall Study|Withdrawal by Subject|1
2695049|NCT00429299|9290551|P1|Overall Study|Withdrawal by Subject|0
2695050|NCT00429299|9290549|P3|Overall Study|Protocol Violation|0
2695051|NCT00429299|9290550|P2|Overall Study|Protocol Violation|0
2695052|NCT00429299|9290551|P1|Overall Study|Protocol Violation|1
2695053|NCT00429299|9290549|P3|Overall Study|Adverse Event|1
2695054|NCT00429299|9290550|P2|Overall Study|Adverse Event|5
2695055|NCT00429299|9290551|P1|Overall Study|Adverse Event|2
2695056|NCT00429299|9290549|P3|Overall Study|Disease Progression|0
2695057|NCT00429299|9290550|P2|Overall Study|Disease Progression|1
2695058|NCT00429299|9290551|P1|Overall Study|Disease Progression|1
2695059|NCT00429273|9290583|P3|Overall Study|Adverse Event|2
2695060|NCT00429273|9290584|P2|Overall Study|Adverse Event|1
2695061|NCT00429273|9290585|P1|Overall Study|Adverse Event|1
2695062|NCT00429273|9290583|P3|Overall Study|Physician Decision|5
2695063|NCT00429273|9290584|P2|Overall Study|Physician Decision|5
2695064|NCT00429273|9290585|P1|Overall Study|Physician Decision|6
2695065|NCT00429273|9290583|P3|Overall Study|Lost to Follow-up|2
2695066|NCT00429273|9290584|P2|Overall Study|Lost to Follow-up|2
2695067|NCT00429273|9290585|P1|Overall Study|Lost to Follow-up|1
2695068|NCT00429182|9290593|P1|Overall Study|Not eligible|5
2695069|NCT00429182|9290593|P1|Overall Study|Not evaluable, Disease Progression|2
2695070|NCT00429169|9290600|P2|Overall Study|Ineligibility discovered after entry|1
2695071|NCT00429169|9290601|P1|Overall Study|Ineligibility discovered after entry|2
2695072|NCT00429169|9290600|P2|Overall Study|Lost to Follow-up|1
2695073|NCT00429169|9290601|P1|Overall Study|Lost to Follow-up|0
2695074|NCT00429104|9290621|P1|Overall Study|Protocol Violation|1
2695075|NCT00429026|9290626|P1|Overall Study|Inevaluable for response.|40
2695076|NCT00428948|9290653|P2|Overall Study|Protocol Deviation|1
2695077|NCT00428948|9290654|P1|Overall Study|Protocol Deviation|1
2695078|NCT00428948|9290653|P2|Overall Study|Subject Withdrew Consent|30
2695079|NCT00428948|9290654|P1|Overall Study|Subject Withdrew Consent|50
2695080|NCT00428948|9290653|P2|Overall Study|Investigator Withdrew Subject|4
2695081|NCT00428948|9290654|P1|Overall Study|Investigator Withdrew Subject|3
2695082|NCT00428948|9290653|P2|Overall Study|Subject Met Withdrawal Criteria|0
2695083|NCT00428948|9290654|P1|Overall Study|Subject Met Withdrawal Criteria|4
2695084|NCT00428948|9290653|P2|Overall Study|Adverse Event|24
2695085|NCT00428948|9290654|P1|Overall Study|Adverse Event|148
2695086|NCT00428948|9290653|P2|Overall Study|Lost to Follow-up|8
2695087|NCT00428948|9290654|P1|Overall Study|Lost to Follow-up|15
2695088|NCT00428844|9290682|P3|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
2695089|NCT00428844|9290683|P2|Completed Test of Cure (TOC) Visit|Microbiologic failure|1
2695090|NCT00428844|9290684|P1|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
2695091|NCT00428844|9290682|P3|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
2695092|NCT00428844|9290683|P2|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
2695093|NCT00428844|9290684|P1|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2
2695094|NCT00428844|9290682|P3|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
2695095|NCT00428844|9290683|P2|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
2695096|NCT00428844|9290684|P1|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1
2695097|NCT00428844|9290682|P3|Completed Test of Cure (TOC) Visit|Protocol Violation|1
2695098|NCT00428844|9290683|P2|Completed Test of Cure (TOC) Visit|Protocol Violation|0
2695099|NCT00428844|9290684|P1|Completed Test of Cure (TOC) Visit|Protocol Violation|0
2695100|NCT00428844|9290682|P3|Completed Test of Cure (TOC) Visit|Adverse Event|1
2695101|NCT00428844|9290683|P2|Completed Test of Cure (TOC) Visit|Adverse Event|1
2695102|NCT00428844|9290684|P1|Completed Test of Cure (TOC) Visit|Adverse Event|0
2695103|NCT00428844|9290682|P3|Completed Study Drug Treatment|Randomized Not Treated|1
2695104|NCT00428844|9290683|P2|Completed Study Drug Treatment|Randomized Not Treated|0
2695105|NCT00428844|9290684|P1|Completed Study Drug Treatment|Randomized Not Treated|0
2695106|NCT00428844|9290682|P3|Completed Study Drug Treatment|Withdrawal by Subject|1
2695107|NCT00428844|9290683|P2|Completed Study Drug Treatment|Withdrawal by Subject|1
2695108|NCT00428844|9290684|P1|Completed Study Drug Treatment|Withdrawal by Subject|0
2695109|NCT00428844|9290682|P3|Completed Study Drug Treatment|Protocol Violation|1
2695110|NCT00428844|9290683|P2|Completed Study Drug Treatment|Protocol Violation|1
2695111|NCT00428844|9290684|P1|Completed Study Drug Treatment|Protocol Violation|0
2695112|NCT00428844|9290682|P3|Completed Study Drug Treatment|Adverse Event|4
2695113|NCT00428844|9290683|P2|Completed Study Drug Treatment|Adverse Event|4
2695114|NCT00428844|9290684|P1|Completed Study Drug Treatment|Adverse Event|2
2695115|NCT00428792|9290707|P2|Overall Study|Lost to Follow-up|1
2695116|NCT00428792|9290708|P1|Overall Study|Lost to Follow-up|0
2695117|NCT00428792|9290707|P2|Overall Study|Lack of Efficacy|3
2695118|NCT00428792|9290708|P1|Overall Study|Lack of Efficacy|1
2695119|NCT00428610|9290735|P3|Overall Study|Withdrawal by Subject|0
2695120|NCT00428610|9290736|P2|Overall Study|Withdrawal by Subject|0
2695121|NCT00428610|9290737|P1|Overall Study|Withdrawal by Subject|4
2695122|NCT00428610|9290735|P3|Overall Study|Progressive Disease|22
2695123|NCT00428610|9290736|P2|Overall Study|Progressive Disease|14
2695124|NCT00428610|9290737|P1|Overall Study|Progressive Disease|42
2695125|NCT00428610|9290735|P3|Overall Study|Investigator Decision|1
2695126|NCT00428610|9290736|P2|Overall Study|Investigator Decision|1
2695127|NCT00428610|9290737|P1|Overall Study|Investigator Decision|2
2695128|NCT00428610|9290735|P3|Overall Study|Adverse Event|2
2695129|NCT00428610|9290736|P2|Overall Study|Adverse Event|3
2695130|NCT00428610|9290737|P1|Overall Study|Adverse Event|2
2695131|NCT00428610|9290735|P3|Overall Study|Death Due to Progressive Disease|2
2695132|NCT00428610|9290736|P2|Overall Study|Death Due to Progressive Disease|0
2695133|NCT00428610|9290737|P1|Overall Study|Death Due to Progressive Disease|0
2695134|NCT00428610|9290735|P3|Overall Study|Death Due to Adverse Event|5
2695135|NCT00428610|9290736|P2|Overall Study|Death Due to Adverse Event|0
2695136|NCT00428610|9290737|P1|Overall Study|Death Due to Adverse Event|3
2695137|NCT00428597|9290771|P2|Overall Study|Death|3
2695138|NCT00428597|9290772|P1|Overall Study|Death|1
2695139|NCT00428597|9290771|P2|Overall Study|Pregnancy|0
2695140|NCT00428597|9290772|P1|Overall Study|Pregnancy|1
2695141|NCT00428597|9290771|P2|Overall Study|Lost to Follow-up|1
2695142|NCT00428597|9290772|P1|Overall Study|Lost to Follow-up|0
2695143|NCT00428597|9290771|P2|Overall Study|Other|1
2695144|NCT00428597|9290772|P1|Overall Study|Other|1
2695145|NCT00428597|9290771|P2|Overall Study|Withdrawal by Subject|1
2695146|NCT00428597|9290772|P1|Overall Study|Withdrawal by Subject|2
2695147|NCT00428597|9290771|P2|Overall Study|Protocol Violation|1
2695148|NCT00428597|9290772|P1|Overall Study|Protocol Violation|2
2695149|NCT00428597|9290771|P2|Overall Study|Global Deterioration of Health Status|5
2695150|NCT00428597|9290772|P1|Overall Study|Global Deterioration of Health Status|1
2695151|NCT00428597|9290771|P2|Overall Study|Adverse Event|7
2695152|NCT00428597|9290772|P1|Overall Study|Adverse Event|15
2695153|NCT00428597|9290771|P2|Overall Study|Study Terminated by Sponsor|16
2695154|NCT00428597|9290772|P1|Overall Study|Study Terminated by Sponsor|41
2695155|NCT00428597|9290771|P2|Overall Study|Objective Progression or Relapse|47
2695156|NCT00428597|9290772|P1|Overall Study|Objective Progression or Relapse|19
2695157|NCT00428597|9290771|P2|Overall Study|Randomized but not treated|3
2695158|NCT00428597|9290772|P1|Overall Study|Randomized but not treated|3
2695159|NCT00428441|9290839|P1|Overall Study|Lost to Follow-up|1
2695160|NCT00428389|9290845|P2|Extension Phase|Administrative problems|1
2695161|NCT00428389|9290846|P1|Extension Phase|Administrative problems|1
2695162|NCT00428389|9290845|P2|Extension Phase|Protocol Violation|2
2695163|NCT00428389|9290846|P1|Extension Phase|Protocol Violation|3
2695164|NCT00428389|9290845|P2|Extension Phase|Death|0
2695165|NCT00428389|9290846|P1|Extension Phase|Death|1
2695166|NCT00428389|9290845|P2|Extension Phase|Lost to Follow-up|3
2695167|NCT00428389|9290846|P1|Extension Phase|Lost to Follow-up|0
2695168|NCT00428389|9290845|P2|Extension Phase|Withdrawal by Subject|6
2695169|NCT00428389|9290846|P1|Extension Phase|Withdrawal by Subject|6
2695170|NCT00428389|9290845|P2|Extension Phase|Lack of Efficacy|3
2695171|NCT00428389|9290846|P1|Extension Phase|Lack of Efficacy|4
2695172|NCT00428389|9290845|P2|Extension Phase|Adverse Event|11
2695173|NCT00428389|9290846|P1|Extension Phase|Adverse Event|17
2695174|NCT00428389|9290845|P2|Core Phase|Protocol deviation|2
2695175|NCT00428389|9290846|P1|Core Phase|Protocol deviation|0
2695176|NCT00428389|9290845|P2|Core Phase|Withdrawal by Subject|4
2695177|NCT00428389|9290846|P1|Core Phase|Withdrawal by Subject|3
2695178|NCT00428389|9290845|P2|Core Phase|Abnormal test procedure result(s)|1
2695179|NCT00428389|9290846|P1|Core Phase|Abnormal test procedure result(s)|0
2695180|NCT00428389|9290845|P2|Core Phase|Lack of Efficacy|0
2695181|NCT00428389|9290846|P1|Core Phase|Lack of Efficacy|2
2695182|NCT00428389|9290845|P2|Core Phase|Adverse Event|4
2695183|NCT00428389|9290846|P1|Core Phase|Adverse Event|6
2695184|NCT00428246|9290880|P3|Overall Study|Adverse Event|0
2695185|NCT00428246|9290881|P2|Overall Study|Adverse Event|0
2695186|NCT00428246|9290882|P1|Overall Study|Adverse Event|1
2695187|NCT00428246|9290880|P3|Overall Study|Withdrawal by Subject|1
2695188|NCT00428246|9290881|P2|Overall Study|Withdrawal by Subject|0
2695189|NCT00428246|9290882|P1|Overall Study|Withdrawal by Subject|0
2695190|NCT00428220|9290890|P1|Overall Study|Other|23
2695191|NCT00428220|9290890|P1|Overall Study|Adverse Event|51
2695192|NCT00428220|9290890|P1|Overall Study|Participant refused continued treatment|7
2695193|NCT00428220|9290890|P1|Overall Study|Objective progression or relapse|123
2695194|NCT00428220|9290890|P1|Overall Study|Lost to Follow-up|4
2695195|NCT00428220|9290890|P1|Overall Study|Global deterioration of health status|7
2695196|NCT00428220|9290890|P1|Overall Study|Participant died|8
2695197|NCT00428116|9290915|P2|Overall Study|Lost to Follow-up|0
2695198|NCT00428116|9290916|P1|Overall Study|Lost to Follow-up|1
2695199|NCT00428116|9290915|P2|Overall Study|Withdrawal by Subject|0
2695200|NCT00428116|9290916|P1|Overall Study|Withdrawal by Subject|1
2695201|NCT00428116|9290915|P2|Overall Study|Death|0
2695202|NCT00428116|9290916|P1|Overall Study|Death|1
2695203|NCT00428090|9290928|P4|Overall Study|Raised Creatinine Value|1
2695204|NCT00428090|9290929|P3|Overall Study|Raised Creatinine Value|0
2695205|NCT00428090|9290930|P2|Overall Study|Raised Creatinine Value|0
2695206|NCT00428090|9290931|P1|Overall Study|Raised Creatinine Value|0
2695207|NCT00428090|9290928|P4|Overall Study|Excluded for heart insufficiency|0
2695208|NCT00428090|9290929|P3|Overall Study|Excluded for heart insufficiency|1
2695209|NCT00428090|9290930|P2|Overall Study|Excluded for heart insufficiency|0
2695210|NCT00428090|9290931|P1|Overall Study|Excluded for heart insufficiency|0
2695211|NCT00428090|9290928|P4|Overall Study|Serious adverse event|0
2695212|NCT00428090|9290929|P3|Overall Study|Serious adverse event|1
2695213|NCT00428090|9290930|P2|Overall Study|Serious adverse event|0
2695214|NCT00428090|9290931|P1|Overall Study|Serious adverse event|0
2695215|NCT00428090|9290928|P4|Overall Study|Deterioration of cognitive status|0
2695216|NCT00428090|9290929|P3|Overall Study|Deterioration of cognitive status|1
2695217|NCT00428090|9290930|P2|Overall Study|Deterioration of cognitive status|0
2695218|NCT00428090|9290931|P1|Overall Study|Deterioration of cognitive status|0
2695219|NCT00428090|9290928|P4|Overall Study|High MMSE scores|0
2695220|NCT00428090|9290929|P3|Overall Study|High MMSE scores|1
2695221|NCT00428090|9290930|P2|Overall Study|High MMSE scores|0
2695222|NCT00428090|9290931|P1|Overall Study|High MMSE scores|0
2695223|NCT00428090|9290928|P4|Overall Study|Insufficient AD documentation|0
2695224|NCT00428090|9290929|P3|Overall Study|Insufficient AD documentation|1
2695225|NCT00428090|9290930|P2|Overall Study|Insufficient AD documentation|0
2695226|NCT00428090|9290931|P1|Overall Study|Insufficient AD documentation|0
2695227|NCT00428090|9290928|P4|Overall Study|Excluded for concerning QTc value|0
2695228|NCT00428090|9290929|P3|Overall Study|Excluded for concerning QTc value|1
2695229|NCT00428090|9290930|P2|Overall Study|Excluded for concerning QTc value|0
2695230|NCT00428090|9290931|P1|Overall Study|Excluded for concerning QTc value|0
2695231|NCT00428090|9290928|P4|Overall Study|Worsening of AD|0
2695232|NCT00428090|9290929|P3|Overall Study|Worsening of AD|1
2695233|NCT00428090|9290930|P2|Overall Study|Worsening of AD|0
2695234|NCT00428090|9290931|P1|Overall Study|Worsening of AD|0
2695235|NCT00428090|9290928|P4|Overall Study|Mental status of par. was|0
2695236|NCT00428090|9290929|P3|Overall Study|Mental status of par. was|0
2695237|NCT00428090|9290930|P2|Overall Study|Mental status of par. was|1
2695238|NCT00428090|9290931|P1|Overall Study|Mental status of par. was|0
2695239|NCT00428090|9290928|P4|Overall Study|Medical monitor terminated par.|0
2695240|NCT00428090|9290929|P3|Overall Study|Medical monitor terminated par.|0
2695241|NCT00428090|9290930|P2|Overall Study|Medical monitor terminated par.|1
2695242|NCT00428090|9290931|P1|Overall Study|Medical monitor terminated par.|0
2695243|NCT00428090|9290928|P4|Overall Study|Visit 7 exceed the visit window|0
2695244|NCT00428090|9290929|P3|Overall Study|Visit 7 exceed the visit window|0
2695245|NCT00428090|9290930|P2|Overall Study|Visit 7 exceed the visit window|1
2695246|NCT00428090|9290931|P1|Overall Study|Visit 7 exceed the visit window|0
2695247|NCT00428090|9290928|P4|Overall Study|Death of par.|0
2695248|NCT00428090|9290929|P3|Overall Study|Death of par.|1
2695249|NCT00428090|9290930|P2|Overall Study|Death of par.|0
2695250|NCT00428090|9290931|P1|Overall Study|Death of par.|1
2695251|NCT00428090|9290928|P4|Overall Study|Prohibited medication used for SAE|0
2695252|NCT00428090|9290929|P3|Overall Study|Prohibited medication used for SAE|0
2695253|NCT00428090|9290930|P2|Overall Study|Prohibited medication used for SAE|0
2695254|NCT00428090|9290931|P1|Overall Study|Prohibited medication used for SAE|1
2695255|NCT00428090|9290928|P4|Overall Study|Follow-Up visit not possible|0
2695256|NCT00428090|9290929|P3|Overall Study|Follow-Up visit not possible|0
2695257|NCT00428090|9290930|P2|Overall Study|Follow-Up visit not possible|0
2695258|NCT00428090|9290931|P1|Overall Study|Follow-Up visit not possible|1
2695259|NCT00428090|9290928|P4|Overall Study|Par. did not returned to visit|1
2695260|NCT00428090|9290929|P3|Overall Study|Par. did not returned to visit|0
2695261|NCT00428090|9290930|P2|Overall Study|Par. did not returned to visit|0
2695262|NCT00428090|9290931|P1|Overall Study|Par. did not returned to visit|1
2695263|NCT00428090|9290928|P4|Overall Study|Non-compliance|3
2695264|NCT00428090|9290929|P3|Overall Study|Non-compliance|1
2695265|NCT00428090|9290930|P2|Overall Study|Non-compliance|0
2695266|NCT00428090|9290931|P1|Overall Study|Non-compliance|4
2695267|NCT00428090|9290928|P4|Overall Study|Sponsor terminated study|0
2695268|NCT00428090|9290929|P3|Overall Study|Sponsor terminated study|0
2695269|NCT00428090|9290930|P2|Overall Study|Sponsor terminated study|1
2695270|NCT00428090|9290931|P1|Overall Study|Sponsor terminated study|0
2695271|NCT00428090|9290928|P4|Overall Study|Withdrawal by Subject|5
2695272|NCT00428090|9290929|P3|Overall Study|Withdrawal by Subject|15
2695273|NCT00428090|9290930|P2|Overall Study|Withdrawal by Subject|12
2695274|NCT00428090|9290931|P1|Overall Study|Withdrawal by Subject|10
2695275|NCT00428090|9290928|P4|Overall Study|Protocol Violation|3
2695276|NCT00428090|9290929|P3|Overall Study|Protocol Violation|3
2695277|NCT00428090|9290930|P2|Overall Study|Protocol Violation|1
2695278|NCT00428090|9290931|P1|Overall Study|Protocol Violation|3
2695279|NCT00428090|9290928|P4|Overall Study|Lost to Follow-up|4
2695280|NCT00428090|9290929|P3|Overall Study|Lost to Follow-up|1
2695281|NCT00428090|9290930|P2|Overall Study|Lost to Follow-up|6
2695282|NCT00428090|9290931|P1|Overall Study|Lost to Follow-up|3
2695283|NCT00428090|9290928|P4|Overall Study|Adverse Event|11
2695284|NCT00428090|9290929|P3|Overall Study|Adverse Event|10
2695285|NCT00428090|9290930|P2|Overall Study|Adverse Event|8
2695286|NCT00428090|9290931|P1|Overall Study|Adverse Event|10
2695287|NCT00427999|9291049|P1|Overall Study|Death|1
2695288|NCT00427999|9291049|P1|Overall Study|Withdrawal by Subject|9
2695289|NCT00427999|9291049|P1|Overall Study|Protocol Violation|2
2695290|NCT00427999|9291049|P1|Overall Study|Unsatisfactory therapeutic effect|13
2695291|NCT00427999|9291049|P1|Overall Study|Abnormal laboratory values|1
2695292|NCT00427999|9291049|P1|Overall Study|Adverse Event|6
2695293|NCT00427960|9291067|P2|Overall Study|Other|1
2695294|NCT00427960|9291068|P1|Overall Study|Other|0
2695295|NCT00427960|9291067|P2|Overall Study|Withdrawal by Subject|3
2695296|NCT00427960|9291068|P1|Overall Study|Withdrawal by Subject|0
2695297|NCT00427960|9291067|P2|Overall Study|Adverse Event|0
2695298|NCT00427960|9291068|P1|Overall Study|Adverse Event|2
2695299|NCT00427934|9291106|P4|Overall Study|Withdrawal by Subject|3
2695300|NCT00427934|9291107|P3|Overall Study|Withdrawal by Subject|1
2695301|NCT00427934|9291108|P2|Overall Study|Withdrawal by Subject|0
2695302|NCT00427934|9291109|P1|Overall Study|Withdrawal by Subject|0
2695303|NCT00427934|9291106|P4|Overall Study|Other|5
2695304|NCT00427934|9291107|P3|Overall Study|Other|11
2695305|NCT00427934|9291108|P2|Overall Study|Other|0
2695306|NCT00427934|9291109|P1|Overall Study|Other|0
2695307|NCT00427934|9291106|P4|Overall Study|Randomized But Did Not Receive Treatment|1
2695308|NCT00427934|9291107|P3|Overall Study|Randomized But Did Not Receive Treatment|1
2695309|NCT00427934|9291108|P2|Overall Study|Randomized But Did Not Receive Treatment|0
2695310|NCT00427934|9291109|P1|Overall Study|Randomized But Did Not Receive Treatment|0
2695311|NCT00427934|9291106|P4|Overall Study|Lack of Efficacy|2
2695312|NCT00427934|9291107|P3|Overall Study|Lack of Efficacy|5
2695313|NCT00427934|9291108|P2|Overall Study|Lack of Efficacy|0
2695314|NCT00427934|9291109|P1|Overall Study|Lack of Efficacy|0
2695315|NCT00427934|9291106|P4|Overall Study|Adverse Event|4
2695316|NCT00427934|9291107|P3|Overall Study|Adverse Event|5
2695317|NCT00427934|9291108|P2|Overall Study|Adverse Event|0
2695318|NCT00427934|9291109|P1|Overall Study|Adverse Event|1
2695319|NCT00427921|9291177|P1|Overall Study|Withdrew Consent + Lack of Efficacy|1
2695320|NCT00427921|9291177|P1|Overall Study|Adverse Event + Withdrawn from Study|1
2695321|NCT00427921|9291177|P1|Overall Study|Adverse Event + Lost Response|1
2695322|NCT00427921|9291177|P1|Overall Study|Adverse Event + No Therapeutic Benefit|1
2695323|NCT00427921|9291177|P1|Overall Study|Adverse Event + Worsening of CD|1
2695324|NCT00427921|9291177|P1|Overall Study|Adverse Event + No Response|1
2695325|NCT00427921|9291177|P1|Overall Study|Adverse Event + Withdrew Consent|1
2695326|NCT00427921|9291177|P1|Overall Study|Adverse Event + Hospitalization|1
2695327|NCT00427921|9291177|P1|Overall Study|Other reason not specified|10
2695328|NCT00427921|9291177|P1|Overall Study|Lost to Follow-up|2
2695329|NCT00427921|9291177|P1|Overall Study|Withdrawal by Subject|4
2695330|NCT00427921|9291177|P1|Overall Study|Adverse Event|26
2695331|NCT00427908|9291200|P4|Primary Phase|Adverse Event|0
2695332|NCT00427908|9291201|P3|Primary Phase|Adverse Event|0
2695333|NCT00427908|9291202|P2|Primary Phase|Adverse Event|1
2695334|NCT00427908|9291203|P1|Primary Phase|Adverse Event|0
2695335|NCT00427908|9291200|P4|Primary Phase|Withdrawal by Subject|0
2695336|NCT00427908|9291201|P3|Primary Phase|Withdrawal by Subject|1
2695337|NCT00427908|9291202|P2|Primary Phase|Withdrawal by Subject|2
2695338|NCT00427908|9291203|P1|Primary Phase|Withdrawal by Subject|1
2695339|NCT00427908|9291200|P4|Primary Phase|Lost to Follow-up|0
2695340|NCT00427908|9291201|P3|Primary Phase|Lost to Follow-up|2
2695341|NCT00427908|9291202|P2|Primary Phase|Lost to Follow-up|0
2695342|NCT00427908|9291203|P1|Primary Phase|Lost to Follow-up|4
2695343|NCT00427895|9291403|P8|Vax 2/Year 3 to 4|Failed to Return|0
2695344|NCT00427895|9291404|P7|Vax 2/Year 3 to 4|Failed to Return|0
2695345|NCT00427895|9291405|P6|Vax 2/Year 3 to 4|Failed to Return|0
2695346|NCT00427895|9291406|P5|Vax 2/Year 3 to 4|Failed to Return|1
2695347|NCT00427895|9291407|P4|Vax 2/Year 3 to 4|Failed to Return|0
2695348|NCT00427895|9291408|P3|Vax 2/Year 3 to 4|Failed to Return|0
2695349|NCT00427895|9291409|P2|Vax 2/Year 3 to 4|Failed to Return|0
2695350|NCT00427895|9291410|P1|Vax 2/Year 3 to 4|Failed to Return|0
2695351|NCT00427895|9291403|P8|Vax 2/Year 3 to 4|Protocol Violation|1
2695352|NCT00427895|9291404|P7|Vax 2/Year 3 to 4|Protocol Violation|0
2695353|NCT00427895|9291405|P6|Vax 2/Year 3 to 4|Protocol Violation|0
2695354|NCT00427895|9291406|P5|Vax 2/Year 3 to 4|Protocol Violation|0
2695355|NCT00427895|9291407|P4|Vax 2/Year 3 to 4|Protocol Violation|0
2695356|NCT00427895|9291408|P3|Vax 2/Year 3 to 4|Protocol Violation|0
2695357|NCT00427895|9291409|P2|Vax 2/Year 3 to 4|Protocol Violation|0
2695358|NCT00427895|9291410|P1|Vax 2/Year 3 to 4|Protocol Violation|0
2695359|NCT00427895|9291403|P8|Vax 2/Year 3 to 4|Lost to Follow-up|1
2695360|NCT00427895|9291404|P7|Vax 2/Year 3 to 4|Lost to Follow-up|0
2695361|NCT00427895|9291405|P6|Vax 2/Year 3 to 4|Lost to Follow-up|0
2695362|NCT00427895|9291406|P5|Vax 2/Year 3 to 4|Lost to Follow-up|0
2695363|NCT00427895|9291407|P4|Vax 2/Year 3 to 4|Lost to Follow-up|0
2695364|NCT00427895|9291408|P3|Vax 2/Year 3 to 4|Lost to Follow-up|0
2695365|NCT00427895|9291409|P2|Vax 2/Year 3 to 4|Lost to Follow-up|0
2695366|NCT00427895|9291410|P1|Vax 2/Year 3 to 4|Lost to Follow-up|0
2695367|NCT00427895|9291403|P8|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
2695368|NCT00427895|9291404|P7|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
2695369|NCT00427895|9291405|P6|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
2695370|NCT00427895|9291406|P5|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
2695371|NCT00427895|9291407|P4|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469
2695372|NCT00427895|9291408|P3|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159
2695373|NCT00427895|9291409|P2|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207
2695374|NCT00427895|9291410|P1|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188
2695375|NCT00427895|9291403|P8|Vax 1/Year 1 Follow-up|Other|0
2695376|NCT00427895|9291404|P7|Vax 1/Year 1 Follow-up|Other|0
2695377|NCT00427895|9291405|P6|Vax 1/Year 1 Follow-up|Other|0
2695378|NCT00427895|9291406|P5|Vax 1/Year 1 Follow-up|Other|0
2695379|NCT00427895|9291407|P4|Vax 1/Year 1 Follow-up|Other|2
2695380|NCT00427895|9291408|P3|Vax 1/Year 1 Follow-up|Other|0
2695381|NCT00427895|9291409|P2|Vax 1/Year 1 Follow-up|Other|0
2695382|NCT00427895|9291410|P1|Vax 1/Year 1 Follow-up|Other|0
2695383|NCT00427895|9291403|P8|Vax 1/Year 1 Follow-up|Failed to Return|0
2695384|NCT00427895|9291404|P7|Vax 1/Year 1 Follow-up|Failed to Return|0
2695385|NCT00427895|9291405|P6|Vax 1/Year 1 Follow-up|Failed to Return|0
2695386|NCT00427895|9291406|P5|Vax 1/Year 1 Follow-up|Failed to Return|0
2695387|NCT00427895|9291407|P4|Vax 1/Year 1 Follow-up|Failed to Return|5
2695388|NCT00427895|9291408|P3|Vax 1/Year 1 Follow-up|Failed to Return|12
2695389|NCT00427895|9291409|P2|Vax 1/Year 1 Follow-up|Failed to Return|0
2695390|NCT00427895|9291410|P1|Vax 1/Year 1 Follow-up|Failed to Return|0
2695391|NCT00427895|9291403|P8|Vax 1/Year 1 Follow-up|Death|0
2695392|NCT00427895|9291404|P7|Vax 1/Year 1 Follow-up|Death|0
2695393|NCT00427895|9291405|P6|Vax 1/Year 1 Follow-up|Death|0
2695394|NCT00427895|9291406|P5|Vax 1/Year 1 Follow-up|Death|0
2695395|NCT00427895|9291407|P4|Vax 1/Year 1 Follow-up|Death|0
2695396|NCT00427895|9291408|P3|Vax 1/Year 1 Follow-up|Death|0
2695397|NCT00427895|9291409|P2|Vax 1/Year 1 Follow-up|Death|0
2695398|NCT00427895|9291410|P1|Vax 1/Year 1 Follow-up|Death|1
2695399|NCT00427895|9291403|P8|Vax 1/Year 1 Follow-up|Adverse Event|0
2695400|NCT00427895|9291404|P7|Vax 1/Year 1 Follow-up|Adverse Event|0
2695401|NCT00427895|9291405|P6|Vax 1/Year 1 Follow-up|Adverse Event|0
2695402|NCT00427895|9291406|P5|Vax 1/Year 1 Follow-up|Adverse Event|0
2695403|NCT00427895|9291407|P4|Vax 1/Year 1 Follow-up|Adverse Event|0
2695404|NCT00427895|9291408|P3|Vax 1/Year 1 Follow-up|Adverse Event|0
2695405|NCT00427895|9291409|P2|Vax 1/Year 1 Follow-up|Adverse Event|1
2695406|NCT00427895|9291410|P1|Vax 1/Year 1 Follow-up|Adverse Event|0
2695407|NCT00427895|9291403|P8|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
2695408|NCT00427895|9291404|P7|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
2695409|NCT00427895|9291405|P6|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
2695410|NCT00427895|9291406|P5|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
2695411|NCT00427895|9291407|P4|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4
2695412|NCT00427895|9291408|P3|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5
2695413|NCT00427895|9291409|P2|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6
2695414|NCT00427895|9291410|P1|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3
2695415|NCT00427895|9291403|P8|Vax 1/Year 1 Follow-up|Protocol Violation|0
2695416|NCT00427895|9291404|P7|Vax 1/Year 1 Follow-up|Protocol Violation|0
2695417|NCT00427895|9291405|P6|Vax 1/Year 1 Follow-up|Protocol Violation|0
2695418|NCT00427895|9291406|P5|Vax 1/Year 1 Follow-up|Protocol Violation|0
2695419|NCT00427895|9291407|P4|Vax 1/Year 1 Follow-up|Protocol Violation|1
2695420|NCT00427895|9291408|P3|Vax 1/Year 1 Follow-up|Protocol Violation|0
2695421|NCT00427895|9291409|P2|Vax 1/Year 1 Follow-up|Protocol Violation|3
2695422|NCT00427895|9291410|P1|Vax 1/Year 1 Follow-up|Protocol Violation|3
2695423|NCT00427895|9291403|P8|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
2695424|NCT00427895|9291404|P7|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
2695425|NCT00427895|9291405|P6|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
2695426|NCT00427895|9291406|P5|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
2695427|NCT00427895|9291407|P4|Vax 1/Year 1 Follow-up|Lost to Follow-up|21
2695428|NCT00427895|9291408|P3|Vax 1/Year 1 Follow-up|Lost to Follow-up|2
2695429|NCT00427895|9291409|P2|Vax 1/Year 1 Follow-up|Lost to Follow-up|5
2695430|NCT00427895|9291410|P1|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
2695431|NCT00427895|9291403|P8|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
2695432|NCT00427895|9291404|P7|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
2695433|NCT00427895|9291405|P6|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
2695434|NCT00427895|9291406|P5|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
2695435|NCT00427895|9291407|P4|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352
2695436|NCT00427895|9291408|P3|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
2695437|NCT00427895|9291409|P2|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
2695438|NCT00427895|9291410|P1|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
2695439|NCT00427895|9291403|P8|Vax 1 Baseline/6-Month Follow-up|Other|0
2695440|NCT00427895|9291404|P7|Vax 1 Baseline/6-Month Follow-up|Other|0
2695441|NCT00427895|9291405|P6|Vax 1 Baseline/6-Month Follow-up|Other|0
2695442|NCT00427895|9291406|P5|Vax 1 Baseline/6-Month Follow-up|Other|0
2695443|NCT00427895|9291407|P4|Vax 1 Baseline/6-Month Follow-up|Other|2
2695444|NCT00427895|9291408|P3|Vax 1 Baseline/6-Month Follow-up|Other|1
2695445|NCT00427895|9291409|P2|Vax 1 Baseline/6-Month Follow-up|Other|0
2695446|NCT00427895|9291410|P1|Vax 1 Baseline/6-Month Follow-up|Other|0
2695447|NCT00427895|9291403|P8|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
2695448|NCT00427895|9291404|P7|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
2695449|NCT00427895|9291405|P6|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
2695450|NCT00427895|9291406|P5|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
2695451|NCT00427895|9291407|P4|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
2695452|NCT00427895|9291408|P3|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2
2695453|NCT00427895|9291409|P2|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3
2695454|NCT00427895|9291410|P1|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
2695455|NCT00427895|9291403|P8|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
2695456|NCT00427895|9291404|P7|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
2695457|NCT00427895|9291405|P6|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
2695458|NCT00427895|9291406|P5|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
2695459|NCT00427895|9291407|P4|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2
2695460|NCT00427895|9291408|P3|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
2695461|NCT00427895|9291409|P2|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
2695462|NCT00427895|9291410|P1|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
2695463|NCT00427895|9291403|P8|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
2695464|NCT00427895|9291404|P7|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
2695465|NCT00427895|9291405|P6|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
2695466|NCT00427895|9291406|P5|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
2695467|NCT00427895|9291407|P4|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7
2695468|NCT00427895|9291408|P3|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4
2695469|NCT00427895|9291409|P2|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
2695470|NCT00427895|9291410|P1|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
2695471|NCT00427895|9291403|P8|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
2695472|NCT00427895|9291404|P7|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
2695473|NCT00427895|9291405|P6|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
2695474|NCT00427895|9291406|P5|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
2695475|NCT00427895|9291407|P4|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
2695476|NCT00427895|9291408|P3|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
2695477|NCT00427895|9291409|P2|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
2695478|NCT00427895|9291410|P1|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
2695479|NCT00427895|9291403|P8|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
2695480|NCT00427895|9291404|P7|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
2695481|NCT00427895|9291405|P6|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
2695482|NCT00427895|9291406|P5|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
2695483|NCT00427895|9291407|P4|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2
2695484|NCT00427895|9291408|P3|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3
2695485|NCT00427895|9291409|P2|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
2695486|NCT00427895|9291410|P1|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4
2695487|NCT00427895|9291403|P8|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
2695488|NCT00427895|9291404|P7|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
2695489|NCT00427895|9291405|P6|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
2695490|NCT00427895|9291406|P5|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
2695491|NCT00427895|9291407|P4|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32
2695492|NCT00427895|9291408|P3|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4
2695493|NCT00427895|9291409|P2|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1
2695494|NCT00427895|9291410|P1|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
2695495|NCT00427778|9291485|P2|First Intervention (4 Weeks)|anxious about using ring|0
2695496|NCT00427778|9291486|P1|First Intervention (4 Weeks)|anxious about using ring|1
2695497|NCT00427778|9291485|P2|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1
2695498|NCT00427778|9291486|P1|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0
2695499|NCT00427778|9291485|P2|First Intervention (4 Weeks)|Not successfully fitted with ring|0
2695500|NCT00427778|9291486|P1|First Intervention (4 Weeks)|Not successfully fitted with ring|2
2695501|NCT00427778|9291485|P2|First Intervention (4 Weeks)|no longer interested|0
2695502|NCT00427778|9291486|P1|First Intervention (4 Weeks)|no longer interested|1
2695503|NCT00427700|9291511|P2|Overall Study|Pregnancy|2
2695504|NCT00427700|9291512|P1|Overall Study|Pregnancy|0
2695505|NCT00427700|9291511|P2|Overall Study|no induction of menses|4
2695506|NCT00427700|9291512|P1|Overall Study|no induction of menses|1
2695507|NCT00427700|9291511|P2|Overall Study|Lost to Follow-up|5
2695508|NCT00427700|9291512|P1|Overall Study|Lost to Follow-up|2
2695509|NCT00427648|9291528|P2|Overall Study|Adverse Event|1
2695510|NCT00427648|9291529|P1|Overall Study|Adverse Event|0
2695511|NCT00427648|9291528|P2|Overall Study|Protocol Violation|2
2695512|NCT00427648|9291529|P1|Overall Study|Protocol Violation|1
2695513|NCT00427635|9291549|P2|Study Completion to Safety Follow-up|Lost to Follow-up|1
2695514|NCT00427635|9291550|P1|Study Completion to Safety Follow-up|Lost to Follow-up|0
2695515|NCT00427635|9291549|P2|Treatment Phase|Withdrawal by Subject|0
2695516|NCT00427635|9291550|P1|Treatment Phase|Withdrawal by Subject|1
2695517|NCT00427349|9291582|P1|Overall Study|Never started therapy|1
2695518|NCT00427349|9291582|P1|Overall Study|Ineligible|1
2695519|NCT00427349|9291582|P1|Overall Study|Other|2
2695520|NCT00427349|9291582|P1|Overall Study|Alternative therapy|1
2695521|NCT00427349|9291582|P1|Overall Study|Withdrawal by Subject|3
2695522|NCT00427349|9291582|P1|Overall Study|Death|1
2695523|NCT00427349|9291582|P1|Overall Study|Adverse Event|14
2695524|NCT00427349|9291582|P1|Overall Study|Lack of Efficacy|23
2695525|NCT00427011|9291639|P1|Overall Study|Other|12
2695526|NCT00427011|9291639|P1|Overall Study|Lack of Efficacy|2
2695527|NCT00427011|9291639|P1|Overall Study|Withdrawal by Subject|1
2695528|NCT00427011|9291639|P1|Overall Study|Adverse Event|10
2695529|NCT00426842|9291654|P1|Overall Study|Lost to Follow-up|1
2695530|NCT00426764|9291660|P1|Overall Study|Other Reasons (Miscellaneous)|10
2695531|NCT00426764|9291660|P1|Overall Study|Death|1
2695532|NCT00426764|9291660|P1|Overall Study|Other|1
2695533|NCT00426764|9291660|P1|Overall Study|Adverse Event|24
2695534|NCT00426764|9291660|P1|Overall Study|Progressive Disease|83
2695535|NCT00426764|9291660|P1|Overall Study|Compassionate Use|1
2695536|NCT00426764|9291660|P1|Overall Study|Physician Decision|6
2695537|NCT00426764|9291660|P1|Overall Study|Withdrawal by Subject|4
2695538|NCT00426764|9291660|P1|Overall Study|Protocol Violation|1
2695539|NCT00426751|9291677|P2|Overall Study|Other Reasons|12
2695540|NCT00426751|9291678|P1|Overall Study|Other Reasons|7
2695541|NCT00426751|9291677|P2|Overall Study|Consent Withdrawn|1
2695542|NCT00426751|9291678|P1|Overall Study|Consent Withdrawn|0
2695543|NCT00426751|9291677|P2|Overall Study|Lost to Follow-up|6
2695544|NCT00426751|9291678|P1|Overall Study|Lost to Follow-up|7
2695545|NCT00426751|9291677|P2|Overall Study|Adverse Event|1
2695546|NCT00426751|9291678|P1|Overall Study|Adverse Event|8
2695547|NCT00426660|9291722|P1|Overall Study|Enrolled Not Treated|15
2695548|NCT00426660|9291722|P1|Overall Study|Protocol Violation|1
2695549|NCT00426660|9291722|P1|Overall Study|Withdrawal by Subject|18
2695550|NCT00426660|9291722|P1|Overall Study|Other|23
2695551|NCT00426660|9291722|P1|Overall Study|Lost to Follow-up|15
2695552|NCT00426660|9291722|P1|Overall Study|Insufficient Clinical Response|22
2695553|NCT00426660|9291722|P1|Overall Study|Adverse Event|23
2695554|NCT00426660|9291722|P1|Overall Study|Death|14
2695555|NCT00426556|9291753|P4|Phase II - Extension Phase|Adverse Event|2
2695556|NCT00426556|9291754|P3|Phase II - Extension Phase|Adverse Event|0
2695557|NCT00426556|9291755|P2|Phase II - Extension Phase|Adverse Event|0
2695558|NCT00426556|9291756|P1|Phase II - Extension Phase|Adverse Event|0
2695559|NCT00426556|9291753|P4|Phase II - Extension Phase|Disease Progression|21
2695560|NCT00426556|9291754|P3|Phase II - Extension Phase|Disease Progression|0
2695561|NCT00426556|9291755|P2|Phase II - Extension Phase|Disease Progression|0
2695562|NCT00426556|9291756|P1|Phase II - Extension Phase|Disease Progression|0
2695563|NCT00426556|9291753|P4|Phase II - Core Phase|Adverse Event|8
2695564|NCT00426556|9291754|P3|Phase II - Core Phase|Adverse Event|0
2695565|NCT00426556|9291755|P2|Phase II - Core Phase|Adverse Event|0
2695566|NCT00426556|9291756|P1|Phase II - Core Phase|Adverse Event|0
2695567|NCT00426556|9291753|P4|Phase II - Core Phase|Disease Progression|16
2695568|NCT00426556|9291754|P3|Phase II - Core Phase|Disease Progression|0
2695569|NCT00426556|9291755|P2|Phase II - Core Phase|Disease Progression|0
2695570|NCT00426556|9291756|P1|Phase II - Core Phase|Disease Progression|0
2695571|NCT00426556|9291753|P4|Phase II - Core Phase|Withdrawal by Subject|3
2695572|NCT00426556|9291754|P3|Phase II - Core Phase|Withdrawal by Subject|0
2695573|NCT00426556|9291755|P2|Phase II - Core Phase|Withdrawal by Subject|0
2695574|NCT00426556|9291756|P1|Phase II - Core Phase|Withdrawal by Subject|0
2695575|NCT00426556|9291753|P4|Phase I - Extension Phase|Disease Progression|0
2695576|NCT00426556|9291754|P3|Phase I - Extension Phase|Disease Progression|6
2695577|NCT00426556|9291755|P2|Phase I - Extension Phase|Disease Progression|5
2695578|NCT00426556|9291756|P1|Phase I - Extension Phase|Disease Progression|5
2695579|NCT00426556|9291753|P4|Phase I - Extension Phase|Adverse Event|0
2695580|NCT00426556|9291754|P3|Phase I - Extension Phase|Adverse Event|1
2695581|NCT00426556|9291755|P2|Phase I - Extension Phase|Adverse Event|1
2695582|NCT00426556|9291756|P1|Phase I - Extension Phase|Adverse Event|0
2695583|NCT00426556|9291753|P4|Phase I - Core Phase|Death|0
2695584|NCT00426556|9291754|P3|Phase I - Core Phase|Death|0
2695585|NCT00426556|9291755|P2|Phase I - Core Phase|Death|1
2695586|NCT00426556|9291756|P1|Phase I - Core Phase|Death|0
2695587|NCT00426556|9291753|P4|Phase I - Core Phase|Adverse Event|0
2695588|NCT00426556|9291754|P3|Phase I - Core Phase|Adverse Event|1
2695589|NCT00426556|9291755|P2|Phase I - Core Phase|Adverse Event|3
2695590|NCT00426556|9291756|P1|Phase I - Core Phase|Adverse Event|1
2695591|NCT00426556|9291753|P4|Phase I - Core Phase|Disease Progression|0
2695592|NCT00426556|9291754|P3|Phase I - Core Phase|Disease Progression|2
2695593|NCT00426556|9291755|P2|Phase I - Core Phase|Disease Progression|6
2695594|NCT00426556|9291756|P1|Phase I - Core Phase|Disease Progression|0
2695595|NCT00426361|9291781|P3|Overall Study|Withdrawal by Subject|0
2695596|NCT00426361|9291782|P2|Overall Study|Withdrawal by Subject|3
2695597|NCT00426361|9291783|P1|Overall Study|Withdrawal by Subject|1
2695598|NCT00426361|9291781|P3|Overall Study|Lost to Follow-up|5
2695599|NCT00426361|9291782|P2|Overall Study|Lost to Follow-up|2
2695600|NCT00426361|9291783|P1|Overall Study|Lost to Follow-up|3
2695601|NCT00426270|9291842|P1|Overall Study|Adverse Event|5
2695602|NCT00426270|9291842|P1|Overall Study|Incorrectly Enrolled in the Study|1
2695603|NCT00426231|9291852|P2|Overall Study|Withdrawal by Subject|12
2695604|NCT00426231|9291853|P1|Overall Study|Withdrawal by Subject|9
2695605|NCT00426127|9291876|P1|Overall Study|Removed due to disease progression|1
2695606|NCT00426127|9291876|P1|Overall Study|Adverse Event|1
2695607|NCT00425945|9291884|P2|Overall Study|Moved from area|1
2695608|NCT00425945|9291885|P1|Overall Study|Moved from area|0
2695609|NCT00425945|9291884|P2|Overall Study|Began cancer treatments|0
2695610|NCT00425945|9291885|P1|Overall Study|Began cancer treatments|1
2695611|NCT00425945|9291884|P2|Overall Study|Began hypertension medication|0
2695612|NCT00425945|9291885|P1|Overall Study|Began hypertension medication|1
2695613|NCT00425945|9291884|P2|Overall Study|Lost to Follow-up|2
2695614|NCT00425945|9291885|P1|Overall Study|Lost to Follow-up|0
2695615|NCT00425945|9291884|P2|Overall Study|Inconvenience|2
2695616|NCT00425945|9291885|P1|Overall Study|Inconvenience|0
2695617|NCT00425945|9291884|P2|Overall Study|Concern about Supplement|0
2695618|NCT00425945|9291885|P1|Overall Study|Concern about Supplement|2
2695619|NCT00425854|9291923|P2|Overall Study|Other Adverse Event|2
2695620|NCT00425854|9291924|P1|Overall Study|Other Adverse Event|2
2695621|NCT00425854|9291923|P2|Overall Study|Dose reduction toxicity AE|7
2695622|NCT00425854|9291924|P1|Overall Study|Dose reduction toxicity AE|8
2695623|NCT00425854|9291923|P2|Overall Study|Progressive Disease|12
2695624|NCT00425854|9291924|P1|Overall Study|Progressive Disease|19
2695625|NCT00425750|9291957|P1|Overall Study|Progression of disease|18
2695626|NCT00425750|9291957|P1|Overall Study|Adverse Event|3
2695627|NCT00425750|9291957|P1|Overall Study|Withdrawal by Subject|3
2695628|NCT00425750|9291957|P1|Overall Study|Death|1
2695629|NCT00425698|9291965|P2|Overall Study|Withdrawal by Subject|1
2695630|NCT00425698|9291966|P1|Overall Study|Withdrawal by Subject|0
2695631|NCT00425698|9291965|P2|Overall Study|Adverse Event|1
2695632|NCT00425698|9291966|P1|Overall Study|Adverse Event|3
2695633|NCT00425607|9291981|P1|Overall Study|Withdrawal by Subject|1
2695634|NCT00425607|9291981|P1|Overall Study|Death|1
2695635|NCT00425503|9291985|P1|Overall Study|Protocol Violation|1
2695636|NCT00425503|9291985|P1|Overall Study|Adverse Event|2
2695637|NCT00425438|9291997|P2|Overall Study|Termination by Sponsor|27
2695638|NCT00425438|9291998|P1|Overall Study|Termination by Sponsor|25
2695639|NCT00425373|9292032|P9|Overall Study|Lack of Efficacy|5
2695640|NCT00425373|9292033|P8|Overall Study|Lack of Efficacy|0
2695641|NCT00425373|9292034|P7|Overall Study|Lack of Efficacy|3
2695642|NCT00425373|9292035|P6|Overall Study|Lack of Efficacy|3
2695643|NCT00425373|9292036|P5|Overall Study|Lack of Efficacy|1
2695644|NCT00425373|9292037|P4|Overall Study|Lack of Efficacy|0
2695645|NCT00425373|9292038|P3|Overall Study|Lack of Efficacy|0
2695646|NCT00425373|9292039|P2|Overall Study|Lack of Efficacy|0
2695647|NCT00425373|9292040|P1|Overall Study|Lack of Efficacy|0
2695648|NCT00425373|9292032|P9|Overall Study|Withdrawal by Subject|2
2695649|NCT00425373|9292033|P8|Overall Study|Withdrawal by Subject|2
2695650|NCT00425373|9292034|P7|Overall Study|Withdrawal by Subject|2
2695651|NCT00425373|9292035|P6|Overall Study|Withdrawal by Subject|0
2695652|NCT00425373|9292036|P5|Overall Study|Withdrawal by Subject|4
2695653|NCT00425373|9292037|P4|Overall Study|Withdrawal by Subject|1
2695654|NCT00425373|9292038|P3|Overall Study|Withdrawal by Subject|2
2695655|NCT00425373|9292039|P2|Overall Study|Withdrawal by Subject|0
2695656|NCT00425373|9292040|P1|Overall Study|Withdrawal by Subject|2
2695657|NCT00425373|9292032|P9|Overall Study|Protocol Violation|3
2695658|NCT00425373|9292033|P8|Overall Study|Protocol Violation|5
2695659|NCT00425373|9292034|P7|Overall Study|Protocol Violation|0
2695660|NCT00425373|9292035|P6|Overall Study|Protocol Violation|0
2695661|NCT00425373|9292036|P5|Overall Study|Protocol Violation|0
2695662|NCT00425373|9292037|P4|Overall Study|Protocol Violation|0
2695663|NCT00425373|9292038|P3|Overall Study|Protocol Violation|1
2695664|NCT00425373|9292039|P2|Overall Study|Protocol Violation|0
2695665|NCT00425373|9292040|P1|Overall Study|Protocol Violation|1
2695666|NCT00425373|9292032|P9|Overall Study|Lost to Follow-up|0
2695667|NCT00425373|9292033|P8|Overall Study|Lost to Follow-up|0
2695668|NCT00425373|9292034|P7|Overall Study|Lost to Follow-up|0
2695669|NCT00425373|9292035|P6|Overall Study|Lost to Follow-up|0
2695670|NCT00425373|9292036|P5|Overall Study|Lost to Follow-up|1
2695671|NCT00425373|9292037|P4|Overall Study|Lost to Follow-up|0
2695672|NCT00425373|9292038|P3|Overall Study|Lost to Follow-up|0
2695673|NCT00425373|9292039|P2|Overall Study|Lost to Follow-up|1
2695674|NCT00425373|9292040|P1|Overall Study|Lost to Follow-up|0
2695675|NCT00425373|9292032|P9|Overall Study|Adverse Event|8
2695676|NCT00425373|9292033|P8|Overall Study|Adverse Event|3
2695677|NCT00425373|9292034|P7|Overall Study|Adverse Event|2
2695678|NCT00425373|9292035|P6|Overall Study|Adverse Event|6
2695679|NCT00425373|9292036|P5|Overall Study|Adverse Event|4
2695680|NCT00425373|9292037|P4|Overall Study|Adverse Event|1
2695681|NCT00425373|9292038|P3|Overall Study|Adverse Event|0
2695682|NCT00425373|9292039|P2|Overall Study|Adverse Event|2
2695683|NCT00425373|9292040|P1|Overall Study|Adverse Event|2
2695684|NCT00425308|9292098|P2|Overall Study|Death|0
2695685|NCT00425308|9292099|P1|Overall Study|Death|1
2695686|NCT00425308|9292098|P2|Overall Study|Withdrawal by Subject|0
2695687|NCT00425308|9292099|P1|Overall Study|Withdrawal by Subject|1
2695688|NCT00425308|9292098|P2|Overall Study|Adverse Event|1
2695689|NCT00425308|9292099|P1|Overall Study|Adverse Event|2
2695690|NCT00425269|9292129|P2|Overall Study|moved or medical reason|4
2695691|NCT00425269|9292130|P1|Overall Study|moved or medical reason|5
2695692|NCT00425269|9292129|P2|Overall Study|Lost to Follow-up|9
2695693|NCT00425269|9292130|P1|Overall Study|Lost to Follow-up|9
2695694|NCT00425269|9292129|P2|Overall Study|Pregnancy|7
2695695|NCT00425269|9292130|P1|Overall Study|Pregnancy|5
2695696|NCT00425113|9292208|P2|Overall Study|Withdrawal by Subject|0
2695697|NCT00425113|9292209|P1|Overall Study|Withdrawal by Subject|1
2695698|NCT00425113|9292208|P2|Overall Study|missing study drug more than 14 days|1
2695699|NCT00425113|9292209|P1|Overall Study|missing study drug more than 14 days|0
2695700|NCT00425113|9292208|P2|Overall Study|diagnosis of abdominal TB|1
2695701|NCT00425113|9292209|P1|Overall Study|diagnosis of abdominal TB|0
2695702|NCT00425113|9292208|P2|Overall Study|uncontrolled diabetes mellitus|0
2695703|NCT00425113|9292209|P1|Overall Study|uncontrolled diabetes mellitus|1
2695704|NCT00425100|9292217|P1|Overall Study|Withdrawal by Subject|7
2695705|NCT00425100|9292217|P1|Overall Study|Protocol Violation|4
2695706|NCT00425100|9292217|P1|Overall Study|Lost to Follow-up|2
2695707|NCT00425100|9292217|P1|Overall Study|Lack of Efficacy|4
2695708|NCT00425100|9292217|P1|Overall Study|Adverse Event|36
2695709|NCT00425061|9292261|P7|Overall Study|Other|1
2695710|NCT00425061|9292262|P6|Overall Study|Other|0
2695711|NCT00425061|9292263|P5|Overall Study|Other|3
2695712|NCT00425061|9292264|P4|Overall Study|Other|0
2695713|NCT00425061|9292265|P3|Overall Study|Other|0
2695714|NCT00425061|9292266|P2|Overall Study|Other|0
2695715|NCT00425061|9292267|P1|Overall Study|Other|0
2695716|NCT00425061|9292261|P7|Overall Study|Physician Decision|0
2695717|NCT00425061|9292262|P6|Overall Study|Physician Decision|0
2695718|NCT00425061|9292263|P5|Overall Study|Physician Decision|1
2695719|NCT00425061|9292264|P4|Overall Study|Physician Decision|0
2695720|NCT00425061|9292265|P3|Overall Study|Physician Decision|0
2695721|NCT00425061|9292266|P2|Overall Study|Physician Decision|0
2695722|NCT00425061|9292267|P1|Overall Study|Physician Decision|0
2695723|NCT00425061|9292261|P7|Overall Study|Sponsor's request|15
2695724|NCT00425061|9292262|P6|Overall Study|Sponsor's request|4
2695725|NCT00425061|9292263|P5|Overall Study|Sponsor's request|19
2695726|NCT00425061|9292264|P4|Overall Study|Sponsor's request|0
2695727|NCT00425061|9292265|P3|Overall Study|Sponsor's request|0
2695728|NCT00425061|9292266|P2|Overall Study|Sponsor's request|0
2695729|NCT00425061|9292267|P1|Overall Study|Sponsor's request|0
2695730|NCT00425061|9292261|P7|Overall Study|Withdrawal by Subject|3
2695731|NCT00425061|9292262|P6|Overall Study|Withdrawal by Subject|0
2695732|NCT00425061|9292263|P5|Overall Study|Withdrawal by Subject|1
2695733|NCT00425061|9292264|P4|Overall Study|Withdrawal by Subject|0
2695734|NCT00425061|9292265|P3|Overall Study|Withdrawal by Subject|0
2695735|NCT00425061|9292266|P2|Overall Study|Withdrawal by Subject|1
2695736|NCT00425061|9292267|P1|Overall Study|Withdrawal by Subject|0
2695737|NCT00425061|9292261|P7|Overall Study|Protocol Violation|0
2695738|NCT00425061|9292262|P6|Overall Study|Protocol Violation|0
2695739|NCT00425061|9292263|P5|Overall Study|Protocol Violation|0
2695740|NCT00425061|9292264|P4|Overall Study|Protocol Violation|0
2695741|NCT00425061|9292265|P3|Overall Study|Protocol Violation|0
2695742|NCT00425061|9292266|P2|Overall Study|Protocol Violation|0
2695743|NCT00425061|9292267|P1|Overall Study|Protocol Violation|1
2695744|NCT00425061|9292261|P7|Overall Study|Lost to Follow-up|0
2695745|NCT00425061|9292262|P6|Overall Study|Lost to Follow-up|0
2695746|NCT00425061|9292263|P5|Overall Study|Lost to Follow-up|0
2695747|NCT00425061|9292264|P4|Overall Study|Lost to Follow-up|0
2695748|NCT00425061|9292265|P3|Overall Study|Lost to Follow-up|0
2695749|NCT00425061|9292266|P2|Overall Study|Lost to Follow-up|1
2695750|NCT00425061|9292267|P1|Overall Study|Lost to Follow-up|0
2695751|NCT00425061|9292261|P7|Overall Study|Adverse Event|0
2695752|NCT00425061|9292262|P6|Overall Study|Adverse Event|0
2695753|NCT00425061|9292263|P5|Overall Study|Adverse Event|2
2695754|NCT00425061|9292264|P4|Overall Study|Adverse Event|2
2695755|NCT00425061|9292265|P3|Overall Study|Adverse Event|0
2695756|NCT00425061|9292266|P2|Overall Study|Adverse Event|0
2695757|NCT00425061|9292267|P1|Overall Study|Adverse Event|1
2695758|NCT00424827|9292391|P1|Overall Study|Adverse Event|1
2695759|NCT00424775|9292399|P2|Overall Study|Lack of Efficacy|0
2695760|NCT00424775|9292400|P1|Overall Study|Lack of Efficacy|1
2695761|NCT00424775|9292399|P2|Overall Study|Adverse Event|0
2695762|NCT00424775|9292400|P1|Overall Study|Adverse Event|2
2695763|NCT00424762|9292410|P2|Overall Study|Lost to Follow-up|3
2695764|NCT00424762|9292411|P1|Overall Study|Lost to Follow-up|2
2695765|NCT00424762|9292410|P2|Overall Study|Withdrawal by Subject|19
2695766|NCT00424762|9292411|P1|Overall Study|Withdrawal by Subject|18
2695767|NCT00424749|9292421|P1|Overall Study|Withdrawal by Subject|1
2695768|NCT00424645|9292428|P2|Overall Study|Death|0
2695769|NCT00424645|9292429|P1|Overall Study|Death|1
2695770|NCT00424632|9292437|P10|Overall Study|Other|0
2695771|NCT00424632|9292438|P9|Overall Study|Other|1
2695772|NCT00424632|9292439|P8|Overall Study|Other|0
2695773|NCT00424632|9292440|P7|Overall Study|Other|0
2695774|NCT00424632|9292441|P6|Overall Study|Other|0
2695775|NCT00424632|9292442|P5|Overall Study|Other|0
2695776|NCT00424632|9292443|P4|Overall Study|Other|1
2695777|NCT00424632|9292444|P3|Overall Study|Other|0
2695778|NCT00424632|9292445|P2|Overall Study|Other|0
2695779|NCT00424632|9292446|P1|Overall Study|Other|0
2695780|NCT00424632|9292437|P10|Overall Study|Objective progression or relapse|4
2695781|NCT00424632|9292438|P9|Overall Study|Objective progression or relapse|12
2695782|NCT00424632|9292439|P8|Overall Study|Objective progression or relapse|3
2695783|NCT00424632|9292440|P7|Overall Study|Objective progression or relapse|7
2695784|NCT00424632|9292441|P6|Overall Study|Objective progression or relapse|13
2695785|NCT00424632|9292442|P5|Overall Study|Objective progression or relapse|2
2695786|NCT00424632|9292443|P4|Overall Study|Objective progression or relapse|2
2695787|NCT00424632|9292444|P3|Overall Study|Objective progression or relapse|1
2695788|NCT00424632|9292445|P2|Overall Study|Objective progression or relapse|1
2695789|NCT00424632|9292446|P1|Overall Study|Objective progression or relapse|1
2695790|NCT00424632|9292437|P10|Overall Study|Global deterioration of health status|0
2695791|NCT00424632|9292438|P9|Overall Study|Global deterioration of health status|0
2695792|NCT00424632|9292439|P8|Overall Study|Global deterioration of health status|0
2695793|NCT00424632|9292440|P7|Overall Study|Global deterioration of health status|0
2695794|NCT00424632|9292441|P6|Overall Study|Global deterioration of health status|0
2695795|NCT00424632|9292442|P5|Overall Study|Global deterioration of health status|1
2695796|NCT00424632|9292443|P4|Overall Study|Global deterioration of health status|1
2695797|NCT00424632|9292444|P3|Overall Study|Global deterioration of health status|0
2695798|NCT00424632|9292445|P2|Overall Study|Global deterioration of health status|0
2695799|NCT00424632|9292446|P1|Overall Study|Global deterioration of health status|0
2695800|NCT00424632|9292437|P10|Overall Study|Adverse Event|2
2695801|NCT00424632|9292438|P9|Overall Study|Adverse Event|3
2695802|NCT00424632|9292439|P8|Overall Study|Adverse Event|0
2695803|NCT00424632|9292440|P7|Overall Study|Adverse Event|0
2695804|NCT00424632|9292441|P6|Overall Study|Adverse Event|0
2695805|NCT00424632|9292442|P5|Overall Study|Adverse Event|0
2695806|NCT00424632|9292443|P4|Overall Study|Adverse Event|0
2695807|NCT00424632|9292444|P3|Overall Study|Adverse Event|0
2695808|NCT00424632|9292445|P2|Overall Study|Adverse Event|0
2695809|NCT00424632|9292446|P1|Overall Study|Adverse Event|0
2695810|NCT00424632|9292437|P10|Overall Study|Death|0
2695811|NCT00424632|9292438|P9|Overall Study|Death|0
2695812|NCT00424632|9292439|P8|Overall Study|Death|0
2695813|NCT00424632|9292440|P7|Overall Study|Death|0
2695814|NCT00424632|9292441|P6|Overall Study|Death|2
2695815|NCT00424632|9292442|P5|Overall Study|Death|0
2695816|NCT00424632|9292443|P4|Overall Study|Death|0
2695817|NCT00424632|9292444|P3|Overall Study|Death|0
2695818|NCT00424632|9292445|P2|Overall Study|Death|0
2695819|NCT00424632|9292446|P1|Overall Study|Death|0
2695820|NCT00424593|9292616|P2|Dose-Blind Extension Period|Physician Decision|0
2695821|NCT00424593|9292617|P1|Dose-Blind Extension Period|Physician Decision|3
2695822|NCT00424593|9292616|P2|Dose-Blind Extension Period|Lost to Follow-up|0
2695823|NCT00424593|9292617|P1|Dose-Blind Extension Period|Lost to Follow-up|6
2695824|NCT00424593|9292616|P2|Dose-Blind Extension Period|Protocol Violation|0
2695825|NCT00424593|9292617|P1|Dose-Blind Extension Period|Protocol Violation|9
2695826|NCT00424593|9292616|P2|Dose-Blind Extension Period|Lack of Efficacy|0
2695827|NCT00424593|9292617|P1|Dose-Blind Extension Period|Lack of Efficacy|9
2695828|NCT00424593|9292616|P2|Dose-Blind Extension Period|Adverse Event|0
2695829|NCT00424593|9292617|P1|Dose-Blind Extension Period|Adverse Event|18
2695830|NCT00424593|9292616|P2|Dose-Blind Extension Period|Withdrawal by Subject|0
2695831|NCT00424593|9292617|P1|Dose-Blind Extension Period|Withdrawal by Subject|19
2695832|NCT00424593|9292616|P2|Acute Double-Blind Period|Lack of Efficacy|1
2695833|NCT00424593|9292617|P1|Acute Double-Blind Period|Lack of Efficacy|0
2695834|NCT00424593|9292616|P2|Acute Double-Blind Period|Lost to Follow-up|1
2695835|NCT00424593|9292617|P1|Acute Double-Blind Period|Lost to Follow-up|1
2695836|NCT00424593|9292616|P2|Acute Double-Blind Period|Physician Decision|2
2695837|NCT00424593|9292617|P1|Acute Double-Blind Period|Physician Decision|1
2695838|NCT00424593|9292616|P2|Acute Double-Blind Period|Protocol Violation|2
2695839|NCT00424593|9292617|P1|Acute Double-Blind Period|Protocol Violation|2
2695840|NCT00424593|9292616|P2|Acute Double-Blind Period|Withdrawal by Subject|10
2695841|NCT00424593|9292617|P1|Acute Double-Blind Period|Withdrawal by Subject|11
2695842|NCT00424593|9292616|P2|Acute Double-Blind Period|Adverse Event|7
2695843|NCT00424593|9292617|P1|Acute Double-Blind Period|Adverse Event|16
2695844|NCT00424528|9292681|P3|Overall Study|noncompliance with study requirements|2
2695845|NCT00424528|9292682|P2|Overall Study|noncompliance with study requirements|1
2695846|NCT00424528|9292683|P1|Overall Study|noncompliance with study requirements|2
2695847|NCT00424528|9292681|P3|Overall Study|Lost to Follow-up|0
2695848|NCT00424528|9292682|P2|Overall Study|Lost to Follow-up|1
2695849|NCT00424528|9292683|P1|Overall Study|Lost to Follow-up|0
2695850|NCT00424528|9292681|P3|Overall Study|Protocol Violation|0
2695851|NCT00424528|9292682|P2|Overall Study|Protocol Violation|1
2695852|NCT00424528|9292683|P1|Overall Study|Protocol Violation|1
2695853|NCT00424528|9292681|P3|Overall Study|Adverse Event|2
2695854|NCT00424528|9292682|P2|Overall Study|Adverse Event|1
2695855|NCT00424528|9292683|P1|Overall Study|Adverse Event|2
2695856|NCT00424515|9292738|P2|Overall Study|Withdrawal by Subject|0
2695857|NCT00424515|9292739|P1|Overall Study|Withdrawal by Subject|1
2695858|NCT00424515|9292738|P2|Overall Study|Intercurrent Illness|1
2695859|NCT00424515|9292739|P1|Overall Study|Intercurrent Illness|0
2695860|NCT00424515|9292738|P2|Overall Study|Adverse Event|1
2695861|NCT00424515|9292739|P1|Overall Study|Adverse Event|0
2695862|NCT00424515|9292738|P2|Overall Study|Progressive Disease|11
2695863|NCT00424515|9292739|P1|Overall Study|Progressive Disease|10
2695864|NCT00424489|9292758|P1|Overall Study|Death|3
2695865|NCT00424476|9292765|P3|Overall Study|Other|9
2695866|NCT00424476|9292766|P2|Overall Study|Other|3
2695867|NCT00424476|9292767|P1|Overall Study|Other|4
2695868|NCT00424476|9292765|P3|Overall Study|Physician Decision|3
2695869|NCT00424476|9292766|P2|Overall Study|Physician Decision|2
2695870|NCT00424476|9292767|P1|Overall Study|Physician Decision|3
2695871|NCT00424476|9292765|P3|Overall Study|Protocol Violation|3
2695872|NCT00424476|9292766|P2|Overall Study|Protocol Violation|2
2695873|NCT00424476|9292767|P1|Overall Study|Protocol Violation|7
2695874|NCT00424476|9292765|P3|Overall Study|Lost to Follow-up|3
2695875|NCT00424476|9292766|P2|Overall Study|Lost to Follow-up|6
2695876|NCT00424476|9292767|P1|Overall Study|Lost to Follow-up|4
2695877|NCT00424476|9292765|P3|Overall Study|Lack of Compliance|1
2695878|NCT00424476|9292766|P2|Overall Study|Lack of Compliance|1
2695879|NCT00424476|9292767|P1|Overall Study|Lack of Compliance|1
2695880|NCT00424476|9292765|P3|Overall Study|Lack of Efficacy|12
2695881|NCT00424476|9292766|P2|Overall Study|Lack of Efficacy|12
2695882|NCT00424476|9292767|P1|Overall Study|Lack of Efficacy|16
2695883|NCT00424476|9292765|P3|Overall Study|Adverse Event|15
2695884|NCT00424476|9292766|P2|Overall Study|Adverse Event|16
2695885|NCT00424476|9292767|P1|Overall Study|Adverse Event|19
2695886|NCT00424476|9292765|P3|Overall Study|Withdrawal by Subject|3
2695887|NCT00424476|9292766|P2|Overall Study|Withdrawal by Subject|6
2695888|NCT00424476|9292767|P1|Overall Study|Withdrawal by Subject|7
2695889|NCT00424463|9292793|P3|Overall Study|Patient’s convenience|1
2695890|NCT00424463|9292794|P2|Overall Study|Patient’s convenience|0
2695891|NCT00424463|9292795|P1|Overall Study|Patient’s convenience|0
2695892|NCT00424463|9292793|P3|Overall Study|Tracheotomy due to worsening of ALS|6
2695893|NCT00424463|9292794|P2|Overall Study|Tracheotomy due to worsening of ALS|7
2695894|NCT00424463|9292795|P1|Overall Study|Tracheotomy due to worsening of ALS|1
2695895|NCT00424463|9292793|P3|Overall Study|Withdrawal by Subject|5
2695896|NCT00424463|9292794|P2|Overall Study|Withdrawal by Subject|2
2695897|NCT00424463|9292795|P1|Overall Study|Withdrawal by Subject|4
2695898|NCT00424463|9292793|P3|Overall Study|Physician Decision|2
2695899|NCT00424463|9292794|P2|Overall Study|Physician Decision|2
2695900|NCT00424463|9292795|P1|Overall Study|Physician Decision|0
2695901|NCT00424463|9292793|P3|Overall Study|Adverse Event|2
2695902|NCT00424463|9292794|P2|Overall Study|Adverse Event|3
2695903|NCT00424463|9292795|P1|Overall Study|Adverse Event|2
2695904|NCT00424398|9292824|P3|Overall Study|Subject met exclusion criteria|0
2695905|NCT00424398|9292825|P2|Overall Study|Subject met exclusion criteria|0
2695906|NCT00424398|9292826|P1|Overall Study|Subject met exclusion criteria|1
2695907|NCT00424398|9292824|P3|Overall Study|Withdrawal by Subject|0
2695908|NCT00424398|9292825|P2|Overall Study|Withdrawal by Subject|1
2695909|NCT00424398|9292826|P1|Overall Study|Withdrawal by Subject|2
2695910|NCT00424385|9292870|P1|Cohort 1|Withdrawal by Subject|1
2695911|NCT00424385|9292870|P1|Cohort 0|Physician Decision|1
2695912|NCT00424385|9292870|P1|Cohort 0|Withdrawal by Subject|5
2695913|NCT00424372|9292877|P1|Overall Study|Lack of Efficacy|6
2695914|NCT00424372|9292877|P1|Overall Study|Protocol Violation|1
2695915|NCT00424372|9292877|P1|Overall Study|Withdrawal by Subject|4
2695916|NCT00424372|9292877|P1|Overall Study|Health deterioration|1
2695917|NCT00424372|9292877|P1|Overall Study|Adverse Event|18
2695918|NCT00424372|9292877|P1|Overall Study|Death|1
2695919|NCT00424346|9292889|P4|Extension Phase|Protocol Violation|0
2695920|NCT00424346|9292890|P3|Extension Phase|Protocol Violation|1
2695921|NCT00424346|9292891|P2|Extension Phase|Protocol Violation|1
2695922|NCT00424346|9292892|P1|Extension Phase|Protocol Violation|0
2695923|NCT00424346|9292889|P4|Extension Phase|Death|1
2695924|NCT00424346|9292890|P3|Extension Phase|Death|0
2695925|NCT00424346|9292891|P2|Extension Phase|Death|0
2695926|NCT00424346|9292892|P1|Extension Phase|Death|0
2695927|NCT00424346|9292889|P4|Extension Phase|Administrative Problems|35
2695928|NCT00424346|9292890|P3|Extension Phase|Administrative Problems|32
2695929|NCT00424346|9292891|P2|Extension Phase|Administrative Problems|69
2695930|NCT00424346|9292892|P1|Extension Phase|Administrative Problems|0
2695931|NCT00424346|9292889|P4|Extension Phase|Lost to Follow-up|0
2695932|NCT00424346|9292890|P3|Extension Phase|Lost to Follow-up|0
2695933|NCT00424346|9292891|P2|Extension Phase|Lost to Follow-up|2
2695934|NCT00424346|9292892|P1|Extension Phase|Lost to Follow-up|0
2695935|NCT00424346|9292889|P4|Extension Phase|Withdrawal by Subject|4
2695936|NCT00424346|9292890|P3|Extension Phase|Withdrawal by Subject|3
2695937|NCT00424346|9292891|P2|Extension Phase|Withdrawal by Subject|5
2695938|NCT00424346|9292892|P1|Extension Phase|Withdrawal by Subject|0
2695939|NCT00424346|9292889|P4|Extension Phase|Lack of Efficacy|11
2695940|NCT00424346|9292890|P3|Extension Phase|Lack of Efficacy|14
2695941|NCT00424346|9292891|P2|Extension Phase|Lack of Efficacy|16
2695942|NCT00424346|9292892|P1|Extension Phase|Lack of Efficacy|0
2695943|NCT00424346|9292889|P4|Extension Phase|Adverse Event|4
2695944|NCT00424346|9292890|P3|Extension Phase|Adverse Event|5
2695945|NCT00424346|9292891|P2|Extension Phase|Adverse Event|9
2695946|NCT00424346|9292892|P1|Extension Phase|Adverse Event|0
2695947|NCT00424346|9292889|P4|Core Study|Protocol Violation|0
2695948|NCT00424346|9292890|P3|Core Study|Protocol Violation|2
2695949|NCT00424346|9292891|P2|Core Study|Protocol Violation|0
2695950|NCT00424346|9292892|P1|Core Study|Protocol Violation|0
2695951|NCT00424346|9292889|P4|Core Study|Administrative Problems|0
2695952|NCT00424346|9292890|P3|Core Study|Administrative Problems|1
2695953|NCT00424346|9292891|P2|Core Study|Administrative Problems|0
2695954|NCT00424346|9292892|P1|Core Study|Administrative Problems|1
2695955|NCT00424346|9292889|P4|Core Study|Lost to Follow-up|0
2695956|NCT00424346|9292890|P3|Core Study|Lost to Follow-up|0
2695957|NCT00424346|9292891|P2|Core Study|Lost to Follow-up|1
2695958|NCT00424346|9292892|P1|Core Study|Lost to Follow-up|1
2695959|NCT00424346|9292889|P4|Core Study|Withdrawal by Subject|2
2695960|NCT00424346|9292890|P3|Core Study|Withdrawal by Subject|0
2695961|NCT00424346|9292891|P2|Core Study|Withdrawal by Subject|0
2695962|NCT00424346|9292892|P1|Core Study|Withdrawal by Subject|1
2695963|NCT00424346|9292889|P4|Core Study|Lack of Efficacy|4
2695964|NCT00424346|9292890|P3|Core Study|Lack of Efficacy|0
2695965|NCT00424346|9292891|P2|Core Study|Lack of Efficacy|3
2695966|NCT00424346|9292892|P1|Core Study|Lack of Efficacy|1
2695967|NCT00424346|9292889|P4|Core Study|Abnormal Laboratory Values|0
2695968|NCT00424346|9292890|P3|Core Study|Abnormal Laboratory Values|0
2695969|NCT00424346|9292891|P2|Core Study|Abnormal Laboratory Values|1
2695970|NCT00424346|9292892|P1|Core Study|Abnormal Laboratory Values|0
2695971|NCT00424346|9292889|P4|Core Study|Adverse Event|1
2695972|NCT00424346|9292890|P3|Core Study|Adverse Event|1
2695973|NCT00424346|9292891|P2|Core Study|Adverse Event|3
2695974|NCT00424346|9292892|P1|Core Study|Adverse Event|5
2695975|NCT00424294|9293007|P2|Overall Study|Randomized but not Treated|0
2695976|NCT00424294|9293008|P1|Overall Study|Randomized but not Treated|1
2695977|NCT00424294|9293007|P2|Overall Study|Other|2
2695978|NCT00424294|9293008|P1|Overall Study|Other|0
2695979|NCT00424294|9293007|P2|Overall Study|Withdrawal by Subject|2
2695980|NCT00424294|9293008|P1|Overall Study|Withdrawal by Subject|1
2695981|NCT00424294|9293007|P2|Overall Study|Lack of Efficacy|1
2695982|NCT00424294|9293008|P1|Overall Study|Lack of Efficacy|2
2695983|NCT00424294|9293007|P2|Overall Study|Adverse Event|10
2695984|NCT00424294|9293008|P1|Overall Study|Adverse Event|4
2695985|NCT00424255|9293075|P2|Overall Study|Sponsor Terminated Study|167
2695986|NCT00424255|9293076|P1|Overall Study|Sponsor Terminated Study|161
2695987|NCT00424255|9293075|P2|Overall Study|Disease Progression|2
2695988|NCT00424255|9293076|P1|Overall Study|Disease Progression|0
2695989|NCT00424255|9293075|P2|Overall Study|Fatigue|0
2695990|NCT00424255|9293076|P1|Overall Study|Fatigue|1
2695991|NCT00424255|9293075|P2|Overall Study|Non-compliance by Participants|0
2695992|NCT00424255|9293076|P1|Overall Study|Non-compliance by Participants|1
2695993|NCT00424255|9293075|P2|Overall Study|Cognitive Disturbance|0
2695994|NCT00424255|9293076|P1|Overall Study|Cognitive Disturbance|1
2695995|NCT00424255|9293075|P2|Overall Study|Physician Decision|7
2695996|NCT00424255|9293076|P1|Overall Study|Physician Decision|3
2695997|NCT00424255|9293075|P2|Overall Study|Withdrawal by Subject|38
2695998|NCT00424255|9293076|P1|Overall Study|Withdrawal by Subject|34
2695999|NCT00424255|9293075|P2|Overall Study|Protocol Violation|1
2696000|NCT00424255|9293076|P1|Overall Study|Protocol Violation|0
2696001|NCT00424255|9293075|P2|Overall Study|Lost to Follow-up|20
2696002|NCT00424255|9293076|P1|Overall Study|Lost to Follow-up|26
2696003|NCT00424255|9293075|P2|Overall Study|Death|111
2696004|NCT00424255|9293076|P1|Overall Study|Death|115
2696005|NCT00424190|9293124|P2|Overall Study|Other|21
2696006|NCT00424190|9293125|P1|Overall Study|Other|15
2696007|NCT00424190|9293124|P2|Overall Study|Diagnosis of osteomyelitis|1
2696008|NCT00424190|9293125|P1|Overall Study|Diagnosis of osteomyelitis|0
2696009|NCT00424190|9293124|P2|Overall Study|Request of sponsor or investigator|2
2696010|NCT00424190|9293125|P1|Overall Study|Request of sponsor or investigator|0
2696011|NCT00424190|9293124|P2|Overall Study|Noncompliance|2
2696012|NCT00424190|9293125|P1|Overall Study|Noncompliance|1
2696013|NCT00424190|9293124|P2|Overall Study|Death|0
2696014|NCT00424190|9293125|P1|Overall Study|Death|3
2696015|NCT00424190|9293124|P2|Overall Study|Withdrew consent|4
2696016|NCT00424190|9293125|P1|Overall Study|Withdrew consent|3
2696017|NCT00424177|9293131|P1|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1
2696018|NCT00424177|9293131|P1|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
2696019|NCT00424177|9293131|P1|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1
2696020|NCT00424177|9293131|P1|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
2696021|NCT00424177|9293131|P1|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1
2696022|NCT00424177|9293131|P1|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2
2696023|NCT00424177|9293131|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1
2696024|NCT00424177|9293131|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1
2696025|NCT00424177|9293131|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1
2696026|NCT00424177|9293131|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8
2696027|NCT00424047|9293160|P2|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0
2696028|NCT00424047|9293161|P1|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1
2696029|NCT00424047|9293160|P2|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3
2696030|NCT00424047|9293161|P1|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7
2696031|NCT00424047|9293160|P2|Long Term Extension (Up to 25 Jun 2013)|Other|4
2696032|NCT00424047|9293161|P1|Long Term Extension (Up to 25 Jun 2013)|Other|12
2696033|NCT00424047|9293160|P2|Long Term Extension (Up to 25 Jun 2013)|Death|1
2696034|NCT00424047|9293161|P1|Long Term Extension (Up to 25 Jun 2013)|Death|0
2696035|NCT00424047|9293160|P2|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0
2696036|NCT00424047|9293161|P1|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1
2696037|NCT00424047|9293160|P2|On Study at Time of Unblinding|Other|4
2696038|NCT00424047|9293161|P1|On Study at Time of Unblinding|Other|5
2696039|NCT00424047|9293160|P2|On Study at Time of Unblinding|Death|11
2696040|NCT00424047|9293161|P1|On Study at Time of Unblinding|Death|11
2696041|NCT00424047|9293160|P2|On Study at Time of Unblinding|Withdrawal by Subject|9
2696042|NCT00424047|9293161|P1|On Study at Time of Unblinding|Withdrawal by Subject|24
2696043|NCT00424047|9293160|P2|On Study at Time of Unblinding|Lack of Efficacy|3
2696044|NCT00424047|9293161|P1|On Study at Time of Unblinding|Lack of Efficacy|1
2696045|NCT00424047|9293160|P2|On Study at Time of Unblinding|Progression of disease|128
2696046|NCT00424047|9293161|P1|On Study at Time of Unblinding|Progression of disease|92
2696047|NCT00424047|9293160|P2|On Study at Time of Unblinding|Adverse Event|12
2696048|NCT00424047|9293161|P1|On Study at Time of Unblinding|Adverse Event|22
2696049|NCT00424047|9293160|P2|Blinded Treatment (Up to 03 Aug 2005)|Other|1
2696050|NCT00424047|9293161|P1|Blinded Treatment (Up to 03 Aug 2005)|Other|2
2696051|NCT00424047|9293160|P2|Blinded Treatment (Up to 03 Aug 2005)|Death|10
2696052|NCT00424047|9293161|P1|Blinded Treatment (Up to 03 Aug 2005)|Death|11
2696053|NCT00424047|9293160|P2|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8
2696054|NCT00424047|9293161|P1|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23
2696055|NCT00424047|9293160|P2|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3
2696056|NCT00424047|9293161|P1|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1
2696057|NCT00424047|9293160|P2|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122
2696058|NCT00424047|9293161|P1|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67
2696059|NCT00424047|9293160|P2|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12
2696060|NCT00424047|9293161|P1|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18
2696061|NCT00424021|9293193|P4|AMB-220-E Study Period|Physician Decision|1
2696062|NCT00424021|9293194|P3|AMB-220-E Study Period|Physician Decision|0
2696063|NCT00424021|9293195|P2|AMB-220-E Study Period|Physician Decision|0
2696064|NCT00424021|9293196|P1|AMB-220-E Study Period|Physician Decision|0
2696065|NCT00424021|9293193|P4|AMB-220-E Study Period|Lost to Follow-up|1
2696066|NCT00424021|9293194|P3|AMB-220-E Study Period|Lost to Follow-up|1
2696067|NCT00424021|9293195|P2|AMB-220-E Study Period|Lost to Follow-up|1
2696068|NCT00424021|9293196|P1|AMB-220-E Study Period|Lost to Follow-up|0
2696069|NCT00424021|9293193|P4|AMB-220-E Study Period|Death|1
2696070|NCT00424021|9293194|P3|AMB-220-E Study Period|Death|1
2696071|NCT00424021|9293195|P2|AMB-220-E Study Period|Death|0
2696072|NCT00424021|9293196|P1|AMB-220-E Study Period|Death|0
2696073|NCT00424021|9293193|P4|AMB-220-E Study Period|Adverse Event|7
2696074|NCT00424021|9293194|P3|AMB-220-E Study Period|Adverse Event|3
2696075|NCT00424021|9293195|P2|AMB-220-E Study Period|Adverse Event|1
2696076|NCT00424021|9293196|P1|AMB-220-E Study Period|Adverse Event|1
2696077|NCT00424021|9293193|P4|NCT00046319 Study Period|Lost to Follow-up|0
2696078|NCT00424021|9293194|P3|NCT00046319 Study Period|Lost to Follow-up|0
2696079|NCT00424021|9293195|P2|NCT00046319 Study Period|Lost to Follow-up|1
2696080|NCT00424021|9293196|P1|NCT00046319 Study Period|Lost to Follow-up|0
2696081|NCT00424021|9293193|P4|NCT00046319 Study Period|Sponsor discretion|0
2696082|NCT00424021|9293194|P3|NCT00046319 Study Period|Sponsor discretion|0
2696083|NCT00424021|9293195|P2|NCT00046319 Study Period|Sponsor discretion|1
2696084|NCT00424021|9293196|P1|NCT00046319 Study Period|Sponsor discretion|0
2696085|NCT00424021|9293193|P4|NCT00046319 Study Period|Withdrawal by Subject|0
2696086|NCT00424021|9293194|P3|NCT00046319 Study Period|Withdrawal by Subject|0
2696087|NCT00424021|9293195|P2|NCT00046319 Study Period|Withdrawal by Subject|1
2696088|NCT00424021|9293196|P1|NCT00046319 Study Period|Withdrawal by Subject|0
2696089|NCT00424021|9293193|P4|NCT00046319 Study Period|Adverse Event|1
2696090|NCT00424021|9293194|P3|NCT00046319 Study Period|Adverse Event|1
2696091|NCT00424021|9293195|P2|NCT00046319 Study Period|Adverse Event|0
2696092|NCT00424021|9293196|P1|NCT00046319 Study Period|Adverse Event|1
2696093|NCT00424008|9293239|P2|Overall Study|Administrative|257
2696094|NCT00424008|9293240|P1|Overall Study|Administrative|266
2696095|NCT00424008|9293239|P2|Overall Study|Did not meet protocol eligibility|21
2696096|NCT00424008|9293240|P1|Overall Study|Did not meet protocol eligibility|16
2696097|NCT00424008|9293239|P2|Overall Study|Noncompliance with protocol|7
2696098|NCT00424008|9293240|P1|Overall Study|Noncompliance with protocol|13
2696099|NCT00424008|9293239|P2|Overall Study|Withdrawal by Subject|8
2696100|NCT00424008|9293240|P1|Overall Study|Withdrawal by Subject|5
2696101|NCT00424008|9293239|P2|Overall Study|Lost to Follow-up|2
2696102|NCT00424008|9293240|P1|Overall Study|Lost to Follow-up|1
2696103|NCT00424008|9293239|P2|Overall Study|Lack of Efficacy|34
2696104|NCT00424008|9293240|P1|Overall Study|Lack of Efficacy|40
2696105|NCT00424008|9293239|P2|Overall Study|Adverse Event|6
2696106|NCT00424008|9293240|P1|Overall Study|Adverse Event|8
2696107|NCT00423943|9293255|P2|Overall Study|Withdrawal by Subject|1
2696108|NCT00423943|9293256|P1|Overall Study|Withdrawal by Subject|3
2696109|NCT00423930|9293270|P1|Overall Study|Withdrawal by Subject|2
2696110|NCT00423917|9293275|P1|Overall Study|Ineligible|1
2696111|NCT00423917|9293275|P1|Overall Study|Cancel|2
2696112|NCT00423891|9293288|P3|Post-Dosing Follow Up|Lost to Follow-up|0
2696113|NCT00423891|9293289|P2|Post-Dosing Follow Up|Lost to Follow-up|0
2696114|NCT00423891|9293290|P1|Post-Dosing Follow Up|Lost to Follow-up|2
2696115|NCT00423891|9293288|P3|Post-Dosing Follow Up|Withdrawal by Subject|2
2696116|NCT00423891|9293289|P2|Post-Dosing Follow Up|Withdrawal by Subject|3
2696117|NCT00423891|9293290|P1|Post-Dosing Follow Up|Withdrawal by Subject|0
2696118|NCT00423891|9293288|P3|Treatment|Lost to Follow-up|0
2696119|NCT00423891|9293289|P2|Treatment|Lost to Follow-up|0
2696120|NCT00423891|9293290|P1|Treatment|Lost to Follow-up|1
2696121|NCT00423891|9293288|P3|Treatment|Withdrawal by Subject|0
2696122|NCT00423891|9293289|P2|Treatment|Withdrawal by Subject|0
2696123|NCT00423891|9293290|P1|Treatment|Withdrawal by Subject|1
2696124|NCT00423891|9293288|P3|Enrolled|No longer met criteria|1
2696125|NCT00423891|9293289|P2|Enrolled|No longer met criteria|2
2696126|NCT00423891|9293290|P1|Enrolled|No longer met criteria|11
2696127|NCT00423891|9293288|P3|Enrolled|Lost to Follow-up|1
2696128|NCT00423891|9293289|P2|Enrolled|Lost to Follow-up|0
2696129|NCT00423891|9293290|P1|Enrolled|Lost to Follow-up|0
2696130|NCT00423891|9293288|P3|Enrolled|Withdrawal by Subject|1
2696131|NCT00423891|9293289|P2|Enrolled|Withdrawal by Subject|0
2696132|NCT00423891|9293290|P1|Enrolled|Withdrawal by Subject|0
2696133|NCT00423852|9293368|P1|Overall Study|Removed pior to the high-dose portion|3
2696134|NCT00423813|9293376|P3|Overall Study|Undergoing tests for Cushings Syndrome|1
2696135|NCT00423813|9293377|P2|Overall Study|Undergoing tests for Cushings Syndrome|0
2696136|NCT00423813|9293378|P1|Overall Study|Undergoing tests for Cushings Syndrome|0
2696137|NCT00423813|9293376|P3|Overall Study|Will start exclusionary medications|0
2696138|NCT00423813|9293377|P2|Overall Study|Will start exclusionary medications|1
2696139|NCT00423813|9293378|P1|Overall Study|Will start exclusionary medications|0
2696140|NCT00423813|9293376|P3|Overall Study|Subject started night shift work|0
2696141|NCT00423813|9293377|P2|Overall Study|Subject started night shift work|0
2696142|NCT00423813|9293378|P1|Overall Study|Subject started night shift work|1
2696143|NCT00423813|9293376|P3|Overall Study|Pregnancy|1
2696144|NCT00423813|9293377|P2|Overall Study|Pregnancy|0
2696145|NCT00423813|9293378|P1|Overall Study|Pregnancy|0
2696146|NCT00423813|9293376|P3|Overall Study|Protocol Violation|4
2696147|NCT00423813|9293377|P2|Overall Study|Protocol Violation|4
2696148|NCT00423813|9293378|P1|Overall Study|Protocol Violation|9
2696149|NCT00423813|9293376|P3|Overall Study|Sponsor Decision|0
2696150|NCT00423813|9293377|P2|Overall Study|Sponsor Decision|1
2696151|NCT00423813|9293378|P1|Overall Study|Sponsor Decision|0
2696152|NCT00423813|9293376|P3|Overall Study|Physician Decision|0
2696153|NCT00423813|9293377|P2|Overall Study|Physician Decision|0
2696154|NCT00423813|9293378|P1|Overall Study|Physician Decision|2
2696155|NCT00423813|9293376|P3|Overall Study|Lack of Efficacy|19
2696156|NCT00423813|9293377|P2|Overall Study|Lack of Efficacy|18
2696157|NCT00423813|9293378|P1|Overall Study|Lack of Efficacy|23
2696158|NCT00423813|9293376|P3|Overall Study|Lost to Follow-up|4
2696159|NCT00423813|9293377|P2|Overall Study|Lost to Follow-up|4
2696160|NCT00423813|9293378|P1|Overall Study|Lost to Follow-up|5
2696161|NCT00423813|9293376|P3|Overall Study|Withdrawal by Subject|5
2696162|NCT00423813|9293377|P2|Overall Study|Withdrawal by Subject|8
2696163|NCT00423813|9293378|P1|Overall Study|Withdrawal by Subject|6
2696164|NCT00423813|9293376|P3|Overall Study|Adverse Event|40
2696165|NCT00423813|9293377|P2|Overall Study|Adverse Event|30
2696166|NCT00423813|9293378|P1|Overall Study|Adverse Event|11
2696167|NCT00423800|9293388|P2|Overall Study|Protocol Violation|1
2696168|NCT00423800|9293389|P1|Overall Study|Protocol Violation|0
2696169|NCT00423735|9293401|P3|Overall Study|Ineligible / No protocol treatment|0
2696170|NCT00423735|9293402|P2|Overall Study|Ineligible / No protocol treatment|6
2696171|NCT00423735|9293403|P1|Overall Study|Ineligible / No protocol treatment|8
2696172|NCT00423722|9293426|P2|Overall Study|Withdrawal by Subject|2
2696173|NCT00423722|9293427|P1|Overall Study|Withdrawal by Subject|4
2696174|NCT00423722|9293426|P2|Overall Study|Unable to complete questionnaires|4
2696175|NCT00423722|9293427|P1|Overall Study|Unable to complete questionnaires|4
2696176|NCT00423722|9293426|P2|Overall Study|Declined to participate|3
2696177|NCT00423722|9293427|P1|Overall Study|Declined to participate|2
2696178|NCT00423722|9293426|P2|Overall Study|Death|4
2696179|NCT00423722|9293427|P1|Overall Study|Death|4
2696180|NCT00423670|9293469|P8|Follow-up Period|Non-compliance with protocol|2
2696181|NCT00423670|9293470|P7|Follow-up Period|Non-compliance with protocol|3
2696182|NCT00423670|9293471|P6|Follow-up Period|Non-compliance with protocol|0
2696183|NCT00423670|9293472|P5|Follow-up Period|Non-compliance with protocol|0
2696184|NCT00423670|9293473|P4|Follow-up Period|Non-compliance with protocol|1
2696185|NCT00423670|9293474|P3|Follow-up Period|Non-compliance with protocol|1
2696186|NCT00423670|9293475|P2|Follow-up Period|Non-compliance with protocol|0
2696187|NCT00423670|9293476|P1|Follow-up Period|Non-compliance with protocol|2
2696188|NCT00423670|9293469|P8|Follow-up Period|Subject withdrew (not treatment related)|1
2696189|NCT00423670|9293470|P7|Follow-up Period|Subject withdrew (not treatment related)|1
2696190|NCT00423670|9293471|P6|Follow-up Period|Subject withdrew (not treatment related)|0
2696191|NCT00423670|9293472|P5|Follow-up Period|Subject withdrew (not treatment related)|1
2696192|NCT00423670|9293473|P4|Follow-up Period|Subject withdrew (not treatment related)|1
2696193|NCT00423670|9293474|P3|Follow-up Period|Subject withdrew (not treatment related)|2
2696194|NCT00423670|9293475|P2|Follow-up Period|Subject withdrew (not treatment related)|4
2696195|NCT00423670|9293476|P1|Follow-up Period|Subject withdrew (not treatment related)|1
2696196|NCT00423670|9293469|P8|Follow-up Period|Lost to Follow-up|0
2696197|NCT00423670|9293470|P7|Follow-up Period|Lost to Follow-up|5
2696198|NCT00423670|9293471|P6|Follow-up Period|Lost to Follow-up|0
2696199|NCT00423670|9293472|P5|Follow-up Period|Lost to Follow-up|1
2696200|NCT00423670|9293473|P4|Follow-up Period|Lost to Follow-up|3
2696201|NCT00423670|9293474|P3|Follow-up Period|Lost to Follow-up|8
2696202|NCT00423670|9293475|P2|Follow-up Period|Lost to Follow-up|12
2696203|NCT00423670|9293476|P1|Follow-up Period|Lost to Follow-up|0
2696204|NCT00423670|9293469|P8|Treatment Period|Non-compliance with protocol|2
2696205|NCT00423670|9293470|P7|Treatment Period|Non-compliance with protocol|2
2696206|NCT00423670|9293471|P6|Treatment Period|Non-compliance with protocol|0
2696207|NCT00423670|9293472|P5|Treatment Period|Non-compliance with protocol|2
2696208|NCT00423670|9293473|P4|Treatment Period|Non-compliance with protocol|3
2696209|NCT00423670|9293474|P3|Treatment Period|Non-compliance with protocol|1
2696210|NCT00423670|9293475|P2|Treatment Period|Non-compliance with protocol|1
2696211|NCT00423670|9293476|P1|Treatment Period|Non-compliance with protocol|3
2696212|NCT00423670|9293469|P8|Treatment Period|Investigator decision|1
2696213|NCT00423670|9293470|P7|Treatment Period|Investigator decision|0
2696214|NCT00423670|9293471|P6|Treatment Period|Investigator decision|0
2696215|NCT00423670|9293472|P5|Treatment Period|Investigator decision|0
2696216|NCT00423670|9293473|P4|Treatment Period|Investigator decision|0
2696217|NCT00423670|9293474|P3|Treatment Period|Investigator decision|0
2696218|NCT00423670|9293475|P2|Treatment Period|Investigator decision|0
2696219|NCT00423670|9293476|P1|Treatment Period|Investigator decision|0
2696220|NCT00423670|9293469|P8|Treatment Period|Subject withdrew (not treatment related)|0
2696221|NCT00423670|9293470|P7|Treatment Period|Subject withdrew (not treatment related)|3
2696222|NCT00423670|9293471|P6|Treatment Period|Subject withdrew (not treatment related)|0
2696223|NCT00423670|9293472|P5|Treatment Period|Subject withdrew (not treatment related)|5
2696224|NCT00423670|9293473|P4|Treatment Period|Subject withdrew (not treatment related)|4
2696225|NCT00423670|9293474|P3|Treatment Period|Subject withdrew (not treatment related)|4
2696226|NCT00423670|9293475|P2|Treatment Period|Subject withdrew (not treatment related)|9
2696227|NCT00423670|9293476|P1|Treatment Period|Subject withdrew (not treatment related)|3
2696228|NCT00423670|9293469|P8|Treatment Period|Lost to Follow-up|1
2696229|NCT00423670|9293470|P7|Treatment Period|Lost to Follow-up|3
2696230|NCT00423670|9293471|P6|Treatment Period|Lost to Follow-up|0
2696231|NCT00423670|9293472|P5|Treatment Period|Lost to Follow-up|6
2696232|NCT00423670|9293473|P4|Treatment Period|Lost to Follow-up|1
2696233|NCT00423670|9293474|P3|Treatment Period|Lost to Follow-up|3
2696234|NCT00423670|9293475|P2|Treatment Period|Lost to Follow-up|1
2696235|NCT00423670|9293476|P1|Treatment Period|Lost to Follow-up|2
2696236|NCT00423670|9293469|P8|Treatment Period|Protocol-defined clinical event|15
2696237|NCT00423670|9293470|P7|Treatment Period|Protocol-defined clinical event|16
2696238|NCT00423670|9293471|P6|Treatment Period|Protocol-defined clinical event|4
2696239|NCT00423670|9293472|P5|Treatment Period|Protocol-defined clinical event|5
2696240|NCT00423670|9293473|P4|Treatment Period|Protocol-defined clinical event|12
2696241|NCT00423670|9293474|P3|Treatment Period|Protocol-defined clinical event|4
2696242|NCT00423670|9293475|P2|Treatment Period|Protocol-defined clinical event|7
2696243|NCT00423670|9293476|P1|Treatment Period|Protocol-defined clinical event|0
2696244|NCT00423670|9293469|P8|Treatment Period|Adverse Event|2
2696245|NCT00423670|9293470|P7|Treatment Period|Adverse Event|7
2696246|NCT00423670|9293471|P6|Treatment Period|Adverse Event|4
2696247|NCT00423670|9293472|P5|Treatment Period|Adverse Event|9
2696248|NCT00423670|9293473|P4|Treatment Period|Adverse Event|20
2696249|NCT00423670|9293474|P3|Treatment Period|Adverse Event|15
2696250|NCT00423670|9293475|P2|Treatment Period|Adverse Event|12
2696251|NCT00423670|9293476|P1|Treatment Period|Adverse Event|8
2696252|NCT00423670|9293469|P8|Treatment Period|Switched to Arm 8 at TW 24|0
2696253|NCT00423670|9293470|P7|Treatment Period|Switched to Arm 8 at TW 24|0
2696254|NCT00423670|9293471|P6|Treatment Period|Switched to Arm 8 at TW 24|0
2696255|NCT00423670|9293472|P5|Treatment Period|Switched to Arm 8 at TW 24|0
2696256|NCT00423670|9293473|P4|Treatment Period|Switched to Arm 8 at TW 24|0
2696257|NCT00423670|9293474|P3|Treatment Period|Switched to Arm 8 at TW 24|0
2696258|NCT00423670|9293475|P2|Treatment Period|Switched to Arm 8 at TW 24|0
2696259|NCT00423670|9293476|P1|Treatment Period|Switched to Arm 8 at TW 24|36
2696260|NCT00423657|9293534|P2|Overall Study|Request of sponsor/investigator|0
2696261|NCT00423657|9293535|P1|Overall Study|Request of sponsor/investigator|1
2696262|NCT00423657|9293534|P2|Overall Study|Other|16
2696263|NCT00423657|9293535|P1|Overall Study|Other|15
2696264|NCT00423657|9293534|P2|Overall Study|Non-compliance|1
2696265|NCT00423657|9293535|P1|Overall Study|Non-compliance|0
2696266|NCT00423657|9293534|P2|Overall Study|Withdrew consent|8
2696267|NCT00423657|9293535|P1|Overall Study|Withdrew consent|10
2696268|NCT00423605|9293541|P1|Overall Study|Not one of the pre-specified options|5
2696269|NCT00423605|9293541|P1|Overall Study|Protocol Violation|7
2696270|NCT00423605|9293541|P1|Overall Study|Physician Decision|8
2696271|NCT00423605|9293541|P1|Overall Study|Sponsor Decision|3
2696272|NCT00423605|9293541|P1|Overall Study|Lack of Efficacy|38
2696273|NCT00423605|9293541|P1|Overall Study|Lost to Follow-up|15
2696274|NCT00423605|9293541|P1|Overall Study|Withdrawal by Subject|36
2696275|NCT00423605|9293541|P1|Overall Study|Adverse Event|129
2696276|NCT00423592|9293545|P1|Overall Study|Adverse Event (post Week 12)|5
2696277|NCT00423592|9293545|P1|Overall Study|Adverse Event (through Week 12)|2
2696278|NCT00423579|9293566|P2|Overall Study|Diagnosis of diabetes|1
2696279|NCT00423579|9293567|P1|Overall Study|Diagnosis of diabetes|0
2696280|NCT00423579|9293566|P2|Overall Study|Protocol Violation|3
2696281|NCT00423579|9293567|P1|Overall Study|Protocol Violation|1
2696282|NCT00423579|9293566|P2|Overall Study|Lost to Follow-up|0
2696283|NCT00423579|9293567|P1|Overall Study|Lost to Follow-up|3
2696284|NCT00423488|9293575|P2|Overall Study|No post baseline data|0
2696285|NCT00423488|9293576|P1|Overall Study|No post baseline data|3
2696286|NCT00423488|9293575|P2|Overall Study|No evidence of study drug intake|1
2696287|NCT00423488|9293576|P1|Overall Study|No evidence of study drug intake|2
2696288|NCT00423449|9293582|P5|Overall Study|Protocol Violation|0
2696289|NCT00423449|9293583|P4|Overall Study|Protocol Violation|1
2696290|NCT00423449|9293584|P3|Overall Study|Protocol Violation|2
2696291|NCT00423449|9293585|P2|Overall Study|Protocol Violation|0
2696292|NCT00423449|9293586|P1|Overall Study|Protocol Violation|0
2696293|NCT00423449|9293582|P5|Overall Study|Other|0
2696294|NCT00423449|9293583|P4|Overall Study|Other|1
2696295|NCT00423449|9293584|P3|Overall Study|Other|0
2696296|NCT00423449|9293585|P2|Overall Study|Other|0
2696297|NCT00423449|9293586|P1|Overall Study|Other|0
2696298|NCT00423449|9293582|P5|Overall Study|Laboratory Adverse Event|0
2696299|NCT00423449|9293583|P4|Overall Study|Laboratory Adverse Event|0
2696300|NCT00423449|9293584|P3|Overall Study|Laboratory Adverse Event|2
2696301|NCT00423449|9293585|P2|Overall Study|Laboratory Adverse Event|1
2696302|NCT00423449|9293586|P1|Overall Study|Laboratory Adverse Event|0
2696303|NCT00423449|9293582|P5|Overall Study|Progressive Disease|4
2696304|NCT00423449|9293583|P4|Overall Study|Progressive Disease|11
2696305|NCT00423449|9293584|P3|Overall Study|Progressive Disease|8
2696306|NCT00423449|9293585|P2|Overall Study|Progressive Disease|3
2696307|NCT00423449|9293586|P1|Overall Study|Progressive Disease|1
2696308|NCT00423449|9293582|P5|Overall Study|Death|1
2696309|NCT00423449|9293583|P4|Overall Study|Death|1
2696310|NCT00423449|9293584|P3|Overall Study|Death|2
2696311|NCT00423449|9293585|P2|Overall Study|Death|0
2696312|NCT00423449|9293586|P1|Overall Study|Death|1
2696313|NCT00423449|9293582|P5|Overall Study|Clinical Adverse Event|2
2696314|NCT00423449|9293583|P4|Overall Study|Clinical Adverse Event|8
2696315|NCT00423449|9293584|P3|Overall Study|Clinical Adverse Event|1
2696316|NCT00423449|9293585|P2|Overall Study|Clinical Adverse Event|0
2696317|NCT00423449|9293586|P1|Overall Study|Clinical Adverse Event|1
2696318|NCT00423332|9293633|P2|Overall Study|Unblinded before 12 weeks|3
2696319|NCT00423332|9293634|P1|Overall Study|Unblinded before 12 weeks|1
2696320|NCT00423332|9293633|P2|Overall Study|Progressive at Week 6|1
2696321|NCT00423332|9293634|P1|Overall Study|Progressive at Week 6|0
2696322|NCT00423332|9293633|P2|Overall Study|Condition under investigation worsened|1
2696323|NCT00423332|9293634|P1|Overall Study|Condition under investigation worsened|1
2696324|NCT00423332|9293633|P2|Overall Study|Withdrawal by Subject|0
2696325|NCT00423332|9293634|P1|Overall Study|Withdrawal by Subject|1
2696326|NCT00423332|9293633|P2|Overall Study|Adverse Event|2
2696327|NCT00423332|9293634|P1|Overall Study|Adverse Event|6
2696328|NCT00423319|9293653|P2|Overall Study|Other|22
2696329|NCT00423319|9293654|P1|Overall Study|Other|23
2696330|NCT00423319|9293653|P2|Overall Study|No longer meets study criteria|15
2696331|NCT00423319|9293654|P1|Overall Study|No longer meets study criteria|15
2696332|NCT00423319|9293653|P2|Overall Study|Poor compliance or noncompliance|1
2696333|NCT00423319|9293654|P1|Overall Study|Poor compliance or noncompliance|1
2696334|NCT00423319|9293653|P2|Overall Study|Lost to Follow-up|3
2696335|NCT00423319|9293654|P1|Overall Study|Lost to Follow-up|4
2696336|NCT00423319|9293653|P2|Overall Study|Withdrawal by Subject|99
2696337|NCT00423319|9293654|P1|Overall Study|Withdrawal by Subject|86
2696338|NCT00423319|9293653|P2|Overall Study|Adverse Event|112
2696339|NCT00423319|9293654|P1|Overall Study|Adverse Event|93
2696340|NCT00423319|9293653|P2|Overall Study|Death|0
2696341|NCT00423319|9293654|P1|Overall Study|Death|2
2696342|NCT00423293|9293686|P1|Overall Study|Ineligible / No protocol treatment|11
2696343|NCT00423267|9293703|P2|Period A|Administrative|0
2696344|NCT00423267|9293704|P1|Period A|Administrative|1
2696345|NCT00423267|9293703|P2|Period A|Non-compliance with protocol|0
2696346|NCT00423267|9293704|P1|Period A|Non-compliance with protocol|1
2696347|NCT00423267|9293703|P2|Period A|Withdrawal by Subject|1
2696348|NCT00423267|9293704|P1|Period A|Withdrawal by Subject|0
2696349|NCT00423189|9293724|P3|Overall Study|Death|0
2696350|NCT00423189|9293725|P2|Overall Study|Death|1
2696351|NCT00423189|9293726|P1|Overall Study|Death|0
2696352|NCT00423176|9293748|P2|Overall Study|Did not meet protocol eligibility|4
2696353|NCT00423176|9293749|P1|Overall Study|Did not meet protocol eligibility|2
2696354|NCT00423176|9293748|P2|Overall Study|Protocol Violation|3
2696355|NCT00423176|9293749|P1|Overall Study|Protocol Violation|1
2696356|NCT00423176|9293748|P2|Overall Study|Withdrawal by Subject|3
2696357|NCT00423176|9293749|P1|Overall Study|Withdrawal by Subject|4
2696358|NCT00423176|9293748|P2|Overall Study|Lost to Follow-up|7
2696359|NCT00423176|9293749|P1|Overall Study|Lost to Follow-up|4
2696360|NCT00423176|9293748|P2|Overall Study|Treatment Failure|6
2696361|NCT00423176|9293749|P1|Overall Study|Treatment Failure|1
2696362|NCT00423176|9293748|P2|Overall Study|Adverse Event|6
2696363|NCT00423176|9293749|P1|Overall Study|Adverse Event|4
2696364|NCT00423150|9293757|P1|Overall Study|Administrative|4
2696365|NCT00423150|9293757|P1|Overall Study|Non-compliance with protocol|1
2696366|NCT00423150|9293757|P1|Overall Study|Withdrawal by Subject|1
2696367|NCT00423150|9293757|P1|Overall Study|Progression of disease being studied|69
2696368|NCT00423150|9293757|P1|Overall Study|Adverse Event|11
2696369|NCT00423098|9293763|P2|Overall Study|Death|0
2696370|NCT00423098|9293764|P1|Overall Study|Death|2
2696371|NCT00423098|9293763|P2|Overall Study|Administrative problems|1
2696372|NCT00423098|9293764|P1|Overall Study|Administrative problems|0
2696373|NCT00423098|9293763|P2|Overall Study|Unsatisfactory therapeutic effect|1
2696374|NCT00423098|9293764|P1|Overall Study|Unsatisfactory therapeutic effect|0
2696375|NCT00423098|9293763|P2|Overall Study|Adverse Event|2
2696376|NCT00423098|9293764|P1|Overall Study|Adverse Event|1
2696377|NCT00423085|9293791|P4|52-Week Open-Label Extension Phase|Death|2
2696378|NCT00423085|9293792|P3|52-Week Open-Label Extension Phase|Death|0
2696379|NCT00423085|9293793|P2|52-Week Open-Label Extension Phase|Death|0
2696380|NCT00423085|9293794|P1|52-Week Open-Label Extension Phase|Death|0
2696381|NCT00423085|9293791|P4|52-Week Open-Label Extension Phase|Protocol deviation|9
2696382|NCT00423085|9293792|P3|52-Week Open-Label Extension Phase|Protocol deviation|0
2696383|NCT00423085|9293793|P2|52-Week Open-Label Extension Phase|Protocol deviation|0
2696384|NCT00423085|9293794|P1|52-Week Open-Label Extension Phase|Protocol deviation|0
2696385|NCT00423085|9293791|P4|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18
2696386|NCT00423085|9293792|P3|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
2696387|NCT00423085|9293793|P2|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
2696388|NCT00423085|9293794|P1|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
2696389|NCT00423085|9293791|P4|52-Week Open-Label Extension Phase|Withdrawal by Subject|37
2696390|NCT00423085|9293792|P3|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
2696391|NCT00423085|9293793|P2|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
2696392|NCT00423085|9293794|P1|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
2696393|NCT00423085|9293791|P4|52-Week Open-Label Extension Phase|Adverse Event|97
2696394|NCT00423085|9293792|P3|52-Week Open-Label Extension Phase|Adverse Event|0
2696395|NCT00423085|9293793|P2|52-Week Open-Label Extension Phase|Adverse Event|0
2696396|NCT00423085|9293794|P1|52-Week Open-Label Extension Phase|Adverse Event|0
2696397|NCT00423085|9293791|P4|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
2696398|NCT00423085|9293792|P3|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
2696399|NCT00423085|9293793|P2|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
2696400|NCT00423085|9293794|P1|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1
2696401|NCT00423085|9293791|P4|24-Week Double-Blind Treatment Phase|Death|0
2696402|NCT00423085|9293792|P3|24-Week Double-Blind Treatment Phase|Death|0
2696403|NCT00423085|9293793|P2|24-Week Double-Blind Treatment Phase|Death|1
2696404|NCT00423085|9293794|P1|24-Week Double-Blind Treatment Phase|Death|1
2696405|NCT00423085|9293791|P4|24-Week Double-Blind Treatment Phase|Protocol Violation|0
2696406|NCT00423085|9293792|P3|24-Week Double-Blind Treatment Phase|Protocol Violation|7
2696407|NCT00423085|9293793|P2|24-Week Double-Blind Treatment Phase|Protocol Violation|3
2696408|NCT00423085|9293794|P1|24-Week Double-Blind Treatment Phase|Protocol Violation|8
2696409|NCT00423085|9293791|P4|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
2696410|NCT00423085|9293792|P3|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
2696497|NCT00422292|9294237|P2|Overall Study|Lost to Follow-up|12
2696411|NCT00423085|9293793|P2|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6
2696412|NCT00423085|9293794|P1|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
2696413|NCT00423085|9293791|P4|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0
2696414|NCT00423085|9293792|P3|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11
2696415|NCT00423085|9293793|P2|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16
2696416|NCT00423085|9293794|P1|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8
2696417|NCT00423085|9293791|P4|24-Week Double-Blind Treatment Phase|Adverse Event|0
2696418|NCT00423085|9293792|P3|24-Week Double-Blind Treatment Phase|Adverse Event|34
2696419|NCT00423085|9293793|P2|24-Week Double-Blind Treatment Phase|Adverse Event|38
2696420|NCT00423085|9293794|P1|24-Week Double-Blind Treatment Phase|Adverse Event|21
2696421|NCT00423046|9293823|P2|Overall Study|Other|345
2696422|NCT00423046|9293824|P1|Overall Study|Other|340
2696423|NCT00422942|9293890|P1|Overall Study|Study terminated by Sponsor|3
2696424|NCT00422903|9293909|P2|Overall Study|Informed Consent Withdrawn|2
2696425|NCT00422903|9293910|P1|Overall Study|Informed Consent Withdrawn|1
2696426|NCT00422903|9293909|P2|Overall Study|Adverse Event|2
2696427|NCT00422903|9293910|P1|Overall Study|Adverse Event|0
2696428|NCT00422903|9293909|P2|Overall Study|Disease Progression|1
2696429|NCT00422903|9293910|P1|Overall Study|Disease Progression|3
2696430|NCT00422799|9293959|P1|Overall Study|Adverse Event|7
2696431|NCT00422799|9293959|P1|Overall Study|Withdrawal by Subject|6
2696432|NCT00422734|9293968|P2|Overall Study|Partner Decision|3
2696433|NCT00422734|9293969|P1|Overall Study|Partner Decision|0
2696434|NCT00422734|9293968|P2|Overall Study|Adverse Event|3
2696435|NCT00422734|9293969|P1|Overall Study|Adverse Event|0
2696436|NCT00422734|9293968|P2|Overall Study|Withdrawal by Subject|8
2696437|NCT00422734|9293969|P1|Overall Study|Withdrawal by Subject|12
2696438|NCT00422734|9293968|P2|Overall Study|Protocol Violation|6
2696439|NCT00422734|9293969|P1|Overall Study|Protocol Violation|1
2696440|NCT00422734|9293968|P2|Overall Study|Physician Decision|1
2696441|NCT00422734|9293969|P1|Overall Study|Physician Decision|1
2696442|NCT00422669|9294015|P3|Overall Study|The study was terminated early.|7
2696443|NCT00422669|9294016|P2|Overall Study|The study was terminated early.|100
2696444|NCT00422669|9294017|P1|Overall Study|The study was terminated early.|98
2696445|NCT00422591|9294045|P1|Overall Study|Withdrawal by Subject|2
2696446|NCT00422591|9294045|P1|Overall Study|Physician Decision|4
2696447|NCT00422513|9294053|P2|Overall Study|Death|7
2696448|NCT00422513|9294054|P1|Overall Study|Death|3
2696449|NCT00422513|9294053|P2|Overall Study|Adverse Event|4
2696450|NCT00422513|9294054|P1|Overall Study|Adverse Event|4
2696451|NCT00422513|9294053|P2|Overall Study|early termination of the study|80
2696452|NCT00422513|9294054|P1|Overall Study|early termination of the study|67
2696453|NCT00422513|9294053|P2|Overall Study|Withdrawal by Subject|1
2696454|NCT00422513|9294054|P1|Overall Study|Withdrawal by Subject|2
2696455|NCT00422513|9294053|P2|Overall Study|Refused Treatment|2
2696456|NCT00422513|9294054|P1|Overall Study|Refused Treatment|4
2696457|NCT00422513|9294053|P2|Overall Study|Protocol Violation|7
2696458|NCT00422513|9294054|P1|Overall Study|Protocol Violation|23
2696459|NCT00422513|9294053|P2|Overall Study|Lack of Efficacy|5
2696460|NCT00422513|9294054|P1|Overall Study|Lack of Efficacy|4
2696461|NCT00422422|9294071|P1|Overall Study|AE, non-serious non-fatal|5
2696462|NCT00422422|9294071|P1|Overall Study|SAE, non-fatal|1
2696463|NCT00422422|9294071|P1|Overall Study|Withdrawal by Subject|2
2696464|NCT00422422|9294071|P1|Overall Study|Protocol Violation|1
2696465|NCT00422422|9294071|P1|Overall Study|Lack of Efficacy|1
2696466|NCT00422383|9294088|P5|Overall Study|Withdrawal by Subject|1
2696467|NCT00422383|9294089|P4|Overall Study|Withdrawal by Subject|0
2696468|NCT00422383|9294090|P3|Overall Study|Withdrawal by Subject|0
2696469|NCT00422383|9294091|P2|Overall Study|Withdrawal by Subject|5
2696470|NCT00422383|9294092|P1|Overall Study|Withdrawal by Subject|5
2696471|NCT00422383|9294088|P5|Overall Study|Protocol Violation|0
2696472|NCT00422383|9294089|P4|Overall Study|Protocol Violation|0
2696473|NCT00422383|9294090|P3|Overall Study|Protocol Violation|1
2696474|NCT00422383|9294091|P2|Overall Study|Protocol Violation|1
2696475|NCT00422383|9294092|P1|Overall Study|Protocol Violation|1
2696476|NCT00422383|9294088|P5|Overall Study|Lost to Follow-up|1
2696477|NCT00422383|9294089|P4|Overall Study|Lost to Follow-up|0
2696478|NCT00422383|9294090|P3|Overall Study|Lost to Follow-up|0
2696479|NCT00422383|9294091|P2|Overall Study|Lost to Follow-up|1
2696480|NCT00422383|9294092|P1|Overall Study|Lost to Follow-up|0
2696481|NCT00422383|9294088|P5|Overall Study|Lack of Efficacy|1
2696482|NCT00422383|9294089|P4|Overall Study|Lack of Efficacy|1
2696483|NCT00422383|9294090|P3|Overall Study|Lack of Efficacy|2
2696484|NCT00422383|9294091|P2|Overall Study|Lack of Efficacy|4
2696485|NCT00422383|9294092|P1|Overall Study|Lack of Efficacy|4
2696486|NCT00422383|9294088|P5|Overall Study|Adverse Event|0
2696487|NCT00422383|9294089|P4|Overall Study|Adverse Event|1
2696488|NCT00422383|9294090|P3|Overall Study|Adverse Event|1
2696489|NCT00422383|9294091|P2|Overall Study|Adverse Event|3
2696490|NCT00422383|9294092|P1|Overall Study|Adverse Event|5
2696491|NCT00422292|9294235|P4|Overall Study|Withdrawal by Subject|13
2696492|NCT00422292|9294236|P3|Overall Study|Withdrawal by Subject|7
2696493|NCT00422292|9294237|P2|Overall Study|Withdrawal by Subject|25
2696494|NCT00422292|9294238|P1|Overall Study|Withdrawal by Subject|6
2696495|NCT00422292|9294235|P4|Overall Study|Lost to Follow-up|6
2696496|NCT00422292|9294236|P3|Overall Study|Lost to Follow-up|6
2696498|NCT00422292|9294238|P1|Overall Study|Lost to Follow-up|6
2696499|NCT00422292|9294235|P4|Overall Study|Protocol Violation|5
2696500|NCT00422292|9294236|P3|Overall Study|Protocol Violation|8
2696501|NCT00422292|9294237|P2|Overall Study|Protocol Violation|25
2696502|NCT00422292|9294238|P1|Overall Study|Protocol Violation|4
2696503|NCT00422292|9294235|P4|Overall Study|Adverse Event|0
2696504|NCT00422292|9294236|P3|Overall Study|Adverse Event|1
2696505|NCT00422292|9294237|P2|Overall Study|Adverse Event|0
2696506|NCT00422292|9294238|P1|Overall Study|Adverse Event|1
2696507|NCT00422292|9294235|P4|Overall Study|Serious adverse events|0
2696508|NCT00422292|9294236|P3|Overall Study|Serious adverse events|0
2696509|NCT00422292|9294237|P2|Overall Study|Serious adverse events|4
2696510|NCT00422292|9294238|P1|Overall Study|Serious adverse events|1
2696511|NCT00422227|9294277|P2|Overall Study|Withdrawal by Subject|4
2696512|NCT00422227|9294278|P1|Overall Study|Withdrawal by Subject|0
2696513|NCT00422227|9294277|P2|Overall Study|Lost to Follow-up|3
2696514|NCT00422227|9294278|P1|Overall Study|Lost to Follow-up|1
2696515|NCT00422227|9294277|P2|Overall Study|Adverse Event|8
2696516|NCT00422227|9294278|P1|Overall Study|Adverse Event|3
2696517|NCT00422162|9294309|P2|Overall Study|Didn't Receive Treatment|1
2696518|NCT00422162|9294310|P1|Overall Study|Didn't Receive Treatment|0
2696519|NCT00422162|9294309|P2|Overall Study|Other|1
2696520|NCT00422162|9294310|P1|Overall Study|Other|0
2696521|NCT00422162|9294309|P2|Overall Study|Non-Compliant with Protocol|1
2696522|NCT00422162|9294310|P1|Overall Study|Non-Compliant with Protocol|1
2696523|NCT00422162|9294309|P2|Overall Study|Lost to Follow-up|2
2696524|NCT00422162|9294310|P1|Overall Study|Lost to Follow-up|1
2696525|NCT00422162|9294309|P2|Overall Study|Withdrawal by Subject|6
2696526|NCT00422162|9294310|P1|Overall Study|Withdrawal by Subject|7
2696527|NCT00422162|9294309|P2|Overall Study|Lack of Efficacy|10
2696528|NCT00422162|9294310|P1|Overall Study|Lack of Efficacy|4
2696529|NCT00422162|9294309|P2|Overall Study|Adverse Event|9
2696530|NCT00422162|9294310|P1|Overall Study|Adverse Event|11
2696531|NCT00422097|9294370|P8|Dose Level 2|Still on treatment|0
2696532|NCT00422097|9294371|P7|Dose Level 2|Still on treatment|0
2696533|NCT00422097|9294372|P6|Dose Level 2|Still on treatment|0
2696534|NCT00422097|9294373|P5|Dose Level 2|Still on treatment|0
2696535|NCT00422097|9294374|P4|Dose Level 2|Still on treatment|0
2696536|NCT00422097|9294375|P3|Dose Level 2|Still on treatment|0
2696537|NCT00422097|9294376|P2|Dose Level 2|Still on treatment|1
2696538|NCT00422097|9294377|P1|Dose Level 2|Still on treatment|0
2696539|NCT00422058|9294442|P6|Open-Label Extension, Week 20-104|Other|18
2696540|NCT00422058|9294443|P5|Open-Label Extension, Week 20-104|Other|16
2696541|NCT00422058|9294444|P4|Open-Label Extension, Week 20-104|Other|13
2696542|NCT00422058|9294445|P3|Open-Label Extension, Week 20-104|Other|6
2696543|NCT00422058|9294446|P2|Open-Label Extension, Week 20-104|Other|14
2696544|NCT00422058|9294447|P1|Open-Label Extension, Week 20-104|Other|13
2696545|NCT00422058|9294442|P6|Open-Label Extension, Week 20-104|Lack of Efficacy|1
2696546|NCT00422058|9294443|P5|Open-Label Extension, Week 20-104|Lack of Efficacy|0
2696547|NCT00422058|9294444|P4|Open-Label Extension, Week 20-104|Lack of Efficacy|2
2696548|NCT00422058|9294445|P3|Open-Label Extension, Week 20-104|Lack of Efficacy|5
2696549|NCT00422058|9294446|P2|Open-Label Extension, Week 20-104|Lack of Efficacy|2
2696550|NCT00422058|9294447|P1|Open-Label Extension, Week 20-104|Lack of Efficacy|3
2696551|NCT00422058|9294442|P6|Open-Label Extension, Week 20-104|Protocol Violation|3
2696552|NCT00422058|9294443|P5|Open-Label Extension, Week 20-104|Protocol Violation|5
2696553|NCT00422058|9294444|P4|Open-Label Extension, Week 20-104|Protocol Violation|1
2696554|NCT00422058|9294445|P3|Open-Label Extension, Week 20-104|Protocol Violation|3
2696555|NCT00422058|9294446|P2|Open-Label Extension, Week 20-104|Protocol Violation|2
2696556|NCT00422058|9294447|P1|Open-Label Extension, Week 20-104|Protocol Violation|1
2696557|NCT00422058|9294442|P6|Open-Label Extension, Week 20-104|Adverse Event|0
2696558|NCT00422058|9294443|P5|Open-Label Extension, Week 20-104|Adverse Event|4
2696559|NCT00422058|9294444|P4|Open-Label Extension, Week 20-104|Adverse Event|4
2696560|NCT00422058|9294445|P3|Open-Label Extension, Week 20-104|Adverse Event|7
2696561|NCT00422058|9294446|P2|Open-Label Extension, Week 20-104|Adverse Event|4
2696562|NCT00422058|9294447|P1|Open-Label Extension, Week 20-104|Adverse Event|3
2696563|NCT00422058|9294442|P6|Open-Label Extension, Week 20-104|Not giving consent for extension|12
2696564|NCT00422058|9294443|P5|Open-Label Extension, Week 20-104|Not giving consent for extension|10
2696565|NCT00422058|9294444|P4|Open-Label Extension, Week 20-104|Not giving consent for extension|8
2696566|NCT00422058|9294445|P3|Open-Label Extension, Week 20-104|Not giving consent for extension|15
2696567|NCT00422058|9294446|P2|Open-Label Extension, Week 20-104|Not giving consent for extension|17
2696568|NCT00422058|9294447|P1|Open-Label Extension, Week 20-104|Not giving consent for extension|12
2696569|NCT00422058|9294442|P6|Double-Blind, Week 0-20|Other|10
2696570|NCT00422058|9294443|P5|Double-Blind, Week 0-20|Other|4
2696571|NCT00422058|9294444|P4|Double-Blind, Week 0-20|Other|8
2696572|NCT00422058|9294445|P3|Double-Blind, Week 0-20|Other|8
2696573|NCT00422058|9294446|P2|Double-Blind, Week 0-20|Other|3
2696574|NCT00422058|9294447|P1|Double-Blind, Week 0-20|Other|11
2696575|NCT00422058|9294442|P6|Double-Blind, Week 0-20|Lack of Efficacy|1
2696576|NCT00422058|9294443|P5|Double-Blind, Week 0-20|Lack of Efficacy|0
2696577|NCT00422058|9294444|P4|Double-Blind, Week 0-20|Lack of Efficacy|0
2696578|NCT00422058|9294445|P3|Double-Blind, Week 0-20|Lack of Efficacy|1
2696579|NCT00422058|9294446|P2|Double-Blind, Week 0-20|Lack of Efficacy|1
2696580|NCT00422058|9294447|P1|Double-Blind, Week 0-20|Lack of Efficacy|2
2696581|NCT00422058|9294442|P6|Double-Blind, Week 0-20|Protocol Violation|2
2696582|NCT00422058|9294443|P5|Double-Blind, Week 0-20|Protocol Violation|2
2696583|NCT00422058|9294444|P4|Double-Blind, Week 0-20|Protocol Violation|3
2696584|NCT00422058|9294445|P3|Double-Blind, Week 0-20|Protocol Violation|2
2696585|NCT00422058|9294446|P2|Double-Blind, Week 0-20|Protocol Violation|2
2696586|NCT00422058|9294447|P1|Double-Blind, Week 0-20|Protocol Violation|3
2696587|NCT00422058|9294442|P6|Double-Blind, Week 0-20|Adverse Event|3
2696588|NCT00422058|9294443|P5|Double-Blind, Week 0-20|Adverse Event|5
2696589|NCT00422058|9294444|P4|Double-Blind, Week 0-20|Adverse Event|9
2696590|NCT00422058|9294445|P3|Double-Blind, Week 0-20|Adverse Event|5
2696591|NCT00422058|9294446|P2|Double-Blind, Week 0-20|Adverse Event|4
2696592|NCT00422058|9294447|P1|Double-Blind, Week 0-20|Adverse Event|3
2696593|NCT00421993|9294588|P4|Overall Study|Subject transportation issues|1
2696594|NCT00421993|9294589|P3|Overall Study|Subject transportation issues|0
2696595|NCT00421993|9294590|P2|Overall Study|Subject transportation issues|0
2696596|NCT00421993|9294591|P1|Overall Study|Subject transportation issues|0
2696597|NCT00421993|9294588|P4|Overall Study|Pregnancy|2
2696598|NCT00421993|9294589|P3|Overall Study|Pregnancy|1
2696599|NCT00421993|9294590|P2|Overall Study|Pregnancy|1
2696600|NCT00421993|9294591|P1|Overall Study|Pregnancy|0
2696601|NCT00421993|9294588|P4|Overall Study|Lack of Efficacy|5
2696602|NCT00421993|9294589|P3|Overall Study|Lack of Efficacy|0
2696603|NCT00421993|9294590|P2|Overall Study|Lack of Efficacy|3
2696604|NCT00421993|9294591|P1|Overall Study|Lack of Efficacy|0
2696605|NCT00421993|9294588|P4|Overall Study|Protocol Violation|1
2696606|NCT00421993|9294589|P3|Overall Study|Protocol Violation|0
2696607|NCT00421993|9294590|P2|Overall Study|Protocol Violation|2
2696608|NCT00421993|9294591|P1|Overall Study|Protocol Violation|2
2696609|NCT00421993|9294588|P4|Overall Study|Adverse Event|4
2696610|NCT00421993|9294589|P3|Overall Study|Adverse Event|6
2696611|NCT00421993|9294590|P2|Overall Study|Adverse Event|1
2696612|NCT00421993|9294591|P1|Overall Study|Adverse Event|11
2696613|NCT00421993|9294588|P4|Overall Study|Lost to Follow-up|20
2696614|NCT00421993|9294589|P3|Overall Study|Lost to Follow-up|22
2696615|NCT00421993|9294590|P2|Overall Study|Lost to Follow-up|19
2696616|NCT00421993|9294591|P1|Overall Study|Lost to Follow-up|18
2696617|NCT00421993|9294588|P4|Overall Study|Withdrawal by Subject|24
2696618|NCT00421993|9294589|P3|Overall Study|Withdrawal by Subject|23
2696619|NCT00421993|9294590|P2|Overall Study|Withdrawal by Subject|23
2696620|NCT00421993|9294591|P1|Overall Study|Withdrawal by Subject|22
2696621|NCT00421928|9294628|P3|Overall Study|Death|0
2696622|NCT00421928|9294629|P2|Overall Study|Death|1
2696623|NCT00421928|9294630|P1|Overall Study|Death|0
2696624|NCT00421928|9294628|P3|Overall Study|All other|27
2696625|NCT00421928|9294629|P2|Overall Study|All other|21
2696626|NCT00421928|9294630|P1|Overall Study|All other|26
2696627|NCT00421928|9294628|P3|Overall Study|Study drug non-compliant|4
2696628|NCT00421928|9294629|P2|Overall Study|Study drug non-compliant|7
2696629|NCT00421928|9294630|P1|Overall Study|Study drug non-compliant|6
2696630|NCT00421928|9294628|P3|Overall Study|Lack of Efficacy|35
2696631|NCT00421928|9294629|P2|Overall Study|Lack of Efficacy|7
2696632|NCT00421928|9294630|P1|Overall Study|Lack of Efficacy|15
2696633|NCT00421928|9294628|P3|Overall Study|Withdrawal by Subject|43
2696634|NCT00421928|9294629|P2|Overall Study|Withdrawal by Subject|48
2696635|NCT00421928|9294630|P1|Overall Study|Withdrawal by Subject|50
2696636|NCT00421928|9294628|P3|Overall Study|Lost to Follow-up|3
2696637|NCT00421928|9294629|P2|Overall Study|Lost to Follow-up|0
2696638|NCT00421928|9294630|P1|Overall Study|Lost to Follow-up|5
2696639|NCT00421928|9294628|P3|Overall Study|Adverse Event|22
2696640|NCT00421928|9294629|P2|Overall Study|Adverse Event|140
2696641|NCT00421928|9294630|P1|Overall Study|Adverse Event|61
2696642|NCT00421889|9294665|P9|Overall Study|Lost to Follow-up|1
2696643|NCT00421889|9294666|P8|Overall Study|Lost to Follow-up|0
2696644|NCT00421889|9294667|P7|Overall Study|Lost to Follow-up|0
2696645|NCT00421889|9294668|P6|Overall Study|Lost to Follow-up|0
2696646|NCT00421889|9294669|P5|Overall Study|Lost to Follow-up|0
2696647|NCT00421889|9294670|P4|Overall Study|Lost to Follow-up|0
2696648|NCT00421889|9294671|P3|Overall Study|Lost to Follow-up|0
2696649|NCT00421889|9294672|P2|Overall Study|Lost to Follow-up|0
2696650|NCT00421889|9294673|P1|Overall Study|Lost to Follow-up|0
2696651|NCT00421889|9294665|P9|Overall Study|Patient/Investigator request|3
2696652|NCT00421889|9294666|P8|Overall Study|Patient/Investigator request|1
2696653|NCT00421889|9294667|P7|Overall Study|Patient/Investigator request|0
2696654|NCT00421889|9294668|P6|Overall Study|Patient/Investigator request|9
2696655|NCT00421889|9294669|P5|Overall Study|Patient/Investigator request|0
2696656|NCT00421889|9294670|P4|Overall Study|Patient/Investigator request|0
2696657|NCT00421889|9294671|P3|Overall Study|Patient/Investigator request|0
2696658|NCT00421889|9294672|P2|Overall Study|Patient/Investigator request|0
2696659|NCT00421889|9294673|P1|Overall Study|Patient/Investigator request|0
2696660|NCT00421889|9294665|P9|Overall Study|Progressive disease|5
2696661|NCT00421889|9294666|P8|Overall Study|Progressive disease|1
2696662|NCT00421889|9294667|P7|Overall Study|Progressive disease|3
2696663|NCT00421889|9294668|P6|Overall Study|Progressive disease|21
2696664|NCT00421889|9294669|P5|Overall Study|Progressive disease|2
2696665|NCT00421889|9294670|P4|Overall Study|Progressive disease|3
2696666|NCT00421889|9294671|P3|Overall Study|Progressive disease|2
2696667|NCT00421889|9294672|P2|Overall Study|Progressive disease|2
2696668|NCT00421889|9294673|P1|Overall Study|Progressive disease|3
2696669|NCT00421889|9294665|P9|Overall Study|Death|0
2696670|NCT00421889|9294666|P8|Overall Study|Death|0
2696671|NCT00421889|9294667|P7|Overall Study|Death|0
2696672|NCT00421889|9294668|P6|Overall Study|Death|1
2696673|NCT00421889|9294669|P5|Overall Study|Death|1
2696674|NCT00421889|9294670|P4|Overall Study|Death|0
2696675|NCT00421889|9294671|P3|Overall Study|Death|0
2696676|NCT00421889|9294672|P2|Overall Study|Death|0
2696677|NCT00421889|9294673|P1|Overall Study|Death|0
2696678|NCT00421889|9294665|P9|Overall Study|Withdrawal by Subject|0
2696679|NCT00421889|9294666|P8|Overall Study|Withdrawal by Subject|0
2696680|NCT00421889|9294667|P7|Overall Study|Withdrawal by Subject|0
2696681|NCT00421889|9294668|P6|Overall Study|Withdrawal by Subject|0
2696682|NCT00421889|9294669|P5|Overall Study|Withdrawal by Subject|2
2696683|NCT00421889|9294670|P4|Overall Study|Withdrawal by Subject|0
2696684|NCT00421889|9294671|P3|Overall Study|Withdrawal by Subject|0
2696685|NCT00421889|9294672|P2|Overall Study|Withdrawal by Subject|3
2696686|NCT00421889|9294673|P1|Overall Study|Withdrawal by Subject|1
2696687|NCT00421889|9294665|P9|Overall Study|Adverse Event|2
2696688|NCT00421889|9294666|P8|Overall Study|Adverse Event|0
2696689|NCT00421889|9294667|P7|Overall Study|Adverse Event|1
2696690|NCT00421889|9294668|P6|Overall Study|Adverse Event|4
2696691|NCT00421889|9294669|P5|Overall Study|Adverse Event|1
2696692|NCT00421889|9294670|P4|Overall Study|Adverse Event|1
2696693|NCT00421889|9294671|P3|Overall Study|Adverse Event|1
2696694|NCT00421889|9294672|P2|Overall Study|Adverse Event|0
2696695|NCT00421889|9294673|P1|Overall Study|Adverse Event|1
2696696|NCT00421733|9294718|P3|Overall Study|Protocol deviation|2
2696697|NCT00421733|9294719|P2|Overall Study|Protocol deviation|7
2696698|NCT00421733|9294720|P1|Overall Study|Protocol deviation|4
2696699|NCT00421733|9294718|P3|Overall Study|Sponsor request|3
2696700|NCT00421733|9294719|P2|Overall Study|Sponsor request|0
2696701|NCT00421733|9294720|P1|Overall Study|Sponsor request|1
2696702|NCT00421733|9294718|P3|Overall Study|Did not satisfy entry criteria|2
2696703|NCT00421733|9294719|P2|Overall Study|Did not satisfy entry criteria|3
2696704|NCT00421733|9294720|P1|Overall Study|Did not satisfy entry criteria|1
2696705|NCT00421733|9294718|P3|Overall Study|Administrative|0
2696706|NCT00421733|9294719|P2|Overall Study|Administrative|0
2696707|NCT00421733|9294720|P1|Overall Study|Administrative|2
2696708|NCT00421733|9294718|P3|Overall Study|Required dialysis|0
2696709|NCT00421733|9294719|P2|Overall Study|Required dialysis|0
2696710|NCT00421733|9294720|P1|Overall Study|Required dialysis|1
2696711|NCT00421733|9294718|P3|Overall Study|Death|0
2696712|NCT00421733|9294719|P2|Overall Study|Death|3
2696713|NCT00421733|9294720|P1|Overall Study|Death|0
2696714|NCT00421733|9294718|P3|Overall Study|Withdrawal by Subject|7
2696715|NCT00421733|9294719|P2|Overall Study|Withdrawal by Subject|2
2696716|NCT00421733|9294720|P1|Overall Study|Withdrawal by Subject|1
2696717|NCT00421733|9294718|P3|Overall Study|Lost to Follow-up|4
2696718|NCT00421733|9294719|P2|Overall Study|Lost to Follow-up|2
2696719|NCT00421733|9294720|P1|Overall Study|Lost to Follow-up|1
2696720|NCT00421733|9294718|P3|Overall Study|Adverse Event|2
2696721|NCT00421733|9294719|P2|Overall Study|Adverse Event|9
2696722|NCT00421733|9294720|P1|Overall Study|Adverse Event|4
2696723|NCT00421707|9294740|P2|Period 3:Treatment Period 2|Adverse Event|2
2696724|NCT00421707|9294741|P1|Period 3:Treatment Period 2|Adverse Event|0
2696725|NCT00421707|9294740|P2|Period 3:Treatment Period 2|Protocol Violation|0
2696726|NCT00421707|9294741|P1|Period 3:Treatment Period 2|Protocol Violation|1
2696727|NCT00421707|9294740|P2|Period 3:Treatment Period 2|Withdrawal by Subject|1
2696728|NCT00421707|9294741|P1|Period 3:Treatment Period 2|Withdrawal by Subject|1
2696729|NCT00421707|9294740|P2|Period 2: Washout|Other: Pregnancy|1
2696730|NCT00421707|9294741|P1|Period 2: Washout|Other: Pregnancy|0
2696731|NCT00421707|9294740|P2|Period 2: Washout|Lost to Follow-up|1
2696732|NCT00421707|9294741|P1|Period 2: Washout|Lost to Follow-up|0
2696733|NCT00421707|9294740|P2|Period 2: Washout|Withdrawal by Subject|1
2696734|NCT00421707|9294741|P1|Period 2: Washout|Withdrawal by Subject|0
2696735|NCT00421707|9294740|P2|Period 2: Washout|Adverse Event|1
2696736|NCT00421707|9294741|P1|Period 2: Washout|Adverse Event|1
2696737|NCT00421707|9294740|P2|Period 1: Treatment Period 1|Protocol Violation|0
2696738|NCT00421707|9294741|P1|Period 1: Treatment Period 1|Protocol Violation|1
2696739|NCT00421707|9294740|P2|Period 1: Treatment Period 1|Lost to Follow-up|2
2696740|NCT00421707|9294741|P1|Period 1: Treatment Period 1|Lost to Follow-up|2
2696741|NCT00421707|9294740|P2|Period 1: Treatment Period 1|Adverse Event|2
2696742|NCT00421707|9294741|P1|Period 1: Treatment Period 1|Adverse Event|7
2696743|NCT00421707|9294740|P2|Period 1: Treatment Period 1|Withdrawal by Subject|5
2696744|NCT00421707|9294741|P1|Period 1: Treatment Period 1|Withdrawal by Subject|1
2696745|NCT00421408|9294792|P2|Overall Study|Discountinued from treatment/ f/u cont.|25
2696746|NCT00421408|9294793|P1|Overall Study|Discountinued from treatment/ f/u cont.|12
2696747|NCT00421408|9294792|P2|Overall Study|Lost to Follow-up|20
2696748|NCT00421408|9294793|P1|Overall Study|Lost to Follow-up|30
2696749|NCT00421343|9294811|P1|Overall Study|Lost to Follow-up|3
2696750|NCT00421343|9294811|P1|Overall Study|Withdrawal by Subject|2
2696751|NCT00421343|9294811|P1|Overall Study|Death|1
2696752|NCT00421174|9294817|P2|Overall Study|Ineligible due to infection|0
2696753|NCT00421174|9294818|P1|Overall Study|Ineligible due to infection|2
2696754|NCT00421174|9294817|P2|Overall Study|Withdrawal by Subject|1
2696755|NCT00421174|9294818|P1|Overall Study|Withdrawal by Subject|0
2696756|NCT00421148|9294866|P20|Overall Study|Protocol Violation|0
2696757|NCT00421148|9294867|P19|Overall Study|Protocol Violation|1
2696758|NCT00421148|9294868|P18|Overall Study|Protocol Violation|0
2696759|NCT00421148|9294869|P17|Overall Study|Protocol Violation|0
2696760|NCT00421148|9294870|P16|Overall Study|Protocol Violation|0
2696761|NCT00421148|9294871|P15|Overall Study|Protocol Violation|0
2696762|NCT00421148|9294872|P14|Overall Study|Protocol Violation|0
2696763|NCT00421148|9294873|P13|Overall Study|Protocol Violation|0
2696764|NCT00421148|9294874|P12|Overall Study|Protocol Violation|0
2696765|NCT00421148|9294875|P11|Overall Study|Protocol Violation|0
2696766|NCT00421148|9294876|P10|Overall Study|Protocol Violation|0
2696767|NCT00421148|9294877|P9|Overall Study|Protocol Violation|0
2696768|NCT00421148|9294878|P8|Overall Study|Protocol Violation|0
2696769|NCT00421148|9294879|P7|Overall Study|Protocol Violation|0
2696770|NCT00421148|9294880|P6|Overall Study|Protocol Violation|1
2696771|NCT00421148|9294881|P5|Overall Study|Protocol Violation|0
2696772|NCT00421148|9294882|P4|Overall Study|Protocol Violation|0
2696773|NCT00421148|9294883|P3|Overall Study|Protocol Violation|0
2696774|NCT00421148|9294884|P2|Overall Study|Protocol Violation|0
2696775|NCT00421148|9294885|P1|Overall Study|Protocol Violation|0
2696776|NCT00421148|9294866|P20|Overall Study|Withdrawal by Subject|0
2696777|NCT00421148|9294867|P19|Overall Study|Withdrawal by Subject|0
2696778|NCT00421148|9294868|P18|Overall Study|Withdrawal by Subject|1
2696779|NCT00421148|9294869|P17|Overall Study|Withdrawal by Subject|0
2696780|NCT00421148|9294870|P16|Overall Study|Withdrawal by Subject|0
2696781|NCT00421148|9294871|P15|Overall Study|Withdrawal by Subject|0
2696782|NCT00421148|9294872|P14|Overall Study|Withdrawal by Subject|0
2696783|NCT00421148|9294873|P13|Overall Study|Withdrawal by Subject|0
2696784|NCT00421148|9294874|P12|Overall Study|Withdrawal by Subject|0
2696785|NCT00421148|9294875|P11|Overall Study|Withdrawal by Subject|0
2696786|NCT00421148|9294876|P10|Overall Study|Withdrawal by Subject|0
2696787|NCT00421148|9294877|P9|Overall Study|Withdrawal by Subject|0
2696788|NCT00421148|9294878|P8|Overall Study|Withdrawal by Subject|0
2696789|NCT00421148|9294879|P7|Overall Study|Withdrawal by Subject|0
2696790|NCT00421148|9294880|P6|Overall Study|Withdrawal by Subject|0
2696791|NCT00421148|9294881|P5|Overall Study|Withdrawal by Subject|0
2696792|NCT00421148|9294882|P4|Overall Study|Withdrawal by Subject|0
2696793|NCT00421148|9294883|P3|Overall Study|Withdrawal by Subject|0
2696794|NCT00421148|9294884|P2|Overall Study|Withdrawal by Subject|0
2696795|NCT00421148|9294885|P1|Overall Study|Withdrawal by Subject|0
2696796|NCT00421148|9294866|P20|Overall Study|Lost to Follow-up|0
2696797|NCT00421148|9294867|P19|Overall Study|Lost to Follow-up|0
2696798|NCT00421148|9294868|P18|Overall Study|Lost to Follow-up|1
2696799|NCT00421148|9294869|P17|Overall Study|Lost to Follow-up|0
2696800|NCT00421148|9294870|P16|Overall Study|Lost to Follow-up|0
2696801|NCT00421148|9294871|P15|Overall Study|Lost to Follow-up|0
2696802|NCT00421148|9294872|P14|Overall Study|Lost to Follow-up|0
2696803|NCT00421148|9294873|P13|Overall Study|Lost to Follow-up|0
2696804|NCT00421148|9294874|P12|Overall Study|Lost to Follow-up|0
2696805|NCT00421148|9294875|P11|Overall Study|Lost to Follow-up|0
2696806|NCT00421148|9294876|P10|Overall Study|Lost to Follow-up|0
2696807|NCT00421148|9294877|P9|Overall Study|Lost to Follow-up|0
2696808|NCT00421148|9294878|P8|Overall Study|Lost to Follow-up|0
2696809|NCT00421148|9294879|P7|Overall Study|Lost to Follow-up|0
2696810|NCT00421148|9294880|P6|Overall Study|Lost to Follow-up|0
2696811|NCT00421148|9294881|P5|Overall Study|Lost to Follow-up|0
2696812|NCT00421148|9294882|P4|Overall Study|Lost to Follow-up|0
2696813|NCT00421148|9294883|P3|Overall Study|Lost to Follow-up|0
2696814|NCT00421148|9294884|P2|Overall Study|Lost to Follow-up|0
2696815|NCT00421148|9294885|P1|Overall Study|Lost to Follow-up|0
2696816|NCT00420927|9294984|P7|Period 2|Took prohibited medication|0
2696817|NCT00420927|9294985|P6|Period 2|Took prohibited medication|0
2696818|NCT00420927|9294986|P5|Period 2|Took prohibited medication|1
2696819|NCT00420927|9294987|P4|Period 2|Took prohibited medication|0
2696820|NCT00420927|9294988|P3|Period 2|Took prohibited medication|0
2696821|NCT00420927|9294989|P2|Period 2|Took prohibited medication|0
2696822|NCT00420927|9294990|P1|Period 2|Took prohibited medication|0
2696823|NCT00420927|9294984|P7|Period 2|Methotrexate intolerance|1
2696824|NCT00420927|9294985|P6|Period 2|Methotrexate intolerance|0
2696825|NCT00420927|9294986|P5|Period 2|Methotrexate intolerance|0
2696826|NCT00420927|9294987|P4|Period 2|Methotrexate intolerance|0
2696827|NCT00420927|9294988|P3|Period 2|Methotrexate intolerance|0
2696828|NCT00420927|9294989|P2|Period 2|Methotrexate intolerance|0
2696829|NCT00420927|9294990|P1|Period 2|Methotrexate intolerance|0
2696830|NCT00420927|9294984|P7|Period 2|Noncompliant with study drug|2
2696831|NCT00420927|9294985|P6|Period 2|Noncompliant with study drug|0
2696832|NCT00420927|9294986|P5|Period 2|Noncompliant with study drug|0
2696833|NCT00420927|9294987|P4|Period 2|Noncompliant with study drug|1
2696834|NCT00420927|9294988|P3|Period 2|Noncompliant with study drug|0
2696835|NCT00420927|9294989|P2|Period 2|Noncompliant with study drug|0
2696836|NCT00420927|9294990|P1|Period 2|Noncompliant with study drug|0
2696837|NCT00420927|9294984|P7|Period 2|Randomization error|0
2696838|NCT00420927|9294985|P6|Period 2|Randomization error|1
2696839|NCT00420927|9294986|P5|Period 2|Randomization error|1
2696840|NCT00420927|9294987|P4|Period 2|Randomization error|0
2696841|NCT00420927|9294988|P3|Period 2|Randomization error|0
2696842|NCT00420927|9294989|P2|Period 2|Randomization error|0
2696843|NCT00420927|9294990|P1|Period 2|Randomization error|0
2696844|NCT00420927|9294984|P7|Period 2|Sponsor decision|1
2696845|NCT00420927|9294985|P6|Period 2|Sponsor decision|0
2696846|NCT00420927|9294986|P5|Period 2|Sponsor decision|0
2696847|NCT00420927|9294987|P4|Period 2|Sponsor decision|0
2696848|NCT00420927|9294988|P3|Period 2|Sponsor decision|1
2696849|NCT00420927|9294989|P2|Period 2|Sponsor decision|0
2696850|NCT00420927|9294990|P1|Period 2|Sponsor decision|0
2696851|NCT00420927|9294984|P7|Period 2|Physician Decision|0
2696852|NCT00420927|9294985|P6|Period 2|Physician Decision|1
2696853|NCT00420927|9294986|P5|Period 2|Physician Decision|1
2696854|NCT00420927|9294987|P4|Period 2|Physician Decision|0
2696855|NCT00420927|9294988|P3|Period 2|Physician Decision|0
2696856|NCT00420927|9294989|P2|Period 2|Physician Decision|0
2696857|NCT00420927|9294990|P1|Period 2|Physician Decision|0
2696858|NCT00420927|9294984|P7|Period 2|Subject unable to find transportation|1
2696859|NCT00420927|9294985|P6|Period 2|Subject unable to find transportation|0
2696860|NCT00420927|9294986|P5|Period 2|Subject unable to find transportation|0
2696861|NCT00420927|9294987|P4|Period 2|Subject unable to find transportation|0
2696862|NCT00420927|9294988|P3|Period 2|Subject unable to find transportation|0
2696863|NCT00420927|9294989|P2|Period 2|Subject unable to find transportation|0
2696864|NCT00420927|9294990|P1|Period 2|Subject unable to find transportation|0
2696865|NCT00420927|9294984|P7|Period 2|Received wrong treatment/incorrect dose|1
2696866|NCT00420927|9294985|P6|Period 2|Received wrong treatment/incorrect dose|0
2696867|NCT00420927|9294986|P5|Period 2|Received wrong treatment/incorrect dose|0
2696868|NCT00420927|9294987|P4|Period 2|Received wrong treatment/incorrect dose|0
2696869|NCT00420927|9294988|P3|Period 2|Received wrong treatment/incorrect dose|0
2696870|NCT00420927|9294989|P2|Period 2|Received wrong treatment/incorrect dose|0
2696871|NCT00420927|9294990|P1|Period 2|Received wrong treatment/incorrect dose|0
2696872|NCT00420927|9294984|P7|Period 2|Lack of efficacy/Loss of efficacy|6
2696873|NCT00420927|9294985|P6|Period 2|Lack of efficacy/Loss of efficacy|2
2696874|NCT00420927|9294986|P5|Period 2|Lack of efficacy/Loss of efficacy|6
2696875|NCT00420927|9294987|P4|Period 2|Lack of efficacy/Loss of efficacy|1
2696876|NCT00420927|9294988|P3|Period 2|Lack of efficacy/Loss of efficacy|2
2696877|NCT00420927|9294989|P2|Period 2|Lack of efficacy/Loss of efficacy|0
2696878|NCT00420927|9294990|P1|Period 2|Lack of efficacy/Loss of efficacy|0
2696879|NCT00420927|9294984|P7|Period 2|Lost to Follow-up|9
2696880|NCT00420927|9294985|P6|Period 2|Lost to Follow-up|3
2696881|NCT00420927|9294986|P5|Period 2|Lost to Follow-up|6
2696882|NCT00420927|9294987|P4|Period 2|Lost to Follow-up|2
2696883|NCT00420927|9294988|P3|Period 2|Lost to Follow-up|2
2696884|NCT00420927|9294989|P2|Period 2|Lost to Follow-up|0
2696885|NCT00420927|9294990|P1|Period 2|Lost to Follow-up|0
2696886|NCT00420927|9294984|P7|Period 2|Withdrawal by Subject|12
2696887|NCT00420927|9294985|P6|Period 2|Withdrawal by Subject|2
2696888|NCT00420927|9294986|P5|Period 2|Withdrawal by Subject|11
2696889|NCT00420927|9294987|P4|Period 2|Withdrawal by Subject|3
2696890|NCT00420927|9294988|P3|Period 2|Withdrawal by Subject|1
2696891|NCT00420927|9294989|P2|Period 2|Withdrawal by Subject|0
2696892|NCT00420927|9294990|P1|Period 2|Withdrawal by Subject|0
2696893|NCT00420927|9294984|P7|Period 2|Adverse Event|20
2696894|NCT00420927|9294985|P6|Period 2|Adverse Event|6
2696895|NCT00420927|9294986|P5|Period 2|Adverse Event|17
2696896|NCT00420927|9294987|P4|Period 2|Adverse Event|3
2696897|NCT00420927|9294988|P3|Period 2|Adverse Event|7
2696898|NCT00420927|9294989|P2|Period 2|Adverse Event|0
2696899|NCT00420927|9294990|P1|Period 2|Adverse Event|0
2696900|NCT00420927|9294984|P7|Period 1|Took prohibited medication|0
2696901|NCT00420927|9294985|P6|Period 1|Took prohibited medication|0
2696902|NCT00420927|9294986|P5|Period 1|Took prohibited medication|0
2696903|NCT00420927|9294987|P4|Period 1|Took prohibited medication|0
2696904|NCT00420927|9294988|P3|Period 1|Took prohibited medication|0
2696905|NCT00420927|9294989|P2|Period 1|Took prohibited medication|3
2696906|NCT00420927|9294990|P1|Period 1|Took prohibited medication|1
2696907|NCT00420927|9294984|P7|Period 1|Failed to meet entry criteria|0
2696908|NCT00420927|9294985|P6|Period 1|Failed to meet entry criteria|0
2696909|NCT00420927|9294986|P5|Period 1|Failed to meet entry criteria|0
2696910|NCT00420927|9294987|P4|Period 1|Failed to meet entry criteria|0
2696911|NCT00420927|9294988|P3|Period 1|Failed to meet entry criteria|0
2696912|NCT00420927|9294989|P2|Period 1|Failed to meet entry criteria|7
2696913|NCT00420927|9294990|P1|Period 1|Failed to meet entry criteria|8
2696914|NCT00420927|9294984|P7|Period 1|Received wrong treatment/incorrect dose|0
2696915|NCT00420927|9294985|P6|Period 1|Received wrong treatment/incorrect dose|0
2696916|NCT00420927|9294986|P5|Period 1|Received wrong treatment/incorrect dose|0
2696917|NCT00420927|9294987|P4|Period 1|Received wrong treatment/incorrect dose|0
2696918|NCT00420927|9294988|P3|Period 1|Received wrong treatment/incorrect dose|0
2696919|NCT00420927|9294989|P2|Period 1|Received wrong treatment/incorrect dose|1
2696920|NCT00420927|9294990|P1|Period 1|Received wrong treatment/incorrect dose|0
2696921|NCT00420927|9294984|P7|Period 1|Subject received new diagnosis|0
2696922|NCT00420927|9294985|P6|Period 1|Subject received new diagnosis|0
2696923|NCT00420927|9294986|P5|Period 1|Subject received new diagnosis|0
2696924|NCT00420927|9294987|P4|Period 1|Subject received new diagnosis|0
2696925|NCT00420927|9294988|P3|Period 1|Subject received new diagnosis|0
2696926|NCT00420927|9294989|P2|Period 1|Subject received new diagnosis|2
2696927|NCT00420927|9294990|P1|Period 1|Subject received new diagnosis|0
2696928|NCT00420927|9294984|P7|Period 1|Study site closure|0
2696929|NCT00420927|9294985|P6|Period 1|Study site closure|0
2696930|NCT00420927|9294986|P5|Period 1|Study site closure|0
2696931|NCT00420927|9294987|P4|Period 1|Study site closure|0
2696932|NCT00420927|9294988|P3|Period 1|Study site closure|0
2696933|NCT00420927|9294989|P2|Period 1|Study site closure|1
2696934|NCT00420927|9294990|P1|Period 1|Study site closure|0
2696935|NCT00420927|9294984|P7|Period 1|Suspected tuberculosis/positive test|0
2696936|NCT00420927|9294985|P6|Period 1|Suspected tuberculosis/positive test|0
2696937|NCT00420927|9294986|P5|Period 1|Suspected tuberculosis/positive test|0
2696938|NCT00420927|9294987|P4|Period 1|Suspected tuberculosis/positive test|0
2696939|NCT00420927|9294988|P3|Period 1|Suspected tuberculosis/positive test|0
2696940|NCT00420927|9294989|P2|Period 1|Suspected tuberculosis/positive test|1
2696941|NCT00420927|9294990|P1|Period 1|Suspected tuberculosis/positive test|1
2696942|NCT00420927|9294984|P7|Period 1|Randomization error|0
2696943|NCT00420927|9294985|P6|Period 1|Randomization error|0
2696944|NCT00420927|9294986|P5|Period 1|Randomization error|0
2696945|NCT00420927|9294987|P4|Period 1|Randomization error|0
2696946|NCT00420927|9294988|P3|Period 1|Randomization error|0
2696947|NCT00420927|9294989|P2|Period 1|Randomization error|0
2696948|NCT00420927|9294990|P1|Period 1|Randomization error|1
2696949|NCT00420927|9294984|P7|Period 1|Noncompliant with study drug|0
2696950|NCT00420927|9294985|P6|Period 1|Noncompliant with study drug|0
2696951|NCT00420927|9294986|P5|Period 1|Noncompliant with study drug|0
2696952|NCT00420927|9294987|P4|Period 1|Noncompliant with study drug|0
2696953|NCT00420927|9294988|P3|Period 1|Noncompliant with study drug|0
2696954|NCT00420927|9294989|P2|Period 1|Noncompliant with study drug|1
2696955|NCT00420927|9294990|P1|Period 1|Noncompliant with study drug|1
2696956|NCT00420927|9294984|P7|Period 1|Subject moved/relocated|0
2696957|NCT00420927|9294985|P6|Period 1|Subject moved/relocated|0
2696958|NCT00420927|9294986|P5|Period 1|Subject moved/relocated|0
2696959|NCT00420927|9294987|P4|Period 1|Subject moved/relocated|0
2696960|NCT00420927|9294988|P3|Period 1|Subject moved/relocated|0
2696961|NCT00420927|9294989|P2|Period 1|Subject moved/relocated|2
2696962|NCT00420927|9294990|P1|Period 1|Subject moved/relocated|0
2696963|NCT00420927|9294984|P7|Period 1|Death|0
2696964|NCT00420927|9294985|P6|Period 1|Death|0
2696965|NCT00420927|9294986|P5|Period 1|Death|0
2696966|NCT00420927|9294987|P4|Period 1|Death|0
2696967|NCT00420927|9294988|P3|Period 1|Death|0
2696968|NCT00420927|9294989|P2|Period 1|Death|0
2696969|NCT00420927|9294990|P1|Period 1|Death|2
2696970|NCT00420927|9294984|P7|Period 1|Lack of efficacy/Loss of efficacy|0
2696971|NCT00420927|9294985|P6|Period 1|Lack of efficacy/Loss of efficacy|0
2696972|NCT00420927|9294986|P5|Period 1|Lack of efficacy/Loss of efficacy|0
2696973|NCT00420927|9294987|P4|Period 1|Lack of efficacy/Loss of efficacy|0
2696974|NCT00420927|9294988|P3|Period 1|Lack of efficacy/Loss of efficacy|0
2696975|NCT00420927|9294989|P2|Period 1|Lack of efficacy/Loss of efficacy|6
2696976|NCT00420927|9294990|P1|Period 1|Lack of efficacy/Loss of efficacy|1
2696977|NCT00420927|9294984|P7|Period 1|Lost to Follow-up|0
2696978|NCT00420927|9294985|P6|Period 1|Lost to Follow-up|0
2696979|NCT00420927|9294986|P5|Period 1|Lost to Follow-up|0
2696980|NCT00420927|9294987|P4|Period 1|Lost to Follow-up|0
2696981|NCT00420927|9294988|P3|Period 1|Lost to Follow-up|0
2696982|NCT00420927|9294989|P2|Period 1|Lost to Follow-up|6
2696983|NCT00420927|9294990|P1|Period 1|Lost to Follow-up|8
2696984|NCT00420927|9294984|P7|Period 1|Withdrawal by Subject|0
2696985|NCT00420927|9294985|P6|Period 1|Withdrawal by Subject|0
2696986|NCT00420927|9294986|P5|Period 1|Withdrawal by Subject|0
2696987|NCT00420927|9294987|P4|Period 1|Withdrawal by Subject|0
2696988|NCT00420927|9294988|P3|Period 1|Withdrawal by Subject|0
2696989|NCT00420927|9294989|P2|Period 1|Withdrawal by Subject|12
2696990|NCT00420927|9294990|P1|Period 1|Withdrawal by Subject|7
2696991|NCT00420927|9294984|P7|Period 1|Adverse Event|0
2696992|NCT00420927|9294985|P6|Period 1|Adverse Event|0
2696993|NCT00420927|9294986|P5|Period 1|Adverse Event|0
2696994|NCT00420927|9294987|P4|Period 1|Adverse Event|0
2696995|NCT00420927|9294988|P3|Period 1|Adverse Event|0
2696996|NCT00420927|9294989|P2|Period 1|Adverse Event|15
2696997|NCT00420927|9294990|P1|Period 1|Adverse Event|19
2696998|NCT00420849|9295094|P1|Overall Study|Lost to Follow-up|1
2696999|NCT00420849|9295094|P1|Overall Study|Protocol Violation|1
2697000|NCT00420849|9295094|P1|Overall Study|Transplant|8
2697001|NCT00420849|9295094|P1|Overall Study|Other|14
2697002|NCT00420849|9295094|P1|Overall Study|Death|18
2697003|NCT00420849|9295094|P1|Overall Study|Withdrawal by Subject|28
2697004|NCT00420849|9295094|P1|Overall Study|Adverse Event|107
2697005|NCT00420849|9295094|P1|Overall Study|Lack of Efficacy|154
2697006|NCT00420784|9295163|P4|Overall Study|Other|5
2697007|NCT00420784|9295164|P3|Overall Study|Other|0
2697008|NCT00420784|9295165|P2|Overall Study|Other|2
2697009|NCT00420784|9295166|P1|Overall Study|Other|1
2697010|NCT00420784|9295163|P4|Overall Study|Virologic Stopping Rule|67
2697011|NCT00420784|9295164|P3|Overall Study|Virologic Stopping Rule|41
2697012|NCT00420784|9295165|P2|Overall Study|Virologic Stopping Rule|26
2697013|NCT00420784|9295166|P1|Overall Study|Virologic Stopping Rule|17
2697014|NCT00420784|9295163|P4|Overall Study|Lost to Follow-up|1
2697015|NCT00420784|9295164|P3|Overall Study|Lost to Follow-up|2
2697016|NCT00420784|9295165|P2|Overall Study|Lost to Follow-up|0
2697017|NCT00420784|9295166|P1|Overall Study|Lost to Follow-up|0
2697018|NCT00420784|9295163|P4|Overall Study|Withdrawal by Subject|0
2697019|NCT00420784|9295164|P3|Overall Study|Withdrawal by Subject|0
2697020|NCT00420784|9295165|P2|Overall Study|Withdrawal by Subject|1
2697021|NCT00420784|9295166|P1|Overall Study|Withdrawal by Subject|0
2697022|NCT00420784|9295163|P4|Overall Study|Adverse Event|5
2697023|NCT00420784|9295164|P3|Overall Study|Adverse Event|10
2697024|NCT00420784|9295165|P2|Overall Study|Adverse Event|29
2697025|NCT00420784|9295166|P1|Overall Study|Adverse Event|11
2697026|NCT00420745|9295204|P2|Overall Study|Age limit exceeded for Dose 2|0
2697027|NCT00420745|9295205|P1|Overall Study|Age limit exceeded for Dose 2|1
2697028|NCT00420745|9295204|P2|Overall Study|Recurrent pneumonia & bronchitis|1
2697029|NCT00420745|9295205|P1|Overall Study|Recurrent pneumonia & bronchitis|0
2697030|NCT00420745|9295204|P2|Overall Study|Physician Decision|1
2697031|NCT00420745|9295205|P1|Overall Study|Physician Decision|1
2697032|NCT00420745|9295204|P2|Overall Study|Protocol Violation|0
2697033|NCT00420745|9295205|P1|Overall Study|Protocol Violation|1
2697034|NCT00420745|9295204|P2|Overall Study|Lost to Follow-up|2
2697035|NCT00420745|9295205|P1|Overall Study|Lost to Follow-up|10
2697036|NCT00420745|9295204|P2|Overall Study|Adverse Event|2
2697037|NCT00420745|9295205|P1|Overall Study|Adverse Event|2
2697038|NCT00420641|9295224|P3|Overall Study|Other|3
2697039|NCT00420641|9295225|P2|Overall Study|Other|4
2697040|NCT00420641|9295226|P1|Overall Study|Other|4
2697041|NCT00420641|9295224|P3|Overall Study|Non-compliance|4
2697042|NCT00420641|9295225|P2|Overall Study|Non-compliance|5
2697043|NCT00420641|9295226|P1|Overall Study|Non-compliance|7
2697044|NCT00420641|9295224|P3|Overall Study|Lack of Efficacy|4
2697045|NCT00420641|9295225|P2|Overall Study|Lack of Efficacy|5
2697046|NCT00420641|9295226|P1|Overall Study|Lack of Efficacy|6
2697047|NCT00420641|9295224|P3|Overall Study|Withdrawal by Subject|14
2697048|NCT00420641|9295225|P2|Overall Study|Withdrawal by Subject|21
2697049|NCT00420641|9295226|P1|Overall Study|Withdrawal by Subject|15
2697050|NCT00420641|9295224|P3|Overall Study|Protocol Violation|7
2697051|NCT00420641|9295225|P2|Overall Study|Protocol Violation|8
2697052|NCT00420641|9295226|P1|Overall Study|Protocol Violation|8
2697053|NCT00420641|9295224|P3|Overall Study|Lost to Follow-up|2
2697054|NCT00420641|9295225|P2|Overall Study|Lost to Follow-up|4
2697055|NCT00420641|9295226|P1|Overall Study|Lost to Follow-up|2
2697056|NCT00420641|9295224|P3|Overall Study|Adverse Event|10
2697057|NCT00420641|9295225|P2|Overall Study|Adverse Event|25
2697058|NCT00420641|9295226|P1|Overall Study|Adverse Event|3
2697059|NCT00420628|9295302|P2|Overall Study|Adverse Event|0
2697060|NCT00420628|9295303|P1|Overall Study|Adverse Event|1
2697061|NCT00420628|9295302|P2|Overall Study|Lost to Follow-up|2
2697062|NCT00420628|9295303|P1|Overall Study|Lost to Follow-up|3
2697063|NCT00420628|9295302|P2|Overall Study|Withdrawn by parent or gaurdian|2
2697064|NCT00420628|9295303|P1|Overall Study|Withdrawn by parent or gaurdian|5
2697065|NCT00420511|9295319|P2|Overall Study|Lost to Follow-up|0
2697066|NCT00420511|9295320|P1|Overall Study|Lost to Follow-up|1
2697067|NCT00420511|9295319|P2|Overall Study|Adverse Event|1
2697068|NCT00420511|9295320|P1|Overall Study|Adverse Event|1
2697069|NCT00420420|9295341|P2|Overall Study|sponsor decision (abnormal ECG @ screen)|0
2697070|NCT00420420|9295342|P1|Overall Study|sponsor decision (abnormal ECG @ screen)|1
2697071|NCT00420420|9295341|P2|Overall Study|Withdrawal by Subject|0
2697072|NCT00420420|9295342|P1|Overall Study|Withdrawal by Subject|1
2697073|NCT00420420|9295341|P2|Overall Study|Protocol Violation|1
2697074|NCT00420420|9295342|P1|Overall Study|Protocol Violation|1
2697075|NCT00420420|9295341|P2|Overall Study|Adverse Event|3
2697076|NCT00420420|9295342|P1|Overall Study|Adverse Event|5
2697077|NCT00420407|9295360|P2|Overall Study|Withdrawal by Subject|2
2697078|NCT00420407|9295361|P1|Overall Study|Withdrawal by Subject|0
2697079|NCT00420407|9295360|P2|Overall Study|subject identified as Jehovah's witness|0
2697080|NCT00420407|9295361|P1|Overall Study|subject identified as Jehovah's witness|1
2697081|NCT00420407|9295360|P2|Overall Study|subject identified as detainee|0
2697082|NCT00420407|9295361|P1|Overall Study|subject identified as detainee|1
2697083|NCT00420407|9295360|P2|Overall Study|Physician Decision|1
2697084|NCT00420407|9295361|P1|Overall Study|Physician Decision|2
2697085|NCT00420407|9295360|P2|Overall Study|Lost to Follow-up|3
2697086|NCT00420407|9295361|P1|Overall Study|Lost to Follow-up|0
2697087|NCT00420342|9295371|P3|Overall Study|Withdrawal by Subject|0
2697088|NCT00420342|9295372|P2|Overall Study|Withdrawal by Subject|2
2697089|NCT00420342|9295373|P1|Overall Study|Withdrawal by Subject|0
2697090|NCT00420342|9295371|P3|Overall Study|Lost to Follow-up|1
2697091|NCT00420342|9295372|P2|Overall Study|Lost to Follow-up|0
2697092|NCT00420342|9295373|P1|Overall Study|Lost to Follow-up|1
2697093|NCT00420316|9295416|P2|Overall Study|Lost to Follow-up|8
2697094|NCT00420316|9295417|P1|Overall Study|Lost to Follow-up|12
2697095|NCT00420316|9295416|P2|Overall Study|Withdrawal by Subject|1
2697096|NCT00420316|9295417|P1|Overall Study|Withdrawal by Subject|0
2697097|NCT00420303|9295441|P2|Overall Study|Physician Decision|1
2697098|NCT00420303|9295442|P1|Overall Study|Physician Decision|0
2697099|NCT00420303|9295441|P2|Overall Study|Lack of Efficacy|3
2697100|NCT00420303|9295442|P1|Overall Study|Lack of Efficacy|0
2697101|NCT00420303|9295441|P2|Overall Study|Serious Adverse Event|0
2697102|NCT00420303|9295442|P1|Overall Study|Serious Adverse Event|1
2697103|NCT00420290|9295454|P2|Overall Study|did not meet inclusion/exclusion|1
2697104|NCT00420290|9295455|P1|Overall Study|did not meet inclusion/exclusion|1
2697105|NCT00420290|9295454|P2|Overall Study|Withdrawal by Subject|2
2697106|NCT00420290|9295455|P1|Overall Study|Withdrawal by Subject|0
2697107|NCT00420290|9295454|P2|Overall Study|Adverse Event|1
2697108|NCT00420290|9295455|P1|Overall Study|Adverse Event|3
2697109|NCT00420238|9295471|P2|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
2697110|NCT00420238|9295472|P1|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
2697111|NCT00420238|9295471|P2|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0
2697112|NCT00420238|9295472|P1|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1
2697113|NCT00420238|9295471|P2|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1
2697114|NCT00420238|9295472|P1|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0
2697115|NCT00420238|9295471|P2|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1
2697116|NCT00420238|9295472|P1|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0
2697117|NCT00420238|9295471|P2|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2
2697118|NCT00420238|9295472|P1|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0
2697119|NCT00420238|9295471|P2|12 Week Double-Blind Treatment Period 1|Adverse Event|0
2697120|NCT00420238|9295472|P1|12 Week Double-Blind Treatment Period 1|Adverse Event|1
2697121|NCT00420212|9295611|P3|Overall Study|Other-Unspecified|18
2697122|NCT00420212|9295612|P2|Overall Study|Other-Unspecified|14
2697123|NCT00420212|9295613|P1|Overall Study|Other-Unspecified|21
2697124|NCT00420212|9295611|P3|Overall Study|Death|1
2697125|NCT00420212|9295612|P2|Overall Study|Death|0
2697126|NCT00420212|9295613|P1|Overall Study|Death|0
2697127|NCT00420212|9295611|P3|Overall Study|Protocol Violation|8
2697128|NCT00420212|9295612|P2|Overall Study|Protocol Violation|4
2697129|NCT00420212|9295613|P1|Overall Study|Protocol Violation|4
2697130|NCT00420212|9295611|P3|Overall Study|Physician Decision|3
2697131|NCT00420212|9295612|P2|Overall Study|Physician Decision|4
2697132|NCT00420212|9295613|P1|Overall Study|Physician Decision|4
2697133|NCT00420212|9295611|P3|Overall Study|Withdrawal by Subject|19
2697134|NCT00420212|9295612|P2|Overall Study|Withdrawal by Subject|22
2697135|NCT00420212|9295613|P1|Overall Study|Withdrawal by Subject|31
2697136|NCT00420212|9295611|P3|Overall Study|Lost to Follow-up|11
2697137|NCT00420212|9295612|P2|Overall Study|Lost to Follow-up|11
2697138|NCT00420212|9295613|P1|Overall Study|Lost to Follow-up|9
2697139|NCT00420212|9295611|P3|Overall Study|Adverse Event|36
2697140|NCT00420212|9295612|P2|Overall Study|Adverse Event|40
2697141|NCT00420212|9295613|P1|Overall Study|Adverse Event|22
2697142|NCT00420199|9295639|P2|Overall Study|Participant no longer met study criteria|0
2697143|NCT00420199|9295640|P1|Overall Study|Participant no longer met study criteria|1
2697144|NCT00420095|9295706|P2|Overall Study|Lost to Follow-up|0
2697145|NCT00420095|9295707|P1|Overall Study|Lost to Follow-up|1
2697146|NCT00420095|9295706|P2|Overall Study|Protocol Violation|1
2697147|NCT00420095|9295707|P1|Overall Study|Protocol Violation|1
2697148|NCT00420095|9295706|P2|Overall Study|Adverse Event|0
2697149|NCT00420095|9295707|P1|Overall Study|Adverse Event|1
2697150|NCT00420056|9295725|P1|Overall Study|Objective progression or relapse|17
2697151|NCT00420004|9295765|P3|Overall Study|Sponsor Decision|1
2697152|NCT00420004|9295766|P2|Overall Study|Sponsor Decision|3
2697153|NCT00420004|9295767|P1|Overall Study|Sponsor Decision|3
2697154|NCT00420004|9295765|P3|Overall Study|Withdrawal by Subject|14
2697155|NCT00420004|9295766|P2|Overall Study|Withdrawal by Subject|42
2697156|NCT00420004|9295767|P1|Overall Study|Withdrawal by Subject|67
2697157|NCT00420004|9295765|P3|Overall Study|Protocol Violation|3
2697158|NCT00420004|9295766|P2|Overall Study|Protocol Violation|4
2697159|NCT00420004|9295767|P1|Overall Study|Protocol Violation|5
2697160|NCT00420004|9295765|P3|Overall Study|Physician Decision|2
2697161|NCT00420004|9295766|P2|Overall Study|Physician Decision|4
2697162|NCT00420004|9295767|P1|Overall Study|Physician Decision|14
2697163|NCT00420004|9295765|P3|Overall Study|Entry Criteria Not Met|0
2697164|NCT00420004|9295766|P2|Overall Study|Entry Criteria Not Met|1
2697165|NCT00420004|9295767|P1|Overall Study|Entry Criteria Not Met|0
2697166|NCT00420004|9295765|P3|Overall Study|Lost to Follow-up|10
2697167|NCT00420004|9295766|P2|Overall Study|Lost to Follow-up|12
2697168|NCT00420004|9295767|P1|Overall Study|Lost to Follow-up|31
2697169|NCT00420004|9295765|P3|Overall Study|Lack of Efficacy|1
2697170|NCT00420004|9295766|P2|Overall Study|Lack of Efficacy|4
2697171|NCT00420004|9295767|P1|Overall Study|Lack of Efficacy|5
2697172|NCT00420004|9295765|P3|Overall Study|Adverse Event|1
2697173|NCT00420004|9295766|P2|Overall Study|Adverse Event|1
2697174|NCT00420004|9295767|P1|Overall Study|Adverse Event|4
2697175|NCT00419952|9295832|P2|Overall Study|Abnormal ECG|0
2697176|NCT00419952|9295833|P1|Overall Study|Abnormal ECG|1
2697177|NCT00419952|9295832|P2|Overall Study|Diary or medication non-compliance|4
2697178|NCT00419952|9295833|P1|Overall Study|Diary or medication non-compliance|2
2697179|NCT00419952|9295832|P2|Overall Study|Occurence of 2 or more exacerbations|0
2697180|NCT00419952|9295833|P1|Overall Study|Occurence of 2 or more exacerbations|2
2697181|NCT00419952|9295832|P2|Overall Study|Intake of prohibited medication|2
2697182|NCT00419952|9295833|P1|Overall Study|Intake of prohibited medication|2
2697183|NCT00419952|9295832|P2|Overall Study|Incorrectly enrolled|3
2697184|NCT00419952|9295833|P1|Overall Study|Incorrectly enrolled|10
2697185|NCT00419952|9295832|P2|Overall Study|Physician Decision|3
2697186|NCT00419952|9295833|P1|Overall Study|Physician Decision|1
2697187|NCT00419952|9295832|P2|Overall Study|Pregnancy|2
2697188|NCT00419952|9295833|P1|Overall Study|Pregnancy|4
2697189|NCT00419952|9295832|P2|Overall Study|Protocol Violation|24
2697190|NCT00419952|9295833|P1|Overall Study|Protocol Violation|32
2697191|NCT00419952|9295832|P2|Overall Study|Lost to Follow-up|34
2697192|NCT00419952|9295833|P1|Overall Study|Lost to Follow-up|43
2697193|NCT00419952|9295832|P2|Overall Study|Withdrawal by Subject|43
2697194|NCT00419952|9295833|P1|Overall Study|Withdrawal by Subject|44
2697195|NCT00419952|9295832|P2|Overall Study|Adverse Event|10
2697196|NCT00419952|9295833|P1|Overall Study|Adverse Event|8
2697197|NCT00419926|9295867|P2|Overall Study|Death|1
2697198|NCT00419926|9295868|P1|Overall Study|Death|2
2697199|NCT00419926|9295867|P2|Overall Study|Lost to Follow-up|2
2697200|NCT00419926|9295868|P1|Overall Study|Lost to Follow-up|1
2697201|NCT00419926|9295867|P2|Overall Study|Administrative Problem|4
2697202|NCT00419926|9295868|P1|Overall Study|Administrative Problem|4
2697203|NCT00419926|9295867|P2|Overall Study|Withdrawal by Subject|3
2697204|NCT00419926|9295868|P1|Overall Study|Withdrawal by Subject|7
2697205|NCT00419770|9295884|P2|Overall Study|Withdrawal by Subject|1
2697206|NCT00419770|9295885|P1|Overall Study|Withdrawal by Subject|5
2697207|NCT00419757|9295893|P2|Overall Study|Multiple reasons|1
2697208|NCT00419757|9295894|P1|Overall Study|Multiple reasons|3
2697209|NCT00419757|9295893|P2|Overall Study|Study specific discontinuation criteria|8
2697210|NCT00419757|9295894|P1|Overall Study|Study specific discontinuation criteria|4
2697211|NCT00419757|9295893|P2|Overall Study|Protocol Violation|3
2697212|NCT00419757|9295894|P1|Overall Study|Protocol Violation|2
2697213|NCT00419757|9295893|P2|Overall Study|Withdrawal by Subject|1
2697214|NCT00419757|9295894|P1|Overall Study|Withdrawal by Subject|7
2697215|NCT00419757|9295893|P2|Overall Study|Lost to Follow-up|4
2697216|NCT00419757|9295894|P1|Overall Study|Lost to Follow-up|1
2697217|NCT00419757|9295893|P2|Overall Study|Adverse Event|4
2697218|NCT00419757|9295894|P1|Overall Study|Adverse Event|1
2697219|NCT00419744|9295933|P3|Overall Study|Incorrect medication kit dispensed|1
2697220|NCT00419744|9295934|P2|Overall Study|Incorrect medication kit dispensed|0
2697221|NCT00419744|9295935|P1|Overall Study|Incorrect medication kit dispensed|0
2697222|NCT00419744|9295933|P3|Overall Study|Spirometry mouthpiece issues|2
2697223|NCT00419744|9295934|P2|Overall Study|Spirometry mouthpiece issues|1
2697224|NCT00419744|9295935|P1|Overall Study|Spirometry mouthpiece issues|0
2697225|NCT00419744|9295933|P3|Overall Study|Physician Decision|6
2697226|NCT00419744|9295934|P2|Overall Study|Physician Decision|5
2697227|NCT00419744|9295935|P1|Overall Study|Physician Decision|10
2697228|NCT00419744|9295933|P3|Overall Study|Moving out of state|1
2697229|NCT00419744|9295934|P2|Overall Study|Moving out of state|0
2697230|NCT00419744|9295935|P1|Overall Study|Moving out of state|2
2697231|NCT00419744|9295933|P3|Overall Study|Randomized in error|7
2697232|NCT00419744|9295934|P2|Overall Study|Randomized in error|6
2697233|NCT00419744|9295935|P1|Overall Study|Randomized in error|9
2697234|NCT00419744|9295933|P3|Overall Study|Protocol Violation|8
2697235|NCT00419744|9295934|P2|Overall Study|Protocol Violation|7
2697236|NCT00419744|9295935|P1|Overall Study|Protocol Violation|4
2697237|NCT00419744|9295933|P3|Overall Study|Lost to Follow-up|6
2697238|NCT00419744|9295934|P2|Overall Study|Lost to Follow-up|10
2697239|NCT00419744|9295935|P1|Overall Study|Lost to Follow-up|8
2697240|NCT00419744|9295933|P3|Overall Study|Withdrawal by Subject|52
2697241|NCT00419744|9295934|P2|Overall Study|Withdrawal by Subject|49
2697242|NCT00419744|9295935|P1|Overall Study|Withdrawal by Subject|45
2697243|NCT00419744|9295933|P3|Overall Study|Adverse Event|50
2697244|NCT00419744|9295934|P2|Overall Study|Adverse Event|40
2697245|NCT00419744|9295935|P1|Overall Study|Adverse Event|39
2697246|NCT00419562|9295978|P2|Overall Study|Participant Institutionalized|0
2697247|NCT00419562|9295979|P1|Overall Study|Participant Institutionalized|1
2697248|NCT00419562|9295978|P2|Overall Study|Withdrawal by Subject|18
2697249|NCT00419562|9295979|P1|Overall Study|Withdrawal by Subject|20
2697250|NCT00419562|9295978|P2|Overall Study|Lost to Follow-up|13
2697251|NCT00419562|9295979|P1|Overall Study|Lost to Follow-up|12
2697252|NCT00419393|9296002|P1|Overall Study|Other: Investigator decision|1
2697253|NCT00419393|9296002|P1|Overall Study|Other: Other health problems|1
2697254|NCT00419393|9296002|P1|Overall Study|Other: Site closure|1
2697255|NCT00419393|9296002|P1|Overall Study|Other: Subject had temporal lobectomy|1
2697256|NCT00419393|9296002|P1|Overall Study|Other: Sponsor request|3
2697257|NCT00419393|9296002|P1|Overall Study|Withdrawal by Subject|7
2697258|NCT00419393|9296002|P1|Overall Study|Protocol Violation|5
2697259|NCT00419393|9296002|P1|Overall Study|Adverse Event|5
2697260|NCT00419380|9296012|P2|Overall Study|Withdrawal by Subject|1
2697261|NCT00419380|9296013|P1|Overall Study|Withdrawal by Subject|0
2697262|NCT00419380|9296012|P2|Overall Study|Lost to Follow-up|1
2697263|NCT00419380|9296013|P1|Overall Study|Lost to Follow-up|0
2697264|NCT00419380|9296012|P2|Overall Study|Physician Decision|1
2697265|NCT00419380|9296013|P1|Overall Study|Physician Decision|0
2697266|NCT00419380|9296012|P2|Overall Study|Lack of Efficacy|7
2697267|NCT00419380|9296013|P1|Overall Study|Lack of Efficacy|1
2697268|NCT00419341|9296021|P1|Efficacy Period|Termination of study site|1
2697269|NCT00419341|9296021|P1|Efficacy Period|Non-compliance|1
2697270|NCT00419341|9296021|P1|Efficacy Period|Lost to Follow-up|1
2697271|NCT00419341|9296021|P1|Efficacy Period|Protocol Violation|1
2697272|NCT00419341|9296021|P1|Efficacy Period|Withdrawal by Subject|6
2697273|NCT00419341|9296021|P1|Wash in/Wash Out Period|Disqualifying laboratory results|1
2697274|NCT00419341|9296021|P1|Wash in/Wash Out Period|Adverse Event|2
2697275|NCT00419341|9296021|P1|Wash in/Wash Out Period|Withdrawal by Subject|8
2697276|NCT00419263|9296056|P3|Overall Study|Withdrawal by Subject|1
2697277|NCT00419263|9296057|P2|Overall Study|Withdrawal by Subject|0
2697278|NCT00419263|9296058|P1|Overall Study|Withdrawal by Subject|0
2697279|NCT00419263|9296056|P3|Overall Study|Adverse Event|1
2697280|NCT00419263|9296057|P2|Overall Study|Adverse Event|0
2697281|NCT00419263|9296058|P1|Overall Study|Adverse Event|0
2697282|NCT00419263|9296056|P3|Overall Study|Randomized in Error, Not Treated|0
2697283|NCT00419263|9296057|P2|Overall Study|Randomized in Error, Not Treated|1
2697284|NCT00419263|9296058|P1|Overall Study|Randomized in Error, Not Treated|1
2697285|NCT00419263|9296056|P3|Overall Study|Lost to Follow-up|1
2697286|NCT00419263|9296057|P2|Overall Study|Lost to Follow-up|1
2697287|NCT00419263|9296058|P1|Overall Study|Lost to Follow-up|2
2697288|NCT00419159|9296087|P2|Overall Study|Disease progression|76
2697289|NCT00419159|9296088|P1|Overall Study|Disease progression|79
2697290|NCT00419159|9296087|P2|Overall Study|Death|2
2697291|NCT00419159|9296088|P1|Overall Study|Death|2
2697292|NCT00419159|9296087|P2|Overall Study|Lost to Follow-up|1
2697293|NCT00419159|9296088|P1|Overall Study|Lost to Follow-up|0
2697294|NCT00419159|9296087|P2|Overall Study|Withdrawal by Subject|3
2697295|NCT00419159|9296088|P1|Overall Study|Withdrawal by Subject|10
2697296|NCT00419159|9296087|P2|Overall Study|Protocol Violation|0
2697297|NCT00419159|9296088|P1|Overall Study|Protocol Violation|1
2697298|NCT00419159|9296087|P2|Overall Study|Subject's no longer requires study drug|1
2697299|NCT00419159|9296088|P1|Overall Study|Subject's no longer requires study drug|0
2697300|NCT00419159|9296087|P2|Overall Study|Abnormal laboratory value(s)|2
2697301|NCT00419159|9296088|P1|Overall Study|Abnormal laboratory value(s)|0
2697302|NCT00419159|9296087|P2|Overall Study|Adverse Event|15
2697303|NCT00419159|9296088|P1|Overall Study|Adverse Event|7
2697304|NCT00419120|9296118|P1|Long Term Follow up Period|study ongoing|10
2697305|NCT00419094|9296125|P2|Overall Study|Other: No contact for extended period|1
2697306|NCT00419094|9296126|P1|Overall Study|Other: No contact for extended period|0
2697307|NCT00419094|9296125|P2|Overall Study|Other: Patient non-compliant|1
2697308|NCT00419094|9296126|P1|Overall Study|Other: Patient non-compliant|0
2697309|NCT00419094|9296125|P2|Overall Study|Other: Error determining exit criteria|0
2697310|NCT00419094|9296126|P1|Overall Study|Other: Error determining exit criteria|1
2697311|NCT00419094|9296125|P2|Overall Study|Withdrawal of consent|5
2697312|NCT00419094|9296126|P1|Overall Study|Withdrawal of consent|1
2697313|NCT00419094|9296125|P2|Overall Study|Protocol Violation|14
2697314|NCT00419094|9296126|P1|Overall Study|Protocol Violation|1
2697315|NCT00419094|9296125|P2|Overall Study|Lost to Follow-up|2
2697316|NCT00419094|9296126|P1|Overall Study|Lost to Follow-up|0
2697317|NCT00419094|9296125|P2|Overall Study|Lack of Efficacy|0
2697318|NCT00419094|9296126|P1|Overall Study|Lack of Efficacy|1
2697319|NCT00419094|9296125|P2|Overall Study|Adverse Event|7
2697320|NCT00419094|9296126|P1|Overall Study|Adverse Event|3
2697321|NCT00419003|9296140|P2|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0
2697322|NCT00419003|9296141|P1|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1
2697323|NCT00419003|9296140|P2|Phase I, Ketamine Infusion|Lack of Efficacy|6
2697324|NCT00419003|9296141|P1|Phase I, Ketamine Infusion|Lack of Efficacy|6
2697325|NCT00418938|9296195|P2|Overall Study|Ineligibility Determined|0
2697326|NCT00418938|9296196|P1|Overall Study|Ineligibility Determined|1
2697327|NCT00418938|9296195|P2|Overall Study|On-going|1
2697328|NCT00418938|9296196|P1|Overall Study|On-going|1
2697329|NCT00418938|9296195|P2|Overall Study|Adverse Event|1
2697330|NCT00418938|9296196|P1|Overall Study|Adverse Event|1
2697331|NCT00418938|9296195|P2|Overall Study|Lost to Follow-up|3
2697332|NCT00418938|9296196|P1|Overall Study|Lost to Follow-up|1
2697333|NCT00418938|9296195|P2|Overall Study|Withdrawal by Subject|15
2697334|NCT00418938|9296196|P1|Overall Study|Withdrawal by Subject|16
2697335|NCT00418938|9296195|P2|Overall Study|Administrative decision|3
2697336|NCT00418938|9296196|P1|Overall Study|Administrative decision|3
2697337|NCT00418938|9296195|P2|Overall Study|Reimbursement|0
2697338|NCT00418938|9296196|P1|Overall Study|Reimbursement|1
2697339|NCT00418886|9296216|P2|Overall Study|randomised but no treatment received|1
2697340|NCT00418886|9296217|P1|Overall Study|randomised but no treatment received|0
2697341|NCT00418886|9296216|P2|Overall Study|withdrawn due to other reason|0
2697342|NCT00418886|9296217|P1|Overall Study|withdrawn due to other reason|1
2697343|NCT00418886|9296216|P2|Overall Study|Lost to Follow-up|6
2697344|NCT00418886|9296217|P1|Overall Study|Lost to Follow-up|4
2697345|NCT00418886|9296216|P2|Overall Study|Withdrawal by Subject|10
2697346|NCT00418886|9296217|P1|Overall Study|Withdrawal by Subject|9
2697347|NCT00418886|9296216|P2|Overall Study|Death|147
2697348|NCT00418886|9296217|P1|Overall Study|Death|122
2697349|NCT00418886|9296216|P2|Overall Study|discontinue treatment survival follow up|91
2697350|NCT00418886|9296217|P1|Overall Study|discontinue treatment survival follow up|90
2697351|NCT00418834|9296243|P2|Overall Study|Withdrawal by Subject|7
2697352|NCT00418834|9296244|P1|Overall Study|Withdrawal by Subject|3
2697353|NCT00418834|9296243|P2|Overall Study|Protocol Violation|3
2697354|NCT00418834|9296244|P1|Overall Study|Protocol Violation|4
2697355|NCT00418834|9296243|P2|Overall Study|Lost to Follow-up|1
2697356|NCT00418834|9296244|P1|Overall Study|Lost to Follow-up|0
2697357|NCT00418834|9296243|P2|Overall Study|Adverse Event|9
2697358|NCT00418834|9296244|P1|Overall Study|Adverse Event|16
2697359|NCT00418717|9296304|P1|Treatment Period B - Weeks 5-12|Adverse Event|2
2697360|NCT00418717|9296304|P1|Treatment Period A - Weeks 1-4|Protocol Violation|1
2697361|NCT00418691|9296312|P3|Overall Study|Progressive Disease|1
2697362|NCT00418691|9296313|P2|Overall Study|Progressive Disease|0
2697363|NCT00418691|9296314|P1|Overall Study|Progressive Disease|1
2697364|NCT00418691|9296312|P3|Overall Study|Started new medication voiding entry|1
2697365|NCT00418691|9296313|P2|Overall Study|Started new medication voiding entry|0
2697366|NCT00418691|9296314|P1|Overall Study|Started new medication voiding entry|0
2697367|NCT00418691|9296312|P3|Overall Study|Lost to Follow-up|3
2697368|NCT00418691|9296313|P2|Overall Study|Lost to Follow-up|2
2697369|NCT00418691|9296314|P1|Overall Study|Lost to Follow-up|1
2697370|NCT00418665|9296325|P3|Treatment Extension|Death|1
2697371|NCT00418665|9296326|P2|Treatment Extension|Death|0
2697372|NCT00418665|9296327|P1|Treatment Extension|Death|0
2697373|NCT00418665|9296325|P3|Treatment Extension|Physician Decision|1
2697374|NCT00418665|9296326|P2|Treatment Extension|Physician Decision|2
2697375|NCT00418665|9296327|P1|Treatment Extension|Physician Decision|2
2697376|NCT00418665|9296325|P3|Treatment Extension|Requirement for alternative therapy|0
2697377|NCT00418665|9296326|P2|Treatment Extension|Requirement for alternative therapy|2
2697378|NCT00418665|9296327|P1|Treatment Extension|Requirement for alternative therapy|2
2697379|NCT00418665|9296325|P3|Treatment Extension|Withdrawal by Subject|0
2697380|NCT00418665|9296326|P2|Treatment Extension|Withdrawal by Subject|0
2697381|NCT00418665|9296327|P1|Treatment Extension|Withdrawal by Subject|1
2697382|NCT00418665|9296325|P3|Treatment Extension|Adverse Event|0
2697383|NCT00418665|9296326|P2|Treatment Extension|Adverse Event|0
2697384|NCT00418665|9296327|P1|Treatment Extension|Adverse Event|1
2697385|NCT00418665|9296325|P3|Treatment Period|Physician Decision|3
2697386|NCT00418665|9296326|P2|Treatment Period|Physician Decision|0
2697387|NCT00418665|9296327|P1|Treatment Period|Physician Decision|1
2697388|NCT00418665|9296325|P3|Treatment Period|Requirement for alternative therapy|0
2697389|NCT00418665|9296326|P2|Treatment Period|Requirement for alternative therapy|0
2697390|NCT00418665|9296327|P1|Treatment Period|Requirement for alternative therapy|1
2697391|NCT00418665|9296325|P3|Treatment Period|Withdrawal by Subject|1
2697392|NCT00418665|9296326|P2|Treatment Period|Withdrawal by Subject|3
2697393|NCT00418665|9296327|P1|Treatment Period|Withdrawal by Subject|0
2697394|NCT00418665|9296325|P3|Treatment Period|Adverse Event|0
2697395|NCT00418665|9296326|P2|Treatment Period|Adverse Event|2
2697396|NCT00418665|9296327|P1|Treatment Period|Adverse Event|2
2697397|NCT00418665|9296325|P3|Treatment Period|Ineligibility determined|0
2697398|NCT00418665|9296326|P2|Treatment Period|Ineligibility determined|1
2697399|NCT00418665|9296327|P1|Treatment Period|Ineligibility determined|1
2697400|NCT00418561|9296361|P3|Overall Study|Participant's (guardian's) decision|0
2697401|NCT00418561|9296362|P2|Overall Study|Participant's (guardian's) decision|1
2697402|NCT00418561|9296363|P1|Overall Study|Participant's (guardian's) decision|0
2697403|NCT00418522|9296433|P2|Overall Study|Randomized but did not receive treatment|4
2697404|NCT00418522|9296434|P1|Overall Study|Randomized but did not receive treatment|7
2697405|NCT00418522|9296433|P2|Overall Study|Other|23
2697406|NCT00418522|9296434|P1|Overall Study|Other|27
2697407|NCT00418522|9296433|P2|Overall Study|Withdrawal by Subject|7
2697408|NCT00418522|9296434|P1|Overall Study|Withdrawal by Subject|31
2697409|NCT00418522|9296433|P2|Overall Study|Lost to Follow-up|4
2697410|NCT00418522|9296434|P1|Overall Study|Lost to Follow-up|10
2697411|NCT00418522|9296433|P2|Overall Study|Lack of Efficacy|3
2697412|NCT00418522|9296434|P1|Overall Study|Lack of Efficacy|1
2697413|NCT00418522|9296433|P2|Overall Study|Adverse Event|1
2697414|NCT00418522|9296434|P1|Overall Study|Adverse Event|7
2697415|NCT00418379|9296481|P3|Year 5|Any other reason not above-mentioned|3
2697416|NCT00418379|9296482|P2|Year 5|Any other reason not above-mentioned|4
2697417|NCT00418379|9296483|P1|Year 5|Any other reason not above-mentioned|2
2697418|NCT00418379|9296481|P3|Year 5|Adverse Event|0
2697419|NCT00418379|9296482|P2|Year 5|Adverse Event|1
2697420|NCT00418379|9296483|P1|Year 5|Adverse Event|0
2697421|NCT00418379|9296481|P3|Year 4|Any other reason not above-mentioned|0
2697422|NCT00418379|9296482|P2|Year 4|Any other reason not above-mentioned|1
2697423|NCT00418379|9296483|P1|Year 4|Any other reason not above-mentioned|1
2697424|NCT00418379|9296481|P3|Year 4|Withdrawal by Subject|2
2697425|NCT00418379|9296482|P2|Year 4|Withdrawal by Subject|3
2697426|NCT00418379|9296483|P1|Year 4|Withdrawal by Subject|2
2697427|NCT00418379|9296481|P3|Year 4|Adverse Event|0
2697428|NCT00418379|9296482|P2|Year 4|Adverse Event|1
2697429|NCT00418379|9296483|P1|Year 4|Adverse Event|0
2697430|NCT00418379|9296481|P3|Year 3|Any other reason not above-mentioned|1
2697431|NCT00418379|9296482|P2|Year 3|Any other reason not above-mentioned|1
2697432|NCT00418379|9296483|P1|Year 3|Any other reason not above-mentioned|2
2697433|NCT00418379|9296481|P3|Year 3|Withdrawal by Subject|2
2697434|NCT00418379|9296482|P2|Year 3|Withdrawal by Subject|1
2697435|NCT00418379|9296483|P1|Year 3|Withdrawal by Subject|1
2697436|NCT00418379|9296481|P3|Year 2|Any other reason not above-mentioned|6
2697437|NCT00418379|9296482|P2|Year 2|Any other reason not above-mentioned|1
2697438|NCT00418379|9296483|P1|Year 2|Any other reason not above-mentioned|2
2697439|NCT00418379|9296481|P3|Year 2|Withdrawal by Subject|3
2697440|NCT00418379|9296482|P2|Year 2|Withdrawal by Subject|1
2697441|NCT00418379|9296483|P1|Year 2|Withdrawal by Subject|1
2697442|NCT00418379|9296481|P3|Year 2|Adverse Event|1
2697443|NCT00418379|9296482|P2|Year 2|Adverse Event|2
2697444|NCT00418379|9296483|P1|Year 2|Adverse Event|5
2697445|NCT00418379|9296481|P3|Year 1|Any other reason not above-mentioned|7
2697446|NCT00418379|9296482|P2|Year 1|Any other reason not above-mentioned|5
2697447|NCT00418379|9296483|P1|Year 1|Any other reason not above-mentioned|2
2697448|NCT00418379|9296481|P3|Year 1|Withdrawal by Subject|5
2697449|NCT00418379|9296482|P2|Year 1|Withdrawal by Subject|8
2697450|NCT00418379|9296483|P1|Year 1|Withdrawal by Subject|7
2697451|NCT00418379|9296481|P3|Year 1|Adverse Event|3
2697452|NCT00418379|9296482|P2|Year 1|Adverse Event|15
2697453|NCT00418379|9296483|P1|Year 1|Adverse Event|9
2697454|NCT00418314|9296493|P2|Overall Study|Withdrawal by Subject|2
2697455|NCT00418314|9296494|P1|Overall Study|Withdrawal by Subject|1
2697456|NCT00418184|9296524|P2|Double-blind Phase|Poor compliance|1
2697457|NCT00418184|9296525|P1|Double-blind Phase|Poor compliance|3
2697458|NCT00418184|9296524|P2|Double-blind Phase|Adverse Event|1
2697459|NCT00418184|9296525|P1|Double-blind Phase|Adverse Event|2
2697460|NCT00418184|9296524|P2|Double-blind Phase|Withdrawal by Subject|9
2697461|NCT00418184|9296525|P1|Double-blind Phase|Withdrawal by Subject|22
2697462|NCT00418145|9296533|P1|Overall Study|study terminated|6
2697463|NCT00417989|9296608|P2|Overall Study|Physician Decision|2
2697464|NCT00417989|9296609|P1|Overall Study|Physician Decision|5
2697465|NCT00417989|9296608|P2|Overall Study|Death|1
2697466|NCT00417989|9296609|P1|Overall Study|Death|0
2697467|NCT00417989|9296608|P2|Overall Study|Protocol Violation|0
2697468|NCT00417989|9296609|P1|Overall Study|Protocol Violation|1
2697469|NCT00417989|9296608|P2|Overall Study|Lost to Follow-up|6
2697470|NCT00417989|9296609|P1|Overall Study|Lost to Follow-up|1
2697471|NCT00417989|9296608|P2|Overall Study|Withdrawal by Subject|13
2697472|NCT00417989|9296609|P1|Overall Study|Withdrawal by Subject|13
2697473|NCT00417976|9296631|P1|Overall Study|Treatment -related toxicity|2
2697474|NCT00417976|9296631|P1|Overall Study|Non compliance unrelated to toxicity|1
2697475|NCT00417963|9296636|P1|Overall Study|Study device could not be deployed|3
2697476|NCT00417963|9296636|P1|Overall Study|Death|17
2697477|NCT00417963|9296636|P1|Overall Study|Withdrawal by Subject|18
2697478|NCT00417963|9296636|P1|Overall Study|Lost to Follow-up|3
2697479|NCT00417885|9296653|P1|Overall Study|Transferred to Another Sunitinib Study|2
2697480|NCT00417885|9296653|P1|Overall Study|Objective Progression or Relapse|3
2697481|NCT00417885|9296653|P1|Overall Study|Adverse Event|1
2697482|NCT00417612|9296679|P2|Overall Study|Lost to Follow-up|0
2697483|NCT00417612|9296680|P1|Overall Study|Lost to Follow-up|1
2697484|NCT00417612|9296679|P2|Overall Study|Protocol Violation|2
2697485|NCT00417612|9296680|P1|Overall Study|Protocol Violation|0
2697486|NCT00417612|9296679|P2|Overall Study|Adverse Event|0
2697487|NCT00417612|9296680|P1|Overall Study|Adverse Event|2
2697488|NCT00417612|9296679|P2|Overall Study|Errant diagnosis|1
2697489|NCT00417612|9296680|P1|Overall Study|Errant diagnosis|0
2697490|NCT00417482|9296706|P3|Phase B 2nd 16 Weeks|Death|0
2697491|NCT00417482|9296707|P2|Phase B 2nd 16 Weeks|Death|1
2697492|NCT00417482|9296708|P1|Phase B 2nd 16 Weeks|Death|1
2697493|NCT00417482|9296706|P3|Phase B 2nd 16 Weeks|Moved; unclear reason|0
2697494|NCT00417482|9296707|P2|Phase B 2nd 16 Weeks|Moved; unclear reason|0
2697495|NCT00417482|9296708|P1|Phase B 2nd 16 Weeks|Moved; unclear reason|1
2697496|NCT00417482|9296706|P3|Phase B 2nd 16 Weeks|Adverse Event|1
2697497|NCT00417482|9296707|P2|Phase B 2nd 16 Weeks|Adverse Event|0
2697498|NCT00417482|9296708|P1|Phase B 2nd 16 Weeks|Adverse Event|0
2697499|NCT00417482|9296706|P3|Phase B 2nd 16 Weeks|Lack of Efficacy|2
2697500|NCT00417482|9296707|P2|Phase B 2nd 16 Weeks|Lack of Efficacy|12
2697501|NCT00417482|9296708|P1|Phase B 2nd 16 Weeks|Lack of Efficacy|1
2697502|NCT00417482|9296706|P3|Phase B 1st 16 Weeks|Death|0
2697503|NCT00417482|9296707|P2|Phase B 1st 16 Weeks|Death|0
2697504|NCT00417482|9296708|P1|Phase B 1st 16 Weeks|Death|1
2697505|NCT00417482|9296706|P3|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
2697506|NCT00417482|9296707|P2|Phase B 1st 16 Weeks|Moved, Unclear reasons|3
2697507|NCT00417482|9296708|P1|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
2697508|NCT00417482|9296706|P3|Phase B 1st 16 Weeks|Adverse Event|1
2697509|NCT00417482|9296707|P2|Phase B 1st 16 Weeks|Adverse Event|0
2697510|NCT00417482|9296708|P1|Phase B 1st 16 Weeks|Adverse Event|2
2697511|NCT00417482|9296706|P3|Phase B 1st 16 Weeks|Lack of Efficacy|24
2697512|NCT00417482|9296707|P2|Phase B 1st 16 Weeks|Lack of Efficacy|8
2697513|NCT00417482|9296708|P1|Phase B 1st 16 Weeks|Lack of Efficacy|14
2697514|NCT00417248|9296747|P1|Overall Study|Lack of Efficacy|1
2697515|NCT00417248|9296747|P1|Overall Study|Death|1
2697516|NCT00417248|9296747|P1|Overall Study|Study Terminated|6
2697517|NCT00417170|9296754|P2|Overall Study|Lost to Follow-up|1
2697518|NCT00417170|9296755|P1|Overall Study|Lost to Follow-up|0
2697519|NCT00417170|9296754|P2|Overall Study|Withdrawal by Subject|1
2697520|NCT00417170|9296755|P1|Overall Study|Withdrawal by Subject|1
2697521|NCT00417170|9296754|P2|Overall Study|Adverse Event|1
2697522|NCT00417170|9296755|P1|Overall Study|Adverse Event|1
2697523|NCT00417079|9296771|P2|Overall Study|abnormal liver function tests|1
2697524|NCT00417079|9296772|P1|Overall Study|abnormal liver function tests|0
2697525|NCT00417079|9296771|P2|Overall Study|Patient unable to come to the clinic|1
2697526|NCT00417079|9296772|P1|Overall Study|Patient unable to come to the clinic|0
2697527|NCT00417079|9296771|P2|Overall Study|Withdrawal by subject's family|1
2697528|NCT00417079|9296772|P1|Overall Study|Withdrawal by subject's family|0
2697529|NCT00417079|9296771|P2|Overall Study|Screening error|1
2697530|NCT00417079|9296772|P1|Overall Study|Screening error|2
2697531|NCT00417079|9296771|P2|Overall Study|Clinical deterioration|0
2697532|NCT00417079|9296772|P1|Overall Study|Clinical deterioration|1
2697533|NCT00417079|9296771|P2|Overall Study|Non-confirmed Disease progression|1
2697534|NCT00417079|9296772|P1|Overall Study|Non-confirmed Disease progression|1
2697535|NCT00417079|9296771|P2|Overall Study|Investigator's decision|4
2697536|NCT00417079|9296772|P1|Overall Study|Investigator's decision|1
2697537|NCT00417079|9296771|P2|Overall Study|Screened failure|1
2697538|NCT00417079|9296772|P1|Overall Study|Screened failure|2
2697539|NCT00417079|9296771|P2|Overall Study|Not treated|7
2697540|NCT00417079|9296772|P1|Overall Study|Not treated|6
2697541|NCT00417079|9296771|P2|Overall Study|Withdrawal by Subject|8
2697542|NCT00417079|9296772|P1|Overall Study|Withdrawal by Subject|17
2697543|NCT00417079|9296771|P2|Overall Study|Lost to Follow-up|0
2697544|NCT00417079|9296772|P1|Overall Study|Lost to Follow-up|2
2697545|NCT00417079|9296771|P2|Overall Study|Non-compliance to protocol|1
2697546|NCT00417079|9296772|P1|Overall Study|Non-compliance to protocol|0
2697547|NCT00417079|9296771|P2|Overall Study|Adverse Event|67
2697548|NCT00417079|9296772|P1|Overall Study|Adverse Event|32
2697549|NCT00417079|9296771|P2|Overall Study|Disease progression|180
2697550|NCT00417079|9296772|P1|Overall Study|Disease progression|267
2697551|NCT00417027|9296795|P3|Overall Study|Protocol Violation|5
2697552|NCT00417027|9296796|P2|Overall Study|Protocol Violation|5
2697553|NCT00417027|9296797|P1|Overall Study|Protocol Violation|0
2697554|NCT00416949|9296823|P1|Overall Study|Patients refused to participate|5
2697555|NCT00416884|9296827|P1|Overall Study|Study terminated due to low accrual|1
2697556|NCT00416715|9296836|P1|Overall Study|Vitamin D levels not evaluable|8
2697557|NCT00416715|9296836|P1|Overall Study|Not evaluable for joint aches|7
2697558|NCT00416624|9296847|P4|Overall Study|Cancel|0
2697559|NCT00416624|9296848|P3|Overall Study|Cancel|0
2697560|NCT00416624|9296849|P2|Overall Study|Cancel|0
2697561|NCT00416624|9296850|P1|Overall Study|Cancel|1
2697562|NCT00416624|9296847|P4|Overall Study|Other|5
2697563|NCT00416624|9296848|P3|Overall Study|Other|5
2697564|NCT00416624|9296849|P2|Overall Study|Other|11
2697565|NCT00416624|9296850|P1|Overall Study|Other|8
2697566|NCT00416624|9296847|P4|Overall Study|Adverse Event|2
2697567|NCT00416624|9296848|P3|Overall Study|Adverse Event|2
2697568|NCT00416624|9296849|P2|Overall Study|Adverse Event|3
2697569|NCT00416624|9296850|P1|Overall Study|Adverse Event|8
2697570|NCT00416624|9296847|P4|Overall Study|Death|1
2697571|NCT00416624|9296848|P3|Overall Study|Death|7
2697572|NCT00416624|9296849|P2|Overall Study|Death|7
2697573|NCT00416624|9296850|P1|Overall Study|Death|4
2697574|NCT00416624|9296847|P4|Overall Study|Withdrawal by Subject|9
2697575|NCT00416624|9296848|P3|Overall Study|Withdrawal by Subject|4
2697576|NCT00416624|9296849|P2|Overall Study|Withdrawal by Subject|6
2697577|NCT00416624|9296850|P1|Overall Study|Withdrawal by Subject|1
2697578|NCT00416598|9296904|P1|Decitabine Maintenance|Physician discretion/other medical issue|9
2697579|NCT00416598|9296904|P1|Decitabine Maintenance|Alternative treatment|2
2697580|NCT00416598|9296904|P1|Decitabine Maintenance|Progression/relapse|38
2697581|NCT00416598|9296904|P1|Decitabine Maintenance|Withdrawal by Subject|18
2697582|NCT00416598|9296904|P1|Decitabine Maintenance|Adverse Event|5
2697583|NCT00416598|9296904|P1|Induction & Intensification|Failed induction|87
2697584|NCT00416598|9296904|P1|Induction & Intensification|Relapse/progression|29
2697585|NCT00416598|9296904|P1|Induction & Intensification|Physician discretion/other medical issue|45
2697586|NCT00416598|9296904|P1|Induction & Intensification|Alternative Treatment|135
2697587|NCT00416598|9296904|P1|Induction & Intensification|Withdrawal by Subject|46
2697588|NCT00416598|9296904|P1|Induction & Intensification|Death|32
2697589|NCT00416598|9296904|P1|Induction & Intensification|Adverse Event|38
2697590|NCT00416520|9296930|P4|Placebo-controlled Withdrawal Period|Protocol Violation|1
2697591|NCT00416520|9296931|P3|Placebo-controlled Withdrawal Period|Protocol Violation|1
2697592|NCT00416520|9296932|P2|Placebo-controlled Withdrawal Period|Protocol Violation|0
2697593|NCT00416520|9296933|P1|Placebo-controlled Withdrawal Period|Protocol Violation|0
2697594|NCT00416520|9296930|P4|Placebo-controlled Withdrawal Period|Lack of Efficacy|3
2697595|NCT00416520|9296931|P3|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
2697596|NCT00416520|9296932|P2|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
2697597|NCT00416520|9296933|P1|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
2697598|NCT00416520|9296930|P4|Placebo-controlled Withdrawal Period|Adverse Event|1
2697599|NCT00416520|9296931|P3|Placebo-controlled Withdrawal Period|Adverse Event|0
2697600|NCT00416520|9296932|P2|Placebo-controlled Withdrawal Period|Adverse Event|0
2697601|NCT00416520|9296933|P1|Placebo-controlled Withdrawal Period|Adverse Event|0
2697602|NCT00416520|9296930|P4|Open-label Period|Other Reasons|0
2697603|NCT00416520|9296931|P3|Open-label Period|Other Reasons|0
2697604|NCT00416520|9296932|P2|Open-label Period|Other Reasons|12
2697605|NCT00416520|9296933|P1|Open-label Period|Other Reasons|3
2697606|NCT00416520|9296930|P4|Open-label Period|Withdrawal by Subject|0
2697607|NCT00416520|9296931|P3|Open-label Period|Withdrawal by Subject|0
2697608|NCT00416520|9296932|P2|Open-label Period|Withdrawal by Subject|5
2697609|NCT00416520|9296933|P1|Open-label Period|Withdrawal by Subject|16
2697610|NCT00416520|9296930|P4|Open-label Period|Protocol Violation|0
2697611|NCT00416520|9296931|P3|Open-label Period|Protocol Violation|0
2697612|NCT00416520|9296932|P2|Open-label Period|Protocol Violation|3
2697613|NCT00416520|9296933|P1|Open-label Period|Protocol Violation|3
2697614|NCT00416520|9296930|P4|Open-label Period|Lack of Efficacy|0
2697615|NCT00416520|9296931|P3|Open-label Period|Lack of Efficacy|0
2697616|NCT00416520|9296932|P2|Open-label Period|Lack of Efficacy|1
2697617|NCT00416520|9296933|P1|Open-label Period|Lack of Efficacy|8
2697618|NCT00416520|9296930|P4|Open-label Period|Death|0
2697619|NCT00416520|9296931|P3|Open-label Period|Death|0
2697620|NCT00416520|9296932|P2|Open-label Period|Death|1
2697621|NCT00416520|9296933|P1|Open-label Period|Death|2
2697622|NCT00416520|9296930|P4|Open-label Period|Adverse Event|0
2697623|NCT00416520|9296931|P3|Open-label Period|Adverse Event|0
2697624|NCT00416520|9296932|P2|Open-label Period|Adverse Event|10
2697625|NCT00416520|9296933|P1|Open-label Period|Adverse Event|28
2697626|NCT00416455|9296962|P2|Overall Study|Inadequate pathology|2
2697627|NCT00416455|9296963|P1|Overall Study|Inadequate pathology|11
2697628|NCT00416455|9296962|P2|Overall Study|PET / CT poor quality|1
2697629|NCT00416455|9296963|P1|Overall Study|PET / CT poor quality|2
2697630|NCT00416455|9296962|P2|Overall Study|PET / CT not done|5
2697631|NCT00416455|9296963|P1|Overall Study|PET / CT not done|3
2697632|NCT00416312|9296998|P1|Overall Study|tumors not visible on imaging|2
2697633|NCT00416195|9297004|P2|Overall Study|Other|1
2697634|NCT00416195|9297005|P1|Overall Study|Other|0
2697635|NCT00416195|9297004|P2|Overall Study|Protocol Violation|1
2697636|NCT00416195|9297005|P1|Overall Study|Protocol Violation|1
2697637|NCT00416195|9297004|P2|Overall Study|Adverse Event|2
2697638|NCT00416195|9297005|P1|Overall Study|Adverse Event|1
2697639|NCT00416078|9297030|P2|Overall Study|Lost to Follow-up|2
2697640|NCT00416078|9297031|P1|Overall Study|Lost to Follow-up|4
2697641|NCT00416078|9297030|P2|Overall Study|Physician Decision|0
2697642|NCT00416078|9297031|P1|Overall Study|Physician Decision|1
2697643|NCT00416078|9297030|P2|Overall Study|Withdrawal by Subject|2
2697644|NCT00416078|9297031|P1|Overall Study|Withdrawal by Subject|3
2697645|NCT00416078|9297030|P2|Overall Study|Death|4
2697646|NCT00416078|9297031|P1|Overall Study|Death|3
2697647|NCT00415909|9297047|P1|Overall Study|Death|1
2697648|NCT00415909|9297047|P1|Overall Study|Withdrawal by Subject|2
2697649|NCT00415636|9297081|P6|Overall Study|Disease progression|1
2697650|NCT00415636|9297082|P5|Overall Study|Disease progression|0
2697651|NCT00415636|9297083|P4|Overall Study|Disease progression|3
2697652|NCT00415636|9297084|P3|Overall Study|Disease progression|0
2697653|NCT00415636|9297085|P2|Overall Study|Disease progression|0
2697654|NCT00415636|9297086|P1|Overall Study|Disease progression|0
2697655|NCT00415636|9297081|P6|Overall Study|Withdrawal by Subject|0
2697656|NCT00415636|9297082|P5|Overall Study|Withdrawal by Subject|1
2697657|NCT00415636|9297083|P4|Overall Study|Withdrawal by Subject|0
2697658|NCT00415636|9297084|P3|Overall Study|Withdrawal by Subject|0
2697659|NCT00415636|9297085|P2|Overall Study|Withdrawal by Subject|0
2697660|NCT00415636|9297086|P1|Overall Study|Withdrawal by Subject|0
2697661|NCT00415636|9297081|P6|Overall Study|Adverse Event|0
2697662|NCT00415636|9297082|P5|Overall Study|Adverse Event|1
2697663|NCT00415636|9297083|P4|Overall Study|Adverse Event|1
2697664|NCT00415636|9297084|P3|Overall Study|Adverse Event|0
2697665|NCT00415636|9297085|P2|Overall Study|Adverse Event|0
2697666|NCT00415636|9297086|P1|Overall Study|Adverse Event|0
2697667|NCT00415636|9297081|P6|Overall Study|Symptomatic deterioration|1
2697668|NCT00415636|9297082|P5|Overall Study|Symptomatic deterioration|0
2697669|NCT00415636|9297083|P4|Overall Study|Symptomatic deterioration|2
2697670|NCT00415636|9297084|P3|Overall Study|Symptomatic deterioration|1
2697671|NCT00415636|9297085|P2|Overall Study|Symptomatic deterioration|0
2697672|NCT00415636|9297086|P1|Overall Study|Symptomatic deterioration|1
2697673|NCT00415623|9297120|P2|Overall Study|Withdrawal by Subject|1
2697674|NCT00415623|9297121|P1|Overall Study|Withdrawal by Subject|1
2697675|NCT00415623|9297120|P2|Overall Study|Death|0
2697676|NCT00415623|9297121|P1|Overall Study|Death|1
2697677|NCT00415623|9297120|P2|Overall Study|Adverse Event|4
2697678|NCT00415623|9297121|P1|Overall Study|Adverse Event|3
2697679|NCT00415610|9297148|P3|Overall Study|Death|5
2697680|NCT00415610|9297149|P2|Overall Study|Death|2
2697681|NCT00415610|9297150|P1|Overall Study|Death|3
2697682|NCT00415597|9297170|P1|Treatment|Multiple Reasons|1
2697683|NCT00415597|9297170|P1|Treatment|Sponsor Decision|1
2697684|NCT00415597|9297170|P1|Treatment|Administrative|3
2697685|NCT00415597|9297170|P1|Treatment|Drug Screen|2
2697686|NCT00415597|9297170|P1|Treatment|Lost to Follow-up|28
2697687|NCT00415597|9297170|P1|Treatment|Withdrawal by Subject|51
2697688|NCT00415597|9297170|P1|Treatment|Physician Decision|3
2697689|NCT00415597|9297170|P1|Treatment|Protocol Violation|67
2697690|NCT00415597|9297170|P1|Treatment|Lack of Efficacy|39
2697691|NCT00415597|9297170|P1|Treatment|Adverse Event|110
2697692|NCT00415597|9297170|P1|Enrollment|Protocol Violation|1
2697693|NCT00415597|9297170|P1|Enrollment|Withdrawal by Subject|1
2697694|NCT00415532|9297178|P2|Safety Follow Up Period|Requirement for alternative therapy|1
2697695|NCT00415532|9297179|P1|Safety Follow Up Period|Requirement for alternative therapy|0
2697696|NCT00415532|9297178|P2|Safety Follow Up Period|Noncompliance|0
2697697|NCT00415532|9297179|P1|Safety Follow Up Period|Noncompliance|1
2697698|NCT00415532|9297178|P2|Safety Follow Up Period|Ineligibility determined|1
2697699|NCT00415532|9297179|P1|Safety Follow Up Period|Ineligibility determined|1
2697700|NCT00415532|9297178|P2|Safety Follow Up Period|Other|4
2697701|NCT00415532|9297179|P1|Safety Follow Up Period|Other|1
2697702|NCT00415532|9297178|P2|Safety Follow Up Period|Withdrawal by Subject|3
2697703|NCT00415532|9297179|P1|Safety Follow Up Period|Withdrawal by Subject|2
2697704|NCT00415532|9297178|P2|Safety Follow Up Period|Death|0
2697705|NCT00415532|9297179|P1|Safety Follow Up Period|Death|3
2697706|NCT00415532|9297178|P2|Safety Follow Up Period|Adverse Event|3
2697707|NCT00415532|9297179|P1|Safety Follow Up Period|Adverse Event|1
2697708|NCT00415532|9297178|P2|Treatment Period|Requirement for alternative therapy|0
2697709|NCT00415532|9297179|P1|Treatment Period|Requirement for alternative therapy|1
2697710|NCT00415532|9297178|P2|Treatment Period|Noncompliance|1
2697711|NCT00415532|9297179|P1|Treatment Period|Noncompliance|1
2697712|NCT00415532|9297178|P2|Treatment Period|Ineligibility determined|1
2697713|NCT00415532|9297179|P1|Treatment Period|Ineligibility determined|1
2697714|NCT00415532|9297178|P2|Treatment Period|Other|2
2697715|NCT00415532|9297179|P1|Treatment Period|Other|2
2697716|NCT00415532|9297178|P2|Treatment Period|Withdrawal by Subject|6
2697717|NCT00415532|9297179|P1|Treatment Period|Withdrawal by Subject|6
2697718|NCT00415532|9297178|P2|Treatment Period|Protocol Violation|0
2697719|NCT00415532|9297179|P1|Treatment Period|Protocol Violation|1
2697720|NCT00415532|9297178|P2|Treatment Period|Lost to Follow-up|1
2697721|NCT00415532|9297179|P1|Treatment Period|Lost to Follow-up|1
2697722|NCT00415532|9297178|P2|Treatment Period|Death|1
2697723|NCT00415532|9297179|P1|Treatment Period|Death|2
2697724|NCT00415532|9297178|P2|Treatment Period|Adverse Event|3
2697725|NCT00415532|9297179|P1|Treatment Period|Adverse Event|2
2697726|NCT00415519|9297201|P2|Overall Study|Patient’s convenience|0
2697727|NCT00415519|9297202|P1|Overall Study|Patient’s convenience|1
2697728|NCT00415519|9297201|P2|Overall Study|Withdrawal by Subject|0
2697729|NCT00415519|9297202|P1|Overall Study|Withdrawal by Subject|2
2697730|NCT00415519|9297201|P2|Overall Study|Adverse Event|0
2697731|NCT00415519|9297202|P1|Overall Study|Adverse Event|1
2697732|NCT00415194|9297242|P2|Overall Study|Death Due to AE (Other Causes)|15
2697733|NCT00415194|9297243|P1|Overall Study|Death Due to AE (Other Causes)|27
2697734|NCT00415194|9297242|P2|Overall Study|Death Due to Procedural Related AE|1
2697735|NCT00415194|9297243|P1|Overall Study|Death Due to Procedural Related AE|0
2697736|NCT00415194|9297242|P2|Overall Study|Death Due to Study Drug Related AE|1
2697737|NCT00415194|9297243|P1|Overall Study|Death Due to Study Drug Related AE|11
2697738|NCT00415194|9297242|P2|Overall Study|Death Due to Study Disease|29
2697739|NCT00415194|9297243|P1|Overall Study|Death Due to Study Disease|26
2697740|NCT00415194|9297242|P2|Overall Study|Withdrawal by Subject|21
2697741|NCT00415194|9297243|P1|Overall Study|Withdrawal by Subject|28
2697742|NCT00415194|9297242|P2|Overall Study|Protocol Violation|2
2697743|NCT00415194|9297243|P1|Overall Study|Protocol Violation|4
2697744|NCT00415194|9297242|P2|Overall Study|Progressive Disease|217
2697745|NCT00415194|9297243|P1|Overall Study|Progressive Disease|180
2697746|NCT00415194|9297242|P2|Overall Study|Physician Decision|16
2697747|NCT00415194|9297243|P1|Overall Study|Physician Decision|10
2697748|NCT00415194|9297242|P2|Overall Study|Lost to Follow-up|0
2697749|NCT00415194|9297243|P1|Overall Study|Lost to Follow-up|1
2697750|NCT00415194|9297242|P2|Overall Study|Entry Criteria Not Met|8
2697751|NCT00415194|9297243|P1|Overall Study|Entry Criteria Not Met|4
2697752|NCT00415194|9297242|P2|Overall Study|Adverse Event|32
2697753|NCT00415194|9297243|P1|Overall Study|Adverse Event|37
2697754|NCT00415168|9297259|P1|Overall Study|Withdrawal by Subject|6
2697755|NCT00415168|9297259|P1|Overall Study|Sponsor Decision|4
2697756|NCT00415168|9297259|P1|Overall Study|Physician Decision|13
2697757|NCT00415168|9297259|P1|Overall Study|Lost to Follow-up|3
2697758|NCT00415168|9297259|P1|Overall Study|Death|26
2697759|NCT00415051|9297269|P1|Overall Study|Protocol Violation|1
2697760|NCT00414973|9297280|P4|Overall Study|Death|0
2697761|NCT00414973|9297281|P3|Overall Study|Death|1
2697762|NCT00414973|9297282|P2|Overall Study|Death|0
2697763|NCT00414973|9297283|P1|Overall Study|Death|0
2697764|NCT00414973|9297280|P4|Overall Study|Sponsor Decision|0
2697765|NCT00414973|9297281|P3|Overall Study|Sponsor Decision|0
2697766|NCT00414973|9297282|P2|Overall Study|Sponsor Decision|0
2697767|NCT00414973|9297283|P1|Overall Study|Sponsor Decision|1
2697768|NCT00414973|9297280|P4|Overall Study|Lost to Follow-up|0
2697769|NCT00414973|9297281|P3|Overall Study|Lost to Follow-up|0
2697770|NCT00414973|9297282|P2|Overall Study|Lost to Follow-up|2
2697771|NCT00414973|9297283|P1|Overall Study|Lost to Follow-up|0
2697772|NCT00414973|9297280|P4|Overall Study|Protocol Violation|0
2697773|NCT00414973|9297281|P3|Overall Study|Protocol Violation|0
2697774|NCT00414973|9297282|P2|Overall Study|Protocol Violation|4
2697775|NCT00414973|9297283|P1|Overall Study|Protocol Violation|3
2697776|NCT00414973|9297280|P4|Overall Study|Adverse Event|0
2697777|NCT00414973|9297281|P3|Overall Study|Adverse Event|1
2697778|NCT00414973|9297282|P2|Overall Study|Adverse Event|0
2697779|NCT00414973|9297283|P1|Overall Study|Adverse Event|10
2697780|NCT00414973|9297280|P4|Overall Study|Withdrawal by Subject|0
2697781|NCT00414973|9297281|P3|Overall Study|Withdrawal by Subject|1
2697782|NCT00414973|9297282|P2|Overall Study|Withdrawal by Subject|4
2697783|NCT00414973|9297283|P1|Overall Study|Withdrawal by Subject|14
2697784|NCT00414908|9297303|P2|Overall Study|Protocol Violation|1
2697785|NCT00414908|9297304|P1|Overall Study|Protocol Violation|1
2697786|NCT00414726|9297341|P2|Overall Study|Withdrawal by Subject|1
2697787|NCT00414726|9297342|P1|Overall Study|Withdrawal by Subject|0
2697788|NCT00414661|9297377|P4|Overall Study|Other|0
2697789|NCT00414661|9297378|P3|Overall Study|Other|0
2697790|NCT00414661|9297379|P2|Overall Study|Other|3
2697791|NCT00414661|9297380|P1|Overall Study|Other|6
2697792|NCT00414661|9297377|P4|Overall Study|Withdrawal by Subject|2
2697793|NCT00414661|9297378|P3|Overall Study|Withdrawal by Subject|2
2697794|NCT00414661|9297379|P2|Overall Study|Withdrawal by Subject|2
2697795|NCT00414661|9297380|P1|Overall Study|Withdrawal by Subject|5
2697796|NCT00414661|9297377|P4|Overall Study|Lost to Follow-up|1
2697797|NCT00414661|9297378|P3|Overall Study|Lost to Follow-up|0
2697798|NCT00414661|9297379|P2|Overall Study|Lost to Follow-up|4
2697799|NCT00414661|9297380|P1|Overall Study|Lost to Follow-up|1
2697800|NCT00414661|9297377|P4|Overall Study|Death|0
2697801|NCT00414661|9297378|P3|Overall Study|Death|0
2697802|NCT00414661|9297379|P2|Overall Study|Death|5
2697803|NCT00414661|9297380|P1|Overall Study|Death|2
2697804|NCT00414609|9297425|P3|Extension Study|Death|17
2697805|NCT00414609|9297426|P2|Extension Study|Death|0
2697806|NCT00414609|9297427|P1|Extension Study|Death|0
2697807|NCT00414609|9297425|P3|Extension Study|Administrative problems|1
2697808|NCT00414609|9297426|P2|Extension Study|Administrative problems|0
2697809|NCT00414609|9297427|P1|Extension Study|Administrative problems|0
2697810|NCT00414609|9297425|P3|Extension Study|Lost to Follow-up|10
2697811|NCT00414609|9297426|P2|Extension Study|Lost to Follow-up|0
2697812|NCT00414609|9297427|P1|Extension Study|Lost to Follow-up|0
2697813|NCT00414609|9297425|P3|Extension Study|Withdrawal by Subject|13
2697814|NCT00414609|9297426|P2|Extension Study|Withdrawal by Subject|0
2697815|NCT00414609|9297427|P1|Extension Study|Withdrawal by Subject|0
2697816|NCT00414609|9297425|P3|Extension Study|Unsatisfactory therapeutic effect|2
2697817|NCT00414609|9297426|P2|Extension Study|Unsatisfactory therapeutic effect|0
2697818|NCT00414609|9297427|P1|Extension Study|Unsatisfactory therapeutic effect|0
2697819|NCT00414609|9297425|P3|Extension Study|Adverse Event|14
2697820|NCT00414609|9297426|P2|Extension Study|Adverse Event|0
2697821|NCT00414609|9297427|P1|Extension Study|Adverse Event|0
2697822|NCT00414609|9297425|P3|Core Study|Death|0
2697823|NCT00414609|9297426|P2|Core Study|Death|14
2697824|NCT00414609|9297427|P1|Core Study|Death|7
2697825|NCT00414609|9297425|P3|Core Study|Administrative problems|0
2697826|NCT00414609|9297426|P2|Core Study|Administrative problems|2
2697827|NCT00414609|9297427|P1|Core Study|Administrative problems|0
2697828|NCT00414609|9297425|P3|Core Study|Lost to Follow-up|0
2697829|NCT00414609|9297426|P2|Core Study|Lost to Follow-up|4
2697830|NCT00414609|9297427|P1|Core Study|Lost to Follow-up|7
2697831|NCT00414609|9297425|P3|Core Study|Patient withdrew consent|0
2697832|NCT00414609|9297426|P2|Core Study|Patient withdrew consent|11
2697833|NCT00414609|9297427|P1|Core Study|Patient withdrew consent|10
2697834|NCT00414609|9297425|P3|Core Study|Protocol deviation|0
2697835|NCT00414609|9297426|P2|Core Study|Protocol deviation|1
2697836|NCT00414609|9297427|P1|Core Study|Protocol deviation|0
2697837|NCT00414609|9297425|P3|Core Study|Abnormal test procedure results|0
2697838|NCT00414609|9297426|P2|Core Study|Abnormal test procedure results|1
2697839|NCT00414609|9297427|P1|Core Study|Abnormal test procedure results|1
2697840|NCT00414609|9297425|P3|Core Study|Abnormal laboratory values|0
2697841|NCT00414609|9297426|P2|Core Study|Abnormal laboratory values|1
2697842|NCT00414609|9297427|P1|Core Study|Abnormal laboratory values|0
2697843|NCT00414609|9297425|P3|Core Study|Adverse Event|0
2697844|NCT00414609|9297426|P2|Core Study|Adverse Event|11
2697845|NCT00414609|9297427|P1|Core Study|Adverse Event|9
2697846|NCT00414596|9297450|P1|Overall Study|Protocol Violation|2
2697847|NCT00414544|9297459|P1|Overall Study|Lost to Follow-up|14
2697848|NCT00414466|9297482|P4|Overall Study|Withdrawn by Sponsor|0
2697849|NCT00414466|9297483|P3|Overall Study|Withdrawn by Sponsor|0
2697850|NCT00414466|9297484|P2|Overall Study|Withdrawn by Sponsor|0
2697851|NCT00414466|9297485|P1|Overall Study|Withdrawn by Sponsor|1
2697852|NCT00414466|9297482|P4|Overall Study|Lack of Efficacy|0
2697853|NCT00414466|9297483|P3|Overall Study|Lack of Efficacy|0
2697854|NCT00414466|9297484|P2|Overall Study|Lack of Efficacy|0
2697855|NCT00414466|9297485|P1|Overall Study|Lack of Efficacy|1
2697856|NCT00414466|9297482|P4|Overall Study|Adverse Event|1
2697857|NCT00414466|9297483|P3|Overall Study|Adverse Event|1
2697858|NCT00414466|9297484|P2|Overall Study|Adverse Event|0
2697859|NCT00414466|9297485|P1|Overall Study|Adverse Event|0
2697860|NCT00414453|9297503|P1|Overall Study|Abnormal lab work|16
2697861|NCT00414440|9297551|P2|Extension Period|Not included in follow up period|8
2697862|NCT00414440|9297552|P1|Extension Period|Not included in follow up period|18
2697863|NCT00414440|9297551|P2|Extension Period|Withdrawal by Subject|7
2697864|NCT00414440|9297552|P1|Extension Period|Withdrawal by Subject|9
2697865|NCT00414440|9297551|P2|Extension Period|Death|2
2697866|NCT00414440|9297552|P1|Extension Period|Death|1
2697867|NCT00414440|9297551|P2|Extension Period|Administrative|16
2697868|NCT00414440|9297552|P1|Extension Period|Administrative|16
2697869|NCT00414440|9297551|P2|Extension Period|Other|1
2697870|NCT00414440|9297552|P1|Extension Period|Other|1
2697871|NCT00414440|9297551|P2|Extension Period|Did not consent to continue follow up|54
2697872|NCT00414440|9297552|P1|Extension Period|Did not consent to continue follow up|61
2697873|NCT00414440|9297551|P2|Extension Period|Lost to Follow-up|52
2697874|NCT00414440|9297552|P1|Extension Period|Lost to Follow-up|44
2697875|NCT00414440|9297551|P2|Core Period|Withdrawal by Subject|32
2697876|NCT00414440|9297552|P1|Core Period|Withdrawal by Subject|70
2697877|NCT00414388|9297566|P1|Overall Study|Adverse Event|1
2697878|NCT00414310|9297574|P2|Overall Study|Not treated|0
2697879|NCT00414310|9297575|P1|Overall Study|Not treated|1
2697880|NCT00414076|9297619|P2|Overall Study|Adverse Event|0
2697881|NCT00414076|9297620|P1|Overall Study|Adverse Event|1
2697882|NCT00414076|9297619|P2|Overall Study|Withdrawal by Subject|3
2697883|NCT00414076|9297620|P1|Overall Study|Withdrawal by Subject|1
2697884|NCT00414076|9297619|P2|Overall Study|Progression|2
2697885|NCT00414076|9297620|P1|Overall Study|Progression|1
2697886|NCT00414050|9297630|P4|Overall Study|Subject Moved|1
2697887|NCT00414050|9297631|P3|Overall Study|Subject Moved|0
2697888|NCT00414050|9297632|P2|Overall Study|Subject Moved|0
2697889|NCT00414050|9297633|P1|Overall Study|Subject Moved|0
2697890|NCT00414050|9297630|P4|Overall Study|Subject discontinued for other reason|1
2697891|NCT00414050|9297631|P3|Overall Study|Subject discontinued for other reason|2
2697892|NCT00414050|9297632|P2|Overall Study|Subject discontinued for other reason|2
2697893|NCT00414050|9297633|P1|Overall Study|Subject discontinued for other reason|1
2697894|NCT00414050|9297630|P4|Overall Study|Withdrawal by Subject|4
2697895|NCT00414050|9297631|P3|Overall Study|Withdrawal by Subject|2
2697896|NCT00414050|9297632|P2|Overall Study|Withdrawal by Subject|3
2697897|NCT00414050|9297633|P1|Overall Study|Withdrawal by Subject|5
2697898|NCT00414050|9297630|P4|Overall Study|Lost to Follow-up|1
2697899|NCT00414050|9297631|P3|Overall Study|Lost to Follow-up|1
2697900|NCT00414050|9297632|P2|Overall Study|Lost to Follow-up|2
2697901|NCT00414050|9297633|P1|Overall Study|Lost to Follow-up|2
2697902|NCT00414050|9297630|P4|Overall Study|Adverse Event|1
2697903|NCT00414050|9297631|P3|Overall Study|Adverse Event|1
2697904|NCT00414050|9297632|P2|Overall Study|Adverse Event|1
2697905|NCT00414050|9297633|P1|Overall Study|Adverse Event|1
2697906|NCT00414011|9297647|P1|Overall Study|Withdrawal by Subject|2
2697907|NCT00414011|9297647|P1|Overall Study|Physician Decision|3
2697908|NCT00413972|9297656|P4|Overall Study|Other|1
2697909|NCT00413972|9297657|P3|Overall Study|Other|0
2697910|NCT00413972|9297658|P2|Overall Study|Other|0
2697911|NCT00413972|9297659|P1|Overall Study|Other|0
2697912|NCT00413972|9297656|P4|Overall Study|Protocol Violation|0
2697913|NCT00413972|9297657|P3|Overall Study|Protocol Violation|2
2697914|NCT00413972|9297658|P2|Overall Study|Protocol Violation|0
2697915|NCT00413972|9297659|P1|Overall Study|Protocol Violation|0
2697916|NCT00413972|9297656|P4|Overall Study|Withdrawal by Subject|2
2697917|NCT00413972|9297657|P3|Overall Study|Withdrawal by Subject|7
2697918|NCT00413972|9297658|P2|Overall Study|Withdrawal by Subject|5
2697919|NCT00413972|9297659|P1|Overall Study|Withdrawal by Subject|4
2697920|NCT00413972|9297656|P4|Overall Study|Lost to Follow-up|0
2697921|NCT00413972|9297657|P3|Overall Study|Lost to Follow-up|1
2697922|NCT00413972|9297658|P2|Overall Study|Lost to Follow-up|2
2697923|NCT00413972|9297659|P1|Overall Study|Lost to Follow-up|1
2697924|NCT00413972|9297656|P4|Overall Study|Adverse Event|0
2697925|NCT00413972|9297657|P3|Overall Study|Adverse Event|0
2697926|NCT00413972|9297658|P2|Overall Study|Adverse Event|1
2697927|NCT00413972|9297659|P1|Overall Study|Adverse Event|2
2697928|NCT00413959|9297669|P1|Overall Study|Pt had only one cycle.|1
2697929|NCT00413920|9297676|P2|Overall Study|Graft Loss|3
2697930|NCT00413920|9297677|P1|Overall Study|Graft Loss|5
2697931|NCT00413920|9297676|P2|Overall Study|Death|5
2697932|NCT00413920|9297677|P1|Overall Study|Death|3
2697933|NCT00413920|9297676|P2|Overall Study|Lack of Efficacy|9
2697934|NCT00413920|9297677|P1|Overall Study|Lack of Efficacy|11
2697935|NCT00413920|9297676|P2|Overall Study|Adverse Event|11
2697936|NCT00413920|9297677|P1|Overall Study|Adverse Event|9
2697937|NCT00413894|9297692|P1|Overall Study|Other|18
2697938|NCT00413894|9297692|P1|Overall Study|Protocol Violation|11
2697939|NCT00413894|9297692|P1|Overall Study|Adverse Event|28
2697940|NCT00413894|9297692|P1|Overall Study|Hb <10 grams/deciliter|12
2697941|NCT00413894|9297692|P1|Overall Study|Administrative Reasons|1
2697942|NCT00413894|9297692|P1|Overall Study|Withdrawal by Subject|10
2697943|NCT00413777|9297709|P2|Fixed-dose Period|Withdrew Consent|1
2697944|NCT00413777|9297710|P1|Fixed-dose Period|Withdrew Consent|0
2697945|NCT00413777|9297709|P2|Fixed-dose Period|Met Withdrawal Criteria|0
2697946|NCT00413777|9297710|P1|Fixed-dose Period|Met Withdrawal Criteria|1
2697947|NCT00413777|9297709|P2|Fixed-dose Period|Adverse Event|1
2697948|NCT00413777|9297710|P1|Fixed-dose Period|Adverse Event|2
2697949|NCT00413777|9297709|P2|Fixed-dose Period|Lost to Follow-up|1
2697950|NCT00413777|9297710|P1|Fixed-dose Period|Lost to Follow-up|1
2697951|NCT00413699|9297758|P3|Extension Period|Adverse Event|2
2697952|NCT00413699|9297759|P2|Extension Period|Adverse Event|0
2697953|NCT00413699|9297760|P1|Extension Period|Adverse Event|0
2697954|NCT00413699|9297758|P3|Extension Period|Protocol Violation|1
2697955|NCT00413699|9297759|P2|Extension Period|Protocol Violation|0
2697956|NCT00413699|9297760|P1|Extension Period|Protocol Violation|0
2697957|NCT00413699|9297758|P3|Extension Period|No Longer Willing to Participate|2
2697958|NCT00413699|9297759|P2|Extension Period|No Longer Willing to Participate|0
2697959|NCT00413699|9297760|P1|Extension Period|No Longer Willing to Participate|0
2697960|NCT00413699|9297758|P3|Initial Period|No longer willing to participate|0
2697961|NCT00413699|9297759|P2|Initial Period|No longer willing to participate|368
2697962|NCT00413699|9297760|P1|Initial Period|No longer willing to participate|116
2697963|NCT00413699|9297758|P3|Initial Period|Missing end of study page|0
2697964|NCT00413699|9297759|P2|Initial Period|Missing end of study page|4
2697965|NCT00413699|9297760|P1|Initial Period|Missing end of study page|0
2697966|NCT00413699|9297758|P3|Initial Period|Adverse event not related to study drug|0
2697967|NCT00413699|9297759|P2|Initial Period|Adverse event not related to study drug|248
2697968|NCT00413699|9297760|P1|Initial Period|Adverse event not related to study drug|113
2697969|NCT00413699|9297758|P3|Initial Period|Adverse event related to study drug|0
2697970|NCT00413699|9297759|P2|Initial Period|Adverse event related to study drug|527
2697971|NCT00413699|9297760|P1|Initial Period|Adverse event related to study drug|178
2697972|NCT00413699|9297758|P3|Initial Period|Other|0
2697973|NCT00413699|9297759|P2|Initial Period|Other|211
2697974|NCT00413699|9297760|P1|Initial Period|Other|67
2697975|NCT00413699|9297758|P3|Initial Period|Study terminated by Sponsor|0
2697976|NCT00413699|9297759|P2|Initial Period|Study terminated by Sponsor|1
2697977|NCT00413699|9297760|P1|Initial Period|Study terminated by Sponsor|0
2697978|NCT00413699|9297758|P3|Initial Period|Medication error without adverse event|0
2697979|NCT00413699|9297759|P2|Initial Period|Medication error without adverse event|1
2697980|NCT00413699|9297760|P1|Initial Period|Medication error without adverse event|0
2697981|NCT00413699|9297758|P3|Initial Period|Did not meet entrance criteria|0
2697982|NCT00413699|9297759|P2|Initial Period|Did not meet entrance criteria|2
2697983|NCT00413699|9297760|P1|Initial Period|Did not meet entrance criteria|2
2697984|NCT00413699|9297758|P3|Initial Period|Pregnancy|0
2697985|NCT00413699|9297759|P2|Initial Period|Pregnancy|8
2697986|NCT00413699|9297760|P1|Initial Period|Pregnancy|10
2697987|NCT00413699|9297758|P3|Initial Period|Protocol Violation|0
2697988|NCT00413699|9297759|P2|Initial Period|Protocol Violation|89
2697989|NCT00413699|9297760|P1|Initial Period|Protocol Violation|38
2697990|NCT00413699|9297758|P3|Initial Period|Lost to Follow-up|0
2697991|NCT00413699|9297759|P2|Initial Period|Lost to Follow-up|101
2697992|NCT00413699|9297760|P1|Initial Period|Lost to Follow-up|31
2697993|NCT00413699|9297758|P3|Initial Period|Lack of Efficacy|0
2697994|NCT00413699|9297759|P2|Initial Period|Lack of Efficacy|115
2697995|NCT00413699|9297760|P1|Initial Period|Lack of Efficacy|59
2697996|NCT00413699|9297758|P3|Initial Period|Death|0
2697997|NCT00413699|9297759|P2|Initial Period|Death|30
2697998|NCT00413699|9297760|P1|Initial Period|Death|25
2697999|NCT00413660|9297842|P11|Post Week 12|Other|0
2698000|NCT00413660|9297843|P10|Post Week 12|Other|0
2698001|NCT00413660|9297844|P9|Post Week 12|Other|0
2698002|NCT00413660|9297845|P8|Post Week 12|Other|0
2698003|NCT00413660|9297846|P7|Post Week 12|Other|1
2698004|NCT00413660|9297847|P6|Post Week 12|Other|1
2698005|NCT00413660|9297848|P5|Post Week 12|Other|1
2698006|NCT00413660|9297849|P4|Post Week 12|Other|0
2698007|NCT00413660|9297850|P3|Post Week 12|Other|3
2698008|NCT00413660|9297851|P2|Post Week 12|Other|2
2698009|NCT00413660|9297852|P1|Post Week 12|Other|1
2698010|NCT00413660|9297842|P11|Post Week 12|Withdrawal by Subject|1
2698011|NCT00413660|9297843|P10|Post Week 12|Withdrawal by Subject|0
2698012|NCT00413660|9297844|P9|Post Week 12|Withdrawal by Subject|0
2698013|NCT00413660|9297845|P8|Post Week 12|Withdrawal by Subject|0
2698014|NCT00413660|9297846|P7|Post Week 12|Withdrawal by Subject|0
2698015|NCT00413660|9297847|P6|Post Week 12|Withdrawal by Subject|0
2698016|NCT00413660|9297848|P5|Post Week 12|Withdrawal by Subject|1
2698017|NCT00413660|9297849|P4|Post Week 12|Withdrawal by Subject|0
2698018|NCT00413660|9297850|P3|Post Week 12|Withdrawal by Subject|1
2698019|NCT00413660|9297851|P2|Post Week 12|Withdrawal by Subject|1
2698020|NCT00413660|9297852|P1|Post Week 12|Withdrawal by Subject|0
2698021|NCT00413660|9297842|P11|Post Week 12|Lost to Follow-up|0
2698022|NCT00413660|9297843|P10|Post Week 12|Lost to Follow-up|0
2698023|NCT00413660|9297844|P9|Post Week 12|Lost to Follow-up|0
2698024|NCT00413660|9297845|P8|Post Week 12|Lost to Follow-up|0
2698025|NCT00413660|9297846|P7|Post Week 12|Lost to Follow-up|0
2698026|NCT00413660|9297847|P6|Post Week 12|Lost to Follow-up|0
2698027|NCT00413660|9297848|P5|Post Week 12|Lost to Follow-up|0
2698028|NCT00413660|9297849|P4|Post Week 12|Lost to Follow-up|0
2698029|NCT00413660|9297850|P3|Post Week 12|Lost to Follow-up|1
2698030|NCT00413660|9297851|P2|Post Week 12|Lost to Follow-up|1
2698031|NCT00413660|9297852|P1|Post Week 12|Lost to Follow-up|0
2698032|NCT00413660|9297842|P11|Post Week 12|Lack of Efficacy|0
2698033|NCT00413660|9297843|P10|Post Week 12|Lack of Efficacy|1
2698034|NCT00413660|9297844|P9|Post Week 12|Lack of Efficacy|0
2698035|NCT00413660|9297845|P8|Post Week 12|Lack of Efficacy|0
2698036|NCT00413660|9297846|P7|Post Week 12|Lack of Efficacy|0
2698037|NCT00413660|9297847|P6|Post Week 12|Lack of Efficacy|0
2698038|NCT00413660|9297848|P5|Post Week 12|Lack of Efficacy|0
2698039|NCT00413660|9297849|P4|Post Week 12|Lack of Efficacy|0
2698040|NCT00413660|9297850|P3|Post Week 12|Lack of Efficacy|1
2698041|NCT00413660|9297851|P2|Post Week 12|Lack of Efficacy|0
2698042|NCT00413660|9297852|P1|Post Week 12|Lack of Efficacy|0
2698043|NCT00413660|9297842|P11|Post Week 12|Adverse Event|0
2698044|NCT00413660|9297843|P10|Post Week 12|Adverse Event|0
2698045|NCT00413660|9297844|P9|Post Week 12|Adverse Event|0
2698046|NCT00413660|9297845|P8|Post Week 12|Adverse Event|0
2698047|NCT00413660|9297846|P7|Post Week 12|Adverse Event|2
2698048|NCT00413660|9297847|P6|Post Week 12|Adverse Event|2
2698049|NCT00413660|9297848|P5|Post Week 12|Adverse Event|4
2698050|NCT00413660|9297849|P4|Post Week 12|Adverse Event|1
2698051|NCT00413660|9297850|P3|Post Week 12|Adverse Event|2
2698052|NCT00413660|9297851|P2|Post Week 12|Adverse Event|0
2698053|NCT00413660|9297852|P1|Post Week 12|Adverse Event|2
2698054|NCT00413660|9297842|P11|Up To Week 12|Other|0
2698055|NCT00413660|9297843|P10|Up To Week 12|Other|0
2698056|NCT00413660|9297844|P9|Up To Week 12|Other|0
2698057|NCT00413660|9297845|P8|Up To Week 12|Other|0
2698058|NCT00413660|9297846|P7|Up To Week 12|Other|3
2698059|NCT00413660|9297847|P6|Up To Week 12|Other|4
2698060|NCT00413660|9297848|P5|Up To Week 12|Other|2
2698061|NCT00413660|9297849|P4|Up To Week 12|Other|1
2698062|NCT00413660|9297850|P3|Up To Week 12|Other|6
2698063|NCT00413660|9297851|P2|Up To Week 12|Other|1
2698064|NCT00413660|9297852|P1|Up To Week 12|Other|3
2698065|NCT00413660|9297842|P11|Up To Week 12|Randomized, Not Treated|0
2698066|NCT00413660|9297843|P10|Up To Week 12|Randomized, Not Treated|0
2698067|NCT00413660|9297844|P9|Up To Week 12|Randomized, Not Treated|0
2698068|NCT00413660|9297845|P8|Up To Week 12|Randomized, Not Treated|0
2698069|NCT00413660|9297846|P7|Up To Week 12|Randomized, Not Treated|0
2698070|NCT00413660|9297847|P6|Up To Week 12|Randomized, Not Treated|0
2698071|NCT00413660|9297848|P5|Up To Week 12|Randomized, Not Treated|0
2698072|NCT00413660|9297849|P4|Up To Week 12|Randomized, Not Treated|1
2698073|NCT00413660|9297850|P3|Up To Week 12|Randomized, Not Treated|0
2698074|NCT00413660|9297851|P2|Up To Week 12|Randomized, Not Treated|0
2698075|NCT00413660|9297852|P1|Up To Week 12|Randomized, Not Treated|1
2698076|NCT00413660|9297842|P11|Up To Week 12|Withdrawal by Subject|0
2698077|NCT00413660|9297843|P10|Up To Week 12|Withdrawal by Subject|0
2698078|NCT00413660|9297844|P9|Up To Week 12|Withdrawal by Subject|0
2698079|NCT00413660|9297845|P8|Up To Week 12|Withdrawal by Subject|0
2698080|NCT00413660|9297846|P7|Up To Week 12|Withdrawal by Subject|2
2698081|NCT00413660|9297847|P6|Up To Week 12|Withdrawal by Subject|2
2698082|NCT00413660|9297848|P5|Up To Week 12|Withdrawal by Subject|0
2698083|NCT00413660|9297849|P4|Up To Week 12|Withdrawal by Subject|2
2698084|NCT00413660|9297850|P3|Up To Week 12|Withdrawal by Subject|0
2698085|NCT00413660|9297851|P2|Up To Week 12|Withdrawal by Subject|2
2698086|NCT00413660|9297852|P1|Up To Week 12|Withdrawal by Subject|0
2698087|NCT00413660|9297842|P11|Up To Week 12|Lost to Follow-up|0
2698088|NCT00413660|9297843|P10|Up To Week 12|Lost to Follow-up|0
2698089|NCT00413660|9297844|P9|Up To Week 12|Lost to Follow-up|0
2698090|NCT00413660|9297845|P8|Up To Week 12|Lost to Follow-up|0
2698091|NCT00413660|9297846|P7|Up To Week 12|Lost to Follow-up|0
2698092|NCT00413660|9297847|P6|Up To Week 12|Lost to Follow-up|0
2698093|NCT00413660|9297848|P5|Up To Week 12|Lost to Follow-up|1
2698094|NCT00413660|9297849|P4|Up To Week 12|Lost to Follow-up|0
2698095|NCT00413660|9297850|P3|Up To Week 12|Lost to Follow-up|0
2698096|NCT00413660|9297851|P2|Up To Week 12|Lost to Follow-up|1
2698097|NCT00413660|9297852|P1|Up To Week 12|Lost to Follow-up|0
2698098|NCT00413660|9297842|P11|Up To Week 12|Lack of Efficacy|0
2698099|NCT00413660|9297843|P10|Up To Week 12|Lack of Efficacy|0
2698100|NCT00413660|9297844|P9|Up To Week 12|Lack of Efficacy|0
2698101|NCT00413660|9297845|P8|Up To Week 12|Lack of Efficacy|0
2698102|NCT00413660|9297846|P7|Up To Week 12|Lack of Efficacy|5
2698103|NCT00413660|9297847|P6|Up To Week 12|Lack of Efficacy|0
2698104|NCT00413660|9297848|P5|Up To Week 12|Lack of Efficacy|0
2698105|NCT00413660|9297849|P4|Up To Week 12|Lack of Efficacy|0
2698106|NCT00413660|9297850|P3|Up To Week 12|Lack of Efficacy|0
2698107|NCT00413660|9297851|P2|Up To Week 12|Lack of Efficacy|0
2698108|NCT00413660|9297852|P1|Up To Week 12|Lack of Efficacy|2
2698109|NCT00413660|9297842|P11|Up To Week 12|Adverse Event|0
2698110|NCT00413660|9297843|P10|Up To Week 12|Adverse Event|0
2698111|NCT00413660|9297844|P9|Up To Week 12|Adverse Event|0
2698112|NCT00413660|9297845|P8|Up To Week 12|Adverse Event|0
2698113|NCT00413660|9297846|P7|Up To Week 12|Adverse Event|1
2698114|NCT00413660|9297847|P6|Up To Week 12|Adverse Event|4
2698115|NCT00413660|9297848|P5|Up To Week 12|Adverse Event|6
2698116|NCT00413660|9297849|P4|Up To Week 12|Adverse Event|4
2698117|NCT00413660|9297850|P3|Up To Week 12|Adverse Event|1
2698118|NCT00413660|9297851|P2|Up To Week 12|Adverse Event|3
2698119|NCT00413660|9297852|P1|Up To Week 12|Adverse Event|1
2698120|NCT00413413|9298255|P3|Double-Blind|Lost to Follow-up|2
2698121|NCT00413413|9298256|P2|Double-Blind|Lost to Follow-up|4
2698122|NCT00413413|9298257|P1|Double-Blind|Lost to Follow-up|3
2698123|NCT00413413|9298255|P3|Double-Blind|Subject withdrew consent|9
2698124|NCT00413413|9298256|P2|Double-Blind|Subject withdrew consent|6
2698125|NCT00413413|9298257|P1|Double-Blind|Subject withdrew consent|4
2698126|NCT00413413|9298255|P3|Double-Blind|Protocol deviation|1
2698127|NCT00413413|9298256|P2|Double-Blind|Protocol deviation|2
2698128|NCT00413413|9298257|P1|Double-Blind|Protocol deviation|1
2698129|NCT00413413|9298255|P3|Double-Blind|Unsatisfactory therapeutic effect|1
2698130|NCT00413413|9298256|P2|Double-Blind|Unsatisfactory therapeutic effect|2
2698131|NCT00413413|9298257|P1|Double-Blind|Unsatisfactory therapeutic effect|1
2698132|NCT00413413|9298255|P3|Double-Blind|Adverse Event|5
2698133|NCT00413413|9298256|P2|Double-Blind|Adverse Event|0
2698134|NCT00413413|9298257|P1|Double-Blind|Adverse Event|6
2698135|NCT00413413|9298255|P3|Single-Blind|Lost to Follow-up|0
2698136|NCT00413413|9298256|P2|Single-Blind|Lost to Follow-up|8
2698137|NCT00413413|9298257|P1|Single-Blind|Lost to Follow-up|0
2698138|NCT00413413|9298255|P3|Single-Blind|Withdrawal by Subject|0
2698139|NCT00413413|9298256|P2|Single-Blind|Withdrawal by Subject|27
2698140|NCT00413413|9298257|P1|Single-Blind|Withdrawal by Subject|0
2698141|NCT00413413|9298255|P3|Single-Blind|Protocol Violation|0
2698142|NCT00413413|9298256|P2|Single-Blind|Protocol Violation|16
2698143|NCT00413413|9298257|P1|Single-Blind|Protocol Violation|0
2698144|NCT00413413|9298255|P3|Single-Blind|Subject no longer requires study drug|0
2698145|NCT00413413|9298256|P2|Single-Blind|Subject no longer requires study drug|151
2698146|NCT00413413|9298257|P1|Single-Blind|Subject no longer requires study drug|0
2698147|NCT00413413|9298255|P3|Single-Blind|Lack of Efficacy|0
2698148|NCT00413413|9298256|P2|Single-Blind|Lack of Efficacy|5
2698149|NCT00413413|9298257|P1|Single-Blind|Lack of Efficacy|0
2698150|NCT00413413|9298255|P3|Single-Blind|Adverse Event|0
2698151|NCT00413413|9298256|P2|Single-Blind|Adverse Event|9
2698152|NCT00413413|9298257|P1|Single-Blind|Adverse Event|0
2698153|NCT00413374|9298310|P2|Overall Study|Surgery|0
2698154|NCT00413374|9298311|P1|Overall Study|Surgery|1
2698155|NCT00413374|9298310|P2|Overall Study|Lost to Follow-up|0
2698156|NCT00413374|9298311|P1|Overall Study|Lost to Follow-up|1
2698157|NCT00413374|9298310|P2|Overall Study|Adverse Event|0
2698158|NCT00413374|9298311|P1|Overall Study|Adverse Event|1
2698159|NCT00413374|9298310|P2|Overall Study|Ineligible due to screening criteria.|0
2698160|NCT00413374|9298311|P1|Overall Study|Ineligible due to screening criteria.|3
2698161|NCT00413283|9298342|P4|Overall Study|Other|0
2698162|NCT00413283|9298343|P3|Overall Study|Other|1
2698163|NCT00413283|9298344|P2|Overall Study|Other|0
2698164|NCT00413283|9298345|P1|Overall Study|Other|0
2698165|NCT00413283|9298342|P4|Overall Study|Requirement for alternative therapy|0
2698166|NCT00413283|9298343|P3|Overall Study|Requirement for alternative therapy|0
2698167|NCT00413283|9298344|P2|Overall Study|Requirement for alternative therapy|2
2698168|NCT00413283|9298345|P1|Overall Study|Requirement for alternative therapy|0
2698169|NCT00413283|9298342|P4|Overall Study|Protocol deviation|0
2698170|NCT00413283|9298343|P3|Overall Study|Protocol deviation|0
2698171|NCT00413283|9298344|P2|Overall Study|Protocol deviation|1
2698172|NCT00413283|9298345|P1|Overall Study|Protocol deviation|0
2698173|NCT00413283|9298342|P4|Overall Study|Ineligibility determined|1
2698174|NCT00413283|9298343|P3|Overall Study|Ineligibility determined|0
2698175|NCT00413283|9298344|P2|Overall Study|Ineligibility determined|0
2698176|NCT00413283|9298345|P1|Overall Study|Ineligibility determined|0
2698177|NCT00413283|9298342|P4|Overall Study|Adverse Event|1
2698178|NCT00413283|9298343|P3|Overall Study|Adverse Event|0
2698179|NCT00413283|9298344|P2|Overall Study|Adverse Event|0
2698180|NCT00413283|9298345|P1|Overall Study|Adverse Event|0
2698181|NCT00413283|9298342|P4|Overall Study|Death|1
2698182|NCT00413283|9298343|P3|Overall Study|Death|1
2698183|NCT00413283|9298344|P2|Overall Study|Death|0
2698184|NCT00413283|9298345|P1|Overall Study|Death|0
2698185|NCT00413283|9298342|P4|Overall Study|Withdrawal by Subject|1
2698186|NCT00413283|9298343|P3|Overall Study|Withdrawal by Subject|0
2698187|NCT00413283|9298344|P2|Overall Study|Withdrawal by Subject|0
2698188|NCT00413283|9298345|P1|Overall Study|Withdrawal by Subject|1
2698189|NCT00413244|9298377|P2|Overall Study|Withdrawal by Subject|1
2698190|NCT00413244|9298378|P1|Overall Study|Withdrawal by Subject|10
2698191|NCT00413231|9298406|P1|365-day to 60-month Post Treatment|Exited after surgical conversion|1
2698192|NCT00413231|9298406|P1|365-day to 60-month Post Treatment|Lost to Follow-up|4
2698193|NCT00413231|9298406|P1|365-day to 60-month Post Treatment|Withdrawal by Subject|5
2698194|NCT00413231|9298406|P1|365-day to 60-month Post Treatment|Death|36
2698195|NCT00413231|9298406|P1|30-day to 365-day Post Treatment|Death|13
2698196|NCT00413231|9298406|P1|0 to 30-day Post Treatment|Intend to treat, but not implanted|3
2698197|NCT00413231|9298406|P1|0 to 30-day Post Treatment|Death|5
2698198|NCT00413218|9298438|P2|Overall Study|Withdrawal by Subject|1
2698199|NCT00413218|9298439|P1|Overall Study|Withdrawal by Subject|9
2698200|NCT00413218|9298438|P2|Overall Study|Missing|0
2698201|NCT00413218|9298439|P1|Overall Study|Missing|1
2698202|NCT00413218|9298438|P2|Overall Study|Admin|14
2698203|NCT00413218|9298439|P1|Overall Study|Admin|20
2698204|NCT00413218|9298438|P2|Overall Study|Lost to Follow-up|17
2698205|NCT00413218|9298439|P1|Overall Study|Lost to Follow-up|14
2698206|NCT00413218|9298438|P2|Overall Study|Death|56
2698207|NCT00413218|9298439|P1|Overall Study|Death|57
2698208|NCT00413218|9298438|P2|Overall Study|Randomized but didn't receive study drug|8
2698209|NCT00413218|9298439|P1|Overall Study|Randomized but didn't receive study drug|2
2698210|NCT00413192|9298465|P4|Overall Study|Not treated|1
2698211|NCT00413192|9298466|P3|Overall Study|Not treated|0
2698212|NCT00413192|9298467|P2|Overall Study|Not treated|0
2698213|NCT00413192|9298468|P1|Overall Study|Not treated|0
2698214|NCT00413192|9298465|P4|Overall Study|Other|2
2698215|NCT00413192|9298466|P3|Overall Study|Other|1
2698216|NCT00413192|9298467|P2|Overall Study|Other|1
2698217|NCT00413192|9298468|P1|Overall Study|Other|5
2698218|NCT00413192|9298465|P4|Overall Study|Intercurrent death|0
2698219|NCT00413192|9298466|P3|Overall Study|Intercurrent death|0
2698220|NCT00413192|9298467|P2|Overall Study|Intercurrent death|1
2698221|NCT00413192|9298468|P1|Overall Study|Intercurrent death|0
2698222|NCT00413192|9298465|P4|Overall Study|Intercurrent illness|1
2698223|NCT00413192|9298466|P3|Overall Study|Intercurrent illness|0
2698224|NCT00413192|9298467|P2|Overall Study|Intercurrent illness|0
2698225|NCT00413192|9298468|P1|Overall Study|Intercurrent illness|0
2698226|NCT00413192|9298465|P4|Overall Study|Withdrawal by Subject|1
2698227|NCT00413192|9298466|P3|Overall Study|Withdrawal by Subject|0
2698228|NCT00413192|9298467|P2|Overall Study|Withdrawal by Subject|5
2698229|NCT00413192|9298468|P1|Overall Study|Withdrawal by Subject|3
2698230|NCT00413192|9298465|P4|Overall Study|Toxicity|2
2698231|NCT00413192|9298466|P3|Overall Study|Toxicity|2
2698232|NCT00413192|9298467|P2|Overall Study|Toxicity|2
2698233|NCT00413192|9298468|P1|Overall Study|Toxicity|3
2698234|NCT00413192|9298465|P4|Overall Study|Disease progression|25
2698235|NCT00413192|9298466|P3|Overall Study|Disease progression|16
2698236|NCT00413192|9298467|P2|Overall Study|Disease progression|31
2698237|NCT00413192|9298468|P1|Overall Study|Disease progression|26
2698238|NCT00413153|9298521|P2|Overall Study|Adverse Event|0
2698239|NCT00413153|9298522|P1|Overall Study|Adverse Event|1
2698240|NCT00413153|9298521|P2|Overall Study|Withdrawal by Subject|1
2698241|NCT00413153|9298522|P1|Overall Study|Withdrawal by Subject|1
2698242|NCT00413062|9298546|P2|Overall Study|Other reason|34
2698243|NCT00413062|9298547|P1|Overall Study|Other reason|70
2698244|NCT00413062|9298546|P2|Overall Study|Lost to Follow-up|73
2698245|NCT00413062|9298547|P1|Overall Study|Lost to Follow-up|175
2698246|NCT00413062|9298546|P2|Overall Study|Pregnancy wish|6
2698247|NCT00413062|9298547|P1|Overall Study|Pregnancy wish|17
2698248|NCT00413062|9298546|P2|Overall Study|Pregnancy|5
2698249|NCT00413062|9298547|P1|Overall Study|Pregnancy|15
2698250|NCT00413062|9298546|P2|Overall Study|Withdrawal of informed consent|36
2698251|NCT00413062|9298547|P1|Overall Study|Withdrawal of informed consent|111
2698252|NCT00413062|9298546|P2|Overall Study|Pre-treatment (serious) adverse event|0
2698253|NCT00413062|9298547|P1|Overall Study|Pre-treatment (serious) adverse event|1
2698254|NCT00413062|9298546|P2|Overall Study|Adverse event/serious adverse event|56
2698255|NCT00413062|9298547|P1|Overall Study|Adverse event/serious adverse event|289
2698256|NCT00413049|9298573|P2|Overall Study|Lack of Efficacy|0
2698257|NCT00413049|9298574|P1|Overall Study|Lack of Efficacy|1
2698258|NCT00413049|9298573|P2|Overall Study|Abnormal laboratory value(s)|0
2698259|NCT00413049|9298574|P1|Overall Study|Abnormal laboratory value(s)|1
2698260|NCT00413049|9298573|P2|Overall Study|Subject no longer requires study drug|1
2698261|NCT00413049|9298574|P1|Overall Study|Subject no longer requires study drug|0
2698262|NCT00413049|9298573|P2|Overall Study|Protocol Violation|1
2698263|NCT00413049|9298574|P1|Overall Study|Protocol Violation|3
2698264|NCT00413049|9298573|P2|Overall Study|Lost to Follow-up|3
2698265|NCT00413049|9298574|P1|Overall Study|Lost to Follow-up|2
2698266|NCT00413049|9298573|P2|Overall Study|Withdrawal by Subject|5
2698267|NCT00413049|9298574|P1|Overall Study|Withdrawal by Subject|7
2698268|NCT00413049|9298573|P2|Overall Study|Adverse Event|8
2698269|NCT00413049|9298574|P1|Overall Study|Adverse Event|10
2698270|NCT00413036|9298590|P1|Overall Study|Missing|2
2698271|NCT00413036|9298590|P1|Overall Study|Other|26
2698272|NCT00413036|9298590|P1|Overall Study|Death|9
2698273|NCT00413036|9298590|P1|Overall Study|Withdrawal by Subject|7
2698274|NCT00413036|9298590|P1|Overall Study|Lack of Efficacy|129
2698275|NCT00413036|9298590|P1|Overall Study|Adverse Event|44
2698276|NCT00413010|9298600|P2|Overall Study|Due to termination of the study|52
2698277|NCT00413010|9298601|P1|Overall Study|Due to termination of the study|54
2698278|NCT00413010|9298600|P2|Overall Study|Withdrawal by Subject|2
2698279|NCT00413010|9298601|P1|Overall Study|Withdrawal by Subject|7
2698280|NCT00413010|9298600|P2|Overall Study|Lost to Follow-up|0
2698281|NCT00413010|9298601|P1|Overall Study|Lost to Follow-up|3
2698282|NCT00413010|9298600|P2|Overall Study|Lack of Efficacy|3
2698283|NCT00413010|9298601|P1|Overall Study|Lack of Efficacy|0
2698284|NCT00413010|9298600|P2|Overall Study|Laboratory abnormality|2
2698285|NCT00413010|9298601|P1|Overall Study|Laboratory abnormality|0
2698286|NCT00413010|9298600|P2|Overall Study|Adverse Event|4
2698287|NCT00413010|9298601|P1|Overall Study|Adverse Event|8
2698288|NCT00412984|9298623|P2|Overall Study|Not Reported|12
2698289|NCT00412984|9298624|P1|Overall Study|Not Reported|11
2698290|NCT00412984|9298623|P2|Overall Study|Other Reason|92
2698291|NCT00412984|9298624|P1|Overall Study|Other Reason|80
2698292|NCT00412984|9298623|P2|Overall Study|Physician Refused to Continue Treatment|89
2698293|NCT00412984|9298624|P1|Overall Study|Physician Refused to Continue Treatment|81
2698294|NCT00412984|9298623|P2|Overall Study|Administrative Reason by Sponsor|8
2698295|NCT00412984|9298624|P1|Overall Study|Administrative Reason by Sponsor|11
2698296|NCT00412984|9298623|P2|Overall Study|Subject No Longer Meets Study Criteria|100
2698297|NCT00412984|9298624|P1|Overall Study|Subject No Longer Meets Study Criteria|87
2698298|NCT00412984|9298623|P2|Overall Study|Pregnancy|0
2698299|NCT00412984|9298624|P1|Overall Study|Pregnancy|1
2698300|NCT00412984|9298623|P2|Overall Study|Poor/Noncompliance|77
2698301|NCT00412984|9298624|P1|Overall Study|Poor/Noncompliance|57
2698302|NCT00412984|9298623|P2|Overall Study|Lost to Follow-up|39
2698303|NCT00412984|9298624|P1|Overall Study|Lost to Follow-up|51
2698304|NCT00412984|9298623|P2|Overall Study|Withdrawal by Subject|989
2698305|NCT00412984|9298624|P1|Overall Study|Withdrawal by Subject|921
2698306|NCT00412984|9298623|P2|Overall Study|Adverse Event|738
2698307|NCT00412984|9298624|P1|Overall Study|Adverse Event|679
2698308|NCT00412984|9298623|P2|Overall Study|Death|349
2698309|NCT00412984|9298624|P1|Overall Study|Death|331
2698310|NCT00412971|9298668|P2|Overall Study|Protocol Violation|1
2698311|NCT00412971|9298669|P1|Overall Study|Protocol Violation|13
2698312|NCT00412971|9298668|P2|Overall Study|Lost to Follow-up|9
2698313|NCT00412971|9298669|P1|Overall Study|Lost to Follow-up|17
2698314|NCT00412958|9298682|P4|Overall Study|Transport issue|0
2698315|NCT00412958|9298683|P3|Overall Study|Transport issue|0
2698316|NCT00412958|9298684|P2|Overall Study|Transport issue|1
2698317|NCT00412958|9298685|P1|Overall Study|Transport issue|0
2698318|NCT00412958|9298682|P4|Overall Study|Death|0
2698319|NCT00412958|9298683|P3|Overall Study|Death|0
2698320|NCT00412958|9298684|P2|Overall Study|Death|1
2698321|NCT00412958|9298685|P1|Overall Study|Death|0
2698322|NCT00412958|9298682|P4|Overall Study|Lost to Follow-up|0
2698323|NCT00412958|9298683|P3|Overall Study|Lost to Follow-up|0
2698324|NCT00412958|9298684|P2|Overall Study|Lost to Follow-up|1
2698325|NCT00412958|9298685|P1|Overall Study|Lost to Follow-up|0
2698326|NCT00412958|9298682|P4|Overall Study|Adverse Event|0
2698327|NCT00412958|9298683|P3|Overall Study|Adverse Event|0
2698328|NCT00412958|9298684|P2|Overall Study|Adverse Event|1
2698329|NCT00412958|9298685|P1|Overall Study|Adverse Event|0
2698330|NCT00412958|9298682|P4|Overall Study|Withdrawal by Subject|1
2698331|NCT00412958|9298683|P3|Overall Study|Withdrawal by Subject|0
2698332|NCT00412958|9298684|P2|Overall Study|Withdrawal by Subject|0
2698333|NCT00412958|9298685|P1|Overall Study|Withdrawal by Subject|3
2698334|NCT00412932|9298695|P1|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1
2698335|NCT00412932|9298695|P1|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1
2698336|NCT00412932|9298695|P1|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3
2698337|NCT00412932|9298695|P1|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3
2698338|NCT00412932|9298695|P1|Olmesartan 40 mg|Withdrawal by Subject|1
2698339|NCT00412932|9298695|P1|Olmesartan 40 mg|Lack of Efficacy|3
2698340|NCT00412932|9298695|P1|Olmesartan 40 mg|Adverse Event|4
2698341|NCT00412932|9298695|P1|Olmesartan (Olm) 20 mg|Other|1
2698342|NCT00412932|9298695|P1|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2
2698343|NCT00412932|9298695|P1|Olmesartan (Olm) 20 mg|Protocol Violation|1
2698344|NCT00412932|9298695|P1|Olmesartan (Olm) 20 mg|Lack of Efficacy|2
2698345|NCT00412932|9298695|P1|Olmesartan (Olm) 20 mg|Adverse Event|1
2698346|NCT00412893|9298706|P2|Overall Study|Randomized but Never Received Study Drug|6
2698347|NCT00412893|9298707|P1|Overall Study|Randomized but Never Received Study Drug|5
2698348|NCT00412893|9298706|P2|Overall Study|Administrative Reason|15
2698349|NCT00412893|9298707|P1|Overall Study|Administrative Reason|12
2698350|NCT00412893|9298706|P2|Overall Study|Did Not Cooperate|9
2698351|NCT00412893|9298707|P1|Overall Study|Did Not Cooperate|12
2698352|NCT00412893|9298706|P2|Overall Study|Other Protocol Violation|6
2698353|NCT00412893|9298707|P1|Overall Study|Other Protocol Violation|10
2698354|NCT00412893|9298706|P2|Overall Study|Violation of Selection at Entry|10
2698355|NCT00412893|9298707|P1|Overall Study|Violation of Selection at Entry|17
2698356|NCT00412893|9298706|P2|Overall Study|Lost to Follow-up|1
2698357|NCT00412893|9298707|P1|Overall Study|Lost to Follow-up|2
2698358|NCT00412893|9298706|P2|Overall Study|Insufficient Therapeutic Response|23
2698359|NCT00412893|9298707|P1|Overall Study|Insufficient Therapeutic Response|39
2698360|NCT00412893|9298706|P2|Overall Study|Death|21
2698361|NCT00412893|9298707|P1|Overall Study|Death|17
2698362|NCT00412893|9298706|P2|Overall Study|Adverse Event|53
2698363|NCT00412893|9298707|P1|Overall Study|Adverse Event|31
2698364|NCT00412854|9298745|P2|Overall Study|Withdrawn for other reasons|11
2698365|NCT00412854|9298746|P1|Overall Study|Withdrawn for other reasons|13
2698366|NCT00412854|9298745|P2|Overall Study|Withdrawn due to adverse events|5
2698367|NCT00412854|9298746|P1|Overall Study|Withdrawn due to adverse events|1
2698368|NCT00412750|9298790|P3|Overall Study|Lack of Efficacy|3
2698369|NCT00412750|9298791|P2|Overall Study|Lack of Efficacy|0
2698370|NCT00412750|9298792|P1|Overall Study|Lack of Efficacy|0
2698371|NCT00412750|9298790|P3|Overall Study|Withdrawal by Subject|2
2698372|NCT00412750|9298791|P2|Overall Study|Withdrawal by Subject|1
2698373|NCT00412750|9298792|P1|Overall Study|Withdrawal by Subject|0
2698374|NCT00412750|9298790|P3|Overall Study|Lost to Follow-up|1
2698375|NCT00412750|9298791|P2|Overall Study|Lost to Follow-up|0
2698376|NCT00412750|9298792|P1|Overall Study|Lost to Follow-up|1
2698377|NCT00412750|9298790|P3|Overall Study|Adverse Event|3
2698378|NCT00412750|9298791|P2|Overall Study|Adverse Event|3
2698379|NCT00412750|9298792|P1|Overall Study|Adverse Event|8
2698380|NCT00412750|9298790|P3|Overall Study|Administrative problems|14
2698381|NCT00412750|9298791|P2|Overall Study|Administrative problems|17
2698382|NCT00412750|9298792|P1|Overall Study|Administrative problems|21
2698383|NCT00412750|9298790|P3|Overall Study|Abnormal laboratory value(s)|0
2698384|NCT00412750|9298791|P2|Overall Study|Abnormal laboratory value(s)|0
2698385|NCT00412750|9298792|P1|Overall Study|Abnormal laboratory value(s)|1
2698386|NCT00412737|9298817|P2|Overall Study|Failure to Return|2
2698387|NCT00412737|9298818|P1|Overall Study|Failure to Return|6
2698388|NCT00412737|9298817|P2|Overall Study|Refused Treatment|2
2698389|NCT00412737|9298818|P1|Overall Study|Refused Treatment|6
2698390|NCT00412737|9298817|P2|Overall Study|Adverse Event|2
2698391|NCT00412737|9298818|P1|Overall Study|Adverse Event|3
2698392|NCT00412737|9298817|P2|Overall Study|Death|0
2698393|NCT00412737|9298818|P1|Overall Study|Death|1
2698394|NCT00412607|9298836|P1|Overall Study|Not meet inclusion/exclusion Criteria|15
2698395|NCT00412607|9298836|P1|Overall Study|Death|61
2698396|NCT00412607|9298836|P1|Overall Study|Lost to Follow-up|19
2698397|NCT00412607|9298836|P1|Overall Study|Withdrawal by Subject|9
2698398|NCT00412542|9298849|P2|Overall Study|Not Eligible|1
2698399|NCT00412542|9298850|P1|Overall Study|Not Eligible|0
2698400|NCT00412542|9298849|P2|Overall Study|Withdrawal by Subject|2
2698401|NCT00412542|9298850|P1|Overall Study|Withdrawal by Subject|0
2698402|NCT00412373|9298935|P2|Overall Study|Other|2
2698403|NCT00412373|9298936|P1|Overall Study|Other|2
2698404|NCT00412373|9298935|P2|Overall Study|Withdrawal by Subject|27
2698405|NCT00412373|9298936|P1|Overall Study|Withdrawal by Subject|8
2698406|NCT00412373|9298935|P2|Overall Study|Lost to Follow-up|13
2698407|NCT00412373|9298936|P1|Overall Study|Lost to Follow-up|7
2698408|NCT00412373|9298935|P2|Overall Study|Lack of Efficacy|22
2698409|NCT00412373|9298936|P1|Overall Study|Lack of Efficacy|16
2698410|NCT00412373|9298935|P2|Overall Study|Adverse Event|13
2698411|NCT00412373|9298936|P1|Overall Study|Adverse Event|8
2698412|NCT00412360|9298978|P2|Overall Study|Not Transplanted|2
2698413|NCT00412360|9298979|P1|Overall Study|Not Transplanted|1
2698414|NCT00412360|9298978|P2|Overall Study|Lost to Follow-up|1
2698415|NCT00412360|9298979|P1|Overall Study|Lost to Follow-up|0
2698416|NCT00412217|9299009|P2|Overall Study|Other|1
2698417|NCT00412217|9299010|P1|Overall Study|Other|1
2698418|NCT00412217|9299009|P2|Overall Study|Study Terminated by Sponsor|33
2698419|NCT00412217|9299010|P1|Overall Study|Study Terminated by Sponsor|26
2698420|NCT00412217|9299009|P2|Overall Study|Lost to Follow-up|4
2698421|NCT00412217|9299010|P1|Overall Study|Lost to Follow-up|1
2698422|NCT00412217|9299009|P2|Overall Study|Withdrawal by Subject|0
2698423|NCT00412217|9299010|P1|Overall Study|Withdrawal by Subject|2
2698424|NCT00412217|9299009|P2|Overall Study|Investigator Decision|0
2698425|NCT00412217|9299010|P1|Overall Study|Investigator Decision|1
2698426|NCT00412217|9299009|P2|Overall Study|Disease Progression|3
2698427|NCT00412217|9299010|P1|Overall Study|Disease Progression|2
2698428|NCT00412217|9299009|P2|Overall Study|Death|4
2698429|NCT00412217|9299010|P1|Overall Study|Death|5
2698430|NCT00412217|9299009|P2|Overall Study|Insufficient Data Available|3
2698431|NCT00412217|9299010|P1|Overall Study|Insufficient Data Available|8
2698432|NCT00412113|9299024|P2|Overall Study|did not receive treatment|0
2698433|NCT00412113|9299025|P1|Overall Study|did not receive treatment|1
2698434|NCT00412113|9299024|P2|Overall Study|Adverse Event|15
2698435|NCT00412113|9299025|P1|Overall Study|Adverse Event|11
2698436|NCT00412061|9299109|P2|Open Label Phase|New Cancer Therapy|1
2698437|NCT00412061|9299110|P1|Open Label Phase|New Cancer Therapy|0
2698438|NCT00412061|9299109|P2|Open Label Phase|Lost to Follow-up|2
2698439|NCT00412061|9299110|P1|Open Label Phase|Lost to Follow-up|0
2698440|NCT00412061|9299109|P2|Open Label Phase|Death|7
2698441|NCT00412061|9299110|P1|Open Label Phase|Death|0
2698442|NCT00412061|9299109|P2|Open Label Phase|Administrative Problems|13
2698443|NCT00412061|9299110|P1|Open Label Phase|Administrative Problems|0
2698444|NCT00412061|9299109|P2|Open Label Phase|Withdrawal by Subject|15
2698445|NCT00412061|9299110|P1|Open Label Phase|Withdrawal by Subject|0
2698446|NCT00412061|9299109|P2|Open Label Phase|Adverse Event|46
2698447|NCT00412061|9299110|P1|Open Label Phase|Adverse Event|0
2698448|NCT00412061|9299109|P2|Open Label Phase|Disease Progression|86
2698449|NCT00412061|9299110|P1|Open Label Phase|Disease Progression|0
2698450|NCT00412061|9299109|P2|Double Blind Phase|Lost to Follow-up|1
2698451|NCT00412061|9299110|P1|Double Blind Phase|Lost to Follow-up|0
2698452|NCT00412061|9299109|P2|Double Blind Phase|New Cander Therapy|1
2698453|NCT00412061|9299110|P1|Double Blind Phase|New Cander Therapy|1
2698454|NCT00412061|9299109|P2|Double Blind Phase|Protocol Violation|4
2698455|NCT00412061|9299110|P1|Double Blind Phase|Protocol Violation|3
2698456|NCT00412061|9299109|P2|Double Blind Phase|Death|3
2698457|NCT00412061|9299110|P1|Double Blind Phase|Death|6
2698458|NCT00412061|9299109|P2|Double Blind Phase|Withdrawal by Subject|20
2698459|NCT00412061|9299110|P1|Double Blind Phase|Withdrawal by Subject|18
2698460|NCT00412061|9299109|P2|Double Blind Phase|Final Primary Analysis|14
2698461|NCT00412061|9299110|P1|Double Blind Phase|Final Primary Analysis|26
2698462|NCT00412061|9299109|P2|Double Blind Phase|Adverse Event|16
2698463|NCT00412061|9299110|P1|Double Blind Phase|Adverse Event|61
2698464|NCT00412061|9299109|P2|Double Blind Phase|Disease Progression|154
2698465|NCT00412061|9299110|P1|Double Blind Phase|Disease Progression|101
2698466|NCT00411788|9299128|P1|Overall Study|Adverse Event|1
2698467|NCT00411788|9299128|P1|Overall Study|Protocol Violation|1
2698468|NCT00411762|9299137|P1|Overall Study|Withdrawal by Subject|5
2698469|NCT00411671|9299161|P1|Overall Study|Lost to Follow-up|3
2698470|NCT00411671|9299161|P1|Overall Study|Death|2
2698471|NCT00411671|9299161|P1|Overall Study|Adverse Event|15
2698472|NCT00411645|9299169|P2|Overall Study|Lost to Follow-up|0
2698473|NCT00411645|9299170|P1|Overall Study|Lost to Follow-up|2
2698474|NCT00411645|9299169|P2|Overall Study|Investigator/Sponsor Decision|7
2698475|NCT00411645|9299170|P1|Overall Study|Investigator/Sponsor Decision|10
2698476|NCT00411645|9299169|P2|Overall Study|Death|135
2698477|NCT00411645|9299170|P1|Overall Study|Death|56
2698478|NCT00411645|9299169|P2|Overall Study|Consent Withdrawn|22
2698479|NCT00411645|9299170|P1|Overall Study|Consent Withdrawn|13
2698480|NCT00411632|9299194|P1|Overall Study|Death|1
2698481|NCT00411554|9299205|P2|Overall Study|Patient Moved|0
2698482|NCT00411554|9299206|P1|Overall Study|Patient Moved|1
2698483|NCT00411554|9299205|P2|Overall Study|Withdrawal by Subject|0
2698484|NCT00411554|9299206|P1|Overall Study|Withdrawal by Subject|3
2698485|NCT00411554|9299205|P2|Overall Study|Lack of Efficacy|5
2698486|NCT00411554|9299206|P1|Overall Study|Lack of Efficacy|2
2698487|NCT00411554|9299205|P2|Overall Study|Adverse Event|4
2698488|NCT00411554|9299206|P1|Overall Study|Adverse Event|2
2698489|NCT00411450|9299232|P1|Overall Study|Ongoing at time of data cut-off.|3
2698490|NCT00411216|9299275|P2|Overall Study|Ten participants were entered into the c|2
2698491|NCT00411216|9299276|P1|Overall Study|Ten participants were entered into the c|0
2698492|NCT00411151|9299282|P1|Overall Study|Trial prematurely closed|4
2698493|NCT00411151|9299282|P1|Overall Study|Protocol Violation|1
2698494|NCT00411151|9299282|P1|Overall Study|Lost to Follow-up|2
2698495|NCT00411151|9299282|P1|Overall Study|Withdrawal by Subject|2
2698496|NCT00411151|9299282|P1|Overall Study|Death|38
2698497|NCT00410813|9299326|P2|Overall Study|Death|2
2698498|NCT00410813|9299327|P1|Overall Study|Death|0
2698499|NCT00410813|9299326|P2|Overall Study|Ineligible|4
2698500|NCT00410813|9299327|P1|Overall Study|Ineligible|2
2698501|NCT00410813|9299326|P2|Overall Study|Not protocol specified|4
2698502|NCT00410813|9299327|P1|Overall Study|Not protocol specified|3
2698503|NCT00410813|9299326|P2|Overall Study|Progression|21
2698504|NCT00410813|9299327|P1|Overall Study|Progression|32
2698505|NCT00410813|9299326|P2|Overall Study|Adverse Event|11
2698506|NCT00410813|9299327|P1|Overall Study|Adverse Event|6
2698507|NCT00410761|9299364|P2|Overall Study|Never received randomised treatment|1
2698508|NCT00410761|9299365|P1|Overall Study|Never received randomised treatment|0
2698509|NCT00410761|9299364|P2|Overall Study|Other|9
2698510|NCT00410761|9299365|P1|Overall Study|Other|12
2698511|NCT00410761|9299364|P2|Overall Study|Withdrawal by Subject|4
2698512|NCT00410761|9299365|P1|Overall Study|Withdrawal by Subject|8
2698513|NCT00410761|9299364|P2|Overall Study|objective disease progression|55
2698514|NCT00410761|9299365|P1|Overall Study|objective disease progression|71
2698515|NCT00410761|9299364|P2|Overall Study|Adverse Event|3
2698516|NCT00410761|9299365|P1|Overall Study|Adverse Event|29
2698517|NCT00410605|9299385|P1|Overall Study|Transferred to another Institution|1
2698518|NCT00410605|9299385|P1|Overall Study|Stopped treatmen to collect stem cells|1
2698519|NCT00410605|9299385|P1|Overall Study|Started Non-Protocol Therapy|3
2698520|NCT00410605|9299385|P1|Overall Study|Withdrawal by Subject|5
2698521|NCT00410605|9299385|P1|Overall Study|Physician Decision|3
2698522|NCT00410605|9299385|P1|Overall Study|Adverse Event|12
2698523|NCT00410514|9299397|P3|Overall Study|Non-compliant with study procedures|2
2698524|NCT00410514|9299398|P2|Overall Study|Non-compliant with study procedures|0
2698525|NCT00410514|9299399|P1|Overall Study|Non-compliant with study procedures|0
2698526|NCT00410514|9299397|P3|Overall Study|Lost to Follow-up|2
2698527|NCT00410514|9299398|P2|Overall Study|Lost to Follow-up|0
2698528|NCT00410514|9299399|P1|Overall Study|Lost to Follow-up|0
2698529|NCT00410514|9299397|P3|Overall Study|Protocol Violation|1
2698530|NCT00410514|9299398|P2|Overall Study|Protocol Violation|1
2698531|NCT00410514|9299399|P1|Overall Study|Protocol Violation|0
2698532|NCT00410514|9299397|P3|Overall Study|Adverse Event|2
2698533|NCT00410514|9299398|P2|Overall Study|Adverse Event|2
2698534|NCT00410514|9299399|P1|Overall Study|Adverse Event|2
2698535|NCT00410410|9299482|P9|Open-Label Period (OL)|Other|7
2698536|NCT00410410|9299483|P8|Open-Label Period (OL)|Other|0
2698537|NCT00410410|9299484|P7|Open-Label Period (OL)|Other|0
2698538|NCT00410410|9299485|P6|Open-Label Period (OL)|Other|0
2698539|NCT00410410|9299486|P5|Open-Label Period (OL)|Other|0
2698540|NCT00410410|9299487|P4|Open-Label Period (OL)|Other|0
2698541|NCT00410410|9299488|P3|Open-Label Period (OL)|Other|0
2698542|NCT00410410|9299489|P2|Open-Label Period (OL)|Other|0
2698543|NCT00410410|9299490|P1|Open-Label Period (OL)|Other|0
2698544|NCT00410410|9299482|P9|Open-Label Period (OL)|Administrative Reason By Sponsor|145
2698545|NCT00410410|9299483|P8|Open-Label Period (OL)|Administrative Reason By Sponsor|0
2698546|NCT00410410|9299484|P7|Open-Label Period (OL)|Administrative Reason By Sponsor|0
2698547|NCT00410410|9299485|P6|Open-Label Period (OL)|Administrative Reason By Sponsor|0
2698548|NCT00410410|9299486|P5|Open-Label Period (OL)|Administrative Reason By Sponsor|0
2698549|NCT00410410|9299487|P4|Open-Label Period (OL)|Administrative Reason By Sponsor|0
2698550|NCT00410410|9299488|P3|Open-Label Period (OL)|Administrative Reason By Sponsor|0
2698551|NCT00410410|9299489|P2|Open-Label Period (OL)|Administrative Reason By Sponsor|0
2698552|NCT00410410|9299490|P1|Open-Label Period (OL)|Administrative Reason By Sponsor|0
2698553|NCT00410410|9299482|P9|Open-Label Period (OL)|Pregnancy|1
2698554|NCT00410410|9299483|P8|Open-Label Period (OL)|Pregnancy|0
2698555|NCT00410410|9299484|P7|Open-Label Period (OL)|Pregnancy|0
2698556|NCT00410410|9299485|P6|Open-Label Period (OL)|Pregnancy|0
2698557|NCT00410410|9299486|P5|Open-Label Period (OL)|Pregnancy|0
2698558|NCT00410410|9299487|P4|Open-Label Period (OL)|Pregnancy|0
2698559|NCT00410410|9299488|P3|Open-Label Period (OL)|Pregnancy|0
2698560|NCT00410410|9299489|P2|Open-Label Period (OL)|Pregnancy|0
2698561|NCT00410410|9299490|P1|Open-Label Period (OL)|Pregnancy|0
2698562|NCT00410410|9299482|P9|Open-Label Period (OL)|Withdrawal by Subject|20
2698563|NCT00410410|9299483|P8|Open-Label Period (OL)|Withdrawal by Subject|0
2698564|NCT00410410|9299484|P7|Open-Label Period (OL)|Withdrawal by Subject|0
2698565|NCT00410410|9299485|P6|Open-Label Period (OL)|Withdrawal by Subject|0
2698566|NCT00410410|9299486|P5|Open-Label Period (OL)|Withdrawal by Subject|0
2698567|NCT00410410|9299487|P4|Open-Label Period (OL)|Withdrawal by Subject|0
2698568|NCT00410410|9299488|P3|Open-Label Period (OL)|Withdrawal by Subject|0
2698569|NCT00410410|9299489|P2|Open-Label Period (OL)|Withdrawal by Subject|0
2698570|NCT00410410|9299490|P1|Open-Label Period (OL)|Withdrawal by Subject|0
2698571|NCT00410410|9299482|P9|Open-Label Period (OL)|Lost to Follow-up|4
2698572|NCT00410410|9299483|P8|Open-Label Period (OL)|Lost to Follow-up|0
2698573|NCT00410410|9299484|P7|Open-Label Period (OL)|Lost to Follow-up|0
2698574|NCT00410410|9299485|P6|Open-Label Period (OL)|Lost to Follow-up|0
2698575|NCT00410410|9299486|P5|Open-Label Period (OL)|Lost to Follow-up|0
2698576|NCT00410410|9299487|P4|Open-Label Period (OL)|Lost to Follow-up|0
2698577|NCT00410410|9299488|P3|Open-Label Period (OL)|Lost to Follow-up|0
2698578|NCT00410410|9299489|P2|Open-Label Period (OL)|Lost to Follow-up|0
2698579|NCT00410410|9299490|P1|Open-Label Period (OL)|Lost to Follow-up|0
2698580|NCT00410410|9299482|P9|Open-Label Period (OL)|Lack of Efficacy|161
2698581|NCT00410410|9299483|P8|Open-Label Period (OL)|Lack of Efficacy|0
2698582|NCT00410410|9299484|P7|Open-Label Period (OL)|Lack of Efficacy|0
2698583|NCT00410410|9299485|P6|Open-Label Period (OL)|Lack of Efficacy|0
2698584|NCT00410410|9299486|P5|Open-Label Period (OL)|Lack of Efficacy|0
2698585|NCT00410410|9299487|P4|Open-Label Period (OL)|Lack of Efficacy|0
2698586|NCT00410410|9299488|P3|Open-Label Period (OL)|Lack of Efficacy|0
2698587|NCT00410410|9299489|P2|Open-Label Period (OL)|Lack of Efficacy|0
2698588|NCT00410410|9299490|P1|Open-Label Period (OL)|Lack of Efficacy|0
2698589|NCT00410410|9299482|P9|Open-Label Period (OL)|Adverse Event|10
2698590|NCT00410410|9299483|P8|Open-Label Period (OL)|Adverse Event|0
2698591|NCT00410410|9299484|P7|Open-Label Period (OL)|Adverse Event|0
2698592|NCT00410410|9299485|P6|Open-Label Period (OL)|Adverse Event|0
2698593|NCT00410410|9299486|P5|Open-Label Period (OL)|Adverse Event|0
2698594|NCT00410410|9299487|P4|Open-Label Period (OL)|Adverse Event|0
2698595|NCT00410410|9299488|P3|Open-Label Period (OL)|Adverse Event|0
2698596|NCT00410410|9299489|P2|Open-Label Period (OL)|Adverse Event|0
2698597|NCT00410410|9299490|P1|Open-Label Period (OL)|Adverse Event|0
2698598|NCT00410410|9299482|P9|Open-Label Period (OL)|Death|1
2698599|NCT00410410|9299483|P8|Open-Label Period (OL)|Death|0
2698600|NCT00410410|9299484|P7|Open-Label Period (OL)|Death|0
2698601|NCT00410410|9299485|P6|Open-Label Period (OL)|Death|0
2698602|NCT00410410|9299486|P5|Open-Label Period (OL)|Death|0
2698603|NCT00410410|9299487|P4|Open-Label Period (OL)|Death|0
2698604|NCT00410410|9299488|P3|Open-Label Period (OL)|Death|0
2698605|NCT00410410|9299489|P2|Open-Label Period (OL)|Death|0
2698606|NCT00410410|9299490|P1|Open-Label Period (OL)|Death|0
2698607|NCT00410410|9299482|P9|Maintenance Period (MP)|Administrative Reason By Sponsor|0
2698608|NCT00410410|9299483|P8|Maintenance Period (MP)|Administrative Reason By Sponsor|25
2698609|NCT00410410|9299484|P7|Maintenance Period (MP)|Administrative Reason By Sponsor|21
2698610|NCT00410410|9299485|P6|Maintenance Period (MP)|Administrative Reason By Sponsor|0
2698611|NCT00410410|9299486|P5|Maintenance Period (MP)|Administrative Reason By Sponsor|0
2698612|NCT00410410|9299487|P4|Maintenance Period (MP)|Administrative Reason By Sponsor|0
2698613|NCT00410410|9299488|P3|Maintenance Period (MP)|Administrative Reason By Sponsor|0
2698614|NCT00410410|9299489|P2|Maintenance Period (MP)|Administrative Reason By Sponsor|0
2698615|NCT00410410|9299490|P1|Maintenance Period (MP)|Administrative Reason By Sponsor|0
2698616|NCT00410410|9299482|P9|Maintenance Period (MP)|Withdrawal by Subject|0
2698617|NCT00410410|9299483|P8|Maintenance Period (MP)|Withdrawal by Subject|1
2698618|NCT00410410|9299484|P7|Maintenance Period (MP)|Withdrawal by Subject|1
2698619|NCT00410410|9299485|P6|Maintenance Period (MP)|Withdrawal by Subject|0
2698620|NCT00410410|9299486|P5|Maintenance Period (MP)|Withdrawal by Subject|0
2698621|NCT00410410|9299487|P4|Maintenance Period (MP)|Withdrawal by Subject|0
2698622|NCT00410410|9299488|P3|Maintenance Period (MP)|Withdrawal by Subject|0
2698623|NCT00410410|9299489|P2|Maintenance Period (MP)|Withdrawal by Subject|0
2698624|NCT00410410|9299490|P1|Maintenance Period (MP)|Withdrawal by Subject|0
2698625|NCT00410410|9299482|P9|Maintenance Period (MP)|Lost to Follow-up|0
2698626|NCT00410410|9299483|P8|Maintenance Period (MP)|Lost to Follow-up|2
2698627|NCT00410410|9299484|P7|Maintenance Period (MP)|Lost to Follow-up|1
2698628|NCT00410410|9299485|P6|Maintenance Period (MP)|Lost to Follow-up|0
2698629|NCT00410410|9299486|P5|Maintenance Period (MP)|Lost to Follow-up|0
2698630|NCT00410410|9299487|P4|Maintenance Period (MP)|Lost to Follow-up|0
2698631|NCT00410410|9299488|P3|Maintenance Period (MP)|Lost to Follow-up|0
2698632|NCT00410410|9299489|P2|Maintenance Period (MP)|Lost to Follow-up|0
2698633|NCT00410410|9299490|P1|Maintenance Period (MP)|Lost to Follow-up|0
2698634|NCT00410410|9299482|P9|Maintenance Period (MP)|Lack of Efficacy|0
2698635|NCT00410410|9299483|P8|Maintenance Period (MP)|Lack of Efficacy|24
2698636|NCT00410410|9299484|P7|Maintenance Period (MP)|Lack of Efficacy|25
2698637|NCT00410410|9299485|P6|Maintenance Period (MP)|Lack of Efficacy|0
2698638|NCT00410410|9299486|P5|Maintenance Period (MP)|Lack of Efficacy|0
2698639|NCT00410410|9299487|P4|Maintenance Period (MP)|Lack of Efficacy|0
2698640|NCT00410410|9299488|P3|Maintenance Period (MP)|Lack of Efficacy|0
2698641|NCT00410410|9299489|P2|Maintenance Period (MP)|Lack of Efficacy|0
2698642|NCT00410410|9299490|P1|Maintenance Period (MP)|Lack of Efficacy|0
2698643|NCT00410410|9299482|P9|Maintenance Period (MP)|Adverse Event|0
2698644|NCT00410410|9299483|P8|Maintenance Period (MP)|Adverse Event|3
2698645|NCT00410410|9299484|P7|Maintenance Period (MP)|Adverse Event|1
2698646|NCT00410410|9299485|P6|Maintenance Period (MP)|Adverse Event|0
2698647|NCT00410410|9299486|P5|Maintenance Period (MP)|Adverse Event|0
2698648|NCT00410410|9299487|P4|Maintenance Period (MP)|Adverse Event|0
2698649|NCT00410410|9299488|P3|Maintenance Period (MP)|Adverse Event|0
2698650|NCT00410410|9299489|P2|Maintenance Period (MP)|Adverse Event|0
2698651|NCT00410410|9299490|P1|Maintenance Period (MP)|Adverse Event|0
2698652|NCT00410410|9299482|P9|Maintenance Period (MP)|Death|0
2698653|NCT00410410|9299483|P8|Maintenance Period (MP)|Death|0
2698654|NCT00410410|9299484|P7|Maintenance Period (MP)|Death|1
2698655|NCT00410410|9299485|P6|Maintenance Period (MP)|Death|0
2698656|NCT00410410|9299486|P5|Maintenance Period (MP)|Death|0
2698657|NCT00410410|9299487|P4|Maintenance Period (MP)|Death|0
2698658|NCT00410410|9299488|P3|Maintenance Period (MP)|Death|0
2698659|NCT00410410|9299489|P2|Maintenance Period (MP)|Death|0
2698660|NCT00410410|9299490|P1|Maintenance Period (MP)|Death|0
2698661|NCT00410410|9299482|P9|Induction Period (IP)|Other|0
2698662|NCT00410410|9299483|P8|Induction Period (IP)|Other|0
2698663|NCT00410410|9299484|P7|Induction Period (IP)|Other|0
2698664|NCT00410410|9299485|P6|Induction Period (IP)|Other|0
2698665|NCT00410410|9299486|P5|Induction Period (IP)|Other|0
2698666|NCT00410410|9299487|P4|Induction Period (IP)|Other|0
2698667|NCT00410410|9299488|P3|Induction Period (IP)|Other|1
2698668|NCT00410410|9299489|P2|Induction Period (IP)|Other|0
2698669|NCT00410410|9299490|P1|Induction Period (IP)|Other|0
2698670|NCT00410410|9299482|P9|Induction Period (IP)|Administrative Reason By Sponsor|0
2698671|NCT00410410|9299483|P8|Induction Period (IP)|Administrative Reason By Sponsor|0
2698672|NCT00410410|9299484|P7|Induction Period (IP)|Administrative Reason By Sponsor|0
2698673|NCT00410410|9299485|P6|Induction Period (IP)|Administrative Reason By Sponsor|21
2698674|NCT00410410|9299486|P5|Induction Period (IP)|Administrative Reason By Sponsor|22
2698675|NCT00410410|9299487|P4|Induction Period (IP)|Administrative Reason By Sponsor|0
2698676|NCT00410410|9299488|P3|Induction Period (IP)|Administrative Reason By Sponsor|0
2698677|NCT00410410|9299489|P2|Induction Period (IP)|Administrative Reason By Sponsor|0
2698678|NCT00410410|9299490|P1|Induction Period (IP)|Administrative Reason By Sponsor|0
2698679|NCT00410410|9299482|P9|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
2698680|NCT00410410|9299483|P8|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
2698681|NCT00410410|9299484|P7|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
2698682|NCT00410410|9299485|P6|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
2698683|NCT00410410|9299486|P5|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
2698684|NCT00410410|9299487|P4|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
2698685|NCT00410410|9299488|P3|Induction Period (IP)|Subject No Longer Meets Study Criteria|1
2698686|NCT00410410|9299489|P2|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
2698687|NCT00410410|9299490|P1|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
2698688|NCT00410410|9299482|P9|Induction Period (IP)|Withdrawal by Subject|0
2698689|NCT00410410|9299483|P8|Induction Period (IP)|Withdrawal by Subject|0
2698690|NCT00410410|9299484|P7|Induction Period (IP)|Withdrawal by Subject|0
2698691|NCT00410410|9299485|P6|Induction Period (IP)|Withdrawal by Subject|0
2698692|NCT00410410|9299486|P5|Induction Period (IP)|Withdrawal by Subject|2
2698693|NCT00410410|9299487|P4|Induction Period (IP)|Withdrawal by Subject|5
2698694|NCT00410410|9299488|P3|Induction Period (IP)|Withdrawal by Subject|3
2698695|NCT00410410|9299489|P2|Induction Period (IP)|Withdrawal by Subject|5
2698696|NCT00410410|9299490|P1|Induction Period (IP)|Withdrawal by Subject|3
2698697|NCT00410410|9299482|P9|Induction Period (IP)|Lost to Follow-up|0
2698698|NCT00410410|9299483|P8|Induction Period (IP)|Lost to Follow-up|0
2698699|NCT00410410|9299484|P7|Induction Period (IP)|Lost to Follow-up|0
2698700|NCT00410410|9299485|P6|Induction Period (IP)|Lost to Follow-up|1
2698701|NCT00410410|9299486|P5|Induction Period (IP)|Lost to Follow-up|0
2698702|NCT00410410|9299487|P4|Induction Period (IP)|Lost to Follow-up|3
2698703|NCT00410410|9299488|P3|Induction Period (IP)|Lost to Follow-up|2
2698704|NCT00410410|9299489|P2|Induction Period (IP)|Lost to Follow-up|2
2698705|NCT00410410|9299490|P1|Induction Period (IP)|Lost to Follow-up|2
2698706|NCT00410410|9299482|P9|Induction Period (IP)|Lack of Efficacy|0
2698707|NCT00410410|9299483|P8|Induction Period (IP)|Lack of Efficacy|0
2698708|NCT00410410|9299484|P7|Induction Period (IP)|Lack of Efficacy|0
2698709|NCT00410410|9299485|P6|Induction Period (IP)|Lack of Efficacy|7
2698710|NCT00410410|9299486|P5|Induction Period (IP)|Lack of Efficacy|7
2698711|NCT00410410|9299487|P4|Induction Period (IP)|Lack of Efficacy|8
2698712|NCT00410410|9299488|P3|Induction Period (IP)|Lack of Efficacy|8
2698713|NCT00410410|9299489|P2|Induction Period (IP)|Lack of Efficacy|24
2698714|NCT00410410|9299490|P1|Induction Period (IP)|Lack of Efficacy|26
2698715|NCT00410410|9299482|P9|Induction Period (IP)|Adverse Event|0
2698716|NCT00410410|9299483|P8|Induction Period (IP)|Adverse Event|0
2698717|NCT00410410|9299484|P7|Induction Period (IP)|Adverse Event|0
2698718|NCT00410410|9299485|P6|Induction Period (IP)|Adverse Event|0
2698719|NCT00410410|9299486|P5|Induction Period (IP)|Adverse Event|1
2698720|NCT00410410|9299487|P4|Induction Period (IP)|Adverse Event|4
2698721|NCT00410410|9299488|P3|Induction Period (IP)|Adverse Event|2
2698722|NCT00410410|9299489|P2|Induction Period (IP)|Adverse Event|4
2698723|NCT00410410|9299490|P1|Induction Period (IP)|Adverse Event|3
2698724|NCT00410410|9299482|P9|Induction Period (IP)|Death|0
2698725|NCT00410410|9299483|P8|Induction Period (IP)|Death|0
2698726|NCT00410410|9299484|P7|Induction Period (IP)|Death|0
2698727|NCT00410410|9299485|P6|Induction Period (IP)|Death|0
2698728|NCT00410410|9299486|P5|Induction Period (IP)|Death|0
2698729|NCT00410410|9299487|P4|Induction Period (IP)|Death|0
2698730|NCT00410410|9299488|P3|Induction Period (IP)|Death|0
2698731|NCT00410410|9299489|P2|Induction Period (IP)|Death|0
2698732|NCT00410410|9299490|P1|Induction Period (IP)|Death|1
2698733|NCT00410384|9299651|P3|Overall Study|Other|4
2698734|NCT00410384|9299652|P2|Overall Study|Other|8
2698735|NCT00410384|9299653|P1|Overall Study|Other|3
2698736|NCT00410384|9299651|P3|Overall Study|Physician Decision|4
2698737|NCT00410384|9299652|P2|Overall Study|Physician Decision|3
2698738|NCT00410384|9299653|P1|Overall Study|Physician Decision|3
2698739|NCT00410384|9299651|P3|Overall Study|Protocol Violation|6
2698740|NCT00410384|9299652|P2|Overall Study|Protocol Violation|6
2698741|NCT00410384|9299653|P1|Overall Study|Protocol Violation|6
2698742|NCT00410384|9299651|P3|Overall Study|Lost to Follow-up|6
2698743|NCT00410384|9299652|P2|Overall Study|Lost to Follow-up|6
2698744|NCT00410384|9299653|P1|Overall Study|Lost to Follow-up|4
2698745|NCT00410384|9299651|P3|Overall Study|Lack of Compliance|2
2698746|NCT00410384|9299652|P2|Overall Study|Lack of Compliance|2
2698747|NCT00410384|9299653|P1|Overall Study|Lack of Compliance|2
2698748|NCT00410384|9299651|P3|Overall Study|Lack of Efficacy|17
2698749|NCT00410384|9299652|P2|Overall Study|Lack of Efficacy|12
2698750|NCT00410384|9299653|P1|Overall Study|Lack of Efficacy|20
2698751|NCT00410384|9299651|P3|Overall Study|Adverse Event|23
2698752|NCT00410384|9299652|P2|Overall Study|Adverse Event|18
2698753|NCT00410384|9299653|P1|Overall Study|Adverse Event|23
2698754|NCT00410384|9299651|P3|Overall Study|Withdrawal by Subject|20
2698755|NCT00410384|9299652|P2|Overall Study|Withdrawal by Subject|17
2698756|NCT00410384|9299653|P1|Overall Study|Withdrawal by Subject|28
2698757|NCT00410202|9299726|P3|Off-treatment Follow up|Lost to Follow-up|0
2698758|NCT00410202|9299727|P2|Off-treatment Follow up|Lost to Follow-up|0
2698759|NCT00410202|9299728|P1|Off-treatment Follow up|Lost to Follow-up|1
2698760|NCT00410202|9299726|P3|Off-treatment Follow up|Follow up not required per protocol|1
2698761|NCT00410202|9299727|P2|Off-treatment Follow up|Follow up not required per protocol|0
2698762|NCT00410202|9299728|P1|Off-treatment Follow up|Follow up not required per protocol|3
2698763|NCT00410202|9299726|P3|Off-treatment Follow up|Continuing off-treatment follow up|11
2698764|NCT00410202|9299727|P2|Off-treatment Follow up|Continuing off-treatment follow up|8
2698765|NCT00410202|9299728|P1|Off-treatment Follow up|Continuing off-treatment follow up|10
2698766|NCT00410202|9299726|P3|On-Treatment|Other Reason|1
2698767|NCT00410202|9299727|P2|On-Treatment|Other Reason|0
2698768|NCT00410202|9299728|P1|On-Treatment|Other Reason|0
2698769|NCT00410202|9299726|P3|On-Treatment|Withdrawal by Subject|1
2698770|NCT00410202|9299727|P2|On-Treatment|Withdrawal by Subject|1
2698771|NCT00410202|9299728|P1|On-Treatment|Withdrawal by Subject|2
2698772|NCT00410202|9299726|P3|On-Treatment|Lack of Efficacy|0
2698773|NCT00410202|9299727|P2|On-Treatment|Lack of Efficacy|4
2698774|NCT00410202|9299728|P1|On-Treatment|Lack of Efficacy|1
2698775|NCT00410202|9299726|P3|On-Treatment|Lost to Follow-up|1
2698776|NCT00410202|9299727|P2|On-Treatment|Lost to Follow-up|0
2698777|NCT00410202|9299728|P1|On-Treatment|Lost to Follow-up|1
2698778|NCT00410202|9299726|P3|On-Treatment|Death|0
2698779|NCT00410202|9299727|P2|On-Treatment|Death|0
2698780|NCT00410202|9299728|P1|On-Treatment|Death|1
2698781|NCT00410202|9299726|P3|On-Treatment|Adverse Event|2
2698782|NCT00410202|9299727|P2|On-Treatment|Adverse Event|3
2698783|NCT00410202|9299728|P1|On-Treatment|Adverse Event|1
2698784|NCT00410202|9299726|P3|On-Treatment|Continuing treatment|66
2698785|NCT00410202|9299727|P2|On-Treatment|Continuing treatment|71
2698786|NCT00410202|9299728|P1|On-Treatment|Continuing treatment|69
2698787|NCT00410163|9299815|P2|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0
2698788|NCT00410163|9299816|P1|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1
2698789|NCT00410163|9299815|P2|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8
2698790|NCT00410163|9299816|P1|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4
2698791|NCT00410163|9299815|P2|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0
2698792|NCT00410163|9299816|P1|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1
2698793|NCT00410163|9299815|P2|Extended Follow-up (FU) Phase (2-5 Years|Death|1
2698794|NCT00410163|9299816|P1|Extended Follow-up (FU) Phase (2-5 Years|Death|1
2698795|NCT00410163|9299815|P2|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1
2698796|NCT00410163|9299816|P1|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3
2698797|NCT00410163|9299815|P2|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1
2698798|NCT00410163|9299816|P1|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0
2698799|NCT00410163|9299815|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0
2698800|NCT00410163|9299816|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1
2698801|NCT00410163|9299815|P2|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
2698802|NCT00410163|9299816|P1|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
2698803|NCT00410163|9299815|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0
2698804|NCT00410163|9299816|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1
2698805|NCT00410163|9299815|P2|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1
2698806|NCT00410163|9299816|P1|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2
2698807|NCT00410163|9299815|P2|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4
2698808|NCT00410163|9299816|P1|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0
2698809|NCT00410163|9299815|P2|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1
2698810|NCT00410163|9299816|P1|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2
2698811|NCT00410163|9299815|P2|Treatment and Follow-up Phase (2 Years)|Death|1
2698812|NCT00410163|9299816|P1|Treatment and Follow-up Phase (2 Years)|Death|1
2698813|NCT00410163|9299815|P2|Treatment and Follow-up Phase (2 Years)|Adverse Event|2
2698814|NCT00410163|9299816|P1|Treatment and Follow-up Phase (2 Years)|Adverse Event|4
2698815|NCT00410124|9299869|P2|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1
2698816|NCT00410124|9299870|P1|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0
2698817|NCT00410124|9299869|P2|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0
2698818|NCT00410124|9299870|P1|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1
2698819|NCT00410124|9299869|P2|Extension Phase - Open Label (45 Months)|Disease Progression|78
2698820|NCT00410124|9299870|P1|Extension Phase - Open Label (45 Months)|Disease Progression|56
2698821|NCT00410124|9299869|P2|Extension Phase - Open Label (45 Months)|Death|10
2698822|NCT00410124|9299870|P1|Extension Phase - Open Label (45 Months)|Death|2
2698823|NCT00410124|9299869|P2|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
2698824|NCT00410124|9299870|P1|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
2698825|NCT00410124|9299869|P2|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1
2698826|NCT00410124|9299870|P1|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0
2698827|NCT00410124|9299869|P2|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1
2698828|NCT00410124|9299870|P1|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0
2698829|NCT00410124|9299869|P2|Extension Phase - Open Label (45 Months)|Adverse Event|19
2698830|NCT00410124|9299870|P1|Extension Phase - Open Label (45 Months)|Adverse Event|7
2698831|NCT00410124|9299869|P2|Core Phase Double Blind (15 Months)|Disease Progression|124
2698832|NCT00410124|9299870|P1|Core Phase Double Blind (15 Months)|Disease Progression|137
2698833|NCT00410124|9299869|P2|Core Phase Double Blind (15 Months)|Death|4
2698834|NCT00410124|9299870|P1|Core Phase Double Blind (15 Months)|Death|7
2698835|NCT00410124|9299869|P2|Core Phase Double Blind (15 Months)|Administrative Problems|0
2698836|NCT00410124|9299870|P1|Core Phase Double Blind (15 Months)|Administrative Problems|2
2698837|NCT00410124|9299869|P2|Core Phase Double Blind (15 Months)|Lost to Follow-up|0
2698838|NCT00410124|9299870|P1|Core Phase Double Blind (15 Months)|Lost to Follow-up|4
2698839|NCT00410124|9299869|P2|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2
2698840|NCT00410124|9299870|P1|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13
2698841|NCT00410124|9299869|P2|Core Phase Double Blind (15 Months)|Protocol Violation|1
2698842|NCT00410124|9299870|P1|Core Phase Double Blind (15 Months)|Protocol Violation|2
2698843|NCT00410124|9299869|P2|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0
2698844|NCT00410124|9299870|P1|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1
2698845|NCT00410124|9299869|P2|Core Phase Double Blind (15 Months)|Adverse Event|2
2698846|NCT00410124|9299870|P1|Core Phase Double Blind (15 Months)|Adverse Event|36
2698847|NCT00410072|9299901|P2|After Week 48 to Week 96|Withdrawal by Subject|1
2698848|NCT00410072|9299902|P1|After Week 48 to Week 96|Withdrawal by Subject|0
2698849|NCT00410072|9299901|P2|After Week 48 to Week 96|Pregnancy|2
2698850|NCT00410072|9299902|P1|After Week 48 to Week 96|Pregnancy|0
2698851|NCT00410072|9299901|P2|After Week 48 to Week 96|Poor compliance/noncompliance|1
2698852|NCT00410072|9299902|P1|After Week 48 to Week 96|Poor compliance/noncompliance|0
2698853|NCT00410072|9299901|P2|After Week 48 to Week 96|Other|0
2698854|NCT00410072|9299902|P1|After Week 48 to Week 96|Other|2
2698855|NCT00410072|9299901|P2|After Week 48 to Week 96|Lost to Follow-up|4
2698856|NCT00410072|9299902|P1|After Week 48 to Week 96|Lost to Follow-up|2
2698857|NCT00410072|9299901|P2|After Week 48 to Week 96|Lack of Efficacy|0
2698858|NCT00410072|9299902|P1|After Week 48 to Week 96|Lack of Efficacy|1
2698859|NCT00410072|9299901|P2|After Week 48 to Week 96|Death|1
2698860|NCT00410072|9299902|P1|After Week 48 to Week 96|Death|0
2698861|NCT00410072|9299901|P2|After Week 48 to Week 96|Adverse Event|2
2698862|NCT00410072|9299902|P1|After Week 48 to Week 96|Adverse Event|1
2698863|NCT00410072|9299901|P2|Day 1 to Week 48|Withdrawal by Subject|2
2698864|NCT00410072|9299902|P1|Day 1 to Week 48|Withdrawal by Subject|0
2698865|NCT00410072|9299901|P2|Day 1 to Week 48|Pregnancy|2
2698866|NCT00410072|9299902|P1|Day 1 to Week 48|Pregnancy|0
2698867|NCT00410072|9299901|P2|Day 1 to Week 48|poor compliance/noncompliance|3
2698868|NCT00410072|9299902|P1|Day 1 to Week 48|poor compliance/noncompliance|0
2698869|NCT00410072|9299901|P2|Day 1 to Week 48|Other|1
2698870|NCT00410072|9299902|P1|Day 1 to Week 48|Other|0
2698871|NCT00410072|9299901|P2|Day 1 to Week 48|Lost to Follow-up|2
2698872|NCT00410072|9299902|P1|Day 1 to Week 48|Lost to Follow-up|5
2698873|NCT00410072|9299901|P2|Day 1 to Week 48|Adverse Event|2
2698874|NCT00410072|9299902|P1|Day 1 to Week 48|Adverse Event|1
2698875|NCT00410046|9299942|P1|Overall Study|Lost to Follow-up|1
2698876|NCT00410046|9299942|P1|Overall Study|Withdrawal by Subject|1
2698877|NCT00410046|9299942|P1|Overall Study|Adverse Event|3
2698878|NCT00409838|9299973|P2|Long-term Extension Period|Pregnancy|0
2698879|NCT00409838|9299974|P1|Long-term Extension Period|Pregnancy|1
2698880|NCT00409838|9299973|P2|Long-term Extension Period|Poor compliance/noncompliance|0
2698881|NCT00409838|9299974|P1|Long-term Extension Period|Poor compliance/noncompliance|1
2698882|NCT00409838|9299973|P2|Long-term Extension Period|Withdrawal by Subject|0
2698883|NCT00409838|9299974|P1|Long-term Extension Period|Withdrawal by Subject|3
2698884|NCT00409838|9299973|P2|Long-term Extension Period|Lack of Efficacy|0
2698885|NCT00409838|9299974|P1|Long-term Extension Period|Lack of Efficacy|2
2698886|NCT00409838|9299973|P2|Long-term Extension Period|Death|0
2698887|NCT00409838|9299974|P1|Long-term Extension Period|Death|1
2698888|NCT00409838|9299973|P2|Long-term Extension Period|Adverse Event|0
2698889|NCT00409838|9299974|P1|Long-term Extension Period|Adverse Event|10
2698890|NCT00409838|9299973|P2|Short-term Period|Never Treated|0
2698891|NCT00409838|9299974|P1|Short-term Period|Never Treated|1
2698892|NCT00409838|9299973|P2|Short-term Period|Withdrawal by Subject|3
2698893|NCT00409838|9299974|P1|Short-term Period|Withdrawal by Subject|2
2698894|NCT00409838|9299973|P2|Short-term Period|Lost to Follow-up|1
2698895|NCT00409838|9299974|P1|Short-term Period|Lost to Follow-up|0
2698896|NCT00409838|9299973|P2|Short-term Period|Adverse Event|1
2698897|NCT00409838|9299974|P1|Short-term Period|Adverse Event|0
2698898|NCT00409786|9300039|P1|Overall Study|Withdrawal by Subject|3
2698899|NCT00409773|9300048|P5|Overall Study|Lack of Eligibility|1
2698900|NCT00409773|9300049|P4|Overall Study|Lack of Eligibility|0
2698901|NCT00409773|9300050|P3|Overall Study|Lack of Eligibility|0
2698902|NCT00409773|9300051|P2|Overall Study|Lack of Eligibility|0
2698903|NCT00409773|9300052|P1|Overall Study|Lack of Eligibility|0
2698904|NCT00409773|9300048|P5|Overall Study|Withdrawal by Subject|1
2698905|NCT00409773|9300049|P4|Overall Study|Withdrawal by Subject|2
2698906|NCT00409773|9300050|P3|Overall Study|Withdrawal by Subject|0
2698907|NCT00409773|9300051|P2|Overall Study|Withdrawal by Subject|0
2698908|NCT00409773|9300052|P1|Overall Study|Withdrawal by Subject|0
2698909|NCT00409773|9300048|P5|Overall Study|Protocol Violation|1
2698910|NCT00409773|9300049|P4|Overall Study|Protocol Violation|3
2698911|NCT00409773|9300050|P3|Overall Study|Protocol Violation|3
2698912|NCT00409773|9300051|P2|Overall Study|Protocol Violation|2
2698913|NCT00409773|9300052|P1|Overall Study|Protocol Violation|0
2698914|NCT00409773|9300048|P5|Overall Study|Physician Decision|0
2698915|NCT00409773|9300049|P4|Overall Study|Physician Decision|2
2698916|NCT00409773|9300050|P3|Overall Study|Physician Decision|0
2698917|NCT00409773|9300051|P2|Overall Study|Physician Decision|0
2698918|NCT00409773|9300052|P1|Overall Study|Physician Decision|0
2698919|NCT00409773|9300048|P5|Overall Study|Lost to Follow-up|1
2698920|NCT00409773|9300049|P4|Overall Study|Lost to Follow-up|3
2698921|NCT00409773|9300050|P3|Overall Study|Lost to Follow-up|2
2698922|NCT00409773|9300051|P2|Overall Study|Lost to Follow-up|1
2698923|NCT00409773|9300052|P1|Overall Study|Lost to Follow-up|6
2698924|NCT00409773|9300048|P5|Overall Study|Adverse Event|6
2698925|NCT00409773|9300049|P4|Overall Study|Adverse Event|2
2698926|NCT00409773|9300050|P3|Overall Study|Adverse Event|4
2698927|NCT00409773|9300051|P2|Overall Study|Adverse Event|4
2698928|NCT00409773|9300052|P1|Overall Study|Adverse Event|3
2698929|NCT00409747|9300134|P1|Overall Study|Withdrawal by Subject|1
2698930|NCT00409708|9300141|P2|Washout|Lost to Follow-up|3
2698931|NCT00409708|9300142|P1|Washout|Lost to Follow-up|1
2698932|NCT00409708|9300141|P2|Washout|Withdrawal by Subject|5
2698933|NCT00409708|9300142|P1|Washout|Withdrawal by Subject|11
2698934|NCT00409708|9300141|P2|Washout|Protocol Violation|1
2698935|NCT00409708|9300142|P1|Washout|Protocol Violation|0
2698936|NCT00409708|9300141|P2|Washout|Lack of Efficacy|1
2698937|NCT00409708|9300142|P1|Washout|Lack of Efficacy|9
2698938|NCT00409708|9300141|P2|Treatment|Administrative problems|0
2698939|NCT00409708|9300142|P1|Treatment|Administrative problems|5
2698940|NCT00409708|9300141|P2|Treatment|Lost to Follow-up|6
2698941|NCT00409708|9300142|P1|Treatment|Lost to Follow-up|0
2698942|NCT00409708|9300141|P2|Treatment|Withdrawal by Subject|8
2698943|NCT00409708|9300142|P1|Treatment|Withdrawal by Subject|3
2698944|NCT00409708|9300141|P2|Treatment|Protocol Violation|2
2698945|NCT00409708|9300142|P1|Treatment|Protocol Violation|6
2698946|NCT00409708|9300141|P2|Treatment|Lack of Efficacy|1
2698947|NCT00409708|9300142|P1|Treatment|Lack of Efficacy|0
2698948|NCT00409708|9300141|P2|Treatment|Abnormal test procedure result(s)|0
2698949|NCT00409708|9300142|P1|Treatment|Abnormal test procedure result(s)|1
2698950|NCT00409682|9300163|P3|EOW Double-blind Maintenance Period|Non-compliance|1
2698951|NCT00409682|9300164|P2|EOW Double-blind Maintenance Period|Non-compliance|0
2698952|NCT00409682|9300165|P1|EOW Double-blind Maintenance Period|Non-compliance|0
2698953|NCT00409682|9300163|P3|EOW Double-blind Maintenance Period|Protocol Violation|1
2698954|NCT00409682|9300164|P2|EOW Double-blind Maintenance Period|Protocol Violation|4
2698955|NCT00409682|9300165|P1|EOW Double-blind Maintenance Period|Protocol Violation|0
2698956|NCT00409682|9300163|P3|EOW Double-blind Maintenance Period|Withdrawal by Subject|2
2698957|NCT00409682|9300164|P2|EOW Double-blind Maintenance Period|Withdrawal by Subject|4
2698958|NCT00409682|9300165|P1|EOW Double-blind Maintenance Period|Withdrawal by Subject|0
2698959|NCT00409682|9300163|P3|EOW Double-blind Maintenance Period|Lost to Follow-up|0
2698960|NCT00409682|9300164|P2|EOW Double-blind Maintenance Period|Lost to Follow-up|1
2698961|NCT00409682|9300165|P1|EOW Double-blind Maintenance Period|Lost to Follow-up|0
2698962|NCT00409682|9300163|P3|EOW Double-blind Maintenance Period|Lack of Efficacy|11
2698963|NCT00409682|9300164|P2|EOW Double-blind Maintenance Period|Lack of Efficacy|18
2698964|NCT00409682|9300165|P1|EOW Double-blind Maintenance Period|Lack of Efficacy|0
2698965|NCT00409682|9300163|P3|EOW Double-blind Maintenance Period|Adverse Event|12
2698966|NCT00409682|9300164|P2|EOW Double-blind Maintenance Period|Adverse Event|10
2698967|NCT00409682|9300165|P1|EOW Double-blind Maintenance Period|Adverse Event|0
2698968|NCT00409682|9300163|P3|Open-label Induction Period|Subject did not satisfy entry criteria|0
2698969|NCT00409682|9300164|P2|Open-label Induction Period|Subject did not satisfy entry criteria|0
2698970|NCT00409682|9300165|P1|Open-label Induction Period|Subject did not satisfy entry criteria|1
2698971|NCT00409682|9300163|P3|Open-label Induction Period|Protocol Violation|0
2698972|NCT00409682|9300164|P2|Open-label Induction Period|Protocol Violation|0
2698973|NCT00409682|9300165|P1|Open-label Induction Period|Protocol Violation|1
2698974|NCT00409682|9300163|P3|Open-label Induction Period|Lack of Efficacy|0
2698975|NCT00409682|9300164|P2|Open-label Induction Period|Lack of Efficacy|0
2698976|NCT00409682|9300165|P1|Open-label Induction Period|Lack of Efficacy|1
2698977|NCT00409682|9300163|P3|Open-label Induction Period|Adverse Event|0
2698978|NCT00409682|9300164|P2|Open-label Induction Period|Adverse Event|0
2698979|NCT00409682|9300165|P1|Open-label Induction Period|Adverse Event|1
2698980|NCT00409617|9300182|P1|Overall Study|Not described|14
2698981|NCT00409617|9300182|P1|Overall Study|Administrative reasons|1
2698982|NCT00409617|9300182|P1|Overall Study|Withdrawal by Subject|8
2698983|NCT00409617|9300182|P1|Overall Study|Protocol Violation|24
2698984|NCT00409617|9300182|P1|Overall Study|Lost to Follow-up|2
2698985|NCT00409617|9300182|P1|Overall Study|Lack of Efficacy|54
2698986|NCT00409617|9300182|P1|Overall Study|Adverse Event|57
2698987|NCT00409578|9300198|P4|Overall Study|Missing|1
2698988|NCT00409578|9300199|P3|Overall Study|Missing|0
2698989|NCT00409578|9300200|P2|Overall Study|Missing|1
2698990|NCT00409578|9300201|P1|Overall Study|Missing|0
2698991|NCT00409578|9300198|P4|Overall Study|Protocol Violation|1
2698992|NCT00409578|9300199|P3|Overall Study|Protocol Violation|3
2698993|NCT00409578|9300200|P2|Overall Study|Protocol Violation|2
2698994|NCT00409578|9300201|P1|Overall Study|Protocol Violation|3
2698995|NCT00409578|9300198|P4|Overall Study|Death|2
2698996|NCT00409578|9300199|P3|Overall Study|Death|4
2698997|NCT00409578|9300200|P2|Overall Study|Death|4
2698998|NCT00409578|9300201|P1|Overall Study|Death|2
2698999|NCT00409578|9300198|P4|Overall Study|Administrative problems|4
2699000|NCT00409578|9300199|P3|Overall Study|Administrative problems|2
2699001|NCT00409578|9300200|P2|Overall Study|Administrative problems|9
2699002|NCT00409578|9300201|P1|Overall Study|Administrative problems|8
2699003|NCT00409578|9300198|P4|Overall Study|Lost to Follow-up|2
2699004|NCT00409578|9300199|P3|Overall Study|Lost to Follow-up|2
2699005|NCT00409578|9300200|P2|Overall Study|Lost to Follow-up|0
2699006|NCT00409578|9300201|P1|Overall Study|Lost to Follow-up|2
2699007|NCT00409578|9300198|P4|Overall Study|Withdrawal by Subject|17
2699008|NCT00409578|9300199|P3|Overall Study|Withdrawal by Subject|16
2699009|NCT00409578|9300200|P2|Overall Study|Withdrawal by Subject|15
2699010|NCT00409578|9300201|P1|Overall Study|Withdrawal by Subject|8
2699011|NCT00409578|9300198|P4|Overall Study|Subject no longer requires study drug|1
2699012|NCT00409578|9300199|P3|Overall Study|Subject no longer requires study drug|0
2699013|NCT00409578|9300200|P2|Overall Study|Subject no longer requires study drug|0
2699014|NCT00409578|9300201|P1|Overall Study|Subject no longer requires study drug|0
2699015|NCT00409578|9300198|P4|Overall Study|Lack of Efficacy|2
2699016|NCT00409578|9300199|P3|Overall Study|Lack of Efficacy|0
2699017|NCT00409578|9300200|P2|Overall Study|Lack of Efficacy|0
2699018|NCT00409578|9300201|P1|Overall Study|Lack of Efficacy|0
2699019|NCT00409578|9300198|P4|Overall Study|Abnormal laboratory value(s)|4
2699020|NCT00409578|9300199|P3|Overall Study|Abnormal laboratory value(s)|2
2699021|NCT00409578|9300200|P2|Overall Study|Abnormal laboratory value(s)|2
2699022|NCT00409578|9300201|P1|Overall Study|Abnormal laboratory value(s)|2
2699023|NCT00409578|9300198|P4|Overall Study|Adverse Event|33
2699024|NCT00409578|9300199|P3|Overall Study|Adverse Event|25
2699025|NCT00409578|9300200|P2|Overall Study|Adverse Event|37
2699026|NCT00409578|9300201|P1|Overall Study|Adverse Event|27
2699027|NCT00409409|9300259|P2|Overall Study|Any other reason not above-mentioned|1
2699028|NCT00409409|9300260|P1|Overall Study|Any other reason not above-mentioned|0
2699029|NCT00409409|9300259|P2|Overall Study|Withdrawal by Subject|1
2699030|NCT00409409|9300260|P1|Overall Study|Withdrawal by Subject|1
2699031|NCT00409409|9300259|P2|Overall Study|Adverse Event|2
2699032|NCT00409409|9300260|P1|Overall Study|Adverse Event|7
2699033|NCT00409344|9300268|P2|Overall Study|no enrollment|0
2699034|NCT00409344|9300269|P1|Overall Study|no enrollment|0
2699035|NCT00409331|9300287|P1|Overall Study|Physician Decision|1
2699036|NCT00409188|9300309|P2|Overall Study|Ongoing at data cut-off|175
2699037|NCT00409188|9300310|P1|Overall Study|Ongoing at data cut-off|383
2699038|NCT00409175|9300326|P2|Overall Study|Liver transplantation|13
2699039|NCT00409175|9300327|P1|Overall Study|Liver transplantation|13
2699040|NCT00409175|9300326|P2|Overall Study|Negative genotype|1
2699041|NCT00409175|9300327|P1|Overall Study|Negative genotype|0
2699042|NCT00409175|9300326|P2|Overall Study|Withdrawal by Subject|2
2699043|NCT00409175|9300327|P1|Overall Study|Withdrawal by Subject|1
2699044|NCT00409175|9300326|P2|Overall Study|Adverse Event|3
2699045|NCT00409175|9300327|P1|Overall Study|Adverse Event|4
2699046|NCT00409006|9300353|P2|Overall Study|Physician Decision|2
2699047|NCT00409006|9300354|P1|Overall Study|Physician Decision|1
2699048|NCT00409006|9300353|P2|Overall Study|Withdrawal by Subject|2
2699049|NCT00409006|9300354|P1|Overall Study|Withdrawal by Subject|3
2699050|NCT00409006|9300353|P2|Overall Study|Lost to Follow-up|2
2699051|NCT00409006|9300354|P1|Overall Study|Lost to Follow-up|1
2699052|NCT00409006|9300353|P2|Overall Study|Death|6
2699053|NCT00409006|9300354|P1|Overall Study|Death|15
2699054|NCT00408993|9300370|P2|Overall Study|Withdrawal by Subject|3
2699055|NCT00408993|9300371|P1|Overall Study|Withdrawal by Subject|2
2699056|NCT00408993|9300370|P2|Overall Study|Lack of Efficacy|4
2699057|NCT00408993|9300371|P1|Overall Study|Lack of Efficacy|1
2699058|NCT00408993|9300370|P2|Overall Study|Protocol Violation|6
2699059|NCT00408993|9300371|P1|Overall Study|Protocol Violation|1
2699060|NCT00408993|9300370|P2|Overall Study|Adverse Event|4
2699061|NCT00408993|9300371|P1|Overall Study|Adverse Event|15
2699062|NCT00408928|9300403|P1|Overall Study|Infection indistinguishable from GVHD|1
2699063|NCT00408928|9300403|P1|Overall Study|Death|1
2699064|NCT00408928|9300403|P1|Overall Study|Withdrawal by Subject|1
2699065|NCT00408902|9300408|P1|Overall Study|Adverse Event|3
2699066|NCT00408902|9300408|P1|Overall Study|Lack of Efficacy|7
2699067|NCT00408876|9300418|P4|Overall Study|Physician Decision|0
2699068|NCT00408876|9300419|P3|Overall Study|Physician Decision|3
2699069|NCT00408876|9300420|P2|Overall Study|Physician Decision|0
2699070|NCT00408876|9300421|P1|Overall Study|Physician Decision|1
2699071|NCT00408876|9300418|P4|Overall Study|Protocol Violation|3
2699072|NCT00408876|9300419|P3|Overall Study|Protocol Violation|4
2699073|NCT00408876|9300420|P2|Overall Study|Protocol Violation|3
2699074|NCT00408876|9300421|P1|Overall Study|Protocol Violation|0
2699075|NCT00408876|9300418|P4|Overall Study|Lost to Follow-up|2
2699076|NCT00408876|9300419|P3|Overall Study|Lost to Follow-up|5
2699077|NCT00408876|9300420|P2|Overall Study|Lost to Follow-up|6
2699078|NCT00408876|9300421|P1|Overall Study|Lost to Follow-up|1
2699079|NCT00408876|9300418|P4|Overall Study|Lack of Efficacy|6
2699080|NCT00408876|9300419|P3|Overall Study|Lack of Efficacy|5
2699081|NCT00408876|9300420|P2|Overall Study|Lack of Efficacy|4
2699082|NCT00408876|9300421|P1|Overall Study|Lack of Efficacy|2
2699083|NCT00408876|9300418|P4|Overall Study|Withdrawal by Subject|14
2699084|NCT00408876|9300419|P3|Overall Study|Withdrawal by Subject|6
2699085|NCT00408876|9300420|P2|Overall Study|Withdrawal by Subject|6
2699086|NCT00408876|9300421|P1|Overall Study|Withdrawal by Subject|3
2699087|NCT00408876|9300418|P4|Overall Study|Adverse Event|10
2699088|NCT00408876|9300419|P3|Overall Study|Adverse Event|27
2699089|NCT00408876|9300420|P2|Overall Study|Adverse Event|17
2699090|NCT00408876|9300421|P1|Overall Study|Adverse Event|9
2699091|NCT00408694|9300671|P1|Overall Study|No protocol treatment|1
2699092|NCT00408694|9300671|P1|Overall Study|Ineligible|1
2699093|NCT00408681|9300683|P1|Overall Study|Adverse Event|7
2699094|NCT00408681|9300683|P1|Overall Study|Lack of Efficacy|2
2699095|NCT00408629|9300702|P2|Overall Study|Miscellaneous|15
2699096|NCT00408629|9300703|P1|Overall Study|Miscellaneous|11
2699097|NCT00408629|9300702|P2|Overall Study|Protocol Violation|5
2699098|NCT00408629|9300703|P1|Overall Study|Protocol Violation|1
2699099|NCT00408629|9300702|P2|Overall Study|Lack of Efficacy|73
2699100|NCT00408629|9300703|P1|Overall Study|Lack of Efficacy|63
2699101|NCT00408629|9300702|P2|Overall Study|Lost to Follow-up|1
2699102|NCT00408629|9300703|P1|Overall Study|Lost to Follow-up|1
2699103|NCT00408629|9300702|P2|Overall Study|Withdrawal by Subject|4
2699104|NCT00408629|9300703|P1|Overall Study|Withdrawal by Subject|8
2699105|NCT00408629|9300702|P2|Overall Study|Adverse Event|27
2699106|NCT00408629|9300703|P1|Overall Study|Adverse Event|13
2699107|NCT00408499|9300799|P5|Phase II- MTD Expansion|treatment delay|3
2699108|NCT00408499|9300800|P4|Phase II- MTD Expansion|treatment delay|0
2699109|NCT00408499|9300801|P3|Phase II- MTD Expansion|treatment delay|0
2699110|NCT00408499|9300802|P2|Phase II- MTD Expansion|treatment delay|0
2699111|NCT00408499|9300803|P1|Phase II- MTD Expansion|treatment delay|0
2699112|NCT00408499|9300799|P5|Phase II- MTD Expansion|Withdrawal by Subject|5
2699113|NCT00408499|9300800|P4|Phase II- MTD Expansion|Withdrawal by Subject|0
2699114|NCT00408499|9300801|P3|Phase II- MTD Expansion|Withdrawal by Subject|0
2699115|NCT00408499|9300802|P2|Phase II- MTD Expansion|Withdrawal by Subject|0
2699116|NCT00408499|9300803|P1|Phase II- MTD Expansion|Withdrawal by Subject|0
2699117|NCT00408499|9300799|P5|Phase II- MTD Expansion|Physician Decision|1
2699118|NCT00408499|9300800|P4|Phase II- MTD Expansion|Physician Decision|0
2699119|NCT00408499|9300801|P3|Phase II- MTD Expansion|Physician Decision|0
2699120|NCT00408499|9300802|P2|Phase II- MTD Expansion|Physician Decision|0
2699121|NCT00408499|9300803|P1|Phase II- MTD Expansion|Physician Decision|0
2699122|NCT00408499|9300799|P5|Phase II- MTD Expansion|Death|2
2699123|NCT00408499|9300800|P4|Phase II- MTD Expansion|Death|0
2699124|NCT00408499|9300801|P3|Phase II- MTD Expansion|Death|0
2699125|NCT00408499|9300802|P2|Phase II- MTD Expansion|Death|0
2699126|NCT00408499|9300803|P1|Phase II- MTD Expansion|Death|0
2699127|NCT00408499|9300799|P5|Phase II- MTD Expansion|Adverse Event|9
2699128|NCT00408499|9300800|P4|Phase II- MTD Expansion|Adverse Event|0
2699129|NCT00408499|9300801|P3|Phase II- MTD Expansion|Adverse Event|0
2699130|NCT00408499|9300802|P2|Phase II- MTD Expansion|Adverse Event|0
2699131|NCT00408499|9300803|P1|Phase II- MTD Expansion|Adverse Event|0
2699132|NCT00408499|9300799|P5|Phase 1: Dose Levels 1-4|Physician Decision|0
2699133|NCT00408499|9300800|P4|Phase 1: Dose Levels 1-4|Physician Decision|0
2699134|NCT00408499|9300801|P3|Phase 1: Dose Levels 1-4|Physician Decision|0
2699135|NCT00408499|9300802|P2|Phase 1: Dose Levels 1-4|Physician Decision|1
2699136|NCT00408499|9300803|P1|Phase 1: Dose Levels 1-4|Physician Decision|1
2699137|NCT00408499|9300799|P5|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
2699138|NCT00408499|9300800|P4|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
2699139|NCT00408499|9300801|P3|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
2699140|NCT00408499|9300802|P2|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
2699141|NCT00408499|9300803|P1|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
2699142|NCT00408499|9300799|P5|Phase 1: Dose Levels 1-4|Adverse Event|0
2699143|NCT00408499|9300800|P4|Phase 1: Dose Levels 1-4|Adverse Event|0
2699144|NCT00408499|9300801|P3|Phase 1: Dose Levels 1-4|Adverse Event|1
2699145|NCT00408499|9300802|P2|Phase 1: Dose Levels 1-4|Adverse Event|0
2699146|NCT00408499|9300803|P1|Phase 1: Dose Levels 1-4|Adverse Event|0
2699147|NCT00408421|9300820|P3|Treatment Re-Randomization|Withdrawal by Subject|0
2699148|NCT00408421|9300821|P2|Treatment Re-Randomization|Withdrawal by Subject|1
2699149|NCT00408421|9300822|P1|Treatment Re-Randomization|Withdrawal by Subject|2
2699150|NCT00408421|9300820|P3|Treatment Re-Randomization|Protocol Violation|0
2699151|NCT00408421|9300821|P2|Treatment Re-Randomization|Protocol Violation|1
2699152|NCT00408421|9300822|P1|Treatment Re-Randomization|Protocol Violation|1
2699153|NCT00408421|9300820|P3|Treatment Re-Randomization|Physician Decision|0
2699154|NCT00408421|9300821|P2|Treatment Re-Randomization|Physician Decision|3
2699155|NCT00408421|9300822|P1|Treatment Re-Randomization|Physician Decision|1
2699156|NCT00408421|9300820|P3|Treatment Re-Randomization|Lost to Follow-up|1
2699157|NCT00408421|9300821|P2|Treatment Re-Randomization|Lost to Follow-up|0
2699158|NCT00408421|9300822|P1|Treatment Re-Randomization|Lost to Follow-up|0
2699159|NCT00408421|9300820|P3|Treatment Re-Randomization|Lack of Efficacy|0
2699160|NCT00408421|9300821|P2|Treatment Re-Randomization|Lack of Efficacy|0
2699161|NCT00408421|9300822|P1|Treatment Re-Randomization|Lack of Efficacy|1
2699162|NCT00408421|9300820|P3|Treatment Re-Randomization|Adverse Event|4
2699163|NCT00408421|9300821|P2|Treatment Re-Randomization|Adverse Event|2
2699164|NCT00408421|9300822|P1|Treatment Re-Randomization|Adverse Event|2
2699165|NCT00408421|9300820|P3|Treatment Initial Randomization|Sponsor Decision|0
2699166|NCT00408421|9300821|P2|Treatment Initial Randomization|Sponsor Decision|0
2699167|NCT00408421|9300822|P1|Treatment Initial Randomization|Sponsor Decision|1
2699168|NCT00408421|9300820|P3|Treatment Initial Randomization|Entry Criteria Not Met|0
2699169|NCT00408421|9300821|P2|Treatment Initial Randomization|Entry Criteria Not Met|0
2699170|NCT00408421|9300822|P1|Treatment Initial Randomization|Entry Criteria Not Met|1
2699171|NCT00408421|9300820|P3|Treatment Initial Randomization|Withdrawal by Subject|0
2699172|NCT00408421|9300821|P2|Treatment Initial Randomization|Withdrawal by Subject|7
2699173|NCT00408421|9300822|P1|Treatment Initial Randomization|Withdrawal by Subject|7
2699174|NCT00408421|9300820|P3|Treatment Initial Randomization|Protocol Violation|0
2699175|NCT00408421|9300821|P2|Treatment Initial Randomization|Protocol Violation|1
2699176|NCT00408421|9300822|P1|Treatment Initial Randomization|Protocol Violation|0
2699177|NCT00408421|9300820|P3|Treatment Initial Randomization|Physician Decision|0
2699178|NCT00408421|9300821|P2|Treatment Initial Randomization|Physician Decision|0
2699179|NCT00408421|9300822|P1|Treatment Initial Randomization|Physician Decision|1
2699180|NCT00408421|9300820|P3|Treatment Initial Randomization|Lost to Follow-up|0
2699181|NCT00408421|9300821|P2|Treatment Initial Randomization|Lost to Follow-up|3
2699182|NCT00408421|9300822|P1|Treatment Initial Randomization|Lost to Follow-up|0
2699183|NCT00408421|9300820|P3|Treatment Initial Randomization|Lack of Efficacy|0
2699184|NCT00408421|9300821|P2|Treatment Initial Randomization|Lack of Efficacy|2
2699185|NCT00408421|9300822|P1|Treatment Initial Randomization|Lack of Efficacy|2
2699186|NCT00408421|9300820|P3|Treatment Initial Randomization|Adverse Event|0
2699187|NCT00408421|9300821|P2|Treatment Initial Randomization|Adverse Event|9
2699188|NCT00408421|9300822|P1|Treatment Initial Randomization|Adverse Event|5
2699189|NCT00408408|9300902|P6|Overall Study|No follow up data|3
2699190|NCT00408408|9300903|P5|Overall Study|No follow up data|5
2699191|NCT00408408|9300904|P4|Overall Study|No follow up data|7
2699192|NCT00408408|9300905|P3|Overall Study|No follow up data|0
2699193|NCT00408408|9300906|P2|Overall Study|No follow up data|3
2699194|NCT00408408|9300907|P1|Overall Study|No follow up data|2
2699195|NCT00408317|9300969|P2|Second Intervention Period|Withdrawal of consent|1
2699196|NCT00408317|9300970|P1|Second Intervention Period|Withdrawal of consent|0
2699197|NCT00408317|9300969|P2|Second Intervention Period|Protocol Violation|1
2699198|NCT00408317|9300970|P1|Second Intervention Period|Protocol Violation|0
2699199|NCT00408317|9300969|P2|Second Intervention Period|Adverse Event|0
2699200|NCT00408317|9300970|P1|Second Intervention Period|Adverse Event|2
2699201|NCT00408317|9300969|P2|First Intervention Period|Adverse Event|1
2699202|NCT00408317|9300970|P1|First Intervention Period|Adverse Event|0
2699203|NCT00408005|9301003|P8|Post Induction Therapy by Tx Assignment|Development of SMN|0
2699204|NCT00408005|9301004|P7|Post Induction Therapy by Tx Assignment|Development of SMN|0
2699205|NCT00408005|9301005|P6|Post Induction Therapy by Tx Assignment|Development of SMN|1
2699206|NCT00408005|9301006|P5|Post Induction Therapy by Tx Assignment|Development of SMN|1
2699207|NCT00408005|9301007|P4|Post Induction Therapy by Tx Assignment|Development of SMN|1
2699208|NCT00408005|9301008|P3|Post Induction Therapy by Tx Assignment|Development of SMN|3
2699209|NCT00408005|9301009|P2|Post Induction Therapy by Tx Assignment|Development of SMN|0
2699210|NCT00408005|9301010|P1|Post Induction Therapy by Tx Assignment|Development of SMN|0
2699211|NCT00408005|9301003|P8|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
2699212|NCT00408005|9301004|P7|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1
2699213|NCT00408005|9301005|P6|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15
2699214|NCT00408005|9301006|P5|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49
2699215|NCT00408005|9301007|P4|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7
2699216|NCT00408005|9301008|P3|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13
2699217|NCT00408005|9301009|P2|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
2699218|NCT00408005|9301010|P1|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
2699219|NCT00408005|9301003|P8|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
2699220|NCT00408005|9301004|P7|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
2699221|NCT00408005|9301005|P6|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2
2699222|NCT00408005|9301006|P5|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1
2699223|NCT00408005|9301007|P4|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
2699224|NCT00408005|9301008|P3|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
2699225|NCT00408005|9301009|P2|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
2699226|NCT00408005|9301010|P1|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
2699227|NCT00408005|9301003|P8|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
2699228|NCT00408005|9301004|P7|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
2699229|NCT00408005|9301005|P6|Post Induction Therapy by Tx Assignment|Protocol Deviation|2
2699230|NCT00408005|9301006|P5|Post Induction Therapy by Tx Assignment|Protocol Deviation|1
2699231|NCT00408005|9301007|P4|Post Induction Therapy by Tx Assignment|Protocol Deviation|1
2699232|NCT00408005|9301008|P3|Post Induction Therapy by Tx Assignment|Protocol Deviation|2
2699233|NCT00408005|9301009|P2|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
2699234|NCT00408005|9301010|P1|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
2699235|NCT00408005|9301003|P8|Post Induction Therapy by Tx Assignment|Inevaluable|0
2699236|NCT00408005|9301004|P7|Post Induction Therapy by Tx Assignment|Inevaluable|0
2699237|NCT00408005|9301005|P6|Post Induction Therapy by Tx Assignment|Inevaluable|1
2699238|NCT00408005|9301006|P5|Post Induction Therapy by Tx Assignment|Inevaluable|0
2699239|NCT00408005|9301007|P4|Post Induction Therapy by Tx Assignment|Inevaluable|0
2699240|NCT00408005|9301008|P3|Post Induction Therapy by Tx Assignment|Inevaluable|0
2699241|NCT00408005|9301009|P2|Post Induction Therapy by Tx Assignment|Inevaluable|0
2699242|NCT00408005|9301010|P1|Post Induction Therapy by Tx Assignment|Inevaluable|0
2699243|NCT00408005|9301003|P8|Post Induction Therapy by Tx Assignment|Progressive Disease|7
2699244|NCT00408005|9301004|P7|Post Induction Therapy by Tx Assignment|Progressive Disease|7
2699245|NCT00408005|9301005|P6|Post Induction Therapy by Tx Assignment|Progressive Disease|0
2699246|NCT00408005|9301006|P5|Post Induction Therapy by Tx Assignment|Progressive Disease|1
2699247|NCT00408005|9301007|P4|Post Induction Therapy by Tx Assignment|Progressive Disease|0
2699248|NCT00408005|9301008|P3|Post Induction Therapy by Tx Assignment|Progressive Disease|0
2699249|NCT00408005|9301009|P2|Post Induction Therapy by Tx Assignment|Progressive Disease|0
2699250|NCT00408005|9301010|P1|Post Induction Therapy by Tx Assignment|Progressive Disease|0
2699251|NCT00408005|9301003|P8|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
2699252|NCT00408005|9301004|P7|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
2699253|NCT00408005|9301005|P6|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
2699254|NCT00408005|9301006|P5|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
2699255|NCT00408005|9301007|P4|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
2699256|NCT00408005|9301008|P3|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3
2699257|NCT00408005|9301009|P2|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
2699258|NCT00408005|9301010|P1|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
2699259|NCT00408005|9301003|P8|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
2699260|NCT00408005|9301004|P7|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
2699261|NCT00408005|9301005|P6|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
2699262|NCT00408005|9301006|P5|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1
2699263|NCT00408005|9301007|P4|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
2699264|NCT00408005|9301008|P3|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
2699265|NCT00408005|9301009|P2|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
2699266|NCT00408005|9301010|P1|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
2699267|NCT00408005|9301003|P8|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2
2699268|NCT00408005|9301004|P7|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4
2699269|NCT00408005|9301005|P6|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16
2699270|NCT00408005|9301006|P5|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36
2699271|NCT00408005|9301007|P4|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10
2699272|NCT00408005|9301008|P3|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27
2699273|NCT00408005|9301009|P2|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0
2699274|NCT00408005|9301010|P1|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0
2699275|NCT00408005|9301003|P8|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
2699276|NCT00408005|9301004|P7|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
2699277|NCT00408005|9301005|P6|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2
2699278|NCT00408005|9301006|P5|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
2699279|NCT00408005|9301007|P4|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1
2699280|NCT00408005|9301008|P3|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1
2699281|NCT00408005|9301009|P2|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
2699282|NCT00408005|9301010|P1|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
2699283|NCT00408005|9301003|P8|Post Induction Therapy by Tx Assignment|Physician Decision|4
2699284|NCT00408005|9301004|P7|Post Induction Therapy by Tx Assignment|Physician Decision|10
2699285|NCT00408005|9301005|P6|Post Induction Therapy by Tx Assignment|Physician Decision|45
2699286|NCT00408005|9301006|P5|Post Induction Therapy by Tx Assignment|Physician Decision|27
2699287|NCT00408005|9301007|P4|Post Induction Therapy by Tx Assignment|Physician Decision|19
2699288|NCT00408005|9301008|P3|Post Induction Therapy by Tx Assignment|Physician Decision|24
2699289|NCT00408005|9301009|P2|Post Induction Therapy by Tx Assignment|Physician Decision|0
2699290|NCT00408005|9301010|P1|Post Induction Therapy by Tx Assignment|Physician Decision|0
2699291|NCT00408005|9301003|P8|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
2699292|NCT00408005|9301004|P7|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
2699293|NCT00408005|9301005|P6|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
2699294|NCT00408005|9301006|P5|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1
2699295|NCT00408005|9301007|P4|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
2699296|NCT00408005|9301008|P3|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2
2699297|NCT00408005|9301009|P2|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
2699298|NCT00408005|9301010|P1|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
2699299|NCT00408005|9301003|P8|Post Induction Therapy by Tx Assignment|Death|1
2699300|NCT00408005|9301004|P7|Post Induction Therapy by Tx Assignment|Death|3
2699301|NCT00408005|9301005|P6|Post Induction Therapy by Tx Assignment|Death|5
2699302|NCT00408005|9301006|P5|Post Induction Therapy by Tx Assignment|Death|5
2699303|NCT00408005|9301007|P4|Post Induction Therapy by Tx Assignment|Death|0
2699304|NCT00408005|9301008|P3|Post Induction Therapy by Tx Assignment|Death|3
2699305|NCT00408005|9301009|P2|Post Induction Therapy by Tx Assignment|Death|0
2699306|NCT00408005|9301010|P1|Post Induction Therapy by Tx Assignment|Death|0
2699307|NCT00408005|9301003|P8|Post Induction Therapy by Tx Assignment|Adverse Event|0
2699308|NCT00408005|9301004|P7|Post Induction Therapy by Tx Assignment|Adverse Event|2
2699309|NCT00408005|9301005|P6|Post Induction Therapy by Tx Assignment|Adverse Event|12
2699310|NCT00408005|9301006|P5|Post Induction Therapy by Tx Assignment|Adverse Event|8
2699311|NCT00408005|9301007|P4|Post Induction Therapy by Tx Assignment|Adverse Event|4
2699312|NCT00408005|9301008|P3|Post Induction Therapy by Tx Assignment|Adverse Event|7
2699313|NCT00408005|9301009|P2|Post Induction Therapy by Tx Assignment|Adverse Event|0
2699314|NCT00408005|9301010|P1|Post Induction Therapy by Tx Assignment|Adverse Event|0
2699315|NCT00408005|9301003|P8|Induction|Recurrent leukemia|0
2699316|NCT00408005|9301004|P7|Induction|Recurrent leukemia|0
2699317|NCT00408005|9301005|P6|Induction|Recurrent leukemia|0
2699318|NCT00408005|9301006|P5|Induction|Recurrent leukemia|0
2699319|NCT00408005|9301007|P4|Induction|Recurrent leukemia|0
2699320|NCT00408005|9301008|P3|Induction|Recurrent leukemia|0
2699321|NCT00408005|9301009|P2|Induction|Recurrent leukemia|0
2699322|NCT00408005|9301010|P1|Induction|Recurrent leukemia|1
2699323|NCT00408005|9301003|P8|Induction|Hematopoietic Stem Cell Transplantation|0
2699324|NCT00408005|9301004|P7|Induction|Hematopoietic Stem Cell Transplantation|0
2699325|NCT00408005|9301005|P6|Induction|Hematopoietic Stem Cell Transplantation|0
2699326|NCT00408005|9301006|P5|Induction|Hematopoietic Stem Cell Transplantation|0
2699327|NCT00408005|9301007|P4|Induction|Hematopoietic Stem Cell Transplantation|0
2699328|NCT00408005|9301008|P3|Induction|Hematopoietic Stem Cell Transplantation|0
2699329|NCT00408005|9301009|P2|Induction|Hematopoietic Stem Cell Transplantation|0
2699330|NCT00408005|9301010|P1|Induction|Hematopoietic Stem Cell Transplantation|1
2699331|NCT00408005|9301003|P8|Induction|Protocol Deviation|0
2699332|NCT00408005|9301004|P7|Induction|Protocol Deviation|0
2699333|NCT00408005|9301005|P6|Induction|Protocol Deviation|0
2699334|NCT00408005|9301006|P5|Induction|Protocol Deviation|0
2699335|NCT00408005|9301007|P4|Induction|Protocol Deviation|0
2699336|NCT00408005|9301008|P3|Induction|Protocol Deviation|0
2699337|NCT00408005|9301009|P2|Induction|Protocol Deviation|1
2699338|NCT00408005|9301010|P1|Induction|Protocol Deviation|3
2699339|NCT00408005|9301003|P8|Induction|Failed to Complete Randomization|0
2699340|NCT00408005|9301004|P7|Induction|Failed to Complete Randomization|0
2699341|NCT00408005|9301005|P6|Induction|Failed to Complete Randomization|0
2699342|NCT00408005|9301006|P5|Induction|Failed to Complete Randomization|0
2699343|NCT00408005|9301007|P4|Induction|Failed to Complete Randomization|0
2699344|NCT00408005|9301008|P3|Induction|Failed to Complete Randomization|0
2699345|NCT00408005|9301009|P2|Induction|Failed to Complete Randomization|2
2699346|NCT00408005|9301010|P1|Induction|Failed to Complete Randomization|3
2699347|NCT00408005|9301003|P8|Induction|Inevaluable|0
2699348|NCT00408005|9301004|P7|Induction|Inevaluable|0
2699349|NCT00408005|9301005|P6|Induction|Inevaluable|0
2699350|NCT00408005|9301006|P5|Induction|Inevaluable|0
2699351|NCT00408005|9301007|P4|Induction|Inevaluable|0
2699352|NCT00408005|9301008|P3|Induction|Inevaluable|0
2699353|NCT00408005|9301009|P2|Induction|Inevaluable|14
2699354|NCT00408005|9301010|P1|Induction|Inevaluable|18
2699355|NCT00408005|9301003|P8|Induction|Progressive Disease|0
2699356|NCT00408005|9301004|P7|Induction|Progressive Disease|0
2699357|NCT00408005|9301005|P6|Induction|Progressive Disease|0
2699358|NCT00408005|9301006|P5|Induction|Progressive Disease|0
2699359|NCT00408005|9301007|P4|Induction|Progressive Disease|0
2699360|NCT00408005|9301008|P3|Induction|Progressive Disease|0
2699361|NCT00408005|9301009|P2|Induction|Progressive Disease|1
2699362|NCT00408005|9301010|P1|Induction|Progressive Disease|0
2699363|NCT00408005|9301003|P8|Induction|Identified as Philadelphia Chr. Positive|0
2699364|NCT00408005|9301004|P7|Induction|Identified as Philadelphia Chr. Positive|0
2699365|NCT00408005|9301005|P6|Induction|Identified as Philadelphia Chr. Positive|0
2699366|NCT00408005|9301006|P5|Induction|Identified as Philadelphia Chr. Positive|0
2699367|NCT00408005|9301007|P4|Induction|Identified as Philadelphia Chr. Positive|0
2699368|NCT00408005|9301008|P3|Induction|Identified as Philadelphia Chr. Positive|0
2699369|NCT00408005|9301009|P2|Induction|Identified as Philadelphia Chr. Positive|0
2699370|NCT00408005|9301010|P1|Induction|Identified as Philadelphia Chr. Positive|6
2699371|NCT00408005|9301003|P8|Induction|Patient transferred Tx to Non-COG Site|0
2699372|NCT00408005|9301004|P7|Induction|Patient transferred Tx to Non-COG Site|0
2699373|NCT00408005|9301005|P6|Induction|Patient transferred Tx to Non-COG Site|0
2699374|NCT00408005|9301006|P5|Induction|Patient transferred Tx to Non-COG Site|0
2699375|NCT00408005|9301007|P4|Induction|Patient transferred Tx to Non-COG Site|0
2699376|NCT00408005|9301008|P3|Induction|Patient transferred Tx to Non-COG Site|0
2699377|NCT00408005|9301009|P2|Induction|Patient transferred Tx to Non-COG Site|2
2699378|NCT00408005|9301010|P1|Induction|Patient transferred Tx to Non-COG Site|3
2699379|NCT00408005|9301003|P8|Induction|Entered another COG therapeutic protocol|0
2699380|NCT00408005|9301004|P7|Induction|Entered another COG therapeutic protocol|0
2699381|NCT00408005|9301005|P6|Induction|Entered another COG therapeutic protocol|0
2699382|NCT00408005|9301006|P5|Induction|Entered another COG therapeutic protocol|0
2699383|NCT00408005|9301007|P4|Induction|Entered another COG therapeutic protocol|0
2699384|NCT00408005|9301008|P3|Induction|Entered another COG therapeutic protocol|0
2699385|NCT00408005|9301009|P2|Induction|Entered another COG therapeutic protocol|0
2699386|NCT00408005|9301010|P1|Induction|Entered another COG therapeutic protocol|4
2699387|NCT00408005|9301003|P8|Induction|Refusal of Further Protocol Therapy|0
2699388|NCT00408005|9301004|P7|Induction|Refusal of Further Protocol Therapy|0
2699389|NCT00408005|9301005|P6|Induction|Refusal of Further Protocol Therapy|0
2699390|NCT00408005|9301006|P5|Induction|Refusal of Further Protocol Therapy|0
2699391|NCT00408005|9301007|P4|Induction|Refusal of Further Protocol Therapy|0
2699392|NCT00408005|9301008|P3|Induction|Refusal of Further Protocol Therapy|0
2699393|NCT00408005|9301009|P2|Induction|Refusal of Further Protocol Therapy|44
2699394|NCT00408005|9301010|P1|Induction|Refusal of Further Protocol Therapy|225
2699395|NCT00408005|9301003|P8|Induction|Ineligible|0
2699396|NCT00408005|9301004|P7|Induction|Ineligible|0
2699397|NCT00408005|9301005|P6|Induction|Ineligible|0
2699398|NCT00408005|9301006|P5|Induction|Ineligible|0
2699399|NCT00408005|9301007|P4|Induction|Ineligible|0
2699400|NCT00408005|9301008|P3|Induction|Ineligible|0
2699401|NCT00408005|9301009|P2|Induction|Ineligible|14
2699402|NCT00408005|9301010|P1|Induction|Ineligible|33
2699403|NCT00408005|9301003|P8|Induction|Withdrawal by Subject|0
2699404|NCT00408005|9301004|P7|Induction|Withdrawal by Subject|0
2699405|NCT00408005|9301005|P6|Induction|Withdrawal by Subject|0
2699406|NCT00408005|9301006|P5|Induction|Withdrawal by Subject|0
2699407|NCT00408005|9301007|P4|Induction|Withdrawal by Subject|0
2699408|NCT00408005|9301008|P3|Induction|Withdrawal by Subject|0
2699409|NCT00408005|9301009|P2|Induction|Withdrawal by Subject|4
2699410|NCT00408005|9301010|P1|Induction|Withdrawal by Subject|2
2699411|NCT00408005|9301003|P8|Induction|Physician Decision|0
2699412|NCT00408005|9301004|P7|Induction|Physician Decision|0
2699413|NCT00408005|9301005|P6|Induction|Physician Decision|0
2699414|NCT00408005|9301006|P5|Induction|Physician Decision|0
2699415|NCT00408005|9301007|P4|Induction|Physician Decision|0
2699416|NCT00408005|9301008|P3|Induction|Physician Decision|0
2699417|NCT00408005|9301009|P2|Induction|Physician Decision|9
2699418|NCT00408005|9301010|P1|Induction|Physician Decision|83
2699419|NCT00408005|9301003|P8|Induction|Death|0
2699420|NCT00408005|9301004|P7|Induction|Death|0
2699421|NCT00408005|9301005|P6|Induction|Death|0
2699422|NCT00408005|9301006|P5|Induction|Death|0
2699423|NCT00408005|9301007|P4|Induction|Death|0
2699424|NCT00408005|9301008|P3|Induction|Death|0
2699425|NCT00408005|9301009|P2|Induction|Death|0
2699426|NCT00408005|9301010|P1|Induction|Death|6
2699427|NCT00408005|9301003|P8|Induction|Adverse Event|0
2699428|NCT00408005|9301004|P7|Induction|Adverse Event|0
2699429|NCT00408005|9301005|P6|Induction|Adverse Event|0
2699430|NCT00408005|9301006|P5|Induction|Adverse Event|0
2699431|NCT00408005|9301007|P4|Induction|Adverse Event|0
2699432|NCT00408005|9301008|P3|Induction|Adverse Event|0
2699433|NCT00408005|9301009|P2|Induction|Adverse Event|3
2699434|NCT00408005|9301010|P1|Induction|Adverse Event|19
2699435|NCT00407797|9301052|P1|Overall Study|Withdrawal by Subject|3
2699436|NCT00407797|9301052|P1|Overall Study|Other|7
2699437|NCT00407797|9301052|P1|Overall Study|Adverse Event|6
2699438|NCT00407797|9301052|P1|Overall Study|Lost to Follow-up|2
2699439|NCT00407758|9301067|P1|Overall Study|ineligible –improper prior treatment|1
2699440|NCT00407745|9301080|P2|Overall Study|Randomized, unknown if treated|1
2699441|NCT00407745|9301081|P1|Overall Study|Randomized, unknown if treated|0
2699442|NCT00407745|9301080|P2|Overall Study|Other|0
2699443|NCT00407745|9301081|P1|Overall Study|Other|2
2699444|NCT00407745|9301080|P2|Overall Study|Adverse Event|8
2699445|NCT00407745|9301081|P1|Overall Study|Adverse Event|8
2699446|NCT00407745|9301080|P2|Overall Study|Protocol Violation|3
2699447|NCT00407745|9301081|P1|Overall Study|Protocol Violation|5
2699448|NCT00407745|9301080|P2|Overall Study|Withdrawal by Subject|3
2699449|NCT00407745|9301081|P1|Overall Study|Withdrawal by Subject|3
2699450|NCT00407745|9301080|P2|Overall Study|Lack of Efficacy|2
2699451|NCT00407745|9301081|P1|Overall Study|Lack of Efficacy|1
2699452|NCT00407563|9301167|P1|Overall Study|Patient continues on treatment|1
2699453|NCT00407550|9301177|P2|Overall Study|Insurance or Other medical condition|1
2699454|NCT00407550|9301178|P1|Overall Study|Insurance or Other medical condition|2
2699455|NCT00407550|9301177|P2|Overall Study|Death|0
2699456|NCT00407550|9301178|P1|Overall Study|Death|1
2699457|NCT00407550|9301177|P2|Overall Study|Withdrawal by Subject|2
2699458|NCT00407550|9301178|P1|Overall Study|Withdrawal by Subject|0
2699459|NCT00407550|9301177|P2|Overall Study|Adverse Event|1
2699460|NCT00407550|9301178|P1|Overall Study|Adverse Event|0
2699461|NCT00407537|9301192|P2|Overall Study|Withdrawal by Subject|16
2699462|NCT00407537|9301193|P1|Overall Study|Withdrawal by Subject|34
2699463|NCT00407537|9301192|P2|Overall Study|Other|7
2699464|NCT00407537|9301193|P1|Overall Study|Other|6
2699465|NCT00407537|9301192|P2|Overall Study|Lost to Follow-up|19
2699466|NCT00407537|9301193|P1|Overall Study|Lost to Follow-up|12
2699467|NCT00407537|9301192|P2|Overall Study|Adverse Event|0
2699468|NCT00407537|9301193|P1|Overall Study|Adverse Event|36
2699469|NCT00407537|9301192|P2|Overall Study|Death|2
2699470|NCT00407537|9301193|P1|Overall Study|Death|5
2699471|NCT00407511|9301241|P1|Overall Study|Withdrawal by Subject|4
2699472|NCT00407511|9301241|P1|Overall Study|Other|5
2699473|NCT00407511|9301241|P1|Overall Study|Lost to Follow-up|4
2699474|NCT00407511|9301241|P1|Overall Study|Adverse Event|9
2699475|NCT00407030|9301302|P3|Extension Period - up to 68 Weeks|Physician Decision|0
2699476|NCT00407030|9301303|P2|Extension Period - up to 68 Weeks|Physician Decision|2
2699477|NCT00407030|9301304|P1|Extension Period - up to 68 Weeks|Physician Decision|1
2699478|NCT00407030|9301302|P3|Extension Period - up to 68 Weeks|Patient Decision|0
2699479|NCT00407030|9301303|P2|Extension Period - up to 68 Weeks|Patient Decision|2
2699480|NCT00407030|9301304|P1|Extension Period - up to 68 Weeks|Patient Decision|1
2699481|NCT00407030|9301302|P3|Extension Period - up to 68 Weeks|Lost to Follow-up|0
2699482|NCT00407030|9301303|P2|Extension Period - up to 68 Weeks|Lost to Follow-up|5
2699483|NCT00407030|9301304|P1|Extension Period - up to 68 Weeks|Lost to Follow-up|5
2699484|NCT00407030|9301302|P3|Extension Period - up to 68 Weeks|Consent Withdrawn|0
2699485|NCT00407030|9301303|P2|Extension Period - up to 68 Weeks|Consent Withdrawn|4
2699486|NCT00407030|9301304|P1|Extension Period - up to 68 Weeks|Consent Withdrawn|4
2699487|NCT00407030|9301302|P3|Extension Period - up to 68 Weeks|Adverse Event|0
2699488|NCT00407030|9301303|P2|Extension Period - up to 68 Weeks|Adverse Event|0
2699489|NCT00407030|9301304|P1|Extension Period - up to 68 Weeks|Adverse Event|1
2699490|NCT00407030|9301302|P3|Extension Period - up to 68 Weeks|Lack of Efficacy|0
2699491|NCT00407030|9301303|P2|Extension Period - up to 68 Weeks|Lack of Efficacy|11
2699492|NCT00407030|9301304|P1|Extension Period - up to 68 Weeks|Lack of Efficacy|11
2699493|NCT00407030|9301302|P3|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
2699494|NCT00407030|9301303|P2|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5
2699495|NCT00407030|9301304|P1|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
2699496|NCT00407030|9301302|P3|Main Period - 8 to 20 Weeks|Patient Decision|0
2699497|NCT00407030|9301303|P2|Main Period - 8 to 20 Weeks|Patient Decision|0
2699498|NCT00407030|9301304|P1|Main Period - 8 to 20 Weeks|Patient Decision|1
2699499|NCT00407030|9301302|P3|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1
2699500|NCT00407030|9301303|P2|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
2699501|NCT00407030|9301304|P1|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
2699502|NCT00407030|9301302|P3|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
2699503|NCT00407030|9301303|P2|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
2699504|NCT00407030|9301304|P1|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
2699505|NCT00407030|9301302|P3|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
2699506|NCT00407030|9301303|P2|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
2699507|NCT00407030|9301304|P1|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
2699508|NCT00407030|9301302|P3|Main Period - 8 to 20 Weeks|Lack of Efficacy|3
2699509|NCT00407030|9301303|P2|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
2699510|NCT00407030|9301304|P1|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
2699511|NCT00407030|9301302|P3|Main Period - 8 to 20 Weeks|Adverse Event|0
2699512|NCT00407030|9301303|P2|Main Period - 8 to 20 Weeks|Adverse Event|1
2699513|NCT00407030|9301304|P1|Main Period - 8 to 20 Weeks|Adverse Event|2
2699514|NCT00406848|9301332|P2|Overall Study|Sponsor Decision|1
2699515|NCT00406848|9301333|P1|Overall Study|Sponsor Decision|1
2699516|NCT00406848|9301332|P2|Overall Study|Physician Decision|2
2699517|NCT00406848|9301333|P1|Overall Study|Physician Decision|2
2699518|NCT00406848|9301332|P2|Overall Study|Lost to Follow-up|2
2699519|NCT00406848|9301333|P1|Overall Study|Lost to Follow-up|6
2699520|NCT00406848|9301332|P2|Overall Study|Protocol Violation|6
2699521|NCT00406848|9301333|P1|Overall Study|Protocol Violation|10
2699522|NCT00406848|9301332|P2|Overall Study|Lack of Efficacy|14
2699523|NCT00406848|9301333|P1|Overall Study|Lack of Efficacy|9
2699524|NCT00406848|9301332|P2|Overall Study|Adverse Event|7
2699525|NCT00406848|9301333|P1|Overall Study|Adverse Event|38
2699526|NCT00406848|9301332|P2|Overall Study|Withdrawal by Subject|22
2699527|NCT00406848|9301333|P1|Overall Study|Withdrawal by Subject|27
2699528|NCT00406783|9301397|P2|Overall Study|Protocol Violation|4
2699529|NCT00406783|9301398|P1|Overall Study|Protocol Violation|4
2699530|NCT00406783|9301397|P2|Overall Study|Withdrawal by Subject|4
2699531|NCT00406783|9301398|P1|Overall Study|Withdrawal by Subject|1
2699532|NCT00406783|9301397|P2|Overall Study|Lost to Follow-up|0
2699533|NCT00406783|9301398|P1|Overall Study|Lost to Follow-up|3
2699534|NCT00406783|9301397|P2|Overall Study|Treatment Failure|3
2699535|NCT00406783|9301398|P1|Overall Study|Treatment Failure|2
2699536|NCT00406783|9301397|P2|Overall Study|Adverse Event|4
2699537|NCT00406783|9301398|P1|Overall Study|Adverse Event|4
2699538|NCT00406718|9301413|P3|Overall Study|Lost to Follow-up|4
2699539|NCT00406718|9301414|P2|Overall Study|Lost to Follow-up|5
2699540|NCT00406718|9301415|P1|Overall Study|Lost to Follow-up|2
2699541|NCT00406718|9301413|P3|Overall Study|Withdrawal by Subject|4
2699542|NCT00406718|9301414|P2|Overall Study|Withdrawal by Subject|9
2699543|NCT00406718|9301415|P1|Overall Study|Withdrawal by Subject|2
2699544|NCT00406692|9301429|P1|Overall Study|Lack of Efficacy|1
2699545|NCT00406692|9301429|P1|Overall Study|Adverse Event|1
2699546|NCT00406692|9301429|P1|Overall Study|Physician Decision|1
2699547|NCT00406692|9301429|P1|Overall Study|Withdrawal by Subject|4
2699548|NCT00406653|9301439|P7|Open-Label Period|Refused followup|1
2699549|NCT00406653|9301440|P6|Open-Label Period|Refused followup|0
2699550|NCT00406653|9301441|P5|Open-Label Period|Refused followup|0
2699551|NCT00406653|9301442|P4|Open-Label Period|Refused followup|0
2699552|NCT00406653|9301443|P3|Open-Label Period|Refused followup|0
2699553|NCT00406653|9301444|P2|Open-Label Period|Refused followup|0
2699554|NCT00406653|9301445|P1|Open-Label Period|Refused followup|0
2699555|NCT00406653|9301439|P7|Open-Label Period|Discontinued by Sponsor|1
2699556|NCT00406653|9301440|P6|Open-Label Period|Discontinued by Sponsor|0
2699557|NCT00406653|9301441|P5|Open-Label Period|Discontinued by Sponsor|0
2699558|NCT00406653|9301442|P4|Open-Label Period|Discontinued by Sponsor|0
2699559|NCT00406653|9301443|P3|Open-Label Period|Discontinued by Sponsor|0
2699560|NCT00406653|9301444|P2|Open-Label Period|Discontinued by Sponsor|0
2699561|NCT00406653|9301445|P1|Open-Label Period|Discontinued by Sponsor|0
2699562|NCT00406653|9301439|P7|Open-Label Period|Declined participation but followup done|8
2699563|NCT00406653|9301440|P6|Open-Label Period|Declined participation but followup done|0
2699564|NCT00406653|9301441|P5|Open-Label Period|Declined participation but followup done|0
2699565|NCT00406653|9301442|P4|Open-Label Period|Declined participation but followup done|0
2699566|NCT00406653|9301443|P3|Open-Label Period|Declined participation but followup done|0
2699567|NCT00406653|9301444|P2|Open-Label Period|Declined participation but followup done|0
2699568|NCT00406653|9301445|P1|Open-Label Period|Declined participation but followup done|0
2699569|NCT00406653|9301439|P7|Open-Label Period|Administrative Reason By Sponsor|115
2699570|NCT00406653|9301440|P6|Open-Label Period|Administrative Reason By Sponsor|0
2699571|NCT00406653|9301441|P5|Open-Label Period|Administrative Reason By Sponsor|0
2699572|NCT00406653|9301442|P4|Open-Label Period|Administrative Reason By Sponsor|0
2699573|NCT00406653|9301443|P3|Open-Label Period|Administrative Reason By Sponsor|0
2699574|NCT00406653|9301444|P2|Open-Label Period|Administrative Reason By Sponsor|0
2699575|NCT00406653|9301445|P1|Open-Label Period|Administrative Reason By Sponsor|0
2699576|NCT00406653|9301439|P7|Open-Label Period|Pregnancy|2
2699577|NCT00406653|9301440|P6|Open-Label Period|Pregnancy|0
2699578|NCT00406653|9301441|P5|Open-Label Period|Pregnancy|0
2699579|NCT00406653|9301442|P4|Open-Label Period|Pregnancy|0
2699580|NCT00406653|9301443|P3|Open-Label Period|Pregnancy|0
2699581|NCT00406653|9301444|P2|Open-Label Period|Pregnancy|0
2699582|NCT00406653|9301445|P1|Open-Label Period|Pregnancy|0
2699583|NCT00406653|9301439|P7|Open-Label Period|Subject No Longer Meets Study Criteria|1
2699584|NCT00406653|9301440|P6|Open-Label Period|Subject No Longer Meets Study Criteria|0
2699585|NCT00406653|9301441|P5|Open-Label Period|Subject No Longer Meets Study Criteria|0
2699586|NCT00406653|9301442|P4|Open-Label Period|Subject No Longer Meets Study Criteria|0
2699587|NCT00406653|9301443|P3|Open-Label Period|Subject No Longer Meets Study Criteria|0
2699588|NCT00406653|9301444|P2|Open-Label Period|Subject No Longer Meets Study Criteria|0
2699589|NCT00406653|9301445|P1|Open-Label Period|Subject No Longer Meets Study Criteria|0
2699590|NCT00406653|9301439|P7|Open-Label Period|Withdrawal of Consent|11
2699591|NCT00406653|9301440|P6|Open-Label Period|Withdrawal of Consent|0
2699592|NCT00406653|9301441|P5|Open-Label Period|Withdrawal of Consent|0
2699593|NCT00406653|9301442|P4|Open-Label Period|Withdrawal of Consent|0
2699594|NCT00406653|9301443|P3|Open-Label Period|Withdrawal of Consent|0
2699595|NCT00406653|9301444|P2|Open-Label Period|Withdrawal of Consent|0
2699596|NCT00406653|9301445|P1|Open-Label Period|Withdrawal of Consent|0
2699597|NCT00406653|9301439|P7|Open-Label Period|Lost to Follow-up|6
2699598|NCT00406653|9301440|P6|Open-Label Period|Lost to Follow-up|0
2699599|NCT00406653|9301441|P5|Open-Label Period|Lost to Follow-up|0
2699600|NCT00406653|9301442|P4|Open-Label Period|Lost to Follow-up|0
2699601|NCT00406653|9301443|P3|Open-Label Period|Lost to Follow-up|0
2699602|NCT00406653|9301444|P2|Open-Label Period|Lost to Follow-up|0
2699603|NCT00406653|9301445|P1|Open-Label Period|Lost to Follow-up|0
2699604|NCT00406653|9301439|P7|Open-Label Period|Lack of Efficacy|160
2699605|NCT00406653|9301440|P6|Open-Label Period|Lack of Efficacy|0
2699606|NCT00406653|9301441|P5|Open-Label Period|Lack of Efficacy|0
2699607|NCT00406653|9301442|P4|Open-Label Period|Lack of Efficacy|0
2699608|NCT00406653|9301443|P3|Open-Label Period|Lack of Efficacy|0
2699609|NCT00406653|9301444|P2|Open-Label Period|Lack of Efficacy|0
2699610|NCT00406653|9301445|P1|Open-Label Period|Lack of Efficacy|0
2699611|NCT00406653|9301439|P7|Open-Label Period|Adverse Event|18
2699612|NCT00406653|9301440|P6|Open-Label Period|Adverse Event|0
2699613|NCT00406653|9301441|P5|Open-Label Period|Adverse Event|0
2699614|NCT00406653|9301442|P4|Open-Label Period|Adverse Event|0
2699615|NCT00406653|9301443|P3|Open-Label Period|Adverse Event|0
2699616|NCT00406653|9301444|P2|Open-Label Period|Adverse Event|0
2699617|NCT00406653|9301445|P1|Open-Label Period|Adverse Event|0
2699618|NCT00406653|9301439|P7|Open-Label Period|Death|1
2699619|NCT00406653|9301440|P6|Open-Label Period|Death|0
2699620|NCT00406653|9301441|P5|Open-Label Period|Death|0
2699621|NCT00406653|9301442|P4|Open-Label Period|Death|0
2699622|NCT00406653|9301443|P3|Open-Label Period|Death|0
2699623|NCT00406653|9301444|P2|Open-Label Period|Death|0
2699624|NCT00406653|9301445|P1|Open-Label Period|Death|0
2699625|NCT00406653|9301439|P7|Maintenance Period|Error in disease score evaluation|0
2699626|NCT00406653|9301440|P6|Maintenance Period|Error in disease score evaluation|0
2699627|NCT00406653|9301441|P5|Maintenance Period|Error in disease score evaluation|1
2699628|NCT00406653|9301442|P4|Maintenance Period|Error in disease score evaluation|0
2699629|NCT00406653|9301443|P3|Maintenance Period|Error in disease score evaluation|0
2699630|NCT00406653|9301444|P2|Maintenance Period|Error in disease score evaluation|0
2699631|NCT00406653|9301445|P1|Maintenance Period|Error in disease score evaluation|0
2699632|NCT00406653|9301439|P7|Maintenance Period|Administrative Reason By Sponsor|0
2699633|NCT00406653|9301440|P6|Maintenance Period|Administrative Reason By Sponsor|7
2699634|NCT00406653|9301441|P5|Maintenance Period|Administrative Reason By Sponsor|4
2699635|NCT00406653|9301442|P4|Maintenance Period|Administrative Reason By Sponsor|0
2699636|NCT00406653|9301443|P3|Maintenance Period|Administrative Reason By Sponsor|0
2699637|NCT00406653|9301444|P2|Maintenance Period|Administrative Reason By Sponsor|0
2699638|NCT00406653|9301445|P1|Maintenance Period|Administrative Reason By Sponsor|0
2699639|NCT00406653|9301439|P7|Maintenance Period|Pregnancy|0
2699640|NCT00406653|9301440|P6|Maintenance Period|Pregnancy|1
2699641|NCT00406653|9301441|P5|Maintenance Period|Pregnancy|0
2699642|NCT00406653|9301442|P4|Maintenance Period|Pregnancy|0
2699643|NCT00406653|9301443|P3|Maintenance Period|Pregnancy|0
2699644|NCT00406653|9301444|P2|Maintenance Period|Pregnancy|0
2699645|NCT00406653|9301445|P1|Maintenance Period|Pregnancy|0
2699646|NCT00406653|9301439|P7|Maintenance Period|Withdrawal of Consent|0
2699647|NCT00406653|9301440|P6|Maintenance Period|Withdrawal of Consent|0
2699648|NCT00406653|9301441|P5|Maintenance Period|Withdrawal of Consent|2
2699649|NCT00406653|9301442|P4|Maintenance Period|Withdrawal of Consent|0
2699650|NCT00406653|9301443|P3|Maintenance Period|Withdrawal of Consent|0
2699651|NCT00406653|9301444|P2|Maintenance Period|Withdrawal of Consent|0
2699652|NCT00406653|9301445|P1|Maintenance Period|Withdrawal of Consent|0
2699653|NCT00406653|9301439|P7|Maintenance Period|Lost to Follow-up|0
2699654|NCT00406653|9301440|P6|Maintenance Period|Lost to Follow-up|1
2699655|NCT00406653|9301441|P5|Maintenance Period|Lost to Follow-up|2
2699656|NCT00406653|9301442|P4|Maintenance Period|Lost to Follow-up|0
2699657|NCT00406653|9301443|P3|Maintenance Period|Lost to Follow-up|0
2699658|NCT00406653|9301444|P2|Maintenance Period|Lost to Follow-up|0
2699659|NCT00406653|9301445|P1|Maintenance Period|Lost to Follow-up|0
2699660|NCT00406653|9301439|P7|Maintenance Period|Lack of Efficacy|0
2699661|NCT00406653|9301440|P6|Maintenance Period|Lack of Efficacy|26
2699662|NCT00406653|9301441|P5|Maintenance Period|Lack of Efficacy|20
2699663|NCT00406653|9301442|P4|Maintenance Period|Lack of Efficacy|0
2699664|NCT00406653|9301443|P3|Maintenance Period|Lack of Efficacy|0
2699665|NCT00406653|9301444|P2|Maintenance Period|Lack of Efficacy|0
2699666|NCT00406653|9301445|P1|Maintenance Period|Lack of Efficacy|0
2699667|NCT00406653|9301439|P7|Maintenance Period|Adverse Event|0
2699668|NCT00406653|9301440|P6|Maintenance Period|Adverse Event|1
2699669|NCT00406653|9301441|P5|Maintenance Period|Adverse Event|1
2699670|NCT00406653|9301442|P4|Maintenance Period|Adverse Event|0
2699671|NCT00406653|9301443|P3|Maintenance Period|Adverse Event|0
2699672|NCT00406653|9301444|P2|Maintenance Period|Adverse Event|0
2699673|NCT00406653|9301445|P1|Maintenance Period|Adverse Event|0
2699674|NCT00406653|9301439|P7|Induction Period|Patient relocated|0
2699675|NCT00406653|9301440|P6|Induction Period|Patient relocated|0
2699676|NCT00406653|9301441|P5|Induction Period|Patient relocated|0
2699677|NCT00406653|9301442|P4|Induction Period|Patient relocated|0
2699678|NCT00406653|9301443|P3|Induction Period|Patient relocated|1
2699679|NCT00406653|9301444|P2|Induction Period|Patient relocated|0
2699680|NCT00406653|9301445|P1|Induction Period|Patient relocated|0
2699681|NCT00406653|9301439|P7|Induction Period|Incarcerated|0
2699682|NCT00406653|9301440|P6|Induction Period|Incarcerated|0
2699683|NCT00406653|9301441|P5|Induction Period|Incarcerated|0
2699684|NCT00406653|9301442|P4|Induction Period|Incarcerated|0
2699685|NCT00406653|9301443|P3|Induction Period|Incarcerated|1
2699686|NCT00406653|9301444|P2|Induction Period|Incarcerated|0
2699687|NCT00406653|9301445|P1|Induction Period|Incarcerated|0
2699688|NCT00406653|9301439|P7|Induction Period|Given prohibited drug|0
2699689|NCT00406653|9301440|P6|Induction Period|Given prohibited drug|0
2699690|NCT00406653|9301441|P5|Induction Period|Given prohibited drug|0
2699691|NCT00406653|9301442|P4|Induction Period|Given prohibited drug|0
2699692|NCT00406653|9301443|P3|Induction Period|Given prohibited drug|2
2699693|NCT00406653|9301444|P2|Induction Period|Given prohibited drug|1
2699694|NCT00406653|9301445|P1|Induction Period|Given prohibited drug|0
2699695|NCT00406653|9301439|P7|Induction Period|Declined participation but followup done|0
2699696|NCT00406653|9301440|P6|Induction Period|Declined participation but followup done|0
2699697|NCT00406653|9301441|P5|Induction Period|Declined participation but followup done|0
2699698|NCT00406653|9301442|P4|Induction Period|Declined participation but followup done|1
2699699|NCT00406653|9301443|P3|Induction Period|Declined participation but followup done|1
2699700|NCT00406653|9301444|P2|Induction Period|Declined participation but followup done|2
2699701|NCT00406653|9301445|P1|Induction Period|Declined participation but followup done|0
2699702|NCT00406653|9301439|P7|Induction Period|Pregnancy|0
2699703|NCT00406653|9301440|P6|Induction Period|Pregnancy|0
2699704|NCT00406653|9301441|P5|Induction Period|Pregnancy|0
2699705|NCT00406653|9301442|P4|Induction Period|Pregnancy|0
2699706|NCT00406653|9301443|P3|Induction Period|Pregnancy|0
2699707|NCT00406653|9301444|P2|Induction Period|Pregnancy|0
2699708|NCT00406653|9301445|P1|Induction Period|Pregnancy|1
2699709|NCT00406653|9301439|P7|Induction Period|Subject No Longer Meets Study Criteria|0
2699710|NCT00406653|9301440|P6|Induction Period|Subject No Longer Meets Study Criteria|0
2699711|NCT00406653|9301441|P5|Induction Period|Subject No Longer Meets Study Criteria|0
2699712|NCT00406653|9301442|P4|Induction Period|Subject No Longer Meets Study Criteria|2
2699713|NCT00406653|9301443|P3|Induction Period|Subject No Longer Meets Study Criteria|0
2699714|NCT00406653|9301444|P2|Induction Period|Subject No Longer Meets Study Criteria|0
2699715|NCT00406653|9301445|P1|Induction Period|Subject No Longer Meets Study Criteria|0
2699716|NCT00406653|9301439|P7|Induction Period|Withdrawal of Consent|0
2699717|NCT00406653|9301440|P6|Induction Period|Withdrawal of Consent|0
2699718|NCT00406653|9301441|P5|Induction Period|Withdrawal of Consent|0
2699719|NCT00406653|9301442|P4|Induction Period|Withdrawal of Consent|2
2699720|NCT00406653|9301443|P3|Induction Period|Withdrawal of Consent|1
2699721|NCT00406653|9301444|P2|Induction Period|Withdrawal of Consent|5
2699722|NCT00406653|9301445|P1|Induction Period|Withdrawal of Consent|2
2699723|NCT00406653|9301439|P7|Induction Period|Lost to Follow-up|0
2699724|NCT00406653|9301440|P6|Induction Period|Lost to Follow-up|0
2699725|NCT00406653|9301441|P5|Induction Period|Lost to Follow-up|0
2699726|NCT00406653|9301442|P4|Induction Period|Lost to Follow-up|0
2699727|NCT00406653|9301443|P3|Induction Period|Lost to Follow-up|0
2699728|NCT00406653|9301444|P2|Induction Period|Lost to Follow-up|2
2699729|NCT00406653|9301445|P1|Induction Period|Lost to Follow-up|0
2699730|NCT00406653|9301439|P7|Induction Period|Lack of Efficacy|0
2699731|NCT00406653|9301440|P6|Induction Period|Lack of Efficacy|0
2699732|NCT00406653|9301441|P5|Induction Period|Lack of Efficacy|0
2699733|NCT00406653|9301442|P4|Induction Period|Lack of Efficacy|10
2699734|NCT00406653|9301443|P3|Induction Period|Lack of Efficacy|8
2699735|NCT00406653|9301444|P2|Induction Period|Lack of Efficacy|14
2699736|NCT00406653|9301445|P1|Induction Period|Lack of Efficacy|11
2699737|NCT00406653|9301439|P7|Induction Period|Adverse Event|0
2699738|NCT00406653|9301440|P6|Induction Period|Adverse Event|0
2699739|NCT00406653|9301441|P5|Induction Period|Adverse Event|0
2699740|NCT00406653|9301442|P4|Induction Period|Adverse Event|11
2699741|NCT00406653|9301443|P3|Induction Period|Adverse Event|4
2699742|NCT00406653|9301444|P2|Induction Period|Adverse Event|10
2699743|NCT00406653|9301445|P1|Induction Period|Adverse Event|1
2699744|NCT00406640|9301526|P2|OL Extension Phase for Non-Responders|Lack of Efficacy|7
2699745|NCT00406640|9301527|P1|OL Extension Phase for Non-Responders|Lack of Efficacy|6
2699746|NCT00406640|9301526|P2|OL Extension Phase for Non-Responders|Withdrawal by Subject|6
2699747|NCT00406640|9301527|P1|OL Extension Phase for Non-Responders|Withdrawal by Subject|3
2699748|NCT00406640|9301526|P2|OL Extension Phase for Non-Responders|non-compliance|2
2699749|NCT00406640|9301527|P1|OL Extension Phase for Non-Responders|non-compliance|3
2699750|NCT00406640|9301526|P2|OL Extension Phase for Non-Responders|Lost to Follow-up|3
2699751|NCT00406640|9301527|P1|OL Extension Phase for Non-Responders|Lost to Follow-up|2
2699752|NCT00406640|9301526|P2|OL Extension Phase for Non-Responders|Physician Decision|0
2699753|NCT00406640|9301527|P1|OL Extension Phase for Non-Responders|Physician Decision|1
2699754|NCT00406640|9301526|P2|OL Extension Phase for Non-Responders|Failed to Return|0
2699755|NCT00406640|9301527|P1|OL Extension Phase for Non-Responders|Failed to Return|1
2699756|NCT00406640|9301526|P2|OL Extension Phase for Non-Responders|Adverse Event|6
2699757|NCT00406640|9301527|P1|OL Extension Phase for Non-Responders|Adverse Event|6
2699758|NCT00406640|9301526|P2|DB Continuation Phase for Responders|Lack of Efficacy|1
2699759|NCT00406640|9301527|P1|DB Continuation Phase for Responders|Lack of Efficacy|1
2699760|NCT00406640|9301526|P2|DB Continuation Phase for Responders|Withdrawal by Subject|6
2699761|NCT00406640|9301527|P1|DB Continuation Phase for Responders|Withdrawal by Subject|8
2699762|NCT00406640|9301526|P2|DB Continuation Phase for Responders|Protocol Violation|2
2699763|NCT00406640|9301527|P1|DB Continuation Phase for Responders|Protocol Violation|2
2699764|NCT00406640|9301526|P2|DB Continuation Phase for Responders|non-compliance|5
2699765|NCT00406640|9301527|P1|DB Continuation Phase for Responders|non-compliance|7
2699766|NCT00406640|9301526|P2|DB Continuation Phase for Responders|Lost to Follow-up|7
2699767|NCT00406640|9301527|P1|DB Continuation Phase for Responders|Lost to Follow-up|1
2699768|NCT00406640|9301526|P2|DB Continuation Phase for Responders|Physician Decision|3
2699769|NCT00406640|9301527|P1|DB Continuation Phase for Responders|Physician Decision|2
2699770|NCT00406640|9301526|P2|DB Continuation Phase for Responders|Failed to Return|2
2699771|NCT00406640|9301527|P1|DB Continuation Phase for Responders|Failed to Return|0
2699772|NCT00406640|9301526|P2|DB Continuation Phase for Responders|Death|0
2699773|NCT00406640|9301527|P1|DB Continuation Phase for Responders|Death|1
2699774|NCT00406640|9301526|P2|DB Continuation Phase for Responders|Adverse Event|11
2699775|NCT00406640|9301527|P1|DB Continuation Phase for Responders|Adverse Event|11
2699776|NCT00406640|9301526|P2|Acute Phase|Lack of Efficacy|3
2699777|NCT00406640|9301527|P1|Acute Phase|Lack of Efficacy|3
2699778|NCT00406640|9301526|P2|Acute Phase|Withdrawal by Subject|9
2699779|NCT00406640|9301527|P1|Acute Phase|Withdrawal by Subject|11
2699780|NCT00406640|9301526|P2|Acute Phase|Protocol Violation|2
2699781|NCT00406640|9301527|P1|Acute Phase|Protocol Violation|3
2699782|NCT00406640|9301526|P2|Acute Phase|Protocol deviation|10
2699783|NCT00406640|9301527|P1|Acute Phase|Protocol deviation|4
2699784|NCT00406640|9301526|P2|Acute Phase|Lost to Follow-up|4
2699785|NCT00406640|9301527|P1|Acute Phase|Lost to Follow-up|7
2699786|NCT00406640|9301526|P2|Acute Phase|Physician Decision|1
2699787|NCT00406640|9301527|P1|Acute Phase|Physician Decision|0
2699788|NCT00406640|9301526|P2|Acute Phase|Failed to Return|1
2699789|NCT00406640|9301527|P1|Acute Phase|Failed to Return|5
2699790|NCT00406640|9301526|P2|Acute Phase|Adverse Event|13
2699791|NCT00406640|9301527|P1|Acute Phase|Adverse Event|18
2699792|NCT00406393|9301559|P2|Overall Study|Did not undergo transplantation|1
2699793|NCT00406393|9301560|P1|Overall Study|Did not undergo transplantation|2
2699794|NCT00406367|9301590|P2|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0
2699795|NCT00406367|9301591|P1|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1
2699796|NCT00406367|9301590|P2|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0
2699797|NCT00406367|9301591|P1|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1
2699798|NCT00406367|9301590|P2|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0
2699799|NCT00406367|9301591|P1|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1
2699800|NCT00406367|9301590|P2|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0
2699801|NCT00406367|9301591|P1|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1
2699802|NCT00406367|9301590|P2|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0
2699803|NCT00406367|9301591|P1|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4
2699804|NCT00406367|9301590|P2|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
2699805|NCT00406367|9301591|P1|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
2699806|NCT00406367|9301590|P2|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0
2699807|NCT00406367|9301591|P1|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6
2699808|NCT00406367|9301590|P2|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0
2699809|NCT00406367|9301591|P1|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2
2699810|NCT00406367|9301590|P2|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1
2699811|NCT00406367|9301591|P1|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0
2699812|NCT00406367|9301590|P2|Main Period - 6 to 20 Weeks|Lost to Follow-up|1
2699813|NCT00406367|9301591|P1|Main Period - 6 to 20 Weeks|Lost to Follow-up|0
2699814|NCT00406367|9301590|P2|Main Period - 6 to 20 Weeks|Consent Withdrawn|0
2699815|NCT00406367|9301591|P1|Main Period - 6 to 20 Weeks|Consent Withdrawn|1
2699816|NCT00406367|9301590|P2|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0
2699817|NCT00406367|9301591|P1|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4
2699818|NCT00406354|9301606|P3|All Randomized and Treated Patients|Physician Decision|1
2699819|NCT00406354|9301607|P2|All Randomized and Treated Patients|Physician Decision|0
2699820|NCT00406354|9301608|P1|All Randomized and Treated Patients|Physician Decision|0
2699821|NCT00406354|9301606|P3|All Randomized and Treated Patients|Withdrawal by Subject|2
2699822|NCT00406354|9301607|P2|All Randomized and Treated Patients|Withdrawal by Subject|1
2699823|NCT00406354|9301608|P1|All Randomized and Treated Patients|Withdrawal by Subject|1
2699824|NCT00406354|9301606|P3|All Randomized and Treated Patients|Parent/Caregiver Decision|1
2699825|NCT00406354|9301607|P2|All Randomized and Treated Patients|Parent/Caregiver Decision|6
2699826|NCT00406354|9301608|P1|All Randomized and Treated Patients|Parent/Caregiver Decision|2
2699827|NCT00406354|9301606|P3|All Randomized and Treated Patients|Adverse Event|1
2699828|NCT00406354|9301607|P2|All Randomized and Treated Patients|Adverse Event|2
2699829|NCT00406354|9301608|P1|All Randomized and Treated Patients|Adverse Event|6
2699830|NCT00406354|9301606|P3|All Randomized and Treated Patients|Lack of Efficacy|17
2699831|NCT00406354|9301607|P2|All Randomized and Treated Patients|Lack of Efficacy|4
2699832|NCT00406354|9301608|P1|All Randomized and Treated Patients|Lack of Efficacy|7
2699833|NCT00406354|9301606|P3|All Randomized Patients|Protocol Violation|1
2699834|NCT00406354|9301607|P2|All Randomized Patients|Protocol Violation|0
2699835|NCT00406354|9301608|P1|All Randomized Patients|Protocol Violation|0
2699836|NCT00406315|9301679|P1|Overall Study|Withdrawal by Subject|30
2699837|NCT00406315|9301679|P1|Overall Study|Lost to Follow-up|21
2699838|NCT00406315|9301679|P1|Overall Study|Other|33
2699839|NCT00406315|9301679|P1|Overall Study|Lack of Efficacy|13
2699840|NCT00406315|9301679|P1|Overall Study|Laboratory Abnormality|4
2699841|NCT00406315|9301679|P1|Overall Study|Adverse Event|39
2699842|NCT00406315|9301679|P1|Overall Study|Death|1
2699843|NCT00406029|9301789|P5|Overall Study|Randomized in Error|1
2699844|NCT00406029|9301790|P4|Overall Study|Randomized in Error|3
2699845|NCT00406029|9301791|P3|Overall Study|Randomized in Error|2
2699846|NCT00406029|9301792|P2|Overall Study|Randomized in Error|0
2699847|NCT00406029|9301793|P1|Overall Study|Randomized in Error|0
2699848|NCT00406029|9301789|P5|Overall Study|Did Not Meet Eligibility Criteria|0
2699849|NCT00406029|9301790|P4|Overall Study|Did Not Meet Eligibility Criteria|0
2699850|NCT00406029|9301791|P3|Overall Study|Did Not Meet Eligibility Criteria|1
2699851|NCT00406029|9301792|P2|Overall Study|Did Not Meet Eligibility Criteria|0
2699852|NCT00406029|9301793|P1|Overall Study|Did Not Meet Eligibility Criteria|0
2699853|NCT00406029|9301789|P5|Overall Study|Protocol Violation|0
2699854|NCT00406029|9301790|P4|Overall Study|Protocol Violation|2
2699855|NCT00406029|9301791|P3|Overall Study|Protocol Violation|0
2699856|NCT00406029|9301792|P2|Overall Study|Protocol Violation|2
2699857|NCT00406029|9301793|P1|Overall Study|Protocol Violation|1
2699858|NCT00406029|9301789|P5|Overall Study|Withdrawal by Subject|0
2699859|NCT00406029|9301790|P4|Overall Study|Withdrawal by Subject|2
2699860|NCT00406029|9301791|P3|Overall Study|Withdrawal by Subject|2
2699861|NCT00406029|9301792|P2|Overall Study|Withdrawal by Subject|4
2699862|NCT00406029|9301793|P1|Overall Study|Withdrawal by Subject|3
2699863|NCT00406029|9301789|P5|Overall Study|Adverse Event|7
2699864|NCT00406029|9301790|P4|Overall Study|Adverse Event|10
2699865|NCT00406029|9301791|P3|Overall Study|Adverse Event|5
2699866|NCT00406029|9301792|P2|Overall Study|Adverse Event|2
2699867|NCT00406029|9301793|P1|Overall Study|Adverse Event|12
2699868|NCT00405964|9301897|P2|Overall Study|Protocol Violation|6
2699869|NCT00405964|9301898|P1|Overall Study|Protocol Violation|11
2699870|NCT00405964|9301897|P2|Overall Study|Withdrawal by Subject|23
2699871|NCT00405964|9301898|P1|Overall Study|Withdrawal by Subject|19
2699872|NCT00405964|9301897|P2|Overall Study|Lost to Follow-up|5
2699873|NCT00405964|9301898|P1|Overall Study|Lost to Follow-up|5
2699874|NCT00405964|9301897|P2|Overall Study|Adverse Event|16
2699875|NCT00405964|9301898|P1|Overall Study|Adverse Event|7
2699876|NCT00405964|9301897|P2|Overall Study|Treatment Failure|45
2699877|NCT00405964|9301898|P1|Overall Study|Treatment Failure|17
2699878|NCT00405912|9301920|P3|Overall Study|Lost to Follow-up|4
2699879|NCT00405912|9301921|P2|Overall Study|Lost to Follow-up|8
2699880|NCT00405912|9301922|P1|Overall Study|Lost to Follow-up|4
2699881|NCT00405912|9301920|P3|Overall Study|Withdrawal by Subject|12
2699882|NCT00405912|9301921|P2|Overall Study|Withdrawal by Subject|11
2699883|NCT00405912|9301922|P1|Overall Study|Withdrawal by Subject|12
2699884|NCT00405821|9301935|P2|Overall Study|initiated ART|8
2699885|NCT00405821|9301936|P1|Overall Study|initiated ART|9
2699886|NCT00405821|9301935|P2|Overall Study|Protocol Violation|0
2699887|NCT00405821|9301936|P1|Overall Study|Protocol Violation|1
2699888|NCT00405821|9301935|P2|Overall Study|Lost to Follow-up|7
2699889|NCT00405821|9301936|P1|Overall Study|Lost to Follow-up|7
2699890|NCT00405821|9301935|P2|Overall Study|Death|7
2699891|NCT00405821|9301936|P1|Overall Study|Death|5
2699892|NCT00405756|9301949|P3|Follow-up|Lost to Follow-up|4
2699893|NCT00405756|9301950|P2|Follow-up|Lost to Follow-up|8
2699894|NCT00405756|9301951|P1|Follow-up|Lost to Follow-up|2
2699895|NCT00405756|9301949|P3|Follow-up|Death|24
2699896|NCT00405756|9301950|P2|Follow-up|Death|31
2699897|NCT00405756|9301951|P1|Follow-up|Death|21
2699898|NCT00405756|9301949|P3|Follow-up|Ongoing in Follow-up Period|60
2699899|NCT00405756|9301950|P2|Follow-up|Ongoing in Follow-up Period|51
2699900|NCT00405756|9301951|P1|Follow-up|Ongoing in Follow-up Period|52
2699901|NCT00405756|9301949|P3|Open-label Extension|Other|7
2699902|NCT00405756|9301950|P2|Open-label Extension|Other|1
2699903|NCT00405756|9301951|P1|Open-label Extension|Other|0
2699904|NCT00405756|9301949|P3|Open-label Extension|Death|4
2699905|NCT00405756|9301950|P2|Open-label Extension|Death|2
2699906|NCT00405756|9301951|P1|Open-label Extension|Death|1
2699907|NCT00405756|9301949|P3|Open-label Extension|Withdrawal by Subject|3
2699908|NCT00405756|9301950|P2|Open-label Extension|Withdrawal by Subject|3
2699909|NCT00405756|9301951|P1|Open-label Extension|Withdrawal by Subject|2
2699910|NCT00405756|9301949|P3|Open-label Extension|Disease Progression|26
2699911|NCT00405756|9301950|P2|Open-label Extension|Disease Progression|23
2699912|NCT00405756|9301951|P1|Open-label Extension|Disease Progression|8
2699913|NCT00405756|9301949|P3|Open-label Extension|Adverse Event|7
2699914|NCT00405756|9301950|P2|Open-label Extension|Adverse Event|3
2699915|NCT00405756|9301951|P1|Open-label Extension|Adverse Event|1
2699916|NCT00405756|9301949|P3|Open-label Extension|Ongoing in Open Label Period|25
2699917|NCT00405756|9301950|P2|Open-label Extension|Ongoing in Open Label Period|15
2699918|NCT00405756|9301951|P1|Open-label Extension|Ongoing in Open Label Period|7
2699919|NCT00405756|9301949|P3|Double-blind Treatment|Other|4
2699920|NCT00405756|9301950|P2|Double-blind Treatment|Other|4
2699921|NCT00405756|9301951|P1|Double-blind Treatment|Other|7
2699922|NCT00405756|9301949|P3|Double-blind Treatment|Protocol Violation|2
2699923|NCT00405756|9301950|P2|Double-blind Treatment|Protocol Violation|0
2699924|NCT00405756|9301951|P1|Double-blind Treatment|Protocol Violation|1
2699925|NCT00405756|9301949|P3|Double-blind Treatment|Death|4
2699926|NCT00405756|9301950|P2|Double-blind Treatment|Death|4
2699927|NCT00405756|9301951|P1|Double-blind Treatment|Death|4
2699928|NCT00405756|9301949|P3|Double-blind Treatment|Lost to Follow-up|0
2699929|NCT00405756|9301950|P2|Double-blind Treatment|Lost to Follow-up|0
2699930|NCT00405756|9301951|P1|Double-blind Treatment|Lost to Follow-up|1
2699931|NCT00405756|9301949|P3|Double-blind Treatment|Withdrawal by Subject|10
2699932|NCT00405756|9301950|P2|Double-blind Treatment|Withdrawal by Subject|9
2699933|NCT00405756|9301951|P1|Double-blind Treatment|Withdrawal by Subject|15
2699934|NCT00405756|9301949|P3|Double-blind Treatment|Lack of Efficacy|2
2699935|NCT00405756|9301950|P2|Double-blind Treatment|Lack of Efficacy|4
2699936|NCT00405756|9301951|P1|Double-blind Treatment|Lack of Efficacy|1
2699937|NCT00405756|9301949|P3|Double-blind Treatment|Disease Progression|102
2699938|NCT00405756|9301950|P2|Double-blind Treatment|Disease Progression|81
2699939|NCT00405756|9301951|P1|Double-blind Treatment|Disease Progression|47
2699940|NCT00405756|9301949|P3|Double-blind Treatment|Adverse Event|12
2699941|NCT00405756|9301950|P2|Double-blind Treatment|Adverse Event|27
2699942|NCT00405756|9301951|P1|Double-blind Treatment|Adverse Event|31
2699943|NCT00405756|9301949|P3|Double-blind Treatment|Ongoing in Double-blind Treatment|18
2699944|NCT00405756|9301950|P2|Double-blind Treatment|Ongoing in Double-blind Treatment|24
2699945|NCT00405756|9301951|P1|Double-blind Treatment|Ongoing in Double-blind Treatment|45
2699946|NCT00405652|9302062|P1|Overall Study|Adverse Event|4
2699947|NCT00405639|9302069|P2|Overall Study|Seizure prior to receiving BNP|0
2699948|NCT00405639|9302070|P1|Overall Study|Seizure prior to receiving BNP|1
2699949|NCT00405639|9302069|P2|Overall Study|Adverse Event|0
2699950|NCT00405639|9302070|P1|Overall Study|Adverse Event|1
2699951|NCT00405639|9302069|P2|Overall Study|Withdrawal by Subject|0
2699952|NCT00405639|9302070|P1|Overall Study|Withdrawal by Subject|1
2699953|NCT00405587|9302086|P4|Overall Study|Participant not dosed|0
2699954|NCT00405587|9302087|P3|Overall Study|Participant not dosed|0
2699955|NCT00405587|9302088|P2|Overall Study|Participant not dosed|1
2699956|NCT00405587|9302089|P1|Overall Study|Participant not dosed|0
2699957|NCT00405587|9302086|P4|Overall Study|Withdrawal by Subject|2
2699958|NCT00405587|9302087|P3|Overall Study|Withdrawal by Subject|0
2699959|NCT00405587|9302088|P2|Overall Study|Withdrawal by Subject|0
2699960|NCT00405587|9302089|P1|Overall Study|Withdrawal by Subject|0
2699961|NCT00405587|9302086|P4|Overall Study|Radiation induced necrosis|0
2699962|NCT00405587|9302087|P3|Overall Study|Radiation induced necrosis|0
2699963|NCT00405587|9302088|P2|Overall Study|Radiation induced necrosis|1
2699964|NCT00405587|9302089|P1|Overall Study|Radiation induced necrosis|0
2699965|NCT00405587|9302086|P4|Overall Study|Lost to Follow-up|0
2699966|NCT00405587|9302087|P3|Overall Study|Lost to Follow-up|1
2699967|NCT00405587|9302088|P2|Overall Study|Lost to Follow-up|1
2699968|NCT00405587|9302089|P1|Overall Study|Lost to Follow-up|0
2699969|NCT00405587|9302086|P4|Overall Study|Adverse Event|0
2699970|NCT00405587|9302087|P3|Overall Study|Adverse Event|0
2699971|NCT00405587|9302088|P2|Overall Study|Adverse Event|0
2699972|NCT00405587|9302089|P1|Overall Study|Adverse Event|1
2699973|NCT00405587|9302086|P4|Overall Study|Physician Decision|0
2699974|NCT00405587|9302087|P3|Overall Study|Physician Decision|0
2699975|NCT00405587|9302088|P2|Overall Study|Physician Decision|2
2699976|NCT00405587|9302089|P1|Overall Study|Physician Decision|3
2699977|NCT00405587|9302086|P4|Overall Study|Disease Progression|17
2699978|NCT00405587|9302087|P3|Overall Study|Disease Progression|21
2699979|NCT00405587|9302088|P2|Overall Study|Disease Progression|23
2699980|NCT00405587|9302089|P1|Overall Study|Disease Progression|22
2699981|NCT00405587|9302086|P4|Overall Study|Death|1
2699982|NCT00405587|9302087|P3|Overall Study|Death|0
2699983|NCT00405587|9302088|P2|Overall Study|Death|0
2699984|NCT00405587|9302089|P1|Overall Study|Death|0
2699985|NCT00405548|9302207|P2|Overall Study|Withdrawal by Subject|0
2699986|NCT00405548|9302208|P1|Overall Study|Withdrawal by Subject|1
2699987|NCT00405548|9302207|P2|Overall Study|Venous access failed during study day|0
2699988|NCT00405548|9302208|P1|Overall Study|Venous access failed during study day|1
2699989|NCT00405548|9302207|P2|Overall Study|Unable to self-administer shots|0
2699990|NCT00405548|9302208|P1|Overall Study|Unable to self-administer shots|1
2699991|NCT00405548|9302207|P2|Overall Study|Amyloidosis on study echo-exclusionary|1
2699992|NCT00405548|9302208|P1|Overall Study|Amyloidosis on study echo-exclusionary|0
2699993|NCT00405548|9302207|P2|Overall Study|Cognitive Memory problems on study day|0
2699994|NCT00405548|9302208|P1|Overall Study|Cognitive Memory problems on study day|1
2699995|NCT00405392|9302252|P2|Overall Study|Other|5
2699996|NCT00405392|9302253|P1|Overall Study|Other|1
2699997|NCT00405392|9302252|P2|Overall Study|Non-compliance|1
2699998|NCT00405392|9302253|P1|Overall Study|Non-compliance|0
2699999|NCT00405392|9302252|P2|Overall Study|Data missing|0
2700000|NCT00405392|9302253|P1|Overall Study|Data missing|2
2700001|NCT00405392|9302252|P2|Overall Study|Lost to Follow-up|2
2700002|NCT00405392|9302253|P1|Overall Study|Lost to Follow-up|1
2700003|NCT00405392|9302252|P2|Overall Study|Withdrawal by Subject|3
2700004|NCT00405392|9302253|P1|Overall Study|Withdrawal by Subject|4
2700005|NCT00405392|9302252|P2|Overall Study|Did not meet Eligibility criteria|2
2700006|NCT00405392|9302253|P1|Overall Study|Did not meet Eligibility criteria|7
2700007|NCT00405392|9302252|P2|Overall Study|Adverse Event|14
2700008|NCT00405392|9302253|P1|Overall Study|Adverse Event|15
2700009|NCT00405275|9302300|P2|Overall Study|Unwilling to continue|9
2700010|NCT00405275|9302301|P1|Overall Study|Unwilling to continue|10
2700011|NCT00405275|9302300|P2|Overall Study|Withdrawal by Subject|9
2700012|NCT00405275|9302301|P1|Overall Study|Withdrawal by Subject|7
2700013|NCT00405275|9302300|P2|Overall Study|Lost to Follow-up|1
2700014|NCT00405275|9302301|P1|Overall Study|Lost to Follow-up|5
2700015|NCT00405275|9302300|P2|Overall Study|Death|0
2700016|NCT00405275|9302301|P1|Overall Study|Death|1
2700017|NCT00405067|9302310|P3|Overall Study|Lost to Follow-up|1
2700018|NCT00405067|9302311|P2|Overall Study|Lost to Follow-up|0
2700019|NCT00405067|9302312|P1|Overall Study|Lost to Follow-up|0
2700020|NCT00405067|9302310|P3|Overall Study|Adverse Event|4
2700021|NCT00405067|9302311|P2|Overall Study|Adverse Event|9
2700022|NCT00405067|9302312|P1|Overall Study|Adverse Event|4
2700023|NCT00404924|9302349|P2|Overall Study|Randomised but not received treatment|1
2700024|NCT00404924|9302350|P1|Overall Study|Randomised but not received treatment|1
2700025|NCT00404924|9302349|P2|Overall Study|Other|11
2700026|NCT00404924|9302350|P1|Overall Study|Other|25
2700027|NCT00404924|9302349|P2|Overall Study|Withdrawal by Subject|13
2700028|NCT00404924|9302350|P1|Overall Study|Withdrawal by Subject|26
2700029|NCT00404924|9302349|P2|Overall Study|Lost to Follow-up|1
2700030|NCT00404924|9302350|P1|Overall Study|Lost to Follow-up|1
2700031|NCT00404924|9302349|P2|Overall Study|Condition under investigation worsened|264
2700032|NCT00404924|9302350|P1|Overall Study|Condition under investigation worsened|475
2700033|NCT00404924|9302349|P2|Overall Study|Adverse Event|16
2700034|NCT00404924|9302350|P1|Overall Study|Adverse Event|75
2700035|NCT00404820|9302368|P2|Overall Study|Other|2
2700036|NCT00404820|9302369|P1|Overall Study|Other|0
2700037|NCT00404820|9302368|P2|Overall Study|Death|0
2700038|NCT00404820|9302369|P1|Overall Study|Death|1
2700039|NCT00404820|9302368|P2|Overall Study|Administrative problems|0
2700040|NCT00404820|9302369|P1|Overall Study|Administrative problems|2
2700041|NCT00404820|9302368|P2|Overall Study|Lost to Follow-up|3
2700042|NCT00404820|9302369|P1|Overall Study|Lost to Follow-up|7
2700043|NCT00404820|9302368|P2|Overall Study|Withdrawal by Subject|3
2700044|NCT00404820|9302369|P1|Overall Study|Withdrawal by Subject|5
2700045|NCT00404820|9302368|P2|Overall Study|Adverse Event|16
2700046|NCT00404820|9302369|P1|Overall Study|Adverse Event|4
2700047|NCT00404768|9302391|P4|Part C|Researcher suspended study medication|1
2700048|NCT00404768|9302392|P3|Part C|Researcher suspended study medication|0
2700049|NCT00404768|9302393|P2|Part C|Researcher suspended study medication|0
2700050|NCT00404768|9302394|P1|Part C|Researcher suspended study medication|0
2700051|NCT00404768|9302391|P4|Part C|Investigator discretion|1
2700052|NCT00404768|9302392|P3|Part C|Investigator discretion|0
2700053|NCT00404768|9302393|P2|Part C|Investigator discretion|0
2700054|NCT00404768|9302394|P1|Part C|Investigator discretion|0
2700055|NCT00404768|9302391|P4|Part C|Treatment failure|1
2700056|NCT00404768|9302392|P3|Part C|Treatment failure|0
2700057|NCT00404768|9302393|P2|Part C|Treatment failure|0
2700058|NCT00404768|9302394|P1|Part C|Treatment failure|0
2700059|NCT00404768|9302391|P4|Part C|Lack of Efficacy|2
2700060|NCT00404768|9302392|P3|Part C|Lack of Efficacy|0
2700061|NCT00404768|9302393|P2|Part C|Lack of Efficacy|0
2700062|NCT00404768|9302394|P1|Part C|Lack of Efficacy|0
2700063|NCT00404768|9302391|P4|Part C|Active labor|1
2700064|NCT00404768|9302392|P3|Part C|Active labor|0
2700065|NCT00404768|9302393|P2|Part C|Active labor|0
2700066|NCT00404768|9302394|P1|Part C|Active labor|0
2700067|NCT00404768|9302391|P4|Part C|Unsatisfactory uterine response to IP|1
2700068|NCT00404768|9302392|P3|Part C|Unsatisfactory uterine response to IP|0
2700069|NCT00404768|9302393|P2|Part C|Unsatisfactory uterine response to IP|0
2700070|NCT00404768|9302394|P1|Part C|Unsatisfactory uterine response to IP|0
2700071|NCT00404768|9302391|P4|Part C|Participant delivered baby|1
2700072|NCT00404768|9302392|P3|Part C|Participant delivered baby|0
2700073|NCT00404768|9302393|P2|Part C|Participant delivered baby|0
2700074|NCT00404768|9302394|P1|Part C|Participant delivered baby|0
2700075|NCT00404768|9302391|P4|Part C|Physician withdrew the study medication|0
2700076|NCT00404768|9302392|P3|Part C|Physician withdrew the study medication|1
2700077|NCT00404768|9302393|P2|Part C|Physician withdrew the study medication|0
2700078|NCT00404768|9302394|P1|Part C|Physician withdrew the study medication|0
2700079|NCT00404768|9302391|P4|Part C|Participant did not respond to therapy|1
2700080|NCT00404768|9302392|P3|Part C|Participant did not respond to therapy|1
2700081|NCT00404768|9302393|P2|Part C|Participant did not respond to therapy|0
2700082|NCT00404768|9302394|P1|Part C|Participant did not respond to therapy|0
2700083|NCT00404768|9302391|P4|Part C|Early withdrawal from study medication|0
2700084|NCT00404768|9302392|P3|Part C|Early withdrawal from study medication|1
2700085|NCT00404768|9302393|P2|Part C|Early withdrawal from study medication|0
2700086|NCT00404768|9302394|P1|Part C|Early withdrawal from study medication|0
2700087|NCT00404768|9302391|P4|Part C|Withdrawal by Subject|1
2700088|NCT00404768|9302392|P3|Part C|Withdrawal by Subject|2
2700089|NCT00404768|9302393|P2|Part C|Withdrawal by Subject|0
2700090|NCT00404768|9302394|P1|Part C|Withdrawal by Subject|0
2700091|NCT00404768|9302391|P4|Part C|Lost to Follow-up|1
2700092|NCT00404768|9302392|P3|Part C|Lost to Follow-up|3
2700093|NCT00404768|9302393|P2|Part C|Lost to Follow-up|0
2700094|NCT00404768|9302394|P1|Part C|Lost to Follow-up|0
2700095|NCT00404768|9302391|P4|Part C|Adverse Event|3
2700096|NCT00404768|9302392|P3|Part C|Adverse Event|0
2700097|NCT00404768|9302393|P2|Part C|Adverse Event|0
2700098|NCT00404768|9302394|P1|Part C|Adverse Event|0
2700099|NCT00404768|9302391|P4|Part A and B|Withdrawn as delivery imminemnt|0
2700100|NCT00404768|9302392|P3|Part A and B|Withdrawn as delivery imminemnt|0
2700101|NCT00404768|9302393|P2|Part A and B|Withdrawn as delivery imminemnt|1
2700102|NCT00404768|9302394|P1|Part A and B|Withdrawn as delivery imminemnt|0
2700103|NCT00404768|9302391|P4|Part A and B|Withdrawn due to labor progression|0
2700104|NCT00404768|9302392|P3|Part A and B|Withdrawn due to labor progression|0
2700105|NCT00404768|9302393|P2|Part A and B|Withdrawn due to labor progression|0
2700106|NCT00404768|9302394|P1|Part A and B|Withdrawn due to labor progression|1
2700107|NCT00404755|9302455|P1|Phase II (Escitalopram)|Lost to Follow-up|2
2700108|NCT00404755|9302455|P1|Phase I (Bupropion)|Other|1
2700109|NCT00404755|9302455|P1|Phase I (Bupropion)|Adverse Event|3
2700110|NCT00404651|9302470|P4|Overall Study|Withdrawal by Subject|6
2700111|NCT00404651|9302471|P3|Overall Study|Withdrawal by Subject|16
2700112|NCT00404651|9302472|P2|Overall Study|Withdrawal by Subject|12
2700113|NCT00404651|9302473|P1|Overall Study|Withdrawal by Subject|14
2700114|NCT00404651|9302470|P4|Overall Study|Lost to Follow-up|10
2700115|NCT00404651|9302471|P3|Overall Study|Lost to Follow-up|13
2700116|NCT00404651|9302472|P2|Overall Study|Lost to Follow-up|11
2700117|NCT00404651|9302473|P1|Overall Study|Lost to Follow-up|15
2700118|NCT00404651|9302470|P4|Overall Study|Protocol Violation|5
2700119|NCT00404651|9302471|P3|Overall Study|Protocol Violation|14
2700120|NCT00404651|9302472|P2|Overall Study|Protocol Violation|5
2700121|NCT00404651|9302473|P1|Overall Study|Protocol Violation|10
2700122|NCT00404651|9302470|P4|Overall Study|Serious Adverse Event|0
2700123|NCT00404651|9302471|P3|Overall Study|Serious Adverse Event|2
2700124|NCT00404651|9302472|P2|Overall Study|Serious Adverse Event|0
2700125|NCT00404651|9302473|P1|Overall Study|Serious Adverse Event|0
2700126|NCT00404547|9302501|P2|Overall Study|Reason not stated|6
2700127|NCT00404547|9302502|P1|Overall Study|Reason not stated|3
2700128|NCT00404547|9302501|P2|Overall Study|Other|0
2700129|NCT00404547|9302502|P1|Overall Study|Other|4
2700130|NCT00404547|9302501|P2|Overall Study|Lack of compliance|1
2700131|NCT00404547|9302502|P1|Overall Study|Lack of compliance|5
2700132|NCT00404547|9302501|P2|Overall Study|Lost to Follow-up|9
2700133|NCT00404547|9302502|P1|Overall Study|Lost to Follow-up|20
2700134|NCT00404547|9302501|P2|Overall Study|Protocol Violation|1
2700135|NCT00404547|9302502|P1|Overall Study|Protocol Violation|0
2700136|NCT00404547|9302501|P2|Overall Study|Withdrawal by Subject|2
2700137|NCT00404547|9302502|P1|Overall Study|Withdrawal by Subject|19
2700138|NCT00404547|9302501|P2|Overall Study|Adverse Event|6
2700139|NCT00404547|9302502|P1|Overall Study|Adverse Event|39
2700140|NCT00404495|9302512|P2|Overall Study|Withdrawal by Subject|0
2700141|NCT00404495|9302513|P1|Overall Study|Withdrawal by Subject|1
2700142|NCT00404495|9302512|P2|Overall Study|Other|0
2700143|NCT00404495|9302513|P1|Overall Study|Other|1
2700144|NCT00404495|9302512|P2|Overall Study|Lost to Follow-up|0
2700145|NCT00404495|9302513|P1|Overall Study|Lost to Follow-up|5
2700146|NCT00404495|9302512|P2|Overall Study|Death|11
2700147|NCT00404495|9302513|P1|Overall Study|Death|37
2700148|NCT00404352|9302532|P9|Open Label Extension (up to 36 Months)|Other|2
2700149|NCT00404352|9302533|P8|Open Label Extension (up to 36 Months)|Other|0
2700150|NCT00404352|9302534|P7|Open Label Extension (up to 36 Months)|Other|0
2700151|NCT00404352|9302535|P6|Open Label Extension (up to 36 Months)|Other|0
2700152|NCT00404352|9302536|P5|Open Label Extension (up to 36 Months)|Other|0
2700153|NCT00404352|9302537|P4|Open Label Extension (up to 36 Months)|Other|0
2700154|NCT00404352|9302538|P3|Open Label Extension (up to 36 Months)|Other|0
2700155|NCT00404352|9302539|P2|Open Label Extension (up to 36 Months)|Other|0
2700156|NCT00404352|9302540|P1|Open Label Extension (up to 36 Months)|Other|0
2700157|NCT00404352|9302532|P9|Open Label Extension (up to 36 Months)|Adverse Event|0
2700158|NCT00404352|9302533|P8|Open Label Extension (up to 36 Months)|Adverse Event|1
2700159|NCT00404352|9302534|P7|Open Label Extension (up to 36 Months)|Adverse Event|1
2700160|NCT00404352|9302535|P6|Open Label Extension (up to 36 Months)|Adverse Event|0
2700161|NCT00404352|9302536|P5|Open Label Extension (up to 36 Months)|Adverse Event|0
2700162|NCT00404352|9302537|P4|Open Label Extension (up to 36 Months)|Adverse Event|0
2700163|NCT00404352|9302538|P3|Open Label Extension (up to 36 Months)|Adverse Event|0
2700164|NCT00404352|9302539|P2|Open Label Extension (up to 36 Months)|Adverse Event|0
2700165|NCT00404352|9302540|P1|Open Label Extension (up to 36 Months)|Adverse Event|0
2700166|NCT00404352|9302532|P9|Open Label (up to 24 Month)|Disease progression|0
2700167|NCT00404352|9302533|P8|Open Label (up to 24 Month)|Disease progression|0
2700168|NCT00404352|9302534|P7|Open Label (up to 24 Month)|Disease progression|0
2700169|NCT00404352|9302535|P6|Open Label (up to 24 Month)|Disease progression|0
2700170|NCT00404352|9302536|P5|Open Label (up to 24 Month)|Disease progression|0
2700171|NCT00404352|9302537|P4|Open Label (up to 24 Month)|Disease progression|1
2700172|NCT00404352|9302538|P3|Open Label (up to 24 Month)|Disease progression|0
2700173|NCT00404352|9302539|P2|Open Label (up to 24 Month)|Disease progression|0
2700174|NCT00404352|9302540|P1|Open Label (up to 24 Month)|Disease progression|0
2700175|NCT00404352|9302532|P9|Open Label (up to 24 Month)|Withdrawal by Subject|0
2700176|NCT00404352|9302533|P8|Open Label (up to 24 Month)|Withdrawal by Subject|0
2700177|NCT00404352|9302534|P7|Open Label (up to 24 Month)|Withdrawal by Subject|0
2700178|NCT00404352|9302535|P6|Open Label (up to 24 Month)|Withdrawal by Subject|5
2700179|NCT00404352|9302536|P5|Open Label (up to 24 Month)|Withdrawal by Subject|0
2700180|NCT00404352|9302537|P4|Open Label (up to 24 Month)|Withdrawal by Subject|0
2700181|NCT00404352|9302538|P3|Open Label (up to 24 Month)|Withdrawal by Subject|0
2700182|NCT00404352|9302539|P2|Open Label (up to 24 Month)|Withdrawal by Subject|0
2700183|NCT00404352|9302540|P1|Open Label (up to 24 Month)|Withdrawal by Subject|0
2700184|NCT00404352|9302532|P9|Open Label (up to 24 Month)|Lost to Follow-up|0
2700185|NCT00404352|9302533|P8|Open Label (up to 24 Month)|Lost to Follow-up|0
2700186|NCT00404352|9302534|P7|Open Label (up to 24 Month)|Lost to Follow-up|0
2700187|NCT00404352|9302535|P6|Open Label (up to 24 Month)|Lost to Follow-up|0
2700188|NCT00404352|9302536|P5|Open Label (up to 24 Month)|Lost to Follow-up|1
2700189|NCT00404352|9302537|P4|Open Label (up to 24 Month)|Lost to Follow-up|0
2700190|NCT00404352|9302538|P3|Open Label (up to 24 Month)|Lost to Follow-up|0
2700191|NCT00404352|9302539|P2|Open Label (up to 24 Month)|Lost to Follow-up|0
2700192|NCT00404352|9302540|P1|Open Label (up to 24 Month)|Lost to Follow-up|0
2700193|NCT00404352|9302532|P9|Open Label (up to 24 Month)|Pregnancy|0
2700194|NCT00404352|9302533|P8|Open Label (up to 24 Month)|Pregnancy|0
2700195|NCT00404352|9302534|P7|Open Label (up to 24 Month)|Pregnancy|0
2700196|NCT00404352|9302535|P6|Open Label (up to 24 Month)|Pregnancy|1
2700197|NCT00404352|9302536|P5|Open Label (up to 24 Month)|Pregnancy|0
2700198|NCT00404352|9302537|P4|Open Label (up to 24 Month)|Pregnancy|0
2700199|NCT00404352|9302538|P3|Open Label (up to 24 Month)|Pregnancy|0
2700200|NCT00404352|9302539|P2|Open Label (up to 24 Month)|Pregnancy|0
2700201|NCT00404352|9302540|P1|Open Label (up to 24 Month)|Pregnancy|0
2700202|NCT00404352|9302532|P9|Open Label (up to 24 Month)|Adverse Event|0
2700203|NCT00404352|9302533|P8|Open Label (up to 24 Month)|Adverse Event|0
2700204|NCT00404352|9302534|P7|Open Label (up to 24 Month)|Adverse Event|0
2700205|NCT00404352|9302535|P6|Open Label (up to 24 Month)|Adverse Event|1
2700206|NCT00404352|9302536|P5|Open Label (up to 24 Month)|Adverse Event|1
2700207|NCT00404352|9302537|P4|Open Label (up to 24 Month)|Adverse Event|2
2700208|NCT00404352|9302538|P3|Open Label (up to 24 Month)|Adverse Event|0
2700209|NCT00404352|9302539|P2|Open Label (up to 24 Month)|Adverse Event|0
2700210|NCT00404352|9302540|P1|Open Label (up to 24 Month)|Adverse Event|0
2700211|NCT00404352|9302532|P9|Double Blind (up to 24 Month)|Other|0
2700212|NCT00404352|9302533|P8|Double Blind (up to 24 Month)|Other|0
2700213|NCT00404352|9302534|P7|Double Blind (up to 24 Month)|Other|0
2700214|NCT00404352|9302535|P6|Double Blind (up to 24 Month)|Other|0
2700215|NCT00404352|9302536|P5|Double Blind (up to 24 Month)|Other|0
2700216|NCT00404352|9302537|P4|Double Blind (up to 24 Month)|Other|0
2700217|NCT00404352|9302538|P3|Double Blind (up to 24 Month)|Other|0
2700218|NCT00404352|9302539|P2|Double Blind (up to 24 Month)|Other|1
2700219|NCT00404352|9302540|P1|Double Blind (up to 24 Month)|Other|0
2700220|NCT00404352|9302532|P9|Double Blind (up to 24 Month)|Physician Decision|0
2700221|NCT00404352|9302533|P8|Double Blind (up to 24 Month)|Physician Decision|0
2700222|NCT00404352|9302534|P7|Double Blind (up to 24 Month)|Physician Decision|0
2700223|NCT00404352|9302535|P6|Double Blind (up to 24 Month)|Physician Decision|0
2700224|NCT00404352|9302536|P5|Double Blind (up to 24 Month)|Physician Decision|0
2700225|NCT00404352|9302537|P4|Double Blind (up to 24 Month)|Physician Decision|0
2700226|NCT00404352|9302538|P3|Double Blind (up to 24 Month)|Physician Decision|1
2700227|NCT00404352|9302539|P2|Double Blind (up to 24 Month)|Physician Decision|0
2700228|NCT00404352|9302540|P1|Double Blind (up to 24 Month)|Physician Decision|0
2700229|NCT00404352|9302532|P9|Double Blind (up to 24 Month)|Randomized but not treated|0
2700230|NCT00404352|9302533|P8|Double Blind (up to 24 Month)|Randomized but not treated|0
2700231|NCT00404352|9302534|P7|Double Blind (up to 24 Month)|Randomized but not treated|0
2700232|NCT00404352|9302535|P6|Double Blind (up to 24 Month)|Randomized but not treated|0
2700233|NCT00404352|9302536|P5|Double Blind (up to 24 Month)|Randomized but not treated|0
2700311|NCT00404248|9302576|P8|Overall Study|pts declining status|0
2700234|NCT00404352|9302537|P4|Double Blind (up to 24 Month)|Randomized but not treated|0
2700235|NCT00404352|9302538|P3|Double Blind (up to 24 Month)|Randomized but not treated|0
2700236|NCT00404352|9302539|P2|Double Blind (up to 24 Month)|Randomized but not treated|2
2700237|NCT00404352|9302540|P1|Double Blind (up to 24 Month)|Randomized but not treated|0
2700238|NCT00404352|9302532|P9|Double Blind (up to 24 Month)|Switched to open label phase|0
2700239|NCT00404352|9302533|P8|Double Blind (up to 24 Month)|Switched to open label phase|0
2700240|NCT00404352|9302534|P7|Double Blind (up to 24 Month)|Switched to open label phase|0
2700241|NCT00404352|9302535|P6|Double Blind (up to 24 Month)|Switched to open label phase|0
2700242|NCT00404352|9302536|P5|Double Blind (up to 24 Month)|Switched to open label phase|0
2700243|NCT00404352|9302537|P4|Double Blind (up to 24 Month)|Switched to open label phase|0
2700244|NCT00404352|9302538|P3|Double Blind (up to 24 Month)|Switched to open label phase|59
2700245|NCT00404352|9302539|P2|Double Blind (up to 24 Month)|Switched to open label phase|30
2700246|NCT00404352|9302540|P1|Double Blind (up to 24 Month)|Switched to open label phase|31
2700247|NCT00404352|9302532|P9|Double Blind (up to 24 Month)|Poor compliance|0
2700248|NCT00404352|9302533|P8|Double Blind (up to 24 Month)|Poor compliance|0
2700249|NCT00404352|9302534|P7|Double Blind (up to 24 Month)|Poor compliance|0
2700250|NCT00404352|9302535|P6|Double Blind (up to 24 Month)|Poor compliance|0
2700251|NCT00404352|9302536|P5|Double Blind (up to 24 Month)|Poor compliance|0
2700252|NCT00404352|9302537|P4|Double Blind (up to 24 Month)|Poor compliance|0
2700253|NCT00404352|9302538|P3|Double Blind (up to 24 Month)|Poor compliance|0
2700254|NCT00404352|9302539|P2|Double Blind (up to 24 Month)|Poor compliance|0
2700255|NCT00404352|9302540|P1|Double Blind (up to 24 Month)|Poor compliance|1
2700256|NCT00404352|9302532|P9|Double Blind (up to 24 Month)|Disease progression|0
2700257|NCT00404352|9302533|P8|Double Blind (up to 24 Month)|Disease progression|0
2700258|NCT00404352|9302534|P7|Double Blind (up to 24 Month)|Disease progression|0
2700259|NCT00404352|9302535|P6|Double Blind (up to 24 Month)|Disease progression|0
2700260|NCT00404352|9302536|P5|Double Blind (up to 24 Month)|Disease progression|0
2700261|NCT00404352|9302537|P4|Double Blind (up to 24 Month)|Disease progression|0
2700262|NCT00404352|9302538|P3|Double Blind (up to 24 Month)|Disease progression|2
2700263|NCT00404352|9302539|P2|Double Blind (up to 24 Month)|Disease progression|0
2700264|NCT00404352|9302540|P1|Double Blind (up to 24 Month)|Disease progression|3
2700265|NCT00404352|9302532|P9|Double Blind (up to 24 Month)|Withdrawal by Subject|0
2700266|NCT00404352|9302533|P8|Double Blind (up to 24 Month)|Withdrawal by Subject|0
2700267|NCT00404352|9302534|P7|Double Blind (up to 24 Month)|Withdrawal by Subject|0
2700268|NCT00404352|9302535|P6|Double Blind (up to 24 Month)|Withdrawal by Subject|0
2700269|NCT00404352|9302536|P5|Double Blind (up to 24 Month)|Withdrawal by Subject|0
2700270|NCT00404352|9302537|P4|Double Blind (up to 24 Month)|Withdrawal by Subject|0
2700271|NCT00404352|9302538|P3|Double Blind (up to 24 Month)|Withdrawal by Subject|7
2700272|NCT00404352|9302539|P2|Double Blind (up to 24 Month)|Withdrawal by Subject|8
2700273|NCT00404352|9302540|P1|Double Blind (up to 24 Month)|Withdrawal by Subject|11
2700274|NCT00404352|9302532|P9|Double Blind (up to 24 Month)|Lost to Follow-up|0
2700275|NCT00404352|9302533|P8|Double Blind (up to 24 Month)|Lost to Follow-up|0
2700276|NCT00404352|9302534|P7|Double Blind (up to 24 Month)|Lost to Follow-up|0
2700277|NCT00404352|9302535|P6|Double Blind (up to 24 Month)|Lost to Follow-up|0
2700278|NCT00404352|9302536|P5|Double Blind (up to 24 Month)|Lost to Follow-up|0
2700279|NCT00404352|9302537|P4|Double Blind (up to 24 Month)|Lost to Follow-up|0
2700280|NCT00404352|9302538|P3|Double Blind (up to 24 Month)|Lost to Follow-up|1
2700281|NCT00404352|9302539|P2|Double Blind (up to 24 Month)|Lost to Follow-up|2
2700282|NCT00404352|9302540|P1|Double Blind (up to 24 Month)|Lost to Follow-up|1
2700283|NCT00404352|9302532|P9|Double Blind (up to 24 Month)|Death|0
2700284|NCT00404352|9302533|P8|Double Blind (up to 24 Month)|Death|0
2700285|NCT00404352|9302534|P7|Double Blind (up to 24 Month)|Death|0
2700286|NCT00404352|9302535|P6|Double Blind (up to 24 Month)|Death|0
2700287|NCT00404352|9302536|P5|Double Blind (up to 24 Month)|Death|0
2700288|NCT00404352|9302537|P4|Double Blind (up to 24 Month)|Death|0
2700289|NCT00404352|9302538|P3|Double Blind (up to 24 Month)|Death|1
2700290|NCT00404352|9302539|P2|Double Blind (up to 24 Month)|Death|0
2700291|NCT00404352|9302540|P1|Double Blind (up to 24 Month)|Death|0
2700292|NCT00404352|9302532|P9|Double Blind (up to 24 Month)|Pregnancy|0
2700293|NCT00404352|9302533|P8|Double Blind (up to 24 Month)|Pregnancy|0
2700294|NCT00404352|9302534|P7|Double Blind (up to 24 Month)|Pregnancy|0
2700295|NCT00404352|9302535|P6|Double Blind (up to 24 Month)|Pregnancy|0
2700296|NCT00404352|9302536|P5|Double Blind (up to 24 Month)|Pregnancy|0
2700297|NCT00404352|9302537|P4|Double Blind (up to 24 Month)|Pregnancy|0
2700298|NCT00404352|9302538|P3|Double Blind (up to 24 Month)|Pregnancy|2
2700299|NCT00404352|9302539|P2|Double Blind (up to 24 Month)|Pregnancy|0
2700300|NCT00404352|9302540|P1|Double Blind (up to 24 Month)|Pregnancy|0
2700301|NCT00404352|9302532|P9|Double Blind (up to 24 Month)|Adverse Event|0
2700302|NCT00404352|9302533|P8|Double Blind (up to 24 Month)|Adverse Event|0
2700303|NCT00404352|9302534|P7|Double Blind (up to 24 Month)|Adverse Event|0
2700304|NCT00404352|9302535|P6|Double Blind (up to 24 Month)|Adverse Event|0
2700305|NCT00404352|9302536|P5|Double Blind (up to 24 Month)|Adverse Event|0
2700306|NCT00404352|9302537|P4|Double Blind (up to 24 Month)|Adverse Event|0
2700307|NCT00404352|9302538|P3|Double Blind (up to 24 Month)|Adverse Event|6
2700308|NCT00404352|9302539|P2|Double Blind (up to 24 Month)|Adverse Event|4
2700309|NCT00404352|9302540|P1|Double Blind (up to 24 Month)|Adverse Event|5
2700310|NCT00404248|9302575|P9|Overall Study|pts declining status|0
2700312|NCT00404248|9302577|P7|Overall Study|pts declining status|0
2700313|NCT00404248|9302578|P6|Overall Study|pts declining status|0
2700314|NCT00404248|9302579|P5|Overall Study|pts declining status|0
2700315|NCT00404248|9302580|P4|Overall Study|pts declining status|0
2700316|NCT00404248|9302581|P3|Overall Study|pts declining status|0
2700317|NCT00404248|9302582|P2|Overall Study|pts declining status|1
2700318|NCT00404248|9302583|P1|Overall Study|pts declining status|0
2700319|NCT00404235|9302616|P2|Overall Study|Withdrawal by Subject|2
2700320|NCT00404235|9302617|P1|Overall Study|Withdrawal by Subject|1
2700321|NCT00404092|9302635|P4|Overall Study|Adverse Event|0
2700322|NCT00404092|9302636|P3|Overall Study|Adverse Event|1
2700323|NCT00404092|9302637|P2|Overall Study|Adverse Event|0
2700324|NCT00404092|9302638|P1|Overall Study|Adverse Event|0
2700325|NCT00404092|9302635|P4|Overall Study|Death|0
2700326|NCT00404092|9302636|P3|Overall Study|Death|0
2700327|NCT00404092|9302637|P2|Overall Study|Death|0
2700328|NCT00404092|9302638|P1|Overall Study|Death|1
2700329|NCT00404079|9302654|P2|Overall Study|Lost to follow up, adverse event etc|20
2700330|NCT00404079|9302655|P1|Overall Study|Lost to follow up, adverse event etc|22
2700331|NCT00404066|9302661|P1|Overall Study|Withdrawal by Subject - Adverse event|2
2700332|NCT00404066|9302661|P1|Overall Study|Withdrawal by Subject - Pre-treatment|1
2700333|NCT00403845|9302666|P4|Treatment Period 3|Adverse Event|1
2700334|NCT00403845|9302667|P3|Treatment Period 3|Adverse Event|0
2700335|NCT00403845|9302668|P2|Treatment Period 3|Adverse Event|0
2700336|NCT00403845|9302669|P1|Treatment Period 3|Adverse Event|0
2700337|NCT00403845|9302666|P4|Treatment Period 3|Subject withdrew consent|1
2700338|NCT00403845|9302667|P3|Treatment Period 3|Subject withdrew consent|0
2700339|NCT00403845|9302668|P2|Treatment Period 3|Subject withdrew consent|0
2700340|NCT00403845|9302669|P1|Treatment Period 3|Subject withdrew consent|0
2700341|NCT00403845|9302666|P4|Treatment Period 2|Subject withdrew consent|0
2700342|NCT00403845|9302667|P3|Treatment Period 2|Subject withdrew consent|0
2700343|NCT00403845|9302668|P2|Treatment Period 2|Subject withdrew consent|0
2700344|NCT00403845|9302669|P1|Treatment Period 2|Subject withdrew consent|1
2700345|NCT00403845|9302666|P4|Treatment Period 1|Subject no longer needs study drug|1
2700346|NCT00403845|9302667|P3|Treatment Period 1|Subject no longer needs study drug|0
2700347|NCT00403845|9302668|P2|Treatment Period 1|Subject no longer needs study drug|0
2700348|NCT00403845|9302669|P1|Treatment Period 1|Subject no longer needs study drug|0
2700349|NCT00403845|9302666|P4|Treatment Period 1|Subject withdrew consent|0
2700350|NCT00403845|9302667|P3|Treatment Period 1|Subject withdrew consent|0
2700351|NCT00403845|9302668|P2|Treatment Period 1|Subject withdrew consent|0
2700352|NCT00403845|9302669|P1|Treatment Period 1|Subject withdrew consent|1
2700353|NCT00403767|9302693|P2|Overall Study|Missing/incomplete data|1
2700354|NCT00403767|9302694|P1|Overall Study|Missing/incomplete data|1
2700355|NCT00403767|9302693|P2|Overall Study|Study terminated by sponsor|69
2700356|NCT00403767|9302694|P1|Overall Study|Study terminated by sponsor|82
2700357|NCT00403767|9302693|P2|Overall Study|Clinical efficacy endpoint reached|332
2700358|NCT00403767|9302694|P1|Overall Study|Clinical efficacy endpoint reached|300
2700359|NCT00403767|9302693|P2|Overall Study|Protocol Violation|124
2700360|NCT00403767|9302694|P1|Overall Study|Protocol Violation|142
2700361|NCT00403767|9302693|P2|Overall Study|Lost to Follow-up|8
2700362|NCT00403767|9302694|P1|Overall Study|Lost to Follow-up|6
2700363|NCT00403767|9302693|P2|Overall Study|Investigator dec./not protocol-related|178
2700364|NCT00403767|9302694|P1|Overall Study|Investigator dec./not protocol-related|191
2700365|NCT00403767|9302693|P2|Overall Study|Consent withdrawn|673
2700366|NCT00403767|9302694|P1|Overall Study|Consent withdrawn|671
2700367|NCT00403767|9302693|P2|Overall Study|Non-compliant with study medication|164
2700368|NCT00403767|9302694|P1|Overall Study|Non-compliant with study medication|134
2700369|NCT00403767|9302693|P2|Overall Study|Adverse Event|919
2700370|NCT00403767|9302694|P1|Overall Study|Adverse Event|993
2700371|NCT00403754|9302718|P4|Core Treatment Period 2|Lack of Efficacy|0
2700372|NCT00403754|9302719|P3|Core Treatment Period 2|Lack of Efficacy|1
2700373|NCT00403754|9302720|P2|Core Treatment Period 2|Lack of Efficacy|0
2700374|NCT00403754|9302721|P1|Core Treatment Period 2|Lack of Efficacy|0
2700375|NCT00403754|9302718|P4|Core Treatment Period 1|Withdrawal by Subject|0
2700376|NCT00403754|9302719|P3|Core Treatment Period 1|Withdrawal by Subject|0
2700377|NCT00403754|9302720|P2|Core Treatment Period 1|Withdrawal by Subject|1
2700378|NCT00403754|9302721|P1|Core Treatment Period 1|Withdrawal by Subject|0
2700379|NCT00403585|9302748|P1|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4
2700380|NCT00403585|9302748|P1|Open-Label Phase; Extension Study|Withdrawal by Subject|2
2700381|NCT00403585|9302748|P1|Initial Treatment Phase|Lost to Follow-up|2
2700382|NCT00403546|9302759|P3|Randomized Trial|Early Terminations|16
2700383|NCT00403546|9302760|P2|Randomized Trial|Early Terminations|17
2700384|NCT00403546|9302761|P1|Randomized Trial|Early Terminations|0
2700385|NCT00403546|9302759|P3|Screening Phase|Terminated Prior to Randomization|0
2700386|NCT00403546|9302760|P2|Screening Phase|Terminated Prior to Randomization|0
2700387|NCT00403546|9302761|P1|Screening Phase|Terminated Prior to Randomization|5
2700388|NCT00403546|9302759|P3|Screening Phase|Adverse Event|0
2700389|NCT00403546|9302760|P2|Screening Phase|Adverse Event|0
2700390|NCT00403546|9302761|P1|Screening Phase|Adverse Event|1
2700391|NCT00403546|9302759|P3|Screening Phase|Screening Failure|0
2700392|NCT00403546|9302760|P2|Screening Phase|Screening Failure|0
2700393|NCT00403546|9302761|P1|Screening Phase|Screening Failure|22
2700394|NCT00403546|9302759|P3|Signed Informed Consent/Open-Label|Adverse Event|0
2700395|NCT00403546|9302760|P2|Signed Informed Consent/Open-Label|Adverse Event|0
2700396|NCT00403546|9302761|P1|Signed Informed Consent/Open-Label|Adverse Event|5
2700397|NCT00403546|9302759|P3|Signed Informed Consent/Open-Label|Terminated by Investigator|0
2700398|NCT00403546|9302760|P2|Signed Informed Consent/Open-Label|Terminated by Investigator|0
2700399|NCT00403546|9302761|P1|Signed Informed Consent/Open-Label|Terminated by Investigator|9
2700400|NCT00403546|9302759|P3|Signed Informed Consent/Open-Label|Early Termination|0
2700401|NCT00403546|9302760|P2|Signed Informed Consent/Open-Label|Early Termination|0
2700402|NCT00403546|9302761|P1|Signed Informed Consent/Open-Label|Early Termination|8
2700403|NCT00403546|9302759|P3|Signed Informed Consent/Open-Label|Withdrew Consent|0
2700404|NCT00403546|9302760|P2|Signed Informed Consent/Open-Label|Withdrew Consent|0
2700405|NCT00403546|9302761|P1|Signed Informed Consent/Open-Label|Withdrew Consent|6
2700406|NCT00403481|9302801|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1
2700407|NCT00403481|9302801|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1
2700408|NCT00403481|9302801|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1
2700409|NCT00403481|9302801|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1
2700410|NCT00403481|9302801|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1
2700411|NCT00403481|9302801|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2
2700412|NCT00403481|9302801|P1|Olm 40 mg|Other|1
2700413|NCT00403481|9302801|P1|Olm 40 mg|Withdrawal by Subject|1
2700414|NCT00403481|9302801|P1|Olm 40 mg|Protocol Violation|1
2700415|NCT00403481|9302801|P1|Olm 40 mg|Adverse Event|2
2700416|NCT00403481|9302801|P1|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1
2700417|NCT00403481|9302801|P1|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3
2700418|NCT00403481|9302801|P1|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1
2700419|NCT00403481|9302801|P1|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1
2700420|NCT00403455|9302816|P1|Overall Study|Withdrawal by Subject|1
2700421|NCT00403390|9302839|P2|Overall Study|non-compliant|0
2700422|NCT00403390|9302840|P1|Overall Study|non-compliant|1
2700423|NCT00403390|9302839|P2|Overall Study|samples lost|0
2700424|NCT00403390|9302840|P1|Overall Study|samples lost|1
2700425|NCT00403390|9302839|P2|Overall Study|Withdrawal by Subject|0
2700426|NCT00403390|9302840|P1|Overall Study|Withdrawal by Subject|1
2700427|NCT00403273|9302848|P2|Overall Study|pt. wanted to have a surgical procedure|1
2700428|NCT00403273|9302849|P1|Overall Study|pt. wanted to have a surgical procedure|0
2700429|NCT00403273|9302848|P2|Overall Study|Physician Decision|1
2700430|NCT00403273|9302849|P1|Overall Study|Physician Decision|0
2700431|NCT00403273|9302848|P2|Overall Study|Lost to Follow-up|2
2700432|NCT00403273|9302849|P1|Overall Study|Lost to Follow-up|3
2700433|NCT00403234|9302891|P4|Overall Study|Adverse Event|0
2700434|NCT00403234|9302892|P3|Overall Study|Adverse Event|1
2700435|NCT00403234|9302893|P2|Overall Study|Adverse Event|0
2700436|NCT00403234|9302894|P1|Overall Study|Adverse Event|1
2700437|NCT00403234|9302891|P4|Overall Study|Withdrawal by Subject|0
2700438|NCT00403234|9302892|P3|Overall Study|Withdrawal by Subject|0
2700439|NCT00403234|9302893|P2|Overall Study|Withdrawal by Subject|1
2700440|NCT00403234|9302894|P1|Overall Study|Withdrawal by Subject|0
2700441|NCT00403130|9302904|P1|Survival Follow-up up to 6 Years|Lost to Follow-up|10
2700442|NCT00403130|9302904|P1|2 Years From Start of Treatment|Withdrawal by Subject|1
2700443|NCT00403130|9302904|P1|2 Years From Start of Treatment|Lost to Follow up|1
2700444|NCT00403130|9302904|P1|2 Years From Start of Treatment|Not Eligible|3
2700445|NCT00402987|9302957|P4|Overall Study|Lack of Efficacy|0
2700446|NCT00402987|9302958|P3|Overall Study|Lack of Efficacy|1
2700447|NCT00402987|9302959|P2|Overall Study|Lack of Efficacy|0
2700448|NCT00402987|9302960|P1|Overall Study|Lack of Efficacy|0
2700449|NCT00402831|9303132|P2|Overall Study|Non-compliance with protocol|1
2700450|NCT00402831|9303133|P1|Overall Study|Non-compliance with protocol|0
2700451|NCT00402831|9303132|P2|Overall Study|Lost to Follow-up|2
2700452|NCT00402831|9303133|P1|Overall Study|Lost to Follow-up|1
2700453|NCT00402779|9303167|P2|Overall Study|Screen Failure|76
2700454|NCT00402779|9303168|P1|Overall Study|Screen Failure|77
2700455|NCT00402740|9303174|P1|Overall Study|Subject disposition unknown.|1
2700456|NCT00402740|9303174|P1|Overall Study|No stent. Completed FU at 30 days.|5
2700457|NCT00402740|9303174|P1|Overall Study|Lost to Follow-up|6
2700458|NCT00402740|9303174|P1|Overall Study|Death|50
2700459|NCT00402740|9303174|P1|Overall Study|Withdrawal by Subject|18
2700460|NCT00402727|9303186|P2|Overall Study|non-compliance|1
2700461|NCT00402727|9303187|P1|Overall Study|non-compliance|0
2700462|NCT00402727|9303186|P2|Overall Study|supply problems|1
2700463|NCT00402727|9303187|P1|Overall Study|supply problems|2
2700464|NCT00402727|9303186|P2|Overall Study|Withdrawal by Subject|7
2700465|NCT00402727|9303187|P1|Overall Study|Withdrawal by Subject|3
2700466|NCT00402727|9303186|P2|Overall Study|Protocol Violation|4
2700467|NCT00402727|9303187|P1|Overall Study|Protocol Violation|0
2700468|NCT00402727|9303186|P2|Overall Study|Physician Decision|1
2700469|NCT00402727|9303187|P1|Overall Study|Physician Decision|1
2700470|NCT00402727|9303186|P2|Overall Study|Lost to Follow-up|11
2700471|NCT00402727|9303187|P1|Overall Study|Lost to Follow-up|24
2700472|NCT00402727|9303186|P2|Overall Study|Lack of Efficacy|3
2700473|NCT00402727|9303187|P1|Overall Study|Lack of Efficacy|1
2700474|NCT00402727|9303186|P2|Overall Study|Death|0
2700475|NCT00402727|9303187|P1|Overall Study|Death|1
2700476|NCT00402727|9303186|P2|Overall Study|Adverse Event|6
2700477|NCT00402727|9303187|P1|Overall Study|Adverse Event|10
2700478|NCT00402688|9303229|P3|Overall Study|Patient Left Town and Forgot Medication|1
2700479|NCT00402688|9303230|P2|Overall Study|Patient Left Town and Forgot Medication|0
2700480|NCT00402688|9303231|P1|Overall Study|Patient Left Town and Forgot Medication|0
2700481|NCT00402688|9303229|P3|Overall Study|Urine Cult. Yield Resistant to Levaquin|1
2700482|NCT00402688|9303230|P2|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
2700483|NCT00402688|9303231|P1|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
2700484|NCT00402688|9303229|P3|Overall Study|Culture Show Fluoroquinolone Resistance|0
2700485|NCT00402688|9303230|P2|Overall Study|Culture Show Fluoroquinolone Resistance|1
2700486|NCT00402688|9303231|P1|Overall Study|Culture Show Fluoroquinolone Resistance|0
2700487|NCT00402688|9303229|P3|Overall Study|Lost to Follow-up|2
2700488|NCT00402688|9303230|P2|Overall Study|Lost to Follow-up|0
2700489|NCT00402688|9303231|P1|Overall Study|Lost to Follow-up|1
2700490|NCT00402688|9303229|P3|Overall Study|Protocol Violation|1
2700491|NCT00402688|9303230|P2|Overall Study|Protocol Violation|1
2700492|NCT00402688|9303231|P1|Overall Study|Protocol Violation|1
2700493|NCT00402688|9303229|P3|Overall Study|Lack of Efficacy|5
2700494|NCT00402688|9303230|P2|Overall Study|Lack of Efficacy|4
2700495|NCT00402688|9303231|P1|Overall Study|Lack of Efficacy|4
2700496|NCT00402688|9303229|P3|Overall Study|Physician Decision|1
2700497|NCT00402688|9303230|P2|Overall Study|Physician Decision|0
2700498|NCT00402688|9303231|P1|Overall Study|Physician Decision|0
2700499|NCT00402688|9303229|P3|Overall Study|Withdrawal by Subject|1
2700500|NCT00402688|9303230|P2|Overall Study|Withdrawal by Subject|1
2700501|NCT00402688|9303231|P1|Overall Study|Withdrawal by Subject|3
2700502|NCT00402688|9303229|P3|Overall Study|Adverse Event|3
2700503|NCT00402688|9303230|P2|Overall Study|Adverse Event|9
2700504|NCT00402688|9303231|P1|Overall Study|Adverse Event|12
2700505|NCT00402649|9303254|P1|Overall Study|Withdrawal by Subject|1
2700506|NCT00402649|9303254|P1|Overall Study|Lost to Follow-up|1
2700507|NCT00402597|9303269|P5|Overall Study|reason not specified|20
2700508|NCT00402597|9303270|P4|Overall Study|reason not specified|14
2700509|NCT00402597|9303271|P3|Overall Study|reason not specified|27
2700510|NCT00402597|9303272|P2|Overall Study|reason not specified|4
2700511|NCT00402597|9303273|P1|Overall Study|reason not specified|30
2700512|NCT00402597|9303269|P5|Overall Study|Withdrawal by Subject|24
2700513|NCT00402597|9303270|P4|Overall Study|Withdrawal by Subject|15
2700514|NCT00402597|9303271|P3|Overall Study|Withdrawal by Subject|65
2700515|NCT00402597|9303272|P2|Overall Study|Withdrawal by Subject|16
2700516|NCT00402597|9303273|P1|Overall Study|Withdrawal by Subject|57
2700517|NCT00402597|9303269|P5|Overall Study|Lost to Follow-up|3
2700518|NCT00402597|9303270|P4|Overall Study|Lost to Follow-up|2
2700519|NCT00402597|9303271|P3|Overall Study|Lost to Follow-up|8
2700520|NCT00402597|9303272|P2|Overall Study|Lost to Follow-up|1
2700521|NCT00402597|9303273|P1|Overall Study|Lost to Follow-up|8
2700522|NCT00402597|9303269|P5|Overall Study|Adverse Event|71
2700523|NCT00402597|9303270|P4|Overall Study|Adverse Event|39
2700524|NCT00402597|9303271|P3|Overall Study|Adverse Event|106
2700525|NCT00402597|9303272|P2|Overall Study|Adverse Event|18
2700526|NCT00402597|9303273|P1|Overall Study|Adverse Event|81
2700527|NCT00402597|9303269|P5|Overall Study|Death|6
2700528|NCT00402597|9303270|P4|Overall Study|Death|4
2700529|NCT00402597|9303271|P3|Overall Study|Death|6
2700530|NCT00402597|9303272|P2|Overall Study|Death|7
2700531|NCT00402597|9303273|P1|Overall Study|Death|15
2700532|NCT00402363|9303314|P4|Overall Study|"Captured as Other"|2
2700533|NCT00402363|9303315|P3|Overall Study|"Captured as Other"|2
2700534|NCT00402363|9303316|P2|Overall Study|"Captured as Other"|2
2700535|NCT00402363|9303317|P1|Overall Study|"Captured as Other"|6
2700536|NCT00402363|9303314|P4|Overall Study|Lost to Follow-up|2
2700537|NCT00402363|9303315|P3|Overall Study|Lost to Follow-up|0
2700538|NCT00402363|9303316|P2|Overall Study|Lost to Follow-up|4
2700539|NCT00402363|9303317|P1|Overall Study|Lost to Follow-up|5
2700540|NCT00402363|9303314|P4|Overall Study|Protocol Violation|3
2700541|NCT00402363|9303315|P3|Overall Study|Protocol Violation|0
2700542|NCT00402363|9303316|P2|Overall Study|Protocol Violation|5
2700543|NCT00402363|9303317|P1|Overall Study|Protocol Violation|3
2700544|NCT00402363|9303314|P4|Overall Study|Withdrew Consent|1
2700545|NCT00402363|9303315|P3|Overall Study|Withdrew Consent|2
2700546|NCT00402363|9303316|P2|Overall Study|Withdrew Consent|5
2700547|NCT00402363|9303317|P1|Overall Study|Withdrew Consent|10
2700548|NCT00402363|9303314|P4|Overall Study|Adverse Event|2
2700549|NCT00402363|9303315|P3|Overall Study|Adverse Event|2
2700550|NCT00402363|9303316|P2|Overall Study|Adverse Event|14
2700551|NCT00402363|9303317|P1|Overall Study|Adverse Event|9
2700552|NCT00402337|9303380|P5|Overall Study|Other Reason|0
2700553|NCT00402337|9303381|P4|Overall Study|Other Reason|0
2700554|NCT00402337|9303382|P3|Overall Study|Other Reason|0
2700555|NCT00402337|9303383|P2|Overall Study|Other Reason|1
2700556|NCT00402337|9303384|P1|Overall Study|Other Reason|0
2700557|NCT00402337|9303380|P5|Overall Study|Physician Decision|0
2700558|NCT00402337|9303381|P4|Overall Study|Physician Decision|1
2700559|NCT00402337|9303382|P3|Overall Study|Physician Decision|0
2700560|NCT00402337|9303383|P2|Overall Study|Physician Decision|0
2700561|NCT00402337|9303384|P1|Overall Study|Physician Decision|0
2700562|NCT00402337|9303380|P5|Overall Study|Lost to Follow-up|0
2700563|NCT00402337|9303381|P4|Overall Study|Lost to Follow-up|2
2700564|NCT00402337|9303382|P3|Overall Study|Lost to Follow-up|1
2700565|NCT00402337|9303383|P2|Overall Study|Lost to Follow-up|0
2700566|NCT00402337|9303384|P1|Overall Study|Lost to Follow-up|0
2700567|NCT00402337|9303380|P5|Overall Study|Withdrawal by Subject|4
2700568|NCT00402337|9303381|P4|Overall Study|Withdrawal by Subject|6
2700569|NCT00402337|9303382|P3|Overall Study|Withdrawal by Subject|1
2700570|NCT00402337|9303383|P2|Overall Study|Withdrawal by Subject|3
2700571|NCT00402337|9303384|P1|Overall Study|Withdrawal by Subject|5
2700572|NCT00402337|9303380|P5|Overall Study|Noncompliance|2
2700573|NCT00402337|9303381|P4|Overall Study|Noncompliance|0
2700574|NCT00402337|9303382|P3|Overall Study|Noncompliance|0
2700575|NCT00402337|9303383|P2|Overall Study|Noncompliance|0
2700576|NCT00402337|9303384|P1|Overall Study|Noncompliance|0
2700577|NCT00402337|9303380|P5|Overall Study|Adverse Event|2
2700578|NCT00402337|9303381|P4|Overall Study|Adverse Event|3
2700579|NCT00402337|9303382|P3|Overall Study|Adverse Event|2
2700580|NCT00402337|9303383|P2|Overall Study|Adverse Event|2
2700581|NCT00402337|9303384|P1|Overall Study|Adverse Event|0
2700582|NCT00402324|9303423|P2|Overall Study|Death|0
2700583|NCT00402324|9303424|P1|Overall Study|Death|1
2700584|NCT00402324|9303423|P2|Overall Study|Adverse Event|4
2700585|NCT00402324|9303424|P1|Overall Study|Adverse Event|6
2700586|NCT00402324|9303423|P2|Overall Study|Lack of Efficacy|4
2700587|NCT00402324|9303424|P1|Overall Study|Lack of Efficacy|1
2700588|NCT00402324|9303423|P2|Overall Study|Sponsor Decision|5
2700589|NCT00402324|9303424|P1|Overall Study|Sponsor Decision|4
2700590|NCT00402324|9303423|P2|Overall Study|Physician Decision|4
2700591|NCT00402324|9303424|P1|Overall Study|Physician Decision|2
2700592|NCT00402324|9303423|P2|Overall Study|Withdrawal by Subject|2
2700593|NCT00402324|9303424|P1|Overall Study|Withdrawal by Subject|5
2700594|NCT00402324|9303423|P2|Overall Study|Protocol Violation|7
2700595|NCT00402324|9303424|P1|Overall Study|Protocol Violation|8
2700596|NCT00402324|9303423|P2|Overall Study|Protocol Entry Criteria Not Met|4
2700597|NCT00402324|9303424|P1|Overall Study|Protocol Entry Criteria Not Met|5
2700598|NCT00402324|9303423|P2|Overall Study|Lost to Follow-up|11
2700599|NCT00402324|9303424|P1|Overall Study|Lost to Follow-up|11
2700600|NCT00402285|9303457|P3|Overall Study|insufficient RNA quality|2
2700601|NCT00402285|9303458|P2|Overall Study|insufficient RNA quality|6
2700602|NCT00402285|9303459|P1|Overall Study|insufficient RNA quality|7
2700603|NCT00402246|9303467|P2|Overall Study|Deterioriating Condition|2
2700604|NCT00402246|9303468|P1|Overall Study|Deterioriating Condition|3
2700605|NCT00402246|9303467|P2|Overall Study|Center Closure|3
2700606|NCT00402246|9303468|P1|Overall Study|Center Closure|5
2700607|NCT00402246|9303467|P2|Overall Study|Patient's device explanted|2
2700608|NCT00402246|9303468|P1|Overall Study|Patient's device explanted|6
2700609|NCT00402246|9303467|P2|Overall Study|Heart Transplant|1
2700610|NCT00402246|9303468|P1|Overall Study|Heart Transplant|0
2700611|NCT00402246|9303467|P2|Overall Study|Insurance Issues|1
2700612|NCT00402246|9303468|P1|Overall Study|Insurance Issues|2
2700613|NCT00402246|9303467|P2|Overall Study|Missed Final Visit|2
2700614|NCT00402246|9303468|P1|Overall Study|Missed Final Visit|1
2700615|NCT00402246|9303467|P2|Overall Study|Protocol Violation|24
2700616|NCT00402246|9303468|P1|Overall Study|Protocol Violation|25
2700617|NCT00402246|9303467|P2|Overall Study|Physician Decision|26
2700618|NCT00402246|9303468|P1|Overall Study|Physician Decision|24
2700619|NCT00402246|9303467|P2|Overall Study|Withdrawal by Subject|87
2700620|NCT00402246|9303468|P1|Overall Study|Withdrawal by Subject|72
2700621|NCT00402246|9303467|P2|Overall Study|Lost to Follow-up|28
2700622|NCT00402246|9303468|P1|Overall Study|Lost to Follow-up|20
2700623|NCT00402246|9303467|P2|Overall Study|Death|58
2700624|NCT00402246|9303468|P1|Overall Study|Death|62
2700625|NCT00402233|9303502|P4|Overall Study|Worsening of other pre-existing disease|0
2700626|NCT00402233|9303503|P3|Overall Study|Worsening of other pre-existing disease|0
2700627|NCT00402233|9303504|P2|Overall Study|Worsening of other pre-existing disease|1
2700628|NCT00402233|9303505|P1|Overall Study|Worsening of other pre-existing disease|0
2700629|NCT00402233|9303502|P4|Overall Study|Worsening of disease under study|0
2700630|NCT00402233|9303503|P3|Overall Study|Worsening of disease under study|0
2700631|NCT00402233|9303504|P2|Overall Study|Worsening of disease under study|0
2700632|NCT00402233|9303505|P1|Overall Study|Worsening of disease under study|2
2700633|NCT00402233|9303502|P4|Overall Study|Withdrawal by Subject|2
2700634|NCT00402233|9303503|P3|Overall Study|Withdrawal by Subject|2
2700635|NCT00402233|9303504|P2|Overall Study|Withdrawal by Subject|1
2700636|NCT00402233|9303505|P1|Overall Study|Withdrawal by Subject|2
2700637|NCT00402233|9303502|P4|Overall Study|Protocol Violation|0
2700638|NCT00402233|9303503|P3|Overall Study|Protocol Violation|0
2700639|NCT00402233|9303504|P2|Overall Study|Protocol Violation|1
2700640|NCT00402233|9303505|P1|Overall Study|Protocol Violation|0
2700641|NCT00402233|9303502|P4|Overall Study|Adverse Event|9
2700642|NCT00402233|9303503|P3|Overall Study|Adverse Event|9
2700643|NCT00402233|9303504|P2|Overall Study|Adverse Event|7
2700644|NCT00402233|9303505|P1|Overall Study|Adverse Event|1
2700645|NCT00402168|9303540|P2|Switched From CNI to Belatacept in LT|Adverse Event|0
2700646|NCT00402168|9303541|P1|Switched From CNI to Belatacept in LT|Adverse Event|4
2700647|NCT00402168|9303540|P2|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0
2700648|NCT00402168|9303541|P1|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2
2700649|NCT00402168|9303540|P2|Long Term (LT)|non-specified|2
2700650|NCT00402168|9303541|P1|Long Term (LT)|non-specified|1
2700651|NCT00402168|9303540|P2|Long Term (LT)|Lack of Efficacy|2
2700652|NCT00402168|9303541|P1|Long Term (LT)|Lack of Efficacy|0
2700653|NCT00402168|9303540|P2|Long Term (LT)|Death|0
2700654|NCT00402168|9303541|P1|Long Term (LT)|Death|4
2700655|NCT00402168|9303540|P2|Long Term (LT)|Lost to Follow-up|0
2700656|NCT00402168|9303541|P1|Long Term (LT)|Lost to Follow-up|1
2700657|NCT00402168|9303540|P2|Long Term (LT)|Pregnancy|1
2700658|NCT00402168|9303541|P1|Long Term (LT)|Pregnancy|0
2700659|NCT00402168|9303540|P2|Long Term (LT)|Withdrawal by Subject|7
2700660|NCT00402168|9303541|P1|Long Term (LT)|Withdrawal by Subject|4
2700661|NCT00402168|9303540|P2|Long Term (LT)|Adverse Event|5
2700662|NCT00402168|9303541|P1|Long Term (LT)|Adverse Event|1
2700663|NCT00402168|9303540|P2|Treatment (up to 12 Months)|non-specified|1
2700664|NCT00402168|9303541|P1|Treatment (up to 12 Months)|non-specified|0
2700665|NCT00402168|9303540|P2|Treatment (up to 12 Months)|Lack of Efficacy|0
2700666|NCT00402168|9303541|P1|Treatment (up to 12 Months)|Lack of Efficacy|2
2700667|NCT00402168|9303540|P2|Treatment (up to 12 Months)|Death|1
2700668|NCT00402168|9303541|P1|Treatment (up to 12 Months)|Death|0
2700669|NCT00402168|9303540|P2|Randomized|Withdrawal by Subject|1
2700670|NCT00402168|9303541|P1|Randomized|Withdrawal by Subject|0
2700671|NCT00402168|9303540|P2|Randomized|Lost to Follow-up|0
2700672|NCT00402168|9303541|P1|Randomized|Lost to Follow-up|1
2700673|NCT00402103|9303598|P2|Overall Study|Administrative problems|0
2700674|NCT00402103|9303599|P1|Overall Study|Administrative problems|2
2700675|NCT00402103|9303598|P2|Overall Study|Lost to Follow-up|3
2700676|NCT00402103|9303599|P1|Overall Study|Lost to Follow-up|6
2700677|NCT00402103|9303598|P2|Overall Study|Patient withdrew consent|1
2700678|NCT00402103|9303599|P1|Overall Study|Patient withdrew consent|12
2700679|NCT00402103|9303598|P2|Overall Study|Protocol Deviation|0
2700680|NCT00402103|9303599|P1|Overall Study|Protocol Deviation|8
2700681|NCT00402103|9303598|P2|Overall Study|Condition no longer requires study drug|0
2700682|NCT00402103|9303599|P1|Overall Study|Condition no longer requires study drug|2
2700683|NCT00402103|9303598|P2|Overall Study|Unsatisfactory therapeutic effect|2
2700684|NCT00402103|9303599|P1|Overall Study|Unsatisfactory therapeutic effect|1
2700685|NCT00402103|9303598|P2|Overall Study|Adverse Event|7
2700686|NCT00402103|9303599|P1|Overall Study|Adverse Event|60
2700687|NCT00402051|9303615|P2|Overall Study|Lost to Follow-up|0
2700688|NCT00402051|9303616|P1|Overall Study|Lost to Follow-up|1
2700689|NCT00402051|9303615|P2|Overall Study|Death Due to Adverse Event|2
2700690|NCT00402051|9303616|P1|Overall Study|Death Due to Adverse Event|0
2700691|NCT00402051|9303615|P2|Overall Study|Death Due to Study Disease|1
2700692|NCT00402051|9303616|P1|Overall Study|Death Due to Study Disease|2
2700693|NCT00402051|9303615|P2|Overall Study|Death - Related to Study Drug|2
2700694|NCT00402051|9303616|P1|Overall Study|Death - Related to Study Drug|1
2700695|NCT00402051|9303615|P2|Overall Study|Withdrawal by Subject|3
2700696|NCT00402051|9303616|P1|Overall Study|Withdrawal by Subject|3
2700697|NCT00402051|9303615|P2|Overall Study|Physician Decision|3
2700698|NCT00402051|9303616|P1|Overall Study|Physician Decision|7
2700699|NCT00402051|9303615|P2|Overall Study|Adverse Event|4
2700700|NCT00402051|9303616|P1|Overall Study|Adverse Event|11
2700701|NCT00402051|9303615|P2|Overall Study|Progressive Disease|20
2700702|NCT00402051|9303616|P1|Overall Study|Progressive Disease|13
2700703|NCT00402025|9303633|P3|Overall Study|Participant Decision|1
2700704|NCT00402025|9303634|P2|Overall Study|Participant Decision|0
2700705|NCT00402025|9303635|P1|Overall Study|Participant Decision|0
2700706|NCT00402025|9303633|P3|Overall Study|Physician Decision|0
2700707|NCT00402025|9303634|P2|Overall Study|Physician Decision|1
2700708|NCT00402025|9303635|P1|Overall Study|Physician Decision|1
2700709|NCT00402025|9303633|P3|Overall Study|Disease Progression|2
2700710|NCT00402025|9303634|P2|Overall Study|Disease Progression|1
2700711|NCT00402025|9303635|P1|Overall Study|Disease Progression|1
2700712|NCT00402025|9303633|P3|Overall Study|Death|5
2700713|NCT00402025|9303634|P2|Overall Study|Death|1
2700714|NCT00402025|9303635|P1|Overall Study|Death|0
2700715|NCT00402025|9303633|P3|Overall Study|Adverse Event|2
2700716|NCT00402025|9303634|P2|Overall Study|Adverse Event|0
2700717|NCT00402025|9303635|P1|Overall Study|Adverse Event|0
2700718|NCT00401973|9303661|P3|Overall Study|Withdrawal by Subject|9
2700719|NCT00401973|9303662|P2|Overall Study|Withdrawal by Subject|12
2700720|NCT00401973|9303663|P1|Overall Study|Withdrawal by Subject|4
2700721|NCT00401973|9303661|P3|Overall Study|Sponsor Decision|0
2700722|NCT00401973|9303662|P2|Overall Study|Sponsor Decision|1
2700723|NCT00401973|9303663|P1|Overall Study|Sponsor Decision|0
2700724|NCT00401973|9303661|P3|Overall Study|Protocol Violation|3
2700725|NCT00401973|9303662|P2|Overall Study|Protocol Violation|2
2700726|NCT00401973|9303663|P1|Overall Study|Protocol Violation|1
2700727|NCT00401973|9303661|P3|Overall Study|Physician Decision|1
2700728|NCT00401973|9303662|P2|Overall Study|Physician Decision|0
2700729|NCT00401973|9303663|P1|Overall Study|Physician Decision|2
2700730|NCT00401973|9303661|P3|Overall Study|Lost to Follow-up|2
2700731|NCT00401973|9303662|P2|Overall Study|Lost to Follow-up|2
2700732|NCT00401973|9303663|P1|Overall Study|Lost to Follow-up|2
2700733|NCT00401973|9303661|P3|Overall Study|Lack of Efficacy|3
2700734|NCT00401973|9303662|P2|Overall Study|Lack of Efficacy|0
2700735|NCT00401973|9303663|P1|Overall Study|Lack of Efficacy|0
2700736|NCT00401973|9303661|P3|Overall Study|Clinical Relapse|1
2700737|NCT00401973|9303662|P2|Overall Study|Clinical Relapse|1
2700738|NCT00401973|9303663|P1|Overall Study|Clinical Relapse|0
2700739|NCT00401973|9303661|P3|Overall Study|Adverse Event|4
2700740|NCT00401973|9303662|P2|Overall Study|Adverse Event|8
2700741|NCT00401973|9303663|P1|Overall Study|Adverse Event|2
2700742|NCT00401960|9303702|P2|Overall Study|Death|0
2700743|NCT00401960|9303703|P1|Overall Study|Death|2
2700744|NCT00401960|9303702|P2|Overall Study|Lost to Follow-up|0
2700745|NCT00401960|9303703|P1|Overall Study|Lost to Follow-up|3
2700746|NCT00401843|9303733|P3|Overall Study|Received incorrect treatment|0
2700747|NCT00401843|9303734|P2|Overall Study|Received incorrect treatment|3
2700748|NCT00401843|9303735|P1|Overall Study|Received incorrect treatment|0
2700749|NCT00401843|9303733|P3|Overall Study|Randomized but not Treated|3
2700750|NCT00401843|9303734|P2|Overall Study|Randomized but not Treated|2
2700751|NCT00401843|9303735|P1|Overall Study|Randomized but not Treated|0
2700752|NCT00401843|9303733|P3|Overall Study|Withdrawal of consent to study agent|17
2700753|NCT00401843|9303734|P2|Overall Study|Withdrawal of consent to study agent|15
2700754|NCT00401843|9303735|P1|Overall Study|Withdrawal of consent to study agent|1
2700755|NCT00401843|9303733|P3|Overall Study|Withdrawal by Subject|5
2700756|NCT00401843|9303734|P2|Overall Study|Withdrawal by Subject|5
2700757|NCT00401843|9303735|P1|Overall Study|Withdrawal by Subject|1
2700758|NCT00401843|9303733|P3|Overall Study|Protocol Violation|1
2700759|NCT00401843|9303734|P2|Overall Study|Protocol Violation|0
2700760|NCT00401843|9303735|P1|Overall Study|Protocol Violation|0
2700761|NCT00401843|9303733|P3|Overall Study|Physician Decision|10
2700762|NCT00401843|9303734|P2|Overall Study|Physician Decision|16
2700763|NCT00401843|9303735|P1|Overall Study|Physician Decision|0
2700764|NCT00401843|9303733|P3|Overall Study|Other Unspecified|5
2700765|NCT00401843|9303734|P2|Overall Study|Other Unspecified|3
2700766|NCT00401843|9303735|P1|Overall Study|Other Unspecified|0
2700767|NCT00401843|9303733|P3|Overall Study|Lost to Follow-up|2
2700768|NCT00401843|9303734|P2|Overall Study|Lost to Follow-up|0
2700769|NCT00401843|9303735|P1|Overall Study|Lost to Follow-up|0
2700770|NCT00401843|9303733|P3|Overall Study|End of Study|2
2700771|NCT00401843|9303734|P2|Overall Study|End of Study|1
2700772|NCT00401843|9303735|P1|Overall Study|End of Study|1
2700773|NCT00401843|9303733|P3|Overall Study|Disease progression|49
2700774|NCT00401843|9303734|P2|Overall Study|Disease progression|60
2700775|NCT00401843|9303735|P1|Overall Study|Disease progression|10
2700776|NCT00401843|9303733|P3|Overall Study|Death|10
2700777|NCT00401843|9303734|P2|Overall Study|Death|8
2700778|NCT00401843|9303735|P1|Overall Study|Death|0
2700779|NCT00401843|9303733|P3|Overall Study|Adverse Event|27
2700780|NCT00401843|9303734|P2|Overall Study|Adverse Event|26
2700781|NCT00401843|9303735|P1|Overall Study|Adverse Event|7
2700782|NCT00401843|9303733|P3|Overall Study|Achieved Complete Response|11
2700783|NCT00401843|9303734|P2|Overall Study|Achieved Complete Response|5
2700784|NCT00401843|9303735|P1|Overall Study|Achieved Complete Response|1
2700785|NCT00401830|9303753|P2|Overall Study|Other: Personal / Family problems|0
2700786|NCT00401830|9303754|P1|Overall Study|Other: Personal / Family problems|1
2700787|NCT00401830|9303753|P2|Overall Study|Lost to Follow-up|3
2700788|NCT00401830|9303754|P1|Overall Study|Lost to Follow-up|1
2700789|NCT00401830|9303753|P2|Overall Study|Non-compliance with drug study|0
2700790|NCT00401830|9303754|P1|Overall Study|Non-compliance with drug study|1
2700791|NCT00401830|9303753|P2|Overall Study|Protocol Violation|3
2700792|NCT00401830|9303754|P1|Overall Study|Protocol Violation|3
2700793|NCT00401830|9303753|P2|Overall Study|Withdrawal by Subject|3
2700794|NCT00401830|9303754|P1|Overall Study|Withdrawal by Subject|4
2700795|NCT00401830|9303753|P2|Overall Study|Lack of Efficacy|5
2700796|NCT00401830|9303754|P1|Overall Study|Lack of Efficacy|11
2700797|NCT00401830|9303753|P2|Overall Study|Adverse Event|18
2700798|NCT00401830|9303754|P1|Overall Study|Adverse Event|10
2700799|NCT00401752|9303812|P2|Overall Study|Physician Decision|1
2700800|NCT00401752|9303813|P1|Overall Study|Physician Decision|1
2700801|NCT00401752|9303812|P2|Overall Study|Development of any exclusion criteria|2
2700802|NCT00401752|9303813|P1|Overall Study|Development of any exclusion criteria|4
2700803|NCT00401752|9303812|P2|Overall Study|Lost to Follow-up|4
2700804|NCT00401752|9303813|P1|Overall Study|Lost to Follow-up|1
2700805|NCT00401752|9303812|P2|Overall Study|Withdrawal by Subject|6
2700806|NCT00401752|9303813|P1|Overall Study|Withdrawal by Subject|2
2700807|NCT00401752|9303812|P2|Overall Study|Adverse Event|5
2700808|NCT00401752|9303813|P1|Overall Study|Adverse Event|2
2700809|NCT00401726|9303831|P2|Overall Study|Protocol Deviation|4
2700810|NCT00401726|9303832|P1|Overall Study|Protocol Deviation|9
2700811|NCT00401726|9303831|P2|Overall Study|Lack of Efficacy|6
2700812|NCT00401726|9303832|P1|Overall Study|Lack of Efficacy|4
2700813|NCT00401726|9303831|P2|Overall Study|Withdrawal by Subject|24
2700814|NCT00401726|9303832|P1|Overall Study|Withdrawal by Subject|18
2700815|NCT00401726|9303831|P2|Overall Study|Protocol Violation|3
2700816|NCT00401726|9303832|P1|Overall Study|Protocol Violation|6
2700817|NCT00401726|9303831|P2|Overall Study|Lost to Follow-up|20
2700818|NCT00401726|9303832|P1|Overall Study|Lost to Follow-up|23
2700819|NCT00401726|9303831|P2|Overall Study|Physician Decision|6
2700820|NCT00401726|9303832|P1|Overall Study|Physician Decision|3
2700821|NCT00401726|9303831|P2|Overall Study|Sponsor Request|1
2700822|NCT00401726|9303832|P1|Overall Study|Sponsor Request|0
2700823|NCT00401726|9303831|P2|Overall Study|Death|3
2700824|NCT00401726|9303832|P1|Overall Study|Death|0
2700825|NCT00401726|9303831|P2|Overall Study|Adverse Event|45
2700826|NCT00401726|9303832|P1|Overall Study|Adverse Event|34
2700827|NCT00401544|9303867|P4|Overall Study|Other|2
2700828|NCT00401544|9303868|P3|Overall Study|Other|2
2700829|NCT00401544|9303869|P2|Overall Study|Other|0
2700830|NCT00401544|9303870|P1|Overall Study|Other|0
2700831|NCT00401544|9303867|P4|Overall Study|Disease progression|0
2700832|NCT00401544|9303868|P3|Overall Study|Disease progression|0
2700833|NCT00401544|9303869|P2|Overall Study|Disease progression|1
2700834|NCT00401544|9303870|P1|Overall Study|Disease progression|0
2700835|NCT00401544|9303867|P4|Overall Study|Ineligibility determined|2
2700836|NCT00401544|9303868|P3|Overall Study|Ineligibility determined|0
2700837|NCT00401544|9303869|P2|Overall Study|Ineligibility determined|1
2700838|NCT00401544|9303870|P1|Overall Study|Ineligibility determined|0
2700839|NCT00401544|9303867|P4|Overall Study|Physician Decision|0
2700840|NCT00401544|9303868|P3|Overall Study|Physician Decision|0
2700841|NCT00401544|9303869|P2|Overall Study|Physician Decision|3
2700842|NCT00401544|9303870|P1|Overall Study|Physician Decision|1
2700843|NCT00401544|9303867|P4|Overall Study|Withdrawal by Subject|5
2700844|NCT00401544|9303868|P3|Overall Study|Withdrawal by Subject|6
2700845|NCT00401544|9303869|P2|Overall Study|Withdrawal by Subject|6
2700846|NCT00401544|9303870|P1|Overall Study|Withdrawal by Subject|7
2700847|NCT00401544|9303867|P4|Overall Study|Lost to Follow-up|1
2700848|NCT00401544|9303868|P3|Overall Study|Lost to Follow-up|1
2700849|NCT00401544|9303869|P2|Overall Study|Lost to Follow-up|0
2700850|NCT00401544|9303870|P1|Overall Study|Lost to Follow-up|2
2700851|NCT00401544|9303867|P4|Overall Study|Death|5
2700852|NCT00401544|9303868|P3|Overall Study|Death|2
2700853|NCT00401544|9303869|P2|Overall Study|Death|6
2700854|NCT00401544|9303870|P1|Overall Study|Death|3
2700855|NCT00401544|9303867|P4|Overall Study|Adverse Event|1
2700856|NCT00401544|9303868|P3|Overall Study|Adverse Event|1
2700857|NCT00401544|9303869|P2|Overall Study|Adverse Event|1
2700858|NCT00401544|9303870|P1|Overall Study|Adverse Event|5
2700859|NCT00401531|9303910|P2|Overall Study|Withdrawal by Subject|2
2700860|NCT00401531|9303911|P1|Overall Study|Withdrawal by Subject|3
2700861|NCT00401531|9303910|P2|Overall Study|Lost to Follow-up|1
2700862|NCT00401531|9303911|P1|Overall Study|Lost to Follow-up|1
2700863|NCT00401531|9303910|P2|Overall Study|Protocol Violation|7
2700864|NCT00401531|9303911|P1|Overall Study|Protocol Violation|3
2700865|NCT00401531|9303910|P2|Overall Study|Adverse Event|0
2700866|NCT00401531|9303911|P1|Overall Study|Adverse Event|2
2700867|NCT00401375|9303984|P3|Overall Study|Randomized but not treated|3
2700868|NCT00401375|9303985|P2|Overall Study|Randomized but not treated|3
2700869|NCT00401375|9303986|P1|Overall Study|Randomized but not treated|3
2700870|NCT00401375|9303984|P3|Overall Study|Other than specified|3
2700871|NCT00401375|9303985|P2|Overall Study|Other than specified|1
2700872|NCT00401375|9303986|P1|Overall Study|Other than specified|2
2700873|NCT00401375|9303984|P3|Overall Study|Lost to Follow-up|1
2700874|NCT00401375|9303985|P2|Overall Study|Lost to Follow-up|1
2700875|NCT00401375|9303986|P1|Overall Study|Lost to Follow-up|0
2700876|NCT00401375|9303984|P3|Overall Study|Withdrawal by Subject|7
2700877|NCT00401375|9303985|P2|Overall Study|Withdrawal by Subject|7
2700878|NCT00401375|9303986|P1|Overall Study|Withdrawal by Subject|9
2700879|NCT00401375|9303984|P3|Overall Study|Adverse Event|10
2700880|NCT00401375|9303985|P2|Overall Study|Adverse Event|11
2700881|NCT00401375|9303986|P1|Overall Study|Adverse Event|6
2700882|NCT00401375|9303984|P3|Overall Study|Protocol Violation|1
2700883|NCT00401375|9303985|P2|Overall Study|Protocol Violation|2
2700884|NCT00401375|9303986|P1|Overall Study|Protocol Violation|2
2700885|NCT00401258|9304003|P1|Overall Study|Adverse Event|7
2700886|NCT00401245|9304018|P8|Double Blind Tapering Phase|Lack of Efficacy|0
2700887|NCT00401245|9304019|P7|Double Blind Tapering Phase|Lack of Efficacy|0
2700888|NCT00401245|9304020|P6|Double Blind Tapering Phase|Lack of Efficacy|1
2700889|NCT00401245|9304021|P5|Double Blind Tapering Phase|Lack of Efficacy|0
2700890|NCT00401245|9304022|P4|Double Blind Tapering Phase|Lack of Efficacy|0
2700891|NCT00401245|9304023|P3|Double Blind Tapering Phase|Lack of Efficacy|0
2700892|NCT00401245|9304024|P2|Double Blind Tapering Phase|Lack of Efficacy|0
2700893|NCT00401245|9304025|P1|Double Blind Tapering Phase|Lack of Efficacy|0
2700894|NCT00401245|9304018|P8|Double Blind Tapering Phase|Withdrawal by Subject|0
2700895|NCT00401245|9304019|P7|Double Blind Tapering Phase|Withdrawal by Subject|3
2700896|NCT00401245|9304020|P6|Double Blind Tapering Phase|Withdrawal by Subject|2
2700897|NCT00401245|9304021|P5|Double Blind Tapering Phase|Withdrawal by Subject|2
2700898|NCT00401245|9304022|P4|Double Blind Tapering Phase|Withdrawal by Subject|0
2700899|NCT00401245|9304023|P3|Double Blind Tapering Phase|Withdrawal by Subject|0
2700900|NCT00401245|9304024|P2|Double Blind Tapering Phase|Withdrawal by Subject|0
2700901|NCT00401245|9304025|P1|Double Blind Tapering Phase|Withdrawal by Subject|0
2700902|NCT00401245|9304018|P8|Double Blind Tapering Phase|Other|2
2700903|NCT00401245|9304019|P7|Double Blind Tapering Phase|Other|2
2700904|NCT00401245|9304020|P6|Double Blind Tapering Phase|Other|0
2700905|NCT00401245|9304021|P5|Double Blind Tapering Phase|Other|1
2700906|NCT00401245|9304022|P4|Double Blind Tapering Phase|Other|0
2700907|NCT00401245|9304023|P3|Double Blind Tapering Phase|Other|0
2700908|NCT00401245|9304024|P2|Double Blind Tapering Phase|Other|0
2700909|NCT00401245|9304025|P1|Double Blind Tapering Phase|Other|0
2700910|NCT00401245|9304018|P8|Double Blind Tapering Phase|Investigator request|1
2700911|NCT00401245|9304019|P7|Double Blind Tapering Phase|Investigator request|0
2700912|NCT00401245|9304020|P6|Double Blind Tapering Phase|Investigator request|0
2700913|NCT00401245|9304021|P5|Double Blind Tapering Phase|Investigator request|0
2700914|NCT00401245|9304022|P4|Double Blind Tapering Phase|Investigator request|0
2700915|NCT00401245|9304023|P3|Double Blind Tapering Phase|Investigator request|0
2700916|NCT00401245|9304024|P2|Double Blind Tapering Phase|Investigator request|0
2700917|NCT00401245|9304025|P1|Double Blind Tapering Phase|Investigator request|0
2700918|NCT00401245|9304018|P8|Double Blind Tapering Phase|Adverse Event|4
2700919|NCT00401245|9304019|P7|Double Blind Tapering Phase|Adverse Event|2
2700920|NCT00401245|9304020|P6|Double Blind Tapering Phase|Adverse Event|1
2700921|NCT00401245|9304021|P5|Double Blind Tapering Phase|Adverse Event|1
2700922|NCT00401245|9304022|P4|Double Blind Tapering Phase|Adverse Event|0
2700923|NCT00401245|9304023|P3|Double Blind Tapering Phase|Adverse Event|0
2700924|NCT00401245|9304024|P2|Double Blind Tapering Phase|Adverse Event|0
2700925|NCT00401245|9304025|P1|Double Blind Tapering Phase|Adverse Event|0
2700926|NCT00401245|9304018|P8|Open Label Phase|Lack of Efficacy|0
2700927|NCT00401245|9304019|P7|Open Label Phase|Lack of Efficacy|0
2700928|NCT00401245|9304020|P6|Open Label Phase|Lack of Efficacy|0
2700929|NCT00401245|9304021|P5|Open Label Phase|Lack of Efficacy|0
2700930|NCT00401245|9304022|P4|Open Label Phase|Lack of Efficacy|0
2700931|NCT00401245|9304023|P3|Open Label Phase|Lack of Efficacy|3
2700932|NCT00401245|9304024|P2|Open Label Phase|Lack of Efficacy|2
2700933|NCT00401245|9304025|P1|Open Label Phase|Lack of Efficacy|4
2700934|NCT00401245|9304018|P8|Open Label Phase|Withdrawal by Subject|0
2700935|NCT00401245|9304019|P7|Open Label Phase|Withdrawal by Subject|0
2700936|NCT00401245|9304020|P6|Open Label Phase|Withdrawal by Subject|0
2700937|NCT00401245|9304021|P5|Open Label Phase|Withdrawal by Subject|0
2700938|NCT00401245|9304022|P4|Open Label Phase|Withdrawal by Subject|1
2700939|NCT00401245|9304023|P3|Open Label Phase|Withdrawal by Subject|2
2700940|NCT00401245|9304024|P2|Open Label Phase|Withdrawal by Subject|3
2700941|NCT00401245|9304025|P1|Open Label Phase|Withdrawal by Subject|3
2700942|NCT00401245|9304018|P8|Open Label Phase|Protocol Violation|0
2700943|NCT00401245|9304019|P7|Open Label Phase|Protocol Violation|0
2700944|NCT00401245|9304020|P6|Open Label Phase|Protocol Violation|0
2700945|NCT00401245|9304021|P5|Open Label Phase|Protocol Violation|0
2700946|NCT00401245|9304022|P4|Open Label Phase|Protocol Violation|1
2700947|NCT00401245|9304023|P3|Open Label Phase|Protocol Violation|0
2700948|NCT00401245|9304024|P2|Open Label Phase|Protocol Violation|1
2700949|NCT00401245|9304025|P1|Open Label Phase|Protocol Violation|0
2700950|NCT00401245|9304018|P8|Open Label Phase|Other|0
2700951|NCT00401245|9304019|P7|Open Label Phase|Other|0
2700952|NCT00401245|9304020|P6|Open Label Phase|Other|0
2700953|NCT00401245|9304021|P5|Open Label Phase|Other|0
2700954|NCT00401245|9304022|P4|Open Label Phase|Other|8
2700955|NCT00401245|9304023|P3|Open Label Phase|Other|7
2700956|NCT00401245|9304024|P2|Open Label Phase|Other|8
2700957|NCT00401245|9304025|P1|Open Label Phase|Other|4
2700958|NCT00401245|9304018|P8|Open Label Phase|Lost to Follow-up|0
2700959|NCT00401245|9304019|P7|Open Label Phase|Lost to Follow-up|0
2700960|NCT00401245|9304020|P6|Open Label Phase|Lost to Follow-up|0
2700961|NCT00401245|9304021|P5|Open Label Phase|Lost to Follow-up|0
2700962|NCT00401245|9304022|P4|Open Label Phase|Lost to Follow-up|4
2700963|NCT00401245|9304023|P3|Open Label Phase|Lost to Follow-up|5
2700964|NCT00401245|9304024|P2|Open Label Phase|Lost to Follow-up|7
2700965|NCT00401245|9304025|P1|Open Label Phase|Lost to Follow-up|5
2700966|NCT00401245|9304018|P8|Open Label Phase|Adverse Event|0
2700967|NCT00401245|9304019|P7|Open Label Phase|Adverse Event|0
2700968|NCT00401245|9304020|P6|Open Label Phase|Adverse Event|0
2700969|NCT00401245|9304021|P5|Open Label Phase|Adverse Event|0
2700970|NCT00401245|9304022|P4|Open Label Phase|Adverse Event|7
2700971|NCT00401245|9304023|P3|Open Label Phase|Adverse Event|6
2700972|NCT00401245|9304024|P2|Open Label Phase|Adverse Event|14
2700973|NCT00401245|9304025|P1|Open Label Phase|Adverse Event|5
2700974|NCT00401245|9304018|P8|Between Titration and Open Label Phase|Did not enter the open label phase|0
2700975|NCT00401245|9304019|P7|Between Titration and Open Label Phase|Did not enter the open label phase|0
2700976|NCT00401245|9304020|P6|Between Titration and Open Label Phase|Did not enter the open label phase|0
2700977|NCT00401245|9304021|P5|Between Titration and Open Label Phase|Did not enter the open label phase|0
2700978|NCT00401245|9304022|P4|Between Titration and Open Label Phase|Did not enter the open label phase|2
2700979|NCT00401245|9304023|P3|Between Titration and Open Label Phase|Did not enter the open label phase|0
2700980|NCT00401245|9304024|P2|Between Titration and Open Label Phase|Did not enter the open label phase|2
2700981|NCT00401245|9304025|P1|Between Titration and Open Label Phase|Did not enter the open label phase|0
2700982|NCT00401245|9304018|P8|Double Blind Titration Phase|Withdrawal by Subject|0
2700983|NCT00401245|9304019|P7|Double Blind Titration Phase|Withdrawal by Subject|0
2700984|NCT00401245|9304020|P6|Double Blind Titration Phase|Withdrawal by Subject|0
2700985|NCT00401245|9304021|P5|Double Blind Titration Phase|Withdrawal by Subject|0
2700986|NCT00401245|9304022|P4|Double Blind Titration Phase|Withdrawal by Subject|2
2700987|NCT00401245|9304023|P3|Double Blind Titration Phase|Withdrawal by Subject|0
2700988|NCT00401245|9304024|P2|Double Blind Titration Phase|Withdrawal by Subject|1
2700989|NCT00401245|9304025|P1|Double Blind Titration Phase|Withdrawal by Subject|1
2700990|NCT00401245|9304018|P8|Double Blind Titration Phase|Protocol Violation|0
2700991|NCT00401245|9304019|P7|Double Blind Titration Phase|Protocol Violation|0
2700992|NCT00401245|9304020|P6|Double Blind Titration Phase|Protocol Violation|0
2700993|NCT00401245|9304021|P5|Double Blind Titration Phase|Protocol Violation|0
2700994|NCT00401245|9304022|P4|Double Blind Titration Phase|Protocol Violation|1
2700995|NCT00401245|9304023|P3|Double Blind Titration Phase|Protocol Violation|0
2700996|NCT00401245|9304024|P2|Double Blind Titration Phase|Protocol Violation|0
2700997|NCT00401245|9304025|P1|Double Blind Titration Phase|Protocol Violation|0
2700998|NCT00401245|9304018|P8|Double Blind Titration Phase|Other|0
2700999|NCT00401245|9304019|P7|Double Blind Titration Phase|Other|0
2701000|NCT00401245|9304020|P6|Double Blind Titration Phase|Other|0
2701001|NCT00401245|9304021|P5|Double Blind Titration Phase|Other|0
2701002|NCT00401245|9304022|P4|Double Blind Titration Phase|Other|0
2701003|NCT00401245|9304023|P3|Double Blind Titration Phase|Other|1
2701004|NCT00401245|9304024|P2|Double Blind Titration Phase|Other|0
2701005|NCT00401245|9304025|P1|Double Blind Titration Phase|Other|0
2701006|NCT00401245|9304018|P8|Double Blind Titration Phase|Adverse Event|0
2701007|NCT00401245|9304019|P7|Double Blind Titration Phase|Adverse Event|0
2701008|NCT00401245|9304020|P6|Double Blind Titration Phase|Adverse Event|0
2701009|NCT00401245|9304021|P5|Double Blind Titration Phase|Adverse Event|0
2701010|NCT00401245|9304022|P4|Double Blind Titration Phase|Adverse Event|12
2701011|NCT00401245|9304023|P3|Double Blind Titration Phase|Adverse Event|5
2701012|NCT00401245|9304024|P2|Double Blind Titration Phase|Adverse Event|2
2701013|NCT00401245|9304025|P1|Double Blind Titration Phase|Adverse Event|3
2701014|NCT00401193|9304093|P3|Overall Study|Other Event|2
2701015|NCT00401193|9304094|P2|Overall Study|Other Event|2
2701016|NCT00401193|9304095|P1|Overall Study|Other Event|3
2701017|NCT00401193|9304093|P3|Overall Study|Withdrawal by Subject|1
2701018|NCT00401193|9304094|P2|Overall Study|Withdrawal by Subject|0
2701019|NCT00401193|9304095|P1|Overall Study|Withdrawal by Subject|2
2701020|NCT00401193|9304093|P3|Overall Study|Lost to Follow-up|1
2701021|NCT00401193|9304094|P2|Overall Study|Lost to Follow-up|5
2701022|NCT00401193|9304095|P1|Overall Study|Lost to Follow-up|6
2701023|NCT00401193|9304093|P3|Overall Study|Protocol Violation|1
2701024|NCT00401193|9304094|P2|Overall Study|Protocol Violation|1
2701025|NCT00401193|9304095|P1|Overall Study|Protocol Violation|3
2701026|NCT00401193|9304093|P3|Overall Study|Adverse Event|1
2701027|NCT00401193|9304094|P2|Overall Study|Adverse Event|3
2701028|NCT00401193|9304095|P1|Overall Study|Adverse Event|1
2701029|NCT00400985|9304113|P1|Overall Study|Lost to Follow-up|9
2701030|NCT00400985|9304113|P1|Overall Study|Death|30
2701031|NCT00400985|9304113|P1|Overall Study|system modification|8
2701032|NCT00400985|9304113|P1|Overall Study|Withdrawal by Subject|5
2701033|NCT00400946|9304122|P5|Overall Study|Other|1
2701034|NCT00400946|9304123|P4|Overall Study|Other|0
2701035|NCT00400946|9304124|P3|Overall Study|Other|0
2701036|NCT00400946|9304125|P2|Overall Study|Other|0
2701037|NCT00400946|9304126|P1|Overall Study|Other|0
2701038|NCT00400946|9304122|P5|Overall Study|Clinical|9
2701039|NCT00400946|9304123|P4|Overall Study|Clinical|2
2701040|NCT00400946|9304124|P3|Overall Study|Clinical|0
2701041|NCT00400946|9304125|P2|Overall Study|Clinical|2
2701042|NCT00400946|9304126|P1|Overall Study|Clinical|1
2701043|NCT00400946|9304122|P5|Overall Study|Withdrawal by Subject|8
2701044|NCT00400946|9304123|P4|Overall Study|Withdrawal by Subject|5
2701045|NCT00400946|9304124|P3|Overall Study|Withdrawal by Subject|1
2701046|NCT00400946|9304125|P2|Overall Study|Withdrawal by Subject|5
2701047|NCT00400946|9304126|P1|Overall Study|Withdrawal by Subject|2
2701048|NCT00400946|9304122|P5|Overall Study|Transplant in CR1|1
2701049|NCT00400946|9304123|P4|Overall Study|Transplant in CR1|10
2701050|NCT00400946|9304124|P3|Overall Study|Transplant in CR1|0
2701051|NCT00400946|9304125|P2|Overall Study|Transplant in CR1|0
2701052|NCT00400946|9304126|P1|Overall Study|Transplant in CR1|0
2701053|NCT00400946|9304122|P5|Overall Study|Relapse|5
2701054|NCT00400946|9304123|P4|Overall Study|Relapse|1
2701055|NCT00400946|9304124|P3|Overall Study|Relapse|1
2701056|NCT00400946|9304125|P2|Overall Study|Relapse|2
2701057|NCT00400946|9304126|P1|Overall Study|Relapse|9
2701058|NCT00400946|9304122|P5|Overall Study|Remission Death|1
2701059|NCT00400946|9304123|P4|Overall Study|Remission Death|0
2701060|NCT00400946|9304124|P3|Overall Study|Remission Death|0
2701061|NCT00400946|9304125|P2|Overall Study|Remission Death|1
2701062|NCT00400946|9304126|P1|Overall Study|Remission Death|1
2701063|NCT00400946|9304122|P5|Overall Study|Lost to Follow-up|1
2701064|NCT00400946|9304123|P4|Overall Study|Lost to Follow-up|0
2701065|NCT00400946|9304124|P3|Overall Study|Lost to Follow-up|0
2701066|NCT00400946|9304125|P2|Overall Study|Lost to Follow-up|1
2701067|NCT00400946|9304126|P1|Overall Study|Lost to Follow-up|1
2701068|NCT00400946|9304122|P5|Overall Study|Induction Death|3
2701069|NCT00400946|9304123|P4|Overall Study|Induction Death|13
2701070|NCT00400946|9304124|P3|Overall Study|Induction Death|0
2701071|NCT00400946|9304125|P2|Overall Study|Induction Death|0
2701072|NCT00400946|9304126|P1|Overall Study|Induction Death|0
2701073|NCT00400946|9304122|P5|Overall Study|Induction Failure|8
2701074|NCT00400946|9304123|P4|Overall Study|Induction Failure|11
2701075|NCT00400946|9304124|P3|Overall Study|Induction Failure|0
2701076|NCT00400946|9304125|P2|Overall Study|Induction Failure|0
2701077|NCT00400946|9304126|P1|Overall Study|Induction Failure|0
2701078|NCT00400946|9304122|P5|Overall Study|Ineligible|1
2701079|NCT00400946|9304123|P4|Overall Study|Ineligible|5
2701080|NCT00400946|9304124|P3|Overall Study|Ineligible|0
2701081|NCT00400946|9304125|P2|Overall Study|Ineligible|0
2701082|NCT00400946|9304126|P1|Overall Study|Ineligible|0
2701083|NCT00400764|9304185|P5|Phase II|Withdrawal by Subject|0
2701084|NCT00400764|9304186|P4|Phase II|Withdrawal by Subject|1
2701085|NCT00400764|9304187|P3|Phase II|Withdrawal by Subject|1
2701086|NCT00400764|9304188|P2|Phase II|Withdrawal by Subject|0
2701087|NCT00400764|9304189|P1|Phase II|Withdrawal by Subject|0
2701088|NCT00400764|9304185|P5|Phase II|Patient began new, non-protocol, therapy|0
2701089|NCT00400764|9304186|P4|Phase II|Patient began new, non-protocol, therapy|0
2701090|NCT00400764|9304187|P3|Phase II|Patient began new, non-protocol, therapy|1
2701091|NCT00400764|9304188|P2|Phase II|Patient began new, non-protocol, therapy|0
2701092|NCT00400764|9304189|P1|Phase II|Patient began new, non-protocol, therapy|0
2701093|NCT00400764|9304185|P5|Phase II|Sponsor’s decision to terminate|11
2701094|NCT00400764|9304186|P4|Phase II|Sponsor’s decision to terminate|22
2701095|NCT00400764|9304187|P3|Phase II|Sponsor’s decision to terminate|18
2701096|NCT00400764|9304188|P2|Phase II|Sponsor’s decision to terminate|0
2701097|NCT00400764|9304189|P1|Phase II|Sponsor’s decision to terminate|0
2701098|NCT00400764|9304185|P5|Phase II|Physician Decision|0
2701099|NCT00400764|9304186|P4|Phase II|Physician Decision|1
2701100|NCT00400764|9304187|P3|Phase II|Physician Decision|1
2701101|NCT00400764|9304188|P2|Phase II|Physician Decision|0
2701102|NCT00400764|9304189|P1|Phase II|Physician Decision|0
2701103|NCT00400764|9304185|P5|Phase II|Lost to Follow-up|0
2701104|NCT00400764|9304186|P4|Phase II|Lost to Follow-up|0
2701105|NCT00400764|9304187|P3|Phase II|Lost to Follow-up|1
2701106|NCT00400764|9304188|P2|Phase II|Lost to Follow-up|0
2701107|NCT00400764|9304189|P1|Phase II|Lost to Follow-up|0
2701108|NCT00400764|9304185|P5|Phase II|Death|0
2701109|NCT00400764|9304186|P4|Phase II|Death|2
2701110|NCT00400764|9304187|P3|Phase II|Death|1
2701111|NCT00400764|9304188|P2|Phase II|Death|0
2701112|NCT00400764|9304189|P1|Phase II|Death|0
2701113|NCT00400764|9304185|P5|Phase Ib|Disease Progression|0
2701114|NCT00400764|9304186|P4|Phase Ib|Disease Progression|0
2701115|NCT00400764|9304187|P3|Phase Ib|Disease Progression|0
2701116|NCT00400764|9304188|P2|Phase Ib|Disease Progression|4
2701117|NCT00400764|9304189|P1|Phase Ib|Disease Progression|4
2701118|NCT00400764|9304185|P5|Phase Ib|Death|0
2701119|NCT00400764|9304186|P4|Phase Ib|Death|0
2701120|NCT00400764|9304187|P3|Phase Ib|Death|0
2701121|NCT00400764|9304188|P2|Phase Ib|Death|0
2701122|NCT00400764|9304189|P1|Phase Ib|Death|1
2701123|NCT00400764|9304185|P5|Phase Ib|Adverse Event|0
2701124|NCT00400764|9304186|P4|Phase Ib|Adverse Event|0
2701125|NCT00400764|9304187|P3|Phase Ib|Adverse Event|0
2701126|NCT00400764|9304188|P2|Phase Ib|Adverse Event|0
2701127|NCT00400764|9304189|P1|Phase Ib|Adverse Event|1
2701128|NCT00400712|9304242|P2|Overall Study|Physician Decision|4
2701129|NCT00400712|9304243|P1|Overall Study|Physician Decision|5
2701130|NCT00400712|9304242|P2|Overall Study|Withdrawal by Subject|12
2701131|NCT00400712|9304243|P1|Overall Study|Withdrawal by Subject|11
2701132|NCT00400712|9304242|P2|Overall Study|Death|0
2701133|NCT00400712|9304243|P1|Overall Study|Death|1
2701134|NCT00400569|9304278|P1|Overall Study|Death|1
2701135|NCT00400517|9304289|P1|Overall Study|Physician Decision|1
2701136|NCT00400517|9304289|P1|Overall Study|Withdrawal by Subject|1
2701137|NCT00400400|9304309|P2|Overall Study|Did not receive study drug|3
2701138|NCT00400400|9304310|P1|Overall Study|Did not receive study drug|1
2701139|NCT00400400|9304309|P2|Overall Study|Lost to Follow-up|1
2701140|NCT00400400|9304310|P1|Overall Study|Lost to Follow-up|0
2701141|NCT00400400|9304309|P2|Overall Study|Administrative Problem|0
2701142|NCT00400400|9304310|P1|Overall Study|Administrative Problem|1
2701143|NCT00400400|9304309|P2|Overall Study|Withdrawal by Subject|3
2701144|NCT00400400|9304310|P1|Overall Study|Withdrawal by Subject|1
2701145|NCT00400400|9304309|P2|Overall Study|Protocol Violation|0
2701146|NCT00400400|9304310|P1|Overall Study|Protocol Violation|2
2701147|NCT00400400|9304309|P2|Overall Study|Adverse Event|8
2701148|NCT00400400|9304310|P1|Overall Study|Adverse Event|9
2701149|NCT00400179|9304335|P2|Overall Study|Randomization error/patient ineligible|6
2701150|NCT00400179|9304336|P1|Overall Study|Randomization error/patient ineligible|1
2701151|NCT00400179|9304335|P2|Overall Study|Investigator judgment|1
2701152|NCT00400179|9304336|P1|Overall Study|Investigator judgment|0
2701153|NCT00400179|9304335|P2|Overall Study|Intercurrent illness|1
2701154|NCT00400179|9304336|P1|Overall Study|Intercurrent illness|0
2701155|NCT00400179|9304335|P2|Overall Study|Disease progression|1
2701156|NCT00400179|9304336|P1|Overall Study|Disease progression|1
2701157|NCT00400179|9304335|P2|Overall Study|Withdrew Consent|5
2701158|NCT00400179|9304336|P1|Overall Study|Withdrew Consent|1
2701159|NCT00400179|9304335|P2|Overall Study|Death|2
2701160|NCT00400179|9304336|P1|Overall Study|Death|1
2701161|NCT00400179|9304335|P2|Overall Study|Adverse Event|2
2701162|NCT00400179|9304336|P1|Overall Study|Adverse Event|2
2701163|NCT00400153|9304353|P3|Overall Study|Other reasons - not mentioned above|3
2701164|NCT00400153|9304354|P2|Overall Study|Other reasons - not mentioned above|5
2701165|NCT00400153|9304355|P1|Overall Study|Other reasons - not mentioned above|8
2701166|NCT00400153|9304353|P3|Overall Study|Withdrawal by Subject|10
2701167|NCT00400153|9304354|P2|Overall Study|Withdrawal by Subject|11
2701168|NCT00400153|9304355|P1|Overall Study|Withdrawal by Subject|12
2701169|NCT00400153|9304353|P3|Overall Study|Lost to Follow-up|4
2701170|NCT00400153|9304354|P2|Overall Study|Lost to Follow-up|1
2701171|NCT00400153|9304355|P1|Overall Study|Lost to Follow-up|2
2701172|NCT00400153|9304353|P3|Overall Study|Protocol Violation|9
2701173|NCT00400153|9304354|P2|Overall Study|Protocol Violation|4
2701174|NCT00400153|9304355|P1|Overall Study|Protocol Violation|7
2701175|NCT00400153|9304353|P3|Overall Study|AE due to other condition|15
2701176|NCT00400153|9304354|P2|Overall Study|AE due to other condition|14
2701177|NCT00400153|9304355|P1|Overall Study|AE due to other condition|3
2701178|NCT00400153|9304353|P3|Overall Study|AE due to other disease worsening|0
2701179|NCT00400153|9304354|P2|Overall Study|AE due to other disease worsening|1
2701180|NCT00400153|9304355|P1|Overall Study|AE due to other disease worsening|2
2701181|NCT00400153|9304353|P3|Overall Study|AE due to study disease worsening|20
2701182|NCT00400153|9304354|P2|Overall Study|AE due to study disease worsening|19
2701183|NCT00400153|9304355|P1|Overall Study|AE due to study disease worsening|14
2701184|NCT00399893|9304602|P2|Overall Study|Withdrawal by Subject|0
2701185|NCT00399893|9304603|P1|Overall Study|Withdrawal by Subject|1
2701186|NCT00399802|9304642|P2|Overall Study|Participant discontinued by mistake|1
2701187|NCT00399802|9304643|P1|Overall Study|Participant discontinued by mistake|0
2701188|NCT00399802|9304642|P2|Overall Study|Adverse Event|2
2701189|NCT00399802|9304643|P1|Overall Study|Adverse Event|0
2701190|NCT00399763|9304657|P2|Overall Study|Lost to Follow-up|3
2701191|NCT00399763|9304658|P1|Overall Study|Lost to Follow-up|2
2701192|NCT00399568|9304670|P2|Overall Study|Lost to Follow-up|2
2701193|NCT00399568|9304671|P1|Overall Study|Lost to Follow-up|2
2701194|NCT00399568|9304670|P2|Overall Study|Protocol non-compliance|2
2701195|NCT00399568|9304671|P1|Overall Study|Protocol non-compliance|2
2701196|NCT00399568|9304670|P2|Overall Study|Withdrawal by Subject|3
2701197|NCT00399568|9304671|P1|Overall Study|Withdrawal by Subject|7
2701198|NCT00399568|9304670|P2|Overall Study|Adverse Event|2
2701199|NCT00399568|9304671|P1|Overall Study|Adverse Event|1
2701200|NCT00399542|9304685|P2|Overall Study|Physician Decision|1
2701201|NCT00399542|9304686|P1|Overall Study|Physician Decision|0
2701202|NCT00399542|9304685|P2|Overall Study|Other|0
2701203|NCT00399542|9304686|P1|Overall Study|Other|1
2701204|NCT00399542|9304685|P2|Overall Study|Lost to Follow-up|6
2701205|NCT00399542|9304686|P1|Overall Study|Lost to Follow-up|6
2701206|NCT00399542|9304685|P2|Overall Study|Lack of Efficacy|8
2701207|NCT00399542|9304686|P1|Overall Study|Lack of Efficacy|18
2701208|NCT00399542|9304685|P2|Overall Study|Withdrawal by Subject|10
2701209|NCT00399542|9304686|P1|Overall Study|Withdrawal by Subject|28
2701210|NCT00399542|9304685|P2|Overall Study|Protocol Violation|3
2701211|NCT00399542|9304686|P1|Overall Study|Protocol Violation|13
2701212|NCT00399542|9304685|P2|Overall Study|Adverse Event|15
2701213|NCT00399542|9304686|P1|Overall Study|Adverse Event|18
2701214|NCT00399529|9304748|P1|Overall Study|Off Study Prior to Treatment|2
2701215|NCT00399516|9304754|P1|Overall Study|Lost to Follow-up|2
2701216|NCT00399360|9304762|P4|Overall Study|Withdrawal by Subject|2
2701217|NCT00399360|9304763|P3|Overall Study|Withdrawal by Subject|0
2701218|NCT00399360|9304764|P2|Overall Study|Withdrawal by Subject|2
2701219|NCT00399360|9304765|P1|Overall Study|Withdrawal by Subject|0
2701220|NCT00399360|9304762|P4|Overall Study|Adverse Event|0
2701221|NCT00399360|9304763|P3|Overall Study|Adverse Event|1
2701222|NCT00399360|9304764|P2|Overall Study|Adverse Event|0
2701223|NCT00399360|9304765|P1|Overall Study|Adverse Event|0
2701224|NCT00399360|9304762|P4|Overall Study|Lost to Follow-up|4
2701225|NCT00399360|9304763|P3|Overall Study|Lost to Follow-up|2
2701226|NCT00399360|9304764|P2|Overall Study|Lost to Follow-up|1
2701227|NCT00399360|9304765|P1|Overall Study|Lost to Follow-up|2
2701228|NCT00399035|9304836|P3|Overall Study|Severe non-compliance with protocol|0
2701229|NCT00399035|9304837|P2|Overall Study|Severe non-compliance with protocol|1
2701230|NCT00399035|9304838|P1|Overall Study|Severe non-compliance with protocol|2
2701231|NCT00399035|9304836|P3|Overall Study|Incorrect enrolment/eligib not fulfilled|1
2701232|NCT00399035|9304837|P2|Overall Study|Incorrect enrolment/eligib not fulfilled|0
2701233|NCT00399035|9304838|P1|Overall Study|Incorrect enrolment/eligib not fulfilled|1
2701234|NCT00399035|9304836|P3|Overall Study|Withdrawal by Subject|12
2701235|NCT00399035|9304837|P2|Overall Study|Withdrawal by Subject|15
2701236|NCT00399035|9304838|P1|Overall Study|Withdrawal by Subject|19
2701237|NCT00399035|9304836|P3|Overall Study|Lost to Follow-up|5
2701238|NCT00399035|9304837|P2|Overall Study|Lost to Follow-up|1
2701239|NCT00399035|9304838|P1|Overall Study|Lost to Follow-up|2
2701240|NCT00399035|9304836|P3|Overall Study|Death|234
2701241|NCT00399035|9304837|P2|Overall Study|Death|141
2701242|NCT00399035|9304838|P1|Overall Study|Death|289
2701243|NCT00398866|9304874|P3|Overall Study|Unable to complete requirements of study|1
2701244|NCT00398866|9304875|P2|Overall Study|Unable to complete requirements of study|1
2701245|NCT00398866|9304876|P1|Overall Study|Unable to complete requirements of study|1
2701246|NCT00398866|9304874|P3|Overall Study|Withdrawal by Subject|2
2701247|NCT00398866|9304875|P2|Overall Study|Withdrawal by Subject|1
2701248|NCT00398866|9304876|P1|Overall Study|Withdrawal by Subject|5
2701249|NCT00398866|9304874|P3|Overall Study|Lost to Follow-up|4
2701250|NCT00398866|9304875|P2|Overall Study|Lost to Follow-up|6
2701251|NCT00398866|9304876|P1|Overall Study|Lost to Follow-up|7
2701252|NCT00398866|9304874|P3|Overall Study|Lack of Efficacy|1
2701253|NCT00398866|9304875|P2|Overall Study|Lack of Efficacy|0
2701254|NCT00398866|9304876|P1|Overall Study|Lack of Efficacy|0
2701255|NCT00398866|9304874|P3|Overall Study|Adverse Event|0
2701256|NCT00398866|9304875|P2|Overall Study|Adverse Event|0
2701257|NCT00398866|9304876|P1|Overall Study|Adverse Event|1
2701258|NCT00398632|9304887|P1|Overall Study|Lack of Efficacy|1
2701259|NCT00398632|9304887|P1|Overall Study|Withdrawal by Subject|1
2701260|NCT00398567|9304895|P3|Overall Study|Protocol Violation|1
2701261|NCT00398567|9304896|P2|Overall Study|Protocol Violation|0
2701262|NCT00398567|9304897|P1|Overall Study|Protocol Violation|0
2701263|NCT00398567|9304895|P3|Overall Study|Adverse Event|2
2701264|NCT00398567|9304896|P2|Overall Study|Adverse Event|0
2701265|NCT00398567|9304897|P1|Overall Study|Adverse Event|0
2701266|NCT00398567|9304895|P3|Overall Study|Withdrawal by Subject|4
2701267|NCT00398567|9304896|P2|Overall Study|Withdrawal by Subject|0
2701268|NCT00398567|9304897|P1|Overall Study|Withdrawal by Subject|1
2701269|NCT00398567|9304895|P3|Overall Study|Disease Progression|27
2701270|NCT00398567|9304896|P2|Overall Study|Disease Progression|4
2701271|NCT00398567|9304897|P1|Overall Study|Disease Progression|3
2701272|NCT00398411|9304951|P2|Overall Study|Death|1
2701273|NCT00398411|9304952|P1|Overall Study|Death|0
2701274|NCT00398320|9304975|P1|Overall Study|Physician Decision|1
2701275|NCT00398320|9304975|P1|Overall Study|Adverse Event|4
2701276|NCT00398320|9304975|P1|Overall Study|Death|1
2701277|NCT00398216|9304988|P5|Overall Study|entrance criteria|2
2701278|NCT00398216|9304989|P4|Overall Study|entrance criteria|0
2701279|NCT00398216|9304990|P3|Overall Study|entrance criteria|0
2701280|NCT00398216|9304991|P2|Overall Study|entrance criteria|0
2701281|NCT00398216|9304992|P1|Overall Study|entrance criteria|0
2701282|NCT00398216|9304988|P5|Overall Study|administrative reasons|3
2701283|NCT00398216|9304989|P4|Overall Study|administrative reasons|3
2701284|NCT00398216|9304990|P3|Overall Study|administrative reasons|4
2701285|NCT00398216|9304991|P2|Overall Study|administrative reasons|4
2701286|NCT00398216|9304992|P1|Overall Study|administrative reasons|3
2701287|NCT00398216|9304988|P5|Overall Study|Withdrawal by Subject|2
2701288|NCT00398216|9304989|P4|Overall Study|Withdrawal by Subject|1
2701289|NCT00398216|9304990|P3|Overall Study|Withdrawal by Subject|3
2701290|NCT00398216|9304991|P2|Overall Study|Withdrawal by Subject|0
2701291|NCT00398216|9304992|P1|Overall Study|Withdrawal by Subject|1
2701292|NCT00398216|9304988|P5|Overall Study|Death|0
2701293|NCT00398216|9304989|P4|Overall Study|Death|0
2701294|NCT00398216|9304990|P3|Overall Study|Death|0
2701295|NCT00398216|9304991|P2|Overall Study|Death|3
2701296|NCT00398216|9304992|P1|Overall Study|Death|0
2701297|NCT00398216|9304988|P5|Overall Study|Lost to Follow-up|1
2701298|NCT00398216|9304989|P4|Overall Study|Lost to Follow-up|4
2701299|NCT00398216|9304990|P3|Overall Study|Lost to Follow-up|4
2701300|NCT00398216|9304991|P2|Overall Study|Lost to Follow-up|6
2701301|NCT00398216|9304992|P1|Overall Study|Lost to Follow-up|1
2701302|NCT00398216|9304988|P5|Overall Study|Protocol Violation|5
2701303|NCT00398216|9304989|P4|Overall Study|Protocol Violation|7
2701304|NCT00398216|9304990|P3|Overall Study|Protocol Violation|5
2701305|NCT00398216|9304991|P2|Overall Study|Protocol Violation|4
2701306|NCT00398216|9304992|P1|Overall Study|Protocol Violation|2
2701307|NCT00398216|9304988|P5|Overall Study|Adverse Event|2
2701308|NCT00398216|9304989|P4|Overall Study|Adverse Event|7
2701309|NCT00398216|9304990|P3|Overall Study|Adverse Event|5
2701310|NCT00398216|9304991|P2|Overall Study|Adverse Event|2
2701311|NCT00398216|9304992|P1|Overall Study|Adverse Event|4
2701312|NCT00398138|9305019|P1|Overall Study|Adverse Event|2
2701313|NCT00398112|9305024|P1|Overall Study|Death|1
2701314|NCT00398112|9305024|P1|Overall Study|Withdrawal by Subject|3
2701315|NCT00398112|9305024|P1|Overall Study|Alternative treatment|1
2701316|NCT00398112|9305024|P1|Overall Study|Disease progression|9
2701317|NCT00398112|9305024|P1|Overall Study|Adverse Event|4
2701318|NCT00398086|9305035|P3|Overall Study|Withdrawal by Subject|0
2701319|NCT00398086|9305036|P2|Overall Study|Withdrawal by Subject|7
2701320|NCT00398086|9305037|P1|Overall Study|Withdrawal by Subject|5
2701321|NCT00398086|9305035|P3|Overall Study|Physician Decision|0
2701322|NCT00398086|9305036|P2|Overall Study|Physician Decision|4
2701323|NCT00398086|9305037|P1|Overall Study|Physician Decision|1
2701324|NCT00398086|9305035|P3|Overall Study|Adverse Event|0
2701325|NCT00398086|9305036|P2|Overall Study|Adverse Event|4
2701326|NCT00398086|9305037|P1|Overall Study|Adverse Event|1
2701327|NCT00398086|9305035|P3|Overall Study|Unacceptable Toxicity|2
2701328|NCT00398086|9305036|P2|Overall Study|Unacceptable Toxicity|8
2701329|NCT00398086|9305037|P1|Overall Study|Unacceptable Toxicity|2
2701330|NCT00398073|9305071|P2|Overall Study|Withdrawal by Subject|0
2701331|NCT00398073|9305072|P1|Overall Study|Withdrawal by Subject|1
2701332|NCT00398047|9305082|P1|Overall Study|all patient progressed before completion|3
2701333|NCT00397982|9305092|P1|Overall Study|Unrelated health issues|1
2701334|NCT00397982|9305092|P1|Overall Study|noncompliance|1
2701335|NCT00397982|9305092|P1|Overall Study|Adverse Event|1
2701336|NCT00397982|9305092|P1|Overall Study|Withdrawal by Subject|1
2701337|NCT00397943|9305106|P5|Overall Study|Unspecified reasons|0
2701338|NCT00397943|9305107|P4|Overall Study|Unspecified reasons|0
2701339|NCT00397943|9305108|P3|Overall Study|Unspecified reasons|0
2701340|NCT00397943|9305109|P2|Overall Study|Unspecified reasons|9
2701341|NCT00397943|9305110|P1|Overall Study|Unspecified reasons|12
2701342|NCT00397930|9305266|P2|Overall Study|Missing data|4
2701343|NCT00397930|9305267|P1|Overall Study|Missing data|0
2701344|NCT00397930|9305266|P2|Overall Study|Withdrawal by Subject|8
2701345|NCT00397930|9305267|P1|Overall Study|Withdrawal by Subject|0
2701346|NCT00397930|9305266|P2|Overall Study|Did not want to be in control group|1
2701347|NCT00397930|9305267|P1|Overall Study|Did not want to be in control group|0
2701348|NCT00397930|9305266|P2|Overall Study|Started own yoga program|1
2701349|NCT00397930|9305267|P1|Overall Study|Started own yoga program|1
2701350|NCT00397930|9305266|P2|Overall Study|Too time-consuming|9
2701351|NCT00397930|9305267|P1|Overall Study|Too time-consuming|2
2701352|NCT00397930|9305266|P2|Overall Study|Noncompliant|2
2701353|NCT00397930|9305267|P1|Overall Study|Noncompliant|3
2701354|NCT00397930|9305266|P2|Overall Study|Unknown reasons|14
2701355|NCT00397930|9305267|P1|Overall Study|Unknown reasons|9
2701356|NCT00397930|9305266|P2|Overall Study|Other medical|4
2701357|NCT00397930|9305267|P1|Overall Study|Other medical|9
2701358|NCT00397930|9305266|P2|Overall Study|Personal reasons|8
2701359|NCT00397930|9305267|P1|Overall Study|Personal reasons|14
2701360|NCT00397891|9305282|P5|Overall Study|Withdrawal by Subject|1
2701361|NCT00397891|9305283|P4|Overall Study|Withdrawal by Subject|0
2701362|NCT00397891|9305284|P3|Overall Study|Withdrawal by Subject|0
2701363|NCT00397891|9305285|P2|Overall Study|Withdrawal by Subject|0
2701364|NCT00397891|9305286|P1|Overall Study|Withdrawal by Subject|1
2701365|NCT00397631|9305459|P2|Overall Study|protocol discontinuation criteria|4
2701366|NCT00397631|9305460|P1|Overall Study|protocol discontinuation criteria|1
2701367|NCT00397631|9305459|P2|Overall Study|Withdrawal by Subject|14
2701368|NCT00397631|9305460|P1|Overall Study|Withdrawal by Subject|7
2701369|NCT00397631|9305459|P2|Overall Study|Protocol Violation|1
2701370|NCT00397631|9305460|P1|Overall Study|Protocol Violation|0
2701371|NCT00397631|9305459|P2|Overall Study|Physician Decision|0
2701372|NCT00397631|9305460|P1|Overall Study|Physician Decision|2
2701373|NCT00397631|9305459|P2|Overall Study|Lost to Follow-up|9
2701374|NCT00397631|9305460|P1|Overall Study|Lost to Follow-up|8
2701375|NCT00397631|9305459|P2|Overall Study|Lack of Efficacy|10
2701376|NCT00397631|9305460|P1|Overall Study|Lack of Efficacy|7
2701377|NCT00397631|9305459|P2|Overall Study|Adverse Event|6
2701378|NCT00397631|9305460|P1|Overall Study|Adverse Event|5
2701379|NCT00397540|9305476|P2|Overall Study|short follow-up duration < 12 months|0
2701380|NCT00397540|9305477|P1|Overall Study|short follow-up duration < 12 months|1
2701381|NCT00397514|9305485|P1|Overall Study|poor echocardiographic windows|1
2701382|NCT00397514|9305485|P1|Overall Study|early extubation|2
2701383|NCT00397514|9305485|P1|Overall Study|Not able to capture & pace LV intraoper.|4
2701384|NCT00397514|9305485|P1|Overall Study|Pacing wire malfunction|1
2701385|NCT00397514|9305485|P1|Overall Study|Withdrawal by Subject|1
2701386|NCT00397488|9305495|P1|Overall Study|Death|1
2701387|NCT00397488|9305495|P1|Overall Study|Adverse Event|3
2701388|NCT00397488|9305495|P1|Overall Study|Withdrawal by Subject|3
2701389|NCT00397254|9305515|P2|Overall Study|Lost to Follow-up|2
2701390|NCT00397254|9305516|P1|Overall Study|Lost to Follow-up|2
2701391|NCT00397215|9305538|P4|Month 6 (Day 180)|Other|0
2701392|NCT00397215|9305539|P3|Month 6 (Day 180)|Other|3
2701393|NCT00397215|9305540|P2|Month 6 (Day 180)|Other|0
2701394|NCT00397215|9305541|P1|Month 6 (Day 180)|Other|2
2701395|NCT00397215|9305538|P4|Month 6 (Day 180)|Adverse Event|0
2701396|NCT00397215|9305539|P3|Month 6 (Day 180)|Adverse Event|2
2701397|NCT00397215|9305540|P2|Month 6 (Day 180)|Adverse Event|3
2701398|NCT00397215|9305541|P1|Month 6 (Day 180)|Adverse Event|0
2701399|NCT00397215|9305538|P4|Month 0 (Day 0)|Other|3
2701400|NCT00397215|9305539|P3|Month 0 (Day 0)|Other|3
2701401|NCT00397215|9305540|P2|Month 0 (Day 0)|Other|1
2701402|NCT00397215|9305541|P1|Month 0 (Day 0)|Other|4
2701403|NCT00397215|9305538|P4|Month 0 (Day 0)|Withdrawal by Subject|1
2701404|NCT00397215|9305539|P3|Month 0 (Day 0)|Withdrawal by Subject|3
2701405|NCT00397215|9305540|P2|Month 0 (Day 0)|Withdrawal by Subject|3
2701406|NCT00397215|9305541|P1|Month 0 (Day 0)|Withdrawal by Subject|3
2701407|NCT00397215|9305538|P4|Month 0 (Day 0)|Adverse Event|0
2701408|NCT00397215|9305539|P3|Month 0 (Day 0)|Adverse Event|0
2701409|NCT00397215|9305540|P2|Month 0 (Day 0)|Adverse Event|1
2701410|NCT00397215|9305541|P1|Month 0 (Day 0)|Adverse Event|0
2701411|NCT00397189|9305677|P2|3 Weeks Period|Other|2
2701412|NCT00397189|9305678|P1|3 Weeks Period|Other|0
2701413|NCT00397189|9305677|P2|3 Weeks Period|Protocol Violation|3
2701414|NCT00397189|9305678|P1|3 Weeks Period|Protocol Violation|0
2701415|NCT00397189|9305677|P2|3 Weeks Period|Physician Decision|2
2701416|NCT00397189|9305678|P1|3 Weeks Period|Physician Decision|0
2701417|NCT00397189|9305677|P2|3 Weeks Period|Withdrawal by Subject|9
2701418|NCT00397189|9305678|P1|3 Weeks Period|Withdrawal by Subject|13
2701419|NCT00397189|9305677|P2|3 Weeks Period|Adverse Event|2
2701420|NCT00397189|9305678|P1|3 Weeks Period|Adverse Event|3
2701421|NCT00397189|9305677|P2|3 Weeks Period|Lost to Follow-up|4
2701422|NCT00397189|9305678|P1|3 Weeks Period|Lost to Follow-up|5
2701423|NCT00397046|9305705|P4|Overall Study|Disease Progression|5
2701424|NCT00397046|9305706|P3|Overall Study|Disease Progression|10
2701425|NCT00397046|9305707|P2|Overall Study|Disease Progression|3
2701426|NCT00397046|9305708|P1|Overall Study|Disease Progression|3
2701427|NCT00397033|9305730|P3|Overall Study|Other|2
2701428|NCT00397033|9305731|P2|Overall Study|Other|5
2701429|NCT00397033|9305732|P1|Overall Study|Other|0
2701430|NCT00397033|9305730|P3|Overall Study|Withdrawal by Subject|5
2701431|NCT00397033|9305731|P2|Overall Study|Withdrawal by Subject|7
2701432|NCT00397033|9305732|P1|Overall Study|Withdrawal by Subject|12
2701433|NCT00397033|9305730|P3|Overall Study|Lost to Follow-up|3
2701434|NCT00397033|9305731|P2|Overall Study|Lost to Follow-up|3
2701435|NCT00397033|9305732|P1|Overall Study|Lost to Follow-up|3
2701436|NCT00397033|9305730|P3|Overall Study|Lack of Efficacy|9
2701437|NCT00397033|9305731|P2|Overall Study|Lack of Efficacy|12
2701438|NCT00397033|9305732|P1|Overall Study|Lack of Efficacy|22
2701439|NCT00397033|9305730|P3|Overall Study|Adverse Event|4
2701440|NCT00397033|9305731|P2|Overall Study|Adverse Event|10
2701441|NCT00397033|9305732|P1|Overall Study|Adverse Event|7
2701442|NCT00396877|9305823|P2|Overall Study|Parent(s)/guardian(s)'s request|7
2701443|NCT00396877|9305824|P1|Overall Study|Parent(s)/guardian(s)'s request|4
2701444|NCT00396877|9305823|P2|Overall Study|Lost to Follow-up|1
2701445|NCT00396877|9305824|P1|Overall Study|Lost to Follow-up|2
2701446|NCT00396812|9305834|P1|Overall Study|Physician Decision|1
2701447|NCT00396656|9305846|P2|Second Treatment Period|Adverse Event|1
2701448|NCT00396656|9305847|P1|Second Treatment Period|Adverse Event|0
2701449|NCT00396656|9305846|P2|First Treatment Period|Withdrawal by Subject|2
2701450|NCT00396656|9305847|P1|First Treatment Period|Withdrawal by Subject|0
2701451|NCT00396630|9305865|P2|Overall Study|Not vaccinated at Visit 3|3
2701452|NCT00396630|9305866|P1|Overall Study|Not vaccinated at Visit 3|3
2701453|NCT00396630|9305865|P2|Overall Study|Withdrawal by Subject|1
2701454|NCT00396630|9305866|P1|Overall Study|Withdrawal by Subject|1
2701455|NCT00396630|9305865|P2|Overall Study|Lost to Follow-up|1
2701456|NCT00396630|9305866|P1|Overall Study|Lost to Follow-up|1
2701457|NCT00396591|9305886|P1|Overall Study|Participant request|1
2701458|NCT00396591|9305886|P1|Overall Study|Adverse Event|2
2701459|NCT00396591|9305886|P1|Overall Study|Disease Progression|13
2701460|NCT00396565|9305899|P3|Overall Study|Lack of Efficacy|11
2701461|NCT00396565|9305900|P2|Overall Study|Lack of Efficacy|64
2701462|NCT00396565|9305901|P1|Overall Study|Lack of Efficacy|32
2701463|NCT00396565|9305899|P3|Overall Study|Withdrawal by Subject|1
2701464|NCT00396565|9305900|P2|Overall Study|Withdrawal by Subject|13
2701465|NCT00396565|9305901|P1|Overall Study|Withdrawal by Subject|8
2701466|NCT00396565|9305899|P3|Overall Study|Adverse Event|3
2701467|NCT00396565|9305900|P2|Overall Study|Adverse Event|13
2701468|NCT00396565|9305901|P1|Overall Study|Adverse Event|5
2701469|NCT00396565|9305899|P3|Overall Study|Physician Decision|2
2701470|NCT00396565|9305900|P2|Overall Study|Physician Decision|1
2701471|NCT00396565|9305901|P1|Overall Study|Physician Decision|3
2701472|NCT00396409|9305926|P2|Period 2 - 2008|Lost to Follow-up|1
2701473|NCT00396409|9305927|P1|Period 2 - 2008|Lost to Follow-up|3
2701474|NCT00396409|9305926|P2|Period 2 - 2008|Withdrawal by Subject|1
2701475|NCT00396409|9305927|P1|Period 2 - 2008|Withdrawal by Subject|3
2701476|NCT00396409|9305926|P2|Period 2 - 2008|Protocol Violation|0
2701477|NCT00396409|9305927|P1|Period 2 - 2008|Protocol Violation|1
2701478|NCT00396409|9305926|P2|Between Period 1 and Period 2|Withdrawal by Subject|2
2701479|NCT00396409|9305927|P1|Between Period 1 and Period 2|Withdrawal by Subject|3
2701480|NCT00396409|9305926|P2|Period 1 - 2007|Lost to Follow-up|3
2701481|NCT00396409|9305927|P1|Period 1 - 2007|Lost to Follow-up|2
2701482|NCT00396409|9305926|P2|Period 1 - 2007|Withdrawal by Subject|1
2701483|NCT00396409|9305927|P1|Period 1 - 2007|Withdrawal by Subject|1
2701484|NCT00396409|9305926|P2|Period 1 - 2007|Lack of Efficacy|1
2701485|NCT00396409|9305927|P1|Period 1 - 2007|Lack of Efficacy|0
2701486|NCT00396409|9305926|P2|Period 1 - 2007|Adverse Event|1
2701487|NCT00396409|9305927|P1|Period 1 - 2007|Adverse Event|0
2701488|NCT00396383|9305957|P1|Overall Study|Lost to Follow-up|1
2701489|NCT00396383|9305957|P1|Overall Study|Death|2
2701490|NCT00396331|9305970|P1|Overall Study|Death|16
2701491|NCT00396331|9305970|P1|Overall Study|Lost to Follow-up|3
2701492|NCT00396331|9305970|P1|Overall Study|Did not go on to transplant|5
2701493|NCT00396331|9305970|P1|Overall Study|Failed to mobilize - no transplant|8
2701494|NCT00396318|9306023|P1|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5
2701495|NCT00396279|9306043|P1|Overall Study|Physician Decision|1
2701496|NCT00396279|9306043|P1|Overall Study|Withdrawal by Subject|1
2701497|NCT00396279|9306043|P1|Overall Study|Disease progression|2
2701498|NCT00396279|9306043|P1|Overall Study|Ongoing in study|26
2701499|NCT00396253|9306076|P1|Overall Study|Change in eligibility status|1
2701500|NCT00396253|9306076|P1|Overall Study|Physician Decision|1
2701501|NCT00396253|9306076|P1|Overall Study|Death|3
2701502|NCT00396253|9306076|P1|Overall Study|Withdrawal by Subject|7
2701503|NCT00396253|9306076|P1|Overall Study|Protocol Violation|1
2701504|NCT00396162|9306107|P2|Overall Study|Withdrawal by Subject|3
2701505|NCT00396162|9306108|P1|Overall Study|Withdrawal by Subject|2
2701506|NCT00396136|9306120|P1|Overall Study|Study device explanted|8
2701507|NCT00396136|9306120|P1|Overall Study|Lost to Follow-up|15
2701508|NCT00396136|9306120|P1|Overall Study|Withdrawal by Subject|59
2701509|NCT00396136|9306120|P1|Overall Study|Death|43
2701510|NCT00396097|9306127|P2|Overall Study|Insufficient Clinical Response|4
2701511|NCT00396097|9306128|P1|Overall Study|Insufficient Clinical Response|1
2701512|NCT00396097|9306127|P2|Overall Study|Adverse Event|5
2701513|NCT00396097|9306128|P1|Overall Study|Adverse Event|1
2701514|NCT00396097|9306127|P2|Overall Study|Protocol Violation|6
2701515|NCT00396097|9306128|P1|Overall Study|Protocol Violation|0
2701516|NCT00396097|9306127|P2|Overall Study|Other|5
2701517|NCT00396097|9306128|P1|Overall Study|Other|3
2701518|NCT00396097|9306127|P2|Overall Study|Lost to Follow-up|9
2701519|NCT00396097|9306128|P1|Overall Study|Lost to Follow-up|4
2701520|NCT00396097|9306127|P2|Overall Study|Withdrawal by Subject|17
2701521|NCT00396097|9306128|P1|Overall Study|Withdrawal by Subject|17
2701522|NCT00396084|9306156|P6|Overall Study|Withdrawal by Subject|0
2701523|NCT00396084|9306157|P5|Overall Study|Withdrawal by Subject|0
2701524|NCT00396084|9306158|P4|Overall Study|Withdrawal by Subject|1
2701525|NCT00396084|9306159|P3|Overall Study|Withdrawal by Subject|0
2701526|NCT00396084|9306160|P2|Overall Study|Withdrawal by Subject|0
2701527|NCT00396084|9306161|P1|Overall Study|Withdrawal by Subject|0
2701528|NCT00396084|9306156|P6|Overall Study|Adverse Event|2
2701529|NCT00396084|9306157|P5|Overall Study|Adverse Event|1
2701530|NCT00396084|9306158|P4|Overall Study|Adverse Event|0
2701531|NCT00396084|9306159|P3|Overall Study|Adverse Event|0
2701532|NCT00396084|9306160|P2|Overall Study|Adverse Event|0
2701533|NCT00396084|9306161|P1|Overall Study|Adverse Event|0
2701534|NCT00395967|9306290|P1|Follow-up Period|Lost to Follow-up|1
2701535|NCT00395967|9306290|P1|Follow-up Period|Death|1
2701536|NCT00395967|9306290|P1|Treatment Period|Failed Mobilization|1
2701537|NCT00395863|9306330|P2|Overall Study|Patients did not complete both exams|3
2701538|NCT00395863|9306331|P1|Overall Study|Patients did not complete both exams|2
2701539|NCT00395850|9306366|P4|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
2701540|NCT00395850|9306367|P3|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
2701541|NCT00395850|9306368|P2|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
2701542|NCT00395850|9306369|P1|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1
2701543|NCT00395850|9306366|P4|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
2701544|NCT00395850|9306367|P3|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
2701545|NCT00395850|9306368|P2|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
2701546|NCT00395850|9306369|P1|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1
2701547|NCT00395850|9306366|P4|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
2701548|NCT00395850|9306367|P3|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
2701549|NCT00395850|9306368|P2|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
2701550|NCT00395850|9306369|P1|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1
2701551|NCT00395850|9306366|P4|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4
2701552|NCT00395850|9306367|P3|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6
2701553|NCT00395850|9306368|P2|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
2701554|NCT00395850|9306369|P1|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
2701555|NCT00395850|9306366|P4|Pre-randomization Baseline/Induction|Inconsistent attendance|0
2701556|NCT00395850|9306367|P3|Pre-randomization Baseline/Induction|Inconsistent attendance|0
2701557|NCT00395850|9306368|P2|Pre-randomization Baseline/Induction|Inconsistent attendance|0
2701558|NCT00395850|9306369|P1|Pre-randomization Baseline/Induction|Inconsistent attendance|1
2701559|NCT00395850|9306366|P4|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
2701560|NCT00395850|9306367|P3|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
2701561|NCT00395850|9306368|P2|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
2701562|NCT00395850|9306369|P1|Pre-randomization Baseline/Induction|Withdrawal by Subject|4
2701563|NCT00395850|9306366|P4|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
2701564|NCT00395850|9306367|P3|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
2701565|NCT00395850|9306368|P2|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
2701566|NCT00395850|9306369|P1|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6
2701567|NCT00395746|9306386|P3|Overall Study|Unable to visit site on schedule|0
2701568|NCT00395746|9306387|P2|Overall Study|Unable to visit site on schedule|0
2701569|NCT00395746|9306388|P1|Overall Study|Unable to visit site on schedule|1
2701570|NCT00395746|9306386|P3|Overall Study|Difficultulty in use of device|1
2701571|NCT00395746|9306387|P2|Overall Study|Difficultulty in use of device|0
2701572|NCT00395746|9306388|P1|Overall Study|Difficultulty in use of device|0
2701573|NCT00395746|9306386|P3|Overall Study|Withdrawal of consent|1
2701574|NCT00395746|9306387|P2|Overall Study|Withdrawal of consent|0
2701575|NCT00395746|9306388|P1|Overall Study|Withdrawal of consent|0
2701576|NCT00395746|9306386|P3|Overall Study|Subject decision|1
2701577|NCT00395746|9306387|P2|Overall Study|Subject decision|0
2701578|NCT00395746|9306388|P1|Overall Study|Subject decision|0
2701579|NCT00395746|9306386|P3|Overall Study|Hypoglycaemia|0
2701580|NCT00395746|9306387|P2|Overall Study|Hypoglycaemia|1
2701581|NCT00395746|9306388|P1|Overall Study|Hypoglycaemia|2
2701582|NCT00395746|9306386|P3|Overall Study|Lack of Efficacy|17
2701583|NCT00395746|9306387|P2|Overall Study|Lack of Efficacy|0
2701584|NCT00395746|9306388|P1|Overall Study|Lack of Efficacy|2
2701585|NCT00395746|9306386|P3|Overall Study|Protocol Violation|0
2701586|NCT00395746|9306387|P2|Overall Study|Protocol Violation|1
2701587|NCT00395746|9306388|P1|Overall Study|Protocol Violation|0
2701588|NCT00395746|9306386|P3|Overall Study|Adverse Event|2
2701589|NCT00395746|9306387|P2|Overall Study|Adverse Event|2
2701590|NCT00395746|9306388|P1|Overall Study|Adverse Event|5
2701591|NCT00395733|9306434|P2|Period 2|Technical problems|0
2701592|NCT00395733|9306435|P1|Period 2|Technical problems|1
2701593|NCT00395733|9306434|P2|Period 2|Adverse Event|2
2701594|NCT00395733|9306435|P1|Period 2|Adverse Event|0
2701595|NCT00395733|9306434|P2|Period 2|Protocol Violation|1
2701596|NCT00395733|9306435|P1|Period 2|Protocol Violation|0
2701597|NCT00395733|9306434|P2|Period 2|Withdrawal by Subject|2
2701598|NCT00395733|9306435|P1|Period 2|Withdrawal by Subject|1
2701599|NCT00395694|9306459|P2|Continuation Phase|Withdrawal by Subject|2
2701600|NCT00395694|9306460|P1|Continuation Phase|Withdrawal by Subject|0
2701601|NCT00395694|9306459|P2|Continuation Phase|Poor Compliance|0
2701602|NCT00395694|9306460|P1|Continuation Phase|Poor Compliance|1
2701603|NCT00395694|9306459|P2|Continuation Phase|Withdrawal Due to Wishes of Family|0
2701604|NCT00395694|9306460|P1|Continuation Phase|Withdrawal Due to Wishes of Family|1
2701605|NCT00395694|9306459|P2|Continuation Phase|Lack of Efficacy|11
2701606|NCT00395694|9306460|P1|Continuation Phase|Lack of Efficacy|12
2701607|NCT00395694|9306459|P2|Continuation Phase|Adverse Event|0
2701608|NCT00395694|9306460|P1|Continuation Phase|Adverse Event|1
2701609|NCT00395694|9306459|P2|Escalation Phase + Maintenance Phase|Adverse Event|2
2701610|NCT00395694|9306460|P1|Escalation Phase + Maintenance Phase|Adverse Event|1
2701611|NCT00395642|9306491|P1|Overall Study|Withdrawal by Subject|1
2701612|NCT00395642|9306491|P1|Overall Study|Physician Decision|7
2701613|NCT00395642|9306491|P1|Overall Study|Lost to Follow-up|1
2701614|NCT00395642|9306491|P1|Overall Study|Death|4
2701615|NCT00395629|9306498|P3|Extension Study|Administrative problems|1
2701616|NCT00395629|9306499|P2|Extension Study|Administrative problems|0
2701617|NCT00395629|9306500|P1|Extension Study|Administrative problems|0
2701618|NCT00395629|9306498|P3|Extension Study|Adverse Event|2
2701619|NCT00395629|9306499|P2|Extension Study|Adverse Event|0
2701620|NCT00395629|9306500|P1|Extension Study|Adverse Event|0
2701621|NCT00395629|9306498|P3|Core Study|Lost to Follow-up|1
2701622|NCT00395629|9306499|P2|Core Study|Lost to Follow-up|0
2701623|NCT00395629|9306500|P1|Core Study|Lost to Follow-up|0
2701624|NCT00395629|9306498|P3|Core Study|Withdrawal by Subject|1
2701625|NCT00395629|9306499|P2|Core Study|Withdrawal by Subject|1
2701626|NCT00395629|9306500|P1|Core Study|Withdrawal by Subject|0
2701627|NCT00395629|9306498|P3|Core Study|Protocol Violation|0
2701628|NCT00395629|9306499|P2|Core Study|Protocol Violation|0
2701629|NCT00395629|9306500|P1|Core Study|Protocol Violation|1
2701630|NCT00395629|9306498|P3|Core Study|Abnormal laboratory value(s)|1
2701631|NCT00395629|9306499|P2|Core Study|Abnormal laboratory value(s)|0
2701632|NCT00395629|9306500|P1|Core Study|Abnormal laboratory value(s)|0
2701633|NCT00395629|9306498|P3|Core Study|Adverse Event|4
2701634|NCT00395629|9306499|P2|Core Study|Adverse Event|3
2701635|NCT00395629|9306500|P1|Core Study|Adverse Event|0
2701636|NCT00395538|9306517|P3|Overall Study|Participant elected to discontinue|1
2701637|NCT00395538|9306518|P2|Overall Study|Participant elected to discontinue|0
2701638|NCT00395538|9306519|P1|Overall Study|Participant elected to discontinue|0
2701639|NCT00395538|9306517|P3|Overall Study|Partial recovery of parathyroid function|1
2701640|NCT00395538|9306518|P2|Overall Study|Partial recovery of parathyroid function|0
2701641|NCT00395538|9306519|P1|Overall Study|Partial recovery of parathyroid function|0
2701642|NCT00395538|9306517|P3|Overall Study|Pregnancy|0
2701643|NCT00395538|9306518|P2|Overall Study|Pregnancy|0
2701644|NCT00395538|9306519|P1|Overall Study|Pregnancy|1
2701645|NCT00395538|9306517|P3|Overall Study|PTH resistance|1
2701646|NCT00395538|9306518|P2|Overall Study|PTH resistance|0
2701647|NCT00395538|9306519|P1|Overall Study|PTH resistance|0
2701648|NCT00395538|9306517|P3|Overall Study|Non-compliance with study protocol|0
2701649|NCT00395538|9306518|P2|Overall Study|Non-compliance with study protocol|1
2701650|NCT00395538|9306519|P1|Overall Study|Non-compliance with study protocol|0
2701651|NCT00395538|9306517|P3|Overall Study|DXA or QCT z-score or t-score<-2|0
2701652|NCT00395538|9306518|P2|Overall Study|DXA or QCT z-score or t-score<-2|2
2701653|NCT00395538|9306519|P1|Overall Study|DXA or QCT z-score or t-score<-2|0
2701654|NCT00395538|9306517|P3|Overall Study|Adverse Event|2
2701655|NCT00395538|9306518|P2|Overall Study|Adverse Event|0
2701656|NCT00395538|9306519|P1|Overall Study|Adverse Event|1
2701657|NCT00395538|9306517|P3|Overall Study|Switch to Natpara|3
2701658|NCT00395538|9306518|P2|Overall Study|Switch to Natpara|0
2701659|NCT00395538|9306519|P1|Overall Study|Switch to Natpara|0
2701660|NCT00395538|9306517|P3|Overall Study|Failed screening|4
2701661|NCT00395538|9306518|P2|Overall Study|Failed screening|0
2701662|NCT00395538|9306519|P1|Overall Study|Failed screening|0
2701663|NCT00395538|9306517|P3|Overall Study|FDA partial hold on PTH|11
2701664|NCT00395538|9306518|P2|Overall Study|FDA partial hold on PTH|0
2701665|NCT00395538|9306519|P1|Overall Study|FDA partial hold on PTH|0
2701666|NCT00395538|9306517|P3|Overall Study|Did not re-consent to revised protocol|0
2701667|NCT00395538|9306518|P2|Overall Study|Did not re-consent to revised protocol|10
2701668|NCT00395538|9306519|P1|Overall Study|Did not re-consent to revised protocol|1
2701669|NCT00395512|9306592|P4|Overall Study|Hyperglycemic Rescue|6
2701670|NCT00395512|9306593|P3|Overall Study|Hyperglycemic Rescue|4
2701671|NCT00395512|9306594|P2|Overall Study|Hyperglycemic Rescue|10
2701672|NCT00395512|9306595|P1|Overall Study|Hyperglycemic Rescue|18
2701673|NCT00395512|9306592|P4|Overall Study|Other|0
2701674|NCT00395512|9306593|P3|Overall Study|Other|0
2701675|NCT00395512|9306594|P2|Overall Study|Other|1
2701676|NCT00395512|9306595|P1|Overall Study|Other|1
2701677|NCT00395512|9306592|P4|Overall Study|Physician Decision|2
2701678|NCT00395512|9306593|P3|Overall Study|Physician Decision|2
2701679|NCT00395512|9306594|P2|Overall Study|Physician Decision|4
2701680|NCT00395512|9306595|P1|Overall Study|Physician Decision|6
2701681|NCT00395512|9306592|P4|Overall Study|Withdrawal by Subject|12
2701682|NCT00395512|9306593|P3|Overall Study|Withdrawal by Subject|5
2701683|NCT00395512|9306594|P2|Overall Study|Withdrawal by Subject|5
2701684|NCT00395512|9306595|P1|Overall Study|Withdrawal by Subject|6
2701685|NCT00395512|9306592|P4|Overall Study|Lost to Follow-up|5
2701686|NCT00395512|9306593|P3|Overall Study|Lost to Follow-up|5
2701687|NCT00395512|9306594|P2|Overall Study|Lost to Follow-up|6
2701688|NCT00395512|9306595|P1|Overall Study|Lost to Follow-up|2
2701689|NCT00395512|9306592|P4|Overall Study|Protocol Violation|7
2701690|NCT00395512|9306593|P3|Overall Study|Protocol Violation|6
2701691|NCT00395512|9306594|P2|Overall Study|Protocol Violation|3
2701692|NCT00395512|9306595|P1|Overall Study|Protocol Violation|2
2701693|NCT00395512|9306592|P4|Overall Study|Adverse Event|6
2701694|NCT00395512|9306593|P3|Overall Study|Adverse Event|6
2701695|NCT00395512|9306594|P2|Overall Study|Adverse Event|8
2701696|NCT00395512|9306595|P1|Overall Study|Adverse Event|3
2701697|NCT00395486|9306767|P2|Overall Study|Lost to Follow-up|1
2701698|NCT00395486|9306768|P1|Overall Study|Lost to Follow-up|0
2701699|NCT00395486|9306767|P2|Overall Study|Withdrawal by Subject|2
2701700|NCT00395486|9306768|P1|Overall Study|Withdrawal by Subject|5
2701701|NCT00395486|9306767|P2|Overall Study|Adverse Event|2
2701702|NCT00395486|9306768|P1|Overall Study|Adverse Event|1
2701703|NCT00395460|9306798|P2|Overall Study|Withdrawal by Subject|0
2701704|NCT00395460|9306799|P1|Overall Study|Withdrawal by Subject|1
2701705|NCT00395447|9306823|P2|Overall Study|Withdrawl - Other (not subject)|17
2701706|NCT00395447|9306824|P1|Overall Study|Withdrawl - Other (not subject)|8
2701707|NCT00395447|9306823|P2|Overall Study|Withdrawal by Subject|19
2701708|NCT00395447|9306824|P1|Overall Study|Withdrawal by Subject|24
2701709|NCT00395447|9306823|P2|Overall Study|Lost to Follow-up|43
2701710|NCT00395447|9306824|P1|Overall Study|Lost to Follow-up|52
2701711|NCT00395447|9306823|P2|Overall Study|Death|32
2701712|NCT00395447|9306824|P1|Overall Study|Death|37
2701713|NCT00395343|9306832|P2|Overall Study|Other|2
2701714|NCT00395343|9306833|P1|Overall Study|Other|5
2701715|NCT00395343|9306832|P2|Overall Study|Withdrawal by Subject|12
2701716|NCT00395343|9306833|P1|Overall Study|Withdrawal by Subject|11
2701717|NCT00395343|9306832|P2|Overall Study|Protocol Violation|8
2701718|NCT00395343|9306833|P1|Overall Study|Protocol Violation|6
2701719|NCT00395343|9306832|P2|Overall Study|Physician Decision|4
2701720|NCT00395343|9306833|P1|Overall Study|Physician Decision|2
2701721|NCT00395343|9306832|P2|Overall Study|Lost to Follow-up|4
2701722|NCT00395343|9306833|P1|Overall Study|Lost to Follow-up|4
2701723|NCT00395343|9306832|P2|Overall Study|Lack of Efficacy|1
2701724|NCT00395343|9306833|P1|Overall Study|Lack of Efficacy|0
2701725|NCT00395343|9306832|P2|Overall Study|Adverse Event|5
2701726|NCT00395343|9306833|P1|Overall Study|Adverse Event|13
2701727|NCT00395304|9306851|P6|Treatment Period 3|Other|0
2701728|NCT00395304|9306852|P5|Treatment Period 3|Other|0
2701729|NCT00395304|9306853|P4|Treatment Period 3|Other|1
2701730|NCT00395304|9306854|P3|Treatment Period 3|Other|0
2701731|NCT00395304|9306855|P2|Treatment Period 3|Other|0
2701732|NCT00395304|9306856|P1|Treatment Period 3|Other|0
2701733|NCT00395304|9306851|P6|Treatment Period 3|Physician Decision|0
2701734|NCT00395304|9306852|P5|Treatment Period 3|Physician Decision|0
2701735|NCT00395304|9306853|P4|Treatment Period 3|Physician Decision|0
2701736|NCT00395304|9306854|P3|Treatment Period 3|Physician Decision|0
2701737|NCT00395304|9306855|P2|Treatment Period 3|Physician Decision|1
2701738|NCT00395304|9306856|P1|Treatment Period 3|Physician Decision|0
2701739|NCT00395304|9306851|P6|Treatment Period 3|Lost to Follow-up|0
2701740|NCT00395304|9306852|P5|Treatment Period 3|Lost to Follow-up|0
2701741|NCT00395304|9306853|P4|Treatment Period 3|Lost to Follow-up|0
2701742|NCT00395304|9306854|P3|Treatment Period 3|Lost to Follow-up|0
2701743|NCT00395304|9306855|P2|Treatment Period 3|Lost to Follow-up|1
2701744|NCT00395304|9306856|P1|Treatment Period 3|Lost to Follow-up|1
2701745|NCT00395304|9306851|P6|Treatment Period 3|Withdrawal by Subject|1
2701746|NCT00395304|9306852|P5|Treatment Period 3|Withdrawal by Subject|0
2701747|NCT00395304|9306853|P4|Treatment Period 3|Withdrawal by Subject|1
2701748|NCT00395304|9306854|P3|Treatment Period 3|Withdrawal by Subject|0
2701749|NCT00395304|9306855|P2|Treatment Period 3|Withdrawal by Subject|0
2701750|NCT00395304|9306856|P1|Treatment Period 3|Withdrawal by Subject|0
2701751|NCT00395304|9306851|P6|Treatment Period 2|Other|0
2701752|NCT00395304|9306852|P5|Treatment Period 2|Other|0
2701753|NCT00395304|9306853|P4|Treatment Period 2|Other|0
2701754|NCT00395304|9306854|P3|Treatment Period 2|Other|0
2701755|NCT00395304|9306855|P2|Treatment Period 2|Other|1
2701756|NCT00395304|9306856|P1|Treatment Period 2|Other|0
2701757|NCT00395304|9306851|P6|Treatment Period 2|Physician Decision|0
2701758|NCT00395304|9306852|P5|Treatment Period 2|Physician Decision|0
2701759|NCT00395304|9306853|P4|Treatment Period 2|Physician Decision|0
2701760|NCT00395304|9306854|P3|Treatment Period 2|Physician Decision|1
2701761|NCT00395304|9306855|P2|Treatment Period 2|Physician Decision|0
2701762|NCT00395304|9306856|P1|Treatment Period 2|Physician Decision|0
2701763|NCT00395304|9306851|P6|Treatment Period 2|Lost to Follow-up|0
2701764|NCT00395304|9306852|P5|Treatment Period 2|Lost to Follow-up|0
2701765|NCT00395304|9306853|P4|Treatment Period 2|Lost to Follow-up|0
2701766|NCT00395304|9306854|P3|Treatment Period 2|Lost to Follow-up|0
2701767|NCT00395304|9306855|P2|Treatment Period 2|Lost to Follow-up|3
2701768|NCT00395304|9306856|P1|Treatment Period 2|Lost to Follow-up|0
2701769|NCT00395304|9306851|P6|Treatment Period 2|Withdrawal by Subject|2
2701770|NCT00395304|9306852|P5|Treatment Period 2|Withdrawal by Subject|0
2701771|NCT00395304|9306853|P4|Treatment Period 2|Withdrawal by Subject|1
2701772|NCT00395304|9306854|P3|Treatment Period 2|Withdrawal by Subject|0
2701773|NCT00395304|9306855|P2|Treatment Period 2|Withdrawal by Subject|0
2701774|NCT00395304|9306856|P1|Treatment Period 2|Withdrawal by Subject|0
2701775|NCT00395304|9306851|P6|Treatment Period 1|Physician Decision|0
2701776|NCT00395304|9306852|P5|Treatment Period 1|Physician Decision|0
2701777|NCT00395304|9306853|P4|Treatment Period 1|Physician Decision|0
2701778|NCT00395304|9306854|P3|Treatment Period 1|Physician Decision|0
2701779|NCT00395304|9306855|P2|Treatment Period 1|Physician Decision|1
2701780|NCT00395304|9306856|P1|Treatment Period 1|Physician Decision|0
2701781|NCT00395304|9306851|P6|Treatment Period 1|Lost to Follow-up|1
2701782|NCT00395304|9306852|P5|Treatment Period 1|Lost to Follow-up|0
2701783|NCT00395304|9306853|P4|Treatment Period 1|Lost to Follow-up|1
2701784|NCT00395304|9306854|P3|Treatment Period 1|Lost to Follow-up|0
2701785|NCT00395304|9306855|P2|Treatment Period 1|Lost to Follow-up|0
2701786|NCT00395304|9306856|P1|Treatment Period 1|Lost to Follow-up|1
2701787|NCT00395304|9306851|P6|Treatment Period 1|Withdrawal by Subject|1
2701788|NCT00395304|9306852|P5|Treatment Period 1|Withdrawal by Subject|1
2701789|NCT00395304|9306853|P4|Treatment Period 1|Withdrawal by Subject|2
2701790|NCT00395304|9306854|P3|Treatment Period 1|Withdrawal by Subject|0
2701791|NCT00395304|9306855|P2|Treatment Period 1|Withdrawal by Subject|3
2701792|NCT00395304|9306856|P1|Treatment Period 1|Withdrawal by Subject|0
2701793|NCT00395226|9306932|P2|Overall Study|Lost to Follow-up|1
2701794|NCT00395226|9306933|P1|Overall Study|Lost to Follow-up|0
2701795|NCT00395226|9306932|P2|Overall Study|Withdrawal by Subject|1
2701796|NCT00395226|9306933|P1|Overall Study|Withdrawal by Subject|0
2701797|NCT00395226|9306932|P2|Overall Study|Adverse Event|3
2701798|NCT00395226|9306933|P1|Overall Study|Adverse Event|4
2701799|NCT00395083|9306980|P2|Overall Study|Developed another disease|3
2701800|NCT00395083|9306981|P1|Overall Study|Developed another disease|4
2701801|NCT00395083|9306980|P2|Overall Study|Withdrawal by Subject|5
2701802|NCT00395083|9306981|P1|Overall Study|Withdrawal by Subject|6
2701803|NCT00395018|9307047|P1|Off-Treatment Follow-up|Poor/non-compliance|1
2701804|NCT00395018|9307047|P1|Off-Treatment Follow-up|Lost to Follow-up|2
2701805|NCT00395018|9307047|P1|Off-Treatment Follow-up|Followup no longer required per protocol|1
2701806|NCT00395018|9307047|P1|On-Treatment|Subject no longer meets study criteria|2
2701807|NCT00395018|9307047|P1|On-Treatment|Poor/non-compliance|2
2701808|NCT00395018|9307047|P1|On-Treatment|Other Reason|2
2701809|NCT00395018|9307047|P1|On-Treatment|Death|4
2701810|NCT00394953|9307068|P2|Second Treatment Period|Not defined|8
2701811|NCT00394953|9307069|P1|Second Treatment Period|Not defined|3
2701812|NCT00394953|9307068|P2|Second Treatment Period|Renal transplant|6
2701813|NCT00394953|9307069|P1|Second Treatment Period|Renal transplant|4
2701814|NCT00394953|9307068|P2|Second Treatment Period|Lost to Follow-up|1
2701815|NCT00394953|9307069|P1|Second Treatment Period|Lost to Follow-up|0
2701816|NCT00394953|9307068|P2|Second Treatment Period|Withdrawal by Subject|3
2701817|NCT00394953|9307069|P1|Second Treatment Period|Withdrawal by Subject|3
2701818|NCT00394953|9307068|P2|Second Treatment Period|Lack of Efficacy|47
2701819|NCT00394953|9307069|P1|Second Treatment Period|Lack of Efficacy|9
2701820|NCT00394953|9307068|P2|Second Treatment Period|Death|4
2701821|NCT00394953|9307069|P1|Second Treatment Period|Death|8
2701822|NCT00394953|9307068|P2|Second Treatment Period|Adverse Event|5
2701823|NCT00394953|9307069|P1|Second Treatment Period|Adverse Event|2
2701824|NCT00394953|9307068|P2|First Treatment Period|Not defined|1
2701825|NCT00394953|9307069|P1|First Treatment Period|Not defined|4
2701826|NCT00394953|9307068|P2|First Treatment Period|Renal transplant|7
2701827|NCT00394953|9307069|P1|First Treatment Period|Renal transplant|11
2701828|NCT00394953|9307068|P2|First Treatment Period|Lost to Follow-up|1
2701829|NCT00394953|9307069|P1|First Treatment Period|Lost to Follow-up|0
2701830|NCT00394953|9307068|P2|First Treatment Period|Withdrawal by Subject|3
2701831|NCT00394953|9307069|P1|First Treatment Period|Withdrawal by Subject|6
2701832|NCT00394953|9307068|P2|First Treatment Period|Lack of Efficacy|1
2701833|NCT00394953|9307069|P1|First Treatment Period|Lack of Efficacy|1
2701834|NCT00394953|9307068|P2|First Treatment Period|Death|7
2701835|NCT00394953|9307069|P1|First Treatment Period|Death|6
2701836|NCT00394953|9307068|P2|First Treatment Period|Adverse Event|2
2701837|NCT00394953|9307069|P1|First Treatment Period|Adverse Event|1
2701838|NCT00394914|9307087|P3|Treatment Period|Did not meet protocol eligibility|1
2701839|NCT00394914|9307088|P2|Treatment Period|Did not meet protocol eligibility|1
2701840|NCT00394914|9307089|P1|Treatment Period|Did not meet protocol eligibility|0
2701841|NCT00394914|9307087|P3|Treatment Period|Noncompliance with protocol|2
2701842|NCT00394914|9307088|P2|Treatment Period|Noncompliance with protocol|3
2701843|NCT00394914|9307089|P1|Treatment Period|Noncompliance with protocol|0
2701844|NCT00394914|9307087|P3|Treatment Period|Withdrawal by Subject|2
2701845|NCT00394914|9307088|P2|Treatment Period|Withdrawal by Subject|2
2701846|NCT00394914|9307089|P1|Treatment Period|Withdrawal by Subject|0
2701847|NCT00394914|9307087|P3|Treatment Period|Lost to Follow-up|0
2701848|NCT00394914|9307088|P2|Treatment Period|Lost to Follow-up|1
2701849|NCT00394914|9307089|P1|Treatment Period|Lost to Follow-up|0
2701850|NCT00394914|9307087|P3|Treatment Period|Adverse Event|1
2701851|NCT00394914|9307088|P2|Treatment Period|Adverse Event|3
2701852|NCT00394914|9307089|P1|Treatment Period|Adverse Event|0
2701853|NCT00394901|9307117|P4|Double-blind Phase|Found not to meet entrance criteria|1
2701854|NCT00394901|9307118|P3|Double-blind Phase|Found not to meet entrance criteria|0
2701855|NCT00394901|9307119|P2|Double-blind Phase|Found not to meet entrance criteria|0
2701856|NCT00394901|9307120|P1|Double-blind Phase|Found not to meet entrance criteria|0
2701857|NCT00394901|9307117|P4|Double-blind Phase|Entry into another study was found|0
2701858|NCT00394901|9307118|P3|Double-blind Phase|Entry into another study was found|1
2701859|NCT00394901|9307119|P2|Double-blind Phase|Entry into another study was found|0
2701860|NCT00394901|9307120|P1|Double-blind Phase|Entry into another study was found|0
2701861|NCT00394901|9307117|P4|Double-blind Phase|Lack of Compliance|0
2701862|NCT00394901|9307118|P3|Double-blind Phase|Lack of Compliance|0
2701863|NCT00394901|9307119|P2|Double-blind Phase|Lack of Compliance|3
2701864|NCT00394901|9307120|P1|Double-blind Phase|Lack of Compliance|0
2701865|NCT00394901|9307117|P4|Double-blind Phase|Subject's Personal Reason|1
2701866|NCT00394901|9307118|P3|Double-blind Phase|Subject's Personal Reason|0
2701867|NCT00394901|9307119|P2|Double-blind Phase|Subject's Personal Reason|0
2701868|NCT00394901|9307120|P1|Double-blind Phase|Subject's Personal Reason|1
2701869|NCT00394901|9307117|P4|Double-blind Phase|Death|0
2701870|NCT00394901|9307118|P3|Double-blind Phase|Death|0
2701871|NCT00394901|9307119|P2|Double-blind Phase|Death|0
2701872|NCT00394901|9307120|P1|Double-blind Phase|Death|1
2701873|NCT00394901|9307117|P4|Double-blind Phase|Protocol Violation|1
2701874|NCT00394901|9307118|P3|Double-blind Phase|Protocol Violation|0
2701875|NCT00394901|9307119|P2|Double-blind Phase|Protocol Violation|0
2701876|NCT00394901|9307120|P1|Double-blind Phase|Protocol Violation|0
2701877|NCT00394901|9307117|P4|Double-blind Phase|Lost to Follow-up|1
2701878|NCT00394901|9307118|P3|Double-blind Phase|Lost to Follow-up|0
2701879|NCT00394901|9307119|P2|Double-blind Phase|Lost to Follow-up|0
2701880|NCT00394901|9307120|P1|Double-blind Phase|Lost to Follow-up|0
2701881|NCT00394901|9307117|P4|Double-blind Phase|Withdrawal by Subject|0
2701882|NCT00394901|9307118|P3|Double-blind Phase|Withdrawal by Subject|0
2701883|NCT00394901|9307119|P2|Double-blind Phase|Withdrawal by Subject|0
2701884|NCT00394901|9307120|P1|Double-blind Phase|Withdrawal by Subject|2
2701885|NCT00394901|9307117|P4|Double-blind Phase|Lack of Efficacy|3
2701886|NCT00394901|9307118|P3|Double-blind Phase|Lack of Efficacy|1
2701887|NCT00394901|9307119|P2|Double-blind Phase|Lack of Efficacy|4
2701888|NCT00394901|9307120|P1|Double-blind Phase|Lack of Efficacy|6
2701889|NCT00394901|9307117|P4|Double-blind Phase|Adverse Event|20
2701890|NCT00394901|9307118|P3|Double-blind Phase|Adverse Event|16
2701891|NCT00394901|9307119|P2|Double-blind Phase|Adverse Event|7
2701892|NCT00394901|9307120|P1|Double-blind Phase|Adverse Event|5
2701893|NCT00394901|9307117|P4|Baseline Phase|Protocol Violation|0
2701894|NCT00394901|9307118|P3|Baseline Phase|Protocol Violation|1
2701895|NCT00394901|9307119|P2|Baseline Phase|Protocol Violation|0
2701896|NCT00394901|9307120|P1|Baseline Phase|Protocol Violation|0
2701897|NCT00394836|9307363|P2|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10
2701898|NCT00394836|9307364|P1|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7
2701899|NCT00394836|9307363|P2|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41
2701900|NCT00394836|9307364|P1|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13
2701901|NCT00394836|9307363|P2|Extended Follow-up Phase (2-5 Years)|Death|1
2701902|NCT00394836|9307364|P1|Extended Follow-up Phase (2-5 Years)|Death|0
2701903|NCT00394836|9307363|P2|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1
2701904|NCT00394836|9307364|P1|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0
2701905|NCT00394836|9307363|P2|Teatment or Follow-up Phase|Non compliance|1
2701906|NCT00394836|9307364|P1|Teatment or Follow-up Phase|Non compliance|0
2701907|NCT00394836|9307363|P2|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1
2701908|NCT00394836|9307364|P1|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0
2701909|NCT00394836|9307363|P2|Teatment or Follow-up Phase|Physician Decision|1
2701910|NCT00394836|9307364|P1|Teatment or Follow-up Phase|Physician Decision|0
2701911|NCT00394836|9307363|P2|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1
2701912|NCT00394836|9307364|P1|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0
2701913|NCT00394836|9307363|P2|Teatment or Follow-up Phase|Started alternative treatment|6
2701914|NCT00394836|9307364|P1|Teatment or Follow-up Phase|Started alternative treatment|0
2701915|NCT00394836|9307363|P2|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1
2701916|NCT00394836|9307364|P1|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0
2701917|NCT00394836|9307363|P2|Teatment or Follow-up Phase|Death|1
2701918|NCT00394836|9307364|P1|Teatment or Follow-up Phase|Death|0
2701919|NCT00394836|9307363|P2|Teatment or Follow-up Phase|Patient Refusal|2
2701920|NCT00394836|9307364|P1|Teatment or Follow-up Phase|Patient Refusal|1
2701921|NCT00394836|9307363|P2|Teatment or Follow-up Phase|Disease Progression|60
2701922|NCT00394836|9307364|P1|Teatment or Follow-up Phase|Disease Progression|27
2701923|NCT00394836|9307363|P2|Teatment or Follow-up Phase|Protocol Violation|2
2701924|NCT00394836|9307364|P1|Teatment or Follow-up Phase|Protocol Violation|0
2701925|NCT00394836|9307363|P2|Teatment or Follow-up Phase|Adverse Event|2
2701926|NCT00394836|9307364|P1|Teatment or Follow-up Phase|Adverse Event|0
2701927|NCT00394771|9307410|P4|Overall Study|Other|0
2701928|NCT00394771|9307411|P3|Overall Study|Other|1
2701929|NCT00394771|9307412|P2|Overall Study|Other|3
2701930|NCT00394771|9307413|P1|Overall Study|Other|3
2701931|NCT00394771|9307410|P4|Overall Study|Lost to Follow-up|10
2701932|NCT00394771|9307411|P3|Overall Study|Lost to Follow-up|13
2701933|NCT00394771|9307412|P2|Overall Study|Lost to Follow-up|15
2701934|NCT00394771|9307413|P1|Overall Study|Lost to Follow-up|15
2701935|NCT00394771|9307410|P4|Overall Study|Participant pregnant|2
2701936|NCT00394771|9307411|P3|Overall Study|Participant pregnant|2
2701937|NCT00394771|9307412|P2|Overall Study|Participant pregnant|1
2701938|NCT00394771|9307413|P1|Overall Study|Participant pregnant|0
2701939|NCT00394771|9307410|P4|Overall Study|Adverse Event|8
2701940|NCT00394771|9307411|P3|Overall Study|Adverse Event|12
2701941|NCT00394771|9307412|P2|Overall Study|Adverse Event|5
2701942|NCT00394771|9307413|P1|Overall Study|Adverse Event|10
2701943|NCT00394771|9307410|P4|Overall Study|Withdrawal by Subject|12
2701944|NCT00394771|9307411|P3|Overall Study|Withdrawal by Subject|8
2701945|NCT00394771|9307412|P2|Overall Study|Withdrawal by Subject|6
2701946|NCT00394771|9307413|P1|Overall Study|Withdrawal by Subject|10
2701947|NCT00394771|9307410|P4|Overall Study|Protocol Violation|7
2701948|NCT00394771|9307411|P3|Overall Study|Protocol Violation|9
2701949|NCT00394771|9307412|P2|Overall Study|Protocol Violation|4
2701950|NCT00394771|9307413|P1|Overall Study|Protocol Violation|2
2701951|NCT00394771|9307410|P4|Overall Study|Did not meet protocol requirements|0
2701952|NCT00394771|9307411|P3|Overall Study|Did not meet protocol requirements|2
2701953|NCT00394771|9307412|P2|Overall Study|Did not meet protocol requirements|0
2701954|NCT00394771|9307413|P1|Overall Study|Did not meet protocol requirements|1
2701955|NCT00394706|9307483|P8|Overall Study|Lost to Follow-up|0
2701956|NCT00394706|9307484|P7|Overall Study|Lost to Follow-up|2
2701957|NCT00394706|9307485|P6|Overall Study|Lost to Follow-up|5
2701958|NCT00394706|9307486|P5|Overall Study|Lost to Follow-up|2
2701959|NCT00394706|9307487|P4|Overall Study|Lost to Follow-up|1
2701960|NCT00394706|9307488|P3|Overall Study|Lost to Follow-up|8
2701961|NCT00394706|9307489|P2|Overall Study|Lost to Follow-up|2
2701962|NCT00394706|9307490|P1|Overall Study|Lost to Follow-up|2
2701963|NCT00394706|9307483|P8|Overall Study|Withdrawal by Subject|0
2701964|NCT00394706|9307484|P7|Overall Study|Withdrawal by Subject|1
2701965|NCT00394706|9307485|P6|Overall Study|Withdrawal by Subject|2
2701966|NCT00394706|9307486|P5|Overall Study|Withdrawal by Subject|0
2701967|NCT00394706|9307487|P4|Overall Study|Withdrawal by Subject|0
2701968|NCT00394706|9307488|P3|Overall Study|Withdrawal by Subject|1
2701969|NCT00394706|9307489|P2|Overall Study|Withdrawal by Subject|0
2701970|NCT00394706|9307490|P1|Overall Study|Withdrawal by Subject|2
2701971|NCT00394654|9307522|P2|Overall Study|PARTICIPANT LEFT STDUY REGION|0
2701972|NCT00394654|9307523|P1|Overall Study|PARTICIPANT LEFT STDUY REGION|1
2701973|NCT00394654|9307522|P2|Overall Study|Lost to Follow-up|0
2701974|NCT00394654|9307523|P1|Overall Study|Lost to Follow-up|1
2701975|NCT00394589|9307588|P3|Overall Study|Protocol Violation|2
2701976|NCT00394589|9307589|P2|Overall Study|Protocol Violation|0
2701977|NCT00394589|9307590|P1|Overall Study|Protocol Violation|4
2701978|NCT00394589|9307588|P3|Overall Study|Lack of Efficacy|3
2701979|NCT00394589|9307589|P2|Overall Study|Lack of Efficacy|2
2701980|NCT00394589|9307590|P1|Overall Study|Lack of Efficacy|2
2701981|NCT00394589|9307588|P3|Overall Study|Adverse Event|2
2701982|NCT00394589|9307589|P2|Overall Study|Adverse Event|1
2701983|NCT00394589|9307590|P1|Overall Study|Adverse Event|2
2701984|NCT00394524|9307600|P2|Overall Study|Withdrawal by Subject|1
2701985|NCT00394524|9307601|P1|Overall Study|Withdrawal by Subject|0
2701986|NCT00394524|9307600|P2|Overall Study|Death|0
2701987|NCT00394524|9307601|P1|Overall Study|Death|1
2701988|NCT00394524|9307600|P2|Overall Study|Protocol Violation|3
2701989|NCT00394524|9307601|P1|Overall Study|Protocol Violation|2
2701990|NCT00394472|9307615|P2|Overall Study|Lost to Follow-up|1
2701991|NCT00394472|9307616|P1|Overall Study|Lost to Follow-up|0
2701992|NCT00394472|9307615|P2|Overall Study|Physician Decision|1
2701993|NCT00394472|9307616|P1|Overall Study|Physician Decision|0
2701994|NCT00394472|9307615|P2|Overall Study|Withdrawal by Subject|2
2701995|NCT00394472|9307616|P1|Overall Study|Withdrawal by Subject|0
2701996|NCT00394472|9307615|P2|Overall Study|Adverse Event|2
2701997|NCT00394472|9307616|P1|Overall Study|Adverse Event|4
2701998|NCT00394472|9307615|P2|Overall Study|incorrect enrolment|2
2701999|NCT00394472|9307616|P1|Overall Study|incorrect enrolment|4
2702000|NCT00394472|9307615|P2|Overall Study|Protocol Violation|3
2702001|NCT00394472|9307616|P1|Overall Study|Protocol Violation|1
2702002|NCT00394433|9307624|P1|Overall Study|Alternative Therapy|1
2702003|NCT00394433|9307624|P1|Overall Study|Adverse Event|2
2702004|NCT00394355|9307635|P4|Overall Study|Lack of Efficacy|3
2702005|NCT00394355|9307636|P3|Overall Study|Lack of Efficacy|2
2702006|NCT00394355|9307637|P2|Overall Study|Lack of Efficacy|0
2702007|NCT00394355|9307638|P1|Overall Study|Lack of Efficacy|0
2702008|NCT00394355|9307635|P4|Overall Study|Administrative|1
2702009|NCT00394355|9307636|P3|Overall Study|Administrative|1
2702010|NCT00394355|9307637|P2|Overall Study|Administrative|1
2702011|NCT00394355|9307638|P1|Overall Study|Administrative|0
2702012|NCT00394355|9307635|P4|Overall Study|Noncompliance with protocol|8
2702013|NCT00394355|9307636|P3|Overall Study|Noncompliance with protocol|10
2702014|NCT00394355|9307637|P2|Overall Study|Noncompliance with protocol|3
2702015|NCT00394355|9307638|P1|Overall Study|Noncompliance with protocol|4
2702016|NCT00394355|9307635|P4|Overall Study|Lost to Follow-up|3
2702017|NCT00394355|9307636|P3|Overall Study|Lost to Follow-up|4
2702018|NCT00394355|9307637|P2|Overall Study|Lost to Follow-up|5
2702019|NCT00394355|9307638|P1|Overall Study|Lost to Follow-up|7
2702020|NCT00394355|9307635|P4|Overall Study|Subject withdrawal - related to drug|0
2702021|NCT00394355|9307636|P3|Overall Study|Subject withdrawal - related to drug|0
2702022|NCT00394355|9307637|P2|Overall Study|Subject withdrawal - related to drug|0
2702023|NCT00394355|9307638|P1|Overall Study|Subject withdrawal - related to drug|1
2702024|NCT00394355|9307635|P4|Overall Study|Subject withdrawal - unrelated to drug|6
2702025|NCT00394355|9307636|P3|Overall Study|Subject withdrawal - unrelated to drug|10
2702026|NCT00394355|9307637|P2|Overall Study|Subject withdrawal - unrelated to drug|14
2702027|NCT00394355|9307638|P1|Overall Study|Subject withdrawal - unrelated to drug|12
2702028|NCT00394355|9307635|P4|Overall Study|Did not meet protocol eligibility|2
2702029|NCT00394355|9307636|P3|Overall Study|Did not meet protocol eligibility|4
2702030|NCT00394355|9307637|P2|Overall Study|Did not meet protocol eligibility|5
2702031|NCT00394355|9307638|P1|Overall Study|Did not meet protocol eligibility|1
2702032|NCT00394355|9307635|P4|Overall Study|Adverse Event|8
2702033|NCT00394355|9307636|P3|Overall Study|Adverse Event|7
2702034|NCT00394355|9307637|P2|Overall Study|Adverse Event|6
2702035|NCT00394355|9307638|P1|Overall Study|Adverse Event|10
2702036|NCT00394251|9307744|P2|Overall Study|Non-compliance, pt moved, pt/inv agree|2
2702037|NCT00394251|9307745|P1|Overall Study|Non-compliance, pt moved, pt/inv agree|2
2702038|NCT00394251|9307744|P2|Overall Study|Withdrawal by Subject|11
2702039|NCT00394251|9307745|P1|Overall Study|Withdrawal by Subject|7
2702040|NCT00394251|9307744|P2|Overall Study|Protocol Violation|1
2702041|NCT00394251|9307745|P1|Overall Study|Protocol Violation|0
2702042|NCT00394251|9307744|P2|Overall Study|Physician Decision|1
2702043|NCT00394251|9307745|P1|Overall Study|Physician Decision|1
2702044|NCT00394251|9307744|P2|Overall Study|Unacceptable Toxicity|18
2702045|NCT00394251|9307745|P1|Overall Study|Unacceptable Toxicity|20
2702046|NCT00394251|9307744|P2|Overall Study|Adverse Event|5
2702047|NCT00394251|9307745|P1|Overall Study|Adverse Event|7
2702048|NCT00394212|9307773|P2|Overall Study|Withdrawal by Subject|1
2702049|NCT00394212|9307774|P1|Overall Study|Withdrawal by Subject|4
2702050|NCT00394212|9307773|P2|Overall Study|Lost to Follow-up|0
2702051|NCT00394212|9307774|P1|Overall Study|Lost to Follow-up|3
2702052|NCT00394095|9307788|P2|Overall Study|Adverse Event|0
2702053|NCT00394095|9307789|P1|Overall Study|Adverse Event|1
2702054|NCT00394082|9307797|P1|Overall Study|Other|1
2702055|NCT00394082|9307797|P1|Overall Study|Withdrawal by Subject|2
2702056|NCT00394082|9307797|P1|Overall Study|Physician Decision|4
2702057|NCT00394082|9307797|P1|Overall Study|Adverse Event|4
2702058|NCT00394082|9307797|P1|Overall Study|Unacceptable toxicity|15
2702059|NCT00393939|9307819|P2|Overall Study|Other|45
2702060|NCT00393939|9307820|P1|Overall Study|Other|37
2702061|NCT00393939|9307819|P2|Overall Study|Withdrawal by Subject|7
2702062|NCT00393939|9307820|P1|Overall Study|Withdrawal by Subject|2
2702063|NCT00393939|9307819|P2|Overall Study|Objective progression or relapse|223
2702064|NCT00393939|9307820|P1|Overall Study|Objective progression or relapse|239
2702065|NCT00393939|9307819|P2|Overall Study|Sponsor|13
2702066|NCT00393939|9307820|P1|Overall Study|Sponsor|5
2702067|NCT00393939|9307819|P2|Overall Study|Death|4
2702068|NCT00393939|9307820|P1|Overall Study|Death|10
2702069|NCT00393939|9307819|P2|Overall Study|Lost to Follow-up|4
2702070|NCT00393939|9307820|P1|Overall Study|Lost to Follow-up|2
2702071|NCT00393939|9307819|P2|Overall Study|Protocol Violation|1
2702072|NCT00393939|9307820|P1|Overall Study|Protocol Violation|1
2702073|NCT00393913|9307838|P1|CPAP|TEchnical problem with CPAP|3
2702074|NCT00393913|9307838|P1|CPAP|Physician Decision|1
2702075|NCT00393913|9307838|P1|CPAP|Withdrawal by Subject|3
2702076|NCT00393913|9307838|P1|Initial Assessment|Withdrawal by Subject|16
2702077|NCT00393913|9307838|P1|Initial Assessment|diagnosed with other sleep disorder|21
2702078|NCT00393887|9307846|P2|Overall Study|Lost to Follow-up|9
2702079|NCT00393887|9307847|P1|Overall Study|Lost to Follow-up|11
2702080|NCT00393887|9307846|P2|Overall Study|Physician Decision|0
2702081|NCT00393887|9307847|P1|Overall Study|Physician Decision|5
2702082|NCT00393861|9307875|P1|Overall Study|Disease Progression|24
2702083|NCT00393861|9307875|P1|Overall Study|Adverse Event|2
2702084|NCT00393848|9307886|P4|Overall Study|Personal reasons|0
2702085|NCT00393848|9307887|P3|Overall Study|Personal reasons|2
2702086|NCT00393848|9307888|P2|Overall Study|Personal reasons|0
2702087|NCT00393848|9307889|P1|Overall Study|Personal reasons|0
2702088|NCT00393848|9307886|P4|Overall Study|Surgical schedule|1
2702089|NCT00393848|9307887|P3|Overall Study|Surgical schedule|0
2702090|NCT00393848|9307888|P2|Overall Study|Surgical schedule|0
2702091|NCT00393848|9307889|P1|Overall Study|Surgical schedule|0
2702092|NCT00393718|9307912|P2|Overall Study|Move|0
2702093|NCT00393718|9307913|P1|Overall Study|Move|1
2702094|NCT00393718|9307912|P2|Overall Study|Missed measurement|0
2702095|NCT00393718|9307913|P1|Overall Study|Missed measurement|1
2702096|NCT00393718|9307912|P2|Overall Study|Withdrawal of consent|1
2702097|NCT00393718|9307913|P1|Overall Study|Withdrawal of consent|2
2702098|NCT00393718|9307912|P2|Overall Study|Subject decision|0
2702099|NCT00393718|9307913|P1|Overall Study|Subject decision|5
2702100|NCT00393718|9307912|P2|Overall Study|Hypoglycaemia|2
2702101|NCT00393718|9307913|P1|Overall Study|Hypoglycaemia|3
2702102|NCT00393718|9307912|P2|Overall Study|Lack of Efficacy|9
2702103|NCT00393718|9307913|P1|Overall Study|Lack of Efficacy|10
2702104|NCT00393718|9307912|P2|Overall Study|Protocol Violation|2
2702105|NCT00393718|9307913|P1|Overall Study|Protocol Violation|1
2702106|NCT00393718|9307912|P2|Overall Study|Adverse Event|8
2702107|NCT00393718|9307913|P1|Overall Study|Adverse Event|20
2702108|NCT00393705|9307945|P2|Overall Study|Physician Decision|2
2702109|NCT00393705|9307946|P1|Overall Study|Physician Decision|2
2702110|NCT00393705|9307945|P2|Overall Study|Withdrawal by Subject|3
2702111|NCT00393705|9307946|P1|Overall Study|Withdrawal by Subject|5
2702112|NCT00393705|9307945|P2|Overall Study|Protocol Violation|3
2702113|NCT00393705|9307946|P1|Overall Study|Protocol Violation|4
2702114|NCT00393705|9307945|P2|Overall Study|Entry Criteria Not Met|10
2702115|NCT00393705|9307946|P1|Overall Study|Entry Criteria Not Met|10
2702116|NCT00393705|9307945|P2|Overall Study|Lost to Follow-up|2
2702117|NCT00393705|9307946|P1|Overall Study|Lost to Follow-up|2
2702118|NCT00393705|9307945|P2|Overall Study|Death|1
2702119|NCT00393705|9307946|P1|Overall Study|Death|0
2702120|NCT00393705|9307945|P2|Overall Study|Adverse Event|2
2702121|NCT00393705|9307946|P1|Overall Study|Adverse Event|0
2702122|NCT00393523|9307975|P5|Overall Study|Vaccine supply issue|0
2702123|NCT00393523|9307976|P4|Overall Study|Vaccine supply issue|0
2702124|NCT00393523|9307977|P3|Overall Study|Vaccine supply issue|1
2702125|NCT00393523|9307978|P2|Overall Study|Vaccine supply issue|0
2702126|NCT00393523|9307979|P1|Overall Study|Vaccine supply issue|0
2702127|NCT00393523|9307975|P5|Overall Study|Difficulties in specimen collection|0
2702128|NCT00393523|9307976|P4|Overall Study|Difficulties in specimen collection|0
2702129|NCT00393523|9307977|P3|Overall Study|Difficulties in specimen collection|1
2702130|NCT00393523|9307978|P2|Overall Study|Difficulties in specimen collection|0
2702131|NCT00393523|9307979|P1|Overall Study|Difficulties in specimen collection|0
2702132|NCT00393523|9307975|P5|Overall Study|Withdrawal by Subject|0
2702133|NCT00393523|9307976|P4|Overall Study|Withdrawal by Subject|3
2702134|NCT00393523|9307977|P3|Overall Study|Withdrawal by Subject|2
2702135|NCT00393523|9307978|P2|Overall Study|Withdrawal by Subject|7
2702136|NCT00393523|9307979|P1|Overall Study|Withdrawal by Subject|6
2702137|NCT00393523|9307975|P5|Overall Study|Protocol Violation|0
2702138|NCT00393523|9307976|P4|Overall Study|Protocol Violation|1
2702139|NCT00393523|9307977|P3|Overall Study|Protocol Violation|0
2702140|NCT00393523|9307978|P2|Overall Study|Protocol Violation|2
2702141|NCT00393523|9307979|P1|Overall Study|Protocol Violation|6
2702142|NCT00393523|9307975|P5|Overall Study|Lost to Follow-up|1
2702143|NCT00393523|9307976|P4|Overall Study|Lost to Follow-up|2
2702144|NCT00393523|9307977|P3|Overall Study|Lost to Follow-up|0
2702145|NCT00393523|9307978|P2|Overall Study|Lost to Follow-up|0
2702146|NCT00393523|9307979|P1|Overall Study|Lost to Follow-up|0
2702147|NCT00393510|9307996|P2|Overall Study|Physician Decision|9
2702148|NCT00393510|9307997|P1|Overall Study|Physician Decision|3
2702149|NCT00393484|9308009|P2|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18
2702150|NCT00393484|9308010|P1|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0
2702151|NCT00393484|9308009|P2|Open-label Period (Weeks 96 to 240)|Noncompliance|2
2702152|NCT00393484|9308010|P1|Open-label Period (Weeks 96 to 240)|Noncompliance|2
2702153|NCT00393484|9308009|P2|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2
2702154|NCT00393484|9308010|P1|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1
2702155|NCT00393484|9308009|P2|Open-label Period (Weeks 96 to 240)|Death|0
2702156|NCT00393484|9308010|P1|Open-label Period (Weeks 96 to 240)|Death|1
2702157|NCT00393484|9308009|P2|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1
2702158|NCT00393484|9308010|P1|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4
2702159|NCT00393484|9308009|P2|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2
2702160|NCT00393484|9308010|P1|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0
2702161|NCT00393484|9308009|P2|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6
2702162|NCT00393484|9308010|P1|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0
2702163|NCT00393484|9308009|P2|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3
2702164|NCT00393484|9308010|P1|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0
2702165|NCT00393484|9308009|P2|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0
2702166|NCT00393484|9308010|P1|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2
2702167|NCT00393484|9308009|P2|Double-blind Period (Day 1 to Week 96)|Adverse Event|1
2702168|NCT00393484|9308010|P1|Double-blind Period (Day 1 to Week 96)|Adverse Event|0
2702169|NCT00393458|9308046|P4|Overall Study|Subject no longer requires study drug|0
2702170|NCT00393458|9308047|P3|Overall Study|Subject no longer requires study drug|0
2702171|NCT00393458|9308048|P2|Overall Study|Subject no longer requires study drug|1
2702172|NCT00393458|9308049|P1|Overall Study|Subject no longer requires study drug|0
2702173|NCT00393458|9308046|P4|Overall Study|Abnormal test procedure result(s)|2
2702174|NCT00393458|9308047|P3|Overall Study|Abnormal test procedure result(s)|1
2702175|NCT00393458|9308048|P2|Overall Study|Abnormal test procedure result(s)|1
2702176|NCT00393458|9308049|P1|Overall Study|Abnormal test procedure result(s)|0
2702177|NCT00393458|9308046|P4|Overall Study|Death|5
2702178|NCT00393458|9308047|P3|Overall Study|Death|5
2702179|NCT00393458|9308048|P2|Overall Study|Death|1
2702180|NCT00393458|9308049|P1|Overall Study|Death|1
2702181|NCT00393458|9308046|P4|Overall Study|Abnormal laboratory value(s)|0
2702182|NCT00393458|9308047|P3|Overall Study|Abnormal laboratory value(s)|0
2702183|NCT00393458|9308048|P2|Overall Study|Abnormal laboratory value(s)|1
2702184|NCT00393458|9308049|P1|Overall Study|Abnormal laboratory value(s)|1
2702185|NCT00393458|9308046|P4|Overall Study|Lost to Follow-up|3
2702186|NCT00393458|9308047|P3|Overall Study|Lost to Follow-up|5
2702187|NCT00393458|9308048|P2|Overall Study|Lost to Follow-up|6
2702188|NCT00393458|9308049|P1|Overall Study|Lost to Follow-up|5
2702189|NCT00393458|9308046|P4|Overall Study|Administrative problems|2
2702190|NCT00393458|9308047|P3|Overall Study|Administrative problems|5
2702191|NCT00393458|9308048|P2|Overall Study|Administrative problems|8
2702192|NCT00393458|9308049|P1|Overall Study|Administrative problems|7
2702193|NCT00393458|9308046|P4|Overall Study|Protocol deviation|10
2702194|NCT00393458|9308047|P3|Overall Study|Protocol deviation|11
2702195|NCT00393458|9308048|P2|Overall Study|Protocol deviation|11
2702196|NCT00393458|9308049|P1|Overall Study|Protocol deviation|11
2702197|NCT00393458|9308046|P4|Overall Study|Unsatisfactory therapeutic effect|30
2702198|NCT00393458|9308047|P3|Overall Study|Unsatisfactory therapeutic effect|12
2702199|NCT00393458|9308048|P2|Overall Study|Unsatisfactory therapeutic effect|9
2702200|NCT00393458|9308049|P1|Overall Study|Unsatisfactory therapeutic effect|12
2702201|NCT00393458|9308046|P4|Overall Study|Subject withdrew consent|50
2702202|NCT00393458|9308047|P3|Overall Study|Subject withdrew consent|33
2702203|NCT00393458|9308048|P2|Overall Study|Subject withdrew consent|40
2702204|NCT00393458|9308049|P1|Overall Study|Subject withdrew consent|27
2702205|NCT00393458|9308046|P4|Overall Study|Adverse Event|35
2702206|NCT00393458|9308047|P3|Overall Study|Adverse Event|40
2702207|NCT00393458|9308048|P2|Overall Study|Adverse Event|24
2702208|NCT00393458|9308049|P1|Overall Study|Adverse Event|35
2702209|NCT00393367|9308076|P2|Overall Study|Withdrawal by Subject|2
2702210|NCT00393367|9308077|P1|Overall Study|Withdrawal by Subject|0
2702211|NCT00393367|9308076|P2|Overall Study|Protocol Violation|5
2702212|NCT00393367|9308077|P1|Overall Study|Protocol Violation|2
2702213|NCT00393094|9308105|P1|Disease Progression After Trtmt: Onstudy|Refused further treatment|1
2702214|NCT00393094|9308105|P1|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1
2702215|NCT00393042|9308116|P2|Second Intervetion|Protocol Violation|1
2702216|NCT00393042|9308117|P1|Second Intervetion|Protocol Violation|1
2702217|NCT00393042|9308116|P2|Second Intervetion|Lost to Follow-up|2
2702218|NCT00393042|9308117|P1|Second Intervetion|Lost to Follow-up|0
2702219|NCT00393042|9308116|P2|Second Intervetion|Lack of Efficacy|0
2702220|NCT00393042|9308117|P1|Second Intervetion|Lack of Efficacy|1
2702221|NCT00393042|9308116|P2|Second Intervetion|Withdrawal by Subject|2
2702222|NCT00393042|9308117|P1|Second Intervetion|Withdrawal by Subject|0
2702223|NCT00393042|9308116|P2|Second Intervetion|Adverse Event|3
2702224|NCT00393042|9308117|P1|Second Intervetion|Adverse Event|0
2702225|NCT00393042|9308116|P2|First Intervention|Adverse Event|1
2702226|NCT00393042|9308117|P1|First Intervention|Adverse Event|0
2702227|NCT00393042|9308116|P2|First Intervention|Protocol Violation|0
2702228|NCT00393042|9308117|P1|First Intervention|Protocol Violation|1
2702229|NCT00393042|9308116|P2|First Intervention|Lost to Follow-up|3
2702230|NCT00393042|9308117|P1|First Intervention|Lost to Follow-up|3
2702231|NCT00393042|9308116|P2|First Intervention|Withdrawal by Subject|2
2702232|NCT00393042|9308117|P1|First Intervention|Withdrawal by Subject|1
2702233|NCT00393029|9308189|P2|Overall Study|Not treated|1
2702234|NCT00393029|9308190|P1|Overall Study|Not treated|0
2702235|NCT00392990|9308201|P2|Follow up for 2 Years|Death|0
2702236|NCT00392990|9308202|P1|Follow up for 2 Years|Death|4
2702237|NCT00392990|9308201|P2|Treatment on Study|Adverse Event|1
2702238|NCT00392990|9308202|P1|Treatment on Study|Adverse Event|3
2702239|NCT00392925|9308226|P4|Randomization to Treatment Group Period|Lost to Follow-up|4
2702240|NCT00392925|9308227|P3|Randomization to Treatment Group Period|Lost to Follow-up|8
2702241|NCT00392925|9308228|P2|Randomization to Treatment Group Period|Lost to Follow-up|3
2702242|NCT00392925|9308229|P1|Randomization to Treatment Group Period|Lost to Follow-up|0
2702243|NCT00392925|9308226|P4|Randomization to Treatment Group Period|Protocol Violation|1
2702244|NCT00392925|9308227|P3|Randomization to Treatment Group Period|Protocol Violation|2
2702245|NCT00392925|9308228|P2|Randomization to Treatment Group Period|Protocol Violation|0
2702246|NCT00392925|9308229|P1|Randomization to Treatment Group Period|Protocol Violation|0
2702247|NCT00392925|9308226|P4|Randomization to Treatment Group Period|Adverse Event|5
2702248|NCT00392925|9308227|P3|Randomization to Treatment Group Period|Adverse Event|3
2702249|NCT00392925|9308228|P2|Randomization to Treatment Group Period|Adverse Event|3
2702250|NCT00392925|9308229|P1|Randomization to Treatment Group Period|Adverse Event|0
2702251|NCT00392925|9308226|P4|Randomization to Treatment Group Period|Withdrawal by Subject|8
2702252|NCT00392925|9308227|P3|Randomization to Treatment Group Period|Withdrawal by Subject|6
2702253|NCT00392925|9308228|P2|Randomization to Treatment Group Period|Withdrawal by Subject|2
2702254|NCT00392925|9308229|P1|Randomization to Treatment Group Period|Withdrawal by Subject|0
2702255|NCT00392925|9308226|P4|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
2702256|NCT00392925|9308227|P3|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
2702257|NCT00392925|9308228|P2|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
2702258|NCT00392925|9308229|P1|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16
2702259|NCT00392925|9308226|P4|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
2702260|NCT00392925|9308227|P3|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
2702261|NCT00392925|9308228|P2|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
2702262|NCT00392925|9308229|P1|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5
2702263|NCT00392925|9308226|P4|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
2702264|NCT00392925|9308227|P3|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
2702265|NCT00392925|9308228|P2|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
2702266|NCT00392925|9308229|P1|4 Week Lead-In Period - Non-Randomized|Physician Decision|1
2702267|NCT00392925|9308226|P4|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
2702268|NCT00392925|9308227|P3|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
2702269|NCT00392925|9308228|P2|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
2702270|NCT00392925|9308229|P1|4 Week Lead-In Period - Non-Randomized|Adverse Event|5
2702271|NCT00392925|9308226|P4|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
2702272|NCT00392925|9308227|P3|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
2702273|NCT00392925|9308228|P2|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
2702274|NCT00392925|9308229|P1|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11
2702275|NCT00392808|9308343|P4|Overall Study|Unable to withdraw blood|2
2702276|NCT00392808|9308344|P3|Overall Study|Unable to withdraw blood|1
2702277|NCT00392808|9308345|P2|Overall Study|Unable to withdraw blood|1
2702278|NCT00392808|9308346|P1|Overall Study|Unable to withdraw blood|3
2702279|NCT00392808|9308343|P4|Overall Study|Lost to Follow-up|2
2702280|NCT00392808|9308344|P3|Overall Study|Lost to Follow-up|1
2702281|NCT00392808|9308345|P2|Overall Study|Lost to Follow-up|2
2702282|NCT00392808|9308346|P1|Overall Study|Lost to Follow-up|3
2702283|NCT00392769|9308370|P1|Overall Study|Adverse Event|1
2702284|NCT00392769|9308370|P1|Overall Study|Clinical Deterioration|9
2702285|NCT00392665|9308422|P2|Overall Study|Lost to Follow-up|1
2702286|NCT00392665|9308423|P1|Overall Study|Lost to Follow-up|1
2702287|NCT00392665|9308422|P2|Overall Study|Death|14
2702288|NCT00392665|9308423|P1|Overall Study|Death|16
2702289|NCT00392379|9308449|P2|Overall Study|Adverse Event|1
2702290|NCT00392379|9308450|P1|Overall Study|Adverse Event|1
2702291|NCT00392379|9308449|P2|Overall Study|Lost to Follow-up|9
2702292|NCT00392379|9308450|P1|Overall Study|Lost to Follow-up|4
2702293|NCT00392379|9308449|P2|Overall Study|Withdrawal by Subject|28
2702294|NCT00392379|9308450|P1|Overall Study|Withdrawal by Subject|17
2702295|NCT00392288|9308463|P3|Overall Study|Other|1
2702296|NCT00392288|9308464|P2|Overall Study|Other|4
2702297|NCT00392288|9308465|P1|Overall Study|Other|3
2702298|NCT00392288|9308463|P3|Overall Study|Parent/legal guardian withdrawal|1
2702299|NCT00392288|9308464|P2|Overall Study|Parent/legal guardian withdrawal|2
2702300|NCT00392288|9308465|P1|Overall Study|Parent/legal guardian withdrawal|1
2702301|NCT00392288|9308463|P3|Overall Study|Withdrawal by Subject|2
2702302|NCT00392288|9308464|P2|Overall Study|Withdrawal by Subject|0
2702303|NCT00392288|9308465|P1|Overall Study|Withdrawal by Subject|1
2702304|NCT00392288|9308463|P3|Overall Study|Lost to Follow-up|1
2702305|NCT00392288|9308464|P2|Overall Study|Lost to Follow-up|1
2702306|NCT00392288|9308465|P1|Overall Study|Lost to Follow-up|1
2702307|NCT00392288|9308463|P3|Overall Study|Protocol Violation|1
2702308|NCT00392288|9308464|P2|Overall Study|Protocol Violation|3
2702309|NCT00392288|9308465|P1|Overall Study|Protocol Violation|1
2702310|NCT00392288|9308463|P3|Overall Study|Lack of Efficacy|3
2702311|NCT00392288|9308464|P2|Overall Study|Lack of Efficacy|5
2702312|NCT00392288|9308465|P1|Overall Study|Lack of Efficacy|8
2702313|NCT00392288|9308463|P3|Overall Study|Adverse Event|8
2702314|NCT00392288|9308464|P2|Overall Study|Adverse Event|7
2702315|NCT00392288|9308465|P1|Overall Study|Adverse Event|17
2702316|NCT00392223|9308490|P2|Overall Study|Withdrawal by Subject|2
2702317|NCT00392223|9308491|P1|Overall Study|Withdrawal by Subject|3
2702318|NCT00392223|9308490|P2|Overall Study|Protocol Violation|3
2702319|NCT00392223|9308491|P1|Overall Study|Protocol Violation|0
2702320|NCT00392223|9308490|P2|Overall Study|Lost to Follow-up|4
2702321|NCT00392223|9308491|P1|Overall Study|Lost to Follow-up|1
2702322|NCT00392223|9308490|P2|Overall Study|Adverse Event|4
2702323|NCT00392223|9308491|P1|Overall Study|Adverse Event|5
2702324|NCT00392210|9308509|P2|First Voiding Trial|Physician Decision|2
2702325|NCT00392210|9308510|P1|First Voiding Trial|Physician Decision|2
2702326|NCT00392197|9308518|P2|Overall Study|Withdrawal by Subject|6
2702327|NCT00392197|9308519|P1|Overall Study|Withdrawal by Subject|4
2702328|NCT00392197|9308518|P2|Overall Study|Protocol Violation|5
2702329|NCT00392197|9308519|P1|Overall Study|Protocol Violation|7
2702330|NCT00392197|9308518|P2|Overall Study|Physician Decision|2
2702331|NCT00392197|9308519|P1|Overall Study|Physician Decision|3
2702332|NCT00392197|9308518|P2|Overall Study|Lost to Follow-up|1
2702333|NCT00392197|9308519|P1|Overall Study|Lost to Follow-up|0
2702334|NCT00392197|9308518|P2|Overall Study|Lack of Efficacy|4
2702335|NCT00392197|9308519|P1|Overall Study|Lack of Efficacy|3
2702336|NCT00392197|9308518|P2|Overall Study|Adverse Event|12
2702337|NCT00392197|9308519|P1|Overall Study|Adverse Event|4
2702338|NCT00392171|9308527|P1|Overall Study|Disease progression|101
2702339|NCT00392171|9308527|P1|Overall Study|Did not meet inclusion criteria|4
2702340|NCT00391976|9308561|P3|Overall Study|Positive P. aeruginosa antibody test|31
2702341|NCT00391976|9308562|P2|Overall Study|Positive P. aeruginosa antibody test|0
2702342|NCT00391976|9308563|P1|Overall Study|Positive P. aeruginosa antibody test|0
2702343|NCT00391976|9308561|P3|Overall Study|Unable to classify|1
2702344|NCT00391976|9308562|P2|Overall Study|Unable to classify|0
2702345|NCT00391976|9308563|P1|Overall Study|Unable to classify|0
2702346|NCT00391976|9308561|P3|Overall Study|Recurrence/no eradication of infection|0
2702347|NCT00391976|9308562|P2|Overall Study|Recurrence/no eradication of infection|19
2702348|NCT00391976|9308563|P1|Overall Study|Recurrence/no eradication of infection|21
2702349|NCT00391976|9308561|P3|Overall Study|Protocol deviation/violation|1
2702350|NCT00391976|9308562|P2|Overall Study|Protocol deviation/violation|2
2702351|NCT00391976|9308563|P1|Overall Study|Protocol deviation/violation|4
2702352|NCT00391976|9308561|P3|Overall Study|Inappropriate enrollment|0
2702353|NCT00391976|9308562|P2|Overall Study|Inappropriate enrollment|1
2702354|NCT00391976|9308563|P1|Overall Study|Inappropriate enrollment|1
2702355|NCT00391976|9308561|P3|Overall Study|Lost to Follow-up|0
2702356|NCT00391976|9308562|P2|Overall Study|Lost to Follow-up|2
2702357|NCT00391976|9308563|P1|Overall Study|Lost to Follow-up|1
2702358|NCT00391976|9308561|P3|Overall Study|Withdrawal of consent|1
2702359|NCT00391976|9308562|P2|Overall Study|Withdrawal of consent|1
2702360|NCT00391976|9308563|P1|Overall Study|Withdrawal of consent|0
2702361|NCT00391976|9308561|P3|Overall Study|Adverse Event|1
2702362|NCT00391976|9308562|P2|Overall Study|Adverse Event|0
2702363|NCT00391976|9308563|P1|Overall Study|Adverse Event|0
2702364|NCT00391898|9308587|P2|Overall Study|Other|10
2702365|NCT00391898|9308588|P1|Overall Study|Other|8
2702366|NCT00391898|9308587|P2|Overall Study|Adverse Event|0
2702367|NCT00391898|9308588|P1|Overall Study|Adverse Event|3
2702368|NCT00391872|9308608|P2|Overall Study|Lost to Follow-up|0
2702369|NCT00391872|9308609|P1|Overall Study|Lost to Follow-up|2
2702370|NCT00391872|9308608|P2|Overall Study|Reason unknown|4
2702371|NCT00391872|9308609|P1|Overall Study|Reason unknown|2
2702372|NCT00391872|9308608|P2|Overall Study|Withdrawal by Subject|249
2702373|NCT00391872|9308609|P1|Overall Study|Withdrawal by Subject|296
2702374|NCT00391872|9308608|P2|Overall Study|Protocol Violation|2
2702375|NCT00391872|9308609|P1|Overall Study|Protocol Violation|7
2702376|NCT00391846|9308647|P2|Overall Study|Developed study specific DC criteria|1
2702377|NCT00391846|9308648|P1|Overall Study|Developed study specific DC criteria|0
2702378|NCT00391846|9308647|P2|Overall Study|Withdrawal by Subject|3
2702379|NCT00391846|9308648|P1|Overall Study|Withdrawal by Subject|2
2702380|NCT00391846|9308647|P2|Overall Study|Did not meet the required elig. crit|2
2702381|NCT00391846|9308648|P1|Overall Study|Did not meet the required elig. crit|2
2702382|NCT00391846|9308647|P2|Overall Study|Adverse Event|1
2702383|NCT00391846|9308648|P1|Overall Study|Adverse Event|4
2702384|NCT00391807|9308668|P1|Overall Study|Various|96
2702385|NCT00391807|9308668|P1|Overall Study|Protocol Violation|20
2702386|NCT00391807|9308668|P1|Overall Study|Withdrawal by Subject|147
2702387|NCT00391807|9308668|P1|Overall Study|Lost to Follow-up|227
2702388|NCT00391807|9308668|P1|Overall Study|Pregnancy|25
2702389|NCT00391807|9308668|P1|Overall Study|Adverse Event|177
2702390|NCT00391807|9308668|P1|Overall Study|Did not receive study medication|23
2702391|NCT00391768|9308695|P7|Overall Study|Lost to Follow-up|3
2702392|NCT00391768|9308696|P6|Overall Study|Lost to Follow-up|2
2702393|NCT00391768|9308697|P5|Overall Study|Lost to Follow-up|2
2702394|NCT00391768|9308698|P4|Overall Study|Lost to Follow-up|1
2702395|NCT00391768|9308699|P3|Overall Study|Lost to Follow-up|0
2702396|NCT00391768|9308700|P2|Overall Study|Lost to Follow-up|0
2702397|NCT00391768|9308701|P1|Overall Study|Lost to Follow-up|0
2702398|NCT00391768|9308695|P7|Overall Study|Withdrawal by Subject|1
2702399|NCT00391768|9308696|P6|Overall Study|Withdrawal by Subject|1
2702400|NCT00391768|9308697|P5|Overall Study|Withdrawal by Subject|0
2702401|NCT00391768|9308698|P4|Overall Study|Withdrawal by Subject|0
2702402|NCT00391768|9308699|P3|Overall Study|Withdrawal by Subject|1
2702403|NCT00391768|9308700|P2|Overall Study|Withdrawal by Subject|0
2702404|NCT00391768|9308701|P1|Overall Study|Withdrawal by Subject|0
2702405|NCT00391625|9308788|P1|Month 50|Physician Decision|1
2702406|NCT00391625|9308788|P1|Month 14|Withdrawal by Subject|1
2702407|NCT00391586|9308841|P1|Overall Study|Death|4
2702408|NCT00391586|9308841|P1|Overall Study|Physician Decision|2
2702409|NCT00391586|9308841|P1|Overall Study|Adverse Event|5
2702410|NCT00391586|9308841|P1|Overall Study|Progressive disease|13
2702411|NCT00391391|9308878|P4|Overall Study|Withdrawal by Subject|7
2702412|NCT00391391|9308879|P3|Overall Study|Withdrawal by Subject|10
2702413|NCT00391391|9308880|P2|Overall Study|Withdrawal by Subject|4
2702414|NCT00391391|9308881|P1|Overall Study|Withdrawal by Subject|6
2702415|NCT00391391|9308878|P4|Overall Study|Protocol Violation|7
2702416|NCT00391391|9308879|P3|Overall Study|Protocol Violation|6
2702417|NCT00391391|9308880|P2|Overall Study|Protocol Violation|3
2702418|NCT00391391|9308881|P1|Overall Study|Protocol Violation|2
2702419|NCT00391391|9308878|P4|Overall Study|Lost to Follow-up|4
2702420|NCT00391391|9308879|P3|Overall Study|Lost to Follow-up|7
2702421|NCT00391391|9308880|P2|Overall Study|Lost to Follow-up|3
2702422|NCT00391391|9308881|P1|Overall Study|Lost to Follow-up|1
2702423|NCT00391391|9308878|P4|Overall Study|Adverse Event|1
2702424|NCT00391391|9308879|P3|Overall Study|Adverse Event|0
2702425|NCT00391391|9308880|P2|Overall Study|Adverse Event|0
2702426|NCT00391391|9308881|P1|Overall Study|Adverse Event|0
2702427|NCT00391274|9308926|P2|Overall Study|Death Not Study Related|1
2702428|NCT00391274|9308927|P1|Overall Study|Death Not Study Related|0
2702429|NCT00391274|9308926|P2|Overall Study|Death Due to Indeterminate Cause|0
2702430|NCT00391274|9308927|P1|Overall Study|Death Due to Indeterminate Cause|1
2702431|NCT00391274|9308926|P2|Overall Study|Death Due to Adverse Event|3
2702432|NCT00391274|9308927|P1|Overall Study|Death Due to Adverse Event|1
2702433|NCT00391274|9308926|P2|Overall Study|Withdrawal by Subject|3
2702434|NCT00391274|9308927|P1|Overall Study|Withdrawal by Subject|0
2702435|NCT00391274|9308926|P2|Overall Study|Physician Decision|2
2702436|NCT00391274|9308927|P1|Overall Study|Physician Decision|4
2702437|NCT00391274|9308926|P2|Overall Study|Lost to Follow-up|3
2702438|NCT00391274|9308927|P1|Overall Study|Lost to Follow-up|0
2702439|NCT00391274|9308926|P2|Overall Study|Death Due to Study Disease|45
2702440|NCT00391274|9308927|P1|Overall Study|Death Due to Study Disease|55
2702441|NCT00391222|9308946|P4|Period III (Double-Blind Treatment)|Other|0
2702442|NCT00391222|9308947|P3|Period III (Double-Blind Treatment)|Other|6
2702443|NCT00391222|9308948|P2|Period III (Double-Blind Treatment)|Other|1
2702444|NCT00391222|9308949|P1|Period III (Double-Blind Treatment)|Other|6
2702445|NCT00391222|9308946|P4|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
2702446|NCT00391222|9308947|P3|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3
2702447|NCT00391222|9308948|P2|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1
2702448|NCT00391222|9308949|P1|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
2702449|NCT00391222|9308946|P4|Period III (Double-Blind Treatment)|Pregnancy|0
2702450|NCT00391222|9308947|P3|Period III (Double-Blind Treatment)|Pregnancy|0
2702451|NCT00391222|9308948|P2|Period III (Double-Blind Treatment)|Pregnancy|2
2702452|NCT00391222|9308949|P1|Period III (Double-Blind Treatment)|Pregnancy|0
2702453|NCT00391222|9308946|P4|Period III (Double-Blind Treatment)|Adverse Event|0
2702454|NCT00391222|9308947|P3|Period III (Double-Blind Treatment)|Adverse Event|4
2702455|NCT00391222|9308948|P2|Period III (Double-Blind Treatment)|Adverse Event|2
2702456|NCT00391222|9308949|P1|Period III (Double-Blind Treatment)|Adverse Event|5
2702457|NCT00391222|9308946|P4|Period III (Double-Blind Treatment)|Lost to Follow-up|0
2702458|NCT00391222|9308947|P3|Period III (Double-Blind Treatment)|Lost to Follow-up|4
2702459|NCT00391222|9308948|P2|Period III (Double-Blind Treatment)|Lost to Follow-up|4
2702460|NCT00391222|9308949|P1|Period III (Double-Blind Treatment)|Lost to Follow-up|2
2702461|NCT00391222|9308946|P4|Period III (Double-Blind Treatment)|Withdrawal by Subject|0
2702462|NCT00391222|9308947|P3|Period III (Double-Blind Treatment)|Withdrawal by Subject|6
2702463|NCT00391222|9308948|P2|Period III (Double-Blind Treatment)|Withdrawal by Subject|12
2702464|NCT00391222|9308949|P1|Period III (Double-Blind Treatment)|Withdrawal by Subject|15
2702465|NCT00391222|9308946|P4|Period II (Open-label Risperidone LAI)|Other|24
2702466|NCT00391222|9308947|P3|Period II (Open-label Risperidone LAI)|Other|0
2702467|NCT00391222|9308948|P2|Period II (Open-label Risperidone LAI)|Other|0
2702468|NCT00391222|9308949|P1|Period II (Open-label Risperidone LAI)|Other|0
2702469|NCT00391222|9308946|P4|Period II (Open-label Risperidone LAI)|Non-responder|97
2702470|NCT00391222|9308947|P3|Period II (Open-label Risperidone LAI)|Non-responder|0
2702471|NCT00391222|9308948|P2|Period II (Open-label Risperidone LAI)|Non-responder|0
2702472|NCT00391222|9308949|P1|Period II (Open-label Risperidone LAI)|Non-responder|0
2702473|NCT00391222|9308946|P4|Period II (Open-label Risperidone LAI)|Adverse Event|10
2702474|NCT00391222|9308947|P3|Period II (Open-label Risperidone LAI)|Adverse Event|0
2702475|NCT00391222|9308948|P2|Period II (Open-label Risperidone LAI)|Adverse Event|0
2702476|NCT00391222|9308949|P1|Period II (Open-label Risperidone LAI)|Adverse Event|0
2702477|NCT00391222|9308946|P4|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5
2702478|NCT00391222|9308947|P3|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
2702479|NCT00391222|9308948|P2|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
2702480|NCT00391222|9308949|P1|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
2702481|NCT00391222|9308946|P4|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26
2702482|NCT00391222|9308947|P3|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
2702483|NCT00391222|9308948|P2|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
2702484|NCT00391222|9308949|P1|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
2702485|NCT00391092|9308975|P2|Overall Study|Alive in follow-up|84
2702486|NCT00391092|9308976|P1|Overall Study|Alive in follow-up|88
2702487|NCT00391092|9308975|P2|Overall Study|Alive on treatment|33
2702488|NCT00391092|9308976|P1|Overall Study|Alive on treatment|29
2702489|NCT00391092|9308975|P2|Overall Study|Lost to Follow-up|18
2702490|NCT00391092|9308976|P1|Overall Study|Lost to Follow-up|13
2702491|NCT00391092|9308975|P2|Overall Study|Death|81
2702492|NCT00391092|9308976|P1|Overall Study|Death|78
2702493|NCT00391053|9309019|P4|Overall Study|Withdrawal by Subject|1
2702494|NCT00391053|9309020|P3|Overall Study|Withdrawal by Subject|1
2702495|NCT00391053|9309021|P2|Overall Study|Withdrawal by Subject|1
2702496|NCT00391053|9309022|P1|Overall Study|Withdrawal by Subject|5
2702497|NCT00391053|9309019|P4|Overall Study|Lost to Follow-up|5
2702498|NCT00391053|9309020|P3|Overall Study|Lost to Follow-up|0
2702499|NCT00391053|9309021|P2|Overall Study|Lost to Follow-up|0
2702500|NCT00391053|9309022|P1|Overall Study|Lost to Follow-up|1
2702501|NCT00391053|9309019|P4|Overall Study|Protocol Violation|0
2702502|NCT00391053|9309020|P3|Overall Study|Protocol Violation|0
2702503|NCT00391053|9309021|P2|Overall Study|Protocol Violation|0
2702504|NCT00391053|9309022|P1|Overall Study|Protocol Violation|2
2702505|NCT00391053|9309019|P4|Overall Study|Serious Adverse Events|4
2702506|NCT00391053|9309020|P3|Overall Study|Serious Adverse Events|1
2702507|NCT00391053|9309021|P2|Overall Study|Serious Adverse Events|0
2702508|NCT00391053|9309022|P1|Overall Study|Serious Adverse Events|1
2702509|NCT00391027|9309046|P2|Overall Study|Other|3
2702510|NCT00391027|9309047|P1|Overall Study|Other|4
2702511|NCT00391027|9309046|P2|Overall Study|Withdrawal by Subject|1
2702512|NCT00391027|9309047|P1|Overall Study|Withdrawal by Subject|10
2702513|NCT00391027|9309046|P2|Overall Study|Lack of Efficacy|0
2702514|NCT00391027|9309047|P1|Overall Study|Lack of Efficacy|3
2702515|NCT00391027|9309046|P2|Overall Study|Adverse Event|8
2702516|NCT00391027|9309047|P1|Overall Study|Adverse Event|8
2702517|NCT00390910|9309097|P3|Overall Study|Migrated/moved from study area|3
2702518|NCT00390910|9309098|P2|Overall Study|Migrated/moved from study area|0
2702519|NCT00390910|9309099|P1|Overall Study|Migrated/moved from study area|0
2702520|NCT00390910|9309097|P3|Overall Study|Withdrawal by Subject|2
2702521|NCT00390910|9309098|P2|Overall Study|Withdrawal by Subject|3
2702522|NCT00390910|9309099|P1|Overall Study|Withdrawal by Subject|1
2702523|NCT00390910|9309097|P3|Overall Study|Lost to Follow-up|5
2702524|NCT00390910|9309098|P2|Overall Study|Lost to Follow-up|1
2702525|NCT00390910|9309099|P1|Overall Study|Lost to Follow-up|0
2702526|NCT00390910|9309097|P3|Overall Study|Adverse Event|0
2702527|NCT00390910|9309098|P2|Overall Study|Adverse Event|0
2702528|NCT00390910|9309099|P1|Overall Study|Adverse Event|1
2702529|NCT00390884|9309187|P2|Overall Study|Withdrawal by Subject|2
2702530|NCT00390884|9309188|P1|Overall Study|Withdrawal by Subject|2
2702531|NCT00390858|9309200|P2|Overall Study|Withdrawal by Subject|4
2702532|NCT00390858|9309201|P1|Overall Study|Withdrawal by Subject|3
2702533|NCT00390858|9309200|P2|Overall Study|Lack of Efficacy|1
2702534|NCT00390858|9309201|P1|Overall Study|Lack of Efficacy|0
2702535|NCT00390858|9309200|P2|Overall Study|Adverse Event|2
2702536|NCT00390858|9309201|P1|Overall Study|Adverse Event|6
2702537|NCT00390806|9309215|P2|Overall Study|Ongoing|2
2702538|NCT00390806|9309216|P1|Overall Study|Ongoing|4
2702539|NCT00390806|9309215|P2|Overall Study|Physician Decision|1
2702540|NCT00390806|9309216|P1|Overall Study|Physician Decision|0
2702541|NCT00390806|9309215|P2|Overall Study|Death|0
2702542|NCT00390806|9309216|P1|Overall Study|Death|1
2702543|NCT00390806|9309215|P2|Overall Study|Investigator Decision|6
2702544|NCT00390806|9309216|P1|Overall Study|Investigator Decision|4
2702545|NCT00390806|9309215|P2|Overall Study|Withdrawal by Subject|15
2702546|NCT00390806|9309216|P1|Overall Study|Withdrawal by Subject|12
2702547|NCT00390806|9309215|P2|Overall Study|Protocol Violation|2
2702548|NCT00390806|9309216|P1|Overall Study|Protocol Violation|2
2702549|NCT00390806|9309215|P2|Overall Study|Lost to Follow-up|6
2702550|NCT00390806|9309216|P1|Overall Study|Lost to Follow-up|7
2702551|NCT00390780|9309284|P2|Overall Study|SAE, death|1
2702552|NCT00390780|9309285|P1|Overall Study|SAE, death|0
2702553|NCT00390780|9309284|P2|Overall Study|Investigator decision, SAE, other reason|1
2702554|NCT00390780|9309285|P1|Overall Study|Investigator decision, SAE, other reason|0
2702555|NCT00390780|9309284|P2|Overall Study|Lost to follow up and other reasons|1
2702556|NCT00390780|9309285|P1|Overall Study|Lost to follow up and other reasons|0
2702557|NCT00390780|9309284|P2|Overall Study|Inclusion criteria not satisfied|2
2702558|NCT00390780|9309285|P1|Overall Study|Inclusion criteria not satisfied|0
2702559|NCT00390780|9309284|P2|Overall Study|Withdrawal by Subject|2
2702560|NCT00390780|9309285|P1|Overall Study|Withdrawal by Subject|1
2702561|NCT00390780|9309284|P2|Overall Study|Death|3
2702562|NCT00390780|9309285|P1|Overall Study|Death|1
2702563|NCT00390780|9309284|P2|Overall Study|Adverse Event|3
2702564|NCT00390780|9309285|P1|Overall Study|Adverse Event|2
2702565|NCT00390780|9309284|P2|Overall Study|Lost to Follow-up|6
2702566|NCT00390780|9309285|P1|Overall Study|Lost to Follow-up|3
2702567|NCT00390780|9309284|P2|Overall Study|Protocol Violation|4
2702568|NCT00390780|9309285|P1|Overall Study|Protocol Violation|6
2702569|NCT00390780|9309284|P2|Overall Study|Not completed|4
2702570|NCT00390780|9309285|P1|Overall Study|Not completed|10
2702571|NCT00390689|9309318|P3|Overall Study|Investigator's judgement|0
2702572|NCT00390689|9309319|P2|Overall Study|Investigator's judgement|0
2702573|NCT00390689|9309320|P1|Overall Study|Investigator's judgement|2
2702574|NCT00390689|9309318|P3|Overall Study|Protocol Violation|0
2702575|NCT00390689|9309319|P2|Overall Study|Protocol Violation|0
2702576|NCT00390689|9309320|P1|Overall Study|Protocol Violation|1
2702577|NCT00390689|9309318|P3|Overall Study|Lack of Efficacy|1
2702578|NCT00390689|9309319|P2|Overall Study|Lack of Efficacy|0
2702579|NCT00390689|9309320|P1|Overall Study|Lack of Efficacy|0
2702580|NCT00390689|9309318|P3|Overall Study|Adverse Event|2
2702581|NCT00390689|9309319|P2|Overall Study|Adverse Event|5
2702582|NCT00390689|9309320|P1|Overall Study|Adverse Event|2
2702583|NCT00390572|9309395|P2|Overall Study|health condition|1
2702584|NCT00390572|9309396|P1|Overall Study|health condition|0
2702585|NCT00390572|9309395|P2|Overall Study|Lost to Follow-up|4
2702586|NCT00390572|9309396|P1|Overall Study|Lost to Follow-up|8
2702587|NCT00390546|9309422|P2|Overall Study|Physician Decision|5
2702588|NCT00390546|9309423|P1|Overall Study|Physician Decision|5
2702589|NCT00390546|9309422|P2|Overall Study|Renal impairment|0
2702590|NCT00390546|9309423|P1|Overall Study|Renal impairment|1
2702591|NCT00390468|9309433|P1|Overall Study|Lack of Efficacy|1
2702592|NCT00390468|9309433|P1|Overall Study|Protocol Violation|2
2702593|NCT00390455|9309439|P2|Overall Study|Other Medical Reasons|11
2702594|NCT00390455|9309440|P1|Overall Study|Other Medical Reasons|7
2702595|NCT00390455|9309439|P2|Overall Study|Alternate Treatment|1
2702596|NCT00390455|9309440|P1|Overall Study|Alternate Treatment|0
2702597|NCT00390455|9309439|P2|Overall Study|Withdrawal by Subject|8
2702598|NCT00390455|9309440|P1|Overall Study|Withdrawal by Subject|8
2702599|NCT00390455|9309439|P2|Overall Study|Adverse Event|3
2702600|NCT00390455|9309440|P1|Overall Study|Adverse Event|17
2702601|NCT00390416|9309485|P1|Overall Study|Not treated|3
2702602|NCT00390416|9309485|P1|Overall Study|Withdrawal by Subject|1
2702603|NCT00390299|9309523|P5|Overall Study|Cancellation|0
2702604|NCT00390299|9309524|P4|Overall Study|Cancellation|0
2702605|NCT00390299|9309525|P3|Overall Study|Cancellation|0
2702606|NCT00390299|9309526|P2|Overall Study|Cancellation|0
2702607|NCT00390299|9309527|P1|Overall Study|Cancellation|1
2702608|NCT00390221|9309558|P3|Overall Study|Other|2
2702609|NCT00390221|9309559|P2|Overall Study|Other|4
2702610|NCT00390221|9309560|P1|Overall Study|Other|3
2702611|NCT00390221|9309558|P3|Overall Study|Subject Non-compliance|2
2702612|NCT00390221|9309559|P2|Overall Study|Subject Non-compliance|0
2702613|NCT00390221|9309560|P1|Overall Study|Subject Non-compliance|1
2702614|NCT00390221|9309558|P3|Overall Study|Withdrawal by Subject|7
2702615|NCT00390221|9309559|P2|Overall Study|Withdrawal by Subject|9
2702616|NCT00390221|9309560|P1|Overall Study|Withdrawal by Subject|13
2702617|NCT00390221|9309558|P3|Overall Study|Investigator Decision|1
2702618|NCT00390221|9309559|P2|Overall Study|Investigator Decision|0
2702619|NCT00390221|9309560|P1|Overall Study|Investigator Decision|0
2702620|NCT00390221|9309558|P3|Overall Study|Adverse Event|3
2702621|NCT00390221|9309559|P2|Overall Study|Adverse Event|4
2702622|NCT00390221|9309560|P1|Overall Study|Adverse Event|1
2702623|NCT00390221|9309558|P3|Overall Study|Lost to Follow-up|0
2702624|NCT00390221|9309559|P2|Overall Study|Lost to Follow-up|3
2702625|NCT00390221|9309560|P1|Overall Study|Lost to Follow-up|0
2702626|NCT00390013|9309590|P4|Phase 2 First Treatment|Withdrawal by Subject|0
2702627|NCT00390013|9309591|P3|Phase 2 First Treatment|Withdrawal by Subject|0
2702628|NCT00390013|9309592|P2|Phase 2 First Treatment|Withdrawal by Subject|1
2702629|NCT00390013|9309593|P1|Phase 2 First Treatment|Withdrawal by Subject|0
2702630|NCT00390013|9309590|P4|Phase 2 First Treatment|tired|0
2702631|NCT00390013|9309591|P3|Phase 2 First Treatment|tired|0
2702632|NCT00390013|9309592|P2|Phase 2 First Treatment|tired|0
2702633|NCT00390013|9309593|P1|Phase 2 First Treatment|tired|1
2702634|NCT00390013|9309590|P4|Phase 1|tired|1
2702635|NCT00390013|9309591|P3|Phase 1|tired|0
2702636|NCT00390013|9309592|P2|Phase 1|tired|0
2702637|NCT00390013|9309593|P1|Phase 1|tired|0
2702638|NCT00389831|9309618|P2|Overall Study|Lost to Follow-up|1
2702639|NCT00389831|9309619|P1|Overall Study|Lost to Follow-up|0
2702640|NCT00389831|9309618|P2|Overall Study|Other reasons|2
2702641|NCT00389831|9309619|P1|Overall Study|Other reasons|0
2702642|NCT00389831|9309618|P2|Overall Study|Did not receive treatment.|2
2702643|NCT00389831|9309619|P1|Overall Study|Did not receive treatment.|0
2702644|NCT00389831|9309618|P2|Overall Study|Lack of Efficacy|2
2702645|NCT00389831|9309619|P1|Overall Study|Lack of Efficacy|0
2702646|NCT00389597|9309682|P4|Overall Study|Lost to Follow-up|6
2702647|NCT00389597|9309683|P3|Overall Study|Lost to Follow-up|4
2702648|NCT00389597|9309684|P2|Overall Study|Lost to Follow-up|6
2702649|NCT00389597|9309685|P1|Overall Study|Lost to Follow-up|8
2702650|NCT00389519|9309710|P4|Treated|Reason not specified|2
2702651|NCT00389519|9309711|P3|Treated|Reason not specified|0
2702652|NCT00389519|9309712|P2|Treated|Reason not specified|1
2702653|NCT00389519|9309713|P1|Treated|Reason not specified|1
2702654|NCT00389519|9309710|P4|Treated|Adverse Event|2
2702655|NCT00389519|9309711|P3|Treated|Adverse Event|0
2702656|NCT00389519|9309712|P2|Treated|Adverse Event|0
2702657|NCT00389519|9309713|P1|Treated|Adverse Event|1
2702658|NCT00389519|9309710|P4|Randomized|Did not receive study drug|0
2702659|NCT00389519|9309711|P3|Randomized|Did not receive study drug|0
2702660|NCT00389519|9309712|P2|Randomized|Did not receive study drug|0
2702661|NCT00389519|9309713|P1|Randomized|Did not receive study drug|2
2702662|NCT00389519|9309710|P4|Placebo Run-In|Reason not specified|0
2702663|NCT00389519|9309711|P3|Placebo Run-In|Reason not specified|0
2702664|NCT00389519|9309712|P2|Placebo Run-In|Reason not specified|0
2702665|NCT00389519|9309713|P1|Placebo Run-In|Reason not specified|40
2702666|NCT00389519|9309710|P4|Placebo Run-In|Withdrawal by Subject|0
2702667|NCT00389519|9309711|P3|Placebo Run-In|Withdrawal by Subject|0
2702668|NCT00389519|9309712|P2|Placebo Run-In|Withdrawal by Subject|0
2702669|NCT00389519|9309713|P1|Placebo Run-In|Withdrawal by Subject|19
2702670|NCT00389519|9309710|P4|Placebo Run-In|Did not meet blood pressure criteria|0
2702671|NCT00389519|9309711|P3|Placebo Run-In|Did not meet blood pressure criteria|0
2702672|NCT00389519|9309712|P2|Placebo Run-In|Did not meet blood pressure criteria|0
2702673|NCT00389519|9309713|P1|Placebo Run-In|Did not meet blood pressure criteria|119
2702674|NCT00389441|9309790|P1|Overall Study|Clinical progression|1
2702675|NCT00389441|9309790|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|2
2702676|NCT00389441|9309790|P1|Overall Study|Objective progression or relapse|26
2702677|NCT00389441|9309790|P1|Overall Study|Global deterioration of health status|4
2702678|NCT00389441|9309790|P1|Overall Study|Protocol Violation|1
2702679|NCT00389441|9309790|P1|Overall Study|Physician Decision|1
2702680|NCT00389441|9309790|P1|Overall Study|Withdrawal by Subject|4
2702681|NCT00389441|9309790|P1|Overall Study|Lost to Follow-up|2
2702682|NCT00389441|9309790|P1|Overall Study|Death|4
2702683|NCT00389441|9309790|P1|Overall Study|Adverse Event|7
2702684|NCT00389324|9309799|P1|Subcutaneous Phase|Lost to Follow-up|1
2702685|NCT00389324|9309799|P1|Subcutaneous Phase|Withdrawal by Subject|2
2702686|NCT00389324|9309799|P1|Subcutaneous Phase|Non-compliance with study medication|2
2702687|NCT00389324|9309799|P1|Subcutaneous Phase|Adverse Event|2
2702688|NCT00389324|9309799|P1|Run-In Phase|Withdrawal by Subject|1
2702689|NCT00389324|9309799|P1|Run-In Phase|Lost to Follow-up|1
2702690|NCT00389324|9309799|P1|Run-In Phase|Adverse Event|1
2702691|NCT00389207|9309809|P3|Overall Study|Other|9
2702692|NCT00389207|9309810|P2|Overall Study|Other|23
2702693|NCT00389207|9309811|P1|Overall Study|Other|17
2702694|NCT00389207|9309809|P3|Overall Study|Withdrawal by Subject|11
2702695|NCT00389207|9309810|P2|Overall Study|Withdrawal by Subject|7
2702696|NCT00389207|9309811|P1|Overall Study|Withdrawal by Subject|5
2702697|NCT00389207|9309809|P3|Overall Study|Lost to Follow-up|7
2702698|NCT00389207|9309810|P2|Overall Study|Lost to Follow-up|9
2702699|NCT00389207|9309811|P1|Overall Study|Lost to Follow-up|12
2702700|NCT00389207|9309809|P3|Overall Study|Protocol Violation|4
2702701|NCT00389207|9309810|P2|Overall Study|Protocol Violation|1
2702702|NCT00389207|9309811|P1|Overall Study|Protocol Violation|3
2702703|NCT00389207|9309809|P3|Overall Study|Adverse Event|10
2702704|NCT00389207|9309810|P2|Overall Study|Adverse Event|32
2702705|NCT00389207|9309811|P1|Overall Study|Adverse Event|26
2702706|NCT00389064|9309934|P2|Overall Study|Multiple Reasons|11
2702707|NCT00389064|9309935|P1|Overall Study|Multiple Reasons|9
2702708|NCT00389064|9309934|P2|Overall Study|Protocol Violation|0
2702709|NCT00389064|9309935|P1|Overall Study|Protocol Violation|2
2702710|NCT00389064|9309934|P2|Overall Study|Lost to Follow-up|2
2702711|NCT00389064|9309935|P1|Overall Study|Lost to Follow-up|1
2702712|NCT00389064|9309934|P2|Overall Study|Physician Decision|2
2702713|NCT00389064|9309935|P1|Overall Study|Physician Decision|2
2702714|NCT00389064|9309934|P2|Overall Study|Withdrawal by Subject|27
2702715|NCT00389064|9309935|P1|Overall Study|Withdrawal by Subject|17
2702716|NCT00389064|9309934|P2|Overall Study|Lack of Efficacy|14
2702717|NCT00389064|9309935|P1|Overall Study|Lack of Efficacy|3
2702718|NCT00389064|9309934|P2|Overall Study|Adverse Event|3
2702719|NCT00389064|9309935|P1|Overall Study|Adverse Event|11
2702720|NCT00388973|9309963|P2|Overall Study|Did not complete 2-week follow-up visit|17
2702721|NCT00388973|9309964|P1|Overall Study|Did not complete 2-week follow-up visit|17
2702722|NCT00388973|9309963|P2|Overall Study|Left region|1
2702723|NCT00388973|9309964|P1|Overall Study|Left region|0
2702724|NCT00388973|9309963|P2|Overall Study|Did not complete 61 days of treatment|4
2702725|NCT00388973|9309964|P1|Overall Study|Did not complete 61 days of treatment|5
2702726|NCT00388973|9309963|P2|Overall Study|Study specific Discontinuation Criteria|1
2702727|NCT00388973|9309964|P1|Overall Study|Study specific Discontinuation Criteria|0
2702728|NCT00388973|9309963|P2|Overall Study|Withdrawal by Subject|17
2702729|NCT00388973|9309964|P1|Overall Study|Withdrawal by Subject|14
2702730|NCT00388973|9309963|P2|Overall Study|Protocol Violation|0
2702731|NCT00388973|9309964|P1|Overall Study|Protocol Violation|3
2702732|NCT00388973|9309963|P2|Overall Study|Lack of Efficacy|12
2702733|NCT00388973|9309964|P1|Overall Study|Lack of Efficacy|1
2702734|NCT00388973|9309963|P2|Overall Study|Adverse Event|6
2702735|NCT00388973|9309964|P1|Overall Study|Adverse Event|16
2702736|NCT00388947|9309984|P1|Overall Study|Protocol Violation|47
2702737|NCT00388726|9310000|P2|Overall Study|Death|2
2702738|NCT00388726|9310001|P1|Overall Study|Death|3
2702739|NCT00388726|9310000|P2|Overall Study|Physician Decision|13
2702740|NCT00388726|9310001|P1|Overall Study|Physician Decision|18
2702741|NCT00388726|9310000|P2|Overall Study|Administrative|9
2702742|NCT00388726|9310001|P1|Overall Study|Administrative|6
2702743|NCT00388726|9310000|P2|Overall Study|Withdrawal by Subject|7
2702744|NCT00388726|9310001|P1|Overall Study|Withdrawal by Subject|10
2702745|NCT00388726|9310000|P2|Overall Study|Clinical Progression|36
2702746|NCT00388726|9310001|P1|Overall Study|Clinical Progression|61
2702747|NCT00388726|9310000|P2|Overall Study|Progressive Disease|153
2702748|NCT00388726|9310001|P1|Overall Study|Progressive Disease|336
2702749|NCT00388726|9310000|P2|Overall Study|Adverse Event|24
2702750|NCT00388726|9310001|P1|Overall Study|Adverse Event|50
2702751|NCT00388674|9310017|P2|End of Study|Not Reported|1
2702752|NCT00388674|9310018|P1|End of Study|Not Reported|0
2702753|NCT00388674|9310017|P2|End of Study|No Off-Treatment Status Data|30
2702754|NCT00388674|9310018|P1|End of Study|No Off-Treatment Status Data|22
2702755|NCT00388674|9310017|P2|End of Study|Participant Withdrew Consent|673
2702756|NCT00388674|9310018|P1|End of Study|Participant Withdrew Consent|437
2702757|NCT00388674|9310017|P2|End of Study|Not Defined|214
2702758|NCT00388674|9310018|P1|End of Study|Not Defined|135
2702759|NCT00388674|9310017|P2|End of Study|Non-Study Related Comorbidities|4
2702760|NCT00388674|9310018|P1|End of Study|Non-Study Related Comorbidities|3
2702761|NCT00388674|9310017|P2|End of Study|Malignancy (Non-HCC)|1
2702762|NCT00388674|9310018|P1|End of Study|Malignancy (Non-HCC)|1
2702763|NCT00388674|9310017|P2|End of Study|Lost to Follow-up|715
2702764|NCT00388674|9310018|P1|End of Study|Lost to Follow-up|587
2702765|NCT00388674|9310017|P2|End of Study|HCC|7
2702766|NCT00388674|9310018|P1|End of Study|HCC|8
2702767|NCT00388674|9310017|P2|End of Study|HBV Disease Progression (Non-HCC)|9
2702768|NCT00388674|9310018|P1|End of Study|HBV Disease Progression (Non-HCC)|3
2702769|NCT00388674|9310017|P2|End of Study|Death|262
2702770|NCT00388674|9310018|P1|End of Study|Death|239
2702771|NCT00388674|9310017|P2|End of Study|Administrative Reason By Sponsor|253
2702772|NCT00388674|9310018|P1|End of Study|Administrative Reason By Sponsor|299
2702773|NCT00388674|9310017|P2|Initial Treatment|Not Reported|12
2702774|NCT00388674|9310018|P1|Initial Treatment|Not Reported|10
2702775|NCT00388674|9310017|P2|Initial Treatment|No Off-Treatment Status Data|13
2702776|NCT00388674|9310018|P1|Initial Treatment|No Off-Treatment Status Data|11
2702777|NCT00388674|9310017|P2|Initial Treatment|Participant Request|673
2702778|NCT00388674|9310018|P1|Initial Treatment|Participant Request|501
2702779|NCT00388674|9310017|P2|Initial Treatment|Study Drug Toxicity|92
2702780|NCT00388674|9310018|P1|Initial Treatment|Study Drug Toxicity|5
2702781|NCT00388674|9310017|P2|Initial Treatment|Pregnancy|16
2702782|NCT00388674|9310018|P1|Initial Treatment|Pregnancy|26
2702783|NCT00388674|9310017|P2|Initial Treatment|Partial or inadequate Treatment|472
2702784|NCT00388674|9310018|P1|Initial Treatment|Partial or inadequate Treatment|112
2702785|NCT00388674|9310017|P2|Initial Treatment|Not Defined|172
2702786|NCT00388674|9310018|P1|Initial Treatment|Not Defined|125
2702787|NCT00388674|9310017|P2|Initial Treatment|Non-Study related Comorbidities|4
2702788|NCT00388674|9310018|P1|Initial Treatment|Non-Study related Comorbidities|3
2702789|NCT00388674|9310017|P2|Initial Treatment|Never Treated with Study Medication|7
2702790|NCT00388674|9310018|P1|Initial Treatment|Never Treated with Study Medication|1
2702791|NCT00388674|9310017|P2|Initial Treatment|Malignancy (Non-HCC)|3
2702792|NCT00388674|9310018|P1|Initial Treatment|Malignancy (Non-HCC)|7
2702793|NCT00388674|9310017|P2|Initial Treatment|Lost to Follow-up|624
2702794|NCT00388674|9310018|P1|Initial Treatment|Lost to Follow-up|526
2702795|NCT00388674|9310017|P2|Initial Treatment|HCC|20
2702796|NCT00388674|9310018|P1|Initial Treatment|HCC|12
2702797|NCT00388674|9310017|P2|Initial Treatment|Non-HCC HBV Disease Progression|17
2702798|NCT00388674|9310018|P1|Initial Treatment|Non-HCC HBV Disease Progression|11
2702799|NCT00388674|9310017|P2|Initial Treatment|Death|216
2702800|NCT00388674|9310018|P1|Initial Treatment|Death|215
2702801|NCT00388674|9310017|P2|Initial Treatment|Adverse Event|87
2702802|NCT00388674|9310018|P1|Initial Treatment|Adverse Event|22
2702803|NCT00388674|9310017|P2|Initial Treatment|Administrative Reason by Sponsor|158
2702804|NCT00388674|9310018|P1|Initial Treatment|Administrative Reason by Sponsor|241
2702805|NCT00388583|9310036|P2|Overall Study|Did not receive vaccine|1
2702806|NCT00388583|9310037|P1|Overall Study|Did not receive vaccine|0
2702807|NCT00388583|9310036|P2|Overall Study|Serious Adverse Event|0
2702808|NCT00388583|9310037|P1|Overall Study|Serious Adverse Event|2
2702809|NCT00388583|9310036|P2|Overall Study|Withdrawal by Subject|3
2702810|NCT00388583|9310037|P1|Overall Study|Withdrawal by Subject|3
2702811|NCT00388583|9310036|P2|Overall Study|Protocol Violation|0
2702812|NCT00388583|9310037|P1|Overall Study|Protocol Violation|1
2702813|NCT00388505|9310051|P2|Overall Study|Unable to classify|3
2702814|NCT00388505|9310052|P1|Overall Study|Unable to classify|4
2702815|NCT00388505|9310051|P2|Overall Study|Protocol Violation|5
2702816|NCT00388505|9310052|P1|Overall Study|Protocol Violation|6
2702817|NCT00388505|9310051|P2|Overall Study|Administrative Reason|0
2702818|NCT00388505|9310052|P1|Overall Study|Administrative Reason|1
2702819|NCT00388505|9310051|P2|Overall Study|Inappropriate Enrollment|1
2702820|NCT00388505|9310052|P1|Overall Study|Inappropriate Enrollment|0
2702821|NCT00388505|9310051|P2|Overall Study|Lost to Follow-up|3
2702822|NCT00388505|9310052|P1|Overall Study|Lost to Follow-up|5
2702823|NCT00388505|9310051|P2|Overall Study|Withdrawal by Subject|9
2702824|NCT00388505|9310052|P1|Overall Study|Withdrawal by Subject|24
2702825|NCT00388505|9310051|P2|Overall Study|Adverse Event or Death|17
2702826|NCT00388505|9310052|P1|Overall Study|Adverse Event or Death|43
2702827|NCT00388362|9310107|P1|Remained on Study Median of 514 Days|Death|2
2702828|NCT00388362|9310107|P1|Enrolled|Withdrawal by Subject|1
2702829|NCT00388362|9310107|P1|Enrolled|Loss insurance|1
2702830|NCT00388362|9310107|P1|Enrolled|Death|1
2702831|NCT00388362|9310107|P1|Enrolled|Adverse Event|9
2702832|NCT00388362|9310107|P1|Enrolled|Ineligible|1
2702833|NCT00388349|9310112|P2|Phase I Dose Escalation|Dose reduction due to DLT|3
2702834|NCT00388349|9310113|P1|Phase I Dose Escalation|Dose reduction due to DLT|0
2702835|NCT00388297|9310126|P4|Overall Study|Lost to Follow-up|8
2702836|NCT00388297|9310127|P3|Overall Study|Lost to Follow-up|11
2702837|NCT00388297|9310128|P2|Overall Study|Lost to Follow-up|12
2702838|NCT00388297|9310129|P1|Overall Study|Lost to Follow-up|16
2702839|NCT00388154|9310239|P1|Overall Study|Withdrawal by Subject|1
2702840|NCT00388037|9310244|P1|Overall Study|Protocol Violation|1
2702841|NCT00387894|9310252|P1|Overall Study|Withdrawal by Subject|1
2702842|NCT00387881|9310259|P2|Overall Study|Not otherwise specified|7
2702843|NCT00387881|9310260|P1|Overall Study|Not otherwise specified|11
2702844|NCT00387881|9310259|P2|Overall Study|No opportunity to treat headache|34
2702845|NCT00387881|9310260|P1|Overall Study|No opportunity to treat headache|32
2702846|NCT00387881|9310259|P2|Overall Study|Not eligible|7
2702847|NCT00387881|9310260|P1|Overall Study|Not eligible|6
2702848|NCT00387881|9310259|P2|Overall Study|Sponsor terminated Study|1
2702849|NCT00387881|9310260|P1|Overall Study|Sponsor terminated Study|0
2702850|NCT00387881|9310259|P2|Overall Study|Withdrawal by Subject|18
2702851|NCT00387881|9310260|P1|Overall Study|Withdrawal by Subject|15
2702852|NCT00387881|9310259|P2|Overall Study|Protocol Violation|12
2702853|NCT00387881|9310260|P1|Overall Study|Protocol Violation|2
2702854|NCT00387881|9310259|P2|Overall Study|Lost to Follow-up|23
2702855|NCT00387881|9310260|P1|Overall Study|Lost to Follow-up|23
2702856|NCT00387790|9310293|P1|Overall Study|Ineligible for study|2
2702857|NCT00387790|9310293|P1|Overall Study|Withdrawal by Subject|3
2702858|NCT00387790|9310293|P1|Overall Study|Physician Decision|2
2702859|NCT00387790|9310293|P1|Overall Study|Lack of Efficacy|2
2702860|NCT00387790|9310293|P1|Overall Study|Adverse Event|5
2702861|NCT00387764|9310299|P1|Overall Study|Death|7
2702862|NCT00387764|9310299|P1|Overall Study|Other|2
2702863|NCT00387764|9310299|P1|Overall Study|Physician Decision|1
2702864|NCT00387764|9310299|P1|Overall Study|Sponsor Terminated Study|1
2702865|NCT00387764|9310299|P1|Overall Study|Withdrawal by Subject|8
2702866|NCT00387764|9310299|P1|Overall Study|Adverse Event|12
2702867|NCT00387725|9310327|P4|Overall Study|Parent/legal guardian request|1
2702868|NCT00387725|9310328|P3|Overall Study|Parent/legal guardian request|1
2702869|NCT00387725|9310329|P2|Overall Study|Parent/legal guardian request|0
2702870|NCT00387725|9310330|P1|Overall Study|Parent/legal guardian request|0
2702871|NCT00387725|9310327|P4|Overall Study|Withdrawal by Subject|0
2702872|NCT00387725|9310328|P3|Overall Study|Withdrawal by Subject|1
2702873|NCT00387725|9310329|P2|Overall Study|Withdrawal by Subject|0
2702874|NCT00387725|9310330|P1|Overall Study|Withdrawal by Subject|1
2702875|NCT00387725|9310327|P4|Overall Study|Protocol Violation|0
2702876|NCT00387725|9310328|P3|Overall Study|Protocol Violation|0
2702877|NCT00387725|9310329|P2|Overall Study|Protocol Violation|1
2702878|NCT00387725|9310330|P1|Overall Study|Protocol Violation|0
2702879|NCT00387725|9310327|P4|Overall Study|Adverse Event|1
2702880|NCT00387725|9310328|P3|Overall Study|Adverse Event|0
2702881|NCT00387725|9310329|P2|Overall Study|Adverse Event|0
2702882|NCT00387725|9310330|P1|Overall Study|Adverse Event|0
2702883|NCT00387712|9310350|P2|Overall Study|Withdrawal by Subject|12
2702884|NCT00387712|9310351|P1|Overall Study|Withdrawal by Subject|6
2702885|NCT00387712|9310350|P2|Overall Study|Lost to Follow-up|20
2702886|NCT00387712|9310351|P1|Overall Study|Lost to Follow-up|17
2702887|NCT00387712|9310350|P2|Overall Study|Physician Decision|4
2702888|NCT00387712|9310351|P1|Overall Study|Physician Decision|6
2702889|NCT00387647|9310382|P1|Overall Study|Death|18
2702890|NCT00387465|9310425|P3|Overall Study|Withdrawal by Subject|0
2702891|NCT00387465|9310426|P2|Overall Study|Withdrawal by Subject|1
2702892|NCT00387465|9310427|P1|Overall Study|Withdrawal by Subject|0
2702893|NCT00387426|9310444|P1|Overall Study|Disease Progression|3
2702894|NCT00387426|9310444|P1|Overall Study|Toxicities|4
2702895|NCT00387426|9310444|P1|Overall Study|Lack of Response|7
2702896|NCT00387348|9310451|P3|Overall Study|Adverse Event|1
2702897|NCT00387348|9310452|P2|Overall Study|Adverse Event|0
2702898|NCT00387348|9310453|P1|Overall Study|Adverse Event|1
2702899|NCT00387348|9310451|P3|Overall Study|Withdrawal by Subject|2
2702900|NCT00387348|9310452|P2|Overall Study|Withdrawal by Subject|2
2702901|NCT00387348|9310453|P1|Overall Study|Withdrawal by Subject|0
2702902|NCT00387348|9310451|P3|Overall Study|Physician Decision|1
2702903|NCT00387348|9310452|P2|Overall Study|Physician Decision|0
2702904|NCT00387348|9310453|P1|Overall Study|Physician Decision|1
2702905|NCT00387348|9310451|P3|Overall Study|Death|0
2702906|NCT00387348|9310452|P2|Overall Study|Death|1
2702907|NCT00387348|9310453|P1|Overall Study|Death|1
2702908|NCT00387153|9310482|P1|Overall Study|Lack of Response|4
2702909|NCT00387153|9310482|P1|Overall Study|Disease Progression|3
2702910|NCT00387153|9310482|P1|Overall Study|Adverse Event|1
2702911|NCT00387127|9310488|P2|Overall Study|Sponsor Unblinded|0
2702912|NCT00387127|9310489|P1|Overall Study|Sponsor Unblinded|1
2702913|NCT00387127|9310488|P2|Overall Study|Serious Adverse Event|1
2702914|NCT00387127|9310489|P1|Overall Study|Serious Adverse Event|1
2702915|NCT00387127|9310488|P2|Overall Study|Required by Protocol Amendment #4|10
2702916|NCT00387127|9310489|P1|Overall Study|Required by Protocol Amendment #4|12
2702917|NCT00387127|9310488|P2|Overall Study|Withdrawal by Subject|2
2702918|NCT00387127|9310489|P1|Overall Study|Withdrawal by Subject|3
2702919|NCT00387127|9310488|P2|Overall Study|Physician Decision|1
2702920|NCT00387127|9310489|P1|Overall Study|Physician Decision|0
2702921|NCT00387127|9310488|P2|Overall Study|Death|16
2702922|NCT00387127|9310489|P1|Overall Study|Death|16
2702923|NCT00387127|9310488|P2|Overall Study|Lost to Follow-up|4
2702924|NCT00387127|9310489|P1|Overall Study|Lost to Follow-up|0
2702925|NCT00387088|9310531|P2|Overall Study|Other|52
2702926|NCT00387088|9310532|P1|Overall Study|Other|58
2702927|NCT00387088|9310531|P2|Overall Study|Lost to Follow-up|28
2702928|NCT00387088|9310532|P1|Overall Study|Lost to Follow-up|22
2702929|NCT00387088|9310531|P2|Overall Study|Lack of Efficacy|67
2702930|NCT00387088|9310532|P1|Overall Study|Lack of Efficacy|28
2702931|NCT00387088|9310531|P2|Overall Study|Withdrawal by Subject|35
2702932|NCT00387088|9310532|P1|Overall Study|Withdrawal by Subject|20
2702933|NCT00387088|9310531|P2|Overall Study|Protocol Violation|35
2702934|NCT00387088|9310532|P1|Overall Study|Protocol Violation|47
2702935|NCT00387088|9310531|P2|Overall Study|Adverse Event|156
2702936|NCT00387088|9310532|P1|Overall Study|Adverse Event|143
2702937|NCT00387010|9310589|P1|Treatment Period|Participant reported study drug stolen|1
2702938|NCT00387010|9310589|P1|Treatment Period|Noncompliance with study procedures|3
2702939|NCT00387010|9310589|P1|Treatment Period|Noncompliance with study medication|2
2702940|NCT00387010|9310589|P1|Treatment Period|Withdrawal by Subject|1
2702941|NCT00387010|9310589|P1|Treatment Period|Adverse Event|4
2702942|NCT00387010|9310589|P1|Dose Titration Period|Noncompliance with study procedures|7
2702943|NCT00387010|9310589|P1|Dose Titration Period|Noncompliance with study medication|8
2702944|NCT00387010|9310589|P1|Dose Titration Period|Lost to Follow-up|2
2702945|NCT00387010|9310589|P1|Dose Titration Period|Protocol Violation|1
2702946|NCT00387010|9310589|P1|Dose Titration Period|Withdrawal by Subject|3
2702947|NCT00387010|9310589|P1|Dose Titration Period|Lack of Efficacy|5
2702948|NCT00387010|9310589|P1|Dose Titration Period|Adverse Event|12
2702949|NCT00386776|9310616|P1|Overall Study|Withdrawal by Subject|8
2702950|NCT00386607|9310626|P2|Extension|Unsatisfactory therapeutic effect|1
2702951|NCT00386607|9310627|P1|Extension|Unsatisfactory therapeutic effect|0
2702952|NCT00386607|9310626|P2|Extension|Patient withdrew consent|5
2702953|NCT00386607|9310627|P1|Extension|Patient withdrew consent|0
2702954|NCT00386607|9310626|P2|Extension|Lost to Follow-up|3
2702955|NCT00386607|9310627|P1|Extension|Lost to Follow-up|0
2702956|NCT00386607|9310626|P2|Extension|Administrative problems|1
2702957|NCT00386607|9310627|P1|Extension|Administrative problems|0
2702958|NCT00386607|9310626|P2|Extension|Abnormal laboratory value(s)|1
2702959|NCT00386607|9310627|P1|Extension|Abnormal laboratory value(s)|0
2702960|NCT00386607|9310626|P2|Extension|Adverse Event|6
2702961|NCT00386607|9310627|P1|Extension|Adverse Event|0
2702962|NCT00386607|9310626|P2|Core|Protocol Deviation|0
2702963|NCT00386607|9310627|P1|Core|Protocol Deviation|6
2702964|NCT00386607|9310626|P2|Core|Administrative problems|0
2702965|NCT00386607|9310627|P1|Core|Administrative problems|1
2702966|NCT00386607|9310626|P2|Core|Lost to Follow-up|0
2702967|NCT00386607|9310627|P1|Core|Lost to Follow-up|23
2702968|NCT00386607|9310626|P2|Core|Patient withdrew consent|0
2702969|NCT00386607|9310627|P1|Core|Patient withdrew consent|15
2702970|NCT00386607|9310626|P2|Core|Condition no longer requires study drug|0
2702971|NCT00386607|9310627|P1|Core|Condition no longer requires study drug|4
2702972|NCT00386607|9310626|P2|Core|Unsatisfactory therapeutic effect|0
2702973|NCT00386607|9310627|P1|Core|Unsatisfactory therapeutic effect|23
2702974|NCT00386607|9310626|P2|Core|Abnormal laboratory value(s)|0
2702975|NCT00386607|9310627|P1|Core|Abnormal laboratory value(s)|3
2702976|NCT00386607|9310626|P2|Core|Adverse Event|0
2702977|NCT00386607|9310627|P1|Core|Adverse Event|40
2702978|NCT00386425|9310655|P3|Overall Study|Withdrawal by Subject|0
2702979|NCT00386425|9310656|P2|Overall Study|Withdrawal by Subject|1
2702980|NCT00386425|9310657|P1|Overall Study|Withdrawal by Subject|0
2702981|NCT00386425|9310655|P3|Overall Study|Physician Decision|0
2702982|NCT00386425|9310656|P2|Overall Study|Physician Decision|0
2702983|NCT00386425|9310657|P1|Overall Study|Physician Decision|3
2702984|NCT00386360|9310683|P2|Overall Study|Did not take any study medication|2
2702985|NCT00386360|9310684|P1|Overall Study|Did not take any study medication|0
2702986|NCT00386360|9310683|P2|Overall Study|Withdrawal by Subject|6
2702987|NCT00386360|9310684|P1|Overall Study|Withdrawal by Subject|3
2702988|NCT00386360|9310683|P2|Overall Study|Protocol Violation|3
2702989|NCT00386360|9310684|P1|Overall Study|Protocol Violation|0
2702990|NCT00386360|9310683|P2|Overall Study|Lost to Follow-up|2
2702991|NCT00386360|9310684|P1|Overall Study|Lost to Follow-up|0
2702992|NCT00386360|9310683|P2|Overall Study|Physician Decision|2
2702993|NCT00386360|9310684|P1|Overall Study|Physician Decision|2
2702994|NCT00386360|9310683|P2|Overall Study|Adverse Event|2
2702995|NCT00386360|9310684|P1|Overall Study|Adverse Event|4
2702996|NCT00386334|9310718|P2|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1
2702997|NCT00386334|9310719|P1|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3
2702998|NCT00386334|9310718|P2|Double Blind Period|Other|3
2702999|NCT00386334|9310719|P1|Double Blind Period|Other|3
2703000|NCT00386334|9310718|P2|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5
2703001|NCT00386334|9310719|P1|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4
2703002|NCT00386334|9310718|P2|Double Blind Period|Lack of Efficacy|11
2703003|NCT00386334|9310719|P1|Double Blind Period|Lack of Efficacy|20
2703004|NCT00386334|9310718|P2|Double Blind Period|Withdrawal by Subject|13
2703005|NCT00386334|9310719|P1|Double Blind Period|Withdrawal by Subject|9
2703006|NCT00386334|9310718|P2|Double Blind Period|Protocol Violation|1
2703007|NCT00386334|9310719|P1|Double Blind Period|Protocol Violation|1
2703008|NCT00386334|9310718|P2|Double Blind Period|Adverse Event|14
2703009|NCT00386334|9310719|P1|Double Blind Period|Adverse Event|9
2703010|NCT00386308|9310863|P2|Overall Study|Other Event|1
2703011|NCT00386308|9310864|P1|Overall Study|Other Event|8
2703012|NCT00386308|9310863|P2|Overall Study|Withdrawal by Subject|2
2703013|NCT00386308|9310864|P1|Overall Study|Withdrawal by Subject|6
2703014|NCT00386308|9310863|P2|Overall Study|Lost to Follow-up|6
2703015|NCT00386308|9310864|P1|Overall Study|Lost to Follow-up|10
2703016|NCT00386308|9310863|P2|Overall Study|Lack of Efficacy|2
2703017|NCT00386308|9310864|P1|Overall Study|Lack of Efficacy|0
2703018|NCT00386308|9310863|P2|Overall Study|Protocol Violation|5
2703019|NCT00386308|9310864|P1|Overall Study|Protocol Violation|2
2703020|NCT00386308|9310863|P2|Overall Study|Adverse Event|3
2703021|NCT00386308|9310864|P1|Overall Study|Adverse Event|3
2703022|NCT00386152|9310921|P3|Overall Study|Withdrawal by Subject|10
2703023|NCT00386152|9310922|P2|Overall Study|Withdrawal by Subject|6
2703024|NCT00386152|9310923|P1|Overall Study|Withdrawal by Subject|3
2703025|NCT00386152|9310921|P3|Overall Study|Protocol Violation|2
2703026|NCT00386152|9310922|P2|Overall Study|Protocol Violation|5
2703027|NCT00386152|9310923|P1|Overall Study|Protocol Violation|3
2703028|NCT00386152|9310921|P3|Overall Study|Completed chemotherapy|1
2703029|NCT00386152|9310922|P2|Overall Study|Completed chemotherapy|5
2703030|NCT00386152|9310923|P1|Overall Study|Completed chemotherapy|4
2703031|NCT00386152|9310921|P3|Overall Study|Lost to Follow-up|0
2703032|NCT00386152|9310922|P2|Overall Study|Lost to Follow-up|0
2703033|NCT00386152|9310923|P1|Overall Study|Lost to Follow-up|1
2703034|NCT00386152|9310921|P3|Overall Study|Physician Decision|4
2703035|NCT00386152|9310922|P2|Overall Study|Physician Decision|10
2703036|NCT00386152|9310923|P1|Overall Study|Physician Decision|13
2703037|NCT00386152|9310921|P3|Overall Study|Disease progression|5
2703038|NCT00386152|9310922|P2|Overall Study|Disease progression|4
2703039|NCT00386152|9310923|P1|Overall Study|Disease progression|7
2703040|NCT00386152|9310921|P3|Overall Study|Death|1
2703041|NCT00386152|9310922|P2|Overall Study|Death|0
2703042|NCT00386152|9310923|P1|Overall Study|Death|3
2703043|NCT00386152|9310921|P3|Overall Study|Chang from original chemo stratification|6
2703044|NCT00386152|9310922|P2|Overall Study|Chang from original chemo stratification|5
2703045|NCT00386152|9310923|P1|Overall Study|Chang from original chemo stratification|4
2703046|NCT00386152|9310921|P3|Overall Study|Adverse Event|4
2703047|NCT00386152|9310922|P2|Overall Study|Adverse Event|5
2703048|NCT00386152|9310923|P1|Overall Study|Adverse Event|6
2703049|NCT00386100|9310942|P2|Overall Study|Participant randomized in error|0
2703050|NCT00386100|9310943|P1|Overall Study|Participant randomized in error|1
2703051|NCT00386100|9310942|P2|Overall Study|Hb1Ac >8%|1
2703052|NCT00386100|9310943|P1|Overall Study|Hb1Ac >8%|0
2703053|NCT00386100|9310942|P2|Overall Study|Out of country for 5 months|0
2703054|NCT00386100|9310943|P1|Overall Study|Out of country for 5 months|1
2703055|NCT00386100|9310942|P2|Overall Study|Positive pregnancy test|3
2703056|NCT00386100|9310943|P1|Overall Study|Positive pregnancy test|1
2703057|NCT00386100|9310942|P2|Overall Study|Osteoporosis|1
2703058|NCT00386100|9310943|P1|Overall Study|Osteoporosis|0
2703059|NCT00386100|9310942|P2|Overall Study|7.6% bone loss|0
2703060|NCT00386100|9310943|P1|Overall Study|7.6% bone loss|1
2703061|NCT00386100|9310942|P2|Overall Study|DBP 93 mmHg at randomization|0
2703062|NCT00386100|9310943|P1|Overall Study|DBP 93 mmHg at randomization|1
2703063|NCT00386100|9310942|P2|Overall Study|Bone loss by DXA bone scan|0
2703064|NCT00386100|9310943|P1|Overall Study|Bone loss by DXA bone scan|1
2703065|NCT00386100|9310942|P2|Overall Study|Bad metabolic control & patient security|0
2703066|NCT00386100|9310943|P1|Overall Study|Bad metabolic control & patient security|1
2703067|NCT00386100|9310942|P2|Overall Study|Osteoporosis findings on Visit 2 DXA|1
2703068|NCT00386100|9310943|P1|Overall Study|Osteoporosis findings on Visit 2 DXA|0
2703069|NCT00386100|9310942|P2|Overall Study|Participant's PCP wanted to stop drug|0
2703070|NCT00386100|9310943|P1|Overall Study|Participant's PCP wanted to stop drug|1
2703071|NCT00386100|9310942|P2|Overall Study|Didn't meet entry criteria|1
2703072|NCT00386100|9310943|P1|Overall Study|Didn't meet entry criteria|1
2703073|NCT00386100|9310942|P2|Overall Study|Excessive bone loss vs. baseline value|1
2703074|NCT00386100|9310943|P1|Overall Study|Excessive bone loss vs. baseline value|0
2703075|NCT00386100|9310942|P2|Overall Study|Participant moving out of state|0
2703076|NCT00386100|9310943|P1|Overall Study|Participant moving out of state|2
2703077|NCT00386100|9310942|P2|Overall Study|Participant's concern due to CPK levels|0
2703078|NCT00386100|9310943|P1|Overall Study|Participant's concern due to CPK levels|1
2703079|NCT00386100|9310942|P2|Overall Study|Laboratory findings|0
2703080|NCT00386100|9310943|P1|Overall Study|Laboratory findings|1
2703081|NCT00386100|9310942|P2|Overall Study|Visit 11 DXA showed excessive bone loss|1
2703082|NCT00386100|9310943|P1|Overall Study|Visit 11 DXA showed excessive bone loss|0
2703083|NCT00386100|9310942|P2|Overall Study|Consecutive elevated Hba1C|0
2703084|NCT00386100|9310943|P1|Overall Study|Consecutive elevated Hba1C|1
2703085|NCT00386100|9310942|P2|Overall Study|BMD <2.5|0
2703086|NCT00386100|9310943|P1|Overall Study|BMD <2.5|1
2703087|NCT00386100|9310942|P2|Overall Study|Bone mass density (BMD) loss >6%|4
2703088|NCT00386100|9310943|P1|Overall Study|Bone mass density (BMD) loss >6%|4
2703089|NCT00386100|9310942|P2|Overall Study|Withdrawal by Subject|31
2703090|NCT00386100|9310943|P1|Overall Study|Withdrawal by Subject|32
2703091|NCT00386100|9310942|P2|Overall Study|Protocol Violation|3
2703092|NCT00386100|9310943|P1|Overall Study|Protocol Violation|5
2703093|NCT00386100|9310942|P2|Overall Study|Non-compliance|19
2703094|NCT00386100|9310943|P1|Overall Study|Non-compliance|18
2703095|NCT00386100|9310942|P2|Overall Study|Lost to Follow-up|29
2703096|NCT00386100|9310943|P1|Overall Study|Lost to Follow-up|29
2703097|NCT00386100|9310942|P2|Overall Study|Insufficient therapeutic effect|6
2703098|NCT00386100|9310943|P1|Overall Study|Insufficient therapeutic effect|30
2703099|NCT00386100|9310942|P2|Overall Study|Death|1
2703100|NCT00386100|9310943|P1|Overall Study|Death|0
2703101|NCT00386100|9310942|P2|Overall Study|Adverse Event|25
2703102|NCT00386100|9310943|P1|Overall Study|Adverse Event|15
2703103|NCT00386100|9310942|P2|Overall Study|Did not receive study medication|4
2703104|NCT00386100|9310943|P1|Overall Study|Did not receive study medication|6
2703105|NCT00386022|9311007|P2|Plus Estrogen|Adverse Event|1
2703106|NCT00386022|9311008|P1|Plus Estrogen|Adverse Event|0
2703107|NCT00386022|9311007|P2|Plus Estrogen|Lost to Follow-up|0
2703108|NCT00386022|9311008|P1|Plus Estrogen|Lost to Follow-up|2
2703109|NCT00386009|9311018|P2|Overall Study|Withdrawal by Subject|4
2703110|NCT00386009|9311019|P1|Overall Study|Withdrawal by Subject|5
2703111|NCT00386009|9311018|P2|Overall Study|Sponsor Decision|1
2703112|NCT00386009|9311019|P1|Overall Study|Sponsor Decision|1
2703113|NCT00386009|9311018|P2|Overall Study|Protocol Violation|0
2703114|NCT00386009|9311019|P1|Overall Study|Protocol Violation|1
2703115|NCT00386009|9311018|P2|Overall Study|Lost to Follow-up|1
2703116|NCT00386009|9311019|P1|Overall Study|Lost to Follow-up|1
2703117|NCT00386009|9311018|P2|Overall Study|Entry Criteria Not Met|2
2703118|NCT00386009|9311019|P1|Overall Study|Entry Criteria Not Met|0
2703119|NCT00386009|9311018|P2|Overall Study|Death|0
2703120|NCT00386009|9311019|P1|Overall Study|Death|1
2703121|NCT00386009|9311018|P2|Overall Study|Adverse Event|2
2703122|NCT00386009|9311019|P1|Overall Study|Adverse Event|0
2703123|NCT00385944|9311066|P3|2nd Maintenance Dose Period|Invalid PD Data|0
2703124|NCT00385944|9311067|P2|2nd Maintenance Dose Period|Invalid PD Data|3
2703125|NCT00385944|9311068|P1|2nd Maintenance Dose Period|Invalid PD Data|2
2703126|NCT00385944|9311066|P3|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
2703127|NCT00385944|9311067|P2|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
2703128|NCT00385944|9311068|P1|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3
2703129|NCT00385944|9311066|P3|1st Maintenance Dose Period|Entry Criteria Exclusion|0
2703130|NCT00385944|9311067|P2|1st Maintenance Dose Period|Entry Criteria Exclusion|1
2703131|NCT00385944|9311068|P1|1st Maintenance Dose Period|Entry Criteria Exclusion|0
2703132|NCT00385944|9311066|P3|1st Maintenance Dose Period|Physician Decision|0
2703133|NCT00385944|9311067|P2|1st Maintenance Dose Period|Physician Decision|0
2703134|NCT00385944|9311068|P1|1st Maintenance Dose Period|Physician Decision|1
2703135|NCT00385918|9311111|P3|Intervention Phase After Randomization|Lost to Follow-up|0
2703136|NCT00385918|9311112|P2|Intervention Phase After Randomization|Lost to Follow-up|0
2703137|NCT00385918|9311113|P1|Intervention Phase After Randomization|Lost to Follow-up|1
2703138|NCT00385918|9311111|P3|Intervention Phase After Randomization|Physician Decision|0
2703139|NCT00385918|9311112|P2|Intervention Phase After Randomization|Physician Decision|0
2703140|NCT00385918|9311113|P1|Intervention Phase After Randomization|Physician Decision|1
2703141|NCT00385918|9311111|P3|Intervention Phase After Randomization|Withdrawal by Subject|0
2703142|NCT00385918|9311112|P2|Intervention Phase After Randomization|Withdrawal by Subject|0
2703143|NCT00385918|9311113|P1|Intervention Phase After Randomization|Withdrawal by Subject|1
2703144|NCT00385918|9311111|P3|Feasibility & Baseline Measurement Phase|Physician Decision|1
2703145|NCT00385918|9311112|P2|Feasibility & Baseline Measurement Phase|Physician Decision|0
2703146|NCT00385918|9311113|P1|Feasibility & Baseline Measurement Phase|Physician Decision|0
2703147|NCT00385918|9311111|P3|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5
2703318|NCT00384930|9311782|P5|Overall Study|Sponsor Decision|0
2703148|NCT00385918|9311112|P2|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
2703149|NCT00385918|9311113|P1|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
2703150|NCT00385918|9311111|P3|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8
2703151|NCT00385918|9311112|P2|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
2703152|NCT00385918|9311113|P1|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
2703153|NCT00385840|9311137|P2|Overall Study|Lost to Follow-up|13
2703154|NCT00385840|9311138|P1|Overall Study|Lost to Follow-up|3
2703155|NCT00385840|9311137|P2|Overall Study|Adverse Event|1
2703156|NCT00385840|9311138|P1|Overall Study|Adverse Event|1
2703157|NCT00385827|9311161|P3|Part 2|Other|21
2703158|NCT00385827|9311162|P2|Part 2|Other|11
2703159|NCT00385827|9311163|P1|Part 2|Other|0
2703160|NCT00385827|9311161|P3|Part 2|Randomized but not treated|2
2703161|NCT00385827|9311162|P2|Part 2|Randomized but not treated|2
2703162|NCT00385827|9311163|P1|Part 2|Randomized but not treated|0
2703163|NCT00385827|9311161|P3|Part 2|Lack of Efficacy|13
2703164|NCT00385827|9311162|P2|Part 2|Lack of Efficacy|14
2703165|NCT00385827|9311163|P1|Part 2|Lack of Efficacy|0
2703166|NCT00385827|9311161|P3|Part 2|Death|2
2703167|NCT00385827|9311162|P2|Part 2|Death|0
2703168|NCT00385827|9311163|P1|Part 2|Death|0
2703169|NCT00385827|9311161|P3|Part 2|Adverse Event|10
2703170|NCT00385827|9311162|P2|Part 2|Adverse Event|6
2703171|NCT00385827|9311163|P1|Part 2|Adverse Event|0
2703172|NCT00385827|9311161|P3|Part 1|Other|0
2703173|NCT00385827|9311162|P2|Part 1|Other|0
2703174|NCT00385827|9311163|P1|Part 1|Other|1
2703175|NCT00385827|9311161|P3|Part 1|Lack of Efficacy|0
2703176|NCT00385827|9311162|P2|Part 1|Lack of Efficacy|0
2703177|NCT00385827|9311163|P1|Part 1|Lack of Efficacy|5
2703178|NCT00385827|9311161|P3|Part 1|Death|0
2703179|NCT00385827|9311162|P2|Part 1|Death|0
2703180|NCT00385827|9311163|P1|Part 1|Death|2
2703181|NCT00385827|9311161|P3|Part 1|Adverse Event|0
2703182|NCT00385827|9311162|P2|Part 1|Adverse Event|0
2703183|NCT00385827|9311163|P1|Part 1|Adverse Event|1
2703184|NCT00385762|9311207|P1|Overall Study|Lost to Follow-up|1
2703185|NCT00385762|9311207|P1|Overall Study|Adverse Event|1
2703186|NCT00385736|9311217|P3|Safety Analysis Set|Other|4
2703187|NCT00385736|9311218|P2|Safety Analysis Set|Other|4
2703188|NCT00385736|9311219|P1|Safety Analysis Set|Other|1
2703189|NCT00385736|9311217|P3|Safety Analysis Set|Protocol Violation|6
2703190|NCT00385736|9311218|P2|Safety Analysis Set|Protocol Violation|1
2703191|NCT00385736|9311219|P1|Safety Analysis Set|Protocol Violation|2
2703192|NCT00385736|9311217|P3|Safety Analysis Set|Lack of Efficacy|31
2703193|NCT00385736|9311218|P2|Safety Analysis Set|Lack of Efficacy|16
2703194|NCT00385736|9311219|P1|Safety Analysis Set|Lack of Efficacy|38
2703195|NCT00385736|9311217|P3|Safety Analysis Set|Lost to Follow-up|2
2703196|NCT00385736|9311218|P2|Safety Analysis Set|Lost to Follow-up|2
2703197|NCT00385736|9311219|P1|Safety Analysis Set|Lost to Follow-up|0
2703198|NCT00385736|9311217|P3|Safety Analysis Set|Withdrawal by Subject|14
2703199|NCT00385736|9311218|P2|Safety Analysis Set|Withdrawal by Subject|6
2703200|NCT00385736|9311219|P1|Safety Analysis Set|Withdrawal by Subject|6
2703201|NCT00385736|9311217|P3|Safety Analysis Set|Adverse Event|23
2703202|NCT00385736|9311218|P2|Safety Analysis Set|Adverse Event|15
2703203|NCT00385736|9311219|P1|Safety Analysis Set|Adverse Event|23
2703204|NCT00385736|9311217|P3|Efficacy Analysis Set - Maintenance|Other|4
2703205|NCT00385736|9311218|P2|Efficacy Analysis Set - Maintenance|Other|4
2703206|NCT00385736|9311219|P1|Efficacy Analysis Set - Maintenance|Other|0
2703207|NCT00385736|9311217|P3|Efficacy Analysis Set - Maintenance|Protocol Violation|6
2703208|NCT00385736|9311218|P2|Efficacy Analysis Set - Maintenance|Protocol Violation|1
2703209|NCT00385736|9311219|P1|Efficacy Analysis Set - Maintenance|Protocol Violation|2
2703210|NCT00385736|9311217|P3|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31
2703211|NCT00385736|9311218|P2|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16
2703212|NCT00385736|9311219|P1|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38
2703213|NCT00385736|9311217|P3|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
2703214|NCT00385736|9311218|P2|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
2703215|NCT00385736|9311219|P1|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0
2703216|NCT00385736|9311217|P3|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14
2703217|NCT00385736|9311218|P2|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
2703218|NCT00385736|9311219|P1|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
2703219|NCT00385736|9311217|P3|Efficacy Analysis Set - Maintenance|Adverse Event|23
2703220|NCT00385736|9311218|P2|Efficacy Analysis Set - Maintenance|Adverse Event|15
2703221|NCT00385736|9311219|P1|Efficacy Analysis Set - Maintenance|Adverse Event|23
2703222|NCT00385736|9311217|P3|Efficacy Analysis Set - Induction|Other|1
2703223|NCT00385736|9311218|P2|Efficacy Analysis Set - Induction|Other|0
2703224|NCT00385736|9311219|P1|Efficacy Analysis Set - Induction|Other|0
2703225|NCT00385736|9311217|P3|Efficacy Analysis Set - Induction|Protocol Violation|2
2703226|NCT00385736|9311218|P2|Efficacy Analysis Set - Induction|Protocol Violation|0
2703227|NCT00385736|9311219|P1|Efficacy Analysis Set - Induction|Protocol Violation|0
2703228|NCT00385736|9311217|P3|Efficacy Analysis Set - Induction|Lack of Efficacy|1
2703229|NCT00385736|9311218|P2|Efficacy Analysis Set - Induction|Lack of Efficacy|2
2703230|NCT00385736|9311219|P1|Efficacy Analysis Set - Induction|Lack of Efficacy|4
2703231|NCT00385736|9311217|P3|Efficacy Analysis Set - Induction|Lost to Follow-up|0
2703232|NCT00385736|9311218|P2|Efficacy Analysis Set - Induction|Lost to Follow-up|2
2703233|NCT00385736|9311219|P1|Efficacy Analysis Set - Induction|Lost to Follow-up|0
2703234|NCT00385736|9311217|P3|Efficacy Analysis Set - Induction|Withdrawal by Subject|1
2703235|NCT00385736|9311218|P2|Efficacy Analysis Set - Induction|Withdrawal by Subject|2
2703236|NCT00385736|9311219|P1|Efficacy Analysis Set - Induction|Withdrawal by Subject|0
2703237|NCT00385736|9311217|P3|Efficacy Analysis Set - Induction|Adverse Event|4
2703238|NCT00385736|9311218|P2|Efficacy Analysis Set - Induction|Adverse Event|6
2703239|NCT00385736|9311219|P1|Efficacy Analysis Set - Induction|Adverse Event|5
2703240|NCT00385723|9311264|P3|Overall Study|Withdrawal by Subject|2
2703241|NCT00385723|9311265|P2|Overall Study|Withdrawal by Subject|0
2703242|NCT00385723|9311266|P1|Overall Study|Withdrawal by Subject|1
2703243|NCT00385723|9311264|P3|Overall Study|Lost to Follow-up|0
2703244|NCT00385723|9311265|P2|Overall Study|Lost to Follow-up|1
2703245|NCT00385723|9311266|P1|Overall Study|Lost to Follow-up|1
2703246|NCT00385684|9311280|P2|SECOND INTERVENTION OF PHASE A|study drug recall|1
2703247|NCT00385684|9311281|P1|SECOND INTERVENTION OF PHASE A|study drug recall|0
2703248|NCT00385684|9311280|P2|SECOND INTERVENTION OF PHASE A|Adverse Event|1
2703249|NCT00385684|9311281|P1|SECOND INTERVENTION OF PHASE A|Adverse Event|0
2703250|NCT00385684|9311280|P2|FIRST INTERVENTION OF PHASE A|Death|0
2703251|NCT00385684|9311281|P1|FIRST INTERVENTION OF PHASE A|Death|1
2703252|NCT00385671|9311290|P3|Overall Study|Withdrawal by Subject|4
2703253|NCT00385671|9311291|P2|Overall Study|Withdrawal by Subject|4
2703254|NCT00385671|9311292|P1|Overall Study|Withdrawal by Subject|4
2703255|NCT00385671|9311290|P3|Overall Study|Sponsor Decision|1
2703256|NCT00385671|9311291|P2|Overall Study|Sponsor Decision|2
2703257|NCT00385671|9311292|P1|Overall Study|Sponsor Decision|2
2703258|NCT00385671|9311290|P3|Overall Study|Protocol Violation|1
2703259|NCT00385671|9311291|P2|Overall Study|Protocol Violation|2
2703260|NCT00385671|9311292|P1|Overall Study|Protocol Violation|5
2703261|NCT00385671|9311290|P3|Overall Study|Physician Decision|2
2703262|NCT00385671|9311291|P2|Overall Study|Physician Decision|1
2703263|NCT00385671|9311292|P1|Overall Study|Physician Decision|2
2703264|NCT00385671|9311290|P3|Overall Study|Lost to Follow-up|5
2703265|NCT00385671|9311291|P2|Overall Study|Lost to Follow-up|6
2703266|NCT00385671|9311292|P1|Overall Study|Lost to Follow-up|6
2703267|NCT00385671|9311290|P3|Overall Study|Lack of Efficacy|5
2703268|NCT00385671|9311291|P2|Overall Study|Lack of Efficacy|9
2703269|NCT00385671|9311292|P1|Overall Study|Lack of Efficacy|5
2703270|NCT00385671|9311290|P3|Overall Study|Adverse Event|18
2703271|NCT00385671|9311291|P2|Overall Study|Adverse Event|27
2703272|NCT00385671|9311292|P1|Overall Study|Adverse Event|14
2703273|NCT00385593|9311448|P2|Overall Study|Incorrect randomization|1
2703274|NCT00385593|9311449|P1|Overall Study|Incorrect randomization|0
2703275|NCT00385593|9311448|P2|Overall Study|Incorrect inclusion|0
2703276|NCT00385593|9311449|P1|Overall Study|Incorrect inclusion|2
2703277|NCT00385593|9311448|P2|Overall Study|Several reasons|15
2703278|NCT00385593|9311449|P1|Overall Study|Several reasons|17
2703279|NCT00385593|9311448|P2|Overall Study|Protocol Violation|4
2703280|NCT00385593|9311449|P1|Overall Study|Protocol Violation|7
2703281|NCT00385593|9311448|P2|Overall Study|Lost to Follow-up|8
2703282|NCT00385593|9311449|P1|Overall Study|Lost to Follow-up|12
2703283|NCT00385593|9311448|P2|Overall Study|Withdrawal by Subject|7
2703284|NCT00385593|9311449|P1|Overall Study|Withdrawal by Subject|17
2703285|NCT00385593|9311448|P2|Overall Study|Adverse Event|2
2703286|NCT00385593|9311449|P1|Overall Study|Adverse Event|3
2703287|NCT00385541|9311559|P2|Overall Study|severe pain, clinician requested unblind|1
2703288|NCT00385541|9311560|P1|Overall Study|severe pain, clinician requested unblind|0
2703289|NCT00385255|9311596|P2|Overall Study|Lost to Follow-up|58
2703290|NCT00385255|9311597|P1|Overall Study|Lost to Follow-up|20
2703291|NCT00385255|9311596|P2|Overall Study|Migrated/moved from study area|1
2703292|NCT00385255|9311597|P1|Overall Study|Migrated/moved from study area|0
2703293|NCT00385255|9311596|P2|Overall Study|Withdrawal by Subject|8
2703294|NCT00385255|9311597|P1|Overall Study|Withdrawal by Subject|0
2703295|NCT00385255|9311596|P2|Overall Study|Protocol Violation|4
2703296|NCT00385255|9311597|P1|Overall Study|Protocol Violation|0
2703297|NCT00385255|9311596|P2|Overall Study|Serious Adverse Event|2
2703298|NCT00385255|9311597|P1|Overall Study|Serious Adverse Event|1
2703299|NCT00385203|9311676|P2|Overall Study|Incorrect enrollment|0
2703300|NCT00385203|9311677|P1|Overall Study|Incorrect enrollment|2
2703301|NCT00385203|9311676|P2|Overall Study|Condition under investigation worsened|3
2703302|NCT00385203|9311677|P1|Overall Study|Condition under investigation worsened|18
2703303|NCT00385203|9311676|P2|Overall Study|Death|0
2703304|NCT00385203|9311677|P1|Overall Study|Death|1
2703305|NCT00385203|9311676|P2|Overall Study|Adverse Event|4
2703306|NCT00385203|9311677|P1|Overall Study|Adverse Event|5
2703307|NCT00384956|9311765|P1|Overall Study|Ineligible (acute myeloid leukemia)|3
2703308|NCT00384930|9311782|P5|Overall Study|Didn't Receive Double-Blind Study Drug|0
2703309|NCT00384930|9311783|P4|Overall Study|Didn't Receive Double-Blind Study Drug|0
2703310|NCT00384930|9311784|P3|Overall Study|Didn't Receive Double-Blind Study Drug|0
2703311|NCT00384930|9311785|P2|Overall Study|Didn't Receive Double-Blind Study Drug|1
2703312|NCT00384930|9311786|P1|Overall Study|Didn't Receive Double-Blind Study Drug|1
2703313|NCT00384930|9311782|P5|Overall Study|Withdrawal by Subject|16
2703314|NCT00384930|9311783|P4|Overall Study|Withdrawal by Subject|6
2703315|NCT00384930|9311784|P3|Overall Study|Withdrawal by Subject|7
2703316|NCT00384930|9311785|P2|Overall Study|Withdrawal by Subject|7
2703317|NCT00384930|9311786|P1|Overall Study|Withdrawal by Subject|9
2703319|NCT00384930|9311783|P4|Overall Study|Sponsor Decision|5
2703320|NCT00384930|9311784|P3|Overall Study|Sponsor Decision|0
2703321|NCT00384930|9311785|P2|Overall Study|Sponsor Decision|4
2703322|NCT00384930|9311786|P1|Overall Study|Sponsor Decision|3
2703323|NCT00384930|9311782|P5|Overall Study|Protocol Violation|4
2703324|NCT00384930|9311783|P4|Overall Study|Protocol Violation|6
2703325|NCT00384930|9311784|P3|Overall Study|Protocol Violation|1
2703326|NCT00384930|9311785|P2|Overall Study|Protocol Violation|0
2703327|NCT00384930|9311786|P1|Overall Study|Protocol Violation|1
2703328|NCT00384930|9311782|P5|Overall Study|Physician Decision|1
2703329|NCT00384930|9311783|P4|Overall Study|Physician Decision|0
2703330|NCT00384930|9311784|P3|Overall Study|Physician Decision|1
2703331|NCT00384930|9311785|P2|Overall Study|Physician Decision|1
2703332|NCT00384930|9311786|P1|Overall Study|Physician Decision|0
2703333|NCT00384930|9311782|P5|Overall Study|Lost to Follow-up|6
2703334|NCT00384930|9311783|P4|Overall Study|Lost to Follow-up|4
2703335|NCT00384930|9311784|P3|Overall Study|Lost to Follow-up|0
2703336|NCT00384930|9311785|P2|Overall Study|Lost to Follow-up|3
2703337|NCT00384930|9311786|P1|Overall Study|Lost to Follow-up|5
2703338|NCT00384930|9311782|P5|Overall Study|Lack of Efficacy|2
2703339|NCT00384930|9311783|P4|Overall Study|Lack of Efficacy|1
2703340|NCT00384930|9311784|P3|Overall Study|Lack of Efficacy|2
2703341|NCT00384930|9311785|P2|Overall Study|Lack of Efficacy|1
2703342|NCT00384930|9311786|P1|Overall Study|Lack of Efficacy|1
2703343|NCT00384930|9311782|P5|Overall Study|Entry Criteria Not Met|4
2703344|NCT00384930|9311783|P4|Overall Study|Entry Criteria Not Met|8
2703345|NCT00384930|9311784|P3|Overall Study|Entry Criteria Not Met|7
2703346|NCT00384930|9311785|P2|Overall Study|Entry Criteria Not Met|6
2703347|NCT00384930|9311786|P1|Overall Study|Entry Criteria Not Met|2
2703348|NCT00384930|9311782|P5|Overall Study|Adverse Event|14
2703349|NCT00384930|9311783|P4|Overall Study|Adverse Event|11
2703350|NCT00384930|9311784|P3|Overall Study|Adverse Event|12
2703351|NCT00384930|9311785|P2|Overall Study|Adverse Event|4
2703352|NCT00384930|9311786|P1|Overall Study|Adverse Event|5
2703353|NCT00384839|9311865|P1|Overall Study|Ineligible|2
2703354|NCT00384839|9311865|P1|Overall Study|Patient Request|1
2703355|NCT00384839|9311865|P1|Overall Study|Investigator Request|1
2703356|NCT00384839|9311865|P1|Overall Study|Adverse Event|4
2703357|NCT00384397|9311998|P3|Overall Study|Withdrawal by Subject|15
2703358|NCT00384397|9311999|P2|Overall Study|Withdrawal by Subject|17
2703359|NCT00384397|9312000|P1|Overall Study|Withdrawal by Subject|14
2703360|NCT00384397|9311998|P3|Overall Study|Lost to Follow-up|3
2703361|NCT00384397|9311999|P2|Overall Study|Lost to Follow-up|13
2703362|NCT00384397|9312000|P1|Overall Study|Lost to Follow-up|11
2703363|NCT00384397|9311998|P3|Overall Study|Protocol Violation|13
2703364|NCT00384397|9311999|P2|Overall Study|Protocol Violation|15
2703365|NCT00384397|9312000|P1|Overall Study|Protocol Violation|7
2703366|NCT00384397|9311998|P3|Overall Study|Adverse Event|2
2703367|NCT00384397|9311999|P2|Overall Study|Adverse Event|1
2703368|NCT00384397|9312000|P1|Overall Study|Adverse Event|0
2703369|NCT00384332|9312019|P2|Overall Study|Lost to Follow-up|0
2703370|NCT00384332|9312020|P1|Overall Study|Lost to Follow-up|4
2703371|NCT00384293|9312030|P3|Post-randomization Period|Patient Randomized in Error|1
2703372|NCT00384293|9312031|P2|Post-randomization Period|Patient Randomized in Error|0
2703373|NCT00384293|9312032|P1|Post-randomization Period|Patient Randomized in Error|0
2703374|NCT00384293|9312030|P3|Post-randomization Period|Trial Termination|204
2703375|NCT00384293|9312031|P2|Post-randomization Period|Trial Termination|180
2703376|NCT00384293|9312032|P1|Post-randomization Period|Trial Termination|0
2703377|NCT00384293|9312030|P3|Post-randomization Period|Withdrawal by Subject|6
2703378|NCT00384293|9312031|P2|Post-randomization Period|Withdrawal by Subject|8
2703379|NCT00384293|9312032|P1|Post-randomization Period|Withdrawal by Subject|0
2703380|NCT00384293|9312030|P3|Post-randomization Period|Protocol Violation|0
2703381|NCT00384293|9312031|P2|Post-randomization Period|Protocol Violation|1
2703382|NCT00384293|9312032|P1|Post-randomization Period|Protocol Violation|0
2703383|NCT00384293|9312030|P3|Post-randomization Period|Lost to Follow-up|1
2703384|NCT00384293|9312031|P2|Post-randomization Period|Lost to Follow-up|2
2703385|NCT00384293|9312032|P1|Post-randomization Period|Lost to Follow-up|0
2703386|NCT00384293|9312030|P3|Post-randomization Period|Adverse Event|7
2703387|NCT00384293|9312031|P2|Post-randomization Period|Adverse Event|23
2703388|NCT00384293|9312032|P1|Post-randomization Period|Adverse Event|0
2703389|NCT00384293|9312030|P3|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
2703390|NCT00384293|9312031|P2|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
2703391|NCT00384293|9312032|P1|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1
2703392|NCT00384293|9312030|P3|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
2703393|NCT00384293|9312031|P2|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
2703394|NCT00384293|9312032|P1|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2
2703395|NCT00384293|9312030|P3|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
2703396|NCT00384293|9312031|P2|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
2703397|NCT00384293|9312032|P1|MK0524A Active Run-In, Pre-randomization|Trial Termination|16
2703398|NCT00384293|9312030|P3|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
2703399|NCT00384293|9312031|P2|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
2703400|NCT00384293|9312032|P1|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340
2703401|NCT00384293|9312030|P3|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
2703402|NCT00384293|9312031|P2|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
2703403|NCT00384293|9312032|P1|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24
2703404|NCT00384293|9312030|P3|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
2703405|NCT00384293|9312031|P2|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
2703406|NCT00384293|9312032|P1|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1
2703407|NCT00384293|9312030|P3|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
2703408|NCT00384293|9312031|P2|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
2703409|NCT00384293|9312032|P1|MK0524A Active Run-In, Pre-randomization|Adverse Event|120
2703410|NCT00384189|9312056|P4|Overall Study|Reason Not Specified|40
2703411|NCT00384189|9312057|P3|Overall Study|Reason Not Specified|58
2703412|NCT00384189|9312058|P2|Overall Study|Reason Not Specified|57
2703413|NCT00384189|9312059|P1|Overall Study|Reason Not Specified|50
2703414|NCT00384176|9312120|P3|Overall Study|Liver metastases, colon resec. planned|0
2703415|NCT00384176|9312121|P2|Overall Study|Liver metastases, colon resec. planned|0
2703416|NCT00384176|9312122|P1|Overall Study|Liver metastases, colon resec. planned|1
2703417|NCT00384176|9312120|P3|Overall Study|Physician Decision|0
2703418|NCT00384176|9312121|P2|Overall Study|Physician Decision|2
2703419|NCT00384176|9312122|P1|Overall Study|Physician Decision|0
2703420|NCT00384176|9312120|P3|Overall Study|Did not receive study treatment|1
2703421|NCT00384176|9312121|P2|Overall Study|Did not receive study treatment|1
2703422|NCT00384176|9312122|P1|Overall Study|Did not receive study treatment|0
2703423|NCT00384176|9312120|P3|Overall Study|Toxicity of treatment|0
2703424|NCT00384176|9312121|P2|Overall Study|Toxicity of treatment|0
2703425|NCT00384176|9312122|P1|Overall Study|Toxicity of treatment|1
2703426|NCT00384176|9312120|P3|Overall Study|Longer QTC as Visit 1|0
2703427|NCT00384176|9312121|P2|Overall Study|Longer QTC as Visit 1|0
2703428|NCT00384176|9312122|P1|Overall Study|Longer QTC as Visit 1|1
2703429|NCT00384176|9312120|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|0
2703430|NCT00384176|9312121|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|3
2703431|NCT00384176|9312122|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|2
2703432|NCT00384176|9312120|P3|Overall Study|Lost to Follow-up|4
2703433|NCT00384176|9312121|P2|Overall Study|Lost to Follow-up|18
2703434|NCT00384176|9312122|P1|Overall Study|Lost to Follow-up|16
2703435|NCT00384176|9312120|P3|Overall Study|Withdrawal by Subject|22
2703436|NCT00384176|9312121|P2|Overall Study|Withdrawal by Subject|48
2703437|NCT00384176|9312122|P1|Overall Study|Withdrawal by Subject|52
2703438|NCT00384176|9312120|P3|Overall Study|Death|105
2703439|NCT00384176|9312121|P2|Overall Study|Death|247
2703440|NCT00384176|9312122|P1|Overall Study|Death|239
2703441|NCT00384085|9312148|P3|Overall Study|Patient required surgery|0
2703442|NCT00384085|9312149|P2|Overall Study|Patient required surgery|1
2703443|NCT00384085|9312150|P1|Overall Study|Patient required surgery|0
2703444|NCT00384085|9312148|P3|Overall Study|Patient moved|1
2703445|NCT00384085|9312149|P2|Overall Study|Patient moved|0
2703446|NCT00384085|9312150|P1|Overall Study|Patient moved|1
2703447|NCT00384085|9312148|P3|Overall Study|Sponsor decision|1
2703448|NCT00384085|9312149|P2|Overall Study|Sponsor decision|2
2703449|NCT00384085|9312150|P1|Overall Study|Sponsor decision|1
2703450|NCT00384085|9312148|P3|Overall Study|Loss of site personnel|1
2703451|NCT00384085|9312149|P2|Overall Study|Loss of site personnel|0
2703452|NCT00384085|9312150|P1|Overall Study|Loss of site personnel|1
2703453|NCT00384085|9312148|P3|Overall Study|Physician Decision|0
2703454|NCT00384085|9312149|P2|Overall Study|Physician Decision|0
2703455|NCT00384085|9312150|P1|Overall Study|Physician Decision|1
2703456|NCT00384085|9312148|P3|Overall Study|Patient non-compliant|5
2703457|NCT00384085|9312149|P2|Overall Study|Patient non-compliant|4
2703458|NCT00384085|9312150|P1|Overall Study|Patient non-compliant|4
2703459|NCT00384085|9312148|P3|Overall Study|Withdrawal by Subject|29
2703460|NCT00384085|9312149|P2|Overall Study|Withdrawal by Subject|19
2703461|NCT00384085|9312150|P1|Overall Study|Withdrawal by Subject|14
2703462|NCT00384085|9312148|P3|Overall Study|Progressive Disease|0
2703463|NCT00384085|9312149|P2|Overall Study|Progressive Disease|1
2703464|NCT00384085|9312150|P1|Overall Study|Progressive Disease|0
2703465|NCT00384085|9312148|P3|Overall Study|Lost to Follow-up|10
2703466|NCT00384085|9312149|P2|Overall Study|Lost to Follow-up|9
2703467|NCT00384085|9312150|P1|Overall Study|Lost to Follow-up|9
2703468|NCT00384085|9312148|P3|Overall Study|Protocol Violation|2
2703469|NCT00384085|9312149|P2|Overall Study|Protocol Violation|2
2703470|NCT00384085|9312150|P1|Overall Study|Protocol Violation|2
2703471|NCT00384085|9312148|P3|Overall Study|No longer Requires Study Treatment|1
2703472|NCT00384085|9312149|P2|Overall Study|No longer Requires Study Treatment|0
2703473|NCT00384085|9312150|P1|Overall Study|No longer Requires Study Treatment|1
2703474|NCT00384085|9312148|P3|Overall Study|Lack of Efficacy|2
2703475|NCT00384085|9312149|P2|Overall Study|Lack of Efficacy|3
2703476|NCT00384085|9312150|P1|Overall Study|Lack of Efficacy|0
2703477|NCT00384085|9312148|P3|Overall Study|Adverse Event|4
2703478|NCT00384085|9312149|P2|Overall Study|Adverse Event|5
2703479|NCT00384085|9312150|P1|Overall Study|Adverse Event|5
2703480|NCT00384059|9312176|P2|Toddler Dose|Failed to return|1
2703481|NCT00384059|9312177|P1|Toddler Dose|Failed to return|0
2703482|NCT00384059|9312176|P2|Toddler Dose|Lost to Follow-up|1
2703483|NCT00384059|9312177|P1|Toddler Dose|Lost to Follow-up|1
2703484|NCT00384059|9312176|P2|After Infant Series|Lost to Follow-up|1
2703485|NCT00384059|9312177|P1|After Infant Series|Lost to Follow-up|0
2703486|NCT00384059|9312176|P2|After Infant Series|Physician Decision|1
2703487|NCT00384059|9312177|P1|After Infant Series|Physician Decision|0
2703488|NCT00384059|9312176|P2|After Infant Series|Adverse Event|1
2703489|NCT00384059|9312177|P1|After Infant Series|Adverse Event|0
2703490|NCT00384059|9312176|P2|After Infant Series|Failed to Return|2
2703491|NCT00384059|9312177|P1|After Infant Series|Failed to Return|0
2703492|NCT00384059|9312176|P2|After Infant Series|Withdrawal by Subject|2
2703493|NCT00384059|9312177|P1|After Infant Series|Withdrawal by Subject|2
2703494|NCT00384059|9312176|P2|After Infant Series|Protocol Violation|3
2703495|NCT00384059|9312177|P1|After Infant Series|Protocol Violation|2
2703496|NCT00384059|9312176|P2|Infant Series|Lost to Follow-up|1
2703497|NCT00384059|9312177|P1|Infant Series|Lost to Follow-up|0
2703498|NCT00384059|9312176|P2|Infant Series|Protocol Violation|2
2703499|NCT00384059|9312177|P1|Infant Series|Protocol Violation|1
2703500|NCT00384059|9312176|P2|Infant Series|Adverse Event|2
2703501|NCT00384059|9312177|P1|Infant Series|Adverse Event|1
2703502|NCT00384059|9312176|P2|Infant Series|Withdrawal by Subject|2
2703503|NCT00384059|9312177|P1|Infant Series|Withdrawal by Subject|2
2703504|NCT00384059|9312176|P2|Infant Series|Not consented|6
2703505|NCT00384059|9312177|P1|Infant Series|Not consented|2
2703506|NCT00384033|9312227|P4|Overall Study|Randomized but not treated|2
2703507|NCT00384033|9312228|P3|Overall Study|Randomized but not treated|10
2703508|NCT00384033|9312229|P2|Overall Study|Randomized but not treated|7
2703509|NCT00384033|9312230|P1|Overall Study|Randomized but not treated|3
2703510|NCT00384033|9312227|P4|Overall Study|Lack of Efficacy|1
2703511|NCT00384033|9312228|P3|Overall Study|Lack of Efficacy|3
2703512|NCT00384033|9312229|P2|Overall Study|Lack of Efficacy|3
2703513|NCT00384033|9312230|P1|Overall Study|Lack of Efficacy|7
2703514|NCT00384033|9312227|P4|Overall Study|Withdrawal by Subject|2
2703515|NCT00384033|9312228|P3|Overall Study|Withdrawal by Subject|5
2703516|NCT00384033|9312229|P2|Overall Study|Withdrawal by Subject|2
2703517|NCT00384033|9312230|P1|Overall Study|Withdrawal by Subject|6
2703518|NCT00384033|9312227|P4|Overall Study|Protocol Violation|6
2703519|NCT00384033|9312228|P3|Overall Study|Protocol Violation|5
2703520|NCT00384033|9312229|P2|Overall Study|Protocol Violation|0
2703521|NCT00384033|9312230|P1|Overall Study|Protocol Violation|5
2703522|NCT00384033|9312227|P4|Overall Study|Other|0
2703523|NCT00384033|9312228|P3|Overall Study|Other|0
2703524|NCT00384033|9312229|P2|Overall Study|Other|0
2703525|NCT00384033|9312230|P1|Overall Study|Other|2
2703526|NCT00384033|9312227|P4|Overall Study|Lost to Follow-up|7
2703527|NCT00384033|9312228|P3|Overall Study|Lost to Follow-up|7
2703528|NCT00384033|9312229|P2|Overall Study|Lost to Follow-up|12
2703529|NCT00384033|9312230|P1|Overall Study|Lost to Follow-up|6
2703530|NCT00384033|9312227|P4|Overall Study|Physician Decision|0
2703531|NCT00384033|9312228|P3|Overall Study|Physician Decision|0
2703532|NCT00384033|9312229|P2|Overall Study|Physician Decision|0
2703533|NCT00384033|9312230|P1|Overall Study|Physician Decision|1
2703534|NCT00384033|9312227|P4|Overall Study|Failed to return|2
2703535|NCT00384033|9312228|P3|Overall Study|Failed to return|2
2703536|NCT00384033|9312229|P2|Overall Study|Failed to return|3
2703537|NCT00384033|9312230|P1|Overall Study|Failed to return|1
2703538|NCT00384033|9312227|P4|Overall Study|Adverse Event|20
2703539|NCT00384033|9312228|P3|Overall Study|Adverse Event|11
2703540|NCT00384033|9312229|P2|Overall Study|Adverse Event|8
2703541|NCT00384033|9312230|P1|Overall Study|Adverse Event|10
2703542|NCT00383786|9312283|P2|Overall Study|Physician Decision|1
2703543|NCT00383786|9312284|P1|Overall Study|Physician Decision|0
2703544|NCT00383786|9312283|P2|Overall Study|Withdrawal by Subject|5
2703545|NCT00383786|9312284|P1|Overall Study|Withdrawal by Subject|2
2703546|NCT00383786|9312283|P2|Overall Study|Protocol Violation|6
2703547|NCT00383786|9312284|P1|Overall Study|Protocol Violation|2
2703548|NCT00383721|9312334|P5|26-Week Treatment Safety Extension|Administrative|0
2703549|NCT00383721|9312335|P4|26-Week Treatment Safety Extension|Administrative|1
2703550|NCT00383721|9312336|P3|26-Week Treatment Safety Extension|Administrative|3
2703551|NCT00383721|9312337|P2|26-Week Treatment Safety Extension|Administrative|2
2703552|NCT00383721|9312338|P1|26-Week Treatment Safety Extension|Administrative|1
2703553|NCT00383721|9312334|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
2703554|NCT00383721|9312335|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
2703555|NCT00383721|9312336|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
2703556|NCT00383721|9312337|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
2703557|NCT00383721|9312338|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
2703558|NCT00383721|9312334|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
2703559|NCT00383721|9312335|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|4
2703560|NCT00383721|9312336|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
2703561|NCT00383721|9312337|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
2703562|NCT00383721|9312338|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|2
2703563|NCT00383721|9312334|P5|26-Week Treatment Safety Extension|Participant withdrawal related|0
2703564|NCT00383721|9312335|P4|26-Week Treatment Safety Extension|Participant withdrawal related|1
2703565|NCT00383721|9312336|P3|26-Week Treatment Safety Extension|Participant withdrawal related|1
2703566|NCT00383721|9312337|P2|26-Week Treatment Safety Extension|Participant withdrawal related|1
2703567|NCT00383721|9312338|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
2703568|NCT00383721|9312334|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
2703569|NCT00383721|9312335|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7
2703570|NCT00383721|9312336|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
2703571|NCT00383721|9312337|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4
2703572|NCT00383721|9312338|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
2703573|NCT00383721|9312334|P5|26-Week Treatment Safety Extension|Lost to Follow-up|0
2703574|NCT00383721|9312335|P4|26-Week Treatment Safety Extension|Lost to Follow-up|1
2703575|NCT00383721|9312336|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
2703576|NCT00383721|9312337|P2|26-Week Treatment Safety Extension|Lost to Follow-up|0
2703577|NCT00383721|9312338|P1|26-Week Treatment Safety Extension|Lost to Follow-up|2
2703578|NCT00383721|9312334|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
2703579|NCT00383721|9312335|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
2703580|NCT00383721|9312336|P3|26-Week Treatment Safety Extension|Lack of Efficacy|4
2703581|NCT00383721|9312337|P2|26-Week Treatment Safety Extension|Lack of Efficacy|2
2703582|NCT00383721|9312338|P1|26-Week Treatment Safety Extension|Lack of Efficacy|0
2703583|NCT00383721|9312334|P5|26-Week Treatment Safety Extension|Adverse Event|0
2703584|NCT00383721|9312335|P4|26-Week Treatment Safety Extension|Adverse Event|1
2703585|NCT00383721|9312336|P3|26-Week Treatment Safety Extension|Adverse Event|10
2703586|NCT00383721|9312337|P2|26-Week Treatment Safety Extension|Adverse Event|7
2703587|NCT00383721|9312338|P1|26-Week Treatment Safety Extension|Adverse Event|6
2703588|NCT00383721|9312334|P5|26-Week Double-Blind Treatment Period|Ongoing|0
2703589|NCT00383721|9312335|P4|26-Week Double-Blind Treatment Period|Ongoing|0
2703590|NCT00383721|9312336|P3|26-Week Double-Blind Treatment Period|Ongoing|0
2703591|NCT00383721|9312337|P2|26-Week Double-Blind Treatment Period|Ongoing|0
2703592|NCT00383721|9312338|P1|26-Week Double-Blind Treatment Period|Ongoing|1
2703593|NCT00383721|9312334|P5|26-Week Double-Blind Treatment Period|Administrative|3
2703594|NCT00383721|9312335|P4|26-Week Double-Blind Treatment Period|Administrative|3
2703595|NCT00383721|9312336|P3|26-Week Double-Blind Treatment Period|Administrative|3
2703596|NCT00383721|9312337|P2|26-Week Double-Blind Treatment Period|Administrative|3
2703597|NCT00383721|9312338|P1|26-Week Double-Blind Treatment Period|Administrative|1
2703598|NCT00383721|9312334|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13
2703599|NCT00383721|9312335|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4
2703600|NCT00383721|9312336|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11
2703601|NCT00383721|9312337|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
2703602|NCT00383721|9312338|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
2703603|NCT00383721|9312334|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
2703604|NCT00383721|9312335|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
2703605|NCT00383721|9312336|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
2703606|NCT00383721|9312337|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
2703607|NCT00383721|9312338|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7
2703608|NCT00383721|9312334|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|9
2703609|NCT00383721|9312335|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|8
2703610|NCT00383721|9312336|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|6
2703611|NCT00383721|9312337|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
2703612|NCT00383721|9312338|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|5
2703613|NCT00383721|9312334|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11
2703614|NCT00383721|9312335|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
2703615|NCT00383721|9312336|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15
2703616|NCT00383721|9312337|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
2703617|NCT00383721|9312338|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4
2703618|NCT00383721|9312334|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|4
2703619|NCT00383721|9312335|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
2703620|NCT00383721|9312336|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
2703621|NCT00383721|9312337|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
2703622|NCT00383721|9312338|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
2703623|NCT00383721|9312334|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
2703624|NCT00383721|9312335|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|4
2703625|NCT00383721|9312336|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
2703626|NCT00383721|9312337|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
2703627|NCT00383721|9312338|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|1
2703628|NCT00383721|9312334|P5|26-Week Double-Blind Treatment Period|Adverse Event|13
2703629|NCT00383721|9312335|P4|26-Week Double-Blind Treatment Period|Adverse Event|14
2703630|NCT00383721|9312336|P3|26-Week Double-Blind Treatment Period|Adverse Event|7
2703631|NCT00383721|9312337|P2|26-Week Double-Blind Treatment Period|Adverse Event|5
2703632|NCT00383721|9312338|P1|26-Week Double-Blind Treatment Period|Adverse Event|11
2703633|NCT00383708|9312375|P1|Co-administration Period|Adverse Event|5
2703634|NCT00383708|9312375|P1|Run-in Period|Claustrophobia|1
2703635|NCT00383708|9312375|P1|Run-in Period|Adverse Event|2
2703636|NCT00383708|9312375|P1|Run-in Period|Protocol Violation|4
2703637|NCT00383708|9312375|P1|Enrolment Through Start Treatment|Did not meet entry criteria|32
2703869|NCT00382967|9312866|P1|Overall Study|Protocol Violation|1
2703638|NCT00383708|9312375|P1|Enrolment Through Start Treatment|Withdrawal by Subject|1
2703639|NCT00383552|9312450|P4|Overall Study|Administrative|1
2703640|NCT00383552|9312451|P3|Overall Study|Administrative|1
2703641|NCT00383552|9312452|P2|Overall Study|Administrative|0
2703642|NCT00383552|9312453|P1|Overall Study|Administrative|1
2703643|NCT00383552|9312450|P4|Overall Study|Did not meet protocol eligibility|3
2703644|NCT00383552|9312451|P3|Overall Study|Did not meet protocol eligibility|2
2703645|NCT00383552|9312452|P2|Overall Study|Did not meet protocol eligibility|6
2703646|NCT00383552|9312453|P1|Overall Study|Did not meet protocol eligibility|8
2703647|NCT00383552|9312450|P4|Overall Study|Noncompliance with the protocol|10
2703648|NCT00383552|9312451|P3|Overall Study|Noncompliance with the protocol|8
2703649|NCT00383552|9312452|P2|Overall Study|Noncompliance with the protocol|6
2703650|NCT00383552|9312453|P1|Overall Study|Noncompliance with the protocol|11
2703651|NCT00383552|9312450|P4|Overall Study|Did not wish to continue (related)|3
2703652|NCT00383552|9312451|P3|Overall Study|Did not wish to continue (related)|2
2703653|NCT00383552|9312452|P2|Overall Study|Did not wish to continue (related)|0
2703654|NCT00383552|9312453|P1|Overall Study|Did not wish to continue (related)|1
2703655|NCT00383552|9312450|P4|Overall Study|Did not wish to continue (unrelated)|6
2703656|NCT00383552|9312451|P3|Overall Study|Did not wish to continue (unrelated)|5
2703657|NCT00383552|9312452|P2|Overall Study|Did not wish to continue (unrelated)|9
2703658|NCT00383552|9312453|P1|Overall Study|Did not wish to continue (unrelated)|4
2703659|NCT00383552|9312450|P4|Overall Study|Lost to Follow-up|1
2703660|NCT00383552|9312451|P3|Overall Study|Lost to Follow-up|5
2703661|NCT00383552|9312452|P2|Overall Study|Lost to Follow-up|1
2703662|NCT00383552|9312453|P1|Overall Study|Lost to Follow-up|0
2703663|NCT00383552|9312450|P4|Overall Study|Lack of Efficacy|42
2703664|NCT00383552|9312451|P3|Overall Study|Lack of Efficacy|29
2703665|NCT00383552|9312452|P2|Overall Study|Lack of Efficacy|13
2703666|NCT00383552|9312453|P1|Overall Study|Lack of Efficacy|4
2703667|NCT00383552|9312450|P4|Overall Study|Adverse Event|6
2703668|NCT00383552|9312451|P3|Overall Study|Adverse Event|9
2703669|NCT00383552|9312452|P2|Overall Study|Adverse Event|6
2703670|NCT00383552|9312453|P1|Overall Study|Adverse Event|7
2703671|NCT00383500|9312495|P3|Overall Study|Lost to Follow-up|2
2703672|NCT00383500|9312496|P2|Overall Study|Lost to Follow-up|0
2703673|NCT00383500|9312497|P1|Overall Study|Lost to Follow-up|0
2703674|NCT00383500|9312495|P3|Overall Study|Withdrawal by Subject|0
2703675|NCT00383500|9312496|P2|Overall Study|Withdrawal by Subject|3
2703676|NCT00383500|9312497|P1|Overall Study|Withdrawal by Subject|8
2703677|NCT00383435|9312521|P5|26-Week Treatment Safety Extension|Administrative|0
2703678|NCT00383435|9312522|P4|26-Week Treatment Safety Extension|Administrative|1
2703679|NCT00383435|9312523|P3|26-Week Treatment Safety Extension|Administrative|0
2703680|NCT00383435|9312524|P2|26-Week Treatment Safety Extension|Administrative|1
2703681|NCT00383435|9312525|P1|26-Week Treatment Safety Extension|Administrative|1
2703682|NCT00383435|9312521|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
2703683|NCT00383435|9312522|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
2703684|NCT00383435|9312523|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
2703685|NCT00383435|9312524|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
2703686|NCT00383435|9312525|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
2703687|NCT00383435|9312521|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
2703688|NCT00383435|9312522|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|1
2703689|NCT00383435|9312523|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
2703690|NCT00383435|9312524|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
2703691|NCT00383435|9312525|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|4
2703692|NCT00383435|9312521|P5|26-Week Treatment Safety Extension|Participant withdrawal related|1
2703693|NCT00383435|9312522|P4|26-Week Treatment Safety Extension|Participant withdrawal related|0
2703694|NCT00383435|9312523|P3|26-Week Treatment Safety Extension|Participant withdrawal related|2
2703695|NCT00383435|9312524|P2|26-Week Treatment Safety Extension|Participant withdrawal related|0
2703696|NCT00383435|9312525|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
2703697|NCT00383435|9312521|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
2703698|NCT00383435|9312522|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
2703699|NCT00383435|9312523|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
2703700|NCT00383435|9312524|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
2703701|NCT00383435|9312525|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
2703702|NCT00383435|9312521|P5|26-Week Treatment Safety Extension|Lost to Follow-up|1
2703703|NCT00383435|9312522|P4|26-Week Treatment Safety Extension|Lost to Follow-up|0
2703704|NCT00383435|9312523|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
2703705|NCT00383435|9312524|P2|26-Week Treatment Safety Extension|Lost to Follow-up|2
2703706|NCT00383435|9312525|P1|26-Week Treatment Safety Extension|Lost to Follow-up|0
2703707|NCT00383435|9312521|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
2703708|NCT00383435|9312522|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
2703709|NCT00383435|9312523|P3|26-Week Treatment Safety Extension|Lack of Efficacy|1
2703710|NCT00383435|9312524|P2|26-Week Treatment Safety Extension|Lack of Efficacy|1
2703711|NCT00383435|9312525|P1|26-Week Treatment Safety Extension|Lack of Efficacy|1
2703712|NCT00383435|9312521|P5|26-Week Treatment Safety Extension|Adverse Event|1
2703713|NCT00383435|9312522|P4|26-Week Treatment Safety Extension|Adverse Event|5
2703714|NCT00383435|9312523|P3|26-Week Treatment Safety Extension|Adverse Event|5
2703715|NCT00383435|9312524|P2|26-Week Treatment Safety Extension|Adverse Event|2
2703716|NCT00383435|9312525|P1|26-Week Treatment Safety Extension|Adverse Event|4
2703717|NCT00383435|9312521|P5|26-Week Double-Blind Treatment Period|Administrative|1
2703718|NCT00383435|9312522|P4|26-Week Double-Blind Treatment Period|Administrative|1
2703719|NCT00383435|9312523|P3|26-Week Double-Blind Treatment Period|Administrative|1
2703720|NCT00383435|9312524|P2|26-Week Double-Blind Treatment Period|Administrative|3
2703721|NCT00383435|9312525|P1|26-Week Double-Blind Treatment Period|Administrative|5
2703722|NCT00383435|9312521|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
2703723|NCT00383435|9312522|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
2703724|NCT00383435|9312523|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9
2703725|NCT00383435|9312524|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8
2703726|NCT00383435|9312525|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10
2703727|NCT00383435|9312521|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
2703728|NCT00383435|9312522|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
2703729|NCT00383435|9312523|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3
2703730|NCT00383435|9312524|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
2703731|NCT00383435|9312525|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1
2703732|NCT00383435|9312521|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
2703733|NCT00383435|9312522|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
2703734|NCT00383435|9312523|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
2703735|NCT00383435|9312524|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
2703736|NCT00383435|9312525|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|2
2703737|NCT00383435|9312521|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17
2703738|NCT00383435|9312522|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
2703739|NCT00383435|9312523|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14
2703740|NCT00383435|9312524|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
2703741|NCT00383435|9312525|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7
2703742|NCT00383435|9312521|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
2703743|NCT00383435|9312522|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
2703744|NCT00383435|9312523|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
2703745|NCT00383435|9312524|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
2703746|NCT00383435|9312525|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
2703747|NCT00383435|9312521|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
2703748|NCT00383435|9312522|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|5
2703749|NCT00383435|9312523|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
2703750|NCT00383435|9312524|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|2
2703751|NCT00383435|9312525|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
2703752|NCT00383435|9312521|P5|26-Week Double-Blind Treatment Period|Adverse Event|8
2703753|NCT00383435|9312522|P4|26-Week Double-Blind Treatment Period|Adverse Event|6
2703754|NCT00383435|9312523|P3|26-Week Double-Blind Treatment Period|Adverse Event|8
2703755|NCT00383435|9312524|P2|26-Week Double-Blind Treatment Period|Adverse Event|2
2703756|NCT00383435|9312525|P1|26-Week Double-Blind Treatment Period|Adverse Event|10
2703757|NCT00383331|9312564|P2|Overall Study|Protocol Violation|1
2703758|NCT00383331|9312565|P1|Overall Study|Protocol Violation|0
2703759|NCT00383292|9312584|P3|Overall Study|Other|0
2703760|NCT00383292|9312585|P2|Overall Study|Other|0
2703761|NCT00383292|9312586|P1|Overall Study|Other|1
2703762|NCT00383292|9312584|P3|Overall Study|Withdrawal by Subject|2
2703763|NCT00383292|9312585|P2|Overall Study|Withdrawal by Subject|2
2703764|NCT00383292|9312586|P1|Overall Study|Withdrawal by Subject|3
2703765|NCT00383292|9312584|P3|Overall Study|Physician Decision|1
2703766|NCT00383292|9312585|P2|Overall Study|Physician Decision|0
2703767|NCT00383292|9312586|P1|Overall Study|Physician Decision|4
2703768|NCT00383292|9312584|P3|Overall Study|Death|3
2703769|NCT00383292|9312585|P2|Overall Study|Death|3
2703770|NCT00383292|9312586|P1|Overall Study|Death|3
2703771|NCT00383292|9312584|P3|Overall Study|Adverse Event|2
2703772|NCT00383292|9312585|P2|Overall Study|Adverse Event|1
2703773|NCT00383292|9312586|P1|Overall Study|Adverse Event|4
2703774|NCT00383240|9312627|P4|Overall Study|Administrative|0
2703775|NCT00383240|9312628|P3|Overall Study|Administrative|0
2703776|NCT00383240|9312629|P2|Overall Study|Administrative|1
2703777|NCT00383240|9312630|P1|Overall Study|Administrative|1
2703778|NCT00383240|9312627|P4|Overall Study|Did not meet protocol eligibility|3
2703779|NCT00383240|9312628|P3|Overall Study|Did not meet protocol eligibility|9
2703780|NCT00383240|9312629|P2|Overall Study|Did not meet protocol eligibility|4
2703781|NCT00383240|9312630|P1|Overall Study|Did not meet protocol eligibility|9
2703782|NCT00383240|9312627|P4|Overall Study|Protocol Violation|6
2703783|NCT00383240|9312628|P3|Overall Study|Protocol Violation|9
2703784|NCT00383240|9312629|P2|Overall Study|Protocol Violation|5
2703785|NCT00383240|9312630|P1|Overall Study|Protocol Violation|4
2703786|NCT00383240|9312627|P4|Overall Study|Withdrawal by subjects, reasons related|5
2703787|NCT00383240|9312628|P3|Overall Study|Withdrawal by subjects, reasons related|3
2703788|NCT00383240|9312629|P2|Overall Study|Withdrawal by subjects, reasons related|1
2703789|NCT00383240|9312630|P1|Overall Study|Withdrawal by subjects, reasons related|0
2703790|NCT00383240|9312627|P4|Overall Study|Withdrawal by subject, reasons unrelated|8
2703791|NCT00383240|9312628|P3|Overall Study|Withdrawal by subject, reasons unrelated|8
2703792|NCT00383240|9312629|P2|Overall Study|Withdrawal by subject, reasons unrelated|3
2703793|NCT00383240|9312630|P1|Overall Study|Withdrawal by subject, reasons unrelated|6
2703794|NCT00383240|9312627|P4|Overall Study|Lost to Follow-up|2
2703795|NCT00383240|9312628|P3|Overall Study|Lost to Follow-up|0
2703796|NCT00383240|9312629|P2|Overall Study|Lost to Follow-up|0
2703797|NCT00383240|9312630|P1|Overall Study|Lost to Follow-up|3
2703798|NCT00383240|9312627|P4|Overall Study|Treatment Failure|46
2703799|NCT00383240|9312628|P3|Overall Study|Treatment Failure|47
2703800|NCT00383240|9312629|P2|Overall Study|Treatment Failure|13
2703801|NCT00383240|9312630|P1|Overall Study|Treatment Failure|8
2703802|NCT00383240|9312627|P4|Overall Study|Adverse Event|7
2703803|NCT00383240|9312628|P3|Overall Study|Adverse Event|9
2703804|NCT00383240|9312629|P2|Overall Study|Adverse Event|6
2703805|NCT00383240|9312630|P1|Overall Study|Adverse Event|4
2703806|NCT00383162|9312661|P2|Migraine Attack 2 (Period 2)|Unknown reason|3
2703807|NCT00383162|9312662|P1|Migraine Attack 2 (Period 2)|Unknown reason|0
2703808|NCT00383162|9312661|P2|Migraine Attack 2 (Period 2)|Adverse Event|0
2703809|NCT00383162|9312662|P1|Migraine Attack 2 (Period 2)|Adverse Event|1
2703810|NCT00383162|9312661|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
2703811|NCT00383162|9312662|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
2703812|NCT00383162|9312661|P2|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3
2703813|NCT00383162|9312662|P1|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1
2703814|NCT00383162|9312661|P2|Migraine Attack 1 (Period 1)|Non-compliant|0
2703815|NCT00383162|9312662|P1|Migraine Attack 1 (Period 1)|Non-compliant|3
2703816|NCT00383162|9312661|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0
2703817|NCT00383162|9312662|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2
2703818|NCT00383162|9312661|P2|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2
2703819|NCT00383162|9312662|P1|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4
2703820|NCT00383162|9312661|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
2703821|NCT00383162|9312662|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|8
2703822|NCT00383162|9312661|P2|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4
2703823|NCT00383162|9312662|P1|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3
2703824|NCT00383149|9312704|P1|Overall Study|Participant Withdrew Consent|1
2703825|NCT00383149|9312704|P1|Overall Study|Request to Discontinue Treatment|4
2703826|NCT00383149|9312704|P1|Overall Study|Study Drug Toxicity|4
2703827|NCT00383149|9312704|P1|Overall Study|Other|1
2703828|NCT00383149|9312704|P1|Overall Study|Lost to Follow-up|1
2703829|NCT00383149|9312704|P1|Overall Study|Disease Progression|38
2703830|NCT00383149|9312704|P1|Overall Study|Death|2
2703831|NCT00383149|9312704|P1|Overall Study|Adverse Event not Related to Study Drug|3
2703832|NCT00383123|9312723|P2|Overall Study|Other reason|6
2703833|NCT00383123|9312724|P1|Overall Study|Other reason|10
2703834|NCT00383123|9312723|P2|Overall Study|Withdrawal by Subject|18
2703835|NCT00383123|9312724|P1|Overall Study|Withdrawal by Subject|27
2703836|NCT00383123|9312723|P2|Overall Study|Protocol Violation|1
2703837|NCT00383123|9312724|P1|Overall Study|Protocol Violation|5
2703838|NCT00383123|9312723|P2|Overall Study|Lost to Follow-up|61
2703839|NCT00383123|9312724|P1|Overall Study|Lost to Follow-up|68
2703840|NCT00383123|9312723|P2|Overall Study|Adverse Event|0
2703841|NCT00383123|9312724|P1|Overall Study|Adverse Event|1
2703842|NCT00383084|9312765|P2|Overall Study|Withdrawal by Subject|10
2703843|NCT00383084|9312766|P1|Overall Study|Withdrawal by Subject|12
2703844|NCT00383019|9312797|P2|Overall Study|Withdrawal by Subject|1
2703845|NCT00383019|9312798|P1|Overall Study|Withdrawal by Subject|0
2703846|NCT00383019|9312797|P2|Overall Study|Adverse Event|1
2703847|NCT00383019|9312798|P1|Overall Study|Adverse Event|5
2703848|NCT00382993|9312820|P2|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
2703849|NCT00382993|9312821|P1|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
2703850|NCT00382993|9312820|P2|Migraine Attack 2 (Period 2)|Protocol Violation|1
2703851|NCT00382993|9312821|P1|Migraine Attack 2 (Period 2)|Protocol Violation|0
2703852|NCT00382993|9312820|P2|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1
2703853|NCT00382993|9312821|P1|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0
2703854|NCT00382993|9312820|P2|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1
2703855|NCT00382993|9312821|P1|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0
2703856|NCT00382993|9312820|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
2703857|NCT00382993|9312821|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
2703858|NCT00382993|9312820|P2|Migraine Attack 1 (Period 1)|Other (no additional data present)|5
2703859|NCT00382993|9312821|P1|Migraine Attack 1 (Period 1)|Other (no additional data present)|3
2703860|NCT00382993|9312820|P2|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
2703861|NCT00382993|9312821|P1|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
2703862|NCT00382993|9312820|P2|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5
2703863|NCT00382993|9312821|P1|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0
2703864|NCT00382993|9312820|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3
2703865|NCT00382993|9312821|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1
2703866|NCT00382993|9312820|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|2
2703867|NCT00382993|9312821|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
2703868|NCT00382967|9312865|P2|Overall Study|Protocol Violation|1
2703870|NCT00382863|9312891|P2|Overall Study|Withdrawal by Subject|25
2703871|NCT00382863|9312892|P1|Overall Study|Withdrawal by Subject|5
2703872|NCT00382863|9312891|P2|Overall Study|Lost to Follow-up|2
2703873|NCT00382863|9312892|P1|Overall Study|Lost to Follow-up|1
2703874|NCT00382863|9312891|P2|Overall Study|Death|9
2703875|NCT00382863|9312892|P1|Overall Study|Death|9
2703876|NCT00382733|9312976|P5|Overall Study|Withdrawal by Subject|0
2703877|NCT00382733|9312977|P4|Overall Study|Withdrawal by Subject|0
2703878|NCT00382733|9312978|P3|Overall Study|Withdrawal by Subject|0
2703879|NCT00382733|9312979|P2|Overall Study|Withdrawal by Subject|1
2703880|NCT00382733|9312980|P1|Overall Study|Withdrawal by Subject|0
2703881|NCT00382720|9313001|P3|Overall Study|Discontinued at end of study|2
2703882|NCT00382720|9313002|P2|Overall Study|Discontinued at end of study|1
2703883|NCT00382720|9313003|P1|Overall Study|Discontinued at end of study|0
2703884|NCT00382720|9313001|P3|Overall Study|Investigator/Clinical decision|6
2703885|NCT00382720|9313002|P2|Overall Study|Investigator/Clinical decision|6
2703886|NCT00382720|9313003|P1|Overall Study|Investigator/Clinical decision|5
2703887|NCT00382720|9313001|P3|Overall Study|Good prognosis|0
2703888|NCT00382720|9313002|P2|Overall Study|Good prognosis|1
2703889|NCT00382720|9313003|P1|Overall Study|Good prognosis|0
2703890|NCT00382720|9313001|P3|Overall Study|Clinically progressive disease|0
2703891|NCT00382720|9313002|P2|Overall Study|Clinically progressive disease|1
2703892|NCT00382720|9313003|P1|Overall Study|Clinically progressive disease|0
2703893|NCT00382720|9313001|P3|Overall Study|Patient did not receive study medication|4
2703894|NCT00382720|9313002|P2|Overall Study|Patient did not receive study medication|1
2703895|NCT00382720|9313003|P1|Overall Study|Patient did not receive study medication|1
2703896|NCT00382720|9313001|P3|Overall Study|Surgery|4
2703897|NCT00382720|9313002|P2|Overall Study|Surgery|1
2703898|NCT00382720|9313003|P1|Overall Study|Surgery|1
2703899|NCT00382720|9313001|P3|Overall Study|Withdrawal by Subject|12
2703900|NCT00382720|9313002|P2|Overall Study|Withdrawal by Subject|20
2703901|NCT00382720|9313003|P1|Overall Study|Withdrawal by Subject|11
2703902|NCT00382720|9313001|P3|Overall Study|Withdrew consent|2
2703903|NCT00382720|9313002|P2|Overall Study|Withdrew consent|1
2703904|NCT00382720|9313003|P1|Overall Study|Withdrew consent|1
2703905|NCT00382720|9313001|P3|Overall Study|Progressive disease|38
2703906|NCT00382720|9313002|P2|Overall Study|Progressive disease|28
2703907|NCT00382720|9313003|P1|Overall Study|Progressive disease|37
2703908|NCT00382720|9313001|P3|Overall Study|Death|2
2703909|NCT00382720|9313002|P2|Overall Study|Death|1
2703910|NCT00382720|9313003|P1|Overall Study|Death|0
2703911|NCT00382720|9313001|P3|Overall Study|Protocol Violation|1
2703912|NCT00382720|9313002|P2|Overall Study|Protocol Violation|5
2703913|NCT00382720|9313003|P1|Overall Study|Protocol Violation|2
2703914|NCT00382720|9313001|P3|Overall Study|Adverse Event|15
2703915|NCT00382720|9313002|P2|Overall Study|Adverse Event|23
2703916|NCT00382720|9313003|P1|Overall Study|Adverse Event|21
2703917|NCT00382408|9313028|P2|Overall Study|Other|35
2703918|NCT00382408|9313029|P1|Overall Study|Other|100
2703919|NCT00382408|9313028|P2|Overall Study|Lost to Follow-up|8
2703920|NCT00382408|9313029|P1|Overall Study|Lost to Follow-up|19
2703921|NCT00382408|9313028|P2|Overall Study|Pregnancy|0
2703922|NCT00382408|9313029|P1|Overall Study|Pregnancy|2
2703923|NCT00382408|9313028|P2|Overall Study|Withdrawal by Subject|6
2703924|NCT00382408|9313029|P1|Overall Study|Withdrawal by Subject|17
2703925|NCT00382408|9313028|P2|Overall Study|Physician Decision|0
2703926|NCT00382408|9313029|P1|Overall Study|Physician Decision|1
2703927|NCT00382408|9313028|P2|Overall Study|Protocol Violation|2
2703928|NCT00382408|9313029|P1|Overall Study|Protocol Violation|2
2703929|NCT00382408|9313028|P2|Overall Study|Did not meet protocol requirement|3
2703930|NCT00382408|9313029|P1|Overall Study|Did not meet protocol requirement|3
2703931|NCT00382291|9313056|P3|Overall Study|Lack of Efficacy|1
2703932|NCT00382291|9313057|P2|Overall Study|Lack of Efficacy|0
2703933|NCT00382291|9313058|P1|Overall Study|Lack of Efficacy|0
2703934|NCT00382291|9313056|P3|Overall Study|Physician Decision|0
2703935|NCT00382291|9313057|P2|Overall Study|Physician Decision|1
2703936|NCT00382291|9313058|P1|Overall Study|Physician Decision|0
2703937|NCT00382291|9313056|P3|Overall Study|Withdrawal by Subject|0
2703938|NCT00382291|9313057|P2|Overall Study|Withdrawal by Subject|2
2703939|NCT00382291|9313058|P1|Overall Study|Withdrawal by Subject|0
2703940|NCT00382291|9313056|P3|Overall Study|Temporary study suspension|5
2703941|NCT00382291|9313057|P2|Overall Study|Temporary study suspension|2
2703942|NCT00382291|9313058|P1|Overall Study|Temporary study suspension|2
2703943|NCT00382291|9313056|P3|Overall Study|Protocol Violation|0
2703944|NCT00382291|9313057|P2|Overall Study|Protocol Violation|0
2703945|NCT00382291|9313058|P1|Overall Study|Protocol Violation|1
2703946|NCT00382291|9313056|P3|Overall Study|Adverse Event|2
2703947|NCT00382291|9313057|P2|Overall Study|Adverse Event|2
2703948|NCT00382291|9313058|P1|Overall Study|Adverse Event|1
2703949|NCT00382174|9313090|P3|Overall Study|Wounds merged|2
2703950|NCT00382174|9313091|P2|Overall Study|Wounds merged|2
2703951|NCT00382174|9313092|P1|Overall Study|Wounds merged|0
2703952|NCT00382174|9313090|P3|Overall Study|Failed to meet criteria|1
2703953|NCT00382174|9313091|P2|Overall Study|Failed to meet criteria|1
2703954|NCT00382174|9313092|P1|Overall Study|Failed to meet criteria|0
2703955|NCT00382174|9313090|P3|Overall Study|Physician Decision|2
2703956|NCT00382174|9313091|P2|Overall Study|Physician Decision|2
2703957|NCT00382174|9313092|P1|Overall Study|Physician Decision|0
2703958|NCT00382174|9313090|P3|Overall Study|Non compliance|1
2703959|NCT00382174|9313091|P2|Overall Study|Non compliance|0
2703960|NCT00382174|9313092|P1|Overall Study|Non compliance|1
2703961|NCT00382174|9313090|P3|Overall Study|Withdrawal by Subject|5
2703962|NCT00382174|9313091|P2|Overall Study|Withdrawal by Subject|4
2703963|NCT00382174|9313092|P1|Overall Study|Withdrawal by Subject|1
2703964|NCT00382174|9313090|P3|Overall Study|Adverse Event|5
2703965|NCT00382174|9313091|P2|Overall Study|Adverse Event|4
2703966|NCT00382174|9313092|P1|Overall Study|Adverse Event|1
2703967|NCT00382174|9313090|P3|Overall Study|Lost to Follow-up|5
2703968|NCT00382174|9313091|P2|Overall Study|Lost to Follow-up|4
2703969|NCT00382174|9313092|P1|Overall Study|Lost to Follow-up|1
2703970|NCT00382109|9313120|P2|Overall Study|consent withdrawal|1
2703971|NCT00382109|9313121|P1|Overall Study|consent withdrawal|0
2703972|NCT00382109|9313120|P2|Overall Study|Other|2
2703973|NCT00382109|9313121|P1|Overall Study|Other|0
2703974|NCT00382109|9313120|P2|Overall Study|ineligible|0
2703975|NCT00382109|9313121|P1|Overall Study|ineligible|2
2703976|NCT00382109|9313120|P2|Overall Study|Withdrawal by Subject|0
2703977|NCT00382109|9313121|P1|Overall Study|Withdrawal by Subject|1
2703978|NCT00382109|9313120|P2|Overall Study|Physician Decision|1
2703979|NCT00382109|9313121|P1|Overall Study|Physician Decision|6
2703980|NCT00382109|9313120|P2|Overall Study|Adverse Event|0
2703981|NCT00382109|9313121|P1|Overall Study|Adverse Event|3
2703982|NCT00382018|9313160|P4|Overall Study|Other, not protocol specified|1
2703983|NCT00382018|9313161|P3|Overall Study|Other, not protocol specified|3
2703984|NCT00382018|9313162|P2|Overall Study|Other, not protocol specified|16
2703985|NCT00382018|9313163|P1|Overall Study|Other, not protocol specified|0
2703986|NCT00382018|9313160|P4|Overall Study|Withdrawal by Subject|4
2703987|NCT00382018|9313161|P3|Overall Study|Withdrawal by Subject|3
2703988|NCT00382018|9313162|P2|Overall Study|Withdrawal by Subject|4
2703989|NCT00382018|9313163|P1|Overall Study|Withdrawal by Subject|0
2703990|NCT00382018|9313160|P4|Overall Study|Death|11
2703991|NCT00382018|9313161|P3|Overall Study|Death|7
2703992|NCT00382018|9313162|P2|Overall Study|Death|9
2703993|NCT00382018|9313163|P1|Overall Study|Death|0
2703994|NCT00382018|9313160|P4|Overall Study|Progression|43
2703995|NCT00382018|9313161|P3|Overall Study|Progression|51
2703996|NCT00382018|9313162|P2|Overall Study|Progression|136
2703997|NCT00382018|9313163|P1|Overall Study|Progression|0
2703998|NCT00381940|9313186|P1|Overall Study|Ineligible|1
2703999|NCT00381940|9313186|P1|Overall Study|Protocol Violation|1
2704000|NCT00381940|9313186|P1|Overall Study|Lack of Efficacy|3
2704001|NCT00381888|9313190|P1|Overall Study|Adverse Event|1
2704002|NCT00381888|9313190|P1|Overall Study|Surgery was cancelled|2
2704003|NCT00381888|9313190|P1|Overall Study|Had laparoscopic surgery|2
2704004|NCT00381888|9313190|P1|Overall Study|Protocol Violation|9
2704005|NCT00381888|9313190|P1|Overall Study|Physician Decision|1
2704006|NCT00381888|9313190|P1|Overall Study|Withdrawal by Subject|1
2704007|NCT00381888|9313190|P1|Overall Study|Death|1
2704008|NCT00381849|9313201|P2|Wash Out|Withdrawal by Subject|1
2704009|NCT00381849|9313202|P1|Wash Out|Withdrawal by Subject|0
2704010|NCT00381797|9313229|P5|Overall Study|Ineligible|0
2704011|NCT00381797|9313230|P4|Overall Study|Ineligible|1
2704012|NCT00381797|9313231|P3|Overall Study|Ineligible|0
2704013|NCT00381797|9313232|P2|Overall Study|Ineligible|0
2704014|NCT00381797|9313233|P1|Overall Study|Ineligible|0
2704015|NCT00381797|9313229|P5|Overall Study|Withdrawal by Subject|2
2704016|NCT00381797|9313230|P4|Overall Study|Withdrawal by Subject|0
2704017|NCT00381797|9313231|P3|Overall Study|Withdrawal by Subject|0
2704018|NCT00381797|9313232|P2|Overall Study|Withdrawal by Subject|1
2704019|NCT00381797|9313233|P1|Overall Study|Withdrawal by Subject|1
2704020|NCT00381706|9313308|P3|Overall Study|Never treated|1
2704021|NCT00381706|9313309|P2|Overall Study|Never treated|2
2704022|NCT00381706|9313310|P1|Overall Study|Never treated|7
2704023|NCT00381693|9313333|P1|Overall Study|Progression|2
2704024|NCT00381693|9313333|P1|Overall Study|Patient Choice|1
2704025|NCT00381693|9313333|P1|Overall Study|Adverse Event|4
2704026|NCT00381693|9313333|P1|Overall Study|Death|1
2704027|NCT00381680|9313342|P2|Overall Study|Ineligible|1
2704028|NCT00381680|9313343|P1|Overall Study|Ineligible|3
2704029|NCT00381680|9313342|P2|Overall Study|Other not otherwise specified|2
2704030|NCT00381680|9313343|P1|Overall Study|Other not otherwise specified|7
2704031|NCT00381680|9313342|P2|Overall Study|Progression|1
2704032|NCT00381680|9313343|P1|Overall Study|Progression|1
2704033|NCT00381680|9313342|P2|Overall Study|Induction Failure|1
2704034|NCT00381680|9313343|P1|Overall Study|Induction Failure|4
2704035|NCT00381680|9313342|P2|Overall Study|Relapse|9
2704036|NCT00381680|9313343|P1|Overall Study|Relapse|18
2704037|NCT00381680|9313342|P2|Overall Study|Stem Cell Transplant|10
2704038|NCT00381680|9313343|P1|Overall Study|Stem Cell Transplant|26
2704039|NCT00381680|9313342|P2|Overall Study|Delay initiation|0
2704040|NCT00381680|9313343|P1|Overall Study|Delay initiation|1
2704041|NCT00381680|9313342|P2|Overall Study|Secondary Malignancy|0
2704042|NCT00381680|9313343|P1|Overall Study|Secondary Malignancy|3
2704043|NCT00381680|9313342|P2|Overall Study|Alternative Therapy|5
2704044|NCT00381680|9313343|P1|Overall Study|Alternative Therapy|11
2704045|NCT00381680|9313342|P2|Overall Study|Entry onto another COG Trial|2
2704046|NCT00381680|9313343|P1|Overall Study|Entry onto another COG Trial|1
2704047|NCT00381680|9313342|P2|Overall Study|Withdrawal by Subject|1
2704048|NCT00381680|9313343|P1|Overall Study|Withdrawal by Subject|3
2704049|NCT00381680|9313342|P2|Overall Study|Physician Decision|6
2704050|NCT00381680|9313343|P1|Overall Study|Physician Decision|25
2704051|NCT00381680|9313342|P2|Overall Study|Lost to Follow-up|2
2704052|NCT00381680|9313343|P1|Overall Study|Lost to Follow-up|3
2704053|NCT00381680|9313342|P2|Overall Study|Death|7
2704054|NCT00381680|9313343|P1|Overall Study|Death|10
2704055|NCT00381680|9313342|P2|Overall Study|Adverse Event|3
2704056|NCT00381680|9313343|P1|Overall Study|Adverse Event|9
2704057|NCT00381641|9313360|P2|Overall Study|Withdrawal by Subject|2
2704058|NCT00381641|9313361|P1|Overall Study|Withdrawal by Subject|0
2704059|NCT00381615|9313394|P4|Overall Study|Protocol Violation|0
2704060|NCT00381615|9313395|P3|Overall Study|Protocol Violation|1
2704061|NCT00381615|9313396|P2|Overall Study|Protocol Violation|0
2704062|NCT00381615|9313397|P1|Overall Study|Protocol Violation|0
2704063|NCT00381615|9313394|P4|Overall Study|Lost to Follow-up|1
2704064|NCT00381615|9313395|P3|Overall Study|Lost to Follow-up|0
2704065|NCT00381615|9313396|P2|Overall Study|Lost to Follow-up|2
2704066|NCT00381615|9313397|P1|Overall Study|Lost to Follow-up|3
2704067|NCT00381615|9313394|P4|Overall Study|Withdrawal by Subject|1
2704068|NCT00381615|9313395|P3|Overall Study|Withdrawal by Subject|0
2704069|NCT00381615|9313396|P2|Overall Study|Withdrawal by Subject|3
2704070|NCT00381615|9313397|P1|Overall Study|Withdrawal by Subject|1
2704071|NCT00381563|9313449|P2|Overall Study|Protocol Violation|1
2704072|NCT00381563|9313450|P1|Overall Study|Protocol Violation|0
2704073|NCT00381563|9313449|P2|Overall Study|Lost to Follow-up|0
2704074|NCT00381563|9313450|P1|Overall Study|Lost to Follow-up|2
2704075|NCT00381563|9313449|P2|Overall Study|Withdrawal by Subject|5
2704076|NCT00381563|9313450|P1|Overall Study|Withdrawal by Subject|5
2704077|NCT00381485|9313465|P4|Double-Blind Treatment Period|Administrative|1
2704078|NCT00381485|9313466|P3|Double-Blind Treatment Period|Administrative|0
2704079|NCT00381485|9313467|P2|Double-Blind Treatment Period|Administrative|1
2704080|NCT00381485|9313468|P1|Double-Blind Treatment Period|Administrative|0
2704081|NCT00381485|9313465|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1
2704082|NCT00381485|9313466|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
2704083|NCT00381485|9313467|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
2704084|NCT00381485|9313468|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
2704085|NCT00381485|9313465|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4
2704086|NCT00381485|9313466|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1
2704087|NCT00381485|9313467|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2
2704088|NCT00381485|9313468|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0
2704089|NCT00381485|9313465|P4|Double-Blind Treatment Period|Did not meet protocol eligibility|5
2704090|NCT00381485|9313466|P3|Double-Blind Treatment Period|Did not meet protocol eligibility|7
2704091|NCT00381485|9313467|P2|Double-Blind Treatment Period|Did not meet protocol eligibility|5
2704092|NCT00381485|9313468|P1|Double-Blind Treatment Period|Did not meet protocol eligibility|0
2704093|NCT00381485|9313465|P4|Double-Blind Treatment Period|Noncompliance with protocol|3
2704094|NCT00381485|9313466|P3|Double-Blind Treatment Period|Noncompliance with protocol|3
2704095|NCT00381485|9313467|P2|Double-Blind Treatment Period|Noncompliance with protocol|9
2704096|NCT00381485|9313468|P1|Double-Blind Treatment Period|Noncompliance with protocol|0
2704097|NCT00381485|9313465|P4|Double-Blind Treatment Period|Lost to Follow-up|1
2704098|NCT00381485|9313466|P3|Double-Blind Treatment Period|Lost to Follow-up|1
2704099|NCT00381485|9313467|P2|Double-Blind Treatment Period|Lost to Follow-up|0
2704100|NCT00381485|9313468|P1|Double-Blind Treatment Period|Lost to Follow-up|0
2704101|NCT00381485|9313465|P4|Double-Blind Treatment Period|Lack of Efficacy|13
2704102|NCT00381485|9313466|P3|Double-Blind Treatment Period|Lack of Efficacy|11
2704103|NCT00381485|9313467|P2|Double-Blind Treatment Period|Lack of Efficacy|8
2704104|NCT00381485|9313468|P1|Double-Blind Treatment Period|Lack of Efficacy|0
2704105|NCT00381485|9313465|P4|Double-Blind Treatment Period|Adverse Event|5
2704106|NCT00381485|9313466|P3|Double-Blind Treatment Period|Adverse Event|2
2704107|NCT00381485|9313467|P2|Double-Blind Treatment Period|Adverse Event|2
2704108|NCT00381485|9313468|P1|Double-Blind Treatment Period|Adverse Event|0
2704109|NCT00381485|9313465|P4|Open-Label Run-In Period|Treatment failure|0
2704110|NCT00381485|9313466|P3|Open-Label Run-In Period|Treatment failure|0
2704111|NCT00381485|9313467|P2|Open-Label Run-In Period|Treatment failure|0
2704112|NCT00381485|9313468|P1|Open-Label Run-In Period|Treatment failure|1
2704113|NCT00381485|9313465|P4|Open-Label Run-In Period|Lost to Follow-up|0
2704114|NCT00381485|9313466|P3|Open-Label Run-In Period|Lost to Follow-up|0
2704115|NCT00381485|9313467|P2|Open-Label Run-In Period|Lost to Follow-up|0
2704116|NCT00381485|9313468|P1|Open-Label Run-In Period|Lost to Follow-up|3
2704117|NCT00381485|9313465|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
2704118|NCT00381485|9313466|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
2704119|NCT00381485|9313467|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
2704120|NCT00381485|9313468|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1
2704121|NCT00381485|9313465|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
2704122|NCT00381485|9313466|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
2704123|NCT00381485|9313467|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
2704124|NCT00381485|9313468|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16
2704125|NCT00381485|9313465|P4|Open-Label Run-In Period|Did not meet protocol eligibility|0
2704126|NCT00381485|9313466|P3|Open-Label Run-In Period|Did not meet protocol eligibility|0
2704127|NCT00381485|9313467|P2|Open-Label Run-In Period|Did not meet protocol eligibility|0
2704128|NCT00381485|9313468|P1|Open-Label Run-In Period|Did not meet protocol eligibility|76
2704129|NCT00381485|9313465|P4|Open-Label Run-In Period|Adverse Event|0
2704130|NCT00381485|9313466|P3|Open-Label Run-In Period|Adverse Event|0
2704131|NCT00381485|9313467|P2|Open-Label Run-In Period|Adverse Event|0
2704132|NCT00381485|9313468|P1|Open-Label Run-In Period|Adverse Event|9
2704133|NCT00381381|9313486|P1|Overall Study|Withdrawal by Subject|9
2704134|NCT00381381|9313486|P1|Overall Study|Lost to Follow-up|52
2704135|NCT00381381|9313486|P1|Overall Study|Adverse Event|3
2704136|NCT00381303|9313495|P2|Overall Study|Subject primary physician's decision|0
2704137|NCT00381303|9313496|P1|Overall Study|Subject primary physician's decision|1
2704138|NCT00381303|9313495|P2|Overall Study|Subject did not continue visits|0
2704139|NCT00381303|9313496|P1|Overall Study|Subject did not continue visits|1
2704140|NCT00381303|9313495|P2|Overall Study|Subject was too busy for appointments|0
2704141|NCT00381303|9313496|P1|Overall Study|Subject was too busy for appointments|1
2704142|NCT00381303|9313495|P2|Overall Study|No virologic response by week 12|0
2704143|NCT00381303|9313496|P1|Overall Study|No virologic response by week 12|1
2704144|NCT00381303|9313495|P2|Overall Study|Subject taking too many different meds|0
2704145|NCT00381303|9313496|P1|Overall Study|Subject taking too many different meds|1
2704146|NCT00381303|9313495|P2|Overall Study|Subject moved out of state|0
2704147|NCT00381303|9313496|P1|Overall Study|Subject moved out of state|2
2704148|NCT00381303|9313495|P2|Overall Study|Physician's decision to close the site|1
2704149|NCT00381303|9313496|P1|Overall Study|Physician's decision to close the site|3
2704150|NCT00381303|9313495|P2|Overall Study|Physician Decision|0
2704151|NCT00381303|9313496|P1|Overall Study|Physician Decision|1
2704152|NCT00381303|9313495|P2|Overall Study|Pregnancy|0
2704153|NCT00381303|9313496|P1|Overall Study|Pregnancy|2
2704154|NCT00381303|9313495|P2|Overall Study|Ineligible to continue the trial|1
2704155|NCT00381303|9313496|P1|Overall Study|Ineligible to continue the trial|2
2704156|NCT00381303|9313495|P2|Overall Study|Virologic failure|4
2704157|NCT00381303|9313496|P1|Overall Study|Virologic failure|6
2704158|NCT00381303|9313495|P2|Overall Study|Withdrawal by Subject|6
2704159|NCT00381303|9313496|P1|Overall Study|Withdrawal by Subject|13
2704160|NCT00381303|9313495|P2|Overall Study|Non-Adherence|6
2704161|NCT00381303|9313496|P1|Overall Study|Non-Adherence|13
2704162|NCT00381303|9313495|P2|Overall Study|AE/HIV-related event|6
2704163|NCT00381303|9313496|P1|Overall Study|AE/HIV-related event|22
2704164|NCT00381303|9313495|P2|Overall Study|Lost to Follow-up|9
2704165|NCT00381303|9313496|P1|Overall Study|Lost to Follow-up|25
2704166|NCT00381238|9313556|P1|Overall Study|Disease progression|1
2704167|NCT00381238|9313556|P1|Overall Study|Withdrew by physician|1
2704168|NCT00381238|9313556|P1|Overall Study|Lack of Efficacy|2
2704169|NCT00381238|9313556|P1|Overall Study|Withdrawal by Subject|4
2704170|NCT00381238|9313556|P1|Overall Study|Protocol Violation|1
2704171|NCT00381238|9313556|P1|Overall Study|Adverse Event|3
2704172|NCT00381095|9313572|P2|Overall Study|Adverse Event|7
2704173|NCT00381095|9313573|P1|Overall Study|Adverse Event|2
2704174|NCT00381095|9313572|P2|Overall Study|Withdrawal by Subject|3
2704175|NCT00381095|9313573|P1|Overall Study|Withdrawal by Subject|3
2704176|NCT00381095|9313572|P2|Overall Study|Protocol Violation|1
2704177|NCT00381095|9313573|P1|Overall Study|Protocol Violation|1
2704178|NCT00381095|9313572|P2|Overall Study|Other|2
2704179|NCT00381095|9313573|P1|Overall Study|Other|2
2704180|NCT00381095|9313572|P2|Overall Study|Lack of Efficacy|4
2704181|NCT00381095|9313573|P1|Overall Study|Lack of Efficacy|2
2704182|NCT00381095|9313572|P2|Overall Study|Death|4
2704183|NCT00381095|9313573|P1|Overall Study|Death|3
2704184|NCT00381043|9313605|P2|Overall Study|incarcerated|0
2704185|NCT00381043|9313606|P1|Overall Study|incarcerated|1
2704186|NCT00381043|9313605|P2|Overall Study|wanted more care|1
2704187|NCT00381043|9313606|P1|Overall Study|wanted more care|0
2704188|NCT00381043|9313605|P2|Overall Study|Withdrawal by Subject|1
2704189|NCT00381043|9313606|P1|Overall Study|Withdrawal by Subject|3
2704190|NCT00381043|9313605|P2|Overall Study|Lost to Follow-up|6
2704191|NCT00381043|9313606|P1|Overall Study|Lost to Follow-up|8
2704192|NCT00380978|9313632|P2|Overall Study|Parous patient|0
2704193|NCT00380978|9313633|P1|Overall Study|Parous patient|1
2704194|NCT00380978|9313632|P2|Overall Study|Allocation prior to analgesia request|2
2704195|NCT00380978|9313633|P1|Overall Study|Allocation prior to analgesia request|1
2704196|NCT00380978|9313632|P2|Overall Study|Wrong study envelope|2
2704197|NCT00380978|9313633|P1|Overall Study|Wrong study envelope|0
2704198|NCT00380978|9313632|P2|Overall Study|Refused allocated intervention|6
2704199|NCT00380978|9313633|P1|Overall Study|Refused allocated intervention|0
2704200|NCT00380874|9313655|P2|Overall Study|Not related to study drug|2
2704201|NCT00380874|9313656|P1|Overall Study|Not related to study drug|3
2704202|NCT00380874|9313655|P2|Overall Study|Withdrawal by Subject|1
2704203|NCT00380874|9313656|P1|Overall Study|Withdrawal by Subject|2
2704204|NCT00380874|9313655|P2|Overall Study|Death|0
2704205|NCT00380874|9313656|P1|Overall Study|Death|1
2704206|NCT00380874|9313655|P2|Overall Study|Adverse Event|7
2704207|NCT00380874|9313656|P1|Overall Study|Adverse Event|7
2704208|NCT00380744|9313688|P7|Overall Study|Withdrawal by Subject|0
2704209|NCT00380744|9313689|P6|Overall Study|Withdrawal by Subject|0
2704210|NCT00380744|9313690|P5|Overall Study|Withdrawal by Subject|0
2704211|NCT00380744|9313691|P4|Overall Study|Withdrawal by Subject|0
2704212|NCT00380744|9313692|P3|Overall Study|Withdrawal by Subject|0
2704213|NCT00380744|9313693|P2|Overall Study|Withdrawal by Subject|0
2704214|NCT00380744|9313694|P1|Overall Study|Withdrawal by Subject|1
2704215|NCT00380744|9313688|P7|Overall Study|Death|1
2704216|NCT00380744|9313689|P6|Overall Study|Death|0
2704217|NCT00380744|9313690|P5|Overall Study|Death|0
2704218|NCT00380744|9313691|P4|Overall Study|Death|0
2704219|NCT00380744|9313692|P3|Overall Study|Death|0
2704220|NCT00380744|9313693|P2|Overall Study|Death|0
2704221|NCT00380744|9313694|P1|Overall Study|Death|0
2704222|NCT00380718|9313744|P1|Overall Study|Death after 30-day post-therapy followup|17
2704223|NCT00380718|9313744|P1|Overall Study|Adverse Event|1
2704224|NCT00380692|9313756|P2|Study Period III - Open Label|Parent/Caregiver Decision|1
2704225|NCT00380692|9313757|P1|Study Period III - Open Label|Parent/Caregiver Decision|1
2704226|NCT00380692|9313756|P2|Study Period III - Open Label|Lack of Efficacy|4
2704227|NCT00380692|9313757|P1|Study Period III - Open Label|Lack of Efficacy|0
2704228|NCT00380692|9313756|P2|Study Period III - Open Label|Physician Decision|3
2704229|NCT00380692|9313757|P1|Study Period III - Open Label|Physician Decision|0
2704230|NCT00380692|9313756|P2|Study Period III - Open Label|Withdrawal by Subject|1
2704231|NCT00380692|9313757|P1|Study Period III - Open Label|Withdrawal by Subject|0
2704232|NCT00380692|9313756|P2|Study Period III - Open Label|Protocol Violation|0
2704233|NCT00380692|9313757|P1|Study Period III - Open Label|Protocol Violation|0
2704234|NCT00380692|9313756|P2|Study Period III - Open Label|Adverse Event|3
2704235|NCT00380692|9313757|P1|Study Period III - Open Label|Adverse Event|5
2704236|NCT00380692|9313756|P2|Study Period II - Double Blind|Parent/Caregiver Decision|0
2704237|NCT00380692|9313757|P1|Study Period II - Double Blind|Parent/Caregiver Decision|1
2704238|NCT00380692|9313756|P2|Study Period II - Double Blind|Lack of Efficacy|0
2704239|NCT00380692|9313757|P1|Study Period II - Double Blind|Lack of Efficacy|1
2704240|NCT00380692|9313756|P2|Study Period II - Double Blind|Physician Decision|1
2704241|NCT00380692|9313757|P1|Study Period II - Double Blind|Physician Decision|0
2704242|NCT00380692|9313756|P2|Study Period II - Double Blind|Withdrawal by Subject|0
2704243|NCT00380692|9313757|P1|Study Period II - Double Blind|Withdrawal by Subject|0
2704244|NCT00380692|9313756|P2|Study Period II - Double Blind|Protocol Violation|2
2704245|NCT00380692|9313757|P1|Study Period II - Double Blind|Protocol Violation|2
2704246|NCT00380692|9313756|P2|Study Period II - Double Blind|Adverse Event|0
2704247|NCT00380692|9313757|P1|Study Period II - Double Blind|Adverse Event|1
2704248|NCT00380588|9313805|P2|Overall Study|Physician Decision|0
2704249|NCT00380588|9313806|P1|Overall Study|Physician Decision|2
2704250|NCT00380588|9313805|P2|Overall Study|Withdrawal by Subject|3
2704251|NCT00380588|9313806|P1|Overall Study|Withdrawal by Subject|1
2704252|NCT00380588|9313805|P2|Overall Study|Adverse Event|3
2704253|NCT00380588|9313806|P1|Overall Study|Adverse Event|7
2704254|NCT00380588|9313805|P2|Overall Study|Next Cycle Not Started|0
2704255|NCT00380588|9313806|P1|Overall Study|Next Cycle Not Started|4
2704256|NCT00380588|9313805|P2|Overall Study|Unequivocal Disease Progression|34
2704257|NCT00380588|9313806|P1|Overall Study|Unequivocal Disease Progression|25
2704258|NCT00380393|9313820|P2|Month 14|Others|6
2704259|NCT00380393|9313821|P1|Month 14|Others|6
2704260|NCT00380393|9313820|P2|Month 14|Protocol Violation|0
2704261|NCT00380393|9313821|P1|Month 14|Protocol Violation|2
2704262|NCT00380393|9313820|P2|Month 14|Migrated/moved from study area|42
2704263|NCT00380393|9313821|P1|Month 14|Migrated/moved from study area|39
2704264|NCT00380393|9313820|P2|Month 14|Lost to Follow-up|1
2704265|NCT00380393|9313821|P1|Month 14|Lost to Follow-up|0
2704266|NCT00380393|9313820|P2|Month 14|Death|0
2704267|NCT00380393|9313821|P1|Month 14|Death|1
2704268|NCT00380393|9313820|P2|Month 14|Withdrawal by Subject|7
2704269|NCT00380393|9313821|P1|Month 14|Withdrawal by Subject|9
2704270|NCT00380393|9313820|P2|Month 8 (Cross-sectional Visit)|Others|4
2704271|NCT00380393|9313821|P1|Month 8 (Cross-sectional Visit)|Others|5
2704272|NCT00380393|9313820|P2|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
2704273|NCT00380393|9313821|P1|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
2704274|NCT00380393|9313820|P2|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29
2704275|NCT00380393|9313821|P1|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37
2704276|NCT00380393|9313820|P2|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1
2704277|NCT00380393|9313821|P1|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0
2704278|NCT00380393|9313820|P2|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5
2704279|NCT00380393|9313821|P1|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6
2704280|NCT00380367|9313869|P1|Overall Study|Withdrawal by Subject|1
2704281|NCT00380367|9313869|P1|Overall Study|Lost to Follow-up|1
2704282|NCT00380250|9313876|P2|Overall Study|Physician Decision|0
2704283|NCT00380250|9313877|P1|Overall Study|Physician Decision|1
2704284|NCT00380250|9313876|P2|Overall Study|Lost to Follow-up|5
2704285|NCT00380250|9313877|P1|Overall Study|Lost to Follow-up|14
2704286|NCT00380250|9313876|P2|Overall Study|Protocol Violation|5
2704287|NCT00380250|9313877|P1|Overall Study|Protocol Violation|15
2704288|NCT00380250|9313876|P2|Overall Study|Lack of Efficacy|8
2704289|NCT00380250|9313877|P1|Overall Study|Lack of Efficacy|10
2704290|NCT00380250|9313876|P2|Overall Study|Adverse Event|9
2704291|NCT00380250|9313877|P1|Overall Study|Adverse Event|20
2704292|NCT00380250|9313876|P2|Overall Study|Withdrawal by Subject|28
2704293|NCT00380250|9313877|P1|Overall Study|Withdrawal by Subject|39
2704294|NCT00380081|9313945|P6|Overall Study|Family Emergency|1
2704295|NCT00380081|9313946|P5|Overall Study|Family Emergency|0
2704296|NCT00380081|9313947|P4|Overall Study|Family Emergency|0
2704297|NCT00380081|9313948|P3|Overall Study|Family Emergency|0
2704298|NCT00380081|9313949|P2|Overall Study|Family Emergency|0
2704299|NCT00380081|9313950|P1|Overall Study|Family Emergency|0
2704300|NCT00380081|9313945|P6|Overall Study|Withdrawal by Subject|0
2704301|NCT00380081|9313946|P5|Overall Study|Withdrawal by Subject|1
2704302|NCT00380081|9313947|P4|Overall Study|Withdrawal by Subject|0
2704303|NCT00380081|9313948|P3|Overall Study|Withdrawal by Subject|0
2704304|NCT00380081|9313949|P2|Overall Study|Withdrawal by Subject|0
2704305|NCT00380081|9313950|P1|Overall Study|Withdrawal by Subject|0
2704306|NCT00380068|9314000|P1|Overall Study|Lack of Efficacy|5
2704307|NCT00380068|9314000|P1|Overall Study|Partipant moved away|1
2704308|NCT00380068|9314000|P1|Overall Study|Physician Decision|2
2704309|NCT00380068|9314000|P1|Overall Study|Lung transplant|3
2704310|NCT00380068|9314000|P1|Overall Study|Addition of other PAH therapeutic agent|1
2704311|NCT00380068|9314000|P1|Overall Study|Lost to Follow-up|1
2704312|NCT00380068|9314000|P1|Overall Study|Not compliant|6
2704313|NCT00380068|9314000|P1|Overall Study|Withdrawal by Subject|10
2704314|NCT00380068|9314000|P1|Overall Study|Adverse Event|40
2704315|NCT00379912|9314032|P2|Overall Study|Lack of Efficacy|0
2704316|NCT00379912|9314033|P1|Overall Study|Lack of Efficacy|1
2704317|NCT00379899|9314055|P2|Overall Study|Other|1
2704318|NCT00379899|9314056|P1|Overall Study|Other|3
2704319|NCT00379899|9314055|P2|Overall Study|Other protocol-specified criteria|4
2704320|NCT00379899|9314056|P1|Overall Study|Other protocol-specified criteria|3
2704321|NCT00379899|9314055|P2|Overall Study|Coronary artery bypass graft|1
2704322|NCT00379899|9314056|P1|Overall Study|Coronary artery bypass graft|1
2704323|NCT00379899|9314055|P2|Overall Study|Renal transplantation|4
2704324|NCT00379899|9314056|P1|Overall Study|Renal transplantation|5
2704325|NCT00379899|9314055|P2|Overall Study|Parathyroidectomy|2
2704326|NCT00379899|9314056|P1|Overall Study|Parathyroidectomy|0
2704327|NCT00379899|9314055|P2|Overall Study|Noncompliance|1
2704328|NCT00379899|9314056|P1|Overall Study|Noncompliance|1
2704329|NCT00379899|9314055|P2|Overall Study|Ineligibility determined|1
2704330|NCT00379899|9314056|P1|Overall Study|Ineligibility determined|0
2704331|NCT00379899|9314055|P2|Overall Study|Withdrawal by Subject|5
2704332|NCT00379899|9314056|P1|Overall Study|Withdrawal by Subject|5
2704333|NCT00379899|9314055|P2|Overall Study|Physician Decision|4
2704334|NCT00379899|9314056|P1|Overall Study|Physician Decision|3
2704335|NCT00379899|9314055|P2|Overall Study|Lost to Follow-up|4
2704336|NCT00379899|9314056|P1|Overall Study|Lost to Follow-up|2
2704337|NCT00379899|9314055|P2|Overall Study|Death|10
2704338|NCT00379899|9314056|P1|Overall Study|Death|10
2704339|NCT00379899|9314055|P2|Overall Study|Adverse Event|3
2704340|NCT00379899|9314056|P1|Overall Study|Adverse Event|7
2704341|NCT00379834|9314084|P1|Overall Study|Time constraints|2
2704342|NCT00379808|9314236|P2|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1
2704343|NCT00379808|9314237|P1|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0
2704344|NCT00379795|9314258|P5|Overall Study|Sponsor's decision|10
2704345|NCT00379795|9314259|P4|Overall Study|Sponsor's decision|47
2704346|NCT00379795|9314260|P3|Overall Study|Sponsor's decision|54
2704347|NCT00379795|9314261|P2|Overall Study|Sponsor's decision|17
2704348|NCT00379795|9314262|P1|Overall Study|Sponsor's decision|257
2704349|NCT00379795|9314258|P5|Overall Study|Subjects condition mandated intervention|7
2704350|NCT00379795|9314259|P4|Overall Study|Subjects condition mandated intervention|5
2704351|NCT00379795|9314260|P3|Overall Study|Subjects condition mandated intervention|7
2704352|NCT00379795|9314261|P2|Overall Study|Subjects condition mandated intervention|9
2704353|NCT00379795|9314262|P1|Overall Study|Subjects condition mandated intervention|34
2704354|NCT00379795|9314258|P5|Overall Study|Verteporfin photodynamic therapy in eye|0
2704355|NCT00379795|9314259|P4|Overall Study|Verteporfin photodynamic therapy in eye|1
2704356|NCT00379795|9314260|P3|Overall Study|Verteporfin photodynamic therapy in eye|0
2704357|NCT00379795|9314261|P2|Overall Study|Verteporfin photodynamic therapy in eye|0
2704358|NCT00379795|9314262|P1|Overall Study|Verteporfin photodynamic therapy in eye|3
2704359|NCT00379795|9314258|P5|Overall Study|Subject non-compliance|1
2704360|NCT00379795|9314259|P4|Overall Study|Subject non-compliance|0
2704361|NCT00379795|9314260|P3|Overall Study|Subject non-compliance|0
2704362|NCT00379795|9314261|P2|Overall Study|Subject non-compliance|2
2704363|NCT00379795|9314262|P1|Overall Study|Subject non-compliance|7
2704364|NCT00379795|9314258|P5|Overall Study|Withdrawal by Subject|14
2704365|NCT00379795|9314259|P4|Overall Study|Withdrawal by Subject|7
2704366|NCT00379795|9314260|P3|Overall Study|Withdrawal by Subject|19
2704367|NCT00379795|9314261|P2|Overall Study|Withdrawal by Subject|11
2704368|NCT00379795|9314262|P1|Overall Study|Withdrawal by Subject|94
2704369|NCT00379795|9314258|P5|Overall Study|Physician Decision|2
2704370|NCT00379795|9314259|P4|Overall Study|Physician Decision|2
2704371|NCT00379795|9314260|P3|Overall Study|Physician Decision|2
2704372|NCT00379795|9314261|P2|Overall Study|Physician Decision|0
2704373|NCT00379795|9314262|P1|Overall Study|Physician Decision|25
2704374|NCT00379795|9314258|P5|Overall Study|Lost to Follow-up|4
2704375|NCT00379795|9314259|P4|Overall Study|Lost to Follow-up|1
2704376|NCT00379795|9314260|P3|Overall Study|Lost to Follow-up|2
2704377|NCT00379795|9314261|P2|Overall Study|Lost to Follow-up|1
2704378|NCT00379795|9314262|P1|Overall Study|Lost to Follow-up|8
2704379|NCT00379795|9314258|P5|Overall Study|Adverse Event|4
2704380|NCT00379795|9314259|P4|Overall Study|Adverse Event|1
2704381|NCT00379795|9314260|P3|Overall Study|Adverse Event|3
2704382|NCT00379795|9314261|P2|Overall Study|Adverse Event|3
2704383|NCT00379795|9314262|P1|Overall Study|Adverse Event|17
2704384|NCT00379795|9314258|P5|Overall Study|Death|7
2704385|NCT00379795|9314259|P4|Overall Study|Death|4
2704386|NCT00379795|9314260|P3|Overall Study|Death|6
2704387|NCT00379795|9314261|P2|Overall Study|Death|8
2704388|NCT00379795|9314262|P1|Overall Study|Death|31
2704389|NCT00379769|9314292|P6|Observational Follow-up|Unknown; Reason Not Provided|1
2704390|NCT00379769|9314293|P5|Observational Follow-up|Unknown; Reason Not Provided|1
2704391|NCT00379769|9314294|P4|Observational Follow-up|Unknown; Reason Not Provided|0
2704392|NCT00379769|9314295|P3|Observational Follow-up|Unknown; Reason Not Provided|0
2704393|NCT00379769|9314296|P2|Observational Follow-up|Unknown; Reason Not Provided|0
2704394|NCT00379769|9314297|P1|Observational Follow-up|Unknown; Reason Not Provided|0
2704395|NCT00379769|9314292|P6|Observational Follow-up|Participant Moved|1
2704396|NCT00379769|9314293|P5|Observational Follow-up|Participant Moved|0
2704397|NCT00379769|9314294|P4|Observational Follow-up|Participant Moved|0
2704398|NCT00379769|9314295|P3|Observational Follow-up|Participant Moved|0
2704399|NCT00379769|9314296|P2|Observational Follow-up|Participant Moved|0
2704400|NCT00379769|9314297|P1|Observational Follow-up|Participant Moved|0
2704401|NCT00379769|9314292|P6|Observational Follow-up|Site Closed Early|7
2704402|NCT00379769|9314293|P5|Observational Follow-up|Site Closed Early|6
2704403|NCT00379769|9314294|P4|Observational Follow-up|Site Closed Early|0
2704404|NCT00379769|9314295|P3|Observational Follow-up|Site Closed Early|0
2704405|NCT00379769|9314296|P2|Observational Follow-up|Site Closed Early|0
2704406|NCT00379769|9314297|P1|Observational Follow-up|Site Closed Early|0
2704407|NCT00379769|9314292|P6|Observational Follow-up|Physician Decision|8
2704408|NCT00379769|9314293|P5|Observational Follow-up|Physician Decision|8
2704409|NCT00379769|9314294|P4|Observational Follow-up|Physician Decision|0
2704410|NCT00379769|9314295|P3|Observational Follow-up|Physician Decision|0
2704411|NCT00379769|9314296|P2|Observational Follow-up|Physician Decision|0
2704412|NCT00379769|9314297|P1|Observational Follow-up|Physician Decision|0
2704413|NCT00379769|9314292|P6|Observational Follow-up|Entered into Another Clinical Trial|22
2704414|NCT00379769|9314293|P5|Observational Follow-up|Entered into Another Clinical Trial|18
2704415|NCT00379769|9314294|P4|Observational Follow-up|Entered into Another Clinical Trial|0
2704416|NCT00379769|9314295|P3|Observational Follow-up|Entered into Another Clinical Trial|0
2704417|NCT00379769|9314296|P2|Observational Follow-up|Entered into Another Clinical Trial|0
2704418|NCT00379769|9314297|P1|Observational Follow-up|Entered into Another Clinical Trial|0
2704419|NCT00379769|9314292|P6|Observational Follow-up|Withdrawal by Subject|12
2704420|NCT00379769|9314293|P5|Observational Follow-up|Withdrawal by Subject|12
2704421|NCT00379769|9314294|P4|Observational Follow-up|Withdrawal by Subject|0
2704422|NCT00379769|9314295|P3|Observational Follow-up|Withdrawal by Subject|0
2704423|NCT00379769|9314296|P2|Observational Follow-up|Withdrawal by Subject|0
2704424|NCT00379769|9314297|P1|Observational Follow-up|Withdrawal by Subject|0
2704425|NCT00379769|9314292|P6|Observational Follow-up|Lost to Follow-up|27
2704426|NCT00379769|9314293|P5|Observational Follow-up|Lost to Follow-up|25
2704427|NCT00379769|9314294|P4|Observational Follow-up|Lost to Follow-up|0
2704428|NCT00379769|9314295|P3|Observational Follow-up|Lost to Follow-up|0
2704429|NCT00379769|9314296|P2|Observational Follow-up|Lost to Follow-up|0
2704430|NCT00379769|9314297|P1|Observational Follow-up|Lost to Follow-up|0
2704431|NCT00379769|9314292|P6|Observational Follow-up|Adverse Event|0
2704432|NCT00379769|9314293|P5|Observational Follow-up|Adverse Event|1
2704433|NCT00379769|9314294|P4|Observational Follow-up|Adverse Event|0
2704434|NCT00379769|9314295|P3|Observational Follow-up|Adverse Event|0
2704435|NCT00379769|9314296|P2|Observational Follow-up|Adverse Event|0
2704436|NCT00379769|9314297|P1|Observational Follow-up|Adverse Event|0
2704437|NCT00379769|9314292|P6|Observational Follow-up|Death|70
2704438|NCT00379769|9314293|P5|Observational Follow-up|Death|78
2704439|NCT00379769|9314294|P4|Observational Follow-up|Death|0
2704440|NCT00379769|9314295|P3|Observational Follow-up|Death|0
2704441|NCT00379769|9314296|P2|Observational Follow-up|Death|0
2704442|NCT00379769|9314297|P1|Observational Follow-up|Death|0
2704443|NCT00379769|9314292|P6|Main Study|Reason unspecified|0
2704444|NCT00379769|9314293|P5|Main Study|Reason unspecified|0
2704445|NCT00379769|9314294|P4|Main Study|Reason unspecified|0
2704446|NCT00379769|9314295|P3|Main Study|Reason unspecified|1
2704447|NCT00379769|9314296|P2|Main Study|Reason unspecified|0
2704448|NCT00379769|9314297|P1|Main Study|Reason unspecified|0
2704449|NCT00379769|9314292|P6|Main Study|Investigator refused to log temperature|0
2704450|NCT00379769|9314293|P5|Main Study|Investigator refused to log temperature|0
2704451|NCT00379769|9314294|P4|Main Study|Investigator refused to log temperature|0
2704452|NCT00379769|9314295|P3|Main Study|Investigator refused to log temperature|1
2704453|NCT00379769|9314296|P2|Main Study|Investigator refused to log temperature|0
2704454|NCT00379769|9314297|P1|Main Study|Investigator refused to log temperature|0
2704455|NCT00379769|9314292|P6|Main Study|Risk of heart failure|0
2704456|NCT00379769|9314293|P5|Main Study|Risk of heart failure|0
2704457|NCT00379769|9314294|P4|Main Study|Risk of heart failure|0
2704458|NCT00379769|9314295|P3|Main Study|Risk of heart failure|0
2704459|NCT00379769|9314296|P2|Main Study|Risk of heart failure|1
2704460|NCT00379769|9314297|P1|Main Study|Risk of heart failure|0
2704461|NCT00379769|9314292|P6|Main Study|Personal reasons|0
2704462|NCT00379769|9314293|P5|Main Study|Personal reasons|0
2704463|NCT00379769|9314294|P4|Main Study|Personal reasons|0
2704464|NCT00379769|9314295|P3|Main Study|Personal reasons|0
2704465|NCT00379769|9314296|P2|Main Study|Personal reasons|0
2704466|NCT00379769|9314297|P1|Main Study|Personal reasons|1
2704467|NCT00379769|9314292|P6|Main Study|Participant completed study at visit 27|0
2704468|NCT00379769|9314293|P5|Main Study|Participant completed study at visit 27|0
2704469|NCT00379769|9314294|P4|Main Study|Participant completed study at visit 27|0
2704470|NCT00379769|9314295|P3|Main Study|Participant completed study at visit 27|0
2704471|NCT00379769|9314296|P2|Main Study|Participant completed study at visit 27|0
2704472|NCT00379769|9314297|P1|Main Study|Participant completed study at visit 27|1
2704473|NCT00379769|9314292|P6|Main Study|Physician Decision|0
2704474|NCT00379769|9314293|P5|Main Study|Physician Decision|0
2704475|NCT00379769|9314294|P4|Main Study|Physician Decision|1
2704476|NCT00379769|9314295|P3|Main Study|Physician Decision|1
2704477|NCT00379769|9314296|P2|Main Study|Physician Decision|2
2704478|NCT00379769|9314297|P1|Main Study|Physician Decision|2
2704479|NCT00379769|9314292|P6|Main Study|Participant did not take study drug|0
2704480|NCT00379769|9314293|P5|Main Study|Participant did not take study drug|0
2704481|NCT00379769|9314294|P4|Main Study|Participant did not take study drug|0
2704482|NCT00379769|9314295|P3|Main Study|Participant did not take study drug|1
2704483|NCT00379769|9314296|P2|Main Study|Participant did not take study drug|0
2704484|NCT00379769|9314297|P1|Main Study|Participant did not take study drug|0
2704485|NCT00379769|9314292|P6|Main Study|Entry criteria violation|0
2704486|NCT00379769|9314293|P5|Main Study|Entry criteria violation|0
2704487|NCT00379769|9314294|P4|Main Study|Entry criteria violation|1
2704488|NCT00379769|9314295|P3|Main Study|Entry criteria violation|1
2704489|NCT00379769|9314296|P2|Main Study|Entry criteria violation|0
2704490|NCT00379769|9314297|P1|Main Study|Entry criteria violation|0
2704491|NCT00379769|9314292|P6|Main Study|Site closed|0
2704492|NCT00379769|9314293|P5|Main Study|Site closed|0
2704493|NCT00379769|9314294|P4|Main Study|Site closed|8
2704494|NCT00379769|9314295|P3|Main Study|Site closed|4
2704495|NCT00379769|9314296|P2|Main Study|Site closed|4
2704496|NCT00379769|9314297|P1|Main Study|Site closed|4
2704497|NCT00379769|9314292|P6|Main Study|Prohibited glucose lowering medication|0
2704498|NCT00379769|9314293|P5|Main Study|Prohibited glucose lowering medication|0
2704499|NCT00379769|9314294|P4|Main Study|Prohibited glucose lowering medication|1
2704500|NCT00379769|9314295|P3|Main Study|Prohibited glucose lowering medication|0
2704501|NCT00379769|9314296|P2|Main Study|Prohibited glucose lowering medication|3
2704502|NCT00379769|9314297|P1|Main Study|Prohibited glucose lowering medication|0
2704503|NCT00379769|9314292|P6|Main Study|Poor compliance|0
2704504|NCT00379769|9314293|P5|Main Study|Poor compliance|0
2704505|NCT00379769|9314294|P4|Main Study|Poor compliance|1
2704506|NCT00379769|9314295|P3|Main Study|Poor compliance|2
2704507|NCT00379769|9314296|P2|Main Study|Poor compliance|2
2704508|NCT00379769|9314297|P1|Main Study|Poor compliance|3
2704509|NCT00379769|9314292|P6|Main Study|Participant moved|0
2704510|NCT00379769|9314293|P5|Main Study|Participant moved|0
2704511|NCT00379769|9314294|P4|Main Study|Participant moved|3
2704512|NCT00379769|9314295|P3|Main Study|Participant moved|3
2704513|NCT00379769|9314296|P2|Main Study|Participant moved|2
2704514|NCT00379769|9314297|P1|Main Study|Participant moved|3
2704515|NCT00379769|9314292|P6|Main Study|Moved to survival status follow-up only|0
2704516|NCT00379769|9314293|P5|Main Study|Moved to survival status follow-up only|0
2704517|NCT00379769|9314294|P4|Main Study|Moved to survival status follow-up only|36
2704518|NCT00379769|9314295|P3|Main Study|Moved to survival status follow-up only|32
2704519|NCT00379769|9314296|P2|Main Study|Moved to survival status follow-up only|25
2704520|NCT00379769|9314297|P1|Main Study|Moved to survival status follow-up only|27
2704521|NCT00379769|9314292|P6|Main Study|Withdrawal by Subject|0
2704522|NCT00379769|9314293|P5|Main Study|Withdrawal by Subject|0
2704523|NCT00379769|9314294|P4|Main Study|Withdrawal by Subject|70
2704524|NCT00379769|9314295|P3|Main Study|Withdrawal by Subject|72
2704525|NCT00379769|9314296|P2|Main Study|Withdrawal by Subject|56
2704526|NCT00379769|9314297|P1|Main Study|Withdrawal by Subject|46
2704527|NCT00379769|9314292|P6|Main Study|Lost to Follow-up|0
2704528|NCT00379769|9314293|P5|Main Study|Lost to Follow-up|0
2704529|NCT00379769|9314294|P4|Main Study|Lost to Follow-up|26
2704530|NCT00379769|9314295|P3|Main Study|Lost to Follow-up|25
2704531|NCT00379769|9314296|P2|Main Study|Lost to Follow-up|29
2704532|NCT00379769|9314297|P1|Main Study|Lost to Follow-up|29
2704533|NCT00379769|9314292|P6|Main Study|Adverse Event|0
2704534|NCT00379769|9314293|P5|Main Study|Adverse Event|0
2704535|NCT00379769|9314294|P4|Main Study|Adverse Event|11
2704536|NCT00379769|9314295|P3|Main Study|Adverse Event|10
2704537|NCT00379769|9314296|P2|Main Study|Adverse Event|8
2704538|NCT00379769|9314297|P1|Main Study|Adverse Event|5
2704539|NCT00379769|9314292|P6|Main Study|Death|0
2704540|NCT00379769|9314293|P5|Main Study|Death|0
2704541|NCT00379769|9314294|P4|Main Study|Death|72
2704542|NCT00379769|9314295|P3|Main Study|Death|54
2704543|NCT00379769|9314296|P2|Main Study|Death|67
2704544|NCT00379769|9314297|P1|Main Study|Death|57
2704545|NCT00379639|9314456|P5|Overall Study|Other|0
2704546|NCT00379639|9314457|P4|Overall Study|Other|0
2704547|NCT00379639|9314458|P3|Overall Study|Other|3
2704548|NCT00379639|9314459|P2|Overall Study|Other|0
2704549|NCT00379639|9314460|P1|Overall Study|Other|0
2704550|NCT00379639|9314456|P5|Overall Study|Lost to Follow-up|0
2704551|NCT00379639|9314457|P4|Overall Study|Lost to Follow-up|1
2704552|NCT00379639|9314458|P3|Overall Study|Lost to Follow-up|0
2704553|NCT00379639|9314459|P2|Overall Study|Lost to Follow-up|0
2704554|NCT00379639|9314460|P1|Overall Study|Lost to Follow-up|0
2704555|NCT00379639|9314456|P5|Overall Study|Adverse Event|1
2704556|NCT00379639|9314457|P4|Overall Study|Adverse Event|0
2704557|NCT00379639|9314458|P3|Overall Study|Adverse Event|1
2704558|NCT00379639|9314459|P2|Overall Study|Adverse Event|0
2704559|NCT00379639|9314460|P1|Overall Study|Adverse Event|0
2704560|NCT00379639|9314456|P5|Overall Study|Symptomatic Deterioration|1
2704561|NCT00379639|9314457|P4|Overall Study|Symptomatic Deterioration|0
2704562|NCT00379639|9314458|P3|Overall Study|Symptomatic Deterioration|1
2704563|NCT00379639|9314459|P2|Overall Study|Symptomatic Deterioration|0
2704564|NCT00379639|9314460|P1|Overall Study|Symptomatic Deterioration|0
2704565|NCT00379639|9314456|P5|Overall Study|Physician Decision|0
2704566|NCT00379639|9314457|P4|Overall Study|Physician Decision|1
2704567|NCT00379639|9314458|P3|Overall Study|Physician Decision|1
2704568|NCT00379639|9314459|P2|Overall Study|Physician Decision|2
2704569|NCT00379639|9314460|P1|Overall Study|Physician Decision|0
2704570|NCT00379639|9314456|P5|Overall Study|Disease Progression|4
2704571|NCT00379639|9314457|P4|Overall Study|Disease Progression|4
2704572|NCT00379639|9314458|P3|Overall Study|Disease Progression|3
2704573|NCT00379639|9314459|P2|Overall Study|Disease Progression|3
2704574|NCT00379639|9314460|P1|Overall Study|Disease Progression|3
2704575|NCT00379587|9314482|P1|Overall Study|Lost to Follow-up|2
2704576|NCT00379353|9314496|P2|Overall Study|Conflicting drug treatment|1
2704577|NCT00379353|9314497|P1|Overall Study|Conflicting drug treatment|0
2704578|NCT00379353|9314496|P2|Overall Study|Non-compliance|0
2704579|NCT00379353|9314497|P1|Overall Study|Non-compliance|1
2704580|NCT00379353|9314496|P2|Overall Study|Cardiac Tamponade|0
2704581|NCT00379353|9314497|P1|Overall Study|Cardiac Tamponade|1
2704582|NCT00379353|9314496|P2|Overall Study|Death|0
2704583|NCT00379353|9314497|P1|Overall Study|Death|1
2704584|NCT00379353|9314496|P2|Overall Study|Withdrawal by Subject|2
2704585|NCT00379353|9314497|P1|Overall Study|Withdrawal by Subject|5
2704586|NCT00379353|9314496|P2|Overall Study|Hospitalization|3
2704587|NCT00379353|9314497|P1|Overall Study|Hospitalization|3
2704588|NCT00379340|9314532|P5|Overall Study|Delayed nephrectomy and anaplasia|1
2704589|NCT00379340|9314533|P4|Overall Study|Delayed nephrectomy and anaplasia|1
2704590|NCT00379340|9314534|P3|Overall Study|Delayed nephrectomy and anaplasia|0
2704591|NCT00379340|9314535|P2|Overall Study|Delayed nephrectomy and anaplasia|0
2704592|NCT00379340|9314536|P1|Overall Study|Delayed nephrectomy and anaplasia|0
2704593|NCT00379340|9314532|P5|Overall Study|On more than 1 tumor therapeutic study|0
2704594|NCT00379340|9314533|P4|Overall Study|On more than 1 tumor therapeutic study|2
2704595|NCT00379340|9314534|P3|Overall Study|On more than 1 tumor therapeutic study|0
2704596|NCT00379340|9314535|P2|Overall Study|On more than 1 tumor therapeutic study|0
2704597|NCT00379340|9314536|P1|Overall Study|On more than 1 tumor therapeutic study|0
2704598|NCT00379340|9314532|P5|Overall Study|Refusal of further protocol therapy|7
2704599|NCT00379340|9314533|P4|Overall Study|Refusal of further protocol therapy|1
2704600|NCT00379340|9314534|P3|Overall Study|Refusal of further protocol therapy|1
2704601|NCT00379340|9314535|P2|Overall Study|Refusal of further protocol therapy|0
2704602|NCT00379340|9314536|P1|Overall Study|Refusal of further protocol therapy|1
2704603|NCT00379340|9314532|P5|Overall Study|Withdrawal by Subject|0
2704604|NCT00379340|9314533|P4|Overall Study|Withdrawal by Subject|1
2704605|NCT00379340|9314534|P3|Overall Study|Withdrawal by Subject|0
2704606|NCT00379340|9314535|P2|Overall Study|Withdrawal by Subject|0
2704607|NCT00379340|9314536|P1|Overall Study|Withdrawal by Subject|0
2704608|NCT00379340|9314532|P5|Overall Study|Physician Decision|3
2704609|NCT00379340|9314533|P4|Overall Study|Physician Decision|2
2704610|NCT00379340|9314534|P3|Overall Study|Physician Decision|1
2704611|NCT00379340|9314535|P2|Overall Study|Physician Decision|2
2704612|NCT00379340|9314536|P1|Overall Study|Physician Decision|6
2704613|NCT00379340|9314532|P5|Overall Study|Lack of Efficacy|3
2704614|NCT00379340|9314533|P4|Overall Study|Lack of Efficacy|4
2704615|NCT00379340|9314534|P3|Overall Study|Lack of Efficacy|0
2704616|NCT00379340|9314535|P2|Overall Study|Lack of Efficacy|1
2704617|NCT00379340|9314536|P1|Overall Study|Lack of Efficacy|6
2704618|NCT00379340|9314532|P5|Overall Study|Death|0
2704619|NCT00379340|9314533|P4|Overall Study|Death|2
2704620|NCT00379340|9314534|P3|Overall Study|Death|0
2704621|NCT00379340|9314535|P2|Overall Study|Death|0
2704622|NCT00379340|9314536|P1|Overall Study|Death|0
2704623|NCT00379288|9314553|P4|Overall Study|Administrative|1
2704624|NCT00379288|9314554|P3|Overall Study|Administrative|0
2704625|NCT00379288|9314555|P2|Overall Study|Administrative|2
2704626|NCT00379288|9314556|P1|Overall Study|Administrative|2
2704627|NCT00379288|9314553|P4|Overall Study|Did not meet protocol eligibility|2
2704628|NCT00379288|9314554|P3|Overall Study|Did not meet protocol eligibility|0
2704629|NCT00379288|9314555|P2|Overall Study|Did not meet protocol eligibility|1
2704630|NCT00379288|9314556|P1|Overall Study|Did not meet protocol eligibility|0
2704631|NCT00379288|9314553|P4|Overall Study|Noncompliance with protocol|1
2704632|NCT00379288|9314554|P3|Overall Study|Noncompliance with protocol|2
2704633|NCT00379288|9314555|P2|Overall Study|Noncompliance with protocol|6
2704634|NCT00379288|9314556|P1|Overall Study|Noncompliance with protocol|8
2704635|NCT00379288|9314553|P4|Overall Study|Subject withdrew-related to study drug|1
2704636|NCT00379288|9314554|P3|Overall Study|Subject withdrew-related to study drug|0
2704637|NCT00379288|9314555|P2|Overall Study|Subject withdrew-related to study drug|0
2704638|NCT00379288|9314556|P1|Overall Study|Subject withdrew-related to study drug|1
2704639|NCT00379288|9314553|P4|Overall Study|Subject withdrew-unrelated to study drug|2
2704640|NCT00379288|9314554|P3|Overall Study|Subject withdrew-unrelated to study drug|4
2704641|NCT00379288|9314555|P2|Overall Study|Subject withdrew-unrelated to study drug|3
2704642|NCT00379288|9314556|P1|Overall Study|Subject withdrew-unrelated to study drug|0
2704643|NCT00379288|9314553|P4|Overall Study|Lost to Follow-up|0
2704644|NCT00379288|9314554|P3|Overall Study|Lost to Follow-up|2
2704645|NCT00379288|9314555|P2|Overall Study|Lost to Follow-up|3
2704646|NCT00379288|9314556|P1|Overall Study|Lost to Follow-up|3
2704647|NCT00379288|9314553|P4|Overall Study|Treatment Failure|1
2704648|NCT00379288|9314554|P3|Overall Study|Treatment Failure|0
2704649|NCT00379288|9314555|P2|Overall Study|Treatment Failure|1
2704650|NCT00379288|9314556|P1|Overall Study|Treatment Failure|0
2704651|NCT00379288|9314553|P4|Overall Study|Adverse Event|0
2704652|NCT00379288|9314554|P3|Overall Study|Adverse Event|2
2704653|NCT00379288|9314555|P2|Overall Study|Adverse Event|6
2704654|NCT00379288|9314556|P1|Overall Study|Adverse Event|5
2704655|NCT00379236|9314568|P3|Open-label Extension|Other|7
2704656|NCT00379236|9314569|P2|Open-label Extension|Other|0
2704657|NCT00379236|9314570|P1|Open-label Extension|Other|0
2704658|NCT00379236|9314568|P3|Open-label Extension|Use of exclusionary medication|3
2704659|NCT00379236|9314569|P2|Open-label Extension|Use of exclusionary medication|0
2704660|NCT00379236|9314570|P1|Open-label Extension|Use of exclusionary medication|0
2704661|NCT00379236|9314568|P3|Open-label Extension|Lost to Follow-up|12
2704662|NCT00379236|9314569|P2|Open-label Extension|Lost to Follow-up|0
2704663|NCT00379236|9314570|P1|Open-label Extension|Lost to Follow-up|0
2704664|NCT00379236|9314568|P3|Open-label Extension|Withdrawal by Subject|13
2704665|NCT00379236|9314569|P2|Open-label Extension|Withdrawal by Subject|0
2704666|NCT00379236|9314570|P1|Open-label Extension|Withdrawal by Subject|0
2704667|NCT00379236|9314568|P3|Open-label Extension|Protocol Violation|7
2704668|NCT00379236|9314569|P2|Open-label Extension|Protocol Violation|0
2704669|NCT00379236|9314570|P1|Open-label Extension|Protocol Violation|0
2704670|NCT00379236|9314568|P3|Open-label Extension|Adverse Event|13
2704671|NCT00379236|9314569|P2|Open-label Extension|Adverse Event|0
2704672|NCT00379236|9314570|P1|Open-label Extension|Adverse Event|0
2704673|NCT00379236|9314568|P3|Double-blind|Data could not be retrieved|0
2704674|NCT00379236|9314569|P2|Double-blind|Data could not be retrieved|2
2704675|NCT00379236|9314570|P1|Double-blind|Data could not be retrieved|2
2704676|NCT00379236|9314568|P3|Double-blind|Other|0
2704677|NCT00379236|9314569|P2|Double-blind|Other|7
2704678|NCT00379236|9314570|P1|Double-blind|Other|3
2704679|NCT00379236|9314568|P3|Double-blind|Use of exclusionary medication|0
2704680|NCT00379236|9314569|P2|Double-blind|Use of exclusionary medication|2
2704681|NCT00379236|9314570|P1|Double-blind|Use of exclusionary medication|1
2704682|NCT00379236|9314568|P3|Double-blind|Lost to Follow-up|0
2704683|NCT00379236|9314569|P2|Double-blind|Lost to Follow-up|3
2704684|NCT00379236|9314570|P1|Double-blind|Lost to Follow-up|4
2704685|NCT00379236|9314568|P3|Double-blind|Withdrawal by Subject|0
2704686|NCT00379236|9314569|P2|Double-blind|Withdrawal by Subject|13
2704687|NCT00379236|9314570|P1|Double-blind|Withdrawal by Subject|12
2704688|NCT00379236|9314568|P3|Double-blind|Protocol Violation|0
2704689|NCT00379236|9314569|P2|Double-blind|Protocol Violation|3
2704690|NCT00379236|9314570|P1|Double-blind|Protocol Violation|3
2704691|NCT00379236|9314568|P3|Double-blind|Adverse Event|0
2704692|NCT00379236|9314569|P2|Double-blind|Adverse Event|6
2704693|NCT00379236|9314570|P1|Double-blind|Adverse Event|11
2704694|NCT00379210|9314615|P2|Overall Study|Withdrawal by Subject|7
2704695|NCT00379210|9314616|P1|Overall Study|Withdrawal by Subject|10
2704696|NCT00379080|9314639|P3|Overall Study|Withdrawal by Subject|0
2704697|NCT00379080|9314640|P2|Overall Study|Withdrawal by Subject|4
2704698|NCT00379080|9314641|P1|Overall Study|Withdrawal by Subject|0
2704699|NCT00378898|9314686|P2|Overall Study|Protocol Violation|1
2704700|NCT00378898|9314687|P1|Overall Study|Protocol Violation|1
2704701|NCT00378898|9314686|P2|Overall Study|Withdrawal by Subject|5
2704702|NCT00378898|9314687|P1|Overall Study|Withdrawal by Subject|10
2704703|NCT00378703|9314699|P4|Overall Study|Other|3
2704704|NCT00378703|9314700|P3|Overall Study|Other|2
2704705|NCT00378703|9314701|P2|Overall Study|Other|1
2704706|NCT00378703|9314702|P1|Overall Study|Other|1
2704707|NCT00378703|9314699|P4|Overall Study|Never started treatment|0
2704708|NCT00378703|9314700|P3|Overall Study|Never started treatment|0
2704709|NCT00378703|9314701|P2|Overall Study|Never started treatment|4
2704710|NCT00378703|9314702|P1|Overall Study|Never started treatment|1
2704711|NCT00378703|9314699|P4|Overall Study|Ineligible|7
2704712|NCT00378703|9314700|P3|Overall Study|Ineligible|7
2704713|NCT00378703|9314701|P2|Overall Study|Ineligible|7
2704714|NCT00378703|9314702|P1|Overall Study|Ineligible|4
2704715|NCT00378703|9314699|P4|Overall Study|Relocation|0
2704716|NCT00378703|9314700|P3|Overall Study|Relocation|1
2704717|NCT00378703|9314701|P2|Overall Study|Relocation|0
2704718|NCT00378703|9314702|P1|Overall Study|Relocation|0
2704719|NCT00378703|9314699|P4|Overall Study|Adverse events and progressive disease|1
2704720|NCT00378703|9314700|P3|Overall Study|Adverse events and progressive disease|0
2704721|NCT00378703|9314701|P2|Overall Study|Adverse events and progressive disease|0
2704722|NCT00378703|9314702|P1|Overall Study|Adverse events and progressive disease|0
2704723|NCT00378703|9314699|P4|Overall Study|Joint decision of physician and patient|0
2704724|NCT00378703|9314700|P3|Overall Study|Joint decision of physician and patient|0
2704725|NCT00378703|9314701|P2|Overall Study|Joint decision of physician and patient|0
2704726|NCT00378703|9314702|P1|Overall Study|Joint decision of physician and patient|1
2704727|NCT00378703|9314699|P4|Overall Study|Surgery|1
2704728|NCT00378703|9314700|P3|Overall Study|Surgery|0
2704729|NCT00378703|9314701|P2|Overall Study|Surgery|0
2704730|NCT00378703|9314702|P1|Overall Study|Surgery|1
2704731|NCT00378703|9314699|P4|Overall Study|Symptomatic deterioration|2
2704732|NCT00378703|9314700|P3|Overall Study|Symptomatic deterioration|0
2704733|NCT00378703|9314701|P2|Overall Study|Symptomatic deterioration|1
2704734|NCT00378703|9314702|P1|Overall Study|Symptomatic deterioration|0
2704735|NCT00378703|9314699|P4|Overall Study|Other complicated disease|0
2704736|NCT00378703|9314700|P3|Overall Study|Other complicated disease|2
2704737|NCT00378703|9314701|P2|Overall Study|Other complicated disease|2
2704738|NCT00378703|9314702|P1|Overall Study|Other complicated disease|0
2704739|NCT00378703|9314699|P4|Overall Study|Alternative therapy|0
2704740|NCT00378703|9314700|P3|Overall Study|Alternative therapy|0
2704741|NCT00378703|9314701|P2|Overall Study|Alternative therapy|2
2704742|NCT00378703|9314702|P1|Overall Study|Alternative therapy|4
2704743|NCT00378703|9314699|P4|Overall Study|Physician Decision|0
2704744|NCT00378703|9314700|P3|Overall Study|Physician Decision|1
2704745|NCT00378703|9314701|P2|Overall Study|Physician Decision|4
2704746|NCT00378703|9314702|P1|Overall Study|Physician Decision|1
2704747|NCT00378703|9314699|P4|Overall Study|Withdrawal by Subject|7
2704748|NCT00378703|9314700|P3|Overall Study|Withdrawal by Subject|5
2704749|NCT00378703|9314701|P2|Overall Study|Withdrawal by Subject|8
2704750|NCT00378703|9314702|P1|Overall Study|Withdrawal by Subject|4
2704751|NCT00378703|9314699|P4|Overall Study|Death|3
2704752|NCT00378703|9314700|P3|Overall Study|Death|4
2704753|NCT00378703|9314701|P2|Overall Study|Death|2
2704754|NCT00378703|9314702|P1|Overall Study|Death|2
2704755|NCT00378703|9314699|P4|Overall Study|Adverse Event|18
2704756|NCT00378703|9314700|P3|Overall Study|Adverse Event|20
2704757|NCT00378703|9314701|P2|Overall Study|Adverse Event|17
2704758|NCT00378703|9314702|P1|Overall Study|Adverse Event|11
2704759|NCT00378703|9314699|P4|Overall Study|Disease progression|49
2704760|NCT00378703|9314700|P3|Overall Study|Disease progression|48
2704761|NCT00378703|9314701|P2|Overall Study|Disease progression|43
2704762|NCT00378703|9314702|P1|Overall Study|Disease progression|59
2704763|NCT00378599|9314724|P1|Overall Study|Withdrawal by Subject|5
2704764|NCT00378599|9314724|P1|Overall Study|Treatment failure|7
2704765|NCT00378599|9314724|P1|Overall Study|Protocol Violation|2
2704766|NCT00378599|9314724|P1|Overall Study|Adverse Event|38
2704767|NCT00378573|9314728|P1|Follow-up|Withdrawal by Subject|1
2704768|NCT00378573|9314728|P1|Follow-up|Lost to Follow-up|1
2704769|NCT00378573|9314728|P1|Follow-up|Death|12
2704770|NCT00378573|9314728|P1|Treatment Period|Sponsor decision to close study|1
2704771|NCT00378573|9314728|P1|Treatment Period|Disease Progression|4
2704772|NCT00378573|9314728|P1|Treatment Period|Withdrawal by Subject|2
2704773|NCT00378573|9314728|P1|Treatment Period|Physician Decision|1
2704774|NCT00378573|9314728|P1|Treatment Period|Adverse Event|9
2704775|NCT00378560|9314736|P2|Overall Study|Laboratory test values abnormal|0
2704776|NCT00378560|9314737|P1|Overall Study|Laboratory test values abnormal|1
2704777|NCT00378560|9314736|P2|Overall Study|Pregnancy|5
2704778|NCT00378560|9314737|P1|Overall Study|Pregnancy|7
2704779|NCT00378560|9314736|P2|Overall Study|Moved|3
2704780|NCT00378560|9314737|P1|Overall Study|Moved|4
2704781|NCT00378560|9314736|P2|Overall Study|Withdrawal by Subject|21
2704782|NCT00378560|9314737|P1|Overall Study|Withdrawal by Subject|17
2704783|NCT00378560|9314736|P2|Overall Study|Protocol Violation|0
2704784|NCT00378560|9314737|P1|Overall Study|Protocol Violation|2
2704785|NCT00378560|9314736|P2|Overall Study|Lost to Follow-up|29
2704786|NCT00378560|9314737|P1|Overall Study|Lost to Follow-up|24
2704787|NCT00378560|9314736|P2|Overall Study|Adverse Event|0
2704788|NCT00378560|9314737|P1|Overall Study|Adverse Event|1
2704789|NCT00378534|9314751|P1|Overall Study|Subjects did not receive a transplant|3
2704790|NCT00378534|9314751|P1|Overall Study|Donors|57
2704791|NCT00378508|9314757|P2|Overall Study|Lost to Follow-up|0
2704792|NCT00378508|9314758|P1|Overall Study|Lost to Follow-up|1
2704793|NCT00378508|9314757|P2|Overall Study|Withdrawal by Subject|3
2704794|NCT00378508|9314758|P1|Overall Study|Withdrawal by Subject|1
2704795|NCT00378378|9314777|P3|Overall Study|Non-compliance with protocol|1
2704796|NCT00378378|9314778|P2|Overall Study|Non-compliance with protocol|0
2704797|NCT00378378|9314779|P1|Overall Study|Non-compliance with protocol|0
2704798|NCT00378378|9314777|P3|Overall Study|Treatment Failure|1
2704799|NCT00378378|9314778|P2|Overall Study|Treatment Failure|0
2704800|NCT00378378|9314779|P1|Overall Study|Treatment Failure|0
2704801|NCT00378378|9314777|P3|Overall Study|Withdrawal by Subject|0
2704802|NCT00378378|9314778|P2|Overall Study|Withdrawal by Subject|1
2704803|NCT00378378|9314779|P1|Overall Study|Withdrawal by Subject|0
2704804|NCT00378209|9314825|P1|Overall Study|Treatment delay|1
2704805|NCT00378209|9314825|P1|Overall Study|Death|1
2704806|NCT00378209|9314825|P1|Overall Study|Physician Decision|3
2704807|NCT00378209|9314825|P1|Overall Study|Initiation of non-protocol therapy|3
2704808|NCT00378209|9314825|P1|Overall Study|Adverse Event|3
2704809|NCT00378209|9314825|P1|Overall Study|Progressive disease|11
2704810|NCT00378105|9314835|P2|Overall Study|necessity to increase lenalidomide dose|1
2704811|NCT00378105|9314836|P1|Overall Study|necessity to increase lenalidomide dose|0
2704812|NCT00378105|9314835|P2|Overall Study|Going non-protocol therapy|1
2704813|NCT00378105|9314836|P1|Overall Study|Going non-protocol therapy|0
2704814|NCT00378105|9314835|P2|Overall Study|Physician Decision|2
2704815|NCT00378105|9314836|P1|Overall Study|Physician Decision|0
2704816|NCT00378105|9314835|P2|Overall Study|remain on study|11
2704817|NCT00378105|9314836|P1|Overall Study|remain on study|3
2704818|NCT00378105|9314835|P2|Overall Study|Progressive disease|3
2704819|NCT00378105|9314836|P1|Overall Study|Progressive disease|3
2704820|NCT00378105|9314835|P2|Overall Study|Going to transplant|8
2704821|NCT00378105|9314836|P1|Overall Study|Going to transplant|7
2704822|NCT00378105|9314835|P2|Overall Study|Death|0
2704823|NCT00378105|9314836|P1|Overall Study|Death|1
2704824|NCT00378105|9314835|P2|Overall Study|Withdrawal by Subject|3
2704825|NCT00378105|9314836|P1|Overall Study|Withdrawal by Subject|3
2704826|NCT00378105|9314835|P2|Overall Study|Adverse Event|1
2704827|NCT00378105|9314836|P1|Overall Study|Adverse Event|3
2704828|NCT00378079|9314848|P3|Overall Study|Lost to Follow-up|0
2704829|NCT00378079|9314849|P2|Overall Study|Lost to Follow-up|1
2704830|NCT00378079|9314850|P1|Overall Study|Lost to Follow-up|6
2704831|NCT00378014|9314872|P2|Extension (Month 12 to Month 59)|Lack of Efficacy|1
2704832|NCT00378014|9314873|P1|Extension (Month 12 to Month 59)|Lack of Efficacy|3
2704833|NCT00378014|9314872|P2|Extension (Month 12 to Month 59)|Withdrawal by Subject|3
2704834|NCT00378014|9314873|P1|Extension (Month 12 to Month 59)|Withdrawal by Subject|0
2704835|NCT00378014|9314872|P2|Extension (Month 12 to Month 59)|Lost to Follow-up|1
2704836|NCT00378014|9314873|P1|Extension (Month 12 to Month 59)|Lost to Follow-up|1
2704837|NCT00378014|9314872|P2|Extension (Month 12 to Month 59)|Administrative problems|0
2704838|NCT00378014|9314873|P1|Extension (Month 12 to Month 59)|Administrative problems|1
2704839|NCT00378014|9314872|P2|Extension (Month 12 to Month 59)|Death|2
2704840|NCT00378014|9314873|P1|Extension (Month 12 to Month 59)|Death|1
2704841|NCT00378014|9314872|P2|Extension (Month 12 to Month 59)|Adverse Event|7
2704842|NCT00378014|9314873|P1|Extension (Month 12 to Month 59)|Adverse Event|8
2704843|NCT00378014|9314872|P2|Core (Randomization to Month 11)|Lack of Efficacy|1
2704844|NCT00378014|9314873|P1|Core (Randomization to Month 11)|Lack of Efficacy|0
2704845|NCT00378014|9314872|P2|Core (Randomization to Month 11)|Protocol deviation|1
2704846|NCT00378014|9314873|P1|Core (Randomization to Month 11)|Protocol deviation|0
2704847|NCT00378014|9314872|P2|Core (Randomization to Month 11)|Withdrawal by Subject|2
2704848|NCT00378014|9314873|P1|Core (Randomization to Month 11)|Withdrawal by Subject|5
2704849|NCT00378014|9314872|P2|Core (Randomization to Month 11)|Lost to Follow-up|1
2704850|NCT00378014|9314873|P1|Core (Randomization to Month 11)|Lost to Follow-up|0
2704851|NCT00378014|9314872|P2|Core (Randomization to Month 11)|Administrative Problems|2
2704852|NCT00378014|9314873|P1|Core (Randomization to Month 11)|Administrative Problems|2
2704853|NCT00378014|9314872|P2|Core (Randomization to Month 11)|Death|3
2704854|NCT00378014|9314873|P1|Core (Randomization to Month 11)|Death|5
2704855|NCT00378014|9314872|P2|Core (Randomization to Month 11)|Graft loss|2
2704856|NCT00378014|9314873|P1|Core (Randomization to Month 11)|Graft loss|1
2704857|NCT00378014|9314872|P2|Core (Randomization to Month 11)|Adverse Event|0
2704858|NCT00378014|9314873|P1|Core (Randomization to Month 11)|Adverse Event|1
2704859|NCT00377962|9314899|P2|Extension Study: 12-24 Months|Unspecified reason|3
2704860|NCT00377962|9314900|P1|Extension Study: 12-24 Months|Unspecified reason|0
2704861|NCT00377962|9314899|P2|Extension Study: 12-24 Months|Abnormal laboratory value|0
2704862|NCT00377962|9314900|P1|Extension Study: 12-24 Months|Abnormal laboratory value|1
2704863|NCT00377962|9314899|P2|Extension Study: 12-24 Months|Adverse Event|0
2704864|NCT00377962|9314900|P1|Extension Study: 12-24 Months|Adverse Event|8
2704865|NCT00377962|9314899|P2|Extension Study: 12-24 Months|Death|1
2704866|NCT00377962|9314900|P1|Extension Study: 12-24 Months|Death|1
2704867|NCT00377962|9314899|P2|Core Study: 0-12 Months|Unspecified reasons|4
2704868|NCT00377962|9314900|P1|Core Study: 0-12 Months|Unspecified reasons|1
2704869|NCT00377962|9314899|P2|Core Study: 0-12 Months|Administrative Reason|1
2704870|NCT00377962|9314900|P1|Core Study: 0-12 Months|Administrative Reason|1
2704871|NCT00377962|9314899|P2|Core Study: 0-12 Months|Withdrew Consent|2
2704872|NCT00377962|9314900|P1|Core Study: 0-12 Months|Withdrew Consent|5
2704873|NCT00377962|9314899|P2|Core Study: 0-12 Months|Death|0
2704874|NCT00377962|9314900|P1|Core Study: 0-12 Months|Death|3
2704875|NCT00377962|9314899|P2|Core Study: 0-12 Months|Adverse Event|2
2704876|NCT00377962|9314900|P1|Core Study: 0-12 Months|Adverse Event|18
2704877|NCT00377858|9314936|P2|Overall Study|Death|3
2704878|NCT00377858|9314937|P1|Overall Study|Death|0
2704879|NCT00377858|9314936|P2|Overall Study|Sponsor Decision|2
2704880|NCT00377858|9314937|P1|Overall Study|Sponsor Decision|1
2704881|NCT00377858|9314936|P2|Overall Study|Entry Criteria Not Met|0
2704882|NCT00377858|9314937|P1|Overall Study|Entry Criteria Not Met|2
2704883|NCT00377858|9314936|P2|Overall Study|Adverse Event|1
2704884|NCT00377858|9314937|P1|Overall Study|Adverse Event|2
2704885|NCT00377858|9314936|P2|Overall Study|Protocol Violation|4
2704886|NCT00377858|9314937|P1|Overall Study|Protocol Violation|3
2704887|NCT00377858|9314936|P2|Overall Study|Physician Decision|5
2704888|NCT00377858|9314937|P1|Overall Study|Physician Decision|5
2704889|NCT00377858|9314936|P2|Overall Study|Lost to Follow-up|1
2704890|NCT00377858|9314937|P1|Overall Study|Lost to Follow-up|6
2704891|NCT00377858|9314936|P2|Overall Study|Withdrawal by Subject|11
2704892|NCT00377858|9314937|P1|Overall Study|Withdrawal by Subject|12
2704893|NCT00377819|9314990|P2|Overall Study|Protocol Violation|1
2704894|NCT00377819|9314991|P1|Overall Study|Protocol Violation|1
2704895|NCT00377819|9314990|P2|Overall Study|Lost to Follow-up|1
2704896|NCT00377819|9314991|P1|Overall Study|Lost to Follow-up|0
2704897|NCT00377819|9314990|P2|Overall Study|Death|1
2704898|NCT00377819|9314991|P1|Overall Study|Death|0
2704899|NCT00377819|9314990|P2|Overall Study|Withdrawal by Subject|4
2704900|NCT00377819|9314991|P1|Overall Study|Withdrawal by Subject|10
2704901|NCT00377819|9314990|P2|Overall Study|Adverse Event|3
2704902|NCT00377819|9314991|P1|Overall Study|Adverse Event|2
2704903|NCT00377676|9315020|P2|Overall Study|Other|58
2704904|NCT00377676|9315021|P1|Overall Study|Other|118
2704905|NCT00377676|9315020|P2|Overall Study|Lost to Follow-up|56
2704906|NCT00377676|9315021|P1|Overall Study|Lost to Follow-up|120
2704907|NCT00377676|9315020|P2|Overall Study|Withdrawal by Subject|72
2704908|NCT00377676|9315021|P1|Overall Study|Withdrawal by Subject|187
2704909|NCT00377676|9315020|P2|Overall Study|Death|2
2704910|NCT00377676|9315021|P1|Overall Study|Death|5
2704911|NCT00377676|9315020|P2|Overall Study|Protocol Violation|27
2704912|NCT00377676|9315021|P1|Overall Study|Protocol Violation|33
2704913|NCT00377676|9315020|P2|Overall Study|Adverse Event|107
2704914|NCT00377676|9315021|P1|Overall Study|Adverse Event|498
2704915|NCT00377637|9315037|P4|Maintenance Phase|Death|1
2704916|NCT00377637|9315038|P3|Maintenance Phase|Death|0
2704917|NCT00377637|9315039|P2|Maintenance Phase|Death|0
2704918|NCT00377637|9315040|P1|Maintenance Phase|Death|0
2704919|NCT00377637|9315037|P4|Maintenance Phase|Study medication stopped > 14 days|1
2704920|NCT00377637|9315038|P3|Maintenance Phase|Study medication stopped > 14 days|0
2704921|NCT00377637|9315039|P2|Maintenance Phase|Study medication stopped > 14 days|0
2704922|NCT00377637|9315040|P1|Maintenance Phase|Study medication stopped > 14 days|0
2704923|NCT00377637|9315037|P4|Maintenance Phase|Non-compliance|1
2704924|NCT00377637|9315038|P3|Maintenance Phase|Non-compliance|1
2704925|NCT00377637|9315039|P2|Maintenance Phase|Non-compliance|0
2704926|NCT00377637|9315040|P1|Maintenance Phase|Non-compliance|0
2704927|NCT00377637|9315037|P4|Maintenance Phase|Sponsor decision|3
2704928|NCT00377637|9315038|P3|Maintenance Phase|Sponsor decision|2
2704929|NCT00377637|9315039|P2|Maintenance Phase|Sponsor decision|0
2704930|NCT00377637|9315040|P1|Maintenance Phase|Sponsor decision|0
2704931|NCT00377637|9315037|P4|Maintenance Phase|Withdrawal by Subject|3
2704932|NCT00377637|9315038|P3|Maintenance Phase|Withdrawal by Subject|3
2704933|NCT00377637|9315039|P2|Maintenance Phase|Withdrawal by Subject|0
2704934|NCT00377637|9315040|P1|Maintenance Phase|Withdrawal by Subject|0
2704935|NCT00377637|9315037|P4|Maintenance Phase|Lost to Follow-up|1
2704936|NCT00377637|9315038|P3|Maintenance Phase|Lost to Follow-up|3
2704937|NCT00377637|9315039|P2|Maintenance Phase|Lost to Follow-up|0
2704938|NCT00377637|9315040|P1|Maintenance Phase|Lost to Follow-up|0
2704939|NCT00377637|9315037|P4|Maintenance Phase|Physician Decision|4
2704940|NCT00377637|9315038|P3|Maintenance Phase|Physician Decision|5
2704941|NCT00377637|9315039|P2|Maintenance Phase|Physician Decision|0
2704942|NCT00377637|9315040|P1|Maintenance Phase|Physician Decision|0
2704943|NCT00377637|9315037|P4|Maintenance Phase|Adverse Event|43
2704944|NCT00377637|9315038|P3|Maintenance Phase|Adverse Event|29
2704945|NCT00377637|9315039|P2|Maintenance Phase|Adverse Event|0
2704946|NCT00377637|9315040|P1|Maintenance Phase|Adverse Event|0
2704947|NCT00377637|9315037|P4|Induction Phase|Reason for withdrawal is not noted|0
2704948|NCT00377637|9315038|P3|Induction Phase|Reason for withdrawal is not noted|0
2704949|NCT00377637|9315039|P2|Induction Phase|Reason for withdrawal is not noted|0
2704950|NCT00377637|9315040|P1|Induction Phase|Reason for withdrawal is not noted|2
2704951|NCT00377637|9315037|P4|Induction Phase|Non-Compliance|0
2704952|NCT00377637|9315038|P3|Induction Phase|Non-Compliance|0
2704953|NCT00377637|9315039|P2|Induction Phase|Non-Compliance|0
2704954|NCT00377637|9315040|P1|Induction Phase|Non-Compliance|1
2704955|NCT00377637|9315037|P4|Induction Phase|Sponsor decision|0
2704956|NCT00377637|9315038|P3|Induction Phase|Sponsor decision|0
2704957|NCT00377637|9315039|P2|Induction Phase|Sponsor decision|2
2704958|NCT00377637|9315040|P1|Induction Phase|Sponsor decision|1
2704959|NCT00377637|9315037|P4|Induction Phase|Physician Decision|0
2704960|NCT00377637|9315038|P3|Induction Phase|Physician Decision|0
2704961|NCT00377637|9315039|P2|Induction Phase|Physician Decision|1
2704962|NCT00377637|9315040|P1|Induction Phase|Physician Decision|3
2704963|NCT00377637|9315037|P4|Induction Phase|Withdrawal by Subject|0
2704964|NCT00377637|9315038|P3|Induction Phase|Withdrawal by Subject|0
2704965|NCT00377637|9315039|P2|Induction Phase|Withdrawal by Subject|6
2704966|NCT00377637|9315040|P1|Induction Phase|Withdrawal by Subject|5
2704967|NCT00377637|9315037|P4|Induction Phase|Death|0
2704968|NCT00377637|9315038|P3|Induction Phase|Death|0
2704969|NCT00377637|9315039|P2|Induction Phase|Death|3
2704970|NCT00377637|9315040|P1|Induction Phase|Death|1
2704971|NCT00377637|9315037|P4|Induction Phase|Lost to Follow-up|0
2704972|NCT00377637|9315038|P3|Induction Phase|Lost to Follow-up|0
2704973|NCT00377637|9315039|P2|Induction Phase|Lost to Follow-up|1
2704974|NCT00377637|9315040|P1|Induction Phase|Lost to Follow-up|2
2704975|NCT00377637|9315037|P4|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
2704976|NCT00377637|9315038|P3|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
2704977|NCT00377637|9315039|P2|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1
2704978|NCT00377637|9315040|P1|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
2704979|NCT00377637|9315037|P4|Induction Phase|Deterioration/serum creatinine|0
2704980|NCT00377637|9315038|P3|Induction Phase|Deterioration/serum creatinine|0
2704981|NCT00377637|9315039|P2|Induction Phase|Deterioration/serum creatinine|0
2704982|NCT00377637|9315040|P1|Induction Phase|Deterioration/serum creatinine|2
2704983|NCT00377637|9315037|P4|Induction Phase|Adverse Event|0
2704984|NCT00377637|9315038|P3|Induction Phase|Adverse Event|0
2704985|NCT00377637|9315039|P2|Induction Phase|Adverse Event|21
2704986|NCT00377637|9315040|P1|Induction Phase|Adverse Event|12
2704987|NCT00377611|9315076|P2|Overall Study|Other|3
2704988|NCT00377611|9315077|P1|Overall Study|Other|0
2704989|NCT00377611|9315076|P2|Overall Study|Lost to Follow-up|16
2704990|NCT00377611|9315077|P1|Overall Study|Lost to Follow-up|18
2704991|NCT00377611|9315076|P2|Overall Study|Withdrawal by Subject|5
2704992|NCT00377611|9315077|P1|Overall Study|Withdrawal by Subject|0
2704993|NCT00377611|9315076|P2|Overall Study|Protocol Violation|0
2704994|NCT00377611|9315077|P1|Overall Study|Protocol Violation|2
2704995|NCT00377611|9315076|P2|Overall Study|Adverse Event|9
2704996|NCT00377611|9315077|P1|Overall Study|Adverse Event|2
2704997|NCT00377520|9315179|P1|Overall Study|Ineligible (Prior radiation)|1
2704998|NCT00377455|9315184|P1|Overall Study|Withdrawal by Subject|1
2704999|NCT00377429|9315192|P1|Overall Study|Patient non-compliance|1
2705000|NCT00377429|9315192|P1|Overall Study|Physician Decision|1
2705001|NCT00377429|9315192|P1|Overall Study|Adverse Event|8
2705002|NCT00377429|9315192|P1|Overall Study|Withdrawal by Subject|5
2705003|NCT00377403|9315203|P2|Overall Study|Unable to contact for telephone intervie|7
2705004|NCT00377403|9315204|P1|Overall Study|Unable to contact for telephone intervie|4
2705005|NCT00377364|9315212|P2|Overall Study|Withdrawal by Subject|0
2705006|NCT00377364|9315213|P1|Overall Study|Withdrawal by Subject|1
2705007|NCT00377364|9315212|P2|Overall Study|Lost to Follow-up|0
2705008|NCT00377364|9315213|P1|Overall Study|Lost to Follow-up|1
2705009|NCT00377312|9315239|P2|Overall Study|Adverse Event|1
2705010|NCT00377312|9315240|P1|Overall Study|Adverse Event|1
2705011|NCT00377299|9315272|P2|Overall Study|Withdrawal by Subject|4
2705012|NCT00377299|9315273|P1|Overall Study|Withdrawal by Subject|5
2705013|NCT00377299|9315272|P2|Overall Study|Adverse Event|1
2705014|NCT00377299|9315273|P1|Overall Study|Adverse Event|0
2705015|NCT00377299|9315272|P2|Overall Study|Lost to Follow-up|19
2705016|NCT00377299|9315273|P1|Overall Study|Lost to Follow-up|14
2705017|NCT00377260|9315289|P2|Overall Study|Withdrawal by Subject|4
2705018|NCT00377260|9315290|P1|Overall Study|Withdrawal by Subject|2
2705019|NCT00377260|9315289|P2|Overall Study|Lost to Follow-up|1
2705020|NCT00377260|9315290|P1|Overall Study|Lost to Follow-up|0
2705021|NCT00377234|9315344|P2|Overall Study|Not assigned|2
2705022|NCT00377234|9315345|P1|Overall Study|Not assigned|3
2705023|NCT00377234|9315344|P2|Overall Study|Administrative|1
2705024|NCT00377234|9315345|P1|Overall Study|Administrative|2
2705025|NCT00377234|9315344|P2|Overall Study|Lost to Follow-up|2
2705026|NCT00377234|9315345|P1|Overall Study|Lost to Follow-up|4
2705027|NCT00377234|9315344|P2|Overall Study|Withdrawal by Subject|9
2705028|NCT00377234|9315345|P1|Overall Study|Withdrawal by Subject|11
2705029|NCT00377234|9315344|P2|Overall Study|Adverse Event|17
2705030|NCT00377234|9315345|P1|Overall Study|Adverse Event|14
2705031|NCT00377156|9315363|P2|Overall Study|Other|2
2705032|NCT00377156|9315364|P1|Overall Study|Other|5
2705033|NCT00377156|9315363|P2|Overall Study|Disability or language problem|1
2705034|NCT00377156|9315364|P1|Overall Study|Disability or language problem|0
2705035|NCT00377156|9315363|P2|Overall Study|Ineligible|1
2705036|NCT00377156|9315364|P1|Overall Study|Ineligible|0
2705037|NCT00377156|9315363|P2|Overall Study|Refused testing|1
2705038|NCT00377156|9315364|P1|Overall Study|Refused testing|0
2705039|NCT00377156|9315363|P2|Overall Study|Cancellation|0
2705040|NCT00377156|9315364|P1|Overall Study|Cancellation|1
2705041|NCT00377156|9315363|P2|Overall Study|Had follow-up <90 d|6
2705042|NCT00377156|9315364|P1|Overall Study|Had follow-up <90 d|3
2705043|NCT00377156|9315363|P2|Overall Study|Withdrawal by Subject|24
2705044|NCT00377156|9315364|P1|Overall Study|Withdrawal by Subject|16
2705045|NCT00377156|9315363|P2|Overall Study|Death|19
2705046|NCT00377156|9315364|P1|Overall Study|Death|23
2705047|NCT00376961|9315378|P2|Maintenance|Ineligible|3
2705048|NCT00376961|9315379|P1|Maintenance|Ineligible|0
2705049|NCT00376961|9315378|P2|Maintenance|Progression/relapse|18
2705050|NCT00376961|9315379|P1|Maintenance|Progression/relapse|0
2705051|NCT00376961|9315378|P2|Maintenance|Refusal Unrelated to Adverse Event|1
2705052|NCT00376961|9315379|P1|Maintenance|Refusal Unrelated to Adverse Event|0
2705053|NCT00376961|9315378|P2|Maintenance|Adverse Event|1
2705054|NCT00376961|9315379|P1|Maintenance|Adverse Event|0
2705055|NCT00376961|9315378|P2|Initial Registration|Ineligible|0
2705056|NCT00376961|9315379|P1|Initial Registration|Ineligible|3
2705057|NCT00376961|9315378|P2|Initial Registration|Progression/relapse|0
2705058|NCT00376961|9315379|P1|Initial Registration|Progression/relapse|1
2705059|NCT00376961|9315378|P2|Initial Registration|Refusal Unrelated to Adverse Event|0
2705060|NCT00376961|9315379|P1|Initial Registration|Refusal Unrelated to Adverse Event|2
2705061|NCT00376961|9315378|P2|Initial Registration|Adverse Event|0
2705062|NCT00376961|9315379|P1|Initial Registration|Adverse Event|1
2705063|NCT00376688|9315445|P1|Overall Study|Death|1
2705064|NCT00376688|9315445|P1|Overall Study|Adverse Event|3
2705065|NCT00376675|9315451|P2|Overall Study|Other Reason|7
2705066|NCT00376675|9315452|P1|Overall Study|Other Reason|1
2705067|NCT00376675|9315451|P2|Overall Study|Adverse Event|5
2705068|NCT00376675|9315452|P1|Overall Study|Adverse Event|10
2705069|NCT00376675|9315451|P2|Overall Study|Withdrawal by Subject|2
2705070|NCT00376675|9315452|P1|Overall Study|Withdrawal by Subject|9
2705071|NCT00376532|9315501|P2|Overall Study|Lack sufficient blood sample|6
2705072|NCT00376532|9315502|P1|Overall Study|Lack sufficient blood sample|6
2705073|NCT00376506|9315512|P2|Overall Study|Death|2
2705074|NCT00376506|9315513|P1|Overall Study|Death|0
2705075|NCT00376259|9315544|P2|Overall Study|Patient request|0
2705076|NCT00376259|9315545|P1|Overall Study|Patient request|1
2705077|NCT00376259|9315544|P2|Overall Study|Sponsor request - study termination|21
2705078|NCT00376259|9315545|P1|Overall Study|Sponsor request - study termination|21
2705079|NCT00376246|9315557|P2|First Intervention (2 Weeks)|Lost to Follow-up|0
2705080|NCT00376246|9315558|P1|First Intervention (2 Weeks)|Lost to Follow-up|1
2705081|NCT00376246|9315557|P2|First Intervention (2 Weeks)|Withdrawal by Subject|2
2705082|NCT00376246|9315558|P1|First Intervention (2 Weeks)|Withdrawal by Subject|1
2705083|NCT00376246|9315557|P2|First Intervention (2 Weeks)|Adverse Event|0
2705084|NCT00376246|9315558|P1|First Intervention (2 Weeks)|Adverse Event|2
2705085|NCT00376220|9315568|P2|Overall Study|Withdrawal by Subject|2
2705086|NCT00376220|9315569|P1|Overall Study|Withdrawal by Subject|3
2705087|NCT00376220|9315568|P2|Overall Study|Lost to Follow-up|10
2705088|NCT00376220|9315569|P1|Overall Study|Lost to Follow-up|7
2705089|NCT00376168|9315577|P2|Overall Study|Pregnancy|0
2705090|NCT00376168|9315578|P1|Overall Study|Pregnancy|1
2705091|NCT00376168|9315577|P2|Overall Study|Adverse Event|1
2705092|NCT00376168|9315578|P1|Overall Study|Adverse Event|1
2705093|NCT00375934|9315619|P2|Overall Study|Physician Decision|1
2705094|NCT00375934|9315620|P1|Overall Study|Physician Decision|0
2705095|NCT00375934|9315619|P2|Overall Study|Lack of Efficacy|2
2705096|NCT00375934|9315620|P1|Overall Study|Lack of Efficacy|0
2705097|NCT00375934|9315619|P2|Overall Study|Withdrawal by Subject|2
2705098|NCT00375934|9315620|P1|Overall Study|Withdrawal by Subject|2
2705099|NCT00375934|9315619|P2|Overall Study|Adverse Event|1
2705100|NCT00375934|9315620|P1|Overall Study|Adverse Event|1
2705101|NCT00375752|9315678|P2|Overall Study|Administrative Problems|1
2705102|NCT00375752|9315679|P1|Overall Study|Administrative Problems|0
2705103|NCT00375752|9315678|P2|Overall Study|Protocol Violation|2
2705104|NCT00375752|9315679|P1|Overall Study|Protocol Violation|0
2705105|NCT00375752|9315678|P2|Overall Study|Abnormal Laboratory Value(s)|1
2705106|NCT00375752|9315679|P1|Overall Study|Abnormal Laboratory Value(s)|1
2705107|NCT00375752|9315678|P2|Overall Study|Withdrawal by Subject|1
2705108|NCT00375752|9315679|P1|Overall Study|Withdrawal by Subject|6
2705109|NCT00375752|9315678|P2|Overall Study|Adverse Event|6
2705110|NCT00375752|9315679|P1|Overall Study|Adverse Event|1
2705111|NCT00375752|9315678|P2|Overall Study|Lack of Efficacy|4
2705112|NCT00375752|9315679|P1|Overall Study|Lack of Efficacy|4
2705113|NCT00375674|9315710|P2|Overall Study|Enrolled but not treated|2
2705114|NCT00375674|9315711|P1|Overall Study|Enrolled but not treated|3
2705115|NCT00375674|9315710|P2|Overall Study|Lost to Follow-up|15
2705116|NCT00375674|9315711|P1|Overall Study|Lost to Follow-up|17
2705117|NCT00375674|9315710|P2|Overall Study|Participants refused further follow-up|30
2705118|NCT00375674|9315711|P1|Overall Study|Participants refused further follow-up|31
2705119|NCT00375674|9315710|P2|Overall Study|Death|76
2705120|NCT00375674|9315711|P1|Overall Study|Death|67
2705121|NCT00375674|9315710|P2|Overall Study|Other|18
2705122|NCT00375674|9315711|P1|Overall Study|Other|26
2705123|NCT00375609|9315740|P3|Overall Study|Neurologist Wanted Pt to start Plavix|0
2705124|NCT00375609|9315741|P2|Overall Study|Neurologist Wanted Pt to start Plavix|0
2705125|NCT00375609|9315742|P1|Overall Study|Neurologist Wanted Pt to start Plavix|1
2705126|NCT00375609|9315740|P3|Overall Study|Withdrawal by Subject|0
2705127|NCT00375609|9315741|P2|Overall Study|Withdrawal by Subject|4
2705128|NCT00375609|9315742|P1|Overall Study|Withdrawal by Subject|1
2705129|NCT00375609|9315740|P3|Overall Study|Physician Decision|1
2705130|NCT00375609|9315741|P2|Overall Study|Physician Decision|0
2705131|NCT00375609|9315742|P1|Overall Study|Physician Decision|0
2705132|NCT00375609|9315740|P3|Overall Study|Lost to Follow-up|0
2705133|NCT00375609|9315741|P2|Overall Study|Lost to Follow-up|0
2705134|NCT00375609|9315742|P1|Overall Study|Lost to Follow-up|1
2705135|NCT00375609|9315740|P3|Overall Study|Adverse Event|0
2705136|NCT00375609|9315741|P2|Overall Study|Adverse Event|3
2705137|NCT00375609|9315742|P1|Overall Study|Adverse Event|0
2705138|NCT00375609|9315740|P3|Overall Study|Did not receive treatment|0
2705139|NCT00375609|9315741|P2|Overall Study|Did not receive treatment|0
2705140|NCT00375609|9315742|P1|Overall Study|Did not receive treatment|1
2705141|NCT00375518|9315758|P2|Overall Study|Death|1
2705142|NCT00375518|9315759|P1|Overall Study|Death|0
2705143|NCT00375518|9315758|P2|Overall Study|Patient Not Treated|6
2705144|NCT00375518|9315759|P1|Overall Study|Patient Not Treated|6
2705145|NCT00375518|9315758|P2|Overall Study|Withdrawal by Subject|10
2705146|NCT00375518|9315759|P1|Overall Study|Withdrawal by Subject|2
2705147|NCT00375505|9315767|P2|Overall Study|Adverse Event|2
2705148|NCT00375505|9315768|P1|Overall Study|Adverse Event|1
2705149|NCT00375492|9315812|P2|Overall Study|Withdrawal by Subject|6
2705150|NCT00375492|9315813|P1|Overall Study|Withdrawal by Subject|6
2705151|NCT00375492|9315812|P2|Overall Study|Sponsor Decision|1
2705152|NCT00375492|9315813|P1|Overall Study|Sponsor Decision|0
2705153|NCT00375492|9315812|P2|Overall Study|Protocol Violation|3
2705154|NCT00375492|9315813|P1|Overall Study|Protocol Violation|6
2705155|NCT00375492|9315812|P2|Overall Study|Physician Decision|4
2705156|NCT00375492|9315813|P1|Overall Study|Physician Decision|0
2705157|NCT00375492|9315812|P2|Overall Study|Lost to Follow-up|5
2705158|NCT00375492|9315813|P1|Overall Study|Lost to Follow-up|10
2705159|NCT00375492|9315812|P2|Overall Study|Loss of Glucose Control|1
2705160|NCT00375492|9315813|P1|Overall Study|Loss of Glucose Control|0
2705161|NCT00375492|9315812|P2|Overall Study|Entry Criteria Not Met|1
2705162|NCT00375492|9315813|P1|Overall Study|Entry Criteria Not Met|0
2705163|NCT00375492|9315812|P2|Overall Study|Adverse Event|5
2705164|NCT00375492|9315813|P1|Overall Study|Adverse Event|4
2705165|NCT00375427|9315843|P2|Overall Study|Death|10
2705166|NCT00375427|9315844|P1|Overall Study|Death|11
2705167|NCT00375427|9315843|P2|Overall Study|Administrative reasons|1
2705168|NCT00375427|9315844|P1|Overall Study|Administrative reasons|0
2705169|NCT00375427|9315843|P2|Overall Study|Lost to Follow-up|1
2705170|NCT00375427|9315844|P1|Overall Study|Lost to Follow-up|1
2705171|NCT00375427|9315843|P2|Overall Study|Withdrawal by Subject|13
2705172|NCT00375427|9315844|P1|Overall Study|Withdrawal by Subject|9
2705173|NCT00375427|9315843|P2|Overall Study|Protocol Violation|8
2705174|NCT00375427|9315844|P1|Overall Study|Protocol Violation|10
2705175|NCT00375427|9315843|P2|Overall Study|Patient no longer requires study drug|7
2705176|NCT00375427|9315844|P1|Overall Study|Patient no longer requires study drug|3
2705177|NCT00375427|9315843|P2|Overall Study|Unsatisfactory therapeutic effect|4
2705178|NCT00375427|9315844|P1|Overall Study|Unsatisfactory therapeutic effect|4
2705179|NCT00375427|9315843|P2|Overall Study|Abnormal laboratory value(s)|2
2705180|NCT00375427|9315844|P1|Overall Study|Abnormal laboratory value(s)|1
2705181|NCT00375427|9315843|P2|Overall Study|Abnormal test procedure result(s)|1
2705182|NCT00375427|9315844|P1|Overall Study|Abnormal test procedure result(s)|0
2705183|NCT00375427|9315843|P2|Overall Study|Adverse Event|27
2705184|NCT00375427|9315844|P1|Overall Study|Adverse Event|21
2705185|NCT00375219|9315869|P3|Overall Study|Withdrawal by Subject|0
2705186|NCT00375219|9315870|P2|Overall Study|Withdrawal by Subject|0
2705187|NCT00375219|9315871|P1|Overall Study|Withdrawal by Subject|1
2705188|NCT00375219|9315869|P3|Overall Study|Cord blood transplantation|0
2705189|NCT00375219|9315870|P2|Overall Study|Cord blood transplantation|0
2705190|NCT00375219|9315871|P1|Overall Study|Cord blood transplantation|1
2705191|NCT00375219|9315869|P3|Overall Study|Allograft|0
2705192|NCT00375219|9315870|P2|Overall Study|Allograft|0
2705193|NCT00375219|9315871|P1|Overall Study|Allograft|2
2705194|NCT00375219|9315869|P3|Overall Study|Specific tyrosine kinase inhibitor avail|0
2705195|NCT00375219|9315870|P2|Overall Study|Specific tyrosine kinase inhibitor avail|0
2705196|NCT00375219|9315871|P1|Overall Study|Specific tyrosine kinase inhibitor avail|1
2705197|NCT00375219|9315869|P3|Overall Study|Hematologic resistance|0
2705198|NCT00375219|9315870|P2|Overall Study|Hematologic resistance|0
2705199|NCT00375219|9315871|P1|Overall Study|Hematologic resistance|1
2705200|NCT00375219|9315869|P3|Overall Study|Death|7
2705201|NCT00375219|9315870|P2|Overall Study|Death|3
2705202|NCT00375219|9315871|P1|Overall Study|Death|4
2705203|NCT00375219|9315869|P3|Overall Study|Disease progression|12
2705204|NCT00375219|9315870|P2|Overall Study|Disease progression|9
2705205|NCT00375219|9315871|P1|Overall Study|Disease progression|18
2705206|NCT00375219|9315869|P3|Overall Study|Lost to Follow-up|0
2705207|NCT00375219|9315870|P2|Overall Study|Lost to Follow-up|1
2705208|NCT00375219|9315871|P1|Overall Study|Lost to Follow-up|1
2705209|NCT00375219|9315869|P3|Overall Study|Request of Patient, PI, Sponsor or RA|0
2705210|NCT00375219|9315870|P2|Overall Study|Request of Patient, PI, Sponsor or RA|3
2705211|NCT00375219|9315871|P1|Overall Study|Request of Patient, PI, Sponsor or RA|5
2705212|NCT00375219|9315869|P3|Overall Study|Protocol Violation|1
2705213|NCT00375219|9315870|P2|Overall Study|Protocol Violation|0
2705214|NCT00375219|9315871|P1|Overall Study|Protocol Violation|1
2705215|NCT00375219|9315869|P3|Overall Study|Adverse Event|1
2705216|NCT00375219|9315870|P2|Overall Study|Adverse Event|2
2705217|NCT00375219|9315871|P1|Overall Study|Adverse Event|8
2705218|NCT00375219|9315869|P3|Overall Study|Failure to achieve a response|0
2705219|NCT00375219|9315870|P2|Overall Study|Failure to achieve a response|2
2705220|NCT00375219|9315871|P1|Overall Study|Failure to achieve a response|16
2705221|NCT00374907|9315954|P2|116-Week Short-term + Long-term Period|Lost to Follow-up|1
2705222|NCT00374907|9315955|P1|116-Week Short-term + Long-term Period|Lost to Follow-up|1
2705223|NCT00374907|9315954|P2|116-Week Short-term + Long-term Period|Adverse Event|2
2705224|NCT00374907|9315955|P1|116-Week Short-term + Long-term Period|Adverse Event|0
2705225|NCT00374907|9315954|P2|116-Week Short-term + Long-term Period|Lack of Efficacy|2
2705226|NCT00374907|9315955|P1|116-Week Short-term + Long-term Period|Lack of Efficacy|4
2705227|NCT00374907|9315954|P2|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9
2705228|NCT00374907|9315955|P1|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8
2705229|NCT00374907|9315954|P2|12-Week Short-term Period|Subject Withdrew Consent|1
2705230|NCT00374907|9315955|P1|12-Week Short-term Period|Subject Withdrew Consent|3
2705231|NCT00374868|9315967|P1|Overall Study|Other - Not Specified|1
2705232|NCT00374868|9315967|P1|Overall Study|Death|2
2705233|NCT00374868|9315967|P1|Overall Study|Lost to Follow-up|1
2705234|NCT00374868|9315967|P1|Overall Study|Physician Decision|13
2705235|NCT00374868|9315967|P1|Overall Study|Progressive Disease|7
2705236|NCT00374868|9315967|P1|Overall Study|Adverse Event|12
2705237|NCT00374556|9316031|P2|Overall Study|Removed at baseline due to medical cond|1
2705238|NCT00374556|9316032|P1|Overall Study|Removed at baseline due to medical cond|0
2705239|NCT00374556|9316031|P2|Overall Study|Lost to Follow-up|0
2705240|NCT00374556|9316032|P1|Overall Study|Lost to Follow-up|1
2705241|NCT00374452|9316093|P2|Overall Study|Withdrawal by Subject|2
2705242|NCT00374452|9316094|P1|Overall Study|Withdrawal by Subject|0
2705243|NCT00374452|9316093|P2|Overall Study|Left clinic after intervention started|1
2705244|NCT00374452|9316094|P1|Overall Study|Left clinic after intervention started|1
2705245|NCT00374452|9316093|P2|Overall Study|Change in job role before intervention|1
2705246|NCT00374452|9316094|P1|Overall Study|Change in job role before intervention|0
2705247|NCT00374452|9316093|P2|Overall Study|Left clinic before intervention started|1
2705248|NCT00374452|9316094|P1|Overall Study|Left clinic before intervention started|4
2705249|NCT00374322|9316107|P2|Overall Study|Did Not Receive Study Medication|6
2705250|NCT00374322|9316108|P1|Overall Study|Did Not Receive Study Medication|8
2705251|NCT00374322|9316107|P2|Overall Study|Withdrew Consent During Follow-up|5
2705252|NCT00374322|9316108|P1|Overall Study|Withdrew Consent During Follow-up|0
2705253|NCT00374322|9316107|P2|Overall Study|Noncompliance with Study Requirements|1
2705254|NCT00374322|9316108|P1|Overall Study|Noncompliance with Study Requirements|0
2705255|NCT00374322|9316107|P2|Overall Study|Started Another Chemotherapy Regimen|1
2705256|NCT00374322|9316108|P1|Overall Study|Started Another Chemotherapy Regimen|0
2705257|NCT00374322|9316107|P2|Overall Study|Participant Changed Physician|0
2705258|NCT00374322|9316108|P1|Overall Study|Participant Changed Physician|1
2705259|NCT00374322|9316107|P2|Overall Study|Site Closed|2
2705260|NCT00374322|9316108|P1|Overall Study|Site Closed|2
2705261|NCT00374322|9316107|P2|Overall Study|Severe Toxicity|0
2705262|NCT00374322|9316108|P1|Overall Study|Severe Toxicity|1
2705263|NCT00374322|9316107|P2|Overall Study|Seen in FU by a Non-Primary Investigator|0
2705264|NCT00374322|9316108|P1|Overall Study|Seen in FU by a Non-Primary Investigator|1
2705265|NCT00374322|9316107|P2|Overall Study|FU by a Non-Principal Investigator (PI)|3
2705266|NCT00374322|9316108|P1|Overall Study|FU by a Non-Principal Investigator (PI)|2
2705267|NCT00374322|9316107|P2|Overall Study|Sponsor Decision|3
2705268|NCT00374322|9316108|P1|Overall Study|Sponsor Decision|2
2705269|NCT00374322|9316107|P2|Overall Study|Par. Consented to Survival FU Only|1
2705270|NCT00374322|9316108|P1|Overall Study|Par. Consented to Survival FU Only|3
2705271|NCT00374322|9316107|P2|Overall Study|Physician Decision|32
2705272|NCT00374322|9316108|P1|Overall Study|Physician Decision|36
2705273|NCT00374322|9316107|P2|Overall Study|Sponsor Terminated Study|990
2705274|NCT00374322|9316108|P1|Overall Study|Sponsor Terminated Study|866
2705275|NCT00374322|9316107|P2|Overall Study|Withdrawal by Subject|167
2705276|NCT00374322|9316108|P1|Overall Study|Withdrawal by Subject|235
2705277|NCT00374322|9316107|P2|Overall Study|Protocol Violation|3
2705278|NCT00374322|9316108|P1|Overall Study|Protocol Violation|8
2705279|NCT00374322|9316107|P2|Overall Study|Lost to Follow-up|90
2705280|NCT00374322|9316108|P1|Overall Study|Lost to Follow-up|92
2705281|NCT00374140|9316199|P1|Overall Study|Protocol Violation|1
2705282|NCT00374140|9316199|P1|Overall Study|Lost to Follow-up|1
2705283|NCT00374127|9316206|P1|Overall Study|Pregnancy|1
2705284|NCT00374127|9316206|P1|Overall Study|Protocol Violation|5
2705285|NCT00374127|9316206|P1|Overall Study|Blood could not be drawn.|2
2705286|NCT00374127|9316206|P1|Overall Study|Did not inhale during smoking procedure.|3
2705287|NCT00373958|9316255|P2|Toddler Dose|Withdrawn after infant series|25
2705288|NCT00373958|9316256|P1|Toddler Dose|Withdrawn after infant series|22
2705289|NCT00373958|9316255|P2|Toddler Dose|Protocol Violation|1
2705290|NCT00373958|9316256|P1|Toddler Dose|Protocol Violation|0
2705291|NCT00373958|9316255|P2|Toddler Dose|Failed to return|2
2705292|NCT00373958|9316256|P1|Toddler Dose|Failed to return|1
2705293|NCT00373958|9316255|P2|Toddler Dose|Withdrawal by Subject|2
2705294|NCT00373958|9316256|P1|Toddler Dose|Withdrawal by Subject|2
2705295|NCT00373958|9316255|P2|Toddler Dose|Lost to Follow-up|8
2705296|NCT00373958|9316256|P1|Toddler Dose|Lost to Follow-up|5
2705297|NCT00373958|9316255|P2|Infant Series|Physician Decision|1
2705298|NCT00373958|9316256|P1|Infant Series|Physician Decision|1
2705299|NCT00373958|9316255|P2|Infant Series|Adverse Event|1
2705300|NCT00373958|9316256|P1|Infant Series|Adverse Event|3
2705301|NCT00373958|9316255|P2|Infant Series|Consent was not received|0
2705302|NCT00373958|9316256|P1|Infant Series|Consent was not received|1
2705303|NCT00373958|9316255|P2|Infant Series|Child relocated|0
2705304|NCT00373958|9316256|P1|Infant Series|Child relocated|1
2705305|NCT00373958|9316255|P2|Infant Series|Lost Kaiser coverage|0
2705306|NCT00373958|9316256|P1|Infant Series|Lost Kaiser coverage|4
2705307|NCT00373958|9316255|P2|Infant Series|Protocol Violation|7
2705308|NCT00373958|9316256|P1|Infant Series|Protocol Violation|3
2705309|NCT00373958|9316255|P2|Infant Series|Lost to Follow-up|5
2705310|NCT00373958|9316256|P1|Infant Series|Lost to Follow-up|6
2705311|NCT00373958|9316255|P2|Infant Series|Failed to return|13
2705312|NCT00373958|9316256|P1|Infant Series|Failed to return|8
2705313|NCT00373958|9316255|P2|Infant Series|Withdrawal by Subject|15
2705314|NCT00373958|9316256|P1|Infant Series|Withdrawal by Subject|13
2705315|NCT00373880|9316304|P1|Overall Study|Protocol Violation|14
2705316|NCT00373880|9316304|P1|Overall Study|Arrested|1
2705317|NCT00373880|9316304|P1|Overall Study|Physician Decision|3
2705318|NCT00373685|9316349|P2|Overall Study|Randomized, not treated|77
2705319|NCT00373685|9316350|P1|Overall Study|Randomized, not treated|51
2705320|NCT00373685|9316349|P2|Overall Study|Final Status Unknown|4
2705321|NCT00373685|9316350|P1|Overall Study|Final Status Unknown|12
2705322|NCT00373685|9316349|P2|Overall Study|Protocol Violation|182
2705323|NCT00373685|9316350|P1|Overall Study|Protocol Violation|191
2705324|NCT00373685|9316349|P2|Overall Study|Other|146
2705325|NCT00373685|9316350|P1|Overall Study|Other|149
2705326|NCT00373685|9316349|P2|Overall Study|No longer willing to participate|352
2705327|NCT00373685|9316350|P1|Overall Study|No longer willing to participate|337
2705328|NCT00373685|9316349|P2|Overall Study|Lost to follow up|103
2705329|NCT00373685|9316350|P1|Overall Study|Lost to follow up|83
2705330|NCT00373685|9316349|P2|Overall Study|Did not meet entrance criteria|184
2705331|NCT00373685|9316350|P1|Overall Study|Did not meet entrance criteria|167
2705332|NCT00373685|9316349|P2|Overall Study|Insufficient clinical response|119
2705333|NCT00373685|9316350|P1|Overall Study|Insufficient clinical response|169
2705334|NCT00373685|9316349|P2|Overall Study|Adverse Event|253
2705335|NCT00373685|9316350|P1|Overall Study|Adverse Event|278
2705336|NCT00373685|9316349|P2|Overall Study|Death|1
2705337|NCT00373685|9316350|P1|Overall Study|Death|2
2705338|NCT00373529|9316384|P1|Overall Study|Consent violation|1
2705339|NCT00373529|9316384|P1|Overall Study|Failed independent confirmation of AML|3
2705340|NCT00373529|9316384|P1|Overall Study|Other|8
2705341|NCT00373529|9316384|P1|Overall Study|Need for treatment prohibited by study|1
2705342|NCT00373529|9316384|P1|Overall Study|Death|16
2705343|NCT00373529|9316384|P1|Overall Study|Disease recurrence|10
2705344|NCT00373529|9316384|P1|Overall Study|Treatment failure|36
2705345|NCT00373529|9316384|P1|Overall Study|Adverse Event|7
2705346|NCT00373529|9316384|P1|Overall Study|Withdrawal by Subject|7
2705347|NCT00373529|9316384|P1|Overall Study|Physician Decision|19
2705348|NCT00373490|9316396|P2|Overall Study|Withdrawal by Subject|1
2705349|NCT00373490|9316397|P1|Overall Study|Withdrawal by Subject|0
2705350|NCT00373490|9316396|P2|Overall Study|Lack of Efficacy|4
2705351|NCT00373490|9316397|P1|Overall Study|Lack of Efficacy|9
2705352|NCT00373490|9316396|P2|Overall Study|Adverse Event|1
2705353|NCT00373490|9316397|P1|Overall Study|Adverse Event|0
2705354|NCT00373425|9316420|P5|Overall Study|Death|0
2705355|NCT00373425|9316421|P4|Overall Study|Death|1
2705356|NCT00373425|9316422|P3|Overall Study|Death|3
2705357|NCT00373425|9316423|P2|Overall Study|Death|0
2705358|NCT00373425|9316424|P1|Overall Study|Death|7
2705359|NCT00373425|9316420|P5|Overall Study|Medical/ethical/noncompliance reason|5
2705360|NCT00373425|9316421|P4|Overall Study|Medical/ethical/noncompliance reason|2
2705361|NCT00373425|9316422|P3|Overall Study|Medical/ethical/noncompliance reason|10
2705362|NCT00373425|9316423|P2|Overall Study|Medical/ethical/noncompliance reason|9
2705363|NCT00373425|9316424|P1|Overall Study|Medical/ethical/noncompliance reason|21
2705364|NCT00373425|9316420|P5|Overall Study|Patient request|7
2705365|NCT00373425|9316421|P4|Overall Study|Patient request|6
2705366|NCT00373425|9316422|P3|Overall Study|Patient request|43
2705367|NCT00373425|9316423|P2|Overall Study|Patient request|18
2705368|NCT00373425|9316424|P1|Overall Study|Patient request|35
2705369|NCT00373425|9316420|P5|Overall Study|Adverse Event|34
2705370|NCT00373425|9316421|P4|Overall Study|Adverse Event|0
2705371|NCT00373425|9316422|P3|Overall Study|Adverse Event|59
2705372|NCT00373425|9316423|P2|Overall Study|Adverse Event|22
2705373|NCT00373425|9316424|P1|Overall Study|Adverse Event|191
2705374|NCT00373425|9316420|P5|Overall Study|Relapse of NSCLC|26
2705375|NCT00373425|9316421|P4|Overall Study|Relapse of NSCLC|2
2705376|NCT00373425|9316422|P3|Overall Study|Relapse of NSCLC|19
2705377|NCT00373425|9316423|P2|Overall Study|Relapse of NSCLC|104
2705378|NCT00373425|9316424|P1|Overall Study|Relapse of NSCLC|116
2705379|NCT00373295|9316519|P6|Intervention 1 (8 Days)|Withdrawal by Subject|0
2705380|NCT00373295|9316520|P5|Intervention 1 (8 Days)|Withdrawal by Subject|1
2705381|NCT00373295|9316521|P4|Intervention 1 (8 Days)|Withdrawal by Subject|0
2705382|NCT00373295|9316522|P3|Intervention 1 (8 Days)|Withdrawal by Subject|0
2705383|NCT00373295|9316523|P2|Intervention 1 (8 Days)|Withdrawal by Subject|2
2705384|NCT00373295|9316524|P1|Intervention 1 (8 Days)|Withdrawal by Subject|0
2705385|NCT00373256|9316545|P2|Overall Study|Study Terminated by Sponsor|13
2705386|NCT00373256|9316546|P1|Overall Study|Study Terminated by Sponsor|41
2705387|NCT00373256|9316545|P2|Overall Study|Protocol Violation|2
2705388|NCT00373256|9316546|P1|Overall Study|Protocol Violation|0
2705389|NCT00373256|9316545|P2|Overall Study|Other|107
2705390|NCT00373256|9316546|P1|Overall Study|Other|73
2705391|NCT00373256|9316545|P2|Overall Study|Refused Treatment-Reason Other Than AE|7
2705392|NCT00373256|9316546|P1|Overall Study|Refused Treatment-Reason Other Than AE|4
2705393|NCT00373256|9316545|P2|Overall Study|Objective Progression or Relapse|104
2705394|NCT00373256|9316546|P1|Overall Study|Objective Progression or Relapse|111
2705395|NCT00373256|9316545|P2|Overall Study|Death|8
2705396|NCT00373256|9316546|P1|Overall Study|Death|9
2705397|NCT00373256|9316545|P2|Overall Study|Lost to Follow-up|1
2705398|NCT00373256|9316546|P1|Overall Study|Lost to Follow-up|2
2705399|NCT00373256|9316545|P2|Overall Study|Adverse Event (AE)|5
2705400|NCT00373256|9316546|P1|Overall Study|Adverse Event (AE)|1
2705401|NCT00373113|9316572|P2|Overall Study|Withdrawal by Subject|15
2705402|NCT00373113|9316573|P1|Overall Study|Withdrawal by Subject|10
2705403|NCT00373113|9316572|P2|Overall Study|Protocol Violation|1
2705404|NCT00373113|9316573|P1|Overall Study|Protocol Violation|5
2705405|NCT00373113|9316572|P2|Overall Study|Other|17
2705406|NCT00373113|9316573|P1|Overall Study|Other|14
2705407|NCT00373113|9316572|P2|Overall Study|Objective progression or relapse|169
2705408|NCT00373113|9316573|P1|Overall Study|Objective progression or relapse|150
2705409|NCT00373113|9316572|P2|Overall Study|Lost to Follow-up|3
2705410|NCT00373113|9316573|P1|Overall Study|Lost to Follow-up|1
2705411|NCT00373113|9316572|P2|Overall Study|Global deterioration of health status|7
2705412|NCT00373113|9316573|P1|Overall Study|Global deterioration of health status|10
2705413|NCT00373113|9316572|P2|Overall Study|Study terminated by sponsor|1
2705414|NCT00373113|9316573|P1|Overall Study|Study terminated by sponsor|9
2705415|NCT00373113|9316572|P2|Overall Study|Adverse Event|24
2705416|NCT00373113|9316573|P1|Overall Study|Adverse Event|38
2705417|NCT00373113|9316572|P2|Overall Study|Death|7
2705418|NCT00373113|9316573|P1|Overall Study|Death|1
2705419|NCT00372996|9316595|P4|Overall Study|Other|7
2705420|NCT00372996|9316596|P3|Overall Study|Other|7
2705421|NCT00372996|9316597|P2|Overall Study|Other|2
2705422|NCT00372996|9316598|P1|Overall Study|Other|10
2705423|NCT00372996|9316595|P4|Overall Study|Study Terminated by Sponsor|0
2705424|NCT00372996|9316596|P3|Overall Study|Study Terminated by Sponsor|4
2705425|NCT00372996|9316597|P2|Overall Study|Study Terminated by Sponsor|0
2705426|NCT00372996|9316598|P1|Overall Study|Study Terminated by Sponsor|4
2705427|NCT00372996|9316595|P4|Overall Study|Withdrawal by Subject|5
2705428|NCT00372996|9316596|P3|Overall Study|Withdrawal by Subject|9
2705429|NCT00372996|9316597|P2|Overall Study|Withdrawal by Subject|6
2705430|NCT00372996|9316598|P1|Overall Study|Withdrawal by Subject|12
2705431|NCT00372996|9316595|P4|Overall Study|Lost to Follow-up|1
2705432|NCT00372996|9316596|P3|Overall Study|Lost to Follow-up|0
2705433|NCT00372996|9316597|P2|Overall Study|Lost to Follow-up|2
2705434|NCT00372996|9316598|P1|Overall Study|Lost to Follow-up|0
2705435|NCT00372996|9316595|P4|Overall Study|Death|7
2705436|NCT00372996|9316596|P3|Overall Study|Death|8
2705437|NCT00372996|9316597|P2|Overall Study|Death|4
2705438|NCT00372996|9316598|P1|Overall Study|Death|11
2705439|NCT00372905|9316683|P4|Follow up Until Relapse or Progression|Other|0
2705440|NCT00372905|9316684|P3|Follow up Until Relapse or Progression|Other|0
2705441|NCT00372905|9316685|P2|Follow up Until Relapse or Progression|Other|1
2705442|NCT00372905|9316686|P1|Follow up Until Relapse or Progression|Other|0
2705443|NCT00372905|9316683|P4|Follow up Until Relapse or Progression|Study closed|3
2705444|NCT00372905|9316684|P3|Follow up Until Relapse or Progression|Study closed|0
2705445|NCT00372905|9316685|P2|Follow up Until Relapse or Progression|Study closed|0
2705446|NCT00372905|9316686|P1|Follow up Until Relapse or Progression|Study closed|0
2705447|NCT00372905|9316683|P4|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2
2705448|NCT00372905|9316684|P3|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
2705449|NCT00372905|9316685|P2|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
2705450|NCT00372905|9316686|P1|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
2705451|NCT00372905|9316683|P4|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
2705452|NCT00372905|9316684|P3|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1
2705453|NCT00372905|9316685|P2|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
2705454|NCT00372905|9316686|P1|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
2705455|NCT00372905|9316683|P4|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
2705456|NCT00372905|9316684|P3|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2
2705457|NCT00372905|9316685|P2|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
2705458|NCT00372905|9316686|P1|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
2705459|NCT00372905|9316683|P4|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
2705460|NCT00372905|9316684|P3|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
2705461|NCT00372905|9316685|P2|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
2705462|NCT00372905|9316686|P1|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2
2705463|NCT00372775|9316698|P1|Overall Study|Not Treated|2
2705464|NCT00372775|9316698|P1|Overall Study|Other|1
2705465|NCT00372775|9316698|P1|Overall Study|Withdrawal by Subject|1
2705466|NCT00372775|9316698|P1|Overall Study|Global deterioration of health status|6
2705467|NCT00372775|9316698|P1|Overall Study|Objective progression or relapse|30
2705468|NCT00372775|9316698|P1|Overall Study|Death|15
2705469|NCT00372775|9316698|P1|Overall Study|Adverse Event|8
2705470|NCT00372697|9316720|P2|Overall Study|Protocol Violation|1
2705471|NCT00372697|9316721|P1|Overall Study|Protocol Violation|1
2705472|NCT00372619|9316746|P7|Overall Study|Inevaluable|0
2705473|NCT00372619|9316747|P6|Overall Study|Inevaluable|1
2705474|NCT00372619|9316748|P5|Overall Study|Inevaluable|0
2705475|NCT00372619|9316749|P4|Overall Study|Inevaluable|0
2705476|NCT00372619|9316750|P3|Overall Study|Inevaluable|0
2705477|NCT00372619|9316751|P2|Overall Study|Inevaluable|0
2705478|NCT00372619|9316752|P1|Overall Study|Inevaluable|0
2705479|NCT00372619|9316746|P7|Overall Study|Ineligible|0
2705480|NCT00372619|9316747|P6|Overall Study|Ineligible|2
2705481|NCT00372619|9316748|P5|Overall Study|Ineligible|0
2705482|NCT00372619|9316749|P4|Overall Study|Ineligible|0
2705483|NCT00372619|9316750|P3|Overall Study|Ineligible|0
2705484|NCT00372619|9316751|P2|Overall Study|Ineligible|0
2705485|NCT00372619|9316752|P1|Overall Study|Ineligible|0
2705486|NCT00372593|9316785|P3|Overall Study|Ineligible|1
2705487|NCT00372593|9316786|P2|Overall Study|Ineligible|21
2705488|NCT00372593|9316787|P1|Overall Study|Ineligible|20
2705489|NCT00372593|9316785|P3|Overall Study|Physician Decision|0
2705490|NCT00372593|9316786|P2|Overall Study|Physician Decision|41
2705491|NCT00372593|9316787|P1|Overall Study|Physician Decision|42
2705492|NCT00372593|9316785|P3|Overall Study|Lost to Follow-up|0
2705493|NCT00372593|9316786|P2|Overall Study|Lost to Follow-up|0
2705494|NCT00372593|9316787|P1|Overall Study|Lost to Follow-up|1
2705495|NCT00372593|9316785|P3|Overall Study|Lack of Efficacy|2
2705496|NCT00372593|9316786|P2|Overall Study|Lack of Efficacy|71
2705497|NCT00372593|9316787|P1|Overall Study|Lack of Efficacy|82
2705498|NCT00372593|9316785|P3|Overall Study|Death|1
2705499|NCT00372593|9316786|P2|Overall Study|Death|20
2705500|NCT00372593|9316787|P1|Overall Study|Death|16
2705501|NCT00372593|9316785|P3|Overall Study|Adverse Event|0
2705502|NCT00372593|9316786|P2|Overall Study|Adverse Event|45
2705503|NCT00372593|9316787|P1|Overall Study|Adverse Event|43
2705504|NCT00372567|9316816|P3|Phase 3 Study|study terminated by sponsor|5
2705505|NCT00372567|9316817|P2|Phase 3 Study|study terminated by sponsor|8
2705506|NCT00372567|9316818|P1|Phase 3 Study|study terminated by sponsor|13
2705507|NCT00372567|9316816|P3|Phase 3 Study|Other|1
2705508|NCT00372567|9316817|P2|Phase 3 Study|Other|2
2705509|NCT00372567|9316818|P1|Phase 3 Study|Other|2
2705510|NCT00372567|9316816|P3|Phase 3 Study|Global deterioration of health status|0
2705511|NCT00372567|9316817|P2|Phase 3 Study|Global deterioration of health status|1
2705512|NCT00372567|9316818|P1|Phase 3 Study|Global deterioration of health status|0
2705513|NCT00372567|9316816|P3|Phase 3 Study|Objective progression or relapse|4
2705514|NCT00372567|9316817|P2|Phase 3 Study|Objective progression or relapse|13
2705515|NCT00372567|9316818|P1|Phase 3 Study|Objective progression or relapse|10
2705516|NCT00372567|9316816|P3|Phase 3 Study|Protocol Violation|1
2705517|NCT00372567|9316817|P2|Phase 3 Study|Protocol Violation|0
2705518|NCT00372567|9316818|P1|Phase 3 Study|Protocol Violation|0
2705519|NCT00372567|9316816|P3|Phase 3 Study|Death|0
2705520|NCT00372567|9316817|P2|Phase 3 Study|Death|1
2705521|NCT00372567|9316818|P1|Phase 3 Study|Death|1
2705522|NCT00372567|9316816|P3|Phase 3 Study|Adverse Event|1
2705523|NCT00372567|9316817|P2|Phase 3 Study|Adverse Event|1
2705524|NCT00372567|9316818|P1|Phase 3 Study|Adverse Event|5
2705525|NCT00372528|9316846|P1|Overall Study|Other|1
2705526|NCT00372528|9316846|P1|Overall Study|Study Terminated by Sponsor|18
2705527|NCT00372528|9316846|P1|Overall Study|Adverse Event|1
2705528|NCT00372528|9316846|P1|Overall Study|Lack of Efficacy|1
2705529|NCT00372489|9316851|P1|Overall Study|Sponsor Decision to Terminate Study|41
2705530|NCT00372489|9316851|P1|Overall Study|Renal transplant|6
2705531|NCT00372489|9316851|P1|Overall Study|Patient Relocation|2
2705532|NCT00372489|9316851|P1|Overall Study|Withdrawal by Subject|5
2705533|NCT00372489|9316851|P1|Overall Study|Physician Decision|3
2705534|NCT00372489|9316851|P1|Overall Study|Lost to Follow-up|3
2705535|NCT00372489|9316851|P1|Overall Study|Lack of Efficacy|1
2705536|NCT00372489|9316851|P1|Overall Study|Adverse Event|18
2705537|NCT00372424|9316855|P1|Overall Study|Enrolled, Not Treated|1
2705538|NCT00372424|9316855|P1|Overall Study|Other|7
2705539|NCT00372424|9316855|P1|Overall Study|Objective Progression or Relapse|14
2705540|NCT00372424|9316855|P1|Overall Study|Death|1
2705541|NCT00372424|9316855|P1|Overall Study|Withdrawal by Subject|1
2705542|NCT00372424|9316855|P1|Overall Study|Adverse Event|2
2705543|NCT00372411|9316869|P3|Overall Study|Adverse Event|0
2705544|NCT00372411|9316870|P2|Overall Study|Adverse Event|1
2705545|NCT00372411|9316871|P1|Overall Study|Adverse Event|1
2705546|NCT00372411|9316869|P3|Overall Study|Lost to Follow-up|1
2705547|NCT00372411|9316870|P2|Overall Study|Lost to Follow-up|1
2705548|NCT00372411|9316871|P1|Overall Study|Lost to Follow-up|1
2705549|NCT00372411|9316869|P3|Overall Study|Death|1
2705550|NCT00372411|9316870|P2|Overall Study|Death|2
2705551|NCT00372411|9316871|P1|Overall Study|Death|0
2705552|NCT00372411|9316869|P3|Overall Study|Withdrawal by Subject|1
2705553|NCT00372411|9316870|P2|Overall Study|Withdrawal by Subject|4
2705554|NCT00372411|9316871|P1|Overall Study|Withdrawal by Subject|3
2705555|NCT00372385|9316895|P4|Overall Study|Virologic Stopping Rule|0
2705556|NCT00372385|9316896|P3|Overall Study|Virologic Stopping Rule|0
2705557|NCT00372385|9316897|P2|Overall Study|Virologic Stopping Rule|0
2705558|NCT00372385|9316898|P1|Overall Study|Virologic Stopping Rule|17
2705559|NCT00372385|9316895|P4|Overall Study|Ineligibility due to Exclusion Criterion|0
2705560|NCT00372385|9316896|P3|Overall Study|Ineligibility due to Exclusion Criterion|0
2705561|NCT00372385|9316897|P2|Overall Study|Ineligibility due to Exclusion Criterion|0
2705562|NCT00372385|9316898|P1|Overall Study|Ineligibility due to Exclusion Criterion|1
2705563|NCT00372385|9316895|P4|Overall Study|No Response|0
2705564|NCT00372385|9316896|P3|Overall Study|No Response|0
2705565|NCT00372385|9316897|P2|Overall Study|No Response|1
2705566|NCT00372385|9316898|P1|Overall Study|No Response|1
2705567|NCT00372385|9316895|P4|Overall Study|Refusal of Treatment|0
2705568|NCT00372385|9316896|P3|Overall Study|Refusal of Treatment|0
2705569|NCT00372385|9316897|P2|Overall Study|Refusal of Treatment|6
2705570|NCT00372385|9316898|P1|Overall Study|Refusal of Treatment|3
2705571|NCT00372385|9316895|P4|Overall Study|Withdrawal by Subject|0
2705572|NCT00372385|9316896|P3|Overall Study|Withdrawal by Subject|0
2705573|NCT00372385|9316897|P2|Overall Study|Withdrawal by Subject|1
2705574|NCT00372385|9316898|P1|Overall Study|Withdrawal by Subject|2
2705575|NCT00372385|9316895|P4|Overall Study|Lost to Follow-up|0
2705576|NCT00372385|9316896|P3|Overall Study|Lost to Follow-up|0
2705577|NCT00372385|9316897|P2|Overall Study|Lost to Follow-up|0
2705578|NCT00372385|9316898|P1|Overall Study|Lost to Follow-up|2
2705579|NCT00372385|9316895|P4|Overall Study|Physician Decision|0
2705580|NCT00372385|9316896|P3|Overall Study|Physician Decision|0
2705581|NCT00372385|9316897|P2|Overall Study|Physician Decision|0
2705582|NCT00372385|9316898|P1|Overall Study|Physician Decision|1
2705583|NCT00372385|9316895|P4|Overall Study|Noncompliance|1
2705584|NCT00372385|9316896|P3|Overall Study|Noncompliance|1
2705585|NCT00372385|9316897|P2|Overall Study|Noncompliance|1
2705586|NCT00372385|9316898|P1|Overall Study|Noncompliance|0
2705587|NCT00372385|9316895|P4|Overall Study|Adverse Event|7
2705588|NCT00372385|9316896|P3|Overall Study|Adverse Event|9
2705589|NCT00372385|9316897|P2|Overall Study|Adverse Event|11
2705590|NCT00372385|9316898|P1|Overall Study|Adverse Event|6
2705591|NCT00372255|9316927|P2|Overall Study|Withdrawn for other reasons|1
2705592|NCT00372255|9316928|P1|Overall Study|Withdrawn for other reasons|2
2705593|NCT00372229|9316950|P2|Follow-Up Phase|Lost to Follow-up|10
2705594|NCT00372229|9316951|P1|Follow-Up Phase|Lost to Follow-up|12
2705595|NCT00372229|9316950|P2|Follow-Up Phase|Reason not specified|3
2705596|NCT00372229|9316951|P1|Follow-Up Phase|Reason not specified|2
2705597|NCT00372229|9316950|P2|Follow-Up Phase|Administrative|0
2705598|NCT00372229|9316951|P1|Follow-Up Phase|Administrative|1
2705599|NCT00372229|9316950|P2|Follow-Up Phase|Death|12
2705600|NCT00372229|9316951|P1|Follow-Up Phase|Death|9
2705601|NCT00372229|9316950|P2|Follow-Up Phase|Adverse event/intercurrent illness|0
2705602|NCT00372229|9316951|P1|Follow-Up Phase|Adverse event/intercurrent illness|1
2705603|NCT00372229|9316950|P2|Follow-Up Phase|Refused treatment/did not cooperate|1
2705604|NCT00372229|9316951|P1|Follow-Up Phase|Refused treatment/did not cooperate|0
2705605|NCT00372229|9316950|P2|Follow-Up Phase|Consent withdrawn|19
2705606|NCT00372229|9316951|P1|Follow-Up Phase|Consent withdrawn|13
2705607|NCT00372229|9316950|P2|Follow-Up Phase|Graft loss|7
2705608|NCT00372229|9316951|P1|Follow-Up Phase|Graft loss|8
2705609|NCT00372229|9316950|P2|Study Phase|Lost to Follow-up|3
2705610|NCT00372229|9316951|P1|Study Phase|Lost to Follow-up|3
2705611|NCT00372229|9316950|P2|Study Phase|Reason not specified|2
2705612|NCT00372229|9316951|P1|Study Phase|Reason not specified|3
2705613|NCT00372229|9316950|P2|Study Phase|Death|2
2705614|NCT00372229|9316951|P1|Study Phase|Death|3
2705615|NCT00372229|9316950|P2|Study Phase|Refused treatment/did not cooperate|1
2705616|NCT00372229|9316951|P1|Study Phase|Refused treatment/did not cooperate|3
2705617|NCT00372229|9316950|P2|Study Phase|Consent withdrawn|14
2705618|NCT00372229|9316951|P1|Study Phase|Consent withdrawn|16
2705619|NCT00372229|9316950|P2|Study Phase|Protocol Violation|4
2705620|NCT00372229|9316951|P1|Study Phase|Protocol Violation|3
2705621|NCT00372229|9316950|P2|Study Phase|Graft loss|3
2705622|NCT00372229|9316951|P1|Study Phase|Graft loss|0
2705623|NCT00372190|9317041|P2|Overall Study|Lost to Follow-up|1
2705624|NCT00372190|9317042|P1|Overall Study|Lost to Follow-up|3
2705625|NCT00372112|9317058|P4|Overall Study|Other-protocol violation|0
2705626|NCT00372112|9317059|P3|Overall Study|Other-protocol violation|1
2705627|NCT00372112|9317060|P2|Overall Study|Other-protocol violation|0
2705628|NCT00372112|9317061|P1|Overall Study|Other-protocol violation|0
2705629|NCT00372112|9317058|P4|Overall Study|Hepatitis B|0
2705630|NCT00372112|9317059|P3|Overall Study|Hepatitis B|0
2705631|NCT00372112|9317060|P2|Overall Study|Hepatitis B|0
2705632|NCT00372112|9317061|P1|Overall Study|Hepatitis B|1
2705633|NCT00372112|9317058|P4|Overall Study|PR >240 at Visit 3|1
2705634|NCT00372112|9317059|P3|Overall Study|PR >240 at Visit 3|0
2705635|NCT00372112|9317060|P2|Overall Study|PR >240 at Visit 3|0
2705636|NCT00372112|9317061|P1|Overall Study|PR >240 at Visit 3|0
2705637|NCT00372112|9317058|P4|Overall Study|Exacerbation|1
2705638|NCT00372112|9317059|P3|Overall Study|Exacerbation|0
2705639|NCT00372112|9317060|P2|Overall Study|Exacerbation|0
2705640|NCT00372112|9317061|P1|Overall Study|Exacerbation|0
2705641|NCT00372112|9317058|P4|Overall Study|Withdrawal by Subject|1
2705642|NCT00372112|9317059|P3|Overall Study|Withdrawal by Subject|2
2705643|NCT00372112|9317060|P2|Overall Study|Withdrawal by Subject|0
2705644|NCT00372112|9317061|P1|Overall Study|Withdrawal by Subject|0
2705645|NCT00372112|9317058|P4|Overall Study|Adverse Event|1
2705646|NCT00372112|9317059|P3|Overall Study|Adverse Event|1
2705647|NCT00372112|9317060|P2|Overall Study|Adverse Event|1
2705648|NCT00372112|9317061|P1|Overall Study|Adverse Event|0
2705649|NCT00372060|9317192|P2|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0
2705650|NCT00372060|9317193|P1|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2
2705651|NCT00372060|9317192|P2|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8
2705652|NCT00372060|9317193|P1|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9
2705653|NCT00372060|9317192|P2|Period II - Open-label (Weeks 12-52)|Adverse Event|0
2705654|NCT00372060|9317193|P1|Period II - Open-label (Weeks 12-52)|Adverse Event|3
2705655|NCT00372060|9317192|P2|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0
2705656|NCT00372060|9317193|P1|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1
2705657|NCT00372060|9317192|P2|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1
2705658|NCT00372060|9317193|P1|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0
2705659|NCT00372060|9317192|P2|Period I - Double-blind (Weeks 0-12)|Adverse Event|0
2705660|NCT00372060|9317193|P1|Period I - Double-blind (Weeks 0-12)|Adverse Event|2
2705661|NCT00371865|9317208|P2|Overall Study|Withdrawal by Subject|10
2705662|NCT00371865|9317209|P1|Overall Study|Withdrawal by Subject|12
2705663|NCT00371865|9317208|P2|Overall Study|Protocol Violation|2
2705664|NCT00371865|9317209|P1|Overall Study|Protocol Violation|3
2705665|NCT00371865|9317208|P2|Overall Study|Lack of Efficacy|2
2705666|NCT00371865|9317209|P1|Overall Study|Lack of Efficacy|0
2705667|NCT00371839|9317226|P3|Overall Study|Lost to Follow-up|2
2705668|NCT00371839|9317227|P2|Overall Study|Lost to Follow-up|3
2705669|NCT00371839|9317228|P1|Overall Study|Lost to Follow-up|6
2705670|NCT00371839|9317226|P3|Overall Study|Withdrawal by Subject|0
2705671|NCT00371839|9317227|P2|Overall Study|Withdrawal by Subject|4
2705672|NCT00371839|9317228|P1|Overall Study|Withdrawal by Subject|7
2705673|NCT00371839|9317226|P3|Overall Study|Death|0
2705674|NCT00371839|9317227|P2|Overall Study|Death|0
2705675|NCT00371839|9317228|P1|Overall Study|Death|4
2705676|NCT00371826|9317237|P3|Extension Phase (24 Months)|Administrative problems|2
2705677|NCT00371826|9317238|P2|Extension Phase (24 Months)|Administrative problems|0
2705678|NCT00371826|9317239|P1|Extension Phase (24 Months)|Administrative problems|0
2705679|NCT00371826|9317237|P3|Extension Phase (24 Months)|Subject withdrew consent|0
2705680|NCT00371826|9317238|P2|Extension Phase (24 Months)|Subject withdrew consent|2
2705681|NCT00371826|9317239|P1|Extension Phase (24 Months)|Subject withdrew consent|1
2705682|NCT00371826|9317237|P3|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
2705683|NCT00371826|9317238|P2|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2
2705684|NCT00371826|9317239|P1|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
2705685|NCT00371826|9317237|P3|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
2705686|NCT00371826|9317238|P2|Extension Phase (24 Months)|Abnormal test procedure result(s)|1
2705687|NCT00371826|9317239|P1|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
2705688|NCT00371826|9317237|P3|Extension Phase (24 Months)|Adverse Event|0
2705689|NCT00371826|9317238|P2|Extension Phase (24 Months)|Adverse Event|5
2705690|NCT00371826|9317239|P1|Extension Phase (24 Months)|Adverse Event|4
2705691|NCT00371826|9317237|P3|Core Phase (12 Months)|Graft Loss|0
2705692|NCT00371826|9317238|P2|Core Phase (12 Months)|Graft Loss|1
2705693|NCT00371826|9317239|P1|Core Phase (12 Months)|Graft Loss|0
2705694|NCT00371826|9317237|P3|Core Phase (12 Months)|Administrative problems|8
2705695|NCT00371826|9317238|P2|Core Phase (12 Months)|Administrative problems|0
2705696|NCT00371826|9317239|P1|Core Phase (12 Months)|Administrative problems|1
2705697|NCT00371826|9317237|P3|Core Phase (12 Months)|Subject withdrew consent|3
2705698|NCT00371826|9317238|P2|Core Phase (12 Months)|Subject withdrew consent|0
2705699|NCT00371826|9317239|P1|Core Phase (12 Months)|Subject withdrew consent|0
2705700|NCT00371826|9317237|P3|Core Phase (12 Months)|Protocol Violation|1
2705701|NCT00371826|9317238|P2|Core Phase (12 Months)|Protocol Violation|0
2705702|NCT00371826|9317239|P1|Core Phase (12 Months)|Protocol Violation|1
2705703|NCT00371826|9317237|P3|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2
2705704|NCT00371826|9317238|P2|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3
2705705|NCT00371826|9317239|P1|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6
2705706|NCT00371826|9317237|P3|Core Phase (12 Months)|Abnormal test procedure result(s)|1
2705707|NCT00371826|9317238|P2|Core Phase (12 Months)|Abnormal test procedure result(s)|0
2705708|NCT00371826|9317239|P1|Core Phase (12 Months)|Abnormal test procedure result(s)|1
2705709|NCT00371826|9317237|P3|Core Phase (12 Months)|Adverse Event|9
2705710|NCT00371826|9317238|P2|Core Phase (12 Months)|Adverse Event|4
2705711|NCT00371826|9317239|P1|Core Phase (12 Months)|Adverse Event|15
2705712|NCT00371787|9317363|P2|Overall Study|Withdrawal by Subject|1
2705713|NCT00371787|9317364|P1|Overall Study|Withdrawal by Subject|3
2705714|NCT00371761|9317378|P2|Overall Study|Study termination|3
2705715|NCT00371761|9317379|P1|Overall Study|Study termination|4
2705716|NCT00371761|9317378|P2|Overall Study|Investigator Judgment|3
2705717|NCT00371761|9317379|P1|Overall Study|Investigator Judgment|2
2705718|NCT00371761|9317378|P2|Overall Study|Withdrawal by Subject|3
2705719|NCT00371761|9317379|P1|Overall Study|Withdrawal by Subject|1
2705720|NCT00371761|9317378|P2|Overall Study|Adverse Event|1
2705721|NCT00371761|9317379|P1|Overall Study|Adverse Event|1
2705722|NCT00371683|9317387|P2|Follow-Up Period - Randomized Patients|non-specified|12
2705723|NCT00371683|9317388|P1|Follow-Up Period - Randomized Patients|non-specified|6
2705724|NCT00371683|9317387|P2|Follow-Up Period - Randomized Patients|Lost to Follow-up|39
2705725|NCT00371683|9317388|P1|Follow-Up Period - Randomized Patients|Lost to Follow-up|38
2705726|NCT00371683|9317387|P2|Follow-Up Period - Randomized Patients|Death|2
2705727|NCT00371683|9317388|P1|Follow-Up Period - Randomized Patients|Death|0
2705728|NCT00371683|9317387|P2|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19
2705729|NCT00371683|9317388|P1|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17
2705730|NCT00371683|9317387|P2|DB Treatment Period-Randomized Patients|non-specified|8
2705731|NCT00371683|9317388|P1|DB Treatment Period-Randomized Patients|non-specified|9
2705732|NCT00371683|9317387|P2|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0
2705733|NCT00371683|9317388|P1|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1
2705734|NCT00371683|9317387|P2|DB Treatment Period-Randomized Patients|No longer meets study criteria|2
2705735|NCT00371683|9317388|P1|DB Treatment Period-Randomized Patients|No longer meets study criteria|1
2705736|NCT00371683|9317387|P2|DB Treatment Period-Randomized Patients|Lost to Follow-up|1
2705737|NCT00371683|9317388|P1|DB Treatment Period-Randomized Patients|Lost to Follow-up|0
2705738|NCT00371683|9317387|P2|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37
2705739|NCT00371683|9317388|P1|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18
2705740|NCT00371683|9317387|P2|DB Treatment Period-Randomized Patients|Adverse Event|58
2705741|NCT00371683|9317388|P1|DB Treatment Period-Randomized Patients|Adverse Event|60
2705742|NCT00371683|9317387|P2|DB Treatment Period-Randomized Patients|Death|1
2705743|NCT00371683|9317388|P1|DB Treatment Period-Randomized Patients|Death|1
2705744|NCT00371566|9317456|P2|Follow Up Phase|Lost to Follow-up|0
2705745|NCT00371566|9317457|P1|Follow Up Phase|Lost to Follow-up|1
2705746|NCT00371566|9317456|P2|Follow Up Phase|Physician Decision|1
2705747|NCT00371566|9317457|P1|Follow Up Phase|Physician Decision|1
2705748|NCT00371566|9317456|P2|Follow Up Phase|Withdrawal by Subject|1
2705749|NCT00371566|9317457|P1|Follow Up Phase|Withdrawal by Subject|0
2705750|NCT00371566|9317456|P2|Follow Up Phase|Disease progression|0
2705751|NCT00371566|9317457|P1|Follow Up Phase|Disease progression|1
2705752|NCT00371566|9317456|P2|Follow Up Phase|Death|5
2705753|NCT00371566|9317457|P1|Follow Up Phase|Death|0
2705754|NCT00371566|9317456|P2|Chemoradiation Phase|Death|0
2705755|NCT00371566|9317457|P1|Chemoradiation Phase|Death|2
2705756|NCT00371566|9317456|P2|Chemoradiation Phase|Progressive Disease|1
2705757|NCT00371566|9317457|P1|Chemoradiation Phase|Progressive Disease|1
2705758|NCT00371566|9317456|P2|Chemoradiation Phase|Non compliant|1
2705759|NCT00371566|9317457|P1|Chemoradiation Phase|Non compliant|0
2705760|NCT00371566|9317456|P2|Chemoradiation Phase|Withdrawal by Subject|1
2705761|NCT00371566|9317457|P1|Chemoradiation Phase|Withdrawal by Subject|0
2705762|NCT00371566|9317456|P2|Chemoradiation Phase|Physician Decision|0
2705763|NCT00371566|9317457|P1|Chemoradiation Phase|Physician Decision|2
2705764|NCT00371566|9317456|P2|Treatment Phase|Protocol Violation|1
2705765|NCT00371566|9317457|P1|Treatment Phase|Protocol Violation|0
2705766|NCT00371566|9317456|P2|Treatment Phase|Adverse Event|1
2705767|NCT00371566|9317457|P1|Treatment Phase|Adverse Event|0
2705768|NCT00371566|9317456|P2|Treatment Phase|Withdrawal by Subject|1
2705769|NCT00371566|9317457|P1|Treatment Phase|Withdrawal by Subject|0
2705770|NCT00371462|9317542|P2|Overall Study|Other|8
2705771|NCT00371462|9317543|P1|Overall Study|Other|7
2705772|NCT00371462|9317542|P2|Overall Study|Withdrawal by Subject|0
2705773|NCT00371462|9317543|P1|Overall Study|Withdrawal by Subject|1
2705774|NCT00371397|9317567|P12|Session 1|Withdrawal by Subject|0
2705775|NCT00371397|9317568|P11|Session 1|Withdrawal by Subject|0
2705776|NCT00371397|9317569|P10|Session 1|Withdrawal by Subject|0
2705777|NCT00371397|9317570|P9|Session 1|Withdrawal by Subject|0
2705778|NCT00371397|9317571|P8|Session 1|Withdrawal by Subject|1
2705779|NCT00371397|9317572|P7|Session 1|Withdrawal by Subject|0
2705780|NCT00371397|9317573|P6|Session 1|Withdrawal by Subject|0
2705781|NCT00371397|9317574|P5|Session 1|Withdrawal by Subject|0
2705782|NCT00371397|9317575|P4|Session 1|Withdrawal by Subject|0
2705783|NCT00371397|9317576|P3|Session 1|Withdrawal by Subject|0
2705784|NCT00371397|9317577|P2|Session 1|Withdrawal by Subject|0
2705785|NCT00371397|9317578|P1|Session 1|Withdrawal by Subject|1
2705786|NCT00371345|9317586|P2|Overall Study|Participant Withdrew Consent|1
2705787|NCT00371345|9317587|P1|Overall Study|Participant Withdrew Consent|0
2705788|NCT00371345|9317586|P2|Overall Study|Participant Request|1
2705789|NCT00371345|9317587|P1|Overall Study|Participant Request|1
2705790|NCT00371345|9317586|P2|Overall Study|Adverse event(AE Unrelated to Study Drug|2
2705791|NCT00371345|9317587|P1|Overall Study|Adverse event(AE Unrelated to Study Drug|1
2705792|NCT00371345|9317586|P2|Overall Study|Study Drug Toxicity|7
2705793|NCT00371345|9317587|P1|Overall Study|Study Drug Toxicity|1
2705794|NCT00371345|9317586|P2|Overall Study|Disease Progression|35
2705795|NCT00371345|9317587|P1|Overall Study|Disease Progression|21
2705796|NCT00371254|9317688|P2|Overall Study|Withdrawal by Subject|1
2705797|NCT00371254|9317689|P1|Overall Study|Withdrawal by Subject|0
2705798|NCT00371254|9317688|P2|Overall Study|Lost to Follow-up|1
2705799|NCT00371254|9317689|P1|Overall Study|Lost to Follow-up|0
2705800|NCT00371254|9317688|P2|Overall Study|Adverse event unrelated to study drug|1
2705801|NCT00371254|9317689|P1|Overall Study|Adverse event unrelated to study drug|0
2705802|NCT00371254|9317688|P2|Overall Study|Investigator Decision|0
2705803|NCT00371254|9317689|P1|Overall Study|Investigator Decision|2
2705804|NCT00371254|9317688|P2|Overall Study|Subject request|0
2705805|NCT00371254|9317689|P1|Overall Study|Subject request|5
2705806|NCT00371254|9317688|P2|Overall Study|Study drug toxicity|5
2705807|NCT00371254|9317689|P1|Overall Study|Study drug toxicity|3
2705808|NCT00371254|9317688|P2|Overall Study|Disease progression|13
2705809|NCT00371254|9317689|P1|Overall Study|Disease progression|13
2705810|NCT00371150|9317772|P2|Overall Study|Lost to Follow-up|2
2705811|NCT00371150|9317773|P1|Overall Study|Lost to Follow-up|3
2705812|NCT00371137|9317808|P3|Overall Study|Protocol Violation|1
2705813|NCT00371137|9317809|P2|Overall Study|Protocol Violation|1
2705814|NCT00371137|9317810|P1|Overall Study|Protocol Violation|2
2705815|NCT00371137|9317808|P3|Overall Study|Physician Decision|1
2705816|NCT00371137|9317809|P2|Overall Study|Physician Decision|1
2705817|NCT00371137|9317810|P1|Overall Study|Physician Decision|1
2705818|NCT00371137|9317808|P3|Overall Study|Sponsor Decision|2
2705819|NCT00371137|9317809|P2|Overall Study|Sponsor Decision|1
2705820|NCT00371137|9317810|P1|Overall Study|Sponsor Decision|2
2705821|NCT00371137|9317808|P3|Overall Study|Lack of Efficacy|13
2705822|NCT00371137|9317809|P2|Overall Study|Lack of Efficacy|12
2705823|NCT00371137|9317810|P1|Overall Study|Lack of Efficacy|30
2705824|NCT00371137|9317808|P3|Overall Study|Lost to Follow-up|5
2705825|NCT00371137|9317809|P2|Overall Study|Lost to Follow-up|3
2705826|NCT00371137|9317810|P1|Overall Study|Lost to Follow-up|6
2705827|NCT00371137|9317808|P3|Overall Study|Withdrawal by Subject|15
2705828|NCT00371137|9317809|P2|Overall Study|Withdrawal by Subject|10
2705829|NCT00371137|9317810|P1|Overall Study|Withdrawal by Subject|11
2705830|NCT00371137|9317808|P3|Overall Study|Adverse Event|42
2705831|NCT00371137|9317809|P2|Overall Study|Adverse Event|35
2705832|NCT00371137|9317810|P1|Overall Study|Adverse Event|20
2705833|NCT00370682|9317853|P3|Overall Study|Lost to Follow-up|1
2705834|NCT00370682|9317854|P2|Overall Study|Lost to Follow-up|1
2705835|NCT00370682|9317855|P1|Overall Study|Lost to Follow-up|0
2705836|NCT00370682|9317853|P3|Overall Study|Moved from area|0
2705837|NCT00370682|9317854|P2|Overall Study|Moved from area|2
2705838|NCT00370682|9317855|P1|Overall Study|Moved from area|0
2705839|NCT00370552|9317897|P3|Overall Study|Planned radiation for palliation|0
2705840|NCT00370552|9317898|P2|Overall Study|Planned radiation for palliation|1
2705841|NCT00370552|9317899|P1|Overall Study|Planned radiation for palliation|0
2705842|NCT00370552|9317897|P3|Overall Study|High risk of allergic reaction|0
2705843|NCT00370552|9317898|P2|Overall Study|High risk of allergic reaction|1
2705844|NCT00370552|9317899|P1|Overall Study|High risk of allergic reaction|0
2705845|NCT00370552|9317897|P3|Overall Study|Investigator decision|0
2705846|NCT00370552|9317898|P2|Overall Study|Investigator decision|1
2705847|NCT00370552|9317899|P1|Overall Study|Investigator decision|2
2705848|NCT00370552|9317897|P3|Overall Study|Physician Decision|0
2705849|NCT00370552|9317898|P2|Overall Study|Physician Decision|1
2705850|NCT00370552|9317899|P1|Overall Study|Physician Decision|1
2705851|NCT00370552|9317897|P3|Overall Study|Never treated|0
2705852|NCT00370552|9317898|P2|Overall Study|Never treated|0
2705853|NCT00370552|9317899|P1|Overall Study|Never treated|1
2705854|NCT00370552|9317897|P3|Overall Study|Still on treatment|2
2705855|NCT00370552|9317898|P2|Overall Study|Still on treatment|3
2705856|NCT00370552|9317899|P1|Overall Study|Still on treatment|1
2705857|NCT00370552|9317897|P3|Overall Study|Withdrawal by Subject|1
2705858|NCT00370552|9317898|P2|Overall Study|Withdrawal by Subject|0
2705859|NCT00370552|9317899|P1|Overall Study|Withdrawal by Subject|2
2705860|NCT00370552|9317897|P3|Overall Study|Study drug toxicity|6
2705861|NCT00370552|9317898|P2|Overall Study|Study drug toxicity|8
2705862|NCT00370552|9317899|P1|Overall Study|Study drug toxicity|11
2705863|NCT00370552|9317897|P3|Overall Study|Poor or noncompliance|1
2705864|NCT00370552|9317898|P2|Overall Study|Poor or noncompliance|0
2705865|NCT00370552|9317899|P1|Overall Study|Poor or noncompliance|0
2705866|NCT00370552|9317897|P3|Overall Study|Maximum clinical benefit|5
2705867|NCT00370552|9317898|P2|Overall Study|Maximum clinical benefit|5
2705868|NCT00370552|9317899|P1|Overall Study|Maximum clinical benefit|3
2705869|NCT00370552|9317897|P3|Overall Study|Disease progression|15
2705870|NCT00370552|9317898|P2|Overall Study|Disease progression|23
2705871|NCT00370552|9317899|P1|Overall Study|Disease progression|23
2705872|NCT00370552|9317897|P3|Overall Study|Adverse Event|2
2705873|NCT00370552|9317898|P2|Overall Study|Adverse Event|2
2705874|NCT00370552|9317899|P1|Overall Study|Adverse Event|2
2705875|NCT00370396|9317940|P3|Overall Study|Lost to Follow-up|0
2705876|NCT00370396|9317941|P2|Overall Study|Lost to Follow-up|1
2705877|NCT00370396|9317942|P1|Overall Study|Lost to Follow-up|11
2705878|NCT00370396|9317940|P3|Overall Study|Withdrawal by Subject|1
2705879|NCT00370396|9317941|P2|Overall Study|Withdrawal by Subject|0
2705880|NCT00370396|9317942|P1|Overall Study|Withdrawal by Subject|0
2705881|NCT00370331|9317996|P2|Overall Study|Protocol Violation|1
2705882|NCT00370331|9317997|P1|Overall Study|Protocol Violation|1
2705883|NCT00370331|9317996|P2|Overall Study|Non-compliance|1
2705884|NCT00370331|9317997|P1|Overall Study|Non-compliance|0
2705885|NCT00370331|9317996|P2|Overall Study|Lack of Efficacy|1
2705886|NCT00370331|9317997|P1|Overall Study|Lack of Efficacy|0
2705887|NCT00370331|9317996|P2|Overall Study|Lost to Follow-up|3
2705888|NCT00370331|9317997|P1|Overall Study|Lost to Follow-up|0
2705889|NCT00370331|9317996|P2|Overall Study|Withdrawal by Subject|4
2705890|NCT00370331|9317997|P1|Overall Study|Withdrawal by Subject|2
2705891|NCT00370331|9317996|P2|Overall Study|Adverse Event|13
2705892|NCT00370331|9317997|P1|Overall Study|Adverse Event|4
2705893|NCT00370292|9318023|P1|Overall Study|Physician Decision|2
2705894|NCT00370292|9318023|P1|Overall Study|Adverse Event|7
2705895|NCT00370292|9318023|P1|Overall Study|Disease Progression|4
2705896|NCT00370149|9318036|P2|Overall Study|Antibiotic coated dressing placed|1
2705897|NCT00370149|9318037|P1|Overall Study|Antibiotic coated dressing placed|0
2705898|NCT00370149|9318036|P2|Overall Study|Pre-existing infection|1
2705899|NCT00370149|9318037|P1|Overall Study|Pre-existing infection|0
2705900|NCT00370149|9318036|P2|Overall Study|Catheter inserted in wrong vessel-|1
2705901|NCT00370149|9318037|P1|Overall Study|Catheter inserted in wrong vessel-|2
2705902|NCT00370149|9318036|P2|Overall Study|Protocol Violation|0
2705903|NCT00370149|9318037|P1|Overall Study|Protocol Violation|1
2705904|NCT00370149|9318036|P2|Overall Study|Physician Decision|16
2705905|NCT00370149|9318037|P1|Overall Study|Physician Decision|16
2705906|NCT00370071|9318047|P1|Overall Study|Withdrawal by Subject|2
2705907|NCT00370032|9318064|P2|Follow-up Period|Withdrawal by Subject|0
2705908|NCT00370032|9318065|P1|Follow-up Period|Withdrawal by Subject|1
2705909|NCT00370032|9318064|P2|Washout Period|Adverse Event|0
2705910|NCT00370032|9318065|P1|Washout Period|Adverse Event|1
2705911|NCT00370032|9318064|P2|Washout Period|Lost to Follow-up|1
2705912|NCT00370032|9318065|P1|Washout Period|Lost to Follow-up|0
2705913|NCT00370032|9318064|P2|Washout Period|Withdrawal by Subject|1
2705914|NCT00370032|9318065|P1|Washout Period|Withdrawal by Subject|0
2705915|NCT00370032|9318064|P2|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1
2705916|NCT00370032|9318065|P1|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0
2705917|NCT00369967|9318085|P2|Overall Study|Lost to Follow-up|12
2705918|NCT00369967|9318086|P1|Overall Study|Lost to Follow-up|23
2705919|NCT00369941|9318104|P2|Overall Study|Miscellaneous|3
2705920|NCT00369941|9318105|P1|Overall Study|Miscellaneous|3
2705921|NCT00369941|9318104|P2|Overall Study|Study Site Terminated|0
2705922|NCT00369941|9318105|P1|Overall Study|Study Site Terminated|2
2705923|NCT00369941|9318104|P2|Overall Study|Employment Interfered with Study Visits|0
2705924|NCT00369941|9318105|P1|Overall Study|Employment Interfered with Study Visits|1
2705925|NCT00369941|9318104|P2|Overall Study|Treatment with Prohibited Medication|1
2705926|NCT00369941|9318105|P1|Overall Study|Treatment with Prohibited Medication|3
2705927|NCT00369941|9318104|P2|Overall Study|Moved|5
2705928|NCT00369941|9318105|P1|Overall Study|Moved|11
2705929|NCT00369941|9318104|P2|Overall Study|Completed, Did Not Enter Extension|6
2705930|NCT00369941|9318105|P1|Overall Study|Completed, Did Not Enter Extension|5
2705931|NCT00369941|9318104|P2|Overall Study|Pregnancy|2
2705932|NCT00369941|9318105|P1|Overall Study|Pregnancy|4
2705933|NCT00369941|9318104|P2|Overall Study|Withdrawal by Subject|18
2705934|NCT00369941|9318105|P1|Overall Study|Withdrawal by Subject|5
2705935|NCT00369941|9318104|P2|Overall Study|Protocol Violation|3
2705936|NCT00369941|9318105|P1|Overall Study|Protocol Violation|5
2705937|NCT00369941|9318104|P2|Overall Study|Lost to Follow-up|22
2705938|NCT00369941|9318105|P1|Overall Study|Lost to Follow-up|12
2705939|NCT00369941|9318104|P2|Overall Study|Lack of Efficacy|10
2705940|NCT00369941|9318105|P1|Overall Study|Lack of Efficacy|6
2705941|NCT00369941|9318104|P2|Overall Study|Adverse Event|28
2705942|NCT00369941|9318105|P1|Overall Study|Adverse Event|14
2705943|NCT00369941|9318104|P2|Overall Study|Never Treated|2
2705944|NCT00369941|9318105|P1|Overall Study|Never Treated|1
2705945|NCT00369915|9318270|P2|Overall Study|W/drawl by investigators|1
2705946|NCT00369915|9318271|P1|Overall Study|W/drawl by investigators|0
2705947|NCT00369915|9318270|P2|Overall Study|Withdrawal by Subject|1
2705948|NCT00369915|9318271|P1|Overall Study|Withdrawal by Subject|4
2705949|NCT00369915|9318270|P2|Overall Study|expected side effects|1
2705950|NCT00369915|9318271|P1|Overall Study|expected side effects|2
2705951|NCT00369824|9318285|P6|Overall Study|Other|3
2705952|NCT00369824|9318286|P5|Overall Study|Other|1
2705953|NCT00369824|9318287|P4|Overall Study|Other|2
2705954|NCT00369824|9318288|P3|Overall Study|Other|0
2705955|NCT00369824|9318289|P2|Overall Study|Other|0
2705956|NCT00369824|9318290|P1|Overall Study|Other|0
2705957|NCT00369824|9318285|P6|Overall Study|Lost to Follow-up|6
2705958|NCT00369824|9318286|P5|Overall Study|Lost to Follow-up|9
2705959|NCT00369824|9318287|P4|Overall Study|Lost to Follow-up|8
2705960|NCT00369824|9318288|P3|Overall Study|Lost to Follow-up|7
2705961|NCT00369824|9318289|P2|Overall Study|Lost to Follow-up|11
2705962|NCT00369824|9318290|P1|Overall Study|Lost to Follow-up|6
2705963|NCT00369824|9318285|P6|Overall Study|Withdrawal by Subject|2
2705964|NCT00369824|9318286|P5|Overall Study|Withdrawal by Subject|6
2705965|NCT00369824|9318287|P4|Overall Study|Withdrawal by Subject|4
2705966|NCT00369824|9318288|P3|Overall Study|Withdrawal by Subject|5
2705967|NCT00369824|9318289|P2|Overall Study|Withdrawal by Subject|5
2705968|NCT00369824|9318290|P1|Overall Study|Withdrawal by Subject|9
2705969|NCT00369824|9318285|P6|Overall Study|Protocol Violation|0
2705970|NCT00369824|9318286|P5|Overall Study|Protocol Violation|1
2705971|NCT00369824|9318287|P4|Overall Study|Protocol Violation|1
2705972|NCT00369824|9318288|P3|Overall Study|Protocol Violation|0
2705973|NCT00369824|9318289|P2|Overall Study|Protocol Violation|1
2705974|NCT00369824|9318290|P1|Overall Study|Protocol Violation|0
2705975|NCT00369824|9318285|P6|Overall Study|Adverse Event|0
2705976|NCT00369824|9318286|P5|Overall Study|Adverse Event|1
2705977|NCT00369824|9318287|P4|Overall Study|Adverse Event|0
2705978|NCT00369824|9318288|P3|Overall Study|Adverse Event|0
2705979|NCT00369824|9318289|P2|Overall Study|Adverse Event|2
2705980|NCT00369824|9318290|P1|Overall Study|Adverse Event|0
2705981|NCT00369785|9318390|P2|Overall Study|Multiple reasons|5
2705982|NCT00369785|9318391|P1|Overall Study|Multiple reasons|6
2705983|NCT00369785|9318390|P2|Overall Study|Progression|4
2705984|NCT00369785|9318391|P1|Overall Study|Progression|4
2705985|NCT00369785|9318390|P2|Overall Study|Never started|2
2705986|NCT00369785|9318391|P1|Overall Study|Never started|0
2705987|NCT00369785|9318390|P2|Overall Study|Toxicity|4
2705988|NCT00369785|9318391|P1|Overall Study|Toxicity|6
2705989|NCT00369785|9318390|P2|Overall Study|Withdrawal by Subject|6
2705990|NCT00369785|9318391|P1|Overall Study|Withdrawal by Subject|7
2705991|NCT00369785|9318390|P2|Overall Study|Death|2
2705992|NCT00369785|9318391|P1|Overall Study|Death|1
2705993|NCT00369785|9318390|P2|Overall Study|Physician Decision|2
2705994|NCT00369785|9318391|P1|Overall Study|Physician Decision|3
2705995|NCT00369707|9318412|P1|Follow up for 2 Years After Treatment|Other|2
2705996|NCT00369707|9318412|P1|Follow up for 2 Years After Treatment|Death|1
2705997|NCT00369707|9318412|P1|Maintenance Period (up to 4 Cycles)|Progressive disease|4
2705998|NCT00369707|9318412|P1|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2
2705999|NCT00369707|9318412|P1|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2
2706000|NCT00369707|9318412|P1|Induction Part B (2 Cycles)|Progressive disease|1
2706001|NCT00369707|9318412|P1|Induction Part B (2 Cycles)|Inadequate response/MD decision|1
2706002|NCT00369707|9318412|P1|Induction Part B (2 Cycles)|Withdrawal by Subject|2
2706003|NCT00369707|9318412|P1|Induction Part B (2 Cycles)|Adverse Event|3
2706004|NCT00369681|9318425|P1|Overall Study|Death|1
2706005|NCT00369668|9318435|P3|Overall Study|Lack of Efficacy|7
2706006|NCT00369668|9318436|P2|Overall Study|Lack of Efficacy|5
2706007|NCT00369668|9318437|P1|Overall Study|Lack of Efficacy|4
2706008|NCT00369655|9318451|P1|Overall Study|Refusal of further treatment|2
2706009|NCT00369629|9318460|P4|Follow up for 1 Year|stopped being followed as study closed|0
2706010|NCT00369629|9318461|P3|Follow up for 1 Year|stopped being followed as study closed|2
2706011|NCT00369629|9318462|P2|Follow up for 1 Year|stopped being followed as study closed|0
2706012|NCT00369629|9318463|P1|Follow up for 1 Year|stopped being followed as study closed|0
2706013|NCT00369629|9318460|P4|Follow up for 1 Year|Lost to Follow-up|0
2706014|NCT00369629|9318461|P3|Follow up for 1 Year|Lost to Follow-up|0
2706015|NCT00369629|9318462|P2|Follow up for 1 Year|Lost to Follow-up|1
2706016|NCT00369629|9318463|P1|Follow up for 1 Year|Lost to Follow-up|0
2706017|NCT00369629|9318460|P4|Follow up for 1 Year|Death|0
2706018|NCT00369629|9318461|P3|Follow up for 1 Year|Death|1
2706019|NCT00369629|9318462|P2|Follow up for 1 Year|Death|1
2706020|NCT00369629|9318463|P1|Follow up for 1 Year|Death|2
2706021|NCT00369629|9318460|P4|Completed 4 More Cycles|Progressive disease|0
2706022|NCT00369629|9318461|P3|Completed 4 More Cycles|Progressive disease|2
2706023|NCT00369629|9318462|P2|Completed 4 More Cycles|Progressive disease|1
2706024|NCT00369629|9318463|P1|Completed 4 More Cycles|Progressive disease|2
2706025|NCT00369629|9318460|P4|Completed 4 More Cycles|Withdrawal by Subject|0
2706026|NCT00369629|9318461|P3|Completed 4 More Cycles|Withdrawal by Subject|0
2706027|NCT00369629|9318462|P2|Completed 4 More Cycles|Withdrawal by Subject|1
2706028|NCT00369629|9318463|P1|Completed 4 More Cycles|Withdrawal by Subject|2
2706029|NCT00369629|9318460|P4|Moved on to 4 More Cycles|Progressive Disease|0
2706030|NCT00369629|9318461|P3|Moved on to 4 More Cycles|Progressive Disease|1
2706031|NCT00369629|9318462|P2|Moved on to 4 More Cycles|Progressive Disease|0
2706032|NCT00369629|9318463|P1|Moved on to 4 More Cycles|Progressive Disease|0
2706033|NCT00369629|9318460|P4|Treated 2 Cycles/Reached First Response|Progressive disease|0
2706034|NCT00369629|9318461|P3|Treated 2 Cycles/Reached First Response|Progressive disease|0
2706035|NCT00369629|9318462|P2|Treated 2 Cycles/Reached First Response|Progressive disease|0
2706036|NCT00369629|9318463|P1|Treated 2 Cycles/Reached First Response|Progressive disease|2
2706037|NCT00369629|9318460|P4|Treated 2 Cycles/Reached First Response|Adverse Event|0
2706038|NCT00369629|9318461|P3|Treated 2 Cycles/Reached First Response|Adverse Event|1
2706039|NCT00369629|9318462|P2|Treated 2 Cycles/Reached First Response|Adverse Event|0
2706040|NCT00369629|9318463|P1|Treated 2 Cycles/Reached First Response|Adverse Event|0
2706041|NCT00369629|9318460|P4|Treated 2 Cycles/Reached First Response|Physician Decision|0
2706042|NCT00369629|9318461|P3|Treated 2 Cycles/Reached First Response|Physician Decision|1
2706043|NCT00369629|9318462|P2|Treated 2 Cycles/Reached First Response|Physician Decision|1
2706044|NCT00369629|9318463|P1|Treated 2 Cycles/Reached First Response|Physician Decision|0
2706045|NCT00369577|9318494|P3|Overall Study|Withdrawal by Subject|1
2706046|NCT00369577|9318495|P2|Overall Study|Withdrawal by Subject|0
2706047|NCT00369577|9318496|P1|Overall Study|Withdrawal by Subject|0
2706048|NCT00369486|9318533|P5|34-Week Visit|Dropped|3
2706049|NCT00369486|9318534|P4|34-Week Visit|Dropped|3
2706050|NCT00369486|9318535|P3|34-Week Visit|Dropped|1
2706051|NCT00369486|9318536|P2|34-Week Visit|Dropped|1
2706052|NCT00369486|9318537|P1|34-Week Visit|Dropped|0
2706053|NCT00369486|9318533|P5|17-Week Visit|Missed visit|1
2706054|NCT00369486|9318534|P4|17-Week Visit|Missed visit|1
2706055|NCT00369486|9318535|P3|17-Week Visit|Missed visit|1
2706056|NCT00369486|9318536|P2|17-Week Visit|Missed visit|0
2706057|NCT00369486|9318537|P1|17-Week Visit|Missed visit|0
2706058|NCT00369486|9318533|P5|8-Week Visit|Dropped|0
2706059|NCT00369486|9318534|P4|8-Week Visit|Dropped|1
2706060|NCT00369486|9318535|P3|8-Week Visit|Dropped|0
2706061|NCT00369486|9318536|P2|8-Week Visit|Dropped|0
2706062|NCT00369486|9318537|P1|8-Week Visit|Dropped|0
2706063|NCT00369486|9318533|P5|8-Week Visit|Missed visit|1
2706064|NCT00369486|9318534|P4|8-Week Visit|Missed visit|0
2706065|NCT00369486|9318535|P3|8-Week Visit|Missed visit|0
2706066|NCT00369486|9318536|P2|8-Week Visit|Missed visit|1
2706067|NCT00369486|9318537|P1|8-Week Visit|Missed visit|0
2706068|NCT00369486|9318533|P5|4-Week Visit|Dropped|0
2706069|NCT00369486|9318534|P4|4-Week Visit|Dropped|0
2706070|NCT00369486|9318535|P3|4-Week Visit|Dropped|1
2706071|NCT00369486|9318536|P2|4-Week Visit|Dropped|0
2706072|NCT00369486|9318537|P1|4-Week Visit|Dropped|0
2706073|NCT00369486|9318533|P5|4-Week Visit|Missed visit|1
2706074|NCT00369486|9318534|P4|4-Week Visit|Missed visit|2
2706075|NCT00369486|9318535|P3|4-Week Visit|Missed visit|0
2706076|NCT00369486|9318536|P2|4-Week Visit|Missed visit|2
2706077|NCT00369486|9318537|P1|4-Week Visit|Missed visit|2
2706078|NCT00369382|9318576|P2|Overall Study|Other|0
2706079|NCT00369382|9318577|P1|Overall Study|Other|1
2706080|NCT00369382|9318576|P2|Overall Study|Randomized, not treated|0
2706081|NCT00369382|9318577|P1|Overall Study|Randomized, not treated|2
2706082|NCT00369382|9318576|P2|Overall Study|Withdrawal by Subject|0
2706083|NCT00369382|9318577|P1|Overall Study|Withdrawal by Subject|5
2706084|NCT00369382|9318576|P2|Overall Study|Physician Decision|1
2706085|NCT00369382|9318577|P1|Overall Study|Physician Decision|2
2706086|NCT00369382|9318576|P2|Overall Study|Death|2
2706087|NCT00369382|9318577|P1|Overall Study|Death|0
2706088|NCT00369343|9318610|P2|Open-label Phase|did not take study drug|2
2706089|NCT00369343|9318611|P1|Open-label Phase|did not take study drug|1
2706090|NCT00369343|9318610|P2|Open-label Phase|Lack of continuance tolerability|4
2706091|NCT00369343|9318611|P1|Open-label Phase|Lack of continuance tolerability|3
2706092|NCT00369343|9318610|P2|Open-label Phase|Lack of Efficacy|3
2706093|NCT00369343|9318611|P1|Open-label Phase|Lack of Efficacy|4
2706094|NCT00369343|9318610|P2|Open-label Phase|Withdrawal by Subject|6
2706095|NCT00369343|9318611|P1|Open-label Phase|Withdrawal by Subject|15
2706096|NCT00369343|9318610|P2|Open-label Phase|Protocol Violation|3
2706097|NCT00369343|9318611|P1|Open-label Phase|Protocol Violation|1
2706098|NCT00369343|9318610|P2|Open-label Phase|inadvertently reported study completers|2
2706099|NCT00369343|9318611|P1|Open-label Phase|inadvertently reported study completers|3
2706100|NCT00369343|9318610|P2|Open-label Phase|Lost to Follow-up|3
2706101|NCT00369343|9318611|P1|Open-label Phase|Lost to Follow-up|5
2706102|NCT00369343|9318610|P2|Open-label Phase|Physician Decision|0
2706103|NCT00369343|9318611|P1|Open-label Phase|Physician Decision|2
2706104|NCT00369343|9318610|P2|Open-label Phase|Failed to return|0
2706105|NCT00369343|9318611|P1|Open-label Phase|Failed to return|4
2706106|NCT00369343|9318610|P2|Open-label Phase|Adverse Event|7
2706107|NCT00369343|9318611|P1|Open-label Phase|Adverse Event|19
2706108|NCT00369343|9318610|P2|Double-blind Phase|Protocol deviation|0
2706109|NCT00369343|9318611|P1|Double-blind Phase|Protocol deviation|4
2706110|NCT00369343|9318610|P2|Double-blind Phase|Lack of Efficacy|4
2706111|NCT00369343|9318611|P1|Double-blind Phase|Lack of Efficacy|0
2706112|NCT00369343|9318610|P2|Double-blind Phase|Withdrawal by Subject|6
2706113|NCT00369343|9318611|P1|Double-blind Phase|Withdrawal by Subject|8
2706114|NCT00369343|9318610|P2|Double-blind Phase|Protocol Violation|0
2706115|NCT00369343|9318611|P1|Double-blind Phase|Protocol Violation|2
2706116|NCT00369343|9318610|P2|Double-blind Phase|Lost to Follow-up|2
2706117|NCT00369343|9318611|P1|Double-blind Phase|Lost to Follow-up|9
2706118|NCT00369343|9318610|P2|Double-blind Phase|Failed to return|0
2706119|NCT00369343|9318611|P1|Double-blind Phase|Failed to return|2
2706120|NCT00369343|9318610|P2|Double-blind Phase|Adverse Event|4
2706121|NCT00369343|9318611|P1|Double-blind Phase|Adverse Event|19
2706122|NCT00369317|9318644|P1|Overall Study|Ineligible|1
2706123|NCT00369317|9318644|P1|Overall Study|Withdrawal by Subject|8
2706124|NCT00369317|9318644|P1|Overall Study|Physician Decision|2
2706125|NCT00369317|9318644|P1|Overall Study|Lack of Efficacy|5
2706126|NCT00369317|9318644|P1|Overall Study|Death|1
2706127|NCT00369317|9318644|P1|Overall Study|Adverse Event|3
2706128|NCT00369278|9318660|P2|Overall Study|Graft loss|2
2706129|NCT00369278|9318661|P1|Overall Study|Graft loss|1
2706130|NCT00369278|9318660|P2|Overall Study|Lost to Follow-up|0
2706131|NCT00369278|9318661|P1|Overall Study|Lost to Follow-up|1
2706132|NCT00369278|9318660|P2|Overall Study|Withdrawal by Subject|2
2706133|NCT00369278|9318661|P1|Overall Study|Withdrawal by Subject|2
2706134|NCT00369278|9318660|P2|Overall Study|Protocol Violation|1
2706135|NCT00369278|9318661|P1|Overall Study|Protocol Violation|2
2706136|NCT00369278|9318660|P2|Overall Study|Unsatisfactory therapeutic effect|5
2706137|NCT00369278|9318661|P1|Overall Study|Unsatisfactory therapeutic effect|4
2706138|NCT00369278|9318660|P2|Overall Study|Adverse Event|11
2706139|NCT00369278|9318661|P1|Overall Study|Adverse Event|14
2706140|NCT00369265|9318677|P2|Overall Study|Study terminated|7
2706141|NCT00369265|9318678|P1|Overall Study|Study terminated|4
2706142|NCT00369161|9318699|P2|Overall Study|Administrative Problem|2
2706143|NCT00369161|9318700|P1|Overall Study|Administrative Problem|2
2706144|NCT00369161|9318699|P2|Overall Study|Graft loss|0
2706145|NCT00369161|9318700|P1|Overall Study|Graft loss|4
2706146|NCT00369161|9318699|P2|Overall Study|Death|2
2706147|NCT00369161|9318700|P1|Overall Study|Death|1
2706148|NCT00369161|9318699|P2|Overall Study|Withdrawal by Subject|3
2706149|NCT00369161|9318700|P1|Overall Study|Withdrawal by Subject|2
2706150|NCT00369161|9318699|P2|Overall Study|Protocol Violation|2
2706151|NCT00369161|9318700|P1|Overall Study|Protocol Violation|0
2706152|NCT00369161|9318699|P2|Overall Study|Lack of Efficacy|1
2706153|NCT00369161|9318700|P1|Overall Study|Lack of Efficacy|3
2706154|NCT00369161|9318699|P2|Overall Study|Abnormal laboratory value|1
2706155|NCT00369161|9318700|P1|Overall Study|Abnormal laboratory value|0
2706156|NCT00369161|9318699|P2|Overall Study|Adverse Event|13
2706157|NCT00369161|9318700|P1|Overall Study|Adverse Event|15
2706158|NCT00369122|9318710|P1|Overall Study|No protocol treatment|1
2706159|NCT00369122|9318710|P1|Overall Study|Ineligible|10
2706160|NCT00368992|9318717|P1|Overall Study|Other|9
2706161|NCT00368992|9318717|P1|Overall Study|Death|4
2706162|NCT00368992|9318717|P1|Overall Study|Adverse Event|26
2706163|NCT00368992|9318717|P1|Overall Study|Lack of Efficacy|63
2706164|NCT00368992|9318717|P1|Overall Study|Refused treatment|3
2706165|NCT00368992|9318717|P1|Overall Study|Ineligible|5
2706166|NCT00368979|9318726|P2|Overall Study|Withdrawal by Subject|9
2706167|NCT00368979|9318727|P1|Overall Study|Withdrawal by Subject|5
2706168|NCT00368979|9318726|P2|Overall Study|Protocol Violation|1
2706169|NCT00368979|9318727|P1|Overall Study|Protocol Violation|2
2706170|NCT00368979|9318726|P2|Overall Study|Lost to Follow-up|0
2706171|NCT00368979|9318727|P1|Overall Study|Lost to Follow-up|1
2706172|NCT00368979|9318726|P2|Overall Study|Other|1
2706173|NCT00368979|9318727|P1|Overall Study|Other|3
2706174|NCT00368979|9318726|P2|Overall Study|Lack of Efficacy|3
2706175|NCT00368979|9318727|P1|Overall Study|Lack of Efficacy|5
2706176|NCT00368979|9318726|P2|Overall Study|Adverse Event|16
2706177|NCT00368979|9318727|P1|Overall Study|Adverse Event|9
2706178|NCT00368966|9318743|P2|Toddler Dose|Lost to Follow-up|2
2706179|NCT00368966|9318744|P1|Toddler Dose|Lost to Follow-up|0
2706180|NCT00368966|9318743|P2|Toddler Dose|Withdrawal by Subject|1
2706181|NCT00368966|9318744|P1|Toddler Dose|Withdrawal by Subject|1
2706182|NCT00368966|9318743|P2|After Infant|Lost to Follow-up|1
2706183|NCT00368966|9318744|P1|After Infant|Lost to Follow-up|0
2706184|NCT00368966|9318743|P2|After Infant|Death|0
2706185|NCT00368966|9318744|P1|After Infant|Death|1
2706186|NCT00368966|9318743|P2|After Infant|Withdrawal by Subject|1
2706187|NCT00368966|9318744|P1|After Infant|Withdrawal by Subject|1
2706188|NCT00368966|9318743|P2|After Infant|Adverse Event|2
2706189|NCT00368966|9318744|P1|After Infant|Adverse Event|1
2706190|NCT00368966|9318743|P2|After Infant|Failed to return|1
2706191|NCT00368966|9318744|P1|After Infant|Failed to return|3
2706192|NCT00368966|9318743|P2|Infant Series|Failed to return|0
2706193|NCT00368966|9318744|P1|Infant Series|Failed to return|1
2706194|NCT00368966|9318743|P2|Infant Series|Adverse Event|1
2706195|NCT00368966|9318744|P1|Infant Series|Adverse Event|0
2706196|NCT00368966|9318743|P2|Infant Series|Failed to meet eligibility criteria|1
2706197|NCT00368966|9318744|P1|Infant Series|Failed to meet eligibility criteria|0
2706198|NCT00368966|9318743|P2|Infant Series|Randomization error|1
2706199|NCT00368966|9318744|P1|Infant Series|Randomization error|0
2706200|NCT00368966|9318743|P2|Infant Series|Lost to Follow-up|0
2706201|NCT00368966|9318744|P1|Infant Series|Lost to Follow-up|2
2706202|NCT00368966|9318743|P2|Infant Series|Protocol Violation|1
2706203|NCT00368966|9318744|P1|Infant Series|Protocol Violation|2
2706204|NCT00368966|9318743|P2|Infant Series|Withdrawal by Subject|6
2706205|NCT00368966|9318744|P1|Infant Series|Withdrawal by Subject|11
2706206|NCT00368927|9318815|P2|Overall Study|Physician Decision|0
2706207|NCT00368927|9318816|P1|Overall Study|Physician Decision|1
2706208|NCT00368927|9318815|P2|Overall Study|Withdrawal by Subject|2
2706209|NCT00368927|9318816|P1|Overall Study|Withdrawal by Subject|1
2706210|NCT00368927|9318815|P2|Overall Study|Adverse Event|1
2706211|NCT00368927|9318816|P1|Overall Study|Adverse Event|1
2706212|NCT00368927|9318815|P2|Overall Study|Lost to Follow-up|0
2706213|NCT00368927|9318816|P1|Overall Study|Lost to Follow-up|2
2706214|NCT00368875|9318824|P2|Overall Study|Alternative Therapy|1
2706215|NCT00368875|9318825|P1|Overall Study|Alternative Therapy|1
2706216|NCT00368875|9318824|P2|Overall Study|Other Reason|2
2706217|NCT00368875|9318825|P1|Overall Study|Other Reason|0
2706218|NCT00368875|9318824|P2|Overall Study|Withdrawal by Subject|6
2706219|NCT00368875|9318825|P1|Overall Study|Withdrawal by Subject|2
2706220|NCT00368875|9318824|P2|Overall Study|Progressive disease|27
2706221|NCT00368875|9318825|P1|Overall Study|Progressive disease|3
2706222|NCT00368875|9318824|P2|Overall Study|Adverse Event|12
2706223|NCT00368875|9318825|P1|Overall Study|Adverse Event|0
2706224|NCT00368849|9318833|P2|Overall Study|Physician Decision|1
2706225|NCT00368849|9318834|P1|Overall Study|Physician Decision|0
2706226|NCT00368849|9318833|P2|Overall Study|Withdrawal by Subject|1
2706227|NCT00368849|9318834|P1|Overall Study|Withdrawal by Subject|0
2706228|NCT00368745|9318850|P2|Double-blind Treatment Period|Other|6
2706229|NCT00368745|9318851|P1|Double-blind Treatment Period|Other|7
2706230|NCT00368745|9318850|P2|Double-blind Treatment Period|Withdrawal by Subject|3
2706231|NCT00368745|9318851|P1|Double-blind Treatment Period|Withdrawal by Subject|5
2706232|NCT00368745|9318850|P2|Double-blind Treatment Period|Lost to Follow-up|0
2706233|NCT00368745|9318851|P1|Double-blind Treatment Period|Lost to Follow-up|1
2706234|NCT00368745|9318850|P2|Double-blind Treatment Period|Lack of Efficacy|16
2706235|NCT00368745|9318851|P1|Double-blind Treatment Period|Lack of Efficacy|7
2706236|NCT00368745|9318850|P2|Double-blind Treatment Period|Adverse Event|6
2706237|NCT00368745|9318851|P1|Double-blind Treatment Period|Adverse Event|6
2706238|NCT00368641|9318904|P2|Overall Study|Sponsor decision to terminate study|5
2706239|NCT00368641|9318905|P1|Overall Study|Sponsor decision to terminate study|2
2706240|NCT00368641|9318904|P2|Overall Study|Withdrawal by Subject|0
2706241|NCT00368641|9318905|P1|Overall Study|Withdrawal by Subject|1
2706242|NCT00368641|9318904|P2|Overall Study|Death|0
2706243|NCT00368641|9318905|P1|Overall Study|Death|1
2706244|NCT00368641|9318904|P2|Overall Study|Adverse Event|1
2706245|NCT00368641|9318905|P1|Overall Study|Adverse Event|2
2706246|NCT00368550|9318913|P2|Overall Study|Withdrawal by Subject|10
2706247|NCT00368550|9318914|P1|Overall Study|Withdrawal by Subject|17
2706248|NCT00368550|9318913|P2|Overall Study|Lack of Efficacy|9
2706249|NCT00368550|9318914|P1|Overall Study|Lack of Efficacy|4
2706250|NCT00368550|9318913|P2|Overall Study|Adverse Event|4
2706251|NCT00368550|9318914|P1|Overall Study|Adverse Event|7
2706252|NCT00368537|9318926|P2|Baseline Participants|Patient uncompliant|1
2706253|NCT00368537|9318927|P1|Baseline Participants|Patient uncompliant|0
2706254|NCT00368537|9318926|P2|Baseline Participants|No susceptibility|0
2706255|NCT00368537|9318927|P1|Baseline Participants|No susceptibility|1
2706256|NCT00368537|9318926|P2|Baseline Participants|Death|2
2706257|NCT00368537|9318927|P1|Baseline Participants|Death|1
2706258|NCT00368537|9318926|P2|Baseline Participants|Withdrawal by Subject|4
2706259|NCT00368537|9318927|P1|Baseline Participants|Withdrawal by Subject|6
2706260|NCT00368537|9318926|P2|Baseline Participants|Lost to Follow-up|17
2706261|NCT00368537|9318927|P1|Baseline Participants|Lost to Follow-up|16
2706262|NCT00368537|9318926|P2|Randomization|No study drug dosed|6
2706263|NCT00368537|9318927|P1|Randomization|No study drug dosed|13
2706264|NCT00368472|9318941|P1|Overall Study|Missing Final Disposition Date|1
2706265|NCT00368472|9318941|P1|Overall Study|Other|32
2706266|NCT00368472|9318941|P1|Overall Study|Diary non-compliance|1
2706267|NCT00368472|9318941|P1|Overall Study|Withdrawal by Subject|40
2706268|NCT00368472|9318941|P1|Overall Study|Request of Investigator or Sponsor|3
2706269|NCT00368472|9318941|P1|Overall Study|Protocol Violation|2
2706270|NCT00368472|9318941|P1|Overall Study|Medication non-compliance|4
2706271|NCT00368472|9318941|P1|Overall Study|Adverse Event|22
2706272|NCT00368355|9318976|P2|Overall Study|Treatment - hematopoietic cell product|0
2706273|NCT00368355|9318977|P1|Overall Study|Treatment - hematopoietic cell product|2
2706274|NCT00368355|9318976|P2|Overall Study|Subsequent transplant|3
2706275|NCT00368355|9318977|P1|Overall Study|Subsequent transplant|0
2706276|NCT00368355|9318976|P2|Overall Study|Relapse|10
2706277|NCT00368355|9318977|P1|Overall Study|Relapse|6
2706278|NCT00368355|9318976|P2|Overall Study|Death|4
2706279|NCT00368355|9318977|P1|Overall Study|Death|2
2706280|NCT00368355|9318976|P2|Overall Study|Adverse Event|0
2706281|NCT00368355|9318977|P1|Overall Study|Adverse Event|1
2706282|NCT00368277|9319017|P2|Overall Study|Lost to Follow-up|6
2706283|NCT00368277|9319018|P1|Overall Study|Lost to Follow-up|8
2706284|NCT00368277|9319017|P2|Overall Study|Patient withdrew consent|28
2706285|NCT00368277|9319018|P1|Overall Study|Patient withdrew consent|32
2706286|NCT00368277|9319017|P2|Overall Study|Protocol deviation|0
2706287|NCT00368277|9319018|P1|Overall Study|Protocol deviation|7
2706288|NCT00368277|9319017|P2|Overall Study|Unsatisfactory therapeutic effect|24
2706289|NCT00368277|9319018|P1|Overall Study|Unsatisfactory therapeutic effect|31
2706290|NCT00368277|9319017|P2|Overall Study|Death|1
2706291|NCT00368277|9319018|P1|Overall Study|Death|2
2706292|NCT00368277|9319017|P2|Overall Study|Adverse Event|49
2706293|NCT00368277|9319018|P1|Overall Study|Adverse Event|33
2706294|NCT00368251|9319033|P3|Overall Study|AE, non-serious non-fatal|1
2706295|NCT00368251|9319034|P2|Overall Study|AE, non-serious non-fatal|0
2706296|NCT00368251|9319035|P1|Overall Study|AE, non-serious non-fatal|0
2706297|NCT00368251|9319033|P3|Overall Study|SAE, non-fatal|0
2706298|NCT00368251|9319034|P2|Overall Study|SAE, non-fatal|0
2706299|NCT00368251|9319035|P1|Overall Study|SAE, non-fatal|1
2706300|NCT00368108|9319058|P3|Overall Study|Other|1
2706301|NCT00368108|9319059|P2|Overall Study|Other|7
2706302|NCT00368108|9319060|P1|Overall Study|Other|3
2706303|NCT00368108|9319058|P3|Overall Study|Physician Decision|1
2706304|NCT00368108|9319059|P2|Overall Study|Physician Decision|0
2706305|NCT00368108|9319060|P1|Overall Study|Physician Decision|2
2706306|NCT00368108|9319058|P3|Overall Study|Lack of Efficacy|5
2706307|NCT00368108|9319059|P2|Overall Study|Lack of Efficacy|8
2706308|NCT00368108|9319060|P1|Overall Study|Lack of Efficacy|7
2706309|NCT00368108|9319058|P3|Overall Study|Withdrawal by Subject|5
2706310|NCT00368108|9319059|P2|Overall Study|Withdrawal by Subject|3
2706311|NCT00368108|9319060|P1|Overall Study|Withdrawal by Subject|9
2706312|NCT00368108|9319058|P3|Overall Study|Protocol Violation|9
2706313|NCT00368108|9319059|P2|Overall Study|Protocol Violation|9
2706314|NCT00368108|9319060|P1|Overall Study|Protocol Violation|5
2706315|NCT00368108|9319058|P3|Overall Study|Abnormal Laboratory Value|3
2706316|NCT00368108|9319059|P2|Overall Study|Abnormal Laboratory Value|0
2706317|NCT00368108|9319060|P1|Overall Study|Abnormal Laboratory Value|0
2706318|NCT00368108|9319058|P3|Overall Study|Adverse Event|44
2706319|NCT00368108|9319059|P2|Overall Study|Adverse Event|26
2706320|NCT00368108|9319060|P1|Overall Study|Adverse Event|38
2706321|NCT00368069|9319079|P2|Overall Study|no blood sampling possible|1
2706322|NCT00368069|9319080|P1|Overall Study|no blood sampling possible|0
2706323|NCT00368069|9319079|P2|Overall Study|Withdrawal of Consent|1
2706324|NCT00368069|9319080|P1|Overall Study|Withdrawal of Consent|2
2706325|NCT00368069|9319079|P2|Overall Study|Protocol Violation|2
2706326|NCT00368069|9319080|P1|Overall Study|Protocol Violation|0
2706327|NCT00368069|9319079|P2|Overall Study|Lost to Follow-up|0
2706328|NCT00368069|9319080|P1|Overall Study|Lost to Follow-up|1
2706329|NCT00368069|9319079|P2|Overall Study|Lack of Efficacy|1
2706330|NCT00368069|9319080|P1|Overall Study|Lack of Efficacy|0
2706331|NCT00368069|9319079|P2|Overall Study|Adverse Event|2
2706332|NCT00368069|9319080|P1|Overall Study|Adverse Event|5
2706333|NCT00367991|9319098|P2|Overall Study|Adverse Event|1
2706334|NCT00367991|9319099|P1|Overall Study|Adverse Event|1
2706335|NCT00367991|9319098|P2|Overall Study|Withdrawal by Subject|1
2706336|NCT00367991|9319099|P1|Overall Study|Withdrawal by Subject|1
2706337|NCT00367835|9319117|P2|Overall Study|History of lead poisoning|1
2706338|NCT00367835|9319118|P1|Overall Study|History of lead poisoning|0
2706339|NCT00367835|9319117|P2|Overall Study|Did not respond to calls|0
2706340|NCT00367835|9319118|P1|Overall Study|Did not respond to calls|1
2706341|NCT00367835|9319117|P2|Overall Study|refused blood collection|0
2706342|NCT00367835|9319118|P1|Overall Study|refused blood collection|1
2706343|NCT00367835|9319117|P2|Overall Study|Subject in juvenile detention center|0
2706344|NCT00367835|9319118|P1|Overall Study|Subject in juvenile detention center|1
2706345|NCT00367835|9319117|P2|Overall Study|Lack of Efficacy|12
2706346|NCT00367835|9319118|P1|Overall Study|Lack of Efficacy|3
2706347|NCT00367835|9319117|P2|Overall Study|Lost to Follow-up|4
2706348|NCT00367835|9319118|P1|Overall Study|Lost to Follow-up|1
2706349|NCT00367835|9319117|P2|Overall Study|Withdrawal by Subject|6
2706350|NCT00367835|9319118|P1|Overall Study|Withdrawal by Subject|7
2706351|NCT00367835|9319117|P2|Overall Study|Protocol Violation|7
2706352|NCT00367835|9319118|P1|Overall Study|Protocol Violation|1
2706353|NCT00367835|9319117|P2|Overall Study|Adverse Event|1
2706354|NCT00367835|9319118|P1|Overall Study|Adverse Event|14
2706355|NCT00367770|9319144|P1|Overall Study|Withdrawal by Subject|1
2706356|NCT00367770|9319144|P1|Overall Study|Adverse Event|1
2706357|NCT00367744|9319152|P2|Overall Study|Lost to Follow-up|5
2706358|NCT00367744|9319153|P1|Overall Study|Lost to Follow-up|4
2706359|NCT00367640|9319182|P4|Overall Study|Any other reason not above-mentioned|4
2706360|NCT00367640|9319183|P3|Overall Study|Any other reason not above-mentioned|3
2706361|NCT00367640|9319184|P2|Overall Study|Any other reason not above-mentioned|5
2706362|NCT00367640|9319185|P1|Overall Study|Any other reason not above-mentioned|7
2706363|NCT00367640|9319182|P4|Overall Study|Withdrawal by Subject|6
2706364|NCT00367640|9319183|P3|Overall Study|Withdrawal by Subject|8
2706365|NCT00367640|9319184|P2|Overall Study|Withdrawal by Subject|11
2706366|NCT00367640|9319185|P1|Overall Study|Withdrawal by Subject|8
2706367|NCT00367640|9319182|P4|Overall Study|Adverse Event|0
2706368|NCT00367640|9319183|P3|Overall Study|Adverse Event|8
2706369|NCT00367640|9319184|P2|Overall Study|Adverse Event|6
2706370|NCT00367640|9319185|P1|Overall Study|Adverse Event|3
2706371|NCT00367484|9319201|P1|Overall Study|Lack of Efficacy|1
2706372|NCT00367484|9319201|P1|Overall Study|The choice of the patient|1
2706373|NCT00367484|9319201|P1|Overall Study|Protocol Violation|1
2706374|NCT00367484|9319201|P1|Overall Study|Lost to Follow-up|1
2706375|NCT00367484|9319201|P1|Overall Study|Travel to USA|1
2706376|NCT00367484|9319201|P1|Overall Study|Withdrew informed consent|5
2706377|NCT00367484|9319201|P1|Overall Study|Adverse Event|7
2706378|NCT00367458|9319207|P2|First Intervention - 8 Weeks|Adverse Event|0
2706379|NCT00367458|9319208|P1|First Intervention - 8 Weeks|Adverse Event|2
2706380|NCT00367432|9319222|P2|Second Period (up to 54 Months)|Other Reason|2
2706381|NCT00367432|9319223|P1|Second Period (up to 54 Months)|Other Reason|6
2706382|NCT00367432|9319222|P2|Second Period (up to 54 Months)|Withdrawal by Subject|5
2706383|NCT00367432|9319223|P1|Second Period (up to 54 Months)|Withdrawal by Subject|8
2706384|NCT00367432|9319222|P2|Second Period (up to 54 Months)|Lost to Follow-up|1
2706385|NCT00367432|9319223|P1|Second Period (up to 54 Months)|Lost to Follow-up|0
2706386|NCT00367432|9319222|P2|Second Period (up to 54 Months)|Lack of Efficacy|5
2706387|NCT00367432|9319223|P1|Second Period (up to 54 Months)|Lack of Efficacy|59
2706388|NCT00367432|9319222|P2|Second Period (up to 54 Months)|Adverse Event|3
2706389|NCT00367432|9319223|P1|Second Period (up to 54 Months)|Adverse Event|14
2706390|NCT00367432|9319222|P2|First Period (16 Weeks)|Other Reason|0
2706391|NCT00367432|9319223|P1|First Period (16 Weeks)|Other Reason|2
2706392|NCT00367432|9319222|P2|First Period (16 Weeks)|Withdrawal by Subject|0
2706393|NCT00367432|9319223|P1|First Period (16 Weeks)|Withdrawal by Subject|6
2706394|NCT00367432|9319222|P2|First Period (16 Weeks)|Lack of Efficacy|0
2706395|NCT00367432|9319223|P1|First Period (16 Weeks)|Lack of Efficacy|24
2706396|NCT00367432|9319222|P2|First Period (16 Weeks)|Adverse Event|0
2706397|NCT00367432|9319223|P1|First Period (16 Weeks)|Adverse Event|6
2706398|NCT00367341|9319250|P2|Overall Study|Protocol Violation|0
2706399|NCT00367341|9319251|P1|Overall Study|Protocol Violation|1
2706400|NCT00367341|9319250|P2|Overall Study|Physician Decision|0
2706401|NCT00367341|9319251|P1|Overall Study|Physician Decision|1
2706402|NCT00367237|9319261|P2|Overall Study|Protocol Violation|5
2706403|NCT00367237|9319262|P1|Overall Study|Protocol Violation|2
2706404|NCT00367237|9319261|P2|Overall Study|Withdrawal by Subject|4
2706405|NCT00367237|9319262|P1|Overall Study|Withdrawal by Subject|0
2706406|NCT00367237|9319261|P2|Overall Study|Lost to Follow-up|0
2706407|NCT00367237|9319262|P1|Overall Study|Lost to Follow-up|1
2706408|NCT00367237|9319261|P2|Overall Study|Adverse Event|2
2706409|NCT00367237|9319262|P1|Overall Study|Adverse Event|7
2706410|NCT00367133|9319271|P3|2 Years|Missed visit|4
2706411|NCT00367133|9319272|P2|2 Years|Missed visit|5
2706412|NCT00367133|9319273|P1|2 Years|Missed visit|4
2706413|NCT00367133|9319271|P3|2 Years|Dropped|33
2706414|NCT00367133|9319272|P2|2 Years|Dropped|19
2706415|NCT00367133|9319273|P1|2 Years|Dropped|34
2706416|NCT00367133|9319271|P3|2 Years|Death|12
2706417|NCT00367133|9319272|P2|2 Years|Death|12
2706418|NCT00367133|9319273|P1|2 Years|Death|20
2706419|NCT00367055|9319325|P2|Overall Study|Participant Living too Far from Hospital|1
2706420|NCT00367055|9319326|P1|Overall Study|Participant Living too Far from Hospital|0
2706421|NCT00367055|9319325|P2|Overall Study|Stopping Criterion Met|1
2706422|NCT00367055|9319326|P1|Overall Study|Stopping Criterion Met|0
2706423|NCT00367055|9319325|P2|Overall Study|Protocol Violation|1
2706424|NCT00367055|9319326|P1|Overall Study|Protocol Violation|0
2706425|NCT00367055|9319325|P2|Overall Study|Lost to Follow-up|1
2706426|NCT00367055|9319326|P1|Overall Study|Lost to Follow-up|1
2706427|NCT00367055|9319325|P2|Overall Study|Lack of Efficacy|2
2706428|NCT00367055|9319326|P1|Overall Study|Lack of Efficacy|1
2706429|NCT00367055|9319325|P2|Overall Study|Patient's Willing|2
2706430|NCT00367055|9319326|P1|Overall Study|Patient's Willing|3
2706431|NCT00367055|9319325|P2|Overall Study|Adverse Event|3
2706432|NCT00367055|9319326|P1|Overall Study|Adverse Event|6
2706433|NCT00366899|9319342|P2|Toddler Dose|Protocol Violation|0
2706434|NCT00366899|9319343|P1|Toddler Dose|Protocol Violation|1
2706435|NCT00366899|9319342|P2|Toddler Dose|Withdrawal by Subject|1
2706436|NCT00366899|9319343|P1|Toddler Dose|Withdrawal by Subject|1
2706437|NCT00366899|9319342|P2|After Infant Series|Protocol Violation|0
2706438|NCT00366899|9319343|P1|After Infant Series|Protocol Violation|1
2706439|NCT00366899|9319342|P2|After Infant Series|Adverse Event|2
2706440|NCT00366899|9319343|P1|After Infant Series|Adverse Event|1
2706441|NCT00366899|9319342|P2|After Infant Series|Withdrawal by Subject|4
2706442|NCT00366899|9319343|P1|After Infant Series|Withdrawal by Subject|1
2706443|NCT00366899|9319342|P2|After Infant Series|Lost to Follow-up|3
2706444|NCT00366899|9319343|P1|After Infant Series|Lost to Follow-up|4
2706445|NCT00366899|9319342|P2|Infant Series|Randomized but not consented|0
2706446|NCT00366899|9319343|P1|Infant Series|Randomized but not consented|1
2706447|NCT00366899|9319342|P2|Infant Series|Physician Decision|0
2706448|NCT00366899|9319343|P1|Infant Series|Physician Decision|1
2706449|NCT00366899|9319342|P2|Infant Series|Adverse Event|1
2706450|NCT00366899|9319343|P1|Infant Series|Adverse Event|0
2706451|NCT00366899|9319342|P2|Infant Series|Lost to Follow-up|2
2706452|NCT00366899|9319343|P1|Infant Series|Lost to Follow-up|0
2706453|NCT00366899|9319342|P2|Infant Series|Failed to return|1
2706454|NCT00366899|9319343|P1|Infant Series|Failed to return|1
2706455|NCT00366899|9319342|P2|Infant Series|Protocol Violation|1
2706456|NCT00366899|9319343|P1|Infant Series|Protocol Violation|2
2706457|NCT00366899|9319342|P2|Infant Series|Withdrawal by Subject|7
2706458|NCT00366899|9319343|P1|Infant Series|Withdrawal by Subject|4
2706459|NCT00366678|9319403|P3|Toddler Dose|protocol deviation|0
2706460|NCT00366678|9319404|P2|Toddler Dose|protocol deviation|0
2706461|NCT00366678|9319405|P1|Toddler Dose|protocol deviation|1
2706462|NCT00366678|9319403|P3|Toddler Dose|Withdrawal by Subject|0
2706463|NCT00366678|9319404|P2|Toddler Dose|Withdrawal by Subject|0
2706464|NCT00366678|9319405|P1|Toddler Dose|Withdrawal by Subject|1
2706465|NCT00366678|9319403|P3|Toddler Dose|Failed to return|0
2706466|NCT00366678|9319404|P2|Toddler Dose|Failed to return|0
2706467|NCT00366678|9319405|P1|Toddler Dose|Failed to return|1
2706468|NCT00366678|9319403|P3|Toddler Dose|Protocol Violation|0
2706469|NCT00366678|9319404|P2|Toddler Dose|Protocol Violation|1
2706470|NCT00366678|9319405|P1|Toddler Dose|Protocol Violation|2
2706471|NCT00366678|9319403|P3|After Infant|Protocol Violation|0
2706472|NCT00366678|9319404|P2|After Infant|Protocol Violation|0
2706473|NCT00366678|9319405|P1|After Infant|Protocol Violation|1
2706474|NCT00366678|9319403|P3|After Infant|Adverse Event|0
2706475|NCT00366678|9319404|P2|After Infant|Adverse Event|0
2706476|NCT00366678|9319405|P1|After Infant|Adverse Event|1
2706477|NCT00366678|9319403|P3|After Infant|Failed to return|0
2706478|NCT00366678|9319404|P2|After Infant|Failed to return|5
2706479|NCT00366678|9319405|P1|After Infant|Failed to return|5
2706480|NCT00366678|9319403|P3|After Infant|Lost to Follow-up|0
2706481|NCT00366678|9319404|P2|After Infant|Lost to Follow-up|1
2706482|NCT00366678|9319405|P1|After Infant|Lost to Follow-up|2
2706483|NCT00366678|9319403|P3|After Infant|Withdrawal by Subject|0
2706484|NCT00366678|9319404|P2|After Infant|Withdrawal by Subject|4
2706485|NCT00366678|9319405|P1|After Infant|Withdrawal by Subject|8
2706486|NCT00366678|9319403|P3|Infant Series|Adverse Event|0
2706487|NCT00366678|9319404|P2|Infant Series|Adverse Event|0
2706488|NCT00366678|9319405|P1|Infant Series|Adverse Event|1
2706489|NCT00366678|9319403|P3|Infant Series|Failed to return|0
2706490|NCT00366678|9319404|P2|Infant Series|Failed to return|1
2706491|NCT00366678|9319405|P1|Infant Series|Failed to return|1
2706492|NCT00366678|9319403|P3|Infant Series|Protocol Violation|0
2706493|NCT00366678|9319404|P2|Infant Series|Protocol Violation|3
2706494|NCT00366678|9319405|P1|Infant Series|Protocol Violation|4
2706495|NCT00366678|9319403|P3|Infant Series|Withdrawal by Subject|0
2706496|NCT00366678|9319404|P2|Infant Series|Withdrawal by Subject|6
2706497|NCT00366678|9319405|P1|Infant Series|Withdrawal by Subject|8
2706498|NCT00366548|9319487|P2|After Infant Series|Lost to Follow-up|0
2706499|NCT00366548|9319488|P1|After Infant Series|Lost to Follow-up|1
2706500|NCT00366548|9319487|P2|After Infant Series|Adverse Event|0
2706501|NCT00366548|9319488|P1|After Infant Series|Adverse Event|2
2706502|NCT00366548|9319487|P2|After Infant Series|Withdrawal by Subject|1
2706503|NCT00366548|9319488|P1|After Infant Series|Withdrawal by Subject|3
2706504|NCT00366548|9319487|P2|Infant Series|Withdrawal by Subject|1
2706505|NCT00366548|9319488|P1|Infant Series|Withdrawal by Subject|3
2706506|NCT00366548|9319487|P2|Infant Series|Protocol Violation|1
2706507|NCT00366548|9319488|P1|Infant Series|Protocol Violation|0
2706508|NCT00366548|9319487|P2|Infant Series|Adverse Event|3
2706509|NCT00366548|9319488|P1|Infant Series|Adverse Event|1
2706510|NCT00366535|9319524|P2|Second Phase: 12 Weeks|Withdrawal by Subject|2
2706511|NCT00366535|9319525|P1|Second Phase: 12 Weeks|Withdrawal by Subject|2
2706512|NCT00366535|9319524|P2|Second Phase: 12 Weeks|Adverse Event|1
2706513|NCT00366535|9319525|P1|Second Phase: 12 Weeks|Adverse Event|1
2706514|NCT00366535|9319524|P2|First Phase: 12 Weeks|Withdrawal by Subject|5
2706515|NCT00366535|9319525|P1|First Phase: 12 Weeks|Withdrawal by Subject|2
2706516|NCT00366535|9319524|P2|First Phase: 12 Weeks|Adverse Event|3
2706517|NCT00366535|9319525|P1|First Phase: 12 Weeks|Adverse Event|1
2706518|NCT00366457|9319539|P1|Overall Study|never began study therapy|2
2706519|NCT00366444|9319548|P2|Overall Study|Lack of Efficacy|1
2706520|NCT00366444|9319549|P1|Overall Study|Lack of Efficacy|0
2706521|NCT00366444|9319548|P2|Overall Study|Withdrawal by Subject|1
2706522|NCT00366444|9319549|P1|Overall Study|Withdrawal by Subject|1
2706523|NCT00366340|9319577|P2|Toddler Dose|Parent/legal guardian request|1
2706524|NCT00366340|9319578|P1|Toddler Dose|Parent/legal guardian request|0
2706525|NCT00366340|9319577|P2|Toddler Dose|Failed to return|0
2706526|NCT00366340|9319578|P1|Toddler Dose|Failed to return|1
2706527|NCT00366340|9319577|P2|After the Infant Series|Lost to Follow-up|1
2706528|NCT00366340|9319578|P1|After the Infant Series|Lost to Follow-up|0
2706529|NCT00366340|9319577|P2|After the Infant Series|Adverse Event|1
2706530|NCT00366340|9319578|P1|After the Infant Series|Adverse Event|0
2706531|NCT00366340|9319577|P2|After the Infant Series|Protocol Violation|2
2706532|NCT00366340|9319578|P1|After the Infant Series|Protocol Violation|2
2706533|NCT00366340|9319577|P2|After the Infant Series|Failed to return|1
2706534|NCT00366340|9319578|P1|After the Infant Series|Failed to return|0
2706535|NCT00366340|9319577|P2|After the Infant Series|Parent/legal guardian request|1
2706536|NCT00366340|9319578|P1|After the Infant Series|Parent/legal guardian request|1
2706537|NCT00366340|9319577|P2|Infant Series|Failure to return|0
2706538|NCT00366340|9319578|P1|Infant Series|Failure to return|1
2706539|NCT00366340|9319577|P2|Infant Series|Lost to Follow-up|1
2706540|NCT00366340|9319578|P1|Infant Series|Lost to Follow-up|1
2706541|NCT00366340|9319577|P2|Infant Series|Adverse Event|2
2706542|NCT00366340|9319578|P1|Infant Series|Adverse Event|0
2706543|NCT00366340|9319577|P2|Infant Series|Withdrawal by Subject|3
2706544|NCT00366340|9319578|P1|Infant Series|Withdrawal by Subject|3
2706545|NCT00366340|9319577|P2|Infant Series|Protocol Violation|4
2706546|NCT00366340|9319578|P1|Infant Series|Protocol Violation|3
2706547|NCT00366301|9319636|P4|Overall Study|Withdrawal by Subject|1
2706548|NCT00366301|9319637|P3|Overall Study|Withdrawal by Subject|1
2706549|NCT00366301|9319638|P2|Overall Study|Withdrawal by Subject|2
2706550|NCT00366301|9319639|P1|Overall Study|Withdrawal by Subject|4
2706551|NCT00366301|9319636|P4|Overall Study|Lost to Follow-up|7
2706552|NCT00366301|9319637|P3|Overall Study|Lost to Follow-up|3
2706553|NCT00366301|9319638|P2|Overall Study|Lost to Follow-up|4
2706554|NCT00366301|9319639|P1|Overall Study|Lost to Follow-up|4
2706555|NCT00366249|9319655|P2|Overall Study|Most due to osteomylitis status|20
2706556|NCT00366249|9319656|P1|Overall Study|Most due to osteomylitis status|31
2706557|NCT00366249|9319655|P2|Overall Study|Lack of Efficacy|21
2706558|NCT00366249|9319656|P1|Overall Study|Lack of Efficacy|21
2706559|NCT00366249|9319655|P2|Overall Study|Withdrawal by Subject|4
2706560|NCT00366249|9319656|P1|Overall Study|Withdrawal by Subject|18
2706561|NCT00366249|9319655|P2|Overall Study|Protocol Violation|2
2706562|NCT00366249|9319656|P1|Overall Study|Protocol Violation|1
2706563|NCT00366249|9319655|P2|Overall Study|Lost to Follow-up|0
2706564|NCT00366249|9319656|P1|Overall Study|Lost to Follow-up|2
2706565|NCT00366249|9319655|P2|Overall Study|Physician Decision|2
2706566|NCT00366249|9319656|P1|Overall Study|Physician Decision|5
2706567|NCT00366249|9319655|P2|Overall Study|Death|1
2706568|NCT00366249|9319656|P1|Overall Study|Death|0
2706569|NCT00366249|9319655|P2|Overall Study|Adverse Event|28
2706570|NCT00366249|9319656|P1|Overall Study|Adverse Event|53
2706571|NCT00365989|9319688|P1|Overall Study|Non-compliance|1
2706572|NCT00365989|9319688|P1|Overall Study|Withdrawal by Subject|1
2706573|NCT00365976|9319696|P2|Overall Study|Withdrawal by Subject|5
2706574|NCT00365976|9319697|P1|Overall Study|Withdrawal by Subject|1
2706575|NCT00365846|9319835|P1|Overall Study|Lost to Follow-up|1
2706576|NCT00365794|9319844|P1|Overall Study|Withdrawal by Subject|2
2706577|NCT00365716|9319873|P7|Extension 2|Withdrawal by Subject|5
2706578|NCT00365716|9319874|P6|Extension 2|Withdrawal by Subject|0
2706579|NCT00365716|9319875|P5|Extension 2|Withdrawal by Subject|0
2706580|NCT00365716|9319876|P4|Extension 2|Withdrawal by Subject|0
2706581|NCT00365716|9319877|P3|Extension 2|Withdrawal by Subject|0
2706582|NCT00365716|9319878|P2|Extension 2|Withdrawal by Subject|0
2706583|NCT00365716|9319879|P1|Extension 2|Withdrawal by Subject|0
2706584|NCT00365716|9319873|P7|Extension 2|Other|3
2706585|NCT00365716|9319874|P6|Extension 2|Other|0
2706586|NCT00365716|9319875|P5|Extension 2|Other|0
2706587|NCT00365716|9319876|P4|Extension 2|Other|0
2706588|NCT00365716|9319877|P3|Extension 2|Other|0
2706589|NCT00365716|9319878|P2|Extension 2|Other|0
2706590|NCT00365716|9319879|P1|Extension 2|Other|0
2706591|NCT00365716|9319873|P7|Extension 2|Lost to Follow-up|2
2706592|NCT00365716|9319874|P6|Extension 2|Lost to Follow-up|0
2706593|NCT00365716|9319875|P5|Extension 2|Lost to Follow-up|0
2706594|NCT00365716|9319876|P4|Extension 2|Lost to Follow-up|0
2706595|NCT00365716|9319877|P3|Extension 2|Lost to Follow-up|0
2706596|NCT00365716|9319878|P2|Extension 2|Lost to Follow-up|0
2706597|NCT00365716|9319879|P1|Extension 2|Lost to Follow-up|0
2706598|NCT00365716|9319873|P7|Extension 1|Protocol Violation|0
2706599|NCT00365716|9319874|P6|Extension 1|Protocol Violation|1
2706600|NCT00365716|9319875|P5|Extension 1|Protocol Violation|0
2706601|NCT00365716|9319876|P4|Extension 1|Protocol Violation|0
2706602|NCT00365716|9319877|P3|Extension 1|Protocol Violation|0
2706603|NCT00365716|9319878|P2|Extension 1|Protocol Violation|0
2706604|NCT00365716|9319879|P1|Extension 1|Protocol Violation|0
2706605|NCT00365716|9319873|P7|Extension 1|Pregnancy|0
2706606|NCT00365716|9319874|P6|Extension 1|Pregnancy|4
2706607|NCT00365716|9319875|P5|Extension 1|Pregnancy|0
2706608|NCT00365716|9319876|P4|Extension 1|Pregnancy|0
2706609|NCT00365716|9319877|P3|Extension 1|Pregnancy|0
2706610|NCT00365716|9319878|P2|Extension 1|Pregnancy|0
2706611|NCT00365716|9319879|P1|Extension 1|Pregnancy|0
2706612|NCT00365716|9319873|P7|Extension 1|Withdrawal by Subject|0
2706613|NCT00365716|9319874|P6|Extension 1|Withdrawal by Subject|3
2706614|NCT00365716|9319875|P5|Extension 1|Withdrawal by Subject|0
2706615|NCT00365716|9319876|P4|Extension 1|Withdrawal by Subject|0
2706616|NCT00365716|9319877|P3|Extension 1|Withdrawal by Subject|0
2706617|NCT00365716|9319878|P2|Extension 1|Withdrawal by Subject|0
2706618|NCT00365716|9319879|P1|Extension 1|Withdrawal by Subject|0
2706619|NCT00365716|9319873|P7|Extension 1|Moved|0
2706620|NCT00365716|9319874|P6|Extension 1|Moved|4
2706621|NCT00365716|9319875|P5|Extension 1|Moved|0
2706622|NCT00365716|9319876|P4|Extension 1|Moved|0
2706623|NCT00365716|9319877|P3|Extension 1|Moved|0
2706624|NCT00365716|9319878|P2|Extension 1|Moved|0
2706625|NCT00365716|9319879|P1|Extension 1|Moved|0
2706626|NCT00365716|9319873|P7|Extension 1|Other|0
2706627|NCT00365716|9319874|P6|Extension 1|Other|9
2706628|NCT00365716|9319875|P5|Extension 1|Other|0
2706629|NCT00365716|9319876|P4|Extension 1|Other|0
2706630|NCT00365716|9319877|P3|Extension 1|Other|0
2706631|NCT00365716|9319878|P2|Extension 1|Other|0
2706632|NCT00365716|9319879|P1|Extension 1|Other|0
2706633|NCT00365716|9319873|P7|Extension 1|Lost to Follow-up|0
2706634|NCT00365716|9319874|P6|Extension 1|Lost to Follow-up|1
2706635|NCT00365716|9319875|P5|Extension 1|Lost to Follow-up|0
2706636|NCT00365716|9319876|P4|Extension 1|Lost to Follow-up|0
2706637|NCT00365716|9319877|P3|Extension 1|Lost to Follow-up|0
2706638|NCT00365716|9319878|P2|Extension 1|Lost to Follow-up|0
2706639|NCT00365716|9319879|P1|Extension 1|Lost to Follow-up|0
2706640|NCT00365716|9319873|P7|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
2706641|NCT00365716|9319874|P6|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
2706642|NCT00365716|9319875|P5|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3
2706643|NCT00365716|9319876|P4|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
2706644|NCT00365716|9319877|P3|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13
2706645|NCT00365716|9319878|P2|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
2706646|NCT00365716|9319879|P1|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7
2706647|NCT00365716|9319873|P7|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
2706648|NCT00365716|9319874|P6|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
2706649|NCT00365716|9319875|P5|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
2706650|NCT00365716|9319876|P4|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
2706651|NCT00365716|9319877|P3|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
2706652|NCT00365716|9319878|P2|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
2706653|NCT00365716|9319879|P1|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
2706654|NCT00365716|9319873|P7|Long Term Follow-up (Month 7 toMonth 36)|Other|0
2706655|NCT00365716|9319874|P6|Long Term Follow-up (Month 7 toMonth 36)|Other|0
2706656|NCT00365716|9319875|P5|Long Term Follow-up (Month 7 toMonth 36)|Other|1
2706657|NCT00365716|9319876|P4|Long Term Follow-up (Month 7 toMonth 36)|Other|0
2706658|NCT00365716|9319877|P3|Long Term Follow-up (Month 7 toMonth 36)|Other|0
2706659|NCT00365716|9319878|P2|Long Term Follow-up (Month 7 toMonth 36)|Other|0
2706660|NCT00365716|9319879|P1|Long Term Follow-up (Month 7 toMonth 36)|Other|2
2706661|NCT00365716|9319873|P7|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
2706662|NCT00365716|9319874|P6|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
2706663|NCT00365716|9319875|P5|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
2706664|NCT00365716|9319876|P4|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
2706665|NCT00365716|9319877|P3|Long Term Follow-up (Month 7 toMonth 36)|Moved|1
2706666|NCT00365716|9319878|P2|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
2706667|NCT00365716|9319879|P1|Long Term Follow-up (Month 7 toMonth 36)|Moved|3
2706668|NCT00365716|9319873|P7|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
2706669|NCT00365716|9319874|P6|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
2706670|NCT00365716|9319875|P5|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3
2706671|NCT00365716|9319876|P4|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4
2706672|NCT00365716|9319877|P3|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5
2706673|NCT00365716|9319878|P2|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8
2706674|NCT00365716|9319879|P1|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6
2706675|NCT00365716|9319873|P7|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
2706676|NCT00365716|9319874|P6|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
2706677|NCT00365716|9319875|P5|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75
2706678|NCT00365716|9319876|P4|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69
2706679|NCT00365716|9319877|P3|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
2706680|NCT00365716|9319878|P2|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
2706681|NCT00365716|9319879|P1|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114
2706682|NCT00365716|9319873|P7|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
2706683|NCT00365716|9319874|P6|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
2706684|NCT00365716|9319875|P5|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3
2706685|NCT00365716|9319876|P4|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4
2706686|NCT00365716|9319877|P3|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
2706687|NCT00365716|9319878|P2|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9
2706688|NCT00365716|9319879|P1|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
2706689|NCT00365716|9319873|P7|Base Study (Day 1 to Month 7)|Protocol Violation|0
2706690|NCT00365716|9319874|P6|Base Study (Day 1 to Month 7)|Protocol Violation|0
2706691|NCT00365716|9319875|P5|Base Study (Day 1 to Month 7)|Protocol Violation|2
2706692|NCT00365716|9319876|P4|Base Study (Day 1 to Month 7)|Protocol Violation|1
2706693|NCT00365716|9319877|P3|Base Study (Day 1 to Month 7)|Protocol Violation|0
2706694|NCT00365716|9319878|P2|Base Study (Day 1 to Month 7)|Protocol Violation|2
2706695|NCT00365716|9319879|P1|Base Study (Day 1 to Month 7)|Protocol Violation|1
2706696|NCT00365716|9319873|P7|Base Study (Day 1 to Month 7)|Pregnancy|0
2706697|NCT00365716|9319874|P6|Base Study (Day 1 to Month 7)|Pregnancy|0
2706698|NCT00365716|9319875|P5|Base Study (Day 1 to Month 7)|Pregnancy|1
2706699|NCT00365716|9319876|P4|Base Study (Day 1 to Month 7)|Pregnancy|1
2706700|NCT00365716|9319877|P3|Base Study (Day 1 to Month 7)|Pregnancy|3
2706701|NCT00365716|9319878|P2|Base Study (Day 1 to Month 7)|Pregnancy|2
2706702|NCT00365716|9319879|P1|Base Study (Day 1 to Month 7)|Pregnancy|3
2706703|NCT00365716|9319873|P7|Base Study (Day 1 to Month 7)|Other|0
2706704|NCT00365716|9319874|P6|Base Study (Day 1 to Month 7)|Other|0
2706705|NCT00365716|9319875|P5|Base Study (Day 1 to Month 7)|Other|0
2706706|NCT00365716|9319876|P4|Base Study (Day 1 to Month 7)|Other|0
2706707|NCT00365716|9319877|P3|Base Study (Day 1 to Month 7)|Other|0
2706708|NCT00365716|9319878|P2|Base Study (Day 1 to Month 7)|Other|1
2706709|NCT00365716|9319879|P1|Base Study (Day 1 to Month 7)|Other|0
2706710|NCT00365716|9319873|P7|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
2706711|NCT00365716|9319874|P6|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
2706712|NCT00365716|9319875|P5|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
2706713|NCT00365716|9319876|P4|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
2706714|NCT00365716|9319877|P3|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
2706715|NCT00365716|9319878|P2|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
2706716|NCT00365716|9319879|P1|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
2706717|NCT00365716|9319873|P7|Base Study (Day 1 to Month 7)|Adverse Event|0
2706718|NCT00365716|9319874|P6|Base Study (Day 1 to Month 7)|Adverse Event|0
2706719|NCT00365716|9319875|P5|Base Study (Day 1 to Month 7)|Adverse Event|1
2706720|NCT00365716|9319876|P4|Base Study (Day 1 to Month 7)|Adverse Event|0
2706721|NCT00365716|9319877|P3|Base Study (Day 1 to Month 7)|Adverse Event|0
2706722|NCT00365716|9319878|P2|Base Study (Day 1 to Month 7)|Adverse Event|2
2706723|NCT00365716|9319879|P1|Base Study (Day 1 to Month 7)|Adverse Event|0
2706724|NCT00365716|9319873|P7|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
2706725|NCT00365716|9319874|P6|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
2706726|NCT00365716|9319875|P5|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
2706727|NCT00365716|9319876|P4|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
2706728|NCT00365716|9319877|P3|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
2706729|NCT00365716|9319878|P2|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2
2706730|NCT00365716|9319879|P1|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1
2706731|NCT00365547|9319900|P1|Overall Study|Withdrawal by Subject|1
2706732|NCT00365547|9319900|P1|Overall Study|Screen failure|1
2706733|NCT00365547|9319900|P1|Overall Study|Insurance did not cover Avastin|1
2706734|NCT00365508|9319910|P2|Overall Study|Lost to Follow-up|154
2706735|NCT00365508|9319911|P1|Overall Study|Lost to Follow-up|139
2706736|NCT00365456|9319919|P2|Trial Period III (12 Months)|Other|1
2706737|NCT00365456|9319920|P1|Trial Period III (12 Months)|Other|1
2706738|NCT00365456|9319919|P2|Trial Period III (12 Months)|Withdrawal by Subject|1
2706739|NCT00365456|9319920|P1|Trial Period III (12 Months)|Withdrawal by Subject|4
2706740|NCT00365456|9319919|P2|Trial Period III (12 Months)|Adverse Event|3
2706741|NCT00365456|9319920|P1|Trial Period III (12 Months)|Adverse Event|13
2706742|NCT00365456|9319919|P2|Trial Period II (12 Months)|Other|1
2706743|NCT00365456|9319920|P1|Trial Period II (12 Months)|Other|0
2706744|NCT00365456|9319919|P2|Trial Period II (12 Months)|Withdrawal by Subject|5
2706745|NCT00365456|9319920|P1|Trial Period II (12 Months)|Withdrawal by Subject|0
2706746|NCT00365456|9319919|P2|Trial Period II (12 Months)|Non-compliance|2
2706747|NCT00365456|9319920|P1|Trial Period II (12 Months)|Non-compliance|0
2706748|NCT00365456|9319919|P2|Trial Period II (12 Months)|Adverse Event|6
2706749|NCT00365456|9319920|P1|Trial Period II (12 Months)|Adverse Event|0
2706750|NCT00365456|9319919|P2|Trial Period I (12 Months)|Other|0
2706751|NCT00365456|9319920|P1|Trial Period I (12 Months)|Other|11
2706752|NCT00365456|9319919|P2|Trial Period I (12 Months)|Withdrawal by Subject|0
2706753|NCT00365456|9319920|P1|Trial Period I (12 Months)|Withdrawal by Subject|27
2706754|NCT00365456|9319919|P2|Trial Period I (12 Months)|Non-compliance|0
2706755|NCT00365456|9319920|P1|Trial Period I (12 Months)|Non-compliance|3
2706756|NCT00365456|9319919|P2|Trial Period I (12 Months)|Adverse Event|0
2706757|NCT00365456|9319920|P1|Trial Period I (12 Months)|Adverse Event|84
2706758|NCT00365378|9319947|P3|Extension|Other|31
2706759|NCT00365378|9319948|P2|Extension|Other|0
2706760|NCT00365378|9319949|P1|Extension|Other|0
2706761|NCT00365378|9319947|P3|Extension|Withdrawal by Subject|98
2706762|NCT00365378|9319948|P2|Extension|Withdrawal by Subject|0
2706763|NCT00365378|9319949|P1|Extension|Withdrawal by Subject|0
2706764|NCT00365378|9319947|P3|Extension|Protocol Violation|2
2706765|NCT00365378|9319948|P2|Extension|Protocol Violation|0
2706766|NCT00365378|9319949|P1|Extension|Protocol Violation|0
2706767|NCT00365378|9319947|P3|Extension|Lost to Follow-up|57
2706768|NCT00365378|9319948|P2|Extension|Lost to Follow-up|0
2706769|NCT00365378|9319949|P1|Extension|Lost to Follow-up|0
2706770|NCT00365378|9319947|P3|Extension|Moved|8
2706771|NCT00365378|9319948|P2|Extension|Moved|0
2706772|NCT00365378|9319949|P1|Extension|Moved|0
2706773|NCT00365378|9319947|P3|Extension|Adverse Event|1
2706774|NCT00365378|9319948|P2|Extension|Adverse Event|0
2706775|NCT00365378|9319949|P1|Extension|Adverse Event|0
2706776|NCT00365378|9319947|P3|Follow-up (Month 7 Though Month 48)|Other|0
2706777|NCT00365378|9319948|P2|Follow-up (Month 7 Though Month 48)|Other|21
2706778|NCT00365378|9319949|P1|Follow-up (Month 7 Though Month 48)|Other|11
2706779|NCT00365378|9319947|P3|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0
2706780|NCT00365378|9319948|P2|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104
2706781|NCT00365378|9319949|P1|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73
2706782|NCT00365378|9319947|P3|Follow-up (Month 7 Though Month 48)|Protocol Violation|0
2706783|NCT00365378|9319948|P2|Follow-up (Month 7 Though Month 48)|Protocol Violation|2
2706784|NCT00365378|9319949|P1|Follow-up (Month 7 Though Month 48)|Protocol Violation|1
2706785|NCT00365378|9319947|P3|Follow-up (Month 7 Though Month 48)|Pregnancy|0
2706786|NCT00365378|9319948|P2|Follow-up (Month 7 Though Month 48)|Pregnancy|1
2706787|NCT00365378|9319949|P1|Follow-up (Month 7 Though Month 48)|Pregnancy|0
2706788|NCT00365378|9319947|P3|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0
2706789|NCT00365378|9319948|P2|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69
2706790|NCT00365378|9319949|P1|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67
2706791|NCT00365378|9319947|P3|Follow-up (Month 7 Though Month 48)|Moved|0
2706792|NCT00365378|9319948|P2|Follow-up (Month 7 Though Month 48)|Moved|5
2706793|NCT00365378|9319949|P1|Follow-up (Month 7 Though Month 48)|Moved|6
2706794|NCT00365378|9319947|P3|Vaccination (Day 1 to Month 7)|Other|0
2706795|NCT00365378|9319948|P2|Vaccination (Day 1 to Month 7)|Other|9
2706796|NCT00365378|9319949|P1|Vaccination (Day 1 to Month 7)|Other|17
2706797|NCT00365378|9319947|P3|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0
2706798|NCT00365378|9319948|P2|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44
2706799|NCT00365378|9319949|P1|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50
2706800|NCT00365378|9319947|P3|Vaccination (Day 1 to Month 7)|Protocol Violation|0
2706801|NCT00365378|9319948|P2|Vaccination (Day 1 to Month 7)|Protocol Violation|13
2706802|NCT00365378|9319949|P1|Vaccination (Day 1 to Month 7)|Protocol Violation|22
2706803|NCT00365378|9319947|P3|Vaccination (Day 1 to Month 7)|Pregnancy|0
2706804|NCT00365378|9319948|P2|Vaccination (Day 1 to Month 7)|Pregnancy|14
2706805|NCT00365378|9319949|P1|Vaccination (Day 1 to Month 7)|Pregnancy|19
2706806|NCT00365378|9319947|P3|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0
2706807|NCT00365378|9319948|P2|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75
2706808|NCT00365378|9319949|P1|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88
2706809|NCT00365378|9319947|P3|Vaccination (Day 1 to Month 7)|Adverse Event|0
2706810|NCT00365378|9319948|P2|Vaccination (Day 1 to Month 7)|Adverse Event|5
2706811|NCT00365378|9319949|P1|Vaccination (Day 1 to Month 7)|Adverse Event|4
2706812|NCT00365378|9319947|P3|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0
2706813|NCT00365378|9319948|P2|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7
2706814|NCT00365378|9319949|P1|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11
2706815|NCT00365365|9319963|P3|Overall Study|Patient/physician decision|1
2706816|NCT00365365|9319964|P2|Overall Study|Patient/physician decision|0
2706817|NCT00365365|9319965|P1|Overall Study|Patient/physician decision|0
2706818|NCT00365365|9319963|P3|Overall Study|Second malignancy|0
2706819|NCT00365365|9319964|P2|Overall Study|Second malignancy|1
2706820|NCT00365365|9319965|P1|Overall Study|Second malignancy|0
2706821|NCT00365365|9319963|P3|Overall Study|Withdrew consent|0
2706822|NCT00365365|9319964|P2|Overall Study|Withdrew consent|1
2706823|NCT00365365|9319965|P1|Overall Study|Withdrew consent|1
2706824|NCT00365365|9319963|P3|Overall Study|New cancer|0
2706825|NCT00365365|9319964|P2|Overall Study|New cancer|0
2706826|NCT00365365|9319965|P1|Overall Study|New cancer|1
2706827|NCT00365365|9319963|P3|Overall Study|Moved|0
2706828|NCT00365365|9319964|P2|Overall Study|Moved|0
2706829|NCT00365365|9319965|P1|Overall Study|Moved|2
2706830|NCT00365365|9319963|P3|Overall Study|Adverse Event|3
2706831|NCT00365365|9319964|P2|Overall Study|Adverse Event|6
2706832|NCT00365365|9319965|P1|Overall Study|Adverse Event|6
2706833|NCT00365365|9319963|P3|Overall Study|Disease progression/relapse|7
2706834|NCT00365365|9319964|P2|Overall Study|Disease progression/relapse|6
2706835|NCT00365365|9319965|P1|Overall Study|Disease progression/relapse|9
2706836|NCT00365365|9319963|P3|Overall Study|Subject's request|1
2706837|NCT00365365|9319964|P2|Overall Study|Subject's request|13
2706838|NCT00365365|9319965|P1|Overall Study|Subject's request|11
2706839|NCT00365365|9319963|P3|Overall Study|Death|0
2706840|NCT00365365|9319964|P2|Overall Study|Death|3
2706841|NCT00365365|9319965|P1|Overall Study|Death|1
2706842|NCT00365365|9319963|P3|Overall Study|Lost to Follow-up|3
2706843|NCT00365365|9319964|P2|Overall Study|Lost to Follow-up|3
2706844|NCT00365365|9319965|P1|Overall Study|Lost to Follow-up|3
2706845|NCT00365365|9319963|P3|Overall Study|Poor compliance to protocol|0
2706846|NCT00365365|9319964|P2|Overall Study|Poor compliance to protocol|1
2706847|NCT00365365|9319965|P1|Overall Study|Poor compliance to protocol|0
2706848|NCT00365365|9319963|P3|Overall Study|Randomized but not treated|0
2706849|NCT00365365|9319964|P2|Overall Study|Randomized but not treated|2
2706850|NCT00365365|9319965|P1|Overall Study|Randomized but not treated|0
2706851|NCT00365352|9319982|P3|Overall Study|Withdrawal of Participant by Sponsor|0
2706852|NCT00365352|9319983|P2|Overall Study|Withdrawal of Participant by Sponsor|0
2706853|NCT00365352|9319984|P1|Overall Study|Withdrawal of Participant by Sponsor|1
2706854|NCT00365352|9319982|P3|Overall Study|Lost to Follow-up|0
2706855|NCT00365352|9319983|P2|Overall Study|Lost to Follow-up|1
2706856|NCT00365352|9319984|P1|Overall Study|Lost to Follow-up|1
2706857|NCT00365352|9319982|P3|Overall Study|Non-Compliance (after Randomization)|1
2706858|NCT00365352|9319983|P2|Overall Study|Non-Compliance (after Randomization)|0
2706859|NCT00365352|9319984|P1|Overall Study|Non-Compliance (after Randomization)|1
2706860|NCT00365352|9319982|P3|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2
2706861|NCT00365352|9319983|P2|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
2706862|NCT00365352|9319984|P1|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
2706863|NCT00365352|9319982|P3|Overall Study|Lack of Efficacy|0
2706864|NCT00365352|9319983|P2|Overall Study|Lack of Efficacy|0
2706865|NCT00365352|9319984|P1|Overall Study|Lack of Efficacy|3
2706866|NCT00365352|9319982|P3|Overall Study|Participant Withdrew Consent|4
2706867|NCT00365352|9319983|P2|Overall Study|Participant Withdrew Consent|3
2706868|NCT00365352|9319984|P1|Overall Study|Participant Withdrew Consent|8
2706869|NCT00365352|9319982|P3|Overall Study|Adverse Event|8
2706870|NCT00365352|9319983|P2|Overall Study|Adverse Event|7
2706871|NCT00365352|9319984|P1|Overall Study|Adverse Event|6
2706872|NCT00365300|9320068|P2|Double-blind Phase|Lack of Efficacy|6
2706873|NCT00365300|9320069|P1|Double-blind Phase|Lack of Efficacy|6
2706874|NCT00365300|9320068|P2|Double-blind Phase|Protocol Violation|1
2706875|NCT00365300|9320069|P1|Double-blind Phase|Protocol Violation|3
2706876|NCT00365300|9320068|P2|Double-blind Phase|Withdrawal by Subject|1
2706877|NCT00365300|9320069|P1|Double-blind Phase|Withdrawal by Subject|0
2706878|NCT00365300|9320068|P2|Double-blind Phase|Noncompliance|1
2706879|NCT00365300|9320069|P1|Double-blind Phase|Noncompliance|1
2706880|NCT00365300|9320068|P2|Double-blind Phase|Failed to return|0
2706881|NCT00365300|9320069|P1|Double-blind Phase|Failed to return|1
2706882|NCT00365300|9320068|P2|Open-label Phase|Patient skipped open label phase|0
2706883|NCT00365300|9320069|P1|Open-label Phase|Patient skipped open label phase|1
2706884|NCT00365300|9320068|P2|Open-label Phase|Lack of Efficacy|0
2706885|NCT00365300|9320069|P1|Open-label Phase|Lack of Efficacy|1
2706886|NCT00365300|9320068|P2|Open-label Phase|Protocol Violation|0
2706887|NCT00365300|9320069|P1|Open-label Phase|Protocol Violation|1
2706888|NCT00365300|9320068|P2|Open-label Phase|Parent/Legal Guardian Request|0
2706889|NCT00365300|9320069|P1|Open-label Phase|Parent/Legal Guardian Request|4
2706890|NCT00365300|9320068|P2|Open-label Phase|Noncompliance|0
2706891|NCT00365300|9320069|P1|Open-label Phase|Noncompliance|9
2706892|NCT00365300|9320068|P2|Open-label Phase|Physician Decision|0
2706893|NCT00365300|9320069|P1|Open-label Phase|Physician Decision|1
2706894|NCT00365300|9320068|P2|Open-label Phase|Failed to Return|0
2706895|NCT00365300|9320069|P1|Open-label Phase|Failed to Return|1
2706896|NCT00365300|9320068|P2|Open-label Phase|Adverse Event|0
2706897|NCT00365300|9320069|P1|Open-label Phase|Adverse Event|4
2706898|NCT00365105|9320134|P2|Overall Study|Protocol Violation|8
2706899|NCT00365105|9320135|P1|Overall Study|Protocol Violation|5
2706900|NCT00364923|9320181|P1|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24
2706901|NCT00364923|9320181|P1|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4
2706902|NCT00364858|9320190|P2|Overall Study|Clinical baseline issue|1
2706903|NCT00364858|9320191|P1|Overall Study|Clinical baseline issue|0
2706904|NCT00364858|9320190|P2|Overall Study|Return to Q2 regimen|1
2706905|NCT00364858|9320191|P1|Overall Study|Return to Q2 regimen|0
2706906|NCT00364858|9320190|P2|Overall Study|Non-compliant|0
2706907|NCT00364858|9320191|P1|Overall Study|Non-compliant|1
2706908|NCT00364858|9320190|P2|Overall Study|Discontinuation at baseline|0
2706909|NCT00364858|9320191|P1|Overall Study|Discontinuation at baseline|1
2706910|NCT00364858|9320190|P2|Overall Study|Clinical failure|13
2706911|NCT00364858|9320191|P1|Overall Study|Clinical failure|2
2706912|NCT00364858|9320190|P2|Overall Study|Pregnancy|1
2706913|NCT00364858|9320191|P1|Overall Study|Pregnancy|1
2706914|NCT00364858|9320190|P2|Overall Study|Withdrawal by Subject|1
2706915|NCT00364858|9320191|P1|Overall Study|Withdrawal by Subject|1
2706916|NCT00364858|9320190|P2|Overall Study|Adverse Event|5
2706917|NCT00364858|9320191|P1|Overall Study|Adverse Event|1
2706918|NCT00364845|9320206|P2|Overall Study|Death|1
2706919|NCT00364845|9320207|P1|Overall Study|Death|0
2706920|NCT00364845|9320206|P2|Overall Study|Lost to Follow-up|1
2706921|NCT00364845|9320207|P1|Overall Study|Lost to Follow-up|0
2706922|NCT00364845|9320206|P2|Overall Study|Physician Decision|8
2706923|NCT00364845|9320207|P1|Overall Study|Physician Decision|8
2706924|NCT00364845|9320206|P2|Overall Study|Withdrawal by Subject|1
2706925|NCT00364845|9320207|P1|Overall Study|Withdrawal by Subject|2
2706926|NCT00364845|9320206|P2|Overall Study|Adverse Event|0
2706927|NCT00364845|9320207|P1|Overall Study|Adverse Event|1
2706928|NCT00364832|9320228|P12|Extension Year 2|Early Withdrawals|3
2706929|NCT00364832|9320229|P11|Extension Year 2|Early Withdrawals|5
2706930|NCT00364832|9320230|P10|Extension Year 2|Early Withdrawals|5
2706931|NCT00364832|9320231|P9|Extension Year 2|Early Withdrawals|0
2706932|NCT00364832|9320232|P8|Extension Year 2|Early Withdrawals|0
2706933|NCT00364832|9320233|P7|Extension Year 2|Early Withdrawals|0
2706934|NCT00364832|9320234|P6|Extension Year 2|Early Withdrawals|0
2706935|NCT00364832|9320235|P5|Extension Year 2|Early Withdrawals|0
2706936|NCT00364832|9320236|P4|Extension Year 2|Early Withdrawals|0
2706937|NCT00364832|9320237|P3|Extension Year 2|Early Withdrawals|0
2706938|NCT00364832|9320238|P2|Extension Year 2|Early Withdrawals|0
2706939|NCT00364832|9320239|P1|Extension Year 2|Early Withdrawals|0
2706940|NCT00364832|9320228|P12|Extension Year 1|Early Withdrawals|10
2706941|NCT00364832|9320229|P11|Extension Year 1|Early Withdrawals|2
2706942|NCT00364832|9320230|P10|Extension Year 1|Early Withdrawals|4
2706943|NCT00364832|9320231|P9|Extension Year 1|Early Withdrawals|0
2706944|NCT00364832|9320232|P8|Extension Year 1|Early Withdrawals|0
2706945|NCT00364832|9320233|P7|Extension Year 1|Early Withdrawals|0
2706946|NCT00364832|9320234|P6|Extension Year 1|Early Withdrawals|0
2706947|NCT00364832|9320235|P5|Extension Year 1|Early Withdrawals|0
2706948|NCT00364832|9320236|P4|Extension Year 1|Early Withdrawals|0
2706949|NCT00364832|9320237|P3|Extension Year 1|Early Withdrawals|0
2706950|NCT00364832|9320238|P2|Extension Year 1|Early Withdrawals|0
2706951|NCT00364832|9320239|P1|Extension Year 1|Early Withdrawals|0
2706952|NCT00364832|9320228|P12|Core Period|Early Withdrawals|0
2706953|NCT00364832|9320229|P11|Core Period|Early Withdrawals|0
2706954|NCT00364832|9320230|P10|Core Period|Early Withdrawals|0
2706955|NCT00364832|9320231|P9|Core Period|Early Withdrawals|0
2706956|NCT00364832|9320232|P8|Core Period|Early Withdrawals|1
2706957|NCT00364832|9320233|P7|Core Period|Early Withdrawals|4
2706958|NCT00364832|9320234|P6|Core Period|Early Withdrawals|0
2706959|NCT00364832|9320235|P5|Core Period|Early Withdrawals|0
2706960|NCT00364832|9320236|P4|Core Period|Early Withdrawals|1
2706961|NCT00364832|9320237|P3|Core Period|Early Withdrawals|1
2706962|NCT00364832|9320238|P2|Core Period|Early Withdrawals|2
2706963|NCT00364832|9320239|P1|Core Period|Early Withdrawals|2
2706964|NCT00364793|9320304|P4|Overall Study|Withdrawal by Subject|0
2706965|NCT00364793|9320305|P3|Overall Study|Withdrawal by Subject|0
2706966|NCT00364793|9320306|P2|Overall Study|Withdrawal by Subject|1
2706967|NCT00364793|9320307|P1|Overall Study|Withdrawal by Subject|0
2706968|NCT00364793|9320304|P4|Overall Study|No longer meets criteria|1
2706969|NCT00364793|9320305|P3|Overall Study|No longer meets criteria|0
2706970|NCT00364793|9320306|P2|Overall Study|No longer meets criteria|0
2706971|NCT00364793|9320307|P1|Overall Study|No longer meets criteria|0
2706972|NCT00364793|9320304|P4|Overall Study|Poor or non-compliance|1
2706973|NCT00364793|9320305|P3|Overall Study|Poor or non-compliance|0
2706974|NCT00364793|9320306|P2|Overall Study|Poor or non-compliance|1
2706975|NCT00364793|9320307|P1|Overall Study|Poor or non-compliance|1
2706976|NCT00364793|9320304|P4|Overall Study|Lost to Follow-up|0
2706977|NCT00364793|9320305|P3|Overall Study|Lost to Follow-up|2
2706978|NCT00364793|9320306|P2|Overall Study|Lost to Follow-up|0
2706979|NCT00364793|9320307|P1|Overall Study|Lost to Follow-up|1
2706980|NCT00364793|9320304|P4|Overall Study|Lack of Efficacy|1
2706981|NCT00364793|9320305|P3|Overall Study|Lack of Efficacy|1
2706982|NCT00364793|9320306|P2|Overall Study|Lack of Efficacy|3
2706983|NCT00364793|9320307|P1|Overall Study|Lack of Efficacy|3
2706984|NCT00364793|9320304|P4|Overall Study|Death|0
2706985|NCT00364793|9320305|P3|Overall Study|Death|1
2706986|NCT00364793|9320306|P2|Overall Study|Death|0
2706987|NCT00364793|9320307|P1|Overall Study|Death|1
2706988|NCT00364793|9320304|P4|Overall Study|Adverse Event|0
2706989|NCT00364793|9320305|P3|Overall Study|Adverse Event|0
2706990|NCT00364793|9320306|P2|Overall Study|Adverse Event|0
2706991|NCT00364793|9320307|P1|Overall Study|Adverse Event|2
2706992|NCT00364689|9320444|P1|Overall Study|Lost to Follow-up|1
2706993|NCT00364611|9320464|P2|Overall Study|Receiving Liver Ablation|1
2706994|NCT00364611|9320465|P1|Overall Study|Receiving Liver Ablation|0
2706995|NCT00364611|9320464|P2|Overall Study|Presumed CR on Study|1
2706996|NCT00364611|9320465|P1|Overall Study|Presumed CR on Study|0
2706997|NCT00364611|9320464|P2|Overall Study|Found Ineligible|0
2706998|NCT00364611|9320465|P1|Overall Study|Found Ineligible|1
2706999|NCT00364611|9320464|P2|Overall Study|Investigator decision|2
2707000|NCT00364611|9320465|P1|Overall Study|Investigator decision|2
2707001|NCT00364611|9320464|P2|Overall Study|Disease Progression|8
2707002|NCT00364611|9320465|P1|Overall Study|Disease Progression|38
2707003|NCT00364611|9320464|P2|Overall Study|Participant's Request|4
2707004|NCT00364611|9320465|P1|Overall Study|Participant's Request|3
2707005|NCT00364611|9320464|P2|Overall Study|Adverse Event|4
2707006|NCT00364611|9320465|P1|Overall Study|Adverse Event|7
2707007|NCT00364611|9320464|P2|Overall Study|Did not receive study medication|1
2707008|NCT00364611|9320465|P1|Overall Study|Did not receive study medication|0
2707009|NCT00364533|9320488|P5|Overall Study|Protocol Violation|0
2707010|NCT00364533|9320489|P4|Overall Study|Protocol Violation|0
2707011|NCT00364533|9320490|P3|Overall Study|Protocol Violation|0
2707012|NCT00364533|9320491|P2|Overall Study|Protocol Violation|1
2707013|NCT00364533|9320492|P1|Overall Study|Protocol Violation|1
2707014|NCT00364533|9320488|P5|Overall Study|Non-compliance|0
2707015|NCT00364533|9320489|P4|Overall Study|Non-compliance|0
2707016|NCT00364533|9320490|P3|Overall Study|Non-compliance|0
2707017|NCT00364533|9320491|P2|Overall Study|Non-compliance|0
2707018|NCT00364533|9320492|P1|Overall Study|Non-compliance|1
2707019|NCT00364533|9320488|P5|Overall Study|Variations in drug compliance|0
2707020|NCT00364533|9320489|P4|Overall Study|Variations in drug compliance|0
2707021|NCT00364533|9320490|P3|Overall Study|Variations in drug compliance|1
2707022|NCT00364533|9320491|P2|Overall Study|Variations in drug compliance|1
2707023|NCT00364533|9320492|P1|Overall Study|Variations in drug compliance|2
2707024|NCT00364533|9320488|P5|Overall Study|Subject discharged from hospital|1
2707025|NCT00364533|9320489|P4|Overall Study|Subject discharged from hospital|3
2707026|NCT00364533|9320490|P3|Overall Study|Subject discharged from hospital|2
2707027|NCT00364533|9320491|P2|Overall Study|Subject discharged from hospital|1
2707028|NCT00364533|9320492|P1|Overall Study|Subject discharged from hospital|4
2707029|NCT00364533|9320488|P5|Overall Study|Lack of Efficacy|42
2707030|NCT00364533|9320489|P4|Overall Study|Lack of Efficacy|17
2707031|NCT00364533|9320490|P3|Overall Study|Lack of Efficacy|21
2707032|NCT00364533|9320491|P2|Overall Study|Lack of Efficacy|22
2707033|NCT00364533|9320492|P1|Overall Study|Lack of Efficacy|22
2707034|NCT00364533|9320488|P5|Overall Study|Withdrawal by Subject|6
2707035|NCT00364533|9320489|P4|Overall Study|Withdrawal by Subject|6
2707036|NCT00364533|9320490|P3|Overall Study|Withdrawal by Subject|6
2707037|NCT00364533|9320491|P2|Overall Study|Withdrawal by Subject|8
2707038|NCT00364533|9320492|P1|Overall Study|Withdrawal by Subject|4
2707039|NCT00364533|9320488|P5|Overall Study|Adverse Event|2
2707040|NCT00364533|9320489|P4|Overall Study|Adverse Event|5
2707041|NCT00364533|9320490|P3|Overall Study|Adverse Event|15
2707042|NCT00364533|9320491|P2|Overall Study|Adverse Event|7
2707043|NCT00364533|9320492|P1|Overall Study|Adverse Event|8
2707044|NCT00364351|9320525|P2|Overall Study|Randomised treatment not started|3
2707045|NCT00364351|9320526|P1|Overall Study|Randomised treatment not started|0
2707046|NCT00364351|9320525|P2|Overall Study|Patient could not travel to site|1
2707047|NCT00364351|9320526|P1|Overall Study|Patient could not travel to site|0
2707048|NCT00364351|9320525|P2|Overall Study|Investigator error|2
2707049|NCT00364351|9320526|P1|Overall Study|Investigator error|0
2707050|NCT00364351|9320525|P2|Overall Study|Poor treatment compliance|3
2707051|NCT00364351|9320526|P1|Overall Study|Poor treatment compliance|0
2707052|NCT00364351|9320525|P2|Overall Study|Sponsor decision|0
2707053|NCT00364351|9320526|P1|Overall Study|Sponsor decision|1
2707054|NCT00364351|9320525|P2|Overall Study|Incorrect enrollment|1
2707055|NCT00364351|9320526|P1|Overall Study|Incorrect enrollment|1
2707056|NCT00364351|9320525|P2|Overall Study|Withdrawal by Subject|29
2707057|NCT00364351|9320526|P1|Overall Study|Withdrawal by Subject|30
2707058|NCT00364351|9320525|P2|Overall Study|Lost to Follow-up|1
2707059|NCT00364351|9320526|P1|Overall Study|Lost to Follow-up|1
2707060|NCT00364351|9320525|P2|Overall Study|Prohibited concomitant medication|2
2707061|NCT00364351|9320526|P1|Overall Study|Prohibited concomitant medication|0
2707062|NCT00364351|9320525|P2|Overall Study|Condition under investigation worsened|497
2707063|NCT00364351|9320526|P1|Overall Study|Condition under investigation worsened|469
2707064|NCT00364351|9320525|P2|Overall Study|Adverse Event|44
2707065|NCT00364351|9320526|P1|Overall Study|Adverse Event|90
2707066|NCT00364286|9320544|P1|Overall Study|Adverse Event|2
2707067|NCT00364286|9320544|P1|Overall Study|Withdrawal by Subject|1
2707068|NCT00364182|9320551|P3|Third Intervention|Lost to Follow-up|1
2707069|NCT00364182|9320552|P2|Third Intervention|Lost to Follow-up|0
2707070|NCT00364182|9320553|P1|Third Intervention|Lost to Follow-up|0
2707071|NCT00364182|9320551|P3|Third Intervention|non-compliance|0
2707072|NCT00364182|9320552|P2|Third Intervention|non-compliance|1
2707073|NCT00364182|9320553|P1|Third Intervention|non-compliance|0
2707074|NCT00364182|9320551|P3|Second Intervention|Adverse Event|1
2707075|NCT00364182|9320552|P2|Second Intervention|Adverse Event|0
2707076|NCT00364182|9320553|P1|Second Intervention|Adverse Event|0
2707077|NCT00364182|9320551|P3|Second Intervention|Protocol Violation|0
2707078|NCT00364182|9320552|P2|Second Intervention|Protocol Violation|1
2707079|NCT00364182|9320553|P1|Second Intervention|Protocol Violation|0
2707080|NCT00364182|9320551|P3|Second Intervention|non-compliance|1
2707081|NCT00364182|9320552|P2|Second Intervention|non-compliance|1
2707082|NCT00364182|9320553|P1|Second Intervention|non-compliance|0
2707083|NCT00364182|9320551|P3|First Intervention|Withdrawal by Subject|0
2707084|NCT00364182|9320552|P2|First Intervention|Withdrawal by Subject|0
2707085|NCT00364182|9320553|P1|First Intervention|Withdrawal by Subject|2
2707086|NCT00364182|9320551|P3|First Intervention|Secondary prophylaxis|0
2707087|NCT00364182|9320552|P2|First Intervention|Secondary prophylaxis|0
2707088|NCT00364182|9320553|P1|First Intervention|Secondary prophylaxis|1
2707089|NCT00364156|9320587|P2|Overall Study|Protocol Violation|1
2707090|NCT00364156|9320588|P1|Overall Study|Protocol Violation|6
2707091|NCT00364156|9320587|P2|Overall Study|Withdrawal by Subject|80
2707092|NCT00364156|9320588|P1|Overall Study|Withdrawal by Subject|73
2707093|NCT00364130|9320596|P2|Post Intervention Follow-up Period|Lost to Follow-up|11
2707094|NCT00364130|9320597|P1|Post Intervention Follow-up Period|Lost to Follow-up|5
2707095|NCT00364130|9320596|P2|Intervention Period|Withdrawal by Subject|5
2707096|NCT00364130|9320597|P1|Intervention Period|Withdrawal by Subject|4
2707097|NCT00364130|9320596|P2|Intervention Period|Pregnancy|0
2707098|NCT00364130|9320597|P1|Intervention Period|Pregnancy|1
2707099|NCT00364130|9320596|P2|Intervention Period|Lost to Follow-up|3
2707100|NCT00364130|9320597|P1|Intervention Period|Lost to Follow-up|4
2707101|NCT00364013|9320619|P2|Overall Study|Ongoing|13
2707102|NCT00364013|9320620|P1|Overall Study|Ongoing|20
2707103|NCT00364013|9320619|P2|Overall Study|Other|47
2707104|NCT00364013|9320620|P1|Overall Study|Other|41
2707105|NCT00364013|9320619|P2|Overall Study|Protocol-specified criteria|6
2707106|NCT00364013|9320620|P1|Overall Study|Protocol-specified criteria|6
2707107|NCT00364013|9320619|P2|Overall Study|Lost to Follow-up|3
2707108|NCT00364013|9320620|P1|Overall Study|Lost to Follow-up|10
2707109|NCT00364013|9320619|P2|Overall Study|Physician Decision|3
2707110|NCT00364013|9320620|P1|Overall Study|Physician Decision|3
2707111|NCT00364013|9320619|P2|Overall Study|Withdrawal by Subject|18
2707112|NCT00364013|9320620|P1|Overall Study|Withdrawal by Subject|13
2707113|NCT00364013|9320619|P2|Overall Study|Adverse Event|3
2707114|NCT00364013|9320620|P1|Overall Study|Adverse Event|4
2707115|NCT00364013|9320619|P2|Overall Study|Ineligibility determined|2
2707116|NCT00364013|9320620|P1|Overall Study|Ineligibility determined|4
2707117|NCT00363896|9320648|P2|Overall Study|Other|2
2707118|NCT00363896|9320649|P1|Overall Study|Other|1
2707119|NCT00363896|9320648|P2|Overall Study|Non-fulfilment of entry criteria|0
2707120|NCT00363896|9320649|P1|Overall Study|Non-fulfilment of entry criteria|1
2707121|NCT00363896|9320648|P2|Overall Study|Lost to Follow-up|0
2707122|NCT00363896|9320649|P1|Overall Study|Lost to Follow-up|3
2707123|NCT00363896|9320648|P2|Overall Study|Protocol Violation|1
2707124|NCT00363896|9320649|P1|Overall Study|Protocol Violation|6
2707125|NCT00363896|9320648|P2|Overall Study|Lack of Efficacy|8
2707126|NCT00363896|9320649|P1|Overall Study|Lack of Efficacy|12
2707127|NCT00363896|9320648|P2|Overall Study|COPD exacerbation|7
2707128|NCT00363896|9320649|P1|Overall Study|COPD exacerbation|13
2707129|NCT00363896|9320648|P2|Overall Study|Adverse Event|13
2707130|NCT00363896|9320649|P1|Overall Study|Adverse Event|24
2707131|NCT00363896|9320648|P2|Overall Study|Withdrawal by Subject|16
2707132|NCT00363896|9320649|P1|Overall Study|Withdrawal by Subject|29
2707133|NCT00363766|9320690|P2|Overall Study|Physician Decision|2
2707134|NCT00363766|9320691|P1|Overall Study|Physician Decision|1
2707135|NCT00363766|9320690|P2|Overall Study|Withdrawal by Subject|0
2707136|NCT00363766|9320691|P1|Overall Study|Withdrawal by Subject|2
2707137|NCT00363766|9320690|P2|Overall Study|Not Disease Related Death|4
2707138|NCT00363766|9320691|P1|Overall Study|Not Disease Related Death|3
2707139|NCT00363766|9320690|P2|Overall Study|Disease Related Death|3
2707140|NCT00363766|9320691|P1|Overall Study|Disease Related Death|1
2707141|NCT00363766|9320690|P2|Overall Study|Adverse Event|2
2707142|NCT00363766|9320691|P1|Overall Study|Adverse Event|10
2707143|NCT00363766|9320690|P2|Overall Study|Progressive Disease|9
2707144|NCT00363766|9320691|P1|Overall Study|Progressive Disease|15
2707145|NCT00363649|9320720|P2|Overall Study|Adverse Event|0
2707146|NCT00363649|9320721|P1|Overall Study|Adverse Event|6
2707147|NCT00363649|9320720|P2|Overall Study|Withdrawal by Subject|1
2707148|NCT00363649|9320721|P1|Overall Study|Withdrawal by Subject|1
2707149|NCT00363545|9320737|P2|Overall Study|Others|0
2707150|NCT00363545|9320738|P1|Overall Study|Others|1
2707151|NCT00363545|9320737|P2|Overall Study|Lost to follow-up (complete vaccination)|17
2707152|NCT00363545|9320738|P1|Overall Study|Lost to follow-up (complete vaccination)|14
2707153|NCT00363545|9320737|P2|Overall Study|Lost to follow-up (incompl. vaccination)|18
2707154|NCT00363545|9320738|P1|Overall Study|Lost to follow-up (incompl. vaccination)|14
2707155|NCT00363545|9320737|P2|Overall Study|Migrated/moved from study area|6
2707156|NCT00363545|9320738|P1|Overall Study|Migrated/moved from study area|3
2707157|NCT00363545|9320737|P2|Overall Study|Withdrawal by Subject|15
2707158|NCT00363545|9320738|P1|Overall Study|Withdrawal by Subject|12
2707159|NCT00363545|9320737|P2|Overall Study|Serious Adverse Event|1
2707160|NCT00363545|9320738|P1|Overall Study|Serious Adverse Event|0
2707161|NCT00363480|9320756|P1|Overall Study|Participant discontinued on its own|1
2707162|NCT00363480|9320756|P1|Overall Study|Non-compliance of subject|1
2707163|NCT00363480|9320756|P1|Overall Study|Withdrawal by Subject|5
2707164|NCT00363480|9320756|P1|Overall Study|Lost to Follow-up|5
2707165|NCT00363480|9320756|P1|Overall Study|Adverse Event|4
2707166|NCT00363480|9320756|P1|Overall Study|Criteria for treatment period not fulfil|1
2707167|NCT00363467|9320776|P1|Overall Study|Physician Decision|1
2707168|NCT00363415|9320786|P2|Overall Study|Protocol Violation|4
2707169|NCT00363415|9320787|P1|Overall Study|Protocol Violation|1
2707170|NCT00363415|9320786|P2|Overall Study|Lost to Follow-up|3
2707171|NCT00363415|9320787|P1|Overall Study|Lost to Follow-up|3
2707172|NCT00363415|9320786|P2|Overall Study|Withdrawal by Subject|15
2707173|NCT00363415|9320787|P1|Overall Study|Withdrawal by Subject|9
2707174|NCT00363415|9320786|P2|Overall Study|Entry Criteria Not Met|10
2707175|NCT00363415|9320787|P1|Overall Study|Entry Criteria Not Met|11
2707176|NCT00363415|9320786|P2|Overall Study|Physician Decision|35
2707177|NCT00363415|9320787|P1|Overall Study|Physician Decision|18
2707178|NCT00363415|9320786|P2|Overall Study|Adverse Event|15
2707179|NCT00363415|9320787|P1|Overall Study|Adverse Event|24
2707180|NCT00363415|9320786|P2|Overall Study|Death|29
2707181|NCT00363415|9320787|P1|Overall Study|Death|32
2707182|NCT00363415|9320786|P2|Overall Study|Sponsor Decision|31
2707183|NCT00363415|9320787|P1|Overall Study|Sponsor Decision|67
2707184|NCT00363415|9320786|P2|Overall Study|Progressive Disease|107
2707185|NCT00363415|9320787|P1|Overall Study|Progressive Disease|196
2707186|NCT00363311|9320805|P2|Overall Study|Participant Moved to Louisiana|1
2707187|NCT00363311|9320806|P1|Overall Study|Participant Moved to Louisiana|0
2707188|NCT00363311|9320805|P2|Overall Study|Withdrawn per Instructions of Monitor|1
2707189|NCT00363311|9320806|P1|Overall Study|Withdrawn per Instructions of Monitor|0
2707190|NCT00363311|9320805|P2|Overall Study|Participant Withdrew Waiting for Surgery|1
2707191|NCT00363311|9320806|P1|Overall Study|Participant Withdrew Waiting for Surgery|0
2707192|NCT00363311|9320805|P2|Overall Study|Participant Moved to Another Country|0
2707193|NCT00363311|9320806|P1|Overall Study|Participant Moved to Another Country|1
2707194|NCT00363311|9320805|P2|Overall Study|Participant Opted for Treatment|0
2707195|NCT00363311|9320806|P1|Overall Study|Participant Opted for Treatment|1
2707196|NCT00363311|9320805|P2|Overall Study|Prostate Volume/PSA Doubled|0
2707197|NCT00363311|9320806|P1|Overall Study|Prostate Volume/PSA Doubled|1
2707198|NCT00363311|9320805|P2|Overall Study|Participant Refused Biopsy|0
2707199|NCT00363311|9320806|P1|Overall Study|Participant Refused Biopsy|1
2707200|NCT00363311|9320805|P2|Overall Study|Non-Compliance|1
2707201|NCT00363311|9320806|P1|Overall Study|Non-Compliance|1
2707202|NCT00363311|9320805|P2|Overall Study|Disease Progression|26
2707203|NCT00363311|9320806|P1|Overall Study|Disease Progression|46
2707204|NCT00363311|9320805|P2|Overall Study|Sponsor Terminated Study|2
2707205|NCT00363311|9320806|P1|Overall Study|Sponsor Terminated Study|2
2707206|NCT00363311|9320805|P2|Overall Study|Physician Decision|1
2707207|NCT00363311|9320806|P1|Overall Study|Physician Decision|1
2707208|NCT00363311|9320805|P2|Overall Study|Withdrawal by Subject|6
2707209|NCT00363311|9320806|P1|Overall Study|Withdrawal by Subject|12
2707210|NCT00363311|9320805|P2|Overall Study|Protocol Violation|2
2707211|NCT00363311|9320806|P1|Overall Study|Protocol Violation|1
2707212|NCT00363311|9320805|P2|Overall Study|Lost to Follow-up|0
2707213|NCT00363311|9320806|P1|Overall Study|Lost to Follow-up|3
2707214|NCT00363311|9320805|P2|Overall Study|Adverse Event|4
2707215|NCT00363311|9320806|P1|Overall Study|Adverse Event|6
2707216|NCT00363298|9320872|P2|4-week Study Continuation Phase|Lack of Efficacy|0
2707217|NCT00363298|9320873|P1|4-week Study Continuation Phase|Lack of Efficacy|1
2707218|NCT00363298|9320872|P2|First Study Week|Lack of Efficacy|5
2707219|NCT00363298|9320873|P1|First Study Week|Lack of Efficacy|6
2707220|NCT00363246|9320881|P1|Overall Study|Eligibility changed due to Hospice move|5
2707221|NCT00363246|9320881|P1|Overall Study|Subject expressed security concerns|2
2707222|NCT00363246|9320881|P1|Overall Study|Stopped using wheelchair|11
2707223|NCT00363246|9320881|P1|Overall Study|Bad health|6
2707224|NCT00363246|9320881|P1|Overall Study|Lost to Follow-up|14
2707225|NCT00363246|9320881|P1|Overall Study|Withdrawal by Subject|19
2707226|NCT00363246|9320881|P1|Overall Study|Death|40
2707227|NCT00363142|9320899|P2|Overall Study|Withdrawal by Subject|1
2707228|NCT00363142|9320900|P1|Overall Study|Withdrawal by Subject|3
2707229|NCT00363142|9320899|P2|Overall Study|Non-compliance|1
2707230|NCT00363142|9320900|P1|Overall Study|Non-compliance|1
2707231|NCT00363142|9320899|P2|Overall Study|Lost to Follow-up|0
2707232|NCT00363142|9320900|P1|Overall Study|Lost to Follow-up|1
2707233|NCT00363142|9320899|P2|Overall Study|Lack of Efficacy|1
2707234|NCT00363142|9320900|P1|Overall Study|Lack of Efficacy|0
2707235|NCT00363142|9320899|P2|Overall Study|Adverse Event|0
2707236|NCT00363142|9320900|P1|Overall Study|Adverse Event|2
2707237|NCT00363129|9320929|P2|Overall Study|Other Reasons|3
2707238|NCT00363129|9320930|P1|Overall Study|Other Reasons|6
2707239|NCT00363129|9320929|P2|Overall Study|Death|1
2707240|NCT00363129|9320930|P1|Overall Study|Death|0
2707241|NCT00363129|9320929|P2|Overall Study|Other Medical Problems|4
2707242|NCT00363129|9320930|P1|Overall Study|Other Medical Problems|2
2707243|NCT00363129|9320929|P2|Overall Study|Alternate Treatment|4
2707244|NCT00363129|9320930|P1|Overall Study|Alternate Treatment|2
2707245|NCT00363129|9320929|P2|Overall Study|Adverse Event|3
2707246|NCT00363129|9320930|P1|Overall Study|Adverse Event|8
2707247|NCT00363129|9320929|P2|Overall Study|Withdrawal by Subject|18
2707248|NCT00363129|9320930|P1|Overall Study|Withdrawal by Subject|11
2707249|NCT00363051|9320973|P2|Overall Study|Death|2
2707250|NCT00363051|9320974|P1|Overall Study|Death|3
2707251|NCT00363051|9320973|P2|Overall Study|Protocol Violation|2
2707252|NCT00363051|9320974|P1|Overall Study|Protocol Violation|0
2707253|NCT00363051|9320973|P2|Overall Study|Lost to Follow-up|1
2707254|NCT00363051|9320974|P1|Overall Study|Lost to Follow-up|0
2707255|NCT00363051|9320973|P2|Overall Study|Withdrawal by Subject|3
2707256|NCT00363051|9320974|P1|Overall Study|Withdrawal by Subject|11
2707257|NCT00363051|9320973|P2|Overall Study|New Cancer Therapy|1
2707258|NCT00363051|9320974|P1|Overall Study|New Cancer Therapy|2
2707259|NCT00363051|9320973|P2|Overall Study|Adverse Event|12
2707260|NCT00363051|9320974|P1|Overall Study|Adverse Event|21
2707261|NCT00363051|9320973|P2|Overall Study|Adminstrative problems|1
2707262|NCT00363051|9320974|P1|Overall Study|Adminstrative problems|1
2707263|NCT00362648|9321023|P4|Overall Study|Withdrawal by Subject|6
2707264|NCT00362648|9321024|P3|Overall Study|Withdrawal by Subject|2
2707265|NCT00362648|9321025|P2|Overall Study|Withdrawal by Subject|42
2707266|NCT00362648|9321026|P1|Overall Study|Withdrawal by Subject|48
2707267|NCT00362648|9321023|P4|Overall Study|Protocol Violation|2
2707268|NCT00362648|9321024|P3|Overall Study|Protocol Violation|2
2707269|NCT00362648|9321025|P2|Overall Study|Protocol Violation|2
2707270|NCT00362648|9321026|P1|Overall Study|Protocol Violation|4
2707271|NCT00362648|9321023|P4|Overall Study|Lost to Follow-up|3
2707272|NCT00362648|9321024|P3|Overall Study|Lost to Follow-up|4
2707273|NCT00362648|9321025|P2|Overall Study|Lost to Follow-up|69
2707274|NCT00362648|9321026|P1|Overall Study|Lost to Follow-up|62
2707275|NCT00362648|9321023|P4|Overall Study|Adverse Event|0
2707276|NCT00362648|9321024|P3|Overall Study|Adverse Event|1
2707277|NCT00362648|9321025|P2|Overall Study|Adverse Event|21
2707278|NCT00362648|9321026|P1|Overall Study|Adverse Event|12
2707279|NCT00362609|9321044|P2|Overall Study|Protocol Violation|1
2707280|NCT00362609|9321045|P1|Overall Study|Protocol Violation|0
2707281|NCT00362609|9321044|P2|Overall Study|Withdrawal by Subject|1
2707282|NCT00362609|9321045|P1|Overall Study|Withdrawal by Subject|0
2707283|NCT00362414|9321126|P1|Overall Study|Adverse Event|1
2707284|NCT00362414|9321126|P1|Overall Study|Death|2
2707285|NCT00362375|9321155|P2|Overall Study|Lost to Follow-up|35
2707286|NCT00362375|9321156|P1|Overall Study|Lost to Follow-up|40
2707287|NCT00362336|9321173|P3|Overall Study|Withdrawal by Subject|1
2707288|NCT00362336|9321174|P2|Overall Study|Withdrawal by Subject|3
2707289|NCT00362336|9321175|P1|Overall Study|Withdrawal by Subject|3
2707290|NCT00362336|9321173|P3|Overall Study|Lost to Follow-up|0
2707291|NCT00362336|9321174|P2|Overall Study|Lost to Follow-up|4
2707292|NCT00362336|9321175|P1|Overall Study|Lost to Follow-up|6
2707293|NCT00362336|9321173|P3|Overall Study|Protocol Violation|1
2707294|NCT00362336|9321174|P2|Overall Study|Protocol Violation|0
2707295|NCT00362336|9321175|P1|Overall Study|Protocol Violation|0
2707296|NCT00362336|9321173|P3|Overall Study|Serious Adverse Event|1
2707297|NCT00362336|9321174|P2|Overall Study|Serious Adverse Event|0
2707298|NCT00362336|9321175|P1|Overall Study|Serious Adverse Event|1
2707299|NCT00362297|9321203|P2|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4
2707300|NCT00362297|9321204|P1|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0
2707301|NCT00362232|9321212|P2|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7
2707302|NCT00362232|9321213|P1|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8
2707303|NCT00362232|9321212|P2|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28
2707304|NCT00362232|9321213|P1|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27
2707305|NCT00362232|9321212|P2|Follow-up (30 (+ 5) Days)|Death|1
2707306|NCT00362232|9321213|P1|Follow-up (30 (+ 5) Days)|Death|1
2707307|NCT00362232|9321212|P2|Follow-up (30 (+ 5) Days)|Adverse Event|3
2707308|NCT00362232|9321213|P1|Follow-up (30 (+ 5) Days)|Adverse Event|2
2707309|NCT00362232|9321212|P2|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18
2707310|NCT00362232|9321213|P1|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10
2707311|NCT00362232|9321212|P2|Treatment (12 +/- 2 Days)|Technical Problems|0
2707312|NCT00362232|9321213|P1|Treatment (12 +/- 2 Days)|Technical Problems|1
2707313|NCT00362232|9321212|P2|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0
2707314|NCT00362232|9321213|P1|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9
2707315|NCT00362232|9321212|P2|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47
2707316|NCT00362232|9321213|P1|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49
2707317|NCT00362232|9321212|P2|Treatment (12 +/- 2 Days)|Protocol Violation|21
2707318|NCT00362232|9321213|P1|Treatment (12 +/- 2 Days)|Protocol Violation|22
2707319|NCT00362232|9321212|P2|Treatment (12 +/- 2 Days)|Physician Decision|5
2707320|NCT00362232|9321213|P1|Treatment (12 +/- 2 Days)|Physician Decision|2
2707321|NCT00362232|9321212|P2|Treatment (12 +/- 2 Days)|Lost to Follow-up|1
2707322|NCT00362232|9321213|P1|Treatment (12 +/- 2 Days)|Lost to Follow-up|3
2707323|NCT00362232|9321212|P2|Treatment (12 +/- 2 Days)|Death|3
2707324|NCT00362232|9321213|P1|Treatment (12 +/- 2 Days)|Death|1
2707325|NCT00362232|9321212|P2|Treatment (12 +/- 2 Days)|Adverse Event|56
2707326|NCT00362232|9321213|P1|Treatment (12 +/- 2 Days)|Adverse Event|62
2707327|NCT00362180|9321258|P9|Treated Period|Adverse Event|0
2707328|NCT00362180|9321259|P8|Treated Period|Adverse Event|1
2707329|NCT00362180|9321260|P7|Treated Period|Adverse Event|0
2707330|NCT00362180|9321261|P6|Treated Period|Adverse Event|1
2707331|NCT00362180|9321262|P5|Treated Period|Adverse Event|0
2707332|NCT00362180|9321263|P4|Treated Period|Adverse Event|0
2707333|NCT00362180|9321264|P3|Treated Period|Adverse Event|0
2707334|NCT00362180|9321265|P2|Treated Period|Adverse Event|0
2707335|NCT00362180|9321266|P1|Treated Period|Adverse Event|0
2707336|NCT00362180|9321258|P9|Treated Period|Withdrawal by Subject|0
2707337|NCT00362180|9321259|P8|Treated Period|Withdrawal by Subject|0
2707338|NCT00362180|9321260|P7|Treated Period|Withdrawal by Subject|0
2707339|NCT00362180|9321261|P6|Treated Period|Withdrawal by Subject|0
2707340|NCT00362180|9321262|P5|Treated Period|Withdrawal by Subject|0
2707341|NCT00362180|9321263|P4|Treated Period|Withdrawal by Subject|0
2707342|NCT00362180|9321264|P3|Treated Period|Withdrawal by Subject|0
2707343|NCT00362180|9321265|P2|Treated Period|Withdrawal by Subject|0
2707344|NCT00362180|9321266|P1|Treated Period|Withdrawal by Subject|1
2707345|NCT00362115|9321338|P7|Overall Study|Other|0
2707346|NCT00362115|9321339|P6|Overall Study|Other|1
2707347|NCT00362115|9321340|P5|Overall Study|Other|0
2707348|NCT00362115|9321341|P4|Overall Study|Other|1
2707349|NCT00362115|9321342|P3|Overall Study|Other|0
2707350|NCT00362115|9321343|P2|Overall Study|Other|1
2707351|NCT00362115|9321344|P1|Overall Study|Other|0
2707352|NCT00362115|9321338|P7|Overall Study|Physician Decision|3
2707353|NCT00362115|9321339|P6|Overall Study|Physician Decision|0
2707354|NCT00362115|9321340|P5|Overall Study|Physician Decision|0
2707355|NCT00362115|9321341|P4|Overall Study|Physician Decision|0
2707356|NCT00362115|9321342|P3|Overall Study|Physician Decision|0
2707357|NCT00362115|9321343|P2|Overall Study|Physician Decision|0
2707358|NCT00362115|9321344|P1|Overall Study|Physician Decision|0
2707359|NCT00362115|9321338|P7|Overall Study|Lack of Efficacy|3
2707360|NCT00362115|9321339|P6|Overall Study|Lack of Efficacy|0
2707361|NCT00362115|9321340|P5|Overall Study|Lack of Efficacy|2
2707362|NCT00362115|9321341|P4|Overall Study|Lack of Efficacy|2
2707363|NCT00362115|9321342|P3|Overall Study|Lack of Efficacy|5
2707364|NCT00362115|9321343|P2|Overall Study|Lack of Efficacy|0
2707365|NCT00362115|9321344|P1|Overall Study|Lack of Efficacy|1
2707366|NCT00362115|9321338|P7|Overall Study|Withdrawal by Subject|4
2707367|NCT00362115|9321339|P6|Overall Study|Withdrawal by Subject|3
2707368|NCT00362115|9321340|P5|Overall Study|Withdrawal by Subject|1
2707369|NCT00362115|9321341|P4|Overall Study|Withdrawal by Subject|0
2707370|NCT00362115|9321342|P3|Overall Study|Withdrawal by Subject|1
2707371|NCT00362115|9321343|P2|Overall Study|Withdrawal by Subject|3
2707372|NCT00362115|9321344|P1|Overall Study|Withdrawal by Subject|1
2707373|NCT00362115|9321338|P7|Overall Study|Lost to Follow-up|1
2707374|NCT00362115|9321339|P6|Overall Study|Lost to Follow-up|0
2707375|NCT00362115|9321340|P5|Overall Study|Lost to Follow-up|2
2707376|NCT00362115|9321341|P4|Overall Study|Lost to Follow-up|0
2707377|NCT00362115|9321342|P3|Overall Study|Lost to Follow-up|0
2707378|NCT00362115|9321343|P2|Overall Study|Lost to Follow-up|1
2707379|NCT00362115|9321344|P1|Overall Study|Lost to Follow-up|0
2707380|NCT00362115|9321338|P7|Overall Study|Protocol Violation|0
2707381|NCT00362115|9321339|P6|Overall Study|Protocol Violation|1
2707382|NCT00362115|9321340|P5|Overall Study|Protocol Violation|0
2707383|NCT00362115|9321341|P4|Overall Study|Protocol Violation|0
2707384|NCT00362115|9321342|P3|Overall Study|Protocol Violation|0
2707385|NCT00362115|9321343|P2|Overall Study|Protocol Violation|0
2707386|NCT00362115|9321344|P1|Overall Study|Protocol Violation|0
2707387|NCT00362115|9321338|P7|Overall Study|Adverse Event|1
2707388|NCT00362115|9321339|P6|Overall Study|Adverse Event|2
2707389|NCT00362115|9321340|P5|Overall Study|Adverse Event|2
2707390|NCT00362115|9321341|P4|Overall Study|Adverse Event|1
2707391|NCT00362115|9321342|P3|Overall Study|Adverse Event|1
2707392|NCT00362115|9321343|P2|Overall Study|Adverse Event|1
2707393|NCT00362115|9321344|P1|Overall Study|Adverse Event|0
2707394|NCT00361634|9321517|P1|Overall Study|Withdrawal by Subject|1
2707395|NCT00361634|9321517|P1|Overall Study|Lost to Follow-up|1
2707396|NCT00361569|9321546|P4|Overall Study|Not specified by investigator|1
2707397|NCT00361569|9321547|P3|Overall Study|Not specified by investigator|0
2707398|NCT00361569|9321548|P2|Overall Study|Not specified by investigator|0
2707399|NCT00361569|9321549|P1|Overall Study|Not specified by investigator|2
2707400|NCT00361569|9321546|P4|Overall Study|Lost to Follow-up|2
2707401|NCT00361569|9321547|P3|Overall Study|Lost to Follow-up|3
2707402|NCT00361569|9321548|P2|Overall Study|Lost to Follow-up|3
2707403|NCT00361569|9321549|P1|Overall Study|Lost to Follow-up|2
2707404|NCT00361569|9321546|P4|Overall Study|Adverse Event|2
2707405|NCT00361569|9321547|P3|Overall Study|Adverse Event|2
2707406|NCT00361569|9321548|P2|Overall Study|Adverse Event|5
2707407|NCT00361569|9321549|P1|Overall Study|Adverse Event|3
2707408|NCT00361569|9321546|P4|Overall Study|Withdrawal by Subject|14
2707409|NCT00361569|9321547|P3|Overall Study|Withdrawal by Subject|9
2707410|NCT00361569|9321548|P2|Overall Study|Withdrawal by Subject|1
2707411|NCT00361569|9321549|P1|Overall Study|Withdrawal by Subject|2
2707412|NCT00361569|9321546|P4|Overall Study|Protocol Violation|2
2707413|NCT00361569|9321547|P3|Overall Study|Protocol Violation|4
2707414|NCT00361569|9321548|P2|Overall Study|Protocol Violation|2
2707415|NCT00361569|9321549|P1|Overall Study|Protocol Violation|3
2707416|NCT00361504|9321573|P2|Overall Study|All other|3
2707417|NCT00361504|9321574|P1|Overall Study|All other|28
2707418|NCT00361504|9321573|P2|Overall Study|Study medication non compliant|15
2707419|NCT00361504|9321574|P1|Overall Study|Study medication non compliant|42
2707420|NCT00361504|9321573|P2|Overall Study|Resolution of Pain|0
2707421|NCT00361504|9321574|P1|Overall Study|Resolution of Pain|2
2707422|NCT00361504|9321573|P2|Overall Study|Lack of Efficacy|7
2707423|NCT00361504|9321574|P1|Overall Study|Lack of Efficacy|72
2707424|NCT00361504|9321573|P2|Overall Study|Adverse Event|82
2707425|NCT00361504|9321574|P1|Overall Study|Adverse Event|203
2707426|NCT00361504|9321573|P2|Overall Study|Lost to Follow-up|7
2707427|NCT00361504|9321574|P1|Overall Study|Lost to Follow-up|40
2707428|NCT00361504|9321573|P2|Overall Study|Withdrawal by Subject|31
2707429|NCT00361504|9321574|P1|Overall Study|Withdrawal by Subject|94
2707430|NCT00361335|9321615|P7|SC Period: Week E0 to Week E24|Lack of Efficacy|3
2707431|NCT00361335|9321616|P6|SC Period: Week E0 to Week E24|Lack of Efficacy|0
2707432|NCT00361335|9321617|P5|SC Period: Week E0 to Week E24|Lack of Efficacy|0
2707433|NCT00361335|9321618|P4|SC Period: Week E0 to Week E24|Lack of Efficacy|0
2707434|NCT00361335|9321619|P3|SC Period: Week E0 to Week E24|Lack of Efficacy|2
2707435|NCT00361335|9321620|P2|SC Period: Week E0 to Week E24|Lack of Efficacy|0
2707436|NCT00361335|9321621|P1|SC Period: Week E0 to Week E24|Lack of Efficacy|0
2707437|NCT00361335|9321615|P7|SC Period: Week E0 to Week E24|Other|2
2707438|NCT00361335|9321616|P6|SC Period: Week E0 to Week E24|Other|1
2707439|NCT00361335|9321617|P5|SC Period: Week E0 to Week E24|Other|0
2707440|NCT00361335|9321618|P4|SC Period: Week E0 to Week E24|Other|1
2707441|NCT00361335|9321619|P3|SC Period: Week E0 to Week E24|Other|0
2707442|NCT00361335|9321620|P2|SC Period: Week E0 to Week E24|Other|0
2707443|NCT00361335|9321621|P1|SC Period: Week E0 to Week E24|Other|1
2707444|NCT00361335|9321615|P7|SC Period: Week E0 to Week E24|Worsening of RA|0
2707445|NCT00361335|9321616|P6|SC Period: Week E0 to Week E24|Worsening of RA|0
2707446|NCT00361335|9321617|P5|SC Period: Week E0 to Week E24|Worsening of RA|0
2707447|NCT00361335|9321618|P4|SC Period: Week E0 to Week E24|Worsening of RA|1
2707448|NCT00361335|9321619|P3|SC Period: Week E0 to Week E24|Worsening of RA|1
2707449|NCT00361335|9321620|P2|SC Period: Week E0 to Week E24|Worsening of RA|1
2707450|NCT00361335|9321621|P1|SC Period: Week E0 to Week E24|Worsening of RA|0
2707451|NCT00361335|9321615|P7|SC Period: Week E0 to Week E24|Death|1
2707452|NCT00361335|9321616|P6|SC Period: Week E0 to Week E24|Death|0
2707453|NCT00361335|9321617|P5|SC Period: Week E0 to Week E24|Death|0
2707454|NCT00361335|9321618|P4|SC Period: Week E0 to Week E24|Death|0
2707455|NCT00361335|9321619|P3|SC Period: Week E0 to Week E24|Death|0
2707456|NCT00361335|9321620|P2|SC Period: Week E0 to Week E24|Death|0
2707457|NCT00361335|9321621|P1|SC Period: Week E0 to Week E24|Death|0
2707458|NCT00361335|9321615|P7|SC Period: Week E0 to Week E24|Lost to Follow-up|1
2707459|NCT00361335|9321616|P6|SC Period: Week E0 to Week E24|Lost to Follow-up|0
2707460|NCT00361335|9321617|P5|SC Period: Week E0 to Week E24|Lost to Follow-up|0
2707461|NCT00361335|9321618|P4|SC Period: Week E0 to Week E24|Lost to Follow-up|0
2707462|NCT00361335|9321619|P3|SC Period: Week E0 to Week E24|Lost to Follow-up|1
2707463|NCT00361335|9321620|P2|SC Period: Week E0 to Week E24|Lost to Follow-up|0
2707464|NCT00361335|9321621|P1|SC Period: Week E0 to Week E24|Lost to Follow-up|1
2707465|NCT00361335|9321615|P7|SC Period: Week E0 to Week E24|Adverse Event|2
2707466|NCT00361335|9321616|P6|SC Period: Week E0 to Week E24|Adverse Event|0
2707467|NCT00361335|9321617|P5|SC Period: Week E0 to Week E24|Adverse Event|0
2707468|NCT00361335|9321618|P4|SC Period: Week E0 to Week E24|Adverse Event|2
2707469|NCT00361335|9321619|P3|SC Period: Week E0 to Week E24|Adverse Event|1
2707470|NCT00361335|9321620|P2|SC Period: Week E0 to Week E24|Adverse Event|2
2707471|NCT00361335|9321621|P1|SC Period: Week E0 to Week E24|Adverse Event|0
2707472|NCT00361335|9321615|P7|IV Period: Baseline to E0|Lack of Efficacy|0
2707473|NCT00361335|9321616|P6|IV Period: Baseline to E0|Lack of Efficacy|0
2707474|NCT00361335|9321617|P5|IV Period: Baseline to E0|Lack of Efficacy|8
2707475|NCT00361335|9321618|P4|IV Period: Baseline to E0|Lack of Efficacy|7
2707476|NCT00361335|9321619|P3|IV Period: Baseline to E0|Lack of Efficacy|3
2707477|NCT00361335|9321620|P2|IV Period: Baseline to E0|Lack of Efficacy|9
2707478|NCT00361335|9321621|P1|IV Period: Baseline to E0|Lack of Efficacy|5
2707479|NCT00361335|9321615|P7|IV Period: Baseline to E0|Other|0
2707480|NCT00361335|9321616|P6|IV Period: Baseline to E0|Other|0
2707481|NCT00361335|9321617|P5|IV Period: Baseline to E0|Other|2
2707482|NCT00361335|9321618|P4|IV Period: Baseline to E0|Other|3
2707483|NCT00361335|9321619|P3|IV Period: Baseline to E0|Other|9
2707484|NCT00361335|9321620|P2|IV Period: Baseline to E0|Other|9
2707485|NCT00361335|9321621|P1|IV Period: Baseline to E0|Other|2
2707486|NCT00361335|9321615|P7|IV Period: Baseline to E0|Worsening of RA|0
2707487|NCT00361335|9321616|P6|IV Period: Baseline to E0|Worsening of RA|0
2707488|NCT00361335|9321617|P5|IV Period: Baseline to E0|Worsening of RA|2
2707489|NCT00361335|9321618|P4|IV Period: Baseline to E0|Worsening of RA|4
2707490|NCT00361335|9321619|P3|IV Period: Baseline to E0|Worsening of RA|1
2707491|NCT00361335|9321620|P2|IV Period: Baseline to E0|Worsening of RA|5
2707492|NCT00361335|9321621|P1|IV Period: Baseline to E0|Worsening of RA|0
2707493|NCT00361335|9321615|P7|IV Period: Baseline to E0|Protocol-prohibited medications|0
2707494|NCT00361335|9321616|P6|IV Period: Baseline to E0|Protocol-prohibited medications|0
2707495|NCT00361335|9321617|P5|IV Period: Baseline to E0|Protocol-prohibited medications|0
2707496|NCT00361335|9321618|P4|IV Period: Baseline to E0|Protocol-prohibited medications|0
2707497|NCT00361335|9321619|P3|IV Period: Baseline to E0|Protocol-prohibited medications|1
2707498|NCT00361335|9321620|P2|IV Period: Baseline to E0|Protocol-prohibited medications|0
2707499|NCT00361335|9321621|P1|IV Period: Baseline to E0|Protocol-prohibited medications|0
2707500|NCT00361335|9321615|P7|IV Period: Baseline to E0|Discontinued oral study agent|0
2707501|NCT00361335|9321616|P6|IV Period: Baseline to E0|Discontinued oral study agent|0
2707502|NCT00361335|9321617|P5|IV Period: Baseline to E0|Discontinued oral study agent|2
2707503|NCT00361335|9321618|P4|IV Period: Baseline to E0|Discontinued oral study agent|1
2707504|NCT00361335|9321619|P3|IV Period: Baseline to E0|Discontinued oral study agent|1
2707505|NCT00361335|9321620|P2|IV Period: Baseline to E0|Discontinued oral study agent|1
2707506|NCT00361335|9321621|P1|IV Period: Baseline to E0|Discontinued oral study agent|2
2707507|NCT00361335|9321615|P7|IV Period: Baseline to E0|Death|0
2707508|NCT00361335|9321616|P6|IV Period: Baseline to E0|Death|0
2707509|NCT00361335|9321617|P5|IV Period: Baseline to E0|Death|0
2707510|NCT00361335|9321618|P4|IV Period: Baseline to E0|Death|1
2707511|NCT00361335|9321619|P3|IV Period: Baseline to E0|Death|1
2707512|NCT00361335|9321620|P2|IV Period: Baseline to E0|Death|1
2707513|NCT00361335|9321621|P1|IV Period: Baseline to E0|Death|1
2707514|NCT00361335|9321615|P7|IV Period: Baseline to E0|Lost to Follow-up|0
2707515|NCT00361335|9321616|P6|IV Period: Baseline to E0|Lost to Follow-up|0
2707516|NCT00361335|9321617|P5|IV Period: Baseline to E0|Lost to Follow-up|2
2707517|NCT00361335|9321618|P4|IV Period: Baseline to E0|Lost to Follow-up|2
2707518|NCT00361335|9321619|P3|IV Period: Baseline to E0|Lost to Follow-up|0
2707519|NCT00361335|9321620|P2|IV Period: Baseline to E0|Lost to Follow-up|0
2707520|NCT00361335|9321621|P1|IV Period: Baseline to E0|Lost to Follow-up|1
2707521|NCT00361335|9321615|P7|IV Period: Baseline to E0|Adverse Event|0
2707522|NCT00361335|9321616|P6|IV Period: Baseline to E0|Adverse Event|0
2707523|NCT00361335|9321617|P5|IV Period: Baseline to E0|Adverse Event|8
2707524|NCT00361335|9321618|P4|IV Period: Baseline to E0|Adverse Event|9
2707525|NCT00361335|9321619|P3|IV Period: Baseline to E0|Adverse Event|5
2707526|NCT00361335|9321620|P2|IV Period: Baseline to E0|Adverse Event|4
2707527|NCT00361335|9321621|P1|IV Period: Baseline to E0|Adverse Event|9
2707528|NCT00361296|9321665|P1|Overall Study|Lack of Efficacy|2
2707529|NCT00361296|9321665|P1|Overall Study|Physician Decision|1
2707530|NCT00361283|9321672|P1|Overall Study|Lost to Follow-up|27
2707531|NCT00361270|9321680|P4|Overall Study|Adverse Event|0
2707532|NCT00361270|9321681|P3|Overall Study|Adverse Event|1
2707533|NCT00361270|9321682|P2|Overall Study|Adverse Event|1
2707534|NCT00361270|9321683|P1|Overall Study|Adverse Event|0
2707535|NCT00361270|9321680|P4|Overall Study|Problems with Transportation|0
2707536|NCT00361270|9321681|P3|Overall Study|Problems with Transportation|0
2707537|NCT00361270|9321682|P2|Overall Study|Problems with Transportation|0
2707538|NCT00361270|9321683|P1|Overall Study|Problems with Transportation|4
2707539|NCT00361270|9321680|P4|Overall Study|Afraid of Hypnosis|0
2707540|NCT00361270|9321681|P3|Overall Study|Afraid of Hypnosis|0
2707541|NCT00361270|9321682|P2|Overall Study|Afraid of Hypnosis|2
2707542|NCT00361270|9321683|P1|Overall Study|Afraid of Hypnosis|1
2707543|NCT00361270|9321680|P4|Overall Study|Withdrawal by Subject|7
2707544|NCT00361270|9321681|P3|Overall Study|Withdrawal by Subject|3
2707545|NCT00361270|9321682|P2|Overall Study|Withdrawal by Subject|6
2707546|NCT00361270|9321683|P1|Overall Study|Withdrawal by Subject|6
2707547|NCT00361270|9321680|P4|Overall Study|Protocol Violation|4
2707548|NCT00361270|9321681|P3|Overall Study|Protocol Violation|5
2707549|NCT00361270|9321682|P2|Overall Study|Protocol Violation|4
2707550|NCT00361270|9321683|P1|Overall Study|Protocol Violation|9
2707551|NCT00361270|9321680|P4|Overall Study|Physician Decision|0
2707552|NCT00361270|9321681|P3|Overall Study|Physician Decision|1
2707553|NCT00361270|9321682|P2|Overall Study|Physician Decision|0
2707554|NCT00361270|9321683|P1|Overall Study|Physician Decision|0
2707555|NCT00361270|9321680|P4|Overall Study|Lost to Follow-up|0
2707556|NCT00361270|9321681|P3|Overall Study|Lost to Follow-up|0
2707557|NCT00361270|9321682|P2|Overall Study|Lost to Follow-up|1
2707558|NCT00361270|9321683|P1|Overall Study|Lost to Follow-up|4
2707559|NCT00361270|9321680|P4|Overall Study|Death|2
2707560|NCT00361270|9321681|P3|Overall Study|Death|0
2707561|NCT00361270|9321682|P2|Overall Study|Death|0
2707562|NCT00361270|9321683|P1|Overall Study|Death|0
2707563|NCT00361231|9321756|P1|Overall Study|Adverse Event|6
2707564|NCT00361231|9321756|P1|Overall Study|Withdrawal by Subject|4
2707565|NCT00361231|9321756|P1|Overall Study|Radiographic disease progression|16
2707566|NCT00361231|9321756|P1|Overall Study|Symptomatic deterioration|5
2707567|NCT00361231|9321756|P1|Overall Study|Physician Decision|3
2707568|NCT00361218|9321761|P1|Overall Study|terminated / withdrawn due to toxicity /|5
2707569|NCT00361218|9321761|P1|Overall Study|Personal Reasons|7
2707570|NCT00361218|9321761|P1|Overall Study|Lost to Follow-up|11
2707571|NCT00360698|9321840|P2|Treatment Period|Early termination by error|1
2707572|NCT00360698|9321841|P1|Treatment Period|Early termination by error|0
2707573|NCT00360698|9321840|P2|Treatment Period|Non compliance with treatment procedure|0
2707574|NCT00360698|9321841|P1|Treatment Period|Non compliance with treatment procedure|1
2707575|NCT00360698|9321840|P2|Run-In|Need of insulin with meals|1
2707576|NCT00360698|9321841|P1|Run-In|Need of insulin with meals|0
2707577|NCT00360698|9321840|P2|Run-In|Patient personal reasons|2
2707578|NCT00360698|9321841|P1|Run-In|Patient personal reasons|0
2707579|NCT00360698|9321840|P2|Run-In|Patient did not meet inclusion criteria|1
2707580|NCT00360698|9321841|P1|Run-In|Patient did not meet inclusion criteria|0
2707581|NCT00360698|9321840|P2|Run-In|Sponsor request|2
2707582|NCT00360698|9321841|P1|Run-In|Sponsor request|0
2707583|NCT00360698|9321840|P2|Run-In|Non compliance with treatment procedure|1
2707584|NCT00360698|9321841|P1|Run-In|Non compliance with treatment procedure|0
2707585|NCT00360698|9321840|P2|Run-In|Withdrawal by Subject|2
2707586|NCT00360698|9321841|P1|Run-In|Withdrawal by Subject|0
2707587|NCT00360698|9321840|P2|Run-In|Physician Decision|1
2707588|NCT00360698|9321841|P1|Run-In|Physician Decision|0
2707589|NCT00360568|9321886|P2|Overall Study|Withdrawal by Subject|3
2707590|NCT00360568|9321887|P1|Overall Study|Withdrawal by Subject|0
2707591|NCT00360568|9321886|P2|Overall Study|Lack of Efficacy|0
2707592|NCT00360568|9321887|P1|Overall Study|Lack of Efficacy|1
2707593|NCT00360568|9321886|P2|Overall Study|Adverse Event|2
2707594|NCT00360568|9321887|P1|Overall Study|Adverse Event|1
2707595|NCT00360529|9322018|P3|Overall Study|Reason discontinued not explained above|11
2707596|NCT00360529|9322019|P2|Overall Study|Reason discontinued not explained above|9
2707597|NCT00360529|9322020|P1|Overall Study|Reason discontinued not explained above|4
2707598|NCT00360529|9322018|P3|Overall Study|Lack of Efficacy|5
2707599|NCT00360529|9322019|P2|Overall Study|Lack of Efficacy|6
2707600|NCT00360529|9322020|P1|Overall Study|Lack of Efficacy|8
2707601|NCT00360529|9322018|P3|Overall Study|Withdrawal by Subject|18
2707602|NCT00360529|9322019|P2|Overall Study|Withdrawal by Subject|14
2707603|NCT00360529|9322020|P1|Overall Study|Withdrawal by Subject|22
2707604|NCT00360529|9322018|P3|Overall Study|Lost to Follow-up|13
2707605|NCT00360529|9322019|P2|Overall Study|Lost to Follow-up|10
2707606|NCT00360529|9322020|P1|Overall Study|Lost to Follow-up|14
2707607|NCT00360529|9322018|P3|Overall Study|Protocol Violation|11
2707608|NCT00360529|9322019|P2|Overall Study|Protocol Violation|3
2707609|NCT00360529|9322020|P1|Overall Study|Protocol Violation|3
2707610|NCT00360529|9322018|P3|Overall Study|Adverse Event|33
2707611|NCT00360529|9322019|P2|Overall Study|Adverse Event|23
2707612|NCT00360529|9322020|P1|Overall Study|Adverse Event|10
2707613|NCT00360490|9322048|P2|Overall Study|Withdrawal by Subject|3
2707614|NCT00360490|9322049|P1|Overall Study|Withdrawal by Subject|1
2707615|NCT00360490|9322048|P2|Overall Study|Protocol Violation|4
2707616|NCT00360490|9322049|P1|Overall Study|Protocol Violation|0
2707617|NCT00360490|9322048|P2|Overall Study|Physician Decision|1
2707618|NCT00360490|9322049|P1|Overall Study|Physician Decision|2
2707619|NCT00360490|9322048|P2|Overall Study|Lost to Follow-up|1
2707620|NCT00360490|9322049|P1|Overall Study|Lost to Follow-up|2
2707621|NCT00360490|9322048|P2|Overall Study|Adverse Event|2
2707622|NCT00360490|9322049|P1|Overall Study|Adverse Event|4
2707623|NCT00360412|9322084|P2|Overall Study|Study termination by Sponsor|469
2707624|NCT00360412|9322085|P1|Overall Study|Study termination by Sponsor|214
2707625|NCT00360412|9322084|P2|Overall Study|Other|6
2707626|NCT00360412|9322085|P1|Overall Study|Other|5
2707627|NCT00360412|9322084|P2|Overall Study|Physician Decision|4
2707628|NCT00360412|9322085|P1|Overall Study|Physician Decision|2
2707629|NCT00360412|9322084|P2|Overall Study|Lack of therapeutic efficacy|61
2707630|NCT00360412|9322085|P1|Overall Study|Lack of therapeutic efficacy|46
2707631|NCT00360412|9322084|P2|Overall Study|Patient withdrew consent|52
2707632|NCT00360412|9322085|P1|Overall Study|Patient withdrew consent|27
2707633|NCT00360412|9322084|P2|Overall Study|Protocol Violation|5
2707634|NCT00360412|9322085|P1|Overall Study|Protocol Violation|2
2707635|NCT00360412|9322084|P2|Overall Study|Adverse Event|65
2707636|NCT00360412|9322085|P1|Overall Study|Adverse Event|37
2707637|NCT00360334|9322132|P2|Overall Study|Subject decision|2
2707638|NCT00360334|9322133|P1|Overall Study|Subject decision|8
2707639|NCT00360334|9322132|P2|Overall Study|Entry criterion not met|2
2707640|NCT00360334|9322133|P1|Overall Study|Entry criterion not met|1
2707641|NCT00360334|9322132|P2|Overall Study|Lack of Efficacy|1
2707642|NCT00360334|9322133|P1|Overall Study|Lack of Efficacy|0
2707643|NCT00360334|9322132|P2|Overall Study|Physician Decision|3
2707644|NCT00360334|9322133|P1|Overall Study|Physician Decision|2
2707645|NCT00360334|9322132|P2|Overall Study|Protocol Violation|1
2707646|NCT00360334|9322133|P1|Overall Study|Protocol Violation|1
2707647|NCT00360334|9322132|P2|Overall Study|Adverse Event|4
2707648|NCT00360334|9322133|P1|Overall Study|Adverse Event|7
2707649|NCT00360308|9322196|P3|Overall Study|Study termination by sponsor|44
2707650|NCT00360308|9322197|P2|Overall Study|Study termination by sponsor|55
2707651|NCT00360308|9322198|P1|Overall Study|Study termination by sponsor|43
2707652|NCT00360308|9322196|P3|Overall Study|Other|1
2707653|NCT00360308|9322197|P2|Overall Study|Other|1
2707654|NCT00360308|9322198|P1|Overall Study|Other|2
2707655|NCT00360308|9322196|P3|Overall Study|Lack of Efficacy|2
2707656|NCT00360308|9322197|P2|Overall Study|Lack of Efficacy|0
2707657|NCT00360308|9322198|P1|Overall Study|Lack of Efficacy|3
2707658|NCT00360308|9322196|P3|Overall Study|Withdrawal by Subject|14
2707659|NCT00360308|9322197|P2|Overall Study|Withdrawal by Subject|7
2707660|NCT00360308|9322198|P1|Overall Study|Withdrawal by Subject|11
2707661|NCT00360308|9322196|P3|Overall Study|Protocol Violation|2
2707662|NCT00360308|9322197|P2|Overall Study|Protocol Violation|1
2707663|NCT00360308|9322198|P1|Overall Study|Protocol Violation|2
2707664|NCT00360308|9322196|P3|Overall Study|Abnormal Laboratory Value(s)|0
2707665|NCT00360308|9322197|P2|Overall Study|Abnormal Laboratory Value(s)|1
2707666|NCT00360308|9322198|P1|Overall Study|Abnormal Laboratory Value(s)|0
2707667|NCT00360308|9322196|P3|Overall Study|Adverse Event|25
2707668|NCT00360308|9322197|P2|Overall Study|Adverse Event|14
2707669|NCT00360308|9322198|P1|Overall Study|Adverse Event|15
2707670|NCT00360282|9322215|P4|Second Intervention|Adverse Event|0
2707671|NCT00360282|9322216|P3|Second Intervention|Adverse Event|0
2707672|NCT00360282|9322217|P2|Second Intervention|Adverse Event|1
2707673|NCT00360282|9322218|P1|Second Intervention|Adverse Event|0
2707674|NCT00360282|9322215|P4|Washout 1-3 Weeks|Lost to Follow-up|0
2707675|NCT00360282|9322216|P3|Washout 1-3 Weeks|Lost to Follow-up|1
2707676|NCT00360282|9322217|P2|Washout 1-3 Weeks|Lost to Follow-up|0
2707677|NCT00360282|9322218|P1|Washout 1-3 Weeks|Lost to Follow-up|0
2707678|NCT00360269|9322230|P2|Overall Study|Withdrawal by Subject|1
2707679|NCT00360269|9322231|P1|Overall Study|Withdrawal by Subject|1
2707680|NCT00360269|9322230|P2|Overall Study|Adverse Event|0
2707681|NCT00360269|9322231|P1|Overall Study|Adverse Event|1
2707682|NCT00360269|9322230|P2|Overall Study|Physician Decision|2
2707683|NCT00360269|9322231|P1|Overall Study|Physician Decision|1
2707684|NCT00360269|9322230|P2|Overall Study|Lost to Follow-up|9
2707685|NCT00360269|9322231|P1|Overall Study|Lost to Follow-up|7
2707686|NCT00360230|9322273|P7|Overall Study|Death|1
2707687|NCT00360230|9322274|P6|Overall Study|Death|1
2707688|NCT00360230|9322275|P5|Overall Study|Death|0
2707689|NCT00360230|9322276|P4|Overall Study|Death|0
2707690|NCT00360230|9322277|P3|Overall Study|Death|0
2707691|NCT00360230|9322278|P2|Overall Study|Death|1
2707692|NCT00360230|9322279|P1|Overall Study|Death|0
2707693|NCT00360230|9322273|P7|Overall Study|Protocol Violation|0
2707694|NCT00360230|9322274|P6|Overall Study|Protocol Violation|1
2707695|NCT00360230|9322275|P5|Overall Study|Protocol Violation|0
2707696|NCT00360230|9322276|P4|Overall Study|Protocol Violation|0
2707697|NCT00360230|9322277|P3|Overall Study|Protocol Violation|0
2707698|NCT00360230|9322278|P2|Overall Study|Protocol Violation|0
2707699|NCT00360230|9322279|P1|Overall Study|Protocol Violation|0
2707700|NCT00360230|9322273|P7|Overall Study|Other|0
2707701|NCT00360230|9322274|P6|Overall Study|Other|0
2707702|NCT00360230|9322275|P5|Overall Study|Other|0
2707703|NCT00360230|9322276|P4|Overall Study|Other|0
2707704|NCT00360230|9322277|P3|Overall Study|Other|0
2707705|NCT00360230|9322278|P2|Overall Study|Other|0
2707706|NCT00360230|9322279|P1|Overall Study|Other|1
2707707|NCT00360230|9322273|P7|Overall Study|Migrated|1
2707708|NCT00360230|9322274|P6|Overall Study|Migrated|1
2707709|NCT00360230|9322275|P5|Overall Study|Migrated|4
2707710|NCT00360230|9322276|P4|Overall Study|Migrated|1
2707711|NCT00360230|9322277|P3|Overall Study|Migrated|3
2707712|NCT00360230|9322278|P2|Overall Study|Migrated|1
2707713|NCT00360230|9322279|P1|Overall Study|Migrated|4
2707714|NCT00360230|9322273|P7|Overall Study|Withdrawal by Subject|0
2707715|NCT00360230|9322274|P6|Overall Study|Withdrawal by Subject|1
2707716|NCT00360230|9322275|P5|Overall Study|Withdrawal by Subject|1
2707717|NCT00360230|9322276|P4|Overall Study|Withdrawal by Subject|1
2707718|NCT00360230|9322277|P3|Overall Study|Withdrawal by Subject|0
2707719|NCT00360230|9322278|P2|Overall Study|Withdrawal by Subject|1
2707720|NCT00360230|9322279|P1|Overall Study|Withdrawal by Subject|1
2707721|NCT00359801|9322435|P2|Overall Study|Sponsor Decision|16
2707722|NCT00359801|9322436|P1|Overall Study|Sponsor Decision|17
2707723|NCT00359801|9322435|P2|Overall Study|Final Status Unknown: missing data|4
2707724|NCT00359801|9322436|P1|Overall Study|Final Status Unknown: missing data|7
2707725|NCT00359801|9322435|P2|Overall Study|Other|46
2707726|NCT00359801|9322436|P1|Overall Study|Other|66
2707727|NCT00359801|9322435|P2|Overall Study|Withdrawal by Subject|96
2707728|NCT00359801|9322436|P1|Overall Study|Withdrawal by Subject|143
2707729|NCT00359801|9322435|P2|Overall Study|Lost to Follow-up|58
2707730|NCT00359801|9322436|P1|Overall Study|Lost to Follow-up|72
2707731|NCT00359788|9322470|P2|Overall Study|Protocol Violation|2
2707732|NCT00359788|9322471|P1|Overall Study|Protocol Violation|4
2707733|NCT00359788|9322470|P2|Overall Study|Withdrawal by Subject|1
2707734|NCT00359788|9322471|P1|Overall Study|Withdrawal by Subject|4
2707735|NCT00359788|9322470|P2|Overall Study|Lost to Follow-up|2
2707736|NCT00359788|9322471|P1|Overall Study|Lost to Follow-up|3
2707737|NCT00359788|9322470|P2|Overall Study|Lack of Efficacy|2
2707738|NCT00359788|9322471|P1|Overall Study|Lack of Efficacy|1
2707739|NCT00359788|9322470|P2|Overall Study|Adverse Event|10
2707740|NCT00359788|9322471|P1|Overall Study|Adverse Event|11
2707741|NCT00359762|9322705|P5|Period III|Subject Decision|0
2707742|NCT00359762|9322706|P4|Period III|Subject Decision|20
2707743|NCT00359762|9322707|P3|Period III|Subject Decision|8
2707744|NCT00359762|9322708|P2|Period III|Subject Decision|7
2707745|NCT00359762|9322709|P1|Period III|Subject Decision|0
2707746|NCT00359762|9322705|P5|Period III|Entry Criteria Not Met|0
2707747|NCT00359762|9322706|P4|Period III|Entry Criteria Not Met|1
2707748|NCT00359762|9322707|P3|Period III|Entry Criteria Not Met|0
2707749|NCT00359762|9322708|P2|Period III|Entry Criteria Not Met|1
2707750|NCT00359762|9322709|P1|Period III|Entry Criteria Not Met|0
2707751|NCT00359762|9322705|P5|Period III|Lost to follow up|0
2707752|NCT00359762|9322706|P4|Period III|Lost to follow up|2
2707753|NCT00359762|9322707|P3|Period III|Lost to follow up|1
2707754|NCT00359762|9322708|P2|Period III|Lost to follow up|1
2707755|NCT00359762|9322709|P1|Period III|Lost to follow up|0
2707756|NCT00359762|9322705|P5|Period III|Lack of Efficacy|0
2707757|NCT00359762|9322706|P4|Period III|Lack of Efficacy|9
2707758|NCT00359762|9322707|P3|Period III|Lack of Efficacy|5
2707759|NCT00359762|9322708|P2|Period III|Lack of Efficacy|7
2707760|NCT00359762|9322709|P1|Period III|Lack of Efficacy|0
2707761|NCT00359762|9322705|P5|Period III|Physician Decision|0
2707762|NCT00359762|9322706|P4|Period III|Physician Decision|15
2707763|NCT00359762|9322707|P3|Period III|Physician Decision|9
2707764|NCT00359762|9322708|P2|Period III|Physician Decision|5
2707765|NCT00359762|9322709|P1|Period III|Physician Decision|0
2707766|NCT00359762|9322705|P5|Period III|Adverse Event|0
2707767|NCT00359762|9322706|P4|Period III|Adverse Event|10
2707768|NCT00359762|9322707|P3|Period III|Adverse Event|4
2707769|NCT00359762|9322708|P2|Period III|Adverse Event|3
2707770|NCT00359762|9322709|P1|Period III|Adverse Event|0
2707771|NCT00359762|9322705|P5|Period III|Protocol Violation|0
2707772|NCT00359762|9322706|P4|Period III|Protocol Violation|8
2707773|NCT00359762|9322707|P3|Period III|Protocol Violation|3
2707774|NCT00359762|9322708|P2|Period III|Protocol Violation|5
2707775|NCT00359762|9322709|P1|Period III|Protocol Violation|0
2707776|NCT00359762|9322705|P5|Period II|Subject Decision|70
2707777|NCT00359762|9322706|P4|Period II|Subject Decision|0
2707778|NCT00359762|9322707|P3|Period II|Subject Decision|0
2707779|NCT00359762|9322708|P2|Period II|Subject Decision|0
2707780|NCT00359762|9322709|P1|Period II|Subject Decision|50
2707781|NCT00359762|9322705|P5|Period II|Entry Criteria Not Met|4
2707782|NCT00359762|9322706|P4|Period II|Entry Criteria Not Met|0
2707783|NCT00359762|9322707|P3|Period II|Entry Criteria Not Met|0
2707784|NCT00359762|9322708|P2|Period II|Entry Criteria Not Met|0
2707785|NCT00359762|9322709|P1|Period II|Entry Criteria Not Met|8
2707786|NCT00359762|9322705|P5|Period II|Lost to follow up|5
2707787|NCT00359762|9322706|P4|Period II|Lost to follow up|0
2707788|NCT00359762|9322707|P3|Period II|Lost to follow up|0
2707789|NCT00359762|9322708|P2|Period II|Lost to follow up|0
2707790|NCT00359762|9322709|P1|Period II|Lost to follow up|5
2707791|NCT00359762|9322705|P5|Period II|Lack of Efficacy|8
2707792|NCT00359762|9322706|P4|Period II|Lack of Efficacy|0
2707793|NCT00359762|9322707|P3|Period II|Lack of Efficacy|0
2707794|NCT00359762|9322708|P2|Period II|Lack of Efficacy|0
2707795|NCT00359762|9322709|P1|Period II|Lack of Efficacy|11
2707796|NCT00359762|9322705|P5|Period II|Death|4
2707797|NCT00359762|9322706|P4|Period II|Death|0
2707798|NCT00359762|9322707|P3|Period II|Death|0
2707799|NCT00359762|9322708|P2|Period II|Death|0
2707800|NCT00359762|9322709|P1|Period II|Death|2
2707801|NCT00359762|9322705|P5|Period II|Physician Decision|23
2707802|NCT00359762|9322706|P4|Period II|Physician Decision|0
2707803|NCT00359762|9322707|P3|Period II|Physician Decision|0
2707804|NCT00359762|9322708|P2|Period II|Physician Decision|0
2707805|NCT00359762|9322709|P1|Period II|Physician Decision|17
2707806|NCT00359762|9322705|P5|Period II|Protocol Violation|11
2707807|NCT00359762|9322706|P4|Period II|Protocol Violation|0
2707808|NCT00359762|9322707|P3|Period II|Protocol Violation|0
2707809|NCT00359762|9322708|P2|Period II|Protocol Violation|0
2707810|NCT00359762|9322709|P1|Period II|Protocol Violation|18
2707811|NCT00359762|9322705|P5|Period II|Adverse Event|49
2707812|NCT00359762|9322706|P4|Period II|Adverse Event|0
2707813|NCT00359762|9322707|P3|Period II|Adverse Event|0
2707814|NCT00359762|9322708|P2|Period II|Adverse Event|0
2707815|NCT00359762|9322709|P1|Period II|Adverse Event|17
2707816|NCT00359632|9322783|P2|Overall Study|Non-compliance with visit schedule|0
2707817|NCT00359632|9322784|P1|Overall Study|Non-compliance with visit schedule|1
2707818|NCT00359632|9322783|P2|Overall Study|Adverse Event|0
2707819|NCT00359632|9322784|P1|Overall Study|Adverse Event|1
2707820|NCT00359632|9322783|P2|Overall Study|Death|0
2707821|NCT00359632|9322784|P1|Overall Study|Death|2
2707822|NCT00359619|9322798|P7|Overall Study|Lost to Follow-up|0
2707823|NCT00359619|9322799|P6|Overall Study|Lost to Follow-up|5
2707824|NCT00359619|9322800|P5|Overall Study|Lost to Follow-up|1
2707825|NCT00359619|9322801|P4|Overall Study|Lost to Follow-up|1
2707826|NCT00359619|9322802|P3|Overall Study|Lost to Follow-up|2
2707827|NCT00359619|9322803|P2|Overall Study|Lost to Follow-up|4
2707828|NCT00359619|9322804|P1|Overall Study|Lost to Follow-up|4
2707829|NCT00359619|9322798|P7|Overall Study|Other|0
2707830|NCT00359619|9322799|P6|Overall Study|Other|0
2707831|NCT00359619|9322800|P5|Overall Study|Other|0
2707832|NCT00359619|9322801|P4|Overall Study|Other|0
2707833|NCT00359619|9322802|P3|Overall Study|Other|0
2707834|NCT00359619|9322803|P2|Overall Study|Other|0
2707835|NCT00359619|9322804|P1|Overall Study|Other|1
2707836|NCT00359619|9322798|P7|Overall Study|Withdrawal by Subject|3
2707837|NCT00359619|9322799|P6|Overall Study|Withdrawal by Subject|0
2707838|NCT00359619|9322800|P5|Overall Study|Withdrawal by Subject|2
2707839|NCT00359619|9322801|P4|Overall Study|Withdrawal by Subject|2
2707840|NCT00359619|9322802|P3|Overall Study|Withdrawal by Subject|4
2707841|NCT00359619|9322803|P2|Overall Study|Withdrawal by Subject|1
2707842|NCT00359619|9322804|P1|Overall Study|Withdrawal by Subject|3
2707843|NCT00359619|9322798|P7|Overall Study|Adverse Event|1
2707844|NCT00359619|9322799|P6|Overall Study|Adverse Event|0
2707845|NCT00359619|9322800|P5|Overall Study|Adverse Event|0
2707846|NCT00359619|9322801|P4|Overall Study|Adverse Event|0
2707847|NCT00359619|9322802|P3|Overall Study|Adverse Event|1
2707848|NCT00359619|9322803|P2|Overall Study|Adverse Event|0
2707849|NCT00359619|9322804|P1|Overall Study|Adverse Event|0
2707850|NCT00359424|9322934|P2|Overall Study|follow up not conducted|0
2707851|NCT00359424|9322935|P1|Overall Study|follow up not conducted|2
2707852|NCT00359424|9322934|P2|Overall Study|Withdrawal by Subject|2
2707853|NCT00359424|9322935|P1|Overall Study|Withdrawal by Subject|10
2707854|NCT00359424|9322934|P2|Overall Study|Lost to Follow-up|7
2707855|NCT00359424|9322935|P1|Overall Study|Lost to Follow-up|19
2707856|NCT00359424|9322934|P2|Overall Study|Death|58
2707857|NCT00359424|9322935|P1|Overall Study|Death|99
2707858|NCT00359281|9322974|P9|Overall Study|Withdrawal by Subject|0
2707859|NCT00359281|9322975|P8|Overall Study|Withdrawal by Subject|0
2707860|NCT00359281|9322976|P7|Overall Study|Withdrawal by Subject|1
2707861|NCT00359281|9322977|P6|Overall Study|Withdrawal by Subject|0
2707862|NCT00359281|9322978|P5|Overall Study|Withdrawal by Subject|0
2707863|NCT00359281|9322979|P4|Overall Study|Withdrawal by Subject|0
2707864|NCT00359281|9322980|P3|Overall Study|Withdrawal by Subject|0
2707865|NCT00359281|9322981|P2|Overall Study|Withdrawal by Subject|0
2707866|NCT00359281|9322982|P1|Overall Study|Withdrawal by Subject|0
2707867|NCT00359281|9322974|P9|Overall Study|Adverse Event|0
2707868|NCT00359281|9322975|P8|Overall Study|Adverse Event|0
2707869|NCT00359281|9322976|P7|Overall Study|Adverse Event|1
2707870|NCT00359281|9322977|P6|Overall Study|Adverse Event|0
2707871|NCT00359281|9322978|P5|Overall Study|Adverse Event|0
2707872|NCT00359281|9322979|P4|Overall Study|Adverse Event|0
2707873|NCT00359281|9322980|P3|Overall Study|Adverse Event|0
2707874|NCT00359281|9322981|P2|Overall Study|Adverse Event|0
2707875|NCT00359281|9322982|P1|Overall Study|Adverse Event|1
2707876|NCT00359073|9323045|P2|Overall Study|developed RV16 antibody|1
2707877|NCT00359073|9323046|P1|Overall Study|developed RV16 antibody|0
2707878|NCT00359073|9323045|P2|Overall Study|Eligibility criteria no longer met|0
2707879|NCT00359073|9323046|P1|Overall Study|Eligibility criteria no longer met|3
2707880|NCT00359073|9323045|P2|Overall Study|Withdrawal by Subject|1
2707881|NCT00359073|9323046|P1|Overall Study|Withdrawal by Subject|1
2707882|NCT00359021|9323058|P2|Overall Study|Pregnancy|0
2707883|NCT00359021|9323059|P1|Overall Study|Pregnancy|1
2707884|NCT00359021|9323058|P2|Overall Study|Other|1
2707885|NCT00359021|9323059|P1|Overall Study|Other|4
2707886|NCT00359021|9323058|P2|Overall Study|Lost to Follow-up|0
2707887|NCT00359021|9323059|P1|Overall Study|Lost to Follow-up|1
2707888|NCT00359021|9323058|P2|Overall Study|Withdrawal by Subject|9
2707889|NCT00359021|9323059|P1|Overall Study|Withdrawal by Subject|2
2707890|NCT00359021|9323058|P2|Overall Study|Subject Reached A Virologic Endpoint|32
2707891|NCT00359021|9323059|P1|Overall Study|Subject Reached A Virologic Endpoint|45
2707892|NCT00359021|9323058|P2|Overall Study|Subject Ineligible To Continue The Trial|0
2707893|NCT00359021|9323059|P1|Overall Study|Subject Ineligible To Continue The Trial|1
2707894|NCT00359021|9323058|P2|Overall Study|Subject Non-Compliant|2
2707895|NCT00359021|9323059|P1|Overall Study|Subject Non-Compliant|1
2707896|NCT00359021|9323058|P2|Overall Study|Adverse Event|8
2707897|NCT00359021|9323059|P1|Overall Study|Adverse Event|26
2707898|NCT00358956|9323071|P1|Overall Study|Withdrawal by Subject|1
2707899|NCT00358956|9323071|P1|Overall Study|condition under investigation worsened|4
2707900|NCT00358956|9323071|P1|Overall Study|Adverse Event|3
2707901|NCT00358917|9323083|P2|Overall Study|Unable to Continue Participation|2
2707902|NCT00358917|9323084|P1|Overall Study|Unable to Continue Participation|2
2707903|NCT00358917|9323083|P2|Overall Study|Virologic failure|8
2707904|NCT00358917|9323084|P1|Overall Study|Virologic failure|11
2707905|NCT00358917|9323083|P2|Overall Study|Death|3
2707906|NCT00358917|9323084|P1|Overall Study|Death|2
2707907|NCT00358917|9323083|P2|Overall Study|Noncompliance|11
2707908|NCT00358917|9323084|P1|Overall Study|Noncompliance|12
2707909|NCT00358917|9323083|P2|Overall Study|Lost to Follow-up|17
2707910|NCT00358917|9323084|P1|Overall Study|Lost to Follow-up|20
2707911|NCT00358917|9323083|P2|Overall Study|Withdrawal by Subject|7
2707912|NCT00358917|9323084|P1|Overall Study|Withdrawal by Subject|5
2707913|NCT00358917|9323083|P2|Overall Study|Adverse Event|21
2707914|NCT00358917|9323084|P1|Overall Study|Adverse Event|14
2707915|NCT00358826|9323102|P8|MDCT Substudy|Withdrawal by Subject|0
2707916|NCT00358826|9323103|P7|MDCT Substudy|Withdrawal by Subject|0
2707917|NCT00358826|9323104|P6|MDCT Substudy|Withdrawal by Subject|1
2707918|NCT00358826|9323105|P5|MDCT Substudy|Withdrawal by Subject|0
2707919|NCT00358826|9323106|P4|MDCT Substudy|Withdrawal by Subject|0
2707920|NCT00358826|9323107|P3|MDCT Substudy|Withdrawal by Subject|0
2707921|NCT00358826|9323108|P2|MDCT Substudy|Withdrawal by Subject|0
2707922|NCT00358826|9323109|P1|MDCT Substudy|Withdrawal by Subject|0
2707923|NCT00358826|9323102|P8|MDCT Substudy|Lost to Follow-up|0
2707924|NCT00358826|9323103|P7|MDCT Substudy|Lost to Follow-up|0
2707925|NCT00358826|9323104|P6|MDCT Substudy|Lost to Follow-up|1
2707926|NCT00358826|9323105|P5|MDCT Substudy|Lost to Follow-up|0
2707927|NCT00358826|9323106|P4|MDCT Substudy|Lost to Follow-up|0
2707928|NCT00358826|9323107|P3|MDCT Substudy|Lost to Follow-up|0
2707929|NCT00358826|9323108|P2|MDCT Substudy|Lost to Follow-up|0
2707930|NCT00358826|9323109|P1|MDCT Substudy|Lost to Follow-up|0
2707931|NCT00358826|9323102|P8|MDCT Substudy|Adverse Event|0
2707932|NCT00358826|9323103|P7|MDCT Substudy|Adverse Event|0
2707933|NCT00358826|9323104|P6|MDCT Substudy|Adverse Event|0
2707934|NCT00358826|9323105|P5|MDCT Substudy|Adverse Event|1
2707935|NCT00358826|9323106|P4|MDCT Substudy|Adverse Event|0
2707936|NCT00358826|9323107|P3|MDCT Substudy|Adverse Event|0
2707937|NCT00358826|9323108|P2|MDCT Substudy|Adverse Event|0
2707938|NCT00358826|9323109|P1|MDCT Substudy|Adverse Event|0
2707939|NCT00358826|9323102|P8|Core Study|Physician Decision|0
2707940|NCT00358826|9323103|P7|Core Study|Physician Decision|0
2707941|NCT00358826|9323104|P6|Core Study|Physician Decision|0
2707942|NCT00358826|9323105|P5|Core Study|Physician Decision|0
2707943|NCT00358826|9323106|P4|Core Study|Physician Decision|0
2707944|NCT00358826|9323107|P3|Core Study|Physician Decision|1
2707945|NCT00358826|9323108|P2|Core Study|Physician Decision|0
2707946|NCT00358826|9323109|P1|Core Study|Physician Decision|0
2707947|NCT00358826|9323102|P8|Core Study|Lost to Follow-up|0
2707948|NCT00358826|9323103|P7|Core Study|Lost to Follow-up|0
2707949|NCT00358826|9323104|P6|Core Study|Lost to Follow-up|0
2707950|NCT00358826|9323105|P5|Core Study|Lost to Follow-up|0
2707951|NCT00358826|9323106|P4|Core Study|Lost to Follow-up|1
2707952|NCT00358826|9323107|P3|Core Study|Lost to Follow-up|0
2707953|NCT00358826|9323108|P2|Core Study|Lost to Follow-up|0
2707954|NCT00358826|9323109|P1|Core Study|Lost to Follow-up|0
2707955|NCT00358826|9323102|P8|Core Study|Withdrawal by Subject|0
2707956|NCT00358826|9323103|P7|Core Study|Withdrawal by Subject|0
2707957|NCT00358826|9323104|P6|Core Study|Withdrawal by Subject|0
2707958|NCT00358826|9323105|P5|Core Study|Withdrawal by Subject|0
2707959|NCT00358826|9323106|P4|Core Study|Withdrawal by Subject|0
2707960|NCT00358826|9323107|P3|Core Study|Withdrawal by Subject|0
2707961|NCT00358826|9323108|P2|Core Study|Withdrawal by Subject|2
2707962|NCT00358826|9323109|P1|Core Study|Withdrawal by Subject|2
2707963|NCT00358826|9323102|P8|Core Study|Adverse Event|0
2707964|NCT00358826|9323103|P7|Core Study|Adverse Event|0
2707965|NCT00358826|9323104|P6|Core Study|Adverse Event|0
2707966|NCT00358826|9323105|P5|Core Study|Adverse Event|0
2707967|NCT00358826|9323106|P4|Core Study|Adverse Event|1
2707968|NCT00358826|9323107|P3|Core Study|Adverse Event|1
2707969|NCT00358826|9323108|P2|Core Study|Adverse Event|3
2707970|NCT00358826|9323109|P1|Core Study|Adverse Event|1
2707971|NCT00358670|9323176|P2|Overall Study|Administrative|125
2707972|NCT00358670|9323177|P1|Overall Study|Administrative|153
2707973|NCT00358670|9323176|P2|Overall Study|Did Not Meet Protocol Eligibility|3
2707974|NCT00358670|9323177|P1|Overall Study|Did Not Meet Protocol Eligibility|0
2707975|NCT00358670|9323176|P2|Overall Study|Protocol Defined Clinical Event|1
2707976|NCT00358670|9323177|P1|Overall Study|Protocol Defined Clinical Event|0
2707977|NCT00358670|9323176|P2|Overall Study|Withdrawal by Subject|24
2707978|NCT00358670|9323177|P1|Overall Study|Withdrawal by Subject|13
2707979|NCT00358670|9323176|P2|Overall Study|Lost to Follow-up|5
2707980|NCT00358670|9323177|P1|Overall Study|Lost to Follow-up|4
2707981|NCT00358670|9323176|P2|Overall Study|Protocol Violation|9
2707982|NCT00358670|9323177|P1|Overall Study|Protocol Violation|6
2707983|NCT00358670|9323176|P2|Overall Study|Lack of Efficacy|23
2707984|NCT00358670|9323177|P1|Overall Study|Lack of Efficacy|20
2707985|NCT00358670|9323176|P2|Overall Study|Adverse Event|29
2707986|NCT00358670|9323177|P1|Overall Study|Adverse Event|26
2707987|NCT00358644|9323191|P1|Overall Study|Patient not eligible for study|1
2707988|NCT00358644|9323191|P1|Overall Study|Physician Decision|6
2707989|NCT00358644|9323191|P1|Overall Study|Withdrawal by Subject|4
2707990|NCT00358644|9323191|P1|Overall Study|Death|11
2707991|NCT00358644|9323191|P1|Overall Study|Adverse Event|7
2707992|NCT00358644|9323191|P1|Overall Study|Progressive Disease|21
2707993|NCT00358527|9323214|P2|Overall Study|Administrative|1
2707994|NCT00358527|9323215|P1|Overall Study|Administrative|2
2707995|NCT00358527|9323214|P2|Overall Study|Non-compliance with protocol|1
2707996|NCT00358527|9323215|P1|Overall Study|Non-compliance with protocol|6
2707997|NCT00358527|9323214|P2|Overall Study|Withdrawal by Subject|1
2707998|NCT00358527|9323215|P1|Overall Study|Withdrawal by Subject|1
2707999|NCT00358527|9323214|P2|Overall Study|Adverse Event|0
2708000|NCT00358527|9323215|P1|Overall Study|Adverse Event|4
2708001|NCT00358449|9323265|P3|Overall Study|Steriod Inhaler was Increased|1
2708002|NCT00358449|9323266|P2|Overall Study|Steriod Inhaler was Increased|0
2708003|NCT00358449|9323267|P1|Overall Study|Steriod Inhaler was Increased|0
2708004|NCT00358449|9323265|P3|Overall Study|Lack of Efficacy|0
2708005|NCT00358449|9323266|P2|Overall Study|Lack of Efficacy|1
2708006|NCT00358449|9323267|P1|Overall Study|Lack of Efficacy|0
2708007|NCT00358449|9323265|P3|Overall Study|Withdrawal by Subject|0
2708008|NCT00358449|9323266|P2|Overall Study|Withdrawal by Subject|0
2708009|NCT00358449|9323267|P1|Overall Study|Withdrawal by Subject|2
2708010|NCT00358449|9323265|P3|Overall Study|Lost to Follow-up|0
2708011|NCT00358449|9323266|P2|Overall Study|Lost to Follow-up|0
2708012|NCT00358449|9323267|P1|Overall Study|Lost to Follow-up|1
2708013|NCT00358449|9323265|P3|Overall Study|Adverse Event|1
2708014|NCT00358449|9323266|P2|Overall Study|Adverse Event|0
2708015|NCT00358449|9323267|P1|Overall Study|Adverse Event|1
2708016|NCT00358436|9323370|P2|Overall Study|Other|1
2708017|NCT00358436|9323371|P1|Overall Study|Other|6
2708018|NCT00358436|9323370|P2|Overall Study|COPD exacerbation|10
2708019|NCT00358436|9323371|P1|Overall Study|COPD exacerbation|22
2708020|NCT00358436|9323370|P2|Overall Study|Non-fulfilment of inclusion/exclusion|0
2708021|NCT00358436|9323371|P1|Overall Study|Non-fulfilment of inclusion/exclusion|4
2708022|NCT00358436|9323370|P2|Overall Study|Withdrawal by Subject|17
2708023|NCT00358436|9323371|P1|Overall Study|Withdrawal by Subject|40
2708024|NCT00358436|9323370|P2|Overall Study|Protocol Violation|3
2708025|NCT00358436|9323371|P1|Overall Study|Protocol Violation|8
2708026|NCT00358436|9323370|P2|Overall Study|Lost to Follow-up|6
2708027|NCT00358436|9323371|P1|Overall Study|Lost to Follow-up|11
2708028|NCT00358436|9323370|P2|Overall Study|Lack of Efficacy|36
2708029|NCT00358436|9323371|P1|Overall Study|Lack of Efficacy|34
2708030|NCT00358436|9323370|P2|Overall Study|Adverse Event|13
2708031|NCT00358436|9323371|P1|Overall Study|Adverse Event|29
2708032|NCT00358215|9323442|P2|Overall Study|Did not receive investigational product|3
2708033|NCT00358215|9323443|P1|Overall Study|Did not receive investigational product|2
2708034|NCT00358215|9323442|P2|Overall Study|Other|14
2708035|NCT00358215|9323443|P1|Overall Study|Other|21
2708036|NCT00358215|9323442|P2|Overall Study|Pregnancy|0
2708037|NCT00358215|9323443|P1|Overall Study|Pregnancy|1
2708038|NCT00358215|9323442|P2|Overall Study|Protocol Violation|59
2708039|NCT00358215|9323443|P1|Overall Study|Protocol Violation|64
2708040|NCT00358215|9323442|P2|Overall Study|Death|281
2708041|NCT00358215|9323443|P1|Overall Study|Death|265
2708042|NCT00358215|9323442|P2|Overall Study|Lost to Follow-up|22
2708043|NCT00358215|9323443|P1|Overall Study|Lost to Follow-up|16
2708044|NCT00358215|9323442|P2|Overall Study|Physician Decision|39
2708045|NCT00358215|9323443|P1|Overall Study|Physician Decision|47
2708046|NCT00358215|9323442|P2|Overall Study|Participant request|64
2708047|NCT00358215|9323443|P1|Overall Study|Participant request|65
2708048|NCT00358215|9323442|P2|Overall Study|Withdrawal by Subject|102
2708049|NCT00358215|9323443|P1|Overall Study|Withdrawal by Subject|111
2708050|NCT00358215|9323442|P2|Overall Study|Adverse Event|65
2708051|NCT00358215|9323443|P1|Overall Study|Adverse Event|83
2708052|NCT00358215|9323442|P2|Overall Study|Ineligibility determined|3
2708053|NCT00358215|9323443|P1|Overall Study|Ineligibility determined|4
2708054|NCT00358150|9323457|P1|Overall Study|Undefined|3
2708055|NCT00358150|9323457|P1|Overall Study|Withdrawal by Subject|1
2708056|NCT00358150|9323457|P1|Overall Study|Adverse Event|3
2708057|NCT00357994|9323486|P2|Overall Study|Protocol Violation|0
2708058|NCT00357994|9323487|P1|Overall Study|Protocol Violation|1
2708059|NCT00357994|9323486|P2|Overall Study|Lack of Efficacy|1
2708060|NCT00357994|9323487|P1|Overall Study|Lack of Efficacy|0
2708061|NCT00357994|9323486|P2|Overall Study|Adverse Event|2
2708062|NCT00357994|9323487|P1|Overall Study|Adverse Event|1
2708063|NCT00357968|9323541|P2|First Maintenance Dose Phase|Withdrawal by Subject|2
2708064|NCT00357968|9323542|P1|First Maintenance Dose Phase|Withdrawal by Subject|1
2708065|NCT00357968|9323541|P2|First Maintenance Dose Phase|Not a PCI patient|42
2708066|NCT00357968|9323542|P1|First Maintenance Dose Phase|Not a PCI patient|47
2708067|NCT00357903|9323595|P2|Overall Study|Other|10
2708068|NCT00357903|9323596|P1|Overall Study|Other|49
2708069|NCT00357903|9323595|P2|Overall Study|Response status|9
2708070|NCT00357903|9323596|P1|Overall Study|Response status|61
2708071|NCT00357903|9323595|P2|Overall Study|Protocol issues|3
2708072|NCT00357903|9323596|P1|Overall Study|Protocol issues|14
2708073|NCT00357903|9323595|P2|Overall Study|Completed month 12 only|1
2708074|NCT00357903|9323596|P1|Overall Study|Completed month 12 only|0
2708075|NCT00357903|9323595|P2|Overall Study|Withdrawal by Subject|7
2708076|NCT00357903|9323596|P1|Overall Study|Withdrawal by Subject|57
2708077|NCT00357903|9323595|P2|Overall Study|Physician Decision|5
2708078|NCT00357903|9323596|P1|Overall Study|Physician Decision|39
2708079|NCT00357903|9323595|P2|Overall Study|Lost to Follow-up|4
2708080|NCT00357903|9323596|P1|Overall Study|Lost to Follow-up|23
2708081|NCT00357903|9323595|P2|Overall Study|Death|0
2708082|NCT00357903|9323596|P1|Overall Study|Death|33
2708083|NCT00357903|9323595|P2|Overall Study|Adverse Event|4
2708084|NCT00357903|9323596|P1|Overall Study|Adverse Event|87
2708085|NCT00357877|9323636|P2|Overall Study|Other|2
2708086|NCT00357877|9323637|P1|Overall Study|Other|0
2708087|NCT00357877|9323636|P2|Overall Study|Administrative withdrawal|1
2708088|NCT00357877|9323637|P1|Overall Study|Administrative withdrawal|1
2708089|NCT00357877|9323636|P2|Overall Study|Withdrawal by Subject|3
2708090|NCT00357877|9323637|P1|Overall Study|Withdrawal by Subject|3
2708091|NCT00357877|9323636|P2|Overall Study|Lost to Follow-up|23
2708092|NCT00357877|9323637|P1|Overall Study|Lost to Follow-up|20
2708093|NCT00357877|9323636|P2|Overall Study|Death|1
2708094|NCT00357877|9323637|P1|Overall Study|Death|2
2708095|NCT00357760|9323651|P2|Overall Study|To receive hospice care|1
2708096|NCT00357760|9323652|P1|Overall Study|To receive hospice care|0
2708097|NCT00357760|9323651|P2|Overall Study|Protocol Violation|1
2708098|NCT00357760|9323652|P1|Overall Study|Protocol Violation|0
2708099|NCT00357760|9323651|P2|Overall Study|Physician Decision|1
2708100|NCT00357760|9323652|P1|Overall Study|Physician Decision|2
2708101|NCT00357760|9323651|P2|Overall Study|Ineligible|2
2708102|NCT00357760|9323652|P1|Overall Study|Ineligible|0
2708103|NCT00357760|9323651|P2|Overall Study|Never started treatment|1
2708104|NCT00357760|9323652|P1|Overall Study|Never started treatment|2
2708105|NCT00357760|9323651|P2|Overall Study|Withdrawal by Subject|2
2708106|NCT00357760|9323652|P1|Overall Study|Withdrawal by Subject|0
2708107|NCT00357760|9323651|P2|Overall Study|Alternative therapy|0
2708108|NCT00357760|9323652|P1|Overall Study|Alternative therapy|1
2708109|NCT00357760|9323651|P2|Overall Study|Death|3
2708110|NCT00357760|9323652|P1|Overall Study|Death|0
2708111|NCT00357760|9323651|P2|Overall Study|Adverse Event|7
2708112|NCT00357760|9323652|P1|Overall Study|Adverse Event|10
2708113|NCT00357760|9323651|P2|Overall Study|Disease progression|17
2708114|NCT00357760|9323652|P1|Overall Study|Disease progression|44
2708115|NCT00357656|9323673|P2|Overall Study|Other, No surgery performed|3
2708116|NCT00357656|9323674|P1|Overall Study|Other, No surgery performed|0
2708117|NCT00357552|9323725|P1|Weeks 24 to 104|Not able to get to clinic|2
2708118|NCT00357552|9323725|P1|Weeks 24 to 104|Death|3
2708119|NCT00357552|9323725|P1|Weeks 0 to 24|Death|1
2708120|NCT00357552|9323725|P1|Screening|Did not meet eligibility criteria|84
2708121|NCT00357500|9323740|P1|Overall Study|Not Started Protocol Therapy|4
2708122|NCT00357500|9323740|P1|Overall Study|Progressive Disease|65
2708123|NCT00357500|9323740|P1|Overall Study|Withdrawal by Subject|5
2708124|NCT00357500|9323740|P1|Overall Study|Adverse Event|3
2708125|NCT00357396|9323749|P2|Overall Study|Adverse Event|0
2708126|NCT00357396|9323750|P1|Overall Study|Adverse Event|1
2708127|NCT00357370|9323758|P3|Cohort 2|Withdrawal by Subject|0
2708128|NCT00357370|9323759|P2|Cohort 2|Withdrawal by Subject|2
2708129|NCT00357370|9323760|P1|Cohort 2|Withdrawal by Subject|0
2708130|NCT00357370|9323758|P3|Cohort 2|non-compliance, not met criteria, etc|0
2708131|NCT00357370|9323759|P2|Cohort 2|non-compliance, not met criteria, etc|1
2708132|NCT00357370|9323760|P1|Cohort 2|non-compliance, not met criteria, etc|1
2708133|NCT00357370|9323758|P3|Cohort 2|Lost to Follow-up|0
2708134|NCT00357370|9323759|P2|Cohort 2|Lost to Follow-up|1
2708135|NCT00357370|9323760|P1|Cohort 2|Lost to Follow-up|0
2708136|NCT00357370|9323758|P3|Cohort 2|Adverse Event|1
2708137|NCT00357370|9323759|P2|Cohort 2|Adverse Event|1
2708138|NCT00357370|9323760|P1|Cohort 2|Adverse Event|1
2708139|NCT00357370|9323758|P3|Cohort 2|Lack of Efficacy|1
2708140|NCT00357370|9323759|P2|Cohort 2|Lack of Efficacy|2
2708141|NCT00357370|9323760|P1|Cohort 2|Lack of Efficacy|0
2708142|NCT00357110|9323823|P2|Overall Study|Early study termination|5
2708143|NCT00357110|9323824|P1|Overall Study|Early study termination|5
2708144|NCT00357097|9323832|P2|Overall Study|Increase of RLS Symptoms|1
2708145|NCT00357097|9323833|P1|Overall Study|Increase of RLS Symptoms|0
2708146|NCT00357097|9323832|P2|Overall Study|Other|1
2708147|NCT00357097|9323833|P1|Overall Study|Other|1
2708148|NCT00357097|9323832|P2|Overall Study|Met Exclusion Criteria|1
2708149|NCT00357097|9323833|P1|Overall Study|Met Exclusion Criteria|3
2708150|NCT00357097|9323832|P2|Overall Study|Lack of Efficacy|8
2708151|NCT00357097|9323833|P1|Overall Study|Lack of Efficacy|2
2708152|NCT00357097|9323832|P2|Overall Study|Non-compliance|2
2708153|NCT00357097|9323833|P1|Overall Study|Non-compliance|1
2708154|NCT00357097|9323832|P2|Overall Study|Withdrawal by Subject|7
2708155|NCT00357097|9323833|P1|Overall Study|Withdrawal by Subject|8
2708156|NCT00357097|9323832|P2|Overall Study|Adverse Event|6
2708157|NCT00357097|9323833|P1|Overall Study|Adverse Event|34
2708158|NCT00357097|9323832|P2|Overall Study|Did not meet inclusion criteria|3
2708159|NCT00357097|9323833|P1|Overall Study|Did not meet inclusion criteria|5
2708160|NCT00357006|9323887|P3|Overall Study|Withdrawal by Subject|2
2708161|NCT00357006|9323888|P2|Overall Study|Withdrawal by Subject|3
2708162|NCT00357006|9323889|P1|Overall Study|Withdrawal by Subject|1
2708163|NCT00357006|9323887|P3|Overall Study|Lost to Follow-up|1
2708164|NCT00357006|9323888|P2|Overall Study|Lost to Follow-up|2
2708165|NCT00357006|9323889|P1|Overall Study|Lost to Follow-up|1
2708166|NCT00356915|9323904|P3|Overall Study|Miscellaneous reasons|3
2708167|NCT00356915|9323905|P2|Overall Study|Miscellaneous reasons|8
2708168|NCT00356915|9323906|P1|Overall Study|Miscellaneous reasons|11
2708169|NCT00356915|9323904|P3|Overall Study|Adverse Event|8
2708170|NCT00356915|9323905|P2|Overall Study|Adverse Event|31
2708171|NCT00356915|9323906|P1|Overall Study|Adverse Event|21
2708172|NCT00356915|9323904|P3|Overall Study|Physician Decision|0
2708173|NCT00356915|9323905|P2|Overall Study|Physician Decision|2
2708174|NCT00356915|9323906|P1|Overall Study|Physician Decision|0
2708175|NCT00356915|9323904|P3|Overall Study|Administrative Decision|1
2708176|NCT00356915|9323905|P2|Overall Study|Administrative Decision|0
2708177|NCT00356915|9323906|P1|Overall Study|Administrative Decision|0
2708178|NCT00356915|9323904|P3|Overall Study|Lost to Follow-up|14
2708179|NCT00356915|9323905|P2|Overall Study|Lost to Follow-up|34
2708180|NCT00356915|9323906|P1|Overall Study|Lost to Follow-up|27
2708181|NCT00356915|9323904|P3|Overall Study|Lack of Efficacy|3
2708182|NCT00356915|9323905|P2|Overall Study|Lack of Efficacy|0
2708183|NCT00356915|9323906|P1|Overall Study|Lack of Efficacy|0
2708184|NCT00356915|9323904|P3|Overall Study|Withdrawal by Subject|10
2708185|NCT00356915|9323905|P2|Overall Study|Withdrawal by Subject|14
2708186|NCT00356915|9323906|P1|Overall Study|Withdrawal by Subject|14
2708187|NCT00356915|9323904|P3|Overall Study|Protocol Violation|2
2708188|NCT00356915|9323905|P2|Overall Study|Protocol Violation|3
2708189|NCT00356915|9323906|P1|Overall Study|Protocol Violation|2
2708190|NCT00356915|9323904|P3|Overall Study|Non compliance|1
2708191|NCT00356915|9323905|P2|Overall Study|Non compliance|2
2708192|NCT00356915|9323906|P1|Overall Study|Non compliance|1
2708193|NCT00356889|9323923|P1|Overall Study|Adverse Event|1
2708194|NCT00356889|9323923|P1|Overall Study|Protocol Violation|2
2708195|NCT00356863|9323932|P2|Overall Study|Lost to Follow-up|43
2708196|NCT00356863|9323933|P1|Overall Study|Lost to Follow-up|76
2708197|NCT00356863|9323932|P2|Overall Study|Death|32
2708198|NCT00356863|9323933|P1|Overall Study|Death|16
2708199|NCT00356811|9323959|P1|Overall Study|Site Closed during Follow-up|2
2708200|NCT00356811|9323959|P1|Overall Study|Study Is Terminating|3
2708201|NCT00356811|9323959|P1|Overall Study|Participant Could Not Make a Checkup|1
2708202|NCT00356811|9323959|P1|Overall Study|Withdrawal by Subject|6
2708203|NCT00356811|9323959|P1|Overall Study|Lost to Follow-up|2
2708204|NCT00356811|9323959|P1|Overall Study|Death|35
2708205|NCT00356759|9323974|P2|Overall Study|Intercurrent disease or persistent extre|2
2708206|NCT00356759|9323975|P1|Overall Study|Intercurrent disease or persistent extre|5
2708207|NCT00356759|9323974|P2|Overall Study|Lost to Follow-up|1
2708208|NCT00356759|9323975|P1|Overall Study|Lost to Follow-up|1
2708209|NCT00356759|9323974|P2|Overall Study|Adverse Event|3
2708210|NCT00356759|9323975|P1|Overall Study|Adverse Event|1
2708211|NCT00356759|9323974|P2|Overall Study|Withdrawal by Subject|2
2708212|NCT00356759|9323975|P1|Overall Study|Withdrawal by Subject|2
2708213|NCT00356759|9323974|P2|Overall Study|Death|2
2708214|NCT00356759|9323975|P1|Overall Study|Death|5
2708215|NCT00356603|9323993|P2|Overall Study|Other|3
2708216|NCT00356603|9323994|P1|Overall Study|Other|6
2708217|NCT00356590|9324008|P1|Overall Study|Other|52
2708218|NCT00356590|9324008|P1|Overall Study|Response status|28
2708219|NCT00356590|9324008|P1|Overall Study|Protocol issues|6
2708220|NCT00356590|9324008|P1|Overall Study|Completed month 12 only|2
2708221|NCT00356590|9324008|P1|Overall Study|Withdrawal by Subject|41
2708222|NCT00356590|9324008|P1|Overall Study|Physician Decision|46
2708223|NCT00356590|9324008|P1|Overall Study|Lost to Follow-up|35
2708224|NCT00356590|9324008|P1|Overall Study|Death|10
2708225|NCT00356590|9324008|P1|Overall Study|Adverse Event|54
2708226|NCT00356525|9324044|P4|Overall Study|Sponsor Decision|1
2708227|NCT00356525|9324045|P3|Overall Study|Sponsor Decision|0
2708228|NCT00356525|9324046|P2|Overall Study|Sponsor Decision|0
2708229|NCT00356525|9324047|P1|Overall Study|Sponsor Decision|0
2708230|NCT00356525|9324044|P4|Overall Study|Death|1
2708231|NCT00356525|9324045|P3|Overall Study|Death|0
2708232|NCT00356525|9324046|P2|Overall Study|Death|0
2708233|NCT00356525|9324047|P1|Overall Study|Death|0
2708234|NCT00356525|9324044|P4|Overall Study|Withdrawal by Subject|3
2708235|NCT00356525|9324045|P3|Overall Study|Withdrawal by Subject|0
2708236|NCT00356525|9324046|P2|Overall Study|Withdrawal by Subject|1
2708237|NCT00356525|9324047|P1|Overall Study|Withdrawal by Subject|1
2708238|NCT00356525|9324044|P4|Overall Study|Protocol Entry Criteria Not Met|0
2708239|NCT00356525|9324045|P3|Overall Study|Protocol Entry Criteria Not Met|0
2708240|NCT00356525|9324046|P2|Overall Study|Protocol Entry Criteria Not Met|0
2708241|NCT00356525|9324047|P1|Overall Study|Protocol Entry Criteria Not Met|1
2708242|NCT00356525|9324044|P4|Overall Study|Physician Decision|1
2708243|NCT00356525|9324045|P3|Overall Study|Physician Decision|2
2708244|NCT00356525|9324046|P2|Overall Study|Physician Decision|2
2708245|NCT00356525|9324047|P1|Overall Study|Physician Decision|2
2708246|NCT00356525|9324044|P4|Overall Study|Lost to Follow-up|0
2708247|NCT00356525|9324045|P3|Overall Study|Lost to Follow-up|0
2708248|NCT00356525|9324046|P2|Overall Study|Lost to Follow-up|0
2708249|NCT00356525|9324047|P1|Overall Study|Lost to Follow-up|1
2708250|NCT00356525|9324044|P4|Overall Study|Adverse Event|1
2708251|NCT00356525|9324045|P3|Overall Study|Adverse Event|1
2708252|NCT00356525|9324046|P2|Overall Study|Adverse Event|3
2708253|NCT00356525|9324047|P1|Overall Study|Adverse Event|1
2708254|NCT00356525|9324044|P4|Overall Study|Progressive Disease|2
2708255|NCT00356525|9324045|P3|Overall Study|Progressive Disease|4
2708256|NCT00356525|9324046|P2|Overall Study|Progressive Disease|5
2708257|NCT00356525|9324047|P1|Overall Study|Progressive Disease|8
2708258|NCT00356421|9324088|P2|Overall Study|Not related to study drug|3
2708259|NCT00356421|9324089|P1|Overall Study|Not related to study drug|5
2708260|NCT00356421|9324088|P2|Overall Study|Related to study drug|12
2708261|NCT00356421|9324089|P1|Overall Study|Related to study drug|15
2708262|NCT00356421|9324088|P2|Overall Study|Withdrawal by Subject|2
2708263|NCT00356421|9324089|P1|Overall Study|Withdrawal by Subject|9
2708264|NCT00356421|9324088|P2|Overall Study|Lack of Efficacy|0
2708265|NCT00356421|9324089|P1|Overall Study|Lack of Efficacy|3
2708266|NCT00356408|9324129|P1|Overall Study|Other: Subject chose commerical dosing|1
2708267|NCT00356408|9324129|P1|Overall Study|Other: Failed to meet Inc/Exc criteria|1
2708268|NCT00356408|9324129|P1|Overall Study|Other: Azathioprine stopped|1
2708269|NCT00356408|9324129|P1|Overall Study|Other: Sponsor request|1
2708270|NCT00356408|9324129|P1|Overall Study|Other: Principal investigator discretion|3
2708271|NCT00356408|9324129|P1|Overall Study|Withdrawal by Subject|6
2708272|NCT00356408|9324129|P1|Overall Study|Lost to Follow-up|2
2708273|NCT00356408|9324129|P1|Overall Study|Lack of Efficacy|36
2708274|NCT00356408|9324129|P1|Overall Study|Adverse Event|9
2708275|NCT00356369|9324146|P2|Active Phase|Withdrawal by Subject|1
2708276|NCT00356369|9324147|P1|Active Phase|Withdrawal by Subject|2
2708277|NCT00356278|9324229|P3|Overall Study|Withdrawal by Subject|19
2708278|NCT00356278|9324230|P2|Overall Study|Withdrawal by Subject|15
2708279|NCT00356278|9324231|P1|Overall Study|Withdrawal by Subject|25
2708280|NCT00356265|9324269|P3|Overall Study|Withdrawal by Subject|1
2708281|NCT00356265|9324270|P2|Overall Study|Withdrawal by Subject|0
2708282|NCT00356265|9324271|P1|Overall Study|Withdrawal by Subject|0
2708283|NCT00356200|9324283|P2|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2
2708284|NCT00356200|9324284|P1|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0
2708285|NCT00356200|9324283|P2|Cohort 1: 10 ug/ml|Lack of Efficacy|0
2708286|NCT00356200|9324284|P1|Cohort 1: 10 ug/ml|Lack of Efficacy|1
2708287|NCT00356148|9324313|P2|Overall Study|Reoperation within 30 days|1
2708288|NCT00356148|9324314|P1|Overall Study|Reoperation within 30 days|2
2708289|NCT00356135|9324325|P3|Overall Study|Subject non-compliance|3
2708290|NCT00356135|9324326|P2|Overall Study|Subject non-compliance|1
2708291|NCT00356135|9324327|P1|Overall Study|Subject non-compliance|1
2708292|NCT00356135|9324325|P3|Overall Study|Physician Decision|1
2708293|NCT00356135|9324326|P2|Overall Study|Physician Decision|1
2708294|NCT00356135|9324327|P1|Overall Study|Physician Decision|1
2708295|NCT00356135|9324325|P3|Overall Study|Lost to Follow-up|1
2708296|NCT00356135|9324326|P2|Overall Study|Lost to Follow-up|0
2708297|NCT00356135|9324327|P1|Overall Study|Lost to Follow-up|0
2708298|NCT00356135|9324325|P3|Overall Study|Adverse Event|0
2708299|NCT00356135|9324326|P2|Overall Study|Adverse Event|0
2708300|NCT00356135|9324327|P1|Overall Study|Adverse Event|1
2708301|NCT00356135|9324325|P3|Overall Study|Protocol Violation|0
2708302|NCT00356135|9324326|P2|Overall Study|Protocol Violation|0
2708303|NCT00356135|9324327|P1|Overall Study|Protocol Violation|1
2708304|NCT00356122|9324349|P1|FOLLOW-UP|Other|2
2708305|NCT00356122|9324349|P1|FOLLOW-UP|Lost to Follow-up|2
2708306|NCT00356122|9324349|P1|FOLLOW-UP|Death|37
2708307|NCT00356122|9324349|P1|TREATMENT|Did not receive study medication|1
2708308|NCT00356122|9324349|P1|TREATMENT|Other|4
2708309|NCT00356122|9324349|P1|TREATMENT|Subject's request|4
2708310|NCT00356122|9324349|P1|TREATMENT|Adverse Event|10
2708311|NCT00356122|9324349|P1|TREATMENT|Lack of Efficacy|26
2708312|NCT00355784|9324457|P3|Overall Study|Withdrawal by Subject|2
2708313|NCT00355784|9324458|P2|Overall Study|Withdrawal by Subject|0
2708314|NCT00355784|9324459|P1|Overall Study|Withdrawal by Subject|0
2708315|NCT00355615|9324508|P5|40-week Rosuvastatin Open Label Period|investigational site closed|1
2708316|NCT00355615|9324509|P4|40-week Rosuvastatin Open Label Period|investigational site closed|0
2708317|NCT00355615|9324510|P3|40-week Rosuvastatin Open Label Period|investigational site closed|0
2708318|NCT00355615|9324511|P2|40-week Rosuvastatin Open Label Period|investigational site closed|0
2708319|NCT00355615|9324512|P1|40-week Rosuvastatin Open Label Period|investigational site closed|0
2708320|NCT00355615|9324508|P5|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3
2708321|NCT00355615|9324509|P4|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
2708322|NCT00355615|9324510|P3|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
2708323|NCT00355615|9324511|P2|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
2708324|NCT00355615|9324512|P1|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
2708325|NCT00355615|9324508|P5|40-week Rosuvastatin Open Label Period|Protocol Violation|1
2708326|NCT00355615|9324509|P4|40-week Rosuvastatin Open Label Period|Protocol Violation|0
2708327|NCT00355615|9324510|P3|40-week Rosuvastatin Open Label Period|Protocol Violation|0
2708328|NCT00355615|9324511|P2|40-week Rosuvastatin Open Label Period|Protocol Violation|0
2708329|NCT00355615|9324512|P1|40-week Rosuvastatin Open Label Period|Protocol Violation|0
2708330|NCT00355615|9324508|P5|40-week Rosuvastatin Open Label Period|Adverse Event|4
2708331|NCT00355615|9324509|P4|40-week Rosuvastatin Open Label Period|Adverse Event|0
2708332|NCT00355615|9324510|P3|40-week Rosuvastatin Open Label Period|Adverse Event|0
2708333|NCT00355615|9324511|P2|40-week Rosuvastatin Open Label Period|Adverse Event|0
2708334|NCT00355615|9324512|P1|40-week Rosuvastatin Open Label Period|Adverse Event|0
2708335|NCT00355615|9324508|P5|Randomized Double Blind Period|Protocol Violation|0
2708336|NCT00355615|9324509|P4|Randomized Double Blind Period|Protocol Violation|1
2708337|NCT00355615|9324510|P3|Randomized Double Blind Period|Protocol Violation|1
2708338|NCT00355615|9324511|P2|Randomized Double Blind Period|Protocol Violation|0
2708339|NCT00355615|9324512|P1|Randomized Double Blind Period|Protocol Violation|0
2708340|NCT00355615|9324508|P5|Randomized Double Blind Period|Adverse Event|0
2708341|NCT00355615|9324509|P4|Randomized Double Blind Period|Adverse Event|0
2708342|NCT00355615|9324510|P3|Randomized Double Blind Period|Adverse Event|0
2708343|NCT00355615|9324511|P2|Randomized Double Blind Period|Adverse Event|0
2708344|NCT00355615|9324512|P1|Randomized Double Blind Period|Adverse Event|1
2708345|NCT00355472|9324571|P1|Overall Study|Physician Decision|1
2708346|NCT00355368|9324617|P2|Overall Study|cardiac arrest prior to intubation|2
2708347|NCT00355368|9324618|P1|Overall Study|cardiac arrest prior to intubation|2
2708348|NCT00355368|9324617|P2|Overall Study|Protocol Violation|7
2708349|NCT00355368|9324618|P1|Overall Study|Protocol Violation|8
2708350|NCT00355342|9324632|P2|Overall Study|Use of protocol excluded medication|1
2708351|NCT00355342|9324633|P1|Overall Study|Use of protocol excluded medication|0
2708352|NCT00355342|9324632|P2|Overall Study|Protocol Violation|1
2708353|NCT00355342|9324633|P1|Overall Study|Protocol Violation|0
2708354|NCT00355342|9324632|P2|Overall Study|Study management|1
2708355|NCT00355342|9324633|P1|Overall Study|Study management|0
2708356|NCT00355342|9324632|P2|Overall Study|Participant discontinued study drug|1
2708357|NCT00355342|9324633|P1|Overall Study|Participant discontinued study drug|0
2708358|NCT00355342|9324632|P2|Overall Study|Participant relocated|1
2708359|NCT00355342|9324633|P1|Overall Study|Participant relocated|0
2708360|NCT00355342|9324632|P2|Overall Study|Withdrawal by participant and physician|0
2708361|NCT00355342|9324633|P1|Overall Study|Withdrawal by participant and physician|1
2708362|NCT00355342|9324632|P2|Overall Study|Non-compliance with Dexa scans|0
2708363|NCT00355342|9324633|P1|Overall Study|Non-compliance with Dexa scans|1
2708364|NCT00355342|9324632|P2|Overall Study|Dispensed wrong study drug kit|0
2708365|NCT00355342|9324633|P1|Overall Study|Dispensed wrong study drug kit|1
2708366|NCT00355342|9324632|P2|Overall Study|COPD exacerbation|1
2708367|NCT00355342|9324633|P1|Overall Study|COPD exacerbation|1
2708368|NCT00355342|9324632|P2|Overall Study|Use of prohibited medication|0
2708369|NCT00355342|9324633|P1|Overall Study|Use of prohibited medication|1
2708370|NCT00355342|9324632|P2|Overall Study|Overcompliant-PI discretion|0
2708371|NCT00355342|9324633|P1|Overall Study|Overcompliant-PI discretion|1
2708372|NCT00355342|9324632|P2|Overall Study|Sponsor terminated study|2
2708373|NCT00355342|9324633|P1|Overall Study|Sponsor terminated study|2
2708374|NCT00355342|9324632|P2|Overall Study|Withdrawal by Subject|11
2708375|NCT00355342|9324633|P1|Overall Study|Withdrawal by Subject|14
2708376|NCT00355342|9324632|P2|Overall Study|Lost to Follow-up|2
2708377|NCT00355342|9324633|P1|Overall Study|Lost to Follow-up|4
2708378|NCT00355342|9324632|P2|Overall Study|Adverse Event|15
2708379|NCT00355342|9324633|P1|Overall Study|Adverse Event|13
2708380|NCT00355147|9324660|P2|Overall Study|Withdrawal by Subject|12
2708381|NCT00355147|9324661|P1|Overall Study|Withdrawal by Subject|8
2708382|NCT00355147|9324660|P2|Overall Study|Lost to Follow-up|8
2708383|NCT00355147|9324661|P1|Overall Study|Lost to Follow-up|10
2708384|NCT00355134|9324680|P5|Extension Phase|Protocol Violation|0
2708385|NCT00355134|9324681|P4|Extension Phase|Protocol Violation|1
2708386|NCT00355134|9324682|P3|Extension Phase|Protocol Violation|0
2708387|NCT00355134|9324683|P2|Extension Phase|Protocol Violation|0
2708388|NCT00355134|9324684|P1|Extension Phase|Protocol Violation|0
2708389|NCT00355134|9324680|P5|Extension Phase|Abnormal test procedure result(s)|1
2708390|NCT00355134|9324681|P4|Extension Phase|Abnormal test procedure result(s)|0
2708391|NCT00355134|9324682|P3|Extension Phase|Abnormal test procedure result(s)|0
2708392|NCT00355134|9324683|P2|Extension Phase|Abnormal test procedure result(s)|1
2708393|NCT00355134|9324684|P1|Extension Phase|Abnormal test procedure result(s)|0
2708394|NCT00355134|9324680|P5|Extension Phase|Unsatisfactory therapeutic effect|1
2708395|NCT00355134|9324681|P4|Extension Phase|Unsatisfactory therapeutic effect|0
2708396|NCT00355134|9324682|P3|Extension Phase|Unsatisfactory therapeutic effect|0
2708397|NCT00355134|9324683|P2|Extension Phase|Unsatisfactory therapeutic effect|4
2708398|NCT00355134|9324684|P1|Extension Phase|Unsatisfactory therapeutic effect|3
2708399|NCT00355134|9324680|P5|Extension Phase|Administrative problems|1
2708400|NCT00355134|9324681|P4|Extension Phase|Administrative problems|1
2708401|NCT00355134|9324682|P3|Extension Phase|Administrative problems|0
2708402|NCT00355134|9324683|P2|Extension Phase|Administrative problems|4
2708403|NCT00355134|9324684|P1|Extension Phase|Administrative problems|2
2708404|NCT00355134|9324680|P5|Extension Phase|Abnormal laboratory value(s)|2
2708405|NCT00355134|9324681|P4|Extension Phase|Abnormal laboratory value(s)|2
2708406|NCT00355134|9324682|P3|Extension Phase|Abnormal laboratory value(s)|0
2708407|NCT00355134|9324683|P2|Extension Phase|Abnormal laboratory value(s)|2
2708408|NCT00355134|9324684|P1|Extension Phase|Abnormal laboratory value(s)|4
2708409|NCT00355134|9324680|P5|Extension Phase|Lost to Follow-up|4
2708410|NCT00355134|9324681|P4|Extension Phase|Lost to Follow-up|2
2708411|NCT00355134|9324682|P3|Extension Phase|Lost to Follow-up|0
2708412|NCT00355134|9324683|P2|Extension Phase|Lost to Follow-up|6
2708413|NCT00355134|9324684|P1|Extension Phase|Lost to Follow-up|2
2708414|NCT00355134|9324680|P5|Extension Phase|Adverse Event|5
2708415|NCT00355134|9324681|P4|Extension Phase|Adverse Event|3
2708416|NCT00355134|9324682|P3|Extension Phase|Adverse Event|0
2708417|NCT00355134|9324683|P2|Extension Phase|Adverse Event|9
2708418|NCT00355134|9324684|P1|Extension Phase|Adverse Event|13
2708419|NCT00355134|9324680|P5|Extension Phase|Withdrawal by Subject|5
2708420|NCT00355134|9324681|P4|Extension Phase|Withdrawal by Subject|7
2708421|NCT00355134|9324682|P3|Extension Phase|Withdrawal by Subject|0
2708422|NCT00355134|9324683|P2|Extension Phase|Withdrawal by Subject|11
2708423|NCT00355134|9324684|P1|Extension Phase|Withdrawal by Subject|7
2708424|NCT00355134|9324680|P5|Core Phase|Condition no longer requires study drug|0
2708425|NCT00355134|9324681|P4|Core Phase|Condition no longer requires study drug|0
2708426|NCT00355134|9324682|P3|Core Phase|Condition no longer requires study drug|1
2708427|NCT00355134|9324683|P2|Core Phase|Condition no longer requires study drug|0
2708428|NCT00355134|9324684|P1|Core Phase|Condition no longer requires study drug|1
2708429|NCT00355134|9324680|P5|Core Phase|Abnormal test procedure result(s)|0
2708430|NCT00355134|9324681|P4|Core Phase|Abnormal test procedure result(s)|0
2708431|NCT00355134|9324682|P3|Core Phase|Abnormal test procedure result(s)|1
2708432|NCT00355134|9324683|P2|Core Phase|Abnormal test procedure result(s)|2
2708433|NCT00355134|9324684|P1|Core Phase|Abnormal test procedure result(s)|1
2708434|NCT00355134|9324680|P5|Core Phase|Protocol Violation|0
2708435|NCT00355134|9324681|P4|Core Phase|Protocol Violation|0
2708436|NCT00355134|9324682|P3|Core Phase|Protocol Violation|2
2708437|NCT00355134|9324683|P2|Core Phase|Protocol Violation|2
2708438|NCT00355134|9324684|P1|Core Phase|Protocol Violation|3
2708439|NCT00355134|9324680|P5|Core Phase|Administrative problems|0
2708440|NCT00355134|9324681|P4|Core Phase|Administrative problems|0
2708441|NCT00355134|9324682|P3|Core Phase|Administrative problems|5
2708442|NCT00355134|9324683|P2|Core Phase|Administrative problems|3
2708443|NCT00355134|9324684|P1|Core Phase|Administrative problems|5
2708444|NCT00355134|9324680|P5|Core Phase|Unsatisfactory therapeutic effect|0
2708445|NCT00355134|9324681|P4|Core Phase|Unsatisfactory therapeutic effect|0
2708446|NCT00355134|9324682|P3|Core Phase|Unsatisfactory therapeutic effect|17
2708447|NCT00355134|9324683|P2|Core Phase|Unsatisfactory therapeutic effect|6
2708448|NCT00355134|9324684|P1|Core Phase|Unsatisfactory therapeutic effect|10
2708449|NCT00355134|9324680|P5|Core Phase|Abnormal laboratory value(s)|0
2708450|NCT00355134|9324681|P4|Core Phase|Abnormal laboratory value(s)|0
2708451|NCT00355134|9324682|P3|Core Phase|Abnormal laboratory value(s)|2
2708452|NCT00355134|9324683|P2|Core Phase|Abnormal laboratory value(s)|14
2708453|NCT00355134|9324684|P1|Core Phase|Abnormal laboratory value(s)|19
2708454|NCT00355134|9324680|P5|Core Phase|Lost to Follow-up|0
2708455|NCT00355134|9324681|P4|Core Phase|Lost to Follow-up|0
2708456|NCT00355134|9324682|P3|Core Phase|Lost to Follow-up|21
2708457|NCT00355134|9324683|P2|Core Phase|Lost to Follow-up|13
2708458|NCT00355134|9324684|P1|Core Phase|Lost to Follow-up|17
2708459|NCT00355134|9324680|P5|Core Phase|Adverse Event|0
2708460|NCT00355134|9324681|P4|Core Phase|Adverse Event|0
2708461|NCT00355134|9324682|P3|Core Phase|Adverse Event|16
2708462|NCT00355134|9324683|P2|Core Phase|Adverse Event|22
2708463|NCT00355134|9324684|P1|Core Phase|Adverse Event|28
2708464|NCT00355134|9324680|P5|Core Phase|Withdrawal by Subject|0
2708465|NCT00355134|9324681|P4|Core Phase|Withdrawal by Subject|0
2708466|NCT00355134|9324682|P3|Core Phase|Withdrawal by Subject|35
2708467|NCT00355134|9324683|P2|Core Phase|Withdrawal by Subject|24
2708468|NCT00355134|9324684|P1|Core Phase|Withdrawal by Subject|35
2708469|NCT00355121|9324727|P3|Overall Study|Serious adverse events|0
2708470|NCT00355121|9324728|P2|Overall Study|Serious adverse events|2
2708471|NCT00355121|9324729|P1|Overall Study|Serious adverse events|0
2708472|NCT00355121|9324727|P3|Overall Study|Withdrawal by Subject|2
2708473|NCT00355121|9324728|P2|Overall Study|Withdrawal by Subject|10
2708474|NCT00355121|9324729|P1|Overall Study|Withdrawal by Subject|9
2708475|NCT00355121|9324727|P3|Overall Study|Lost to Follow-up|1
2708476|NCT00355121|9324728|P2|Overall Study|Lost to Follow-up|7
2708477|NCT00355121|9324729|P1|Overall Study|Lost to Follow-up|4
2708478|NCT00355121|9324727|P3|Overall Study|Protocol Violation|1
2708479|NCT00355121|9324728|P2|Overall Study|Protocol Violation|9
2708480|NCT00355121|9324729|P1|Overall Study|Protocol Violation|7
2708481|NCT00355121|9324727|P3|Overall Study|Adverse Event|0
2708482|NCT00355121|9324728|P2|Overall Study|Adverse Event|1
2708483|NCT00355121|9324729|P1|Overall Study|Adverse Event|0
2708484|NCT00355121|9324727|P3|Overall Study|Did not receive study vaccine|1
2708485|NCT00355121|9324728|P2|Overall Study|Did not receive study vaccine|0
2708486|NCT00355121|9324729|P1|Overall Study|Did not receive study vaccine|1
2708487|NCT00355082|9324760|P3|Continuation Phase|Ran Out of Drug Due to Travel|0
2708488|NCT00355082|9324761|P2|Continuation Phase|Ran Out of Drug Due to Travel|0
2708489|NCT00355082|9324762|P1|Continuation Phase|Ran Out of Drug Due to Travel|1
2708490|NCT00355082|9324760|P3|Continuation Phase|Scheduling Error|0
2708491|NCT00355082|9324761|P2|Continuation Phase|Scheduling Error|0
2708492|NCT00355082|9324762|P1|Continuation Phase|Scheduling Error|1
2708493|NCT00355082|9324760|P3|Continuation Phase|Site Closed by Sponsor|0
2708494|NCT00355082|9324761|P2|Continuation Phase|Site Closed by Sponsor|0
2708495|NCT00355082|9324762|P1|Continuation Phase|Site Closed by Sponsor|8
2708496|NCT00355082|9324760|P3|Continuation Phase|Lack of Efficacy|0
2708497|NCT00355082|9324761|P2|Continuation Phase|Lack of Efficacy|0
2708498|NCT00355082|9324762|P1|Continuation Phase|Lack of Efficacy|5
2708499|NCT00355082|9324760|P3|Continuation Phase|Withdrawal by Subject|0
2708500|NCT00355082|9324761|P2|Continuation Phase|Withdrawal by Subject|0
2708501|NCT00355082|9324762|P1|Continuation Phase|Withdrawal by Subject|4
2708502|NCT00355082|9324760|P3|Continuation Phase|Protocol Violation|1
2708503|NCT00355082|9324761|P2|Continuation Phase|Protocol Violation|0
2708504|NCT00355082|9324762|P1|Continuation Phase|Protocol Violation|1
2708505|NCT00355082|9324760|P3|Continuation Phase|Lost to Follow-up|1
2708506|NCT00355082|9324761|P2|Continuation Phase|Lost to Follow-up|0
2708507|NCT00355082|9324762|P1|Continuation Phase|Lost to Follow-up|2
2708508|NCT00355082|9324760|P3|Continuation Phase|Adverse Event|1
2708509|NCT00355082|9324761|P2|Continuation Phase|Adverse Event|0
2708510|NCT00355082|9324762|P1|Continuation Phase|Adverse Event|2
2708511|NCT00355082|9324760|P3|Double-Blind (DB) Treatment Phase|Pregnancy|0
2708512|NCT00355082|9324761|P2|Double-Blind (DB) Treatment Phase|Pregnancy|1
2708513|NCT00355082|9324762|P1|Double-Blind (DB) Treatment Phase|Pregnancy|0
2708514|NCT00355082|9324760|P3|Double-Blind (DB) Treatment Phase|Protocol Violation|0
2708515|NCT00355082|9324761|P2|Double-Blind (DB) Treatment Phase|Protocol Violation|4
2708516|NCT00355082|9324762|P1|Double-Blind (DB) Treatment Phase|Protocol Violation|0
2708517|NCT00355082|9324760|P3|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
2708518|NCT00355082|9324761|P2|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4
2708519|NCT00355082|9324762|P1|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
2708520|NCT00355082|9324760|P3|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0
2708521|NCT00355082|9324761|P2|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7
2708522|NCT00355082|9324762|P1|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6
2708523|NCT00355082|9324760|P3|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0
2708524|NCT00355082|9324761|P2|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8
2708525|NCT00355082|9324762|P1|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9
2708526|NCT00355082|9324760|P3|Double-Blind (DB) Treatment Phase|Adverse Event|0
2708527|NCT00355082|9324761|P2|Double-Blind (DB) Treatment Phase|Adverse Event|10
2708528|NCT00355082|9324762|P1|Double-Blind (DB) Treatment Phase|Adverse Event|4
2708529|NCT00355030|9324784|P2|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
2708530|NCT00355030|9324785|P1|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
2708531|NCT00355030|9324784|P2|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1
2708532|NCT00355030|9324785|P1|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0
2708533|NCT00355030|9324784|P2|Study Period 1 Treatment|Other|6
2708534|NCT00355030|9324785|P1|Study Period 1 Treatment|Other|2
2708623|NCT00353873|9325032|P2|Overall Study|Protocol Violation|2
2708535|NCT00355030|9324784|P2|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1
2708536|NCT00355030|9324785|P1|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0
2708537|NCT00355030|9324784|P2|Study Period 1 Treatment|Sponsor Decision|32
2708538|NCT00355030|9324785|P1|Study Period 1 Treatment|Sponsor Decision|34
2708539|NCT00355030|9324784|P2|Study Period 1 Treatment|Physician Decision|1
2708540|NCT00355030|9324785|P1|Study Period 1 Treatment|Physician Decision|0
2708541|NCT00355030|9324784|P2|Study Period 1 Treatment|Parent/Caregiver Decision|2
2708542|NCT00355030|9324785|P1|Study Period 1 Treatment|Parent/Caregiver Decision|1
2708543|NCT00355030|9324784|P2|Study Period 1 Treatment|Withdrawal by Subject|1
2708544|NCT00355030|9324785|P1|Study Period 1 Treatment|Withdrawal by Subject|4
2708545|NCT00355030|9324784|P2|Study Period 1 Treatment|Lost to Follow-up|0
2708546|NCT00355030|9324785|P1|Study Period 1 Treatment|Lost to Follow-up|3
2708547|NCT00355030|9324784|P2|Study Period 1 Treatment|Adverse Event|1
2708548|NCT00355030|9324785|P1|Study Period 1 Treatment|Adverse Event|1
2708549|NCT00354835|9324824|P2|Overall Study|Refusal of further therapy|8
2708550|NCT00354835|9324825|P1|Overall Study|Refusal of further therapy|3
2708551|NCT00354835|9324824|P2|Overall Study|Adverse Event|0
2708552|NCT00354835|9324825|P1|Overall Study|Adverse Event|6
2708553|NCT00354835|9324824|P2|Overall Study|Disease progression or relapse|22
2708554|NCT00354835|9324825|P1|Overall Study|Disease progression or relapse|15
2708555|NCT00354835|9324824|P2|Overall Study|Ineligible|16
2708556|NCT00354835|9324825|P1|Overall Study|Ineligible|17
2708557|NCT00354835|9324824|P2|Overall Study|Withdrawal by Subject|1
2708558|NCT00354835|9324825|P1|Overall Study|Withdrawal by Subject|2
2708559|NCT00354835|9324824|P2|Overall Study|Physician Decision|13
2708560|NCT00354835|9324825|P1|Overall Study|Physician Decision|8
2708561|NCT00354835|9324824|P2|Overall Study|Death|1
2708562|NCT00354835|9324825|P1|Overall Study|Death|1
2708563|NCT00354744|9324864|P1|Overall Study|Withdrawal by Subject|14
2708564|NCT00354744|9324864|P1|Overall Study|Physician Decision|11
2708565|NCT00354744|9324864|P1|Overall Study|Lost to Follow-up|2
2708566|NCT00354744|9324864|P1|Overall Study|Lack of Efficacy|11
2708567|NCT00354744|9324864|P1|Overall Study|Death|2
2708568|NCT00354744|9324864|P1|Overall Study|Adverse Event|2
2708569|NCT00354679|9324870|P1|Overall Study|Patient Not Treated|1
2708570|NCT00354614|9324879|P1|Overall Study|Lack of Efficacy|28
2708571|NCT00354601|9324883|P1|Overall Study|progression|1
2708572|NCT00354601|9324883|P1|Overall Study|Protocol Violation|1
2708573|NCT00354432|9324903|P4|Overall Study|Off/Toxicity|5
2708574|NCT00354432|9324904|P3|Overall Study|Off/Toxicity|5
2708575|NCT00354432|9324905|P2|Overall Study|Off/Toxicity|7
2708576|NCT00354432|9324906|P1|Overall Study|Off/Toxicity|3
2708577|NCT00354432|9324903|P4|Overall Study|Adverse Event|5
2708578|NCT00354432|9324904|P3|Overall Study|Adverse Event|5
2708579|NCT00354432|9324905|P2|Overall Study|Adverse Event|1
2708580|NCT00354432|9324906|P1|Overall Study|Adverse Event|3
2708581|NCT00354341|9324922|P2|Overall Study|Other|2
2708582|NCT00354341|9324923|P1|Overall Study|Other|1
2708583|NCT00354341|9324922|P2|Overall Study|Failure to return|1
2708584|NCT00354341|9324923|P1|Overall Study|Failure to return|0
2708585|NCT00354341|9324922|P2|Overall Study|Refused treatment|2
2708586|NCT00354341|9324923|P1|Overall Study|Refused treatment|1
2708587|NCT00354341|9324922|P2|Overall Study|Death|2
2708588|NCT00354341|9324923|P1|Overall Study|Death|0
2708589|NCT00354341|9324922|P2|Overall Study|Adverse Event|0
2708590|NCT00354341|9324923|P1|Overall Study|Adverse Event|1
2708591|NCT00354172|9324945|P1|Overall Study|Did not receive transplant|1
2708592|NCT00354159|9324965|P2|Long-term Follow-up|Study Closed|34
2708593|NCT00354159|9324966|P1|Long-term Follow-up|Study Closed|29
2708594|NCT00354159|9324965|P2|Long-term Follow-up|Death|11
2708595|NCT00354159|9324966|P1|Long-term Follow-up|Death|14
2708596|NCT00354159|9324965|P2|Long-term Follow-up|Lost to Follow-up|0
2708597|NCT00354159|9324966|P1|Long-term Follow-up|Lost to Follow-up|1
2708598|NCT00354159|9324965|P2|Long-term Follow-up|Physician Decision|122
2708599|NCT00354159|9324966|P1|Long-term Follow-up|Physician Decision|127
2708600|NCT00354159|9324965|P2|Long-term Follow-up|Withdrawal by Subject|9
2708601|NCT00354159|9324966|P1|Long-term Follow-up|Withdrawal by Subject|9
2708602|NCT00354159|9324965|P2|Randomized Study Period|Death|9
2708603|NCT00354159|9324966|P1|Randomized Study Period|Death|7
2708604|NCT00354159|9324965|P2|Randomized Study Period|Lost to Follow-up|0
2708605|NCT00354159|9324966|P1|Randomized Study Period|Lost to Follow-up|4
2708606|NCT00354159|9324965|P2|Randomized Study Period|Physician Decision|10
2708607|NCT00354159|9324966|P1|Randomized Study Period|Physician Decision|6
2708608|NCT00354159|9324965|P2|Randomized Study Period|Withdrawal by Subject|3
2708609|NCT00354159|9324966|P1|Randomized Study Period|Withdrawal by Subject|5
2708610|NCT00354107|9325009|P1|Overall Study|Withdrawal by Subject|1
2708611|NCT00354107|9325009|P1|Overall Study|Physician Decision|2
2708612|NCT00354107|9325009|P1|Overall Study|Adverse Event|2
2708613|NCT00354029|9325019|P2|Overall Study|Protocol Violation|2
2708614|NCT00354029|9325020|P1|Overall Study|Protocol Violation|4
2708615|NCT00353873|9325032|P2|Overall Study|Withdrawal by Subject|1
2708616|NCT00353873|9325033|P1|Overall Study|Withdrawal by Subject|1
2708617|NCT00353873|9325032|P2|Overall Study|Physician Decision|0
2708618|NCT00353873|9325033|P1|Overall Study|Physician Decision|2
2708619|NCT00353873|9325032|P2|Overall Study|Adverse Event|0
2708620|NCT00353873|9325033|P1|Overall Study|Adverse Event|1
2708621|NCT00353873|9325032|P2|Overall Study|Exacerbation|0
2708622|NCT00353873|9325033|P1|Overall Study|Exacerbation|1
2708624|NCT00353873|9325033|P1|Overall Study|Protocol Violation|1
2708625|NCT00353704|9325062|P2|Overall Study|Protocol Violation|1
2708626|NCT00353704|9325063|P1|Overall Study|Protocol Violation|3
2708627|NCT00353496|9325133|P2|Overall Study|Not otherwise specified|2
2708628|NCT00353496|9325134|P1|Overall Study|Not otherwise specified|4
2708629|NCT00353496|9325133|P2|Overall Study|Physician Decision|9
2708630|NCT00353496|9325134|P1|Overall Study|Physician Decision|6
2708631|NCT00353496|9325133|P2|Overall Study|Withdrawal by Subject|4
2708632|NCT00353496|9325134|P1|Overall Study|Withdrawal by Subject|3
2708633|NCT00353496|9325133|P2|Overall Study|Protocol Violation|2
2708634|NCT00353496|9325134|P1|Overall Study|Protocol Violation|2
2708635|NCT00353496|9325133|P2|Overall Study|Adverse Event|0
2708636|NCT00353496|9325134|P1|Overall Study|Adverse Event|1
2708637|NCT00353366|9325187|P1|Overall Study|Other|135
2708638|NCT00353366|9325187|P1|Overall Study|Adverse Event|8
2708639|NCT00353262|9325214|P1|Overall Study|Break from Chemotherapy|1
2708640|NCT00353262|9325214|P1|Overall Study|Surgery|4
2708641|NCT00353262|9325214|P1|Overall Study|Progression|1
2708642|NCT00353262|9325214|P1|Overall Study|Insufficient Therapeutic Response|13
2708643|NCT00353262|9325214|P1|Overall Study|Withdrawal by Subject|2
2708644|NCT00353262|9325214|P1|Overall Study|Adverse Event|8
2708645|NCT00352885|9325255|P2|Overall Study|Side effects of IL-2 administration|0
2708646|NCT00352885|9325256|P1|Overall Study|Side effects of IL-2 administration|1
2708647|NCT00352885|9325255|P2|Overall Study|Progression of metastatic melanoma|3
2708648|NCT00352885|9325256|P1|Overall Study|Progression of metastatic melanoma|5
2708649|NCT00352885|9325255|P2|Overall Study|Development of major depression|1
2708650|NCT00352885|9325256|P1|Overall Study|Development of major depression|0
2708651|NCT00352885|9325255|P2|Overall Study|Withdrawal by Subject|3
2708652|NCT00352885|9325256|P1|Overall Study|Withdrawal by Subject|0
2708653|NCT00352846|9325274|P2|Overall Study|Death|1
2708654|NCT00352846|9325275|P1|Overall Study|Death|0
2708655|NCT00352846|9325274|P2|Overall Study|Non-compliance|0
2708656|NCT00352846|9325275|P1|Overall Study|Non-compliance|2
2708657|NCT00352846|9325274|P2|Overall Study|Ineligible|2
2708658|NCT00352846|9325275|P1|Overall Study|Ineligible|3
2708659|NCT00352846|9325274|P2|Overall Study|Withdrawal by Subject|8
2708660|NCT00352846|9325275|P1|Overall Study|Withdrawal by Subject|3
2708661|NCT00352846|9325274|P2|Overall Study|Disease progression|2
2708662|NCT00352846|9325275|P1|Overall Study|Disease progression|0
2708663|NCT00352755|9325290|P1|Overall Study|Adverse Event|1
2708664|NCT00352755|9325290|P1|Overall Study|Physician Decision|1
2708665|NCT00352690|9325300|P2|Overall Study|Determined to be ineligible|0
2708666|NCT00352690|9325301|P1|Overall Study|Determined to be ineligible|2
2708667|NCT00352664|9325321|P2|Overall Study|Withdrawal by Subject|0
2708668|NCT00352664|9325322|P1|Overall Study|Withdrawal by Subject|7
2708669|NCT00352534|9325339|P7|Final Risk Group Assignment|Death|0
2708670|NCT00352534|9325340|P6|Final Risk Group Assignment|Death|2
2708671|NCT00352534|9325341|P5|Final Risk Group Assignment|Death|0
2708672|NCT00352534|9325342|P4|Final Risk Group Assignment|Death|0
2708673|NCT00352534|9325343|P3|Final Risk Group Assignment|Death|0
2708674|NCT00352534|9325344|P2|Final Risk Group Assignment|Death|0
2708675|NCT00352534|9325345|P1|Final Risk Group Assignment|Death|0
2708676|NCT00352534|9325339|P7|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11
2708677|NCT00352534|9325340|P6|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
2708678|NCT00352534|9325341|P5|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
2708679|NCT00352534|9325342|P4|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
2708680|NCT00352534|9325343|P3|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
2708681|NCT00352534|9325344|P2|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
2708682|NCT00352534|9325345|P1|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
2708683|NCT00352534|9325339|P7|Final Risk Group Assignment|Enrollment onto another COG study|28
2708684|NCT00352534|9325340|P6|Final Risk Group Assignment|Enrollment onto another COG study|0
2708685|NCT00352534|9325341|P5|Final Risk Group Assignment|Enrollment onto another COG study|0
2708686|NCT00352534|9325342|P4|Final Risk Group Assignment|Enrollment onto another COG study|0
2708687|NCT00352534|9325343|P3|Final Risk Group Assignment|Enrollment onto another COG study|0
2708688|NCT00352534|9325344|P2|Final Risk Group Assignment|Enrollment onto another COG study|0
2708689|NCT00352534|9325345|P1|Final Risk Group Assignment|Enrollment onto another COG study|0
2708690|NCT00352534|9325339|P7|Final Risk Group Assignment|Ineligible|0
2708691|NCT00352534|9325340|P6|Final Risk Group Assignment|Ineligible|13
2708692|NCT00352534|9325341|P5|Final Risk Group Assignment|Ineligible|0
2708693|NCT00352534|9325342|P4|Final Risk Group Assignment|Ineligible|1
2708694|NCT00352534|9325343|P3|Final Risk Group Assignment|Ineligible|3
2708695|NCT00352534|9325344|P2|Final Risk Group Assignment|Ineligible|0
2708696|NCT00352534|9325345|P1|Final Risk Group Assignment|Ineligible|0
2708697|NCT00352534|9325339|P7|Final Risk Group Assignment|Withdrawal by Subject|0
2708698|NCT00352534|9325340|P6|Final Risk Group Assignment|Withdrawal by Subject|3
2708699|NCT00352534|9325341|P5|Final Risk Group Assignment|Withdrawal by Subject|0
2708700|NCT00352534|9325342|P4|Final Risk Group Assignment|Withdrawal by Subject|0
2708701|NCT00352534|9325343|P3|Final Risk Group Assignment|Withdrawal by Subject|0
2708702|NCT00352534|9325344|P2|Final Risk Group Assignment|Withdrawal by Subject|0
2708703|NCT00352534|9325345|P1|Final Risk Group Assignment|Withdrawal by Subject|0
2708704|NCT00352534|9325339|P7|Final Risk Group Assignment|Physician Decision|0
2708705|NCT00352534|9325340|P6|Final Risk Group Assignment|Physician Decision|8
2708706|NCT00352534|9325341|P5|Final Risk Group Assignment|Physician Decision|0
2708707|NCT00352534|9325342|P4|Final Risk Group Assignment|Physician Decision|0
2708708|NCT00352534|9325343|P3|Final Risk Group Assignment|Physician Decision|0
2708709|NCT00352534|9325344|P2|Final Risk Group Assignment|Physician Decision|0
2708710|NCT00352534|9325345|P1|Final Risk Group Assignment|Physician Decision|0
2708711|NCT00352534|9325339|P7|Final Risk Group Assignment|Lack of Efficacy|0
2708712|NCT00352534|9325340|P6|Final Risk Group Assignment|Lack of Efficacy|19
2708713|NCT00352534|9325341|P5|Final Risk Group Assignment|Lack of Efficacy|1
2708714|NCT00352534|9325342|P4|Final Risk Group Assignment|Lack of Efficacy|2
2708715|NCT00352534|9325343|P3|Final Risk Group Assignment|Lack of Efficacy|0
2708716|NCT00352534|9325344|P2|Final Risk Group Assignment|Lack of Efficacy|0
2708717|NCT00352534|9325345|P1|Final Risk Group Assignment|Lack of Efficacy|0
2708718|NCT00352534|9325339|P7|Initial Staging|Ineligible|0
2708719|NCT00352534|9325340|P6|Initial Staging|Ineligible|0
2708720|NCT00352534|9325341|P5|Initial Staging|Ineligible|0
2708721|NCT00352534|9325342|P4|Initial Staging|Ineligible|0
2708722|NCT00352534|9325343|P3|Initial Staging|Ineligible|0
2708723|NCT00352534|9325344|P2|Initial Staging|Ineligible|9
2708724|NCT00352534|9325345|P1|Initial Staging|Ineligible|8
2708725|NCT00352417|9325362|P2|Overall Study|Schedule Change|1
2708726|NCT00352417|9325363|P1|Overall Study|Schedule Change|2
2708727|NCT00352417|9325362|P2|Overall Study|Lost to Follow-up|0
2708728|NCT00352417|9325363|P1|Overall Study|Lost to Follow-up|1
2708729|NCT00352417|9325362|P2|Overall Study|Withdrawal by Subject|2
2708730|NCT00352417|9325363|P1|Overall Study|Withdrawal by Subject|1
2708731|NCT00352417|9325362|P2|Overall Study|Protocol Violation|2
2708732|NCT00352417|9325363|P1|Overall Study|Protocol Violation|0
2708733|NCT00352417|9325362|P2|Overall Study|Adverse Event|0
2708734|NCT00352417|9325363|P1|Overall Study|Adverse Event|1
2708735|NCT00352365|9325377|P1|Maintenance Therapy|Not eligible|4
2708736|NCT00352365|9325377|P1|Maintenance Therapy|Not protocol specified|3
2708737|NCT00352365|9325377|P1|Maintenance Therapy|Death|2
2708738|NCT00352365|9325377|P1|Maintenance Therapy|Progression/Relapse|3
2708739|NCT00352365|9325377|P1|Induction Therapy|Death before starting protocol therapy|1
2708740|NCT00352365|9325377|P1|Induction Therapy|Not eligible|3
2708741|NCT00352365|9325377|P1|Induction Therapy|Not protocol specified|1
2708742|NCT00352365|9325377|P1|Induction Therapy|Death|7
2708743|NCT00352365|9325377|P1|Induction Therapy|Progression/Relapse|8
2708744|NCT00352365|9325377|P1|Induction Therapy|Adverse Event|7
2708745|NCT00352118|9325387|P1|Overall Study|Physician Decision|4
2708746|NCT00352105|9325397|P1|Overall Study|Protocol Violation|2
2708747|NCT00352105|9325397|P1|Overall Study|Adverse Event|19
2708748|NCT00352105|9325397|P1|Overall Study|Lack of Efficacy|9
2708749|NCT00352105|9325397|P1|Overall Study|Withdrawal by Subject|5
2708750|NCT00352105|9325397|P1|Overall Study|Death|5
2708751|NCT00352053|9325408|P2|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1
2708752|NCT00352053|9325409|P1|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0
2708753|NCT00352053|9325408|P2|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
2708754|NCT00352053|9325409|P1|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
2708755|NCT00352053|9325408|P2|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
2708756|NCT00352053|9325409|P1|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
2708757|NCT00352053|9325408|P2|Second Extension Phase (Weeks 144-240)|Physician Decision|4
2708758|NCT00352053|9325409|P1|Second Extension Phase (Weeks 144-240)|Physician Decision|4
2708759|NCT00352053|9325408|P2|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0
2708760|NCT00352053|9325409|P1|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1
2708761|NCT00352053|9325408|P2|First Extension Phase (Weeks 48-144)|Pregnancy|0
2708762|NCT00352053|9325409|P1|First Extension Phase (Weeks 48-144)|Pregnancy|1
2708763|NCT00352053|9325408|P2|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4
2708764|NCT00352053|9325409|P1|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1
2708765|NCT00352053|9325408|P2|First Extension Phase (Weeks 48-144)|Physician Decision|13
2708766|NCT00352053|9325409|P1|First Extension Phase (Weeks 48-144)|Physician Decision|9
2708767|NCT00352053|9325408|P2|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0
2708768|NCT00352053|9325409|P1|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1
2708769|NCT00352053|9325408|P2|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1
2708770|NCT00352053|9325409|P1|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0
2708771|NCT00352053|9325408|P2|Double-Blind Phase (Through Week 48)|Adverse Event|0
2708772|NCT00352053|9325409|P1|Double-Blind Phase (Through Week 48)|Adverse Event|1
2708773|NCT00352053|9325408|P2|Double-Blind Phase (Through Week 48)|Physician Decision|2
2708774|NCT00352053|9325409|P1|Double-Blind Phase (Through Week 48)|Physician Decision|2
2708775|NCT00352053|9325408|P2|Double-Blind Phase (Through Week 48)|Virologic Failure|10
2708776|NCT00352053|9325409|P1|Double-Blind Phase (Through Week 48)|Virologic Failure|14
2708777|NCT00352027|9325576|P1|Overall Study|Progressive disease|3
2708778|NCT00351819|9325875|P2|Overall Study|Enrolled in another trial|1
2708779|NCT00351819|9325876|P1|Overall Study|Enrolled in another trial|0
2708780|NCT00351819|9325875|P2|Overall Study|Incarcerated|1
2708781|NCT00351819|9325876|P1|Overall Study|Incarcerated|0
2708782|NCT00351819|9325875|P2|Overall Study|Non-compliance|1
2708783|NCT00351819|9325876|P1|Overall Study|Non-compliance|0
2708784|NCT00351819|9325875|P2|Overall Study|Unprofessional behavior|0
2708785|NCT00351819|9325876|P1|Overall Study|Unprofessional behavior|1
2708786|NCT00351819|9325875|P2|Overall Study|Traumatic ankle fracture|0
2708787|NCT00351819|9325876|P1|Overall Study|Traumatic ankle fracture|1
2708788|NCT00351819|9325875|P2|Overall Study|Elevated PSA|1
2708789|NCT00351819|9325876|P1|Overall Study|Elevated PSA|1
2708790|NCT00351819|9325875|P2|Overall Study|Withdrawal by Subject|4
2708791|NCT00351819|9325876|P1|Overall Study|Withdrawal by Subject|0
2708792|NCT00351819|9325875|P2|Overall Study|Lost to Follow-up|4
2708793|NCT00351819|9325876|P1|Overall Study|Lost to Follow-up|4
2708794|NCT00351533|9325947|P2|Overall Study|Withdrawal by Subject|1
2708795|NCT00351533|9325948|P1|Overall Study|Withdrawal by Subject|0
2708796|NCT00351533|9325947|P2|Overall Study|Physician Decision|1
2708797|NCT00351533|9325948|P1|Overall Study|Physician Decision|0
2708798|NCT00351533|9325947|P2|Overall Study|Lost to Follow-up|3
2708799|NCT00351533|9325948|P1|Overall Study|Lost to Follow-up|1
2708800|NCT00351533|9325947|P2|Overall Study|Extubated before first BAL|0
2708801|NCT00351533|9325948|P1|Overall Study|Extubated before first BAL|1
2708802|NCT00351468|9326008|P1|Overall Study|Protocol Violation|3
2708803|NCT00351468|9326008|P1|Overall Study|Lost to Follow-up|4
2708804|NCT00351468|9326008|P1|Overall Study|Non-compliance|8
2708805|NCT00351468|9326008|P1|Overall Study|Lack of Efficacy|32
2708806|NCT00351468|9326008|P1|Overall Study|Various -follow up w clinical team|39
2708807|NCT00351468|9326008|P1|Overall Study|Withdrawal by Subject|39
2708808|NCT00351468|9326008|P1|Overall Study|Adverse Event|42
2708809|NCT00351377|9326032|P1|Overall Study|Unsatisfactory therapeutic effect|1
2708810|NCT00351377|9326032|P1|Overall Study|Death|1
2708811|NCT00351377|9326032|P1|Overall Study|Adverse Event|5
2708812|NCT00351351|9326046|P2|Overall Study|surgical access pbs; device issues|4
2708813|NCT00351351|9326047|P1|Overall Study|surgical access pbs; device issues|9
2708814|NCT00351273|9326073|P3|Overall Study|Lost to Follow-up|5
2708815|NCT00351273|9326074|P2|Overall Study|Lost to Follow-up|2
2708816|NCT00351273|9326075|P1|Overall Study|Lost to Follow-up|1
2708817|NCT00350870|9326118|P4|Overall Study|Physician Decision|1
2708818|NCT00350870|9326119|P3|Overall Study|Physician Decision|1
2708819|NCT00350870|9326120|P2|Overall Study|Physician Decision|0
2708820|NCT00350870|9326121|P1|Overall Study|Physician Decision|1
2708821|NCT00350870|9326118|P4|Overall Study|Withdrawal by Subject|14
2708822|NCT00350870|9326119|P3|Overall Study|Withdrawal by Subject|15
2708823|NCT00350870|9326120|P2|Overall Study|Withdrawal by Subject|17
2708824|NCT00350870|9326121|P1|Overall Study|Withdrawal by Subject|21
2708825|NCT00350844|9326135|P1|Overall Study|Lost to Follow-up|1
2708826|NCT00350792|9326139|P1|Overall Study|Lack of Efficacy|11
2708827|NCT00350792|9326139|P1|Overall Study|Physician Decision|2
2708828|NCT00350792|9326139|P1|Overall Study|Withdrawal by Subject|4
2708829|NCT00350792|9326139|P1|Overall Study|Protocol Violation|1
2708830|NCT00350792|9326139|P1|Overall Study|Death Not Study Drug Related|2
2708831|NCT00350792|9326139|P1|Overall Study|Death from Study Drug Toxicity|1
2708832|NCT00350792|9326139|P1|Overall Study|Death from Study Disease|1
2708833|NCT00350792|9326139|P1|Overall Study|Adverse Event|11
2708834|NCT00350779|9326149|P2|Overall Study|Non-compliance with study procedures|1
2708835|NCT00350779|9326150|P1|Overall Study|Non-compliance with study procedures|0
2708836|NCT00350779|9326149|P2|Overall Study|Patient Moved|1
2708837|NCT00350779|9326150|P1|Overall Study|Patient Moved|2
2708838|NCT00350779|9326149|P2|Overall Study|Withdrawal by Subject|8
2708839|NCT00350779|9326150|P1|Overall Study|Withdrawal by Subject|9
2708840|NCT00350779|9326149|P2|Overall Study|Protocol Violation|1
2708841|NCT00350779|9326150|P1|Overall Study|Protocol Violation|3
2708842|NCT00350779|9326149|P2|Overall Study|Physician Decision|4
2708843|NCT00350779|9326150|P1|Overall Study|Physician Decision|2
2708844|NCT00350779|9326149|P2|Overall Study|Lost to Follow-up|0
2708845|NCT00350779|9326150|P1|Overall Study|Lost to Follow-up|2
2708846|NCT00350779|9326149|P2|Overall Study|Lack of Efficacy|4
2708847|NCT00350779|9326150|P1|Overall Study|Lack of Efficacy|0
2708848|NCT00350779|9326149|P2|Overall Study|Adverse Event|2
2708849|NCT00350779|9326150|P1|Overall Study|Adverse Event|4
2708850|NCT00350727|9326171|P3|Phase II|Enrolled in Rollover Study|1
2708851|NCT00350727|9326172|P2|Phase II|Enrolled in Rollover Study|0
2708852|NCT00350727|9326173|P1|Phase II|Enrolled in Rollover Study|0
2708853|NCT00350727|9326171|P3|Phase II|Sponsor Terminated Study|1
2708854|NCT00350727|9326172|P2|Phase II|Sponsor Terminated Study|0
2708855|NCT00350727|9326173|P1|Phase II|Sponsor Terminated Study|0
2708856|NCT00350727|9326171|P3|Phase II|Death|2
2708857|NCT00350727|9326172|P2|Phase II|Death|0
2708858|NCT00350727|9326173|P1|Phase II|Death|0
2708859|NCT00350727|9326171|P3|Phase II|Adverse Event|1
2708860|NCT00350727|9326172|P2|Phase II|Adverse Event|1
2708861|NCT00350727|9326173|P1|Phase II|Adverse Event|0
2708862|NCT00350727|9326171|P3|Phase II|Withdrawal by Subject|1
2708863|NCT00350727|9326172|P2|Phase II|Withdrawal by Subject|2
2708864|NCT00350727|9326173|P1|Phase II|Withdrawal by Subject|0
2708865|NCT00350727|9326171|P3|Phase II|Clinical Deterioration|0
2708866|NCT00350727|9326172|P2|Phase II|Clinical Deterioration|1
2708867|NCT00350727|9326173|P1|Phase II|Clinical Deterioration|0
2708868|NCT00350727|9326171|P3|Phase II|Disease Progression|16
2708869|NCT00350727|9326172|P2|Phase II|Disease Progression|15
2708870|NCT00350727|9326173|P1|Phase II|Disease Progression|0
2708871|NCT00350727|9326171|P3|Phase I: Dose Escalation|Transition to Extension Phase|0
2708872|NCT00350727|9326172|P2|Phase I: Dose Escalation|Transition to Extension Phase|0
2708873|NCT00350727|9326173|P1|Phase I: Dose Escalation|Transition to Extension Phase|3
2708874|NCT00350727|9326171|P3|Phase I: Dose Escalation|Physician Decision|0
2708875|NCT00350727|9326172|P2|Phase I: Dose Escalation|Physician Decision|0
2708876|NCT00350727|9326173|P1|Phase I: Dose Escalation|Physician Decision|1
2708877|NCT00350727|9326171|P3|Phase I: Dose Escalation|Death|0
2708878|NCT00350727|9326172|P2|Phase I: Dose Escalation|Death|0
2708879|NCT00350727|9326173|P1|Phase I: Dose Escalation|Death|1
2708880|NCT00350727|9326171|P3|Phase I: Dose Escalation|Lack of Efficacy|0
2708881|NCT00350727|9326172|P2|Phase I: Dose Escalation|Lack of Efficacy|0
2708882|NCT00350727|9326173|P1|Phase I: Dose Escalation|Lack of Efficacy|25
2708883|NCT00350727|9326171|P3|Phase I: Dose Escalation|Adverse Event|0
2708884|NCT00350727|9326172|P2|Phase I: Dose Escalation|Adverse Event|0
2708885|NCT00350727|9326173|P1|Phase I: Dose Escalation|Adverse Event|4
2708886|NCT00350636|9326317|P2|Overall Study|Other|2
2708887|NCT00350636|9326318|P1|Overall Study|Other|1
2708888|NCT00350636|9326317|P2|Overall Study|Physician Decision|2
2708889|NCT00350636|9326318|P1|Overall Study|Physician Decision|0
2708890|NCT00350636|9326317|P2|Overall Study|Lost to Follow-up|8
2708891|NCT00350636|9326318|P1|Overall Study|Lost to Follow-up|9
2708892|NCT00350636|9326317|P2|Overall Study|Withdrawal by Subject|17
2708893|NCT00350636|9326318|P1|Overall Study|Withdrawal by Subject|13
2708894|NCT00350636|9326317|P2|Overall Study|Protocol Violation|3
2708895|NCT00350636|9326318|P1|Overall Study|Protocol Violation|1
2708896|NCT00350636|9326317|P2|Overall Study|Adverse Event|13
2708897|NCT00350636|9326318|P1|Overall Study|Adverse Event|19
2708898|NCT00350623|9326337|P3|Overall Study|patient traveling outside the country|1
2708899|NCT00350623|9326338|P2|Overall Study|patient traveling outside the country|0
2708900|NCT00350623|9326339|P1|Overall Study|patient traveling outside the country|0
2708901|NCT00350623|9326337|P3|Overall Study|Withdrawal by Subject|1
2708902|NCT00350623|9326338|P2|Overall Study|Withdrawal by Subject|1
2708903|NCT00350623|9326339|P1|Overall Study|Withdrawal by Subject|0
2708904|NCT00350623|9326337|P3|Overall Study|Lost to Follow-up|4
2708905|NCT00350623|9326338|P2|Overall Study|Lost to Follow-up|3
2708906|NCT00350623|9326339|P1|Overall Study|Lost to Follow-up|8
2708907|NCT00350545|9326347|P1|Overall Study|Withdrawal by Subject|2
2708908|NCT00350519|9326366|P2|Overall Study|Withdrawal by Subject|2
2708909|NCT00350519|9326367|P1|Overall Study|Withdrawal by Subject|3
2708910|NCT00350519|9326366|P2|Overall Study|Protocol Violation|2
2708911|NCT00350519|9326367|P1|Overall Study|Protocol Violation|1
2708912|NCT00350519|9326366|P2|Overall Study|Physician Decision|1
2708913|NCT00350519|9326367|P1|Overall Study|Physician Decision|0
2708914|NCT00350519|9326366|P2|Overall Study|Death|1
2708915|NCT00350519|9326367|P1|Overall Study|Death|0
2708916|NCT00350402|9326381|P2|Overall Study|Lost to Follow-up|1
2708917|NCT00350402|9326382|P1|Overall Study|Lost to Follow-up|1
2708918|NCT00350272|9326455|P2|Open-Label 84 Week Treatment|Sponsor decision|1
2708919|NCT00350272|9326456|P1|Open-Label 84 Week Treatment|Sponsor decision|2
2708920|NCT00350272|9326455|P2|Open-Label 84 Week Treatment|Physician Decision|2
2708921|NCT00350272|9326456|P1|Open-Label 84 Week Treatment|Physician Decision|1
2708922|NCT00350272|9326455|P2|Open-Label 84 Week Treatment|Withdrawal by Subject|2
2708923|NCT00350272|9326456|P1|Open-Label 84 Week Treatment|Withdrawal by Subject|1
2708924|NCT00350272|9326455|P2|Open-Label 84 Week Treatment|Lost to Follow-up|2
2708925|NCT00350272|9326456|P1|Open-Label 84 Week Treatment|Lost to Follow-up|3
2708926|NCT00350272|9326455|P2|Open-Label 84 Week Treatment|Adverse Event|1
2708927|NCT00350272|9326456|P1|Open-Label 84 Week Treatment|Adverse Event|2
2708928|NCT00350272|9326455|P2|Blinded 12 Week Treatment|Sponsor decision|1
2708929|NCT00350272|9326456|P1|Blinded 12 Week Treatment|Sponsor decision|0
2708930|NCT00350272|9326455|P2|Blinded 12 Week Treatment|Physician Decision|1
2708931|NCT00350272|9326456|P1|Blinded 12 Week Treatment|Physician Decision|2
2708932|NCT00350272|9326455|P2|Blinded 12 Week Treatment|Withdrawal by Subject|0
2708933|NCT00350272|9326456|P1|Blinded 12 Week Treatment|Withdrawal by Subject|3
2708934|NCT00350272|9326455|P2|Blinded 12 Week Treatment|Lost to Follow-up|0
2708935|NCT00350272|9326456|P1|Blinded 12 Week Treatment|Lost to Follow-up|2
2708936|NCT00350272|9326455|P2|Blinded 12 Week Treatment|Death|0
2708937|NCT00350272|9326456|P1|Blinded 12 Week Treatment|Death|1
2708938|NCT00350272|9326455|P2|Blinded 12 Week Treatment|Adverse Event|0
2708939|NCT00350272|9326456|P1|Blinded 12 Week Treatment|Adverse Event|1
2708940|NCT00350207|9326478|P3|Overall Study|Other|1
2708941|NCT00350207|9326479|P2|Overall Study|Other|3
2708942|NCT00350207|9326480|P1|Overall Study|Other|1
2708943|NCT00350207|9326478|P3|Overall Study|Withdrawal by Subject|1
2708944|NCT00350207|9326479|P2|Overall Study|Withdrawal by Subject|1
2708945|NCT00350207|9326480|P1|Overall Study|Withdrawal by Subject|0
2708946|NCT00350207|9326478|P3|Overall Study|Lost to Follow-up|1
2708947|NCT00350207|9326479|P2|Overall Study|Lost to Follow-up|0
2708948|NCT00350207|9326480|P1|Overall Study|Lost to Follow-up|1
2708949|NCT00350207|9326478|P3|Overall Study|Lack of Efficacy|2
2708950|NCT00350207|9326479|P2|Overall Study|Lack of Efficacy|0
2708951|NCT00350207|9326480|P1|Overall Study|Lack of Efficacy|1
2708952|NCT00350207|9326478|P3|Overall Study|Adverse Event|2
2708953|NCT00350207|9326479|P2|Overall Study|Adverse Event|2
2708954|NCT00350207|9326480|P1|Overall Study|Adverse Event|5
2708955|NCT00349973|9326692|P2|Overall Study|Withdrawal by Subject|0
2708956|NCT00349973|9326693|P1|Overall Study|Withdrawal by Subject|1
2708957|NCT00349973|9326692|P2|Overall Study|Adverse Event|3
2708958|NCT00349973|9326693|P1|Overall Study|Adverse Event|3
2708959|NCT00349921|9326707|P4|First Spinal Injection|Adverse Event|0
2708960|NCT00349921|9326708|P3|First Spinal Injection|Adverse Event|1
2708961|NCT00349921|9326709|P2|First Spinal Injection|Adverse Event|0
2708962|NCT00349921|9326710|P1|First Spinal Injection|Adverse Event|0
2708963|NCT00349921|9326707|P4|First Spinal Injection|Physician Decision|0
2708964|NCT00349921|9326708|P3|First Spinal Injection|Physician Decision|0
2708965|NCT00349921|9326709|P2|First Spinal Injection|Physician Decision|0
2708966|NCT00349921|9326710|P1|First Spinal Injection|Physician Decision|1
2708967|NCT00349908|9326721|P2|Overall Study|Withdrawal by Subject|4
2708968|NCT00349908|9326722|P1|Overall Study|Withdrawal by Subject|0
2708969|NCT00349752|9326748|P2|Overall Study|Other:History of squamous cell carcinoma|0
2708970|NCT00349752|9326749|P1|Overall Study|Other:History of squamous cell carcinoma|1
2708971|NCT00349752|9326748|P2|Overall Study|Other: Inadvertently unblinded|0
2708972|NCT00349752|9326749|P1|Overall Study|Other: Inadvertently unblinded|1
2708973|NCT00349752|9326748|P2|Overall Study|Other: Ineligible|0
2708974|NCT00349752|9326749|P1|Overall Study|Other: Ineligible|1
2708975|NCT00349752|9326748|P2|Overall Study|Other: Patient's steroid use|0
2708976|NCT00349752|9326749|P1|Overall Study|Other: Patient's steroid use|1
2708977|NCT00349752|9326748|P2|Overall Study|Other: Patient stopped steroids|1
2708978|NCT00349752|9326749|P1|Overall Study|Other: Patient stopped steroids|0
2708979|NCT00349752|9326748|P2|Overall Study|Other: Non compliance|1
2708980|NCT00349752|9326749|P1|Overall Study|Other: Non compliance|0
2708981|NCT00349752|9326748|P2|Overall Study|Other: Required exclusionary medication|1
2708982|NCT00349752|9326749|P1|Overall Study|Other: Required exclusionary medication|0
2708983|NCT00349752|9326748|P2|Overall Study|Personal reasons|5
2708984|NCT00349752|9326749|P1|Overall Study|Personal reasons|6
2708985|NCT00349752|9326748|P2|Overall Study|Lost to Follow-up|2
2708986|NCT00349752|9326749|P1|Overall Study|Lost to Follow-up|4
2708987|NCT00349752|9326748|P2|Overall Study|Lack of Efficacy|42
2708988|NCT00349752|9326749|P1|Overall Study|Lack of Efficacy|37
2708989|NCT00349752|9326748|P2|Overall Study|Adverse Event|12
2708990|NCT00349752|9326749|P1|Overall Study|Adverse Event|8
2708991|NCT00349622|9326802|P2|Overall Study|Withdrawal by Subject|9
2708992|NCT00349622|9326803|P1|Overall Study|Withdrawal by Subject|5
2708993|NCT00349622|9326802|P2|Overall Study|Lost to Follow-up|1
2708994|NCT00349622|9326803|P1|Overall Study|Lost to Follow-up|5
2708995|NCT00349622|9326802|P2|Overall Study|Death|86
2708996|NCT00349622|9326803|P1|Overall Study|Death|168
2708997|NCT00349349|9326842|P3|Overall Study|New Malignancy (Bladder Cancer)|0
2708998|NCT00349349|9326843|P2|Overall Study|New Malignancy (Bladder Cancer)|1
2708999|NCT00349349|9326844|P1|Overall Study|New Malignancy (Bladder Cancer)|0
2709000|NCT00349349|9326842|P3|Overall Study|No Response|0
2709001|NCT00349349|9326843|P2|Overall Study|No Response|3
2709002|NCT00349349|9326844|P1|Overall Study|No Response|0
2709003|NCT00349349|9326842|P3|Overall Study|Physician Decision|1
2709004|NCT00349349|9326843|P2|Overall Study|Physician Decision|2
2709005|NCT00349349|9326844|P1|Overall Study|Physician Decision|1
2709006|NCT00349349|9326842|P3|Overall Study|Participant Reduced General Condition|0
2709007|NCT00349349|9326843|P2|Overall Study|Participant Reduced General Condition|1
2709008|NCT00349349|9326844|P1|Overall Study|Participant Reduced General Condition|0
2709009|NCT00349349|9326842|P3|Overall Study|Other Treatment Selected|0
2709010|NCT00349349|9326843|P2|Overall Study|Other Treatment Selected|0
2709011|NCT00349349|9326844|P1|Overall Study|Other Treatment Selected|2
2709012|NCT00349349|9326842|P3|Overall Study|Death|1
2709013|NCT00349349|9326843|P2|Overall Study|Death|10
2709014|NCT00349349|9326844|P1|Overall Study|Death|13
2709015|NCT00349349|9326842|P3|Overall Study|Withdrawn due to Disease Progression|1
2709016|NCT00349349|9326843|P2|Overall Study|Withdrawn due to Disease Progression|37
2709017|NCT00349349|9326844|P1|Overall Study|Withdrawn due to Disease Progression|27
2709018|NCT00349349|9326842|P3|Overall Study|Withdrawal by Subject|1
2709019|NCT00349349|9326843|P2|Overall Study|Withdrawal by Subject|2
2709020|NCT00349349|9326844|P1|Overall Study|Withdrawal by Subject|5
2709021|NCT00349349|9326842|P3|Overall Study|Adverse Event|2
2709022|NCT00349349|9326843|P2|Overall Study|Adverse Event|6
2709023|NCT00349349|9326844|P1|Overall Study|Adverse Event|5
2709024|NCT00348933|9326933|P1|Overall Study|Adverse Event|7
2709025|NCT00348933|9326933|P1|Overall Study|Protocol Violation|2
2709026|NCT00348933|9326933|P1|Overall Study|Lost to Follow-up|6
2709027|NCT00348933|9326933|P1|Overall Study|Withdrawal by Subject|10
2709028|NCT00348881|9326941|P2|Overall Study|Serious Adverse Event|2
2709029|NCT00348881|9326942|P1|Overall Study|Serious Adverse Event|0
2709030|NCT00348881|9326941|P2|Overall Study|Adverse Event|0
2709031|NCT00348881|9326942|P1|Overall Study|Adverse Event|2
2709032|NCT00348881|9326941|P2|Overall Study|Withdrawal by Subject|4
2709033|NCT00348881|9326942|P1|Overall Study|Withdrawal by Subject|3
2709034|NCT00348881|9326941|P2|Overall Study|Lost to Follow-up|6
2709035|NCT00348881|9326942|P1|Overall Study|Lost to Follow-up|12
2709036|NCT00348816|9326954|P1|Overall Study|Noncompliance with radiation treatment|1
2709037|NCT00348790|9326961|P1|Completed Treatment|Unable to travel to study site|1
2709038|NCT00348790|9326961|P1|Completed Treatment|Required surgery|2
2709039|NCT00348790|9326961|P1|Completed Treatment|Adverse Event|4
2709040|NCT00348790|9326961|P1|Completed Treatment|Disease progression|14
2709041|NCT00348790|9326961|P1|Completed Treatment|Withdrawal by Subject|4
2709042|NCT00348686|9326973|P1|Overall Study|Multiple Reasons|8
2709043|NCT00348686|9326973|P1|Overall Study|Lost to Follow-up|2
2709044|NCT00348686|9326973|P1|Overall Study|Protocol Violation|6
2709045|NCT00348686|9326973|P1|Overall Study|Adverse Event|5
2709046|NCT00348686|9326973|P1|Overall Study|Withdrawal by Subject|45
2709047|NCT00348673|9326990|P9|Stage 1|Randomized but not Treated|0
2709048|NCT00348673|9326991|P8|Stage 1|Randomized but not Treated|0
2709049|NCT00348673|9326992|P7|Stage 1|Randomized but not Treated|0
2709050|NCT00348673|9326993|P6|Stage 1|Randomized but not Treated|0
2709051|NCT00348673|9326994|P5|Stage 1|Randomized but not Treated|0
2709052|NCT00348673|9326995|P4|Stage 1|Randomized but not Treated|0
2709053|NCT00348673|9326996|P3|Stage 1|Randomized but not Treated|1
2709054|NCT00348673|9326997|P2|Stage 1|Randomized but not Treated|0
2709055|NCT00348673|9326998|P1|Stage 1|Randomized but not Treated|0
2709056|NCT00348595|9327047|P2|Overall Study|Adverse Event|8
2709057|NCT00348595|9327048|P1|Overall Study|Adverse Event|5
2709058|NCT00348556|9327060|P1|Overall Study|Adverse Event|1
2709059|NCT00348374|9327067|P2|Overall Study|randomized but did not receive treatment|7
2709060|NCT00348374|9327068|P1|Overall Study|randomized but did not receive treatment|0
2709061|NCT00348374|9327067|P2|Overall Study|ongoing at date of cutoff|1
2709062|NCT00348374|9327068|P1|Overall Study|ongoing at date of cutoff|1
2709063|NCT00348374|9327067|P2|Overall Study|Other|12
2709064|NCT00348374|9327068|P1|Overall Study|Other|11
2709065|NCT00348374|9327067|P2|Overall Study|Withdrawal by Subject|5
2709066|NCT00348374|9327068|P1|Overall Study|Withdrawal by Subject|5
2709067|NCT00348374|9327067|P2|Overall Study|Lost to Follow-up|3
2709068|NCT00348374|9327068|P1|Overall Study|Lost to Follow-up|1
2709069|NCT00348374|9327067|P2|Overall Study|Adverse Event|4
2709070|NCT00348374|9327068|P1|Overall Study|Adverse Event|1
2709071|NCT00348348|9327115|P2|Overall Study|Adverse event probably related to study|0
2709072|NCT00348348|9327116|P1|Overall Study|Adverse event probably related to study|1
2709073|NCT00348348|9327115|P2|Overall Study|Worsening of BC - Unlikely related|2
2709074|NCT00348348|9327116|P1|Overall Study|Worsening of BC - Unlikely related|1
2709075|NCT00348348|9327115|P2|Overall Study|Worsening of BC - Unrelated to study|3
2709076|NCT00348348|9327116|P1|Overall Study|Worsening of BC - Unrelated to study|0
2709077|NCT00348348|9327115|P2|Overall Study|Dissallowed Meds - possibly releated|1
2709078|NCT00348348|9327116|P1|Overall Study|Dissallowed Meds - possibly releated|1
2709079|NCT00348348|9327115|P2|Overall Study|Dissallowed Meds - unlikley related|1
2709080|NCT00348348|9327116|P1|Overall Study|Dissallowed Meds - unlikley related|1
2709081|NCT00348348|9327115|P2|Overall Study|Dissallowed Meds - unrelated to study|3
2709082|NCT00348348|9327116|P1|Overall Study|Dissallowed Meds - unrelated to study|1
2709083|NCT00348348|9327115|P2|Overall Study|Other|4
2709084|NCT00348348|9327116|P1|Overall Study|Other|7
2709085|NCT00348348|9327115|P2|Overall Study|Withdrawal by Subject|1
2709086|NCT00348348|9327116|P1|Overall Study|Withdrawal by Subject|4
2709087|NCT00348348|9327115|P2|Overall Study|Lost to Follow-up|10
2709088|NCT00348348|9327116|P1|Overall Study|Lost to Follow-up|8
2709089|NCT00348348|9327115|P2|Overall Study|Lack of Efficacy|1
2709090|NCT00348348|9327116|P1|Overall Study|Lack of Efficacy|1
2709091|NCT00348348|9327115|P2|Overall Study|Adverse event - unrelated to study drug|1
2709092|NCT00348348|9327116|P1|Overall Study|Adverse event - unrelated to study drug|0
2709093|NCT00348309|9327131|P3|Overall Study|HCV career|1
2709094|NCT00348309|9327132|P2|Overall Study|HCV career|0
2709095|NCT00348309|9327133|P1|Overall Study|HCV career|0
2709096|NCT00348309|9327131|P3|Overall Study|Cardiologist recommendations|1
2709097|NCT00348309|9327132|P2|Overall Study|Cardiologist recommendations|0
2709098|NCT00348309|9327133|P1|Overall Study|Cardiologist recommendations|0
2709099|NCT00348309|9327131|P3|Overall Study|ECG abnormal|2
2709100|NCT00348309|9327132|P2|Overall Study|ECG abnormal|0
2709101|NCT00348309|9327133|P1|Overall Study|ECG abnormal|0
2709102|NCT00348309|9327131|P3|Overall Study|Adverse event not attended|1
2709103|NCT00348309|9327132|P2|Overall Study|Adverse event not attended|0
2709104|NCT00348309|9327133|P1|Overall Study|Adverse event not attended|0
2709105|NCT00348309|9327131|P3|Overall Study|Site closure|1
2709106|NCT00348309|9327132|P2|Overall Study|Site closure|0
2709107|NCT00348309|9327133|P1|Overall Study|Site closure|0
2709108|NCT00348309|9327131|P3|Overall Study|Increased dose of Aricept|1
2709109|NCT00348309|9327132|P2|Overall Study|Increased dose of Aricept|0
2709110|NCT00348309|9327133|P1|Overall Study|Increased dose of Aricept|0
2709111|NCT00348309|9327131|P3|Overall Study|Medical Monitor decision|1
2709112|NCT00348309|9327132|P2|Overall Study|Medical Monitor decision|0
2709113|NCT00348309|9327133|P1|Overall Study|Medical Monitor decision|0
2709114|NCT00348309|9327131|P3|Overall Study|Forgot often medication|0
2709115|NCT00348309|9327132|P2|Overall Study|Forgot often medication|1
2709116|NCT00348309|9327133|P1|Overall Study|Forgot often medication|0
2709117|NCT00348309|9327131|P3|Overall Study|Sponsor refuseal|1
2709118|NCT00348309|9327132|P2|Overall Study|Sponsor refuseal|1
2709119|NCT00348309|9327133|P1|Overall Study|Sponsor refuseal|0
2709120|NCT00348309|9327131|P3|Overall Study|Participant was hospitalized|0
2709121|NCT00348309|9327132|P2|Overall Study|Participant was hospitalized|1
2709122|NCT00348309|9327133|P1|Overall Study|Participant was hospitalized|0
2709123|NCT00348309|9327131|P3|Overall Study|A foul of exclusion criteria|0
2709124|NCT00348309|9327132|P2|Overall Study|A foul of exclusion criteria|1
2709125|NCT00348309|9327133|P1|Overall Study|A foul of exclusion criteria|0
2709126|NCT00348309|9327131|P3|Overall Study|Ineffectiveness of treatment|0
2709127|NCT00348309|9327132|P2|Overall Study|Ineffectiveness of treatment|1
2709128|NCT00348309|9327133|P1|Overall Study|Ineffectiveness of treatment|0
2709129|NCT00348309|9327131|P3|Overall Study|Decision of sponsor|0
2709130|NCT00348309|9327132|P2|Overall Study|Decision of sponsor|0
2709131|NCT00348309|9327133|P1|Overall Study|Decision of sponsor|1
2709132|NCT00348309|9327131|P3|Overall Study|Participant died|1
2709133|NCT00348309|9327132|P2|Overall Study|Participant died|1
2709134|NCT00348309|9327133|P1|Overall Study|Participant died|2
2709135|NCT00348309|9327131|P3|Overall Study|Did not appear in time for Visit 3|0
2709136|NCT00348309|9327132|P2|Overall Study|Did not appear in time for Visit 3|0
2709137|NCT00348309|9327133|P1|Overall Study|Did not appear in time for Visit 3|1
2709138|NCT00348309|9327131|P3|Overall Study|Worsening of alzheimer|1
2709139|NCT00348309|9327132|P2|Overall Study|Worsening of alzheimer|0
2709140|NCT00348309|9327133|P1|Overall Study|Worsening of alzheimer|1
2709141|NCT00348309|9327131|P3|Overall Study|Cognitive and behaviour worsening|0
2709142|NCT00348309|9327132|P2|Overall Study|Cognitive and behaviour worsening|0
2709143|NCT00348309|9327133|P1|Overall Study|Cognitive and behaviour worsening|2
2709144|NCT00348309|9327131|P3|Overall Study|Worsened neurodegenerative disease|0
2709145|NCT00348309|9327132|P2|Overall Study|Worsened neurodegenerative disease|0
2709146|NCT00348309|9327133|P1|Overall Study|Worsened neurodegenerative disease|1
2709147|NCT00348309|9327131|P3|Overall Study|No disponibility of medication|0
2709148|NCT00348309|9327132|P2|Overall Study|No disponibility of medication|0
2709149|NCT00348309|9327133|P1|Overall Study|No disponibility of medication|1
2709150|NCT00348309|9327131|P3|Overall Study|Principal investigator's decision|0
2709151|NCT00348309|9327132|P2|Overall Study|Principal investigator's decision|0
2709152|NCT00348309|9327133|P1|Overall Study|Principal investigator's decision|1
2709153|NCT00348309|9327131|P3|Overall Study|PI closing medical practice|0
2709154|NCT00348309|9327132|P2|Overall Study|PI closing medical practice|0
2709155|NCT00348309|9327133|P1|Overall Study|PI closing medical practice|1
2709156|NCT00348309|9327131|P3|Overall Study|Unable to complete ET visit|0
2709157|NCT00348309|9327132|P2|Overall Study|Unable to complete ET visit|0
2709158|NCT00348309|9327133|P1|Overall Study|Unable to complete ET visit|1
2709159|NCT00348309|9327131|P3|Overall Study|Caregiver withdrawal|7
2709160|NCT00348309|9327132|P2|Overall Study|Caregiver withdrawal|0
2709161|NCT00348309|9327133|P1|Overall Study|Caregiver withdrawal|3
2709162|NCT00348309|9327131|P3|Overall Study|Use of prohibited medication|2
2709163|NCT00348309|9327132|P2|Overall Study|Use of prohibited medication|2
2709164|NCT00348309|9327133|P1|Overall Study|Use of prohibited medication|5
2709165|NCT00348309|9327131|P3|Overall Study|Caregiver sick|0
2709166|NCT00348309|9327132|P2|Overall Study|Caregiver sick|0
2709167|NCT00348309|9327133|P1|Overall Study|Caregiver sick|1
2709168|NCT00348309|9327131|P3|Overall Study|Wrong bottle allocated|0
2709169|NCT00348309|9327132|P2|Overall Study|Wrong bottle allocated|0
2709170|NCT00348309|9327133|P1|Overall Study|Wrong bottle allocated|1
2709171|NCT00348309|9327131|P3|Overall Study|Lack of insight, dementia|0
2709172|NCT00348309|9327132|P2|Overall Study|Lack of insight, dementia|0
2709173|NCT00348309|9327133|P1|Overall Study|Lack of insight, dementia|1
2709174|NCT00348309|9327131|P3|Overall Study|Death of caregiver|1
2709175|NCT00348309|9327132|P2|Overall Study|Death of caregiver|0
2709176|NCT00348309|9327133|P1|Overall Study|Death of caregiver|1
2709177|NCT00348309|9327131|P3|Overall Study|Non-compliance|8
2709178|NCT00348309|9327132|P2|Overall Study|Non-compliance|6
2709179|NCT00348309|9327133|P1|Overall Study|Non-compliance|8
2709180|NCT00348309|9327131|P3|Overall Study|Withdrawal by Subject|40
2709181|NCT00348309|9327132|P2|Overall Study|Withdrawal by Subject|37
2709182|NCT00348309|9327133|P1|Overall Study|Withdrawal by Subject|33
2709183|NCT00348309|9327131|P3|Overall Study|Protocol Violation|7
2709184|NCT00348309|9327132|P2|Overall Study|Protocol Violation|12
2709185|NCT00348309|9327133|P1|Overall Study|Protocol Violation|7
2709186|NCT00348309|9327131|P3|Overall Study|Lost to Follow-up|4
2709187|NCT00348309|9327132|P2|Overall Study|Lost to Follow-up|7
2709188|NCT00348309|9327133|P1|Overall Study|Lost to Follow-up|6
2709189|NCT00348309|9327131|P3|Overall Study|Adverse Event|63
2709190|NCT00348309|9327132|P2|Overall Study|Adverse Event|28
2709191|NCT00348309|9327133|P1|Overall Study|Adverse Event|56
2709192|NCT00348283|9327206|P2|Open Label|Sponsor decision|1
2709193|NCT00348283|9327207|P1|Open Label|Sponsor decision|0
2709194|NCT00348283|9327206|P2|Open Label|Pregnancy|1
2709195|NCT00348283|9327207|P1|Open Label|Pregnancy|0
2709196|NCT00348283|9327206|P2|Open Label|Subject moved to the United States|1
2709197|NCT00348283|9327207|P1|Open Label|Subject moved to the United States|0
2709198|NCT00348283|9327206|P2|Open Label|Administrative reasons|5
2709199|NCT00348283|9327207|P1|Open Label|Administrative reasons|0
2709200|NCT00348283|9327206|P2|Open Label|Lack of Efficacy|13
2709201|NCT00348283|9327207|P1|Open Label|Lack of Efficacy|0
2709202|NCT00348283|9327206|P2|Open Label|Lost to Follow-up|1
2709203|NCT00348283|9327207|P1|Open Label|Lost to Follow-up|0
2709204|NCT00348283|9327206|P2|Open Label|Withdrawal by Subject|4
2709205|NCT00348283|9327207|P1|Open Label|Withdrawal by Subject|0
2709206|NCT00348283|9327206|P2|Open Label|Adverse Event|8
2709207|NCT00348283|9327207|P1|Open Label|Adverse Event|0
2709208|NCT00348283|9327206|P2|Double Blind|Pregnancy|1
2709209|NCT00348283|9327207|P1|Double Blind|Pregnancy|0
2709210|NCT00348283|9327206|P2|Double Blind|Lack of Efficacy|2
2709211|NCT00348283|9327207|P1|Double Blind|Lack of Efficacy|2
2709212|NCT00348283|9327206|P2|Double Blind|Protocol Violation|1
2709213|NCT00348283|9327207|P1|Double Blind|Protocol Violation|0
2709214|NCT00348283|9327206|P2|Double Blind|Withdrawal by Subject|1
2709215|NCT00348283|9327207|P1|Double Blind|Withdrawal by Subject|1
2709216|NCT00348283|9327206|P2|Double Blind|Adverse Event|5
2709217|NCT00348283|9327207|P1|Double Blind|Adverse Event|2
2709218|NCT00348283|9327206|P2|Induction|Protocol Violation|4
2709219|NCT00348283|9327207|P1|Induction|Protocol Violation|0
2709220|NCT00348283|9327206|P2|Induction|Adverse Event|2
2709221|NCT00348283|9327207|P1|Induction|Adverse Event|0
2709222|NCT00348140|9327226|P3|Overall Study|Memory declined|1
2709223|NCT00348140|9327227|P2|Overall Study|Memory declined|0
2709224|NCT00348140|9327228|P1|Overall Study|Memory declined|0
2709225|NCT00348140|9327226|P3|Overall Study|Exclusion criteria met|1
2709226|NCT00348140|9327227|P2|Overall Study|Exclusion criteria met|0
2709227|NCT00348140|9327228|P1|Overall Study|Exclusion criteria met|0
2709228|NCT00348140|9327226|P3|Overall Study|Participant died|0
2709229|NCT00348140|9327227|P2|Overall Study|Participant died|1
2709230|NCT00348140|9327228|P1|Overall Study|Participant died|0
2709231|NCT00348140|9327226|P3|Overall Study|Abnormal ECG|3
2709232|NCT00348140|9327227|P2|Overall Study|Abnormal ECG|1
2709233|NCT00348140|9327228|P1|Overall Study|Abnormal ECG|0
2709234|NCT00348140|9327226|P3|Overall Study|Serious adverse event|0
2709235|NCT00348140|9327227|P2|Overall Study|Serious adverse event|1
2709236|NCT00348140|9327228|P1|Overall Study|Serious adverse event|0
2709237|NCT00348140|9327226|P3|Overall Study|Increased risk of cardiac infarction|0
2709238|NCT00348140|9327227|P2|Overall Study|Increased risk of cardiac infarction|1
2709239|NCT00348140|9327228|P1|Overall Study|Increased risk of cardiac infarction|0
2709240|NCT00348140|9327226|P3|Overall Study|Disease progression|5
2709241|NCT00348140|9327227|P2|Overall Study|Disease progression|2
2709242|NCT00348140|9327228|P1|Overall Study|Disease progression|1
2709243|NCT00348140|9327226|P3|Overall Study|Use of prohibited drug|2
2709244|NCT00348140|9327227|P2|Overall Study|Use of prohibited drug|0
2709245|NCT00348140|9327228|P1|Overall Study|Use of prohibited drug|1
2709246|NCT00348140|9327226|P3|Overall Study|Decided to discontinue on their own|1
2709247|NCT00348140|9327227|P2|Overall Study|Decided to discontinue on their own|4
2709248|NCT00348140|9327228|P1|Overall Study|Decided to discontinue on their own|1
2709249|NCT00348140|9327226|P3|Overall Study|Investigator decided to discontinue|4
2709250|NCT00348140|9327227|P2|Overall Study|Investigator decided to discontinue|1
2709251|NCT00348140|9327228|P1|Overall Study|Investigator decided to discontinue|4
2709252|NCT00348140|9327226|P3|Overall Study|Screen failure|0
2709253|NCT00348140|9327227|P2|Overall Study|Screen failure|0
2709254|NCT00348140|9327228|P1|Overall Study|Screen failure|1
2709255|NCT00348140|9327226|P3|Overall Study|Participant unwell|0
2709256|NCT00348140|9327227|P2|Overall Study|Participant unwell|0
2709257|NCT00348140|9327228|P1|Overall Study|Participant unwell|1
2709258|NCT00348140|9327226|P3|Overall Study|Unmet inclusion-exclusion criteria|1
2709259|NCT00348140|9327227|P2|Overall Study|Unmet inclusion-exclusion criteria|0
2709260|NCT00348140|9327228|P1|Overall Study|Unmet inclusion-exclusion criteria|1
2709261|NCT00348140|9327226|P3|Overall Study|Administration related|1
2709262|NCT00348140|9327227|P2|Overall Study|Administration related|1
2709263|NCT00348140|9327228|P1|Overall Study|Administration related|3
2709264|NCT00348140|9327226|P3|Overall Study|Efficacy related|0
2709265|NCT00348140|9327227|P2|Overall Study|Efficacy related|1
2709266|NCT00348140|9327228|P1|Overall Study|Efficacy related|1
2709267|NCT00348140|9327226|P3|Overall Study|Participant hospitalised|0
2709268|NCT00348140|9327227|P2|Overall Study|Participant hospitalised|0
2709269|NCT00348140|9327228|P1|Overall Study|Participant hospitalised|3
2709270|NCT00348140|9327226|P3|Overall Study|Caregiver related|3
2709271|NCT00348140|9327227|P2|Overall Study|Caregiver related|7
2709272|NCT00348140|9327228|P1|Overall Study|Caregiver related|4
2709273|NCT00348140|9327226|P3|Overall Study|Conditional medication increased dose|0
2709274|NCT00348140|9327227|P2|Overall Study|Conditional medication increased dose|0
2709275|NCT00348140|9327228|P1|Overall Study|Conditional medication increased dose|1
2709276|NCT00348140|9327226|P3|Overall Study|Participant at risk due to study drug|0
2709277|NCT00348140|9327227|P2|Overall Study|Participant at risk due to study drug|0
2709278|NCT00348140|9327228|P1|Overall Study|Participant at risk due to study drug|2
2709279|NCT00348140|9327226|P3|Overall Study|Non-compliance|5
2709280|NCT00348140|9327227|P2|Overall Study|Non-compliance|13
2709281|NCT00348140|9327228|P1|Overall Study|Non-compliance|8
2709282|NCT00348140|9327226|P3|Overall Study|Withdrawal by Subject|40
2709283|NCT00348140|9327227|P2|Overall Study|Withdrawal by Subject|40
2709284|NCT00348140|9327228|P1|Overall Study|Withdrawal by Subject|32
2709285|NCT00348140|9327226|P3|Overall Study|Protocol Violation|14
2709286|NCT00348140|9327227|P2|Overall Study|Protocol Violation|13
2709287|NCT00348140|9327228|P1|Overall Study|Protocol Violation|12
2709288|NCT00348140|9327226|P3|Overall Study|Lost to Follow-up|4
2709289|NCT00348140|9327227|P2|Overall Study|Lost to Follow-up|4
2709290|NCT00348140|9327228|P1|Overall Study|Lost to Follow-up|4
2709291|NCT00348140|9327226|P3|Overall Study|Adverse Event|78
2709292|NCT00348140|9327227|P2|Overall Study|Adverse Event|49
2709293|NCT00348140|9327228|P1|Overall Study|Adverse Event|46
2709294|NCT00347958|9327326|P1|Overall Study|Withdrawal by Subject|1
2709295|NCT00347958|9327326|P1|Overall Study|Protocol Violation|2
2709296|NCT00347958|9327326|P1|Overall Study|Adverse Event|1
2709297|NCT00347932|9327335|P2|Overall Study|Did not meet inclusion criteria|8
2709298|NCT00347932|9327336|P1|Overall Study|Did not meet inclusion criteria|4
2709299|NCT00347932|9327335|P2|Overall Study|Withdrawal by Subject|16
2709300|NCT00347932|9327336|P1|Overall Study|Withdrawal by Subject|10
2709301|NCT00347932|9327335|P2|Overall Study|Lost to Follow-up|9
2709302|NCT00347932|9327336|P1|Overall Study|Lost to Follow-up|10
2709303|NCT00347932|9327335|P2|Overall Study|Lack of Efficacy|14
2709304|NCT00347932|9327336|P1|Overall Study|Lack of Efficacy|3
2709305|NCT00347932|9327335|P2|Overall Study|Adverse Event|5
2709306|NCT00347932|9327336|P1|Overall Study|Adverse Event|4
2709307|NCT00347919|9327351|P3|Overall Study|Missing|2
2709308|NCT00347919|9327352|P2|Overall Study|Missing|1
2709309|NCT00347919|9327353|P1|Overall Study|Missing|2
2709310|NCT00347919|9327351|P3|Overall Study|Par. Started Other Treatment|1
2709311|NCT00347919|9327352|P2|Overall Study|Par. Started Other Treatment|1
2709312|NCT00347919|9327353|P1|Overall Study|Par. Started Other Treatment|1
2709313|NCT00347919|9327351|P3|Overall Study|Death|19
2709314|NCT00347919|9327352|P2|Overall Study|Death|42
2709315|NCT00347919|9327353|P1|Overall Study|Death|35
2709316|NCT00347919|9327351|P3|Overall Study|Sponsor terminated study|16
2709317|NCT00347919|9327352|P2|Overall Study|Sponsor terminated study|10
2709318|NCT00347919|9327353|P1|Overall Study|Sponsor terminated study|15
2709319|NCT00347919|9327351|P3|Overall Study|Physician Decision|0
2709320|NCT00347919|9327352|P2|Overall Study|Physician Decision|1
2709321|NCT00347919|9327353|P1|Overall Study|Physician Decision|1
2709322|NCT00347919|9327351|P3|Overall Study|Withdrawal by Subject|0
2709323|NCT00347919|9327352|P2|Overall Study|Withdrawal by Subject|8
2709324|NCT00347919|9327353|P1|Overall Study|Withdrawal by Subject|6
2709325|NCT00347919|9327351|P3|Overall Study|Lost to Follow-up|0
2709326|NCT00347919|9327352|P2|Overall Study|Lost to Follow-up|13
2709327|NCT00347919|9327353|P1|Overall Study|Lost to Follow-up|11
2709328|NCT00347776|9327376|P3|12 Month Follow-up|Reached endpoint|9
2709329|NCT00347776|9327377|P2|12 Month Follow-up|Reached endpoint|6
2709330|NCT00347776|9327378|P1|12 Month Follow-up|Reached endpoint|13
2709331|NCT00347776|9327376|P3|12 Month Follow-up|Death|4
2709332|NCT00347776|9327377|P2|12 Month Follow-up|Death|4
2709333|NCT00347776|9327378|P1|12 Month Follow-up|Death|3
2709334|NCT00347776|9327376|P3|12 Month Follow-up|Lost to Follow-up|6
2709335|NCT00347776|9327377|P2|12 Month Follow-up|Lost to Follow-up|6
2709336|NCT00347776|9327378|P1|12 Month Follow-up|Lost to Follow-up|7
2709337|NCT00347776|9327376|P3|6 Month Follow-up|reached endpont|15
2709338|NCT00347776|9327377|P2|6 Month Follow-up|reached endpont|12
2709339|NCT00347776|9327378|P1|6 Month Follow-up|reached endpont|20
2709340|NCT00347776|9327376|P3|6 Month Follow-up|Death|3
2709341|NCT00347776|9327377|P2|6 Month Follow-up|Death|1
2709342|NCT00347776|9327378|P1|6 Month Follow-up|Death|2
2709343|NCT00347776|9327376|P3|1.5 Month Follow-up|reached the endpoint|12
2709344|NCT00347776|9327377|P2|1.5 Month Follow-up|reached the endpoint|8
2709345|NCT00347776|9327378|P1|1.5 Month Follow-up|reached the endpoint|12
2709346|NCT00347776|9327376|P3|1.5 Month Follow-up|Death|0
2709347|NCT00347776|9327377|P2|1.5 Month Follow-up|Death|0
2709348|NCT00347776|9327378|P1|1.5 Month Follow-up|Death|2
2709349|NCT00347438|9327390|P1|Overall Study|Physician Decision|1
2709350|NCT00347438|9327390|P1|Overall Study|Withdrawal by Subject|1
2709351|NCT00347360|9327412|P15|Overall Study|Visits conflicted with new job|0
2709352|NCT00347360|9327413|P14|Overall Study|Visits conflicted with new job|0
2709353|NCT00347360|9327414|P13|Overall Study|Visits conflicted with new job|0
2709354|NCT00347360|9327415|P12|Overall Study|Visits conflicted with new job|0
2709355|NCT00347360|9327416|P11|Overall Study|Visits conflicted with new job|0
2709356|NCT00347360|9327417|P10|Overall Study|Visits conflicted with new job|0
2709357|NCT00347360|9327418|P9|Overall Study|Visits conflicted with new job|0
2709358|NCT00347360|9327419|P8|Overall Study|Visits conflicted with new job|0
2709359|NCT00347360|9327420|P7|Overall Study|Visits conflicted with new job|1
2709360|NCT00347360|9327421|P6|Overall Study|Visits conflicted with new job|0
2709361|NCT00347360|9327422|P5|Overall Study|Visits conflicted with new job|0
2709362|NCT00347360|9327423|P4|Overall Study|Visits conflicted with new job|0
2709363|NCT00347360|9327424|P3|Overall Study|Visits conflicted with new job|0
2709364|NCT00347360|9327425|P2|Overall Study|Visits conflicted with new job|0
2709365|NCT00347360|9327426|P1|Overall Study|Visits conflicted with new job|0
2709366|NCT00347360|9327412|P15|Overall Study|Subject refuse to sign updated consent|1
2709367|NCT00347360|9327413|P14|Overall Study|Subject refuse to sign updated consent|0
2709368|NCT00347360|9327414|P13|Overall Study|Subject refuse to sign updated consent|0
2709369|NCT00347360|9327415|P12|Overall Study|Subject refuse to sign updated consent|0
2709370|NCT00347360|9327416|P11|Overall Study|Subject refuse to sign updated consent|0
2709371|NCT00347360|9327417|P10|Overall Study|Subject refuse to sign updated consent|0
2709372|NCT00347360|9327418|P9|Overall Study|Subject refuse to sign updated consent|0
2709373|NCT00347360|9327419|P8|Overall Study|Subject refuse to sign updated consent|0
2709374|NCT00347360|9327420|P7|Overall Study|Subject refuse to sign updated consent|0
2709375|NCT00347360|9327421|P6|Overall Study|Subject refuse to sign updated consent|0
2709376|NCT00347360|9327422|P5|Overall Study|Subject refuse to sign updated consent|0
2709377|NCT00347360|9327423|P4|Overall Study|Subject refuse to sign updated consent|0
2709378|NCT00347360|9327424|P3|Overall Study|Subject refuse to sign updated consent|0
2709379|NCT00347360|9327425|P2|Overall Study|Subject refuse to sign updated consent|0
2709380|NCT00347360|9327426|P1|Overall Study|Subject refuse to sign updated consent|0
2709381|NCT00347360|9327412|P15|Overall Study|Subject left town, ran out of study drug|0
2709382|NCT00347360|9327413|P14|Overall Study|Subject left town, ran out of study drug|1
2709383|NCT00347360|9327414|P13|Overall Study|Subject left town, ran out of study drug|0
2709384|NCT00347360|9327415|P12|Overall Study|Subject left town, ran out of study drug|0
2709385|NCT00347360|9327416|P11|Overall Study|Subject left town, ran out of study drug|0
2709386|NCT00347360|9327417|P10|Overall Study|Subject left town, ran out of study drug|0
2709544|NCT00347360|9327425|P2|Overall Study|Reason not listed/blank|0
2709387|NCT00347360|9327418|P9|Overall Study|Subject left town, ran out of study drug|0
2709388|NCT00347360|9327419|P8|Overall Study|Subject left town, ran out of study drug|0
2709389|NCT00347360|9327420|P7|Overall Study|Subject left town, ran out of study drug|0
2709390|NCT00347360|9327421|P6|Overall Study|Subject left town, ran out of study drug|0
2709391|NCT00347360|9327422|P5|Overall Study|Subject left town, ran out of study drug|0
2709392|NCT00347360|9327423|P4|Overall Study|Subject left town, ran out of study drug|0
2709393|NCT00347360|9327424|P3|Overall Study|Subject left town, ran out of study drug|0
2709394|NCT00347360|9327425|P2|Overall Study|Subject left town, ran out of study drug|0
2709395|NCT00347360|9327426|P1|Overall Study|Subject left town, ran out of study drug|0
2709396|NCT00347360|9327412|P15|Overall Study|Prolonged duration between visits|0
2709397|NCT00347360|9327413|P14|Overall Study|Prolonged duration between visits|0
2709398|NCT00347360|9327414|P13|Overall Study|Prolonged duration between visits|1
2709399|NCT00347360|9327415|P12|Overall Study|Prolonged duration between visits|0
2709400|NCT00347360|9327416|P11|Overall Study|Prolonged duration between visits|0
2709401|NCT00347360|9327417|P10|Overall Study|Prolonged duration between visits|0
2709402|NCT00347360|9327418|P9|Overall Study|Prolonged duration between visits|0
2709403|NCT00347360|9327419|P8|Overall Study|Prolonged duration between visits|0
2709404|NCT00347360|9327420|P7|Overall Study|Prolonged duration between visits|0
2709405|NCT00347360|9327421|P6|Overall Study|Prolonged duration between visits|0
2709406|NCT00347360|9327422|P5|Overall Study|Prolonged duration between visits|0
2709407|NCT00347360|9327423|P4|Overall Study|Prolonged duration between visits|0
2709408|NCT00347360|9327424|P3|Overall Study|Prolonged duration between visits|0
2709409|NCT00347360|9327425|P2|Overall Study|Prolonged duration between visits|0
2709410|NCT00347360|9327426|P1|Overall Study|Prolonged duration between visits|0
2709411|NCT00347360|9327412|P15|Overall Study|Failed inclusion criteria #4|0
2709412|NCT00347360|9327413|P14|Overall Study|Failed inclusion criteria #4|0
2709413|NCT00347360|9327414|P13|Overall Study|Failed inclusion criteria #4|0
2709414|NCT00347360|9327415|P12|Overall Study|Failed inclusion criteria #4|1
2709415|NCT00347360|9327416|P11|Overall Study|Failed inclusion criteria #4|0
2709416|NCT00347360|9327417|P10|Overall Study|Failed inclusion criteria #4|0
2709417|NCT00347360|9327418|P9|Overall Study|Failed inclusion criteria #4|0
2709418|NCT00347360|9327419|P8|Overall Study|Failed inclusion criteria #4|0
2709419|NCT00347360|9327420|P7|Overall Study|Failed inclusion criteria #4|0
2709420|NCT00347360|9327421|P6|Overall Study|Failed inclusion criteria #4|0
2709421|NCT00347360|9327422|P5|Overall Study|Failed inclusion criteria #4|0
2709422|NCT00347360|9327423|P4|Overall Study|Failed inclusion criteria #4|0
2709423|NCT00347360|9327424|P3|Overall Study|Failed inclusion criteria #4|0
2709424|NCT00347360|9327425|P2|Overall Study|Failed inclusion criteria #4|0
2709425|NCT00347360|9327426|P1|Overall Study|Failed inclusion criteria #4|0
2709426|NCT00347360|9327412|P15|Overall Study|Randomized in error|0
2709427|NCT00347360|9327413|P14|Overall Study|Randomized in error|0
2709428|NCT00347360|9327414|P13|Overall Study|Randomized in error|0
2709429|NCT00347360|9327415|P12|Overall Study|Randomized in error|1
2709430|NCT00347360|9327416|P11|Overall Study|Randomized in error|0
2709431|NCT00347360|9327417|P10|Overall Study|Randomized in error|0
2709432|NCT00347360|9327418|P9|Overall Study|Randomized in error|0
2709433|NCT00347360|9327419|P8|Overall Study|Randomized in error|0
2709434|NCT00347360|9327420|P7|Overall Study|Randomized in error|0
2709435|NCT00347360|9327421|P6|Overall Study|Randomized in error|0
2709436|NCT00347360|9327422|P5|Overall Study|Randomized in error|0
2709437|NCT00347360|9327423|P4|Overall Study|Randomized in error|0
2709438|NCT00347360|9327424|P3|Overall Study|Randomized in error|0
2709439|NCT00347360|9327425|P2|Overall Study|Randomized in error|0
2709440|NCT00347360|9327426|P1|Overall Study|Randomized in error|0
2709441|NCT00347360|9327412|P15|Overall Study|Did not meet criteria before ABPM|0
2709442|NCT00347360|9327413|P14|Overall Study|Did not meet criteria before ABPM|0
2709443|NCT00347360|9327414|P13|Overall Study|Did not meet criteria before ABPM|0
2709444|NCT00347360|9327415|P12|Overall Study|Did not meet criteria before ABPM|0
2709445|NCT00347360|9327416|P11|Overall Study|Did not meet criteria before ABPM|1
2709446|NCT00347360|9327417|P10|Overall Study|Did not meet criteria before ABPM|0
2709447|NCT00347360|9327418|P9|Overall Study|Did not meet criteria before ABPM|0
2709448|NCT00347360|9327419|P8|Overall Study|Did not meet criteria before ABPM|0
2709449|NCT00347360|9327420|P7|Overall Study|Did not meet criteria before ABPM|0
2709450|NCT00347360|9327421|P6|Overall Study|Did not meet criteria before ABPM|0
2709451|NCT00347360|9327422|P5|Overall Study|Did not meet criteria before ABPM|0
2709452|NCT00347360|9327423|P4|Overall Study|Did not meet criteria before ABPM|0
2709453|NCT00347360|9327424|P3|Overall Study|Did not meet criteria before ABPM|0
2709454|NCT00347360|9327425|P2|Overall Study|Did not meet criteria before ABPM|0
2709455|NCT00347360|9327426|P1|Overall Study|Did not meet criteria before ABPM|0
2709456|NCT00347360|9327412|P15|Overall Study|PI recommended early withdrawal|0
2709457|NCT00347360|9327413|P14|Overall Study|PI recommended early withdrawal|0
2709458|NCT00347360|9327414|P13|Overall Study|PI recommended early withdrawal|0
2709459|NCT00347360|9327415|P12|Overall Study|PI recommended early withdrawal|0
2709460|NCT00347360|9327416|P11|Overall Study|PI recommended early withdrawal|0
2709461|NCT00347360|9327417|P10|Overall Study|PI recommended early withdrawal|1
2709462|NCT00347360|9327418|P9|Overall Study|PI recommended early withdrawal|0
2709463|NCT00347360|9327419|P8|Overall Study|PI recommended early withdrawal|0
2709464|NCT00347360|9327420|P7|Overall Study|PI recommended early withdrawal|0
2709465|NCT00347360|9327421|P6|Overall Study|PI recommended early withdrawal|0
2709466|NCT00347360|9327422|P5|Overall Study|PI recommended early withdrawal|0
2709467|NCT00347360|9327423|P4|Overall Study|PI recommended early withdrawal|0
2709468|NCT00347360|9327424|P3|Overall Study|PI recommended early withdrawal|0
2709469|NCT00347360|9327425|P2|Overall Study|PI recommended early withdrawal|0
2709470|NCT00347360|9327426|P1|Overall Study|PI recommended early withdrawal|0
2709471|NCT00347360|9327412|P15|Overall Study|Abnormal lab values|0
2709472|NCT00347360|9327413|P14|Overall Study|Abnormal lab values|0
2709473|NCT00347360|9327414|P13|Overall Study|Abnormal lab values|0
2709474|NCT00347360|9327415|P12|Overall Study|Abnormal lab values|0
2709475|NCT00347360|9327416|P11|Overall Study|Abnormal lab values|0
2709476|NCT00347360|9327417|P10|Overall Study|Abnormal lab values|0
2709477|NCT00347360|9327418|P9|Overall Study|Abnormal lab values|0
2709478|NCT00347360|9327419|P8|Overall Study|Abnormal lab values|0
2709479|NCT00347360|9327420|P7|Overall Study|Abnormal lab values|1
2709480|NCT00347360|9327421|P6|Overall Study|Abnormal lab values|0
2709481|NCT00347360|9327422|P5|Overall Study|Abnormal lab values|0
2709482|NCT00347360|9327423|P4|Overall Study|Abnormal lab values|0
2709483|NCT00347360|9327424|P3|Overall Study|Abnormal lab values|0
2709484|NCT00347360|9327425|P2|Overall Study|Abnormal lab values|0
2709485|NCT00347360|9327426|P1|Overall Study|Abnormal lab values|0
2709486|NCT00347360|9327412|P15|Overall Study|Subject did not meet end of study ABPM|0
2709487|NCT00347360|9327413|P14|Overall Study|Subject did not meet end of study ABPM|1
2709488|NCT00347360|9327414|P13|Overall Study|Subject did not meet end of study ABPM|1
2709489|NCT00347360|9327415|P12|Overall Study|Subject did not meet end of study ABPM|0
2709490|NCT00347360|9327416|P11|Overall Study|Subject did not meet end of study ABPM|1
2709491|NCT00347360|9327417|P10|Overall Study|Subject did not meet end of study ABPM|0
2709492|NCT00347360|9327418|P9|Overall Study|Subject did not meet end of study ABPM|0
2709493|NCT00347360|9327419|P8|Overall Study|Subject did not meet end of study ABPM|0
2709494|NCT00347360|9327420|P7|Overall Study|Subject did not meet end of study ABPM|1
2709495|NCT00347360|9327421|P6|Overall Study|Subject did not meet end of study ABPM|0
2709496|NCT00347360|9327422|P5|Overall Study|Subject did not meet end of study ABPM|0
2709497|NCT00347360|9327423|P4|Overall Study|Subject did not meet end of study ABPM|0
2709498|NCT00347360|9327424|P3|Overall Study|Subject did not meet end of study ABPM|0
2709499|NCT00347360|9327425|P2|Overall Study|Subject did not meet end of study ABPM|0
2709500|NCT00347360|9327426|P1|Overall Study|Subject did not meet end of study ABPM|0
2709501|NCT00347360|9327412|P15|Overall Study|P.I. recommended due to blood pressure|0
2709502|NCT00347360|9327413|P14|Overall Study|P.I. recommended due to blood pressure|0
2709503|NCT00347360|9327414|P13|Overall Study|P.I. recommended due to blood pressure|0
2709504|NCT00347360|9327415|P12|Overall Study|P.I. recommended due to blood pressure|0
2709505|NCT00347360|9327416|P11|Overall Study|P.I. recommended due to blood pressure|0
2709506|NCT00347360|9327417|P10|Overall Study|P.I. recommended due to blood pressure|0
2709507|NCT00347360|9327418|P9|Overall Study|P.I. recommended due to blood pressure|0
2709508|NCT00347360|9327419|P8|Overall Study|P.I. recommended due to blood pressure|0
2709509|NCT00347360|9327420|P7|Overall Study|P.I. recommended due to blood pressure|0
2709510|NCT00347360|9327421|P6|Overall Study|P.I. recommended due to blood pressure|0
2709511|NCT00347360|9327422|P5|Overall Study|P.I. recommended due to blood pressure|1
2709512|NCT00347360|9327423|P4|Overall Study|P.I. recommended due to blood pressure|0
2709513|NCT00347360|9327424|P3|Overall Study|P.I. recommended due to blood pressure|0
2709514|NCT00347360|9327425|P2|Overall Study|P.I. recommended due to blood pressure|0
2709515|NCT00347360|9327426|P1|Overall Study|P.I. recommended due to blood pressure|0
2709516|NCT00347360|9327412|P15|Overall Study|Per sponsors instruction|0
2709517|NCT00347360|9327413|P14|Overall Study|Per sponsors instruction|0
2709518|NCT00347360|9327414|P13|Overall Study|Per sponsors instruction|0
2709519|NCT00347360|9327415|P12|Overall Study|Per sponsors instruction|0
2709520|NCT00347360|9327416|P11|Overall Study|Per sponsors instruction|0
2709521|NCT00347360|9327417|P10|Overall Study|Per sponsors instruction|0
2709522|NCT00347360|9327418|P9|Overall Study|Per sponsors instruction|0
2709523|NCT00347360|9327419|P8|Overall Study|Per sponsors instruction|0
2709524|NCT00347360|9327420|P7|Overall Study|Per sponsors instruction|0
2709525|NCT00347360|9327421|P6|Overall Study|Per sponsors instruction|0
2709526|NCT00347360|9327422|P5|Overall Study|Per sponsors instruction|0
2709527|NCT00347360|9327423|P4|Overall Study|Per sponsors instruction|0
2709528|NCT00347360|9327424|P3|Overall Study|Per sponsors instruction|0
2709529|NCT00347360|9327425|P2|Overall Study|Per sponsors instruction|1
2709530|NCT00347360|9327426|P1|Overall Study|Per sponsors instruction|0
2709531|NCT00347360|9327412|P15|Overall Study|Reason not listed/blank|0
2709532|NCT00347360|9327413|P14|Overall Study|Reason not listed/blank|1
2709533|NCT00347360|9327414|P13|Overall Study|Reason not listed/blank|0
2709534|NCT00347360|9327415|P12|Overall Study|Reason not listed/blank|0
2709535|NCT00347360|9327416|P11|Overall Study|Reason not listed/blank|0
2709536|NCT00347360|9327417|P10|Overall Study|Reason not listed/blank|0
2709537|NCT00347360|9327418|P9|Overall Study|Reason not listed/blank|0
2709538|NCT00347360|9327419|P8|Overall Study|Reason not listed/blank|0
2709539|NCT00347360|9327420|P7|Overall Study|Reason not listed/blank|1
2709540|NCT00347360|9327421|P6|Overall Study|Reason not listed/blank|0
2709541|NCT00347360|9327422|P5|Overall Study|Reason not listed/blank|0
2709542|NCT00347360|9327423|P4|Overall Study|Reason not listed/blank|0
2709543|NCT00347360|9327424|P3|Overall Study|Reason not listed/blank|0
2709545|NCT00347360|9327426|P1|Overall Study|Reason not listed/blank|1
2709546|NCT00347360|9327412|P15|Overall Study|Lack of Efficacy|0
2709547|NCT00347360|9327413|P14|Overall Study|Lack of Efficacy|0
2709548|NCT00347360|9327414|P13|Overall Study|Lack of Efficacy|0
2709549|NCT00347360|9327415|P12|Overall Study|Lack of Efficacy|0
2709550|NCT00347360|9327416|P11|Overall Study|Lack of Efficacy|0
2709551|NCT00347360|9327417|P10|Overall Study|Lack of Efficacy|0
2709552|NCT00347360|9327418|P9|Overall Study|Lack of Efficacy|1
2709553|NCT00347360|9327419|P8|Overall Study|Lack of Efficacy|1
2709554|NCT00347360|9327420|P7|Overall Study|Lack of Efficacy|0
2709555|NCT00347360|9327421|P6|Overall Study|Lack of Efficacy|1
2709556|NCT00347360|9327422|P5|Overall Study|Lack of Efficacy|0
2709557|NCT00347360|9327423|P4|Overall Study|Lack of Efficacy|1
2709558|NCT00347360|9327424|P3|Overall Study|Lack of Efficacy|3
2709559|NCT00347360|9327425|P2|Overall Study|Lack of Efficacy|1
2709560|NCT00347360|9327426|P1|Overall Study|Lack of Efficacy|1
2709561|NCT00347360|9327412|P15|Overall Study|Withdrawal by Subject|1
2709562|NCT00347360|9327413|P14|Overall Study|Withdrawal by Subject|2
2709563|NCT00347360|9327414|P13|Overall Study|Withdrawal by Subject|4
2709564|NCT00347360|9327415|P12|Overall Study|Withdrawal by Subject|3
2709565|NCT00347360|9327416|P11|Overall Study|Withdrawal by Subject|0
2709566|NCT00347360|9327417|P10|Overall Study|Withdrawal by Subject|1
2709567|NCT00347360|9327418|P9|Overall Study|Withdrawal by Subject|1
2709568|NCT00347360|9327419|P8|Overall Study|Withdrawal by Subject|1
2709569|NCT00347360|9327420|P7|Overall Study|Withdrawal by Subject|1
2709570|NCT00347360|9327421|P6|Overall Study|Withdrawal by Subject|2
2709571|NCT00347360|9327422|P5|Overall Study|Withdrawal by Subject|1
2709572|NCT00347360|9327423|P4|Overall Study|Withdrawal by Subject|4
2709573|NCT00347360|9327424|P3|Overall Study|Withdrawal by Subject|2
2709574|NCT00347360|9327425|P2|Overall Study|Withdrawal by Subject|1
2709575|NCT00347360|9327426|P1|Overall Study|Withdrawal by Subject|0
2709576|NCT00347360|9327412|P15|Overall Study|Protocol Violation|0
2709577|NCT00347360|9327413|P14|Overall Study|Protocol Violation|1
2709578|NCT00347360|9327414|P13|Overall Study|Protocol Violation|0
2709579|NCT00347360|9327415|P12|Overall Study|Protocol Violation|0
2709580|NCT00347360|9327416|P11|Overall Study|Protocol Violation|0
2709581|NCT00347360|9327417|P10|Overall Study|Protocol Violation|2
2709582|NCT00347360|9327418|P9|Overall Study|Protocol Violation|1
2709583|NCT00347360|9327419|P8|Overall Study|Protocol Violation|0
2709584|NCT00347360|9327420|P7|Overall Study|Protocol Violation|0
2709585|NCT00347360|9327421|P6|Overall Study|Protocol Violation|2
2709586|NCT00347360|9327422|P5|Overall Study|Protocol Violation|1
2709587|NCT00347360|9327423|P4|Overall Study|Protocol Violation|2
2709588|NCT00347360|9327424|P3|Overall Study|Protocol Violation|1
2709589|NCT00347360|9327425|P2|Overall Study|Protocol Violation|3
2709590|NCT00347360|9327426|P1|Overall Study|Protocol Violation|2
2709591|NCT00347360|9327412|P15|Overall Study|Lost to Follow-up|0
2709592|NCT00347360|9327413|P14|Overall Study|Lost to Follow-up|0
2709593|NCT00347360|9327414|P13|Overall Study|Lost to Follow-up|1
2709594|NCT00347360|9327415|P12|Overall Study|Lost to Follow-up|0
2709595|NCT00347360|9327416|P11|Overall Study|Lost to Follow-up|0
2709596|NCT00347360|9327417|P10|Overall Study|Lost to Follow-up|2
2709597|NCT00347360|9327418|P9|Overall Study|Lost to Follow-up|1
2709598|NCT00347360|9327419|P8|Overall Study|Lost to Follow-up|1
2709599|NCT00347360|9327420|P7|Overall Study|Lost to Follow-up|0
2709600|NCT00347360|9327421|P6|Overall Study|Lost to Follow-up|1
2709601|NCT00347360|9327422|P5|Overall Study|Lost to Follow-up|1
2709602|NCT00347360|9327423|P4|Overall Study|Lost to Follow-up|2
2709603|NCT00347360|9327424|P3|Overall Study|Lost to Follow-up|0
2709604|NCT00347360|9327425|P2|Overall Study|Lost to Follow-up|0
2709605|NCT00347360|9327426|P1|Overall Study|Lost to Follow-up|0
2709606|NCT00347360|9327412|P15|Overall Study|Adverse Event|2
2709607|NCT00347360|9327413|P14|Overall Study|Adverse Event|2
2709608|NCT00347360|9327414|P13|Overall Study|Adverse Event|3
2709609|NCT00347360|9327415|P12|Overall Study|Adverse Event|1
2709610|NCT00347360|9327416|P11|Overall Study|Adverse Event|3
2709611|NCT00347360|9327417|P10|Overall Study|Adverse Event|3
2709612|NCT00347360|9327418|P9|Overall Study|Adverse Event|2
2709613|NCT00347360|9327419|P8|Overall Study|Adverse Event|0
2709614|NCT00347360|9327420|P7|Overall Study|Adverse Event|2
2709615|NCT00347360|9327421|P6|Overall Study|Adverse Event|2
2709616|NCT00347360|9327422|P5|Overall Study|Adverse Event|1
2709617|NCT00347360|9327423|P4|Overall Study|Adverse Event|4
2709618|NCT00347360|9327424|P3|Overall Study|Adverse Event|0
2709619|NCT00347360|9327425|P2|Overall Study|Adverse Event|2
2709620|NCT00347360|9327426|P1|Overall Study|Adverse Event|1
2709621|NCT00347269|9327614|P2|Overall Study|Death|3
2709622|NCT00347269|9327615|P1|Overall Study|Death|2
2709623|NCT00347269|9327614|P2|Overall Study|Withdrawal by Subject|38
2709624|NCT00347269|9327615|P1|Overall Study|Withdrawal by Subject|18
2709625|NCT00347269|9327614|P2|Overall Study|Lost to Follow-up|65
2709626|NCT00347269|9327615|P1|Overall Study|Lost to Follow-up|74
2709627|NCT00347009|9327630|P1|Overall Study|Serious Adverse Event|1
2709628|NCT00347009|9327630|P1|Overall Study|Increased ALT/HBV DNA|1
2709629|NCT00347009|9327630|P1|Overall Study|Insufficient Viral Suppression|3
2709630|NCT00347009|9327630|P1|Overall Study|Adverse Laboratory Experience|1
2709631|NCT00347009|9327630|P1|Overall Study|Protocol Violation|2
2709632|NCT00347009|9327630|P1|Overall Study|Lost to Follow-up|4
2709633|NCT00347009|9327630|P1|Overall Study|Physician Decision|5
2709634|NCT00347009|9327630|P1|Overall Study|Withdrawal by Subject|3
2709635|NCT00347009|9327630|P1|Overall Study|Adverse Event|6
2709636|NCT00347009|9327630|P1|Overall Study|Death|1
2709637|NCT00346775|9327651|P2|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0
2709638|NCT00346775|9327652|P1|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1
2709639|NCT00346775|9327651|P2|Period 1: Intervention Period 1|Protocol Violation|2
2709640|NCT00346775|9327652|P1|Period 1: Intervention Period 1|Protocol Violation|3
2709641|NCT00346775|9327651|P2|Period 1: Intervention Period 1|Lost to Follow-up|1
2709642|NCT00346775|9327652|P1|Period 1: Intervention Period 1|Lost to Follow-up|1
2709643|NCT00346697|9327664|P2|Overall Study|Lost to Follow-up|1
2709644|NCT00346697|9327665|P1|Overall Study|Lost to Follow-up|0
2709645|NCT00346632|9327701|P10|Overall Study|Not Stated|1
2709646|NCT00346632|9327702|P9|Overall Study|Not Stated|2
2709647|NCT00346632|9327703|P8|Overall Study|Not Stated|2
2709648|NCT00346632|9327704|P7|Overall Study|Not Stated|0
2709649|NCT00346632|9327705|P6|Overall Study|Not Stated|0
2709650|NCT00346632|9327706|P5|Overall Study|Not Stated|0
2709651|NCT00346632|9327707|P4|Overall Study|Not Stated|0
2709652|NCT00346632|9327708|P3|Overall Study|Not Stated|0
2709653|NCT00346632|9327709|P2|Overall Study|Not Stated|1
2709654|NCT00346632|9327710|P1|Overall Study|Not Stated|1
2709655|NCT00346632|9327701|P10|Overall Study|Switched to alternative treatment|0
2709656|NCT00346632|9327702|P9|Overall Study|Switched to alternative treatment|0
2709657|NCT00346632|9327703|P8|Overall Study|Switched to alternative treatment|0
2709658|NCT00346632|9327704|P7|Overall Study|Switched to alternative treatment|0
2709659|NCT00346632|9327705|P6|Overall Study|Switched to alternative treatment|0
2709660|NCT00346632|9327706|P5|Overall Study|Switched to alternative treatment|0
2709661|NCT00346632|9327707|P4|Overall Study|Switched to alternative treatment|0
2709662|NCT00346632|9327708|P3|Overall Study|Switched to alternative treatment|1
2709663|NCT00346632|9327709|P2|Overall Study|Switched to alternative treatment|0
2709664|NCT00346632|9327710|P1|Overall Study|Switched to alternative treatment|0
2709665|NCT00346632|9327701|P10|Overall Study|Withdrawal by Subject|0
2709666|NCT00346632|9327702|P9|Overall Study|Withdrawal by Subject|0
2709667|NCT00346632|9327703|P8|Overall Study|Withdrawal by Subject|0
2709668|NCT00346632|9327704|P7|Overall Study|Withdrawal by Subject|1
2709669|NCT00346632|9327705|P6|Overall Study|Withdrawal by Subject|0
2709670|NCT00346632|9327706|P5|Overall Study|Withdrawal by Subject|0
2709671|NCT00346632|9327707|P4|Overall Study|Withdrawal by Subject|0
2709672|NCT00346632|9327708|P3|Overall Study|Withdrawal by Subject|0
2709673|NCT00346632|9327709|P2|Overall Study|Withdrawal by Subject|0
2709674|NCT00346632|9327710|P1|Overall Study|Withdrawal by Subject|0
2709675|NCT00346632|9327701|P10|Overall Study|Protocol Violation|0
2709676|NCT00346632|9327702|P9|Overall Study|Protocol Violation|0
2709677|NCT00346632|9327703|P8|Overall Study|Protocol Violation|0
2709678|NCT00346632|9327704|P7|Overall Study|Protocol Violation|1
2709679|NCT00346632|9327705|P6|Overall Study|Protocol Violation|0
2709680|NCT00346632|9327706|P5|Overall Study|Protocol Violation|0
2709681|NCT00346632|9327707|P4|Overall Study|Protocol Violation|0
2709682|NCT00346632|9327708|P3|Overall Study|Protocol Violation|0
2709683|NCT00346632|9327709|P2|Overall Study|Protocol Violation|0
2709684|NCT00346632|9327710|P1|Overall Study|Protocol Violation|0
2709685|NCT00346632|9327701|P10|Overall Study|Death|0
2709686|NCT00346632|9327702|P9|Overall Study|Death|0
2709687|NCT00346632|9327703|P8|Overall Study|Death|0
2709688|NCT00346632|9327704|P7|Overall Study|Death|0
2709689|NCT00346632|9327705|P6|Overall Study|Death|0
2709690|NCT00346632|9327706|P5|Overall Study|Death|0
2709691|NCT00346632|9327707|P4|Overall Study|Death|0
2709692|NCT00346632|9327708|P3|Overall Study|Death|1
2709693|NCT00346632|9327709|P2|Overall Study|Death|0
2709694|NCT00346632|9327710|P1|Overall Study|Death|0
2709695|NCT00346632|9327701|P10|Overall Study|Adverse Event|0
2709696|NCT00346632|9327702|P9|Overall Study|Adverse Event|0
2709697|NCT00346632|9327703|P8|Overall Study|Adverse Event|0
2709698|NCT00346632|9327704|P7|Overall Study|Adverse Event|1
2709699|NCT00346632|9327705|P6|Overall Study|Adverse Event|1
2709700|NCT00346632|9327706|P5|Overall Study|Adverse Event|1
2709701|NCT00346632|9327707|P4|Overall Study|Adverse Event|0
2709702|NCT00346632|9327708|P3|Overall Study|Adverse Event|0
2709703|NCT00346632|9327709|P2|Overall Study|Adverse Event|0
2709704|NCT00346632|9327710|P1|Overall Study|Adverse Event|0
2709705|NCT00346632|9327701|P10|Overall Study|Progressive Disease|2
2709706|NCT00346632|9327702|P9|Overall Study|Progressive Disease|2
2709707|NCT00346632|9327703|P8|Overall Study|Progressive Disease|2
2709708|NCT00346632|9327704|P7|Overall Study|Progressive Disease|2
2709709|NCT00346632|9327705|P6|Overall Study|Progressive Disease|1
2709710|NCT00346632|9327706|P5|Overall Study|Progressive Disease|3
2709711|NCT00346632|9327707|P4|Overall Study|Progressive Disease|3
2709712|NCT00346632|9327708|P3|Overall Study|Progressive Disease|4
2709713|NCT00346632|9327709|P2|Overall Study|Progressive Disease|2
2709714|NCT00346632|9327710|P1|Overall Study|Progressive Disease|2
2709715|NCT00346398|9327860|P2|Overall Study|Withdrawal by Subject|2
2709716|NCT00346398|9327861|P1|Overall Study|Withdrawal by Subject|0
2709717|NCT00346398|9327860|P2|Overall Study|Lost to Follow-up|0
2709718|NCT00346398|9327861|P1|Overall Study|Lost to Follow-up|3
2709719|NCT00346333|9327873|P2|Overall Study|unwilling or unable to continue|8
2709720|NCT00346333|9327874|P1|Overall Study|unwilling or unable to continue|4
2709721|NCT00346333|9327873|P2|Overall Study|Death|0
2709722|NCT00346333|9327874|P1|Overall Study|Death|1
2709723|NCT00346268|9327890|P2|Overall Study|Participant refused|3
2709724|NCT00346268|9327891|P1|Overall Study|Participant refused|0
2709725|NCT00346268|9327890|P2|Overall Study|Protocol Violation|0
2709726|NCT00346268|9327891|P1|Overall Study|Protocol Violation|1
2709727|NCT00346268|9327890|P2|Overall Study|Adverse Event|0
2709728|NCT00346268|9327891|P1|Overall Study|Adverse Event|1
2709729|NCT00346216|9327926|P3|Overall Study|Missing Subject Summary Status|62
2709730|NCT00346216|9327927|P2|Overall Study|Missing Subject Summary Status|61
2709731|NCT00346216|9327928|P1|Overall Study|Missing Subject Summary Status|62
2709732|NCT00346216|9327926|P3|Overall Study|Study terminated by sponsor|8
2709733|NCT00346216|9327927|P2|Overall Study|Study terminated by sponsor|4
2709734|NCT00346216|9327928|P1|Overall Study|Study terminated by sponsor|11
2709735|NCT00346216|9327926|P3|Overall Study|Death|228
2709736|NCT00346216|9327927|P2|Overall Study|Death|192
2709737|NCT00346216|9327928|P1|Overall Study|Death|189
2709738|NCT00346216|9327926|P3|Overall Study|Does not meet entrance criteria|8
2709739|NCT00346216|9327927|P2|Overall Study|Does not meet entrance criteria|10
2709740|NCT00346216|9327928|P1|Overall Study|Does not meet entrance criteria|13
2709741|NCT00346216|9327926|P3|Overall Study|Physician Decision|59
2709742|NCT00346216|9327927|P2|Overall Study|Physician Decision|76
2709743|NCT00346216|9327928|P1|Overall Study|Physician Decision|80
2709744|NCT00346216|9327926|P3|Overall Study|Lost to Follow-up|542
2709745|NCT00346216|9327927|P2|Overall Study|Lost to Follow-up|588
2709746|NCT00346216|9327928|P1|Overall Study|Lost to Follow-up|611
2709747|NCT00346216|9327926|P3|Overall Study|Withdrawal by Subject|651
2709748|NCT00346216|9327927|P2|Overall Study|Withdrawal by Subject|692
2709749|NCT00346216|9327928|P1|Overall Study|Withdrawal by Subject|661
2709750|NCT00346216|9327926|P3|Overall Study|No longer willing to participate|585
2709751|NCT00346216|9327927|P2|Overall Study|No longer willing to participate|606
2709752|NCT00346216|9327928|P1|Overall Study|No longer willing to participate|600
2709753|NCT00346216|9327926|P3|Overall Study|Other|205
2709754|NCT00346216|9327927|P2|Overall Study|Other|231
2709755|NCT00346216|9327928|P1|Overall Study|Other|181
2709756|NCT00346164|9327949|P4|Overall Study|Inability to start week 16 tx on time|11
2709757|NCT00346164|9327950|P3|Overall Study|Inability to start week 16 tx on time|0
2709758|NCT00346164|9327951|P2|Overall Study|Inability to start week 16 tx on time|0
2709759|NCT00346164|9327952|P1|Overall Study|Inability to start week 16 tx on time|0
2709760|NCT00346164|9327949|P4|Overall Study|Refusal of further protocol therapy|15
2709761|NCT00346164|9327950|P3|Overall Study|Refusal of further protocol therapy|3
2709762|NCT00346164|9327951|P2|Overall Study|Refusal of further protocol therapy|1
2709763|NCT00346164|9327952|P1|Overall Study|Refusal of further protocol therapy|0
2709764|NCT00346164|9327949|P4|Overall Study|Ineligible|23
2709765|NCT00346164|9327950|P3|Overall Study|Ineligible|2
2709766|NCT00346164|9327951|P2|Overall Study|Ineligible|2
2709767|NCT00346164|9327952|P1|Overall Study|Ineligible|11
2709768|NCT00346164|9327949|P4|Overall Study|Withdrawal by Subject|0
2709769|NCT00346164|9327950|P3|Overall Study|Withdrawal by Subject|2
2709770|NCT00346164|9327951|P2|Overall Study|Withdrawal by Subject|0
2709771|NCT00346164|9327952|P1|Overall Study|Withdrawal by Subject|0
2709772|NCT00346164|9327949|P4|Overall Study|Protocol Violation|4
2709773|NCT00346164|9327950|P3|Overall Study|Protocol Violation|10
2709774|NCT00346164|9327951|P2|Overall Study|Protocol Violation|2
2709775|NCT00346164|9327952|P1|Overall Study|Protocol Violation|6
2709776|NCT00346164|9327949|P4|Overall Study|Physician Decision|27
2709777|NCT00346164|9327950|P3|Overall Study|Physician Decision|2
2709778|NCT00346164|9327951|P2|Overall Study|Physician Decision|1
2709779|NCT00346164|9327952|P1|Overall Study|Physician Decision|0
2709780|NCT00346164|9327949|P4|Overall Study|Lack of Efficacy|25
2709781|NCT00346164|9327950|P3|Overall Study|Lack of Efficacy|7
2709782|NCT00346164|9327951|P2|Overall Study|Lack of Efficacy|1
2709783|NCT00346164|9327952|P1|Overall Study|Lack of Efficacy|0
2709784|NCT00346164|9327949|P4|Overall Study|Adverse Event|1
2709785|NCT00346164|9327950|P3|Overall Study|Adverse Event|0
2709786|NCT00346164|9327951|P2|Overall Study|Adverse Event|0
2709787|NCT00346164|9327952|P1|Overall Study|Adverse Event|0
2709788|NCT00346151|9327987|P1|Overall Study|Withdrawal by Subject|3
2709789|NCT00346073|9328007|P2|Overall Study|Lost to Follow-up|24
2709790|NCT00346073|9328008|P1|Overall Study|Lost to Follow-up|39
2709791|NCT00346073|9328007|P2|Overall Study|Serious Adverse Event|0
2709792|NCT00346073|9328008|P1|Overall Study|Serious Adverse Event|2
2709793|NCT00346034|9328042|P1|Overall Study|Not Willing to Follow Dosing Regimen|1
2709794|NCT00346034|9328042|P1|Overall Study|Patient Stopped Taking Study Drug|1
2709795|NCT00346034|9328042|P1|Overall Study|Withdrawal by Subject|13
2709796|NCT00346034|9328042|P1|Overall Study|Lack of Efficacy|8
2709797|NCT00346034|9328042|P1|Overall Study|Adverse Event|34
2709798|NCT00345878|9328082|P2|Overall Study|Other|0
2709799|NCT00345878|9328083|P1|Overall Study|Other|1
2709800|NCT00345878|9328082|P2|Overall Study|Lost to Follow-up|1
2709801|NCT00345878|9328083|P1|Overall Study|Lost to Follow-up|2
2709802|NCT00345878|9328082|P2|Overall Study|Adverse Event|0
2709803|NCT00345878|9328083|P1|Overall Study|Adverse Event|1
2709804|NCT00345839|9328101|P2|Overall Study|Lost to Follow-up|61
2709805|NCT00345839|9328102|P1|Overall Study|Lost to Follow-up|58
2709806|NCT00345839|9328101|P2|Overall Study|Withdrawal by Subject|98
2709807|NCT00345839|9328102|P1|Overall Study|Withdrawal by Subject|91
2709808|NCT00345683|9328128|P2|Overall Study|Other|2
2709809|NCT00345683|9328129|P1|Overall Study|Other|6
2709810|NCT00345683|9328128|P2|Overall Study|Lost to Follow-up|7
2709811|NCT00345683|9328129|P1|Overall Study|Lost to Follow-up|19
2709812|NCT00345631|9328152|P3|Overall Study|Other reasons|1
2709813|NCT00345631|9328153|P2|Overall Study|Other reasons|0
2709814|NCT00345631|9328154|P1|Overall Study|Other reasons|0
2709815|NCT00345631|9328152|P3|Overall Study|Lost to Follow-up|4
2709816|NCT00345631|9328153|P2|Overall Study|Lost to Follow-up|7
2709817|NCT00345631|9328154|P1|Overall Study|Lost to Follow-up|3
2709818|NCT00345631|9328152|P3|Overall Study|Adverse Event|0
2709819|NCT00345631|9328153|P2|Overall Study|Adverse Event|1
2709820|NCT00345631|9328154|P1|Overall Study|Adverse Event|0
2709821|NCT00345631|9328152|P3|Overall Study|Withdrawal by Subject|1
2709822|NCT00345631|9328153|P2|Overall Study|Withdrawal by Subject|0
2709823|NCT00345631|9328154|P1|Overall Study|Withdrawal by Subject|1
2709824|NCT00345605|9328186|P2|Arm 2, Opposite Treatment|Adverse Event|0
2709825|NCT00345605|9328187|P1|Arm 2, Opposite Treatment|Adverse Event|1
2709826|NCT00345605|9328186|P2|Arm 1|Adverse Event|1
2709827|NCT00345605|9328187|P1|Arm 1|Adverse Event|0
2709828|NCT00345592|9328207|P2|Overall Study|Withdrawal by Subject|8
2709829|NCT00345592|9328208|P1|Overall Study|Withdrawal by Subject|11
2709830|NCT00345592|9328207|P2|Overall Study|Death|16
2709831|NCT00345592|9328208|P1|Overall Study|Death|14
2709832|NCT00345579|9328216|P2|Overall Study|Other|1
2709833|NCT00345579|9328217|P1|Overall Study|Other|9
2709834|NCT00345579|9328216|P2|Overall Study|Lost to Follow-up|36
2709835|NCT00345579|9328217|P1|Overall Study|Lost to Follow-up|82
2709836|NCT00345579|9328216|P2|Overall Study|Withdrawal by Subject|17
2709837|NCT00345579|9328217|P1|Overall Study|Withdrawal by Subject|50
2709838|NCT00345579|9328216|P2|Overall Study|Protocol Violation|5
2709839|NCT00345579|9328217|P1|Overall Study|Protocol Violation|14
2709840|NCT00345579|9328216|P2|Overall Study|Adverse Event|6
2709841|NCT00345579|9328217|P1|Overall Study|Adverse Event|9
2709842|NCT00345540|9328237|P1|Overall Study|Withdrawal by Subject|1
2709843|NCT00345397|9328243|P1|Overall Study|Death|1
2709844|NCT00345358|9328274|P4|Booster Vaccination Phase|Lost to Follow-up|0
2709845|NCT00345358|9328275|P3|Booster Vaccination Phase|Lost to Follow-up|0
2709846|NCT00345358|9328276|P2|Booster Vaccination Phase|Lost to Follow-up|0
2709847|NCT00345358|9328277|P1|Booster Vaccination Phase|Lost to Follow-up|3
2709848|NCT00345358|9328274|P4|Booster Vaccination Phase|Withdrawal by Subject|0
2709849|NCT00345358|9328275|P3|Booster Vaccination Phase|Withdrawal by Subject|0
2709850|NCT00345358|9328276|P2|Booster Vaccination Phase|Withdrawal by Subject|0
2709851|NCT00345358|9328277|P1|Booster Vaccination Phase|Withdrawal by Subject|1
2709852|NCT00345358|9328274|P4|Primary Vaccination Phase|Lost to Follow-up|2
2709853|NCT00345358|9328275|P3|Primary Vaccination Phase|Lost to Follow-up|2
2709854|NCT00345358|9328276|P2|Primary Vaccination Phase|Lost to Follow-up|0
2709855|NCT00345358|9328277|P1|Primary Vaccination Phase|Lost to Follow-up|1
2709856|NCT00345358|9328274|P4|Primary Vaccination Phase|Withdrawal by Subject|0
2709857|NCT00345358|9328275|P3|Primary Vaccination Phase|Withdrawal by Subject|4
2709858|NCT00345358|9328276|P2|Primary Vaccination Phase|Withdrawal by Subject|2
2709859|NCT00345358|9328277|P1|Primary Vaccination Phase|Withdrawal by Subject|1
2709860|NCT00345358|9328274|P4|Primary Vaccination Phase|Adverse event, non-fatal|0
2709861|NCT00345358|9328275|P3|Primary Vaccination Phase|Adverse event, non-fatal|1
2709862|NCT00345358|9328276|P2|Primary Vaccination Phase|Adverse event, non-fatal|1
2709863|NCT00345358|9328277|P1|Primary Vaccination Phase|Adverse event, non-fatal|3
2709864|NCT00345358|9328274|P4|Primary Vaccination Phase|Other|0
2709865|NCT00345358|9328275|P3|Primary Vaccination Phase|Other|1
2709866|NCT00345358|9328276|P2|Primary Vaccination Phase|Other|1
2709867|NCT00345358|9328277|P1|Primary Vaccination Phase|Other|0
2709868|NCT00345293|9328367|P2|Overall Study|Withdrawal by Subject|0
2709869|NCT00345293|9328368|P1|Overall Study|Withdrawal by Subject|1
2709870|NCT00345293|9328367|P2|Overall Study|Unable to access line for sample|0
2709871|NCT00345293|9328368|P1|Overall Study|Unable to access line for sample|1
2709872|NCT00345046|9328414|P3|Overall Study|Protocol Violation|2
2709873|NCT00345046|9328415|P2|Overall Study|Protocol Violation|1
2709874|NCT00345046|9328416|P1|Overall Study|Protocol Violation|1
2709875|NCT00344968|9328446|P3|Overall Study|Other|0
2709876|NCT00344968|9328447|P2|Overall Study|Other|1
2709877|NCT00344968|9328448|P1|Overall Study|Other|0
2709878|NCT00344968|9328446|P3|Overall Study|Death|31
2709879|NCT00344968|9328447|P2|Overall Study|Death|27
2709880|NCT00344968|9328448|P1|Overall Study|Death|11
2709881|NCT00344968|9328446|P3|Overall Study|Lost to Follow-up|37
2709882|NCT00344968|9328447|P2|Overall Study|Lost to Follow-up|37
2709883|NCT00344968|9328448|P1|Overall Study|Lost to Follow-up|24
2709884|NCT00344968|9328446|P3|Overall Study|Withdrawal by Subject|27
2709885|NCT00344968|9328447|P2|Overall Study|Withdrawal by Subject|31
2709886|NCT00344968|9328448|P1|Overall Study|Withdrawal by Subject|14
2709887|NCT00344968|9328446|P3|Overall Study|Protocol Violation|5
2709888|NCT00344968|9328447|P2|Overall Study|Protocol Violation|2
2709889|NCT00344968|9328448|P1|Overall Study|Protocol Violation|2
2709890|NCT00344968|9328446|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
2709891|NCT00344968|9328447|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
2709892|NCT00344968|9328448|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
2709893|NCT00344968|9328446|P3|Overall Study|Adverse Event|15
2709894|NCT00344968|9328447|P2|Overall Study|Adverse Event|4
2709895|NCT00344968|9328448|P1|Overall Study|Adverse Event|5
2709896|NCT00344773|9328459|P1|Overall Study|Not Eligible for the study|2
2709897|NCT00344773|9328459|P1|Overall Study|Withdrawal by Subject|1
2709898|NCT00344773|9328459|P1|Overall Study|Objective Disease Progression|16
2709899|NCT00344773|9328459|P1|Overall Study|Adverse Event|2
2709900|NCT00344500|9328482|P3|Overall Study|Not Noted|0
2709901|NCT00344500|9328483|P2|Overall Study|Not Noted|3
2709902|NCT00344500|9328484|P1|Overall Study|Not Noted|1
2709903|NCT00344500|9328482|P3|Overall Study|Protocol Violation|1
2709904|NCT00344500|9328483|P2|Overall Study|Protocol Violation|7
2709905|NCT00344500|9328484|P1|Overall Study|Protocol Violation|4
2709906|NCT00344500|9328482|P3|Overall Study|Withdrawal by Subject|0
2709907|NCT00344500|9328483|P2|Overall Study|Withdrawal by Subject|10
2709908|NCT00344500|9328484|P1|Overall Study|Withdrawal by Subject|7
2709909|NCT00344500|9328482|P3|Overall Study|Lost to Follow-up|1
2709910|NCT00344500|9328483|P2|Overall Study|Lost to Follow-up|13
2709911|NCT00344500|9328484|P1|Overall Study|Lost to Follow-up|5
2709912|NCT00344500|9328482|P3|Overall Study|Adverse Event|0
2709913|NCT00344500|9328483|P2|Overall Study|Adverse Event|2
2709914|NCT00344500|9328484|P1|Overall Study|Adverse Event|6
2709915|NCT00344487|9328495|P1|Overall Study|immunologic failure|1
2709916|NCT00344461|9328499|P1|Overall Study|Withdrawal by Subject|2
2709917|NCT00344461|9328499|P1|Overall Study|Protocol Violation|6
2709918|NCT00344461|9328499|P1|Overall Study|Physician Decision|2
2709919|NCT00344461|9328499|P1|Overall Study|Lost to Follow-up|2
2709920|NCT00344461|9328499|P1|Overall Study|Lack of Efficacy|2
2709921|NCT00344461|9328499|P1|Overall Study|Death|1
2709922|NCT00344461|9328499|P1|Overall Study|Adverse Event|6
2709923|NCT00344448|9328510|P2|Open Label|Study terminated|0
2709924|NCT00344448|9328511|P1|Open Label|Study terminated|1
2709925|NCT00344448|9328510|P2|Open Label|Withdrawal by Subject|1
2709926|NCT00344448|9328511|P1|Open Label|Withdrawal by Subject|1
2709927|NCT00344448|9328510|P2|Double Blind, Placebo Controlled|Study terminated|0
2709928|NCT00344448|9328511|P1|Double Blind, Placebo Controlled|Study terminated|1
2709929|NCT00344448|9328510|P2|Double Blind, Placebo Controlled|Withdrawal by Subject|0
2709930|NCT00344448|9328511|P1|Double Blind, Placebo Controlled|Withdrawal by Subject|1
2709931|NCT00344448|9328510|P2|Screening|Withdrawal by Subject|1
2709932|NCT00344448|9328511|P1|Screening|Withdrawal by Subject|0
2709933|NCT00344318|9328532|P4|Overall Study|Lost to Follow-up|0
2709934|NCT00344318|9328533|P3|Overall Study|Lost to Follow-up|1
2709935|NCT00344318|9328534|P2|Overall Study|Lost to Follow-up|0
2709936|NCT00344318|9328535|P1|Overall Study|Lost to Follow-up|2
2709937|NCT00344318|9328532|P4|Overall Study|Withdrawal by Subject|2
2709938|NCT00344318|9328533|P3|Overall Study|Withdrawal by Subject|0
2709939|NCT00344318|9328534|P2|Overall Study|Withdrawal by Subject|2
2709940|NCT00344318|9328535|P1|Overall Study|Withdrawal by Subject|2
2709941|NCT00344318|9328532|P4|Overall Study|Adverse Event|1
2709942|NCT00344318|9328533|P3|Overall Study|Adverse Event|0
2709943|NCT00344318|9328534|P2|Overall Study|Adverse Event|3
2709944|NCT00344318|9328535|P1|Overall Study|Adverse Event|0
2709945|NCT00344305|9328657|P2|Overall Study|Participant was not contacted in window|1
2709946|NCT00344305|9328658|P1|Overall Study|Participant was not contacted in window|0
2709947|NCT00344305|9328657|P2|Overall Study|Lost to Follow-up|0
2709948|NCT00344305|9328658|P1|Overall Study|Lost to Follow-up|2
2709949|NCT00344032|9328708|P2|Overall Study|Physician Decision|1
2709950|NCT00344032|9328709|P1|Overall Study|Physician Decision|4
2709951|NCT00344032|9328708|P2|Overall Study|Lost to Follow-up|6
2709952|NCT00344032|9328709|P1|Overall Study|Lost to Follow-up|4
2709953|NCT00344032|9328708|P2|Overall Study|Withdrawal by Subject|2
2709954|NCT00344032|9328709|P1|Overall Study|Withdrawal by Subject|6
2709955|NCT00344032|9328708|P2|Overall Study|Adverse Event|1
2709956|NCT00344032|9328709|P1|Overall Study|Adverse Event|0
2709957|NCT00344019|9328728|P3|Overall Study|did not meet final inclusion criteria|74
2709958|NCT00344019|9328729|P2|Overall Study|did not meet final inclusion criteria|0
2709959|NCT00344019|9328730|P1|Overall Study|did not meet final inclusion criteria|0
2709960|NCT00343915|9328748|P2|Primary Study|Other|0
2709961|NCT00343915|9328749|P1|Primary Study|Other|1
2709962|NCT00343915|9328748|P2|Primary Study|Lost to Follow-up|3
2709963|NCT00343915|9328749|P1|Primary Study|Lost to Follow-up|2
2709964|NCT00343915|9328748|P2|Primary Study|Withdrawal by Subject|0
2709965|NCT00343915|9328749|P1|Primary Study|Withdrawal by Subject|1
2709966|NCT00343889|9328775|P2|Overall Study|Protocol Violation|0
2709967|NCT00343889|9328776|P1|Overall Study|Protocol Violation|1
2709968|NCT00343889|9328775|P2|Overall Study|Withdrawal by Subject|1
2709969|NCT00343889|9328776|P1|Overall Study|Withdrawal by Subject|0
2709970|NCT00343889|9328775|P2|Overall Study|Lost to Follow-up|0
2709971|NCT00343889|9328776|P1|Overall Study|Lost to Follow-up|2
2709972|NCT00343512|9328940|P1|Overall Study|Withdrawal by Subject|2
2709973|NCT00343382|9329028|P3|Overall Study|Other Reason Not Specified|4
2709974|NCT00343382|9329029|P2|Overall Study|Other Reason Not Specified|2
2709975|NCT00343382|9329030|P1|Overall Study|Other Reason Not Specified|1
2709976|NCT00343382|9329028|P3|Overall Study|Withdrawal by Subject|6
2709977|NCT00343382|9329029|P2|Overall Study|Withdrawal by Subject|2
2709978|NCT00343382|9329030|P1|Overall Study|Withdrawal by Subject|1
2709979|NCT00343382|9329028|P3|Overall Study|Adverse Event|7
2709980|NCT00343382|9329029|P2|Overall Study|Adverse Event|10
2709981|NCT00343382|9329030|P1|Overall Study|Adverse Event|2
2709982|NCT00343291|9329049|P2|Overall Study|Other|5
2709983|NCT00343291|9329050|P1|Overall Study|Other|8
2709984|NCT00343291|9329049|P2|Overall Study|Withdrawal by Subject|2
2709985|NCT00343291|9329050|P1|Overall Study|Withdrawal by Subject|0
2709986|NCT00343291|9329049|P2|Overall Study|Progressive disease|34
2709987|NCT00343291|9329050|P1|Overall Study|Progressive disease|33
2709988|NCT00343291|9329049|P2|Overall Study|Death|2
2709989|NCT00343291|9329050|P1|Overall Study|Death|3
2709990|NCT00343291|9329049|P2|Overall Study|Adverse Event|13
2709991|NCT00343291|9329050|P1|Overall Study|Adverse Event|13
2709992|NCT00343252|9329066|P2|18 Months (All Treated Participants)|Withdrawal by Subject|20
2709993|NCT00343252|9329067|P1|18 Months (All Treated Participants)|Withdrawal by Subject|36
2709994|NCT00343252|9329066|P2|18 Months (All Treated Participants)|Sponsor Decision|5
2709995|NCT00343252|9329067|P1|18 Months (All Treated Participants)|Sponsor Decision|8
2709996|NCT00343252|9329066|P2|18 Months (All Treated Participants)|Protocol Violation|3
2709997|NCT00343252|9329067|P1|18 Months (All Treated Participants)|Protocol Violation|3
2709998|NCT00343252|9329066|P2|18 Months (All Treated Participants)|Physician Decision|7
2709999|NCT00343252|9329067|P1|18 Months (All Treated Participants)|Physician Decision|4
2710000|NCT00343252|9329066|P2|18 Months (All Treated Participants)|Lost to Follow-up|7
2710001|NCT00343252|9329067|P1|18 Months (All Treated Participants)|Lost to Follow-up|3
2710002|NCT00343252|9329066|P2|18 Months (All Treated Participants)|Lack of Efficacy|1
2710003|NCT00343252|9329067|P1|18 Months (All Treated Participants)|Lack of Efficacy|1
2710004|NCT00343252|9329066|P2|18 Months (All Treated Participants)|Entry Criteria Not Met|10
2710005|NCT00343252|9329067|P1|18 Months (All Treated Participants)|Entry Criteria Not Met|11
2710006|NCT00343252|9329066|P2|18 Months (All Treated Participants)|Death|5
2710007|NCT00343252|9329067|P1|18 Months (All Treated Participants)|Death|4
2710008|NCT00343252|9329066|P2|18 Months (All Treated Participants)|Adverse Event|23
2710009|NCT00343252|9329067|P1|18 Months (All Treated Participants)|Adverse Event|31
2710010|NCT00343252|9329066|P2|12 Months (All Treated Participants)|Withdrawal by Subject|17
2710011|NCT00343252|9329067|P1|12 Months (All Treated Participants)|Withdrawal by Subject|33
2710012|NCT00343252|9329066|P2|12 Months (All Treated Participants)|Sponsor Decision|6
2710013|NCT00343252|9329067|P1|12 Months (All Treated Participants)|Sponsor Decision|9
2710014|NCT00343252|9329066|P2|12 Months (All Treated Participants)|Protocol Violation|2
2710015|NCT00343252|9329067|P1|12 Months (All Treated Participants)|Protocol Violation|3
2710016|NCT00343252|9329066|P2|12 Months (All Treated Participants)|Physician Decision|5
2710017|NCT00343252|9329067|P1|12 Months (All Treated Participants)|Physician Decision|4
2710018|NCT00343252|9329066|P2|12 Months (All Treated Participants)|Lost to Follow-up|5
2710019|NCT00343252|9329067|P1|12 Months (All Treated Participants)|Lost to Follow-up|1
2710020|NCT00343252|9329066|P2|12 Months (All Treated Participants)|Lack of Efficacy|1
2710021|NCT00343252|9329067|P1|12 Months (All Treated Participants)|Lack of Efficacy|1
2710022|NCT00343252|9329066|P2|12 Months (All Treated Participants)|Entry Criteria Not Met|10
2710023|NCT00343252|9329067|P1|12 Months (All Treated Participants)|Entry Criteria Not Met|10
2710024|NCT00343252|9329066|P2|12 Months (All Treated Participants)|Death|3
2710025|NCT00343252|9329067|P1|12 Months (All Treated Participants)|Death|3
2710026|NCT00343252|9329066|P2|12 Months (All Treated Participants)|Adverse Event|20
2710027|NCT00343252|9329067|P1|12 Months (All Treated Participants)|Adverse Event|22
2710028|NCT00343252|9329066|P2|6 Months (All Treated Participants)|Withdrawal by Subject|9
2710029|NCT00343252|9329067|P1|6 Months (All Treated Participants)|Withdrawal by Subject|19
2710030|NCT00343252|9329066|P2|6 Months (All Treated Participants)|Sponsor Decision|4
2710031|NCT00343252|9329067|P1|6 Months (All Treated Participants)|Sponsor Decision|7
2710032|NCT00343252|9329066|P2|6 Months (All Treated Participants)|Protocol Violation|2
2710033|NCT00343252|9329067|P1|6 Months (All Treated Participants)|Protocol Violation|2
2710034|NCT00343252|9329066|P2|6 Months (All Treated Participants)|Physician Decision|3
2710035|NCT00343252|9329067|P1|6 Months (All Treated Participants)|Physician Decision|1
2710036|NCT00343252|9329066|P2|6 Months (All Treated Participants)|Lost to Follow-up|4
2710037|NCT00343252|9329067|P1|6 Months (All Treated Participants)|Lost to Follow-up|0
2710038|NCT00343252|9329066|P2|6 Months (All Treated Participants)|Lack of Efficacy|1
2710039|NCT00343252|9329067|P1|6 Months (All Treated Participants)|Lack of Efficacy|0
2710040|NCT00343252|9329066|P2|6 Months (All Treated Participants)|Entry Criteria Not Met|8
2710041|NCT00343252|9329067|P1|6 Months (All Treated Participants)|Entry Criteria Not Met|10
2710042|NCT00343252|9329066|P2|6 Months (All Treated Participants)|Death|2
2710043|NCT00343252|9329067|P1|6 Months (All Treated Participants)|Death|0
2710044|NCT00343252|9329066|P2|6 Months (All Treated Participants)|Adverse Event|11
2710045|NCT00343252|9329067|P1|6 Months (All Treated Participants)|Adverse Event|17
2710046|NCT00342628|9329132|P3|Overall Study|moved residence|1
2710047|NCT00342628|9329133|P2|Overall Study|moved residence|1
2710048|NCT00342628|9329134|P1|Overall Study|moved residence|0
2710049|NCT00342628|9329132|P3|Overall Study|Death|0
2710050|NCT00342628|9329133|P2|Overall Study|Death|1
2710051|NCT00342628|9329134|P1|Overall Study|Death|1
2710052|NCT00342628|9329132|P3|Overall Study|Withdrawal by Subject|18
2710053|NCT00342628|9329133|P2|Overall Study|Withdrawal by Subject|19
2710054|NCT00342628|9329134|P1|Overall Study|Withdrawal by Subject|19
2710055|NCT00340834|9329200|P5|Extension Phase of Study|Death|1
2710056|NCT00340834|9329201|P4|Extension Phase of Study|Death|0
2710057|NCT00340834|9329202|P3|Extension Phase of Study|Death|0
2710058|NCT00340834|9329203|P2|Extension Phase of Study|Death|0
2710059|NCT00340834|9329204|P1|Extension Phase of Study|Death|0
2710060|NCT00340834|9329200|P5|Extension Phase of Study|Protocol Violation|0
2710061|NCT00340834|9329201|P4|Extension Phase of Study|Protocol Violation|0
2710062|NCT00340834|9329202|P3|Extension Phase of Study|Protocol Violation|0
2710063|NCT00340834|9329203|P2|Extension Phase of Study|Protocol Violation|0
2710064|NCT00340834|9329204|P1|Extension Phase of Study|Protocol Violation|3
2710065|NCT00340834|9329200|P5|Extension Phase of Study|Abnormal test procedure result(s)|2
2710066|NCT00340834|9329201|P4|Extension Phase of Study|Abnormal test procedure result(s)|0
2710067|NCT00340834|9329202|P3|Extension Phase of Study|Abnormal test procedure result(s)|0
2710068|NCT00340834|9329203|P2|Extension Phase of Study|Abnormal test procedure result(s)|1
2710069|NCT00340834|9329204|P1|Extension Phase of Study|Abnormal test procedure result(s)|0
2710070|NCT00340834|9329200|P5|Extension Phase of Study|Administrative problems|1
2710071|NCT00340834|9329201|P4|Extension Phase of Study|Administrative problems|1
2710072|NCT00340834|9329202|P3|Extension Phase of Study|Administrative problems|0
2710073|NCT00340834|9329203|P2|Extension Phase of Study|Administrative problems|0
2710074|NCT00340834|9329204|P1|Extension Phase of Study|Administrative problems|3
2710075|NCT00340834|9329200|P5|Extension Phase of Study|Subject no longer requires study drug|2
2710076|NCT00340834|9329201|P4|Extension Phase of Study|Subject no longer requires study drug|0
2710077|NCT00340834|9329202|P3|Extension Phase of Study|Subject no longer requires study drug|0
2710078|NCT00340834|9329203|P2|Extension Phase of Study|Subject no longer requires study drug|0
2710079|NCT00340834|9329204|P1|Extension Phase of Study|Subject no longer requires study drug|4
2710080|NCT00340834|9329200|P5|Extension Phase of Study|Lost to Follow-up|3
2710081|NCT00340834|9329201|P4|Extension Phase of Study|Lost to Follow-up|2
2710082|NCT00340834|9329202|P3|Extension Phase of Study|Lost to Follow-up|0
2710083|NCT00340834|9329203|P2|Extension Phase of Study|Lost to Follow-up|1
2710084|NCT00340834|9329204|P1|Extension Phase of Study|Lost to Follow-up|1
2710085|NCT00340834|9329200|P5|Extension Phase of Study|Unsatisfactory therapeutic effect|9
2710086|NCT00340834|9329201|P4|Extension Phase of Study|Unsatisfactory therapeutic effect|4
2710087|NCT00340834|9329202|P3|Extension Phase of Study|Unsatisfactory therapeutic effect|0
2710088|NCT00340834|9329203|P2|Extension Phase of Study|Unsatisfactory therapeutic effect|7
2710089|NCT00340834|9329204|P1|Extension Phase of Study|Unsatisfactory therapeutic effect|13
2710090|NCT00340834|9329200|P5|Extension Phase of Study|Abnormal laboratory value(s)|4
2710091|NCT00340834|9329201|P4|Extension Phase of Study|Abnormal laboratory value(s)|13
2710092|NCT00340834|9329202|P3|Extension Phase of Study|Abnormal laboratory value(s)|0
2710093|NCT00340834|9329203|P2|Extension Phase of Study|Abnormal laboratory value(s)|13
2710094|NCT00340834|9329204|P1|Extension Phase of Study|Abnormal laboratory value(s)|14
2710095|NCT00340834|9329200|P5|Extension Phase of Study|Adverse Event|7
2710096|NCT00340834|9329201|P4|Extension Phase of Study|Adverse Event|19
2710097|NCT00340834|9329202|P3|Extension Phase of Study|Adverse Event|0
2710098|NCT00340834|9329203|P2|Extension Phase of Study|Adverse Event|22
2710099|NCT00340834|9329204|P1|Extension Phase of Study|Adverse Event|21
2710100|NCT00340834|9329200|P5|Extension Phase of Study|Subject withdrew consent|15
2710101|NCT00340834|9329201|P4|Extension Phase of Study|Subject withdrew consent|12
2710102|NCT00340834|9329202|P3|Extension Phase of Study|Subject withdrew consent|0
2710103|NCT00340834|9329203|P2|Extension Phase of Study|Subject withdrew consent|31
2710104|NCT00340834|9329204|P1|Extension Phase of Study|Subject withdrew consent|26
2710105|NCT00340834|9329200|P5|Extension Phase of Study|Subject did not receive study drug|0
2710106|NCT00340834|9329201|P4|Extension Phase of Study|Subject did not receive study drug|2
2710107|NCT00340834|9329202|P3|Extension Phase of Study|Subject did not receive study drug|0
2710108|NCT00340834|9329203|P2|Extension Phase of Study|Subject did not receive study drug|1
2710109|NCT00340834|9329204|P1|Extension Phase of Study|Subject did not receive study drug|0
2710110|NCT00340834|9329200|P5|Core Phase of Study|Protocol Violation|0
2710111|NCT00340834|9329201|P4|Core Phase of Study|Protocol Violation|0
2710112|NCT00340834|9329202|P3|Core Phase of Study|Protocol Violation|2
2710113|NCT00340834|9329203|P2|Core Phase of Study|Protocol Violation|0
2710114|NCT00340834|9329204|P1|Core Phase of Study|Protocol Violation|0
2710115|NCT00340834|9329200|P5|Core Phase of Study|Death|0
2710116|NCT00340834|9329201|P4|Core Phase of Study|Death|0
2710117|NCT00340834|9329202|P3|Core Phase of Study|Death|0
2710118|NCT00340834|9329203|P2|Core Phase of Study|Death|0
2710119|NCT00340834|9329204|P1|Core Phase of Study|Death|2
2710120|NCT00340834|9329200|P5|Core Phase of Study|Lost to Follow-up|0
2710121|NCT00340834|9329201|P4|Core Phase of Study|Lost to Follow-up|0
2710122|NCT00340834|9329202|P3|Core Phase of Study|Lost to Follow-up|4
2710123|NCT00340834|9329203|P2|Core Phase of Study|Lost to Follow-up|1
2710124|NCT00340834|9329204|P1|Core Phase of Study|Lost to Follow-up|1
2710125|NCT00340834|9329200|P5|Core Phase of Study|Abnormal test procedure result(s)|0
2710126|NCT00340834|9329201|P4|Core Phase of Study|Abnormal test procedure result(s)|0
2710127|NCT00340834|9329202|P3|Core Phase of Study|Abnormal test procedure result(s)|3
2710128|NCT00340834|9329203|P2|Core Phase of Study|Abnormal test procedure result(s)|3
2710129|NCT00340834|9329204|P1|Core Phase of Study|Abnormal test procedure result(s)|4
2710130|NCT00340834|9329200|P5|Core Phase of Study|Abnormal laboratory value(s)|0
2710131|NCT00340834|9329201|P4|Core Phase of Study|Abnormal laboratory value(s)|0
2710132|NCT00340834|9329202|P3|Core Phase of Study|Abnormal laboratory value(s)|1
2710133|NCT00340834|9329203|P2|Core Phase of Study|Abnormal laboratory value(s)|6
2710134|NCT00340834|9329204|P1|Core Phase of Study|Abnormal laboratory value(s)|4
2710135|NCT00340834|9329200|P5|Core Phase of Study|Lack of Efficacy|0
2710136|NCT00340834|9329201|P4|Core Phase of Study|Lack of Efficacy|0
2710137|NCT00340834|9329202|P3|Core Phase of Study|Lack of Efficacy|7
2710138|NCT00340834|9329203|P2|Core Phase of Study|Lack of Efficacy|3
2710139|NCT00340834|9329204|P1|Core Phase of Study|Lack of Efficacy|3
2710140|NCT00340834|9329200|P5|Core Phase of Study|Administrative Problems|0
2710141|NCT00340834|9329201|P4|Core Phase of Study|Administrative Problems|0
2710142|NCT00340834|9329202|P3|Core Phase of Study|Administrative Problems|7
2710143|NCT00340834|9329203|P2|Core Phase of Study|Administrative Problems|2
2710144|NCT00340834|9329204|P1|Core Phase of Study|Administrative Problems|6
2710145|NCT00340834|9329200|P5|Core Phase of Study|Withdrawal by Subject|0
2710146|NCT00340834|9329201|P4|Core Phase of Study|Withdrawal by Subject|0
2710147|NCT00340834|9329202|P3|Core Phase of Study|Withdrawal by Subject|16
2710148|NCT00340834|9329203|P2|Core Phase of Study|Withdrawal by Subject|9
2710149|NCT00340834|9329204|P1|Core Phase of Study|Withdrawal by Subject|11
2710150|NCT00340834|9329200|P5|Core Phase of Study|Adverse Event|0
2710151|NCT00340834|9329201|P4|Core Phase of Study|Adverse Event|0
2710152|NCT00340834|9329202|P3|Core Phase of Study|Adverse Event|9
2710153|NCT00340834|9329203|P2|Core Phase of Study|Adverse Event|9
2710154|NCT00340834|9329204|P1|Core Phase of Study|Adverse Event|26
2710155|NCT00340704|9329238|P9|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28
2710156|NCT00340704|9329239|P8|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11
2710157|NCT00340704|9329240|P7|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53
2710158|NCT00340704|9329241|P6|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3
2710159|NCT00340704|9329242|P5|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
2710160|NCT00340704|9329243|P4|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
2710161|NCT00340704|9329244|P3|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
2710162|NCT00340704|9329245|P2|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
2710163|NCT00340704|9329246|P1|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
2710164|NCT00340704|9329238|P9|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
2710165|NCT00340704|9329239|P8|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
2710166|NCT00340704|9329240|P7|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
2710167|NCT00340704|9329241|P6|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3
2710168|NCT00340704|9329242|P5|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1
2710169|NCT00340704|9329243|P4|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
2710170|NCT00340704|9329244|P3|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
2710171|NCT00340704|9329245|P2|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
2710172|NCT00340704|9329246|P1|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
2710173|NCT00340704|9329238|P9|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
2710174|NCT00340704|9329239|P8|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
2710175|NCT00340704|9329240|P7|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
2710176|NCT00340704|9329241|P6|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1
2710177|NCT00340704|9329242|P5|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
2710178|NCT00340704|9329243|P4|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
2710179|NCT00340704|9329244|P3|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
2710180|NCT00340704|9329245|P2|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
2710181|NCT00340704|9329246|P1|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
2710182|NCT00340704|9329238|P9|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
2710183|NCT00340704|9329239|P8|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
2710184|NCT00340704|9329240|P7|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
2710185|NCT00340704|9329241|P6|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
2710186|NCT00340704|9329242|P5|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4
2710187|NCT00340704|9329243|P4|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2
2710188|NCT00340704|9329244|P3|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
2710189|NCT00340704|9329245|P2|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
2710190|NCT00340704|9329246|P1|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
2710191|NCT00340704|9329238|P9|PK Study|Not treated|0
2710192|NCT00340704|9329239|P8|PK Study|Not treated|0
2710193|NCT00340704|9329240|P7|PK Study|Not treated|0
2710194|NCT00340704|9329241|P6|PK Study|Not treated|0
2710195|NCT00340704|9329242|P5|PK Study|Not treated|0
2710196|NCT00340704|9329243|P4|PK Study|Not treated|0
2710197|NCT00340704|9329244|P3|PK Study|Not treated|1
2710198|NCT00340704|9329245|P2|PK Study|Not treated|0
2710199|NCT00340704|9329246|P1|PK Study|Not treated|0
2710200|NCT00340704|9329238|P9|PK Study|Adverse Event|0
2710201|NCT00340704|9329239|P8|PK Study|Adverse Event|0
2710202|NCT00340704|9329240|P7|PK Study|Adverse Event|0
2710203|NCT00340704|9329241|P6|PK Study|Adverse Event|0
2710204|NCT00340704|9329242|P5|PK Study|Adverse Event|0
2710205|NCT00340704|9329243|P4|PK Study|Adverse Event|0
2710206|NCT00340704|9329244|P3|PK Study|Adverse Event|0
2710207|NCT00340704|9329245|P2|PK Study|Adverse Event|1
2710208|NCT00340704|9329246|P1|PK Study|Adverse Event|0
2710209|NCT00340678|9329352|P4|Overall Study|Lost to Follow-up|0
2710210|NCT00340678|9329353|P3|Overall Study|Lost to Follow-up|0
2710211|NCT00340678|9329354|P2|Overall Study|Lost to Follow-up|0
2710212|NCT00340678|9329355|P1|Overall Study|Lost to Follow-up|1
2710213|NCT00339833|9329382|P2|Overall Study|Error in data records|0
2710214|NCT00339833|9329383|P1|Overall Study|Error in data records|1
2710215|NCT00339833|9329382|P2|Overall Study|anaemia or excess drop in glycaemia|0
2710216|NCT00339833|9329383|P1|Overall Study|anaemia or excess drop in glycaemia|2
2710217|NCT00339833|9329382|P2|Overall Study|Poor venous access|2
2710218|NCT00339833|9329383|P1|Overall Study|Poor venous access|2
2710219|NCT00339833|9329382|P2|Overall Study|minor infection|1
2710220|NCT00339833|9329383|P1|Overall Study|minor infection|0
2710221|NCT00339833|9329382|P2|Overall Study|Chest pain|1
2710222|NCT00339833|9329383|P1|Overall Study|Chest pain|0
2710223|NCT00339833|9329382|P2|Overall Study|indigestion|1
2710224|NCT00339833|9329383|P1|Overall Study|indigestion|0
2710225|NCT00339833|9329382|P2|Overall Study|toothache|1
2710226|NCT00339833|9329383|P1|Overall Study|toothache|0
2710227|NCT00339833|9329382|P2|Overall Study|Withdrawal by Subject|2
2710228|NCT00339833|9329383|P1|Overall Study|Withdrawal by Subject|1
2710229|NCT00339183|9329393|P2|Overall Study|Ongoing|13
2710230|NCT00339183|9329394|P1|Overall Study|Ongoing|20
2710231|NCT00339183|9329393|P2|Overall Study|Other|40
2710232|NCT00339183|9329394|P1|Overall Study|Other|46
2710233|NCT00339183|9329393|P2|Overall Study|Missing reason|1
2710234|NCT00339183|9329394|P1|Overall Study|Missing reason|3
2710235|NCT00339183|9329393|P2|Overall Study|Protocol-specified criteria|8
2710236|NCT00339183|9329394|P1|Overall Study|Protocol-specified criteria|12
2710237|NCT00339183|9329393|P2|Overall Study|Lost to Follow-up|17
2710238|NCT00339183|9329394|P1|Overall Study|Lost to Follow-up|17
2710239|NCT00339183|9329393|P2|Overall Study|Physician Decision|4
2710240|NCT00339183|9329394|P1|Overall Study|Physician Decision|2
2710241|NCT00339183|9329393|P2|Overall Study|Withdrawal by Subject|19
2710242|NCT00339183|9329394|P1|Overall Study|Withdrawal by Subject|16
2710243|NCT00339183|9329393|P2|Overall Study|Adverse Event|3
2710244|NCT00339183|9329394|P1|Overall Study|Adverse Event|5
2710245|NCT00339144|9329423|P3|Overall Study|Participant's request to discontinuation|1
2710246|NCT00339144|9329424|P2|Overall Study|Participant's request to discontinuation|0
2710247|NCT00339144|9329425|P1|Overall Study|Participant's request to discontinuation|1
2710248|NCT00339144|9329423|P3|Overall Study|Study drug toxicity|1
2710249|NCT00339144|9329424|P2|Overall Study|Study drug toxicity|1
2710250|NCT00339144|9329425|P1|Overall Study|Study drug toxicity|3
2710251|NCT00339144|9329423|P3|Overall Study|Disease progression|2
2710252|NCT00339144|9329424|P2|Overall Study|Disease progression|2
2710253|NCT00339144|9329425|P1|Overall Study|Disease progression|5
2710254|NCT00339040|9329530|P2|Stage II|Site closing|0
2710255|NCT00339040|9329531|P1|Stage II|Site closing|2
2710256|NCT00339040|9329530|P2|Stage II|Not able to attend clinic|0
2710257|NCT00339040|9329531|P1|Stage II|Not able to attend clinic|1
2710258|NCT00339040|9329530|P2|Stage II|Protocol Violation|0
2710259|NCT00339040|9329531|P1|Stage II|Protocol Violation|3
2710260|NCT00339040|9329530|P2|Stage II|Withdrawal by Subject|2
2710261|NCT00339040|9329531|P1|Stage II|Withdrawal by Subject|1
2710262|NCT00339040|9329530|P2|Stage II|Lost to Follow-up|0
2710263|NCT00339040|9329531|P1|Stage II|Lost to Follow-up|3
2710264|NCT00339040|9329530|P2|Stage I|Protocol Violation|1
2710265|NCT00339040|9329531|P1|Stage I|Protocol Violation|1
2710266|NCT00339040|9329530|P2|Stage I|Not able to attend clinic|0
2710267|NCT00339040|9329531|P1|Stage I|Not able to attend clinic|1
2710268|NCT00338962|9329558|P4|Overall Study|Poor Compliance|0
2710269|NCT00338962|9329559|P3|Overall Study|Poor Compliance|2
2710270|NCT00338962|9329560|P2|Overall Study|Poor Compliance|0
2710271|NCT00338962|9329561|P1|Overall Study|Poor Compliance|0
2710272|NCT00338962|9329558|P4|Overall Study|Adverse Event|0
2710273|NCT00338962|9329559|P3|Overall Study|Adverse Event|2
2710274|NCT00338962|9329560|P2|Overall Study|Adverse Event|0
2710275|NCT00338962|9329561|P1|Overall Study|Adverse Event|0
2710276|NCT00338962|9329558|P4|Overall Study|Moved|0
2710277|NCT00338962|9329559|P3|Overall Study|Moved|0
2710278|NCT00338962|9329560|P2|Overall Study|Moved|1
2710279|NCT00338962|9329561|P1|Overall Study|Moved|0
2710280|NCT00338962|9329558|P4|Overall Study|Time Constraint|0
2710281|NCT00338962|9329559|P3|Overall Study|Time Constraint|0
2710282|NCT00338962|9329560|P2|Overall Study|Time Constraint|0
2710283|NCT00338962|9329561|P1|Overall Study|Time Constraint|2
2710284|NCT00338962|9329558|P4|Overall Study|No Transportation|0
2710285|NCT00338962|9329559|P3|Overall Study|No Transportation|0
2710286|NCT00338962|9329560|P2|Overall Study|No Transportation|0
2710287|NCT00338962|9329561|P1|Overall Study|No Transportation|2
2710288|NCT00338962|9329558|P4|Overall Study|Withdrawal by Subject|0
2710289|NCT00338962|9329559|P3|Overall Study|Withdrawal by Subject|0
2710290|NCT00338962|9329560|P2|Overall Study|Withdrawal by Subject|0
2710291|NCT00338962|9329561|P1|Overall Study|Withdrawal by Subject|1
2710292|NCT00338962|9329558|P4|Overall Study|Lost to Follow-up|3
2710293|NCT00338962|9329559|P3|Overall Study|Lost to Follow-up|2
2710294|NCT00338962|9329560|P2|Overall Study|Lost to Follow-up|3
2710295|NCT00338962|9329561|P1|Overall Study|Lost to Follow-up|3
2710296|NCT00338884|9329583|P1|Overall Study|Randomized But Did Not Receive Treatment|1
2710297|NCT00338884|9329583|P1|Overall Study|Lost to Follow-up|1
2710298|NCT00338884|9329583|P1|Overall Study|Withdrawal by Subject|3
2710299|NCT00338884|9329583|P1|Overall Study|Global Deterioration of Health Status|3
2710300|NCT00338884|9329583|P1|Overall Study|Other|4
2710301|NCT00338884|9329583|P1|Overall Study|Death|8
2710302|NCT00338884|9329583|P1|Overall Study|Adverse Event|14
2710303|NCT00338884|9329583|P1|Overall Study|Objective Disease Progression or Relapse|44
2710304|NCT00338806|9329617|P2|Follow-up|Lost to Follow-up|3
2710305|NCT00338806|9329618|P1|Follow-up|Lost to Follow-up|1
2710306|NCT00338806|9329617|P2|Acute Phase|Withdrawal by Subject|1
2710307|NCT00338806|9329618|P1|Acute Phase|Withdrawal by Subject|0
2710308|NCT00338741|9329680|P2|Overall Study|Lost to Follow-up|0
2710309|NCT00338741|9329681|P1|Overall Study|Lost to Follow-up|2
2710310|NCT00338728|9329689|P1|Overall Study|Screen Failure|14
2710311|NCT00338455|9329717|P2|Overall Study|Physician Decision|0
2710312|NCT00338455|9329718|P1|Overall Study|Physician Decision|1
2710313|NCT00338455|9329717|P2|Overall Study|Death|1
2710314|NCT00338455|9329718|P1|Overall Study|Death|2
2710315|NCT00338286|9329732|P2|Overall Study|Other|93
2710316|NCT00338286|9329733|P1|Overall Study|Other|103
2710317|NCT00338286|9329732|P2|Overall Study|Lost to Follow-up|66
2710318|NCT00338286|9329733|P1|Overall Study|Lost to Follow-up|80
2710319|NCT00338286|9329732|P2|Overall Study|Withdrawal by Subject|54
2710320|NCT00338286|9329733|P1|Overall Study|Withdrawal by Subject|50
2710321|NCT00338104|9329750|P3|Overall Study|Protocol Violation|3
2710322|NCT00338104|9329751|P2|Overall Study|Protocol Violation|1
2710323|NCT00338104|9329752|P1|Overall Study|Protocol Violation|2
2710324|NCT00337935|9329775|P2|Overall Study|Lack of Efficacy|1
2710325|NCT00337935|9329776|P1|Overall Study|Lack of Efficacy|0
2710326|NCT00337935|9329775|P2|Overall Study|Other|1
2710327|NCT00337935|9329776|P1|Overall Study|Other|0
2710328|NCT00337935|9329775|P2|Overall Study|Withdrawal by Subject|7
2710329|NCT00337935|9329776|P1|Overall Study|Withdrawal by Subject|1
2710330|NCT00337935|9329775|P2|Overall Study|Protocol Violation|3
2710331|NCT00337935|9329776|P1|Overall Study|Protocol Violation|4
2710332|NCT00337935|9329775|P2|Overall Study|Lost to Follow-up|1
2710333|NCT00337935|9329776|P1|Overall Study|Lost to Follow-up|0
2710334|NCT00337935|9329775|P2|Overall Study|Physician Decision|1
2710335|NCT00337935|9329776|P1|Overall Study|Physician Decision|1
2710336|NCT00337935|9329775|P2|Overall Study|Death|8
2710337|NCT00337935|9329776|P1|Overall Study|Death|2
2710338|NCT00337935|9329775|P2|Overall Study|Adverse Event|5
2710339|NCT00337935|9329776|P1|Overall Study|Adverse Event|2
2710340|NCT00337818|9329789|P3|Overall Study|Lost to Follow-up|107
2710341|NCT00337818|9329790|P2|Overall Study|Lost to Follow-up|91
2710342|NCT00337818|9329791|P1|Overall Study|Lost to Follow-up|289
2710343|NCT00337779|9329813|P2|Overall Study|Death|1
2710344|NCT00337779|9329814|P1|Overall Study|Death|0
2710345|NCT00337779|9329813|P2|Overall Study|Pregnancy|2
2710346|NCT00337779|9329814|P1|Overall Study|Pregnancy|3
2710347|NCT00337779|9329813|P2|Overall Study|Adverse Event|51
2710348|NCT00337779|9329814|P1|Overall Study|Adverse Event|28
2710349|NCT00337779|9329813|P2|Overall Study|Lost to Follow-up|5
2710350|NCT00337779|9329814|P1|Overall Study|Lost to Follow-up|6
2710351|NCT00337779|9329813|P2|Overall Study|Protocol Violation|1
2710352|NCT00337779|9329814|P1|Overall Study|Protocol Violation|1
2710353|NCT00337779|9329813|P2|Overall Study|Physician Decision|6
2710354|NCT00337779|9329814|P1|Overall Study|Physician Decision|3
2710355|NCT00337779|9329813|P2|Overall Study|Sponsor decision|1
2710356|NCT00337779|9329814|P1|Overall Study|Sponsor decision|1
2710357|NCT00337779|9329813|P2|Overall Study|Withdrawal by Subject|12
2710358|NCT00337779|9329814|P1|Overall Study|Withdrawal by Subject|10
2710359|NCT00337727|9329826|P2|Overall Study|Withdrawal by Subject|5
2710360|NCT00337727|9329827|P1|Overall Study|Withdrawal by Subject|3
2710361|NCT00337727|9329826|P2|Overall Study|Protocol Violation|0
2710362|NCT00337727|9329827|P1|Overall Study|Protocol Violation|4
2710363|NCT00337727|9329826|P2|Overall Study|Physician Decision|0
2710364|NCT00337727|9329827|P1|Overall Study|Physician Decision|1
2710365|NCT00337727|9329826|P2|Overall Study|Lost to Follow-up|4
2710366|NCT00337727|9329827|P1|Overall Study|Lost to Follow-up|5
2710367|NCT00337727|9329826|P2|Overall Study|Adverse Event|3
2710368|NCT00337727|9329827|P1|Overall Study|Adverse Event|5
2710369|NCT00337675|9329838|P3|Overall Study|Trial Terminated|2
2710370|NCT00337675|9329839|P2|Overall Study|Trial Terminated|0
2710371|NCT00337675|9329840|P1|Overall Study|Trial Terminated|0
2710372|NCT00337675|9329838|P3|Overall Study|Progressive Disease|0
2710373|NCT00337675|9329839|P2|Overall Study|Progressive Disease|2
2710374|NCT00337675|9329840|P1|Overall Study|Progressive Disease|0
2710375|NCT00337675|9329838|P3|Overall Study|Withdrawal by Subject|19
2710376|NCT00337675|9329839|P2|Overall Study|Withdrawal by Subject|25
2710377|NCT00337675|9329840|P1|Overall Study|Withdrawal by Subject|25
2710378|NCT00337675|9329838|P3|Overall Study|Protocol Violation|19
2710379|NCT00337675|9329839|P2|Overall Study|Protocol Violation|24
2710380|NCT00337675|9329840|P1|Overall Study|Protocol Violation|21
2710381|NCT00337675|9329838|P3|Overall Study|Physician Decision|14
2710382|NCT00337675|9329839|P2|Overall Study|Physician Decision|17
2710383|NCT00337675|9329840|P1|Overall Study|Physician Decision|9
2710384|NCT00337675|9329838|P3|Overall Study|Lost to Follow-up|17
2710385|NCT00337675|9329839|P2|Overall Study|Lost to Follow-up|19
2710386|NCT00337675|9329840|P1|Overall Study|Lost to Follow-up|22
2710387|NCT00337675|9329838|P3|Overall Study|Lack of Efficacy|9
2710388|NCT00337675|9329839|P2|Overall Study|Lack of Efficacy|7
2710389|NCT00337675|9329840|P1|Overall Study|Lack of Efficacy|10
2710390|NCT00337675|9329838|P3|Overall Study|Adverse Event|19
2710391|NCT00337675|9329839|P2|Overall Study|Adverse Event|9
2710392|NCT00337675|9329840|P1|Overall Study|Adverse Event|10
2710393|NCT00337662|9329857|P4|Study Period III|Clinical Relapse|0
2710394|NCT00337662|9329858|P3|Study Period III|Clinical Relapse|0
2710395|NCT00337662|9329859|P2|Study Period III|Clinical Relapse|0
2710396|NCT00337662|9329860|P1|Study Period III|Clinical Relapse|1
2710397|NCT00337662|9329857|P4|Study Period III|Sponsor Decision|0
2710398|NCT00337662|9329858|P3|Study Period III|Sponsor Decision|1
2710399|NCT00337662|9329859|P2|Study Period III|Sponsor Decision|0
2710400|NCT00337662|9329860|P1|Study Period III|Sponsor Decision|1
2710401|NCT00337662|9329857|P4|Study Period III|Parent/Caregiver Decision|0
2710402|NCT00337662|9329858|P3|Study Period III|Parent/Caregiver Decision|2
2710403|NCT00337662|9329859|P2|Study Period III|Parent/Caregiver Decision|0
2710404|NCT00337662|9329860|P1|Study Period III|Parent/Caregiver Decision|0
2710405|NCT00337662|9329857|P4|Study Period III|Lack of Efficacy|0
2710406|NCT00337662|9329858|P3|Study Period III|Lack of Efficacy|2
2710407|NCT00337662|9329859|P2|Study Period III|Lack of Efficacy|4
2710408|NCT00337662|9329860|P1|Study Period III|Lack of Efficacy|4
2710409|NCT00337662|9329857|P4|Study Period III|Entry Criteria Not Met|0
2710410|NCT00337662|9329858|P3|Study Period III|Entry Criteria Not Met|3
2710411|NCT00337662|9329859|P2|Study Period III|Entry Criteria Not Met|1
2710412|NCT00337662|9329860|P1|Study Period III|Entry Criteria Not Met|4
2710413|NCT00337662|9329857|P4|Study Period III|Physician Decision|0
2710414|NCT00337662|9329858|P3|Study Period III|Physician Decision|0
2710415|NCT00337662|9329859|P2|Study Period III|Physician Decision|5
2710416|NCT00337662|9329860|P1|Study Period III|Physician Decision|6
2710417|NCT00337662|9329857|P4|Study Period III|Protocol Violation|0
2710418|NCT00337662|9329858|P3|Study Period III|Protocol Violation|2
2710419|NCT00337662|9329859|P2|Study Period III|Protocol Violation|8
2710420|NCT00337662|9329860|P1|Study Period III|Protocol Violation|3
2710421|NCT00337662|9329857|P4|Study Period III|Adverse Event|0
2710422|NCT00337662|9329858|P3|Study Period III|Adverse Event|8
2710423|NCT00337662|9329859|P2|Study Period III|Adverse Event|10
2710424|NCT00337662|9329860|P1|Study Period III|Adverse Event|9
2710425|NCT00337662|9329857|P4|Study Period III|Withdrawal by Subject|0
2710426|NCT00337662|9329858|P3|Study Period III|Withdrawal by Subject|12
2710427|NCT00337662|9329859|P2|Study Period III|Withdrawal by Subject|14
2710428|NCT00337662|9329860|P1|Study Period III|Withdrawal by Subject|18
2710429|NCT00337662|9329857|P4|Study Period III|Lost to Follow-up|0
2710430|NCT00337662|9329858|P3|Study Period III|Lost to Follow-up|14
2710431|NCT00337662|9329859|P2|Study Period III|Lost to Follow-up|16
2710432|NCT00337662|9329860|P1|Study Period III|Lost to Follow-up|14
2710433|NCT00337662|9329857|P4|Study Period II|Parent/Caregiver Decision|1
2710434|NCT00337662|9329858|P3|Study Period II|Parent/Caregiver Decision|0
2710435|NCT00337662|9329859|P2|Study Period II|Parent/Caregiver Decision|0
2710436|NCT00337662|9329860|P1|Study Period II|Parent/Caregiver Decision|0
2710437|NCT00337662|9329857|P4|Study Period II|Sponsor Decision|2
2710438|NCT00337662|9329858|P3|Study Period II|Sponsor Decision|0
2710439|NCT00337662|9329859|P2|Study Period II|Sponsor Decision|0
2710440|NCT00337662|9329860|P1|Study Period II|Sponsor Decision|0
2710441|NCT00337662|9329857|P4|Study Period II|Lack of Efficacy|7
2710442|NCT00337662|9329858|P3|Study Period II|Lack of Efficacy|0
2710443|NCT00337662|9329859|P2|Study Period II|Lack of Efficacy|0
2710444|NCT00337662|9329860|P1|Study Period II|Lack of Efficacy|0
2710445|NCT00337662|9329857|P4|Study Period II|Protocol Violation|6
2710446|NCT00337662|9329858|P3|Study Period II|Protocol Violation|0
2710447|NCT00337662|9329859|P2|Study Period II|Protocol Violation|0
2710448|NCT00337662|9329860|P1|Study Period II|Protocol Violation|0
2710449|NCT00337662|9329857|P4|Study Period II|Entry Criteria Not Met|6
2710450|NCT00337662|9329858|P3|Study Period II|Entry Criteria Not Met|0
2710451|NCT00337662|9329859|P2|Study Period II|Entry Criteria Not Met|0
2710452|NCT00337662|9329860|P1|Study Period II|Entry Criteria Not Met|0
2710453|NCT00337662|9329857|P4|Study Period II|Physician Decision|13
2710454|NCT00337662|9329858|P3|Study Period II|Physician Decision|0
2710455|NCT00337662|9329859|P2|Study Period II|Physician Decision|0
2710456|NCT00337662|9329860|P1|Study Period II|Physician Decision|0
2710457|NCT00337662|9329857|P4|Study Period II|Adverse Event|16
2710458|NCT00337662|9329858|P3|Study Period II|Adverse Event|0
2710459|NCT00337662|9329859|P2|Study Period II|Adverse Event|0
2710460|NCT00337662|9329860|P1|Study Period II|Adverse Event|0
2710461|NCT00337662|9329857|P4|Study Period II|Withdrawal by Subject|20
2710462|NCT00337662|9329858|P3|Study Period II|Withdrawal by Subject|0
2710463|NCT00337662|9329859|P2|Study Period II|Withdrawal by Subject|0
2710464|NCT00337662|9329860|P1|Study Period II|Withdrawal by Subject|0
2710465|NCT00337662|9329857|P4|Study Period II|Lost to Follow-up|35
2710466|NCT00337662|9329858|P3|Study Period II|Lost to Follow-up|0
2710467|NCT00337662|9329859|P2|Study Period II|Lost to Follow-up|0
2710468|NCT00337662|9329860|P1|Study Period II|Lost to Follow-up|0
2710469|NCT00337610|9329914|P2|Overall Study|Withdrawal by Subject|5
2710470|NCT00337610|9329915|P1|Overall Study|Withdrawal by Subject|6
2710471|NCT00337610|9329914|P2|Overall Study|Lost to Follow-up|3
2710472|NCT00337610|9329915|P1|Overall Study|Lost to Follow-up|3
2710473|NCT00337610|9329914|P2|Overall Study|Lack of Efficacy|3
2710474|NCT00337610|9329915|P1|Overall Study|Lack of Efficacy|6
2710475|NCT00337610|9329914|P2|Overall Study|Death|1
2710476|NCT00337610|9329915|P1|Overall Study|Death|0
2710477|NCT00337610|9329914|P2|Overall Study|Adverse Event|2
2710478|NCT00337610|9329915|P1|Overall Study|Adverse Event|2
2710479|NCT00337571|9329931|P4|Overall Study|High Potassium level|1
2710480|NCT00337571|9329932|P3|Overall Study|High Potassium level|0
2710481|NCT00337571|9329933|P2|Overall Study|High Potassium level|0
2710482|NCT00337571|9329934|P1|Overall Study|High Potassium level|0
2710483|NCT00337571|9329931|P4|Overall Study|No longer met study criteria|0
2710484|NCT00337571|9329932|P3|Overall Study|No longer met study criteria|0
2710485|NCT00337571|9329933|P2|Overall Study|No longer met study criteria|0
2710486|NCT00337571|9329934|P1|Overall Study|No longer met study criteria|1
2710487|NCT00337571|9329931|P4|Overall Study|Poor/noncompliance|1
2710488|NCT00337571|9329932|P3|Overall Study|Poor/noncompliance|1
2710489|NCT00337571|9329933|P2|Overall Study|Poor/noncompliance|1
2710490|NCT00337571|9329934|P1|Overall Study|Poor/noncompliance|1
2710491|NCT00337571|9329931|P4|Overall Study|Lost to Follow-up|1
2710492|NCT00337571|9329932|P3|Overall Study|Lost to Follow-up|0
2710493|NCT00337571|9329933|P2|Overall Study|Lost to Follow-up|1
2710494|NCT00337571|9329934|P1|Overall Study|Lost to Follow-up|3
2710495|NCT00337571|9329931|P4|Overall Study|Withdrawal by Subject|0
2710496|NCT00337571|9329932|P3|Overall Study|Withdrawal by Subject|1
2710497|NCT00337571|9329933|P2|Overall Study|Withdrawal by Subject|2
2710498|NCT00337571|9329934|P1|Overall Study|Withdrawal by Subject|2
2710499|NCT00337571|9329931|P4|Overall Study|Adverse Event|4
2710500|NCT00337571|9329932|P3|Overall Study|Adverse Event|8
2710501|NCT00337571|9329933|P2|Overall Study|Adverse Event|5
2710502|NCT00337571|9329934|P1|Overall Study|Adverse Event|4
2710503|NCT00337571|9329931|P4|Overall Study|Lack of Efficacy|0
2710504|NCT00337571|9329932|P3|Overall Study|Lack of Efficacy|0
2710505|NCT00337571|9329933|P2|Overall Study|Lack of Efficacy|0
2710506|NCT00337571|9329934|P1|Overall Study|Lack of Efficacy|3
2710507|NCT00337467|9329972|P1|Overall Study|Subject No Longer Met Study Criteria|2
2710508|NCT00337467|9329972|P1|Overall Study|Lost to Follow-up|2
2710509|NCT00337467|9329972|P1|Overall Study|Pregnancy|1
2710510|NCT00337467|9329972|P1|Overall Study|Subject Withdrew Consent|2
2710511|NCT00337467|9329972|P1|Overall Study|Adverse Event|3
2710512|NCT00337428|9329991|P2|Overall Study|Anorexia|0
2710513|NCT00337428|9329992|P1|Overall Study|Anorexia|1
2710514|NCT00337428|9329991|P2|Overall Study|Unwilling to Continue|0
2710515|NCT00337428|9329992|P1|Overall Study|Unwilling to Continue|1
2710516|NCT00337428|9329991|P2|Overall Study|Lack of Time|1
2710517|NCT00337428|9329992|P1|Overall Study|Lack of Time|1
2710518|NCT00337428|9329991|P2|Overall Study|Withdrawal by Subject|2
2710519|NCT00337428|9329992|P1|Overall Study|Withdrawal by Subject|1
2710520|NCT00337285|9330043|P1|Overall Study|Lack of protocol compliance|7
2710521|NCT00337285|9330043|P1|Overall Study|Physician Decision|1
2710522|NCT00337285|9330043|P1|Overall Study|Death|1
2710523|NCT00337285|9330043|P1|Overall Study|Lack of Efficacy|11
2710524|NCT00337285|9330043|P1|Overall Study|Protocol Violation|27
2710525|NCT00337285|9330043|P1|Overall Study|Adverse Event|28
2710526|NCT00337285|9330043|P1|Overall Study|Lost to Follow-up|41
2710527|NCT00337285|9330043|P1|Overall Study|Withdrawal by Subject|42
2710528|NCT00337272|9330051|P2|Withdrawal Period|Non-compliance|1
2710529|NCT00337272|9330052|P1|Withdrawal Period|Non-compliance|0
2710530|NCT00337272|9330051|P2|Treatment Period|Withdrawal by Subject|1
2710531|NCT00337272|9330052|P1|Treatment Period|Withdrawal by Subject|0
2710532|NCT00337272|9330051|P2|Treatment Period|Non-compliance|1
2710533|NCT00337272|9330052|P1|Treatment Period|Non-compliance|1
2710534|NCT00337272|9330051|P2|Screening Period (Pre-randomization)|Screen failure|0
2710535|NCT00337272|9330052|P1|Screening Period (Pre-randomization)|Screen failure|3
2710536|NCT00337272|9330051|P2|Screening Period (Pre-randomization)|Non-compliance|0
2710537|NCT00337272|9330052|P1|Screening Period (Pre-randomization)|Non-compliance|1
2710538|NCT00337272|9330051|P2|Screening Period (Pre-randomization)|Withdrawal by Subject|0
2710539|NCT00337272|9330052|P1|Screening Period (Pre-randomization)|Withdrawal by Subject|2
2710540|NCT00337207|9330072|P1|Overall Study|Withdrawal by Subject|3
2710541|NCT00337194|9330080|P2|Overall Study|Subsequent non-protocol therapy|1
2710542|NCT00337194|9330081|P1|Overall Study|Subsequent non-protocol therapy|3
2710543|NCT00337194|9330080|P2|Overall Study|Disease progression|2
2710544|NCT00337194|9330081|P1|Overall Study|Disease progression|1
2710545|NCT00337194|9330080|P2|Overall Study|Withdrawal by Subject|0
2710546|NCT00337194|9330081|P1|Overall Study|Withdrawal by Subject|1
2710547|NCT00337194|9330080|P2|Overall Study|Death|0
2710548|NCT00337194|9330081|P1|Overall Study|Death|2
2710549|NCT00337194|9330080|P2|Overall Study|Adverse Event|1
2710550|NCT00337194|9330081|P1|Overall Study|Adverse Event|5
2710551|NCT00337168|9330105|P1|Overall Study|Did not start therapy|1
2710552|NCT00337168|9330105|P1|Overall Study|Not protocol specified|2
2710553|NCT00337168|9330105|P1|Overall Study|Death|5
2710554|NCT00337129|9330112|P1|Overall Study|not protocol specified|1
2710555|NCT00337129|9330112|P1|Overall Study|Death|2
2710556|NCT00337129|9330112|P1|Overall Study|Lack of Efficacy|32
2710557|NCT00337129|9330112|P1|Overall Study|Withdrawal by Subject|1
2710558|NCT00337129|9330112|P1|Overall Study|Adverse Event|4
2710559|NCT00337103|9330121|P2|Overall Study|Death|0
2710560|NCT00337103|9330122|P1|Overall Study|Death|1
2710561|NCT00337103|9330121|P2|Overall Study|Lost to Follow-up|2
2710562|NCT00337103|9330122|P1|Overall Study|Lost to Follow-up|1
2710563|NCT00337103|9330121|P2|Overall Study|Entry Criteria Not Met|1
2710564|NCT00337103|9330122|P1|Overall Study|Entry Criteria Not Met|4
2710565|NCT00337103|9330121|P2|Overall Study|Other|6
2710566|NCT00337103|9330122|P1|Overall Study|Other|5
2710567|NCT00337103|9330121|P2|Overall Study|Withdrawal by Subject|5
2710568|NCT00337103|9330122|P1|Overall Study|Withdrawal by Subject|8
2710569|NCT00337103|9330121|P2|Overall Study|Physician Decision|14
2710570|NCT00337103|9330122|P1|Overall Study|Physician Decision|15
2710571|NCT00337103|9330121|P2|Overall Study|Clinical Progression|24
2710572|NCT00337103|9330122|P1|Overall Study|Clinical Progression|27
2710573|NCT00337103|9330121|P2|Overall Study|Subject Choice|27
2710574|NCT00337103|9330122|P1|Overall Study|Subject Choice|34
2710575|NCT00337103|9330121|P2|Overall Study|Adverse Event|59
2710576|NCT00337103|9330122|P1|Overall Study|Adverse Event|45
2710577|NCT00337103|9330121|P2|Overall Study|Progressive Disease|405
2710578|NCT00337103|9330122|P1|Overall Study|Progressive Disease|409
2710579|NCT00337077|9330133|P3|Overall Study|Ineligible|1
2710580|NCT00337077|9330134|P2|Overall Study|Ineligible|1
2710581|NCT00337077|9330135|P1|Overall Study|Ineligible|1
2710582|NCT00337077|9330133|P3|Overall Study|Never started treatment|0
2710583|NCT00337077|9330134|P2|Overall Study|Never started treatment|1
2710584|NCT00337077|9330135|P1|Overall Study|Never started treatment|1
2710585|NCT00337077|9330133|P3|Overall Study|Physician Decision|2
2710586|NCT00337077|9330134|P2|Overall Study|Physician Decision|4
2710587|NCT00337077|9330135|P1|Overall Study|Physician Decision|1
2710588|NCT00337077|9330133|P3|Overall Study|Alternative therapy|0
2710589|NCT00337077|9330134|P2|Overall Study|Alternative therapy|0
2710590|NCT00337077|9330135|P1|Overall Study|Alternative therapy|1
2710591|NCT00337077|9330133|P3|Overall Study|Withdrawal by Subject|2
2710592|NCT00337077|9330134|P2|Overall Study|Withdrawal by Subject|2
2710593|NCT00337077|9330135|P1|Overall Study|Withdrawal by Subject|7
2710594|NCT00337077|9330133|P3|Overall Study|Death|0
2710595|NCT00337077|9330134|P2|Overall Study|Death|1
2710596|NCT00337077|9330135|P1|Overall Study|Death|0
2710597|NCT00337077|9330133|P3|Overall Study|Adverse Event|1
2710598|NCT00337077|9330134|P2|Overall Study|Adverse Event|7
2710599|NCT00337077|9330135|P1|Overall Study|Adverse Event|7
2710600|NCT00337077|9330133|P3|Overall Study|Progressive disease|19
2710601|NCT00337077|9330134|P2|Overall Study|Progressive disease|37
2710602|NCT00337077|9330135|P1|Overall Study|Progressive disease|25
2710603|NCT00336895|9330150|P1|Overall Study|screen failed|1
2710604|NCT00336895|9330150|P1|Overall Study|Physician Decision|1
2710605|NCT00336895|9330150|P1|Overall Study|nausea and upset stomach|1
2710606|NCT00336895|9330150|P1|Overall Study|diarrhea|1
2710607|NCT00336856|9330156|P1|Overall Study|Found ineligible at time of analysis|1
2710608|NCT00336856|9330156|P1|Overall Study|Withdrawal by Subject|3
2710609|NCT00336583|9330204|P1|Overall Study|Death|1
2710610|NCT00336583|9330204|P1|Overall Study|Lost to Follow-up|1
2710611|NCT00336544|9330211|P2|Overall Study|Other|5
2710612|NCT00336544|9330212|P1|Overall Study|Other|3
2710613|NCT00336544|9330211|P2|Overall Study|Withdrawal by Subject|3
2710614|NCT00336544|9330212|P1|Overall Study|Withdrawal by Subject|4
2710615|NCT00336544|9330211|P2|Overall Study|Adverse Event|9
2710616|NCT00336544|9330212|P1|Overall Study|Adverse Event|4
2710617|NCT00336544|9330211|P2|Overall Study|Lack of Efficacy|5
2710618|NCT00336544|9330212|P1|Overall Study|Lack of Efficacy|8
2710619|NCT00336505|9330226|P2|Overall Study|Other|7
2710620|NCT00336505|9330227|P1|Overall Study|Other|7
2710621|NCT00336505|9330226|P2|Overall Study|Withdrawal by Subject|3
2710622|NCT00336505|9330227|P1|Overall Study|Withdrawal by Subject|5
2710623|NCT00336505|9330226|P2|Overall Study|Lost to Follow-up|4
2710624|NCT00336505|9330227|P1|Overall Study|Lost to Follow-up|7
2710625|NCT00336505|9330226|P2|Overall Study|Lack of Efficacy|4
2710626|NCT00336505|9330227|P1|Overall Study|Lack of Efficacy|8
2710627|NCT00336505|9330226|P2|Overall Study|Adverse Event|9
2710628|NCT00336505|9330227|P1|Overall Study|Adverse Event|10
2710629|NCT00336492|9330242|P3|Overall Study|Other|1
2710630|NCT00336492|9330243|P2|Overall Study|Other|0
2710631|NCT00336492|9330244|P1|Overall Study|Other|5
2710632|NCT00336492|9330242|P3|Overall Study|Lack of Efficacy|4
2710633|NCT00336492|9330243|P2|Overall Study|Lack of Efficacy|1
2710634|NCT00336492|9330244|P1|Overall Study|Lack of Efficacy|6
2710635|NCT00336492|9330242|P3|Overall Study|Adverse Event|6
2710636|NCT00336492|9330243|P2|Overall Study|Adverse Event|3
2710637|NCT00336492|9330244|P1|Overall Study|Adverse Event|4
2710638|NCT00336479|9330256|P4|Overall Study|Virologic Stopping Rule|0
2710639|NCT00336479|9330257|P3|Overall Study|Virologic Stopping Rule|0
2710640|NCT00336479|9330258|P2|Overall Study|Virologic Stopping Rule|0
2710641|NCT00336479|9330259|P1|Overall Study|Virologic Stopping Rule|20
2710642|NCT00336479|9330256|P4|Overall Study|Other|0
2710643|NCT00336479|9330257|P3|Overall Study|Other|1
2710644|NCT00336479|9330258|P2|Overall Study|Other|0
2710645|NCT00336479|9330259|P1|Overall Study|Other|0
2710646|NCT00336479|9330256|P4|Overall Study|Withdrawal by Subject|0
2710647|NCT00336479|9330257|P3|Overall Study|Withdrawal by Subject|3
2710648|NCT00336479|9330258|P2|Overall Study|Withdrawal by Subject|2
2710649|NCT00336479|9330259|P1|Overall Study|Withdrawal by Subject|3
2710650|NCT00336479|9330256|P4|Overall Study|Lost to Follow-up|0
2710651|NCT00336479|9330257|P3|Overall Study|Lost to Follow-up|0
2710652|NCT00336479|9330258|P2|Overall Study|Lost to Follow-up|2
2710653|NCT00336479|9330259|P1|Overall Study|Lost to Follow-up|3
2710654|NCT00336479|9330256|P4|Overall Study|Physician Decision|0
2710655|NCT00336479|9330257|P3|Overall Study|Physician Decision|1
2710656|NCT00336479|9330258|P2|Overall Study|Physician Decision|3
2710657|NCT00336479|9330259|P1|Overall Study|Physician Decision|2
2710658|NCT00336479|9330256|P4|Overall Study|Noncompliant|0
2710659|NCT00336479|9330257|P3|Overall Study|Noncompliant|3
2710660|NCT00336479|9330258|P2|Overall Study|Noncompliant|7
2710661|NCT00336479|9330259|P1|Overall Study|Noncompliant|1
2710662|NCT00336479|9330256|P4|Overall Study|Adverse Event|4
2710663|NCT00336479|9330257|P3|Overall Study|Adverse Event|18
2710664|NCT00336479|9330258|P2|Overall Study|Adverse Event|11
2710665|NCT00336479|9330259|P1|Overall Study|Adverse Event|8
2710666|NCT00336284|9330348|P2|Overall Study|Withdrawal by Physician or Subject|64
2710667|NCT00336284|9330349|P1|Overall Study|Withdrawal by Physician or Subject|102
2710668|NCT00336284|9330348|P2|Overall Study|Lost to Follow-up|61
2710669|NCT00336284|9330349|P1|Overall Study|Lost to Follow-up|82
2710670|NCT00336284|9330348|P2|Overall Study|Death|26
2710671|NCT00336284|9330349|P1|Overall Study|Death|52
2710672|NCT00336024|9330367|P2|Overall Study|Ineligible|7
2710673|NCT00336024|9330368|P1|Overall Study|Ineligible|7
2710674|NCT00336024|9330367|P2|Overall Study|Progressive Disease|7
2710675|NCT00336024|9330368|P1|Overall Study|Progressive Disease|4
2710676|NCT00336024|9330367|P2|Overall Study|Failure to fulfill consolidation|1
2710677|NCT00336024|9330368|P1|Overall Study|Failure to fulfill consolidation|1
2710678|NCT00336024|9330367|P2|Overall Study|Withdrawal by Subject|2
2710679|NCT00336024|9330368|P1|Overall Study|Withdrawal by Subject|1
2710680|NCT00336024|9330367|P2|Overall Study|Protocol Violation|0
2710681|NCT00336024|9330368|P1|Overall Study|Protocol Violation|1
2710682|NCT00336024|9330367|P2|Overall Study|Physician Decision|1
2710683|NCT00336024|9330368|P1|Overall Study|Physician Decision|4
2710684|NCT00336024|9330367|P2|Overall Study|Death|1
2710685|NCT00336024|9330368|P1|Overall Study|Death|2
2710686|NCT00335972|9330402|P2|Overall Study|not given treatments|3
2710687|NCT00335972|9330403|P1|Overall Study|not given treatments|0
2710688|NCT00335959|9330413|P1|Overall Study|Ineligible|1
2710689|NCT00335959|9330413|P1|Overall Study|Adverse Event|2
2710690|NCT00335829|9330418|P1|Overall Study|Adverse Event|1
2710691|NCT00335829|9330418|P1|Overall Study|Lost to Follow-up|1
2710692|NCT00335829|9330418|P1|Overall Study|Withdrawal by Subject|1
2710693|NCT00335777|9330432|P1|Treated 2 Headaches Per Protocol|Treated 1 early and 1 late out of protoc|12
2710694|NCT00335777|9330432|P1|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1
2710695|NCT00335777|9330432|P1|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18
2710696|NCT00335777|9330432|P1|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6
2710697|NCT00335777|9330432|P1|Enrolled and Dispensed Study Medication|Lost to Follow-up|5
2710698|NCT00335764|9330442|P5|Overall Study|wrong histology|1
2710699|NCT00335764|9330443|P4|Overall Study|wrong histology|0
2710700|NCT00335764|9330444|P3|Overall Study|wrong histology|0
2710701|NCT00335764|9330445|P2|Overall Study|wrong histology|0
2710702|NCT00335764|9330446|P1|Overall Study|wrong histology|1
2710703|NCT00335738|9330495|P2|Overall Study|Ineligible|4
2710704|NCT00335738|9330496|P1|Overall Study|Ineligible|3
2710705|NCT00335738|9330495|P2|Overall Study|Withdrawal by Subject|0
2710706|NCT00335738|9330496|P1|Overall Study|Withdrawal by Subject|2
2710707|NCT00335738|9330495|P2|Overall Study|Physician Decision|0
2710708|NCT00335738|9330496|P1|Overall Study|Physician Decision|6
2710709|NCT00335556|9330528|P6|Overall Study|Refusal of further protocol therapy|0
2710710|NCT00335556|9330529|P5|Overall Study|Refusal of further protocol therapy|0
2710711|NCT00335556|9330530|P4|Overall Study|Refusal of further protocol therapy|1
2710712|NCT00335556|9330531|P3|Overall Study|Refusal of further protocol therapy|0
2710713|NCT00335556|9330532|P2|Overall Study|Refusal of further protocol therapy|4
2710714|NCT00335556|9330533|P1|Overall Study|Refusal of further protocol therapy|0
2710715|NCT00335556|9330528|P6|Overall Study|Ineligible|0
2710716|NCT00335556|9330529|P5|Overall Study|Ineligible|0
2710717|NCT00335556|9330530|P4|Overall Study|Ineligible|0
2710718|NCT00335556|9330531|P3|Overall Study|Ineligible|0
2710719|NCT00335556|9330532|P2|Overall Study|Ineligible|0
2710720|NCT00335556|9330533|P1|Overall Study|Ineligible|2
2710721|NCT00335556|9330528|P6|Overall Study|Physician Decision|0
2710722|NCT00335556|9330529|P5|Overall Study|Physician Decision|0
2710723|NCT00335556|9330530|P4|Overall Study|Physician Decision|1
2710724|NCT00335556|9330531|P3|Overall Study|Physician Decision|2
2710725|NCT00335556|9330532|P2|Overall Study|Physician Decision|6
2710726|NCT00335556|9330533|P1|Overall Study|Physician Decision|0
2710727|NCT00335556|9330528|P6|Overall Study|Lack of Efficacy|1
2710728|NCT00335556|9330529|P5|Overall Study|Lack of Efficacy|0
2710729|NCT00335556|9330530|P4|Overall Study|Lack of Efficacy|3
2710730|NCT00335556|9330531|P3|Overall Study|Lack of Efficacy|3
2710731|NCT00335556|9330532|P2|Overall Study|Lack of Efficacy|19
2710732|NCT00335556|9330533|P1|Overall Study|Lack of Efficacy|0
2710733|NCT00335556|9330528|P6|Overall Study|Death|0
2710734|NCT00335556|9330529|P5|Overall Study|Death|1
2710735|NCT00335556|9330530|P4|Overall Study|Death|0
2710736|NCT00335556|9330531|P3|Overall Study|Death|0
2710737|NCT00335556|9330532|P2|Overall Study|Death|5
2710738|NCT00335556|9330533|P1|Overall Study|Death|0
2710739|NCT00335452|9330595|P4|Overall Study|Lost to Follow-up|2
2710740|NCT00335452|9330596|P3|Overall Study|Lost to Follow-up|1
2710741|NCT00335452|9330597|P2|Overall Study|Lost to Follow-up|3
2710742|NCT00335452|9330598|P1|Overall Study|Lost to Follow-up|2
2710743|NCT00335452|9330595|P4|Overall Study|Death|129
2710744|NCT00335452|9330596|P3|Overall Study|Death|158
2710745|NCT00335452|9330597|P2|Overall Study|Death|144
2710746|NCT00335452|9330598|P1|Overall Study|Death|156
2710747|NCT00335322|9330623|P3|Overall Study|Randomised but withdrew prior to ART sta|2
2710748|NCT00335322|9330624|P2|Overall Study|Randomised but withdrew prior to ART sta|2
2710749|NCT00335322|9330625|P1|Overall Study|Randomised but withdrew prior to ART sta|1
2710750|NCT00335153|9330673|P1|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2
2710751|NCT00335153|9330673|P1|Post-PEG-J Long-Term Treatment Period|Administrative|13
2710752|NCT00335153|9330673|P1|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13
2710753|NCT00335153|9330673|P1|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2
2710754|NCT00335153|9330673|P1|Post-PEG-J Long-Term Treatment Period|Adverse Event|22
2710755|NCT00335153|9330673|P1|Nasojejunal (NJ) Test Period|Protocol Violation|7
2710756|NCT00335153|9330673|P1|Nasojejunal (NJ) Test Period|Administrative|1
2710757|NCT00335153|9330673|P1|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12
2710758|NCT00335153|9330673|P1|Nasojejunal (NJ) Test Period|Lack of Efficacy|5
2710759|NCT00335153|9330673|P1|Nasojejunal (NJ) Test Period|Adverse Event|5
2710760|NCT00335140|9330710|P1|Overall Study|Ineligible|1
2710761|NCT00334958|9330716|P2|Overall Study|Other|2
2710762|NCT00334958|9330717|P1|Overall Study|Other|1
2710763|NCT00334958|9330716|P2|Overall Study|Adverse Event|12
2710764|NCT00334958|9330717|P1|Overall Study|Adverse Event|27
2710765|NCT00334958|9330716|P2|Overall Study|Withdrawal by Subject|4
2710766|NCT00334958|9330717|P1|Overall Study|Withdrawal by Subject|7
2710767|NCT00334958|9330716|P2|Overall Study|Request of the investigator or sponsor|1
2710768|NCT00334958|9330717|P1|Overall Study|Request of the investigator or sponsor|0
2710769|NCT00334958|9330716|P2|Overall Study|Protocol Violation|2
2710770|NCT00334958|9330717|P1|Overall Study|Protocol Violation|2
2710771|NCT00334958|9330716|P2|Overall Study|Medication Noncompliance|3
2710772|NCT00334958|9330717|P1|Overall Study|Medication Noncompliance|0
2710773|NCT00334893|9330731|P2|Overall Study|Not Treated|0
2710774|NCT00334893|9330732|P1|Overall Study|Not Treated|1
2710775|NCT00334815|9330742|P2|Overall Study|Physician Decision|4
2710776|NCT00334815|9330743|P1|Overall Study|Physician Decision|2
2710777|NCT00334815|9330742|P2|Overall Study|patient refused treatment|1
2710778|NCT00334815|9330743|P1|Overall Study|patient refused treatment|0
2710779|NCT00334815|9330742|P2|Overall Study|ineligible|1
2710780|NCT00334815|9330743|P1|Overall Study|ineligible|1
2710781|NCT00334815|9330742|P2|Overall Study|Progression|0
2710782|NCT00334815|9330743|P1|Overall Study|Progression|1
2710783|NCT00334815|9330742|P2|Overall Study|Death|2
2710784|NCT00334815|9330743|P1|Overall Study|Death|0
2710785|NCT00334815|9330742|P2|Overall Study|Adverse Event|2
2710786|NCT00334815|9330743|P1|Overall Study|Adverse Event|3
2710787|NCT00334802|9330757|P2|Overall Study|Criteria for Starting Next Cycle Not Met|1
2710788|NCT00334802|9330758|P1|Overall Study|Criteria for Starting Next Cycle Not Met|0
2710789|NCT00334802|9330757|P2|Overall Study|Adverse Event|3
2710790|NCT00334802|9330758|P1|Overall Study|Adverse Event|0
2710791|NCT00334802|9330757|P2|Overall Study|Withdrawal by Subject|4
2710792|NCT00334802|9330758|P1|Overall Study|Withdrawal by Subject|0
2710793|NCT00334802|9330757|P2|Overall Study|Physician Decision|0
2710794|NCT00334802|9330758|P1|Overall Study|Physician Decision|1
2710795|NCT00334802|9330757|P2|Overall Study|Patient Condition Aggrevated|0
2710796|NCT00334802|9330758|P1|Overall Study|Patient Condition Aggrevated|1
2710797|NCT00334802|9330757|P2|Overall Study|Lack of Efficacy|3
2710798|NCT00334802|9330758|P1|Overall Study|Lack of Efficacy|1
2710799|NCT00334802|9330757|P2|Overall Study|Toxicity|5
2710800|NCT00334802|9330758|P1|Overall Study|Toxicity|1
2710801|NCT00334802|9330757|P2|Overall Study|Progressive Disease|24
2710802|NCT00334802|9330758|P1|Overall Study|Progressive Disease|2
2710803|NCT00334737|9330778|P3|Follow up Phase|Lost to Follow-up|6
2710804|NCT00334737|9330779|P2|Follow up Phase|Lost to Follow-up|3
2710805|NCT00334737|9330780|P1|Follow up Phase|Lost to Follow-up|5
2710806|NCT00334737|9330778|P3|Hospital Phase|Did not receive study drug|0
2710807|NCT00334737|9330779|P2|Hospital Phase|Did not receive study drug|0
2710808|NCT00334737|9330780|P1|Hospital Phase|Did not receive study drug|1
2710809|NCT00334737|9330778|P3|Hospital Phase|Withdrawal by Subject|1
2710810|NCT00334737|9330779|P2|Hospital Phase|Withdrawal by Subject|0
2710811|NCT00334737|9330780|P1|Hospital Phase|Withdrawal by Subject|0
2710812|NCT00334737|9330778|P3|Hospital Phase|Death|3
2710813|NCT00334737|9330779|P2|Hospital Phase|Death|2
2710814|NCT00334737|9330780|P1|Hospital Phase|Death|1
2710815|NCT00334542|9330828|P1|Overall Study|New cancer diagnosis|1
2710816|NCT00334542|9330828|P1|Overall Study|Withdrawal by Subject|1
2710817|NCT00334542|9330828|P1|Overall Study|Adverse Event|3
2710818|NCT00334295|9330835|P1|Overall Study|Patients received fewer than 3 injection|5
2710819|NCT00334282|9330845|P2|Overall Study|Death|100
2710820|NCT00334282|9330846|P1|Overall Study|Death|194
2710821|NCT00334282|9330845|P2|Overall Study|Withdrawal by Subject|3
2710822|NCT00334282|9330846|P1|Overall Study|Withdrawal by Subject|17
2710823|NCT00334282|9330845|P2|Overall Study|Lost to Follow-up|5
2710824|NCT00334282|9330846|P1|Overall Study|Lost to Follow-up|11
2710825|NCT00334113|9330877|P2|Overall Study|Withdrawal by Subject|1
2710826|NCT00334113|9330878|P1|Overall Study|Withdrawal by Subject|0
2710827|NCT00334113|9330877|P2|Overall Study|Lost to Follow-up|2
2710828|NCT00334113|9330878|P1|Overall Study|Lost to Follow-up|2
2710829|NCT00333983|9330901|P3|Overall Study|Withdrawal by Subject|1
2710830|NCT00333983|9330902|P2|Overall Study|Withdrawal by Subject|3
2710831|NCT00333983|9330903|P1|Overall Study|Withdrawal by Subject|0
2710832|NCT00333983|9330901|P3|Overall Study|Adverse Event|1
2710833|NCT00333983|9330902|P2|Overall Study|Adverse Event|1
2710834|NCT00333983|9330903|P1|Overall Study|Adverse Event|1
2710835|NCT00333983|9330901|P3|Overall Study|Lost to Follow-up|0
2710836|NCT00333983|9330902|P2|Overall Study|Lost to Follow-up|1
2710837|NCT00333983|9330903|P1|Overall Study|Lost to Follow-up|2
2710838|NCT00333970|9330913|P2|Overall Study|Withdrawal by Subject|7
2710839|NCT00333970|9330914|P1|Overall Study|Withdrawal by Subject|13
2710840|NCT00333866|9330929|P4|Overall Study|Randomized but not Treated|1
2710841|NCT00333866|9330930|P3|Overall Study|Randomized but not Treated|2
2710842|NCT00333866|9330931|P2|Overall Study|Randomized but not Treated|3
2710843|NCT00333866|9330932|P1|Overall Study|Randomized but not Treated|5
2710844|NCT00333866|9330929|P4|Overall Study|Withdrawal by Subject|9
2710845|NCT00333866|9330930|P3|Overall Study|Withdrawal by Subject|4
2710846|NCT00333866|9330931|P2|Overall Study|Withdrawal by Subject|14
2710847|NCT00333866|9330932|P1|Overall Study|Withdrawal by Subject|8
2710848|NCT00333866|9330929|P4|Overall Study|Lost to Follow-up|2
2710849|NCT00333866|9330930|P3|Overall Study|Lost to Follow-up|2
2710850|NCT00333866|9330931|P2|Overall Study|Lost to Follow-up|2
2710851|NCT00333866|9330932|P1|Overall Study|Lost to Follow-up|1
2710852|NCT00333866|9330929|P4|Overall Study|Lack of Efficacy|5
2710853|NCT00333866|9330930|P3|Overall Study|Lack of Efficacy|3
2710854|NCT00333866|9330931|P2|Overall Study|Lack of Efficacy|6
2710855|NCT00333866|9330932|P1|Overall Study|Lack of Efficacy|8
2710856|NCT00333866|9330929|P4|Overall Study|Other|2
2710857|NCT00333866|9330930|P3|Overall Study|Other|2
2710858|NCT00333866|9330931|P2|Overall Study|Other|2
2710859|NCT00333866|9330932|P1|Overall Study|Other|3
2710860|NCT00333866|9330929|P4|Overall Study|Adverse Event|47
2710861|NCT00333866|9330930|P3|Overall Study|Adverse Event|38
2710862|NCT00333866|9330931|P2|Overall Study|Adverse Event|37
2710863|NCT00333866|9330932|P1|Overall Study|Adverse Event|23
2710864|NCT00333840|9330992|P4|Second-line Treatment Period|Death|9
2710865|NCT00333840|9330993|P3|Second-line Treatment Period|Death|0
2710866|NCT00333840|9330994|P2|Second-line Treatment Period|Death|0
2710867|NCT00333840|9330995|P1|Second-line Treatment Period|Death|0
2710868|NCT00333840|9330992|P4|Second-line Treatment Period|Administrative problems|7
2710869|NCT00333840|9330993|P3|Second-line Treatment Period|Administrative problems|0
2710870|NCT00333840|9330994|P2|Second-line Treatment Period|Administrative problems|0
2710871|NCT00333840|9330995|P1|Second-line Treatment Period|Administrative problems|0
2710872|NCT00333840|9330992|P4|Second-line Treatment Period|Lost to Follow-up|6
2710873|NCT00333840|9330993|P3|Second-line Treatment Period|Lost to Follow-up|0
2710874|NCT00333840|9330994|P2|Second-line Treatment Period|Lost to Follow-up|0
2710875|NCT00333840|9330995|P1|Second-line Treatment Period|Lost to Follow-up|0
2710876|NCT00333840|9330992|P4|Second-line Treatment Period|Subject withdrew consent|34
2710877|NCT00333840|9330993|P3|Second-line Treatment Period|Subject withdrew consent|0
2710878|NCT00333840|9330994|P2|Second-line Treatment Period|Subject withdrew consent|0
2710879|NCT00333840|9330995|P1|Second-line Treatment Period|Subject withdrew consent|0
2710880|NCT00333840|9330992|P4|Second-line Treatment Period|Protocol Violation|10
2710881|NCT00333840|9330993|P3|Second-line Treatment Period|Protocol Violation|1
2710882|NCT00333840|9330994|P2|Second-line Treatment Period|Protocol Violation|0
2710883|NCT00333840|9330995|P1|Second-line Treatment Period|Protocol Violation|0
2710884|NCT00333840|9330992|P4|Second-line Treatment Period|No longer required study drug|14
2710885|NCT00333840|9330993|P3|Second-line Treatment Period|No longer required study drug|1
2710886|NCT00333840|9330994|P2|Second-line Treatment Period|No longer required study drug|0
2710887|NCT00333840|9330995|P1|Second-line Treatment Period|No longer required study drug|0
2710888|NCT00333840|9330992|P4|Second-line Treatment Period|Unsatisfactory therapeutic effect|70
2710889|NCT00333840|9330993|P3|Second-line Treatment Period|Unsatisfactory therapeutic effect|9
2710890|NCT00333840|9330994|P2|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
2710891|NCT00333840|9330995|P1|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
2710892|NCT00333840|9330992|P4|Second-line Treatment Period|Abnormal procedure|1
2710893|NCT00333840|9330993|P3|Second-line Treatment Period|Abnormal procedure|0
2710894|NCT00333840|9330994|P2|Second-line Treatment Period|Abnormal procedure|0
2710895|NCT00333840|9330995|P1|Second-line Treatment Period|Abnormal procedure|0
2710896|NCT00333840|9330992|P4|Second-line Treatment Period|Abnormal Laboratory Values|3
2710897|NCT00333840|9330993|P3|Second-line Treatment Period|Abnormal Laboratory Values|0
2710898|NCT00333840|9330994|P2|Second-line Treatment Period|Abnormal Laboratory Values|0
2710899|NCT00333840|9330995|P1|Second-line Treatment Period|Abnormal Laboratory Values|0
2710900|NCT00333840|9330992|P4|Second-line Treatment Period|Adverse Event|34
2710901|NCT00333840|9330993|P3|Second-line Treatment Period|Adverse Event|3
2710902|NCT00333840|9330994|P2|Second-line Treatment Period|Adverse Event|0
2710903|NCT00333840|9330995|P1|Second-line Treatment Period|Adverse Event|0
2710904|NCT00333840|9330992|P4|First-line Treatment Period|Crossed over to other treatment arm|0
2710905|NCT00333840|9330993|P3|First-line Treatment Period|Crossed over to other treatment arm|0
2710906|NCT00333840|9330994|P2|First-line Treatment Period|Crossed over to other treatment arm|363
2710907|NCT00333840|9330995|P1|First-line Treatment Period|Crossed over to other treatment arm|14
2710908|NCT00333840|9330992|P4|First-line Treatment Period|Death|0
2710909|NCT00333840|9330993|P3|First-line Treatment Period|Death|0
2710910|NCT00333840|9330994|P2|First-line Treatment Period|Death|2
2710911|NCT00333840|9330995|P1|First-line Treatment Period|Death|19
2710912|NCT00333840|9330992|P4|First-line Treatment Period|Administrative problems|0
2710913|NCT00333840|9330993|P3|First-line Treatment Period|Administrative problems|0
2710914|NCT00333840|9330994|P2|First-line Treatment Period|Administrative problems|6
2710915|NCT00333840|9330995|P1|First-line Treatment Period|Administrative problems|12
2710916|NCT00333840|9330992|P4|First-line Treatment Period|Lost to Follow-up|0
2710917|NCT00333840|9330993|P3|First-line Treatment Period|Lost to Follow-up|0
2710918|NCT00333840|9330994|P2|First-line Treatment Period|Lost to Follow-up|6
2710919|NCT00333840|9330995|P1|First-line Treatment Period|Lost to Follow-up|15
2710920|NCT00333840|9330992|P4|First-line Treatment Period|Subject withdrew consent|0
2710921|NCT00333840|9330993|P3|First-line Treatment Period|Subject withdrew consent|0
2710922|NCT00333840|9330994|P2|First-line Treatment Period|Subject withdrew consent|77
2710923|NCT00333840|9330995|P1|First-line Treatment Period|Subject withdrew consent|57
2710924|NCT00333840|9330992|P4|First-line Treatment Period|Protocol Violation|0
2710925|NCT00333840|9330993|P3|First-line Treatment Period|Protocol Violation|0
2710926|NCT00333840|9330994|P2|First-line Treatment Period|Protocol Violation|17
2710927|NCT00333840|9330995|P1|First-line Treatment Period|Protocol Violation|17
2710928|NCT00333840|9330992|P4|First-line Treatment Period|No longer required study drug|0
2710929|NCT00333840|9330993|P3|First-line Treatment Period|No longer required study drug|0
2710930|NCT00333840|9330994|P2|First-line Treatment Period|No longer required study drug|8
2710931|NCT00333840|9330995|P1|First-line Treatment Period|No longer required study drug|21
2710932|NCT00333840|9330992|P4|First-line Treatment Period|Unsatisfactory therapeutic effect|0
2710933|NCT00333840|9330993|P3|First-line Treatment Period|Unsatisfactory therapeutic effect|0
2710934|NCT00333840|9330994|P2|First-line Treatment Period|Unsatisfactory therapeutic effect|29
2710935|NCT00333840|9330995|P1|First-line Treatment Period|Unsatisfactory therapeutic effect|88
2710936|NCT00333840|9330992|P4|First-line Treatment Period|Abnormal procedure|0
2710937|NCT00333840|9330993|P3|First-line Treatment Period|Abnormal procedure|0
2710938|NCT00333840|9330994|P2|First-line Treatment Period|Abnormal procedure|0
2710939|NCT00333840|9330995|P1|First-line Treatment Period|Abnormal procedure|2
2710940|NCT00333840|9330992|P4|First-line Treatment Period|Abnormal laboratory values|0
2710941|NCT00333840|9330993|P3|First-line Treatment Period|Abnormal laboratory values|0
2710942|NCT00333840|9330994|P2|First-line Treatment Period|Abnormal laboratory values|1
2710943|NCT00333840|9330995|P1|First-line Treatment Period|Abnormal laboratory values|3
2710944|NCT00333840|9330992|P4|First-line Treatment Period|Adverse Event|0
2710945|NCT00333840|9330993|P3|First-line Treatment Period|Adverse Event|0
2710946|NCT00333840|9330994|P2|First-line Treatment Period|Adverse Event|37
2710947|NCT00333840|9330995|P1|First-line Treatment Period|Adverse Event|38
2710948|NCT00333801|9331041|P2|Overall Study|Withdrawal by Subject|1
2710949|NCT00333801|9331042|P1|Overall Study|Withdrawal by Subject|0
2710950|NCT00333801|9331041|P2|Overall Study|Incarcerated|2
2710951|NCT00333801|9331042|P1|Overall Study|Incarcerated|1
2710952|NCT00333801|9331041|P2|Overall Study|Lost to Follow-up|0
2710953|NCT00333801|9331042|P1|Overall Study|Lost to Follow-up|2
2710954|NCT00333801|9331041|P2|Overall Study|Moved to another state|3
2710955|NCT00333801|9331042|P1|Overall Study|Moved to another state|5
2710956|NCT00333788|9331060|P1|Overall Study|Other: Signed consent for another study|1
2710957|NCT00333788|9331060|P1|Overall Study|Other: Physician decision|1
2710958|NCT00333788|9331060|P1|Overall Study|Other: Medical monitor decision|1
2710959|NCT00333788|9331060|P1|Overall Study|Other: Subject in need of an Entocort|1
2710960|NCT00333788|9331060|P1|Overall Study|Other: Sponsor decision|1
2710961|NCT00333788|9331060|P1|Overall Study|Other: Quality of life concern|1
2710962|NCT00333788|9331060|P1|Overall Study|Other: Investigator decision|1
2710963|NCT00333788|9331060|P1|Overall Study|Other: Recurrent squamaous cell cancer|1
2710964|NCT00333788|9331060|P1|Overall Study|Other: Moved|2
2710965|NCT00333788|9331060|P1|Overall Study|Other: Non-compliance|2
2710966|NCT00333788|9331060|P1|Overall Study|Withdrawal by Subject|24
2710967|NCT00333788|9331060|P1|Overall Study|Lost to Follow-up|2
2710968|NCT00333788|9331060|P1|Overall Study|Lack of Efficacy|80
2710969|NCT00333788|9331060|P1|Overall Study|Adverse Event|44
2710970|NCT00333775|9331090|P3|Overall Study|Lost to Follow-up|8
2710971|NCT00333775|9331091|P2|Overall Study|Lost to Follow-up|7
2710972|NCT00333775|9331092|P1|Overall Study|Lost to Follow-up|10
2710973|NCT00333775|9331090|P3|Overall Study|In Follow−up When Study Stopped|96
2710974|NCT00333775|9331091|P2|Overall Study|In Follow−up When Study Stopped|92
2710975|NCT00333775|9331092|P1|Overall Study|In Follow−up When Study Stopped|87
2710976|NCT00333775|9331090|P3|Overall Study|Death|143
2710977|NCT00333775|9331091|P2|Overall Study|Death|149
2710978|NCT00333775|9331092|P1|Overall Study|Death|144
2710979|NCT00333619|9331131|P2|Overall Study|Lost to Follow-up|3
2710980|NCT00333619|9331132|P1|Overall Study|Lost to Follow-up|3
2710981|NCT00333619|9331131|P2|Overall Study|Withdrawal by Subject|1
2710982|NCT00333619|9331132|P1|Overall Study|Withdrawal by Subject|6
2710983|NCT00333619|9331131|P2|Overall Study|Death|6
2710984|NCT00333619|9331132|P1|Overall Study|Death|12
2710985|NCT00333359|9331161|P2|Overall Study|Withdrew before Receiving One Dose|6
2710986|NCT00333359|9331162|P1|Overall Study|Withdrew before Receiving One Dose|2
2710987|NCT00333359|9331161|P2|Overall Study|Treatment Failure|8
2710988|NCT00333359|9331162|P1|Overall Study|Treatment Failure|3
2710989|NCT00333359|9331161|P2|Overall Study|Termination or Withdrawal by Sponsor|1
2710990|NCT00333359|9331162|P1|Overall Study|Termination or Withdrawal by Sponsor|1
2710991|NCT00333359|9331161|P2|Overall Study|Lost to Follow-up|25
2710992|NCT00333359|9331162|P1|Overall Study|Lost to Follow-up|15
2710993|NCT00333359|9331161|P2|Overall Study|Protocol Non-compliance|8
2710994|NCT00333359|9331162|P1|Overall Study|Protocol Non-compliance|2
2710995|NCT00333359|9331161|P2|Overall Study|Physician Decision|2
2710996|NCT00333359|9331162|P1|Overall Study|Physician Decision|2
2710997|NCT00333359|9331161|P2|Overall Study|Withdrawal by Subject|37
2710998|NCT00333359|9331162|P1|Overall Study|Withdrawal by Subject|19
2710999|NCT00333359|9331161|P2|Overall Study|Adverse Event|35
2711000|NCT00333359|9331162|P1|Overall Study|Adverse Event|29
2711001|NCT00333229|9331205|P2|Overall Study|Lack of Efficacy|1
2711002|NCT00333229|9331206|P1|Overall Study|Lack of Efficacy|0
2711003|NCT00333138|9331276|P3|Extension Study (Month6 to End of Study)|Death|0
2711004|NCT00333138|9331277|P2|Extension Study (Month6 to End of Study)|Death|1
2711005|NCT00333138|9331278|P1|Extension Study (Month6 to End of Study)|Death|0
2711006|NCT00333138|9331276|P3|Extension Study (Month6 to End of Study)|Lost to Follow-up|0
2711007|NCT00333138|9331277|P2|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
2711008|NCT00333138|9331278|P1|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
2711009|NCT00333138|9331276|P3|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0
2711010|NCT00333138|9331277|P2|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1
2711011|NCT00333138|9331278|P1|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2
2711012|NCT00333138|9331276|P3|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
2711013|NCT00333138|9331277|P2|Extension Study (Month6 to End of Study)|Lack of Efficacy|4
2711014|NCT00333138|9331278|P1|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
2711015|NCT00333138|9331276|P3|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
2711016|NCT00333138|9331277|P2|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13
2711017|NCT00333138|9331278|P1|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
2711018|NCT00333138|9331276|P3|Extension Study (Month6 to End of Study)|Protocol Violation|3
2711019|NCT00333138|9331277|P2|Extension Study (Month6 to End of Study)|Protocol Violation|0
2711020|NCT00333138|9331278|P1|Extension Study (Month6 to End of Study)|Protocol Violation|0
2711021|NCT00333138|9331276|P3|Extension Study (Month6 to End of Study)|Adverse Event|15
2711022|NCT00333138|9331277|P2|Extension Study (Month6 to End of Study)|Adverse Event|19
2711023|NCT00333138|9331278|P1|Extension Study (Month6 to End of Study)|Adverse Event|15
2711024|NCT00333138|9331276|P3|Extension Study (Month6 to End of Study)|Administrative problems|2
2711025|NCT00333138|9331277|P2|Extension Study (Month6 to End of Study)|Administrative problems|1
2711026|NCT00333138|9331278|P1|Extension Study (Month6 to End of Study)|Administrative problems|1
2711027|NCT00333138|9331276|P3|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
2711028|NCT00333138|9331277|P2|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
2711029|NCT00333138|9331278|P1|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3
2711030|NCT00333138|9331276|P3|Core Study (6 Months)|Laboratory abnormality|1
2711031|NCT00333138|9331277|P2|Core Study (6 Months)|Laboratory abnormality|0
2711032|NCT00333138|9331278|P1|Core Study (6 Months)|Laboratory abnormality|0
2711033|NCT00333138|9331276|P3|Core Study (6 Months)|Protocol Violation|1
2711034|NCT00333138|9331277|P2|Core Study (6 Months)|Protocol Violation|0
2711035|NCT00333138|9331278|P1|Core Study (6 Months)|Protocol Violation|1
2711036|NCT00333138|9331276|P3|Core Study (6 Months)|Lack of Efficacy|0
2711037|NCT00333138|9331277|P2|Core Study (6 Months)|Lack of Efficacy|0
2711038|NCT00333138|9331278|P1|Core Study (6 Months)|Lack of Efficacy|1
2711039|NCT00333138|9331276|P3|Core Study (6 Months)|Withdrawal by Subject|2
2711040|NCT00333138|9331277|P2|Core Study (6 Months)|Withdrawal by Subject|1
2711041|NCT00333138|9331278|P1|Core Study (6 Months)|Withdrawal by Subject|1
2711042|NCT00333138|9331276|P3|Core Study (6 Months)|Adverse Event|8
2711043|NCT00333138|9331277|P2|Core Study (6 Months)|Adverse Event|5
2711044|NCT00333138|9331278|P1|Core Study (6 Months)|Adverse Event|4
2711045|NCT00332839|9331317|P2|Follow-up (Months 12 - 60)|Death|1
2711046|NCT00332839|9331318|P1|Follow-up (Months 12 - 60)|Death|1
2711047|NCT00332839|9331317|P2|Follow-up (Months 12 - 60)|Lost to Follow-up|1
2711048|NCT00332839|9331318|P1|Follow-up (Months 12 - 60)|Lost to Follow-up|2
2711049|NCT00332839|9331317|P2|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
2711050|NCT00332839|9331318|P1|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
2711051|NCT00332839|9331317|P2|Core (Months 0 - 12)|Adverse Event|15
2711052|NCT00332839|9331318|P1|Core (Months 0 - 12)|Adverse Event|5
2711053|NCT00332839|9331317|P2|Core (Months 0 - 12)|Protocol deviation|1
2711054|NCT00332839|9331318|P1|Core (Months 0 - 12)|Protocol deviation|1
2711055|NCT00332839|9331317|P2|Core (Months 0 - 12)|Withdrawal by Subject|1
2711056|NCT00332839|9331318|P1|Core (Months 0 - 12)|Withdrawal by Subject|3
2711057|NCT00332839|9331317|P2|Core (Months 0 - 12)|Administrative problems|1
2711058|NCT00332839|9331318|P1|Core (Months 0 - 12)|Administrative problems|1
2711059|NCT00332709|9331349|P2|Overall Study|Abnormal test procedure result|0
2711060|NCT00332709|9331350|P1|Overall Study|Abnormal test procedure result|1
2711061|NCT00332709|9331349|P2|Overall Study|Administrative Problems|3
2711062|NCT00332709|9331350|P1|Overall Study|Administrative Problems|0
2711063|NCT00332709|9331349|P2|Overall Study|Lost to Follow-up|0
2711064|NCT00332709|9331350|P1|Overall Study|Lost to Follow-up|2
2711065|NCT00332709|9331349|P2|Overall Study|Withdrawal by Subject|3
2711066|NCT00332709|9331350|P1|Overall Study|Withdrawal by Subject|2
2711067|NCT00332709|9331349|P2|Overall Study|Adverse Event|14
2711068|NCT00332709|9331350|P1|Overall Study|Adverse Event|11
2711069|NCT00332696|9331374|P2|Overall Study|Withdrawal by Subject|0
2711070|NCT00332696|9331375|P1|Overall Study|Withdrawal by Subject|1
2711071|NCT00332696|9331374|P2|Overall Study|Lost to Follow-up|1
2711072|NCT00332696|9331375|P1|Overall Study|Lost to Follow-up|0
2711073|NCT00332696|9331374|P2|Overall Study|Condition does not justify treatment|2
2711074|NCT00332696|9331375|P1|Overall Study|Condition does not justify treatment|0
2711075|NCT00332696|9331374|P2|Overall Study|Adverse Event|2
2711076|NCT00332696|9331375|P1|Overall Study|Adverse Event|1
2711077|NCT00332696|9331374|P2|Overall Study|Insufficient therapeutic effect|11
2711078|NCT00332696|9331375|P1|Overall Study|Insufficient therapeutic effect|4
2711079|NCT00332696|9331374|P2|Overall Study|Death|14
2711080|NCT00332696|9331375|P1|Overall Study|Death|24
2711081|NCT00332488|9331451|P3|Transfer Treatment Phase (Weeks 12 – 24)|Various|5
2711082|NCT00332488|9331452|P2|Transfer Treatment Phase (Weeks 12 – 24)|Various|0
2711083|NCT00332488|9331453|P1|Transfer Treatment Phase (Weeks 12 – 24)|Various|0
2711084|NCT00332488|9331451|P3|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|8
2711085|NCT00332488|9331452|P2|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|2
2711086|NCT00332488|9331453|P1|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|2
2711087|NCT00332488|9331451|P3|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|1
2711088|NCT00332488|9331452|P2|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|0
2711089|NCT00332488|9331453|P1|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|0
2711090|NCT00332488|9331451|P3|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|3
2711091|NCT00332488|9331452|P2|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|0
2711092|NCT00332488|9331453|P1|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|0
2711093|NCT00332488|9331451|P3|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|1
2711094|NCT00332488|9331452|P2|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|0
2711095|NCT00332488|9331453|P1|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|0
2711096|NCT00332488|9331451|P3|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|3
2711097|NCT00332488|9331452|P2|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|0
2711098|NCT00332488|9331453|P1|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|0
2711099|NCT00332488|9331451|P3|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0
2711100|NCT00332488|9331452|P2|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1
2711101|NCT00332488|9331453|P1|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3
2711102|NCT00332488|9331451|P3|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0
2711103|NCT00332488|9331452|P2|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3
2711104|NCT00332488|9331453|P1|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1
2711105|NCT00332488|9331451|P3|Initial Treatment Phase (Weeks 0 - 12)|Various|20
2711106|NCT00332488|9331452|P2|Initial Treatment Phase (Weeks 0 - 12)|Various|0
2711107|NCT00332488|9331453|P1|Initial Treatment Phase (Weeks 0 - 12)|Various|4
2711108|NCT00332488|9331451|P3|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20
2711109|NCT00332488|9331452|P2|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10
2711110|NCT00332488|9331453|P1|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21
2711111|NCT00332488|9331451|P3|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10
2711112|NCT00332488|9331452|P2|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2
2711113|NCT00332488|9331453|P1|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13
2711114|NCT00332488|9331451|P3|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6
2711115|NCT00332488|9331452|P2|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2
2711116|NCT00332488|9331453|P1|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8
2711117|NCT00332462|9331465|P1|Overall Study|Graft Loss|2
2711118|NCT00332462|9331465|P1|Overall Study|Death|3
2711119|NCT00332462|9331465|P1|Overall Study|no longer requires study drug|1
2711120|NCT00332462|9331465|P1|Overall Study|Unsatisfactory therapeutic effect|4
2711121|NCT00332462|9331465|P1|Overall Study|Abnormal Lab Value|1
2711122|NCT00332462|9331465|P1|Overall Study|Adverse Event|5
2711123|NCT00332332|9331472|P1|Overall Study|Did not receive study treatment|16
2711124|NCT00332332|9331472|P1|Overall Study|Other|18
2711125|NCT00332332|9331472|P1|Overall Study|Disease progression|2
2711126|NCT00332332|9331472|P1|Overall Study|Noncompliance|2
2711127|NCT00332332|9331472|P1|Overall Study|Protocol deviation|4
2711128|NCT00332332|9331472|P1|Overall Study|Lost to Follow-up|3
2711129|NCT00332332|9331472|P1|Overall Study|Physician Decision|1
2711130|NCT00332332|9331472|P1|Overall Study|Withdrawal by Subject|8
2711131|NCT00332332|9331472|P1|Overall Study|Death|1
2711132|NCT00332332|9331472|P1|Overall Study|Adverse Event|13
2711133|NCT00332241|9331481|P2|Overall Study|Lost to Follow-up|1
2711134|NCT00332241|9331482|P1|Overall Study|Lost to Follow-up|4
2711135|NCT00332241|9331481|P2|Overall Study|Withdrawal by Subject|1
2711136|NCT00332241|9331482|P1|Overall Study|Withdrawal by Subject|2
2711137|NCT00332241|9331481|P2|Overall Study|Adverse Event|5
2711138|NCT00332241|9331482|P1|Overall Study|Adverse Event|3
2711139|NCT00332241|9331481|P2|Overall Study|Lack of Efficacy|1
2711140|NCT00332241|9331482|P1|Overall Study|Lack of Efficacy|6
2711141|NCT00332202|9331504|P2|Overall Study|Death|2
2711142|NCT00332202|9331505|P1|Overall Study|Death|5
2711143|NCT00332202|9331504|P2|Overall Study|Progressive Disease|60
2711144|NCT00332202|9331505|P1|Overall Study|Progressive Disease|106
2711145|NCT00332202|9331504|P2|Overall Study|Withdrawal by Subject|17
2711146|NCT00332202|9331505|P1|Overall Study|Withdrawal by Subject|36
2711147|NCT00332202|9331504|P2|Overall Study|Sponsor Decision|2
2711148|NCT00332202|9331505|P1|Overall Study|Sponsor Decision|1
2711149|NCT00332202|9331504|P2|Overall Study|Protocol Violation|2
2711150|NCT00332202|9331505|P1|Overall Study|Protocol Violation|7
2711151|NCT00332202|9331504|P2|Overall Study|Protocol Entry Criteria Not Met|5
2711152|NCT00332202|9331505|P1|Overall Study|Protocol Entry Criteria Not Met|6
2711153|NCT00332202|9331504|P2|Overall Study|Physician Decision|8
2711154|NCT00332202|9331505|P1|Overall Study|Physician Decision|6
2711155|NCT00332202|9331504|P2|Overall Study|Lost to Follow-up|1
2711156|NCT00332202|9331505|P1|Overall Study|Lost to Follow-up|2
2711157|NCT00332202|9331504|P2|Overall Study|Adverse Event|28
2711158|NCT00332202|9331505|P1|Overall Study|Adverse Event|72
2711159|NCT00332189|9331534|P1|Overall Study|Moved out of country|2
2711160|NCT00332189|9331534|P1|Overall Study|Lack of Efficacy|4
2711161|NCT00332189|9331534|P1|Overall Study|Withdrawal by Subject|9
2711162|NCT00332189|9331534|P1|Overall Study|Uncooperative/Noncompliant|3
2711163|NCT00332189|9331534|P1|Overall Study|Adverse Event|3
2711164|NCT00331864|9331576|P2|Overall Study|Death|0
2711165|NCT00331864|9331577|P1|Overall Study|Death|6
2711166|NCT00331864|9331576|P2|Overall Study|Administrative Problems|0
2711167|NCT00331864|9331577|P1|Overall Study|Administrative Problems|1
2711168|NCT00331864|9331576|P2|Overall Study|Lost to Follow-up|3
2711169|NCT00331864|9331577|P1|Overall Study|Lost to Follow-up|4
2711170|NCT00331864|9331576|P2|Overall Study|Withdrawal by Subject|0
2711171|NCT00331864|9331577|P1|Overall Study|Withdrawal by Subject|10
2711172|NCT00331864|9331576|P2|Overall Study|Protocol Violation|0
2711173|NCT00331864|9331577|P1|Overall Study|Protocol Violation|3
2711174|NCT00331864|9331576|P2|Overall Study|Lack of Efficacy|0
2711175|NCT00331864|9331577|P1|Overall Study|Lack of Efficacy|4
2711176|NCT00331864|9331576|P2|Overall Study|Adverse Event|1
2711177|NCT00331864|9331577|P1|Overall Study|Adverse Event|30
2711178|NCT00331799|9331596|P1|Overall Study|Sedation|1
2711179|NCT00331799|9331596|P1|Overall Study|Withdrawal by Subject|2
2711180|NCT00331773|9331602|P2|Overall Study|Protocol Violation|3
2711181|NCT00331773|9331603|P1|Overall Study|Protocol Violation|10
2711182|NCT00331773|9331602|P2|Overall Study|Withdrawal by Subject|4
2711183|NCT00331773|9331603|P1|Overall Study|Withdrawal by Subject|6
2711184|NCT00331760|9331633|P2|Overall Study|Ineligible / no protocol treatment|8
2711185|NCT00331760|9331634|P1|Overall Study|Ineligible / no protocol treatment|15
2711186|NCT00331682|9331655|P1|Overall Study|Adverse Event|1
2711187|NCT00331630|9331661|P1|Follow up for 5 Years|Data collection was stopped|24
2711188|NCT00331630|9331661|P1|Follow up for 5 Years|Death|5
2711189|NCT00331630|9331661|P1|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1
2711190|NCT00331630|9331661|P1|Evaluated for and Completed SOC Surgery|Progressive Disease|1
2711191|NCT00331552|9331673|P2|Period 3: Phase II|Severe Nausea|0
2711192|NCT00331552|9331674|P1|Period 3: Phase II|Severe Nausea|1
2711193|NCT00331552|9331673|P2|Period 3: Phase II|Neurological Symptoms|0
2711194|NCT00331552|9331674|P1|Period 3: Phase II|Neurological Symptoms|1
2711195|NCT00331422|9331688|P1|Overall Study|Did not receive entire study regimen|5
2711196|NCT00331409|9331697|P1|Overall Study|Lack of Efficacy|4
2711197|NCT00331344|9331705|P9|Phase II|Death|4
2711198|NCT00331344|9331706|P8|Phase II|Death|0
2711199|NCT00331344|9331707|P7|Phase II|Death|0
2711200|NCT00331344|9331708|P6|Phase II|Death|0
2711201|NCT00331344|9331709|P5|Phase II|Death|0
2711202|NCT00331344|9331710|P4|Phase II|Death|0
2711203|NCT00331344|9331711|P3|Phase II|Death|0
2711204|NCT00331344|9331712|P2|Phase II|Death|0
2711205|NCT00331344|9331713|P1|Phase II|Death|0
2711206|NCT00331344|9331705|P9|Phase I|Adverse Event|0
2711207|NCT00331344|9331706|P8|Phase I|Adverse Event|1
2711208|NCT00331344|9331707|P7|Phase I|Adverse Event|0
2711209|NCT00331344|9331708|P6|Phase I|Adverse Event|2
2711210|NCT00331344|9331709|P5|Phase I|Adverse Event|2
2711211|NCT00331344|9331710|P4|Phase I|Adverse Event|1
2711212|NCT00331344|9331711|P3|Phase I|Adverse Event|0
2711213|NCT00331344|9331712|P2|Phase I|Adverse Event|0
2711214|NCT00331344|9331713|P1|Phase I|Adverse Event|0
2711215|NCT00331006|9331750|P1|Follow-Up Phase II|Lost to Follow-up|3
2711216|NCT00331006|9331750|P1|Follow-Up Phase I|Lost to Follow-up|1
2711217|NCT00331006|9331750|P1|Treatment Phase|Withdrawal by Subject|1
2711218|NCT00331006|9331750|P1|Screening Phase|Ineligible for treatment phase|4
2711219|NCT00331006|9331750|P1|Screening Phase|Lost to Follow-up|1
2711220|NCT00331006|9331750|P1|Screening Phase|enrollment halted|1
2711221|NCT00331006|9331750|P1|Screening Phase|Withdrawal by Subject|1
2711222|NCT00330967|9331763|P2|Overall Study|Physician Decision|9
2711223|NCT00330967|9331764|P1|Overall Study|Physician Decision|0
2711224|NCT00330967|9331763|P2|Overall Study|Withdrawal by Subject|5
2711225|NCT00330967|9331764|P1|Overall Study|Withdrawal by Subject|0
2711226|NCT00330928|9331775|P1|Overall Study|IVUS could not be performed.|1
2711227|NCT00330928|9331775|P1|Overall Study|Death|1
2711228|NCT00330928|9331775|P1|Overall Study|Physician Decision|9
2711229|NCT00330928|9331775|P1|Overall Study|Lost to Follow-up|6
2711230|NCT00330759|9331817|P2|Overall Study|Other|44
2711231|NCT00330759|9331818|P1|Overall Study|Other|36
2711232|NCT00330759|9331817|P2|Overall Study|Ineligibility determined|1
2711233|NCT00330759|9331818|P1|Overall Study|Ineligibility determined|2
2711234|NCT00330759|9331817|P2|Overall Study|Protocol deviation|2
2711235|NCT00330759|9331818|P1|Overall Study|Protocol deviation|0
2711236|NCT00330759|9331817|P2|Overall Study|Physician Decision|2
2711237|NCT00330759|9331818|P1|Overall Study|Physician Decision|1
2711238|NCT00330759|9331817|P2|Overall Study|Noncompliance|17
2711239|NCT00330759|9331818|P1|Overall Study|Noncompliance|15
2711240|NCT00330759|9331817|P2|Overall Study|Lost to Follow-up|22
2711241|NCT00330759|9331818|P1|Overall Study|Lost to Follow-up|16
2711242|NCT00330759|9331817|P2|Overall Study|Participant request|22
2711243|NCT00330759|9331818|P1|Overall Study|Participant request|31
2711244|NCT00330759|9331817|P2|Overall Study|Adverse Event|36
2711245|NCT00330759|9331818|P1|Overall Study|Adverse Event|48
2711246|NCT00330759|9331817|P2|Overall Study|Withdrawal by Subject|124
2711247|NCT00330759|9331818|P1|Overall Study|Withdrawal by Subject|143
2711248|NCT00330759|9331817|P2|Overall Study|Disease progression|126
2711249|NCT00330759|9331818|P1|Overall Study|Disease progression|104
2711250|NCT00330759|9331817|P2|Overall Study|Death|310
2711251|NCT00330759|9331818|P1|Overall Study|Death|316
2711252|NCT00330681|9331851|P2|Overall Study|Tracheotomy due to worsening of ALS|2
2711253|NCT00330681|9331852|P1|Overall Study|Tracheotomy due to worsening of ALS|1
2711254|NCT00330681|9331851|P2|Overall Study|Withdrawal by Subject|5
2711255|NCT00330681|9331852|P1|Overall Study|Withdrawal by Subject|5
2711256|NCT00330681|9331851|P2|Overall Study|Protocol Violation|1
2711257|NCT00330681|9331852|P1|Overall Study|Protocol Violation|0
2711258|NCT00330681|9331851|P2|Overall Study|Adverse Event|6
2711259|NCT00330681|9331852|P1|Overall Study|Adverse Event|3
2711260|NCT00330668|9331874|P1|Overall Study|Patient started Lupron|1
2711261|NCT00330668|9331874|P1|Overall Study|Use of exclusionary medication|1
2711262|NCT00330668|9331874|P1|Overall Study|Lack of Efficacy|1
2711263|NCT00330668|9331874|P1|Overall Study|Sponsor's decision|76
2711264|NCT00330668|9331874|P1|Overall Study|Withdrawal by Subject|20
2711265|NCT00330668|9331874|P1|Overall Study|Non-Compliance|5
2711266|NCT00330668|9331874|P1|Overall Study|Lost to Follow-up|9
2711267|NCT00330668|9331874|P1|Overall Study|Adverse Event|1
2711268|NCT00330616|9331881|P1|Overall Study|Other|1
2711269|NCT00330616|9331881|P1|Overall Study|Withdrawal by Subject|4
2711270|NCT00330616|9331881|P1|Overall Study|Lost to Follow-up|2
2711271|NCT00330616|9331881|P1|Overall Study|Lack of Efficacy|1
2711272|NCT00330616|9331881|P1|Overall Study|Adverse Event|13
2711273|NCT00330460|9331932|P2|Overall Study|Other|0
2711274|NCT00330460|9331933|P1|Overall Study|Other|1
2711275|NCT00330460|9331932|P2|Overall Study|Noncompliance|1
2711276|NCT00330460|9331933|P1|Overall Study|Noncompliance|2
2711277|NCT00330460|9331932|P2|Overall Study|Lost to Follow-up|3
2711278|NCT00330460|9331933|P1|Overall Study|Lost to Follow-up|8
2711279|NCT00330460|9331932|P2|Overall Study|Ineligibility determined|3
2711280|NCT00330460|9331933|P1|Overall Study|Ineligibility determined|1
2711281|NCT00330460|9331932|P2|Overall Study|Death|1
2711282|NCT00330460|9331933|P1|Overall Study|Death|1
2711283|NCT00330460|9331932|P2|Overall Study|Withdrawal by Subject|17
2711284|NCT00330460|9331933|P1|Overall Study|Withdrawal by Subject|18
2711285|NCT00330460|9331932|P2|Overall Study|Adverse Event|8
2711286|NCT00330460|9331933|P1|Overall Study|Adverse Event|10
2711287|NCT00330460|9331932|P2|Overall Study|Physician Decision|0
2711288|NCT00330460|9331933|P1|Overall Study|Physician Decision|1
2711289|NCT00330343|9331976|P1|Overall Study|Lost to Follow-up|5
2711290|NCT00330187|9331984|P4|Overall Study|Withdrawal by Subject|4
2711291|NCT00330187|9331985|P3|Overall Study|Withdrawal by Subject|4
2711292|NCT00330187|9331986|P2|Overall Study|Withdrawal by Subject|5
2711293|NCT00330187|9331987|P1|Overall Study|Withdrawal by Subject|8
2711294|NCT00330187|9331984|P4|Overall Study|Lost to Follow-up|10
2711295|NCT00330187|9331985|P3|Overall Study|Lost to Follow-up|14
2711296|NCT00330187|9331986|P2|Overall Study|Lost to Follow-up|13
2711297|NCT00330187|9331987|P1|Overall Study|Lost to Follow-up|12
2711298|NCT00330174|9331999|P2|Overall Study|Miscellaneous reasons|1
2711299|NCT00330174|9332000|P1|Overall Study|Miscellaneous reasons|7
2711300|NCT00330174|9331999|P2|Overall Study|Excessive missed visits|8
2711301|NCT00330174|9332000|P1|Overall Study|Excessive missed visits|3
2711302|NCT00330174|9331999|P2|Overall Study|Clinical deterioration|2
2711303|NCT00330174|9332000|P1|Overall Study|Clinical deterioration|1
2711304|NCT00330174|9331999|P2|Overall Study|Lost to Follow-up|1
2711305|NCT00330174|9332000|P1|Overall Study|Lost to Follow-up|4
2711306|NCT00330174|9331999|P2|Overall Study|Withdrawal by Subject|7
2711307|NCT00330174|9332000|P1|Overall Study|Withdrawal by Subject|7
2711308|NCT00329901|9332024|P3|Overall Study|Unable to classify|0
2711309|NCT00329901|9332025|P2|Overall Study|Unable to classify|2
2711310|NCT00329901|9332026|P1|Overall Study|Unable to classify|2
2711311|NCT00329901|9332024|P3|Overall Study|Protocol Violation|1
2711312|NCT00329901|9332025|P2|Overall Study|Protocol Violation|0
2711313|NCT00329901|9332026|P1|Overall Study|Protocol Violation|1
2711314|NCT00329901|9332024|P3|Overall Study|Lost to Follow-up|1
2711315|NCT00329901|9332025|P2|Overall Study|Lost to Follow-up|0
2711316|NCT00329901|9332026|P1|Overall Study|Lost to Follow-up|2
2711317|NCT00329901|9332024|P3|Overall Study|Withdrawal by Subject|2
2711318|NCT00329901|9332025|P2|Overall Study|Withdrawal by Subject|3
2711319|NCT00329901|9332026|P1|Overall Study|Withdrawal by Subject|4
2711320|NCT00329849|9332056|P2|Overall Study|Withdrawal by Subject|4
2711321|NCT00329849|9332057|P1|Overall Study|Withdrawal by Subject|6
2711322|NCT00329797|9332083|P2|Overall Study|Withdrawal by Subject|6
2711323|NCT00329797|9332084|P1|Overall Study|Withdrawal by Subject|6
2711324|NCT00329797|9332083|P2|Overall Study|Protocol Violation|0
2711325|NCT00329797|9332084|P1|Overall Study|Protocol Violation|1
2711326|NCT00329784|9332100|P4|Overall Study|Other|0
2711327|NCT00329784|9332101|P3|Overall Study|Other|0
2711328|NCT00329784|9332102|P2|Overall Study|Other|2
2711329|NCT00329784|9332103|P1|Overall Study|Other|1
2711330|NCT00329784|9332100|P4|Overall Study|Withdrawal by Subject|0
2711331|NCT00329784|9332101|P3|Overall Study|Withdrawal by Subject|0
2711332|NCT00329784|9332102|P2|Overall Study|Withdrawal by Subject|2
2711333|NCT00329784|9332103|P1|Overall Study|Withdrawal by Subject|4
2711334|NCT00329784|9332100|P4|Overall Study|Lost to Follow-up|0
2711335|NCT00329784|9332101|P3|Overall Study|Lost to Follow-up|0
2711336|NCT00329784|9332102|P2|Overall Study|Lost to Follow-up|1
2711337|NCT00329784|9332103|P1|Overall Study|Lost to Follow-up|0
2711338|NCT00329745|9332131|P2|Overall Study|Lost to Follow-up|101
2711339|NCT00329745|9332132|P1|Overall Study|Lost to Follow-up|86
2711340|NCT00329745|9332131|P2|Overall Study|Withdrawal by Subject|1
2711341|NCT00329745|9332132|P1|Overall Study|Withdrawal by Subject|0
2711342|NCT00329745|9332131|P2|Overall Study|Protocol Violation|0
2711343|NCT00329745|9332132|P1|Overall Study|Protocol Violation|1
2711344|NCT00329719|9332152|P4|Overall Study|Lost to Follow-up|1
2711345|NCT00329719|9332153|P3|Overall Study|Lost to Follow-up|0
2711346|NCT00329719|9332154|P2|Overall Study|Lost to Follow-up|0
2711347|NCT00329719|9332155|P1|Overall Study|Lost to Follow-up|0
2711348|NCT00329641|9332177|P1|Overall Study|Other reason, not protocol specified|1
2711349|NCT00329641|9332177|P1|Overall Study|Adverse Event|3
2711350|NCT00329641|9332177|P1|Overall Study|Not eligible|1
2711351|NCT00329641|9332177|P1|Overall Study|Did not start treatment|1
2711352|NCT00329602|9332186|P3|40-Week Open-Label Treatment Phase|Captured as Other|4
2711353|NCT00329602|9332187|P2|40-Week Open-Label Treatment Phase|Captured as Other|0
2711354|NCT00329602|9332188|P1|40-Week Open-Label Treatment Phase|Captured as Other|0
2711355|NCT00329602|9332186|P3|40-Week Open-Label Treatment Phase|Lack of Efficacy|9
2711356|NCT00329602|9332187|P2|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
2711357|NCT00329602|9332188|P1|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
2711358|NCT00329602|9332186|P3|40-Week Open-Label Treatment Phase|Protocol Violation|2
2711359|NCT00329602|9332187|P2|40-Week Open-Label Treatment Phase|Protocol Violation|0
2711360|NCT00329602|9332188|P1|40-Week Open-Label Treatment Phase|Protocol Violation|0
2711361|NCT00329602|9332186|P3|40-Week Open-Label Treatment Phase|Lost to Follow-up|1
2711362|NCT00329602|9332187|P2|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
2711363|NCT00329602|9332188|P1|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
2711364|NCT00329602|9332186|P3|40-Week Open-Label Treatment Phase|Adverse Event|20
2711365|NCT00329602|9332187|P2|40-Week Open-Label Treatment Phase|Adverse Event|0
2711366|NCT00329602|9332188|P1|40-Week Open-Label Treatment Phase|Adverse Event|0
2711367|NCT00329602|9332186|P3|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0
2711368|NCT00329602|9332187|P2|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99
2711369|NCT00329602|9332188|P1|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119
2711370|NCT00329550|9332226|P3|Overall Study|Due to Relocation|1
2711371|NCT00329550|9332227|P2|Overall Study|Due to Relocation|0
2711372|NCT00329550|9332228|P1|Overall Study|Due to Relocation|0
2711373|NCT00329550|9332226|P3|Overall Study|Withdrawal of Consent|1
2711374|NCT00329550|9332227|P2|Overall Study|Withdrawal of Consent|0
2711375|NCT00329550|9332228|P1|Overall Study|Withdrawal of Consent|1
2711376|NCT00329550|9332226|P3|Overall Study|Adverse Event|2
2711377|NCT00329550|9332227|P2|Overall Study|Adverse Event|4
2711378|NCT00329550|9332228|P1|Overall Study|Adverse Event|3
2711379|NCT00329420|9332497|P3|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
2711380|NCT00329420|9332498|P2|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
2711381|NCT00329420|9332499|P1|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1
2711382|NCT00329420|9332497|P3|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0
2711383|NCT00329420|9332498|P2|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
2711384|NCT00329420|9332499|P1|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
2711385|NCT00329420|9332497|P3|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
2711386|NCT00329420|9332498|P2|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
2711387|NCT00329420|9332499|P1|4-weekly Dosing Phase (Responders Only)|Adverse Event|2
2711388|NCT00329420|9332497|P3|Re-induction Phase|Did not respond to re-induction|7
2711389|NCT00329420|9332498|P2|Re-induction Phase|Did not respond to re-induction|5
2711390|NCT00329420|9332499|P1|Re-induction Phase|Did not respond to re-induction|6
2711391|NCT00329420|9332497|P3|Re-induction Phase|Withdrawal of Consent|1
2711392|NCT00329420|9332498|P2|Re-induction Phase|Withdrawal of Consent|0
2711393|NCT00329420|9332499|P1|Re-induction Phase|Withdrawal of Consent|0
2711394|NCT00329420|9332497|P3|Re-induction Phase|Lack of Efficacy|0
2711395|NCT00329420|9332498|P2|Re-induction Phase|Lack of Efficacy|1
2711396|NCT00329420|9332499|P1|Re-induction Phase|Lack of Efficacy|0
2711397|NCT00329407|9332878|P1|Overall Study|Withdrawal by Subject|1
2711398|NCT00329303|9332885|P2|Overall Study|Patient relocated|1
2711399|NCT00329303|9332886|P1|Overall Study|Patient relocated|0
2711400|NCT00329303|9332885|P2|Overall Study|Patient no longer available|0
2711401|NCT00329303|9332886|P1|Overall Study|Patient no longer available|1
2711402|NCT00329303|9332885|P2|Overall Study|Decision of the sponsor|1
2711403|NCT00329303|9332886|P1|Overall Study|Decision of the sponsor|0
2711404|NCT00329303|9332885|P2|Overall Study|Lack of Efficacy|0
2711405|NCT00329303|9332886|P1|Overall Study|Lack of Efficacy|1
2711406|NCT00329238|9333048|P2|Overall Study|Other reason (not specified)|54
2711407|NCT00329238|9333049|P1|Overall Study|Other reason (not specified)|40
2711408|NCT00329238|9333048|P2|Overall Study|Withdrawal by Subject|58
2711409|NCT00329238|9333049|P1|Overall Study|Withdrawal by Subject|64
2711410|NCT00329238|9333048|P2|Overall Study|Lost to Follow-up|6
2711411|NCT00329238|9333049|P1|Overall Study|Lost to Follow-up|2
2711412|NCT00329238|9333048|P2|Overall Study|Protocol Violation|34
2711413|NCT00329238|9333049|P1|Overall Study|Protocol Violation|23
2711414|NCT00329238|9333048|P2|Overall Study|Adverse Event|129
2711415|NCT00329238|9333049|P1|Overall Study|Adverse Event|147
2711416|NCT00329160|9333085|P1|Overall Study|Incomplete IVUS|45
2711417|NCT00329160|9333085|P1|Overall Study|Did not Receive Study Drug|1
2711418|NCT00329160|9333085|P1|Overall Study|Protocol Violation|2
2711419|NCT00329160|9333085|P1|Overall Study|Withdrawal by Subject|13
2711420|NCT00329160|9333085|P1|Overall Study|Adverse Event|27
2711421|NCT00329108|9333094|P2|Overall Study|Protocol Violation|2
2711422|NCT00329108|9333095|P1|Overall Study|Protocol Violation|0
2711423|NCT00329108|9333094|P2|Overall Study|withdrew patient after SAE resolved|0
2711424|NCT00329108|9333095|P1|Overall Study|withdrew patient after SAE resolved|1
2711425|NCT00329108|9333094|P2|Overall Study|study terminated by sponsor|0
2711426|NCT00329108|9333095|P1|Overall Study|study terminated by sponsor|1
2711427|NCT00329108|9333094|P2|Overall Study|Subject no longer willing to participate|2
2711428|NCT00329108|9333095|P1|Overall Study|Subject no longer willing to participate|2
2711429|NCT00329108|9333094|P2|Overall Study|symptomatic deterioration|1
2711430|NCT00329108|9333095|P1|Overall Study|symptomatic deterioration|1
2711431|NCT00329108|9333094|P2|Overall Study|Withdrawal by Subject|2
2711432|NCT00329108|9333095|P1|Overall Study|Withdrawal by Subject|0
2711433|NCT00329108|9333094|P2|Overall Study|Lack of Efficacy|3
2711434|NCT00329108|9333095|P1|Overall Study|Lack of Efficacy|3
2711435|NCT00329108|9333094|P2|Overall Study|Adverse Event|2
2711436|NCT00329108|9333095|P1|Overall Study|Adverse Event|2
2711437|NCT00329030|9333103|P2|Overall Study|Ineligible Pathology|1
2711438|NCT00329030|9333104|P1|Overall Study|Ineligible Pathology|1
2711439|NCT00329030|9333103|P2|Overall Study|Progressive Disease|2
2711440|NCT00329030|9333104|P1|Overall Study|Progressive Disease|6
2711441|NCT00329030|9333103|P2|Overall Study|Withdrawal by Subject|3
2711442|NCT00329030|9333104|P1|Overall Study|Withdrawal by Subject|1
2711443|NCT00328926|9333135|P3|Overall Study|Lack of ovarian response|0
2711444|NCT00328926|9333136|P2|Overall Study|Lack of ovarian response|1
2711445|NCT00328926|9333137|P1|Overall Study|Lack of ovarian response|0
2711446|NCT00328926|9333135|P3|Overall Study|In vitro fertilization treatment|1
2711447|NCT00328926|9333136|P2|Overall Study|In vitro fertilization treatment|0
2711448|NCT00328926|9333137|P1|Overall Study|In vitro fertilization treatment|0
2711449|NCT00328926|9333135|P3|Overall Study|Death|1
2711450|NCT00328926|9333136|P2|Overall Study|Death|0
2711451|NCT00328926|9333137|P1|Overall Study|Death|0
2711452|NCT00328926|9333135|P3|Overall Study|Lost to Follow-up|0
2711453|NCT00328926|9333136|P2|Overall Study|Lost to Follow-up|1
2711454|NCT00328926|9333137|P1|Overall Study|Lost to Follow-up|0
2711455|NCT00328926|9333135|P3|Overall Study|Pregnancy|0
2711456|NCT00328926|9333136|P2|Overall Study|Pregnancy|1
2711457|NCT00328926|9333137|P1|Overall Study|Pregnancy|2
2711458|NCT00328783|9333162|P1|Overall Study|Withdrawal by Subject|1
2711459|NCT00328783|9333162|P1|Overall Study|No heart in RT field|4
2711460|NCT00328783|9333162|P1|Overall Study|Could not tolerate ABC|21
2711461|NCT00328627|9333188|P12|Overall Study|Other|0
2711462|NCT00328627|9333189|P11|Overall Study|Other|1
2711463|NCT00328627|9333190|P10|Overall Study|Other|1
2711464|NCT00328627|9333191|P9|Overall Study|Other|0
2711465|NCT00328627|9333192|P8|Overall Study|Other|0
2711466|NCT00328627|9333193|P7|Overall Study|Other|1
2711467|NCT00328627|9333194|P6|Overall Study|Other|0
2711468|NCT00328627|9333195|P5|Overall Study|Other|0
2711469|NCT00328627|9333196|P4|Overall Study|Other|1
2711470|NCT00328627|9333197|P3|Overall Study|Other|0
2711471|NCT00328627|9333198|P2|Overall Study|Other|0
2711472|NCT00328627|9333199|P1|Overall Study|Other|0
2711473|NCT00328627|9333188|P12|Overall Study|Physician Decision|0
2711474|NCT00328627|9333189|P11|Overall Study|Physician Decision|1
2711475|NCT00328627|9333190|P10|Overall Study|Physician Decision|2
2711476|NCT00328627|9333191|P9|Overall Study|Physician Decision|3
2711477|NCT00328627|9333192|P8|Overall Study|Physician Decision|0
2711478|NCT00328627|9333193|P7|Overall Study|Physician Decision|1
2711479|NCT00328627|9333194|P6|Overall Study|Physician Decision|1
2711480|NCT00328627|9333195|P5|Overall Study|Physician Decision|1
2711481|NCT00328627|9333196|P4|Overall Study|Physician Decision|2
2711482|NCT00328627|9333197|P3|Overall Study|Physician Decision|1
2711483|NCT00328627|9333198|P2|Overall Study|Physician Decision|3
2711484|NCT00328627|9333199|P1|Overall Study|Physician Decision|4
2711485|NCT00328627|9333188|P12|Overall Study|Pregnancy|0
2711486|NCT00328627|9333189|P11|Overall Study|Pregnancy|0
2711487|NCT00328627|9333190|P10|Overall Study|Pregnancy|0
2711488|NCT00328627|9333191|P9|Overall Study|Pregnancy|0
2711489|NCT00328627|9333192|P8|Overall Study|Pregnancy|0
2711490|NCT00328627|9333193|P7|Overall Study|Pregnancy|0
2711491|NCT00328627|9333194|P6|Overall Study|Pregnancy|0
2711492|NCT00328627|9333195|P5|Overall Study|Pregnancy|0
2711493|NCT00328627|9333196|P4|Overall Study|Pregnancy|0
2711494|NCT00328627|9333197|P3|Overall Study|Pregnancy|0
2711495|NCT00328627|9333198|P2|Overall Study|Pregnancy|1
2711496|NCT00328627|9333199|P1|Overall Study|Pregnancy|0
2711497|NCT00328627|9333188|P12|Overall Study|Withdrawal by Subject|7
2711498|NCT00328627|9333189|P11|Overall Study|Withdrawal by Subject|2
2711499|NCT00328627|9333190|P10|Overall Study|Withdrawal by Subject|5
2711500|NCT00328627|9333191|P9|Overall Study|Withdrawal by Subject|4
2711501|NCT00328627|9333192|P8|Overall Study|Withdrawal by Subject|4
2711502|NCT00328627|9333193|P7|Overall Study|Withdrawal by Subject|4
2711503|NCT00328627|9333194|P6|Overall Study|Withdrawal by Subject|5
2711504|NCT00328627|9333195|P5|Overall Study|Withdrawal by Subject|2
2711505|NCT00328627|9333196|P4|Overall Study|Withdrawal by Subject|6
2711506|NCT00328627|9333197|P3|Overall Study|Withdrawal by Subject|5
2711507|NCT00328627|9333198|P2|Overall Study|Withdrawal by Subject|4
2711508|NCT00328627|9333199|P1|Overall Study|Withdrawal by Subject|5
2711509|NCT00328627|9333188|P12|Overall Study|Lost to Follow-up|1
2711510|NCT00328627|9333189|P11|Overall Study|Lost to Follow-up|0
2711511|NCT00328627|9333190|P10|Overall Study|Lost to Follow-up|2
2711512|NCT00328627|9333191|P9|Overall Study|Lost to Follow-up|3
2711513|NCT00328627|9333192|P8|Overall Study|Lost to Follow-up|0
2711514|NCT00328627|9333193|P7|Overall Study|Lost to Follow-up|3
2711515|NCT00328627|9333194|P6|Overall Study|Lost to Follow-up|2
2711516|NCT00328627|9333195|P5|Overall Study|Lost to Follow-up|0
2711517|NCT00328627|9333196|P4|Overall Study|Lost to Follow-up|4
2711518|NCT00328627|9333197|P3|Overall Study|Lost to Follow-up|2
2711519|NCT00328627|9333198|P2|Overall Study|Lost to Follow-up|2
2711520|NCT00328627|9333199|P1|Overall Study|Lost to Follow-up|4
2711521|NCT00328627|9333188|P12|Overall Study|Protocol Violation|2
2711522|NCT00328627|9333189|P11|Overall Study|Protocol Violation|6
2711523|NCT00328627|9333190|P10|Overall Study|Protocol Violation|4
2711524|NCT00328627|9333191|P9|Overall Study|Protocol Violation|1
2711525|NCT00328627|9333192|P8|Overall Study|Protocol Violation|2
2711526|NCT00328627|9333193|P7|Overall Study|Protocol Violation|6
2711527|NCT00328627|9333194|P6|Overall Study|Protocol Violation|5
2711528|NCT00328627|9333195|P5|Overall Study|Protocol Violation|5
2711529|NCT00328627|9333196|P4|Overall Study|Protocol Violation|8
2711530|NCT00328627|9333197|P3|Overall Study|Protocol Violation|2
2711531|NCT00328627|9333198|P2|Overall Study|Protocol Violation|2
2711532|NCT00328627|9333199|P1|Overall Study|Protocol Violation|2
2711533|NCT00328627|9333188|P12|Overall Study|Adverse Event|4
2711534|NCT00328627|9333189|P11|Overall Study|Adverse Event|5
2711535|NCT00328627|9333190|P10|Overall Study|Adverse Event|7
2711536|NCT00328627|9333191|P9|Overall Study|Adverse Event|0
2711537|NCT00328627|9333192|P8|Overall Study|Adverse Event|2
2711538|NCT00328627|9333193|P7|Overall Study|Adverse Event|1
2711539|NCT00328627|9333194|P6|Overall Study|Adverse Event|2
2711540|NCT00328627|9333195|P5|Overall Study|Adverse Event|1
2711541|NCT00328627|9333196|P4|Overall Study|Adverse Event|3
2711542|NCT00328627|9333197|P3|Overall Study|Adverse Event|2
2711543|NCT00328627|9333198|P2|Overall Study|Adverse Event|1
2711544|NCT00328627|9333199|P1|Overall Study|Adverse Event|3
2711545|NCT00328627|9333188|P12|Overall Study|Hyperglycemic Rescue|2
2711546|NCT00328627|9333189|P11|Overall Study|Hyperglycemic Rescue|3
2711547|NCT00328627|9333190|P10|Overall Study|Hyperglycemic Rescue|11
2711548|NCT00328627|9333191|P9|Overall Study|Hyperglycemic Rescue|6
2711549|NCT00328627|9333192|P8|Overall Study|Hyperglycemic Rescue|6
2711550|NCT00328627|9333193|P7|Overall Study|Hyperglycemic Rescue|19
2711551|NCT00328627|9333194|P6|Overall Study|Hyperglycemic Rescue|5
2711552|NCT00328627|9333195|P5|Overall Study|Hyperglycemic Rescue|6
2711553|NCT00328627|9333196|P4|Overall Study|Hyperglycemic Rescue|13
2711554|NCT00328627|9333197|P3|Overall Study|Hyperglycemic Rescue|16
2711555|NCT00328627|9333198|P2|Overall Study|Hyperglycemic Rescue|18
2711556|NCT00328627|9333199|P1|Overall Study|Hyperglycemic Rescue|41
2711557|NCT00328562|9334736|P1|Overall Study|Disease progression|1
2711558|NCT00328510|9334745|P2|Overall Study|Treatment changed to a single fraction|1
2711559|NCT00328510|9334746|P1|Overall Study|Treatment changed to a single fraction|1
2711560|NCT00328510|9334745|P2|Overall Study|Severe kyphosis, could not use mask|1
2711561|NCT00328510|9334746|P1|Overall Study|Severe kyphosis, could not use mask|0
2711562|NCT00328510|9334745|P2|Overall Study|Withdrawal by Subject|2
2711563|NCT00328510|9334746|P1|Overall Study|Withdrawal by Subject|4
2711564|NCT00328510|9334745|P2|Overall Study|Dentition problems, could not use frame|0
2711565|NCT00328510|9334746|P1|Overall Study|Dentition problems, could not use frame|1
2711566|NCT00328510|9334745|P2|Overall Study|Gag disorder, could not use frame|0
2711567|NCT00328510|9334746|P1|Overall Study|Gag disorder, could not use frame|4
2711568|NCT00328198|9334761|P1|Follow-up|Death|31
2711569|NCT00328198|9334761|P1|Follow-up|Lost to Follow-up|4
2711570|NCT00328198|9334761|P1|Treatment|Confirmed complete response, MRD -|3
2711571|NCT00328198|9334761|P1|Treatment|Non-compliance|1
2711572|NCT00328198|9334761|P1|Treatment|Evidence of disease progression|2
2711573|NCT00328198|9334761|P1|Treatment|Withdrawal by Subject|5
2711574|NCT00328198|9334761|P1|Treatment|Physician Decision|5
2711575|NCT00328198|9334761|P1|Treatment|Death|1
2711576|NCT00328198|9334761|P1|Treatment|Adverse Event|21
2711577|NCT00328172|9334776|P5|Overall Study|Other reason (not specified)|0
2711578|NCT00328172|9334777|P4|Overall Study|Other reason (not specified)|0
2711579|NCT00328172|9334778|P3|Overall Study|Other reason (not specified)|1
2711580|NCT00328172|9334779|P2|Overall Study|Other reason (not specified)|0
2711581|NCT00328172|9334780|P1|Overall Study|Other reason (not specified)|3
2711582|NCT00328172|9334776|P5|Overall Study|Lack of Efficacy|3
2711583|NCT00328172|9334777|P4|Overall Study|Lack of Efficacy|4
2711584|NCT00328172|9334778|P3|Overall Study|Lack of Efficacy|4
2711585|NCT00328172|9334779|P2|Overall Study|Lack of Efficacy|9
2711586|NCT00328172|9334780|P1|Overall Study|Lack of Efficacy|14
2711587|NCT00328172|9334776|P5|Overall Study|Withdrawal by Subject|0
2711588|NCT00328172|9334777|P4|Overall Study|Withdrawal by Subject|6
2711589|NCT00328172|9334778|P3|Overall Study|Withdrawal by Subject|1
2711590|NCT00328172|9334779|P2|Overall Study|Withdrawal by Subject|1
2711591|NCT00328172|9334780|P1|Overall Study|Withdrawal by Subject|1
2711592|NCT00328172|9334776|P5|Overall Study|Lost to Follow-up|1
2711593|NCT00328172|9334777|P4|Overall Study|Lost to Follow-up|1
2711594|NCT00328172|9334778|P3|Overall Study|Lost to Follow-up|2
2711595|NCT00328172|9334779|P2|Overall Study|Lost to Follow-up|1
2711596|NCT00328172|9334780|P1|Overall Study|Lost to Follow-up|1
2711597|NCT00328172|9334776|P5|Overall Study|Protocol Violation|0
2711598|NCT00328172|9334777|P4|Overall Study|Protocol Violation|0
2711599|NCT00328172|9334778|P3|Overall Study|Protocol Violation|1
2711600|NCT00328172|9334779|P2|Overall Study|Protocol Violation|1
2711601|NCT00328172|9334780|P1|Overall Study|Protocol Violation|0
2711602|NCT00328172|9334776|P5|Overall Study|Adverse Event|1
2711603|NCT00328172|9334777|P4|Overall Study|Adverse Event|2
2711604|NCT00328172|9334778|P3|Overall Study|Adverse Event|1
2711605|NCT00328172|9334779|P2|Overall Study|Adverse Event|2
2711606|NCT00328172|9334780|P1|Overall Study|Adverse Event|3
2711607|NCT00328094|9334804|P2|Overall Study|Physician Decision|3
2711608|NCT00328094|9334805|P1|Overall Study|Physician Decision|3
2711609|NCT00327717|9334839|P2|Overall Study|Withdrawal by Subject|7
2711610|NCT00327717|9334840|P1|Overall Study|Withdrawal by Subject|3
2711611|NCT00327717|9334839|P2|Overall Study|Lack of Efficacy|1
2711612|NCT00327717|9334840|P1|Overall Study|Lack of Efficacy|0
2711613|NCT00327717|9334839|P2|Overall Study|Adverse Event|6
2711614|NCT00327717|9334840|P1|Overall Study|Adverse Event|6
2711615|NCT00327470|9334866|P2|Overall Study|Death|4
2711616|NCT00327470|9334867|P1|Overall Study|Death|1
2711617|NCT00327470|9334866|P2|Overall Study|Withdrawal by Subject|12
2711618|NCT00327470|9334867|P1|Overall Study|Withdrawal by Subject|6
2711619|NCT00327470|9334866|P2|Overall Study|Lost to Follow-up|3
2711620|NCT00327470|9334867|P1|Overall Study|Lost to Follow-up|1
2711621|NCT00327470|9334866|P2|Overall Study|Other|9
2711622|NCT00327470|9334867|P1|Overall Study|Other|5
2711623|NCT00327470|9334866|P2|Overall Study|Lack of Efficacy|19
2711624|NCT00327470|9334867|P1|Overall Study|Lack of Efficacy|7
2711625|NCT00327470|9334866|P2|Overall Study|Adverse Event|14
2711626|NCT00327470|9334867|P1|Overall Study|Adverse Event|9
2711627|NCT00327470|9334866|P2|Overall Study|Randomized, but not treated|2
2711628|NCT00327470|9334867|P1|Overall Study|Randomized, but not treated|0
2711629|NCT00327444|9334887|P2|Open Label Treatment (OL) Period|Ongoing Treatment|0
2711630|NCT00327444|9334888|P1|Open Label Treatment (OL) Period|Ongoing Treatment|1
2711631|NCT00327444|9334887|P2|Open Label Treatment (OL) Period|Worsening dyspnea|1
2711632|NCT00327444|9334888|P1|Open Label Treatment (OL) Period|Worsening dyspnea|0
2711633|NCT00327444|9334887|P2|Open Label Treatment (OL) Period|Adverse Event|2
2711634|NCT00327444|9334888|P1|Open Label Treatment (OL) Period|Adverse Event|2
2711635|NCT00327444|9334887|P2|Open Label Treatment (OL) Period|Disease progression|7
2711636|NCT00327444|9334888|P1|Open Label Treatment (OL) Period|Disease progression|8
2711637|NCT00327444|9334887|P2|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10
2711638|NCT00327444|9334888|P1|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11
2711639|NCT00327444|9334887|P2|Double Blind Treatment (DB) Period|Subject request|1
2711640|NCT00327444|9334888|P1|Double Blind Treatment (DB) Period|Subject request|0
2711641|NCT00327444|9334887|P2|Double Blind Treatment (DB) Period|Adverse Event|5
2711642|NCT00327444|9334888|P1|Double Blind Treatment (DB) Period|Adverse Event|5
2711643|NCT00327444|9334887|P2|Double Blind Treatment (DB) Period|Disease progression|13
2711644|NCT00327444|9334888|P1|Double Blind Treatment (DB) Period|Disease progression|10
2711645|NCT00327340|9334906|P2|Overall Study|Adverse Event|3
2711646|NCT00327340|9334907|P1|Overall Study|Adverse Event|3
2711647|NCT00327340|9334906|P2|Overall Study|Symptomatic Disease|2
2711648|NCT00327340|9334907|P1|Overall Study|Symptomatic Disease|0
2711649|NCT00327340|9334906|P2|Overall Study|Disease Progression|19
2711650|NCT00327340|9334907|P1|Overall Study|Disease Progression|10
2711651|NCT00327340|9334906|P2|Overall Study|Physician Decision|1
2711652|NCT00327340|9334907|P1|Overall Study|Physician Decision|1
2711653|NCT00327340|9334906|P2|Overall Study|Withdrawal by Subject|5
2711654|NCT00327340|9334907|P1|Overall Study|Withdrawal by Subject|1
2711655|NCT00327171|9334921|P2|Overall Study|Other|0
2711656|NCT00327171|9334922|P1|Overall Study|Other|1
2711657|NCT00327171|9334921|P2|Overall Study|Undisclosed history of ischemia|1
2711658|NCT00327171|9334922|P1|Overall Study|Undisclosed history of ischemia|0
2711659|NCT00327171|9334921|P2|Overall Study|Clinical progression|8
2711660|NCT00327171|9334922|P1|Overall Study|Clinical progression|12
2711661|NCT00327171|9334921|P2|Overall Study|Investigator/participant request|8
2711662|NCT00327171|9334922|P1|Overall Study|Investigator/participant request|1
2711663|NCT00327171|9334921|P2|Overall Study|Disease progression/lack of efficacy|69
2711664|NCT00327171|9334922|P1|Overall Study|Disease progression/lack of efficacy|68
2711665|NCT00327171|9334921|P2|Overall Study|Adverse Event|23
2711666|NCT00327171|9334922|P1|Overall Study|Adverse Event|23
2711667|NCT00327171|9334921|P2|Overall Study|Did not receive study medication|0
2711668|NCT00327171|9334922|P1|Overall Study|Did not receive study medication|3
2711669|NCT00327015|9334954|P4|Overall Study|Administrative Reason by Sponsor|1
2711670|NCT00327015|9334955|P3|Overall Study|Administrative Reason by Sponsor|2
2711671|NCT00327015|9334956|P2|Overall Study|Administrative Reason by Sponsor|2
2711672|NCT00327015|9334957|P1|Overall Study|Administrative Reason by Sponsor|1
2711673|NCT00327015|9334954|P4|Overall Study|Pregnancy|1
2711674|NCT00327015|9334955|P3|Overall Study|Pregnancy|1
2711675|NCT00327015|9334956|P2|Overall Study|Pregnancy|2
2711676|NCT00327015|9334957|P1|Overall Study|Pregnancy|0
2711677|NCT00327015|9334954|P4|Overall Study|Death|3
2711678|NCT00327015|9334955|P3|Overall Study|Death|2
2711679|NCT00327015|9334956|P2|Overall Study|Death|2
2711680|NCT00327015|9334957|P1|Overall Study|Death|1
2711681|NCT00327015|9334954|P4|Overall Study|Physician Decision|2
2711682|NCT00327015|9334955|P3|Overall Study|Physician Decision|3
2711683|NCT00327015|9334956|P2|Overall Study|Physician Decision|1
2711684|NCT00327015|9334957|P1|Overall Study|Physician Decision|0
2711685|NCT00327015|9334954|P4|Overall Study|Poor/Noncompliance|5
2711686|NCT00327015|9334955|P3|Overall Study|Poor/Noncompliance|4
2711687|NCT00327015|9334956|P2|Overall Study|Poor/Noncompliance|8
2711688|NCT00327015|9334957|P1|Overall Study|Poor/Noncompliance|11
2711689|NCT00327015|9334954|P4|Overall Study|Subject no longer meets study criteria|7
2711690|NCT00327015|9334955|P3|Overall Study|Subject no longer meets study criteria|8
2711691|NCT00327015|9334956|P2|Overall Study|Subject no longer meets study criteria|2
2711692|NCT00327015|9334957|P1|Overall Study|Subject no longer meets study criteria|4
2711693|NCT00327015|9334954|P4|Overall Study|Adverse Event|14
2711694|NCT00327015|9334955|P3|Overall Study|Adverse Event|14
2711695|NCT00327015|9334956|P2|Overall Study|Adverse Event|10
2711696|NCT00327015|9334957|P1|Overall Study|Adverse Event|14
2711697|NCT00327015|9334954|P4|Overall Study|Lost to Follow-up|22
2711698|NCT00327015|9334955|P3|Overall Study|Lost to Follow-up|29
2711699|NCT00327015|9334956|P2|Overall Study|Lost to Follow-up|23
2711700|NCT00327015|9334957|P1|Overall Study|Lost to Follow-up|22
2711701|NCT00327015|9334954|P4|Overall Study|Withdrawal of Consent by Subject|25
2711702|NCT00327015|9334955|P3|Overall Study|Withdrawal of Consent by Subject|28
2711703|NCT00327015|9334956|P2|Overall Study|Withdrawal of Consent by Subject|24
2711704|NCT00327015|9334957|P1|Overall Study|Withdrawal of Consent by Subject|20
2711705|NCT00327015|9334954|P4|Overall Study|Lack of Efficacy|29
2711706|NCT00327015|9334955|P3|Overall Study|Lack of Efficacy|35
2711707|NCT00327015|9334956|P2|Overall Study|Lack of Efficacy|18
2711708|NCT00327015|9334957|P1|Overall Study|Lack of Efficacy|18
2711709|NCT00326963|9334999|P1|Overall Study|Administrative / other|1
2711710|NCT00326963|9334999|P1|Overall Study|Other protocol violation|1
2711711|NCT00326963|9334999|P1|Overall Study|Violation of selection criteria at entry|2
2711712|NCT00326963|9334999|P1|Overall Study|Refused treatment / did not cooperate|5
2711713|NCT00326963|9334999|P1|Overall Study|Withdrawal by Subject|10
2711714|NCT00326963|9334999|P1|Overall Study|Failure to return|10
2711715|NCT00326963|9334999|P1|Overall Study|Death|1
2711716|NCT00326963|9334999|P1|Overall Study|Injection site reaction|1
2711717|NCT00326963|9334999|P1|Overall Study|Adverse Event|2
2711718|NCT00326950|9335019|P1|Overall Study|Progressive Disease|1
2711719|NCT00326911|9335041|P2|Overall Study|Withdrawal by subject prior to treatment|1
2711720|NCT00326911|9335042|P1|Overall Study|Withdrawal by subject prior to treatment|0
2711721|NCT00326911|9335041|P2|Overall Study|Physician decision prior to treatment|0
2711722|NCT00326911|9335042|P1|Overall Study|Physician decision prior to treatment|1
2711723|NCT00326911|9335041|P2|Overall Study|Hospitalization prior to treatment|1
2711724|NCT00326911|9335042|P1|Overall Study|Hospitalization prior to treatment|0
2711725|NCT00326898|9335095|P3|Overall Study|Other/Missing/Unknown|32
2711726|NCT00326898|9335096|P2|Overall Study|Other/Missing/Unknown|28
2711727|NCT00326898|9335097|P1|Overall Study|Other/Missing/Unknown|33
2711728|NCT00326898|9335095|P3|Overall Study|Other complicating disease|4
2711729|NCT00326898|9335096|P2|Overall Study|Other complicating disease|5
2711730|NCT00326898|9335097|P1|Overall Study|Other complicating disease|5
2711731|NCT00326898|9335095|P3|Overall Study|Alternative therapy|0
2711732|NCT00326898|9335096|P2|Overall Study|Alternative therapy|0
2711733|NCT00326898|9335097|P1|Overall Study|Alternative therapy|1
2711734|NCT00326898|9335095|P3|Overall Study|Withdrawal by Subject|32
2711735|NCT00326898|9335096|P2|Overall Study|Withdrawal by Subject|128
2711736|NCT00326898|9335097|P1|Overall Study|Withdrawal by Subject|134
2711737|NCT00326898|9335095|P3|Overall Study|Death|0
2711738|NCT00326898|9335096|P2|Overall Study|Death|0
2711739|NCT00326898|9335097|P1|Overall Study|Death|2
2711740|NCT00326898|9335095|P3|Overall Study|Adverse Event|33
2711741|NCT00326898|9335096|P2|Overall Study|Adverse Event|128
2711742|NCT00326898|9335097|P1|Overall Study|Adverse Event|124
2711743|NCT00326898|9335095|P3|Overall Study|Disease progression|102
2711744|NCT00326898|9335096|P2|Overall Study|Disease progression|54
2711745|NCT00326898|9335097|P1|Overall Study|Disease progression|52
2711746|NCT00326885|9335114|P1|Overall Study|Hospice withdrew consent|2
2711747|NCT00326885|9335114|P1|Overall Study|Physician Decision|1
2711748|NCT00326885|9335114|P1|Overall Study|Withdrawal by Subject|3
2711749|NCT00326885|9335114|P1|Overall Study|Adverse Event|1
2711750|NCT00326716|9335145|P4|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
2711751|NCT00326716|9335146|P3|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
2711752|NCT00326716|9335147|P2|Pre-Natal Mothers|Discontinued ATV Before Delivery|2
2711753|NCT00326716|9335148|P1|Pre-Natal Mothers|Discontinued ATV Before Delivery|1
2711754|NCT00326612|9335220|P2|Overall Study|They did not have a seizure requiring tx|137
2711755|NCT00326612|9335221|P1|Overall Study|They did not have a seizure requiring tx|129
2711756|NCT00326599|9335243|P4|Overall Study|Other Unspecified Reason|1
2711757|NCT00326599|9335244|P3|Overall Study|Other Unspecified Reason|2
2711758|NCT00326599|9335245|P2|Overall Study|Other Unspecified Reason|0
2711759|NCT00326599|9335246|P1|Overall Study|Other Unspecified Reason|0
2711760|NCT00326599|9335243|P4|Overall Study|Death|2
2711761|NCT00326599|9335244|P3|Overall Study|Death|1
2711762|NCT00326599|9335245|P2|Overall Study|Death|0
2711763|NCT00326599|9335246|P1|Overall Study|Death|0
2711764|NCT00326599|9335243|P4|Overall Study|Alternate Treatment|0
2711765|NCT00326599|9335244|P3|Overall Study|Alternate Treatment|0
2711766|NCT00326599|9335245|P2|Overall Study|Alternate Treatment|0
2711767|NCT00326599|9335246|P1|Overall Study|Alternate Treatment|1
2711768|NCT00326599|9335243|P4|Overall Study|Disease Progression|11
2711769|NCT00326599|9335244|P3|Overall Study|Disease Progression|13
2711770|NCT00326599|9335245|P2|Overall Study|Disease Progression|1
2711771|NCT00326599|9335246|P1|Overall Study|Disease Progression|3
2711772|NCT00326599|9335243|P4|Overall Study|Adverse Event|3
2711773|NCT00326599|9335244|P3|Overall Study|Adverse Event|32
2711774|NCT00326599|9335245|P2|Overall Study|Adverse Event|0
2711775|NCT00326599|9335246|P1|Overall Study|Adverse Event|1
2711776|NCT00326599|9335243|P4|Overall Study|Withdrawal by Subject|2
2711777|NCT00326599|9335244|P3|Overall Study|Withdrawal by Subject|5
2711778|NCT00326599|9335245|P2|Overall Study|Withdrawal by Subject|0
2711779|NCT00326599|9335246|P1|Overall Study|Withdrawal by Subject|1
2711780|NCT00326495|9335265|P1|Overall Study|Subject off study before assessment|1
2711781|NCT00326495|9335265|P1|Overall Study|Refused further treatment|2
2711782|NCT00326495|9335265|P1|Overall Study|Disease progression before treatment|1
2711783|NCT00326495|9335265|P1|Overall Study|Switched to alternative treatment|1
2711784|NCT00326417|9335272|P4|Overall Study|Death|0
2711785|NCT00326417|9335273|P3|Overall Study|Death|0
2711786|NCT00326417|9335274|P2|Overall Study|Death|0
2711787|NCT00326417|9335275|P1|Overall Study|Death|7
2711788|NCT00326417|9335272|P4|Overall Study|Arm Closed|3
2711789|NCT00326417|9335273|P3|Overall Study|Arm Closed|0
2711790|NCT00326417|9335274|P2|Overall Study|Arm Closed|0
2711791|NCT00326417|9335275|P1|Overall Study|Arm Closed|7
2711792|NCT00326417|9335272|P4|Overall Study|Withdrawal by Subject|0
2711793|NCT00326417|9335273|P3|Overall Study|Withdrawal by Subject|1
2711794|NCT00326417|9335274|P2|Overall Study|Withdrawal by Subject|0
2711795|NCT00326417|9335275|P1|Overall Study|Withdrawal by Subject|0
2711796|NCT00326209|9335291|P1|Overall Study|Pregnancy|1
2711797|NCT00326209|9335291|P1|Overall Study|Withdrawn in error|1
2711798|NCT00326209|9335291|P1|Overall Study|Violation of entry criteria|1
2711799|NCT00326209|9335291|P1|Overall Study|Prohibited medication use|1
2711800|NCT00326209|9335291|P1|Overall Study|Sponsor closed study|173
2711801|NCT00326209|9335291|P1|Overall Study|Participant non-compliant|6
2711802|NCT00326209|9335291|P1|Overall Study|Lost to Follow-up|18
2711803|NCT00326209|9335291|P1|Overall Study|Lack of Efficacy|31
2711804|NCT00326209|9335291|P1|Overall Study|Withdrawal by Subject|22
2711805|NCT00326209|9335291|P1|Overall Study|Adverse Event|28
2711806|NCT00326183|9335309|P2|Overall Study|Adverse Event|0
2711807|NCT00326183|9335310|P1|Overall Study|Adverse Event|1
2711808|NCT00326183|9335309|P2|Overall Study|Other|13
2711809|NCT00326183|9335310|P1|Overall Study|Other|47
2711810|NCT00326183|9335309|P2|Overall Study|Subject Moved|4
2711811|NCT00326183|9335310|P1|Overall Study|Subject Moved|7
2711812|NCT00326183|9335309|P2|Overall Study|Withdrawal by Subject|7
2711813|NCT00326183|9335310|P1|Overall Study|Withdrawal by Subject|35
2711814|NCT00326183|9335309|P2|Overall Study|Protocol Violation|3
2711815|NCT00326183|9335310|P1|Overall Study|Protocol Violation|6
2711816|NCT00326183|9335309|P2|Overall Study|Lost to Follow-up|56
2711817|NCT00326183|9335310|P1|Overall Study|Lost to Follow-up|104
2711818|NCT00326118|9335342|P2|Active Phase|Withdrawal by Subject|1
2711819|NCT00326118|9335343|P1|Active Phase|Withdrawal by Subject|4
2711820|NCT00326001|9335379|P2|Overall Study|Physician Decision|3
2711821|NCT00326001|9335380|P1|Overall Study|Physician Decision|3
2711822|NCT00326001|9335379|P2|Overall Study|Adverse Event|5
2711823|NCT00326001|9335380|P1|Overall Study|Adverse Event|4
2711824|NCT00325897|9335394|P2|Overall Study|Lost to Follow-up|13
2711825|NCT00325897|9335395|P1|Overall Study|Lost to Follow-up|12
2711826|NCT00325819|9335415|P2|Overall Study|Lost to Follow-up|3
2711827|NCT00325819|9335416|P1|Overall Study|Lost to Follow-up|3
2711828|NCT00325819|9335415|P2|Overall Study|Did not take a dose of study product|9
2711829|NCT00325819|9335416|P1|Overall Study|Did not take a dose of study product|4
2711830|NCT00325819|9335415|P2|Overall Study|Study product lost in mail|1
2711831|NCT00325819|9335416|P1|Overall Study|Study product lost in mail|2
2711832|NCT00325754|9335443|P2|Overall Study|Adverse Event|1
2711833|NCT00325754|9335444|P1|Overall Study|Adverse Event|4
2711834|NCT00325468|9335499|P5|Overall Study|site closure etc|1
2711835|NCT00325468|9335500|P4|Overall Study|site closure etc|8
2711836|NCT00325468|9335501|P3|Overall Study|site closure etc|1
2711837|NCT00325468|9335502|P2|Overall Study|site closure etc|2
2711838|NCT00325468|9335503|P1|Overall Study|site closure etc|4
2711839|NCT00325468|9335499|P5|Overall Study|Withdrawal by Subject|4
2711840|NCT00325468|9335500|P4|Overall Study|Withdrawal by Subject|14
2711841|NCT00325468|9335501|P3|Overall Study|Withdrawal by Subject|0
2711842|NCT00325468|9335502|P2|Overall Study|Withdrawal by Subject|1
2711843|NCT00325468|9335503|P1|Overall Study|Withdrawal by Subject|3
2711844|NCT00325468|9335499|P5|Overall Study|Physician Decision|0
2711845|NCT00325468|9335500|P4|Overall Study|Physician Decision|1
2711846|NCT00325468|9335501|P3|Overall Study|Physician Decision|0
2711847|NCT00325468|9335502|P2|Overall Study|Physician Decision|1
2711848|NCT00325468|9335503|P1|Overall Study|Physician Decision|1
2711849|NCT00325468|9335499|P5|Overall Study|Lost to Follow-up|2
2711850|NCT00325468|9335500|P4|Overall Study|Lost to Follow-up|2
2711851|NCT00325468|9335501|P3|Overall Study|Lost to Follow-up|1
2711852|NCT00325468|9335502|P2|Overall Study|Lost to Follow-up|0
2711853|NCT00325468|9335503|P1|Overall Study|Lost to Follow-up|0
2711854|NCT00325468|9335499|P5|Overall Study|Death|0
2711855|NCT00325468|9335500|P4|Overall Study|Death|4
2711856|NCT00325468|9335501|P3|Overall Study|Death|2
2711857|NCT00325468|9335502|P2|Overall Study|Death|0
2711858|NCT00325468|9335503|P1|Overall Study|Death|2
2711859|NCT00325468|9335499|P5|Overall Study|Adverse Event|1
2711860|NCT00325468|9335500|P4|Overall Study|Adverse Event|5
2711861|NCT00325468|9335501|P3|Overall Study|Adverse Event|0
2711862|NCT00325468|9335502|P2|Overall Study|Adverse Event|1
2711863|NCT00325468|9335503|P1|Overall Study|Adverse Event|1
2711864|NCT00325416|9335586|P2|Phase II: Treatment at MTD|Withdrawal by Subject|1
2711865|NCT00325416|9335587|P1|Phase II: Treatment at MTD|Withdrawal by Subject|0
2711866|NCT00325416|9335586|P2|Phase II: Treatment at MTD|denial of insurance coverage|1
2711867|NCT00325416|9335587|P1|Phase II: Treatment at MTD|denial of insurance coverage|0
2711868|NCT00325416|9335586|P2|Phase I: Dose Escalation|Inability to collect adequate stem cells|1
2711869|NCT00325416|9335587|P1|Phase I: Dose Escalation|Inability to collect adequate stem cells|0
2711870|NCT00325416|9335586|P2|Phase I: Dose Escalation|Withdrawal by Subject|2
2711871|NCT00325416|9335587|P1|Phase I: Dose Escalation|Withdrawal by Subject|7
2711872|NCT00325416|9335586|P2|Phase I: Dose Escalation|Denial of insurance coverage|4
2711873|NCT00325416|9335587|P1|Phase I: Dose Escalation|Denial of insurance coverage|7
2711874|NCT00325416|9335586|P2|Phase I: Dose Escalation|Pre-transplant screen failure|9
2711875|NCT00325416|9335587|P1|Phase I: Dose Escalation|Pre-transplant screen failure|8
2711876|NCT00325234|9335640|P2|Overall Study|Progressive Disease|37
2711877|NCT00325234|9335641|P1|Overall Study|Progressive Disease|34
2711878|NCT00325234|9335640|P2|Overall Study|Physician Decision|12
2711879|NCT00325234|9335641|P1|Overall Study|Physician Decision|17
2711880|NCT00325234|9335640|P2|Overall Study|Subject Decision|8
2711881|NCT00325234|9335641|P1|Overall Study|Subject Decision|6
2711882|NCT00325234|9335640|P2|Overall Study|Entry Criteria Not Met|2
2711883|NCT00325234|9335641|P1|Overall Study|Entry Criteria Not Met|1
2711884|NCT00325234|9335640|P2|Overall Study|Death due to Study Disease|0
2711885|NCT00325234|9335641|P1|Overall Study|Death due to Study Disease|1
2711886|NCT00325234|9335640|P2|Overall Study|Adverse Event|7
2711887|NCT00325234|9335641|P1|Overall Study|Adverse Event|10
2711888|NCT00325195|9335660|P3|Received Intervention: ITT Population|Protocol violation/non-compliance|0
2711889|NCT00325195|9335661|P2|Received Intervention: ITT Population|Protocol violation/non-compliance|1
2711890|NCT00325195|9335662|P1|Received Intervention: ITT Population|Protocol violation/non-compliance|1
2711891|NCT00325195|9335660|P3|Received Intervention: ITT Population|Lost to Follow-up|2
2711892|NCT00325195|9335661|P2|Received Intervention: ITT Population|Lost to Follow-up|0
2711893|NCT00325195|9335662|P1|Received Intervention: ITT Population|Lost to Follow-up|0
2711894|NCT00325195|9335660|P3|Received Intervention: ITT Population|Withdrawal by Subject|1
2711895|NCT00325195|9335661|P2|Received Intervention: ITT Population|Withdrawal by Subject|6
2711896|NCT00325195|9335662|P1|Received Intervention: ITT Population|Withdrawal by Subject|7
2711897|NCT00325195|9335660|P3|Received Intervention: ITT Population|Death|0
2711898|NCT00325195|9335661|P2|Received Intervention: ITT Population|Death|1
2711899|NCT00325195|9335662|P1|Received Intervention: ITT Population|Death|3
2711900|NCT00325195|9335660|P3|Received Intervention: ITT Population|Adverse Event|1
2711901|NCT00325195|9335661|P2|Received Intervention: ITT Population|Adverse Event|17
2711902|NCT00325195|9335662|P1|Received Intervention: ITT Population|Adverse Event|15
2711903|NCT00325195|9335660|P3|Randomized|Not dosed|3
2711904|NCT00325195|9335661|P2|Randomized|Not dosed|5
2711905|NCT00325195|9335662|P1|Randomized|Not dosed|5
2711906|NCT00325156|9335685|P1|Overall Study|Withdrawal by Subject|31
2711907|NCT00325156|9335685|P1|Overall Study|Other|1
2711908|NCT00325156|9335685|P1|Overall Study|Lost to follow-up (incompl. vaccination)|16
2711909|NCT00325156|9335685|P1|Overall Study|Adverse event, non-fatal|3
2711910|NCT00325156|9335685|P1|Overall Study|Migrated/moved from study area|12
2711911|NCT00325156|9335685|P1|Overall Study|Lost to follow-up (complete vaccination)|41
2711912|NCT00325156|9335685|P1|Overall Study|Protocol Violation|8
2711913|NCT00325143|9335692|P1|Overall Study|Withdrawal by Subject|8
2711914|NCT00325143|9335692|P1|Overall Study|Lost to follow-up(incompl. vacc. course)|4
2711915|NCT00325143|9335692|P1|Overall Study|Migrated/moved from study area|1
2711916|NCT00325143|9335692|P1|Overall Study|Lost to follow-up(complete vacc. course)|13
2711917|NCT00325130|9335702|P2|Overall Study|Patient Discontinued for Other|0
2711918|NCT00325130|9335703|P1|Overall Study|Patient Discontinued for Other|1
2711919|NCT00325130|9335702|P2|Overall Study|Moved|1
2711920|NCT00325130|9335703|P1|Overall Study|Moved|0
2711921|NCT00325130|9335702|P2|Overall Study|Protocol Deviation|1
2711922|NCT00325130|9335703|P1|Overall Study|Protocol Deviation|0
2711923|NCT00325130|9335702|P2|Overall Study|Withdrawal by Subject|14
2711924|NCT00325130|9335703|P1|Overall Study|Withdrawal by Subject|12
2711925|NCT00325130|9335702|P2|Overall Study|Lost to Follow-up|14
2711926|NCT00325130|9335703|P1|Overall Study|Lost to Follow-up|6
2711927|NCT00325039|9335760|P2|Overall Study|Lost to Follow-up|14
2711928|NCT00325039|9335761|P1|Overall Study|Lost to Follow-up|18
2711929|NCT00324987|9335777|P2|Overall Study|symptomatic deterioration, toxicity, etc|3
2711930|NCT00324987|9335778|P1|Overall Study|symptomatic deterioration, toxicity, etc|2
2711931|NCT00324987|9335777|P2|Overall Study|Progression|1
2711932|NCT00324987|9335778|P1|Overall Study|Progression|1
2711933|NCT00324987|9335777|P2|Overall Study|Withdrawal by Subject|1
2711934|NCT00324987|9335778|P1|Overall Study|Withdrawal by Subject|1
2711935|NCT00324987|9335777|P2|Overall Study|Adverse Event|1
2711936|NCT00324987|9335778|P1|Overall Study|Adverse Event|2
2711937|NCT00324961|9335792|P1|Overall Study|Other|2
2711938|NCT00324961|9335792|P1|Overall Study|Protocol Violation|3
2711939|NCT00324961|9335792|P1|Overall Study|Lost to Follow-up|22
2711940|NCT00324961|9335792|P1|Overall Study|Consent Withdrawn|11
2711941|NCT00324961|9335792|P1|Overall Study|Adverse Event|5
2711942|NCT00324805|9335843|P2|Overall Study|Did not start therapy|17
2711943|NCT00324805|9335844|P1|Overall Study|Did not start therapy|12
2711944|NCT00324805|9335843|P2|Overall Study|Other|2
2711945|NCT00324805|9335844|P1|Overall Study|Other|0
2711946|NCT00324805|9335843|P2|Overall Study|Other reasons|26
2711947|NCT00324805|9335844|P1|Overall Study|Other reasons|7
2711948|NCT00324805|9335843|P2|Overall Study|Other complicating disease|9
2711949|NCT00324805|9335844|P1|Overall Study|Other complicating disease|1
2711950|NCT00324805|9335843|P2|Overall Study|Alternative therapy|8
2711951|NCT00324805|9335844|P1|Overall Study|Alternative therapy|4
2711952|NCT00324805|9335843|P2|Overall Study|Death|9
2711953|NCT00324805|9335844|P1|Overall Study|Death|6
2711954|NCT00324805|9335843|P2|Overall Study|Withdrawal by Subject|174
2711955|NCT00324805|9335844|P1|Overall Study|Withdrawal by Subject|51
2711956|NCT00324805|9335843|P2|Overall Study|Progression|35
2711957|NCT00324805|9335844|P1|Overall Study|Progression|7
2711958|NCT00324805|9335843|P2|Overall Study|Adverse Event|203
2711959|NCT00324805|9335844|P1|Overall Study|Adverse Event|62
2711960|NCT00324740|9335869|P3|Overall Study|Withdrawal by Subject|1
2711961|NCT00324740|9335870|P2|Overall Study|Withdrawal by Subject|0
2711962|NCT00324740|9335871|P1|Overall Study|Withdrawal by Subject|1
2711963|NCT00324675|9335891|P2|Overall Study|Adverse Event|0
2711964|NCT00324675|9335892|P1|Overall Study|Adverse Event|1
2711965|NCT00324649|9335900|P2|Overall Study|Noncompliance|0
2711966|NCT00324649|9335901|P1|Overall Study|Noncompliance|1
2711967|NCT00324649|9335900|P2|Overall Study|Withdrawal by Subject|1
2711968|NCT00324649|9335901|P1|Overall Study|Withdrawal by Subject|0
2711969|NCT00324649|9335900|P2|Overall Study|Adverse Event|4
2711970|NCT00324649|9335901|P1|Overall Study|Adverse Event|1
2711971|NCT00324233|9336032|P2|Second Period|Protocol Violation|6
2711972|NCT00324233|9336033|P1|Second Period|Protocol Violation|4
2711973|NCT00324233|9336032|P2|Second Period|unable to insert catheter|1
2711974|NCT00324233|9336033|P1|Second Period|unable to insert catheter|1
2711975|NCT00324233|9336032|P2|First Period|unable to insert catheter|0
2711976|NCT00324233|9336033|P1|First Period|unable to insert catheter|1
2711977|NCT00324168|9336041|P2|Overall Study|Patient did not visit in f/u window|9
2711978|NCT00324168|9336042|P1|Overall Study|Patient did not visit in f/u window|6
2711979|NCT00324168|9336041|P2|Overall Study|Death|3
2711980|NCT00324168|9336042|P1|Overall Study|Death|3
2711981|NCT00324168|9336041|P2|Overall Study|Lost to Follow-up|18
2711982|NCT00324168|9336042|P1|Overall Study|Lost to Follow-up|19
2711983|NCT00324155|9336070|P2|Follow-up Phase|On-going participants still on drug|6
2711984|NCT00324155|9336071|P1|Follow-up Phase|On-going participants still on drug|11
2711985|NCT00324155|9336070|P2|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0
2711986|NCT00324155|9336071|P1|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1
2711987|NCT00324155|9336070|P2|Received Treatment in Maintenance Phase|Adverse Event|3
2711988|NCT00324155|9336071|P1|Received Treatment in Maintenance Phase|Adverse Event|0
2711989|NCT00324155|9336070|P2|Received Treatment in Maintenance Phase|Withdrawal by Subject|3
2711990|NCT00324155|9336071|P1|Received Treatment in Maintenance Phase|Withdrawal by Subject|1
2711991|NCT00324155|9336070|P2|Received Treatment in Maintenance Phase|Study Drug Toxicity|0
2711992|NCT00324155|9336071|P1|Received Treatment in Maintenance Phase|Study Drug Toxicity|4
2711993|NCT00324155|9336070|P2|Received Treatment in Maintenance Phase|Disease Progression|41
2711994|NCT00324155|9336071|P1|Received Treatment in Maintenance Phase|Disease Progression|26
2711995|NCT00324155|9336070|P2|Received Treatment in Induction Phase|Physician Decision|0
2711996|NCT00324155|9336071|P1|Received Treatment in Induction Phase|Physician Decision|2
2711997|NCT00324155|9336070|P2|Received Treatment in Induction Phase|Withdrawal by Subject|5
2711998|NCT00324155|9336071|P1|Received Treatment in Induction Phase|Withdrawal by Subject|6
2711999|NCT00324155|9336070|P2|Received Treatment in Induction Phase|Adverse Event|7
2712000|NCT00324155|9336071|P1|Received Treatment in Induction Phase|Adverse Event|6
2712001|NCT00324155|9336070|P2|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8
2712002|NCT00324155|9336071|P1|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9
2712003|NCT00324155|9336070|P2|Received Treatment in Induction Phase|Death|15
2712004|NCT00324155|9336071|P1|Received Treatment in Induction Phase|Death|8
2712005|NCT00324155|9336070|P2|Received Treatment in Induction Phase|Study Drug Toxicity|10
2712006|NCT00324155|9336071|P1|Received Treatment in Induction Phase|Study Drug Toxicity|83
2712007|NCT00324155|9336070|P2|Received Treatment in Induction Phase|Disease Progression|152
2712008|NCT00324155|9336071|P1|Received Treatment in Induction Phase|Disease Progression|88
2712009|NCT00324155|9336070|P2|Enrolled and Randomized|Lost to Follow-up|1
2712010|NCT00324155|9336071|P1|Enrolled and Randomized|Lost to Follow-up|0
2712011|NCT00324155|9336070|P2|Enrolled and Randomized|No longer met study criteria|0
2712012|NCT00324155|9336071|P1|Enrolled and Randomized|No longer met study criteria|3
2712013|NCT00324116|9336101|P1|Overall Study|Other|5
2712014|NCT00324116|9336101|P1|Overall Study|Withdrawal by Subject|5
2712015|NCT00324116|9336101|P1|Overall Study|Lack of Efficacy|17
2712016|NCT00324116|9336101|P1|Overall Study|Adverse Event|5
2712017|NCT00324038|9336113|P2|Overall Study|Other|13
2712018|NCT00324038|9336114|P1|Overall Study|Other|6
2712019|NCT00324038|9336113|P2|Overall Study|Lost to Follow-up|2
2712020|NCT00324038|9336114|P1|Overall Study|Lost to Follow-up|0
2712021|NCT00324038|9336113|P2|Overall Study|Lack of Efficacy|13
2712022|NCT00324038|9336114|P1|Overall Study|Lack of Efficacy|5
2712023|NCT00324038|9336113|P2|Overall Study|Adverse Event|23
2712024|NCT00324038|9336114|P1|Overall Study|Adverse Event|38
2712025|NCT00323882|9336125|P5|Overall Study|Other|1
2712026|NCT00323882|9336126|P4|Overall Study|Other|1
2712027|NCT00323882|9336127|P3|Overall Study|Other|0
2712028|NCT00323882|9336128|P2|Overall Study|Other|0
2712029|NCT00323882|9336129|P1|Overall Study|Other|0
2712030|NCT00323882|9336125|P5|Overall Study|Lost to Follow-up|1
2712031|NCT00323882|9336126|P4|Overall Study|Lost to Follow-up|0
2712032|NCT00323882|9336127|P3|Overall Study|Lost to Follow-up|1
2712033|NCT00323882|9336128|P2|Overall Study|Lost to Follow-up|0
2712034|NCT00323882|9336129|P1|Overall Study|Lost to Follow-up|0
2712035|NCT00323882|9336125|P5|Overall Study|Death|5
2712036|NCT00323882|9336126|P4|Overall Study|Death|0
2712037|NCT00323882|9336127|P3|Overall Study|Death|1
2712038|NCT00323882|9336128|P2|Overall Study|Death|1
2712039|NCT00323882|9336129|P1|Overall Study|Death|0
2712040|NCT00323882|9336125|P5|Overall Study|Disease Progression|22
2712041|NCT00323882|9336126|P4|Overall Study|Disease Progression|5
2712042|NCT00323882|9336127|P3|Overall Study|Disease Progression|10
2712043|NCT00323882|9336128|P2|Overall Study|Disease Progression|4
2712044|NCT00323882|9336129|P1|Overall Study|Disease Progression|6
2712045|NCT00323882|9336125|P5|Overall Study|Adverse Event|3
2712046|NCT00323882|9336126|P4|Overall Study|Adverse Event|1
2712047|NCT00323882|9336127|P3|Overall Study|Adverse Event|1
2712048|NCT00323882|9336128|P2|Overall Study|Adverse Event|1
2712049|NCT00323882|9336129|P1|Overall Study|Adverse Event|2
2712050|NCT00323869|9336200|P1|Overall Study|Death|1
2712051|NCT00323622|9336256|P8|Overall Study|Death|2
2712052|NCT00323622|9336257|P7|Overall Study|Death|0
2712053|NCT00323622|9336258|P6|Overall Study|Death|0
2712054|NCT00323622|9336259|P5|Overall Study|Death|7
2712055|NCT00323622|9336260|P4|Overall Study|Death|0
2712056|NCT00323622|9336261|P3|Overall Study|Death|0
2712057|NCT00323622|9336262|P2|Overall Study|Death|1
2712058|NCT00323622|9336263|P1|Overall Study|Death|1
2712059|NCT00323622|9336256|P8|Overall Study|Other|13
2712060|NCT00323622|9336257|P7|Overall Study|Other|5
2712061|NCT00323622|9336258|P6|Overall Study|Other|74
2712062|NCT00323622|9336259|P5|Overall Study|Other|32
2712063|NCT00323622|9336260|P4|Overall Study|Other|12
2712064|NCT00323622|9336261|P3|Overall Study|Other|4
2712065|NCT00323622|9336262|P2|Overall Study|Other|91
2712066|NCT00323622|9336263|P1|Overall Study|Other|30
2712067|NCT00323609|9336305|P4|Overall Study|Other reason|9
2712068|NCT00323609|9336306|P3|Overall Study|Other reason|4
2712069|NCT00323609|9336307|P2|Overall Study|Other reason|8
2712070|NCT00323609|9336308|P1|Overall Study|Other reason|11
2712071|NCT00323609|9336305|P4|Overall Study|Logistical withdrawal|1
2712072|NCT00323609|9336306|P3|Overall Study|Logistical withdrawal|0
2712073|NCT00323609|9336307|P2|Overall Study|Logistical withdrawal|5
2712074|NCT00323609|9336308|P1|Overall Study|Logistical withdrawal|9
2712075|NCT00323609|9336305|P4|Overall Study|Unrelenting or severe back pain|0
2712076|NCT00323609|9336306|P3|Overall Study|Unrelenting or severe back pain|0
2712077|NCT00323609|9336307|P2|Overall Study|Unrelenting or severe back pain|1
2712078|NCT00323609|9336308|P1|Overall Study|Unrelenting or severe back pain|1
2712079|NCT00323609|9336305|P4|Overall Study|Sponsor discontinued trial|0
2712080|NCT00323609|9336306|P3|Overall Study|Sponsor discontinued trial|0
2712081|NCT00323609|9336307|P2|Overall Study|Sponsor discontinued trial|29
2712082|NCT00323609|9336308|P1|Overall Study|Sponsor discontinued trial|29
2712083|NCT00323609|9336305|P4|Overall Study|Other non-VCF-related medical condition|0
2712084|NCT00323609|9336306|P3|Overall Study|Other non-VCF-related medical condition|0
2712085|NCT00323609|9336307|P2|Overall Study|Other non-VCF-related medical condition|2
2712086|NCT00323609|9336308|P1|Overall Study|Other non-VCF-related medical condition|3
2712087|NCT00323609|9336305|P4|Overall Study|Withdrawal by Subject|4
2712088|NCT00323609|9336306|P3|Overall Study|Withdrawal by Subject|4
2712089|NCT00323609|9336307|P2|Overall Study|Withdrawal by Subject|23
2712090|NCT00323609|9336308|P1|Overall Study|Withdrawal by Subject|11
2712091|NCT00323609|9336305|P4|Overall Study|Physician Decision|1
2712092|NCT00323609|9336306|P3|Overall Study|Physician Decision|0
2712093|NCT00323609|9336307|P2|Overall Study|Physician Decision|0
2712094|NCT00323609|9336308|P1|Overall Study|Physician Decision|2
2712095|NCT00323609|9336305|P4|Overall Study|Lost to Follow-up|0
2712096|NCT00323609|9336306|P3|Overall Study|Lost to Follow-up|0
2712097|NCT00323609|9336307|P2|Overall Study|Lost to Follow-up|10
2712098|NCT00323609|9336308|P1|Overall Study|Lost to Follow-up|9
2712099|NCT00323609|9336305|P4|Overall Study|Death|0
2712100|NCT00323609|9336306|P3|Overall Study|Death|0
2712101|NCT00323609|9336307|P2|Overall Study|Death|21
2712102|NCT00323609|9336308|P1|Overall Study|Death|16
2712103|NCT00323557|9336344|P2|Overall Study|Physician Decision|0
2712104|NCT00323557|9336345|P1|Overall Study|Physician Decision|1
2712105|NCT00323492|9336354|P3|Study Phase 2|Protocol Violation|0
2712106|NCT00323492|9336355|P2|Study Phase 2|Protocol Violation|0
2712107|NCT00323492|9336356|P1|Study Phase 2|Protocol Violation|1
2712108|NCT00323492|9336354|P3|Study Phase 2|Noncompliance with study schedule|1
2712109|NCT00323492|9336355|P2|Study Phase 2|Noncompliance with study schedule|0
2712110|NCT00323492|9336356|P1|Study Phase 2|Noncompliance with study schedule|0
2712111|NCT00323492|9336354|P3|Study Phase 2|Withdrawal by Subject|0
2712112|NCT00323492|9336355|P2|Study Phase 2|Withdrawal by Subject|1
2712113|NCT00323492|9336356|P1|Study Phase 2|Withdrawal by Subject|0
2712114|NCT00323492|9336354|P3|Study Phase 2|Lost to Follow-up|0
2712115|NCT00323492|9336355|P2|Study Phase 2|Lost to Follow-up|0
2712116|NCT00323492|9336356|P1|Study Phase 2|Lost to Follow-up|1
2712117|NCT00323492|9336354|P3|Study Phase 2|Physician Decision|0
2712118|NCT00323492|9336355|P2|Study Phase 2|Physician Decision|0
2712119|NCT00323492|9336356|P1|Study Phase 2|Physician Decision|1
2712120|NCT00323492|9336354|P3|Study Phase 2|Adverse Event|0
2712121|NCT00323492|9336355|P2|Study Phase 2|Adverse Event|0
2712122|NCT00323492|9336356|P1|Study Phase 2|Adverse Event|1
2712123|NCT00323492|9336354|P3|Study Phase 1|Adverse Event|0
2712124|NCT00323492|9336355|P2|Study Phase 1|Adverse Event|0
2712125|NCT00323492|9336356|P1|Study Phase 1|Adverse Event|2
2712126|NCT00323479|9336387|P1|Overall Study|house moving|1
2712127|NCT00323479|9336387|P1|Overall Study|Protocol Violation|3
2712128|NCT00323479|9336387|P1|Overall Study|Withdrawal by Subject|2
2712129|NCT00323479|9336387|P1|Overall Study|Adverse Event|2
2712130|NCT00323414|9336420|P2|Overall Study|Withdrawal by Subject|1
2712131|NCT00323414|9336421|P1|Overall Study|Withdrawal by Subject|0
2712132|NCT00323310|9336443|P1|Overall Study|did not complete the 24-hr f-up visit|1
2712133|NCT00323310|9336443|P1|Overall Study|a parent refused blood draw|1
2712134|NCT00323310|9336443|P1|Overall Study|Withdrawal by Subject|1
2712135|NCT00323297|9336458|P2|Part B (Open-label)|Protocol Violation|1
2712136|NCT00323297|9336459|P1|Part B (Open-label)|Protocol Violation|0
2712137|NCT00323297|9336458|P2|Part B (Open-label)|Adverse Event|5
2712138|NCT00323297|9336459|P1|Part B (Open-label)|Adverse Event|5
2712139|NCT00323297|9336458|P2|Part B (Open-label)|Lack of Efficacy|1
2712140|NCT00323297|9336459|P1|Part B (Open-label)|Lack of Efficacy|3
2712141|NCT00323297|9336458|P2|Part B (Open-label)|Withdrawal by Subject|3
2712142|NCT00323297|9336459|P1|Part B (Open-label)|Withdrawal by Subject|1
2712143|NCT00323297|9336458|P2|Part B (Open-label)|Reason unspecified|1
2712144|NCT00323297|9336459|P1|Part B (Open-label)|Reason unspecified|0
2712145|NCT00323297|9336458|P2|Part B (Open-label)|Death|1
2712146|NCT00323297|9336459|P1|Part B (Open-label)|Death|0
2712147|NCT00323297|9336458|P2|Part A (Double Blind Randomized)|Related adverse event|2
2712148|NCT00323297|9336459|P1|Part A (Double Blind Randomized)|Related adverse event|2
2712149|NCT00323297|9336458|P2|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0
2712150|NCT00323297|9336459|P1|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1
2712151|NCT00323297|9336458|P2|Part A (Double Blind Randomized)|Unrelated adverse event|0
2712152|NCT00323297|9336459|P1|Part A (Double Blind Randomized)|Unrelated adverse event|1
2712153|NCT00323297|9336458|P2|Part A (Double Blind Randomized)|Protocol Violation|3
2712154|NCT00323297|9336459|P1|Part A (Double Blind Randomized)|Protocol Violation|1
2712155|NCT00323297|9336458|P2|Part A (Double Blind Randomized)|Death|1
2712156|NCT00323297|9336459|P1|Part A (Double Blind Randomized)|Death|0
2712157|NCT00323297|9336458|P2|Part A (Double Blind Randomized)|Reason unspecified|1
2712158|NCT00323297|9336459|P1|Part A (Double Blind Randomized)|Reason unspecified|0
2712159|NCT00323258|9336499|P2|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2
2712160|NCT00323258|9336500|P1|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1
2712161|NCT00323258|9336499|P2|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10
2712162|NCT00323258|9336500|P1|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12
2712163|NCT00323258|9336499|P2|Secondary Outcome (6 Mon Refill Records)|Death|2
2712164|NCT00323258|9336500|P1|Secondary Outcome (6 Mon Refill Records)|Death|1
2712165|NCT00323258|9336499|P2|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1
2712166|NCT00323258|9336500|P1|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2
2712167|NCT00323258|9336499|P2|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5
2712168|NCT00323258|9336500|P1|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1
2712169|NCT00323258|9336499|P2|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11
2712170|NCT00323258|9336500|P1|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12
2712171|NCT00323258|9336499|P2|Primary Outcome (Phone Call at 6 Months)|Death|2
2712172|NCT00323258|9336500|P1|Primary Outcome (Phone Call at 6 Months)|Death|1
2712173|NCT00323115|9336525|P1|Adjuvant Therapy & Survival Follow-Up|Death|8
2712174|NCT00323115|9336525|P1|Vaccine Administration|Adverse Event|1
2712175|NCT00323063|9336552|P2|Overall Study|brain mets discovered prior to treatment|0
2712176|NCT00323063|9336553|P1|Overall Study|brain mets discovered prior to treatment|1
2712177|NCT00323063|9336552|P2|Overall Study|Adverse Event|0
2712178|NCT00323063|9336553|P1|Overall Study|Adverse Event|1
2712179|NCT00322881|9336570|P1|Overall Study|Disease Progression|2
2712180|NCT00322881|9336570|P1|Overall Study|Adverse Event|1
2712181|NCT00322881|9336570|P1|Overall Study|Death|2
2712182|NCT00322868|9336574|P1|Overall Study|disease progression|1
2712183|NCT00322842|9336599|P2|Overall Study|Death|0
2712184|NCT00322842|9336600|P1|Overall Study|Death|1
2712185|NCT00322842|9336599|P2|Overall Study|Refused transplant|0
2712186|NCT00322842|9336600|P1|Overall Study|Refused transplant|1
2712187|NCT00322842|9336599|P2|Overall Study|Lost to Follow-up|1
2712188|NCT00322842|9336600|P1|Overall Study|Lost to Follow-up|0
2712189|NCT00322842|9336599|P2|Overall Study|Withdrawal by Subject|1
2712190|NCT00322842|9336600|P1|Overall Study|Withdrawal by Subject|0
2712191|NCT00322712|9336638|P1|Overall Study|treated with bevacizumab not cetuximab|1
2712192|NCT00322621|9336642|P3|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
2712193|NCT00322621|9336643|P2|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
2712194|NCT00322621|9336644|P1|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0
2712195|NCT00322621|9336642|P3|Period III - Maintenance / Rescue Phase|Death|0
2712196|NCT00322621|9336643|P2|Period III - Maintenance / Rescue Phase|Death|1
2712197|NCT00322621|9336644|P1|Period III - Maintenance / Rescue Phase|Death|0
2712198|NCT00322621|9336642|P3|Period III - Maintenance / Rescue Phase|Protocol Violation|5
2712199|NCT00322621|9336643|P2|Period III - Maintenance / Rescue Phase|Protocol Violation|2
2712200|NCT00322621|9336644|P1|Period III - Maintenance / Rescue Phase|Protocol Violation|0
2712201|NCT00322621|9336642|P3|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1
2712202|NCT00322621|9336643|P2|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7
2712203|NCT00322621|9336644|P1|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0
2712204|NCT00322621|9336642|P3|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24
2712205|NCT00322621|9336643|P2|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4
2712206|NCT00322621|9336644|P1|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0
2712207|NCT00322621|9336642|P3|Period III - Maintenance / Rescue Phase|Adverse Event|5
2712208|NCT00322621|9336643|P2|Period III - Maintenance / Rescue Phase|Adverse Event|14
2712209|NCT00322621|9336644|P1|Period III - Maintenance / Rescue Phase|Adverse Event|0
2712210|NCT00322621|9336642|P3|Period II - Acute Therapy Phase|Physician Decision|0
2712211|NCT00322621|9336643|P2|Period II - Acute Therapy Phase|Physician Decision|0
2712212|NCT00322621|9336644|P1|Period II - Acute Therapy Phase|Physician Decision|1
2712213|NCT00322621|9336642|P3|Period II - Acute Therapy Phase|Protocol Violation|0
2712214|NCT00322621|9336643|P2|Period II - Acute Therapy Phase|Protocol Violation|0
2712215|NCT00322621|9336644|P1|Period II - Acute Therapy Phase|Protocol Violation|2
2712216|NCT00322621|9336642|P3|Period II - Acute Therapy Phase|Withdrawal by Subject|0
2712217|NCT00322621|9336643|P2|Period II - Acute Therapy Phase|Withdrawal by Subject|0
2712218|NCT00322621|9336644|P1|Period II - Acute Therapy Phase|Withdrawal by Subject|8
2712219|NCT00322621|9336642|P3|Period II - Acute Therapy Phase|Lack of Efficacy|0
2712220|NCT00322621|9336643|P2|Period II - Acute Therapy Phase|Lack of Efficacy|0
2712221|NCT00322621|9336644|P1|Period II - Acute Therapy Phase|Lack of Efficacy|1
2712222|NCT00322621|9336642|P3|Period II - Acute Therapy Phase|Adverse Event|0
2712223|NCT00322621|9336643|P2|Period II - Acute Therapy Phase|Adverse Event|0
2712224|NCT00322621|9336644|P1|Period II - Acute Therapy Phase|Adverse Event|20
2712225|NCT00322556|9336696|P1|Overall Study|Other Reason|7
2712226|NCT00322556|9336696|P1|Overall Study|Lost to Follow-up|3
2712227|NCT00322556|9336696|P1|Overall Study|Withdrawal by Subject|1
2712228|NCT00322556|9336696|P1|Overall Study|Adverse Event|1
2712229|NCT00322491|9336712|P2|Overall Study|Death|2
2712230|NCT00322491|9336713|P1|Overall Study|Death|1
2712231|NCT00322491|9336712|P2|Overall Study|Adverse Event|0
2712232|NCT00322491|9336713|P1|Overall Study|Adverse Event|1
2712233|NCT00322452|9336803|P2|Overall Study|Death|227
2712234|NCT00322452|9336804|P1|Overall Study|Death|223
2712235|NCT00322452|9336803|P2|Overall Study|Withdrawal by Subject|46
2712236|NCT00322452|9336804|P1|Overall Study|Withdrawal by Subject|19
2712237|NCT00322452|9336803|P2|Overall Study|Lost to Follow-up|2
2712238|NCT00322452|9336804|P1|Overall Study|Lost to Follow-up|5
2712239|NCT00322452|9336803|P2|Overall Study|Eligibility criteria not fulfilled|1
2712240|NCT00322452|9336804|P1|Overall Study|Eligibility criteria not fulfilled|0
2712241|NCT00322387|9336855|P2|Follow-up Period|Death|0
2712242|NCT00322387|9336856|P1|Follow-up Period|Death|1
2712243|NCT00322387|9336855|P2|Follow-up Period|Final assessment not done|3
2712244|NCT00322387|9336856|P1|Follow-up Period|Final assessment not done|1
2712245|NCT00322387|9336855|P2|Treatment Period|Adverse Event|1
2712246|NCT00322387|9336856|P1|Treatment Period|Adverse Event|0
2712247|NCT00322374|9336890|P4|Second Escalation|Study Drug Toxicity|0
2712248|NCT00322374|9336891|P3|Second Escalation|Study Drug Toxicity|1
2712249|NCT00322374|9336892|P2|Second Escalation|Study Drug Toxicity|0
2712250|NCT00322374|9336893|P1|Second Escalation|Study Drug Toxicity|0
2712251|NCT00322374|9336890|P4|Second Escalation|Physician Decision|0
2712252|NCT00322374|9336891|P3|Second Escalation|Physician Decision|5
2712253|NCT00322374|9336892|P2|Second Escalation|Physician Decision|0
2712254|NCT00322374|9336893|P1|Second Escalation|Physician Decision|0
2712255|NCT00322374|9336890|P4|First Escalation|Participant Request|0
2712256|NCT00322374|9336891|P3|First Escalation|Participant Request|0
2712257|NCT00322374|9336892|P2|First Escalation|Participant Request|1
2712258|NCT00322374|9336893|P1|First Escalation|Participant Request|0
2712259|NCT00322374|9336890|P4|First Escalation|Study Drug Toxicity|0
2712260|NCT00322374|9336891|P3|First Escalation|Study Drug Toxicity|0
2712261|NCT00322374|9336892|P2|First Escalation|Study Drug Toxicity|11
2712262|NCT00322374|9336893|P1|First Escalation|Study Drug Toxicity|0
2712263|NCT00322374|9336890|P4|First Escalation|Physician Decision|0
2712264|NCT00322374|9336891|P3|First Escalation|Physician Decision|0
2712265|NCT00322374|9336892|P2|First Escalation|Physician Decision|12
2712266|NCT00322374|9336893|P1|First Escalation|Physician Decision|0
2712267|NCT00322374|9336890|P4|First Escalation|Documented Disease Progression|0
2712268|NCT00322374|9336891|P3|First Escalation|Documented Disease Progression|0
2712269|NCT00322374|9336892|P2|First Escalation|Documented Disease Progression|6
2712270|NCT00322374|9336893|P1|First Escalation|Documented Disease Progression|0
2712271|NCT00322374|9336890|P4|Starting Dose|Study Drug Toxicity|0
2712272|NCT00322374|9336891|P3|Starting Dose|Study Drug Toxicity|0
2712273|NCT00322374|9336892|P2|Starting Dose|Study Drug Toxicity|0
2712274|NCT00322374|9336893|P1|Starting Dose|Study Drug Toxicity|4
2712275|NCT00322374|9336890|P4|Starting Dose|Physician Decision|0
2712276|NCT00322374|9336891|P3|Starting Dose|Physician Decision|0
2712277|NCT00322374|9336892|P2|Starting Dose|Physician Decision|0
2712278|NCT00322374|9336893|P1|Starting Dose|Physician Decision|2
2712279|NCT00322348|9336943|P2|Overall Study|Reasons not specified|1
2712280|NCT00322348|9336944|P1|Overall Study|Reasons not specified|5
2712281|NCT00322348|9336943|P2|Overall Study|Disease Progression|25
2712282|NCT00322348|9336944|P1|Overall Study|Disease Progression|30
2712283|NCT00322348|9336943|P2|Overall Study|Death|2
2712284|NCT00322348|9336944|P1|Overall Study|Death|0
2712285|NCT00322348|9336943|P2|Overall Study|Lost to Follow-up|0
2712286|NCT00322348|9336944|P1|Overall Study|Lost to Follow-up|1
2712287|NCT00322348|9336943|P2|Overall Study|Withdrawal by Subject|4
2712288|NCT00322348|9336944|P1|Overall Study|Withdrawal by Subject|1
2712289|NCT00322348|9336943|P2|Overall Study|Adverse Event|1
2712290|NCT00322348|9336944|P1|Overall Study|Adverse Event|0
2712291|NCT00322153|9337035|P2|Overall Study|Withdrawn for other reasons|4
2712292|NCT00322153|9337036|P1|Overall Study|Withdrawn for other reasons|5
2712293|NCT00322153|9337035|P2|Overall Study|Lost to Follow-up|4
2712294|NCT00322153|9337036|P1|Overall Study|Lost to Follow-up|5
2712295|NCT00322153|9337035|P2|Overall Study|Lack of Efficacy|3
2712296|NCT00322153|9337036|P1|Overall Study|Lack of Efficacy|8
2712297|NCT00322153|9337035|P2|Overall Study|Withdrawal by Subject|10
2712298|NCT00322153|9337036|P1|Overall Study|Withdrawal by Subject|18
2712299|NCT00322153|9337035|P2|Overall Study|Protocol Violation|14
2712300|NCT00322153|9337036|P1|Overall Study|Protocol Violation|6
2712301|NCT00322153|9337035|P2|Overall Study|Adverse Event|34
2712302|NCT00322153|9337036|P1|Overall Study|Adverse Event|21
2712303|NCT00322049|9337069|P4|Overall Study|Infected with Dengue during study|0
2712304|NCT00322049|9337070|P3|Overall Study|Infected with Dengue during study|0
2712305|NCT00322049|9337071|P2|Overall Study|Infected with Dengue during study|1
2712306|NCT00322049|9337072|P1|Overall Study|Infected with Dengue during study|0
2712307|NCT00322049|9337069|P4|Overall Study|Moved out of area|1
2712308|NCT00322049|9337070|P3|Overall Study|Moved out of area|0
2712309|NCT00322049|9337071|P2|Overall Study|Moved out of area|0
2712310|NCT00322049|9337072|P1|Overall Study|Moved out of area|0
2712311|NCT00321984|9337105|P3|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
2712312|NCT00321984|9337106|P2|Overall Study|Per Sponsor Due to High Baseline Gastrin|1
2712313|NCT00321984|9337107|P1|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
2712314|NCT00321984|9337105|P3|Overall Study|Per Investigator Request|0
2712315|NCT00321984|9337106|P2|Overall Study|Per Investigator Request|0
2712316|NCT00321984|9337107|P1|Overall Study|Per Investigator Request|1
2712317|NCT00321984|9337105|P3|Overall Study|Per Subject Request|0
2712318|NCT00321984|9337106|P2|Overall Study|Per Subject Request|0
2712319|NCT00321984|9337107|P1|Overall Study|Per Subject Request|1
2712320|NCT00321984|9337105|P3|Overall Study|Pregnancy|0
2712321|NCT00321984|9337106|P2|Overall Study|Pregnancy|1
2712322|NCT00321984|9337107|P1|Overall Study|Pregnancy|0
2712323|NCT00321984|9337105|P3|Overall Study|Noncompliant|2
2712324|NCT00321984|9337106|P2|Overall Study|Noncompliant|0
2712325|NCT00321984|9337107|P1|Overall Study|Noncompliant|0
2712326|NCT00321984|9337105|P3|Overall Study|Lack of Efficacy|3
2712327|NCT00321984|9337106|P2|Overall Study|Lack of Efficacy|1
2712328|NCT00321984|9337107|P1|Overall Study|Lack of Efficacy|3
2712329|NCT00321984|9337105|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
2712330|NCT00321984|9337106|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|1
2712331|NCT00321984|9337107|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|3
2712332|NCT00321984|9337105|P3|Overall Study|Withdrawal by Subject|5
2712333|NCT00321984|9337106|P2|Overall Study|Withdrawal by Subject|6
2712334|NCT00321984|9337107|P1|Overall Study|Withdrawal by Subject|8
2712335|NCT00321984|9337105|P3|Overall Study|Lost to Follow-up|2
2712336|NCT00321984|9337106|P2|Overall Study|Lost to Follow-up|4
2712337|NCT00321984|9337107|P1|Overall Study|Lost to Follow-up|2
2712338|NCT00321984|9337105|P3|Overall Study|Protocol Violation|1
2712339|NCT00321984|9337106|P2|Overall Study|Protocol Violation|1
2712340|NCT00321984|9337107|P1|Overall Study|Protocol Violation|0
2712341|NCT00321984|9337105|P3|Overall Study|Adverse Event|8
2712342|NCT00321984|9337106|P2|Overall Study|Adverse Event|6
2712343|NCT00321984|9337107|P1|Overall Study|Adverse Event|9
2712344|NCT00321932|9337135|P2|Overall Study|Missing data|1
2712345|NCT00321932|9337136|P1|Overall Study|Missing data|2
2712346|NCT00321932|9337135|P2|Overall Study|Early relapse|8
2712347|NCT00321932|9337136|P1|Overall Study|Early relapse|2
2712348|NCT00321932|9337135|P2|Overall Study|Withdrawal by Subject|6
2712349|NCT00321932|9337136|P1|Overall Study|Withdrawal by Subject|3
2712350|NCT00321932|9337135|P2|Overall Study|Death|6
2712351|NCT00321932|9337136|P1|Overall Study|Death|3
2712352|NCT00321919|9337160|P2|Overall Study|Other withdrawal reason|6
2712353|NCT00321919|9337161|P1|Overall Study|Other withdrawal reason|7
2712354|NCT00321919|9337160|P2|Overall Study|Failure to Return|1
2712355|NCT00321919|9337161|P1|Overall Study|Failure to Return|3
2712356|NCT00321919|9337160|P2|Overall Study|Other Protocol Violation|3
2712357|NCT00321919|9337161|P1|Overall Study|Other Protocol Violation|2
2712358|NCT00321919|9337160|P2|Overall Study|Refused Treatment|14
2712359|NCT00321919|9337161|P1|Overall Study|Refused Treatment|23
2712360|NCT00321919|9337160|P2|Overall Study|Violation of Selection Criteria at Entry|1
2712361|NCT00321919|9337161|P1|Overall Study|Violation of Selection Criteria at Entry|1
2712362|NCT00321919|9337160|P2|Overall Study|Insufficient Therapeutic Response|0
2712363|NCT00321919|9337161|P1|Overall Study|Insufficient Therapeutic Response|1
2712364|NCT00321919|9337160|P2|Overall Study|Death|17
2712365|NCT00321919|9337161|P1|Overall Study|Death|21
2712366|NCT00321919|9337160|P2|Overall Study|Adverse Event|10
2712367|NCT00321919|9337161|P1|Overall Study|Adverse Event|17
2712368|NCT00321906|9337203|P2|Overall Study|Withdrawal by Subject|4
2712369|NCT00321906|9337204|P1|Overall Study|Withdrawal by Subject|0
2712370|NCT00321906|9337203|P2|Overall Study|Lost to Follow-up|2
2712371|NCT00321906|9337204|P1|Overall Study|Lost to Follow-up|1
2712372|NCT00321906|9337203|P2|Overall Study|Death|6
2712373|NCT00321906|9337204|P1|Overall Study|Death|9
2712374|NCT00321906|9337203|P2|Overall Study|Adverse Event|44
2712375|NCT00321906|9337204|P1|Overall Study|Adverse Event|36
2712376|NCT00321893|9337226|P2|Overall Study|Adverse Event|3
2712377|NCT00321893|9337227|P1|Overall Study|Adverse Event|6
2712378|NCT00321893|9337226|P2|Overall Study|Lost to Follow-up|1
2712379|NCT00321893|9337227|P1|Overall Study|Lost to Follow-up|2
2712380|NCT00321893|9337226|P2|Overall Study|Non-Compliance/Refusal|10
2712381|NCT00321893|9337227|P1|Overall Study|Non-Compliance/Refusal|16
2712382|NCT00321854|9337241|P2|Overall Study|Other|1
2712383|NCT00321854|9337242|P1|Overall Study|Other|1
2712384|NCT00321854|9337241|P2|Overall Study|Withdrawal by Subject|17
2712385|NCT00321854|9337242|P1|Overall Study|Withdrawal by Subject|6
2712386|NCT00321854|9337241|P2|Overall Study|Lost to Follow-up|2
2712387|NCT00321854|9337242|P1|Overall Study|Lost to Follow-up|0
2712388|NCT00321854|9337241|P2|Overall Study|Protocol Violation|5
2712389|NCT00321854|9337242|P1|Overall Study|Protocol Violation|6
2712390|NCT00321854|9337241|P2|Overall Study|Lack of Efficacy|14
2712391|NCT00321854|9337242|P1|Overall Study|Lack of Efficacy|9
2712392|NCT00321854|9337241|P2|Overall Study|Adverse Event|43
2712393|NCT00321854|9337242|P1|Overall Study|Adverse Event|41
2712394|NCT00321828|9337360|P1|Overall Study|No follow up data|1
2712395|NCT00321828|9337360|P1|Overall Study|Ineligible|3
2712396|NCT00321789|9337366|P2|Overall Study|Protocol Violation|3
2712397|NCT00321789|9337367|P1|Overall Study|Protocol Violation|5
2712398|NCT00321789|9337366|P2|Overall Study|Withdrawal by Subject|6
2712399|NCT00321789|9337367|P1|Overall Study|Withdrawal by Subject|6
2712400|NCT00321789|9337366|P2|Overall Study|Lost to Follow-up|7
2712401|NCT00321789|9337367|P1|Overall Study|Lost to Follow-up|4
2712402|NCT00321763|9337399|P4|Overall Study|Lost to Follow-up|4
2712403|NCT00321763|9337400|P3|Overall Study|Lost to Follow-up|5
2712404|NCT00321763|9337401|P2|Overall Study|Lost to Follow-up|1
2712405|NCT00321763|9337402|P1|Overall Study|Lost to Follow-up|3
2712406|NCT00321763|9337399|P4|Overall Study|Withdrawal by Subject|0
2712407|NCT00321763|9337400|P3|Overall Study|Withdrawal by Subject|1
2712408|NCT00321763|9337401|P2|Overall Study|Withdrawal by Subject|0
2712409|NCT00321763|9337402|P1|Overall Study|Withdrawal by Subject|2
2712410|NCT00321763|9337399|P4|Overall Study|Adverse Event|1
2712411|NCT00321763|9337400|P3|Overall Study|Adverse Event|0
2712412|NCT00321763|9337401|P2|Overall Study|Adverse Event|1
2712413|NCT00321763|9337402|P1|Overall Study|Adverse Event|1
2712414|NCT00321737|9337462|P3|Overall Study|Subject Request/ Subject Unavailable|2
2712415|NCT00321737|9337463|P2|Overall Study|Subject Request/ Subject Unavailable|0
2712416|NCT00321737|9337464|P1|Overall Study|Subject Request/ Subject Unavailable|0
2712417|NCT00321737|9337462|P3|Overall Study|Noncompliance|0
2712418|NCT00321737|9337463|P2|Overall Study|Noncompliance|0
2712419|NCT00321737|9337464|P1|Overall Study|Noncompliance|2
2712420|NCT00321737|9337462|P3|Overall Study|Pregnancy|0
2712421|NCT00321737|9337463|P2|Overall Study|Pregnancy|2
2712422|NCT00321737|9337464|P1|Overall Study|Pregnancy|0
2712423|NCT00321737|9337462|P3|Overall Study|Therapeutic Failure|2
2712424|NCT00321737|9337463|P2|Overall Study|Therapeutic Failure|0
2712425|NCT00321737|9337464|P1|Overall Study|Therapeutic Failure|6
2712426|NCT00321737|9337462|P3|Overall Study|Possible Barrett's Esophagus|1
2712427|NCT00321737|9337463|P2|Overall Study|Possible Barrett's Esophagus|1
2712428|NCT00321737|9337464|P1|Overall Study|Possible Barrett's Esophagus|2
2712429|NCT00321737|9337462|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|0
2712430|NCT00321737|9337463|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|0
2712431|NCT00321737|9337464|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|1
2712432|NCT00321737|9337462|P3|Overall Study|Protocol Violation|1
2712433|NCT00321737|9337463|P2|Overall Study|Protocol Violation|0
2712434|NCT00321737|9337464|P1|Overall Study|Protocol Violation|0
2712435|NCT00321737|9337462|P3|Overall Study|Withdrawal by Subject|17
2712436|NCT00321737|9337463|P2|Overall Study|Withdrawal by Subject|12
2712437|NCT00321737|9337464|P1|Overall Study|Withdrawal by Subject|19
2712438|NCT00321737|9337462|P3|Overall Study|Lost to Follow-up|6
2712439|NCT00321737|9337463|P2|Overall Study|Lost to Follow-up|5
2712440|NCT00321737|9337464|P1|Overall Study|Lost to Follow-up|5
2712441|NCT00321737|9337462|P3|Overall Study|Adverse Event|6
2712442|NCT00321737|9337463|P2|Overall Study|Adverse Event|3
2712443|NCT00321737|9337464|P1|Overall Study|Adverse Event|11
2712444|NCT00321737|9337462|P3|Overall Study|Relapse of Erosive Esophagitis|19
2712445|NCT00321737|9337463|P2|Overall Study|Relapse of Erosive Esophagitis|25
2712446|NCT00321737|9337464|P1|Overall Study|Relapse of Erosive Esophagitis|76
2712447|NCT00321711|9337492|P5|Part B|Death|1
2712448|NCT00321711|9337493|P4|Part B|Death|2
2712449|NCT00321711|9337494|P3|Part B|Death|0
2712450|NCT00321711|9337495|P2|Part B|Death|0
2712451|NCT00321711|9337496|P1|Part B|Death|0
2712452|NCT00321711|9337492|P5|Part B|Physician Decision|2
2712453|NCT00321711|9337493|P4|Part B|Physician Decision|1
2712454|NCT00321711|9337494|P3|Part B|Physician Decision|0
2712455|NCT00321711|9337495|P2|Part B|Physician Decision|0
2712456|NCT00321711|9337496|P1|Part B|Physician Decision|0
2712457|NCT00321711|9337492|P5|Part B|Disease progression|0
2712458|NCT00321711|9337493|P4|Part B|Disease progression|1
2712459|NCT00321711|9337494|P3|Part B|Disease progression|0
2712460|NCT00321711|9337495|P2|Part B|Disease progression|0
2712461|NCT00321711|9337496|P1|Part B|Disease progression|0
2712462|NCT00321711|9337492|P5|Part B|Adverse Event|1
2712463|NCT00321711|9337493|P4|Part B|Adverse Event|2
2712464|NCT00321711|9337494|P3|Part B|Adverse Event|0
2712465|NCT00321711|9337495|P2|Part B|Adverse Event|0
2712466|NCT00321711|9337496|P1|Part B|Adverse Event|0
2712467|NCT00321711|9337492|P5|Part B|Noncompliance|1
2712468|NCT00321711|9337493|P4|Part B|Noncompliance|0
2712469|NCT00321711|9337494|P3|Part B|Noncompliance|0
2712470|NCT00321711|9337495|P2|Part B|Noncompliance|0
2712471|NCT00321711|9337496|P1|Part B|Noncompliance|0
2712472|NCT00321711|9337492|P5|Part A|Protocol deviation|0
2712473|NCT00321711|9337493|P4|Part A|Protocol deviation|0
2712474|NCT00321711|9337494|P3|Part A|Protocol deviation|1
2712475|NCT00321711|9337495|P2|Part A|Protocol deviation|0
2712476|NCT00321711|9337496|P1|Part A|Protocol deviation|0
2712477|NCT00321711|9337492|P5|Part A|Other|0
2712478|NCT00321711|9337493|P4|Part A|Other|0
2712479|NCT00321711|9337494|P3|Part A|Other|3
2712480|NCT00321711|9337495|P2|Part A|Other|2
2712481|NCT00321711|9337496|P1|Part A|Other|1
2712482|NCT00321711|9337492|P5|Part A|Physician Decision|0
2712483|NCT00321711|9337493|P4|Part A|Physician Decision|0
2712484|NCT00321711|9337494|P3|Part A|Physician Decision|3
2712485|NCT00321711|9337495|P2|Part A|Physician Decision|1
2712486|NCT00321711|9337496|P1|Part A|Physician Decision|0
2712487|NCT00321711|9337492|P5|Part A|Requirement for alternative therapy|0
2712488|NCT00321711|9337493|P4|Part A|Requirement for alternative therapy|0
2712489|NCT00321711|9337494|P3|Part A|Requirement for alternative therapy|1
2712490|NCT00321711|9337495|P2|Part A|Requirement for alternative therapy|2
2712491|NCT00321711|9337496|P1|Part A|Requirement for alternative therapy|0
2712492|NCT00321711|9337492|P5|Part A|Disease progression|0
2712493|NCT00321711|9337493|P4|Part A|Disease progression|0
2712494|NCT00321711|9337494|P3|Part A|Disease progression|0
2712495|NCT00321711|9337495|P2|Part A|Disease progression|1
2712496|NCT00321711|9337496|P1|Part A|Disease progression|0
2712497|NCT00321711|9337492|P5|Part A|Withdrawal by Subject|0
2712498|NCT00321711|9337493|P4|Part A|Withdrawal by Subject|0
2712499|NCT00321711|9337494|P3|Part A|Withdrawal by Subject|1
2712500|NCT00321711|9337495|P2|Part A|Withdrawal by Subject|1
2712501|NCT00321711|9337496|P1|Part A|Withdrawal by Subject|1
2712502|NCT00321711|9337492|P5|Part A|Adverse Event|0
2712503|NCT00321711|9337493|P4|Part A|Adverse Event|0
2712504|NCT00321711|9337494|P3|Part A|Adverse Event|2
2712505|NCT00321711|9337495|P2|Part A|Adverse Event|3
2712506|NCT00321711|9337496|P1|Part A|Adverse Event|3
2712507|NCT00321685|9337546|P1|Overall Study|Ineligible|2
2712508|NCT00321685|9337546|P1|Overall Study|Not start protocol therapy|2
2712509|NCT00321685|9337546|P1|Overall Study|Other|5
2712510|NCT00321685|9337546|P1|Overall Study|Complicating disese|1
2712511|NCT00321685|9337546|P1|Overall Study|Alternative therapy|1
2712512|NCT00321685|9337546|P1|Overall Study|Withdrawal by Subject|8
2712513|NCT00321685|9337546|P1|Overall Study|Death|2
2712514|NCT00321685|9337546|P1|Overall Study|Adverse Event|18
2712515|NCT00321672|9337558|P4|Overall Study|Extensive travel required for new job|0
2712516|NCT00321672|9337559|P3|Overall Study|Extensive travel required for new job|0
2712517|NCT00321672|9337560|P2|Overall Study|Extensive travel required for new job|1
2712518|NCT00321672|9337561|P1|Overall Study|Extensive travel required for new job|0
2712519|NCT00321672|9337558|P4|Overall Study|Diagnosis of testicular cancer|0
2712520|NCT00321672|9337559|P3|Overall Study|Diagnosis of testicular cancer|0
2712521|NCT00321672|9337560|P2|Overall Study|Diagnosis of testicular cancer|1
2712522|NCT00321672|9337561|P1|Overall Study|Diagnosis of testicular cancer|0
2712523|NCT00321672|9337558|P4|Overall Study|Protocol Violation|0
2712524|NCT00321672|9337559|P3|Overall Study|Protocol Violation|1
2712525|NCT00321672|9337560|P2|Overall Study|Protocol Violation|0
2712526|NCT00321672|9337561|P1|Overall Study|Protocol Violation|0
2712527|NCT00321672|9337558|P4|Overall Study|Moved out of state|0
2712528|NCT00321672|9337559|P3|Overall Study|Moved out of state|1
2712529|NCT00321672|9337560|P2|Overall Study|Moved out of state|1
2712530|NCT00321672|9337561|P1|Overall Study|Moved out of state|0
2712531|NCT00321672|9337558|P4|Overall Study|Incarcerated|0
2712532|NCT00321672|9337559|P3|Overall Study|Incarcerated|2
2712533|NCT00321672|9337560|P2|Overall Study|Incarcerated|0
2712534|NCT00321672|9337561|P1|Overall Study|Incarcerated|0
2712535|NCT00321672|9337558|P4|Overall Study|Too far to travel for visits|0
2712536|NCT00321672|9337559|P3|Overall Study|Too far to travel for visits|0
2712537|NCT00321672|9337560|P2|Overall Study|Too far to travel for visits|0
2712538|NCT00321672|9337561|P1|Overall Study|Too far to travel for visits|1
2712539|NCT00321672|9337558|P4|Overall Study|Death|0
2712540|NCT00321672|9337559|P3|Overall Study|Death|0
2712541|NCT00321672|9337560|P2|Overall Study|Death|0
2712542|NCT00321672|9337561|P1|Overall Study|Death|1
2712543|NCT00321672|9337558|P4|Overall Study|Lost to Follow-up|2
2712544|NCT00321672|9337559|P3|Overall Study|Lost to Follow-up|4
2712545|NCT00321672|9337560|P2|Overall Study|Lost to Follow-up|0
2712546|NCT00321672|9337561|P1|Overall Study|Lost to Follow-up|2
2712547|NCT00321672|9337558|P4|Overall Study|Lack of Efficacy|0
2712548|NCT00321672|9337559|P3|Overall Study|Lack of Efficacy|0
2712549|NCT00321672|9337560|P2|Overall Study|Lack of Efficacy|1
2712550|NCT00321672|9337561|P1|Overall Study|Lack of Efficacy|1
2712551|NCT00321672|9337558|P4|Overall Study|Adverse Event|0
2712552|NCT00321672|9337559|P3|Overall Study|Adverse Event|0
2712553|NCT00321672|9337560|P2|Overall Study|Adverse Event|1
2712554|NCT00321672|9337561|P1|Overall Study|Adverse Event|1
2712555|NCT00321672|9337558|P4|Overall Study|Noncompliance|0
2712556|NCT00321672|9337559|P3|Overall Study|Noncompliance|1
2712557|NCT00321672|9337560|P2|Overall Study|Noncompliance|2
2712558|NCT00321672|9337561|P1|Overall Study|Noncompliance|1
2712559|NCT00321672|9337558|P4|Overall Study|Withdrawal by Subject|0
2712560|NCT00321672|9337559|P3|Overall Study|Withdrawal by Subject|2
2712561|NCT00321672|9337560|P2|Overall Study|Withdrawal by Subject|1
2712562|NCT00321672|9337561|P1|Overall Study|Withdrawal by Subject|5
2712563|NCT00321646|9337587|P1|Neoadjuvant Chemotherapy|Disease progression|1
2712564|NCT00321646|9337587|P1|Neoadjuvant Chemotherapy|Adverse Event|2
2712565|NCT00321646|9337587|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
2712566|NCT00321620|9337594|P2|Overall Study|Other|33
2712567|NCT00321620|9337595|P1|Overall Study|Other|42
2712568|NCT00321620|9337594|P2|Overall Study|Participant request|52
2712569|NCT00321620|9337595|P1|Overall Study|Participant request|75
2712570|NCT00321620|9337594|P2|Overall Study|Ineligibility determined|3
2712571|NCT00321620|9337595|P1|Overall Study|Ineligibility determined|2
2712572|NCT00321620|9337594|P2|Overall Study|Protocol deviation|3
2712573|NCT00321620|9337595|P1|Overall Study|Protocol deviation|4
2712574|NCT00321620|9337594|P2|Overall Study|Noncompliance|7
2712575|NCT00321620|9337595|P1|Overall Study|Noncompliance|14
2712576|NCT00321620|9337594|P2|Overall Study|Physician Decision|1
2712577|NCT00321620|9337595|P1|Overall Study|Physician Decision|4
2712578|NCT00321620|9337594|P2|Overall Study|Lost to Follow-up|9
2712579|NCT00321620|9337595|P1|Overall Study|Lost to Follow-up|13
2712580|NCT00321620|9337594|P2|Overall Study|Adverse Event|56
2712581|NCT00321620|9337595|P1|Overall Study|Adverse Event|43
2712582|NCT00321620|9337594|P2|Overall Study|Disease progression|117
2712583|NCT00321620|9337595|P1|Overall Study|Disease progression|113
2712584|NCT00321620|9337594|P2|Overall Study|Withdrawal by Subject|147
2712585|NCT00321620|9337595|P1|Overall Study|Withdrawal by Subject|164
2712586|NCT00321620|9337594|P2|Overall Study|Death|294
2712587|NCT00321620|9337595|P1|Overall Study|Death|269
2712588|NCT00321555|9337623|P1|Overall Study|Disease progression on study|1
2712589|NCT00321555|9337623|P1|Overall Study|Physician Decision|1
2712590|NCT00321555|9337623|P1|Overall Study|Switched to alternative treatment|3
2712591|NCT00321555|9337623|P1|Overall Study|Developed antibodies|1
2712592|NCT00321464|9337631|P2|Overall Study|Other|18
2712593|NCT00321464|9337632|P1|Overall Study|Other|21
2712594|NCT00321464|9337631|P2|Overall Study|Ineligibility determined|1
2712595|NCT00321464|9337632|P1|Overall Study|Ineligibility determined|2
2712596|NCT00321464|9337631|P2|Overall Study|Protocol deviation|2
2712597|NCT00321464|9337632|P1|Overall Study|Protocol deviation|0
2712598|NCT00321464|9337631|P2|Overall Study|Lost to Follow-up|8
2712599|NCT00321464|9337632|P1|Overall Study|Lost to Follow-up|7
2712600|NCT00321464|9337631|P2|Overall Study|Noncompliance|10
2712601|NCT00321464|9337632|P1|Overall Study|Noncompliance|4
2712602|NCT00321464|9337631|P2|Overall Study|Physician Decision|14
2712603|NCT00321464|9337632|P1|Overall Study|Physician Decision|15
2712604|NCT00321464|9337631|P2|Overall Study|Adverse Event|28
2712605|NCT00321464|9337632|P1|Overall Study|Adverse Event|43
2712606|NCT00321464|9337631|P2|Overall Study|Participant request|61
2712607|NCT00321464|9337632|P1|Overall Study|Participant request|57
2712608|NCT00321464|9337631|P2|Overall Study|Withdrawal by Subject|118
2712609|NCT00321464|9337632|P1|Overall Study|Withdrawal by Subject|117
2712610|NCT00321464|9337631|P2|Overall Study|Disease progression|124
2712611|NCT00321464|9337632|P1|Overall Study|Disease progression|124
2712612|NCT00321464|9337631|P2|Overall Study|Death|174
2712613|NCT00321464|9337632|P1|Overall Study|Death|169
2712614|NCT00321373|9337645|P3|Overall Study|Other|1
2712615|NCT00321373|9337646|P2|Overall Study|Other|0
2712616|NCT00321373|9337647|P1|Overall Study|Other|0
2712617|NCT00321373|9337645|P3|Overall Study|Withdrawal by Subject|0
2712618|NCT00321373|9337646|P2|Overall Study|Withdrawal by Subject|0
2712619|NCT00321373|9337647|P1|Overall Study|Withdrawal by Subject|1
2712620|NCT00321373|9337645|P3|Overall Study|Lost to Follow-up|1
2712621|NCT00321373|9337646|P2|Overall Study|Lost to Follow-up|0
2712622|NCT00321373|9337647|P1|Overall Study|Lost to Follow-up|1
2712623|NCT00321373|9337645|P3|Overall Study|Adverse Event|1
2712624|NCT00321373|9337646|P2|Overall Study|Adverse Event|0
2712625|NCT00321373|9337647|P1|Overall Study|Adverse Event|0
2712626|NCT00321048|9337687|P2|Overall Study|Withdrawal by Subject|8
2712627|NCT00321048|9337688|P1|Overall Study|Withdrawal by Subject|6
2712628|NCT00320801|9337696|P4|Extension Phase|Lost to Follow-up|3
2712629|NCT00320801|9337697|P3|Extension Phase|Lost to Follow-up|0
2712630|NCT00320801|9337698|P2|Extension Phase|Lost to Follow-up|0
2712631|NCT00320801|9337699|P1|Extension Phase|Lost to Follow-up|0
2712632|NCT00320801|9337696|P4|Extension Phase|Lack of Efficacy|2
2712633|NCT00320801|9337697|P3|Extension Phase|Lack of Efficacy|0
2712634|NCT00320801|9337698|P2|Extension Phase|Lack of Efficacy|0
2712635|NCT00320801|9337699|P1|Extension Phase|Lack of Efficacy|0
2712636|NCT00320801|9337696|P4|Extension Phase|Administrative|29
2712637|NCT00320801|9337697|P3|Extension Phase|Administrative|0
2712638|NCT00320801|9337698|P2|Extension Phase|Administrative|0
2712639|NCT00320801|9337699|P1|Extension Phase|Administrative|0
2712640|NCT00320801|9337696|P4|Extension Phase|Adverse Event|8
2712641|NCT00320801|9337697|P3|Extension Phase|Adverse Event|0
2712642|NCT00320801|9337698|P2|Extension Phase|Adverse Event|0
2712643|NCT00320801|9337699|P1|Extension Phase|Adverse Event|0
2712644|NCT00320801|9337696|P4|Extension Phase|Withdrawal by Subject|6
2712645|NCT00320801|9337697|P3|Extension Phase|Withdrawal by Subject|0
2712646|NCT00320801|9337698|P2|Extension Phase|Withdrawal by Subject|0
2712647|NCT00320801|9337699|P1|Extension Phase|Withdrawal by Subject|0
2712648|NCT00320801|9337696|P4|Double-blind Phase|Lack of Efficacy|0
2712649|NCT00320801|9337697|P3|Double-blind Phase|Lack of Efficacy|1
2712650|NCT00320801|9337698|P2|Double-blind Phase|Lack of Efficacy|9
2712651|NCT00320801|9337699|P1|Double-blind Phase|Lack of Efficacy|0
2712652|NCT00320801|9337696|P4|Double-blind Phase|Administrative|0
2712653|NCT00320801|9337697|P3|Double-blind Phase|Administrative|4
2712654|NCT00320801|9337698|P2|Double-blind Phase|Administrative|0
2712655|NCT00320801|9337699|P1|Double-blind Phase|Administrative|0
2712656|NCT00320801|9337696|P4|Double-blind Phase|Adverse Event|0
2712657|NCT00320801|9337697|P3|Double-blind Phase|Adverse Event|8
2712658|NCT00320801|9337698|P2|Double-blind Phase|Adverse Event|2
2712659|NCT00320801|9337699|P1|Double-blind Phase|Adverse Event|0
2712660|NCT00320801|9337696|P4|Double-blind Phase|Withdrawal by Subject|0
2712661|NCT00320801|9337697|P3|Double-blind Phase|Withdrawal by Subject|1
2712662|NCT00320801|9337698|P2|Double-blind Phase|Withdrawal by Subject|0
2712663|NCT00320801|9337699|P1|Double-blind Phase|Withdrawal by Subject|0
2712664|NCT00320801|9337696|P4|Open-label Run-in Period|Did not qualify|0
2712665|NCT00320801|9337697|P3|Open-label Run-in Period|Did not qualify|0
2712666|NCT00320801|9337698|P2|Open-label Run-in Period|Did not qualify|0
2712667|NCT00320801|9337699|P1|Open-label Run-in Period|Did not qualify|1
2712668|NCT00320801|9337696|P4|Open-label Run-in Period|Lost to Follow-up|0
2712669|NCT00320801|9337697|P3|Open-label Run-in Period|Lost to Follow-up|0
2712670|NCT00320801|9337698|P2|Open-label Run-in Period|Lost to Follow-up|0
2712671|NCT00320801|9337699|P1|Open-label Run-in Period|Lost to Follow-up|2
2712672|NCT00320801|9337696|P4|Open-label Run-in Period|Lack of Efficacy|0
2712673|NCT00320801|9337697|P3|Open-label Run-in Period|Lack of Efficacy|0
2712674|NCT00320801|9337698|P2|Open-label Run-in Period|Lack of Efficacy|0
2712675|NCT00320801|9337699|P1|Open-label Run-in Period|Lack of Efficacy|44
2712676|NCT00320801|9337696|P4|Open-label Run-in Period|Administrative|0
2712677|NCT00320801|9337697|P3|Open-label Run-in Period|Administrative|0
2712678|NCT00320801|9337698|P2|Open-label Run-in Period|Administrative|0
2712679|NCT00320801|9337699|P1|Open-label Run-in Period|Administrative|10
2712680|NCT00320801|9337696|P4|Open-label Run-in Period|Adverse Event|0
2712681|NCT00320801|9337697|P3|Open-label Run-in Period|Adverse Event|0
2712682|NCT00320801|9337698|P2|Open-label Run-in Period|Adverse Event|0
2712683|NCT00320801|9337699|P1|Open-label Run-in Period|Adverse Event|33
2712684|NCT00320801|9337696|P4|Open-label Run-in Period|Withdrawal by Subject|0
2712685|NCT00320801|9337697|P3|Open-label Run-in Period|Withdrawal by Subject|0
2712686|NCT00320801|9337698|P2|Open-label Run-in Period|Withdrawal by Subject|0
2712687|NCT00320801|9337699|P1|Open-label Run-in Period|Withdrawal by Subject|2
2712688|NCT00320788|9337714|P5|Overall Study|Withdrawal by Subject|1
2712689|NCT00320788|9337715|P4|Overall Study|Withdrawal by Subject|3
2712690|NCT00320788|9337716|P3|Overall Study|Withdrawal by Subject|0
2712691|NCT00320788|9337717|P2|Overall Study|Withdrawal by Subject|0
2712692|NCT00320788|9337718|P1|Overall Study|Withdrawal by Subject|3
2712693|NCT00320788|9337714|P5|Overall Study|Protocol Violation|1
2712694|NCT00320788|9337715|P4|Overall Study|Protocol Violation|0
2712695|NCT00320788|9337716|P3|Overall Study|Protocol Violation|0
2712696|NCT00320788|9337717|P2|Overall Study|Protocol Violation|0
2712697|NCT00320788|9337718|P1|Overall Study|Protocol Violation|0
2712698|NCT00320788|9337714|P5|Overall Study|Physician Decision|0
2712699|NCT00320788|9337715|P4|Overall Study|Physician Decision|0
2712700|NCT00320788|9337716|P3|Overall Study|Physician Decision|0
2712701|NCT00320788|9337717|P2|Overall Study|Physician Decision|1
2712702|NCT00320788|9337718|P1|Overall Study|Physician Decision|1
2712703|NCT00320788|9337714|P5|Overall Study|Other|1
2712704|NCT00320788|9337715|P4|Overall Study|Other|1
2712705|NCT00320788|9337716|P3|Overall Study|Other|1
2712706|NCT00320788|9337717|P2|Overall Study|Other|2
2712707|NCT00320788|9337718|P1|Overall Study|Other|1
2712708|NCT00320788|9337714|P5|Overall Study|Decision by the Sponsor|1
2712709|NCT00320788|9337715|P4|Overall Study|Decision by the Sponsor|0
2712710|NCT00320788|9337716|P3|Overall Study|Decision by the Sponsor|0
2712711|NCT00320788|9337717|P2|Overall Study|Decision by the Sponsor|1
2712712|NCT00320788|9337718|P1|Overall Study|Decision by the Sponsor|1
2712713|NCT00320788|9337714|P5|Overall Study|Lost to Follow-up|0
2712714|NCT00320788|9337715|P4|Overall Study|Lost to Follow-up|0
2712715|NCT00320788|9337716|P3|Overall Study|Lost to Follow-up|1
2712716|NCT00320788|9337717|P2|Overall Study|Lost to Follow-up|2
2712717|NCT00320788|9337718|P1|Overall Study|Lost to Follow-up|0
2712718|NCT00320788|9337714|P5|Overall Study|Death|1
2712719|NCT00320788|9337715|P4|Overall Study|Death|0
2712720|NCT00320788|9337716|P3|Overall Study|Death|1
2712721|NCT00320788|9337717|P2|Overall Study|Death|0
2712722|NCT00320788|9337718|P1|Overall Study|Death|0
2712723|NCT00320788|9337714|P5|Overall Study|Adverse Event|0
2712724|NCT00320788|9337715|P4|Overall Study|Adverse Event|1
2712725|NCT00320788|9337716|P3|Overall Study|Adverse Event|0
2712726|NCT00320788|9337717|P2|Overall Study|Adverse Event|0
2712727|NCT00320788|9337718|P1|Overall Study|Adverse Event|0
2712728|NCT00320710|9337772|P3|Overall Study|Lost to Follow-up|0
2712729|NCT00320710|9337773|P2|Overall Study|Lost to Follow-up|0
2712730|NCT00320710|9337774|P1|Overall Study|Lost to Follow-up|1
2712731|NCT00320710|9337772|P3|Overall Study|Adverse Event|1
2712732|NCT00320710|9337773|P2|Overall Study|Adverse Event|14
2712733|NCT00320710|9337774|P1|Overall Study|Adverse Event|18
2712734|NCT00320710|9337772|P3|Overall Study|Abnormal laboratory value(s)|0
2712735|NCT00320710|9337773|P2|Overall Study|Abnormal laboratory value(s)|3
2712736|NCT00320710|9337774|P1|Overall Study|Abnormal laboratory value(s)|12
2712737|NCT00320710|9337772|P3|Overall Study|Abnormal test procedure result(s)|0
2712738|NCT00320710|9337773|P2|Overall Study|Abnormal test procedure result(s)|0
2712739|NCT00320710|9337774|P1|Overall Study|Abnormal test procedure result(s)|2
2712740|NCT00320710|9337772|P3|Overall Study|Protocol Violation|0
2712741|NCT00320710|9337773|P2|Overall Study|Protocol Violation|5
2712742|NCT00320710|9337774|P1|Overall Study|Protocol Violation|6
2712743|NCT00320710|9337772|P3|Overall Study|Withdrawal by Subject|1
2712744|NCT00320710|9337773|P2|Overall Study|Withdrawal by Subject|26
2712745|NCT00320710|9337774|P1|Overall Study|Withdrawal by Subject|20
2712746|NCT00320710|9337772|P3|Overall Study|Administrative problems|0
2712747|NCT00320710|9337773|P2|Overall Study|Administrative problems|2
2712748|NCT00320710|9337774|P1|Overall Study|Administrative problems|1
2712749|NCT00320710|9337772|P3|Overall Study|Death|1
2712750|NCT00320710|9337773|P2|Overall Study|Death|7
2712751|NCT00320710|9337774|P1|Overall Study|Death|10
2712752|NCT00320710|9337772|P3|Overall Study|Disease progression|2
2712753|NCT00320710|9337773|P2|Overall Study|Disease progression|19
2712754|NCT00320710|9337774|P1|Overall Study|Disease progression|24
2712755|NCT00320606|9337804|P1|Overall Study|Withdrawal by Subject|1
2712756|NCT00320606|9337804|P1|Overall Study|Protocol Violation|1
2712757|NCT00320606|9337804|P1|Overall Study|Adverse Event|1
2712758|NCT00320593|9337820|P2|Overall Study|Withdrawal by clinical center|0
2712759|NCT00320593|9337821|P1|Overall Study|Withdrawal by clinical center|1
2712760|NCT00320593|9337820|P2|Overall Study|Withdrawal by Subject|1
2712761|NCT00320593|9337821|P1|Overall Study|Withdrawal by Subject|2
2712762|NCT00320593|9337820|P2|Overall Study|Moved to another state|0
2712763|NCT00320593|9337821|P1|Overall Study|Moved to another state|1
2712764|NCT00320593|9337820|P2|Overall Study|Lost to Follow-up|0
2712765|NCT00320593|9337821|P1|Overall Study|Lost to Follow-up|3
2712766|NCT00320541|9337845|P2|Overall Study|Protocol Entry Criterion Not Met|0
2712767|NCT00320541|9337846|P1|Overall Study|Protocol Entry Criterion Not Met|1
2712768|NCT00320541|9337845|P2|Overall Study|Death due to Adverse Event(s)|0
2712769|NCT00320541|9337846|P1|Overall Study|Death due to Adverse Event(s)|1
2712770|NCT00320541|9337845|P2|Overall Study|Death due to Study Disease|3
2712771|NCT00320541|9337846|P1|Overall Study|Death due to Study Disease|1
2712772|NCT00320541|9337845|P2|Overall Study|Sponsor Decision|1
2712773|NCT00320541|9337846|P1|Overall Study|Sponsor Decision|2
2712774|NCT00320541|9337845|P2|Overall Study|Other|4
2712775|NCT00320541|9337846|P1|Overall Study|Other|3
2712776|NCT00320541|9337845|P2|Overall Study|Physician Decision|13
2712777|NCT00320541|9337846|P1|Overall Study|Physician Decision|9
2712778|NCT00320541|9337845|P2|Overall Study|Withdrawal by Subject|16
2712779|NCT00320541|9337846|P1|Overall Study|Withdrawal by Subject|12
2712780|NCT00320541|9337845|P2|Overall Study|Protocol Violation|1
2712781|NCT00320541|9337846|P1|Overall Study|Protocol Violation|0
2712782|NCT00320541|9337845|P2|Overall Study|Adverse Event|19
2712783|NCT00320541|9337846|P1|Overall Study|Adverse Event|21
2712784|NCT00320528|9337873|P3|Study Period III|Atomoxetine Commercially Available|90
2712785|NCT00320528|9337874|P2|Study Period III|Atomoxetine Commercially Available|25
2712786|NCT00320528|9337875|P1|Study Period III|Atomoxetine Commercially Available|68
2712787|NCT00320528|9337873|P3|Study Period III|Sponsor Decision|1
2712788|NCT00320528|9337874|P2|Study Period III|Sponsor Decision|0
2712789|NCT00320528|9337875|P1|Study Period III|Sponsor Decision|0
2712790|NCT00320528|9337873|P3|Study Period III|Physician Decision|2
2712791|NCT00320528|9337874|P2|Study Period III|Physician Decision|1
2712792|NCT00320528|9337875|P1|Study Period III|Physician Decision|0
2712793|NCT00320528|9337873|P3|Study Period III|Protocol Violation|0
2712794|NCT00320528|9337874|P2|Study Period III|Protocol Violation|1
2712795|NCT00320528|9337875|P1|Study Period III|Protocol Violation|0
2712796|NCT00320528|9337873|P3|Study Period III|Parent/Caregiver Decision|11
2712797|NCT00320528|9337874|P2|Study Period III|Parent/Caregiver Decision|3
2712798|NCT00320528|9337875|P1|Study Period III|Parent/Caregiver Decision|14
2712799|NCT00320528|9337873|P3|Study Period III|Lack of Efficacy|0
2712800|NCT00320528|9337874|P2|Study Period III|Lack of Efficacy|0
2712801|NCT00320528|9337875|P1|Study Period III|Lack of Efficacy|2
2712802|NCT00320528|9337873|P3|Study Period III|Withdrawal by Subject|2
2712803|NCT00320528|9337874|P2|Study Period III|Withdrawal by Subject|1
2712804|NCT00320528|9337875|P1|Study Period III|Withdrawal by Subject|1
2712805|NCT00320528|9337873|P3|Study Period III|Lost to Follow-up|0
2712806|NCT00320528|9337874|P2|Study Period III|Lost to Follow-up|0
2712807|NCT00320528|9337875|P1|Study Period III|Lost to Follow-up|1
2712808|NCT00320528|9337873|P3|Study Period III|Adverse Event|0
2712809|NCT00320528|9337874|P2|Study Period III|Adverse Event|0
2712810|NCT00320528|9337875|P1|Study Period III|Adverse Event|1
2712811|NCT00320528|9337873|P3|Study Period II|Entry Criteria Exclusion|2
2712812|NCT00320528|9337874|P2|Study Period II|Entry Criteria Exclusion|2
2712813|NCT00320528|9337875|P1|Study Period II|Entry Criteria Exclusion|0
2712814|NCT00320528|9337873|P3|Study Period II|Withdrawal by Subject|1
2712815|NCT00320528|9337874|P2|Study Period II|Withdrawal by Subject|1
2712816|NCT00320528|9337875|P1|Study Period II|Withdrawal by Subject|0
2712817|NCT00320528|9337873|P3|Study Period II|Parent/Caregiver Decision|11
2712818|NCT00320528|9337874|P2|Study Period II|Parent/Caregiver Decision|3
2712819|NCT00320528|9337875|P1|Study Period II|Parent/Caregiver Decision|8
2712820|NCT00320528|9337873|P3|Study Period II|Adverse Event|8
2712821|NCT00320528|9337874|P2|Study Period II|Adverse Event|4
2712822|NCT00320528|9337875|P1|Study Period II|Adverse Event|3
2712823|NCT00320515|9337910|P1|Overall Study|Withdrawal by Subject|8
2712824|NCT00320515|9337910|P1|Overall Study|Physician Decision|2
2712825|NCT00320515|9337910|P1|Overall Study|Lost to Follow-up|6
2712826|NCT00320515|9337910|P1|Overall Study|Death|33
2712827|NCT00320489|9337919|P2|Overall Study|Withdrawal by Subject|41
2712828|NCT00320489|9337920|P1|Overall Study|Withdrawal by Subject|39
2712829|NCT00320489|9337919|P2|Overall Study|Sponsor Decision|3
2712830|NCT00320489|9337920|P1|Overall Study|Sponsor Decision|3
2712831|NCT00320489|9337919|P2|Overall Study|Protocol Violation|4
2712832|NCT00320489|9337920|P1|Overall Study|Protocol Violation|4
2712833|NCT00320489|9337919|P2|Overall Study|Physician Decision|8
2712834|NCT00320489|9337920|P1|Overall Study|Physician Decision|8
2712835|NCT00320489|9337919|P2|Overall Study|Lost to Follow-up|22
2712836|NCT00320489|9337920|P1|Overall Study|Lost to Follow-up|21
2712837|NCT00320489|9337919|P2|Overall Study|Lack of Efficacy|7
2712838|NCT00320489|9337920|P1|Overall Study|Lack of Efficacy|16
2712839|NCT00320489|9337919|P2|Overall Study|Entry Criteria Exclusion|4
2712840|NCT00320489|9337920|P1|Overall Study|Entry Criteria Exclusion|2
2712841|NCT00320489|9337919|P2|Overall Study|Death|2
2712842|NCT00320489|9337920|P1|Overall Study|Death|0
2712843|NCT00320489|9337919|P2|Overall Study|Clinical Relapse|20
2712844|NCT00320489|9337920|P1|Overall Study|Clinical Relapse|26
2712845|NCT00320489|9337919|P2|Overall Study|Adverse Event|25
2712846|NCT00320489|9337920|P1|Overall Study|Adverse Event|26
2712847|NCT00320424|9337976|P1|Overall Study|Other|3
2712848|NCT00320424|9337976|P1|Overall Study|Adverse Event|3
2712849|NCT00320411|9337990|P1|Overall Study|No investigational product admin.|4
2712850|NCT00320398|9338013|P2|Overall Study|Other|0
2712851|NCT00320398|9338014|P1|Overall Study|Other|1
2712852|NCT00320398|9338013|P2|Overall Study|Adverse Event|4
2712853|NCT00320398|9338014|P1|Overall Study|Adverse Event|1
2712854|NCT00320385|9338042|P2|Overall Study|Adverse Event|1
2712855|NCT00320385|9338043|P1|Overall Study|Adverse Event|0
2712856|NCT00320385|9338042|P2|Overall Study|Withdrew Consent|0
2712857|NCT00320385|9338043|P1|Overall Study|Withdrew Consent|1
2712858|NCT00320385|9338042|P2|Overall Study|Serious Adverse Event|0
2712859|NCT00320385|9338043|P1|Overall Study|Serious Adverse Event|1
2712860|NCT00320385|9338042|P2|Overall Study|Death|2
2712861|NCT00320385|9338043|P1|Overall Study|Death|1
2712862|NCT00320385|9338042|P2|Overall Study|Investigator Decision|1
2712863|NCT00320385|9338043|P1|Overall Study|Investigator Decision|0
2712864|NCT00320385|9338042|P2|Overall Study|Sponsor Terminated Study|1
2712865|NCT00320385|9338043|P1|Overall Study|Sponsor Terminated Study|2
2712866|NCT00320385|9338042|P2|Overall Study|Withdrawal by Subject|7
2712867|NCT00320385|9338043|P1|Overall Study|Withdrawal by Subject|6
2712868|NCT00320385|9338042|P2|Overall Study|Lost to Follow-up|10
2712869|NCT00320385|9338043|P1|Overall Study|Lost to Follow-up|7
2712870|NCT00320372|9338066|P2|Overall Study|Other (i.e. lost to f/u, site closure)|71
2712871|NCT00320372|9338067|P1|Overall Study|Other (i.e. lost to f/u, site closure)|86
2712872|NCT00320372|9338066|P2|Overall Study|Did not Meet (I/E)|1
2712873|NCT00320372|9338067|P1|Overall Study|Did not Meet (I/E)|3
2712874|NCT00320372|9338066|P2|Overall Study|Non-Compliance|39
2712875|NCT00320372|9338067|P1|Overall Study|Non-Compliance|40
2712876|NCT00320372|9338066|P2|Overall Study|Withdrawal by Subject|37
2712877|NCT00320372|9338067|P1|Overall Study|Withdrawal by Subject|55
2712878|NCT00320372|9338066|P2|Overall Study|Death|8
2712879|NCT00320372|9338067|P1|Overall Study|Death|7
2712880|NCT00320372|9338066|P2|Overall Study|Physician Decision|7
2712881|NCT00320372|9338067|P1|Overall Study|Physician Decision|4
2712882|NCT00320255|9338107|P6|Overall Study|Other|0
2712883|NCT00320255|9338108|P5|Overall Study|Other|0
2712884|NCT00320255|9338109|P4|Overall Study|Other|0
2712885|NCT00320255|9338110|P3|Overall Study|Other|1
2712886|NCT00320255|9338111|P2|Overall Study|Other|2
2712887|NCT00320255|9338112|P1|Overall Study|Other|3
2712888|NCT00320255|9338107|P6|Overall Study|No longer meets study criteria|0
2712889|NCT00320255|9338108|P5|Overall Study|No longer meets study criteria|0
2712890|NCT00320255|9338109|P4|Overall Study|No longer meets study criteria|1
2712891|NCT00320255|9338110|P3|Overall Study|No longer meets study criteria|0
2712892|NCT00320255|9338111|P2|Overall Study|No longer meets study criteria|0
2712893|NCT00320255|9338112|P1|Overall Study|No longer meets study criteria|0
2712894|NCT00320255|9338107|P6|Overall Study|Poor compliance/noncompliance|0
2712895|NCT00320255|9338108|P5|Overall Study|Poor compliance/noncompliance|0
2712896|NCT00320255|9338109|P4|Overall Study|Poor compliance/noncompliance|1
2712897|NCT00320255|9338110|P3|Overall Study|Poor compliance/noncompliance|0
2712898|NCT00320255|9338111|P2|Overall Study|Poor compliance/noncompliance|1
2712899|NCT00320255|9338112|P1|Overall Study|Poor compliance/noncompliance|1
2712900|NCT00320255|9338107|P6|Overall Study|Withdrawal by Subject|0
2712901|NCT00320255|9338108|P5|Overall Study|Withdrawal by Subject|0
2712902|NCT00320255|9338109|P4|Overall Study|Withdrawal by Subject|4
2712903|NCT00320255|9338110|P3|Overall Study|Withdrawal by Subject|2
2712904|NCT00320255|9338111|P2|Overall Study|Withdrawal by Subject|2
2712905|NCT00320255|9338112|P1|Overall Study|Withdrawal by Subject|1
2712906|NCT00320255|9338107|P6|Overall Study|Adverse Event|0
2712907|NCT00320255|9338108|P5|Overall Study|Adverse Event|0
2712908|NCT00320255|9338109|P4|Overall Study|Adverse Event|2
2712909|NCT00320255|9338110|P3|Overall Study|Adverse Event|3
2712910|NCT00320255|9338111|P2|Overall Study|Adverse Event|2
2712911|NCT00320255|9338112|P1|Overall Study|Adverse Event|5
2712912|NCT00320255|9338107|P6|Overall Study|Lack of Efficacy|0
2712913|NCT00320255|9338108|P5|Overall Study|Lack of Efficacy|0
2712914|NCT00320255|9338109|P4|Overall Study|Lack of Efficacy|0
2712915|NCT00320255|9338110|P3|Overall Study|Lack of Efficacy|0
2712916|NCT00320255|9338111|P2|Overall Study|Lack of Efficacy|0
2712917|NCT00320255|9338112|P1|Overall Study|Lack of Efficacy|1
2712918|NCT00320216|9338205|P5|Overall Study|Other|3
2712919|NCT00320216|9338206|P4|Overall Study|Other|1
2712920|NCT00320216|9338207|P3|Overall Study|Other|5
2712921|NCT00320216|9338208|P2|Overall Study|Other|2
2712922|NCT00320216|9338209|P1|Overall Study|Other|7
2712923|NCT00320216|9338205|P5|Overall Study|Lost to Follow-up|0
2712924|NCT00320216|9338206|P4|Overall Study|Lost to Follow-up|0
2712925|NCT00320216|9338207|P3|Overall Study|Lost to Follow-up|0
2712926|NCT00320216|9338208|P2|Overall Study|Lost to Follow-up|0
2712927|NCT00320216|9338209|P1|Overall Study|Lost to Follow-up|3
2712928|NCT00320216|9338205|P5|Overall Study|Lack of Efficacy|1
2712929|NCT00320216|9338206|P4|Overall Study|Lack of Efficacy|0
2712930|NCT00320216|9338207|P3|Overall Study|Lack of Efficacy|1
2712931|NCT00320216|9338208|P2|Overall Study|Lack of Efficacy|2
2712932|NCT00320216|9338209|P1|Overall Study|Lack of Efficacy|6
2712933|NCT00320216|9338205|P5|Overall Study|Adverse Event|2
2712934|NCT00320216|9338206|P4|Overall Study|Adverse Event|2
2712935|NCT00320216|9338207|P3|Overall Study|Adverse Event|0
2712936|NCT00320216|9338208|P2|Overall Study|Adverse Event|6
2712937|NCT00320216|9338209|P1|Overall Study|Adverse Event|0
2712938|NCT00320190|9338243|P2|Long-term (12-month) Extension|Withdrawal by Subject|0
2712939|NCT00320190|9338244|P1|Long-term (12-month) Extension|Withdrawal by Subject|1
2712940|NCT00320190|9338243|P2|Long-term (12-month) Extension|Lack of major molecular response|2
2712941|NCT00320190|9338244|P1|Long-term (12-month) Extension|Lack of major molecular response|1
2712942|NCT00320190|9338243|P2|Long-term (12-month) Extension|Sponsor terminated study|0
2712943|NCT00320190|9338244|P1|Long-term (12-month) Extension|Sponsor terminated study|7
2712944|NCT00320190|9338243|P2|First 12 Months|Withdrawal by Subject|1
2712945|NCT00320190|9338244|P1|First 12 Months|Withdrawal by Subject|0
2712946|NCT00320190|9338243|P2|First 12 Months|Study drug toxicity|1
2712947|NCT00320190|9338244|P1|First 12 Months|Study drug toxicity|0
2712948|NCT00320190|9338243|P2|First 12 Months|Investigator request|1
2712949|NCT00320190|9338244|P1|First 12 Months|Investigator request|0
2712950|NCT00320190|9338243|P2|First 12 Months|Adverse event unrelated to study drug|0
2712951|NCT00320190|9338244|P1|First 12 Months|Adverse event unrelated to study drug|1
2712952|NCT00320190|9338243|P2|First 12 Months|Enrollment failure|1
2712953|NCT00320190|9338244|P1|First 12 Months|Enrollment failure|0
2712954|NCT00320190|9338243|P2|First 12 Months|Lost to Follow-up|1
2712955|NCT00320190|9338244|P1|First 12 Months|Lost to Follow-up|0
2712956|NCT00320190|9338243|P2|First 12 Months|Sponsor terminated study|2
2712957|NCT00320190|9338244|P1|First 12 Months|Sponsor terminated study|2
2712958|NCT00320190|9338243|P2|First 12 Months|Completed but did not enter extension|3
2712959|NCT00320190|9338244|P1|First 12 Months|Completed but did not enter extension|5
2712960|NCT00320112|9338264|P2|Overall Study|Death|1
2712961|NCT00320112|9338265|P1|Overall Study|Death|2
2712962|NCT00320112|9338264|P2|Overall Study|Withdrawal by Subject|0
2712963|NCT00320112|9338265|P1|Overall Study|Withdrawal by Subject|3
2712964|NCT00320112|9338264|P2|Overall Study|Lost to Follow-up|4
2712965|NCT00320112|9338265|P1|Overall Study|Lost to Follow-up|3
2712966|NCT00319982|9338279|P2|Overall Study|Withdrawal by Subject|0
2712967|NCT00319982|9338280|P1|Overall Study|Withdrawal by Subject|1
2712968|NCT00319956|9338300|P2|Overall Study|Death|24
2712969|NCT00319956|9338301|P1|Overall Study|Death|20
2712970|NCT00319839|9338313|P1|Overall Study|Withdrawal by Subject|1
2712971|NCT00319839|9338313|P1|Overall Study|Adverse Event|5
2712972|NCT00319735|9338329|P1|Overall Study|Death|2
2712973|NCT00319696|9338342|P1|Overall Study|Lost to Follow-up|3
2712974|NCT00319696|9338342|P1|Overall Study|administrative|7
2712975|NCT00319696|9338342|P1|Overall Study|withdrawal of consent|14
2712976|NCT00319696|9338342|P1|Overall Study|Adverse Event|36
2712977|NCT00319592|9338379|P2|Overall Study|Physician Decision|1
2712978|NCT00319592|9338380|P1|Overall Study|Physician Decision|0
2712979|NCT00319592|9338379|P2|Overall Study|Protocol Violation|0
2712980|NCT00319592|9338380|P1|Overall Study|Protocol Violation|1
2712981|NCT00319553|9338396|P2|Overall Study|Withdrawal by Subject|1
2712982|NCT00319553|9338397|P1|Overall Study|Withdrawal by Subject|1
2712983|NCT00319553|9338396|P2|Overall Study|Lost to Follow-up|1
2712984|NCT00319553|9338397|P1|Overall Study|Lost to Follow-up|2
2712985|NCT00319553|9338396|P2|Overall Study|Protocol Violation|2
2712986|NCT00319553|9338397|P1|Overall Study|Protocol Violation|1
2712987|NCT00319501|9338411|P2|Open-label Extension Period|Withdrawal by Subject|0
2712988|NCT00319501|9338412|P1|Open-label Extension Period|Withdrawal by Subject|2
2712989|NCT00319501|9338411|P2|Open-label Extension Period|Sponsor request|0
2712990|NCT00319501|9338412|P1|Open-label Extension Period|Sponsor request|26
2712991|NCT00319501|9338411|P2|Open-label Extension Period|Principal investigator decision|0
2712992|NCT00319501|9338412|P1|Open-label Extension Period|Principal investigator decision|2
2712993|NCT00319501|9338411|P2|Open-label Extension Period|Other|0
2712994|NCT00319501|9338412|P1|Open-label Extension Period|Other|1
2712995|NCT00319501|9338411|P2|Open-label Extension Period|Did not receive treatment|0
2712996|NCT00319501|9338412|P1|Open-label Extension Period|Did not receive treatment|18
2712997|NCT00319501|9338411|P2|Open-label Extension Period|Adverse Event|0
2712998|NCT00319501|9338412|P1|Open-label Extension Period|Adverse Event|2
2712999|NCT00319501|9338411|P2|Open-label Period|Other|0
2713000|NCT00319501|9338412|P1|Open-label Period|Other|11
2713001|NCT00319501|9338411|P2|Open-label Period|Did not receive treatment|0
2713002|NCT00319501|9338412|P1|Open-label Period|Did not receive treatment|33
2713003|NCT00319501|9338411|P2|Open-label Period|Lost to Follow-up|0
2713004|NCT00319501|9338412|P1|Open-label Period|Lost to Follow-up|5
2713005|NCT00319501|9338411|P2|Open-label Period|Sponsor request|0
2713006|NCT00319501|9338412|P1|Open-label Period|Sponsor request|12
2713007|NCT00319501|9338411|P2|Open-label Period|Principal Investigator decision|0
2713008|NCT00319501|9338412|P1|Open-label Period|Principal Investigator decision|6
2713009|NCT00319501|9338411|P2|Open-label Period|Withdrawal by Subject|0
2713010|NCT00319501|9338412|P1|Open-label Period|Withdrawal by Subject|38
2713011|NCT00319501|9338411|P2|Open-label Period|Protocol Violation|0
2713012|NCT00319501|9338412|P1|Open-label Period|Protocol Violation|6
2713013|NCT00319501|9338411|P2|Open-label Period|Adverse Event|0
2713014|NCT00319501|9338412|P1|Open-label Period|Adverse Event|5
2713015|NCT00319501|9338411|P2|Double-blind Period|Did not receive treatment|29
2713016|NCT00319501|9338412|P1|Double-blind Period|Did not receive treatment|42
2713017|NCT00319501|9338411|P2|Double-blind Period|Sponsor Request|0
2713018|NCT00319501|9338412|P1|Double-blind Period|Sponsor Request|1
2713019|NCT00319501|9338411|P2|Double-blind Period|Withdrawal by Subject|3
2713020|NCT00319501|9338412|P1|Double-blind Period|Withdrawal by Subject|0
2713021|NCT00319449|9338438|P2|Overall Study|Noncompliance with the protocol|0
2713022|NCT00319449|9338439|P1|Overall Study|Noncompliance with the protocol|1
2713023|NCT00319449|9338438|P2|Overall Study|Subject did not wish to continue|0
2713024|NCT00319449|9338439|P1|Overall Study|Subject did not wish to continue|1
2713025|NCT00319436|9338451|P2|Overall Study|Withdrawal by Subject|7
2713026|NCT00319436|9338452|P1|Overall Study|Withdrawal by Subject|6
2713027|NCT00319254|9338470|P1|Overall Study|Enrolled, Not Treated|2
2713028|NCT00319254|9338470|P1|Overall Study|Lost to Follow-up|2
2713029|NCT00319254|9338470|P1|Overall Study|Death|46
2713030|NCT00319254|9338470|P1|Overall Study|Withdrawal by Subject|4
2713031|NCT00319111|9338483|P1|Overall Study|Treatment failure|1
2713032|NCT00319111|9338483|P1|Overall Study|Administrative|2
2713033|NCT00319111|9338483|P1|Overall Study|Lack of clinical improvement|4
2713034|NCT00319111|9338483|P1|Overall Study|Death|9
2713035|NCT00319111|9338483|P1|Overall Study|Withdrawal of consent|11
2713036|NCT00319111|9338483|P1|Overall Study|Adverse Event|20
2713037|NCT00319098|9338497|P2|Overall Study|Protocol Violation|1
2713038|NCT00319098|9338498|P1|Overall Study|Protocol Violation|3
2713039|NCT00319098|9338497|P2|Overall Study|Others|8
2713040|NCT00319098|9338498|P1|Overall Study|Others|33
2713041|NCT00319098|9338497|P2|Overall Study|Lost to Follow-up|13
2713042|NCT00319098|9338498|P1|Overall Study|Lost to Follow-up|37
2713043|NCT00319098|9338497|P2|Overall Study|Migrated/moved from study area|1
2713044|NCT00319098|9338498|P1|Overall Study|Migrated/moved from study area|2
2713045|NCT00319098|9338497|P2|Overall Study|Withdrawal by Subject|8
2713046|NCT00319098|9338498|P1|Overall Study|Withdrawal by Subject|37
2713047|NCT00319098|9338497|P2|Overall Study|Adverse Event|1
2713048|NCT00319098|9338498|P1|Overall Study|Adverse Event|20
2713049|NCT00319098|9338497|P2|Overall Study|Serious adverse event|0
2713050|NCT00319098|9338498|P1|Overall Study|Serious adverse event|3
2713051|NCT00319046|9338556|P1|Overall Study|administrative reason|1
2713052|NCT00319046|9338556|P1|Overall Study|withdrawal of subject's consent|7
2713053|NCT00319020|9338565|P2|Overall Study|Adverse Event|1
2713054|NCT00319020|9338566|P1|Overall Study|Adverse Event|0
2713055|NCT00319020|9338565|P2|Overall Study|Treatment failure|1
2713056|NCT00319020|9338566|P1|Overall Study|Treatment failure|0
2713057|NCT00319020|9338565|P2|Overall Study|Transplant|1
2713058|NCT00319020|9338566|P1|Overall Study|Transplant|0
2713059|NCT00319020|9338565|P2|Overall Study|Disease progression|2
2713060|NCT00319020|9338566|P1|Overall Study|Disease progression|0
2713061|NCT00319020|9338565|P2|Overall Study|Administrative reason|5
2713062|NCT00319020|9338566|P1|Overall Study|Administrative reason|0
2713063|NCT00319020|9338565|P2|Overall Study|F-1 completed but not enrolled in F-2|0
2713064|NCT00319020|9338566|P1|Overall Study|F-1 completed but not enrolled in F-2|1
2713065|NCT00319020|9338565|P2|Overall Study|Withdrawal by Subject|1
2713066|NCT00319020|9338566|P1|Overall Study|Withdrawal by Subject|4
2713067|NCT00319020|9338565|P2|Overall Study|Death|2
2713068|NCT00319020|9338566|P1|Overall Study|Death|2
2713069|NCT00318656|9338638|P2|Overall Study|Did not receive any treatment|1
2713070|NCT00318656|9338639|P1|Overall Study|Did not receive any treatment|0
2713071|NCT00318656|9338638|P2|Overall Study|Took Avandamet instead of Glim/Met|1
2713072|NCT00318656|9338639|P1|Overall Study|Took Avandamet instead of Glim/Met|0
2713073|NCT00318565|9338696|P1|Overall Study|Excluded per protocol|24
2713074|NCT00318474|9338703|P2|Overall Study|Trial terminated|7
2713075|NCT00318474|9338704|P1|Overall Study|Trial terminated|10
2713076|NCT00318474|9338703|P2|Overall Study|Post-therapy hyperflycemia|1
2713077|NCT00318474|9338704|P1|Overall Study|Post-therapy hyperflycemia|0
2713078|NCT00318474|9338703|P2|Overall Study|Fall in GFR|3
2713079|NCT00318474|9338704|P1|Overall Study|Fall in GFR|3
2713080|NCT00318474|9338703|P2|Overall Study|Withdrawal by Subject|2
2713081|NCT00318474|9338704|P1|Overall Study|Withdrawal by Subject|3
2713082|NCT00318474|9338703|P2|Overall Study|Protocol Violation|0
2713083|NCT00318474|9338704|P1|Overall Study|Protocol Violation|1
2713084|NCT00318474|9338703|P2|Overall Study|Pregnancy|2
2713085|NCT00318474|9338704|P1|Overall Study|Pregnancy|0
2713086|NCT00318474|9338703|P2|Overall Study|Lost to Follow-up|1
2713087|NCT00318474|9338704|P1|Overall Study|Lost to Follow-up|0
2713088|NCT00318474|9338703|P2|Overall Study|Adverse Event|1
2713089|NCT00318474|9338704|P1|Overall Study|Adverse Event|1
2713090|NCT00318461|9338715|P5|Open-Label Extension, 18 Months|Protocol Violation|6
2713091|NCT00318461|9338716|P4|Open-Label Extension, 18 Months|Protocol Violation|4
2713092|NCT00318461|9338717|P3|Open-Label Extension, 18 Months|Protocol Violation|3
2713093|NCT00318461|9338718|P2|Open-Label Extension, 18 Months|Protocol Violation|5
2713094|NCT00318461|9338719|P1|Open-Label Extension, 18 Months|Protocol Violation|7
2713095|NCT00318461|9338715|P5|Open-Label Extension, 18 Months|Lack of Efficacy|63
2713096|NCT00318461|9338716|P4|Open-Label Extension, 18 Months|Lack of Efficacy|27
2713097|NCT00318461|9338717|P3|Open-Label Extension, 18 Months|Lack of Efficacy|37
2713098|NCT00318461|9338718|P2|Open-Label Extension, 18 Months|Lack of Efficacy|33
2713099|NCT00318461|9338719|P1|Open-Label Extension, 18 Months|Lack of Efficacy|41
2713100|NCT00318461|9338715|P5|Open-Label Extension, 18 Months|Adverse Event|6
2713101|NCT00318461|9338716|P4|Open-Label Extension, 18 Months|Adverse Event|1
2713102|NCT00318461|9338717|P3|Open-Label Extension, 18 Months|Adverse Event|6
2713103|NCT00318461|9338718|P2|Open-Label Extension, 18 Months|Adverse Event|8
2713104|NCT00318461|9338719|P1|Open-Label Extension, 18 Months|Adverse Event|11
2713105|NCT00318461|9338715|P5|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22
2713106|NCT00318461|9338716|P4|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11
2713107|NCT00318461|9338717|P3|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27
2713108|NCT00318461|9338718|P2|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14
2713109|NCT00318461|9338719|P1|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19
2713110|NCT00318461|9338715|P5|Double-Blind, 6 Months|Fear of experiencing AE again|0
2713111|NCT00318461|9338716|P4|Double-Blind, 6 Months|Fear of experiencing AE again|0
2713112|NCT00318461|9338717|P3|Double-Blind, 6 Months|Fear of experiencing AE again|0
2713113|NCT00318461|9338718|P2|Double-Blind, 6 Months|Fear of experiencing AE again|1
2713114|NCT00318461|9338719|P1|Double-Blind, 6 Months|Fear of experiencing AE again|0
2713115|NCT00318461|9338715|P5|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1
2713116|NCT00318461|9338716|P4|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
2713117|NCT00318461|9338717|P3|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
2713118|NCT00318461|9338718|P2|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
2713119|NCT00318461|9338719|P1|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
2713120|NCT00318461|9338715|P5|Double-Blind, 6 Months|Hyperglicaemia|0
2713121|NCT00318461|9338716|P4|Double-Blind, 6 Months|Hyperglicaemia|1
2713122|NCT00318461|9338717|P3|Double-Blind, 6 Months|Hyperglicaemia|0
2713123|NCT00318461|9338718|P2|Double-Blind, 6 Months|Hyperglicaemia|0
2713124|NCT00318461|9338719|P1|Double-Blind, 6 Months|Hyperglicaemia|0
2713125|NCT00318461|9338715|P5|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2
2713126|NCT00318461|9338716|P4|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
2713127|NCT00318461|9338717|P3|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
2713128|NCT00318461|9338718|P2|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
2713129|NCT00318461|9338719|P1|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
2713130|NCT00318461|9338715|P5|Double-Blind, 6 Months|Lack of time|0
2713131|NCT00318461|9338716|P4|Double-Blind, 6 Months|Lack of time|0
2713132|NCT00318461|9338717|P3|Double-Blind, 6 Months|Lack of time|0
2713133|NCT00318461|9338718|P2|Double-Blind, 6 Months|Lack of time|0
2713134|NCT00318461|9338719|P1|Double-Blind, 6 Months|Lack of time|1
2713135|NCT00318461|9338715|P5|Double-Blind, 6 Months|Investigator decision|1
2713136|NCT00318461|9338716|P4|Double-Blind, 6 Months|Investigator decision|0
2713137|NCT00318461|9338717|P3|Double-Blind, 6 Months|Investigator decision|0
2713138|NCT00318461|9338718|P2|Double-Blind, 6 Months|Investigator decision|0
2713139|NCT00318461|9338719|P1|Double-Blind, 6 Months|Investigator decision|0
2713140|NCT00318461|9338715|P5|Double-Blind, 6 Months|Work commitment|1
2713141|NCT00318461|9338716|P4|Double-Blind, 6 Months|Work commitment|0
2713142|NCT00318461|9338717|P3|Double-Blind, 6 Months|Work commitment|0
2713143|NCT00318461|9338718|P2|Double-Blind, 6 Months|Work commitment|0
2713144|NCT00318461|9338719|P1|Double-Blind, 6 Months|Work commitment|0
2713145|NCT00318461|9338715|P5|Double-Blind, 6 Months|FPG exceeds limits/too high|0
2713146|NCT00318461|9338716|P4|Double-Blind, 6 Months|FPG exceeds limits/too high|2
2713147|NCT00318461|9338717|P3|Double-Blind, 6 Months|FPG exceeds limits/too high|0
2713148|NCT00318461|9338718|P2|Double-Blind, 6 Months|FPG exceeds limits/too high|0
2713149|NCT00318461|9338719|P1|Double-Blind, 6 Months|FPG exceeds limits/too high|1
2713150|NCT00318461|9338715|P5|Double-Blind, 6 Months|Tendency to low blood glucose levels|1
2713151|NCT00318461|9338716|P4|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
2713152|NCT00318461|9338717|P3|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
2713153|NCT00318461|9338718|P2|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
2713242|NCT00318149|9338859|P1|Overall Study|Adverse Event|0
2713154|NCT00318461|9338719|P1|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
2713155|NCT00318461|9338715|P5|Double-Blind, 6 Months|Move|0
2713156|NCT00318461|9338716|P4|Double-Blind, 6 Months|Move|0
2713157|NCT00318461|9338717|P3|Double-Blind, 6 Months|Move|0
2713158|NCT00318461|9338718|P2|Double-Blind, 6 Months|Move|1
2713159|NCT00318461|9338719|P1|Double-Blind, 6 Months|Move|0
2713160|NCT00318461|9338715|P5|Double-Blind, 6 Months|Subject decision/No wish to continue|2
2713161|NCT00318461|9338716|P4|Double-Blind, 6 Months|Subject decision/No wish to continue|0
2713162|NCT00318461|9338717|P3|Double-Blind, 6 Months|Subject decision/No wish to continue|1
2713163|NCT00318461|9338718|P2|Double-Blind, 6 Months|Subject decision/No wish to continue|2
2713164|NCT00318461|9338719|P1|Double-Blind, 6 Months|Subject decision/No wish to continue|0
2713165|NCT00318461|9338715|P5|Double-Blind, 6 Months|Consent withdrawn|4
2713166|NCT00318461|9338716|P4|Double-Blind, 6 Months|Consent withdrawn|10
2713167|NCT00318461|9338717|P3|Double-Blind, 6 Months|Consent withdrawn|4
2713168|NCT00318461|9338718|P2|Double-Blind, 6 Months|Consent withdrawn|3
2713169|NCT00318461|9338719|P1|Double-Blind, 6 Months|Consent withdrawn|0
2713170|NCT00318461|9338715|P5|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
2713171|NCT00318461|9338716|P4|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
2713172|NCT00318461|9338717|P3|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
2713173|NCT00318461|9338718|P2|Double-Blind, 6 Months|Poor compliance/Non-compliance|1
2713174|NCT00318461|9338719|P1|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
2713175|NCT00318461|9338715|P5|Double-Blind, 6 Months|Lost to follow up|0
2713176|NCT00318461|9338716|P4|Double-Blind, 6 Months|Lost to follow up|0
2713177|NCT00318461|9338717|P3|Double-Blind, 6 Months|Lost to follow up|0
2713178|NCT00318461|9338718|P2|Double-Blind, 6 Months|Lost to follow up|1
2713179|NCT00318461|9338719|P1|Double-Blind, 6 Months|Lost to follow up|0
2713180|NCT00318461|9338715|P5|Double-Blind, 6 Months|Protocol Violation|5
2713181|NCT00318461|9338716|P4|Double-Blind, 6 Months|Protocol Violation|4
2713182|NCT00318461|9338717|P3|Double-Blind, 6 Months|Protocol Violation|4
2713183|NCT00318461|9338718|P2|Double-Blind, 6 Months|Protocol Violation|4
2713184|NCT00318461|9338719|P1|Double-Blind, 6 Months|Protocol Violation|2
2713185|NCT00318461|9338715|P5|Double-Blind, 6 Months|Lack of Efficacy|9
2713186|NCT00318461|9338716|P4|Double-Blind, 6 Months|Lack of Efficacy|29
2713187|NCT00318461|9338717|P3|Double-Blind, 6 Months|Lack of Efficacy|13
2713188|NCT00318461|9338718|P2|Double-Blind, 6 Months|Lack of Efficacy|8
2713189|NCT00318461|9338719|P1|Double-Blind, 6 Months|Lack of Efficacy|19
2713190|NCT00318461|9338715|P5|Double-Blind, 6 Months|Adverse Event|8
2713191|NCT00318461|9338716|P4|Double-Blind, 6 Months|Adverse Event|2
2713192|NCT00318461|9338717|P3|Double-Blind, 6 Months|Adverse Event|29
2713193|NCT00318461|9338718|P2|Double-Blind, 6 Months|Adverse Event|23
2713194|NCT00318461|9338719|P1|Double-Blind, 6 Months|Adverse Event|11
2713195|NCT00318370|9338818|P3|Period 3|Other|3
2713196|NCT00318370|9338819|P2|Period 3|Other|0
2713197|NCT00318370|9338820|P1|Period 3|Other|0
2713198|NCT00318370|9338818|P3|Period 3|Withdrawal by Subject|3
2713199|NCT00318370|9338819|P2|Period 3|Withdrawal by Subject|0
2713200|NCT00318370|9338820|P1|Period 3|Withdrawal by Subject|0
2713201|NCT00318370|9338818|P3|Period 3|Physician Decision|1
2713202|NCT00318370|9338819|P2|Period 3|Physician Decision|0
2713203|NCT00318370|9338820|P1|Period 3|Physician Decision|0
2713204|NCT00318370|9338818|P3|Period 3|Death|1
2713205|NCT00318370|9338819|P2|Period 3|Death|0
2713206|NCT00318370|9338820|P1|Period 3|Death|0
2713207|NCT00318370|9338818|P3|Period 3|Lack of Efficacy|24
2713208|NCT00318370|9338819|P2|Period 3|Lack of Efficacy|0
2713209|NCT00318370|9338820|P1|Period 3|Lack of Efficacy|0
2713210|NCT00318370|9338818|P3|Period 3|Adverse Event|1
2713211|NCT00318370|9338819|P2|Period 3|Adverse Event|0
2713212|NCT00318370|9338820|P1|Period 3|Adverse Event|0
2713213|NCT00318370|9338818|P3|Period 2|Other|0
2713214|NCT00318370|9338819|P2|Period 2|Other|1
2713215|NCT00318370|9338820|P1|Period 2|Other|0
2713216|NCT00318370|9338818|P3|Period 2|Withdrawal by Subject|0
2713217|NCT00318370|9338819|P2|Period 2|Withdrawal by Subject|1
2713218|NCT00318370|9338820|P1|Period 2|Withdrawal by Subject|0
2713219|NCT00318370|9338818|P3|Period 2|Physician Decision|0
2713220|NCT00318370|9338819|P2|Period 2|Physician Decision|1
2713221|NCT00318370|9338820|P1|Period 2|Physician Decision|0
2713222|NCT00318370|9338818|P3|Period 2|Lack of Efficacy|0
2713223|NCT00318370|9338819|P2|Period 2|Lack of Efficacy|5
2713224|NCT00318370|9338820|P1|Period 2|Lack of Efficacy|0
2713225|NCT00318370|9338818|P3|Period 2|Adverse Event|0
2713226|NCT00318370|9338819|P2|Period 2|Adverse Event|3
2713227|NCT00318370|9338820|P1|Period 2|Adverse Event|0
2713228|NCT00318370|9338818|P3|Period 1|Withdrawal by Subject|0
2713229|NCT00318370|9338819|P2|Period 1|Withdrawal by Subject|0
2713230|NCT00318370|9338820|P1|Period 1|Withdrawal by Subject|1
2713231|NCT00318370|9338818|P3|Period 1|Physician Decision|0
2713232|NCT00318370|9338819|P2|Period 1|Physician Decision|0
2713233|NCT00318370|9338820|P1|Period 1|Physician Decision|1
2713234|NCT00318370|9338818|P3|Period 1|Lack of Efficacy|0
2713235|NCT00318370|9338819|P2|Period 1|Lack of Efficacy|0
2713236|NCT00318370|9338820|P1|Period 1|Lack of Efficacy|5
2713237|NCT00318149|9338854|P6|Overall Study|Adverse Event|2
2713238|NCT00318149|9338855|P5|Overall Study|Adverse Event|0
2713239|NCT00318149|9338856|P4|Overall Study|Adverse Event|0
2713240|NCT00318149|9338857|P3|Overall Study|Adverse Event|0
2713241|NCT00318149|9338858|P2|Overall Study|Adverse Event|0
2713243|NCT00317642|9339005|P2|Overall Study|AML Not Centrally Confirmed|5
2713244|NCT00317642|9339006|P1|Overall Study|AML Not Centrally Confirmed|1
2713245|NCT00317642|9339005|P2|Overall Study|Referred For Transplantation|0
2713246|NCT00317642|9339006|P1|Overall Study|Referred For Transplantation|1
2713247|NCT00317642|9339005|P2|Overall Study|Withdrawal by Subject|1
2713248|NCT00317642|9339006|P1|Overall Study|Withdrawal by Subject|0
2713249|NCT00317642|9339005|P2|Overall Study|Not Continue to Consolidation|0
2713250|NCT00317642|9339006|P1|Overall Study|Not Continue to Consolidation|2
2713251|NCT00317642|9339005|P2|Overall Study|Death|7
2713252|NCT00317642|9339006|P1|Overall Study|Death|14
2713253|NCT00317642|9339005|P2|Overall Study|Disease Recurrence|2
2713254|NCT00317642|9339006|P1|Overall Study|Disease Recurrence|1
2713255|NCT00317642|9339005|P2|Overall Study|Treatment Failure|102
2713256|NCT00317642|9339006|P1|Overall Study|Treatment Failure|56
2713257|NCT00317642|9339005|P2|Overall Study|Adverse Event|5
2713258|NCT00317642|9339006|P1|Overall Study|Adverse Event|17
2713259|NCT00317642|9339005|P2|Overall Study|Participant declined treatment|3
2713260|NCT00317642|9339006|P1|Overall Study|Participant declined treatment|14
2713261|NCT00317642|9339005|P2|Overall Study|Physician Decision|7
2713262|NCT00317642|9339006|P1|Overall Study|Physician Decision|15
2713263|NCT00317642|9339005|P2|Overall Study|Not Received Either Study Drug|3
2713264|NCT00317642|9339006|P1|Overall Study|Not Received Either Study Drug|1
2713265|NCT00317473|9339085|P6|Overall Study|Other|0
2713266|NCT00317473|9339086|P5|Overall Study|Other|0
2713267|NCT00317473|9339087|P4|Overall Study|Other|0
2713268|NCT00317473|9339088|P3|Overall Study|Other|0
2713269|NCT00317473|9339089|P2|Overall Study|Other|2
2713270|NCT00317473|9339090|P1|Overall Study|Other|0
2713271|NCT00317473|9339085|P6|Overall Study|Death|0
2713272|NCT00317473|9339086|P5|Overall Study|Death|0
2713273|NCT00317473|9339087|P4|Overall Study|Death|0
2713274|NCT00317473|9339088|P3|Overall Study|Death|0
2713275|NCT00317473|9339089|P2|Overall Study|Death|0
2713276|NCT00317473|9339090|P1|Overall Study|Death|1
2713277|NCT00317473|9339085|P6|Overall Study|Relocation|2
2713278|NCT00317473|9339086|P5|Overall Study|Relocation|5
2713279|NCT00317473|9339087|P4|Overall Study|Relocation|1
2713280|NCT00317473|9339088|P3|Overall Study|Relocation|1
2713281|NCT00317473|9339089|P2|Overall Study|Relocation|0
2713282|NCT00317473|9339090|P1|Overall Study|Relocation|1
2713283|NCT00317473|9339085|P6|Overall Study|Withdrawal by Subject|1
2713284|NCT00317473|9339086|P5|Overall Study|Withdrawal by Subject|3
2713285|NCT00317473|9339087|P4|Overall Study|Withdrawal by Subject|1
2713286|NCT00317473|9339088|P3|Overall Study|Withdrawal by Subject|2
2713287|NCT00317473|9339089|P2|Overall Study|Withdrawal by Subject|1
2713288|NCT00317473|9339090|P1|Overall Study|Withdrawal by Subject|2
2713289|NCT00317109|9339129|P2|Overall Study|Migated/moved from study area|0
2713290|NCT00317109|9339130|P1|Overall Study|Migated/moved from study area|1
2713291|NCT00317109|9339129|P2|Overall Study|Withdrawal by Subject|0
2713292|NCT00317109|9339130|P1|Overall Study|Withdrawal by Subject|2
2713293|NCT00317044|9339167|P3|Overall Study|Multiple Reasons|6
2713294|NCT00317044|9339168|P2|Overall Study|Multiple Reasons|2
2713295|NCT00317044|9339169|P1|Overall Study|Multiple Reasons|6
2713296|NCT00317044|9339167|P3|Overall Study|Lost to Follow-up|3
2713297|NCT00317044|9339168|P2|Overall Study|Lost to Follow-up|2
2713298|NCT00317044|9339169|P1|Overall Study|Lost to Follow-up|0
2713299|NCT00317044|9339167|P3|Overall Study|Withdrawal by Subject|12
2713300|NCT00317044|9339168|P2|Overall Study|Withdrawal by Subject|7
2713301|NCT00317044|9339169|P1|Overall Study|Withdrawal by Subject|10
2713302|NCT00317044|9339167|P3|Overall Study|Adverse Event|4
2713303|NCT00317044|9339168|P2|Overall Study|Adverse Event|7
2713304|NCT00317044|9339169|P1|Overall Study|Adverse Event|4
2713305|NCT00317044|9339167|P3|Overall Study|Protocol Violation|20
2713306|NCT00317044|9339168|P2|Overall Study|Protocol Violation|22
2713307|NCT00317044|9339169|P1|Overall Study|Protocol Violation|28
2713308|NCT00316914|9339215|P2|Overall Study|Missing end of treatment documentation|15
2713309|NCT00316914|9339216|P1|Overall Study|Missing end of treatment documentation|14
2713310|NCT00316914|9339215|P2|Overall Study|Other Problems|11
2713311|NCT00316914|9339216|P1|Overall Study|Other Problems|6
2713312|NCT00316914|9339215|P2|Overall Study|Adverse Event|7
2713313|NCT00316914|9339216|P1|Overall Study|Adverse Event|8
2713314|NCT00316914|9339215|P2|Overall Study|Withdrawal by Subject|3
2713315|NCT00316914|9339216|P1|Overall Study|Withdrawal by Subject|5
2713316|NCT00316888|9339246|P2|Overall Study|Not start protocol therapy|1
2713317|NCT00316888|9339247|P1|Overall Study|Not start protocol therapy|0
2713318|NCT00316888|9339246|P2|Overall Study|Withdrawal by Subject|2
2713319|NCT00316888|9339247|P1|Overall Study|Withdrawal by Subject|2
2713320|NCT00316888|9339246|P2|Overall Study|Adverse Event|5
2713321|NCT00316888|9339247|P1|Overall Study|Adverse Event|4
2713322|NCT00316719|9339269|P2|Overall Study|Consent withdrawn|0
2713323|NCT00316719|9339270|P1|Overall Study|Consent withdrawn|2
2713324|NCT00316719|9339269|P2|Overall Study|Adverse Event|6
2713325|NCT00316719|9339270|P1|Overall Study|Adverse Event|0
2713326|NCT00316706|9339296|P2|Overall Study|Lost to Follow-up|48
2713327|NCT00316706|9339297|P1|Overall Study|Lost to Follow-up|38
2713328|NCT00316693|9339313|P2|Overall Study|Other|44
2713329|NCT00316693|9339314|P1|Overall Study|Other|38
2713330|NCT00316693|9339313|P2|Overall Study|Lost to Follow-up|34
2713331|NCT00316693|9339314|P1|Overall Study|Lost to Follow-up|26
2713332|NCT00316693|9339313|P2|Overall Study|Withdrawal by Subject|6
2713333|NCT00316693|9339314|P1|Overall Study|Withdrawal by Subject|6
2713334|NCT00316693|9339313|P2|Overall Study|Protocol Violation|0
2713335|NCT00316693|9339314|P1|Overall Study|Protocol Violation|1
2713336|NCT00316693|9339313|P2|Overall Study|Adverse Event|1
2713337|NCT00316693|9339314|P1|Overall Study|Adverse Event|6
2713338|NCT00316602|9339356|P2|Overall Study|Other|6
2713339|NCT00316602|9339357|P1|Overall Study|Other|3
2713340|NCT00316602|9339356|P2|Overall Study|Adverse Event|0
2713341|NCT00316602|9339357|P1|Overall Study|Adverse Event|1
2713342|NCT00316602|9339356|P2|Overall Study|Subject unwilling/unable to comply with|17
2713343|NCT00316602|9339357|P1|Overall Study|Subject unwilling/unable to comply with|3
2713344|NCT00316602|9339356|P2|Overall Study|Withdrawal by Subject|2
2713345|NCT00316602|9339357|P1|Overall Study|Withdrawal by Subject|3
2713346|NCT00316589|9339389|P4|Overall Study|Other reason|1
2713347|NCT00316589|9339390|P3|Overall Study|Other reason|1
2713348|NCT00316589|9339391|P2|Overall Study|Other reason|12
2713349|NCT00316589|9339392|P1|Overall Study|Other reason|0
2713350|NCT00316589|9339389|P4|Overall Study|Physician Decision|0
2713351|NCT00316589|9339390|P3|Overall Study|Physician Decision|0
2713352|NCT00316589|9339391|P2|Overall Study|Physician Decision|1
2713353|NCT00316589|9339392|P1|Overall Study|Physician Decision|0
2713354|NCT00316589|9339389|P4|Overall Study|Adverse Event|1
2713355|NCT00316589|9339390|P3|Overall Study|Adverse Event|0
2713356|NCT00316589|9339391|P2|Overall Study|Adverse Event|0
2713357|NCT00316589|9339392|P1|Overall Study|Adverse Event|1
2713358|NCT00316589|9339389|P4|Overall Study|Subject unwilling/unable to comply|2
2713359|NCT00316589|9339390|P3|Overall Study|Subject unwilling/unable to comply|0
2713360|NCT00316589|9339391|P2|Overall Study|Subject unwilling/unable to comply|6
2713361|NCT00316589|9339392|P1|Overall Study|Subject unwilling/unable to comply|0
2713362|NCT00316589|9339389|P4|Overall Study|Withdrawal by Subject|1
2713363|NCT00316589|9339390|P3|Overall Study|Withdrawal by Subject|0
2713364|NCT00316589|9339391|P2|Overall Study|Withdrawal by Subject|5
2713365|NCT00316589|9339392|P1|Overall Study|Withdrawal by Subject|0
2713366|NCT00316303|9339526|P2|Overall Study|Lost to Follow-up|16
2713367|NCT00316303|9339527|P1|Overall Study|Lost to Follow-up|11
2713368|NCT00316277|9339543|P2|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1
2713369|NCT00316277|9339544|P1|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0
2713370|NCT00316277|9339543|P2|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18
2713371|NCT00316277|9339544|P1|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19
2713372|NCT00316277|9339543|P2|Phase 1 (12 Weeks)|Eligible for Phase 2|225
2713373|NCT00316277|9339544|P1|Phase 1 (12 Weeks)|Eligible for Phase 2|220
2713374|NCT00316277|9339543|P2|Phase 1 (12 Weeks)|Investigator-initiated termination|0
2713375|NCT00316277|9339544|P1|Phase 1 (12 Weeks)|Investigator-initiated termination|2
2713376|NCT00316277|9339543|P2|Phase 1 (12 Weeks)|Lost to Follow-up|75
2713377|NCT00316277|9339544|P1|Phase 1 (12 Weeks)|Lost to Follow-up|88
2713378|NCT00316264|9339565|P3|Overall Study|Other|0
2713379|NCT00316264|9339566|P2|Overall Study|Other|1
2713380|NCT00316264|9339567|P1|Overall Study|Other|1
2713381|NCT00316264|9339565|P3|Overall Study|Death|0
2713382|NCT00316264|9339566|P2|Overall Study|Death|0
2713383|NCT00316264|9339567|P1|Overall Study|Death|2
2713384|NCT00316264|9339565|P3|Overall Study|Withdrawal of Consent|6
2713385|NCT00316264|9339566|P2|Overall Study|Withdrawal of Consent|5
2713386|NCT00316264|9339567|P1|Overall Study|Withdrawal of Consent|3
2713387|NCT00316264|9339565|P3|Overall Study|Lost to Follow-up|0
2713388|NCT00316264|9339566|P2|Overall Study|Lost to Follow-up|1
2713389|NCT00316264|9339567|P1|Overall Study|Lost to Follow-up|0
2713390|NCT00316225|9339635|P1|Overall Study|Death|2
2713391|NCT00316225|9339635|P1|Overall Study|Withdrawal by Subject|3
2713392|NCT00316225|9339635|P1|Overall Study|Progressive Disease|15
2713393|NCT00316225|9339635|P1|Overall Study|Physician Decision|3
2713394|NCT00316225|9339635|P1|Overall Study|Adverse Event|2
2713395|NCT00316199|9339644|P1|Overall Study|Lost to Follow-up|2
2713396|NCT00316199|9339644|P1|Overall Study|Death|8
2713397|NCT00316199|9339644|P1|Overall Study|Adverse Event|2
2713398|NCT00316186|9339652|P1|Overall Study|Other|1
2713399|NCT00316186|9339652|P1|Overall Study|Lost to Follow-up|1
2713400|NCT00316186|9339652|P1|Overall Study|Disease Progression|4
2713401|NCT00316186|9339652|P1|Overall Study|Adverse Event|6
2713402|NCT00316173|9339666|P2|Treatment Phase|Study Follow-up Stopped|34
2713403|NCT00316173|9339667|P1|Treatment Phase|Study Follow-up Stopped|0
2713404|NCT00316173|9339666|P2|Treatment Phase|Withdrawal by Subject|1
2713405|NCT00316173|9339667|P1|Treatment Phase|Withdrawal by Subject|0
2713406|NCT00316173|9339666|P2|Treatment Phase|Lost to Follow-up|3
2713407|NCT00316173|9339667|P1|Treatment Phase|Lost to Follow-up|0
2713408|NCT00316173|9339666|P2|Treatment Phase|Lack of Efficacy|3
2713409|NCT00316173|9339667|P1|Treatment Phase|Lack of Efficacy|0
2713410|NCT00316173|9339666|P2|Treatment Phase|Adverse Event|1
2713411|NCT00316173|9339667|P1|Treatment Phase|Adverse Event|0
2713412|NCT00316173|9339666|P2|Run-in Phase|Study Follow-up Stopped|0
2713413|NCT00316173|9339667|P1|Run-in Phase|Study Follow-up Stopped|5
2713414|NCT00316173|9339666|P2|Run-in Phase|Protocol Violation|0
2713415|NCT00316173|9339667|P1|Run-in Phase|Protocol Violation|1
2713416|NCT00316173|9339666|P2|Run-in Phase|Adverse Event|0
2713417|NCT00316173|9339667|P1|Run-in Phase|Adverse Event|1
2713418|NCT00316121|9339680|P2|Overall Study|Subject did not have 24 month visit|0
2713419|NCT00316121|9339681|P1|Overall Study|Subject did not have 24 month visit|1
2713420|NCT00316121|9339680|P2|Overall Study|Subject no show for visit x 3|0
2713421|NCT00316121|9339681|P1|Overall Study|Subject no show for visit x 3|1
2713422|NCT00316121|9339680|P2|Overall Study|Subject refused to return|0
2713423|NCT00316121|9339681|P1|Overall Study|Subject refused to return|1
2713424|NCT00316121|9339680|P2|Overall Study|Subject relocated|1
2713425|NCT00316121|9339681|P1|Overall Study|Subject relocated|1
2713426|NCT00316121|9339680|P2|Overall Study|Reason is missing|0
2713427|NCT00316121|9339681|P1|Overall Study|Reason is missing|1
2713428|NCT00316121|9339680|P2|Overall Study|Withdrawal by Subject|0
2713429|NCT00316121|9339681|P1|Overall Study|Withdrawal by Subject|2
2713430|NCT00316121|9339680|P2|Overall Study|Lost to Follow-up|8
2713431|NCT00316121|9339681|P1|Overall Study|Lost to Follow-up|14
2713432|NCT00316121|9339680|P2|Overall Study|Death|0
2713433|NCT00316121|9339681|P1|Overall Study|Death|1
2713434|NCT00316082|9339692|P5|Overall Study|Administrative reason by sponsor|0
2713435|NCT00316082|9339693|P4|Overall Study|Administrative reason by sponsor|0
2713436|NCT00316082|9339694|P3|Overall Study|Administrative reason by sponsor|1
2713437|NCT00316082|9339695|P2|Overall Study|Administrative reason by sponsor|0
2713438|NCT00316082|9339696|P1|Overall Study|Administrative reason by sponsor|0
2713439|NCT00316082|9339692|P5|Overall Study|Death|0
2713440|NCT00316082|9339693|P4|Overall Study|Death|0
2713441|NCT00316082|9339694|P3|Overall Study|Death|1
2713442|NCT00316082|9339695|P2|Overall Study|Death|0
2713443|NCT00316082|9339696|P1|Overall Study|Death|0
2713444|NCT00316082|9339692|P5|Overall Study|Physician Decision|1
2713445|NCT00316082|9339693|P4|Overall Study|Physician Decision|1
2713446|NCT00316082|9339694|P3|Overall Study|Physician Decision|2
2713447|NCT00316082|9339695|P2|Overall Study|Physician Decision|1
2713448|NCT00316082|9339696|P1|Overall Study|Physician Decision|1
2713449|NCT00316082|9339692|P5|Overall Study|Subject no longer meets study criteria|1
2713450|NCT00316082|9339693|P4|Overall Study|Subject no longer meets study criteria|2
2713451|NCT00316082|9339694|P3|Overall Study|Subject no longer meets study criteria|2
2713452|NCT00316082|9339695|P2|Overall Study|Subject no longer meets study criteria|1
2713453|NCT00316082|9339696|P1|Overall Study|Subject no longer meets study criteria|3
2713454|NCT00316082|9339692|P5|Overall Study|Adverse Event|3
2713455|NCT00316082|9339693|P4|Overall Study|Adverse Event|1
2713456|NCT00316082|9339694|P3|Overall Study|Adverse Event|5
2713457|NCT00316082|9339695|P2|Overall Study|Adverse Event|2
2713458|NCT00316082|9339696|P1|Overall Study|Adverse Event|4
2713459|NCT00316082|9339692|P5|Overall Study|Poor/noncompliance|4
2713460|NCT00316082|9339693|P4|Overall Study|Poor/noncompliance|1
2713461|NCT00316082|9339694|P3|Overall Study|Poor/noncompliance|4
2713462|NCT00316082|9339695|P2|Overall Study|Poor/noncompliance|1
2713463|NCT00316082|9339696|P1|Overall Study|Poor/noncompliance|6
2713464|NCT00316082|9339692|P5|Overall Study|Lost to Follow-up|6
2713465|NCT00316082|9339693|P4|Overall Study|Lost to Follow-up|8
2713466|NCT00316082|9339694|P3|Overall Study|Lost to Follow-up|7
2713467|NCT00316082|9339695|P2|Overall Study|Lost to Follow-up|6
2713468|NCT00316082|9339696|P1|Overall Study|Lost to Follow-up|7
2713469|NCT00316082|9339692|P5|Overall Study|Withdrawal of Consent by Subject|5
2713470|NCT00316082|9339693|P4|Overall Study|Withdrawal of Consent by Subject|9
2713471|NCT00316082|9339694|P3|Overall Study|Withdrawal of Consent by Subject|2
2713472|NCT00316082|9339695|P2|Overall Study|Withdrawal of Consent by Subject|8
2713473|NCT00316082|9339696|P1|Overall Study|Withdrawal of Consent by Subject|10
2713474|NCT00316082|9339692|P5|Overall Study|Lack of Efficacy|6
2713475|NCT00316082|9339693|P4|Overall Study|Lack of Efficacy|4
2713476|NCT00316082|9339694|P3|Overall Study|Lack of Efficacy|3
2713477|NCT00316082|9339695|P2|Overall Study|Lack of Efficacy|3
2713478|NCT00316082|9339696|P1|Overall Study|Lack of Efficacy|2
2713479|NCT00316017|9339727|P3|Overall Study|Protocol Violation|19
2713480|NCT00316017|9339728|P2|Overall Study|Protocol Violation|13
2713481|NCT00316017|9339729|P1|Overall Study|Protocol Violation|11
2713482|NCT00316004|9339803|P3|Overall Study|Subject was not given study fluid.|21
2713483|NCT00316004|9339804|P2|Overall Study|Subject was not given study fluid.|14
2713484|NCT00316004|9339805|P1|Overall Study|Subject was not given study fluid.|14
2713485|NCT00315731|9339876|P1|Overall Study|Death|5
2713486|NCT00315731|9339876|P1|Overall Study|Lost to Follow-up|1
2713487|NCT00315705|9339904|P1|Phase 2|Death|7
2713488|NCT00315705|9339904|P1|Phase 2|Other|1
2713489|NCT00315705|9339904|P1|Phase 2|Scheduled for transplant|8
2713490|NCT00315705|9339904|P1|Phase 2|Disease relapse|1
2713491|NCT00315705|9339904|P1|Phase 2|Failure to achieve response|3
2713492|NCT00315705|9339904|P1|Phase 2|Adverse Event|1
2713493|NCT00315705|9339904|P1|Phase 2|Physician Decision|4
2713494|NCT00315705|9339904|P1|Phase 1|Death|3
2713495|NCT00315705|9339904|P1|Phase 1|Scheduled for transplant|9
2713496|NCT00315705|9339904|P1|Phase 1|Disease relapse|4
2713497|NCT00315705|9339904|P1|Phase 1|Failure to achieve response|8
2713498|NCT00315705|9339904|P1|Phase 1|Refused further treatment|1
2713499|NCT00315458|9339965|P4|Overall Study|Did not qualify|0
2713500|NCT00315458|9339966|P3|Overall Study|Did not qualify|1
2713501|NCT00315458|9339967|P2|Overall Study|Did not qualify|0
2713502|NCT00315458|9339968|P1|Overall Study|Did not qualify|0
2713503|NCT00315458|9339965|P4|Overall Study|Lack of Efficacy|1
2713504|NCT00315458|9339966|P3|Overall Study|Lack of Efficacy|20
2713505|NCT00315458|9339967|P2|Overall Study|Lack of Efficacy|0
2713506|NCT00315458|9339968|P1|Overall Study|Lack of Efficacy|0
2713507|NCT00315458|9339965|P4|Overall Study|Withdrawal by Subject|2
2713508|NCT00315458|9339966|P3|Overall Study|Withdrawal by Subject|0
2713509|NCT00315458|9339967|P2|Overall Study|Withdrawal by Subject|3
2713510|NCT00315458|9339968|P1|Overall Study|Withdrawal by Subject|0
2713511|NCT00315458|9339965|P4|Overall Study|Lost to Follow-up|2
2713512|NCT00315458|9339966|P3|Overall Study|Lost to Follow-up|0
2713513|NCT00315458|9339967|P2|Overall Study|Lost to Follow-up|2
2713514|NCT00315458|9339968|P1|Overall Study|Lost to Follow-up|1
2713515|NCT00315458|9339965|P4|Overall Study|Adverse Event|3
2713516|NCT00315458|9339966|P3|Overall Study|Adverse Event|23
2713517|NCT00315458|9339967|P2|Overall Study|Adverse Event|4
2713518|NCT00315458|9339968|P1|Overall Study|Adverse Event|2
2713519|NCT00315458|9339965|P4|Overall Study|Administrative|21
2713520|NCT00315458|9339966|P3|Overall Study|Administrative|8
2713521|NCT00315458|9339967|P2|Overall Study|Administrative|3
2713522|NCT00315458|9339968|P1|Overall Study|Administrative|0
2713523|NCT00315445|9339981|P3|Overall Study|Other|0
2713524|NCT00315445|9339982|P2|Overall Study|Other|3
2713525|NCT00315445|9339983|P1|Overall Study|Other|1
2713526|NCT00315445|9339981|P3|Overall Study|Protocol Violation|1
2713527|NCT00315445|9339982|P2|Overall Study|Protocol Violation|0
2713528|NCT00315445|9339983|P1|Overall Study|Protocol Violation|2
2713529|NCT00315445|9339981|P3|Overall Study|Lost to Follow-up|1
2713530|NCT00315445|9339982|P2|Overall Study|Lost to Follow-up|0
2713531|NCT00315445|9339983|P1|Overall Study|Lost to Follow-up|1
2713532|NCT00315445|9339981|P3|Overall Study|Lack of Efficacy|7
2713533|NCT00315445|9339982|P2|Overall Study|Lack of Efficacy|1
2713534|NCT00315445|9339983|P1|Overall Study|Lack of Efficacy|16
2713535|NCT00315445|9339981|P3|Overall Study|Adverse Event|15
2713536|NCT00315445|9339982|P2|Overall Study|Adverse Event|12
2713537|NCT00315445|9339983|P1|Overall Study|Adverse Event|7
2713538|NCT00315055|9340273|P2|Overall Study|Lost to Follow-up|1
2713539|NCT00315055|9340274|P1|Overall Study|Lost to Follow-up|1
2713540|NCT00315055|9340273|P2|Overall Study|Protocol Violation|4
2713541|NCT00315055|9340274|P1|Overall Study|Protocol Violation|2
2713542|NCT00314951|9340292|P2|Follow-up|mITT failure|34
2713543|NCT00314951|9340293|P1|Follow-up|mITT failure|44
2713544|NCT00314951|9340292|P2|Treatment|Didn't meet criteria for mITT population|11
2713545|NCT00314951|9340293|P1|Treatment|Didn't meet criteria for mITT population|16
2713546|NCT00314808|9340303|P1|Overall Study|Withdrawal by Subject/PI without AE|4
2713547|NCT00314808|9340303|P1|Overall Study|Disease Progression without AE|4
2713548|NCT00314795|9340311|P1|Overall Study|Participants Withdrew Consent|2
2713549|NCT00314795|9340311|P1|Overall Study|Renal Transplant|3
2713550|NCT00314795|9340311|P1|Overall Study|Reason not Specified|3
2713551|NCT00314795|9340311|P1|Overall Study|Death|4
2713552|NCT00314795|9340311|P1|Overall Study|Adverse Event|8
2713553|NCT00314574|9340321|P2|Overall Study|Data unknown at database lock|1
2713554|NCT00314574|9340322|P1|Overall Study|Data unknown at database lock|0
2713555|NCT00314574|9340321|P2|Overall Study|Pregnancy|4
2713556|NCT00314574|9340322|P1|Overall Study|Pregnancy|6
2713557|NCT00314574|9340321|P2|Overall Study|Physician Decision|15
2713558|NCT00314574|9340322|P1|Overall Study|Physician Decision|22
2713559|NCT00314574|9340321|P2|Overall Study|Withdrawal by Subject|22
2713560|NCT00314574|9340322|P1|Overall Study|Withdrawal by Subject|33
2713561|NCT00314574|9340321|P2|Overall Study|Lost to Follow-up|25
2713562|NCT00314574|9340322|P1|Overall Study|Lost to Follow-up|19
2713563|NCT00314574|9340321|P2|Overall Study|Adverse Event|16
2713564|NCT00314574|9340322|P1|Overall Study|Adverse Event|11
2713565|NCT00314574|9340321|P2|Overall Study|Death|0
2713566|NCT00314574|9340322|P1|Overall Study|Death|3
2713567|NCT00314366|9340338|P2|Overall Study|not treated due to patient medical condi|0
2713568|NCT00314366|9340339|P1|Overall Study|not treated due to patient medical condi|1
2713569|NCT00314340|9340384|P1|Overall Study|lost interest|1
2713570|NCT00314327|9340390|P1|Overall Study|Withdrawal by Subject|1
2713571|NCT00314262|9340395|P1|Overall Study|Physician Decision|1
2713572|NCT00314262|9340395|P1|Overall Study|Withdrawal by Subject|2
2713573|NCT00314262|9340395|P1|Overall Study|Adverse Event|2
2713574|NCT00314249|9340403|P2|Overall Study|Non-Compliant|6
2713575|NCT00314249|9340404|P1|Overall Study|Non-Compliant|5
2713576|NCT00314249|9340403|P2|Overall Study|Withdrawn for other reasons|1
2713577|NCT00314249|9340404|P1|Overall Study|Withdrawn for other reasons|4
2713578|NCT00314249|9340403|P2|Overall Study|Physician Decision|1
2713579|NCT00314249|9340404|P1|Overall Study|Physician Decision|1
2713580|NCT00314249|9340403|P2|Overall Study|Lost to Follow-up|9
2713581|NCT00314249|9340404|P1|Overall Study|Lost to Follow-up|15
2713582|NCT00314249|9340403|P2|Overall Study|Withdrawal by Subject|28
2713583|NCT00314249|9340404|P1|Overall Study|Withdrawal by Subject|21
2713584|NCT00314249|9340403|P2|Overall Study|Lack of Efficacy|24
2713585|NCT00314249|9340404|P1|Overall Study|Lack of Efficacy|33
2713586|NCT00314249|9340403|P2|Overall Study|Adverse Event|94
2713587|NCT00314249|9340404|P1|Overall Study|Adverse Event|73
2713588|NCT00314145|9340437|P2|Overall Study|Sponsor Decision|0
2713589|NCT00314145|9340438|P1|Overall Study|Sponsor Decision|2
2713590|NCT00314145|9340437|P2|Overall Study|Protocol Violation|0
2713591|NCT00314145|9340438|P1|Overall Study|Protocol Violation|3
2713592|NCT00314145|9340437|P2|Overall Study|Adverse Event|3
2713593|NCT00314145|9340438|P1|Overall Study|Adverse Event|0
2713594|NCT00314145|9340437|P2|Overall Study|Physician Decision|4
2713595|NCT00314145|9340438|P1|Overall Study|Physician Decision|3
2713596|NCT00314145|9340437|P2|Overall Study|Lost to Follow-up|12
2713597|NCT00314145|9340438|P1|Overall Study|Lost to Follow-up|5
2713598|NCT00314145|9340437|P2|Overall Study|Withdrawal by Subject|10
2713599|NCT00314145|9340438|P1|Overall Study|Withdrawal by Subject|8
2713600|NCT00314132|9340452|P2|Overall Study|Physician Decision|0
2713601|NCT00314132|9340453|P1|Overall Study|Physician Decision|1
2713602|NCT00314132|9340452|P2|Overall Study|Adverse Event|0
2713603|NCT00314132|9340453|P1|Overall Study|Adverse Event|1
2713604|NCT00314132|9340452|P2|Overall Study|Withdrawal by Subject|5
2713605|NCT00314132|9340453|P1|Overall Study|Withdrawal by Subject|3
2713606|NCT00314132|9340452|P2|Overall Study|Lost to Follow-up|13
2713607|NCT00314132|9340453|P1|Overall Study|Lost to Follow-up|3
2713608|NCT00313911|9340480|P2|Overall Study|Did not meet age criteria|1
2713609|NCT00313911|9340481|P1|Overall Study|Did not meet age criteria|1
2713610|NCT00313911|9340480|P2|Overall Study|Withdrawal by Subject|12
2713611|NCT00313911|9340481|P1|Overall Study|Withdrawal by Subject|39
2713612|NCT00313911|9340480|P2|Overall Study|Lost to Follow-up|14
2713613|NCT00313911|9340481|P1|Overall Study|Lost to Follow-up|27
2713614|NCT00313911|9340480|P2|Overall Study|Protocol Violation|10
2713615|NCT00313911|9340481|P1|Overall Study|Protocol Violation|19
2713616|NCT00313911|9340480|P2|Overall Study|Adverse Event|3
2713617|NCT00313911|9340481|P1|Overall Study|Adverse Event|2
2713618|NCT00313911|9340480|P2|Overall Study|Serious adverse event|1
2713619|NCT00313911|9340481|P1|Overall Study|Serious adverse event|6
2713620|NCT00313846|9340495|P2|Overall Study|Administrative|3
2713621|NCT00313846|9340496|P1|Overall Study|Administrative|2
2713622|NCT00313846|9340495|P2|Overall Study|Adverse Event|8
2713623|NCT00313846|9340496|P1|Overall Study|Adverse Event|1
2713624|NCT00313846|9340495|P2|Overall Study|Withdrawal by Subject|0
2713625|NCT00313846|9340496|P1|Overall Study|Withdrawal by Subject|2
2713626|NCT00313820|9340507|P2|Pregabalin or Placebo Treatment Period|Other|3
2713627|NCT00313820|9340508|P1|Pregabalin or Placebo Treatment Period|Other|2
2713628|NCT00313820|9340507|P2|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4
2713629|NCT00313820|9340508|P1|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6
2713630|NCT00313820|9340507|P2|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7
2713631|NCT00313820|9340508|P1|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0
2713632|NCT00313820|9340507|P2|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1
2713633|NCT00313820|9340508|P1|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0
2713634|NCT00313820|9340507|P2|Pregabalin or Placebo Treatment Period|Adverse Event|4
2713635|NCT00313820|9340508|P1|Pregabalin or Placebo Treatment Period|Adverse Event|9
2713636|NCT00313820|9340507|P2|Assigned to Treatment|Other|0
2713637|NCT00313820|9340508|P1|Assigned to Treatment|Other|1
2713638|NCT00313781|9340546|P3|After Crossover|Other|18
2713639|NCT00313781|9340547|P2|After Crossover|Other|0
2713640|NCT00313781|9340548|P1|After Crossover|Other|0
2713641|NCT00313781|9340546|P3|After Crossover|Withdrawal by Subject|3
2713642|NCT00313781|9340547|P2|After Crossover|Withdrawal by Subject|0
2713643|NCT00313781|9340548|P1|After Crossover|Withdrawal by Subject|0
2713644|NCT00313781|9340546|P3|After Crossover|Death|6
2713645|NCT00313781|9340547|P2|After Crossover|Death|0
2713646|NCT00313781|9340548|P1|After Crossover|Death|0
2713647|NCT00313781|9340546|P3|Before Crossover|Randomized, not treated|0
2713648|NCT00313781|9340547|P2|Before Crossover|Randomized, not treated|0
2713649|NCT00313781|9340548|P1|Before Crossover|Randomized, not treated|5
2713650|NCT00313781|9340546|P3|Before Crossover|Crossover|0
2713651|NCT00313781|9340547|P2|Before Crossover|Crossover|37
2713652|NCT00313781|9340548|P1|Before Crossover|Crossover|0
2713653|NCT00313781|9340546|P3|Before Crossover|Other|0
2713654|NCT00313781|9340547|P2|Before Crossover|Other|30
2713655|NCT00313781|9340548|P1|Before Crossover|Other|45
2713656|NCT00313781|9340546|P3|Before Crossover|Withdrawal by Subject|0
2713657|NCT00313781|9340547|P2|Before Crossover|Withdrawal by Subject|1
2713658|NCT00313781|9340548|P1|Before Crossover|Withdrawal by Subject|3
2713659|NCT00313781|9340546|P3|Before Crossover|Lost to Follow-up|0
2713660|NCT00313781|9340547|P2|Before Crossover|Lost to Follow-up|3
2713661|NCT00313781|9340548|P1|Before Crossover|Lost to Follow-up|0
2713662|NCT00313781|9340546|P3|Before Crossover|Death|0
2713663|NCT00313781|9340547|P2|Before Crossover|Death|8
2713664|NCT00313781|9340548|P1|Before Crossover|Death|22
2713665|NCT00313716|9340594|P6|Overall Study|Withdrawal by Subject|0
2713666|NCT00313716|9340595|P5|Overall Study|Withdrawal by Subject|1
2713667|NCT00313716|9340596|P4|Overall Study|Withdrawal by Subject|0
2713668|NCT00313716|9340597|P3|Overall Study|Withdrawal by Subject|1
2713669|NCT00313716|9340598|P2|Overall Study|Withdrawal by Subject|1
2713670|NCT00313716|9340599|P1|Overall Study|Withdrawal by Subject|0
2713671|NCT00313716|9340594|P6|Overall Study|Lost to Follow-up|4
2713672|NCT00313716|9340595|P5|Overall Study|Lost to Follow-up|0
2713673|NCT00313716|9340596|P4|Overall Study|Lost to Follow-up|1
2713674|NCT00313716|9340597|P3|Overall Study|Lost to Follow-up|2
2713675|NCT00313716|9340598|P2|Overall Study|Lost to Follow-up|5
2713676|NCT00313716|9340599|P1|Overall Study|Lost to Follow-up|2
2713677|NCT00313716|9340594|P6|Overall Study|Death|9
2713678|NCT00313716|9340595|P5|Overall Study|Death|5
2713679|NCT00313716|9340596|P4|Overall Study|Death|3
2713680|NCT00313716|9340597|P3|Overall Study|Death|9
2713681|NCT00313716|9340598|P2|Overall Study|Death|2
2713682|NCT00313716|9340599|P1|Overall Study|Death|3
2713683|NCT00313703|9340626|P4|Overall Study|Lost to Follow-up|12
2713684|NCT00313703|9340627|P3|Overall Study|Lost to Follow-up|5
2713685|NCT00313703|9340628|P2|Overall Study|Lost to Follow-up|2
2713686|NCT00313703|9340629|P1|Overall Study|Lost to Follow-up|11
2713687|NCT00313612|9340645|P2|Overall Study|Patient never received treatment|1
2713688|NCT00313612|9340646|P1|Overall Study|Patient never received treatment|0
2713689|NCT00313586|9340658|P4|Overall Study|Death before starting treatment|0
2713690|NCT00313586|9340659|P3|Overall Study|Death before starting treatment|0
2713691|NCT00313586|9340660|P2|Overall Study|Death before starting treatment|0
2713692|NCT00313586|9340661|P1|Overall Study|Death before starting treatment|1
2713693|NCT00313586|9340658|P4|Overall Study|Moved|0
2713694|NCT00313586|9340659|P3|Overall Study|Moved|0
2713695|NCT00313586|9340660|P2|Overall Study|Moved|1
2713696|NCT00313586|9340661|P1|Overall Study|Moved|0
2713697|NCT00313586|9340658|P4|Overall Study|Lost insurance|0
2713698|NCT00313586|9340659|P3|Overall Study|Lost insurance|0
2713699|NCT00313586|9340660|P2|Overall Study|Lost insurance|1
2713700|NCT00313586|9340661|P1|Overall Study|Lost insurance|0
2713701|NCT00313586|9340658|P4|Overall Study|Absolute neutrophil count not recovered|0
2713702|NCT00313586|9340659|P3|Overall Study|Absolute neutrophil count not recovered|0
2713703|NCT00313586|9340660|P2|Overall Study|Absolute neutrophil count not recovered|1
2713704|NCT00313586|9340661|P1|Overall Study|Absolute neutrophil count not recovered|2
2713705|NCT00313586|9340658|P4|Overall Study|Physician Decision|0
2713706|NCT00313586|9340659|P3|Overall Study|Physician Decision|0
2713707|NCT00313586|9340660|P2|Overall Study|Physician Decision|1
2713708|NCT00313586|9340661|P1|Overall Study|Physician Decision|2
2713709|NCT00313586|9340658|P4|Overall Study|Did not achieve HI-major/better response|1
2713710|NCT00313586|9340659|P3|Overall Study|Did not achieve HI-major/better response|2
2713711|NCT00313586|9340660|P2|Overall Study|Did not achieve HI-major/better response|7
2713712|NCT00313586|9340661|P1|Overall Study|Did not achieve HI-major/better response|10
2713713|NCT00313586|9340658|P4|Overall Study|Other complicating disease|0
2713714|NCT00313586|9340659|P3|Overall Study|Other complicating disease|0
2713715|NCT00313586|9340660|P2|Overall Study|Other complicating disease|2
2713716|NCT00313586|9340661|P1|Overall Study|Other complicating disease|2
2713717|NCT00313586|9340658|P4|Overall Study|Alternative therapy|0
2713718|NCT00313586|9340659|P3|Overall Study|Alternative therapy|2
2713719|NCT00313586|9340660|P2|Overall Study|Alternative therapy|6
2713720|NCT00313586|9340661|P1|Overall Study|Alternative therapy|3
2713721|NCT00313586|9340658|P4|Overall Study|Withdrawal by Subject|2
2713722|NCT00313586|9340659|P3|Overall Study|Withdrawal by Subject|6
2713723|NCT00313586|9340660|P2|Overall Study|Withdrawal by Subject|6
2713724|NCT00313586|9340661|P1|Overall Study|Withdrawal by Subject|13
2713725|NCT00313586|9340658|P4|Overall Study|Death|7
2713726|NCT00313586|9340659|P3|Overall Study|Death|1
2713727|NCT00313586|9340660|P2|Overall Study|Death|8
2713728|NCT00313586|9340661|P1|Overall Study|Death|11
2713729|NCT00313586|9340658|P4|Overall Study|Adverse Event|10
2713730|NCT00313586|9340659|P3|Overall Study|Adverse Event|3
2713731|NCT00313586|9340660|P2|Overall Study|Adverse Event|18
2713732|NCT00313586|9340661|P1|Overall Study|Adverse Event|12
2713733|NCT00313586|9340658|P4|Overall Study|Disease progression|3
2713734|NCT00313586|9340659|P3|Overall Study|Disease progression|10
2713735|NCT00313586|9340660|P2|Overall Study|Disease progression|19
2713736|NCT00313586|9340661|P1|Overall Study|Disease progression|14
2713737|NCT00313313|9340684|P3|Overall Study|Subject No Longer Meets Study Criteria|2
2713738|NCT00313313|9340685|P2|Overall Study|Subject No Longer Meets Study Criteria|3
2713739|NCT00313313|9340686|P1|Overall Study|Subject No Longer Meets Study Criteria|0
2713740|NCT00313313|9340684|P3|Overall Study|Death|2
2713741|NCT00313313|9340685|P2|Overall Study|Death|0
2713742|NCT00313313|9340686|P1|Overall Study|Death|0
2713743|NCT00313313|9340684|P3|Overall Study|Pregnancy|0
2713744|NCT00313313|9340685|P2|Overall Study|Pregnancy|2
2713745|NCT00313313|9340686|P1|Overall Study|Pregnancy|1
2713746|NCT00313313|9340684|P3|Overall Study|Poor/Noncompliance|2
2713747|NCT00313313|9340685|P2|Overall Study|Poor/Noncompliance|6
2713748|NCT00313313|9340686|P1|Overall Study|Poor/Noncompliance|3
2713749|NCT00313313|9340684|P3|Overall Study|Physician Decision|4
2713750|NCT00313313|9340685|P2|Overall Study|Physician Decision|6
2713751|NCT00313313|9340686|P1|Overall Study|Physician Decision|2
2713752|NCT00313313|9340684|P3|Overall Study|Adverse Event|12
2713753|NCT00313313|9340685|P2|Overall Study|Adverse Event|16
2713754|NCT00313313|9340686|P1|Overall Study|Adverse Event|15
2713755|NCT00313313|9340684|P3|Overall Study|Lost to Follow-up|9
2713756|NCT00313313|9340685|P2|Overall Study|Lost to Follow-up|7
2713757|NCT00313313|9340686|P1|Overall Study|Lost to Follow-up|10
2713758|NCT00313313|9340684|P3|Overall Study|Withdrawal of consent by subject|31
2713759|NCT00313313|9340685|P2|Overall Study|Withdrawal of consent by subject|17
2713760|NCT00313313|9340686|P1|Overall Study|Withdrawal of consent by subject|18
2713761|NCT00313313|9340684|P3|Overall Study|Lack of Efficacy|20
2713762|NCT00313313|9340685|P2|Overall Study|Lack of Efficacy|9
2713763|NCT00313313|9340686|P1|Overall Study|Lack of Efficacy|14
2713764|NCT00313300|9340708|P5|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
2713765|NCT00313300|9340709|P4|Follow-Up(30days)-Randomized Phase B|missing end of study status|2
2713766|NCT00313300|9340710|P3|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
2713767|NCT00313300|9340711|P2|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
2713768|NCT00313300|9340712|P1|Follow-Up(30days)-Randomized Phase B|missing end of study status|1
2713769|NCT00313300|9340708|P5|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1
2713770|NCT00313300|9340709|P4|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2
2713771|NCT00313300|9340710|P3|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
2713772|NCT00313300|9340711|P2|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
2713773|NCT00313300|9340712|P1|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
2713774|NCT00313300|9340708|P5|Follow-Up(30days)-Randomized Phase B|Death|0
2713775|NCT00313300|9340709|P4|Follow-Up(30days)-Randomized Phase B|Death|0
2713776|NCT00313300|9340710|P3|Follow-Up(30days)-Randomized Phase B|Death|0
2713777|NCT00313300|9340711|P2|Follow-Up(30days)-Randomized Phase B|Death|0
2713778|NCT00313300|9340712|P1|Follow-Up(30days)-Randomized Phase B|Death|1
2713779|NCT00313300|9340708|P5|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
2713780|NCT00313300|9340709|P4|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
2713781|NCT00313300|9340710|P3|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2
2713782|NCT00313300|9340711|P2|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0
2713783|NCT00313300|9340712|P1|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
2713784|NCT00313300|9340708|P5|Follow-Up(30days)-Randomized Phase A|Death|0
2713785|NCT00313300|9340709|P4|Follow-Up(30days)-Randomized Phase A|Death|0
2713786|NCT00313300|9340710|P3|Follow-Up(30days)-Randomized Phase A|Death|0
2713787|NCT00313300|9340711|P2|Follow-Up(30days)-Randomized Phase A|Death|1
2713788|NCT00313300|9340712|P1|Follow-Up(30days)-Randomized Phase A|Death|0
2713789|NCT00313300|9340708|P5|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
2713790|NCT00313300|9340709|P4|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
2713791|NCT00313300|9340710|P3|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2
2713792|NCT00313300|9340711|P2|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
2713793|NCT00313300|9340712|P1|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
2713794|NCT00313300|9340708|P5|Randomized in Phase B (26 Weeks)|non-specified|0
2713795|NCT00313300|9340709|P4|Randomized in Phase B (26 Weeks)|non-specified|0
2713796|NCT00313300|9340710|P3|Randomized in Phase B (26 Weeks)|non-specified|0
2713797|NCT00313300|9340711|P2|Randomized in Phase B (26 Weeks)|non-specified|0
2713798|NCT00313300|9340712|P1|Randomized in Phase B (26 Weeks)|non-specified|1
2713799|NCT00313300|9340708|P5|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164
2713800|NCT00313300|9340709|P4|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193
2713801|NCT00313300|9340710|P3|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0
2713802|NCT00313300|9340711|P2|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1
2713803|NCT00313300|9340712|P1|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2
2713804|NCT00313300|9340708|P5|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
2713805|NCT00313300|9340709|P4|Randomized in Phase B (26 Weeks)|no longer meets criteria|0
2713806|NCT00313300|9340710|P3|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
2713807|NCT00313300|9340711|P2|Randomized in Phase B (26 Weeks)|no longer meets criteria|3
2713808|NCT00313300|9340712|P1|Randomized in Phase B (26 Weeks)|no longer meets criteria|9
2713809|NCT00313300|9340708|P5|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
2713810|NCT00313300|9340709|P4|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
2713811|NCT00313300|9340710|P3|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
2713812|NCT00313300|9340711|P2|Randomized in Phase B (26 Weeks)|poor/non-compliance|1
2713813|NCT00313300|9340712|P1|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
2713814|NCT00313300|9340708|P5|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
2713815|NCT00313300|9340709|P4|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
2713816|NCT00313300|9340710|P3|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
2713817|NCT00313300|9340711|P2|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
2713818|NCT00313300|9340712|P1|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5
2713819|NCT00313300|9340708|P5|Randomized in Phase B (26 Weeks)|Death|1
2713820|NCT00313300|9340709|P4|Randomized in Phase B (26 Weeks)|Death|0
2713821|NCT00313300|9340710|P3|Randomized in Phase B (26 Weeks)|Death|1
2713822|NCT00313300|9340711|P2|Randomized in Phase B (26 Weeks)|Death|3
2713823|NCT00313300|9340712|P1|Randomized in Phase B (26 Weeks)|Death|5
2713824|NCT00313300|9340708|P5|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
2713825|NCT00313300|9340709|P4|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15
2713826|NCT00313300|9340710|P3|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
2713827|NCT00313300|9340711|P2|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14
2713828|NCT00313300|9340712|P1|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35
2713829|NCT00313300|9340708|P5|Randomized in Phase B (26 Weeks)|Adverse Event|19
2713830|NCT00313300|9340709|P4|Randomized in Phase B (26 Weeks)|Adverse Event|23
2713831|NCT00313300|9340710|P3|Randomized in Phase B (26 Weeks)|Adverse Event|12
2713832|NCT00313300|9340711|P2|Randomized in Phase B (26 Weeks)|Adverse Event|9
2713833|NCT00313300|9340712|P1|Randomized in Phase B (26 Weeks)|Adverse Event|34
2713834|NCT00313300|9340708|P5|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
2713835|NCT00313300|9340709|P4|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
2713836|NCT00313300|9340710|P3|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
2713837|NCT00313300|9340711|P2|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
2713838|NCT00313300|9340712|P1|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1
2713839|NCT00313300|9340708|P5|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
2713840|NCT00313300|9340709|P4|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
2713841|NCT00313300|9340710|P3|Randomized in Phase A (26 Weeks)|no longer meets criteria|2
2713842|NCT00313300|9340711|P2|Randomized in Phase A (26 Weeks)|no longer meets criteria|3
2713843|NCT00313300|9340712|P1|Randomized in Phase A (26 Weeks)|no longer meets criteria|4
2713844|NCT00313300|9340708|P5|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
2713845|NCT00313300|9340709|P4|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
2713846|NCT00313300|9340710|P3|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1
2713847|NCT00313300|9340711|P2|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2
2713848|NCT00313300|9340712|P1|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3
2713849|NCT00313300|9340708|P5|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
2713850|NCT00313300|9340709|P4|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
2713851|NCT00313300|9340710|P3|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2
2713852|NCT00313300|9340711|P2|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
2713853|NCT00313300|9340712|P1|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
2713854|NCT00313300|9340708|P5|Randomized in Phase A (26 Weeks)|Death|0
2713855|NCT00313300|9340709|P4|Randomized in Phase A (26 Weeks)|Death|0
2713856|NCT00313300|9340710|P3|Randomized in Phase A (26 Weeks)|Death|0
2713857|NCT00313300|9340711|P2|Randomized in Phase A (26 Weeks)|Death|4
2713858|NCT00313300|9340712|P1|Randomized in Phase A (26 Weeks)|Death|3
2713859|NCT00313300|9340708|P5|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
2713860|NCT00313300|9340709|P4|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
2713861|NCT00313300|9340710|P3|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13
2713862|NCT00313300|9340711|P2|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12
2713863|NCT00313300|9340712|P1|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20
2713864|NCT00313300|9340708|P5|Randomized in Phase A (26 Weeks)|Adverse Event|0
2713865|NCT00313300|9340709|P4|Randomized in Phase A (26 Weeks)|Adverse Event|0
2713866|NCT00313300|9340710|P3|Randomized in Phase A (26 Weeks)|Adverse Event|17
2713867|NCT00313300|9340711|P2|Randomized in Phase A (26 Weeks)|Adverse Event|14
2713868|NCT00313300|9340712|P1|Randomized in Phase A (26 Weeks)|Adverse Event|19
2713869|NCT00313170|9340782|P3|Overall Study|Progression (investigators opinion)|0
2713870|NCT00313170|9340783|P2|Overall Study|Progression (investigators opinion)|0
2713871|NCT00313170|9340784|P1|Overall Study|Progression (investigators opinion)|1
2713872|NCT00313170|9340782|P3|Overall Study|Lost to Follow-up|1
2713873|NCT00313170|9340783|P2|Overall Study|Lost to Follow-up|0
2713874|NCT00313170|9340784|P1|Overall Study|Lost to Follow-up|0
2713875|NCT00313170|9340782|P3|Overall Study|Incorrect enrollment|1
2713876|NCT00313170|9340783|P2|Overall Study|Incorrect enrollment|2
2713877|NCT00313170|9340784|P1|Overall Study|Incorrect enrollment|0
2713878|NCT00313170|9340782|P3|Overall Study|Withdrawal by Subject|1
2713879|NCT00313170|9340783|P2|Overall Study|Withdrawal by Subject|0
2713880|NCT00313170|9340784|P1|Overall Study|Withdrawal by Subject|1
2713881|NCT00313170|9340782|P3|Overall Study|Disease progression|27
2713882|NCT00313170|9340783|P2|Overall Study|Disease progression|26
2713883|NCT00313170|9340784|P1|Overall Study|Disease progression|31
2713884|NCT00313170|9340782|P3|Overall Study|Adverse Event|0
2713885|NCT00313170|9340783|P2|Overall Study|Adverse Event|2
2713886|NCT00313170|9340784|P1|Overall Study|Adverse Event|1
2713887|NCT00313170|9340782|P3|Overall Study|Death|2
2713888|NCT00313170|9340783|P2|Overall Study|Death|4
2713889|NCT00313170|9340784|P1|Overall Study|Death|2
2713890|NCT00313144|9340803|P1|Overall Study|Due to termination of the study|66
2713891|NCT00313144|9340803|P1|Overall Study|Change to different product|1
2713892|NCT00313144|9340803|P1|Overall Study|Insurance (homecare provider) change|1
2713893|NCT00313144|9340803|P1|Overall Study|Liver transplant|1
2713894|NCT00313144|9340803|P1|Overall Study|Adverse event - transient|5
2713895|NCT00313144|9340803|P1|Overall Study|Physician Decision|4
2713896|NCT00313144|9340803|P1|Overall Study|Terminated by sponsor/ homecare provider|4
2713897|NCT00313144|9340803|P1|Overall Study|Withdrawal by Subject|4
2713898|NCT00313144|9340803|P1|Overall Study|Lost to Follow-up|5
2713899|NCT00313144|9340803|P1|Overall Study|Death|7
2713900|NCT00313144|9340803|P1|Overall Study|Discontinue Aralast ≥4 consecutive doses|12
2713901|NCT00313014|9340890|P3|Overall Study|Lack of Efficacy|16
2713902|NCT00313014|9340891|P2|Overall Study|Lack of Efficacy|25
2713903|NCT00313014|9340892|P1|Overall Study|Lack of Efficacy|52
2713904|NCT00313014|9340890|P3|Overall Study|Administrative|14
2713905|NCT00313014|9340891|P2|Overall Study|Administrative|6
2713906|NCT00313014|9340892|P1|Overall Study|Administrative|9
2713907|NCT00313014|9340890|P3|Overall Study|Lost to Follow-up|10
2713908|NCT00313014|9340891|P2|Overall Study|Lost to Follow-up|6
2713909|NCT00313014|9340892|P1|Overall Study|Lost to Follow-up|7
2713910|NCT00313014|9340890|P3|Overall Study|Adverse Event|16
2713911|NCT00313014|9340891|P2|Overall Study|Adverse Event|29
2713912|NCT00313014|9340892|P1|Overall Study|Adverse Event|14
2713913|NCT00313014|9340890|P3|Overall Study|Withdrawal by Subject|5
2713914|NCT00313014|9340891|P2|Overall Study|Withdrawal by Subject|7
2713915|NCT00313014|9340892|P1|Overall Study|Withdrawal by Subject|11
2713916|NCT00312897|9340923|P2|Overall Study|discontinued prior to getting treatment|3
2713917|NCT00312897|9340924|P1|Overall Study|discontinued prior to getting treatment|0
2713918|NCT00312897|9340923|P2|Overall Study|Pregnancy|0
2713919|NCT00312897|9340924|P1|Overall Study|Pregnancy|1
2713920|NCT00312897|9340923|P2|Overall Study|Withdrawal by Subject|3
2713921|NCT00312897|9340924|P1|Overall Study|Withdrawal by Subject|1
2713922|NCT00312897|9340923|P2|Overall Study|Physician Decision|0
2713923|NCT00312897|9340924|P1|Overall Study|Physician Decision|1
2713924|NCT00312897|9340923|P2|Overall Study|Lost to Follow-up|0
2713925|NCT00312897|9340924|P1|Overall Study|Lost to Follow-up|2
2713926|NCT00312897|9340923|P2|Overall Study|Adverse Event|0
2713927|NCT00312897|9340924|P1|Overall Study|Adverse Event|1
2713928|NCT00312858|9340949|P2|Overall Study|Other|12
2713929|NCT00312858|9340950|P1|Overall Study|Other|9
2713930|NCT00312858|9340949|P2|Overall Study|Participant Moved|10
2713931|NCT00312858|9340950|P1|Overall Study|Participant Moved|11
2713932|NCT00312858|9340949|P2|Overall Study|Withdraw by Participant|20
2713933|NCT00312858|9340950|P1|Overall Study|Withdraw by Participant|20
2713934|NCT00312858|9340949|P2|Overall Study|Protocol Violation|8
2713935|NCT00312858|9340950|P1|Overall Study|Protocol Violation|3
2713936|NCT00312858|9340949|P2|Overall Study|Lost to Follow-up|42
2713937|NCT00312858|9340950|P1|Overall Study|Lost to Follow-up|25
2713938|NCT00312858|9340949|P2|Overall Study|Adverse Event|1
2713939|NCT00312858|9340950|P1|Overall Study|Adverse Event|0
2713940|NCT00312845|9341004|P2|Overall Study|Other|5
2713941|NCT00312845|9341005|P1|Overall Study|Other|6
2713942|NCT00312845|9341004|P2|Overall Study|Lost to Follow-up|0
2713943|NCT00312845|9341005|P1|Overall Study|Lost to Follow-up|2
2713944|NCT00312845|9341004|P2|Overall Study|Disease Progression|77
2713945|NCT00312845|9341005|P1|Overall Study|Disease Progression|56
2713946|NCT00312845|9341004|P2|Overall Study|Withdrawal by Subject|6
2713947|NCT00312845|9341005|P1|Overall Study|Withdrawal by Subject|14
2713948|NCT00312845|9341004|P2|Overall Study|Death|2
2713949|NCT00312845|9341005|P1|Overall Study|Death|2
2713950|NCT00312845|9341004|P2|Overall Study|Adverse Event|5
2713951|NCT00312845|9341005|P1|Overall Study|Adverse Event|19
2713952|NCT00312728|9341013|P1|Overall Study|Other|1
2713953|NCT00312728|9341013|P1|Overall Study|Other|10
2713954|NCT00312728|9341013|P1|Overall Study|Protocol Violation|2
2713955|NCT00312728|9341013|P1|Overall Study|Required non-protocol cancer treatment|2
2713956|NCT00312728|9341013|P1|Overall Study|Withdrawal by Subject|10
2713957|NCT00312728|9341013|P1|Overall Study|Adverse Event|32
2713958|NCT00312728|9341013|P1|Overall Study|Progressive disease|53
2713959|NCT00312702|9341025|P3|Immunization Phase|Lost to Follow-up|0
2713960|NCT00312702|9341026|P2|Immunization Phase|Lost to Follow-up|1
2713961|NCT00312702|9341027|P1|Immunization Phase|Lost to Follow-up|0
2713962|NCT00312663|9341040|P3|Immunization Phase|Adverse Event|0
2713963|NCT00312663|9341041|P2|Immunization Phase|Adverse Event|1
2713964|NCT00312663|9341042|P1|Immunization Phase|Adverse Event|0
2713965|NCT00312572|9341055|P2|Overall Study|Lack of Efficacy|2
2713966|NCT00312572|9341056|P1|Overall Study|Lack of Efficacy|1
2713967|NCT00312572|9341055|P2|Overall Study|Administrative|2
2713968|NCT00312572|9341056|P1|Overall Study|Administrative|4
2713969|NCT00312572|9341055|P2|Overall Study|Lost to Follow-up|1
2713970|NCT00312572|9341056|P1|Overall Study|Lost to Follow-up|1
2713971|NCT00312572|9341055|P2|Overall Study|Adverse Event|16
2713972|NCT00312572|9341056|P1|Overall Study|Adverse Event|10
2713973|NCT00312494|9341067|P3|Overall Study|Other|1
2713974|NCT00312494|9341068|P2|Overall Study|Other|10
2713975|NCT00312494|9341069|P1|Overall Study|Other|10
2713976|NCT00312494|9341067|P3|Overall Study|Withdrawal by Subject|10
2713977|NCT00312494|9341068|P2|Overall Study|Withdrawal by Subject|9
2713978|NCT00312494|9341069|P1|Overall Study|Withdrawal by Subject|6
2713979|NCT00312494|9341067|P3|Overall Study|Lost to Follow-up|8
2713980|NCT00312494|9341068|P2|Overall Study|Lost to Follow-up|8
2713981|NCT00312494|9341069|P1|Overall Study|Lost to Follow-up|8
2713982|NCT00312494|9341067|P3|Overall Study|Laboratory abnormality|0
2713983|NCT00312494|9341068|P2|Overall Study|Laboratory abnormality|0
2713984|NCT00312494|9341069|P1|Overall Study|Laboratory abnormality|1
2713985|NCT00312494|9341067|P3|Overall Study|Lack of Efficacy|8
2713986|NCT00312494|9341068|P2|Overall Study|Lack of Efficacy|6
2713987|NCT00312494|9341069|P1|Overall Study|Lack of Efficacy|4
2713988|NCT00312494|9341067|P3|Overall Study|Adverse Event|11
2713989|NCT00312494|9341068|P2|Overall Study|Adverse Event|15
2713990|NCT00312494|9341069|P1|Overall Study|Adverse Event|33
2713991|NCT00312494|9341067|P3|Overall Study|Randomized; not treated with study drug|5
2713992|NCT00312494|9341068|P2|Overall Study|Randomized; not treated with study drug|10
2713993|NCT00312494|9341069|P1|Overall Study|Randomized; not treated with study drug|9
2713994|NCT00312377|9341103|P2|Overall Study|Site ended participation in study|0
2713995|NCT00312377|9341104|P1|Overall Study|Site ended participation in study|1
2713996|NCT00312377|9341103|P2|Overall Study|Discontinue treatment survival follow up|200
2713997|NCT00312377|9341104|P1|Overall Study|Discontinue treatment survival follow up|202
2713998|NCT00312377|9341103|P2|Overall Study|Randomised but never received treatment|6
2713999|NCT00312377|9341104|P1|Overall Study|Randomised but never received treatment|6
2714000|NCT00312377|9341103|P2|Overall Study|Non-compliance|2
2714001|NCT00312377|9341104|P1|Overall Study|Non-compliance|0
2714002|NCT00312377|9341103|P2|Overall Study|Lost to Follow-up|12
2714003|NCT00312377|9341104|P1|Overall Study|Lost to Follow-up|9
2714004|NCT00312377|9341103|P2|Overall Study|Withdrawal by Subject|30
2714005|NCT00312377|9341104|P1|Overall Study|Withdrawal by Subject|23
2714006|NCT00312377|9341103|P2|Overall Study|Death|418
2714007|NCT00312377|9341104|P1|Overall Study|Death|403
2714008|NCT00312338|9341128|P2|Overall Study|Subsequent infection|0
2714009|NCT00312338|9341129|P1|Overall Study|Subsequent infection|2
2714010|NCT00312338|9341128|P2|Overall Study|Withdrawal by Subject|0
2714011|NCT00312338|9341129|P1|Overall Study|Withdrawal by Subject|4
2714012|NCT00312338|9341128|P2|Overall Study|Lost to Follow-up|1
2714013|NCT00312338|9341129|P1|Overall Study|Lost to Follow-up|9
2714014|NCT00312338|9341128|P2|Overall Study|Adverse Event|2
2714015|NCT00312338|9341129|P1|Overall Study|Adverse Event|7
2714016|NCT00312221|9341142|P4|Double-blind Phase|Lack of Efficacy|10
2714017|NCT00312221|9341143|P3|Double-blind Phase|Lack of Efficacy|6
2714018|NCT00312221|9341144|P2|Double-blind Phase|Lack of Efficacy|17
2714019|NCT00312221|9341145|P1|Double-blind Phase|Lack of Efficacy|0
2714020|NCT00312221|9341142|P4|Double-blind Phase|Administrative|33
2714021|NCT00312221|9341143|P3|Double-blind Phase|Administrative|37
2714022|NCT00312221|9341144|P2|Double-blind Phase|Administrative|26
2714023|NCT00312221|9341145|P1|Double-blind Phase|Administrative|0
2714024|NCT00312221|9341142|P4|Double-blind Phase|Lost to Follow-up|2
2714025|NCT00312221|9341143|P3|Double-blind Phase|Lost to Follow-up|2
2714026|NCT00312221|9341144|P2|Double-blind Phase|Lost to Follow-up|0
2714027|NCT00312221|9341145|P1|Double-blind Phase|Lost to Follow-up|0
2714028|NCT00312221|9341142|P4|Double-blind Phase|Adverse Event|18
2714029|NCT00312221|9341143|P3|Double-blind Phase|Adverse Event|19
2714030|NCT00312221|9341144|P2|Double-blind Phase|Adverse Event|10
2714031|NCT00312221|9341145|P1|Double-blind Phase|Adverse Event|0
2714032|NCT00312221|9341142|P4|Double-blind Phase|Withdrawal by Subject|7
2714033|NCT00312221|9341143|P3|Double-blind Phase|Withdrawal by Subject|8
2714034|NCT00312221|9341144|P2|Double-blind Phase|Withdrawal by Subject|6
2714035|NCT00312221|9341145|P1|Double-blind Phase|Withdrawal by Subject|0
2714036|NCT00312221|9341142|P4|Open-label Run-in Period|Did not qualify|0
2714037|NCT00312221|9341143|P3|Open-label Run-in Period|Did not qualify|0
2714038|NCT00312221|9341144|P2|Open-label Run-in Period|Did not qualify|0
2714039|NCT00312221|9341145|P1|Open-label Run-in Period|Did not qualify|5
2714040|NCT00312221|9341142|P4|Open-label Run-in Period|Lack of Efficacy|0
2714041|NCT00312221|9341143|P3|Open-label Run-in Period|Lack of Efficacy|0
2714042|NCT00312221|9341144|P2|Open-label Run-in Period|Lack of Efficacy|0
2714043|NCT00312221|9341145|P1|Open-label Run-in Period|Lack of Efficacy|102
2714044|NCT00312221|9341142|P4|Open-label Run-in Period|Administrative|0
2714045|NCT00312221|9341143|P3|Open-label Run-in Period|Administrative|0
2714046|NCT00312221|9341144|P2|Open-label Run-in Period|Administrative|0
2714047|NCT00312221|9341145|P1|Open-label Run-in Period|Administrative|42
2714048|NCT00312221|9341142|P4|Open-label Run-in Period|Lost to Follow-up|0
2714049|NCT00312221|9341143|P3|Open-label Run-in Period|Lost to Follow-up|0
2714050|NCT00312221|9341144|P2|Open-label Run-in Period|Lost to Follow-up|0
2714051|NCT00312221|9341145|P1|Open-label Run-in Period|Lost to Follow-up|5
2714052|NCT00312221|9341142|P4|Open-label Run-in Period|Adverse Event|0
2714053|NCT00312221|9341143|P3|Open-label Run-in Period|Adverse Event|0
2714054|NCT00312221|9341144|P2|Open-label Run-in Period|Adverse Event|0
2714055|NCT00312221|9341145|P1|Open-label Run-in Period|Adverse Event|74
2714056|NCT00312221|9341142|P4|Open-label Run-in Period|Withdrawal by Subject|0
2714057|NCT00312221|9341143|P3|Open-label Run-in Period|Withdrawal by Subject|0
2714058|NCT00312221|9341144|P2|Open-label Run-in Period|Withdrawal by Subject|0
2714059|NCT00312221|9341145|P1|Open-label Run-in Period|Withdrawal by Subject|6
2714060|NCT00312208|9341165|P2|Overall Study|Other|7
2714061|NCT00312208|9341166|P1|Overall Study|Other|5
2714062|NCT00312208|9341165|P2|Overall Study|Withdrawal by Subject|42
2714063|NCT00312208|9341166|P1|Overall Study|Withdrawal by Subject|53
2714064|NCT00312208|9341165|P2|Overall Study|Lost to Follow-up|5
2714065|NCT00312208|9341166|P1|Overall Study|Lost to Follow-up|3
2714066|NCT00312208|9341165|P2|Overall Study|Lack of Efficacy|4
2714067|NCT00312208|9341166|P1|Overall Study|Lack of Efficacy|7
2714068|NCT00312208|9341165|P2|Overall Study|Death|1
2714069|NCT00312208|9341166|P1|Overall Study|Death|2
2714070|NCT00312208|9341165|P2|Overall Study|Protocol Violation|3
2714071|NCT00312208|9341166|P1|Overall Study|Protocol Violation|5
2714072|NCT00312208|9341165|P2|Overall Study|Adverse Event|61
2714073|NCT00312208|9341166|P1|Overall Study|Adverse Event|97
2714074|NCT00312195|9341176|P2|Overall Study|Protocol Violation|0
2714075|NCT00312195|9341177|P1|Overall Study|Protocol Violation|1
2714076|NCT00312195|9341176|P2|Overall Study|Lost to Follow-up|0
2714077|NCT00312195|9341177|P1|Overall Study|Lost to Follow-up|1
2714078|NCT00312195|9341176|P2|Overall Study|Adverse Event|6
2714079|NCT00312195|9341177|P1|Overall Study|Adverse Event|4
2714080|NCT00311623|9341205|P3|Overall Study|Physician Decision|2
2714081|NCT00311623|9341206|P2|Overall Study|Physician Decision|0
2714082|NCT00311623|9341207|P1|Overall Study|Physician Decision|0
2714083|NCT00311584|9341249|P2|Overall Study|ineligible|2
2714084|NCT00311584|9341250|P1|Overall Study|ineligible|2
2714085|NCT00311584|9341249|P2|Overall Study|Withdrawal by Subject|1
2714086|NCT00311584|9341250|P1|Overall Study|Withdrawal by Subject|1
2714087|NCT00311584|9341249|P2|Overall Study|Physician Decision|5
2714088|NCT00311584|9341250|P1|Overall Study|Physician Decision|4
2714089|NCT00311584|9341249|P2|Overall Study|Lack of Efficacy|15
2714090|NCT00311584|9341250|P1|Overall Study|Lack of Efficacy|12
2714091|NCT00311584|9341249|P2|Overall Study|Death|0
2714092|NCT00311584|9341250|P1|Overall Study|Death|1
2714093|NCT00311402|9341258|P2|Overall Study|IRB's rejection etc.|3
2714094|NCT00311402|9341259|P1|Overall Study|IRB's rejection etc.|10
2714095|NCT00311402|9341258|P2|Overall Study|Protocol Violation|6
2714096|NCT00311402|9341259|P1|Overall Study|Protocol Violation|7
2714097|NCT00311402|9341258|P2|Overall Study|Lack of Efficacy|42
2714098|NCT00311402|9341259|P1|Overall Study|Lack of Efficacy|58
2714099|NCT00311402|9341258|P2|Overall Study|Withdrawal by Subject|18
2714100|NCT00311402|9341259|P1|Overall Study|Withdrawal by Subject|17
2714101|NCT00311402|9341258|P2|Overall Study|Lost to Follow-up|3
2714102|NCT00311402|9341259|P1|Overall Study|Lost to Follow-up|0
2714103|NCT00311402|9341258|P2|Overall Study|Adverse Event|105
2714104|NCT00311402|9341259|P1|Overall Study|Adverse Event|118
2714105|NCT00311363|9341308|P3|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
2714106|NCT00311363|9341309|P2|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1
2714107|NCT00311363|9341310|P1|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
2714108|NCT00311363|9341308|P3|12-Week Double-Blind Treatment Period|Protocol Violation|2
2714109|NCT00311363|9341309|P2|12-Week Double-Blind Treatment Period|Protocol Violation|1
2714110|NCT00311363|9341310|P1|12-Week Double-Blind Treatment Period|Protocol Violation|0
2714111|NCT00311363|9341308|P3|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4
2714112|NCT00311363|9341309|P2|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2
2714113|NCT00311363|9341310|P1|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0
2714114|NCT00311363|9341308|P3|12-Week Double-Blind Treatment Period|Lack of Efficacy|4
2714115|NCT00311363|9341309|P2|12-Week Double-Blind Treatment Period|Lack of Efficacy|6
2714116|NCT00311363|9341310|P1|12-Week Double-Blind Treatment Period|Lack of Efficacy|0
2714117|NCT00311363|9341308|P3|12-Week Double-Blind Treatment Period|Lost to Follow-up|2
2714118|NCT00311363|9341309|P2|12-Week Double-Blind Treatment Period|Lost to Follow-up|1
2714119|NCT00311363|9341310|P1|12-Week Double-Blind Treatment Period|Lost to Follow-up|0
2714120|NCT00311363|9341308|P3|12-Week Double-Blind Treatment Period|Adverse Event|0
2714121|NCT00311363|9341309|P2|12-Week Double-Blind Treatment Period|Adverse Event|3
2714122|NCT00311363|9341310|P1|12-Week Double-Blind Treatment Period|Adverse Event|0
2714123|NCT00311363|9341308|P3|24-Week Single-Blind Treatment Period|Death|0
2714124|NCT00311363|9341309|P2|24-Week Single-Blind Treatment Period|Death|0
2714125|NCT00311363|9341310|P1|24-Week Single-Blind Treatment Period|Death|1
2714126|NCT00311363|9341308|P3|24-Week Single-Blind Treatment Period|Pregnancy|0
2714127|NCT00311363|9341309|P2|24-Week Single-Blind Treatment Period|Pregnancy|0
2714128|NCT00311363|9341310|P1|24-Week Single-Blind Treatment Period|Pregnancy|1
2714129|NCT00311363|9341308|P3|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
2714130|NCT00311363|9341309|P2|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
2714131|NCT00311363|9341310|P1|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1
2714132|NCT00311363|9341308|P3|24-Week Single-Blind Treatment Period|Elective Surgery|0
2714133|NCT00311363|9341309|P2|24-Week Single-Blind Treatment Period|Elective Surgery|0
2714134|NCT00311363|9341310|P1|24-Week Single-Blind Treatment Period|Elective Surgery|1
2714135|NCT00311363|9341308|P3|24-Week Single-Blind Treatment Period|Protocol Violation|0
2714136|NCT00311363|9341309|P2|24-Week Single-Blind Treatment Period|Protocol Violation|0
2714137|NCT00311363|9341310|P1|24-Week Single-Blind Treatment Period|Protocol Violation|8
2714138|NCT00311363|9341308|P3|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
2714139|NCT00311363|9341309|P2|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
2714140|NCT00311363|9341310|P1|24-Week Single-Blind Treatment Period|Lost to Follow-up|12
2714141|NCT00311363|9341308|P3|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
2714142|NCT00311363|9341309|P2|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
2714143|NCT00311363|9341310|P1|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27
2714144|NCT00311363|9341308|P3|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
2714145|NCT00311363|9341309|P2|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
2714146|NCT00311363|9341310|P1|24-Week Single-Blind Treatment Period|Lack of Efficacy|13
2714147|NCT00311363|9341308|P3|24-Week Single-Blind Treatment Period|Adverse Event|0
2714148|NCT00311363|9341309|P2|24-Week Single-Blind Treatment Period|Adverse Event|0
2714149|NCT00311363|9341310|P1|24-Week Single-Blind Treatment Period|Adverse Event|42
2714150|NCT00311311|9341370|P2|Overall Study|Lack of ancillary assistance|1
2714151|NCT00311311|9341371|P1|Overall Study|Lack of ancillary assistance|0
2714152|NCT00311311|9341370|P2|Overall Study|Death|0
2714153|NCT00311311|9341371|P1|Overall Study|Death|1
2714154|NCT00311311|9341370|P2|Overall Study|Study Termination by Sponsor|4
2714155|NCT00311311|9341371|P1|Overall Study|Study Termination by Sponsor|3
2714156|NCT00311311|9341370|P2|Overall Study|Noncompliance|1
2714157|NCT00311311|9341371|P1|Overall Study|Noncompliance|0
2714158|NCT00311311|9341370|P2|Overall Study|Withdrawal by Subject|1
2714159|NCT00311311|9341371|P1|Overall Study|Withdrawal by Subject|1
2714160|NCT00311311|9341370|P2|Overall Study|Adverse Event|2
2714161|NCT00311311|9341371|P1|Overall Study|Adverse Event|3
2714162|NCT00311181|9341421|P1|Overall Study|Final DFTs were not obtained|96
2714163|NCT00311155|9341427|P1|Overall Study|Did not meet entry criteria|55
2714164|NCT00311155|9341427|P1|Overall Study|Withdrawal by Subject|17
2714165|NCT00311155|9341427|P1|Overall Study|Adverse Event|21
2714166|NCT00310856|9341439|P3|Overall Study|Unable to classify|0
2714167|NCT00310856|9341440|P2|Overall Study|Unable to classify|0
2714168|NCT00310856|9341441|P1|Overall Study|Unable to classify|1
2714169|NCT00310856|9341439|P3|Overall Study|Inappropriate enrollment|0
2714170|NCT00310856|9341440|P2|Overall Study|Inappropriate enrollment|1
2714171|NCT00310856|9341441|P1|Overall Study|Inappropriate enrollment|1
2714172|NCT00310856|9341439|P3|Overall Study|Lost to Follow-up|6
2714173|NCT00310856|9341440|P2|Overall Study|Lost to Follow-up|2
2714174|NCT00310856|9341441|P1|Overall Study|Lost to Follow-up|1
2714175|NCT00310856|9341439|P3|Overall Study|Withdrawal by Subject|2
2714176|NCT00310856|9341440|P2|Overall Study|Withdrawal by Subject|2
2714177|NCT00310856|9341441|P1|Overall Study|Withdrawal by Subject|2
2714178|NCT00310817|9341465|P4|Overall Study|Unable to classify|0
2714179|NCT00310817|9341466|P3|Overall Study|Unable to classify|0
2714180|NCT00310817|9341467|P2|Overall Study|Unable to classify|1
2714181|NCT00310817|9341468|P1|Overall Study|Unable to classify|3
2714182|NCT00310817|9341465|P4|Overall Study|Protocol Violation|1
2714183|NCT00310817|9341466|P3|Overall Study|Protocol Violation|1
2714184|NCT00310817|9341467|P2|Overall Study|Protocol Violation|1
2714185|NCT00310817|9341468|P1|Overall Study|Protocol Violation|1
2714186|NCT00310817|9341465|P4|Overall Study|Inappropriate Enrollment|0
2714187|NCT00310817|9341466|P3|Overall Study|Inappropriate Enrollment|1
2714188|NCT00310817|9341467|P2|Overall Study|Inappropriate Enrollment|0
2714189|NCT00310817|9341468|P1|Overall Study|Inappropriate Enrollment|1
2714190|NCT00310817|9341465|P4|Overall Study|Lost to Follow-up|0
2714191|NCT00310817|9341466|P3|Overall Study|Lost to Follow-up|0
2714192|NCT00310817|9341467|P2|Overall Study|Lost to Follow-up|1
2714193|NCT00310817|9341468|P1|Overall Study|Lost to Follow-up|2
2714194|NCT00310817|9341465|P4|Overall Study|Withdrawal by Subject|7
2714195|NCT00310817|9341466|P3|Overall Study|Withdrawal by Subject|6
2714196|NCT00310817|9341467|P2|Overall Study|Withdrawal by Subject|4
2714197|NCT00310817|9341468|P1|Overall Study|Withdrawal by Subject|1
2714198|NCT00310817|9341465|P4|Overall Study|AE or Death|0
2714199|NCT00310817|9341466|P3|Overall Study|AE or Death|0
2714200|NCT00310817|9341467|P2|Overall Study|AE or Death|1
2714201|NCT00310817|9341468|P1|Overall Study|AE or Death|3
2714202|NCT00310804|9341556|P2|Overall Study|Withdrawal by Subject|0
2714203|NCT00310804|9341557|P1|Overall Study|Withdrawal by Subject|3
2714204|NCT00310804|9341556|P2|Overall Study|Lost to Follow-up|0
2714205|NCT00310804|9341557|P1|Overall Study|Lost to Follow-up|2
2714206|NCT00310440|9341616|P2|Overall Study|Missed 12 Month Visit|4
2714207|NCT00310440|9341617|P1|Overall Study|Missed 12 Month Visit|7
2714208|NCT00310440|9341616|P2|Overall Study|Withdrawal by Subject|1
2714209|NCT00310440|9341617|P1|Overall Study|Withdrawal by Subject|2
2714210|NCT00310440|9341616|P2|Overall Study|Lost to Follow-up|8
2714211|NCT00310440|9341617|P1|Overall Study|Lost to Follow-up|17
2714212|NCT00310388|9341681|P2|Safety Follow-up Continuation Phase|Study Closed/Terminated|2
2714213|NCT00310388|9341682|P1|Safety Follow-up Continuation Phase|Study Closed/Terminated|0
2714214|NCT00310388|9341681|P2|Safety Follow-up Continuation Phase|Withdrawal by Subject|5
2714215|NCT00310388|9341682|P1|Safety Follow-up Continuation Phase|Withdrawal by Subject|0
2714216|NCT00310388|9341681|P2|Safety Follow-up Continuation Phase|Adverse Event|1
2714217|NCT00310388|9341682|P1|Safety Follow-up Continuation Phase|Adverse Event|0
2714218|NCT00310388|9341681|P2|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5
2714219|NCT00310388|9341682|P1|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0
2714220|NCT00310388|9341681|P2|Primary Reporting Phase|Other|0
2714221|NCT00310388|9341682|P1|Primary Reporting Phase|Other|1
2714222|NCT00310388|9341681|P2|Primary Reporting Phase|Missing|0
2714223|NCT00310388|9341682|P1|Primary Reporting Phase|Missing|1
2714224|NCT00310388|9341681|P2|Primary Reporting Phase|Participant retired the informed consent|0
2714225|NCT00310388|9341682|P1|Primary Reporting Phase|Participant retired the informed consent|1
2714226|NCT00310388|9341681|P2|Primary Reporting Phase|Participant passed away|0
2714227|NCT00310388|9341682|P1|Primary Reporting Phase|Participant passed away|1
2714228|NCT00310388|9341681|P2|Primary Reporting Phase|Due to pigmentation risk concerns|0
2714229|NCT00310388|9341682|P1|Primary Reporting Phase|Due to pigmentation risk concerns|2
2714230|NCT00310388|9341681|P2|Primary Reporting Phase|Ongoing SAE from parent study|0
2714231|NCT00310388|9341682|P1|Primary Reporting Phase|Ongoing SAE from parent study|1
2714232|NCT00310388|9341681|P2|Primary Reporting Phase|Termination of study at sponsor request|0
2714233|NCT00310388|9341682|P1|Primary Reporting Phase|Termination of study at sponsor request|3
2714234|NCT00310388|9341681|P2|Primary Reporting Phase|Participant Immigrated to New Zealand|0
2714235|NCT00310388|9341682|P1|Primary Reporting Phase|Participant Immigrated to New Zealand|1
2714236|NCT00310388|9341681|P2|Primary Reporting Phase|Discontinuation of study|0
2714237|NCT00310388|9341682|P1|Primary Reporting Phase|Discontinuation of study|1
2714238|NCT00310388|9341681|P2|Primary Reporting Phase|Ministry of Health decision|0
2714239|NCT00310388|9341682|P1|Primary Reporting Phase|Ministry of Health decision|25
2714240|NCT00310388|9341681|P2|Primary Reporting Phase|Participant request|0
2714241|NCT00310388|9341682|P1|Primary Reporting Phase|Participant request|2
2714242|NCT00310388|9341681|P2|Primary Reporting Phase|Participant request unrelated to study|0
2714243|NCT00310388|9341682|P1|Primary Reporting Phase|Participant request unrelated to study|2
2714244|NCT00310388|9341681|P2|Primary Reporting Phase|Failed to return|0
2714245|NCT00310388|9341682|P1|Primary Reporting Phase|Failed to return|8
2714246|NCT00310388|9341681|P2|Primary Reporting Phase|Request of the sponsor|0
2714247|NCT00310388|9341682|P1|Primary Reporting Phase|Request of the sponsor|19
2714248|NCT00310388|9341681|P2|Primary Reporting Phase|Physician Decision|0
2714249|NCT00310388|9341682|P1|Primary Reporting Phase|Physician Decision|2
2714250|NCT00310388|9341681|P2|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0
2714251|NCT00310388|9341682|P1|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3
2714252|NCT00310388|9341681|P2|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0
2714253|NCT00310388|9341682|P1|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3
2714254|NCT00310388|9341681|P2|Primary Reporting Phase|Change in participant medical condition|0
2714255|NCT00310388|9341682|P1|Primary Reporting Phase|Change in participant medical condition|3
2714256|NCT00310388|9341681|P2|Primary Reporting Phase|Pregnancy|0
2714257|NCT00310388|9341682|P1|Primary Reporting Phase|Pregnancy|3
2714258|NCT00310388|9341681|P2|Primary Reporting Phase|Protocol Violation|0
2714259|NCT00310388|9341682|P1|Primary Reporting Phase|Protocol Violation|10
2714260|NCT00310388|9341681|P2|Primary Reporting Phase|Withdrawal by Subject|0
2714261|NCT00310388|9341682|P1|Primary Reporting Phase|Withdrawal by Subject|97
2714262|NCT00310388|9341681|P2|Primary Reporting Phase|Lack of Efficacy|0
2714263|NCT00310388|9341682|P1|Primary Reporting Phase|Lack of Efficacy|56
2714264|NCT00310388|9341681|P2|Primary Reporting Phase|Adverse Event|0
2714265|NCT00310388|9341682|P1|Primary Reporting Phase|Adverse Event|101
2714266|NCT00310375|9341724|P3|Safety Follow-up Continuation Phase|Lost to Follow-up|1
2714267|NCT00310375|9341725|P2|Safety Follow-up Continuation Phase|Lost to Follow-up|0
2714268|NCT00310375|9341726|P1|Safety Follow-up Continuation Phase|Lost to Follow-up|0
2714269|NCT00310375|9341724|P3|Primary Reporting Phase|Request of Ethics Committee|0
2714270|NCT00310375|9341725|P2|Primary Reporting Phase|Request of Ethics Committee|1
2714271|NCT00310375|9341726|P1|Primary Reporting Phase|Request of Ethics Committee|0
2714272|NCT00310375|9341724|P3|Primary Reporting Phase|Par. switched to commercial product|0
2714273|NCT00310375|9341725|P2|Primary Reporting Phase|Par. switched to commercial product|1
2714274|NCT00310375|9341726|P1|Primary Reporting Phase|Par. switched to commercial product|0
2714275|NCT00310375|9341724|P3|Primary Reporting Phase|Missed study drug for 2 months|0
2714276|NCT00310375|9341725|P2|Primary Reporting Phase|Missed study drug for 2 months|0
2714277|NCT00310375|9341726|P1|Primary Reporting Phase|Missed study drug for 2 months|1
2714278|NCT00310375|9341724|P3|Primary Reporting Phase|Site closure|0
2714279|NCT00310375|9341725|P2|Primary Reporting Phase|Site closure|0
2714280|NCT00310375|9341726|P1|Primary Reporting Phase|Site closure|3
2714281|NCT00310375|9341724|P3|Primary Reporting Phase|Missed study drug >5 days|0
2714282|NCT00310375|9341725|P2|Primary Reporting Phase|Missed study drug >5 days|0
2714283|NCT00310375|9341726|P1|Primary Reporting Phase|Missed study drug >5 days|1
2714284|NCT00310375|9341724|P3|Primary Reporting Phase|Going for temporal lobectomy|0
2714285|NCT00310375|9341725|P2|Primary Reporting Phase|Going for temporal lobectomy|0
2714286|NCT00310375|9341726|P1|Primary Reporting Phase|Going for temporal lobectomy|1
2714287|NCT00310375|9341724|P3|Primary Reporting Phase|Participant request unrelated to study|0
2714288|NCT00310375|9341725|P2|Primary Reporting Phase|Participant request unrelated to study|2
2714289|NCT00310375|9341726|P1|Primary Reporting Phase|Participant request unrelated to study|1
2714290|NCT00310375|9341724|P3|Primary Reporting Phase|Failed to return|0
2714291|NCT00310375|9341725|P2|Primary Reporting Phase|Failed to return|3
2714292|NCT00310375|9341726|P1|Primary Reporting Phase|Failed to return|1
2714293|NCT00310375|9341724|P3|Primary Reporting Phase|Request of the sponsor|0
2714294|NCT00310375|9341725|P2|Primary Reporting Phase|Request of the sponsor|2
2714295|NCT00310375|9341726|P1|Primary Reporting Phase|Request of the sponsor|2
2714296|NCT00310375|9341724|P3|Primary Reporting Phase|Physician Decision|0
2714297|NCT00310375|9341725|P2|Primary Reporting Phase|Physician Decision|3
2714298|NCT00310375|9341726|P1|Primary Reporting Phase|Physician Decision|5
2714299|NCT00310375|9341724|P3|Primary Reporting Phase|Transaminase >5 upper limit of normal|0
2714300|NCT00310375|9341725|P2|Primary Reporting Phase|Transaminase >5 upper limit of normal|1
2714301|NCT00310375|9341726|P1|Primary Reporting Phase|Transaminase >5 upper limit of normal|2
2714302|NCT00310375|9341724|P3|Primary Reporting Phase|Change in Par medical condition|0
2714303|NCT00310375|9341725|P2|Primary Reporting Phase|Change in Par medical condition|0
2714304|NCT00310375|9341726|P1|Primary Reporting Phase|Change in Par medical condition|2
2714305|NCT00310375|9341724|P3|Primary Reporting Phase|Protocol Violation|0
2714306|NCT00310375|9341725|P2|Primary Reporting Phase|Protocol Violation|5
2714307|NCT00310375|9341726|P1|Primary Reporting Phase|Protocol Violation|8
2714308|NCT00310375|9341724|P3|Primary Reporting Phase|Withdrawal by Subject|0
2714309|NCT00310375|9341725|P2|Primary Reporting Phase|Withdrawal by Subject|7
2714310|NCT00310375|9341726|P1|Primary Reporting Phase|Withdrawal by Subject|10
2714311|NCT00310375|9341724|P3|Primary Reporting Phase|Pregnancy|0
2714312|NCT00310375|9341725|P2|Primary Reporting Phase|Pregnancy|2
2714313|NCT00310375|9341726|P1|Primary Reporting Phase|Pregnancy|2
2714314|NCT00310375|9341724|P3|Primary Reporting Phase|Lack of Efficacy|0
2714315|NCT00310375|9341725|P2|Primary Reporting Phase|Lack of Efficacy|19
2714316|NCT00310375|9341726|P1|Primary Reporting Phase|Lack of Efficacy|24
2714317|NCT00310375|9341724|P3|Primary Reporting Phase|Adverse Event|0
2714318|NCT00310375|9341725|P2|Primary Reporting Phase|Adverse Event|22
2714319|NCT00310375|9341726|P1|Primary Reporting Phase|Adverse Event|28
2714320|NCT00310037|9341862|P2|Overall Study|Non-protocol treatment|0
2714321|NCT00310037|9341863|P1|Overall Study|Non-protocol treatment|1
2714322|NCT00310037|9341862|P2|Overall Study|Progression|0
2714323|NCT00310037|9341863|P1|Overall Study|Progression|6
2714324|NCT00310037|9341862|P2|Overall Study|Withdrawal by Subject|3
2714325|NCT00310037|9341863|P1|Overall Study|Withdrawal by Subject|4
2714326|NCT00310037|9341862|P2|Overall Study|Adverse Event|14
2714327|NCT00310037|9341863|P1|Overall Study|Adverse Event|7
2714328|NCT00309985|9341877|P2|Overall Study|Chemotherapy discontinued only|0
2714329|NCT00309985|9341878|P1|Overall Study|Chemotherapy discontinued only|1
2714330|NCT00309985|9341877|P2|Overall Study|Non-compliance|0
2714331|NCT00309985|9341878|P1|Overall Study|Non-compliance|1
2714332|NCT00309985|9341877|P2|Overall Study|Complicating disease|0
2714333|NCT00309985|9341878|P1|Overall Study|Complicating disease|1
2714334|NCT00309985|9341877|P2|Overall Study|Never started treatment|0
2714335|NCT00309985|9341878|P1|Overall Study|Never started treatment|7
2714336|NCT00309985|9341877|P2|Overall Study|Physician Decision|0
2714337|NCT00309985|9341878|P1|Overall Study|Physician Decision|3
2714338|NCT00309985|9341877|P2|Overall Study|Withdrawal by Subject|1
2714339|NCT00309985|9341878|P1|Overall Study|Withdrawal by Subject|5
2714340|NCT00309985|9341877|P2|Overall Study|Death|0
2714341|NCT00309985|9341878|P1|Overall Study|Death|2
2714342|NCT00309985|9341877|P2|Overall Study|Adverse Event|0
2714343|NCT00309985|9341878|P1|Overall Study|Adverse Event|30
2714344|NCT00309985|9341877|P2|Overall Study|Disease progression|0
2714345|NCT00309985|9341878|P1|Overall Study|Disease progression|12
2714346|NCT00309959|9341894|P1|Overall Study|Ineligible - no prior chemotherapy|2
2714347|NCT00309946|9341903|P1|Overall Study|Withdrawal by Subject|1
2714348|NCT00309907|9341909|P1|Overall Study|Major infectious event|4
2714349|NCT00309907|9341909|P1|Overall Study|Ineligible|11
2714350|NCT00309907|9341909|P1|Overall Study|Physician Decision|1
2714351|NCT00309907|9341909|P1|Overall Study|Death|4
2714352|NCT00309777|9341922|P4|Overall Study|Death|0
2714353|NCT00309777|9341923|P3|Overall Study|Death|0
2714354|NCT00309777|9341924|P2|Overall Study|Death|1
2714355|NCT00309777|9341925|P1|Overall Study|Death|0
2714356|NCT00309777|9341922|P4|Overall Study|Lost to Follow-up|0
2714357|NCT00309777|9341923|P3|Overall Study|Lost to Follow-up|1
2714358|NCT00309777|9341924|P2|Overall Study|Lost to Follow-up|0
2714359|NCT00309777|9341925|P1|Overall Study|Lost to Follow-up|0
2714360|NCT00309777|9341922|P4|Overall Study|Withdrawal by Subject|2
2714361|NCT00309777|9341923|P3|Overall Study|Withdrawal by Subject|7
2714362|NCT00309777|9341924|P2|Overall Study|Withdrawal by Subject|5
2714363|NCT00309777|9341925|P1|Overall Study|Withdrawal by Subject|6
2714364|NCT00309777|9341922|P4|Overall Study|Protocol Violation|1
2714365|NCT00309777|9341923|P3|Overall Study|Protocol Violation|3
2714366|NCT00309777|9341924|P2|Overall Study|Protocol Violation|1
2714367|NCT00309777|9341925|P1|Overall Study|Protocol Violation|4
2714368|NCT00309777|9341922|P4|Overall Study|Adverse Event|1
2714369|NCT00309777|9341923|P3|Overall Study|Adverse Event|8
2714370|NCT00309777|9341924|P2|Overall Study|Adverse Event|2
2714371|NCT00309777|9341925|P1|Overall Study|Adverse Event|13
2714372|NCT00309608|9341966|P5|Overall Study|Other incl. Lack of efficacy|0
2714373|NCT00309608|9341967|P4|Overall Study|Other incl. Lack of efficacy|4
2714374|NCT00309608|9341968|P3|Overall Study|Other incl. Lack of efficacy|3
2714375|NCT00309608|9341969|P2|Overall Study|Other incl. Lack of efficacy|4
2714376|NCT00309608|9341970|P1|Overall Study|Other incl. Lack of efficacy|10
2714377|NCT00309608|9341966|P5|Overall Study|Withdrawal by Subject|0
2714378|NCT00309608|9341967|P4|Overall Study|Withdrawal by Subject|0
2714379|NCT00309608|9341968|P3|Overall Study|Withdrawal by Subject|2
2714380|NCT00309608|9341969|P2|Overall Study|Withdrawal by Subject|4
2714381|NCT00309608|9341970|P1|Overall Study|Withdrawal by Subject|1
2714382|NCT00309608|9341966|P5|Overall Study|Lost to Follow-up|1
2714383|NCT00309608|9341967|P4|Overall Study|Lost to Follow-up|0
2714384|NCT00309608|9341968|P3|Overall Study|Lost to Follow-up|2
2714385|NCT00309608|9341969|P2|Overall Study|Lost to Follow-up|0
2714386|NCT00309608|9341970|P1|Overall Study|Lost to Follow-up|0
2714387|NCT00309608|9341966|P5|Overall Study|Protocol Violation|0
2714388|NCT00309608|9341967|P4|Overall Study|Protocol Violation|0
2714389|NCT00309608|9341968|P3|Overall Study|Protocol Violation|0
2714390|NCT00309608|9341969|P2|Overall Study|Protocol Violation|0
2714391|NCT00309608|9341970|P1|Overall Study|Protocol Violation|2
2714392|NCT00309608|9341966|P5|Overall Study|Adverse Event|3
2714393|NCT00309608|9341967|P4|Overall Study|Adverse Event|2
2714394|NCT00309608|9341968|P3|Overall Study|Adverse Event|3
2714395|NCT00309608|9341969|P2|Overall Study|Adverse Event|5
2714396|NCT00309608|9341970|P1|Overall Study|Adverse Event|1
2714397|NCT00309452|9342018|P2|Overall Study|Withdrawal by Subject|0
2714398|NCT00309452|9342019|P1|Overall Study|Withdrawal by Subject|3
2714399|NCT00309387|9342047|P2|Overall Study|Lost to Follow-up|86
2714400|NCT00309387|9342048|P1|Overall Study|Lost to Follow-up|70
2714401|NCT00309387|9342047|P2|Overall Study|Death|73
2714402|NCT00309387|9342048|P1|Overall Study|Death|72
2714403|NCT00309244|9342066|P2|Overall Study|Death|1
2714404|NCT00309244|9342067|P1|Overall Study|Death|4
2714405|NCT00309244|9342066|P2|Overall Study|Randomized but not dosed|12
2714406|NCT00309244|9342067|P1|Overall Study|Randomized but not dosed|11
2714407|NCT00309244|9342066|P2|Overall Study|Various|7
2714408|NCT00309244|9342067|P1|Overall Study|Various|7
2714409|NCT00309244|9342066|P2|Overall Study|Withdrawal by Subject|32
2714410|NCT00309244|9342067|P1|Overall Study|Withdrawal by Subject|50
2714411|NCT00309244|9342066|P2|Overall Study|Protocol Violation|3
2714412|NCT00309244|9342067|P1|Overall Study|Protocol Violation|6
2714413|NCT00309244|9342066|P2|Overall Study|Physician Decision|8
2714414|NCT00309244|9342067|P1|Overall Study|Physician Decision|5
2714415|NCT00309244|9342066|P2|Overall Study|Lost to Follow-up|22
2714416|NCT00309244|9342067|P1|Overall Study|Lost to Follow-up|6
2714417|NCT00309244|9342066|P2|Overall Study|Adverse Event|12
2714418|NCT00309244|9342067|P1|Overall Study|Adverse Event|29
2714419|NCT00309166|9342089|P2|Overall Study|Withdrawal by Subject|3
2714420|NCT00309166|9342090|P1|Overall Study|Withdrawal by Subject|4
2714421|NCT00309166|9342089|P2|Overall Study|Adverse event, non-fatal|0
2714422|NCT00309166|9342090|P1|Overall Study|Adverse event, non-fatal|1
2714423|NCT00308997|9342118|P2|Overall Study|Unable to tolerate intervention|0
2714424|NCT00308997|9342119|P1|Overall Study|Unable to tolerate intervention|1
2714425|NCT00308997|9342118|P2|Overall Study|Subject feigned clinical data|1
2714426|NCT00308997|9342119|P1|Overall Study|Subject feigned clinical data|0
2714427|NCT00308737|9342138|P3|Overall Study|Various|8
2714428|NCT00308737|9342139|P2|Overall Study|Various|20
2714429|NCT00308737|9342140|P1|Overall Study|Various|32
2714430|NCT00308737|9342138|P3|Overall Study|Withdrawal by Subject|18
2714431|NCT00308737|9342139|P2|Overall Study|Withdrawal by Subject|166
2714432|NCT00308737|9342140|P1|Overall Study|Withdrawal by Subject|218
2714433|NCT00308737|9342138|P3|Overall Study|Protocol Violation|5
2714434|NCT00308737|9342139|P2|Overall Study|Protocol Violation|9
2714435|NCT00308737|9342140|P1|Overall Study|Protocol Violation|34
2714436|NCT00308737|9342138|P3|Overall Study|Physician Decision|1
2714437|NCT00308737|9342139|P2|Overall Study|Physician Decision|2
2714438|NCT00308737|9342140|P1|Overall Study|Physician Decision|15
2714439|NCT00308737|9342138|P3|Overall Study|Lost to Follow-up|5
2714440|NCT00308737|9342139|P2|Overall Study|Lost to Follow-up|80
2714441|NCT00308737|9342140|P1|Overall Study|Lost to Follow-up|56
2714442|NCT00308737|9342138|P3|Overall Study|Death|0
2714443|NCT00308737|9342139|P2|Overall Study|Death|3
2714444|NCT00308737|9342140|P1|Overall Study|Death|4
2714445|NCT00308737|9342138|P3|Overall Study|Adverse Event|0
2714446|NCT00308737|9342139|P2|Overall Study|Adverse Event|9
2714447|NCT00308737|9342140|P1|Overall Study|Adverse Event|104
2714448|NCT00308711|9342180|P3|Overall Study|Subject incarcerated, data not allowed|1
2714449|NCT00308711|9342181|P2|Overall Study|Subject incarcerated, data not allowed|0
2714450|NCT00308711|9342182|P1|Overall Study|Subject incarcerated, data not allowed|0
2714451|NCT00308711|9342180|P3|Overall Study|Baby not born within 7 days of treatment|2
2714452|NCT00308711|9342181|P2|Overall Study|Baby not born within 7 days of treatment|2
2714453|NCT00308711|9342182|P1|Overall Study|Baby not born within 7 days of treatment|1
2714454|NCT00308711|9342180|P3|Overall Study|Lost to Follow-up|0
2714455|NCT00308711|9342181|P2|Overall Study|Lost to Follow-up|1
2714456|NCT00308711|9342182|P1|Overall Study|Lost to Follow-up|0
2714457|NCT00308711|9342180|P3|Overall Study|Protocol Violation|1
2714458|NCT00308711|9342181|P2|Overall Study|Protocol Violation|1
2714459|NCT00308711|9342182|P1|Overall Study|Protocol Violation|0
2714460|NCT00308711|9342180|P3|Overall Study|Withdrawal by Subject|1
2714461|NCT00308711|9342181|P2|Overall Study|Withdrawal by Subject|0
2714462|NCT00308711|9342182|P1|Overall Study|Withdrawal by Subject|1
2714463|NCT00308620|9342217|P3|Overall Study|Lost to Follow-up|1
2714464|NCT00308620|9342218|P2|Overall Study|Lost to Follow-up|0
2714465|NCT00308620|9342219|P1|Overall Study|Lost to Follow-up|0
2714466|NCT00308620|9342217|P3|Overall Study|Death|0
2714467|NCT00308620|9342218|P2|Overall Study|Death|1
2714468|NCT00308620|9342219|P1|Overall Study|Death|1
2714469|NCT00308581|9342228|P3|Randomized Maintenance Phase|Unknown reason|0
2714470|NCT00308581|9342229|P2|Randomized Maintenance Phase|Unknown reason|0
2714471|NCT00308581|9342230|P1|Randomized Maintenance Phase|Unknown reason|3
2714472|NCT00308581|9342228|P3|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0
2714473|NCT00308581|9342229|P2|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59
2714474|NCT00308581|9342230|P1|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82
2714475|NCT00308581|9342228|P3|Randomized Maintenance Phase|Withdrawal by Subject|0
2714476|NCT00308581|9342229|P2|Randomized Maintenance Phase|Withdrawal by Subject|4
2714477|NCT00308581|9342230|P1|Randomized Maintenance Phase|Withdrawal by Subject|1
2714478|NCT00308581|9342228|P3|Randomized Maintenance Phase|Lost to Follow-up|0
2714479|NCT00308581|9342229|P2|Randomized Maintenance Phase|Lost to Follow-up|2
2714480|NCT00308581|9342230|P1|Randomized Maintenance Phase|Lost to Follow-up|0
2714481|NCT00308581|9342228|P3|Randomized Maintenance Phase|Lack of Efficacy|0
2714482|NCT00308581|9342229|P2|Randomized Maintenance Phase|Lack of Efficacy|21
2714483|NCT00308581|9342230|P1|Randomized Maintenance Phase|Lack of Efficacy|9
2714484|NCT00308581|9342228|P3|Randomized Maintenance Phase|Adverse Event|0
2714485|NCT00308581|9342229|P2|Randomized Maintenance Phase|Adverse Event|17
2714486|NCT00308581|9342230|P1|Randomized Maintenance Phase|Adverse Event|10
2714487|NCT00308581|9342228|P3|Induction Phase|Unknown reason|3
2714488|NCT00308581|9342229|P2|Induction Phase|Unknown reason|0
2714489|NCT00308581|9342230|P1|Induction Phase|Unknown reason|0
2714490|NCT00308581|9342228|P3|Induction Phase|Withdrawal by Subject|5
2714491|NCT00308581|9342229|P2|Induction Phase|Withdrawal by Subject|0
2714492|NCT00308581|9342230|P1|Induction Phase|Withdrawal by Subject|0
2714493|NCT00308581|9342228|P3|Induction Phase|Lack of Efficacy|121
2714494|NCT00308581|9342229|P2|Induction Phase|Lack of Efficacy|0
2714495|NCT00308581|9342230|P1|Induction Phase|Lack of Efficacy|0
2714496|NCT00308581|9342228|P3|Induction Phase|Adverse Event|37
2714497|NCT00308581|9342229|P2|Induction Phase|Adverse Event|0
2714498|NCT00308581|9342230|P1|Induction Phase|Adverse Event|0
2714499|NCT00308555|9342356|P2|Overall Study|Physician Decision|0
2714500|NCT00308555|9342357|P1|Overall Study|Physician Decision|2
2714501|NCT00308555|9342356|P2|Overall Study|Withdrawal by Subject|0
2714502|NCT00308555|9342357|P1|Overall Study|Withdrawal by Subject|1
2714503|NCT00308308|9342374|P2|Overall Study|Other|0
2714504|NCT00308308|9342375|P1|Overall Study|Other|1
2714505|NCT00308308|9342374|P2|Overall Study|Randomized but not dosed|16
2714506|NCT00308308|9342375|P1|Overall Study|Randomized but not dosed|8
2714507|NCT00308308|9342374|P2|Overall Study|Various|5
2714508|NCT00308308|9342375|P1|Overall Study|Various|7
2714509|NCT00308308|9342374|P2|Overall Study|Withdrawal by Subject|19
2714510|NCT00308308|9342375|P1|Overall Study|Withdrawal by Subject|47
2714511|NCT00308308|9342374|P2|Overall Study|Protocol Violation|14
2714512|NCT00308308|9342375|P1|Overall Study|Protocol Violation|3
2714513|NCT00308308|9342374|P2|Overall Study|Physician Decision|7
2714514|NCT00308308|9342375|P1|Overall Study|Physician Decision|15
2714515|NCT00308308|9342374|P2|Overall Study|Lost to Follow-up|5
2714516|NCT00308308|9342375|P1|Overall Study|Lost to Follow-up|5
2714517|NCT00308308|9342374|P2|Overall Study|Adverse Event|2
2714518|NCT00308308|9342375|P1|Overall Study|Adverse Event|17
2714519|NCT00308139|9342454|P2|Overall Study|Other|0
2714520|NCT00308139|9342455|P1|Overall Study|Other|1
2714521|NCT00308139|9342454|P2|Overall Study|Administrative|4
2714522|NCT00308139|9342455|P1|Overall Study|Administrative|1
2714523|NCT00308139|9342454|P2|Overall Study|Loss of Glucose Control|7
2714524|NCT00308139|9342455|P1|Overall Study|Loss of Glucose Control|5
2714525|NCT00308139|9342454|P2|Overall Study|Investigator Decision|10
2714526|NCT00308139|9342455|P1|Overall Study|Investigator Decision|11
2714527|NCT00308139|9342454|P2|Overall Study|Withdrawal of Consent|42
2714528|NCT00308139|9342455|P1|Overall Study|Withdrawal of Consent|40
2714529|NCT00308139|9342454|P2|Overall Study|Protocol Violation|2
2714530|NCT00308139|9342455|P1|Overall Study|Protocol Violation|3
2714531|NCT00308139|9342454|P2|Overall Study|Lost to Follow-up|8
2714532|NCT00308139|9342455|P1|Overall Study|Lost to Follow-up|13
2714533|NCT00308139|9342454|P2|Overall Study|Adverse Event|14
2714534|NCT00308139|9342455|P1|Overall Study|Adverse Event|20
2714535|NCT00308113|9342529|P4|Overall Study|Protocol closure|1
2714536|NCT00308113|9342530|P3|Overall Study|Protocol closure|0
2714537|NCT00308113|9342531|P2|Overall Study|Protocol closure|0
2714538|NCT00308113|9342532|P1|Overall Study|Protocol closure|0
2714539|NCT00308087|9342552|P2|Overall Study|Other|3
2714540|NCT00308087|9342553|P1|Overall Study|Other|4
2714541|NCT00308087|9342552|P2|Overall Study|Withdrawal by Subject|1
2714542|NCT00308087|9342553|P1|Overall Study|Withdrawal by Subject|2
2714543|NCT00308087|9342552|P2|Overall Study|Study Closure|12
2714544|NCT00308087|9342553|P1|Overall Study|Study Closure|11
2714545|NCT00308087|9342552|P2|Overall Study|Progressive Disease|21
2714546|NCT00308087|9342553|P1|Overall Study|Progressive Disease|19
2714547|NCT00308074|9342569|P1|Overall Study|Withdrawal by Subject|1
2714548|NCT00307931|9342586|P1|Overall Study|Adverse Event|1
2714549|NCT00307801|9342603|P2|Overall Study|Pregnancy|1
2714550|NCT00307801|9342604|P1|Overall Study|Pregnancy|0
2714551|NCT00307801|9342603|P2|Overall Study|No reason specified|0
2714552|NCT00307801|9342604|P1|Overall Study|No reason specified|2
2714553|NCT00307801|9342603|P2|Overall Study|Protocol Violation|2
2714554|NCT00307801|9342604|P1|Overall Study|Protocol Violation|3
2714555|NCT00307801|9342603|P2|Overall Study|Frustration with e-diary|0
2714556|NCT00307801|9342604|P1|Overall Study|Frustration with e-diary|1
2714557|NCT00307801|9342603|P2|Overall Study|Lost to Follow-up, moved abroad|1
2714558|NCT00307801|9342604|P1|Overall Study|Lost to Follow-up, moved abroad|1
2714559|NCT00307801|9342603|P2|Overall Study|Lack of Efficacy|2
2714560|NCT00307801|9342604|P1|Overall Study|Lack of Efficacy|0
2714561|NCT00307801|9342603|P2|Overall Study|Wrong Randomization|0
2714562|NCT00307801|9342604|P1|Overall Study|Wrong Randomization|1
2714563|NCT00307801|9342603|P2|Overall Study|Decreased Libido (AE at discontinuation)|1
2714564|NCT00307801|9342604|P1|Overall Study|Decreased Libido (AE at discontinuation)|0
2714565|NCT00307801|9342603|P2|Overall Study|Adverse event (AE)/Withdrawal of consent|0
2714566|NCT00307801|9342604|P1|Overall Study|Adverse event (AE)/Withdrawal of consent|2
2714567|NCT00307801|9342603|P2|Overall Study|Non-compliance, not taken all tablets|2
2714568|NCT00307801|9342604|P1|Overall Study|Non-compliance, not taken all tablets|1
2714569|NCT00307801|9342603|P2|Overall Study|Withdrawal by Subject|4
2714570|NCT00307801|9342604|P1|Overall Study|Withdrawal by Subject|9
2714571|NCT00307801|9342603|P2|Overall Study|Adverse Event|4
2714572|NCT00307801|9342604|P1|Overall Study|Adverse Event|12
2714573|NCT00307736|9342716|P4|Overall Study|Withdrawal by Subject|0
2714574|NCT00307736|9342717|P3|Overall Study|Withdrawal by Subject|2
2714575|NCT00307736|9342718|P2|Overall Study|Withdrawal by Subject|0
2714576|NCT00307736|9342719|P1|Overall Study|Withdrawal by Subject|0
2714577|NCT00307736|9342716|P4|Overall Study|Adverse Event|3
2714578|NCT00307736|9342717|P3|Overall Study|Adverse Event|1
2714579|NCT00307736|9342718|P2|Overall Study|Adverse Event|0
2714580|NCT00307736|9342719|P1|Overall Study|Adverse Event|0
2714581|NCT00307684|9342730|P3|Double Blind Phase|Lack of Efficacy|0
2714582|NCT00307684|9342731|P2|Double Blind Phase|Lack of Efficacy|5
2714583|NCT00307684|9342732|P1|Double Blind Phase|Lack of Efficacy|2
2714584|NCT00307684|9342730|P3|Open Label Phase|other|6
2714585|NCT00307684|9342731|P2|Open Label Phase|other|0
2714586|NCT00307684|9342732|P1|Open Label Phase|other|0
2714587|NCT00307684|9342730|P3|Open Label Phase|non compliance|5
2714588|NCT00307684|9342731|P2|Open Label Phase|non compliance|0
2714589|NCT00307684|9342732|P1|Open Label Phase|non compliance|0
2714590|NCT00307684|9342730|P3|Open Label Phase|Lost to Follow-up|11
2714591|NCT00307684|9342731|P2|Open Label Phase|Lost to Follow-up|0
2714592|NCT00307684|9342732|P1|Open Label Phase|Lost to Follow-up|0
2714593|NCT00307684|9342730|P3|Open Label Phase|Withdrawal by Subject|15
2714594|NCT00307684|9342731|P2|Open Label Phase|Withdrawal by Subject|0
2714595|NCT00307684|9342732|P1|Open Label Phase|Withdrawal by Subject|0
2714596|NCT00307684|9342730|P3|Open Label Phase|Adverse Event|16
2714597|NCT00307684|9342731|P2|Open Label Phase|Adverse Event|0
2714598|NCT00307684|9342732|P1|Open Label Phase|Adverse Event|0
2714599|NCT00307684|9342730|P3|Open Label Phase|Lack of Efficacy|3
2714600|NCT00307684|9342731|P2|Open Label Phase|Lack of Efficacy|0
2714601|NCT00307684|9342732|P1|Open Label Phase|Lack of Efficacy|0
2714602|NCT00307489|9342760|P2|Week 48 Through Week 168|Seroconversion|0
2714603|NCT00307489|9342761|P1|Week 48 Through Week 168|Seroconversion|1
2714604|NCT00307489|9342760|P2|Week 48 Through Week 168|Lost to Follow-up|1
2714605|NCT00307489|9342761|P1|Week 48 Through Week 168|Lost to Follow-up|0
2714606|NCT00307489|9342760|P2|Week 48 Through Week 168|Death|1
2714607|NCT00307489|9342761|P1|Week 48 Through Week 168|Death|0
2714608|NCT00307489|9342760|P2|Week 48 Through Week 168|Lack of Efficacy|2
2714609|NCT00307489|9342761|P1|Week 48 Through Week 168|Lack of Efficacy|2
2714610|NCT00307489|9342760|P2|Week 48 Through Week 168|Withdrawal by Subject|2
2714611|NCT00307489|9342761|P1|Week 48 Through Week 168|Withdrawal by Subject|1
2714612|NCT00307489|9342760|P2|Week 48 Through Week 168|Physician Decision|0
2714613|NCT00307489|9342761|P1|Week 48 Through Week 168|Physician Decision|1
2714614|NCT00307489|9342760|P2|Week 48 Through Week 168|Adverse Event|0
2714615|NCT00307489|9342761|P1|Week 48 Through Week 168|Adverse Event|1
2714616|NCT00307489|9342760|P2|Baseline Through Week 48|Withdrawal by Subject|1
2714617|NCT00307489|9342761|P1|Baseline Through Week 48|Withdrawal by Subject|0
2714618|NCT00307489|9342760|P2|Baseline Through Week 48|Physician Decision|0
2714619|NCT00307489|9342761|P1|Baseline Through Week 48|Physician Decision|1
2714620|NCT00307489|9342760|P2|Baseline Through Week 48|Lost to Follow-up|1
2714621|NCT00307489|9342761|P1|Baseline Through Week 48|Lost to Follow-up|0
2714622|NCT00307437|9342806|P7|After Controlled Period|Other|28
2714623|NCT00307437|9342807|P6|After Controlled Period|Other|40
2714624|NCT00307437|9342808|P5|After Controlled Period|Other|9
2714625|NCT00307437|9342809|P4|After Controlled Period|Other|15
2714626|NCT00307437|9342810|P3|After Controlled Period|Other|0
2714627|NCT00307437|9342811|P2|After Controlled Period|Other|0
2714628|NCT00307437|9342812|P1|After Controlled Period|Other|0
2714629|NCT00307437|9342806|P7|After Controlled Period|Lost to Follow-up|18
2714630|NCT00307437|9342807|P6|After Controlled Period|Lost to Follow-up|13
2714631|NCT00307437|9342808|P5|After Controlled Period|Lost to Follow-up|12
2714632|NCT00307437|9342809|P4|After Controlled Period|Lost to Follow-up|7
2714633|NCT00307437|9342810|P3|After Controlled Period|Lost to Follow-up|0
2714634|NCT00307437|9342811|P2|After Controlled Period|Lost to Follow-up|0
2714635|NCT00307437|9342812|P1|After Controlled Period|Lost to Follow-up|0
2714636|NCT00307437|9342806|P7|After Controlled Period|Lack of Efficacy|24
2714637|NCT00307437|9342807|P6|After Controlled Period|Lack of Efficacy|37
2714638|NCT00307437|9342808|P5|After Controlled Period|Lack of Efficacy|17
2714639|NCT00307437|9342809|P4|After Controlled Period|Lack of Efficacy|15
2714640|NCT00307437|9342810|P3|After Controlled Period|Lack of Efficacy|0
2714641|NCT00307437|9342811|P2|After Controlled Period|Lack of Efficacy|0
2714642|NCT00307437|9342812|P1|After Controlled Period|Lack of Efficacy|0
2714643|NCT00307437|9342806|P7|After Controlled Period|Death|3
2714644|NCT00307437|9342807|P6|After Controlled Period|Death|1
2714645|NCT00307437|9342808|P5|After Controlled Period|Death|1
2714646|NCT00307437|9342809|P4|After Controlled Period|Death|3
2714647|NCT00307437|9342810|P3|After Controlled Period|Death|0
2714648|NCT00307437|9342811|P2|After Controlled Period|Death|0
2714649|NCT00307437|9342812|P1|After Controlled Period|Death|0
2714650|NCT00307437|9342806|P7|After Controlled Period|Adverse Event|40
2714651|NCT00307437|9342807|P6|After Controlled Period|Adverse Event|31
2714652|NCT00307437|9342808|P5|After Controlled Period|Adverse Event|16
2714653|NCT00307437|9342809|P4|After Controlled Period|Adverse Event|18
2714654|NCT00307437|9342810|P3|After Controlled Period|Adverse Event|0
2714655|NCT00307437|9342811|P2|After Controlled Period|Adverse Event|0
2714656|NCT00307437|9342812|P1|After Controlled Period|Adverse Event|0
2714657|NCT00307437|9342806|P7|Controlled Period|Other|0
2714658|NCT00307437|9342807|P6|Controlled Period|Other|0
2714659|NCT00307437|9342808|P5|Controlled Period|Other|0
2714660|NCT00307437|9342809|P4|Controlled Period|Other|0
2714661|NCT00307437|9342810|P3|Controlled Period|Other|3
2714662|NCT00307437|9342811|P2|Controlled Period|Other|1
2714663|NCT00307437|9342812|P1|Controlled Period|Other|5
2714664|NCT00307437|9342806|P7|Controlled Period|Lost to Follow-up|0
2714665|NCT00307437|9342807|P6|Controlled Period|Lost to Follow-up|0
2714666|NCT00307437|9342808|P5|Controlled Period|Lost to Follow-up|0
2714667|NCT00307437|9342809|P4|Controlled Period|Lost to Follow-up|0
2714668|NCT00307437|9342810|P3|Controlled Period|Lost to Follow-up|0
2714669|NCT00307437|9342811|P2|Controlled Period|Lost to Follow-up|3
2714670|NCT00307437|9342812|P1|Controlled Period|Lost to Follow-up|2
2714671|NCT00307437|9342806|P7|Controlled Period|Lack of Efficacy|0
2714672|NCT00307437|9342807|P6|Controlled Period|Lack of Efficacy|0
2714673|NCT00307437|9342808|P5|Controlled Period|Lack of Efficacy|0
2714674|NCT00307437|9342809|P4|Controlled Period|Lack of Efficacy|0
2714675|NCT00307437|9342810|P3|Controlled Period|Lack of Efficacy|0
2714676|NCT00307437|9342811|P2|Controlled Period|Lack of Efficacy|0
2714677|NCT00307437|9342812|P1|Controlled Period|Lack of Efficacy|2
2714678|NCT00307437|9342806|P7|Controlled Period|Death|0
2714679|NCT00307437|9342807|P6|Controlled Period|Death|0
2714680|NCT00307437|9342808|P5|Controlled Period|Death|0
2714681|NCT00307437|9342809|P4|Controlled Period|Death|0
2714682|NCT00307437|9342810|P3|Controlled Period|Death|1
2714683|NCT00307437|9342811|P2|Controlled Period|Death|0
2714684|NCT00307437|9342812|P1|Controlled Period|Death|0
2714685|NCT00307437|9342806|P7|Controlled Period|Adverse Event|0
2714686|NCT00307437|9342807|P6|Controlled Period|Adverse Event|0
2714687|NCT00307437|9342808|P5|Controlled Period|Adverse Event|0
2714688|NCT00307437|9342809|P4|Controlled Period|Adverse Event|0
2714689|NCT00307437|9342810|P3|Controlled Period|Adverse Event|5
2714690|NCT00307437|9342811|P2|Controlled Period|Adverse Event|2
2714691|NCT00307437|9342812|P1|Controlled Period|Adverse Event|7
2714692|NCT00307333|9342838|P2|Overall Study|Lost to Follow-up|3
2714693|NCT00307333|9342839|P1|Overall Study|Lost to Follow-up|11
2714694|NCT00307294|9342851|P1|Overall Study|Withdrawal by Subject|1
2714695|NCT00307164|9342860|P2|Overall Study|Lost to Follow-up|1
2714696|NCT00307164|9342861|P1|Overall Study|Lost to Follow-up|6
2714697|NCT00307164|9342860|P2|Overall Study|Not compliant with requirements|4
2714698|NCT00307164|9342861|P1|Overall Study|Not compliant with requirements|4
2714699|NCT00307164|9342860|P2|Overall Study|Withdrawal by Subject|8
2714700|NCT00307164|9342861|P1|Overall Study|Withdrawal by Subject|1
2714701|NCT00307164|9342860|P2|Overall Study|Subject/parent not able to get to clinic|1
2714702|NCT00307164|9342861|P1|Overall Study|Subject/parent not able to get to clinic|2
2714703|NCT00307164|9342860|P2|Overall Study|Severe debilitation, unable to continue|0
2714704|NCT00307164|9342861|P1|Overall Study|Severe debilitation, unable to continue|1
2714705|NCT00307164|9342860|P2|Overall Study|Death|0
2714706|NCT00307164|9342861|P1|Overall Study|Death|1
2714707|NCT00307151|9342901|P4|Overall Study|Clinic unable to contact subject|1
2714708|NCT00307151|9342902|P3|Overall Study|Clinic unable to contact subject|1
2714709|NCT00307151|9342903|P2|Overall Study|Clinic unable to contact subject|3
2714710|NCT00307151|9342904|P1|Overall Study|Clinic unable to contact subject|3
2714711|NCT00307151|9342901|P4|Overall Study|Not willing to adhere to study reqs|2
2714712|NCT00307151|9342902|P3|Overall Study|Not willing to adhere to study reqs|2
2714713|NCT00307151|9342903|P2|Overall Study|Not willing to adhere to study reqs|0
2714714|NCT00307151|9342904|P1|Overall Study|Not willing to adhere to study reqs|2
2714715|NCT00307151|9342901|P4|Overall Study|Withdrew consent|3
2714716|NCT00307151|9342902|P3|Overall Study|Withdrew consent|1
2714717|NCT00307151|9342903|P2|Overall Study|Withdrew consent|1
2714718|NCT00307151|9342904|P1|Overall Study|Withdrew consent|0
2714719|NCT00307151|9342901|P4|Overall Study|Subject unable to get to clinic|2
2714720|NCT00307151|9342902|P3|Overall Study|Subject unable to get to clinic|6
2714721|NCT00307151|9342903|P2|Overall Study|Subject unable to get to clinic|0
2714722|NCT00307151|9342904|P1|Overall Study|Subject unable to get to clinic|1
2714723|NCT00307151|9342901|P4|Overall Study|Severe debilitation, unable to continue|0
2714724|NCT00307151|9342902|P3|Overall Study|Severe debilitation, unable to continue|0
2714725|NCT00307151|9342903|P2|Overall Study|Severe debilitation, unable to continue|0
2714726|NCT00307151|9342904|P1|Overall Study|Severe debilitation, unable to continue|1
2714727|NCT00307151|9342901|P4|Overall Study|Death|3
2714728|NCT00307151|9342902|P3|Overall Study|Death|10
2714729|NCT00307151|9342903|P2|Overall Study|Death|3
2714730|NCT00307151|9342904|P1|Overall Study|Death|4
2714731|NCT00307125|9342948|P3|Pilot Phase|Withdrawal by Subject|1
2714732|NCT00307125|9342949|P2|Pilot Phase|Withdrawal by Subject|1
2714733|NCT00307125|9342950|P1|Pilot Phase|Withdrawal by Subject|0
2714734|NCT00307125|9342948|P3|Pilot Phase|Lost to Follow-up|0
2714735|NCT00307125|9342949|P2|Pilot Phase|Lost to Follow-up|1
2714736|NCT00307125|9342950|P1|Pilot Phase|Lost to Follow-up|0
2714737|NCT00307125|9342948|P3|Screening Phase|Coronary artery bypass|0
2714738|NCT00307125|9342949|P2|Screening Phase|Coronary artery bypass|0
2714739|NCT00307125|9342950|P1|Screening Phase|Coronary artery bypass|1
2714740|NCT00307125|9342948|P3|Screening Phase|AMR and treated with rituximab|0
2714741|NCT00307125|9342949|P2|Screening Phase|AMR and treated with rituximab|0
2714742|NCT00307125|9342950|P1|Screening Phase|AMR and treated with rituximab|1
2714743|NCT00307125|9342948|P3|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
2714744|NCT00307125|9342949|P2|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
2714745|NCT00307125|9342950|P1|Screening Phase|Sample of Anti-HLA Ab was not obtained|1
2714746|NCT00307125|9342948|P3|Screening Phase|Screen Error|0
2714747|NCT00307125|9342949|P2|Screening Phase|Screen Error|0
2714748|NCT00307125|9342950|P1|Screening Phase|Screen Error|1
2714749|NCT00307125|9342948|P3|Screening Phase|Ineligible|0
2714750|NCT00307125|9342949|P2|Screening Phase|Ineligible|0
2714751|NCT00307125|9342950|P1|Screening Phase|Ineligible|1
2714752|NCT00307125|9342948|P3|Screening Phase|PAK|0
2714753|NCT00307125|9342949|P2|Screening Phase|PAK|0
2714754|NCT00307125|9342950|P1|Screening Phase|PAK|1
2714755|NCT00307125|9342948|P3|Screening Phase|Malignancy|0
2714756|NCT00307125|9342949|P2|Screening Phase|Malignancy|0
2714757|NCT00307125|9342950|P1|Screening Phase|Malignancy|1
2714758|NCT00307125|9342948|P3|Screening Phase|Metastatic colon cancer|0
2714759|NCT00307125|9342949|P2|Screening Phase|Metastatic colon cancer|0
2714760|NCT00307125|9342950|P1|Screening Phase|Metastatic colon cancer|1
2714761|NCT00307125|9342948|P3|Screening Phase|Developed acute leukemia|0
2714762|NCT00307125|9342949|P2|Screening Phase|Developed acute leukemia|0
2714763|NCT00307125|9342950|P1|Screening Phase|Developed acute leukemia|1
2714764|NCT00307125|9342948|P3|Screening Phase|Try to get pregnant|0
2714765|NCT00307125|9342949|P2|Screening Phase|Try to get pregnant|0
2714766|NCT00307125|9342950|P1|Screening Phase|Try to get pregnant|1
2714767|NCT00307125|9342948|P3|Screening Phase|Ineligible for pilot|0
2714768|NCT00307125|9342949|P2|Screening Phase|Ineligible for pilot|0
2714769|NCT00307125|9342950|P1|Screening Phase|Ineligible for pilot|4
2714770|NCT00307125|9342948|P3|Screening Phase|Received Pancreas Transplant|0
2714771|NCT00307125|9342949|P2|Screening Phase|Received Pancreas Transplant|0
2714772|NCT00307125|9342950|P1|Screening Phase|Received Pancreas Transplant|8
2714773|NCT00307125|9342948|P3|Screening Phase|Moved or transferred facilities|0
2714774|NCT00307125|9342949|P2|Screening Phase|Moved or transferred facilities|0
2714775|NCT00307125|9342950|P1|Screening Phase|Moved or transferred facilities|34
2714776|NCT00307125|9342948|P3|Screening Phase|Scheduling issues/Non-compliance|0
2714777|NCT00307125|9342949|P2|Screening Phase|Scheduling issues/Non-compliance|0
2714778|NCT00307125|9342950|P1|Screening Phase|Scheduling issues/Non-compliance|55
2714779|NCT00307125|9342948|P3|Screening Phase|Follow-up period ended on Dec 31, 2011|0
2714780|NCT00307125|9342949|P2|Screening Phase|Follow-up period ended on Dec 31, 2011|0
2714781|NCT00307125|9342950|P1|Screening Phase|Follow-up period ended on Dec 31, 2011|83
2714782|NCT00307125|9342948|P3|Screening Phase|Graft Failure|0
2714783|NCT00307125|9342949|P2|Screening Phase|Graft Failure|0
2714784|NCT00307125|9342950|P1|Screening Phase|Graft Failure|8
2714785|NCT00307125|9342948|P3|Screening Phase|Graft Loss|0
2714786|NCT00307125|9342949|P2|Screening Phase|Graft Loss|0
2714787|NCT00307125|9342950|P1|Screening Phase|Graft Loss|3
2714788|NCT00307125|9342948|P3|Screening Phase|Study Terminated|0
2714789|NCT00307125|9342949|P2|Screening Phase|Study Terminated|0
2714790|NCT00307125|9342950|P1|Screening Phase|Study Terminated|17
2714791|NCT00307125|9342948|P3|Screening Phase|Sponsor Decision|0
2714792|NCT00307125|9342949|P2|Screening Phase|Sponsor Decision|0
2714793|NCT00307125|9342950|P1|Screening Phase|Sponsor Decision|4
2714794|NCT00307125|9342948|P3|Screening Phase|Physician Decision|0
2714795|NCT00307125|9342949|P2|Screening Phase|Physician Decision|0
2714796|NCT00307125|9342950|P1|Screening Phase|Physician Decision|26
2714797|NCT00307125|9342948|P3|Screening Phase|Withdrawal by Subject|0
2714798|NCT00307125|9342949|P2|Screening Phase|Withdrawal by Subject|0
2714799|NCT00307125|9342950|P1|Screening Phase|Withdrawal by Subject|77
2714800|NCT00307125|9342948|P3|Screening Phase|Death|0
2714801|NCT00307125|9342949|P2|Screening Phase|Death|0
2714802|NCT00307125|9342950|P1|Screening Phase|Death|10
2714803|NCT00307125|9342948|P3|Screening Phase|Lost to Follow-up|0
2714804|NCT00307125|9342949|P2|Screening Phase|Lost to Follow-up|0
2714805|NCT00307125|9342950|P1|Screening Phase|Lost to Follow-up|87
2714806|NCT00307125|9342948|P3|Screening Phase|Protocol Violation|0
2714807|NCT00307125|9342949|P2|Screening Phase|Protocol Violation|0
2714808|NCT00307125|9342950|P1|Screening Phase|Protocol Violation|27
2714809|NCT00307125|9342948|P3|Screening Phase|Adverse Event|0
2714810|NCT00307125|9342949|P2|Screening Phase|Adverse Event|0
2714811|NCT00307125|9342950|P1|Screening Phase|Adverse Event|1
2714812|NCT00307086|9342972|P1|Overall Study|ineligible|5
2714813|NCT00307047|9342978|P2|Overall Study|All death, all MI, all Revascularization|16
2714814|NCT00307047|9342979|P1|Overall Study|All death, all MI, all Revascularization|27
2714815|NCT00307047|9342978|P2|Overall Study|Lost to follow-up for other reasons|1
2714816|NCT00307047|9342979|P1|Overall Study|Lost to follow-up for other reasons|0
2714817|NCT00307047|9342978|P2|Overall Study|Physician Decision|2
2714818|NCT00307047|9342979|P1|Overall Study|Physician Decision|1
2714819|NCT00307047|9342978|P2|Overall Study|Withdrawal by Subject|6
2714820|NCT00307047|9342979|P1|Overall Study|Withdrawal by Subject|6
2714821|NCT00307047|9342978|P2|Overall Study|Lost to Follow-up|24
2714822|NCT00307047|9342979|P1|Overall Study|Lost to Follow-up|35
2714823|NCT00307034|9343117|P2|Overall Study|Lost to Follow-up|3
2714824|NCT00307034|9343118|P1|Overall Study|Lost to Follow-up|0
2714825|NCT00307034|9343117|P2|Overall Study|Withdrawal by Subject|2
2714826|NCT00307034|9343118|P1|Overall Study|Withdrawal by Subject|1
2714827|NCT00307034|9343117|P2|Overall Study|Adverse Event|2
2714828|NCT00307034|9343118|P1|Overall Study|Adverse Event|1
2714829|NCT00306995|9343163|P7|Study Part II for Subset 2|Serious Adverse Event|0
2714830|NCT00306995|9343164|P6|Study Part II for Subset 2|Serious Adverse Event|0
2714831|NCT00306995|9343165|P5|Study Part II for Subset 2|Serious Adverse Event|0
2714832|NCT00306995|9343166|P4|Study Part II for Subset 2|Serious Adverse Event|0
2714833|NCT00306995|9343167|P3|Study Part II for Subset 2|Serious Adverse Event|0
2714834|NCT00306995|9343168|P2|Study Part II for Subset 2|Serious Adverse Event|1
2714835|NCT00306995|9343169|P1|Study Part II for Subset 2|Serious Adverse Event|0
2714836|NCT00306995|9343163|P7|Study Part I|Withdrawal by Subject|1
2714837|NCT00306995|9343164|P6|Study Part I|Withdrawal by Subject|0
2714838|NCT00306995|9343165|P5|Study Part I|Withdrawal by Subject|0
2714839|NCT00306995|9343166|P4|Study Part I|Withdrawal by Subject|0
2714840|NCT00306995|9343167|P3|Study Part I|Withdrawal by Subject|0
2714841|NCT00306995|9343168|P2|Study Part I|Withdrawal by Subject|0
2714842|NCT00306995|9343169|P1|Study Part I|Withdrawal by Subject|0
2714843|NCT00306891|9343562|P4|Part B|Development of study specific disc crit.|1
2714844|NCT00306891|9343563|P3|Part B|Development of study specific disc crit.|0
2714845|NCT00306891|9343564|P2|Part B|Development of study specific disc crit.|0
2714846|NCT00306891|9343565|P1|Part B|Development of study specific disc crit.|0
2714847|NCT00306891|9343562|P4|Part B|Condition under investigation worsened|8
2714848|NCT00306891|9343563|P3|Part B|Condition under investigation worsened|2
2714849|NCT00306891|9343564|P2|Part B|Condition under investigation worsened|0
2714850|NCT00306891|9343565|P1|Part B|Condition under investigation worsened|0
2714851|NCT00306891|9343562|P4|Part B|Withdrawal by Subject|1
2714852|NCT00306891|9343563|P3|Part B|Withdrawal by Subject|3
2714853|NCT00306891|9343564|P2|Part B|Withdrawal by Subject|0
2714854|NCT00306891|9343565|P1|Part B|Withdrawal by Subject|0
2714855|NCT00306891|9343562|P4|Part B|Adverse Event|5
2714856|NCT00306891|9343563|P3|Part B|Adverse Event|5
2714857|NCT00306891|9343564|P2|Part B|Adverse Event|0
2714858|NCT00306891|9343565|P1|Part B|Adverse Event|0
2714859|NCT00306891|9343562|P4|Part B|Death|2
2714860|NCT00306891|9343563|P3|Part B|Death|1
2714861|NCT00306891|9343564|P2|Part B|Death|0
2714862|NCT00306891|9343565|P1|Part B|Death|0
2714863|NCT00306891|9343562|P4|Part A|QTC interval outwith elig. criteria|0
2714864|NCT00306891|9343563|P3|Part A|QTC interval outwith elig. criteria|0
2714865|NCT00306891|9343564|P2|Part A|QTC interval outwith elig. criteria|0
2714866|NCT00306891|9343565|P1|Part A|QTC interval outwith elig. criteria|1
2714867|NCT00306891|9343562|P4|Part A|Suspicion of second malignancy|0
2714868|NCT00306891|9343563|P3|Part A|Suspicion of second malignancy|0
2714869|NCT00306891|9343564|P2|Part A|Suspicion of second malignancy|1
2714870|NCT00306891|9343565|P1|Part A|Suspicion of second malignancy|0
2714871|NCT00306891|9343562|P4|Part A|Reaccumul. of ascites following drainage|0
2714872|NCT00306891|9343563|P3|Part A|Reaccumul. of ascites following drainage|0
2714873|NCT00306891|9343564|P2|Part A|Reaccumul. of ascites following drainage|1
2714874|NCT00306891|9343565|P1|Part A|Reaccumul. of ascites following drainage|0
2714875|NCT00306891|9343562|P4|Part A|Partial bowel obstruction|0
2714876|NCT00306891|9343563|P3|Part A|Partial bowel obstruction|0
2714877|NCT00306891|9343564|P2|Part A|Partial bowel obstruction|0
2714878|NCT00306891|9343565|P1|Part A|Partial bowel obstruction|1
2714879|NCT00306891|9343562|P4|Part A|Incorrect enrol/entry crit not fulfilled|0
2714880|NCT00306891|9343563|P3|Part A|Incorrect enrol/entry crit not fulfilled|0
2714881|NCT00306891|9343564|P2|Part A|Incorrect enrol/entry crit not fulfilled|1
2714882|NCT00306891|9343565|P1|Part A|Incorrect enrol/entry crit not fulfilled|0
2714883|NCT00306891|9343562|P4|Part A|Condition under investigation worsened|0
2714884|NCT00306891|9343563|P3|Part A|Condition under investigation worsened|0
2714885|NCT00306891|9343564|P2|Part A|Condition under investigation worsened|2
2714886|NCT00306891|9343565|P1|Part A|Condition under investigation worsened|2
2714887|NCT00306891|9343562|P4|Part A|Withdrawal by Subject|0
2714888|NCT00306891|9343563|P3|Part A|Withdrawal by Subject|0
2714889|NCT00306891|9343564|P2|Part A|Withdrawal by Subject|1
2714890|NCT00306891|9343565|P1|Part A|Withdrawal by Subject|1
2714891|NCT00306852|9343588|P2|Overall Study|Lost to Follow-up|24
2714892|NCT00306852|9343589|P1|Overall Study|Lost to Follow-up|15
2714893|NCT00306852|9343588|P2|Overall Study|Death|14
2714894|NCT00306852|9343589|P1|Overall Study|Death|14
2714895|NCT00306787|9343607|P2|Overall Study|Abnormal laboratory value(s)|0
2714896|NCT00306787|9343608|P1|Overall Study|Abnormal laboratory value(s)|1
2714897|NCT00306787|9343607|P2|Overall Study|Administrative problems|0
2714898|NCT00306787|9343608|P1|Overall Study|Administrative problems|4
2714899|NCT00306787|9343607|P2|Overall Study|Lost to Follow-up|6
2714900|NCT00306787|9343608|P1|Overall Study|Lost to Follow-up|9
2714901|NCT00306787|9343607|P2|Overall Study|Withdrawal by Subject|9
2714902|NCT00306787|9343608|P1|Overall Study|Withdrawal by Subject|2
2714903|NCT00306787|9343607|P2|Overall Study|Protocol Violation|10
2714904|NCT00306787|9343608|P1|Overall Study|Protocol Violation|8
2714905|NCT00306787|9343607|P2|Overall Study|Lack of Efficacy|0
2714906|NCT00306787|9343608|P1|Overall Study|Lack of Efficacy|1
2714907|NCT00306787|9343607|P2|Overall Study|Adverse Event|1
2714908|NCT00306787|9343608|P1|Overall Study|Adverse Event|1
2714909|NCT00306787|9343607|P2|Overall Study|Discontinued without taking study drug|215
2714910|NCT00306787|9343608|P1|Overall Study|Discontinued without taking study drug|208
2714911|NCT00306670|9343626|P2|Overall Study|patients recruited; Genentech, the st|2
2714912|NCT00306670|9343627|P1|Overall Study|patients recruited; Genentech, the st|0
2714913|NCT00306592|9343633|P2|Overall Study|48-week Treatment Period Ongoing|20
2714914|NCT00306592|9343634|P1|Overall Study|48-week Treatment Period Ongoing|0
2714915|NCT00306592|9343633|P2|Overall Study|Other|2
2714916|NCT00306592|9343634|P1|Overall Study|Other|1
2714917|NCT00306592|9343633|P2|Overall Study|Other|10
2714918|NCT00306592|9343634|P1|Overall Study|Other|5
2714919|NCT00306592|9343633|P2|Overall Study|Voluntary|6
2714920|NCT00306592|9343634|P1|Overall Study|Voluntary|10
2714921|NCT00306592|9343633|P2|Overall Study|Persistent Antibodies|3
2714922|NCT00306592|9343634|P1|Overall Study|Persistent Antibodies|6
2714923|NCT00306592|9343633|P2|Overall Study|Noncompliance|2
2714924|NCT00306592|9343634|P1|Overall Study|Noncompliance|0
2714925|NCT00306592|9343633|P2|Overall Study|Lost to Follow-up|0
2714926|NCT00306592|9343634|P1|Overall Study|Lost to Follow-up|1
2714927|NCT00306592|9343633|P2|Overall Study|Adverse Event|15
2714928|NCT00306592|9343634|P1|Overall Study|Adverse Event|8
2714929|NCT00306527|9343644|P4|Overall Study|Death|2
2714930|NCT00306527|9343645|P3|Overall Study|Death|1
2714931|NCT00306527|9343646|P2|Overall Study|Death|0
2714932|NCT00306527|9343647|P1|Overall Study|Death|1
2714933|NCT00306527|9343644|P4|Overall Study|Adverse Event|1
2714934|NCT00306527|9343645|P3|Overall Study|Adverse Event|1
2714935|NCT00306527|9343646|P2|Overall Study|Adverse Event|0
2714936|NCT00306527|9343647|P1|Overall Study|Adverse Event|0
2714937|NCT00306527|9343644|P4|Overall Study|Withdrawal by Subject|3
2714938|NCT00306527|9343645|P3|Overall Study|Withdrawal by Subject|0
2714939|NCT00306527|9343646|P2|Overall Study|Withdrawal by Subject|3
2714940|NCT00306527|9343647|P1|Overall Study|Withdrawal by Subject|2
2714941|NCT00306527|9343644|P4|Overall Study|Lost to Follow-up|0
2714942|NCT00306527|9343645|P3|Overall Study|Lost to Follow-up|3
2714943|NCT00306527|9343646|P2|Overall Study|Lost to Follow-up|4
2714944|NCT00306527|9343647|P1|Overall Study|Lost to Follow-up|3
2714945|NCT00306384|9343716|P3|Overall Study|Site closure|0
2714946|NCT00306384|9343717|P2|Overall Study|Site closure|0
2714947|NCT00306384|9343718|P1|Overall Study|Site closure|2
2714948|NCT00306384|9343716|P3|Overall Study|Other|32
2714949|NCT00306384|9343717|P2|Overall Study|Other|70
2714950|NCT00306384|9343718|P1|Overall Study|Other|80
2714951|NCT00306384|9343716|P3|Overall Study|Investigator discretion|21
2714952|NCT00306384|9343717|P2|Overall Study|Investigator discretion|31
2714953|NCT00306384|9343718|P1|Overall Study|Investigator discretion|28
2714954|NCT00306384|9343716|P3|Overall Study|Lack of Efficacy|38
2714955|NCT00306384|9343717|P2|Overall Study|Lack of Efficacy|40
2714956|NCT00306384|9343718|P1|Overall Study|Lack of Efficacy|26
2714957|NCT00306384|9343716|P3|Overall Study|Pregnancy|1
2714958|NCT00306384|9343717|P2|Overall Study|Pregnancy|1
2714959|NCT00306384|9343718|P1|Overall Study|Pregnancy|3
2714960|NCT00306384|9343716|P3|Overall Study|Study termination|1
2714961|NCT00306384|9343717|P2|Overall Study|Study termination|0
2714962|NCT00306384|9343718|P1|Overall Study|Study termination|1
2714963|NCT00306384|9343716|P3|Overall Study|Voluntary withdrawal|91
2714964|NCT00306384|9343717|P2|Overall Study|Voluntary withdrawal|187
2714965|NCT00306384|9343718|P1|Overall Study|Voluntary withdrawal|199
2714966|NCT00306384|9343716|P3|Overall Study|Lost to Follow-up|35
2714967|NCT00306384|9343717|P2|Overall Study|Lost to Follow-up|41
2714968|NCT00306384|9343718|P1|Overall Study|Lost to Follow-up|57
2714969|NCT00306384|9343716|P3|Overall Study|Major protocol deviation|18
2714970|NCT00306384|9343717|P2|Overall Study|Major protocol deviation|51
2714971|NCT00306384|9343718|P1|Overall Study|Major protocol deviation|43
2714972|NCT00306384|9343716|P3|Overall Study|Adverse Event|40
2714973|NCT00306384|9343717|P2|Overall Study|Adverse Event|87
2714974|NCT00306384|9343718|P1|Overall Study|Adverse Event|103
2714975|NCT00306293|9343750|P2|Period 2 (Day 67 to Day 126 )|Pregnancy|0
2714976|NCT00306293|9343751|P1|Period 2 (Day 67 to Day 126 )|Pregnancy|1
2714977|NCT00306293|9343750|P2|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1
2714978|NCT00306293|9343751|P1|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0
2714979|NCT00306293|9343750|P2|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0
2714980|NCT00306293|9343751|P1|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1
2714981|NCT00306293|9343750|P2|Period 2 (Day 67 to Day 126 )|Adverse Event|0
2714982|NCT00306293|9343751|P1|Period 2 (Day 67 to Day 126 )|Adverse Event|1
2714983|NCT00306293|9343750|P2|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
2714984|NCT00306293|9343751|P1|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
2714985|NCT00306293|9343750|P2|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
2714986|NCT00306293|9343751|P1|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
2714987|NCT00306293|9343750|P2|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4
2714988|NCT00306293|9343751|P1|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3
2714989|NCT00306293|9343750|P2|Period 1 (Day 1 to Day 60)|Adverse Event|0
2714990|NCT00306293|9343751|P1|Period 1 (Day 1 to Day 60)|Adverse Event|1
2714991|NCT00306202|9343772|P3|Overall Study|Still on treatment|0
2714992|NCT00306202|9343773|P2|Overall Study|Still on treatment|1
2714993|NCT00306202|9343774|P1|Overall Study|Still on treatment|6
2714994|NCT00306189|9343934|P4|Overall Study|Other|0
2714995|NCT00306189|9343935|P3|Overall Study|Other|0
2714996|NCT00306189|9343936|P2|Overall Study|Other|0
2714997|NCT00306189|9343937|P1|Overall Study|Other|1
2714998|NCT00306189|9343934|P4|Overall Study|Ineligibility determined|1
2714999|NCT00306189|9343935|P3|Overall Study|Ineligibility determined|1
2715000|NCT00306189|9343936|P2|Overall Study|Ineligibility determined|1
2715001|NCT00306189|9343937|P1|Overall Study|Ineligibility determined|1
2715002|NCT00306189|9343934|P4|Overall Study|Withdrawal by Subject|1
2715003|NCT00306189|9343935|P3|Overall Study|Withdrawal by Subject|8
2715004|NCT00306189|9343936|P2|Overall Study|Withdrawal by Subject|2
2715005|NCT00306189|9343937|P1|Overall Study|Withdrawal by Subject|4
2715006|NCT00306189|9343934|P4|Overall Study|Adverse Event|2
2715007|NCT00306189|9343935|P3|Overall Study|Adverse Event|2
2715008|NCT00306189|9343936|P2|Overall Study|Adverse Event|3
2715009|NCT00306189|9343937|P1|Overall Study|Adverse Event|3
2715010|NCT00306189|9343934|P4|Overall Study|Physician Decision|1
2715011|NCT00306189|9343935|P3|Overall Study|Physician Decision|0
2715012|NCT00306189|9343936|P2|Overall Study|Physician Decision|0
2715013|NCT00306189|9343937|P1|Overall Study|Physician Decision|0
2715014|NCT00305877|9343964|P2|Overall Study|Transportation issue with daily RT|1
2715015|NCT00305877|9343965|P1|Overall Study|Transportation issue with daily RT|0
2715016|NCT00305877|9343964|P2|Overall Study|Ineligible|1
2715017|NCT00305877|9343965|P1|Overall Study|Ineligible|2
2715018|NCT00305877|9343964|P2|Overall Study|Never start treatment|5
2715019|NCT00305877|9343965|P1|Overall Study|Never start treatment|2
2715020|NCT00305877|9343964|P2|Overall Study|Physician Decision|1
2715021|NCT00305877|9343965|P1|Overall Study|Physician Decision|1
2715022|NCT00305877|9343964|P2|Overall Study|Withdrawal by Subject|2
2715023|NCT00305877|9343965|P1|Overall Study|Withdrawal by Subject|4
2715024|NCT00305877|9343964|P2|Overall Study|Death|1
2715025|NCT00305877|9343965|P1|Overall Study|Death|0
2715026|NCT00305877|9343964|P2|Overall Study|Adverse Event|14
2715027|NCT00305877|9343965|P1|Overall Study|Adverse Event|9
2715028|NCT00305877|9343964|P2|Overall Study|Lack of Efficacy|9
2715029|NCT00305877|9343965|P1|Overall Study|Lack of Efficacy|6
2715030|NCT00305864|9343979|P4|Overall Study|Ineligible / No protocol treatment|13
2715031|NCT00305864|9343980|P3|Overall Study|Ineligible / No protocol treatment|1
2715032|NCT00305864|9343981|P2|Overall Study|Ineligible / No protocol treatment|1
2715033|NCT00305864|9343982|P1|Overall Study|Ineligible / No protocol treatment|0
2715034|NCT00305773|9343995|P2|Overall Study|All other reasons|2
2715035|NCT00305773|9343996|P1|Overall Study|All other reasons|3
2715036|NCT00305773|9343995|P2|Overall Study|Disease Progression|3
2715037|NCT00305773|9343996|P1|Overall Study|Disease Progression|1
2715038|NCT00305773|9343995|P2|Overall Study|Withdrawal by Subject|4
2715039|NCT00305773|9343996|P1|Overall Study|Withdrawal by Subject|1
2715040|NCT00305773|9343995|P2|Overall Study|Physician Decision|1
2715041|NCT00305773|9343996|P1|Overall Study|Physician Decision|1
2715042|NCT00305773|9343995|P2|Overall Study|Alternative Treatment|4
2715043|NCT00305773|9343996|P1|Overall Study|Alternative Treatment|4
2715044|NCT00305773|9343995|P2|Overall Study|Adverse Event|2
2715045|NCT00305773|9343996|P1|Overall Study|Adverse Event|1
2715046|NCT00305773|9343995|P2|Overall Study|Death|2
2715047|NCT00305773|9343996|P1|Overall Study|Death|3
2715048|NCT00305695|9344016|P2|Overall Study|Did not have baseline scan|1
2715049|NCT00305695|9344017|P1|Overall Study|Did not have baseline scan|1
2715050|NCT00305695|9344016|P2|Overall Study|Withdrawal by subject prior to 18 month|26
2715051|NCT00305695|9344017|P1|Overall Study|Withdrawal by subject prior to 18 month|40
2715052|NCT00305604|9344042|P2|Overall Study|Patient moved|0
2715053|NCT00305604|9344043|P1|Overall Study|Patient moved|1
2715054|NCT00305604|9344042|P2|Overall Study|Withdrawal by Subject|21
2715055|NCT00305604|9344043|P1|Overall Study|Withdrawal by Subject|12
2715056|NCT00305604|9344042|P2|Overall Study|Protocol Violation|1
2715057|NCT00305604|9344043|P1|Overall Study|Protocol Violation|2
2715058|NCT00305604|9344042|P2|Overall Study|Lost to Follow-up|4
2715059|NCT00305604|9344043|P1|Overall Study|Lost to Follow-up|0
2715060|NCT00305604|9344042|P2|Overall Study|Lack of Efficacy|18
2715061|NCT00305604|9344043|P1|Overall Study|Lack of Efficacy|11
2715062|NCT00305604|9344042|P2|Overall Study|Adverse Event|3
2715063|NCT00305604|9344043|P1|Overall Study|Adverse Event|6
2715064|NCT00305448|9344187|P3|Overall Study|Tumor Marker Elevation|1
2715065|NCT00305448|9344188|P2|Overall Study|Tumor Marker Elevation|0
2715066|NCT00305448|9344189|P1|Overall Study|Tumor Marker Elevation|0
2715067|NCT00305448|9344187|P3|Overall Study|Subjective Disease Progression|2
2715068|NCT00305448|9344188|P2|Overall Study|Subjective Disease Progression|2
2715069|NCT00305448|9344189|P1|Overall Study|Subjective Disease Progression|1
2715070|NCT00305448|9344187|P3|Overall Study|Disease Progression|28
2715071|NCT00305448|9344188|P2|Overall Study|Disease Progression|31
2715072|NCT00305448|9344189|P1|Overall Study|Disease Progression|27
2715073|NCT00305448|9344187|P3|Overall Study|Adverse Event|1
2715074|NCT00305448|9344188|P2|Overall Study|Adverse Event|0
2715075|NCT00305448|9344189|P1|Overall Study|Adverse Event|1
2715076|NCT00305448|9344187|P3|Overall Study|Withdrawal by Subject|1
2715077|NCT00305448|9344188|P2|Overall Study|Withdrawal by Subject|0
2715078|NCT00305448|9344189|P1|Overall Study|Withdrawal by Subject|2
2715079|NCT00305448|9344187|P3|Overall Study|Protocol Violation|0
2715080|NCT00305448|9344188|P2|Overall Study|Protocol Violation|1
2715081|NCT00305448|9344189|P1|Overall Study|Protocol Violation|0
2715082|NCT00305253|9344211|P2|Overall Study|Withdrawal by Subject|1
2715083|NCT00305253|9344212|P1|Overall Study|Withdrawal by Subject|0
2715084|NCT00305227|9344224|P2|Overall Study|Lost to Follow-up|6
2715085|NCT00305227|9344225|P1|Overall Study|Lost to Follow-up|7
2715086|NCT00305110|9344272|P1|Overall Study|Missing data|29
2715087|NCT00305058|9344345|P2|Overall Study|Missing outcome data|2
2715088|NCT00305058|9344346|P1|Overall Study|Missing outcome data|3
2715089|NCT00305058|9344345|P2|Overall Study|Missing data collection instrument|2
2715090|NCT00305058|9344346|P1|Overall Study|Missing data collection instrument|3
2715091|NCT00305058|9344345|P2|Overall Study|Participant too young|0
2715092|NCT00305058|9344346|P1|Overall Study|Participant too young|1
2715093|NCT00304954|9344362|P4|Overall Study|Adverse Event|0
2715094|NCT00304954|9344363|P3|Overall Study|Adverse Event|0
2715095|NCT00304954|9344364|P2|Overall Study|Adverse Event|0
2715096|NCT00304954|9344365|P1|Overall Study|Adverse Event|1
2715097|NCT00304954|9344362|P4|Overall Study|Withdrawal by Subject|0
2715098|NCT00304954|9344363|P3|Overall Study|Withdrawal by Subject|1
2715099|NCT00304954|9344364|P2|Overall Study|Withdrawal by Subject|0
2715100|NCT00304954|9344365|P1|Overall Study|Withdrawal by Subject|0
2715101|NCT00304915|9344385|P2|Overall Study|Withdrawal by Subject|0
2715102|NCT00304915|9344386|P1|Overall Study|Withdrawal by Subject|3
2715103|NCT00304915|9344385|P2|Overall Study|Death|5
2715104|NCT00304915|9344386|P1|Overall Study|Death|4
2715105|NCT00304915|9344385|P2|Overall Study|Lost to Follow-up|11
2715106|NCT00304915|9344386|P1|Overall Study|Lost to Follow-up|11
2715107|NCT00304356|9344431|P1|Nitazoxanide|Physician Decision|1
2715108|NCT00304356|9344431|P1|Nitazoxanide|Physician Decision|1
2715109|NCT00304356|9344431|P1|Nitazoxanide|Physician Decision|1
2715110|NCT00304356|9344431|P1|Nitazoxanide|number is 0|1
2715111|NCT00304356|9344431|P1|Nitazoxanide|Physician Decision|1
2715112|NCT00304356|9344431|P1|Nitazoxanide|Physician Decision|5
2715113|NCT00304278|9344435|P1|Overall Study|PT had medical condition preventing TX|1
2715114|NCT00304278|9344435|P1|Overall Study|lack of insurance coverage for chemoRT|1
2715115|NCT00304083|9344484|P2|Overall Study|Other|2
2715116|NCT00304083|9344485|P1|Overall Study|Other|5
2715117|NCT00304083|9344484|P2|Overall Study|Disease Progression|1
2715118|NCT00304083|9344485|P1|Overall Study|Disease Progression|5
2715119|NCT00304083|9344484|P2|Overall Study|Physician Decision|3
2715120|NCT00304083|9344485|P1|Overall Study|Physician Decision|8
2715121|NCT00304083|9344484|P2|Overall Study|Withdrawal by Subject|2
2715122|NCT00304083|9344485|P1|Overall Study|Withdrawal by Subject|4
2715123|NCT00304070|9344504|P3|Overall Study|Progressive Disease|4
2715124|NCT00304070|9344505|P2|Overall Study|Progressive Disease|7
2715125|NCT00304070|9344506|P1|Overall Study|Progressive Disease|3
2715126|NCT00304070|9344504|P3|Overall Study|Withdrawal by Subject|1
2715127|NCT00304070|9344505|P2|Overall Study|Withdrawal by Subject|0
2715128|NCT00304070|9344506|P1|Overall Study|Withdrawal by Subject|0
2715129|NCT00304070|9344504|P3|Overall Study|Physician Decision|3
2715130|NCT00304070|9344505|P2|Overall Study|Physician Decision|0
2715131|NCT00304070|9344506|P1|Overall Study|Physician Decision|0
2715132|NCT00304070|9344504|P3|Overall Study|Lost to Follow-up|1
2715133|NCT00304070|9344505|P2|Overall Study|Lost to Follow-up|0
2715134|NCT00304070|9344506|P1|Overall Study|Lost to Follow-up|0
2715135|NCT00304070|9344504|P3|Overall Study|Death|3
2715136|NCT00304070|9344505|P2|Overall Study|Death|0
2715137|NCT00304070|9344506|P1|Overall Study|Death|0
2715138|NCT00304031|9344521|P3|Randomization to Adjuvant TMZ Arm|No follow-up collected|2
2715139|NCT00304031|9344522|P2|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
2715140|NCT00304031|9344523|P1|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
2715141|NCT00304031|9344521|P3|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|0
2715142|NCT00304031|9344522|P2|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|0
2715143|NCT00304031|9344523|P1|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|37
2715144|NCT00304031|9344521|P3|Concomitant Radiation Therapy and TMZ|Other complicating disease|0
2715145|NCT00304031|9344522|P2|Concomitant Radiation Therapy and TMZ|Other complicating disease|0
2715146|NCT00304031|9344523|P1|Concomitant Radiation Therapy and TMZ|Other complicating disease|1
2715147|NCT00304031|9344521|P3|Concomitant Radiation Therapy and TMZ|Toxicity|0
2715148|NCT00304031|9344522|P2|Concomitant Radiation Therapy and TMZ|Toxicity|0
2715149|NCT00304031|9344523|P1|Concomitant Radiation Therapy and TMZ|Toxicity|10
2715150|NCT00304031|9344521|P3|Concomitant Radiation Therapy and TMZ|Physician preference|0
2715151|NCT00304031|9344522|P2|Concomitant Radiation Therapy and TMZ|Physician preference|0
2715152|NCT00304031|9344523|P1|Concomitant Radiation Therapy and TMZ|Physician preference|15
2715153|NCT00304031|9344521|P3|Concomitant Radiation Therapy and TMZ|Death|0
2715154|NCT00304031|9344522|P2|Concomitant Radiation Therapy and TMZ|Death|0
2715155|NCT00304031|9344523|P1|Concomitant Radiation Therapy and TMZ|Death|18
2715156|NCT00304031|9344521|P3|Concomitant Radiation Therapy and TMZ|Patient refusal|0
2715157|NCT00304031|9344522|P2|Concomitant Radiation Therapy and TMZ|Patient refusal|0
2715158|NCT00304031|9344523|P1|Concomitant Radiation Therapy and TMZ|Patient refusal|19
2715159|NCT00304031|9344521|P3|Concomitant Radiation Therapy and TMZ|Disease progression|0
2715160|NCT00304031|9344522|P2|Concomitant Radiation Therapy and TMZ|Disease progression|0
2715161|NCT00304031|9344523|P1|Concomitant Radiation Therapy and TMZ|Disease progression|48
2715162|NCT00304031|9344521|P3|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|0
2715163|NCT00304031|9344522|P2|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|0
2715164|NCT00304031|9344523|P1|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|144
2715165|NCT00304031|9344521|P3|Registration|Ineligible|0
2715166|NCT00304031|9344522|P2|Registration|Ineligible|0
2715167|NCT00304031|9344523|P1|Registration|Ineligible|48
2715168|NCT00303953|9344562|P1|Overall Study|Physician Decision|1
2715169|NCT00303953|9344562|P1|Overall Study|Lack of Efficacy|12
2715170|NCT00303953|9344562|P1|Overall Study|Adverse Event|4
2715171|NCT00303953|9344562|P1|Overall Study|Death|1
2715172|NCT00303953|9344562|P1|Overall Study|Ineligible|1
2715173|NCT00303667|9344597|P2|Overall Study|Death|4
2715174|NCT00303667|9344598|P1|Overall Study|Death|0
2715175|NCT00303628|9344622|P2|Overall Study|Other|9
2715176|NCT00303628|9344623|P1|Overall Study|Other|8
2715177|NCT00303628|9344622|P2|Overall Study|Not start protocol therapy|5
2715178|NCT00303628|9344623|P1|Overall Study|Not start protocol therapy|3
2715179|NCT00303628|9344622|P2|Overall Study|Other complicating disease|1
2715180|NCT00303628|9344623|P1|Overall Study|Other complicating disease|0
2715181|NCT00303628|9344622|P2|Overall Study|Alternative therapy|0
2715182|NCT00303628|9344623|P1|Overall Study|Alternative therapy|2
2715183|NCT00303628|9344622|P2|Overall Study|Withdrawal by Subject|20
2715184|NCT00303628|9344623|P1|Overall Study|Withdrawal by Subject|11
2715185|NCT00303628|9344622|P2|Overall Study|Death|1
2715186|NCT00303628|9344623|P1|Overall Study|Death|0
2715187|NCT00303628|9344622|P2|Overall Study|Adverse Event|36
2715188|NCT00303628|9344623|P1|Overall Study|Adverse Event|26
2715189|NCT00303628|9344622|P2|Overall Study|Disease progression|1
2715190|NCT00303628|9344623|P1|Overall Study|Disease progression|0
2715191|NCT00303602|9344641|P2|Overall Study|Protocol Violation|0
2715192|NCT00303602|9344642|P1|Overall Study|Protocol Violation|1
2715193|NCT00303602|9344641|P2|Overall Study|Noncompliance|2
2715194|NCT00303602|9344642|P1|Overall Study|Noncompliance|2
2715195|NCT00303602|9344641|P2|Overall Study|Physician Decision|1
2715196|NCT00303602|9344642|P1|Overall Study|Physician Decision|2
2715197|NCT00303602|9344641|P2|Overall Study|Protocol entry criteria not met|2
2715198|NCT00303602|9344642|P1|Overall Study|Protocol entry criteria not met|2
2715199|NCT00303602|9344641|P2|Overall Study|Lost to Follow-up|2
2715200|NCT00303602|9344642|P1|Overall Study|Lost to Follow-up|5
2715201|NCT00303602|9344641|P2|Overall Study|Withdrawal by Subject|6
2715202|NCT00303602|9344642|P1|Overall Study|Withdrawal by Subject|5
2715203|NCT00303602|9344641|P2|Overall Study|Adverse Event|2
2715204|NCT00303602|9344642|P1|Overall Study|Adverse Event|2
2715205|NCT00303485|9344688|P2|Overall Study|Withdrawal by Subject|0
2715206|NCT00303485|9344689|P1|Overall Study|Withdrawal by Subject|1
2715207|NCT00303485|9344688|P2|Overall Study|Failure to return|1
2715208|NCT00303485|9344689|P1|Overall Study|Failure to return|0
2715209|NCT00303485|9344688|P2|Overall Study|Adverse Event/Intercurrent Illness|1
2715210|NCT00303485|9344689|P1|Overall Study|Adverse Event/Intercurrent Illness|0
2715211|NCT00303472|9344720|P7|Treatment Extension (Optional)|Disease Progression (to AML)|0
2715212|NCT00303472|9344721|P6|Treatment Extension (Optional)|Disease Progression (to AML)|1
2715213|NCT00303472|9344722|P5|Treatment Extension (Optional)|Disease Progression (to AML)|0
2715214|NCT00303472|9344723|P4|Treatment Extension (Optional)|Disease Progression (to AML)|0
2715215|NCT00303472|9344724|P3|Treatment Extension (Optional)|Disease Progression (to AML)|0
2715216|NCT00303472|9344725|P2|Treatment Extension (Optional)|Disease Progression (to AML)|0
2715217|NCT00303472|9344726|P1|Treatment Extension (Optional)|Disease Progression (to AML)|1
2715218|NCT00303472|9344720|P7|Treatment Extension (Optional)|Other|0
2715219|NCT00303472|9344721|P6|Treatment Extension (Optional)|Other|0
2715220|NCT00303472|9344722|P5|Treatment Extension (Optional)|Other|1
2715221|NCT00303472|9344723|P4|Treatment Extension (Optional)|Other|2
2715222|NCT00303472|9344724|P3|Treatment Extension (Optional)|Other|4
2715223|NCT00303472|9344725|P2|Treatment Extension (Optional)|Other|2
2715224|NCT00303472|9344726|P1|Treatment Extension (Optional)|Other|0
2715225|NCT00303472|9344720|P7|Treatment Extension (Optional)|Withdrawal by Subject|0
2715226|NCT00303472|9344721|P6|Treatment Extension (Optional)|Withdrawal by Subject|0
2715227|NCT00303472|9344722|P5|Treatment Extension (Optional)|Withdrawal by Subject|1
2715228|NCT00303472|9344723|P4|Treatment Extension (Optional)|Withdrawal by Subject|2
2715229|NCT00303472|9344724|P3|Treatment Extension (Optional)|Withdrawal by Subject|1
2715230|NCT00303472|9344725|P2|Treatment Extension (Optional)|Withdrawal by Subject|0
2715231|NCT00303472|9344726|P1|Treatment Extension (Optional)|Withdrawal by Subject|1
2715232|NCT00303472|9344720|P7|Treatment Extension (Optional)|Physician Decision|0
2715233|NCT00303472|9344721|P6|Treatment Extension (Optional)|Physician Decision|0
2715234|NCT00303472|9344722|P5|Treatment Extension (Optional)|Physician Decision|2
2715235|NCT00303472|9344723|P4|Treatment Extension (Optional)|Physician Decision|3
2715236|NCT00303472|9344724|P3|Treatment Extension (Optional)|Physician Decision|2
2715237|NCT00303472|9344725|P2|Treatment Extension (Optional)|Physician Decision|4
2715238|NCT00303472|9344726|P1|Treatment Extension (Optional)|Physician Decision|0
2715239|NCT00303472|9344720|P7|Treatment Extension (Optional)|Lost to Follow-up|0
2715240|NCT00303472|9344721|P6|Treatment Extension (Optional)|Lost to Follow-up|0
2715241|NCT00303472|9344722|P5|Treatment Extension (Optional)|Lost to Follow-up|0
2715242|NCT00303472|9344723|P4|Treatment Extension (Optional)|Lost to Follow-up|1
2715243|NCT00303472|9344724|P3|Treatment Extension (Optional)|Lost to Follow-up|0
2715244|NCT00303472|9344725|P2|Treatment Extension (Optional)|Lost to Follow-up|0
2715245|NCT00303472|9344726|P1|Treatment Extension (Optional)|Lost to Follow-up|0
2715246|NCT00303472|9344720|P7|Treatment Extension (Optional)|Death|0
2715247|NCT00303472|9344721|P6|Treatment Extension (Optional)|Death|0
2715248|NCT00303472|9344722|P5|Treatment Extension (Optional)|Death|0
2715249|NCT00303472|9344723|P4|Treatment Extension (Optional)|Death|0
2715250|NCT00303472|9344724|P3|Treatment Extension (Optional)|Death|1
2715251|NCT00303472|9344725|P2|Treatment Extension (Optional)|Death|0
2715252|NCT00303472|9344726|P1|Treatment Extension (Optional)|Death|2
2715253|NCT00303472|9344720|P7|Treatment Extension (Optional)|Adverse Event|0
2715254|NCT00303472|9344721|P6|Treatment Extension (Optional)|Adverse Event|0
2715255|NCT00303472|9344722|P5|Treatment Extension (Optional)|Adverse Event|0
2715256|NCT00303472|9344723|P4|Treatment Extension (Optional)|Adverse Event|0
2715257|NCT00303472|9344724|P3|Treatment Extension (Optional)|Adverse Event|1
2715258|NCT00303472|9344725|P2|Treatment Extension (Optional)|Adverse Event|0
2715259|NCT00303472|9344726|P1|Treatment Extension (Optional)|Adverse Event|1
2715260|NCT00303472|9344720|P7|Treatment Period|Disease Progression (to AML)|0
2715261|NCT00303472|9344721|P6|Treatment Period|Disease Progression (to AML)|0
2715262|NCT00303472|9344722|P5|Treatment Period|Disease Progression (to AML)|1
2715263|NCT00303472|9344723|P4|Treatment Period|Disease Progression (to AML)|0
2715264|NCT00303472|9344724|P3|Treatment Period|Disease Progression (to AML)|0
2715265|NCT00303472|9344725|P2|Treatment Period|Disease Progression (to AML)|0
2715266|NCT00303472|9344726|P1|Treatment Period|Disease Progression (to AML)|0
2715267|NCT00303472|9344720|P7|Treatment Period|Other|1
2715268|NCT00303472|9344721|P6|Treatment Period|Other|0
2715269|NCT00303472|9344722|P5|Treatment Period|Other|1
2715270|NCT00303472|9344723|P4|Treatment Period|Other|0
2715271|NCT00303472|9344724|P3|Treatment Period|Other|0
2715272|NCT00303472|9344725|P2|Treatment Period|Other|0
2715273|NCT00303472|9344726|P1|Treatment Period|Other|0
2715274|NCT00303472|9344720|P7|Treatment Period|Withdrawal by Subject|0
2715275|NCT00303472|9344721|P6|Treatment Period|Withdrawal by Subject|1
2715276|NCT00303472|9344722|P5|Treatment Period|Withdrawal by Subject|0
2715277|NCT00303472|9344723|P4|Treatment Period|Withdrawal by Subject|1
2715278|NCT00303472|9344724|P3|Treatment Period|Withdrawal by Subject|0
2715279|NCT00303472|9344725|P2|Treatment Period|Withdrawal by Subject|0
2715280|NCT00303472|9344726|P1|Treatment Period|Withdrawal by Subject|0
2715281|NCT00303472|9344720|P7|Treatment Period|Death|1
2715282|NCT00303472|9344721|P6|Treatment Period|Death|0
2715283|NCT00303472|9344722|P5|Treatment Period|Death|0
2715284|NCT00303472|9344723|P4|Treatment Period|Death|1
2715285|NCT00303472|9344724|P3|Treatment Period|Death|0
2715286|NCT00303472|9344725|P2|Treatment Period|Death|0
2715287|NCT00303472|9344726|P1|Treatment Period|Death|0
2715288|NCT00303472|9344720|P7|Treatment Period|Adverse Event|0
2715289|NCT00303472|9344721|P6|Treatment Period|Adverse Event|0
2715290|NCT00303472|9344722|P5|Treatment Period|Adverse Event|1
2715291|NCT00303472|9344723|P4|Treatment Period|Adverse Event|0
2715292|NCT00303472|9344724|P3|Treatment Period|Adverse Event|0
2715293|NCT00303472|9344725|P2|Treatment Period|Adverse Event|0
2715294|NCT00303472|9344726|P1|Treatment Period|Adverse Event|0
2715295|NCT00303459|9344786|P2|Overall Study|Lung transplantation|1
2715296|NCT00303459|9344787|P1|Overall Study|Lung transplantation|1
2715297|NCT00303459|9344786|P2|Overall Study|Decision by the investigator|7
2715298|NCT00303459|9344787|P1|Overall Study|Decision by the investigator|5
2715299|NCT00303459|9344786|P2|Overall Study|Administrative reason|7
2715300|NCT00303459|9344787|P1|Overall Study|Administrative reason|7
2715301|NCT00303459|9344786|P2|Overall Study|Lost to Follow-up|4
2715302|NCT00303459|9344787|P1|Overall Study|Lost to Follow-up|5
2715303|NCT00303459|9344786|P2|Overall Study|Withdrawal of consent|26
2715304|NCT00303459|9344787|P1|Overall Study|Withdrawal of consent|32
2715305|NCT00303459|9344786|P2|Overall Study|Death|44
2715306|NCT00303459|9344787|P1|Overall Study|Death|33
2715307|NCT00303446|9344813|P2|Overall Study|Physician Decision|1
2715308|NCT00303446|9344814|P1|Overall Study|Physician Decision|0
2715309|NCT00303446|9344813|P2|Overall Study|Death|1
2715310|NCT00303446|9344814|P1|Overall Study|Death|0
2715311|NCT00303446|9344813|P2|Overall Study|Withdrawal by Subject|2
2715312|NCT00303446|9344814|P1|Overall Study|Withdrawal by Subject|2
2715313|NCT00303329|9344850|P2|Overall Study|Stopped at end of extension 1|0
2715314|NCT00303329|9344851|P1|Overall Study|Stopped at end of extension 1|1
2715315|NCT00303329|9344850|P2|Overall Study|Stopped at end of core|9
2715316|NCT00303329|9344851|P1|Overall Study|Stopped at end of core|3
2715317|NCT00303329|9344850|P2|Overall Study|Death|12
2715318|NCT00303329|9344851|P1|Overall Study|Death|2
2715319|NCT00303329|9344850|P2|Overall Study|Administrative problems|0
2715320|NCT00303329|9344851|P1|Overall Study|Administrative problems|1
2715321|NCT00303329|9344850|P2|Overall Study|Lost to Follow-up|1
2715322|NCT00303329|9344851|P1|Overall Study|Lost to Follow-up|0
2715323|NCT00303329|9344850|P2|Overall Study|Withdrawal by Subject|15
2715324|NCT00303329|9344851|P1|Overall Study|Withdrawal by Subject|9
2715325|NCT00303329|9344850|P2|Overall Study|Protocol Violation|0
2715326|NCT00303329|9344851|P1|Overall Study|Protocol Violation|3
2715327|NCT00303329|9344850|P2|Overall Study|Condition no longer requires study drug|8
2715328|NCT00303329|9344851|P1|Overall Study|Condition no longer requires study drug|0
2715329|NCT00303329|9344850|P2|Overall Study|Unsatisfactory therapeutic effect|2
2715330|NCT00303329|9344851|P1|Overall Study|Unsatisfactory therapeutic effect|9
2715331|NCT00303329|9344850|P2|Overall Study|Abnormal Laboratory Values|1
2715332|NCT00303329|9344851|P1|Overall Study|Abnormal Laboratory Values|0
2715333|NCT00303329|9344850|P2|Overall Study|Adverse Event|14
2715334|NCT00303329|9344851|P1|Overall Study|Adverse Event|7
2715335|NCT00303316|9344865|P2|Overall Study|Withdrawal by Subject|2
2715336|NCT00303316|9344866|P1|Overall Study|Withdrawal by Subject|1
2715337|NCT00303316|9344865|P2|Overall Study|Lost to Follow-up|1
2715338|NCT00303316|9344866|P1|Overall Study|Lost to Follow-up|0
2715339|NCT00303316|9344865|P2|Overall Study|Protocol Violation|0
2715340|NCT00303316|9344866|P1|Overall Study|Protocol Violation|1
2715341|NCT00303186|9344878|P1|Overall Study|Other|52
2715342|NCT00303108|9344912|P3|Overall Study|ineligible|0
2715343|NCT00303108|9344913|P2|Overall Study|ineligible|1
2715344|NCT00303108|9344914|P1|Overall Study|ineligible|2
2715345|NCT00303108|9344912|P3|Overall Study|Failed Entry|1
2715346|NCT00303108|9344913|P2|Overall Study|Failed Entry|0
2715347|NCT00303108|9344914|P1|Overall Study|Failed Entry|1
2715348|NCT00303108|9344912|P3|Overall Study|Patient Request|8
2715349|NCT00303108|9344913|P2|Overall Study|Patient Request|2
2715350|NCT00303108|9344914|P1|Overall Study|Patient Request|4
2715351|NCT00303108|9344912|P3|Overall Study|Adverse Event|7
2715352|NCT00303108|9344913|P2|Overall Study|Adverse Event|6
2715353|NCT00303108|9344914|P1|Overall Study|Adverse Event|5
2715354|NCT00303069|9344934|P4|Overall Study|Recruitment into Army Reserves|0
2715355|NCT00303069|9344935|P3|Overall Study|Recruitment into Army Reserves|1
2715356|NCT00303069|9344936|P2|Overall Study|Recruitment into Army Reserves|0
2715357|NCT00303069|9344937|P1|Overall Study|Recruitment into Army Reserves|0
2715358|NCT00303069|9344934|P4|Overall Study|subject moved|0
2715359|NCT00303069|9344935|P3|Overall Study|subject moved|0
2715360|NCT00303069|9344936|P2|Overall Study|subject moved|0
2715361|NCT00303069|9344937|P1|Overall Study|subject moved|1
2715362|NCT00303069|9344934|P4|Overall Study|Lost to Follow-up|2
2715363|NCT00303069|9344935|P3|Overall Study|Lost to Follow-up|0
2715364|NCT00303069|9344936|P2|Overall Study|Lost to Follow-up|0
2715365|NCT00303069|9344937|P1|Overall Study|Lost to Follow-up|1
2715366|NCT00302952|9344957|P2|Overall Study|Elevated SGOT (AST) lab value|1
2715367|NCT00302952|9344958|P1|Overall Study|Elevated SGOT (AST) lab value|0
2715368|NCT00302952|9344957|P2|Overall Study|Withdrawal by Subject|3
2715369|NCT00302952|9344958|P1|Overall Study|Withdrawal by Subject|2
2715370|NCT00302952|9344957|P2|Overall Study|Physician Decision|1
2715371|NCT00302952|9344958|P1|Overall Study|Physician Decision|1
2715372|NCT00302731|9345008|P4|Overall Study|cancer unrelated to study discovered|0
2715373|NCT00302731|9345009|P3|Overall Study|cancer unrelated to study discovered|1
2715374|NCT00302731|9345010|P2|Overall Study|cancer unrelated to study discovered|0
2715375|NCT00302731|9345011|P1|Overall Study|cancer unrelated to study discovered|1
2715376|NCT00302731|9345008|P4|Overall Study|Protocol Violation|0
2715377|NCT00302731|9345009|P3|Overall Study|Protocol Violation|0
2715378|NCT00302731|9345010|P2|Overall Study|Protocol Violation|0
2715379|NCT00302731|9345011|P1|Overall Study|Protocol Violation|1
2715380|NCT00302731|9345008|P4|Overall Study|Withdrawal by Subject|0
2715381|NCT00302731|9345009|P3|Overall Study|Withdrawal by Subject|0
2715382|NCT00302731|9345010|P2|Overall Study|Withdrawal by Subject|1
2715383|NCT00302731|9345011|P1|Overall Study|Withdrawal by Subject|1
2715384|NCT00302731|9345008|P4|Overall Study|Adverse Event|0
2715385|NCT00302731|9345009|P3|Overall Study|Adverse Event|2
2715386|NCT00302731|9345010|P2|Overall Study|Adverse Event|2
2715387|NCT00302731|9345011|P1|Overall Study|Adverse Event|0
2715388|NCT00302731|9345008|P4|Overall Study|Lost to Follow-up|0
2715389|NCT00302731|9345009|P3|Overall Study|Lost to Follow-up|0
2715390|NCT00302731|9345010|P2|Overall Study|Lost to Follow-up|2
2715391|NCT00302731|9345011|P1|Overall Study|Lost to Follow-up|1
2715392|NCT00302718|9345037|P4|Overall Study|Participant left primary care setting|1
2715393|NCT00302718|9345038|P3|Overall Study|Participant left primary care setting|2
2715394|NCT00302718|9345039|P2|Overall Study|Participant left primary care setting|0
2715395|NCT00302718|9345040|P1|Overall Study|Participant left primary care setting|0
2715396|NCT00302718|9345037|P4|Overall Study|Withdrawal by Subject|0
2715397|NCT00302718|9345038|P3|Overall Study|Withdrawal by Subject|0
2715398|NCT00302718|9345039|P2|Overall Study|Withdrawal by Subject|1
2715399|NCT00302718|9345040|P1|Overall Study|Withdrawal by Subject|0
2715400|NCT00302718|9345037|P4|Overall Study|Participant left the hospital|1
2715401|NCT00302718|9345038|P3|Overall Study|Participant left the hospital|0
2715402|NCT00302718|9345039|P2|Overall Study|Participant left the hospital|0
2715403|NCT00302718|9345040|P1|Overall Study|Participant left the hospital|1
2715404|NCT00302458|9345106|P1|Overall Study|Withdrawal by Subject|1
2715405|NCT00302458|9345106|P1|Overall Study|Ineligible after screening|1
2715406|NCT00302458|9345106|P1|Overall Study|Lost to Follow-up|1
2715407|NCT00302328|9345117|P3|Overall Study|Physician Decision|0
2715408|NCT00302328|9345118|P2|Overall Study|Physician Decision|1
2715409|NCT00302328|9345119|P1|Overall Study|Physician Decision|0
2715410|NCT00302211|9345136|P5|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
2715411|NCT00302211|9345137|P4|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1
2715412|NCT00302211|9345138|P3|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
2715413|NCT00302211|9345139|P2|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
2715414|NCT00302211|9345140|P1|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
2715415|NCT00302211|9345136|P5|Open Label-Patients From Double-Blind|PH requiring lung transplant|1
2715416|NCT00302211|9345137|P4|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
2715417|NCT00302211|9345138|P3|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
2715418|NCT00302211|9345139|P2|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
2715419|NCT00302211|9345140|P1|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
2715420|NCT00302211|9345136|P5|Open Label-Patients From Double-Blind|Lost to Follow-up|1
2715421|NCT00302211|9345137|P4|Open Label-Patients From Double-Blind|Lost to Follow-up|0
2715422|NCT00302211|9345138|P3|Open Label-Patients From Double-Blind|Lost to Follow-up|0
2715423|NCT00302211|9345139|P2|Open Label-Patients From Double-Blind|Lost to Follow-up|0
2715424|NCT00302211|9345140|P1|Open Label-Patients From Double-Blind|Lost to Follow-up|0
2715425|NCT00302211|9345136|P5|Open Label-Patients From Double-Blind|Death|1
2715426|NCT00302211|9345137|P4|Open Label-Patients From Double-Blind|Death|1
2715427|NCT00302211|9345138|P3|Open Label-Patients From Double-Blind|Death|0
2715428|NCT00302211|9345139|P2|Open Label-Patients From Double-Blind|Death|0
2715429|NCT00302211|9345140|P1|Open Label-Patients From Double-Blind|Death|0
2715430|NCT00302211|9345136|P5|Open Label-Patients From Double-Blind|Disease progression|2
2715431|NCT00302211|9345137|P4|Open Label-Patients From Double-Blind|Disease progression|1
2715432|NCT00302211|9345138|P3|Open Label-Patients From Double-Blind|Disease progression|0
2715433|NCT00302211|9345139|P2|Open Label-Patients From Double-Blind|Disease progression|0
2715434|NCT00302211|9345140|P1|Open Label-Patients From Double-Blind|Disease progression|0
2715435|NCT00302211|9345136|P5|Open Label-Patients From Double-Blind|Investigator's judgement|0
2715436|NCT00302211|9345137|P4|Open Label-Patients From Double-Blind|Investigator's judgement|1
2715437|NCT00302211|9345138|P3|Open Label-Patients From Double-Blind|Investigator's judgement|0
2715438|NCT00302211|9345139|P2|Open Label-Patients From Double-Blind|Investigator's judgement|0
2715439|NCT00302211|9345140|P1|Open Label-Patients From Double-Blind|Investigator's judgement|0
2715440|NCT00302211|9345136|P5|Open Label-Patients From Double-Blind|Adverse Event|0
2715441|NCT00302211|9345137|P4|Open Label-Patients From Double-Blind|Adverse Event|1
2715442|NCT00302211|9345138|P3|Open Label-Patients From Double-Blind|Adverse Event|0
2715443|NCT00302211|9345139|P2|Open Label-Patients From Double-Blind|Adverse Event|0
2715444|NCT00302211|9345140|P1|Open Label-Patients From Double-Blind|Adverse Event|0
2715445|NCT00302211|9345136|P5|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
2715446|NCT00302211|9345137|P4|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
2715447|NCT00302211|9345138|P3|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
2715448|NCT00302211|9345139|P2|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
2715449|NCT00302211|9345140|P1|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
2715450|NCT00302211|9345136|P5|Double Blind Period (New Patients)|Disease progression|0
2715451|NCT00302211|9345137|P4|Double Blind Period (New Patients)|Disease progression|0
2715452|NCT00302211|9345138|P3|Double Blind Period (New Patients)|Disease progression|1
2715453|NCT00302211|9345139|P2|Double Blind Period (New Patients)|Disease progression|1
2715454|NCT00302211|9345140|P1|Double Blind Period (New Patients)|Disease progression|0
2715455|NCT00302211|9345136|P5|Double Blind Period (New Patients)|Investigator's judgement|0
2715456|NCT00302211|9345137|P4|Double Blind Period (New Patients)|Investigator's judgement|0
2715457|NCT00302211|9345138|P3|Double Blind Period (New Patients)|Investigator's judgement|0
2715458|NCT00302211|9345139|P2|Double Blind Period (New Patients)|Investigator's judgement|0
2715459|NCT00302211|9345140|P1|Double Blind Period (New Patients)|Investigator's judgement|1
2715460|NCT00302211|9345136|P5|Double Blind Period (New Patients)|Adverse Event|0
2715461|NCT00302211|9345137|P4|Double Blind Period (New Patients)|Adverse Event|0
2715462|NCT00302211|9345138|P3|Double Blind Period (New Patients)|Adverse Event|3
2715463|NCT00302211|9345139|P2|Double Blind Period (New Patients)|Adverse Event|0
2715464|NCT00302211|9345140|P1|Double Blind Period (New Patients)|Adverse Event|0
2715465|NCT00302211|9345136|P5|Double Blind Period (New Patients)|Withdrawal by Subject|0
2715466|NCT00302211|9345137|P4|Double Blind Period (New Patients)|Withdrawal by Subject|0
2715467|NCT00302211|9345138|P3|Double Blind Period (New Patients)|Withdrawal by Subject|0
2715468|NCT00302211|9345139|P2|Double Blind Period (New Patients)|Withdrawal by Subject|1
2715469|NCT00302211|9345140|P1|Double Blind Period (New Patients)|Withdrawal by Subject|2
2715470|NCT00302159|9345166|P1|Overall Study|pt started Avastin|1
2715471|NCT00302159|9345166|P1|Overall Study|pt declined before treatment started|1
2715472|NCT00302107|9345188|P2|Overall Study|Adverse Event|0
2715473|NCT00302107|9345189|P1|Overall Study|Adverse Event|1
2715474|NCT00302107|9345188|P2|Overall Study|Withdrawal by Subject|3
2715475|NCT00302107|9345189|P1|Overall Study|Withdrawal by Subject|0
2715476|NCT00302107|9345188|P2|Overall Study|Relocation|1
2715477|NCT00302107|9345189|P1|Overall Study|Relocation|0
2715478|NCT00302107|9345188|P2|Overall Study|Protocol Violation|0
2715479|NCT00302107|9345189|P1|Overall Study|Protocol Violation|1
2715480|NCT00302107|9345188|P2|Overall Study|Lost to Follow-up|5
2715481|NCT00302107|9345189|P1|Overall Study|Lost to Follow-up|6
2715482|NCT00302081|9345198|P3|Overall Study|Other|5
2715483|NCT00302081|9345199|P2|Overall Study|Other|6
2715484|NCT00302081|9345200|P1|Overall Study|Other|13
2715485|NCT00302081|9345198|P3|Overall Study|Death|0
2715486|NCT00302081|9345199|P2|Overall Study|Death|1
2715487|NCT00302081|9345200|P1|Overall Study|Death|2
2715488|NCT00302081|9345198|P3|Overall Study|Lack of Efficacy|5
2715489|NCT00302081|9345199|P2|Overall Study|Lack of Efficacy|0
2715490|NCT00302081|9345200|P1|Overall Study|Lack of Efficacy|1
2715491|NCT00302081|9345198|P3|Overall Study|Protocol Violation|2
2715492|NCT00302081|9345199|P2|Overall Study|Protocol Violation|1
2715493|NCT00302081|9345200|P1|Overall Study|Protocol Violation|5
2715494|NCT00302081|9345198|P3|Overall Study|Withdrawal by Subject|8
2715495|NCT00302081|9345199|P2|Overall Study|Withdrawal by Subject|12
2715496|NCT00302081|9345200|P1|Overall Study|Withdrawal by Subject|8
2715497|NCT00302081|9345198|P3|Overall Study|Lost to Follow-up|28
2715498|NCT00302081|9345199|P2|Overall Study|Lost to Follow-up|18
2715499|NCT00302081|9345200|P1|Overall Study|Lost to Follow-up|21
2715500|NCT00302081|9345198|P3|Overall Study|Adverse Event|4
2715501|NCT00302081|9345199|P2|Overall Study|Adverse Event|5
2715502|NCT00302081|9345200|P1|Overall Study|Adverse Event|6
2715503|NCT00302003|9345257|P1|Overall Study|Protocol Violation|1
2715504|NCT00302003|9345257|P1|Overall Study|Ineligible|9
2715505|NCT00302003|9345257|P1|Overall Study|Withdrawal by Subject|5
2715506|NCT00302003|9345257|P1|Overall Study|Physician Decision|2
2715507|NCT00302003|9345257|P1|Overall Study|Lost to Follow-up|1
2715508|NCT00302003|9345257|P1|Overall Study|Lack of Efficacy|62
2715509|NCT00301964|9345264|P1|Overall Study|Inadequate pathology|1
2715510|NCT00301964|9345264|P1|Overall Study|Wrong primary|1
2715511|NCT00301964|9345264|P1|Overall Study|Second primary|2
2715512|NCT00301834|9345285|P1|Overall Study|Death|1
2715513|NCT00301821|9345294|P1|Overall Study|Cancel|1
2715514|NCT00301821|9345294|P1|Overall Study|Ineligible|25
2715515|NCT00301808|9345301|P1|Overall Study|Lack of Efficacy|4
2715516|NCT00301808|9345301|P1|Overall Study|Death|3
2715517|NCT00301808|9345301|P1|Overall Study|Adverse Event|5
2715518|NCT00301366|9345326|P1|Overall Study|Adverse Event|1
2715519|NCT00301262|9345332|P2|Open Label Phase (OL)|Other|0
2715520|NCT00301262|9345333|P1|Open Label Phase (OL)|Other|2
2715521|NCT00301262|9345332|P2|Open Label Phase (OL)|Lost to Follow-up|2
2715522|NCT00301262|9345333|P1|Open Label Phase (OL)|Lost to Follow-up|1
2715523|NCT00301262|9345332|P2|Open Label Phase (OL)|Adverse Event|0
2715524|NCT00301262|9345333|P1|Open Label Phase (OL)|Adverse Event|1
2715525|NCT00301262|9345332|P2|Double Blind Phase (DB)|Other|4
2715526|NCT00301262|9345333|P1|Double Blind Phase (DB)|Other|1
2715527|NCT00301262|9345332|P2|Double Blind Phase (DB)|Withdrawal by Subject|5
2715528|NCT00301262|9345333|P1|Double Blind Phase (DB)|Withdrawal by Subject|5
2715529|NCT00301262|9345332|P2|Double Blind Phase (DB)|Lost to Follow-up|3
2715530|NCT00301262|9345333|P1|Double Blind Phase (DB)|Lost to Follow-up|3
2715531|NCT00301262|9345332|P2|Double Blind Phase (DB)|Lack of Efficacy|1
2715532|NCT00301262|9345333|P1|Double Blind Phase (DB)|Lack of Efficacy|0
2715533|NCT00301262|9345332|P2|Double Blind Phase (DB)|Adverse Event|0
2715534|NCT00301262|9345333|P1|Double Blind Phase (DB)|Adverse Event|1
2715535|NCT00301080|9345491|P5|Original Version (2 Arms & 4 Weeks)|Never received drug|0
2715536|NCT00301080|9345492|P4|Original Version (2 Arms & 4 Weeks)|Never received drug|0
2715537|NCT00301080|9345493|P3|Original Version (2 Arms & 4 Weeks)|Never received drug|0
2715538|NCT00301080|9345494|P2|Original Version (2 Arms & 4 Weeks)|Never received drug|0
2715539|NCT00301080|9345495|P1|Original Version (2 Arms & 4 Weeks)|Never received drug|1
2715540|NCT00301067|9345524|P4|Follow up Until Death|Alive at last data cut point|1
2715541|NCT00301067|9345525|P3|Follow up Until Death|Alive at last data cut point|0
2715542|NCT00301067|9345526|P2|Follow up Until Death|Alive at last data cut point|0
2715543|NCT00301067|9345527|P1|Follow up Until Death|Alive at last data cut point|1
2715544|NCT00301067|9345524|P4|Completed 12 Cycles of Treatment|Adverse Event|1
2715545|NCT00301067|9345525|P3|Completed 12 Cycles of Treatment|Adverse Event|0
2715546|NCT00301067|9345526|P2|Completed 12 Cycles of Treatment|Adverse Event|0
2715547|NCT00301067|9345527|P1|Completed 12 Cycles of Treatment|Adverse Event|0
2715548|NCT00301067|9345524|P4|Completed 12 Cycles of Treatment|Progressive Disease|1
2715549|NCT00301067|9345525|P3|Completed 12 Cycles of Treatment|Progressive Disease|0
2715550|NCT00301067|9345526|P2|Completed 12 Cycles of Treatment|Progressive Disease|1
2715551|NCT00301067|9345527|P1|Completed 12 Cycles of Treatment|Progressive Disease|0
2715552|NCT00301067|9345524|P4|Completed 4 Cycles of Treatment|Progressive disease|5
2715553|NCT00301067|9345525|P3|Completed 4 Cycles of Treatment|Progressive disease|2
2715554|NCT00301067|9345526|P2|Completed 4 Cycles of Treatment|Progressive disease|1
2715555|NCT00301067|9345527|P1|Completed 4 Cycles of Treatment|Progressive disease|1
2715556|NCT00301067|9345524|P4|Reached 1st Response/2 Cycles|Progressive Disease|2
2715557|NCT00301067|9345525|P3|Reached 1st Response/2 Cycles|Progressive Disease|1
2715558|NCT00301067|9345526|P2|Reached 1st Response/2 Cycles|Progressive Disease|1
2715559|NCT00301067|9345527|P1|Reached 1st Response/2 Cycles|Progressive Disease|2
2715560|NCT00301067|9345524|P4|Completed DLT Period/1st Cycle|Progressive Disease|1
2715561|NCT00301067|9345525|P3|Completed DLT Period/1st Cycle|Progressive Disease|0
2715562|NCT00301067|9345526|P2|Completed DLT Period/1st Cycle|Progressive Disease|0
2715563|NCT00301067|9345527|P1|Completed DLT Period/1st Cycle|Progressive Disease|1
2715564|NCT00300885|9345552|P2|Follow-up|Withdrawal by Subject|25
2715565|NCT00300885|9345553|P1|Follow-up|Withdrawal by Subject|26
2715566|NCT00300885|9345552|P2|Follow-up|Lost to Follow-up|7
2715567|NCT00300885|9345553|P1|Follow-up|Lost to Follow-up|11
2715568|NCT00300885|9345552|P2|Follow-up|Death|163
2715569|NCT00300885|9345553|P1|Follow-up|Death|141
2715570|NCT00300885|9345552|P2|Treatment|Non-compliant with study medication|4
2715571|NCT00300885|9345553|P1|Treatment|Non-compliant with study medication|3
2715572|NCT00300885|9345552|P2|Treatment|Random code broken (subject died)|1
2715573|NCT00300885|9345553|P1|Treatment|Random code broken (subject died)|0
2715574|NCT00300885|9345552|P2|Treatment|Disease progression|238
2715575|NCT00300885|9345553|P1|Treatment|Disease progression|171
2715576|NCT00300885|9345552|P2|Treatment|Withdrawal by Subject|23
2715577|NCT00300885|9345553|P1|Treatment|Withdrawal by Subject|26
2715578|NCT00300885|9345552|P2|Treatment|Protocol Violation|11
2715579|NCT00300885|9345553|P1|Treatment|Protocol Violation|11
2715580|NCT00300885|9345552|P2|Treatment|Physician Decision|5
2715581|NCT00300885|9345553|P1|Treatment|Physician Decision|4
2715582|NCT00300885|9345552|P2|Treatment|Lost to Follow-up|2
2715583|NCT00300885|9345553|P1|Treatment|Lost to Follow-up|3
2715584|NCT00300885|9345552|P2|Treatment|Lack of Efficacy|1
2715585|NCT00300885|9345553|P1|Treatment|Lack of Efficacy|1
2715586|NCT00300885|9345552|P2|Treatment|Death|7
2715587|NCT00300885|9345553|P1|Treatment|Death|20
2715588|NCT00300885|9345552|P2|Treatment|Adverse Event|82
2715589|NCT00300885|9345553|P1|Treatment|Adverse Event|134
2715590|NCT00300781|9345571|P2|Overall Study|Lost to Follow-up|1
2715591|NCT00300781|9345572|P1|Overall Study|Lost to Follow-up|0
2715592|NCT00300781|9345571|P2|Overall Study|Symptomatic Deterioration|0
2715593|NCT00300781|9345572|P1|Overall Study|Symptomatic Deterioration|1
2715594|NCT00300781|9345571|P2|Overall Study|Not Recorded|1
2715595|NCT00300781|9345572|P1|Overall Study|Not Recorded|0
2715596|NCT00300781|9345571|P2|Overall Study|Physician Decision|0
2715597|NCT00300781|9345572|P1|Overall Study|Physician Decision|1
2715598|NCT00300781|9345571|P2|Overall Study|Withdrawal by Subject|2
2715599|NCT00300781|9345572|P1|Overall Study|Withdrawal by Subject|1
2715600|NCT00300781|9345571|P2|Overall Study|Adverse Event|6
2715601|NCT00300781|9345572|P1|Overall Study|Adverse Event|5
2715602|NCT00300781|9345571|P2|Overall Study|Disease Progression|52
2715603|NCT00300781|9345572|P1|Overall Study|Disease Progression|55
2715604|NCT00300755|9345587|P3|Overall Study|Protocol Violation|1
2715605|NCT00300755|9345588|P2|Overall Study|Protocol Violation|0
2715606|NCT00300755|9345589|P1|Overall Study|Protocol Violation|0
2715607|NCT00300755|9345587|P3|Overall Study|Withdrawal by Subject|0
2715608|NCT00300755|9345588|P2|Overall Study|Withdrawal by Subject|2
2715609|NCT00300755|9345589|P1|Overall Study|Withdrawal by Subject|0
2715610|NCT00300755|9345587|P3|Overall Study|Adverse Event|1
2715611|NCT00300755|9345588|P2|Overall Study|Adverse Event|2
2715612|NCT00300755|9345589|P1|Overall Study|Adverse Event|1
2715613|NCT00300495|9345623|P2|Overall Study|Protocol Violation|1
2715614|NCT00300495|9345624|P1|Overall Study|Protocol Violation|4
2715615|NCT00300365|9345891|P2|Overall Study|Adverse Event|2
2715616|NCT00300365|9345892|P1|Overall Study|Adverse Event|0
2715617|NCT00300365|9345891|P2|Overall Study|Withdrawal by Subject|0
2715618|NCT00300365|9345892|P1|Overall Study|Withdrawal by Subject|1
2715619|NCT00300365|9345891|P2|Overall Study|Physician Decision|0
2715620|NCT00300365|9345892|P1|Overall Study|Physician Decision|2
2715621|NCT00300365|9345891|P2|Overall Study|Lost to Follow-up|0
2715622|NCT00300365|9345892|P1|Overall Study|Lost to Follow-up|1
2715623|NCT00300274|9345901|P3|Overall Study|Re-transplant|1
2715624|NCT00300274|9345902|P2|Overall Study|Re-transplant|0
2715625|NCT00300274|9345903|P1|Overall Study|Re-transplant|0
2715626|NCT00300274|9345901|P3|Overall Study|Death|25
2715627|NCT00300274|9345902|P2|Overall Study|Death|20
2715628|NCT00300274|9345903|P1|Overall Study|Death|31
2715629|NCT00300274|9345901|P3|Overall Study|Lost to Follow-up|5
2715630|NCT00300274|9345902|P2|Overall Study|Lost to Follow-up|4
2715631|NCT00300274|9345903|P1|Overall Study|Lost to Follow-up|3
2715632|NCT00300274|9345901|P3|Overall Study|Withdrawal by Subject|14
2715633|NCT00300274|9345902|P2|Overall Study|Withdrawal by Subject|3
2715634|NCT00300274|9345903|P1|Overall Study|Withdrawal by Subject|12
2715635|NCT00299975|9345973|P3|Overall Study|Physician Decision|1
2715636|NCT00299975|9345974|P2|Overall Study|Physician Decision|0
2715637|NCT00299975|9345975|P1|Overall Study|Physician Decision|0
2715638|NCT00299975|9345973|P3|Overall Study|Withdrawal by Subject|3
2715639|NCT00299975|9345974|P2|Overall Study|Withdrawal by Subject|1
2715640|NCT00299975|9345975|P1|Overall Study|Withdrawal by Subject|0
2715641|NCT00299975|9345973|P3|Overall Study|Lost to Follow-up|0
2715642|NCT00299975|9345974|P2|Overall Study|Lost to Follow-up|0
2715643|NCT00299975|9345975|P1|Overall Study|Lost to Follow-up|1
2715644|NCT00299975|9345973|P3|Overall Study|Lack of Efficacy|1
2715645|NCT00299975|9345974|P2|Overall Study|Lack of Efficacy|0
2715646|NCT00299975|9345975|P1|Overall Study|Lack of Efficacy|1
2715647|NCT00299975|9345973|P3|Overall Study|Pregnancy|1
2715648|NCT00299975|9345974|P2|Overall Study|Pregnancy|0
2715649|NCT00299975|9345975|P1|Overall Study|Pregnancy|0
2715650|NCT00299975|9345973|P3|Overall Study|Adverse Event|2
2715651|NCT00299975|9345974|P2|Overall Study|Adverse Event|0
2715652|NCT00299975|9345975|P1|Overall Study|Adverse Event|1
2715653|NCT00299702|9346032|P2|Overall Study|Admin issues, sponsor decision, etc.|9
2715654|NCT00299702|9346033|P1|Overall Study|Admin issues, sponsor decision, etc.|5
2715655|NCT00299702|9346032|P2|Overall Study|Insufficient Response|3
2715656|NCT00299702|9346033|P1|Overall Study|Insufficient Response|4
2715657|NCT00299702|9346032|P2|Overall Study|Pregnancy|1
2715658|NCT00299702|9346033|P1|Overall Study|Pregnancy|0
2715659|NCT00299702|9346032|P2|Overall Study|Withdrawal by Subject|23
2715660|NCT00299702|9346033|P1|Overall Study|Withdrawal by Subject|25
2715661|NCT00299702|9346032|P2|Overall Study|Lost to Follow-up|10
2715662|NCT00299702|9346033|P1|Overall Study|Lost to Follow-up|18
2715663|NCT00299702|9346032|P2|Overall Study|Adverse Event|4
2715664|NCT00299702|9346033|P1|Overall Study|Adverse Event|0
2715665|NCT00299702|9346032|P2|Overall Study|Death|0
2715666|NCT00299702|9346033|P1|Overall Study|Death|1
2715667|NCT00299546|9346048|P3|Overall Study|Not treated|1
2715668|NCT00299546|9346049|P2|Overall Study|Not treated|1
2715669|NCT00299546|9346050|P1|Overall Study|Not treated|0
2715670|NCT00299546|9346048|P3|Overall Study|Other|19
2715671|NCT00299546|9346049|P2|Overall Study|Other|26
2715672|NCT00299546|9346050|P1|Overall Study|Other|24
2715673|NCT00299546|9346048|P3|Overall Study|Unsatisfactory therapeutic effect|34
2715674|NCT00299546|9346049|P2|Overall Study|Unsatisfactory therapeutic effect|39
2715675|NCT00299546|9346050|P1|Overall Study|Unsatisfactory therapeutic effect|34
2715676|NCT00299546|9346048|P3|Overall Study|Adverse Event|27
2715677|NCT00299546|9346049|P2|Overall Study|Adverse Event|22
2715678|NCT00299546|9346050|P1|Overall Study|Adverse Event|37
2715679|NCT00299546|9346048|P3|Overall Study|Lost to Follow-up|5
2715680|NCT00299546|9346049|P2|Overall Study|Lost to Follow-up|2
2715681|NCT00299546|9346050|P1|Overall Study|Lost to Follow-up|2
2715682|NCT00299546|9346048|P3|Overall Study|Death|0
2715683|NCT00299546|9346049|P2|Overall Study|Death|2
2715684|NCT00299546|9346050|P1|Overall Study|Death|3
2715685|NCT00299494|9346081|P6|Overall Study|Other - site closure|1
2715686|NCT00299494|9346082|P5|Overall Study|Other - site closure|1
2715687|NCT00299494|9346083|P4|Overall Study|Other - site closure|1
2715688|NCT00299494|9346084|P3|Overall Study|Other - site closure|0
2715689|NCT00299494|9346085|P2|Overall Study|Other - site closure|0
2715690|NCT00299494|9346086|P1|Overall Study|Other - site closure|0
2715691|NCT00299494|9346081|P6|Overall Study|Other - Unspecified|1
2715692|NCT00299494|9346082|P5|Overall Study|Other - Unspecified|3
2715693|NCT00299494|9346083|P4|Overall Study|Other - Unspecified|0
2715694|NCT00299494|9346084|P3|Overall Study|Other - Unspecified|0
2715695|NCT00299494|9346085|P2|Overall Study|Other - Unspecified|0
2715696|NCT00299494|9346086|P1|Overall Study|Other - Unspecified|0
2715697|NCT00299494|9346081|P6|Overall Study|Lost to Follow-up|1
2715698|NCT00299494|9346082|P5|Overall Study|Lost to Follow-up|3
2715699|NCT00299494|9346083|P4|Overall Study|Lost to Follow-up|0
2715700|NCT00299494|9346084|P3|Overall Study|Lost to Follow-up|0
2715701|NCT00299494|9346085|P2|Overall Study|Lost to Follow-up|0
2715702|NCT00299494|9346086|P1|Overall Study|Lost to Follow-up|0
2715703|NCT00299494|9346081|P6|Overall Study|Death|19
2715704|NCT00299494|9346082|P5|Overall Study|Death|18
2715705|NCT00299494|9346083|P4|Overall Study|Death|6
2715706|NCT00299494|9346084|P3|Overall Study|Death|4
2715707|NCT00299494|9346085|P2|Overall Study|Death|1
2715708|NCT00299494|9346086|P1|Overall Study|Death|3
2715709|NCT00299494|9346081|P6|Overall Study|Physician Decision|0
2715710|NCT00299494|9346082|P5|Overall Study|Physician Decision|1
2715711|NCT00299494|9346083|P4|Overall Study|Physician Decision|0
2715712|NCT00299494|9346084|P3|Overall Study|Physician Decision|0
2715713|NCT00299494|9346085|P2|Overall Study|Physician Decision|0
2715714|NCT00299494|9346086|P1|Overall Study|Physician Decision|0
2715715|NCT00299494|9346081|P6|Overall Study|Withdrawal by Subject|4
2715716|NCT00299494|9346082|P5|Overall Study|Withdrawal by Subject|1
2715717|NCT00299494|9346083|P4|Overall Study|Withdrawal by Subject|3
2715718|NCT00299494|9346084|P3|Overall Study|Withdrawal by Subject|0
2715719|NCT00299494|9346085|P2|Overall Study|Withdrawal by Subject|0
2715720|NCT00299494|9346086|P1|Overall Study|Withdrawal by Subject|0
2715721|NCT00299156|9346215|P3|Period 2 (Randomized)|Screen Failure|0
2715722|NCT00299156|9346216|P2|Period 2 (Randomized)|Screen Failure|1
2715723|NCT00299156|9346217|P1|Period 2 (Randomized)|Screen Failure|0
2715724|NCT00299130|9346228|P3|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4
2715725|NCT00299130|9346229|P2|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3
2715726|NCT00299130|9346230|P1|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0
2715727|NCT00299130|9346228|P3|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
2715728|NCT00299130|9346229|P2|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
2715729|NCT00299130|9346230|P1|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0
2715730|NCT00299130|9346228|P3|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
2715731|NCT00299130|9346229|P2|Extended SFU (ESFU) (up to 5.1 Years)|Death|3
2715732|NCT00299130|9346230|P1|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
2715733|NCT00299130|9346228|P3|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21
2715734|NCT00299130|9346229|P2|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
2715735|NCT00299130|9346230|P1|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
2715736|NCT00299130|9346228|P3|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
2715737|NCT00299130|9346229|P2|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1
2715738|NCT00299130|9346230|P1|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
2715739|NCT00299130|9346228|P3|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15
2715740|NCT00299130|9346229|P2|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7
2715741|NCT00299130|9346230|P1|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14
2715742|NCT00299130|9346228|P3|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2
2715743|NCT00299130|9346229|P2|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
2715744|NCT00299130|9346230|P1|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
2715745|NCT00299130|9346228|P3|Safety Follow-up (SFU) (48 Weeks)|Death|3
2715746|NCT00299130|9346229|P2|Safety Follow-up (SFU) (48 Weeks)|Death|5
2715747|NCT00299130|9346230|P1|Safety Follow-up (SFU) (48 Weeks)|Death|4
2715748|NCT00299130|9346228|P3|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
2715749|NCT00299130|9346229|P2|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9
2715750|NCT00299130|9346230|P1|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
2715751|NCT00299130|9346228|P3|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
2715752|NCT00299130|9346229|P2|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
2715753|NCT00299130|9346230|P1|Treatment Period (up to 5 Years)|Withdrawal by Subject|0
2715754|NCT00299130|9346228|P3|Treatment Period (up to 5 Years)|Reason not Specified|4
2715755|NCT00299130|9346229|P2|Treatment Period (up to 5 Years)|Reason not Specified|6
2715756|NCT00299130|9346230|P1|Treatment Period (up to 5 Years)|Reason not Specified|4
2715757|NCT00299130|9346228|P3|Treatment Period (up to 5 Years)|Failure to Return|6
2715758|NCT00299130|9346229|P2|Treatment Period (up to 5 Years)|Failure to Return|6
2715759|NCT00299130|9346230|P1|Treatment Period (up to 5 Years)|Failure to Return|4
2715760|NCT00299130|9346228|P3|Treatment Period (up to 5 Years)|Refused Treatment|19
2715761|NCT00299130|9346229|P2|Treatment Period (up to 5 Years)|Refused Treatment|12
2715762|NCT00299130|9346230|P1|Treatment Period (up to 5 Years)|Refused Treatment|12
2715763|NCT00299130|9346228|P3|Treatment Period (up to 5 Years)|Protocol Violation|0
2715764|NCT00299130|9346229|P2|Treatment Period (up to 5 Years)|Protocol Violation|1
2715765|NCT00299130|9346230|P1|Treatment Period (up to 5 Years)|Protocol Violation|0
2715766|NCT00299130|9346228|P3|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
2715767|NCT00299130|9346229|P2|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
2715768|NCT00299130|9346230|P1|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19
2715769|NCT00299130|9346228|P3|Treatment Period (up to 5 Years)|Death|1
2715770|NCT00299130|9346229|P2|Treatment Period (up to 5 Years)|Death|3
2715771|NCT00299130|9346230|P1|Treatment Period (up to 5 Years)|Death|1
2715772|NCT00299130|9346228|P3|Treatment Period (up to 5 Years)|Adverse Event|13
2715773|NCT00299130|9346229|P2|Treatment Period (up to 5 Years)|Adverse Event|8
2715774|NCT00299130|9346230|P1|Treatment Period (up to 5 Years)|Adverse Event|13
2715775|NCT00299104|9346335|P3|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
2715776|NCT00299104|9346336|P2|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
2715777|NCT00299104|9346337|P1|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1
2715778|NCT00299104|9346335|P3|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8
2715779|NCT00299104|9346336|P2|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4
2715780|NCT00299104|9346337|P1|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2
2715781|NCT00299104|9346335|P3|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
2715782|NCT00299104|9346336|P2|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
2715783|NCT00299104|9346337|P1|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
2715784|NCT00299104|9346335|P3|Extended Safety Follow-Up (ESFU) Period|Death|0
2715785|NCT00299104|9346336|P2|Extended Safety Follow-Up (ESFU) Period|Death|1
2715786|NCT00299104|9346337|P1|Extended Safety Follow-Up (ESFU) Period|Death|0
2715787|NCT00299104|9346335|P3|Safety Follow-Up (SFU) Period|Administrative reasons|5
2715788|NCT00299104|9346336|P2|Safety Follow-Up (SFU) Period|Administrative reasons|7
2715789|NCT00299104|9346337|P1|Safety Follow-Up (SFU) Period|Administrative reasons|27
2715790|NCT00299104|9346335|P3|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11
2715791|NCT00299104|9346336|P2|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21
2715792|NCT00299104|9346337|P1|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16
2715793|NCT00299104|9346335|P3|Safety Follow-Up (SFU) Period|Lost to Follow-up|20
2715794|NCT00299104|9346336|P2|Safety Follow-Up (SFU) Period|Lost to Follow-up|11
2715795|NCT00299104|9346337|P1|Safety Follow-Up (SFU) Period|Lost to Follow-up|9
2715796|NCT00299104|9346335|P3|Safety Follow-Up (SFU) Period|Death|1
2715797|NCT00299104|9346336|P2|Safety Follow-Up (SFU) Period|Death|2
2715798|NCT00299104|9346337|P1|Safety Follow-Up (SFU) Period|Death|3
2715799|NCT00299104|9346335|P3|Treatment Period|Administrative reasons|137
2715800|NCT00299104|9346336|P2|Treatment Period|Administrative reasons|120
2715801|NCT00299104|9346337|P1|Treatment Period|Administrative reasons|106
2715802|NCT00299104|9346335|P3|Treatment Period|Withdrew consent|9
2715803|NCT00299104|9346336|P2|Treatment Period|Withdrew consent|19
2715804|NCT00299104|9346337|P1|Treatment Period|Withdrew consent|14
2715805|NCT00299104|9346335|P3|Treatment Period|Refused treatment|2
2715806|NCT00299104|9346336|P2|Treatment Period|Refused treatment|2
2715807|NCT00299104|9346337|P1|Treatment Period|Refused treatment|9
2715808|NCT00299104|9346335|P3|Treatment Period|Protocol Violation|0
2715809|NCT00299104|9346336|P2|Treatment Period|Protocol Violation|1
2715810|NCT00299104|9346337|P1|Treatment Period|Protocol Violation|1
2715811|NCT00299104|9346335|P3|Treatment Period|Violation of selection criteria|0
2715812|NCT00299104|9346336|P2|Treatment Period|Violation of selection criteria|2
2715813|NCT00299104|9346337|P1|Treatment Period|Violation of selection criteria|1
2715814|NCT00299104|9346335|P3|Treatment Period|Failure to return|8
2715815|NCT00299104|9346336|P2|Treatment Period|Failure to return|8
2715816|NCT00299104|9346337|P1|Treatment Period|Failure to return|9
2715817|NCT00299104|9346335|P3|Treatment Period|Insufficient therapeutic response|8
2715818|NCT00299104|9346336|P2|Treatment Period|Insufficient therapeutic response|13
2715819|NCT00299104|9346337|P1|Treatment Period|Insufficient therapeutic response|34
2715820|NCT00299104|9346335|P3|Treatment Period|Death|1
2715821|NCT00299104|9346336|P2|Treatment Period|Death|1
2715822|NCT00299104|9346337|P1|Treatment Period|Death|1
2715823|NCT00299104|9346335|P3|Treatment Period|Adverse Event|7
2715824|NCT00299104|9346336|P2|Treatment Period|Adverse Event|9
2715825|NCT00299104|9346337|P1|Treatment Period|Adverse Event|14
2715826|NCT00298896|9346447|P1|Overall Study|Assigned to treatment in error|1
2715827|NCT00298896|9346447|P1|Overall Study|Withdrawal by Subject|2
2715828|NCT00298896|9346447|P1|Overall Study|Disease Progression|41
2715829|NCT00298896|9346447|P1|Overall Study|Intercurrent Illness|1
2715830|NCT00298896|9346447|P1|Overall Study|Physician Decision|2
2715831|NCT00298896|9346447|P1|Overall Study|Death|3
2715832|NCT00298831|9346452|P1|Overall Study|Participants did not receive treatment|27
2715833|NCT00298831|9346452|P1|Overall Study|Withdrawal by Subject|1
2715834|NCT00298831|9346452|P1|Overall Study|Lost to Follow-up|3
2715835|NCT00298831|9346452|P1|Overall Study|Adverse Event|1
2715836|NCT00298766|9346461|P1|Overall Study|Other|4
2715837|NCT00298766|9346461|P1|Overall Study|Subjects overall condition deterioration|4
2715838|NCT00298766|9346461|P1|Overall Study|Deterioration in KPS and organ function|1
2715839|NCT00298766|9346461|P1|Overall Study|Progression of amyloid markers|4
2715840|NCT00298766|9346461|P1|Overall Study|Treatment ongoing|4
2715841|NCT00298766|9346461|P1|Overall Study|Withdrawal by Subject|9
2715842|NCT00298766|9346461|P1|Overall Study|Death|2
2715843|NCT00298766|9346461|P1|Overall Study|Adverse Event|18
2715844|NCT00298740|9346470|P1|Overall Study|Withdrawal by Subject|3
2715845|NCT00298740|9346470|P1|Overall Study|Lack of Efficacy|6
2715846|NCT00298363|9346540|P3|Overall Study|Lack of Efficacy|0
2715847|NCT00298363|9346541|P2|Overall Study|Lack of Efficacy|3
2715848|NCT00298363|9346542|P1|Overall Study|Lack of Efficacy|2
2715849|NCT00298363|9346540|P3|Overall Study|Adverse Event|2
2715850|NCT00298363|9346541|P2|Overall Study|Adverse Event|2
2715851|NCT00298363|9346542|P1|Overall Study|Adverse Event|5
2715852|NCT00298363|9346540|P3|Overall Study|Withdrawal by Subject|3
2715853|NCT00298363|9346541|P2|Overall Study|Withdrawal by Subject|1
2715854|NCT00298363|9346542|P1|Overall Study|Withdrawal by Subject|5
2715855|NCT00298363|9346540|P3|Overall Study|Protocol Violation|0
2715856|NCT00298363|9346541|P2|Overall Study|Protocol Violation|1
2715857|NCT00298363|9346542|P1|Overall Study|Protocol Violation|1
2715858|NCT00298363|9346540|P3|Overall Study|Physician Decision|0
2715859|NCT00298363|9346541|P2|Overall Study|Physician Decision|1
2715860|NCT00298363|9346542|P1|Overall Study|Physician Decision|4
2715861|NCT00298363|9346540|P3|Overall Study|Lost to Follow-up|1
2715862|NCT00298363|9346541|P2|Overall Study|Lost to Follow-up|0
2715863|NCT00298363|9346542|P1|Overall Study|Lost to Follow-up|0
2715864|NCT00298272|9346700|P2|Safety Follow-up Phase|Administrative/Other Reason|1
2715865|NCT00298272|9346701|P1|Safety Follow-up Phase|Administrative/Other Reason|1
2715866|NCT00298272|9346700|P2|Safety Follow-up Phase|Withdrawal by Subject|2
2715867|NCT00298272|9346701|P1|Safety Follow-up Phase|Withdrawal by Subject|2
2715868|NCT00298272|9346700|P2|Safety Follow-up Phase|Failure to Return|1
2715869|NCT00298272|9346701|P1|Safety Follow-up Phase|Failure to Return|1
2715870|NCT00298272|9346700|P2|Open Label Retreatment Phase|Administrative/Other Reason|0
2715871|NCT00298272|9346701|P1|Open Label Retreatment Phase|Administrative/Other Reason|2
2715872|NCT00298272|9346700|P2|Open Label Retreatment Phase|Withdrawal by Subject|0
2715873|NCT00298272|9346701|P1|Open Label Retreatment Phase|Withdrawal by Subject|1
2715874|NCT00298272|9346700|P2|Open Label Retreatment Phase|Protocol Violation|1
2715875|NCT00298272|9346701|P1|Open Label Retreatment Phase|Protocol Violation|2
2715876|NCT00298272|9346700|P2|Open Label Retreatment Phase|Failure to Return|0
2715877|NCT00298272|9346701|P1|Open Label Retreatment Phase|Failure to Return|1
2715878|NCT00298272|9346700|P2|Open Label Retreatment Phase|Insufficient Therapeutic Response|1
2715879|NCT00298272|9346701|P1|Open Label Retreatment Phase|Insufficient Therapeutic Response|2
2715880|NCT00298272|9346700|P2|Open Label Retreatment Phase|Adverse Event|2
2715881|NCT00298272|9346701|P1|Open Label Retreatment Phase|Adverse Event|1
2715882|NCT00298272|9346700|P2|Double-blind Phase|Withdrawal by Subject|0
2715883|NCT00298272|9346701|P1|Double-blind Phase|Withdrawal by Subject|2
2715884|NCT00298272|9346700|P2|Double-blind Phase|Protocol Violation|0
2715885|NCT00298272|9346701|P1|Double-blind Phase|Protocol Violation|2
2715886|NCT00298272|9346700|P2|Double-blind Phase|Failure to Return|0
2715887|NCT00298272|9346701|P1|Double-blind Phase|Failure to Return|2
2715888|NCT00298272|9346700|P2|Double-blind Phase|Adverse Event|0
2715889|NCT00298272|9346701|P1|Double-blind Phase|Adverse Event|2
2715890|NCT00298038|9346765|P2|Overall Study|Severe Gastrointestinal Bleed|0
2715891|NCT00298038|9346766|P1|Overall Study|Severe Gastrointestinal Bleed|1
2715892|NCT00298038|9346765|P2|Overall Study|Cocaine Abuse|0
2715893|NCT00298038|9346766|P1|Overall Study|Cocaine Abuse|1
2715894|NCT00298038|9346765|P2|Overall Study|Noncompliance|0
2715895|NCT00298038|9346766|P1|Overall Study|Noncompliance|1
2715896|NCT00298038|9346765|P2|Overall Study|Breakthrough overt HE episode|69
2715897|NCT00298038|9346766|P1|Overall Study|Breakthrough overt HE episode|28
2715898|NCT00298038|9346765|P2|Overall Study|Adverse Event|7
2715899|NCT00298038|9346766|P1|Overall Study|Adverse Event|8
2715900|NCT00298038|9346765|P2|Overall Study|Withdrawal by Subject|9
2715901|NCT00298038|9346766|P1|Overall Study|Withdrawal by Subject|6
2715902|NCT00298038|9346765|P2|Overall Study|Death|3
2715903|NCT00298038|9346766|P1|Overall Study|Death|6
2715904|NCT00298038|9346765|P2|Overall Study|Protocol Violation|3
2715905|NCT00298038|9346766|P1|Overall Study|Protocol Violation|1
2715906|NCT00298038|9346765|P2|Overall Study|Liver Transplant|1
2715907|NCT00298038|9346766|P1|Overall Study|Liver Transplant|0
2715908|NCT00298038|9346765|P2|Overall Study|Lost to Follow-up|1
2715909|NCT00298038|9346766|P1|Overall Study|Lost to Follow-up|0
2715910|NCT00297830|9346785|P3|12 Month Visit|Withdrawal by Subject|0
2715911|NCT00297830|9346786|P2|12 Month Visit|Withdrawal by Subject|3
2715912|NCT00297830|9346787|P1|12 Month Visit|Withdrawal by Subject|0
2715913|NCT00297830|9346785|P3|12 Month Visit|Adverse Event|0
2715914|NCT00297830|9346786|P2|12 Month Visit|Adverse Event|3
2715915|NCT00297830|9346787|P1|12 Month Visit|Adverse Event|0
2715916|NCT00297830|9346785|P3|12 Month Visit|Lost to Follow-up|0
2715917|NCT00297830|9346786|P2|12 Month Visit|Lost to Follow-up|0
2715918|NCT00297830|9346787|P1|12 Month Visit|Lost to Follow-up|1
2715919|NCT00297830|9346785|P3|6 Month Visit|Adverse Event|0
2715920|NCT00297830|9346786|P2|6 Month Visit|Adverse Event|1
2715921|NCT00297830|9346787|P1|6 Month Visit|Adverse Event|0
2715922|NCT00297830|9346785|P3|6 Month Visit|Withdrawal by Subject|1
2715923|NCT00297830|9346786|P2|6 Month Visit|Withdrawal by Subject|1
2715924|NCT00297830|9346787|P1|6 Month Visit|Withdrawal by Subject|2
2715925|NCT00297830|9346785|P3|6 Month Visit|Death|2
2715926|NCT00297830|9346786|P2|6 Month Visit|Death|0
2715927|NCT00297830|9346787|P1|6 Month Visit|Death|1
2715928|NCT00297778|9346806|P2|Overall Study|Other|1
2715929|NCT00297778|9346807|P1|Overall Study|Other|0
2715930|NCT00297778|9346806|P2|Overall Study|Non-compliant with trial protocol|3
2715931|NCT00297778|9346807|P1|Overall Study|Non-compliant with trial protocol|0
2715932|NCT00297778|9346806|P2|Overall Study|Lack of Efficacy|1
2715933|NCT00297778|9346807|P1|Overall Study|Lack of Efficacy|2
2715934|NCT00297778|9346806|P2|Overall Study|Withdrawal by Subject|5
2715935|NCT00297778|9346807|P1|Overall Study|Withdrawal by Subject|1
2715936|NCT00297778|9346806|P2|Overall Study|Adverse Event|10
2715937|NCT00297778|9346807|P1|Overall Study|Adverse Event|16
2715938|NCT00297648|9346841|P1|Overall Study|Other: Incompliance|1
2715939|NCT00297648|9346841|P1|Overall Study|Withdrawal by Subject|3
2715940|NCT00297648|9346841|P1|Overall Study|Lost to Follow-up|1
2715941|NCT00297648|9346841|P1|Overall Study|Lack of Efficacy|18
2715942|NCT00297648|9346841|P1|Overall Study|Adverse Event|13
2715943|NCT00297492|9346887|P3|6 Month Follow-up|Lost to Follow-up|27
2715944|NCT00297492|9346888|P2|6 Month Follow-up|Lost to Follow-up|49
2715945|NCT00297492|9346889|P1|6 Month Follow-up|Lost to Follow-up|63
2715946|NCT00297492|9346887|P3|Set Quit Date|Lost to Follow-up|5
2715947|NCT00297492|9346888|P2|Set Quit Date|Lost to Follow-up|13
2715948|NCT00297492|9346889|P1|Set Quit Date|Lost to Follow-up|7
2715949|NCT00297427|9346899|P2|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0
2715950|NCT00297427|9346900|P1|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2
2715951|NCT00297427|9346899|P2|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0
2715952|NCT00297427|9346900|P1|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3
2715953|NCT00297427|9346899|P2|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0
2715954|NCT00297427|9346900|P1|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29
2715955|NCT00297427|9346899|P2|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0
2715956|NCT00297427|9346900|P1|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1
2715957|NCT00297427|9346899|P2|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0
2715958|NCT00297427|9346900|P1|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15
2715959|NCT00297427|9346899|P2|Phase 1: Initial Intervention|Death|1
2715960|NCT00297427|9346900|P1|Phase 1: Initial Intervention|Death|0
2715961|NCT00297427|9346899|P2|Phase 1: Initial Intervention|Lost to Follow-up|3
2715962|NCT00297427|9346900|P1|Phase 1: Initial Intervention|Lost to Follow-up|0
2715963|NCT00297427|9346899|P2|Phase 1: Initial Intervention|Withdrawal by Subject|5
2715964|NCT00297427|9346900|P1|Phase 1: Initial Intervention|Withdrawal by Subject|8
2715965|NCT00297258|9346941|P1|Overall Study|Interruption: Cold/Flu-like Symptoms|1
2715966|NCT00297258|9346941|P1|Overall Study|Switch to Commercial Treatment|1
2715967|NCT00297258|9346941|P1|Overall Study|Surgery Performed on Target Lesion|1
2715968|NCT00297258|9346941|P1|Overall Study|Radiotherapy to Destroy Last Lesion|1
2715969|NCT00297258|9346941|P1|Overall Study|Deteriorization of General Condition|1
2715970|NCT00297258|9346941|P1|Overall Study|Intercurrent Death|2
2715971|NCT00297258|9346941|P1|Overall Study|Intercurrent Illness|3
2715972|NCT00297258|9346941|P1|Overall Study|Patient Refusal: Not Related to Toxicity|2
2715973|NCT00297258|9346941|P1|Overall Study|Toxicity (or Toxic Death)|10
2715974|NCT00297258|9346941|P1|Overall Study|Disease Progression, Relapse, Death|120
2715975|NCT00297232|9346960|P1|Overall Study|Other|1
2715976|NCT00297232|9346960|P1|Overall Study|No data available after Week 264|161
2715977|NCT00297232|9346960|P1|Overall Study|Did Not Enroll to Week 480|17
2715978|NCT00297232|9346960|P1|Overall Study|Did Not Enroll to Week 264|34
2715979|NCT00297232|9346960|P1|Overall Study|Investigator Withdrew From Program|19
2715980|NCT00297232|9346960|P1|Overall Study|Persistently Positive Antibodies|11
2715981|NCT00297232|9346960|P1|Overall Study|Subject Withdrew Consent|37
2715982|NCT00297232|9346960|P1|Overall Study|Subject Relocated|7
2715983|NCT00297232|9346960|P1|Overall Study|Sponsor Decision|34
2715984|NCT00297232|9346960|P1|Overall Study|Miscellaneous|5
2715985|NCT00297232|9346960|P1|Overall Study|Anti-JCV Antibody Positive|13
2715986|NCT00297232|9346960|P1|Overall Study|Fear of PML|10
2715987|NCT00297232|9346960|P1|Overall Study|Disease Progression|8
2715988|NCT00297232|9346960|P1|Overall Study|Switched to Commercial Tysabri|22
2715989|NCT00297232|9346960|P1|Overall Study|Anti-natalizumab Positive|8
2715990|NCT00297232|9346960|P1|Overall Study|Death|9
2715991|NCT00297232|9346960|P1|Overall Study|Subject was Noncompliant|9
2715992|NCT00297232|9346960|P1|Overall Study|Voluntary Withdrawal|120
2715993|NCT00297232|9346960|P1|Overall Study|Adverse Event|63
2715994|NCT00297232|9346960|P1|Overall Study|Lost to Follow-up|10
2715995|NCT00297232|9346960|P1|Overall Study|Lack of Efficacy|7
2715996|NCT00297167|9346966|P3|Second Double-blind Intervention Period|Protocol Violation|0
2715997|NCT00297167|9346967|P2|Second Double-blind Intervention Period|Protocol Violation|0
2715998|NCT00297167|9346968|P1|Second Double-blind Intervention Period|Protocol Violation|1
2715999|NCT00297167|9346966|P3|Open-label Dose Normalization Period 1|Withdrawal by Subject|1
2716000|NCT00297167|9346967|P2|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
2716001|NCT00297167|9346968|P1|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
2716002|NCT00297037|9347032|P2|Overall Study|Withdrawal by Subject|0
2716003|NCT00297037|9347033|P1|Overall Study|Withdrawal by Subject|2
2716004|NCT00296816|9347045|P1|Overall Study|ineligibility due to radiation treatment|1
2716005|NCT00296816|9347045|P1|Overall Study|Proteinuria|1
2716006|NCT00296816|9347045|P1|Overall Study|Neuropathy/patient preference|1
2716007|NCT00296816|9347045|P1|Overall Study|Urine protein/creatinine ratio delay|1
2716008|NCT00296816|9347045|P1|Overall Study|Noncompliance/decision to discontinue|1
2716009|NCT00296816|9347045|P1|Overall Study|Relocation to Florida|1
2716010|NCT00296816|9347045|P1|Overall Study|Poor performance status|1
2716011|NCT00296816|9347045|P1|Overall Study|Progression based on CA-125 (biomarker)|2
2716012|NCT00296816|9347045|P1|Overall Study|Missing for end of treatment|4
2716013|NCT00296816|9347045|P1|Overall Study|Non-compliance|1
2716014|NCT00296816|9347045|P1|Overall Study|Investigator/Participant request|5
2716015|NCT00296816|9347045|P1|Overall Study|Adverse Event|18
2716016|NCT00296816|9347045|P1|Overall Study|Disease Progression|37
2716017|NCT00296725|9347057|P1|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1
2716018|NCT00296725|9347057|P1|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4
2716019|NCT00296725|9347057|P1|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1
2716020|NCT00296647|9347070|P5|Overall Study|Withdrawal by Subject|19
2716021|NCT00296647|9347071|P4|Overall Study|Withdrawal by Subject|16
2716022|NCT00296647|9347072|P3|Overall Study|Withdrawal by Subject|32
2716023|NCT00296647|9347073|P2|Overall Study|Withdrawal by Subject|27
2716024|NCT00296647|9347074|P1|Overall Study|Withdrawal by Subject|28
2716025|NCT00296647|9347070|P5|Overall Study|Death|1
2716026|NCT00296647|9347071|P4|Overall Study|Death|1
2716027|NCT00296647|9347072|P3|Overall Study|Death|2
2716028|NCT00296647|9347073|P2|Overall Study|Death|1
2716029|NCT00296647|9347074|P1|Overall Study|Death|4
2716030|NCT00296517|9347088|P2|Dose Level 3 - Weeks 3-12|Other|2
2716031|NCT00296517|9347089|P1|Dose Level 3 - Weeks 3-12|Other|0
2716032|NCT00296517|9347088|P2|Dose Level 3 - Weeks 3-12|Non - Compliance|0
2716033|NCT00296517|9347089|P1|Dose Level 3 - Weeks 3-12|Non - Compliance|1
2716034|NCT00296517|9347088|P2|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18
2716035|NCT00296517|9347089|P1|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7
2716036|NCT00296517|9347088|P2|Dose Level 3 - Weeks 3-12|Protocol Violation|0
2716037|NCT00296517|9347089|P1|Dose Level 3 - Weeks 3-12|Protocol Violation|1
2716038|NCT00296517|9347088|P2|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2
2716039|NCT00296517|9347089|P1|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3
2716040|NCT00296517|9347088|P2|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6
2716041|NCT00296517|9347089|P1|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3
2716042|NCT00296517|9347088|P2|Dose Level 3 - Weeks 3-12|Adverse Event|34
2716043|NCT00296517|9347089|P1|Dose Level 3 - Weeks 3-12|Adverse Event|30
2716044|NCT00296517|9347088|P2|Dose Level 2 - Week 2|Withdrawal by Subject|0
2716045|NCT00296517|9347089|P1|Dose Level 2 - Week 2|Withdrawal by Subject|1
2716046|NCT00296517|9347088|P2|Dose Level 2 - Week 2|Adverse Event|5
2716047|NCT00296517|9347089|P1|Dose Level 2 - Week 2|Adverse Event|1
2716048|NCT00296504|9347125|P9|Final Analysis|Poor Adherence|1
2716049|NCT00296504|9347126|P8|Final Analysis|Poor Adherence|0
2716050|NCT00296504|9347127|P7|Final Analysis|Poor Adherence|0
2716051|NCT00296504|9347128|P6|Final Analysis|Poor Adherence|0
2716052|NCT00296504|9347129|P5|Final Analysis|Poor Adherence|0
2716053|NCT00296504|9347130|P4|Final Analysis|Poor Adherence|0
2716054|NCT00296504|9347131|P3|Final Analysis|Poor Adherence|0
2716055|NCT00296504|9347132|P2|Final Analysis|Poor Adherence|0
2716056|NCT00296504|9347133|P1|Final Analysis|Poor Adherence|0
2716057|NCT00296504|9347125|P9|Final Analysis|Participant Moved to Another Country|1
2716058|NCT00296504|9347126|P8|Final Analysis|Participant Moved to Another Country|0
2716059|NCT00296504|9347127|P7|Final Analysis|Participant Moved to Another Country|0
2716060|NCT00296504|9347128|P6|Final Analysis|Participant Moved to Another Country|0
2716061|NCT00296504|9347129|P5|Final Analysis|Participant Moved to Another Country|0
2716062|NCT00296504|9347130|P4|Final Analysis|Participant Moved to Another Country|0
2716063|NCT00296504|9347131|P3|Final Analysis|Participant Moved to Another Country|0
2716064|NCT00296504|9347132|P2|Final Analysis|Participant Moved to Another Country|0
2716065|NCT00296504|9347133|P1|Final Analysis|Participant Moved to Another Country|0
2716066|NCT00296504|9347125|P9|Final Analysis|Tuberculosis|1
2716067|NCT00296504|9347126|P8|Final Analysis|Tuberculosis|0
2716068|NCT00296504|9347127|P7|Final Analysis|Tuberculosis|0
2716069|NCT00296504|9347128|P6|Final Analysis|Tuberculosis|0
2716070|NCT00296504|9347129|P5|Final Analysis|Tuberculosis|0
2716071|NCT00296504|9347130|P4|Final Analysis|Tuberculosis|0
2716072|NCT00296504|9347131|P3|Final Analysis|Tuberculosis|0
2716073|NCT00296504|9347132|P2|Final Analysis|Tuberculosis|0
2716074|NCT00296504|9347133|P1|Final Analysis|Tuberculosis|0
2716075|NCT00296504|9347125|P9|Final Analysis|Pregnancy|4
2716076|NCT00296504|9347126|P8|Final Analysis|Pregnancy|0
2716077|NCT00296504|9347127|P7|Final Analysis|Pregnancy|0
2716078|NCT00296504|9347128|P6|Final Analysis|Pregnancy|0
2716079|NCT00296504|9347129|P5|Final Analysis|Pregnancy|0
2716080|NCT00296504|9347130|P4|Final Analysis|Pregnancy|0
2716081|NCT00296504|9347131|P3|Final Analysis|Pregnancy|0
2716082|NCT00296504|9347132|P2|Final Analysis|Pregnancy|0
2716083|NCT00296504|9347133|P1|Final Analysis|Pregnancy|0
2716084|NCT00296504|9347125|P9|Final Analysis|Adverse Event|2
2716085|NCT00296504|9347126|P8|Final Analysis|Adverse Event|0
2716086|NCT00296504|9347127|P7|Final Analysis|Adverse Event|0
2716087|NCT00296504|9347128|P6|Final Analysis|Adverse Event|0
2716088|NCT00296504|9347129|P5|Final Analysis|Adverse Event|0
2716089|NCT00296504|9347130|P4|Final Analysis|Adverse Event|0
2716090|NCT00296504|9347131|P3|Final Analysis|Adverse Event|0
2716091|NCT00296504|9347132|P2|Final Analysis|Adverse Event|0
2716092|NCT00296504|9347133|P1|Final Analysis|Adverse Event|0
2716093|NCT00296504|9347125|P9|Final Analysis|Insufficient Viral Load Response|6
2716094|NCT00296504|9347126|P8|Final Analysis|Insufficient Viral Load Response|0
2716095|NCT00296504|9347127|P7|Final Analysis|Insufficient Viral Load Response|0
2716096|NCT00296504|9347128|P6|Final Analysis|Insufficient Viral Load Response|0
2716097|NCT00296504|9347129|P5|Final Analysis|Insufficient Viral Load Response|0
2716098|NCT00296504|9347130|P4|Final Analysis|Insufficient Viral Load Response|0
2716099|NCT00296504|9347131|P3|Final Analysis|Insufficient Viral Load Response|0
2716100|NCT00296504|9347132|P2|Final Analysis|Insufficient Viral Load Response|0
2716101|NCT00296504|9347133|P1|Final Analysis|Insufficient Viral Load Response|0
2716102|NCT00296504|9347125|P9|Final Analysis|Lost to Follow-up|5
2716103|NCT00296504|9347126|P8|Final Analysis|Lost to Follow-up|0
2716104|NCT00296504|9347127|P7|Final Analysis|Lost to Follow-up|0
2716105|NCT00296504|9347128|P6|Final Analysis|Lost to Follow-up|0
2716106|NCT00296504|9347129|P5|Final Analysis|Lost to Follow-up|0
2716107|NCT00296504|9347130|P4|Final Analysis|Lost to Follow-up|0
2716108|NCT00296504|9347131|P3|Final Analysis|Lost to Follow-up|0
2716109|NCT00296504|9347132|P2|Final Analysis|Lost to Follow-up|0
2716110|NCT00296504|9347133|P1|Final Analysis|Lost to Follow-up|0
2716111|NCT00296504|9347125|P9|Final Analysis|Withdrawal by Subject|1
2716112|NCT00296504|9347126|P8|Final Analysis|Withdrawal by Subject|0
2716113|NCT00296504|9347127|P7|Final Analysis|Withdrawal by Subject|0
2716114|NCT00296504|9347128|P6|Final Analysis|Withdrawal by Subject|0
2716115|NCT00296504|9347129|P5|Final Analysis|Withdrawal by Subject|0
2716116|NCT00296504|9347130|P4|Final Analysis|Withdrawal by Subject|0
2716117|NCT00296504|9347131|P3|Final Analysis|Withdrawal by Subject|0
2716118|NCT00296504|9347132|P2|Final Analysis|Withdrawal by Subject|0
2716119|NCT00296504|9347133|P1|Final Analysis|Withdrawal by Subject|0
2716120|NCT00296504|9347125|P9|Interim Analysis|Ongoing|0
2716121|NCT00296504|9347126|P8|Interim Analysis|Ongoing|1
2716122|NCT00296504|9347127|P7|Interim Analysis|Ongoing|30
2716123|NCT00296504|9347128|P6|Interim Analysis|Ongoing|0
2716124|NCT00296504|9347129|P5|Interim Analysis|Ongoing|0
2716125|NCT00296504|9347130|P4|Interim Analysis|Ongoing|22
2716126|NCT00296504|9347131|P3|Interim Analysis|Ongoing|16
2716127|NCT00296504|9347132|P2|Interim Analysis|Ongoing|12
2716128|NCT00296504|9347133|P1|Interim Analysis|Ongoing|32
2716129|NCT00296504|9347125|P9|Interim Analysis|Participant Needed Interferon|0
2716130|NCT00296504|9347126|P8|Interim Analysis|Participant Needed Interferon|1
2716131|NCT00296504|9347127|P7|Interim Analysis|Participant Needed Interferon|0
2716132|NCT00296504|9347128|P6|Interim Analysis|Participant Needed Interferon|0
2716133|NCT00296504|9347129|P5|Interim Analysis|Participant Needed Interferon|0
2716134|NCT00296504|9347130|P4|Interim Analysis|Participant Needed Interferon|0
2716135|NCT00296504|9347131|P3|Interim Analysis|Participant Needed Interferon|0
2716136|NCT00296504|9347132|P2|Interim Analysis|Participant Needed Interferon|0
2716137|NCT00296504|9347133|P1|Interim Analysis|Participant Needed Interferon|0
2716138|NCT00296504|9347125|P9|Interim Analysis|Study Ended|0
2716139|NCT00296504|9347126|P8|Interim Analysis|Study Ended|0
2716140|NCT00296504|9347127|P7|Interim Analysis|Study Ended|1
2716141|NCT00296504|9347128|P6|Interim Analysis|Study Ended|0
2716142|NCT00296504|9347129|P5|Interim Analysis|Study Ended|0
2716143|NCT00296504|9347130|P4|Interim Analysis|Study Ended|0
2716144|NCT00296504|9347131|P3|Interim Analysis|Study Ended|0
2716145|NCT00296504|9347132|P2|Interim Analysis|Study Ended|0
2716146|NCT00296504|9347133|P1|Interim Analysis|Study Ended|0
2716147|NCT00296504|9347125|P9|Interim Analysis|Participant Stopped HIV Medications|0
2716148|NCT00296504|9347126|P8|Interim Analysis|Participant Stopped HIV Medications|0
2716149|NCT00296504|9347127|P7|Interim Analysis|Participant Stopped HIV Medications|1
2716150|NCT00296504|9347128|P6|Interim Analysis|Participant Stopped HIV Medications|0
2716151|NCT00296504|9347129|P5|Interim Analysis|Participant Stopped HIV Medications|0
2716152|NCT00296504|9347130|P4|Interim Analysis|Participant Stopped HIV Medications|0
2716153|NCT00296504|9347131|P3|Interim Analysis|Participant Stopped HIV Medications|0
2716154|NCT00296504|9347132|P2|Interim Analysis|Participant Stopped HIV Medications|0
2716155|NCT00296504|9347133|P1|Interim Analysis|Participant Stopped HIV Medications|0
2716156|NCT00296504|9347125|P9|Interim Analysis|Physician and Participant Decision|0
2716157|NCT00296504|9347126|P8|Interim Analysis|Physician and Participant Decision|0
2716158|NCT00296504|9347127|P7|Interim Analysis|Physician and Participant Decision|0
2716159|NCT00296504|9347128|P6|Interim Analysis|Physician and Participant Decision|1
2716160|NCT00296504|9347129|P5|Interim Analysis|Physician and Participant Decision|0
2716161|NCT00296504|9347130|P4|Interim Analysis|Physician and Participant Decision|0
2716162|NCT00296504|9347131|P3|Interim Analysis|Physician and Participant Decision|0
2716163|NCT00296504|9347132|P2|Interim Analysis|Physician and Participant Decision|0
2716164|NCT00296504|9347133|P1|Interim Analysis|Physician and Participant Decision|0
2716165|NCT00296504|9347125|P9|Interim Analysis|Participant Stopped|0
2716166|NCT00296504|9347126|P8|Interim Analysis|Participant Stopped|0
2716167|NCT00296504|9347127|P7|Interim Analysis|Participant Stopped|0
2716168|NCT00296504|9347128|P6|Interim Analysis|Participant Stopped|0
2716169|NCT00296504|9347129|P5|Interim Analysis|Participant Stopped|1
2716170|NCT00296504|9347130|P4|Interim Analysis|Participant Stopped|0
2716171|NCT00296504|9347131|P3|Interim Analysis|Participant Stopped|0
2716172|NCT00296504|9347132|P2|Interim Analysis|Participant Stopped|0
2716173|NCT00296504|9347133|P1|Interim Analysis|Participant Stopped|0
2716174|NCT00296504|9347125|P9|Interim Analysis|Inclusion in Other Protocol|0
2716175|NCT00296504|9347126|P8|Interim Analysis|Inclusion in Other Protocol|0
2716176|NCT00296504|9347127|P7|Interim Analysis|Inclusion in Other Protocol|0
2716177|NCT00296504|9347128|P6|Interim Analysis|Inclusion in Other Protocol|0
2716178|NCT00296504|9347129|P5|Interim Analysis|Inclusion in Other Protocol|0
2716179|NCT00296504|9347130|P4|Interim Analysis|Inclusion in Other Protocol|1
2716180|NCT00296504|9347131|P3|Interim Analysis|Inclusion in Other Protocol|0
2716181|NCT00296504|9347132|P2|Interim Analysis|Inclusion in Other Protocol|0
2716182|NCT00296504|9347133|P1|Interim Analysis|Inclusion in Other Protocol|0
2716183|NCT00296504|9347125|P9|Interim Analysis|Missed Schedule Date|0
2716184|NCT00296504|9347126|P8|Interim Analysis|Missed Schedule Date|0
2716185|NCT00296504|9347127|P7|Interim Analysis|Missed Schedule Date|0
2716186|NCT00296504|9347128|P6|Interim Analysis|Missed Schedule Date|0
2716187|NCT00296504|9347129|P5|Interim Analysis|Missed Schedule Date|0
2716188|NCT00296504|9347130|P4|Interim Analysis|Missed Schedule Date|0
2716189|NCT00296504|9347131|P3|Interim Analysis|Missed Schedule Date|0
2716190|NCT00296504|9347132|P2|Interim Analysis|Missed Schedule Date|0
2716191|NCT00296504|9347133|P1|Interim Analysis|Missed Schedule Date|1
2716192|NCT00296504|9347125|P9|Interim Analysis|Lack of Personnel at Site|0
2716193|NCT00296504|9347126|P8|Interim Analysis|Lack of Personnel at Site|0
2716194|NCT00296504|9347127|P7|Interim Analysis|Lack of Personnel at Site|0
2716195|NCT00296504|9347128|P6|Interim Analysis|Lack of Personnel at Site|0
2716196|NCT00296504|9347129|P5|Interim Analysis|Lack of Personnel at Site|0
2716197|NCT00296504|9347130|P4|Interim Analysis|Lack of Personnel at Site|0
2716198|NCT00296504|9347131|P3|Interim Analysis|Lack of Personnel at Site|0
2716199|NCT00296504|9347132|P2|Interim Analysis|Lack of Personnel at Site|0
2716200|NCT00296504|9347133|P1|Interim Analysis|Lack of Personnel at Site|1
2716201|NCT00296504|9347125|P9|Interim Analysis|Site Closing|0
2716202|NCT00296504|9347126|P8|Interim Analysis|Site Closing|0
2716203|NCT00296504|9347127|P7|Interim Analysis|Site Closing|2
2716204|NCT00296504|9347128|P6|Interim Analysis|Site Closing|1
2716205|NCT00296504|9347129|P5|Interim Analysis|Site Closing|0
2716206|NCT00296504|9347130|P4|Interim Analysis|Site Closing|0
2716207|NCT00296504|9347131|P3|Interim Analysis|Site Closing|0
2716208|NCT00296504|9347132|P2|Interim Analysis|Site Closing|0
2716209|NCT00296504|9347133|P1|Interim Analysis|Site Closing|1
2716210|NCT00296504|9347125|P9|Interim Analysis|Non-adherence|0
2716211|NCT00296504|9347126|P8|Interim Analysis|Non-adherence|1
2716212|NCT00296504|9347127|P7|Interim Analysis|Non-adherence|0
2716213|NCT00296504|9347128|P6|Interim Analysis|Non-adherence|0
2716214|NCT00296504|9347129|P5|Interim Analysis|Non-adherence|1
2716215|NCT00296504|9347130|P4|Interim Analysis|Non-adherence|0
2716216|NCT00296504|9347131|P3|Interim Analysis|Non-adherence|0
2716217|NCT00296504|9347132|P2|Interim Analysis|Non-adherence|0
2716218|NCT00296504|9347133|P1|Interim Analysis|Non-adherence|2
2716219|NCT00296504|9347125|P9|Interim Analysis|Principle Investigator Terminated Study|0
2716220|NCT00296504|9347126|P8|Interim Analysis|Principle Investigator Terminated Study|0
2716221|NCT00296504|9347127|P7|Interim Analysis|Principle Investigator Terminated Study|0
2716222|NCT00296504|9347128|P6|Interim Analysis|Principle Investigator Terminated Study|0
2716223|NCT00296504|9347129|P5|Interim Analysis|Principle Investigator Terminated Study|0
2716224|NCT00296504|9347130|P4|Interim Analysis|Principle Investigator Terminated Study|0
2716225|NCT00296504|9347131|P3|Interim Analysis|Principle Investigator Terminated Study|1
2716226|NCT00296504|9347132|P2|Interim Analysis|Principle Investigator Terminated Study|0
2716227|NCT00296504|9347133|P1|Interim Analysis|Principle Investigator Terminated Study|0
2716228|NCT00296504|9347125|P9|Interim Analysis|Principle Investigator Discretion|0
2716229|NCT00296504|9347126|P8|Interim Analysis|Principle Investigator Discretion|0
2716230|NCT00296504|9347127|P7|Interim Analysis|Principle Investigator Discretion|0
2716231|NCT00296504|9347128|P6|Interim Analysis|Principle Investigator Discretion|0
2716232|NCT00296504|9347129|P5|Interim Analysis|Principle Investigator Discretion|0
2716233|NCT00296504|9347130|P4|Interim Analysis|Principle Investigator Discretion|1
2716234|NCT00296504|9347131|P3|Interim Analysis|Principle Investigator Discretion|1
2716235|NCT00296504|9347132|P2|Interim Analysis|Principle Investigator Discretion|0
2716236|NCT00296504|9347133|P1|Interim Analysis|Principle Investigator Discretion|2
2716237|NCT00296504|9347125|P9|Interim Analysis|Physician Decision|0
2716238|NCT00296504|9347126|P8|Interim Analysis|Physician Decision|0
2716239|NCT00296504|9347127|P7|Interim Analysis|Physician Decision|0
2716240|NCT00296504|9347128|P6|Interim Analysis|Physician Decision|0
2716241|NCT00296504|9347129|P5|Interim Analysis|Physician Decision|0
2716242|NCT00296504|9347130|P4|Interim Analysis|Physician Decision|0
2716243|NCT00296504|9347131|P3|Interim Analysis|Physician Decision|1
2716244|NCT00296504|9347132|P2|Interim Analysis|Physician Decision|0
2716245|NCT00296504|9347133|P1|Interim Analysis|Physician Decision|0
2716246|NCT00296504|9347125|P9|Interim Analysis|Resistance to FPV|0
2716247|NCT00296504|9347126|P8|Interim Analysis|Resistance to FPV|0
2716248|NCT00296504|9347127|P7|Interim Analysis|Resistance to FPV|0
2716249|NCT00296504|9347128|P6|Interim Analysis|Resistance to FPV|0
2716250|NCT00296504|9347129|P5|Interim Analysis|Resistance to FPV|0
2716251|NCT00296504|9347130|P4|Interim Analysis|Resistance to FPV|0
2716252|NCT00296504|9347131|P3|Interim Analysis|Resistance to FPV|1
2716253|NCT00296504|9347132|P2|Interim Analysis|Resistance to FPV|0
2716254|NCT00296504|9347133|P1|Interim Analysis|Resistance to FPV|0
2716255|NCT00296504|9347125|P9|Interim Analysis|Participant Was Incarcerated|0
2716256|NCT00296504|9347126|P8|Interim Analysis|Participant Was Incarcerated|0
2716257|NCT00296504|9347127|P7|Interim Analysis|Participant Was Incarcerated|0
2716258|NCT00296504|9347128|P6|Interim Analysis|Participant Was Incarcerated|0
2716259|NCT00296504|9347129|P5|Interim Analysis|Participant Was Incarcerated|0
2716260|NCT00296504|9347130|P4|Interim Analysis|Participant Was Incarcerated|0
2716261|NCT00296504|9347131|P3|Interim Analysis|Participant Was Incarcerated|1
2716262|NCT00296504|9347132|P2|Interim Analysis|Participant Was Incarcerated|0
2716263|NCT00296504|9347133|P1|Interim Analysis|Participant Was Incarcerated|2
2716264|NCT00296504|9347125|P9|Interim Analysis|Participant Moved|0
2716265|NCT00296504|9347126|P8|Interim Analysis|Participant Moved|0
2716266|NCT00296504|9347127|P7|Interim Analysis|Participant Moved|1
2716267|NCT00296504|9347128|P6|Interim Analysis|Participant Moved|1
2716268|NCT00296504|9347129|P5|Interim Analysis|Participant Moved|0
2716269|NCT00296504|9347130|P4|Interim Analysis|Participant Moved|0
2716270|NCT00296504|9347131|P3|Interim Analysis|Participant Moved|1
2716271|NCT00296504|9347132|P2|Interim Analysis|Participant Moved|0
2716272|NCT00296504|9347133|P1|Interim Analysis|Participant Moved|1
2716273|NCT00296504|9347125|P9|Interim Analysis|Participant Had Problems with Alcohol|0
2716274|NCT00296504|9347126|P8|Interim Analysis|Participant Had Problems with Alcohol|0
2716275|NCT00296504|9347127|P7|Interim Analysis|Participant Had Problems with Alcohol|0
2716276|NCT00296504|9347128|P6|Interim Analysis|Participant Had Problems with Alcohol|0
2716277|NCT00296504|9347129|P5|Interim Analysis|Participant Had Problems with Alcohol|0
2716278|NCT00296504|9347130|P4|Interim Analysis|Participant Had Problems with Alcohol|0
2716279|NCT00296504|9347131|P3|Interim Analysis|Participant Had Problems with Alcohol|1
2716280|NCT00296504|9347132|P2|Interim Analysis|Participant Had Problems with Alcohol|0
2716281|NCT00296504|9347133|P1|Interim Analysis|Participant Had Problems with Alcohol|0
2716282|NCT00296504|9347125|P9|Interim Analysis|To Simplify Treatment|0
2716283|NCT00296504|9347126|P8|Interim Analysis|To Simplify Treatment|0
2716284|NCT00296504|9347127|P7|Interim Analysis|To Simplify Treatment|2
2716285|NCT00296504|9347128|P6|Interim Analysis|To Simplify Treatment|0
2716286|NCT00296504|9347129|P5|Interim Analysis|To Simplify Treatment|0
2716287|NCT00296504|9347130|P4|Interim Analysis|To Simplify Treatment|0
2716288|NCT00296504|9347131|P3|Interim Analysis|To Simplify Treatment|1
2716289|NCT00296504|9347132|P2|Interim Analysis|To Simplify Treatment|0
2716290|NCT00296504|9347133|P1|Interim Analysis|To Simplify Treatment|0
2716291|NCT00296504|9347125|P9|Interim Analysis|Participant Wanted to Become Pregnant|0
2716292|NCT00296504|9347126|P8|Interim Analysis|Participant Wanted to Become Pregnant|0
2716293|NCT00296504|9347127|P7|Interim Analysis|Participant Wanted to Become Pregnant|0
2716294|NCT00296504|9347128|P6|Interim Analysis|Participant Wanted to Become Pregnant|1
2716295|NCT00296504|9347129|P5|Interim Analysis|Participant Wanted to Become Pregnant|0
2716296|NCT00296504|9347130|P4|Interim Analysis|Participant Wanted to Become Pregnant|0
2716297|NCT00296504|9347131|P3|Interim Analysis|Participant Wanted to Become Pregnant|2
2716298|NCT00296504|9347132|P2|Interim Analysis|Participant Wanted to Become Pregnant|0
2716299|NCT00296504|9347133|P1|Interim Analysis|Participant Wanted to Become Pregnant|0
2716300|NCT00296504|9347125|P9|Interim Analysis|Participant Non-compliant|0
2716301|NCT00296504|9347126|P8|Interim Analysis|Participant Non-compliant|2
2716302|NCT00296504|9347127|P7|Interim Analysis|Participant Non-compliant|6
2716303|NCT00296504|9347128|P6|Interim Analysis|Participant Non-compliant|3
2716304|NCT00296504|9347129|P5|Interim Analysis|Participant Non-compliant|1
2716305|NCT00296504|9347130|P4|Interim Analysis|Participant Non-compliant|1
2716306|NCT00296504|9347131|P3|Interim Analysis|Participant Non-compliant|2
2716307|NCT00296504|9347132|P2|Interim Analysis|Participant Non-compliant|1
2716308|NCT00296504|9347133|P1|Interim Analysis|Participant Non-compliant|0
2716309|NCT00296504|9347125|P9|Interim Analysis|Death|0
2716310|NCT00296504|9347126|P8|Interim Analysis|Death|0
2716311|NCT00296504|9347127|P7|Interim Analysis|Death|0
2716312|NCT00296504|9347128|P6|Interim Analysis|Death|0
2716313|NCT00296504|9347129|P5|Interim Analysis|Death|0
2716314|NCT00296504|9347130|P4|Interim Analysis|Death|0
2716315|NCT00296504|9347131|P3|Interim Analysis|Death|3
2716316|NCT00296504|9347132|P2|Interim Analysis|Death|0
2716317|NCT00296504|9347133|P1|Interim Analysis|Death|1
2716318|NCT00296504|9347125|P9|Interim Analysis|Pregnancy|0
2716319|NCT00296504|9347126|P8|Interim Analysis|Pregnancy|1
2716320|NCT00296504|9347127|P7|Interim Analysis|Pregnancy|1
2716321|NCT00296504|9347128|P6|Interim Analysis|Pregnancy|1
2716322|NCT00296504|9347129|P5|Interim Analysis|Pregnancy|0
2716323|NCT00296504|9347130|P4|Interim Analysis|Pregnancy|2
2716324|NCT00296504|9347131|P3|Interim Analysis|Pregnancy|4
2716325|NCT00296504|9347132|P2|Interim Analysis|Pregnancy|1
2716326|NCT00296504|9347133|P1|Interim Analysis|Pregnancy|4
2716327|NCT00296504|9347125|P9|Interim Analysis|Switched to Commercially Available Drug|0
2716328|NCT00296504|9347126|P8|Interim Analysis|Switched to Commercially Available Drug|4
2716329|NCT00296504|9347127|P7|Interim Analysis|Switched to Commercially Available Drug|3
2716330|NCT00296504|9347128|P6|Interim Analysis|Switched to Commercially Available Drug|5
2716331|NCT00296504|9347129|P5|Interim Analysis|Switched to Commercially Available Drug|0
2716332|NCT00296504|9347130|P4|Interim Analysis|Switched to Commercially Available Drug|1
2716333|NCT00296504|9347131|P3|Interim Analysis|Switched to Commercially Available Drug|4
2716334|NCT00296504|9347132|P2|Interim Analysis|Switched to Commercially Available Drug|0
2716335|NCT00296504|9347133|P1|Interim Analysis|Switched to Commercially Available Drug|2
2716336|NCT00296504|9347125|P9|Interim Analysis|Insufficient CD4 Response|0
2716337|NCT00296504|9347126|P8|Interim Analysis|Insufficient CD4 Response|0
2716338|NCT00296504|9347127|P7|Interim Analysis|Insufficient CD4 Response|0
2716339|NCT00296504|9347128|P6|Interim Analysis|Insufficient CD4 Response|1
2716340|NCT00296504|9347129|P5|Interim Analysis|Insufficient CD4 Response|1
2716341|NCT00296504|9347130|P4|Interim Analysis|Insufficient CD4 Response|0
2716342|NCT00296504|9347131|P3|Interim Analysis|Insufficient CD4 Response|0
2716343|NCT00296504|9347132|P2|Interim Analysis|Insufficient CD4 Response|0
2716344|NCT00296504|9347133|P1|Interim Analysis|Insufficient CD4 Response|0
2716345|NCT00296504|9347125|P9|Interim Analysis|Protocol Violation|0
2716346|NCT00296504|9347126|P8|Interim Analysis|Protocol Violation|1
2716347|NCT00296504|9347127|P7|Interim Analysis|Protocol Violation|0
2716348|NCT00296504|9347128|P6|Interim Analysis|Protocol Violation|0
2716349|NCT00296504|9347129|P5|Interim Analysis|Protocol Violation|1
2716350|NCT00296504|9347130|P4|Interim Analysis|Protocol Violation|0
2716351|NCT00296504|9347131|P3|Interim Analysis|Protocol Violation|2
2716352|NCT00296504|9347132|P2|Interim Analysis|Protocol Violation|0
2716353|NCT00296504|9347133|P1|Interim Analysis|Protocol Violation|0
2716354|NCT00296504|9347125|P9|Interim Analysis|Adverse Event|0
2716355|NCT00296504|9347126|P8|Interim Analysis|Adverse Event|5
2716356|NCT00296504|9347127|P7|Interim Analysis|Adverse Event|4
2716357|NCT00296504|9347128|P6|Interim Analysis|Adverse Event|3
2716358|NCT00296504|9347129|P5|Interim Analysis|Adverse Event|6
2716359|NCT00296504|9347130|P4|Interim Analysis|Adverse Event|4
2716360|NCT00296504|9347131|P3|Interim Analysis|Adverse Event|13
2716361|NCT00296504|9347132|P2|Interim Analysis|Adverse Event|0
2716362|NCT00296504|9347133|P1|Interim Analysis|Adverse Event|0
2716363|NCT00296504|9347125|P9|Interim Analysis|Insufficient Viral Load Response|0
2716364|NCT00296504|9347126|P8|Interim Analysis|Insufficient Viral Load Response|24
2716365|NCT00296504|9347127|P7|Interim Analysis|Insufficient Viral Load Response|2
2716366|NCT00296504|9347128|P6|Interim Analysis|Insufficient Viral Load Response|9
2716367|NCT00296504|9347129|P5|Interim Analysis|Insufficient Viral Load Response|7
2716368|NCT00296504|9347130|P4|Interim Analysis|Insufficient Viral Load Response|2
2716369|NCT00296504|9347131|P3|Interim Analysis|Insufficient Viral Load Response|12
2716370|NCT00296504|9347132|P2|Interim Analysis|Insufficient Viral Load Response|1
2716371|NCT00296504|9347133|P1|Interim Analysis|Insufficient Viral Load Response|5
2716372|NCT00296504|9347125|P9|Interim Analysis|Clinical Progression|0
2716373|NCT00296504|9347126|P8|Interim Analysis|Clinical Progression|2
2716374|NCT00296504|9347127|P7|Interim Analysis|Clinical Progression|1
2716375|NCT00296504|9347128|P6|Interim Analysis|Clinical Progression|2
2716376|NCT00296504|9347129|P5|Interim Analysis|Clinical Progression|0
2716377|NCT00296504|9347130|P4|Interim Analysis|Clinical Progression|1
2716378|NCT00296504|9347131|P3|Interim Analysis|Clinical Progression|1
2716379|NCT00296504|9347132|P2|Interim Analysis|Clinical Progression|0
2716380|NCT00296504|9347133|P1|Interim Analysis|Clinical Progression|1
2716381|NCT00296504|9347125|P9|Interim Analysis|Lost to Follow-up|0
2716382|NCT00296504|9347126|P8|Interim Analysis|Lost to Follow-up|4
2716383|NCT00296504|9347127|P7|Interim Analysis|Lost to Follow-up|11
2716384|NCT00296504|9347128|P6|Interim Analysis|Lost to Follow-up|4
2716385|NCT00296504|9347129|P5|Interim Analysis|Lost to Follow-up|14
2716386|NCT00296504|9347130|P4|Interim Analysis|Lost to Follow-up|8
2716387|NCT00296504|9347131|P3|Interim Analysis|Lost to Follow-up|26
2716388|NCT00296504|9347132|P2|Interim Analysis|Lost to Follow-up|3
2716389|NCT00296504|9347133|P1|Interim Analysis|Lost to Follow-up|13
2716390|NCT00296504|9347125|P9|Interim Analysis|Withdrawal by Subject|0
2716391|NCT00296504|9347126|P8|Interim Analysis|Withdrawal by Subject|3
2716392|NCT00296504|9347127|P7|Interim Analysis|Withdrawal by Subject|9
2716393|NCT00296504|9347128|P6|Interim Analysis|Withdrawal by Subject|5
2716394|NCT00296504|9347129|P5|Interim Analysis|Withdrawal by Subject|5
2716395|NCT00296504|9347130|P4|Interim Analysis|Withdrawal by Subject|0
2716396|NCT00296504|9347131|P3|Interim Analysis|Withdrawal by Subject|12
2716397|NCT00296504|9347132|P2|Interim Analysis|Withdrawal by Subject|0
2716398|NCT00296504|9347133|P1|Interim Analysis|Withdrawal by Subject|8
2716399|NCT00296491|9347226|P4|Overall Study|Lost to Follow-up|0
2716400|NCT00296491|9347227|P3|Overall Study|Lost to Follow-up|2
2716401|NCT00296491|9347228|P2|Overall Study|Lost to Follow-up|2
2716402|NCT00296491|9347229|P1|Overall Study|Lost to Follow-up|0
2716403|NCT00296491|9347226|P4|Overall Study|Non-Compliance|14
2716404|NCT00296491|9347227|P3|Overall Study|Non-Compliance|10
2716405|NCT00296491|9347228|P2|Overall Study|Non-Compliance|13
2716406|NCT00296491|9347229|P1|Overall Study|Non-Compliance|12
2716407|NCT00296491|9347226|P4|Overall Study|Withdrawal by Subject|2
2716408|NCT00296491|9347227|P3|Overall Study|Withdrawal by Subject|3
2716409|NCT00296491|9347228|P2|Overall Study|Withdrawal by Subject|3
2716410|NCT00296491|9347229|P1|Overall Study|Withdrawal by Subject|7
2716411|NCT00296491|9347226|P4|Overall Study|Withdrawn due to Asthma|4
2716412|NCT00296491|9347227|P3|Overall Study|Withdrawn due to Asthma|0
2716413|NCT00296491|9347228|P2|Overall Study|Withdrawn due to Asthma|0
2716414|NCT00296491|9347229|P1|Overall Study|Withdrawn due to Asthma|0
2716415|NCT00296491|9347226|P4|Overall Study|Adverse Event|4
2716416|NCT00296491|9347227|P3|Overall Study|Adverse Event|1
2716417|NCT00296491|9347228|P2|Overall Study|Adverse Event|3
2716418|NCT00296491|9347229|P1|Overall Study|Adverse Event|1
2716419|NCT00296491|9347226|P4|Overall Study|Protocol Violation|3
2716420|NCT00296491|9347227|P3|Overall Study|Protocol Violation|2
2716421|NCT00296491|9347228|P2|Overall Study|Protocol Violation|6
2716422|NCT00296491|9347229|P1|Overall Study|Protocol Violation|4
2716423|NCT00296491|9347226|P4|Overall Study|Low Pollen Counts|16
2716424|NCT00296491|9347227|P3|Overall Study|Low Pollen Counts|25
2716425|NCT00296491|9347228|P2|Overall Study|Low Pollen Counts|26
2716426|NCT00296491|9347229|P1|Overall Study|Low Pollen Counts|18
2716427|NCT00296400|9347258|P3|Overall Study|Pregnancy|0
2716428|NCT00296400|9347259|P2|Overall Study|Pregnancy|2
2716429|NCT00296400|9347260|P1|Overall Study|Pregnancy|1
2716430|NCT00296400|9347258|P3|Overall Study|Visit 10 was performed earlier|0
2716431|NCT00296400|9347259|P2|Overall Study|Visit 10 was performed earlier|1
2716432|NCT00296400|9347260|P1|Overall Study|Visit 10 was performed earlier|0
2716433|NCT00296400|9347258|P3|Overall Study|Study specific discontinuation criteria|1
2716434|NCT00296400|9347259|P2|Overall Study|Study specific discontinuation criteria|0
2716435|NCT00296400|9347260|P1|Overall Study|Study specific discontinuation criteria|0
2716436|NCT00296400|9347258|P3|Overall Study|Lost to Follow-up|2
2716437|NCT00296400|9347259|P2|Overall Study|Lost to Follow-up|1
2716438|NCT00296400|9347260|P1|Overall Study|Lost to Follow-up|1
2716439|NCT00296400|9347258|P3|Overall Study|Protocol Violation|1
2716440|NCT00296400|9347259|P2|Overall Study|Protocol Violation|1
2716441|NCT00296400|9347260|P1|Overall Study|Protocol Violation|1
2716442|NCT00296400|9347258|P3|Overall Study|Incorrect enrollment|0
2716443|NCT00296400|9347259|P2|Overall Study|Incorrect enrollment|0
2716444|NCT00296400|9347260|P1|Overall Study|Incorrect enrollment|2
2716445|NCT00296400|9347258|P3|Overall Study|Withdrawal by Subject|2
2716446|NCT00296400|9347259|P2|Overall Study|Withdrawal by Subject|6
2716447|NCT00296400|9347260|P1|Overall Study|Withdrawal by Subject|5
2716448|NCT00296400|9347258|P3|Overall Study|Adverse Event|7
2716449|NCT00296400|9347259|P2|Overall Study|Adverse Event|7
2716450|NCT00296400|9347260|P1|Overall Study|Adverse Event|7
2716451|NCT00296374|9347484|P3|Overall Study|Other|1
2716452|NCT00296374|9347485|P2|Overall Study|Other|0
2716453|NCT00296374|9347486|P1|Overall Study|Other|0
2716454|NCT00296374|9347484|P3|Overall Study|Pregnancy|2
2716455|NCT00296374|9347485|P2|Overall Study|Pregnancy|0
2716456|NCT00296374|9347486|P1|Overall Study|Pregnancy|0
2716457|NCT00296374|9347484|P3|Overall Study|Nephrologist introduced ACE|0
2716458|NCT00296374|9347485|P2|Overall Study|Nephrologist introduced ACE|1
2716459|NCT00296374|9347486|P1|Overall Study|Nephrologist introduced ACE|0
2716460|NCT00296374|9347484|P3|Overall Study|Stopped drug before end of study visit|0
2716461|NCT00296374|9347485|P2|Overall Study|Stopped drug before end of study visit|1
2716462|NCT00296374|9347486|P1|Overall Study|Stopped drug before end of study visit|0
2716463|NCT00296374|9347484|P3|Overall Study|Relocated to another state|0
2716464|NCT00296374|9347485|P2|Overall Study|Relocated to another state|0
2716465|NCT00296374|9347486|P1|Overall Study|Relocated to another state|1
2716466|NCT00296374|9347484|P3|Overall Study|Lost to Follow-up|1
2716467|NCT00296374|9347485|P2|Overall Study|Lost to Follow-up|1
2716468|NCT00296374|9347486|P1|Overall Study|Lost to Follow-up|3
2716469|NCT00296374|9347484|P3|Overall Study|Protocol Violation|3
2716470|NCT00296374|9347485|P2|Overall Study|Protocol Violation|2
2716471|NCT00296374|9347486|P1|Overall Study|Protocol Violation|1
2716472|NCT00296374|9347484|P3|Overall Study|Incorrect enrollment|4
2716473|NCT00296374|9347485|P2|Overall Study|Incorrect enrollment|3
2716474|NCT00296374|9347486|P1|Overall Study|Incorrect enrollment|3
2716475|NCT00296374|9347484|P3|Overall Study|Withdrawal by Subject|11
2716476|NCT00296374|9347485|P2|Overall Study|Withdrawal by Subject|5
2716477|NCT00296374|9347486|P1|Overall Study|Withdrawal by Subject|3
2716478|NCT00296374|9347484|P3|Overall Study|Adverse Event|7
2716479|NCT00296374|9347485|P2|Overall Study|Adverse Event|10
2716480|NCT00296374|9347486|P1|Overall Study|Adverse Event|14
2716481|NCT00296335|9347709|P2|Overall Study|Physician Decision|11
2716482|NCT00296335|9347710|P1|Overall Study|Physician Decision|3
2716483|NCT00296335|9347709|P2|Overall Study|Lost to Follow-up|33
2716484|NCT00296335|9347710|P1|Overall Study|Lost to Follow-up|7
2716485|NCT00296335|9347709|P2|Overall Study|Adverse Event|27
2716486|NCT00296335|9347710|P1|Overall Study|Adverse Event|17
2716487|NCT00296335|9347709|P2|Overall Study|Recurrence|51
2716488|NCT00296335|9347710|P1|Overall Study|Recurrence|3
2716489|NCT00296244|9347750|P2|Overall Study|Underwent retransplant|1
2716490|NCT00296244|9347751|P1|Overall Study|Underwent retransplant|0
2716491|NCT00296140|9347815|P2|Overall Study|Discharge to Nursing Home|0
2716492|NCT00296140|9347816|P1|Overall Study|Discharge to Nursing Home|1
2716493|NCT00296140|9347815|P2|Overall Study|Withdrawal by Subject|0
2716494|NCT00296140|9347816|P1|Overall Study|Withdrawal by Subject|1
2716495|NCT00296140|9347815|P2|Overall Study|Lost to Follow-up|0
2716496|NCT00296140|9347816|P1|Overall Study|Lost to Follow-up|1
2716497|NCT00296036|9347828|P6|Overall Study|Protocol Violation|3
2716498|NCT00296036|9347829|P5|Overall Study|Protocol Violation|0
2716499|NCT00296036|9347830|P4|Overall Study|Protocol Violation|0
2716500|NCT00296036|9347831|P3|Overall Study|Protocol Violation|0
2716501|NCT00296036|9347832|P2|Overall Study|Protocol Violation|0
2716502|NCT00296036|9347833|P1|Overall Study|Protocol Violation|0
2716503|NCT00296036|9347828|P6|Overall Study|Withdrawal by Subject|1
2716504|NCT00296036|9347829|P5|Overall Study|Withdrawal by Subject|2
2716505|NCT00296036|9347830|P4|Overall Study|Withdrawal by Subject|1
2716506|NCT00296036|9347831|P3|Overall Study|Withdrawal by Subject|2
2716507|NCT00296036|9347832|P2|Overall Study|Withdrawal by Subject|0
2716508|NCT00296036|9347833|P1|Overall Study|Withdrawal by Subject|1
2716509|NCT00295932|9347870|P11|Overall Study|Not Treated|1
2716510|NCT00295932|9347871|P10|Overall Study|Not Treated|0
2716511|NCT00295932|9347872|P9|Overall Study|Not Treated|0
2716512|NCT00295932|9347873|P8|Overall Study|Not Treated|0
2716513|NCT00295932|9347874|P7|Overall Study|Not Treated|0
2716514|NCT00295932|9347875|P6|Overall Study|Not Treated|0
2716515|NCT00295932|9347876|P5|Overall Study|Not Treated|0
2716516|NCT00295932|9347877|P4|Overall Study|Not Treated|0
2716517|NCT00295932|9347878|P3|Overall Study|Not Treated|0
2716518|NCT00295932|9347879|P2|Overall Study|Not Treated|0
2716519|NCT00295932|9347880|P1|Overall Study|Not Treated|0
2716520|NCT00295880|9347914|P1|Overall Study|Unit randomization did not occur|1
2716521|NCT00295880|9347914|P1|Overall Study|IBMI unit could not be volume reduced|1
2716522|NCT00295854|9347928|P3|Overall Study|Other|1
2716523|NCT00295854|9347929|P2|Overall Study|Other|5
2716524|NCT00295854|9347930|P1|Overall Study|Other|3
2716525|NCT00295854|9347928|P3|Overall Study|required a prohibited medication|0
2716526|NCT00295854|9347929|P2|Overall Study|required a prohibited medication|0
2716527|NCT00295854|9347930|P1|Overall Study|required a prohibited medication|1
2716528|NCT00295854|9347928|P3|Overall Study|did not continue to meet criteria|2
2716529|NCT00295854|9347929|P2|Overall Study|did not continue to meet criteria|1
2716530|NCT00295854|9347930|P1|Overall Study|did not continue to meet criteria|1
2716531|NCT00295854|9347928|P3|Overall Study|Withdrawal by Subject|4
2716532|NCT00295854|9347929|P2|Overall Study|Withdrawal by Subject|7
2716533|NCT00295854|9347930|P1|Overall Study|Withdrawal by Subject|3
2716534|NCT00295854|9347928|P3|Overall Study|Lost to Follow-up|1
2716535|NCT00295854|9347929|P2|Overall Study|Lost to Follow-up|0
2716536|NCT00295854|9347930|P1|Overall Study|Lost to Follow-up|2
2716537|NCT00295854|9347928|P3|Overall Study|Protocol Violation|1
2716538|NCT00295854|9347929|P2|Overall Study|Protocol Violation|1
2716539|NCT00295854|9347930|P1|Overall Study|Protocol Violation|1
2716540|NCT00295854|9347928|P3|Overall Study|Adverse Event|6
2716541|NCT00295854|9347929|P2|Overall Study|Adverse Event|7
2716542|NCT00295854|9347930|P1|Overall Study|Adverse Event|7
2716543|NCT00295750|9347944|P3|Overall Study|Protocol Violation|2
2716544|NCT00295750|9347945|P2|Overall Study|Protocol Violation|4
2716545|NCT00295750|9347946|P1|Overall Study|Protocol Violation|2
2716546|NCT00295750|9347944|P3|Overall Study|Withdrawal by Subject|7
2716547|NCT00295750|9347945|P2|Overall Study|Withdrawal by Subject|4
2716548|NCT00295750|9347946|P1|Overall Study|Withdrawal by Subject|9
2716549|NCT00295750|9347944|P3|Overall Study|Randomized but never received trial drug|3
2716550|NCT00295750|9347945|P2|Overall Study|Randomized but never received trial drug|3
2716551|NCT00295750|9347946|P1|Overall Study|Randomized but never received trial drug|4
2716552|NCT00295750|9347944|P3|Overall Study|Personal reasons|0
2716553|NCT00295750|9347945|P2|Overall Study|Personal reasons|1
2716554|NCT00295750|9347946|P1|Overall Study|Personal reasons|0
2716555|NCT00295750|9347944|P3|Overall Study|Disease progression|0
2716556|NCT00295750|9347945|P2|Overall Study|Disease progression|1
2716557|NCT00295750|9347946|P1|Overall Study|Disease progression|2
2716558|NCT00295750|9347944|P3|Overall Study|Trial drug errors|0
2716559|NCT00295750|9347945|P2|Overall Study|Trial drug errors|1
2716560|NCT00295750|9347946|P1|Overall Study|Trial drug errors|1
2716561|NCT00295750|9347944|P3|Overall Study|Administrative errors|5
2716562|NCT00295750|9347945|P2|Overall Study|Administrative errors|4
2716563|NCT00295750|9347946|P1|Overall Study|Administrative errors|2
2716564|NCT00295750|9347944|P3|Overall Study|Taking prohibited therapy|2
2716565|NCT00295750|9347945|P2|Overall Study|Taking prohibited therapy|3
2716566|NCT00295750|9347946|P1|Overall Study|Taking prohibited therapy|2
2716567|NCT00295750|9347944|P3|Overall Study|Lost to Follow-up|1
2716568|NCT00295750|9347945|P2|Overall Study|Lost to Follow-up|4
2716569|NCT00295750|9347946|P1|Overall Study|Lost to Follow-up|1
2716570|NCT00295750|9347944|P3|Overall Study|Lack of Efficacy|0
2716571|NCT00295750|9347945|P2|Overall Study|Lack of Efficacy|1
2716572|NCT00295750|9347946|P1|Overall Study|Lack of Efficacy|1
2716573|NCT00295750|9347944|P3|Overall Study|Adverse Event|12
2716574|NCT00295750|9347945|P2|Overall Study|Adverse Event|15
2716575|NCT00295750|9347946|P1|Overall Study|Adverse Event|19
2716576|NCT00295633|9347981|P3|Overall Study|Administrative reason by sponsor|1
2716577|NCT00295633|9347982|P2|Overall Study|Administrative reason by sponsor|0
2716578|NCT00295633|9347983|P1|Overall Study|Administrative reason by sponsor|0
2716579|NCT00295633|9347981|P3|Overall Study|Death|0
2716580|NCT00295633|9347982|P2|Overall Study|Death|1
2716581|NCT00295633|9347983|P1|Overall Study|Death|1
2716582|NCT00295633|9347981|P3|Overall Study|Subject No Longer Meets Study Criteria|3
2716583|NCT00295633|9347982|P2|Overall Study|Subject No Longer Meets Study Criteria|3
2716584|NCT00295633|9347983|P1|Overall Study|Subject No Longer Meets Study Criteria|0
2716585|NCT00295633|9347981|P3|Overall Study|Poor/Noncompliance|6
2716586|NCT00295633|9347982|P2|Overall Study|Poor/Noncompliance|2
2716587|NCT00295633|9347983|P1|Overall Study|Poor/Noncompliance|2
2716588|NCT00295633|9347981|P3|Overall Study|Physician Decision|8
2716589|NCT00295633|9347982|P2|Overall Study|Physician Decision|10
2716590|NCT00295633|9347983|P1|Overall Study|Physician Decision|9
2716591|NCT00295633|9347981|P3|Overall Study|Lost to Follow-up|7
2716592|NCT00295633|9347982|P2|Overall Study|Lost to Follow-up|11
2716593|NCT00295633|9347983|P1|Overall Study|Lost to Follow-up|6
2716594|NCT00295633|9347981|P3|Overall Study|Adverse Event|9
2716595|NCT00295633|9347982|P2|Overall Study|Adverse Event|17
2716596|NCT00295633|9347983|P1|Overall Study|Adverse Event|9
2716597|NCT00295633|9347981|P3|Overall Study|Withdrawal of consent by subject|26
2716598|NCT00295633|9347982|P2|Overall Study|Withdrawal of consent by subject|16
2716599|NCT00295633|9347983|P1|Overall Study|Withdrawal of consent by subject|16
2716600|NCT00295633|9347981|P3|Overall Study|Lack of Efficacy|16
2716601|NCT00295633|9347982|P2|Overall Study|Lack of Efficacy|7
2716602|NCT00295633|9347983|P1|Overall Study|Lack of Efficacy|19
2716603|NCT00295620|9348002|P2|Overall Study|Protocol Violation|32
2716604|NCT00295620|9348003|P1|Overall Study|Protocol Violation|30
2716605|NCT00295620|9348002|P2|Overall Study|Discontinuation by sponsor|593
2716606|NCT00295620|9348003|P1|Overall Study|Discontinuation by sponsor|580
2716607|NCT00295620|9348002|P2|Overall Study|Other reasons|9
2716608|NCT00295620|9348003|P1|Overall Study|Other reasons|10
2716609|NCT00295620|9348002|P2|Overall Study|Death|207
2716610|NCT00295620|9348003|P1|Overall Study|Death|206
2716611|NCT00295620|9348002|P2|Overall Study|Withdrawal by Subject|50
2716612|NCT00295620|9348003|P1|Overall Study|Withdrawal by Subject|37
2716613|NCT00295620|9348002|P2|Overall Study|Lost to Follow-up|5
2716614|NCT00295620|9348003|P1|Overall Study|Lost to Follow-up|9
2716615|NCT00295490|9348027|P4|Overall Study|Other|1
2716616|NCT00295490|9348028|P3|Overall Study|Other|0
2716617|NCT00295490|9348029|P2|Overall Study|Other|2
2716618|NCT00295490|9348030|P1|Overall Study|Other|0
2716619|NCT00295490|9348027|P4|Overall Study|Adverse Event|0
2716620|NCT00295490|9348028|P3|Overall Study|Adverse Event|0
2716621|NCT00295490|9348029|P2|Overall Study|Adverse Event|0
2716622|NCT00295490|9348030|P1|Overall Study|Adverse Event|1
2716623|NCT00295490|9348027|P4|Overall Study|Lost to Follow-up|0
2716624|NCT00295490|9348028|P3|Overall Study|Lost to Follow-up|1
2716625|NCT00295490|9348029|P2|Overall Study|Lost to Follow-up|0
2716626|NCT00295490|9348030|P1|Overall Study|Lost to Follow-up|0
2716627|NCT00295490|9348027|P4|Overall Study|Withdrawal by Subject|1
2716628|NCT00295490|9348028|P3|Overall Study|Withdrawal by Subject|0
2716629|NCT00295490|9348029|P2|Overall Study|Withdrawal by Subject|2
2716630|NCT00295490|9348030|P1|Overall Study|Withdrawal by Subject|0
2716631|NCT00295490|9348027|P4|Overall Study|Protocol Violation|3
2716632|NCT00295490|9348028|P3|Overall Study|Protocol Violation|3
2716633|NCT00295490|9348029|P2|Overall Study|Protocol Violation|0
2716634|NCT00295490|9348030|P1|Overall Study|Protocol Violation|0
2716635|NCT00295022|9348080|P3|Overall Study|Withdrawal by Subject|2
2716636|NCT00295022|9348081|P2|Overall Study|Withdrawal by Subject|0
2716637|NCT00295022|9348082|P1|Overall Study|Withdrawal by Subject|0
2716638|NCT00295022|9348080|P3|Overall Study|Lost to Follow-up|1
2716639|NCT00295022|9348081|P2|Overall Study|Lost to Follow-up|0
2716640|NCT00295022|9348082|P1|Overall Study|Lost to Follow-up|0
2716641|NCT00295022|9348080|P3|Overall Study|Adverse Event|2
2716642|NCT00295022|9348081|P2|Overall Study|Adverse Event|1
2716643|NCT00295022|9348082|P1|Overall Study|Adverse Event|1
2716644|NCT00294762|9348198|P2|Overall Study|Did not receive study treatment|3
2716645|NCT00294762|9348199|P1|Overall Study|Did not receive study treatment|3
2716646|NCT00294723|9348218|P3|Additional Open-Label Extension 91 Weeks|Not specified in study report|3
2716647|NCT00294723|9348219|P2|Additional Open-Label Extension 91 Weeks|Not specified in study report|5
2716648|NCT00294723|9348220|P1|Additional Open-Label Extension 91 Weeks|Not specified in study report|2
2716649|NCT00294723|9348218|P3|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
2716650|NCT00294723|9348219|P2|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
2716651|NCT00294723|9348220|P1|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
2716652|NCT00294723|9348218|P3|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16
2716653|NCT00294723|9348219|P2|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14
2716654|NCT00294723|9348220|P1|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24
2716655|NCT00294723|9348218|P3|Additional Open-Label Extension 91 Weeks|Adverse Event|0
2716656|NCT00294723|9348219|P2|Additional Open-Label Extension 91 Weeks|Adverse Event|1
2716657|NCT00294723|9348220|P1|Additional Open-Label Extension 91 Weeks|Adverse Event|1
2716658|NCT00294723|9348218|P3|Open-Label Extension 52 Weeks|Not specified in study report|14
2716659|NCT00294723|9348219|P2|Open-Label Extension 52 Weeks|Not specified in study report|16
2716660|NCT00294723|9348220|P1|Open-Label Extension 52 Weeks|Not specified in study report|19
2716661|NCT00294723|9348218|P3|Open-Label Extension 52 Weeks|Protocol Violation|3
2716662|NCT00294723|9348219|P2|Open-Label Extension 52 Weeks|Protocol Violation|3
2716663|NCT00294723|9348220|P1|Open-Label Extension 52 Weeks|Protocol Violation|4
2716664|NCT00294723|9348218|P3|Open-Label Extension 52 Weeks|Lack of Efficacy|21
2716665|NCT00294723|9348219|P2|Open-Label Extension 52 Weeks|Lack of Efficacy|15
2716666|NCT00294723|9348220|P1|Open-Label Extension 52 Weeks|Lack of Efficacy|12
2716667|NCT00294723|9348218|P3|Open-Label Extension 52 Weeks|Adverse Event|2
2716668|NCT00294723|9348219|P2|Open-Label Extension 52 Weeks|Adverse Event|5
2716669|NCT00294723|9348220|P1|Open-Label Extension 52 Weeks|Adverse Event|5
2716670|NCT00294723|9348218|P3|Double-Blind Period 52 Weeks|Not specified in study report|51
2716671|NCT00294723|9348219|P2|Double-Blind Period 52 Weeks|Not specified in study report|38
2716672|NCT00294723|9348220|P1|Double-Blind Period 52 Weeks|Not specified in study report|36
2716673|NCT00294723|9348218|P3|Double-Blind Period 52 Weeks|Protocol Violation|5
2716674|NCT00294723|9348219|P2|Double-Blind Period 52 Weeks|Protocol Violation|11
2716675|NCT00294723|9348220|P1|Double-Blind Period 52 Weeks|Protocol Violation|11
2716676|NCT00294723|9348218|P3|Double-Blind Period 52 Weeks|Lack of Efficacy|25
2716677|NCT00294723|9348219|P2|Double-Blind Period 52 Weeks|Lack of Efficacy|15
2716678|NCT00294723|9348220|P1|Double-Blind Period 52 Weeks|Lack of Efficacy|9
2716679|NCT00294723|9348218|P3|Double-Blind Period 52 Weeks|Adverse Event|15
2716680|NCT00294723|9348219|P2|Double-Blind Period 52 Weeks|Adverse Event|25
2716681|NCT00294723|9348220|P1|Double-Blind Period 52 Weeks|Adverse Event|18
2716682|NCT00294684|9348281|P2|Overall Study|Lost to Follow-up|8
2716683|NCT00294684|9348282|P1|Overall Study|Lost to Follow-up|5
2716684|NCT00294671|9348322|P2|Overall Study|Death|1
2716685|NCT00294671|9348323|P1|Overall Study|Death|0
2716686|NCT00294671|9348322|P2|Overall Study|Non-compliance|0
2716687|NCT00294671|9348323|P1|Overall Study|Non-compliance|1
2716688|NCT00294671|9348322|P2|Overall Study|Lost to Follow-up|3
2716689|NCT00294671|9348323|P1|Overall Study|Lost to Follow-up|1
2716690|NCT00294671|9348322|P2|Overall Study|Non-drug related AE|2
2716691|NCT00294671|9348323|P1|Overall Study|Non-drug related AE|3
2716692|NCT00294671|9348322|P2|Overall Study|Drug related adverse event (AE)|2
2716693|NCT00294671|9348323|P1|Overall Study|Drug related adverse event (AE)|4
2716694|NCT00294671|9348322|P2|Overall Study|Liver transplant|9
2716695|NCT00294671|9348323|P1|Overall Study|Liver transplant|7
2716696|NCT00294671|9348322|P2|Overall Study|Lack of Efficacy|23
2716697|NCT00294671|9348323|P1|Overall Study|Lack of Efficacy|11
2716698|NCT00294658|9348339|P2|Overall Study|Patient and family were not satisfied|1
2716699|NCT00294658|9348340|P1|Overall Study|Patient and family were not satisfied|0
2716700|NCT00294658|9348339|P2|Overall Study|Found to have invasive thymoma|0
2716701|NCT00294658|9348340|P1|Overall Study|Found to have invasive thymoma|1
2716702|NCT00294658|9348339|P2|Overall Study|Withdrawal by Subject|4
2716703|NCT00294658|9348340|P1|Overall Study|Withdrawal by Subject|0
2716704|NCT00294658|9348339|P2|Overall Study|Pregnancy|1
2716705|NCT00294658|9348340|P1|Overall Study|Pregnancy|0
2716706|NCT00294658|9348339|P2|Overall Study|Physician Decision|2
2716707|NCT00294658|9348340|P1|Overall Study|Physician Decision|1
2716708|NCT00294658|9348339|P2|Overall Study|Lost to Follow-up|0
2716709|NCT00294658|9348340|P1|Overall Study|Lost to Follow-up|4
2716710|NCT00294658|9348339|P2|Overall Study|Death|1
2716711|NCT00294658|9348340|P1|Overall Study|Death|0
2716712|NCT00294645|9348404|P2|Overall Study|Other|10
2716713|NCT00294645|9348405|P1|Overall Study|Other|4
2716714|NCT00294645|9348404|P2|Overall Study|Physician Decision|20
2716715|NCT00294645|9348405|P1|Overall Study|Physician Decision|15
2716716|NCT00294645|9348404|P2|Overall Study|Withdrawal by Subject|34
2716717|NCT00294645|9348405|P1|Overall Study|Withdrawal by Subject|18
2716718|NCT00294645|9348404|P2|Overall Study|Lost to Follow-up|10
2716719|NCT00294645|9348405|P1|Overall Study|Lost to Follow-up|1
2716720|NCT00294645|9348404|P2|Overall Study|Death|18
2716721|NCT00294645|9348405|P1|Overall Study|Death|10
2716722|NCT00294554|9348449|P2|Overall Study|Physician Decision|1
2716723|NCT00294554|9348450|P1|Overall Study|Physician Decision|0
2716724|NCT00294554|9348449|P2|Overall Study|Lack of Efficacy|1
2716725|NCT00294554|9348450|P1|Overall Study|Lack of Efficacy|0
2716726|NCT00294398|9348477|P2|Overall Study|Lost to Follow-up|26
2716727|NCT00294398|9348478|P1|Overall Study|Lost to Follow-up|21
2716728|NCT00294060|9348486|P1|Overall Study|Device explanted/not replaced|23
2716729|NCT00294060|9348486|P1|Overall Study|Medical condition|3
2716730|NCT00294060|9348486|P1|Overall Study|Physician Decision|797
2716731|NCT00294060|9348486|P1|Overall Study|Withdrawal by Subject|11
2716732|NCT00294060|9348486|P1|Overall Study|Lost to Follow-up|55
2716733|NCT00294060|9348486|P1|Overall Study|Other|59
2716734|NCT00294060|9348486|P1|Overall Study|Death|225
2716735|NCT00294047|9348494|P2|Month 84|No consent for Month 84 Follow-up|754
2716736|NCT00294047|9348495|P1|Month 84|No consent for Month 84 Follow-up|731
2716737|NCT00294047|9348494|P2|Month 84|Visit missed|1
2716738|NCT00294047|9348495|P1|Month 84|Visit missed|0
2716739|NCT00294047|9348494|P2|Month 84|Under investigation locally|0
2716740|NCT00294047|9348495|P1|Month 84|Under investigation locally|1
2716741|NCT00294047|9348494|P2|Month 84|Unable to reach study site|0
2716742|NCT00294047|9348495|P1|Month 84|Unable to reach study site|1
2716743|NCT00294047|9348494|P2|Month 84|Transport reimbursement delayed|1
2716744|NCT00294047|9348495|P1|Month 84|Transport reimbursement delayed|0
2716745|NCT00294047|9348494|P2|Month 84|Subject does not want male physician|0
2716746|NCT00294047|9348495|P1|Month 84|Subject does not want male physician|1
2716747|NCT00294047|9348494|P2|Month 84|Personal reason|4
2716748|NCT00294047|9348495|P1|Month 84|Personal reason|2
2716749|NCT00294047|9348494|P2|Month 84|Lack of time|1
2716750|NCT00294047|9348495|P1|Month 84|Lack of time|3
2716751|NCT00294047|9348494|P2|Month 84|Family problems|2
2716752|NCT00294047|9348495|P1|Month 84|Family problems|2
2716753|NCT00294047|9348494|P2|Month 84|Center closed, subject did not transfer|0
2716754|NCT00294047|9348495|P1|Month 84|Center closed, subject did not transfer|1
2716755|NCT00294047|9348494|P2|Month 84|Work related reasons|2
2716756|NCT00294047|9348495|P1|Month 84|Work related reasons|4
2716757|NCT00294047|9348494|P2|Month 84|Absent Cervix|0
2716758|NCT00294047|9348495|P1|Month 84|Absent Cervix|2
2716759|NCT00294047|9348494|P2|Month 84|Lost to Follow-up|190
2716760|NCT00294047|9348495|P1|Month 84|Lost to Follow-up|187
2716761|NCT00294047|9348494|P2|Month 84|Withdrawal by Subject|31
2716762|NCT00294047|9348495|P1|Month 84|Withdrawal by Subject|33
2716763|NCT00294047|9348494|P2|Month 84|Protocol Violation|1
2716764|NCT00294047|9348495|P1|Month 84|Protocol Violation|1
2716765|NCT00294047|9348494|P2|Month 84|Adverse Event|2
2716766|NCT00294047|9348495|P1|Month 84|Adverse Event|4
2716767|NCT00294047|9348494|P2|Month 48|Other|14
2716768|NCT00294047|9348495|P1|Month 48|Other|10
2716769|NCT00294047|9348494|P2|Month 48|Lost to Follow-up|287
2716770|NCT00294047|9348495|P1|Month 48|Lost to Follow-up|272
2716771|NCT00294047|9348494|P2|Month 48|Withdrawal by Subject|115
2716772|NCT00294047|9348495|P1|Month 48|Withdrawal by Subject|111
2716773|NCT00294047|9348494|P2|Month 48|Protocol Violation|4
2716774|NCT00294047|9348495|P1|Month 48|Protocol Violation|4
2716775|NCT00294047|9348494|P2|Month 48|Adverse Event|13
2716776|NCT00294047|9348495|P1|Month 48|Adverse Event|28
2716777|NCT00293813|9348600|P3|Overall Study|Noncompliance|0
2716778|NCT00293813|9348601|P2|Overall Study|Noncompliance|1
2716779|NCT00293813|9348602|P1|Overall Study|Noncompliance|0
2716780|NCT00293813|9348600|P3|Overall Study|Lost to Follow-up|3
2716781|NCT00293813|9348601|P2|Overall Study|Lost to Follow-up|2
2716782|NCT00293813|9348602|P1|Overall Study|Lost to Follow-up|3
2716783|NCT00293813|9348600|P3|Overall Study|Withdrawal by Subject|4
2716784|NCT00293813|9348601|P2|Overall Study|Withdrawal by Subject|4
2716785|NCT00293813|9348602|P1|Overall Study|Withdrawal by Subject|7
2716786|NCT00293813|9348600|P3|Overall Study|Adverse Event|1
2716787|NCT00293813|9348601|P2|Overall Study|Adverse Event|1
2716788|NCT00293813|9348602|P1|Overall Study|Adverse Event|3
2716789|NCT00293813|9348600|P3|Overall Study|Physician Decision|0
2716790|NCT00293813|9348601|P2|Overall Study|Physician Decision|1
2716791|NCT00293813|9348602|P1|Overall Study|Physician Decision|0
2716792|NCT00293722|9348613|P1|Overall Study|Other|427
2716793|NCT00293709|9348627|P1|Overall Study|Other|47
2716794|NCT00293579|9348641|P1|Overall Study|Withdrawal by Subject|1
2716795|NCT00293462|9348660|P3|Overall Study|Physician Decision|0
2716796|NCT00293462|9348661|P2|Overall Study|Physician Decision|1
2716797|NCT00293462|9348662|P1|Overall Study|Physician Decision|0
2716798|NCT00293462|9348660|P3|Overall Study|Low radiation dose in oral cavity|0
2716799|NCT00293462|9348661|P2|Overall Study|Low radiation dose in oral cavity|1
2716800|NCT00293462|9348662|P1|Overall Study|Low radiation dose in oral cavity|0
2716801|NCT00293462|9348660|P3|Overall Study|Possible Tracheostomy leakage|0
2716802|NCT00293462|9348661|P2|Overall Study|Possible Tracheostomy leakage|1
2716803|NCT00293462|9348662|P1|Overall Study|Possible Tracheostomy leakage|0
2716804|NCT00293462|9348660|P3|Overall Study|Ischemic stroke after chemotherapy|1
2716805|NCT00293462|9348661|P2|Overall Study|Ischemic stroke after chemotherapy|0
2716806|NCT00293462|9348662|P1|Overall Study|Ischemic stroke after chemotherapy|0
2716807|NCT00293462|9348660|P3|Overall Study|Blood clot after chemotherapy|1
2716808|NCT00293462|9348661|P2|Overall Study|Blood clot after chemotherapy|0
2716809|NCT00293462|9348662|P1|Overall Study|Blood clot after chemotherapy|0
2716810|NCT00293462|9348660|P3|Overall Study|Went back to his home country|1
2716811|NCT00293462|9348661|P2|Overall Study|Went back to his home country|0
2716812|NCT00293462|9348662|P1|Overall Study|Went back to his home country|0
2716813|NCT00293462|9348660|P3|Overall Study|No Show|1
2716814|NCT00293462|9348661|P2|Overall Study|No Show|0
2716815|NCT00293462|9348662|P1|Overall Study|No Show|0
2716816|NCT00293462|9348660|P3|Overall Study|Refuse Radiation Treatment|0
2716817|NCT00293462|9348661|P2|Overall Study|Refuse Radiation Treatment|0
2716818|NCT00293462|9348662|P1|Overall Study|Refuse Radiation Treatment|1
2716819|NCT00293462|9348660|P3|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
2716820|NCT00293462|9348661|P2|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1
2716821|NCT00293462|9348662|P1|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
2716822|NCT00293462|9348660|P3|Overall Study|Change Treatment Regimen (ineligible)|0
2716823|NCT00293462|9348661|P2|Overall Study|Change Treatment Regimen (ineligible)|0
2716824|NCT00293462|9348662|P1|Overall Study|Change Treatment Regimen (ineligible)|1
2716825|NCT00293462|9348660|P3|Overall Study|Lost to Follow-up|0
2716826|NCT00293462|9348661|P2|Overall Study|Lost to Follow-up|1
2716827|NCT00293462|9348662|P1|Overall Study|Lost to Follow-up|0
2716828|NCT00293462|9348660|P3|Overall Study|Death|0
2716829|NCT00293462|9348661|P2|Overall Study|Death|0
2716830|NCT00293462|9348662|P1|Overall Study|Death|1
2716831|NCT00293462|9348660|P3|Overall Study|Withdrawal by Subject|6
2716832|NCT00293462|9348661|P2|Overall Study|Withdrawal by Subject|3
2716833|NCT00293462|9348662|P1|Overall Study|Withdrawal by Subject|4
2716834|NCT00293397|9348681|P1|Overall Study|Death|2
2716835|NCT00293384|9348691|P1|Overall Study|Ineligible|2
2716836|NCT00293384|9348691|P1|Overall Study|Missed dosage/study drug|1
2716837|NCT00293384|9348691|P1|Overall Study|Non-compliance|2
2716838|NCT00293293|9348700|P2|Overall Study|Patient discontinued chemotherapy|1
2716839|NCT00293293|9348701|P1|Overall Study|Patient discontinued chemotherapy|0
2716840|NCT00293293|9348700|P2|Overall Study|"Patient too anxious to complete trial"|0
2716841|NCT00293293|9348701|P1|Overall Study|"Patient too anxious to complete trial"|1
2716842|NCT00293293|9348700|P2|Overall Study|Withdrawal by Subject|1
2716843|NCT00293293|9348701|P1|Overall Study|Withdrawal by Subject|1
2716844|NCT00293267|9348729|P2|Open-Label Post Virologic Failure Phase|Other Reason|5
2716845|NCT00293267|9348730|P1|Open-Label Post Virologic Failure Phase|Other Reason|4
2716846|NCT00293267|9348729|P2|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2
2716847|NCT00293267|9348730|P1|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0
2716848|NCT00293267|9348729|P2|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2
2716849|NCT00293267|9348730|P1|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0
2716850|NCT00293267|9348729|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
2716851|NCT00293267|9348730|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
2716852|NCT00293267|9348729|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4
2716853|NCT00293267|9348730|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2
2716854|NCT00293267|9348729|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19
2716855|NCT00293267|9348730|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23
2716856|NCT00293267|9348729|P2|Open-Label Post Virologic Failure Phase|Adverse Event|3
2716857|NCT00293267|9348730|P1|Open-Label Post Virologic Failure Phase|Adverse Event|2
2716858|NCT00293267|9348729|P2|Extension - Open-Label Week 157-240|Other Reason|1
2716859|NCT00293267|9348730|P1|Extension - Open-Label Week 157-240|Other Reason|3
2716860|NCT00293267|9348729|P2|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0
2716861|NCT00293267|9348730|P1|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2
2716862|NCT00293267|9348729|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
2716863|NCT00293267|9348730|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|2
2716864|NCT00293267|9348729|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
2716865|NCT00293267|9348730|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|1
2716866|NCT00293267|9348729|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
2716867|NCT00293267|9348730|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|7
2716868|NCT00293267|9348729|P2|Extension - Open-Label Week 157-240|Adverse Event|0
2716869|NCT00293267|9348730|P1|Extension - Open-Label Week 157-240|Adverse Event|5
2716870|NCT00293267|9348729|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6
2716871|NCT00293267|9348730|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
2716872|NCT00293267|9348729|P2|Extension - Double-Blind Week 49-156|Other Reason|0
2716873|NCT00293267|9348730|P1|Extension - Double-Blind Week 49-156|Other Reason|7
2716874|NCT00293267|9348729|P2|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0
2716875|NCT00293267|9348730|P1|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2
2716876|NCT00293267|9348729|P2|Extension - Double-Blind Week 49-156|Death|0
2716877|NCT00293267|9348730|P1|Extension - Double-Blind Week 49-156|Death|3
2716878|NCT00293267|9348729|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4
2716879|NCT00293267|9348730|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13
2716880|NCT00293267|9348729|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|0
2716881|NCT00293267|9348730|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|4
2716882|NCT00293267|9348729|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|1
2716883|NCT00293267|9348730|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|7
2716884|NCT00293267|9348729|P2|Extension - Double-Blind Week 49-156|Adverse Event|4
2716885|NCT00293267|9348730|P1|Extension - Double-Blind Week 49-156|Adverse Event|1
2716886|NCT00293267|9348729|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60
2716887|NCT00293267|9348730|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33
2716888|NCT00293267|9348729|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
2716889|NCT00293267|9348730|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
2716890|NCT00293267|9348729|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
2716891|NCT00293267|9348730|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
2716892|NCT00293267|9348729|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
2716893|NCT00293267|9348730|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0
2716894|NCT00293267|9348729|P2|Primary Study - Double-Blind Week 0-48|Death|3
2716895|NCT00293267|9348730|P1|Primary Study - Double-Blind Week 0-48|Death|3
2716896|NCT00293267|9348729|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
2716897|NCT00293267|9348730|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|1
2716898|NCT00293267|9348729|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
2716899|NCT00293267|9348730|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
2716900|NCT00293254|9348770|P2|Open-Label Post Virologic Failure Phase|Other Reason|2
2716901|NCT00293254|9348771|P1|Open-Label Post Virologic Failure Phase|Other Reason|1
2716902|NCT00293254|9348770|P2|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
2716903|NCT00293254|9348771|P1|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
2716904|NCT00293254|9348770|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0
2716905|NCT00293254|9348771|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3
2716906|NCT00293254|9348770|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3
2716907|NCT00293254|9348771|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6
2716908|NCT00293254|9348770|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14
2716909|NCT00293254|9348771|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16
2716910|NCT00293254|9348770|P2|Open-Label Post Virologic Failure Phase|Adverse Event|7
2716911|NCT00293254|9348771|P1|Open-Label Post Virologic Failure Phase|Adverse Event|4
2716912|NCT00293254|9348770|P2|Extension - Open-Label Week 157-240|Other Reason|0
2716913|NCT00293254|9348771|P1|Extension - Open-Label Week 157-240|Other Reason|4
2716914|NCT00293254|9348770|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
2716915|NCT00293254|9348771|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|2
2716916|NCT00293254|9348770|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|0
2716917|NCT00293254|9348771|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
2716918|NCT00293254|9348770|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
2716919|NCT00293254|9348771|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|1
2716920|NCT00293254|9348770|P2|Extension - Open-Label Week 157-240|Adverse Event|1
2716921|NCT00293254|9348771|P1|Extension - Open-Label Week 157-240|Adverse Event|2
2716922|NCT00293254|9348770|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7
2716923|NCT00293254|9348771|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
2716924|NCT00293254|9348770|P2|Extension - Double-Blind Week 49-156|Other Reason|2
2716925|NCT00293254|9348771|P1|Extension - Double-Blind Week 49-156|Other Reason|10
2716926|NCT00293254|9348770|P2|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3
2716927|NCT00293254|9348771|P1|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6
2716928|NCT00293254|9348770|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8
2716929|NCT00293254|9348771|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12
2716930|NCT00293254|9348770|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
2716931|NCT00293254|9348771|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
2716932|NCT00293254|9348770|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|4
2716933|NCT00293254|9348771|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|3
2716934|NCT00293254|9348770|P2|Extension - Double-Blind Week 49-156|Death|1
2716935|NCT00293254|9348771|P1|Extension - Double-Blind Week 49-156|Death|4
2716936|NCT00293254|9348770|P2|Extension - Double-Blind Week 49-156|Adverse Event|1
2716937|NCT00293254|9348771|P1|Extension - Double-Blind Week 49-156|Adverse Event|4
2716938|NCT00293254|9348770|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57
2716939|NCT00293254|9348771|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35
2716940|NCT00293254|9348770|P2|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0
2716941|NCT00293254|9348771|P1|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1
2716942|NCT00293254|9348770|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
2716943|NCT00293254|9348771|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5
2716944|NCT00293254|9348770|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
2716945|NCT00293254|9348771|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3
2716946|NCT00293254|9348770|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
2716947|NCT00293254|9348771|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
2716948|NCT00293254|9348770|P2|Primary Study - Double-Blind Week 0-48|Death|2
2716949|NCT00293254|9348771|P1|Primary Study - Double-Blind Week 0-48|Death|5
2716950|NCT00293254|9348770|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
2716951|NCT00293254|9348771|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|2
2716952|NCT00293254|9348770|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
2716953|NCT00293254|9348771|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
2716954|NCT00293241|9348811|P2|Overall Study|Withdrawal by Subject|8
2716955|NCT00293241|9348812|P1|Overall Study|Withdrawal by Subject|4
2716956|NCT00293241|9348811|P2|Overall Study|Physician Decision|17
2716957|NCT00293241|9348812|P1|Overall Study|Physician Decision|23
2716958|NCT00293241|9348811|P2|Overall Study|Lost to Follow-up|16
2716959|NCT00293241|9348812|P1|Overall Study|Lost to Follow-up|9
2716960|NCT00293059|9348856|P2|Overall Study|missing|5
2716961|NCT00293059|9348857|P1|Overall Study|missing|3
2716962|NCT00293059|9348856|P2|Overall Study|Noncompliant - sanitary pads collection|1
2716963|NCT00293059|9348857|P1|Overall Study|Noncompliant - sanitary pads collection|0
2716964|NCT00293059|9348856|P2|Overall Study|Participant stopped study drug|0
2716965|NCT00293059|9348857|P1|Overall Study|Participant stopped study drug|1
2716966|NCT00293059|9348856|P2|Overall Study|Participant moved out of state|0
2716967|NCT00293059|9348857|P1|Overall Study|Participant moved out of state|1
2716968|NCT00293059|9348856|P2|Overall Study|Withdrawal by Subject|5
2716969|NCT00293059|9348857|P1|Overall Study|Withdrawal by Subject|11
2716970|NCT00293059|9348856|P2|Overall Study|Protocol Violation|0
2716971|NCT00293059|9348857|P1|Overall Study|Protocol Violation|2
2716972|NCT00293059|9348856|P2|Overall Study|Pregnancy|1
2716973|NCT00293059|9348857|P1|Overall Study|Pregnancy|1
2716974|NCT00293059|9348856|P2|Overall Study|Lost to Follow-up|3
2716975|NCT00293059|9348857|P1|Overall Study|Lost to Follow-up|2
2716976|NCT00293059|9348856|P2|Overall Study|Lack of Efficacy|0
2716977|NCT00293059|9348857|P1|Overall Study|Lack of Efficacy|2
2716978|NCT00293059|9348856|P2|Overall Study|Adverse Event|4
2716979|NCT00293059|9348857|P1|Overall Study|Adverse Event|12
2716980|NCT00293033|9348969|P1|Double-blind Treatment Period|Noncompliance|4
2716981|NCT00293033|9348969|P1|Double-blind Treatment Period|Withdrawal by Subject|4
2716982|NCT00293033|9348969|P1|Double-blind Treatment Period|Lack of Efficacy|1
2716983|NCT00293033|9348969|P1|Double-blind Treatment Period|Adverse Event|3
2716984|NCT00293033|9348969|P1|Open-label Titration Period|Noncompliance and other|27
2716985|NCT00293033|9348969|P1|Open-label Titration Period|Withdrawal by Subject|22
2716986|NCT00293033|9348969|P1|Open-label Titration Period|Protocol Violation|2
2716987|NCT00293033|9348969|P1|Open-label Titration Period|Lack of Efficacy|5
2716988|NCT00293033|9348969|P1|Open-label Titration Period|Death|3
2716989|NCT00293033|9348969|P1|Open-label Titration Period|Adverse Event|10
2716990|NCT00293020|9349072|P1|Overall Study|No dose taken|1
2716991|NCT00293020|9349072|P1|Overall Study|Other Reason|22
2716992|NCT00293020|9349072|P1|Overall Study|Physician Decision|21
2716993|NCT00293020|9349072|P1|Overall Study|Protocol Violation|6
2716994|NCT00293020|9349072|P1|Overall Study|Lost to Follow-up|4
2716995|NCT00293020|9349072|P1|Overall Study|Lack of Efficacy|12
2716996|NCT00293020|9349072|P1|Overall Study|Death|32
2716997|NCT00293020|9349072|P1|Overall Study|Adverse Event|30
2716998|NCT00293020|9349072|P1|Overall Study|Withdrawal by Subject|34
2716999|NCT00292981|9349076|P1|Overall Study|Other|3
2717000|NCT00292981|9349076|P1|Overall Study|Withdrawal by Subject|22
2717001|NCT00292981|9349076|P1|Overall Study|Lost to Follow-up|13
2717002|NCT00292981|9349076|P1|Overall Study|Adverse Event|1
2717003|NCT00292942|9349087|P4|Overall Study|Adverse Event|1
2717004|NCT00292942|9349088|P3|Overall Study|Adverse Event|0
2717005|NCT00292942|9349089|P2|Overall Study|Adverse Event|0
2717006|NCT00292942|9349090|P1|Overall Study|Adverse Event|0
2717007|NCT00292942|9349087|P4|Overall Study|Withdrawal by Subject|0
2717008|NCT00292942|9349088|P3|Overall Study|Withdrawal by Subject|1
2717009|NCT00292942|9349089|P2|Overall Study|Withdrawal by Subject|0
2717010|NCT00292942|9349090|P1|Overall Study|Withdrawal by Subject|0
2717011|NCT00292461|9349136|P2|Overall Study|Lost to Follow-up|0
2717012|NCT00292461|9349137|P1|Overall Study|Lost to Follow-up|1
2717013|NCT00292461|9349136|P2|Overall Study|Protocol Violation|3
2717014|NCT00292461|9349137|P1|Overall Study|Protocol Violation|4
2717015|NCT00292461|9349136|P2|Overall Study|Withdrawal by Subject|1
2717016|NCT00292461|9349137|P1|Overall Study|Withdrawal by Subject|0
2717017|NCT00292461|9349136|P2|Overall Study|Lack of Efficacy|0
2717018|NCT00292461|9349137|P1|Overall Study|Lack of Efficacy|1
2717019|NCT00292461|9349136|P2|Overall Study|Adverse Event|2
2717020|NCT00292461|9349137|P1|Overall Study|Adverse Event|4
2717021|NCT00292370|9349152|P3|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5
2717022|NCT00292370|9349153|P2|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1
2717023|NCT00292370|9349154|P1|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0
2717024|NCT00292370|9349152|P3|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2
2717025|NCT00292370|9349153|P2|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3
2717026|NCT00292370|9349154|P1|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0
2717027|NCT00292370|9349152|P3|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
2717028|NCT00292370|9349153|P2|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
2717029|NCT00292370|9349154|P1|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4
2717030|NCT00292370|9349152|P3|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
2717031|NCT00292370|9349153|P2|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
2717032|NCT00292370|9349154|P1|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8
2717033|NCT00292370|9349152|P3|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
2717034|NCT00292370|9349153|P2|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
2717035|NCT00292370|9349154|P1|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22
2717036|NCT00292370|9349152|P3|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
2717037|NCT00292370|9349153|P2|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
2717038|NCT00292370|9349154|P1|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12
2717039|NCT00292318|9349179|P2|Overall Study|Study terminated by officials|1
2717040|NCT00292318|9349180|P1|Overall Study|Study terminated by officials|2
2717041|NCT00292227|9349190|P3|Patch Period|Withdrawal by Subject|1
2717042|NCT00292227|9349191|P2|Patch Period|Withdrawal by Subject|0
2717043|NCT00292227|9349192|P1|Patch Period|Withdrawal by Subject|0
2717044|NCT00292227|9349190|P3|Patch Period|Adverse Event|2
2717045|NCT00292227|9349191|P2|Patch Period|Adverse Event|0
2717046|NCT00292227|9349192|P1|Patch Period|Adverse Event|1
2717047|NCT00292188|9349274|P3|Double-Blind|Laboratory Abnormality|1
2717048|NCT00292188|9349275|P2|Double-Blind|Laboratory Abnormality|0
2717049|NCT00292188|9349276|P1|Double-Blind|Laboratory Abnormality|0
2717050|NCT00292188|9349274|P3|Double-Blind|Withdrawal by Subject|3
2717051|NCT00292188|9349275|P2|Double-Blind|Withdrawal by Subject|0
2717052|NCT00292188|9349276|P1|Double-Blind|Withdrawal by Subject|0
2717053|NCT00292188|9349274|P3|Double-Blind|Other|4
2717054|NCT00292188|9349275|P2|Double-Blind|Other|3
2717055|NCT00292188|9349276|P1|Double-Blind|Other|0
2717056|NCT00292188|9349274|P3|Double-Blind|Lost to Follow-up|0
2717057|NCT00292188|9349275|P2|Double-Blind|Lost to Follow-up|1
2717058|NCT00292188|9349276|P1|Double-Blind|Lost to Follow-up|0
2717059|NCT00292188|9349274|P3|Double-Blind|Lack of Efficacy|12
2717060|NCT00292188|9349275|P2|Double-Blind|Lack of Efficacy|2
2717061|NCT00292188|9349276|P1|Double-Blind|Lack of Efficacy|0
2717062|NCT00292188|9349274|P3|Double-Blind|Adverse Event|9
2717063|NCT00292188|9349275|P2|Double-Blind|Adverse Event|25
2717064|NCT00292188|9349276|P1|Double-Blind|Adverse Event|0
2717065|NCT00292188|9349274|P3|Single-Blind|Did not receive treatment|0
2717066|NCT00292188|9349275|P2|Single-Blind|Did not receive treatment|0
2717067|NCT00292188|9349276|P1|Single-Blind|Did not receive treatment|1
2717068|NCT00292188|9349274|P3|Single-Blind|Withdrawal by Subject|0
2717069|NCT00292188|9349275|P2|Single-Blind|Withdrawal by Subject|0
2717070|NCT00292188|9349276|P1|Single-Blind|Withdrawal by Subject|12
2717071|NCT00292188|9349274|P3|Single-Blind|Other|0
2717072|NCT00292188|9349275|P2|Single-Blind|Other|0
2717073|NCT00292188|9349276|P1|Single-Blind|Other|77
2717074|NCT00292188|9349274|P3|Single-Blind|Lost to Follow-up|0
2717075|NCT00292188|9349275|P2|Single-Blind|Lost to Follow-up|0
2717076|NCT00292188|9349276|P1|Single-Blind|Lost to Follow-up|3
2717077|NCT00292188|9349274|P3|Single-Blind|Laboratory Abnormality|0
2717078|NCT00292188|9349275|P2|Single-Blind|Laboratory Abnormality|0
2717079|NCT00292188|9349276|P1|Single-Blind|Laboratory Abnormality|5
2717080|NCT00292188|9349274|P3|Single-Blind|Lack of Efficacy|0
2717081|NCT00292188|9349275|P2|Single-Blind|Lack of Efficacy|0
2717082|NCT00292188|9349276|P1|Single-Blind|Lack of Efficacy|2
2717083|NCT00292188|9349274|P3|Single-Blind|Adverse Event|0
2717084|NCT00292188|9349275|P2|Single-Blind|Adverse Event|0
2717085|NCT00292188|9349276|P1|Single-Blind|Adverse Event|14
2717086|NCT00291642|9349393|P5|Overall Study|Intake of prohibited medication|0
2717087|NCT00291642|9349394|P4|Overall Study|Intake of prohibited medication|0
2717088|NCT00291642|9349395|P3|Overall Study|Intake of prohibited medication|0
2717089|NCT00291642|9349396|P2|Overall Study|Intake of prohibited medication|0
2717090|NCT00291642|9349397|P1|Overall Study|Intake of prohibited medication|1
2717091|NCT00291642|9349393|P5|Overall Study|Patient missed visit|0
2717092|NCT00291642|9349394|P4|Overall Study|Patient missed visit|0
2717093|NCT00291642|9349395|P3|Overall Study|Patient missed visit|1
2717094|NCT00291642|9349396|P2|Overall Study|Patient missed visit|0
2717095|NCT00291642|9349397|P1|Overall Study|Patient missed visit|0
2717096|NCT00291642|9349393|P5|Overall Study|Adverse Event|1
2717097|NCT00291642|9349394|P4|Overall Study|Adverse Event|0
2717098|NCT00291642|9349395|P3|Overall Study|Adverse Event|1
2717099|NCT00291642|9349396|P2|Overall Study|Adverse Event|0
2717100|NCT00291642|9349397|P1|Overall Study|Adverse Event|1
2717101|NCT00291577|9349449|P1|Overall Study|Lack of Efficacy|14
2717102|NCT00291577|9349449|P1|Overall Study|Withdrawal by Subject|2
2717103|NCT00291577|9349449|P1|Overall Study|Other|4
2717104|NCT00291577|9349449|P1|Overall Study|Adverse Event|1
2717105|NCT00291551|9349468|P1|Overall Study|Withdrawal by Subject|6
2717106|NCT00291551|9349468|P1|Overall Study|Death|7
2717107|NCT00291330|9349516|P2|Overall Study|Other|1
2717108|NCT00291330|9349517|P1|Overall Study|Other|3
2717109|NCT00291330|9349516|P2|Overall Study|Withdrawal by Subject|25
2717110|NCT00291330|9349517|P1|Overall Study|Withdrawal by Subject|22
2717111|NCT00291330|9349516|P2|Overall Study|Lost to Follow-up|11
2717112|NCT00291330|9349517|P1|Overall Study|Lost to Follow-up|16
2717113|NCT00291330|9349516|P2|Overall Study|Protocol Violation|20
2717114|NCT00291330|9349517|P1|Overall Study|Protocol Violation|13
2717115|NCT00291330|9349516|P2|Overall Study|Adverse Event|40
2717116|NCT00291330|9349517|P1|Overall Study|Adverse Event|47
2717117|NCT00291187|9349559|P4|Overall Study|Protocol Violation- No Drug Administered|0
2717118|NCT00291187|9349560|P3|Overall Study|Protocol Violation- No Drug Administered|1
2717119|NCT00291187|9349561|P2|Overall Study|Protocol Violation- No Drug Administered|0
2717120|NCT00291187|9349562|P1|Overall Study|Protocol Violation- No Drug Administered|0
2717121|NCT00291018|9349606|P3|Overall Study|Lost to Follow-up|18
2717122|NCT00291018|9349607|P2|Overall Study|Lost to Follow-up|4
2717123|NCT00291018|9349608|P1|Overall Study|Lost to Follow-up|3
2717124|NCT00291018|9349606|P3|Overall Study|Failures|5
2717125|NCT00291018|9349607|P2|Overall Study|Failures|12
2717126|NCT00291018|9349608|P1|Overall Study|Failures|5
2717127|NCT00291018|9349606|P3|Overall Study|Withdrawal by Subject|1
2717128|NCT00291018|9349607|P2|Overall Study|Withdrawal by Subject|8
2717129|NCT00291018|9349608|P1|Overall Study|Withdrawal by Subject|2
2717130|NCT00291018|9349606|P3|Overall Study|Death|4
2717131|NCT00291018|9349607|P2|Overall Study|Death|3
2717132|NCT00291018|9349608|P1|Overall Study|Death|3
2717133|NCT00291018|9349606|P3|Overall Study|Not Consented or Declined PAS|15
2717134|NCT00291018|9349607|P2|Overall Study|Not Consented or Declined PAS|15
2717135|NCT00291018|9349608|P1|Overall Study|Not Consented or Declined PAS|12
2717136|NCT00290888|9349648|P2|Overall Study|Physician Decision|1
2717137|NCT00290888|9349649|P1|Overall Study|Physician Decision|3
2717138|NCT00290771|9349666|P2|Overall Study|Lost to Follow-up|1
2717139|NCT00290771|9349667|P1|Overall Study|Lost to Follow-up|0
2717140|NCT00290771|9349666|P2|Overall Study|Protocol Violation|0
2717141|NCT00290771|9349667|P1|Overall Study|Protocol Violation|2
2717142|NCT00290771|9349666|P2|Overall Study|Administrative problems|1
2717143|NCT00290771|9349667|P1|Overall Study|Administrative problems|2
2717144|NCT00290771|9349666|P2|Overall Study|Withdrawal by Subject|6
2717145|NCT00290771|9349667|P1|Overall Study|Withdrawal by Subject|5
2717146|NCT00290771|9349666|P2|Overall Study|Adverse Event|6
2717147|NCT00290771|9349667|P1|Overall Study|Adverse Event|12
2717148|NCT00290771|9349666|P2|Overall Study|Death|10
2717149|NCT00290771|9349667|P1|Overall Study|Death|11
2717150|NCT00290771|9349666|P2|Overall Study|Disease progression|73
2717151|NCT00290771|9349667|P1|Overall Study|Disease progression|95
2717152|NCT00290758|9349691|P2|Post Intervention rFNA|<4000 Epithelial Cells|5
2717153|NCT00290758|9349692|P1|Post Intervention rFNA|<4000 Epithelial Cells|6
2717154|NCT00290758|9349691|P2|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1
2717155|NCT00290758|9349692|P1|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0
2717156|NCT00290758|9349691|P2|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0
2717157|NCT00290758|9349692|P1|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1
2717158|NCT00290758|9349691|P2|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5
2717159|NCT00290758|9349692|P1|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0
2717160|NCT00290758|9349691|P2|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
2717161|NCT00290758|9349692|P1|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
2717162|NCT00290758|9349691|P2|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1
2717163|NCT00290758|9349692|P1|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3
2717164|NCT00290758|9349691|P2|Pre-Intervention rFNA Through Follow-Up|ConMeds|0
2717165|NCT00290758|9349692|P1|Pre-Intervention rFNA Through Follow-Up|ConMeds|1
2717166|NCT00290758|9349691|P2|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2
2717167|NCT00290758|9349692|P1|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1
2717168|NCT00290732|9349714|P5|Overall Study|Inability to instill drug intraductally.|0
2717169|NCT00290732|9349715|P4|Overall Study|Inability to instill drug intraductally.|0
2717170|NCT00290732|9349716|P3|Overall Study|Inability to instill drug intraductally.|1
2717171|NCT00290732|9349717|P2|Overall Study|Inability to instill drug intraductally.|1
2717172|NCT00290732|9349718|P1|Overall Study|Inability to instill drug intraductally.|0
2717173|NCT00290706|9349740|P4|Overall Study|Physician Decision|1
2717174|NCT00290706|9349741|P3|Overall Study|Physician Decision|0
2717175|NCT00290706|9349742|P2|Overall Study|Physician Decision|0
2717176|NCT00290706|9349743|P1|Overall Study|Physician Decision|0
2717177|NCT00290706|9349740|P4|Overall Study|Receive auto transplant or radiation|1
2717178|NCT00290706|9349741|P3|Overall Study|Receive auto transplant or radiation|0
2717179|NCT00290706|9349742|P2|Overall Study|Receive auto transplant or radiation|0
2717180|NCT00290706|9349743|P1|Overall Study|Receive auto transplant or radiation|0
2717181|NCT00290706|9349740|P4|Overall Study|Adverse Event|0
2717182|NCT00290706|9349741|P3|Overall Study|Adverse Event|2
2717183|NCT00290706|9349742|P2|Overall Study|Adverse Event|1
2717184|NCT00290706|9349743|P1|Overall Study|Adverse Event|0
2717185|NCT00290706|9349740|P4|Overall Study|Progressive Disease|10
2717186|NCT00290706|9349741|P3|Overall Study|Progressive Disease|4
2717187|NCT00290706|9349742|P2|Overall Study|Progressive Disease|5
2717188|NCT00290706|9349743|P1|Overall Study|Progressive Disease|3
2717189|NCT00290706|9349740|P4|Overall Study|Withdrawal by Subject|0
2717190|NCT00290706|9349741|P3|Overall Study|Withdrawal by Subject|0
2717191|NCT00290706|9349742|P2|Overall Study|Withdrawal by Subject|0
2717192|NCT00290706|9349743|P1|Overall Study|Withdrawal by Subject|2
2717193|NCT00290693|9349762|P1|Overall Study|Withdrawal by Subject|2
2717194|NCT00290589|9349790|P2|Overall Study|Lost to Follow-up|2
2717195|NCT00290589|9349791|P1|Overall Study|Lost to Follow-up|2
2717196|NCT00290407|9349824|P1|Overall Study|Physician Decision|2
2717197|NCT00290355|9349831|P2|Overall Study|Other|0
2717198|NCT00290355|9349832|P1|Overall Study|Other|2
2717199|NCT00290355|9349831|P2|Overall Study|Lost to Follow-up|1
2717200|NCT00290355|9349832|P1|Overall Study|Lost to Follow-up|3
2717201|NCT00290355|9349831|P2|Overall Study|Migrated / moved from the study area|0
2717202|NCT00290355|9349832|P1|Overall Study|Migrated / moved from the study area|1
2717203|NCT00290355|9349831|P2|Overall Study|Withdrawal by Subject|0
2717204|NCT00290355|9349832|P1|Overall Study|Withdrawal by Subject|2
2717205|NCT00290355|9349831|P2|Overall Study|Protocol Violation|0
2717206|NCT00290355|9349832|P1|Overall Study|Protocol Violation|1
2717207|NCT00290355|9349831|P2|Overall Study|Study product reactogenicity|0
2717208|NCT00290355|9349832|P1|Overall Study|Study product reactogenicity|1
2717209|NCT00290355|9349831|P2|Overall Study|Serious adverse event|4
2717210|NCT00290355|9349832|P1|Overall Study|Serious adverse event|7
2717211|NCT00290342|9349876|P2|Overall Study|Lost to Follow-up|0
2717212|NCT00290342|9349877|P1|Overall Study|Lost to Follow-up|1
2717213|NCT00290342|9349876|P2|Overall Study|Withdrawal by Subject|4
2717214|NCT00290342|9349877|P1|Overall Study|Withdrawal by Subject|6
2717215|NCT00290342|9349876|P2|Overall Study|Other|1
2717216|NCT00290342|9349877|P1|Overall Study|Other|0
2717217|NCT00290290|9349932|P2|Overall Study|Underwent clean surgical procedure|12
2717218|NCT00290290|9349933|P1|Overall Study|Underwent clean surgical procedure|13
2717219|NCT00290290|9349932|P2|Overall Study|Withdrawal by Subject|2
2717220|NCT00290290|9349933|P1|Overall Study|Withdrawal by Subject|2
2717221|NCT00290290|9349932|P2|Overall Study|Death|4
2717222|NCT00290290|9349933|P1|Overall Study|Death|3
2717223|NCT00290251|9349939|P3|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
2717224|NCT00290251|9349940|P2|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
2717225|NCT00290251|9349941|P1|Treatment 2 (Months 4 - 6)|Lost to Follow-up|2
2717226|NCT00290251|9349939|P3|Treatment 1 (Months 1 - 3)|Out of body experience|0
2717227|NCT00290251|9349940|P2|Treatment 1 (Months 1 - 3)|Out of body experience|0
2717228|NCT00290251|9349941|P1|Treatment 1 (Months 1 - 3)|Out of body experience|1
2717229|NCT00290251|9349939|P3|Treatment 1 (Months 1 - 3)|headache|0
2717230|NCT00290251|9349940|P2|Treatment 1 (Months 1 - 3)|headache|1
2717231|NCT00290251|9349941|P1|Treatment 1 (Months 1 - 3)|headache|0
2717232|NCT00290251|9349939|P3|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|2
2717233|NCT00290251|9349940|P2|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
2717234|NCT00290251|9349941|P1|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
2717235|NCT00290238|9349953|P2|Overall Study|Withdrawal by Subject|13
2717236|NCT00290238|9349954|P1|Overall Study|Withdrawal by Subject|15
2717237|NCT00290238|9349953|P2|Overall Study|Lost to Follow-up|1
2717238|NCT00290238|9349954|P1|Overall Study|Lost to Follow-up|0
2717239|NCT00290238|9349953|P2|Overall Study|Study terminated|27
2717240|NCT00290238|9349954|P1|Overall Study|Study terminated|27
2717241|NCT00290186|9349979|P2|Overall Study|Withdrawal by Subject|1
2717242|NCT00290186|9349980|P1|Overall Study|Withdrawal by Subject|0
2717243|NCT00290186|9349979|P2|Overall Study|Study was terminated prior to 3-month te|1
2717244|NCT00290186|9349980|P1|Overall Study|Study was terminated prior to 3-month te|1
2717245|NCT00290186|9349979|P2|Overall Study|Lost to Follow-up|2
2717246|NCT00290186|9349980|P1|Overall Study|Lost to Follow-up|3
2717247|NCT00290186|9349979|P2|Overall Study|Adverse Event|1
2717248|NCT00290186|9349980|P1|Overall Study|Adverse Event|1
2717249|NCT00289991|9350031|P2|Overall Study|Other|14
2717250|NCT00289991|9350032|P1|Overall Study|Other|5
2717251|NCT00289991|9350031|P2|Overall Study|Withdrawal by Subject|12
2717252|NCT00289991|9350032|P1|Overall Study|Withdrawal by Subject|2
2717253|NCT00289991|9350031|P2|Overall Study|Lost to Follow-up|1
2717254|NCT00289991|9350032|P1|Overall Study|Lost to Follow-up|0
2717255|NCT00289991|9350031|P2|Overall Study|Fungal breakthrough infection|1
2717256|NCT00289991|9350032|P1|Overall Study|Fungal breakthrough infection|0
2717257|NCT00289991|9350031|P2|Overall Study|Failure of prophylaxis|1
2717258|NCT00289991|9350032|P1|Overall Study|Failure of prophylaxis|1
2717259|NCT00289991|9350031|P2|Overall Study|Adverse Event|13
2717260|NCT00289991|9350032|P1|Overall Study|Adverse Event|15
2717261|NCT00289991|9350031|P2|Overall Study|Death|38
2717262|NCT00289991|9350032|P1|Overall Study|Death|35
2717263|NCT00289978|9350057|P3|Overall Study|Death|2
2717264|NCT00289978|9350058|P2|Overall Study|Death|0
2717265|NCT00289978|9350059|P1|Overall Study|Death|1
2717266|NCT00289978|9350057|P3|Overall Study|Abnormal test procedure result(s)|1
2717267|NCT00289978|9350058|P2|Overall Study|Abnormal test procedure result(s)|1
2717268|NCT00289978|9350059|P1|Overall Study|Abnormal test procedure result(s)|2
2717269|NCT00289978|9350057|P3|Overall Study|Protocol Violation|4
2717270|NCT00289978|9350058|P2|Overall Study|Protocol Violation|5
2717271|NCT00289978|9350059|P1|Overall Study|Protocol Violation|5
2717272|NCT00289978|9350057|P3|Overall Study|Lost to Follow-up|7
2717273|NCT00289978|9350058|P2|Overall Study|Lost to Follow-up|5
2717274|NCT00289978|9350059|P1|Overall Study|Lost to Follow-up|3
2717275|NCT00289978|9350057|P3|Overall Study|Abnormal laboratory value(s)|1
2717276|NCT00289978|9350058|P2|Overall Study|Abnormal laboratory value(s)|9
2717277|NCT00289978|9350059|P1|Overall Study|Abnormal laboratory value(s)|20
2717278|NCT00289978|9350057|P3|Overall Study|Lack of Efficacy|25
2717279|NCT00289978|9350058|P2|Overall Study|Lack of Efficacy|6
2717280|NCT00289978|9350059|P1|Overall Study|Lack of Efficacy|13
2717281|NCT00289978|9350057|P3|Overall Study|Adverse Event|18
2717282|NCT00289978|9350058|P2|Overall Study|Adverse Event|13
2717283|NCT00289978|9350059|P1|Overall Study|Adverse Event|22
2717284|NCT00289978|9350057|P3|Overall Study|Withdrawal by Subject|28
2717285|NCT00289978|9350058|P2|Overall Study|Withdrawal by Subject|17
2717286|NCT00289978|9350059|P1|Overall Study|Withdrawal by Subject|31
2717287|NCT00289913|9350078|P5|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
2717288|NCT00289913|9350079|P4|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
2717289|NCT00289913|9350080|P3|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
2717290|NCT00289913|9350081|P2|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1
2717291|NCT00289913|9350082|P1|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
2717292|NCT00289913|9350078|P5|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1
2717293|NCT00289913|9350079|P4|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
2717294|NCT00289913|9350080|P3|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
2717295|NCT00289913|9350081|P2|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
2717296|NCT00289913|9350082|P1|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
2717297|NCT00289913|9350078|P5|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
2717298|NCT00289913|9350079|P4|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
2717299|NCT00289913|9350080|P3|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
2717300|NCT00289913|9350081|P2|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
2717301|NCT00289913|9350082|P1|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
2717302|NCT00289913|9350078|P5|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4
2717303|NCT00289913|9350079|P4|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
2717304|NCT00289913|9350080|P3|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0
2717305|NCT00289913|9350081|P2|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2
2717306|NCT00289913|9350082|P1|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
2717307|NCT00289913|9350078|P5|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1
2717308|NCT00289913|9350079|P4|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
2717309|NCT00289913|9350080|P3|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
2717310|NCT00289913|9350081|P2|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
2717311|NCT00289913|9350082|P1|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
2717312|NCT00289913|9350078|P5|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
2717313|NCT00289913|9350079|P4|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1
2717314|NCT00289913|9350080|P3|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
2717315|NCT00289913|9350081|P2|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
2717316|NCT00289913|9350082|P1|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
2717317|NCT00289913|9350078|P5|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
2717318|NCT00289913|9350079|P4|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
2717319|NCT00289913|9350080|P3|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1
2717320|NCT00289913|9350081|P2|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3
2717321|NCT00289913|9350082|P1|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8
2717322|NCT00289913|9350078|P5|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
2717323|NCT00289913|9350079|P4|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
2717324|NCT00289913|9350080|P3|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
2717325|NCT00289913|9350081|P2|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1
2717326|NCT00289913|9350082|P1|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
2717327|NCT00289913|9350078|P5|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9
2717328|NCT00289913|9350079|P4|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
2717329|NCT00289913|9350080|P3|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
2717330|NCT00289913|9350081|P2|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
2717331|NCT00289913|9350082|P1|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
2717332|NCT00289913|9350078|P5|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7
2717333|NCT00289913|9350079|P4|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
2717334|NCT00289913|9350080|P3|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
2717335|NCT00289913|9350081|P2|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
2717336|NCT00289913|9350082|P1|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
2717337|NCT00289913|9350078|P5|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6
2717338|NCT00289913|9350079|P4|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
2717339|NCT00289913|9350080|P3|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
2717340|NCT00289913|9350081|P2|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
2717341|NCT00289913|9350082|P1|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
2717342|NCT00289913|9350078|P5|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11
2717343|NCT00289913|9350079|P4|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
2717344|NCT00289913|9350080|P3|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
2717345|NCT00289913|9350081|P2|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
2717346|NCT00289913|9350082|P1|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
2717347|NCT00289913|9350078|P5|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7
2717348|NCT00289913|9350079|P4|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
2717349|NCT00289913|9350080|P3|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
2717350|NCT00289913|9350081|P2|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
2717351|NCT00289913|9350082|P1|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
2717352|NCT00289913|9350078|P5|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
2717353|NCT00289913|9350079|P4|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
2717354|NCT00289913|9350080|P3|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
2717355|NCT00289913|9350081|P2|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
2717356|NCT00289913|9350082|P1|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1
2717357|NCT00289913|9350078|P5|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
2717358|NCT00289913|9350079|P4|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
2717359|NCT00289913|9350080|P3|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2
2717360|NCT00289913|9350081|P2|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1
2717361|NCT00289913|9350082|P1|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
2717362|NCT00289913|9350078|P5|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
2717363|NCT00289913|9350079|P4|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3
2717364|NCT00289913|9350080|P3|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
2717365|NCT00289913|9350081|P2|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5
2717366|NCT00289913|9350082|P1|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2
2717367|NCT00289913|9350078|P5|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
2717368|NCT00289913|9350079|P4|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
2717369|NCT00289913|9350080|P3|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3
2717370|NCT00289913|9350081|P2|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
2717371|NCT00289913|9350082|P1|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
2717372|NCT00289913|9350078|P5|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
2717373|NCT00289913|9350079|P4|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
2717374|NCT00289913|9350080|P3|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
2717375|NCT00289913|9350081|P2|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
2717376|NCT00289913|9350082|P1|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
2717377|NCT00289913|9350078|P5|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
2717378|NCT00289913|9350079|P4|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
2717379|NCT00289913|9350080|P3|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1
2717380|NCT00289913|9350081|P2|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2
2717381|NCT00289913|9350082|P1|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3
2717382|NCT00289913|9350078|P5|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
2717383|NCT00289913|9350079|P4|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
2717384|NCT00289913|9350080|P3|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
2717385|NCT00289913|9350081|P2|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1
2717386|NCT00289913|9350082|P1|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
2717387|NCT00289913|9350078|P5|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0
2717388|NCT00289913|9350079|P4|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
2717389|NCT00289913|9350080|P3|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
2717390|NCT00289913|9350081|P2|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11
2717391|NCT00289913|9350082|P1|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8
2717392|NCT00289913|9350078|P5|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
2717393|NCT00289913|9350079|P4|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
2717394|NCT00289913|9350080|P3|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1
2717395|NCT00289913|9350081|P2|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
2717396|NCT00289913|9350082|P1|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
2717397|NCT00289913|9350078|P5|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
2717398|NCT00289913|9350079|P4|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
2717399|NCT00289913|9350080|P3|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2
2717400|NCT00289913|9350081|P2|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
2717401|NCT00289913|9350082|P1|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1
2717402|NCT00289913|9350078|P5|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
2717403|NCT00289913|9350079|P4|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6
2717404|NCT00289913|9350080|P3|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5
2717405|NCT00289913|9350081|P2|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8
2717406|NCT00289913|9350082|P1|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
2717407|NCT00289913|9350078|P5|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5
2717408|NCT00289913|9350079|P4|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
2717409|NCT00289913|9350080|P3|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
2717410|NCT00289913|9350081|P2|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1
2717411|NCT00289913|9350082|P1|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2
2717412|NCT00289913|9350078|P5|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
2717413|NCT00289913|9350079|P4|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
2717414|NCT00289913|9350080|P3|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
2717415|NCT00289913|9350081|P2|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2
2717416|NCT00289913|9350082|P1|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1
2717417|NCT00289913|9350078|P5|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
2717418|NCT00289913|9350079|P4|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1
2717419|NCT00289913|9350080|P3|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
2717420|NCT00289913|9350081|P2|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
2717421|NCT00289913|9350082|P1|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
2717422|NCT00289913|9350078|P5|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1
2717423|NCT00289913|9350079|P4|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
2717424|NCT00289913|9350080|P3|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
2717425|NCT00289913|9350081|P2|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
2717426|NCT00289913|9350082|P1|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
2717512|NCT00289874|9350241|P2|Overall Study|Lost to Follow-up|1
2717427|NCT00289913|9350078|P5|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
2717428|NCT00289913|9350079|P4|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
2717429|NCT00289913|9350080|P3|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0
2717430|NCT00289913|9350081|P2|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
2717431|NCT00289913|9350082|P1|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
2717432|NCT00289913|9350078|P5|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1
2717433|NCT00289913|9350079|P4|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
2717434|NCT00289913|9350080|P3|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
2717435|NCT00289913|9350081|P2|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
2717436|NCT00289913|9350082|P1|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3
2717437|NCT00289913|9350078|P5|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
2717438|NCT00289913|9350079|P4|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
2717439|NCT00289913|9350080|P3|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
2717440|NCT00289913|9350081|P2|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1
2717441|NCT00289913|9350082|P1|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
2717442|NCT00289900|9350113|P6|Overall Study|Not treated|0
2717443|NCT00289900|9350114|P5|Overall Study|Not treated|0
2717444|NCT00289900|9350115|P4|Overall Study|Not treated|0
2717445|NCT00289900|9350116|P3|Overall Study|Not treated|0
2717446|NCT00289900|9350117|P2|Overall Study|Not treated|1
2717447|NCT00289900|9350118|P1|Overall Study|Not treated|0
2717448|NCT00289900|9350113|P6|Overall Study|site terminated|0
2717449|NCT00289900|9350114|P5|Overall Study|site terminated|0
2717450|NCT00289900|9350115|P4|Overall Study|site terminated|0
2717451|NCT00289900|9350116|P3|Overall Study|site terminated|1
2717452|NCT00289900|9350117|P2|Overall Study|site terminated|0
2717453|NCT00289900|9350118|P1|Overall Study|site terminated|1
2717454|NCT00289900|9350113|P6|Overall Study|Protocol Violation|4
2717455|NCT00289900|9350114|P5|Overall Study|Protocol Violation|7
2717456|NCT00289900|9350115|P4|Overall Study|Protocol Violation|6
2717457|NCT00289900|9350116|P3|Overall Study|Protocol Violation|2
2717458|NCT00289900|9350117|P2|Overall Study|Protocol Violation|9
2717459|NCT00289900|9350118|P1|Overall Study|Protocol Violation|3
2717460|NCT00289900|9350113|P6|Overall Study|Withdrawal by Subject|11
2717461|NCT00289900|9350114|P5|Overall Study|Withdrawal by Subject|12
2717462|NCT00289900|9350115|P4|Overall Study|Withdrawal by Subject|18
2717463|NCT00289900|9350116|P3|Overall Study|Withdrawal by Subject|8
2717464|NCT00289900|9350117|P2|Overall Study|Withdrawal by Subject|21
2717465|NCT00289900|9350118|P1|Overall Study|Withdrawal by Subject|10
2717466|NCT00289900|9350113|P6|Overall Study|Participant moved|1
2717467|NCT00289900|9350114|P5|Overall Study|Participant moved|1
2717468|NCT00289900|9350115|P4|Overall Study|Participant moved|1
2717469|NCT00289900|9350116|P3|Overall Study|Participant moved|0
2717470|NCT00289900|9350117|P2|Overall Study|Participant moved|0
2717471|NCT00289900|9350118|P1|Overall Study|Participant moved|1
2717472|NCT00289900|9350113|P6|Overall Study|Other|0
2717473|NCT00289900|9350114|P5|Overall Study|Other|1
2717474|NCT00289900|9350115|P4|Overall Study|Other|5
2717475|NCT00289900|9350116|P3|Overall Study|Other|0
2717476|NCT00289900|9350117|P2|Overall Study|Other|0
2717477|NCT00289900|9350118|P1|Overall Study|Other|0
2717478|NCT00289900|9350113|P6|Overall Study|Participant had flushing|4
2717479|NCT00289900|9350114|P5|Overall Study|Participant had flushing|0
2717480|NCT00289900|9350115|P4|Overall Study|Participant had flushing|2
2717481|NCT00289900|9350116|P3|Overall Study|Participant had flushing|1
2717482|NCT00289900|9350117|P2|Overall Study|Participant had flushing|42
2717483|NCT00289900|9350118|P1|Overall Study|Participant had flushing|18
2717484|NCT00289900|9350113|P6|Overall Study|Lost to Follow-up|8
2717485|NCT00289900|9350114|P5|Overall Study|Lost to Follow-up|4
2717486|NCT00289900|9350115|P4|Overall Study|Lost to Follow-up|8
2717487|NCT00289900|9350116|P3|Overall Study|Lost to Follow-up|8
2717488|NCT00289900|9350117|P2|Overall Study|Lost to Follow-up|7
2717489|NCT00289900|9350118|P1|Overall Study|Lost to Follow-up|7
2717490|NCT00289900|9350113|P6|Overall Study|Adverse Event|33
2717491|NCT00289900|9350114|P5|Overall Study|Adverse Event|20
2717492|NCT00289900|9350115|P4|Overall Study|Adverse Event|19
2717493|NCT00289900|9350116|P3|Overall Study|Adverse Event|13
2717494|NCT00289900|9350117|P2|Overall Study|Adverse Event|40
2717495|NCT00289900|9350118|P1|Overall Study|Adverse Event|28
2717496|NCT00289887|9350222|P2|Overall Study|Other|3
2717497|NCT00289887|9350223|P1|Overall Study|Other|7
2717498|NCT00289887|9350222|P2|Overall Study|Withdrawal by Subject|8
2717499|NCT00289887|9350223|P1|Overall Study|Withdrawal by Subject|3
2717500|NCT00289887|9350222|P2|Overall Study|Protocol Violation|1
2717501|NCT00289887|9350223|P1|Overall Study|Protocol Violation|3
2717502|NCT00289887|9350222|P2|Overall Study|Lost to Follow-up|3
2717503|NCT00289887|9350223|P1|Overall Study|Lost to Follow-up|3
2717504|NCT00289887|9350222|P2|Overall Study|Lack of Efficacy|11
2717505|NCT00289887|9350223|P1|Overall Study|Lack of Efficacy|3
2717506|NCT00289887|9350222|P2|Overall Study|Adverse Event|3
2717507|NCT00289887|9350223|P1|Overall Study|Adverse Event|3
2717508|NCT00289874|9350241|P2|Overall Study|Did not meet eligibility|0
2717509|NCT00289874|9350242|P1|Overall Study|Did not meet eligibility|1
2717510|NCT00289874|9350241|P2|Overall Study|Protocol Violation|2
2717511|NCT00289874|9350242|P1|Overall Study|Protocol Violation|3
2717513|NCT00289874|9350242|P1|Overall Study|Lost to Follow-up|1
2717514|NCT00289874|9350241|P2|Overall Study|Adverse Event|5
2717515|NCT00289874|9350242|P1|Overall Study|Adverse Event|1
2717516|NCT00289848|9350252|P2|Overall Study|Open-Label AHA Treatment Requested|1
2717517|NCT00289848|9350253|P1|Overall Study|Open-Label AHA Treatment Requested|0
2717518|NCT00289848|9350252|P2|Overall Study|Patient Moved|2
2717519|NCT00289848|9350253|P1|Overall Study|Patient Moved|6
2717520|NCT00289848|9350252|P2|Overall Study|Withdrawal by Subject|11
2717521|NCT00289848|9350253|P1|Overall Study|Withdrawal by Subject|5
2717522|NCT00289848|9350252|P2|Overall Study|Protocol Violation|2
2717523|NCT00289848|9350253|P1|Overall Study|Protocol Violation|5
2717524|NCT00289848|9350252|P2|Overall Study|Lost to Follow-up|1
2717525|NCT00289848|9350253|P1|Overall Study|Lost to Follow-up|3
2717526|NCT00289848|9350252|P2|Overall Study|Lack of Efficacy|24
2717527|NCT00289848|9350253|P1|Overall Study|Lack of Efficacy|20
2717528|NCT00289848|9350252|P2|Overall Study|Death|0
2717529|NCT00289848|9350253|P1|Overall Study|Death|1
2717530|NCT00289848|9350252|P2|Overall Study|Adverse Event|4
2717531|NCT00289848|9350253|P1|Overall Study|Adverse Event|6
2717532|NCT00289783|9350265|P2|Fourth Dose Phase|Other|10
2717533|NCT00289783|9350266|P1|Fourth Dose Phase|Other|22
2717534|NCT00289783|9350265|P2|Fourth Dose Phase|Migration from the study area|1
2717535|NCT00289783|9350266|P1|Fourth Dose Phase|Migration from the study area|1
2717536|NCT00289783|9350265|P2|Fourth Dose Phase|Lost to Follow-up|12
2717537|NCT00289783|9350266|P1|Fourth Dose Phase|Lost to Follow-up|53
2717538|NCT00289783|9350265|P2|Fourth Dose Phase|Withdrawal by Subject|1
2717539|NCT00289783|9350266|P1|Fourth Dose Phase|Withdrawal by Subject|10
2717540|NCT00289783|9350265|P2|Fourth Dose Phase|Adverse Event|0
2717541|NCT00289783|9350266|P1|Fourth Dose Phase|Adverse Event|1
2717542|NCT00289783|9350265|P2|Primary Phase|Other|12
2717543|NCT00289783|9350266|P1|Primary Phase|Other|32
2717544|NCT00289783|9350265|P2|Primary Phase|Migration from the study area|10
2717545|NCT00289783|9350266|P1|Primary Phase|Migration from the study area|26
2717546|NCT00289783|9350265|P2|Primary Phase|Lost to Follow-up|14
2717547|NCT00289783|9350266|P1|Primary Phase|Lost to Follow-up|60
2717548|NCT00289783|9350265|P2|Primary Phase|Withdrawal by Subject|40
2717549|NCT00289783|9350266|P1|Primary Phase|Withdrawal by Subject|93
2717550|NCT00289783|9350265|P2|Primary Phase|Protocol Violation|6
2717551|NCT00289783|9350266|P1|Primary Phase|Protocol Violation|27
2717552|NCT00289783|9350265|P2|Primary Phase|Adverse Event|1
2717553|NCT00289783|9350266|P1|Primary Phase|Adverse Event|10
2717554|NCT00289770|9350444|P1|Year 15|Withdrawal by Subject|1
2717555|NCT00289731|9350490|P3|Overall Study|Other|0
2717556|NCT00289731|9350491|P2|Overall Study|Other|0
2717557|NCT00289731|9350492|P1|Overall Study|Other|1
2717558|NCT00289731|9350490|P3|Overall Study|Adverse Event|2
2717559|NCT00289731|9350491|P2|Overall Study|Adverse Event|2
2717560|NCT00289731|9350492|P1|Overall Study|Adverse Event|1
2717561|NCT00289536|9350604|P3|Period 3|Lost to Follow-up|1
2717562|NCT00289536|9350605|P2|Period 3|Lost to Follow-up|0
2717563|NCT00289536|9350606|P1|Period 3|Lost to Follow-up|0
2717564|NCT00289458|9350652|P3|Overall Study|Withdrawal by Subject|4
2717565|NCT00289458|9350653|P2|Overall Study|Withdrawal by Subject|2
2717566|NCT00289458|9350654|P1|Overall Study|Withdrawal by Subject|2
2717567|NCT00289458|9350652|P3|Overall Study|Physician Decision|2
2717568|NCT00289458|9350653|P2|Overall Study|Physician Decision|4
2717569|NCT00289458|9350654|P1|Overall Study|Physician Decision|3
2717570|NCT00289458|9350652|P3|Overall Study|Death|0
2717571|NCT00289458|9350653|P2|Overall Study|Death|0
2717572|NCT00289458|9350654|P1|Overall Study|Death|1
2717573|NCT00289289|9350715|P3|Overall Study|Other Exit Reason|12
2717574|NCT00289289|9350716|P2|Overall Study|Other Exit Reason|4
2717575|NCT00289289|9350717|P1|Overall Study|Other Exit Reason|6
2717576|NCT00289289|9350715|P3|Overall Study|Did not meet inclusion/exclusion|6
2717577|NCT00289289|9350716|P2|Overall Study|Did not meet inclusion/exclusion|0
2717578|NCT00289289|9350717|P1|Overall Study|Did not meet inclusion/exclusion|0
2717579|NCT00289289|9350715|P3|Overall Study|Non-study device implanted|3
2717580|NCT00289289|9350716|P2|Overall Study|Non-study device implanted|1
2717581|NCT00289289|9350717|P1|Overall Study|Non-study device implanted|2
2717582|NCT00289289|9350715|P3|Overall Study|Physician Decision|6
2717583|NCT00289289|9350716|P2|Overall Study|Physician Decision|0
2717584|NCT00289289|9350717|P1|Overall Study|Physician Decision|1
2717585|NCT00289289|9350715|P3|Overall Study|No implant attempted|1
2717586|NCT00289289|9350716|P2|Overall Study|No implant attempted|0
2717587|NCT00289289|9350717|P1|Overall Study|No implant attempted|0
2717588|NCT00289289|9350715|P3|Overall Study|Death|5
2717589|NCT00289289|9350716|P2|Overall Study|Death|2
2717590|NCT00289289|9350717|P1|Overall Study|Death|4
2717591|NCT00289289|9350715|P3|Overall Study|Lost to Follow-up|1
2717592|NCT00289289|9350716|P2|Overall Study|Lost to Follow-up|0
2717593|NCT00289289|9350717|P1|Overall Study|Lost to Follow-up|1
2717594|NCT00289289|9350715|P3|Overall Study|Withdrawal by Subject|15
2717595|NCT00289289|9350716|P2|Overall Study|Withdrawal by Subject|3
2717596|NCT00289289|9350717|P1|Overall Study|Withdrawal by Subject|5
2717597|NCT00289276|9350732|P2|Second Part of FAST Study (Expansion)|Lost to Follow-up|1
2717598|NCT00289276|9350733|P1|Second Part of FAST Study (Expansion)|Lost to Follow-up|0
2717599|NCT00289276|9350732|P2|Second Part of FAST Study (Expansion)|Death|2
2717600|NCT00289276|9350733|P1|Second Part of FAST Study (Expansion)|Death|0
2717601|NCT00289198|9350768|P2|Overall Study|Other: Impossible to come on visit|1
2717602|NCT00289198|9350769|P1|Overall Study|Other: Impossible to come on visit|0
2717603|NCT00289198|9350768|P2|Overall Study|Other: Miscalculation of the visit date|22
2717604|NCT00289198|9350769|P1|Overall Study|Other: Miscalculation of the visit date|21
2717605|NCT00289198|9350768|P2|Overall Study|Other: Unable to attend on schedule|1
2717606|NCT00289198|9350769|P1|Overall Study|Other: Unable to attend on schedule|2
2717607|NCT00289198|9350768|P2|Overall Study|Other: Physician's decision|1
2717608|NCT00289198|9350769|P1|Overall Study|Other: Physician's decision|0
2717609|NCT00289198|9350768|P2|Overall Study|Other: Low compliance|1
2717610|NCT00289198|9350769|P1|Overall Study|Other: Low compliance|0
2717611|NCT00289198|9350768|P2|Overall Study|Lack of Efficacy|0
2717612|NCT00289198|9350769|P1|Overall Study|Lack of Efficacy|2
2717613|NCT00289198|9350768|P2|Overall Study|Withdrawal by Subject|1
2717614|NCT00289198|9350769|P1|Overall Study|Withdrawal by Subject|4
2717615|NCT00289198|9350768|P2|Overall Study|Protocol Violation|1
2717616|NCT00289198|9350769|P1|Overall Study|Protocol Violation|2
2717617|NCT00289198|9350768|P2|Overall Study|Adverse Event|2
2717618|NCT00289198|9350769|P1|Overall Study|Adverse Event|0
2717619|NCT00289185|9350819|P2|Overall Study|Death|1
2717620|NCT00289185|9350820|P1|Overall Study|Death|1
2717621|NCT00289185|9350819|P2|Overall Study|Lost to Follow-up|17
2717622|NCT00289185|9350820|P1|Overall Study|Lost to Follow-up|23
2717623|NCT00289185|9350819|P2|Overall Study|Withdrawal by Subject|8
2717624|NCT00289185|9350820|P1|Overall Study|Withdrawal by Subject|4
2717625|NCT00289133|9350867|P2|Overall Study|Lost to Follow-up|115
2717626|NCT00289133|9350868|P1|Overall Study|Lost to Follow-up|92
2717627|NCT00289133|9350867|P2|Overall Study|Revision|6
2717628|NCT00289133|9350868|P1|Overall Study|Revision|8
2717629|NCT00289133|9350867|P2|Overall Study|Physician Decision|45
2717630|NCT00289133|9350868|P1|Overall Study|Physician Decision|41
2717631|NCT00289133|9350867|P2|Overall Study|Lost to Follow-up - Hurricane Katri|74
2717632|NCT00289133|9350868|P1|Overall Study|Lost to Follow-up - Hurricane Katri|73
2717633|NCT00289133|9350867|P2|Overall Study|Death|10
2717634|NCT00289133|9350868|P1|Overall Study|Death|5
2717635|NCT00289133|9350867|P2|Overall Study|Withdrawal by Subject|10
2717636|NCT00289133|9350868|P1|Overall Study|Withdrawal by Subject|9
2717637|NCT00289133|9350867|P2|Overall Study|Protocol Violation|38
2717638|NCT00289133|9350868|P1|Overall Study|Protocol Violation|32
2717639|NCT00289133|9350867|P2|Overall Study|Non-study device implanted|0
2717640|NCT00289133|9350868|P1|Overall Study|Non-study device implanted|12
2717641|NCT00289016|9350924|P1|Overall Study|Other|1
2717642|NCT00289016|9350924|P1|Overall Study|Adverse Event|1
2717643|NCT00289016|9350924|P1|Overall Study|Withdrawal by Subject|2
2717644|NCT00289016|9350924|P1|Overall Study|Unrelated Medical Condition or Accident|2
2717645|NCT00289016|9350924|P1|Overall Study|Death|2
2717646|NCT00289016|9350924|P1|Overall Study|Disease Progression|29
2717647|NCT00288912|9350936|P3|Overall Study|Withdrawal by Subject|12
2717648|NCT00288912|9350937|P2|Overall Study|Withdrawal by Subject|5
2717649|NCT00288912|9350938|P1|Overall Study|Withdrawal by Subject|4
2717650|NCT00288912|9350936|P3|Overall Study|Lost to Follow-up|9
2717651|NCT00288912|9350937|P2|Overall Study|Lost to Follow-up|6
2717652|NCT00288912|9350938|P1|Overall Study|Lost to Follow-up|9
2717653|NCT00288912|9350936|P3|Overall Study|Developed exclusion criterion|7
2717654|NCT00288912|9350937|P2|Overall Study|Developed exclusion criterion|6
2717655|NCT00288912|9350938|P1|Overall Study|Developed exclusion criterion|4
2717656|NCT00288860|9350978|P2|Overall Study|Lost to Follow-up|71
2717657|NCT00288860|9350979|P1|Overall Study|Lost to Follow-up|74
2717658|NCT00288860|9350978|P2|Overall Study|Withdrawal by Subject|15
2717659|NCT00288860|9350979|P1|Overall Study|Withdrawal by Subject|20
2717660|NCT00288860|9350978|P2|Overall Study|Death|3
2717661|NCT00288860|9350979|P1|Overall Study|Death|4
2717662|NCT00288860|9350978|P2|Overall Study|Did not complete intake|8
2717663|NCT00288860|9350979|P1|Overall Study|Did not complete intake|4
2717664|NCT00288704|9350992|P3|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1
2717665|NCT00288704|9350993|P2|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
2717666|NCT00288704|9350994|P1|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
2717667|NCT00288704|9350992|P3|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15
2717668|NCT00288704|9350993|P2|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
2717669|NCT00288704|9350994|P1|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
2717670|NCT00288704|9350992|P3|Open-Label Extension (OLE) Weeks 24-117|Death|2
2717671|NCT00288704|9350993|P2|Open-Label Extension (OLE) Weeks 24-117|Death|0
2717672|NCT00288704|9350994|P1|Open-Label Extension (OLE) Weeks 24-117|Death|0
2717673|NCT00288704|9350992|P3|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1
2717674|NCT00288704|9350993|P2|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
2717675|NCT00288704|9350994|P1|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
2717676|NCT00288704|9350992|P3|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1
2717677|NCT00288704|9350993|P2|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
2717678|NCT00288704|9350994|P1|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
2717679|NCT00288704|9350992|P3|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
2717680|NCT00288704|9350993|P2|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1
2717681|NCT00288704|9350994|P1|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
2717682|NCT00288704|9350992|P3|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
2717683|NCT00288704|9350993|P2|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1
2717684|NCT00288704|9350994|P1|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
2717685|NCT00288639|9351021|P1|Overall Study|Other|1
2717686|NCT00288639|9351021|P1|Overall Study|Withdrawal by Subject|2
2717687|NCT00288639|9351021|P1|Overall Study|Lack of Efficacy|4
2717688|NCT00288639|9351021|P1|Overall Study|Adverse Event|5
2717689|NCT00288626|9351038|P1|Overall Study|Withdrawal by Subject|4
2717690|NCT00288626|9351038|P1|Overall Study|Death|3
2717691|NCT00288587|9351072|P2|Overall Study|Severe Aortic Stenosis|0
2717692|NCT00288587|9351073|P1|Overall Study|Severe Aortic Stenosis|1
2717693|NCT00288587|9351072|P2|Overall Study|Physician Decision|2
2717694|NCT00288587|9351073|P1|Overall Study|Physician Decision|0
2717695|NCT00288587|9351072|P2|Overall Study|Adverse Event|1
2717696|NCT00288587|9351073|P1|Overall Study|Adverse Event|0
2717697|NCT00288587|9351072|P2|Overall Study|Transplant|3
2717698|NCT00288587|9351073|P1|Overall Study|Transplant|0
2717699|NCT00288587|9351072|P2|Overall Study|Death|4
2717700|NCT00288587|9351073|P1|Overall Study|Death|4
2717701|NCT00288509|9351116|P1|Treatment Cycle 4|Treatment stopped according to protocol|1
2717702|NCT00288509|9351116|P1|Treatment Cycle 4|Physician Decision|4
2717703|NCT00288509|9351116|P1|Treatment Cycle 4|Withdrawal by Subject|3
2717704|NCT00288509|9351116|P1|Treatment Cycle 3|Treatment stopped according to protocol|1
2717705|NCT00288509|9351116|P1|Treatment Cycle 3|Lost to Follow-up|2
2717706|NCT00288509|9351116|P1|Treatment Cycle 3|Withdrawal by Subject|1
2717707|NCT00288509|9351116|P1|Treatment Cycle 3|Lack of Efficacy|1
2717708|NCT00288509|9351116|P1|Treatment Cycle 2|Withdrawal by Subject|2
2717709|NCT00288509|9351116|P1|Treatment Cycle 2|Lack of Efficacy|1
2717710|NCT00288509|9351116|P1|Treatment Cycle 1|Treatment stopped according to protocol|1
2717711|NCT00288509|9351116|P1|Treatment Cycle 1|Lost to Follow-up|2
2717712|NCT00288509|9351116|P1|Treatment Cycle 1|Withdrawal by Subject|1
2717713|NCT00288509|9351116|P1|Treatment Cycle 1|Lack of Efficacy|1
2717714|NCT00288509|9351116|P1|Treatment Cycle 1|Adverse Event|1
2717715|NCT00288080|9351134|P2|Overall Study|Protocol Violation|20
2717716|NCT00288080|9351135|P1|Overall Study|Protocol Violation|25
2717717|NCT00288080|9351134|P2|Overall Study|Withdrawal by Subject|3
2717718|NCT00288080|9351135|P1|Overall Study|Withdrawal by Subject|1
2717719|NCT00288054|9351157|P1|Overall Study|Not protocol specified|2
2717720|NCT00288054|9351157|P1|Overall Study|Withdrawal by Subject|1
2717721|NCT00288054|9351157|P1|Overall Study|Adverse Event|3
2717722|NCT00288054|9351157|P1|Overall Study|Lack of Efficacy|16
2717723|NCT00288054|9351157|P1|Overall Study|Protocol Violation|2
2717724|NCT00288015|9351165|P1|Follow up for Survival x 2 Years|Other|9
2717725|NCT00288015|9351165|P1|Follow up for Survival x 2 Years|Lost to Follow-up|4
2717726|NCT00288015|9351165|P1|Follow up for Survival x 2 Years|Death|13
2717727|NCT00288015|9351165|P1|Continued Bevacizumab Cycle 3+|Disease progressed|7
2717728|NCT00288015|9351165|P1|First Response Assessment|Physician Decision|2
2717729|NCT00288015|9351165|P1|First Response Assessment|Death|1
2717730|NCT00288015|9351165|P1|First Response Assessment|Withdrawal by Subject|1
2717731|NCT00288015|9351165|P1|Bevacizumab Treatment Cycles 1-2|Physician Decision|1
2717732|NCT00288015|9351165|P1|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1
2717733|NCT00287690|9351257|P2|Overall Study|Protocol Violation|26
2717734|NCT00287690|9351258|P1|Overall Study|Protocol Violation|20
2717735|NCT00287586|9351270|P2|Overall Study|Recurrent Melanoma|1
2717736|NCT00287586|9351271|P1|Overall Study|Recurrent Melanoma|0
2717737|NCT00287586|9351270|P2|Overall Study|Itchy Swollen Eyes|1
2717738|NCT00287586|9351271|P1|Overall Study|Itchy Swollen Eyes|0
2717739|NCT00287586|9351270|P2|Overall Study|Bradycardia|1
2717740|NCT00287586|9351271|P1|Overall Study|Bradycardia|0
2717741|NCT00287586|9351270|P2|Overall Study|Mood Swings and Irritability|1
2717742|NCT00287586|9351271|P1|Overall Study|Mood Swings and Irritability|0
2717743|NCT00287586|9351270|P2|Overall Study|Mastodynia and Gynecomastia|1
2717744|NCT00287586|9351271|P1|Overall Study|Mastodynia and Gynecomastia|0
2717745|NCT00287586|9351270|P2|Overall Study|Retroperitoneal Cancer|1
2717746|NCT00287586|9351271|P1|Overall Study|Retroperitoneal Cancer|0
2717747|NCT00287586|9351270|P2|Overall Study|Elevated IPSS Score|1
2717748|NCT00287586|9351271|P1|Overall Study|Elevated IPSS Score|0
2717749|NCT00287586|9351270|P2|Overall Study|Lung Cancer|2
2717750|NCT00287586|9351271|P1|Overall Study|Lung Cancer|0
2717751|NCT00287586|9351270|P2|Overall Study|Major Depression|2
2717752|NCT00287586|9351271|P1|Overall Study|Major Depression|0
2717753|NCT00287586|9351270|P2|Overall Study|Enrolled in Another Study|0
2717754|NCT00287586|9351271|P1|Overall Study|Enrolled in Another Study|1
2717755|NCT00287586|9351270|P2|Overall Study|Nonadherence|1
2717756|NCT00287586|9351271|P1|Overall Study|Nonadherence|1
2717757|NCT00287586|9351270|P2|Overall Study|Inappropriate Behaviour with Staff|0
2717758|NCT00287586|9351271|P1|Overall Study|Inappropriate Behaviour with Staff|1
2717759|NCT00287586|9351270|P2|Overall Study|Shoulder Pain|0
2717760|NCT00287586|9351271|P1|Overall Study|Shoulder Pain|1
2717761|NCT00287586|9351270|P2|Overall Study|Sleep Apnea|0
2717762|NCT00287586|9351271|P1|Overall Study|Sleep Apnea|1
2717763|NCT00287586|9351270|P2|Overall Study|Pancreatic Cancer|3
2717764|NCT00287586|9351271|P1|Overall Study|Pancreatic Cancer|1
2717765|NCT00287586|9351270|P2|Overall Study|Cognitive Impairment|0
2717766|NCT00287586|9351271|P1|Overall Study|Cognitive Impairment|1
2717767|NCT00287586|9351270|P2|Overall Study|Lower Urinary Tract Symptoms|0
2717768|NCT00287586|9351271|P1|Overall Study|Lower Urinary Tract Symptoms|1
2717769|NCT00287586|9351270|P2|Overall Study|Myocardial Infarction|0
2717770|NCT00287586|9351271|P1|Overall Study|Myocardial Infarction|1
2717771|NCT00287586|9351270|P2|Overall Study|Stroke|0
2717772|NCT00287586|9351271|P1|Overall Study|Stroke|2
2717773|NCT00287586|9351270|P2|Overall Study|Elevated Prostate Specific Antigen|0
2717774|NCT00287586|9351271|P1|Overall Study|Elevated Prostate Specific Antigen|2
2717775|NCT00287586|9351270|P2|Overall Study|Rash|0
2717776|NCT00287586|9351271|P1|Overall Study|Rash|3
2717777|NCT00287586|9351270|P2|Overall Study|Elevated Hematocrit|0
2717778|NCT00287586|9351271|P1|Overall Study|Elevated Hematocrit|3
2717779|NCT00287586|9351270|P2|Overall Study|Death|3
2717780|NCT00287586|9351271|P1|Overall Study|Death|2
2717781|NCT00287586|9351270|P2|Overall Study|Lost to Follow-up|4
2717782|NCT00287586|9351271|P1|Overall Study|Lost to Follow-up|5
2717783|NCT00287586|9351270|P2|Overall Study|Withdrew Consent|30
2717784|NCT00287586|9351271|P1|Overall Study|Withdrew Consent|19
2717785|NCT00287469|9351309|P2|Overall Study|Lost to Follow-up|69
2717786|NCT00287469|9351310|P1|Overall Study|Lost to Follow-up|74
2717787|NCT00287469|9351309|P2|Overall Study|moved from area|138
2717788|NCT00287469|9351310|P1|Overall Study|moved from area|144
2717789|NCT00287469|9351309|P2|Overall Study|Adverse Event|1
2717790|NCT00287469|9351310|P1|Overall Study|Adverse Event|1
2717791|NCT00287469|9351309|P2|Overall Study|serious adverse event|6
2717792|NCT00287469|9351310|P1|Overall Study|serious adverse event|1
2717793|NCT00287365|9351320|P1|Overall Study|sample not acquired|13
2717794|NCT00287118|9351342|P1|Overall Study|Other|7
2717795|NCT00287118|9351342|P1|Overall Study|Protocol Violation|2
2717796|NCT00287118|9351342|P1|Overall Study|Lost to Follow-up|1
2717797|NCT00287118|9351342|P1|Overall Study|Lack of Efficacy|11
2717798|NCT00287118|9351342|P1|Overall Study|Death|1
2717799|NCT00287118|9351342|P1|Overall Study|Adverse Event|30
2717800|NCT00287079|9351348|P2|Overall Study|Other|0
2717801|NCT00287079|9351349|P1|Overall Study|Other|3
2717802|NCT00287079|9351348|P2|Overall Study|Protocol Violation|0
2717803|NCT00287079|9351349|P1|Overall Study|Protocol Violation|1
2717804|NCT00287079|9351348|P2|Overall Study|Adverse Event|0
2717805|NCT00287079|9351349|P1|Overall Study|Adverse Event|5
2717806|NCT00287079|9351348|P2|Overall Study|Non-qualifying relapse|0
2717807|NCT00287079|9351349|P1|Overall Study|Non-qualifying relapse|1
2717808|NCT00287079|9351348|P2|Overall Study|Qualifying relapse|1
2717809|NCT00287079|9351349|P1|Overall Study|Qualifying relapse|12
2717810|NCT00286754|9351377|P3|Overall Study|Moved out of state|1
2717811|NCT00286754|9351378|P2|Overall Study|Moved out of state|0
2717812|NCT00286754|9351379|P1|Overall Study|Moved out of state|0
2717813|NCT00286754|9351377|P3|Overall Study|Lost to Follow-up|6
2717814|NCT00286754|9351378|P2|Overall Study|Lost to Follow-up|14
2717815|NCT00286754|9351379|P1|Overall Study|Lost to Follow-up|12
2717816|NCT00286754|9351377|P3|Overall Study|Withdrawal by Subject|0
2717817|NCT00286754|9351378|P2|Overall Study|Withdrawal by Subject|2
2717818|NCT00286754|9351379|P1|Overall Study|Withdrawal by Subject|6
2717819|NCT00286754|9351377|P3|Overall Study|Adverse Event|3
2717820|NCT00286754|9351378|P2|Overall Study|Adverse Event|2
2717821|NCT00286754|9351379|P1|Overall Study|Adverse Event|2
2717822|NCT00286494|9351438|P3|Overall Study|Protocol Violation|2
2717823|NCT00286494|9351439|P2|Overall Study|Protocol Violation|1
2717824|NCT00286494|9351440|P1|Overall Study|Protocol Violation|1
2717825|NCT00286494|9351438|P3|Overall Study|Lost to Follow-up|3
2717826|NCT00286494|9351439|P2|Overall Study|Lost to Follow-up|1
2717827|NCT00286494|9351440|P1|Overall Study|Lost to Follow-up|3
2717828|NCT00286494|9351438|P3|Overall Study|Physician Decision|1
2717829|NCT00286494|9351439|P2|Overall Study|Physician Decision|5
2717830|NCT00286494|9351440|P1|Overall Study|Physician Decision|5
2717831|NCT00286494|9351438|P3|Overall Study|Adverse Event|6
2717832|NCT00286494|9351439|P2|Overall Study|Adverse Event|8
2717833|NCT00286494|9351440|P1|Overall Study|Adverse Event|3
2717834|NCT00286494|9351438|P3|Overall Study|Withdrawal by Subject|9
2717835|NCT00286494|9351439|P2|Overall Study|Withdrawal by Subject|10
2717836|NCT00286494|9351440|P1|Overall Study|Withdrawal by Subject|2
2717837|NCT00286494|9351438|P3|Overall Study|Hyperglycemic rescue|18
2717838|NCT00286494|9351439|P2|Overall Study|Hyperglycemic rescue|19
2717839|NCT00286494|9351440|P1|Overall Study|Hyperglycemic rescue|12
2717840|NCT00286468|9351601|P3|Overall Study|Physician Decision|1
2717841|NCT00286468|9351602|P2|Overall Study|Physician Decision|2
2717842|NCT00286468|9351603|P1|Overall Study|Physician Decision|3
2717843|NCT00286468|9351601|P3|Overall Study|Withdrawal by Subject|11
2717844|NCT00286468|9351602|P2|Overall Study|Withdrawal by Subject|8
2717845|NCT00286468|9351603|P1|Overall Study|Withdrawal by Subject|3
2717846|NCT00286468|9351601|P3|Overall Study|Lost to Follow-up|2
2717847|NCT00286468|9351602|P2|Overall Study|Lost to Follow-up|1
2717848|NCT00286468|9351603|P1|Overall Study|Lost to Follow-up|1
2717849|NCT00286468|9351601|P3|Overall Study|Protocol Violation|1
2717850|NCT00286468|9351602|P2|Overall Study|Protocol Violation|3
2717851|NCT00286468|9351603|P1|Overall Study|Protocol Violation|0
2717852|NCT00286468|9351601|P3|Overall Study|Adverse Event|4
2717853|NCT00286468|9351602|P2|Overall Study|Adverse Event|6
2717854|NCT00286468|9351603|P1|Overall Study|Adverse Event|2
2717855|NCT00286468|9351601|P3|Overall Study|Hyperglycemic Rescue|31
2717856|NCT00286468|9351602|P2|Overall Study|Hyperglycemic Rescue|30
2717857|NCT00286468|9351603|P1|Overall Study|Hyperglycemic Rescue|28
2717858|NCT00286455|9351764|P3|Overall Study|Withdrawal by Subject|7
2717859|NCT00286455|9351765|P2|Overall Study|Withdrawal by Subject|8
2717860|NCT00286455|9351766|P1|Overall Study|Withdrawal by Subject|0
2717861|NCT00286455|9351764|P3|Overall Study|Participant Non-compliance|0
2717862|NCT00286455|9351765|P2|Overall Study|Participant Non-compliance|0
2717863|NCT00286455|9351766|P1|Overall Study|Participant Non-compliance|1
2717864|NCT00286455|9351764|P3|Overall Study|Protocol Violation|0
2717865|NCT00286455|9351765|P2|Overall Study|Protocol Violation|1
2717866|NCT00286455|9351766|P1|Overall Study|Protocol Violation|1
2717867|NCT00286455|9351764|P3|Overall Study|Physician Decision|2
2717868|NCT00286455|9351765|P2|Overall Study|Physician Decision|0
2717869|NCT00286455|9351766|P1|Overall Study|Physician Decision|3
2717870|NCT00286455|9351764|P3|Overall Study|Lost to Follow-up|3
2717871|NCT00286455|9351765|P2|Overall Study|Lost to Follow-up|3
2717872|NCT00286455|9351766|P1|Overall Study|Lost to Follow-up|0
2717873|NCT00286455|9351764|P3|Overall Study|Adverse Event|2
2717874|NCT00286455|9351765|P2|Overall Study|Adverse Event|3
2717875|NCT00286455|9351766|P1|Overall Study|Adverse Event|1
2717876|NCT00286455|9351764|P3|Overall Study|Hyperglycemia rescue|10
2717877|NCT00286455|9351765|P2|Overall Study|Hyperglycemia rescue|13
2717878|NCT00286455|9351766|P1|Overall Study|Hyperglycemia rescue|19
2717879|NCT00286442|9351945|P3|Overall Study|Withdrawal by Subject|2
2717880|NCT00286442|9351946|P2|Overall Study|Withdrawal by Subject|14
2717881|NCT00286442|9351947|P1|Overall Study|Withdrawal by Subject|2
2717882|NCT00286442|9351945|P3|Overall Study|Administrative Error|0
2717883|NCT00286442|9351946|P2|Overall Study|Administrative Error|1
2717884|NCT00286442|9351947|P1|Overall Study|Administrative Error|1
2717885|NCT00286442|9351945|P3|Overall Study|Physician Decision|1
2717886|NCT00286442|9351946|P2|Overall Study|Physician Decision|1
2717887|NCT00286442|9351947|P1|Overall Study|Physician Decision|1
2717888|NCT00286442|9351945|P3|Overall Study|Lost to Follow-up|1
2717889|NCT00286442|9351946|P2|Overall Study|Lost to Follow-up|2
2717890|NCT00286442|9351947|P1|Overall Study|Lost to Follow-up|5
2717891|NCT00286442|9351945|P3|Overall Study|Protocol Violation|2
2717892|NCT00286442|9351946|P2|Overall Study|Protocol Violation|4
2717893|NCT00286442|9351947|P1|Overall Study|Protocol Violation|2
2717894|NCT00286442|9351945|P3|Overall Study|Adverse Event|1
2717895|NCT00286442|9351946|P2|Overall Study|Adverse Event|6
2717896|NCT00286442|9351947|P1|Overall Study|Adverse Event|7
2717897|NCT00286442|9351945|P3|Overall Study|Hyperglycemic Rescue|25
2717898|NCT00286442|9351946|P2|Overall Study|Hyperglycemic Rescue|17
2717899|NCT00286442|9351947|P1|Overall Study|Hyperglycemic Rescue|19
2717900|NCT00286429|9352108|P3|Overall Study|Administrative Decision|0
2717901|NCT00286429|9352109|P2|Overall Study|Administrative Decision|1
2717902|NCT00286429|9352110|P1|Overall Study|Administrative Decision|0
2717903|NCT00286429|9352108|P3|Overall Study|Administrative Error|1
2717904|NCT00286429|9352109|P2|Overall Study|Administrative Error|1
2717905|NCT00286429|9352110|P1|Overall Study|Administrative Error|1
2717906|NCT00286429|9352108|P3|Overall Study|Withdrawal by Subject|6
2717907|NCT00286429|9352109|P2|Overall Study|Withdrawal by Subject|2
2717908|NCT00286429|9352110|P1|Overall Study|Withdrawal by Subject|3
2717909|NCT00286429|9352108|P3|Overall Study|Protocol Violation|4
2717910|NCT00286429|9352109|P2|Overall Study|Protocol Violation|5
2717911|NCT00286429|9352110|P1|Overall Study|Protocol Violation|3
2717912|NCT00286429|9352108|P3|Overall Study|Physician Decision|7
2717913|NCT00286429|9352109|P2|Overall Study|Physician Decision|7
2717914|NCT00286429|9352110|P1|Overall Study|Physician Decision|10
2717915|NCT00286429|9352108|P3|Overall Study|Lost to Follow-up|3
2717916|NCT00286429|9352109|P2|Overall Study|Lost to Follow-up|4
2717917|NCT00286429|9352110|P1|Overall Study|Lost to Follow-up|2
2717918|NCT00286429|9352108|P3|Overall Study|Lack of Efficacy|25
2717919|NCT00286429|9352109|P2|Overall Study|Lack of Efficacy|27
2717920|NCT00286429|9352110|P1|Overall Study|Lack of Efficacy|52
2717921|NCT00286429|9352108|P3|Overall Study|Adverse Event|6
2717922|NCT00286429|9352109|P2|Overall Study|Adverse Event|1
2717923|NCT00286429|9352110|P1|Overall Study|Adverse Event|4
2717924|NCT00286221|9352226|P4|Overall Study|Unrecognized exclusion criteria met|0
2717925|NCT00286221|9352227|P3|Overall Study|Unrecognized exclusion criteria met|0
2717926|NCT00286221|9352228|P2|Overall Study|Unrecognized exclusion criteria met|1
2717927|NCT00286221|9352229|P1|Overall Study|Unrecognized exclusion criteria met|0
2717928|NCT00286221|9352226|P4|Overall Study|Inability to trigger PCA|0
2717929|NCT00286221|9352227|P3|Overall Study|Inability to trigger PCA|0
2717930|NCT00286221|9352228|P2|Overall Study|Inability to trigger PCA|0
2717931|NCT00286221|9352229|P1|Overall Study|Inability to trigger PCA|2
2717932|NCT00286221|9352226|P4|Overall Study|Unanticipated Neurosurgical Complication|2
2717933|NCT00286221|9352227|P3|Overall Study|Unanticipated Neurosurgical Complication|3
2717934|NCT00286221|9352228|P2|Overall Study|Unanticipated Neurosurgical Complication|3
2717935|NCT00286221|9352229|P1|Overall Study|Unanticipated Neurosurgical Complication|6
2717936|NCT00286221|9352226|P4|Overall Study|Protocol Violation|4
2717937|NCT00286221|9352227|P3|Overall Study|Protocol Violation|6
2717938|NCT00286221|9352228|P2|Overall Study|Protocol Violation|1
2717939|NCT00286221|9352229|P1|Overall Study|Protocol Violation|2
2717940|NCT00286156|9352255|P3|Overall Study|AE: pneumonia|0
2717941|NCT00286156|9352256|P2|Overall Study|AE: pneumonia|0
2717942|NCT00286156|9352257|P1|Overall Study|AE: pneumonia|1
2717943|NCT00286156|9352255|P3|Overall Study|AE: nephrotic-range proteinuruia|0
2717944|NCT00286156|9352256|P2|Overall Study|AE: nephrotic-range proteinuruia|0
2717945|NCT00286156|9352257|P1|Overall Study|AE: nephrotic-range proteinuruia|1
2717946|NCT00286156|9352255|P3|Overall Study|AE: pulmonary embolus|0
2717947|NCT00286156|9352256|P2|Overall Study|AE: pulmonary embolus|1
2717948|NCT00286156|9352257|P1|Overall Study|AE: pulmonary embolus|0
2717949|NCT00286156|9352255|P3|Overall Study|Missed 12 month visit|1
2717950|NCT00286156|9352256|P2|Overall Study|Missed 12 month visit|0
2717951|NCT00286156|9352257|P1|Overall Study|Missed 12 month visit|0
2717952|NCT00286091|9352270|P2|Open-label Treatment Phase|Missing End of Study Information|1
2717953|NCT00286091|9352271|P1|Open-label Treatment Phase|Missing End of Study Information|0
2717954|NCT00286091|9352270|P2|Open-label Treatment Phase|Protocol-specified Criteria|0
2717955|NCT00286091|9352271|P1|Open-label Treatment Phase|Protocol-specified Criteria|1
2717956|NCT00286091|9352270|P2|Open-label Treatment Phase|Lost to Follow-up|1
2717957|NCT00286091|9352271|P1|Open-label Treatment Phase|Lost to Follow-up|0
2717958|NCT00286091|9352270|P2|Open-label Treatment Phase|Noncompliance|1
2717959|NCT00286091|9352271|P1|Open-label Treatment Phase|Noncompliance|3
2717960|NCT00286091|9352270|P2|Open-label Treatment Phase|Disease Progression|3
2717961|NCT00286091|9352271|P1|Open-label Treatment Phase|Disease Progression|9
2717962|NCT00286091|9352270|P2|Open-label Treatment Phase|Death|7
2717963|NCT00286091|9352271|P1|Open-label Treatment Phase|Death|10
2717964|NCT00286091|9352270|P2|Open-label Treatment Phase|Withdrawal by Subject|10
2717965|NCT00286091|9352271|P1|Open-label Treatment Phase|Withdrawal by Subject|14
2717966|NCT00286091|9352270|P2|Open-label Treatment Phase|Other|11
2717967|NCT00286091|9352271|P1|Open-label Treatment Phase|Other|11
2717968|NCT00286091|9352270|P2|Open-label Treatment Phase|Adverse Event|16
2717969|NCT00286091|9352271|P1|Open-label Treatment Phase|Adverse Event|5
2717970|NCT00286091|9352270|P2|Open-label Treatment Phase|Physician Decision|21
2717971|NCT00286091|9352271|P1|Open-label Treatment Phase|Physician Decision|24
2717972|NCT00286091|9352270|P2|Double-blind Treatment Phase|Ineligibility Determined|2
2717973|NCT00286091|9352271|P1|Double-blind Treatment Phase|Ineligibility Determined|1
2717974|NCT00286091|9352270|P2|Double-blind Treatment Phase|Protocol Deviation|3
2717975|NCT00286091|9352271|P1|Double-blind Treatment Phase|Protocol Deviation|1
2717976|NCT00286091|9352270|P2|Double-blind Treatment Phase|Lost to Follow-up|4
2717977|NCT00286091|9352271|P1|Double-blind Treatment Phase|Lost to Follow-up|11
2717978|NCT00286091|9352270|P2|Double-blind Treatment Phase|Noncompliance|8
2717979|NCT00286091|9352271|P1|Double-blind Treatment Phase|Noncompliance|8
2717980|NCT00286091|9352270|P2|Double-blind Treatment Phase|Administrative Decision|21
2717981|NCT00286091|9352271|P1|Double-blind Treatment Phase|Administrative Decision|20
2717982|NCT00286091|9352270|P2|Double-blind Treatment Phase|Other|33
2717983|NCT00286091|9352271|P1|Double-blind Treatment Phase|Other|25
2717984|NCT00286091|9352270|P2|Double-blind Treatment Phase|Disease Progression|35
2717985|NCT00286091|9352271|P1|Double-blind Treatment Phase|Disease Progression|22
2717986|NCT00286091|9352270|P2|Double-blind Treatment Phase|Adverse Event|40
2717987|NCT00286091|9352271|P1|Double-blind Treatment Phase|Adverse Event|28
2717988|NCT00286091|9352270|P2|Double-blind Treatment Phase|Death|65
2717989|NCT00286091|9352271|P1|Double-blind Treatment Phase|Death|58
2717990|NCT00286091|9352270|P2|Double-blind Treatment Phase|Protocol-Specified Criteria|269
2717991|NCT00286091|9352271|P1|Double-blind Treatment Phase|Protocol-Specified Criteria|307
2717992|NCT00286091|9352270|P2|Double-blind Treatment Phase|Withdrawal by Subject|113
2717993|NCT00286091|9352271|P1|Double-blind Treatment Phase|Withdrawal by Subject|103
2717994|NCT00285857|9352294|P1|Overall Study|Adverse Event|1
2717995|NCT00285857|9352294|P1|Overall Study|Inadequate initial breast cytology|1
2717996|NCT00285857|9352294|P1|Overall Study|Withdrawal by Subject|2
2717997|NCT00285818|9352307|P2|Overall Study|Lost to Follow-up|0
2717998|NCT00285818|9352308|P1|Overall Study|Lost to Follow-up|1
2717999|NCT00285818|9352307|P2|Overall Study|Withdrawal by Subject|2
2718000|NCT00285818|9352308|P1|Overall Study|Withdrawal by Subject|3
2718001|NCT00285649|9352353|P3|Overall Study|Withdrawal by Subject|2
2718002|NCT00285649|9352354|P2|Overall Study|Withdrawal by Subject|2
2718003|NCT00285649|9352355|P1|Overall Study|Withdrawal by Subject|3
2718004|NCT00285649|9352353|P3|Overall Study|Lost to Follow-up|4
2718005|NCT00285649|9352354|P2|Overall Study|Lost to Follow-up|4
2718006|NCT00285649|9352355|P1|Overall Study|Lost to Follow-up|6
2718007|NCT00285584|9352365|P2|Month 6|Lost to Follow-up|1
2718008|NCT00285584|9352366|P1|Month 6|Lost to Follow-up|0
2718009|NCT00285584|9352365|P2|Month 3|Withdrawal by Subject|0
2718010|NCT00285584|9352366|P1|Month 3|Withdrawal by Subject|1
2718011|NCT00285584|9352365|P2|Month 3|Lost to Follow-up|3
2718012|NCT00285584|9352366|P1|Month 3|Lost to Follow-up|3
2718013|NCT00285207|9352398|P2|Overall Study|non-compliance|1
2718014|NCT00285207|9352399|P1|Overall Study|non-compliance|0
2718015|NCT00285207|9352398|P2|Overall Study|Pregnancy|1
2718016|NCT00285207|9352399|P1|Overall Study|Pregnancy|1
2718017|NCT00285207|9352398|P2|Overall Study|Withdrawal by Subject|2
2718018|NCT00285207|9352399|P1|Overall Study|Withdrawal by Subject|5
2718019|NCT00285207|9352398|P2|Overall Study|Lost to Follow-up|2
2718020|NCT00285207|9352399|P1|Overall Study|Lost to Follow-up|3
2718021|NCT00285012|9352407|P2|Received Study Tx|Other|5
2718022|NCT00285012|9352408|P1|Received Study Tx|Other|5
2718023|NCT00285012|9352407|P2|Received Study Tx|Withdrawal by Subject|43
2718024|NCT00285012|9352408|P1|Received Study Tx|Withdrawal by Subject|31
2718025|NCT00285012|9352407|P2|Received Study Tx|Lost to Follow-up|31
2718026|NCT00285012|9352408|P1|Received Study Tx|Lost to Follow-up|29
2718027|NCT00285012|9352407|P2|Received Study Tx|Lack of Efficacy|3
2718028|NCT00285012|9352408|P1|Received Study Tx|Lack of Efficacy|0
2718029|NCT00285012|9352407|P2|Received Study Tx|Adverse Event|11
2718030|NCT00285012|9352408|P1|Received Study Tx|Adverse Event|5
2718031|NCT00285012|9352407|P2|Received Study Tx|Death|1
2718032|NCT00285012|9352408|P1|Received Study Tx|Death|2
2718033|NCT00285012|9352407|P2|Assigned to Study Treatment (Tx)|Other|3
2718034|NCT00285012|9352408|P1|Assigned to Study Treatment (Tx)|Other|2
2718035|NCT00284934|9352434|P2|Overall Study|Other reasons|1
2718036|NCT00284934|9352435|P1|Overall Study|Other reasons|3
2718037|NCT00284934|9352434|P2|Overall Study|Adverse Event|2
2718038|NCT00284934|9352435|P1|Overall Study|Adverse Event|1
2718039|NCT00284856|9352450|P3|Overall Study|Other|4
2718040|NCT00284856|9352451|P2|Overall Study|Other|5
2718041|NCT00284856|9352452|P1|Overall Study|Other|4
2718042|NCT00284856|9352450|P3|Overall Study|Withdrawal by Subject|18
2718043|NCT00284856|9352451|P2|Overall Study|Withdrawal by Subject|16
2718044|NCT00284856|9352452|P1|Overall Study|Withdrawal by Subject|12
2718045|NCT00284856|9352450|P3|Overall Study|Protocol Violation|5
2718046|NCT00284856|9352451|P2|Overall Study|Protocol Violation|4
2718047|NCT00284856|9352452|P1|Overall Study|Protocol Violation|5
2718048|NCT00284856|9352450|P3|Overall Study|Lost to Follow-up|22
2718049|NCT00284856|9352451|P2|Overall Study|Lost to Follow-up|21
2718050|NCT00284856|9352452|P1|Overall Study|Lost to Follow-up|25
2718051|NCT00284856|9352450|P3|Overall Study|Lack of Efficacy|8
2718052|NCT00284856|9352451|P2|Overall Study|Lack of Efficacy|1
2718053|NCT00284856|9352452|P1|Overall Study|Lack of Efficacy|2
2718054|NCT00284856|9352450|P3|Overall Study|Adverse Event|3
2718055|NCT00284856|9352451|P2|Overall Study|Adverse Event|3
2718056|NCT00284856|9352452|P1|Overall Study|Adverse Event|3
2718057|NCT00284141|9352551|P1|Overall Study|Ongoing treatment|2
2718058|NCT00284141|9352551|P1|Overall Study|Did not take study medication|2
2718059|NCT00284141|9352551|P1|Overall Study|Pneumonia|1
2718060|NCT00284141|9352551|P1|Overall Study|General decline|1
2718061|NCT00284141|9352551|P1|Overall Study|Clinical deterioration / death|2
2718062|NCT00284141|9352551|P1|Overall Study|Symptomatic / Clinical Progression|11
2718063|NCT00284141|9352551|P1|Overall Study|Participant's request|9
2718064|NCT00284141|9352551|P1|Overall Study|Adverse Event|19
2718065|NCT00284141|9352551|P1|Overall Study|Disease Progression / Lack of efficacy|51
2718066|NCT00284089|9352574|P4|Extension Phase|Withdrawal by Subject|3
2718067|NCT00284089|9352575|P3|Extension Phase|Withdrawal by Subject|1
2718068|NCT00284089|9352576|P2|Extension Phase|Withdrawal by Subject|0
2718069|NCT00284089|9352577|P1|Extension Phase|Withdrawal by Subject|0
2718070|NCT00284089|9352574|P4|Extension Phase|Protocol Violation|0
2718071|NCT00284089|9352575|P3|Extension Phase|Protocol Violation|1
2718072|NCT00284089|9352576|P2|Extension Phase|Protocol Violation|0
2718073|NCT00284089|9352577|P1|Extension Phase|Protocol Violation|0
2718074|NCT00284089|9352574|P4|Extension Phase|condition no longer requires study drug|7
2718075|NCT00284089|9352575|P3|Extension Phase|condition no longer requires study drug|2
2718076|NCT00284089|9352576|P2|Extension Phase|condition no longer requires study drug|0
2718077|NCT00284089|9352577|P1|Extension Phase|condition no longer requires study drug|2
2718078|NCT00284089|9352574|P4|Extension Phase|Adverse Event|2
2718079|NCT00284089|9352575|P3|Extension Phase|Adverse Event|2
2718080|NCT00284089|9352576|P2|Extension Phase|Adverse Event|0
2718081|NCT00284089|9352577|P1|Extension Phase|Adverse Event|0
2718082|NCT00284089|9352574|P4|Multiple Dose Phase|Death|1
2718083|NCT00284089|9352575|P3|Multiple Dose Phase|Death|1
2718084|NCT00284089|9352576|P2|Multiple Dose Phase|Death|0
2718085|NCT00284089|9352577|P1|Multiple Dose Phase|Death|0
2718086|NCT00284089|9352574|P4|Multiple Dose Phase|Withdrawal by Subject|2
2718087|NCT00284089|9352575|P3|Multiple Dose Phase|Withdrawal by Subject|1
2718088|NCT00284089|9352576|P2|Multiple Dose Phase|Withdrawal by Subject|0
2718089|NCT00284089|9352577|P1|Multiple Dose Phase|Withdrawal by Subject|0
2718090|NCT00284089|9352574|P4|Multiple Dose Phase|Protocol Violation|0
2718091|NCT00284089|9352575|P3|Multiple Dose Phase|Protocol Violation|1
2718092|NCT00284089|9352576|P2|Multiple Dose Phase|Protocol Violation|0
2718093|NCT00284089|9352577|P1|Multiple Dose Phase|Protocol Violation|0
2718094|NCT00284089|9352574|P4|Multiple Dose Phase|Adverse Event|1
2718095|NCT00284089|9352575|P3|Multiple Dose Phase|Adverse Event|1
2718096|NCT00284089|9352576|P2|Multiple Dose Phase|Adverse Event|0
2718097|NCT00284089|9352577|P1|Multiple Dose Phase|Adverse Event|1
2718098|NCT00284050|9352606|P3|Overall Study|Death|0
2718099|NCT00284050|9352607|P2|Overall Study|Death|0
2718100|NCT00284050|9352608|P1|Overall Study|Death|1
2718101|NCT00284050|9352606|P3|Overall Study|Lost to Follow-up|1
2718102|NCT00284050|9352607|P2|Overall Study|Lost to Follow-up|0
2718103|NCT00284050|9352608|P1|Overall Study|Lost to Follow-up|1
2718104|NCT00284050|9352606|P3|Overall Study|Withdrawal by Subject|2
2718105|NCT00284050|9352607|P2|Overall Study|Withdrawal by Subject|2
2718106|NCT00284050|9352608|P1|Overall Study|Withdrawal by Subject|2
2718107|NCT00284050|9352606|P3|Overall Study|Protocol Violation|2
2718108|NCT00284050|9352607|P2|Overall Study|Protocol Violation|1
2718109|NCT00284050|9352608|P1|Overall Study|Protocol Violation|0
2718110|NCT00284050|9352606|P3|Overall Study|Lack of Efficacy|3
2718111|NCT00284050|9352607|P2|Overall Study|Lack of Efficacy|1
2718112|NCT00284050|9352608|P1|Overall Study|Lack of Efficacy|0
2718113|NCT00284050|9352606|P3|Overall Study|Adverse Event|1
2718114|NCT00284050|9352607|P2|Overall Study|Adverse Event|1
2718115|NCT00284050|9352608|P1|Overall Study|Adverse Event|1
2718116|NCT00283959|9352622|P1|Extension Period|Low Compliance|1
2718117|NCT00283868|9352634|P2|Overall Study|Lost to Follow-up|8
2718118|NCT00283868|9352635|P1|Overall Study|Lost to Follow-up|7
2718119|NCT00283842|9352652|P5|Overall Study|Lost to Follow-up|1
2718120|NCT00283842|9352653|P4|Overall Study|Lost to Follow-up|1
2718121|NCT00283842|9352654|P3|Overall Study|Lost to Follow-up|4
2718122|NCT00283842|9352655|P2|Overall Study|Lost to Follow-up|2
2718123|NCT00283842|9352656|P1|Overall Study|Lost to Follow-up|0
2718124|NCT00283842|9352652|P5|Overall Study|Lack of Efficacy|3
2718125|NCT00283842|9352653|P4|Overall Study|Lack of Efficacy|0
2718126|NCT00283842|9352654|P3|Overall Study|Lack of Efficacy|1
2718127|NCT00283842|9352655|P2|Overall Study|Lack of Efficacy|3
2718128|NCT00283842|9352656|P1|Overall Study|Lack of Efficacy|1
2718129|NCT00283842|9352652|P5|Overall Study|Withdrawal by Subject|4
2718130|NCT00283842|9352653|P4|Overall Study|Withdrawal by Subject|5
2718131|NCT00283842|9352654|P3|Overall Study|Withdrawal by Subject|1
2718132|NCT00283842|9352655|P2|Overall Study|Withdrawal by Subject|1
2718133|NCT00283842|9352656|P1|Overall Study|Withdrawal by Subject|2
2718134|NCT00283842|9352652|P5|Overall Study|Protocol deviation|2
2718135|NCT00283842|9352653|P4|Overall Study|Protocol deviation|0
2718136|NCT00283842|9352654|P3|Overall Study|Protocol deviation|0
2718137|NCT00283842|9352655|P2|Overall Study|Protocol deviation|0
2718138|NCT00283842|9352656|P1|Overall Study|Protocol deviation|0
2718139|NCT00283842|9352652|P5|Overall Study|Protocol Violation|0
2718140|NCT00283842|9352653|P4|Overall Study|Protocol Violation|0
2718141|NCT00283842|9352654|P3|Overall Study|Protocol Violation|4
2718142|NCT00283842|9352655|P2|Overall Study|Protocol Violation|5
2718143|NCT00283842|9352656|P1|Overall Study|Protocol Violation|1
2718144|NCT00283842|9352652|P5|Overall Study|Adverse Event|5
2718145|NCT00283842|9352653|P4|Overall Study|Adverse Event|21
2718146|NCT00283842|9352654|P3|Overall Study|Adverse Event|21
2718147|NCT00283842|9352655|P2|Overall Study|Adverse Event|7
2718148|NCT00283842|9352656|P1|Overall Study|Adverse Event|8
2718149|NCT00283803|9352688|P1|Overall Study|Withdrawal by Subject|4
2718150|NCT00283803|9352688|P1|Overall Study|Physician Decision|9
2718151|NCT00283712|9352696|P2|Overall Study|Death|1
2718152|NCT00283712|9352697|P1|Overall Study|Death|0
2718153|NCT00283686|9352735|P4|Overall Study|Less than full participation|12
2718154|NCT00283686|9352736|P3|Overall Study|Less than full participation|6
2718155|NCT00283686|9352737|P2|Overall Study|Less than full participation|9
2718156|NCT00283686|9352738|P1|Overall Study|Less than full participation|7
2718157|NCT00283686|9352735|P4|Overall Study|Lost to Follow-up|20
2718158|NCT00283686|9352736|P3|Overall Study|Lost to Follow-up|26
2718159|NCT00283686|9352737|P2|Overall Study|Lost to Follow-up|31
2718160|NCT00283686|9352738|P1|Overall Study|Lost to Follow-up|21
2718161|NCT00283686|9352735|P4|Overall Study|Death|0
2718162|NCT00283686|9352736|P3|Overall Study|Death|1
2718163|NCT00283686|9352737|P2|Overall Study|Death|1
2718164|NCT00283686|9352738|P1|Overall Study|Death|1
2718165|NCT00283595|9352782|P2|Overall Study|Withdrawal by Subject|2
2718166|NCT00283595|9352783|P1|Overall Study|Withdrawal by Subject|1
2718167|NCT00283439|9352808|P4|Overall Study|Other|0
2718168|NCT00283439|9352809|P3|Overall Study|Other|0
2718169|NCT00283439|9352810|P2|Overall Study|Other|0
2718170|NCT00283439|9352811|P1|Overall Study|Other|1
2718171|NCT00283439|9352808|P4|Overall Study|Treatment discontinued|3
2718172|NCT00283439|9352809|P3|Overall Study|Treatment discontinued|1
2718173|NCT00283439|9352810|P2|Overall Study|Treatment discontinued|2
2718174|NCT00283439|9352811|P1|Overall Study|Treatment discontinued|0
2718175|NCT00283439|9352808|P4|Overall Study|Stem cell transplant|3
2718176|NCT00283439|9352809|P3|Overall Study|Stem cell transplant|4
2718177|NCT00283439|9352810|P2|Overall Study|Stem cell transplant|6
2718178|NCT00283439|9352811|P1|Overall Study|Stem cell transplant|6
2718179|NCT00283439|9352808|P4|Overall Study|Requirement for alternative therapy|2
2718180|NCT00283439|9352809|P3|Overall Study|Requirement for alternative therapy|5
2718181|NCT00283439|9352810|P2|Overall Study|Requirement for alternative therapy|2
2718182|NCT00283439|9352811|P1|Overall Study|Requirement for alternative therapy|1
2718183|NCT00283439|9352808|P4|Overall Study|Disease progression|0
2718184|NCT00283439|9352809|P3|Overall Study|Disease progression|0
2718185|NCT00283439|9352810|P2|Overall Study|Disease progression|1
2718186|NCT00283439|9352811|P1|Overall Study|Disease progression|0
2718187|NCT00283439|9352808|P4|Overall Study|Death|0
2718188|NCT00283439|9352809|P3|Overall Study|Death|1
2718189|NCT00283439|9352810|P2|Overall Study|Death|0
2718190|NCT00283439|9352811|P1|Overall Study|Death|0
2718191|NCT00283439|9352808|P4|Overall Study|Adverse Event|1
2718192|NCT00283439|9352809|P3|Overall Study|Adverse Event|0
2718193|NCT00283439|9352810|P2|Overall Study|Adverse Event|0
2718194|NCT00283439|9352811|P1|Overall Study|Adverse Event|0
2718195|NCT00283400|9352837|P4|Overall Study|Death|0
2718196|NCT00283400|9352838|P3|Overall Study|Death|1
2718197|NCT00283400|9352839|P2|Overall Study|Death|0
2718198|NCT00283400|9352840|P1|Overall Study|Death|1
2718199|NCT00283400|9352837|P4|Overall Study|Withdrawal by Subject|0
2718200|NCT00283400|9352838|P3|Overall Study|Withdrawal by Subject|0
2718201|NCT00283400|9352839|P2|Overall Study|Withdrawal by Subject|1
2718202|NCT00283400|9352840|P1|Overall Study|Withdrawal by Subject|1
2718203|NCT00283387|9352858|P2|First Intervention|Withdrawal by Subject|1
2718204|NCT00283387|9352859|P1|First Intervention|Withdrawal by Subject|0
2718205|NCT00283387|9352858|P2|First Intervention|Subject non-compliant|1
2718206|NCT00283387|9352859|P1|First Intervention|Subject non-compliant|1
2718207|NCT00283296|9352865|P1|Overall Study|in-home trial not completed|5
2718208|NCT00283244|9352874|P3|Overall Study|Clinical deterioration|3
2718209|NCT00283244|9352875|P2|Overall Study|Clinical deterioration|3
2718210|NCT00283244|9352876|P1|Overall Study|Clinical deterioration|1
2718211|NCT00283244|9352874|P3|Overall Study|Medical illness (other complicating dz)|6
2718212|NCT00283244|9352875|P2|Overall Study|Medical illness (other complicating dz)|3
2718213|NCT00283244|9352876|P1|Overall Study|Medical illness (other complicating dz)|4
2718214|NCT00283244|9352874|P3|Overall Study|Physician Decision|1
2718215|NCT00283244|9352875|P2|Overall Study|Physician Decision|0
2718216|NCT00283244|9352876|P1|Overall Study|Physician Decision|0
2718217|NCT00283244|9352874|P3|Overall Study|Withdrawal by Subject|2
2718218|NCT00283244|9352875|P2|Overall Study|Withdrawal by Subject|2
2718219|NCT00283244|9352876|P1|Overall Study|Withdrawal by Subject|1
2718220|NCT00283244|9352874|P3|Overall Study|Lack of Efficacy|26
2718221|NCT00283244|9352875|P2|Overall Study|Lack of Efficacy|32
2718222|NCT00283244|9352876|P1|Overall Study|Lack of Efficacy|8
2718223|NCT00283244|9352874|P3|Overall Study|Death|2
2718224|NCT00283244|9352875|P2|Overall Study|Death|3
2718225|NCT00283244|9352876|P1|Overall Study|Death|4
2718226|NCT00283244|9352874|P3|Overall Study|Adverse Event|11
2718227|NCT00283244|9352875|P2|Overall Study|Adverse Event|8
2718228|NCT00283244|9352876|P1|Overall Study|Adverse Event|0
2718229|NCT00283062|9352912|P4|Overall Study|chemotherapy not completed (cycle 6)|0
2718230|NCT00283062|9352913|P3|Overall Study|chemotherapy not completed (cycle 6)|0
2718231|NCT00283062|9352914|P2|Overall Study|chemotherapy not completed (cycle 6)|0
2718232|NCT00283062|9352915|P1|Overall Study|chemotherapy not completed (cycle 6)|1
2718233|NCT00283062|9352912|P4|Overall Study|Undefined|4
2718234|NCT00283062|9352913|P3|Overall Study|Undefined|1
2718235|NCT00283062|9352914|P2|Overall Study|Undefined|1
2718236|NCT00283062|9352915|P1|Overall Study|Undefined|0
2718237|NCT00283062|9352912|P4|Overall Study|Participant did not wish to continue|0
2718238|NCT00283062|9352913|P3|Overall Study|Participant did not wish to continue|1
2718239|NCT00283062|9352914|P2|Overall Study|Participant did not wish to continue|2
2718240|NCT00283062|9352915|P1|Overall Study|Participant did not wish to continue|3
2718241|NCT00283062|9352912|P4|Overall Study|Progressive disease|0
2718242|NCT00283062|9352913|P3|Overall Study|Progressive disease|1
2718243|NCT00283062|9352914|P2|Overall Study|Progressive disease|0
2718244|NCT00283062|9352915|P1|Overall Study|Progressive disease|0
2718245|NCT00283062|9352912|P4|Overall Study|Lost to Follow-up|0
2718246|NCT00283062|9352913|P3|Overall Study|Lost to Follow-up|1
2718247|NCT00283062|9352914|P2|Overall Study|Lost to Follow-up|0
2718248|NCT00283062|9352915|P1|Overall Study|Lost to Follow-up|1
2718249|NCT00283062|9352912|P4|Overall Study|Adverse Event|0
2718250|NCT00283062|9352913|P3|Overall Study|Adverse Event|1
2718251|NCT00283062|9352914|P2|Overall Study|Adverse Event|0
2718252|NCT00283062|9352915|P1|Overall Study|Adverse Event|2
2718253|NCT00283062|9352912|P4|Overall Study|Did not receive any study medication|45
2718254|NCT00283062|9352913|P3|Overall Study|Did not receive any study medication|36
2718255|NCT00283062|9352914|P2|Overall Study|Did not receive any study medication|4
2718256|NCT00283062|9352915|P1|Overall Study|Did not receive any study medication|5
2718257|NCT00283049|9352948|P3|Overall Study|No longer requires study treatment|1
2718258|NCT00283049|9352949|P2|Overall Study|No longer requires study treatment|0
2718259|NCT00283049|9352950|P1|Overall Study|No longer requires study treatment|0
2718260|NCT00283049|9352948|P3|Overall Study|Discontinuation of Study|20
2718261|NCT00283049|9352949|P2|Overall Study|Discontinuation of Study|16
2718262|NCT00283049|9352950|P1|Overall Study|Discontinuation of Study|18
2718263|NCT00283049|9352948|P3|Overall Study|Withdrawal by Subject|19
2718264|NCT00283049|9352949|P2|Overall Study|Withdrawal by Subject|24
2718265|NCT00283049|9352950|P1|Overall Study|Withdrawal by Subject|26
2718266|NCT00283049|9352948|P3|Overall Study|Lost to Follow-up|5
2718267|NCT00283049|9352949|P2|Overall Study|Lost to Follow-up|2
2718268|NCT00283049|9352950|P1|Overall Study|Lost to Follow-up|4
2718269|NCT00283049|9352948|P3|Overall Study|Lack of Efficacy|1
2718270|NCT00283049|9352949|P2|Overall Study|Lack of Efficacy|1
2718271|NCT00283049|9352950|P1|Overall Study|Lack of Efficacy|0
2718272|NCT00283049|9352948|P3|Overall Study|Death|1
2718273|NCT00283049|9352949|P2|Overall Study|Death|1
2718274|NCT00283049|9352950|P1|Overall Study|Death|1
2718275|NCT00283049|9352948|P3|Overall Study|Protocol Violation|3
2718276|NCT00283049|9352949|P2|Overall Study|Protocol Violation|0
2718277|NCT00283049|9352950|P1|Overall Study|Protocol Violation|3
2718278|NCT00283049|9352948|P3|Overall Study|Adverse Event|4
2718279|NCT00283049|9352949|P2|Overall Study|Adverse Event|1
2718280|NCT00283049|9352950|P1|Overall Study|Adverse Event|6
2718281|NCT00282984|9352978|P2|Overall Study|Protocol Violation|0
2718282|NCT00282984|9352979|P1|Overall Study|Protocol Violation|2
2718283|NCT00282984|9352978|P2|Overall Study|in prison|1
2718284|NCT00282984|9352979|P1|Overall Study|in prison|0
2718285|NCT00282984|9352978|P2|Overall Study|lack of motivation|0
2718286|NCT00282984|9352979|P1|Overall Study|lack of motivation|1
2718287|NCT00282984|9352978|P2|Overall Study|Participant used antipsychosis meds|1
2718288|NCT00282984|9352979|P1|Overall Study|Participant used antipsychosis meds|0
2718289|NCT00282984|9352978|P2|Overall Study|Participant only allowed phone follow-up|1
2718290|NCT00282984|9352979|P1|Overall Study|Participant only allowed phone follow-up|0
2718291|NCT00282984|9352978|P2|Overall Study|Participant stopped study medication|2
2718292|NCT00282984|9352979|P1|Overall Study|Participant stopped study medication|2
2718293|NCT00282984|9352978|P2|Overall Study|Withdrawal by Participant|34
2718294|NCT00282984|9352979|P1|Overall Study|Withdrawal by Participant|22
2718295|NCT00282984|9352978|P2|Overall Study|Lost to Follow-up|10
2718296|NCT00282984|9352979|P1|Overall Study|Lost to Follow-up|14
2718297|NCT00282984|9352978|P2|Overall Study|Lack of Efficacy|2
2718298|NCT00282984|9352979|P1|Overall Study|Lack of Efficacy|0
2718299|NCT00282984|9352978|P2|Overall Study|Adverse Event|5
2718300|NCT00282984|9352979|P1|Overall Study|Adverse Event|8
2718301|NCT00282984|9352978|P2|Overall Study|Death|5
2718302|NCT00282984|9352979|P1|Overall Study|Death|2
2718303|NCT00282919|9353016|P1|Overall Study|Asymptomatic Parasitemia|2
2718304|NCT00282919|9353016|P1|Overall Study|Withdrawal by Subject|1
2718305|NCT00282919|9353016|P1|Overall Study|Lack of Efficacy|4
2718306|NCT00282867|9353031|P3|Overall Study|d/c prior to prim outcome, 3 m f/u done|0
2718307|NCT00282867|9353032|P2|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
2718308|NCT00282867|9353033|P1|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
2718309|NCT00282568|9353135|P1|Extended Treatment Period|Lost to Follow-up|2
2718310|NCT00282568|9353135|P1|Extended Treatment Period|Physician Decision|1
2718311|NCT00282568|9353135|P1|Extended Treatment Period|Non-compliance|4
2718312|NCT00282568|9353135|P1|Extended Treatment Period|Adverse Event|17
2718313|NCT00282568|9353135|P1|Pharmacokinetic Treatment Period|Enrolled erroneously|1
2718314|NCT00282568|9353135|P1|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2
2718315|NCT00282464|9353161|P2|Overall Study|dropped due to missed visits|1
2718316|NCT00282464|9353162|P1|Overall Study|dropped due to missed visits|0
2718317|NCT00282464|9353161|P2|Overall Study|dispensed wrong kit|1
2718318|NCT00282464|9353162|P1|Overall Study|dispensed wrong kit|0
2718319|NCT00282464|9353161|P2|Overall Study|family crisis|1
2718320|NCT00282464|9353162|P1|Overall Study|family crisis|0
2718321|NCT00282464|9353161|P2|Overall Study|patient incarcerated|1
2718322|NCT00282464|9353162|P1|Overall Study|patient incarcerated|0
2718323|NCT00282464|9353161|P2|Overall Study|patient no show|1
2718324|NCT00282464|9353162|P1|Overall Study|patient no show|0
2718325|NCT00282464|9353161|P2|Overall Study|patient non-compliant|0
2718326|NCT00282464|9353162|P1|Overall Study|patient non-compliant|3
2718327|NCT00282464|9353161|P2|Overall Study|Patient moved|0
2718328|NCT00282464|9353162|P1|Overall Study|Patient moved|1
2718329|NCT00282464|9353161|P2|Overall Study|Protocol Violation|7
2718330|NCT00282464|9353162|P1|Overall Study|Protocol Violation|0
2718331|NCT00282464|9353161|P2|Overall Study|laboratory abnormality|2
2718332|NCT00282464|9353162|P1|Overall Study|laboratory abnormality|1
2718333|NCT00282464|9353161|P2|Overall Study|Withdrawal by Subject|10
2718334|NCT00282464|9353162|P1|Overall Study|Withdrawal by Subject|24
2718335|NCT00282464|9353161|P2|Overall Study|Lost to Follow-up|10
2718336|NCT00282464|9353162|P1|Overall Study|Lost to Follow-up|10
2718337|NCT00282464|9353161|P2|Overall Study|Lack of Efficacy|8
2718338|NCT00282464|9353162|P1|Overall Study|Lack of Efficacy|8
2718339|NCT00282464|9353161|P2|Overall Study|Adverse Event|20
2718340|NCT00282464|9353162|P1|Overall Study|Adverse Event|26
2718341|NCT00282438|9353212|P2|Overall Study|Death|1
2718342|NCT00282438|9353213|P1|Overall Study|Death|0
2718343|NCT00282438|9353212|P2|Overall Study|Lack of Efficacy|0
2718344|NCT00282438|9353213|P1|Overall Study|Lack of Efficacy|1
2718345|NCT00282412|9353223|P1|Overall Study|Death|2
2718346|NCT00282347|9353229|P2|B Cell Follow-up Period|Reason Not Specified|0
2718347|NCT00282347|9353230|P1|B Cell Follow-up Period|Reason Not Specified|2
2718348|NCT00282347|9353229|P2|B Cell Follow-up Period|Physician Decision|0
2718349|NCT00282347|9353230|P1|B Cell Follow-up Period|Physician Decision|1
2718350|NCT00282347|9353229|P2|B Cell Follow-up Period|Withdrawal by Subject|0
2718351|NCT00282347|9353230|P1|B Cell Follow-up Period|Withdrawal by Subject|2
2718352|NCT00282347|9353229|P2|Safety Follow-up Period|Protocol Deviation|2
2718353|NCT00282347|9353230|P1|Safety Follow-up Period|Protocol Deviation|0
2718354|NCT00282347|9353229|P2|Safety Follow-up Period|Physician Decision|1
2718355|NCT00282347|9353230|P1|Safety Follow-up Period|Physician Decision|1
2718356|NCT00282347|9353229|P2|Safety Follow-up Period|Withdrawal by Subject|1
2718357|NCT00282347|9353230|P1|Safety Follow-up Period|Withdrawal by Subject|2
2718358|NCT00282347|9353229|P2|Safety Follow-up Period|Lost to Follow-up|2
2718359|NCT00282347|9353230|P1|Safety Follow-up Period|Lost to Follow-up|0
2718360|NCT00282347|9353229|P2|Treatment Period|Physician Decision|1
2718361|NCT00282347|9353230|P1|Treatment Period|Physician Decision|0
2718362|NCT00282347|9353229|P2|Treatment Period|Withdrawal by Subject|3
2718363|NCT00282347|9353230|P1|Treatment Period|Withdrawal by Subject|1
2718364|NCT00282347|9353229|P2|Treatment Period|Lost to Follow-up|5
2718365|NCT00282347|9353230|P1|Treatment Period|Lost to Follow-up|2
2718366|NCT00282347|9353229|P2|Treatment Period|Death|0
2718367|NCT00282347|9353230|P1|Treatment Period|Death|2
2718368|NCT00282334|9353256|P2|Overall Study|Withdrawal by Subject|5
2718369|NCT00282334|9353257|P1|Overall Study|Withdrawal by Subject|8
2718370|NCT00282308|9353265|P3|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12
2718371|NCT00282308|9353266|P2|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
2718372|NCT00282308|9353267|P1|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
2718373|NCT00282308|9353265|P3|Safety Follow-up Period|Physician Decision to Withdraw|1
2718374|NCT00282308|9353266|P2|Safety Follow-up Period|Physician Decision to Withdraw|0
2718375|NCT00282308|9353267|P1|Safety Follow-up Period|Physician Decision to Withdraw|0
2718376|NCT00282308|9353265|P3|Safety Follow-up Period|Lost to Follow-up|5
2718377|NCT00282308|9353266|P2|Safety Follow-up Period|Lost to Follow-up|0
2718378|NCT00282308|9353267|P1|Safety Follow-up Period|Lost to Follow-up|0
2718379|NCT00282308|9353265|P3|Safety Follow-up Period|Adverse Event|1
2718380|NCT00282308|9353266|P2|Safety Follow-up Period|Adverse Event|0
2718381|NCT00282308|9353267|P1|Safety Follow-up Period|Adverse Event|0
2718382|NCT00282308|9353265|P3|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1
2718383|NCT00282308|9353266|P2|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
2718384|NCT00282308|9353267|P1|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
2718385|NCT00282308|9353265|P3|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1
2718386|NCT00282308|9353266|P2|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
2718387|NCT00282308|9353267|P1|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
2718388|NCT00282308|9353265|P3|Optional Extension Re-treatment Period|Adverse Event|4
2718389|NCT00282308|9353266|P2|Optional Extension Re-treatment Period|Adverse Event|0
2718390|NCT00282308|9353267|P1|Optional Extension Re-treatment Period|Adverse Event|0
2718391|NCT00282308|9353265|P3|Treatment Period|Not Treated with Study Drug|0
2718392|NCT00282308|9353266|P2|Treatment Period|Not Treated with Study Drug|0
2718393|NCT00282308|9353267|P1|Treatment Period|Not Treated with Study Drug|1
2718394|NCT00282308|9353265|P3|Treatment Period|Adverse Event|0
2718395|NCT00282308|9353266|P2|Treatment Period|Adverse Event|2
2718396|NCT00282308|9353267|P1|Treatment Period|Adverse Event|0
2718397|NCT00282308|9353265|P3|Treatment Period|Subject/Guardian Decision to Withdraw|0
2718398|NCT00282308|9353266|P2|Treatment Period|Subject/Guardian Decision to Withdraw|4
2718399|NCT00282308|9353267|P1|Treatment Period|Subject/Guardian Decision to Withdraw|2
2718400|NCT00282308|9353265|P3|Treatment Period|Lost to Follow-up|0
2718401|NCT00282308|9353266|P2|Treatment Period|Lost to Follow-up|0
2718402|NCT00282308|9353267|P1|Treatment Period|Lost to Follow-up|1
2718403|NCT00282295|9353297|P3|Overall Study|Other|0
2718404|NCT00282295|9353298|P2|Overall Study|Other|1
2718405|NCT00282295|9353299|P1|Overall Study|Other|0
2718406|NCT00282295|9353297|P3|Overall Study|Lost to Follow-up|2
2718407|NCT00282295|9353298|P2|Overall Study|Lost to Follow-up|7
2718408|NCT00282295|9353299|P1|Overall Study|Lost to Follow-up|1
2718409|NCT00282295|9353297|P3|Overall Study|Withdrawal by Subject|4
2718410|NCT00282295|9353298|P2|Overall Study|Withdrawal by Subject|6
2718411|NCT00282295|9353299|P1|Overall Study|Withdrawal by Subject|2
2718412|NCT00282295|9353297|P3|Overall Study|Protocol Violation|1
2718413|NCT00282295|9353298|P2|Overall Study|Protocol Violation|2
2718414|NCT00282295|9353299|P1|Overall Study|Protocol Violation|0
2718415|NCT00282295|9353297|P3|Overall Study|Serious Adverse Events|1
2718416|NCT00282295|9353298|P2|Overall Study|Serious Adverse Events|0
2718417|NCT00282295|9353299|P1|Overall Study|Serious Adverse Events|0
2718418|NCT00282295|9353297|P3|Overall Study|Adverse Event|0
2718419|NCT00282295|9353298|P2|Overall Study|Adverse Event|1
2718420|NCT00282295|9353299|P1|Overall Study|Adverse Event|0
2718421|NCT00282256|9353354|P1|Extension Treatment Period|Adverse Event|2
2718422|NCT00282256|9353354|P1|Pharmacokinetic Treatment Period|Poor venous access|1
2718423|NCT00282243|9353375|P1|Extension Treatment Period|Physician Decision|1
2718424|NCT00282243|9353375|P1|Extension Treatment Period|Non-compliance|2
2718425|NCT00282243|9353375|P1|Extension Treatment Period|Withdrawal by Subject|4
2718426|NCT00282243|9353375|P1|Extension Treatment Period|Adverse Event|15
2718427|NCT00282243|9353375|P1|Pharmacokinetic Treatment Period|Withdrawal by Subject|2
2718428|NCT00282243|9353375|P1|Pharmacokinetic Treatment Period|Adverse Event|3
2718429|NCT00282152|9353401|P2|Overall Study|Withdrawal by Subject|0
2718430|NCT00282152|9353402|P1|Overall Study|Withdrawal by Subject|1
2718431|NCT00282113|9353423|P3|Overall Study|Removed at parents request|0
2718432|NCT00282113|9353424|P2|Overall Study|Removed at parents request|0
2718433|NCT00282113|9353425|P1|Overall Study|Removed at parents request|1
2718434|NCT00282087|9353439|P1|Overall Study|Death|1
2718435|NCT00282048|9353452|P1|Overall Study|Ongoing|1
2718436|NCT00282048|9353452|P1|Overall Study|Other|8
2718437|NCT00282048|9353452|P1|Overall Study|Withdrawal by Subject|1
2718438|NCT00282048|9353452|P1|Overall Study|Adverse Event|22
2718439|NCT00282048|9353452|P1|Overall Study|Lack of Efficacy|30
2718440|NCT00281957|9353466|P2|Overall Study|Refusal unrelated to adverse events|1
2718441|NCT00281957|9353467|P1|Overall Study|Refusal unrelated to adverse events|0
2718442|NCT00281957|9353466|P2|Overall Study|Did not start treatment|1
2718443|NCT00281957|9353467|P1|Overall Study|Did not start treatment|3
2718444|NCT00281957|9353466|P2|Overall Study|Not eligible|2
2718445|NCT00281957|9353467|P1|Overall Study|Not eligible|1
2718446|NCT00281957|9353466|P2|Overall Study|Not protocol specified|1
2718447|NCT00281957|9353467|P1|Overall Study|Not protocol specified|8
2718448|NCT00281957|9353466|P2|Overall Study|Progression/relapse|35
2718449|NCT00281957|9353467|P1|Overall Study|Progression/relapse|47
2718450|NCT00281957|9353466|P2|Overall Study|Death|0
2718451|NCT00281957|9353467|P1|Overall Study|Death|1
2718452|NCT00281957|9353466|P2|Overall Study|Adverse Event|2
2718453|NCT00281957|9353467|P1|Overall Study|Adverse Event|7
2718454|NCT00281840|9353541|P1|Overall Study|Complicating Disease|1
2718455|NCT00281840|9353541|P1|Overall Study|exceed maximum delay in treatment|1
2718456|NCT00281840|9353541|P1|Overall Study|Disease Progression|2
2718457|NCT00281840|9353541|P1|Overall Study|Withdrawal by Subject|3
2718458|NCT00281840|9353541|P1|Overall Study|Physician Decision|6
2718459|NCT00281840|9353541|P1|Overall Study|Adverse Event|12
2718460|NCT00281697|9353557|P2|Overall Study|Did not receive study drug|2
2718461|NCT00281697|9353558|P1|Overall Study|Did not receive study drug|3
2718462|NCT00281697|9353557|P2|Overall Study|Subject/guardian's decision to withdraw|6
2718463|NCT00281697|9353558|P1|Overall Study|Subject/guardian's decision to withdraw|33
2718464|NCT00281697|9353557|P2|Overall Study|Physician's decision to withdraw|12
2718465|NCT00281697|9353558|P1|Overall Study|Physician's decision to withdraw|15
2718466|NCT00281697|9353557|P2|Overall Study|Other|6
2718467|NCT00281697|9353558|P1|Overall Study|Other|5
2718468|NCT00281697|9353557|P2|Overall Study|Disease progression|149
2718469|NCT00281697|9353558|P1|Overall Study|Disease progression|279
2718470|NCT00281697|9353557|P2|Overall Study|Death|3
2718471|NCT00281697|9353558|P1|Overall Study|Death|8
2718472|NCT00281697|9353557|P2|Overall Study|Adverse Event|15
2718473|NCT00281697|9353558|P1|Overall Study|Adverse Event|54
2718474|NCT00281697|9353557|P2|Overall Study|> 60 days since last dose of study drug|4
2718475|NCT00281697|9353558|P1|Overall Study|> 60 days since last dose of study drug|4
2718476|NCT00281684|9353578|P4|Overall Study|Withdrawal by Subject|0
2718477|NCT00281684|9353579|P3|Overall Study|Withdrawal by Subject|0
2718478|NCT00281684|9353580|P2|Overall Study|Withdrawal by Subject|0
2718479|NCT00281684|9353581|P1|Overall Study|Withdrawal by Subject|1
2718480|NCT00281684|9353578|P4|Overall Study|Lost to Follow-up|0
2718481|NCT00281684|9353579|P3|Overall Study|Lost to Follow-up|1
2718482|NCT00281684|9353580|P2|Overall Study|Lost to Follow-up|0
2718483|NCT00281684|9353581|P1|Overall Study|Lost to Follow-up|0
2718484|NCT00281658|9353655|P3|Open-label Monotherapy Extension Phase|Withdrawal by Subject|1
2718485|NCT00281658|9353656|P2|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
2718486|NCT00281658|9353657|P1|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
2718487|NCT00281658|9353655|P3|Open-label Monotherapy Extension Phase|Lost to Follow-up|3
2718488|NCT00281658|9353656|P2|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
2718489|NCT00281658|9353657|P1|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
2718490|NCT00281658|9353655|P3|Open-label Monotherapy Extension Phase|Death|97
2718491|NCT00281658|9353656|P2|Open-label Monotherapy Extension Phase|Death|0
2718492|NCT00281658|9353657|P1|Open-label Monotherapy Extension Phase|Death|0
2718493|NCT00281658|9353655|P3|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
2718494|NCT00281658|9353656|P2|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|1
2718495|NCT00281658|9353657|P1|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
2718496|NCT00281658|9353655|P3|Double-blind, Randomized Phase|Participant Entered New Protocol|0
2718497|NCT00281658|9353656|P2|Double-blind, Randomized Phase|Participant Entered New Protocol|1
2718498|NCT00281658|9353657|P1|Double-blind, Randomized Phase|Participant Entered New Protocol|1
2718499|NCT00281658|9353655|P3|Double-blind, Randomized Phase|Withdrawal by Subject|0
2718500|NCT00281658|9353656|P2|Double-blind, Randomized Phase|Withdrawal by Subject|1
2718501|NCT00281658|9353657|P1|Double-blind, Randomized Phase|Withdrawal by Subject|4
2718502|NCT00281658|9353655|P3|Double-blind, Randomized Phase|Lost to Follow-up|0
2718503|NCT00281658|9353656|P2|Double-blind, Randomized Phase|Lost to Follow-up|5
2718504|NCT00281658|9353657|P1|Double-blind, Randomized Phase|Lost to Follow-up|12
2718505|NCT00281658|9353655|P3|Double-blind, Randomized Phase|Death|0
2718506|NCT00281658|9353656|P2|Double-blind, Randomized Phase|Death|46
2718507|NCT00281658|9353657|P1|Double-blind, Randomized Phase|Death|120
2718508|NCT00281632|9353674|P1|Overall Study|Ongoing|3
2718509|NCT00281632|9353674|P1|Overall Study|Physician Decision|1
2718510|NCT00281632|9353674|P1|Overall Study|Death|1
2718511|NCT00281632|9353674|P1|Overall Study|Disease Progression|22
2718512|NCT00281632|9353674|P1|Overall Study|Withdrawal by Subject|2
2718513|NCT00281632|9353674|P1|Overall Study|Adverse Event|7
2718514|NCT00281580|9353716|P16|Overall Study|Randomised in error; pregnancy; moving|2
2718515|NCT00281580|9353717|P15|Overall Study|Randomised in error; pregnancy; moving|1
2718516|NCT00281580|9353718|P14|Overall Study|Randomised in error; pregnancy; moving|0
2718517|NCT00281580|9353719|P13|Overall Study|Randomised in error; pregnancy; moving|2
2718518|NCT00281580|9353720|P12|Overall Study|Randomised in error; pregnancy; moving|1
2718519|NCT00281580|9353721|P11|Overall Study|Randomised in error; pregnancy; moving|1
2718520|NCT00281580|9353722|P10|Overall Study|Randomised in error; pregnancy; moving|1
2718521|NCT00281580|9353723|P9|Overall Study|Randomised in error; pregnancy; moving|2
2718522|NCT00281580|9353724|P8|Overall Study|Randomised in error; pregnancy; moving|0
2718523|NCT00281580|9353725|P7|Overall Study|Randomised in error; pregnancy; moving|1
2718524|NCT00281580|9353726|P6|Overall Study|Randomised in error; pregnancy; moving|0
2718525|NCT00281580|9353727|P5|Overall Study|Randomised in error; pregnancy; moving|0
2718526|NCT00281580|9353728|P4|Overall Study|Randomised in error; pregnancy; moving|2
2718527|NCT00281580|9353729|P3|Overall Study|Randomised in error; pregnancy; moving|0
2718528|NCT00281580|9353730|P2|Overall Study|Randomised in error; pregnancy; moving|0
2718529|NCT00281580|9353731|P1|Overall Study|Randomised in error; pregnancy; moving|0
2718530|NCT00281580|9353716|P16|Overall Study|Lost to Follow-up|0
2718531|NCT00281580|9353717|P15|Overall Study|Lost to Follow-up|0
2718532|NCT00281580|9353718|P14|Overall Study|Lost to Follow-up|0
2718533|NCT00281580|9353719|P13|Overall Study|Lost to Follow-up|1
2718534|NCT00281580|9353720|P12|Overall Study|Lost to Follow-up|0
2718535|NCT00281580|9353721|P11|Overall Study|Lost to Follow-up|1
2718536|NCT00281580|9353722|P10|Overall Study|Lost to Follow-up|1
2718537|NCT00281580|9353723|P9|Overall Study|Lost to Follow-up|2
2718538|NCT00281580|9353724|P8|Overall Study|Lost to Follow-up|1
2718539|NCT00281580|9353725|P7|Overall Study|Lost to Follow-up|0
2718540|NCT00281580|9353726|P6|Overall Study|Lost to Follow-up|1
2718541|NCT00281580|9353727|P5|Overall Study|Lost to Follow-up|0
2718542|NCT00281580|9353728|P4|Overall Study|Lost to Follow-up|3
2718543|NCT00281580|9353729|P3|Overall Study|Lost to Follow-up|0
2718544|NCT00281580|9353730|P2|Overall Study|Lost to Follow-up|0
2718545|NCT00281580|9353731|P1|Overall Study|Lost to Follow-up|0
2718546|NCT00281580|9353716|P16|Overall Study|Lack of Efficacy|0
2718547|NCT00281580|9353717|P15|Overall Study|Lack of Efficacy|1
2718548|NCT00281580|9353718|P14|Overall Study|Lack of Efficacy|2
2718549|NCT00281580|9353719|P13|Overall Study|Lack of Efficacy|0
2718550|NCT00281580|9353720|P12|Overall Study|Lack of Efficacy|1
2718551|NCT00281580|9353721|P11|Overall Study|Lack of Efficacy|0
2718552|NCT00281580|9353722|P10|Overall Study|Lack of Efficacy|0
2718553|NCT00281580|9353723|P9|Overall Study|Lack of Efficacy|0
2718554|NCT00281580|9353724|P8|Overall Study|Lack of Efficacy|0
2718555|NCT00281580|9353725|P7|Overall Study|Lack of Efficacy|0
2718556|NCT00281580|9353726|P6|Overall Study|Lack of Efficacy|0
2718557|NCT00281580|9353727|P5|Overall Study|Lack of Efficacy|2
2718558|NCT00281580|9353728|P4|Overall Study|Lack of Efficacy|6
2718559|NCT00281580|9353729|P3|Overall Study|Lack of Efficacy|1
2718560|NCT00281580|9353730|P2|Overall Study|Lack of Efficacy|1
2718561|NCT00281580|9353731|P1|Overall Study|Lack of Efficacy|2
2718562|NCT00281580|9353716|P16|Overall Study|Withdrawal by Subject|5
2718563|NCT00281580|9353717|P15|Overall Study|Withdrawal by Subject|1
2718564|NCT00281580|9353718|P14|Overall Study|Withdrawal by Subject|2
2718565|NCT00281580|9353719|P13|Overall Study|Withdrawal by Subject|2
2718566|NCT00281580|9353720|P12|Overall Study|Withdrawal by Subject|1
2718567|NCT00281580|9353721|P11|Overall Study|Withdrawal by Subject|1
2718568|NCT00281580|9353722|P10|Overall Study|Withdrawal by Subject|4
2718569|NCT00281580|9353723|P9|Overall Study|Withdrawal by Subject|1
2718570|NCT00281580|9353724|P8|Overall Study|Withdrawal by Subject|0
2718571|NCT00281580|9353725|P7|Overall Study|Withdrawal by Subject|2
2718572|NCT00281580|9353726|P6|Overall Study|Withdrawal by Subject|2
2718573|NCT00281580|9353727|P5|Overall Study|Withdrawal by Subject|1
2718574|NCT00281580|9353728|P4|Overall Study|Withdrawal by Subject|1
2718575|NCT00281580|9353729|P3|Overall Study|Withdrawal by Subject|1
2718576|NCT00281580|9353730|P2|Overall Study|Withdrawal by Subject|0
2718577|NCT00281580|9353731|P1|Overall Study|Withdrawal by Subject|3
2718578|NCT00281580|9353716|P16|Overall Study|Protocol Violation|3
2718579|NCT00281580|9353717|P15|Overall Study|Protocol Violation|1
2718580|NCT00281580|9353718|P14|Overall Study|Protocol Violation|1
2718581|NCT00281580|9353719|P13|Overall Study|Protocol Violation|0
2718582|NCT00281580|9353720|P12|Overall Study|Protocol Violation|2
2718583|NCT00281580|9353721|P11|Overall Study|Protocol Violation|1
2718584|NCT00281580|9353722|P10|Overall Study|Protocol Violation|0
2718585|NCT00281580|9353723|P9|Overall Study|Protocol Violation|2
2718586|NCT00281580|9353724|P8|Overall Study|Protocol Violation|0
2718587|NCT00281580|9353725|P7|Overall Study|Protocol Violation|1
2718588|NCT00281580|9353726|P6|Overall Study|Protocol Violation|0
2718589|NCT00281580|9353727|P5|Overall Study|Protocol Violation|0
2718590|NCT00281580|9353728|P4|Overall Study|Protocol Violation|1
2718591|NCT00281580|9353729|P3|Overall Study|Protocol Violation|1
2718592|NCT00281580|9353730|P2|Overall Study|Protocol Violation|0
2718593|NCT00281580|9353731|P1|Overall Study|Protocol Violation|0
2718594|NCT00281580|9353716|P16|Overall Study|Adverse Event|3
2718595|NCT00281580|9353717|P15|Overall Study|Adverse Event|3
2718596|NCT00281580|9353718|P14|Overall Study|Adverse Event|2
2718597|NCT00281580|9353719|P13|Overall Study|Adverse Event|8
2718598|NCT00281580|9353720|P12|Overall Study|Adverse Event|5
2718599|NCT00281580|9353721|P11|Overall Study|Adverse Event|0
2718600|NCT00281580|9353722|P10|Overall Study|Adverse Event|6
2718601|NCT00281580|9353723|P9|Overall Study|Adverse Event|1
2718602|NCT00281580|9353724|P8|Overall Study|Adverse Event|0
2718603|NCT00281580|9353725|P7|Overall Study|Adverse Event|1
2718604|NCT00281580|9353726|P6|Overall Study|Adverse Event|0
2718605|NCT00281580|9353727|P5|Overall Study|Adverse Event|1
2718606|NCT00281580|9353728|P4|Overall Study|Adverse Event|4
2718607|NCT00281580|9353729|P3|Overall Study|Adverse Event|2
2718608|NCT00281580|9353730|P2|Overall Study|Adverse Event|0
2718609|NCT00281580|9353731|P1|Overall Study|Adverse Event|2
2718610|NCT00281528|9354078|P3|Overall Study|Other|5
2718611|NCT00281528|9354079|P2|Overall Study|Other|3
2718612|NCT00281528|9354080|P1|Overall Study|Other|6
2718613|NCT00281528|9354078|P3|Overall Study|Withdrawal by Subject|7
2718614|NCT00281528|9354079|P2|Overall Study|Withdrawal by Subject|5
2718615|NCT00281528|9354080|P1|Overall Study|Withdrawal by Subject|5
2718616|NCT00281528|9354078|P3|Overall Study|Protocol Violation|1
2718617|NCT00281528|9354079|P2|Overall Study|Protocol Violation|0
2718618|NCT00281528|9354080|P1|Overall Study|Protocol Violation|1
2718619|NCT00281528|9354078|P3|Overall Study|Physician Decision|5
2718620|NCT00281528|9354079|P2|Overall Study|Physician Decision|4
2718621|NCT00281528|9354080|P1|Overall Study|Physician Decision|11
2718622|NCT00281528|9354078|P3|Overall Study|Adverse Event-unrelated to treatment|2
2718623|NCT00281528|9354079|P2|Overall Study|Adverse Event-unrelated to treatment|0
2718624|NCT00281528|9354080|P1|Overall Study|Adverse Event-unrelated to treatment|3
2718625|NCT00281528|9354078|P3|Overall Study|Unacceptable Toxicity-related to trt|32
2718626|NCT00281528|9354079|P2|Overall Study|Unacceptable Toxicity-related to trt|24
2718627|NCT00281528|9354080|P1|Overall Study|Unacceptable Toxicity-related to trt|21
2718628|NCT00281528|9354078|P3|Overall Study|Progressive Disease|27
2718629|NCT00281528|9354079|P2|Overall Study|Progressive Disease|18
2718630|NCT00281528|9354080|P1|Overall Study|Progressive Disease|28
2718631|NCT00281320|9354131|P2|Overall Study|Other|1
2718632|NCT00281320|9354132|P1|Overall Study|Other|3
2718633|NCT00281320|9354131|P2|Overall Study|Lost to Follow-up|2
2718634|NCT00281320|9354132|P1|Overall Study|Lost to Follow-up|1
2718635|NCT00281320|9354131|P2|Overall Study|Withdrawal by Subject|6
2718636|NCT00281320|9354132|P1|Overall Study|Withdrawal by Subject|5
2718637|NCT00281320|9354131|P2|Overall Study|Lack of Efficacy|3
2718638|NCT00281320|9354132|P1|Overall Study|Lack of Efficacy|4
2718639|NCT00281320|9354131|P2|Overall Study|Adverse Event|9
2718640|NCT00281320|9354132|P1|Overall Study|Adverse Event|12
2718641|NCT00281099|9354154|P2|Overall Study|Heart Transplant/Device Exit/Changeout|4
2718642|NCT00281099|9354155|P1|Overall Study|Heart Transplant/Device Exit/Changeout|5
2718643|NCT00281099|9354154|P2|Overall Study|Physician Decision|72
2718644|NCT00281099|9354155|P1|Overall Study|Physician Decision|79
2718645|NCT00281099|9354154|P2|Overall Study|Withdrawal by Subject|70
2718646|NCT00281099|9354155|P1|Overall Study|Withdrawal by Subject|65
2718647|NCT00281099|9354154|P2|Overall Study|Lost to Follow-up|19
2718648|NCT00281099|9354155|P1|Overall Study|Lost to Follow-up|10
2718649|NCT00281099|9354154|P2|Overall Study|Death|57
2718650|NCT00281099|9354155|P1|Overall Study|Death|46
2718651|NCT00280917|9354204|P4|Overall Study|Noncompliance|0
2718652|NCT00280917|9354205|P3|Overall Study|Noncompliance|2
2718653|NCT00280917|9354206|P2|Overall Study|Noncompliance|1
2718654|NCT00280917|9354207|P1|Overall Study|Noncompliance|0
2718655|NCT00280917|9354204|P4|Overall Study|Withdrawal by Subject|1
2718656|NCT00280917|9354205|P3|Overall Study|Withdrawal by Subject|0
2718657|NCT00280917|9354206|P2|Overall Study|Withdrawal by Subject|2
2718658|NCT00280917|9354207|P1|Overall Study|Withdrawal by Subject|0
2718659|NCT00280917|9354204|P4|Overall Study|Change Therapy|0
2718660|NCT00280917|9354205|P3|Overall Study|Change Therapy|0
2718661|NCT00280917|9354206|P2|Overall Study|Change Therapy|2
2718662|NCT00280917|9354207|P1|Overall Study|Change Therapy|1
2718663|NCT00280917|9354204|P4|Overall Study|Adverse Event|1
2718664|NCT00280917|9354205|P3|Overall Study|Adverse Event|4
2718665|NCT00280917|9354206|P2|Overall Study|Adverse Event|1
2718666|NCT00280917|9354207|P1|Overall Study|Adverse Event|1
2718667|NCT00280748|9354230|P1|Overall Study|Extra-cranial disease progression|1
2718668|NCT00280748|9354230|P1|Overall Study|Decline in performance|3
2718669|NCT00280735|9354240|P1|Overall Study|Intercurrent Illness|2
2718670|NCT00280735|9354240|P1|Overall Study|Withdrawal by Subject|8
2718671|NCT00280735|9354240|P1|Overall Study|Lack of Efficacy|3
2718672|NCT00280735|9354240|P1|Overall Study|Adverse Event|5
2718673|NCT00280683|9354252|P2|Overall Study|Adverse Event|1
2718674|NCT00280683|9354253|P1|Overall Study|Adverse Event|1
2718675|NCT00280683|9354252|P2|Overall Study|Withdrawal by Subject|2
2718676|NCT00280683|9354253|P1|Overall Study|Withdrawal by Subject|1
2718677|NCT00280566|9354263|P3|Period 2 Double Blind|miscellaneous|5
2718678|NCT00280566|9354264|P2|Period 2 Double Blind|miscellaneous|10
2718679|NCT00280566|9354265|P1|Period 2 Double Blind|miscellaneous|0
2718680|NCT00280566|9354263|P3|Period 2 Double Blind|Withdrawal by Subject|9
2718681|NCT00280566|9354264|P2|Period 2 Double Blind|Withdrawal by Subject|9
2718682|NCT00280566|9354265|P1|Period 2 Double Blind|Withdrawal by Subject|0
2718683|NCT00280566|9354263|P3|Period 2 Double Blind|Lost to Follow-up|6
2718684|NCT00280566|9354264|P2|Period 2 Double Blind|Lost to Follow-up|3
2718685|NCT00280566|9354265|P1|Period 2 Double Blind|Lost to Follow-up|0
2718686|NCT00280566|9354263|P3|Period 2 Double Blind|Adverse Event|15
2718687|NCT00280566|9354264|P2|Period 2 Double Blind|Adverse Event|11
2718688|NCT00280566|9354265|P1|Period 2 Double Blind|Adverse Event|0
2718689|NCT00280566|9354263|P3|Period 2 Double Blind|Laboratory Abnormality|0
2718690|NCT00280566|9354264|P2|Period 2 Double Blind|Laboratory Abnormality|1
2718691|NCT00280566|9354265|P1|Period 2 Double Blind|Laboratory Abnormality|0
2718692|NCT00280566|9354263|P3|Period 2 Double Blind|Lack of Efficacy|22
2718693|NCT00280566|9354264|P2|Period 2 Double Blind|Lack of Efficacy|9
2718694|NCT00280566|9354265|P1|Period 2 Double Blind|Lack of Efficacy|0
2718695|NCT00280566|9354263|P3|Period 1 Open Label Ziprasidone|Miscellaneous|0
2718696|NCT00280566|9354264|P2|Period 1 Open Label Ziprasidone|Miscellaneous|0
2718697|NCT00280566|9354265|P1|Period 1 Open Label Ziprasidone|Miscellaneous|50
2718698|NCT00280566|9354263|P3|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
2718699|NCT00280566|9354264|P2|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
2718700|NCT00280566|9354265|P1|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76
2718701|NCT00280566|9354263|P3|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
2718702|NCT00280566|9354264|P2|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
2718703|NCT00280566|9354265|P1|Period 1 Open Label Ziprasidone|Lost to Follow-up|35
2718704|NCT00280566|9354263|P3|Period 1 Open Label Ziprasidone|Adverse Event|0
2718705|NCT00280566|9354264|P2|Period 1 Open Label Ziprasidone|Adverse Event|0
2718706|NCT00280566|9354265|P1|Period 1 Open Label Ziprasidone|Adverse Event|148
2718707|NCT00280566|9354263|P3|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
2718708|NCT00280566|9354264|P2|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
2718709|NCT00280566|9354265|P1|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3
2718710|NCT00280566|9354263|P3|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
2718711|NCT00280566|9354264|P2|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
2718712|NCT00280566|9354265|P1|Period 1 Open Label Ziprasidone|Lack of Efficacy|31
2718713|NCT00280397|9354290|P1|Overall Study|Adverse Event|1
2718714|NCT00280293|9354356|P2|Overall Study|Adverse Event|1
2718715|NCT00280293|9354357|P1|Overall Study|Adverse Event|0
2718716|NCT00280293|9354356|P2|Overall Study|Incarceration/Legal Reasons|1
2718717|NCT00280293|9354357|P1|Overall Study|Incarceration/Legal Reasons|1
2718718|NCT00280293|9354356|P2|Overall Study|Withdrawal by Subject|5
2718719|NCT00280293|9354357|P1|Overall Study|Withdrawal by Subject|3
2718720|NCT00280293|9354356|P2|Overall Study|Lost to Follow-up|12
2718721|NCT00280293|9354357|P1|Overall Study|Lost to Follow-up|14
2718722|NCT00280293|9354356|P2|Overall Study|Physician Decision|4
2718723|NCT00280293|9354357|P1|Overall Study|Physician Decision|5
2718724|NCT00280293|9354356|P2|Overall Study|Protocol Violation|0
2718725|NCT00280293|9354357|P1|Overall Study|Protocol Violation|3
2718726|NCT00280150|9354380|P4|Overall Study|Declining Performance Status|1
2718727|NCT00280150|9354381|P3|Overall Study|Declining Performance Status|0
2718728|NCT00280150|9354382|P2|Overall Study|Declining Performance Status|0
2718729|NCT00280150|9354383|P1|Overall Study|Declining Performance Status|0
2718730|NCT00280150|9354380|P4|Overall Study|Did not get consolidation therapy|0
2718731|NCT00280150|9354381|P3|Overall Study|Did not get consolidation therapy|3
2718732|NCT00280150|9354382|P2|Overall Study|Did not get consolidation therapy|0
2718733|NCT00280150|9354383|P1|Overall Study|Did not get consolidation therapy|3
2718734|NCT00280150|9354380|P4|Overall Study|Withdrawal by Subject|1
2718735|NCT00280150|9354381|P3|Overall Study|Withdrawal by Subject|0
2718736|NCT00280150|9354382|P2|Overall Study|Withdrawal by Subject|0
2718737|NCT00280150|9354383|P1|Overall Study|Withdrawal by Subject|0
2718738|NCT00280150|9354380|P4|Overall Study|Protocol Violation|1
2718739|NCT00280150|9354381|P3|Overall Study|Protocol Violation|0
2718740|NCT00280150|9354382|P2|Overall Study|Protocol Violation|0
2718741|NCT00280150|9354383|P1|Overall Study|Protocol Violation|0
2718742|NCT00280150|9354380|P4|Overall Study|Physician Decision|1
2718743|NCT00280150|9354381|P3|Overall Study|Physician Decision|0
2718744|NCT00280150|9354382|P2|Overall Study|Physician Decision|0
2718745|NCT00280150|9354383|P1|Overall Study|Physician Decision|0
2718746|NCT00280150|9354380|P4|Overall Study|Lack of Efficacy|3
2718747|NCT00280150|9354381|P3|Overall Study|Lack of Efficacy|0
2718748|NCT00280150|9354382|P2|Overall Study|Lack of Efficacy|0
2718749|NCT00280150|9354383|P1|Overall Study|Lack of Efficacy|0
2718750|NCT00280150|9354380|P4|Overall Study|Adverse Event|3
2718751|NCT00280150|9354381|P3|Overall Study|Adverse Event|2
2718752|NCT00280150|9354382|P2|Overall Study|Adverse Event|1
2718753|NCT00280150|9354383|P1|Overall Study|Adverse Event|0
2718754|NCT00280059|9354398|P2|Efficacy Assessment Phase|Withdrawal by Subject|25
2718755|NCT00280059|9354399|P1|Efficacy Assessment Phase|Withdrawal by Subject|26
2718756|NCT00280059|9354398|P2|Efficacy Assessment Phase|Other|8
2718757|NCT00280059|9354399|P1|Efficacy Assessment Phase|Other|7
2718758|NCT00280059|9354398|P2|Efficacy Assessment Phase|Lost to Follow-up|13
2718759|NCT00280059|9354399|P1|Efficacy Assessment Phase|Lost to Follow-up|6
2718760|NCT00280059|9354398|P2|Efficacy Assessment Phase|Lack of Efficacy|3
2718761|NCT00280059|9354399|P1|Efficacy Assessment Phase|Lack of Efficacy|19
2718762|NCT00280059|9354398|P2|Efficacy Assessment Phase|Laboratory abnormaility|0
2718763|NCT00280059|9354399|P1|Efficacy Assessment Phase|Laboratory abnormaility|1
2718764|NCT00280059|9354398|P2|Efficacy Assessment Phase|Adverse Event|31
2718765|NCT00280059|9354399|P1|Efficacy Assessment Phase|Adverse Event|33
2718766|NCT00280059|9354398|P2|Efficacy Assessment Phase|Death|0
2718767|NCT00280059|9354399|P1|Efficacy Assessment Phase|Death|2
2718768|NCT00279916|9354463|P2|Overall Study|Lost to Follow-up|2
2718769|NCT00279916|9354464|P1|Overall Study|Lost to Follow-up|3
2718770|NCT00279916|9354463|P2|Overall Study|Withdrawal by Subject|3
2718771|NCT00279916|9354464|P1|Overall Study|Withdrawal by Subject|4
2718772|NCT00279812|9354490|P6|Overall Study|Adverse Event|1
2718773|NCT00279812|9354491|P5|Overall Study|Adverse Event|2
2718774|NCT00279812|9354492|P4|Overall Study|Adverse Event|0
2718775|NCT00279812|9354493|P3|Overall Study|Adverse Event|1
2718776|NCT00279812|9354494|P2|Overall Study|Adverse Event|1
2718777|NCT00279812|9354495|P1|Overall Study|Adverse Event|0
2718778|NCT00279812|9354490|P6|Overall Study|Withdrawal by Subject|0
2718779|NCT00279812|9354491|P5|Overall Study|Withdrawal by Subject|0
2718780|NCT00279812|9354492|P4|Overall Study|Withdrawal by Subject|0
2718781|NCT00279812|9354493|P3|Overall Study|Withdrawal by Subject|2
2718782|NCT00279812|9354494|P2|Overall Study|Withdrawal by Subject|4
2718783|NCT00279812|9354495|P1|Overall Study|Withdrawal by Subject|0
2718784|NCT00279812|9354490|P6|Overall Study|Protocol Violation|0
2718785|NCT00279812|9354491|P5|Overall Study|Protocol Violation|1
2718786|NCT00279812|9354492|P4|Overall Study|Protocol Violation|0
2718787|NCT00279812|9354493|P3|Overall Study|Protocol Violation|0
2718788|NCT00279812|9354494|P2|Overall Study|Protocol Violation|1
2718789|NCT00279812|9354495|P1|Overall Study|Protocol Violation|1
2718790|NCT00279708|9354523|P2|Overall Study|Adverse Event|1
2718791|NCT00279708|9354524|P1|Overall Study|Adverse Event|1
2718792|NCT00279708|9354523|P2|Overall Study|Withdrawal by Subject|3
2718793|NCT00279708|9354524|P1|Overall Study|Withdrawal by Subject|2
2718794|NCT00279305|9354553|P2|Overall Study|FDA Safety Alert|1
2718795|NCT00279305|9354554|P1|Overall Study|FDA Safety Alert|4
2718796|NCT00279305|9354553|P2|Overall Study|Dificulting establishing IV|0
2718797|NCT00279305|9354554|P1|Overall Study|Dificulting establishing IV|1
2718798|NCT00279305|9354553|P2|Overall Study|Withdrawal by Subject|0
2718799|NCT00279305|9354554|P1|Overall Study|Withdrawal by Subject|2
2718800|NCT00279305|9354553|P2|Overall Study|Pregnancy|0
2718801|NCT00279305|9354554|P1|Overall Study|Pregnancy|1
2718802|NCT00279214|9354562|P2|Overall Study|Physician Decision|2
2718803|NCT00279214|9354563|P1|Overall Study|Physician Decision|3
2718804|NCT00279201|9354593|P6|Intensification Addendum|Death|0
2718805|NCT00279201|9354594|P5|Intensification Addendum|Death|1
2718806|NCT00279201|9354595|P4|Intensification Addendum|Death|0
2718807|NCT00279201|9354596|P3|Intensification Addendum|Death|0
2718808|NCT00279201|9354597|P2|Intensification Addendum|Death|0
2718809|NCT00279201|9354598|P1|Intensification Addendum|Death|0
2718810|NCT00279201|9354593|P6|Intensification Addendum|Lack of Efficacy|0
2718811|NCT00279201|9354594|P5|Intensification Addendum|Lack of Efficacy|1
2718812|NCT00279201|9354595|P4|Intensification Addendum|Lack of Efficacy|1
2718813|NCT00279201|9354596|P3|Intensification Addendum|Lack of Efficacy|0
2718814|NCT00279201|9354597|P2|Intensification Addendum|Lack of Efficacy|0
2718815|NCT00279201|9354598|P1|Intensification Addendum|Lack of Efficacy|0
2718816|NCT00279201|9354593|P6|Intensification Addendum|Entry Criteria Exclusion|0
2718817|NCT00279201|9354594|P5|Intensification Addendum|Entry Criteria Exclusion|0
2718818|NCT00279201|9354595|P4|Intensification Addendum|Entry Criteria Exclusion|0
2718819|NCT00279201|9354596|P3|Intensification Addendum|Entry Criteria Exclusion|1
2718820|NCT00279201|9354597|P2|Intensification Addendum|Entry Criteria Exclusion|0
2718821|NCT00279201|9354598|P1|Intensification Addendum|Entry Criteria Exclusion|0
2718822|NCT00279201|9354593|P6|Intensification Addendum|Sponsor Decision|1
2718823|NCT00279201|9354594|P5|Intensification Addendum|Sponsor Decision|1
2718824|NCT00279201|9354595|P4|Intensification Addendum|Sponsor Decision|0
2718825|NCT00279201|9354596|P3|Intensification Addendum|Sponsor Decision|0
2718826|NCT00279201|9354597|P2|Intensification Addendum|Sponsor Decision|0
2718827|NCT00279201|9354598|P1|Intensification Addendum|Sponsor Decision|0
2718828|NCT00279201|9354593|P6|Intensification Addendum|Physician Decision|2
2718829|NCT00279201|9354594|P5|Intensification Addendum|Physician Decision|3
2718830|NCT00279201|9354595|P4|Intensification Addendum|Physician Decision|1
2718831|NCT00279201|9354596|P3|Intensification Addendum|Physician Decision|4
2718832|NCT00279201|9354597|P2|Intensification Addendum|Physician Decision|0
2718833|NCT00279201|9354598|P1|Intensification Addendum|Physician Decision|0
2718834|NCT00279201|9354593|P6|Intensification Addendum|Adverse Event|3
2718835|NCT00279201|9354594|P5|Intensification Addendum|Adverse Event|1
2718836|NCT00279201|9354595|P4|Intensification Addendum|Adverse Event|4
2718837|NCT00279201|9354596|P3|Intensification Addendum|Adverse Event|0
2718838|NCT00279201|9354597|P2|Intensification Addendum|Adverse Event|0
2718839|NCT00279201|9354598|P1|Intensification Addendum|Adverse Event|0
2718840|NCT00279201|9354593|P6|Intensification Addendum|Protocol Violation|6
2718841|NCT00279201|9354594|P5|Intensification Addendum|Protocol Violation|6
2718842|NCT00279201|9354595|P4|Intensification Addendum|Protocol Violation|2
2718843|NCT00279201|9354596|P3|Intensification Addendum|Protocol Violation|2
2718844|NCT00279201|9354597|P2|Intensification Addendum|Protocol Violation|0
2718845|NCT00279201|9354598|P1|Intensification Addendum|Protocol Violation|0
2718846|NCT00279201|9354593|P6|Intensification Addendum|Lost to Follow-up|7
2718847|NCT00279201|9354594|P5|Intensification Addendum|Lost to Follow-up|7
2718848|NCT00279201|9354595|P4|Intensification Addendum|Lost to Follow-up|6
2718849|NCT00279201|9354596|P3|Intensification Addendum|Lost to Follow-up|4
2718850|NCT00279201|9354597|P2|Intensification Addendum|Lost to Follow-up|0
2718851|NCT00279201|9354598|P1|Intensification Addendum|Lost to Follow-up|0
2718852|NCT00279201|9354593|P6|Intensification Addendum|Withdrawal by Subject|18
2718853|NCT00279201|9354594|P5|Intensification Addendum|Withdrawal by Subject|9
2718854|NCT00279201|9354595|P4|Intensification Addendum|Withdrawal by Subject|14
2718855|NCT00279201|9354596|P3|Intensification Addendum|Withdrawal by Subject|12
2718856|NCT00279201|9354597|P2|Intensification Addendum|Withdrawal by Subject|0
2718857|NCT00279201|9354598|P1|Intensification Addendum|Withdrawal by Subject|0
2718858|NCT00279201|9354593|P6|Maintenance|HbA1c>7.5%|0
2718859|NCT00279201|9354594|P5|Maintenance|HbA1c>7.5%|0
2718860|NCT00279201|9354595|P4|Maintenance|HbA1c>7.5%|0
2718861|NCT00279201|9354596|P3|Maintenance|HbA1c>7.5%|0
2718862|NCT00279201|9354597|P2|Maintenance|HbA1c>7.5%|126
2718863|NCT00279201|9354598|P1|Maintenance|HbA1c>7.5%|123
2718864|NCT00279201|9354593|P6|Maintenance|Sponsor Decision|0
2718865|NCT00279201|9354594|P5|Maintenance|Sponsor Decision|0
2718866|NCT00279201|9354595|P4|Maintenance|Sponsor Decision|0
2718867|NCT00279201|9354596|P3|Maintenance|Sponsor Decision|0
2718868|NCT00279201|9354597|P2|Maintenance|Sponsor Decision|0
2718869|NCT00279201|9354598|P1|Maintenance|Sponsor Decision|4
2718870|NCT00279201|9354593|P6|Maintenance|Physician Decision|0
2718871|NCT00279201|9354594|P5|Maintenance|Physician Decision|0
2718872|NCT00279201|9354595|P4|Maintenance|Physician Decision|0
2718873|NCT00279201|9354596|P3|Maintenance|Physician Decision|0
2718874|NCT00279201|9354597|P2|Maintenance|Physician Decision|9
2718875|NCT00279201|9354598|P1|Maintenance|Physician Decision|9
2718876|NCT00279201|9354593|P6|Maintenance|Withdrawal by Subject|0
2718877|NCT00279201|9354594|P5|Maintenance|Withdrawal by Subject|0
2718878|NCT00279201|9354595|P4|Maintenance|Withdrawal by Subject|0
2718879|NCT00279201|9354596|P3|Maintenance|Withdrawal by Subject|0
2718880|NCT00279201|9354597|P2|Maintenance|Withdrawal by Subject|18
2718881|NCT00279201|9354598|P1|Maintenance|Withdrawal by Subject|18
2718882|NCT00279201|9354593|P6|Maintenance|Protocol Violation|0
2718883|NCT00279201|9354594|P5|Maintenance|Protocol Violation|0
2718884|NCT00279201|9354595|P4|Maintenance|Protocol Violation|0
2718885|NCT00279201|9354596|P3|Maintenance|Protocol Violation|0
2718886|NCT00279201|9354597|P2|Maintenance|Protocol Violation|24
2718887|NCT00279201|9354598|P1|Maintenance|Protocol Violation|16
2718888|NCT00279201|9354593|P6|Maintenance|Entry Criteria Exclusion|0
2718889|NCT00279201|9354594|P5|Maintenance|Entry Criteria Exclusion|0
2718890|NCT00279201|9354595|P4|Maintenance|Entry Criteria Exclusion|0
2718891|NCT00279201|9354596|P3|Maintenance|Entry Criteria Exclusion|0
2718892|NCT00279201|9354597|P2|Maintenance|Entry Criteria Exclusion|4
2718893|NCT00279201|9354598|P1|Maintenance|Entry Criteria Exclusion|1
2718894|NCT00279201|9354593|P6|Maintenance|Lost to Follow-up|0
2718895|NCT00279201|9354594|P5|Maintenance|Lost to Follow-up|0
2718896|NCT00279201|9354595|P4|Maintenance|Lost to Follow-up|0
2718897|NCT00279201|9354596|P3|Maintenance|Lost to Follow-up|0
2718898|NCT00279201|9354597|P2|Maintenance|Lost to Follow-up|13
2718899|NCT00279201|9354598|P1|Maintenance|Lost to Follow-up|17
2718900|NCT00279201|9354593|P6|Maintenance|Death|0
2718901|NCT00279201|9354594|P5|Maintenance|Death|0
2718902|NCT00279201|9354595|P4|Maintenance|Death|0
2718903|NCT00279201|9354596|P3|Maintenance|Death|0
2718904|NCT00279201|9354597|P2|Maintenance|Death|4
2718905|NCT00279201|9354598|P1|Maintenance|Death|4
2718906|NCT00279201|9354593|P6|Maintenance|Adverse Event|0
2718907|NCT00279201|9354594|P5|Maintenance|Adverse Event|0
2718908|NCT00279201|9354595|P4|Maintenance|Adverse Event|0
2718909|NCT00279201|9354596|P3|Maintenance|Adverse Event|0
2718910|NCT00279201|9354597|P2|Maintenance|Adverse Event|4
2718911|NCT00279201|9354598|P1|Maintenance|Adverse Event|4
2718912|NCT00279201|9354593|P6|Maintenance|Discontinuation Antihyperglycemic Drugs|0
2718913|NCT00279201|9354594|P5|Maintenance|Discontinuation Antihyperglycemic Drugs|0
2718914|NCT00279201|9354595|P4|Maintenance|Discontinuation Antihyperglycemic Drugs|0
2718915|NCT00279201|9354596|P3|Maintenance|Discontinuation Antihyperglycemic Drugs|0
2718916|NCT00279201|9354597|P2|Maintenance|Discontinuation Antihyperglycemic Drugs|2
2718917|NCT00279201|9354598|P1|Maintenance|Discontinuation Antihyperglycemic Drugs|3
2718918|NCT00279201|9354593|P6|Maintenance|Lack of Efficacy|0
2718919|NCT00279201|9354594|P5|Maintenance|Lack of Efficacy|0
2718920|NCT00279201|9354595|P4|Maintenance|Lack of Efficacy|0
2718921|NCT00279201|9354596|P3|Maintenance|Lack of Efficacy|0
2718922|NCT00279201|9354597|P2|Maintenance|Lack of Efficacy|30
2718923|NCT00279201|9354598|P1|Maintenance|Lack of Efficacy|32
2718924|NCT00279201|9354593|P6|Initiation|Discontinuation Oral Antihyperglycemics|0
2718925|NCT00279201|9354594|P5|Initiation|Discontinuation Oral Antihyperglycemics|0
2718926|NCT00279201|9354595|P4|Initiation|Discontinuation Oral Antihyperglycemics|0
2718927|NCT00279201|9354596|P3|Initiation|Discontinuation Oral Antihyperglycemics|0
2718928|NCT00279201|9354597|P2|Initiation|Discontinuation Oral Antihyperglycemics|1
2718929|NCT00279201|9354598|P1|Initiation|Discontinuation Oral Antihyperglycemics|0
2718930|NCT00279201|9354593|P6|Initiation|Sponsor Decision|0
2718931|NCT00279201|9354594|P5|Initiation|Sponsor Decision|0
2718932|NCT00279201|9354595|P4|Initiation|Sponsor Decision|0
2718933|NCT00279201|9354596|P3|Initiation|Sponsor Decision|0
2718934|NCT00279201|9354597|P2|Initiation|Sponsor Decision|5
2718935|NCT00279201|9354598|P1|Initiation|Sponsor Decision|13
2718936|NCT00279201|9354593|P6|Initiation|Physician Decision|0
2718937|NCT00279201|9354594|P5|Initiation|Physician Decision|0
2718938|NCT00279201|9354595|P4|Initiation|Physician Decision|0
2718939|NCT00279201|9354596|P3|Initiation|Physician Decision|0
2718940|NCT00279201|9354597|P2|Initiation|Physician Decision|18
2718941|NCT00279201|9354598|P1|Initiation|Physician Decision|15
2718942|NCT00279201|9354593|P6|Initiation|Withdrawal by Subject|0
2718943|NCT00279201|9354594|P5|Initiation|Withdrawal by Subject|0
2718944|NCT00279201|9354595|P4|Initiation|Withdrawal by Subject|0
2718945|NCT00279201|9354596|P3|Initiation|Withdrawal by Subject|0
2718946|NCT00279201|9354597|P2|Initiation|Withdrawal by Subject|41
2718947|NCT00279201|9354598|P1|Initiation|Withdrawal by Subject|35
2718948|NCT00279201|9354593|P6|Initiation|Protocol Violation|0
2718949|NCT00279201|9354594|P5|Initiation|Protocol Violation|0
2718950|NCT00279201|9354595|P4|Initiation|Protocol Violation|0
2718951|NCT00279201|9354596|P3|Initiation|Protocol Violation|0
2718952|NCT00279201|9354597|P2|Initiation|Protocol Violation|10
2718953|NCT00279201|9354598|P1|Initiation|Protocol Violation|9
2718954|NCT00279201|9354593|P6|Initiation|Entry Criteria Exclusion|0
2718955|NCT00279201|9354594|P5|Initiation|Entry Criteria Exclusion|0
2718956|NCT00279201|9354595|P4|Initiation|Entry Criteria Exclusion|0
2718957|NCT00279201|9354596|P3|Initiation|Entry Criteria Exclusion|0
2718958|NCT00279201|9354597|P2|Initiation|Entry Criteria Exclusion|9
2718959|NCT00279201|9354598|P1|Initiation|Entry Criteria Exclusion|7
2718960|NCT00279201|9354593|P6|Initiation|Lost to Follow-up|0
2718961|NCT00279201|9354594|P5|Initiation|Lost to Follow-up|0
2718962|NCT00279201|9354595|P4|Initiation|Lost to Follow-up|0
2718963|NCT00279201|9354596|P3|Initiation|Lost to Follow-up|0
2718964|NCT00279201|9354597|P2|Initiation|Lost to Follow-up|41
2718965|NCT00279201|9354598|P1|Initiation|Lost to Follow-up|42
2718966|NCT00279201|9354593|P6|Initiation|Adverse Event|0
2718967|NCT00279201|9354594|P5|Initiation|Adverse Event|0
2718968|NCT00279201|9354595|P4|Initiation|Adverse Event|0
2718969|NCT00279201|9354596|P3|Initiation|Adverse Event|0
2718970|NCT00279201|9354597|P2|Initiation|Adverse Event|15
2718971|NCT00279201|9354598|P1|Initiation|Adverse Event|6
2718972|NCT00279201|9354593|P6|Initiation|Death|0
2718973|NCT00279201|9354594|P5|Initiation|Death|0
2718974|NCT00279201|9354595|P4|Initiation|Death|0
2718975|NCT00279201|9354596|P3|Initiation|Death|0
2718976|NCT00279201|9354597|P2|Initiation|Death|5
2718977|NCT00279201|9354598|P1|Initiation|Death|1
2718978|NCT00278993|9354742|P1|Overall Study|Not Otherwise Specified|4
2718979|NCT00278993|9354742|P1|Overall Study|Physician Decision|9
2718980|NCT00278993|9354742|P1|Overall Study|Progressive Disease|65
2718981|NCT00278993|9354742|P1|Overall Study|Withdrawal by Subject|5
2718982|NCT00278993|9354742|P1|Overall Study|Adverse Event|24
2718983|NCT00278954|9354750|P1|Overall Study|Withdrawal by Subject|1
2718984|NCT00278954|9354750|P1|Overall Study|Lost to Follow-up|1
2718985|NCT00278954|9354750|P1|Overall Study|Adverse Event|3
2718986|NCT00278915|9354758|P1|Overall Study|Lack of Efficacy|1
2718987|NCT00278889|9354794|P3|Overall Study|Death|17
2718988|NCT00278889|9354795|P2|Overall Study|Death|21
2718989|NCT00278889|9354796|P1|Overall Study|Death|24
2718990|NCT00278889|9354794|P3|Overall Study|Lost to Follow-up|0
2718991|NCT00278889|9354795|P2|Overall Study|Lost to Follow-up|1
2718992|NCT00278889|9354796|P1|Overall Study|Lost to Follow-up|1
2718993|NCT00278889|9354794|P3|Overall Study|Withdrawal by Subject|3
2718994|NCT00278889|9354795|P2|Overall Study|Withdrawal by Subject|5
2718995|NCT00278889|9354796|P1|Overall Study|Withdrawal by Subject|0
2718996|NCT00278564|9354844|P1|Overall Study|Lack of Efficacy|4
2718997|NCT00278512|9354865|P2|Overall Study|Death|0
2718998|NCT00278512|9354866|P1|Overall Study|Death|1
2718999|NCT00278473|9354874|P2|Overall Study|drop out|3
2719000|NCT00278473|9354875|P1|Overall Study|drop out|4
2719001|NCT00278395|9354891|P1|Overall Study|Nonevaluable|1
2719002|NCT00278395|9354891|P1|Overall Study|Adverse Event|2
2719003|NCT00278200|9354909|P2|Overall Study|Physician Decision|1
2719004|NCT00278200|9354910|P1|Overall Study|Physician Decision|0
2719005|NCT00278200|9354909|P2|Overall Study|Death|3
2719006|NCT00278200|9354910|P1|Overall Study|Death|1
2719007|NCT00278161|9354919|P1|Overall Study|Death|11
2719008|NCT00278109|9354925|P1|Overall Study|social circumstances|1
2719009|NCT00278109|9354925|P1|Overall Study|Adverse Event|3
2719010|NCT00277355|9354971|P2|Overall Study|Physician Decision|0
2719011|NCT00277355|9354972|P1|Overall Study|Physician Decision|1
2719012|NCT00277355|9354971|P2|Overall Study|Death|0
2719013|NCT00277355|9354972|P1|Overall Study|Death|3
2719014|NCT00277355|9354971|P2|Overall Study|Adverse Event|0
2719015|NCT00277355|9354972|P1|Overall Study|Adverse Event|5
2719016|NCT00277355|9354971|P2|Overall Study|Lost to Follow-up|2
2719017|NCT00277355|9354972|P1|Overall Study|Lost to Follow-up|2
2719018|NCT00277355|9354971|P2|Overall Study|Withdrawal by Subject|3
2719019|NCT00277355|9354972|P1|Overall Study|Withdrawal by Subject|3
2719020|NCT00277212|9354980|P3|Phase 2 - Double-Blind Treatment|Other reasons|5
2719021|NCT00277212|9354981|P2|Phase 2 - Double-Blind Treatment|Other reasons|7
2719022|NCT00277212|9354982|P1|Phase 2 - Double-Blind Treatment|Other reasons|0
2719023|NCT00277212|9354980|P3|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3
2719024|NCT00277212|9354981|P2|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1
2719025|NCT00277212|9354982|P1|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0
2719026|NCT00277212|9354980|P3|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6
2719027|NCT00277212|9354981|P2|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4
2719028|NCT00277212|9354982|P1|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0
2719029|NCT00277212|9354980|P3|Phase 2 - Double-Blind Treatment|Pregnancy|2
2719030|NCT00277212|9354981|P2|Phase 2 - Double-Blind Treatment|Pregnancy|2
2719031|NCT00277212|9354982|P1|Phase 2 - Double-Blind Treatment|Pregnancy|0
2719032|NCT00277212|9354980|P3|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8
2719033|NCT00277212|9354981|P2|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7
2719034|NCT00277212|9354982|P1|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0
2719035|NCT00277212|9354980|P3|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
2719036|NCT00277212|9354981|P2|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
2719037|NCT00277212|9354982|P1|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0
2719038|NCT00277212|9354980|P3|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16
2719039|NCT00277212|9354981|P2|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17
2719040|NCT00277212|9354982|P1|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0
2719041|NCT00277212|9354980|P3|Phase 2 - Double-Blind Treatment|Adverse Event|16
2719042|NCT00277212|9354981|P2|Phase 2 - Double-Blind Treatment|Adverse Event|10
2719043|NCT00277212|9354982|P1|Phase 2 - Double-Blind Treatment|Adverse Event|0
2719044|NCT00277212|9354980|P3|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39
2719045|NCT00277212|9354981|P2|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54
2719046|NCT00277212|9354982|P1|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0
2719047|NCT00277212|9354980|P3|Phase 1 - Single-Blind Treatment|Other Reasons|0
2719048|NCT00277212|9354981|P2|Phase 1 - Single-Blind Treatment|Other Reasons|0
2719049|NCT00277212|9354982|P1|Phase 1 - Single-Blind Treatment|Other Reasons|12
2719050|NCT00277212|9354980|P3|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
2719051|NCT00277212|9354981|P2|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
2719052|NCT00277212|9354982|P1|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1
2719053|NCT00277212|9354980|P3|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
2719054|NCT00277212|9354981|P2|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
2719055|NCT00277212|9354982|P1|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44
2719056|NCT00277212|9354980|P3|Phase 1 - Single-Blind Treatment|Pregnancy|0
2719057|NCT00277212|9354981|P2|Phase 1 - Single-Blind Treatment|Pregnancy|0
2719058|NCT00277212|9354982|P1|Phase 1 - Single-Blind Treatment|Pregnancy|6
2719059|NCT00277212|9354980|P3|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
2719060|NCT00277212|9354981|P2|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
2719061|NCT00277212|9354982|P1|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35
2719062|NCT00277212|9354980|P3|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
2719063|NCT00277212|9354981|P2|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
2719064|NCT00277212|9354982|P1|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87
2719065|NCT00277212|9354980|P3|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
2719066|NCT00277212|9354981|P2|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
2719067|NCT00277212|9354982|P1|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96
2719068|NCT00277212|9354980|P3|Phase 1 - Single-Blind Treatment|Adverse Event|0
2719069|NCT00277212|9354981|P2|Phase 1 - Single-Blind Treatment|Adverse Event|0
2719070|NCT00277212|9354982|P1|Phase 1 - Single-Blind Treatment|Adverse Event|93
2719071|NCT00277212|9354980|P3|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
2719072|NCT00277212|9354981|P2|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
2719073|NCT00277212|9354982|P1|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61
2719074|NCT00277095|9355020|P1|Overall Study|Physician Decision|1
2719075|NCT00277095|9355020|P1|Overall Study|Missed Follow-up|9
2719076|NCT00277095|9355020|P1|Overall Study|Lost to Follow-up|2
2719077|NCT00277095|9355020|P1|Overall Study|Explanted|7
2719078|NCT00277095|9355020|P1|Overall Study|Death|2
2719079|NCT00276744|9355029|P1|PART A|Reason unknown|98
2719080|NCT00276614|9355033|P1|Overall Study|Progression of disease under study|3
2719081|NCT00276484|9355044|P2|Overall Study|Could not take time off work|1
2719082|NCT00276484|9355045|P1|Overall Study|Could not take time off work|0
2719083|NCT00276484|9355044|P2|Overall Study|Withdrawal by Subject|3
2719084|NCT00276484|9355045|P1|Overall Study|Withdrawal by Subject|4
2719085|NCT00276484|9355044|P2|Overall Study|Protocol Violation|1
2719086|NCT00276484|9355045|P1|Overall Study|Protocol Violation|0
2719087|NCT00276484|9355044|P2|Overall Study|Lost to Follow-up|1
2719088|NCT00276484|9355045|P1|Overall Study|Lost to Follow-up|1
2719089|NCT00276484|9355044|P2|Overall Study|Adverse Event|7
2719090|NCT00276484|9355045|P1|Overall Study|Adverse Event|4
2719091|NCT00276458|9355077|P2|Overall Study|Protocol Violation|3
2719092|NCT00276458|9355078|P1|Overall Study|Protocol Violation|4
2719093|NCT00276458|9355077|P2|Overall Study|Lost to Follow-up|2
2719094|NCT00276458|9355078|P1|Overall Study|Lost to Follow-up|2
2719095|NCT00276458|9355077|P2|Overall Study|Adverse Event|2
2719096|NCT00276458|9355078|P1|Overall Study|Adverse Event|0
2719097|NCT00276419|9355112|P2|First Intervention|Withdrawal by Subject|2
2719098|NCT00276419|9355113|P1|First Intervention|Withdrawal by Subject|0
2719099|NCT00276419|9355112|P2|First Intervention|Adverse Event|0
2719100|NCT00276419|9355113|P1|First Intervention|Adverse Event|1
2719101|NCT00276380|9355156|P2|Overall Study|Abnormal aPPT Levels|1
2719102|NCT00276380|9355157|P1|Overall Study|Abnormal aPPT Levels|0
2719103|NCT00276380|9355156|P2|Overall Study|Death|3
2719104|NCT00276380|9355157|P1|Overall Study|Death|5
2719105|NCT00276380|9355156|P2|Overall Study|Withdrawal by Subject|6
2719106|NCT00276380|9355157|P1|Overall Study|Withdrawal by Subject|3
2719107|NCT00276380|9355156|P2|Overall Study|Lost to Follow-up|1
2719108|NCT00276380|9355157|P1|Overall Study|Lost to Follow-up|1
2719109|NCT00276380|9355156|P2|Overall Study|Adverse Event|3
2719110|NCT00276380|9355157|P1|Overall Study|Adverse Event|5
2719111|NCT00276159|9355212|P1|Overall Study|Did not receive all 24 doses of 852A|6
2719112|NCT00276094|9355222|P3|Overall Study|Other-Study medication lost|1
2719113|NCT00276094|9355223|P2|Overall Study|Other-Study medication lost|0
2719114|NCT00276094|9355224|P1|Overall Study|Other-Study medication lost|0
2719115|NCT00276094|9355222|P3|Overall Study|Other-Relocation|0
2719116|NCT00276094|9355223|P2|Overall Study|Other-Relocation|1
2719117|NCT00276094|9355224|P1|Overall Study|Other-Relocation|0
2719118|NCT00276094|9355222|P3|Overall Study|Other-Repeat safety labs-exclusionary|0
2719119|NCT00276094|9355223|P2|Overall Study|Other-Repeat safety labs-exclusionary|1
2719120|NCT00276094|9355224|P1|Overall Study|Other-Repeat safety labs-exclusionary|0
2719121|NCT00276094|9355222|P3|Overall Study|Other-Refused follow-up visit|0
2719122|NCT00276094|9355223|P2|Overall Study|Other-Refused follow-up visit|0
2719123|NCT00276094|9355224|P1|Overall Study|Other-Refused follow-up visit|1
2719124|NCT00276094|9355222|P3|Overall Study|Other-Lack of efficacy|0
2719125|NCT00276094|9355223|P2|Overall Study|Other-Lack of efficacy|0
2719126|NCT00276094|9355224|P1|Overall Study|Other-Lack of efficacy|1
2719127|NCT00276094|9355222|P3|Overall Study|Other-Scheduled gastroplasty|0
2719128|NCT00276094|9355223|P2|Overall Study|Other-Scheduled gastroplasty|0
2719129|NCT00276094|9355224|P1|Overall Study|Other-Scheduled gastroplasty|1
2719130|NCT00276094|9355222|P3|Overall Study|Other-Subject moved out of country|0
2719131|NCT00276094|9355223|P2|Overall Study|Other-Subject moved out of country|0
2719132|NCT00276094|9355224|P1|Overall Study|Other-Subject moved out of country|1
2719133|NCT00276094|9355222|P3|Overall Study|Lost to Follow-up|4
2719134|NCT00276094|9355223|P2|Overall Study|Lost to Follow-up|6
2719135|NCT00276094|9355224|P1|Overall Study|Lost to Follow-up|8
2719136|NCT00276094|9355222|P3|Overall Study|Protocol Violation|10
2719137|NCT00276094|9355223|P2|Overall Study|Protocol Violation|7
2719138|NCT00276094|9355224|P1|Overall Study|Protocol Violation|16
2719139|NCT00276094|9355222|P3|Overall Study|Withdrawal by Subject|12
2719140|NCT00276094|9355223|P2|Overall Study|Withdrawal by Subject|14
2719141|NCT00276094|9355224|P1|Overall Study|Withdrawal by Subject|14
2719142|NCT00276094|9355222|P3|Overall Study|Adverse Event|11
2719143|NCT00276094|9355223|P2|Overall Study|Adverse Event|13
2719144|NCT00276094|9355224|P1|Overall Study|Adverse Event|15
2719145|NCT00276016|9355277|P6|Intervention 1|Withdrawal by Subject|0
2719146|NCT00276016|9355278|P5|Intervention 1|Withdrawal by Subject|0
2719147|NCT00276016|9355279|P4|Intervention 1|Withdrawal by Subject|0
2719148|NCT00276016|9355280|P3|Intervention 1|Withdrawal by Subject|0
2719149|NCT00276016|9355281|P2|Intervention 1|Withdrawal by Subject|1
2719150|NCT00276016|9355282|P1|Intervention 1|Withdrawal by Subject|0
2719151|NCT00275821|9355328|P3|Overall Study|Protocol Violation|0
2719152|NCT00275821|9355329|P2|Overall Study|Protocol Violation|1
2719153|NCT00275821|9355330|P1|Overall Study|Protocol Violation|5
2719154|NCT00275821|9355328|P3|Overall Study|Lack of Efficacy|0
2719155|NCT00275821|9355329|P2|Overall Study|Lack of Efficacy|1
2719156|NCT00275821|9355330|P1|Overall Study|Lack of Efficacy|2
2719157|NCT00275821|9355328|P3|Overall Study|Death|1
2719158|NCT00275821|9355329|P2|Overall Study|Death|2
2719159|NCT00275821|9355330|P1|Overall Study|Death|0
2719160|NCT00275821|9355328|P3|Overall Study|Lost to Follow-up|1
2719161|NCT00275821|9355329|P2|Overall Study|Lost to Follow-up|1
2719162|NCT00275821|9355330|P1|Overall Study|Lost to Follow-up|0
2719163|NCT00275821|9355328|P3|Overall Study|Withdrawal by Subject|1
2719164|NCT00275821|9355329|P2|Overall Study|Withdrawal by Subject|2
2719165|NCT00275821|9355330|P1|Overall Study|Withdrawal by Subject|0
2719166|NCT00275821|9355328|P3|Overall Study|Administrative problems|4
2719167|NCT00275821|9355329|P2|Overall Study|Administrative problems|4
2719168|NCT00275821|9355330|P1|Overall Study|Administrative problems|3
2719169|NCT00275821|9355328|P3|Overall Study|Adverse Event|5
2719170|NCT00275821|9355329|P2|Overall Study|Adverse Event|12
2719171|NCT00275821|9355330|P1|Overall Study|Adverse Event|4
2719172|NCT00275561|9355349|P2|Overall Study|Family Issues|2
2719173|NCT00275561|9355350|P1|Overall Study|Family Issues|0
2719174|NCT00275561|9355349|P2|Overall Study|Scheduling|2
2719175|NCT00275561|9355350|P1|Overall Study|Scheduling|1
2719176|NCT00275561|9355349|P2|Overall Study|Travel|1
2719177|NCT00275561|9355350|P1|Overall Study|Travel|1
2719178|NCT00275561|9355349|P2|Overall Study|Withdrawal by Subject|1
2719179|NCT00275561|9355350|P1|Overall Study|Withdrawal by Subject|0
2719180|NCT00275509|9355362|P2|Overall Study|graft thrombosis, post-operative day #8|1
2719181|NCT00275509|9355363|P1|Overall Study|graft thrombosis, post-operative day #8|0
2719182|NCT00275340|9355386|P2|Overall Study|Lost to Follow-up|4
2719183|NCT00275340|9355387|P1|Overall Study|Lost to Follow-up|2
2719184|NCT00275301|9355391|P1|Overall Study|Adverse Event|5
2719185|NCT00275262|9355410|P2|Overall Study|Started Chemotherapy|0
2719186|NCT00275262|9355411|P1|Overall Study|Started Chemotherapy|1
2719187|NCT00275262|9355410|P2|Overall Study|Death|0
2719188|NCT00275262|9355411|P1|Overall Study|Death|1
2719189|NCT00275262|9355410|P2|Overall Study|Protocol Violation|2
2719190|NCT00275262|9355411|P1|Overall Study|Protocol Violation|0
2719191|NCT00275262|9355410|P2|Overall Study|Lost to Follow-up|2
2719192|NCT00275262|9355411|P1|Overall Study|Lost to Follow-up|0
2719193|NCT00275262|9355410|P2|Overall Study|Disease progression|5
2719194|NCT00275262|9355411|P1|Overall Study|Disease progression|2
2719195|NCT00275262|9355410|P2|Overall Study|Adverse Event|0
2719196|NCT00275262|9355411|P1|Overall Study|Adverse Event|2
2719197|NCT00275028|9355425|P1|Overall Study|Physician Decision|2
2719198|NCT00275028|9355425|P1|Overall Study|Progressive Disease|30
2719199|NCT00275028|9355425|P1|Overall Study|Adverse Event|9
2719200|NCT00275028|9355425|P1|Overall Study|Withdrawal by Subject|5
2719201|NCT00275028|9355425|P1|Overall Study|Withdrew consent before treatment began|1
2719202|NCT00275002|9355432|P2|Overall Study|Adverse Event|1
2719203|NCT00275002|9355433|P1|Overall Study|Adverse Event|0
2719204|NCT00275002|9355432|P2|Overall Study|Disease progression|15
2719205|NCT00275002|9355433|P1|Overall Study|Disease progression|21
2719206|NCT00275002|9355432|P2|Overall Study|Death|0
2719207|NCT00275002|9355433|P1|Overall Study|Death|1
2719208|NCT00274937|9355441|P1|Overall Study|Progressive Disease|4
2719209|NCT00274937|9355441|P1|Overall Study|Withdrawal by Subject|6
2719210|NCT00274937|9355441|P1|Overall Study|Physician Decision|10
2719211|NCT00274924|9355453|P3|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
2719212|NCT00274924|9355454|P2|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1
2719213|NCT00274924|9355455|P1|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
2719214|NCT00274924|9355453|P3|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
2719215|NCT00274924|9355454|P2|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1
2719216|NCT00274924|9355455|P1|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
2719217|NCT00274924|9355453|P3|Step 2 (Tx Based on Mid-treatment PET)|Death|0
2719218|NCT00274924|9355454|P2|Step 2 (Tx Based on Mid-treatment PET)|Death|1
2719219|NCT00274924|9355455|P1|Step 2 (Tx Based on Mid-treatment PET)|Death|0
2719220|NCT00274924|9355453|P3|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
2719221|NCT00274924|9355454|P2|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
2719222|NCT00274924|9355455|P1|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1
2719223|NCT00274924|9355453|P3|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
2719224|NCT00274924|9355454|P2|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
2719225|NCT00274924|9355455|P1|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1
2719226|NCT00274924|9355453|P3|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
2719227|NCT00274924|9355454|P2|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
2719228|NCT00274924|9355455|P1|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1
2719229|NCT00274924|9355453|P3|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0
2719230|NCT00274924|9355454|P2|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15
2719231|NCT00274924|9355455|P1|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4
2719232|NCT00274924|9355453|P3|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1
2719233|NCT00274924|9355454|P2|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
2719234|NCT00274924|9355455|P1|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
2719235|NCT00274924|9355453|P3|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1
2719236|NCT00274924|9355454|P2|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
2719237|NCT00274924|9355455|P1|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
2719238|NCT00274924|9355453|P3|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1
2719239|NCT00274924|9355454|P2|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
2719240|NCT00274924|9355455|P1|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
2719241|NCT00274924|9355453|P3|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1
2719242|NCT00274924|9355454|P2|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
2719243|NCT00274924|9355455|P1|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
2719244|NCT00274924|9355453|P3|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1
2719245|NCT00274924|9355454|P2|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
2719246|NCT00274924|9355455|P1|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
2719247|NCT00274924|9355453|P3|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1
2719248|NCT00274924|9355454|P2|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14
2719249|NCT00274924|9355455|P1|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4
2719250|NCT00274846|9355464|P1|Overall Study|Did not receive adequate NK cells|1
2719251|NCT00274742|9355493|P6|Overall Study|Other|0
2719252|NCT00274742|9355494|P5|Overall Study|Other|2
2719253|NCT00274742|9355495|P4|Overall Study|Other|0
2719254|NCT00274742|9355496|P3|Overall Study|Other|0
2719255|NCT00274742|9355497|P2|Overall Study|Other|3
2719256|NCT00274742|9355498|P1|Overall Study|Other|0
2719257|NCT00274742|9355493|P6|Overall Study|Disease Progression|0
2719258|NCT00274742|9355494|P5|Overall Study|Disease Progression|1
2719259|NCT00274742|9355495|P4|Overall Study|Disease Progression|0
2719260|NCT00274742|9355496|P3|Overall Study|Disease Progression|1
2719261|NCT00274742|9355497|P2|Overall Study|Disease Progression|1
2719262|NCT00274742|9355498|P1|Overall Study|Disease Progression|0
2719263|NCT00274742|9355493|P6|Overall Study|End of Study|0
2719264|NCT00274742|9355494|P5|Overall Study|End of Study|0
2719265|NCT00274742|9355495|P4|Overall Study|End of Study|1
2719266|NCT00274742|9355496|P3|Overall Study|End of Study|0
2719267|NCT00274742|9355497|P2|Overall Study|End of Study|0
2719268|NCT00274742|9355498|P1|Overall Study|End of Study|0
2719269|NCT00274742|9355493|P6|Overall Study|Lost to Follow-up|0
2719270|NCT00274742|9355494|P5|Overall Study|Lost to Follow-up|1
2719271|NCT00274742|9355495|P4|Overall Study|Lost to Follow-up|0
2719272|NCT00274742|9355496|P3|Overall Study|Lost to Follow-up|0
2719273|NCT00274742|9355497|P2|Overall Study|Lost to Follow-up|0
2719274|NCT00274742|9355498|P1|Overall Study|Lost to Follow-up|0
2719275|NCT00274742|9355493|P6|Overall Study|Adverse Event|3
2719276|NCT00274742|9355494|P5|Overall Study|Adverse Event|12
2719277|NCT00274742|9355495|P4|Overall Study|Adverse Event|4
2719278|NCT00274742|9355496|P3|Overall Study|Adverse Event|1
2719279|NCT00274742|9355497|P2|Overall Study|Adverse Event|4
2719280|NCT00274742|9355498|P1|Overall Study|Adverse Event|0
2719281|NCT00274716|9355536|P6|Phase B|Lost to Follow-up|0
2719282|NCT00274716|9355537|P5|Phase B|Lost to Follow-up|0
2719283|NCT00274716|9355538|P4|Phase B|Lost to Follow-up|0
2719284|NCT00274716|9355539|P3|Phase B|Lost to Follow-up|0
2719285|NCT00274716|9355540|P2|Phase B|Lost to Follow-up|1
2719286|NCT00274716|9355541|P1|Phase B|Lost to Follow-up|0
2719287|NCT00274716|9355536|P6|Phase B|Other non-reported reason|0
2719288|NCT00274716|9355537|P5|Phase B|Other non-reported reason|0
2719289|NCT00274716|9355538|P4|Phase B|Other non-reported reason|1
2719290|NCT00274716|9355539|P3|Phase B|Other non-reported reason|1
2719291|NCT00274716|9355540|P2|Phase B|Other non-reported reason|0
2719292|NCT00274716|9355541|P1|Phase B|Other non-reported reason|0
2719293|NCT00274716|9355536|P6|Phase B|Participant moved|0
2719294|NCT00274716|9355537|P5|Phase B|Participant moved|0
2719295|NCT00274716|9355538|P4|Phase B|Participant moved|0
2719296|NCT00274716|9355539|P3|Phase B|Participant moved|0
2719297|NCT00274716|9355540|P2|Phase B|Participant moved|0
2719298|NCT00274716|9355541|P1|Phase B|Participant moved|1
2719299|NCT00274716|9355536|P6|Phase B|Withdrawal by Subject|0
2719300|NCT00274716|9355537|P5|Phase B|Withdrawal by Subject|0
2719301|NCT00274716|9355538|P4|Phase B|Withdrawal by Subject|0
2719302|NCT00274716|9355539|P3|Phase B|Withdrawal by Subject|0
2719303|NCT00274716|9355540|P2|Phase B|Withdrawal by Subject|1
2719304|NCT00274716|9355541|P1|Phase B|Withdrawal by Subject|0
2719305|NCT00274716|9355536|P6|Phase B|Protocol Violation|0
2719306|NCT00274716|9355537|P5|Phase B|Protocol Violation|0
2719307|NCT00274716|9355538|P4|Phase B|Protocol Violation|0
2719308|NCT00274716|9355539|P3|Phase B|Protocol Violation|0
2719309|NCT00274716|9355540|P2|Phase B|Protocol Violation|2
2719310|NCT00274716|9355541|P1|Phase B|Protocol Violation|0
2719311|NCT00274716|9355536|P6|Phase B|Adverse Event|1
2719312|NCT00274716|9355537|P5|Phase B|Adverse Event|0
2719313|NCT00274716|9355538|P4|Phase B|Adverse Event|0
2719314|NCT00274716|9355539|P3|Phase B|Adverse Event|2
2719315|NCT00274716|9355540|P2|Phase B|Adverse Event|0
2719316|NCT00274716|9355541|P1|Phase B|Adverse Event|0
2719317|NCT00274716|9355536|P6|Phase A|Completed but did not enter Phase B|1
2719318|NCT00274716|9355537|P5|Phase A|Completed but did not enter Phase B|1
2719319|NCT00274716|9355538|P4|Phase A|Completed but did not enter Phase B|2
2719320|NCT00274716|9355539|P3|Phase A|Completed but did not enter Phase B|2
2719321|NCT00274716|9355540|P2|Phase A|Completed but did not enter Phase B|2
2719322|NCT00274716|9355541|P1|Phase A|Completed but did not enter Phase B|1
2719323|NCT00274716|9355536|P6|Phase A|Adverse Event|0
2719324|NCT00274716|9355537|P5|Phase A|Adverse Event|2
2719325|NCT00274716|9355538|P4|Phase A|Adverse Event|0
2719326|NCT00274716|9355539|P3|Phase A|Adverse Event|3
2719327|NCT00274716|9355540|P2|Phase A|Adverse Event|3
2719328|NCT00274716|9355541|P1|Phase A|Adverse Event|2
2719329|NCT00274716|9355536|P6|Phase A|Withdrawal by Subject|1
2719330|NCT00274716|9355537|P5|Phase A|Withdrawal by Subject|0
2719331|NCT00274716|9355538|P4|Phase A|Withdrawal by Subject|3
2719332|NCT00274716|9355539|P3|Phase A|Withdrawal by Subject|1
2719333|NCT00274716|9355540|P2|Phase A|Withdrawal by Subject|2
2719334|NCT00274716|9355541|P1|Phase A|Withdrawal by Subject|2
2719335|NCT00274716|9355536|P6|Phase A|Met criteria for discontinuation|0
2719336|NCT00274716|9355537|P5|Phase A|Met criteria for discontinuation|0
2719337|NCT00274716|9355538|P4|Phase A|Met criteria for discontinuation|0
2719338|NCT00274716|9355539|P3|Phase A|Met criteria for discontinuation|0
2719339|NCT00274716|9355540|P2|Phase A|Met criteria for discontinuation|1
2719340|NCT00274716|9355541|P1|Phase A|Met criteria for discontinuation|1
2719341|NCT00274716|9355536|P6|Phase A|Protocol Violation|0
2719342|NCT00274716|9355537|P5|Phase A|Protocol Violation|0
2719343|NCT00274716|9355538|P4|Phase A|Protocol Violation|1
2719344|NCT00274716|9355539|P3|Phase A|Protocol Violation|0
2719345|NCT00274716|9355540|P2|Phase A|Protocol Violation|0
2719346|NCT00274716|9355541|P1|Phase A|Protocol Violation|1
2719347|NCT00274716|9355536|P6|Phase A|Site Terminated|0
2719348|NCT00274716|9355537|P5|Phase A|Site Terminated|0
2719349|NCT00274716|9355538|P4|Phase A|Site Terminated|1
2719350|NCT00274716|9355539|P3|Phase A|Site Terminated|0
2719351|NCT00274716|9355540|P2|Phase A|Site Terminated|0
2719352|NCT00274716|9355541|P1|Phase A|Site Terminated|0
2719353|NCT00274716|9355536|P6|Phase A|Participant moved|1
2719354|NCT00274716|9355537|P5|Phase A|Participant moved|0
2719355|NCT00274716|9355538|P4|Phase A|Participant moved|0
2719356|NCT00274716|9355539|P3|Phase A|Participant moved|1
2719357|NCT00274716|9355540|P2|Phase A|Participant moved|0
2719358|NCT00274716|9355541|P1|Phase A|Participant moved|0
2719359|NCT00274716|9355536|P6|Phase A|Other non-reported reason|1
2719360|NCT00274716|9355537|P5|Phase A|Other non-reported reason|0
2719361|NCT00274716|9355538|P4|Phase A|Other non-reported reason|2
2719362|NCT00274716|9355539|P3|Phase A|Other non-reported reason|1
2719363|NCT00274716|9355540|P2|Phase A|Other non-reported reason|2
2719364|NCT00274716|9355541|P1|Phase A|Other non-reported reason|4
2719365|NCT00274651|9355603|P2|Overall Study|Physician Decision|7
2719366|NCT00274651|9355604|P1|Overall Study|Physician Decision|8
2719367|NCT00274651|9355603|P2|Overall Study|Withdrawal by Subject|1
2719368|NCT00274651|9355604|P1|Overall Study|Withdrawal by Subject|0
2719369|NCT00274651|9355603|P2|Overall Study|Death|3
2719370|NCT00274651|9355604|P1|Overall Study|Death|1
2719371|NCT00274651|9355603|P2|Overall Study|Lack of Efficacy|6
2719372|NCT00274651|9355604|P1|Overall Study|Lack of Efficacy|13
2719373|NCT00274651|9355603|P2|Overall Study|Adverse Event|3
2719374|NCT00274651|9355604|P1|Overall Study|Adverse Event|6
2719375|NCT00274625|9355619|P2|Overall Study|Excluded from analysis|8
2719376|NCT00274625|9355620|P1|Overall Study|Excluded from analysis|14
2719377|NCT00274625|9355619|P2|Overall Study|Lost to Follow-up|54
2719378|NCT00274625|9355620|P1|Overall Study|Lost to Follow-up|46
2719379|NCT00274469|9355628|P2|Overall Study|Did not consent to OS follow-up|19
2719380|NCT00274469|9355629|P1|Overall Study|Did not consent to OS follow-up|16
2719381|NCT00274469|9355628|P2|Overall Study|Death|74
2719382|NCT00274469|9355629|P1|Overall Study|Death|63
2719383|NCT00274456|9355649|P4|Overall Study|Withdrawal by Subject|13
2719384|NCT00274456|9355650|P3|Overall Study|Withdrawal by Subject|9
2719385|NCT00274456|9355651|P2|Overall Study|Withdrawal by Subject|13
2719386|NCT00274456|9355652|P1|Overall Study|Withdrawal by Subject|18
2719387|NCT00274456|9355649|P4|Overall Study|Lost to Follow-up|0
2719388|NCT00274456|9355650|P3|Overall Study|Lost to Follow-up|1
2719389|NCT00274456|9355651|P2|Overall Study|Lost to Follow-up|0
2719390|NCT00274456|9355652|P1|Overall Study|Lost to Follow-up|0
2719391|NCT00274456|9355649|P4|Overall Study|Physician Decision|13
2719392|NCT00274456|9355650|P3|Overall Study|Physician Decision|6
2719393|NCT00274456|9355651|P2|Overall Study|Physician Decision|5
2719394|NCT00274456|9355652|P1|Overall Study|Physician Decision|7
2719395|NCT00274456|9355649|P4|Overall Study|Adverse Event|2
2719396|NCT00274456|9355650|P3|Overall Study|Adverse Event|2
2719397|NCT00274456|9355651|P2|Overall Study|Adverse Event|1
2719398|NCT00274456|9355652|P1|Overall Study|Adverse Event|0
2719399|NCT00274456|9355649|P4|Overall Study|Unacceptable toxicity|16
2719400|NCT00274456|9355650|P3|Overall Study|Unacceptable toxicity|12
2719401|NCT00274456|9355651|P2|Overall Study|Unacceptable toxicity|5
2719402|NCT00274456|9355652|P1|Overall Study|Unacceptable toxicity|10
2719403|NCT00274456|9355649|P4|Overall Study|Still on treatment|1
2719404|NCT00274456|9355650|P3|Overall Study|Still on treatment|5
2719405|NCT00274456|9355651|P2|Overall Study|Still on treatment|3
2719406|NCT00274456|9355652|P1|Overall Study|Still on treatment|2
2719407|NCT00274287|9355694|P1|Overall Study|subject non-compliance|1
2719408|NCT00274287|9355694|P1|Overall Study|Withdrawal by Subject|1
2719409|NCT00274261|9355704|P2|Overall Study|Lost to Follow-up|75
2719410|NCT00274261|9355705|P1|Overall Study|Lost to Follow-up|106
2719411|NCT00274261|9355704|P2|Overall Study|Protocol Violation|42
2719412|NCT00274261|9355705|P1|Overall Study|Protocol Violation|71
2719413|NCT00274261|9355704|P2|Overall Study|Withdrawal by Subject|126
2719414|NCT00274261|9355705|P1|Overall Study|Withdrawal by Subject|179
2719415|NCT00274261|9355704|P2|Overall Study|Pregnancy|83
2719416|NCT00274261|9355705|P1|Overall Study|Pregnancy|114
2719417|NCT00274261|9355704|P2|Overall Study|Adverse Event|11
2719418|NCT00274261|9355705|P1|Overall Study|Adverse Event|19
2719419|NCT00273858|9355744|P1|Overall Study|Adverse Event|81
2719420|NCT00273858|9355744|P1|Overall Study|Withdrawal by Subject|21
2719421|NCT00273858|9355744|P1|Overall Study|Lost to Follow-up|101
2719422|NCT00273858|9355744|P1|Overall Study|Not completed 24 month observation time|334
2719423|NCT00273182|9355803|P1|Overall Study|Site exit, system change, 36 m FU missed|36
2719424|NCT00273182|9355803|P1|Overall Study|Device/System Explant|154
2719425|NCT00273182|9355803|P1|Overall Study|Withdrawal by Subject|257
2719426|NCT00273182|9355803|P1|Overall Study|Lost to Follow-up|88
2719427|NCT00273182|9355803|P1|Overall Study|Death|450
2719428|NCT00273052|9355813|P2|Overall Study|Worsening serum lipid levels|2
2719429|NCT00273052|9355814|P1|Overall Study|Worsening serum lipid levels|0
2719430|NCT00273052|9355813|P2|Overall Study|Other|0
2719431|NCT00273052|9355814|P1|Overall Study|Other|2
2719432|NCT00273052|9355813|P2|Overall Study|Non-Compliance|1
2719433|NCT00273052|9355814|P1|Overall Study|Non-Compliance|3
2719434|NCT00273052|9355813|P2|Overall Study|Lack of Efficacy|4
2719435|NCT00273052|9355814|P1|Overall Study|Lack of Efficacy|6
2719436|NCT00273052|9355813|P2|Overall Study|Lost to Follow-up|25
2719437|NCT00273052|9355814|P1|Overall Study|Lost to Follow-up|7
2719438|NCT00273052|9355813|P2|Overall Study|Protocol Violation|18
2719439|NCT00273052|9355814|P1|Overall Study|Protocol Violation|14
2719440|NCT00273052|9355813|P2|Overall Study|Adverse Event|19
2719441|NCT00273052|9355814|P1|Overall Study|Adverse Event|21
2719442|NCT00273052|9355813|P2|Overall Study|Withdrawal by Subject|19
2719443|NCT00273052|9355814|P1|Overall Study|Withdrawal by Subject|16
2719444|NCT00272987|9355849|P3|Overall Study|Ongoing|15
2719445|NCT00272987|9355850|P2|Overall Study|Ongoing|14
2719446|NCT00272987|9355851|P1|Overall Study|Ongoing|20
2719447|NCT00272987|9355849|P3|Overall Study|Missed >3 Visits|1
2719448|NCT00272987|9355850|P2|Overall Study|Missed >3 Visits|0
2719449|NCT00272987|9355851|P1|Overall Study|Missed >3 Visits|0
2719450|NCT00272987|9355849|P3|Overall Study|Withdrawal by Subject|3
2719451|NCT00272987|9355850|P2|Overall Study|Withdrawal by Subject|0
2719452|NCT00272987|9355851|P1|Overall Study|Withdrawal by Subject|0
2719453|NCT00272987|9355849|P3|Overall Study|Adverse Event|0
2719454|NCT00272987|9355850|P2|Overall Study|Adverse Event|0
2719455|NCT00272987|9355851|P1|Overall Study|Adverse Event|1
2719456|NCT00272961|9355915|P5|Treatment Phase: Week 3 Up to Week 12|Other|2
2719457|NCT00272961|9355916|P4|Treatment Phase: Week 3 Up to Week 12|Other|2
2719458|NCT00272961|9355917|P3|Treatment Phase: Week 3 Up to Week 12|Other|3
2719459|NCT00272961|9355918|P2|Treatment Phase: Week 3 Up to Week 12|Other|3
2719460|NCT00272961|9355919|P1|Treatment Phase: Week 3 Up to Week 12|Other|1
2719461|NCT00272961|9355915|P5|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
2719462|NCT00272961|9355916|P4|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
2719463|NCT00272961|9355917|P3|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
2719464|NCT00272961|9355918|P2|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
2719465|NCT00272961|9355919|P1|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
2719466|NCT00272961|9355915|P5|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2
2719467|NCT00272961|9355916|P4|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
2719468|NCT00272961|9355917|P3|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
2719469|NCT00272961|9355918|P2|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
2719470|NCT00272961|9355919|P1|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
2719471|NCT00272961|9355915|P5|Placebo Run-in Phase: Up to Week 2|Other|0
2719472|NCT00272961|9355916|P4|Placebo Run-in Phase: Up to Week 2|Other|0
2719473|NCT00272961|9355917|P3|Placebo Run-in Phase: Up to Week 2|Other|0
2719474|NCT00272961|9355918|P2|Placebo Run-in Phase: Up to Week 2|Other|0
2719475|NCT00272961|9355919|P1|Placebo Run-in Phase: Up to Week 2|Other|2
2719476|NCT00272961|9355915|P5|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
2719477|NCT00272961|9355916|P4|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
2719478|NCT00272961|9355917|P3|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
2719479|NCT00272961|9355918|P2|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
2719480|NCT00272961|9355919|P1|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2
2719481|NCT00272961|9355915|P5|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
2719482|NCT00272961|9355916|P4|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
2719483|NCT00272961|9355917|P3|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
2719484|NCT00272961|9355918|P2|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
2719485|NCT00272961|9355919|P1|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5
2719486|NCT00272961|9355915|P5|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
2719487|NCT00272961|9355916|P4|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
2719488|NCT00272961|9355917|P3|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
2719489|NCT00272961|9355918|P2|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
2719490|NCT00272961|9355919|P1|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1
2719491|NCT00272961|9355915|P5|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
2719492|NCT00272961|9355916|P4|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
2719493|NCT00272961|9355917|P3|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
2719494|NCT00272961|9355918|P2|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
2719495|NCT00272961|9355919|P1|Placebo Run-in Phase: Up to Week 2|Physician Decision|1
2719496|NCT00272844|9355976|P1|Overall Study|Withdrawal by Subject|5
2719497|NCT00272792|9355984|P2|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1
2719498|NCT00272792|9355985|P1|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0
2719499|NCT00272792|9355984|P2|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0
2719500|NCT00272792|9355985|P1|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1
2719501|NCT00272792|9355984|P2|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2
2719502|NCT00272792|9355985|P1|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0
2719503|NCT00272792|9355984|P2|Part 1: Responsiveness|Lost to Follow-up|0
2719504|NCT00272792|9355985|P1|Part 1: Responsiveness|Lost to Follow-up|1
2719505|NCT00272779|9355995|P2|Baseline Through Week 96|Continuing on treatment|38
2719506|NCT00272779|9355996|P1|Baseline Through Week 96|Continuing on treatment|61
2719507|NCT00272779|9355995|P2|Baseline Through Week 96|Never treated|3
2719508|NCT00272779|9355996|P1|Baseline Through Week 96|Never treated|2
2719509|NCT00272779|9355995|P2|Baseline Through Week 96|Pregnancy at Week 96|0
2719510|NCT00272779|9355996|P1|Baseline Through Week 96|Pregnancy at Week 96|1
2719511|NCT00272779|9355995|P2|Baseline Through Week 96|Poor/non compliance at Week 96]|0
2719512|NCT00272779|9355996|P1|Baseline Through Week 96|Poor/non compliance at Week 96]|2
2719513|NCT00272779|9355995|P2|Baseline Through Week 96|Lost to follow-up at Week 96|0
2719514|NCT00272779|9355996|P1|Baseline Through Week 96|Lost to follow-up at Week 96|1
2719515|NCT00272779|9355995|P2|Baseline Through Week 96|Changed address before Week 96|1
2719516|NCT00272779|9355996|P1|Baseline Through Week 96|Changed address before Week 96|0
2719517|NCT00272779|9355995|P2|Baseline Through Week 96|Withdrew consent before Week 96|18
2719518|NCT00272779|9355996|P1|Baseline Through Week 96|Withdrew consent before Week 96|5
2719519|NCT00272779|9355995|P2|Baseline Through Week 96|No longer meets criteria before Week 96|3
2719520|NCT00272779|9355996|P1|Baseline Through Week 96|No longer meets criteria before Week 96|4
2719521|NCT00272779|9355995|P2|Baseline Through Week 96|Pregnancy before Week 96|7
2719522|NCT00272779|9355996|P1|Baseline Through Week 96|Pregnancy before Week 96|5
2719523|NCT00272779|9355995|P2|Baseline Through Week 96|Poor/non compliance before Week 96|16
2719524|NCT00272779|9355996|P1|Baseline Through Week 96|Poor/non compliance before Week 96|12
2719525|NCT00272779|9355995|P2|Baseline Through Week 96|Participant Imprisoned before Week 96|0
2719526|NCT00272779|9355996|P1|Baseline Through Week 96|Participant Imprisoned before Week 96|1
2719527|NCT00272779|9355995|P2|Baseline Through Week 96|Lost to follow up before Week 96|13
2719528|NCT00272779|9355996|P1|Baseline Through Week 96|Lost to follow up before Week 96|10
2719529|NCT00272779|9355995|P2|Baseline Through Week 96|Lack of efficacy before Week 96|10
2719530|NCT00272779|9355996|P1|Baseline Through Week 96|Lack of efficacy before Week 96|16
2719531|NCT00272779|9355995|P2|Baseline Through Week 96|Death before Week 96|5
2719532|NCT00272779|9355996|P1|Baseline Through Week 96|Death before Week 96|6
2719533|NCT00272779|9355995|P2|Baseline Through Week 96|Adverse event before Week 96|22
2719534|NCT00272779|9355996|P1|Baseline Through Week 96|Adverse event before Week 96|13
2719535|NCT00272779|9355995|P2|Baseline Through Week 48|Never treated|3
2719536|NCT00272779|9355996|P1|Baseline Through Week 48|Never treated|2
2719537|NCT00272779|9355995|P2|Baseline Through Week 48|Lost to follow-up on/after Week 48|3
2719538|NCT00272779|9355996|P1|Baseline Through Week 48|Lost to follow-up on/after Week 48|0
2719539|NCT00272779|9355995|P2|Baseline Through Week 48|Continuing treatment|368
2719540|NCT00272779|9355996|P1|Baseline Through Week 48|Continuing treatment|385
2719541|NCT00272779|9355995|P2|Baseline Through Week 48|Withdrew consent on/after Week 48|2
2719542|NCT00272779|9355996|P1|Baseline Through Week 48|Withdrew consent on/after Week 48|0
2719543|NCT00272779|9355995|P2|Baseline Through Week 48|Pregnancy on/after Week 48|2
2719544|NCT00272779|9355996|P1|Baseline Through Week 48|Pregnancy on/after Week 48|1
2719545|NCT00272779|9355995|P2|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
2719546|NCT00272779|9355996|P1|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
2719547|NCT00272779|9355995|P2|Baseline Through Week 48|Poor/non compliance on/after Week|2
2719548|NCT00272779|9355996|P1|Baseline Through Week 48|Poor/non compliance on/after Week|2
2719549|NCT00272779|9355995|P2|Baseline Through Week 48|Lack of efficacy on/after Week 48|1
2719550|NCT00272779|9355996|P1|Baseline Through Week 48|Lack of efficacy on/after Week 48|7
2719551|NCT00272779|9355995|P2|Baseline Through Week 48|Death on/after Week 48|1
2719552|NCT00272779|9355996|P1|Baseline Through Week 48|Death on/after Week 48|1
2719553|NCT00272779|9355995|P2|Baseline Through Week 48|Adverse event on/after Week 48|1
2719554|NCT00272779|9355996|P1|Baseline Through Week 48|Adverse event on/after Week 48|1
2719555|NCT00272779|9355995|P2|Baseline Through Week 48|Chose different site before wk 48|1
2719556|NCT00272779|9355996|P1|Baseline Through Week 48|Chose different site before wk 48|0
2719557|NCT00272779|9355995|P2|Baseline Through Week 48|Participant's decision before wk 48|1
2719558|NCT00272779|9355996|P1|Baseline Through Week 48|Participant's decision before wk 48|0
2719559|NCT00272779|9355995|P2|Baseline Through Week 48|Withdrew consent before Week 48|13
2719560|NCT00272779|9355996|P1|Baseline Through Week 48|Withdrew consent before Week 48|4
2719561|NCT00272779|9355995|P2|Baseline Through Week 48|No longer meets criteria before Week 48|0
2719562|NCT00272779|9355996|P1|Baseline Through Week 48|No longer meets criteria before Week 48|1
2719563|NCT00272779|9355995|P2|Baseline Through Week 48|Pregnancy before Week 48|2
2719564|NCT00272779|9355996|P1|Baseline Through Week 48|Pregnancy before Week 48|2
2719565|NCT00272779|9355995|P2|Baseline Through Week 48|Poor/non compliance before Week 48|9
2719566|NCT00272779|9355996|P1|Baseline Through Week 48|Poor/non compliance before Week 48|6
2719567|NCT00272779|9355995|P2|Baseline Through Week 48|Viral load rebound before Week 48|0
2719568|NCT00272779|9355996|P1|Baseline Through Week 48|Viral load rebound before Week 48|1
2719569|NCT00272779|9355995|P2|Baseline Through Week 48|Lost to follow-up before Week 48|6
2719570|NCT00272779|9355996|P1|Baseline Through Week 48|Lost to follow-up before Week 48|6
2719571|NCT00272779|9355995|P2|Baseline Through Week 48|Lack of efficacy before Week 48|8
2719572|NCT00272779|9355996|P1|Baseline Through Week 48|Lack of efficacy before Week 48|5
2719573|NCT00272779|9355995|P2|Baseline Through Week 48|Death before Week 48|4
2719574|NCT00272779|9355996|P1|Baseline Through Week 48|Death before Week 48|4
2719575|NCT00272779|9355995|P2|Baseline Through Week 48|Adverse event before Week 48|14
2719576|NCT00272779|9355996|P1|Baseline Through Week 48|Adverse event before Week 48|10
2719577|NCT00272038|9356256|P1|Overall Study|withdrew before they received 2 cycles|7
2719578|NCT00271947|9356262|P1|Overall Study|Lost to Follow-up|1
2719579|NCT00271856|9356268|P2|Overall Study|Lost to Follow-up|11
2719580|NCT00271856|9356269|P1|Overall Study|Lost to Follow-up|10
2719581|NCT00271856|9356268|P2|Overall Study|Withdrawal by Subject|7
2719582|NCT00271856|9356269|P1|Overall Study|Withdrawal by Subject|1
2719583|NCT00271817|9356288|P3|Part 2|LDL < 50 mg/dL|4
2719584|NCT00271817|9356289|P2|Part 2|LDL < 50 mg/dL|3
2719585|NCT00271817|9356290|P1|Part 2|LDL < 50 mg/dL|0
2719586|NCT00271817|9356288|P3|Part 2|Withdrawal by Subject|13
2719587|NCT00271817|9356289|P2|Part 2|Withdrawal by Subject|2
2719588|NCT00271817|9356290|P1|Part 2|Withdrawal by Subject|0
2719589|NCT00271817|9356288|P3|Part 2|Patient Moved|5
2719590|NCT00271817|9356289|P2|Part 2|Patient Moved|0
2719591|NCT00271817|9356290|P1|Part 2|Patient Moved|0
2719592|NCT00271817|9356288|P3|Part 2|Protocol Violation|5
2719593|NCT00271817|9356289|P2|Part 2|Protocol Violation|3
2719594|NCT00271817|9356290|P1|Part 2|Protocol Violation|0
2719595|NCT00271817|9356288|P3|Part 2|Lost to Follow-up|18
2719596|NCT00271817|9356289|P2|Part 2|Lost to Follow-up|6
2719597|NCT00271817|9356290|P1|Part 2|Lost to Follow-up|0
2719598|NCT00271817|9356288|P3|Part 2|Lack of Efficacy|6
2719599|NCT00271817|9356289|P2|Part 2|Lack of Efficacy|1
2719600|NCT00271817|9356290|P1|Part 2|Lack of Efficacy|0
2719601|NCT00271817|9356288|P3|Part 2|Adverse Event|33
2719602|NCT00271817|9356289|P2|Part 2|Adverse Event|17
2719603|NCT00271817|9356290|P1|Part 2|Adverse Event|0
2719604|NCT00271817|9356288|P3|Part 1|LDL < 50 mg/dL|48
2719605|NCT00271817|9356289|P2|Part 1|LDL < 50 mg/dL|4
2719606|NCT00271817|9356290|P1|Part 1|LDL < 50 mg/dL|1
2719607|NCT00271817|9356288|P3|Part 1|Withdrawal by Subject|45
2719608|NCT00271817|9356289|P2|Part 1|Withdrawal by Subject|17
2719609|NCT00271817|9356290|P1|Part 1|Withdrawal by Subject|23
2719610|NCT00271817|9356288|P3|Part 1|Patient Moved|5
2719611|NCT00271817|9356289|P2|Part 1|Patient Moved|1
2719612|NCT00271817|9356290|P1|Part 1|Patient Moved|3
2719613|NCT00271817|9356288|P3|Part 1|Protocol Violation|7
2719614|NCT00271817|9356289|P2|Part 1|Protocol Violation|4
2719615|NCT00271817|9356290|P1|Part 1|Protocol Violation|5
2719616|NCT00271817|9356288|P3|Part 1|Lost to Follow-up|24
2719617|NCT00271817|9356289|P2|Part 1|Lost to Follow-up|8
2719618|NCT00271817|9356290|P1|Part 1|Lost to Follow-up|6
2719619|NCT00271817|9356288|P3|Part 1|Adverse Event|156
2719620|NCT00271817|9356289|P2|Part 1|Adverse Event|25
2719621|NCT00271817|9356290|P1|Part 1|Adverse Event|68
2719622|NCT00271609|9356332|P2|Overall Study|Withdrawal by Subject|0
2719623|NCT00271609|9356333|P1|Overall Study|Withdrawal by Subject|2
2719624|NCT00271609|9356332|P2|Overall Study|Adverse Event|3
2719625|NCT00271609|9356333|P1|Overall Study|Adverse Event|11
2719626|NCT00271596|9356343|P2|Overall Study|Withdrawal by Subject|1
2719627|NCT00271596|9356344|P1|Overall Study|Withdrawal by Subject|0
2719628|NCT00271596|9356343|P2|Overall Study|Protocol Violation|0
2719629|NCT00271596|9356344|P1|Overall Study|Protocol Violation|1
2719630|NCT00271544|9356379|P1|Overall Study|Implant not attempted|4
2719631|NCT00271544|9356379|P1|Overall Study|Model 4196 lead not attempted|9
2719632|NCT00271544|9356379|P1|Overall Study|Subjects did not receive a 4196 lead|7
2719633|NCT00271024|9356493|P4|Overall Study|Time Commitment, Scheduling, or Travel|4
2719634|NCT00271024|9356494|P3|Overall Study|Time Commitment, Scheduling, or Travel|4
2719635|NCT00271024|9356495|P2|Overall Study|Time Commitment, Scheduling, or Travel|2
2719636|NCT00271024|9356496|P1|Overall Study|Time Commitment, Scheduling, or Travel|6
2719637|NCT00271024|9356493|P4|Overall Study|Unpleasant Reaction To Tablet|2
2719638|NCT00271024|9356494|P3|Overall Study|Unpleasant Reaction To Tablet|4
2719639|NCT00271024|9356495|P2|Overall Study|Unpleasant Reaction To Tablet|3
2719640|NCT00271024|9356496|P1|Overall Study|Unpleasant Reaction To Tablet|1
2719641|NCT00271024|9356493|P4|Overall Study|Protocol Violation|11
2719642|NCT00271024|9356494|P3|Overall Study|Protocol Violation|5
2719643|NCT00271024|9356495|P2|Overall Study|Protocol Violation|6
2719644|NCT00271024|9356496|P1|Overall Study|Protocol Violation|1
2719645|NCT00271024|9356493|P4|Overall Study|Unknown/Unspecified|4
2719646|NCT00271024|9356494|P3|Overall Study|Unknown/Unspecified|8
2719647|NCT00271024|9356495|P2|Overall Study|Unknown/Unspecified|11
2719648|NCT00271024|9356496|P1|Overall Study|Unknown/Unspecified|11
2719649|NCT00271024|9356493|P4|Overall Study|Lost Interest|3
2719650|NCT00271024|9356494|P3|Overall Study|Lost Interest|2
2719651|NCT00271024|9356495|P2|Overall Study|Lost Interest|4
2719652|NCT00271024|9356496|P1|Overall Study|Lost Interest|3
2719653|NCT00270998|9356546|P3|12 Month Follow-up|Received/desired alternate treatment|1
2719654|NCT00270998|9356547|P2|12 Month Follow-up|Received/desired alternate treatment|4
2719655|NCT00270998|9356548|P1|12 Month Follow-up|Received/desired alternate treatment|1
2719656|NCT00270998|9356546|P3|12 Month Follow-up|Personal/family health|1
2719657|NCT00270998|9356547|P2|12 Month Follow-up|Personal/family health|5
2719658|NCT00270998|9356548|P1|12 Month Follow-up|Personal/family health|0
2719659|NCT00270998|9356546|P3|12 Month Follow-up|Pessary did not fit|0
2719660|NCT00270998|9356547|P2|12 Month Follow-up|Pessary did not fit|0
2719661|NCT00270998|9356548|P1|12 Month Follow-up|Pessary did not fit|1
2719662|NCT00270998|9356546|P3|12 Month Follow-up|Withdrawal by Subject|16
2719663|NCT00270998|9356547|P2|12 Month Follow-up|Withdrawal by Subject|12
2719664|NCT00270998|9356548|P1|12 Month Follow-up|Withdrawal by Subject|7
2719665|NCT00270998|9356546|P3|12 Month Follow-up|Lack of Efficacy|3
2719666|NCT00270998|9356547|P2|12 Month Follow-up|Lack of Efficacy|4
2719667|NCT00270998|9356548|P1|12 Month Follow-up|Lack of Efficacy|5
2719668|NCT00270998|9356546|P3|3 Month Follow-up|Received/desired alternate treatment|2
2719669|NCT00270998|9356547|P2|3 Month Follow-up|Received/desired alternate treatment|5
2719670|NCT00270998|9356548|P1|3 Month Follow-up|Received/desired alternate treatment|13
2719671|NCT00270998|9356546|P3|3 Month Follow-up|Personal/family health|0
2719672|NCT00270998|9356547|P2|3 Month Follow-up|Personal/family health|1
2719673|NCT00270998|9356548|P1|3 Month Follow-up|Personal/family health|1
2719674|NCT00270998|9356546|P3|3 Month Follow-up|Pessary did not fit|0
2719675|NCT00270998|9356547|P2|3 Month Follow-up|Pessary did not fit|0
2719676|NCT00270998|9356548|P1|3 Month Follow-up|Pessary did not fit|12
2719677|NCT00270998|9356546|P3|3 Month Follow-up|Withdrawal by Subject|15
2719678|NCT00270998|9356547|P2|3 Month Follow-up|Withdrawal by Subject|14
2719679|NCT00270998|9356548|P1|3 Month Follow-up|Withdrawal by Subject|11
2719680|NCT00270998|9356546|P3|3 Month Follow-up|Lack of Efficacy|1
2719681|NCT00270998|9356547|P2|3 Month Follow-up|Lack of Efficacy|2
2719682|NCT00270998|9356548|P1|3 Month Follow-up|Lack of Efficacy|1
2719683|NCT00270998|9356546|P3|3 Month Follow-up|Adverse Event|0
2719684|NCT00270998|9356547|P2|3 Month Follow-up|Adverse Event|0
2719685|NCT00270998|9356548|P1|3 Month Follow-up|Adverse Event|1
2719686|NCT00270894|9356577|P1|Overall Study|Withdrawal by Subject|1
2719687|NCT00270894|9356577|P1|Overall Study|Adverse Event|1
2719688|NCT00270855|9356589|P2|Overall Study|Withdrawal by Subject|8
2719689|NCT00270855|9356590|P1|Overall Study|Withdrawal by Subject|8
2719690|NCT00270257|9356726|P2|Overall Study|Data Safety Monitoring Board (DSMB) halt|424
2719691|NCT00270257|9356727|P1|Overall Study|Data Safety Monitoring Board (DSMB) halt|412
2719692|NCT00270231|9356745|P2|Second Intervention|Lost to Follow-up|1
2719693|NCT00270231|9356746|P1|Second Intervention|Lost to Follow-up|0
2719694|NCT00270231|9356745|P2|Washout Period|Lost to Follow-up|0
2719695|NCT00270231|9356746|P1|Washout Period|Lost to Follow-up|1
2719696|NCT00270231|9356745|P2|First Intervention|Lost to Follow-up|1
2719697|NCT00270231|9356746|P1|First Intervention|Lost to Follow-up|1
2719698|NCT00270205|9356756|P4|Overall Study|Lost to Follow-up|1
2719699|NCT00270205|9356757|P3|Overall Study|Lost to Follow-up|0
2719700|NCT00270205|9356758|P2|Overall Study|Lost to Follow-up|0
2719701|NCT00270205|9356759|P1|Overall Study|Lost to Follow-up|1
2719702|NCT00269919|9356877|P1|Overall Study|Started but not treated|1
2719703|NCT00269919|9356877|P1|Overall Study|Other|26
2719704|NCT00269633|9356896|P2|Overall Study|Withdrawal by Subject|0
2719705|NCT00269633|9356897|P1|Overall Study|Withdrawal by Subject|1
2719706|NCT00269477|9356907|P4|Overall Study|Missed post-vaccination blood draw|0
2719707|NCT00269477|9356908|P3|Overall Study|Missed post-vaccination blood draw|0
2719708|NCT00269477|9356909|P2|Overall Study|Missed post-vaccination blood draw|1
2719709|NCT00269477|9356910|P1|Overall Study|Missed post-vaccination blood draw|0
2719710|NCT00269477|9356907|P4|Overall Study|Protocol Violation|0
2719711|NCT00269477|9356908|P3|Overall Study|Protocol Violation|1
2719712|NCT00269477|9356909|P2|Overall Study|Protocol Violation|5
2719713|NCT00269477|9356910|P1|Overall Study|Protocol Violation|5
2719714|NCT00269399|9356926|P2|Overall Study|Development of exclusion criteria|1
2719715|NCT00269399|9356927|P1|Overall Study|Development of exclusion criteria|0
2719716|NCT00269399|9356926|P2|Overall Study|Other|4
2719717|NCT00269399|9356927|P1|Overall Study|Other|0
2719718|NCT00269399|9356926|P2|Overall Study|Negative Lab Result for C. difficile|3
2719719|NCT00269399|9356927|P1|Overall Study|Negative Lab Result for C. difficile|2
2719720|NCT00269399|9356926|P2|Overall Study|Withdrawal by Subject|5
2719721|NCT00269399|9356927|P1|Overall Study|Withdrawal by Subject|2
2719722|NCT00269399|9356926|P2|Overall Study|Adverse Event|4
2719723|NCT00269399|9356927|P1|Overall Study|Adverse Event|10
2719724|NCT00269399|9356926|P2|Overall Study|Lack of Efficacy|10
2719725|NCT00269399|9356927|P1|Overall Study|Lack of Efficacy|27
2719726|NCT00269152|9356937|P2|Overall Study|Protocol Violation|1
2719727|NCT00269152|9356938|P1|Overall Study|Protocol Violation|0
2719728|NCT00269152|9356937|P2|Overall Study|Physician Decision|3
2719729|NCT00269152|9356938|P1|Overall Study|Physician Decision|2
2719730|NCT00269152|9356937|P2|Overall Study|Withdrawal by Subject|3
2719731|NCT00269152|9356938|P1|Overall Study|Withdrawal by Subject|7
2719732|NCT00269152|9356937|P2|Overall Study|Adverse Event|3
2719733|NCT00269152|9356938|P1|Overall Study|Adverse Event|9
2719734|NCT00269113|9356954|P2|Overall Study|Other|2
2719735|NCT00269113|9356955|P1|Overall Study|Other|0
2719736|NCT00269113|9356954|P2|Overall Study|Protocol Violation|5
2719737|NCT00269113|9356955|P1|Overall Study|Protocol Violation|15
2719738|NCT00269113|9356954|P2|Overall Study|Lost to Follow-up|1
2719739|NCT00269113|9356955|P1|Overall Study|Lost to Follow-up|2
2719740|NCT00269113|9356954|P2|Overall Study|Death|2
2719741|NCT00269113|9356955|P1|Overall Study|Death|6
2719742|NCT00269113|9356954|P2|Overall Study|Withdrawal by Subject|2
2719743|NCT00269113|9356955|P1|Overall Study|Withdrawal by Subject|0
2719744|NCT00269113|9356954|P2|Overall Study|Early Improvement|0
2719745|NCT00269113|9356955|P1|Overall Study|Early Improvement|2
2719746|NCT00269113|9356954|P2|Overall Study|Lack of Efficacy|18
2719747|NCT00269113|9356955|P1|Overall Study|Lack of Efficacy|35
2719748|NCT00269113|9356954|P2|Overall Study|Adverse Event|7
2719749|NCT00269113|9356955|P1|Overall Study|Adverse Event|14
2719750|NCT00269087|9356973|P1|Overall Study|Exacerbation of COPD|13
2719751|NCT00269087|9356973|P1|Overall Study|Withdrawal by Subject|1
2719752|NCT00269087|9356973|P1|Overall Study|Adverse Event|20
2719753|NCT00268996|9357003|P2|Overall Study|Other|1
2719754|NCT00268996|9357004|P1|Overall Study|Other|1
2719755|NCT00268996|9357003|P2|Overall Study|Non-compliance|0
2719756|NCT00268996|9357004|P1|Overall Study|Non-compliance|1
2719757|NCT00268996|9357003|P2|Overall Study|Withdrawal by Subject|11
2719758|NCT00268996|9357004|P1|Overall Study|Withdrawal by Subject|5
2719759|NCT00268996|9357003|P2|Overall Study|Lost to Follow-up|1
2719760|NCT00268996|9357004|P1|Overall Study|Lost to Follow-up|3
2719761|NCT00268996|9357003|P2|Overall Study|Adverse Event|7
2719762|NCT00268996|9357004|P1|Overall Study|Adverse Event|11
2719763|NCT00268983|9357048|P2|Overall Study|Death|0
2719764|NCT00268983|9357049|P1|Overall Study|Death|3
2719765|NCT00268905|9357092|P3|Overall Study|Clinical Progression|1
2719766|NCT00268905|9357093|P2|Overall Study|Clinical Progression|4
2719767|NCT00268905|9357094|P1|Overall Study|Clinical Progression|9
2719768|NCT00268905|9357092|P3|Overall Study|Physician Decision|1
2719769|NCT00268905|9357093|P2|Overall Study|Physician Decision|0
2719770|NCT00268905|9357094|P1|Overall Study|Physician Decision|3
2719771|NCT00268905|9357092|P3|Overall Study|Progressive Disease|3
2719772|NCT00268905|9357093|P2|Overall Study|Progressive Disease|4
2719773|NCT00268905|9357094|P1|Overall Study|Progressive Disease|28
2719774|NCT00268905|9357092|P3|Overall Study|Withdrawal by Subject|3
2719775|NCT00268905|9357093|P2|Overall Study|Withdrawal by Subject|0
2719776|NCT00268905|9357094|P1|Overall Study|Withdrawal by Subject|0
2719777|NCT00268905|9357092|P3|Overall Study|Lost to Follow-up|0
2719778|NCT00268905|9357093|P2|Overall Study|Lost to Follow-up|1
2719779|NCT00268905|9357094|P1|Overall Study|Lost to Follow-up|0
2719780|NCT00268905|9357092|P3|Overall Study|Adverse Event|4
2719781|NCT00268905|9357093|P2|Overall Study|Adverse Event|0
2719782|NCT00268905|9357094|P1|Overall Study|Adverse Event|3
2719783|NCT00268892|9357111|P3|Overall Study|Trial Site Closed|2
2719784|NCT00268892|9357112|P2|Overall Study|Trial Site Closed|2
2719785|NCT00268892|9357113|P1|Overall Study|Trial Site Closed|4
2719786|NCT00268892|9357111|P3|Overall Study|Disease Progression|0
2719787|NCT00268892|9357112|P2|Overall Study|Disease Progression|1
2719788|NCT00268892|9357113|P1|Overall Study|Disease Progression|1
2719789|NCT00268892|9357111|P3|Overall Study|Protocol Violation|0
2719790|NCT00268892|9357112|P2|Overall Study|Protocol Violation|1
2719791|NCT00268892|9357113|P1|Overall Study|Protocol Violation|0
2719792|NCT00268892|9357111|P3|Overall Study|Lost to Follow-up|4
2719793|NCT00268892|9357112|P2|Overall Study|Lost to Follow-up|2
2719794|NCT00268892|9357113|P1|Overall Study|Lost to Follow-up|5
2719795|NCT00268892|9357111|P3|Overall Study|Physician Decision|0
2719796|NCT00268892|9357112|P2|Overall Study|Physician Decision|1
2719797|NCT00268892|9357113|P1|Overall Study|Physician Decision|0
2719798|NCT00268892|9357111|P3|Overall Study|Withdrawal by Subject|13
2719799|NCT00268892|9357112|P2|Overall Study|Withdrawal by Subject|15
2719800|NCT00268892|9357113|P1|Overall Study|Withdrawal by Subject|14
2719801|NCT00268892|9357111|P3|Overall Study|Lack of Efficacy|0
2719802|NCT00268892|9357112|P2|Overall Study|Lack of Efficacy|3
2719803|NCT00268892|9357113|P1|Overall Study|Lack of Efficacy|1
2719804|NCT00268892|9357111|P3|Overall Study|Adverse Event|20
2719805|NCT00268892|9357112|P2|Overall Study|Adverse Event|17
2719806|NCT00268892|9357113|P1|Overall Study|Adverse Event|14
2719807|NCT00268463|9357132|P2|Overall Study|study terminated due to low accrual|12
2719808|NCT00268463|9357133|P1|Overall Study|study terminated due to low accrual|10
2719809|NCT00268437|9357149|P1|Overall Study|Ineligible|1
2719810|NCT00268346|9357156|P2|Overall Study|Withdrawal by Subject|1
2719811|NCT00268346|9357157|P1|Overall Study|Withdrawal by Subject|0
2719812|NCT00268346|9357156|P2|Overall Study|Death|1
2719813|NCT00268346|9357157|P1|Overall Study|Death|0
2719814|NCT00268346|9357156|P2|Overall Study|Adverse Event|1
2719815|NCT00268346|9357157|P1|Overall Study|Adverse Event|0
2719816|NCT00268242|9357163|P1|Overall Study|Death|1
2719817|NCT00268203|9357172|P1|Overall Study|Completed 2 Years of Follow-up|62
2719818|NCT00268203|9357172|P1|Overall Study|Reason Not Specified|34
2719819|NCT00268203|9357172|P1|Overall Study|Death|84
2719820|NCT00268203|9357172|P1|Overall Study|Progressive Disease|359
2719821|NCT00268203|9357172|P1|Overall Study|Received Other NHL Therapy|7
2719822|NCT00268203|9357172|P1|Overall Study|Withdrawal by Subject|9
2719823|NCT00268203|9357172|P1|Overall Study|Lost to Follow-up|92
2719824|NCT00267969|9357186|P7|After Controlled Period|Other|25
2719825|NCT00267969|9357187|P6|After Controlled Period|Other|22
2719826|NCT00267969|9357188|P5|After Controlled Period|Other|11
2719827|NCT00267969|9357189|P4|After Controlled Period|Other|13
2719828|NCT00267969|9357190|P3|After Controlled Period|Other|0
2719829|NCT00267969|9357191|P2|After Controlled Period|Other|0
2719830|NCT00267969|9357192|P1|After Controlled Period|Other|0
2719831|NCT00267969|9357186|P7|After Controlled Period|Lost to Follow-up|10
2719832|NCT00267969|9357187|P6|After Controlled Period|Lost to Follow-up|9
2719833|NCT00267969|9357188|P5|After Controlled Period|Lost to Follow-up|8
2719834|NCT00267969|9357189|P4|After Controlled Period|Lost to Follow-up|5
2719835|NCT00267969|9357190|P3|After Controlled Period|Lost to Follow-up|0
2719836|NCT00267969|9357191|P2|After Controlled Period|Lost to Follow-up|0
2719837|NCT00267969|9357192|P1|After Controlled Period|Lost to Follow-up|0
2719838|NCT00267969|9357186|P7|After Controlled Period|Lack of Efficacy|15
2719839|NCT00267969|9357187|P6|After Controlled Period|Lack of Efficacy|28
2719840|NCT00267969|9357188|P5|After Controlled Period|Lack of Efficacy|6
2719841|NCT00267969|9357189|P4|After Controlled Period|Lack of Efficacy|10
2719842|NCT00267969|9357190|P3|After Controlled Period|Lack of Efficacy|0
2719843|NCT00267969|9357191|P2|After Controlled Period|Lack of Efficacy|0
2719844|NCT00267969|9357192|P1|After Controlled Period|Lack of Efficacy|0
2719845|NCT00267969|9357186|P7|After Controlled Period|Death|1
2719846|NCT00267969|9357187|P6|After Controlled Period|Death|0
2719847|NCT00267969|9357188|P5|After Controlled Period|Death|2
2719848|NCT00267969|9357189|P4|After Controlled Period|Death|1
2719849|NCT00267969|9357190|P3|After Controlled Period|Death|0
2719850|NCT00267969|9357191|P2|After Controlled Period|Death|0
2719851|NCT00267969|9357192|P1|After Controlled Period|Death|0
2719852|NCT00267969|9357186|P7|After Controlled Period|Adverse Event|21
2719853|NCT00267969|9357187|P6|After Controlled Period|Adverse Event|23
2719854|NCT00267969|9357188|P5|After Controlled Period|Adverse Event|8
2719855|NCT00267969|9357189|P4|After Controlled Period|Adverse Event|7
2719856|NCT00267969|9357190|P3|After Controlled Period|Adverse Event|0
2719857|NCT00267969|9357191|P2|After Controlled Period|Adverse Event|0
2719858|NCT00267969|9357192|P1|After Controlled Period|Adverse Event|0
2719859|NCT00267969|9357186|P7|Controlled Period|Other|0
2719860|NCT00267969|9357187|P6|Controlled Period|Other|0
2719861|NCT00267969|9357188|P5|Controlled Period|Other|0
2719862|NCT00267969|9357189|P4|Controlled Period|Other|0
2719863|NCT00267969|9357190|P3|Controlled Period|Other|6
2719864|NCT00267969|9357191|P2|Controlled Period|Other|1
2719865|NCT00267969|9357192|P1|Controlled Period|Other|2
2719866|NCT00267969|9357186|P7|Controlled Period|Randomized but not treated|0
2719867|NCT00267969|9357187|P6|Controlled Period|Randomized but not treated|0
2719868|NCT00267969|9357188|P5|Controlled Period|Randomized but not treated|0
2719869|NCT00267969|9357189|P4|Controlled Period|Randomized but not treated|0
2719870|NCT00267969|9357190|P3|Controlled Period|Randomized but not treated|1
2719871|NCT00267969|9357191|P2|Controlled Period|Randomized but not treated|0
2719872|NCT00267969|9357192|P1|Controlled Period|Randomized but not treated|0
2719873|NCT00267969|9357186|P7|Controlled Period|Lost to Follow-up|0
2719874|NCT00267969|9357187|P6|Controlled Period|Lost to Follow-up|0
2719875|NCT00267969|9357188|P5|Controlled Period|Lost to Follow-up|0
2719876|NCT00267969|9357189|P4|Controlled Period|Lost to Follow-up|0
2719877|NCT00267969|9357190|P3|Controlled Period|Lost to Follow-up|1
2719878|NCT00267969|9357191|P2|Controlled Period|Lost to Follow-up|0
2719879|NCT00267969|9357192|P1|Controlled Period|Lost to Follow-up|1
2719880|NCT00267969|9357186|P7|Controlled Period|Lack of Efficacy|0
2719881|NCT00267969|9357187|P6|Controlled Period|Lack of Efficacy|0
2719882|NCT00267969|9357188|P5|Controlled Period|Lack of Efficacy|0
2719883|NCT00267969|9357189|P4|Controlled Period|Lack of Efficacy|0
2719884|NCT00267969|9357190|P3|Controlled Period|Lack of Efficacy|1
2719885|NCT00267969|9357191|P2|Controlled Period|Lack of Efficacy|0
2719886|NCT00267969|9357192|P1|Controlled Period|Lack of Efficacy|3
2719887|NCT00267969|9357186|P7|Controlled Period|Adverse Event|0
2719888|NCT00267969|9357187|P6|Controlled Period|Adverse Event|0
2719889|NCT00267969|9357188|P5|Controlled Period|Adverse Event|0
2719890|NCT00267969|9357189|P4|Controlled Period|Adverse Event|0
2719891|NCT00267969|9357190|P3|Controlled Period|Adverse Event|2
2719892|NCT00267969|9357191|P2|Controlled Period|Adverse Event|0
2719893|NCT00267969|9357192|P1|Controlled Period|Adverse Event|6
2719894|NCT00267956|9357218|P4|After Controlled Period|Withdrew consent|0
2719895|NCT00267956|9357219|P3|After Controlled Period|Withdrew consent|1
2719896|NCT00267956|9357220|P2|After Controlled Period|Withdrew consent|0
2719897|NCT00267956|9357221|P1|After Controlled Period|Withdrew consent|0
2719898|NCT00267956|9357218|P4|After Controlled Period|Lost to Follow-up|0
2719899|NCT00267956|9357219|P3|After Controlled Period|Lost to Follow-up|1
2719900|NCT00267956|9357220|P2|After Controlled Period|Lost to Follow-up|0
2719901|NCT00267956|9357221|P1|After Controlled Period|Lost to Follow-up|0
2719902|NCT00267956|9357218|P4|After Controlled Period|Lack of Efficacy|1
2719903|NCT00267956|9357219|P3|After Controlled Period|Lack of Efficacy|1
2719904|NCT00267956|9357220|P2|After Controlled Period|Lack of Efficacy|0
2719905|NCT00267956|9357221|P1|After Controlled Period|Lack of Efficacy|0
2719906|NCT00267956|9357218|P4|After Controlled Period|Adverse Event|1
2719907|NCT00267956|9357219|P3|After Controlled Period|Adverse Event|2
2719908|NCT00267956|9357220|P2|After Controlled Period|Adverse Event|0
2719909|NCT00267956|9357221|P1|After Controlled Period|Adverse Event|0
2719910|NCT00267956|9357218|P4|Controlled Period|Withdrew consent|0
2719911|NCT00267956|9357219|P3|Controlled Period|Withdrew consent|0
2719912|NCT00267956|9357220|P2|Controlled Period|Withdrew consent|1
2719913|NCT00267956|9357221|P1|Controlled Period|Withdrew consent|3
2719914|NCT00267956|9357218|P4|Controlled Period|Lost to Follow-up|0
2719915|NCT00267956|9357219|P3|Controlled Period|Lost to Follow-up|0
2719916|NCT00267956|9357220|P2|Controlled Period|Lost to Follow-up|0
2719917|NCT00267956|9357221|P1|Controlled Period|Lost to Follow-up|2
2719918|NCT00267956|9357218|P4|Controlled Period|Lack of Efficacy|0
2719919|NCT00267956|9357219|P3|Controlled Period|Lack of Efficacy|0
2719920|NCT00267956|9357220|P2|Controlled Period|Lack of Efficacy|2
2719921|NCT00267956|9357221|P1|Controlled Period|Lack of Efficacy|4
2719922|NCT00267956|9357218|P4|Controlled Period|Adverse Event|0
2719923|NCT00267956|9357219|P3|Controlled Period|Adverse Event|0
2719924|NCT00267956|9357220|P2|Controlled Period|Adverse Event|1
2719925|NCT00267956|9357221|P1|Controlled Period|Adverse Event|4
2719926|NCT00267748|9357253|P3|Randomized Period|randomized but not treated|3
2719927|NCT00267748|9357254|P2|Randomized Period|randomized but not treated|0
2719928|NCT00267748|9357255|P1|Randomized Period|randomized but not treated|0
2719929|NCT00267748|9357253|P3|Randomized Period|Other|6
2719930|NCT00267748|9357254|P2|Randomized Period|Other|9
2719931|NCT00267748|9357255|P1|Randomized Period|Other|0
2719932|NCT00267748|9357253|P3|Randomized Period|Withdrawal by Subject|2
2719933|NCT00267748|9357254|P2|Randomized Period|Withdrawal by Subject|9
2719934|NCT00267748|9357255|P1|Randomized Period|Withdrawal by Subject|0
2719935|NCT00267748|9357253|P3|Randomized Period|Objective progression or relapse|86
2719936|NCT00267748|9357254|P2|Randomized Period|Objective progression or relapse|77
2719937|NCT00267748|9357255|P1|Randomized Period|Objective progression or relapse|0
2719938|NCT00267748|9357253|P3|Randomized Period|Lost to Follow-up|0
2719939|NCT00267748|9357254|P2|Randomized Period|Lost to Follow-up|1
2719940|NCT00267748|9357255|P1|Randomized Period|Lost to Follow-up|0
2719941|NCT00267748|9357253|P3|Randomized Period|Global deterioration of health status|7
2719942|NCT00267748|9357254|P2|Randomized Period|Global deterioration of health status|6
2719943|NCT00267748|9357255|P1|Randomized Period|Global deterioration of health status|0
2719944|NCT00267748|9357253|P3|Randomized Period|Adverse Event|25
2719945|NCT00267748|9357254|P2|Randomized Period|Adverse Event|23
2719946|NCT00267748|9357255|P1|Randomized Period|Adverse Event|0
2719947|NCT00267748|9357253|P3|Randomized Period|Death|3
2719948|NCT00267748|9357254|P2|Randomized Period|Death|2
2719949|NCT00267748|9357255|P1|Randomized Period|Death|0
2719950|NCT00267748|9357253|P3|Non-randomized Period|Other|0
2719951|NCT00267748|9357254|P2|Non-randomized Period|Other|0
2719952|NCT00267748|9357255|P1|Non-randomized Period|Other|3
2719953|NCT00267748|9357253|P3|Non-randomized Period|Participant not willing to participate|0
2719954|NCT00267748|9357254|P2|Non-randomized Period|Participant not willing to participate|0
2719955|NCT00267748|9357255|P1|Non-randomized Period|Participant not willing to participate|1
2719956|NCT00267748|9357253|P3|Non-randomized Period|Death|0
2719957|NCT00267748|9357254|P2|Non-randomized Period|Death|0
2719958|NCT00267748|9357255|P1|Non-randomized Period|Death|1
2719959|NCT00267748|9357253|P3|Non-randomized Period|Adverse Event|0
2719960|NCT00267748|9357254|P2|Non-randomized Period|Adverse Event|0
2719961|NCT00267748|9357255|P1|Non-randomized Period|Adverse Event|8
2719962|NCT00267748|9357253|P3|Non-randomized Period|Progressive disease|0
2719963|NCT00267748|9357254|P2|Non-randomized Period|Progressive disease|0
2719964|NCT00267748|9357255|P1|Non-randomized Period|Progressive disease|10
2719965|NCT00267488|9357312|P1|Overall Study|Other (Disease Progression)|1
2719966|NCT00267488|9357312|P1|Overall Study|Protocol Violation|1
2719967|NCT00267488|9357312|P1|Overall Study|Sponsor Terminated Study|9
2719968|NCT00267202|9357336|P2|Overall Study|Lost to Follow-up|0
2719969|NCT00267202|9357337|P1|Overall Study|Lost to Follow-up|3
2719970|NCT00267202|9357336|P2|Overall Study|Administrative problems|1
2719971|NCT00267202|9357337|P1|Overall Study|Administrative problems|2
2719972|NCT00267202|9357336|P2|Overall Study|Protocol Violation|3
2719973|NCT00267202|9357337|P1|Overall Study|Protocol Violation|2
2719974|NCT00267202|9357336|P2|Overall Study|Adverse Event|7
2719975|NCT00267202|9357337|P1|Overall Study|Adverse Event|13
2719976|NCT00267202|9357336|P2|Overall Study|Withdrawal by Subject|15
2719977|NCT00267202|9357337|P1|Overall Study|Withdrawal by Subject|12
2719978|NCT00267202|9357336|P2|Overall Study|Unsatisfactory therapeutic effect|8
2719979|NCT00267202|9357337|P1|Overall Study|Unsatisfactory therapeutic effect|21
2719980|NCT00267189|9357358|P2|Overall Study|Missing|0
2719981|NCT00267189|9357359|P1|Overall Study|Missing|3
2719982|NCT00267189|9357358|P2|Overall Study|Death|0
2719983|NCT00267189|9357359|P1|Overall Study|Death|1
2719984|NCT00267189|9357358|P2|Overall Study|Patient withdrew consent|1
2719985|NCT00267189|9357359|P1|Overall Study|Patient withdrew consent|1
2719986|NCT00267150|9357369|P1|Overall Study|Adverse Event|1
2719987|NCT00267098|9357393|P8|Overall Study|Sponsor withdrew subject|0
2719988|NCT00267098|9357394|P7|Overall Study|Sponsor withdrew subject|0
2719989|NCT00267098|9357395|P6|Overall Study|Sponsor withdrew subject|0
2719990|NCT00267098|9357396|P5|Overall Study|Sponsor withdrew subject|0
2719991|NCT00267098|9357397|P4|Overall Study|Sponsor withdrew subject|1
2719992|NCT00267098|9357398|P3|Overall Study|Sponsor withdrew subject|0
2719993|NCT00267098|9357399|P2|Overall Study|Sponsor withdrew subject|0
2719994|NCT00267098|9357400|P1|Overall Study|Sponsor withdrew subject|0
2719995|NCT00267098|9357393|P8|Overall Study|Subject listed for heart transplant|0
2719996|NCT00267098|9357394|P7|Overall Study|Subject listed for heart transplant|1
2719997|NCT00267098|9357395|P6|Overall Study|Subject listed for heart transplant|0
2719998|NCT00267098|9357396|P5|Overall Study|Subject listed for heart transplant|0
2719999|NCT00267098|9357397|P4|Overall Study|Subject listed for heart transplant|0
2720000|NCT00267098|9357398|P3|Overall Study|Subject listed for heart transplant|0
2720001|NCT00267098|9357399|P2|Overall Study|Subject listed for heart transplant|0
2720002|NCT00267098|9357400|P1|Overall Study|Subject listed for heart transplant|0
2720003|NCT00267098|9357393|P8|Overall Study|Non-Medtronic LV Lead Implanted|0
2720004|NCT00267098|9357394|P7|Overall Study|Non-Medtronic LV Lead Implanted|0
2720005|NCT00267098|9357395|P6|Overall Study|Non-Medtronic LV Lead Implanted|0
2720006|NCT00267098|9357396|P5|Overall Study|Non-Medtronic LV Lead Implanted|2
2720007|NCT00267098|9357397|P4|Overall Study|Non-Medtronic LV Lead Implanted|0
2720008|NCT00267098|9357398|P3|Overall Study|Non-Medtronic LV Lead Implanted|0
2720009|NCT00267098|9357399|P2|Overall Study|Non-Medtronic LV Lead Implanted|0
2720010|NCT00267098|9357400|P1|Overall Study|Non-Medtronic LV Lead Implanted|0
2720011|NCT00267098|9357393|P8|Overall Study|Explanted Medtronic device|0
2720012|NCT00267098|9357394|P7|Overall Study|Explanted Medtronic device|0
2720013|NCT00267098|9357395|P6|Overall Study|Explanted Medtronic device|0
2720014|NCT00267098|9357396|P5|Overall Study|Explanted Medtronic device|0
2720015|NCT00267098|9357397|P4|Overall Study|Explanted Medtronic device|1
2720016|NCT00267098|9357398|P3|Overall Study|Explanted Medtronic device|0
2720017|NCT00267098|9357399|P2|Overall Study|Explanted Medtronic device|0
2720018|NCT00267098|9357400|P1|Overall Study|Explanted Medtronic device|0
2720019|NCT00267098|9357393|P8|Overall Study|Site closure|0
2720020|NCT00267098|9357394|P7|Overall Study|Site closure|1
2720021|NCT00267098|9357395|P6|Overall Study|Site closure|1
2720022|NCT00267098|9357396|P5|Overall Study|Site closure|0
2720023|NCT00267098|9357397|P4|Overall Study|Site closure|1
2720024|NCT00267098|9357398|P3|Overall Study|Site closure|0
2720025|NCT00267098|9357399|P2|Overall Study|Site closure|0
2720026|NCT00267098|9357400|P1|Overall Study|Site closure|0
2720027|NCT00267098|9357393|P8|Overall Study|Unsuccessful Implant Exit Per Protocol|0
2720028|NCT00267098|9357394|P7|Overall Study|Unsuccessful Implant Exit Per Protocol|0
2720029|NCT00267098|9357395|P6|Overall Study|Unsuccessful Implant Exit Per Protocol|0
2720030|NCT00267098|9357396|P5|Overall Study|Unsuccessful Implant Exit Per Protocol|0
2720031|NCT00267098|9357397|P4|Overall Study|Unsuccessful Implant Exit Per Protocol|0
2720032|NCT00267098|9357398|P3|Overall Study|Unsuccessful Implant Exit Per Protocol|0
2720033|NCT00267098|9357399|P2|Overall Study|Unsuccessful Implant Exit Per Protocol|51
2720034|NCT00267098|9357400|P1|Overall Study|Unsuccessful Implant Exit Per Protocol|0
2720035|NCT00267098|9357393|P8|Overall Study|Inclusion/Exclusion Criteria Not Met|0
2720036|NCT00267098|9357394|P7|Overall Study|Inclusion/Exclusion Criteria Not Met|0
2720037|NCT00267098|9357395|P6|Overall Study|Inclusion/Exclusion Criteria Not Met|0
2720038|NCT00267098|9357396|P5|Overall Study|Inclusion/Exclusion Criteria Not Met|2
2720039|NCT00267098|9357397|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
2720040|NCT00267098|9357398|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
2720041|NCT00267098|9357399|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
2720042|NCT00267098|9357400|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|96
2720043|NCT00267098|9357393|P8|Overall Study|Physician Decision|0
2720044|NCT00267098|9357394|P7|Overall Study|Physician Decision|3
2720045|NCT00267098|9357395|P6|Overall Study|Physician Decision|4
2720046|NCT00267098|9357396|P5|Overall Study|Physician Decision|5
2720047|NCT00267098|9357397|P4|Overall Study|Physician Decision|11
2720048|NCT00267098|9357398|P3|Overall Study|Physician Decision|7
2720049|NCT00267098|9357399|P2|Overall Study|Physician Decision|0
2720050|NCT00267098|9357400|P1|Overall Study|Physician Decision|5
2720051|NCT00267098|9357393|P8|Overall Study|Withdrawal by Subject|5
2720052|NCT00267098|9357394|P7|Overall Study|Withdrawal by Subject|12
2720053|NCT00267098|9357395|P6|Overall Study|Withdrawal by Subject|9
2720054|NCT00267098|9357396|P5|Overall Study|Withdrawal by Subject|12
2720055|NCT00267098|9357397|P4|Overall Study|Withdrawal by Subject|21
2720056|NCT00267098|9357398|P3|Overall Study|Withdrawal by Subject|24
2720057|NCT00267098|9357399|P2|Overall Study|Withdrawal by Subject|0
2720058|NCT00267098|9357400|P1|Overall Study|Withdrawal by Subject|8
2720059|NCT00267098|9357393|P8|Overall Study|Lost to Follow-up|1
2720060|NCT00267098|9357394|P7|Overall Study|Lost to Follow-up|1
2720061|NCT00267098|9357395|P6|Overall Study|Lost to Follow-up|3
2720062|NCT00267098|9357396|P5|Overall Study|Lost to Follow-up|2
2720063|NCT00267098|9357397|P4|Overall Study|Lost to Follow-up|5
2720064|NCT00267098|9357398|P3|Overall Study|Lost to Follow-up|6
2720065|NCT00267098|9357399|P2|Overall Study|Lost to Follow-up|0
2720066|NCT00267098|9357400|P1|Overall Study|Lost to Follow-up|0
2720067|NCT00267098|9357393|P8|Overall Study|Death|9
2720068|NCT00267098|9357394|P7|Overall Study|Death|28
2720069|NCT00267098|9357395|P6|Overall Study|Death|23
2720070|NCT00267098|9357396|P5|Overall Study|Death|14
2720071|NCT00267098|9357397|P4|Overall Study|Death|66
2720072|NCT00267098|9357398|P3|Overall Study|Death|57
2720073|NCT00267098|9357399|P2|Overall Study|Death|0
2720074|NCT00267098|9357400|P1|Overall Study|Death|0
2720075|NCT00267046|9357543|P2|Overall Study|Radiation|1
2720076|NCT00267046|9357544|P1|Overall Study|Radiation|0
2720077|NCT00267046|9357543|P2|Overall Study|Withdrawal by Subject|0
2720078|NCT00267046|9357544|P1|Overall Study|Withdrawal by Subject|1
2720079|NCT00267046|9357543|P2|Overall Study|Surgery|1
2720080|NCT00267046|9357544|P1|Overall Study|Surgery|3
2720081|NCT00267046|9357543|P2|Overall Study|Open-label palifermin|7
2720082|NCT00267046|9357544|P1|Overall Study|Open-label palifermin|2
2720083|NCT00267046|9357543|P2|Overall Study|Chemotoxicity|0
2720084|NCT00267046|9357544|P1|Overall Study|Chemotoxicity|2
2720085|NCT00267046|9357543|P2|Overall Study|Disease progression|2
2720086|NCT00267046|9357544|P1|Overall Study|Disease progression|4
2720087|NCT00267007|9357554|P2|Overall Study|Adverse Event|0
2720088|NCT00267007|9357555|P1|Overall Study|Adverse Event|1
2720089|NCT00267007|9357554|P2|Overall Study|Non-compliance|1
2720090|NCT00267007|9357555|P1|Overall Study|Non-compliance|0
2720091|NCT00267007|9357554|P2|Overall Study|Lost to Follow-up|0
2720092|NCT00267007|9357555|P1|Overall Study|Lost to Follow-up|1
2720093|NCT00267007|9357554|P2|Overall Study|Withdrawal by Subject|0
2720094|NCT00267007|9357555|P1|Overall Study|Withdrawal by Subject|6
2720095|NCT00266877|9357566|P3|Overall Study|Concomitant Radiotherapy|0
2720096|NCT00266877|9357567|P2|Overall Study|Concomitant Radiotherapy|1
2720097|NCT00266877|9357568|P1|Overall Study|Concomitant Radiotherapy|0
2720098|NCT00266877|9357566|P3|Overall Study|Hospitalization|0
2720099|NCT00266877|9357567|P2|Overall Study|Hospitalization|0
2720100|NCT00266877|9357568|P1|Overall Study|Hospitalization|1
2720101|NCT00266877|9357566|P3|Overall Study|Symptomatic Deterioration|1
2720102|NCT00266877|9357567|P2|Overall Study|Symptomatic Deterioration|3
2720103|NCT00266877|9357568|P1|Overall Study|Symptomatic Deterioration|6
2720104|NCT00266877|9357566|P3|Overall Study|Disease Progression|23
2720105|NCT00266877|9357567|P2|Overall Study|Disease Progression|37
2720106|NCT00266877|9357568|P1|Overall Study|Disease Progression|72
2720107|NCT00266877|9357566|P3|Overall Study|Withdrawal by Subject|1
2720108|NCT00266877|9357567|P2|Overall Study|Withdrawal by Subject|1
2720109|NCT00266877|9357568|P1|Overall Study|Withdrawal by Subject|3
2720110|NCT00266877|9357566|P3|Overall Study|Physician Decision|1
2720111|NCT00266877|9357567|P2|Overall Study|Physician Decision|1
2720112|NCT00266877|9357568|P1|Overall Study|Physician Decision|2
2720113|NCT00266877|9357566|P3|Overall Study|Adverse Event|1
2720114|NCT00266877|9357567|P2|Overall Study|Adverse Event|4
2720115|NCT00266877|9357568|P1|Overall Study|Adverse Event|6
2720116|NCT00266877|9357566|P3|Overall Study|Death|1
2720117|NCT00266877|9357567|P2|Overall Study|Death|1
2720118|NCT00266877|9357568|P1|Overall Study|Death|1
2720119|NCT00266864|9357587|P2|Overall Study|Withdrawal by Subject|1
2720120|NCT00266864|9357588|P1|Overall Study|Withdrawal by Subject|1
2720121|NCT00266864|9357587|P2|Overall Study|Lost to Follow-up|1
2720122|NCT00266864|9357588|P1|Overall Study|Lost to Follow-up|4
2720123|NCT00266825|9357619|P2|Completed Follow-Up|Withdrawal by Subject|5
2720124|NCT00266825|9357620|P1|Completed Follow-Up|Withdrawal by Subject|11
2720125|NCT00266825|9357619|P2|Completed Follow-Up|Lost to Follow-up|19
2720126|NCT00266825|9357620|P1|Completed Follow-Up|Lost to Follow-up|14
2720127|NCT00266812|9357646|P2|Overall Study|Discontinued before starting study drug|0
2720128|NCT00266812|9357647|P1|Overall Study|Discontinued before starting study drug|4
2720129|NCT00266812|9357646|P2|Overall Study|Withdrawal by Subject|2
2720130|NCT00266812|9357647|P1|Overall Study|Withdrawal by Subject|0
2720131|NCT00266812|9357646|P2|Overall Study|Protocol Violation|1
2720132|NCT00266812|9357647|P1|Overall Study|Protocol Violation|0
2720133|NCT00266812|9357646|P2|Overall Study|Adverse Event|1
2720134|NCT00266812|9357647|P1|Overall Study|Adverse Event|3
2720135|NCT00266812|9357646|P2|Overall Study|Death|4
2720136|NCT00266812|9357647|P1|Overall Study|Death|5
2720137|NCT00266812|9357646|P2|Overall Study|Disease Progression|3
2720138|NCT00266812|9357647|P1|Overall Study|Disease Progression|9
2720139|NCT00266708|9357672|P2|Overall Study|Asthma|2
2720140|NCT00266708|9357673|P1|Overall Study|Asthma|0
2720141|NCT00266708|9357672|P2|Overall Study|Refused biopsy|6
2720142|NCT00266708|9357673|P1|Overall Study|Refused biopsy|3
2720143|NCT00266708|9357672|P2|Overall Study|No renal function|1
2720144|NCT00266708|9357673|P1|Overall Study|No renal function|1
2720145|NCT00266695|9357713|P1|Overall Study|Withdrawal by Subject|15
2720146|NCT00266695|9357713|P1|Overall Study|Lost to Follow-up|3
2720147|NCT00266695|9357713|P1|Overall Study|Physician Decision|1
2720148|NCT00266695|9357713|P1|Overall Study|Death|9
2720149|NCT00266695|9357713|P1|Overall Study|Adverse Event|1
2720150|NCT00266656|9357725|P2|Overall Study|Parent/Caregiver Decision|2
2720151|NCT00266656|9357726|P1|Overall Study|Parent/Caregiver Decision|1
2720152|NCT00266656|9357725|P2|Overall Study|Did Not Reach Final Height|8
2720153|NCT00266656|9357726|P1|Overall Study|Did Not Reach Final Height|4
2720154|NCT00266656|9357725|P2|Overall Study|Withdrawal by Subject|2
2720155|NCT00266656|9357726|P1|Overall Study|Withdrawal by Subject|4
2720156|NCT00266656|9357725|P2|Overall Study|Lost to Follow-up|1
2720157|NCT00266656|9357726|P1|Overall Study|Lost to Follow-up|4
2720158|NCT00266656|9357725|P2|Overall Study|Death|0
2720159|NCT00266656|9357726|P1|Overall Study|Death|1
2720160|NCT00266630|9357750|P2|Overall Study|Other|11
2720161|NCT00266630|9357751|P1|Overall Study|Other|19
2720162|NCT00266630|9357750|P2|Overall Study|Lost to Follow-up|0
2720163|NCT00266630|9357751|P1|Overall Study|Lost to Follow-up|1
2720164|NCT00266630|9357750|P2|Overall Study|Withdrawal by Subject|2
2720165|NCT00266630|9357751|P1|Overall Study|Withdrawal by Subject|10
2720166|NCT00266630|9357750|P2|Overall Study|Physician Decision|2
2720167|NCT00266630|9357751|P1|Overall Study|Physician Decision|1
2720168|NCT00266630|9357750|P2|Overall Study|Protocol Violation|3
2720169|NCT00266630|9357751|P1|Overall Study|Protocol Violation|1
2720170|NCT00266630|9357750|P2|Overall Study|Entry Criteria not met|0
2720171|NCT00266630|9357751|P1|Overall Study|Entry Criteria not met|1
2720172|NCT00266630|9357750|P2|Overall Study|Lack of Efficacy|4
2720173|NCT00266630|9357751|P1|Overall Study|Lack of Efficacy|1
2720174|NCT00266630|9357750|P2|Overall Study|Adverse Event|6
2720175|NCT00266630|9357751|P1|Overall Study|Adverse Event|8
2720176|NCT00266409|9357793|P4|Overall Study|Other|0
2720177|NCT00266409|9357794|P3|Overall Study|Other|2
2720178|NCT00266409|9357795|P2|Overall Study|Other|4
2720179|NCT00266409|9357796|P1|Overall Study|Other|7
2720180|NCT00266409|9357793|P4|Overall Study|Protocol Violation|2
2720181|NCT00266409|9357794|P3|Overall Study|Protocol Violation|4
2720182|NCT00266409|9357795|P2|Overall Study|Protocol Violation|3
2720183|NCT00266409|9357796|P1|Overall Study|Protocol Violation|5
2720184|NCT00266409|9357793|P4|Overall Study|Withdrawal by Subject|9
2720185|NCT00266409|9357794|P3|Overall Study|Withdrawal by Subject|3
2720186|NCT00266409|9357795|P2|Overall Study|Withdrawal by Subject|10
2720187|NCT00266409|9357796|P1|Overall Study|Withdrawal by Subject|6
2720188|NCT00266409|9357793|P4|Overall Study|Lost to Follow-up|8
2720189|NCT00266409|9357794|P3|Overall Study|Lost to Follow-up|6
2720190|NCT00266409|9357795|P2|Overall Study|Lost to Follow-up|21
2720191|NCT00266409|9357796|P1|Overall Study|Lost to Follow-up|18
2720192|NCT00266409|9357793|P4|Overall Study|Adverse Event|1
2720193|NCT00266409|9357794|P3|Overall Study|Adverse Event|1
2720194|NCT00266409|9357795|P2|Overall Study|Adverse Event|2
2720195|NCT00266409|9357796|P1|Overall Study|Adverse Event|7
2720196|NCT00266409|9357793|P4|Overall Study|Lack of Efficacy|2
2720197|NCT00266409|9357794|P3|Overall Study|Lack of Efficacy|1
2720198|NCT00266409|9357795|P2|Overall Study|Lack of Efficacy|6
2720199|NCT00266409|9357796|P1|Overall Study|Lack of Efficacy|2
2720200|NCT00266227|9358084|P3|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0
2720201|NCT00266227|9358085|P2|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10
2720202|NCT00266227|9358086|P1|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15
2720203|NCT00266227|9358084|P3|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0
2720204|NCT00266227|9358085|P2|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29
2720205|NCT00266227|9358086|P1|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41
2720206|NCT00266227|9358084|P3|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
2720207|NCT00266227|9358085|P2|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
2720208|NCT00266227|9358086|P1|Retreatment: Week 48 to Week 72|Lost to Follow-up|1
2720209|NCT00266227|9358084|P3|Retreatment: Week 48 to Week 72|Adverse Event|0
2720210|NCT00266227|9358085|P2|Retreatment: Week 48 to Week 72|Adverse Event|2
2720211|NCT00266227|9358086|P1|Retreatment: Week 48 to Week 72|Adverse Event|6
2720212|NCT00266227|9358084|P3|Retreatment: Week 48 to Week 72|Death|0
2720213|NCT00266227|9358085|P2|Retreatment: Week 48 to Week 72|Death|1
2720214|NCT00266227|9358086|P1|Retreatment: Week 48 to Week 72|Death|1
2720215|NCT00266227|9358084|P3|Retreatment: Up to Week 48|Pregnancy|0
2720216|NCT00266227|9358085|P2|Retreatment: Up to Week 48|Pregnancy|0
2720217|NCT00266227|9358086|P1|Retreatment: Up to Week 48|Pregnancy|1
2720218|NCT00266227|9358084|P3|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0
2720219|NCT00266227|9358085|P2|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2
2720220|NCT00266227|9358086|P1|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4
2720221|NCT00266227|9358084|P3|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0
2720222|NCT00266227|9358085|P2|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14
2720223|NCT00266227|9358086|P1|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11
2720224|NCT00266227|9358084|P3|Retreatment: Up to Week 48|Lost to Follow-up|0
2720225|NCT00266227|9358085|P2|Retreatment: Up to Week 48|Lost to Follow-up|0
2720226|NCT00266227|9358086|P1|Retreatment: Up to Week 48|Lost to Follow-up|3
2720227|NCT00266227|9358084|P3|Retreatment: Up to Week 48|Adverse Event|0
2720228|NCT00266227|9358085|P2|Retreatment: Up to Week 48|Adverse Event|7
2720229|NCT00266227|9358086|P1|Retreatment: Up to Week 48|Adverse Event|7
2720230|NCT00266227|9358084|P3|Retreatment: Up to Week 48|Death|0
2720231|NCT00266227|9358085|P2|Retreatment: Up to Week 48|Death|0
2720232|NCT00266227|9358086|P1|Retreatment: Up to Week 48|Death|1
2720233|NCT00266227|9358084|P3|Initial Treatment|Pregnancy|1
2720234|NCT00266227|9358085|P2|Initial Treatment|Pregnancy|0
2720235|NCT00266227|9358086|P1|Initial Treatment|Pregnancy|0
2720236|NCT00266227|9358084|P3|Initial Treatment|Physician decision to withdraw|12
2720237|NCT00266227|9358085|P2|Initial Treatment|Physician decision to withdraw|0
2720238|NCT00266227|9358086|P1|Initial Treatment|Physician decision to withdraw|0
2720239|NCT00266227|9358084|P3|Initial Treatment|Subject/Guardian decision to withdraw|45
2720240|NCT00266227|9358085|P2|Initial Treatment|Subject/Guardian decision to withdraw|0
2720241|NCT00266227|9358086|P1|Initial Treatment|Subject/Guardian decision to withdraw|0
2720242|NCT00266227|9358084|P3|Initial Treatment|Lost to Follow-up|6
2720243|NCT00266227|9358085|P2|Initial Treatment|Lost to Follow-up|0
2720244|NCT00266227|9358086|P1|Initial Treatment|Lost to Follow-up|0
2720245|NCT00266227|9358084|P3|Initial Treatment|Adverse Event|13
2720246|NCT00266227|9358085|P2|Initial Treatment|Adverse Event|0
2720247|NCT00266227|9358086|P1|Initial Treatment|Adverse Event|0
2720248|NCT00266032|9358140|P3|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1
2720249|NCT00266032|9358141|P2|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2
2720250|NCT00266032|9358142|P1|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10
2720251|NCT00266032|9358140|P3|Open-label Safety Extension|Withdrawal by Subject|12
2720252|NCT00266032|9358141|P2|Open-label Safety Extension|Withdrawal by Subject|3
2720253|NCT00266032|9358142|P1|Open-label Safety Extension|Withdrawal by Subject|19
2720254|NCT00266032|9358140|P3|Open-label Safety Extension|Protocol Violation|2
2720255|NCT00266032|9358141|P2|Open-label Safety Extension|Protocol Violation|3
2720256|NCT00266032|9358142|P1|Open-label Safety Extension|Protocol Violation|1
2720257|NCT00266032|9358140|P3|Open-label Safety Extension|Pregnancy|2
2720258|NCT00266032|9358141|P2|Open-label Safety Extension|Pregnancy|1
2720259|NCT00266032|9358142|P1|Open-label Safety Extension|Pregnancy|4
2720260|NCT00266032|9358140|P3|Open-label Safety Extension|Lost to Follow-up|4
2720261|NCT00266032|9358141|P2|Open-label Safety Extension|Lost to Follow-up|5
2720262|NCT00266032|9358142|P1|Open-label Safety Extension|Lost to Follow-up|2
2720263|NCT00266032|9358140|P3|Open-label Safety Extension|Adverse Event|4
2720264|NCT00266032|9358141|P2|Open-label Safety Extension|Adverse Event|0
2720265|NCT00266032|9358142|P1|Open-label Safety Extension|Adverse Event|5
2720266|NCT00266032|9358140|P3|Treatment|patient moved/wish for pregnancy/no need|8
2720267|NCT00266032|9358141|P2|Treatment|patient moved/wish for pregnancy/no need|5
2720268|NCT00266032|9358142|P1|Treatment|patient moved/wish for pregnancy/no need|13
2720269|NCT00266032|9358140|P3|Treatment|Withdrawal by Subject|12
2720270|NCT00266032|9358141|P2|Treatment|Withdrawal by Subject|13
2720271|NCT00266032|9358142|P1|Treatment|Withdrawal by Subject|28
2720272|NCT00266032|9358140|P3|Treatment|Protocol Violation|13
2720273|NCT00266032|9358141|P2|Treatment|Protocol Violation|14
2720274|NCT00266032|9358142|P1|Treatment|Protocol Violation|6
2720275|NCT00266032|9358140|P3|Treatment|Pregnancy|2
2720276|NCT00266032|9358141|P2|Treatment|Pregnancy|2
2720277|NCT00266032|9358142|P1|Treatment|Pregnancy|3
2720278|NCT00266032|9358140|P3|Treatment|Lost to Follow-up|2
2720279|NCT00266032|9358141|P2|Treatment|Lost to Follow-up|4
2720280|NCT00266032|9358142|P1|Treatment|Lost to Follow-up|19
2720281|NCT00266032|9358140|P3|Treatment|Adverse Event|10
2720282|NCT00266032|9358141|P2|Treatment|Adverse Event|26
2720283|NCT00266032|9358142|P1|Treatment|Adverse Event|42
2720284|NCT00265941|9358177|P2|Overall Study|Lost to Follow-up|1
2720285|NCT00265941|9358178|P1|Overall Study|Lost to Follow-up|1
2720286|NCT00265941|9358177|P2|Overall Study|Protocol Violation|25
2720287|NCT00265941|9358178|P1|Overall Study|Protocol Violation|22
2720288|NCT00265889|9358210|P1|Overall Study|Insurance denied the request|3
2720289|NCT00265889|9358210|P1|Overall Study|Protocol Violation|1
2720290|NCT00265889|9358210|P1|Overall Study|Physician Decision|1
2720291|NCT00265785|9358237|P1|Overall Study|Did not receive protocol treatment|2
2720292|NCT00265785|9358237|P1|Overall Study|Ineligible|1
2720293|NCT00265785|9358237|P1|Overall Study|Not protocol specified|2
2720294|NCT00265785|9358237|P1|Overall Study|Progression/Relapse|15
2720295|NCT00265785|9358237|P1|Overall Study|Withdrawal by Subject|3
2720296|NCT00265785|9358237|P1|Overall Study|Adverse Event|4
2720297|NCT00265759|9358250|P4|Overall Study|Discontinued due to intolerability|1
2720298|NCT00265759|9358251|P3|Overall Study|Discontinued due to intolerability|0
2720299|NCT00265759|9358252|P2|Overall Study|Discontinued due to intolerability|0
2720300|NCT00265759|9358253|P1|Overall Study|Discontinued due to intolerability|0
2720301|NCT00265759|9358250|P4|Overall Study|Bilateral disease|2
2720302|NCT00265759|9358251|P3|Overall Study|Bilateral disease|0
2720303|NCT00265759|9358252|P2|Overall Study|Bilateral disease|0
2720304|NCT00265759|9358253|P1|Overall Study|Bilateral disease|0
2720305|NCT00265759|9358250|P4|Overall Study|Ineligible|1
2720306|NCT00265759|9358251|P3|Overall Study|Ineligible|0
2720307|NCT00265759|9358252|P2|Overall Study|Ineligible|0
2720308|NCT00265759|9358253|P1|Overall Study|Ineligible|0
2720309|NCT00265759|9358250|P4|Overall Study|Cancel|3
2720310|NCT00265759|9358251|P3|Overall Study|Cancel|0
2720311|NCT00265759|9358252|P2|Overall Study|Cancel|0
2720312|NCT00265759|9358253|P1|Overall Study|Cancel|0
2720313|NCT00265759|9358250|P4|Overall Study|Withdrawal by Subject|2
2720314|NCT00265759|9358251|P3|Overall Study|Withdrawal by Subject|2
2720315|NCT00265759|9358252|P2|Overall Study|Withdrawal by Subject|1
2720316|NCT00265759|9358253|P1|Overall Study|Withdrawal by Subject|0
2720317|NCT00265395|9358341|P2|Overall Study|Administrative|1
2720318|NCT00265395|9358342|P1|Overall Study|Administrative|0
2720319|NCT00265395|9358341|P2|Overall Study|Lack of Efficacy|1
2720320|NCT00265395|9358342|P1|Overall Study|Lack of Efficacy|0
2720321|NCT00265395|9358341|P2|Overall Study|Protocol Violation|2
2720322|NCT00265395|9358342|P1|Overall Study|Protocol Violation|2
2720323|NCT00265395|9358341|P2|Overall Study|Withdrawal by Subject|6
2720324|NCT00265395|9358342|P1|Overall Study|Withdrawal by Subject|1
2720325|NCT00265395|9358341|P2|Overall Study|Lost to Follow-up|1
2720326|NCT00265395|9358342|P1|Overall Study|Lost to Follow-up|2
2720327|NCT00265395|9358341|P2|Overall Study|Adverse Event|6
2720328|NCT00265395|9358342|P1|Overall Study|Adverse Event|3
2720329|NCT00265382|9358347|P1|Overall Study|Death|1
2720330|NCT00265382|9358347|P1|Overall Study|Study terminated by sponsor|94
2720331|NCT00265382|9358347|P1|Overall Study|Withdrawal by Subject|13
2720332|NCT00265382|9358347|P1|Overall Study|Miscellaneous|6
2720333|NCT00265382|9358347|P1|Overall Study|Lack of Efficacy|6
2720334|NCT00265382|9358347|P1|Overall Study|Lost to Follow-up|3
2720335|NCT00265382|9358347|P1|Overall Study|Laboratory Abnormality|1
2720336|NCT00265382|9358347|P1|Overall Study|Adverse Event|21
2720337|NCT00265343|9358367|P2|Overall Study|Other|3
2720338|NCT00265343|9358368|P1|Overall Study|Other|8
2720339|NCT00265343|9358367|P2|Overall Study|Withdrawal by Subject|9
2720340|NCT00265343|9358368|P1|Overall Study|Withdrawal by Subject|3
2720341|NCT00265343|9358367|P2|Overall Study|Adverse Event|7
2720342|NCT00265343|9358368|P1|Overall Study|Adverse Event|10
2720343|NCT00265330|9358376|P1|Overall Study|Protocol Violation|1
2720344|NCT00265330|9358376|P1|Overall Study|Withdrew Consent|1
2720345|NCT00265330|9358376|P1|Overall Study|Principal Investigators Request|1
2720346|NCT00265330|9358376|P1|Overall Study|Site Closed by Sponsor|1
2720347|NCT00265330|9358376|P1|Overall Study|Discharged from Unit for Long Term Care|1
2720348|NCT00265330|9358376|P1|Overall Study|Began Taking Formulary Geodon|1
2720349|NCT00265330|9358376|P1|Overall Study|Family Scheduling Conflicts|1
2720350|NCT00265330|9358376|P1|Overall Study|Lack of Efficacy|4
2720351|NCT00265330|9358376|P1|Overall Study|Patient Wanted to Start Psychotherapy|1
2720352|NCT00265330|9358376|P1|Overall Study|Withdrawal by Subject|34
2720353|NCT00265330|9358376|P1|Overall Study|Lost to Follow-up|8
2720354|NCT00265330|9358376|P1|Overall Study|Adverse Event|41
2720355|NCT00265317|9358402|P4|Phase 2|Other|1
2720356|NCT00265317|9358403|P3|Phase 2|Other|1
2720357|NCT00265317|9358404|P2|Phase 2|Other|0
2720358|NCT00265317|9358405|P1|Phase 2|Other|0
2720359|NCT00265317|9358402|P4|Phase 2|Study terminated by sponsor|0
2720360|NCT00265317|9358403|P3|Phase 2|Study terminated by sponsor|1
2720361|NCT00265317|9358404|P2|Phase 2|Study terminated by sponsor|0
2720362|NCT00265317|9358405|P1|Phase 2|Study terminated by sponsor|0
2720363|NCT00265317|9358402|P4|Phase 2|Withdrawal/other than adverse event|1
2720364|NCT00265317|9358403|P3|Phase 2|Withdrawal/other than adverse event|2
2720365|NCT00265317|9358404|P2|Phase 2|Withdrawal/other than adverse event|0
2720366|NCT00265317|9358405|P1|Phase 2|Withdrawal/other than adverse event|0
2720367|NCT00265317|9358402|P4|Phase 2|Lost to Follow-up|1
2720368|NCT00265317|9358403|P3|Phase 2|Lost to Follow-up|0
2720369|NCT00265317|9358404|P2|Phase 2|Lost to Follow-up|0
2720370|NCT00265317|9358405|P1|Phase 2|Lost to Follow-up|0
2720371|NCT00265317|9358402|P4|Phase 2|Protocol Violation|4
2720372|NCT00265317|9358403|P3|Phase 2|Protocol Violation|1
2720373|NCT00265317|9358404|P2|Phase 2|Protocol Violation|0
2720374|NCT00265317|9358405|P1|Phase 2|Protocol Violation|0
2720375|NCT00265317|9358402|P4|Phase 2|Death|15
2720376|NCT00265317|9358403|P3|Phase 2|Death|12
2720377|NCT00265317|9358404|P2|Phase 2|Death|0
2720378|NCT00265317|9358405|P1|Phase 2|Death|0
2720379|NCT00265317|9358402|P4|Phase 2|Adverse Event|5
2720380|NCT00265317|9358403|P3|Phase 2|Adverse Event|7
2720381|NCT00265317|9358404|P2|Phase 2|Adverse Event|0
2720382|NCT00265317|9358405|P1|Phase 2|Adverse Event|0
2720383|NCT00265317|9358402|P4|Phase 2|Global deterioration of health status|0
2720384|NCT00265317|9358403|P3|Phase 2|Global deterioration of health status|3
2720385|NCT00265317|9358404|P2|Phase 2|Global deterioration of health status|0
2720386|NCT00265317|9358405|P1|Phase 2|Global deterioration of health status|0
2720387|NCT00265317|9358402|P4|Phase 2|Objective progression or relapse|38
2720388|NCT00265317|9358403|P3|Phase 2|Objective progression or relapse|37
2720389|NCT00265317|9358404|P2|Phase 2|Objective progression or relapse|0
2720390|NCT00265317|9358405|P1|Phase 2|Objective progression or relapse|0
2720391|NCT00265317|9358402|P4|Lead-In|Withdrawal/other than adverse event|0
2720392|NCT00265317|9358403|P3|Lead-In|Withdrawal/other than adverse event|0
2720393|NCT00265317|9358404|P2|Lead-In|Withdrawal/other than adverse event|0
2720394|NCT00265317|9358405|P1|Lead-In|Withdrawal/other than adverse event|1
2720395|NCT00265317|9358402|P4|Lead-In|Death|0
2720396|NCT00265317|9358403|P3|Lead-In|Death|0
2720397|NCT00265317|9358404|P2|Lead-In|Death|5
2720398|NCT00265317|9358405|P1|Lead-In|Death|3
2720399|NCT00265317|9358402|P4|Lead-In|Adverse Event|0
2720400|NCT00265317|9358403|P3|Lead-In|Adverse Event|0
2720401|NCT00265317|9358404|P2|Lead-In|Adverse Event|1
2720402|NCT00265317|9358405|P1|Lead-In|Adverse Event|2
2720403|NCT00265317|9358402|P4|Lead-In|Objective progression or relapse|0
2720404|NCT00265317|9358403|P3|Lead-In|Objective progression or relapse|0
2720405|NCT00265317|9358404|P2|Lead-In|Objective progression or relapse|11
2720406|NCT00265317|9358405|P1|Lead-In|Objective progression or relapse|6
2720407|NCT00265239|9358520|P2|Overall Study|Adverse Event|1
2720408|NCT00265239|9358521|P1|Overall Study|Adverse Event|2
2720409|NCT00265122|9358543|P6|Intervention Period 2 (Weeks 8 to 28):|Other|0
2720410|NCT00265122|9358544|P5|Intervention Period 2 (Weeks 8 to 28):|Other|0
2720411|NCT00265122|9358545|P4|Intervention Period 2 (Weeks 8 to 28):|Other|1
2720412|NCT00265122|9358546|P3|Intervention Period 2 (Weeks 8 to 28):|Other|1
2720413|NCT00265122|9358547|P2|Intervention Period 2 (Weeks 8 to 28):|Other|0
2720414|NCT00265122|9358548|P1|Intervention Period 2 (Weeks 8 to 28):|Other|4
2720415|NCT00265122|9358543|P6|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
2720416|NCT00265122|9358544|P5|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
2720417|NCT00265122|9358545|P4|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
2720418|NCT00265122|9358546|P3|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
2720419|NCT00265122|9358547|P2|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
2720420|NCT00265122|9358548|P1|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
2720421|NCT00265122|9358543|P6|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0
2720422|NCT00265122|9358544|P5|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
2720423|NCT00265122|9358545|P4|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
2720424|NCT00265122|9358546|P3|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
2720425|NCT00265122|9358547|P2|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
2720426|NCT00265122|9358548|P1|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2
2720427|NCT00265122|9358543|P6|Intervention Period 1 (Weeks 0 to 8):|Other|0
2720428|NCT00265122|9358544|P5|Intervention Period 1 (Weeks 0 to 8):|Other|0
2720429|NCT00265122|9358545|P4|Intervention Period 1 (Weeks 0 to 8):|Other|1
2720430|NCT00265122|9358546|P3|Intervention Period 1 (Weeks 0 to 8):|Other|2
2720431|NCT00265122|9358547|P2|Intervention Period 1 (Weeks 0 to 8):|Other|1
2720432|NCT00265122|9358548|P1|Intervention Period 1 (Weeks 0 to 8):|Other|0
2720433|NCT00265122|9358543|P6|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
2720434|NCT00265122|9358544|P5|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
2720435|NCT00265122|9358545|P4|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
2720436|NCT00265122|9358546|P3|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
2720437|NCT00265122|9358547|P2|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
2720438|NCT00265122|9358548|P1|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
2720439|NCT00265122|9358543|P6|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
2720440|NCT00265122|9358544|P5|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
2720441|NCT00265122|9358545|P4|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
2720442|NCT00265122|9358546|P3|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3
2720443|NCT00265122|9358547|P2|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
2720444|NCT00265122|9358548|P1|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
2720445|NCT00265109|9358570|P1|Overall Study|Adverse Event|1
2720446|NCT00265109|9358570|P1|Overall Study|Withdrawal by Subject|5
2720447|NCT00265096|9358589|P3|Overall Study|Other|10
2720448|NCT00265096|9358590|P2|Overall Study|Other|19
2720449|NCT00265096|9358591|P1|Overall Study|Other|11
2720450|NCT00265096|9358589|P3|Overall Study|Unsatisfactory therapeutic effect|6
2720451|NCT00265096|9358590|P2|Overall Study|Unsatisfactory therapeutic effect|8
2720452|NCT00265096|9358591|P1|Overall Study|Unsatisfactory therapeutic effect|9
2720453|NCT00265096|9358589|P3|Overall Study|Death|2
2720454|NCT00265096|9358590|P2|Overall Study|Death|1
2720455|NCT00265096|9358591|P1|Overall Study|Death|0
2720456|NCT00265096|9358589|P3|Overall Study|Lost to Follow-up|3
2720457|NCT00265096|9358590|P2|Overall Study|Lost to Follow-up|5
2720458|NCT00265096|9358591|P1|Overall Study|Lost to Follow-up|2
2720459|NCT00265096|9358589|P3|Overall Study|Adverse Event|18
2720460|NCT00265096|9358590|P2|Overall Study|Adverse Event|18
2720461|NCT00265096|9358591|P1|Overall Study|Adverse Event|14
2720462|NCT00265083|9358623|P3|Overall Study|Other|9
2720463|NCT00265083|9358624|P2|Overall Study|Other|12
2720464|NCT00265083|9358625|P1|Overall Study|Other|1
2720465|NCT00265083|9358623|P3|Overall Study|Unsatisfactory therapeutic effect|14
2720466|NCT00265083|9358624|P2|Overall Study|Unsatisfactory therapeutic effect|13
2720467|NCT00265083|9358625|P1|Overall Study|Unsatisfactory therapeutic effect|8
2720468|NCT00265083|9358623|P3|Overall Study|Lost to Follow-up|4
2720469|NCT00265083|9358624|P2|Overall Study|Lost to Follow-up|4
2720470|NCT00265083|9358625|P1|Overall Study|Lost to Follow-up|3
2720471|NCT00265083|9358623|P3|Overall Study|Adverse Event|15
2720472|NCT00265083|9358624|P2|Overall Study|Adverse Event|13
2720473|NCT00265083|9358625|P1|Overall Study|Adverse Event|5
2720474|NCT00264875|9358646|P1|Overall Study|Withdrawal by Subject|7
2720475|NCT00264875|9358646|P1|Overall Study|Protocol Violation|11
2720476|NCT00264875|9358646|P1|Overall Study|Lost to Follow-up|6
2720477|NCT00264875|9358646|P1|Overall Study|Adverse Event|6
2720478|NCT00264849|9358652|P2|Overall Study|Administrative Problems|0
2720479|NCT00264849|9358653|P1|Overall Study|Administrative Problems|2
2720480|NCT00264849|9358652|P2|Overall Study|Death|1
2720481|NCT00264849|9358653|P1|Overall Study|Death|0
2720482|NCT00264849|9358652|P2|Overall Study|Lost to Follow-up|2
2720483|NCT00264849|9358653|P1|Overall Study|Lost to Follow-up|0
2720484|NCT00264849|9358652|P2|Overall Study|Lack of Efficacy|6
2720485|NCT00264849|9358653|P1|Overall Study|Lack of Efficacy|1
2720486|NCT00264849|9358652|P2|Overall Study|Protocol Violation|3
2720487|NCT00264849|9358653|P1|Overall Study|Protocol Violation|5
2720488|NCT00264849|9358652|P2|Overall Study|Withdrawal by Subject|11
2720489|NCT00264849|9358653|P1|Overall Study|Withdrawal by Subject|7
2720490|NCT00264849|9358652|P2|Overall Study|Adverse Event|2
2720491|NCT00264849|9358653|P1|Overall Study|Adverse Event|7
2720492|NCT00264810|9358687|P2|Open Label Evaluation Period|Pursue Other Treatment Options|3
2720493|NCT00264810|9358688|P1|Open Label Evaluation Period|Pursue Other Treatment Options|2
2720494|NCT00264810|9358687|P2|Open Label Evaluation Period|Death|2
2720495|NCT00264810|9358688|P1|Open Label Evaluation Period|Death|3
2720496|NCT00264810|9358687|P2|Open Label Evaluation Period|Explant due to infection|1
2720497|NCT00264810|9358688|P1|Open Label Evaluation Period|Explant due to infection|1
2720498|NCT00264810|9358687|P2|Blinded Evaluation Period|Explant due to infection|1
2720499|NCT00264810|9358688|P1|Blinded Evaluation Period|Explant due to infection|1
2720500|NCT00264810|9358687|P2|Stimulation Optimization Period|Death|1
2720501|NCT00264810|9358688|P1|Stimulation Optimization Period|Death|0
2720502|NCT00264810|9358687|P2|Stimulation Optimization Period|Withdrawal by Subject|0
2720503|NCT00264810|9358688|P1|Stimulation Optimization Period|Withdrawal by Subject|1
2720504|NCT00264810|9358687|P2|Baseline|Other|1
2720505|NCT00264810|9358688|P1|Baseline|Other|0
2720506|NCT00264810|9358687|P2|Baseline|Did not Meet/Maintain Study I/E Criteria|2
2720507|NCT00264810|9358688|P1|Baseline|Did not Meet/Maintain Study I/E Criteria|1
2720508|NCT00264810|9358687|P2|Baseline|Insufficient Seizure Frequency|2
2720509|NCT00264810|9358688|P1|Baseline|Insufficient Seizure Frequency|2
2720510|NCT00264810|9358687|P2|Baseline|Subject Compliance Failure|3
2720511|NCT00264810|9358688|P1|Baseline|Subject Compliance Failure|3
2720512|NCT00264810|9358687|P2|Baseline|Physician Decision|8
2720513|NCT00264810|9358688|P1|Baseline|Physician Decision|7
2720514|NCT00264810|9358687|P2|Baseline|Withdrawal by Subject|10
2720515|NCT00264810|9358688|P1|Baseline|Withdrawal by Subject|10
2720516|NCT00264797|9358698|P2|Overall Study|Other|4
2720517|NCT00264797|9358699|P1|Overall Study|Other|3
2720518|NCT00264797|9358698|P2|Overall Study|Feels treatment not necessary, not worki|1
2720519|NCT00264797|9358699|P1|Overall Study|Feels treatment not necessary, not worki|0
2720520|NCT00264797|9358698|P2|Overall Study|Pressure/advice from Outsiders|1
2720521|NCT00264797|9358699|P1|Overall Study|Pressure/advice from Outsiders|1
2720522|NCT00264797|9358698|P2|Overall Study|Incarceration|5
2720523|NCT00264797|9358699|P1|Overall Study|Incarceration|4
2720524|NCT00264797|9358698|P2|Overall Study|Practical Problems|3
2720525|NCT00264797|9358699|P1|Overall Study|Practical Problems|2
2720526|NCT00264797|9358698|P2|Overall Study|Moved from area|1
2720527|NCT00264797|9358699|P1|Overall Study|Moved from area|3
2720528|NCT00264797|9358698|P2|Overall Study|Lost to Follow-up|17
2720529|NCT00264797|9358699|P1|Overall Study|Lost to Follow-up|9
2720530|NCT00264797|9358698|P2|Overall Study|Withdrawal by Subject|11
2720531|NCT00264797|9358699|P1|Overall Study|Withdrawal by Subject|11
2720532|NCT00264576|9358721|P2|Overall Study|Lost to Follow-up|1
2720533|NCT00264576|9358722|P1|Overall Study|Lost to Follow-up|1
2720534|NCT00264550|9358746|P4|Overall Study|Other|9
2720535|NCT00264550|9358747|P3|Overall Study|Other|3
2720536|NCT00264550|9358748|P2|Overall Study|Other|7
2720537|NCT00264550|9358749|P1|Overall Study|Other|13
2720538|NCT00264550|9358746|P4|Overall Study|Discontinued oral study agent|0
2720539|NCT00264550|9358747|P3|Overall Study|Discontinued oral study agent|0
2720540|NCT00264550|9358748|P2|Overall Study|Discontinued oral study agent|1
2720541|NCT00264550|9358749|P1|Overall Study|Discontinued oral study agent|0
2720542|NCT00264550|9358746|P4|Overall Study|Unsatisfactory therapeutic effect|6
2720543|NCT00264550|9358747|P3|Overall Study|Unsatisfactory therapeutic effect|4
2720544|NCT00264550|9358748|P2|Overall Study|Unsatisfactory therapeutic effect|11
2720545|NCT00264550|9358749|P1|Overall Study|Unsatisfactory therapeutic effect|4
2720546|NCT00264550|9358746|P4|Overall Study|Adverse Event|14
2720547|NCT00264550|9358747|P3|Overall Study|Adverse Event|9
2720548|NCT00264550|9358748|P2|Overall Study|Adverse Event|18
2720549|NCT00264550|9358749|P1|Overall Study|Adverse Event|23
2720550|NCT00264550|9358746|P4|Overall Study|Lost to Follow-up|1
2720551|NCT00264550|9358747|P3|Overall Study|Lost to Follow-up|1
2720552|NCT00264550|9358748|P2|Overall Study|Lost to Follow-up|1
2720553|NCT00264550|9358749|P1|Overall Study|Lost to Follow-up|3
2720554|NCT00264550|9358746|P4|Overall Study|Death|0
2720555|NCT00264550|9358747|P3|Overall Study|Death|0
2720556|NCT00264550|9358748|P2|Overall Study|Death|3
2720557|NCT00264550|9358749|P1|Overall Study|Death|0
2720558|NCT00264537|9358788|P4|Overall Study|Not treated|0
2720559|NCT00264537|9358789|P3|Overall Study|Not treated|1
2720560|NCT00264537|9358790|P2|Overall Study|Not treated|2
2720561|NCT00264537|9358791|P1|Overall Study|Not treated|0
2720562|NCT00264537|9358788|P4|Overall Study|Other|11
2720563|NCT00264537|9358789|P3|Overall Study|Other|10
2720564|NCT00264537|9358790|P2|Overall Study|Other|11
2720565|NCT00264537|9358791|P1|Overall Study|Other|21
2720566|NCT00264537|9358788|P4|Overall Study|Unsatisfactory therapeutic effect|7
2720567|NCT00264537|9358789|P3|Overall Study|Unsatisfactory therapeutic effect|5
2720568|NCT00264537|9358790|P2|Overall Study|Unsatisfactory therapeutic effect|6
2720569|NCT00264537|9358791|P1|Overall Study|Unsatisfactory therapeutic effect|5
2720570|NCT00264537|9358788|P4|Overall Study|Adverse Event|34
2720571|NCT00264537|9358789|P3|Overall Study|Adverse Event|24
2720572|NCT00264537|9358790|P2|Overall Study|Adverse Event|32
2720573|NCT00264537|9358791|P1|Overall Study|Adverse Event|21
2720574|NCT00264537|9358788|P4|Overall Study|Lost to Follow-up|6
2720575|NCT00264537|9358789|P3|Overall Study|Lost to Follow-up|7
2720576|NCT00264537|9358790|P2|Overall Study|Lost to Follow-up|4
2720577|NCT00264537|9358791|P1|Overall Study|Lost to Follow-up|3
2720578|NCT00264537|9358788|P4|Overall Study|Death|2
2720579|NCT00264537|9358789|P3|Overall Study|Death|3
2720580|NCT00264537|9358790|P2|Overall Study|Death|3
2720581|NCT00264537|9358791|P1|Overall Study|Death|0
2720582|NCT00264498|9358823|P2|Crossover Treatment|Withdrawal by Subject|0
2720583|NCT00264498|9358824|P1|Crossover Treatment|Withdrawal by Subject|1
2720584|NCT00264498|9358823|P2|Crossover Treatment|Study closure|1
2720585|NCT00264498|9358824|P1|Crossover Treatment|Study closure|0
2720586|NCT00264498|9358823|P2|Crossover Treatment|Objective disease progression|5
2720587|NCT00264498|9358824|P1|Crossover Treatment|Objective disease progression|4
2720588|NCT00264498|9358823|P2|Crossover Treatment|Death|3
2720589|NCT00264498|9358824|P1|Crossover Treatment|Death|1
2720590|NCT00264498|9358823|P2|Randomized Treatment|Protocol Violation|0
2720591|NCT00264498|9358824|P1|Randomized Treatment|Protocol Violation|1
2720592|NCT00264498|9358823|P2|Randomized Treatment|Study Closure|0
2720593|NCT00264498|9358824|P1|Randomized Treatment|Study Closure|1
2720594|NCT00264498|9358823|P2|Randomized Treatment|Incorrectly randomized|0
2720595|NCT00264498|9358824|P1|Randomized Treatment|Incorrectly randomized|1
2720596|NCT00264498|9358823|P2|Randomized Treatment|Physician Decision|0
2720597|NCT00264498|9358824|P1|Randomized Treatment|Physician Decision|1
2720598|NCT00264498|9358823|P2|Randomized Treatment|Objective disease Progression|14
2720599|NCT00264498|9358824|P1|Randomized Treatment|Objective disease Progression|13
2720600|NCT00264498|9358823|P2|Randomized Treatment|Withdrawal by Subject|1
2720601|NCT00264498|9358824|P1|Randomized Treatment|Withdrawal by Subject|0
2720602|NCT00264498|9358823|P2|Randomized Treatment|Death|3
2720603|NCT00264498|9358824|P1|Randomized Treatment|Death|0
2720604|NCT00264303|9358847|P2|Overall Study|Various reasons listed in study report|7
2720605|NCT00264303|9358848|P1|Overall Study|Various reasons listed in study report|6
2720606|NCT00264303|9358847|P2|Overall Study|Withdrawal by Subject|3
2720607|NCT00264303|9358848|P1|Overall Study|Withdrawal by Subject|2
2720608|NCT00264303|9358847|P2|Overall Study|Lost to Follow-up|3
2720609|NCT00264303|9358848|P1|Overall Study|Lost to Follow-up|3
2720610|NCT00264303|9358847|P2|Overall Study|Lack of Efficacy|13
2720611|NCT00264303|9358848|P1|Overall Study|Lack of Efficacy|10
2720612|NCT00264303|9358847|P2|Overall Study|Adverse Event|3
2720613|NCT00264303|9358848|P1|Overall Study|Adverse Event|4
2720614|NCT00264290|9358866|P2|Intervention (8 Weeks)|Adverse Event|0
2720615|NCT00264290|9358867|P1|Intervention (8 Weeks)|Adverse Event|1
2720616|NCT00264238|9358873|P1|Overall Study|Protocol Violation|1
2720617|NCT00264147|9358885|P6|Treatment II Period|Pre-scheduled total hip replacement|1
2720618|NCT00264147|9358886|P5|Treatment II Period|Pre-scheduled total hip replacement|0
2720619|NCT00264147|9358887|P4|Treatment II Period|Pre-scheduled total hip replacement|0
2720620|NCT00264147|9358888|P3|Treatment II Period|Pre-scheduled total hip replacement|0
2720621|NCT00264147|9358889|P2|Treatment II Period|Pre-scheduled total hip replacement|0
2720622|NCT00264147|9358890|P1|Treatment II Period|Pre-scheduled total hip replacement|0
2720623|NCT00264147|9358885|P6|Treatment II Period|Withdrawal by Subject|2
2720624|NCT00264147|9358886|P5|Treatment II Period|Withdrawal by Subject|3
2720625|NCT00264147|9358887|P4|Treatment II Period|Withdrawal by Subject|0
2720626|NCT00264147|9358888|P3|Treatment II Period|Withdrawal by Subject|0
2720627|NCT00264147|9358889|P2|Treatment II Period|Withdrawal by Subject|0
2720628|NCT00264147|9358890|P1|Treatment II Period|Withdrawal by Subject|0
2720629|NCT00264147|9358885|P6|Treatment II Period|Lost to Follow-up|1
2720630|NCT00264147|9358886|P5|Treatment II Period|Lost to Follow-up|1
2720631|NCT00264147|9358887|P4|Treatment II Period|Lost to Follow-up|0
2720632|NCT00264147|9358888|P3|Treatment II Period|Lost to Follow-up|0
2720633|NCT00264147|9358889|P2|Treatment II Period|Lost to Follow-up|0
2720634|NCT00264147|9358890|P1|Treatment II Period|Lost to Follow-up|0
2720635|NCT00264147|9358885|P6|Treatment II Period|Lack of Efficacy|19
2720636|NCT00264147|9358886|P5|Treatment II Period|Lack of Efficacy|20
2720637|NCT00264147|9358887|P4|Treatment II Period|Lack of Efficacy|0
2720638|NCT00264147|9358888|P3|Treatment II Period|Lack of Efficacy|0
2720639|NCT00264147|9358889|P2|Treatment II Period|Lack of Efficacy|0
2720640|NCT00264147|9358890|P1|Treatment II Period|Lack of Efficacy|0
2720641|NCT00264147|9358885|P6|Treatment II Period|Laboratory Adverse Event|1
2720642|NCT00264147|9358886|P5|Treatment II Period|Laboratory Adverse Event|0
2720643|NCT00264147|9358887|P4|Treatment II Period|Laboratory Adverse Event|0
2720644|NCT00264147|9358888|P3|Treatment II Period|Laboratory Adverse Event|0
2720645|NCT00264147|9358889|P2|Treatment II Period|Laboratory Adverse Event|0
2720646|NCT00264147|9358890|P1|Treatment II Period|Laboratory Adverse Event|0
2720647|NCT00264147|9358885|P6|Treatment II Period|Adverse Event|9
2720648|NCT00264147|9358886|P5|Treatment II Period|Adverse Event|9
2720649|NCT00264147|9358887|P4|Treatment II Period|Adverse Event|0
2720650|NCT00264147|9358888|P3|Treatment II Period|Adverse Event|0
2720651|NCT00264147|9358889|P2|Treatment II Period|Adverse Event|0
2720652|NCT00264147|9358890|P1|Treatment II Period|Adverse Event|0
2720653|NCT00264147|9358885|P6|Treatment I Period|Reassigned to Treatment II Period|0
2720654|NCT00264147|9358886|P5|Treatment I Period|Reassigned to Treatment II Period|45
2720655|NCT00264147|9358887|P4|Treatment I Period|Reassigned to Treatment II Period|63
2720656|NCT00264147|9358888|P3|Treatment I Period|Reassigned to Treatment II Period|65
2720657|NCT00264147|9358889|P2|Treatment I Period|Reassigned to Treatment II Period|72
2720658|NCT00264147|9358890|P1|Treatment I Period|Reassigned to Treatment II Period|84
2720659|NCT00264147|9358885|P6|Treatment I Period|Unblinded due to Serious Adverse Event|0
2720660|NCT00264147|9358886|P5|Treatment I Period|Unblinded due to Serious Adverse Event|0
2720661|NCT00264147|9358887|P4|Treatment I Period|Unblinded due to Serious Adverse Event|0
2720662|NCT00264147|9358888|P3|Treatment I Period|Unblinded due to Serious Adverse Event|1
2720663|NCT00264147|9358889|P2|Treatment I Period|Unblinded due to Serious Adverse Event|0
2720664|NCT00264147|9358890|P1|Treatment I Period|Unblinded due to Serious Adverse Event|0
2720665|NCT00264147|9358885|P6|Treatment I Period|Patient out of town for an extended time|0
2720666|NCT00264147|9358886|P5|Treatment I Period|Patient out of town for an extended time|0
2720667|NCT00264147|9358887|P4|Treatment I Period|Patient out of town for an extended time|0
2720668|NCT00264147|9358888|P3|Treatment I Period|Patient out of town for an extended time|0
2720669|NCT00264147|9358889|P2|Treatment I Period|Patient out of town for an extended time|1
2720670|NCT00264147|9358890|P1|Treatment I Period|Patient out of town for an extended time|0
2720671|NCT00264147|9358885|P6|Treatment I Period|Withdrawal by Subject|0
2720672|NCT00264147|9358886|P5|Treatment I Period|Withdrawal by Subject|2
2720673|NCT00264147|9358887|P4|Treatment I Period|Withdrawal by Subject|2
2720674|NCT00264147|9358888|P3|Treatment I Period|Withdrawal by Subject|0
2720675|NCT00264147|9358889|P2|Treatment I Period|Withdrawal by Subject|0
2720676|NCT00264147|9358890|P1|Treatment I Period|Withdrawal by Subject|2
2720677|NCT00264147|9358885|P6|Treatment I Period|Protocol Violation|0
2720678|NCT00264147|9358886|P5|Treatment I Period|Protocol Violation|0
2720679|NCT00264147|9358887|P4|Treatment I Period|Protocol Violation|0
2720680|NCT00264147|9358888|P3|Treatment I Period|Protocol Violation|0
2720681|NCT00264147|9358889|P2|Treatment I Period|Protocol Violation|2
2720682|NCT00264147|9358890|P1|Treatment I Period|Protocol Violation|2
2720683|NCT00264147|9358885|P6|Treatment I Period|Lost to Follow-up|0
2720684|NCT00264147|9358886|P5|Treatment I Period|Lost to Follow-up|1
2720685|NCT00264147|9358887|P4|Treatment I Period|Lost to Follow-up|1
2720686|NCT00264147|9358888|P3|Treatment I Period|Lost to Follow-up|0
2720687|NCT00264147|9358889|P2|Treatment I Period|Lost to Follow-up|0
2720688|NCT00264147|9358890|P1|Treatment I Period|Lost to Follow-up|1
2720689|NCT00264147|9358885|P6|Treatment I Period|Lack of Efficacy|0
2720690|NCT00264147|9358886|P5|Treatment I Period|Lack of Efficacy|1
2720691|NCT00264147|9358887|P4|Treatment I Period|Lack of Efficacy|0
2720692|NCT00264147|9358888|P3|Treatment I Period|Lack of Efficacy|8
2720693|NCT00264147|9358889|P2|Treatment I Period|Lack of Efficacy|2
2720694|NCT00264147|9358890|P1|Treatment I Period|Lack of Efficacy|6
2720695|NCT00264147|9358885|P6|Treatment I Period|Laboratory Adverse Event|0
2720696|NCT00264147|9358886|P5|Treatment I Period|Laboratory Adverse Event|0
2720697|NCT00264147|9358887|P4|Treatment I Period|Laboratory Adverse Event|1
2720698|NCT00264147|9358888|P3|Treatment I Period|Laboratory Adverse Event|0
2720699|NCT00264147|9358889|P2|Treatment I Period|Laboratory Adverse Event|0
2720700|NCT00264147|9358890|P1|Treatment I Period|Laboratory Adverse Event|0
2720701|NCT00264147|9358885|P6|Treatment I Period|Adverse Event|0
2720702|NCT00264147|9358886|P5|Treatment I Period|Adverse Event|7
2720703|NCT00264147|9358887|P4|Treatment I Period|Adverse Event|5
2720704|NCT00264147|9358888|P3|Treatment I Period|Adverse Event|3
2720705|NCT00264147|9358889|P2|Treatment I Period|Adverse Event|6
2720706|NCT00264147|9358890|P1|Treatment I Period|Adverse Event|3
2720707|NCT00264004|9358933|P4|Overall Study|Not treated|2
2720708|NCT00264004|9358934|P3|Overall Study|Not treated|2
2720709|NCT00264004|9358935|P2|Overall Study|Not treated|0
2720710|NCT00264004|9358936|P1|Overall Study|Not treated|3
2720711|NCT00264004|9358933|P4|Overall Study|Cond. under inv. worsened|4
2720712|NCT00264004|9358934|P3|Overall Study|Cond. under inv. worsened|3
2720713|NCT00264004|9358935|P2|Overall Study|Cond. under inv. worsened|5
2720714|NCT00264004|9358936|P1|Overall Study|Cond. under inv. worsened|9
2720715|NCT00264004|9358933|P4|Overall Study|Development study specific disc. crit.|0
2720716|NCT00264004|9358934|P3|Overall Study|Development study specific disc. crit.|1
2720717|NCT00264004|9358935|P2|Overall Study|Development study specific disc. crit.|0
2720718|NCT00264004|9358936|P1|Overall Study|Development study specific disc. crit.|1
2720719|NCT00264004|9358933|P4|Overall Study|Other|3
2720720|NCT00264004|9358934|P3|Overall Study|Other|0
2720721|NCT00264004|9358935|P2|Overall Study|Other|2
2720722|NCT00264004|9358936|P1|Overall Study|Other|2
2720723|NCT00264004|9358933|P4|Overall Study|Withdrawal by Subject|2
2720724|NCT00264004|9358934|P3|Overall Study|Withdrawal by Subject|2
2720725|NCT00264004|9358935|P2|Overall Study|Withdrawal by Subject|1
2720726|NCT00264004|9358936|P1|Overall Study|Withdrawal by Subject|0
2720727|NCT00264004|9358933|P4|Overall Study|Adverse Event|4
2720728|NCT00264004|9358934|P3|Overall Study|Adverse Event|6
2720729|NCT00264004|9358935|P2|Overall Study|Adverse Event|3
2720730|NCT00264004|9358936|P1|Overall Study|Adverse Event|2
2720731|NCT00263887|9358964|P2|Overall Study|Lack of Efficacy|1
2720732|NCT00263887|9358965|P1|Overall Study|Lack of Efficacy|0
2720733|NCT00263887|9358964|P2|Overall Study|Disease progression|1
2720734|NCT00263887|9358965|P1|Overall Study|Disease progression|0
2720735|NCT00263887|9358964|P2|Overall Study|Adverse Event|2
2720736|NCT00263887|9358965|P1|Overall Study|Adverse Event|0
2720737|NCT00263887|9358964|P2|Overall Study|Too ill to attend visit|0
2720738|NCT00263887|9358965|P1|Overall Study|Too ill to attend visit|1
2720739|NCT00263887|9358964|P2|Overall Study|Lung transplantation|2
2720740|NCT00263887|9358965|P1|Overall Study|Lung transplantation|1
2720741|NCT00263887|9358964|P2|Overall Study|Withdrawal by Subject|1
2720742|NCT00263887|9358965|P1|Overall Study|Withdrawal by Subject|1
2720743|NCT00263757|9358973|P2|Overall Study|Adverse Event|3
2720744|NCT00263757|9358974|P1|Overall Study|Adverse Event|3
2720745|NCT00263757|9358973|P2|Overall Study|Screen failure|1
2720746|NCT00263757|9358974|P1|Overall Study|Screen failure|0
2720747|NCT00263757|9358973|P2|Overall Study|Withdrawal by Subject|4
2720748|NCT00263757|9358974|P1|Overall Study|Withdrawal by Subject|5
2720749|NCT00263666|9358986|P2|Overall Study|Withdrawal by Subject|1
2720750|NCT00263666|9358987|P1|Overall Study|Withdrawal by Subject|0
2720751|NCT00263666|9358986|P2|Overall Study|Lost to Follow-up|2
2720752|NCT00263666|9358987|P1|Overall Study|Lost to Follow-up|1
2720753|NCT00263666|9358986|P2|Overall Study|Adverse Event|8
2720754|NCT00263666|9358987|P1|Overall Study|Adverse Event|6
2720755|NCT00263588|9359040|P2|Overall Study|Sponsor terminated study|1
2720756|NCT00263588|9359041|P1|Overall Study|Sponsor terminated study|0
2720757|NCT00263588|9359040|P2|Overall Study|Investigator decision|15
2720758|NCT00263588|9359041|P1|Overall Study|Investigator decision|7
2720759|NCT00263588|9359040|P2|Overall Study|Protocol Violation|1
2720760|NCT00263588|9359041|P1|Overall Study|Protocol Violation|0
2720761|NCT00263588|9359040|P2|Overall Study|Withdrawal by Subject|4
2720762|NCT00263588|9359041|P1|Overall Study|Withdrawal by Subject|3
2720763|NCT00263588|9359040|P2|Overall Study|Lost to Follow-up|10
2720764|NCT00263588|9359041|P1|Overall Study|Lost to Follow-up|7
2720765|NCT00263588|9359040|P2|Overall Study|disease progression, coma, 1 unknown|11
2720766|NCT00263588|9359041|P1|Overall Study|disease progression, coma, 1 unknown|10
2720767|NCT00263588|9359040|P2|Overall Study|Death|90
2720768|NCT00263588|9359041|P1|Overall Study|Death|54
2720769|NCT00263328|9359067|P3|Overall Study|Adverse Event|4
2720770|NCT00263328|9359068|P2|Overall Study|Adverse Event|1
2720771|NCT00263328|9359069|P1|Overall Study|Adverse Event|1
2720772|NCT00263328|9359067|P3|Overall Study|Other|1
2720773|NCT00263328|9359068|P2|Overall Study|Other|0
2720774|NCT00263328|9359069|P1|Overall Study|Other|3
2720775|NCT00263328|9359067|P3|Overall Study|Withdrawal by Subject|1
2720776|NCT00263328|9359068|P2|Overall Study|Withdrawal by Subject|0
2720777|NCT00263328|9359069|P1|Overall Study|Withdrawal by Subject|3
2720778|NCT00263328|9359067|P3|Overall Study|Lost to Follow-up|0
2720779|NCT00263328|9359068|P2|Overall Study|Lost to Follow-up|1
2720780|NCT00263328|9359069|P1|Overall Study|Lost to Follow-up|1
2720781|NCT00263328|9359067|P3|Overall Study|Death|1
2720782|NCT00263328|9359068|P2|Overall Study|Death|0
2720783|NCT00263328|9359069|P1|Overall Study|Death|0
2720784|NCT00263211|9359227|P2|Overall Study|Disease Progression|1
2720785|NCT00263211|9359228|P1|Overall Study|Disease Progression|0
2720786|NCT00263211|9359227|P2|Overall Study|Protocol Violation|0
2720787|NCT00263211|9359228|P1|Overall Study|Protocol Violation|1
2720788|NCT00263211|9359227|P2|Overall Study|Withdrawal by Subject|0
2720789|NCT00263211|9359228|P1|Overall Study|Withdrawal by Subject|3
2720790|NCT00263211|9359227|P2|Overall Study|Death|0
2720791|NCT00263211|9359228|P1|Overall Study|Death|1
2720792|NCT00262951|9359279|P1|Overall Study|Off treatment for other disease|1
2720793|NCT00262951|9359279|P1|Overall Study|Alternative treatment|3
2720794|NCT00262951|9359279|P1|Overall Study|Withdrawal by Subject|1
2720795|NCT00262951|9359279|P1|Overall Study|Death|1
2720796|NCT00262951|9359279|P1|Overall Study|Adverse Event|7
2720797|NCT00262951|9359279|P1|Overall Study|Progressive disease/relapse|3
2720798|NCT00262925|9359284|P1|Overall Study|Other|1
2720799|NCT00262925|9359284|P1|Overall Study|alternative therapy|1
2720800|NCT00262925|9359284|P1|Overall Study|Death|2
2720801|NCT00262925|9359284|P1|Overall Study|Adverse Event|4
2720802|NCT00262925|9359284|P1|Overall Study|Lack of Efficacy|3
2720803|NCT00262873|9359290|P1|Overall Study|Withdrawal by Subject|5
2720804|NCT00262873|9359290|P1|Overall Study|Adverse Event|3
2720805|NCT00262860|9359301|P1|Overall Study|Adverse Event|2
2720806|NCT00262847|9359310|P3|Overall Study|Did not receive study treatment|4
2720807|NCT00262847|9359311|P2|Overall Study|Did not receive study treatment|1
2720808|NCT00262847|9359312|P1|Overall Study|Did not receive study treatment|4
2720809|NCT00262847|9359310|P3|Overall Study|Other Reasons|27
2720810|NCT00262847|9359311|P2|Overall Study|Other Reasons|88
2720811|NCT00262847|9359312|P1|Overall Study|Other Reasons|79
2720812|NCT00262847|9359310|P3|Overall Study|Concomitant disease|4
2720813|NCT00262847|9359311|P2|Overall Study|Concomitant disease|2
2720814|NCT00262847|9359312|P1|Overall Study|Concomitant disease|3
2720815|NCT00262847|9359310|P3|Overall Study|Death|11
2720816|NCT00262847|9359311|P2|Overall Study|Death|8
2720817|NCT00262847|9359312|P1|Overall Study|Death|8
2720818|NCT00262847|9359310|P3|Overall Study|Adverse Event|108
2720819|NCT00262847|9359311|P2|Overall Study|Adverse Event|88
2720820|NCT00262847|9359312|P1|Overall Study|Adverse Event|74
2720821|NCT00262847|9359310|P3|Overall Study|Patient Refusal|47
2720822|NCT00262847|9359311|P2|Overall Study|Patient Refusal|52
2720823|NCT00262847|9359312|P1|Overall Study|Patient Refusal|41
2720824|NCT00262847|9359310|P3|Overall Study|Disease Progression|195
2720825|NCT00262847|9359311|P2|Overall Study|Disease Progression|274
2720826|NCT00262847|9359312|P1|Overall Study|Disease Progression|309
2720827|NCT00262834|9359331|P2|Overall Study|Surgery delayed/tissue not collected|4
2720828|NCT00262834|9359332|P1|Overall Study|Surgery delayed/tissue not collected|1
2720829|NCT00262821|9359345|P2|Overall Study|Inevaluable - inadequate data|4
2720830|NCT00262821|9359346|P1|Overall Study|Inevaluable - inadequate data|0
2720831|NCT00262821|9359345|P2|Overall Study|Ineligible - required test not done|4
2720832|NCT00262821|9359346|P1|Overall Study|Ineligible - required test not done|1
2720833|NCT00262821|9359345|P2|Overall Study|Ineligible - elevated creatinine|2
2720834|NCT00262821|9359346|P1|Overall Study|Ineligible - elevated creatinine|0
2720835|NCT00262821|9359345|P2|Overall Study|Ineligible - inadequate pathology|3
2720836|NCT00262821|9359346|P1|Overall Study|Ineligible - inadequate pathology|1
2720837|NCT00262821|9359345|P2|Overall Study|Ineligible - wrong primary|1
2720838|NCT00262821|9359346|P1|Overall Study|Ineligible - wrong primary|0
2720839|NCT00262821|9359345|P2|Overall Study|Ineligible - wrong cell type|2
2720840|NCT00262821|9359346|P1|Overall Study|Ineligible - wrong cell type|2
2720841|NCT00262821|9359345|P2|Overall Study|Ineligible - wrong stage|3
2720842|NCT00262821|9359346|P1|Overall Study|Ineligible - wrong stage|0
2720843|NCT00262743|9359358|P2|Overall Study|Disease progression|3
2720844|NCT00262743|9359359|P1|Overall Study|Disease progression|0
2720845|NCT00262743|9359358|P2|Overall Study|Adverse Event|9
2720846|NCT00262743|9359359|P1|Overall Study|Adverse Event|0
2720847|NCT00262600|9359394|P3|Overall Study|Other|62
2720848|NCT00262600|9359395|P2|Overall Study|Other|59
2720849|NCT00262600|9359396|P1|Overall Study|Other|58
2720850|NCT00262600|9359394|P3|Overall Study|Not Treated|24
2720851|NCT00262600|9359395|P2|Overall Study|Not Treated|17
2720852|NCT00262600|9359396|P1|Overall Study|Not Treated|32
2720853|NCT00262600|9359394|P3|Overall Study|Withdrawal by Subject|139
2720854|NCT00262600|9359395|P2|Overall Study|Withdrawal by Subject|145
2720855|NCT00262600|9359396|P1|Overall Study|Withdrawal by Subject|128
2720856|NCT00262600|9359394|P3|Overall Study|Lost to Follow-up|41
2720857|NCT00262600|9359395|P2|Overall Study|Lost to Follow-up|31
2720858|NCT00262600|9359396|P1|Overall Study|Lost to Follow-up|17
2720859|NCT00262522|9359423|P4|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
2720860|NCT00262522|9359424|P3|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9
2720861|NCT00262522|9359425|P2|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
2720862|NCT00262522|9359426|P1|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10
2720863|NCT00262522|9359423|P4|Study Start Through 96 Weeks|Virologic failure|0
2720864|NCT00262522|9359424|P3|Study Start Through 96 Weeks|Virologic failure|8
2720865|NCT00262522|9359425|P2|Study Start Through 96 Weeks|Virologic failure|0
2720866|NCT00262522|9359426|P1|Study Start Through 96 Weeks|Virologic failure|5
2720867|NCT00262522|9359423|P4|Study Start Through 96 Weeks|Death|0
2720868|NCT00262522|9359424|P3|Study Start Through 96 Weeks|Death|2
2720869|NCT00262522|9359425|P2|Study Start Through 96 Weeks|Death|0
2720870|NCT00262522|9359426|P1|Study Start Through 96 Weeks|Death|2
2720871|NCT00262522|9359423|P4|Study Start Through 96 Weeks|Noncompliance|0
2720872|NCT00262522|9359424|P3|Study Start Through 96 Weeks|Noncompliance|11
2720873|NCT00262522|9359425|P2|Study Start Through 96 Weeks|Noncompliance|0
2720874|NCT00262522|9359426|P1|Study Start Through 96 Weeks|Noncompliance|6
2720875|NCT00262522|9359423|P4|Study Start Through 96 Weeks|Lost to Follow-up|0
2720876|NCT00262522|9359424|P3|Study Start Through 96 Weeks|Lost to Follow-up|18
2720877|NCT00262522|9359425|P2|Study Start Through 96 Weeks|Lost to Follow-up|0
2720878|NCT00262522|9359426|P1|Study Start Through 96 Weeks|Lost to Follow-up|19
2720879|NCT00262522|9359423|P4|Study Start Through 96 Weeks|Withdrawal by Subject|0
2720880|NCT00262522|9359424|P3|Study Start Through 96 Weeks|Withdrawal by Subject|13
2720881|NCT00262522|9359425|P2|Study Start Through 96 Weeks|Withdrawal by Subject|0
2720882|NCT00262522|9359426|P1|Study Start Through 96 Weeks|Withdrawal by Subject|15
2720883|NCT00262522|9359423|P4|Study Start Through 96 Weeks|Adverse Event|0
2720884|NCT00262522|9359424|P3|Study Start Through 96 Weeks|Adverse Event|16
2720885|NCT00262522|9359425|P2|Study Start Through 96 Weeks|Adverse Event|0
2720886|NCT00262522|9359426|P1|Study Start Through 96 Weeks|Adverse Event|20
2720887|NCT00262522|9359423|P4|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
2720888|NCT00262522|9359424|P3|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7
2720889|NCT00262522|9359425|P2|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
2720890|NCT00262522|9359426|P1|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8
2720891|NCT00262522|9359423|P4|Study Start Through 48 Weeks|Virologic failure|0
2720892|NCT00262522|9359424|P3|Study Start Through 48 Weeks|Virologic failure|4
2720893|NCT00262522|9359425|P2|Study Start Through 48 Weeks|Virologic failure|0
2720894|NCT00262522|9359426|P1|Study Start Through 48 Weeks|Virologic failure|2
2720895|NCT00262522|9359423|P4|Study Start Through 48 Weeks|Death|0
2720896|NCT00262522|9359424|P3|Study Start Through 48 Weeks|Death|1
2720897|NCT00262522|9359425|P2|Study Start Through 48 Weeks|Death|0
2720898|NCT00262522|9359426|P1|Study Start Through 48 Weeks|Death|2
2720899|NCT00262522|9359423|P4|Study Start Through 48 Weeks|Noncompliance|0
2720900|NCT00262522|9359424|P3|Study Start Through 48 Weeks|Noncompliance|8
2720901|NCT00262522|9359425|P2|Study Start Through 48 Weeks|Noncompliance|0
2720902|NCT00262522|9359426|P1|Study Start Through 48 Weeks|Noncompliance|3
2720903|NCT00262522|9359423|P4|Study Start Through 48 Weeks|Lost to Follow-up|0
2720904|NCT00262522|9359424|P3|Study Start Through 48 Weeks|Lost to Follow-up|14
2720905|NCT00262522|9359425|P2|Study Start Through 48 Weeks|Lost to Follow-up|0
2720906|NCT00262522|9359426|P1|Study Start Through 48 Weeks|Lost to Follow-up|8
2720907|NCT00262522|9359423|P4|Study Start Through 48 Weeks|Withdrawal by Subject|0
2720908|NCT00262522|9359424|P3|Study Start Through 48 Weeks|Withdrawal by Subject|11
2720909|NCT00262522|9359425|P2|Study Start Through 48 Weeks|Withdrawal by Subject|0
2720910|NCT00262522|9359426|P1|Study Start Through 48 Weeks|Withdrawal by Subject|10
2720911|NCT00262522|9359423|P4|Study Start Through 48 Weeks|Adverse Event|0
2720912|NCT00262522|9359424|P3|Study Start Through 48 Weeks|Adverse Event|10
2720913|NCT00262522|9359425|P2|Study Start Through 48 Weeks|Adverse Event|0
2720914|NCT00262522|9359426|P1|Study Start Through 48 Weeks|Adverse Event|16
2720915|NCT00262522|9359423|P4|Study Start Through 8 Weeks|Death|0
2720916|NCT00262522|9359424|P3|Study Start Through 8 Weeks|Death|0
2720917|NCT00262522|9359425|P2|Study Start Through 8 Weeks|Death|0
2720918|NCT00262522|9359426|P1|Study Start Through 8 Weeks|Death|1
2720919|NCT00262522|9359423|P4|Study Start Through 8 Weeks|Noncompliance|2
2720920|NCT00262522|9359424|P3|Study Start Through 8 Weeks|Noncompliance|2
2720921|NCT00262522|9359425|P2|Study Start Through 8 Weeks|Noncompliance|0
2720922|NCT00262522|9359426|P1|Study Start Through 8 Weeks|Noncompliance|0
2720923|NCT00262522|9359423|P4|Study Start Through 8 Weeks|Lost to Follow-up|2
2720924|NCT00262522|9359424|P3|Study Start Through 8 Weeks|Lost to Follow-up|3
2720925|NCT00262522|9359425|P2|Study Start Through 8 Weeks|Lost to Follow-up|2
2720926|NCT00262522|9359426|P1|Study Start Through 8 Weeks|Lost to Follow-up|1
2720927|NCT00262522|9359423|P4|Study Start Through 8 Weeks|Withdrawal by Subject|0
2720928|NCT00262522|9359424|P3|Study Start Through 8 Weeks|Withdrawal by Subject|3
2720929|NCT00262522|9359425|P2|Study Start Through 8 Weeks|Withdrawal by Subject|1
2720930|NCT00262522|9359426|P1|Study Start Through 8 Weeks|Withdrawal by Subject|1
2720931|NCT00262522|9359423|P4|Study Start Through 8 Weeks|Adverse Event|1
2720932|NCT00262522|9359424|P3|Study Start Through 8 Weeks|Adverse Event|3
2720933|NCT00262522|9359425|P2|Study Start Through 8 Weeks|Adverse Event|2
2720934|NCT00262522|9359426|P1|Study Start Through 8 Weeks|Adverse Event|1
2720935|NCT00262314|9359455|P1|Overall Study|Administrative withdrawal|30
2720936|NCT00262314|9359455|P1|Overall Study|Lost to Follow-up|70
2720937|NCT00262314|9359455|P1|Overall Study|Other|95
2720938|NCT00262314|9359455|P1|Overall Study|Patient's decision|92
2720939|NCT00262314|9359455|P1|Overall Study|Death|12
2720940|NCT00262314|9359455|P1|Overall Study|Changing physicians|38
2720941|NCT00262301|9359473|P3|Double-blind Phase|"worsening of HAE symptoms"|0
2720942|NCT00262301|9359474|P2|Double-blind Phase|"worsening of HAE symptoms"|1
2720943|NCT00262301|9359475|P1|Double-blind Phase|"worsening of HAE symptoms"|0
2720944|NCT00262301|9359473|P3|Double-blind Phase|Lost to Follow-up|0
2720945|NCT00262301|9359474|P2|Double-blind Phase|Lost to Follow-up|0
2720946|NCT00262301|9359475|P1|Double-blind Phase|Lost to Follow-up|1
2720947|NCT00262223|9359488|P2|12-month Post-treatment Follow-up|Lost to Follow-up|7
2720948|NCT00262223|9359489|P1|12-month Post-treatment Follow-up|Lost to Follow-up|7
2720949|NCT00262223|9359488|P2|6-month Post-treatment Follow-up|Lost to Follow-up|1
2720950|NCT00262223|9359489|P1|6-month Post-treatment Follow-up|Lost to Follow-up|6
2720951|NCT00262223|9359488|P2|1-week Post-treatment Follow-up|Lost to Follow-up|4
2720952|NCT00262223|9359489|P1|1-week Post-treatment Follow-up|Lost to Follow-up|4
2720953|NCT00262223|9359488|P2|Treatment Phase|Adverse Event|2
2720954|NCT00262223|9359489|P1|Treatment Phase|Adverse Event|1
2720955|NCT00262223|9359488|P2|Treatment Phase|Withdrawal by Subject|6
2720956|NCT00262223|9359489|P1|Treatment Phase|Withdrawal by Subject|3
2720957|NCT00262119|9359500|P3|Overall Study|Death|16
2720958|NCT00262119|9359501|P2|Overall Study|Death|19
2720959|NCT00262119|9359502|P1|Overall Study|Death|20
2720960|NCT00262119|9359500|P3|Overall Study|Lost to Follow-up|42
2720961|NCT00262119|9359501|P2|Overall Study|Lost to Follow-up|51
2720962|NCT00262119|9359502|P1|Overall Study|Lost to Follow-up|38
2720963|NCT00262080|9359522|P3|Repeat Dose Treatment Period|enrolled in EDEMA4|0
2720964|NCT00262080|9359523|P2|Repeat Dose Treatment Period|enrolled in EDEMA4|0
2720965|NCT00262080|9359524|P1|Repeat Dose Treatment Period|enrolled in EDEMA4|1
2720966|NCT00262080|9359522|P3|Repeat Dose Treatment Period|Decision to discontinue the study|2
2720967|NCT00262080|9359523|P2|Repeat Dose Treatment Period|Decision to discontinue the study|0
2720968|NCT00262080|9359524|P1|Repeat Dose Treatment Period|Decision to discontinue the study|0
2720969|NCT00262080|9359522|P3|Repeat Dose Treatment Period|Lost to Follow-up|2
2720970|NCT00262080|9359523|P2|Repeat Dose Treatment Period|Lost to Follow-up|0
2720971|NCT00262080|9359524|P1|Repeat Dose Treatment Period|Lost to Follow-up|2
2720972|NCT00262080|9359522|P3|Repeat Dose Treatment Period|Withdrawal by Subject|1
2720973|NCT00262080|9359523|P2|Repeat Dose Treatment Period|Withdrawal by Subject|1
2720974|NCT00262080|9359524|P1|Repeat Dose Treatment Period|Withdrawal by Subject|0
2720975|NCT00262080|9359522|P3|Repeat Dose Treatment Period|Adverse Event|0
2720976|NCT00262080|9359523|P2|Repeat Dose Treatment Period|Adverse Event|0
2720977|NCT00262080|9359524|P1|Repeat Dose Treatment Period|Adverse Event|1
2720978|NCT00262080|9359522|P3|Double Blind Treatment Period|Lost to Follow-up|0
2720979|NCT00262080|9359523|P2|Double Blind Treatment Period|Lost to Follow-up|0
2720980|NCT00262080|9359524|P1|Double Blind Treatment Period|Lost to Follow-up|1
2720981|NCT00262067|9359544|P4|Overall Study|Patient Withdrew for Survival Follow-up|9
2720982|NCT00262067|9359545|P3|Overall Study|Patient Withdrew for Survival Follow-up|23
2720983|NCT00262067|9359546|P2|Overall Study|Patient Withdrew for Survival Follow-up|7
2720984|NCT00262067|9359547|P1|Overall Study|Patient Withdrew for Survival Follow-up|23
2720985|NCT00262067|9359544|P4|Overall Study|Sponsor's Decision to Terminate Study|0
2720986|NCT00262067|9359545|P3|Overall Study|Sponsor's Decision to Terminate Study|0
2720987|NCT00262067|9359546|P2|Overall Study|Sponsor's Decision to Terminate Study|0
2720988|NCT00262067|9359547|P1|Overall Study|Sponsor's Decision to Terminate Study|1
2720989|NCT00262067|9359544|P4|Overall Study|Lost to Follow-up|5
2720990|NCT00262067|9359545|P3|Overall Study|Lost to Follow-up|7
2720991|NCT00262067|9359546|P2|Overall Study|Lost to Follow-up|4
2720992|NCT00262067|9359547|P1|Overall Study|Lost to Follow-up|5
2720993|NCT00262067|9359544|P4|Overall Study|Death|99
2720994|NCT00262067|9359545|P3|Overall Study|Death|186
2720995|NCT00262067|9359546|P2|Overall Study|Death|89
2720996|NCT00262067|9359547|P1|Overall Study|Death|190
2720997|NCT00262041|9359581|P3|Overall Study|Unable to classify|0
2720998|NCT00262041|9359582|P2|Overall Study|Unable to classify|0
2720999|NCT00262041|9359583|P1|Overall Study|Unable to classify|1
2721000|NCT00262041|9359581|P3|Overall Study|Lost to Follow-up|5
2721001|NCT00262041|9359582|P2|Overall Study|Lost to Follow-up|1
2721002|NCT00262041|9359583|P1|Overall Study|Lost to Follow-up|1
2721003|NCT00262041|9359581|P3|Overall Study|Withdrawal by Subject|1
2721004|NCT00262041|9359582|P2|Overall Study|Withdrawal by Subject|3
2721005|NCT00262041|9359583|P1|Overall Study|Withdrawal by Subject|0
2721006|NCT00262028|9359612|P9|Overall Study|Unable to classify|1
2721007|NCT00262028|9359613|P8|Overall Study|Unable to classify|0
2721008|NCT00262028|9359614|P7|Overall Study|Unable to classify|0
2721009|NCT00262028|9359615|P6|Overall Study|Unable to classify|0
2721010|NCT00262028|9359616|P5|Overall Study|Unable to classify|0
2721011|NCT00262028|9359617|P4|Overall Study|Unable to classify|0
2721012|NCT00262028|9359618|P3|Overall Study|Unable to classify|0
2721013|NCT00262028|9359619|P2|Overall Study|Unable to classify|3
2721014|NCT00262028|9359620|P1|Overall Study|Unable to classify|0
2721015|NCT00262028|9359612|P9|Overall Study|Protocol Violation|0
2721016|NCT00262028|9359613|P8|Overall Study|Protocol Violation|0
2721017|NCT00262028|9359614|P7|Overall Study|Protocol Violation|0
2721018|NCT00262028|9359615|P6|Overall Study|Protocol Violation|0
2721019|NCT00262028|9359616|P5|Overall Study|Protocol Violation|0
2721020|NCT00262028|9359617|P4|Overall Study|Protocol Violation|1
2721021|NCT00262028|9359618|P3|Overall Study|Protocol Violation|0
2721022|NCT00262028|9359619|P2|Overall Study|Protocol Violation|0
2721023|NCT00262028|9359620|P1|Overall Study|Protocol Violation|0
2721024|NCT00262028|9359612|P9|Overall Study|Administrative Reason|10
2721025|NCT00262028|9359613|P8|Overall Study|Administrative Reason|6
2721026|NCT00262028|9359614|P7|Overall Study|Administrative Reason|4
2721027|NCT00262028|9359615|P6|Overall Study|Administrative Reason|7
2721028|NCT00262028|9359616|P5|Overall Study|Administrative Reason|6
2721029|NCT00262028|9359617|P4|Overall Study|Administrative Reason|12
2721030|NCT00262028|9359618|P3|Overall Study|Administrative Reason|9
2721031|NCT00262028|9359619|P2|Overall Study|Administrative Reason|14
2721032|NCT00262028|9359620|P1|Overall Study|Administrative Reason|11
2721033|NCT00262028|9359612|P9|Overall Study|Lost to Follow-up|6
2721034|NCT00262028|9359613|P8|Overall Study|Lost to Follow-up|5
2721035|NCT00262028|9359614|P7|Overall Study|Lost to Follow-up|3
2721036|NCT00262028|9359615|P6|Overall Study|Lost to Follow-up|3
2721037|NCT00262028|9359616|P5|Overall Study|Lost to Follow-up|4
2721038|NCT00262028|9359617|P4|Overall Study|Lost to Follow-up|5
2721039|NCT00262028|9359618|P3|Overall Study|Lost to Follow-up|5
2721040|NCT00262028|9359619|P2|Overall Study|Lost to Follow-up|7
2721041|NCT00262028|9359620|P1|Overall Study|Lost to Follow-up|7
2721042|NCT00262028|9359612|P9|Overall Study|Withdrawal by Subject|2
2721043|NCT00262028|9359613|P8|Overall Study|Withdrawal by Subject|7
2721044|NCT00262028|9359614|P7|Overall Study|Withdrawal by Subject|5
2721045|NCT00262028|9359615|P6|Overall Study|Withdrawal by Subject|3
2721046|NCT00262028|9359616|P5|Overall Study|Withdrawal by Subject|2
2721047|NCT00262028|9359617|P4|Overall Study|Withdrawal by Subject|5
2721048|NCT00262028|9359618|P3|Overall Study|Withdrawal by Subject|6
2721049|NCT00262028|9359619|P2|Overall Study|Withdrawal by Subject|3
2721050|NCT00262028|9359620|P1|Overall Study|Withdrawal by Subject|6
2721051|NCT00262002|9359682|P7|Overall Study|Unable to classify|2
2721052|NCT00262002|9359683|P6|Overall Study|Unable to classify|0
2721053|NCT00262002|9359684|P5|Overall Study|Unable to classify|0
2721054|NCT00262002|9359685|P4|Overall Study|Unable to classify|0
2721055|NCT00262002|9359686|P3|Overall Study|Unable to classify|0
2721056|NCT00262002|9359687|P2|Overall Study|Unable to classify|0
2721057|NCT00262002|9359688|P1|Overall Study|Unable to classify|0
2721058|NCT00262002|9359682|P7|Overall Study|Protocol Violation|2
2721059|NCT00262002|9359683|P6|Overall Study|Protocol Violation|3
2721060|NCT00262002|9359684|P5|Overall Study|Protocol Violation|5
2721061|NCT00262002|9359685|P4|Overall Study|Protocol Violation|2
2721062|NCT00262002|9359686|P3|Overall Study|Protocol Violation|0
2721063|NCT00262002|9359687|P2|Overall Study|Protocol Violation|2
2721064|NCT00262002|9359688|P1|Overall Study|Protocol Violation|3
2721065|NCT00262002|9359682|P7|Overall Study|Inapropriate enrollment|0
2721066|NCT00262002|9359683|P6|Overall Study|Inapropriate enrollment|0
2721067|NCT00262002|9359684|P5|Overall Study|Inapropriate enrollment|0
2721068|NCT00262002|9359685|P4|Overall Study|Inapropriate enrollment|0
2721069|NCT00262002|9359686|P3|Overall Study|Inapropriate enrollment|0
2721070|NCT00262002|9359687|P2|Overall Study|Inapropriate enrollment|1
2721071|NCT00262002|9359688|P1|Overall Study|Inapropriate enrollment|0
2721072|NCT00262002|9359682|P7|Overall Study|Lost to Follow-up|0
2721073|NCT00262002|9359683|P6|Overall Study|Lost to Follow-up|1
2721074|NCT00262002|9359684|P5|Overall Study|Lost to Follow-up|0
2721075|NCT00262002|9359685|P4|Overall Study|Lost to Follow-up|2
2721076|NCT00262002|9359686|P3|Overall Study|Lost to Follow-up|0
2721077|NCT00262002|9359687|P2|Overall Study|Lost to Follow-up|0
2721078|NCT00262002|9359688|P1|Overall Study|Lost to Follow-up|2
2721079|NCT00262002|9359682|P7|Overall Study|Withdrawal by Subject|2
2721080|NCT00262002|9359683|P6|Overall Study|Withdrawal by Subject|2
2721081|NCT00262002|9359684|P5|Overall Study|Withdrawal by Subject|2
2721082|NCT00262002|9359685|P4|Overall Study|Withdrawal by Subject|1
2721083|NCT00262002|9359686|P3|Overall Study|Withdrawal by Subject|0
2721084|NCT00262002|9359687|P2|Overall Study|Withdrawal by Subject|2
2721085|NCT00262002|9359688|P1|Overall Study|Withdrawal by Subject|4
2721086|NCT00262002|9359682|P7|Overall Study|Adverse Event|0
2721087|NCT00262002|9359683|P6|Overall Study|Adverse Event|1
2721088|NCT00262002|9359684|P5|Overall Study|Adverse Event|0
2721089|NCT00262002|9359685|P4|Overall Study|Adverse Event|0
2721090|NCT00262002|9359686|P3|Overall Study|Adverse Event|0
2721091|NCT00262002|9359687|P2|Overall Study|Adverse Event|1
2721092|NCT00262002|9359688|P1|Overall Study|Adverse Event|2
2721093|NCT00261950|9359781|P1|Overall Study|Protocol specified Criteria|11
2721094|NCT00261950|9359781|P1|Overall Study|Physician Decision|1
2721095|NCT00261950|9359781|P1|Overall Study|Other|1
2721096|NCT00261950|9359781|P1|Overall Study|Withdrawal by Subject|5
2721097|NCT00261950|9359781|P1|Overall Study|Death|6
2721098|NCT00261950|9359781|P1|Overall Study|Lost to Follow-up|2
2721099|NCT00261846|9359806|P12|Period 2: Part 2 (Efficacy)|Extension study|1
2721100|NCT00261846|9359807|P11|Period 2: Part 2 (Efficacy)|Extension study|1
2721101|NCT00261846|9359808|P10|Period 2: Part 2 (Efficacy)|Extension study|9
2721102|NCT00261846|9359809|P9|Period 2: Part 2 (Efficacy)|Extension study|5
2721103|NCT00261846|9359810|P8|Period 2: Part 2 (Efficacy)|Extension study|9
2721104|NCT00261846|9359811|P7|Period 2: Part 2 (Efficacy)|Extension study|4
2721105|NCT00261846|9359812|P6|Period 2: Part 2 (Efficacy)|Extension study|0
2721106|NCT00261846|9359813|P5|Period 2: Part 2 (Efficacy)|Extension study|27
2721107|NCT00261846|9359814|P4|Period 2: Part 2 (Efficacy)|Extension study|61
2721108|NCT00261846|9359815|P3|Period 2: Part 2 (Efficacy)|Extension study|0
2721109|NCT00261846|9359816|P2|Period 2: Part 2 (Efficacy)|Extension study|0
2721110|NCT00261846|9359817|P1|Period 2: Part 2 (Efficacy)|Extension study|0
2721111|NCT00261846|9359806|P12|Period 2: Part 2 (Efficacy)|Death|22
2721112|NCT00261846|9359807|P11|Period 2: Part 2 (Efficacy)|Death|44
2721113|NCT00261846|9359808|P10|Period 2: Part 2 (Efficacy)|Death|30
2721114|NCT00261846|9359809|P9|Period 2: Part 2 (Efficacy)|Death|3
2721115|NCT00261846|9359810|P8|Period 2: Part 2 (Efficacy)|Death|12
2721116|NCT00261846|9359811|P7|Period 2: Part 2 (Efficacy)|Death|10
2721117|NCT00261846|9359812|P6|Period 2: Part 2 (Efficacy)|Death|1
2721118|NCT00261846|9359813|P5|Period 2: Part 2 (Efficacy)|Death|7
2721119|NCT00261846|9359814|P4|Period 2: Part 2 (Efficacy)|Death|37
2721120|NCT00261846|9359815|P3|Period 2: Part 2 (Efficacy)|Death|0
2721121|NCT00261846|9359816|P2|Period 2: Part 2 (Efficacy)|Death|0
2721122|NCT00261846|9359817|P1|Period 2: Part 2 (Efficacy)|Death|0
2721123|NCT00261846|9359806|P12|Period 2: Part 2 (Efficacy)|Other|0
2721124|NCT00261846|9359807|P11|Period 2: Part 2 (Efficacy)|Other|0
2721125|NCT00261846|9359808|P10|Period 2: Part 2 (Efficacy)|Other|4
2721126|NCT00261846|9359809|P9|Period 2: Part 2 (Efficacy)|Other|4
2721127|NCT00261846|9359810|P8|Period 2: Part 2 (Efficacy)|Other|5
2721128|NCT00261846|9359811|P7|Period 2: Part 2 (Efficacy)|Other|1
2721129|NCT00261846|9359812|P6|Period 2: Part 2 (Efficacy)|Other|0
2721130|NCT00261846|9359813|P5|Period 2: Part 2 (Efficacy)|Other|4
2721131|NCT00261846|9359814|P4|Period 2: Part 2 (Efficacy)|Other|15
2721132|NCT00261846|9359815|P3|Period 2: Part 2 (Efficacy)|Other|0
2721133|NCT00261846|9359816|P2|Period 2: Part 2 (Efficacy)|Other|0
2721134|NCT00261846|9359817|P1|Period 2: Part 2 (Efficacy)|Other|0
2721135|NCT00261846|9359806|P12|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
2721136|NCT00261846|9359807|P11|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
2721137|NCT00261846|9359808|P10|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
2721138|NCT00261846|9359809|P9|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1
2721139|NCT00261846|9359810|P8|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
2721140|NCT00261846|9359811|P7|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
2721141|NCT00261846|9359812|P6|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
2721142|NCT00261846|9359813|P5|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
2721143|NCT00261846|9359814|P4|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12
2721144|NCT00261846|9359815|P3|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
2721145|NCT00261846|9359816|P2|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
2721146|NCT00261846|9359817|P1|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
2721147|NCT00261846|9359806|P12|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
2721148|NCT00261846|9359807|P11|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
2721149|NCT00261846|9359808|P10|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2
2721150|NCT00261846|9359809|P9|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
2721151|NCT00261846|9359810|P8|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
2721152|NCT00261846|9359811|P7|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
2721153|NCT00261846|9359812|P6|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1
2721154|NCT00261846|9359813|P5|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8
2721155|NCT00261846|9359814|P4|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9
2721156|NCT00261846|9359815|P3|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
2721157|NCT00261846|9359816|P2|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
2721158|NCT00261846|9359817|P1|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
2721159|NCT00261846|9359806|P12|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
2721160|NCT00261846|9359807|P11|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
2721161|NCT00261846|9359808|P10|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
2721162|NCT00261846|9359809|P9|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
2721163|NCT00261846|9359810|P8|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
2721164|NCT00261846|9359811|P7|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
2721165|NCT00261846|9359812|P6|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
2721166|NCT00261846|9359813|P5|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
2721167|NCT00261846|9359814|P4|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
2721168|NCT00261846|9359815|P3|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
2721169|NCT00261846|9359816|P2|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
2721170|NCT00261846|9359817|P1|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
2721171|NCT00261846|9359806|P12|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
2721172|NCT00261846|9359807|P11|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
2721173|NCT00261846|9359808|P10|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
2721174|NCT00261846|9359809|P9|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
2721175|NCT00261846|9359810|P8|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
2721176|NCT00261846|9359811|P7|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
2721177|NCT00261846|9359812|P6|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
2721178|NCT00261846|9359813|P5|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
2721179|NCT00261846|9359814|P4|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
2721180|NCT00261846|9359815|P3|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12
2721181|NCT00261846|9359816|P2|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
2721182|NCT00261846|9359817|P1|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
2721183|NCT00261833|9360076|P2|Overall Study|Not interested in being participant|1
2721184|NCT00261833|9360077|P1|Overall Study|Not interested in being participant|0
2721185|NCT00261833|9360076|P2|Overall Study|Missing reason|0
2721186|NCT00261833|9360077|P1|Overall Study|Missing reason|1
2721187|NCT00261833|9360076|P2|Overall Study|Lung transplantation|1
2721188|NCT00261833|9360077|P1|Overall Study|Lung transplantation|1
2721189|NCT00261833|9360076|P2|Overall Study|Suspicion of pulmonary cancer|1
2721190|NCT00261833|9360077|P1|Overall Study|Suspicion of pulmonary cancer|0
2721191|NCT00261833|9360076|P2|Overall Study|Protocol Violation|1
2721192|NCT00261833|9360077|P1|Overall Study|Protocol Violation|0
2721193|NCT00261833|9360076|P2|Overall Study|Withdrawal by Subject|7
2721194|NCT00261833|9360077|P1|Overall Study|Withdrawal by Subject|5
2721195|NCT00261833|9360076|P2|Overall Study|Adverse Event|4
2721196|NCT00261833|9360077|P1|Overall Study|Adverse Event|1
2721197|NCT00261833|9360076|P2|Overall Study|Death|3
2721198|NCT00261833|9360077|P1|Overall Study|Death|1
2721199|NCT00261716|9360111|P2|Overall Study|Lost to Follow-up|2
2721200|NCT00261716|9360112|P1|Overall Study|Lost to Follow-up|0
2721201|NCT00261716|9360111|P2|Overall Study|Withdrawal by Subject|8
2721202|NCT00261716|9360112|P1|Overall Study|Withdrawal by Subject|6
2721203|NCT00261495|9360132|P2|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
2721204|NCT00261495|9360133|P1|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
2721205|NCT00261495|9360132|P2|Extension Phase (Weeks 24 to 52)|Non-compliance|0
2721206|NCT00261495|9360133|P1|Extension Phase (Weeks 24 to 52)|Non-compliance|1
2721207|NCT00261495|9360132|P2|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
2721208|NCT00261495|9360133|P1|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
2721209|NCT00261495|9360132|P2|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
2721210|NCT00261495|9360133|P1|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
2721211|NCT00261495|9360132|P2|Extension Phase (Weeks 24 to 52)|Adverse Event|1
2721212|NCT00261495|9360133|P1|Extension Phase (Weeks 24 to 52)|Adverse Event|4
2721213|NCT00261495|9360132|P2|Extension Phase (Weeks 24 to 52)|Other|2
2721214|NCT00261495|9360133|P1|Extension Phase (Weeks 24 to 52)|Other|4
2721215|NCT00261495|9360132|P2|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0
2721216|NCT00261495|9360133|P1|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2
2721217|NCT00261495|9360132|P2|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0
2721218|NCT00261495|9360133|P1|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2
2721219|NCT00261495|9360132|P2|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
2721220|NCT00261495|9360133|P1|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
2721221|NCT00261495|9360132|P2|Maintenance Phase (Weeks 4 to 24)|Other|5
2721222|NCT00261495|9360133|P1|Maintenance Phase (Weeks 4 to 24)|Other|6
2721223|NCT00261495|9360132|P2|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2
2721224|NCT00261495|9360133|P1|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5
2721225|NCT00261495|9360132|P2|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5
2721226|NCT00261495|9360133|P1|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1
2721227|NCT00261495|9360132|P2|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5
2721228|NCT00261495|9360133|P1|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6
2721229|NCT00261495|9360132|P2|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10
2721230|NCT00261495|9360133|P1|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14
2721231|NCT00261495|9360132|P2|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20
2721232|NCT00261495|9360133|P1|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29
2721233|NCT00261495|9360132|P2|Titration Phase (Weeks 0 to 4)|Protocol Violation|4
2721234|NCT00261495|9360133|P1|Titration Phase (Weeks 0 to 4)|Protocol Violation|1
2721235|NCT00261495|9360132|P2|Titration Phase (Weeks 0 to 4)|Non-compliance|5
2721236|NCT00261495|9360133|P1|Titration Phase (Weeks 0 to 4)|Non-compliance|2
2721237|NCT00261495|9360132|P2|Titration Phase (Weeks 0 to 4)|Physician Decision|1
2721238|NCT00261495|9360133|P1|Titration Phase (Weeks 0 to 4)|Physician Decision|3
2721239|NCT00261495|9360132|P2|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
2721240|NCT00261495|9360133|P1|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
2721241|NCT00261495|9360132|P2|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11
2721242|NCT00261495|9360133|P1|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6
2721243|NCT00261495|9360132|P2|Titration Phase (Weeks 0 to 4)|Adverse Event|36
2721244|NCT00261495|9360133|P1|Titration Phase (Weeks 0 to 4)|Adverse Event|28
2721245|NCT00261443|9360297|P3|4: Extension Phase|Lost to Follow-up|0
2721246|NCT00261443|9360298|P2|4: Extension Phase|Lost to Follow-up|1
2721247|NCT00261443|9360299|P1|4: Extension Phase|Lost to Follow-up|0
2721248|NCT00261443|9360297|P3|4: Extension Phase|Withdrawal by Subject|2
2721249|NCT00261443|9360298|P2|4: Extension Phase|Withdrawal by Subject|1
2721250|NCT00261443|9360299|P1|4: Extension Phase|Withdrawal by Subject|0
2721251|NCT00261443|9360297|P3|4: Extension Phase|Adverse Event|0
2721252|NCT00261443|9360298|P2|4: Extension Phase|Adverse Event|1
2721253|NCT00261443|9360299|P1|4: Extension Phase|Adverse Event|0
2721254|NCT00261443|9360297|P3|3: Assessment of Relapse|Other Reasons|3
2721255|NCT00261443|9360298|P2|3: Assessment of Relapse|Other Reasons|4
2721256|NCT00261443|9360299|P1|3: Assessment of Relapse|Other Reasons|0
2721257|NCT00261443|9360297|P3|3: Assessment of Relapse|Administrative Reason By Sponsor|2
2721258|NCT00261443|9360298|P2|3: Assessment of Relapse|Administrative Reason By Sponsor|0
2721259|NCT00261443|9360299|P1|3: Assessment of Relapse|Administrative Reason By Sponsor|0
2721260|NCT00261443|9360297|P3|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1
2721261|NCT00261443|9360298|P2|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2
2721262|NCT00261443|9360299|P1|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0
2721263|NCT00261443|9360297|P3|3: Assessment of Relapse|Pregnancy|1
2721264|NCT00261443|9360298|P2|3: Assessment of Relapse|Pregnancy|2
2721265|NCT00261443|9360299|P1|3: Assessment of Relapse|Pregnancy|0
2721266|NCT00261443|9360297|P3|3: Assessment of Relapse|Poor/Noncompliance|3
2721267|NCT00261443|9360298|P2|3: Assessment of Relapse|Poor/Noncompliance|5
2721268|NCT00261443|9360299|P1|3: Assessment of Relapse|Poor/Noncompliance|0
2721269|NCT00261443|9360297|P3|3: Assessment of Relapse|Lost to Follow-up|6
2721270|NCT00261443|9360298|P2|3: Assessment of Relapse|Lost to Follow-up|7
2721271|NCT00261443|9360299|P1|3: Assessment of Relapse|Lost to Follow-up|0
2721272|NCT00261443|9360297|P3|3: Assessment of Relapse|Death|1
2721273|NCT00261443|9360298|P2|3: Assessment of Relapse|Death|0
2721274|NCT00261443|9360299|P1|3: Assessment of Relapse|Death|0
2721275|NCT00261443|9360297|P3|3: Assessment of Relapse|Withdrawal by Subject|15
2721276|NCT00261443|9360298|P2|3: Assessment of Relapse|Withdrawal by Subject|14
2721277|NCT00261443|9360299|P1|3: Assessment of Relapse|Withdrawal by Subject|0
2721278|NCT00261443|9360297|P3|3: Assessment of Relapse|Adverse Event|19
2721279|NCT00261443|9360298|P2|3: Assessment of Relapse|Adverse Event|15
2721280|NCT00261443|9360299|P1|3: Assessment of Relapse|Adverse Event|0
2721281|NCT00261443|9360297|P3|3: Assessment of Relapse|Lack of Efficacy|14
2721282|NCT00261443|9360298|P2|3: Assessment of Relapse|Lack of Efficacy|31
2721283|NCT00261443|9360299|P1|3: Assessment of Relapse|Lack of Efficacy|0
2721284|NCT00261443|9360297|P3|2: Stability & Maintenance of Stability|Other Reasons|0
2721285|NCT00261443|9360298|P2|2: Stability & Maintenance of Stability|Other Reasons|0
2721286|NCT00261443|9360299|P1|2: Stability & Maintenance of Stability|Other Reasons|13
2721287|NCT00261443|9360297|P3|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
2721288|NCT00261443|9360298|P2|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
2721289|NCT00261443|9360299|P1|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1
2721290|NCT00261443|9360297|P3|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
2721291|NCT00261443|9360298|P2|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
2721292|NCT00261443|9360299|P1|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32
2721293|NCT00261443|9360297|P3|2: Stability & Maintenance of Stability|Pregnancy|0
2721294|NCT00261443|9360298|P2|2: Stability & Maintenance of Stability|Pregnancy|0
2721295|NCT00261443|9360299|P1|2: Stability & Maintenance of Stability|Pregnancy|1
2721296|NCT00261443|9360297|P3|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
2721297|NCT00261443|9360298|P2|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
2721298|NCT00261443|9360299|P1|2: Stability & Maintenance of Stability|Poor/Noncompliance|33
2721299|NCT00261443|9360297|P3|2: Stability & Maintenance of Stability|Lost to Follow-up|0
2721300|NCT00261443|9360298|P2|2: Stability & Maintenance of Stability|Lost to Follow-up|0
2721301|NCT00261443|9360299|P1|2: Stability & Maintenance of Stability|Lost to Follow-up|59
2721302|NCT00261443|9360297|P3|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
2721303|NCT00261443|9360298|P2|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
2721304|NCT00261443|9360299|P1|2: Stability & Maintenance of Stability|Withdrawal by Subject|65
2721305|NCT00261443|9360297|P3|2: Stability & Maintenance of Stability|Adverse Event|0
2721306|NCT00261443|9360298|P2|2: Stability & Maintenance of Stability|Adverse Event|0
2721307|NCT00261443|9360299|P1|2: Stability & Maintenance of Stability|Adverse Event|93
2721308|NCT00261443|9360297|P3|2: Stability & Maintenance of Stability|Lack of Efficacy|0
2721309|NCT00261443|9360298|P2|2: Stability & Maintenance of Stability|Lack of Efficacy|0
2721310|NCT00261443|9360299|P1|2: Stability & Maintenance of Stability|Lack of Efficacy|43
2721311|NCT00261443|9360297|P3|1: Confirmation of Partial Nonresponse|Other Reasons|0
2721312|NCT00261443|9360298|P2|1: Confirmation of Partial Nonresponse|Other Reasons|0
2721313|NCT00261443|9360299|P1|1: Confirmation of Partial Nonresponse|Other Reasons|16
2721314|NCT00261443|9360297|P3|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
2721315|NCT00261443|9360298|P2|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
2721316|NCT00261443|9360299|P1|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307
2721317|NCT00261443|9360297|P3|1: Confirmation of Partial Nonresponse|Pregnancy|0
2721318|NCT00261443|9360298|P2|1: Confirmation of Partial Nonresponse|Pregnancy|0
2721319|NCT00261443|9360299|P1|1: Confirmation of Partial Nonresponse|Pregnancy|1
2721320|NCT00261443|9360297|P3|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
2721321|NCT00261443|9360298|P2|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
2721322|NCT00261443|9360299|P1|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23
2721323|NCT00261443|9360297|P3|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
2721324|NCT00261443|9360298|P2|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
2721325|NCT00261443|9360299|P1|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111
2721326|NCT00261443|9360297|P3|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
2721327|NCT00261443|9360298|P2|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
2721328|NCT00261443|9360299|P1|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93
2721329|NCT00261443|9360297|P3|1: Confirmation of Partial Nonresponse|Adverse Event|0
2721330|NCT00261443|9360298|P2|1: Confirmation of Partial Nonresponse|Adverse Event|0
2721331|NCT00261443|9360299|P1|1: Confirmation of Partial Nonresponse|Adverse Event|33
2721332|NCT00260832|9360584|P2|Overall Study|Protocol Violation|1
2721333|NCT00260832|9360585|P1|Overall Study|Protocol Violation|3
2721334|NCT00260832|9360584|P2|Overall Study|Other|7
2721335|NCT00260832|9360585|P1|Overall Study|Other|10
2721336|NCT00260832|9360584|P2|Overall Study|Death|62
2721337|NCT00260832|9360585|P1|Overall Study|Death|43
2721338|NCT00260832|9360584|P2|Overall Study|Physician Decision|9
2721339|NCT00260832|9360585|P1|Overall Study|Physician Decision|15
2721340|NCT00260832|9360584|P2|Overall Study|Withdrawal by Subject|17
2721341|NCT00260832|9360585|P1|Overall Study|Withdrawal by Subject|15
2721342|NCT00260832|9360584|P2|Overall Study|Progression|96
2721343|NCT00260832|9360585|P1|Overall Study|Progression|116
2721344|NCT00260832|9360584|P2|Overall Study|Adverse Event|19
2721345|NCT00260832|9360585|P1|Overall Study|Adverse Event|26
2721346|NCT00260533|9360614|P2|Overall Study|Other|3
2721347|NCT00260533|9360615|P1|Overall Study|Other|3
2721348|NCT00260429|9360623|P2|Overall Study|scheduled hand surgery|0
2721349|NCT00260429|9360624|P1|Overall Study|scheduled hand surgery|1
2721350|NCT00260429|9360623|P2|Overall Study|failure to follow appointments|0
2721351|NCT00260429|9360624|P1|Overall Study|failure to follow appointments|1
2721352|NCT00260208|9360632|P2|Overall Study|Missing|16
2721353|NCT00260208|9360633|P1|Overall Study|Missing|18
2721354|NCT00260208|9360632|P2|Overall Study|Death|10
2721355|NCT00260208|9360633|P1|Overall Study|Death|12
2721356|NCT00260208|9360632|P2|Overall Study|Lost to Follow-up|1
2721357|NCT00260208|9360633|P1|Overall Study|Lost to Follow-up|6
2721358|NCT00260208|9360632|P2|Overall Study|Subject withdrew consent|7
2721359|NCT00260208|9360633|P1|Overall Study|Subject withdrew consent|11
2721360|NCT00260065|9360676|P1|Overall Study|Medication Noncompliance|1
2721361|NCT00260065|9360676|P1|Overall Study|Not otherwise specified|8
2721362|NCT00260065|9360676|P1|Overall Study|Physician Decision|19
2721363|NCT00260065|9360676|P1|Overall Study|Withdrawal by Subject|13
2721364|NCT00260065|9360676|P1|Overall Study|Death|13
2721365|NCT00260065|9360676|P1|Overall Study|Adverse Event|17
2721366|NCT00260065|9360676|P1|Overall Study|Progressive Disease|22
2721367|NCT00259857|9360683|P2|24 Months Treatment|Lost to Follow-up|3
2721368|NCT00259857|9360684|P1|24 Months Treatment|Lost to Follow-up|0
2721369|NCT00259857|9360683|P2|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2
2721370|NCT00259857|9360684|P1|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1
2721371|NCT00259740|9360702|P2|Overall Study|Requirement for alternative therapy|4
2721372|NCT00259740|9360703|P1|Overall Study|Requirement for alternative therapy|0
2721373|NCT00259740|9360702|P2|Overall Study|Other|0
2721374|NCT00259740|9360703|P1|Overall Study|Other|3
2721375|NCT00259740|9360702|P2|Overall Study|Ongoing|3
2721376|NCT00259740|9360703|P1|Overall Study|Ongoing|17
2721377|NCT00259740|9360702|P2|Overall Study|Disease progression|36
2721378|NCT00259740|9360703|P1|Overall Study|Disease progression|19
2721379|NCT00259740|9360702|P2|Overall Study|Death|1
2721380|NCT00259740|9360703|P1|Overall Study|Death|1
2721381|NCT00259740|9360702|P2|Overall Study|Withdrawal by Subject|6
2721382|NCT00259740|9360703|P1|Overall Study|Withdrawal by Subject|2
2721383|NCT00259740|9360702|P2|Overall Study|Adverse Event|2
2721384|NCT00259740|9360703|P1|Overall Study|Adverse Event|0
2721385|NCT00259740|9360702|P2|Overall Study|Physician Decision|1
2721386|NCT00259740|9360703|P1|Overall Study|Physician Decision|1
2721387|NCT00259649|9360713|P1|Overall Study|irregular menses|3
2721388|NCT00259649|9360713|P1|Overall Study|Lost to Follow-up|7
2721389|NCT00259610|9360721|P4|Overall Study|Serious Adverse Event|2
2721390|NCT00259610|9360722|P3|Overall Study|Serious Adverse Event|2
2721391|NCT00259610|9360723|P2|Overall Study|Serious Adverse Event|2
2721392|NCT00259610|9360724|P1|Overall Study|Serious Adverse Event|8
2721393|NCT00259610|9360721|P4|Overall Study|Adverse Event|2
2721394|NCT00259610|9360722|P3|Overall Study|Adverse Event|5
2721395|NCT00259610|9360723|P2|Overall Study|Adverse Event|4
2721396|NCT00259610|9360724|P1|Overall Study|Adverse Event|3
2721397|NCT00259610|9360721|P4|Overall Study|non medical reason|3
2721398|NCT00259610|9360722|P3|Overall Study|non medical reason|10
2721399|NCT00259610|9360723|P2|Overall Study|non medical reason|2
2721400|NCT00259610|9360724|P1|Overall Study|non medical reason|6
2721401|NCT00259610|9360721|P4|Overall Study|Death|0
2721402|NCT00259610|9360722|P3|Overall Study|Death|2
2721403|NCT00259610|9360723|P2|Overall Study|Death|1
2721404|NCT00259610|9360724|P1|Overall Study|Death|1
2721405|NCT00259610|9360721|P4|Overall Study|Physician Decision|2
2721406|NCT00259610|9360722|P3|Overall Study|Physician Decision|7
2721407|NCT00259610|9360723|P2|Overall Study|Physician Decision|4
2721408|NCT00259610|9360724|P1|Overall Study|Physician Decision|6
2721409|NCT00259610|9360721|P4|Overall Study|Lost to Follow-up|15
2721410|NCT00259610|9360722|P3|Overall Study|Lost to Follow-up|18
2721411|NCT00259610|9360723|P2|Overall Study|Lost to Follow-up|8
2721412|NCT00259610|9360724|P1|Overall Study|Lost to Follow-up|19
2721413|NCT00259610|9360721|P4|Overall Study|Withdrawal by Subject|19
2721414|NCT00259610|9360722|P3|Overall Study|Withdrawal by Subject|29
2721415|NCT00259610|9360723|P2|Overall Study|Withdrawal by Subject|25
2721416|NCT00259610|9360724|P1|Overall Study|Withdrawal by Subject|33
2721417|NCT00259298|9360738|P1|Overall Study|Physician Decision|2
2721418|NCT00259298|9360738|P1|Overall Study|Withdrawal by Subject|1
2721419|NCT00259272|9360756|P4|Overall Study|Lost to Follow-up|1
2721420|NCT00259272|9360757|P3|Overall Study|Lost to Follow-up|0
2721421|NCT00259272|9360758|P2|Overall Study|Lost to Follow-up|0
2721422|NCT00259272|9360759|P1|Overall Study|Lost to Follow-up|1
2721423|NCT00259272|9360756|P4|Overall Study|Withdrawal by Subject|7
2721424|NCT00259272|9360757|P3|Overall Study|Withdrawal by Subject|2
2721425|NCT00259272|9360758|P2|Overall Study|Withdrawal by Subject|2
2721426|NCT00259272|9360759|P1|Overall Study|Withdrawal by Subject|4
2721427|NCT00259272|9360756|P4|Overall Study|Sponsor Decision|0
2721428|NCT00259272|9360757|P3|Overall Study|Sponsor Decision|0
2721429|NCT00259272|9360758|P2|Overall Study|Sponsor Decision|1
2721430|NCT00259272|9360759|P1|Overall Study|Sponsor Decision|0
2721431|NCT00259272|9360756|P4|Overall Study|Protocol Violation|1
2721432|NCT00259272|9360757|P3|Overall Study|Protocol Violation|0
2721433|NCT00259272|9360758|P2|Overall Study|Protocol Violation|0
2721434|NCT00259272|9360759|P1|Overall Study|Protocol Violation|2
2721435|NCT00259272|9360756|P4|Overall Study|Physician Decision|3
2721436|NCT00259272|9360757|P3|Overall Study|Physician Decision|1
2721437|NCT00259272|9360758|P2|Overall Study|Physician Decision|2
2721438|NCT00259272|9360759|P1|Overall Study|Physician Decision|1
2721439|NCT00259272|9360756|P4|Overall Study|Lack of Efficacy|6
2721440|NCT00259272|9360757|P3|Overall Study|Lack of Efficacy|2
2721441|NCT00259272|9360758|P2|Overall Study|Lack of Efficacy|1
2721442|NCT00259272|9360759|P1|Overall Study|Lack of Efficacy|5
2721443|NCT00259272|9360756|P4|Overall Study|Adverse Event|3
2721444|NCT00259272|9360757|P3|Overall Study|Adverse Event|0
2721445|NCT00259272|9360758|P2|Overall Study|Adverse Event|1
2721446|NCT00259272|9360759|P1|Overall Study|Adverse Event|2
2721447|NCT00259012|9360855|P2|Overall Study|Protocol Violation|1
2721448|NCT00259012|9360856|P1|Overall Study|Protocol Violation|1
2721449|NCT00259012|9360855|P2|Overall Study|Lost to Follow-up|1
2721450|NCT00259012|9360856|P1|Overall Study|Lost to Follow-up|0
2721451|NCT00259012|9360855|P2|Overall Study|Physician Decision|1
2721452|NCT00259012|9360856|P1|Overall Study|Physician Decision|0
2721453|NCT00259012|9360855|P2|Overall Study|Withdrawal by Subject|0
2721454|NCT00259012|9360856|P1|Overall Study|Withdrawal by Subject|1
2721455|NCT00259012|9360855|P2|Overall Study|Adverse Event|1
2721456|NCT00259012|9360856|P1|Overall Study|Adverse Event|0
2721457|NCT00258960|9360888|P1|Overall Study|Mistake|2
2721458|NCT00258960|9360888|P1|Overall Study|Withdrawal by Subject|1
2721459|NCT00258960|9360888|P1|Overall Study|Physician Decision|1
2721460|NCT00258960|9360888|P1|Overall Study|Adverse Event|4
2721461|NCT00258960|9360888|P1|Overall Study|Disease Progression|7
2721462|NCT00258960|9360888|P1|Overall Study|Death|2
2721463|NCT00258895|9360904|P2|Overall Study|Withdrawal by Subject|0
2721464|NCT00258895|9360905|P1|Overall Study|Withdrawal by Subject|1
2721465|NCT00258895|9360904|P2|Overall Study|Protocol Violation|2
2721466|NCT00258895|9360905|P1|Overall Study|Protocol Violation|6
2721467|NCT00258895|9360904|P2|Overall Study|Lost to Follow-up|1
2721468|NCT00258895|9360905|P1|Overall Study|Lost to Follow-up|3
2721469|NCT00258856|9360941|P4|Overall Study|Non-compliance|1
2721470|NCT00258856|9360942|P3|Overall Study|Non-compliance|0
2721471|NCT00258856|9360943|P2|Overall Study|Non-compliance|0
2721472|NCT00258856|9360944|P1|Overall Study|Non-compliance|2
2721473|NCT00258856|9360941|P4|Overall Study|Lost to Follow-up|0
2721474|NCT00258856|9360942|P3|Overall Study|Lost to Follow-up|2
2721475|NCT00258856|9360943|P2|Overall Study|Lost to Follow-up|0
2721476|NCT00258856|9360944|P1|Overall Study|Lost to Follow-up|1
2721477|NCT00258674|9360985|P3|Overall Study|Death|34
2721478|NCT00258674|9360986|P2|Overall Study|Death|53
2721479|NCT00258674|9360987|P1|Overall Study|Death|32
2721480|NCT00258440|9361046|P3|Overall Study|Withdrawal by Subject|1
2721481|NCT00258440|9361047|P2|Overall Study|Withdrawal by Subject|0
2721482|NCT00258440|9361048|P1|Overall Study|Withdrawal by Subject|0
2721483|NCT00258154|9361086|P2|Overall Study|Patient Moved|1
2721484|NCT00258154|9361087|P1|Overall Study|Patient Moved|3
2721485|NCT00258154|9361086|P2|Overall Study|Withdrawal by Subject|4
2721486|NCT00258154|9361087|P1|Overall Study|Withdrawal by Subject|3
2721487|NCT00258154|9361086|P2|Overall Study|Protocol Violation|1
2721488|NCT00258154|9361087|P1|Overall Study|Protocol Violation|2
2721489|NCT00258154|9361086|P2|Overall Study|Lost to Follow-up|1
2721490|NCT00258154|9361087|P1|Overall Study|Lost to Follow-up|0
2721491|NCT00258154|9361086|P2|Overall Study|Adverse Event|0
2721492|NCT00258154|9361087|P1|Overall Study|Adverse Event|1
2721493|NCT00257920|9361182|P2|Period: Second Intervention|Other|1
2721494|NCT00257920|9361183|P1|Period: Second Intervention|Other|2
2721495|NCT00257920|9361182|P2|Period: Washout Period of Two Weeks|Lost to Follow-up|1
2721496|NCT00257920|9361183|P1|Period: Washout Period of Two Weeks|Lost to Follow-up|0
2721497|NCT00257660|9361239|P2|Overall Study|No longer wanted to do blood draws|0
2721498|NCT00257660|9361240|P1|Overall Study|No longer wanted to do blood draws|1
2721499|NCT00257660|9361239|P2|Overall Study|PI & Subject Schedule Conflicts|0
2721500|NCT00257660|9361240|P1|Overall Study|PI & Subject Schedule Conflicts|1
2721501|NCT00257660|9361239|P2|Overall Study|Lost to Follow-up|0
2721502|NCT00257660|9361240|P1|Overall Study|Lost to Follow-up|1
2721503|NCT00257660|9361239|P2|Overall Study|Withdrawal by Subject|0
2721504|NCT00257660|9361240|P1|Overall Study|Withdrawal by Subject|2
2721505|NCT00257660|9361239|P2|Overall Study|Lack of Efficacy|23
2721506|NCT00257660|9361240|P1|Overall Study|Lack of Efficacy|5
2721507|NCT00257608|9361270|P3|Post Chemotherapy Phase|Not treated|7
2721508|NCT00257608|9361271|P2|Post Chemotherapy Phase|Not treated|4
2721509|NCT00257608|9361272|P1|Post Chemotherapy Phase|Not treated|0
2721510|NCT00257608|9361270|P3|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
2721511|NCT00257608|9361271|P2|Post Chemotherapy Phase|Sponsor's decision to terminate study|1
2721512|NCT00257608|9361272|P1|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
2721513|NCT00257608|9361270|P3|Post Chemotherapy Phase|Physician Decision|11
2721514|NCT00257608|9361271|P2|Post Chemotherapy Phase|Physician Decision|8
2721515|NCT00257608|9361272|P1|Post Chemotherapy Phase|Physician Decision|0
2721516|NCT00257608|9361270|P3|Post Chemotherapy Phase|Lost to Follow-up|1
2721517|NCT00257608|9361271|P2|Post Chemotherapy Phase|Lost to Follow-up|0
2721518|NCT00257608|9361272|P1|Post Chemotherapy Phase|Lost to Follow-up|0
2721519|NCT00257608|9361270|P3|Post Chemotherapy Phase|Unrelated intercurrent illness|1
2721520|NCT00257608|9361271|P2|Post Chemotherapy Phase|Unrelated intercurrent illness|0
2721521|NCT00257608|9361272|P1|Post Chemotherapy Phase|Unrelated intercurrent illness|0
2721522|NCT00257608|9361270|P3|Post Chemotherapy Phase|Patient's decision to discontinue|8
2721523|NCT00257608|9361271|P2|Post Chemotherapy Phase|Patient's decision to discontinue|4
2721524|NCT00257608|9361272|P1|Post Chemotherapy Phase|Patient's decision to discontinue|0
2721525|NCT00257608|9361270|P3|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
2721526|NCT00257608|9361271|P2|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
2721527|NCT00257608|9361272|P1|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0
2721528|NCT00257608|9361270|P3|Post Chemotherapy Phase|Unwillingness or inability to comply|5
2721529|NCT00257608|9361271|P2|Post Chemotherapy Phase|Unwillingness or inability to comply|4
2721530|NCT00257608|9361272|P1|Post Chemotherapy Phase|Unwillingness or inability to comply|0
2721531|NCT00257608|9361270|P3|Post Chemotherapy Phase|Disease progression|168
2721532|NCT00257608|9361271|P2|Post Chemotherapy Phase|Disease progression|204
2721533|NCT00257608|9361272|P1|Post Chemotherapy Phase|Disease progression|0
2721534|NCT00257608|9361270|P3|Post Chemotherapy Phase|Adverse Event|38
2721535|NCT00257608|9361271|P2|Post Chemotherapy Phase|Adverse Event|34
2721536|NCT00257608|9361272|P1|Post Chemotherapy Phase|Adverse Event|0
2721537|NCT00257608|9361270|P3|Chemotherapy Phase|Physician Decision|0
2721538|NCT00257608|9361271|P2|Chemotherapy Phase|Physician Decision|0
2721539|NCT00257608|9361272|P1|Chemotherapy Phase|Physician Decision|28
2721540|NCT00257608|9361270|P3|Chemotherapy Phase|Unrelated intercurrent illness|0
2721541|NCT00257608|9361271|P2|Chemotherapy Phase|Unrelated intercurrent illness|0
2721542|NCT00257608|9361272|P1|Chemotherapy Phase|Unrelated intercurrent illness|3
2721543|NCT00257608|9361270|P3|Chemotherapy Phase|Patient's decision to discontinue|0
2721544|NCT00257608|9361271|P2|Chemotherapy Phase|Patient's decision to discontinue|0
2721545|NCT00257608|9361272|P1|Chemotherapy Phase|Patient's decision to discontinue|35
2721546|NCT00257608|9361270|P3|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
2721547|NCT00257608|9361271|P2|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
2721548|NCT00257608|9361272|P1|Chemotherapy Phase|Need for concomitant/ancillary therapy|27
2721549|NCT00257608|9361270|P3|Chemotherapy Phase|Unwillingness or inability to comply|0
2721550|NCT00257608|9361271|P2|Chemotherapy Phase|Unwillingness or inability to comply|0
2721551|NCT00257608|9361272|P1|Chemotherapy Phase|Unwillingness or inability to comply|6
2721552|NCT00257608|9361270|P3|Chemotherapy Phase|Disease progression|0
2721553|NCT00257608|9361271|P2|Chemotherapy Phase|Disease progression|0
2721554|NCT00257608|9361272|P1|Chemotherapy Phase|Disease progression|139
2721555|NCT00257608|9361270|P3|Chemotherapy Phase|Adverse Event|0
2721556|NCT00257608|9361271|P2|Chemotherapy Phase|Adverse Event|0
2721557|NCT00257608|9361272|P1|Chemotherapy Phase|Adverse Event|138
2721558|NCT00257556|9361298|P2|Overall Study|other reason|6
2721559|NCT00257556|9361299|P1|Overall Study|other reason|4
2721560|NCT00257556|9361298|P2|Overall Study|Did not meet hCG criterion|0
2721561|NCT00257556|9361299|P1|Overall Study|Did not meet hCG criterion|3
2721562|NCT00257556|9361298|P2|Overall Study|Physician Decision|0
2721563|NCT00257556|9361299|P1|Overall Study|Physician Decision|6
2721564|NCT00257556|9361298|P2|Overall Study|Adverse Event|4
2721565|NCT00257556|9361299|P1|Overall Study|Adverse Event|1
2721566|NCT00257192|9361343|P2|Overall Study|Miscellaneous|4
2721567|NCT00257192|9361344|P1|Overall Study|Miscellaneous|0
2721568|NCT00257192|9361343|P2|Overall Study|Study terminated by sponsor|0
2721569|NCT00257192|9361344|P1|Overall Study|Study terminated by sponsor|1
2721570|NCT00257192|9361343|P2|Overall Study|Randomized but not treated|1
2721571|NCT00257192|9361344|P1|Overall Study|Randomized but not treated|0
2721572|NCT00257192|9361343|P2|Overall Study|Withdrawal by Subject|2
2721573|NCT00257192|9361344|P1|Overall Study|Withdrawal by Subject|14
2721574|NCT00257192|9361343|P2|Overall Study|Insufficient clinical response|18
2721575|NCT00257192|9361344|P1|Overall Study|Insufficient clinical response|18
2721576|NCT00257192|9361343|P2|Overall Study|Lost to Follow-up|3
2721577|NCT00257192|9361344|P1|Overall Study|Lost to Follow-up|3
2721578|NCT00257192|9361343|P2|Overall Study|Laboratory abnormality|1
2721579|NCT00257192|9361344|P1|Overall Study|Laboratory abnormality|1
2721580|NCT00257192|9361343|P2|Overall Study|Adverse Event|10
2721581|NCT00257192|9361344|P1|Overall Study|Adverse Event|21
2721582|NCT00257166|9361388|P2|Overall Study|Randomized, but not treated|0
2721583|NCT00257166|9361389|P1|Overall Study|Randomized, but not treated|1
2721584|NCT00257166|9361388|P2|Overall Study|Other|21
2721585|NCT00257166|9361389|P1|Overall Study|Other|16
2721586|NCT00257166|9361388|P2|Overall Study|Withdrawal by Subject|2
2721587|NCT00257166|9361389|P1|Overall Study|Withdrawal by Subject|9
2721588|NCT00257166|9361388|P2|Overall Study|Lost to Follow-up|1
2721589|NCT00257166|9361389|P1|Overall Study|Lost to Follow-up|8
2721590|NCT00257166|9361388|P2|Overall Study|Laboratory abnormality|0
2721591|NCT00257166|9361389|P1|Overall Study|Laboratory abnormality|1
2721592|NCT00257166|9361388|P2|Overall Study|Adverse Event|13
2721593|NCT00257166|9361389|P1|Overall Study|Adverse Event|18
2721594|NCT00257010|9361401|P1|Overall Study|no headache reported|9
2721595|NCT00257010|9361401|P1|Overall Study|various|11
2721596|NCT00257010|9361401|P1|Overall Study|Adverse Event|10
2721597|NCT00257010|9361401|P1|Overall Study|Withdrawal by Subject|34
2721598|NCT00257010|9361401|P1|Overall Study|Lost to Follow-up|53
2721599|NCT00257010|9361401|P1|Overall Study|Lack of Efficacy|11
2721600|NCT00256997|9361412|P2|Overall Study|Investigator Withdrew Participant|1
2721601|NCT00256997|9361413|P1|Overall Study|Investigator Withdrew Participant|2
2721602|NCT00256997|9361412|P2|Overall Study|Participant Non-compliant|6
2721603|NCT00256997|9361413|P1|Overall Study|Participant Non-compliant|3
2721604|NCT00256997|9361412|P2|Overall Study|End of Study (As Per Sponsor)|24
2721605|NCT00256997|9361413|P1|Overall Study|End of Study (As Per Sponsor)|12
2721606|NCT00256997|9361412|P2|Overall Study|Other|8
2721607|NCT00256997|9361413|P1|Overall Study|Other|5
2721608|NCT00256997|9361412|P2|Overall Study|Started but not treated|0
2721609|NCT00256997|9361413|P1|Overall Study|Started but not treated|2
2721610|NCT00256997|9361412|P2|Overall Study|Withdrawal by Subject|3
2721611|NCT00256997|9361413|P1|Overall Study|Withdrawal by Subject|13
2721612|NCT00256997|9361412|P2|Overall Study|Lost to Follow-up|5
2721613|NCT00256997|9361413|P1|Overall Study|Lost to Follow-up|3
2721614|NCT00256997|9361412|P2|Overall Study|Adverse Event|0
2721615|NCT00256997|9361413|P1|Overall Study|Adverse Event|4
2721616|NCT00256997|9361412|P2|Overall Study|Death|0
2721617|NCT00256997|9361413|P1|Overall Study|Death|2
2721618|NCT00256997|9361412|P2|Overall Study|Lack of Efficacy|4
2721619|NCT00256997|9361413|P1|Overall Study|Lack of Efficacy|1
2721620|NCT00256997|9361412|P2|Overall Study|Protocol Violation|4
2721621|NCT00256997|9361413|P1|Overall Study|Protocol Violation|1
2721622|NCT00256867|9361455|P8|Overall Study|Withdrawal by participant|0
2721623|NCT00256867|9361456|P7|Overall Study|Withdrawal by participant|0
2721624|NCT00256867|9361457|P6|Overall Study|Withdrawal by participant|1
2721625|NCT00256867|9361458|P5|Overall Study|Withdrawal by participant|0
2721626|NCT00256867|9361459|P4|Overall Study|Withdrawal by participant|0
2721627|NCT00256867|9361460|P3|Overall Study|Withdrawal by participant|0
2721628|NCT00256867|9361461|P2|Overall Study|Withdrawal by participant|0
2721629|NCT00256867|9361462|P1|Overall Study|Withdrawal by participant|0
2721630|NCT00256867|9361455|P8|Overall Study|Participant out of assessment window|0
2721631|NCT00256867|9361456|P7|Overall Study|Participant out of assessment window|0
2721632|NCT00256867|9361457|P6|Overall Study|Participant out of assessment window|0
2721633|NCT00256867|9361458|P5|Overall Study|Participant out of assessment window|0
2721634|NCT00256867|9361459|P4|Overall Study|Participant out of assessment window|0
2721635|NCT00256867|9361460|P3|Overall Study|Participant out of assessment window|1
2721636|NCT00256867|9361461|P2|Overall Study|Participant out of assessment window|0
2721637|NCT00256867|9361462|P1|Overall Study|Participant out of assessment window|0
2721638|NCT00256867|9361455|P8|Overall Study|Participant travelled Overseas|0
2721639|NCT00256867|9361456|P7|Overall Study|Participant travelled Overseas|0
2721640|NCT00256867|9361457|P6|Overall Study|Participant travelled Overseas|0
2721641|NCT00256867|9361458|P5|Overall Study|Participant travelled Overseas|0
2721642|NCT00256867|9361459|P4|Overall Study|Participant travelled Overseas|0
2721643|NCT00256867|9361460|P3|Overall Study|Participant travelled Overseas|0
2721644|NCT00256867|9361461|P2|Overall Study|Participant travelled Overseas|1
2721645|NCT00256867|9361462|P1|Overall Study|Participant travelled Overseas|0
2721646|NCT00256867|9361455|P8|Overall Study|Non-compliance with study medication|1
2721647|NCT00256867|9361456|P7|Overall Study|Non-compliance with study medication|0
2721648|NCT00256867|9361457|P6|Overall Study|Non-compliance with study medication|0
2721649|NCT00256867|9361458|P5|Overall Study|Non-compliance with study medication|0
2721650|NCT00256867|9361459|P4|Overall Study|Non-compliance with study medication|0
2721651|NCT00256867|9361460|P3|Overall Study|Non-compliance with study medication|0
2721652|NCT00256867|9361461|P2|Overall Study|Non-compliance with study medication|0
2721653|NCT00256867|9361462|P1|Overall Study|Non-compliance with study medication|0
2721654|NCT00256867|9361455|P8|Overall Study|Investigator's Decision|0
2721655|NCT00256867|9361456|P7|Overall Study|Investigator's Decision|0
2721656|NCT00256867|9361457|P6|Overall Study|Investigator's Decision|0
2721657|NCT00256867|9361458|P5|Overall Study|Investigator's Decision|1
2721658|NCT00256867|9361459|P4|Overall Study|Investigator's Decision|0
2721659|NCT00256867|9361460|P3|Overall Study|Investigator's Decision|0
2721660|NCT00256867|9361461|P2|Overall Study|Investigator's Decision|0
2721661|NCT00256867|9361462|P1|Overall Study|Investigator's Decision|0
2721662|NCT00256867|9361455|P8|Overall Study|Glycemia over 13.3 millimole per litre|1
2721663|NCT00256867|9361456|P7|Overall Study|Glycemia over 13.3 millimole per litre|0
2721664|NCT00256867|9361457|P6|Overall Study|Glycemia over 13.3 millimole per litre|0
2721665|NCT00256867|9361458|P5|Overall Study|Glycemia over 13.3 millimole per litre|0
2721666|NCT00256867|9361459|P4|Overall Study|Glycemia over 13.3 millimole per litre|0
2721667|NCT00256867|9361460|P3|Overall Study|Glycemia over 13.3 millimole per litre|0
2721668|NCT00256867|9361461|P2|Overall Study|Glycemia over 13.3 millimole per litre|0
2721669|NCT00256867|9361462|P1|Overall Study|Glycemia over 13.3 millimole per litre|0
2721670|NCT00256867|9361455|P8|Overall Study|Fasting plasma glucose >240 mg/dL|0
2721671|NCT00256867|9361456|P7|Overall Study|Fasting plasma glucose >240 mg/dL|0
2721672|NCT00256867|9361457|P6|Overall Study|Fasting plasma glucose >240 mg/dL|0
2721673|NCT00256867|9361458|P5|Overall Study|Fasting plasma glucose >240 mg/dL|0
2721674|NCT00256867|9361459|P4|Overall Study|Fasting plasma glucose >240 mg/dL|0
2721675|NCT00256867|9361460|P3|Overall Study|Fasting plasma glucose >240 mg/dL|0
2721676|NCT00256867|9361461|P2|Overall Study|Fasting plasma glucose >240 mg/dL|1
2721677|NCT00256867|9361462|P1|Overall Study|Fasting plasma glucose >240 mg/dL|0
2721678|NCT00256867|9361455|P8|Overall Study|Withdrawal by Subject|2
2721679|NCT00256867|9361456|P7|Overall Study|Withdrawal by Subject|3
2721680|NCT00256867|9361457|P6|Overall Study|Withdrawal by Subject|2
2721681|NCT00256867|9361458|P5|Overall Study|Withdrawal by Subject|2
2721682|NCT00256867|9361459|P4|Overall Study|Withdrawal by Subject|1
2721683|NCT00256867|9361460|P3|Overall Study|Withdrawal by Subject|1
2721684|NCT00256867|9361461|P2|Overall Study|Withdrawal by Subject|0
2721685|NCT00256867|9361462|P1|Overall Study|Withdrawal by Subject|0
2721686|NCT00256867|9361455|P8|Overall Study|Protocol Violation|1
2721687|NCT00256867|9361456|P7|Overall Study|Protocol Violation|0
2721688|NCT00256867|9361457|P6|Overall Study|Protocol Violation|1
2721689|NCT00256867|9361458|P5|Overall Study|Protocol Violation|0
2721690|NCT00256867|9361459|P4|Overall Study|Protocol Violation|1
2721691|NCT00256867|9361460|P3|Overall Study|Protocol Violation|0
2721692|NCT00256867|9361461|P2|Overall Study|Protocol Violation|0
2721693|NCT00256867|9361462|P1|Overall Study|Protocol Violation|0
2721694|NCT00256867|9361455|P8|Overall Study|Lost to Follow-up|2
2721695|NCT00256867|9361456|P7|Overall Study|Lost to Follow-up|1
2721696|NCT00256867|9361457|P6|Overall Study|Lost to Follow-up|0
2721697|NCT00256867|9361458|P5|Overall Study|Lost to Follow-up|2
2721698|NCT00256867|9361459|P4|Overall Study|Lost to Follow-up|3
2721699|NCT00256867|9361460|P3|Overall Study|Lost to Follow-up|2
2721700|NCT00256867|9361461|P2|Overall Study|Lost to Follow-up|2
2721701|NCT00256867|9361462|P1|Overall Study|Lost to Follow-up|2
2721702|NCT00256867|9361455|P8|Overall Study|Adverse Event|4
2721703|NCT00256867|9361456|P7|Overall Study|Adverse Event|1
2721704|NCT00256867|9361457|P6|Overall Study|Adverse Event|2
2721705|NCT00256867|9361458|P5|Overall Study|Adverse Event|2
2721706|NCT00256867|9361459|P4|Overall Study|Adverse Event|1
2721707|NCT00256867|9361460|P3|Overall Study|Adverse Event|1
2721708|NCT00256867|9361461|P2|Overall Study|Adverse Event|1
2721709|NCT00256867|9361462|P1|Overall Study|Adverse Event|0
2721710|NCT00256854|9361552|P6|Overall Study|Not compliant with the study drug|0
2721711|NCT00256854|9361553|P5|Overall Study|Not compliant with the study drug|1
2721712|NCT00256854|9361554|P4|Overall Study|Not compliant with the study drug|0
2721713|NCT00256854|9361555|P3|Overall Study|Not compliant with the study drug|0
2721714|NCT00256854|9361556|P2|Overall Study|Not compliant with the study drug|0
2721715|NCT00256854|9361557|P1|Overall Study|Not compliant with the study drug|0
2721716|NCT00256854|9361552|P6|Overall Study|Adverse Event|1
2721717|NCT00256854|9361553|P5|Overall Study|Adverse Event|0
2721718|NCT00256854|9361554|P4|Overall Study|Adverse Event|2
2721719|NCT00256854|9361555|P3|Overall Study|Adverse Event|2
2721720|NCT00256854|9361556|P2|Overall Study|Adverse Event|0
2721721|NCT00256854|9361557|P1|Overall Study|Adverse Event|0
2721722|NCT00256854|9361552|P6|Overall Study|Protocol Violation|0
2721723|NCT00256854|9361553|P5|Overall Study|Protocol Violation|0
2721724|NCT00256854|9361554|P4|Overall Study|Protocol Violation|1
2721725|NCT00256854|9361555|P3|Overall Study|Protocol Violation|1
2721726|NCT00256854|9361556|P2|Overall Study|Protocol Violation|1
2721727|NCT00256854|9361557|P1|Overall Study|Protocol Violation|0
2721728|NCT00256854|9361552|P6|Overall Study|Lack of Efficacy|0
2721729|NCT00256854|9361553|P5|Overall Study|Lack of Efficacy|0
2721730|NCT00256854|9361554|P4|Overall Study|Lack of Efficacy|0
2721731|NCT00256854|9361555|P3|Overall Study|Lack of Efficacy|0
2721732|NCT00256854|9361556|P2|Overall Study|Lack of Efficacy|0
2721733|NCT00256854|9361557|P1|Overall Study|Lack of Efficacy|1
2721734|NCT00256854|9361552|P6|Overall Study|Withdrawal by Subject|0
2721735|NCT00256854|9361553|P5|Overall Study|Withdrawal by Subject|0
2721736|NCT00256854|9361554|P4|Overall Study|Withdrawal by Subject|0
2721737|NCT00256854|9361555|P3|Overall Study|Withdrawal by Subject|0
2721738|NCT00256854|9361556|P2|Overall Study|Withdrawal by Subject|3
2721739|NCT00256854|9361557|P1|Overall Study|Withdrawal by Subject|2
2721740|NCT00256750|9361616|P3|Long Term Extension (LTE; 84 Months)|Other|5
2721741|NCT00256750|9361617|P2|Long Term Extension (LTE; 84 Months)|Other|4
2721742|NCT00256750|9361618|P1|Long Term Extension (LTE; 84 Months)|Other|5
2721743|NCT00256750|9361616|P3|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0
2721744|NCT00256750|9361617|P2|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
2721745|NCT00256750|9361618|P1|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
2721746|NCT00256750|9361616|P3|Long Term Extension (LTE; 84 Months)|Pregnancy|2
2721747|NCT00256750|9361617|P2|Long Term Extension (LTE; 84 Months)|Pregnancy|1
2721748|NCT00256750|9361618|P1|Long Term Extension (LTE; 84 Months)|Pregnancy|0
2721749|NCT00256750|9361616|P3|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
2721750|NCT00256750|9361617|P2|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
2721751|NCT00256750|9361618|P1|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4
2721752|NCT00256750|9361616|P3|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0
2721753|NCT00256750|9361617|P2|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3
2721754|NCT00256750|9361618|P1|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6
2721755|NCT00256750|9361616|P3|Long Term Extension (LTE; 84 Months)|Death|4
2721756|NCT00256750|9361617|P2|Long Term Extension (LTE; 84 Months)|Death|4
2721757|NCT00256750|9361618|P1|Long Term Extension (LTE; 84 Months)|Death|9
2721758|NCT00256750|9361616|P3|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
2721759|NCT00256750|9361617|P2|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
2721760|NCT00256750|9361618|P1|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4
2721761|NCT00256750|9361616|P3|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1
2721762|NCT00256750|9361617|P2|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4
2721763|NCT00256750|9361618|P1|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5
2721764|NCT00256750|9361616|P3|Long Term Extension (LTE; 84 Months)|Adverse Event|14
2721765|NCT00256750|9361617|P2|Long Term Extension (LTE; 84 Months)|Adverse Event|11
2721766|NCT00256750|9361618|P1|Long Term Extension (LTE; 84 Months)|Adverse Event|13
2721767|NCT00256750|9361616|P3|Post-Transplant Treated (36 Months)|Other|1
2721768|NCT00256750|9361617|P2|Post-Transplant Treated (36 Months)|Other|1
2721769|NCT00256750|9361618|P1|Post-Transplant Treated (36 Months)|Other|0
2721770|NCT00256750|9361616|P3|Post-Transplant Treated (36 Months)|Protocol Violation|0
2721771|NCT00256750|9361617|P2|Post-Transplant Treated (36 Months)|Protocol Violation|1
2721772|NCT00256750|9361618|P1|Post-Transplant Treated (36 Months)|Protocol Violation|0
2721773|NCT00256750|9361616|P3|Post-Transplant Treated (36 Months)|Lack of Efficacy|0
2721774|NCT00256750|9361617|P2|Post-Transplant Treated (36 Months)|Lack of Efficacy|1
2721775|NCT00256750|9361618|P1|Post-Transplant Treated (36 Months)|Lack of Efficacy|4
2721776|NCT00256750|9361616|P3|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1
2721777|NCT00256750|9361617|P2|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
2721778|NCT00256750|9361618|P1|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
2721779|NCT00256750|9361616|P3|Post-Transplant Treated (36 Months)|Death|1
2721780|NCT00256750|9361617|P2|Post-Transplant Treated (36 Months)|Death|2
2721781|NCT00256750|9361618|P1|Post-Transplant Treated (36 Months)|Death|0
2721782|NCT00256750|9361616|P3|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
2721783|NCT00256750|9361617|P2|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0
2721784|NCT00256750|9361618|P1|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
2721785|NCT00256750|9361616|P3|Post-Transplant Treated (36 Months)|Adverse Event|2
2721786|NCT00256750|9361617|P2|Post-Transplant Treated (36 Months)|Adverse Event|1
2721787|NCT00256750|9361618|P1|Post-Transplant Treated (36 Months)|Adverse Event|5
2721788|NCT00256750|9361616|P3|Post-Transplant Treated (24 Months)|Other|1
2721789|NCT00256750|9361617|P2|Post-Transplant Treated (24 Months)|Other|0
2721790|NCT00256750|9361618|P1|Post-Transplant Treated (24 Months)|Other|2
2721791|NCT00256750|9361616|P3|Post-Transplant Treated (24 Months)|Lack of Efficacy|2
2721792|NCT00256750|9361617|P2|Post-Transplant Treated (24 Months)|Lack of Efficacy|3
2721793|NCT00256750|9361618|P1|Post-Transplant Treated (24 Months)|Lack of Efficacy|4
2721794|NCT00256750|9361616|P3|Post-Transplant Treated (24 Months)|Death|0
2721795|NCT00256750|9361617|P2|Post-Transplant Treated (24 Months)|Death|0
2721796|NCT00256750|9361618|P1|Post-Transplant Treated (24 Months)|Death|3
2721797|NCT00256750|9361616|P3|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0
2721798|NCT00256750|9361617|P2|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1
2721799|NCT00256750|9361618|P1|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5
2721800|NCT00256750|9361616|P3|Post-Transplant Treated (24 Months)|Adverse Event|6
2721801|NCT00256750|9361617|P2|Post-Transplant Treated (24 Months)|Adverse Event|3
2721802|NCT00256750|9361618|P1|Post-Transplant Treated (24 Months)|Adverse Event|7
2721803|NCT00256750|9361616|P3|Post-Transplant Treated (12 Months)|Protocol Violation|0
2721804|NCT00256750|9361617|P2|Post-Transplant Treated (12 Months)|Protocol Violation|0
2721805|NCT00256750|9361618|P1|Post-Transplant Treated (12 Months)|Protocol Violation|2
2721806|NCT00256750|9361616|P3|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5
2721807|NCT00256750|9361617|P2|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3
2721808|NCT00256750|9361618|P1|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0
2721809|NCT00256750|9361616|P3|Post-Transplant Treated (12 Months)|Other|2
2721810|NCT00256750|9361617|P2|Post-Transplant Treated (12 Months)|Other|4
2721811|NCT00256750|9361618|P1|Post-Transplant Treated (12 Months)|Other|5
2721812|NCT00256750|9361616|P3|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
2721813|NCT00256750|9361617|P2|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
2721814|NCT00256750|9361618|P1|Post-Transplant Treated (12 Months)|Lost to Follow-up|1
2721815|NCT00256750|9361616|P3|Post-Transplant Treated (12 Months)|Lack of Efficacy|27
2721816|NCT00256750|9361617|P2|Post-Transplant Treated (12 Months)|Lack of Efficacy|22
2721817|NCT00256750|9361618|P1|Post-Transplant Treated (12 Months)|Lack of Efficacy|10
2721818|NCT00256750|9361616|P3|Post-Transplant Treated (12 Months)|Death|4
2721819|NCT00256750|9361617|P2|Post-Transplant Treated (12 Months)|Death|2
2721820|NCT00256750|9361618|P1|Post-Transplant Treated (12 Months)|Death|3
2721821|NCT00256750|9361616|P3|Post-Transplant Treated (12 Months)|Adverse Event|8
2721822|NCT00256750|9361617|P2|Post-Transplant Treated (12 Months)|Adverse Event|12
2721823|NCT00256750|9361618|P1|Post-Transplant Treated (12 Months)|Adverse Event|20
2721824|NCT00256750|9361616|P3|Transplanted Pre-Treatment|Death|0
2721825|NCT00256750|9361617|P2|Transplanted Pre-Treatment|Death|0
2721826|NCT00256750|9361618|P1|Transplanted Pre-Treatment|Death|1
2721827|NCT00256750|9361616|P3|Transplanted Pre-Treatment|Other|0
2721828|NCT00256750|9361617|P2|Transplanted Pre-Treatment|Other|0
2721829|NCT00256750|9361618|P1|Transplanted Pre-Treatment|Other|2
2721830|NCT00256750|9361616|P3|Transplanted Pre-Treatment|Withdrawal by Subject|0
2721831|NCT00256750|9361617|P2|Transplanted Pre-Treatment|Withdrawal by Subject|0
2721832|NCT00256750|9361618|P1|Transplanted Pre-Treatment|Withdrawal by Subject|3
2721833|NCT00256724|9361754|P2|Overall Study|Protocol Violation|3
2721834|NCT00256724|9361755|P1|Overall Study|Protocol Violation|3
2721835|NCT00256724|9361754|P2|Overall Study|Physician Decision|5
2721836|NCT00256724|9361755|P1|Overall Study|Physician Decision|2
2721837|NCT00256698|9361765|P2|Overall Study|Prematurely Discontinued|0
2721838|NCT00256698|9361766|P1|Overall Study|Prematurely Discontinued|1
2721839|NCT00256698|9361765|P2|Overall Study|withdrawn due to osteoporosis|0
2721840|NCT00256698|9361766|P1|Overall Study|withdrawn due to osteoporosis|1
2721841|NCT00256698|9361765|P2|Overall Study|still ongoing at data cut-off|46
2721842|NCT00256698|9361766|P1|Overall Study|still ongoing at data cut-off|41
2721843|NCT00256698|9361765|P2|Overall Study|disease progression|105
2721844|NCT00256698|9361766|P1|Overall Study|disease progression|97
2721845|NCT00256698|9361765|P2|Overall Study|Lost to Follow-up|3
2721846|NCT00256698|9361766|P1|Overall Study|Lost to Follow-up|1
2721847|NCT00256698|9361765|P2|Overall Study|Protocol Violation|5
2721848|NCT00256698|9361766|P1|Overall Study|Protocol Violation|6
2721849|NCT00256698|9361765|P2|Overall Study|Adverse Event|6
2721850|NCT00256698|9361766|P1|Overall Study|Adverse Event|13
2721851|NCT00256698|9361765|P2|Overall Study|Withdrawal by Subject|7
2721852|NCT00256698|9361766|P1|Overall Study|Withdrawal by Subject|7
2721853|NCT00256308|9361813|P1|Overall Study|Death|2
2721854|NCT00256295|9361821|P1|Overall Study|Death|1
2721855|NCT00256295|9361821|P1|Overall Study|Withdrawal by Subject|3
2721856|NCT00256282|9361827|P1|Overall Study|Physician Decision|1
2721857|NCT00256282|9361827|P1|Overall Study|Adverse Event|3
2721858|NCT00256282|9361827|P1|Overall Study|Disease progression, relapse during acti|12
2721859|NCT00256243|9361832|P1|Overall Study|Not treated|1
2721860|NCT00256243|9361832|P1|Overall Study|Death|7
2721861|NCT00256243|9361832|P1|Overall Study|Lost to Follow-up|2
2721862|NCT00256204|9361841|P4|Overall Study|Need for additional prohibited treatment|25
2721863|NCT00256204|9361842|P3|Overall Study|Need for additional prohibited treatment|27
2721864|NCT00256204|9361843|P2|Overall Study|Need for additional prohibited treatment|28
2721865|NCT00256204|9361844|P1|Overall Study|Need for additional prohibited treatment|38
2721866|NCT00256204|9361841|P4|Overall Study|Withdrawal by Subject|5
2721867|NCT00256204|9361842|P3|Overall Study|Withdrawal by Subject|7
2721868|NCT00256204|9361843|P2|Overall Study|Withdrawal by Subject|6
2721869|NCT00256204|9361844|P1|Overall Study|Withdrawal by Subject|17
2721870|NCT00256204|9361841|P4|Overall Study|Physician Decision|2
2721871|NCT00256204|9361842|P3|Overall Study|Physician Decision|1
2721872|NCT00256204|9361843|P2|Overall Study|Physician Decision|0
2721873|NCT00256204|9361844|P1|Overall Study|Physician Decision|0
2721874|NCT00256204|9361841|P4|Overall Study|Protocol Violation|1
2721875|NCT00256204|9361842|P3|Overall Study|Protocol Violation|2
2721876|NCT00256204|9361843|P2|Overall Study|Protocol Violation|0
2721877|NCT00256204|9361844|P1|Overall Study|Protocol Violation|1
2721878|NCT00256204|9361841|P4|Overall Study|Lost to Follow-up|2
2721879|NCT00256204|9361842|P3|Overall Study|Lost to Follow-up|1
2721880|NCT00256204|9361843|P2|Overall Study|Lost to Follow-up|1
2721881|NCT00256204|9361844|P1|Overall Study|Lost to Follow-up|1
2721882|NCT00256204|9361841|P4|Overall Study|Death|0
2721883|NCT00256204|9361842|P3|Overall Study|Death|0
2721884|NCT00256204|9361843|P2|Overall Study|Death|1
2721885|NCT00256204|9361844|P1|Overall Study|Death|0
2721886|NCT00256204|9361841|P4|Overall Study|Adverse Event|14
2721887|NCT00256204|9361842|P3|Overall Study|Adverse Event|16
2721888|NCT00256204|9361843|P2|Overall Study|Adverse Event|14
2721889|NCT00256204|9361844|P1|Overall Study|Adverse Event|10
2721890|NCT00256126|9361859|P2|Overall Study|Other|2
2721891|NCT00256126|9361860|P1|Overall Study|Other|1
2721892|NCT00256126|9361859|P2|Overall Study|Adverse Event|0
2721893|NCT00256126|9361860|P1|Overall Study|Adverse Event|1
2721894|NCT00255840|9361899|P2|Overall Study|Discontinued intervention|56
2721895|NCT00255840|9361900|P1|Overall Study|Discontinued intervention|53
2721896|NCT00255840|9361899|P2|Overall Study|Lost to Follow-up|14
2721897|NCT00255840|9361900|P1|Overall Study|Lost to Follow-up|10
2721898|NCT00255723|9361913|P2|Overall Study|Response Data Not Available|0
2721899|NCT00255723|9361914|P1|Overall Study|Response Data Not Available|1
2721900|NCT00255723|9361913|P2|Overall Study|Death|1
2721901|NCT00255723|9361914|P1|Overall Study|Death|0
2721902|NCT00255723|9361913|P2|Overall Study|Adverse Event|1
2721903|NCT00255723|9361914|P1|Overall Study|Adverse Event|1
2721904|NCT00255346|9361930|P5|Overall Study|Adverse Event|0
2721905|NCT00255346|9361931|P4|Overall Study|Adverse Event|0
2721906|NCT00255346|9361932|P3|Overall Study|Adverse Event|0
2721907|NCT00255346|9361933|P2|Overall Study|Adverse Event|0
2721908|NCT00255346|9361934|P1|Overall Study|Adverse Event|1
2721909|NCT00255190|9361949|P2|Overall Study|Various|23
2721910|NCT00255190|9361950|P1|Overall Study|Various|4
2721911|NCT00255190|9361949|P2|Overall Study|Erosive esophagitis not healed|20
2721912|NCT00255190|9361950|P1|Overall Study|Erosive esophagitis not healed|0
2721913|NCT00255190|9361949|P2|Overall Study|Inclusion/Exclusion criteria not met|1
2721914|NCT00255190|9361950|P1|Overall Study|Inclusion/Exclusion criteria not met|0
2721915|NCT00255190|9361949|P2|Overall Study|Withdrew Consent|48
2721916|NCT00255190|9361950|P1|Overall Study|Withdrew Consent|17
2721917|NCT00255190|9361949|P2|Overall Study|Lost to Follow-up|27
2721918|NCT00255190|9361950|P1|Overall Study|Lost to Follow-up|10
2721919|NCT00255190|9361949|P2|Overall Study|Protocol Violation|2
2721920|NCT00255190|9361950|P1|Overall Study|Protocol Violation|2
2721921|NCT00255190|9361949|P2|Overall Study|Adverse Event|36
2721922|NCT00255190|9361950|P1|Overall Study|Adverse Event|17
2721923|NCT00255164|9362034|P3|Overall Study|Therapeutic Failure|3
2721924|NCT00255164|9362035|P2|Overall Study|Therapeutic Failure|2
2721925|NCT00255164|9362036|P1|Overall Study|Therapeutic Failure|11
2721926|NCT00255164|9362034|P3|Overall Study|Esophageal Stricture|1
2721927|NCT00255164|9362035|P2|Overall Study|Esophageal Stricture|0
2721928|NCT00255164|9362036|P1|Overall Study|Esophageal Stricture|0
2721929|NCT00255164|9362034|P3|Overall Study|Possible Barrett's Esophagus|8
2721930|NCT00255164|9362035|P2|Overall Study|Possible Barrett's Esophagus|3
2721931|NCT00255164|9362036|P1|Overall Study|Possible Barrett's Esophagus|1
2721932|NCT00255164|9362034|P3|Overall Study|Relapse of Erosive Esophagitis|12
2721933|NCT00255164|9362035|P2|Overall Study|Relapse of Erosive Esophagitis|16
2721934|NCT00255164|9362036|P1|Overall Study|Relapse of Erosive Esophagitis|78
2721935|NCT00255164|9362034|P3|Overall Study|Subject Request/Subject Unavailable|2
2721936|NCT00255164|9362035|P2|Overall Study|Subject Request/Subject Unavailable|1
2721937|NCT00255164|9362036|P1|Overall Study|Subject Request/Subject Unavailable|1
2721938|NCT00255164|9362034|P3|Overall Study|Noncompliance|2
2721939|NCT00255164|9362035|P2|Overall Study|Noncompliance|1
2721940|NCT00255164|9362036|P1|Overall Study|Noncompliance|0
2721941|NCT00255164|9362034|P3|Overall Study|Withdrawal by Subject|8
2721942|NCT00255164|9362035|P2|Overall Study|Withdrawal by Subject|17
2721943|NCT00255164|9362036|P1|Overall Study|Withdrawal by Subject|18
2721944|NCT00255164|9362034|P3|Overall Study|Lost to Follow-up|4
2721945|NCT00255164|9362035|P2|Overall Study|Lost to Follow-up|3
2721946|NCT00255164|9362036|P1|Overall Study|Lost to Follow-up|4
2721947|NCT00255164|9362034|P3|Overall Study|Adverse Event|9
2721948|NCT00255164|9362035|P2|Overall Study|Adverse Event|6
2721949|NCT00255164|9362036|P1|Overall Study|Adverse Event|10
2721950|NCT00255151|9362062|P3|Overall Study|Therapeutic Failure|3
2721951|NCT00255151|9362063|P2|Overall Study|Therapeutic Failure|2
2721952|NCT00255151|9362064|P1|Overall Study|Therapeutic Failure|11
2721953|NCT00255151|9362062|P3|Overall Study|Esophageal Stricture|1
2721954|NCT00255151|9362063|P2|Overall Study|Esophageal Stricture|0
2721955|NCT00255151|9362064|P1|Overall Study|Esophageal Stricture|0
2721956|NCT00255151|9362062|P3|Overall Study|Possible Barrett's Esophagus|8
2721957|NCT00255151|9362063|P2|Overall Study|Possible Barrett's Esophagus|3
2721958|NCT00255151|9362064|P1|Overall Study|Possible Barrett's Esophagus|1
2721959|NCT00255151|9362062|P3|Overall Study|Relapse of Erosive Esophagitis|12
2721960|NCT00255151|9362063|P2|Overall Study|Relapse of Erosive Esophagitis|16
2721961|NCT00255151|9362064|P1|Overall Study|Relapse of Erosive Esophagitis|78
2721962|NCT00255151|9362062|P3|Overall Study|Subject Request/Subject Unavailable|2
2721963|NCT00255151|9362063|P2|Overall Study|Subject Request/Subject Unavailable|1
2721964|NCT00255151|9362064|P1|Overall Study|Subject Request/Subject Unavailable|1
2721965|NCT00255151|9362062|P3|Overall Study|Noncompliance|2
2721966|NCT00255151|9362063|P2|Overall Study|Noncompliance|1
2721967|NCT00255151|9362064|P1|Overall Study|Noncompliance|0
2721968|NCT00255151|9362062|P3|Overall Study|Withdrawal by Subject|8
2721969|NCT00255151|9362063|P2|Overall Study|Withdrawal by Subject|17
2721970|NCT00255151|9362064|P1|Overall Study|Withdrawal by Subject|18
2721971|NCT00255151|9362062|P3|Overall Study|Lost to Follow-up|4
2721972|NCT00255151|9362063|P2|Overall Study|Lost to Follow-up|3
2721973|NCT00255151|9362064|P1|Overall Study|Lost to Follow-up|4
2721974|NCT00255151|9362062|P3|Overall Study|Adverse Event|9
2721975|NCT00255151|9362063|P2|Overall Study|Adverse Event|6
2721976|NCT00255151|9362064|P1|Overall Study|Adverse Event|10
2721977|NCT00255086|9362102|P2|Overall Study|Protocol Violation|1
2721978|NCT00255086|9362103|P1|Overall Study|Protocol Violation|1
2721979|NCT00255086|9362102|P2|Overall Study|Adverse Event|1
2721980|NCT00255086|9362103|P1|Overall Study|Adverse Event|1
2721981|NCT00255047|9362115|P4|Overall Study|Withdrawal by Subject|18
2721982|NCT00255047|9362116|P3|Overall Study|Withdrawal by Subject|25
2721983|NCT00255047|9362117|P2|Overall Study|Withdrawal by Subject|23
2721984|NCT00255047|9362118|P1|Overall Study|Withdrawal by Subject|24
2721985|NCT00255047|9362115|P4|Overall Study|Lost to Follow-up|6
2721986|NCT00255047|9362116|P3|Overall Study|Lost to Follow-up|5
2721987|NCT00255047|9362117|P2|Overall Study|Lost to Follow-up|8
2721988|NCT00255047|9362118|P1|Overall Study|Lost to Follow-up|9
2721989|NCT00255047|9362115|P4|Overall Study|Protocol Violation|20
2721990|NCT00255047|9362116|P3|Overall Study|Protocol Violation|16
2721991|NCT00255047|9362117|P2|Overall Study|Protocol Violation|13
2721992|NCT00255047|9362118|P1|Overall Study|Protocol Violation|13
2721993|NCT00255047|9362115|P4|Overall Study|Adverse Event|1
2721994|NCT00255047|9362116|P3|Overall Study|Adverse Event|2
2721995|NCT00255047|9362117|P2|Overall Study|Adverse Event|3
2721996|NCT00255047|9362118|P1|Overall Study|Adverse Event|0
2721997|NCT00255047|9362115|P4|Overall Study|Serious Adverse Events|1
2721998|NCT00255047|9362116|P3|Overall Study|Serious Adverse Events|2
2721999|NCT00255047|9362117|P2|Overall Study|Serious Adverse Events|1
2722000|NCT00255047|9362118|P1|Overall Study|Serious Adverse Events|2
2722001|NCT00255034|9362142|P2|Overall Study|Withdrawal by Subject|38
2722002|NCT00255034|9362143|P1|Overall Study|Withdrawal by Subject|15
2722003|NCT00255008|9362153|P4|Overall Study|Other|2
2722004|NCT00255008|9362154|P3|Overall Study|Other|3
2722005|NCT00255008|9362155|P2|Overall Study|Other|0
2722006|NCT00255008|9362156|P1|Overall Study|Other|7
2722007|NCT00255008|9362153|P4|Overall Study|Adverse lab experience|0
2722008|NCT00255008|9362154|P3|Overall Study|Adverse lab experience|0
2722009|NCT00255008|9362155|P2|Overall Study|Adverse lab experience|0
2722010|NCT00255008|9362156|P1|Overall Study|Adverse lab experience|1
2722011|NCT00255008|9362153|P4|Overall Study|Sponsor request|17
2722012|NCT00255008|9362154|P3|Overall Study|Sponsor request|8
2722013|NCT00255008|9362155|P2|Overall Study|Sponsor request|3
2722014|NCT00255008|9362156|P1|Overall Study|Sponsor request|18
2722015|NCT00255008|9362153|P4|Overall Study|Withdrew consent|0
2722016|NCT00255008|9362154|P3|Overall Study|Withdrew consent|2
2722017|NCT00255008|9362155|P2|Overall Study|Withdrew consent|0
2722018|NCT00255008|9362156|P1|Overall Study|Withdrew consent|0
2722183|NCT00254293|9362338|P2|LTE Open Label Variable SC Dosing|Death|0
2722019|NCT00255008|9362153|P4|Overall Study|Did not meet viral reduction criteria|1
2722020|NCT00255008|9362154|P3|Overall Study|Did not meet viral reduction criteria|0
2722021|NCT00255008|9362155|P2|Overall Study|Did not meet viral reduction criteria|5
2722022|NCT00255008|9362156|P1|Overall Study|Did not meet viral reduction criteria|4
2722023|NCT00255008|9362153|P4|Overall Study|Lost to Follow-up|2
2722024|NCT00255008|9362154|P3|Overall Study|Lost to Follow-up|1
2722025|NCT00255008|9362155|P2|Overall Study|Lost to Follow-up|0
2722026|NCT00255008|9362156|P1|Overall Study|Lost to Follow-up|1
2722027|NCT00255008|9362153|P4|Overall Study|Adverse Event|0
2722028|NCT00255008|9362154|P3|Overall Study|Adverse Event|2
2722029|NCT00255008|9362155|P2|Overall Study|Adverse Event|1
2722030|NCT00255008|9362156|P1|Overall Study|Adverse Event|1
2722031|NCT00254982|9362192|P2|Overall Study|Abnormal liver function tests|1
2722032|NCT00254982|9362193|P1|Overall Study|Abnormal liver function tests|2
2722033|NCT00254982|9362192|P2|Overall Study|Opportunistic infection|0
2722034|NCT00254982|9362193|P1|Overall Study|Opportunistic infection|1
2722035|NCT00254982|9362192|P2|Overall Study|Malignancy|2
2722036|NCT00254982|9362193|P1|Overall Study|Malignancy|0
2722037|NCT00254982|9362192|P2|Overall Study|Diagnosis of Tuberculosis|1
2722038|NCT00254982|9362193|P1|Overall Study|Diagnosis of Tuberculosis|1
2722039|NCT00254982|9362192|P2|Overall Study|Protocol deviation|1
2722040|NCT00254982|9362193|P1|Overall Study|Protocol deviation|1
2722041|NCT00254982|9362192|P2|Overall Study|Inclusion/exclusion criteria violation|2
2722042|NCT00254982|9362193|P1|Overall Study|Inclusion/exclusion criteria violation|0
2722043|NCT00254982|9362192|P2|Overall Study|Withdrawal by Subject|1
2722044|NCT00254982|9362193|P1|Overall Study|Withdrawal by Subject|1
2722045|NCT00254982|9362192|P2|Overall Study|Adverse Event|16
2722046|NCT00254982|9362193|P1|Overall Study|Adverse Event|18
2722047|NCT00254982|9362192|P2|Overall Study|Lost to Follow-up|3
2722048|NCT00254982|9362193|P1|Overall Study|Lost to Follow-up|5
2722049|NCT00254982|9362192|P2|Overall Study|Lack of Efficacy|3
2722050|NCT00254982|9362193|P1|Overall Study|Lack of Efficacy|5
2722051|NCT00254982|9362192|P2|Overall Study|Other|1
2722052|NCT00254982|9362193|P1|Overall Study|Other|2
2722053|NCT00254566|9362205|P2|Overall Study|Lost to Follow-up|2
2722054|NCT00254566|9362206|P1|Overall Study|Lost to Follow-up|7
2722055|NCT00254566|9362205|P2|Overall Study|Withdrawal by Subject|6
2722056|NCT00254566|9362206|P1|Overall Study|Withdrawal by Subject|5
2722057|NCT00254566|9362205|P2|Overall Study|Other|5
2722058|NCT00254566|9362206|P1|Overall Study|Other|1
2722059|NCT00254566|9362205|P2|Overall Study|Lack of Efficacy|9
2722060|NCT00254566|9362206|P1|Overall Study|Lack of Efficacy|12
2722061|NCT00254566|9362205|P2|Overall Study|Adverse Event|4
2722062|NCT00254566|9362206|P1|Overall Study|Adverse Event|5
2722063|NCT00254566|9362205|P2|Overall Study|Death|0
2722064|NCT00254566|9362206|P1|Overall Study|Death|1
2722065|NCT00254540|9362230|P2|Overall Study|Laboratory Test Abnormality|1
2722066|NCT00254540|9362231|P1|Overall Study|Laboratory Test Abnormality|0
2722067|NCT00254540|9362230|P2|Overall Study|Death|1
2722068|NCT00254540|9362231|P1|Overall Study|Death|0
2722069|NCT00254540|9362230|P2|Overall Study|Lack of Efficacy|13
2722070|NCT00254540|9362231|P1|Overall Study|Lack of Efficacy|13
2722071|NCT00254540|9362230|P2|Overall Study|Adverse Event|7
2722072|NCT00254540|9362231|P1|Overall Study|Adverse Event|6
2722073|NCT00254501|9362260|P2|Overall Study|Lost to Follow-up|1
2722074|NCT00254501|9362261|P1|Overall Study|Lost to Follow-up|1
2722075|NCT00254397|9362306|P4|Overall Study|Adverse Event|1
2722076|NCT00254397|9362307|P3|Overall Study|Adverse Event|3
2722077|NCT00254397|9362308|P2|Overall Study|Adverse Event|0
2722078|NCT00254397|9362309|P1|Overall Study|Adverse Event|2
2722079|NCT00254397|9362306|P4|Overall Study|Non-Compliant|1
2722080|NCT00254397|9362307|P3|Overall Study|Non-Compliant|0
2722081|NCT00254397|9362308|P2|Overall Study|Non-Compliant|0
2722082|NCT00254397|9362309|P1|Overall Study|Non-Compliant|0
2722083|NCT00254397|9362306|P4|Overall Study|Disease Progression|23
2722084|NCT00254397|9362307|P3|Overall Study|Disease Progression|16
2722085|NCT00254397|9362308|P2|Overall Study|Disease Progression|1
2722086|NCT00254397|9362309|P1|Overall Study|Disease Progression|4
2722087|NCT00254293|9362333|P7|LTE Open Label Fixed Dosing|Other|1
2722088|NCT00254293|9362334|P6|LTE Open Label Fixed Dosing|Other|0
2722089|NCT00254293|9362335|P5|LTE Open Label Fixed Dosing|Other|0
2722090|NCT00254293|9362336|P4|LTE Open Label Fixed Dosing|Other|0
2722091|NCT00254293|9362337|P3|LTE Open Label Fixed Dosing|Other|0
2722092|NCT00254293|9362338|P2|LTE Open Label Fixed Dosing|Other|0
2722093|NCT00254293|9362339|P1|LTE Open Label Fixed Dosing|Other|0
2722094|NCT00254293|9362333|P7|LTE Open Label Fixed Dosing|Poor or non-compliance|1
2722095|NCT00254293|9362334|P6|LTE Open Label Fixed Dosing|Poor or non-compliance|0
2722096|NCT00254293|9362335|P5|LTE Open Label Fixed Dosing|Poor or non-compliance|0
2722097|NCT00254293|9362336|P4|LTE Open Label Fixed Dosing|Poor or non-compliance|0
2722098|NCT00254293|9362337|P3|LTE Open Label Fixed Dosing|Poor or non-compliance|0
2722099|NCT00254293|9362338|P2|LTE Open Label Fixed Dosing|Poor or non-compliance|0
2722100|NCT00254293|9362339|P1|LTE Open Label Fixed Dosing|Poor or non-compliance|0
2722101|NCT00254293|9362333|P7|LTE Open Label Fixed Dosing|Withdrawal by Subject|3
2722102|NCT00254293|9362334|P6|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
2722103|NCT00254293|9362335|P5|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
2722104|NCT00254293|9362336|P4|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
2722105|NCT00254293|9362337|P3|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
2722184|NCT00254293|9362339|P1|LTE Open Label Variable SC Dosing|Death|0
2722106|NCT00254293|9362338|P2|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
2722107|NCT00254293|9362339|P1|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
2722108|NCT00254293|9362333|P7|LTE Open Label Fixed Dosing|Lost to Follow-up|1
2722109|NCT00254293|9362334|P6|LTE Open Label Fixed Dosing|Lost to Follow-up|0
2722110|NCT00254293|9362335|P5|LTE Open Label Fixed Dosing|Lost to Follow-up|0
2722111|NCT00254293|9362336|P4|LTE Open Label Fixed Dosing|Lost to Follow-up|0
2722112|NCT00254293|9362337|P3|LTE Open Label Fixed Dosing|Lost to Follow-up|0
2722113|NCT00254293|9362338|P2|LTE Open Label Fixed Dosing|Lost to Follow-up|0
2722114|NCT00254293|9362339|P1|LTE Open Label Fixed Dosing|Lost to Follow-up|0
2722115|NCT00254293|9362333|P7|LTE Open Label Fixed Dosing|Lack of Efficacy|3
2722116|NCT00254293|9362334|P6|LTE Open Label Fixed Dosing|Lack of Efficacy|0
2722117|NCT00254293|9362335|P5|LTE Open Label Fixed Dosing|Lack of Efficacy|0
2722118|NCT00254293|9362336|P4|LTE Open Label Fixed Dosing|Lack of Efficacy|0
2722119|NCT00254293|9362337|P3|LTE Open Label Fixed Dosing|Lack of Efficacy|0
2722120|NCT00254293|9362338|P2|LTE Open Label Fixed Dosing|Lack of Efficacy|0
2722121|NCT00254293|9362339|P1|LTE Open Label Fixed Dosing|Lack of Efficacy|0
2722122|NCT00254293|9362333|P7|LTE Open Label Fixed Dosing|Adverse Event|1
2722123|NCT00254293|9362334|P6|LTE Open Label Fixed Dosing|Adverse Event|0
2722124|NCT00254293|9362335|P5|LTE Open Label Fixed Dosing|Adverse Event|0
2722125|NCT00254293|9362336|P4|LTE Open Label Fixed Dosing|Adverse Event|0
2722126|NCT00254293|9362337|P3|LTE Open Label Fixed Dosing|Adverse Event|0
2722127|NCT00254293|9362338|P2|LTE Open Label Fixed Dosing|Adverse Event|0
2722128|NCT00254293|9362339|P1|LTE Open Label Fixed Dosing|Adverse Event|0
2722129|NCT00254293|9362333|P7|LTE Open Label Fixed Dosing|Death|3
2722130|NCT00254293|9362334|P6|LTE Open Label Fixed Dosing|Death|0
2722131|NCT00254293|9362335|P5|LTE Open Label Fixed Dosing|Death|0
2722132|NCT00254293|9362336|P4|LTE Open Label Fixed Dosing|Death|0
2722133|NCT00254293|9362337|P3|LTE Open Label Fixed Dosing|Death|0
2722134|NCT00254293|9362338|P2|LTE Open Label Fixed Dosing|Death|0
2722135|NCT00254293|9362339|P1|LTE Open Label Fixed Dosing|Death|0
2722136|NCT00254293|9362333|P7|LTE Open Label Variable SC Dosing|Other|0
2722137|NCT00254293|9362334|P6|LTE Open Label Variable SC Dosing|Other|0
2722138|NCT00254293|9362335|P5|LTE Open Label Variable SC Dosing|Other|0
2722139|NCT00254293|9362336|P4|LTE Open Label Variable SC Dosing|Other|0
2722140|NCT00254293|9362337|P3|LTE Open Label Variable SC Dosing|Other|2
2722141|NCT00254293|9362338|P2|LTE Open Label Variable SC Dosing|Other|0
2722142|NCT00254293|9362339|P1|LTE Open Label Variable SC Dosing|Other|0
2722143|NCT00254293|9362333|P7|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
2722144|NCT00254293|9362334|P6|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
2722145|NCT00254293|9362335|P5|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
2722146|NCT00254293|9362336|P4|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
2722147|NCT00254293|9362337|P3|LTE Open Label Variable SC Dosing|Poor or non-compliance|1
2722148|NCT00254293|9362338|P2|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
2722149|NCT00254293|9362339|P1|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
2722150|NCT00254293|9362333|P7|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
2722151|NCT00254293|9362334|P6|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
2722152|NCT00254293|9362335|P5|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
2722153|NCT00254293|9362336|P4|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
2722154|NCT00254293|9362337|P3|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1
2722155|NCT00254293|9362338|P2|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
2722156|NCT00254293|9362339|P1|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
2722157|NCT00254293|9362333|P7|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
2722158|NCT00254293|9362334|P6|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
2722159|NCT00254293|9362335|P5|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
2722160|NCT00254293|9362336|P4|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
2722161|NCT00254293|9362337|P3|LTE Open Label Variable SC Dosing|Lost to Follow-up|1
2722162|NCT00254293|9362338|P2|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
2722163|NCT00254293|9362339|P1|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
2722164|NCT00254293|9362333|P7|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
2722165|NCT00254293|9362334|P6|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
2722166|NCT00254293|9362335|P5|LTE Open Label Variable SC Dosing|Lack of Efficacy|1
2722167|NCT00254293|9362336|P4|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
2722168|NCT00254293|9362337|P3|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
2722169|NCT00254293|9362338|P2|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
2722170|NCT00254293|9362339|P1|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
2722171|NCT00254293|9362333|P7|LTE Open Label Variable SC Dosing|Adverse Event|0
2722172|NCT00254293|9362334|P6|LTE Open Label Variable SC Dosing|Adverse Event|0
2722173|NCT00254293|9362335|P5|LTE Open Label Variable SC Dosing|Adverse Event|1
2722174|NCT00254293|9362336|P4|LTE Open Label Variable SC Dosing|Adverse Event|0
2722175|NCT00254293|9362337|P3|LTE Open Label Variable SC Dosing|Adverse Event|2
2722176|NCT00254293|9362338|P2|LTE Open Label Variable SC Dosing|Adverse Event|0
2722177|NCT00254293|9362339|P1|LTE Open Label Variable SC Dosing|Adverse Event|1
2722178|NCT00254293|9362333|P7|LTE Open Label Variable SC Dosing|Death|0
2722179|NCT00254293|9362334|P6|LTE Open Label Variable SC Dosing|Death|0
2722180|NCT00254293|9362335|P5|LTE Open Label Variable SC Dosing|Death|0
2722181|NCT00254293|9362336|P4|LTE Open Label Variable SC Dosing|Death|0
2722182|NCT00254293|9362337|P3|LTE Open Label Variable SC Dosing|Death|1
2722185|NCT00254293|9362333|P7|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
2722186|NCT00254293|9362334|P6|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
2722187|NCT00254293|9362335|P5|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
2722188|NCT00254293|9362336|P4|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
2722189|NCT00254293|9362337|P3|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2
2722190|NCT00254293|9362338|P2|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
2722191|NCT00254293|9362339|P1|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
2722192|NCT00254293|9362333|P7|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
2722193|NCT00254293|9362334|P6|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
2722194|NCT00254293|9362335|P5|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
2722195|NCT00254293|9362336|P4|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
2722196|NCT00254293|9362337|P3|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1
2722197|NCT00254293|9362338|P2|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
2722198|NCT00254293|9362339|P1|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
2722199|NCT00254293|9362333|P7|Short Term (12 Week) Randomized Dosing|Adverse Event|0
2722200|NCT00254293|9362334|P6|Short Term (12 Week) Randomized Dosing|Adverse Event|0
2722201|NCT00254293|9362335|P5|Short Term (12 Week) Randomized Dosing|Adverse Event|0
2722202|NCT00254293|9362336|P4|Short Term (12 Week) Randomized Dosing|Adverse Event|1
2722203|NCT00254293|9362337|P3|Short Term (12 Week) Randomized Dosing|Adverse Event|0
2722204|NCT00254293|9362338|P2|Short Term (12 Week) Randomized Dosing|Adverse Event|1
2722205|NCT00254293|9362339|P1|Short Term (12 Week) Randomized Dosing|Adverse Event|0
2722206|NCT00254163|9362422|P2|Overall Study|Other|8
2722207|NCT00254163|9362423|P1|Overall Study|Other|8
2722208|NCT00254163|9362422|P2|Overall Study|Death|1
2722209|NCT00254163|9362423|P1|Overall Study|Death|0
2722210|NCT00254163|9362422|P2|Overall Study|Progressive disease|1
2722211|NCT00254163|9362423|P1|Overall Study|Progressive disease|0
2722212|NCT00254163|9362422|P2|Overall Study|Failed entry|3
2722213|NCT00254163|9362423|P1|Overall Study|Failed entry|1
2722214|NCT00254163|9362422|P2|Overall Study|Investigator request|3
2722215|NCT00254163|9362423|P1|Overall Study|Investigator request|1
2722216|NCT00254163|9362422|P2|Overall Study|Patient request/withdrew consent|4
2722217|NCT00254163|9362423|P1|Overall Study|Patient request/withdrew consent|6
2722218|NCT00254163|9362422|P2|Overall Study|Adverse Event|26
2722219|NCT00254163|9362423|P1|Overall Study|Adverse Event|29
2722220|NCT00253747|9362474|P2|Overall Study|Administrative Discharge (1), Other (2)|2
2722221|NCT00253747|9362475|P1|Overall Study|Administrative Discharge (1), Other (2)|1
2722222|NCT00253747|9362474|P2|Overall Study|Withdrawal by Subject|11
2722223|NCT00253747|9362475|P1|Overall Study|Withdrawal by Subject|10
2722224|NCT00253747|9362474|P2|Overall Study|Lost to Follow-up|14
2722225|NCT00253747|9362475|P1|Overall Study|Lost to Follow-up|13
2722226|NCT00253643|9362528|P4|Overall Study|Non-Compliance|2
2722227|NCT00253643|9362529|P3|Overall Study|Non-Compliance|0
2722228|NCT00253643|9362530|P2|Overall Study|Non-Compliance|0
2722229|NCT00253643|9362531|P1|Overall Study|Non-Compliance|0
2722230|NCT00253643|9362528|P4|Overall Study|Withdrawal by Subject|1
2722231|NCT00253643|9362529|P3|Overall Study|Withdrawal by Subject|1
2722232|NCT00253643|9362530|P2|Overall Study|Withdrawal by Subject|0
2722233|NCT00253643|9362531|P1|Overall Study|Withdrawal by Subject|0
2722234|NCT00253630|9362545|P1|Overall Study|ineligible|2
2722235|NCT00253448|9362561|P1|Overall Study|Withdrawal by Subject|1
2722236|NCT00253370|9362580|P1|Overall Study|Abdominal pain due to disease|1
2722237|NCT00253370|9362580|P1|Overall Study|Protocol Violation|1
2722238|NCT00253370|9362580|P1|Overall Study|Physician Decision|1
2722239|NCT00253370|9362580|P1|Overall Study|Non-protocol therapy|1
2722240|NCT00253370|9362580|P1|Overall Study|Withdrawal by Subject|6
2722241|NCT00253370|9362580|P1|Overall Study|Death|2
2722242|NCT00253370|9362580|P1|Overall Study|Disease progression|13
2722243|NCT00253370|9362580|P1|Overall Study|Adverse Event|18
2722244|NCT00252733|9362626|P2|Overall Study|Multiple Reasons|14
2722245|NCT00252733|9362627|P1|Overall Study|Multiple Reasons|14
2722246|NCT00252733|9362626|P2|Overall Study|Lost to Follow-up|6
2722247|NCT00252733|9362627|P1|Overall Study|Lost to Follow-up|12
2722248|NCT00252733|9362626|P2|Overall Study|Death|5
2722249|NCT00252733|9362627|P1|Overall Study|Death|7
2722250|NCT00252733|9362626|P2|Overall Study|Withdrawal by Subject|67
2722251|NCT00252733|9362627|P1|Overall Study|Withdrawal by Subject|73
2722252|NCT00252720|9362637|P2|Overall Study|Mainly patients lost to follow-up|18
2722253|NCT00252720|9362638|P1|Overall Study|Mainly patients lost to follow-up|7
2722254|NCT00252720|9362637|P2|Overall Study|Moving|42
2722255|NCT00252720|9362638|P1|Overall Study|Moving|23
2722256|NCT00252720|9362637|P2|Overall Study|Death|8
2722257|NCT00252720|9362638|P1|Overall Study|Death|7
2722258|NCT00252720|9362637|P2|Overall Study|Withdrawal by Subject|97
2722259|NCT00252720|9362638|P1|Overall Study|Withdrawal by Subject|95
2722260|NCT00252694|9362652|P2|Overall Study|Patient Moving|16
2722261|NCT00252694|9362653|P1|Overall Study|Patient Moving|17
2722262|NCT00252694|9362652|P2|Overall Study|Mostly Lost to Follow Up|13
2722263|NCT00252694|9362653|P1|Overall Study|Mostly Lost to Follow Up|8
2722264|NCT00252694|9362652|P2|Overall Study|Death|34
2722265|NCT00252694|9362653|P1|Overall Study|Death|36
2722266|NCT00252694|9362652|P2|Overall Study|Withdrawal by Subject|91
2722267|NCT00252694|9362653|P1|Overall Study|Withdrawal by Subject|83
2722268|NCT00252577|9362699|P1|Overall Study|Lost to Follow-up|20
2722269|NCT00252564|9362705|P2|Overall Study|Withdrawal by Subject|2
2722270|NCT00252564|9362706|P1|Overall Study|Withdrawal by Subject|0
2722271|NCT00252564|9362705|P2|Overall Study|Patient Request|5
2722272|NCT00252564|9362706|P1|Overall Study|Patient Request|4
2722273|NCT00252564|9362705|P2|Overall Study|Lost to Follow-up|0
2722274|NCT00252564|9362706|P1|Overall Study|Lost to Follow-up|1
2722275|NCT00252564|9362705|P2|Overall Study|Physician Decision|0
2722276|NCT00252564|9362706|P1|Overall Study|Physician Decision|1
2722277|NCT00252564|9362705|P2|Overall Study|Death|3
2722278|NCT00252564|9362706|P1|Overall Study|Death|0
2722279|NCT00252564|9362705|P2|Overall Study|Disease Progression|20
2722280|NCT00252564|9362706|P1|Overall Study|Disease Progression|14
2722281|NCT00252564|9362705|P2|Overall Study|Unrelated Complication|1
2722282|NCT00252564|9362706|P1|Overall Study|Unrelated Complication|2
2722283|NCT00252564|9362705|P2|Overall Study|Adverse Event|13
2722284|NCT00252564|9362706|P1|Overall Study|Adverse Event|17
2722285|NCT00252499|9362746|P3|Overall Study|Lost to Follow-up|0
2722286|NCT00252499|9362747|P2|Overall Study|Lost to Follow-up|0
2722287|NCT00252499|9362748|P1|Overall Study|Lost to Follow-up|1
2722288|NCT00252239|9362780|P4|Overall Study|Lost to Follow-up|0
2722289|NCT00252239|9362781|P3|Overall Study|Lost to Follow-up|2
2722290|NCT00252239|9362782|P2|Overall Study|Lost to Follow-up|0
2722291|NCT00252239|9362783|P1|Overall Study|Lost to Follow-up|0
2722292|NCT00252239|9362780|P4|Overall Study|Withdrawal by Subject|1
2722293|NCT00252239|9362781|P3|Overall Study|Withdrawal by Subject|0
2722294|NCT00252239|9362782|P2|Overall Study|Withdrawal by Subject|0
2722295|NCT00252239|9362783|P1|Overall Study|Withdrawal by Subject|1
2722296|NCT00252187|9362795|P2|Overall Study|Withdrawal by Subject|0
2722297|NCT00252187|9362796|P1|Overall Study|Withdrawal by Subject|1
2722298|NCT00252187|9362795|P2|Overall Study|Adverse Event|1
2722299|NCT00252187|9362796|P1|Overall Study|Adverse Event|3
2722300|NCT00252174|9362819|P3|Overall Study|Withdrawal by Subject|0
2722301|NCT00252174|9362820|P2|Overall Study|Withdrawal by Subject|1
2722302|NCT00252174|9362821|P1|Overall Study|Withdrawal by Subject|0
2722303|NCT00252057|9362861|P2|Overall Study|Participant previously enrolled|1
2722304|NCT00252057|9362862|P1|Overall Study|Participant previously enrolled|0
2722305|NCT00252057|9362861|P2|Overall Study|Death|2
2722306|NCT00252057|9362862|P1|Overall Study|Death|1
2722307|NCT00252057|9362861|P2|Overall Study|Withdrawal by Subject|5
2722308|NCT00252057|9362862|P1|Overall Study|Withdrawal by Subject|2
2722309|NCT00251979|9362870|P2|Overall Study|Death|5
2722310|NCT00251979|9362871|P1|Overall Study|Death|3
2722311|NCT00251979|9362870|P2|Overall Study|Lost to Follow-up|6
2722312|NCT00251979|9362871|P1|Overall Study|Lost to Follow-up|8
2722313|NCT00251979|9362870|P2|Overall Study|Withdrawal by Subject|7
2722314|NCT00251979|9362871|P1|Overall Study|Withdrawal by Subject|13
2722315|NCT00251979|9362870|P2|Overall Study|Adverse Event|17
2722316|NCT00251979|9362871|P1|Overall Study|Adverse Event|11
2722317|NCT00251979|9362870|P2|Overall Study|Protocol Violation|5
2722318|NCT00251979|9362871|P1|Overall Study|Protocol Violation|3
2722319|NCT00251927|9362903|P2|Overall Study|Study procedure non-compliance|6
2722320|NCT00251927|9362904|P1|Overall Study|Study procedure non-compliance|5
2722321|NCT00251927|9362903|P2|Overall Study|Study-specific discont. achieved|2
2722322|NCT00251927|9362904|P1|Overall Study|Study-specific discont. achieved|13
2722323|NCT00251927|9362903|P2|Overall Study|Withdrawal by Subject|25
2722324|NCT00251927|9362904|P1|Overall Study|Withdrawal by Subject|40
2722325|NCT00251927|9362903|P2|Overall Study|Pregnancy|0
2722326|NCT00251927|9362904|P1|Overall Study|Pregnancy|2
2722327|NCT00251927|9362903|P2|Overall Study|Protocol Violation|2
2722328|NCT00251927|9362904|P1|Overall Study|Protocol Violation|1
2722329|NCT00251927|9362903|P2|Overall Study|Lost to Follow-up|8
2722330|NCT00251927|9362904|P1|Overall Study|Lost to Follow-up|22
2722331|NCT00251927|9362903|P2|Overall Study|Lack of Efficacy|16
2722332|NCT00251927|9362904|P1|Overall Study|Lack of Efficacy|22
2722333|NCT00251927|9362903|P2|Overall Study|Adverse Event|15
2722334|NCT00251927|9362904|P1|Overall Study|Adverse Event|3
2722335|NCT00251758|9362956|P3|Overall Study|Per Investigator Request|0
2722336|NCT00251758|9362957|P2|Overall Study|Per Investigator Request|0
2722337|NCT00251758|9362958|P1|Overall Study|Per Investigator Request|1
2722338|NCT00251758|9362956|P3|Overall Study|Per Subject Request|1
2722339|NCT00251758|9362957|P2|Overall Study|Per Subject Request|0
2722340|NCT00251758|9362958|P1|Overall Study|Per Subject Request|0
2722341|NCT00251758|9362956|P3|Overall Study|Pregnancy|0
2722342|NCT00251758|9362957|P2|Overall Study|Pregnancy|1
2722343|NCT00251758|9362958|P1|Overall Study|Pregnancy|0
2722344|NCT00251758|9362956|P3|Overall Study|Noncompliant|2
2722345|NCT00251758|9362957|P2|Overall Study|Noncompliant|2
2722346|NCT00251758|9362958|P1|Overall Study|Noncompliant|0
2722347|NCT00251758|9362956|P3|Overall Study|Lack of Efficacy|0
2722348|NCT00251758|9362957|P2|Overall Study|Lack of Efficacy|0
2722349|NCT00251758|9362958|P1|Overall Study|Lack of Efficacy|3
2722350|NCT00251758|9362956|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
2722351|NCT00251758|9362957|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
2722352|NCT00251758|9362958|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
2722353|NCT00251758|9362956|P3|Overall Study|Withdrawal by Subject|3
2722354|NCT00251758|9362957|P2|Overall Study|Withdrawal by Subject|7
2722355|NCT00251758|9362958|P1|Overall Study|Withdrawal by Subject|13
2722356|NCT00251758|9362956|P3|Overall Study|Lost to Follow-up|5
2722357|NCT00251758|9362957|P2|Overall Study|Lost to Follow-up|2
2722358|NCT00251758|9362958|P1|Overall Study|Lost to Follow-up|4
2722359|NCT00251758|9362956|P3|Overall Study|Adverse Event|11
2722360|NCT00251758|9362957|P2|Overall Study|Adverse Event|9
2722361|NCT00251758|9362958|P1|Overall Study|Adverse Event|7
2722362|NCT00251745|9362978|P3|Overall Study|Per Investigator Request|0
2722363|NCT00251745|9362979|P2|Overall Study|Per Investigator Request|0
2722364|NCT00251745|9362980|P1|Overall Study|Per Investigator Request|1
2722365|NCT00251745|9362978|P3|Overall Study|Per Subject Request|1
2722366|NCT00251745|9362979|P2|Overall Study|Per Subject Request|0
2722367|NCT00251745|9362980|P1|Overall Study|Per Subject Request|0
2722368|NCT00251745|9362978|P3|Overall Study|Pregnancy|0
2722369|NCT00251745|9362979|P2|Overall Study|Pregnancy|1
2722370|NCT00251745|9362980|P1|Overall Study|Pregnancy|0
2722371|NCT00251745|9362978|P3|Overall Study|Noncompliant|2
2722372|NCT00251745|9362979|P2|Overall Study|Noncompliant|2
2722373|NCT00251745|9362980|P1|Overall Study|Noncompliant|0
2722374|NCT00251745|9362978|P3|Overall Study|Lack of Efficacy|0
2722375|NCT00251745|9362979|P2|Overall Study|Lack of Efficacy|0
2722376|NCT00251745|9362980|P1|Overall Study|Lack of Efficacy|3
2722377|NCT00251745|9362978|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
2722378|NCT00251745|9362979|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
2722379|NCT00251745|9362980|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
2722380|NCT00251745|9362978|P3|Overall Study|Withdrawal by Subject|3
2722381|NCT00251745|9362979|P2|Overall Study|Withdrawal by Subject|7
2722382|NCT00251745|9362980|P1|Overall Study|Withdrawal by Subject|13
2722383|NCT00251745|9362978|P3|Overall Study|Lost to Follow-up|5
2722384|NCT00251745|9362979|P2|Overall Study|Lost to Follow-up|2
2722385|NCT00251745|9362980|P1|Overall Study|Lost to Follow-up|4
2722386|NCT00251745|9362978|P3|Overall Study|Adverse Event|11
2722387|NCT00251745|9362979|P2|Overall Study|Adverse Event|9
2722388|NCT00251745|9362980|P1|Overall Study|Adverse Event|7
2722389|NCT00251719|9363000|P3|Overall Study|Barrett's esophagus|0
2722390|NCT00251719|9363001|P2|Overall Study|Barrett's esophagus|2
2722391|NCT00251719|9363002|P1|Overall Study|Barrett's esophagus|2
2722392|NCT00251719|9363000|P3|Overall Study|Noncompliance|1
2722393|NCT00251719|9363001|P2|Overall Study|Noncompliance|3
2722394|NCT00251719|9363002|P1|Overall Study|Noncompliance|2
2722395|NCT00251719|9363000|P3|Overall Study|Investigator decision|0
2722396|NCT00251719|9363001|P2|Overall Study|Investigator decision|1
2722397|NCT00251719|9363002|P1|Overall Study|Investigator decision|1
2722398|NCT00251719|9363000|P3|Overall Study|Inclusion/exclusion criteria not met|2
2722399|NCT00251719|9363001|P2|Overall Study|Inclusion/exclusion criteria not met|6
2722400|NCT00251719|9363002|P1|Overall Study|Inclusion/exclusion criteria not met|12
2722401|NCT00251719|9363000|P3|Overall Study|Lack of Efficacy|0
2722402|NCT00251719|9363001|P2|Overall Study|Lack of Efficacy|1
2722403|NCT00251719|9363002|P1|Overall Study|Lack of Efficacy|2
2722404|NCT00251719|9363000|P3|Overall Study|Withdrawal by Subject|11
2722405|NCT00251719|9363001|P2|Overall Study|Withdrawal by Subject|12
2722406|NCT00251719|9363002|P1|Overall Study|Withdrawal by Subject|14
2722407|NCT00251719|9363000|P3|Overall Study|Lost to Follow-up|8
2722408|NCT00251719|9363001|P2|Overall Study|Lost to Follow-up|11
2722409|NCT00251719|9363002|P1|Overall Study|Lost to Follow-up|5
2722410|NCT00251719|9363000|P3|Overall Study|Protocol Violation|1
2722411|NCT00251719|9363001|P2|Overall Study|Protocol Violation|1
2722412|NCT00251719|9363002|P1|Overall Study|Protocol Violation|1
2722413|NCT00251719|9363000|P3|Overall Study|Adverse Event|7
2722414|NCT00251719|9363001|P2|Overall Study|Adverse Event|8
2722415|NCT00251719|9363002|P1|Overall Study|Adverse Event|14
2722416|NCT00251693|9363028|P3|Overall Study|Abnormal laboratory findings|1
2722417|NCT00251693|9363029|P2|Overall Study|Abnormal laboratory findings|0
2722418|NCT00251693|9363030|P1|Overall Study|Abnormal laboratory findings|0
2722419|NCT00251693|9363028|P3|Overall Study|Subject request/subject unavailable|0
2722420|NCT00251693|9363029|P2|Overall Study|Subject request/subject unavailable|2
2722421|NCT00251693|9363030|P1|Overall Study|Subject request/subject unavailable|1
2722422|NCT00251693|9363028|P3|Overall Study|Possible Barrett's esophagus|2
2722423|NCT00251693|9363029|P2|Overall Study|Possible Barrett's esophagus|5
2722424|NCT00251693|9363030|P1|Overall Study|Possible Barrett's esophagus|3
2722425|NCT00251693|9363028|P3|Overall Study|Noncompliant|2
2722426|NCT00251693|9363029|P2|Overall Study|Noncompliant|0
2722427|NCT00251693|9363030|P1|Overall Study|Noncompliant|0
2722428|NCT00251693|9363028|P3|Overall Study|Inclusion/exclusion criteria not met|8
2722429|NCT00251693|9363029|P2|Overall Study|Inclusion/exclusion criteria not met|3
2722430|NCT00251693|9363030|P1|Overall Study|Inclusion/exclusion criteria not met|5
2722431|NCT00251693|9363028|P3|Overall Study|Lack of Efficacy|0
2722432|NCT00251693|9363029|P2|Overall Study|Lack of Efficacy|1
2722433|NCT00251693|9363030|P1|Overall Study|Lack of Efficacy|0
2722434|NCT00251693|9363028|P3|Overall Study|Withdrawal by Subject|14
2722435|NCT00251693|9363029|P2|Overall Study|Withdrawal by Subject|17
2722436|NCT00251693|9363030|P1|Overall Study|Withdrawal by Subject|11
2722437|NCT00251693|9363028|P3|Overall Study|Lost to Follow-up|8
2722438|NCT00251693|9363029|P2|Overall Study|Lost to Follow-up|7
2722439|NCT00251693|9363030|P1|Overall Study|Lost to Follow-up|12
2722440|NCT00251693|9363028|P3|Overall Study|Protocol Violation|2
2722441|NCT00251693|9363029|P2|Overall Study|Protocol Violation|0
2722442|NCT00251693|9363030|P1|Overall Study|Protocol Violation|2
2722443|NCT00251693|9363028|P3|Overall Study|Adverse Event|9
2722444|NCT00251693|9363029|P2|Overall Study|Adverse Event|9
2722445|NCT00251693|9363030|P1|Overall Study|Adverse Event|17
2722446|NCT00251641|9363055|P2|Overall Study|Switched Treatment|63
2722447|NCT00251641|9363056|P1|Overall Study|Switched Treatment|9
2722448|NCT00251641|9363055|P2|Overall Study|Did not Meet protocol Eligibility|1
2722449|NCT00251641|9363056|P1|Overall Study|Did not Meet protocol Eligibility|2
2722450|NCT00251641|9363055|P2|Overall Study|Protocol Violation|2
2722451|NCT00251641|9363056|P1|Overall Study|Protocol Violation|10
2722452|NCT00251641|9363055|P2|Overall Study|Withdrawal by Subject|8
2722453|NCT00251641|9363056|P1|Overall Study|Withdrawal by Subject|6
2722454|NCT00251641|9363055|P2|Overall Study|Lost to Follow-up|3
2722455|NCT00251641|9363056|P1|Overall Study|Lost to Follow-up|3
2722456|NCT00251641|9363055|P2|Overall Study|Progression of Disease|2
2722457|NCT00251641|9363056|P1|Overall Study|Progression of Disease|0
2722458|NCT00251641|9363055|P2|Overall Study|Lack of Efficacy|1
2722459|NCT00251641|9363056|P1|Overall Study|Lack of Efficacy|2
2722460|NCT00251641|9363055|P2|Overall Study|Adverse Event|8
2722461|NCT00251641|9363056|P1|Overall Study|Adverse Event|80
2722462|NCT00251589|9363074|P4|Overall Study|Discontinued due to progressive disease|1
2722463|NCT00251589|9363075|P3|Overall Study|Discontinued due to progressive disease|0
2722464|NCT00251589|9363076|P2|Overall Study|Discontinued due to progressive disease|1
2722465|NCT00251589|9363077|P1|Overall Study|Discontinued due to progressive disease|9
2722466|NCT00251589|9363074|P4|Overall Study|Withdrawal by Subject|0
2722467|NCT00251589|9363075|P3|Overall Study|Withdrawal by Subject|0
2722468|NCT00251589|9363076|P2|Overall Study|Withdrawal by Subject|1
2722469|NCT00251589|9363077|P1|Overall Study|Withdrawal by Subject|1
2722470|NCT00251589|9363074|P4|Overall Study|Adverse Event|1
2722471|NCT00251589|9363075|P3|Overall Study|Adverse Event|2
2722472|NCT00251589|9363076|P2|Overall Study|Adverse Event|1
2722473|NCT00251589|9363077|P1|Overall Study|Adverse Event|5
2722474|NCT00251316|9363114|P2|Overall Study|Physician Decision|3
2722475|NCT00251316|9363115|P1|Overall Study|Physician Decision|2
2722476|NCT00251004|9363154|P3|Overall Study|Graft Loss|8
2722477|NCT00251004|9363155|P2|Overall Study|Graft Loss|13
2722478|NCT00251004|9363156|P1|Overall Study|Graft Loss|12
2722479|NCT00251004|9363154|P3|Overall Study|Lost to Follow-up|1
2722480|NCT00251004|9363155|P2|Overall Study|Lost to Follow-up|2
2722481|NCT00251004|9363156|P1|Overall Study|Lost to Follow-up|1
2722482|NCT00251004|9363154|P3|Overall Study|Death|8
2722483|NCT00251004|9363155|P2|Overall Study|Death|10
2722484|NCT00251004|9363156|P1|Overall Study|Death|9
2722485|NCT00251004|9363154|P3|Overall Study|Withdrawal by Subject|14
2722486|NCT00251004|9363155|P2|Overall Study|Withdrawal by Subject|16
2722487|NCT00251004|9363156|P1|Overall Study|Withdrawal by Subject|23
2722488|NCT00250835|9363180|P1|Overall Study|Withdrawal by Subject|1
2722489|NCT00250718|9363189|P1|Overall Study|Withdrawal by Subject|1
2722490|NCT00250718|9363189|P1|Overall Study|Adverse Event|1
2722491|NCT00250718|9363189|P1|Overall Study|Death|1
2722492|NCT00250705|9363194|P1|Overall Study|Lack of Efficacy|2
2722493|NCT00250679|9363205|P3|Overall Study|various single events: hip surgery,diary|1
2722494|NCT00250679|9363206|P2|Overall Study|various single events: hip surgery,diary|1
2722495|NCT00250679|9363207|P1|Overall Study|various single events: hip surgery,diary|3
2722496|NCT00250679|9363205|P3|Overall Study|Non-compliance|0
2722497|NCT00250679|9363206|P2|Overall Study|Non-compliance|1
2722498|NCT00250679|9363207|P1|Overall Study|Non-compliance|1
2722499|NCT00250679|9363205|P3|Overall Study|Moved|0
2722500|NCT00250679|9363206|P2|Overall Study|Moved|1
2722501|NCT00250679|9363207|P1|Overall Study|Moved|1
2722502|NCT00250679|9363205|P3|Overall Study|Technical Holter issues|2
2722503|NCT00250679|9363206|P2|Overall Study|Technical Holter issues|0
2722504|NCT00250679|9363207|P1|Overall Study|Technical Holter issues|1
2722505|NCT00250679|9363205|P3|Overall Study|Lack of Efficacy|3
2722506|NCT00250679|9363206|P2|Overall Study|Lack of Efficacy|1
2722507|NCT00250679|9363207|P1|Overall Study|Lack of Efficacy|0
2722508|NCT00250679|9363205|P3|Overall Study|Does Not Meet Entry Criteria|2
2722509|NCT00250679|9363206|P2|Overall Study|Does Not Meet Entry Criteria|4
2722510|NCT00250679|9363207|P1|Overall Study|Does Not Meet Entry Criteria|1
2722511|NCT00250679|9363205|P3|Overall Study|Lost to Follow-up|2
2722512|NCT00250679|9363206|P2|Overall Study|Lost to Follow-up|4
2722513|NCT00250679|9363207|P1|Overall Study|Lost to Follow-up|3
2722514|NCT00250679|9363205|P3|Overall Study|Withdrawal by Subject|15
2722515|NCT00250679|9363206|P2|Overall Study|Withdrawal by Subject|18
2722516|NCT00250679|9363207|P1|Overall Study|Withdrawal by Subject|15
2722517|NCT00250679|9363205|P3|Overall Study|Protocol Violation|3
2722518|NCT00250679|9363206|P2|Overall Study|Protocol Violation|4
2722519|NCT00250679|9363207|P1|Overall Study|Protocol Violation|2
2722520|NCT00250679|9363205|P3|Overall Study|Adverse Event|16
2722521|NCT00250679|9363206|P2|Overall Study|Adverse Event|15
2722522|NCT00250679|9363207|P1|Overall Study|Adverse Event|12
2722523|NCT00250588|9363308|P3|Overall Study|Lost to Follow-up|13
2722524|NCT00250588|9363309|P2|Overall Study|Lost to Follow-up|13
2722525|NCT00250588|9363310|P1|Overall Study|Lost to Follow-up|6
2722526|NCT00250588|9363308|P3|Overall Study|Withdrawal by Subject|0
2722527|NCT00250588|9363309|P2|Overall Study|Withdrawal by Subject|6
2722528|NCT00250588|9363310|P1|Overall Study|Withdrawal by Subject|3
2722529|NCT00250458|9363358|P2|Overall Study|Other|0
2722530|NCT00250458|9363359|P1|Overall Study|Other|1
2722531|NCT00250458|9363358|P2|Overall Study|Qualifying migraine but did not treat|3
2722532|NCT00250458|9363359|P1|Overall Study|Qualifying migraine but did not treat|3
2722533|NCT00250458|9363358|P2|Overall Study|Lack of Migraine Attack|9
2722534|NCT00250458|9363359|P1|Overall Study|Lack of Migraine Attack|20
2722535|NCT00250458|9363358|P2|Overall Study|Withdrawal by Subject|2
2722536|NCT00250458|9363359|P1|Overall Study|Withdrawal by Subject|4
2722537|NCT00250458|9363358|P2|Overall Study|Protocol Violation|1
2722538|NCT00250458|9363359|P1|Overall Study|Protocol Violation|0
2722539|NCT00250458|9363358|P2|Overall Study|Lost to Follow-up|2
2722540|NCT00250458|9363359|P1|Overall Study|Lost to Follow-up|4
2722541|NCT00250432|9363369|P2|Overall Study|Pt was considered untreatable|1
2722542|NCT00250432|9363370|P1|Overall Study|Pt was considered untreatable|0
2722543|NCT00250432|9363369|P2|Overall Study|Pt died out of posttherapy report period|5
2722544|NCT00250432|9363370|P1|Overall Study|Pt died out of posttherapy report period|6
2722545|NCT00250432|9363369|P2|Overall Study|Withdrawal by Subject|2
2722546|NCT00250432|9363370|P1|Overall Study|Withdrawal by Subject|6
2722547|NCT00250432|9363369|P2|Overall Study|Protocol Violation|3
2722548|NCT00250432|9363370|P1|Overall Study|Protocol Violation|0
2722549|NCT00250432|9363369|P2|Overall Study|Patient Moved|1
2722550|NCT00250432|9363370|P1|Overall Study|Patient Moved|0
2722551|NCT00250432|9363369|P2|Overall Study|Lost to Follow-up|5
2722552|NCT00250432|9363370|P1|Overall Study|Lost to Follow-up|6
2722553|NCT00250432|9363369|P2|Overall Study|Lack of Efficacy|1
2722554|NCT00250432|9363370|P1|Overall Study|Lack of Efficacy|2
2722555|NCT00250432|9363369|P2|Overall Study|Adverse Event|29
2722556|NCT00250432|9363370|P1|Overall Study|Adverse Event|25
2722557|NCT00250276|9363382|P4|Overall Study|Lost to Follow-up|8
2722558|NCT00250276|9363383|P3|Overall Study|Lost to Follow-up|13
2722559|NCT00250276|9363384|P2|Overall Study|Lost to Follow-up|18
2722560|NCT00250276|9363385|P1|Overall Study|Lost to Follow-up|11
2722561|NCT00250276|9363382|P4|Overall Study|Migrated/moved from study area|7
2722562|NCT00250276|9363383|P3|Overall Study|Migrated/moved from study area|2
2722563|NCT00250276|9363384|P2|Overall Study|Migrated/moved from study area|0
2722564|NCT00250276|9363385|P1|Overall Study|Migrated/moved from study area|3
2722565|NCT00250276|9363382|P4|Overall Study|Withdrawal by Subject|2
2722566|NCT00250276|9363383|P3|Overall Study|Withdrawal by Subject|3
2722567|NCT00250276|9363384|P2|Overall Study|Withdrawal by Subject|2
2722568|NCT00250276|9363385|P1|Overall Study|Withdrawal by Subject|1
2722569|NCT00250276|9363382|P4|Overall Study|Protocol Violation|0
2722570|NCT00250276|9363383|P3|Overall Study|Protocol Violation|0
2722571|NCT00250276|9363384|P2|Overall Study|Protocol Violation|1
2722572|NCT00250276|9363385|P1|Overall Study|Protocol Violation|0
2722573|NCT00250276|9363382|P4|Overall Study|Non-serious Adverse Event|2
2722574|NCT00250276|9363383|P3|Overall Study|Non-serious Adverse Event|0
2722575|NCT00250276|9363384|P2|Overall Study|Non-serious Adverse Event|0
2722576|NCT00250276|9363385|P1|Overall Study|Non-serious Adverse Event|2
2722577|NCT00250276|9363382|P4|Overall Study|Serious Adverse Event|0
2722578|NCT00250276|9363383|P3|Overall Study|Serious Adverse Event|1
2722579|NCT00250276|9363384|P2|Overall Study|Serious Adverse Event|0
2722580|NCT00250276|9363385|P1|Overall Study|Serious Adverse Event|0
2722581|NCT00249873|9363465|P2|Overall Study|Thromboembolic/outcome event|122
2722582|NCT00249873|9363466|P1|Overall Study|Thromboembolic/outcome event|82
2722583|NCT00249873|9363465|P2|Overall Study|Event related to cardiac condition|21
2722584|NCT00249873|9363466|P1|Overall Study|Event related to cardiac condition|12
2722585|NCT00249873|9363465|P2|Overall Study|Surgery/ procedure|9
2722586|NCT00249873|9363466|P1|Overall Study|Surgery/ procedure|9
2722587|NCT00249873|9363465|P2|Overall Study|Study drug intolerance|0
2722588|NCT00249873|9363466|P1|Overall Study|Study drug intolerance|5
2722589|NCT00249873|9363465|P2|Overall Study|Oral anticoagulant required|157
2722590|NCT00249873|9363466|P1|Overall Study|Oral anticoagulant required|159
2722591|NCT00249873|9363465|P2|Overall Study|Angiotensin II receptor blocker required|0
2722592|NCT00249873|9363466|P1|Overall Study|Angiotensin II receptor blocker required|1
2722593|NCT00249873|9363465|P2|Overall Study|Open label clopidogrel required|42
2722594|NCT00249873|9363466|P1|Overall Study|Open label clopidogrel required|31
2722595|NCT00249873|9363465|P2|Overall Study|Physician withdrew consent|60
2722596|NCT00249873|9363466|P1|Overall Study|Physician withdrew consent|59
2722597|NCT00249873|9363465|P2|Overall Study|Patient not wish to continue after May08|4
2722598|NCT00249873|9363466|P1|Overall Study|Patient not wish to continue after May08|3
2722599|NCT00249873|9363465|P2|Overall Study|Other contraindicated medication|0
2722600|NCT00249873|9363466|P1|Overall Study|Other contraindicated medication|1
2722601|NCT00249873|9363465|P2|Overall Study|Other non serious Adverse Event|108
2722602|NCT00249873|9363466|P1|Overall Study|Other non serious Adverse Event|112
2722603|NCT00249873|9363465|P2|Overall Study|Non-compliance|46
2722604|NCT00249873|9363466|P1|Overall Study|Non-compliance|41
2722605|NCT00249873|9363465|P2|Overall Study|Minor bleeding|37
2722606|NCT00249873|9363466|P1|Overall Study|Minor bleeding|99
2722607|NCT00249873|9363465|P2|Overall Study|Lost to Follow-up|7
2722608|NCT00249873|9363466|P1|Overall Study|Lost to Follow-up|4
2722609|NCT00249873|9363465|P2|Overall Study|Withdrawal by Subject|466
2722610|NCT00249873|9363466|P1|Overall Study|Withdrawal by Subject|504
2722611|NCT00249873|9363465|P2|Overall Study|Contraindication to oral anticoagulant|8
2722612|NCT00249873|9363466|P1|Overall Study|Contraindication to oral anticoagulant|4
2722613|NCT00249873|9363465|P2|Overall Study|Qualifying condition not present|23
2722614|NCT00249873|9363466|P1|Overall Study|Qualifying condition not present|20
2722615|NCT00249873|9363465|P2|Overall Study|Other Serious Adverse Event|97
2722616|NCT00249873|9363466|P1|Overall Study|Other Serious Adverse Event|86
2722617|NCT00249873|9363465|P2|Overall Study|Serious haemorrhagic Adverse Event|30
2722618|NCT00249873|9363466|P1|Overall Study|Serious haemorrhagic Adverse Event|74
2722619|NCT00249873|9363465|P2|Overall Study|Severe allergic reaction|1
2722620|NCT00249873|9363466|P1|Overall Study|Severe allergic reaction|8
2722621|NCT00249873|9363465|P2|Overall Study|Significant thrombocytopenia|8
2722622|NCT00249873|9363466|P1|Overall Study|Significant thrombocytopenia|9
2722623|NCT00249873|9363465|P2|Overall Study|Not treated|8
2722624|NCT00249873|9363466|P1|Overall Study|Not treated|7
2722625|NCT00249834|9363486|P8|Overall Study|Protocol Violation|0
2722626|NCT00249834|9363487|P7|Overall Study|Protocol Violation|0
2722627|NCT00249834|9363488|P6|Overall Study|Protocol Violation|2
2722628|NCT00249834|9363489|P5|Overall Study|Protocol Violation|5
2722629|NCT00249834|9363490|P4|Overall Study|Protocol Violation|8
2722630|NCT00249834|9363491|P3|Overall Study|Protocol Violation|14
2722631|NCT00249834|9363492|P2|Overall Study|Protocol Violation|19
2722632|NCT00249834|9363493|P1|Overall Study|Protocol Violation|0
2722633|NCT00249834|9363486|P8|Overall Study|Failure of down-regulation|0
2722634|NCT00249834|9363487|P7|Overall Study|Failure of down-regulation|1
2722635|NCT00249834|9363488|P6|Overall Study|Failure of down-regulation|0
2722636|NCT00249834|9363489|P5|Overall Study|Failure of down-regulation|0
2722637|NCT00249834|9363490|P4|Overall Study|Failure of down-regulation|0
2722638|NCT00249834|9363491|P3|Overall Study|Failure of down-regulation|0
2722639|NCT00249834|9363492|P2|Overall Study|Failure of down-regulation|0
2722640|NCT00249834|9363493|P1|Overall Study|Failure of down-regulation|0
2722641|NCT00249834|9363486|P8|Overall Study|Ovarian stimulation failed|0
2722642|NCT00249834|9363487|P7|Overall Study|Ovarian stimulation failed|0
2722643|NCT00249834|9363488|P6|Overall Study|Ovarian stimulation failed|0
2722644|NCT00249834|9363489|P5|Overall Study|Ovarian stimulation failed|0
2722645|NCT00249834|9363490|P4|Overall Study|Ovarian stimulation failed|0
2722646|NCT00249834|9363491|P3|Overall Study|Ovarian stimulation failed|0
2722647|NCT00249834|9363492|P2|Overall Study|Ovarian stimulation failed|0
2722648|NCT00249834|9363493|P1|Overall Study|Ovarian stimulation failed|1
2722649|NCT00249821|9363542|P2|Overall Study|Technical problem|1
2722650|NCT00249821|9363543|P1|Overall Study|Technical problem|0
2722651|NCT00249808|9363563|P1|Overall Study|Did Not Provide Post-Baseline Data|11
2722652|NCT00249808|9363563|P1|Overall Study|Lack of Efficacy|52
2722653|NCT00249808|9363563|P1|Overall Study|Adverse Event|81
2722654|NCT00249808|9363563|P1|Overall Study|Lost to Follow-up|8
2722655|NCT00249808|9363563|P1|Overall Study|Protocol Violation|3
2722656|NCT00249808|9363563|P1|Overall Study|Other|27
2722657|NCT00249795|9363571|P2|Overall Study|Missing|1
2722658|NCT00249795|9363572|P1|Overall Study|Missing|0
2722659|NCT00249795|9363571|P2|Overall Study|Lost to Follow-up|2
2722660|NCT00249795|9363572|P1|Overall Study|Lost to Follow-up|0
2722661|NCT00249795|9363571|P2|Overall Study|Site not agree to continue after May08|1
2722662|NCT00249795|9363572|P1|Overall Study|Site not agree to continue after May08|1
2722663|NCT00249795|9363571|P2|Overall Study|Patient not wish to continue after May08|6
2722664|NCT00249795|9363572|P1|Overall Study|Patient not wish to continue after May08|4
2722665|NCT00249795|9363571|P2|Overall Study|Event related to cardiac condition|16
2722666|NCT00249795|9363572|P1|Overall Study|Event related to cardiac condition|17
2722667|NCT00249795|9363571|P2|Overall Study|Other contraindicated medication|1
2722668|NCT00249795|9363572|P1|Overall Study|Other contraindicated medication|1
2722669|NCT00249795|9363571|P2|Overall Study|Hypotension (non-symptomatic)|5
2722670|NCT00249795|9363572|P1|Overall Study|Hypotension (non-symptomatic)|5
2722671|NCT00249795|9363571|P2|Overall Study|Lightheadedness / dizziness|11
2722672|NCT00249795|9363572|P1|Overall Study|Lightheadedness / dizziness|15
2722673|NCT00249795|9363571|P2|Overall Study|Angiotensin II receptor blocker required|58
2722674|NCT00249795|9363572|P1|Overall Study|Angiotensin II receptor blocker required|35
2722675|NCT00249795|9363571|P2|Overall Study|Surgery / procedure|5
2722676|NCT00249795|9363572|P1|Overall Study|Surgery / procedure|4
2722677|NCT00249795|9363571|P2|Overall Study|Physician withdrew consent|63
2722678|NCT00249795|9363572|P1|Overall Study|Physician withdrew consent|71
2722679|NCT00249795|9363571|P2|Overall Study|Other adverse events (non-serious)|159
2722680|NCT00249795|9363572|P1|Overall Study|Other adverse events (non-serious)|188
2722681|NCT00249795|9363571|P2|Overall Study|Study drug intolerance|3
2722682|NCT00249795|9363572|P1|Overall Study|Study drug intolerance|3
2722683|NCT00249795|9363571|P2|Overall Study|Non-compliance|69
2722684|NCT00249795|9363572|P1|Overall Study|Non-compliance|71
2722685|NCT00249795|9363571|P2|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3
2722686|NCT00249795|9363572|P1|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7
2722687|NCT00249795|9363571|P2|Overall Study|Oral anticoagulant required|0
2722688|NCT00249795|9363572|P1|Overall Study|Oral anticoagulant required|2
2722689|NCT00249795|9363571|P2|Overall Study|Thromboembolic / outcome event|45
2722690|NCT00249795|9363572|P1|Overall Study|Thromboembolic / outcome event|39
2722691|NCT00249795|9363571|P2|Overall Study|Withdrawal by Subject|742
2722692|NCT00249795|9363572|P1|Overall Study|Withdrawal by Subject|678
2722693|NCT00249795|9363571|P2|Overall Study|Qualifying condition not present|29
2722694|NCT00249795|9363572|P1|Overall Study|Qualifying condition not present|26
2722695|NCT00249795|9363571|P2|Overall Study|Other Serious Adverse Event|93
2722696|NCT00249795|9363572|P1|Overall Study|Other Serious Adverse Event|84
2722697|NCT00249795|9363571|P2|Overall Study|Symptomatic hypotension|64
2722698|NCT00249795|9363572|P1|Overall Study|Symptomatic hypotension|127
2722699|NCT00249795|9363571|P2|Overall Study|Not treated|14
2722700|NCT00249795|9363572|P1|Overall Study|Not treated|16
2722701|NCT00249769|9363593|P3|Overall Study|Lost to Follow-up|3
2722702|NCT00249769|9363594|P2|Overall Study|Lost to Follow-up|0
2722703|NCT00249769|9363595|P1|Overall Study|Lost to Follow-up|0
2722704|NCT00249769|9363593|P3|Overall Study|Physician Decision|2
2722705|NCT00249769|9363594|P2|Overall Study|Physician Decision|0
2722706|NCT00249769|9363595|P1|Overall Study|Physician Decision|0
2722707|NCT00249769|9363593|P3|Overall Study|Adverse Event|1
2722708|NCT00249769|9363594|P2|Overall Study|Adverse Event|0
2722709|NCT00249769|9363595|P1|Overall Study|Adverse Event|0
2722710|NCT00249769|9363593|P3|Overall Study|Miscellaneous|2
2722711|NCT00249769|9363594|P2|Overall Study|Miscellaneous|2
2722712|NCT00249769|9363595|P1|Overall Study|Miscellaneous|0
2722713|NCT00249769|9363593|P3|Overall Study|Migration from Study Area|14
2722714|NCT00249769|9363594|P2|Overall Study|Migration from Study Area|3
2722715|NCT00249769|9363595|P1|Overall Study|Migration from Study Area|1
2722716|NCT00249769|9363593|P3|Overall Study|Withdrawal by Subject|6
2722717|NCT00249769|9363594|P2|Overall Study|Withdrawal by Subject|10
2722718|NCT00249769|9363595|P1|Overall Study|Withdrawal by Subject|1
2722719|NCT00249613|9363623|P2|12 Month Follow-up|Lost to Follow-up|8
2722720|NCT00249613|9363624|P1|12 Month Follow-up|Lost to Follow-up|10
2722721|NCT00249613|9363623|P2|12 Month Follow-up|Withdrawal by Subject|6
2722722|NCT00249613|9363624|P1|12 Month Follow-up|Withdrawal by Subject|6
2722723|NCT00249613|9363623|P2|12 Month Follow-up|Death|1
2722724|NCT00249613|9363624|P1|12 Month Follow-up|Death|1
2722725|NCT00249444|9363665|P2|Overall Study|life event|1
2722726|NCT00249444|9363666|P1|Overall Study|life event|0
2722727|NCT00249444|9363665|P2|Overall Study|Adverse Event|1
2722728|NCT00249444|9363666|P1|Overall Study|Adverse Event|1
2722729|NCT00249444|9363665|P2|Overall Study|non-compliant|11
2722730|NCT00249444|9363666|P1|Overall Study|non-compliant|9
2722731|NCT00249444|9363665|P2|Overall Study|Lost to Follow-up|2
2722732|NCT00249444|9363666|P1|Overall Study|Lost to Follow-up|2
2722733|NCT00249288|9363691|P2|Overall Study|Withdrawal by Subject|2
2722734|NCT00249288|9363692|P1|Overall Study|Withdrawal by Subject|2
2722735|NCT00249288|9363691|P2|Overall Study|Lost to Follow-up|3
2722736|NCT00249288|9363692|P1|Overall Study|Lost to Follow-up|3
2722737|NCT00249002|9363784|P1|Overall Study|Other|2
2722738|NCT00249002|9363784|P1|Overall Study|Study cancellation|3
2722739|NCT00249002|9363784|P1|Overall Study|Adverse Event|2
2722740|NCT00248833|9363803|P3|Overall Study|Other|0
2722741|NCT00248833|9363804|P2|Overall Study|Other|1
2722742|NCT00248833|9363805|P1|Overall Study|Other|0
2722743|NCT00248833|9363803|P3|Overall Study|Lost to Follow-up|1
2722744|NCT00248833|9363804|P2|Overall Study|Lost to Follow-up|1
2722745|NCT00248833|9363805|P1|Overall Study|Lost to Follow-up|1
2722746|NCT00248833|9363803|P3|Overall Study|Withdrawal by Subject|1
2722747|NCT00248833|9363804|P2|Overall Study|Withdrawal by Subject|1
2722748|NCT00248833|9363805|P1|Overall Study|Withdrawal by Subject|0
2722749|NCT00248833|9363803|P3|Overall Study|Adverse Event|0
2722750|NCT00248833|9363804|P2|Overall Study|Adverse Event|0
2722751|NCT00248833|9363805|P1|Overall Study|Adverse Event|2
2722752|NCT00248794|9363841|P3|Overall Study|Lost to Follow-up|3
2722753|NCT00248794|9363842|P2|Overall Study|Lost to Follow-up|8
2722754|NCT00248794|9363843|P1|Overall Study|Lost to Follow-up|6
2722755|NCT00248651|9363893|P3|Overall Study|Withdrawal by Subject|32
2722756|NCT00248651|9363894|P2|Overall Study|Withdrawal by Subject|40
2722757|NCT00248651|9363895|P1|Overall Study|Withdrawal by Subject|28
2722758|NCT00248625|9363931|P2|Overall Study|Withdrawal by Subject|2
2722759|NCT00248625|9363932|P1|Overall Study|Withdrawal by Subject|0
2722760|NCT00248495|9364024|P1|Overall Study|Withdrawal by Subject|1
2722761|NCT00248287|9364035|P2|Overall Study|Other|2
2722762|NCT00248287|9364036|P1|Overall Study|Other|3
2722763|NCT00248287|9364035|P2|Overall Study|Patient Request|3
2722764|NCT00248287|9364036|P1|Overall Study|Patient Request|5
2722765|NCT00248287|9364035|P2|Overall Study|Investigator Request|3
2722766|NCT00248287|9364036|P1|Overall Study|Investigator Request|4
2722767|NCT00248287|9364035|P2|Overall Study|Lost to Follow-up|1
2722768|NCT00248287|9364036|P1|Overall Study|Lost to Follow-up|0
2722769|NCT00248287|9364035|P2|Overall Study|Death|0
2722770|NCT00248287|9364036|P1|Overall Study|Death|1
2722771|NCT00248287|9364035|P2|Overall Study|Adverse Event|10
2722772|NCT00248287|9364036|P1|Overall Study|Adverse Event|11
2722773|NCT00248170|9364050|P2|Overall Study|Protocol deviation|19
2722774|NCT00248170|9364051|P1|Overall Study|Protocol deviation|17
2722775|NCT00248170|9364050|P2|Overall Study|Abnormal laboratory values|0
2722776|NCT00248170|9364051|P1|Overall Study|Abnormal laboratory values|4
2722777|NCT00248170|9364050|P2|Overall Study|Abnormal test procedure(s) result|61
2722778|NCT00248170|9364051|P1|Overall Study|Abnormal test procedure(s) result|49
2722779|NCT00248170|9364050|P2|Overall Study|Administrative problems|25
2722780|NCT00248170|9364051|P1|Overall Study|Administrative problems|22
2722781|NCT00248170|9364050|P2|Overall Study|Adverse Event|296
2722782|NCT00248170|9364051|P1|Overall Study|Adverse Event|311
2722783|NCT00248170|9364050|P2|Overall Study|Death|47
2722784|NCT00248170|9364051|P1|Overall Study|Death|28
2722785|NCT00248170|9364050|P2|Overall Study|Disease progression|216
2722786|NCT00248170|9364051|P1|Overall Study|Disease progression|196
2722787|NCT00248170|9364050|P2|Overall Study|Lost to Follow-up|35
2722788|NCT00248170|9364051|P1|Overall Study|Lost to Follow-up|28
2722789|NCT00248170|9364050|P2|Overall Study|Protocol Violation|30
2722790|NCT00248170|9364051|P1|Overall Study|Protocol Violation|35
2722791|NCT00248170|9364050|P2|Overall Study|Withdrawal by Subject|79
2722792|NCT00248170|9364051|P1|Overall Study|Withdrawal by Subject|71
2722793|NCT00248040|9364074|P3|Overall Study|Death|1
2722794|NCT00248040|9364075|P2|Overall Study|Death|0
2722795|NCT00248040|9364076|P1|Overall Study|Death|0
2722796|NCT00248040|9364074|P3|Overall Study|transplant cancelled post treat start|0
2722797|NCT00248040|9364075|P2|Overall Study|transplant cancelled post treat start|0
2722798|NCT00248040|9364076|P1|Overall Study|transplant cancelled post treat start|1
2722799|NCT00248040|9364074|P3|Overall Study|transplantectomy|3
2722800|NCT00248040|9364075|P2|Overall Study|transplantectomy|1
2722801|NCT00248040|9364076|P1|Overall Study|transplantectomy|2
2722802|NCT00247962|9364125|P2|Overall Study|Lack of Efficacy|2
2722803|NCT00247962|9364126|P1|Overall Study|Lack of Efficacy|4
2722804|NCT00247962|9364125|P2|Overall Study|Withdrawal by Subject|2
2722805|NCT00247962|9364126|P1|Overall Study|Withdrawal by Subject|3
2722806|NCT00247962|9364125|P2|Overall Study|Protocol Violation|1
2722807|NCT00247962|9364126|P1|Overall Study|Protocol Violation|1
2722808|NCT00247962|9364125|P2|Overall Study|Physician Decision|1
2722809|NCT00247962|9364126|P1|Overall Study|Physician Decision|0
2722810|NCT00247962|9364125|P2|Overall Study|Lost to Follow-up|1
2722811|NCT00247962|9364126|P1|Overall Study|Lost to Follow-up|3
2722812|NCT00247962|9364125|P2|Overall Study|Adverse Event|12
2722813|NCT00247962|9364126|P1|Overall Study|Adverse Event|15
2722814|NCT00247676|9364134|P1|Overall Study|Withdrawal by Subject|2
2722815|NCT00247676|9364134|P1|Overall Study|Other|3
2722816|NCT00247676|9364134|P1|Overall Study|Lack of Efficacy|15
2722817|NCT00247676|9364134|P1|Overall Study|Adverse Event|11
2722818|NCT00247676|9364134|P1|Overall Study|Death|5
2722819|NCT00247611|9364179|P2|Baselined|Completed baseline only|8
2722820|NCT00247611|9364180|P1|Baselined|Completed baseline only|9
2722821|NCT00247611|9364179|P2|Baselined|Completed baseline, never placed on ARVs|5
2722822|NCT00247611|9364180|P1|Baselined|Completed baseline, never placed on ARVs|8
2722823|NCT00247416|9364198|P2|Overall Study|3 patients were found to be ineligible|2
2722824|NCT00247416|9364199|P1|Overall Study|3 patients were found to be ineligible|1
2722825|NCT00247273|9364240|P2|Overall Study|Did not take any study drug|0
2722826|NCT00247273|9364241|P1|Overall Study|Did not take any study drug|2
2722827|NCT00247273|9364240|P2|Overall Study|Withdrawal by Subject|47
2722828|NCT00247273|9364241|P1|Overall Study|Withdrawal by Subject|46
2722829|NCT00247273|9364240|P2|Overall Study|Lost to Follow-up|7
2722830|NCT00247273|9364241|P1|Overall Study|Lost to Follow-up|7
2722831|NCT00247273|9364240|P2|Overall Study|Physician Decision|3
2722832|NCT00247273|9364241|P1|Overall Study|Physician Decision|6
2722833|NCT00247273|9364240|P2|Overall Study|Adverse Event|80
2722834|NCT00247273|9364241|P1|Overall Study|Adverse Event|85
2722835|NCT00246805|9364287|P2|Phase 1|Lost to Follow-up|0
2722836|NCT00246805|9364288|P1|Phase 1|Lost to Follow-up|1
2722837|NCT00246753|9364294|P1|Overall Study|Unacceptable toxicity|2
2722838|NCT00246753|9364294|P1|Overall Study|Adverse Event|2
2722839|NCT00246753|9364294|P1|Overall Study|Physician Decision|2
2722840|NCT00246753|9364294|P1|Overall Study|Withdrawal by Subject|2
2722841|NCT00246740|9364302|P2|Initial Enrollment|Other|2
2722842|NCT00246740|9364303|P1|Initial Enrollment|Other|1
2722843|NCT00246740|9364302|P2|Initial Enrollment|Surgery schedule change|4
2722844|NCT00246740|9364303|P1|Initial Enrollment|Surgery schedule change|4
2722845|NCT00246740|9364302|P2|Initial Enrollment|Additional surgery scheduled|2
2722846|NCT00246740|9364303|P1|Initial Enrollment|Additional surgery scheduled|0
2722847|NCT00246740|9364302|P2|Initial Enrollment|Death|0
2722848|NCT00246740|9364303|P1|Initial Enrollment|Death|1
2722849|NCT00246571|9364327|P2|Overall Study|Crossover participants|74
2722850|NCT00246571|9364328|P1|Overall Study|Crossover participants|0
2722851|NCT00246571|9364327|P2|Overall Study|Laboratory abnormalities|0
2722852|NCT00246571|9364328|P1|Overall Study|Laboratory abnormalities|1
2722853|NCT00246571|9364327|P2|Overall Study|Did not meet entrance criteria|1
2722854|NCT00246571|9364328|P1|Overall Study|Did not meet entrance criteria|2
2722855|NCT00246571|9364327|P2|Overall Study|Sponsor|1
2722856|NCT00246571|9364328|P1|Overall Study|Sponsor|0
2722857|NCT00246571|9364327|P2|Overall Study|Death|3
2722858|NCT00246571|9364328|P1|Overall Study|Death|17
2722859|NCT00246571|9364327|P2|Overall Study|Lack of Efficacy|21
2722860|NCT00246571|9364328|P1|Overall Study|Lack of Efficacy|84
2722861|NCT00246571|9364327|P2|Overall Study|Withdrawal by Subject|3
2722862|NCT00246571|9364328|P1|Overall Study|Withdrawal by Subject|2
2722863|NCT00246571|9364327|P2|Overall Study|Protocol Violation|1
2722864|NCT00246571|9364328|P1|Overall Study|Protocol Violation|0
2722865|NCT00246571|9364327|P2|Overall Study|Adverse Event|0
2722866|NCT00246571|9364328|P1|Overall Study|Adverse Event|7
2722867|NCT00246376|9364393|P5|Overall Study|Lost to Follow-up|13
2722868|NCT00246376|9364394|P4|Overall Study|Lost to Follow-up|16
2722869|NCT00246376|9364395|P3|Overall Study|Lost to Follow-up|11
2722870|NCT00246376|9364396|P2|Overall Study|Lost to Follow-up|11
2722871|NCT00246376|9364397|P1|Overall Study|Lost to Follow-up|2
2722872|NCT00246376|9364393|P5|Overall Study|Adverse Event|1
2722873|NCT00246376|9364394|P4|Overall Study|Adverse Event|3
2722874|NCT00246376|9364395|P3|Overall Study|Adverse Event|1
2722875|NCT00246376|9364396|P2|Overall Study|Adverse Event|3
2722876|NCT00246376|9364397|P1|Overall Study|Adverse Event|2
2722877|NCT00246376|9364393|P5|Overall Study|Dropped/withdrew during dietary run-in|3
2722878|NCT00246376|9364394|P4|Overall Study|Dropped/withdrew during dietary run-in|7
2722879|NCT00246376|9364395|P3|Overall Study|Dropped/withdrew during dietary run-in|4
2722880|NCT00246376|9364396|P2|Overall Study|Dropped/withdrew during dietary run-in|5
2722881|NCT00246376|9364397|P1|Overall Study|Dropped/withdrew during dietary run-in|11
2722882|NCT00246337|9364448|P9|Overall Study|Reported as completing trial in error|0
2722883|NCT00246337|9364449|P8|Overall Study|Reported as completing trial in error|1
2722884|NCT00246337|9364450|P7|Overall Study|Reported as completing trial in error|0
2722885|NCT00246337|9364451|P6|Overall Study|Reported as completing trial in error|0
2722886|NCT00246337|9364452|P5|Overall Study|Reported as completing trial in error|0
2722887|NCT00246337|9364453|P4|Overall Study|Reported as completing trial in error|0
2722888|NCT00246337|9364454|P3|Overall Study|Reported as completing trial in error|0
2722889|NCT00246337|9364455|P2|Overall Study|Reported as completing trial in error|0
2722890|NCT00246337|9364456|P1|Overall Study|Reported as completing trial in error|0
2722891|NCT00246337|9364448|P9|Overall Study|Protocol Violator|0
2722892|NCT00246337|9364449|P8|Overall Study|Protocol Violator|0
2722893|NCT00246337|9364450|P7|Overall Study|Protocol Violator|0
2722894|NCT00246337|9364451|P6|Overall Study|Protocol Violator|0
2722895|NCT00246337|9364452|P5|Overall Study|Protocol Violator|0
2722896|NCT00246337|9364453|P4|Overall Study|Protocol Violator|0
2722897|NCT00246337|9364454|P3|Overall Study|Protocol Violator|0
2722898|NCT00246337|9364455|P2|Overall Study|Protocol Violator|0
2722899|NCT00246337|9364456|P1|Overall Study|Protocol Violator|1
2722900|NCT00246337|9364448|P9|Overall Study|Overwhelmed|0
2722901|NCT00246337|9364449|P8|Overall Study|Overwhelmed|0
2722902|NCT00246337|9364450|P7|Overall Study|Overwhelmed|0
2722903|NCT00246337|9364451|P6|Overall Study|Overwhelmed|1
2722904|NCT00246337|9364452|P5|Overall Study|Overwhelmed|0
2722905|NCT00246337|9364453|P4|Overall Study|Overwhelmed|0
2722906|NCT00246337|9364454|P3|Overall Study|Overwhelmed|0
2722907|NCT00246337|9364455|P2|Overall Study|Overwhelmed|0
2722908|NCT00246337|9364456|P1|Overall Study|Overwhelmed|0
2722909|NCT00246337|9364448|P9|Overall Study|Abnormal baseline lab values|4
2722910|NCT00246337|9364449|P8|Overall Study|Abnormal baseline lab values|0
2722911|NCT00246337|9364450|P7|Overall Study|Abnormal baseline lab values|2
2722912|NCT00246337|9364451|P6|Overall Study|Abnormal baseline lab values|2
2722913|NCT00246337|9364452|P5|Overall Study|Abnormal baseline lab values|0
2722914|NCT00246337|9364453|P4|Overall Study|Abnormal baseline lab values|0
2722915|NCT00246337|9364454|P3|Overall Study|Abnormal baseline lab values|2
2722916|NCT00246337|9364455|P2|Overall Study|Abnormal baseline lab values|0
2722917|NCT00246337|9364456|P1|Overall Study|Abnormal baseline lab values|7
2722918|NCT00246337|9364448|P9|Overall Study|Site Terminated|2
2722919|NCT00246337|9364449|P8|Overall Study|Site Terminated|6
2722920|NCT00246337|9364450|P7|Overall Study|Site Terminated|1
2722921|NCT00246337|9364451|P6|Overall Study|Site Terminated|7
2722922|NCT00246337|9364452|P5|Overall Study|Site Terminated|0
2722923|NCT00246337|9364453|P4|Overall Study|Site Terminated|0
2722924|NCT00246337|9364454|P3|Overall Study|Site Terminated|0
2722925|NCT00246337|9364455|P2|Overall Study|Site Terminated|0
2722926|NCT00246337|9364456|P1|Overall Study|Site Terminated|10
2722927|NCT00246337|9364448|P9|Overall Study|Lack of Qualifying Event|5
2722928|NCT00246337|9364449|P8|Overall Study|Lack of Qualifying Event|2
2722929|NCT00246337|9364450|P7|Overall Study|Lack of Qualifying Event|3
2722930|NCT00246337|9364451|P6|Overall Study|Lack of Qualifying Event|3
2722931|NCT00246337|9364452|P5|Overall Study|Lack of Qualifying Event|1
2722932|NCT00246337|9364453|P4|Overall Study|Lack of Qualifying Event|1
2722933|NCT00246337|9364454|P3|Overall Study|Lack of Qualifying Event|1
2722934|NCT00246337|9364455|P2|Overall Study|Lack of Qualifying Event|2
2722935|NCT00246337|9364456|P1|Overall Study|Lack of Qualifying Event|8
2722936|NCT00246337|9364448|P9|Overall Study|Withdrawal by Subject|0
2722937|NCT00246337|9364449|P8|Overall Study|Withdrawal by Subject|1
2722938|NCT00246337|9364450|P7|Overall Study|Withdrawal by Subject|1
2722939|NCT00246337|9364451|P6|Overall Study|Withdrawal by Subject|0
2722940|NCT00246337|9364452|P5|Overall Study|Withdrawal by Subject|0
2722941|NCT00246337|9364453|P4|Overall Study|Withdrawal by Subject|0
2722942|NCT00246337|9364454|P3|Overall Study|Withdrawal by Subject|0
2722943|NCT00246337|9364455|P2|Overall Study|Withdrawal by Subject|0
2722944|NCT00246337|9364456|P1|Overall Study|Withdrawal by Subject|2
2722945|NCT00246337|9364448|P9|Overall Study|Protocol Violation|0
2722946|NCT00246337|9364449|P8|Overall Study|Protocol Violation|1
2722947|NCT00246337|9364450|P7|Overall Study|Protocol Violation|1
2722948|NCT00246337|9364451|P6|Overall Study|Protocol Violation|0
2722949|NCT00246337|9364452|P5|Overall Study|Protocol Violation|1
2722950|NCT00246337|9364453|P4|Overall Study|Protocol Violation|0
2722951|NCT00246337|9364454|P3|Overall Study|Protocol Violation|0
2722952|NCT00246337|9364455|P2|Overall Study|Protocol Violation|0
2722953|NCT00246337|9364456|P1|Overall Study|Protocol Violation|1
2722954|NCT00246337|9364448|P9|Overall Study|Lost to Follow-up|0
2722955|NCT00246337|9364449|P8|Overall Study|Lost to Follow-up|2
2722956|NCT00246337|9364450|P7|Overall Study|Lost to Follow-up|1
2722957|NCT00246337|9364451|P6|Overall Study|Lost to Follow-up|2
2722958|NCT00246337|9364452|P5|Overall Study|Lost to Follow-up|2
2722959|NCT00246337|9364453|P4|Overall Study|Lost to Follow-up|0
2722960|NCT00246337|9364454|P3|Overall Study|Lost to Follow-up|0
2722961|NCT00246337|9364455|P2|Overall Study|Lost to Follow-up|0
2722962|NCT00246337|9364456|P1|Overall Study|Lost to Follow-up|3
2722963|NCT00246324|9364503|P1|Overall Study|Withdrawal by Subject|1
2722964|NCT00246259|9364510|P2|Overall Study|randomly assigned, not eligible for ITT|6
2722965|NCT00246259|9364511|P1|Overall Study|randomly assigned, not eligible for ITT|2
2722966|NCT00246259|9364510|P2|Overall Study|Withdrawal by Subject|1
2722967|NCT00246259|9364511|P1|Overall Study|Withdrawal by Subject|5
2722968|NCT00246259|9364510|P2|Overall Study|Lost to Follow-up|4
2722969|NCT00246259|9364511|P1|Overall Study|Lost to Follow-up|3
2722970|NCT00246259|9364510|P2|Overall Study|Adverse Event|0
2722971|NCT00246259|9364511|P1|Overall Study|Adverse Event|5
2722972|NCT00246259|9364510|P2|Overall Study|Investigator withdrew participant|0
2722973|NCT00246259|9364511|P1|Overall Study|Investigator withdrew participant|2
2722974|NCT00246259|9364510|P2|Overall Study|Lack of Efficacy|2
2722975|NCT00246259|9364511|P1|Overall Study|Lack of Efficacy|2
2722976|NCT00246259|9364510|P2|Overall Study|Participant non-compliant|9
2722977|NCT00246259|9364511|P1|Overall Study|Participant non-compliant|4
2722978|NCT00246259|9364510|P2|Overall Study|Not stable by Week 18|1
2722979|NCT00246259|9364511|P1|Overall Study|Not stable by Week 18|2
2722980|NCT00246259|9364510|P2|Overall Study|Other|3
2722981|NCT00246259|9364511|P1|Overall Study|Other|3
2722982|NCT00246090|9364545|P1|Overall Study|Not Otherwise Specified|10
2722983|NCT00246090|9364545|P1|Overall Study|Physician Decision|11
2722984|NCT00246090|9364545|P1|Overall Study|Clinical Progression|30
2722985|NCT00246090|9364545|P1|Overall Study|Progressive Disease|212
2722986|NCT00246090|9364545|P1|Overall Study|Withdrawal by Subject|7
2722987|NCT00246090|9364545|P1|Overall Study|Adverse Event|25
2722988|NCT00246025|9364554|P4|Overall Study|unsuitable medical history was found|1
2722989|NCT00246025|9364555|P3|Overall Study|unsuitable medical history was found|0
2722990|NCT00246025|9364556|P2|Overall Study|unsuitable medical history was found|0
2722991|NCT00246025|9364557|P1|Overall Study|unsuitable medical history was found|0
2722992|NCT00246025|9364554|P4|Overall Study|Withdrawal by Subject|2
2722993|NCT00246025|9364555|P3|Overall Study|Withdrawal by Subject|1
2722994|NCT00246025|9364556|P2|Overall Study|Withdrawal by Subject|0
2722995|NCT00246025|9364557|P1|Overall Study|Withdrawal by Subject|3
2722996|NCT00246025|9364554|P4|Overall Study|Adverse Event|10
2722997|NCT00246025|9364555|P3|Overall Study|Adverse Event|9
2722998|NCT00246025|9364556|P2|Overall Study|Adverse Event|9
2722999|NCT00246025|9364557|P1|Overall Study|Adverse Event|7
2723000|NCT00246012|9364616|P9|Overall Study|Randomly assigned but not treated|0
2723001|NCT00246012|9364617|P8|Overall Study|Randomly assigned but not treated|0
2723002|NCT00246012|9364618|P7|Overall Study|Randomly assigned but not treated|1
2723003|NCT00246012|9364619|P6|Overall Study|Randomly assigned but not treated|1
2723004|NCT00246012|9364620|P5|Overall Study|Randomly assigned but not treated|0
2723005|NCT00246012|9364621|P4|Overall Study|Randomly assigned but not treated|0
2723006|NCT00246012|9364622|P3|Overall Study|Randomly assigned but not treated|0
2723007|NCT00246012|9364623|P2|Overall Study|Randomly assigned but not treated|0
2723008|NCT00246012|9364624|P1|Overall Study|Randomly assigned but not treated|0
2723009|NCT00246012|9364616|P9|Overall Study|Other|0
2723010|NCT00246012|9364617|P8|Overall Study|Other|1
2723011|NCT00246012|9364618|P7|Overall Study|Other|0
2723012|NCT00246012|9364619|P6|Overall Study|Other|0
2723013|NCT00246012|9364620|P5|Overall Study|Other|0
2723014|NCT00246012|9364621|P4|Overall Study|Other|0
2723015|NCT00246012|9364622|P3|Overall Study|Other|0
2723016|NCT00246012|9364623|P2|Overall Study|Other|0
2723017|NCT00246012|9364624|P1|Overall Study|Other|0
2723018|NCT00246012|9364616|P9|Overall Study|Disease progression|26
2723019|NCT00246012|9364617|P8|Overall Study|Disease progression|27
2723020|NCT00246012|9364618|P7|Overall Study|Disease progression|30
2723021|NCT00246012|9364619|P6|Overall Study|Disease progression|25
2723022|NCT00246012|9364620|P5|Overall Study|Disease progression|3
2723023|NCT00246012|9364621|P4|Overall Study|Disease progression|3
2723024|NCT00246012|9364622|P3|Overall Study|Disease progression|2
2723025|NCT00246012|9364623|P2|Overall Study|Disease progression|1
2723026|NCT00246012|9364624|P1|Overall Study|Disease progression|3
2723027|NCT00246012|9364616|P9|Overall Study|Withdrawal by Subject|0
2723028|NCT00246012|9364617|P8|Overall Study|Withdrawal by Subject|0
2723029|NCT00246012|9364618|P7|Overall Study|Withdrawal by Subject|0
2723030|NCT00246012|9364619|P6|Overall Study|Withdrawal by Subject|1
2723031|NCT00246012|9364620|P5|Overall Study|Withdrawal by Subject|0
2723032|NCT00246012|9364621|P4|Overall Study|Withdrawal by Subject|0
2723033|NCT00246012|9364622|P3|Overall Study|Withdrawal by Subject|0
2723034|NCT00246012|9364623|P2|Overall Study|Withdrawal by Subject|0
2723035|NCT00246012|9364624|P1|Overall Study|Withdrawal by Subject|0
2723036|NCT00246012|9364616|P9|Overall Study|Adverse Event|2
2723037|NCT00246012|9364617|P8|Overall Study|Adverse Event|0
2723038|NCT00246012|9364618|P7|Overall Study|Adverse Event|0
2723039|NCT00246012|9364619|P6|Overall Study|Adverse Event|1
2723040|NCT00246012|9364620|P5|Overall Study|Adverse Event|0
2723041|NCT00246012|9364621|P4|Overall Study|Adverse Event|0
2723042|NCT00246012|9364622|P3|Overall Study|Adverse Event|0
2723043|NCT00246012|9364623|P2|Overall Study|Adverse Event|0
2723044|NCT00246012|9364624|P1|Overall Study|Adverse Event|0
2723045|NCT00245960|9364719|P2|Overall Study|Lack of Efficacy|6
2723046|NCT00245960|9364720|P1|Overall Study|Lack of Efficacy|4
2723047|NCT00245960|9364719|P2|Overall Study|Withdrawal by Subject|7
2723048|NCT00245960|9364720|P1|Overall Study|Withdrawal by Subject|5
2723049|NCT00245960|9364719|P2|Overall Study|Protocol Violation|3
2723050|NCT00245960|9364720|P1|Overall Study|Protocol Violation|4
2723051|NCT00245960|9364719|P2|Overall Study|Lost to Follow-up|2
2723052|NCT00245960|9364720|P1|Overall Study|Lost to Follow-up|2
2723053|NCT00245960|9364719|P2|Overall Study|Adverse Event|10
2723054|NCT00245960|9364720|P1|Overall Study|Adverse Event|14
2723055|NCT00245856|9364728|P2|Period Two|Withdrawal by Subject|1
2723056|NCT00245856|9364729|P1|Period Two|Withdrawal by Subject|0
2723057|NCT00245765|9364739|P3|Overall Study|Other|4
2723058|NCT00245765|9364740|P2|Overall Study|Other|4
2723059|NCT00245765|9364741|P1|Overall Study|Other|13
2723060|NCT00245765|9364739|P3|Overall Study|Other reason|1
2723061|NCT00245765|9364740|P2|Overall Study|Other reason|0
2723062|NCT00245765|9364741|P1|Overall Study|Other reason|2
2723063|NCT00245765|9364739|P3|Overall Study|Withdrawal by Subject|3
2723064|NCT00245765|9364740|P2|Overall Study|Withdrawal by Subject|0
2723065|NCT00245765|9364741|P1|Overall Study|Withdrawal by Subject|1
2723066|NCT00245765|9364739|P3|Overall Study|Lost to Follow-up|0
2723067|NCT00245765|9364740|P2|Overall Study|Lost to Follow-up|2
2723068|NCT00245765|9364741|P1|Overall Study|Lost to Follow-up|1
2723069|NCT00245765|9364739|P3|Overall Study|Lack of Efficacy|0
2723070|NCT00245765|9364740|P2|Overall Study|Lack of Efficacy|7
2723071|NCT00245765|9364741|P1|Overall Study|Lack of Efficacy|14
2723072|NCT00245765|9364739|P3|Overall Study|Adverse Event|0
2723073|NCT00245765|9364740|P2|Overall Study|Adverse Event|1
2723074|NCT00245765|9364741|P1|Overall Study|Adverse Event|1
2723075|NCT00245583|9364790|P2|Overall Study|Withdrawal by Subject|3
2723076|NCT00245583|9364791|P1|Overall Study|Withdrawal by Subject|2
2723077|NCT00245583|9364790|P2|Overall Study|Lack of Efficacy|0
2723078|NCT00245583|9364791|P1|Overall Study|Lack of Efficacy|1
2723079|NCT00245583|9364790|P2|Overall Study|Adverse Event|1
2723080|NCT00245583|9364791|P1|Overall Study|Adverse Event|2
2723081|NCT00245583|9364790|P2|Overall Study|Lost to Follow-up|5
2723082|NCT00245583|9364791|P1|Overall Study|Lost to Follow-up|1
2723083|NCT00245570|9364811|P6|Washout Between Periods III and IV|Adverse Event|0
2723084|NCT00245570|9364812|P5|Washout Between Periods III and IV|Adverse Event|0
2723085|NCT00245570|9364813|P4|Washout Between Periods III and IV|Adverse Event|0
2723086|NCT00245570|9364814|P3|Washout Between Periods III and IV|Adverse Event|0
2723087|NCT00245570|9364815|P2|Washout Between Periods III and IV|Adverse Event|1
2723088|NCT00245570|9364816|P1|Washout Between Periods III and IV|Adverse Event|0
2723089|NCT00245466|9364950|P3|Overall Study|Administrative reasons|0
2723090|NCT00245466|9364951|P2|Overall Study|Administrative reasons|1
2723091|NCT00245466|9364952|P1|Overall Study|Administrative reasons|0
2723092|NCT00245466|9364950|P3|Overall Study|Death|0
2723093|NCT00245466|9364951|P2|Overall Study|Death|2
2723094|NCT00245466|9364952|P1|Overall Study|Death|0
2723095|NCT00245466|9364950|P3|Overall Study|Protocol Violation|2
2723096|NCT00245466|9364951|P2|Overall Study|Protocol Violation|2
2723097|NCT00245466|9364952|P1|Overall Study|Protocol Violation|1
2723098|NCT00245466|9364950|P3|Overall Study|Disease progression|1
2723099|NCT00245466|9364951|P2|Overall Study|Disease progression|3
2723100|NCT00245466|9364952|P1|Overall Study|Disease progression|0
2723101|NCT00245466|9364950|P3|Overall Study|Lost to Follow-up|0
2723102|NCT00245466|9364951|P2|Overall Study|Lost to Follow-up|0
2723103|NCT00245466|9364952|P1|Overall Study|Lost to Follow-up|3
2723104|NCT00245466|9364950|P3|Overall Study|Withdrawal by Subject|1
2723105|NCT00245466|9364951|P2|Overall Study|Withdrawal by Subject|2
2723106|NCT00245466|9364952|P1|Overall Study|Withdrawal by Subject|2
2723107|NCT00245466|9364950|P3|Overall Study|Insufficient PSA and testosterone suppr|3
2723108|NCT00245466|9364951|P2|Overall Study|Insufficient PSA and testosterone suppr|0
2723109|NCT00245466|9364952|P1|Overall Study|Insufficient PSA and testosterone suppr|0
2723110|NCT00245466|9364950|P3|Overall Study|Insufficient testosterone suppr|21
2723111|NCT00245466|9364951|P2|Overall Study|Insufficient testosterone suppr|12
2723112|NCT00245466|9364952|P1|Overall Study|Insufficient testosterone suppr|12
2723113|NCT00245466|9364950|P3|Overall Study|Low prostate specific antigen suppr|5
2723114|NCT00245466|9364951|P2|Overall Study|Low prostate specific antigen suppr|14
2723115|NCT00245466|9364952|P1|Overall Study|Low prostate specific antigen suppr|16
2723116|NCT00245466|9364950|P3|Overall Study|Adverse Event|4
2723117|NCT00245466|9364951|P2|Overall Study|Adverse Event|8
2723118|NCT00245466|9364952|P1|Overall Study|Adverse Event|2
2723119|NCT00245102|9364995|P6|Overall Study|Clinical progression|0
2723120|NCT00245102|9364996|P5|Overall Study|Clinical progression|0
2723121|NCT00245102|9364997|P4|Overall Study|Clinical progression|0
2723122|NCT00245102|9364998|P3|Overall Study|Clinical progression|0
2723123|NCT00245102|9364999|P2|Overall Study|Clinical progression|0
2723124|NCT00245102|9365000|P1|Overall Study|Clinical progression|1
2723125|NCT00245102|9364995|P6|Overall Study|Participant needed surgery|0
2723126|NCT00245102|9364996|P5|Overall Study|Participant needed surgery|0
2723127|NCT00245102|9364997|P4|Overall Study|Participant needed surgery|0
2723128|NCT00245102|9364998|P3|Overall Study|Participant needed surgery|1
2723129|NCT00245102|9364999|P2|Overall Study|Participant needed surgery|0
2723130|NCT00245102|9365000|P1|Overall Study|Participant needed surgery|0
2723131|NCT00245102|9364995|P6|Overall Study|Decline in performance|2
2723132|NCT00245102|9364996|P5|Overall Study|Decline in performance|0
2723133|NCT00245102|9364997|P4|Overall Study|Decline in performance|1
2723134|NCT00245102|9364998|P3|Overall Study|Decline in performance|0
2723135|NCT00245102|9364999|P2|Overall Study|Decline in performance|2
2723136|NCT00245102|9365000|P1|Overall Study|Decline in performance|0
2723137|NCT00245102|9364995|P6|Overall Study|Adverse Event|2
2723138|NCT00245102|9364996|P5|Overall Study|Adverse Event|0
2723139|NCT00245102|9364997|P4|Overall Study|Adverse Event|1
2723140|NCT00245102|9364998|P3|Overall Study|Adverse Event|5
2723141|NCT00245102|9364999|P2|Overall Study|Adverse Event|2
2723142|NCT00245102|9365000|P1|Overall Study|Adverse Event|4
2723143|NCT00245102|9364995|P6|Overall Study|Death|0
2723144|NCT00245102|9364996|P5|Overall Study|Death|0
2723145|NCT00245102|9364997|P4|Overall Study|Death|1
2723146|NCT00245102|9364998|P3|Overall Study|Death|0
2723147|NCT00245102|9364999|P2|Overall Study|Death|0
2723148|NCT00245102|9365000|P1|Overall Study|Death|0
2723149|NCT00245102|9364995|P6|Overall Study|Protocol Violation|0
2723150|NCT00245102|9364996|P5|Overall Study|Protocol Violation|0
2723151|NCT00245102|9364997|P4|Overall Study|Protocol Violation|0
2723152|NCT00245102|9364998|P3|Overall Study|Protocol Violation|0
2723153|NCT00245102|9364999|P2|Overall Study|Protocol Violation|0
2723154|NCT00245102|9365000|P1|Overall Study|Protocol Violation|1
2723155|NCT00245102|9364995|P6|Overall Study|Not Treated|0
2723156|NCT00245102|9364996|P5|Overall Study|Not Treated|0
2723157|NCT00245102|9364997|P4|Overall Study|Not Treated|0
2723158|NCT00245102|9364998|P3|Overall Study|Not Treated|1
2723159|NCT00245102|9364999|P2|Overall Study|Not Treated|0
2723160|NCT00245102|9365000|P1|Overall Study|Not Treated|1
2723161|NCT00245063|9365016|P2|Overall Study|Death|0
2723162|NCT00245063|9365017|P1|Overall Study|Death|1
2723163|NCT00245063|9365016|P2|Overall Study|Adverse Event|5
2723164|NCT00245063|9365017|P1|Overall Study|Adverse Event|6
2723165|NCT00245050|9365025|P2|Overall Study|Adverse Event|2
2723166|NCT00245050|9365026|P1|Overall Study|Adverse Event|3
2723167|NCT00245037|9365034|P1|Overall Study|Death|17
2723168|NCT00245011|9365044|P1|Overall Study|Lack of Efficacy|1
2723169|NCT00244933|9365061|P1|Overall Study|Not response evaluable|2
2723170|NCT00244881|9365065|P1|Overall Study|Withdrawal by Subject|3
2723171|NCT00244855|9365073|P2|Overall Study|Withdrawal by Subject|1
2723172|NCT00244855|9365074|P1|Overall Study|Withdrawal by Subject|0
2723173|NCT00244764|9365082|P1|Overall Study|Developed Secondary Malignancy|1
2723174|NCT00244764|9365082|P1|Overall Study|Sponsor Terminated Study|2
2723175|NCT00244764|9365082|P1|Overall Study|Primary Investigator Discretion|2
2723176|NCT00244764|9365082|P1|Overall Study|Participant was Hospitalized until Death|1
2723177|NCT00244764|9365082|P1|Overall Study|Declining Performance Status|1
2723178|NCT00244764|9365082|P1|Overall Study|Off Study Medication for >21 Days|1
2723179|NCT00244764|9365082|P1|Overall Study|Death|1
2723180|NCT00244764|9365082|P1|Overall Study|Protocol Violation|2
2723181|NCT00244764|9365082|P1|Overall Study|Disease Progression|13
2723182|NCT00244764|9365082|P1|Overall Study|Withdrawal by Subject|12
2723183|NCT00244764|9365082|P1|Overall Study|Lost to Follow-up|23
2723184|NCT00244764|9365082|P1|Overall Study|Adverse Event|37
2723185|NCT00244751|9365092|P3|Overall Study|Participant randomized by mistake|1
2723186|NCT00244751|9365093|P2|Overall Study|Participant randomized by mistake|0
2723187|NCT00244751|9365094|P1|Overall Study|Participant randomized by mistake|0
2723188|NCT00244751|9365092|P3|Overall Study|Safety reasons|0
2723189|NCT00244751|9365093|P2|Overall Study|Safety reasons|1
2723190|NCT00244751|9365094|P1|Overall Study|Safety reasons|0
2723191|NCT00244751|9365092|P3|Overall Study|Lack of compliance with protocol|0
2723192|NCT00244751|9365093|P2|Overall Study|Lack of compliance with protocol|1
2723193|NCT00244751|9365094|P1|Overall Study|Lack of compliance with protocol|0
2723194|NCT00244751|9365092|P3|Overall Study|Elevated liver enzymes|0
2723195|NCT00244751|9365093|P2|Overall Study|Elevated liver enzymes|0
2723196|NCT00244751|9365094|P1|Overall Study|Elevated liver enzymes|1
2723197|NCT00244751|9365092|P3|Overall Study|Withdrawal by Subject|3
2723198|NCT00244751|9365093|P2|Overall Study|Withdrawal by Subject|5
2723199|NCT00244751|9365094|P1|Overall Study|Withdrawal by Subject|7
2723200|NCT00244751|9365092|P3|Overall Study|Protocol Violation|1
2723201|NCT00244751|9365093|P2|Overall Study|Protocol Violation|0
2723202|NCT00244751|9365094|P1|Overall Study|Protocol Violation|1
2723203|NCT00244751|9365092|P3|Overall Study|Lost to Follow-up|0
2723204|NCT00244751|9365093|P2|Overall Study|Lost to Follow-up|1
2723205|NCT00244751|9365094|P1|Overall Study|Lost to Follow-up|0
2723206|NCT00244751|9365092|P3|Overall Study|Adverse Event|5
2723207|NCT00244751|9365093|P2|Overall Study|Adverse Event|7
2723208|NCT00244751|9365094|P1|Overall Study|Adverse Event|7
2723209|NCT00244725|9365195|P4|Overall Study|Failed to follow-up|1
2723210|NCT00244725|9365196|P3|Overall Study|Failed to follow-up|1
2723211|NCT00244725|9365197|P2|Overall Study|Failed to follow-up|0
2723212|NCT00244725|9365198|P1|Overall Study|Failed to follow-up|0
2723213|NCT00244725|9365195|P4|Overall Study|Vomit|0
2723214|NCT00244725|9365196|P3|Overall Study|Vomit|1
2723215|NCT00244725|9365197|P2|Overall Study|Vomit|0
2723216|NCT00244725|9365198|P1|Overall Study|Vomit|0
2723217|NCT00244725|9365195|P4|Overall Study|Administrative reason|0
2723218|NCT00244725|9365196|P3|Overall Study|Administrative reason|1
2723219|NCT00244725|9365197|P2|Overall Study|Administrative reason|0
2723220|NCT00244725|9365198|P1|Overall Study|Administrative reason|0
2723221|NCT00244725|9365195|P4|Overall Study|Confirmed venous thromboembolism (VTE)|0
2723222|NCT00244725|9365196|P3|Overall Study|Confirmed venous thromboembolism (VTE)|0
2723223|NCT00244725|9365197|P2|Overall Study|Confirmed venous thromboembolism (VTE)|1
2723224|NCT00244725|9365198|P1|Overall Study|Confirmed venous thromboembolism (VTE)|0
2723225|NCT00244725|9365195|P4|Overall Study|Received prohibited medication|1
2723226|NCT00244725|9365196|P3|Overall Study|Received prohibited medication|0
2723227|NCT00244725|9365197|P2|Overall Study|Received prohibited medication|1
2723228|NCT00244725|9365198|P1|Overall Study|Received prohibited medication|0
2723229|NCT00244725|9365195|P4|Overall Study|Headache|0
2723230|NCT00244725|9365196|P3|Overall Study|Headache|0
2723231|NCT00244725|9365197|P2|Overall Study|Headache|1
2723232|NCT00244725|9365198|P1|Overall Study|Headache|0
2723233|NCT00244725|9365195|P4|Overall Study|Rehab Refused to allow participantion|0
2723234|NCT00244725|9365196|P3|Overall Study|Rehab Refused to allow participantion|0
2723235|NCT00244725|9365197|P2|Overall Study|Rehab Refused to allow participantion|1
2723236|NCT00244725|9365198|P1|Overall Study|Rehab Refused to allow participantion|0
2723237|NCT00244725|9365195|P4|Overall Study|Mediciation Error|0
2723238|NCT00244725|9365196|P3|Overall Study|Mediciation Error|0
2723239|NCT00244725|9365197|P2|Overall Study|Mediciation Error|1
2723240|NCT00244725|9365198|P1|Overall Study|Mediciation Error|0
2723241|NCT00244725|9365195|P4|Overall Study|Sponsor withdrew the participant|1
2723242|NCT00244725|9365196|P3|Overall Study|Sponsor withdrew the participant|0
2723243|NCT00244725|9365197|P2|Overall Study|Sponsor withdrew the participant|0
2723244|NCT00244725|9365198|P1|Overall Study|Sponsor withdrew the participant|1
2723245|NCT00244725|9365195|P4|Overall Study|Liver function test abnormality|1
2723246|NCT00244725|9365196|P3|Overall Study|Liver function test abnormality|0
2723247|NCT00244725|9365197|P2|Overall Study|Liver function test abnormality|0
2723248|NCT00244725|9365198|P1|Overall Study|Liver function test abnormality|2
2723249|NCT00244725|9365195|P4|Overall Study|Withdrwal by participant|1
2723250|NCT00244725|9365196|P3|Overall Study|Withdrwal by participant|0
2723251|NCT00244725|9365197|P2|Overall Study|Withdrwal by participant|0
2723252|NCT00244725|9365198|P1|Overall Study|Withdrwal by participant|1
2723253|NCT00244725|9365195|P4|Overall Study|Adverse Events|4
2723254|NCT00244725|9365196|P3|Overall Study|Adverse Events|4
2723255|NCT00244725|9365197|P2|Overall Study|Adverse Events|1
2723256|NCT00244725|9365198|P1|Overall Study|Adverse Events|3
2723257|NCT00244725|9365195|P4|Overall Study|Physician Decision|2
2723258|NCT00244725|9365196|P3|Overall Study|Physician Decision|1
2723259|NCT00244725|9365197|P2|Overall Study|Physician Decision|0
2723260|NCT00244725|9365198|P1|Overall Study|Physician Decision|3
2723261|NCT00244725|9365195|P4|Overall Study|Not meet treatment eligibility criteria|0
2723262|NCT00244725|9365196|P3|Overall Study|Not meet treatment eligibility criteria|0
2723263|NCT00244725|9365197|P2|Overall Study|Not meet treatment eligibility criteria|2
2723264|NCT00244725|9365198|P1|Overall Study|Not meet treatment eligibility criteria|1
2723265|NCT00244725|9365195|P4|Overall Study|Withdrawal by Subject|8
2723266|NCT00244725|9365196|P3|Overall Study|Withdrawal by Subject|7
2723267|NCT00244725|9365197|P2|Overall Study|Withdrawal by Subject|7
2723268|NCT00244725|9365198|P1|Overall Study|Withdrawal by Subject|9
2723269|NCT00244725|9365195|P4|Overall Study|Lost to Follow-up|2
2723270|NCT00244725|9365196|P3|Overall Study|Lost to Follow-up|9
2723271|NCT00244725|9365197|P2|Overall Study|Lost to Follow-up|4
2723272|NCT00244725|9365198|P1|Overall Study|Lost to Follow-up|3
2723273|NCT00244712|9365254|P2|Overall Study|Protocol Violation, disease progression|11
2723274|NCT00244712|9365255|P1|Overall Study|Protocol Violation, disease progression|13
2723275|NCT00244712|9365254|P2|Overall Study|Withdrawal by Subject|23
2723276|NCT00244712|9365255|P1|Overall Study|Withdrawal by Subject|13
2723277|NCT00244712|9365254|P2|Overall Study|Lost to Follow-up|52
2723278|NCT00244712|9365255|P1|Overall Study|Lost to Follow-up|45
2723279|NCT00244712|9365254|P2|Overall Study|Lack of Compliance|11
2723280|NCT00244712|9365255|P1|Overall Study|Lack of Compliance|10
2723281|NCT00244712|9365254|P2|Overall Study|Protocol-Defined Virologic Failure|6
2723282|NCT00244712|9365255|P1|Overall Study|Protocol-Defined Virologic Failure|8
2723283|NCT00244712|9365254|P2|Overall Study|Adverse Event|21
2723284|NCT00244712|9365255|P1|Overall Study|Adverse Event|20
2723285|NCT00244621|9365290|P3|Open-label Treatment Period|Moved abroad|1
2723286|NCT00244621|9365291|P2|Open-label Treatment Period|Moved abroad|0
2723287|NCT00244621|9365292|P1|Open-label Treatment Period|Moved abroad|0
2723288|NCT00244621|9365290|P3|Open-label Treatment Period|Adverse Event|1
2723289|NCT00244621|9365291|P2|Open-label Treatment Period|Adverse Event|0
2723290|NCT00244621|9365292|P1|Open-label Treatment Period|Adverse Event|0
2723291|NCT00244621|9365290|P3|Open-label Treatment Period|Withdrawal by Subject|0
2723292|NCT00244621|9365291|P2|Open-label Treatment Period|Withdrawal by Subject|0
2723293|NCT00244621|9365292|P1|Open-label Treatment Period|Withdrawal by Subject|1
2723294|NCT00244621|9365290|P3|Open-label Treatment Period|Lost to Follow-up|0
2723295|NCT00244621|9365291|P2|Open-label Treatment Period|Lost to Follow-up|1
2723296|NCT00244621|9365292|P1|Open-label Treatment Period|Lost to Follow-up|0
2723297|NCT00244621|9365290|P3|Double-blind Treatment Period|Multiple Reasons|1
2723298|NCT00244621|9365291|P2|Double-blind Treatment Period|Multiple Reasons|1
2723299|NCT00244621|9365292|P1|Double-blind Treatment Period|Multiple Reasons|2
2723300|NCT00244621|9365290|P3|Double-blind Treatment Period|Lack of Efficacy|0
2723301|NCT00244621|9365291|P2|Double-blind Treatment Period|Lack of Efficacy|1
2723302|NCT00244621|9365292|P1|Double-blind Treatment Period|Lack of Efficacy|0
2723303|NCT00244621|9365290|P3|Double-blind Treatment Period|Withdrawal by Subject|0
2723304|NCT00244621|9365291|P2|Double-blind Treatment Period|Withdrawal by Subject|1
2723305|NCT00244621|9365292|P1|Double-blind Treatment Period|Withdrawal by Subject|0
2723306|NCT00244621|9365290|P3|Double-blind Treatment Period|Lost to Follow-up|1
2723307|NCT00244621|9365291|P2|Double-blind Treatment Period|Lost to Follow-up|0
2723308|NCT00244621|9365292|P1|Double-blind Treatment Period|Lost to Follow-up|0
2723309|NCT00244374|9365309|P5|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
2723310|NCT00244374|9365310|P4|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
2723311|NCT00244374|9365311|P3|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
2723312|NCT00244374|9365312|P2|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
2723313|NCT00244374|9365313|P1|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12
2723314|NCT00244374|9365309|P5|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
2723315|NCT00244374|9365310|P4|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
2723316|NCT00244374|9365311|P3|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
2723317|NCT00244374|9365312|P2|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
2723318|NCT00244374|9365313|P1|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4
2723319|NCT00244374|9365309|P5|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
2723320|NCT00244374|9365310|P4|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
2723321|NCT00244374|9365311|P3|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
2723322|NCT00244374|9365312|P2|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
2723323|NCT00244374|9365313|P1|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34
2723324|NCT00244374|9365309|P5|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
2723325|NCT00244374|9365310|P4|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
2723326|NCT00244374|9365311|P3|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
2723327|NCT00244374|9365312|P2|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
2723328|NCT00244374|9365313|P1|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51
2723329|NCT00244374|9365309|P5|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
2723330|NCT00244374|9365310|P4|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
2723331|NCT00244374|9365311|P3|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
2723332|NCT00244374|9365312|P2|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
2723333|NCT00244374|9365313|P1|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172
2723334|NCT00244374|9365309|P5|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
2723335|NCT00244374|9365310|P4|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
2723336|NCT00244374|9365311|P3|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
2723337|NCT00244374|9365312|P2|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
2723338|NCT00244374|9365313|P1|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1
2723339|NCT00244374|9365309|P5|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
2723340|NCT00244374|9365310|P4|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
2723341|NCT00244374|9365311|P3|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
2723342|NCT00244374|9365312|P2|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
2723343|NCT00244374|9365313|P1|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14
2723344|NCT00244374|9365309|P5|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
2723345|NCT00244374|9365310|P4|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
2723346|NCT00244374|9365311|P3|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
2723347|NCT00244374|9365312|P2|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
2723348|NCT00244374|9365313|P1|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17
2723349|NCT00244374|9365309|P5|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
2723350|NCT00244374|9365310|P4|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
2723351|NCT00244374|9365311|P3|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
2723352|NCT00244374|9365312|P2|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
2723353|NCT00244374|9365313|P1|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105
2723354|NCT00243932|9365369|P3|Stage 1: Dose Selection|Lost to Follow-up|0
2723355|NCT00243932|9365370|P2|Stage 1: Dose Selection|Lost to Follow-up|0
2723356|NCT00243932|9365371|P1|Stage 1: Dose Selection|Lost to Follow-up|2
2723357|NCT00243919|9365382|P3|Overall Study|Physician Decision|0
2723358|NCT00243919|9365383|P2|Overall Study|Physician Decision|1
2723359|NCT00243919|9365384|P1|Overall Study|Physician Decision|1
2723360|NCT00243919|9365382|P3|Overall Study|Administrative Error|0
2723361|NCT00243919|9365383|P2|Overall Study|Administrative Error|0
2723362|NCT00243919|9365384|P1|Overall Study|Administrative Error|1
2723363|NCT00243919|9365382|P3|Overall Study|Lost to Follow-up|3
2723364|NCT00243919|9365383|P2|Overall Study|Lost to Follow-up|7
2723365|NCT00243919|9365384|P1|Overall Study|Lost to Follow-up|6
2723366|NCT00243919|9365382|P3|Overall Study|Withdrawal by Subject|2
2723367|NCT00243919|9365383|P2|Overall Study|Withdrawal by Subject|6
2723368|NCT00243919|9365384|P1|Overall Study|Withdrawal by Subject|6
2723369|NCT00243919|9365382|P3|Overall Study|Death|6
2723370|NCT00243919|9365383|P2|Overall Study|Death|4
2723371|NCT00243919|9365384|P1|Overall Study|Death|3
2723372|NCT00243841|9365428|P6|Overall Study|Physician Decision|2
2723373|NCT00243841|9365429|P5|Overall Study|Physician Decision|0
2723374|NCT00243841|9365430|P4|Overall Study|Physician Decision|0
2723375|NCT00243841|9365431|P3|Overall Study|Physician Decision|1
2723376|NCT00243841|9365432|P2|Overall Study|Physician Decision|0
2723377|NCT00243841|9365433|P1|Overall Study|Physician Decision|0
2723378|NCT00243659|9365455|P2|Overall Study|Protocol Violation|2
2723379|NCT00243659|9365456|P1|Overall Study|Protocol Violation|1
2723380|NCT00243659|9365455|P2|Overall Study|Withdrawal by Subject|1
2723381|NCT00243659|9365456|P1|Overall Study|Withdrawal by Subject|1
2723382|NCT00243503|9365464|P1|Overall Study|Other|1
2723383|NCT00243503|9365464|P1|Overall Study|Death|1
2723384|NCT00243503|9365464|P1|Overall Study|Lack of Efficacy|44
2723385|NCT00243503|9365464|P1|Overall Study|Withdrawal by Subject|1
2723386|NCT00243503|9365464|P1|Overall Study|Adverse Event|11
2723387|NCT00243412|9365481|P2|Overall Study|Other|1
2723388|NCT00243412|9365482|P1|Overall Study|Other|1
2723389|NCT00243412|9365481|P2|Overall Study|Withdrawal by Subject|5
2723390|NCT00243412|9365482|P1|Overall Study|Withdrawal by Subject|4
2723391|NCT00243412|9365481|P2|Overall Study|Physician Decision|1
2723392|NCT00243412|9365482|P1|Overall Study|Physician Decision|1
2723393|NCT00243412|9365481|P2|Overall Study|Lost to Follow-up|1
2723394|NCT00243412|9365482|P1|Overall Study|Lost to Follow-up|0
2723395|NCT00243412|9365481|P2|Overall Study|Adverse Event|2
2723396|NCT00243412|9365482|P1|Overall Study|Adverse Event|4
2723397|NCT00243412|9365481|P2|Overall Study|Death|1
2723398|NCT00243412|9365482|P1|Overall Study|Death|0
2723399|NCT00243386|9365508|P3|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
2723400|NCT00243386|9365509|P2|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1
2723401|NCT00243386|9365510|P1|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
2723402|NCT00243386|9365508|P3|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
2723403|NCT00243386|9365509|P2|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2
2723404|NCT00243386|9365510|P1|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
2723405|NCT00243386|9365508|P3|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
2723406|NCT00243386|9365509|P2|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
2723407|NCT00243386|9365510|P1|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1
2723408|NCT00243386|9365508|P3|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
2723409|NCT00243386|9365509|P2|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
2723410|NCT00243386|9365510|P1|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1
2723411|NCT00243386|9365508|P3|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
2723412|NCT00243386|9365509|P2|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
2723413|NCT00243386|9365510|P1|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1
2723414|NCT00243386|9365508|P3|On-Demand Regimen (Study Part 1)|Screen Failures|0
2723415|NCT00243386|9365509|P2|On-Demand Regimen (Study Part 1)|Screen Failures|0
2723416|NCT00243386|9365510|P1|On-Demand Regimen (Study Part 1)|Screen Failures|2
2723417|NCT00243386|9365508|P3|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
2723418|NCT00243386|9365509|P2|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
2723419|NCT00243386|9365510|P1|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1
2723420|NCT00243386|9365508|P3|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
2723421|NCT00243386|9365509|P2|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
2723422|NCT00243386|9365510|P1|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1
2723423|NCT00243347|9365575|P1|Overall Study|Condition worsened|7
2723424|NCT00243347|9365575|P1|Overall Study|Withdrawal by Subject|5
2723425|NCT00243347|9365575|P1|Overall Study|Death|1
2723426|NCT00243347|9365575|P1|Overall Study|Adverse Event|2
2723427|NCT00243347|9365575|P1|Overall Study|Lack of Efficacy|4
2723428|NCT00243269|9365584|P4|Overall Study|Lost to Follow-up|3
2723429|NCT00243269|9365585|P3|Overall Study|Lost to Follow-up|1
2723430|NCT00243269|9365586|P2|Overall Study|Lost to Follow-up|0
2723431|NCT00243269|9365587|P1|Overall Study|Lost to Follow-up|1
2723432|NCT00243269|9365584|P4|Overall Study|Protocol Violation|1
2723433|NCT00243269|9365585|P3|Overall Study|Protocol Violation|0
2723434|NCT00243269|9365586|P2|Overall Study|Protocol Violation|1
2723435|NCT00243269|9365587|P1|Overall Study|Protocol Violation|2
2723436|NCT00243074|9365622|P1|Overall Study|Did not receive any treatment|1
2723437|NCT00243074|9365622|P1|Overall Study|not protocol specified|1
2723438|NCT00243074|9365622|P1|Overall Study|Death|2
2723439|NCT00243074|9365622|P1|Overall Study|Lack of Efficacy|36
2723440|NCT00243074|9365622|P1|Overall Study|Withdrawal by Subject|2
2723441|NCT00243074|9365622|P1|Overall Study|Adverse Event|6
2723442|NCT00243074|9365622|P1|Overall Study|Ineligible|6
2723443|NCT00243022|9365648|P2|Overall Study|Difficult Travel Distance|1
2723444|NCT00243022|9365649|P1|Overall Study|Difficult Travel Distance|0
2723445|NCT00243022|9365648|P2|Overall Study|Death|0
2723446|NCT00243022|9365649|P1|Overall Study|Death|1
2723447|NCT00243022|9365648|P2|Overall Study|Withdrawal by Subject|0
2723448|NCT00243022|9365649|P1|Overall Study|Withdrawal by Subject|1
2723449|NCT00242710|9365673|P4|Study Extension (up to Year 2)|Withdrawal by Subject|1
2723450|NCT00242710|9365674|P3|Study Extension (up to Year 2)|Withdrawal by Subject|4
2723451|NCT00242710|9365675|P2|Study Extension (up to Year 2)|Withdrawal by Subject|6
2723452|NCT00242710|9365676|P1|Study Extension (up to Year 2)|Withdrawal by Subject|10
2723453|NCT00242710|9365673|P4|Study Extension (up to Year 2)|Protocol Violation|1
2723454|NCT00242710|9365674|P3|Study Extension (up to Year 2)|Protocol Violation|0
2723455|NCT00242710|9365675|P2|Study Extension (up to Year 2)|Protocol Violation|2
2723456|NCT00242710|9365676|P1|Study Extension (up to Year 2)|Protocol Violation|0
2723457|NCT00242710|9365673|P4|Study Extension (up to Year 2)|Other|3
2723458|NCT00242710|9365674|P3|Study Extension (up to Year 2)|Other|4
2723459|NCT00242710|9365675|P2|Study Extension (up to Year 2)|Other|5
2723460|NCT00242710|9365676|P1|Study Extension (up to Year 2)|Other|3
2723539|NCT00242580|9365766|P2|Overall Study|Lost to Follow-up|3
2723461|NCT00242710|9365673|P4|Study Extension (up to Year 2)|Lost to Follow-up|0
2723462|NCT00242710|9365674|P3|Study Extension (up to Year 2)|Lost to Follow-up|5
2723463|NCT00242710|9365675|P2|Study Extension (up to Year 2)|Lost to Follow-up|7
2723464|NCT00242710|9365676|P1|Study Extension (up to Year 2)|Lost to Follow-up|7
2723465|NCT00242710|9365673|P4|Study Extension (up to Year 2)|Death|1
2723466|NCT00242710|9365674|P3|Study Extension (up to Year 2)|Death|0
2723467|NCT00242710|9365675|P2|Study Extension (up to Year 2)|Death|0
2723468|NCT00242710|9365676|P1|Study Extension (up to Year 2)|Death|0
2723469|NCT00242710|9365673|P4|Study Extension (up to Year 2)|Adverse Event|4
2723470|NCT00242710|9365674|P3|Study Extension (up to Year 2)|Adverse Event|2
2723471|NCT00242710|9365675|P2|Study Extension (up to Year 2)|Adverse Event|9
2723472|NCT00242710|9365676|P1|Study Extension (up to Year 2)|Adverse Event|7
2723473|NCT00242710|9365673|P4|Period Between Core Study and Extension|Withdrawal by Subject|28
2723474|NCT00242710|9365674|P3|Period Between Core Study and Extension|Withdrawal by Subject|24
2723475|NCT00242710|9365675|P2|Period Between Core Study and Extension|Withdrawal by Subject|63
2723476|NCT00242710|9365676|P1|Period Between Core Study and Extension|Withdrawal by Subject|75
2723477|NCT00242710|9365673|P4|Period Between Core Study and Extension|Protocol Violation|1
2723478|NCT00242710|9365674|P3|Period Between Core Study and Extension|Protocol Violation|2
2723479|NCT00242710|9365675|P2|Period Between Core Study and Extension|Protocol Violation|0
2723480|NCT00242710|9365676|P1|Period Between Core Study and Extension|Protocol Violation|0
2723481|NCT00242710|9365673|P4|Period Between Core Study and Extension|Extension not Available|7
2723482|NCT00242710|9365674|P3|Period Between Core Study and Extension|Extension not Available|8
2723483|NCT00242710|9365675|P2|Period Between Core Study and Extension|Extension not Available|21
2723484|NCT00242710|9365676|P1|Period Between Core Study and Extension|Extension not Available|17
2723485|NCT00242710|9365673|P4|Period Between Core Study and Extension|Other|11
2723486|NCT00242710|9365674|P3|Period Between Core Study and Extension|Other|9
2723487|NCT00242710|9365675|P2|Period Between Core Study and Extension|Other|24
2723488|NCT00242710|9365676|P1|Period Between Core Study and Extension|Other|24
2723489|NCT00242710|9365673|P4|Period Between Core Study and Extension|Physician Decision|0
2723490|NCT00242710|9365674|P3|Period Between Core Study and Extension|Physician Decision|0
2723491|NCT00242710|9365675|P2|Period Between Core Study and Extension|Physician Decision|1
2723492|NCT00242710|9365676|P1|Period Between Core Study and Extension|Physician Decision|1
2723493|NCT00242710|9365673|P4|Period Between Core Study and Extension|Adverse Event|2
2723494|NCT00242710|9365674|P3|Period Between Core Study and Extension|Adverse Event|5
2723495|NCT00242710|9365675|P2|Period Between Core Study and Extension|Adverse Event|3
2723496|NCT00242710|9365676|P1|Period Between Core Study and Extension|Adverse Event|2
2723497|NCT00242710|9365673|P4|Core Study (up to Year 1)|Randomized but not Treated|2
2723498|NCT00242710|9365674|P3|Core Study (up to Year 1)|Randomized but not Treated|4
2723499|NCT00242710|9365675|P2|Core Study (up to Year 1)|Randomized but not Treated|4
2723500|NCT00242710|9365676|P1|Core Study (up to Year 1)|Randomized but not Treated|12
2723501|NCT00242710|9365673|P4|Core Study (up to Year 1)|Lack of Efficacy|0
2723502|NCT00242710|9365674|P3|Core Study (up to Year 1)|Lack of Efficacy|0
2723503|NCT00242710|9365675|P2|Core Study (up to Year 1)|Lack of Efficacy|0
2723504|NCT00242710|9365676|P1|Core Study (up to Year 1)|Lack of Efficacy|1
2723505|NCT00242710|9365673|P4|Core Study (up to Year 1)|Withdrawal by Subject|6
2723506|NCT00242710|9365674|P3|Core Study (up to Year 1)|Withdrawal by Subject|15
2723507|NCT00242710|9365675|P2|Core Study (up to Year 1)|Withdrawal by Subject|16
2723508|NCT00242710|9365676|P1|Core Study (up to Year 1)|Withdrawal by Subject|27
2723509|NCT00242710|9365673|P4|Core Study (up to Year 1)|Protocol Violation|3
2723510|NCT00242710|9365674|P3|Core Study (up to Year 1)|Protocol Violation|1
2723511|NCT00242710|9365675|P2|Core Study (up to Year 1)|Protocol Violation|9
2723512|NCT00242710|9365676|P1|Core Study (up to Year 1)|Protocol Violation|2
2723513|NCT00242710|9365673|P4|Core Study (up to Year 1)|Other|2
2723514|NCT00242710|9365674|P3|Core Study (up to Year 1)|Other|0
2723515|NCT00242710|9365675|P2|Core Study (up to Year 1)|Other|1
2723516|NCT00242710|9365676|P1|Core Study (up to Year 1)|Other|6
2723517|NCT00242710|9365673|P4|Core Study (up to Year 1)|Lost to Follow-up|3
2723518|NCT00242710|9365674|P3|Core Study (up to Year 1)|Lost to Follow-up|7
2723519|NCT00242710|9365675|P2|Core Study (up to Year 1)|Lost to Follow-up|8
2723520|NCT00242710|9365676|P1|Core Study (up to Year 1)|Lost to Follow-up|8
2723521|NCT00242710|9365673|P4|Core Study (up to Year 1)|Physician Decision|1
2723522|NCT00242710|9365674|P3|Core Study (up to Year 1)|Physician Decision|0
2723523|NCT00242710|9365675|P2|Core Study (up to Year 1)|Physician Decision|1
2723524|NCT00242710|9365676|P1|Core Study (up to Year 1)|Physician Decision|0
2723525|NCT00242710|9365673|P4|Core Study (up to Year 1)|Death|0
2723526|NCT00242710|9365674|P3|Core Study (up to Year 1)|Death|1
2723527|NCT00242710|9365675|P2|Core Study (up to Year 1)|Death|0
2723528|NCT00242710|9365676|P1|Core Study (up to Year 1)|Death|0
2723529|NCT00242710|9365673|P4|Core Study (up to Year 1)|Adverse Event|14
2723530|NCT00242710|9365674|P3|Core Study (up to Year 1)|Adverse Event|23
2723531|NCT00242710|9365675|P2|Core Study (up to Year 1)|Adverse Event|25
2723532|NCT00242710|9365676|P1|Core Study (up to Year 1)|Adverse Event|30
2723533|NCT00242658|9365733|P2|Overall Study|Lost to Follow-up|19
2723534|NCT00242658|9365734|P1|Overall Study|Lost to Follow-up|22
2723535|NCT00242580|9365765|P3|Overall Study|Death|1
2723536|NCT00242580|9365766|P2|Overall Study|Death|2
2723537|NCT00242580|9365767|P1|Overall Study|Death|1
2723538|NCT00242580|9365765|P3|Overall Study|Lost to Follow-up|0
2723540|NCT00242580|9365767|P1|Overall Study|Lost to Follow-up|0
2723541|NCT00242580|9365765|P3|Overall Study|Subject withdrew consent|5
2723542|NCT00242580|9365766|P2|Overall Study|Subject withdrew consent|2
2723543|NCT00242580|9365767|P1|Overall Study|Subject withdrew consent|2
2723544|NCT00242580|9365765|P3|Overall Study|Protocol Violation|1
2723545|NCT00242580|9365766|P2|Overall Study|Protocol Violation|0
2723546|NCT00242580|9365767|P1|Overall Study|Protocol Violation|0
2723547|NCT00242580|9365765|P3|Overall Study|Unsatisfactory therapeutic effect|5
2723548|NCT00242580|9365766|P2|Overall Study|Unsatisfactory therapeutic effect|5
2723549|NCT00242580|9365767|P1|Overall Study|Unsatisfactory therapeutic effect|4
2723550|NCT00242580|9365765|P3|Overall Study|Adverse Event|2
2723551|NCT00242580|9365766|P2|Overall Study|Adverse Event|0
2723552|NCT00242580|9365767|P1|Overall Study|Adverse Event|3
2723553|NCT00242567|9365792|P2|Overall Study|Other|9
2723554|NCT00242567|9365793|P1|Overall Study|Other|14
2723555|NCT00242567|9365792|P2|Overall Study|Use of an inhibitor of bone resorption|2
2723556|NCT00242567|9365793|P1|Overall Study|Use of an inhibitor of bone resorption|0
2723557|NCT00242567|9365792|P2|Overall Study|Protocol Violation|12
2723558|NCT00242567|9365793|P1|Overall Study|Protocol Violation|12
2723559|NCT00242567|9365792|P2|Overall Study|Withdrawal by Subject|28
2723560|NCT00242567|9365793|P1|Overall Study|Withdrawal by Subject|33
2723561|NCT00242567|9365792|P2|Overall Study|Lost to Follow-up|19
2723562|NCT00242567|9365793|P1|Overall Study|Lost to Follow-up|9
2723563|NCT00242567|9365792|P2|Overall Study|Lack of Efficacy|2
2723564|NCT00242567|9365793|P1|Overall Study|Lack of Efficacy|2
2723565|NCT00242567|9365792|P2|Overall Study|Symptomatic deterioration|3
2723566|NCT00242567|9365793|P1|Overall Study|Symptomatic deterioration|9
2723567|NCT00242567|9365792|P2|Overall Study|Disease Progression|22
2723568|NCT00242567|9365793|P1|Overall Study|Disease Progression|17
2723569|NCT00242567|9365792|P2|Overall Study|Adverse Event|43
2723570|NCT00242567|9365793|P1|Overall Study|Adverse Event|70
2723571|NCT00242216|9365840|P2|Overall Study|no medicaiton dispensed|1
2723572|NCT00242216|9365841|P1|Overall Study|no medicaiton dispensed|1
2723573|NCT00242216|9365840|P2|Overall Study|Lack of Efficacy|2
2723574|NCT00242216|9365841|P1|Overall Study|Lack of Efficacy|1
2723575|NCT00242216|9365840|P2|Overall Study|Death|2
2723576|NCT00242216|9365841|P1|Overall Study|Death|4
2723577|NCT00242216|9365840|P2|Overall Study|Lost to Follow-up|17
2723578|NCT00242216|9365841|P1|Overall Study|Lost to Follow-up|12
2723579|NCT00241839|9365879|P2|Overall Study|Adverse Event|1
2723580|NCT00241839|9365880|P1|Overall Study|Adverse Event|1
2723581|NCT00241839|9365879|P2|Overall Study|Withdrawal by Subject|17
2723582|NCT00241839|9365880|P1|Overall Study|Withdrawal by Subject|18
2723583|NCT00241644|9365896|P4|Second Efficacy Period (Year 2)|Consenting parent passed away|2
2723584|NCT00241644|9365897|P3|Second Efficacy Period (Year 2)|Consenting parent passed away|2
2723585|NCT00241644|9365898|P2|Second Efficacy Period (Year 2)|Consenting parent passed away|1
2723586|NCT00241644|9365899|P1|Second Efficacy Period (Year 2)|Consenting parent passed away|1
2723587|NCT00241644|9365896|P4|Second Efficacy Period (Year 2)|Lost to Follow-up|86
2723588|NCT00241644|9365897|P3|Second Efficacy Period (Year 2)|Lost to Follow-up|46
2723589|NCT00241644|9365898|P2|Second Efficacy Period (Year 2)|Lost to Follow-up|43
2723590|NCT00241644|9365899|P1|Second Efficacy Period (Year 2)|Lost to Follow-up|43
2723591|NCT00241644|9365896|P4|Second Efficacy Period (Year 2)|Withdrawal by Subject|7
2723592|NCT00241644|9365897|P3|Second Efficacy Period (Year 2)|Withdrawal by Subject|2
2723593|NCT00241644|9365898|P2|Second Efficacy Period (Year 2)|Withdrawal by Subject|3
2723594|NCT00241644|9365899|P1|Second Efficacy Period (Year 2)|Withdrawal by Subject|4
2723595|NCT00241644|9365896|P4|Second Efficacy Period (Year 2)|Protocol Violation|3
2723596|NCT00241644|9365897|P3|Second Efficacy Period (Year 2)|Protocol Violation|2
2723597|NCT00241644|9365898|P2|Second Efficacy Period (Year 2)|Protocol Violation|1
2723598|NCT00241644|9365899|P1|Second Efficacy Period (Year 2)|Protocol Violation|2
2723599|NCT00241644|9365896|P4|Second Efficacy Period (Year 2)|Adverse Event|20
2723600|NCT00241644|9365897|P3|Second Efficacy Period (Year 2)|Adverse Event|12
2723601|NCT00241644|9365898|P2|Second Efficacy Period (Year 2)|Adverse Event|9
2723602|NCT00241644|9365899|P1|Second Efficacy Period (Year 2)|Adverse Event|11
2723603|NCT00241644|9365896|P4|First Efficacy Period (Year 1)|Subject's parent passed away|1
2723604|NCT00241644|9365897|P3|First Efficacy Period (Year 1)|Subject's parent passed away|0
2723605|NCT00241644|9365898|P2|First Efficacy Period (Year 1)|Subject's parent passed away|1
2723606|NCT00241644|9365899|P1|First Efficacy Period (Year 1)|Subject's parent passed away|0
2723607|NCT00241644|9365896|P4|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
2723608|NCT00241644|9365897|P3|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1
2723609|NCT00241644|9365898|P2|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
2723610|NCT00241644|9365899|P1|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
2723611|NCT00241644|9365896|P4|First Efficacy Period (Year 1)|Return dates not reliable|1
2723612|NCT00241644|9365897|P3|First Efficacy Period (Year 1)|Return dates not reliable|0
2723613|NCT00241644|9365898|P2|First Efficacy Period (Year 1)|Return dates not reliable|0
2723614|NCT00241644|9365899|P1|First Efficacy Period (Year 1)|Return dates not reliable|1
2723615|NCT00241644|9365896|P4|First Efficacy Period (Year 1)|Non-compliance|3
2723616|NCT00241644|9365897|P3|First Efficacy Period (Year 1)|Non-compliance|2
2723617|NCT00241644|9365898|P2|First Efficacy Period (Year 1)|Non-compliance|1
2723618|NCT00241644|9365899|P1|First Efficacy Period (Year 1)|Non-compliance|2
2723619|NCT00241644|9365896|P4|First Efficacy Period (Year 1)|Lost to Follow-up|258
2723620|NCT00241644|9365897|P3|First Efficacy Period (Year 1)|Lost to Follow-up|116
2723621|NCT00241644|9365898|P2|First Efficacy Period (Year 1)|Lost to Follow-up|142
2723622|NCT00241644|9365899|P1|First Efficacy Period (Year 1)|Lost to Follow-up|116
2723623|NCT00241644|9365896|P4|First Efficacy Period (Year 1)|Withdrawal by Subject|133
2723624|NCT00241644|9365897|P3|First Efficacy Period (Year 1)|Withdrawal by Subject|81
2723625|NCT00241644|9365898|P2|First Efficacy Period (Year 1)|Withdrawal by Subject|74
2723626|NCT00241644|9365899|P1|First Efficacy Period (Year 1)|Withdrawal by Subject|59
2723627|NCT00241644|9365896|P4|First Efficacy Period (Year 1)|Protocol Violation|8
2723628|NCT00241644|9365897|P3|First Efficacy Period (Year 1)|Protocol Violation|4
2723629|NCT00241644|9365898|P2|First Efficacy Period (Year 1)|Protocol Violation|5
2723630|NCT00241644|9365899|P1|First Efficacy Period (Year 1)|Protocol Violation|3
2723631|NCT00241644|9365896|P4|First Efficacy Period (Year 1)|Adverse Event|91
2723632|NCT00241644|9365897|P3|First Efficacy Period (Year 1)|Adverse Event|45
2723633|NCT00241644|9365898|P2|First Efficacy Period (Year 1)|Adverse Event|45
2723634|NCT00241644|9365899|P1|First Efficacy Period (Year 1)|Adverse Event|46
2723635|NCT00241631|9365983|P2|Phase 1 (4 Weeks)|Lack of Efficacy|1
2723636|NCT00241631|9365984|P1|Phase 1 (4 Weeks)|Lack of Efficacy|0
2723637|NCT00241631|9365983|P2|Phase 1 (4 Weeks)|Lost to Follow-up|0
2723638|NCT00241631|9365984|P1|Phase 1 (4 Weeks)|Lost to Follow-up|3
2723639|NCT00241631|9365983|P2|Phase 1 (4 Weeks)|Withdrawal by Subject|4
2723640|NCT00241631|9365984|P1|Phase 1 (4 Weeks)|Withdrawal by Subject|4
2723641|NCT00241631|9365983|P2|Phase 1 (4 Weeks)|sore throat|0
2723642|NCT00241631|9365984|P1|Phase 1 (4 Weeks)|sore throat|1
2723643|NCT00241631|9365983|P2|Run in (2 Weeks)|Physician Decision|3
2723644|NCT00241631|9365984|P1|Run in (2 Weeks)|Physician Decision|3
2723645|NCT00241358|9365997|P3|Overall Study|Determined to be not ineligible|1
2723646|NCT00241358|9365998|P2|Overall Study|Determined to be not ineligible|1
2723647|NCT00241358|9365999|P1|Overall Study|Determined to be not ineligible|0
2723648|NCT00241280|9366032|P2|Overall Study|Excessive Dryness|1
2723649|NCT00241280|9366033|P1|Overall Study|Excessive Dryness|0
2723650|NCT00241280|9366032|P2|Overall Study|Coating on Lens|0
2723651|NCT00241280|9366033|P1|Overall Study|Coating on Lens|1
2723652|NCT00241280|9366032|P2|Overall Study|History of Ocular Surgery|1
2723653|NCT00241280|9366033|P1|Overall Study|History of Ocular Surgery|0
2723654|NCT00241280|9366032|P2|Overall Study|Scheduling Conflict|2
2723655|NCT00241280|9366033|P1|Overall Study|Scheduling Conflict|0
2723656|NCT00241280|9366032|P2|Overall Study|Unacceptable Fit|1
2723657|NCT00241280|9366033|P1|Overall Study|Unacceptable Fit|0
2723658|NCT00241280|9366032|P2|Overall Study|Dispensed incorrect test article|2
2723659|NCT00241280|9366033|P1|Overall Study|Dispensed incorrect test article|1
2723660|NCT00241280|9366032|P2|Overall Study|Subject Ineligible/Dispensed|6
2723661|NCT00241280|9366033|P1|Overall Study|Subject Ineligible/Dispensed|9
2723662|NCT00241280|9366032|P2|Overall Study|Diabetic|0
2723663|NCT00241280|9366033|P1|Overall Study|Diabetic|1
2723664|NCT00241280|9366032|P2|Overall Study|Unsatisfactory Visual Response|1
2723665|NCT00241280|9366033|P1|Overall Study|Unsatisfactory Visual Response|1
2723666|NCT00241280|9366032|P2|Overall Study|Unsatisfactory Physiological Response|1
2723667|NCT00241280|9366033|P1|Overall Study|Unsatisfactory Physiological Response|1
2723668|NCT00241280|9366032|P2|Overall Study|Relocation|4
2723669|NCT00241280|9366033|P1|Overall Study|Relocation|4
2723670|NCT00241280|9366032|P2|Overall Study|Protocol Violation|10
2723671|NCT00241280|9366033|P1|Overall Study|Protocol Violation|4
2723672|NCT00241280|9366032|P2|Overall Study|Withdrawal by Subject|4
2723673|NCT00241280|9366033|P1|Overall Study|Withdrawal by Subject|7
2723674|NCT00241280|9366032|P2|Overall Study|Lost to Follow-up|8
2723675|NCT00241280|9366033|P1|Overall Study|Lost to Follow-up|5
2723676|NCT00241280|9366032|P2|Overall Study|Pregnancy|5
2723677|NCT00241280|9366033|P1|Overall Study|Pregnancy|1
2723678|NCT00241280|9366032|P2|Overall Study|Discomfort|16
2723679|NCT00241280|9366033|P1|Overall Study|Discomfort|11
2723680|NCT00241280|9366032|P2|Overall Study|Adverse Event|6
2723681|NCT00241280|9366033|P1|Overall Study|Adverse Event|2
2723682|NCT00240994|9366048|P1|Overall Study|Graft failure|1
2723683|NCT00240994|9366048|P1|Overall Study|Protocol Violation|1
2723684|NCT00240994|9366048|P1|Overall Study|Lost to Follow-up|1
2723685|NCT00240331|9366183|P2|Overall Study|Option selected by investigator|2
2723686|NCT00240331|9366184|P1|Overall Study|Option selected by investigator|1
2723687|NCT00240331|9366183|P2|Overall Study|Withdrawal by Subject|132
2723688|NCT00240331|9366184|P1|Overall Study|Withdrawal by Subject|125
2723689|NCT00240110|9366227|P2|Overall Study|Lost to Follow-up|7
2723690|NCT00240110|9366228|P1|Overall Study|Lost to Follow-up|6
2723691|NCT00240097|9366236|P1|Part II|did not continue from Part I|23
2723692|NCT00240097|9366236|P1|Part I|unevaluable|1
2723693|NCT00240097|9366236|P1|Part I|histology|1
2723694|NCT00240097|9366236|P1|Part I|Death|1
2723695|NCT00240097|9366236|P1|Part I|Adverse Event|1
2723696|NCT00240071|9366246|P1|Overall Study|Withdrawal by Subject|3
2723697|NCT00239928|9366251|P1|Overall Study|Withdrawal by Subject|2
2723698|NCT00239928|9366251|P1|Overall Study|Not need to continue study|3
2723699|NCT00239928|9366251|P1|Overall Study|Adverse Event|4
2723700|NCT00239928|9366251|P1|Overall Study|Lack of Efficacy|1
2723701|NCT00239837|9366263|P2|Overall Study|Lost to Follow-up|7
2723702|NCT00239837|9366264|P1|Overall Study|Lost to Follow-up|3
2723703|NCT00239720|9366291|P2|Overall Study|Lost to Follow-up|1
2723704|NCT00239720|9366292|P1|Overall Study|Lost to Follow-up|0
2723705|NCT00239720|9366291|P2|Overall Study|Adverse Event|0
2723706|NCT00239720|9366292|P1|Overall Study|Adverse Event|1
2723707|NCT00239681|9366300|P2|Overall Study|No information chacked on CaseReportForm|84
2723708|NCT00239681|9366301|P1|Overall Study|No information chacked on CaseReportForm|90
2723709|NCT00239681|9366300|P2|Overall Study|Physician Decision|17
2723710|NCT00239681|9366301|P1|Overall Study|Physician Decision|13
2723711|NCT00239681|9366300|P2|Overall Study|Protocol Violation|4
2723712|NCT00239681|9366301|P1|Overall Study|Protocol Violation|4
2723713|NCT00239681|9366300|P2|Overall Study|Lost to Follow-up|22
2723714|NCT00239681|9366301|P1|Overall Study|Lost to Follow-up|28
2723715|NCT00239681|9366300|P2|Overall Study|Withdrawal by Subject|489
2723716|NCT00239681|9366301|P1|Overall Study|Withdrawal by Subject|458
2723717|NCT00239681|9366300|P2|Overall Study|Adverse Event|99
2723718|NCT00239681|9366301|P1|Overall Study|Adverse Event|100
2723719|NCT00239590|9366354|P2|Completed Study Protocol|Withdrawal by Subject|1
2723720|NCT00239590|9366355|P1|Completed Study Protocol|Withdrawal by Subject|0
2723721|NCT00239590|9366354|P2|Completed Study Protocol|Adverse Event|1
2723722|NCT00239590|9366355|P1|Completed Study Protocol|Adverse Event|1
2723723|NCT00239590|9366354|P2|Randomized|Withdrawal by Subject|1
2723724|NCT00239590|9366355|P1|Randomized|Withdrawal by Subject|0
2723725|NCT00239590|9366354|P2|Randomized|Lost to Follow-up|1
2723726|NCT00239590|9366355|P1|Randomized|Lost to Follow-up|0
2723727|NCT00239577|9366367|P4|Primary Phase|Other|0
2723728|NCT00239577|9366368|P3|Primary Phase|Other|2
2723729|NCT00239577|9366369|P2|Primary Phase|Other|3
2723730|NCT00239577|9366370|P1|Primary Phase|Other|5
2723731|NCT00239577|9366367|P4|Primary Phase|Adverse Event|0
2723732|NCT00239577|9366368|P3|Primary Phase|Adverse Event|1
2723733|NCT00239577|9366369|P2|Primary Phase|Adverse Event|0
2723734|NCT00239577|9366370|P1|Primary Phase|Adverse Event|0
2723735|NCT00239356|9366474|P2|Overall Study|Drug available on market|2
2723736|NCT00239356|9366475|P1|Overall Study|Drug available on market|11
2723737|NCT00239356|9366474|P2|Overall Study|Administrative reason|1
2723738|NCT00239356|9366475|P1|Overall Study|Administrative reason|0
2723739|NCT00239356|9366474|P2|Overall Study|Pregnancy|0
2723740|NCT00239356|9366475|P1|Overall Study|Pregnancy|1
2723741|NCT00239356|9366474|P2|Overall Study|poor/non-compliance|0
2723742|NCT00239356|9366475|P1|Overall Study|poor/non-compliance|2
2723743|NCT00239356|9366474|P2|Overall Study|Lost to Follow-up|0
2723744|NCT00239356|9366475|P1|Overall Study|Lost to Follow-up|3
2723745|NCT00239356|9366474|P2|Overall Study|Withdrawal by Subject|6
2723746|NCT00239356|9366475|P1|Overall Study|Withdrawal by Subject|15
2723747|NCT00239356|9366474|P2|Overall Study|Adverse Event|0
2723748|NCT00239356|9366475|P1|Overall Study|Adverse Event|6
2723749|NCT00239356|9366474|P2|Overall Study|Lack of Efficacy|0
2723750|NCT00239356|9366475|P1|Overall Study|Lack of Efficacy|1
2723751|NCT00239226|9366497|P4|Overall Study|Lost to Follow-up|0
2723752|NCT00239226|9366498|P3|Overall Study|Lost to Follow-up|1
2723753|NCT00239226|9366499|P2|Overall Study|Lost to Follow-up|0
2723754|NCT00239226|9366500|P1|Overall Study|Lost to Follow-up|1
2723755|NCT00239226|9366497|P4|Overall Study|permAF during stabilization period|3
2723756|NCT00239226|9366498|P3|Overall Study|permAF during stabilization period|0
2723757|NCT00239226|9366499|P2|Overall Study|permAF during stabilization period|0
2723758|NCT00239226|9366500|P1|Overall Study|permAF during stabilization period|0
2723759|NCT00239005|9366512|P2|Overall Study|Lost to Follow-up|1
2723760|NCT00239005|9366513|P1|Overall Study|Lost to Follow-up|0
2723761|NCT00239005|9366512|P2|Overall Study|Subj. cond. no longer needs study drug|1
2723762|NCT00239005|9366513|P1|Overall Study|Subj. cond. no longer needs study drug|0
2723763|NCT00239005|9366512|P2|Overall Study|Protocol Violation|0
2723764|NCT00239005|9366513|P1|Overall Study|Protocol Violation|1
2723765|NCT00239005|9366512|P2|Overall Study|Unsatisfactory Therapeutic effect|0
2723766|NCT00239005|9366513|P1|Overall Study|Unsatisfactory Therapeutic effect|2
2723767|NCT00239005|9366512|P2|Overall Study|Withdrawal by Subject|4
2723768|NCT00239005|9366513|P1|Overall Study|Withdrawal by Subject|3
2723769|NCT00239005|9366512|P2|Overall Study|Adverse Event|6
2723770|NCT00239005|9366513|P1|Overall Study|Adverse Event|6
2723771|NCT00238433|9366529|P1|Overall Study|Death|1
2723772|NCT00238433|9366529|P1|Overall Study|Lost to Follow-up|1
2723773|NCT00238433|9366529|P1|Overall Study|Screen failure|1
2723774|NCT00238420|9366536|P2|Overall Study|Protocol Violation|1
2723775|NCT00238420|9366537|P1|Overall Study|Protocol Violation|1
2723776|NCT00238303|9366554|P3|Overall Study|Adverse Event|3
2723777|NCT00238303|9366555|P2|Overall Study|Adverse Event|1
2723778|NCT00238303|9366556|P1|Overall Study|Adverse Event|0
2723779|NCT00238303|9366554|P3|Overall Study|Poor tolerance of study treatment|1
2723780|NCT00238303|9366555|P2|Overall Study|Poor tolerance of study treatment|0
2723781|NCT00238303|9366556|P1|Overall Study|Poor tolerance of study treatment|1
2723782|NCT00238303|9366554|P3|Overall Study|Other Medical Problems|2
2723783|NCT00238303|9366555|P2|Overall Study|Other Medical Problems|0
2723784|NCT00238303|9366556|P1|Overall Study|Other Medical Problems|2
2723785|NCT00238303|9366554|P3|Overall Study|Death|1
2723786|NCT00238303|9366555|P2|Overall Study|Death|0
2723787|NCT00238303|9366556|P1|Overall Study|Death|1
2723788|NCT00238303|9366554|P3|Overall Study|Withdrawal by Subject|2
2723789|NCT00238303|9366555|P2|Overall Study|Withdrawal by Subject|1
2723790|NCT00238303|9366556|P1|Overall Study|Withdrawal by Subject|11
2723791|NCT00238264|9366573|P1|Overall Study|Ineligible|7
2723792|NCT00238264|9366573|P1|Overall Study|Withdrawal by Subject|4
2723793|NCT00238264|9366573|P1|Overall Study|Lost to Follow-up|18
2723794|NCT00238264|9366573|P1|Overall Study|Death|7
2723795|NCT00238238|9366586|P3|Overall Study|Withdrawal by Subject|0
2723796|NCT00238238|9366587|P2|Overall Study|Withdrawal by Subject|3
2723797|NCT00238238|9366588|P1|Overall Study|Withdrawal by Subject|0
2723798|NCT00238121|9366601|P2|Overall Study|Adverse Event|1
2723799|NCT00238121|9366602|P1|Overall Study|Adverse Event|2
2723800|NCT00238121|9366601|P2|Overall Study|Withdrawal by Subject|1
2723801|NCT00238121|9366602|P1|Overall Study|Withdrawal by Subject|1
2723802|NCT00237809|9366628|P4|Overall Study|Lost to Follow-up|9
2723803|NCT00237809|9366629|P3|Overall Study|Lost to Follow-up|9
2723804|NCT00237809|9366630|P2|Overall Study|Lost to Follow-up|10
2723805|NCT00237809|9366631|P1|Overall Study|Lost to Follow-up|11
2723806|NCT00237796|9366667|P2|Overall Study|Baseline and one other ILSS required|5
2723807|NCT00237796|9366668|P1|Overall Study|Baseline and one other ILSS required|10
2723808|NCT00237744|9366702|P3|Overall Study|Withdrawal by Subject|0
2723809|NCT00237744|9366703|P2|Overall Study|Withdrawal by Subject|1
2723810|NCT00237744|9366704|P1|Overall Study|Withdrawal by Subject|3
2723811|NCT00237692|9366730|P4|Overall Study|Withdrawal by Subject|4
2723812|NCT00237692|9366731|P3|Overall Study|Withdrawal by Subject|10
2723813|NCT00237692|9366732|P2|Overall Study|Withdrawal by Subject|6
2723814|NCT00237692|9366733|P1|Overall Study|Withdrawal by Subject|4
2723815|NCT00237692|9366730|P4|Overall Study|Excluded - did not meet criteria|9
2723816|NCT00237692|9366731|P3|Overall Study|Excluded - did not meet criteria|5
2723817|NCT00237692|9366732|P2|Overall Study|Excluded - did not meet criteria|3
2723818|NCT00237692|9366733|P1|Overall Study|Excluded - did not meet criteria|4
2723819|NCT00237692|9366730|P4|Overall Study|Death|3
2723820|NCT00237692|9366731|P3|Overall Study|Death|2
2723821|NCT00237692|9366732|P2|Overall Study|Death|2
2723822|NCT00237692|9366733|P1|Overall Study|Death|1
2723823|NCT00237692|9366730|P4|Overall Study|Lost to Follow-up|3
2723824|NCT00237692|9366731|P3|Overall Study|Lost to Follow-up|5
2723825|NCT00237692|9366732|P2|Overall Study|Lost to Follow-up|3
2723826|NCT00237692|9366733|P1|Overall Study|Lost to Follow-up|9
2723827|NCT00237458|9366773|P1|Overall Study|Withdrawal by Subject|1
2723828|NCT00237458|9366773|P1|Overall Study|Adverse Event|1
2723829|NCT00237458|9366773|P1|Overall Study|Lack of Efficacy|1
2723830|NCT00237185|9366791|P2|Extension|Death|1
2723831|NCT00237185|9366792|P1|Extension|Death|1
2723832|NCT00237185|9366791|P2|Extension|Administrative problems|0
2723833|NCT00237185|9366792|P1|Extension|Administrative problems|1
2723834|NCT00237185|9366791|P2|Extension|Lost to Follow-up|0
2723835|NCT00237185|9366792|P1|Extension|Lost to Follow-up|1
2723836|NCT00237185|9366791|P2|Extension|Withdrawal by Subject|2
2723837|NCT00237185|9366792|P1|Extension|Withdrawal by Subject|3
2723838|NCT00237185|9366791|P2|Extension|Condition no longer required study drug|1
2723839|NCT00237185|9366792|P1|Extension|Condition no longer required study drug|0
2723840|NCT00237185|9366791|P2|Extension|Lack of Efficacy|14
2723841|NCT00237185|9366792|P1|Extension|Lack of Efficacy|9
2723842|NCT00237185|9366791|P2|Extension|Abnormal laboratory value|1
2723843|NCT00237185|9366792|P1|Extension|Abnormal laboratory value|0
2723844|NCT00237185|9366791|P2|Extension|Adverse Event|0
2723845|NCT00237185|9366792|P1|Extension|Adverse Event|1
2723846|NCT00237185|9366791|P2|Core|Determined ineligible post randomization|0
2723847|NCT00237185|9366792|P1|Core|Determined ineligible post randomization|1
2723848|NCT00237185|9366791|P2|Core|Death|0
2723849|NCT00237185|9366792|P1|Core|Death|4
2723850|NCT00237185|9366791|P2|Core|Administrative problems|1
2723851|NCT00237185|9366792|P1|Core|Administrative problems|0
2723852|NCT00237185|9366791|P2|Core|Withdrawal by Subject|4
2723853|NCT00237185|9366792|P1|Core|Withdrawal by Subject|4
2723854|NCT00237185|9366791|P2|Core|Protocol Violation|1
2723855|NCT00237185|9366792|P1|Core|Protocol Violation|1
2723856|NCT00237185|9366791|P2|Core|Lack of Efficacy|23
2723857|NCT00237185|9366792|P1|Core|Lack of Efficacy|30
2723858|NCT00237185|9366791|P2|Core|Abnormal test procedure results|0
2723859|NCT00237185|9366792|P1|Core|Abnormal test procedure results|1
2723860|NCT00237185|9366791|P2|Core|Abnormal laboratory value|4
2723861|NCT00237185|9366792|P1|Core|Abnormal laboratory value|0
2723862|NCT00237185|9366791|P2|Core|Adverse Event|4
2723863|NCT00237185|9366792|P1|Core|Adverse Event|3
2723864|NCT00237042|9366823|P3|Long Term (12 Month) Follow up|Lost to Follow-up|9
2723865|NCT00237042|9366824|P2|Long Term (12 Month) Follow up|Lost to Follow-up|9
2723866|NCT00237042|9366825|P1|Long Term (12 Month) Follow up|Lost to Follow-up|11
2723867|NCT00237042|9366823|P3|Short Term (6 Month) Follow up|Lost to Follow-up|11
2723868|NCT00237042|9366824|P2|Short Term (6 Month) Follow up|Lost to Follow-up|8
2723869|NCT00237042|9366825|P1|Short Term (6 Month) Follow up|Lost to Follow-up|9
2723870|NCT00237042|9366823|P3|Treatment|Completed no treatment|21
2723871|NCT00237042|9366824|P2|Treatment|Completed no treatment|5
2723872|NCT00237042|9366825|P1|Treatment|Completed no treatment|5
2723873|NCT00237042|9366823|P3|Treatment|Moved out of state|1
2723874|NCT00237042|9366824|P2|Treatment|Moved out of state|1
2723875|NCT00237042|9366825|P1|Treatment|Moved out of state|1
2723876|NCT00237042|9366823|P3|Treatment|Became ineligible post-randomization|16
2723877|NCT00237042|9366824|P2|Treatment|Became ineligible post-randomization|1
2723878|NCT00237042|9366825|P1|Treatment|Became ineligible post-randomization|0
2723879|NCT00236899|9366899|P4|Overall Study|Lack of Efficacy|23
2723880|NCT00236899|9366900|P3|Overall Study|Lack of Efficacy|25
2723881|NCT00236899|9366901|P2|Overall Study|Lack of Efficacy|18
2723882|NCT00236899|9366902|P1|Overall Study|Lack of Efficacy|18
2723883|NCT00236899|9366899|P4|Overall Study|Satisfactory Response|1
2723884|NCT00236899|9366900|P3|Overall Study|Satisfactory Response|0
2723885|NCT00236899|9366901|P2|Overall Study|Satisfactory Response|0
2723886|NCT00236899|9366902|P1|Overall Study|Satisfactory Response|2
2723887|NCT00236899|9366899|P4|Overall Study|Physician Decision|6
2723888|NCT00236899|9366900|P3|Overall Study|Physician Decision|7
2723889|NCT00236899|9366901|P2|Overall Study|Physician Decision|8
2723890|NCT00236899|9366902|P1|Overall Study|Physician Decision|7
2723891|NCT00236899|9366899|P4|Overall Study|Withdrawal by Subject|2
2723892|NCT00236899|9366900|P3|Overall Study|Withdrawal by Subject|5
2723893|NCT00236899|9366901|P2|Overall Study|Withdrawal by Subject|4
2723894|NCT00236899|9366902|P1|Overall Study|Withdrawal by Subject|6
2723895|NCT00236899|9366899|P4|Overall Study|Protocol Violation|0
2723896|NCT00236899|9366900|P3|Overall Study|Protocol Violation|0
2723897|NCT00236899|9366901|P2|Overall Study|Protocol Violation|0
2723898|NCT00236899|9366902|P1|Overall Study|Protocol Violation|1
2723899|NCT00236899|9366899|P4|Overall Study|Entry Criteria Exclusion|0
2723900|NCT00236899|9366900|P3|Overall Study|Entry Criteria Exclusion|1
2723901|NCT00236899|9366901|P2|Overall Study|Entry Criteria Exclusion|1
2723902|NCT00236899|9366902|P1|Overall Study|Entry Criteria Exclusion|0
2723903|NCT00236899|9366899|P4|Overall Study|Lost to Follow-up|0
2723904|NCT00236899|9366900|P3|Overall Study|Lost to Follow-up|0
2723905|NCT00236899|9366901|P2|Overall Study|Lost to Follow-up|1
2723906|NCT00236899|9366902|P1|Overall Study|Lost to Follow-up|0
2723907|NCT00236899|9366899|P4|Overall Study|Death (Study Drug Toxicity)|0
2723908|NCT00236899|9366900|P3|Overall Study|Death (Study Drug Toxicity)|0
2723909|NCT00236899|9366901|P2|Overall Study|Death (Study Drug Toxicity)|0
2723910|NCT00236899|9366902|P1|Overall Study|Death (Study Drug Toxicity)|1
2723911|NCT00236899|9366899|P4|Overall Study|Death (Not Study Related)|0
2723912|NCT00236899|9366900|P3|Overall Study|Death (Not Study Related)|0
2723913|NCT00236899|9366901|P2|Overall Study|Death (Not Study Related)|0
2723914|NCT00236899|9366902|P1|Overall Study|Death (Not Study Related)|2
2723915|NCT00236899|9366899|P4|Overall Study|Death (Study Disease)|0
2723916|NCT00236899|9366900|P3|Overall Study|Death (Study Disease)|0
2723917|NCT00236899|9366901|P2|Overall Study|Death (Study Disease)|4
2723918|NCT00236899|9366902|P1|Overall Study|Death (Study Disease)|1
2723919|NCT00236899|9366899|P4|Overall Study|Adverse Event (Not Study Related)|7
2723920|NCT00236899|9366900|P3|Overall Study|Adverse Event (Not Study Related)|4
2723921|NCT00236899|9366901|P2|Overall Study|Adverse Event (Not Study Related)|3
2723922|NCT00236899|9366902|P1|Overall Study|Adverse Event (Not Study Related)|3
2723923|NCT00236899|9366899|P4|Overall Study|Adverse Event (Study Related)|1
2723924|NCT00236899|9366900|P3|Overall Study|Adverse Event (Study Related)|2
2723925|NCT00236899|9366901|P2|Overall Study|Adverse Event (Study Related)|1
2723926|NCT00236899|9366902|P1|Overall Study|Adverse Event (Study Related)|1
2723927|NCT00236197|9366934|P2|Overall Study|Other|2
2723928|NCT00236197|9366935|P1|Overall Study|Other|0
2723929|NCT00236197|9366934|P2|Overall Study|Medication non-compliance|2
2723930|NCT00236197|9366935|P1|Overall Study|Medication non-compliance|1
2723931|NCT00236197|9366934|P2|Overall Study|Protocol Violation|3
2723932|NCT00236197|9366935|P1|Overall Study|Protocol Violation|0
2723933|NCT00236197|9366934|P2|Overall Study|Lost to Follow-up|5
2723934|NCT00236197|9366935|P1|Overall Study|Lost to Follow-up|1
2723935|NCT00236197|9366934|P2|Overall Study|Withdrawal by Subject|2
2723936|NCT00236197|9366935|P1|Overall Study|Withdrawal by Subject|3
2723937|NCT00236184|9366943|P2|Overall Study|other|2
2723938|NCT00236184|9366944|P1|Overall Study|other|1
2723939|NCT00236184|9366943|P2|Overall Study|non-compliance with study drug|1
2723940|NCT00236184|9366944|P1|Overall Study|non-compliance with study drug|2
2723941|NCT00236184|9366943|P2|Overall Study|Protocol Violation|0
2723942|NCT00236184|9366944|P1|Overall Study|Protocol Violation|3
2723943|NCT00236184|9366943|P2|Overall Study|Withdrawal by Subject|0
2723944|NCT00236184|9366944|P1|Overall Study|Withdrawal by Subject|3
2723945|NCT00236184|9366943|P2|Overall Study|Physician Decision|1
2723946|NCT00236184|9366944|P1|Overall Study|Physician Decision|1
2723947|NCT00236184|9366943|P2|Overall Study|Lost to Follow-up|4
2723948|NCT00236184|9366944|P1|Overall Study|Lost to Follow-up|3
2723949|NCT00236184|9366943|P2|Overall Study|Lack of Efficacy|1
2723950|NCT00236184|9366944|P1|Overall Study|Lack of Efficacy|0
2723951|NCT00236184|9366943|P2|Overall Study|Adverse Event|2
2723952|NCT00236184|9366944|P1|Overall Study|Adverse Event|5
2723953|NCT00236080|9366955|P5|Overall Study|Miscellaneous|0
2723954|NCT00236080|9366956|P4|Overall Study|Miscellaneous|0
2723955|NCT00236080|9366957|P3|Overall Study|Miscellaneous|1
2723956|NCT00236080|9366958|P2|Overall Study|Miscellaneous|0
2723957|NCT00236080|9366959|P1|Overall Study|Miscellaneous|0
2723958|NCT00236080|9366955|P5|Overall Study|Withdrawal by Subject|0
2723959|NCT00236080|9366956|P4|Overall Study|Withdrawal by Subject|0
2723960|NCT00236080|9366957|P3|Overall Study|Withdrawal by Subject|0
2723961|NCT00236080|9366958|P2|Overall Study|Withdrawal by Subject|0
2723962|NCT00236080|9366959|P1|Overall Study|Withdrawal by Subject|1
2723963|NCT00236080|9366955|P5|Overall Study|Physician Decision|1
2723964|NCT00236080|9366956|P4|Overall Study|Physician Decision|1
2723965|NCT00236080|9366957|P3|Overall Study|Physician Decision|1
2723966|NCT00236080|9366958|P2|Overall Study|Physician Decision|0
2723967|NCT00236080|9366959|P1|Overall Study|Physician Decision|1
2723968|NCT00236080|9366955|P5|Overall Study|Lost to Follow-up|0
2723969|NCT00236080|9366956|P4|Overall Study|Lost to Follow-up|0
2723970|NCT00236080|9366957|P3|Overall Study|Lost to Follow-up|0
2723971|NCT00236080|9366958|P2|Overall Study|Lost to Follow-up|1
2723972|NCT00236080|9366959|P1|Overall Study|Lost to Follow-up|0
2723973|NCT00236080|9366955|P5|Overall Study|Adverse Event|0
2723974|NCT00236080|9366956|P4|Overall Study|Adverse Event|1
2723975|NCT00236080|9366957|P3|Overall Study|Adverse Event|3
2723976|NCT00236080|9366958|P2|Overall Study|Adverse Event|0
2723977|NCT00236080|9366959|P1|Overall Study|Adverse Event|0
2723978|NCT00235989|9366980|P6|Extension Treatment Period (ET)|´Other´ not further itemized|0
2723979|NCT00235989|9366981|P5|Extension Treatment Period (ET)|´Other´ not further itemized|0
2723980|NCT00235989|9366982|P4|Extension Treatment Period (ET)|´Other´ not further itemized|2
2723981|NCT00235989|9366983|P3|Extension Treatment Period (ET)|´Other´ not further itemized|1
2723982|NCT00235989|9366984|P2|Extension Treatment Period (ET)|´Other´ not further itemized|3
2723983|NCT00235989|9366985|P1|Extension Treatment Period (ET)|´Other´ not further itemized|2
2723984|NCT00235989|9366980|P6|Extension Treatment Period (ET)|Withdrawal by Subject|0
2723985|NCT00235989|9366981|P5|Extension Treatment Period (ET)|Withdrawal by Subject|0
2723986|NCT00235989|9366982|P4|Extension Treatment Period (ET)|Withdrawal by Subject|4
2723987|NCT00235989|9366983|P3|Extension Treatment Period (ET)|Withdrawal by Subject|1
2723988|NCT00235989|9366984|P2|Extension Treatment Period (ET)|Withdrawal by Subject|1
2723989|NCT00235989|9366985|P1|Extension Treatment Period (ET)|Withdrawal by Subject|1
2723990|NCT00235989|9366980|P6|Extension Treatment Period (ET)|Lost to Follow-up|0
2723991|NCT00235989|9366981|P5|Extension Treatment Period (ET)|Lost to Follow-up|0
2723992|NCT00235989|9366982|P4|Extension Treatment Period (ET)|Lost to Follow-up|0
2723993|NCT00235989|9366983|P3|Extension Treatment Period (ET)|Lost to Follow-up|1
2723994|NCT00235989|9366984|P2|Extension Treatment Period (ET)|Lost to Follow-up|0
2723995|NCT00235989|9366985|P1|Extension Treatment Period (ET)|Lost to Follow-up|2
2723996|NCT00235989|9366980|P6|Extension Treatment Period (ET)|Adverse Event|0
2723997|NCT00235989|9366981|P5|Extension Treatment Period (ET)|Adverse Event|0
2723998|NCT00235989|9366982|P4|Extension Treatment Period (ET)|Adverse Event|0
2723999|NCT00235989|9366983|P3|Extension Treatment Period (ET)|Adverse Event|2
2724000|NCT00235989|9366984|P2|Extension Treatment Period (ET)|Adverse Event|0
2724001|NCT00235989|9366985|P1|Extension Treatment Period (ET)|Adverse Event|3
2724002|NCT00235989|9366980|P6|Core Treatment Period (CT)|Lost to Follow-up|2
2724003|NCT00235989|9366981|P5|Core Treatment Period (CT)|Lost to Follow-up|0
2724004|NCT00235989|9366982|P4|Core Treatment Period (CT)|Lost to Follow-up|0
2724005|NCT00235989|9366983|P3|Core Treatment Period (CT)|Lost to Follow-up|0
2724006|NCT00235989|9366984|P2|Core Treatment Period (CT)|Lost to Follow-up|0
2724007|NCT00235989|9366985|P1|Core Treatment Period (CT)|Lost to Follow-up|0
2724008|NCT00235872|9366999|P1|Overall Study|Administrative reason|61
2724009|NCT00235872|9366999|P1|Overall Study|Withdrawal by Subject|50
2724010|NCT00235872|9366999|P1|Overall Study|Lost to Follow-up|1
2724011|NCT00235872|9366999|P1|Overall Study|Death|1
2724012|NCT00235872|9366999|P1|Overall Study|Adverse Event|34
2724013|NCT00235755|9367030|P3|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
2724014|NCT00235755|9367031|P2|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
2724015|NCT00235755|9367032|P1|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1
2724016|NCT00235755|9367030|P3|12-Week Maintenance Phase|Withdrawal by Subject|3
2724017|NCT00235755|9367031|P2|12-Week Maintenance Phase|Withdrawal by Subject|8
2724018|NCT00235755|9367032|P1|12-Week Maintenance Phase|Withdrawal by Subject|0
2724019|NCT00235755|9367030|P3|12-Week Maintenance Phase|Protocol Violation|2
2724020|NCT00235755|9367031|P2|12-Week Maintenance Phase|Protocol Violation|4
2724021|NCT00235755|9367032|P1|12-Week Maintenance Phase|Protocol Violation|0
2724022|NCT00235755|9367030|P3|12-Week Maintenance Phase|Lack of Efficacy|0
2724023|NCT00235755|9367031|P2|12-Week Maintenance Phase|Lack of Efficacy|0
2724024|NCT00235755|9367032|P1|12-Week Maintenance Phase|Lack of Efficacy|5
2724025|NCT00235755|9367030|P3|12-Week Maintenance Phase|Lost to Follow-up|0
2724026|NCT00235755|9367031|P2|12-Week Maintenance Phase|Lost to Follow-up|3
2724027|NCT00235755|9367032|P1|12-Week Maintenance Phase|Lost to Follow-up|2
2724028|NCT00235755|9367030|P3|12-Week Maintenance Phase|Adverse Event|26
2724029|NCT00235755|9367031|P2|12-Week Maintenance Phase|Adverse Event|12
2724030|NCT00235755|9367032|P1|12-Week Maintenance Phase|Adverse Event|8
2724031|NCT00235755|9367030|P3|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
2724032|NCT00235755|9367031|P2|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
2724033|NCT00235755|9367032|P1|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1
2724034|NCT00235755|9367030|P3|4-Week Titration Phase|Randomization Occurred in Error|0
2724035|NCT00235755|9367031|P2|4-Week Titration Phase|Randomization Occurred in Error|0
2724036|NCT00235755|9367032|P1|4-Week Titration Phase|Randomization Occurred in Error|1
2724037|NCT00235755|9367030|P3|4-Week Titration Phase|Participant Did Not Receive Study Drug|1
2724038|NCT00235755|9367031|P2|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
2724039|NCT00235755|9367032|P1|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
2724040|NCT00235755|9367030|P3|4-Week Titration Phase|Withdrawal by Subject|3
2724041|NCT00235755|9367031|P2|4-Week Titration Phase|Withdrawal by Subject|2
2724042|NCT00235755|9367032|P1|4-Week Titration Phase|Withdrawal by Subject|1
2724043|NCT00235755|9367030|P3|4-Week Titration Phase|Protocol Violation|1
2724044|NCT00235755|9367031|P2|4-Week Titration Phase|Protocol Violation|2
2724045|NCT00235755|9367032|P1|4-Week Titration Phase|Protocol Violation|2
2724046|NCT00235755|9367030|P3|4-Week Titration Phase|Lost to Follow-up|1
2724047|NCT00235755|9367031|P2|4-Week Titration Phase|Lost to Follow-up|1
2724048|NCT00235755|9367032|P1|4-Week Titration Phase|Lost to Follow-up|0
2724049|NCT00235755|9367030|P3|4-Week Titration Phase|Adverse Event|20
2724050|NCT00235755|9367031|P2|4-Week Titration Phase|Adverse Event|14
2724051|NCT00235755|9367032|P1|4-Week Titration Phase|Adverse Event|6
2724052|NCT00235716|9367110|P4|Overall Study|Physician Decision|3
2724053|NCT00235716|9367111|P3|Overall Study|Physician Decision|1
2724054|NCT00235716|9367112|P2|Overall Study|Physician Decision|1
2724055|NCT00235716|9367113|P1|Overall Study|Physician Decision|0
2724056|NCT00235716|9367110|P4|Overall Study|Adverse Event|0
2724057|NCT00235716|9367111|P3|Overall Study|Adverse Event|1
2724058|NCT00235716|9367112|P2|Overall Study|Adverse Event|1
2724059|NCT00235716|9367113|P1|Overall Study|Adverse Event|1
2724060|NCT00235716|9367110|P4|Overall Study|Lost to Follow-up|10
2724061|NCT00235716|9367111|P3|Overall Study|Lost to Follow-up|14
2724062|NCT00235716|9367112|P2|Overall Study|Lost to Follow-up|7
2724063|NCT00235716|9367113|P1|Overall Study|Lost to Follow-up|12
2724064|NCT00235716|9367110|P4|Overall Study|Withdrawal by Subject|18
2724065|NCT00235716|9367111|P3|Overall Study|Withdrawal by Subject|17
2724066|NCT00235716|9367112|P2|Overall Study|Withdrawal by Subject|19
2724067|NCT00235716|9367113|P1|Overall Study|Withdrawal by Subject|23
2724068|NCT00235716|9367110|P4|Overall Study|Death|31
2724069|NCT00235716|9367111|P3|Overall Study|Death|32
2724070|NCT00235716|9367112|P2|Overall Study|Death|39
2724071|NCT00235716|9367113|P1|Overall Study|Death|26
2724072|NCT00235495|9367164|P2|Overall Study|Visit/assessmen outside window/missing|10
2724073|NCT00235495|9367165|P1|Overall Study|Visit/assessmen outside window/missing|0
2724074|NCT00235495|9367164|P2|Overall Study|Lost to Follow-up|13
2724075|NCT00235495|9367165|P1|Overall Study|Lost to Follow-up|11
2724076|NCT00235495|9367164|P2|Overall Study|Withdrawal by Subject|3
2724077|NCT00235495|9367165|P1|Overall Study|Withdrawal by Subject|5
2724078|NCT00235495|9367164|P2|Overall Study|Death|42
2724079|NCT00235495|9367165|P1|Overall Study|Death|52
2724080|NCT00235443|9367238|P6|Overall Study|Other reasons for premature termination|6
2724081|NCT00235443|9367239|P5|Overall Study|Other reasons for premature termination|3
2724082|NCT00235443|9367240|P4|Overall Study|Other reasons for premature termination|7
2724083|NCT00235443|9367241|P3|Overall Study|Other reasons for premature termination|6
2724084|NCT00235443|9367242|P2|Overall Study|Other reasons for premature termination|6
2724085|NCT00235443|9367243|P1|Overall Study|Other reasons for premature termination|1
2724086|NCT00235443|9367238|P6|Overall Study|Unsatisfactory compliance|0
2724087|NCT00235443|9367239|P5|Overall Study|Unsatisfactory compliance|1
2724088|NCT00235443|9367240|P4|Overall Study|Unsatisfactory compliance|4
2724089|NCT00235443|9367241|P3|Overall Study|Unsatisfactory compliance|3
2724090|NCT00235443|9367242|P2|Overall Study|Unsatisfactory compliance|2
2724091|NCT00235443|9367243|P1|Overall Study|Unsatisfactory compliance|0
2724092|NCT00235443|9367238|P6|Overall Study|Lost to Follow-up|3
2724093|NCT00235443|9367239|P5|Overall Study|Lost to Follow-up|4
2724094|NCT00235443|9367240|P4|Overall Study|Lost to Follow-up|6
2724095|NCT00235443|9367241|P3|Overall Study|Lost to Follow-up|6
2724096|NCT00235443|9367242|P2|Overall Study|Lost to Follow-up|8
2724097|NCT00235443|9367243|P1|Overall Study|Lost to Follow-up|0
2724098|NCT00235443|9367238|P6|Overall Study|Withdrawal by Subject|12
2724099|NCT00235443|9367239|P5|Overall Study|Withdrawal by Subject|10
2724100|NCT00235443|9367240|P4|Overall Study|Withdrawal by Subject|24
2724101|NCT00235443|9367241|P3|Overall Study|Withdrawal by Subject|25
2724102|NCT00235443|9367242|P2|Overall Study|Withdrawal by Subject|9
2724103|NCT00235443|9367243|P1|Overall Study|Withdrawal by Subject|3
2724104|NCT00235443|9367238|P6|Overall Study|Lack of Efficacy|9
2724105|NCT00235443|9367239|P5|Overall Study|Lack of Efficacy|2
2724106|NCT00235443|9367240|P4|Overall Study|Lack of Efficacy|12
2724107|NCT00235443|9367241|P3|Overall Study|Lack of Efficacy|5
2724108|NCT00235443|9367242|P2|Overall Study|Lack of Efficacy|1
2724109|NCT00235443|9367243|P1|Overall Study|Lack of Efficacy|0
2724110|NCT00235443|9367238|P6|Overall Study|Adverse Event|15
2724111|NCT00235443|9367239|P5|Overall Study|Adverse Event|10
2724112|NCT00235443|9367240|P4|Overall Study|Adverse Event|44
2724113|NCT00235443|9367241|P3|Overall Study|Adverse Event|17
2724114|NCT00235443|9367242|P2|Overall Study|Adverse Event|12
2724115|NCT00235443|9367243|P1|Overall Study|Adverse Event|4
2724116|NCT00235391|9367384|P6|Overall Study|Death|0
2724117|NCT00235391|9367385|P5|Overall Study|Death|0
2724118|NCT00235391|9367386|P4|Overall Study|Death|4
2724119|NCT00235391|9367387|P3|Overall Study|Death|1
2724120|NCT00235391|9367388|P2|Overall Study|Death|0
2724121|NCT00235391|9367389|P1|Overall Study|Death|0
2724122|NCT00235391|9367384|P6|Overall Study|Administrative problems|0
2724123|NCT00235391|9367385|P5|Overall Study|Administrative problems|0
2724124|NCT00235391|9367386|P4|Overall Study|Administrative problems|1
2724125|NCT00235391|9367387|P3|Overall Study|Administrative problems|0
2724126|NCT00235391|9367388|P2|Overall Study|Administrative problems|0
2724127|NCT00235391|9367389|P1|Overall Study|Administrative problems|0
2724128|NCT00235391|9367384|P6|Overall Study|Lost to Follow-up|0
2724129|NCT00235391|9367385|P5|Overall Study|Lost to Follow-up|0
2724130|NCT00235391|9367386|P4|Overall Study|Lost to Follow-up|16
2724131|NCT00235391|9367387|P3|Overall Study|Lost to Follow-up|3
2724132|NCT00235391|9367388|P2|Overall Study|Lost to Follow-up|3
2724133|NCT00235391|9367389|P1|Overall Study|Lost to Follow-up|0
2724134|NCT00235391|9367384|P6|Overall Study|Withdrawal by Subject|0
2724135|NCT00235391|9367385|P5|Overall Study|Withdrawal by Subject|5
2724136|NCT00235391|9367386|P4|Overall Study|Withdrawal by Subject|61
2724137|NCT00235391|9367387|P3|Overall Study|Withdrawal by Subject|3
2724138|NCT00235391|9367388|P2|Overall Study|Withdrawal by Subject|3
2724139|NCT00235391|9367389|P1|Overall Study|Withdrawal by Subject|2
2724140|NCT00235391|9367384|P6|Overall Study|Protocol deviation|0
2724141|NCT00235391|9367385|P5|Overall Study|Protocol deviation|0
2724142|NCT00235391|9367386|P4|Overall Study|Protocol deviation|11
2724143|NCT00235391|9367387|P3|Overall Study|Protocol deviation|1
2724144|NCT00235391|9367388|P2|Overall Study|Protocol deviation|0
2724145|NCT00235391|9367389|P1|Overall Study|Protocol deviation|0
2724146|NCT00235391|9367384|P6|Overall Study|Condition no longer requires treatment|0
2724147|NCT00235391|9367385|P5|Overall Study|Condition no longer requires treatment|1
2724148|NCT00235391|9367386|P4|Overall Study|Condition no longer requires treatment|11
2724149|NCT00235391|9367387|P3|Overall Study|Condition no longer requires treatment|0
2724150|NCT00235391|9367388|P2|Overall Study|Condition no longer requires treatment|0
2724151|NCT00235391|9367389|P1|Overall Study|Condition no longer requires treatment|3
2724152|NCT00235391|9367384|P6|Overall Study|Unsatisfactory therapeutic effect|0
2724153|NCT00235391|9367385|P5|Overall Study|Unsatisfactory therapeutic effect|0
2724154|NCT00235391|9367386|P4|Overall Study|Unsatisfactory therapeutic effect|17
2724155|NCT00235391|9367387|P3|Overall Study|Unsatisfactory therapeutic effect|2
2724156|NCT00235391|9367388|P2|Overall Study|Unsatisfactory therapeutic effect|2
2724157|NCT00235391|9367389|P1|Overall Study|Unsatisfactory therapeutic effect|0
2724158|NCT00235391|9367384|P6|Overall Study|Abnormal laboratory value(s)|2
2724159|NCT00235391|9367385|P5|Overall Study|Abnormal laboratory value(s)|1
2724160|NCT00235391|9367386|P4|Overall Study|Abnormal laboratory value(s)|27
2724161|NCT00235391|9367387|P3|Overall Study|Abnormal laboratory value(s)|4
2724162|NCT00235391|9367388|P2|Overall Study|Abnormal laboratory value(s)|5
2724163|NCT00235391|9367389|P1|Overall Study|Abnormal laboratory value(s)|3
2724164|NCT00235391|9367384|P6|Overall Study|Adverse Event|2
2724165|NCT00235391|9367385|P5|Overall Study|Adverse Event|5
2724166|NCT00235391|9367386|P4|Overall Study|Adverse Event|72
2724167|NCT00235391|9367387|P3|Overall Study|Adverse Event|10
2724168|NCT00235391|9367388|P2|Overall Study|Adverse Event|5
2724169|NCT00235391|9367389|P1|Overall Study|Adverse Event|4
2724170|NCT00235326|9367406|P2|Overall Study|Lost to Follow-up|1400
2724171|NCT00235326|9367407|P1|Overall Study|Lost to Follow-up|746
2724172|NCT00234533|9367447|P1|Overall Study|Enrolled but not treated|3
2724173|NCT00234533|9367447|P1|Overall Study|Adverse Event|2
2724174|NCT00234533|9367447|P1|Overall Study|Withdrawal by Subject|6
2724175|NCT00234494|9367466|P1|Overall Study|Protocol Violation|2
2724176|NCT00234104|9367512|P4|Overall Study|Physician Decision|2
2724177|NCT00234104|9367513|P3|Overall Study|Physician Decision|2
2724178|NCT00234104|9367514|P2|Overall Study|Physician Decision|1
2724179|NCT00234104|9367515|P1|Overall Study|Physician Decision|0
2724180|NCT00234104|9367512|P4|Overall Study|Protocol Violation|1
2724181|NCT00234104|9367513|P3|Overall Study|Protocol Violation|0
2724182|NCT00234104|9367514|P2|Overall Study|Protocol Violation|0
2724183|NCT00234104|9367515|P1|Overall Study|Protocol Violation|0
2724184|NCT00234104|9367512|P4|Overall Study|Adverse Event|5
2724185|NCT00234104|9367513|P3|Overall Study|Adverse Event|3
2724186|NCT00234104|9367514|P2|Overall Study|Adverse Event|0
2724187|NCT00234104|9367515|P1|Overall Study|Adverse Event|4
2724188|NCT00234065|9367556|P2|Overall Study|Not Classified|112
2724189|NCT00234065|9367557|P1|Overall Study|Not Classified|111
2724190|NCT00234065|9367556|P2|Overall Study|Physician Decision|22
2724191|NCT00234065|9367557|P1|Overall Study|Physician Decision|23
2724192|NCT00234065|9367556|P2|Overall Study|Withdrawal by Subject|56
2724193|NCT00234065|9367557|P1|Overall Study|Withdrawal by Subject|73
2724194|NCT00234065|9367556|P2|Overall Study|Adverse Event|166
2724195|NCT00234065|9367557|P1|Overall Study|Adverse Event|268
2724196|NCT00234052|9367573|P1|Follow-up for 5 Years|Other|7
2724197|NCT00234052|9367573|P1|Follow-up for 5 Years|Lost to Follow-up|1
2724198|NCT00234052|9367573|P1|Follow-up for 5 Years|Death|41
2724199|NCT00234052|9367573|P1|Treatment|Progressive Disease|11
2724200|NCT00234052|9367573|P1|Treatment|Death|2
2724201|NCT00234052|9367573|P1|Treatment|Adverse Event|5
2724202|NCT00234052|9367573|P1|Treatment|Withdrawal by Subject|3
2724203|NCT00234039|9367583|P1|Overall Study|No Protocol Treatment Received|2
2724204|NCT00234039|9367583|P1|Overall Study|Ineligible|9
2724205|NCT00234039|9367583|P1|Overall Study|Other - Not Protocol Specified|3
2724206|NCT00234039|9367583|P1|Overall Study|Progression/relapse|34
2724207|NCT00234039|9367583|P1|Overall Study|Adverse Event|2
2724208|NCT00233987|9367590|P1|Overall Study|Ineligible|4
2724209|NCT00233987|9367590|P1|Overall Study|Eligible but No Treatment Received|2
2724210|NCT00233987|9367590|P1|Overall Study|Other - Not Protocol Specified|5
2724211|NCT00233987|9367590|P1|Overall Study|Reason Under Review|1
2724212|NCT00233987|9367590|P1|Overall Study|Lack of Efficacy|2
2724213|NCT00233987|9367590|P1|Overall Study|Withdrawal by Subject|1
2724214|NCT00233948|9367599|P6|Overall Study|Adverse Event|0
2724215|NCT00233948|9367600|P5|Overall Study|Adverse Event|0
2724216|NCT00233948|9367601|P4|Overall Study|Adverse Event|0
2724217|NCT00233948|9367602|P3|Overall Study|Adverse Event|0
2724218|NCT00233948|9367603|P2|Overall Study|Adverse Event|0
2724219|NCT00233948|9367604|P1|Overall Study|Adverse Event|1
2724220|NCT00233480|9367630|P2|Overall Study|Underwent status II heart transplant|1
2724221|NCT00233480|9367631|P1|Overall Study|Underwent status II heart transplant|0
2724222|NCT00233454|9367647|P1|Overall Study|Death|6
2724223|NCT00233402|9367655|P2|Overall Study|Lost to follow up etc|21
2724224|NCT00233402|9367656|P1|Overall Study|Lost to follow up etc|3
2724225|NCT00233402|9367655|P2|Overall Study|No Ta/T1|94
2724226|NCT00233402|9367656|P1|Overall Study|No Ta/T1|89
2724227|NCT00233402|9367655|P2|Overall Study|No pathology data|9
2724228|NCT00233402|9367656|P1|Overall Study|No pathology data|12
2724229|NCT00233324|9367671|P4|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
2724230|NCT00233324|9367672|P3|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13
2724231|NCT00233324|9367673|P2|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
2724232|NCT00233324|9367674|P1|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8
2724233|NCT00233324|9367671|P4|Follow up at 18-22 Months Corrected Age|Death|4
2724234|NCT00233324|9367672|P3|Follow up at 18-22 Months Corrected Age|Death|5
2724235|NCT00233324|9367673|P2|Follow up at 18-22 Months Corrected Age|Death|7
2724236|NCT00233324|9367674|P1|Follow up at 18-22 Months Corrected Age|Death|5
2724237|NCT00233324|9367671|P4|Main Study|Death|47
2724238|NCT00233324|9367672|P3|Main Study|Death|62
2724239|NCT00233324|9367673|P2|Main Study|Death|60
2724240|NCT00233324|9367674|P1|Main Study|Death|68
2724241|NCT00233064|9367796|P2|Overall Study|Moved to Dom. Republic|0
2724242|NCT00233064|9367797|P1|Overall Study|Moved to Dom. Republic|1
2724243|NCT00233064|9367796|P2|Overall Study|Protocol Violation|0
2724244|NCT00233064|9367797|P1|Overall Study|Protocol Violation|1
2724245|NCT00233064|9367796|P2|Overall Study|Relocation|1
2724246|NCT00233064|9367797|P1|Overall Study|Relocation|0
2724247|NCT00233064|9367796|P2|Overall Study|Death|1
2724248|NCT00233064|9367797|P1|Overall Study|Death|0
2724249|NCT00233064|9367796|P2|Overall Study|Withdrawal by Subject|3
2724250|NCT00233064|9367797|P1|Overall Study|Withdrawal by Subject|5
2724251|NCT00233064|9367796|P2|Overall Study|Lost to Follow-up|7
2724252|NCT00233064|9367797|P1|Overall Study|Lost to Follow-up|7
2724253|NCT00232596|9367823|P2|12-Week Maintenance Phase|Other|3
2724254|NCT00232596|9367824|P1|12-Week Maintenance Phase|Other|1
2724255|NCT00232596|9367823|P2|12-Week Maintenance Phase|Protocol Violation|1
2724256|NCT00232596|9367824|P1|12-Week Maintenance Phase|Protocol Violation|3
2724257|NCT00232596|9367823|P2|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2
2724258|NCT00232596|9367824|P1|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1
2724259|NCT00232596|9367823|P2|12-Week Maintenance Phase|Adverse Event|22
2724260|NCT00232596|9367824|P1|12-Week Maintenance Phase|Adverse Event|7
2724261|NCT00232596|9367823|P2|6-Week Titration Phase|Participant Did Not Receive Study Drug|1
2724262|NCT00232596|9367824|P1|6-Week Titration Phase|Participant Did Not Receive Study Drug|0
2724263|NCT00232596|9367823|P2|6-Week Titration Phase|Other|3
2724264|NCT00232596|9367824|P1|6-Week Titration Phase|Other|3
2724265|NCT00232596|9367823|P2|6-Week Titration Phase|Participant Request Unrelated to Study|0
2724266|NCT00232596|9367824|P1|6-Week Titration Phase|Participant Request Unrelated to Study|1
2724267|NCT00232596|9367823|P2|6-Week Titration Phase|Protocol Violation|3
2724268|NCT00232596|9367824|P1|6-Week Titration Phase|Protocol Violation|1
2724269|NCT00232596|9367823|P2|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2
2724270|NCT00232596|9367824|P1|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1
2724271|NCT00232596|9367823|P2|6-Week Titration Phase|Failed to Return|1
2724272|NCT00232596|9367824|P1|6-Week Titration Phase|Failed to Return|2
2724273|NCT00232596|9367823|P2|6-Week Titration Phase|Adverse Event|19
2724274|NCT00232596|9367824|P1|6-Week Titration Phase|Adverse Event|6
2724275|NCT00232557|9367915|P2|Overall Study|Lost to Follow-up|5
2724276|NCT00232557|9367916|P1|Overall Study|Lost to Follow-up|3
2724277|NCT00232544|9367926|P2|Overall Study|Lost to Follow-up|15
2724278|NCT00232544|9367927|P1|Overall Study|Lost to Follow-up|20
2724279|NCT00232180|9367958|P3|Open Label Phase|Randomized but not treated|1
2724280|NCT00232180|9367959|P2|Open Label Phase|Randomized but not treated|0
2724281|NCT00232180|9367960|P1|Open Label Phase|Randomized but not treated|0
2724282|NCT00232180|9367958|P3|Open Label Phase|Laboratory abnormality|10
2724283|NCT00232180|9367959|P2|Open Label Phase|Laboratory abnormality|0
2724284|NCT00232180|9367960|P1|Open Label Phase|Laboratory abnormality|0
2724285|NCT00232180|9367958|P3|Open Label Phase|Adverse Event|25
2724286|NCT00232180|9367959|P2|Open Label Phase|Adverse Event|0
2724287|NCT00232180|9367960|P1|Open Label Phase|Adverse Event|0
2724288|NCT00232180|9367958|P3|Open Label Phase|Other|16
2724289|NCT00232180|9367959|P2|Open Label Phase|Other|0
2724290|NCT00232180|9367960|P1|Open Label Phase|Other|0
2724291|NCT00232180|9367958|P3|Open Label Phase|Withdrawal by Subject|37
2724292|NCT00232180|9367959|P2|Open Label Phase|Withdrawal by Subject|0
2724293|NCT00232180|9367960|P1|Open Label Phase|Withdrawal by Subject|0
2724294|NCT00232180|9367958|P3|Open Label Phase|Study terminated by sponsor|3
2724295|NCT00232180|9367959|P2|Open Label Phase|Study terminated by sponsor|0
2724296|NCT00232180|9367960|P1|Open Label Phase|Study terminated by sponsor|0
2724297|NCT00232180|9367958|P3|Open Label Phase|Protocol Violation|3
2724298|NCT00232180|9367959|P2|Open Label Phase|Protocol Violation|0
2724299|NCT00232180|9367960|P1|Open Label Phase|Protocol Violation|0
2724300|NCT00232180|9367958|P3|Open Label Phase|Lost to Follow-up|5
2724301|NCT00232180|9367959|P2|Open Label Phase|Lost to Follow-up|0
2724302|NCT00232180|9367960|P1|Open Label Phase|Lost to Follow-up|0
2724303|NCT00232180|9367958|P3|Open Label Phase|Death|48
2724304|NCT00232180|9367959|P2|Open Label Phase|Death|0
2724305|NCT00232180|9367960|P1|Open Label Phase|Death|0
2724306|NCT00232180|9367958|P3|Double-blind (DB) Phase|Laboratory abnormality|0
2724307|NCT00232180|9367959|P2|Double-blind (DB) Phase|Laboratory abnormality|7
2724308|NCT00232180|9367960|P1|Double-blind (DB) Phase|Laboratory abnormality|6
2724309|NCT00232180|9367958|P3|Double-blind (DB) Phase|Randomized but not treated|0
2724310|NCT00232180|9367959|P2|Double-blind (DB) Phase|Randomized but not treated|4
2724311|NCT00232180|9367960|P1|Double-blind (DB) Phase|Randomized but not treated|3
2724312|NCT00232180|9367958|P3|Double-blind (DB) Phase|Other|0
2724313|NCT00232180|9367959|P2|Double-blind (DB) Phase|Other|75
2724314|NCT00232180|9367960|P1|Double-blind (DB) Phase|Other|70
2724315|NCT00232180|9367958|P3|Double-blind (DB) Phase|Adverse Event|0
2724316|NCT00232180|9367959|P2|Double-blind (DB) Phase|Adverse Event|100
2724317|NCT00232180|9367960|P1|Double-blind (DB) Phase|Adverse Event|83
2724318|NCT00232180|9367958|P3|Double-blind (DB) Phase|Protocol Violation|0
2724319|NCT00232180|9367959|P2|Double-blind (DB) Phase|Protocol Violation|21
2724320|NCT00232180|9367960|P1|Double-blind (DB) Phase|Protocol Violation|28
2724321|NCT00232180|9367958|P3|Double-blind (DB) Phase|Withdrawal by Subject|0
2724322|NCT00232180|9367959|P2|Double-blind (DB) Phase|Withdrawal by Subject|148
2724323|NCT00232180|9367960|P1|Double-blind (DB) Phase|Withdrawal by Subject|131
2724324|NCT00232180|9367958|P3|Double-blind (DB) Phase|Lost to Follow-up|0
2724325|NCT00232180|9367959|P2|Double-blind (DB) Phase|Lost to Follow-up|28
2724326|NCT00232180|9367960|P1|Double-blind (DB) Phase|Lost to Follow-up|34
2724327|NCT00232180|9367958|P3|Double-blind (DB) Phase|Death|0
2724328|NCT00232180|9367959|P2|Double-blind (DB) Phase|Death|222
2724329|NCT00232180|9367960|P1|Double-blind (DB) Phase|Death|186
2724330|NCT00232141|9368005|P2|Overall Study|Withdrawal by Subject|3
2724331|NCT00232141|9368006|P1|Overall Study|Withdrawal by Subject|5
2724332|NCT00232141|9368005|P2|Overall Study|Other|10
2724333|NCT00232141|9368006|P1|Overall Study|Other|8
2724334|NCT00232141|9368005|P2|Overall Study|Lost to Follow-up|6
2724335|NCT00232141|9368006|P1|Overall Study|Lost to Follow-up|9
2724336|NCT00232141|9368005|P2|Overall Study|Lack of Efficacy|3
2724337|NCT00232141|9368006|P1|Overall Study|Lack of Efficacy|0
2724338|NCT00232141|9368005|P2|Overall Study|Adverse Event|4
2724339|NCT00232141|9368006|P1|Overall Study|Adverse Event|9
2724340|NCT00231894|9368076|P2|Overall Study|Withdrawal by Subject|1
2724341|NCT00231894|9368077|P1|Overall Study|Withdrawal by Subject|1
2724342|NCT00231842|9368099|P1|Overall Study|Did not complete the last 3 cycle|8
2724343|NCT00231842|9368099|P1|Overall Study|Withdrawal by Subject|3
2724344|NCT00231816|9368106|P2|Overall Study|Other|1
2724345|NCT00231816|9368107|P1|Overall Study|Other|2
2724346|NCT00231816|9368106|P2|Overall Study|Withdrawal by Subject|3
2724347|NCT00231816|9368107|P1|Overall Study|Withdrawal by Subject|3
2724348|NCT00231816|9368106|P2|Overall Study|Protocol Violation|3
2724349|NCT00231816|9368107|P1|Overall Study|Protocol Violation|2
2724350|NCT00231816|9368106|P2|Overall Study|Lost to Follow-up|5
2724351|NCT00231816|9368107|P1|Overall Study|Lost to Follow-up|8
2724352|NCT00231816|9368106|P2|Overall Study|Adverse Event|0
2724353|NCT00231816|9368107|P1|Overall Study|Adverse Event|1
2724354|NCT00231777|9368122|P2|Overall Study|Other|2
2724355|NCT00231777|9368123|P1|Overall Study|Other|3
2724356|NCT00231777|9368122|P2|Overall Study|Lost to Follow-up|0
2724357|NCT00231777|9368123|P1|Overall Study|Lost to Follow-up|3
2724358|NCT00231478|9368137|P2|Overall Study|Administrative|2
2724359|NCT00231478|9368138|P1|Overall Study|Administrative|3
2724360|NCT00231478|9368137|P2|Overall Study|Adverse Event|1
2724361|NCT00231478|9368138|P1|Overall Study|Adverse Event|0
2724362|NCT00231478|9368137|P2|Overall Study|Withdrawal by Subject|0
2724363|NCT00231478|9368138|P1|Overall Study|Withdrawal by Subject|1
2724364|NCT00231478|9368137|P2|Overall Study|Refused Treatment|1
2724365|NCT00231478|9368138|P1|Overall Study|Refused Treatment|1
2724366|NCT00231478|9368137|P2|Overall Study|Protocol Violation|2
2724367|NCT00231478|9368138|P1|Overall Study|Protocol Violation|3
2724368|NCT00231465|9368150|P1|Overall Study|Did not have follow up CT scans|1
2724369|NCT00231465|9368150|P1|Overall Study|Completed only one cycle|1
2724370|NCT00231413|9368163|P7|Overall Study|Pregnancy|0
2724371|NCT00231413|9368164|P6|Overall Study|Pregnancy|0
2724372|NCT00231413|9368165|P5|Overall Study|Pregnancy|0
2724373|NCT00231413|9368166|P4|Overall Study|Pregnancy|0
2724374|NCT00231413|9368167|P3|Overall Study|Pregnancy|0
2724375|NCT00231413|9368168|P2|Overall Study|Pregnancy|0
2724376|NCT00231413|9368169|P1|Overall Study|Pregnancy|1
2724377|NCT00231413|9368163|P7|Overall Study|Lost to Follow-up|0
2724378|NCT00231413|9368164|P6|Overall Study|Lost to Follow-up|4
2724379|NCT00231413|9368165|P5|Overall Study|Lost to Follow-up|1
2724380|NCT00231413|9368166|P4|Overall Study|Lost to Follow-up|1
2724381|NCT00231413|9368167|P3|Overall Study|Lost to Follow-up|1
2724382|NCT00231413|9368168|P2|Overall Study|Lost to Follow-up|4
2724383|NCT00231413|9368169|P1|Overall Study|Lost to Follow-up|4
2724384|NCT00231413|9368163|P7|Overall Study|Migrated/moved from study area|0
2724385|NCT00231413|9368164|P6|Overall Study|Migrated/moved from study area|1
2724386|NCT00231413|9368165|P5|Overall Study|Migrated/moved from study area|0
2724387|NCT00231413|9368166|P4|Overall Study|Migrated/moved from study area|0
2724388|NCT00231413|9368167|P3|Overall Study|Migrated/moved from study area|1
2724389|NCT00231413|9368168|P2|Overall Study|Migrated/moved from study area|0
2724390|NCT00231413|9368169|P1|Overall Study|Migrated/moved from study area|0
2724391|NCT00231413|9368163|P7|Overall Study|Withdrawal by Subject|3
2724392|NCT00231413|9368164|P6|Overall Study|Withdrawal by Subject|0
2724393|NCT00231413|9368165|P5|Overall Study|Withdrawal by Subject|2
2724394|NCT00231413|9368166|P4|Overall Study|Withdrawal by Subject|2
2724395|NCT00231413|9368167|P3|Overall Study|Withdrawal by Subject|4
2724396|NCT00231413|9368168|P2|Overall Study|Withdrawal by Subject|1
2724397|NCT00231413|9368169|P1|Overall Study|Withdrawal by Subject|3
2724398|NCT00231413|9368163|P7|Overall Study|Non-serious AE|1
2724399|NCT00231413|9368164|P6|Overall Study|Non-serious AE|0
2724400|NCT00231413|9368165|P5|Overall Study|Non-serious AE|0
2724401|NCT00231413|9368166|P4|Overall Study|Non-serious AE|0
2724402|NCT00231413|9368167|P3|Overall Study|Non-serious AE|1
2724403|NCT00231413|9368168|P2|Overall Study|Non-serious AE|0
2724404|NCT00231413|9368169|P1|Overall Study|Non-serious AE|0
2724405|NCT00231179|9368339|P2|Overall Study|Withdrawal by Subject|3
2724406|NCT00231179|9368340|P1|Overall Study|Withdrawal by Subject|3
2724407|NCT00231179|9368339|P2|Overall Study|Lost to Follow-up|21
2724408|NCT00231179|9368340|P1|Overall Study|Lost to Follow-up|21
2724409|NCT00231114|9368367|P2|Post-Treatment Period|Withdrawal by Subject|0
2724410|NCT00231114|9368368|P1|Post-Treatment Period|Withdrawal by Subject|1
2724411|NCT00231114|9368367|P2|Post-Treatment Period|Physician Decision|0
2724412|NCT00231114|9368368|P1|Post-Treatment Period|Physician Decision|1
2724413|NCT00231114|9368367|P2|Post-Treatment Period|Lost to Follow-up|1
2724414|NCT00231114|9368368|P1|Post-Treatment Period|Lost to Follow-up|6
2724415|NCT00231114|9368367|P2|Treatment Period|Death: Motor Vehicle Accident|0
2724416|NCT00231114|9368368|P1|Treatment Period|Death: Motor Vehicle Accident|1
2724417|NCT00231114|9368367|P2|Randomized|Withdrawal by Subject|3
2724418|NCT00231114|9368368|P1|Randomized|Withdrawal by Subject|6
2724419|NCT00231062|9368404|P1|Overall Study|Physician Decision|6
2724420|NCT00230971|9368412|P2|Baseline Participants|Reintervention|0
2724421|NCT00230971|9368413|P1|Baseline Participants|Reintervention|1
2724422|NCT00230971|9368412|P2|Baseline Participants|Failure to return|1
2724423|NCT00230971|9368413|P1|Baseline Participants|Failure to return|1
2724424|NCT00230971|9368412|P2|Baseline Participants|No bacteria observed|0
2724425|NCT00230971|9368413|P1|Baseline Participants|No bacteria observed|1
2724426|NCT00230971|9368412|P2|Baseline Participants|Adverse Event|0
2724427|NCT00230971|9368413|P1|Baseline Participants|Adverse Event|1
2724428|NCT00230971|9368412|P2|Baseline Participants|Withdrawal by Subject|1
2724429|NCT00230971|9368413|P1|Baseline Participants|Withdrawal by Subject|7
2724430|NCT00230971|9368412|P2|Baseline Participants|Death|5
2724431|NCT00230971|9368413|P1|Baseline Participants|Death|6
2724432|NCT00230971|9368412|P2|Baseline Participants|Lost to Follow-up|12
2724433|NCT00230971|9368413|P1|Baseline Participants|Lost to Follow-up|5
2724434|NCT00230971|9368412|P2|Randomization|No study drug administered|3
2724435|NCT00230971|9368413|P1|Randomization|No study drug administered|3
2724436|NCT00230282|9368451|P1|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2
2724437|NCT00230282|9368451|P1|Fludarabine + Cyclophosphamide|Change in diagnosis|1
2724438|NCT00230282|9368451|P1|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1
2724439|NCT00230282|9368451|P1|Fludarabine + Cyclophosphamide|Lost to Follow-up|4
2724440|NCT00230178|9368459|P3|Overall Study|Various other reasons|4
2724441|NCT00230178|9368460|P2|Overall Study|Various other reasons|2
2724442|NCT00230178|9368461|P1|Overall Study|Various other reasons|3
2724443|NCT00230178|9368459|P3|Overall Study|Withdrawal by Subject|1
2724444|NCT00230178|9368460|P2|Overall Study|Withdrawal by Subject|0
2724445|NCT00230178|9368461|P1|Overall Study|Withdrawal by Subject|0
2724446|NCT00230178|9368459|P3|Overall Study|Adverse Event|2
2724447|NCT00230178|9368460|P2|Overall Study|Adverse Event|5
2724448|NCT00230178|9368461|P1|Overall Study|Adverse Event|1
2724449|NCT00230048|9368513|P2|Overall Study|Lost to Follow-up|18
2724450|NCT00230048|9368514|P1|Overall Study|Lost to Follow-up|13
2724451|NCT00229931|9368572|P2|Overall Study|Lost to Follow-up|2
2724452|NCT00229931|9368573|P1|Overall Study|Lost to Follow-up|3
2724453|NCT00229931|9368572|P2|Overall Study|Death|0
2724454|NCT00229931|9368573|P1|Overall Study|Death|1
2724455|NCT00229723|9368588|P7|Maintenance Phase|Other|1
2724456|NCT00229723|9368589|P6|Maintenance Phase|Other|3
2724457|NCT00229723|9368590|P5|Maintenance Phase|Other|3
2724458|NCT00229723|9368591|P4|Maintenance Phase|Other|2
2724459|NCT00229723|9368592|P3|Maintenance Phase|Other|1
2724460|NCT00229723|9368593|P2|Maintenance Phase|Other|4
2724461|NCT00229723|9368594|P1|Maintenance Phase|Other|5
2724462|NCT00229723|9368588|P7|Maintenance Phase|Severe non-compliance|0
2724463|NCT00229723|9368589|P6|Maintenance Phase|Severe non-compliance|0
2724464|NCT00229723|9368590|P5|Maintenance Phase|Severe non-compliance|1
2724465|NCT00229723|9368591|P4|Maintenance Phase|Severe non-compliance|0
2724466|NCT00229723|9368592|P3|Maintenance Phase|Severe non-compliance|0
2724467|NCT00229723|9368593|P2|Maintenance Phase|Severe non-compliance|1
2724468|NCT00229723|9368594|P1|Maintenance Phase|Severe non-compliance|3
2724469|NCT00229723|9368588|P7|Maintenance Phase|Informed consent withdrawn|0
2724470|NCT00229723|9368589|P6|Maintenance Phase|Informed consent withdrawn|1
2724471|NCT00229723|9368590|P5|Maintenance Phase|Informed consent withdrawn|1
2724472|NCT00229723|9368591|P4|Maintenance Phase|Informed consent withdrawn|1
2724473|NCT00229723|9368592|P3|Maintenance Phase|Informed consent withdrawn|0
2724474|NCT00229723|9368593|P2|Maintenance Phase|Informed consent withdrawn|0
2724475|NCT00229723|9368594|P1|Maintenance Phase|Informed consent withdrawn|1
2724476|NCT00229723|9368588|P7|Maintenance Phase|Lost to Follow-up|1
2724477|NCT00229723|9368589|P6|Maintenance Phase|Lost to Follow-up|0
2724478|NCT00229723|9368590|P5|Maintenance Phase|Lost to Follow-up|0
2724479|NCT00229723|9368591|P4|Maintenance Phase|Lost to Follow-up|2
2724480|NCT00229723|9368592|P3|Maintenance Phase|Lost to Follow-up|2
2724481|NCT00229723|9368593|P2|Maintenance Phase|Lost to Follow-up|1
2724482|NCT00229723|9368594|P1|Maintenance Phase|Lost to Follow-up|0
2724483|NCT00229723|9368588|P7|Maintenance Phase|Clinical progression|1
2724484|NCT00229723|9368589|P6|Maintenance Phase|Clinical progression|1
2724485|NCT00229723|9368590|P5|Maintenance Phase|Clinical progression|1
2724486|NCT00229723|9368591|P4|Maintenance Phase|Clinical progression|2
2724487|NCT00229723|9368592|P3|Maintenance Phase|Clinical progression|2
2724488|NCT00229723|9368593|P2|Maintenance Phase|Clinical progression|1
2724489|NCT00229723|9368594|P1|Maintenance Phase|Clinical progression|4
2724490|NCT00229723|9368588|P7|Maintenance Phase|Objective disease progression|5
2724491|NCT00229723|9368589|P6|Maintenance Phase|Objective disease progression|9
2724492|NCT00229723|9368590|P5|Maintenance Phase|Objective disease progression|2
2724493|NCT00229723|9368591|P4|Maintenance Phase|Objective disease progression|6
2724494|NCT00229723|9368592|P3|Maintenance Phase|Objective disease progression|3
2724495|NCT00229723|9368593|P2|Maintenance Phase|Objective disease progression|5
2724496|NCT00229723|9368594|P1|Maintenance Phase|Objective disease progression|5
2724497|NCT00229723|9368588|P7|Maintenance Phase|Adverse Event|2
2724498|NCT00229723|9368589|P6|Maintenance Phase|Adverse Event|5
2724499|NCT00229723|9368590|P5|Maintenance Phase|Adverse Event|7
2724500|NCT00229723|9368591|P4|Maintenance Phase|Adverse Event|4
2724501|NCT00229723|9368592|P3|Maintenance Phase|Adverse Event|1
2724502|NCT00229723|9368593|P2|Maintenance Phase|Adverse Event|2
2724503|NCT00229723|9368594|P1|Maintenance Phase|Adverse Event|7
2724504|NCT00229723|9368588|P7|Concomitant Phase|Other|0
2724505|NCT00229723|9368589|P6|Concomitant Phase|Other|2
2724506|NCT00229723|9368590|P5|Concomitant Phase|Other|0
2724507|NCT00229723|9368591|P4|Concomitant Phase|Other|1
2724508|NCT00229723|9368592|P3|Concomitant Phase|Other|1
2724509|NCT00229723|9368593|P2|Concomitant Phase|Other|0
2724510|NCT00229723|9368594|P1|Concomitant Phase|Other|3
2724511|NCT00229723|9368588|P7|Concomitant Phase|Severe non-compliance|0
2724512|NCT00229723|9368589|P6|Concomitant Phase|Severe non-compliance|0
2724513|NCT00229723|9368590|P5|Concomitant Phase|Severe non-compliance|1
2724514|NCT00229723|9368591|P4|Concomitant Phase|Severe non-compliance|0
2724515|NCT00229723|9368592|P3|Concomitant Phase|Severe non-compliance|0
2724516|NCT00229723|9368593|P2|Concomitant Phase|Severe non-compliance|1
2724517|NCT00229723|9368594|P1|Concomitant Phase|Severe non-compliance|0
2724518|NCT00229723|9368588|P7|Concomitant Phase|Informed consent withdrawn|0
2724519|NCT00229723|9368589|P6|Concomitant Phase|Informed consent withdrawn|0
2724520|NCT00229723|9368590|P5|Concomitant Phase|Informed consent withdrawn|0
2724521|NCT00229723|9368591|P4|Concomitant Phase|Informed consent withdrawn|2
2724522|NCT00229723|9368592|P3|Concomitant Phase|Informed consent withdrawn|0
2724523|NCT00229723|9368593|P2|Concomitant Phase|Informed consent withdrawn|2
2724524|NCT00229723|9368594|P1|Concomitant Phase|Informed consent withdrawn|3
2724525|NCT00229723|9368588|P7|Concomitant Phase|Lost to Follow-up|0
2724526|NCT00229723|9368589|P6|Concomitant Phase|Lost to Follow-up|0
2724527|NCT00229723|9368590|P5|Concomitant Phase|Lost to Follow-up|1
2724528|NCT00229723|9368591|P4|Concomitant Phase|Lost to Follow-up|0
2724529|NCT00229723|9368592|P3|Concomitant Phase|Lost to Follow-up|0
2724530|NCT00229723|9368593|P2|Concomitant Phase|Lost to Follow-up|0
2724531|NCT00229723|9368594|P1|Concomitant Phase|Lost to Follow-up|0
2724532|NCT00229723|9368588|P7|Concomitant Phase|Clinical progression|1
2724533|NCT00229723|9368589|P6|Concomitant Phase|Clinical progression|0
2724534|NCT00229723|9368590|P5|Concomitant Phase|Clinical progression|0
2724535|NCT00229723|9368591|P4|Concomitant Phase|Clinical progression|0
2724536|NCT00229723|9368592|P3|Concomitant Phase|Clinical progression|0
2724537|NCT00229723|9368593|P2|Concomitant Phase|Clinical progression|0
2724538|NCT00229723|9368594|P1|Concomitant Phase|Clinical progression|0
2724539|NCT00229723|9368588|P7|Concomitant Phase|Objective disease progression|0
2724540|NCT00229723|9368589|P6|Concomitant Phase|Objective disease progression|0
2724541|NCT00229723|9368590|P5|Concomitant Phase|Objective disease progression|0
2724542|NCT00229723|9368591|P4|Concomitant Phase|Objective disease progression|0
2724543|NCT00229723|9368592|P3|Concomitant Phase|Objective disease progression|0
2724544|NCT00229723|9368593|P2|Concomitant Phase|Objective disease progression|0
2724545|NCT00229723|9368594|P1|Concomitant Phase|Objective disease progression|0
2724546|NCT00229723|9368588|P7|Concomitant Phase|Adverse Event|2
2724547|NCT00229723|9368589|P6|Concomitant Phase|Adverse Event|1
2724548|NCT00229723|9368590|P5|Concomitant Phase|Adverse Event|0
2724549|NCT00229723|9368591|P4|Concomitant Phase|Adverse Event|2
2724550|NCT00229723|9368592|P3|Concomitant Phase|Adverse Event|5
2724551|NCT00229723|9368593|P2|Concomitant Phase|Adverse Event|2
2724552|NCT00229723|9368594|P1|Concomitant Phase|Adverse Event|4
2724553|NCT00229658|9368647|P2|Overall Study|Withdrawal of consent|39
2724554|NCT00229658|9368648|P1|Overall Study|Withdrawal of consent|46
2724555|NCT00229658|9368647|P2|Overall Study|Serious Adverse Event|2
2724556|NCT00229658|9368648|P1|Overall Study|Serious Adverse Event|2
2724557|NCT00229658|9368647|P2|Overall Study|Lost to Follow-up|55
2724558|NCT00229658|9368648|P1|Overall Study|Lost to Follow-up|82
2724559|NCT00229658|9368647|P2|Overall Study|Other|60
2724560|NCT00229658|9368648|P1|Overall Study|Other|80
2724561|NCT00229658|9368647|P2|Overall Study|Investigator decision|10
2724562|NCT00229658|9368648|P1|Overall Study|Investigator decision|13
2724563|NCT00229658|9368647|P2|Overall Study|Administrative|1
2724564|NCT00229658|9368648|P1|Overall Study|Administrative|2
2724565|NCT00229203|9368684|P2|Overall Study|Withdrawal by Subject|4
2724566|NCT00229203|9368685|P1|Overall Study|Withdrawal by Subject|1
2724567|NCT00229203|9368684|P2|Overall Study|Other|3
2724568|NCT00229203|9368685|P1|Overall Study|Other|3
2724569|NCT00229203|9368684|P2|Overall Study|Death|2
2724570|NCT00229203|9368685|P1|Overall Study|Death|4
2724571|NCT00229203|9368684|P2|Overall Study|Toxicity|1
2724572|NCT00229203|9368685|P1|Overall Study|Toxicity|6
2724573|NCT00229203|9368684|P2|Overall Study|Progressive disease|9
2724574|NCT00229203|9368685|P1|Overall Study|Progressive disease|18
2724575|NCT00228917|9368713|P8|Overall Study|Migrated/moved from study area|0
2724576|NCT00228917|9368714|P7|Overall Study|Migrated/moved from study area|0
2724577|NCT00228917|9368715|P6|Overall Study|Migrated/moved from study area|2
2724578|NCT00228917|9368716|P5|Overall Study|Migrated/moved from study area|0
2724579|NCT00228917|9368717|P4|Overall Study|Migrated/moved from study area|0
2724580|NCT00228917|9368718|P3|Overall Study|Migrated/moved from study area|0
2724581|NCT00228917|9368719|P2|Overall Study|Migrated/moved from study area|0
2724582|NCT00228917|9368720|P1|Overall Study|Migrated/moved from study area|0
2724583|NCT00228813|9368766|P1|Overall Study|Death|4
2724584|NCT00228566|9368772|P1|Overall Study|Miscellaneous|1
2724585|NCT00228566|9368772|P1|Overall Study|Withdrawal by Subject|4
2724586|NCT00228566|9368772|P1|Overall Study|Physician Decision|5
2724587|NCT00228566|9368772|P1|Overall Study|Lost to Follow-up|16
2724588|NCT00228566|9368772|P1|Overall Study|Lack of Efficacy|14
2724589|NCT00228566|9368772|P1|Overall Study|Adverse Event|31
2724590|NCT00228553|9368776|P1|Overall Study|Miscellaneous|46
2724591|NCT00228553|9368776|P1|Overall Study|Pregnancy|2
2724592|NCT00228553|9368776|P1|Overall Study|Withdrawal by Subject|115
2724593|NCT00228553|9368776|P1|Overall Study|Protocol Violation|6
2724594|NCT00228553|9368776|P1|Overall Study|Physician Decision|48
2724595|NCT00228553|9368776|P1|Overall Study|Lost to Follow-up|67
2724596|NCT00228553|9368776|P1|Overall Study|Lack of Efficacy|34
2724597|NCT00228553|9368776|P1|Overall Study|Adverse Event|112
2724598|NCT00228384|9368782|P2|Overall Study|Physician Decision|1
2724599|NCT00228384|9368783|P1|Overall Study|Physician Decision|0
2724600|NCT00228384|9368782|P2|Overall Study|Withdrawal by Subject|10
2724601|NCT00228384|9368783|P1|Overall Study|Withdrawal by Subject|9
2724602|NCT00228384|9368782|P2|Overall Study|Surgical Intervention (bypass)|5
2724603|NCT00228384|9368783|P1|Overall Study|Surgical Intervention (bypass)|5
2724604|NCT00228384|9368782|P2|Overall Study|Lost to Follow-up|10
2724605|NCT00228384|9368783|P1|Overall Study|Lost to Follow-up|6
2724606|NCT00228384|9368782|P2|Overall Study|Death|3
2724607|NCT00228384|9368783|P1|Overall Study|Death|9
2724608|NCT00227903|9368834|P2|Overall Study|Miscarriage|0
2724609|NCT00227903|9368835|P1|Overall Study|Miscarriage|1
2724610|NCT00227903|9368834|P2|Overall Study|Lost to Follow-up|3
2724611|NCT00227903|9368835|P1|Overall Study|Lost to Follow-up|1
2724612|NCT00227903|9368834|P2|Overall Study|Subject moved out of area|2
2724613|NCT00227903|9368835|P1|Overall Study|Subject moved out of area|1
2724614|NCT00227903|9368834|P2|Overall Study|Withdrawal by Subject|5
2724615|NCT00227903|9368835|P1|Overall Study|Withdrawal by Subject|2
2724616|NCT00227877|9368899|P4|12-months Follow-up|Lost to Follow-up|26
2724617|NCT00227877|9368900|P3|12-months Follow-up|Lost to Follow-up|30
2724618|NCT00227877|9368901|P2|12-months Follow-up|Lost to Follow-up|189
2724619|NCT00227877|9368902|P1|12-months Follow-up|Lost to Follow-up|232
2724620|NCT00227877|9368899|P4|12-months Follow-up|Completed late|0
2724621|NCT00227877|9368900|P3|12-months Follow-up|Completed late|1
2724622|NCT00227877|9368901|P2|12-months Follow-up|Completed late|74
2724623|NCT00227877|9368902|P1|12-months Follow-up|Completed late|78
2724624|NCT00227877|9368899|P4|3-months Follow-up|Lost to Follow-up|13
2724625|NCT00227877|9368900|P3|3-months Follow-up|Lost to Follow-up|18
2724626|NCT00227877|9368901|P2|3-months Follow-up|Lost to Follow-up|139
2724627|NCT00227877|9368902|P1|3-months Follow-up|Lost to Follow-up|178
2724628|NCT00227877|9368899|P4|3-months Follow-up|Completed late|8
2724629|NCT00227877|9368900|P3|3-months Follow-up|Completed late|34
2724630|NCT00227877|9368901|P2|3-months Follow-up|Completed late|128
2724631|NCT00227877|9368902|P1|3-months Follow-up|Completed late|135
2724632|NCT00227877|9368899|P4|Post-visit Checklist|Lost to Follow-up|0
2724633|NCT00227877|9368900|P3|Post-visit Checklist|Lost to Follow-up|1
2724634|NCT00227877|9368901|P2|Post-visit Checklist|Lost to Follow-up|13
2724635|NCT00227877|9368902|P1|Post-visit Checklist|Lost to Follow-up|24
2724636|NCT00227877|9368899|P4|Pre-visit Assessment|Technical difficulties|0
2724637|NCT00227877|9368900|P3|Pre-visit Assessment|Technical difficulties|0
2724638|NCT00227877|9368901|P2|Pre-visit Assessment|Technical difficulties|3
2724639|NCT00227877|9368902|P1|Pre-visit Assessment|Technical difficulties|7
2724640|NCT00227721|9368938|P1|Overall Study|On study, but never treated.|1
2724641|NCT00227591|9368960|P1|Overall Study|Withdrawal by Subject|1
2724642|NCT00227539|9368964|P1|Overall Study|Protocol Violation|1
2724643|NCT00227370|9368972|P2|Overall Study|Other reasons|1
2724644|NCT00227370|9368973|P1|Overall Study|Other reasons|2
2724645|NCT00227370|9368972|P2|Overall Study|Physician Decision|6
2724646|NCT00227370|9368973|P1|Overall Study|Physician Decision|9
2724647|NCT00227370|9368972|P2|Overall Study|Adverse Event|11
2724648|NCT00227370|9368973|P1|Overall Study|Adverse Event|6
2724649|NCT00227370|9368972|P2|Overall Study|Death|4
2724650|NCT00227370|9368973|P1|Overall Study|Death|3
2724651|NCT00227370|9368972|P2|Overall Study|Withdrawal by Subject|2
2724652|NCT00227370|9368973|P1|Overall Study|Withdrawal by Subject|1
2724653|NCT00227344|9368993|P2|Overall Study|study terminated early|5
2724654|NCT00227344|9368994|P1|Overall Study|study terminated early|12
2724655|NCT00227305|9369014|P1|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1
2724656|NCT00227305|9369014|P1|Overall Study|LEAVING TOWN FOR 6 WEEKS|1
2724657|NCT00227305|9369014|P1|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1
2724658|NCT00227305|9369014|P1|Overall Study|Physician Decision|3
2724659|NCT00227305|9369014|P1|Overall Study|Lack of Efficacy|7
2724660|NCT00227305|9369014|P1|Overall Study|MOVED OUT OF AREA|3
2724661|NCT00227305|9369014|P1|Overall Study|Study specific discontinuation|13
2724662|NCT00227305|9369014|P1|Overall Study|Lost to Follow-up|33
2724663|NCT00227305|9369014|P1|Overall Study|Withdrawal by Subject|42
2724664|NCT00227305|9369014|P1|Overall Study|Adverse Event|40
2724665|NCT00227266|9369031|P3|Overall Study|Excessive weight gain|2
2724666|NCT00227266|9369032|P2|Overall Study|Excessive weight gain|0
2724667|NCT00227266|9369033|P1|Overall Study|Excessive weight gain|0
2724668|NCT00227266|9369031|P3|Overall Study|Protocol Violation|1
2724669|NCT00227266|9369032|P2|Overall Study|Protocol Violation|0
2724670|NCT00227266|9369033|P1|Overall Study|Protocol Violation|1
2724671|NCT00227266|9369031|P3|Overall Study|Withdrawal by Subject|1
2724672|NCT00227266|9369032|P2|Overall Study|Withdrawal by Subject|0
2724673|NCT00227266|9369033|P1|Overall Study|Withdrawal by Subject|0
2724674|NCT00226941|9369063|P4|Overall Study|Withdrawn by investigator - unrelated AE|1
2724675|NCT00226941|9369064|P3|Overall Study|Withdrawn by investigator - unrelated AE|0
2724676|NCT00226941|9369065|P2|Overall Study|Withdrawn by investigator - unrelated AE|0
2724677|NCT00226941|9369066|P1|Overall Study|Withdrawn by investigator - unrelated AE|0
2724678|NCT00226941|9369063|P4|Overall Study|Withdrawal by subject - toxicity|1
2724679|NCT00226941|9369064|P3|Overall Study|Withdrawal by subject - toxicity|0
2724680|NCT00226941|9369065|P2|Overall Study|Withdrawal by subject - toxicity|0
2724681|NCT00226941|9369066|P1|Overall Study|Withdrawal by subject - toxicity|0
2724682|NCT00226811|9369100|P1|Overall Study|Withdrawal by Subject|2
2724683|NCT00226811|9369100|P1|Overall Study|Lack of Efficacy|55
2724684|NCT00226811|9369100|P1|Overall Study|Adverse Event|11
2724685|NCT00226811|9369100|P1|Overall Study|Death|8
2724686|NCT00226655|9369110|P1|Overall Study|Clinical deterioration|10
2724687|NCT00226655|9369110|P1|Overall Study|Physician Decision|6
2724688|NCT00226655|9369110|P1|Overall Study|Adverse Event|35
2724689|NCT00226655|9369110|P1|Overall Study|Withdrawal by Subject|15
2724690|NCT00226655|9369110|P1|Overall Study|Death|13
2724691|NCT00226499|9369132|P3|Overall Study|Others|356
2724692|NCT00226499|9369133|P2|Overall Study|Others|1066
2724693|NCT00226499|9369134|P1|Overall Study|Others|1064
2724694|NCT00226499|9369132|P3|Overall Study|Adverse Event|3
2724695|NCT00226499|9369133|P2|Overall Study|Adverse Event|6
2724696|NCT00226499|9369134|P1|Overall Study|Adverse Event|10
2724697|NCT00225758|9369269|P1|Overall Study|Adverse Event|4
2724698|NCT00225277|9369301|P2|Overall Study|Other|9
2724699|NCT00225277|9369302|P1|Overall Study|Other|7
2724700|NCT00225277|9369301|P2|Overall Study|Withdrawal by Subject|34
2724701|NCT00225277|9369302|P1|Overall Study|Withdrawal by Subject|40
2724702|NCT00225277|9369301|P2|Overall Study|Protocol Violation|3
2724703|NCT00225277|9369302|P1|Overall Study|Protocol Violation|6
2724704|NCT00225277|9369301|P2|Overall Study|Physician Decision|8
2724705|NCT00225277|9369302|P1|Overall Study|Physician Decision|6
2724706|NCT00225277|9369301|P2|Overall Study|Lost to Follow-up|6
2724707|NCT00225277|9369302|P1|Overall Study|Lost to Follow-up|4
2724708|NCT00225277|9369301|P2|Overall Study|Lack of Efficacy|1
2724709|NCT00225277|9369302|P1|Overall Study|Lack of Efficacy|4
2724710|NCT00225277|9369301|P2|Overall Study|Adverse Event|34
2724711|NCT00225277|9369302|P1|Overall Study|Adverse Event|30
2724712|NCT00225251|9369320|P2|Overall Study|Withdrawal by Subject|1
2724713|NCT00225251|9369321|P1|Overall Study|Withdrawal by Subject|1
2724714|NCT00225212|9369335|P1|Overall Study|Intercurrent illness|1
2724715|NCT00225212|9369335|P1|Overall Study|Adverse Event|2
2724716|NCT00225212|9369335|P1|Overall Study|Death|1
2724717|NCT00225212|9369335|P1|Overall Study|Disease progression|2
2724718|NCT00225147|9369344|P4|Open-label Phase|Withdrawal by Subject|6
2724719|NCT00225147|9369345|P3|Open-label Phase|Withdrawal by Subject|0
2724720|NCT00225147|9369346|P2|Open-label Phase|Withdrawal by Subject|0
2724721|NCT00225147|9369347|P1|Open-label Phase|Withdrawal by Subject|0
2724722|NCT00225147|9369344|P4|Open-label Phase|Lost to Follow-up|4
2724723|NCT00225147|9369345|P3|Open-label Phase|Lost to Follow-up|0
2724724|NCT00225147|9369346|P2|Open-label Phase|Lost to Follow-up|0
2724725|NCT00225147|9369347|P1|Open-label Phase|Lost to Follow-up|0
2724726|NCT00224874|9369394|P4|Overall Study|Withdrawal by Subject|0
2724727|NCT00224874|9369395|P3|Overall Study|Withdrawal by Subject|1
2724728|NCT00224874|9369396|P2|Overall Study|Withdrawal by Subject|0
2724729|NCT00224874|9369397|P1|Overall Study|Withdrawal by Subject|0
2724730|NCT00224770|9369442|P3|Overall Study|Lost to Follow-up|0
2724731|NCT00224770|9369443|P2|Overall Study|Lost to Follow-up|2
2724732|NCT00224770|9369444|P1|Overall Study|Lost to Follow-up|4
2724733|NCT00224484|9369479|P3|Overall Study|Reason not specified|2
2724734|NCT00224484|9369480|P2|Overall Study|Reason not specified|4
2724735|NCT00224484|9369481|P1|Overall Study|Reason not specified|5
2724736|NCT00224484|9369479|P3|Overall Study|Lost to Follow-up|36
2724737|NCT00224484|9369480|P2|Overall Study|Lost to Follow-up|28
2724738|NCT00224484|9369481|P1|Overall Study|Lost to Follow-up|66
2724739|NCT00224484|9369479|P3|Overall Study|Migrated/moved from study area|5
2724740|NCT00224484|9369480|P2|Overall Study|Migrated/moved from study area|5
2724741|NCT00224484|9369481|P1|Overall Study|Migrated/moved from study area|18
2724742|NCT00224484|9369479|P3|Overall Study|Withdrawal by Subject|16
2724743|NCT00224484|9369480|P2|Overall Study|Withdrawal by Subject|18
2724744|NCT00224484|9369481|P1|Overall Study|Withdrawal by Subject|49
2724745|NCT00224484|9369479|P3|Overall Study|Protocol Violation|0
2724746|NCT00224484|9369480|P2|Overall Study|Protocol Violation|2
2724747|NCT00224484|9369481|P1|Overall Study|Protocol Violation|2
2724748|NCT00224484|9369479|P3|Overall Study|Non-Serious Adverse Event|3
2724749|NCT00224484|9369480|P2|Overall Study|Non-Serious Adverse Event|7
2724750|NCT00224484|9369481|P1|Overall Study|Non-Serious Adverse Event|5
2724751|NCT00224484|9369479|P3|Overall Study|Serious Adverse Event|0
2724752|NCT00224484|9369480|P2|Overall Study|Serious Adverse Event|1
2724753|NCT00224484|9369481|P1|Overall Study|Serious Adverse Event|1
2724754|NCT00224133|9369545|P1|Overall Study|Other|14
2724755|NCT00224133|9369545|P1|Overall Study|Physician Decision|1
2724756|NCT00224133|9369545|P1|Overall Study|Lost to Follow-up|21
2724757|NCT00224133|9369545|P1|Overall Study|Lack of Efficacy|58
2724758|NCT00224133|9369545|P1|Overall Study|Withdrawal by Subject|33
2724759|NCT00224133|9369545|P1|Overall Study|Protocol Violation|6
2724760|NCT00224133|9369545|P1|Overall Study|Adverse Event|93
2724761|NCT00224120|9369551|P2|Overall Study|Other|5
2724762|NCT00224120|9369552|P1|Overall Study|Other|4
2724763|NCT00224120|9369551|P2|Overall Study|Lost to Follow-up|3
2724764|NCT00224120|9369552|P1|Overall Study|Lost to Follow-up|2
2724765|NCT00224120|9369551|P2|Overall Study|Lack of Efficacy|2
2724766|NCT00224120|9369552|P1|Overall Study|Lack of Efficacy|0
2724767|NCT00224120|9369551|P2|Overall Study|Withdrawal by Subject|10
2724768|NCT00224120|9369552|P1|Overall Study|Withdrawal by Subject|5
2724769|NCT00224120|9369551|P2|Overall Study|Protocol Violation|0
2724770|NCT00224120|9369552|P1|Overall Study|Protocol Violation|1
2724771|NCT00224120|9369551|P2|Overall Study|Adverse Event|4
2724772|NCT00224120|9369552|P1|Overall Study|Adverse Event|10
2724773|NCT00224107|9369562|P2|Overall Study|Other|1
2724774|NCT00224107|9369563|P1|Overall Study|Other|1
2724775|NCT00224107|9369562|P2|Overall Study|Physician Decision|0
2724776|NCT00224107|9369563|P1|Overall Study|Physician Decision|1
2724777|NCT00224107|9369562|P2|Overall Study|Lost to Follow-up|0
2724778|NCT00224107|9369563|P1|Overall Study|Lost to Follow-up|4
2724779|NCT00224107|9369562|P2|Overall Study|Lack of Efficacy|0
2724780|NCT00224107|9369563|P1|Overall Study|Lack of Efficacy|2
2724781|NCT00224107|9369562|P2|Overall Study|Withdrawal by Subject|4
2724782|NCT00224107|9369563|P1|Overall Study|Withdrawal by Subject|1
2724783|NCT00224107|9369562|P2|Overall Study|Protocol Violation|3
2724784|NCT00224107|9369563|P1|Overall Study|Protocol Violation|2
2724785|NCT00224107|9369562|P2|Overall Study|Adverse Event|6
2724786|NCT00224107|9369563|P1|Overall Study|Adverse Event|20
2724787|NCT00224055|9369573|P2|Overall Study|Other|0
2724788|NCT00224055|9369574|P1|Overall Study|Other|1
2724789|NCT00224055|9369573|P2|Overall Study|Withdrawal by Subject|2
2724790|NCT00224055|9369574|P1|Overall Study|Withdrawal by Subject|0
2724791|NCT00224055|9369573|P2|Overall Study|Inclusion Violation|6
2724792|NCT00224055|9369574|P1|Overall Study|Inclusion Violation|3
2724793|NCT00224055|9369573|P2|Overall Study|Protocol Violation|1
2724794|NCT00224055|9369574|P1|Overall Study|Protocol Violation|1
2724795|NCT00224055|9369573|P2|Overall Study|Lost to Follow-up|2
2724796|NCT00224055|9369574|P1|Overall Study|Lost to Follow-up|1
2724797|NCT00224055|9369573|P2|Overall Study|Adverse Event|3
2724798|NCT00224055|9369574|P1|Overall Study|Adverse Event|9
2724799|NCT00224042|9369584|P2|Overall Study|Other|0
2724800|NCT00224042|9369585|P1|Overall Study|Other|2
2724801|NCT00224042|9369584|P2|Overall Study|Did not meet lab incusion criteria|3
2724802|NCT00224042|9369585|P1|Overall Study|Did not meet lab incusion criteria|2
2724803|NCT00224042|9369584|P2|Overall Study|Physician Decision|1
2724804|NCT00224042|9369585|P1|Overall Study|Physician Decision|0
2724805|NCT00224042|9369584|P2|Overall Study|Protocol Violation|1
2724806|NCT00224042|9369585|P1|Overall Study|Protocol Violation|0
2724807|NCT00224042|9369584|P2|Overall Study|Adverse Event|1
2724808|NCT00224042|9369585|P1|Overall Study|Adverse Event|2
2724809|NCT00224029|9369597|P1|Overall Study|Other|1
2724810|NCT00224029|9369597|P1|Overall Study|Withdrawal by Subject|4
2724811|NCT00224029|9369597|P1|Overall Study|Lost to Follow-up|1
2724812|NCT00224016|9369603|P2|Maintenance Period|Lost to Follow-up|1
2724813|NCT00224016|9369604|P1|Maintenance Period|Lost to Follow-up|0
2724814|NCT00224016|9369603|P2|Maintenance Period|Withdrawal by Subject|0
2724815|NCT00224016|9369604|P1|Maintenance Period|Withdrawal by Subject|2
2724816|NCT00224016|9369603|P2|Titration Period|Lost to Follow-up|0
2724817|NCT00224016|9369604|P1|Titration Period|Lost to Follow-up|1
2724818|NCT00224016|9369603|P2|Titration Period|Withdrawal by Subject|1
2724819|NCT00224016|9369604|P1|Titration Period|Withdrawal by Subject|0
2724820|NCT00224003|9369612|P1|Overall Study|unk|3
2724821|NCT00224003|9369612|P1|Overall Study|Withdrawal by Subject|1
2724822|NCT00224003|9369612|P1|Overall Study|Protocol Violation|2
2724823|NCT00224003|9369612|P1|Overall Study|Adverse Event|1
2724824|NCT00223977|9369619|P3|Overall Study|Other|0
2724825|NCT00223977|9369620|P2|Overall Study|Other|0
2724826|NCT00223977|9369621|P1|Overall Study|Other|1
2724827|NCT00223977|9369619|P3|Overall Study|Withdrawal by Subject|2
2724828|NCT00223977|9369620|P2|Overall Study|Withdrawal by Subject|1
2724829|NCT00223977|9369621|P1|Overall Study|Withdrawal by Subject|1
2724830|NCT00223977|9369619|P3|Overall Study|Protocol Violation|1
2724831|NCT00223977|9369620|P2|Overall Study|Protocol Violation|0
2724832|NCT00223977|9369621|P1|Overall Study|Protocol Violation|0
2724833|NCT00223977|9369619|P3|Overall Study|Adverse Event|0
2724834|NCT00223977|9369620|P2|Overall Study|Adverse Event|10
2724835|NCT00223977|9369621|P1|Overall Study|Adverse Event|7
2724836|NCT00223808|9369655|P3|Overall Study|<5 hrs therapy before discharge|5
2724837|NCT00223808|9369656|P2|Overall Study|<5 hrs therapy before discharge|5
2724838|NCT00223808|9369657|P1|Overall Study|<5 hrs therapy before discharge|3
2724839|NCT00223795|9369674|P2|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
2724840|NCT00223795|9369675|P1|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
2724841|NCT00223795|9369674|P2|First Intervention - Eight Weeks|Lost to Follow-up|9
2724842|NCT00223795|9369675|P1|First Intervention - Eight Weeks|Lost to Follow-up|7
2724843|NCT00223496|9369753|P1|Overall Study|Physician Decision|2
2724844|NCT00223496|9369753|P1|Overall Study|Withdrawal by Subject|1
2724845|NCT00223496|9369753|P1|Overall Study|Lack of Efficacy|6
2724846|NCT00223496|9369753|P1|Overall Study|Lost to Follow-up|4
2724847|NCT00223496|9369753|P1|Overall Study|screen failure|9
2724848|NCT00223080|9369783|P2|Overall Study|Adverse Event|1
2724849|NCT00223080|9369784|P1|Overall Study|Adverse Event|0
2724850|NCT00223080|9369783|P2|Overall Study|Reason not provided|140
2724851|NCT00223080|9369784|P1|Overall Study|Reason not provided|141
2724852|NCT00223080|9369783|P2|Overall Study|Other|11
2724853|NCT00223080|9369784|P1|Overall Study|Other|14
2724854|NCT00223080|9369783|P2|Overall Study|Death|74
2724855|NCT00223080|9369784|P1|Overall Study|Death|85
2724856|NCT00223080|9369783|P2|Overall Study|Lost to Follow-up|284
2724857|NCT00223080|9369784|P1|Overall Study|Lost to Follow-up|259
2724858|NCT00223080|9369783|P2|Overall Study|Moved from study area|47
2724859|NCT00223080|9369784|P1|Overall Study|Moved from study area|37
2724860|NCT00223080|9369783|P2|Overall Study|Non-compliant|7
2724861|NCT00223080|9369784|P1|Overall Study|Non-compliant|7
2724862|NCT00223080|9369783|P2|Overall Study|Required contraindicated med|1
2724863|NCT00223080|9369784|P1|Overall Study|Required contraindicated med|0
2724864|NCT00223080|9369783|P2|Overall Study|Withdrawal by Subject|232
2724865|NCT00223080|9369784|P1|Overall Study|Withdrawal by Subject|253
2724866|NCT00222729|9369802|P1|Overall Study|Adverse Event|3
2724867|NCT00222105|9369820|P1|Overall Study|Death|2
2724868|NCT00222105|9369820|P1|Overall Study|Treatment delays|2
2724869|NCT00222105|9369820|P1|Overall Study|Adverse Event|8
2724870|NCT00222105|9369820|P1|Overall Study|Withdrawal by Subject|1
2724871|NCT00222105|9369820|P1|Overall Study|Removed due to wrong diagnosis|1
2724872|NCT00221195|9369841|P2|Therapy 2 (Months 10-15)|Adverse Event|0
2724873|NCT00221195|9369842|P1|Therapy 2 (Months 10-15)|Adverse Event|1
2724874|NCT00221195|9369841|P2|Therapy 2 (Months 10-15)|Death|0
2724875|NCT00221195|9369842|P1|Therapy 2 (Months 10-15)|Death|1
2724876|NCT00221195|9369841|P2|Washout Period (Months 7-9)|Death|1
2724877|NCT00221195|9369842|P1|Washout Period (Months 7-9)|Death|0
2724878|NCT00221195|9369841|P2|Therapy 1 (Months 1-6)|Lost to Follow-up|1
2724879|NCT00221195|9369842|P1|Therapy 1 (Months 1-6)|Lost to Follow-up|0
2724880|NCT00221195|9369841|P2|Therapy 1 (Months 1-6)|Withdrawal by Subject|1
2724881|NCT00221195|9369842|P1|Therapy 1 (Months 1-6)|Withdrawal by Subject|3
2724882|NCT00221104|9369864|P2|Overall Study|Others|47
2724883|NCT00221104|9369865|P1|Overall Study|Others|37
2724884|NCT00221104|9369864|P2|Overall Study|Withdrawal by Subject|29
2724885|NCT00221104|9369865|P1|Overall Study|Withdrawal by Subject|42
2724886|NCT00221104|9369864|P2|Overall Study|Protocol Violation|0
2724887|NCT00221104|9369865|P1|Overall Study|Protocol Violation|2
2724888|NCT00221104|9369864|P2|Overall Study|Physician Decision|0
2724889|NCT00221104|9369865|P1|Overall Study|Physician Decision|1
2724890|NCT00221104|9369864|P2|Overall Study|Adverse Event|0
2724891|NCT00221104|9369865|P1|Overall Study|Adverse Event|1
2724892|NCT00220805|9369898|P2|Overall Study|Develop. of choroidal neovascularization|8
2724893|NCT00220805|9369899|P1|Overall Study|Develop. of choroidal neovascularization|3
2724894|NCT00220805|9369898|P2|Overall Study|Lack of Efficacy|0
2724895|NCT00220805|9369899|P1|Overall Study|Lack of Efficacy|1
2724896|NCT00220805|9369898|P2|Overall Study|Withdrawal by Subject|0
2724897|NCT00220805|9369899|P1|Overall Study|Withdrawal by Subject|3
2724898|NCT00220805|9369898|P2|Overall Study|Adverse Event|3
2724899|NCT00220805|9369899|P1|Overall Study|Adverse Event|1
2724900|NCT00220779|9369920|P3|Overall Study|Lack of Efficacy|1
2724901|NCT00220779|9369921|P2|Overall Study|Lack of Efficacy|0
2724902|NCT00220779|9369922|P1|Overall Study|Lack of Efficacy|3
2724903|NCT00220779|9369920|P3|Overall Study|Pregnancy|2
2724904|NCT00220779|9369921|P2|Overall Study|Pregnancy|0
2724905|NCT00220779|9369922|P1|Overall Study|Pregnancy|0
2724906|NCT00220779|9369920|P3|Overall Study|Too time consuming|0
2724907|NCT00220779|9369921|P2|Overall Study|Too time consuming|0
2724908|NCT00220779|9369922|P1|Overall Study|Too time consuming|1
2724909|NCT00220779|9369920|P3|Overall Study|Non-compliance|0
2724910|NCT00220779|9369921|P2|Overall Study|Non-compliance|0
2724911|NCT00220779|9369922|P1|Overall Study|Non-compliance|1
2724912|NCT00220779|9369920|P3|Overall Study|Withdrawal by Subject|1
2724913|NCT00220779|9369921|P2|Overall Study|Withdrawal by Subject|4
2724914|NCT00220779|9369922|P1|Overall Study|Withdrawal by Subject|1
2724915|NCT00220779|9369920|P3|Overall Study|Adverse Event|0
2724916|NCT00220779|9369921|P2|Overall Study|Adverse Event|0
2724917|NCT00220779|9369922|P1|Overall Study|Adverse Event|1
2724918|NCT00220740|9369932|P2|Efficacy Period|Entered Rescue Treatment with IGIV-C|45
2724919|NCT00220740|9369933|P1|Efficacy Period|Entered Rescue Treatment with IGIV-C|0
2724920|NCT00220740|9369932|P2|Efficacy Period|Protocol Violation|0
2724921|NCT00220740|9369933|P1|Efficacy Period|Protocol Violation|1
2724922|NCT00220740|9369932|P2|Efficacy Period|Withdrawal by Subject|0
2724923|NCT00220740|9369933|P1|Efficacy Period|Withdrawal by Subject|1
2724924|NCT00220740|9369932|P2|Efficacy Period|Adverse Event|1
2724925|NCT00220740|9369933|P1|Efficacy Period|Adverse Event|1
2724926|NCT00220740|9369932|P2|Efficacy Period|Entered rescue treatment with placebo|0
2724927|NCT00220740|9369933|P1|Efficacy Period|Entered rescue treatment with placebo|23
2724928|NCT00220727|9369947|P2|Second Infusion (Week <6)|Pt did not meet study requirement|0
2724929|NCT00220727|9369948|P1|Second Infusion (Week <6)|Pt did not meet study requirement|1
2724930|NCT00220701|9369964|P2|Overall Study|Lost to Follow-up|4
2724931|NCT00220701|9369965|P1|Overall Study|Lost to Follow-up|5
2724932|NCT00220636|9369981|P1|Overall Study|Withdrawal by Subject|4
2724933|NCT00219557|9369991|P3|Phase 2|Treatment not received|3
2724934|NCT00219557|9369992|P2|Phase 2|Treatment not received|1
2724935|NCT00219557|9369993|P1|Phase 2|Treatment not received|0
2724936|NCT00219557|9369991|P3|Phase 2|Withdrawal by Subject|5
2724937|NCT00219557|9369992|P2|Phase 2|Withdrawal by Subject|9
2724938|NCT00219557|9369993|P1|Phase 2|Withdrawal by Subject|0
2724939|NCT00219557|9369991|P3|Phase 2|Other|6
2724940|NCT00219557|9369992|P2|Phase 2|Other|8
2724941|NCT00219557|9369993|P1|Phase 2|Other|0
2724942|NCT00219557|9369991|P3|Phase 2|Death|2
2724943|NCT00219557|9369992|P2|Phase 2|Death|8
2724944|NCT00219557|9369993|P1|Phase 2|Death|0
2724945|NCT00219557|9369991|P3|Phase 2|Adverse Event|2
2724946|NCT00219557|9369992|P2|Phase 2|Adverse Event|22
2724947|NCT00219557|9369993|P1|Phase 2|Adverse Event|0
2724948|NCT00219557|9369991|P3|Phase 2|Lack of Efficacy|15
2724949|NCT00219557|9369992|P2|Phase 2|Lack of Efficacy|21
2724950|NCT00219557|9369993|P1|Phase 2|Lack of Efficacy|0
2724951|NCT00219557|9369991|P3|Phase 1|Started chemotherapy at other institute|0
2724952|NCT00219557|9369992|P2|Phase 1|Started chemotherapy at other institute|0
2724953|NCT00219557|9369993|P1|Phase 1|Started chemotherapy at other institute|1
2724954|NCT00219557|9369991|P3|Phase 1|Withdrawal by Subject|0
2724955|NCT00219557|9369992|P2|Phase 1|Withdrawal by Subject|0
2724956|NCT00219557|9369993|P1|Phase 1|Withdrawal by Subject|1
2724957|NCT00219557|9369991|P3|Phase 1|Adverse Event|0
2724958|NCT00219557|9369992|P2|Phase 1|Adverse Event|0
2724959|NCT00219557|9369993|P1|Phase 1|Adverse Event|2
2724960|NCT00219557|9369991|P3|Phase 1|Lack of Efficacy|0
2724961|NCT00219557|9369992|P2|Phase 1|Lack of Efficacy|0
2724962|NCT00219557|9369993|P1|Phase 1|Lack of Efficacy|3
2724963|NCT00219544|9370021|P2|Single Blind Treatment Period|Withdrawal by Subject|0
2724964|NCT00219544|9370022|P1|Single Blind Treatment Period|Withdrawal by Subject|1
2724965|NCT00219544|9370021|P2|Single Blind Treatment Period|Investigator decision to withdraw|0
2724966|NCT00219544|9370022|P1|Single Blind Treatment Period|Investigator decision to withdraw|1
2724967|NCT00219544|9370021|P2|Single Blind Treatment Period|Lost to Follow-up|0
2724968|NCT00219544|9370022|P1|Single Blind Treatment Period|Lost to Follow-up|2
2724969|NCT00219544|9370021|P2|Single Blind Treatment Period|Protocol Violation|0
2724970|NCT00219544|9370022|P1|Single Blind Treatment Period|Protocol Violation|4
2724971|NCT00219544|9370021|P2|Single Blind Treatment Period|Adverse Event|0
2724972|NCT00219544|9370022|P1|Single Blind Treatment Period|Adverse Event|9
2724973|NCT00219544|9370021|P2|Single Blind Treatment Period|Lack of Efficacy|0
2724974|NCT00219544|9370022|P1|Single Blind Treatment Period|Lack of Efficacy|5
2724975|NCT00219349|9370060|P1|Escitalopram Phase|Withdrawal by Subject|3
2724976|NCT00219349|9370060|P1|Cognitive Behavioral Therapy Phase|Protocol Violation|2
2724977|NCT00219349|9370060|P1|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2
2724978|NCT00219349|9370060|P1|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6
2724979|NCT00219284|9370073|P2|Extension Phase - 8 Weeks|Lost to Follow-up|2
2724980|NCT00219284|9370074|P1|Extension Phase - 8 Weeks|Lost to Follow-up|0
2724981|NCT00219284|9370073|P2|Extension Phase - 8 Weeks|Withdrawal by Subject|2
2724982|NCT00219284|9370074|P1|Extension Phase - 8 Weeks|Withdrawal by Subject|0
2724983|NCT00219284|9370073|P2|Extension Phase - 8 Weeks|Adverse Event|3
2724984|NCT00219284|9370074|P1|Extension Phase - 8 Weeks|Adverse Event|2
2724985|NCT00219284|9370073|P2|Treatment Phase - 16 Weeks|Lost to Follow-up|2
2724986|NCT00219284|9370074|P1|Treatment Phase - 16 Weeks|Lost to Follow-up|1
2724987|NCT00219284|9370073|P2|Treatment Phase - 16 Weeks|Withdrawal by Subject|9
2724988|NCT00219284|9370074|P1|Treatment Phase - 16 Weeks|Withdrawal by Subject|5
2724989|NCT00219284|9370073|P2|Treatment Phase - 16 Weeks|Protocol Violation|5
2724990|NCT00219284|9370074|P1|Treatment Phase - 16 Weeks|Protocol Violation|9
2724991|NCT00219284|9370073|P2|Treatment Phase - 16 Weeks|Lack of Efficacy|10
2724992|NCT00219284|9370074|P1|Treatment Phase - 16 Weeks|Lack of Efficacy|3
2724993|NCT00219284|9370073|P2|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1
2724994|NCT00219284|9370074|P1|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0
2724995|NCT00219284|9370073|P2|Treatment Phase - 16 Weeks|Adverse Event|24
2724996|NCT00219284|9370074|P1|Treatment Phase - 16 Weeks|Adverse Event|26
2724997|NCT00219141|9370099|P3|Overall Study|Condition no longer requires study drug|0
2724998|NCT00219141|9370100|P2|Overall Study|Condition no longer requires study drug|0
2724999|NCT00219141|9370101|P1|Overall Study|Condition no longer requires study drug|1
2725000|NCT00219141|9370099|P3|Overall Study|Withdrawal by Subject|5
2725001|NCT00219141|9370100|P2|Overall Study|Withdrawal by Subject|3
2725002|NCT00219141|9370101|P1|Overall Study|Withdrawal by Subject|1
2725003|NCT00219141|9370099|P3|Overall Study|Protocol Violation|1
2725004|NCT00219141|9370100|P2|Overall Study|Protocol Violation|1
2725005|NCT00219141|9370101|P1|Overall Study|Protocol Violation|3
2725006|NCT00219141|9370099|P3|Overall Study|Lost to Follow-up|1
2725007|NCT00219141|9370100|P2|Overall Study|Lost to Follow-up|4
2725008|NCT00219141|9370101|P1|Overall Study|Lost to Follow-up|2
2725009|NCT00219141|9370099|P3|Overall Study|Administrative problems|0
2725010|NCT00219141|9370100|P2|Overall Study|Administrative problems|1
2725011|NCT00219141|9370101|P1|Overall Study|Administrative problems|0
2725012|NCT00219141|9370099|P3|Overall Study|Lack of Efficacy|0
2725013|NCT00219141|9370100|P2|Overall Study|Lack of Efficacy|2
2725014|NCT00219141|9370101|P1|Overall Study|Lack of Efficacy|3
2725015|NCT00219141|9370099|P3|Overall Study|Adverse Event|5
2725016|NCT00219141|9370100|P2|Overall Study|Adverse Event|10
2725017|NCT00219141|9370101|P1|Overall Study|Adverse Event|4
2725018|NCT00218634|9370147|P2|Overall Study|Lost to Follow-up|15
2725019|NCT00218634|9370148|P1|Overall Study|Lost to Follow-up|8
2725020|NCT00218543|9370168|P1|Overall Study|Adverse Event|2
2725021|NCT00218543|9370168|P1|Overall Study|Physician Decision|3
2725022|NCT00218543|9370168|P1|Overall Study|Withdrawal by Subject|1
2725023|NCT00218543|9370168|P1|Overall Study|relocated|1
2725024|NCT00218543|9370168|P1|Overall Study|Lost to Follow-up|8
2725025|NCT00218296|9370346|P2|Overall Study|Randomized but did not enter treatment|67
2725026|NCT00218296|9370347|P1|Overall Study|Randomized but did not enter treatment|66
2725027|NCT00218296|9370346|P2|Overall Study|Withdrawal by Subject|47
2725028|NCT00218296|9370347|P1|Overall Study|Withdrawal by Subject|36
2725029|NCT00218296|9370346|P2|Overall Study|Lost to Follow-up|7
2725030|NCT00218296|9370347|P1|Overall Study|Lost to Follow-up|9
2725031|NCT00217971|9370450|P2|Overall Study|non compliant|0
2725032|NCT00217971|9370451|P1|Overall Study|non compliant|1
2725033|NCT00217971|9370450|P2|Overall Study|Withdrawal by Subject|12
2725034|NCT00217971|9370451|P1|Overall Study|Withdrawal by Subject|7
2725035|NCT00217971|9370450|P2|Overall Study|Physician Decision|1
2725036|NCT00217971|9370451|P1|Overall Study|Physician Decision|0
2725037|NCT00217971|9370450|P2|Overall Study|Lost to Follow-up|19
2725038|NCT00217971|9370451|P1|Overall Study|Lost to Follow-up|15
2725039|NCT00217971|9370450|P2|Overall Study|Adverse Event|1
2725040|NCT00217971|9370451|P1|Overall Study|Adverse Event|1
2725041|NCT00217672|9370466|P2|Follow-up|Lost to Follow-up|0
2725042|NCT00217672|9370467|P1|Follow-up|Lost to Follow-up|1
2725043|NCT00217672|9370466|P2|Follow-up|Withdrawal by Subject|0
2725044|NCT00217672|9370467|P1|Follow-up|Withdrawal by Subject|4
2725045|NCT00217672|9370466|P2|Treatment|secondary malignancy|0
2725046|NCT00217672|9370467|P1|Treatment|secondary malignancy|1
2725047|NCT00217672|9370466|P2|Treatment|Death|0
2725048|NCT00217672|9370467|P1|Treatment|Death|2
2725049|NCT00217672|9370466|P2|Treatment|insurance issues|1
2725050|NCT00217672|9370467|P1|Treatment|insurance issues|1
2725051|NCT00217672|9370466|P2|Treatment|Physician Decision|0
2725052|NCT00217672|9370467|P1|Treatment|Physician Decision|6
2725053|NCT00217672|9370466|P2|Treatment|reqd treatment not permitted by protocol|0
2725054|NCT00217672|9370467|P1|Treatment|reqd treatment not permitted by protocol|6
2725055|NCT00217672|9370466|P2|Treatment|Adverse Event|2
2725056|NCT00217672|9370467|P1|Treatment|Adverse Event|18
2725057|NCT00217672|9370466|P2|Treatment|disease progression|4
2725058|NCT00217672|9370467|P1|Treatment|disease progression|33
2725059|NCT00217672|9370466|P2|Allocation|Ineligible|0
2725060|NCT00217672|9370467|P1|Allocation|Ineligible|2
2725061|NCT00217620|9370473|P1|Overall Study|Never received treatment|1
2725062|NCT00217620|9370473|P1|Overall Study|Ineligible|13
2725063|NCT00217620|9370473|P1|Overall Study|Not Protocol Specified|4
2725064|NCT00217620|9370473|P1|Overall Study|Progression|31
2725065|NCT00217620|9370473|P1|Overall Study|Adverse Event|2
2725066|NCT00217581|9370488|P1|Overall Study|Withdrawal by Subject|1
2725067|NCT00217464|9370517|P1|Overall Study|Other|2
2725068|NCT00217464|9370517|P1|Overall Study|Progression|15
2725069|NCT00217425|9370533|P1|Overall Study|Other|4
2725070|NCT00217425|9370533|P1|Overall Study|Other complicating disease|1
2725071|NCT00217425|9370533|P1|Overall Study|Withdrawal by Subject|4
2725072|NCT00217425|9370533|P1|Overall Study|Adverse Event|8
2725073|NCT00217425|9370533|P1|Overall Study|Lack of Efficacy|13
2725074|NCT00217425|9370533|P1|Overall Study|Patient ineligible|5
2725075|NCT00217425|9370533|P1|Overall Study|Never started treatment|2
2725076|NCT00217087|9370547|P2|Overall Study|completed less than 12 months return|18
2725077|NCT00217087|9370548|P1|Overall Study|completed less than 12 months return|10
2725078|NCT00217087|9370547|P2|Overall Study|decided to have esophagectomy|2
2725079|NCT00217087|9370548|P1|Overall Study|decided to have esophagectomy|1
2725080|NCT00217022|9370562|P2|Overall Study|Withdrawal by Subject|1
2725081|NCT00217022|9370563|P1|Overall Study|Withdrawal by Subject|1
2725082|NCT00216736|9370573|P2|Overall Study|Lost to Follow-up|1
2725083|NCT00216736|9370574|P1|Overall Study|Lost to Follow-up|1
2725084|NCT00216671|9370588|P2|Overall Study|Insufficient Response Adverse Event|1
2725085|NCT00216671|9370589|P1|Overall Study|Insufficient Response Adverse Event|2
2725086|NCT00216671|9370588|P2|Overall Study|Ineligible, no efficacy data|2
2725087|NCT00216671|9370589|P1|Overall Study|Ineligible, no efficacy data|2
2725088|NCT00216671|9370588|P2|Overall Study|Patient Moved|1
2725089|NCT00216671|9370589|P1|Overall Study|Patient Moved|0
2725090|NCT00216671|9370588|P2|Overall Study|Investigator Illness|1
2725091|NCT00216671|9370589|P1|Overall Study|Investigator Illness|0
2725092|NCT00216671|9370588|P2|Overall Study|Relapse|0
2725093|NCT00216671|9370589|P1|Overall Study|Relapse|1
2725094|NCT00216671|9370588|P2|Overall Study|Protocol Violation|5
2725095|NCT00216671|9370589|P1|Overall Study|Protocol Violation|3
2725096|NCT00216671|9370588|P2|Overall Study|Physician Decision|1
2725097|NCT00216671|9370589|P1|Overall Study|Physician Decision|1
2725098|NCT00216671|9370588|P2|Overall Study|Ineligible|2
2725099|NCT00216671|9370589|P1|Overall Study|Ineligible|0
2725100|NCT00216671|9370588|P2|Overall Study|Non compliant|2
2725101|NCT00216671|9370589|P1|Overall Study|Non compliant|2
2725102|NCT00216671|9370588|P2|Overall Study|Lost to Follow-up|5
2725103|NCT00216671|9370589|P1|Overall Study|Lost to Follow-up|3
2725104|NCT00216671|9370588|P2|Overall Study|Insufficient Response|4
2725105|NCT00216671|9370589|P1|Overall Study|Insufficient Response|9
2725106|NCT00216671|9370588|P2|Overall Study|No Need to Continue Medication|1
2725107|NCT00216671|9370589|P1|Overall Study|No Need to Continue Medication|1
2725108|NCT00216671|9370588|P2|Overall Study|Refused Injections|13
2725109|NCT00216671|9370589|P1|Overall Study|Refused Injections|3
2725110|NCT00216671|9370588|P2|Overall Study|Withdrawal by Subject|2
2725111|NCT00216671|9370589|P1|Overall Study|Withdrawal by Subject|4
2725112|NCT00216671|9370588|P2|Overall Study|Pregnancy|1
2725113|NCT00216671|9370589|P1|Overall Study|Pregnancy|0
2725114|NCT00216671|9370588|P2|Overall Study|Adverse Event|9
2725115|NCT00216671|9370589|P1|Overall Study|Adverse Event|4
2725116|NCT00216476|9370607|P3|Overall Study|Patient Moved|0
2725117|NCT00216476|9370608|P2|Overall Study|Patient Moved|2
2725118|NCT00216476|9370609|P1|Overall Study|Patient Moved|2
2725119|NCT00216476|9370607|P3|Overall Study|Protocol Deviation|0
2725120|NCT00216476|9370608|P2|Overall Study|Protocol Deviation|1
2725121|NCT00216476|9370609|P1|Overall Study|Protocol Deviation|5
2725122|NCT00216476|9370607|P3|Overall Study|Administrative Reasons|0
2725123|NCT00216476|9370608|P2|Overall Study|Administrative Reasons|1
2725124|NCT00216476|9370609|P1|Overall Study|Administrative Reasons|1
2725125|NCT00216476|9370607|P3|Overall Study|Higher dose/Extra Medication Required|2
2725126|NCT00216476|9370608|P2|Overall Study|Higher dose/Extra Medication Required|0
2725127|NCT00216476|9370609|P1|Overall Study|Higher dose/Extra Medication Required|2
2725128|NCT00216476|9370607|P3|Overall Study|Non-compliance|1
2725129|NCT00216476|9370608|P2|Overall Study|Non-compliance|4
2725130|NCT00216476|9370609|P1|Overall Study|Non-compliance|0
2725131|NCT00216476|9370607|P3|Overall Study|No Further Need for Treatment|1
2725132|NCT00216476|9370608|P2|Overall Study|No Further Need for Treatment|4
2725133|NCT00216476|9370609|P1|Overall Study|No Further Need for Treatment|3
2725134|NCT00216476|9370607|P3|Overall Study|Refuses Injection|0
2725135|NCT00216476|9370608|P2|Overall Study|Refuses Injection|0
2725136|NCT00216476|9370609|P1|Overall Study|Refuses Injection|11
2725137|NCT00216476|9370607|P3|Overall Study|Other|1
2725138|NCT00216476|9370608|P2|Overall Study|Other|0
2725139|NCT00216476|9370609|P1|Overall Study|Other|0
2725140|NCT00216476|9370607|P3|Overall Study|Pregnancy|1
2725141|NCT00216476|9370608|P2|Overall Study|Pregnancy|1
2725142|NCT00216476|9370609|P1|Overall Study|Pregnancy|0
2725143|NCT00216476|9370607|P3|Overall Study|Death|0
2725144|NCT00216476|9370608|P2|Overall Study|Death|0
2725145|NCT00216476|9370609|P1|Overall Study|Death|2
2725146|NCT00216476|9370607|P3|Overall Study|Lack of Efficacy|0
2725147|NCT00216476|9370608|P2|Overall Study|Lack of Efficacy|3
2725148|NCT00216476|9370609|P1|Overall Study|Lack of Efficacy|4
2725149|NCT00216476|9370607|P3|Overall Study|Adverse Event|1
2725150|NCT00216476|9370608|P2|Overall Study|Adverse Event|10
2725151|NCT00216476|9370609|P1|Overall Study|Adverse Event|6
2725152|NCT00216476|9370607|P3|Overall Study|Lost to Follow-up|1
2725153|NCT00216476|9370608|P2|Overall Study|Lost to Follow-up|9
2725154|NCT00216476|9370609|P1|Overall Study|Lost to Follow-up|10
2725155|NCT00216476|9370607|P3|Overall Study|Withdrawal by Subject|9
2725156|NCT00216476|9370608|P2|Overall Study|Withdrawal by Subject|72
2725157|NCT00216476|9370609|P1|Overall Study|Withdrawal by Subject|59
2725158|NCT00216203|9370646|P1|Overall Study|Withdrawal by Subject|2
2725159|NCT00216086|9370676|P1|Overall Study|Social Reasons|2
2725160|NCT00216086|9370676|P1|Overall Study|Diagnosis of Metastatic Disease|1
2725161|NCT00216086|9370676|P1|Overall Study|Protocol Violation|1
2725162|NCT00215943|9370708|P2|Overall Study|Other complications|1
2725163|NCT00215943|9370709|P1|Overall Study|Other complications|3
2725164|NCT00215943|9370708|P2|Overall Study|Other disease|1
2725165|NCT00215943|9370709|P1|Overall Study|Other disease|0
2725166|NCT00215943|9370708|P2|Overall Study|Adverse Event|6
2725167|NCT00215943|9370709|P1|Overall Study|Adverse Event|3
2725168|NCT00215943|9370708|P2|Overall Study|Alternate therapy|1
2725169|NCT00215943|9370709|P1|Overall Study|Alternate therapy|0
2725170|NCT00215943|9370708|P2|Overall Study|Disease Progression|5
2725171|NCT00215943|9370709|P1|Overall Study|Disease Progression|3
2725172|NCT00215683|9370734|P3|Overall Study|Intermittent therapy required|0
2725173|NCT00215683|9370735|P2|Overall Study|Intermittent therapy required|1
2725174|NCT00215683|9370736|P1|Overall Study|Intermittent therapy required|0
2725175|NCT00215683|9370734|P3|Overall Study|No study drug available|0
2725176|NCT00215683|9370735|P2|Overall Study|No study drug available|1
2725177|NCT00215683|9370736|P1|Overall Study|No study drug available|0
2725178|NCT00215683|9370734|P3|Overall Study|Difficult to attend visits|0
2725179|NCT00215683|9370735|P2|Overall Study|Difficult to attend visits|1
2725180|NCT00215683|9370736|P1|Overall Study|Difficult to attend visits|0
2725181|NCT00215683|9370734|P3|Overall Study|Physician Decision|1
2725182|NCT00215683|9370735|P2|Overall Study|Physician Decision|0
2725183|NCT00215683|9370736|P1|Overall Study|Physician Decision|0
2725184|NCT00215683|9370734|P3|Overall Study|Withdrawal by Subject|13
2725185|NCT00215683|9370735|P2|Overall Study|Withdrawal by Subject|4
2725186|NCT00215683|9370736|P1|Overall Study|Withdrawal by Subject|9
2725187|NCT00215683|9370734|P3|Overall Study|Lost to Follow-up|1
2725188|NCT00215683|9370735|P2|Overall Study|Lost to Follow-up|2
2725189|NCT00215683|9370736|P1|Overall Study|Lost to Follow-up|0
2725190|NCT00215683|9370734|P3|Overall Study|Lack of Efficacy|2
2725191|NCT00215683|9370735|P2|Overall Study|Lack of Efficacy|1
2725192|NCT00215683|9370736|P1|Overall Study|Lack of Efficacy|5
2725193|NCT00215683|9370734|P3|Overall Study|Adverse Event|15
2725194|NCT00215683|9370735|P2|Overall Study|Adverse Event|16
2725195|NCT00215683|9370736|P1|Overall Study|Adverse Event|15
2725196|NCT00215657|9370755|P8|Overall Study|Other|1
2725197|NCT00215657|9370756|P7|Overall Study|Other|6
2725198|NCT00215657|9370757|P6|Overall Study|Other|4
2725199|NCT00215657|9370758|P5|Overall Study|Other|5
2725200|NCT00215657|9370759|P4|Overall Study|Other|3
2725201|NCT00215657|9370760|P3|Overall Study|Other|2
2725202|NCT00215657|9370761|P2|Overall Study|Other|1
2725203|NCT00215657|9370762|P1|Overall Study|Other|3
2725204|NCT00215657|9370755|P8|Overall Study|Insufficient testosterone response|7
2725205|NCT00215657|9370756|P7|Overall Study|Insufficient testosterone response|4
2725206|NCT00215657|9370757|P6|Overall Study|Insufficient testosterone response|12
2725207|NCT00215657|9370758|P5|Overall Study|Insufficient testosterone response|8
2725208|NCT00215657|9370759|P4|Overall Study|Insufficient testosterone response|12
2725209|NCT00215657|9370760|P3|Overall Study|Insufficient testosterone response|1
2725210|NCT00215657|9370761|P2|Overall Study|Insufficient testosterone response|4
2725211|NCT00215657|9370762|P1|Overall Study|Insufficient testosterone response|5
2725212|NCT00215657|9370755|P8|Overall Study|Insuff prostate specific antigen resp|2
2725213|NCT00215657|9370756|P7|Overall Study|Insuff prostate specific antigen resp|3
2725214|NCT00215657|9370757|P6|Overall Study|Insuff prostate specific antigen resp|2
2725215|NCT00215657|9370758|P5|Overall Study|Insuff prostate specific antigen resp|1
2725216|NCT00215657|9370759|P4|Overall Study|Insuff prostate specific antigen resp|2
2725217|NCT00215657|9370760|P3|Overall Study|Insuff prostate specific antigen resp|2
2725218|NCT00215657|9370761|P2|Overall Study|Insuff prostate specific antigen resp|2
2725219|NCT00215657|9370762|P1|Overall Study|Insuff prostate specific antigen resp|3
2725220|NCT00215657|9370755|P8|Overall Study|Withdrawal by Subject|3
2725221|NCT00215657|9370756|P7|Overall Study|Withdrawal by Subject|10
2725222|NCT00215657|9370757|P6|Overall Study|Withdrawal by Subject|1
2725223|NCT00215657|9370758|P5|Overall Study|Withdrawal by Subject|6
2725224|NCT00215657|9370759|P4|Overall Study|Withdrawal by Subject|1
2725225|NCT00215657|9370760|P3|Overall Study|Withdrawal by Subject|3
2725226|NCT00215657|9370761|P2|Overall Study|Withdrawal by Subject|3
2725227|NCT00215657|9370762|P1|Overall Study|Withdrawal by Subject|6
2725228|NCT00215657|9370755|P8|Overall Study|Adverse Event|3
2725229|NCT00215657|9370756|P7|Overall Study|Adverse Event|0
2725230|NCT00215657|9370757|P6|Overall Study|Adverse Event|1
2725231|NCT00215657|9370758|P5|Overall Study|Adverse Event|3
2725232|NCT00215657|9370759|P4|Overall Study|Adverse Event|0
2725233|NCT00215657|9370760|P3|Overall Study|Adverse Event|3
2725234|NCT00215657|9370761|P2|Overall Study|Adverse Event|1
2725235|NCT00215657|9370762|P1|Overall Study|Adverse Event|5
2725236|NCT00215644|9370790|P2|Overall Study|Randomized but Not Treated|0
2725237|NCT00215644|9370791|P1|Overall Study|Randomized but Not Treated|1
2725238|NCT00215644|9370790|P2|Overall Study|Other|15
2725239|NCT00215644|9370791|P1|Overall Study|Other|3
2725240|NCT00215644|9370790|P2|Overall Study|Withdrawal by Subject|0
2725241|NCT00215644|9370791|P1|Overall Study|Withdrawal by Subject|1
2725242|NCT00215644|9370790|P2|Overall Study|Death|2
2725243|NCT00215644|9370791|P1|Overall Study|Death|1
2725244|NCT00215644|9370790|P2|Overall Study|Adverse Event|9
2725245|NCT00215644|9370791|P1|Overall Study|Adverse Event|2
2725246|NCT00215644|9370790|P2|Overall Study|Disease Progression|10
2725247|NCT00215644|9370791|P1|Overall Study|Disease Progression|28
2725248|NCT00215553|9370818|P7|Overall Study|Adverse Event|0
2725249|NCT00215553|9370819|P6|Overall Study|Adverse Event|6
2725250|NCT00215553|9370820|P5|Overall Study|Adverse Event|2
2725251|NCT00215553|9370821|P4|Overall Study|Adverse Event|1
2725252|NCT00215553|9370822|P3|Overall Study|Adverse Event|2
2725253|NCT00215553|9370823|P2|Overall Study|Adverse Event|1
2725254|NCT00215553|9370824|P1|Overall Study|Adverse Event|0
2725255|NCT00215540|9370857|P3|Overall Study|Withdrew from study medication|0
2725256|NCT00215540|9370858|P2|Overall Study|Withdrew from study medication|0
2725257|NCT00215540|9370859|P1|Overall Study|Withdrew from study medication|1
2725258|NCT00215150|9370894|P1|Randomization Phase Placebo|Withdrawal by Subject|1
2725259|NCT00215150|9370894|P1|Randomization Phase Ziprasidone|Withdrawal by Subject|1
2725260|NCT00215150|9370894|P1|Randomization Phase Ziprasidone|Lost to Follow-up|2
2725261|NCT00215150|9370894|P1|Open Label Phase|Did not meet randomization criteria|9
2725262|NCT00215150|9370894|P1|Open Label Phase|Did not complete a post base visit|13
2725263|NCT00215150|9370894|P1|Open Label Phase|Withdrawal by Subject|1
2725264|NCT00215150|9370894|P1|Open Label Phase|Lost to Follow-up|7
2725265|NCT00215137|9370902|P3|Randomization Period|Withdrawal by Subject|0
2725266|NCT00215137|9370903|P2|Randomization Period|Withdrawal by Subject|1
2725267|NCT00215137|9370904|P1|Randomization Period|Withdrawal by Subject|0
2725268|NCT00215137|9370902|P3|Randomization Period|Lost to Follow-up|0
2725269|NCT00215137|9370903|P2|Randomization Period|Lost to Follow-up|1
2725270|NCT00215137|9370904|P1|Randomization Period|Lost to Follow-up|0
2725271|NCT00215137|9370902|P3|Open Label Escitalopram|Lack of Efficacy|0
2725272|NCT00215137|9370903|P2|Open Label Escitalopram|Lack of Efficacy|0
2725273|NCT00215137|9370904|P1|Open Label Escitalopram|Lack of Efficacy|1
2725274|NCT00214500|9371002|P1|Extension Period|Withdrawal by Subject|2
2725275|NCT00214500|9371002|P1|Treatment Period|Adverse Event|1
2725276|NCT00214461|9371023|P4|Overall Study|Withdrawal by Subject|0
2725277|NCT00214461|9371024|P3|Overall Study|Withdrawal by Subject|1
2725278|NCT00214461|9371025|P2|Overall Study|Withdrawal by Subject|0
2725279|NCT00214461|9371026|P1|Overall Study|Withdrawal by Subject|0
2725280|NCT00214461|9371023|P4|Overall Study|Adverse Event|1
2725281|NCT00214461|9371024|P3|Overall Study|Adverse Event|1
2725282|NCT00214461|9371025|P2|Overall Study|Adverse Event|0
2725283|NCT00214461|9371026|P1|Overall Study|Adverse Event|0
2725284|NCT00214422|9371043|P3|Overall Study|Unable to make a radiation treatment|1
2725285|NCT00214422|9371044|P2|Overall Study|Unable to make a radiation treatment|0
2725286|NCT00214422|9371045|P1|Overall Study|Unable to make a radiation treatment|0
2725287|NCT00214422|9371043|P3|Overall Study|Disease progression on study|0
2725288|NCT00214422|9371044|P2|Overall Study|Disease progression on study|0
2725289|NCT00214422|9371045|P1|Overall Study|Disease progression on study|1
2725290|NCT00214422|9371043|P3|Overall Study|Pt taken off study|0
2725291|NCT00214422|9371044|P2|Overall Study|Pt taken off study|1
2725292|NCT00214422|9371045|P1|Overall Study|Pt taken off study|1
2725293|NCT00214422|9371043|P3|Overall Study|Developed esophageal ca|0
2725294|NCT00214422|9371044|P2|Overall Study|Developed esophageal ca|0
2725295|NCT00214422|9371045|P1|Overall Study|Developed esophageal ca|1
2725296|NCT00214422|9371043|P3|Overall Study|Physician Decision|0
2725297|NCT00214422|9371044|P2|Overall Study|Physician Decision|0
2725298|NCT00214422|9371045|P1|Overall Study|Physician Decision|2
2725299|NCT00214383|9371068|P2|Overall Study|Lost to Follow-up|26
2725300|NCT00214383|9371069|P1|Overall Study|Lost to Follow-up|16
2725301|NCT00214201|9371081|P2|Overall Study|Death|2
2725302|NCT00214201|9371082|P1|Overall Study|Death|0
2725303|NCT00214201|9371081|P2|Overall Study|Withdrawal by Subject|0
2725304|NCT00214201|9371082|P1|Overall Study|Withdrawal by Subject|2
2725305|NCT00214136|9371097|P1|Overall Study|Death|5
2725306|NCT00214019|9371142|P1|Overall Study|Screen Failed prior to randomization|17
2725307|NCT00214019|9371142|P1|Overall Study|Withdrawal by Subject|2
2725308|NCT00214019|9371142|P1|Overall Study|Lost to Follow-up|11
2725309|NCT00213980|9371151|P2|Overall Study|Failed to obtain all 3 DXAs|3
2725310|NCT00213980|9371152|P1|Overall Study|Failed to obtain all 3 DXAs|1
2725311|NCT00213980|9371151|P2|Overall Study|Developed ovarian cancer|0
2725312|NCT00213980|9371152|P1|Overall Study|Developed ovarian cancer|1
2725313|NCT00213980|9371151|P2|Overall Study|Disease progression|2
2725314|NCT00213980|9371152|P1|Overall Study|Disease progression|0
2725315|NCT00213980|9371151|P2|Overall Study|Adverse Event|1
2725316|NCT00213980|9371152|P1|Overall Study|Adverse Event|1
2725317|NCT00213980|9371151|P2|Overall Study|Withdrawal by Subject|1
2725318|NCT00213980|9371152|P1|Overall Study|Withdrawal by Subject|3
2725319|NCT00213148|9371179|P5|Cycle 3 (1 Month)|Other|0
2725320|NCT00213148|9371180|P4|Cycle 3 (1 Month)|Other|1
2725321|NCT00213148|9371181|P3|Cycle 3 (1 Month)|Other|1
2725322|NCT00213148|9371182|P2|Cycle 3 (1 Month)|Other|0
2725323|NCT00213148|9371183|P1|Cycle 3 (1 Month)|Other|0
2725324|NCT00213148|9371179|P5|Cycle 3 (1 Month)|Lost to Follow-up|1
2725325|NCT00213148|9371180|P4|Cycle 3 (1 Month)|Lost to Follow-up|0
2725326|NCT00213148|9371181|P3|Cycle 3 (1 Month)|Lost to Follow-up|0
2725327|NCT00213148|9371182|P2|Cycle 3 (1 Month)|Lost to Follow-up|2
2725328|NCT00213148|9371183|P1|Cycle 3 (1 Month)|Lost to Follow-up|0
2725329|NCT00213148|9371179|P5|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6
2725330|NCT00213148|9371180|P4|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
2725331|NCT00213148|9371181|P3|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
2725332|NCT00213148|9371182|P2|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1
2725333|NCT00213148|9371183|P1|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10
2725334|NCT00213148|9371179|P5|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
2725335|NCT00213148|9371180|P4|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
2725336|NCT00213148|9371181|P3|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
2725337|NCT00213148|9371182|P2|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
2725338|NCT00213148|9371183|P1|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1
2725339|NCT00213148|9371179|P5|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
2725340|NCT00213148|9371180|P4|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
2725341|NCT00213148|9371181|P3|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
2725342|NCT00213148|9371182|P2|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1
2725343|NCT00213148|9371183|P1|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
2725344|NCT00213148|9371179|P5|Cycle 2 (1 Month)|Other|7
2725345|NCT00213148|9371180|P4|Cycle 2 (1 Month)|Other|8
2725346|NCT00213148|9371181|P3|Cycle 2 (1 Month)|Other|2
2725347|NCT00213148|9371182|P2|Cycle 2 (1 Month)|Other|1
2725348|NCT00213148|9371183|P1|Cycle 2 (1 Month)|Other|2
2725349|NCT00213148|9371179|P5|Cycle 2 (1 Month)|Lack of Efficacy|16
2725350|NCT00213148|9371180|P4|Cycle 2 (1 Month)|Lack of Efficacy|6
2725351|NCT00213148|9371181|P3|Cycle 2 (1 Month)|Lack of Efficacy|7
2725352|NCT00213148|9371182|P2|Cycle 2 (1 Month)|Lack of Efficacy|3
2725353|NCT00213148|9371183|P1|Cycle 2 (1 Month)|Lack of Efficacy|1
2725354|NCT00213148|9371179|P5|Cycle 2 (1 Month)|Lost to Follow-up|1
2725355|NCT00213148|9371180|P4|Cycle 2 (1 Month)|Lost to Follow-up|2
2725356|NCT00213148|9371181|P3|Cycle 2 (1 Month)|Lost to Follow-up|2
2725357|NCT00213148|9371182|P2|Cycle 2 (1 Month)|Lost to Follow-up|0
2725358|NCT00213148|9371183|P1|Cycle 2 (1 Month)|Lost to Follow-up|0
2725359|NCT00213148|9371179|P5|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
2725360|NCT00213148|9371180|P4|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8
2725361|NCT00213148|9371181|P3|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
2725362|NCT00213148|9371182|P2|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0
2725363|NCT00213148|9371183|P1|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15
2725364|NCT00213148|9371179|P5|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1
2725365|NCT00213148|9371180|P4|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
2725366|NCT00213148|9371181|P3|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
2725367|NCT00213148|9371182|P2|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
2725368|NCT00213148|9371183|P1|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
2725369|NCT00213148|9371179|P5|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
2725370|NCT00213148|9371180|P4|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1
2725371|NCT00213148|9371181|P3|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
2725372|NCT00213148|9371182|P2|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
2725373|NCT00213148|9371183|P1|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
2725374|NCT00213148|9371179|P5|Cycle 1 (1 Month)|Other|7
2725375|NCT00213148|9371180|P4|Cycle 1 (1 Month)|Other|2
2725376|NCT00213148|9371181|P3|Cycle 1 (1 Month)|Other|2
2725377|NCT00213148|9371182|P2|Cycle 1 (1 Month)|Other|0
2725378|NCT00213148|9371183|P1|Cycle 1 (1 Month)|Other|3
2725379|NCT00213148|9371179|P5|Cycle 1 (1 Month)|Protocol Violation|0
2725380|NCT00213148|9371180|P4|Cycle 1 (1 Month)|Protocol Violation|0
2725381|NCT00213148|9371181|P3|Cycle 1 (1 Month)|Protocol Violation|1
2725382|NCT00213148|9371182|P2|Cycle 1 (1 Month)|Protocol Violation|0
2725383|NCT00213148|9371183|P1|Cycle 1 (1 Month)|Protocol Violation|1
2725384|NCT00213148|9371179|P5|Cycle 1 (1 Month)|Lack of Efficacy|8
2725385|NCT00213148|9371180|P4|Cycle 1 (1 Month)|Lack of Efficacy|5
2725386|NCT00213148|9371181|P3|Cycle 1 (1 Month)|Lack of Efficacy|8
2725387|NCT00213148|9371182|P2|Cycle 1 (1 Month)|Lack of Efficacy|0
2725388|NCT00213148|9371183|P1|Cycle 1 (1 Month)|Lack of Efficacy|4
2725389|NCT00213148|9371179|P5|Cycle 1 (1 Month)|Adverse Event|0
2725390|NCT00213148|9371180|P4|Cycle 1 (1 Month)|Adverse Event|0
2725391|NCT00213148|9371181|P3|Cycle 1 (1 Month)|Adverse Event|1
2725392|NCT00213148|9371182|P2|Cycle 1 (1 Month)|Adverse Event|0
2725393|NCT00213148|9371183|P1|Cycle 1 (1 Month)|Adverse Event|0
2725394|NCT00213148|9371179|P5|Cycle 1 (1 Month)|Lost to Follow-up|1
2725395|NCT00213148|9371180|P4|Cycle 1 (1 Month)|Lost to Follow-up|2
2725396|NCT00213148|9371181|P3|Cycle 1 (1 Month)|Lost to Follow-up|2
2725397|NCT00213148|9371182|P2|Cycle 1 (1 Month)|Lost to Follow-up|0
2725398|NCT00213148|9371183|P1|Cycle 1 (1 Month)|Lost to Follow-up|1
2725399|NCT00213135|9371210|P3|Overall Study|Other|15
2725400|NCT00213135|9371211|P2|Overall Study|Other|12
2725401|NCT00213135|9371212|P1|Overall Study|Other|21
2725402|NCT00213135|9371210|P3|Overall Study|Disease progression|21
2725403|NCT00213135|9371211|P2|Overall Study|Disease progression|5
2725404|NCT00213135|9371212|P1|Overall Study|Disease progression|4
2725405|NCT00213135|9371210|P3|Overall Study|Death|2
2725406|NCT00213135|9371211|P2|Overall Study|Death|1
2725407|NCT00213135|9371212|P1|Overall Study|Death|1
2725408|NCT00213135|9371210|P3|Overall Study|Protocol Violation|10
2725409|NCT00213135|9371211|P2|Overall Study|Protocol Violation|4
2725410|NCT00213135|9371212|P1|Overall Study|Protocol Violation|4
2725411|NCT00213135|9371210|P3|Overall Study|Lost to Follow-up|4
2725412|NCT00213135|9371211|P2|Overall Study|Lost to Follow-up|8
2725413|NCT00213135|9371212|P1|Overall Study|Lost to Follow-up|11
2725414|NCT00213135|9371210|P3|Overall Study|Adverse Event|5
2725415|NCT00213135|9371211|P2|Overall Study|Adverse Event|5
2725416|NCT00213135|9371212|P1|Overall Study|Adverse Event|9
2725417|NCT00212758|9371255|P2|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
2725418|NCT00212758|9371256|P1|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
2725419|NCT00212758|9371255|P2|Standard Therapy of GH (12 Months)|Adverse Event|0
2725420|NCT00212758|9371256|P1|Standard Therapy of GH (12 Months)|Adverse Event|1
2725421|NCT00212355|9371272|P1|Overall Study|A change of address|1
2725422|NCT00212355|9371272|P1|Overall Study|Withdrawal by Subject|1
2725423|NCT00212355|9371272|P1|Overall Study|Adverse Event|1
2725424|NCT00212134|9371293|P2|Phase 3 (Age 10 Years)|On Going|21
2725425|NCT00212134|9371294|P1|Phase 3 (Age 10 Years)|On Going|21
2725426|NCT00211887|9371315|P3|Overall Study|Side effects|5
2725427|NCT00211887|9371316|P2|Overall Study|Side effects|13
2725428|NCT00211887|9371317|P1|Overall Study|Side effects|19
2725429|NCT00211887|9371315|P3|Overall Study|Other medical reason|7
2725430|NCT00211887|9371316|P2|Overall Study|Other medical reason|11
2725431|NCT00211887|9371317|P1|Overall Study|Other medical reason|15
2725432|NCT00211887|9371315|P3|Overall Study|Non-medical reason|8
2725433|NCT00211887|9371316|P2|Overall Study|Non-medical reason|14
2725434|NCT00211887|9371317|P1|Overall Study|Non-medical reason|31
2725435|NCT00211887|9371315|P3|Overall Study|Lost to Follow-up|9
2725436|NCT00211887|9371316|P2|Overall Study|Lost to Follow-up|13
2725437|NCT00211887|9371317|P1|Overall Study|Lost to Follow-up|28
2725438|NCT00211887|9371315|P3|Overall Study|Death|1
2725439|NCT00211887|9371316|P2|Overall Study|Death|1
2725440|NCT00211887|9371317|P1|Overall Study|Death|1
2725441|NCT00211887|9371315|P3|Overall Study|Adverse Event|6
2725442|NCT00211887|9371316|P2|Overall Study|Adverse Event|4
2725443|NCT00211887|9371317|P1|Overall Study|Adverse Event|8
2725444|NCT00211809|9371334|P1|Overall Study|side effects|2
2725445|NCT00211809|9371334|P1|Overall Study|Pregnancy|1
2725446|NCT00211809|9371334|P1|Overall Study|Lost to Follow-up|2
2725447|NCT00211809|9371334|P1|Overall Study|Lack of Efficacy|1
2725448|NCT00211757|9371350|P2|Overall Study|Lack of Efficacy|1
2725449|NCT00211757|9371351|P1|Overall Study|Lack of Efficacy|0
2725450|NCT00211757|9371350|P2|Overall Study|Withdrawal by Subject|1
2725451|NCT00211757|9371351|P1|Overall Study|Withdrawal by Subject|1
2725452|NCT00211536|9371372|P2|Overall Study|Adverse Event|0
2725453|NCT00211536|9371373|P1|Overall Study|Adverse Event|2
2725454|NCT00211536|9371372|P2|Overall Study|Physician Decision|5
2725455|NCT00211536|9371373|P1|Overall Study|Physician Decision|0
2725456|NCT00211536|9371372|P2|Overall Study|Withdrawal by Subject|2
2725457|NCT00211536|9371373|P1|Overall Study|Withdrawal by Subject|2
2725458|NCT00211510|9371389|P2|Overall Study|Withdrawal by Subject|1
2725459|NCT00211510|9371390|P1|Overall Study|Withdrawal by Subject|3
2725460|NCT00211510|9371389|P2|Overall Study|Physician Decision|1
2725461|NCT00211510|9371390|P1|Overall Study|Physician Decision|3
2725462|NCT00211237|9371408|P3|12 Months|unrelated medical problem|1
2725463|NCT00211237|9371409|P2|12 Months|unrelated medical problem|0
2725464|NCT00211237|9371410|P1|12 Months|unrelated medical problem|0
2725465|NCT00211237|9371408|P3|12 Months|Withdrew|1
2725466|NCT00211237|9371409|P2|12 Months|Withdrew|0
2725467|NCT00211237|9371410|P1|12 Months|Withdrew|0
2725468|NCT00211237|9371408|P3|12 Months|Lost to Follow-up|1
2725469|NCT00211237|9371409|P2|12 Months|Lost to Follow-up|0
2725470|NCT00211237|9371410|P1|12 Months|Lost to Follow-up|1
2725471|NCT00211237|9371408|P3|12 Months|Death|3
2725472|NCT00211237|9371409|P2|12 Months|Death|2
2725473|NCT00211237|9371410|P1|12 Months|Death|8
2725474|NCT00211237|9371408|P3|6 Months|Could not comply with protocol|0
2725475|NCT00211237|9371409|P2|6 Months|Could not comply with protocol|2
2725476|NCT00211237|9371410|P1|6 Months|Could not comply with protocol|0
2725477|NCT00211237|9371408|P3|6 Months|Lost to Follow-up|0
2725478|NCT00211237|9371409|P2|6 Months|Lost to Follow-up|0
2725479|NCT00211237|9371410|P1|6 Months|Lost to Follow-up|2
2725480|NCT00211237|9371408|P3|6 Months|Death|3
2725481|NCT00211237|9371409|P2|6 Months|Death|0
2725482|NCT00211237|9371410|P1|6 Months|Death|6
2725483|NCT00211237|9371408|P3|3 Months|Non-medical problem|1
2725484|NCT00211237|9371409|P2|3 Months|Non-medical problem|0
2725485|NCT00211237|9371410|P1|3 Months|Non-medical problem|0
2725486|NCT00211237|9371408|P3|3 Months|Withdrew|0
2725487|NCT00211237|9371409|P2|3 Months|Withdrew|1
2725488|NCT00211237|9371410|P1|3 Months|Withdrew|0
2725489|NCT00211237|9371408|P3|3 Months|Could not comply with protocol|0
2725490|NCT00211237|9371409|P2|3 Months|Could not comply with protocol|0
2725491|NCT00211237|9371410|P1|3 Months|Could not comply with protocol|1
2725492|NCT00211237|9371408|P3|3 Months|Death|0
2725493|NCT00211237|9371409|P2|3 Months|Death|3
2725494|NCT00211237|9371410|P1|3 Months|Death|7
2725495|NCT00211237|9371408|P3|1 Month|Non-medical problem|0
2725496|NCT00211237|9371409|P2|1 Month|Non-medical problem|2
2725497|NCT00211237|9371410|P1|1 Month|Non-medical problem|0
2725498|NCT00211237|9371408|P3|1 Month|Additional surgery needed|0
2725499|NCT00211237|9371409|P2|1 Month|Additional surgery needed|0
2725500|NCT00211237|9371410|P1|1 Month|Additional surgery needed|1
2725501|NCT00211237|9371408|P3|1 Month|Withdrew|0
2725502|NCT00211237|9371409|P2|1 Month|Withdrew|4
2725503|NCT00211237|9371410|P1|1 Month|Withdrew|0
2725504|NCT00211237|9371408|P3|1 Month|Lost to Follow-up|0
2725505|NCT00211237|9371409|P2|1 Month|Lost to Follow-up|2
2725506|NCT00211237|9371410|P1|1 Month|Lost to Follow-up|0
2725507|NCT00211237|9371408|P3|1 Month|Death|0
2725508|NCT00211237|9371409|P2|1 Month|Death|1
2725509|NCT00211237|9371410|P1|1 Month|Death|2
2725510|NCT00211237|9371408|P3|Baseline|Refused random assignment|0
2725511|NCT00211237|9371409|P2|Baseline|Refused random assignment|0
2725512|NCT00211237|9371410|P1|Baseline|Refused random assignment|1
2725513|NCT00211237|9371408|P3|Baseline|Withdrew|0
2725514|NCT00211237|9371409|P2|Baseline|Withdrew|3
2725515|NCT00211237|9371410|P1|Baseline|Withdrew|1
2725516|NCT00211185|9371500|P1|Overall Study|Physician Decision|5
2725517|NCT00211185|9371500|P1|Overall Study|Withdrawal by Subject|6
2725518|NCT00211185|9371500|P1|Overall Study|Disease progression|7
2725519|NCT00211185|9371500|P1|Overall Study|Death|2
2725520|NCT00211172|9371514|P2|Overall Study|Died or lost health plan eligibility|32
2725521|NCT00211172|9371515|P1|Overall Study|Died or lost health plan eligibility|39
2725522|NCT00211081|9371521|P1|Overall Study|Withdrawal by Subject|2
2725523|NCT00210639|9371533|P2|Overall Study|Other|12
2725524|NCT00210639|9371534|P1|Overall Study|Other|18
2725525|NCT00210639|9371533|P2|Overall Study|Withdrawal by Subject|1
2725526|NCT00210639|9371534|P1|Overall Study|Withdrawal by Subject|8
2725527|NCT00210639|9371533|P2|Overall Study|Lost to Follow-up|29
2725528|NCT00210639|9371534|P1|Overall Study|Lost to Follow-up|37
2725529|NCT00210626|9371542|P2|Overall Study|Other|5
2725530|NCT00210626|9371543|P1|Overall Study|Other|4
2725531|NCT00210626|9371542|P2|Overall Study|Sponser Request|0
2725532|NCT00210626|9371543|P1|Overall Study|Sponser Request|1
2725533|NCT00210626|9371542|P2|Overall Study|Physician Decision|2
2725534|NCT00210626|9371543|P1|Overall Study|Physician Decision|0
2725535|NCT00210626|9371542|P2|Overall Study|Withdrawal by Subject|20
2725536|NCT00210626|9371543|P1|Overall Study|Withdrawal by Subject|29
2725537|NCT00210626|9371542|P2|Overall Study|Death|0
2725538|NCT00210626|9371543|P1|Overall Study|Death|1
2725539|NCT00210626|9371542|P2|Overall Study|Lost to Follow-up|11
2725540|NCT00210626|9371543|P1|Overall Study|Lost to Follow-up|11
2725541|NCT00210626|9371542|P2|Overall Study|Protocol Violation|5
2725542|NCT00210626|9371543|P1|Overall Study|Protocol Violation|1
2725543|NCT00210626|9371542|P2|Overall Study|Adverse Event|2
2725544|NCT00210626|9371543|P1|Overall Study|Adverse Event|1
2725545|NCT00210470|9371551|P1|Overall Study|Subject did not continue to surgery|1
2725546|NCT00209560|9371582|P2|Overall Study|Lack of Efficacy|0
2725547|NCT00209560|9371583|P1|Overall Study|Lack of Efficacy|1
2725548|NCT00209339|9371602|P1|At 5 Years Follow-up|Death|1
2725549|NCT00209339|9371602|P1|At 5 Years Follow-up|Withdrawal because of other reasons|5
2725550|NCT00209339|9371602|P1|At 5 Years Follow-up|Withdrawal by Subject|2
2725551|NCT00209339|9371602|P1|At 4 Years Follow-up|Death|1
2725552|NCT00209339|9371602|P1|At 4 Years Follow-up|Withdrawal by Subject|4
2725553|NCT00209339|9371602|P1|At 3 Years Follow-up|Withdrawal by Subject|1
2725554|NCT00209339|9371602|P1|At 24 Months Follow-up|Death|1
2725555|NCT00209339|9371602|P1|At 24 Months Follow-up|Withdrawal because of other reasons|6
2725556|NCT00209339|9371602|P1|At 24 Months Follow-up|Withdrawal by Subject|4
2725557|NCT00209339|9371602|P1|At 12 Months Follow-up|No MitraClip Device Implanted|6
2725558|NCT00209339|9371602|P1|At 12 Months Follow-up|Death|1
2725559|NCT00209339|9371602|P1|At 12 Months Follow-up|Withdrawal by Subject|8
2725560|NCT00209274|9371686|P2|Overall Study|Randomized not treated (RNT)|15
2725561|NCT00209274|9371687|P1|Overall Study|Randomized not treated (RNT)|6
2725562|NCT00209274|9371686|P2|Overall Study|Withdrawal by Subject|15
2725563|NCT00209274|9371687|P1|Overall Study|Withdrawal by Subject|30
2725564|NCT00209274|9371686|P2|Overall Study|Death|15
2725565|NCT00209274|9371687|P1|Overall Study|Death|32
2725566|NCT00209274|9371686|P2|Overall Study|Missed visit|2
2725567|NCT00209274|9371687|P1|Overall Study|Missed visit|3
2725568|NCT00209170|9372007|P2|Overall Study|Lack of Efficacy|1
2725569|NCT00209170|9372008|P1|Overall Study|Lack of Efficacy|0
2725570|NCT00209170|9372007|P2|Overall Study|Withdrawal by Subject|1
2725571|NCT00209170|9372008|P1|Overall Study|Withdrawal by Subject|2
2725572|NCT00209170|9372007|P2|Overall Study|Adverse Event|1
2725573|NCT00209170|9372008|P1|Overall Study|Adverse Event|0
2725574|NCT00209131|9372016|P2|Overall Study|Lack of personnel due to turnovers.|11
2725575|NCT00209131|9372017|P1|Overall Study|Lack of personnel due to turnovers.|15
2725576|NCT00209092|9372027|P2|Overall Study|Withdrawal by Subject|0
2725577|NCT00209092|9372028|P1|Overall Study|Withdrawal by Subject|1
2725578|NCT00209092|9372027|P2|Overall Study|Adverse Event|1
2725579|NCT00209092|9372028|P1|Overall Study|Adverse Event|0
2725580|NCT00209092|9372027|P2|Overall Study|Progression of disease|1
2725581|NCT00209092|9372028|P1|Overall Study|Progression of disease|7
2725582|NCT00209027|9372038|P2|Overall Study|study terminated|0
2725583|NCT00209027|9372039|P1|Overall Study|study terminated|10
2725584|NCT00208767|9372063|P2|Overall Study|Lost to Follow-up|3
2725585|NCT00208767|9372064|P1|Overall Study|Lost to Follow-up|3
2725586|NCT00208767|9372063|P2|Overall Study|Death|0
2725587|NCT00208767|9372064|P1|Overall Study|Death|1
2725588|NCT00208767|9372063|P2|Overall Study|Withdrawal by Subject|3
2725589|NCT00208767|9372064|P1|Overall Study|Withdrawal by Subject|14
2725590|NCT00208767|9372063|P2|Overall Study|Adverse Event|1
2725591|NCT00208767|9372064|P1|Overall Study|Adverse Event|9
2725592|NCT00208325|9372092|P4|Overall Study|Mis-Randomized|0
2725593|NCT00208325|9372093|P3|Overall Study|Mis-Randomized|0
2725594|NCT00208325|9372094|P2|Overall Study|Mis-Randomized|20
2725595|NCT00208325|9372095|P1|Overall Study|Mis-Randomized|17
2725596|NCT00208325|9372092|P4|Overall Study|Other|0
2725597|NCT00208325|9372093|P3|Overall Study|Other|1
2725598|NCT00208325|9372094|P2|Overall Study|Other|1
2725599|NCT00208325|9372095|P1|Overall Study|Other|2
2725600|NCT00208325|9372092|P4|Overall Study|Does not wish to Continue in Study|2
2725601|NCT00208325|9372093|P3|Overall Study|Does not wish to Continue in Study|3
2725602|NCT00208325|9372094|P2|Overall Study|Does not wish to Continue in Study|8
2725603|NCT00208325|9372095|P1|Overall Study|Does not wish to Continue in Study|5
2725604|NCT00208325|9372092|P4|Overall Study|Unsurfaced to Resurfaced Patella|3
2725605|NCT00208325|9372093|P3|Overall Study|Unsurfaced to Resurfaced Patella|1
2725606|NCT00208325|9372094|P2|Overall Study|Unsurfaced to Resurfaced Patella|4
2725607|NCT00208325|9372095|P1|Overall Study|Unsurfaced to Resurfaced Patella|4
2725608|NCT00208325|9372092|P4|Overall Study|Lost to Follow-up|0
2725609|NCT00208325|9372093|P3|Overall Study|Lost to Follow-up|2
2725610|NCT00208325|9372094|P2|Overall Study|Lost to Follow-up|0
2725611|NCT00208325|9372095|P1|Overall Study|Lost to Follow-up|1
2725612|NCT00208325|9372092|P4|Overall Study|Revision|4
2725613|NCT00208325|9372093|P3|Overall Study|Revision|0
2725614|NCT00208325|9372094|P2|Overall Study|Revision|1
2725615|NCT00208325|9372095|P1|Overall Study|Revision|4
2725616|NCT00208325|9372092|P4|Overall Study|Withdrawal by Subject|0
2725617|NCT00208325|9372093|P3|Overall Study|Withdrawal by Subject|0
2725618|NCT00208325|9372094|P2|Overall Study|Withdrawal by Subject|1
2725619|NCT00208325|9372095|P1|Overall Study|Withdrawal by Subject|0
2725620|NCT00208325|9372092|P4|Overall Study|Death|5
2725621|NCT00208325|9372093|P3|Overall Study|Death|7
2725622|NCT00208325|9372094|P2|Overall Study|Death|19
2725623|NCT00208325|9372095|P1|Overall Study|Death|18
2725624|NCT00207740|9372232|P4|Overall Study|Other|5
2725625|NCT00207740|9372233|P3|Overall Study|Other|7
2725626|NCT00207740|9372234|P2|Overall Study|Other|10
2725627|NCT00207740|9372235|P1|Overall Study|Other|2
2725628|NCT00207740|9372232|P4|Overall Study|Sponsor Directive|21
2725629|NCT00207740|9372233|P3|Overall Study|Sponsor Directive|16
2725630|NCT00207740|9372234|P2|Overall Study|Sponsor Directive|15
2725631|NCT00207740|9372235|P1|Overall Study|Sponsor Directive|22
2725632|NCT00207740|9372232|P4|Overall Study|Death|1
2725633|NCT00207740|9372233|P3|Overall Study|Death|0
2725634|NCT00207740|9372234|P2|Overall Study|Death|0
2725635|NCT00207740|9372235|P1|Overall Study|Death|0
2725636|NCT00207740|9372232|P4|Overall Study|Lost to Follow-up|1
2725637|NCT00207740|9372233|P3|Overall Study|Lost to Follow-up|1
2725638|NCT00207740|9372234|P2|Overall Study|Lost to Follow-up|2
2725639|NCT00207740|9372235|P1|Overall Study|Lost to Follow-up|0
2725640|NCT00207740|9372232|P4|Overall Study|Unsatisfactory therapeutic effect|4
2725641|NCT00207740|9372233|P3|Overall Study|Unsatisfactory therapeutic effect|2
2725642|NCT00207740|9372234|P2|Overall Study|Unsatisfactory therapeutic effect|0
2725643|NCT00207740|9372235|P1|Overall Study|Unsatisfactory therapeutic effect|1
2725644|NCT00207740|9372232|P4|Overall Study|Adverse Event|11
2725645|NCT00207740|9372233|P3|Overall Study|Adverse Event|14
2725646|NCT00207740|9372234|P2|Overall Study|Adverse Event|14
2725647|NCT00207740|9372235|P1|Overall Study|Adverse Event|4
2725648|NCT00207727|9372281|P5|Overall Study|Other|33
2725649|NCT00207727|9372282|P4|Overall Study|Other|37
2725650|NCT00207727|9372283|P3|Overall Study|Other|41
2725651|NCT00207727|9372284|P2|Overall Study|Other|41
2725652|NCT00207727|9372285|P1|Overall Study|Other|38
2725653|NCT00207727|9372281|P5|Overall Study|Lost to Follow-up|0
2725654|NCT00207727|9372282|P4|Overall Study|Lost to Follow-up|0
2725655|NCT00207727|9372283|P3|Overall Study|Lost to Follow-up|0
2725656|NCT00207727|9372284|P2|Overall Study|Lost to Follow-up|1
2725657|NCT00207727|9372285|P1|Overall Study|Lost to Follow-up|0
2725658|NCT00207727|9372281|P5|Overall Study|Withdrawal by Subject|1
2725659|NCT00207727|9372282|P4|Overall Study|Withdrawal by Subject|0
2725660|NCT00207727|9372283|P3|Overall Study|Withdrawal by Subject|0
2725661|NCT00207727|9372284|P2|Overall Study|Withdrawal by Subject|0
2725662|NCT00207727|9372285|P1|Overall Study|Withdrawal by Subject|0
2725663|NCT00207714|9372312|P5|Overall Study|Other|0
2725664|NCT00207714|9372313|P4|Overall Study|Other|1
2725665|NCT00207714|9372314|P3|Overall Study|Other|5
2725666|NCT00207714|9372315|P2|Overall Study|Other|2
2725667|NCT00207714|9372316|P1|Overall Study|Other|3
2725668|NCT00207714|9372312|P5|Overall Study|Unsatisfactory therapeutic effect|4
2725669|NCT00207714|9372313|P4|Overall Study|Unsatisfactory therapeutic effect|4
2725670|NCT00207714|9372314|P3|Overall Study|Unsatisfactory therapeutic effect|1
2725671|NCT00207714|9372315|P2|Overall Study|Unsatisfactory therapeutic effect|3
2725672|NCT00207714|9372316|P1|Overall Study|Unsatisfactory therapeutic effect|5
2725673|NCT00207714|9372312|P5|Overall Study|Adverse Event|1
2725674|NCT00207714|9372313|P4|Overall Study|Adverse Event|3
2725675|NCT00207714|9372314|P3|Overall Study|Adverse Event|4
2725676|NCT00207714|9372315|P2|Overall Study|Adverse Event|2
2725677|NCT00207714|9372316|P1|Overall Study|Adverse Event|6
2725678|NCT00207142|9372338|P4|Maintenance Phase/Rescue Phase|Lack of Efficacy|1
2725679|NCT00207142|9372339|P3|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
2725680|NCT00207142|9372340|P2|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
2725681|NCT00207142|9372341|P1|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
2725682|NCT00207142|9372338|P4|Maintenance Phase/Rescue Phase|Death|1
2725683|NCT00207142|9372339|P3|Maintenance Phase/Rescue Phase|Death|0
2725684|NCT00207142|9372340|P2|Maintenance Phase/Rescue Phase|Death|0
2725685|NCT00207142|9372341|P1|Maintenance Phase/Rescue Phase|Death|0
2725686|NCT00207142|9372338|P4|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1
2725687|NCT00207142|9372339|P3|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
2725688|NCT00207142|9372340|P2|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
2725689|NCT00207142|9372341|P1|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0
2725690|NCT00207142|9372338|P4|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
2725691|NCT00207142|9372339|P3|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1
2725692|NCT00207142|9372340|P2|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
2725693|NCT00207142|9372341|P1|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
2725694|NCT00207142|9372338|P4|Maintenance Phase/Rescue Phase|Pregnancy|0
2725695|NCT00207142|9372339|P3|Maintenance Phase/Rescue Phase|Pregnancy|2
2725696|NCT00207142|9372340|P2|Maintenance Phase/Rescue Phase|Pregnancy|2
2725697|NCT00207142|9372341|P1|Maintenance Phase/Rescue Phase|Pregnancy|0
2725698|NCT00207142|9372338|P4|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
2725699|NCT00207142|9372339|P3|Maintenance Phase/Rescue Phase|Poor/noncompliance|2
2725700|NCT00207142|9372340|P2|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
2725701|NCT00207142|9372341|P1|Maintenance Phase/Rescue Phase|Poor/noncompliance|0
2725702|NCT00207142|9372338|P4|Maintenance Phase/Rescue Phase|RTV intake impossible|0
2725703|NCT00207142|9372339|P3|Maintenance Phase/Rescue Phase|RTV intake impossible|1
2725704|NCT00207142|9372340|P2|Maintenance Phase/Rescue Phase|RTV intake impossible|0
2725705|NCT00207142|9372341|P1|Maintenance Phase/Rescue Phase|RTV intake impossible|0
2725706|NCT00207142|9372338|P4|Maintenance Phase/Rescue Phase|Lost to Follow-up|2
2725707|NCT00207142|9372339|P3|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
2725708|NCT00207142|9372340|P2|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
2725709|NCT00207142|9372341|P1|Maintenance Phase/Rescue Phase|Lost to Follow-up|0
2725710|NCT00207142|9372338|P4|Maintenance Phase/Rescue Phase|Adverse Event|1
2725711|NCT00207142|9372339|P3|Maintenance Phase/Rescue Phase|Adverse Event|4
2725712|NCT00207142|9372340|P2|Maintenance Phase/Rescue Phase|Adverse Event|1
2725713|NCT00207142|9372341|P1|Maintenance Phase/Rescue Phase|Adverse Event|0
2725714|NCT00207142|9372338|P4|Induction Phase|Missing lab data|0
2725715|NCT00207142|9372339|P3|Induction Phase|Missing lab data|0
2725716|NCT00207142|9372340|P2|Induction Phase|Missing lab data|0
2725717|NCT00207142|9372341|P1|Induction Phase|Missing lab data|1
2725718|NCT00207142|9372338|P4|Induction Phase|Incarceration|0
2725719|NCT00207142|9372339|P3|Induction Phase|Incarceration|0
2725720|NCT00207142|9372340|P2|Induction Phase|Incarceration|0
2725721|NCT00207142|9372341|P1|Induction Phase|Incarceration|1
2725722|NCT00207142|9372338|P4|Induction Phase|Withdrawal by Subject|0
2725723|NCT00207142|9372339|P3|Induction Phase|Withdrawal by Subject|0
2725724|NCT00207142|9372340|P2|Induction Phase|Withdrawal by Subject|0
2725725|NCT00207142|9372341|P1|Induction Phase|Withdrawal by Subject|4
2725726|NCT00207142|9372338|P4|Induction Phase|Subject no longer meets study criteria|0
2725727|NCT00207142|9372339|P3|Induction Phase|Subject no longer meets study criteria|0
2725728|NCT00207142|9372340|P2|Induction Phase|Subject no longer meets study criteria|0
2725729|NCT00207142|9372341|P1|Induction Phase|Subject no longer meets study criteria|3
2725730|NCT00207142|9372338|P4|Induction Phase|Pregnancy|0
2725731|NCT00207142|9372339|P3|Induction Phase|Pregnancy|0
2725732|NCT00207142|9372340|P2|Induction Phase|Pregnancy|0
2725733|NCT00207142|9372341|P1|Induction Phase|Pregnancy|1
2725734|NCT00207142|9372338|P4|Induction Phase|Poor/noncompliance|0
2725735|NCT00207142|9372339|P3|Induction Phase|Poor/noncompliance|0
2725736|NCT00207142|9372340|P2|Induction Phase|Poor/noncompliance|0
2725737|NCT00207142|9372341|P1|Induction Phase|Poor/noncompliance|2
2725738|NCT00207142|9372338|P4|Induction Phase|Physician Decision|0
2725739|NCT00207142|9372339|P3|Induction Phase|Physician Decision|0
2725740|NCT00207142|9372340|P2|Induction Phase|Physician Decision|0
2725741|NCT00207142|9372341|P1|Induction Phase|Physician Decision|2
2725742|NCT00207142|9372338|P4|Induction Phase|Lost to Follow-up|0
2725743|NCT00207142|9372339|P3|Induction Phase|Lost to Follow-up|0
2725744|NCT00207142|9372340|P2|Induction Phase|Lost to Follow-up|0
2725745|NCT00207142|9372341|P1|Induction Phase|Lost to Follow-up|5
2725746|NCT00207142|9372338|P4|Induction Phase|Lack of Efficacy|0
2725747|NCT00207142|9372339|P3|Induction Phase|Lack of Efficacy|0
2725748|NCT00207142|9372340|P2|Induction Phase|Lack of Efficacy|0
2725749|NCT00207142|9372341|P1|Induction Phase|Lack of Efficacy|1
2725750|NCT00207142|9372338|P4|Induction Phase|Death|0
2725751|NCT00207142|9372339|P3|Induction Phase|Death|0
2725752|NCT00207142|9372340|P2|Induction Phase|Death|0
2725753|NCT00207142|9372341|P1|Induction Phase|Death|1
2725754|NCT00207142|9372338|P4|Induction Phase|Adverse Event|0
2725755|NCT00207142|9372339|P3|Induction Phase|Adverse Event|0
2725756|NCT00207142|9372340|P2|Induction Phase|Adverse Event|0
2725757|NCT00207142|9372341|P1|Induction Phase|Adverse Event|9
2725758|NCT00207090|9372378|P1|Overall Study|Physician Decision|1
2725759|NCT00207090|9372378|P1|Overall Study|Disease progression/relapse|2
2725760|NCT00207090|9372378|P1|Overall Study|Chest wall mass larger|1
2725761|NCT00207090|9372378|P1|Overall Study|Study drug toxicity|3
2725762|NCT00206726|9372407|P1|Overall Study|Withdrawal by Subject|8
2725763|NCT00206726|9372407|P1|Overall Study|Protocol Violation|1
2725764|NCT00206726|9372407|P1|Overall Study|Death|4
2725765|NCT00206726|9372407|P1|Overall Study|Adverse Event|17
2725766|NCT00206726|9372407|P1|Overall Study|Bone marrow transplant|1
2725767|NCT00206726|9372407|P1|Overall Study|Placed on new protocol|1
2725768|NCT00206726|9372407|P1|Overall Study|Progressive disease or relapsed disease|18
2725769|NCT00206726|9372407|P1|Overall Study|Delayed recovery of blood counts|1
2725770|NCT00206518|9372418|P2|Overall Study|Protocol Violation|1
2725771|NCT00206518|9372419|P1|Overall Study|Protocol Violation|1
2725772|NCT00206518|9372418|P2|Overall Study|Physician Decision|0
2725773|NCT00206518|9372419|P1|Overall Study|Physician Decision|1
2725774|NCT00206518|9372418|P2|Overall Study|Adverse Event|1
2725775|NCT00206518|9372419|P1|Overall Study|Adverse Event|2
2725776|NCT00206518|9372418|P2|Overall Study|Lack of Efficacy|4
2725777|NCT00206518|9372419|P1|Overall Study|Lack of Efficacy|6
2725778|NCT00206440|9372431|P2|Overall Study|Adverse Event|2
2725779|NCT00206440|9372432|P1|Overall Study|Adverse Event|4
2725780|NCT00206440|9372431|P2|Overall Study|Protocol Violation|2
2725781|NCT00206440|9372432|P1|Overall Study|Protocol Violation|1
2725782|NCT00206427|9372438|P1|Overall Study|Adverse Event|2
2725783|NCT00206323|9372448|P2|Overall Study|Lost to Follow-up|1
2725784|NCT00206323|9372449|P1|Overall Study|Lost to Follow-up|1
2725785|NCT00206323|9372448|P2|Overall Study|Adverse Event|1
2725786|NCT00206323|9372449|P1|Overall Study|Adverse Event|1
2725787|NCT00206323|9372448|P2|Overall Study|Lack of Efficacy|1
2725788|NCT00206323|9372449|P1|Overall Study|Lack of Efficacy|4
2725789|NCT00206102|9372457|P2|Overall Study|None of those categories|36
2725790|NCT00206102|9372458|P1|Overall Study|None of those categories|42
2725791|NCT00206102|9372457|P2|Overall Study|Study-specific discontinuation criteria|17
2725792|NCT00206102|9372458|P1|Overall Study|Study-specific discontinuation criteria|18
2725793|NCT00206102|9372457|P2|Overall Study|Withdrawal by Subject|101
2725794|NCT00206102|9372458|P1|Overall Study|Withdrawal by Subject|118
2725795|NCT00206102|9372457|P2|Overall Study|Lost to Follow-up|66
2725796|NCT00206102|9372458|P1|Overall Study|Lost to Follow-up|95
2725797|NCT00206102|9372457|P2|Overall Study|Lack of therapeutic response|11
2725798|NCT00206102|9372458|P1|Overall Study|Lack of therapeutic response|16
2725799|NCT00206102|9372457|P2|Overall Study|Protocol Violation|2
2725800|NCT00206102|9372458|P1|Overall Study|Protocol Violation|0
2725801|NCT00206102|9372457|P2|Overall Study|Adverse Event|82
2725802|NCT00206102|9372458|P1|Overall Study|Adverse Event|119
2725803|NCT00206076|9372494|P2|Overall Study|Withdrawal by Subject|1
2725804|NCT00206076|9372495|P1|Overall Study|Withdrawal by Subject|1
2725805|NCT00206076|9372494|P2|Overall Study|Physician Decision|0
2725806|NCT00206076|9372495|P1|Overall Study|Physician Decision|2
2725807|NCT00205881|9372505|P1|Overall Study|Withdrawal by Subject|16
2725808|NCT00205855|9372510|P1|Overall Study|Withdrawal by Subject|5
2725809|NCT00205855|9372510|P1|Overall Study|Only received temporary implants|16
2725810|NCT00205803|9372516|P2|Toddler Dose|Lost to Follow-up|3
2725811|NCT00205803|9372517|P1|Toddler Dose|Lost to Follow-up|2
2725812|NCT00205803|9372516|P2|After Infant Series|Other|4
2725813|NCT00205803|9372517|P1|After Infant Series|Other|10
2725814|NCT00205803|9372516|P2|After Infant Series|Withdrawal by Subject|4
2725815|NCT00205803|9372517|P1|After Infant Series|Withdrawal by Subject|1
2725816|NCT00205803|9372516|P2|After Infant Series|Physician Decision|2
2725817|NCT00205803|9372517|P1|After Infant Series|Physician Decision|3
2725818|NCT00205803|9372516|P2|After Infant Series|Lost to Follow-up|1
2725819|NCT00205803|9372517|P1|After Infant Series|Lost to Follow-up|2
2725820|NCT00205803|9372516|P2|After Infant Series|Protocol Violation|1
2725821|NCT00205803|9372517|P1|After Infant Series|Protocol Violation|1
2725822|NCT00205803|9372516|P2|After Infant Series|Adverse Event|1
2725823|NCT00205803|9372517|P1|After Infant Series|Adverse Event|1
2725824|NCT00205803|9372516|P2|Infant Series|Sponsor request|0
2725825|NCT00205803|9372517|P1|Infant Series|Sponsor request|1
2725826|NCT00205803|9372516|P2|Infant Series|Non-compliant|0
2725827|NCT00205803|9372517|P1|Infant Series|Non-compliant|1
2725828|NCT00205803|9372516|P2|Infant Series|Lost Kaiser coverage|1
2725829|NCT00205803|9372517|P1|Infant Series|Lost Kaiser coverage|0
2725830|NCT00205803|9372516|P2|Infant Series|Protocol Violation|0
2725831|NCT00205803|9372517|P1|Infant Series|Protocol Violation|1
2725832|NCT00205803|9372516|P2|Infant Series|Physician Decision|1
2725833|NCT00205803|9372517|P1|Infant Series|Physician Decision|3
2725834|NCT00205803|9372516|P2|Infant Series|Withdrawal by Subject|5
2725835|NCT00205803|9372517|P1|Infant Series|Withdrawal by Subject|2
2725836|NCT00205803|9372516|P2|Infant Series|Lost to Follow-up|4
2725837|NCT00205803|9372517|P1|Infant Series|Lost to Follow-up|10
2725838|NCT00205777|9372573|P6|Study Extension II|Enrolled but not treated|131
2725839|NCT00205777|9372574|P5|Study Extension II|Enrolled but not treated|0
2725840|NCT00205777|9372575|P4|Study Extension II|Enrolled but not treated|71
2725841|NCT00205777|9372576|P3|Study Extension II|Enrolled but not treated|0
2725842|NCT00205777|9372577|P2|Study Extension II|Enrolled but not treated|0
2725843|NCT00205777|9372578|P1|Study Extension II|Enrolled but not treated|0
2725844|NCT00205777|9372573|P6|Study Extension II|Other Event|20
2725845|NCT00205777|9372574|P5|Study Extension II|Other Event|0
2725846|NCT00205777|9372575|P4|Study Extension II|Other Event|12
2725847|NCT00205777|9372576|P3|Study Extension II|Other Event|0
2725848|NCT00205777|9372577|P2|Study Extension II|Other Event|0
2725849|NCT00205777|9372578|P1|Study Extension II|Other Event|0
2725850|NCT00205777|9372573|P6|Study Extension II|Failed to return|26
2725851|NCT00205777|9372574|P5|Study Extension II|Failed to return|0
2725852|NCT00205777|9372575|P4|Study Extension II|Failed to return|14
2725853|NCT00205777|9372576|P3|Study Extension II|Failed to return|0
2725854|NCT00205777|9372577|P2|Study Extension II|Failed to return|0
2725855|NCT00205777|9372578|P1|Study Extension II|Failed to return|0
2725856|NCT00205777|9372573|P6|Study Extension II|Lack of Efficacy|1
2725857|NCT00205777|9372574|P5|Study Extension II|Lack of Efficacy|0
2725858|NCT00205777|9372575|P4|Study Extension II|Lack of Efficacy|0
2725859|NCT00205777|9372576|P3|Study Extension II|Lack of Efficacy|0
2725860|NCT00205777|9372577|P2|Study Extension II|Lack of Efficacy|0
2725861|NCT00205777|9372578|P1|Study Extension II|Lack of Efficacy|0
2725862|NCT00205777|9372573|P6|Study Extension II|Protocol Violation|10
2725863|NCT00205777|9372574|P5|Study Extension II|Protocol Violation|0
2725864|NCT00205777|9372575|P4|Study Extension II|Protocol Violation|1
2725865|NCT00205777|9372576|P3|Study Extension II|Protocol Violation|0
2725866|NCT00205777|9372577|P2|Study Extension II|Protocol Violation|0
2725867|NCT00205777|9372578|P1|Study Extension II|Protocol Violation|0
2725868|NCT00205777|9372573|P6|Study Extension II|Withdrawal by Subject|59
2725869|NCT00205777|9372574|P5|Study Extension II|Withdrawal by Subject|0
2725870|NCT00205777|9372575|P4|Study Extension II|Withdrawal by Subject|35
2725871|NCT00205777|9372576|P3|Study Extension II|Withdrawal by Subject|0
2725872|NCT00205777|9372577|P2|Study Extension II|Withdrawal by Subject|0
2725873|NCT00205777|9372578|P1|Study Extension II|Withdrawal by Subject|0
2725874|NCT00205777|9372573|P6|Study Extension II|Death|5
2725875|NCT00205777|9372574|P5|Study Extension II|Death|0
2725876|NCT00205777|9372575|P4|Study Extension II|Death|2
2725877|NCT00205777|9372576|P3|Study Extension II|Death|0
2725878|NCT00205777|9372577|P2|Study Extension II|Death|0
2725879|NCT00205777|9372578|P1|Study Extension II|Death|0
2725880|NCT00205777|9372573|P6|Study Extension II|Adverse Event|30
2725881|NCT00205777|9372574|P5|Study Extension II|Adverse Event|0
2725882|NCT00205777|9372575|P4|Study Extension II|Adverse Event|14
2725883|NCT00205777|9372576|P3|Study Extension II|Adverse Event|0
2725884|NCT00205777|9372577|P2|Study Extension II|Adverse Event|0
2725885|NCT00205777|9372578|P1|Study Extension II|Adverse Event|0
2725886|NCT00205777|9372573|P6|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
2725887|NCT00205777|9372574|P5|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258
2725888|NCT00205777|9372575|P4|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240
2725889|NCT00205777|9372576|P3|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
2725890|NCT00205777|9372577|P2|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
2725891|NCT00205777|9372578|P1|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273
2725892|NCT00205777|9372573|P6|Study Extension I|Withdrawn as per protocol|0
2725893|NCT00205777|9372574|P5|Study Extension I|Withdrawn as per protocol|0
2725894|NCT00205777|9372575|P4|Study Extension I|Withdrawn as per protocol|0
2725895|NCT00205777|9372576|P3|Study Extension I|Withdrawn as per protocol|1070
2725896|NCT00205777|9372577|P2|Study Extension I|Withdrawn as per protocol|0
2725897|NCT00205777|9372578|P1|Study Extension I|Withdrawn as per protocol|0
2725898|NCT00205777|9372573|P6|Study Extension I|Other Event|0
2725899|NCT00205777|9372574|P5|Study Extension I|Other Event|29
2725900|NCT00205777|9372575|P4|Study Extension I|Other Event|34
2725901|NCT00205777|9372576|P3|Study Extension I|Other Event|0
2725902|NCT00205777|9372577|P2|Study Extension I|Other Event|0
2725903|NCT00205777|9372578|P1|Study Extension I|Other Event|34
2725904|NCT00205777|9372573|P6|Study Extension I|Failed to return|0
2725905|NCT00205777|9372574|P5|Study Extension I|Failed to return|13
2725906|NCT00205777|9372575|P4|Study Extension I|Failed to return|17
2725907|NCT00205777|9372576|P3|Study Extension I|Failed to return|0
2725908|NCT00205777|9372577|P2|Study Extension I|Failed to return|0
2725909|NCT00205777|9372578|P1|Study Extension I|Failed to return|15
2725910|NCT00205777|9372573|P6|Study Extension I|Lack of Efficacy|0
2725911|NCT00205777|9372574|P5|Study Extension I|Lack of Efficacy|2
2725912|NCT00205777|9372575|P4|Study Extension I|Lack of Efficacy|1
2725913|NCT00205777|9372576|P3|Study Extension I|Lack of Efficacy|0
2725914|NCT00205777|9372577|P2|Study Extension I|Lack of Efficacy|0
2725915|NCT00205777|9372578|P1|Study Extension I|Lack of Efficacy|0
2725916|NCT00205777|9372573|P6|Study Extension I|Protocol Violation|0
2725917|NCT00205777|9372574|P5|Study Extension I|Protocol Violation|8
2725918|NCT00205777|9372575|P4|Study Extension I|Protocol Violation|8
2725919|NCT00205777|9372576|P3|Study Extension I|Protocol Violation|0
2725920|NCT00205777|9372577|P2|Study Extension I|Protocol Violation|0
2725921|NCT00205777|9372578|P1|Study Extension I|Protocol Violation|4
2725922|NCT00205777|9372573|P6|Study Extension I|Withdrawal by Subject|0
2725923|NCT00205777|9372574|P5|Study Extension I|Withdrawal by Subject|89
2725924|NCT00205777|9372575|P4|Study Extension I|Withdrawal by Subject|106
2725925|NCT00205777|9372576|P3|Study Extension I|Withdrawal by Subject|0
2725926|NCT00205777|9372577|P2|Study Extension I|Withdrawal by Subject|0
2725927|NCT00205777|9372578|P1|Study Extension I|Withdrawal by Subject|99
2725928|NCT00205777|9372573|P6|Study Extension I|Death|0
2725929|NCT00205777|9372574|P5|Study Extension I|Death|2
2725930|NCT00205777|9372575|P4|Study Extension I|Death|1
2725931|NCT00205777|9372576|P3|Study Extension I|Death|0
2725932|NCT00205777|9372577|P2|Study Extension I|Death|0
2725933|NCT00205777|9372578|P1|Study Extension I|Death|5
2725934|NCT00205777|9372573|P6|Study Extension I|Adverse Event|0
2725935|NCT00205777|9372574|P5|Study Extension I|Adverse Event|58
2725936|NCT00205777|9372575|P4|Study Extension I|Adverse Event|61
2725937|NCT00205777|9372576|P3|Study Extension I|Adverse Event|0
2725938|NCT00205777|9372577|P2|Study Extension I|Adverse Event|0
2725939|NCT00205777|9372578|P1|Study Extension I|Adverse Event|57
2725940|NCT00205777|9372573|P6|Completed Core Study, Entered SE I|Other Event|0
2725941|NCT00205777|9372574|P5|Completed Core Study, Entered SE I|Other Event|0
2725942|NCT00205777|9372575|P4|Completed Core Study, Entered SE I|Other Event|50
2725943|NCT00205777|9372576|P3|Completed Core Study, Entered SE I|Other Event|47
2725944|NCT00205777|9372577|P2|Completed Core Study, Entered SE I|Other Event|46
2725945|NCT00205777|9372578|P1|Completed Core Study, Entered SE I|Other Event|52
2725946|NCT00205777|9372573|P6|Completed Core Study, Entered SE I|Withdrawal by Subject|0
2725947|NCT00205777|9372574|P5|Completed Core Study, Entered SE I|Withdrawal by Subject|0
2725948|NCT00205777|9372575|P4|Completed Core Study, Entered SE I|Withdrawal by Subject|174
2725949|NCT00205777|9372576|P3|Completed Core Study, Entered SE I|Withdrawal by Subject|160
2725950|NCT00205777|9372577|P2|Completed Core Study, Entered SE I|Withdrawal by Subject|158
2725951|NCT00205777|9372578|P1|Completed Core Study, Entered SE I|Withdrawal by Subject|180
2725952|NCT00205777|9372573|P6|Core Study (Up to 3 Years)|Randomized but not treated|0
2725953|NCT00205777|9372574|P5|Core Study (Up to 3 Years)|Randomized but not treated|0
2725954|NCT00205777|9372575|P4|Core Study (Up to 3 Years)|Randomized but not treated|29
2725955|NCT00205777|9372576|P3|Core Study (Up to 3 Years)|Randomized but not treated|35
2725956|NCT00205777|9372577|P2|Core Study (Up to 3 Years)|Randomized but not treated|32
2725957|NCT00205777|9372578|P1|Core Study (Up to 3 Years)|Randomized but not treated|21
2725958|NCT00205777|9372573|P6|Core Study (Up to 3 Years)|Lack of Efficacy|0
2725959|NCT00205777|9372574|P5|Core Study (Up to 3 Years)|Lack of Efficacy|0
2725960|NCT00205777|9372575|P4|Core Study (Up to 3 Years)|Lack of Efficacy|75
2725961|NCT00205777|9372576|P3|Core Study (Up to 3 Years)|Lack of Efficacy|39
2725962|NCT00205777|9372577|P2|Core Study (Up to 3 Years)|Lack of Efficacy|52
2725963|NCT00205777|9372578|P1|Core Study (Up to 3 Years)|Lack of Efficacy|52
2725964|NCT00205777|9372573|P6|Core Study (Up to 3 Years)|Protocol Violation|0
2725965|NCT00205777|9372574|P5|Core Study (Up to 3 Years)|Protocol Violation|0
2725966|NCT00205777|9372575|P4|Core Study (Up to 3 Years)|Protocol Violation|42
2725967|NCT00205777|9372576|P3|Core Study (Up to 3 Years)|Protocol Violation|50
2725968|NCT00205777|9372577|P2|Core Study (Up to 3 Years)|Protocol Violation|55
2725969|NCT00205777|9372578|P1|Core Study (Up to 3 Years)|Protocol Violation|53
2725970|NCT00205777|9372573|P6|Core Study (Up to 3 Years)|Withdrawal by Subject|0
2725971|NCT00205777|9372574|P5|Core Study (Up to 3 Years)|Withdrawal by Subject|0
2725972|NCT00205777|9372575|P4|Core Study (Up to 3 Years)|Withdrawal by Subject|162
2725973|NCT00205777|9372576|P3|Core Study (Up to 3 Years)|Withdrawal by Subject|149
2725974|NCT00205777|9372577|P2|Core Study (Up to 3 Years)|Withdrawal by Subject|169
2725975|NCT00205777|9372578|P1|Core Study (Up to 3 Years)|Withdrawal by Subject|144
2725976|NCT00205777|9372573|P6|Core Study (Up to 3 Years)|Other Event|0
2725977|NCT00205777|9372574|P5|Core Study (Up to 3 Years)|Other Event|0
2725978|NCT00205777|9372575|P4|Core Study (Up to 3 Years)|Other Event|58
2725979|NCT00205777|9372576|P3|Core Study (Up to 3 Years)|Other Event|41
2725980|NCT00205777|9372577|P2|Core Study (Up to 3 Years)|Other Event|52
2725981|NCT00205777|9372578|P1|Core Study (Up to 3 Years)|Other Event|49
2725982|NCT00205777|9372573|P6|Core Study (Up to 3 Years)|Failed to return|0
2725983|NCT00205777|9372574|P5|Core Study (Up to 3 Years)|Failed to return|0
2725984|NCT00205777|9372575|P4|Core Study (Up to 3 Years)|Failed to return|27
2725985|NCT00205777|9372576|P3|Core Study (Up to 3 Years)|Failed to return|27
2725986|NCT00205777|9372577|P2|Core Study (Up to 3 Years)|Failed to return|25
2725987|NCT00205777|9372578|P1|Core Study (Up to 3 Years)|Failed to return|40
2725988|NCT00205777|9372573|P6|Core Study (Up to 3 Years)|Death|0
2725989|NCT00205777|9372574|P5|Core Study (Up to 3 Years)|Death|0
2725990|NCT00205777|9372575|P4|Core Study (Up to 3 Years)|Death|7
2725991|NCT00205777|9372576|P3|Core Study (Up to 3 Years)|Death|14
2725992|NCT00205777|9372577|P2|Core Study (Up to 3 Years)|Death|7
2725993|NCT00205777|9372578|P1|Core Study (Up to 3 Years)|Death|9
2725994|NCT00205777|9372573|P6|Core Study (Up to 3 Years)|Adverse Event|0
2725995|NCT00205777|9372574|P5|Core Study (Up to 3 Years)|Adverse Event|0
2725996|NCT00205777|9372575|P4|Core Study (Up to 3 Years)|Adverse Event|232
2725997|NCT00205777|9372576|P3|Core Study (Up to 3 Years)|Adverse Event|252
2725998|NCT00205777|9372577|P2|Core Study (Up to 3 Years)|Adverse Event|267
2725999|NCT00205777|9372578|P1|Core Study (Up to 3 Years)|Adverse Event|260
2726000|NCT00205712|9372787|P2|Overall Study|Lost to Follow-up|1
2726001|NCT00205712|9372788|P1|Overall Study|Lost to Follow-up|0
2726002|NCT00205699|9372801|P3|Overall Study|Lack of Efficacy|0
2726003|NCT00205699|9372802|P2|Overall Study|Lack of Efficacy|1
2726004|NCT00205699|9372803|P1|Overall Study|Lack of Efficacy|0
2726005|NCT00205699|9372801|P3|Overall Study|Withdrawal by Subject|1
2726006|NCT00205699|9372802|P2|Overall Study|Withdrawal by Subject|2
2726007|NCT00205699|9372803|P1|Overall Study|Withdrawal by Subject|1
2726008|NCT00205699|9372801|P3|Overall Study|Adverse Event|0
2726009|NCT00205699|9372802|P2|Overall Study|Adverse Event|0
2726010|NCT00205699|9372803|P1|Overall Study|Adverse Event|1
2726011|NCT00205699|9372801|P3|Overall Study|Lost to Follow-up|5
2726012|NCT00205699|9372802|P2|Overall Study|Lost to Follow-up|3
2726013|NCT00205699|9372803|P1|Overall Study|Lost to Follow-up|1
2726014|NCT00205179|9372883|P2|Overall Study|Adverse Event|1
2726015|NCT00205179|9372884|P1|Overall Study|Adverse Event|1
2726016|NCT00205179|9372883|P2|Overall Study|Physician Decision|1
2726017|NCT00205179|9372884|P1|Overall Study|Physician Decision|1
2726018|NCT00205179|9372883|P2|Overall Study|Death|2
2726019|NCT00205179|9372884|P1|Overall Study|Death|0
2726020|NCT00203996|9372975|P10|Overall Study|Scheduling issue|0
2726021|NCT00203996|9372976|P9|Overall Study|Scheduling issue|0
2726022|NCT00203996|9372977|P8|Overall Study|Scheduling issue|2
2726023|NCT00203996|9372978|P7|Overall Study|Scheduling issue|0
2726024|NCT00203996|9372979|P6|Overall Study|Scheduling issue|0
2726025|NCT00203996|9372980|P5|Overall Study|Scheduling issue|0
2726026|NCT00203996|9372981|P4|Overall Study|Scheduling issue|0
2726027|NCT00203996|9372982|P3|Overall Study|Scheduling issue|0
2726028|NCT00203996|9372983|P2|Overall Study|Scheduling issue|0
2726029|NCT00203996|9372984|P1|Overall Study|Scheduling issue|0
2726030|NCT00203996|9372975|P10|Overall Study|CPAP machine malfunction|0
2726031|NCT00203996|9372976|P9|Overall Study|CPAP machine malfunction|0
2726032|NCT00203996|9372977|P8|Overall Study|CPAP machine malfunction|0
2726033|NCT00203996|9372978|P7|Overall Study|CPAP machine malfunction|0
2726034|NCT00203996|9372979|P6|Overall Study|CPAP machine malfunction|0
2726035|NCT00203996|9372980|P5|Overall Study|CPAP machine malfunction|0
2726036|NCT00203996|9372981|P4|Overall Study|CPAP machine malfunction|1
2726037|NCT00203996|9372982|P3|Overall Study|CPAP machine malfunction|0
2726038|NCT00203996|9372983|P2|Overall Study|CPAP machine malfunction|0
2726039|NCT00203996|9372984|P1|Overall Study|CPAP machine malfunction|0
2726040|NCT00203996|9372975|P10|Overall Study|Physician Decision|1
2726041|NCT00203996|9372976|P9|Overall Study|Physician Decision|0
2726042|NCT00203996|9372977|P8|Overall Study|Physician Decision|0
2726043|NCT00203996|9372978|P7|Overall Study|Physician Decision|0
2726044|NCT00203996|9372979|P6|Overall Study|Physician Decision|0
2726045|NCT00203996|9372980|P5|Overall Study|Physician Decision|0
2726046|NCT00203996|9372981|P4|Overall Study|Physician Decision|2
2726047|NCT00203996|9372982|P3|Overall Study|Physician Decision|0
2726048|NCT00203996|9372983|P2|Overall Study|Physician Decision|0
2726049|NCT00203996|9372984|P1|Overall Study|Physician Decision|0
2726050|NCT00203996|9372975|P10|Overall Study|Protocol Violation|0
2726051|NCT00203996|9372976|P9|Overall Study|Protocol Violation|0
2726052|NCT00203996|9372977|P8|Overall Study|Protocol Violation|0
2726053|NCT00203996|9372978|P7|Overall Study|Protocol Violation|0
2726054|NCT00203996|9372979|P6|Overall Study|Protocol Violation|0
2726055|NCT00203996|9372980|P5|Overall Study|Protocol Violation|1
2726056|NCT00203996|9372981|P4|Overall Study|Protocol Violation|6
2726057|NCT00203996|9372982|P3|Overall Study|Protocol Violation|0
2726058|NCT00203996|9372983|P2|Overall Study|Protocol Violation|0
2726059|NCT00203996|9372984|P1|Overall Study|Protocol Violation|0
2726060|NCT00203996|9372975|P10|Overall Study|Lost to Follow-up|0
2726061|NCT00203996|9372976|P9|Overall Study|Lost to Follow-up|0
2726062|NCT00203996|9372977|P8|Overall Study|Lost to Follow-up|0
2726063|NCT00203996|9372978|P7|Overall Study|Lost to Follow-up|0
2726064|NCT00203996|9372979|P6|Overall Study|Lost to Follow-up|0
2726065|NCT00203996|9372980|P5|Overall Study|Lost to Follow-up|0
2726066|NCT00203996|9372981|P4|Overall Study|Lost to Follow-up|1
2726067|NCT00203996|9372982|P3|Overall Study|Lost to Follow-up|0
2726068|NCT00203996|9372983|P2|Overall Study|Lost to Follow-up|0
2726069|NCT00203996|9372984|P1|Overall Study|Lost to Follow-up|0
2726070|NCT00203892|9373051|P3|Overall Study|Death|0
2726071|NCT00203892|9373052|P2|Overall Study|Death|0
2726072|NCT00203892|9373053|P1|Overall Study|Death|1
2726073|NCT00203892|9373051|P3|Overall Study|Physician Decision|0
2726074|NCT00203892|9373052|P2|Overall Study|Physician Decision|2
2726075|NCT00203892|9373053|P1|Overall Study|Physician Decision|1
2726076|NCT00203502|9373064|P1|Overall Study|Death|1
2726077|NCT00203476|9373075|P3|Overall Study|Withdrawal by Subject|0
2726078|NCT00203476|9373076|P2|Overall Study|Withdrawal by Subject|1
2726079|NCT00203476|9373077|P1|Overall Study|Withdrawal by Subject|0
2726080|NCT00203476|9373075|P3|Overall Study|Lost to Follow-up|0
2726081|NCT00203476|9373076|P2|Overall Study|Lost to Follow-up|0
2726082|NCT00203476|9373077|P1|Overall Study|Lost to Follow-up|1
2726083|NCT00203424|9373094|P1|Follow-up Period|Lost to Follow-up|1
2726084|NCT00203424|9373094|P1|Follow-up Period|progressive disease|4
2726085|NCT00203424|9373094|P1|Follow-up Period|Withdrawal by Subject|1
2726086|NCT00203424|9373094|P1|Treatment Period|progressive disease|2
2726087|NCT00203424|9373094|P1|Treatment Period|Adverse Event|5
2726088|NCT00203424|9373094|P1|Treatment Period|Withdrawal by Subject|4
2726089|NCT00203411|9373101|P1|Follow-up|Progressive Disease|4
2726090|NCT00203307|9373110|P2|First Intervention|Adverse Event|0
2726091|NCT00203307|9373111|P1|First Intervention|Adverse Event|2
2726092|NCT00203294|9373119|P2|Overall Study|Withdrawal by Subject|13
2726093|NCT00203294|9373120|P1|Overall Study|Withdrawal by Subject|8
2726094|NCT00203268|9373126|P1|Early Treatment|Withdrawal by Subject|1
2726095|NCT00203268|9373126|P1|Early Treatment|Lost to Follow-up|1
2726096|NCT00203268|9373126|P1|Early Treatment|only treated one headache|2
2726097|NCT00203242|9373132|P1|Overall Study|Lost to Follow-up|1
2726098|NCT00203047|9373184|P2|Overall Study|Other|5
2726099|NCT00203047|9373185|P1|Overall Study|Other|5
2726100|NCT00203047|9373184|P2|Overall Study|Pregnancy|0
2726101|NCT00203047|9373185|P1|Overall Study|Pregnancy|3
2726102|NCT00203047|9373184|P2|Overall Study|Death|2
2726103|NCT00203047|9373185|P1|Overall Study|Death|1
2726104|NCT00203047|9373184|P2|Overall Study|Adverse Event|18
2726105|NCT00203047|9373185|P1|Overall Study|Adverse Event|8
2726106|NCT00203047|9373184|P2|Overall Study|Lost to Follow-up|5
2726107|NCT00203047|9373185|P1|Overall Study|Lost to Follow-up|11
2726108|NCT00203047|9373184|P2|Overall Study|Protocol Violation|0
2726109|NCT00203047|9373185|P1|Overall Study|Protocol Violation|1
2726110|NCT00203047|9373184|P2|Overall Study|Non-compliance|8
2726111|NCT00203047|9373185|P1|Overall Study|Non-compliance|4
2726112|NCT00203047|9373184|P2|Overall Study|Physician Decision|7
2726113|NCT00203047|9373185|P1|Overall Study|Physician Decision|8
2726114|NCT00203047|9373184|P2|Overall Study|Teva requested participant withdrawal|1
2726115|NCT00203047|9373185|P1|Overall Study|Teva requested participant withdrawal|1
2726116|NCT00203047|9373184|P2|Overall Study|Withdrawal by Subject|47
2726117|NCT00203047|9373185|P1|Overall Study|Withdrawal by Subject|13
2726118|NCT00203047|9373184|P2|Overall Study|Ongoing: not in database - Jan 29, 2009|1
2726119|NCT00203047|9373185|P1|Overall Study|Ongoing: not in database - Jan 29, 2009|5
2726120|NCT00203047|9373184|P2|Overall Study|Ongoing: in database - January 29, 2009|109
2726121|NCT00203047|9373185|P1|Overall Study|Ongoing: in database - January 29, 2009|131
2726122|NCT00203021|9373199|P2|Overall Study|Other than specified|16
2726123|NCT00203021|9373200|P1|Overall Study|Other than specified|11
2726124|NCT00203021|9373199|P2|Overall Study|Lost to Follow-up|7
2726125|NCT00203021|9373200|P1|Overall Study|Lost to Follow-up|9
2726126|NCT00203021|9373199|P2|Overall Study|Withdrawal by Subject|48
2726127|NCT00203021|9373200|P1|Overall Study|Withdrawal by Subject|45
2726128|NCT00203021|9373199|P2|Overall Study|Adverse Event|5
2726129|NCT00203021|9373200|P1|Overall Study|Adverse Event|10
2726130|NCT00203021|9373199|P2|Overall Study|Death|1
2726131|NCT00203021|9373200|P1|Overall Study|Death|4
2726132|NCT00202878|9373210|P2|Overall Study|Withdrawal by Subject|808
2726133|NCT00202878|9373211|P1|Overall Study|Withdrawal by Subject|795
2726134|NCT00202878|9373210|P2|Overall Study|Site Closure|36
2726135|NCT00202878|9373211|P1|Overall Study|Site Closure|39
2726136|NCT00202878|9373210|P2|Overall Study|Lost to Follow-up|49
2726137|NCT00202878|9373211|P1|Overall Study|Lost to Follow-up|44
2726138|NCT00202878|9373210|P2|Overall Study|Only Vital Status Known|356
2726139|NCT00202878|9373211|P1|Overall Study|Only Vital Status Known|357
2726140|NCT00202878|9373210|P2|Overall Study|Death|968
2726141|NCT00202878|9373211|P1|Overall Study|Death|964
2726142|NCT00202839|9373225|P2|Overall Study|Lost to Follow-up|2
2726143|NCT00202839|9373226|P1|Overall Study|Lost to Follow-up|3
2726144|NCT00202839|9373225|P2|Overall Study|Protocol Violation|1
2726145|NCT00202839|9373226|P1|Overall Study|Protocol Violation|2
2726146|NCT00202839|9373225|P2|Overall Study|Withdrawal by Subject|2
2726147|NCT00202839|9373226|P1|Overall Study|Withdrawal by Subject|6
2726148|NCT00202839|9373225|P2|Overall Study|Physician Decision|0
2726149|NCT00202839|9373226|P1|Overall Study|Physician Decision|12
2726150|NCT00202839|9373225|P2|Overall Study|Adverse Event|5
2726151|NCT00202839|9373226|P1|Overall Study|Adverse Event|1
2726152|NCT00202644|9373241|P2|Overall Study|Other|1
2726153|NCT00202644|9373242|P1|Overall Study|Other|9
2726154|NCT00202644|9373241|P2|Overall Study|Lost to Follow-up|1
2726155|NCT00202644|9373242|P1|Overall Study|Lost to Follow-up|0
2726156|NCT00202644|9373241|P2|Overall Study|Lack of Efficacy|6
2726157|NCT00202644|9373242|P1|Overall Study|Lack of Efficacy|6
2726158|NCT00202644|9373241|P2|Overall Study|Withdrawal by Subject|6
2726159|NCT00202644|9373242|P1|Overall Study|Withdrawal by Subject|8
2726160|NCT00202644|9373241|P2|Overall Study|Adverse Event|13
2726161|NCT00202644|9373242|P1|Overall Study|Adverse Event|12
2726162|NCT00201851|9373303|P3|Overall Study|Ineligible post enrollment|1
2726163|NCT00201851|9373304|P2|Overall Study|Ineligible post enrollment|1
2726164|NCT00201851|9373305|P1|Overall Study|Ineligible post enrollment|6
2726165|NCT00201851|9373303|P3|Overall Study|Lost to Follow-up|0
2726166|NCT00201851|9373304|P2|Overall Study|Lost to Follow-up|1
2726167|NCT00201851|9373305|P1|Overall Study|Lost to Follow-up|2
2726168|NCT00201643|9373377|P2|Overall Study|Withdrawal by Subject|4
2726169|NCT00201643|9373378|P1|Overall Study|Withdrawal by Subject|5
2726170|NCT00201201|9373442|P2|Overall Study|Withdrawal by Subject|5
2726171|NCT00201201|9373443|P1|Overall Study|Withdrawal by Subject|5
2726172|NCT00201201|9373442|P2|Overall Study|Death|2
2726173|NCT00201201|9373443|P1|Overall Study|Death|0
2726174|NCT00201006|9373481|P3|Overall Study|Adverse Event|1
2726175|NCT00201006|9373482|P2|Overall Study|Adverse Event|0
2726176|NCT00201006|9373483|P1|Overall Study|Adverse Event|1
2726177|NCT00201006|9373481|P3|Overall Study|Withdrawal by Subject|3
2726178|NCT00201006|9373482|P2|Overall Study|Withdrawal by Subject|2
2726179|NCT00201006|9373483|P1|Overall Study|Withdrawal by Subject|7
2726180|NCT00200967|9373493|P2|Run-out Period|Lost to Follow-up|0
2726181|NCT00200967|9373494|P1|Run-out Period|Lost to Follow-up|1
2726182|NCT00200967|9373493|P2|Second Treatment Period|Withdrawal by Subject|2
2726183|NCT00200967|9373494|P1|Second Treatment Period|Withdrawal by Subject|1
2726184|NCT00200967|9373493|P2|Wash-out Period|Lost to Follow-up|1
2726185|NCT00200967|9373494|P1|Wash-out Period|Lost to Follow-up|0
2726186|NCT00200967|9373493|P2|First Treatment Period|Pregnancy|0
2726187|NCT00200967|9373494|P1|First Treatment Period|Pregnancy|1
2726188|NCT00200967|9373493|P2|First Treatment Period|Withdrawal by Subject|1
2726189|NCT00200967|9373494|P1|First Treatment Period|Withdrawal by Subject|5
2726190|NCT00200850|9373544|P3|Overall Study|Adverse Event|2
2726191|NCT00200850|9373545|P2|Overall Study|Adverse Event|1
2726192|NCT00200850|9373546|P1|Overall Study|Adverse Event|1
2726193|NCT00200850|9373544|P3|Overall Study|optic neuritis|1
2726194|NCT00200850|9373545|P2|Overall Study|optic neuritis|0
2726195|NCT00200850|9373546|P1|Overall Study|optic neuritis|0
2726196|NCT00200850|9373544|P3|Overall Study|Poor adherence|1
2726197|NCT00200850|9373545|P2|Overall Study|Poor adherence|0
2726198|NCT00200850|9373546|P1|Overall Study|Poor adherence|0
2726199|NCT00200850|9373544|P3|Overall Study|Pregnancy|1
2726200|NCT00200850|9373545|P2|Overall Study|Pregnancy|0
2726201|NCT00200850|9373546|P1|Overall Study|Pregnancy|0
2726202|NCT00200850|9373544|P3|Overall Study|too busy|0
2726203|NCT00200850|9373545|P2|Overall Study|too busy|0
2726204|NCT00200850|9373546|P1|Overall Study|too busy|1
2726205|NCT00200850|9373544|P3|Overall Study|relocation|1
2726206|NCT00200850|9373545|P2|Overall Study|relocation|0
2726207|NCT00200850|9373546|P1|Overall Study|relocation|1
2726208|NCT00200356|9373567|P2|Overall Study|Nontreatment|0
2726209|NCT00200356|9373568|P1|Overall Study|Nontreatment|1
2726210|NCT00200356|9373567|P2|Overall Study|Protocol Violation|4
2726211|NCT00200356|9373568|P1|Overall Study|Protocol Violation|4
2726212|NCT00200356|9373567|P2|Overall Study|Lack of Efficacy|3
2726213|NCT00200356|9373568|P1|Overall Study|Lack of Efficacy|3
2726214|NCT00200057|9373635|P1|Overall Study|Death|1
2726215|NCT00200057|9373635|P1|Overall Study|Infection|1
2726216|NCT00200057|9373635|P1|Overall Study|Change in medical condition|1
2726217|NCT00200057|9373635|P1|Overall Study|Withdrawal by Subject|1
2726218|NCT00200057|9373635|P1|Overall Study|Exited due to terminal illness of PI|2
2726219|NCT00200057|9373635|P1|Overall Study|Lack of Efficacy|3
2726220|NCT00199875|9373659|P5|Overall Study|Withdrawal by Subject|1
2726221|NCT00199875|9373660|P4|Overall Study|Withdrawal by Subject|0
2726222|NCT00199875|9373661|P3|Overall Study|Withdrawal by Subject|0
2726223|NCT00199875|9373662|P2|Overall Study|Withdrawal by Subject|0
2726224|NCT00199875|9373663|P1|Overall Study|Withdrawal by Subject|0
2726225|NCT00199381|9373685|P1|Overall Study|Study termination by Sponsor|323
2726226|NCT00199381|9373685|P1|Overall Study|Not including due to early termination|37
2726227|NCT00199381|9373685|P1|Overall Study|Lack of Efficacy|27
2726228|NCT00199381|9373685|P1|Overall Study|Protocol Violation|6
2726229|NCT00199381|9373685|P1|Overall Study|Adverse Event|73
2726230|NCT00199381|9373685|P1|Overall Study|Withdrawal by Subject|38
2726231|NCT00198822|9373692|P3|Overall Study|Lost to Follow-up|21
2726232|NCT00198822|9373693|P2|Overall Study|Lost to Follow-up|20
2726233|NCT00198822|9373694|P1|Overall Study|Lost to Follow-up|14
2726234|NCT00198133|9373713|P2|Overall Study|Physician Decision|0
2726235|NCT00198133|9373714|P1|Overall Study|Physician Decision|1
2726236|NCT00198133|9373713|P2|Overall Study|Withdrawal by Subject|0
2726237|NCT00198133|9373714|P1|Overall Study|Withdrawal by Subject|1
2726238|NCT00198133|9373713|P2|Overall Study|Adverse Event|3
2726239|NCT00198133|9373714|P1|Overall Study|Adverse Event|1
2726240|NCT00198133|9373713|P2|Overall Study|Disease progression|5
2726241|NCT00198133|9373714|P1|Overall Study|Disease progression|2
2726242|NCT00198107|9373726|P3|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2
2726243|NCT00198107|9373727|P2|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0
2726244|NCT00198107|9373728|P1|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0
2726245|NCT00198107|9373726|P3|Double-Blind Period|Withdrawal by Subject|0
2726246|NCT00198107|9373727|P2|Double-Blind Period|Withdrawal by Subject|1
2726247|NCT00198107|9373728|P1|Double-Blind Period|Withdrawal by Subject|0
2726248|NCT00198107|9373726|P3|Double-Blind Period|Physician Decision|0
2726249|NCT00198107|9373727|P2|Double-Blind Period|Physician Decision|0
2726250|NCT00198107|9373728|P1|Double-Blind Period|Physician Decision|1
2726251|NCT00198107|9373726|P3|Double-Blind Period|Lost to Follow-up|0
2726252|NCT00198107|9373727|P2|Double-Blind Period|Lost to Follow-up|1
2726253|NCT00198107|9373728|P1|Double-Blind Period|Lost to Follow-up|2
2726254|NCT00198107|9373726|P3|Double-Blind Period|Lack of Efficacy|0
2726255|NCT00198107|9373727|P2|Double-Blind Period|Lack of Efficacy|0
2726256|NCT00198107|9373728|P1|Double-Blind Period|Lack of Efficacy|2
2726257|NCT00198107|9373726|P3|Double-Blind Period|Adverse Event|0
2726258|NCT00198107|9373727|P2|Double-Blind Period|Adverse Event|1
2726259|NCT00198107|9373728|P1|Double-Blind Period|Adverse Event|1
2726260|NCT00198029|9373796|P1|Overall Study|Withdrawal by Subject|4
2726261|NCT00197496|9373803|P2|Follow-up|Lost to Follow-up|1
2726262|NCT00197496|9373804|P1|Follow-up|Lost to Follow-up|2
2726263|NCT00197496|9373803|P2|Baseline to Discharge|Protocol Violation|1
2726264|NCT00197496|9373804|P1|Baseline to Discharge|Protocol Violation|0
2726265|NCT00197496|9373803|P2|Baseline to Discharge|Physician Decision|1
2726266|NCT00197496|9373804|P1|Baseline to Discharge|Physician Decision|0
2726267|NCT00197496|9373803|P2|Baseline to Discharge|MRSA|0
2726268|NCT00197496|9373804|P1|Baseline to Discharge|MRSA|1
2726269|NCT00197496|9373803|P2|Baseline to Discharge|not interested|0
2726270|NCT00197496|9373804|P1|Baseline to Discharge|not interested|1
2726271|NCT00197236|9373852|P3|Overall Study|Returned out of specified time window|1
2726272|NCT00197236|9373853|P2|Overall Study|Returned out of specified time window|0
2726273|NCT00197236|9373854|P1|Overall Study|Returned out of specified time window|0
2726274|NCT00197236|9373852|P3|Overall Study|Study drug/medication expiration|3
2726275|NCT00197236|9373853|P2|Overall Study|Study drug/medication expiration|0
2726276|NCT00197236|9373854|P1|Overall Study|Study drug/medication expiration|1
2726277|NCT00197236|9373852|P3|Overall Study|Withdrawal by Subject|11
2726278|NCT00197236|9373853|P2|Overall Study|Withdrawal by Subject|3
2726279|NCT00197236|9373854|P1|Overall Study|Withdrawal by Subject|7
2726280|NCT00197236|9373852|P3|Overall Study|Protocol Violation|1
2726281|NCT00197236|9373853|P2|Overall Study|Protocol Violation|0
2726282|NCT00197236|9373854|P1|Overall Study|Protocol Violation|0
2726283|NCT00197236|9373852|P3|Overall Study|Lost to Follow-up|6
2726284|NCT00197236|9373853|P2|Overall Study|Lost to Follow-up|14
2726285|NCT00197236|9373854|P1|Overall Study|Lost to Follow-up|5
2726286|NCT00197236|9373852|P3|Overall Study|Adverse Event|1
2726287|NCT00197236|9373853|P2|Overall Study|Adverse Event|0
2726288|NCT00197236|9373854|P1|Overall Study|Adverse Event|1
2726289|NCT00197145|9373928|P2|Period 2 : Open Label Phase|Other|0
2726290|NCT00197145|9373929|P1|Period 2 : Open Label Phase|Other|1
2726291|NCT00197145|9373928|P2|Period 2 : Open Label Phase|Were ongoing till data freeze|0
2726292|NCT00197145|9373929|P1|Period 2 : Open Label Phase|Were ongoing till data freeze|3
2726293|NCT00197145|9373928|P2|Period 2 : Open Label Phase|Availability of alternative ART|0
2726294|NCT00197145|9373929|P1|Period 2 : Open Label Phase|Availability of alternative ART|2
2726295|NCT00197145|9373928|P2|Period 2 : Open Label Phase|Protocol defined virological failure|0
2726296|NCT00197145|9373929|P1|Period 2 : Open Label Phase|Protocol defined virological failure|3
2726297|NCT00197145|9373928|P2|Period 2 : Open Label Phase|Insufficient viral load response|0
2726298|NCT00197145|9373929|P1|Period 2 : Open Label Phase|Insufficient viral load response|1
2726299|NCT00197145|9373928|P2|Period 1: Randomized Treatment Phase|Other|2
2726300|NCT00197145|9373929|P1|Period 1: Randomized Treatment Phase|Other|2
2726301|NCT00197145|9373928|P2|Period 1: Randomized Treatment Phase|Sponsor terminated study|8
2726302|NCT00197145|9373929|P1|Period 1: Randomized Treatment Phase|Sponsor terminated study|10
2726303|NCT00197145|9373928|P2|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
2726304|NCT00197145|9373929|P1|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
2726305|NCT00197106|9374000|P3|Overall Treatment Period|Withdrawal by Subject|2
2726306|NCT00197106|9374001|P2|Overall Treatment Period|Withdrawal by Subject|0
2726307|NCT00197106|9374002|P1|Overall Treatment Period|Withdrawal by Subject|0
2726308|NCT00197106|9374000|P3|Overall Treatment Period|Protocol Violation|2
2726309|NCT00197106|9374001|P2|Overall Treatment Period|Protocol Violation|0
2726310|NCT00197106|9374002|P1|Overall Treatment Period|Protocol Violation|0
2726311|NCT00197106|9374000|P3|Overall Treatment Period|Lost to Follow-up|2
2726312|NCT00197106|9374001|P2|Overall Treatment Period|Lost to Follow-up|0
2726313|NCT00197106|9374002|P1|Overall Treatment Period|Lost to Follow-up|0
2726314|NCT00197106|9374000|P3|Overall Treatment Period|Lack of Efficacy|0
2726315|NCT00197106|9374001|P2|Overall Treatment Period|Lack of Efficacy|1
2726316|NCT00197106|9374002|P1|Overall Treatment Period|Lack of Efficacy|0
2726317|NCT00197106|9374000|P3|4-Week Run-In Period|Did not meet entry criteria|0
2726318|NCT00197106|9374001|P2|4-Week Run-In Period|Did not meet entry criteria|0
2726319|NCT00197106|9374002|P1|4-Week Run-In Period|Did not meet entry criteria|99
2726320|NCT00197028|9374038|P2|Overall Study|Other|6
2726321|NCT00197028|9374039|P1|Overall Study|Other|3
2726322|NCT00197028|9374038|P2|Overall Study|Lost to Follow-up|0
2726323|NCT00197028|9374039|P1|Overall Study|Lost to Follow-up|1
2726324|NCT00197028|9374038|P2|Overall Study|Withdrawal by Subject|12
2726325|NCT00197028|9374039|P1|Overall Study|Withdrawal by Subject|8
2726326|NCT00197028|9374038|P2|Overall Study|Protocol Violation|1
2726327|NCT00197028|9374039|P1|Overall Study|Protocol Violation|2
2726328|NCT00197028|9374038|P2|Overall Study|Adverse Event|2
2726329|NCT00197028|9374039|P1|Overall Study|Adverse Event|2
2726330|NCT00197015|9374082|P3|Overall Study|Other|2
2726331|NCT00197015|9374083|P2|Overall Study|Other|3
2726332|NCT00197015|9374084|P1|Overall Study|Other|2
2726333|NCT00197015|9374082|P3|Overall Study|Lost to Follow-up|37
2726334|NCT00197015|9374083|P2|Overall Study|Lost to Follow-up|46
2726335|NCT00197015|9374084|P1|Overall Study|Lost to Follow-up|28
2726336|NCT00197015|9374082|P3|Overall Study|Withdrawal by Subject|34
2726337|NCT00197015|9374083|P2|Overall Study|Withdrawal by Subject|37
2726338|NCT00197015|9374084|P1|Overall Study|Withdrawal by Subject|17
2726339|NCT00197015|9374082|P3|Overall Study|Protocol Violation|3
2726340|NCT00197015|9374083|P2|Overall Study|Protocol Violation|3
2726341|NCT00197015|9374084|P1|Overall Study|Protocol Violation|0
2726342|NCT00197015|9374082|P3|Overall Study|Adverse Event|1
2726343|NCT00197015|9374083|P2|Overall Study|Adverse Event|0
2726344|NCT00197015|9374084|P1|Overall Study|Adverse Event|3
2726345|NCT00197002|9374143|P3|Overall Study|Others|1
2726346|NCT00197002|9374144|P2|Overall Study|Others|1
2726347|NCT00197002|9374145|P1|Overall Study|Others|3
2726348|NCT00197002|9374143|P3|Overall Study|Lost to follow-up (compl. vaccination)|1
2726349|NCT00197002|9374144|P2|Overall Study|Lost to follow-up (compl. vaccination)|2
2726350|NCT00197002|9374145|P1|Overall Study|Lost to follow-up (compl. vaccination)|2
2726351|NCT00197002|9374143|P3|Overall Study|Lost to follow-up (incompl. vaccination)|5
2726352|NCT00197002|9374144|P2|Overall Study|Lost to follow-up (incompl. vaccination)|4
2726353|NCT00197002|9374145|P1|Overall Study|Lost to follow-up (incompl. vaccination)|4
2726354|NCT00197002|9374143|P3|Overall Study|Migrated/moved from study area|1
2726355|NCT00197002|9374144|P2|Overall Study|Migrated/moved from study area|5
2726356|NCT00197002|9374145|P1|Overall Study|Migrated/moved from study area|3
2726357|NCT00197002|9374143|P3|Overall Study|Withdrawal by Subject|7
2726358|NCT00197002|9374144|P2|Overall Study|Withdrawal by Subject|5
2726359|NCT00197002|9374145|P1|Overall Study|Withdrawal by Subject|9
2726360|NCT00197002|9374143|P3|Overall Study|Protocol Violation|2
2726361|NCT00197002|9374144|P2|Overall Study|Protocol Violation|0
2726362|NCT00197002|9374145|P1|Overall Study|Protocol Violation|1
2726363|NCT00197002|9374143|P3|Overall Study|Adverse Event|0
2726364|NCT00197002|9374144|P2|Overall Study|Adverse Event|1
2726365|NCT00197002|9374145|P1|Overall Study|Adverse Event|0
2726366|NCT00196976|9374196|P14|Booster Study|Lost to Follow-up|0
2726367|NCT00196976|9374197|P13|Booster Study|Lost to Follow-up|0
2726368|NCT00196976|9374198|P12|Booster Study|Lost to Follow-up|2
2726369|NCT00196976|9374199|P11|Booster Study|Lost to Follow-up|1
2726370|NCT00196976|9374200|P10|Booster Study|Lost to Follow-up|0
2726371|NCT00196976|9374201|P9|Booster Study|Lost to Follow-up|0
2726372|NCT00196976|9374202|P8|Booster Study|Lost to Follow-up|0
2726373|NCT00196976|9374203|P7|Booster Study|Lost to Follow-up|0
2726374|NCT00196976|9374204|P6|Booster Study|Lost to Follow-up|0
2726375|NCT00196976|9374205|P5|Booster Study|Lost to Follow-up|0
2726376|NCT00196976|9374206|P4|Booster Study|Lost to Follow-up|0
2726377|NCT00196976|9374207|P3|Booster Study|Lost to Follow-up|0
2726378|NCT00196976|9374208|P2|Booster Study|Lost to Follow-up|0
2726379|NCT00196976|9374209|P1|Booster Study|Lost to Follow-up|0
2726380|NCT00196976|9374196|P14|Booster Study|Withdrawal by Subject|0
2726381|NCT00196976|9374197|P13|Booster Study|Withdrawal by Subject|0
2726382|NCT00196976|9374198|P12|Booster Study|Withdrawal by Subject|0
2726383|NCT00196976|9374199|P11|Booster Study|Withdrawal by Subject|1
2726384|NCT00196976|9374200|P10|Booster Study|Withdrawal by Subject|0
2726385|NCT00196976|9374201|P9|Booster Study|Withdrawal by Subject|0
2726386|NCT00196976|9374202|P8|Booster Study|Withdrawal by Subject|0
2726387|NCT00196976|9374203|P7|Booster Study|Withdrawal by Subject|0
2726388|NCT00196976|9374204|P6|Booster Study|Withdrawal by Subject|0
2726389|NCT00196976|9374205|P5|Booster Study|Withdrawal by Subject|0
2726390|NCT00196976|9374206|P4|Booster Study|Withdrawal by Subject|0
2726391|NCT00196976|9374207|P3|Booster Study|Withdrawal by Subject|0
2726392|NCT00196976|9374208|P2|Booster Study|Withdrawal by Subject|0
2726393|NCT00196976|9374209|P1|Booster Study|Withdrawal by Subject|0
2726394|NCT00196976|9374196|P14|Primary Study|Other|0
2726395|NCT00196976|9374197|P13|Primary Study|Other|0
2726396|NCT00196976|9374198|P12|Primary Study|Other|0
2726397|NCT00196976|9374199|P11|Primary Study|Other|0
2726398|NCT00196976|9374200|P10|Primary Study|Other|0
2726399|NCT00196976|9374201|P9|Primary Study|Other|0
2726400|NCT00196976|9374202|P8|Primary Study|Other|0
2726401|NCT00196976|9374203|P7|Primary Study|Other|0
2726402|NCT00196976|9374204|P6|Primary Study|Other|0
2726403|NCT00196976|9374205|P5|Primary Study|Other|0
2726404|NCT00196976|9374206|P4|Primary Study|Other|0
2726405|NCT00196976|9374207|P3|Primary Study|Other|2
2726406|NCT00196976|9374208|P2|Primary Study|Other|0
2726407|NCT00196976|9374209|P1|Primary Study|Other|0
2726408|NCT00196976|9374196|P14|Primary Study|Lost to Follow-up|0
2726409|NCT00196976|9374197|P13|Primary Study|Lost to Follow-up|0
2726410|NCT00196976|9374198|P12|Primary Study|Lost to Follow-up|0
2726411|NCT00196976|9374199|P11|Primary Study|Lost to Follow-up|0
2726412|NCT00196976|9374200|P10|Primary Study|Lost to Follow-up|0
2726413|NCT00196976|9374201|P9|Primary Study|Lost to Follow-up|0
2726414|NCT00196976|9374202|P8|Primary Study|Lost to Follow-up|2
2726415|NCT00196976|9374203|P7|Primary Study|Lost to Follow-up|0
2726416|NCT00196976|9374204|P6|Primary Study|Lost to Follow-up|1
2726417|NCT00196976|9374205|P5|Primary Study|Lost to Follow-up|1
2726418|NCT00196976|9374206|P4|Primary Study|Lost to Follow-up|0
2726419|NCT00196976|9374207|P3|Primary Study|Lost to Follow-up|0
2726420|NCT00196976|9374208|P2|Primary Study|Lost to Follow-up|0
2726421|NCT00196976|9374209|P1|Primary Study|Lost to Follow-up|0
2726422|NCT00196976|9374196|P14|Primary Study|Withdrawal by Subject|0
2726423|NCT00196976|9374197|P13|Primary Study|Withdrawal by Subject|0
2726424|NCT00196976|9374198|P12|Primary Study|Withdrawal by Subject|0
2726425|NCT00196976|9374199|P11|Primary Study|Withdrawal by Subject|0
2726426|NCT00196976|9374200|P10|Primary Study|Withdrawal by Subject|1
2726427|NCT00196976|9374201|P9|Primary Study|Withdrawal by Subject|0
2726428|NCT00196976|9374202|P8|Primary Study|Withdrawal by Subject|0
2726429|NCT00196976|9374203|P7|Primary Study|Withdrawal by Subject|0
2726430|NCT00196976|9374204|P6|Primary Study|Withdrawal by Subject|1
2726431|NCT00196976|9374205|P5|Primary Study|Withdrawal by Subject|2
2726432|NCT00196976|9374206|P4|Primary Study|Withdrawal by Subject|1
2726433|NCT00196976|9374207|P3|Primary Study|Withdrawal by Subject|1
2726434|NCT00196976|9374208|P2|Primary Study|Withdrawal by Subject|0
2726435|NCT00196976|9374209|P1|Primary Study|Withdrawal by Subject|1
2726436|NCT00196976|9374196|P14|Primary Study|Protocol Violation|0
2726437|NCT00196976|9374197|P13|Primary Study|Protocol Violation|0
2726438|NCT00196976|9374198|P12|Primary Study|Protocol Violation|0
2726439|NCT00196976|9374199|P11|Primary Study|Protocol Violation|0
2726440|NCT00196976|9374200|P10|Primary Study|Protocol Violation|0
2726441|NCT00196976|9374201|P9|Primary Study|Protocol Violation|0
2726442|NCT00196976|9374202|P8|Primary Study|Protocol Violation|0
2726443|NCT00196976|9374203|P7|Primary Study|Protocol Violation|0
2726444|NCT00196976|9374204|P6|Primary Study|Protocol Violation|0
2726445|NCT00196976|9374205|P5|Primary Study|Protocol Violation|0
2726446|NCT00196976|9374206|P4|Primary Study|Protocol Violation|0
2726447|NCT00196976|9374207|P3|Primary Study|Protocol Violation|1
2726448|NCT00196976|9374208|P2|Primary Study|Protocol Violation|1
2726449|NCT00196976|9374209|P1|Primary Study|Protocol Violation|0
2726450|NCT00196976|9374196|P14|Primary Study|Migrated from study area|0
2726451|NCT00196976|9374197|P13|Primary Study|Migrated from study area|0
2726452|NCT00196976|9374198|P12|Primary Study|Migrated from study area|0
2726453|NCT00196976|9374199|P11|Primary Study|Migrated from study area|0
2726454|NCT00196976|9374200|P10|Primary Study|Migrated from study area|0
2726455|NCT00196976|9374201|P9|Primary Study|Migrated from study area|0
2726456|NCT00196976|9374202|P8|Primary Study|Migrated from study area|1
2726457|NCT00196976|9374203|P7|Primary Study|Migrated from study area|0
2726458|NCT00196976|9374204|P6|Primary Study|Migrated from study area|0
2726459|NCT00196976|9374205|P5|Primary Study|Migrated from study area|0
2726460|NCT00196976|9374206|P4|Primary Study|Migrated from study area|0
2726461|NCT00196976|9374207|P3|Primary Study|Migrated from study area|0
2726462|NCT00196976|9374208|P2|Primary Study|Migrated from study area|0
2726463|NCT00196976|9374209|P1|Primary Study|Migrated from study area|0
2726464|NCT00196937|9374405|P3|Overall Study|Other|1
2726465|NCT00196937|9374406|P2|Overall Study|Other|1
2726466|NCT00196937|9374407|P1|Overall Study|Other|3
2726467|NCT00196937|9374405|P3|Overall Study|Lost to Follow-up|3
2726468|NCT00196937|9374406|P2|Overall Study|Lost to Follow-up|3
2726469|NCT00196937|9374407|P1|Overall Study|Lost to Follow-up|4
2726470|NCT00196937|9374405|P3|Overall Study|Withdrawal by Subject|2
2726471|NCT00196937|9374406|P2|Overall Study|Withdrawal by Subject|0
2726472|NCT00196937|9374407|P1|Overall Study|Withdrawal by Subject|0
2726473|NCT00196937|9374405|P3|Overall Study|Non-serious adverse event|1
2726474|NCT00196937|9374406|P2|Overall Study|Non-serious adverse event|1
2726475|NCT00196937|9374407|P1|Overall Study|Non-serious adverse event|1
2726476|NCT00196937|9374405|P3|Overall Study|Serious Adverse Event|0
2726477|NCT00196937|9374406|P2|Overall Study|Serious Adverse Event|0
2726478|NCT00196937|9374407|P1|Overall Study|Serious Adverse Event|1
2726479|NCT00196326|9374461|P1|Overall Study|Other|22
2726480|NCT00196326|9374461|P1|Overall Study|Lost to Follow-up|304
2726481|NCT00196326|9374461|P1|Overall Study|Pregnancy|34
2726482|NCT00196326|9374461|P1|Overall Study|Adverse Event|253
2726483|NCT00196326|9374461|P1|Overall Study|Withdrawal by Subject|225
2726484|NCT00196326|9374461|P1|Overall Study|Physician Decision|3
2726485|NCT00196326|9374461|P1|Overall Study|Non-compliance with the protocol|81
2726486|NCT00196326|9374461|P1|Overall Study|Did not meet protocol requirements|64
2726487|NCT00196313|9374469|P2|Overall Study|Lost to Follow-up|2
2726488|NCT00196313|9374470|P1|Overall Study|Lost to Follow-up|2
2726489|NCT00196313|9374469|P2|Overall Study|Subject Pregnant|1
2726490|NCT00196313|9374470|P1|Overall Study|Subject Pregnant|1
2726491|NCT00196313|9374469|P2|Overall Study|Adverse Event|1
2726492|NCT00196313|9374470|P1|Overall Study|Adverse Event|3
2726493|NCT00196313|9374469|P2|Overall Study|Withdrawal by Subject|1
2726494|NCT00196313|9374470|P1|Overall Study|Withdrawal by Subject|3
2726495|NCT00196313|9374469|P2|Overall Study|Protocol Violation|3
2726496|NCT00196313|9374470|P1|Overall Study|Protocol Violation|2
2726497|NCT00196196|9374484|P1|Overall Study|Did not have required condition (hydroce|5
2726498|NCT00196196|9374484|P1|Overall Study|Withdrawal by Subject|2
2726499|NCT00196105|9374492|P3|Overall Study|Lost to Follow-up|7
2726500|NCT00196105|9374493|P2|Overall Study|Lost to Follow-up|5
2726501|NCT00196105|9374494|P1|Overall Study|Lost to Follow-up|4
2726502|NCT00195819|9374514|P2|Open-label|Withdrawal by Subject|5
2726503|NCT00195819|9374515|P1|Open-label|Withdrawal by Subject|0
2726504|NCT00195819|9374514|P2|Open-label|Moved|1
2726505|NCT00195819|9374515|P1|Open-label|Moved|0
2726506|NCT00195819|9374514|P2|Open-label|Protocol Violation|2
2726507|NCT00195819|9374515|P1|Open-label|Protocol Violation|0
2726508|NCT00195819|9374514|P2|Open-label|Pregnancy|1
2726509|NCT00195819|9374515|P1|Open-label|Pregnancy|0
2726510|NCT00195819|9374514|P2|Open-label|Lack of Efficacy|2
2726511|NCT00195819|9374515|P1|Open-label|Lack of Efficacy|0
2726512|NCT00195819|9374514|P2|Open-label|Adverse Event|9
2726513|NCT00195819|9374515|P1|Open-label|Adverse Event|0
2726514|NCT00195819|9374514|P2|Double-Blind|Moved|0
2726515|NCT00195819|9374515|P1|Double-Blind|Moved|1
2726516|NCT00195819|9374514|P2|Double-Blind|Withdrawal by Subject|0
2726517|NCT00195819|9374515|P1|Double-Blind|Withdrawal by Subject|1
2726518|NCT00195715|9374565|P1|Overall Study|Sponsor discretion - trial ended early|1
2726519|NCT00195715|9374565|P1|Overall Study|Sponsor discontinued trial|1
2726520|NCT00195715|9374565|P1|Overall Study|Colonic stricture|1
2726521|NCT00195715|9374565|P1|Overall Study|Ineligible|1
2726522|NCT00195715|9374565|P1|Overall Study|Increased infection rate|1
2726523|NCT00195715|9374565|P1|Overall Study|Planned surgery|2
2726524|NCT00195715|9374565|P1|Overall Study|Use of prohibited medication|2
2726525|NCT00195715|9374565|P1|Overall Study|Subject wants to get pregnant|4
2726526|NCT00195715|9374565|P1|Overall Study|Investigator's decision|2
2726527|NCT00195715|9374565|P1|Overall Study|Administrative reasons|2
2726528|NCT00195715|9374565|P1|Overall Study|Sponsor stopped study|1
2726529|NCT00195715|9374565|P1|Overall Study|Loss of response/no improvement|3
2726530|NCT00195715|9374565|P1|Overall Study|Subject choice|3
2726531|NCT00195715|9374565|P1|Overall Study|Subject started commercial Humira|5
2726532|NCT00195715|9374565|P1|Overall Study|Subject non-compliance|6
2726533|NCT00195715|9374565|P1|Overall Study|Subject moved/relocated|7
2726534|NCT00195715|9374565|P1|Overall Study|Investigative site closure|8
2726535|NCT00195715|9374565|P1|Overall Study|Pregnancy|14
2726536|NCT00195715|9374565|P1|Overall Study|Lack of Efficacy|93
2726537|NCT00195715|9374565|P1|Overall Study|Protocol Violation|13
2726538|NCT00195715|9374565|P1|Overall Study|Lost to Follow-up|27
2726539|NCT00195715|9374565|P1|Overall Study|Withdrawal by Subject|58
2726540|NCT00195715|9374565|P1|Overall Study|Adverse Event|122
2726541|NCT00195676|9374665|P1|Period R - Retreatment 16 Weeks|Other reasons|6
2726542|NCT00195676|9374665|P1|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9
2726543|NCT00195676|9374665|P1|Period R - Retreatment 16 Weeks|Lost to Follow-up|11
2726544|NCT00195676|9374665|P1|Period R - Retreatment 16 Weeks|Lack of Efficacy|5
2726545|NCT00195676|9374665|P1|Period R - Retreatment 16 Weeks|Adverse Event|4
2726546|NCT00195676|9374665|P1|Period W (Withdrawal) - No Treatment|Other reasons|18
2726547|NCT00195676|9374665|P1|Period W (Withdrawal) - No Treatment|Administrative reasons|1
2726548|NCT00195676|9374665|P1|Period W (Withdrawal) - No Treatment|Period W Close-out|129
2726549|NCT00195676|9374665|P1|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397
2726550|NCT00195676|9374665|P1|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46
2726551|NCT00195676|9374665|P1|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11
2726552|NCT00195676|9374665|P1|Period W (Withdrawal) - No Treatment|Death|2
2726553|NCT00195676|9374665|P1|Period W (Withdrawal) - No Treatment|Adverse Event|4
2726554|NCT00195676|9374665|P1|Period O - Open-label Treatment|Other reasons|68
2726555|NCT00195676|9374665|P1|Period O - Open-label Treatment|Administrative reasons|2
2726556|NCT00195676|9374665|P1|Period O - Open-label Treatment|Withdrawal by Subject|147
2726557|NCT00195676|9374665|P1|Period O - Open-label Treatment|Protocol Violation|12
2726558|NCT00195676|9374665|P1|Period O - Open-label Treatment|Lost to Follow-up|91
2726559|NCT00195676|9374665|P1|Period O - Open-label Treatment|Lack of Efficacy|198
2726560|NCT00195676|9374665|P1|Period O - Open-label Treatment|Death|6
2726561|NCT00195676|9374665|P1|Period O - Open-label Treatment|Adverse Event|82
2726562|NCT00195663|9374679|P3|Open-Label Extension Period|Administrative reasons|13
2726563|NCT00195663|9374680|P2|Open-Label Extension Period|Administrative reasons|11
2726564|NCT00195663|9374681|P1|Open-Label Extension Period|Administrative reasons|11
2726565|NCT00195663|9374679|P3|Open-Label Extension Period|Lack of Efficacy|12
2726566|NCT00195663|9374680|P2|Open-Label Extension Period|Lack of Efficacy|6
2726567|NCT00195663|9374681|P1|Open-Label Extension Period|Lack of Efficacy|14
2726568|NCT00195663|9374679|P3|Open-Label Extension Period|Withdrawal by Subject|22
2726569|NCT00195663|9374680|P2|Open-Label Extension Period|Withdrawal by Subject|15
2726570|NCT00195663|9374681|P1|Open-Label Extension Period|Withdrawal by Subject|16
2726571|NCT00195663|9374679|P3|Open-Label Extension Period|Death|2
2726572|NCT00195663|9374680|P2|Open-Label Extension Period|Death|2
2726573|NCT00195663|9374681|P1|Open-Label Extension Period|Death|2
2726574|NCT00195663|9374679|P3|Open-Label Extension Period|Protocol Violation|4
2726575|NCT00195663|9374680|P2|Open-Label Extension Period|Protocol Violation|4
2726576|NCT00195663|9374681|P1|Open-Label Extension Period|Protocol Violation|3
2726577|NCT00195663|9374679|P3|Open-Label Extension Period|Recovery|2
2726578|NCT00195663|9374680|P2|Open-Label Extension Period|Recovery|2
2726579|NCT00195663|9374681|P1|Open-Label Extension Period|Recovery|0
2726580|NCT00195663|9374679|P3|Open-Label Extension Period|Lost to Follow-up|6
2726581|NCT00195663|9374680|P2|Open-Label Extension Period|Lost to Follow-up|2
2726582|NCT00195663|9374681|P1|Open-Label Extension Period|Lost to Follow-up|9
2726583|NCT00195663|9374679|P3|Open-Label Extension Period|Adverse Event|36
2726584|NCT00195663|9374680|P2|Open-Label Extension Period|Adverse Event|32
2726585|NCT00195663|9374681|P1|Open-Label Extension Period|Adverse Event|21
2726586|NCT00195663|9374679|P3|2-year Double-blind Treatment Period|Administrative reasons|9
2726587|NCT00195663|9374680|P2|2-year Double-blind Treatment Period|Administrative reasons|2
2726588|NCT00195663|9374681|P1|2-year Double-blind Treatment Period|Administrative reasons|3
2726589|NCT00195663|9374679|P3|2-year Double-blind Treatment Period|Recovery|1
2726590|NCT00195663|9374680|P2|2-year Double-blind Treatment Period|Recovery|0
2726591|NCT00195663|9374681|P1|2-year Double-blind Treatment Period|Recovery|1
2726592|NCT00195663|9374679|P3|2-year Double-blind Treatment Period|Planned selection criteria|0
2726593|NCT00195663|9374680|P2|2-year Double-blind Treatment Period|Planned selection criteria|1
2726594|NCT00195663|9374681|P1|2-year Double-blind Treatment Period|Planned selection criteria|0
2726595|NCT00195663|9374679|P3|2-year Double-blind Treatment Period|Protocol Violation|4
2726596|NCT00195663|9374680|P2|2-year Double-blind Treatment Period|Protocol Violation|6
2726597|NCT00195663|9374681|P1|2-year Double-blind Treatment Period|Protocol Violation|6
2726598|NCT00195663|9374679|P3|2-year Double-blind Treatment Period|Lack of Efficacy|13
2726599|NCT00195663|9374680|P2|2-year Double-blind Treatment Period|Lack of Efficacy|52
2726600|NCT00195663|9374681|P1|2-year Double-blind Treatment Period|Lack of Efficacy|47
2726601|NCT00195663|9374679|P3|2-year Double-blind Treatment Period|Withdrawal by Subject|12
2726602|NCT00195663|9374680|P2|2-year Double-blind Treatment Period|Withdrawal by Subject|18
2726603|NCT00195663|9374681|P1|2-year Double-blind Treatment Period|Withdrawal by Subject|15
2726604|NCT00195663|9374679|P3|2-year Double-blind Treatment Period|Lost to Follow-up|1
2726605|NCT00195663|9374680|P2|2-year Double-blind Treatment Period|Lost to Follow-up|0
2726606|NCT00195663|9374681|P1|2-year Double-blind Treatment Period|Lost to Follow-up|0
2726607|NCT00195663|9374679|P3|2-year Double-blind Treatment Period|Death|0
2726608|NCT00195663|9374680|P2|2-year Double-blind Treatment Period|Death|2
2726609|NCT00195663|9374681|P1|2-year Double-blind Treatment Period|Death|0
2726610|NCT00195663|9374679|P3|2-year Double-blind Treatment Period|Adverse Event|32
2726611|NCT00195663|9374680|P2|2-year Double-blind Treatment Period|Adverse Event|27
2726612|NCT00195663|9374681|P1|2-year Double-blind Treatment Period|Adverse Event|21
2726613|NCT00195650|9374775|P1|Overall Study|Administrative reasons|83
2726614|NCT00195650|9374775|P1|Overall Study|Protocol Violation|15
2726615|NCT00195650|9374775|P1|Overall Study|Death|23
2726616|NCT00195650|9374775|P1|Overall Study|Lost to Follow-up|44
2726617|NCT00195650|9374775|P1|Overall Study|Withdrawal by Subject|67
2726618|NCT00195650|9374775|P1|Overall Study|Lack of Efficacy|99
2726619|NCT00195650|9374775|P1|Overall Study|Adverse Event|194
2726620|NCT00195507|9374800|P2|Overall Study|Protocol Deviation|3
2726621|NCT00195507|9374801|P1|Overall Study|Protocol Deviation|6
2726622|NCT00195507|9374800|P2|Overall Study|Withdrawal by Subject|23
2726623|NCT00195507|9374801|P1|Overall Study|Withdrawal by Subject|16
2726624|NCT00195507|9374800|P2|Overall Study|Lack of Efficacy|67
2726625|NCT00195507|9374801|P1|Overall Study|Lack of Efficacy|40
2726626|NCT00195507|9374800|P2|Overall Study|Protocol Violation|4
2726627|NCT00195507|9374801|P1|Overall Study|Protocol Violation|5
2726628|NCT00195507|9374800|P2|Overall Study|Lost to Follow-up|2
2726629|NCT00195507|9374801|P1|Overall Study|Lost to Follow-up|3
2726630|NCT00195507|9374800|P2|Overall Study|Physician Decision|2
2726631|NCT00195507|9374801|P1|Overall Study|Physician Decision|1
2726632|NCT00195507|9374800|P2|Overall Study|Failed to Return|3
2726633|NCT00195507|9374801|P1|Overall Study|Failed to Return|4
2726634|NCT00195507|9374800|P2|Overall Study|Death|1
2726635|NCT00195507|9374801|P1|Overall Study|Death|0
2726636|NCT00195507|9374800|P2|Overall Study|Adverse Event|13
2726637|NCT00195507|9374801|P1|Overall Study|Adverse Event|24
2726638|NCT00195494|9374815|P6|Year 2|System toxicity|0
2726639|NCT00195494|9374816|P5|Year 2|System toxicity|0
2726640|NCT00195494|9374817|P4|Year 2|System toxicity|1
2726641|NCT00195494|9374818|P3|Year 2|System toxicity|0
2726642|NCT00195494|9374819|P2|Year 2|System toxicity|0
2726643|NCT00195494|9374820|P1|Year 2|System toxicity|0
2726644|NCT00195494|9374815|P6|Year 2|Withdrawal by Subject|0
2726645|NCT00195494|9374816|P5|Year 2|Withdrawal by Subject|0
2726646|NCT00195494|9374817|P4|Year 2|Withdrawal by Subject|3
2726647|NCT00195494|9374818|P3|Year 2|Withdrawal by Subject|4
2726648|NCT00195494|9374819|P2|Year 2|Withdrawal by Subject|5
2726649|NCT00195494|9374820|P1|Year 2|Withdrawal by Subject|1
2726650|NCT00195494|9374815|P6|Year 2|Physician Decision|0
2726651|NCT00195494|9374816|P5|Year 2|Physician Decision|0
2726652|NCT00195494|9374817|P4|Year 2|Physician Decision|0
2726653|NCT00195494|9374818|P3|Year 2|Physician Decision|0
2726654|NCT00195494|9374819|P2|Year 2|Physician Decision|1
2726655|NCT00195494|9374820|P1|Year 2|Physician Decision|1
2726656|NCT00195494|9374815|P6|Year 2|Protocol deviation|0
2726657|NCT00195494|9374816|P5|Year 2|Protocol deviation|0
2726658|NCT00195494|9374817|P4|Year 2|Protocol deviation|0
2726659|NCT00195494|9374818|P3|Year 2|Protocol deviation|0
2726660|NCT00195494|9374819|P2|Year 2|Protocol deviation|1
2726661|NCT00195494|9374820|P1|Year 2|Protocol deviation|0
2726662|NCT00195494|9374815|P6|Year 2|Missed >4 consecutive doses|0
2726663|NCT00195494|9374816|P5|Year 2|Missed >4 consecutive doses|0
2726664|NCT00195494|9374817|P4|Year 2|Missed >4 consecutive doses|0
2726665|NCT00195494|9374818|P3|Year 2|Missed >4 consecutive doses|1
2726666|NCT00195494|9374819|P2|Year 2|Missed >4 consecutive doses|1
2726667|NCT00195494|9374820|P1|Year 2|Missed >4 consecutive doses|1
2726668|NCT00195494|9374815|P6|Year 2|Lost to Follow-up|0
2726669|NCT00195494|9374816|P5|Year 2|Lost to Follow-up|0
2726670|NCT00195494|9374817|P4|Year 2|Lost to Follow-up|1
2726671|NCT00195494|9374818|P3|Year 2|Lost to Follow-up|1
2726672|NCT00195494|9374819|P2|Year 2|Lost to Follow-up|0
2726673|NCT00195494|9374820|P1|Year 2|Lost to Follow-up|0
2726674|NCT00195494|9374815|P6|Year 2|Compliance|0
2726675|NCT00195494|9374816|P5|Year 2|Compliance|0
2726676|NCT00195494|9374817|P4|Year 2|Compliance|2
2726677|NCT00195494|9374818|P3|Year 2|Compliance|0
2726678|NCT00195494|9374819|P2|Year 2|Compliance|0
2726679|NCT00195494|9374820|P1|Year 2|Compliance|1
2726680|NCT00195494|9374815|P6|Year 2|Lack of Efficacy|0
2726681|NCT00195494|9374816|P5|Year 2|Lack of Efficacy|0
2726682|NCT00195494|9374817|P4|Year 2|Lack of Efficacy|7
2726683|NCT00195494|9374818|P3|Year 2|Lack of Efficacy|7
2726684|NCT00195494|9374819|P2|Year 2|Lack of Efficacy|1
2726685|NCT00195494|9374820|P1|Year 2|Lack of Efficacy|0
2726686|NCT00195494|9374815|P6|Year 2|Adverse Event|0
2726687|NCT00195494|9374816|P5|Year 2|Adverse Event|0
2726688|NCT00195494|9374817|P4|Year 2|Adverse Event|9
2726689|NCT00195494|9374818|P3|Year 2|Adverse Event|5
2726690|NCT00195494|9374819|P2|Year 2|Adverse Event|7
2726691|NCT00195494|9374820|P1|Year 2|Adverse Event|3
2726692|NCT00195494|9374815|P6|Year 1|Protocol Violation|1
2726693|NCT00195494|9374816|P5|Year 1|Protocol Violation|1
2726694|NCT00195494|9374817|P4|Year 1|Protocol Violation|0
2726695|NCT00195494|9374818|P3|Year 1|Protocol Violation|0
2726696|NCT00195494|9374819|P2|Year 1|Protocol Violation|0
2726697|NCT00195494|9374820|P1|Year 1|Protocol Violation|0
2726698|NCT00195494|9374815|P6|Year 1|Withdrawal by Subject|9
2726699|NCT00195494|9374816|P5|Year 1|Withdrawal by Subject|8
2726700|NCT00195494|9374817|P4|Year 1|Withdrawal by Subject|0
2726701|NCT00195494|9374818|P3|Year 1|Withdrawal by Subject|0
2726702|NCT00195494|9374819|P2|Year 1|Withdrawal by Subject|0
2726703|NCT00195494|9374820|P1|Year 1|Withdrawal by Subject|0
2726704|NCT00195494|9374815|P6|Year 1|Physician Decision|0
2726705|NCT00195494|9374816|P5|Year 1|Physician Decision|1
2726706|NCT00195494|9374817|P4|Year 1|Physician Decision|0
2726707|NCT00195494|9374818|P3|Year 1|Physician Decision|0
2726708|NCT00195494|9374819|P2|Year 1|Physician Decision|0
2726709|NCT00195494|9374820|P1|Year 1|Physician Decision|0
2726710|NCT00195494|9374815|P6|Year 1|Protocol deviation|3
2726711|NCT00195494|9374816|P5|Year 1|Protocol deviation|2
2726712|NCT00195494|9374817|P4|Year 1|Protocol deviation|0
2726713|NCT00195494|9374818|P3|Year 1|Protocol deviation|0
2726714|NCT00195494|9374819|P2|Year 1|Protocol deviation|0
2726715|NCT00195494|9374820|P1|Year 1|Protocol deviation|0
2726716|NCT00195494|9374815|P6|Year 1|Missed >4 consecutive doses|2
2726717|NCT00195494|9374816|P5|Year 1|Missed >4 consecutive doses|3
2726718|NCT00195494|9374817|P4|Year 1|Missed >4 consecutive doses|0
2726719|NCT00195494|9374818|P3|Year 1|Missed >4 consecutive doses|0
2726720|NCT00195494|9374819|P2|Year 1|Missed >4 consecutive doses|0
2726721|NCT00195494|9374820|P1|Year 1|Missed >4 consecutive doses|0
2726722|NCT00195494|9374815|P6|Year 1|Lost to Follow-up|0
2726723|NCT00195494|9374816|P5|Year 1|Lost to Follow-up|1
2726724|NCT00195494|9374817|P4|Year 1|Lost to Follow-up|0
2726725|NCT00195494|9374818|P3|Year 1|Lost to Follow-up|0
2726726|NCT00195494|9374819|P2|Year 1|Lost to Follow-up|0
2726727|NCT00195494|9374820|P1|Year 1|Lost to Follow-up|0
2726728|NCT00195494|9374815|P6|Year 1|Compliance|1
2726729|NCT00195494|9374816|P5|Year 1|Compliance|5
2726730|NCT00195494|9374817|P4|Year 1|Compliance|0
2726731|NCT00195494|9374818|P3|Year 1|Compliance|0
2726732|NCT00195494|9374819|P2|Year 1|Compliance|0
2726733|NCT00195494|9374820|P1|Year 1|Compliance|0
2726734|NCT00195494|9374815|P6|Year 1|Lack of Efficacy|9
2726735|NCT00195494|9374816|P5|Year 1|Lack of Efficacy|24
2726736|NCT00195494|9374817|P4|Year 1|Lack of Efficacy|0
2726737|NCT00195494|9374818|P3|Year 1|Lack of Efficacy|0
2726738|NCT00195494|9374819|P2|Year 1|Lack of Efficacy|0
2726739|NCT00195494|9374820|P1|Year 1|Lack of Efficacy|0
2726740|NCT00195494|9374815|P6|Year 1|System Toxicity|1
2726741|NCT00195494|9374816|P5|Year 1|System Toxicity|0
2726742|NCT00195494|9374817|P4|Year 1|System Toxicity|0
2726743|NCT00195494|9374818|P3|Year 1|System Toxicity|0
2726744|NCT00195494|9374819|P2|Year 1|System Toxicity|0
2726745|NCT00195494|9374820|P1|Year 1|System Toxicity|0
2726746|NCT00195494|9374815|P6|Year 1|Adverse Event|27
2726747|NCT00195494|9374816|P5|Year 1|Adverse Event|34
2726748|NCT00195494|9374817|P4|Year 1|Adverse Event|0
2726749|NCT00195494|9374818|P3|Year 1|Adverse Event|0
2726750|NCT00195494|9374819|P2|Year 1|Adverse Event|0
2726751|NCT00195494|9374820|P1|Year 1|Adverse Event|0
2726752|NCT00195442|9374838|P1|Overall Study|Other|14
2726753|NCT00195442|9374838|P1|Overall Study|Poor cooperation|2
2726754|NCT00195442|9374838|P1|Overall Study|No reason specified|4
2726755|NCT00195442|9374838|P1|Overall Study|Death|7
2726756|NCT00195442|9374838|P1|Overall Study|Intermittent product shortage|21
2726757|NCT00195442|9374838|P1|Overall Study|Switch to other Factor VIII preparation|23
2726758|NCT00195442|9374838|P1|Overall Study|Lost to Follow-up|27
2726759|NCT00195442|9374838|P1|Overall Study|Less than expected therapeutic effect|38
2726760|NCT00195429|9374857|P2|Overall Study|Lost to Follow-up|0
2726761|NCT00195429|9374858|P1|Overall Study|Lost to Follow-up|1
2726762|NCT00195429|9374857|P2|Overall Study|Lack of Efficacy|1
2726763|NCT00195429|9374858|P1|Overall Study|Lack of Efficacy|2
2726764|NCT00195429|9374857|P2|Overall Study|Adverse Event|4
2726765|NCT00195429|9374858|P1|Overall Study|Adverse Event|2
2726766|NCT00195351|9374874|P2|Overall Study|Lack of Efficacy|1
2726767|NCT00195351|9374875|P1|Overall Study|Lack of Efficacy|0
2726768|NCT00195351|9374874|P2|Overall Study|Death|1
2726769|NCT00195351|9374875|P1|Overall Study|Death|3
2726770|NCT00195351|9374874|P2|Overall Study|Protocol Deviation|2
2726771|NCT00195351|9374875|P1|Overall Study|Protocol Deviation|3
2726772|NCT00195351|9374874|P2|Overall Study|Withdrawal by Subject|3
2726773|NCT00195351|9374875|P1|Overall Study|Withdrawal by Subject|6
2726774|NCT00195351|9374874|P2|Overall Study|Lost to Follow-up|9
2726775|NCT00195351|9374875|P1|Overall Study|Lost to Follow-up|9
2726776|NCT00195338|9374885|P1|Overall Study|Early closure of the site|4
2726777|NCT00195338|9374885|P1|Overall Study|Lack of Efficacy|1
2726778|NCT00195338|9374885|P1|Overall Study|Adverse Event|5
2726779|NCT00195338|9374885|P1|Overall Study|Lost to Follow-up|2
2726780|NCT00195273|9374895|P2|Overall Study|Procedural complications|3
2726781|NCT00195273|9374896|P1|Overall Study|Procedural complications|9
2726782|NCT00195273|9374895|P2|Overall Study|Lack of Efficacy|1
2726783|NCT00195273|9374896|P1|Overall Study|Lack of Efficacy|3
2726784|NCT00195273|9374895|P2|Overall Study|Protocol deviation|1
2726785|NCT00195273|9374896|P1|Overall Study|Protocol deviation|0
2726786|NCT00195273|9374895|P2|Overall Study|Adverse Event|9
2726787|NCT00195273|9374896|P1|Overall Study|Adverse Event|9
2726788|NCT00195260|9374910|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3
2726789|NCT00195260|9374911|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4
2726790|NCT00195260|9374912|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6
2726791|NCT00195260|9374913|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
2726792|NCT00195260|9374914|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
2726793|NCT00195260|9374915|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
2726794|NCT00195260|9374916|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
2726795|NCT00195260|9374917|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
2726796|NCT00195260|9374918|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
2726797|NCT00195260|9374919|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
2726798|NCT00195260|9374920|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
2726799|NCT00195260|9374910|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3
2726800|NCT00195260|9374911|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2
2726801|NCT00195260|9374912|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1
2726802|NCT00195260|9374913|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
2726803|NCT00195260|9374914|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
2726804|NCT00195260|9374915|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
2726805|NCT00195260|9374916|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
2726806|NCT00195260|9374917|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
2726807|NCT00195260|9374918|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
2726808|NCT00195260|9374919|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
2726809|NCT00195260|9374920|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
2726810|NCT00195260|9374910|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2
2726811|NCT00195260|9374911|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3
2726812|NCT00195260|9374912|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5
2726813|NCT00195260|9374913|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
2726814|NCT00195260|9374914|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
2726815|NCT00195260|9374915|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
2726816|NCT00195260|9374916|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
2726817|NCT00195260|9374917|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
2726818|NCT00195260|9374918|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
2726819|NCT00195260|9374919|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
2726820|NCT00195260|9374920|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
2726821|NCT00195260|9374910|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15
2726822|NCT00195260|9374911|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29
2726823|NCT00195260|9374912|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21
2726824|NCT00195260|9374913|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
2726825|NCT00195260|9374914|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
2726826|NCT00195260|9374915|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
2726827|NCT00195260|9374916|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
2726828|NCT00195260|9374917|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
2726829|NCT00195260|9374918|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
2726830|NCT00195260|9374919|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
2726831|NCT00195260|9374920|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
2726832|NCT00195260|9374910|P11|Part 1: Dose Escalation|Symptomatic Deterioration|0
2726833|NCT00195260|9374911|P10|Part 1: Dose Escalation|Symptomatic Deterioration|0
2726834|NCT00195260|9374912|P9|Part 1: Dose Escalation|Symptomatic Deterioration|0
2726835|NCT00195260|9374913|P8|Part 1: Dose Escalation|Symptomatic Deterioration|0
2726836|NCT00195260|9374914|P7|Part 1: Dose Escalation|Symptomatic Deterioration|0
2726837|NCT00195260|9374915|P6|Part 1: Dose Escalation|Symptomatic Deterioration|1
2726838|NCT00195260|9374916|P5|Part 1: Dose Escalation|Symptomatic Deterioration|0
2726839|NCT00195260|9374917|P4|Part 1: Dose Escalation|Symptomatic Deterioration|0
2726840|NCT00195260|9374918|P3|Part 1: Dose Escalation|Symptomatic Deterioration|1
2726841|NCT00195260|9374919|P2|Part 1: Dose Escalation|Symptomatic Deterioration|1
2726842|NCT00195260|9374920|P1|Part 1: Dose Escalation|Symptomatic Deterioration|1
2726843|NCT00195260|9374910|P11|Part 1: Dose Escalation|Disease Progression|0
2726844|NCT00195260|9374911|P10|Part 1: Dose Escalation|Disease Progression|0
2726845|NCT00195260|9374912|P9|Part 1: Dose Escalation|Disease Progression|0
2726846|NCT00195260|9374913|P8|Part 1: Dose Escalation|Disease Progression|4
2726847|NCT00195260|9374914|P7|Part 1: Dose Escalation|Disease Progression|7
2726848|NCT00195260|9374915|P6|Part 1: Dose Escalation|Disease Progression|6
2726849|NCT00195260|9374916|P5|Part 1: Dose Escalation|Disease Progression|4
2726850|NCT00195260|9374917|P4|Part 1: Dose Escalation|Disease Progression|6
2726851|NCT00195260|9374918|P3|Part 1: Dose Escalation|Disease Progression|5
2726852|NCT00195260|9374919|P2|Part 1: Dose Escalation|Disease Progression|2
2726853|NCT00195260|9374920|P1|Part 1: Dose Escalation|Disease Progression|3
2726854|NCT00195260|9374910|P11|Part 1: Dose Escalation|Death|0
2726855|NCT00195260|9374911|P10|Part 1: Dose Escalation|Death|0
2726856|NCT00195260|9374912|P9|Part 1: Dose Escalation|Death|0
2726857|NCT00195260|9374913|P8|Part 1: Dose Escalation|Death|1
2726858|NCT00195260|9374914|P7|Part 1: Dose Escalation|Death|0
2726859|NCT00195260|9374915|P6|Part 1: Dose Escalation|Death|0
2726860|NCT00195260|9374916|P5|Part 1: Dose Escalation|Death|0
2726861|NCT00195260|9374917|P4|Part 1: Dose Escalation|Death|0
2726862|NCT00195260|9374918|P3|Part 1: Dose Escalation|Death|0
2726863|NCT00195260|9374919|P2|Part 1: Dose Escalation|Death|0
2726864|NCT00195260|9374920|P1|Part 1: Dose Escalation|Death|0
2726865|NCT00195260|9374910|P11|Part 1: Dose Escalation|Withdrawal by Subject|0
2726866|NCT00195260|9374911|P10|Part 1: Dose Escalation|Withdrawal by Subject|0
2726867|NCT00195260|9374912|P9|Part 1: Dose Escalation|Withdrawal by Subject|0
2726868|NCT00195260|9374913|P8|Part 1: Dose Escalation|Withdrawal by Subject|1
2726869|NCT00195260|9374914|P7|Part 1: Dose Escalation|Withdrawal by Subject|0
2726870|NCT00195260|9374915|P6|Part 1: Dose Escalation|Withdrawal by Subject|0
2726871|NCT00195260|9374916|P5|Part 1: Dose Escalation|Withdrawal by Subject|2
2726872|NCT00195260|9374917|P4|Part 1: Dose Escalation|Withdrawal by Subject|0
2726873|NCT00195260|9374918|P3|Part 1: Dose Escalation|Withdrawal by Subject|0
2726874|NCT00195260|9374919|P2|Part 1: Dose Escalation|Withdrawal by Subject|0
2726875|NCT00195260|9374920|P1|Part 1: Dose Escalation|Withdrawal by Subject|0
2726876|NCT00195260|9374910|P11|Part 1: Dose Escalation|Adverse Event|0
2726877|NCT00195260|9374911|P10|Part 1: Dose Escalation|Adverse Event|0
2726878|NCT00195260|9374912|P9|Part 1: Dose Escalation|Adverse Event|0
2726879|NCT00195260|9374913|P8|Part 1: Dose Escalation|Adverse Event|0
2726880|NCT00195260|9374914|P7|Part 1: Dose Escalation|Adverse Event|3
2726881|NCT00195260|9374915|P6|Part 1: Dose Escalation|Adverse Event|0
2726882|NCT00195260|9374916|P5|Part 1: Dose Escalation|Adverse Event|1
2726883|NCT00195260|9374917|P4|Part 1: Dose Escalation|Adverse Event|1
2726884|NCT00195260|9374918|P3|Part 1: Dose Escalation|Adverse Event|0
2726885|NCT00195260|9374919|P2|Part 1: Dose Escalation|Adverse Event|1
2726886|NCT00195260|9374920|P1|Part 1: Dose Escalation|Adverse Event|0
2726887|NCT00194987|9375088|P2|Overall Study|Withdrawal by Subject|3
2726888|NCT00194987|9375089|P1|Overall Study|Withdrawal by Subject|0
2726889|NCT00194792|9375122|P1|Overall Study|Withdrawal by Subject|1
2726890|NCT00194675|9375146|P2|Overall Study|Death|0
2726891|NCT00194675|9375147|P1|Overall Study|Death|1
2726892|NCT00194675|9375146|P2|Overall Study|Protocol Violation|0
2726893|NCT00194675|9375147|P1|Overall Study|Protocol Violation|1
2726894|NCT00194675|9375146|P2|Overall Study|"withdrew due to edgy feeling"|0
2726895|NCT00194675|9375147|P1|Overall Study|"withdrew due to edgy feeling"|1
2726896|NCT00194675|9375146|P2|Overall Study|lack of interest|1
2726897|NCT00194675|9375147|P1|Overall Study|lack of interest|1
2726898|NCT00194675|9375146|P2|Overall Study|Lost to Follow-up|1
2726899|NCT00194675|9375147|P1|Overall Study|Lost to Follow-up|1
2726900|NCT00194077|9375222|P2|Overall Study|Withdrawal by Subject|1
2726901|NCT00194077|9375223|P1|Overall Study|Withdrawal by Subject|1
2726902|NCT00194077|9375222|P2|Overall Study|Study nonadherence|0
2726903|NCT00194077|9375223|P1|Overall Study|Study nonadherence|1
2726904|NCT00194077|9375222|P2|Overall Study|Lack of Efficacy|29
2726905|NCT00194077|9375223|P1|Overall Study|Lack of Efficacy|22
2726906|NCT00194025|9375229|P1|Overall Study|non-adherence with study medication|4
2726907|NCT00194025|9375229|P1|Overall Study|Adverse Event|1
2726908|NCT00194012|9375244|P2|Open Label Extension (OLE)|Lack of Efficacy|0
2726909|NCT00194012|9375245|P1|Open Label Extension (OLE)|Lack of Efficacy|1
2726910|NCT00194012|9375244|P2|Open Label Extension (OLE)|Lost to Follow-up|5
2726911|NCT00194012|9375245|P1|Open Label Extension (OLE)|Lost to Follow-up|3
2726912|NCT00194012|9375244|P2|Open Label Extension (OLE)|Drowsiness; Jittery|1
2726913|NCT00194012|9375245|P1|Open Label Extension (OLE)|Drowsiness; Jittery|0
2726914|NCT00194012|9375244|P2|Open Label Extension (OLE)|Weight Gain|0
2726915|NCT00194012|9375245|P1|Open Label Extension (OLE)|Weight Gain|1
2726916|NCT00194012|9375244|P2|Randomized Phase|Oral/nasal twitching|1
2726917|NCT00194012|9375245|P1|Randomized Phase|Oral/nasal twitching|0
2726918|NCT00194012|9375244|P2|Randomized Phase|Emesis and enuresis|1
2726919|NCT00194012|9375245|P1|Randomized Phase|Emesis and enuresis|0
2726920|NCT00194012|9375244|P2|Randomized Phase|Participant reported having a rash|0
2726921|NCT00194012|9375245|P1|Randomized Phase|Participant reported having a rash|1
2726922|NCT00194012|9375244|P2|Randomized Phase|Adverse Event|1
2726923|NCT00194012|9375245|P1|Randomized Phase|Adverse Event|2
2726924|NCT00194012|9375244|P2|Randomized Phase|Withdrawal by Subject|3
2726925|NCT00194012|9375245|P1|Randomized Phase|Withdrawal by Subject|3
2726926|NCT00194012|9375244|P2|Randomized Phase|Study nonadherence|1
2726927|NCT00194012|9375245|P1|Randomized Phase|Study nonadherence|2
2726928|NCT00194012|9375244|P2|Randomized Phase|Lack of Efficacy|18
2726929|NCT00194012|9375245|P1|Randomized Phase|Lack of Efficacy|8
2726930|NCT00193609|9375281|P1|Overall Study|Adverse Event|2
2726931|NCT00193609|9375281|P1|Overall Study|Lack of Efficacy|2
2726932|NCT00193479|9375308|P1|Induction Chemotherapy|Disease Progression|1
2726933|NCT00193479|9375308|P1|Induction Chemotherapy|Adverse Event|2
2726934|NCT00193206|9375349|P1|Postoperative Therapy|Protocol Violation|1
2726935|NCT00193206|9375349|P1|Postoperative Therapy|Lack of Efficacy|1
2726936|NCT00193206|9375349|P1|Postoperative Therapy|Intercurrent Illness|2
2726937|NCT00193206|9375349|P1|Postoperative Therapy|Physician Decision|3
2726938|NCT00193206|9375349|P1|Postoperative Therapy|Withdrawal by Subject|7
2726939|NCT00193206|9375349|P1|Preoperative Therapy|False Positive Pregnancy Test|1
2726940|NCT00193206|9375349|P1|Preoperative Therapy|Withdrawal by Subject|2
2726941|NCT00193206|9375349|P1|Preoperative Therapy|Adverse Event|2
2726942|NCT00193206|9375349|P1|Preoperative Therapy|Lack of Efficacy|2
2726943|NCT00193180|9375353|P1|Overall Study|Protocol Violation|1
2726944|NCT00193180|9375353|P1|Overall Study|Adverse Event|8
2726945|NCT00193180|9375353|P1|Overall Study|Lack of Efficacy|1
2726946|NCT00193063|9375368|P1|Overall Study|Adverse Event|1
2726947|NCT00193063|9375368|P1|Overall Study|Lack of Efficacy|3
2726948|NCT00193050|9375374|P1|Adjuvant|Lack of Efficacy|2
2726949|NCT00193050|9375374|P1|Adjuvant|Intercurrent Hospitalization|3
2726950|NCT00193050|9375374|P1|Adjuvant|Physician Decision|5
2726951|NCT00193050|9375374|P1|Neoadjuvant Treatment|Adverse Event|2
2726952|NCT00193050|9375374|P1|Neoadjuvant Treatment|Physician Decision|2
2726953|NCT00193050|9375374|P1|Neoadjuvant Treatment|Intercurrent Illness|3
2726954|NCT00193050|9375374|P1|Neoadjuvant Treatment|Lack of Efficacy|2
2726955|NCT00192647|9375391|P2|Overall Study|Other/Administrative|3
2726956|NCT00192647|9375392|P1|Overall Study|Other/Administrative|5
2726957|NCT00192647|9375391|P2|Overall Study|Failure to Return|13
2726958|NCT00192647|9375392|P1|Overall Study|Failure to Return|11
2726959|NCT00192647|9375391|P2|Overall Study|Refused Treatment/Did not Cooperate|8
2726960|NCT00192647|9375392|P1|Overall Study|Refused Treatment/Did not Cooperate|10
2726961|NCT00192647|9375391|P2|Overall Study|Protocol Violation|1
2726962|NCT00192647|9375392|P1|Overall Study|Protocol Violation|3
2726963|NCT00192647|9375391|P2|Overall Study|Entry Criteria Violation|6
2726964|NCT00192647|9375392|P1|Overall Study|Entry Criteria Violation|6
2726965|NCT00192647|9375391|P2|Overall Study|Insufficient Therapeutic Response|83
2726966|NCT00192647|9375392|P1|Overall Study|Insufficient Therapeutic Response|53
2726967|NCT00192647|9375391|P2|Overall Study|Laboratory Test Abnormality|2
2726968|NCT00192647|9375392|P1|Overall Study|Laboratory Test Abnormality|4
2726969|NCT00192647|9375391|P2|Overall Study|Adverse Event|29
2726970|NCT00192647|9375392|P1|Overall Study|Adverse Event|35
2726971|NCT00192647|9375391|P2|Overall Study|Death|1
2726972|NCT00192647|9375392|P1|Overall Study|Death|1
2726973|NCT00192296|9375412|P4|Overall Study|Withdrawal by Subject|0
2726974|NCT00192296|9375413|P3|Overall Study|Withdrawal by Subject|0
2726975|NCT00192296|9375414|P2|Overall Study|Withdrawal by Subject|1
2726976|NCT00192296|9375415|P1|Overall Study|Withdrawal by Subject|0
2726977|NCT00192075|9375471|P2|Overall Study|Other|2
2726978|NCT00192075|9375472|P1|Overall Study|Other|5
2726979|NCT00192075|9375471|P2|Overall Study|Unacceptable Toxicity Exhibited by Drug|1
2726980|NCT00192075|9375472|P1|Overall Study|Unacceptable Toxicity Exhibited by Drug|2
2726981|NCT00192075|9375471|P2|Overall Study|Patient Non-Compliance|1
2726982|NCT00192075|9375472|P1|Overall Study|Patient Non-Compliance|0
2726983|NCT00192075|9375471|P2|Overall Study|Withdrawal by Subject|5
2726984|NCT00192075|9375472|P1|Overall Study|Withdrawal by Subject|5
2726985|NCT00192075|9375471|P2|Overall Study|Physician Decision|0
2726986|NCT00192075|9375472|P1|Overall Study|Physician Decision|3
2726987|NCT00192075|9375471|P2|Overall Study|Lack of Efficacy|0
2726988|NCT00192075|9375472|P1|Overall Study|Lack of Efficacy|0
2726989|NCT00192075|9375471|P2|Overall Study|Death|1
2726990|NCT00192075|9375472|P1|Overall Study|Death|0
2726991|NCT00192075|9375471|P2|Overall Study|Adverse Event|3
2726992|NCT00192075|9375472|P1|Overall Study|Adverse Event|1
2726993|NCT00192075|9375471|P2|Overall Study|Disease Progression|6
2726994|NCT00192075|9375472|P1|Overall Study|Disease Progression|23
2726995|NCT00192036|9375497|P1|Overall Study|Unknown or Not Specified|5
2726996|NCT00192036|9375497|P1|Overall Study|Death|1
2726997|NCT00192036|9375497|P1|Overall Study|Clinical Disease Progression|1
2726998|NCT00192036|9375497|P1|Overall Study|Objective Tumor Progression|4
2726999|NCT00192036|9375497|P1|Overall Study|Patient/Physician Perception|1
2727000|NCT00192036|9375497|P1|Overall Study|Adverse Event|6
2727001|NCT00192036|9375497|P1|Overall Study|Protocol Violation|3
2727002|NCT00192023|9375507|P2|Period IV - Optional Open-Label|Physician Decision|0
2727003|NCT00192023|9375508|P1|Period IV - Optional Open-Label|Physician Decision|9
2727004|NCT00192023|9375507|P2|Period IV - Optional Open-Label|Withdrawal by Subject|0
2727005|NCT00192023|9375508|P1|Period IV - Optional Open-Label|Withdrawal by Subject|4
2727006|NCT00192023|9375507|P2|Period IV - Optional Open-Label|Protocol Violation|0
2727007|NCT00192023|9375508|P1|Period IV - Optional Open-Label|Protocol Violation|1
2727008|NCT00192023|9375507|P2|Period IV - Optional Open-Label|Lost to Follow-up|0
2727009|NCT00192023|9375508|P1|Period IV - Optional Open-Label|Lost to Follow-up|2
2727010|NCT00192023|9375507|P2|Period IV - Optional Open-Label|Patient/Caregiver Decision|0
2727011|NCT00192023|9375508|P1|Period IV - Optional Open-Label|Patient/Caregiver Decision|46
2727012|NCT00192023|9375507|P2|Period IV - Optional Open-Label|Lack of Efficacy|0
2727013|NCT00192023|9375508|P1|Period IV - Optional Open-Label|Lack of Efficacy|7
2727014|NCT00192023|9375507|P2|Period IV - Optional Open-Label|Adverse Event|0
2727015|NCT00192023|9375508|P1|Period IV - Optional Open-Label|Adverse Event|6
2727016|NCT00192023|9375507|P2|Period III - Double-Blind|Parent/Caregiver Decision|0
2727017|NCT00192023|9375508|P1|Period III - Double-Blind|Parent/Caregiver Decision|2
2727018|NCT00192023|9375507|P2|Period III - Double-Blind|Physician Decision|0
2727019|NCT00192023|9375508|P1|Period III - Double-Blind|Physician Decision|2
2727020|NCT00192023|9375507|P2|Period III - Double-Blind|Adverse Event|0
2727021|NCT00192023|9375508|P1|Period III - Double-Blind|Adverse Event|3
2727022|NCT00191984|9375530|P1|Overall Study|Physician Decision|4
2727023|NCT00191984|9375530|P1|Overall Study|Withdrawal by Subject|7
2727024|NCT00191984|9375530|P1|Overall Study|Entry Criteria Exclusion|1
2727025|NCT00191984|9375530|P1|Overall Study|Death|2
2727026|NCT00191984|9375530|P1|Overall Study|Adverse Event|4
2727027|NCT00191984|9375530|P1|Overall Study|Disease Progression|21
2727028|NCT00191945|9375540|P2|Double-Blind Acute Treatment|Physician Decision|2
2727029|NCT00191945|9375541|P1|Double-Blind Acute Treatment|Physician Decision|0
2727030|NCT00191945|9375540|P2|Double-Blind Acute Treatment|Non Protocol Compliance|0
2727031|NCT00191945|9375541|P1|Double-Blind Acute Treatment|Non Protocol Compliance|3
2727032|NCT00191945|9375540|P2|Double-Blind Acute Treatment|Lost to Follow-up|1
2727033|NCT00191945|9375541|P1|Double-Blind Acute Treatment|Lost to Follow-up|0
2727034|NCT00191945|9375540|P2|Double-Blind Acute Treatment|Parent's Decision|0
2727035|NCT00191945|9375541|P1|Double-Blind Acute Treatment|Parent's Decision|3
2727036|NCT00191906|9375577|P4|Study Period III|Lack of Efficacy|0
2727037|NCT00191906|9375578|P3|Study Period III|Lack of Efficacy|0
2727038|NCT00191906|9375579|P2|Study Period III|Lack of Efficacy|3
2727039|NCT00191906|9375580|P1|Study Period III|Lack of Efficacy|3
2727040|NCT00191906|9375577|P4|Study Period III|Parent/Caregiver Decision|0
2727041|NCT00191906|9375578|P3|Study Period III|Parent/Caregiver Decision|0
2727042|NCT00191906|9375579|P2|Study Period III|Parent/Caregiver Decision|0
2727043|NCT00191906|9375580|P1|Study Period III|Parent/Caregiver Decision|1
2727044|NCT00191906|9375577|P4|Study Period III|Lost to Follow-up|0
2727045|NCT00191906|9375578|P3|Study Period III|Lost to Follow-up|0
2727046|NCT00191906|9375579|P2|Study Period III|Lost to Follow-up|1
2727047|NCT00191906|9375580|P1|Study Period III|Lost to Follow-up|0
2727048|NCT00191906|9375577|P4|Study Period III|Adverse Event|0
2727049|NCT00191906|9375578|P3|Study Period III|Adverse Event|0
2727050|NCT00191906|9375579|P2|Study Period III|Adverse Event|0
2727051|NCT00191906|9375580|P1|Study Period III|Adverse Event|1
2727052|NCT00191906|9375577|P4|Study Period II|Entry Criteria Exclusion|0
2727053|NCT00191906|9375578|P3|Study Period II|Entry Criteria Exclusion|1
2727054|NCT00191906|9375579|P2|Study Period II|Entry Criteria Exclusion|0
2727055|NCT00191906|9375580|P1|Study Period II|Entry Criteria Exclusion|0
2727056|NCT00191906|9375577|P4|Study Period II|Parent/Caregiver Decision|0
2727057|NCT00191906|9375578|P3|Study Period II|Parent/Caregiver Decision|0
2727058|NCT00191906|9375579|P2|Study Period II|Parent/Caregiver Decision|1
2727059|NCT00191906|9375580|P1|Study Period II|Parent/Caregiver Decision|0
2727060|NCT00191906|9375577|P4|Study Period II|Withdrawal by Subject|0
2727061|NCT00191906|9375578|P3|Study Period II|Withdrawal by Subject|0
2727062|NCT00191906|9375579|P2|Study Period II|Withdrawal by Subject|3
2727063|NCT00191906|9375580|P1|Study Period II|Withdrawal by Subject|0
2727064|NCT00191906|9375577|P4|Study Period II|Adverse Event|0
2727065|NCT00191906|9375578|P3|Study Period II|Adverse Event|0
2727066|NCT00191906|9375579|P2|Study Period II|Adverse Event|1
2727067|NCT00191906|9375580|P1|Study Period II|Adverse Event|0
2727068|NCT00191854|9375623|P3|Overall Study|Screen Failure|1
2727069|NCT00191854|9375624|P2|Overall Study|Screen Failure|0
2727070|NCT00191854|9375625|P1|Overall Study|Screen Failure|0
2727071|NCT00191854|9375623|P3|Overall Study|Sponsor Decision|1
2727072|NCT00191854|9375624|P2|Overall Study|Sponsor Decision|0
2727073|NCT00191854|9375625|P1|Overall Study|Sponsor Decision|0
2727074|NCT00191854|9375623|P3|Overall Study|Withdrawal by Subject|3
2727075|NCT00191854|9375624|P2|Overall Study|Withdrawal by Subject|2
2727076|NCT00191854|9375625|P1|Overall Study|Withdrawal by Subject|4
2727077|NCT00191854|9375623|P3|Overall Study|Lost to Follow-up|5
2727078|NCT00191854|9375624|P2|Overall Study|Lost to Follow-up|5
2727079|NCT00191854|9375625|P1|Overall Study|Lost to Follow-up|7
2727080|NCT00191854|9375623|P3|Overall Study|Death|29
2727081|NCT00191854|9375624|P2|Overall Study|Death|23
2727082|NCT00191854|9375625|P1|Overall Study|Death|26
2727083|NCT00191815|9375645|P1|Overall Study|Withdrawal by Subject|7
2727084|NCT00191815|9375645|P1|Overall Study|Physician Decision|2
2727085|NCT00191815|9375645|P1|Overall Study|Protocol Violation|3
2727086|NCT00191815|9375645|P1|Overall Study|Death|2
2727087|NCT00191815|9375645|P1|Overall Study|Disease progression or relapse|24
2727088|NCT00191815|9375645|P1|Overall Study|Adverse Event|2
2727089|NCT00191789|9375657|P1|Overall Study|Death - Not Study-Drug Related|1
2727090|NCT00191789|9375657|P1|Overall Study|Progressive Disease/Lack of Efficacy|2
2727091|NCT00191789|9375657|P1|Overall Study|Death - Possibly Study Drug Related|4
2727092|NCT00191789|9375657|P1|Overall Study|Withdrawal by Subject|4
2727093|NCT00191789|9375657|P1|Overall Study|Patient/Physician: Satisfactory Response|4
2727094|NCT00191789|9375657|P1|Overall Study|Patient: Satisfactory Response|5
2727095|NCT00191789|9375657|P1|Overall Study|Adverse Event|5
2727096|NCT00191724|9375674|P5|Overall Study|Withdrawal by Subject|0
2727097|NCT00191724|9375675|P4|Overall Study|Withdrawal by Subject|1
2727098|NCT00191724|9375676|P3|Overall Study|Withdrawal by Subject|0
2727099|NCT00191724|9375677|P2|Overall Study|Withdrawal by Subject|0
2727100|NCT00191724|9375678|P1|Overall Study|Withdrawal by Subject|0
2727101|NCT00191724|9375674|P5|Overall Study|Lost to Follow-up|3
2727102|NCT00191724|9375675|P4|Overall Study|Lost to Follow-up|2
2727103|NCT00191724|9375676|P3|Overall Study|Lost to Follow-up|0
2727104|NCT00191724|9375677|P2|Overall Study|Lost to Follow-up|1
2727105|NCT00191724|9375678|P1|Overall Study|Lost to Follow-up|1
2727106|NCT00191724|9375674|P5|Overall Study|Adverse Event|0
2727107|NCT00191724|9375675|P4|Overall Study|Adverse Event|0
2727108|NCT00191724|9375676|P3|Overall Study|Adverse Event|1
2727109|NCT00191724|9375677|P2|Overall Study|Adverse Event|0
2727110|NCT00191724|9375678|P1|Overall Study|Adverse Event|0
2727111|NCT00191646|9375707|P2|Overall Study|Missing Data|11
2727112|NCT00191646|9375708|P1|Overall Study|Missing Data|18
2727113|NCT00191646|9375707|P2|Overall Study|Other|34
2727114|NCT00191646|9375708|P1|Overall Study|Other|33
2727115|NCT00191646|9375707|P2|Overall Study|Death|8
2727116|NCT00191646|9375708|P1|Overall Study|Death|6
2727117|NCT00191646|9375707|P2|Overall Study|Protocol Violation|7
2727118|NCT00191646|9375708|P1|Overall Study|Protocol Violation|5
2727119|NCT00191646|9375707|P2|Overall Study|Withdrawal by Subject|39
2727120|NCT00191646|9375708|P1|Overall Study|Withdrawal by Subject|58
2727121|NCT00191646|9375707|P2|Overall Study|Physician Decision|11
2727122|NCT00191646|9375708|P1|Overall Study|Physician Decision|20
2727123|NCT00191646|9375707|P2|Overall Study|Disease Progression|6
2727124|NCT00191646|9375708|P1|Overall Study|Disease Progression|5
2727125|NCT00191646|9375707|P2|Overall Study|Toxicity|37
2727126|NCT00191646|9375708|P1|Overall Study|Toxicity|26
2727127|NCT00191477|9375728|P2|Overall Study|Discontinued Prior to Instillation|14
2727128|NCT00191477|9375729|P1|Overall Study|Discontinued Prior to Instillation|13
2727129|NCT00191477|9375728|P2|Overall Study|Pathological Specimen Lost|0
2727130|NCT00191477|9375729|P1|Overall Study|Pathological Specimen Lost|1
2727131|NCT00191477|9375728|P2|Overall Study|Not Eligible|38
2727132|NCT00191477|9375729|P1|Overall Study|Not Eligible|41
2727133|NCT00191477|9375728|P2|Overall Study|Other|0
2727134|NCT00191477|9375729|P1|Overall Study|Other|2
2727135|NCT00191477|9375728|P2|Overall Study|Withdrawal by Subject|0
2727136|NCT00191477|9375729|P1|Overall Study|Withdrawal by Subject|2
2727137|NCT00191477|9375728|P2|Overall Study|Treatment Change|0
2727138|NCT00191477|9375729|P1|Overall Study|Treatment Change|2
2727139|NCT00191477|9375728|P2|Overall Study|Protocol Violation|1
2727140|NCT00191477|9375729|P1|Overall Study|Protocol Violation|1
2727141|NCT00191477|9375728|P2|Overall Study|Lost to Follow-up|21
2727142|NCT00191477|9375729|P1|Overall Study|Lost to Follow-up|23
2727143|NCT00191477|9375728|P2|Overall Study|Death, Other Cause|6
2727144|NCT00191477|9375729|P1|Overall Study|Death, Other Cause|3
2727145|NCT00191477|9375728|P2|Overall Study|Death, Study Disease|1
2727146|NCT00191477|9375729|P1|Overall Study|Death, Study Disease|1
2727147|NCT00191477|9375728|P2|Overall Study|Tumor Recurrence|48
2727148|NCT00191477|9375729|P1|Overall Study|Tumor Recurrence|49
2727149|NCT00191451|9375748|P3|Overall Study|Reason Not Specified|3
2727150|NCT00191451|9375749|P2|Overall Study|Reason Not Specified|1
2727151|NCT00191451|9375750|P1|Overall Study|Reason Not Specified|2
2727152|NCT00191451|9375748|P3|Overall Study|Ineligible|0
2727153|NCT00191451|9375749|P2|Overall Study|Ineligible|1
2727154|NCT00191451|9375750|P1|Overall Study|Ineligible|0
2727155|NCT00191451|9375748|P3|Overall Study|Sponsor Decision|0
2727156|NCT00191451|9375749|P2|Overall Study|Sponsor Decision|0
2727157|NCT00191451|9375750|P1|Overall Study|Sponsor Decision|1
2727158|NCT00191451|9375748|P3|Overall Study|Physician Decision|6
2727159|NCT00191451|9375749|P2|Overall Study|Physician Decision|9
2727160|NCT00191451|9375750|P1|Overall Study|Physician Decision|2
2727161|NCT00191451|9375748|P3|Overall Study|Withdrawal by Subject|5
2727162|NCT00191451|9375749|P2|Overall Study|Withdrawal by Subject|3
2727163|NCT00191451|9375750|P1|Overall Study|Withdrawal by Subject|2
2727164|NCT00191386|9375770|P1|Overall Study|Lack of Efficacy|15
2727165|NCT00191386|9375770|P1|Overall Study|Physician Decision|11
2727166|NCT00191386|9375770|P1|Overall Study|Withdrawal by Subject|96
2727167|NCT00191386|9375770|P1|Overall Study|Protocol Violation|18
2727168|NCT00191386|9375770|P1|Overall Study|Entry Criteria Exclusion|3
2727169|NCT00191386|9375770|P1|Overall Study|Lost to Follow-up|1
2727170|NCT00191386|9375770|P1|Overall Study|Adverse Event|16
2727171|NCT00191334|9375777|P1|Overall Study|Withdrawal by Subject|4
2727172|NCT00191334|9375777|P1|Overall Study|Physician Decision|1
2727173|NCT00191334|9375777|P1|Overall Study|Disease Progression or Relapse|8
2727174|NCT00191334|9375777|P1|Overall Study|Adverse Event|4
2727175|NCT00191308|9375785|P1|Overall Study|Adverse Event|1
2727176|NCT00191282|9375795|P2|Overall Study|Lost to Follow-up|31
2727177|NCT00191282|9375796|P1|Overall Study|Lost to Follow-up|24
2727178|NCT00191282|9375795|P2|Overall Study|Sponsor's decision|2
2727179|NCT00191282|9375796|P1|Overall Study|Sponsor's decision|2
2727180|NCT00191282|9375795|P2|Overall Study|Severity of outcome|5
2727181|NCT00191282|9375796|P1|Overall Study|Severity of outcome|2
2727182|NCT00191282|9375795|P2|Overall Study|Protocol Violation|12
2727183|NCT00191282|9375796|P1|Overall Study|Protocol Violation|9
2727184|NCT00191282|9375795|P2|Overall Study|Protocol entry criteria not met|9
2727185|NCT00191282|9375796|P1|Overall Study|Protocol entry criteria not met|14
2727186|NCT00191282|9375795|P2|Overall Study|Physician Decision|15
2727187|NCT00191282|9375796|P1|Overall Study|Physician Decision|18
2727188|NCT00191282|9375795|P2|Overall Study|Withdrawal by Subject|44
2727189|NCT00191282|9375796|P1|Overall Study|Withdrawal by Subject|59
2727190|NCT00191282|9375795|P2|Overall Study|Patient moved|14
2727191|NCT00191282|9375796|P1|Overall Study|Patient moved|11
2727192|NCT00191282|9375795|P2|Overall Study|Noncompliance|17
2727193|NCT00191282|9375796|P1|Overall Study|Noncompliance|14
2727194|NCT00191282|9375795|P2|Overall Study|Lack of Efficacy|6
2727195|NCT00191282|9375796|P1|Overall Study|Lack of Efficacy|11
2727196|NCT00191282|9375795|P2|Overall Study|Death|51
2727197|NCT00191282|9375796|P1|Overall Study|Death|51
2727198|NCT00191282|9375795|P2|Overall Study|Adverse Event|6
2727199|NCT00191282|9375796|P1|Overall Study|Adverse Event|5
2727200|NCT00191269|9375856|P2|Overall Study|Physician Decision|3
2727201|NCT00191269|9375857|P1|Overall Study|Physician Decision|0
2727202|NCT00191269|9375856|P2|Overall Study|Pathologic Aggrevation|1
2727203|NCT00191269|9375857|P1|Overall Study|Pathologic Aggrevation|0
2727204|NCT00191269|9375856|P2|Overall Study|Withdrawal by Subject|1
2727205|NCT00191269|9375857|P1|Overall Study|Withdrawal by Subject|0
2727206|NCT00191269|9375856|P2|Overall Study|Lack of Efficacy|5
2727207|NCT00191269|9375857|P1|Overall Study|Lack of Efficacy|1
2727208|NCT00191269|9375856|P2|Overall Study|Progression of Disease|42
2727209|NCT00191269|9375857|P1|Overall Study|Progression of Disease|4
2727210|NCT00191269|9375856|P2|Overall Study|Adverse Event|4
2727211|NCT00191269|9375857|P1|Overall Study|Adverse Event|1
2727212|NCT00191269|9375856|P2|Overall Study|Protocol Violation|2
2727213|NCT00191269|9375857|P1|Overall Study|Protocol Violation|0
2727214|NCT00191191|9375873|P2|Overall Study|Good Clinical Practice Violation|1
2727215|NCT00191191|9375874|P1|Overall Study|Good Clinical Practice Violation|0
2727216|NCT00191191|9375873|P2|Overall Study|Physician Decision|2
2727217|NCT00191191|9375874|P1|Overall Study|Physician Decision|3
2727218|NCT00191191|9375873|P2|Overall Study|Lost to Follow-up|0
2727219|NCT00191191|9375874|P1|Overall Study|Lost to Follow-up|1
2727220|NCT00191191|9375873|P2|Overall Study|Family/Caregiver Decision|7
2727221|NCT00191191|9375874|P1|Overall Study|Family/Caregiver Decision|5
2727222|NCT00191191|9375873|P2|Overall Study|Toxicity After Dose Reduction|8
2727223|NCT00191191|9375874|P1|Overall Study|Toxicity After Dose Reduction|7
2727224|NCT00191191|9375873|P2|Overall Study|Progressive Disease|72
2727225|NCT00191191|9375874|P1|Overall Study|Progressive Disease|84
2727226|NCT00191191|9375873|P2|Overall Study|Adverse Event|21
2727227|NCT00191191|9375874|P1|Overall Study|Adverse Event|11
2727228|NCT00191191|9375873|P2|Overall Study|Treated with Another Systemic Agent|1
2727229|NCT00191191|9375874|P1|Overall Study|Treated with Another Systemic Agent|1
2727230|NCT00191191|9375873|P2|Overall Study|Entry Criteria Exclusion|0
2727231|NCT00191191|9375874|P1|Overall Study|Entry Criteria Exclusion|2
2727232|NCT00191165|9375890|P2|Overall Study|Participant Moved Away|1
2727233|NCT00191165|9375891|P1|Overall Study|Participant Moved Away|0
2727234|NCT00191165|9375890|P2|Overall Study|Protocol Violation|1
2727235|NCT00191165|9375891|P1|Overall Study|Protocol Violation|0
2727236|NCT00191165|9375890|P2|Overall Study|Adverse Event|0
2727237|NCT00191165|9375891|P1|Overall Study|Adverse Event|2
2727238|NCT00191152|9375903|P2|Crossover Treatment|Other|3
2727239|NCT00191152|9375904|P1|Crossover Treatment|Other|4
2727240|NCT00191152|9375903|P2|Crossover Treatment|Lost to Follow-up|1
2727241|NCT00191152|9375904|P1|Crossover Treatment|Lost to Follow-up|2
2727242|NCT00191152|9375903|P2|Crossover Treatment|Withdrawal by Subject|9
2727243|NCT00191152|9375904|P1|Crossover Treatment|Withdrawal by Subject|6
2727244|NCT00191152|9375903|P2|Crossover Treatment|Physician Decision|7
2727245|NCT00191152|9375904|P1|Crossover Treatment|Physician Decision|7
2727246|NCT00191152|9375903|P2|Crossover Treatment|Adverse Event|8
2727247|NCT00191152|9375904|P1|Crossover Treatment|Adverse Event|8
2727248|NCT00191152|9375903|P2|Initial Treatment|Other|21
2727249|NCT00191152|9375904|P1|Initial Treatment|Other|18
2727250|NCT00191152|9375903|P2|Initial Treatment|Lost to Follow-up|6
2727251|NCT00191152|9375904|P1|Initial Treatment|Lost to Follow-up|0
2727252|NCT00191152|9375903|P2|Initial Treatment|Withdrawal by Subject|28
2727253|NCT00191152|9375904|P1|Initial Treatment|Withdrawal by Subject|40
2727254|NCT00191152|9375903|P2|Initial Treatment|Physician Decision|31
2727255|NCT00191152|9375904|P1|Initial Treatment|Physician Decision|40
2727256|NCT00191152|9375903|P2|Initial Treatment|Adverse Event|67
2727257|NCT00191152|9375904|P1|Initial Treatment|Adverse Event|43
2727258|NCT00191139|9375936|P2|Overall Study|Other|2
2727259|NCT00191139|9375937|P1|Overall Study|Other|1
2727260|NCT00191139|9375936|P2|Overall Study|Disease Progression|1
2727261|NCT00191139|9375937|P1|Overall Study|Disease Progression|0
2727262|NCT00191139|9375936|P2|Overall Study|Withdrawal by Subject|3
2727263|NCT00191139|9375937|P1|Overall Study|Withdrawal by Subject|0
2727264|NCT00191139|9375936|P2|Overall Study|Death|0
2727265|NCT00191139|9375937|P1|Overall Study|Death|2
2727266|NCT00191139|9375936|P2|Overall Study|Adverse Event|6
2727267|NCT00191139|9375937|P1|Overall Study|Adverse Event|2
2727268|NCT00191113|9375953|P2|Core Study|Death|0
2727269|NCT00191113|9375954|P1|Core Study|Death|1
2727270|NCT00191113|9375953|P2|Core Study|Lack of Efficacy|2
2727271|NCT00191113|9375954|P1|Core Study|Lack of Efficacy|0
2727272|NCT00191113|9375953|P2|Core Study|Adverse Event|2
2727273|NCT00191113|9375954|P1|Core Study|Adverse Event|0
2727274|NCT00191113|9375953|P2|Core Study|Lost to Follow-up|0
2727275|NCT00191113|9375954|P1|Core Study|Lost to Follow-up|3
2727276|NCT00191113|9375953|P2|Core Study|Protocol Violation|2
2727277|NCT00191113|9375954|P1|Core Study|Protocol Violation|6
2727278|NCT00191113|9375953|P2|Core Study|Withdrawal by Subject|9
2727279|NCT00191113|9375954|P1|Core Study|Withdrawal by Subject|25
2727280|NCT00191100|9375996|P2|Overall Study|Reason Not Specified|1
2727281|NCT00191100|9375997|P1|Overall Study|Reason Not Specified|0
2727282|NCT00191100|9375996|P2|Overall Study|Death from Other Cause|0
2727283|NCT00191100|9375997|P1|Overall Study|Death from Other Cause|1
2727284|NCT00191100|9375996|P2|Overall Study|Protocol Violation|1
2727285|NCT00191100|9375997|P1|Overall Study|Protocol Violation|1
2727286|NCT00191100|9375996|P2|Overall Study|Death from Study Drug Toxicity|0
2727287|NCT00191100|9375997|P1|Overall Study|Death from Study Drug Toxicity|2
2727288|NCT00191100|9375996|P2|Overall Study|Physician Decision|1
2727289|NCT00191100|9375997|P1|Overall Study|Physician Decision|3
2727290|NCT00191100|9375996|P2|Overall Study|Lack of Efficacy, Stable Disease|0
2727291|NCT00191100|9375997|P1|Overall Study|Lack of Efficacy, Stable Disease|1
2727292|NCT00191100|9375996|P2|Overall Study|Lack of Efficacy, Progressive Disease|2
2727293|NCT00191100|9375997|P1|Overall Study|Lack of Efficacy, Progressive Disease|1
2727294|NCT00191100|9375996|P2|Overall Study|Clinical Relapse|1
2727295|NCT00191100|9375997|P1|Overall Study|Clinical Relapse|2
2727296|NCT00191100|9375996|P2|Overall Study|Protocol Entry Criteria Not Met|1
2727297|NCT00191100|9375997|P1|Overall Study|Protocol Entry Criteria Not Met|2
2727298|NCT00191100|9375996|P2|Overall Study|Withdrawal by Subject|3
2727299|NCT00191100|9375997|P1|Overall Study|Withdrawal by Subject|9
2727300|NCT00191100|9375996|P2|Overall Study|Patient Moved|1
2727301|NCT00191100|9375997|P1|Overall Study|Patient Moved|0
2727302|NCT00191100|9375996|P2|Overall Study|Lost to Follow-up|0
2727303|NCT00191100|9375997|P1|Overall Study|Lost to Follow-up|2
2727304|NCT00191100|9375996|P2|Overall Study|Adverse Event|1
2727305|NCT00191100|9375997|P1|Overall Study|Adverse Event|18
2727306|NCT00190983|9376013|P1|Overall Study|Inevaluable (never treated)|2
2727307|NCT00190775|9376022|P2|Overall Study|Exclusion Criteria Met|3
2727308|NCT00190775|9376023|P1|Overall Study|Exclusion Criteria Met|1
2727309|NCT00190775|9376022|P2|Overall Study|Protocol Violation|1
2727310|NCT00190775|9376023|P1|Overall Study|Protocol Violation|0
2727311|NCT00190775|9376022|P2|Overall Study|Noncompliance|5
2727312|NCT00190775|9376023|P1|Overall Study|Noncompliance|3
2727313|NCT00190775|9376022|P2|Overall Study|Physician Decision|0
2727314|NCT00190775|9376023|P1|Overall Study|Physician Decision|3
2727315|NCT00190775|9376022|P2|Overall Study|Sponsor Decision|0
2727316|NCT00190775|9376023|P1|Overall Study|Sponsor Decision|1
2727317|NCT00190775|9376022|P2|Overall Study|Withdrawal by Subject|13
2727318|NCT00190775|9376023|P1|Overall Study|Withdrawal by Subject|24
2727319|NCT00190775|9376022|P2|Overall Study|Participant Moved|1
2727320|NCT00190775|9376023|P1|Overall Study|Participant Moved|0
2727321|NCT00190775|9376022|P2|Overall Study|Lost to Follow-up|23
2727322|NCT00190775|9376023|P1|Overall Study|Lost to Follow-up|31
2727323|NCT00190775|9376022|P2|Overall Study|Lack of Efficacy|32
2727324|NCT00190775|9376023|P1|Overall Study|Lack of Efficacy|28
2727325|NCT00190775|9376022|P2|Overall Study|Satisfactory Response|0
2727326|NCT00190775|9376023|P1|Overall Study|Satisfactory Response|1
2727327|NCT00190775|9376022|P2|Overall Study|Adverse Event|22
2727328|NCT00190775|9376023|P1|Overall Study|Adverse Event|57
2727329|NCT00190749|9376094|P2|Overall Study|Sponsor Decision|0
2727330|NCT00190749|9376095|P1|Overall Study|Sponsor Decision|1
2727331|NCT00190749|9376094|P2|Overall Study|Reason Not Specified|2
2727332|NCT00190749|9376095|P1|Overall Study|Reason Not Specified|0
2727333|NCT00190749|9376094|P2|Overall Study|Lack of Efficacy|3
2727334|NCT00190749|9376095|P1|Overall Study|Lack of Efficacy|2
2727335|NCT00190749|9376094|P2|Overall Study|Adverse Event|5
2727336|NCT00190749|9376095|P1|Overall Study|Adverse Event|0
2727337|NCT00190749|9376094|P2|Overall Study|Protocol Violation|4
2727338|NCT00190749|9376095|P1|Overall Study|Protocol Violation|5
2727339|NCT00190749|9376094|P2|Overall Study|Withdrawal by Subject|6
2727340|NCT00190749|9376095|P1|Overall Study|Withdrawal by Subject|10
2727341|NCT00190749|9376094|P2|Overall Study|Lost to Follow-up|11
2727342|NCT00190749|9376095|P1|Overall Study|Lost to Follow-up|8
2727343|NCT00190684|9376159|P1|Overall Study|Study Period V Completed|1
2727344|NCT00190684|9376159|P1|Overall Study|Study Period III Completed|103
2727345|NCT00190684|9376159|P1|Overall Study|Protocol Violation|123
2727346|NCT00190684|9376159|P1|Overall Study|Physician Decision|84
2727347|NCT00190684|9376159|P1|Overall Study|Sponsor's decision|17
2727348|NCT00190684|9376159|P1|Overall Study|Clinical relapse|67
2727349|NCT00190684|9376159|P1|Overall Study|Patient Decision|432
2727350|NCT00190684|9376159|P1|Overall Study|Patient moved|60
2727351|NCT00190684|9376159|P1|Overall Study|Lost to Follow-up|232
2727352|NCT00190684|9376159|P1|Overall Study|Lack of efficacy|204
2727353|NCT00190684|9376159|P1|Overall Study|Satisfactory response|80
2727354|NCT00190684|9376159|P1|Overall Study|Adverse Event|86
2727355|NCT00190671|9376180|P2|Overall Study|Withdrawal by Subject|2
2727356|NCT00190671|9376181|P1|Overall Study|Withdrawal by Subject|0
2727357|NCT00190671|9376180|P2|Overall Study|Protocol Violation|1
2727358|NCT00190671|9376181|P1|Overall Study|Protocol Violation|0
2727359|NCT00190671|9376180|P2|Overall Study|Death from Other Causes|2
2727360|NCT00190671|9376181|P1|Overall Study|Death from Other Causes|0
2727361|NCT00190671|9376180|P2|Overall Study|Death from Study-Drug Toxicity|2
2727362|NCT00190671|9376181|P1|Overall Study|Death from Study-Drug Toxicity|0
2727363|NCT00190671|9376180|P2|Overall Study|Clinical Relapse|1
2727364|NCT00190671|9376181|P1|Overall Study|Clinical Relapse|0
2727365|NCT00190671|9376180|P2|Overall Study|Adverse Event|2
2727366|NCT00190671|9376181|P1|Overall Study|Adverse Event|3
2727367|NCT00190671|9376180|P2|Overall Study|Death from Study Disease|1
2727368|NCT00190671|9376181|P1|Overall Study|Death from Study Disease|1
2727369|NCT00190671|9376180|P2|Overall Study|Lack of Efficacy|24
2727370|NCT00190671|9376181|P1|Overall Study|Lack of Efficacy|19
2727371|NCT00190671|9376180|P2|Overall Study|Satisfactory Response|7
2727372|NCT00190671|9376181|P1|Overall Study|Satisfactory Response|4
2727373|NCT00189540|9376201|P2|Overall Study|Death|1
2727374|NCT00189540|9376202|P1|Overall Study|Death|4
2727375|NCT00189540|9376201|P2|Overall Study|Withdrawal by Subject|0
2727376|NCT00189540|9376202|P1|Overall Study|Withdrawal by Subject|3
2727377|NCT00189488|9376220|P2|Overall Study|Other|0
2727378|NCT00189488|9376221|P1|Overall Study|Other|1
2727379|NCT00189488|9376220|P2|Overall Study|Death|8
2727380|NCT00189488|9376221|P1|Overall Study|Death|5
2727381|NCT00189488|9376220|P2|Overall Study|Administrative Decision|2
2727382|NCT00189488|9376221|P1|Overall Study|Administrative Decision|0
2727383|NCT00189488|9376220|P2|Overall Study|Disease progression|4
2727384|NCT00189488|9376221|P1|Overall Study|Disease progression|2
2727385|NCT00189488|9376220|P2|Overall Study|Withdrawal by Subject|6
2727386|NCT00189488|9376221|P1|Overall Study|Withdrawal by Subject|2
2727387|NCT00189488|9376220|P2|Overall Study|Adverse Event|1
2727388|NCT00189488|9376221|P1|Overall Study|Adverse Event|2
2727389|NCT00189488|9376220|P2|Overall Study|Protocol deviation|1
2727390|NCT00189488|9376221|P1|Overall Study|Protocol deviation|2
2727391|NCT00189488|9376220|P2|Overall Study|Ineligibility determined|0
2727392|NCT00189488|9376221|P1|Overall Study|Ineligibility determined|1
2727393|NCT00189462|9376252|P2|Overall Study|Lost to Follow-up|20
2727394|NCT00189462|9376253|P1|Overall Study|Lost to Follow-up|18
2727395|NCT00189462|9376252|P2|Overall Study|Lack of Efficacy|1
2727396|NCT00189462|9376253|P1|Overall Study|Lack of Efficacy|5
2727397|NCT00189423|9376270|P2|Overall Study|Lost to Follow-up|10
2727398|NCT00189423|9376271|P1|Overall Study|Lost to Follow-up|10
2727399|NCT00189423|9376270|P2|Overall Study|Withdrawal by Subject|9
2727400|NCT00189423|9376271|P1|Overall Study|Withdrawal by Subject|9
2727401|NCT00189423|9376270|P2|Overall Study|Death|747
2727402|NCT00189423|9376271|P1|Overall Study|Death|746
2727403|NCT00189306|9376293|P1|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20
2727404|NCT00189306|9376293|P1|Long-Term Follow-up|Lost to Follow-up|9
2727405|NCT00189306|9376293|P1|Long-Term Follow-up|Intercurrent disease|2
2727406|NCT00189306|9376293|P1|Long-Term Follow-up|Withdrawal by Subject|1
2727407|NCT00189306|9376293|P1|Long-Term Follow-up|Death|4
2727408|NCT00189306|9376293|P1|Long-Term Follow-up|Adverse Event|2
2727409|NCT00189306|9376293|P1|Posttreatment Period|Local skin reaction/sign|1
2727410|NCT00189306|9376293|P1|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5
2727411|NCT00189306|9376293|P1|Posttreatment Period|Protocol Violation|1
2727412|NCT00189306|9376293|P1|Posttreatment Period|Target lesion excised|1
2727413|NCT00189306|9376293|P1|Posttreatment Period|Noncompliance|1
2727414|NCT00189306|9376293|P1|Posttreatment Period|Withdrawal by Subject|2
2727415|NCT00189306|9376293|P1|Posttreatment Period|Death|1
2727416|NCT00189306|9376293|P1|Treatment Period|Protocol Violation|1
2727417|NCT00189306|9376293|P1|Treatment Period|Adverse Event|2
2727418|NCT00189306|9376293|P1|Treatment Period|Withdrawal by Subject|2
2727419|NCT00189202|9376302|P1|Overall Study|Physician Decision|5
2727420|NCT00187889|9376343|P2|Overall Study|Withdrawal by Subject|4
2727421|NCT00187889|9376344|P1|Overall Study|Withdrawal by Subject|6
2727422|NCT00187486|9376386|P1|Overall Study|Protocol Violation|1
2727423|NCT00187135|9376437|P6|Visit Three|Study Discontinued|6
2727424|NCT00187135|9376438|P5|Visit Three|Study Discontinued|7
2727425|NCT00187135|9376439|P4|Visit Three|Study Discontinued|7
2727426|NCT00187135|9376440|P3|Visit Three|Study Discontinued|7
2727427|NCT00187135|9376441|P2|Visit Three|Study Discontinued|6
2727428|NCT00187135|9376442|P1|Visit Three|Study Discontinued|7
2727429|NCT00187135|9376437|P6|Visit Three|Withdrawal by Subject|0
2727430|NCT00187135|9376438|P5|Visit Three|Withdrawal by Subject|0
2727431|NCT00187135|9376439|P4|Visit Three|Withdrawal by Subject|2
2727432|NCT00187135|9376440|P3|Visit Three|Withdrawal by Subject|1
2727433|NCT00187135|9376441|P2|Visit Three|Withdrawal by Subject|1
2727434|NCT00187135|9376442|P1|Visit Three|Withdrawal by Subject|0
2727435|NCT00187135|9376437|P6|Visit Three|Death|0
2727436|NCT00187135|9376438|P5|Visit Three|Death|1
2727437|NCT00187135|9376439|P4|Visit Three|Death|0
2727438|NCT00187135|9376440|P3|Visit Three|Death|1
2727439|NCT00187135|9376441|P2|Visit Three|Death|0
2727440|NCT00187135|9376442|P1|Visit Three|Death|0
2727441|NCT00187135|9376437|P6|Visit Two|Study Discontinued|6
2727442|NCT00187135|9376438|P5|Visit Two|Study Discontinued|5
2727443|NCT00187135|9376439|P4|Visit Two|Study Discontinued|7
2727444|NCT00187135|9376440|P3|Visit Two|Study Discontinued|1
2727445|NCT00187135|9376441|P2|Visit Two|Study Discontinued|2
2727446|NCT00187135|9376442|P1|Visit Two|Study Discontinued|3
2727447|NCT00187135|9376437|P6|Visit Two|Withdrawal by Subject|1
2727448|NCT00187135|9376438|P5|Visit Two|Withdrawal by Subject|1
2727449|NCT00187135|9376439|P4|Visit Two|Withdrawal by Subject|0
2727450|NCT00187135|9376440|P3|Visit Two|Withdrawal by Subject|1
2727451|NCT00187135|9376441|P2|Visit Two|Withdrawal by Subject|1
2727452|NCT00187135|9376442|P1|Visit Two|Withdrawal by Subject|1
2727453|NCT00187135|9376437|P6|Visit Two|Physician Decision|0
2727454|NCT00187135|9376438|P5|Visit Two|Physician Decision|0
2727455|NCT00187135|9376439|P4|Visit Two|Physician Decision|0
2727456|NCT00187135|9376440|P3|Visit Two|Physician Decision|0
2727457|NCT00187135|9376441|P2|Visit Two|Physician Decision|0
2727458|NCT00187135|9376442|P1|Visit Two|Physician Decision|1
2727459|NCT00187135|9376437|P6|Visit Two|Death|1
2727460|NCT00187135|9376438|P5|Visit Two|Death|0
2727461|NCT00187135|9376439|P4|Visit Two|Death|1
2727462|NCT00187135|9376440|P3|Visit Two|Death|0
2727463|NCT00187135|9376441|P2|Visit Two|Death|0
2727464|NCT00187135|9376442|P1|Visit Two|Death|0
2727465|NCT00187135|9376437|P6|Visit One|Physician Decision|1
2727466|NCT00187135|9376438|P5|Visit One|Physician Decision|0
2727467|NCT00187135|9376439|P4|Visit One|Physician Decision|0
2727468|NCT00187135|9376440|P3|Visit One|Physician Decision|0
2727469|NCT00187135|9376441|P2|Visit One|Physician Decision|1
2727470|NCT00187135|9376442|P1|Visit One|Physician Decision|3
2727471|NCT00187135|9376437|P6|Visit One|Withdrawal by Subject|1
2727472|NCT00187135|9376438|P5|Visit One|Withdrawal by Subject|0
2727473|NCT00187135|9376439|P4|Visit One|Withdrawal by Subject|0
2727474|NCT00187135|9376440|P3|Visit One|Withdrawal by Subject|0
2727475|NCT00187135|9376441|P2|Visit One|Withdrawal by Subject|0
2727476|NCT00187135|9376442|P1|Visit One|Withdrawal by Subject|1
2727477|NCT00187096|9376465|P3|Overall Study|unacceptable toxicity|1
2727478|NCT00187096|9376466|P2|Overall Study|unacceptable toxicity|0
2727479|NCT00187096|9376467|P1|Overall Study|unacceptable toxicity|0
2727480|NCT00186901|9376505|P3|Overall Study|Bone Mineral Density > 0|149
2727481|NCT00186901|9376506|P2|Overall Study|Bone Mineral Density > 0|0
2727482|NCT00186901|9376507|P1|Overall Study|Bone Mineral Density > 0|0
2727483|NCT00186901|9376505|P3|Overall Study|Limited adherence to study requirements|0
2727484|NCT00186901|9376506|P2|Overall Study|Limited adherence to study requirements|23
2727485|NCT00186901|9376507|P1|Overall Study|Limited adherence to study requirements|20
2727486|NCT00186901|9376505|P3|Overall Study|Open label|0
2727487|NCT00186901|9376506|P2|Overall Study|Open label|2
2727488|NCT00186901|9376507|P1|Overall Study|Open label|3
2727489|NCT00186901|9376505|P3|Overall Study|Withdrawal by Subject|0
2727490|NCT00186901|9376506|P2|Overall Study|Withdrawal by Subject|5
2727491|NCT00186901|9376507|P1|Overall Study|Withdrawal by Subject|4
2727492|NCT00186901|9376505|P3|Overall Study|ALL relapse or second malignancy|0
2727493|NCT00186901|9376506|P2|Overall Study|ALL relapse or second malignancy|2
2727494|NCT00186901|9376507|P1|Overall Study|ALL relapse or second malignancy|1
2727495|NCT00186901|9376505|P3|Overall Study|Bone Mineral Density dropped > 5%|0
2727496|NCT00186901|9376506|P2|Overall Study|Bone Mineral Density dropped > 5%|7
2727497|NCT00186901|9376507|P1|Overall Study|Bone Mineral Density dropped > 5%|9
2727498|NCT00186901|9376505|P3|Overall Study|Lost to Follow-up|0
2727499|NCT00186901|9376506|P2|Overall Study|Lost to Follow-up|3
2727500|NCT00186901|9376507|P1|Overall Study|Lost to Follow-up|6
2727501|NCT00186901|9376505|P3|Overall Study|Pregnancy|0
2727502|NCT00186901|9376506|P2|Overall Study|Pregnancy|3
2727503|NCT00186901|9376507|P1|Overall Study|Pregnancy|6
2727504|NCT00186888|9376547|P3|Overall Study|Relapse or progression of disease|0
2727505|NCT00186888|9376548|P2|Overall Study|Relapse or progression of disease|2
2727506|NCT00186888|9376549|P1|Overall Study|Relapse or progression of disease|4
2727507|NCT00186888|9376547|P3|Overall Study|Toxicity|0
2727508|NCT00186888|9376548|P2|Overall Study|Toxicity|1
2727509|NCT00186888|9376549|P1|Overall Study|Toxicity|0
2727510|NCT00186628|9376641|P1|Overall Study|Withdrawal by subject (before treatment)|1
2727511|NCT00186628|9376641|P1|Overall Study|Death|2
2727512|NCT00186537|9376652|P3|Overall Study|ALT > 1.5 x ULN|0
2727513|NCT00186537|9376653|P2|Overall Study|ALT > 1.5 x ULN|0
2727514|NCT00186537|9376654|P1|Overall Study|ALT > 1.5 x ULN|3
2727515|NCT00186537|9376652|P3|Overall Study|Withdrawal by Subject|3
2727516|NCT00186537|9376653|P2|Overall Study|Withdrawal by Subject|0
2727517|NCT00186537|9376654|P1|Overall Study|Withdrawal by Subject|4
2727518|NCT00186485|9376677|P1|Overall Study|Lost to Follow-up|3
2727519|NCT00186186|9376689|P1|Overall Study|Not reported as to reason|2
2727520|NCT00186186|9376689|P1|Overall Study|Withdrawal by Subject|3
2727521|NCT00186186|9376689|P1|Overall Study|Lack of Efficacy|3
2727522|NCT00186121|9376694|P1|Overall Study|Not eligible (no treatment)|1
2727523|NCT00186121|9376694|P1|Overall Study|Underwent oophorectomy (no treatment)|1
2727524|NCT00186121|9376694|P1|Overall Study|Subject withdrawal (no treatment)|1
2727525|NCT00186043|9376728|P2|Overall Study|Protocol Violation|1
2727526|NCT00186043|9376729|P1|Overall Study|Protocol Violation|2
2727527|NCT00186043|9376728|P2|Overall Study|Adverse Event|3
2727528|NCT00186043|9376729|P1|Overall Study|Adverse Event|7
2727529|NCT00186043|9376728|P2|Overall Study|Withdrawal by Subject|0
2727530|NCT00186043|9376729|P1|Overall Study|Withdrawal by Subject|1
2727531|NCT00186043|9376728|P2|Overall Study|Lost to Follow-up|6
2727532|NCT00186043|9376729|P1|Overall Study|Lost to Follow-up|4
2727533|NCT00186043|9376728|P2|Overall Study|Lack of Efficacy|3
2727534|NCT00186043|9376729|P1|Overall Study|Lack of Efficacy|1
2727535|NCT00185965|9376756|P2|Overall Study|Adverse Event|1
2727536|NCT00185965|9376757|P1|Overall Study|Adverse Event|0
2727537|NCT00185731|9376782|P1|Overall Study|Not Eligible|1
2727538|NCT00185731|9376782|P1|Overall Study|Withdrawal by Subject|1
2727539|NCT00185640|9376799|P1|Overall Study|Death|138
2727540|NCT00185640|9376799|P1|Overall Study|Withdrawal by Subject|3
2727541|NCT00185640|9376799|P1|Overall Study|Not Eligible|4
2727542|NCT00185614|9376808|P1|Inter-treatment Period|Lack of allogenic donor|1
2727543|NCT00185614|9376808|P1|Inter-treatment Period|Relapse|2
2727544|NCT00185614|9376808|P1|Inter-treatment Period|Physician Decision|1
2727545|NCT00185588|9376820|P4|Overall Study|Physician Decision|0
2727546|NCT00185588|9376821|P3|Overall Study|Physician Decision|1
2727547|NCT00185588|9376822|P2|Overall Study|Physician Decision|0
2727548|NCT00185588|9376823|P1|Overall Study|Physician Decision|0
2727549|NCT00185588|9376820|P4|Overall Study|Withdrawal by Subject|0
2727550|NCT00185588|9376821|P3|Overall Study|Withdrawal by Subject|0
2727551|NCT00185588|9376822|P2|Overall Study|Withdrawal by Subject|1
2727552|NCT00185588|9376823|P1|Overall Study|Withdrawal by Subject|0
2727553|NCT00185588|9376820|P4|Overall Study|Lost to Follow-up|2
2727554|NCT00185588|9376821|P3|Overall Study|Lost to Follow-up|1
2727555|NCT00185588|9376822|P2|Overall Study|Lost to Follow-up|0
2727556|NCT00185588|9376823|P1|Overall Study|Lost to Follow-up|0
2727557|NCT00185588|9376820|P4|Overall Study|Adverse Event|2
2727558|NCT00185588|9376821|P3|Overall Study|Adverse Event|4
2727559|NCT00185588|9376822|P2|Overall Study|Adverse Event|1
2727560|NCT00185588|9376823|P1|Overall Study|Adverse Event|3
2727561|NCT00185458|9376837|P1|HRT Phase|Withdrawal by Subject|3
2727562|NCT00185458|9376837|P1|HRT Phase|Protocol Violation|2
2727563|NCT00185458|9376837|P1|HRT Phase|Lost to Follow-up|4
2727564|NCT00185458|9376837|P1|HRT Phase|Adverse Event|18
2727565|NCT00185458|9376837|P1|Contraception Phase|Withdrawal by Subject|7
2727566|NCT00185458|9376837|P1|Contraception Phase|Physician Decision|2
2727567|NCT00185458|9376837|P1|Contraception Phase|Protocol Violation|2
2727568|NCT00185458|9376837|P1|Contraception Phase|Lost to Follow-up|10
2727569|NCT00185458|9376837|P1|Contraception Phase|Adverse Event|37
2727570|NCT00185380|9376900|P3|Overall Study|personal reason|1
2727571|NCT00185380|9376901|P2|Overall Study|personal reason|1
2727572|NCT00185380|9376902|P1|Overall Study|personal reason|6
2727573|NCT00185380|9376900|P3|Overall Study|Could not attend visits|4
2727574|NCT00185380|9376901|P2|Overall Study|Could not attend visits|0
2727575|NCT00185380|9376902|P1|Overall Study|Could not attend visits|2
2727576|NCT00185380|9376900|P3|Overall Study|No need for contraception|3
2727577|NCT00185380|9376901|P2|Overall Study|No need for contraception|3
2727578|NCT00185380|9376902|P1|Overall Study|No need for contraception|3
2727579|NCT00185380|9376900|P3|Overall Study|Planned pregnancy|12
2727580|NCT00185380|9376901|P2|Overall Study|Planned pregnancy|12
2727581|NCT00185380|9376902|P1|Overall Study|Planned pregnancy|9
2727582|NCT00185380|9376900|P3|Overall Study|Failed insertion|2
2727583|NCT00185380|9376901|P2|Overall Study|Failed insertion|1
2727584|NCT00185380|9376902|P1|Overall Study|Failed insertion|1
2727585|NCT00185380|9376900|P3|Overall Study|Withdrawal by Subject|0
2727586|NCT00185380|9376901|P2|Overall Study|Withdrawal by Subject|2
2727587|NCT00185380|9376902|P1|Overall Study|Withdrawal by Subject|1
2727588|NCT00185380|9376900|P3|Overall Study|Protocol Violation|1
2727589|NCT00185380|9376901|P2|Overall Study|Protocol Violation|2
2727590|NCT00185380|9376902|P1|Overall Study|Protocol Violation|2
2727591|NCT00185380|9376900|P3|Overall Study|Pregnancy|0
2727592|NCT00185380|9376901|P2|Overall Study|Pregnancy|4
2727593|NCT00185380|9376902|P1|Overall Study|Pregnancy|1
2727594|NCT00185380|9376900|P3|Overall Study|Lost to Follow-up|3
2727595|NCT00185380|9376901|P2|Overall Study|Lost to Follow-up|4
2727596|NCT00185380|9376902|P1|Overall Study|Lost to Follow-up|0
2727597|NCT00185380|9376900|P3|Overall Study|Adverse Event|48
2727598|NCT00185380|9376901|P2|Overall Study|Adverse Event|43
2727599|NCT00185380|9376902|P1|Overall Study|Adverse Event|41
2727600|NCT00185211|9376930|P2|Follow-up Study (91031 - This Study)|other disease modif. treatment|2
2727601|NCT00185211|9376931|P1|Follow-up Study (91031 - This Study)|other disease modif. treatment|0
2727602|NCT00185211|9376930|P2|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21
2727603|NCT00185211|9376931|P1|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13
2727604|NCT00185211|9376930|P2|Follow-up Study (91031 - This Study)|Pregnancy|1
2727605|NCT00185211|9376931|P1|Follow-up Study (91031 - This Study)|Pregnancy|0
2727606|NCT00185211|9376930|P2|Follow-up Study (91031 - This Study)|Physician Decision|0
2727607|NCT00185211|9376931|P1|Follow-up Study (91031 - This Study)|Physician Decision|1
2727608|NCT00185211|9376930|P2|Follow-up Study (91031 - This Study)|Lost to Follow-up|4
2727609|NCT00185211|9376931|P1|Follow-up Study (91031 - This Study)|Lost to Follow-up|6
2727610|NCT00185211|9376930|P2|Follow-up Study (91031 - This Study)|Lack of Efficacy|0
2727611|NCT00185211|9376931|P1|Follow-up Study (91031 - This Study)|Lack of Efficacy|1
2727612|NCT00185211|9376930|P2|Follow-up Study (91031 - This Study)|Adverse Event|6
2727613|NCT00185211|9376931|P1|Follow-up Study (91031 - This Study)|Adverse Event|5
2727614|NCT00185211|9376930|P2|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0
2727615|NCT00185211|9376931|P1|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1
2727616|NCT00185211|9376930|P2|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1
2727617|NCT00185211|9376931|P1|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0
2727618|NCT00185211|9376930|P2|Placebo-controlled Study (92012)|Withdrawal by Subject|7
2727619|NCT00185211|9376931|P1|Placebo-controlled Study (92012)|Withdrawal by Subject|9
2727620|NCT00185211|9376930|P2|Placebo-controlled Study (92012)|Lost to Follow-up|2
2727621|NCT00185211|9376931|P1|Placebo-controlled Study (92012)|Lost to Follow-up|3
2727622|NCT00185211|9376930|P2|Placebo-controlled Study (92012)|Adverse Event|0
2727623|NCT00185211|9376931|P1|Placebo-controlled Study (92012)|Adverse Event|8
2727624|NCT00184600|9377004|P3|Overall Study|Unclassified|3
2727625|NCT00184600|9377005|P2|Overall Study|Unclassified|5
2727626|NCT00184600|9377006|P1|Overall Study|Unclassified|4
2727627|NCT00184600|9377004|P3|Overall Study|Withdrawal by Subject|12
2727628|NCT00184600|9377005|P2|Overall Study|Withdrawal by Subject|28
2727629|NCT00184600|9377006|P1|Overall Study|Withdrawal by Subject|20
2727630|NCT00184600|9377004|P3|Overall Study|Protocol Violation|3
2727631|NCT00184600|9377005|P2|Overall Study|Protocol Violation|2
2727632|NCT00184600|9377006|P1|Overall Study|Protocol Violation|2
2727633|NCT00184600|9377004|P3|Overall Study|Lost to Follow-up|1
2727634|NCT00184600|9377005|P2|Overall Study|Lost to Follow-up|6
2727635|NCT00184600|9377006|P1|Overall Study|Lost to Follow-up|4
2727636|NCT00184600|9377004|P3|Overall Study|Lack of Efficacy|3
2727637|NCT00184600|9377005|P2|Overall Study|Lack of Efficacy|1
2727638|NCT00184600|9377006|P1|Overall Study|Lack of Efficacy|3
2727639|NCT00184600|9377004|P3|Overall Study|Death|7
2727640|NCT00184600|9377005|P2|Overall Study|Death|9
2727641|NCT00184600|9377006|P1|Overall Study|Death|3
2727642|NCT00184600|9377004|P3|Overall Study|Adverse Event|5
2727643|NCT00184600|9377005|P2|Overall Study|Adverse Event|0
2727644|NCT00184600|9377006|P1|Overall Study|Adverse Event|9
2727645|NCT00184093|9377097|P1|Overall Study|Withdrawal by Subject|2
2727646|NCT00184093|9377097|P1|Overall Study|Physician Decision|1
2727647|NCT00184093|9377097|P1|Overall Study|Lost to Follow-up|3
2727648|NCT00184093|9377097|P1|Overall Study|Adverse Event|3
2727649|NCT00184054|9377102|P1|Overall Study|Adverse Event|1
2727650|NCT00184028|9377107|P1|Overall Study|Non-compliance|2
2727651|NCT00184028|9377107|P1|Overall Study|Withdrawal by Subject|1
2727652|NCT00184028|9377107|P1|Overall Study|Adverse Event|2
2727653|NCT00184028|9377107|P1|Overall Study|Lack of Efficacy|4
2727654|NCT00184028|9377107|P1|Overall Study|Death|1
2727655|NCT00184002|9377112|P1|Overall Study|Withdrawal by Subject|4
2727656|NCT00184002|9377112|P1|Overall Study|Physician Decision|1
2727657|NCT00184002|9377112|P1|Overall Study|Death|3
2727658|NCT00184002|9377112|P1|Overall Study|Adverse Event|9
2727659|NCT00183872|9377138|P1|Overall Study|Drug delayed more than 28 days|2
2727660|NCT00183872|9377138|P1|Overall Study|Withdrawal by Subject|2
2727661|NCT00183872|9377138|P1|Overall Study|Adverse Event|9
2727662|NCT00183872|9377138|P1|Overall Study|Death|3
2727663|NCT00183625|9377167|P4|Overall Study|Withdrawal by Subject|14
2727664|NCT00183625|9377168|P3|Overall Study|Withdrawal by Subject|19
2727665|NCT00183625|9377169|P2|Overall Study|Withdrawal by Subject|18
2727666|NCT00183625|9377170|P1|Overall Study|Withdrawal by Subject|18
2727667|NCT00183430|9377267|P2|Overall Study|Withdrawal by Subject|0
2727668|NCT00183430|9377268|P1|Overall Study|Withdrawal by Subject|1
2727669|NCT00183430|9377267|P2|Overall Study|did not meet inclusion criteria|0
2727670|NCT00183430|9377268|P1|Overall Study|did not meet inclusion criteria|1
2727671|NCT00183430|9377267|P2|Overall Study|Lost to Follow-up|0
2727672|NCT00183430|9377268|P1|Overall Study|Lost to Follow-up|3
2727673|NCT00183430|9377267|P2|Overall Study|Adverse Event|0
2727674|NCT00183430|9377268|P1|Overall Study|Adverse Event|1
2727675|NCT00183391|9377280|P2|Block 2 - 5 Weeks|Withdrawal by Subject|2
2727676|NCT00183391|9377281|P1|Block 2 - 5 Weeks|Withdrawal by Subject|4
2727677|NCT00183391|9377280|P2|Block 1 - 5 Weeks|Withdrawal by Subject|14
2727678|NCT00183391|9377281|P1|Block 1 - 5 Weeks|Withdrawal by Subject|13
2727679|NCT00183274|9377354|P6|Phase 3: Double-Blind|Relapsed|2
2727680|NCT00183274|9377355|P5|Phase 3: Double-Blind|Relapsed|11
2727681|NCT00183274|9377356|P4|Phase 3: Double-Blind|Relapsed|1
2727682|NCT00183274|9377357|P3|Phase 3: Double-Blind|Relapsed|0
2727683|NCT00183274|9377358|P2|Phase 3: Double-Blind|Relapsed|0
2727684|NCT00183274|9377359|P1|Phase 3: Double-Blind|Relapsed|0
2727685|NCT00183274|9377354|P6|Phase 3: Double-Blind|Withdrawal by Subject|2
2727686|NCT00183274|9377355|P5|Phase 3: Double-Blind|Withdrawal by Subject|9
2727687|NCT00183274|9377356|P4|Phase 3: Double-Blind|Withdrawal by Subject|1
2727688|NCT00183274|9377357|P3|Phase 3: Double-Blind|Withdrawal by Subject|0
2727689|NCT00183274|9377358|P2|Phase 3: Double-Blind|Withdrawal by Subject|0
2727690|NCT00183274|9377359|P1|Phase 3: Double-Blind|Withdrawal by Subject|0
2727691|NCT00183274|9377354|P6|Phase 2: Double-Blind|Withdrawal by Subject|0
2727692|NCT00183274|9377355|P5|Phase 2: Double-Blind|Withdrawal by Subject|0
2727693|NCT00183274|9377356|P4|Phase 2: Double-Blind|Withdrawal by Subject|0
2727694|NCT00183274|9377357|P3|Phase 2: Double-Blind|Withdrawal by Subject|14
2727695|NCT00183274|9377358|P2|Phase 2: Double-Blind|Withdrawal by Subject|18
2727696|NCT00183274|9377359|P1|Phase 2: Double-Blind|Withdrawal by Subject|0
2727697|NCT00183274|9377354|P6|Phase 2: Double-Blind|Relapsed|0
2727698|NCT00183274|9377355|P5|Phase 2: Double-Blind|Relapsed|0
2727699|NCT00183274|9377356|P4|Phase 2: Double-Blind|Relapsed|0
2727700|NCT00183274|9377357|P3|Phase 2: Double-Blind|Relapsed|29
2727701|NCT00183274|9377358|P2|Phase 2: Double-Blind|Relapsed|8
2727702|NCT00183274|9377359|P1|Phase 2: Double-Blind|Relapsed|0
2727703|NCT00183274|9377354|P6|Phase 1: Open-Label|Other|0
2727704|NCT00183274|9377355|P5|Phase 1: Open-Label|Other|0
2727705|NCT00183274|9377356|P4|Phase 1: Open-Label|Other|0
2727706|NCT00183274|9377357|P3|Phase 1: Open-Label|Other|0
2727707|NCT00183274|9377358|P2|Phase 1: Open-Label|Other|0
2727708|NCT00183274|9377359|P1|Phase 1: Open-Label|Other|9
2727709|NCT00183274|9377354|P6|Phase 1: Open-Label|Lost to Follow-up|0
2727710|NCT00183274|9377355|P5|Phase 1: Open-Label|Lost to Follow-up|0
2727711|NCT00183274|9377356|P4|Phase 1: Open-Label|Lost to Follow-up|0
2727712|NCT00183274|9377357|P3|Phase 1: Open-Label|Lost to Follow-up|0
2727713|NCT00183274|9377358|P2|Phase 1: Open-Label|Lost to Follow-up|0
2727714|NCT00183274|9377359|P1|Phase 1: Open-Label|Lost to Follow-up|33
2727715|NCT00183274|9377354|P6|Phase 1: Open-Label|Withdrawal by Subject|0
2727716|NCT00183274|9377355|P5|Phase 1: Open-Label|Withdrawal by Subject|0
2727717|NCT00183274|9377356|P4|Phase 1: Open-Label|Withdrawal by Subject|0
2727718|NCT00183274|9377357|P3|Phase 1: Open-Label|Withdrawal by Subject|0
2727719|NCT00183274|9377358|P2|Phase 1: Open-Label|Withdrawal by Subject|0
2727720|NCT00183274|9377359|P1|Phase 1: Open-Label|Withdrawal by Subject|13
2727721|NCT00183274|9377354|P6|Phase 1: Open-Label|Protocol Violation|0
2727722|NCT00183274|9377355|P5|Phase 1: Open-Label|Protocol Violation|0
2727723|NCT00183274|9377356|P4|Phase 1: Open-Label|Protocol Violation|0
2727724|NCT00183274|9377357|P3|Phase 1: Open-Label|Protocol Violation|0
2727725|NCT00183274|9377358|P2|Phase 1: Open-Label|Protocol Violation|0
2727726|NCT00183274|9377359|P1|Phase 1: Open-Label|Protocol Violation|11
2727727|NCT00183274|9377354|P6|Phase 1: Open-Label|Lack of Efficacy|0
2727728|NCT00183274|9377355|P5|Phase 1: Open-Label|Lack of Efficacy|0
2727729|NCT00183274|9377356|P4|Phase 1: Open-Label|Lack of Efficacy|0
2727730|NCT00183274|9377357|P3|Phase 1: Open-Label|Lack of Efficacy|0
2727731|NCT00183274|9377358|P2|Phase 1: Open-Label|Lack of Efficacy|0
2727732|NCT00183274|9377359|P1|Phase 1: Open-Label|Lack of Efficacy|13
2727733|NCT00183274|9377354|P6|Phase 1: Open-Label|Adverse Event|0
2727734|NCT00183274|9377355|P5|Phase 1: Open-Label|Adverse Event|0
2727735|NCT00183274|9377356|P4|Phase 1: Open-Label|Adverse Event|0
2727736|NCT00183274|9377357|P3|Phase 1: Open-Label|Adverse Event|0
2727737|NCT00183274|9377358|P2|Phase 1: Open-Label|Adverse Event|0
2727738|NCT00183274|9377359|P1|Phase 1: Open-Label|Adverse Event|31
2727739|NCT00183248|9377376|P2|Overall Study|Focal glomerulosclerosis proteinuria|0
2727740|NCT00183248|9377377|P1|Overall Study|Focal glomerulosclerosis proteinuria|1
2727741|NCT00183248|9377376|P2|Overall Study|Lost to Follow-up|1
2727742|NCT00183248|9377377|P1|Overall Study|Lost to Follow-up|0
2727743|NCT00183196|9377398|P3|Overall Study|Required more intensive care|2
2727744|NCT00183196|9377399|P2|Overall Study|Required more intensive care|1
2727745|NCT00183196|9377400|P1|Overall Study|Required more intensive care|0
2727746|NCT00183196|9377398|P3|Overall Study|Legal event|1
2727747|NCT00183196|9377399|P2|Overall Study|Legal event|1
2727748|NCT00183196|9377400|P1|Overall Study|Legal event|1
2727749|NCT00183196|9377398|P3|Overall Study|Adverse Event|2
2727750|NCT00183196|9377399|P2|Overall Study|Adverse Event|2
2727751|NCT00183196|9377400|P1|Overall Study|Adverse Event|1
2727752|NCT00183196|9377398|P3|Overall Study|Withdrawal by Subject|13
2727753|NCT00183196|9377399|P2|Overall Study|Withdrawal by Subject|11
2727754|NCT00183196|9377400|P1|Overall Study|Withdrawal by Subject|18
2727755|NCT00182689|9377483|P2|Overall Study|Never received treatment|0
2727756|NCT00182689|9377484|P1|Overall Study|Never received treatment|1
2727757|NCT00182689|9377483|P2|Overall Study|Ineligible|4
2727758|NCT00182689|9377484|P1|Overall Study|Ineligible|1
2727759|NCT00182689|9377483|P2|Overall Study|not protocol specified|3
2727760|NCT00182689|9377484|P1|Overall Study|not protocol specified|0
2727761|NCT00182689|9377483|P2|Overall Study|Death|0
2727762|NCT00182689|9377484|P1|Overall Study|Death|1
2727763|NCT00182689|9377483|P2|Overall Study|Progression|29
2727764|NCT00182689|9377484|P1|Overall Study|Progression|27
2727765|NCT00182689|9377483|P2|Overall Study|Withdrawal by Subject|2
2727766|NCT00182689|9377484|P1|Overall Study|Withdrawal by Subject|2
2727767|NCT00182689|9377483|P2|Overall Study|Adverse Event|11
2727768|NCT00182689|9377484|P1|Overall Study|Adverse Event|8
2727769|NCT00182637|9377494|P1|Overall Study|Disease Progression|1
2727770|NCT00182637|9377494|P1|Overall Study|Adverse Event|2
2727771|NCT00182325|9377502|P2|Overall Study|Did not complete survey|43
2727772|NCT00182325|9377503|P1|Overall Study|Did not complete survey|22
2727773|NCT00182325|9377502|P2|Overall Study|Miscarriage|3
2727774|NCT00182325|9377503|P1|Overall Study|Miscarriage|5
2727775|NCT00182325|9377502|P2|Overall Study|Lost to Follow-up|7
2727776|NCT00182325|9377503|P1|Overall Study|Lost to Follow-up|7
2727777|NCT00182091|9377531|P4|Overall Study|Withdrawal by Subject|0
2727778|NCT00182091|9377532|P3|Overall Study|Withdrawal by Subject|0
2727779|NCT00182091|9377533|P2|Overall Study|Withdrawal by Subject|0
2727780|NCT00182091|9377534|P1|Overall Study|Withdrawal by Subject|1
2727781|NCT00182078|9377550|P2|Overall Study|Withdrawal by Subject|0
2727782|NCT00182078|9377551|P1|Overall Study|Withdrawal by Subject|1
2727783|NCT00181883|9377579|P1|Overall Study|Lost to Follow-up|1
2727784|NCT00181883|9377579|P1|Overall Study|Withdrawal by Subject|4
2727785|NCT00181883|9377579|P1|Overall Study|Treatment Limiting AEs|3
2727786|NCT00181883|9377579|P1|Overall Study|Lack of Efficacy|2
2727787|NCT00181844|9377583|P1|Exposed to Study Medication|Difficulty meeting study schedule|2
2727788|NCT00181844|9377583|P1|Exposed to Study Medication|Withdrawal by Subject|1
2727789|NCT00181844|9377583|P1|Exposed to Study Medication|Non-compliance|2
2727790|NCT00181844|9377583|P1|Exposed to Study Medication|Lack of Efficacy|2
2727791|NCT00181844|9377583|P1|Exposed to Study Medication|Adverse Event|10
2727792|NCT00181844|9377583|P1|Signed Consent|Did not meet entrance criteria|7
2727793|NCT00181844|9377583|P1|Signed Consent|Withdrawal by Subject|5
2727794|NCT00181766|9377587|P1|Overall Study|non-compliance|2
2727795|NCT00181766|9377587|P1|Overall Study|Adverse Event|4
2727796|NCT00181766|9377587|P1|Overall Study|Lost to Follow-up|6
2727797|NCT00181155|9377661|P2|Overall Study|Withdrawal by Subject|0
2727798|NCT00181155|9377662|P1|Overall Study|Withdrawal by Subject|1
2727799|NCT00181155|9377661|P2|Overall Study|Physician Decision|0
2727800|NCT00181155|9377662|P1|Overall Study|Physician Decision|1
2727801|NCT00180713|9377672|P2|Overall Study|Adverse Event|3
2727802|NCT00180713|9377673|P1|Overall Study|Adverse Event|3
2727803|NCT00180713|9377672|P2|Overall Study|Withdrawal by Subject|0
2727804|NCT00180713|9377673|P1|Overall Study|Withdrawal by Subject|2
2727805|NCT00180479|9377737|P2|Overall Study|Informed consent not signed|1
2727806|NCT00180479|9377738|P1|Overall Study|Informed consent not signed|0
2727807|NCT00180479|9377737|P2|Overall Study|Withdrawal by Subject|3
2727808|NCT00180479|9377738|P1|Overall Study|Withdrawal by Subject|3
2727809|NCT00180479|9377737|P2|Overall Study|Lost to Follow-up|7
2727810|NCT00180479|9377738|P1|Overall Study|Lost to Follow-up|9
2727811|NCT00180479|9377737|P2|Overall Study|Death|2
2727812|NCT00180479|9377738|P1|Overall Study|Death|4
2727813|NCT00179959|9377863|P2|Overall Study|Withdrawal by Subject|2
2727814|NCT00179959|9377864|P1|Overall Study|Withdrawal by Subject|3
2727815|NCT00179959|9377863|P2|Overall Study|Lost to Follow-up|1
2727816|NCT00179959|9377864|P1|Overall Study|Lost to Follow-up|3
2727817|NCT00179673|9377870|P1|Overall Study|Other Observations and options|14
2727818|NCT00179673|9377870|P1|Overall Study|Death|4
2727819|NCT00179673|9377870|P1|Overall Study|Withdrawal by Subject|3
2727820|NCT00179673|9377870|P1|Overall Study|Lack of Efficacy|15
2727821|NCT00179673|9377870|P1|Overall Study|Adverse Event|7
2727822|NCT00179660|9377878|P1|Overall Study|Other - Unspecified|9
2727823|NCT00179660|9377878|P1|Overall Study|Death|3
2727824|NCT00179660|9377878|P1|Overall Study|Lost to Follow-up|1
2727825|NCT00179660|9377878|P1|Overall Study|Withdrawal by Subject|2
2727826|NCT00179660|9377878|P1|Overall Study|Lack of therapeutic effect|28
2727827|NCT00179660|9377878|P1|Overall Study|Adverse Event|7
2727828|NCT00179647|9377887|P1|Overall Study|Other|960
2727829|NCT00179647|9377887|P1|Overall Study|Death|94
2727830|NCT00179647|9377887|P1|Overall Study|Lost to Follow-up|4
2727831|NCT00179647|9377887|P1|Overall Study|Withdrawal by Subject|83
2727832|NCT00179647|9377887|P1|Overall Study|Lack of Efficacy|478
2727833|NCT00179647|9377887|P1|Overall Study|Adverse Event|294
2727834|NCT00179621|9377894|P4|Open-Label Period|Other|2
2727835|NCT00179621|9377895|P3|Open-Label Period|Other|1
2727836|NCT00179621|9377896|P2|Open-Label Period|Other|1
2727837|NCT00179621|9377897|P1|Open-Label Period|Other|0
2727838|NCT00179621|9377894|P4|Open-Label Period|Death|2
2727839|NCT00179621|9377895|P3|Open-Label Period|Death|1
2727840|NCT00179621|9377896|P2|Open-Label Period|Death|0
2727841|NCT00179621|9377897|P1|Open-Label Period|Death|0
2727842|NCT00179621|9377894|P4|Open-Label Period|Withdrawal by Subject|2
2727843|NCT00179621|9377895|P3|Open-Label Period|Withdrawal by Subject|2
2727844|NCT00179621|9377896|P2|Open-Label Period|Withdrawal by Subject|2
2727845|NCT00179621|9377897|P1|Open-Label Period|Withdrawal by Subject|0
2727846|NCT00179621|9377894|P4|Open-Label Period|Adverse Event|6
2727847|NCT00179621|9377895|P3|Open-Label Period|Adverse Event|5
2727848|NCT00179621|9377896|P2|Open-Label Period|Adverse Event|6
2727849|NCT00179621|9377897|P1|Open-Label Period|Adverse Event|0
2727850|NCT00179621|9377894|P4|Open-Label Period|Lack of Therapeutic Effect|31
2727851|NCT00179621|9377895|P3|Open-Label Period|Lack of Therapeutic Effect|19
2727852|NCT00179621|9377896|P2|Open-Label Period|Lack of Therapeutic Effect|19
2727853|NCT00179621|9377897|P1|Open-Label Period|Lack of Therapeutic Effect|0
2727854|NCT00179621|9377894|P4|Double-Blind Period|Other|0
2727855|NCT00179621|9377895|P3|Double-Blind Period|Other|2
2727856|NCT00179621|9377896|P2|Double-Blind Period|Other|2
2727857|NCT00179621|9377897|P1|Double-Blind Period|Other|0
2727858|NCT00179621|9377894|P4|Double-Blind Period|Protocol Violation|0
2727859|NCT00179621|9377895|P3|Double-Blind Period|Protocol Violation|0
2727860|NCT00179621|9377896|P2|Double-Blind Period|Protocol Violation|0
2727861|NCT00179621|9377897|P1|Double-Blind Period|Protocol Violation|1
2727862|NCT00179621|9377894|P4|Double-Blind Period|Death|0
2727863|NCT00179621|9377895|P3|Double-Blind Period|Death|2
2727864|NCT00179621|9377896|P2|Double-Blind Period|Death|1
2727865|NCT00179621|9377897|P1|Double-Blind Period|Death|0
2727866|NCT00179621|9377894|P4|Double-Blind Period|Withdrawal by Subject|0
2727867|NCT00179621|9377895|P3|Double-Blind Period|Withdrawal by Subject|3
2727868|NCT00179621|9377896|P2|Double-Blind Period|Withdrawal by Subject|1
2727869|NCT00179621|9377897|P1|Double-Blind Period|Withdrawal by Subject|2
2727870|NCT00179621|9377894|P4|Double-Blind Period|Adverse Event|0
2727871|NCT00179621|9377895|P3|Double-Blind Period|Adverse Event|4
2727872|NCT00179621|9377896|P2|Double-Blind Period|Adverse Event|7
2727873|NCT00179621|9377897|P1|Double-Blind Period|Adverse Event|2
2727874|NCT00179621|9377894|P4|Double-Blind Period|Lack of Therapeutic Effect|0
2727875|NCT00179621|9377895|P3|Double-Blind Period|Lack of Therapeutic Effect|19
2727876|NCT00179621|9377896|P2|Double-Blind Period|Lack of Therapeutic Effect|35
2727877|NCT00179621|9377897|P1|Double-Blind Period|Lack of Therapeutic Effect|59
2727878|NCT00179517|9377950|P2|Overall Study|Withdrawal by Subject|1
2727879|NCT00179517|9377951|P1|Overall Study|Withdrawal by Subject|2
2727880|NCT00179413|9377989|P2|Overall Study|Withdrawal by Subject|95
2727881|NCT00179413|9377990|P1|Overall Study|Withdrawal by Subject|87
2727882|NCT00179413|9377989|P2|Overall Study|Adverse Event|20
2727883|NCT00179413|9377990|P1|Overall Study|Adverse Event|38
2727884|NCT00179309|9378002|P2|Treatment|Allergy|0
2727885|NCT00179309|9378003|P1|Treatment|Allergy|1
2727886|NCT00179309|9378002|P2|Treatment|Withdrawal by Subject|2
2727887|NCT00179309|9378003|P1|Treatment|Withdrawal by Subject|1
2727888|NCT00179309|9378002|P2|Treatment|Toxicity|3
2727889|NCT00179309|9378003|P1|Treatment|Toxicity|2
2727890|NCT00179010|9378026|P2|Overall Study|Failure to place arterial line|1
2727891|NCT00179010|9378027|P1|Overall Study|Failure to place arterial line|0
2727892|NCT00179010|9378026|P2|Overall Study|Muscle probe defective|1
2727893|NCT00179010|9378027|P1|Overall Study|Muscle probe defective|1
2727894|NCT00178685|9378066|P3|Overall Study|Withdrawal by Subject|7
2727895|NCT00178685|9378067|P2|Overall Study|Withdrawal by Subject|14
2727896|NCT00178685|9378068|P1|Overall Study|Withdrawal by Subject|8
2727897|NCT00178685|9378066|P3|Overall Study|Lost to Follow-up|183
2727898|NCT00178685|9378067|P2|Overall Study|Lost to Follow-up|187
2727899|NCT00178685|9378068|P1|Overall Study|Lost to Follow-up|100
2727900|NCT00178685|9378066|P3|Overall Study|Death|6
2727901|NCT00178685|9378067|P2|Overall Study|Death|3
2727902|NCT00178685|9378068|P1|Overall Study|Death|3
2727903|NCT00178633|9378079|P1|Overall Study|Lost to Follow-up|6
2727904|NCT00178464|9378109|P1|Overall Study|Physician Decision|1
2727905|NCT00178464|9378109|P1|Overall Study|Withdrawal by Subject|1
2727906|NCT00178399|9378114|P1|Overall Study|Lost to Follow-up|1
2727907|NCT00178399|9378114|P1|Overall Study|Withdrawal by Subject|8
2727908|NCT00178399|9378114|P1|Overall Study|Physician Decision|4
2727909|NCT00178256|9378121|P4|Overall Study|Cancer progression|1
2727910|NCT00178256|9378122|P3|Overall Study|Cancer progression|0
2727911|NCT00178256|9378123|P2|Overall Study|Cancer progression|0
2727912|NCT00178256|9378124|P1|Overall Study|Cancer progression|2
2727913|NCT00178256|9378121|P4|Overall Study|Death|1
2727914|NCT00178256|9378122|P3|Overall Study|Death|0
2727915|NCT00178256|9378123|P2|Overall Study|Death|1
2727916|NCT00178256|9378124|P1|Overall Study|Death|0
2727917|NCT00178256|9378121|P4|Overall Study|Adverse Event|0
2727918|NCT00178256|9378122|P3|Overall Study|Adverse Event|0
2727919|NCT00178256|9378123|P2|Overall Study|Adverse Event|0
2727920|NCT00178256|9378124|P1|Overall Study|Adverse Event|2
2727921|NCT00178126|9378163|P2|Overall Study|did not receive intervention|6
2727922|NCT00178126|9378164|P1|Overall Study|did not receive intervention|4
2727923|NCT00178126|9378163|P2|Overall Study|Lost to Follow-up|21
2727924|NCT00178126|9378164|P1|Overall Study|Lost to Follow-up|21
2727925|NCT00177671|9378206|P2|Overall Study|Physician Decision|8
2727926|NCT00177671|9378207|P1|Overall Study|Physician Decision|12
2727927|NCT00177671|9378206|P2|Overall Study|Adverse Event|0
2727928|NCT00177671|9378207|P1|Overall Study|Adverse Event|6
2727929|NCT00177671|9378206|P2|Overall Study|medical complications|0
2727930|NCT00177671|9378207|P1|Overall Study|medical complications|2
2727931|NCT00177671|9378206|P2|Overall Study|Withdrawal by Subject|6
2727932|NCT00177671|9378207|P1|Overall Study|Withdrawal by Subject|5
2727933|NCT00177307|9378219|P1|Overall Study|Withdrawal by Subject|1
2727934|NCT00177294|9378228|P2|Overall Study|Withdrawal by Subject|5
2727935|NCT00177294|9378229|P1|Overall Study|Withdrawal by Subject|7
2727936|NCT00177216|9378243|P3|Overall Study|Withdrawal by Subject|1
2727937|NCT00177216|9378244|P2|Overall Study|Withdrawal by Subject|3
2727938|NCT00177216|9378245|P1|Overall Study|Withdrawal by Subject|6
2727939|NCT00177164|9378261|P2|Overall Study|Pregnancy|1
2727940|NCT00177164|9378262|P1|Overall Study|Pregnancy|0
2727941|NCT00177164|9378261|P2|Overall Study|Lack of Efficacy|1
2727942|NCT00177164|9378262|P1|Overall Study|Lack of Efficacy|2
2727943|NCT00177164|9378261|P2|Overall Study|discharge from hospital|0
2727944|NCT00177164|9378262|P1|Overall Study|discharge from hospital|1
2727945|NCT00177164|9378261|P2|Overall Study|Adverse Event|0
2727946|NCT00177164|9378262|P1|Overall Study|Adverse Event|1
2727947|NCT00177164|9378261|P2|Overall Study|increase in alcohol and drug use|2
2727948|NCT00177164|9378262|P1|Overall Study|increase in alcohol and drug use|1
2727949|NCT00177164|9378261|P2|Overall Study|Lost to Follow-up|5
2727950|NCT00177164|9378262|P1|Overall Study|Lost to Follow-up|4
2727951|NCT00177164|9378261|P2|Overall Study|Protocol Violation|7
2727952|NCT00177164|9378262|P1|Overall Study|Protocol Violation|0
2727953|NCT00176644|9378435|P1|Overall Study|Withdrawal by Subject|1
2727954|NCT00176605|9378448|P1|Overall Study|Withdrawal by Subject|2
2727955|NCT00176488|9378459|P1|Overall Study|Initiated Cycle 1 Day 1 only|1
2727956|NCT00176462|9378467|P2|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3
2727957|NCT00176462|9378468|P1|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0
2727958|NCT00176462|9378467|P2|Intensive Continuation (8X8-week Cycles)|Death|0
2727959|NCT00176462|9378468|P1|Intensive Continuation (8X8-week Cycles)|Death|1
2727960|NCT00176462|9378467|P2|Consolidation (12 Weeks)|Not documented|1
2727961|NCT00176462|9378468|P1|Consolidation (12 Weeks)|Not documented|0
2727962|NCT00176462|9378467|P2|Consolidation (12 Weeks)|Lack of Efficacy|2
2727963|NCT00176462|9378468|P1|Consolidation (12 Weeks)|Lack of Efficacy|0
2727964|NCT00176462|9378467|P2|Consolidation (12 Weeks)|Adverse Event|1
2727965|NCT00176462|9378468|P1|Consolidation (12 Weeks)|Adverse Event|0
2727966|NCT00176462|9378467|P2|Consolidation (12 Weeks)|Patient moved to another state|1
2727967|NCT00176462|9378468|P1|Consolidation (12 Weeks)|Patient moved to another state|0
2727968|NCT00176462|9378467|P2|Induction (4 Weeks)|Lack of Efficacy|1
2727969|NCT00176462|9378468|P1|Induction (4 Weeks)|Lack of Efficacy|0
2727970|NCT00176462|9378467|P2|Induction (4 Weeks)|Death|2
2727971|NCT00176462|9378468|P1|Induction (4 Weeks)|Death|1
2727972|NCT00176462|9378467|P2|Induction (4 Weeks)|Withdrawal by Subject|2
2727973|NCT00176462|9378468|P1|Induction (4 Weeks)|Withdrawal by Subject|0
2727974|NCT00176254|9378488|P1|Overall Study|Lost to Follow-up|1
2727975|NCT00175877|9378516|P1|Overall Study|Withdrawal by subject & Other|1
2727976|NCT00175877|9378516|P1|Overall Study|AE & Other|1
2727977|NCT00175877|9378516|P1|Overall Study|Other Reason|20
2727978|NCT00175877|9378516|P1|Overall Study|Protocol Violation|15
2727979|NCT00175877|9378516|P1|Overall Study|Lack of Efficacy|26
2727980|NCT00175877|9378516|P1|Overall Study|Lost to Follow-up|9
2727981|NCT00175877|9378516|P1|Overall Study|Withdrawal by Subject|141
2727982|NCT00175877|9378516|P1|Overall Study|Adverse Event|136
2727983|NCT00175825|9378551|P4|Overall Study|Withdrawal by Subject|0
2727984|NCT00175825|9378552|P3|Overall Study|Withdrawal by Subject|0
2727985|NCT00175825|9378553|P2|Overall Study|Withdrawal by Subject|0
2727986|NCT00175825|9378554|P1|Overall Study|Withdrawal by Subject|1
2727987|NCT00175825|9378551|P4|Overall Study|Lost to Follow-up|0
2727988|NCT00175825|9378552|P3|Overall Study|Lost to Follow-up|0
2727989|NCT00175825|9378553|P2|Overall Study|Lost to Follow-up|2
2727990|NCT00175825|9378554|P1|Overall Study|Lost to Follow-up|1
2727991|NCT00175825|9378551|P4|Overall Study|Adverse Event|1
2727992|NCT00175825|9378552|P3|Overall Study|Adverse Event|1
2727993|NCT00175825|9378553|P2|Overall Study|Adverse Event|2
2727994|NCT00175825|9378554|P1|Overall Study|Adverse Event|3
2727995|NCT00175019|9378607|P3|Overall Study|Reason Not Specified|11
2727996|NCT00175019|9378608|P2|Overall Study|Reason Not Specified|34
2727997|NCT00175019|9378609|P1|Overall Study|Reason Not Specified|40
2727998|NCT00175019|9378607|P3|Overall Study|Gout Flare|0
2727999|NCT00175019|9378608|P2|Overall Study|Gout Flare|3
2728000|NCT00175019|9378609|P1|Overall Study|Gout Flare|2
2728001|NCT00175019|9378607|P3|Overall Study|Therapeutic Failure|22
2728002|NCT00175019|9378608|P2|Overall Study|Therapeutic Failure|38
2728003|NCT00175019|9378609|P1|Overall Study|Therapeutic Failure|10
2728004|NCT00175019|9378607|P3|Overall Study|Personal Reason(s)|8
2728005|NCT00175019|9378608|P2|Overall Study|Personal Reason(s)|31
2728006|NCT00175019|9378609|P1|Overall Study|Personal Reason(s)|39
2728007|NCT00175019|9378607|P3|Overall Study|Did not continue under Amendment 4|2
2728008|NCT00175019|9378608|P2|Overall Study|Did not continue under Amendment 4|1
2728009|NCT00175019|9378609|P1|Overall Study|Did not continue under Amendment 4|1
2728010|NCT00175019|9378607|P3|Overall Study|Lost to Follow-up|9
2728011|NCT00175019|9378608|P2|Overall Study|Lost to Follow-up|39
2728012|NCT00175019|9378609|P1|Overall Study|Lost to Follow-up|42
2728013|NCT00175019|9378607|P3|Overall Study|Protocol Violation|3
2728014|NCT00175019|9378608|P2|Overall Study|Protocol Violation|3
2728015|NCT00175019|9378609|P1|Overall Study|Protocol Violation|6
2728016|NCT00175019|9378607|P3|Overall Study|Adverse Event|2
2728017|NCT00175019|9378608|P2|Overall Study|Adverse Event|22
2728018|NCT00175019|9378609|P1|Overall Study|Adverse Event|54
2728019|NCT00174967|9378662|P4|Overall Study|Other|0
2728020|NCT00174967|9378663|P3|Overall Study|Other|0
2728021|NCT00174967|9378664|P2|Overall Study|Other|1
2728022|NCT00174967|9378665|P1|Overall Study|Other|0
2728023|NCT00174967|9378662|P4|Overall Study|Gout Flare|1
2728024|NCT00174967|9378663|P3|Overall Study|Gout Flare|0
2728025|NCT00174967|9378664|P2|Overall Study|Gout Flare|0
2728026|NCT00174967|9378665|P1|Overall Study|Gout Flare|0
2728027|NCT00174967|9378662|P4|Overall Study|Adverse Event|1
2728028|NCT00174967|9378663|P3|Overall Study|Adverse Event|2
2728029|NCT00174967|9378664|P2|Overall Study|Adverse Event|2
2728030|NCT00174967|9378665|P1|Overall Study|Adverse Event|1
2728031|NCT00174954|9378711|P1|Overall Study|Physician Decision|1
2728032|NCT00174954|9378711|P1|Overall Study|No tophi found in MRI|1
2728033|NCT00174954|9378711|P1|Overall Study|Adverse Event|2
2728034|NCT00174941|9378719|P4|Overall Study|Reason Not Specified|9
2728035|NCT00174941|9378720|P3|Overall Study|Reason Not Specified|2
2728036|NCT00174941|9378721|P2|Overall Study|Reason Not Specified|6
2728037|NCT00174941|9378722|P1|Overall Study|Reason Not Specified|1
2728038|NCT00174941|9378719|P4|Overall Study|Gout Flare|8
2728039|NCT00174941|9378720|P3|Overall Study|Gout Flare|4
2728040|NCT00174941|9378721|P2|Overall Study|Gout Flare|4
2728041|NCT00174941|9378722|P1|Overall Study|Gout Flare|0
2728042|NCT00174941|9378719|P4|Overall Study|Personal Reason(s)|22
2728043|NCT00174941|9378720|P3|Overall Study|Personal Reason(s)|8
2728044|NCT00174941|9378721|P2|Overall Study|Personal Reason(s)|14
2728045|NCT00174941|9378722|P1|Overall Study|Personal Reason(s)|0
2728046|NCT00174941|9378719|P4|Overall Study|Lost to Follow-up|5
2728047|NCT00174941|9378720|P3|Overall Study|Lost to Follow-up|2
2728048|NCT00174941|9378721|P2|Overall Study|Lost to Follow-up|3
2728049|NCT00174941|9378722|P1|Overall Study|Lost to Follow-up|0
2728050|NCT00174941|9378719|P4|Overall Study|Protocol Violation|1
2728051|NCT00174941|9378720|P3|Overall Study|Protocol Violation|0
2728052|NCT00174941|9378721|P2|Overall Study|Protocol Violation|1
2728053|NCT00174941|9378722|P1|Overall Study|Protocol Violation|0
2728054|NCT00174941|9378719|P4|Overall Study|Adverse Event|13
2728055|NCT00174941|9378720|P3|Overall Study|Adverse Event|2
2728056|NCT00174941|9378721|P2|Overall Study|Adverse Event|10
2728057|NCT00174941|9378722|P1|Overall Study|Adverse Event|1
2728058|NCT00174915|9378797|P5|Overall Study|Therapeutic Failure|3
2728059|NCT00174915|9378798|P4|Overall Study|Therapeutic Failure|1
2728060|NCT00174915|9378799|P3|Overall Study|Therapeutic Failure|2
2728061|NCT00174915|9378800|P2|Overall Study|Therapeutic Failure|3
2728062|NCT00174915|9378801|P1|Overall Study|Therapeutic Failure|6
2728063|NCT00174915|9378797|P5|Overall Study|Protocol Violation|3
2728064|NCT00174915|9378798|P4|Overall Study|Protocol Violation|6
2728065|NCT00174915|9378799|P3|Overall Study|Protocol Violation|3
2728066|NCT00174915|9378800|P2|Overall Study|Protocol Violation|3
2728067|NCT00174915|9378801|P1|Overall Study|Protocol Violation|6
2728068|NCT00174915|9378797|P5|Overall Study|Gout Flare|0
2728069|NCT00174915|9378798|P4|Overall Study|Gout Flare|1
2728070|NCT00174915|9378799|P3|Overall Study|Gout Flare|8
2728071|NCT00174915|9378800|P2|Overall Study|Gout Flare|6
2728072|NCT00174915|9378801|P1|Overall Study|Gout Flare|13
2728073|NCT00174915|9378797|P5|Overall Study|Other|3
2728074|NCT00174915|9378798|P4|Overall Study|Other|5
2728075|NCT00174915|9378799|P3|Overall Study|Other|6
2728076|NCT00174915|9378800|P2|Overall Study|Other|8
2728077|NCT00174915|9378801|P1|Overall Study|Other|15
2728078|NCT00174915|9378797|P5|Overall Study|Personal Reason(s)|9
2728079|NCT00174915|9378798|P4|Overall Study|Personal Reason(s)|9
2728080|NCT00174915|9378799|P3|Overall Study|Personal Reason(s)|9
2728081|NCT00174915|9378800|P2|Overall Study|Personal Reason(s)|16
2728082|NCT00174915|9378801|P1|Overall Study|Personal Reason(s)|16
2728083|NCT00174915|9378797|P5|Overall Study|Adverse Event|5
2728084|NCT00174915|9378798|P4|Overall Study|Adverse Event|18
2728085|NCT00174915|9378799|P3|Overall Study|Adverse Event|11
2728086|NCT00174915|9378800|P2|Overall Study|Adverse Event|16
2728087|NCT00174915|9378801|P1|Overall Study|Adverse Event|18
2728088|NCT00174915|9378797|P5|Overall Study|Lost to Follow-up|10
2728089|NCT00174915|9378798|P4|Overall Study|Lost to Follow-up|17
2728090|NCT00174915|9378799|P3|Overall Study|Lost to Follow-up|9
2728091|NCT00174915|9378800|P2|Overall Study|Lost to Follow-up|17
2728092|NCT00174915|9378801|P1|Overall Study|Lost to Follow-up|19
2728093|NCT00174785|9378860|P2|Overall Study|Not pre-specified/Not coded|70
2728094|NCT00174785|9378861|P1|Overall Study|Not pre-specified/Not coded|56
2728095|NCT00174785|9378860|P2|Overall Study|Family request|8
2728096|NCT00174785|9378861|P1|Overall Study|Family request|6
2728097|NCT00174785|9378860|P2|Overall Study|Other prohibited medication|3
2728098|NCT00174785|9378861|P1|Overall Study|Other prohibited medication|5
2728099|NCT00174785|9378860|P2|Overall Study|Prohibited antiarrhythmic medication|88
2728100|NCT00174785|9378861|P1|Overall Study|Prohibited antiarrhythmic medication|39
2728101|NCT00174785|9378860|P2|Overall Study|Atrial Fibrillation/Flutter recurrence|167
2728102|NCT00174785|9378861|P1|Overall Study|Atrial Fibrillation/Flutter recurrence|110
2728103|NCT00174785|9378860|P2|Overall Study|Withdrawal by Subject|175
2728104|NCT00174785|9378861|P1|Overall Study|Withdrawal by Subject|173
2728105|NCT00174785|9378860|P2|Overall Study|Protocol Violation|14
2728106|NCT00174785|9378861|P1|Overall Study|Protocol Violation|14
2728107|NCT00174785|9378860|P2|Overall Study|Adverse Event|191
2728108|NCT00174785|9378861|P1|Overall Study|Adverse Event|293
2728109|NCT00174460|9378877|P2|Overall Study|Withdrawal by Subject|1
2728110|NCT00174460|9378878|P1|Overall Study|Withdrawal by Subject|0
2728111|NCT00174447|9378924|P1|Overall Study|Administrative reason/Other|2
2728112|NCT00174447|9378924|P1|Overall Study|Lack of Efficacy|1
2728113|NCT00174447|9378924|P1|Overall Study|Protocol Violation|1
2728114|NCT00174447|9378924|P1|Overall Study|Withdrawal by Subject|15
2728115|NCT00174447|9378924|P1|Overall Study|Adverse Event|19
2728116|NCT00174382|9378933|P1|Overall Study|Lost to Follow-up|1
2728117|NCT00174382|9378933|P1|Overall Study|Subject felt pill not effective enough|1
2728118|NCT00174382|9378933|P1|Overall Study|Arrived early for last visit in error|1
2728119|NCT00174382|9378933|P1|Overall Study|Protocol Violation|3
2728120|NCT00174382|9378933|P1|Overall Study|Withdrawal by Subject|6
2728121|NCT00174382|9378933|P1|Overall Study|Adverse Event|19
2728122|NCT00174382|9378933|P1|Overall Study|Death|2
2728123|NCT00174291|9378952|P2|Overall Study|Withdrawal by Subject|3
2728124|NCT00174291|9378953|P1|Overall Study|Withdrawal by Subject|3
2728125|NCT00174291|9378952|P2|Overall Study|Study terminated by sponsor|0
2728126|NCT00174291|9378953|P1|Overall Study|Study terminated by sponsor|1
2728127|NCT00174291|9378952|P2|Overall Study|Protocol Violation|2
2728128|NCT00174291|9378953|P1|Overall Study|Protocol Violation|0
2728129|NCT00174291|9378952|P2|Overall Study|Lost to Follow-up|1
2728130|NCT00174291|9378953|P1|Overall Study|Lost to Follow-up|1
2728131|NCT00174265|9378983|P2|Overall Study|Other (Not specified)|10
2728132|NCT00174265|9378984|P1|Overall Study|Other (Not specified)|16
2728133|NCT00174265|9378983|P2|Overall Study|Lost to Follow-up|0
2728134|NCT00174265|9378984|P1|Overall Study|Lost to Follow-up|1
2728135|NCT00174265|9378983|P2|Overall Study|Withdrawal by Subject|5
2728136|NCT00174265|9378984|P1|Overall Study|Withdrawal by Subject|3
2728137|NCT00174265|9378983|P2|Overall Study|Lack of Efficacy|2
2728138|NCT00174265|9378984|P1|Overall Study|Lack of Efficacy|2
2728139|NCT00174265|9378983|P2|Overall Study|Adverse Event|4
2728140|NCT00174265|9378984|P1|Overall Study|Adverse Event|7
2728141|NCT00174252|9378992|P1|Overall Study|Protocol Violation|2
2728142|NCT00174187|9379027|P3|Period 2 (After 3 Years)|Other|5
2728143|NCT00174187|9379028|P2|Period 2 (After 3 Years)|Other|0
2728144|NCT00174187|9379029|P1|Period 2 (After 3 Years)|Other|0
2728145|NCT00174187|9379027|P3|Period 2 (After 3 Years)|Withdrawal by Subject|1
2728146|NCT00174187|9379028|P2|Period 2 (After 3 Years)|Withdrawal by Subject|0
2728147|NCT00174187|9379029|P1|Period 2 (After 3 Years)|Withdrawal by Subject|0
2728148|NCT00174187|9379027|P3|Period 2 (After 3 Years)|Lost to Follow-up|2
2728149|NCT00174187|9379028|P2|Period 2 (After 3 Years)|Lost to Follow-up|0
2728150|NCT00174187|9379029|P1|Period 2 (After 3 Years)|Lost to Follow-up|0
2728151|NCT00174187|9379027|P3|Between Period 1 and Period 2|Consented, not assigned to treatment|3
2728152|NCT00174187|9379028|P2|Between Period 1 and Period 2|Consented, not assigned to treatment|0
2728153|NCT00174187|9379029|P1|Between Period 1 and Period 2|Consented, not assigned to treatment|0
2728154|NCT00174187|9379027|P3|Between Period 1 and Period 2|Did not consent to continue treatment|2
2728155|NCT00174187|9379028|P2|Between Period 1 and Period 2|Did not consent to continue treatment|0
2728156|NCT00174187|9379029|P1|Between Period 1 and Period 2|Did not consent to continue treatment|0
2728157|NCT00174187|9379027|P3|Period 1 (up to 3 Years)|Other|0
2728158|NCT00174187|9379028|P2|Period 1 (up to 3 Years)|Other|1
2728159|NCT00174187|9379029|P1|Period 1 (up to 3 Years)|Other|0
2728160|NCT00174187|9379027|P3|Period 1 (up to 3 Years)|Withdrawal by Subject|0
2728161|NCT00174187|9379028|P2|Period 1 (up to 3 Years)|Withdrawal by Subject|1
2728162|NCT00174187|9379029|P1|Period 1 (up to 3 Years)|Withdrawal by Subject|0
2728163|NCT00174187|9379027|P3|Period 1 (up to 3 Years)|Non compliance|0
2728164|NCT00174187|9379028|P2|Period 1 (up to 3 Years)|Non compliance|1
2728165|NCT00174187|9379029|P1|Period 1 (up to 3 Years)|Non compliance|0
2728166|NCT00174187|9379027|P3|Period 1 (up to 3 Years)|Serious adverse event|0
2728167|NCT00174187|9379028|P2|Period 1 (up to 3 Years)|Serious adverse event|1
2728168|NCT00174187|9379029|P1|Period 1 (up to 3 Years)|Serious adverse event|0
2728169|NCT00172185|9379094|P4|Overall Study|Withdrawal by Subject|0
2728170|NCT00172185|9379095|P3|Overall Study|Withdrawal by Subject|1
2728171|NCT00172185|9379096|P2|Overall Study|Withdrawal by Subject|0
2728172|NCT00172185|9379097|P1|Overall Study|Withdrawal by Subject|0
2728173|NCT00172185|9379094|P4|Overall Study|SPONSOR Decision|0
2728174|NCT00172185|9379095|P3|Overall Study|SPONSOR Decision|0
2728175|NCT00172185|9379096|P2|Overall Study|SPONSOR Decision|1
2728176|NCT00172185|9379097|P1|Overall Study|SPONSOR Decision|0
2728177|NCT00172185|9379094|P4|Overall Study|Physician Decision|0
2728178|NCT00172185|9379095|P3|Overall Study|Physician Decision|1
2728179|NCT00172185|9379096|P2|Overall Study|Physician Decision|0
2728180|NCT00172185|9379097|P1|Overall Study|Physician Decision|0
2728181|NCT00172185|9379094|P4|Overall Study|Adverse Event|4
2728182|NCT00172185|9379095|P3|Overall Study|Adverse Event|3
2728183|NCT00172185|9379096|P2|Overall Study|Adverse Event|1
2728184|NCT00172185|9379097|P1|Overall Study|Adverse Event|0
2728185|NCT00172042|9379113|P2|Overall Study|Death|42
2728186|NCT00172042|9379114|P1|Overall Study|Death|42
2728187|NCT00172042|9379113|P2|Overall Study|Administrative problems|10
2728188|NCT00172042|9379114|P1|Overall Study|Administrative problems|13
2728189|NCT00172042|9379113|P2|Overall Study|Lost to Follow-up|5
2728190|NCT00172042|9379114|P1|Overall Study|Lost to Follow-up|3
2728191|NCT00172042|9379113|P2|Overall Study|Withdrawal by Subject|25
2728192|NCT00172042|9379114|P1|Overall Study|Withdrawal by Subject|37
2728193|NCT00172042|9379113|P2|Overall Study|Protocol Violation|7
2728194|NCT00172042|9379114|P1|Overall Study|Protocol Violation|8
2728195|NCT00172042|9379113|P2|Overall Study|Patient no longer requires study drug|8
2728196|NCT00172042|9379114|P1|Overall Study|Patient no longer requires study drug|10
2728197|NCT00172042|9379113|P2|Overall Study|Unsatisfactory therapeutic effect|11
2728198|NCT00172042|9379114|P1|Overall Study|Unsatisfactory therapeutic effect|13
2728199|NCT00172042|9379113|P2|Overall Study|Abnormal test procedure(s)|3
2728200|NCT00172042|9379114|P1|Overall Study|Abnormal test procedure(s)|0
2728201|NCT00172042|9379113|P2|Overall Study|Abnormal laboratory value(s)|1
2728202|NCT00172042|9379114|P1|Overall Study|Abnormal laboratory value(s)|5
2728203|NCT00172042|9379113|P2|Overall Study|Adverse Event|13
2728204|NCT00172042|9379114|P1|Overall Study|Adverse Event|27
2728205|NCT00171925|9379136|P2|Overall Study|Death|2
2728206|NCT00171925|9379137|P1|Overall Study|Death|1
2728207|NCT00171925|9379136|P2|Overall Study|Administrative problems|11
2728208|NCT00171925|9379137|P1|Overall Study|Administrative problems|10
2728209|NCT00171925|9379136|P2|Overall Study|Lost to Follow-up|2
2728210|NCT00171925|9379137|P1|Overall Study|Lost to Follow-up|2
2728211|NCT00171925|9379136|P2|Overall Study|Withdrawal by Subject|9
2728212|NCT00171925|9379137|P1|Overall Study|Withdrawal by Subject|6
2728213|NCT00171925|9379136|P2|Overall Study|Protocol Violation|1
2728214|NCT00171925|9379137|P1|Overall Study|Protocol Violation|1
2728215|NCT00171925|9379136|P2|Overall Study|Adverse Event|6
2728216|NCT00171925|9379137|P1|Overall Study|Adverse Event|10
2728217|NCT00171873|9379149|P2|Overall Study|Switched to Octreotide|1
2728218|NCT00171873|9379150|P1|Overall Study|Switched to Octreotide|0
2728219|NCT00171873|9379149|P2|Overall Study|Adverse Event|0
2728220|NCT00171873|9379150|P1|Overall Study|Adverse Event|5
2728221|NCT00171873|9379149|P2|Overall Study|Withdrawal by Subject|2
2728222|NCT00171873|9379150|P1|Overall Study|Withdrawal by Subject|4
2728223|NCT00171834|9379163|P7|Overall Study|Treatment Duration Completed|0
2728224|NCT00171834|9379164|P6|Overall Study|Treatment Duration Completed|1
2728225|NCT00171834|9379165|P5|Overall Study|Treatment Duration Completed|2
2728226|NCT00171834|9379166|P4|Overall Study|Treatment Duration Completed|0
2728227|NCT00171834|9379167|P3|Overall Study|Treatment Duration Completed|1
2728228|NCT00171834|9379168|P2|Overall Study|Treatment Duration Completed|0
2728229|NCT00171834|9379169|P1|Overall Study|Treatment Duration Completed|0
2728230|NCT00171834|9379163|P7|Overall Study|Disease Progression|3
2728231|NCT00171834|9379164|P6|Overall Study|Disease Progression|18
2728232|NCT00171834|9379165|P5|Overall Study|Disease Progression|2
2728233|NCT00171834|9379166|P4|Overall Study|Disease Progression|9
2728234|NCT00171834|9379167|P3|Overall Study|Disease Progression|8
2728235|NCT00171834|9379168|P2|Overall Study|Disease Progression|8
2728236|NCT00171834|9379169|P1|Overall Study|Disease Progression|4
2728237|NCT00171834|9379163|P7|Overall Study|Death from study indication|0
2728238|NCT00171834|9379164|P6|Overall Study|Death from study indication|0
2728239|NCT00171834|9379165|P5|Overall Study|Death from study indication|1
2728240|NCT00171834|9379166|P4|Overall Study|Death from study indication|0
2728241|NCT00171834|9379167|P3|Overall Study|Death from study indication|0
2728242|NCT00171834|9379168|P2|Overall Study|Death from study indication|1
2728243|NCT00171834|9379169|P1|Overall Study|Death from study indication|0
2728244|NCT00171834|9379163|P7|Overall Study|Withdrawal by Subject|0
2728245|NCT00171834|9379164|P6|Overall Study|Withdrawal by Subject|1
2728246|NCT00171834|9379165|P5|Overall Study|Withdrawal by Subject|1
2728247|NCT00171834|9379166|P4|Overall Study|Withdrawal by Subject|1
2728248|NCT00171834|9379167|P3|Overall Study|Withdrawal by Subject|0
2728249|NCT00171834|9379168|P2|Overall Study|Withdrawal by Subject|2
2728250|NCT00171834|9379169|P1|Overall Study|Withdrawal by Subject|0
2728251|NCT00171834|9379163|P7|Overall Study|Adverse Event|1
2728252|NCT00171834|9379164|P6|Overall Study|Adverse Event|15
2728253|NCT00171834|9379165|P5|Overall Study|Adverse Event|2
2728254|NCT00171834|9379166|P4|Overall Study|Adverse Event|2
2728255|NCT00171834|9379167|P3|Overall Study|Adverse Event|3
2728256|NCT00171834|9379168|P2|Overall Study|Adverse Event|1
2728257|NCT00171834|9379169|P1|Overall Study|Adverse Event|2
2728258|NCT00171704|9379209|P2|Overall Study|Protocol Violation|1
2728259|NCT00171704|9379210|P1|Overall Study|Protocol Violation|0
2728260|NCT00171704|9379209|P2|Overall Study|Withdrawal by Subject|3
2728261|NCT00171704|9379210|P1|Overall Study|Withdrawal by Subject|1
2728262|NCT00171704|9379209|P2|Overall Study|Death|2
2728263|NCT00171704|9379210|P1|Overall Study|Death|2
2728264|NCT00171704|9379209|P2|Overall Study|Administrative Problems|1
2728265|NCT00171704|9379210|P1|Overall Study|Administrative Problems|2
2728266|NCT00171704|9379209|P2|Overall Study|New therapy for 2nd non-breast prim canc|0
2728267|NCT00171704|9379210|P1|Overall Study|New therapy for 2nd non-breast prim canc|1
2728268|NCT00171704|9379209|P2|Overall Study|Disease Progression|9
2728269|NCT00171704|9379210|P1|Overall Study|Disease Progression|14
2728270|NCT00171704|9379209|P2|Overall Study|Adverse Event|33
2728271|NCT00171704|9379210|P1|Overall Study|Adverse Event|24
2728272|NCT00171340|9379232|P2|Overall Study|Death|6
2728273|NCT00171340|9379233|P1|Overall Study|Death|6
2728274|NCT00171340|9379232|P2|Overall Study|Administrative Problems|2
2728275|NCT00171340|9379233|P1|Overall Study|Administrative Problems|5
2728276|NCT00171340|9379232|P2|Overall Study|No Longer Required Study Drug|1
2728277|NCT00171340|9379233|P1|Overall Study|No Longer Required Study Drug|1
2728278|NCT00171340|9379232|P2|Overall Study|Abnormal Test Procedure Results|11
2728279|NCT00171340|9379233|P1|Overall Study|Abnormal Test Procedure Results|6
2728280|NCT00171340|9379232|P2|Overall Study|Abnormal Laboratory Results|0
2728281|NCT00171340|9379233|P1|Overall Study|Abnormal Laboratory Results|2
2728282|NCT00171340|9379232|P2|Overall Study|Lost to Follow-up|5
2728283|NCT00171340|9379233|P1|Overall Study|Lost to Follow-up|0
2728284|NCT00171340|9379232|P2|Overall Study|Withdrawal by Subject|19
2728285|NCT00171340|9379233|P1|Overall Study|Withdrawal by Subject|22
2728286|NCT00171340|9379232|P2|Overall Study|Protocol Violation|8
2728287|NCT00171340|9379233|P1|Overall Study|Protocol Violation|7
2728288|NCT00171340|9379232|P2|Overall Study|Lack of Efficacy|41
2728289|NCT00171340|9379233|P1|Overall Study|Lack of Efficacy|29
2728290|NCT00171340|9379232|P2|Overall Study|Adverse Event|42
2728291|NCT00171340|9379233|P1|Overall Study|Adverse Event|46
2728292|NCT00171314|9379249|P2|Overall Study|Death|1
2728293|NCT00171314|9379250|P1|Overall Study|Death|2
2728294|NCT00171314|9379249|P2|Overall Study|Lost to Follow-up|3
2728295|NCT00171314|9379250|P1|Overall Study|Lost to Follow-up|1
2728296|NCT00171314|9379249|P2|Overall Study|Administrative Problems|3
2728297|NCT00171314|9379250|P1|Overall Study|Administrative Problems|4
2728298|NCT00171314|9379249|P2|Overall Study|Protocol Violation|7
2728299|NCT00171314|9379250|P1|Overall Study|Protocol Violation|3
2728300|NCT00171314|9379249|P2|Overall Study|Abnormal Test Procedure Results|3
2728301|NCT00171314|9379250|P1|Overall Study|Abnormal Test Procedure Results|9
2728302|NCT00171314|9379249|P2|Overall Study|Withdrawal by Subject|6
2728303|NCT00171314|9379250|P1|Overall Study|Withdrawal by Subject|9
2728304|NCT00171314|9379249|P2|Overall Study|Lack of Efficacy|14
2728305|NCT00171314|9379250|P1|Overall Study|Lack of Efficacy|19
2728306|NCT00171314|9379249|P2|Overall Study|Adverse Event|41
2728307|NCT00171314|9379250|P1|Overall Study|Adverse Event|44
2728308|NCT00171301|9379266|P2|Overall Study|Withdrawal by Subject|1
2728309|NCT00171301|9379267|P1|Overall Study|Withdrawal by Subject|0
2728310|NCT00171301|9379266|P2|Overall Study|Protocol Violation|2
2728311|NCT00171301|9379267|P1|Overall Study|Protocol Violation|0
2728312|NCT00171301|9379266|P2|Overall Study|Lost to Follow-up|2
2728313|NCT00171301|9379267|P1|Overall Study|Lost to Follow-up|6
2728314|NCT00171301|9379266|P2|Overall Study|Adverse Event|2
2728315|NCT00171301|9379267|P1|Overall Study|Adverse Event|1
2728316|NCT00171301|9379266|P2|Overall Study|Death|2
2728317|NCT00171301|9379267|P1|Overall Study|Death|1
2728318|NCT00171210|9379280|P2|Overall Study|Stopped at end of extension 1|1
2728319|NCT00171210|9379281|P1|Overall Study|Stopped at end of extension 1|0
2728320|NCT00171210|9379280|P2|Overall Study|Stopped at end of core|32
2728321|NCT00171210|9379281|P1|Overall Study|Stopped at end of core|0
2728322|NCT00171210|9379280|P2|Overall Study|Death|3
2728323|NCT00171210|9379281|P1|Overall Study|Death|2
2728324|NCT00171210|9379280|P2|Overall Study|Administrative problems|1
2728325|NCT00171210|9379281|P1|Overall Study|Administrative problems|1
2728326|NCT00171210|9379280|P2|Overall Study|Lost to Follow-up|0
2728327|NCT00171210|9379281|P1|Overall Study|Lost to Follow-up|1
2728328|NCT00171210|9379280|P2|Overall Study|Withdrawal by Subject|30
2728329|NCT00171210|9379281|P1|Overall Study|Withdrawal by Subject|32
2728330|NCT00171210|9379280|P2|Overall Study|Protocol Violation|2
2728331|NCT00171210|9379281|P1|Overall Study|Protocol Violation|0
2728332|NCT00171210|9379280|P2|Overall Study|Unsatisfactory therapeutic effect|15
2728333|NCT00171210|9379281|P1|Overall Study|Unsatisfactory therapeutic effect|11
2728334|NCT00171210|9379280|P2|Overall Study|Abnormal test procedure result(s)|1
2728335|NCT00171210|9379281|P1|Overall Study|Abnormal test procedure result(s)|0
2728336|NCT00171210|9379280|P2|Overall Study|Abnormal laboratory value(s)|3
2728337|NCT00171210|9379281|P1|Overall Study|Abnormal laboratory value(s)|6
2728338|NCT00171210|9379280|P2|Overall Study|Adverse Event|27
2728339|NCT00171210|9379281|P1|Overall Study|Adverse Event|16
2728340|NCT00171054|9379311|P2|Overall Study|Condition no longer required study drug|1
2728341|NCT00171054|9379312|P1|Overall Study|Condition no longer required study drug|0
2728342|NCT00171054|9379311|P2|Overall Study|Adverse Event|8
2728343|NCT00171054|9379312|P1|Overall Study|Adverse Event|8
2728344|NCT00171054|9379311|P2|Overall Study|Lost to Follow-up|1
2728345|NCT00171054|9379312|P1|Overall Study|Lost to Follow-up|0
2728346|NCT00171054|9379311|P2|Overall Study|Patient withdrew consent|0
2728347|NCT00171054|9379312|P1|Overall Study|Patient withdrew consent|1
2728348|NCT00171054|9379311|P2|Overall Study|Protocol Violation|2
2728349|NCT00171054|9379312|P1|Overall Study|Protocol Violation|1
2728350|NCT00170950|9379344|P2|Overall Study|Termination Data Not Recorded|22
2728351|NCT00170950|9379345|P1|Overall Study|Termination Data Not Recorded|17
2728352|NCT00170950|9379344|P2|Overall Study|Missing|1
2728353|NCT00170950|9379345|P1|Overall Study|Missing|2
2728354|NCT00170950|9379344|P2|Overall Study|Lost to Follow-up|115
2728355|NCT00170950|9379345|P1|Overall Study|Lost to Follow-up|134
2728356|NCT00170950|9379344|P2|Overall Study|Withdrawal by Subject|498
2728357|NCT00170950|9379345|P1|Overall Study|Withdrawal by Subject|496
2728358|NCT00170950|9379344|P2|Overall Study|Death|274
2728359|NCT00170950|9379345|P1|Overall Study|Death|236
2728360|NCT00170846|9379358|P3|Overall Study|Reason Missing|0
2728361|NCT00170846|9379359|P2|Overall Study|Reason Missing|1
2728362|NCT00170846|9379360|P1|Overall Study|Reason Missing|0
2728363|NCT00170846|9379358|P3|Overall Study|Death|3
2728364|NCT00170846|9379359|P2|Overall Study|Death|3
2728365|NCT00170846|9379360|P1|Overall Study|Death|0
2728366|NCT00170846|9379358|P3|Overall Study|Lost to Follow-up|2
2728367|NCT00170846|9379359|P2|Overall Study|Lost to Follow-up|3
2728368|NCT00170846|9379360|P1|Overall Study|Lost to Follow-up|6
2728369|NCT00170846|9379358|P3|Overall Study|Subject withdrew Informed Consent|8
2728370|NCT00170846|9379359|P2|Overall Study|Subject withdrew Informed Consent|12
2728371|NCT00170846|9379360|P1|Overall Study|Subject withdrew Informed Consent|5
2728372|NCT00169442|9379392|P6|Overall Study|Lost to follow-up (compl. vaccination)|0
2728373|NCT00169442|9379393|P5|Overall Study|Lost to follow-up (compl. vaccination)|0
2728374|NCT00169442|9379394|P4|Overall Study|Lost to follow-up (compl. vaccination)|0
2728375|NCT00169442|9379395|P3|Overall Study|Lost to follow-up (compl. vaccination)|0
2728376|NCT00169442|9379396|P2|Overall Study|Lost to follow-up (compl. vaccination)|1
2728377|NCT00169442|9379397|P1|Overall Study|Lost to follow-up (compl. vaccination)|0
2728378|NCT00169442|9379392|P6|Overall Study|Lost to follow-up (incompl. vaccination)|0
2728379|NCT00169442|9379393|P5|Overall Study|Lost to follow-up (incompl. vaccination)|1
2728380|NCT00169442|9379394|P4|Overall Study|Lost to follow-up (incompl. vaccination)|0
2728381|NCT00169442|9379395|P3|Overall Study|Lost to follow-up (incompl. vaccination)|0
2728382|NCT00169442|9379396|P2|Overall Study|Lost to follow-up (incompl. vaccination)|0
2728383|NCT00169442|9379397|P1|Overall Study|Lost to follow-up (incompl. vaccination)|0
2728384|NCT00169442|9379392|P6|Overall Study|Migrated/moved from study area|2
2728385|NCT00169442|9379393|P5|Overall Study|Migrated/moved from study area|0
2728386|NCT00169442|9379394|P4|Overall Study|Migrated/moved from study area|0
2728387|NCT00169442|9379395|P3|Overall Study|Migrated/moved from study area|0
2728388|NCT00169442|9379396|P2|Overall Study|Migrated/moved from study area|0
2728389|NCT00169442|9379397|P1|Overall Study|Migrated/moved from study area|0
2728390|NCT00169442|9379392|P6|Overall Study|Withdrawal by Subject|0
2728391|NCT00169442|9379393|P5|Overall Study|Withdrawal by Subject|0
2728392|NCT00169442|9379394|P4|Overall Study|Withdrawal by Subject|0
2728393|NCT00169442|9379395|P3|Overall Study|Withdrawal by Subject|1
2728394|NCT00169442|9379396|P2|Overall Study|Withdrawal by Subject|0
2728395|NCT00169442|9379397|P1|Overall Study|Withdrawal by Subject|0
2728396|NCT00169104|9379506|P2|Overall Study|Physician Decision|1
2728397|NCT00169104|9379507|P1|Overall Study|Physician Decision|0
2728398|NCT00169104|9379506|P2|Overall Study|Protocol Violation|1
2728399|NCT00169104|9379507|P1|Overall Study|Protocol Violation|0
2728400|NCT00169104|9379506|P2|Overall Study|Withdrawal by Subject|0
2728401|NCT00169104|9379507|P1|Overall Study|Withdrawal by Subject|2
2728402|NCT00168844|9379521|P3|Overall Study|Other|9
2728403|NCT00168844|9379522|P2|Overall Study|Other|7
2728404|NCT00168844|9379523|P1|Overall Study|Other|6
2728405|NCT00168844|9379521|P3|Overall Study|Protocol Violation|4
2728406|NCT00168844|9379522|P2|Overall Study|Protocol Violation|2
2728407|NCT00168844|9379523|P1|Overall Study|Protocol Violation|2
2728408|NCT00168844|9379521|P3|Overall Study|Withdrawal by Subject|19
2728409|NCT00168844|9379522|P2|Overall Study|Withdrawal by Subject|9
2728410|NCT00168844|9379523|P1|Overall Study|Withdrawal by Subject|12
2728411|NCT00168844|9379521|P3|Overall Study|Lost to Follow-up|11
2728412|NCT00168844|9379522|P2|Overall Study|Lost to Follow-up|5
2728413|NCT00168844|9379523|P1|Overall Study|Lost to Follow-up|4
2728414|NCT00168844|9379521|P3|Overall Study|Adverse Event|48
2728415|NCT00168844|9379522|P2|Overall Study|Adverse Event|32
2728416|NCT00168844|9379523|P1|Overall Study|Adverse Event|31
2728417|NCT00168831|9379705|P3|Overall Study|Other|6
2728418|NCT00168831|9379706|P2|Overall Study|Other|3
2728419|NCT00168831|9379707|P1|Overall Study|Other|6
2728420|NCT00168831|9379705|P3|Overall Study|Protocol Violation|11
2728421|NCT00168831|9379706|P2|Overall Study|Protocol Violation|11
2728422|NCT00168831|9379707|P1|Overall Study|Protocol Violation|6
2728423|NCT00168831|9379705|P3|Overall Study|Withdrawal by Subject|19
2728424|NCT00168831|9379706|P2|Overall Study|Withdrawal by Subject|14
2728425|NCT00168831|9379707|P1|Overall Study|Withdrawal by Subject|7
2728426|NCT00168831|9379705|P3|Overall Study|Lost to Follow-up|4
2728427|NCT00168831|9379706|P2|Overall Study|Lost to Follow-up|6
2728428|NCT00168831|9379707|P1|Overall Study|Lost to Follow-up|5
2728429|NCT00168831|9379705|P3|Overall Study|Adverse Event|74
2728430|NCT00168831|9379706|P2|Overall Study|Adverse Event|47
2728431|NCT00168831|9379707|P1|Overall Study|Adverse Event|36
2728432|NCT00168818|9379889|P3|Treatment|Other|31
2728433|NCT00168818|9379890|P2|Treatment|Other|29
2728434|NCT00168818|9379891|P1|Treatment|Other|23
2728435|NCT00168818|9379889|P3|Treatment|Withdrawal by Subject|22
2728436|NCT00168818|9379890|P2|Treatment|Withdrawal by Subject|20
2728437|NCT00168818|9379891|P1|Treatment|Withdrawal by Subject|25
2728438|NCT00168818|9379889|P3|Treatment|Lost to Follow-up|1
2728439|NCT00168818|9379890|P2|Treatment|Lost to Follow-up|2
2728440|NCT00168818|9379891|P1|Treatment|Lost to Follow-up|0
2728441|NCT00168818|9379889|P3|Treatment|Protocol Violation|11
2728442|NCT00168818|9379890|P2|Treatment|Protocol Violation|11
2728443|NCT00168818|9379891|P1|Treatment|Protocol Violation|8
2728444|NCT00168818|9379889|P3|Treatment|Adverse Event|68
2728445|NCT00168818|9379890|P2|Treatment|Adverse Event|89
2728446|NCT00168818|9379891|P1|Treatment|Adverse Event|77
2728447|NCT00168818|9379889|P3|Overall Study|Other|30
2728448|NCT00168818|9379890|P2|Overall Study|Other|24
2728449|NCT00168818|9379891|P1|Overall Study|Other|22
2728450|NCT00168818|9379889|P3|Overall Study|Withdrawal by Subject|37
2728451|NCT00168818|9379890|P2|Overall Study|Withdrawal by Subject|41
2728452|NCT00168818|9379891|P1|Overall Study|Withdrawal by Subject|43
2728453|NCT00168818|9379889|P3|Overall Study|Lost to Follow-up|15
2728454|NCT00168818|9379890|P2|Overall Study|Lost to Follow-up|4
2728455|NCT00168818|9379891|P1|Overall Study|Lost to Follow-up|13
2728456|NCT00168818|9379889|P3|Overall Study|Protocol Violation|11
2728457|NCT00168818|9379890|P2|Overall Study|Protocol Violation|11
2728458|NCT00168818|9379891|P1|Overall Study|Protocol Violation|16
2728459|NCT00168818|9379889|P3|Overall Study|Adverse Event|31
2728460|NCT00168818|9379890|P2|Overall Study|Adverse Event|29
2728461|NCT00168818|9379891|P1|Overall Study|Adverse Event|23
2728462|NCT00168805|9379935|P3|Treatment|Other|17
2728463|NCT00168805|9379936|P2|Treatment|Other|18
2728464|NCT00168805|9379937|P1|Treatment|Other|18
2728465|NCT00168805|9379935|P3|Treatment|Withdrawal by Subject|8
2728466|NCT00168805|9379936|P2|Treatment|Withdrawal by Subject|7
2728467|NCT00168805|9379937|P1|Treatment|Withdrawal by Subject|3
2728468|NCT00168805|9379935|P3|Treatment|Protocol Violation|5
2728469|NCT00168805|9379936|P2|Treatment|Protocol Violation|5
2728470|NCT00168805|9379937|P1|Treatment|Protocol Violation|3
2728471|NCT00168805|9379935|P3|Treatment|Adverse Event|32
2728472|NCT00168805|9379936|P2|Treatment|Adverse Event|26
2728473|NCT00168805|9379937|P1|Treatment|Adverse Event|25
2728474|NCT00168805|9379935|P3|Overall Study|Other|22
2728475|NCT00168805|9379936|P2|Overall Study|Other|21
2728476|NCT00168805|9379937|P1|Overall Study|Other|24
2728477|NCT00168805|9379935|P3|Overall Study|Withdrawal by Subject|21
2728478|NCT00168805|9379936|P2|Overall Study|Withdrawal by Subject|18
2728479|NCT00168805|9379937|P1|Overall Study|Withdrawal by Subject|16
2728480|NCT00168805|9379935|P3|Overall Study|Lost to Follow-up|11
2728481|NCT00168805|9379936|P2|Overall Study|Lost to Follow-up|17
2728482|NCT00168805|9379937|P1|Overall Study|Lost to Follow-up|12
2728483|NCT00168805|9379935|P3|Overall Study|Protocol Violation|8
2728484|NCT00168805|9379936|P2|Overall Study|Protocol Violation|11
2728485|NCT00168805|9379937|P1|Overall Study|Protocol Violation|12
2728486|NCT00168805|9379935|P3|Overall Study|Adverse Event|16
2728487|NCT00168805|9379936|P2|Overall Study|Adverse Event|11
2728488|NCT00168805|9379937|P1|Overall Study|Adverse Event|7
2728489|NCT00168103|9380173|P4|Overall Study|Lost to Follow-up|0
2728490|NCT00168103|9380174|P3|Overall Study|Lost to Follow-up|0
2728491|NCT00168103|9380175|P2|Overall Study|Lost to Follow-up|3
2728492|NCT00168103|9380176|P1|Overall Study|Lost to Follow-up|1
2728493|NCT00168103|9380173|P4|Overall Study|Withdrawal by Subject|0
2728494|NCT00168103|9380174|P3|Overall Study|Withdrawal by Subject|1
2728495|NCT00168103|9380175|P2|Overall Study|Withdrawal by Subject|2
2728496|NCT00168103|9380176|P1|Overall Study|Withdrawal by Subject|1
2728497|NCT00168064|9380198|P2|Overall Study|Various|3
2728498|NCT00168064|9380199|P1|Overall Study|Various|4
2728499|NCT00168064|9380198|P2|Overall Study|Subject's Best interest|2
2728500|NCT00168064|9380199|P1|Overall Study|Subject's Best interest|2
2728501|NCT00168064|9380198|P2|Overall Study|Concurrent Illness|3
2728502|NCT00168064|9380199|P1|Overall Study|Concurrent Illness|4
2728503|NCT00168064|9380198|P2|Overall Study|Non-compliance|3
2728504|NCT00168064|9380199|P1|Overall Study|Non-compliance|2
2728505|NCT00168064|9380198|P2|Overall Study|Lost to Follow-up|3
2728506|NCT00168064|9380199|P1|Overall Study|Lost to Follow-up|4
2728507|NCT00168064|9380198|P2|Overall Study|Lack of Efficacy|4
2728508|NCT00168064|9380199|P1|Overall Study|Lack of Efficacy|4
2728509|NCT00168064|9380198|P2|Overall Study|Withdrawal by Subject|4
2728510|NCT00168064|9380199|P1|Overall Study|Withdrawal by Subject|3
2728511|NCT00168064|9380198|P2|Overall Study|Adverse Event|22
2728512|NCT00168064|9380199|P1|Overall Study|Adverse Event|26
2728513|NCT00168038|9380207|P1|Overall Study|Therapy failure|1
2728514|NCT00168038|9380207|P1|Overall Study|Adverse Event|1
2728515|NCT00167778|9380230|P1|Overall Study|Withdrawal by Subject|1
2728516|NCT00167414|9380296|P1|Overall Study|Death|10
2728517|NCT00167310|9380321|P2|Overall Study|Withdrawal by Subject|7
2728518|NCT00167310|9380322|P1|Overall Study|Withdrawal by Subject|3
2728519|NCT00167310|9380321|P2|Overall Study|Protocol Violation|3
2728520|NCT00167310|9380322|P1|Overall Study|Protocol Violation|5
2728521|NCT00167245|9380332|P2|Overall Study|Drowsy|0
2728522|NCT00167245|9380333|P1|Overall Study|Drowsy|1
2728523|NCT00167245|9380332|P2|Overall Study|Incarcerated|2
2728524|NCT00167245|9380333|P1|Overall Study|Incarcerated|3
2728525|NCT00167245|9380332|P2|Overall Study|Withdrawal by Subject|8
2728526|NCT00167245|9380333|P1|Overall Study|Withdrawal by Subject|5
2728527|NCT00167245|9380332|P2|Overall Study|Lost to Follow-up|31
2728528|NCT00167245|9380333|P1|Overall Study|Lost to Follow-up|20
2728529|NCT00166712|9380383|P2|Overall Study|Physician Decision|2
2728530|NCT00166712|9380384|P1|Overall Study|Physician Decision|0
2728531|NCT00166712|9380383|P2|Overall Study|Withdrawal by Subject|2
2728532|NCT00166712|9380384|P1|Overall Study|Withdrawal by Subject|1
2728533|NCT00166712|9380383|P2|Overall Study|Adverse Event|0
2728534|NCT00166712|9380384|P1|Overall Study|Adverse Event|1
2728535|NCT00166712|9380383|P2|Overall Study|Death|1
2728536|NCT00166712|9380384|P1|Overall Study|Death|0
2728537|NCT00166517|9380401|P2|Overall Study|Withdrawal by Subject|1
2728538|NCT00166517|9380402|P1|Overall Study|Withdrawal by Subject|0
2728539|NCT00166517|9380401|P2|Overall Study|Protocol Violation|1
2728540|NCT00166517|9380402|P1|Overall Study|Protocol Violation|4
2728541|NCT00166517|9380401|P2|Overall Study|Lost to Follow-up|0
2728542|NCT00166517|9380402|P1|Overall Study|Lost to Follow-up|1
2728543|NCT00166504|9380412|P2|Overall Study|Withdrawal by Subject|0
2728544|NCT00166504|9380413|P1|Overall Study|Withdrawal by Subject|1
2728545|NCT00166504|9380412|P2|Overall Study|Lost to Follow-up|1
2728546|NCT00166504|9380413|P1|Overall Study|Lost to Follow-up|1
2728547|NCT00166504|9380412|P2|Overall Study|Adverse Event|3
2728548|NCT00166504|9380413|P1|Overall Study|Adverse Event|3
2728549|NCT00166439|9380419|P1|Overall Study|Ineligible|5
2728550|NCT00166296|9380436|P2|Overall Study|Lost to Follow-up|2
2728551|NCT00166296|9380437|P1|Overall Study|Lost to Follow-up|4
2728552|NCT00166296|9380436|P2|Overall Study|Adverse Event|4
2728553|NCT00166296|9380437|P1|Overall Study|Adverse Event|2
2728554|NCT00166296|9380436|P2|Overall Study|Withdrawal by Subject|3
2728555|NCT00166296|9380437|P1|Overall Study|Withdrawal by Subject|1
2728556|NCT00166114|9380489|P2|Overall Study|Adverse Event|1
2728557|NCT00166114|9380490|P1|Overall Study|Adverse Event|2
2728558|NCT00166114|9380489|P2|Overall Study|Withdrawal by Subject|4
2728559|NCT00166114|9380490|P1|Overall Study|Withdrawal by Subject|10
2728560|NCT00166114|9380489|P2|Overall Study|Protocol Violation|1
2728561|NCT00166114|9380490|P1|Overall Study|Protocol Violation|2
2728562|NCT00165984|9380507|P1|Overall Study|Death|15
2728563|NCT00165841|9380525|P2|Overall Study|Medication Noncompliance|1
2728564|NCT00165841|9380526|P1|Overall Study|Medication Noncompliance|1
2728565|NCT00165841|9380525|P2|Overall Study|Other|5
2728566|NCT00165841|9380526|P1|Overall Study|Other|3
2728567|NCT00165841|9380525|P2|Overall Study|Protocol Violation|8
2728568|NCT00165841|9380526|P1|Overall Study|Protocol Violation|6
2728569|NCT00165841|9380525|P2|Overall Study|Physician Decision|0
2728570|NCT00165841|9380526|P1|Overall Study|Physician Decision|1
2728571|NCT00165841|9380525|P2|Overall Study|Withdrawal by Subject|8
2728572|NCT00165841|9380526|P1|Overall Study|Withdrawal by Subject|7
2728573|NCT00165841|9380525|P2|Overall Study|Lost to Follow-up|4
2728574|NCT00165841|9380526|P1|Overall Study|Lost to Follow-up|4
2728575|NCT00165841|9380525|P2|Overall Study|Lack of Efficacy|33
2728576|NCT00165841|9380526|P1|Overall Study|Lack of Efficacy|6
2728577|NCT00165841|9380525|P2|Overall Study|Adverse Event|3
2728578|NCT00165841|9380526|P1|Overall Study|Adverse Event|2
2728579|NCT00165789|9380536|P4|Overall Study|Withdrawal by Subject|2
2728580|NCT00165789|9380537|P3|Overall Study|Withdrawal by Subject|1
2728581|NCT00165789|9380538|P2|Overall Study|Withdrawal by Subject|1
2728582|NCT00165789|9380539|P1|Overall Study|Withdrawal by Subject|0
2728583|NCT00165789|9380536|P4|Overall Study|Adverse Event|12
2728584|NCT00165789|9380537|P3|Overall Study|Adverse Event|0
2728585|NCT00165789|9380538|P2|Overall Study|Adverse Event|3
2728586|NCT00165789|9380539|P1|Overall Study|Adverse Event|0
2728587|NCT00165776|9380593|P4|Overall Study|Worsening of Cervical Dystonia|1
2728588|NCT00165776|9380594|P3|Overall Study|Worsening of Cervical Dystonia|0
2728589|NCT00165776|9380595|P2|Overall Study|Worsening of Cervical Dystonia|0
2728590|NCT00165776|9380596|P1|Overall Study|Worsening of Cervical Dystonia|0
2728591|NCT00165776|9380593|P4|Overall Study|Withdrawal by Subject|0
2728592|NCT00165776|9380594|P3|Overall Study|Withdrawal by Subject|2
2728593|NCT00165776|9380595|P2|Overall Study|Withdrawal by Subject|1
2728594|NCT00165776|9380596|P1|Overall Study|Withdrawal by Subject|4
2728595|NCT00165776|9380593|P4|Overall Study|Lack of Efficacy|1
2728596|NCT00165776|9380594|P3|Overall Study|Lack of Efficacy|0
2728597|NCT00165776|9380595|P2|Overall Study|Lack of Efficacy|0
2728598|NCT00165776|9380596|P1|Overall Study|Lack of Efficacy|0
2728599|NCT00165698|9380632|P2|Overall Study|Not Taken/Lost the medicine|2
2728600|NCT00165698|9380633|P1|Overall Study|Not Taken/Lost the medicine|1
2728601|NCT00165698|9380632|P2|Overall Study|Protocol Violation|0
2728602|NCT00165698|9380633|P1|Overall Study|Protocol Violation|1
2728603|NCT00165698|9380632|P2|Overall Study|Withdrawal by Subject|1
2728604|NCT00165698|9380633|P1|Overall Study|Withdrawal by Subject|2
2728605|NCT00165698|9380632|P2|Overall Study|Lost to Follow-up|2
2728606|NCT00165698|9380633|P1|Overall Study|Lost to Follow-up|2
2728607|NCT00165698|9380632|P2|Overall Study|Adverse Event|10
2728608|NCT00165698|9380633|P1|Overall Study|Adverse Event|2
2728609|NCT00165672|9380659|P2|Overall Study|Adverse Event|1
2728610|NCT00165672|9380660|P1|Overall Study|Adverse Event|0
2728611|NCT00165646|9380669|P3|Overall Study|Protocol Violation|0
2728612|NCT00165646|9380670|P2|Overall Study|Protocol Violation|0
2728613|NCT00165646|9380671|P1|Overall Study|Protocol Violation|1
2728614|NCT00165646|9380669|P3|Overall Study|Physician Decision|2
2728615|NCT00165646|9380670|P2|Overall Study|Physician Decision|0
2728616|NCT00165646|9380671|P1|Overall Study|Physician Decision|2
2728617|NCT00165646|9380669|P3|Overall Study|Withdrawal by Subject|1
2728618|NCT00165646|9380670|P2|Overall Study|Withdrawal by Subject|2
2728619|NCT00165646|9380671|P1|Overall Study|Withdrawal by Subject|0
2728620|NCT00165646|9380669|P3|Overall Study|Lack of Efficacy|0
2728621|NCT00165646|9380670|P2|Overall Study|Lack of Efficacy|2
2728622|NCT00165646|9380671|P1|Overall Study|Lack of Efficacy|1
2728623|NCT00165646|9380669|P3|Overall Study|Adverse Event|1
2728624|NCT00165646|9380670|P2|Overall Study|Adverse Event|1
2728625|NCT00165646|9380671|P1|Overall Study|Adverse Event|1
2728626|NCT00165503|9380679|P1|Overall Study|Unresectable|3
2728627|NCT00165503|9380679|P1|Overall Study|Lost to Follow-up|12
2728628|NCT00165503|9380679|P1|Overall Study|Death|1
2728629|NCT00163657|9380686|P3|Overall Study|Other reason|3
2728630|NCT00163657|9380687|P2|Overall Study|Other reason|1
2728631|NCT00163657|9380688|P1|Overall Study|Other reason|0
2728632|NCT00163657|9380686|P3|Overall Study|Lost to Follow-up|10
2728633|NCT00163657|9380687|P2|Overall Study|Lost to Follow-up|3
2728634|NCT00163657|9380688|P1|Overall Study|Lost to Follow-up|1
2728635|NCT00163657|9380686|P3|Overall Study|Non Compliance|0
2728636|NCT00163657|9380687|P2|Overall Study|Non Compliance|0
2728637|NCT00163657|9380688|P1|Overall Study|Non Compliance|1
2728638|NCT00163657|9380686|P3|Overall Study|Physician Decision|1
2728639|NCT00163657|9380687|P2|Overall Study|Physician Decision|1
2728640|NCT00163657|9380688|P1|Overall Study|Physician Decision|0
2728641|NCT00163657|9380686|P3|Overall Study|Withdrawal by Subject|2
2728642|NCT00163657|9380687|P2|Overall Study|Withdrawal by Subject|3
2728643|NCT00163657|9380688|P1|Overall Study|Withdrawal by Subject|2
2728644|NCT00163657|9380686|P3|Overall Study|graft loss|2
2728645|NCT00163657|9380687|P2|Overall Study|graft loss|1
2728646|NCT00163657|9380688|P1|Overall Study|graft loss|4
2728647|NCT00163657|9380686|P3|Overall Study|Death|19
2728648|NCT00163657|9380687|P2|Overall Study|Death|14
2728649|NCT00163657|9380688|P1|Overall Study|Death|12
2728650|NCT00163215|9380778|P1|Overall Study|Other|7
2728651|NCT00163215|9380778|P1|Overall Study|Withdrawal by Subject|5
2728652|NCT00163215|9380778|P1|Overall Study|Lack of Efficacy|3
2728653|NCT00163189|9380798|P1|Overall Study|Did not meet continuation criterion|16
2728654|NCT00163189|9380798|P1|Overall Study|Withdrawal by Subject|11
2728655|NCT00163189|9380798|P1|Overall Study|Study terminated by sponsor|11
2728656|NCT00163189|9380798|P1|Overall Study|Lack of Efficacy|7
2728657|NCT00163189|9380798|P1|Overall Study|Adverse Event|6
2728658|NCT00163189|9380798|P1|Overall Study|Death|3
2728659|NCT00163189|9380798|P1|Overall Study|Protocol Violation|2
2728660|NCT00163189|9380798|P1|Overall Study|Lost to Follow-up|1
2728661|NCT00163189|9380798|P1|Overall Study|Other|6
2728662|NCT00163020|9380822|P2|Overall Study|Lost to Follow-up|2
2728663|NCT00163020|9380823|P1|Overall Study|Lost to Follow-up|0
2728664|NCT00162981|9380863|P2|Overall Study|Physician Decision|0
2728665|NCT00162981|9380864|P1|Overall Study|Physician Decision|1
2728666|NCT00162981|9380863|P2|Overall Study|Withdrawal by Subject|1
2728667|NCT00162981|9380864|P1|Overall Study|Withdrawal by Subject|1
2728668|NCT00162981|9380863|P2|Overall Study|Adverse Event|5
2728669|NCT00162981|9380864|P1|Overall Study|Adverse Event|2
2728670|NCT00162942|9380880|P2|Overall Study|2 or more consecutive treatments missed|0
2728671|NCT00162942|9380881|P1|Overall Study|2 or more consecutive treatments missed|1
2728672|NCT00162942|9380880|P2|Overall Study|Flare During Active Treatment|3
2728673|NCT00162942|9380881|P1|Overall Study|Flare During Active Treatment|7
2728674|NCT00162942|9380880|P2|Overall Study|Lack of Efficacy|0
2728675|NCT00162942|9380881|P1|Overall Study|Lack of Efficacy|1
2728676|NCT00162942|9380880|P2|Overall Study|Alternate Therapy|2
2728677|NCT00162942|9380881|P1|Overall Study|Alternate Therapy|6
2728678|NCT00162942|9380880|P2|Overall Study|Enter Open-Label Study|35
2728679|NCT00162942|9380881|P1|Overall Study|Enter Open-Label Study|76
2728680|NCT00162942|9380880|P2|Overall Study|Physician Decision|0
2728681|NCT00162942|9380881|P1|Overall Study|Physician Decision|1
2728682|NCT00162942|9380880|P2|Overall Study|Withdrawal by Subject|6
2728683|NCT00162942|9380881|P1|Overall Study|Withdrawal by Subject|3
2728684|NCT00162942|9380880|P2|Overall Study|Death|0
2728685|NCT00162942|9380881|P1|Overall Study|Death|1
2728686|NCT00162942|9380880|P2|Overall Study|Adverse Event|6
2728687|NCT00162942|9380881|P1|Overall Study|Adverse Event|10
2728688|NCT00162773|9380929|P1|Overall Study|P.I, Left institution. Study terminated|22
2728689|NCT00162370|9380933|P1|Efficacy Population|Lost to Follow-up|51
2728690|NCT00162266|9380941|P4|Open-Label Period|Other Reasons|15
2728691|NCT00162266|9380942|P3|Open-Label Period|Other Reasons|0
2728692|NCT00162266|9380943|P2|Open-Label Period|Other Reasons|0
2728693|NCT00162266|9380944|P1|Open-Label Period|Other Reasons|0
2728694|NCT00162266|9380941|P4|Open-Label Period|Administrative Reason By Sponsor|9
2728695|NCT00162266|9380942|P3|Open-Label Period|Administrative Reason By Sponsor|0
2728696|NCT00162266|9380943|P2|Open-Label Period|Administrative Reason By Sponsor|0
2728697|NCT00162266|9380944|P1|Open-Label Period|Administrative Reason By Sponsor|0
2728698|NCT00162266|9380941|P4|Open-Label Period|Withdrawal by Subject|31
2728699|NCT00162266|9380942|P3|Open-Label Period|Withdrawal by Subject|0
2728700|NCT00162266|9380943|P2|Open-Label Period|Withdrawal by Subject|0
2728701|NCT00162266|9380944|P1|Open-Label Period|Withdrawal by Subject|0
2728702|NCT00162266|9380941|P4|Open-Label Period|Lost to Follow-up|3
2728703|NCT00162266|9380942|P3|Open-Label Period|Lost to Follow-up|0
2728704|NCT00162266|9380943|P2|Open-Label Period|Lost to Follow-up|0
2728705|NCT00162266|9380944|P1|Open-Label Period|Lost to Follow-up|0
2728706|NCT00162266|9380941|P4|Open-Label Period|Lack of Efficacy|26
2728707|NCT00162266|9380942|P3|Open-Label Period|Lack of Efficacy|0
2728708|NCT00162266|9380943|P2|Open-Label Period|Lack of Efficacy|0
2728709|NCT00162266|9380944|P1|Open-Label Period|Lack of Efficacy|0
2728710|NCT00162266|9380941|P4|Open-Label Period|Adverse Event|46
2728711|NCT00162266|9380942|P3|Open-Label Period|Adverse Event|0
2728712|NCT00162266|9380943|P2|Open-Label Period|Adverse Event|0
2728713|NCT00162266|9380944|P1|Open-Label Period|Adverse Event|0
2728714|NCT00162266|9380941|P4|Open-Label Period|Death|7
2728715|NCT00162266|9380942|P3|Open-Label Period|Death|0
2728716|NCT00162266|9380943|P2|Open-Label Period|Death|0
2728717|NCT00162266|9380944|P1|Open-Label Period|Death|0
2728718|NCT00162266|9380941|P4|Double-Blind Period|Withdrawal by Subject|0
2728719|NCT00162266|9380942|P3|Double-Blind Period|Withdrawal by Subject|6
2728720|NCT00162266|9380943|P2|Double-Blind Period|Withdrawal by Subject|2
2728721|NCT00162266|9380944|P1|Double-Blind Period|Withdrawal by Subject|5
2728722|NCT00162266|9380941|P4|Double-Blind Period|Lack of Efficacy|0
2728723|NCT00162266|9380942|P3|Double-Blind Period|Lack of Efficacy|30
2728724|NCT00162266|9380943|P2|Double-Blind Period|Lack of Efficacy|17
2728725|NCT00162266|9380944|P1|Double-Blind Period|Lack of Efficacy|13
2728726|NCT00162266|9380941|P4|Double-Blind Period|Other Reason|0
2728727|NCT00162266|9380942|P3|Double-Blind Period|Other Reason|1
2728728|NCT00162266|9380943|P2|Double-Blind Period|Other Reason|0
2728729|NCT00162266|9380944|P1|Double-Blind Period|Other Reason|1
2728730|NCT00162266|9380941|P4|Double-Blind Period|Lost to Follow-up|0
2728731|NCT00162266|9380942|P3|Double-Blind Period|Lost to Follow-up|0
2728732|NCT00162266|9380943|P2|Double-Blind Period|Lost to Follow-up|2
2728733|NCT00162266|9380944|P1|Double-Blind Period|Lost to Follow-up|1
2728734|NCT00162266|9380941|P4|Double-Blind Period|Death|0
2728735|NCT00162266|9380942|P3|Double-Blind Period|Death|0
2728736|NCT00162266|9380943|P2|Double-Blind Period|Death|1
2728737|NCT00162266|9380944|P1|Double-Blind Period|Death|0
2728738|NCT00162266|9380941|P4|Double-Blind Period|Adverse Event|0
2728739|NCT00162266|9380942|P3|Double-Blind Period|Adverse Event|11
2728740|NCT00162266|9380943|P2|Double-Blind Period|Adverse Event|9
2728741|NCT00162266|9380944|P1|Double-Blind Period|Adverse Event|5
2728742|NCT00162136|9381145|P1|Overall Study|Withdrawal by Subject|1
2728743|NCT00162136|9381145|P1|Overall Study|Study Drug Toxicity|4
2728744|NCT00162136|9381145|P1|Overall Study|Investigator Request|5
2728745|NCT00162136|9381145|P1|Overall Study|Disease Progression/Relapse|23
2728746|NCT00162136|9381145|P1|Overall Study|Death|1
2728747|NCT00162136|9381145|P1|Overall Study|Adverse Event|1
2728748|NCT00162123|9381177|P8|Overall Study|Follow-up only (not treated or assessed)|57
2728749|NCT00162123|9381178|P7|Overall Study|Follow-up only (not treated or assessed)|0
2728750|NCT00162123|9381179|P6|Overall Study|Follow-up only (not treated or assessed)|0
2728751|NCT00162123|9381180|P5|Overall Study|Follow-up only (not treated or assessed)|0
2728752|NCT00162123|9381181|P4|Overall Study|Follow-up only (not treated or assessed)|0
2728753|NCT00162123|9381182|P3|Overall Study|Follow-up only (not treated or assessed)|0
2728754|NCT00162123|9381183|P2|Overall Study|Follow-up only (not treated or assessed)|0
2728755|NCT00162123|9381184|P1|Overall Study|Follow-up only (not treated or assessed)|0
2728756|NCT00162123|9381177|P8|Overall Study|Tumor assessment only (not treated)|1
2728757|NCT00162123|9381178|P7|Overall Study|Tumor assessment only (not treated)|0
2728758|NCT00162123|9381179|P6|Overall Study|Tumor assessment only (not treated)|0
2728759|NCT00162123|9381180|P5|Overall Study|Tumor assessment only (not treated)|0
2728760|NCT00162123|9381181|P4|Overall Study|Tumor assessment only (not treated)|0
2728761|NCT00162123|9381182|P3|Overall Study|Tumor assessment only (not treated)|0
2728762|NCT00162123|9381183|P2|Overall Study|Tumor assessment only (not treated)|0
2728763|NCT00162123|9381184|P1|Overall Study|Tumor assessment only (not treated)|0
2728764|NCT00162123|9381177|P8|Overall Study|Physician Decision|0
2728765|NCT00162123|9381178|P7|Overall Study|Physician Decision|1
2728766|NCT00162123|9381179|P6|Overall Study|Physician Decision|1
2728767|NCT00162123|9381180|P5|Overall Study|Physician Decision|0
2728768|NCT00162123|9381181|P4|Overall Study|Physician Decision|0
2728769|NCT00162123|9381182|P3|Overall Study|Physician Decision|0
2728770|NCT00162123|9381183|P2|Overall Study|Physician Decision|2
2728771|NCT00162123|9381184|P1|Overall Study|Physician Decision|1
2728772|NCT00162123|9381177|P8|Overall Study|Not specified (after start of treatment)|0
2728773|NCT00162123|9381178|P7|Overall Study|Not specified (after start of treatment)|0
2728774|NCT00162123|9381179|P6|Overall Study|Not specified (after start of treatment)|0
2728775|NCT00162123|9381180|P5|Overall Study|Not specified (after start of treatment)|3
2728776|NCT00162123|9381181|P4|Overall Study|Not specified (after start of treatment)|0
2728777|NCT00162123|9381182|P3|Overall Study|Not specified (after start of treatment)|0
2728778|NCT00162123|9381183|P2|Overall Study|Not specified (after start of treatment)|0
2728779|NCT00162123|9381184|P1|Overall Study|Not specified (after start of treatment)|0
2728780|NCT00162123|9381177|P8|Overall Study|Not specified (before treatment)|0
2728781|NCT00162123|9381178|P7|Overall Study|Not specified (before treatment)|0
2728782|NCT00162123|9381179|P6|Overall Study|Not specified (before treatment)|1
2728783|NCT00162123|9381180|P5|Overall Study|Not specified (before treatment)|12
2728784|NCT00162123|9381181|P4|Overall Study|Not specified (before treatment)|0
2728785|NCT00162123|9381182|P3|Overall Study|Not specified (before treatment)|0
2728786|NCT00162123|9381183|P2|Overall Study|Not specified (before treatment)|0
2728787|NCT00162123|9381184|P1|Overall Study|Not specified (before treatment)|2
2728788|NCT00162123|9381177|P8|Overall Study|Adverse Event|0
2728789|NCT00162123|9381178|P7|Overall Study|Adverse Event|0
2728790|NCT00162123|9381179|P6|Overall Study|Adverse Event|0
2728791|NCT00162123|9381180|P5|Overall Study|Adverse Event|1
2728792|NCT00162123|9381181|P4|Overall Study|Adverse Event|2
2728793|NCT00162123|9381182|P3|Overall Study|Adverse Event|0
2728794|NCT00162123|9381183|P2|Overall Study|Adverse Event|2
2728795|NCT00162123|9381184|P1|Overall Study|Adverse Event|1
2728796|NCT00162123|9381177|P8|Overall Study|Deterioration without progression|0
2728797|NCT00162123|9381178|P7|Overall Study|Deterioration without progression|0
2728798|NCT00162123|9381179|P6|Overall Study|Deterioration without progression|0
2728799|NCT00162123|9381180|P5|Overall Study|Deterioration without progression|1
2728800|NCT00162123|9381181|P4|Overall Study|Deterioration without progression|0
2728801|NCT00162123|9381182|P3|Overall Study|Deterioration without progression|3
2728802|NCT00162123|9381183|P2|Overall Study|Deterioration without progression|2
2728803|NCT00162123|9381184|P1|Overall Study|Deterioration without progression|2
2728804|NCT00162123|9381177|P8|Overall Study|Withdrawal by Subject|0
2728805|NCT00162123|9381178|P7|Overall Study|Withdrawal by Subject|1
2728806|NCT00162123|9381179|P6|Overall Study|Withdrawal by Subject|2
2728807|NCT00162123|9381180|P5|Overall Study|Withdrawal by Subject|1
2728808|NCT00162123|9381181|P4|Overall Study|Withdrawal by Subject|1
2728809|NCT00162123|9381182|P3|Overall Study|Withdrawal by Subject|2
2728810|NCT00162123|9381183|P2|Overall Study|Withdrawal by Subject|0
2728811|NCT00162123|9381184|P1|Overall Study|Withdrawal by Subject|2
2728812|NCT00162123|9381177|P8|Overall Study|Death|0
2728813|NCT00162123|9381178|P7|Overall Study|Death|0
2728814|NCT00162123|9381179|P6|Overall Study|Death|1
2728815|NCT00162123|9381180|P5|Overall Study|Death|1
2728816|NCT00162123|9381181|P4|Overall Study|Death|1
2728817|NCT00162123|9381182|P3|Overall Study|Death|1
2728818|NCT00162123|9381183|P2|Overall Study|Death|3
2728819|NCT00162123|9381184|P1|Overall Study|Death|3
2728820|NCT00162123|9381177|P8|Overall Study|Study drug toxicity|0
2728821|NCT00162123|9381178|P7|Overall Study|Study drug toxicity|1
2728822|NCT00162123|9381179|P6|Overall Study|Study drug toxicity|1
2728823|NCT00162123|9381180|P5|Overall Study|Study drug toxicity|4
2728824|NCT00162123|9381181|P4|Overall Study|Study drug toxicity|0
2728825|NCT00162123|9381182|P3|Overall Study|Study drug toxicity|5
2728826|NCT00162123|9381183|P2|Overall Study|Study drug toxicity|1
2728827|NCT00162123|9381184|P1|Overall Study|Study drug toxicity|6
2728828|NCT00162123|9381177|P8|Overall Study|Disease progression|0
2728829|NCT00162123|9381178|P7|Overall Study|Disease progression|1
2728830|NCT00162123|9381179|P6|Overall Study|Disease progression|3
2728831|NCT00162123|9381180|P5|Overall Study|Disease progression|8
2728832|NCT00162123|9381181|P4|Overall Study|Disease progression|4
2728833|NCT00162123|9381182|P3|Overall Study|Disease progression|10
2728834|NCT00162123|9381183|P2|Overall Study|Disease progression|19
2728835|NCT00162123|9381184|P1|Overall Study|Disease progression|27
2728836|NCT00162097|9381217|P4|Overall Study|Participant no longer met study criteria|1
2728837|NCT00162097|9381218|P3|Overall Study|Participant no longer met study criteria|0
2728838|NCT00162097|9381219|P2|Overall Study|Participant no longer met study criteria|0
2728839|NCT00162097|9381220|P1|Overall Study|Participant no longer met study criteria|0
2728840|NCT00162032|9381282|P2|Overall Study|Reason not specified|0
2728841|NCT00162032|9381283|P1|Overall Study|Reason not specified|1
2728842|NCT00162032|9381282|P2|Overall Study|Lost to Follow-up|2
2728843|NCT00162032|9381283|P1|Overall Study|Lost to Follow-up|4
2728844|NCT00161616|9381304|P2|Overall Study|Protocol deviation|0
2728845|NCT00161616|9381305|P1|Overall Study|Protocol deviation|1
2728846|NCT00161616|9381304|P2|Overall Study|Lost to Follow-up|13
2728847|NCT00161616|9381305|P1|Overall Study|Lost to Follow-up|17
2728848|NCT00161616|9381304|P2|Overall Study|Death|1
2728849|NCT00161616|9381305|P1|Overall Study|Death|1
2728850|NCT00161616|9381304|P2|Overall Study|Physician Decision|0
2728851|NCT00161616|9381305|P1|Overall Study|Physician Decision|1
2728852|NCT00161616|9381304|P2|Overall Study|Withdrawal by Subject|5
2728853|NCT00161616|9381305|P1|Overall Study|Withdrawal by Subject|6
2728854|NCT00161213|9381337|P1|Overall Study|Evaluable for toxicity but not response|1
2728855|NCT00161213|9381337|P1|Overall Study|Withdrawal by Subject|1
2728856|NCT00160706|9381344|P1|Overall Study|Other Reason|11
2728857|NCT00160706|9381344|P1|Overall Study|Lack of Efficacy and Other|1
2728858|NCT00160706|9381344|P1|Overall Study|Lack of Efficacy|42
2728859|NCT00160706|9381344|P1|Overall Study|Lost to Follow-up and Other|1
2728860|NCT00160706|9381344|P1|Overall Study|Lost to Follow-up|4
2728861|NCT00160706|9381344|P1|Overall Study|Physician Decision and Other|3
2728862|NCT00160706|9381344|P1|Overall Study|Physician Decision|10
2728863|NCT00160706|9381344|P1|Overall Study|Withdrawal by Subject and Other|12
2728864|NCT00160706|9381344|P1|Overall Study|Withdrawal by Subject|41
2728865|NCT00160706|9381344|P1|Overall Study|Protocol Violation|3
2728866|NCT00160706|9381344|P1|Overall Study|Adverse Event and Other Reason|105
2728867|NCT00160706|9381344|P1|Overall Study|Adverse Event|53
2728868|NCT00160693|9381356|P1|Overall Study|Study terminated by sponsor|15
2728869|NCT00160693|9381356|P1|Overall Study|Withdrawal by Subject|54
2728870|NCT00160693|9381356|P1|Overall Study|Lost to Follow-up|15
2728871|NCT00160693|9381356|P1|Overall Study|Protocol Violation|24
2728872|NCT00160693|9381356|P1|Overall Study|Lack of Efficacy|30
2728873|NCT00160693|9381356|P1|Overall Study|Adverse Event|97
2728874|NCT00160680|9381375|P2|Overall Study|Withdrawal by Subject|9
2728875|NCT00160680|9381376|P1|Overall Study|Withdrawal by Subject|4
2728876|NCT00160680|9381375|P2|Overall Study|Lost to Follow-up|2
2728877|NCT00160680|9381376|P1|Overall Study|Lost to Follow-up|3
2728878|NCT00160680|9381375|P2|Overall Study|Lack of Efficacy|1
2728879|NCT00160680|9381376|P1|Overall Study|Lack of Efficacy|2
2728880|NCT00160680|9381375|P2|Overall Study|Adverse Event|1
2728881|NCT00160680|9381376|P1|Overall Study|Adverse Event|0
2728882|NCT00160667|9381411|P3|Overall Study|Patient decision|1
2728883|NCT00160667|9381412|P2|Overall Study|Patient decision|0
2728884|NCT00160667|9381413|P1|Overall Study|Patient decision|0
2728885|NCT00160667|9381411|P3|Overall Study|Protocol Violation|0
2728886|NCT00160667|9381412|P2|Overall Study|Protocol Violation|1
2728887|NCT00160667|9381413|P1|Overall Study|Protocol Violation|0
2728888|NCT00160667|9381411|P3|Overall Study|Lack of Efficacy|0
2728889|NCT00160667|9381412|P2|Overall Study|Lack of Efficacy|1
2728890|NCT00160667|9381413|P1|Overall Study|Lack of Efficacy|0
2728891|NCT00160667|9381411|P3|Overall Study|Withdrawal by Subject|1
2728892|NCT00160667|9381412|P2|Overall Study|Withdrawal by Subject|0
2728893|NCT00160667|9381413|P1|Overall Study|Withdrawal by Subject|2
2728894|NCT00160667|9381411|P3|Overall Study|Adverse Event|4
2728895|NCT00160667|9381412|P2|Overall Study|Adverse Event|1
2728896|NCT00160667|9381413|P1|Overall Study|Adverse Event|3
2728897|NCT00160641|9381460|P1|Overall Study|Other|9
2728898|NCT00160641|9381460|P1|Overall Study|Protocol Violation|3
2728899|NCT00160641|9381460|P1|Overall Study|Lack of Efficacy|12
2728900|NCT00160641|9381460|P1|Overall Study|Lost to Follow-up|8
2728901|NCT00160641|9381460|P1|Overall Study|Withdrawal by Subject|87
2728902|NCT00160641|9381460|P1|Overall Study|Adverse Event|102
2728903|NCT00160615|9381493|P2|Overall Study|Poor compliance|1
2728904|NCT00160615|9381494|P1|Overall Study|Poor compliance|0
2728905|NCT00160615|9381493|P2|Overall Study|Non-compliance was suspected|1
2728906|NCT00160615|9381494|P1|Overall Study|Non-compliance was suspected|0
2728907|NCT00160615|9381493|P2|Overall Study|Switch to surgical treatment|2
2728908|NCT00160615|9381494|P1|Overall Study|Switch to surgical treatment|0
2728909|NCT00160615|9381493|P2|Overall Study|AE agents had to be discontinued (exam.)|1
2728910|NCT00160615|9381494|P1|Overall Study|AE agents had to be discontinued (exam.)|0
2728911|NCT00160615|9381493|P2|Overall Study|Investigator decision|1
2728912|NCT00160615|9381494|P1|Overall Study|Investigator decision|1
2728913|NCT00160615|9381493|P2|Overall Study|Patient decision|2
2728914|NCT00160615|9381494|P1|Overall Study|Patient decision|1
2728915|NCT00160615|9381493|P2|Overall Study|Lack of Efficacy|23
2728916|NCT00160615|9381494|P1|Overall Study|Lack of Efficacy|11
2728917|NCT00160615|9381493|P2|Overall Study|Withdrawal by Subject|2
2728918|NCT00160615|9381494|P1|Overall Study|Withdrawal by Subject|0
2728919|NCT00160615|9381493|P2|Overall Study|Adverse Event|12
2728920|NCT00160615|9381494|P1|Overall Study|Adverse Event|5
2728921|NCT00160563|9381517|P3|Overall Study|Missing reason|0
2728922|NCT00160563|9381518|P2|Overall Study|Missing reason|1
2728923|NCT00160563|9381519|P1|Overall Study|Missing reason|0
2728924|NCT00160563|9381517|P3|Overall Study|Other (listed in the study report)|81
2728925|NCT00160563|9381518|P2|Overall Study|Other (listed in the study report)|40
2728926|NCT00160563|9381519|P1|Overall Study|Other (listed in the study report)|48
2728927|NCT00160563|9381517|P3|Overall Study|Withdrawal by Subject|3
2728928|NCT00160563|9381518|P2|Overall Study|Withdrawal by Subject|2
2728929|NCT00160563|9381519|P1|Overall Study|Withdrawal by Subject|1
2728930|NCT00160563|9381517|P3|Overall Study|Protocol Violation|3
2728931|NCT00160563|9381518|P2|Overall Study|Protocol Violation|0
2728932|NCT00160563|9381519|P1|Overall Study|Protocol Violation|0
2728933|NCT00160563|9381517|P3|Overall Study|Lost to Follow-up|2
2728934|NCT00160563|9381518|P2|Overall Study|Lost to Follow-up|1
2728935|NCT00160563|9381519|P1|Overall Study|Lost to Follow-up|1
2728936|NCT00160563|9381517|P3|Overall Study|Adverse Event|1
2728937|NCT00160563|9381518|P2|Overall Study|Adverse Event|1
2728938|NCT00160563|9381519|P1|Overall Study|Adverse Event|1
2728939|NCT00160524|9381531|P1|Overall Study|Other|20
2728940|NCT00160524|9381531|P1|Overall Study|Lack of Efficacy and Other|1
2728941|NCT00160524|9381531|P1|Overall Study|Lack of Efficacy|21
2728942|NCT00160524|9381531|P1|Overall Study|Lost to Follow-up and Other|1
2728943|NCT00160524|9381531|P1|Overall Study|Lost to Follow-up|13
2728944|NCT00160524|9381531|P1|Overall Study|Physician Decision and Other|6
2728945|NCT00160524|9381531|P1|Overall Study|Physician Decision|27
2728946|NCT00160524|9381531|P1|Overall Study|Withdrawal by Subject and Other|17
2728947|NCT00160524|9381531|P1|Overall Study|Withdrawal by Subject|141
2728948|NCT00160524|9381531|P1|Overall Study|Protocol Violation and Other|2
2728949|NCT00160524|9381531|P1|Overall Study|Protocol Violation|16
2728950|NCT00160524|9381531|P1|Overall Study|Adverse Event and Other|94
2728951|NCT00160524|9381531|P1|Overall Study|Adverse Event|119
2728952|NCT00160251|9381548|P8|Post-amendment 2|Lost to follow-up/withdrawal by subject|11
2728953|NCT00160251|9381549|P7|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
2728954|NCT00160251|9381550|P6|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
2728955|NCT00160251|9381551|P5|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
2728956|NCT00160251|9381552|P4|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
2728957|NCT00160251|9381553|P3|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
2728958|NCT00160251|9381554|P2|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
2728959|NCT00160251|9381555|P1|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
2728960|NCT00160251|9381548|P8|Post-amendment 2|Lack of Efficacy|24
2728961|NCT00160251|9381549|P7|Post-amendment 2|Lack of Efficacy|0
2728962|NCT00160251|9381550|P6|Post-amendment 2|Lack of Efficacy|0
2728963|NCT00160251|9381551|P5|Post-amendment 2|Lack of Efficacy|0
2728964|NCT00160251|9381552|P4|Post-amendment 2|Lack of Efficacy|0
2728965|NCT00160251|9381553|P3|Post-amendment 2|Lack of Efficacy|0
2728966|NCT00160251|9381554|P2|Post-amendment 2|Lack of Efficacy|0
2728967|NCT00160251|9381555|P1|Post-amendment 2|Lack of Efficacy|0
2728968|NCT00160251|9381548|P8|Post-amendment 2|Adverse Event|20
2728969|NCT00160251|9381549|P7|Post-amendment 2|Adverse Event|0
2728970|NCT00160251|9381550|P6|Post-amendment 2|Adverse Event|0
2728971|NCT00160251|9381551|P5|Post-amendment 2|Adverse Event|0
2728972|NCT00160251|9381552|P4|Post-amendment 2|Adverse Event|0
2728973|NCT00160251|9381553|P3|Post-amendment 2|Adverse Event|0
2728974|NCT00160251|9381554|P2|Post-amendment 2|Adverse Event|0
2728975|NCT00160251|9381555|P1|Post-amendment 2|Adverse Event|0
2728976|NCT00160251|9381548|P8|Prior to Amendment 2|Completed Treatment Phase|0
2728977|NCT00160251|9381549|P7|Prior to Amendment 2|Completed Treatment Phase|0
2728978|NCT00160251|9381550|P6|Prior to Amendment 2|Completed Treatment Phase|23
2728979|NCT00160251|9381551|P5|Prior to Amendment 2|Completed Treatment Phase|0
2728980|NCT00160251|9381552|P4|Prior to Amendment 2|Completed Treatment Phase|0
2728981|NCT00160251|9381553|P3|Prior to Amendment 2|Completed Treatment Phase|0
2728982|NCT00160251|9381554|P2|Prior to Amendment 2|Completed Treatment Phase|0
2728983|NCT00160251|9381555|P1|Prior to Amendment 2|Completed Treatment Phase|3
2728984|NCT00160251|9381548|P8|Prior to Amendment 2|Noncompliance with protocol|0
2728985|NCT00160251|9381549|P7|Prior to Amendment 2|Noncompliance with protocol|0
2728986|NCT00160251|9381550|P6|Prior to Amendment 2|Noncompliance with protocol|0
2728987|NCT00160251|9381551|P5|Prior to Amendment 2|Noncompliance with protocol|0
2728988|NCT00160251|9381552|P4|Prior to Amendment 2|Noncompliance with protocol|0
2728989|NCT00160251|9381553|P3|Prior to Amendment 2|Noncompliance with protocol|0
2728990|NCT00160251|9381554|P2|Prior to Amendment 2|Noncompliance with protocol|0
2728991|NCT00160251|9381555|P1|Prior to Amendment 2|Noncompliance with protocol|1
2728992|NCT00160251|9381548|P8|Prior to Amendment 2|Withdrawal by Subject|0
2728993|NCT00160251|9381549|P7|Prior to Amendment 2|Withdrawal by Subject|3
2728994|NCT00160251|9381550|P6|Prior to Amendment 2|Withdrawal by Subject|3
2728995|NCT00160251|9381551|P5|Prior to Amendment 2|Withdrawal by Subject|2
2728996|NCT00160251|9381552|P4|Prior to Amendment 2|Withdrawal by Subject|4
2728997|NCT00160251|9381553|P3|Prior to Amendment 2|Withdrawal by Subject|3
2728998|NCT00160251|9381554|P2|Prior to Amendment 2|Withdrawal by Subject|1
2728999|NCT00160251|9381555|P1|Prior to Amendment 2|Withdrawal by Subject|3
2729000|NCT00160251|9381548|P8|Prior to Amendment 2|Lost to Follow-up|0
2729001|NCT00160251|9381549|P7|Prior to Amendment 2|Lost to Follow-up|0
2729002|NCT00160251|9381550|P6|Prior to Amendment 2|Lost to Follow-up|1
2729003|NCT00160251|9381551|P5|Prior to Amendment 2|Lost to Follow-up|1
2729004|NCT00160251|9381552|P4|Prior to Amendment 2|Lost to Follow-up|0
2729005|NCT00160251|9381553|P3|Prior to Amendment 2|Lost to Follow-up|1
2729006|NCT00160251|9381554|P2|Prior to Amendment 2|Lost to Follow-up|0
2729007|NCT00160251|9381555|P1|Prior to Amendment 2|Lost to Follow-up|0
2729008|NCT00160251|9381548|P8|Prior to Amendment 2|Lack of Efficacy|0
2729009|NCT00160251|9381549|P7|Prior to Amendment 2|Lack of Efficacy|0
2729010|NCT00160251|9381550|P6|Prior to Amendment 2|Lack of Efficacy|55
2729011|NCT00160251|9381551|P5|Prior to Amendment 2|Lack of Efficacy|24
2729012|NCT00160251|9381552|P4|Prior to Amendment 2|Lack of Efficacy|35
2729013|NCT00160251|9381553|P3|Prior to Amendment 2|Lack of Efficacy|37
2729014|NCT00160251|9381554|P2|Prior to Amendment 2|Lack of Efficacy|4
2729015|NCT00160251|9381555|P1|Prior to Amendment 2|Lack of Efficacy|0
2729016|NCT00160251|9381548|P8|Prior to Amendment 2|Adverse Event|0
2729017|NCT00160251|9381549|P7|Prior to Amendment 2|Adverse Event|1
2729018|NCT00160251|9381550|P6|Prior to Amendment 2|Adverse Event|1
2729019|NCT00160251|9381551|P5|Prior to Amendment 2|Adverse Event|1
2729020|NCT00160251|9381552|P4|Prior to Amendment 2|Adverse Event|1
2729021|NCT00160251|9381553|P3|Prior to Amendment 2|Adverse Event|3
2729022|NCT00160251|9381554|P2|Prior to Amendment 2|Adverse Event|1
2729023|NCT00160251|9381555|P1|Prior to Amendment 2|Adverse Event|2
2729024|NCT00160199|9381631|P2|Overall Study|Protocol Violation|8
2729025|NCT00160199|9381632|P1|Overall Study|Protocol Violation|8
2729026|NCT00160199|9381631|P2|Overall Study|Administrative|1
2729027|NCT00160199|9381632|P1|Overall Study|Administrative|0
2729028|NCT00160199|9381631|P2|Overall Study|Withdrawal by Subject|6
2729029|NCT00160199|9381632|P1|Overall Study|Withdrawal by Subject|4
2729030|NCT00160199|9381631|P2|Overall Study|Lost to Follow-up|7
2729031|NCT00160199|9381632|P1|Overall Study|Lost to Follow-up|7
2729032|NCT00160199|9381631|P2|Overall Study|Lack of Efficacy|1
2729033|NCT00160199|9381632|P1|Overall Study|Lack of Efficacy|0
2729034|NCT00160199|9381631|P2|Overall Study|Adverse Event|14
2729035|NCT00160199|9381632|P1|Overall Study|Adverse Event|5
2729036|NCT00159913|9381689|P4|Overall Study|Protocol Violation|0
2729037|NCT00159913|9381690|P3|Overall Study|Protocol Violation|1
2729038|NCT00159913|9381691|P2|Overall Study|Protocol Violation|0
2729039|NCT00159913|9381692|P1|Overall Study|Protocol Violation|1
2729040|NCT00159913|9381689|P4|Overall Study|Lost to Follow-up|1
2729041|NCT00159913|9381690|P3|Overall Study|Lost to Follow-up|0
2729042|NCT00159913|9381691|P2|Overall Study|Lost to Follow-up|0
2729043|NCT00159913|9381692|P1|Overall Study|Lost to Follow-up|0
2729044|NCT00159913|9381689|P4|Overall Study|Withdrawal by Subject|1
2729045|NCT00159913|9381690|P3|Overall Study|Withdrawal by Subject|0
2729046|NCT00159913|9381691|P2|Overall Study|Withdrawal by Subject|0
2729047|NCT00159913|9381692|P1|Overall Study|Withdrawal by Subject|0
2729048|NCT00159913|9381689|P4|Overall Study|Adverse Event|0
2729049|NCT00159913|9381690|P3|Overall Study|Adverse Event|1
2729050|NCT00159913|9381691|P2|Overall Study|Adverse Event|0
2729051|NCT00159913|9381692|P1|Overall Study|Adverse Event|1
2729052|NCT00159874|9381766|P7|Overall Study|Pregnancy|0
2729053|NCT00159874|9381767|P6|Overall Study|Pregnancy|0
2729054|NCT00159874|9381768|P5|Overall Study|Pregnancy|0
2729055|NCT00159874|9381769|P4|Overall Study|Pregnancy|0
2729056|NCT00159874|9381770|P3|Overall Study|Pregnancy|0
2729057|NCT00159874|9381771|P2|Overall Study|Pregnancy|1
2729058|NCT00159874|9381772|P1|Overall Study|Pregnancy|1
2729059|NCT00159874|9381766|P7|Overall Study|Withdrawal by Subject|1
2729060|NCT00159874|9381767|P6|Overall Study|Withdrawal by Subject|2
2729061|NCT00159874|9381768|P5|Overall Study|Withdrawal by Subject|3
2729062|NCT00159874|9381769|P4|Overall Study|Withdrawal by Subject|4
2729063|NCT00159874|9381770|P3|Overall Study|Withdrawal by Subject|8
2729064|NCT00159874|9381771|P2|Overall Study|Withdrawal by Subject|6
2729065|NCT00159874|9381772|P1|Overall Study|Withdrawal by Subject|2
2729066|NCT00159874|9381766|P7|Overall Study|Death|0
2729067|NCT00159874|9381767|P6|Overall Study|Death|2
2729068|NCT00159874|9381768|P5|Overall Study|Death|1
2729069|NCT00159874|9381769|P4|Overall Study|Death|0
2729070|NCT00159874|9381770|P3|Overall Study|Death|15
2729071|NCT00159874|9381771|P2|Overall Study|Death|8
2729072|NCT00159874|9381772|P1|Overall Study|Death|3
2729073|NCT00159874|9381766|P7|Overall Study|Protocol Violation|0
2729074|NCT00159874|9381767|P6|Overall Study|Protocol Violation|0
2729075|NCT00159874|9381768|P5|Overall Study|Protocol Violation|0
2729076|NCT00159874|9381769|P4|Overall Study|Protocol Violation|0
2729077|NCT00159874|9381770|P3|Overall Study|Protocol Violation|2
2729078|NCT00159874|9381771|P2|Overall Study|Protocol Violation|5
2729079|NCT00159874|9381772|P1|Overall Study|Protocol Violation|0
2729080|NCT00159874|9381766|P7|Overall Study|Other|3
2729081|NCT00159874|9381767|P6|Overall Study|Other|1
2729082|NCT00159874|9381768|P5|Overall Study|Other|2
2729083|NCT00159874|9381769|P4|Overall Study|Other|0
2729084|NCT00159874|9381770|P3|Overall Study|Other|8
2729085|NCT00159874|9381771|P2|Overall Study|Other|8
2729086|NCT00159874|9381772|P1|Overall Study|Other|8
2729087|NCT00159874|9381766|P7|Overall Study|Lost to Follow-up|1
2729088|NCT00159874|9381767|P6|Overall Study|Lost to Follow-up|2
2729089|NCT00159874|9381768|P5|Overall Study|Lost to Follow-up|1
2729090|NCT00159874|9381769|P4|Overall Study|Lost to Follow-up|0
2729091|NCT00159874|9381770|P3|Overall Study|Lost to Follow-up|3
2729092|NCT00159874|9381771|P2|Overall Study|Lost to Follow-up|0
2729093|NCT00159874|9381772|P1|Overall Study|Lost to Follow-up|1
2729094|NCT00159874|9381766|P7|Overall Study|Lack of Efficacy|0
2729095|NCT00159874|9381767|P6|Overall Study|Lack of Efficacy|3
2729096|NCT00159874|9381768|P5|Overall Study|Lack of Efficacy|0
2729097|NCT00159874|9381769|P4|Overall Study|Lack of Efficacy|1
2729098|NCT00159874|9381770|P3|Overall Study|Lack of Efficacy|1
2729099|NCT00159874|9381771|P2|Overall Study|Lack of Efficacy|0
2729100|NCT00159874|9381772|P1|Overall Study|Lack of Efficacy|2
2729101|NCT00159874|9381766|P7|Overall Study|Does Not Meet Entrance Criteria|0
2729102|NCT00159874|9381767|P6|Overall Study|Does Not Meet Entrance Criteria|0
2729103|NCT00159874|9381768|P5|Overall Study|Does Not Meet Entrance Criteria|0
2729104|NCT00159874|9381769|P4|Overall Study|Does Not Meet Entrance Criteria|0
2729105|NCT00159874|9381770|P3|Overall Study|Does Not Meet Entrance Criteria|1
2729106|NCT00159874|9381771|P2|Overall Study|Does Not Meet Entrance Criteria|0
2729107|NCT00159874|9381772|P1|Overall Study|Does Not Meet Entrance Criteria|1
2729108|NCT00159874|9381766|P7|Overall Study|Adverse Event|0
2729109|NCT00159874|9381767|P6|Overall Study|Adverse Event|2
2729110|NCT00159874|9381768|P5|Overall Study|Adverse Event|1
2729111|NCT00159874|9381769|P4|Overall Study|Adverse Event|1
2729112|NCT00159874|9381770|P3|Overall Study|Adverse Event|5
2729113|NCT00159874|9381771|P2|Overall Study|Adverse Event|2
2729114|NCT00159874|9381772|P1|Overall Study|Adverse Event|2
2729115|NCT00159861|9381942|P2|Extension Study - up to 3 Years|Withdrawal by Subject|9
2729116|NCT00159861|9381943|P1|Extension Study - up to 3 Years|Withdrawal by Subject|7
2729117|NCT00159861|9381942|P2|Extension Study - up to 3 Years|Reason Unspecified|19
2729118|NCT00159861|9381943|P1|Extension Study - up to 3 Years|Reason Unspecified|12
2729119|NCT00159861|9381942|P2|Extension Study - up to 3 Years|Lack of Efficacy|1
2729120|NCT00159861|9381943|P1|Extension Study - up to 3 Years|Lack of Efficacy|5
2729121|NCT00159861|9381942|P2|Extension Study - up to 3 Years|Adverse Event|14
2729122|NCT00159861|9381943|P1|Extension Study - up to 3 Years|Adverse Event|14
2729123|NCT00159861|9381942|P2|Extension Study - up to 3 Years|Death|28
2729124|NCT00159861|9381943|P1|Extension Study - up to 3 Years|Death|24
2729125|NCT00159861|9381942|P2|Core Study - 16 Weeks|Randomized but not Treated|0
2729126|NCT00159861|9381943|P1|Core Study - 16 Weeks|Randomized but not Treated|2
2729127|NCT00159861|9381942|P2|Core Study - 16 Weeks|Subject Defaulted|0
2729128|NCT00159861|9381943|P1|Core Study - 16 Weeks|Subject Defaulted|1
2729129|NCT00159861|9381942|P2|Core Study - 16 Weeks|Reason Unspecified|3
2729130|NCT00159861|9381943|P1|Core Study - 16 Weeks|Reason Unspecified|5
2729131|NCT00159861|9381942|P2|Core Study - 16 Weeks|Lack of Efficacy|3
2729132|NCT00159861|9381943|P1|Core Study - 16 Weeks|Lack of Efficacy|2
2729133|NCT00159861|9381942|P2|Core Study - 16 Weeks|Adverse Event|6
2729134|NCT00159861|9381943|P1|Core Study - 16 Weeks|Adverse Event|12
2729135|NCT00159861|9381942|P2|Core Study - 16 Weeks|Death|0
2729136|NCT00159861|9381943|P1|Core Study - 16 Weeks|Death|3
2729137|NCT00159822|9381964|P1|Post-treatment Follow-up Period|Reason unspecified|1
2729138|NCT00159822|9381964|P1|Post-treatment Follow-up Period|Withdrawal by Subject|1
2729139|NCT00159822|9381964|P1|Post-treatment Follow-up Period|Death|1
2729140|NCT00159822|9381964|P1|Voriconazole Treatment Period|Withdrawal by Subject|2
2729141|NCT00159822|9381964|P1|Voriconazole Treatment Period|Lost to Follow-up|2
2729142|NCT00159822|9381964|P1|Voriconazole Treatment Period|Protocol Violation|2
2729143|NCT00159822|9381964|P1|Voriconazole Treatment Period|Death|4
2729144|NCT00159822|9381964|P1|Voriconazole Treatment Period|Adverse Event|9
2729145|NCT00159822|9381964|P1|Voriconazole Treatment Period|Lack of Efficacy|3
2729146|NCT00159783|9381982|P3|Overall Study|Other|4
2729147|NCT00159783|9381983|P2|Overall Study|Other|2
2729148|NCT00159783|9381984|P1|Overall Study|Other|0
2729149|NCT00159783|9381982|P3|Overall Study|Lost to Follow-up|11
2729150|NCT00159783|9381983|P2|Overall Study|Lost to Follow-up|5
2729151|NCT00159783|9381984|P1|Overall Study|Lost to Follow-up|6
2729152|NCT00159783|9381982|P3|Overall Study|Withdrawal by Subject|12
2729153|NCT00159783|9381983|P2|Overall Study|Withdrawal by Subject|11
2729154|NCT00159783|9381984|P1|Overall Study|Withdrawal by Subject|7
2729155|NCT00159783|9381982|P3|Overall Study|Lack of Efficacy|3
2729156|NCT00159783|9381983|P2|Overall Study|Lack of Efficacy|2
2729157|NCT00159783|9381984|P1|Overall Study|Lack of Efficacy|1
2729158|NCT00159783|9381982|P3|Overall Study|Adverse Event|9
2729159|NCT00159783|9381983|P2|Overall Study|Adverse Event|7
2729160|NCT00159783|9381984|P1|Overall Study|Adverse Event|5
2729161|NCT00159432|9382014|P1|Overall Study|Lack of Efficacy|8
2729162|NCT00159432|9382014|P1|Overall Study|Death|1
2729163|NCT00159432|9382014|P1|Overall Study|Adverse Event|1
2729164|NCT00158860|9382088|P2|Overall Study|Closed per sponsor|1
2729165|NCT00158860|9382089|P1|Overall Study|Closed per sponsor|0
2729166|NCT00158860|9382088|P2|Overall Study|Lost to Follow up but returned per GSK|1
2729167|NCT00158860|9382089|P1|Overall Study|Lost to Follow up but returned per GSK|0
2729168|NCT00158860|9382088|P2|Overall Study|SPONSOR REQUEST|1
2729169|NCT00158860|9382089|P1|Overall Study|SPONSOR REQUEST|0
2729170|NCT00158860|9382088|P2|Overall Study|SPONSOR STOPPED STUDY|2
2729171|NCT00158860|9382089|P1|Overall Study|SPONSOR STOPPED STUDY|2
2729172|NCT00158860|9382088|P2|Overall Study|Pregnancy|3
2729173|NCT00158860|9382089|P1|Overall Study|Pregnancy|3
2729174|NCT00158860|9382088|P2|Overall Study|MOVING OUT OF STATE|0
2729175|NCT00158860|9382089|P1|Overall Study|MOVING OUT OF STATE|1
2729176|NCT00158860|9382088|P2|Overall Study|Withdrawal by Subject|17
2729177|NCT00158860|9382089|P1|Overall Study|Withdrawal by Subject|7
2729178|NCT00158860|9382088|P2|Overall Study|Protocol Violation|23
2729179|NCT00158860|9382089|P1|Overall Study|Protocol Violation|8
2729180|NCT00158860|9382088|P2|Overall Study|Lost to Follow-up|17
2729181|NCT00158860|9382089|P1|Overall Study|Lost to Follow-up|11
2729182|NCT00158860|9382088|P2|Overall Study|Adverse Event|6
2729183|NCT00158860|9382089|P1|Overall Study|Adverse Event|3
2729184|NCT00158756|9382108|P5|Overall Study|Serious adverse event|0
2729185|NCT00158756|9382109|P4|Overall Study|Serious adverse event|0
2729186|NCT00158756|9382110|P3|Overall Study|Serious adverse event|1
2729187|NCT00158756|9382111|P2|Overall Study|Serious adverse event|0
2729188|NCT00158756|9382112|P1|Overall Study|Serious adverse event|0
2729189|NCT00158756|9382108|P5|Overall Study|Adverse Event|0
2729190|NCT00158756|9382109|P4|Overall Study|Adverse Event|0
2729191|NCT00158756|9382110|P3|Overall Study|Adverse Event|1
2729192|NCT00158756|9382111|P2|Overall Study|Adverse Event|0
2729193|NCT00158756|9382112|P1|Overall Study|Adverse Event|0
2729194|NCT00158756|9382108|P5|Overall Study|Withdrawal by Subject|3
2729195|NCT00158756|9382109|P4|Overall Study|Withdrawal by Subject|1
2729196|NCT00158756|9382110|P3|Overall Study|Withdrawal by Subject|6
2729197|NCT00158756|9382111|P2|Overall Study|Withdrawal by Subject|0
2729198|NCT00158756|9382112|P1|Overall Study|Withdrawal by Subject|5
2729199|NCT00158600|9382218|P2|Overall Study|Withdrawal by Subject|2
2729200|NCT00158600|9382219|P1|Overall Study|Withdrawal by Subject|2
2729201|NCT00158600|9382218|P2|Overall Study|Death|0
2729202|NCT00158600|9382219|P1|Overall Study|Death|1
2729203|NCT00158600|9382218|P2|Overall Study|Adverse Event|1
2729204|NCT00158600|9382219|P1|Overall Study|Adverse Event|2
2729205|NCT00158600|9382218|P2|Overall Study|unable to commit time to study|1
2729206|NCT00158600|9382219|P1|Overall Study|unable to commit time to study|0
2729207|NCT00158262|9382244|P2|Overall Study|Lost to Follow-up|1
2729208|NCT00158262|9382245|P1|Overall Study|Lost to Follow-up|1
2729209|NCT00158184|9382306|P2|Overall Study|Adverse Event|1
2729210|NCT00158184|9382307|P1|Overall Study|Adverse Event|1
2729211|NCT00158184|9382306|P2|Overall Study|failed for follow unit/study rules|0
2729212|NCT00158184|9382307|P1|Overall Study|failed for follow unit/study rules|2
2729213|NCT00158184|9382306|P2|Overall Study|personal issues|1
2729214|NCT00158184|9382307|P1|Overall Study|personal issues|3
2729215|NCT00158054|9382317|P2|Overall Study|Unavailable for follow up|3
2729216|NCT00158054|9382318|P1|Overall Study|Unavailable for follow up|7
2729217|NCT00158054|9382317|P2|Overall Study|Refused to continue|0
2729218|NCT00158054|9382318|P1|Overall Study|Refused to continue|3
2729219|NCT00157950|9382332|P2|Overall Study|Death|0
2729220|NCT00157950|9382333|P1|Overall Study|Death|1
2729221|NCT00157820|9382350|P3|2nd 8 Months|Premature cross-over|9
2729222|NCT00157820|9382351|P2|2nd 8 Months|Premature cross-over|7
2729223|NCT00157820|9382352|P1|2nd 8 Months|Premature cross-over|1
2729224|NCT00157820|9382350|P3|2nd 8 Months|Lost to Follow-up|2
2729225|NCT00157820|9382351|P2|2nd 8 Months|Lost to Follow-up|5
2729226|NCT00157820|9382352|P1|2nd 8 Months|Lost to Follow-up|1
2729227|NCT00157820|9382350|P3|2nd 8 Months|Death|3
2729228|NCT00157820|9382351|P2|2nd 8 Months|Death|1
2729229|NCT00157820|9382352|P1|2nd 8 Months|Death|3
2729230|NCT00157820|9382350|P3|1st 8 Month|Premature cross-over|2
2729231|NCT00157820|9382351|P2|1st 8 Month|Premature cross-over|2
2729232|NCT00157820|9382352|P1|1st 8 Month|Premature cross-over|0
2729233|NCT00157820|9382350|P3|1st 8 Month|Lost to Follow-up|1
2729234|NCT00157820|9382351|P2|1st 8 Month|Lost to Follow-up|2
2729235|NCT00157820|9382352|P1|1st 8 Month|Lost to Follow-up|1
2729236|NCT00157820|9382350|P3|1st 8 Month|Death|3
2729237|NCT00157820|9382351|P2|1st 8 Month|Death|8
2729238|NCT00157820|9382352|P1|1st 8 Month|Death|7
2729239|NCT00157820|9382350|P3|Randomized|Protocol Violation|2
2729240|NCT00157820|9382351|P2|Randomized|Protocol Violation|1
2729241|NCT00157820|9382352|P1|Randomized|Protocol Violation|2
2729242|NCT00157820|9382350|P3|Randomized|Withdrawal by Subject|3
2729243|NCT00157820|9382351|P2|Randomized|Withdrawal by Subject|2
2729244|NCT00157820|9382352|P1|Randomized|Withdrawal by Subject|1
2729245|NCT00157820|9382350|P3|Randomized|Physician Decision|3
2729246|NCT00157820|9382351|P2|Randomized|Physician Decision|2
2729247|NCT00157820|9382352|P1|Randomized|Physician Decision|4
2729248|NCT00157755|9382365|P6|Overall Study|Study completion|2
2729249|NCT00157755|9382366|P5|Overall Study|Study completion|1
2729250|NCT00157755|9382367|P4|Overall Study|Study completion|0
2729251|NCT00157755|9382368|P3|Overall Study|Study completion|0
2729252|NCT00157755|9382369|P2|Overall Study|Study completion|0
2729253|NCT00157755|9382370|P1|Overall Study|Study completion|0
2729254|NCT00157755|9382365|P6|Overall Study|Subject non-compliance|1
2729255|NCT00157755|9382366|P5|Overall Study|Subject non-compliance|0
2729256|NCT00157755|9382367|P4|Overall Study|Subject non-compliance|0
2729257|NCT00157755|9382368|P3|Overall Study|Subject non-compliance|0
2729258|NCT00157755|9382369|P2|Overall Study|Subject non-compliance|0
2729259|NCT00157755|9382370|P1|Overall Study|Subject non-compliance|0
2729260|NCT00157755|9382365|P6|Overall Study|Study site closure|0
2729261|NCT00157755|9382366|P5|Overall Study|Study site closure|0
2729262|NCT00157755|9382367|P4|Overall Study|Study site closure|0
2729263|NCT00157755|9382368|P3|Overall Study|Study site closure|0
2729264|NCT00157755|9382369|P2|Overall Study|Study site closure|1
2729265|NCT00157755|9382370|P1|Overall Study|Study site closure|0
2729266|NCT00157755|9382365|P6|Overall Study|Medical reason|0
2729267|NCT00157755|9382366|P5|Overall Study|Medical reason|0
2729268|NCT00157755|9382367|P4|Overall Study|Medical reason|1
2729269|NCT00157755|9382368|P3|Overall Study|Medical reason|1
2729270|NCT00157755|9382369|P2|Overall Study|Medical reason|0
2729271|NCT00157755|9382370|P1|Overall Study|Medical reason|0
2729272|NCT00157755|9382365|P6|Overall Study|Explant due to infection|0
2729273|NCT00157755|9382366|P5|Overall Study|Explant due to infection|0
2729274|NCT00157755|9382367|P4|Overall Study|Explant due to infection|0
2729275|NCT00157755|9382368|P3|Overall Study|Explant due to infection|1
2729276|NCT00157755|9382369|P2|Overall Study|Explant due to infection|0
2729277|NCT00157755|9382370|P1|Overall Study|Explant due to infection|0
2729278|NCT00157755|9382365|P6|Overall Study|Withdrawal by Subject|2
2729279|NCT00157755|9382366|P5|Overall Study|Withdrawal by Subject|1
2729280|NCT00157755|9382367|P4|Overall Study|Withdrawal by Subject|1
2729281|NCT00157755|9382368|P3|Overall Study|Withdrawal by Subject|1
2729282|NCT00157755|9382369|P2|Overall Study|Withdrawal by Subject|0
2729283|NCT00157755|9382370|P1|Overall Study|Withdrawal by Subject|0
2729284|NCT00157755|9382365|P6|Overall Study|Lost to Follow-up|0
2729285|NCT00157755|9382366|P5|Overall Study|Lost to Follow-up|0
2729286|NCT00157755|9382367|P4|Overall Study|Lost to Follow-up|0
2729287|NCT00157755|9382368|P3|Overall Study|Lost to Follow-up|1
2729288|NCT00157755|9382369|P2|Overall Study|Lost to Follow-up|0
2729289|NCT00157755|9382370|P1|Overall Study|Lost to Follow-up|0
2729290|NCT00157755|9382365|P6|Overall Study|Death|0
2729291|NCT00157755|9382366|P5|Overall Study|Death|0
2729292|NCT00157755|9382367|P4|Overall Study|Death|2
2729293|NCT00157755|9382368|P3|Overall Study|Death|3
2729294|NCT00157755|9382369|P2|Overall Study|Death|3
2729295|NCT00157755|9382370|P1|Overall Study|Death|2
2729296|NCT00157248|9382406|P4|Overall Study|site closures, subject moving|9
2729297|NCT00157248|9382407|P3|Overall Study|site closures, subject moving|3
2729298|NCT00157248|9382408|P2|Overall Study|site closures, subject moving|7
2729299|NCT00157248|9382409|P1|Overall Study|site closures, subject moving|7
2729300|NCT00157248|9382406|P4|Overall Study|Withdrawal by Subject|3
2729301|NCT00157248|9382407|P3|Overall Study|Withdrawal by Subject|3
2729302|NCT00157248|9382408|P2|Overall Study|Withdrawal by Subject|4
2729303|NCT00157248|9382409|P1|Overall Study|Withdrawal by Subject|1
2729304|NCT00157248|9382406|P4|Overall Study|Lost to Follow-up|0
2729305|NCT00157248|9382407|P3|Overall Study|Lost to Follow-up|0
2729306|NCT00157248|9382408|P2|Overall Study|Lost to Follow-up|1
2729307|NCT00157248|9382409|P1|Overall Study|Lost to Follow-up|0
2729308|NCT00157248|9382406|P4|Overall Study|Protocol Violation|2
2729309|NCT00157248|9382407|P3|Overall Study|Protocol Violation|2
2729310|NCT00157248|9382408|P2|Overall Study|Protocol Violation|0
2729311|NCT00157248|9382409|P1|Overall Study|Protocol Violation|4
2729312|NCT00157248|9382406|P4|Overall Study|Adverse Event|33
2729313|NCT00157248|9382407|P3|Overall Study|Adverse Event|13
2729314|NCT00157248|9382408|P2|Overall Study|Adverse Event|25
2729315|NCT00157248|9382409|P1|Overall Study|Adverse Event|36
2729316|NCT00157209|9382515|P2|Overall Study|Ongoing at data cut-off|0
2729317|NCT00157209|9382516|P1|Overall Study|Ongoing at data cut-off|10
2729318|NCT00157196|9382530|P1|Overall Study|Ongoing at data cut-off|9
2729319|NCT00157157|9382536|P1|Overall Study|Inclusion not met- baseline FVIII value|1
2729320|NCT00157157|9382536|P1|Overall Study|Met exclusion criteria|1
2729321|NCT00157157|9382536|P1|Overall Study|Enrolled in another study|1
2729322|NCT00157157|9382536|P1|Overall Study|Lost to Follow-up|1
2729323|NCT00157157|9382536|P1|Overall Study|Physician Decision|1
2729324|NCT00157157|9382536|P1|Overall Study|Withdrawal by Subject|6
2729325|NCT00157014|9382563|P4|Overall Study|Withdrawal by Subject|0
2729326|NCT00157014|9382564|P3|Overall Study|Withdrawal by Subject|0
2729327|NCT00157014|9382565|P2|Overall Study|Withdrawal by Subject|0
2729328|NCT00157014|9382566|P1|Overall Study|Withdrawal by Subject|1
2729329|NCT00157014|9382563|P4|Overall Study|Patient would not receive transplant|0
2729330|NCT00157014|9382564|P3|Overall Study|Patient would not receive transplant|0
2729331|NCT00157014|9382565|P2|Overall Study|Patient would not receive transplant|1
2729332|NCT00157014|9382566|P1|Overall Study|Patient would not receive transplant|0
2729333|NCT00157014|9382563|P4|Overall Study|Patient unable to return in nursing home|0
2729334|NCT00157014|9382564|P3|Overall Study|Patient unable to return in nursing home|0
2729335|NCT00157014|9382565|P2|Overall Study|Patient unable to return in nursing home|0
2729336|NCT00157014|9382566|P1|Overall Study|Patient unable to return in nursing home|1
2729337|NCT00157014|9382563|P4|Overall Study|Patient withdrawn by investigator|0
2729338|NCT00157014|9382564|P3|Overall Study|Patient withdrawn by investigator|0
2729339|NCT00157014|9382565|P2|Overall Study|Patient withdrawn by investigator|0
2729340|NCT00157014|9382566|P1|Overall Study|Patient withdrawn by investigator|1
2729341|NCT00157014|9382563|P4|Overall Study|Medications withdrawn on family request|0
2729342|NCT00157014|9382564|P3|Overall Study|Medications withdrawn on family request|0
2729343|NCT00157014|9382565|P2|Overall Study|Medications withdrawn on family request|1
2729344|NCT00157014|9382566|P1|Overall Study|Medications withdrawn on family request|0
2729345|NCT00157014|9382563|P4|Overall Study|Physician Decision|0
2729346|NCT00157014|9382564|P3|Overall Study|Physician Decision|0
2729347|NCT00157014|9382565|P2|Overall Study|Physician Decision|1
2729348|NCT00157014|9382566|P1|Overall Study|Physician Decision|0
2729349|NCT00157014|9382563|P4|Overall Study|Death|1
2729350|NCT00157014|9382564|P3|Overall Study|Death|1
2729351|NCT00157014|9382565|P2|Overall Study|Death|2
2729352|NCT00157014|9382566|P1|Overall Study|Death|4
2729353|NCT00156819|9382682|P3|Overall Study|Lost to Follow-up|3
2729354|NCT00156819|9382683|P2|Overall Study|Lost to Follow-up|1
2729355|NCT00156819|9382684|P1|Overall Study|Lost to Follow-up|1
2729356|NCT00156533|9382701|P4|Overall Study|Failed Screening|1
2729357|NCT00156533|9382702|P3|Overall Study|Failed Screening|1
2729358|NCT00156533|9382703|P2|Overall Study|Failed Screening|0
2729359|NCT00156533|9382704|P1|Overall Study|Failed Screening|1
2729360|NCT00156533|9382701|P4|Overall Study|Withdrawal by Subject|1
2729361|NCT00156533|9382702|P3|Overall Study|Withdrawal by Subject|0
2729362|NCT00156533|9382703|P2|Overall Study|Withdrawal by Subject|0
2729363|NCT00156533|9382704|P1|Overall Study|Withdrawal by Subject|1
2729364|NCT00156533|9382701|P4|Overall Study|Withdrawn - Medication Expiration|0
2729365|NCT00156533|9382702|P3|Overall Study|Withdrawn - Medication Expiration|1
2729366|NCT00156533|9382703|P2|Overall Study|Withdrawn - Medication Expiration|2
2729367|NCT00156533|9382704|P1|Overall Study|Withdrawn - Medication Expiration|0
2729368|NCT00156065|9382738|P3|Overall Study|Other|3
2729369|NCT00156065|9382739|P2|Overall Study|Other|9
2729370|NCT00156065|9382740|P1|Overall Study|Other|2
2729371|NCT00156065|9382738|P3|Overall Study|Lost to Follow-up|1
2729372|NCT00156065|9382739|P2|Overall Study|Lost to Follow-up|7
2729373|NCT00156065|9382740|P1|Overall Study|Lost to Follow-up|5
2729374|NCT00156065|9382738|P3|Overall Study|Withdrawal by Subject|16
2729375|NCT00156065|9382739|P2|Overall Study|Withdrawal by Subject|26
2729376|NCT00156065|9382740|P1|Overall Study|Withdrawal by Subject|13
2729377|NCT00156065|9382738|P3|Overall Study|Lack of Efficacy|3
2729378|NCT00156065|9382739|P2|Overall Study|Lack of Efficacy|9
2729379|NCT00156065|9382740|P1|Overall Study|Lack of Efficacy|2
2729380|NCT00156065|9382738|P3|Overall Study|Adverse Event|4
2729381|NCT00156065|9382739|P2|Overall Study|Adverse Event|11
2729382|NCT00156065|9382740|P1|Overall Study|Adverse Event|8
2729383|NCT00156065|9382738|P3|Overall Study|Enrolled But Never Received Treatment|0
2729384|NCT00156065|9382739|P2|Overall Study|Enrolled But Never Received Treatment|1
2729385|NCT00156065|9382740|P1|Overall Study|Enrolled But Never Received Treatment|1
2729386|NCT00154375|9382774|P2|Overall Study|Suspected progression of disease|30
2729387|NCT00154375|9382775|P1|Overall Study|Suspected progression of disease|44
2729388|NCT00154375|9382774|P2|Overall Study|Protocol Violation|1
2729389|NCT00154375|9382775|P1|Overall Study|Protocol Violation|0
2729390|NCT00154375|9382774|P2|Overall Study|Abnormal laboratory value(s)|2
2729391|NCT00154375|9382775|P1|Overall Study|Abnormal laboratory value(s)|0
2729392|NCT00154375|9382774|P2|Overall Study|Lost to Follow-up|1
2729393|NCT00154375|9382775|P1|Overall Study|Lost to Follow-up|2
2729394|NCT00154375|9382774|P2|Overall Study|Study drug no longer required|3
2729395|NCT00154375|9382775|P1|Overall Study|Study drug no longer required|5
2729396|NCT00154375|9382774|P2|Overall Study|Death|13
2729397|NCT00154375|9382775|P1|Overall Study|Death|5
2729398|NCT00154375|9382774|P2|Overall Study|Withdrawal by Subject|10
2729399|NCT00154375|9382775|P1|Overall Study|Withdrawal by Subject|14
2729400|NCT00154375|9382774|P2|Overall Study|Adverse Event|20
2729401|NCT00154375|9382775|P1|Overall Study|Adverse Event|18
2729402|NCT00154375|9382774|P2|Overall Study|Unsatisfactory therapeutic effect|26
2729403|NCT00154375|9382775|P1|Overall Study|Unsatisfactory therapeutic effect|25
2729404|NCT00154310|9382786|P2|Overall Study|Death|1
2729405|NCT00154310|9382787|P1|Overall Study|Death|0
2729406|NCT00154310|9382786|P2|Overall Study|Administrative problems|1
2729407|NCT00154310|9382787|P1|Overall Study|Administrative problems|0
2729408|NCT00154310|9382786|P2|Overall Study|Lost to Follow-up|8
2729409|NCT00154310|9382787|P1|Overall Study|Lost to Follow-up|0
2729410|NCT00154310|9382786|P2|Overall Study|Withdrawal by Subject|3
2729411|NCT00154310|9382787|P1|Overall Study|Withdrawal by Subject|9
2729412|NCT00154310|9382786|P2|Overall Study|Protocol Violation|2
2729413|NCT00154310|9382787|P1|Overall Study|Protocol Violation|4
2729414|NCT00154310|9382786|P2|Overall Study|Lack of Efficacy|4
2729415|NCT00154310|9382787|P1|Overall Study|Lack of Efficacy|5
2729416|NCT00154310|9382786|P2|Overall Study|Adverse Event|9
2729417|NCT00154310|9382787|P1|Overall Study|Adverse Event|19
2729418|NCT00154297|9382803|P2|Overall Study|Lost to Follow-up|0
2729419|NCT00154297|9382804|P1|Overall Study|Lost to Follow-up|3
2729420|NCT00154297|9382803|P2|Overall Study|Withdrawal by Subject|5
2729421|NCT00154297|9382804|P1|Overall Study|Withdrawal by Subject|0
2729422|NCT00154297|9382803|P2|Overall Study|Death|2
2729423|NCT00154297|9382804|P1|Overall Study|Death|5
2729424|NCT00154284|9382822|P2|Overall Study|Protocol Violation|1
2729425|NCT00154284|9382823|P1|Overall Study|Protocol Violation|0
2729426|NCT00154284|9382822|P2|Overall Study|Lack of Efficacy|2
2729427|NCT00154284|9382823|P1|Overall Study|Lack of Efficacy|1
2729428|NCT00154284|9382822|P2|Overall Study|Abnormal laboratory value(s)|1
2729429|NCT00154284|9382823|P1|Overall Study|Abnormal laboratory value(s)|0
2729430|NCT00154284|9382822|P2|Overall Study|Adverse Event|9
2729431|NCT00154284|9382823|P1|Overall Study|Adverse Event|6
2729432|NCT00154102|9382837|P2|Overall Study|investigational study phase ongoing|2
2729433|NCT00154102|9382838|P1|Overall Study|investigational study phase ongoing|7
2729434|NCT00154063|9382874|P2|Overall Study|Other|3
2729435|NCT00154063|9382875|P1|Overall Study|Other|3
2729436|NCT00154063|9382874|P2|Overall Study|Withdrawal by Subject|9
2729437|NCT00154063|9382875|P1|Overall Study|Withdrawal by Subject|4
2729438|NCT00154063|9382874|P2|Overall Study|Investigator or Sponsor Request|1
2729439|NCT00154063|9382875|P1|Overall Study|Investigator or Sponsor Request|0
2729440|NCT00154063|9382874|P2|Overall Study|Protocol Violation|1
2729441|NCT00154063|9382875|P1|Overall Study|Protocol Violation|1
2729442|NCT00154063|9382874|P2|Overall Study|Adverse Event|8
2729443|NCT00154063|9382875|P1|Overall Study|Adverse Event|4
2729444|NCT00153920|9382937|P1|Overall Study|Progressive Disease before Trt|1
2729445|NCT00153920|9382937|P1|Overall Study|Withdrawal of Consent before Trt|1
2729446|NCT00153920|9382937|P1|Overall Study|Non-Protocol Therapy|1
2729447|NCT00153920|9382937|P1|Overall Study|Withdrawal by Subject|1
2729448|NCT00153920|9382937|P1|Overall Study|Death|2
2729449|NCT00153920|9382937|P1|Overall Study|Lack of Response|3
2729450|NCT00153920|9382937|P1|Overall Study|Physician Decision|3
2729451|NCT00153920|9382937|P1|Overall Study|Progressive Disease|9
2729452|NCT00153920|9382937|P1|Overall Study|Adverse Event|9
2729453|NCT00153816|9382963|P6|Overall Study|Follow-up exam done, histology missing|2
2729454|NCT00153816|9382964|P5|Overall Study|Follow-up exam done, histology missing|1
2729455|NCT00153816|9382965|P4|Overall Study|Follow-up exam done, histology missing|3
2729456|NCT00153816|9382966|P3|Overall Study|Follow-up exam done, histology missing|3
2729457|NCT00153816|9382967|P2|Overall Study|Follow-up exam done, histology missing|3
2729458|NCT00153816|9382968|P1|Overall Study|Follow-up exam done, histology missing|2
2729459|NCT00153816|9382963|P6|Overall Study|Follow-up exam not done|9
2729460|NCT00153816|9382964|P5|Overall Study|Follow-up exam not done|8
2729461|NCT00153816|9382965|P4|Overall Study|Follow-up exam not done|10
2729462|NCT00153816|9382966|P3|Overall Study|Follow-up exam not done|11
2729463|NCT00153816|9382967|P2|Overall Study|Follow-up exam not done|7
2729464|NCT00153816|9382968|P1|Overall Study|Follow-up exam not done|8
2729465|NCT00153816|9382963|P6|Overall Study|Withdrawal by Subject|5
2729466|NCT00153816|9382964|P5|Overall Study|Withdrawal by Subject|1
2729467|NCT00153816|9382965|P4|Overall Study|Withdrawal by Subject|4
2729468|NCT00153816|9382966|P3|Overall Study|Withdrawal by Subject|9
2729469|NCT00153816|9382967|P2|Overall Study|Withdrawal by Subject|9
2729470|NCT00153816|9382968|P1|Overall Study|Withdrawal by Subject|9
2729471|NCT00153816|9382963|P6|Overall Study|Lost to Follow-up|9
2729472|NCT00153816|9382964|P5|Overall Study|Lost to Follow-up|7
2729473|NCT00153816|9382965|P4|Overall Study|Lost to Follow-up|8
2729474|NCT00153816|9382966|P3|Overall Study|Lost to Follow-up|5
2729475|NCT00153816|9382967|P2|Overall Study|Lost to Follow-up|8
2729476|NCT00153816|9382968|P1|Overall Study|Lost to Follow-up|7
2729477|NCT00153816|9382963|P6|Overall Study|Death|2
2729478|NCT00153816|9382964|P5|Overall Study|Death|0
2729479|NCT00153816|9382965|P4|Overall Study|Death|6
2729480|NCT00153816|9382966|P3|Overall Study|Death|4
2729481|NCT00153816|9382967|P2|Overall Study|Death|5
2729482|NCT00153816|9382968|P1|Overall Study|Death|6
2729483|NCT00153179|9383009|P4|Study Visit Day 2|Withdrawal by Subject|2
2729484|NCT00153179|9383010|P3|Study Visit Day 2|Withdrawal by Subject|2
2729485|NCT00153179|9383011|P2|Study Visit Day 2|Withdrawal by Subject|0
2729486|NCT00153179|9383012|P1|Study Visit Day 2|Withdrawal by Subject|1
2729487|NCT00153101|9383044|P5|Overall Study|Withdrawal by Subject|5
2729488|NCT00153101|9383045|P4|Overall Study|Withdrawal by Subject|3
2729489|NCT00153101|9383046|P3|Overall Study|Withdrawal by Subject|3
2729490|NCT00153101|9383047|P2|Overall Study|Withdrawal by Subject|4
2729491|NCT00153101|9383048|P1|Overall Study|Withdrawal by Subject|3
2729492|NCT00153101|9383044|P5|Overall Study|Lost to Follow-up|5
2729493|NCT00153101|9383045|P4|Overall Study|Lost to Follow-up|5
2729494|NCT00153101|9383046|P3|Overall Study|Lost to Follow-up|12
2729495|NCT00153101|9383047|P2|Overall Study|Lost to Follow-up|14
2729496|NCT00153101|9383048|P1|Overall Study|Lost to Follow-up|14
2729497|NCT00153062|9383156|P4|Overall Study|Other|0
2729498|NCT00153062|9383157|P3|Overall Study|Other|1
2729499|NCT00153062|9383158|P2|Overall Study|Other|0
2729500|NCT00153062|9383159|P1|Overall Study|Other|0
2729501|NCT00153062|9383156|P4|Overall Study|No disposition data available|1
2729502|NCT00153062|9383157|P3|Overall Study|No disposition data available|1
2729503|NCT00153062|9383158|P2|Overall Study|No disposition data available|1
2729504|NCT00153062|9383159|P1|Overall Study|No disposition data available|1
2729505|NCT00153062|9383156|P4|Overall Study|Protocol Violation|1
2729506|NCT00153062|9383157|P3|Overall Study|Protocol Violation|1
2729507|NCT00153062|9383158|P2|Overall Study|Protocol Violation|2
2729508|NCT00153062|9383159|P1|Overall Study|Protocol Violation|0
2729509|NCT00153062|9383156|P4|Overall Study|Adverse Event|0
2729510|NCT00153062|9383157|P3|Overall Study|Adverse Event|1
2729511|NCT00153062|9383158|P2|Overall Study|Adverse Event|1
2729512|NCT00153062|9383159|P1|Overall Study|Adverse Event|0
2729513|NCT00153062|9383156|P4|Overall Study|Lost to Follow-up|16
2729514|NCT00153062|9383157|P3|Overall Study|Lost to Follow-up|15
2729515|NCT00153062|9383158|P2|Overall Study|Lost to Follow-up|20
2729516|NCT00153062|9383159|P1|Overall Study|Lost to Follow-up|12
2729517|NCT00153062|9383156|P4|Overall Study|Withdrawal by Subject|28
2729518|NCT00153062|9383157|P3|Overall Study|Withdrawal by Subject|27
2729519|NCT00153062|9383158|P2|Overall Study|Withdrawal by Subject|30
2729520|NCT00153062|9383159|P1|Overall Study|Withdrawal by Subject|14
2729521|NCT00153062|9383156|P4|Overall Study|Death|365
2729522|NCT00153062|9383157|P3|Overall Study|Death|369
2729523|NCT00153062|9383158|P2|Overall Study|Death|352
2729524|NCT00153062|9383159|P1|Overall Study|Death|360
2729525|NCT00152971|9383178|P3|Treatment|Other|10
2729526|NCT00152971|9383179|P2|Treatment|Other|11
2729527|NCT00152971|9383180|P1|Treatment|Other|9
2729528|NCT00152971|9383178|P3|Treatment|Withdrawal by Subject|5
2729529|NCT00152971|9383179|P2|Treatment|Withdrawal by Subject|4
2729530|NCT00152971|9383180|P1|Treatment|Withdrawal by Subject|4
2729531|NCT00152971|9383178|P3|Treatment|Lost to Follow-up|1
2729532|NCT00152971|9383179|P2|Treatment|Lost to Follow-up|2
2729533|NCT00152971|9383180|P1|Treatment|Lost to Follow-up|1
2729534|NCT00152971|9383178|P3|Treatment|Protocol Violation|10
2729535|NCT00152971|9383179|P2|Treatment|Protocol Violation|6
2729536|NCT00152971|9383180|P1|Treatment|Protocol Violation|8
2729537|NCT00152971|9383178|P3|Treatment|Adverse Event|54
2729538|NCT00152971|9383179|P2|Treatment|Adverse Event|40
2729539|NCT00152971|9383180|P1|Treatment|Adverse Event|49
2729540|NCT00152971|9383178|P3|Overall Study|Other|5
2729541|NCT00152971|9383179|P2|Overall Study|Other|5
2729542|NCT00152971|9383180|P1|Overall Study|Other|3
2729543|NCT00152971|9383178|P3|Overall Study|Withdrawal by Subject|14
2729544|NCT00152971|9383179|P2|Overall Study|Withdrawal by Subject|8
2729545|NCT00152971|9383180|P1|Overall Study|Withdrawal by Subject|9
2729546|NCT00152971|9383178|P3|Overall Study|Lost to Follow-up|13
2729547|NCT00152971|9383179|P2|Overall Study|Lost to Follow-up|14
2729548|NCT00152971|9383180|P1|Overall Study|Lost to Follow-up|17
2729549|NCT00152971|9383178|P3|Overall Study|Protocol Violation|8
2729550|NCT00152971|9383179|P2|Overall Study|Protocol Violation|11
2729551|NCT00152971|9383180|P1|Overall Study|Protocol Violation|10
2729552|NCT00152971|9383178|P3|Overall Study|Adverse Event|9
2729553|NCT00152971|9383179|P2|Overall Study|Adverse Event|10
2729554|NCT00152971|9383180|P1|Overall Study|Adverse Event|12
2729555|NCT00152763|9383216|P4|Overall Study|Lost to Follow-up|13
2729556|NCT00152763|9383217|P3|Overall Study|Lost to Follow-up|2
2729557|NCT00152763|9383218|P2|Overall Study|Lost to Follow-up|4
2729558|NCT00152763|9383219|P1|Overall Study|Lost to Follow-up|6
2729559|NCT00152763|9383216|P4|Overall Study|Death|1
2729560|NCT00152763|9383217|P3|Overall Study|Death|2
2729561|NCT00152763|9383218|P2|Overall Study|Death|1
2729562|NCT00152763|9383219|P1|Overall Study|Death|4
2729563|NCT00152516|9383335|P1|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1
2729564|NCT00152516|9383335|P1|Overall Study|Other: Underwent Surgery for Epilepsy|1
2729565|NCT00152516|9383335|P1|Overall Study|Other: Moved Out Of State|1
2729566|NCT00152516|9383335|P1|Overall Study|Other: Primary Care Physician's Decision|1
2729567|NCT00152516|9383335|P1|Overall Study|Other: Non-Compliance|2
2729568|NCT00152516|9383335|P1|Overall Study|Other: Parents Withdrew Consent|2
2729569|NCT00152516|9383335|P1|Overall Study|Other: Given Commercial Drug in Error|2
2729570|NCT00152516|9383335|P1|Overall Study|Other: Mother Refused To Cooperate|1
2729571|NCT00152516|9383335|P1|Overall Study|Protocol Violation|3
2729572|NCT00152516|9383335|P1|Overall Study|Withdrawal by Subject|8
2729573|NCT00152516|9383335|P1|Overall Study|Lost to Follow-up|5
2729574|NCT00152516|9383335|P1|Overall Study|Lack and Loss of Efficacy|30
2729575|NCT00152516|9383335|P1|Overall Study|Adverse Event|18
2729576|NCT00152464|9383361|P2|Overall Study|Patient relocated|0
2729577|NCT00152464|9383362|P1|Overall Study|Patient relocated|1
2729578|NCT00152464|9383361|P2|Overall Study|Eczema poorly controlled|0
2729579|NCT00152464|9383362|P1|Overall Study|Eczema poorly controlled|1
2729580|NCT00152464|9383361|P2|Overall Study|Lack of Efficacy|0
2729581|NCT00152464|9383362|P1|Overall Study|Lack of Efficacy|1
2729582|NCT00152464|9383361|P2|Overall Study|Investigator decision|0
2729583|NCT00152464|9383362|P1|Overall Study|Investigator decision|1
2729584|NCT00152464|9383361|P2|Overall Study|Parent decision|1
2729585|NCT00152464|9383362|P1|Overall Study|Parent decision|1
2729586|NCT00152464|9383361|P2|Overall Study|Eczema deterioration|1
2729587|NCT00152464|9383362|P1|Overall Study|Eczema deterioration|0
2729588|NCT00152464|9383361|P2|Overall Study|Atopic dermatitis poorly controlled|1
2729589|NCT00152464|9383362|P1|Overall Study|Atopic dermatitis poorly controlled|0
2729590|NCT00152464|9383361|P2|Overall Study|Withdrawal by Subject|22
2729591|NCT00152464|9383362|P1|Overall Study|Withdrawal by Subject|21
2729592|NCT00152464|9383361|P2|Overall Study|Protocol Violation|1
2729593|NCT00152464|9383362|P1|Overall Study|Protocol Violation|3
2729594|NCT00152464|9383361|P2|Overall Study|Lost to Follow-up|4
2729595|NCT00152464|9383362|P1|Overall Study|Lost to Follow-up|8
2729596|NCT00152464|9383361|P2|Overall Study|Adverse Event|6
2729597|NCT00152464|9383362|P1|Overall Study|Adverse Event|3
2729598|NCT00152009|9383390|P4|Overall Study|Sponsor's decision|3
2729599|NCT00152009|9383391|P3|Overall Study|Sponsor's decision|1
2729600|NCT00152009|9383392|P2|Overall Study|Sponsor's decision|3
2729601|NCT00152009|9383393|P1|Overall Study|Sponsor's decision|3
2729602|NCT00152009|9383390|P4|Overall Study|ECG abnormalities|1
2729603|NCT00152009|9383391|P3|Overall Study|ECG abnormalities|2
2729604|NCT00152009|9383392|P2|Overall Study|ECG abnormalities|2
2729605|NCT00152009|9383393|P1|Overall Study|ECG abnormalities|2
2729606|NCT00152009|9383390|P4|Overall Study|Lack of Efficacy|15
2729607|NCT00152009|9383391|P3|Overall Study|Lack of Efficacy|7
2729608|NCT00152009|9383392|P2|Overall Study|Lack of Efficacy|6
2729609|NCT00152009|9383393|P1|Overall Study|Lack of Efficacy|8
2729610|NCT00152009|9383390|P4|Overall Study|Lost to Follow-up|3
2729611|NCT00152009|9383391|P3|Overall Study|Lost to Follow-up|3
2729612|NCT00152009|9383392|P2|Overall Study|Lost to Follow-up|4
2729613|NCT00152009|9383393|P1|Overall Study|Lost to Follow-up|2
2729614|NCT00152009|9383390|P4|Overall Study|Withdrawal by Subject|9
2729615|NCT00152009|9383391|P3|Overall Study|Withdrawal by Subject|4
2729616|NCT00152009|9383392|P2|Overall Study|Withdrawal by Subject|3
2729617|NCT00152009|9383393|P1|Overall Study|Withdrawal by Subject|2
2729618|NCT00152009|9383390|P4|Overall Study|Protocol Violation|1
2729619|NCT00152009|9383391|P3|Overall Study|Protocol Violation|0
2729620|NCT00152009|9383392|P2|Overall Study|Protocol Violation|0
2729621|NCT00152009|9383393|P1|Overall Study|Protocol Violation|3
2729622|NCT00152009|9383390|P4|Overall Study|Adverse Event|1
2729623|NCT00152009|9383391|P3|Overall Study|Adverse Event|20
2729624|NCT00152009|9383392|P2|Overall Study|Adverse Event|13
2729625|NCT00152009|9383393|P1|Overall Study|Adverse Event|9
2729626|NCT00151996|9383425|P2|Overall Study|Sponsor's decision|2
2729627|NCT00151996|9383426|P1|Overall Study|Sponsor's decision|0
2729628|NCT00151996|9383425|P2|Overall Study|Protocol Violation|2
2729629|NCT00151996|9383426|P1|Overall Study|Protocol Violation|1
2729630|NCT00151996|9383425|P2|Overall Study|Withdrawal by Subject|1
2729631|NCT00151996|9383426|P1|Overall Study|Withdrawal by Subject|1
2729632|NCT00151996|9383425|P2|Overall Study|Adverse Event|2
2729633|NCT00151996|9383426|P1|Overall Study|Adverse Event|3
2729634|NCT00151892|9383442|P2|Overall Study|Lack of study medication at center|1
2729635|NCT00151892|9383443|P1|Overall Study|Lack of study medication at center|0
2729636|NCT00151892|9383442|P2|Overall Study|Used prohibited corticosteroids|0
2729637|NCT00151892|9383443|P1|Overall Study|Used prohibited corticosteroids|1
2729638|NCT00151892|9383442|P2|Overall Study|Did not return for a visit|0
2729639|NCT00151892|9383443|P1|Overall Study|Did not return for a visit|1
2729640|NCT00151892|9383442|P2|Overall Study|Pregnancy|1
2729641|NCT00151892|9383443|P1|Overall Study|Pregnancy|0
2729642|NCT00151892|9383442|P2|Overall Study|Non-compliance|1
2729643|NCT00151892|9383443|P1|Overall Study|Non-compliance|0
2729644|NCT00151892|9383442|P2|Overall Study|Protocol Violation|3
2729645|NCT00151892|9383443|P1|Overall Study|Protocol Violation|3
2729646|NCT00151892|9383442|P2|Overall Study|Adverse Event|3
2729647|NCT00151892|9383443|P1|Overall Study|Adverse Event|6
2729648|NCT00151892|9383442|P2|Overall Study|Lost to Follow-up|10
2729649|NCT00151892|9383443|P1|Overall Study|Lost to Follow-up|5
2729650|NCT00151892|9383442|P2|Overall Study|Patient request|7
2729651|NCT00151892|9383443|P1|Overall Study|Patient request|10
2729652|NCT00151892|9383442|P2|Overall Study|Lack of Efficacy|57
2729653|NCT00151892|9383443|P1|Overall Study|Lack of Efficacy|50
2729654|NCT00151775|9383488|P12|Period 4: Open Label|Protocol Violation|0
2729655|NCT00151775|9383489|P11|Period 4: Open Label|Protocol Violation|0
2729656|NCT00151775|9383490|P10|Period 4: Open Label|Protocol Violation|0
2729657|NCT00151775|9383491|P9|Period 4: Open Label|Protocol Violation|0
2729658|NCT00151775|9383492|P8|Period 4: Open Label|Protocol Violation|0
2729659|NCT00151775|9383493|P7|Period 4: Open Label|Protocol Violation|0
2729660|NCT00151775|9383494|P6|Period 4: Open Label|Protocol Violation|0
2729661|NCT00151775|9383495|P5|Period 4: Open Label|Protocol Violation|1
2729662|NCT00151775|9383496|P4|Period 4: Open Label|Protocol Violation|0
2729663|NCT00151775|9383497|P3|Period 4: Open Label|Protocol Violation|0
2729664|NCT00151775|9383498|P2|Period 4: Open Label|Protocol Violation|0
2729665|NCT00151775|9383499|P1|Period 4: Open Label|Protocol Violation|0
2729666|NCT00151775|9383488|P12|Period 4: Open Label|Physician Decision|0
2729667|NCT00151775|9383489|P11|Period 4: Open Label|Physician Decision|0
2729668|NCT00151775|9383490|P10|Period 4: Open Label|Physician Decision|2
2729669|NCT00151775|9383491|P9|Period 4: Open Label|Physician Decision|0
2729670|NCT00151775|9383492|P8|Period 4: Open Label|Physician Decision|0
2729671|NCT00151775|9383493|P7|Period 4: Open Label|Physician Decision|0
2729672|NCT00151775|9383494|P6|Period 4: Open Label|Physician Decision|0
2729673|NCT00151775|9383495|P5|Period 4: Open Label|Physician Decision|0
2729674|NCT00151775|9383496|P4|Period 4: Open Label|Physician Decision|0
2729675|NCT00151775|9383497|P3|Period 4: Open Label|Physician Decision|0
2729676|NCT00151775|9383498|P2|Period 4: Open Label|Physician Decision|0
2729677|NCT00151775|9383499|P1|Period 4: Open Label|Physician Decision|0
2729678|NCT00151775|9383488|P12|Period 4: Open Label|Other|0
2729679|NCT00151775|9383489|P11|Period 4: Open Label|Other|0
2729680|NCT00151775|9383490|P10|Period 4: Open Label|Other|3
2729681|NCT00151775|9383491|P9|Period 4: Open Label|Other|0
2729682|NCT00151775|9383492|P8|Period 4: Open Label|Other|0
2729683|NCT00151775|9383493|P7|Period 4: Open Label|Other|0
2729684|NCT00151775|9383494|P6|Period 4: Open Label|Other|0
2729685|NCT00151775|9383495|P5|Period 4: Open Label|Other|1
2729686|NCT00151775|9383496|P4|Period 4: Open Label|Other|0
2729687|NCT00151775|9383497|P3|Period 4: Open Label|Other|0
2729688|NCT00151775|9383498|P2|Period 4: Open Label|Other|0
2729689|NCT00151775|9383499|P1|Period 4: Open Label|Other|0
2729690|NCT00151775|9383488|P12|Period 4: Open Label|Non-compliance with protocol|0
2729691|NCT00151775|9383489|P11|Period 4: Open Label|Non-compliance with protocol|0
2729692|NCT00151775|9383490|P10|Period 4: Open Label|Non-compliance with protocol|4
2729693|NCT00151775|9383491|P9|Period 4: Open Label|Non-compliance with protocol|0
2729694|NCT00151775|9383492|P8|Period 4: Open Label|Non-compliance with protocol|0
2729695|NCT00151775|9383493|P7|Period 4: Open Label|Non-compliance with protocol|0
2729696|NCT00151775|9383494|P6|Period 4: Open Label|Non-compliance with protocol|0
2729697|NCT00151775|9383495|P5|Period 4: Open Label|Non-compliance with protocol|4
2729698|NCT00151775|9383496|P4|Period 4: Open Label|Non-compliance with protocol|0
2729699|NCT00151775|9383497|P3|Period 4: Open Label|Non-compliance with protocol|0
2729700|NCT00151775|9383498|P2|Period 4: Open Label|Non-compliance with protocol|0
2729701|NCT00151775|9383499|P1|Period 4: Open Label|Non-compliance with protocol|0
2729702|NCT00151775|9383488|P12|Period 4: Open Label|Lost to Follow-up|0
2729703|NCT00151775|9383489|P11|Period 4: Open Label|Lost to Follow-up|0
2729704|NCT00151775|9383490|P10|Period 4: Open Label|Lost to Follow-up|7
2729705|NCT00151775|9383491|P9|Period 4: Open Label|Lost to Follow-up|0
2729706|NCT00151775|9383492|P8|Period 4: Open Label|Lost to Follow-up|0
2729707|NCT00151775|9383493|P7|Period 4: Open Label|Lost to Follow-up|0
2729708|NCT00151775|9383494|P6|Period 4: Open Label|Lost to Follow-up|0
2729709|NCT00151775|9383495|P5|Period 4: Open Label|Lost to Follow-up|17
2729710|NCT00151775|9383496|P4|Period 4: Open Label|Lost to Follow-up|0
2729711|NCT00151775|9383497|P3|Period 4: Open Label|Lost to Follow-up|0
2729712|NCT00151775|9383498|P2|Period 4: Open Label|Lost to Follow-up|0
2729713|NCT00151775|9383499|P1|Period 4: Open Label|Lost to Follow-up|0
2729714|NCT00151775|9383488|P12|Period 4: Open Label|Adverse Event|0
2729715|NCT00151775|9383489|P11|Period 4: Open Label|Adverse Event|0
2729716|NCT00151775|9383490|P10|Period 4: Open Label|Adverse Event|2
2729717|NCT00151775|9383491|P9|Period 4: Open Label|Adverse Event|0
2729718|NCT00151775|9383492|P8|Period 4: Open Label|Adverse Event|0
2729719|NCT00151775|9383493|P7|Period 4: Open Label|Adverse Event|0
2729720|NCT00151775|9383494|P6|Period 4: Open Label|Adverse Event|0
2729721|NCT00151775|9383495|P5|Period 4: Open Label|Adverse Event|1
2729722|NCT00151775|9383496|P4|Period 4: Open Label|Adverse Event|0
2729723|NCT00151775|9383497|P3|Period 4: Open Label|Adverse Event|0
2729724|NCT00151775|9383498|P2|Period 4: Open Label|Adverse Event|0
2729725|NCT00151775|9383499|P1|Period 4: Open Label|Adverse Event|0
2729726|NCT00151775|9383488|P12|Period 4: Open Label|Withdrawal by Subject|0
2729727|NCT00151775|9383489|P11|Period 4: Open Label|Withdrawal by Subject|0
2729728|NCT00151775|9383490|P10|Period 4: Open Label|Withdrawal by Subject|2
2729729|NCT00151775|9383491|P9|Period 4: Open Label|Withdrawal by Subject|0
2729730|NCT00151775|9383492|P8|Period 4: Open Label|Withdrawal by Subject|0
2729731|NCT00151775|9383493|P7|Period 4: Open Label|Withdrawal by Subject|0
2729732|NCT00151775|9383494|P6|Period 4: Open Label|Withdrawal by Subject|0
2729733|NCT00151775|9383495|P5|Period 4: Open Label|Withdrawal by Subject|5
2729734|NCT00151775|9383496|P4|Period 4: Open Label|Withdrawal by Subject|0
2729735|NCT00151775|9383497|P3|Period 4: Open Label|Withdrawal by Subject|0
2729736|NCT00151775|9383498|P2|Period 4: Open Label|Withdrawal by Subject|0
2729737|NCT00151775|9383499|P1|Period 4: Open Label|Withdrawal by Subject|0
2729738|NCT00151775|9383488|P12|Period 4: Open Label|Increased blood pressure|0
2729739|NCT00151775|9383489|P11|Period 4: Open Label|Increased blood pressure|0
2729740|NCT00151775|9383490|P10|Period 4: Open Label|Increased blood pressure|1
2729741|NCT00151775|9383491|P9|Period 4: Open Label|Increased blood pressure|0
2729742|NCT00151775|9383492|P8|Period 4: Open Label|Increased blood pressure|0
2729743|NCT00151775|9383493|P7|Period 4: Open Label|Increased blood pressure|0
2729744|NCT00151775|9383494|P6|Period 4: Open Label|Increased blood pressure|0
2729745|NCT00151775|9383495|P5|Period 4: Open Label|Increased blood pressure|1
2729746|NCT00151775|9383496|P4|Period 4: Open Label|Increased blood pressure|0
2729747|NCT00151775|9383497|P3|Period 4: Open Label|Increased blood pressure|0
2729748|NCT00151775|9383498|P2|Period 4: Open Label|Increased blood pressure|0
2729749|NCT00151775|9383499|P1|Period 4: Open Label|Increased blood pressure|0
2729750|NCT00151775|9383488|P12|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1
2729751|NCT00151775|9383489|P11|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
2729752|NCT00151775|9383490|P10|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
2729753|NCT00151775|9383491|P9|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
2729754|NCT00151775|9383492|P8|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
2729755|NCT00151775|9383493|P7|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
2729756|NCT00151775|9383494|P6|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
2729757|NCT00151775|9383495|P5|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
2729758|NCT00151775|9383496|P4|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
2729759|NCT00151775|9383497|P3|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
2729760|NCT00151775|9383498|P2|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
2729761|NCT00151775|9383499|P1|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
2729762|NCT00151775|9383488|P12|Period 3: Double-blind, Withdrawal|Protocol Violation|0
2729763|NCT00151775|9383489|P11|Period 3: Double-blind, Withdrawal|Protocol Violation|0
2729764|NCT00151775|9383490|P10|Period 3: Double-blind, Withdrawal|Protocol Violation|0
2729765|NCT00151775|9383491|P9|Period 3: Double-blind, Withdrawal|Protocol Violation|0
2729766|NCT00151775|9383492|P8|Period 3: Double-blind, Withdrawal|Protocol Violation|0
2729767|NCT00151775|9383493|P7|Period 3: Double-blind, Withdrawal|Protocol Violation|0
2729768|NCT00151775|9383494|P6|Period 3: Double-blind, Withdrawal|Protocol Violation|0
2729769|NCT00151775|9383495|P5|Period 3: Double-blind, Withdrawal|Protocol Violation|0
2729770|NCT00151775|9383496|P4|Period 3: Double-blind, Withdrawal|Protocol Violation|0
2729771|NCT00151775|9383497|P3|Period 3: Double-blind, Withdrawal|Protocol Violation|1
2729772|NCT00151775|9383498|P2|Period 3: Double-blind, Withdrawal|Protocol Violation|0
2729773|NCT00151775|9383499|P1|Period 3: Double-blind, Withdrawal|Protocol Violation|0
2729774|NCT00151775|9383488|P12|Period 3: Double-blind, Withdrawal|Adverse Event|0
2729775|NCT00151775|9383489|P11|Period 3: Double-blind, Withdrawal|Adverse Event|0
2729776|NCT00151775|9383490|P10|Period 3: Double-blind, Withdrawal|Adverse Event|0
2729777|NCT00151775|9383491|P9|Period 3: Double-blind, Withdrawal|Adverse Event|0
2729778|NCT00151775|9383492|P8|Period 3: Double-blind, Withdrawal|Adverse Event|0
2729779|NCT00151775|9383493|P7|Period 3: Double-blind, Withdrawal|Adverse Event|0
2729780|NCT00151775|9383494|P6|Period 3: Double-blind, Withdrawal|Adverse Event|0
2729781|NCT00151775|9383495|P5|Period 3: Double-blind, Withdrawal|Adverse Event|0
2729782|NCT00151775|9383496|P4|Period 3: Double-blind, Withdrawal|Adverse Event|0
2729783|NCT00151775|9383497|P3|Period 3: Double-blind, Withdrawal|Adverse Event|1
2729784|NCT00151775|9383498|P2|Period 3: Double-blind, Withdrawal|Adverse Event|0
2729785|NCT00151775|9383499|P1|Period 3: Double-blind, Withdrawal|Adverse Event|0
2729786|NCT00151775|9383488|P12|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
2729787|NCT00151775|9383489|P11|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
2729788|NCT00151775|9383490|P10|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
2729789|NCT00151775|9383491|P9|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
2729790|NCT00151775|9383492|P8|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
2729791|NCT00151775|9383493|P7|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1
2729792|NCT00151775|9383494|P6|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
2729793|NCT00151775|9383495|P5|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
2729794|NCT00151775|9383496|P4|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
2729795|NCT00151775|9383497|P3|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
2729796|NCT00151775|9383498|P2|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
2729797|NCT00151775|9383499|P1|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
2729798|NCT00151775|9383488|P12|Period 3: Double-blind, Withdrawal|Other|0
2729799|NCT00151775|9383489|P11|Period 3: Double-blind, Withdrawal|Other|0
2729800|NCT00151775|9383490|P10|Period 3: Double-blind, Withdrawal|Other|0
2729801|NCT00151775|9383491|P9|Period 3: Double-blind, Withdrawal|Other|0
2729802|NCT00151775|9383492|P8|Period 3: Double-blind, Withdrawal|Other|1
2729803|NCT00151775|9383493|P7|Period 3: Double-blind, Withdrawal|Other|0
2729804|NCT00151775|9383494|P6|Period 3: Double-blind, Withdrawal|Other|0
2729805|NCT00151775|9383495|P5|Period 3: Double-blind, Withdrawal|Other|0
2729806|NCT00151775|9383496|P4|Period 3: Double-blind, Withdrawal|Other|0
2729807|NCT00151775|9383497|P3|Period 3: Double-blind, Withdrawal|Other|1
2729808|NCT00151775|9383498|P2|Period 3: Double-blind, Withdrawal|Other|0
2729809|NCT00151775|9383499|P1|Period 3: Double-blind, Withdrawal|Other|0
2729810|NCT00151775|9383488|P12|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
2729811|NCT00151775|9383489|P11|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
2729812|NCT00151775|9383490|P10|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
2729813|NCT00151775|9383491|P9|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
2729814|NCT00151775|9383492|P8|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
2729815|NCT00151775|9383493|P7|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
2729816|NCT00151775|9383494|P6|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1
2729817|NCT00151775|9383495|P5|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
2729818|NCT00151775|9383496|P4|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
2729819|NCT00151775|9383497|P3|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
2729820|NCT00151775|9383498|P2|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
2729821|NCT00151775|9383499|P1|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
2729822|NCT00151775|9383488|P12|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
2729823|NCT00151775|9383489|P11|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
2729824|NCT00151775|9383490|P10|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
2729825|NCT00151775|9383491|P9|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
2729826|NCT00151775|9383492|P8|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
2729827|NCT00151775|9383493|P7|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1
2729828|NCT00151775|9383494|P6|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
2729829|NCT00151775|9383495|P5|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
2729830|NCT00151775|9383496|P4|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
2729831|NCT00151775|9383497|P3|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
2729832|NCT00151775|9383498|P2|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
2729833|NCT00151775|9383499|P1|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
2729834|NCT00151775|9383488|P12|Period 2 - Double-Blind Dose Response|Physician Decision|0
2729835|NCT00151775|9383489|P11|Period 2 - Double-Blind Dose Response|Physician Decision|0
2729836|NCT00151775|9383490|P10|Period 2 - Double-Blind Dose Response|Physician Decision|0
2729837|NCT00151775|9383491|P9|Period 2 - Double-Blind Dose Response|Physician Decision|0
2729838|NCT00151775|9383492|P8|Period 2 - Double-Blind Dose Response|Physician Decision|0
2729839|NCT00151775|9383493|P7|Period 2 - Double-Blind Dose Response|Physician Decision|0
2729840|NCT00151775|9383494|P6|Period 2 - Double-Blind Dose Response|Physician Decision|1
2729841|NCT00151775|9383495|P5|Period 2 - Double-Blind Dose Response|Physician Decision|0
2729842|NCT00151775|9383496|P4|Period 2 - Double-Blind Dose Response|Physician Decision|0
2729843|NCT00151775|9383497|P3|Period 2 - Double-Blind Dose Response|Physician Decision|0
2729844|NCT00151775|9383498|P2|Period 2 - Double-Blind Dose Response|Physician Decision|0
2729845|NCT00151775|9383499|P1|Period 2 - Double-Blind Dose Response|Physician Decision|0
2729846|NCT00151775|9383488|P12|Period 2 - Double-Blind Dose Response|non-compliance|0
2729847|NCT00151775|9383489|P11|Period 2 - Double-Blind Dose Response|non-compliance|0
2729848|NCT00151775|9383490|P10|Period 2 - Double-Blind Dose Response|non-compliance|0
2729849|NCT00151775|9383491|P9|Period 2 - Double-Blind Dose Response|non-compliance|0
2729850|NCT00151775|9383492|P8|Period 2 - Double-Blind Dose Response|non-compliance|0
2729851|NCT00151775|9383493|P7|Period 2 - Double-Blind Dose Response|non-compliance|0
2729852|NCT00151775|9383494|P6|Period 2 - Double-Blind Dose Response|non-compliance|1
2729853|NCT00151775|9383495|P5|Period 2 - Double-Blind Dose Response|non-compliance|0
2729854|NCT00151775|9383496|P4|Period 2 - Double-Blind Dose Response|non-compliance|0
2729855|NCT00151775|9383497|P3|Period 2 - Double-Blind Dose Response|non-compliance|0
2729856|NCT00151775|9383498|P2|Period 2 - Double-Blind Dose Response|non-compliance|0
2729857|NCT00151775|9383499|P1|Period 2 - Double-Blind Dose Response|non-compliance|0
2729858|NCT00151775|9383488|P12|Period 2 - Double-Blind Dose Response|Other|0
2729859|NCT00151775|9383489|P11|Period 2 - Double-Blind Dose Response|Other|0
2729860|NCT00151775|9383490|P10|Period 2 - Double-Blind Dose Response|Other|0
2729861|NCT00151775|9383491|P9|Period 2 - Double-Blind Dose Response|Other|0
2729862|NCT00151775|9383492|P8|Period 2 - Double-Blind Dose Response|Other|0
2729863|NCT00151775|9383493|P7|Period 2 - Double-Blind Dose Response|Other|1
2729864|NCT00151775|9383494|P6|Period 2 - Double-Blind Dose Response|Other|0
2729865|NCT00151775|9383495|P5|Period 2 - Double-Blind Dose Response|Other|0
2729866|NCT00151775|9383496|P4|Period 2 - Double-Blind Dose Response|Other|0
2729867|NCT00151775|9383497|P3|Period 2 - Double-Blind Dose Response|Other|0
2729868|NCT00151775|9383498|P2|Period 2 - Double-Blind Dose Response|Other|0
2729869|NCT00151775|9383499|P1|Period 2 - Double-Blind Dose Response|Other|0
2729870|NCT00151775|9383488|P12|Period 2 - Double-Blind Dose Response|Protocol Violation|0
2729871|NCT00151775|9383489|P11|Period 2 - Double-Blind Dose Response|Protocol Violation|0
2729872|NCT00151775|9383490|P10|Period 2 - Double-Blind Dose Response|Protocol Violation|0
2729873|NCT00151775|9383491|P9|Period 2 - Double-Blind Dose Response|Protocol Violation|0
2729874|NCT00151775|9383492|P8|Period 2 - Double-Blind Dose Response|Protocol Violation|0
2729875|NCT00151775|9383493|P7|Period 2 - Double-Blind Dose Response|Protocol Violation|0
2729876|NCT00151775|9383494|P6|Period 2 - Double-Blind Dose Response|Protocol Violation|0
2729877|NCT00151775|9383495|P5|Period 2 - Double-Blind Dose Response|Protocol Violation|0
2729878|NCT00151775|9383496|P4|Period 2 - Double-Blind Dose Response|Protocol Violation|0
2729879|NCT00151775|9383497|P3|Period 2 - Double-Blind Dose Response|Protocol Violation|0
2729880|NCT00151775|9383498|P2|Period 2 - Double-Blind Dose Response|Protocol Violation|4
2729881|NCT00151775|9383499|P1|Period 2 - Double-Blind Dose Response|Protocol Violation|0
2729882|NCT00151775|9383488|P12|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
2729883|NCT00151775|9383489|P11|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
2729884|NCT00151775|9383490|P10|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
2729885|NCT00151775|9383491|P9|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
2729886|NCT00151775|9383492|P8|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
2729887|NCT00151775|9383493|P7|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
2729888|NCT00151775|9383494|P6|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
2729889|NCT00151775|9383495|P5|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
2729890|NCT00151775|9383496|P4|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
2729891|NCT00151775|9383497|P3|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
2729892|NCT00151775|9383498|P2|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
2729893|NCT00151775|9383499|P1|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
2729894|NCT00151775|9383488|P12|Period 2 - Double-Blind Dose Response|Adverse Event|0
2729895|NCT00151775|9383489|P11|Period 2 - Double-Blind Dose Response|Adverse Event|0
2729896|NCT00151775|9383490|P10|Period 2 - Double-Blind Dose Response|Adverse Event|0
2729897|NCT00151775|9383491|P9|Period 2 - Double-Blind Dose Response|Adverse Event|0
2729898|NCT00151775|9383492|P8|Period 2 - Double-Blind Dose Response|Adverse Event|0
2729899|NCT00151775|9383493|P7|Period 2 - Double-Blind Dose Response|Adverse Event|0
2729900|NCT00151775|9383494|P6|Period 2 - Double-Blind Dose Response|Adverse Event|0
2729901|NCT00151775|9383495|P5|Period 2 - Double-Blind Dose Response|Adverse Event|0
2729902|NCT00151775|9383496|P4|Period 2 - Double-Blind Dose Response|Adverse Event|0
2729903|NCT00151775|9383497|P3|Period 2 - Double-Blind Dose Response|Adverse Event|0
2729904|NCT00151775|9383498|P2|Period 2 - Double-Blind Dose Response|Adverse Event|2
2729905|NCT00151775|9383499|P1|Period 2 - Double-Blind Dose Response|Adverse Event|1
2729906|NCT00151476|9383543|P2|FAP Analyzed Subjects|Other study participation|1
2729907|NCT00151476|9383544|P1|FAP Analyzed Subjects|Other study participation|0
2729908|NCT00151476|9383543|P2|FAP Analyzed Subjects|Lost to Follow-up|2
2729909|NCT00151476|9383544|P1|FAP Analyzed Subjects|Lost to Follow-up|0
2729910|NCT00151476|9383543|P2|FAP Identified Subjects|Protocol Violation|1
2729911|NCT00151476|9383544|P1|FAP Identified Subjects|Protocol Violation|0
2729912|NCT00151411|9383601|P2|Overall Study|Pregnancy|4
2729913|NCT00151411|9383602|P1|Overall Study|Pregnancy|0
2729914|NCT00151411|9383601|P2|Overall Study|Adverse Event|0
2729915|NCT00151411|9383602|P1|Overall Study|Adverse Event|6
2729916|NCT00151411|9383601|P2|Overall Study|Withdrawal by Subject|20
2729917|NCT00151411|9383602|P1|Overall Study|Withdrawal by Subject|12
2729918|NCT00151411|9383601|P2|Overall Study|Lost to Follow-up|19
2729919|NCT00151411|9383602|P1|Overall Study|Lost to Follow-up|15
2729920|NCT00151372|9383614|P2|Overall Study|Withdrawal by Subject|7
2729921|NCT00151372|9383615|P1|Overall Study|Withdrawal by Subject|7
2729922|NCT00151372|9383614|P2|Overall Study|Too sick medically to continue|6
2729923|NCT00151372|9383615|P1|Overall Study|Too sick medically to continue|5
2729924|NCT00151372|9383614|P2|Overall Study|Lost to Follow-up|5
2729925|NCT00151372|9383615|P1|Overall Study|Lost to Follow-up|5
2729926|NCT00151372|9383614|P2|Overall Study|Death|11
2729927|NCT00151372|9383615|P1|Overall Study|Death|12
2729928|NCT00151281|9383630|P1|Overall Study|Not evaluable|3
2729929|NCT00150969|9383639|P2|24-48 Month Extension|Other Reason|91
2729930|NCT00150969|9383640|P1|24-48 Month Extension|Other Reason|81
2729931|NCT00150969|9383639|P2|24-48 Month Extension|Adverse Event|3
2729932|NCT00150969|9383640|P1|24-48 Month Extension|Adverse Event|1
2729933|NCT00150969|9383639|P2|24-48 Month Extension|Lack of Efficacy|1
2729934|NCT00150969|9383640|P1|24-48 Month Extension|Lack of Efficacy|0
2729935|NCT00150969|9383639|P2|24-48 Month Extension|Withdrawal by Subject|5
2729936|NCT00150969|9383640|P1|24-48 Month Extension|Withdrawal by Subject|6
2729937|NCT00150969|9383639|P2|24 Month Main Study|Withdrawal by Subject|4
2729938|NCT00150969|9383640|P1|24 Month Main Study|Withdrawal by Subject|7
2729939|NCT00150969|9383639|P2|24 Month Main Study|Protocol Violation|2
2729940|NCT00150969|9383640|P1|24 Month Main Study|Protocol Violation|4
2729941|NCT00150969|9383639|P2|24 Month Main Study|Lost to Follow-up|2
2729942|NCT00150969|9383640|P1|24 Month Main Study|Lost to Follow-up|3
2729943|NCT00150969|9383639|P2|24 Month Main Study|Lack of Efficacy|8
2729944|NCT00150969|9383640|P1|24 Month Main Study|Lack of Efficacy|1
2729945|NCT00150969|9383639|P2|24 Month Main Study|Death|1
2729946|NCT00150969|9383640|P1|24 Month Main Study|Death|1
2729947|NCT00150969|9383639|P2|24 Month Main Study|Adverse Event|4
2729948|NCT00150969|9383640|P1|24 Month Main Study|Adverse Event|3
2729949|NCT00150813|9383672|P1|Overall Study|Switch to commercially available LEV|2
2729950|NCT00150813|9383672|P1|Overall Study|Planned pregancy|1
2729951|NCT00150813|9383672|P1|Overall Study|Remission|3
2729952|NCT00150813|9383672|P1|Overall Study|Withdrawal by Subject|5
2729953|NCT00150813|9383672|P1|Overall Study|Lost to Follow-up|5
2729954|NCT00150813|9383672|P1|Overall Study|Lack of Efficacy|1
2729955|NCT00150813|9383672|P1|Overall Study|Adverse Event|1
2729956|NCT00150800|9383676|P1|Overall Study|PI discontinuation request|1
2729957|NCT00150800|9383676|P1|Overall Study|Pregnancy planned|1
2729958|NCT00150800|9383676|P1|Overall Study|Surgical intervention|4
2729959|NCT00150800|9383676|P1|Overall Study|Patient insurance|1
2729960|NCT00150800|9383676|P1|Overall Study|PI leaving site|2
2729961|NCT00150800|9383676|P1|Overall Study|PI retiring|2
2729962|NCT00150800|9383676|P1|Overall Study|Moved from area/country|8
2729963|NCT00150800|9383676|P1|Overall Study|Generalized Epilepsy|1
2729964|NCT00150800|9383676|P1|Overall Study|Sponsor's request|2
2729965|NCT00150800|9383676|P1|Overall Study|Visit refusal|3
2729966|NCT00150800|9383676|P1|Overall Study|BRV monotherapy|1
2729967|NCT00150800|9383676|P1|Overall Study|Neurosurgery|2
2729968|NCT00150800|9383676|P1|Overall Study|Distance too long for patient|1
2729969|NCT00150800|9383676|P1|Overall Study|Nobody to accompany patient|1
2729970|NCT00150800|9383676|P1|Overall Study|Protocol non-adherence|2
2729971|NCT00150800|9383676|P1|Overall Study|Site closure|24
2729972|NCT00150800|9383676|P1|Overall Study|IP misshandling|1
2729973|NCT00150800|9383676|P1|Overall Study|No compliance|18
2729974|NCT00150800|9383676|P1|Overall Study|Subject's choice|90
2729975|NCT00150800|9383676|P1|Overall Study|Lost to Follow-up|58
2729976|NCT00150800|9383676|P1|Overall Study|Lack of Efficacy|166
2729977|NCT00150800|9383676|P1|Overall Study|Death|18
2729978|NCT00150800|9383676|P1|Overall Study|Adverse Event|89
2729979|NCT00150618|9383690|P5|Overall Study|Sponsor's decision|0
2729980|NCT00150618|9383691|P4|Overall Study|Sponsor's decision|1
2729981|NCT00150618|9383692|P3|Overall Study|Sponsor's decision|0
2729982|NCT00150618|9383693|P2|Overall Study|Sponsor's decision|0
2729983|NCT00150618|9383694|P1|Overall Study|Sponsor's decision|0
2729984|NCT00150618|9383690|P5|Overall Study|Abnormal ECG|0
2729985|NCT00150618|9383691|P4|Overall Study|Abnormal ECG|0
2729986|NCT00150618|9383692|P3|Overall Study|Abnormal ECG|0
2729987|NCT00150618|9383693|P2|Overall Study|Abnormal ECG|0
2729988|NCT00150618|9383694|P1|Overall Study|Abnormal ECG|1
2729989|NCT00150618|9383690|P5|Overall Study|Lack of compliance|1
2729990|NCT00150618|9383691|P4|Overall Study|Lack of compliance|0
2729991|NCT00150618|9383692|P3|Overall Study|Lack of compliance|1
2729992|NCT00150618|9383693|P2|Overall Study|Lack of compliance|1
2729993|NCT00150618|9383694|P1|Overall Study|Lack of compliance|2
2729994|NCT00150618|9383690|P5|Overall Study|Physician Decision|1
2729995|NCT00150618|9383691|P4|Overall Study|Physician Decision|0
2729996|NCT00150618|9383692|P3|Overall Study|Physician Decision|0
2729997|NCT00150618|9383693|P2|Overall Study|Physician Decision|2
2729998|NCT00150618|9383694|P1|Overall Study|Physician Decision|0
2729999|NCT00150618|9383690|P5|Overall Study|No study meds|2
2730000|NCT00150618|9383691|P4|Overall Study|No study meds|0
2730001|NCT00150618|9383692|P3|Overall Study|No study meds|0
2730002|NCT00150618|9383693|P2|Overall Study|No study meds|0
2730003|NCT00150618|9383694|P1|Overall Study|No study meds|0
2730004|NCT00150618|9383690|P5|Overall Study|Lack of Efficacy|6
2730005|NCT00150618|9383691|P4|Overall Study|Lack of Efficacy|4
2730006|NCT00150618|9383692|P3|Overall Study|Lack of Efficacy|7
2730007|NCT00150618|9383693|P2|Overall Study|Lack of Efficacy|4
2730008|NCT00150618|9383694|P1|Overall Study|Lack of Efficacy|1
2730009|NCT00150618|9383690|P5|Overall Study|Protocol Violation|1
2730010|NCT00150618|9383691|P4|Overall Study|Protocol Violation|0
2730011|NCT00150618|9383692|P3|Overall Study|Protocol Violation|0
2730012|NCT00150618|9383693|P2|Overall Study|Protocol Violation|0
2730013|NCT00150618|9383694|P1|Overall Study|Protocol Violation|1
2730014|NCT00150618|9383690|P5|Overall Study|Lost to Follow-up|4
2730015|NCT00150618|9383691|P4|Overall Study|Lost to Follow-up|8
2730016|NCT00150618|9383692|P3|Overall Study|Lost to Follow-up|5
2730017|NCT00150618|9383693|P2|Overall Study|Lost to Follow-up|1
2730018|NCT00150618|9383694|P1|Overall Study|Lost to Follow-up|4
2730019|NCT00150618|9383690|P5|Overall Study|Withdrawal by Subject|5
2730020|NCT00150618|9383691|P4|Overall Study|Withdrawal by Subject|4
2730021|NCT00150618|9383692|P3|Overall Study|Withdrawal by Subject|8
2730022|NCT00150618|9383693|P2|Overall Study|Withdrawal by Subject|8
2730023|NCT00150618|9383694|P1|Overall Study|Withdrawal by Subject|6
2730024|NCT00150618|9383690|P5|Overall Study|Adverse Event|5
2730025|NCT00150618|9383691|P4|Overall Study|Adverse Event|9
2730026|NCT00150618|9383692|P3|Overall Study|Adverse Event|6
2730027|NCT00150618|9383693|P2|Overall Study|Adverse Event|2
2730028|NCT00150618|9383694|P1|Overall Study|Adverse Event|2
2730029|NCT00150592|9383728|P2|Overall Study|Non-compliance|0
2730030|NCT00150592|9383729|P1|Overall Study|Non-compliance|1
2730031|NCT00150592|9383728|P2|Overall Study|Withdrawal by Subject|2
2730032|NCT00150592|9383729|P1|Overall Study|Withdrawal by Subject|1
2730033|NCT00150592|9383728|P2|Overall Study|Protocol Violation|0
2730034|NCT00150592|9383729|P1|Overall Study|Protocol Violation|1
2730035|NCT00150592|9383728|P2|Overall Study|Adverse Event|1
2730036|NCT00150592|9383729|P1|Overall Study|Adverse Event|4
2730037|NCT00150462|9383760|P11|Overall Study|Other|1
2730038|NCT00150462|9383761|P10|Overall Study|Other|1
2730039|NCT00150462|9383762|P9|Overall Study|Other|0
2730040|NCT00150462|9383763|P8|Overall Study|Other|0
2730041|NCT00150462|9383764|P7|Overall Study|Other|0
2730042|NCT00150462|9383765|P6|Overall Study|Other|0
2730043|NCT00150462|9383766|P5|Overall Study|Other|0
2730044|NCT00150462|9383767|P4|Overall Study|Other|0
2730045|NCT00150462|9383768|P3|Overall Study|Other|0
2730046|NCT00150462|9383769|P2|Overall Study|Other|0
2730047|NCT00150462|9383770|P1|Overall Study|Other|0
2730048|NCT00150462|9383760|P11|Overall Study|Physician Decision|0
2730049|NCT00150462|9383761|P10|Overall Study|Physician Decision|0
2730050|NCT00150462|9383762|P9|Overall Study|Physician Decision|0
2730051|NCT00150462|9383763|P8|Overall Study|Physician Decision|0
2730052|NCT00150462|9383764|P7|Overall Study|Physician Decision|0
2730053|NCT00150462|9383765|P6|Overall Study|Physician Decision|0
2730054|NCT00150462|9383766|P5|Overall Study|Physician Decision|0
2730055|NCT00150462|9383767|P4|Overall Study|Physician Decision|1
2730056|NCT00150462|9383768|P3|Overall Study|Physician Decision|1
2730057|NCT00150462|9383769|P2|Overall Study|Physician Decision|0
2730058|NCT00150462|9383770|P1|Overall Study|Physician Decision|0
2730059|NCT00150462|9383760|P11|Overall Study|Adverse Event|0
2730060|NCT00150462|9383761|P10|Overall Study|Adverse Event|1
2730061|NCT00150462|9383762|P9|Overall Study|Adverse Event|0
2730062|NCT00150462|9383763|P8|Overall Study|Adverse Event|2
2730063|NCT00150462|9383764|P7|Overall Study|Adverse Event|0
2730064|NCT00150462|9383765|P6|Overall Study|Adverse Event|0
2730065|NCT00150462|9383766|P5|Overall Study|Adverse Event|0
2730066|NCT00150462|9383767|P4|Overall Study|Adverse Event|1
2730067|NCT00150462|9383768|P3|Overall Study|Adverse Event|0
2730068|NCT00150462|9383769|P2|Overall Study|Adverse Event|0
2730069|NCT00150462|9383770|P1|Overall Study|Adverse Event|0
2730070|NCT00150462|9383760|P11|Overall Study|Death|0
2730071|NCT00150462|9383761|P10|Overall Study|Death|0
2730072|NCT00150462|9383762|P9|Overall Study|Death|1
2730073|NCT00150462|9383763|P8|Overall Study|Death|0
2730074|NCT00150462|9383764|P7|Overall Study|Death|0
2730075|NCT00150462|9383765|P6|Overall Study|Death|0
2730076|NCT00150462|9383766|P5|Overall Study|Death|0
2730077|NCT00150462|9383767|P4|Overall Study|Death|0
2730078|NCT00150462|9383768|P3|Overall Study|Death|0
2730079|NCT00150462|9383769|P2|Overall Study|Death|1
2730080|NCT00150462|9383770|P1|Overall Study|Death|0
2730081|NCT00150462|9383760|P11|Overall Study|Withdrawal by Subject|0
2730082|NCT00150462|9383761|P10|Overall Study|Withdrawal by Subject|1
2730083|NCT00150462|9383762|P9|Overall Study|Withdrawal by Subject|0
2730084|NCT00150462|9383763|P8|Overall Study|Withdrawal by Subject|1
2730085|NCT00150462|9383764|P7|Overall Study|Withdrawal by Subject|0
2730086|NCT00150462|9383765|P6|Overall Study|Withdrawal by Subject|2
2730087|NCT00150462|9383766|P5|Overall Study|Withdrawal by Subject|1
2730088|NCT00150462|9383767|P4|Overall Study|Withdrawal by Subject|0
2730089|NCT00150462|9383768|P3|Overall Study|Withdrawal by Subject|1
2730090|NCT00150462|9383769|P2|Overall Study|Withdrawal by Subject|1
2730091|NCT00150462|9383770|P1|Overall Study|Withdrawal by Subject|0
2730092|NCT00150462|9383760|P11|Overall Study|Disease Progression or Relapse|2
2730093|NCT00150462|9383761|P10|Overall Study|Disease Progression or Relapse|3
2730094|NCT00150462|9383762|P9|Overall Study|Disease Progression or Relapse|5
2730095|NCT00150462|9383763|P8|Overall Study|Disease Progression or Relapse|5
2730096|NCT00150462|9383764|P7|Overall Study|Disease Progression or Relapse|3
2730097|NCT00150462|9383765|P6|Overall Study|Disease Progression or Relapse|2
2730098|NCT00150462|9383766|P5|Overall Study|Disease Progression or Relapse|2
2730099|NCT00150462|9383767|P4|Overall Study|Disease Progression or Relapse|1
2730100|NCT00150462|9383768|P3|Overall Study|Disease Progression or Relapse|2
2730101|NCT00150462|9383769|P2|Overall Study|Disease Progression or Relapse|1
2730102|NCT00150462|9383770|P1|Overall Study|Disease Progression or Relapse|3
2730103|NCT00150345|9383880|P2|Overall Study|Other|14
2730104|NCT00150345|9383881|P1|Overall Study|Other|12
2730105|NCT00150345|9383880|P2|Overall Study|Laboratory abnormality|2
2730106|NCT00150345|9383881|P1|Overall Study|Laboratory abnormality|1
2730107|NCT00150345|9383880|P2|Overall Study|Withdrawal by Subject|4
2730108|NCT00150345|9383881|P1|Overall Study|Withdrawal by Subject|3
2730109|NCT00150345|9383880|P2|Overall Study|Lack of Efficacy|4
2730110|NCT00150345|9383881|P1|Overall Study|Lack of Efficacy|5
2730111|NCT00150345|9383880|P2|Overall Study|Adverse Event|6
2730112|NCT00150345|9383881|P1|Overall Study|Adverse Event|8
2730113|NCT00150345|9383880|P2|Overall Study|Death|2
2730114|NCT00150345|9383881|P1|Overall Study|Death|5
2730115|NCT00150176|9383945|P2|Overall Study|OTHER|13
2730116|NCT00150176|9383946|P1|Overall Study|OTHER|11
2730117|NCT00150176|9383945|P2|Overall Study|Lost to Follow-up|3
2730118|NCT00150176|9383946|P1|Overall Study|Lost to Follow-up|3
2730119|NCT00150176|9383945|P2|Overall Study|Withdrawal by Subject|12
2730120|NCT00150176|9383946|P1|Overall Study|Withdrawal by Subject|19
2730121|NCT00150176|9383945|P2|Overall Study|Relapse/Impending relapse, non-AE|39
2730122|NCT00150176|9383946|P1|Overall Study|Relapse/Impending relapse, non-AE|10
2730123|NCT00150176|9383945|P2|Overall Study|Adverse Event|53
2730124|NCT00150176|9383946|P1|Overall Study|Adverse Event|16
2730125|NCT00149994|9383957|P2|Overall Study|Protocol Violation|1
2730126|NCT00149994|9383958|P1|Overall Study|Protocol Violation|0
2730127|NCT00149994|9383957|P2|Overall Study|Administrative problems:|0
2730128|NCT00149994|9383958|P1|Overall Study|Administrative problems:|1
2730129|NCT00149890|9383966|P2|Overall Study|Graft Loss|1
2730130|NCT00149890|9383967|P1|Overall Study|Graft Loss|2
2730131|NCT00149890|9383966|P2|Overall Study|Lost to Follow-up|0
2730132|NCT00149890|9383967|P1|Overall Study|Lost to Follow-up|1
2730133|NCT00149890|9383966|P2|Overall Study|Protocol Violation|0
2730134|NCT00149890|9383967|P1|Overall Study|Protocol Violation|1
2730135|NCT00149890|9383966|P2|Overall Study|Lack of Efficacy|9
2730136|NCT00149890|9383967|P1|Overall Study|Lack of Efficacy|8
2730137|NCT00149890|9383966|P2|Overall Study|Adverse Event|8
2730138|NCT00149890|9383967|P1|Overall Study|Adverse Event|1
2730139|NCT00149825|9384002|P2|Overall Study|Other|0
2730140|NCT00149825|9384003|P1|Overall Study|Other|1
2730141|NCT00149825|9384002|P2|Overall Study|Not liking insomnia therapy|0
2730142|NCT00149825|9384003|P1|Overall Study|Not liking insomnia therapy|1
2730143|NCT00149825|9384002|P2|Overall Study|Time commitments|1
2730144|NCT00149825|9384003|P1|Overall Study|Time commitments|2
2730145|NCT00149825|9384002|P2|Overall Study|Intolerance to medication side effects|2
2730146|NCT00149825|9384003|P1|Overall Study|Intolerance to medication side effects|1
2730147|NCT00149747|9384031|P2|Overall Study|Withdrawal by Subject|3
2730148|NCT00149747|9384032|P1|Overall Study|Withdrawal by Subject|3
2730149|NCT00149747|9384031|P2|Overall Study|Death|0
2730150|NCT00149747|9384032|P1|Overall Study|Death|1
2730151|NCT00149630|9384078|P2|Overall Study|Adverse Event|0
2730152|NCT00149630|9384079|P1|Overall Study|Adverse Event|2
2730153|NCT00149630|9384078|P2|Overall Study|Treatment Programs|5
2730154|NCT00149630|9384079|P1|Overall Study|Treatment Programs|4
2730155|NCT00149630|9384078|P2|Overall Study|Incarceration|0
2730156|NCT00149630|9384079|P1|Overall Study|Incarceration|2
2730157|NCT00149396|9384089|P1|Overall Study|other treatment|5
2730158|NCT00149396|9384089|P1|Overall Study|Subject noncompliance|2
2730159|NCT00149396|9384089|P1|Overall Study|Withdrawal by Subject|1
2730160|NCT00149396|9384089|P1|Overall Study|Death|15
2730161|NCT00149214|9384159|P2|Overall Study|Progressive Disease|3
2730162|NCT00149214|9384160|P1|Overall Study|Progressive Disease|7
2730163|NCT00149214|9384159|P2|Overall Study|Sponsor Decision|1
2730164|NCT00149214|9384160|P1|Overall Study|Sponsor Decision|0
2730165|NCT00149214|9384159|P2|Overall Study|Physician Decision|3
2730166|NCT00149214|9384160|P1|Overall Study|Physician Decision|3
2730167|NCT00149214|9384159|P2|Overall Study|Withdrawal by Subject|1
2730168|NCT00149214|9384160|P1|Overall Study|Withdrawal by Subject|4
2730169|NCT00149214|9384159|P2|Overall Study|Adverse Event|9
2730170|NCT00149214|9384160|P1|Overall Study|Adverse Event|12
2730171|NCT00148941|9384187|P4|Overall Study|Other|2
2730172|NCT00148941|9384188|P3|Overall Study|Other|1
2730173|NCT00148941|9384189|P2|Overall Study|Other|0
2730174|NCT00148941|9384190|P1|Overall Study|Other|0
2730175|NCT00148941|9384187|P4|Overall Study|Withdrawal by Subject|0
2730176|NCT00148941|9384188|P3|Overall Study|Withdrawal by Subject|1
2730177|NCT00148941|9384189|P2|Overall Study|Withdrawal by Subject|0
2730178|NCT00148941|9384190|P1|Overall Study|Withdrawal by Subject|1
2730179|NCT00148941|9384187|P4|Overall Study|Lost to Follow-up|22
2730180|NCT00148941|9384188|P3|Overall Study|Lost to Follow-up|18
2730181|NCT00148941|9384189|P2|Overall Study|Lost to Follow-up|24
2730182|NCT00148941|9384190|P1|Overall Study|Lost to Follow-up|17
2730183|NCT00148759|9384305|P2|Overall Study|Lost to Follow-up|0
2730184|NCT00148759|9384306|P1|Overall Study|Lost to Follow-up|1
2730185|NCT00148759|9384305|P2|Overall Study|Withdrawal by Subject|1
2730186|NCT00148759|9384306|P1|Overall Study|Withdrawal by Subject|1
2730187|NCT00148343|9384334|P2|Overall Study|Physician Decision|4
2730188|NCT00148343|9384335|P1|Overall Study|Physician Decision|3
2730189|NCT00148343|9384334|P2|Overall Study|Withdrawal by Subject|7
2730190|NCT00148343|9384335|P1|Overall Study|Withdrawal by Subject|12
2730191|NCT00148317|9384349|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1
2730192|NCT00148317|9384349|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2
2730193|NCT00148317|9384349|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8
2730194|NCT00148122|9384356|P1|Overall Study|Withdrawal by Subject|2
2730195|NCT00148109|9384364|P2|Overall Study|Withdrawal by Subject|0
2730196|NCT00148109|9384365|P1|Overall Study|Withdrawal by Subject|2
2730197|NCT00148109|9384364|P2|Overall Study|Adverse Event|2
2730198|NCT00148109|9384365|P1|Overall Study|Adverse Event|0
2730199|NCT00148109|9384364|P2|Overall Study|Lack of Efficacy|18
2730200|NCT00148109|9384365|P1|Overall Study|Lack of Efficacy|10
2730201|NCT00147823|9384381|P2|Overall Study|Did not receive vitoss due to infection|2
2730202|NCT00147823|9384382|P1|Overall Study|Did not receive vitoss due to infection|6
2730203|NCT00147823|9384381|P2|Overall Study|Withdrawal by Subject|1
2730204|NCT00147823|9384382|P1|Overall Study|Withdrawal by Subject|0
2730205|NCT00147823|9384381|P2|Overall Study|Physician Decision|0
2730206|NCT00147823|9384382|P1|Overall Study|Physician Decision|1
2730207|NCT00147823|9384381|P2|Overall Study|Lost to Follow-up|12
2730208|NCT00147823|9384382|P1|Overall Study|Lost to Follow-up|6
2730209|NCT00147745|9384413|P3|Overall Study|Withdrawal by Subject|0
2730210|NCT00147745|9384414|P2|Overall Study|Withdrawal by Subject|0
2730211|NCT00147745|9384415|P1|Overall Study|Withdrawal by Subject|1
2730212|NCT00147537|9384437|P11|Phase 2|Randomized but not treated|1
2730213|NCT00147537|9384438|P10|Phase 2|Randomized but not treated|1
2730214|NCT00147537|9384439|P9|Phase 2|Randomized but not treated|0
2730215|NCT00147537|9384440|P8|Phase 2|Randomized but not treated|0
2730216|NCT00147537|9384441|P7|Phase 2|Randomized but not treated|0
2730217|NCT00147537|9384442|P6|Phase 2|Randomized but not treated|0
2730218|NCT00147537|9384443|P5|Phase 2|Randomized but not treated|0
2730219|NCT00147537|9384444|P4|Phase 2|Randomized but not treated|0
2730220|NCT00147537|9384445|P3|Phase 2|Randomized but not treated|0
2730221|NCT00147537|9384446|P2|Phase 2|Randomized but not treated|0
2730222|NCT00147537|9384447|P1|Phase 2|Randomized but not treated|0
2730223|NCT00147537|9384437|P11|Phase 2|Withdrawal by Subject|4
2730224|NCT00147537|9384438|P10|Phase 2|Withdrawal by Subject|16
2730225|NCT00147537|9384439|P9|Phase 2|Withdrawal by Subject|0
2730226|NCT00147537|9384440|P8|Phase 2|Withdrawal by Subject|0
2730227|NCT00147537|9384441|P7|Phase 2|Withdrawal by Subject|0
2730228|NCT00147537|9384442|P6|Phase 2|Withdrawal by Subject|0
2730229|NCT00147537|9384443|P5|Phase 2|Withdrawal by Subject|0
2730230|NCT00147537|9384444|P4|Phase 2|Withdrawal by Subject|0
2730231|NCT00147537|9384445|P3|Phase 2|Withdrawal by Subject|0
2730232|NCT00147537|9384446|P2|Phase 2|Withdrawal by Subject|0
2730233|NCT00147537|9384447|P1|Phase 2|Withdrawal by Subject|0
2730234|NCT00147537|9384437|P11|Phase 2|Other|12
2730235|NCT00147537|9384438|P10|Phase 2|Other|47
2730236|NCT00147537|9384439|P9|Phase 2|Other|0
2730237|NCT00147537|9384440|P8|Phase 2|Other|0
2730238|NCT00147537|9384441|P7|Phase 2|Other|0
2730239|NCT00147537|9384442|P6|Phase 2|Other|0
2730240|NCT00147537|9384443|P5|Phase 2|Other|0
2730241|NCT00147537|9384444|P4|Phase 2|Other|0
2730242|NCT00147537|9384445|P3|Phase 2|Other|0
2730243|NCT00147537|9384446|P2|Phase 2|Other|0
2730244|NCT00147537|9384447|P1|Phase 2|Other|0
2730245|NCT00147537|9384437|P11|Phase 2|Lost to Follow-up|4
2730246|NCT00147537|9384438|P10|Phase 2|Lost to Follow-up|12
2730247|NCT00147537|9384439|P9|Phase 2|Lost to Follow-up|0
2730248|NCT00147537|9384440|P8|Phase 2|Lost to Follow-up|0
2730249|NCT00147537|9384441|P7|Phase 2|Lost to Follow-up|0
2730250|NCT00147537|9384442|P6|Phase 2|Lost to Follow-up|0
2730251|NCT00147537|9384443|P5|Phase 2|Lost to Follow-up|0
2730252|NCT00147537|9384444|P4|Phase 2|Lost to Follow-up|0
2730253|NCT00147537|9384445|P3|Phase 2|Lost to Follow-up|0
2730254|NCT00147537|9384446|P2|Phase 2|Lost to Follow-up|0
2730255|NCT00147537|9384447|P1|Phase 2|Lost to Follow-up|0
2730256|NCT00147537|9384437|P11|Phase 2|Death|31
2730257|NCT00147537|9384438|P10|Phase 2|Death|85
2730258|NCT00147537|9384439|P9|Phase 2|Death|0
2730259|NCT00147537|9384440|P8|Phase 2|Death|0
2730260|NCT00147537|9384441|P7|Phase 2|Death|0
2730261|NCT00147537|9384442|P6|Phase 2|Death|0
2730262|NCT00147537|9384443|P5|Phase 2|Death|0
2730263|NCT00147537|9384444|P4|Phase 2|Death|0
2730264|NCT00147537|9384445|P3|Phase 2|Death|0
2730265|NCT00147537|9384446|P2|Phase 2|Death|0
2730266|NCT00147537|9384447|P1|Phase 2|Death|0
2730267|NCT00147537|9384437|P11|Phase 1b|Randomized but not treated|0
2730268|NCT00147537|9384438|P10|Phase 1b|Randomized but not treated|0
2730269|NCT00147537|9384439|P9|Phase 1b|Randomized but not treated|1
2730270|NCT00147537|9384440|P8|Phase 1b|Randomized but not treated|0
2730271|NCT00147537|9384441|P7|Phase 1b|Randomized but not treated|1
2730272|NCT00147537|9384442|P6|Phase 1b|Randomized but not treated|0
2730273|NCT00147537|9384443|P5|Phase 1b|Randomized but not treated|0
2730274|NCT00147537|9384444|P4|Phase 1b|Randomized but not treated|0
2730275|NCT00147537|9384445|P3|Phase 1b|Randomized but not treated|0
2730276|NCT00147537|9384446|P2|Phase 1b|Randomized but not treated|0
2730277|NCT00147537|9384447|P1|Phase 1b|Randomized but not treated|0
2730278|NCT00147537|9384437|P11|Phase 1b|Withdrawal by Subject|0
2730279|NCT00147537|9384438|P10|Phase 1b|Withdrawal by Subject|0
2730280|NCT00147537|9384439|P9|Phase 1b|Withdrawal by Subject|2
2730281|NCT00147537|9384440|P8|Phase 1b|Withdrawal by Subject|0
2730282|NCT00147537|9384441|P7|Phase 1b|Withdrawal by Subject|0
2730283|NCT00147537|9384442|P6|Phase 1b|Withdrawal by Subject|0
2730284|NCT00147537|9384443|P5|Phase 1b|Withdrawal by Subject|0
2730285|NCT00147537|9384444|P4|Phase 1b|Withdrawal by Subject|0
2730286|NCT00147537|9384445|P3|Phase 1b|Withdrawal by Subject|0
2730287|NCT00147537|9384446|P2|Phase 1b|Withdrawal by Subject|0
2730288|NCT00147537|9384447|P1|Phase 1b|Withdrawal by Subject|0
2730289|NCT00147537|9384437|P11|Phase 1b|Other|0
2730290|NCT00147537|9384438|P10|Phase 1b|Other|0
2730291|NCT00147537|9384439|P9|Phase 1b|Other|4
2730292|NCT00147537|9384440|P8|Phase 1b|Other|4
2730293|NCT00147537|9384441|P7|Phase 1b|Other|14
2730294|NCT00147537|9384442|P6|Phase 1b|Other|1
2730295|NCT00147537|9384443|P5|Phase 1b|Other|1
2730296|NCT00147537|9384444|P4|Phase 1b|Other|1
2730297|NCT00147537|9384445|P3|Phase 1b|Other|2
2730298|NCT00147537|9384446|P2|Phase 1b|Other|0
2730299|NCT00147537|9384447|P1|Phase 1b|Other|0
2730300|NCT00147537|9384437|P11|Phase 1b|Lost to Follow-up|0
2730301|NCT00147537|9384438|P10|Phase 1b|Lost to Follow-up|0
2730302|NCT00147537|9384439|P9|Phase 1b|Lost to Follow-up|1
2730303|NCT00147537|9384440|P8|Phase 1b|Lost to Follow-up|0
2730304|NCT00147537|9384441|P7|Phase 1b|Lost to Follow-up|2
2730305|NCT00147537|9384442|P6|Phase 1b|Lost to Follow-up|0
2730306|NCT00147537|9384443|P5|Phase 1b|Lost to Follow-up|0
2730307|NCT00147537|9384444|P4|Phase 1b|Lost to Follow-up|0
2730308|NCT00147537|9384445|P3|Phase 1b|Lost to Follow-up|0
2730309|NCT00147537|9384446|P2|Phase 1b|Lost to Follow-up|1
2730310|NCT00147537|9384447|P1|Phase 1b|Lost to Follow-up|2
2730311|NCT00147537|9384437|P11|Phase 1b|Death|0
2730312|NCT00147537|9384438|P10|Phase 1b|Death|0
2730313|NCT00147537|9384439|P9|Phase 1b|Death|9
2730314|NCT00147537|9384440|P8|Phase 1b|Death|3
2730315|NCT00147537|9384441|P7|Phase 1b|Death|1
2730316|NCT00147537|9384442|P6|Phase 1b|Death|2
2730317|NCT00147537|9384443|P5|Phase 1b|Death|2
2730318|NCT00147537|9384444|P4|Phase 1b|Death|1
2730319|NCT00147537|9384445|P3|Phase 1b|Death|2
2730320|NCT00147537|9384446|P2|Phase 1b|Death|1
2730321|NCT00147537|9384447|P1|Phase 1b|Death|0
2730322|NCT00147498|9384630|P4|Overall Study|Other|3
2730323|NCT00147498|9384631|P3|Overall Study|Other|3
2730324|NCT00147498|9384632|P2|Overall Study|Other|1
2730325|NCT00147498|9384633|P1|Overall Study|Other|1
2730326|NCT00147498|9384630|P4|Overall Study|Participant defaulted|3
2730327|NCT00147498|9384631|P3|Overall Study|Participant defaulted|4
2730328|NCT00147498|9384632|P2|Overall Study|Participant defaulted|1
2730329|NCT00147498|9384633|P1|Overall Study|Participant defaulted|0
2730330|NCT00147498|9384630|P4|Overall Study|Laboratory abnormality|0
2730331|NCT00147498|9384631|P3|Overall Study|Laboratory abnormality|2
2730332|NCT00147498|9384632|P2|Overall Study|Laboratory abnormality|0
2730333|NCT00147498|9384633|P1|Overall Study|Laboratory abnormality|0
2730334|NCT00147498|9384630|P4|Overall Study|Lack of Efficacy|8
2730335|NCT00147498|9384631|P3|Overall Study|Lack of Efficacy|1
2730336|NCT00147498|9384632|P2|Overall Study|Lack of Efficacy|1
2730337|NCT00147498|9384633|P1|Overall Study|Lack of Efficacy|1
2730338|NCT00147498|9384630|P4|Overall Study|Adverse Event|3
2730339|NCT00147498|9384631|P3|Overall Study|Adverse Event|7
2730340|NCT00147498|9384632|P2|Overall Study|Adverse Event|6
2730341|NCT00147498|9384633|P1|Overall Study|Adverse Event|1
2730342|NCT00147238|9384757|P1|Overall Study|Inevaluable|8
2730343|NCT00147225|9384767|P6|Overall Study|Chemotherapy Changed|1
2730344|NCT00147225|9384768|P5|Overall Study|Chemotherapy Changed|0
2730345|NCT00147225|9384769|P4|Overall Study|Chemotherapy Changed|0
2730346|NCT00147225|9384770|P3|Overall Study|Chemotherapy Changed|0
2730347|NCT00147225|9384771|P2|Overall Study|Chemotherapy Changed|0
2730348|NCT00147225|9384772|P1|Overall Study|Chemotherapy Changed|0
2730349|NCT00147225|9384767|P6|Overall Study|Screen Failure|0
2730350|NCT00147225|9384768|P5|Overall Study|Screen Failure|1
2730351|NCT00147225|9384769|P4|Overall Study|Screen Failure|0
2730352|NCT00147225|9384770|P3|Overall Study|Screen Failure|0
2730353|NCT00147225|9384771|P2|Overall Study|Screen Failure|0
2730354|NCT00147225|9384772|P1|Overall Study|Screen Failure|0
2730355|NCT00147225|9384767|P6|Overall Study|Adverse Event|0
2730356|NCT00147225|9384768|P5|Overall Study|Adverse Event|0
2730357|NCT00147225|9384769|P4|Overall Study|Adverse Event|1
2730358|NCT00147225|9384770|P3|Overall Study|Adverse Event|1
2730359|NCT00147225|9384771|P2|Overall Study|Adverse Event|0
2730360|NCT00147225|9384772|P1|Overall Study|Adverse Event|0
2730361|NCT00147225|9384767|P6|Overall Study|Withdrawal by Subject|1
2730362|NCT00147225|9384768|P5|Overall Study|Withdrawal by Subject|0
2730363|NCT00147225|9384769|P4|Overall Study|Withdrawal by Subject|0
2730364|NCT00147225|9384770|P3|Overall Study|Withdrawal by Subject|1
2730365|NCT00147225|9384771|P2|Overall Study|Withdrawal by Subject|0
2730366|NCT00147225|9384772|P1|Overall Study|Withdrawal by Subject|1
2730367|NCT00146848|9384947|P3|Post-randomization|Withdrawn|27
2730368|NCT00146848|9384948|P2|Post-randomization|Withdrawn|32
2730369|NCT00146848|9384949|P1|Post-randomization|Withdrawn|26
2730370|NCT00146848|9384947|P3|Post-randomization|Lost to Follow-up|12
2730371|NCT00146848|9384948|P2|Post-randomization|Lost to Follow-up|15
2730372|NCT00146848|9384949|P1|Post-randomization|Lost to Follow-up|12
2730373|NCT00146848|9384947|P3|Pre-randomization|Withdrawal by Subject|0
2730374|NCT00146848|9384948|P2|Pre-randomization|Withdrawal by Subject|0
2730375|NCT00146848|9384949|P1|Pre-randomization|Withdrawal by Subject|40
2730376|NCT00146848|9384947|P3|Pre-randomization|Protocol Violation|0
2730377|NCT00146848|9384948|P2|Pre-randomization|Protocol Violation|0
2730378|NCT00146848|9384949|P1|Pre-randomization|Protocol Violation|172
2730379|NCT00146848|9384947|P3|Pre-randomization|Physician Decision|0
2730380|NCT00146848|9384948|P2|Pre-randomization|Physician Decision|0
2730381|NCT00146848|9384949|P1|Pre-randomization|Physician Decision|8
2730382|NCT00146848|9384947|P3|Pre-randomization|Lost to Follow-up|0
2730383|NCT00146848|9384948|P2|Pre-randomization|Lost to Follow-up|0
2730384|NCT00146848|9384949|P1|Pre-randomization|Lost to Follow-up|70
2730385|NCT00146848|9384947|P3|Pre-randomization|Death|0
2730386|NCT00146848|9384948|P2|Pre-randomization|Death|0
2730387|NCT00146848|9384949|P1|Pre-randomization|Death|19
2730388|NCT00146770|9384965|P2|Overall Study|Withdrawal by Subject|0
2730389|NCT00146770|9384966|P1|Overall Study|Withdrawal by Subject|2
2730390|NCT00146770|9384965|P2|Overall Study|Pregnancy|0
2730391|NCT00146770|9384966|P1|Overall Study|Pregnancy|1
2730392|NCT00146770|9384965|P2|Overall Study|Adverse Event|0
2730393|NCT00146770|9384966|P1|Overall Study|Adverse Event|2
2730394|NCT00146757|9384984|P2|Overall Study|Adverse Event|0
2730395|NCT00146757|9384985|P1|Overall Study|Adverse Event|1
2730396|NCT00146757|9384984|P2|Overall Study|Death|0
2730397|NCT00146757|9384985|P1|Overall Study|Death|1
2730398|NCT00146640|9385004|P2|Overall Study|Non-Medical Reasons|4
2730399|NCT00146640|9385005|P1|Overall Study|Non-Medical Reasons|8
2730400|NCT00146640|9385004|P2|Overall Study|Medical Reasons|0
2730401|NCT00146640|9385005|P1|Overall Study|Medical Reasons|3
2730402|NCT00146640|9385004|P2|Overall Study|Adverse Event|10
2730403|NCT00146640|9385005|P1|Overall Study|Adverse Event|12
2730404|NCT00146328|9385028|P3|Overall Study|Interaction with other medication|1
2730405|NCT00146328|9385029|P2|Overall Study|Interaction with other medication|0
2730406|NCT00146328|9385030|P1|Overall Study|Interaction with other medication|2
2730407|NCT00146328|9385028|P3|Overall Study|Moved|0
2730408|NCT00146328|9385029|P2|Overall Study|Moved|0
2730409|NCT00146328|9385030|P1|Overall Study|Moved|2
2730410|NCT00146328|9385028|P3|Overall Study|Death|1
2730411|NCT00146328|9385029|P2|Overall Study|Death|1
2730412|NCT00146328|9385030|P1|Overall Study|Death|0
2730413|NCT00146328|9385028|P3|Overall Study|Enroll into other trial|2
2730414|NCT00146328|9385029|P2|Overall Study|Enroll into other trial|4
2730415|NCT00146328|9385030|P1|Overall Study|Enroll into other trial|2
2730416|NCT00146328|9385028|P3|Overall Study|Patient decision to end|6
2730417|NCT00146328|9385029|P2|Overall Study|Patient decision to end|1
2730418|NCT00146328|9385030|P1|Overall Study|Patient decision to end|0
2730419|NCT00146328|9385028|P3|Overall Study|Trial ended/site closed|19
2730420|NCT00146328|9385029|P2|Overall Study|Trial ended/site closed|2
2730421|NCT00146328|9385030|P1|Overall Study|Trial ended/site closed|8
2730422|NCT00146328|9385028|P3|Overall Study|Virologic Failure/lack of efficacy|142
2730423|NCT00146328|9385029|P2|Overall Study|Virologic Failure/lack of efficacy|72
2730424|NCT00146328|9385030|P1|Overall Study|Virologic Failure/lack of efficacy|54
2730425|NCT00146328|9385028|P3|Overall Study|Withdrawal by Subject|22
2730426|NCT00146328|9385029|P2|Overall Study|Withdrawal by Subject|16
2730427|NCT00146328|9385030|P1|Overall Study|Withdrawal by Subject|16
2730428|NCT00146328|9385028|P3|Overall Study|Lost to Follow-up|7
2730429|NCT00146328|9385029|P2|Overall Study|Lost to Follow-up|4
2730430|NCT00146328|9385030|P1|Overall Study|Lost to Follow-up|7
2730431|NCT00146328|9385028|P3|Overall Study|Protocol Violation|12
2730432|NCT00146328|9385029|P2|Overall Study|Protocol Violation|6
2730433|NCT00146328|9385030|P1|Overall Study|Protocol Violation|11
2730434|NCT00146328|9385028|P3|Overall Study|Adverse Event|79
2730435|NCT00146328|9385029|P2|Overall Study|Adverse Event|48
2730436|NCT00146328|9385030|P1|Overall Study|Adverse Event|39
2730437|NCT00146172|9385121|P8|Overall Study|Symptomatic Deterioration|2
2730438|NCT00146172|9385122|P7|Overall Study|Symptomatic Deterioration|0
2730439|NCT00146172|9385123|P6|Overall Study|Symptomatic Deterioration|2
2730440|NCT00146172|9385124|P5|Overall Study|Symptomatic Deterioration|1
2730441|NCT00146172|9385125|P4|Overall Study|Symptomatic Deterioration|0
2730442|NCT00146172|9385126|P3|Overall Study|Symptomatic Deterioration|1
2730443|NCT00146172|9385127|P2|Overall Study|Symptomatic Deterioration|0
2730444|NCT00146172|9385128|P1|Overall Study|Symptomatic Deterioration|1
2730445|NCT00146172|9385121|P8|Overall Study|Withdrawal by Subject|4
2730446|NCT00146172|9385122|P7|Overall Study|Withdrawal by Subject|1
2730447|NCT00146172|9385123|P6|Overall Study|Withdrawal by Subject|1
2730448|NCT00146172|9385124|P5|Overall Study|Withdrawal by Subject|0
2730449|NCT00146172|9385125|P4|Overall Study|Withdrawal by Subject|0
2730450|NCT00146172|9385126|P3|Overall Study|Withdrawal by Subject|0
2730451|NCT00146172|9385127|P2|Overall Study|Withdrawal by Subject|0
2730452|NCT00146172|9385128|P1|Overall Study|Withdrawal by Subject|0
2730453|NCT00146172|9385121|P8|Overall Study|Physician Decision|1
2730454|NCT00146172|9385122|P7|Overall Study|Physician Decision|0
2730455|NCT00146172|9385123|P6|Overall Study|Physician Decision|0
2730456|NCT00146172|9385124|P5|Overall Study|Physician Decision|0
2730457|NCT00146172|9385125|P4|Overall Study|Physician Decision|0
2730458|NCT00146172|9385126|P3|Overall Study|Physician Decision|0
2730459|NCT00146172|9385127|P2|Overall Study|Physician Decision|0
2730460|NCT00146172|9385128|P1|Overall Study|Physician Decision|0
2730461|NCT00146172|9385121|P8|Overall Study|Death|0
2730462|NCT00146172|9385122|P7|Overall Study|Death|1
2730463|NCT00146172|9385123|P6|Overall Study|Death|0
2730464|NCT00146172|9385124|P5|Overall Study|Death|0
2730465|NCT00146172|9385125|P4|Overall Study|Death|0
2730466|NCT00146172|9385126|P3|Overall Study|Death|0
2730467|NCT00146172|9385127|P2|Overall Study|Death|0
2730468|NCT00146172|9385128|P1|Overall Study|Death|0
2730469|NCT00146172|9385121|P8|Overall Study|Disease Progression|22
2730470|NCT00146172|9385122|P7|Overall Study|Disease Progression|1
2730471|NCT00146172|9385123|P6|Overall Study|Disease Progression|2
2730472|NCT00146172|9385124|P5|Overall Study|Disease Progression|2
2730473|NCT00146172|9385125|P4|Overall Study|Disease Progression|5
2730474|NCT00146172|9385126|P3|Overall Study|Disease Progression|2
2730475|NCT00146172|9385127|P2|Overall Study|Disease Progression|4
2730476|NCT00146172|9385128|P1|Overall Study|Disease Progression|2
2730477|NCT00146172|9385121|P8|Overall Study|Lost to Follow-up|1
2730478|NCT00146172|9385122|P7|Overall Study|Lost to Follow-up|0
2730479|NCT00146172|9385123|P6|Overall Study|Lost to Follow-up|0
2730480|NCT00146172|9385124|P5|Overall Study|Lost to Follow-up|0
2730481|NCT00146172|9385125|P4|Overall Study|Lost to Follow-up|0
2730482|NCT00146172|9385126|P3|Overall Study|Lost to Follow-up|0
2730483|NCT00146172|9385127|P2|Overall Study|Lost to Follow-up|0
2730484|NCT00146172|9385128|P1|Overall Study|Lost to Follow-up|0
2730485|NCT00146172|9385121|P8|Overall Study|Adverse Event|10
2730486|NCT00146172|9385122|P7|Overall Study|Adverse Event|3
2730487|NCT00146172|9385123|P6|Overall Study|Adverse Event|2
2730488|NCT00146172|9385124|P5|Overall Study|Adverse Event|0
2730489|NCT00146172|9385125|P4|Overall Study|Adverse Event|1
2730490|NCT00146172|9385126|P3|Overall Study|Adverse Event|1
2730491|NCT00146172|9385127|P2|Overall Study|Adverse Event|0
2730492|NCT00146172|9385128|P1|Overall Study|Adverse Event|0
2730493|NCT00145977|9385163|P2|Overall Study|Withdrawal by Subject|0
2730494|NCT00145977|9385164|P1|Overall Study|Withdrawal by Subject|1
2730495|NCT00145977|9385163|P2|Overall Study|Lost to Follow-up|0
2730496|NCT00145977|9385164|P1|Overall Study|Lost to Follow-up|1
2730497|NCT00145977|9385163|P2|Overall Study|Lack of Efficacy|4
2730498|NCT00145977|9385164|P1|Overall Study|Lack of Efficacy|0
2730499|NCT00145795|9385190|P2|Overall Study|Adverse Event|0
2730500|NCT00145795|9385191|P1|Overall Study|Adverse Event|1
2730501|NCT00145626|9385226|P1|Overall Study|Withdrawal by Subject|1
2730502|NCT00145626|9385226|P1|Overall Study|Death|1
2730503|NCT00145626|9385226|P1|Overall Study|Turned 2 years old before treatment|1
2730504|NCT00145626|9385226|P1|Overall Study|Did not have NK infusions|2
2730505|NCT00145600|9385272|P4|Overall Study|Withdrawal by Subject|1
2730506|NCT00145600|9385273|P3|Overall Study|Withdrawal by Subject|0
2730507|NCT00145600|9385274|P2|Overall Study|Withdrawal by Subject|2
2730508|NCT00145600|9385275|P1|Overall Study|Withdrawal by Subject|1
2730509|NCT00145600|9385272|P4|Overall Study|Noncompliance|0
2730510|NCT00145600|9385273|P3|Overall Study|Noncompliance|0
2730511|NCT00145600|9385274|P2|Overall Study|Noncompliance|0
2730512|NCT00145600|9385275|P1|Overall Study|Noncompliance|1
2730513|NCT00145600|9385272|P4|Overall Study|Lost to Follow-up|4
2730514|NCT00145600|9385273|P3|Overall Study|Lost to Follow-up|2
2730515|NCT00145600|9385274|P2|Overall Study|Lost to Follow-up|6
2730516|NCT00145600|9385275|P1|Overall Study|Lost to Follow-up|2
2730517|NCT00145600|9385272|P4|Overall Study|Ineligible|5
2730518|NCT00145600|9385273|P3|Overall Study|Ineligible|1
2730519|NCT00145600|9385274|P2|Overall Study|Ineligible|0
2730520|NCT00145600|9385275|P1|Overall Study|Ineligible|3
2730521|NCT00145600|9385272|P4|Overall Study|Death|6
2730522|NCT00145600|9385273|P3|Overall Study|Death|2
2730523|NCT00145600|9385274|P2|Overall Study|Death|2
2730524|NCT00145600|9385275|P1|Overall Study|Death|1
2730525|NCT00145574|9385399|P3|Open Label Long-term Extension|required restricted medicine|1
2730526|NCT00145574|9385400|P2|Open Label Long-term Extension|required restricted medicine|0
2730527|NCT00145574|9385401|P1|Open Label Long-term Extension|required restricted medicine|0
2730528|NCT00145574|9385399|P3|Open Label Long-term Extension|Withdrawal by Subject|4
2730529|NCT00145574|9385400|P2|Open Label Long-term Extension|Withdrawal by Subject|0
2730530|NCT00145574|9385401|P1|Open Label Long-term Extension|Withdrawal by Subject|0
2730531|NCT00145574|9385399|P3|Open Label Long-term Extension|Lost to Follow-up|1
2730532|NCT00145574|9385400|P2|Open Label Long-term Extension|Lost to Follow-up|0
2730533|NCT00145574|9385401|P1|Open Label Long-term Extension|Lost to Follow-up|0
2730534|NCT00145574|9385399|P3|Open Label Long-term Extension|Adverse Event|5
2730535|NCT00145574|9385400|P2|Open Label Long-term Extension|Adverse Event|0
2730536|NCT00145574|9385401|P1|Open Label Long-term Extension|Adverse Event|0
2730537|NCT00145574|9385399|P3|Double Blind|required restricted medicine|0
2730538|NCT00145574|9385400|P2|Double Blind|required restricted medicine|1
2730539|NCT00145574|9385401|P1|Double Blind|required restricted medicine|0
2730540|NCT00145574|9385399|P3|Double Blind|Withdrawal by Subject|1
2730541|NCT00145574|9385400|P2|Double Blind|Withdrawal by Subject|1
2730542|NCT00145574|9385401|P1|Double Blind|Withdrawal by Subject|1
2730543|NCT00145574|9385399|P3|Double Blind|Adverse Event|1
2730544|NCT00145574|9385400|P2|Double Blind|Adverse Event|3
2730545|NCT00145574|9385401|P1|Double Blind|Adverse Event|0
2730546|NCT00145509|9385458|P2|Overall Study|Reason not provided|1
2730547|NCT00145509|9385459|P1|Overall Study|Reason not provided|2
2730548|NCT00145509|9385458|P2|Overall Study|Withdrew Consent|7
2730549|NCT00145509|9385459|P1|Overall Study|Withdrew Consent|2
2730550|NCT00145509|9385458|P2|Overall Study|Lost to Follow-up|9
2730551|NCT00145509|9385459|P1|Overall Study|Lost to Follow-up|5
2730552|NCT00145509|9385458|P2|Overall Study|Lack of Efficacy|1
2730553|NCT00145509|9385459|P1|Overall Study|Lack of Efficacy|3
2730554|NCT00145509|9385458|P2|Overall Study|Adverse Event|3
2730555|NCT00145509|9385459|P1|Overall Study|Adverse Event|10
2730556|NCT00145496|9385473|P2|Overall Study|Other|13
2730557|NCT00145496|9385474|P1|Overall Study|Other|25
2730558|NCT00145496|9385473|P2|Overall Study|Lost to Follow-up|5
2730559|NCT00145496|9385474|P1|Overall Study|Lost to Follow-up|12
2730560|NCT00145496|9385473|P2|Overall Study|Withdrawal by Subject|26
2730561|NCT00145496|9385474|P1|Overall Study|Withdrawal by Subject|32
2730562|NCT00145496|9385473|P2|Overall Study|Lack of Efficacy|7
2730563|NCT00145496|9385474|P1|Overall Study|Lack of Efficacy|12
2730564|NCT00145496|9385473|P2|Overall Study|Adverse Event|30
2730565|NCT00145496|9385474|P1|Overall Study|Adverse Event|42
2730566|NCT00145470|9385486|P2|Overall Study|Reason Not Reported|9
2730567|NCT00145470|9385487|P1|Overall Study|Reason Not Reported|9
2730568|NCT00145470|9385486|P2|Overall Study|Lost to Follow-up|17
2730569|NCT00145470|9385487|P1|Overall Study|Lost to Follow-up|21
2730570|NCT00145470|9385486|P2|Overall Study|Withdrawal by Subject|34
2730571|NCT00145470|9385487|P1|Overall Study|Withdrawal by Subject|36
2730572|NCT00145470|9385486|P2|Overall Study|Lack of Efficacy|13
2730573|NCT00145470|9385487|P1|Overall Study|Lack of Efficacy|27
2730574|NCT00145470|9385486|P2|Overall Study|Adverse Event|25
2730575|NCT00145470|9385487|P1|Overall Study|Adverse Event|19
2730576|NCT00145327|9385557|P3|Overall Study|Missing – not stated|1
2730577|NCT00145327|9385558|P2|Overall Study|Missing – not stated|0
2730578|NCT00145327|9385559|P1|Overall Study|Missing – not stated|1
2730579|NCT00145327|9385557|P3|Overall Study|Abnormal laboratory value(s)|2
2730580|NCT00145327|9385558|P2|Overall Study|Abnormal laboratory value(s)|0
2730581|NCT00145327|9385559|P1|Overall Study|Abnormal laboratory value(s)|1
2730582|NCT00145327|9385557|P3|Overall Study|Protocol Violation|2
2730583|NCT00145327|9385558|P2|Overall Study|Protocol Violation|0
2730584|NCT00145327|9385559|P1|Overall Study|Protocol Violation|2
2730585|NCT00145327|9385557|P3|Overall Study|Administrative problems|13
2730586|NCT00145327|9385558|P2|Overall Study|Administrative problems|9
2730587|NCT00145327|9385559|P1|Overall Study|Administrative problems|12
2730588|NCT00145327|9385557|P3|Overall Study|Lost to Follow-up|14
2730589|NCT00145327|9385558|P2|Overall Study|Lost to Follow-up|14
2730590|NCT00145327|9385559|P1|Overall Study|Lost to Follow-up|9
2730591|NCT00145327|9385557|P3|Overall Study|Adverse Event|22
2730592|NCT00145327|9385558|P2|Overall Study|Adverse Event|11
2730593|NCT00145327|9385559|P1|Overall Study|Adverse Event|14
2730594|NCT00145327|9385557|P3|Overall Study|Death|30
2730595|NCT00145327|9385558|P2|Overall Study|Death|18
2730596|NCT00145327|9385559|P1|Overall Study|Death|26
2730597|NCT00145327|9385557|P3|Overall Study|Withdrawal by Subject|164
2730598|NCT00145327|9385558|P2|Overall Study|Withdrawal by Subject|72
2730599|NCT00145327|9385559|P1|Overall Study|Withdrawal by Subject|77
2730600|NCT00145119|9385658|P1|Overall Study|Death|45
2730601|NCT00144781|9385676|P4|Overall Study|Non-compliant|0
2730602|NCT00144781|9385677|P3|Overall Study|Non-compliant|0
2730603|NCT00144781|9385678|P2|Overall Study|Non-compliant|1
2730604|NCT00144781|9385679|P1|Overall Study|Non-compliant|0
2730605|NCT00144781|9385676|P4|Overall Study|Adverse Event|0
2730606|NCT00144781|9385677|P3|Overall Study|Adverse Event|0
2730607|NCT00144781|9385678|P2|Overall Study|Adverse Event|1
2730608|NCT00144781|9385679|P1|Overall Study|Adverse Event|0
2730609|NCT00144339|9385708|P2|Overall Study|Other|60
2730610|NCT00144339|9385709|P1|Overall Study|Other|58
2730611|NCT00144339|9385708|P2|Overall Study|Lost to Follow-up|64
2730612|NCT00144339|9385709|P1|Overall Study|Lost to Follow-up|76
2730613|NCT00144339|9385708|P2|Overall Study|Withdrawal by Subject|300
2730614|NCT00144339|9385709|P1|Overall Study|Withdrawal by Subject|403
2730615|NCT00144339|9385708|P2|Overall Study|Protocol Violation|48
2730616|NCT00144339|9385709|P1|Overall Study|Protocol Violation|75
2730617|NCT00144339|9385708|P2|Overall Study|Adverse Event|627
2730618|NCT00144339|9385709|P1|Overall Study|Adverse Event|746
2730619|NCT00144300|9385917|P2|Overall Study|Other reason (not specified)|3
2730620|NCT00144300|9385918|P1|Overall Study|Other reason (not specified)|1
2730621|NCT00144300|9385917|P2|Overall Study|Withdrawal by Subject|6
2730622|NCT00144300|9385918|P1|Overall Study|Withdrawal by Subject|6
2730623|NCT00144300|9385917|P2|Overall Study|Lost to Follow-up|0
2730624|NCT00144300|9385918|P1|Overall Study|Lost to Follow-up|3
2730625|NCT00144300|9385917|P2|Overall Study|Protocol Violation|3
2730626|NCT00144300|9385918|P1|Overall Study|Protocol Violation|1
2730627|NCT00144300|9385917|P2|Overall Study|Adverse Event|16
2730628|NCT00144300|9385918|P1|Overall Study|Adverse Event|18
2730629|NCT00144170|9385966|P2|Overall Study|Other reason not defined above|316
2730630|NCT00144170|9385967|P1|Overall Study|Other reason not defined above|211
2730631|NCT00144170|9385966|P2|Overall Study|Withdrawal by Subject|13
2730632|NCT00144170|9385967|P1|Overall Study|Withdrawal by Subject|29
2730633|NCT00144170|9385966|P2|Overall Study|Lost to Follow-up|10
2730634|NCT00144170|9385967|P1|Overall Study|Lost to Follow-up|5
2730635|NCT00144170|9385966|P2|Overall Study|Protocol Violation|16
2730636|NCT00144170|9385967|P1|Overall Study|Protocol Violation|23
2730637|NCT00144170|9385966|P2|Overall Study|Adverse Event|41
2730638|NCT00144170|9385967|P1|Overall Study|Adverse Event|84
2730639|NCT00144027|9386157|P2|Overall Study|did not complete baseline assessment|6
2730640|NCT00144027|9386158|P1|Overall Study|did not complete baseline assessment|0
2730641|NCT00144027|9386157|P2|Overall Study|Withdrawal by Subject|2
2730642|NCT00144027|9386158|P1|Overall Study|Withdrawal by Subject|2
2730643|NCT00144027|9386157|P2|Overall Study|Lost to Follow-up|3
2730644|NCT00144027|9386158|P1|Overall Study|Lost to Follow-up|1
2730645|NCT00143598|9386188|P2|Overall Study|Death|36
2730646|NCT00143598|9386189|P1|Overall Study|Death|36
2730647|NCT00143598|9386188|P2|Overall Study|Withdrawal by Subject|37
2730648|NCT00143598|9386189|P1|Overall Study|Withdrawal by Subject|33
2730649|NCT00143598|9386188|P2|Overall Study|Lost to Follow-up|21
2730650|NCT00143598|9386189|P1|Overall Study|Lost to Follow-up|23
2730651|NCT00143507|9386203|P2|Overall Study|Withdrawn by sponsor's decision|3
2730652|NCT00143507|9386204|P1|Overall Study|Withdrawn by sponsor's decision|0
2730653|NCT00143507|9386203|P2|Overall Study|Lost to Follow-up|0
2730654|NCT00143507|9386204|P1|Overall Study|Lost to Follow-up|1
2730655|NCT00143507|9386203|P2|Overall Study|Withdrawal by Subject|102
2730656|NCT00143507|9386204|P1|Overall Study|Withdrawal by Subject|114
2730657|NCT00143507|9386203|P2|Overall Study|Death|547
2730658|NCT00143507|9386204|P1|Overall Study|Death|572
2730659|NCT00143455|9386238|P4|Cohort 2|Randomized But Not Treated|1
2730660|NCT00143455|9386239|P3|Cohort 2|Randomized But Not Treated|1
2730661|NCT00143455|9386240|P2|Cohort 2|Randomized But Not Treated|0
2730662|NCT00143455|9386241|P1|Cohort 2|Randomized But Not Treated|0
2730663|NCT00143455|9386238|P4|Cohort 2|Other|6
2730664|NCT00143455|9386239|P3|Cohort 2|Other|7
2730665|NCT00143455|9386240|P2|Cohort 2|Other|0
2730666|NCT00143455|9386241|P1|Cohort 2|Other|0
2730667|NCT00143455|9386238|P4|Cohort 2|Withdrawal by Subject|12
2730668|NCT00143455|9386239|P3|Cohort 2|Withdrawal by Subject|13
2730669|NCT00143455|9386240|P2|Cohort 2|Withdrawal by Subject|0
2730670|NCT00143455|9386241|P1|Cohort 2|Withdrawal by Subject|0
2730671|NCT00143455|9386238|P4|Cohort 2|Progressive Disease|27
2730672|NCT00143455|9386239|P3|Cohort 2|Progressive Disease|20
2730673|NCT00143455|9386240|P2|Cohort 2|Progressive Disease|0
2730674|NCT00143455|9386241|P1|Cohort 2|Progressive Disease|0
2730675|NCT00143455|9386238|P4|Cohort 2|Death|12
2730676|NCT00143455|9386239|P3|Cohort 2|Death|20
2730677|NCT00143455|9386240|P2|Cohort 2|Death|0
2730678|NCT00143455|9386241|P1|Cohort 2|Death|0
2730679|NCT00143455|9386238|P4|Cohort 2|Lost to Follow-up|4
2730680|NCT00143455|9386239|P3|Cohort 2|Lost to Follow-up|1
2730681|NCT00143455|9386240|P2|Cohort 2|Lost to Follow-up|0
2730682|NCT00143455|9386241|P1|Cohort 2|Lost to Follow-up|0
2730683|NCT00143455|9386238|P4|Cohort 2|Protocol Violation|1
2730684|NCT00143455|9386239|P3|Cohort 2|Protocol Violation|1
2730685|NCT00143455|9386240|P2|Cohort 2|Protocol Violation|0
2730686|NCT00143455|9386241|P1|Cohort 2|Protocol Violation|0
2730687|NCT00143455|9386238|P4|Cohort 2|No Longer Required Study Treatment|0
2730688|NCT00143455|9386239|P3|Cohort 2|No Longer Required Study Treatment|1
2730689|NCT00143455|9386240|P2|Cohort 2|No Longer Required Study Treatment|0
2730690|NCT00143455|9386241|P1|Cohort 2|No Longer Required Study Treatment|0
2730691|NCT00143455|9386238|P4|Cohort 2|Adverse Event|30
2730692|NCT00143455|9386239|P3|Cohort 2|Adverse Event|42
2730693|NCT00143455|9386240|P2|Cohort 2|Adverse Event|0
2730694|NCT00143455|9386241|P1|Cohort 2|Adverse Event|0
2730695|NCT00143455|9386238|P4|Cohort 1|Randomized But Not Treated|0
2730696|NCT00143455|9386239|P3|Cohort 1|Randomized But Not Treated|0
2730697|NCT00143455|9386240|P2|Cohort 1|Randomized But Not Treated|1
2730698|NCT00143455|9386241|P1|Cohort 1|Randomized But Not Treated|0
2730699|NCT00143455|9386238|P4|Cohort 1|Withdrawal by Subject|0
2730700|NCT00143455|9386239|P3|Cohort 1|Withdrawal by Subject|0
2730701|NCT00143455|9386240|P2|Cohort 1|Withdrawal by Subject|4
2730702|NCT00143455|9386241|P1|Cohort 1|Withdrawal by Subject|1
2730703|NCT00143455|9386238|P4|Cohort 1|Progressive Disease|0
2730704|NCT00143455|9386239|P3|Cohort 1|Progressive Disease|0
2730705|NCT00143455|9386240|P2|Cohort 1|Progressive Disease|6
2730706|NCT00143455|9386241|P1|Cohort 1|Progressive Disease|0
2730707|NCT00143455|9386238|P4|Cohort 1|Death|0
2730708|NCT00143455|9386239|P3|Cohort 1|Death|0
2730709|NCT00143455|9386240|P2|Cohort 1|Death|2
2730710|NCT00143455|9386241|P1|Cohort 1|Death|5
2730711|NCT00143455|9386238|P4|Cohort 1|Adverse Event|0
2730712|NCT00143455|9386239|P3|Cohort 1|Adverse Event|0
2730713|NCT00143455|9386240|P2|Cohort 1|Adverse Event|4
2730714|NCT00143455|9386241|P1|Cohort 1|Adverse Event|8
2730715|NCT00143403|9386275|P2|Overall Study|Randomized Not Treated|8
2730716|NCT00143403|9386276|P1|Overall Study|Randomized Not Treated|7
2730717|NCT00143403|9386275|P2|Overall Study|specified by site|9
2730718|NCT00143403|9386276|P1|Overall Study|specified by site|4
2730719|NCT00143403|9386275|P2|Overall Study|Protocol Violation|2
2730720|NCT00143403|9386276|P1|Overall Study|Protocol Violation|2
2730721|NCT00143403|9386275|P2|Overall Study|Relapse|7
2730722|NCT00143403|9386276|P1|Overall Study|Relapse|15
2730723|NCT00143403|9386275|P2|Overall Study|Withdrawal by Subject|12
2730724|NCT00143403|9386276|P1|Overall Study|Withdrawal by Subject|3
2730725|NCT00143403|9386275|P2|Overall Study|Death|0
2730726|NCT00143403|9386276|P1|Overall Study|Death|1
2730727|NCT00143403|9386275|P2|Overall Study|Adverse Event|8
2730728|NCT00143403|9386276|P1|Overall Study|Adverse Event|3
2730729|NCT00143390|9386286|P2|Overall Study|Other|2
2730730|NCT00143390|9386287|P1|Overall Study|Other|1
2730731|NCT00143390|9386286|P2|Overall Study|Adverse Event|8
2730732|NCT00143390|9386287|P1|Overall Study|Adverse Event|9
2730733|NCT00143390|9386286|P2|Overall Study|Study termination|15
2730734|NCT00143390|9386287|P1|Overall Study|Study termination|10
2730735|NCT00143390|9386286|P2|Overall Study|Protocol Violation|0
2730736|NCT00143390|9386287|P1|Overall Study|Protocol Violation|2
2730737|NCT00143390|9386286|P2|Overall Study|Progressive disease|115
2730738|NCT00143390|9386287|P1|Overall Study|Progressive disease|119
2730739|NCT00143390|9386286|P2|Overall Study|Withdrawal by Subject|4
2730740|NCT00143390|9386287|P1|Overall Study|Withdrawal by Subject|4
2730741|NCT00143390|9386286|P2|Overall Study|Not meeting entry criteria|5
2730742|NCT00143390|9386287|P1|Overall Study|Not meeting entry criteria|2
2730743|NCT00143390|9386286|P2|Overall Study|Death|0
2730744|NCT00143390|9386287|P1|Overall Study|Death|2
2730745|NCT00143312|9386303|P1|Overall Study|Withdrawal by Subject|1
2730746|NCT00143312|9386303|P1|Overall Study|Other|1
2730747|NCT00143312|9386303|P1|Overall Study|Lost to Follow-up|1
2730748|NCT00143312|9386303|P1|Overall Study|Adverse Event|2
2730749|NCT00143312|9386303|P1|Overall Study|Death|11
2730750|NCT00143247|9386313|P1|Overall Study|Other|12
2730751|NCT00143247|9386313|P1|Overall Study|following inaccurate lab adverse event|1
2730752|NCT00143247|9386313|P1|Overall Study|Lost to Follow-up|12
2730753|NCT00143247|9386313|P1|Overall Study|Protocol Violation|15
2730754|NCT00143247|9386313|P1|Overall Study|Study terminated by sponsor|31
2730755|NCT00143247|9386313|P1|Overall Study|Withdrawal by Subject|55
2730756|NCT00143247|9386313|P1|Overall Study|Lack of Efficacy|3
2730757|NCT00143247|9386313|P1|Overall Study|Adverse Event|19
2730758|NCT00143247|9386313|P1|Overall Study|Death|8
2730759|NCT00142935|9386330|P3|Overall Study|Death|1
2730760|NCT00142935|9386331|P2|Overall Study|Death|2
2730761|NCT00142935|9386332|P1|Overall Study|Death|0
2730762|NCT00142935|9386330|P3|Overall Study|Lost to Follow-up|5
2730763|NCT00142935|9386331|P2|Overall Study|Lost to Follow-up|5
2730764|NCT00142935|9386332|P1|Overall Study|Lost to Follow-up|2
2730765|NCT00142935|9386330|P3|Overall Study|Other reason|1
2730766|NCT00142935|9386331|P2|Overall Study|Other reason|1
2730767|NCT00142935|9386332|P1|Overall Study|Other reason|1
2730768|NCT00142909|9386357|P2|Medications Begin|Withdrawal by Subject|0
2730769|NCT00142909|9386358|P1|Medications Begin|Withdrawal by Subject|2
2730770|NCT00142909|9386357|P2|Medications Begin|Withdrawal by Subject|3
2730771|NCT00142909|9386358|P1|Medications Begin|Withdrawal by Subject|5
2730772|NCT00142909|9386357|P2|Medications Begin|Protocol Violation|0
2730773|NCT00142909|9386358|P1|Medications Begin|Protocol Violation|2
2730774|NCT00142909|9386357|P2|Randomization|Various Reasons|10
2730775|NCT00142909|9386358|P1|Randomization|Various Reasons|7
2730776|NCT00142792|9386394|P3|Overall Study|No category|1
2730777|NCT00142792|9386395|P2|Overall Study|No category|2
2730778|NCT00142792|9386396|P1|Overall Study|No category|1
2730779|NCT00142792|9386394|P3|Overall Study|Lost to Follow-up|7
2730780|NCT00142792|9386395|P2|Overall Study|Lost to Follow-up|11
2730781|NCT00142792|9386396|P1|Overall Study|Lost to Follow-up|8
2730782|NCT00142792|9386394|P3|Overall Study|Withdrawal by Subject|3
2730783|NCT00142792|9386395|P2|Overall Study|Withdrawal by Subject|2
2730784|NCT00142792|9386396|P1|Overall Study|Withdrawal by Subject|3
2730785|NCT00142792|9386394|P3|Overall Study|Death|1
2730786|NCT00142792|9386395|P2|Overall Study|Death|0
2730787|NCT00142792|9386396|P1|Overall Study|Death|0
2730788|NCT00142519|9386418|P2|Overall Study|Withdrawal by Subject|7
2730789|NCT00142519|9386419|P1|Overall Study|Withdrawal by Subject|10
2730790|NCT00142519|9386418|P2|Overall Study|Protocol Violation|0
2730791|NCT00142519|9386419|P1|Overall Study|Protocol Violation|1
2730792|NCT00142519|9386418|P2|Overall Study|Not Treated|9
2730793|NCT00142519|9386419|P1|Overall Study|Not Treated|7
2730794|NCT00142415|9386442|P6|Overall Study|Physician Decision|2
2730795|NCT00142415|9386443|P5|Overall Study|Physician Decision|1
2730796|NCT00142415|9386444|P4|Overall Study|Physician Decision|0
2730797|NCT00142415|9386445|P3|Overall Study|Physician Decision|0
2730798|NCT00142415|9386446|P2|Overall Study|Physician Decision|0
2730799|NCT00142415|9386447|P1|Overall Study|Physician Decision|0
2730800|NCT00142298|9386485|P10|Overall Study|Treatment Failure|0
2730801|NCT00142298|9386486|P9|Overall Study|Treatment Failure|0
2730802|NCT00142298|9386487|P8|Overall Study|Treatment Failure|0
2730803|NCT00142298|9386488|P7|Overall Study|Treatment Failure|2
2730804|NCT00142298|9386489|P6|Overall Study|Treatment Failure|2
2730805|NCT00142298|9386490|P5|Overall Study|Treatment Failure|0
2730806|NCT00142298|9386491|P4|Overall Study|Treatment Failure|0
2730807|NCT00142298|9386492|P3|Overall Study|Treatment Failure|0
2730808|NCT00142298|9386493|P2|Overall Study|Treatment Failure|0
2730809|NCT00142298|9386494|P1|Overall Study|Treatment Failure|0
2730810|NCT00142298|9386485|P10|Overall Study|Lost to Follow-up|0
2730811|NCT00142298|9386486|P9|Overall Study|Lost to Follow-up|0
2730812|NCT00142298|9386487|P8|Overall Study|Lost to Follow-up|0
2730813|NCT00142298|9386488|P7|Overall Study|Lost to Follow-up|2
2730814|NCT00142298|9386489|P6|Overall Study|Lost to Follow-up|0
2730815|NCT00142298|9386490|P5|Overall Study|Lost to Follow-up|0
2730816|NCT00142298|9386491|P4|Overall Study|Lost to Follow-up|0
2730817|NCT00142298|9386492|P3|Overall Study|Lost to Follow-up|0
2730818|NCT00142298|9386493|P2|Overall Study|Lost to Follow-up|0
2730819|NCT00142298|9386494|P1|Overall Study|Lost to Follow-up|0
2730820|NCT00142298|9386485|P10|Overall Study|Other- not specified|0
2730821|NCT00142298|9386486|P9|Overall Study|Other- not specified|0
2730822|NCT00142298|9386487|P8|Overall Study|Other- not specified|0
2730823|NCT00142298|9386488|P7|Overall Study|Other- not specified|0
2730824|NCT00142298|9386489|P6|Overall Study|Other- not specified|0
2730825|NCT00142298|9386490|P5|Overall Study|Other- not specified|0
2730826|NCT00142298|9386491|P4|Overall Study|Other- not specified|1
2730827|NCT00142298|9386492|P3|Overall Study|Other- not specified|0
2730828|NCT00142298|9386493|P2|Overall Study|Other- not specified|3
2730829|NCT00142298|9386494|P1|Overall Study|Other- not specified|0
2730830|NCT00142298|9386485|P10|Overall Study|Virologic breakthrough|0
2730831|NCT00142298|9386486|P9|Overall Study|Virologic breakthrough|0
2730832|NCT00142298|9386487|P8|Overall Study|Virologic breakthrough|0
2730833|NCT00142298|9386488|P7|Overall Study|Virologic breakthrough|3
2730834|NCT00142298|9386489|P6|Overall Study|Virologic breakthrough|3
2730835|NCT00142298|9386490|P5|Overall Study|Virologic breakthrough|2
2730836|NCT00142298|9386491|P4|Overall Study|Virologic breakthrough|7
2730837|NCT00142298|9386492|P3|Overall Study|Virologic breakthrough|9
2730838|NCT00142298|9386493|P2|Overall Study|Virologic breakthrough|23
2730839|NCT00142298|9386494|P1|Overall Study|Virologic breakthrough|19
2730840|NCT00142298|9386485|P10|Overall Study|Pregnancy|0
2730841|NCT00142298|9386486|P9|Overall Study|Pregnancy|1
2730842|NCT00142298|9386487|P8|Overall Study|Pregnancy|0
2730843|NCT00142298|9386488|P7|Overall Study|Pregnancy|0
2730844|NCT00142298|9386489|P6|Overall Study|Pregnancy|0
2730845|NCT00142298|9386490|P5|Overall Study|Pregnancy|0
2730846|NCT00142298|9386491|P4|Overall Study|Pregnancy|3
2730847|NCT00142298|9386492|P3|Overall Study|Pregnancy|2
2730848|NCT00142298|9386493|P2|Overall Study|Pregnancy|4
2730849|NCT00142298|9386494|P1|Overall Study|Pregnancy|4
2730850|NCT00142298|9386485|P10|Overall Study|Patient, Investigator,or Sponsor request|0
2730851|NCT00142298|9386486|P9|Overall Study|Patient, Investigator,or Sponsor request|1
2730852|NCT00142298|9386487|P8|Overall Study|Patient, Investigator,or Sponsor request|4
2730853|NCT00142298|9386488|P7|Overall Study|Patient, Investigator,or Sponsor request|1
2730854|NCT00142298|9386489|P6|Overall Study|Patient, Investigator,or Sponsor request|3
2730855|NCT00142298|9386490|P5|Overall Study|Patient, Investigator,or Sponsor request|4
2730856|NCT00142298|9386491|P4|Overall Study|Patient, Investigator,or Sponsor request|51
2730857|NCT00142298|9386492|P3|Overall Study|Patient, Investigator,or Sponsor request|11
2730858|NCT00142298|9386493|P2|Overall Study|Patient, Investigator,or Sponsor request|60
2730859|NCT00142298|9386494|P1|Overall Study|Patient, Investigator,or Sponsor request|66
2730860|NCT00142298|9386485|P10|Overall Study|Non-compliance|0
2730861|NCT00142298|9386486|P9|Overall Study|Non-compliance|3
2730862|NCT00142298|9386487|P8|Overall Study|Non-compliance|3
2730863|NCT00142298|9386488|P7|Overall Study|Non-compliance|0
2730864|NCT00142298|9386489|P6|Overall Study|Non-compliance|0
2730865|NCT00142298|9386490|P5|Overall Study|Non-compliance|1
2730866|NCT00142298|9386491|P4|Overall Study|Non-compliance|6
2730867|NCT00142298|9386492|P3|Overall Study|Non-compliance|0
2730868|NCT00142298|9386493|P2|Overall Study|Non-compliance|13
2730869|NCT00142298|9386494|P1|Overall Study|Non-compliance|15
2730870|NCT00142298|9386485|P10|Overall Study|Lack of Efficacy|0
2730871|NCT00142298|9386486|P9|Overall Study|Lack of Efficacy|0
2730872|NCT00142298|9386487|P8|Overall Study|Lack of Efficacy|1
2730873|NCT00142298|9386488|P7|Overall Study|Lack of Efficacy|0
2730874|NCT00142298|9386489|P6|Overall Study|Lack of Efficacy|0
2730875|NCT00142298|9386490|P5|Overall Study|Lack of Efficacy|1
2730876|NCT00142298|9386491|P4|Overall Study|Lack of Efficacy|12
2730877|NCT00142298|9386492|P3|Overall Study|Lack of Efficacy|9
2730878|NCT00142298|9386493|P2|Overall Study|Lack of Efficacy|62
2730879|NCT00142298|9386494|P1|Overall Study|Lack of Efficacy|44
2730880|NCT00142298|9386485|P10|Overall Study|Death|0
2730881|NCT00142298|9386486|P9|Overall Study|Death|0
2730882|NCT00142298|9386487|P8|Overall Study|Death|0
2730883|NCT00142298|9386488|P7|Overall Study|Death|0
2730884|NCT00142298|9386489|P6|Overall Study|Death|6
2730885|NCT00142298|9386490|P5|Overall Study|Death|0
2730886|NCT00142298|9386491|P4|Overall Study|Death|0
2730887|NCT00142298|9386492|P3|Overall Study|Death|1
2730888|NCT00142298|9386493|P2|Overall Study|Death|1
2730889|NCT00142298|9386494|P1|Overall Study|Death|1
2730890|NCT00142298|9386485|P10|Overall Study|Clinical disease progression|0
2730891|NCT00142298|9386486|P9|Overall Study|Clinical disease progression|0
2730892|NCT00142298|9386487|P8|Overall Study|Clinical disease progression|0
2730893|NCT00142298|9386488|P7|Overall Study|Clinical disease progression|0
2730894|NCT00142298|9386489|P6|Overall Study|Clinical disease progression|0
2730895|NCT00142298|9386490|P5|Overall Study|Clinical disease progression|0
2730896|NCT00142298|9386491|P4|Overall Study|Clinical disease progression|0
2730897|NCT00142298|9386492|P3|Overall Study|Clinical disease progression|0
2730898|NCT00142298|9386493|P2|Overall Study|Clinical disease progression|0
2730899|NCT00142298|9386494|P1|Overall Study|Clinical disease progression|1
2730900|NCT00142298|9386485|P10|Overall Study|Adverse Event|0
2730901|NCT00142298|9386486|P9|Overall Study|Adverse Event|0
2730902|NCT00142298|9386487|P8|Overall Study|Adverse Event|0
2730903|NCT00142298|9386488|P7|Overall Study|Adverse Event|0
2730904|NCT00142298|9386489|P6|Overall Study|Adverse Event|2
2730905|NCT00142298|9386490|P5|Overall Study|Adverse Event|2
2730906|NCT00142298|9386491|P4|Overall Study|Adverse Event|5
2730907|NCT00142298|9386492|P3|Overall Study|Adverse Event|1
2730908|NCT00142298|9386493|P2|Overall Study|Adverse Event|10
2730909|NCT00142298|9386494|P1|Overall Study|Adverse Event|10
2730910|NCT00141921|9386528|P1|Overall Study|Other|8
2730911|NCT00141921|9386528|P1|Overall Study|Ineligibility Determined|2
2730912|NCT00141921|9386528|P1|Overall Study|Pregnancy|4
2730913|NCT00141921|9386528|P1|Overall Study|Administrative Decision|2
2730914|NCT00141921|9386528|P1|Overall Study|Adverse Event|5
2730915|NCT00141921|9386528|P1|Overall Study|Protocol Deviation|7
2730916|NCT00141921|9386528|P1|Overall Study|Disease Progression|7
2730917|NCT00141921|9386528|P1|Overall Study|Noncompliance|17
2730918|NCT00141921|9386528|P1|Overall Study|Lost to Follow-up|19
2730919|NCT00141921|9386528|P1|Overall Study|Withdrawal by Subject|42
2730920|NCT00141921|9386528|P1|Overall Study|Remain on Study|28
2730921|NCT00141817|9386554|P4|Overall Study|Parent request|0
2730922|NCT00141817|9386555|P3|Overall Study|Parent request|0
2730923|NCT00141817|9386556|P2|Overall Study|Parent request|0
2730924|NCT00141817|9386557|P1|Overall Study|Parent request|1
2730925|NCT00141817|9386554|P4|Overall Study|Protocol Violation|0
2730926|NCT00141817|9386555|P3|Overall Study|Protocol Violation|1
2730927|NCT00141817|9386556|P2|Overall Study|Protocol Violation|0
2730928|NCT00141817|9386557|P1|Overall Study|Protocol Violation|0
2730929|NCT00141778|9386598|P3|Started Study Medication|Chest Discomfort|1
2730930|NCT00141778|9386599|P2|Started Study Medication|Chest Discomfort|0
2730931|NCT00141778|9386600|P1|Started Study Medication|Chest Discomfort|0
2730932|NCT00141778|9386598|P3|Started Study Medication|Difficulty Swallowing|0
2730933|NCT00141778|9386599|P2|Started Study Medication|Difficulty Swallowing|1
2730934|NCT00141778|9386600|P1|Started Study Medication|Difficulty Swallowing|0
2730935|NCT00141778|9386598|P3|Started Study Medication|Withdrawal by Subject|0
2730936|NCT00141778|9386599|P2|Started Study Medication|Withdrawal by Subject|2
2730937|NCT00141778|9386600|P1|Started Study Medication|Withdrawal by Subject|0
2730938|NCT00141778|9386598|P3|Started Study Medication|Met safety criteria for discontinuation|3
2730939|NCT00141778|9386599|P2|Started Study Medication|Met safety criteria for discontinuation|4
2731032|NCT00141271|9387155|P2|Overall Study|Lack of Efficacy|7
2730940|NCT00141778|9386600|P1|Started Study Medication|Met safety criteria for discontinuation|2
2730941|NCT00141778|9386598|P3|Randomization Prior to Study Med|Withdrawal by Subject|6
2730942|NCT00141778|9386599|P2|Randomization Prior to Study Med|Withdrawal by Subject|2
2730943|NCT00141778|9386600|P1|Randomization Prior to Study Med|Withdrawal by Subject|5
2730944|NCT00141726|9386653|P1|Overall Study|Completed <50% Scheduled Dosing|3
2730945|NCT00141518|9386661|P3|Overall Study|Lack of Efficacy|0
2730946|NCT00141518|9386662|P2|Overall Study|Lack of Efficacy|0
2730947|NCT00141518|9386663|P1|Overall Study|Lack of Efficacy|5
2730948|NCT00141518|9386661|P3|Overall Study|Protocol Violation|2
2730949|NCT00141518|9386662|P2|Overall Study|Protocol Violation|1
2730950|NCT00141518|9386663|P1|Overall Study|Protocol Violation|1
2730951|NCT00141518|9386661|P3|Overall Study|Withdrawal by Subject|2
2730952|NCT00141518|9386662|P2|Overall Study|Withdrawal by Subject|0
2730953|NCT00141518|9386663|P1|Overall Study|Withdrawal by Subject|2
2730954|NCT00141518|9386661|P3|Overall Study|Adverse Event|2
2730955|NCT00141518|9386662|P2|Overall Study|Adverse Event|5
2730956|NCT00141518|9386663|P1|Overall Study|Adverse Event|7
2730957|NCT00141518|9386661|P3|Overall Study|Withdrew Consent Prior to Treatment|0
2730958|NCT00141518|9386662|P2|Overall Study|Withdrew Consent Prior to Treatment|0
2730959|NCT00141518|9386663|P1|Overall Study|Withdrew Consent Prior to Treatment|1
2730960|NCT00141453|9386852|P2|Overall Study|Protocol Violation|5
2730961|NCT00141453|9386853|P1|Overall Study|Protocol Violation|6
2730962|NCT00141297|9386867|P10|Overall Study|Transitioned|0
2730963|NCT00141297|9386868|P9|Overall Study|Transitioned|0
2730964|NCT00141297|9386869|P8|Overall Study|Transitioned|0
2730965|NCT00141297|9386870|P7|Overall Study|Transitioned|0
2730966|NCT00141297|9386871|P6|Overall Study|Transitioned|0
2730967|NCT00141297|9386872|P5|Overall Study|Transitioned|1
2730968|NCT00141297|9386873|P4|Overall Study|Transitioned|0
2730969|NCT00141297|9386874|P3|Overall Study|Transitioned|0
2730970|NCT00141297|9386875|P2|Overall Study|Transitioned|0
2730971|NCT00141297|9386876|P1|Overall Study|Transitioned|0
2730972|NCT00141297|9386867|P10|Overall Study|Progressive Disease|6
2730973|NCT00141297|9386868|P9|Overall Study|Progressive Disease|15
2730974|NCT00141297|9386869|P8|Overall Study|Progressive Disease|3
2730975|NCT00141297|9386870|P7|Overall Study|Progressive Disease|3
2730976|NCT00141297|9386871|P6|Overall Study|Progressive Disease|2
2730977|NCT00141297|9386872|P5|Overall Study|Progressive Disease|15
2730978|NCT00141297|9386873|P4|Overall Study|Progressive Disease|2
2730979|NCT00141297|9386874|P3|Overall Study|Progressive Disease|6
2730980|NCT00141297|9386875|P2|Overall Study|Progressive Disease|3
2730981|NCT00141297|9386876|P1|Overall Study|Progressive Disease|2
2730982|NCT00141297|9386867|P10|Overall Study|Other|0
2730983|NCT00141297|9386868|P9|Overall Study|Other|2
2730984|NCT00141297|9386869|P8|Overall Study|Other|0
2730985|NCT00141297|9386870|P7|Overall Study|Other|0
2730986|NCT00141297|9386871|P6|Overall Study|Other|0
2730987|NCT00141297|9386872|P5|Overall Study|Other|5
2730988|NCT00141297|9386873|P4|Overall Study|Other|1
2730989|NCT00141297|9386874|P3|Overall Study|Other|0
2730990|NCT00141297|9386875|P2|Overall Study|Other|0
2730991|NCT00141297|9386876|P1|Overall Study|Other|0
2730992|NCT00141297|9386867|P10|Overall Study|Withdrawal by Subject|0
2730993|NCT00141297|9386868|P9|Overall Study|Withdrawal by Subject|1
2730994|NCT00141297|9386869|P8|Overall Study|Withdrawal by Subject|0
2730995|NCT00141297|9386870|P7|Overall Study|Withdrawal by Subject|0
2730996|NCT00141297|9386871|P6|Overall Study|Withdrawal by Subject|0
2730997|NCT00141297|9386872|P5|Overall Study|Withdrawal by Subject|0
2730998|NCT00141297|9386873|P4|Overall Study|Withdrawal by Subject|0
2730999|NCT00141297|9386874|P3|Overall Study|Withdrawal by Subject|0
2731000|NCT00141297|9386875|P2|Overall Study|Withdrawal by Subject|0
2731001|NCT00141297|9386876|P1|Overall Study|Withdrawal by Subject|0
2731002|NCT00141297|9386867|P10|Overall Study|Death|0
2731003|NCT00141297|9386868|P9|Overall Study|Death|1
2731004|NCT00141297|9386869|P8|Overall Study|Death|0
2731005|NCT00141297|9386870|P7|Overall Study|Death|0
2731006|NCT00141297|9386871|P6|Overall Study|Death|0
2731007|NCT00141297|9386872|P5|Overall Study|Death|0
2731008|NCT00141297|9386873|P4|Overall Study|Death|0
2731009|NCT00141297|9386874|P3|Overall Study|Death|0
2731010|NCT00141297|9386875|P2|Overall Study|Death|0
2731011|NCT00141297|9386876|P1|Overall Study|Death|1
2731012|NCT00141297|9386867|P10|Overall Study|Adverse Event|0
2731013|NCT00141297|9386868|P9|Overall Study|Adverse Event|1
2731014|NCT00141297|9386869|P8|Overall Study|Adverse Event|1
2731015|NCT00141297|9386870|P7|Overall Study|Adverse Event|0
2731016|NCT00141297|9386871|P6|Overall Study|Adverse Event|1
2731017|NCT00141297|9386872|P5|Overall Study|Adverse Event|1
2731018|NCT00141297|9386873|P4|Overall Study|Adverse Event|0
2731019|NCT00141297|9386874|P3|Overall Study|Adverse Event|1
2731020|NCT00141297|9386875|P2|Overall Study|Adverse Event|0
2731021|NCT00141297|9386876|P1|Overall Study|Adverse Event|0
2731022|NCT00141271|9387154|P3|Overall Study|Other|5
2731023|NCT00141271|9387155|P2|Overall Study|Other|12
2731024|NCT00141271|9387156|P1|Overall Study|Other|11
2731025|NCT00141271|9387154|P3|Overall Study|Withdrawal by Subject|10
2731026|NCT00141271|9387155|P2|Overall Study|Withdrawal by Subject|9
2731027|NCT00141271|9387156|P1|Overall Study|Withdrawal by Subject|14
2731028|NCT00141271|9387154|P3|Overall Study|Lost to Follow-up|21
2731029|NCT00141271|9387155|P2|Overall Study|Lost to Follow-up|15
2731030|NCT00141271|9387156|P1|Overall Study|Lost to Follow-up|15
2731031|NCT00141271|9387154|P3|Overall Study|Lack of Efficacy|3
2731033|NCT00141271|9387156|P1|Overall Study|Lack of Efficacy|7
2731034|NCT00141271|9387154|P3|Overall Study|Laboratory Abnormality|1
2731035|NCT00141271|9387155|P2|Overall Study|Laboratory Abnormality|1
2731036|NCT00141271|9387156|P1|Overall Study|Laboratory Abnormality|2
2731037|NCT00141271|9387154|P3|Overall Study|Adverse Event|17
2731038|NCT00141271|9387155|P2|Overall Study|Adverse Event|19
2731039|NCT00141271|9387156|P1|Overall Study|Adverse Event|31
2731040|NCT00141219|9387277|P2|Overall Study|Withdrawal by Subject|2
2731041|NCT00141219|9387278|P1|Overall Study|Withdrawal by Subject|6
2731042|NCT00141219|9387277|P2|Overall Study|Lack of Efficacy|4
2731043|NCT00141219|9387278|P1|Overall Study|Lack of Efficacy|5
2731044|NCT00141219|9387277|P2|Overall Study|Adverse Event|6
2731045|NCT00141219|9387278|P1|Overall Study|Adverse Event|8
2731046|NCT00141219|9387277|P2|Overall Study|Protocol violations|4
2731047|NCT00141219|9387278|P1|Overall Study|Protocol violations|5
2731048|NCT00141102|9387335|P2|Overall Study|Death|2
2731049|NCT00141102|9387336|P1|Overall Study|Death|2
2731050|NCT00141102|9387335|P2|Overall Study|Randomized But Did Not Receive Treatment|9
2731051|NCT00141102|9387336|P1|Overall Study|Randomized But Did Not Receive Treatment|15
2731052|NCT00141102|9387335|P2|Overall Study|Withdrawal by Subject|142
2731053|NCT00141102|9387336|P1|Overall Study|Withdrawal by Subject|112
2731054|NCT00141102|9387335|P2|Overall Study|Other|76
2731055|NCT00141102|9387336|P1|Overall Study|Other|87
2731056|NCT00141102|9387335|P2|Overall Study|Lost to Follow-up|32
2731057|NCT00141102|9387336|P1|Overall Study|Lost to Follow-up|29
2731058|NCT00141102|9387335|P2|Overall Study|Lack of Efficacy|26
2731059|NCT00141102|9387336|P1|Overall Study|Lack of Efficacy|21
2731060|NCT00141102|9387335|P2|Overall Study|Laboratory Abnormality|33
2731061|NCT00141102|9387336|P1|Overall Study|Laboratory Abnormality|9
2731062|NCT00141102|9387335|P2|Overall Study|Adverse Event|305
2731063|NCT00141102|9387336|P1|Overall Study|Adverse Event|233
2731064|NCT00141037|9387376|P2|Overall Study|Graft Failure|4
2731065|NCT00141037|9387377|P1|Overall Study|Graft Failure|3
2731066|NCT00141037|9387376|P2|Overall Study|Moved from area|7
2731067|NCT00141037|9387377|P1|Overall Study|Moved from area|1
2731068|NCT00141037|9387376|P2|Overall Study|Other|1
2731069|NCT00141037|9387377|P1|Overall Study|Other|0
2731070|NCT00141037|9387376|P2|Overall Study|Withdrawal by Subject|1
2731071|NCT00141037|9387377|P1|Overall Study|Withdrawal by Subject|2
2731072|NCT00141037|9387376|P2|Overall Study|Protocol Violation|2
2731073|NCT00141037|9387377|P1|Overall Study|Protocol Violation|0
2731074|NCT00141037|9387376|P2|Overall Study|Lost to Follow-up|1
2731075|NCT00141037|9387377|P1|Overall Study|Lost to Follow-up|3
2731076|NCT00141037|9387376|P2|Overall Study|Physician Decision|2
2731077|NCT00141037|9387377|P1|Overall Study|Physician Decision|1
2731078|NCT00140426|9387412|P2|Overall Study|Withdrawal by Subject|3
2731079|NCT00140426|9387413|P1|Overall Study|Withdrawal by Subject|0
2731080|NCT00140413|9387446|P2|Overall Study|Withdrawal by Subject|0
2731081|NCT00140413|9387447|P1|Overall Study|Withdrawal by Subject|2
2731082|NCT00140413|9387446|P2|Overall Study|Lost to Follow-up|0
2731083|NCT00140413|9387447|P1|Overall Study|Lost to Follow-up|1
2731084|NCT00140140|9387578|P3|Overall Study|Physician Decision|0
2731085|NCT00140140|9387579|P2|Overall Study|Physician Decision|1
2731086|NCT00140140|9387580|P1|Overall Study|Physician Decision|1
2731087|NCT00140140|9387578|P3|Overall Study|Unacceptable toxicity|2
2731088|NCT00140140|9387579|P2|Overall Study|Unacceptable toxicity|1
2731089|NCT00140140|9387580|P1|Overall Study|Unacceptable toxicity|1
2731090|NCT00139776|9387630|P4|Period III|Withdrawal by Subject|21
2731091|NCT00139776|9387631|P3|Period III|Withdrawal by Subject|16
2731092|NCT00139776|9387632|P2|Period III|Withdrawal by Subject|0
2731093|NCT00139776|9387633|P1|Period III|Withdrawal by Subject|0
2731094|NCT00139776|9387630|P4|Period III|Lost to Follow-up|4
2731095|NCT00139776|9387631|P3|Period III|Lost to Follow-up|5
2731096|NCT00139776|9387632|P2|Period III|Lost to Follow-up|0
2731097|NCT00139776|9387633|P1|Period III|Lost to Follow-up|0
2731098|NCT00139776|9387630|P4|Period III|Lack of Efficacy|24
2731099|NCT00139776|9387631|P3|Period III|Lack of Efficacy|10
2731100|NCT00139776|9387632|P2|Period III|Lack of Efficacy|0
2731101|NCT00139776|9387633|P1|Period III|Lack of Efficacy|0
2731102|NCT00139776|9387630|P4|Period III|Other|34
2731103|NCT00139776|9387631|P3|Period III|Other|23
2731104|NCT00139776|9387632|P2|Period III|Other|0
2731105|NCT00139776|9387633|P1|Period III|Other|0
2731106|NCT00139776|9387630|P4|Period III|Adverse Event|23
2731107|NCT00139776|9387631|P3|Period III|Adverse Event|22
2731108|NCT00139776|9387632|P2|Period III|Adverse Event|0
2731109|NCT00139776|9387633|P1|Period III|Adverse Event|0
2731110|NCT00139776|9387630|P4|Period II|Not Randomized into Period III|0
2731111|NCT00139776|9387631|P3|Period II|Not Randomized into Period III|0
2731112|NCT00139776|9387632|P2|Period II|Not Randomized into Period III|322
2731113|NCT00139776|9387633|P1|Period II|Not Randomized into Period III|0
2731114|NCT00139776|9387630|P4|Period I|Did not enter Period II|0
2731115|NCT00139776|9387631|P3|Period I|Did not enter Period II|0
2731116|NCT00139776|9387632|P2|Period I|Did not enter Period II|0
2731117|NCT00139776|9387633|P1|Period I|Did not enter Period II|575
2731118|NCT00139737|9387668|P1|Overall Study|Screened, Not Treated|13
2731119|NCT00139737|9387668|P1|Overall Study|Did Not Meet Entrance Criteria|1
2731120|NCT00139737|9387668|P1|Overall Study|Withdrew During Screening Phase|8
2731121|NCT00139737|9387668|P1|Overall Study|Protocol Violation|18
2731122|NCT00139737|9387668|P1|Overall Study|Laboratory Abnormality|2
2731123|NCT00139737|9387668|P1|Overall Study|Death|3
2731124|NCT00139737|9387668|P1|Overall Study|Lost to Follow-up|8
2731125|NCT00139737|9387668|P1|Overall Study|Lack of Efficacy|40
2731126|NCT00139737|9387668|P1|Overall Study|Adverse Event|58
2731127|NCT00139737|9387668|P1|Overall Study|Withdrawal by Subject|190
2731128|NCT00139659|9387674|P2|Overall Study|Withdrawal by Subject|10
2731129|NCT00139659|9387675|P1|Overall Study|Withdrawal by Subject|14
2731130|NCT00139659|9387674|P2|Overall Study|Reason not Specified|3
2731131|NCT00139659|9387675|P1|Overall Study|Reason not Specified|6
2731132|NCT00139659|9387674|P2|Overall Study|Lost to Follow-up|3
2731133|NCT00139659|9387675|P1|Overall Study|Lost to Follow-up|7
2731134|NCT00139659|9387674|P2|Overall Study|Lack of Efficacy|1
2731135|NCT00139659|9387675|P1|Overall Study|Lack of Efficacy|1
2731136|NCT00139659|9387674|P2|Overall Study|Adverse Event|1
2731137|NCT00139659|9387675|P1|Overall Study|Adverse Event|12
2731138|NCT00139477|9387753|P2|Second Intervention -6Months to 12Months|Lost to Follow-up|3
2731139|NCT00139477|9387754|P1|Second Intervention -6Months to 12Months|Lost to Follow-up|4
2731140|NCT00139477|9387753|P2|Second Intervention -6Months to 12Months|Relocation|0
2731141|NCT00139477|9387754|P1|Second Intervention -6Months to 12Months|Relocation|1
2731142|NCT00139477|9387753|P2|Second Intervention -6Months to 12Months|No Longer Interested|2
2731143|NCT00139477|9387754|P1|Second Intervention -6Months to 12Months|No Longer Interested|0
2731144|NCT00139477|9387753|P2|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0
2731145|NCT00139477|9387754|P1|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2
2731146|NCT00139477|9387753|P2|First Intervention -Baseline to 6Months|Lost to Follow-up|3
2731147|NCT00139477|9387754|P1|First Intervention -Baseline to 6Months|Lost to Follow-up|3
2731148|NCT00139477|9387753|P2|First Intervention -Baseline to 6Months|Relocation|2
2731149|NCT00139477|9387754|P1|First Intervention -Baseline to 6Months|Relocation|1
2731150|NCT00139477|9387753|P2|First Intervention -Baseline to 6Months|No Longer Interested|7
2731151|NCT00139477|9387754|P1|First Intervention -Baseline to 6Months|No Longer Interested|6
2731152|NCT00138671|9387789|P2|Overall Study|Other|3
2731153|NCT00138671|9387790|P1|Overall Study|Other|3
2731154|NCT00138671|9387789|P2|Overall Study|Withdrawal by Subject|5
2731155|NCT00138671|9387790|P1|Overall Study|Withdrawal by Subject|3
2731156|NCT00138671|9387789|P2|Overall Study|Lost to Follow-up|2
2731157|NCT00138671|9387790|P1|Overall Study|Lost to Follow-up|1
2731158|NCT00138671|9387789|P2|Overall Study|Adverse Event|3
2731159|NCT00138671|9387790|P1|Overall Study|Adverse Event|6
2731160|NCT00138671|9387789|P2|Overall Study|Death|3
2731161|NCT00138671|9387790|P1|Overall Study|Death|0
2731162|NCT00138658|9387840|P1|Overall Study|Withdrawal by Subject|5
2731163|NCT00138658|9387840|P1|Overall Study|Physician Decision|11
2731164|NCT00138658|9387840|P1|Overall Study|Disease Progression|21
2731165|NCT00138658|9387840|P1|Overall Study|Death|1
2731166|NCT00138658|9387840|P1|Overall Study|Adverse Event|23
2731167|NCT00138424|9387863|P4|Overall Study|Physician Decision|0
2731168|NCT00138424|9387864|P3|Overall Study|Physician Decision|0
2731169|NCT00138424|9387865|P2|Overall Study|Physician Decision|1
2731170|NCT00138424|9387866|P1|Overall Study|Physician Decision|0
2731171|NCT00138151|9387949|P1|Overall Study|Physician Decision|1
2731172|NCT00138151|9387949|P1|Overall Study|Withdrawal by Subject|3
2731173|NCT00138073|9387959|P1|Overall Study|lack of resources|55
2731174|NCT00137839|9387998|P1|Overall Study|Prolonged Treatment Delay|1
2731175|NCT00137839|9387998|P1|Overall Study|Not Start Treatment|1
2731176|NCT00137839|9387998|P1|Overall Study|Disease Progression|60
2731177|NCT00137839|9387998|P1|Overall Study|Death|8
2731178|NCT00137839|9387998|P1|Overall Study|Physician Decision|7
2731179|NCT00137839|9387998|P1|Overall Study|Adverse Event|7
2731180|NCT00137631|9388011|P2|Overall Study|Lost to Follow-up|41
2731181|NCT00137631|9388012|P1|Overall Study|Lost to Follow-up|37
2731182|NCT00137449|9388028|P2|Overall Study|Withdrawal by Subject|1
2731183|NCT00137449|9388029|P1|Overall Study|Withdrawal by Subject|1
2731184|NCT00137449|9388028|P2|Overall Study|Adverse Event|1
2731185|NCT00137449|9388029|P1|Overall Study|Adverse Event|3
2731186|NCT00137449|9388028|P2|Overall Study|Death|3
2731187|NCT00137449|9388029|P1|Overall Study|Death|4
2731188|NCT00137449|9388028|P2|Overall Study|Disease Progression|13
2731189|NCT00137449|9388029|P1|Overall Study|Disease Progression|8
2731190|NCT00137436|9388066|P1|Overall Study|Other|5
2731191|NCT00137436|9388066|P1|Overall Study|Withdrawal by Subject|6
2731192|NCT00137436|9388066|P1|Overall Study|Lack of Efficacy|17
2731193|NCT00137436|9388066|P1|Overall Study|Death|2
2731194|NCT00137436|9388066|P1|Overall Study|Adverse Event|13
2731195|NCT00137423|9388085|P2|Overall Study|Death|1
2731196|NCT00137423|9388086|P1|Overall Study|Death|0
2731197|NCT00137423|9388085|P2|Overall Study|Lack of Efficacy|33
2731198|NCT00137423|9388086|P1|Overall Study|Lack of Efficacy|31
2731199|NCT00137423|9388085|P2|Overall Study|consent withdrawn|1
2731200|NCT00137423|9388086|P1|Overall Study|consent withdrawn|1
2731201|NCT00137423|9388085|P2|Overall Study|Adverse Event|9
2731202|NCT00137423|9388086|P1|Overall Study|Adverse Event|7
2731203|NCT00137267|9388123|P2|Overall Study|Lost to Follow-up|21
2731204|NCT00137267|9388124|P1|Overall Study|Lost to Follow-up|15
2731205|NCT00137111|9388136|P4|Total Therapy|Non Compliance|0
2731206|NCT00137111|9388137|P3|Total Therapy|Non Compliance|0
2731207|NCT00137111|9388138|P2|Total Therapy|Non Compliance|0
2731208|NCT00137111|9388139|P1|Total Therapy|Non Compliance|5
2731209|NCT00137111|9388136|P4|Total Therapy|Death|0
2731210|NCT00137111|9388137|P3|Total Therapy|Death|0
2731211|NCT00137111|9388138|P2|Total Therapy|Death|0
2731212|NCT00137111|9388139|P1|Total Therapy|Death|35
2731213|NCT00137046|9388153|P2|Overall Study|Withdrew prior to study treatment|1
2731214|NCT00137046|9388154|P1|Overall Study|Withdrew prior to study treatment|1
2731215|NCT00137046|9388153|P2|Overall Study|Adverse Event 4 Days after Last Dose|0
2731216|NCT00137046|9388154|P1|Overall Study|Adverse Event 4 Days after Last Dose|1
2731217|NCT00137046|9388153|P2|Overall Study|Withdrawal by Subject|42
2731218|NCT00137046|9388154|P1|Overall Study|Withdrawal by Subject|33
2731219|NCT00137046|9388153|P2|Overall Study|Other|19
2731220|NCT00137046|9388154|P1|Overall Study|Other|23
2731221|NCT00137046|9388153|P2|Overall Study|Lost to Follow-up|24
2731222|NCT00137046|9388154|P1|Overall Study|Lost to Follow-up|8
2731223|NCT00137046|9388153|P2|Overall Study|Lack of Efficacy|1
2731224|NCT00137046|9388154|P1|Overall Study|Lack of Efficacy|13
2731225|NCT00137046|9388153|P2|Overall Study|Laboratory Abnormality|0
2731226|NCT00137046|9388154|P1|Overall Study|Laboratory Abnormality|2
2731227|NCT00137046|9388153|P2|Overall Study|Adverse Event|5
2731228|NCT00137046|9388154|P1|Overall Study|Adverse Event|16
2731229|NCT00137046|9388153|P2|Overall Study|Death|1
2731230|NCT00137046|9388154|P1|Overall Study|Death|2
2731231|NCT00136955|9388202|P1|Overall Study|Incl. prog. disease, protocol violation|12
2731232|NCT00136955|9388202|P1|Overall Study|Withdrawal by Subject|2
2731233|NCT00136955|9388202|P1|Overall Study|Lost to Follow-up|1
2731234|NCT00136955|9388202|P1|Overall Study|Adverse Event|8
2731235|NCT00136916|9388211|P2|Overall Study|Discontinued in follow up period|0
2731236|NCT00136916|9388212|P1|Overall Study|Discontinued in follow up period|3
2731237|NCT00136916|9388211|P2|Overall Study|Other|24
2731238|NCT00136916|9388212|P1|Overall Study|Other|22
2731239|NCT00136916|9388211|P2|Overall Study|Withdrawal by Subject|46
2731240|NCT00136916|9388212|P1|Overall Study|Withdrawal by Subject|44
2731241|NCT00136916|9388211|P2|Overall Study|Lost to Follow-up|14
2731242|NCT00136916|9388212|P1|Overall Study|Lost to Follow-up|12
2731243|NCT00136916|9388211|P2|Overall Study|Lack of Efficacy|3
2731244|NCT00136916|9388212|P1|Overall Study|Lack of Efficacy|13
2731245|NCT00136916|9388211|P2|Overall Study|Laboratory abnormality|1
2731246|NCT00136916|9388212|P1|Overall Study|Laboratory abnormality|0
2731247|NCT00136916|9388211|P2|Overall Study|Adverse Event|8
2731248|NCT00136916|9388212|P1|Overall Study|Adverse Event|27
2731249|NCT00136916|9388211|P2|Overall Study|Death|3
2731250|NCT00136916|9388212|P1|Overall Study|Death|1
2731251|NCT00136916|9388211|P2|Overall Study|Never received study treatment|5
2731252|NCT00136916|9388212|P1|Overall Study|Never received study treatment|3
2731253|NCT00136604|9388319|P5|Overall Study|Migrated/moved from study area|0
2731254|NCT00136604|9388320|P4|Overall Study|Migrated/moved from study area|0
2731255|NCT00136604|9388321|P3|Overall Study|Migrated/moved from study area|0
2731256|NCT00136604|9388322|P2|Overall Study|Migrated/moved from study area|1
2731257|NCT00136604|9388323|P1|Overall Study|Migrated/moved from study area|0
2731258|NCT00136604|9388319|P5|Overall Study|Lost to Follow-up|1
2731259|NCT00136604|9388320|P4|Overall Study|Lost to Follow-up|0
2731260|NCT00136604|9388321|P3|Overall Study|Lost to Follow-up|0
2731261|NCT00136604|9388322|P2|Overall Study|Lost to Follow-up|0
2731262|NCT00136604|9388323|P1|Overall Study|Lost to Follow-up|1
2731263|NCT00136357|9388431|P2|Overall Study|Withdrawal by Subject|2
2731264|NCT00136357|9388432|P1|Overall Study|Withdrawal by Subject|3
2731265|NCT00136318|9388440|P2|Overall Study|Withdrawal by Subject|2
2731266|NCT00136318|9388441|P1|Overall Study|Withdrawal by Subject|2
2731267|NCT00136318|9388440|P2|Overall Study|Adverse Event|5
2731268|NCT00136318|9388441|P1|Overall Study|Adverse Event|5
2731269|NCT00136084|9388468|P2|Overall Study|Withdrawal by Subject|1
2731270|NCT00136084|9388469|P1|Overall Study|Withdrawal by Subject|5
2731271|NCT00136084|9388468|P2|Overall Study|No Response|2
2731272|NCT00136084|9388469|P1|Overall Study|No Response|1
2731273|NCT00136084|9388468|P2|Overall Study|Lost to Follow-up|0
2731274|NCT00136084|9388469|P1|Overall Study|Lost to Follow-up|2
2731275|NCT00136084|9388468|P2|Overall Study|Relapse|23
2731276|NCT00136084|9388469|P1|Overall Study|Relapse|20
2731277|NCT00136084|9388468|P2|Overall Study|Unacceptable toxicity|11
2731278|NCT00136084|9388469|P1|Overall Study|Unacceptable toxicity|8
2731279|NCT00136084|9388468|P2|Overall Study|Death|5
2731280|NCT00136084|9388469|P1|Overall Study|Death|12
2731281|NCT00135707|9388505|P2|Overall Study|Institutional review board request|0
2731282|NCT00135707|9388506|P1|Overall Study|Institutional review board request|1
2731283|NCT00135707|9388505|P2|Overall Study|Withdrawal by Subject|1
2731284|NCT00135707|9388506|P1|Overall Study|Withdrawal by Subject|0
2731285|NCT00135707|9388505|P2|Overall Study|Lost to Follow-up|89
2731286|NCT00135707|9388506|P1|Overall Study|Lost to Follow-up|94
2731287|NCT00135694|9388589|P3|Overall Study|Ineligible for Random assignment|0
2731288|NCT00135694|9388590|P2|Overall Study|Ineligible for Random assignment|0
2731289|NCT00135694|9388591|P1|Overall Study|Ineligible for Random assignment|42
2731290|NCT00135694|9388589|P3|Overall Study|Hepatitis C related reasons|0
2731291|NCT00135694|9388590|P2|Overall Study|Hepatitis C related reasons|1
2731292|NCT00135694|9388591|P1|Overall Study|Hepatitis C related reasons|39
2731293|NCT00135694|9388589|P3|Overall Study|Protocol Violation|0
2731294|NCT00135694|9388590|P2|Overall Study|Protocol Violation|1
2731295|NCT00135694|9388591|P1|Overall Study|Protocol Violation|19
2731296|NCT00135694|9388589|P3|Overall Study|Withdrawal by Subject|4
2731297|NCT00135694|9388590|P2|Overall Study|Withdrawal by Subject|7
2731298|NCT00135694|9388591|P1|Overall Study|Withdrawal by Subject|41
2731299|NCT00135694|9388589|P3|Overall Study|Lost to Follow-up|1
2731300|NCT00135694|9388590|P2|Overall Study|Lost to Follow-up|7
2731301|NCT00135694|9388591|P1|Overall Study|Lost to Follow-up|8
2731302|NCT00135694|9388589|P3|Overall Study|Death|2
2731303|NCT00135694|9388590|P2|Overall Study|Death|1
2731304|NCT00135694|9388591|P1|Overall Study|Death|14
2731305|NCT00135694|9388589|P3|Overall Study|Adverse Event|0
2731306|NCT00135694|9388590|P2|Overall Study|Adverse Event|4
2731307|NCT00135694|9388591|P1|Overall Study|Adverse Event|17
2731308|NCT00135512|9388609|P1|Overall Study|Other|42
2731309|NCT00135512|9388609|P1|Overall Study|Lack of Efficacy|25
2731310|NCT00135512|9388609|P1|Overall Study|Adverse Event|56
2731311|NCT00135356|9388621|P2|Overall Study|Withdrawal by Subject|4
2731312|NCT00135356|9388622|P1|Overall Study|Withdrawal by Subject|2
2731313|NCT00135356|9388621|P2|Overall Study|No longer meets study criteria|0
2731314|NCT00135356|9388622|P1|Overall Study|No longer meets study criteria|2
2731315|NCT00135356|9388621|P2|Overall Study|Poor/noncompliance|1
2731316|NCT00135356|9388622|P1|Overall Study|Poor/noncompliance|1
2731317|NCT00135356|9388621|P2|Overall Study|Change in antiviral regimen|1
2731318|NCT00135356|9388622|P1|Overall Study|Change in antiviral regimen|0
2731319|NCT00135356|9388621|P2|Overall Study|Surgery for abdominal fat|0
2731320|NCT00135356|9388622|P1|Overall Study|Surgery for abdominal fat|1
2731321|NCT00135356|9388621|P2|Overall Study|Lost to Follow-up|1
2731322|NCT00135356|9388622|P1|Overall Study|Lost to Follow-up|3
2731323|NCT00135356|9388621|P2|Overall Study|Lack of Efficacy|0
2731324|NCT00135356|9388622|P1|Overall Study|Lack of Efficacy|2
2731325|NCT00135356|9388621|P2|Overall Study|Adverse Event|2
2731326|NCT00135356|9388622|P1|Overall Study|Adverse Event|6
2731327|NCT00135330|9388665|P3|Overall Study|Sponsor Decision|0
2731328|NCT00135330|9388666|P2|Overall Study|Sponsor Decision|1
2731329|NCT00135330|9388667|P1|Overall Study|Sponsor Decision|0
2731330|NCT00135330|9388665|P3|Overall Study|Patient Decision|4
2731331|NCT00135330|9388666|P2|Overall Study|Patient Decision|1
2731332|NCT00135330|9388667|P1|Overall Study|Patient Decision|5
2731333|NCT00135330|9388665|P3|Overall Study|Protocol Violation|3
2731334|NCT00135330|9388666|P2|Overall Study|Protocol Violation|3
2731335|NCT00135330|9388667|P1|Overall Study|Protocol Violation|4
2731336|NCT00135330|9388665|P3|Overall Study|Physician Decision|0
2731337|NCT00135330|9388666|P2|Overall Study|Physician Decision|1
2731338|NCT00135330|9388667|P1|Overall Study|Physician Decision|1
2731339|NCT00135330|9388665|P3|Overall Study|Lost to Follow-up|3
2731340|NCT00135330|9388666|P2|Overall Study|Lost to Follow-up|2
2731341|NCT00135330|9388667|P1|Overall Study|Lost to Follow-up|0
2731342|NCT00135330|9388665|P3|Overall Study|Adverse Event|1
2731343|NCT00135330|9388666|P2|Overall Study|Adverse Event|5
2731344|NCT00135330|9388667|P1|Overall Study|Adverse Event|2
2731345|NCT00134901|9388865|P2|Overall Study|discontinued intervention|10
2731346|NCT00134901|9388866|P1|Overall Study|discontinued intervention|12
2731347|NCT00134901|9388865|P2|Overall Study|Lost to Follow-up|5
2731348|NCT00134901|9388866|P1|Overall Study|Lost to Follow-up|5
2731349|NCT00134784|9388878|P4|Overall Study|Withdrawal by Subject|1
2731350|NCT00134784|9388879|P3|Overall Study|Withdrawal by Subject|2
2731351|NCT00134784|9388880|P2|Overall Study|Withdrawal by Subject|2
2731352|NCT00134784|9388881|P1|Overall Study|Withdrawal by Subject|2
2731353|NCT00134719|9388891|P3|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
2731354|NCT00134719|9388892|P2|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
2731355|NCT00134719|9388893|P1|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1
2731356|NCT00134719|9388891|P3|Fourth Dose Vaccination Phase|Lost to Follow-up|1
2731357|NCT00134719|9388892|P2|Fourth Dose Vaccination Phase|Lost to Follow-up|3
2731358|NCT00134719|9388893|P1|Fourth Dose Vaccination Phase|Lost to Follow-up|1
2731359|NCT00134719|9388891|P3|Primary Vaccination Phase|Lost to Follow-up|3
2731360|NCT00134719|9388892|P2|Primary Vaccination Phase|Lost to Follow-up|3
2731361|NCT00134719|9388893|P1|Primary Vaccination Phase|Lost to Follow-up|7
2731362|NCT00134719|9388891|P3|Primary Vaccination Phase|Withdrawal by Subject|2
2731363|NCT00134719|9388892|P2|Primary Vaccination Phase|Withdrawal by Subject|3
2731364|NCT00134719|9388893|P1|Primary Vaccination Phase|Withdrawal by Subject|2
2731365|NCT00134719|9388891|P3|Primary Vaccination Phase|Protocol Violation|0
2731366|NCT00134719|9388892|P2|Primary Vaccination Phase|Protocol Violation|0
2731367|NCT00134719|9388893|P1|Primary Vaccination Phase|Protocol Violation|1
2731368|NCT00134719|9388891|P3|Primary Vaccination Phase|Adverse Event|0
2731369|NCT00134719|9388892|P2|Primary Vaccination Phase|Adverse Event|0
2731370|NCT00134719|9388893|P1|Primary Vaccination Phase|Adverse Event|4
2731371|NCT00134563|9389024|P3|Overall Study|Reason other than above|5
2731372|NCT00134563|9389025|P2|Overall Study|Reason other than above|2
2731373|NCT00134563|9389026|P1|Overall Study|Reason other than above|0
2731374|NCT00134563|9389024|P3|Overall Study|did not wish to continue|26
2731375|NCT00134563|9389025|P2|Overall Study|did not wish to continue|32
2731376|NCT00134563|9389026|P1|Overall Study|did not wish to continue|33
2731377|NCT00134563|9389024|P3|Overall Study|progressive disease|2
2731378|NCT00134563|9389025|P2|Overall Study|progressive disease|4
2731379|NCT00134563|9389026|P1|Overall Study|progressive disease|11
2731380|NCT00134563|9389024|P3|Overall Study|Lost to Follow-up|2
2731381|NCT00134563|9389025|P2|Overall Study|Lost to Follow-up|0
2731382|NCT00134563|9389026|P1|Overall Study|Lost to Follow-up|4
2731383|NCT00134563|9389024|P3|Overall Study|Protocol Violation|5
2731384|NCT00134563|9389025|P2|Overall Study|Protocol Violation|2
2731385|NCT00134563|9389026|P1|Overall Study|Protocol Violation|3
2731386|NCT00134563|9389024|P3|Overall Study|Lack of Efficacy|17
2731387|NCT00134563|9389025|P2|Overall Study|Lack of Efficacy|14
2731388|NCT00134563|9389026|P1|Overall Study|Lack of Efficacy|24
2731389|NCT00134563|9389024|P3|Overall Study|Adverse Event|38
2731390|NCT00134563|9389025|P2|Overall Study|Adverse Event|37
2731391|NCT00134563|9389026|P1|Overall Study|Adverse Event|29
2731392|NCT00134563|9389024|P3|Overall Study|Not treated due to protocol violation|1
2731393|NCT00134563|9389025|P2|Overall Study|Not treated due to protocol violation|1
2731394|NCT00134563|9389026|P1|Overall Study|Not treated due to protocol violation|0
2731395|NCT00134082|9389087|P1|Overall Study|Death|1
2731396|NCT00134082|9389087|P1|Overall Study|Adverse Event|2
2731397|NCT00134056|9389096|P2|Eligible for Protocol Assigned Treatment|Other|56
2731398|NCT00134056|9389097|P1|Eligible for Protocol Assigned Treatment|Other|55
2731399|NCT00134056|9389096|P2|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21
2731400|NCT00134056|9389097|P1|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20
2731401|NCT00134056|9389096|P2|Eligible for Protocol Assigned Treatment|Adverse Event|67
2731402|NCT00134056|9389097|P1|Eligible for Protocol Assigned Treatment|Adverse Event|81
2731403|NCT00134056|9389096|P2|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
2731404|NCT00134056|9389097|P1|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
2731405|NCT00134056|9389096|P2|Randomization|Not eligible for assigned treatment|20
2731406|NCT00134056|9389097|P1|Randomization|Not eligible for assigned treatment|22
2731407|NCT00133991|9389141|P1|Overall Study|Death|4
2731408|NCT00133952|9389180|P2|Overall Study|Sponsor Decision|1
2731409|NCT00133952|9389181|P1|Overall Study|Sponsor Decision|0
2731410|NCT00133952|9389180|P2|Overall Study|Physician Decision|3
2731411|NCT00133952|9389181|P1|Overall Study|Physician Decision|4
2731412|NCT00133952|9389180|P2|Overall Study|Withdrawal by Subject|4
2731413|NCT00133952|9389181|P1|Overall Study|Withdrawal by Subject|20
2731414|NCT00133952|9389180|P2|Overall Study|Protocol Violation|1
2731415|NCT00133952|9389181|P1|Overall Study|Protocol Violation|1
2731416|NCT00133952|9389180|P2|Overall Study|Protocol Entry Criteria Exclusion|1
2731417|NCT00133952|9389181|P1|Overall Study|Protocol Entry Criteria Exclusion|4
2731418|NCT00133952|9389180|P2|Overall Study|Lost to Follow-up|14
2731419|NCT00133952|9389181|P1|Overall Study|Lost to Follow-up|9
2731420|NCT00133952|9389180|P2|Overall Study|Death|2
2731421|NCT00133952|9389181|P1|Overall Study|Death|3
2731422|NCT00133952|9389180|P2|Overall Study|Adverse Event|2
2731423|NCT00133952|9389181|P1|Overall Study|Adverse Event|1
2731424|NCT00133705|9389212|P2|Overall Study|Withdrawal by Subject|3
2731425|NCT00133705|9389213|P1|Overall Study|Withdrawal by Subject|2
2731426|NCT00132873|9389348|P1|Overall Study|Planned Pregnancy|1
2731427|NCT00132873|9389348|P1|Overall Study|Withdrawal by Subject|3
2731428|NCT00132873|9389348|P1|Overall Study|Lack of Efficacy|1
2731429|NCT00132873|9389348|P1|Overall Study|Lost to Follow-up|1
2731430|NCT00132873|9389348|P1|Overall Study|Adverse Event|3
2731431|NCT00132808|9389356|P3|Stratum II|Withdrawal by Subject|6
2731432|NCT00132808|9389357|P2|Stratum II|Withdrawal by Subject|9
2731433|NCT00132808|9389358|P1|Stratum II|Withdrawal by Subject|4
2731434|NCT00132808|9389356|P3|Stratum II|Protocol Violation|1
2731435|NCT00132808|9389357|P2|Stratum II|Protocol Violation|2
2731436|NCT00132808|9389358|P1|Stratum II|Protocol Violation|0
2731437|NCT00132808|9389356|P3|Stratum II|Lost to Follow-up|1
2731438|NCT00132808|9389357|P2|Stratum II|Lost to Follow-up|2
2731439|NCT00132808|9389358|P1|Stratum II|Lost to Follow-up|2
2731440|NCT00132808|9389356|P3|Stratum II|Death|0
2731441|NCT00132808|9389357|P2|Stratum II|Death|0
2731442|NCT00132808|9389358|P1|Stratum II|Death|1
2731443|NCT00132808|9389356|P3|Stratum II|Adverse Event|1
2731444|NCT00132808|9389357|P2|Stratum II|Adverse Event|2
2731445|NCT00132808|9389358|P1|Stratum II|Adverse Event|1
2731446|NCT00132808|9389356|P3|Stratum I|Abnormal test procedure result (s)|1
2731447|NCT00132808|9389357|P2|Stratum I|Abnormal test procedure result (s)|0
2731448|NCT00132808|9389358|P1|Stratum I|Abnormal test procedure result (s)|0
2731449|NCT00132808|9389356|P3|Stratum I|Withdrawal by Subject|3
2731450|NCT00132808|9389357|P2|Stratum I|Withdrawal by Subject|7
2731451|NCT00132808|9389358|P1|Stratum I|Withdrawal by Subject|4
2731452|NCT00132808|9389356|P3|Stratum I|Lost to Follow-up|1
2731453|NCT00132808|9389357|P2|Stratum I|Lost to Follow-up|4
2731454|NCT00132808|9389358|P1|Stratum I|Lost to Follow-up|3
2731455|NCT00132808|9389356|P3|Stratum I|Adverse Event|0
2731456|NCT00132808|9389357|P2|Stratum I|Adverse Event|1
2731457|NCT00132808|9389358|P1|Stratum I|Adverse Event|2
2731458|NCT00132769|9389383|P2|Overall Study|Protocol Violation|1
2731459|NCT00132769|9389384|P1|Overall Study|Protocol Violation|1
2731460|NCT00132769|9389383|P2|Overall Study|Adverse Event|1
2731461|NCT00132769|9389384|P1|Overall Study|Adverse Event|2
2731462|NCT00132769|9389383|P2|Overall Study|Lack of Efficacy|6
2731463|NCT00132769|9389384|P1|Overall Study|Lack of Efficacy|7
2731464|NCT00132769|9389383|P2|Overall Study|Withdrawal by Subject|3
2731465|NCT00132769|9389384|P1|Overall Study|Withdrawal by Subject|1
2731466|NCT00132730|9389410|P6|Period V - Open-label Extension (EXT2)|Site terminated|2
2731467|NCT00132730|9389411|P5|Period V - Open-label Extension (EXT2)|Site terminated|7
2731468|NCT00132730|9389412|P4|Period V - Open-label Extension (EXT2)|Site terminated|0
2731469|NCT00132730|9389413|P3|Period V - Open-label Extension (EXT2)|Site terminated|0
2731470|NCT00132730|9389414|P2|Period V - Open-label Extension (EXT2)|Site terminated|0
2731471|NCT00132730|9389415|P1|Period V - Open-label Extension (EXT2)|Site terminated|0
2731472|NCT00132730|9389410|P6|Period IV - Open-label Extension (EXT2)|Other reasons|0
2731473|NCT00132730|9389411|P5|Period IV - Open-label Extension (EXT2)|Other reasons|6
2731474|NCT00132730|9389412|P4|Period IV - Open-label Extension (EXT2)|Other reasons|0
2731475|NCT00132730|9389413|P3|Period IV - Open-label Extension (EXT2)|Other reasons|0
2731476|NCT00132730|9389414|P2|Period IV - Open-label Extension (EXT2)|Other reasons|0
2731477|NCT00132730|9389415|P1|Period IV - Open-label Extension (EXT2)|Other reasons|0
2731478|NCT00132730|9389410|P6|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
2731479|NCT00132730|9389411|P5|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1
2731480|NCT00132730|9389412|P4|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
2731481|NCT00132730|9389413|P3|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
2731482|NCT00132730|9389414|P2|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
2731483|NCT00132730|9389415|P1|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
2731484|NCT00132730|9389410|P6|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
2731485|NCT00132730|9389411|P5|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3
2731486|NCT00132730|9389412|P4|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
2731487|NCT00132730|9389413|P3|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
2731488|NCT00132730|9389414|P2|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
2731489|NCT00132730|9389415|P1|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
2731490|NCT00132730|9389410|P6|Period IV - Open-label Extension (EXT2)|Site terminated|68
2731491|NCT00132730|9389411|P5|Period IV - Open-label Extension (EXT2)|Site terminated|169
2731492|NCT00132730|9389412|P4|Period IV - Open-label Extension (EXT2)|Site terminated|0
2731493|NCT00132730|9389413|P3|Period IV - Open-label Extension (EXT2)|Site terminated|0
2731494|NCT00132730|9389414|P2|Period IV - Open-label Extension (EXT2)|Site terminated|0
2731495|NCT00132730|9389415|P1|Period IV - Open-label Extension (EXT2)|Site terminated|0
2731496|NCT00132730|9389410|P6|Period III - Blinded Extension (EXT1)|Other reasons|0
2731497|NCT00132730|9389411|P5|Period III - Blinded Extension (EXT1)|Other reasons|0
2731498|NCT00132730|9389412|P4|Period III - Blinded Extension (EXT1)|Other reasons|3
2731499|NCT00132730|9389413|P3|Period III - Blinded Extension (EXT1)|Other reasons|14
2731500|NCT00132730|9389414|P2|Period III - Blinded Extension (EXT1)|Other reasons|0
2731501|NCT00132730|9389415|P1|Period III - Blinded Extension (EXT1)|Other reasons|0
2731502|NCT00132730|9389410|P6|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
2731503|NCT00132730|9389411|P5|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
2731504|NCT00132730|9389412|P4|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1
2731505|NCT00132730|9389413|P3|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
2731506|NCT00132730|9389414|P2|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
2731507|NCT00132730|9389415|P1|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
2731508|NCT00132730|9389410|P6|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
2731509|NCT00132730|9389411|P5|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
2731510|NCT00132730|9389412|P4|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1
2731511|NCT00132730|9389413|P3|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11
2731512|NCT00132730|9389414|P2|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
2731513|NCT00132730|9389415|P1|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
2731514|NCT00132730|9389410|P6|Period III - Blinded Extension (EXT1)|Site terminated|0
2731515|NCT00132730|9389411|P5|Period III - Blinded Extension (EXT1)|Site terminated|0
2731516|NCT00132730|9389412|P4|Period III - Blinded Extension (EXT1)|Site terminated|20
2731517|NCT00132730|9389413|P3|Period III - Blinded Extension (EXT1)|Site terminated|57
2731518|NCT00132730|9389414|P2|Period III - Blinded Extension (EXT1)|Site terminated|0
2731519|NCT00132730|9389415|P1|Period III - Blinded Extension (EXT1)|Site terminated|0
2731520|NCT00132730|9389410|P6|Period II - 12-week Treatment (Base)|Other reasons|0
2731521|NCT00132730|9389411|P5|Period II - 12-week Treatment (Base)|Other reasons|0
2731522|NCT00132730|9389412|P4|Period II - 12-week Treatment (Base)|Other reasons|13
2731523|NCT00132730|9389413|P3|Period II - 12-week Treatment (Base)|Other reasons|9
2731524|NCT00132730|9389414|P2|Period II - 12-week Treatment (Base)|Other reasons|10
2731525|NCT00132730|9389415|P1|Period II - 12-week Treatment (Base)|Other reasons|11
2731526|NCT00132730|9389410|P6|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
2731527|NCT00132730|9389411|P5|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
2731528|NCT00132730|9389412|P4|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
2731529|NCT00132730|9389413|P3|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
2731530|NCT00132730|9389414|P2|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
2731531|NCT00132730|9389415|P1|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
2731532|NCT00132730|9389410|P6|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
2731533|NCT00132730|9389411|P5|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
2731534|NCT00132730|9389412|P4|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
2731535|NCT00132730|9389413|P3|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
2731536|NCT00132730|9389414|P2|Period II - 12-week Treatment (Base)|Clinical adverse experience|4
2731537|NCT00132730|9389415|P1|Period II - 12-week Treatment (Base)|Clinical adverse experience|11
2731538|NCT00132691|9389459|P2|Overall Study|Death|0
2731539|NCT00132691|9389460|P1|Overall Study|Death|2
2731540|NCT00132691|9389459|P2|Overall Study|Missed 2-year visit|4
2731541|NCT00132691|9389460|P1|Overall Study|Missed 2-year visit|4
2731542|NCT00132691|9389459|P2|Overall Study|Lost to Follow-up|8
2731543|NCT00132691|9389460|P1|Overall Study|Lost to Follow-up|5
2731544|NCT00132678|9389500|P3|Period IV (Double-Blind Treatment)|Pregnancy|0
2731545|NCT00132678|9389501|P2|Period IV (Double-Blind Treatment)|Pregnancy|2
2731546|NCT00132678|9389502|P1|Period IV (Double-Blind Treatment)|Pregnancy|0
2731547|NCT00132678|9389500|P3|Period IV (Double-Blind Treatment)|Subject Non-compliant|0
2731548|NCT00132678|9389501|P2|Period IV (Double-Blind Treatment)|Subject Non-compliant|1
2731549|NCT00132678|9389502|P1|Period IV (Double-Blind Treatment)|Subject Non-compliant|2
2731550|NCT00132678|9389500|P3|Period IV (Double-Blind Treatment)|Physician Decision|0
2731551|NCT00132678|9389501|P2|Period IV (Double-Blind Treatment)|Physician Decision|14
2731552|NCT00132678|9389502|P1|Period IV (Double-Blind Treatment)|Physician Decision|10
2731553|NCT00132678|9389500|P3|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0
2731554|NCT00132678|9389501|P2|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15
2731555|NCT00132678|9389502|P1|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14
2731556|NCT00132678|9389500|P3|Period IV (Double-Blind Treatment)|Lost to Follow-up|0
2731557|NCT00132678|9389501|P2|Period IV (Double-Blind Treatment)|Lost to Follow-up|3
2731558|NCT00132678|9389502|P1|Period IV (Double-Blind Treatment)|Lost to Follow-up|6
2731559|NCT00132678|9389500|P3|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0
2731560|NCT00132678|9389501|P2|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
2731561|NCT00132678|9389502|P1|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
2731562|NCT00132678|9389500|P3|Period IV (Double-Blind Treatment)|Adverse Event|0
2731563|NCT00132678|9389501|P2|Period IV (Double-Blind Treatment)|Adverse Event|1
2731564|NCT00132678|9389502|P1|Period IV (Double-Blind Treatment)|Adverse Event|1
2731565|NCT00132678|9389500|P3|Period III (Open-Label Stabilization)|Pregnancy|0
2731566|NCT00132678|9389501|P2|Period III (Open-Label Stabilization)|Pregnancy|0
2731567|NCT00132678|9389502|P1|Period III (Open-Label Stabilization)|Pregnancy|2
2731568|NCT00132678|9389500|P3|Period III (Open-Label Stabilization)|Physician Decision|0
2731569|NCT00132678|9389501|P2|Period III (Open-Label Stabilization)|Physician Decision|0
2731570|NCT00132678|9389502|P1|Period III (Open-Label Stabilization)|Physician Decision|1
2731571|NCT00132678|9389500|P3|Period III (Open-Label Stabilization)|Subject non-compliant|0
2731572|NCT00132678|9389501|P2|Period III (Open-Label Stabilization)|Subject non-compliant|0
2731573|NCT00132678|9389502|P1|Period III (Open-Label Stabilization)|Subject non-compliant|1
2731574|NCT00132678|9389500|P3|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
2731575|NCT00132678|9389501|P2|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
2731576|NCT00132678|9389502|P1|Period III (Open-Label Stabilization)|Withdrawal by Subject|49
2731577|NCT00132678|9389500|P3|Period III (Open-Label Stabilization)|Lost to Follow-up|0
2731578|NCT00132678|9389501|P2|Period III (Open-Label Stabilization)|Lost to Follow-up|0
2731579|NCT00132678|9389502|P1|Period III (Open-Label Stabilization)|Lost to Follow-up|19
2731580|NCT00132678|9389500|P3|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
2731581|NCT00132678|9389501|P2|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
2731582|NCT00132678|9389502|P1|Period III (Open-Label Stabilization)|Ineligible to continue trial|5
2731583|NCT00132678|9389500|P3|Period III (Open-Label Stabilization)|Non responder|0
2731584|NCT00132678|9389501|P2|Period III (Open-Label Stabilization)|Non responder|0
2731585|NCT00132678|9389502|P1|Period III (Open-Label Stabilization)|Non responder|107
2731586|NCT00132678|9389500|P3|Period III (Open-Label Stabilization)|Adverse Event|0
2731587|NCT00132678|9389501|P2|Period III (Open-Label Stabilization)|Adverse Event|0
2731588|NCT00132678|9389502|P1|Period III (Open-Label Stabilization)|Adverse Event|12
2731589|NCT00132678|9389500|P3|Period III (Open-Label Stabilization)|Death|0
2731590|NCT00132678|9389501|P2|Period III (Open-Label Stabilization)|Death|0
2731591|NCT00132678|9389502|P1|Period III (Open-Label Stabilization)|Death|2
2731592|NCT00132678|9389500|P3|Period II (Open-Label Oral Risperidone)|Physician Decision|1
2731593|NCT00132678|9389501|P2|Period II (Open-Label Oral Risperidone)|Physician Decision|0
2731594|NCT00132678|9389502|P1|Period II (Open-Label Oral Risperidone)|Physician Decision|0
2731595|NCT00132678|9389500|P3|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16
2731596|NCT00132678|9389501|P2|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
2731597|NCT00132678|9389502|P1|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
2731598|NCT00132678|9389500|P3|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14
2731599|NCT00132678|9389501|P2|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
2731600|NCT00132678|9389502|P1|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
2731601|NCT00132678|9389500|P3|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7
2731602|NCT00132678|9389501|P2|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
2731603|NCT00132678|9389502|P1|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
2731604|NCT00132678|9389500|P3|Period II (Open-Label Oral Risperidone)|Non responder|6
2731605|NCT00132678|9389501|P2|Period II (Open-Label Oral Risperidone)|Non responder|0
2731606|NCT00132678|9389502|P1|Period II (Open-Label Oral Risperidone)|Non responder|0
2731607|NCT00132678|9389500|P3|Period II (Open-Label Oral Risperidone)|Adverse Event|13
2731608|NCT00132678|9389501|P2|Period II (Open-Label Oral Risperidone)|Adverse Event|0
2731609|NCT00132678|9389502|P1|Period II (Open-Label Oral Risperidone)|Adverse Event|0
2731610|NCT00132678|9389500|P3|Period II (Open-Label Oral Risperidone)|Death|1
2731611|NCT00132678|9389501|P2|Period II (Open-Label Oral Risperidone)|Death|0
2731612|NCT00132678|9389502|P1|Period II (Open-Label Oral Risperidone)|Death|0
2731613|NCT00132496|9389516|P2|Overall Study|Physician Decision|0
2731614|NCT00132496|9389517|P1|Overall Study|Physician Decision|1
2731615|NCT00132496|9389516|P2|Overall Study|Withdrawal by Subject|2
2731616|NCT00132496|9389517|P1|Overall Study|Withdrawal by Subject|1
2731617|NCT00132314|9389525|P2|Overall Study|Refused intervention at baseline|7
2731618|NCT00132314|9389526|P1|Overall Study|Refused intervention at baseline|2
2731619|NCT00132314|9389525|P2|Overall Study|Lacked SSN|3
2731620|NCT00132314|9389526|P1|Overall Study|Lacked SSN|1
2731621|NCT00132314|9389525|P2|Overall Study|Lost to Follow-up|62
2731622|NCT00132314|9389526|P1|Overall Study|Lost to Follow-up|70
2731623|NCT00132301|9389536|P2|Overall Study|Excluded by Data Monitoring Committee|0
2731624|NCT00132301|9389537|P1|Overall Study|Excluded by Data Monitoring Committee|1
2731625|NCT00132301|9389536|P2|Overall Study|Other|1
2731626|NCT00132301|9389537|P1|Overall Study|Other|1
2731627|NCT00132301|9389536|P2|Overall Study|Lost to Follow-up|3
2731628|NCT00132301|9389537|P1|Overall Study|Lost to Follow-up|5
2731629|NCT00132301|9389536|P2|Overall Study|Physician Decision|1
2731630|NCT00132301|9389537|P1|Overall Study|Physician Decision|1
2731631|NCT00132301|9389536|P2|Overall Study|Withdrawal by Subject|2
2731632|NCT00132301|9389537|P1|Overall Study|Withdrawal by Subject|5
2731633|NCT00132301|9389536|P2|Overall Study|Death|6
2731634|NCT00132301|9389537|P1|Overall Study|Death|7
2731635|NCT00132132|9389545|P2|Overall Study|Lost to Follow-up|2
2731636|NCT00132132|9389546|P1|Overall Study|Lost to Follow-up|7
2731637|NCT00132028|9389554|P1|Overall Study|Physician Decision|3
2731638|NCT00132028|9389554|P1|Overall Study|not eligible|2
2731639|NCT00132028|9389554|P1|Overall Study|Withdrawal by Subject|2
2731640|NCT00132028|9389554|P1|Overall Study|Lack of Efficacy|11
2731641|NCT00132028|9389554|P1|Overall Study|Death|2
2731642|NCT00132028|9389554|P1|Overall Study|Adverse Event|7
2731643|NCT00131937|9389566|P1|Overall Study|Alternative therapy|1
2731644|NCT00131937|9389566|P1|Overall Study|Disease Progression|7
2731645|NCT00131937|9389566|P1|Overall Study|Physician Decision|1
2731646|NCT00131937|9389566|P1|Overall Study|Withdrawal by Subject|2
2731647|NCT00131937|9389566|P1|Overall Study|Adverse Event|3
2731648|NCT00131911|9389574|P2|Overall Study|Withdrawal by Subject|0
2731649|NCT00131911|9389575|P1|Overall Study|Withdrawal by Subject|1
2731650|NCT00131664|9389645|P6|Second Period (Additional Drug Added)|Administrative reasons|0
2731651|NCT00131664|9389646|P5|Second Period (Additional Drug Added)|Administrative reasons|1
2731652|NCT00131664|9389647|P4|Second Period (Additional Drug Added)|Administrative reasons|0
2731653|NCT00131664|9389648|P3|Second Period (Additional Drug Added)|Administrative reasons|0
2731654|NCT00131664|9389649|P2|Second Period (Additional Drug Added)|Administrative reasons|2
2731655|NCT00131664|9389650|P1|Second Period (Additional Drug Added)|Administrative reasons|4
2731656|NCT00131664|9389645|P6|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
2731657|NCT00131664|9389646|P5|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
2731658|NCT00131664|9389647|P4|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1
2731659|NCT00131664|9389648|P3|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
2731660|NCT00131664|9389649|P2|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
2731661|NCT00131664|9389650|P1|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
2731662|NCT00131664|9389645|P6|Second Period (Additional Drug Added)|Adverse Event|1
2731663|NCT00131664|9389646|P5|Second Period (Additional Drug Added)|Adverse Event|0
2731664|NCT00131664|9389647|P4|Second Period (Additional Drug Added)|Adverse Event|0
2731665|NCT00131664|9389648|P3|Second Period (Additional Drug Added)|Adverse Event|0
2731666|NCT00131664|9389649|P2|Second Period (Additional Drug Added)|Adverse Event|1
2731667|NCT00131664|9389650|P1|Second Period (Additional Drug Added)|Adverse Event|0
2731668|NCT00131664|9389645|P6|Second Period (Additional Drug Added)|Withdrawal by Subject|0
2731669|NCT00131664|9389646|P5|Second Period (Additional Drug Added)|Withdrawal by Subject|0
2731670|NCT00131664|9389647|P4|Second Period (Additional Drug Added)|Withdrawal by Subject|0
2731671|NCT00131664|9389648|P3|Second Period (Additional Drug Added)|Withdrawal by Subject|0
2731672|NCT00131664|9389649|P2|Second Period (Additional Drug Added)|Withdrawal by Subject|0
2731673|NCT00131664|9389650|P1|Second Period (Additional Drug Added)|Withdrawal by Subject|2
2731674|NCT00131664|9389645|P6|Second Period (Additional Drug Added)|Protocol Violation|0
2731675|NCT00131664|9389646|P5|Second Period (Additional Drug Added)|Protocol Violation|0
2731676|NCT00131664|9389647|P4|Second Period (Additional Drug Added)|Protocol Violation|0
2731677|NCT00131664|9389648|P3|Second Period (Additional Drug Added)|Protocol Violation|1
2731678|NCT00131664|9389649|P2|Second Period (Additional Drug Added)|Protocol Violation|1
2731679|NCT00131664|9389650|P1|Second Period (Additional Drug Added)|Protocol Violation|0
2731680|NCT00131664|9389645|P6|Second Period (Additional Drug Added)|Lost to Follow-up|2
2731681|NCT00131664|9389646|P5|Second Period (Additional Drug Added)|Lost to Follow-up|0
2731682|NCT00131664|9389647|P4|Second Period (Additional Drug Added)|Lost to Follow-up|1
2731683|NCT00131664|9389648|P3|Second Period (Additional Drug Added)|Lost to Follow-up|2
2731684|NCT00131664|9389649|P2|Second Period (Additional Drug Added)|Lost to Follow-up|0
2731685|NCT00131664|9389650|P1|Second Period (Additional Drug Added)|Lost to Follow-up|3
2731686|NCT00131664|9389645|P6|First Period (First 6 Months)|Administrative reasons|0
2731687|NCT00131664|9389646|P5|First Period (First 6 Months)|Administrative reasons|0
2731688|NCT00131664|9389647|P4|First Period (First 6 Months)|Administrative reasons|0
2731689|NCT00131664|9389648|P3|First Period (First 6 Months)|Administrative reasons|5
2731690|NCT00131664|9389649|P2|First Period (First 6 Months)|Administrative reasons|0
2731691|NCT00131664|9389650|P1|First Period (First 6 Months)|Administrative reasons|2
2731692|NCT00131664|9389645|P6|First Period (First 6 Months)|Clinically significant lab abnormalities|0
2731693|NCT00131664|9389646|P5|First Period (First 6 Months)|Clinically significant lab abnormalities|0
2731694|NCT00131664|9389647|P4|First Period (First 6 Months)|Clinically significant lab abnormalities|0
2731695|NCT00131664|9389648|P3|First Period (First 6 Months)|Clinically significant lab abnormalities|0
2731696|NCT00131664|9389649|P2|First Period (First 6 Months)|Clinically significant lab abnormalities|2
2731697|NCT00131664|9389650|P1|First Period (First 6 Months)|Clinically significant lab abnormalities|1
2731698|NCT00131664|9389645|P6|First Period (First 6 Months)|Adverse Event|0
2731699|NCT00131664|9389646|P5|First Period (First 6 Months)|Adverse Event|0
2731700|NCT00131664|9389647|P4|First Period (First 6 Months)|Adverse Event|0
2731701|NCT00131664|9389648|P3|First Period (First 6 Months)|Adverse Event|5
2731702|NCT00131664|9389649|P2|First Period (First 6 Months)|Adverse Event|4
2731703|NCT00131664|9389650|P1|First Period (First 6 Months)|Adverse Event|9
2731704|NCT00131664|9389645|P6|First Period (First 6 Months)|Withdrawal by Subject|0
2731705|NCT00131664|9389646|P5|First Period (First 6 Months)|Withdrawal by Subject|0
2731706|NCT00131664|9389647|P4|First Period (First 6 Months)|Withdrawal by Subject|0
2731707|NCT00131664|9389648|P3|First Period (First 6 Months)|Withdrawal by Subject|2
2731708|NCT00131664|9389649|P2|First Period (First 6 Months)|Withdrawal by Subject|6
2731709|NCT00131664|9389650|P1|First Period (First 6 Months)|Withdrawal by Subject|4
2731710|NCT00131664|9389645|P6|First Period (First 6 Months)|Protocol Violation|0
2731711|NCT00131664|9389646|P5|First Period (First 6 Months)|Protocol Violation|0
2731712|NCT00131664|9389647|P4|First Period (First 6 Months)|Protocol Violation|0
2731713|NCT00131664|9389648|P3|First Period (First 6 Months)|Protocol Violation|1
2731714|NCT00131664|9389649|P2|First Period (First 6 Months)|Protocol Violation|2
2731715|NCT00131664|9389650|P1|First Period (First 6 Months)|Protocol Violation|2
2731716|NCT00131664|9389645|P6|First Period (First 6 Months)|Death|0
2731717|NCT00131664|9389646|P5|First Period (First 6 Months)|Death|0
2731718|NCT00131664|9389647|P4|First Period (First 6 Months)|Death|0
2731719|NCT00131664|9389648|P3|First Period (First 6 Months)|Death|0
2731720|NCT00131664|9389649|P2|First Period (First 6 Months)|Death|1
2731721|NCT00131664|9389650|P1|First Period (First 6 Months)|Death|0
2731722|NCT00131664|9389645|P6|First Period (First 6 Months)|Lost to Follow-up|0
2731723|NCT00131664|9389646|P5|First Period (First 6 Months)|Lost to Follow-up|0
2731724|NCT00131664|9389647|P4|First Period (First 6 Months)|Lost to Follow-up|0
2731725|NCT00131664|9389648|P3|First Period (First 6 Months)|Lost to Follow-up|3
2731726|NCT00131664|9389649|P2|First Period (First 6 Months)|Lost to Follow-up|3
2731727|NCT00131664|9389650|P1|First Period (First 6 Months)|Lost to Follow-up|7
2731728|NCT00131508|9389722|P2|Overall Study|Withdrawal by Subject|2
2731729|NCT00131508|9389723|P1|Overall Study|Withdrawal by Subject|1
2731730|NCT00131508|9389722|P2|Overall Study|Non-Compliance|4
2731731|NCT00131508|9389723|P1|Overall Study|Non-Compliance|2
2731732|NCT00131508|9389722|P2|Overall Study|Disease progression|2
2731733|NCT00131508|9389723|P1|Overall Study|Disease progression|0
2731734|NCT00131469|9389747|P2|Overall Study|scan not analyzable|6
2731735|NCT00131469|9389748|P1|Overall Study|scan not analyzable|3
2731736|NCT00131469|9389747|P2|Overall Study|Lost to Follow-up|1
2731737|NCT00131469|9389748|P1|Overall Study|Lost to Follow-up|0
2731738|NCT00131469|9389747|P2|Overall Study|Death|1
2731739|NCT00131469|9389748|P1|Overall Study|Death|0
2731740|NCT00131469|9389747|P2|Overall Study|Protocol Violation|1
2731741|NCT00131469|9389748|P1|Overall Study|Protocol Violation|3
2731742|NCT00131469|9389747|P2|Overall Study|Withdrawal by Subject|4
2731743|NCT00131469|9389748|P1|Overall Study|Withdrawal by Subject|3
2731744|NCT00131365|9389794|P1|Overall Study|Alternative treatment|3
2731745|NCT00131365|9389794|P1|Overall Study|Withdrawal by Subject|1
2731746|NCT00131352|9389801|P2|Repeat Treatment Period|Other|0
2731747|NCT00131352|9389802|P1|Repeat Treatment Period|Other|1
2731748|NCT00131352|9389801|P2|Repeat Treatment Period|Adverse Event|0
2731749|NCT00131352|9389802|P1|Repeat Treatment Period|Adverse Event|1
2731750|NCT00131352|9389801|P2|Initial Treatment Period|Other|2
2731751|NCT00131352|9389802|P1|Initial Treatment Period|Other|0
2731752|NCT00131352|9389801|P2|Initial Treatment Period|Lack of Efficacy|4
2731753|NCT00131352|9389802|P1|Initial Treatment Period|Lack of Efficacy|6
2731754|NCT00131352|9389801|P2|Initial Treatment Period|Withdrawal by Subject|1
2731755|NCT00131352|9389802|P1|Initial Treatment Period|Withdrawal by Subject|1
2731756|NCT00131352|9389801|P2|Initial Treatment Period|Non-compliant|2
2731757|NCT00131352|9389802|P1|Initial Treatment Period|Non-compliant|1
2731758|NCT00131352|9389801|P2|Initial Treatment Period|Adverse Event|3
2731759|NCT00131352|9389802|P1|Initial Treatment Period|Adverse Event|1
2731760|NCT00131248|9389824|P2|Intervention 1 (3-day Course)|Withdrawal by Subject|0
2731761|NCT00131248|9389825|P1|Intervention 1 (3-day Course)|Withdrawal by Subject|1
2731762|NCT00130832|9389852|P2|Overall Study|Other|3
2731763|NCT00130832|9389853|P1|Overall Study|Other|0
2731764|NCT00130832|9389852|P2|Overall Study|Moved|2
2731765|NCT00130832|9389853|P1|Overall Study|Moved|2
2731766|NCT00130832|9389852|P2|Overall Study|Withdrawal by Subject|1
2731767|NCT00130832|9389853|P1|Overall Study|Withdrawal by Subject|6
2731768|NCT00130832|9389852|P2|Overall Study|Protocol Violation|8
2731769|NCT00130832|9389853|P1|Overall Study|Protocol Violation|6
2731770|NCT00130832|9389852|P2|Overall Study|Lost to Follow-up|2
2731771|NCT00130832|9389853|P1|Overall Study|Lost to Follow-up|1
2731772|NCT00130832|9389852|P2|Overall Study|Adverse Event|1
2731773|NCT00130832|9389853|P1|Overall Study|Adverse Event|1
2731774|NCT00130793|9389865|P2|Overall Study|Withdrew consent|0
2731775|NCT00130793|9389866|P1|Overall Study|Withdrew consent|2
2731776|NCT00130793|9389865|P2|Overall Study|Lost to Follow-up|4
2731777|NCT00130793|9389866|P1|Overall Study|Lost to Follow-up|1
2731778|NCT00130728|9389887|P2|Overall Study|Withdrawal by Subject|2
2731779|NCT00130728|9389888|P1|Overall Study|Withdrawal by Subject|0
2731780|NCT00130728|9389887|P2|Overall Study|Lost to Follow-up|0
2731781|NCT00130728|9389888|P1|Overall Study|Lost to Follow-up|4
2731782|NCT00130728|9389887|P2|Overall Study|Death|211
2731783|NCT00130728|9389888|P1|Overall Study|Death|207
2731784|NCT00130689|9389900|P1|Overall Study|Ineligible|6
2731785|NCT00130689|9389900|P1|Overall Study|Withdrawal by Subject|3
2731786|NCT00130689|9389900|P1|Overall Study|Clinical Deterioration|4
2731787|NCT00130689|9389900|P1|Overall Study|Death|1
2731788|NCT00130689|9389900|P1|Overall Study|Progressive Disease|29
2731789|NCT00130637|9389904|P1|Overall Study|Withdrawal by Subject|1
2731790|NCT00130637|9389904|P1|Overall Study|Adverse Event|2
2731791|NCT00130533|9389911|P2|Overall Study|Other|5
2731792|NCT00130533|9389912|P1|Overall Study|Other|12
2731793|NCT00130533|9389911|P2|Overall Study|Second Primary Malignancy|1
2731794|NCT00130533|9389912|P1|Overall Study|Second Primary Malignancy|0
2731795|NCT00130533|9389911|P2|Overall Study|Sponsor´s decision|0
2731796|NCT00130533|9389912|P1|Overall Study|Sponsor´s decision|2
2731797|NCT00130533|9389911|P2|Overall Study|Lost to Follow-up|1
2731798|NCT00130533|9389912|P1|Overall Study|Lost to Follow-up|1
2731799|NCT00130533|9389911|P2|Overall Study|Protocol Violation|1
2731800|NCT00130533|9389912|P1|Overall Study|Protocol Violation|5
2731801|NCT00130533|9389911|P2|Overall Study|Death|2
2731802|NCT00130533|9389912|P1|Overall Study|Death|4
2731803|NCT00130533|9389911|P2|Overall Study|Interruption of treatment > 3 weeks|0
2731804|NCT00130533|9389912|P1|Overall Study|Interruption of treatment > 3 weeks|11
2731805|NCT00130533|9389911|P2|Overall Study|Disease relapse|13
2731806|NCT00130533|9389912|P1|Overall Study|Disease relapse|9
2731807|NCT00130533|9389911|P2|Overall Study|Adverse Event|1
2731808|NCT00130533|9389912|P1|Overall Study|Adverse Event|34
2731809|NCT00130533|9389911|P2|Overall Study|Withdrawal by Subject|6
2731810|NCT00130533|9389912|P1|Overall Study|Withdrawal by Subject|33
2731811|NCT00130520|9389924|P1|Overall Study|Did not meet re-treatment criteria|1
2731812|NCT00130520|9389924|P1|Overall Study|Protocol non-compliance|1
2731813|NCT00130520|9389924|P1|Overall Study|Disease Progression|23
2731814|NCT00130520|9389924|P1|Overall Study|Withdrawal by Subject|1
2731815|NCT00130520|9389924|P1|Overall Study|Physician Decision|1
2731816|NCT00130520|9389924|P1|Overall Study|Death|1
2731817|NCT00130520|9389924|P1|Overall Study|Adverse Event|11
2731818|NCT00130286|9389934|P4|Overall Study|Missing lab specimens|0
2731819|NCT00130286|9389935|P3|Overall Study|Missing lab specimens|0
2731820|NCT00130286|9389936|P2|Overall Study|Missing lab specimens|2
2731821|NCT00130286|9389937|P1|Overall Study|Missing lab specimens|0
2731822|NCT00130286|9389934|P4|Overall Study|Adverse Event|0
2731823|NCT00130286|9389935|P3|Overall Study|Adverse Event|2
2731824|NCT00130286|9389936|P2|Overall Study|Adverse Event|0
2731825|NCT00130286|9389937|P1|Overall Study|Adverse Event|0
2731826|NCT00130286|9389934|P4|Overall Study|Withdrawal by Subject|2
2731827|NCT00130286|9389935|P3|Overall Study|Withdrawal by Subject|2
2731828|NCT00130286|9389936|P2|Overall Study|Withdrawal by Subject|1
2731829|NCT00130286|9389937|P1|Overall Study|Withdrawal by Subject|0
2731830|NCT00130247|9389957|P2|Overall Study|Not compliant with DOT|2
2731831|NCT00130247|9389958|P1|Overall Study|Not compliant with DOT|0
2731832|NCT00130247|9389957|P2|Overall Study|Post-randomization exclusion|2
2731833|NCT00130247|9389958|P1|Overall Study|Post-randomization exclusion|1
2731834|NCT00130247|9389957|P2|Overall Study|Pregnancy|0
2731835|NCT00130247|9389958|P1|Overall Study|Pregnancy|1
2731836|NCT00130208|9389976|P2|Washout Period (8 Weeks)|Other|1
2731837|NCT00130208|9389977|P1|Washout Period (8 Weeks)|Other|1
2731838|NCT00130208|9389976|P2|Washout Period (8 Weeks)|Lost to Follow-up|1
2731839|NCT00130208|9389977|P1|Washout Period (8 Weeks)|Lost to Follow-up|0
2731840|NCT00130208|9389976|P2|Washout Period (8 Weeks)|Withdrawal by Subject|4
2731841|NCT00130208|9389977|P1|Washout Period (8 Weeks)|Withdrawal by Subject|2
2731842|NCT00130208|9389976|P2|Washout Period (8 Weeks)|Adverse Event|6
2731843|NCT00130208|9389977|P1|Washout Period (8 Weeks)|Adverse Event|3
2731844|NCT00130208|9389976|P2|Maintenance Period (26 Weeks)|Other|1
2731845|NCT00130208|9389977|P1|Maintenance Period (26 Weeks)|Other|1
2731846|NCT00130208|9389976|P2|Maintenance Period (26 Weeks)|Lost to Follow-up|4
2731847|NCT00130208|9389977|P1|Maintenance Period (26 Weeks)|Lost to Follow-up|5
2731848|NCT00130208|9389976|P2|Maintenance Period (26 Weeks)|Withdrawal by Subject|11
2731849|NCT00130208|9389977|P1|Maintenance Period (26 Weeks)|Withdrawal by Subject|8
2731850|NCT00130208|9389976|P2|Maintenance Period (26 Weeks)|Physician Decision|2
2731851|NCT00130208|9389977|P1|Maintenance Period (26 Weeks)|Physician Decision|0
2731852|NCT00130208|9389976|P2|Maintenance Period (26 Weeks)|Adverse Event|12
2731853|NCT00130208|9389977|P1|Maintenance Period (26 Weeks)|Adverse Event|10
2731854|NCT00130039|9390013|P2|Overall Study|clinical events without follow up MRI|4
2731855|NCT00130039|9390014|P1|Overall Study|clinical events without follow up MRI|5
2731856|NCT00130039|9390013|P2|Overall Study|Physician Decision|0
2731857|NCT00130039|9390014|P1|Overall Study|Physician Decision|3
2731858|NCT00130039|9390013|P2|Overall Study|Adverse Event|2
2731859|NCT00130039|9390014|P1|Overall Study|Adverse Event|4
2731860|NCT00130039|9390013|P2|Overall Study|Lost to Follow-up|1
2731861|NCT00130039|9390014|P1|Overall Study|Lost to Follow-up|3
2731862|NCT00130039|9390013|P2|Overall Study|Withdrawal by Subject|11
2731863|NCT00130039|9390014|P1|Overall Study|Withdrawal by Subject|15
2731864|NCT00129987|9390032|P2|1 Year|Withdrawal by Subject|21
2731865|NCT00129987|9390033|P1|1 Year|Withdrawal by Subject|32
2731866|NCT00129987|9390032|P2|1st Educational Session|Withdrawal by Subject|109
2731867|NCT00129987|9390033|P1|1st Educational Session|Withdrawal by Subject|141
2731868|NCT00129974|9390045|P1|Overall Study|Other|1
2731869|NCT00129961|9390052|P2|Overall Study|Missing Record|1
2731870|NCT00129961|9390053|P1|Overall Study|Missing Record|0
2731871|NCT00129961|9390052|P2|Overall Study|Withdrawal by Subject|1
2731872|NCT00129961|9390053|P1|Overall Study|Withdrawal by Subject|2
2731873|NCT00129961|9390052|P2|Overall Study|Physician Decision|0
2731874|NCT00129961|9390053|P1|Overall Study|Physician Decision|1
2731875|NCT00129961|9390052|P2|Overall Study|Withdrawal by Sponsor|20
2731876|NCT00129961|9390053|P1|Overall Study|Withdrawal by Sponsor|14
2731877|NCT00129961|9390052|P2|Overall Study|Death|1
2731878|NCT00129961|9390053|P1|Overall Study|Death|1
2731879|NCT00129961|9390052|P2|Overall Study|Adverse Event|0
2731880|NCT00129961|9390053|P1|Overall Study|Adverse Event|1
2731881|NCT00129935|9390089|P2|Overall Study|Incorrect study treatment|0
2731882|NCT00129935|9390090|P1|Overall Study|Incorrect study treatment|1
2731883|NCT00129935|9390089|P2|Overall Study|Crossed to the other arm|1
2731884|NCT00129935|9390090|P1|Overall Study|Crossed to the other arm|2
2731885|NCT00129935|9390089|P2|Overall Study|Other|2
2731886|NCT00129935|9390090|P1|Overall Study|Other|3
2731887|NCT00129935|9390089|P2|Overall Study|Second primary|1
2731888|NCT00129935|9390090|P1|Overall Study|Second primary|0
2731889|NCT00129935|9390089|P2|Overall Study|Recurrence|3
2731890|NCT00129935|9390090|P1|Overall Study|Recurrence|1
2731891|NCT00129935|9390089|P2|Overall Study|Physician Decision|4
2731892|NCT00129935|9390090|P1|Overall Study|Physician Decision|3
2731893|NCT00129935|9390089|P2|Overall Study|Protocol Violation|4
2731894|NCT00129935|9390090|P1|Overall Study|Protocol Violation|0
2731895|NCT00129935|9390089|P2|Overall Study|Withdrawal by Subject|20
2731896|NCT00129935|9390090|P1|Overall Study|Withdrawal by Subject|7
2731897|NCT00129935|9390089|P2|Overall Study|Death|1
2731898|NCT00129935|9390090|P1|Overall Study|Death|1
2731899|NCT00129935|9390089|P2|Overall Study|Adverse Event|56
2731900|NCT00129935|9390090|P1|Overall Study|Adverse Event|18
2731901|NCT00129766|9390108|P2|Overall Study|Lost to Follow-up|21
2731902|NCT00129766|9390109|P1|Overall Study|Lost to Follow-up|26
2731903|NCT00129766|9390108|P2|Overall Study|Withdrawal of consent|30
2731904|NCT00129766|9390109|P1|Overall Study|Withdrawal of consent|31
2731905|NCT00129766|9390108|P2|Overall Study|Death|8
2731906|NCT00129766|9390109|P1|Overall Study|Death|3
2731907|NCT00129701|9390158|P1|Overall Study|Withdrawal by Subject|33
2731908|NCT00129649|9390167|P2|Overall Study|Withdrawal by Subject|65
2731909|NCT00129649|9390168|P1|Overall Study|Withdrawal by Subject|76
2731910|NCT00129623|9390176|P2|Overall Study|Uncertainty to return|1
2731911|NCT00129623|9390177|P1|Overall Study|Uncertainty to return|0
2731912|NCT00129623|9390176|P2|Overall Study|Relocated job out of state|0
2731913|NCT00129623|9390177|P1|Overall Study|Relocated job out of state|1
2731914|NCT00129623|9390176|P2|Overall Study|Failure to Return|1
2731915|NCT00129623|9390177|P1|Overall Study|Failure to Return|1
2731916|NCT00129623|9390176|P2|Overall Study|Refused Treatment|3
2731917|NCT00129623|9390177|P1|Overall Study|Refused Treatment|5
2731918|NCT00129623|9390176|P2|Overall Study|Adverse Event|7
2731919|NCT00129623|9390177|P1|Overall Study|Adverse Event|3
2731920|NCT00129545|9390202|P3|Overall Study|Device not implanted|0
2731921|NCT00129545|9390203|P2|Overall Study|Device not implanted|61
2731922|NCT00129545|9390204|P1|Overall Study|Device not implanted|16
2731923|NCT00129545|9390202|P3|Overall Study|Physician Decision|10
2731924|NCT00129545|9390203|P2|Overall Study|Physician Decision|3
2731925|NCT00129545|9390204|P1|Overall Study|Physician Decision|0
2731926|NCT00129545|9390202|P3|Overall Study|Lost to Follow-up|13
2731927|NCT00129545|9390203|P2|Overall Study|Lost to Follow-up|22
2731928|NCT00129545|9390204|P1|Overall Study|Lost to Follow-up|2
2731929|NCT00129545|9390202|P3|Overall Study|Withdrawal by Subject|44
2731930|NCT00129545|9390203|P2|Overall Study|Withdrawal by Subject|18
2731931|NCT00129545|9390204|P1|Overall Study|Withdrawal by Subject|3
2731932|NCT00129545|9390202|P3|Overall Study|Death|44
2731933|NCT00129545|9390203|P2|Overall Study|Death|60
2731934|NCT00129545|9390204|P1|Overall Study|Death|5
2731935|NCT00129467|9390233|P2|Open Label for SSRI+Methylphenidate Arm|Delirium|0
2731936|NCT00129467|9390234|P1|Open Label for SSRI+Methylphenidate Arm|Delirium|1
2731937|NCT00129467|9390233|P2|Open Label for SSRI+Methylphenidate Arm|Death|0
2731938|NCT00129467|9390234|P1|Open Label for SSRI+Methylphenidate Arm|Death|1
2731939|NCT00129467|9390233|P2|Received Intervention|Dizzyness, fatigue|1
2731940|NCT00129467|9390234|P1|Received Intervention|Dizzyness, fatigue|0
2731941|NCT00129467|9390233|P2|Received Intervention|Intolerance to citalopram|1
2731942|NCT00129467|9390234|P1|Received Intervention|Intolerance to citalopram|0
2731943|NCT00129467|9390233|P2|Received Intervention|Nausea|0
2731944|NCT00129467|9390234|P1|Received Intervention|Nausea|1
2731945|NCT00129467|9390233|P2|Received Intervention|Withdrawal by Subject|0
2731946|NCT00129467|9390234|P1|Received Intervention|Withdrawal by Subject|1
2731947|NCT00129467|9390233|P2|Received Intervention|Delirium|0
2731948|NCT00129467|9390234|P1|Received Intervention|Delirium|2
2731949|NCT00129467|9390233|P2|Received Intervention|Cardiac SAE (hypertension)|1
2731950|NCT00129467|9390234|P1|Received Intervention|Cardiac SAE (hypertension)|1
2731951|NCT00129467|9390233|P2|Received Intervention|Death|1
2731952|NCT00129467|9390234|P1|Received Intervention|Death|1
2731953|NCT00129402|9390265|P7|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1
2731954|NCT00129402|9390266|P6|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
2731955|NCT00129402|9390267|P5|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
2731956|NCT00129402|9390268|P4|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
2731957|NCT00129402|9390269|P3|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
2731958|NCT00129402|9390270|P2|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
2731959|NCT00129402|9390271|P1|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
2731960|NCT00129402|9390265|P7|Start Period3 to End Period3(Week 34-53)|Subject moved|1
2731961|NCT00129402|9390266|P6|Start Period3 to End Period3(Week 34-53)|Subject moved|0
2731962|NCT00129402|9390267|P5|Start Period3 to End Period3(Week 34-53)|Subject moved|0
2731963|NCT00129402|9390268|P4|Start Period3 to End Period3(Week 34-53)|Subject moved|0
2731964|NCT00129402|9390269|P3|Start Period3 to End Period3(Week 34-53)|Subject moved|0
2731965|NCT00129402|9390270|P2|Start Period3 to End Period3(Week 34-53)|Subject moved|0
2731966|NCT00129402|9390271|P1|Start Period3 to End Period3(Week 34-53)|Subject moved|0
2731967|NCT00129402|9390265|P7|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3
2731968|NCT00129402|9390266|P6|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
2731969|NCT00129402|9390267|P5|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
2731970|NCT00129402|9390268|P4|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
2731971|NCT00129402|9390269|P3|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
2731972|NCT00129402|9390270|P2|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
2731973|NCT00129402|9390271|P1|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
2731974|NCT00129402|9390265|P7|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1
2731975|NCT00129402|9390266|P6|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
2731976|NCT00129402|9390267|P5|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
2731977|NCT00129402|9390268|P4|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
2731978|NCT00129402|9390269|P3|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
2731979|NCT00129402|9390270|P2|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
2731980|NCT00129402|9390271|P1|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
2731981|NCT00129402|9390265|P7|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
2731982|NCT00129402|9390266|P6|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
2731983|NCT00129402|9390267|P5|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
2731984|NCT00129402|9390268|P4|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
2731985|NCT00129402|9390269|P3|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
2731986|NCT00129402|9390270|P2|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
2731987|NCT00129402|9390271|P1|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
2731988|NCT00129402|9390265|P7|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
2731989|NCT00129402|9390266|P6|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3
2731990|NCT00129402|9390267|P5|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
2731991|NCT00129402|9390268|P4|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
2731992|NCT00129402|9390269|P3|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1
2731993|NCT00129402|9390270|P2|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
2731994|NCT00129402|9390271|P1|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
2731995|NCT00129402|9390265|P7|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
2731996|NCT00129402|9390266|P6|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
2731997|NCT00129402|9390267|P5|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
2731998|NCT00129402|9390268|P4|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
2731999|NCT00129402|9390269|P3|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1
2732000|NCT00129402|9390270|P2|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
2732001|NCT00129402|9390271|P1|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
2732002|NCT00129402|9390265|P7|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
2732003|NCT00129402|9390266|P6|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1
2732004|NCT00129402|9390267|P5|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
2732005|NCT00129402|9390268|P4|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
2732006|NCT00129402|9390269|P3|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3
2732007|NCT00129402|9390270|P2|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
2732008|NCT00129402|9390271|P1|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
2732009|NCT00129402|9390265|P7|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
2732010|NCT00129402|9390266|P6|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
2732011|NCT00129402|9390267|P5|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
2732012|NCT00129402|9390268|P4|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
2732013|NCT00129402|9390269|P3|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2
2732014|NCT00129402|9390270|P2|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
2732015|NCT00129402|9390271|P1|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
2732016|NCT00129402|9390265|P7|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
2732017|NCT00129402|9390266|P6|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
2732018|NCT00129402|9390267|P5|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
2732019|NCT00129402|9390268|P4|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
2732020|NCT00129402|9390269|P3|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
2732021|NCT00129402|9390270|P2|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
2732022|NCT00129402|9390271|P1|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
2732023|NCT00129402|9390265|P7|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
2732024|NCT00129402|9390266|P6|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
2732025|NCT00129402|9390267|P5|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
2732026|NCT00129402|9390268|P4|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1
2732027|NCT00129402|9390269|P3|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
2732028|NCT00129402|9390270|P2|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
2732029|NCT00129402|9390271|P1|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
2732030|NCT00129402|9390265|P7|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
2732031|NCT00129402|9390266|P6|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1
2732032|NCT00129402|9390267|P5|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
2732033|NCT00129402|9390268|P4|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
2732034|NCT00129402|9390269|P3|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
2732035|NCT00129402|9390270|P2|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
2732036|NCT00129402|9390271|P1|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
2732037|NCT00129402|9390265|P7|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
2732038|NCT00129402|9390266|P6|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
2732039|NCT00129402|9390267|P5|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
2732040|NCT00129402|9390268|P4|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
2732041|NCT00129402|9390269|P3|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
2732042|NCT00129402|9390270|P2|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
2732043|NCT00129402|9390271|P1|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
2732044|NCT00129389|9390290|P2|Overall Study|Crossed to the other arm|16
2732045|NCT00129389|9390291|P1|Overall Study|Crossed to the other arm|1
2732046|NCT00129389|9390290|P2|Overall Study|Not eligible|2
2732047|NCT00129389|9390291|P1|Overall Study|Not eligible|1
2732048|NCT00129389|9390290|P2|Overall Study|Relapse|0
2732049|NCT00129389|9390291|P1|Overall Study|Relapse|1
2732050|NCT00129389|9390290|P2|Overall Study|Withdrawal by Subject|23
2732051|NCT00129389|9390291|P1|Overall Study|Withdrawal by Subject|9
2732052|NCT00129389|9390290|P2|Overall Study|Protocol Violation|6
2732053|NCT00129389|9390291|P1|Overall Study|Protocol Violation|0
2732054|NCT00129389|9390290|P2|Overall Study|Physician Decision|4
2732055|NCT00129389|9390291|P1|Overall Study|Physician Decision|0
2732056|NCT00129389|9390290|P2|Overall Study|Lost to Follow-up|1
2732057|NCT00129389|9390291|P1|Overall Study|Lost to Follow-up|2
2732058|NCT00129389|9390290|P2|Overall Study|Death|1
2732059|NCT00129389|9390291|P1|Overall Study|Death|0
2732060|NCT00129389|9390290|P2|Overall Study|Adverse Event|87
2732061|NCT00129389|9390291|P1|Overall Study|Adverse Event|19
2732062|NCT00129376|9390299|P1|Overall Study|Lack of Efficacy|1
2732063|NCT00129376|9390299|P1|Overall Study|Adverse Event|1
2732064|NCT00129311|9390309|P2|Overall Study|Withdrawal by Subject|19
2732065|NCT00129311|9390310|P1|Overall Study|Withdrawal by Subject|12
2732066|NCT00129272|9390339|P2|Overall Study|Withdrawal by Subject|11
2732067|NCT00129272|9390340|P1|Overall Study|Withdrawal by Subject|5
2732068|NCT00129272|9390339|P2|Overall Study|Lost to Follow-up|11
2732069|NCT00129272|9390340|P1|Overall Study|Lost to Follow-up|12
2732070|NCT00129259|9390350|P2|Overall Study|Only available minimal phone assessments|1
2732071|NCT00129259|9390351|P1|Overall Study|Only available minimal phone assessments|0
2732072|NCT00129259|9390350|P2|Overall Study|Withdrawal by Subject|1
2732073|NCT00129259|9390351|P1|Overall Study|Withdrawal by Subject|2
2732074|NCT00129259|9390350|P2|Overall Study|Lost to Follow-up|1
2732075|NCT00129259|9390351|P1|Overall Study|Lost to Follow-up|1
2732076|NCT00129220|9390379|P3|Study Period III|Reason Not Specified|2
2732077|NCT00129220|9390380|P2|Study Period III|Reason Not Specified|0
2732078|NCT00129220|9390381|P1|Study Period III|Reason Not Specified|9
2732079|NCT00129220|9390379|P3|Study Period III|Sponsor Decision|0
2732080|NCT00129220|9390380|P2|Study Period III|Sponsor Decision|0
2732081|NCT00129220|9390381|P1|Study Period III|Sponsor Decision|1
2732082|NCT00129220|9390379|P3|Study Period III|Withdrawal by Subject|3
2732083|NCT00129220|9390380|P2|Study Period III|Withdrawal by Subject|0
2732084|NCT00129220|9390381|P1|Study Period III|Withdrawal by Subject|1
2732085|NCT00129220|9390379|P3|Study Period III|Protocol Violation|2
2732086|NCT00129220|9390380|P2|Study Period III|Protocol Violation|1
2732087|NCT00129220|9390381|P1|Study Period III|Protocol Violation|1
2732088|NCT00129220|9390379|P3|Study Period III|Adverse Event|3
2732089|NCT00129220|9390380|P2|Study Period III|Adverse Event|0
2732090|NCT00129220|9390381|P1|Study Period III|Adverse Event|1
2732091|NCT00129220|9390379|P3|Study Period II|Reason Not Specified|5
2732092|NCT00129220|9390380|P2|Study Period II|Reason Not Specified|0
2732093|NCT00129220|9390381|P1|Study Period II|Reason Not Specified|2
2732094|NCT00129220|9390379|P3|Study Period II|Withdrawal by Subject|4
2732095|NCT00129220|9390380|P2|Study Period II|Withdrawal by Subject|3
2732096|NCT00129220|9390381|P1|Study Period II|Withdrawal by Subject|1
2732097|NCT00129220|9390379|P3|Study Period II|Physician Decision|0
2732098|NCT00129220|9390380|P2|Study Period II|Physician Decision|1
2732099|NCT00129220|9390381|P1|Study Period II|Physician Decision|0
2732100|NCT00129220|9390379|P3|Study Period II|Protocol Violation|1
2732101|NCT00129220|9390380|P2|Study Period II|Protocol Violation|2
2732102|NCT00129220|9390381|P1|Study Period II|Protocol Violation|4
2732103|NCT00129220|9390379|P3|Study Period II|Entry Criteria Not Met|2
2732104|NCT00129220|9390380|P2|Study Period II|Entry Criteria Not Met|0
2732105|NCT00129220|9390381|P1|Study Period II|Entry Criteria Not Met|2
2732106|NCT00129220|9390379|P3|Study Period II|Lack of Efficacy|28
2732107|NCT00129220|9390380|P2|Study Period II|Lack of Efficacy|1
2732108|NCT00129220|9390381|P1|Study Period II|Lack of Efficacy|15
2732109|NCT00129220|9390379|P3|Study Period II|Adverse Event|7
2732110|NCT00129220|9390380|P2|Study Period II|Adverse Event|5
2732111|NCT00129220|9390381|P1|Study Period II|Adverse Event|9
2732112|NCT00129129|9390421|P5|Fourth Dose Phase|Protocol Violation|0
2732113|NCT00129129|9390422|P4|Fourth Dose Phase|Protocol Violation|1
2732114|NCT00129129|9390423|P3|Fourth Dose Phase|Protocol Violation|0
2732115|NCT00129129|9390424|P2|Fourth Dose Phase|Protocol Violation|0
2732116|NCT00129129|9390425|P1|Fourth Dose Phase|Protocol Violation|0
2732117|NCT00129129|9390421|P5|Fourth Dose Phase|Other|1
2732118|NCT00129129|9390422|P4|Fourth Dose Phase|Other|1
2732119|NCT00129129|9390423|P3|Fourth Dose Phase|Other|0
2732120|NCT00129129|9390424|P2|Fourth Dose Phase|Other|0
2732121|NCT00129129|9390425|P1|Fourth Dose Phase|Other|0
2732122|NCT00129129|9390421|P5|Fourth Dose Phase|Migration from study area|2
2732123|NCT00129129|9390422|P4|Fourth Dose Phase|Migration from study area|0
2732124|NCT00129129|9390423|P3|Fourth Dose Phase|Migration from study area|0
2732125|NCT00129129|9390424|P2|Fourth Dose Phase|Migration from study area|0
2732126|NCT00129129|9390425|P1|Fourth Dose Phase|Migration from study area|0
2732127|NCT00129129|9390421|P5|Fourth Dose Phase|Withdrawal by Subject|1
2732128|NCT00129129|9390422|P4|Fourth Dose Phase|Withdrawal by Subject|0
2732129|NCT00129129|9390423|P3|Fourth Dose Phase|Withdrawal by Subject|0
2732130|NCT00129129|9390424|P2|Fourth Dose Phase|Withdrawal by Subject|0
2732131|NCT00129129|9390425|P1|Fourth Dose Phase|Withdrawal by Subject|0
2732132|NCT00129129|9390421|P5|Fourth Dose Phase|Lost to Follow-up|2
2732133|NCT00129129|9390422|P4|Fourth Dose Phase|Lost to Follow-up|2
2732134|NCT00129129|9390423|P3|Fourth Dose Phase|Lost to Follow-up|0
2732135|NCT00129129|9390424|P2|Fourth Dose Phase|Lost to Follow-up|0
2732136|NCT00129129|9390425|P1|Fourth Dose Phase|Lost to Follow-up|4
2732137|NCT00129129|9390421|P5|Primary Phase|Other|0
2732138|NCT00129129|9390422|P4|Primary Phase|Other|0
2732139|NCT00129129|9390423|P3|Primary Phase|Other|0
2732140|NCT00129129|9390424|P2|Primary Phase|Other|5
2732141|NCT00129129|9390425|P1|Primary Phase|Other|2
2732142|NCT00129129|9390421|P5|Primary Phase|Lost to Follow-up|0
2732143|NCT00129129|9390422|P4|Primary Phase|Lost to Follow-up|0
2732144|NCT00129129|9390423|P3|Primary Phase|Lost to Follow-up|0
2732145|NCT00129129|9390424|P2|Primary Phase|Lost to Follow-up|6
2732146|NCT00129129|9390425|P1|Primary Phase|Lost to Follow-up|8
2732147|NCT00129129|9390421|P5|Primary Phase|Migration from study area|0
2732148|NCT00129129|9390422|P4|Primary Phase|Migration from study area|0
2732149|NCT00129129|9390423|P3|Primary Phase|Migration from study area|0
2732150|NCT00129129|9390424|P2|Primary Phase|Migration from study area|3
2732151|NCT00129129|9390425|P1|Primary Phase|Migration from study area|1
2732152|NCT00129129|9390421|P5|Primary Phase|Withdrawal by Subject|0
2732153|NCT00129129|9390422|P4|Primary Phase|Withdrawal by Subject|0
2732154|NCT00129129|9390423|P3|Primary Phase|Withdrawal by Subject|0
2732155|NCT00129129|9390424|P2|Primary Phase|Withdrawal by Subject|10
2732156|NCT00129129|9390425|P1|Primary Phase|Withdrawal by Subject|12
2732157|NCT00129129|9390421|P5|Primary Phase|Adverse Event|0
2732158|NCT00129129|9390422|P4|Primary Phase|Adverse Event|0
2732159|NCT00129129|9390423|P3|Primary Phase|Adverse Event|0
2732160|NCT00129129|9390424|P2|Primary Phase|Adverse Event|1
2732161|NCT00129129|9390425|P1|Primary Phase|Adverse Event|2
2732162|NCT00129116|9390632|P5|Booster Phase|Lost to Follow-up|1
2732163|NCT00129116|9390633|P4|Booster Phase|Lost to Follow-up|0
2732164|NCT00129116|9390634|P3|Booster Phase|Lost to Follow-up|0
2732165|NCT00129116|9390635|P2|Booster Phase|Lost to Follow-up|0
2732166|NCT00129116|9390636|P1|Booster Phase|Lost to Follow-up|2
2732167|NCT00129116|9390632|P5|Primary Phase|Other|0
2732168|NCT00129116|9390633|P4|Primary Phase|Other|0
2732169|NCT00129116|9390634|P3|Primary Phase|Other|1
2732170|NCT00129116|9390635|P2|Primary Phase|Other|0
2732171|NCT00129116|9390636|P1|Primary Phase|Other|0
2732172|NCT00129116|9390632|P5|Primary Phase|Withdrawal by Subject|0
2732173|NCT00129116|9390633|P4|Primary Phase|Withdrawal by Subject|0
2732174|NCT00129116|9390634|P3|Primary Phase|Withdrawal by Subject|0
2732175|NCT00129116|9390635|P2|Primary Phase|Withdrawal by Subject|1
2732176|NCT00129116|9390636|P1|Primary Phase|Withdrawal by Subject|0
2732177|NCT00129116|9390632|P5|Primary Phase|Adverse Event|0
2732178|NCT00129116|9390633|P4|Primary Phase|Adverse Event|0
2732179|NCT00129116|9390634|P3|Primary Phase|Adverse Event|0
2732180|NCT00129116|9390635|P2|Primary Phase|Adverse Event|1
2732181|NCT00129116|9390636|P1|Primary Phase|Adverse Event|1
2732182|NCT00129116|9390632|P5|Primary Phase|Protocol Violation|0
2732183|NCT00129116|9390633|P4|Primary Phase|Protocol Violation|0
2732184|NCT00129116|9390634|P3|Primary Phase|Protocol Violation|0
2732185|NCT00129116|9390635|P2|Primary Phase|Protocol Violation|1
2732186|NCT00129116|9390636|P1|Primary Phase|Protocol Violation|0
2732187|NCT00129116|9390632|P5|Primary Phase|Lost to Follow-up|1
2732188|NCT00129116|9390633|P4|Primary Phase|Lost to Follow-up|1
2732189|NCT00129116|9390634|P3|Primary Phase|Lost to Follow-up|0
2732190|NCT00129116|9390635|P2|Primary Phase|Lost to Follow-up|1
2732191|NCT00129116|9390636|P1|Primary Phase|Lost to Follow-up|1
2732192|NCT00128830|9390920|P1|Overall Study|Other|9
2732193|NCT00128830|9390920|P1|Overall Study|Discontinued or ineligible for study|2
2732194|NCT00128830|9390920|P1|Overall Study|Non-compliant|4
2732195|NCT00128830|9390920|P1|Overall Study|Reached a virologic endpoint|29
2732196|NCT00128830|9390920|P1|Overall Study|Lost to Follow-up|4
2732197|NCT00128830|9390920|P1|Overall Study|Withdrawal by Subject|14
2732198|NCT00128830|9390920|P1|Overall Study|Adverse Event|10
2732199|NCT00128661|9390962|P2|Overall Study|Other|8
2732200|NCT00128661|9390963|P1|Overall Study|Other|7
2732201|NCT00128661|9390962|P2|Overall Study|Withdrawal by Subject|232
2732202|NCT00128661|9390963|P1|Overall Study|Withdrawal by Subject|243
2732203|NCT00128661|9390962|P2|Overall Study|Lost to Follow-up|7
2732204|NCT00128661|9390963|P1|Overall Study|Lost to Follow-up|10
2732205|NCT00128661|9390962|P2|Overall Study|Adverse Event|11
2732206|NCT00128661|9390963|P1|Overall Study|Adverse Event|14
2732207|NCT00128492|9391009|P2|Overall Study|Pregnancy|1
2732208|NCT00128492|9391010|P1|Overall Study|Pregnancy|0
2732209|NCT00128492|9391009|P2|Overall Study|Withdrawal by Subject|5
2732210|NCT00128492|9391010|P1|Overall Study|Withdrawal by Subject|3
2732211|NCT00128492|9391009|P2|Overall Study|Personal or administrative|22
2732212|NCT00128492|9391010|P1|Overall Study|Personal or administrative|10
2732213|NCT00128492|9391009|P2|Overall Study|Noncompliance|5
2732214|NCT00128492|9391010|P1|Overall Study|Noncompliance|0
2732215|NCT00128492|9391009|P2|Overall Study|Lost to Follow-up|5
2732216|NCT00128492|9391010|P1|Overall Study|Lost to Follow-up|1
2732217|NCT00128492|9391009|P2|Overall Study|Death|0
2732218|NCT00128492|9391010|P1|Overall Study|Death|1
2732219|NCT00128492|9391009|P2|Overall Study|AE related to study|4
2732220|NCT00128492|9391010|P1|Overall Study|AE related to study|1
2732221|NCT00128492|9391009|P2|Overall Study|Study drug intolerance (AE)|8
2732222|NCT00128492|9391010|P1|Overall Study|Study drug intolerance (AE)|2
2732223|NCT00128492|9391009|P2|Overall Study|AE unrelated to study|9
2732224|NCT00128492|9391010|P1|Overall Study|AE unrelated to study|2
2732225|NCT00128206|9391167|P2|Overall Study|Adverse Event|2
2732226|NCT00128206|9391168|P1|Overall Study|Adverse Event|0
2732227|NCT00128206|9391167|P2|Overall Study|Lost to Follow-up|118
2732228|NCT00128206|9391168|P1|Overall Study|Lost to Follow-up|137
2732229|NCT00127933|9391460|P2|Overall Study|Randomized but not dosed|0
2732230|NCT00127933|9391461|P1|Overall Study|Randomized but not dosed|1
2732231|NCT00127855|9391482|P5|Primary Vaccination Course|Other|1
2732232|NCT00127855|9391483|P4|Primary Vaccination Course|Other|0
2732233|NCT00127855|9391484|P3|Primary Vaccination Course|Other|0
2732234|NCT00127855|9391485|P2|Primary Vaccination Course|Other|0
2732235|NCT00127855|9391486|P1|Primary Vaccination Course|Other|0
2732236|NCT00127855|9391482|P5|Primary Vaccination Course|Lost to Follow-up|2
2732237|NCT00127855|9391483|P4|Primary Vaccination Course|Lost to Follow-up|0
2732238|NCT00127855|9391484|P3|Primary Vaccination Course|Lost to Follow-up|1
2732239|NCT00127855|9391485|P2|Primary Vaccination Course|Lost to Follow-up|1
2732240|NCT00127855|9391486|P1|Primary Vaccination Course|Lost to Follow-up|1
2732241|NCT00127855|9391482|P5|Primary Vaccination Course|Withdrawal by Subject|1
2732242|NCT00127855|9391483|P4|Primary Vaccination Course|Withdrawal by Subject|0
2732243|NCT00127855|9391484|P3|Primary Vaccination Course|Withdrawal by Subject|0
2732244|NCT00127855|9391485|P2|Primary Vaccination Course|Withdrawal by Subject|0
2732245|NCT00127855|9391486|P1|Primary Vaccination Course|Withdrawal by Subject|1
2732246|NCT00127855|9391482|P5|Primary Vaccination Course|Adverse Event|0
2732247|NCT00127855|9391483|P4|Primary Vaccination Course|Adverse Event|0
2732248|NCT00127855|9391484|P3|Primary Vaccination Course|Adverse Event|1
2732249|NCT00127855|9391485|P2|Primary Vaccination Course|Adverse Event|0
2732250|NCT00127855|9391486|P1|Primary Vaccination Course|Adverse Event|0
2732251|NCT00127842|9391668|P1|Overall Study|Other|5
2732252|NCT00127842|9391668|P1|Overall Study|Protocol Violation|1
2732253|NCT00127842|9391668|P1|Overall Study|Noncompliance|2
2732254|NCT00127842|9391668|P1|Overall Study|Lack of Efficacy|12
2732255|NCT00127842|9391668|P1|Overall Study|Lost to Follow-up|1
2732256|NCT00127842|9391668|P1|Overall Study|Withdrawal by Subject|3
2732257|NCT00127842|9391668|P1|Overall Study|Adverse Event|15
2732258|NCT00127803|9391686|P4|Overall Study|Lost to Follow-up|1
2732259|NCT00127803|9391687|P3|Overall Study|Lost to Follow-up|0
2732260|NCT00127803|9391688|P2|Overall Study|Lost to Follow-up|0
2732261|NCT00127803|9391689|P1|Overall Study|Lost to Follow-up|0
2732262|NCT00127803|9391686|P4|Overall Study|Withdrawal by Subject|0
2732263|NCT00127803|9391687|P3|Overall Study|Withdrawal by Subject|0
2732264|NCT00127803|9391688|P2|Overall Study|Withdrawal by Subject|0
2732265|NCT00127803|9391689|P1|Overall Study|Withdrawal by Subject|1
2732266|NCT00127803|9391686|P4|Overall Study|Adverse Event|0
2732267|NCT00127803|9391687|P3|Overall Study|Adverse Event|0
2732268|NCT00127803|9391688|P2|Overall Study|Adverse Event|0
2732269|NCT00127803|9391689|P1|Overall Study|Adverse Event|2
2732270|NCT00127712|9391738|P2|Overall Study|Lack of GI access to continue|0
2732271|NCT00127712|9391739|P1|Overall Study|Lack of GI access to continue|2
2732272|NCT00127712|9391738|P2|Overall Study|Adverse Event|0
2732273|NCT00127712|9391739|P1|Overall Study|Adverse Event|3
2732274|NCT00127660|9391755|P4|Overall Study|Protocol Violation|0
2732275|NCT00127660|9391756|P3|Overall Study|Protocol Violation|5
2732276|NCT00127660|9391757|P2|Overall Study|Protocol Violation|3
2732277|NCT00127660|9391758|P1|Overall Study|Protocol Violation|3
2732278|NCT00127608|9391768|P1|Overall Study|VZV DNA negative|1
2732279|NCT00127413|9391812|P4|Overall Study|Lost to Follow-up|2
2732280|NCT00127413|9391813|P3|Overall Study|Lost to Follow-up|8
2732281|NCT00127413|9391814|P2|Overall Study|Lost to Follow-up|4
2732282|NCT00127413|9391815|P1|Overall Study|Lost to Follow-up|6
2732283|NCT00127205|9391856|P3|Overall Study|Progression|84
2732284|NCT00127205|9391857|P2|Overall Study|Progression|130
2732285|NCT00127205|9391858|P1|Overall Study|Progression|127
2732286|NCT00127205|9391856|P3|Overall Study|Under Review|6
2732287|NCT00127205|9391857|P2|Overall Study|Under Review|21
2732288|NCT00127205|9391858|P1|Overall Study|Under Review|13
2732289|NCT00127205|9391856|P3|Overall Study|Other-non protocol specified|77
2732290|NCT00127205|9391857|P2|Overall Study|Other-non protocol specified|129
2732291|NCT00127205|9391858|P1|Overall Study|Other-non protocol specified|141
2732292|NCT00127205|9391856|P3|Overall Study|Withdrawal by Subject|172
2732293|NCT00127205|9391857|P2|Overall Study|Withdrawal by Subject|308
2732294|NCT00127205|9391858|P1|Overall Study|Withdrawal by Subject|318
2732295|NCT00127205|9391856|P3|Overall Study|Death|6
2732296|NCT00127205|9391857|P2|Overall Study|Death|6
2732297|NCT00127205|9391858|P1|Overall Study|Death|8
2732298|NCT00127205|9391856|P3|Overall Study|Adverse Event|272
2732299|NCT00127205|9391857|P2|Overall Study|Adverse Event|386
2732300|NCT00127205|9391858|P1|Overall Study|Adverse Event|228
2732301|NCT00127192|9391880|P5|Overall Study|Adverse event in pre-treatment period|0
2732302|NCT00127192|9391881|P4|Overall Study|Adverse event in pre-treatment period|0
2732303|NCT00127192|9391882|P3|Overall Study|Adverse event in pre-treatment period|0
2732304|NCT00127192|9391883|P2|Overall Study|Adverse event in pre-treatment period|0
2732305|NCT00127192|9391884|P1|Overall Study|Adverse event in pre-treatment period|1
2732306|NCT00127192|9391880|P5|Overall Study|Withdrawal by Subject|3
2732307|NCT00127192|9391881|P4|Overall Study|Withdrawal by Subject|0
2732308|NCT00127192|9391882|P3|Overall Study|Withdrawal by Subject|1
2732309|NCT00127192|9391883|P2|Overall Study|Withdrawal by Subject|0
2732310|NCT00127192|9391884|P1|Overall Study|Withdrawal by Subject|0
2732311|NCT00127192|9391880|P5|Overall Study|Lack of Efficacy|2
2732312|NCT00127192|9391881|P4|Overall Study|Lack of Efficacy|0
2732313|NCT00127192|9391882|P3|Overall Study|Lack of Efficacy|0
2732314|NCT00127192|9391883|P2|Overall Study|Lack of Efficacy|0
2732315|NCT00127192|9391884|P1|Overall Study|Lack of Efficacy|2
2732316|NCT00127192|9391880|P5|Overall Study|Adverse Event|0
2732317|NCT00127192|9391881|P4|Overall Study|Adverse Event|1
2732318|NCT00127192|9391882|P3|Overall Study|Adverse Event|1
2732319|NCT00127192|9391883|P2|Overall Study|Adverse Event|1
2732320|NCT00127192|9391884|P1|Overall Study|Adverse Event|0
2732321|NCT00127166|9391908|P2|Period II|Patient did not perform Visit 6 exercise|0
2732322|NCT00127166|9391909|P1|Period II|Patient did not perform Visit 6 exercise|1
2732323|NCT00127166|9391908|P2|Period II|Withdrawal by Subject|0
2732324|NCT00127166|9391909|P1|Period II|Withdrawal by Subject|2
2732325|NCT00127166|9391908|P2|Washout Period|Patient did not meet inclusion criteria|1
2732326|NCT00127166|9391909|P1|Washout Period|Patient did not meet inclusion criteria|0
2732327|NCT00127166|9391908|P2|Period I|Patient did not meet inclusion criteria|0
2732328|NCT00127166|9391909|P1|Period I|Patient did not meet inclusion criteria|1
2732329|NCT00127166|9391908|P2|Period I|Withdrawal by Subject|0
2732330|NCT00127166|9391909|P1|Period I|Withdrawal by Subject|2
2732331|NCT00127166|9391908|P2|Period I|Protocol Violation|2
2732332|NCT00127166|9391909|P1|Period I|Protocol Violation|0
2732333|NCT00127101|9391929|P6|Continuation Phase|Withdrawal by Subject|1
2732334|NCT00127101|9391930|P5|Continuation Phase|Withdrawal by Subject|2
2732335|NCT00127101|9391931|P4|Continuation Phase|Withdrawal by Subject|0
2732336|NCT00127101|9391932|P3|Continuation Phase|Withdrawal by Subject|1
2732337|NCT00127101|9391933|P2|Continuation Phase|Withdrawal by Subject|0
2732338|NCT00127101|9391934|P1|Continuation Phase|Withdrawal by Subject|0
2732339|NCT00127101|9391929|P6|Continuation Phase|Lack of Efficacy|1
2732340|NCT00127101|9391930|P5|Continuation Phase|Lack of Efficacy|0
2732341|NCT00127101|9391931|P4|Continuation Phase|Lack of Efficacy|0
2732342|NCT00127101|9391932|P3|Continuation Phase|Lack of Efficacy|0
2732343|NCT00127101|9391933|P2|Continuation Phase|Lack of Efficacy|0
2732344|NCT00127101|9391934|P1|Continuation Phase|Lack of Efficacy|0
2732345|NCT00127101|9391929|P6|Continuation Phase|Adverse Event|1
2732346|NCT00127101|9391930|P5|Continuation Phase|Adverse Event|1
2732347|NCT00127101|9391931|P4|Continuation Phase|Adverse Event|0
2732348|NCT00127101|9391932|P3|Continuation Phase|Adverse Event|0
2732349|NCT00127101|9391933|P2|Continuation Phase|Adverse Event|0
2732350|NCT00127101|9391934|P1|Continuation Phase|Adverse Event|0
2732351|NCT00127101|9391929|P6|Base Protocol|Withdrawal by Subject|1
2732352|NCT00127101|9391930|P5|Base Protocol|Withdrawal by Subject|0
2732353|NCT00127101|9391931|P4|Base Protocol|Withdrawal by Subject|0
2732354|NCT00127101|9391932|P3|Base Protocol|Withdrawal by Subject|1
2732355|NCT00127101|9391933|P2|Base Protocol|Withdrawal by Subject|2
2732356|NCT00127101|9391934|P1|Base Protocol|Withdrawal by Subject|1
2732357|NCT00127101|9391929|P6|Base Protocol|Lack of Efficacy|0
2732358|NCT00127101|9391930|P5|Base Protocol|Lack of Efficacy|2
2732359|NCT00127101|9391931|P4|Base Protocol|Lack of Efficacy|0
2732360|NCT00127101|9391932|P3|Base Protocol|Lack of Efficacy|0
2732361|NCT00127101|9391933|P2|Base Protocol|Lack of Efficacy|0
2732362|NCT00127101|9391934|P1|Base Protocol|Lack of Efficacy|1
2732363|NCT00127101|9391929|P6|Base Protocol|Adverse Event|0
2732364|NCT00127101|9391930|P5|Base Protocol|Adverse Event|0
2732365|NCT00127101|9391931|P4|Base Protocol|Adverse Event|0
2732366|NCT00127101|9391932|P3|Base Protocol|Adverse Event|1
2732367|NCT00127101|9391933|P2|Base Protocol|Adverse Event|2
2732368|NCT00127101|9391934|P1|Base Protocol|Adverse Event|0
2732369|NCT00127036|9391969|P2|Overall Study|Screen Failure|0
2732370|NCT00127036|9391970|P1|Overall Study|Screen Failure|2
2732371|NCT00127036|9391969|P2|Overall Study|Insufficient Data for Analysis|11
2732372|NCT00127036|9391970|P1|Overall Study|Insufficient Data for Analysis|6
2732373|NCT00126776|9391982|P2|Overall Study|follow up complete on all patients|0
2732374|NCT00126776|9391983|P1|Overall Study|follow up complete on all patients|0
2732375|NCT00126659|9392032|P3|Overall Study|Adverse Event|2
2732376|NCT00126659|9392033|P2|Overall Study|Adverse Event|0
2732377|NCT00126659|9392034|P1|Overall Study|Adverse Event|0
2732378|NCT00126594|9392042|P2|Overall Study|Disease Progression|24
2732379|NCT00126594|9392043|P1|Overall Study|Disease Progression|29
2732380|NCT00126594|9392042|P2|Overall Study|Non-compliance|1
2732381|NCT00126594|9392043|P1|Overall Study|Non-compliance|0
2732382|NCT00126594|9392042|P2|Overall Study|Adverse Event|5
2732383|NCT00126594|9392043|P1|Overall Study|Adverse Event|7
2732384|NCT00126594|9392042|P2|Overall Study|Physician Decision|3
2732385|NCT00126594|9392043|P1|Overall Study|Physician Decision|1
2732386|NCT00126594|9392042|P2|Overall Study|Withdrawal by Subject|4
2732387|NCT00126594|9392043|P1|Overall Study|Withdrawal by Subject|0
2732388|NCT00126594|9392042|P2|Overall Study|Ineligible|0
2732389|NCT00126594|9392043|P1|Overall Study|Ineligible|2
2732390|NCT00126581|9392060|P2|Overall Study|Other illness/MD discretion|4
2732391|NCT00126581|9392061|P1|Overall Study|Other illness/MD discretion|3
2732392|NCT00126581|9392060|P2|Overall Study|Alternative therapy|3
2732393|NCT00126581|9392061|P1|Overall Study|Alternative therapy|3
2732394|NCT00126581|9392060|P2|Overall Study|Withdrawal by Subject|4
2732395|NCT00126581|9392061|P1|Overall Study|Withdrawal by Subject|1
2732396|NCT00126581|9392060|P2|Overall Study|Death|2
2732397|NCT00126581|9392061|P1|Overall Study|Death|3
2732398|NCT00126581|9392060|P2|Overall Study|Adverse Event|7
2732399|NCT00126581|9392061|P1|Overall Study|Adverse Event|3
2732400|NCT00126568|9392081|P1|Overall Study|Death|2
2732401|NCT00126555|9392088|P1|Overall Study|Progressive Disease|3
2732402|NCT00126555|9392088|P1|Overall Study|Adverse Event|2
2732403|NCT00126555|9392088|P1|Overall Study|Withdrawal by Subject|1
2732404|NCT00126503|9392110|P2|Overall Study|Physician Decision|1
2732405|NCT00126503|9392111|P1|Overall Study|Physician Decision|2
2732406|NCT00126503|9392110|P2|Overall Study|non-compliant|0
2732407|NCT00126503|9392111|P1|Overall Study|non-compliant|1
2732408|NCT00126503|9392110|P2|Overall Study|Adverse Event|3
2732409|NCT00126503|9392111|P1|Overall Study|Adverse Event|13
2732410|NCT00126503|9392110|P2|Overall Study|Death|0
2732411|NCT00126503|9392111|P1|Overall Study|Death|3
2732412|NCT00126503|9392110|P2|Overall Study|other complicating disease|1
2732413|NCT00126503|9392111|P1|Overall Study|other complicating disease|4
2732414|NCT00126503|9392110|P2|Overall Study|alternative therapy|1
2732415|NCT00126503|9392111|P1|Overall Study|alternative therapy|1
2732416|NCT00126503|9392110|P2|Overall Study|Withdrawal by Subject|1
2732417|NCT00126503|9392111|P1|Overall Study|Withdrawal by Subject|0
2732418|NCT00126503|9392110|P2|Overall Study|disease progression|14
2732419|NCT00126503|9392111|P1|Overall Study|disease progression|23
2732420|NCT00126490|9392123|P1|Overall Study|Stopped after 1 infusion (fall/injury)|1
2732421|NCT00126438|9392133|P2|Overall Study|Withdrawal by Subject|2
2732422|NCT00126438|9392134|P1|Overall Study|Withdrawal by Subject|3
2732423|NCT00126438|9392133|P2|Overall Study|Protocol Violation|8
2732424|NCT00126438|9392134|P1|Overall Study|Protocol Violation|8
2732425|NCT00126438|9392133|P2|Overall Study|Lost to Follow-up|0
2732426|NCT00126438|9392134|P1|Overall Study|Lost to Follow-up|22
2732427|NCT00126438|9392133|P2|Overall Study|Withdrawal due to adverse event|0
2732428|NCT00126438|9392134|P1|Overall Study|Withdrawal due to adverse event|1
2732429|NCT00126425|9392142|P2|Overall Study|Other|0
2732430|NCT00126425|9392143|P1|Overall Study|Other|5
2732431|NCT00126425|9392142|P2|Overall Study|Failed Inclusion Exclusion Criteria|0
2732432|NCT00126425|9392143|P1|Overall Study|Failed Inclusion Exclusion Criteria|1
2732433|NCT00126425|9392142|P2|Overall Study|Adverse Event|0
2732434|NCT00126425|9392143|P1|Overall Study|Adverse Event|1
2732435|NCT00126425|9392142|P2|Overall Study|Protocol Violation|6
2732436|NCT00126425|9392143|P1|Overall Study|Protocol Violation|9
2732437|NCT00126425|9392142|P2|Overall Study|Lost to Follow-up|4
2732438|NCT00126425|9392143|P1|Overall Study|Lost to Follow-up|8
2732439|NCT00126425|9392142|P2|Overall Study|Withdrawal by Subject|1
2732440|NCT00126425|9392143|P1|Overall Study|Withdrawal by Subject|17
2732441|NCT00126191|9392151|P2|Overall Study|Death|1
2732442|NCT00126191|9392152|P1|Overall Study|Death|0
2732443|NCT00126191|9392151|P2|Overall Study|Physician Decision|1
2732444|NCT00126191|9392152|P1|Overall Study|Physician Decision|0
2732445|NCT00126126|9392162|P2|Overall Study|Lost to Follow-up|2
2732446|NCT00126126|9392163|P1|Overall Study|Lost to Follow-up|0
2732447|NCT00125853|9392202|P2|Wash-out (4 Weeks)|Lost to Follow-up|7
2732448|NCT00125853|9392203|P1|Wash-out (4 Weeks)|Lost to Follow-up|3
2732449|NCT00125359|9392317|P1|Overall Study|Physician Decision|14
2732450|NCT00125359|9392317|P1|Overall Study|Adverse Event|5
2732451|NCT00125359|9392317|P1|Overall Study|Death|4
2732452|NCT00125268|9392326|P2|Overall Study|Withdrawal by Subject|1
2732453|NCT00125268|9392327|P1|Overall Study|Withdrawal by Subject|1
2732454|NCT00125242|9392339|P2|Overall Study|did not qualify|2
2732455|NCT00125242|9392340|P1|Overall Study|did not qualify|7
2732456|NCT00125190|9392345|P1|Overall Study|Non-compliance|2
2732457|NCT00125190|9392345|P1|Overall Study|other|1
2732458|NCT00125190|9392345|P1|Overall Study|Patient/Parent Decision|7
2732459|NCT00125190|9392345|P1|Overall Study|Lost to Follow-up|4
2732460|NCT00125190|9392345|P1|Overall Study|Adverse Event|1
2732461|NCT00125164|9392363|P4|Overall Study|Withdrawal by Subject|1
2732462|NCT00125164|9392364|P3|Overall Study|Withdrawal by Subject|1
2732463|NCT00125164|9392365|P2|Overall Study|Withdrawal by Subject|0
2732464|NCT00125164|9392366|P1|Overall Study|Withdrawal by Subject|2
2732465|NCT00125164|9392363|P4|Overall Study|Lost to Follow-up|1
2732466|NCT00125164|9392364|P3|Overall Study|Lost to Follow-up|1
2732467|NCT00125164|9392365|P2|Overall Study|Lost to Follow-up|0
2732468|NCT00125164|9392366|P1|Overall Study|Lost to Follow-up|0
2732469|NCT00125164|9392363|P4|Overall Study|Adverse Event|4
2732470|NCT00125164|9392364|P3|Overall Study|Adverse Event|2
2732471|NCT00125164|9392365|P2|Overall Study|Adverse Event|0
2732472|NCT00125164|9392366|P1|Overall Study|Adverse Event|0
2732473|NCT00125138|9392420|P4|Overall Study|Sponsor decision-pt moved to assist care|1
2732474|NCT00125138|9392421|P3|Overall Study|Sponsor decision-pt moved to assist care|0
2732475|NCT00125138|9392422|P2|Overall Study|Sponsor decision-pt moved to assist care|0
2732476|NCT00125138|9392423|P1|Overall Study|Sponsor decision-pt moved to assist care|0
2732477|NCT00125138|9392420|P4|Overall Study|Lack of Efficacy|1
2732478|NCT00125138|9392421|P3|Overall Study|Lack of Efficacy|0
2732479|NCT00125138|9392422|P2|Overall Study|Lack of Efficacy|0
2732480|NCT00125138|9392423|P1|Overall Study|Lack of Efficacy|0
2732481|NCT00125138|9392420|P4|Overall Study|Withdrawal by Subject|1
2732482|NCT00125138|9392421|P3|Overall Study|Withdrawal by Subject|1
2732483|NCT00125138|9392422|P2|Overall Study|Withdrawal by Subject|3
2732484|NCT00125138|9392423|P1|Overall Study|Withdrawal by Subject|2
2732485|NCT00125138|9392420|P4|Overall Study|Adverse Event|2
2732486|NCT00125138|9392421|P3|Overall Study|Adverse Event|3
2732487|NCT00125138|9392422|P2|Overall Study|Adverse Event|0
2732488|NCT00125138|9392423|P1|Overall Study|Adverse Event|1
2732489|NCT00124982|9392472|P3|Long-term Period|Neurologist Recommendation|1
2732490|NCT00124982|9392473|P2|Long-term Period|Neurologist Recommendation|0
2732491|NCT00124982|9392474|P1|Long-term Period|Neurologist Recommendation|0
2732492|NCT00124982|9392472|P3|Long-term Period|Administrative Reason by Sponsor|1
2732493|NCT00124982|9392473|P2|Long-term Period|Administrative Reason by Sponsor|0
2732494|NCT00124982|9392474|P1|Long-term Period|Administrative Reason by Sponsor|0
2732495|NCT00124982|9392472|P3|Long-term Period|Poor/Non-compliance|2
2732496|NCT00124982|9392473|P2|Long-term Period|Poor/Non-compliance|0
2732497|NCT00124982|9392474|P1|Long-term Period|Poor/Non-compliance|0
2732498|NCT00124982|9392472|P3|Long-term Period|Pregnancy|1
2732499|NCT00124982|9392473|P2|Long-term Period|Pregnancy|0
2732500|NCT00124982|9392474|P1|Long-term Period|Pregnancy|0
2732501|NCT00124982|9392472|P3|Long-term Period|Withdrawal by Subject|16
2732502|NCT00124982|9392473|P2|Long-term Period|Withdrawal by Subject|0
2732503|NCT00124982|9392474|P1|Long-term Period|Withdrawal by Subject|0
2732504|NCT00124982|9392472|P3|Long-term Period|Lost to Follow-up|4
2732505|NCT00124982|9392473|P2|Long-term Period|Lost to Follow-up|0
2732506|NCT00124982|9392474|P1|Long-term Period|Lost to Follow-up|0
2732507|NCT00124982|9392472|P3|Long-term Period|Lack of Efficacy|46
2732508|NCT00124982|9392473|P2|Long-term Period|Lack of Efficacy|0
2732509|NCT00124982|9392474|P1|Long-term Period|Lack of Efficacy|0
2732510|NCT00124982|9392472|P3|Long-term Period|Adverse Event|17
2732511|NCT00124982|9392473|P2|Long-term Period|Adverse Event|0
2732512|NCT00124982|9392474|P1|Long-term Period|Adverse Event|0
2732513|NCT00124982|9392472|P3|Long-term Period|Death|1
2732514|NCT00124982|9392473|P2|Long-term Period|Death|0
2732515|NCT00124982|9392474|P1|Long-term Period|Death|0
2732516|NCT00124982|9392472|P3|Short-term Period|Participant Had Lymphopenia|0
2732517|NCT00124982|9392473|P2|Short-term Period|Participant Had Lymphopenia|0
2732518|NCT00124982|9392474|P1|Short-term Period|Participant Had Lymphopenia|1
2732519|NCT00124982|9392472|P3|Short-term Period|Investigator Decision-No Specific AE|0
2732520|NCT00124982|9392473|P2|Short-term Period|Investigator Decision-No Specific AE|0
2732521|NCT00124982|9392474|P1|Short-term Period|Investigator Decision-No Specific AE|1
2732522|NCT00124982|9392472|P3|Short-term Period|Participant Chose Own Doctor|0
2732523|NCT00124982|9392473|P2|Short-term Period|Participant Chose Own Doctor|1
2732524|NCT00124982|9392474|P1|Short-term Period|Participant Chose Own Doctor|0
2732525|NCT00124982|9392472|P3|Short-term Period|Participant Decision|0
2732526|NCT00124982|9392473|P2|Short-term Period|Participant Decision|0
2732527|NCT00124982|9392474|P1|Short-term Period|Participant Decision|1
2732528|NCT00124982|9392472|P3|Short-term Period|No Longer Meets Study Criteria|0
2732529|NCT00124982|9392473|P2|Short-term Period|No Longer Meets Study Criteria|2
2732530|NCT00124982|9392474|P1|Short-term Period|No Longer Meets Study Criteria|1
2732531|NCT00124982|9392472|P3|Short-term Period|Poor/Non-compliance|0
2732532|NCT00124982|9392473|P2|Short-term Period|Poor/Non-compliance|1
2732533|NCT00124982|9392474|P1|Short-term Period|Poor/Non-compliance|3
2732534|NCT00124982|9392472|P3|Short-term Period|Withdrawal of Consent|0
2732535|NCT00124982|9392473|P2|Short-term Period|Withdrawal of Consent|9
2732536|NCT00124982|9392474|P1|Short-term Period|Withdrawal of Consent|7
2732537|NCT00124982|9392472|P3|Short-term Period|Lost to Follow-up|0
2732538|NCT00124982|9392473|P2|Short-term Period|Lost to Follow-up|5
2732539|NCT00124982|9392474|P1|Short-term Period|Lost to Follow-up|8
2732540|NCT00124982|9392472|P3|Short-term Period|Lack of Efficacy|0
2732541|NCT00124982|9392473|P2|Short-term Period|Lack of Efficacy|73
2732542|NCT00124982|9392474|P1|Short-term Period|Lack of Efficacy|32
2732543|NCT00124982|9392472|P3|Short-term Period|Adverse Event|0
2732544|NCT00124982|9392473|P2|Short-term Period|Adverse Event|22
2732545|NCT00124982|9392474|P1|Short-term Period|Adverse Event|17
2732546|NCT00124982|9392472|P3|Short-term Period|Death|0
2732547|NCT00124982|9392473|P2|Short-term Period|Death|1
2732548|NCT00124982|9392474|P1|Short-term Period|Death|1
2732549|NCT00124943|9392556|P4|Phase II|Withdrawal by Subject|2
2732550|NCT00124943|9392557|P3|Phase II|Withdrawal by Subject|0
2732551|NCT00124943|9392558|P2|Phase II|Withdrawal by Subject|0
2732552|NCT00124943|9392559|P1|Phase II|Withdrawal by Subject|0
2732553|NCT00124943|9392556|P4|Phase II|Lost to Follow-up|1
2732554|NCT00124943|9392557|P3|Phase II|Lost to Follow-up|0
2732555|NCT00124943|9392558|P2|Phase II|Lost to Follow-up|0
2732556|NCT00124943|9392559|P1|Phase II|Lost to Follow-up|0
2732557|NCT00124943|9392556|P4|Phase II|Protocol Violation|1
2732558|NCT00124943|9392557|P3|Phase II|Protocol Violation|0
2732559|NCT00124943|9392558|P2|Phase II|Protocol Violation|0
2732560|NCT00124943|9392559|P1|Phase II|Protocol Violation|0
2732561|NCT00124943|9392556|P4|Phase II|Adverse Event|1
2732562|NCT00124943|9392557|P3|Phase II|Adverse Event|0
2732563|NCT00124943|9392558|P2|Phase II|Adverse Event|2
2732564|NCT00124943|9392559|P1|Phase II|Adverse Event|0
2732565|NCT00124917|9392597|P1|Overall Study|Physician Decision|3
2732566|NCT00124748|9392607|P2|Overall Study|Death|3
2732567|NCT00124748|9392608|P1|Overall Study|Death|1
2732568|NCT00124748|9392607|P2|Overall Study|Administrative Problem(Study Terminated)|174
2732569|NCT00124748|9392608|P1|Overall Study|Administrative Problem(Study Terminated)|101
2732570|NCT00124748|9392607|P2|Overall Study|Lost to Follow-up|7
2732571|NCT00124748|9392608|P1|Overall Study|Lost to Follow-up|2
2732572|NCT00124748|9392607|P2|Overall Study|Withdrawal by Subject|15
2732573|NCT00124748|9392608|P1|Overall Study|Withdrawal by Subject|5
2732574|NCT00124748|9392607|P2|Overall Study|Protocol Violation|1
2732575|NCT00124748|9392608|P1|Overall Study|Protocol Violation|3
2732576|NCT00124748|9392607|P2|Overall Study|No longer requires study drug|1
2732577|NCT00124748|9392608|P1|Overall Study|No longer requires study drug|1
2732578|NCT00124748|9392607|P2|Overall Study|Lack of Efficacy|41
2732579|NCT00124748|9392608|P1|Overall Study|Lack of Efficacy|20
2732580|NCT00124748|9392607|P2|Overall Study|Abnormal Procedure|1
2732581|NCT00124748|9392608|P1|Overall Study|Abnormal Procedure|0
2732582|NCT00124748|9392607|P2|Overall Study|Abnormal laboratory Value|2
2732583|NCT00124748|9392608|P1|Overall Study|Abnormal laboratory Value|2
2732584|NCT00124748|9392607|P2|Overall Study|Adverse Event|39
2732585|NCT00124748|9392608|P1|Overall Study|Adverse Event|8
2732586|NCT00124709|9392715|P2|Overall Study|Lost to Follow-up|120
2732587|NCT00124709|9392716|P1|Overall Study|Lost to Follow-up|114
2732588|NCT00124709|9392715|P2|Overall Study|Withdrawal by Subject|136
2732589|NCT00124709|9392716|P1|Overall Study|Withdrawal by Subject|127
2732590|NCT00124709|9392715|P2|Overall Study|Protocol Violation|5
2732591|NCT00124709|9392716|P1|Overall Study|Protocol Violation|3
2732592|NCT00124709|9392715|P2|Overall Study|Lack of Efficacy|10
2732593|NCT00124709|9392716|P1|Overall Study|Lack of Efficacy|5
2732594|NCT00124709|9392715|P2|Overall Study|Adverse Event|0
2732595|NCT00124709|9392716|P1|Overall Study|Adverse Event|3
2732596|NCT00124709|9392715|P2|Overall Study|Randomized but did not take medication|1
2732597|NCT00124709|9392716|P1|Overall Study|Randomized but did not take medication|3
2732598|NCT00124657|9392733|P3|Overall Study|Intercurrent illness|0
2732599|NCT00124657|9392734|P2|Overall Study|Intercurrent illness|0
2732600|NCT00124657|9392735|P1|Overall Study|Intercurrent illness|1
2732601|NCT00124657|9392733|P3|Overall Study|Progressive disease|27
2732602|NCT00124657|9392734|P2|Overall Study|Progressive disease|5
2732603|NCT00124657|9392735|P1|Overall Study|Progressive disease|14
2732604|NCT00124657|9392733|P3|Overall Study|Non-compliance|4
2732605|NCT00124657|9392734|P2|Overall Study|Non-compliance|0
2732606|NCT00124657|9392735|P1|Overall Study|Non-compliance|1
2732607|NCT00124657|9392733|P3|Overall Study|Toxicity|1
2732608|NCT00124657|9392734|P2|Overall Study|Toxicity|0
2732609|NCT00124657|9392735|P1|Overall Study|Toxicity|0
2732610|NCT00124618|9392770|P1|Overall Study|Ineligible|1
2732611|NCT00124462|9392785|P2|Overall Study|Device fitting, n=2, other hlth issues|1
2732612|NCT00124462|9392786|P1|Overall Study|Device fitting, n=2, other hlth issues|1
2732613|NCT00124462|9392785|P2|Overall Study|Withdrawal by Subject|5
2732614|NCT00124462|9392786|P1|Overall Study|Withdrawal by Subject|4
2732615|NCT00124462|9392785|P2|Overall Study|Physician Decision|4
2732616|NCT00124462|9392786|P1|Overall Study|Physician Decision|3
2732617|NCT00124462|9392785|P2|Overall Study|Lost to Follow-up|3
2732618|NCT00124462|9392786|P1|Overall Study|Lost to Follow-up|3
2732619|NCT00124449|9392796|P2|18-Month Untreated Observation Period|Relocated|0
2732620|NCT00124449|9392797|P1|18-Month Untreated Observation Period|Relocated|1
2732621|NCT00124449|9392796|P2|18-Month Untreated Observation Period|Poor/Noncompliance|0
2732622|NCT00124449|9392797|P1|18-Month Untreated Observation Period|Poor/Noncompliance|1
2732623|NCT00124449|9392796|P2|18-Month Untreated Observation Period|Pregnancy|0
2732624|NCT00124449|9392797|P1|18-Month Untreated Observation Period|Pregnancy|1
2732625|NCT00124449|9392796|P2|18-Month Untreated Observation Period|Lost to Follow-up|0
2732626|NCT00124449|9392797|P1|18-Month Untreated Observation Period|Lost to Follow-up|1
2732627|NCT00124449|9392796|P2|18-Month Untreated Observation Period|Lack of Efficacy|12
2732628|NCT00124449|9392797|P1|18-Month Untreated Observation Period|Lack of Efficacy|11
2732629|NCT00124449|9392796|P2|18-Month Untreated Observation Period|Adverse Event|1
2732630|NCT00124449|9392797|P1|18-Month Untreated Observation Period|Adverse Event|0
2732631|NCT00124449|9392796|P2|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1
2732632|NCT00124449|9392797|P1|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0
2732633|NCT00124449|9392796|P2|6-month Double-Blind Treatment Period|Sponsor request|1
2732634|NCT00124449|9392797|P1|6-month Double-Blind Treatment Period|Sponsor request|0
2732635|NCT00124449|9392796|P2|6-month Double-Blind Treatment Period|Poor/Noncompliance|0
2732636|NCT00124449|9392797|P1|6-month Double-Blind Treatment Period|Poor/Noncompliance|1
2732637|NCT00124449|9392796|P2|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
2732638|NCT00124449|9392797|P1|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
2732639|NCT00124449|9392796|P2|6-month Double-Blind Treatment Period|Lack of Efficacy|8
2732640|NCT00124449|9392797|P1|6-month Double-Blind Treatment Period|Lack of Efficacy|3
2732641|NCT00124449|9392796|P2|6-month Double-Blind Treatment Period|Adverse Event|0
2732642|NCT00124449|9392797|P1|6-month Double-Blind Treatment Period|Adverse Event|1
2732643|NCT00124072|9392851|P4|Overall Study|Death|480
2732644|NCT00124072|9392852|P3|Overall Study|Death|471
2732645|NCT00124072|9392853|P2|Overall Study|Death|484
2732646|NCT00124072|9392854|P1|Overall Study|Death|499
2732647|NCT00124072|9392851|P4|Overall Study|Lost to Follow-up for Morbidity|18
2732648|NCT00124072|9392852|P3|Overall Study|Lost to Follow-up for Morbidity|19
2732649|NCT00124072|9392853|P2|Overall Study|Lost to Follow-up for Morbidity|25
2732650|NCT00124072|9392854|P1|Overall Study|Lost to Follow-up for Morbidity|15
2732651|NCT00124072|9392851|P4|Overall Study|Lost to Follow-up for Mortality|2
2732652|NCT00124072|9392852|P3|Overall Study|Lost to Follow-up for Mortality|2
2732653|NCT00124072|9392853|P2|Overall Study|Lost to Follow-up for Mortality|3
2732654|NCT00124072|9392854|P1|Overall Study|Lost to Follow-up for Mortality|0
2732655|NCT00124020|9392866|P2|Overall Study|Transfer to another hospital|0
2732656|NCT00124020|9392867|P1|Overall Study|Transfer to another hospital|2
2732657|NCT00124020|9392866|P2|Overall Study|Other|1
2732658|NCT00124020|9392867|P1|Overall Study|Other|1
2732659|NCT00124020|9392866|P2|Overall Study|Lost to Follow-up|8
2732660|NCT00124020|9392867|P1|Overall Study|Lost to Follow-up|5
2732661|NCT00124020|9392866|P2|Overall Study|Withdrawal by Subject|11
2732662|NCT00124020|9392867|P1|Overall Study|Withdrawal by Subject|13
2732663|NCT00124020|9392866|P2|Overall Study|Death|71
2732664|NCT00124020|9392867|P1|Overall Study|Death|67
2732665|NCT00123955|9392875|P2|Overall Study|Death|1
2732666|NCT00123955|9392876|P1|Overall Study|Death|0
2732667|NCT00123955|9392875|P2|Overall Study|Withdrawal by Subject|3
2732668|NCT00123955|9392876|P1|Overall Study|Withdrawal by Subject|4
2732669|NCT00123955|9392875|P2|Overall Study|Adverse Event|0
2732670|NCT00123955|9392876|P1|Overall Study|Adverse Event|1
2732671|NCT00123734|9392888|P1|Overall Study|Withdrawal by Subject|1
2732672|NCT00123734|9392888|P1|Overall Study|Dropout|1
2732673|NCT00123734|9392888|P1|Overall Study|Lost to Follow-up|3
2732674|NCT00123734|9392888|P1|Overall Study|Death|3
2732675|NCT00123487|9392973|P2|Treated With Study Drug|Unknown (case report form lost)|1
2732676|NCT00123487|9392974|P1|Treated With Study Drug|Unknown (case report form lost)|0
2732677|NCT00123487|9392973|P2|Treated With Study Drug|Withdrawal by Subject|13
2732678|NCT00123487|9392974|P1|Treated With Study Drug|Withdrawal by Subject|11
2732679|NCT00123487|9392973|P2|Treated With Study Drug|Study Drug Toxicity|80
2732680|NCT00123487|9392974|P1|Treated With Study Drug|Study Drug Toxicity|62
2732681|NCT00123487|9392973|P2|Treated With Study Drug|Other|58
2732682|NCT00123487|9392974|P1|Treated With Study Drug|Other|59
2732683|NCT00123487|9392973|P2|Treated With Study Drug|Physician Decision|9
2732684|NCT00123487|9392974|P1|Treated With Study Drug|Physician Decision|8
2732685|NCT00123487|9392973|P2|Treated With Study Drug|Disease Progression|122
2732686|NCT00123487|9392974|P1|Treated With Study Drug|Disease Progression|141
2732687|NCT00123487|9392973|P2|Treated With Study Drug|Adverse Event|22
2732688|NCT00123487|9392974|P1|Treated With Study Drug|Adverse Event|23
2732689|NCT00123487|9392973|P2|Randomized|SAE prior to starting treatment|0
2732690|NCT00123487|9392974|P1|Randomized|SAE prior to starting treatment|1
2732691|NCT00123487|9392973|P2|Randomized|Death prior to starting treatment|1
2732692|NCT00123487|9392974|P1|Randomized|Death prior to starting treatment|0
2732693|NCT00123474|9393018|P4|As Treated at Study Closure|Withdrawal by Subject|16
2732694|NCT00123474|9393019|P3|As Treated at Study Closure|Withdrawal by Subject|18
2732695|NCT00123474|9393020|P2|As Treated at Study Closure|Withdrawal by Subject|19
2732696|NCT00123474|9393021|P1|As Treated at Study Closure|Withdrawal by Subject|14
2732697|NCT00123474|9393018|P4|As Treated at Study Closure|Study Drug Toxicity|51
2732698|NCT00123474|9393019|P3|As Treated at Study Closure|Study Drug Toxicity|45
2732699|NCT00123474|9393020|P2|As Treated at Study Closure|Study Drug Toxicity|45
2732700|NCT00123474|9393021|P1|As Treated at Study Closure|Study Drug Toxicity|39
2732701|NCT00123474|9393018|P4|As Treated at Study Closure|non-specified|60
2732702|NCT00123474|9393019|P3|As Treated at Study Closure|non-specified|57
2732703|NCT00123474|9393020|P2|As Treated at Study Closure|non-specified|47
2732704|NCT00123474|9393021|P1|As Treated at Study Closure|non-specified|54
2732705|NCT00123474|9393018|P4|As Treated at Study Closure|Investigator Request|5
2732706|NCT00123474|9393019|P3|As Treated at Study Closure|Investigator Request|7
2732707|NCT00123474|9393020|P2|As Treated at Study Closure|Investigator Request|6
2732708|NCT00123474|9393021|P1|As Treated at Study Closure|Investigator Request|12
2732709|NCT00123474|9393018|P4|As Treated at Study Closure|Disease Progression|27
2732710|NCT00123474|9393019|P3|As Treated at Study Closure|Disease Progression|29
2732711|NCT00123474|9393020|P2|As Treated at Study Closure|Disease Progression|42
2732712|NCT00123474|9393021|P1|As Treated at Study Closure|Disease Progression|35
2732713|NCT00123474|9393018|P4|As Treated at Study Closure|Adverse Event|8
2732714|NCT00123474|9393019|P3|As Treated at Study Closure|Adverse Event|10
2732715|NCT00123474|9393020|P2|As Treated at Study Closure|Adverse Event|4
2732716|NCT00123474|9393021|P1|As Treated at Study Closure|Adverse Event|10
2732717|NCT00123474|9393018|P4|As Treated at Study Closure|not reported when site closed|0
2732718|NCT00123474|9393019|P3|As Treated at Study Closure|not reported when site closed|1
2732719|NCT00123474|9393020|P2|As Treated at Study Closure|not reported when site closed|0
2732720|NCT00123474|9393021|P1|As Treated at Study Closure|not reported when site closed|1
2732721|NCT00123474|9393018|P4|Randomized to Treatment|Randomized, never treated|1
2732722|NCT00123474|9393019|P3|Randomized to Treatment|Randomized, never treated|2
2732723|NCT00123474|9393020|P2|Randomized to Treatment|Randomized, never treated|4
2732724|NCT00123474|9393021|P1|Randomized to Treatment|Randomized, never treated|1
2732725|NCT00123422|9393115|P3|Overall Study|Lost to Follow-up|2
2732726|NCT00123422|9393116|P2|Overall Study|Lost to Follow-up|2
2732727|NCT00123422|9393117|P1|Overall Study|Lost to Follow-up|1
2732728|NCT00123422|9393115|P3|Overall Study|Withdrawal by Subject|2
2732729|NCT00123422|9393116|P2|Overall Study|Withdrawal by Subject|2
2732730|NCT00123422|9393117|P1|Overall Study|Withdrawal by Subject|1
2732731|NCT00123422|9393115|P3|Overall Study|Physician Decision|6
2732732|NCT00123422|9393116|P2|Overall Study|Physician Decision|2
2732733|NCT00123422|9393117|P1|Overall Study|Physician Decision|2
2732734|NCT00122980|9393205|P2|Overall Study|Study termination|35
2732735|NCT00122980|9393206|P1|Overall Study|Study termination|27
2732736|NCT00122980|9393205|P2|Overall Study|Adjudicated stroke (study endpoint)|0
2732737|NCT00122980|9393206|P1|Overall Study|Adjudicated stroke (study endpoint)|7
2732738|NCT00122980|9393205|P2|Overall Study|Withdrawal by Subject|3
2732739|NCT00122980|9393206|P1|Overall Study|Withdrawal by Subject|2
2732740|NCT00122980|9393205|P2|Overall Study|Protocol Violation|1
2732741|NCT00122980|9393206|P1|Overall Study|Protocol Violation|5
2732742|NCT00122980|9393205|P2|Overall Study|Physician Decision|0
2732743|NCT00122980|9393206|P1|Overall Study|Physician Decision|2
2732744|NCT00122980|9393205|P2|Overall Study|Death|1
2732745|NCT00122980|9393206|P1|Overall Study|Death|0
2732746|NCT00122954|9393230|P2|Overall Study|Protocol Violation|1
2732747|NCT00122954|9393231|P1|Overall Study|Protocol Violation|0
2732748|NCT00122954|9393230|P2|Overall Study|Withdrawal by Subject|2
2732749|NCT00122954|9393231|P1|Overall Study|Withdrawal by Subject|2
2732750|NCT00122681|9393241|P2|Overall Study|Personal reasons|147
2732751|NCT00122681|9393242|P1|Overall Study|Personal reasons|150
2732752|NCT00122681|9393241|P2|Overall Study|Withdrawal by Subject|251
2732753|NCT00122681|9393242|P1|Overall Study|Withdrawal by Subject|257
2732754|NCT00122681|9393241|P2|Overall Study|Protocol Violation|10
2732755|NCT00122681|9393242|P1|Overall Study|Protocol Violation|7
2732756|NCT00122681|9393241|P2|Overall Study|Lost to Follow-up|1097
2732757|NCT00122681|9393242|P1|Overall Study|Lost to Follow-up|1080
2732758|NCT00122681|9393241|P2|Overall Study|Adverse Event|16
2732759|NCT00122681|9393242|P1|Overall Study|Adverse Event|20
2732760|NCT00122460|9393316|P2|Overall Study|investigational study phase ongoing|1
2732761|NCT00122460|9393317|P1|Overall Study|investigational study phase ongoing|7
2732762|NCT00122382|9393366|P3|Open-Label Study|Withdrawal of Consent|4
2732763|NCT00122382|9393367|P2|Open-Label Study|Withdrawal of Consent|0
2732764|NCT00122382|9393368|P1|Open-Label Study|Withdrawal of Consent|0
2732765|NCT00122382|9393366|P3|Open-Label Study|Poor/Non-Compliance|1
2732766|NCT00122382|9393367|P2|Open-Label Study|Poor/Non-Compliance|0
2732767|NCT00122382|9393368|P1|Open-Label Study|Poor/Non-Compliance|0
2732768|NCT00122382|9393366|P3|Open-Label Study|Pregnancy|2
2732769|NCT00122382|9393367|P2|Open-Label Study|Pregnancy|0
2732770|NCT00122382|9393368|P1|Open-Label Study|Pregnancy|0
2732771|NCT00122382|9393366|P3|Open-Label Study|Lost to Follow-up|3
2732772|NCT00122382|9393367|P2|Open-Label Study|Lost to Follow-up|0
2732773|NCT00122382|9393368|P1|Open-Label Study|Lost to Follow-up|0
2732774|NCT00122382|9393366|P3|Open-Label Study|Lack of Efficacy|3
2732775|NCT00122382|9393367|P2|Open-Label Study|Lack of Efficacy|0
2732776|NCT00122382|9393368|P1|Open-Label Study|Lack of Efficacy|0
2732777|NCT00122382|9393366|P3|Open-Label Study|Death|2
2732778|NCT00122382|9393367|P2|Open-Label Study|Death|0
2732779|NCT00122382|9393368|P1|Open-Label Study|Death|0
2732780|NCT00122382|9393366|P3|Open-Label Study|Adverse Event|11
2732781|NCT00122382|9393367|P2|Open-Label Study|Adverse Event|0
2732782|NCT00122382|9393368|P1|Open-Label Study|Adverse Event|0
2732783|NCT00122382|9393366|P3|Double-Blind Study|Randomized but not treated|0
2732784|NCT00122382|9393367|P2|Double-Blind Study|Randomized but not treated|2
2732785|NCT00122382|9393368|P1|Double-Blind Study|Randomized but not treated|0
2732786|NCT00122382|9393366|P3|Double-Blind Study|Methotrexate Discontinued|0
2732787|NCT00122382|9393367|P2|Double-Blind Study|Methotrexate Discontinued|1
2732788|NCT00122382|9393368|P1|Double-Blind Study|Methotrexate Discontinued|0
2732789|NCT00122382|9393366|P3|Double-Blind Study|Protocol Violation|0
2732790|NCT00122382|9393367|P2|Double-Blind Study|Protocol Violation|0
2732791|NCT00122382|9393368|P1|Double-Blind Study|Protocol Violation|1
2732792|NCT00122382|9393366|P3|Double-Blind Study|Withdrawal of Consent|0
2732793|NCT00122382|9393367|P2|Double-Blind Study|Withdrawal of Consent|3
2732794|NCT00122382|9393368|P1|Double-Blind Study|Withdrawal of Consent|7
2732795|NCT00122382|9393366|P3|Double-Blind Study|Subject No Longer Meets Study Criteria|0
2732796|NCT00122382|9393367|P2|Double-Blind Study|Subject No Longer Meets Study Criteria|0
2732797|NCT00122382|9393368|P1|Double-Blind Study|Subject No Longer Meets Study Criteria|1
2732798|NCT00122382|9393366|P3|Double-Blind Study|Pregnancy|0
2732799|NCT00122382|9393367|P2|Double-Blind Study|Pregnancy|0
2732800|NCT00122382|9393368|P1|Double-Blind Study|Pregnancy|2
2732801|NCT00122382|9393366|P3|Double-Blind Study|Lost to Follow-up|0
2732802|NCT00122382|9393367|P2|Double-Blind Study|Lost to Follow-up|1
2732803|NCT00122382|9393368|P1|Double-Blind Study|Lost to Follow-up|2
2732804|NCT00122382|9393366|P3|Double-Blind Study|Lack of Efficacy|0
2732805|NCT00122382|9393367|P2|Double-Blind Study|Lack of Efficacy|8
2732806|NCT00122382|9393368|P1|Double-Blind Study|Lack of Efficacy|0
2732807|NCT00122382|9393366|P3|Double-Blind Study|Death|0
2732808|NCT00122382|9393367|P2|Double-Blind Study|Death|2
2732809|NCT00122382|9393368|P1|Double-Blind Study|Death|2
2732810|NCT00122382|9393366|P3|Double-Blind Study|Adverse Event|0
2732811|NCT00122382|9393367|P2|Double-Blind Study|Adverse Event|11
2732812|NCT00122382|9393368|P1|Double-Blind Study|Adverse Event|9
2732813|NCT00122317|9393512|P1|Overall Study|Withdrawal by Subject|1
2732814|NCT00122317|9393512|P1|Overall Study|patient non-compliance|1
2732815|NCT00122317|9393512|P1|Overall Study|Physician Decision|2
2732816|NCT00122317|9393512|P1|Overall Study|Adverse Event|4
2732817|NCT00122317|9393512|P1|Overall Study|Death|3
2732818|NCT00122278|9393521|P2|Overall Study|Lost to Follow-up|0
2732819|NCT00122278|9393522|P1|Overall Study|Lost to Follow-up|2
2732820|NCT00122187|9393532|P2|Overall Study|Withdrew because of resource limitations|2
2732821|NCT00122187|9393533|P1|Overall Study|Withdrew because of resource limitations|2
2732822|NCT00122135|9393547|P2|Overall Study|Withdrawal by Subject|0
2732823|NCT00122135|9393548|P1|Overall Study|Withdrawal by Subject|3
2732824|NCT00122109|9393556|P2|Overall Study|Did not meet criteria|7
2732825|NCT00122109|9393557|P1|Overall Study|Did not meet criteria|6
2732826|NCT00121667|9393823|P4|Short Term (ST) + Long Term (LT) Period|Death|2
2732827|NCT00121667|9393824|P3|Short Term (ST) + Long Term (LT) Period|Death|0
2732828|NCT00121667|9393825|P2|Short Term (ST) + Long Term (LT) Period|Death|0
2732829|NCT00121667|9393826|P1|Short Term (ST) + Long Term (LT) Period|Death|1
2732830|NCT00121667|9393823|P4|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
2732831|NCT00121667|9393824|P3|Short Term (ST) + Long Term (LT) Period|Pregnancy|0
2732832|NCT00121667|9393825|P2|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
2732833|NCT00121667|9393826|P1|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
2732834|NCT00121667|9393823|P4|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4
2732835|NCT00121667|9393824|P3|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8
2732836|NCT00121667|9393825|P2|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5
2732837|NCT00121667|9393826|P1|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3
2732838|NCT00121667|9393823|P4|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9
2732839|NCT00121667|9393824|P3|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5
2732840|NCT00121667|9393825|P2|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6
2732841|NCT00121667|9393826|P1|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3
2732842|NCT00121667|9393823|P4|Short Term (ST) + Long Term (LT) Period|Other Reason|3
2732843|NCT00121667|9393824|P3|Short Term (ST) + Long Term (LT) Period|Other Reason|6
2732844|NCT00121667|9393825|P2|Short Term (ST) + Long Term (LT) Period|Other Reason|7
2732845|NCT00121667|9393826|P1|Short Term (ST) + Long Term (LT) Period|Other Reason|5
2732846|NCT00121667|9393823|P4|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16
2732847|NCT00121667|9393824|P3|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13
2732848|NCT00121667|9393825|P2|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
2732849|NCT00121667|9393826|P1|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
2732850|NCT00121667|9393823|P4|Short Term (ST) + Long Term (LT) Period|Adverse Event|10
2732851|NCT00121667|9393824|P3|Short Term (ST) + Long Term (LT) Period|Adverse Event|13
2732852|NCT00121667|9393825|P2|Short Term (ST) + Long Term (LT) Period|Adverse Event|18
2732853|NCT00121667|9393826|P1|Short Term (ST) + Long Term (LT) Period|Adverse Event|12
2732854|NCT00121667|9393823|P4|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30
2732855|NCT00121667|9393824|P3|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26
2732856|NCT00121667|9393825|P2|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34
2732857|NCT00121667|9393826|P1|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38
2732858|NCT00121667|9393823|P4|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65
2732859|NCT00121667|9393824|P3|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42
2732860|NCT00121667|9393825|P2|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51
2732861|NCT00121667|9393826|P1|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54
2732862|NCT00121667|9393823|P4|Short Term (ST) Period|Pregnancy|1
2732863|NCT00121667|9393824|P3|Short Term (ST) Period|Pregnancy|0
2732864|NCT00121667|9393825|P2|Short Term (ST) Period|Pregnancy|0
2732865|NCT00121667|9393826|P1|Short Term (ST) Period|Pregnancy|0
2732866|NCT00121667|9393823|P4|Short Term (ST) Period|Death|1
2732867|NCT00121667|9393824|P3|Short Term (ST) Period|Death|0
2732868|NCT00121667|9393825|P2|Short Term (ST) Period|Death|0
2732869|NCT00121667|9393826|P1|Short Term (ST) Period|Death|0
2732870|NCT00121667|9393823|P4|Short Term (ST) Period|Other Reason|0
2732871|NCT00121667|9393824|P3|Short Term (ST) Period|Other Reason|0
2732872|NCT00121667|9393825|P2|Short Term (ST) Period|Other Reason|0
2732873|NCT00121667|9393826|P1|Short Term (ST) Period|Other Reason|3
2732874|NCT00121667|9393823|P4|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
2732875|NCT00121667|9393824|P3|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
2732876|NCT00121667|9393825|P2|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
2732877|NCT00121667|9393826|P1|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
2732878|NCT00121667|9393823|P4|Short Term (ST) Period|Poor / Non-compliance|2
2732879|NCT00121667|9393824|P3|Short Term (ST) Period|Poor / Non-compliance|1
2732880|NCT00121667|9393825|P2|Short Term (ST) Period|Poor / Non-compliance|1
2732881|NCT00121667|9393826|P1|Short Term (ST) Period|Poor / Non-compliance|0
2732882|NCT00121667|9393823|P4|Short Term (ST) Period|Lost to Follow-up|3
2732883|NCT00121667|9393824|P3|Short Term (ST) Period|Lost to Follow-up|4
2732884|NCT00121667|9393825|P2|Short Term (ST) Period|Lost to Follow-up|4
2732885|NCT00121667|9393826|P1|Short Term (ST) Period|Lost to Follow-up|3
2732886|NCT00121667|9393823|P4|Short Term (ST) Period|Adverse Event|3
2732887|NCT00121667|9393824|P3|Short Term (ST) Period|Adverse Event|5
2732888|NCT00121667|9393825|P2|Short Term (ST) Period|Adverse Event|6
2732889|NCT00121667|9393826|P1|Short Term (ST) Period|Adverse Event|5
2732890|NCT00121667|9393823|P4|Short Term (ST) Period|Subject Withdrew Consent|11
2732891|NCT00121667|9393824|P3|Short Term (ST) Period|Subject Withdrew Consent|4
2732892|NCT00121667|9393825|P2|Short Term (ST) Period|Subject Withdrew Consent|13
2732893|NCT00121667|9393826|P1|Short Term (ST) Period|Subject Withdrew Consent|8
2732894|NCT00121667|9393823|P4|Short Term (ST) Period|Lack of Efficacy|44
2732895|NCT00121667|9393824|P3|Short Term (ST) Period|Lack of Efficacy|27
2732896|NCT00121667|9393825|P2|Short Term (ST) Period|Lack of Efficacy|22
2732897|NCT00121667|9393826|P1|Short Term (ST) Period|Lack of Efficacy|25
2732898|NCT00121641|9393924|P5|48-month Short Term + Long Term Period|Other Reason|1
2732899|NCT00121641|9393925|P4|48-month Short Term + Long Term Period|Other Reason|0
2732900|NCT00121641|9393926|P3|48-month Short Term + Long Term Period|Other Reason|2
2732901|NCT00121641|9393927|P2|48-month Short Term + Long Term Period|Other Reason|3
2732902|NCT00121641|9393928|P1|48-month Short Term + Long Term Period|Other Reason|5
2732903|NCT00121641|9393924|P5|48-month Short Term + Long Term Period|Missing|0
2732904|NCT00121641|9393925|P4|48-month Short Term + Long Term Period|Missing|0
2732905|NCT00121641|9393926|P3|48-month Short Term + Long Term Period|Missing|1
2732906|NCT00121641|9393927|P2|48-month Short Term + Long Term Period|Missing|0
2732907|NCT00121641|9393928|P1|48-month Short Term + Long Term Period|Missing|0
2732908|NCT00121641|9393924|P5|48-month Short Term + Long Term Period|Death|0
2732909|NCT00121641|9393925|P4|48-month Short Term + Long Term Period|Death|1
2732910|NCT00121641|9393926|P3|48-month Short Term + Long Term Period|Death|0
2732911|NCT00121641|9393927|P2|48-month Short Term + Long Term Period|Death|0
2732912|NCT00121641|9393928|P1|48-month Short Term + Long Term Period|Death|0
2732913|NCT00121641|9393924|P5|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
2732914|NCT00121641|9393925|P4|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
2732915|NCT00121641|9393926|P3|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
2732916|NCT00121641|9393927|P2|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2
2732917|NCT00121641|9393928|P1|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
2732918|NCT00121641|9393924|P5|48-month Short Term + Long Term Period|Pregnancy|0
2732919|NCT00121641|9393925|P4|48-month Short Term + Long Term Period|Pregnancy|1
2732920|NCT00121641|9393926|P3|48-month Short Term + Long Term Period|Pregnancy|0
2732921|NCT00121641|9393927|P2|48-month Short Term + Long Term Period|Pregnancy|1
2732922|NCT00121641|9393928|P1|48-month Short Term + Long Term Period|Pregnancy|0
2732923|NCT00121641|9393924|P5|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
2732924|NCT00121641|9393925|P4|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
2732925|NCT00121641|9393926|P3|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
2732926|NCT00121641|9393927|P2|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3
2732927|NCT00121641|9393928|P1|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
2732928|NCT00121641|9393924|P5|48-month Short Term + Long Term Period|Poor / Non-compliance|2
2732929|NCT00121641|9393925|P4|48-month Short Term + Long Term Period|Poor / Non-compliance|2
2732930|NCT00121641|9393926|P3|48-month Short Term + Long Term Period|Poor / Non-compliance|4
2732931|NCT00121641|9393927|P2|48-month Short Term + Long Term Period|Poor / Non-compliance|1
2732932|NCT00121641|9393928|P1|48-month Short Term + Long Term Period|Poor / Non-compliance|4
2732933|NCT00121641|9393924|P5|48-month Short Term + Long Term Period|Lost to Follow-up|12
2732934|NCT00121641|9393925|P4|48-month Short Term + Long Term Period|Lost to Follow-up|11
2732935|NCT00121641|9393926|P3|48-month Short Term + Long Term Period|Lost to Follow-up|12
2732936|NCT00121641|9393927|P2|48-month Short Term + Long Term Period|Lost to Follow-up|7
2732937|NCT00121641|9393928|P1|48-month Short Term + Long Term Period|Lost to Follow-up|9
2732938|NCT00121641|9393924|P5|48-month Short Term + Long Term Period|Adverse Event|5
2732939|NCT00121641|9393925|P4|48-month Short Term + Long Term Period|Adverse Event|5
2732940|NCT00121641|9393926|P3|48-month Short Term + Long Term Period|Adverse Event|10
2732941|NCT00121641|9393927|P2|48-month Short Term + Long Term Period|Adverse Event|10
2732942|NCT00121641|9393928|P1|48-month Short Term + Long Term Period|Adverse Event|9
2732943|NCT00121641|9393924|P5|48-month Short Term + Long Term Period|Subject Withdrew Consent|10
2732944|NCT00121641|9393925|P4|48-month Short Term + Long Term Period|Subject Withdrew Consent|24
2732945|NCT00121641|9393926|P3|48-month Short Term + Long Term Period|Subject Withdrew Consent|17
2732946|NCT00121641|9393927|P2|48-month Short Term + Long Term Period|Subject Withdrew Consent|28
2732947|NCT00121641|9393928|P1|48-month Short Term + Long Term Period|Subject Withdrew Consent|25
2732948|NCT00121641|9393924|P5|48-month Short Term + Long Term Period|Lack of Efficacy|25
2732949|NCT00121641|9393925|P4|48-month Short Term + Long Term Period|Lack of Efficacy|26
2732950|NCT00121641|9393926|P3|48-month Short Term + Long Term Period|Lack of Efficacy|21
2732951|NCT00121641|9393927|P2|48-month Short Term + Long Term Period|Lack of Efficacy|27
2732952|NCT00121641|9393928|P1|48-month Short Term + Long Term Period|Lack of Efficacy|26
2732953|NCT00121641|9393924|P5|24-week Short-term Treatment Period|Other Reason|0
2732954|NCT00121641|9393925|P4|24-week Short-term Treatment Period|Other Reason|0
2732955|NCT00121641|9393926|P3|24-week Short-term Treatment Period|Other Reason|0
2732956|NCT00121641|9393927|P2|24-week Short-term Treatment Period|Other Reason|0
2732957|NCT00121641|9393928|P1|24-week Short-term Treatment Period|Other Reason|1
2732958|NCT00121641|9393924|P5|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
2732959|NCT00121641|9393925|P4|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
2732960|NCT00121641|9393926|P3|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
2732961|NCT00121641|9393927|P2|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
2732962|NCT00121641|9393928|P1|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
2732963|NCT00121641|9393924|P5|24-week Short-term Treatment Period|Poor / Non-compliance|1
2732964|NCT00121641|9393925|P4|24-week Short-term Treatment Period|Poor / Non-compliance|1
2732965|NCT00121641|9393926|P3|24-week Short-term Treatment Period|Poor / Non-compliance|3
2732966|NCT00121641|9393927|P2|24-week Short-term Treatment Period|Poor / Non-compliance|0
2732967|NCT00121641|9393928|P1|24-week Short-term Treatment Period|Poor / Non-compliance|0
2732968|NCT00121641|9393924|P5|24-week Short-term Treatment Period|Lost to Follow-up|4
2732969|NCT00121641|9393925|P4|24-week Short-term Treatment Period|Lost to Follow-up|4
2732970|NCT00121641|9393926|P3|24-week Short-term Treatment Period|Lost to Follow-up|3
2732971|NCT00121641|9393927|P2|24-week Short-term Treatment Period|Lost to Follow-up|2
2732972|NCT00121641|9393928|P1|24-week Short-term Treatment Period|Lost to Follow-up|0
2732973|NCT00121641|9393924|P5|24-week Short-term Treatment Period|Adverse Event|2
2732974|NCT00121641|9393925|P4|24-week Short-term Treatment Period|Adverse Event|0
2732975|NCT00121641|9393926|P3|24-week Short-term Treatment Period|Adverse Event|4
2732976|NCT00121641|9393927|P2|24-week Short-term Treatment Period|Adverse Event|3
2732977|NCT00121641|9393928|P1|24-week Short-term Treatment Period|Adverse Event|3
2732978|NCT00121641|9393924|P5|24-week Short-term Treatment Period|Subject Withdrew Consent|3
2732979|NCT00121641|9393925|P4|24-week Short-term Treatment Period|Subject Withdrew Consent|10
2732980|NCT00121641|9393926|P3|24-week Short-term Treatment Period|Subject Withdrew Consent|5
2732981|NCT00121641|9393927|P2|24-week Short-term Treatment Period|Subject Withdrew Consent|11
2732982|NCT00121641|9393928|P1|24-week Short-term Treatment Period|Subject Withdrew Consent|9
2732983|NCT00121641|9393924|P5|24-week Short-term Treatment Period|Lack of Efficacy|30
2732984|NCT00121641|9393925|P4|24-week Short-term Treatment Period|Lack of Efficacy|25
2732985|NCT00121641|9393926|P3|24-week Short-term Treatment Period|Lack of Efficacy|14
2732986|NCT00121641|9393927|P2|24-week Short-term Treatment Period|Lack of Efficacy|21
2732987|NCT00121641|9393928|P1|24-week Short-term Treatment Period|Lack of Efficacy|15
2732988|NCT00121485|9394041|P2|Overall Study|Crossover|2
2732989|NCT00121485|9394042|P1|Overall Study|Crossover|0
2732990|NCT00121485|9394041|P2|Overall Study|Not implanted|5
2732991|NCT00121485|9394042|P1|Overall Study|Not implanted|1
2732992|NCT00121238|9394087|P1|Overall Study|Protocol Violation|2
2732993|NCT00121238|9394087|P1|Overall Study|disease progression before intervention|1
2732994|NCT00121199|9394103|P1|Overall Study|Ineligible|9
2732995|NCT00121199|9394103|P1|Overall Study|Other - Not Protocol Specified|3
2732996|NCT00121199|9394103|P1|Overall Study|Death|3
2732997|NCT00121199|9394103|P1|Overall Study|Progression/Relapse|1
2732998|NCT00121199|9394103|P1|Overall Study|Refusal Unrelated to Adverse Event|1
2732999|NCT00121199|9394103|P1|Overall Study|Adverse Event|11
2733000|NCT00121134|9394147|P4|Overall Study|Patient Personal Reasons|0
2733001|NCT00121134|9394148|P3|Overall Study|Patient Personal Reasons|0
2733002|NCT00121134|9394149|P2|Overall Study|Patient Personal Reasons|1
2733003|NCT00121134|9394150|P1|Overall Study|Patient Personal Reasons|0
2733004|NCT00121134|9394147|P4|Overall Study|Intercurrent Illness|1
2733005|NCT00121134|9394148|P3|Overall Study|Intercurrent Illness|0
2733006|NCT00121134|9394149|P2|Overall Study|Intercurrent Illness|0
2733007|NCT00121134|9394150|P1|Overall Study|Intercurrent Illness|0
2733008|NCT00121134|9394147|P4|Overall Study|Treatment Delay|0
2733009|NCT00121134|9394148|P3|Overall Study|Treatment Delay|0
2733010|NCT00121134|9394149|P2|Overall Study|Treatment Delay|0
2733011|NCT00121134|9394150|P1|Overall Study|Treatment Delay|1
2733012|NCT00121134|9394147|P4|Overall Study|Physician Decision|1
2733013|NCT00121134|9394148|P3|Overall Study|Physician Decision|4
2733014|NCT00121134|9394149|P2|Overall Study|Physician Decision|4
2733015|NCT00121134|9394150|P1|Overall Study|Physician Decision|6
2733016|NCT00121134|9394147|P4|Overall Study|Toxicity|5
2733017|NCT00121134|9394148|P3|Overall Study|Toxicity|13
2733018|NCT00121134|9394149|P2|Overall Study|Toxicity|7
2733019|NCT00121134|9394150|P1|Overall Study|Toxicity|4
2733020|NCT00121134|9394147|P4|Overall Study|Progression of Disease|2
2733021|NCT00121134|9394148|P3|Overall Study|Progression of Disease|4
2733022|NCT00121134|9394149|P2|Overall Study|Progression of Disease|3
2733023|NCT00121134|9394150|P1|Overall Study|Progression of Disease|5
2733024|NCT00120874|9394162|P2|Overall Study|Death|1
2733025|NCT00120874|9394163|P1|Overall Study|Death|0
2733026|NCT00120627|9394201|P2|Overall Study|Withdrawal by Subject|5
2733027|NCT00120627|9394202|P1|Overall Study|Withdrawal by Subject|5
2733028|NCT00120406|9394253|P2|Overall Study|patient moved but has not withdrawn|1
2733029|NCT00120406|9394254|P1|Overall Study|patient moved but has not withdrawn|0
2733030|NCT00120406|9394253|P2|Overall Study|received non-study stent|2
2733031|NCT00120406|9394254|P1|Overall Study|received non-study stent|0
2733032|NCT00120406|9394253|P2|Overall Study|Lost to Follow-up|2
2733033|NCT00120406|9394254|P1|Overall Study|Lost to Follow-up|5
2733034|NCT00120406|9394253|P2|Overall Study|Withdrawal by Subject|7
2733035|NCT00120406|9394254|P1|Overall Study|Withdrawal by Subject|5
2733036|NCT00120406|9394253|P2|Overall Study|Death|4
2733037|NCT00120406|9394254|P1|Overall Study|Death|9
2733038|NCT00120289|9394264|P2|Overall Study|Withdrawal by Subject|13
2733039|NCT00120289|9394265|P1|Overall Study|Withdrawal by Subject|14
2733040|NCT00120289|9394264|P2|Overall Study|Lost to Follow-up|14
2733041|NCT00120289|9394265|P1|Overall Study|Lost to Follow-up|11
2733042|NCT00120289|9394264|P2|Overall Study|Death|82
2733043|NCT00120289|9394265|P1|Overall Study|Death|96
2733044|NCT00120250|9394277|P2|Overall Study|Protocol Violation|1
2733045|NCT00120250|9394278|P1|Overall Study|Protocol Violation|0
2733046|NCT00120250|9394277|P2|Overall Study|Lost to Follow-up|1
2733047|NCT00120250|9394278|P1|Overall Study|Lost to Follow-up|1
2733048|NCT00120042|9394294|P3|Overall Study|all completed protocl|0
2733049|NCT00120042|9394295|P2|Overall Study|all completed protocl|0
2733050|NCT00120042|9394296|P1|Overall Study|all completed protocl|0
2733051|NCT00119678|9394319|P2|Open-label Treatment Period|Administrative reasons by sponsor|0
2733052|NCT00119678|9394320|P1|Open-label Treatment Period|Administrative reasons by sponsor|87
2733053|NCT00119678|9394319|P2|Open-label Treatment Period|Pregnancy|0
2733054|NCT00119678|9394320|P1|Open-label Treatment Period|Pregnancy|1
2733055|NCT00119678|9394319|P2|Open-label Treatment Period|Participants not meeting study criteria|0
2733056|NCT00119678|9394320|P1|Open-label Treatment Period|Participants not meeting study criteria|2
2733057|NCT00119678|9394319|P2|Open-label Treatment Period|Participant withdrew consent|0
2733058|NCT00119678|9394320|P1|Open-label Treatment Period|Participant withdrew consent|4
2733059|NCT00119678|9394319|P2|Open-label Treatment Period|Lost to Follow-up|0
2733060|NCT00119678|9394320|P1|Open-label Treatment Period|Lost to Follow-up|3
2733061|NCT00119678|9394319|P2|Open-label Treatment Period|Lack of Efficacy|0
2733062|NCT00119678|9394320|P1|Open-label Treatment Period|Lack of Efficacy|9
2733063|NCT00119678|9394319|P2|Open-label Treatment Period|Adverse Event|0
2733064|NCT00119678|9394320|P1|Open-label Treatment Period|Adverse Event|3
2733065|NCT00119678|9394319|P2|Open-label Treatment Period|Death|0
2733066|NCT00119678|9394320|P1|Open-label Treatment Period|Death|1
2733067|NCT00119678|9394319|P2|Double-blind Treatment Period|Site closed due to non-compliance|2
2733068|NCT00119678|9394320|P1|Double-blind Treatment Period|Site closed due to non-compliance|3
2733069|NCT00119678|9394319|P2|Double-blind Treatment Period|Not treated|2
2733070|NCT00119678|9394320|P1|Double-blind Treatment Period|Not treated|1
2733071|NCT00119678|9394319|P2|Double-blind Treatment Period|Pregnancy|2
2733072|NCT00119678|9394320|P1|Double-blind Treatment Period|Pregnancy|0
2733073|NCT00119678|9394319|P2|Double-blind Treatment Period|Poor/Non-compliance|0
2733074|NCT00119678|9394320|P1|Double-blind Treatment Period|Poor/Non-compliance|3
2733075|NCT00119678|9394319|P2|Double-blind Treatment Period|Participants not meeting study criteria|1
2733076|NCT00119678|9394320|P1|Double-blind Treatment Period|Participants not meeting study criteria|0
2733077|NCT00119678|9394319|P2|Double-blind Treatment Period|Participant withdrew consent|4
2733078|NCT00119678|9394320|P1|Double-blind Treatment Period|Participant withdrew consent|4
2733079|NCT00119678|9394319|P2|Double-blind Treatment Period|Lost to Follow-up|2
2733080|NCT00119678|9394320|P1|Double-blind Treatment Period|Lost to Follow-up|1
2733081|NCT00119678|9394319|P2|Double-blind Treatment Period|Lack of Efficacy|12
2733082|NCT00119678|9394320|P1|Double-blind Treatment Period|Lack of Efficacy|21
2733083|NCT00119678|9394319|P2|Double-blind Treatment Period|Adverse Event|1
2733084|NCT00119678|9394320|P1|Double-blind Treatment Period|Adverse Event|7
2733085|NCT00119678|9394319|P2|Double-blind Treatment Period|Death|0
2733086|NCT00119678|9394320|P1|Double-blind Treatment Period|Death|1
2733087|NCT00119405|9394366|P1|Overall Study|Withdrawal by Subject|1
2733088|NCT00119379|9394380|P2|Overall Study|Adverse Event|1
2733089|NCT00119379|9394381|P1|Overall Study|Adverse Event|4
2733090|NCT00119262|9394399|P2|Overall Study|others|5
2733091|NCT00119262|9394400|P1|Overall Study|others|0
2733092|NCT00119262|9394399|P2|Overall Study|ineligble|2
2733093|NCT00119262|9394400|P1|Overall Study|ineligble|1
2733094|NCT00119262|9394399|P2|Overall Study|other disease|2
2733095|NCT00119262|9394400|P1|Overall Study|other disease|0
2733096|NCT00119262|9394399|P2|Overall Study|Adverse Event|35
2733097|NCT00119262|9394400|P1|Overall Study|Adverse Event|33
2733098|NCT00119262|9394399|P2|Overall Study|Withdrawal by Subject|11
2733099|NCT00119262|9394400|P1|Overall Study|Withdrawal by Subject|12
2733100|NCT00119262|9394399|P2|Overall Study|Lack of Efficacy|3
2733101|NCT00119262|9394400|P1|Overall Study|Lack of Efficacy|0
2733102|NCT00119015|9394437|P3|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
2733103|NCT00119015|9394438|P2|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
2733104|NCT00119015|9394439|P1|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48
2733105|NCT00118911|9394455|P2|Overall Study|Withdrawal by Subject|5
2733106|NCT00118911|9394456|P1|Overall Study|Withdrawal by Subject|2
2733107|NCT00118898|9394468|P4|Overall Study|Not able to get to clinic|40
2733108|NCT00118898|9394469|P3|Overall Study|Not able to get to clinic|31
2733109|NCT00118898|9394470|P2|Overall Study|Not able to get to clinic|43
2733110|NCT00118898|9394471|P1|Overall Study|Not able to get to clinic|34
2733111|NCT00118898|9394468|P4|Overall Study|Not compliant with requirements|11
2733112|NCT00118898|9394469|P3|Overall Study|Not compliant with requirements|11
2733113|NCT00118898|9394470|P2|Overall Study|Not compliant with requirements|13
2733114|NCT00118898|9394471|P1|Overall Study|Not compliant with requirements|11
2733115|NCT00118898|9394468|P4|Overall Study|Severe debilitation|4
2733116|NCT00118898|9394469|P3|Overall Study|Severe debilitation|6
2733117|NCT00118898|9394470|P2|Overall Study|Severe debilitation|4
2733118|NCT00118898|9394471|P1|Overall Study|Severe debilitation|1
2733119|NCT00118898|9394468|P4|Overall Study|Site Closure|37
2733120|NCT00118898|9394469|P3|Overall Study|Site Closure|28
2733121|NCT00118898|9394470|P2|Overall Study|Site Closure|31
2733122|NCT00118898|9394471|P1|Overall Study|Site Closure|33
2733123|NCT00118898|9394468|P4|Overall Study|Withdrawal by Subject|8
2733124|NCT00118898|9394469|P3|Overall Study|Withdrawal by Subject|8
2733125|NCT00118898|9394470|P2|Overall Study|Withdrawal by Subject|5
2733126|NCT00118898|9394471|P1|Overall Study|Withdrawal by Subject|10
2733127|NCT00118898|9394468|P4|Overall Study|Lost to Follow-up|33
2733128|NCT00118898|9394469|P3|Overall Study|Lost to Follow-up|33
2733129|NCT00118898|9394470|P2|Overall Study|Lost to Follow-up|34
2733130|NCT00118898|9394471|P1|Overall Study|Lost to Follow-up|26
2733131|NCT00118898|9394468|P4|Overall Study|Death|8
2733132|NCT00118898|9394469|P3|Overall Study|Death|6
2733133|NCT00118898|9394470|P2|Overall Study|Death|11
2733134|NCT00118898|9394471|P1|Overall Study|Death|6
2733135|NCT00118716|9394597|P2|Overall Study|Investigator discretion|1
2733136|NCT00118716|9394598|P1|Overall Study|Investigator discretion|0
2733137|NCT00118716|9394597|P2|Overall Study|Expired drug use|2
2733138|NCT00118716|9394598|P1|Overall Study|Expired drug use|1
2733139|NCT00118716|9394597|P2|Overall Study|misrandomized|1
2733140|NCT00118716|9394598|P1|Overall Study|misrandomized|1
2733141|NCT00118716|9394597|P2|Overall Study|Non-compliance|3
2733142|NCT00118716|9394598|P1|Overall Study|Non-compliance|1
2733143|NCT00118716|9394597|P2|Overall Study|Discontinued by sponsor|1
2733144|NCT00118716|9394598|P1|Overall Study|Discontinued by sponsor|1
2733145|NCT00118716|9394597|P2|Overall Study|Exacerbation|2
2733146|NCT00118716|9394598|P1|Overall Study|Exacerbation|2
2733147|NCT00118716|9394597|P2|Overall Study|Withdrawal by Subject|1
2733148|NCT00118716|9394598|P1|Overall Study|Withdrawal by Subject|0
2733149|NCT00118716|9394597|P2|Overall Study|Protocol Violation|4
2733150|NCT00118716|9394598|P1|Overall Study|Protocol Violation|5
2733151|NCT00118716|9394597|P2|Overall Study|Adverse Event|7
2733152|NCT00118716|9394598|P1|Overall Study|Adverse Event|2
2733153|NCT00118703|9394618|P2|Overall Study|Lost to Follow-up|2
2733154|NCT00118703|9394619|P1|Overall Study|Lost to Follow-up|1
2733155|NCT00118703|9394618|P2|Overall Study|Withdrawal by Subject|5
2733156|NCT00118703|9394619|P1|Overall Study|Withdrawal by Subject|2
2733157|NCT00118703|9394618|P2|Overall Study|Participant took two different treatment|1
2733158|NCT00118703|9394619|P1|Overall Study|Participant took two different treatment|0
2733159|NCT00118703|9394618|P2|Overall Study|Adverse Event|1
2733160|NCT00118703|9394619|P1|Overall Study|Adverse Event|1
2733161|NCT00118703|9394618|P2|Overall Study|Protocol Violation|0
2733162|NCT00118703|9394619|P1|Overall Study|Protocol Violation|1
2733163|NCT00118482|9394716|P2|Overall Study|Withdrawal by Subject|22
2733164|NCT00118482|9394717|P1|Overall Study|Withdrawal by Subject|23
2733165|NCT00118482|9394716|P2|Overall Study|Lost to Follow-up|7
2733166|NCT00118482|9394717|P1|Overall Study|Lost to Follow-up|7
2733167|NCT00118430|9394732|P3|Overall Study|Lost to Follow-up|28
2733168|NCT00118430|9394733|P2|Overall Study|Lost to Follow-up|22
2733169|NCT00118430|9394734|P1|Overall Study|Lost to Follow-up|15
2733170|NCT00118430|9394732|P3|Overall Study|Withdrawal by Subject|0
2733171|NCT00118430|9394733|P2|Overall Study|Withdrawal by Subject|2
2733172|NCT00118430|9394734|P1|Overall Study|Withdrawal by Subject|6
2733173|NCT00118417|9394749|P2|Phase II (Weeks 6 to 12)|Remission|2
2733174|NCT00118417|9394750|P1|Phase II (Weeks 6 to 12)|Remission|1
2733175|NCT00118417|9394749|P2|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
2733176|NCT00118417|9394750|P1|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
2733177|NCT00118417|9394749|P2|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0
2733178|NCT00118417|9394750|P1|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4
2733179|NCT00118417|9394749|P2|Phase I (Weeks 0 to 6)|Lost to Follow-up|0
2733180|NCT00118417|9394750|P1|Phase I (Weeks 0 to 6)|Lost to Follow-up|6
2733181|NCT00118417|9394749|P2|Phase I (Weeks 0 to 6)|Remission|0
2733182|NCT00118417|9394750|P1|Phase I (Weeks 0 to 6)|Remission|8
2733183|NCT00118287|9394894|P1|Overall Study|Muscle pain|1
2733184|NCT00118287|9394894|P1|Overall Study|Intracranial haemorrhage|1
2733185|NCT00118157|9394927|P1|Overall Study|Withdrawal by Subject|2
2733186|NCT00118157|9394927|P1|Overall Study|Death|8
2733187|NCT00118157|9394927|P1|Overall Study|Adverse Event|2
2733188|NCT00118092|9394945|P1|Overall Study|Protocol Violation|1
2733189|NCT00118092|9394945|P1|Overall Study|Withdrawal by Subject|1
2733190|NCT00118040|9394963|P3|Overall Study|Other|1
2733191|NCT00118040|9394964|P2|Overall Study|Other|0
2733192|NCT00118040|9394965|P1|Overall Study|Other|0
2733193|NCT00118040|9394963|P3|Overall Study|Non-Compliant Participant|2
2733194|NCT00118040|9394964|P2|Overall Study|Non-Compliant Participant|1
2733195|NCT00118040|9394965|P1|Overall Study|Non-Compliant Participant|1
2733196|NCT00118040|9394963|P3|Overall Study|Medical Contraindication|1
2733197|NCT00118040|9394964|P2|Overall Study|Medical Contraindication|0
2733198|NCT00118040|9394965|P1|Overall Study|Medical Contraindication|0
2733199|NCT00118040|9394963|P3|Overall Study|Withdrawal by Subject|2
2733200|NCT00118040|9394964|P2|Overall Study|Withdrawal by Subject|0
2733201|NCT00118040|9394965|P1|Overall Study|Withdrawal by Subject|0
2733202|NCT00118040|9394963|P3|Overall Study|Adverse Event|0
2733203|NCT00118040|9394964|P2|Overall Study|Adverse Event|1
2733204|NCT00118040|9394965|P1|Overall Study|Adverse Event|0
2733205|NCT00117988|9395026|P1|Overall Study|Adverse Event|1
2733206|NCT00117988|9395026|P1|Overall Study|Death|3
2733207|NCT00117949|9395049|P4|Overall Study|Hepatic abnormalities|1
2733208|NCT00117949|9395050|P3|Overall Study|Hepatic abnormalities|0
2733209|NCT00117949|9395051|P2|Overall Study|Hepatic abnormalities|1
2733210|NCT00117949|9395052|P1|Overall Study|Hepatic abnormalities|0
2733211|NCT00117949|9395049|P4|Overall Study|PSA reduction <=50%|4
2733212|NCT00117949|9395050|P3|Overall Study|PSA reduction <=50%|2
2733213|NCT00117949|9395051|P2|Overall Study|PSA reduction <=50%|2
2733214|NCT00117949|9395052|P1|Overall Study|PSA reduction <=50%|0
2733215|NCT00117949|9395049|P4|Overall Study|PSA increase >=10ng/mL|0
2733216|NCT00117949|9395050|P3|Overall Study|PSA increase >=10ng/mL|1
2733217|NCT00117949|9395051|P2|Overall Study|PSA increase >=10ng/mL|1
2733218|NCT00117949|9395052|P1|Overall Study|PSA increase >=10ng/mL|0
2733219|NCT00117949|9395049|P4|Overall Study|Prostate-specific antigen increase >=25%|2
2733220|NCT00117949|9395050|P3|Overall Study|Prostate-specific antigen increase >=25%|1
2733221|NCT00117949|9395051|P2|Overall Study|Prostate-specific antigen increase >=25%|1
2733222|NCT00117949|9395052|P1|Overall Study|Prostate-specific antigen increase >=25%|0
2733223|NCT00117949|9395049|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
2733224|NCT00117949|9395050|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
2733225|NCT00117949|9395051|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
2733226|NCT00117949|9395052|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
2733227|NCT00117949|9395049|P4|Overall Study|Testosterone >1.0 ng/mL|15
2733228|NCT00117949|9395050|P3|Overall Study|Testosterone >1.0 ng/mL|17
2733229|NCT00117949|9395051|P2|Overall Study|Testosterone >1.0 ng/mL|18
2733230|NCT00117949|9395052|P1|Overall Study|Testosterone >1.0 ng/mL|10
2733231|NCT00117845|9395086|P1|Overall Study|stopped treatment/drug supplyinterrupted|1
2733232|NCT00117793|9395104|P1|Overall Study|Withdrawal by Subject|12
2733233|NCT00117676|9395127|P2|Open-label Period: Weeks 433 - 480|Withdrew Consent|1
2733234|NCT00117676|9395128|P1|Open-label Period: Weeks 433 - 480|Withdrew Consent|0
2733235|NCT00117676|9395127|P2|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
2733236|NCT00117676|9395128|P1|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
2733237|NCT00117676|9395127|P2|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0
2733238|NCT00117676|9395128|P1|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1
2733239|NCT00117676|9395127|P2|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1
2733240|NCT00117676|9395128|P1|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0
2733241|NCT00117676|9395127|P2|Open-label Period: Weeks 385 - 432|Investigator’s Discretion|1
2733242|NCT00117676|9395128|P1|Open-label Period: Weeks 385 - 432|Investigator’s Discretion|0
2733243|NCT00117676|9395127|P2|Open-label Period: Weeks 337 - 384|Withdrew Consent|1
2733244|NCT00117676|9395128|P1|Open-label Period: Weeks 337 - 384|Withdrew Consent|2
2733245|NCT00117676|9395127|P2|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0
2733246|NCT00117676|9395128|P1|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1
2733247|NCT00117676|9395127|P2|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1
2733248|NCT00117676|9395128|P1|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3
2733249|NCT00117676|9395127|P2|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
2733250|NCT00117676|9395128|P1|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
2733251|NCT00117676|9395127|P2|Open-label Period: Weeks 289 - 336|Withdrew Consent|1
2733252|NCT00117676|9395128|P1|Open-label Period: Weeks 289 - 336|Withdrew Consent|0
2733253|NCT00117676|9395127|P2|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
2733254|NCT00117676|9395128|P1|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
2733255|NCT00117676|9395127|P2|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4
2733256|NCT00117676|9395128|P1|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7
2733257|NCT00117676|9395127|P2|Open-label Period: Weeks 241 - 288|Withdrew Consent|1
2733258|NCT00117676|9395128|P1|Open-label Period: Weeks 241 - 288|Withdrew Consent|5
2733259|NCT00117676|9395127|P2|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
2733260|NCT00117676|9395128|P1|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1
2733261|NCT00117676|9395127|P2|Open-label Period: Weeks 241 - 288|Protocol Violation|0
2733262|NCT00117676|9395128|P1|Open-label Period: Weeks 241 - 288|Protocol Violation|2
2733263|NCT00117676|9395127|P2|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1
2733264|NCT00117676|9395128|P1|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2
2733265|NCT00117676|9395127|P2|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1
2733266|NCT00117676|9395128|P1|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0
2733267|NCT00117676|9395127|P2|Open-label Period: Weeks 193 - 240|Withdrew Consent|1
2733268|NCT00117676|9395128|P1|Open-label Period: Weeks 193 - 240|Withdrew Consent|4
2733269|NCT00117676|9395127|P2|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0
2733270|NCT00117676|9395128|P1|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
2733271|NCT00117676|9395127|P2|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1
2733272|NCT00117676|9395128|P1|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0
2733273|NCT00117676|9395127|P2|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
2733274|NCT00117676|9395128|P1|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
2733275|NCT00117676|9395127|P2|Open-label Period: Weeks 145 - 192|Withdrew Consent|2
2733276|NCT00117676|9395128|P1|Open-label Period: Weeks 145 - 192|Withdrew Consent|5
2733277|NCT00117676|9395127|P2|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1
2733278|NCT00117676|9395128|P1|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3
2733279|NCT00117676|9395127|P2|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0
2733280|NCT00117676|9395128|P1|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2
2733281|NCT00117676|9395127|P2|Open-label Period: Weeks 97 - 144|Withdrew Consent|0
2733282|NCT00117676|9395128|P1|Open-label Period: Weeks 97 - 144|Withdrew Consent|1
2733283|NCT00117676|9395127|P2|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0
2733284|NCT00117676|9395128|P1|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1
2733285|NCT00117676|9395127|P2|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1
2733286|NCT00117676|9395128|P1|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4
2733287|NCT00117676|9395127|P2|Open-label Period: Weeks 49 - 96|Withdrew Consent|1
2733288|NCT00117676|9395128|P1|Open-label Period: Weeks 49 - 96|Withdrew Consent|5
2733289|NCT00117676|9395127|P2|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
2733290|NCT00117676|9395128|P1|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3
2733291|NCT00117676|9395127|P2|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0
2733292|NCT00117676|9395128|P1|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2
2733293|NCT00117676|9395127|P2|Double-blind Period Through Week 48|Withdrew Consent|1
2733294|NCT00117676|9395128|P1|Double-blind Period Through Week 48|Withdrew Consent|0
2733295|NCT00117676|9395127|P2|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2
2733296|NCT00117676|9395128|P1|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5
2733297|NCT00117676|9395127|P2|Double-blind Period Through Week 48|Protocol Violation|1
2733298|NCT00117676|9395128|P1|Double-blind Period Through Week 48|Protocol Violation|0
2733299|NCT00117676|9395127|P2|Double-blind Period Through Week 48|Lost to Follow-up|0
2733300|NCT00117676|9395128|P1|Double-blind Period Through Week 48|Lost to Follow-up|1
2733301|NCT00117676|9395127|P2|Double-blind Period Through Week 48|Randomized but Not Treated|3
2733302|NCT00117676|9395128|P1|Double-blind Period Through Week 48|Randomized but Not Treated|4
2733303|NCT00117637|9395217|P2|Second Intervention (Period 2)|reason not reported|0
2733304|NCT00117637|9395218|P1|Second Intervention (Period 2)|reason not reported|1
2733305|NCT00117637|9395217|P2|Second Intervention (Period 2)|non compliant with study medication|1
2733306|NCT00117637|9395218|P1|Second Intervention (Period 2)|non compliant with study medication|1
2733307|NCT00117637|9395217|P2|Second Intervention (Period 2)|study terminated by the sponsor|9
2733308|NCT00117637|9395218|P1|Second Intervention (Period 2)|study terminated by the sponsor|2
2733309|NCT00117637|9395217|P2|Second Intervention (Period 2)|Withdrawal by Subject|3
2733310|NCT00117637|9395218|P1|Second Intervention (Period 2)|Withdrawal by Subject|4
2733311|NCT00117637|9395217|P2|Second Intervention (Period 2)|Protocol Violation|0
2733312|NCT00117637|9395218|P1|Second Intervention (Period 2)|Protocol Violation|1
2733313|NCT00117637|9395217|P2|Second Intervention (Period 2)|Lost to Follow-up|0
2733314|NCT00117637|9395218|P1|Second Intervention (Period 2)|Lost to Follow-up|1
2733315|NCT00117637|9395217|P2|Second Intervention (Period 2)|Adverse Event|9
2733316|NCT00117637|9395218|P1|Second Intervention (Period 2)|Adverse Event|0
2733317|NCT00117637|9395217|P2|First Intervention (Period 1)|reason not reported|1
2733318|NCT00117637|9395218|P1|First Intervention (Period 1)|reason not reported|0
2733319|NCT00117637|9395217|P2|First Intervention (Period 1)|investig. decision, not protocol driven|1
2733320|NCT00117637|9395218|P1|First Intervention (Period 1)|investig. decision, not protocol driven|0
2733321|NCT00117637|9395217|P2|First Intervention (Period 1)|protocol driven decision point|0
2733322|NCT00117637|9395218|P1|First Intervention (Period 1)|protocol driven decision point|1
2733323|NCT00117637|9395217|P2|First Intervention (Period 1)|study terminated by the sponsor|1
2733324|NCT00117637|9395218|P1|First Intervention (Period 1)|study terminated by the sponsor|3
2733325|NCT00117637|9395217|P2|First Intervention (Period 1)|Withdrawal by Subject|4
2733326|NCT00117637|9395218|P1|First Intervention (Period 1)|Withdrawal by Subject|2
2733327|NCT00117637|9395217|P2|First Intervention (Period 1)|Protocol Violation|0
2733328|NCT00117637|9395218|P1|First Intervention (Period 1)|Protocol Violation|1
2733329|NCT00117637|9395217|P2|First Intervention (Period 1)|Lost to Follow-up|2
2733330|NCT00117637|9395218|P1|First Intervention (Period 1)|Lost to Follow-up|0
2733331|NCT00117637|9395217|P2|First Intervention (Period 1)|Adverse Event|16
2733332|NCT00117637|9395218|P1|First Intervention (Period 1)|Adverse Event|11
2733333|NCT00117598|9395293|P5|After Treament Cross Over|Other|2
2733334|NCT00117598|9395294|P4|After Treament Cross Over|Other|1
2733335|NCT00117598|9395295|P3|After Treament Cross Over|Other|0
2733336|NCT00117598|9395296|P2|After Treament Cross Over|Other|0
2733337|NCT00117598|9395297|P1|After Treament Cross Over|Other|0
2733338|NCT00117598|9395293|P5|After Treament Cross Over|Withdrawal by Subject|0
2733339|NCT00117598|9395294|P4|After Treament Cross Over|Withdrawal by Subject|1
2733340|NCT00117598|9395295|P3|After Treament Cross Over|Withdrawal by Subject|0
2733341|NCT00117598|9395296|P2|After Treament Cross Over|Withdrawal by Subject|0
2733342|NCT00117598|9395297|P1|After Treament Cross Over|Withdrawal by Subject|0
2733343|NCT00117598|9395293|P5|After Treament Cross Over|Death|2
2733344|NCT00117598|9395294|P4|After Treament Cross Over|Death|1
2733345|NCT00117598|9395295|P3|After Treament Cross Over|Death|0
2733346|NCT00117598|9395296|P2|After Treament Cross Over|Death|0
2733347|NCT00117598|9395297|P1|After Treament Cross Over|Death|0
2733348|NCT00117598|9395293|P5|Prior to Treatment Cross Over|Other|0
2733349|NCT00117598|9395294|P4|Prior to Treatment Cross Over|Other|0
2733350|NCT00117598|9395295|P3|Prior to Treatment Cross Over|Other|9
2733351|NCT00117598|9395296|P2|Prior to Treatment Cross Over|Other|9
2733352|NCT00117598|9395297|P1|Prior to Treatment Cross Over|Other|15
2733353|NCT00117598|9395293|P5|Prior to Treatment Cross Over|Withdrawal by Subject|0
2733354|NCT00117598|9395294|P4|Prior to Treatment Cross Over|Withdrawal by Subject|0
2733355|NCT00117598|9395295|P3|Prior to Treatment Cross Over|Withdrawal by Subject|4
2733356|NCT00117598|9395296|P2|Prior to Treatment Cross Over|Withdrawal by Subject|1
2733357|NCT00117598|9395297|P1|Prior to Treatment Cross Over|Withdrawal by Subject|2
2733358|NCT00117598|9395293|P5|Prior to Treatment Cross Over|Lost to Follow-up|0
2733359|NCT00117598|9395294|P4|Prior to Treatment Cross Over|Lost to Follow-up|0
2733360|NCT00117598|9395295|P3|Prior to Treatment Cross Over|Lost to Follow-up|2
2733361|NCT00117598|9395296|P2|Prior to Treatment Cross Over|Lost to Follow-up|2
2733362|NCT00117598|9395297|P1|Prior to Treatment Cross Over|Lost to Follow-up|0
2733363|NCT00117598|9395293|P5|Prior to Treatment Cross Over|Death|0
2733364|NCT00117598|9395294|P4|Prior to Treatment Cross Over|Death|0
2733365|NCT00117598|9395295|P3|Prior to Treatment Cross Over|Death|37
2733366|NCT00117598|9395296|P2|Prior to Treatment Cross Over|Death|41
2733367|NCT00117598|9395297|P1|Prior to Treatment Cross Over|Death|40
2733368|NCT00117572|9395331|P2|Overall Study|Protocol Violation|0
2733369|NCT00117572|9395332|P1|Overall Study|Protocol Violation|1
2733370|NCT00117572|9395331|P2|Overall Study|Withdrawal by Subject|3
2733371|NCT00117572|9395332|P1|Overall Study|Withdrawal by Subject|3
2733372|NCT00117572|9395331|P2|Overall Study|Site withdrew before starting treatment|3
2733373|NCT00117572|9395332|P1|Overall Study|Site withdrew before starting treatment|2
2733374|NCT00117338|9395373|P2|Overall Study|Lack of Efficacy|1
2733375|NCT00117338|9395374|P1|Overall Study|Lack of Efficacy|0
2733376|NCT00117338|9395373|P2|Overall Study|Did not meet Inclusion Criteria|0
2733377|NCT00117338|9395374|P1|Overall Study|Did not meet Inclusion Criteria|1
2733378|NCT00117338|9395373|P2|Overall Study|Withdrawal by Subject|0
2733379|NCT00117338|9395374|P1|Overall Study|Withdrawal by Subject|1
2733380|NCT00117338|9395373|P2|Overall Study|Protocol Violation|2
2733381|NCT00117338|9395374|P1|Overall Study|Protocol Violation|3
2733382|NCT00117338|9395373|P2|Overall Study|Adverse Event|1
2733383|NCT00117338|9395374|P1|Overall Study|Adverse Event|0
2733384|NCT00117325|9395394|P2|Overall Study|Admisnitrative|0
2733385|NCT00117325|9395395|P1|Overall Study|Admisnitrative|1
2733386|NCT00117325|9395394|P2|Overall Study|Early termination|1
2733387|NCT00117325|9395395|P1|Overall Study|Early termination|1
2733388|NCT00117325|9395394|P2|Overall Study|Use of prohibited medicine|2
2733389|NCT00117325|9395395|P1|Overall Study|Use of prohibited medicine|1
2733390|NCT00117325|9395394|P2|Overall Study|Lack of Efficacy|0
2733391|NCT00117325|9395395|P1|Overall Study|Lack of Efficacy|1
2733392|NCT00117325|9395394|P2|Overall Study|Withdrawal by Subject|2
2733393|NCT00117325|9395395|P1|Overall Study|Withdrawal by Subject|3
2733394|NCT00117325|9395394|P2|Overall Study|Protocol Violation|3
2733395|NCT00117325|9395395|P1|Overall Study|Protocol Violation|2
2733396|NCT00117325|9395394|P2|Overall Study|Lost to Follow-up|1
2733397|NCT00117325|9395395|P1|Overall Study|Lost to Follow-up|1
2733398|NCT00117325|9395394|P2|Overall Study|Adverse Event|3
2733399|NCT00117325|9395395|P1|Overall Study|Adverse Event|3
2733400|NCT00117312|9395427|P4|Overall Study|Withdrawal by Subject|0
2733401|NCT00117312|9395428|P3|Overall Study|Withdrawal by Subject|0
2733402|NCT00117312|9395429|P2|Overall Study|Withdrawal by Subject|2
2733403|NCT00117312|9395430|P1|Overall Study|Withdrawal by Subject|0
2733404|NCT00117312|9395427|P4|Overall Study|Hepatic abnormality|1
2733405|NCT00117312|9395428|P3|Overall Study|Hepatic abnormality|0
2733406|NCT00117312|9395429|P2|Overall Study|Hepatic abnormality|1
2733407|NCT00117312|9395430|P1|Overall Study|Hepatic abnormality|0
2733408|NCT00117312|9395427|P4|Overall Study|PSA increase >= 10ng/mL|0
2733409|NCT00117312|9395428|P3|Overall Study|PSA increase >= 10ng/mL|1
2733410|NCT00117312|9395429|P2|Overall Study|PSA increase >= 10ng/mL|1
2733411|NCT00117312|9395430|P1|Overall Study|PSA increase >= 10ng/mL|0
2733412|NCT00117312|9395427|P4|Overall Study|PSA decrease <=50%|4
2733413|NCT00117312|9395428|P3|Overall Study|PSA decrease <=50%|2
2733414|NCT00117312|9395429|P2|Overall Study|PSA decrease <=50%|2
2733415|NCT00117312|9395430|P1|Overall Study|PSA decrease <=50%|0
2733416|NCT00117312|9395427|P4|Overall Study|Protocol Violation|0
2733417|NCT00117312|9395428|P3|Overall Study|Protocol Violation|3
2733418|NCT00117312|9395429|P2|Overall Study|Protocol Violation|1
2733419|NCT00117312|9395430|P1|Overall Study|Protocol Violation|0
2733420|NCT00117312|9395427|P4|Overall Study|Adverse Event|0
2733421|NCT00117312|9395428|P3|Overall Study|Adverse Event|0
2733422|NCT00117312|9395429|P2|Overall Study|Adverse Event|2
2733423|NCT00117312|9395430|P1|Overall Study|Adverse Event|0
2733424|NCT00117312|9395427|P4|Overall Study|Patient choice|1
2733425|NCT00117312|9395428|P3|Overall Study|Patient choice|2
2733426|NCT00117312|9395429|P2|Overall Study|Patient choice|0
2733427|NCT00117312|9395430|P1|Overall Study|Patient choice|0
2733428|NCT00117312|9395427|P4|Overall Study|Other|1
2733429|NCT00117312|9395428|P3|Overall Study|Other|3
2733430|NCT00117312|9395429|P2|Overall Study|Other|1
2733431|NCT00117312|9395430|P1|Overall Study|Other|0
2733432|NCT00117312|9395427|P4|Overall Study|Prostate-specific antigen increase >=25%|3
2733433|NCT00117312|9395428|P3|Overall Study|Prostate-specific antigen increase >=25%|5
2733434|NCT00117312|9395429|P2|Overall Study|Prostate-specific antigen increase >=25%|1
2733435|NCT00117312|9395430|P1|Overall Study|Prostate-specific antigen increase >=25%|0
2733436|NCT00117312|9395427|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
2733437|NCT00117312|9395428|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
2733438|NCT00117312|9395429|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
2733439|NCT00117312|9395430|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
2733440|NCT00117312|9395427|P4|Overall Study|Testosterone >1.0 ng/mL|9
2733441|NCT00117312|9395428|P3|Overall Study|Testosterone >1.0 ng/mL|5
2733442|NCT00117312|9395429|P2|Overall Study|Testosterone >1.0 ng/mL|9
2733443|NCT00117312|9395430|P1|Overall Study|Testosterone >1.0 ng/mL|9
2733444|NCT00117286|9395446|P2|Overall Study|Research site closing|2
2733445|NCT00117286|9395447|P1|Overall Study|Research site closing|0
2733446|NCT00117286|9395446|P2|Overall Study|Lack of Efficacy|1
2733447|NCT00117286|9395447|P1|Overall Study|Lack of Efficacy|2
2733448|NCT00117286|9395446|P2|Overall Study|Physician Decision|7
2733449|NCT00117286|9395447|P1|Overall Study|Physician Decision|3
2733450|NCT00117286|9395446|P2|Overall Study|Withdrawal by Subject|2
2733451|NCT00117286|9395447|P1|Overall Study|Withdrawal by Subject|6
2733452|NCT00117286|9395446|P2|Overall Study|Protocol Violation|3
2733453|NCT00117286|9395447|P1|Overall Study|Protocol Violation|3
2733454|NCT00117286|9395446|P2|Overall Study|Lost to Follow-up|0
2733455|NCT00117286|9395447|P1|Overall Study|Lost to Follow-up|2
2733456|NCT00117286|9395446|P2|Overall Study|Adverse Event|6
2733457|NCT00117286|9395447|P1|Overall Study|Adverse Event|12
2733458|NCT00117156|9395455|P1|Overall Study|Trt for Pre-Exist Second Primary|1
2733459|NCT00117156|9395455|P1|Overall Study|Physician Decision|1
2733460|NCT00117156|9395455|P1|Overall Study|Adverse Event|9
2733461|NCT00116844|9395523|P2|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
2733462|NCT00116844|9395524|P1|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
2733463|NCT00116844|9395523|P2|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1
2733464|NCT00116844|9395524|P1|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0
2733465|NCT00116844|9395523|P2|Period 1: Treatment Period 2 (60 Days)|Other|2
2733466|NCT00116844|9395524|P1|Period 1: Treatment Period 2 (60 Days)|Other|0
2733467|NCT00116844|9395523|P2|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1
2733468|NCT00116844|9395524|P1|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2
2733469|NCT00116844|9395523|P2|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0
2733470|NCT00116844|9395524|P1|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1
2733471|NCT00116844|9395523|P2|Period 1: Treatment Period 1 (60 Days)|Other|1
2733472|NCT00116844|9395524|P1|Period 1: Treatment Period 1 (60 Days)|Other|1
2733473|NCT00116844|9395523|P2|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0
2733474|NCT00116844|9395524|P1|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5
2733475|NCT00116844|9395523|P2|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1
2733476|NCT00116844|9395524|P1|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0
2733477|NCT00116844|9395523|P2|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
2733478|NCT00116844|9395524|P1|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
2733479|NCT00116831|9395542|P2|Overall Study|Missing data for participant|0
2733480|NCT00116831|9395543|P1|Overall Study|Missing data for participant|1
2733481|NCT00116831|9395542|P2|Overall Study|Insufficient therapeutic effect|1
2733482|NCT00116831|9395543|P1|Overall Study|Insufficient therapeutic effect|0
2733483|NCT00116831|9395542|P2|Overall Study|Withdrawal by Subject|32
2733484|NCT00116831|9395543|P1|Overall Study|Withdrawal by Subject|32
2733485|NCT00116831|9395542|P2|Overall Study|Withdrawn investigational product|0
2733486|NCT00116831|9395543|P1|Overall Study|Withdrawn investigational product|1
2733487|NCT00116831|9395542|P2|Overall Study|Low haemoglobin on screening|0
2733488|NCT00116831|9395543|P1|Overall Study|Low haemoglobin on screening|1
2733489|NCT00116831|9395542|P2|Overall Study|Hypoglycaemic events|0
2733490|NCT00116831|9395543|P1|Overall Study|Hypoglycaemic events|1
2733491|NCT00116831|9395542|P2|Overall Study|Protocol Violation|6
2733492|NCT00116831|9395543|P1|Overall Study|Protocol Violation|3
2733493|NCT00116831|9395542|P2|Overall Study|Lost to Follow-up|6
2733494|NCT00116831|9395543|P1|Overall Study|Lost to Follow-up|8
2733495|NCT00116831|9395542|P2|Overall Study|Baseline IVUS determined unevaluable|11
2733496|NCT00116831|9395543|P1|Overall Study|Baseline IVUS determined unevaluable|12
2733497|NCT00116831|9395542|P2|Overall Study|Adverse Event|16
2733498|NCT00116831|9395543|P1|Overall Study|Adverse Event|14
2733499|NCT00116805|9395621|P2|Open-label Period Weeks 433 - 480|Withdrew Consent|0
2733500|NCT00116805|9395622|P1|Open-label Period Weeks 433 - 480|Withdrew Consent|3
2733501|NCT00116805|9395621|P2|Open-label Period Weeks 433 - 480|Investigator’s Discretion|0
2733502|NCT00116805|9395622|P1|Open-label Period Weeks 433 - 480|Investigator’s Discretion|1
2733503|NCT00116805|9395621|P2|Open-label Period Weeks 385 - 432|Withdrew Consent|0
2733504|NCT00116805|9395622|P1|Open-label Period Weeks 385 - 432|Withdrew Consent|1
2733505|NCT00116805|9395621|P2|Open-label Period Weeks 385 - 432|Investigator’s Discretion|0
2733506|NCT00116805|9395622|P1|Open-label Period Weeks 385 - 432|Investigator’s Discretion|1
2733507|NCT00116805|9395621|P2|Open-label Period Weeks 337 - 384|Withdrew Consent|1
2733508|NCT00116805|9395622|P1|Open-label Period Weeks 337 - 384|Withdrew Consent|3
2733509|NCT00116805|9395621|P2|Open-label Period Weeks 337 - 384|Protocol Violation|0
2733510|NCT00116805|9395622|P1|Open-label Period Weeks 337 - 384|Protocol Violation|1
2733511|NCT00116805|9395621|P2|Open-label Period Weeks 337 - 384|Lost to Follow-up|0
2733512|NCT00116805|9395622|P1|Open-label Period Weeks 337 - 384|Lost to Follow-up|2
2733513|NCT00116805|9395621|P2|Open-label Period Weeks 337 - 384|Investigator's Discretion|0
2733514|NCT00116805|9395622|P1|Open-label Period Weeks 337 - 384|Investigator's Discretion|1
2733515|NCT00116805|9395621|P2|Open-label Period Weeks 337 - 384|Completed Study|0
2733516|NCT00116805|9395622|P1|Open-label Period Weeks 337 - 384|Completed Study|1
2733517|NCT00116805|9395621|P2|Open-label Period Weeks 289 - 336|Withdrew Consent|0
2733518|NCT00116805|9395622|P1|Open-label Period Weeks 289 - 336|Withdrew Consent|2
2733519|NCT00116805|9395621|P2|Open-label Period Weeks 289 - 336|Study Site Discontinued|1
2733520|NCT00116805|9395622|P1|Open-label Period Weeks 289 - 336|Study Site Discontinued|0
2733521|NCT00116805|9395621|P2|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1
2733522|NCT00116805|9395622|P1|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0
2733523|NCT00116805|9395621|P2|Open-label Period Weeks 289 - 336|Protocol Violation|1
2733524|NCT00116805|9395622|P1|Open-label Period Weeks 289 - 336|Protocol Violation|0
2733525|NCT00116805|9395621|P2|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
2733526|NCT00116805|9395622|P1|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
2733527|NCT00116805|9395621|P2|Open-label Period Weeks 289 - 336|Investigator's Discretion|2
2733528|NCT00116805|9395622|P1|Open-label Period Weeks 289 - 336|Investigator's Discretion|3
2733529|NCT00116805|9395621|P2|Open-label Period Weeks 289 - 336|Completed Study|1
2733530|NCT00116805|9395622|P1|Open-label Period Weeks 289 - 336|Completed Study|0
2733531|NCT00116805|9395621|P2|Open-label Period Weeks 241 - 288|Withdrew Consent|0
2733532|NCT00116805|9395622|P1|Open-label Period Weeks 241 - 288|Withdrew Consent|4
2733533|NCT00116805|9395621|P2|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
2733534|NCT00116805|9395622|P1|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2
2733535|NCT00116805|9395621|P2|Open-label Period Weeks 193 - 240|Withdrew Consent|1
2733536|NCT00116805|9395622|P1|Open-label Period Weeks 193 - 240|Withdrew Consent|7
2733537|NCT00116805|9395621|P2|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
2733538|NCT00116805|9395622|P1|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
2733539|NCT00116805|9395621|P2|Open-label Period Weeks 193 - 240|Lost to Follow-up|0
2733540|NCT00116805|9395622|P1|Open-label Period Weeks 193 - 240|Lost to Follow-up|3
2733541|NCT00116805|9395621|P2|Open-label Period Weeks 193 - 240|Investigator's Discretion|0
2733542|NCT00116805|9395622|P1|Open-label Period Weeks 193 - 240|Investigator's Discretion|1
2733543|NCT00116805|9395621|P2|Open-label Period Weeks 193 - 240|Completed Study|1
2733544|NCT00116805|9395622|P1|Open-label Period Weeks 193 - 240|Completed Study|0
2733545|NCT00116805|9395621|P2|Open-label Period Weeks 145 - 192|Withdrew Consent|2
2733546|NCT00116805|9395622|P1|Open-label Period Weeks 145 - 192|Withdrew Consent|3
2733547|NCT00116805|9395621|P2|Open-label Period Weeks 145 - 192|Seroconversion|1
2733548|NCT00116805|9395622|P1|Open-label Period Weeks 145 - 192|Seroconversion|0
2733549|NCT00116805|9395621|P2|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1
2733550|NCT00116805|9395622|P1|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0
2733551|NCT00116805|9395621|P2|Open-label Period Weeks 145 - 192|Protocol Violation|0
2733552|NCT00116805|9395622|P1|Open-label Period Weeks 145 - 192|Protocol Violation|1
2733553|NCT00116805|9395621|P2|Open-label Period Weeks 145 - 192|Lost to Follow-up|1
2733554|NCT00116805|9395622|P1|Open-label Period Weeks 145 - 192|Lost to Follow-up|3
2733555|NCT00116805|9395621|P2|Open-label Period Weeks 145 - 192|Investigator's Discretion|0
2733556|NCT00116805|9395622|P1|Open-label Period Weeks 145 - 192|Investigator's Discretion|2
2733557|NCT00116805|9395621|P2|Open-label Period Weeks 145 - 192|Completed Study|1
2733558|NCT00116805|9395622|P1|Open-label Period Weeks 145 - 192|Completed Study|1
2733559|NCT00116805|9395621|P2|Open-label Period Weeks 97 - 144|Withdrew Consent|3
2733560|NCT00116805|9395622|P1|Open-label Period Weeks 97 - 144|Withdrew Consent|1
2733561|NCT00116805|9395621|P2|Open-label Period Weeks 97 - 144|Seroconversion|3
2733562|NCT00116805|9395622|P1|Open-label Period Weeks 97 - 144|Seroconversion|2
2733563|NCT00116805|9395621|P2|Open-label Period Weeks 97 - 144|Protocol Violation|1
2733564|NCT00116805|9395622|P1|Open-label Period Weeks 97 - 144|Protocol Violation|0
2733565|NCT00116805|9395621|P2|Open-label Period Weeks 97 - 144|Lost to Follow-up|2
2733566|NCT00116805|9395622|P1|Open-label Period Weeks 97 - 144|Lost to Follow-up|5
2733567|NCT00116805|9395621|P2|Open-label Period Weeks 97 - 144|Investigator's Discretion|0
2733568|NCT00116805|9395622|P1|Open-label Period Weeks 97 - 144|Investigator's Discretion|2
2733569|NCT00116805|9395621|P2|Open-label Period Weeks 97 - 144|Completed Study|0
2733570|NCT00116805|9395622|P1|Open-label Period Weeks 97 - 144|Completed Study|1
2733571|NCT00116805|9395621|P2|Open-label Period Weeks 49 - 96|Withdrew Consent|1
2733572|NCT00116805|9395622|P1|Open-label Period Weeks 49 - 96|Withdrew Consent|2
2733573|NCT00116805|9395621|P2|Open-label Period Weeks 49 - 96|Seroconversion|0
2733574|NCT00116805|9395622|P1|Open-label Period Weeks 49 - 96|Seroconversion|2
2733575|NCT00116805|9395621|P2|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0
2733576|NCT00116805|9395622|P1|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
2733577|NCT00116805|9395621|P2|Open-label Period Weeks 49 - 96|Protocol Violation|0
2733578|NCT00116805|9395622|P1|Open-label Period Weeks 49 - 96|Protocol Violation|2
2733579|NCT00116805|9395621|P2|Open-label Period Weeks 49 - 96|Lost to Follow-up|0
2733580|NCT00116805|9395622|P1|Open-label Period Weeks 49 - 96|Lost to Follow-up|2
2733581|NCT00116805|9395621|P2|Open-label Period Weeks 49 - 96|Investigator's Discretion|0
2733582|NCT00116805|9395622|P1|Open-label Period Weeks 49 - 96|Investigator's Discretion|1
2733583|NCT00116805|9395621|P2|Double-blind Period Through Week 48|Withdrew Consent|2
2733584|NCT00116805|9395622|P1|Double-blind Period Through Week 48|Withdrew Consent|4
2733585|NCT00116805|9395621|P2|Double-blind Period Through Week 48|Protocol Violation|1
2733586|NCT00116805|9395622|P1|Double-blind Period Through Week 48|Protocol Violation|1
2733587|NCT00116805|9395621|P2|Double-blind Period Through Week 48|Lost to Follow-up|2
2733588|NCT00116805|9395622|P1|Double-blind Period Through Week 48|Lost to Follow-up|6
2733589|NCT00116779|9395715|P2|Overall Study|Elevated PSA levels|2
2733590|NCT00116779|9395716|P1|Overall Study|Elevated PSA levels|2
2733591|NCT00116779|9395715|P2|Overall Study|Physician Decision|1
2733592|NCT00116779|9395716|P1|Overall Study|Physician Decision|3
2733593|NCT00116779|9395715|P2|Overall Study|Inadequate testosterone suppression|9
2733594|NCT00116779|9395716|P1|Overall Study|Inadequate testosterone suppression|7
2733595|NCT00116779|9395715|P2|Overall Study|Withdrawal by Subject|1
2733596|NCT00116779|9395716|P1|Overall Study|Withdrawal by Subject|4
2733597|NCT00116779|9395715|P2|Overall Study|Protocol Violation|4
2733598|NCT00116779|9395716|P1|Overall Study|Protocol Violation|1
2733599|NCT00116779|9395715|P2|Overall Study|Adverse Event|2
2733600|NCT00116779|9395716|P1|Overall Study|Adverse Event|4
2733601|NCT00116753|9395749|P3|Overall Study|Dosing Error|0
2733602|NCT00116753|9395750|P2|Overall Study|Dosing Error|1
2733603|NCT00116753|9395751|P1|Overall Study|Dosing Error|0
2733604|NCT00116753|9395749|P3|Overall Study|Progressive Parkinson's Disease|0
2733605|NCT00116753|9395750|P2|Overall Study|Progressive Parkinson's Disease|0
2733606|NCT00116753|9395751|P1|Overall Study|Progressive Parkinson's Disease|1
2733607|NCT00116753|9395749|P3|Overall Study|Abnormal Echocardiogram|1
2733608|NCT00116753|9395750|P2|Overall Study|Abnormal Echocardiogram|0
2733609|NCT00116753|9395751|P1|Overall Study|Abnormal Echocardiogram|0
2733610|NCT00116753|9395749|P3|Overall Study|Disease Progression|3
2733611|NCT00116753|9395750|P2|Overall Study|Disease Progression|4
2733612|NCT00116753|9395751|P1|Overall Study|Disease Progression|3
2733613|NCT00116753|9395749|P3|Overall Study|Did not Fulfil Eligibility Criteria|3
2733614|NCT00116753|9395750|P2|Overall Study|Did not Fulfil Eligibility Criteria|1
2733615|NCT00116753|9395751|P1|Overall Study|Did not Fulfil Eligibility Criteria|1
2733616|NCT00116753|9395749|P3|Overall Study|Protocol Violation|1
2733617|NCT00116753|9395750|P2|Overall Study|Protocol Violation|0
2733618|NCT00116753|9395751|P1|Overall Study|Protocol Violation|0
2733619|NCT00116753|9395749|P3|Overall Study|Lost to Follow-up|1
2733620|NCT00116753|9395750|P2|Overall Study|Lost to Follow-up|2
2733621|NCT00116753|9395751|P1|Overall Study|Lost to Follow-up|0
2733622|NCT00116753|9395749|P3|Overall Study|Withdrawal by Subject|8
2733623|NCT00116753|9395750|P2|Overall Study|Withdrawal by Subject|12
2733624|NCT00116753|9395751|P1|Overall Study|Withdrawal by Subject|11
2733625|NCT00116753|9395749|P3|Overall Study|Adverse Event|7
2733626|NCT00116753|9395750|P2|Overall Study|Adverse Event|10
2733627|NCT00116753|9395751|P1|Overall Study|Adverse Event|16
2733628|NCT00116688|9395773|P2|Overall Study|Other|0
2733629|NCT00116688|9395774|P1|Overall Study|Other|11
2733630|NCT00116688|9395773|P2|Overall Study|Pregnancy|0
2733631|NCT00116688|9395774|P1|Overall Study|Pregnancy|1
2733632|NCT00116688|9395773|P2|Overall Study|Protocol-specified criteria|0
2733633|NCT00116688|9395774|P1|Overall Study|Protocol-specified criteria|3
2733634|NCT00116688|9395773|P2|Overall Study|Death|0
2733635|NCT00116688|9395774|P1|Overall Study|Death|15
2733636|NCT00116688|9395773|P2|Overall Study|Lost to Follow-up|0
2733637|NCT00116688|9395774|P1|Overall Study|Lost to Follow-up|3
2733638|NCT00116688|9395773|P2|Overall Study|Physician Decision|0
2733639|NCT00116688|9395774|P1|Overall Study|Physician Decision|7
2733640|NCT00116688|9395773|P2|Overall Study|Requirement for alternative therapy|1
2733641|NCT00116688|9395774|P1|Overall Study|Requirement for alternative therapy|11
2733642|NCT00116688|9395773|P2|Overall Study|Withdrawal by Subject|2
2733643|NCT00116688|9395774|P1|Overall Study|Withdrawal by Subject|26
2733644|NCT00116688|9395773|P2|Overall Study|Adverse Event|0
2733645|NCT00116688|9395774|P1|Overall Study|Adverse Event|11
2733646|NCT00116688|9395773|P2|Overall Study|Noncompliance|1
2733647|NCT00116688|9395774|P1|Overall Study|Noncompliance|3
2733648|NCT00116688|9395773|P2|Overall Study|Protocol deviation|0
2733649|NCT00116688|9395774|P1|Overall Study|Protocol deviation|1
2733650|NCT00116649|9395789|P1|Overall Study|Protocol Specified|7
2733651|NCT00116649|9395789|P1|Overall Study|Various Reasons|18
2733652|NCT00116649|9395789|P1|Overall Study|Local Skin Reaction|9
2733653|NCT00116649|9395789|P1|Overall Study|Withdrawal by Subject|68
2733654|NCT00116649|9395789|P1|Overall Study|Lost to Follow-up|32
2733655|NCT00116649|9395789|P1|Overall Study|Lack of Efficacy|1
2733656|NCT00116649|9395789|P1|Overall Study|Adverse Event|20
2733657|NCT00116558|9395797|P3|Overall Study|disease progression|18
2733658|NCT00116558|9395798|P2|Overall Study|disease progression|7
2733659|NCT00116558|9395799|P1|Overall Study|disease progression|3
2733660|NCT00116558|9395797|P3|Overall Study|Withdrawal by Subject|12
2733661|NCT00116558|9395798|P2|Overall Study|Withdrawal by Subject|3
2733662|NCT00116558|9395799|P1|Overall Study|Withdrawal by Subject|17
2733663|NCT00116558|9395797|P3|Overall Study|Death|3
2733664|NCT00116558|9395798|P2|Overall Study|Death|5
2733665|NCT00116558|9395799|P1|Overall Study|Death|11
2733666|NCT00116428|9395810|P2|Overall Study|Did not meet inclusion criteria|0
2733667|NCT00116428|9395811|P1|Overall Study|Did not meet inclusion criteria|1
2733668|NCT00116428|9395810|P2|Overall Study|Withdrawal by Subject|5
2733669|NCT00116428|9395811|P1|Overall Study|Withdrawal by Subject|2
2733670|NCT00116272|9395840|P2|Overall Study|Lost to Follow-up|6
2733671|NCT00116272|9395841|P1|Overall Study|Lost to Follow-up|11
2733672|NCT00116168|9395910|P4|Overall Study|Lost to Follow-up|0
2733673|NCT00116168|9395911|P3|Overall Study|Lost to Follow-up|0
2733674|NCT00116168|9395912|P2|Overall Study|Lost to Follow-up|5
2733675|NCT00116168|9395913|P1|Overall Study|Lost to Follow-up|6
2733676|NCT00115934|9395977|P2|Overall Study|Did not receive intervention|2
2733677|NCT00115934|9395978|P1|Overall Study|Did not receive intervention|3
2733678|NCT00115934|9395977|P2|Overall Study|Lost to Follow-up|0
2733679|NCT00115934|9395978|P1|Overall Study|Lost to Follow-up|1
2733680|NCT00115804|9396027|P1|Overall Study|Adverse Event|2
2733681|NCT00115778|9396038|P2|Overall Study|Withdrawal by Subject|1
2733682|NCT00115778|9396039|P1|Overall Study|Withdrawal by Subject|0
2733683|NCT00115765|9396059|P4|Overall Study|Other|2
2733684|NCT00115765|9396060|P3|Overall Study|Other|9
2733685|NCT00115765|9396061|P2|Overall Study|Other|12
2733686|NCT00115765|9396062|P1|Overall Study|Other|6
2733687|NCT00115765|9396059|P4|Overall Study|Lost to Follow-up|1
2733688|NCT00115765|9396060|P3|Overall Study|Lost to Follow-up|18
2733689|NCT00115765|9396061|P2|Overall Study|Lost to Follow-up|20
2733690|NCT00115765|9396062|P1|Overall Study|Lost to Follow-up|3
2733691|NCT00115765|9396059|P4|Overall Study|Physician Decision|13
2733692|NCT00115765|9396060|P3|Overall Study|Physician Decision|18
2733693|NCT00115765|9396061|P2|Overall Study|Physician Decision|15
2733694|NCT00115765|9396062|P1|Overall Study|Physician Decision|4
2733695|NCT00115765|9396059|P4|Overall Study|Withdrawal by Subject|15
2733696|NCT00115765|9396060|P3|Overall Study|Withdrawal by Subject|76
2733697|NCT00115765|9396061|P2|Overall Study|Withdrawal by Subject|53
2733698|NCT00115765|9396062|P1|Overall Study|Withdrawal by Subject|22
2733699|NCT00115739|9396100|P1|Overall Study|Lost to Follow-up|3
2733700|NCT00115349|9396109|P2|Overall Study|Study closed due to low enrollment.|9
2733701|NCT00115349|9396110|P1|Overall Study|Study closed due to low enrollment.|11
2733702|NCT00115063|9396131|P2|Overall Study|Death|0
2733703|NCT00115063|9396132|P1|Overall Study|Death|1
2733704|NCT00115063|9396131|P2|Overall Study|Lost to Follow-up|104
2733705|NCT00115063|9396132|P1|Overall Study|Lost to Follow-up|98
2733706|NCT00115037|9396150|P6|Phase2|Lost to Follow-up|10
2733707|NCT00115037|9396151|P5|Phase2|Lost to Follow-up|4
2733708|NCT00115037|9396152|P4|Phase2|Lost to Follow-up|14
2733709|NCT00115037|9396153|P3|Phase2|Lost to Follow-up|12
2733710|NCT00115037|9396154|P2|Phase2|Lost to Follow-up|0
2733711|NCT00115037|9396155|P1|Phase2|Lost to Follow-up|0
2733712|NCT00115037|9396150|P6|Phase2|Withdrawal by Subject|1
2733713|NCT00115037|9396151|P5|Phase2|Withdrawal by Subject|2
2733714|NCT00115037|9396152|P4|Phase2|Withdrawal by Subject|1
2733715|NCT00115037|9396153|P3|Phase2|Withdrawal by Subject|2
2733716|NCT00115037|9396154|P2|Phase2|Withdrawal by Subject|0
2733717|NCT00115037|9396155|P1|Phase2|Withdrawal by Subject|0
2733718|NCT00115037|9396150|P6|Phase2|Death|1
2733719|NCT00115037|9396151|P5|Phase2|Death|0
2733720|NCT00115037|9396152|P4|Phase2|Death|0
2733721|NCT00115037|9396153|P3|Phase2|Death|1
2733722|NCT00115037|9396154|P2|Phase2|Death|0
2733723|NCT00115037|9396155|P1|Phase2|Death|0
2733724|NCT00115037|9396150|P6|Phase1|Withdrawal by Subject|0
2733725|NCT00115037|9396151|P5|Phase1|Withdrawal by Subject|0
2733726|NCT00115037|9396152|P4|Phase1|Withdrawal by Subject|0
2733727|NCT00115037|9396153|P3|Phase1|Withdrawal by Subject|0
2733728|NCT00115037|9396154|P2|Phase1|Withdrawal by Subject|4
2733729|NCT00115037|9396155|P1|Phase1|Withdrawal by Subject|9
2733730|NCT00115037|9396150|P6|Phase1|Lost to Follow-up|0
2733731|NCT00115037|9396151|P5|Phase1|Lost to Follow-up|0
2733732|NCT00115037|9396152|P4|Phase1|Lost to Follow-up|0
2733733|NCT00115037|9396153|P3|Phase1|Lost to Follow-up|0
2733734|NCT00115037|9396154|P2|Phase1|Lost to Follow-up|23
2733735|NCT00115037|9396155|P1|Phase1|Lost to Follow-up|16
2733736|NCT00114972|9396171|P2|Overall Study|Lost to Follow-up|5
2733737|NCT00114972|9396172|P1|Overall Study|Lost to Follow-up|8
2733738|NCT00114972|9396171|P2|Overall Study|Withdrawal by Subject|7
2733739|NCT00114972|9396172|P1|Overall Study|Withdrawal by Subject|40
2733740|NCT00114959|9396192|P1|Overall Study|Death|1
2733741|NCT00114959|9396192|P1|Overall Study|Physician Decision|1
2733742|NCT00114959|9396192|P1|Overall Study|Lack of Efficacy|6
2733743|NCT00114777|9396202|P3|Long-Term Extension to Month 84|Other|2
2733744|NCT00114777|9396203|P2|Long-Term Extension to Month 84|Other|0
2733745|NCT00114777|9396204|P1|Long-Term Extension to Month 84|Other|2
2733746|NCT00114777|9396202|P3|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1
2733747|NCT00114777|9396203|P2|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
2733748|NCT00114777|9396204|P1|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
2733749|NCT00114777|9396202|P3|Long-Term Extension to Month 84|Lost to Follow-up|2
2733750|NCT00114777|9396203|P2|Long-Term Extension to Month 84|Lost to Follow-up|0
2733751|NCT00114777|9396204|P1|Long-Term Extension to Month 84|Lost to Follow-up|0
2733752|NCT00114777|9396202|P3|Long-Term Extension to Month 84|Withdrawal by Subject|6
2733753|NCT00114777|9396203|P2|Long-Term Extension to Month 84|Withdrawal by Subject|1
2733754|NCT00114777|9396204|P1|Long-Term Extension to Month 84|Withdrawal by Subject|2
2733755|NCT00114777|9396202|P3|Long-Term Extension to Month 84|Adverse Event|7
2733756|NCT00114777|9396203|P2|Long-Term Extension to Month 84|Adverse Event|14
2733757|NCT00114777|9396204|P1|Long-Term Extension to Month 84|Adverse Event|15
2733758|NCT00114777|9396202|P3|Long-Term Extension to Month 84|Poor or Non-Compliance|3
2733759|NCT00114777|9396203|P2|Long-Term Extension to Month 84|Poor or Non-Compliance|1
2733760|NCT00114777|9396204|P1|Long-Term Extension to Month 84|Poor or Non-Compliance|1
2733761|NCT00114777|9396202|P3|Long-Term Extension to Month 84|Lack of Efficacy|1
2733762|NCT00114777|9396203|P2|Long-Term Extension to Month 84|Lack of Efficacy|0
2733763|NCT00114777|9396204|P1|Long-Term Extension to Month 84|Lack of Efficacy|1
2733764|NCT00114777|9396202|P3|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
2733765|NCT00114777|9396203|P2|Long-Term Extension to Month 84|No Longer Met Study Criteria|0
2733766|NCT00114777|9396204|P1|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
2733767|NCT00114777|9396202|P3|Long-Term Extension to Month 84|Death|7
2733768|NCT00114777|9396203|P2|Long-Term Extension to Month 84|Death|13
2733769|NCT00114777|9396204|P1|Long-Term Extension to Month 84|Death|8
2733770|NCT00114777|9396202|P3|Randomization to Month 36|Other|12
2733771|NCT00114777|9396203|P2|Randomization to Month 36|Other|3
2733772|NCT00114777|9396204|P1|Randomization to Month 36|Other|9
2733773|NCT00114777|9396202|P3|Randomization to Month 36|Withdrawal by Subject|5
2733774|NCT00114777|9396203|P2|Randomization to Month 36|Withdrawal by Subject|4
2733775|NCT00114777|9396204|P1|Randomization to Month 36|Withdrawal by Subject|3
2733776|NCT00114777|9396202|P3|Randomization to Month 36|Adverse Event|44
2733777|NCT00114777|9396203|P2|Randomization to Month 36|Adverse Event|35
2733778|NCT00114777|9396204|P1|Randomization to Month 36|Adverse Event|34
2733779|NCT00114777|9396202|P3|Randomization to Month 36|Poor or Non-Compliance|1
2733780|NCT00114777|9396203|P2|Randomization to Month 36|Poor or Non-Compliance|0
2733781|NCT00114777|9396204|P1|Randomization to Month 36|Poor or Non-Compliance|0
2733782|NCT00114777|9396202|P3|Randomization to Month 36|Lack of Efficacy|17
2733783|NCT00114777|9396203|P2|Randomization to Month 36|Lack of Efficacy|15
2733784|NCT00114777|9396204|P1|Randomization to Month 36|Lack of Efficacy|19
2733785|NCT00114777|9396202|P3|Randomization to Month 36|No Longer Met Study Criteria|2
2733786|NCT00114777|9396203|P2|Randomization to Month 36|No Longer Met Study Criteria|0
2733787|NCT00114777|9396204|P1|Randomization to Month 36|No Longer Met Study Criteria|0
2733788|NCT00114777|9396202|P3|Randomization to Month 36|Death|3
2733789|NCT00114777|9396203|P2|Randomization to Month 36|Death|4
2733790|NCT00114777|9396204|P1|Randomization to Month 36|Death|10
2733791|NCT00114738|9396278|P3|Screening for Randomization|Other|0
2733792|NCT00114738|9396279|P2|Screening for Randomization|Other|0
2733793|NCT00114738|9396280|P1|Screening for Randomization|Other|1
2733794|NCT00114738|9396278|P3|Screening for Randomization|CNS Hemorrhage|0
2733795|NCT00114738|9396279|P2|Screening for Randomization|CNS Hemorrhage|0
2733796|NCT00114738|9396280|P1|Screening for Randomization|CNS Hemorrhage|1
2733797|NCT00114738|9396278|P3|Screening for Randomization|Progressive disease|0
2733798|NCT00114738|9396279|P2|Screening for Randomization|Progressive disease|0
2733799|NCT00114738|9396280|P1|Screening for Randomization|Progressive disease|2
2733800|NCT00114738|9396278|P3|Screening for Randomization|Neuropathy|0
2733801|NCT00114738|9396279|P2|Screening for Randomization|Neuropathy|0
2733802|NCT00114738|9396280|P1|Screening for Randomization|Neuropathy|17
2733803|NCT00114738|9396278|P3|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
2733804|NCT00114738|9396279|P2|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
2733805|NCT00114738|9396280|P1|Bortezomib Then Bortezomib + Induction|Progressive Disease|1
2733806|NCT00114738|9396278|P3|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
2733807|NCT00114738|9396279|P2|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
2733808|NCT00114738|9396280|P1|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1
2733809|NCT00114634|9396293|P1|Overall Study|failure to return forms|3
2733810|NCT00114530|9396309|P2|Overall Study|Ineligible|0
2733811|NCT00114530|9396310|P1|Overall Study|Ineligible|1
2733812|NCT00114530|9396309|P2|Overall Study|Subject decision after endpoint failure|1
2733813|NCT00114530|9396310|P1|Overall Study|Subject decision after endpoint failure|0
2733814|NCT00114530|9396309|P2|Overall Study|Breast Cancer|0
2733815|NCT00114530|9396310|P1|Overall Study|Breast Cancer|1
2733816|NCT00114530|9396309|P2|Overall Study|Withdrawal by Subject|6
2733817|NCT00114530|9396310|P1|Overall Study|Withdrawal by Subject|2
2733818|NCT00114530|9396309|P2|Overall Study|Physician Decision|1
2733819|NCT00114530|9396310|P1|Overall Study|Physician Decision|1
2733820|NCT00114530|9396309|P2|Overall Study|Lost to Follow-up|1
2733821|NCT00114530|9396310|P1|Overall Study|Lost to Follow-up|1
2733822|NCT00114530|9396309|P2|Overall Study|Death|11
2733823|NCT00114530|9396310|P1|Overall Study|Death|3
2733824|NCT00114244|9396447|P2|Overall Study|Withdrawal by Subject|2
2733825|NCT00114244|9396448|P1|Overall Study|Withdrawal by Subject|0
2733826|NCT00114244|9396447|P2|Overall Study|Adverse Event|5
2733827|NCT00114244|9396448|P1|Overall Study|Adverse Event|2
2733828|NCT00114231|9396460|P2|Overall Study|Biopsy done after registration|0
2733829|NCT00114231|9396461|P1|Overall Study|Biopsy done after registration|1
2733830|NCT00114231|9396460|P2|Overall Study|No Absolute Neutrophil Count|0
2733831|NCT00114231|9396461|P1|Overall Study|No Absolute Neutrophil Count|2
2733832|NCT00114231|9396460|P2|Overall Study|Tumor fixed on digital exam|1
2733833|NCT00114231|9396461|P1|Overall Study|Tumor fixed on digital exam|0
2733834|NCT00114231|9396460|P2|Overall Study|Tumor size > 4cm|0
2733835|NCT00114231|9396461|P1|Overall Study|Tumor size > 4cm|1
2733836|NCT00114231|9396460|P2|Overall Study|Low creatinine clearance|1
2733837|NCT00114231|9396461|P1|Overall Study|Low creatinine clearance|0
2733838|NCT00114231|9396460|P2|Overall Study|No adenocarcinoma|0
2733839|NCT00114231|9396461|P1|Overall Study|No adenocarcinoma|1
2733840|NCT00114231|9396460|P2|Overall Study|Suspected metastatic disease|0
2733841|NCT00114231|9396461|P1|Overall Study|Suspected metastatic disease|1
2733842|NCT00114231|9396460|P2|Overall Study|QARC requirement not met|0
2733843|NCT00114231|9396461|P1|Overall Study|QARC requirement not met|1
2733844|NCT00114231|9396460|P2|Overall Study|No consent|0
2733845|NCT00114231|9396461|P1|Overall Study|No consent|2
2733846|NCT00114218|9396470|P1|Overall Study|Never Treated|1
2733847|NCT00114218|9396470|P1|Overall Study|Wrong Primary|1
2733848|NCT00114218|9396470|P1|Overall Study|Wrong Cell Type|2
2733849|NCT00114166|9396477|P2|Overall Study|Wrong primary|1
2733850|NCT00114166|9396478|P1|Overall Study|Wrong primary|0
2733851|NCT00114140|9396488|P1|Overall Study|Protocol Violation|7
2733852|NCT00114127|9396502|P2|Overall Study|Withdrawal by Subject|3
2733853|NCT00114127|9396503|P1|Overall Study|Withdrawal by Subject|1
2733854|NCT00114127|9396502|P2|Overall Study|Lost to Follow-up|0
2733855|NCT00114127|9396503|P1|Overall Study|Lost to Follow-up|1
2733856|NCT00114127|9396502|P2|Overall Study|Adverse Event|1
2733857|NCT00114127|9396503|P1|Overall Study|Adverse Event|2
2733858|NCT00113919|9396575|P1|Overall Study|Death|6
2733859|NCT00113919|9396575|P1|Overall Study|Physician Decision|8
2733860|NCT00113841|9396643|P2|Overall Study|Non-compliant|0
2733861|NCT00113841|9396644|P1|Overall Study|Non-compliant|1
2733862|NCT00113841|9396643|P2|Overall Study|Disease progression|2
2733863|NCT00113841|9396644|P1|Overall Study|Disease progression|0
2733864|NCT00113763|9396652|P2|Overall Study|Ongoing|0
2733865|NCT00113763|9396653|P1|Overall Study|Ongoing|1
2733866|NCT00113763|9396652|P2|Overall Study|Non-compliance|0
2733867|NCT00113763|9396653|P1|Overall Study|Non-compliance|1
2733868|NCT00113763|9396652|P2|Overall Study|Other|6
2733869|NCT00113763|9396653|P1|Overall Study|Other|27
2733870|NCT00113763|9396652|P2|Overall Study|Withdrawal by Subject|4
2733871|NCT00113763|9396653|P1|Overall Study|Withdrawal by Subject|1
2733872|NCT00113763|9396652|P2|Overall Study|Lost to Follow-up|0
2733873|NCT00113763|9396653|P1|Overall Study|Lost to Follow-up|10
2733874|NCT00113763|9396652|P2|Overall Study|Disease Progression|14
2733875|NCT00113763|9396653|P1|Overall Study|Disease Progression|28
2733876|NCT00113763|9396652|P2|Overall Study|Adverse Event|2
2733877|NCT00113763|9396653|P1|Overall Study|Adverse Event|5
2733878|NCT00113607|9396679|P2|Overall Study|Other|32
2733879|NCT00113607|9396680|P1|Overall Study|Other|43
2733880|NCT00113607|9396679|P2|Overall Study|Complete Response (Confirmed)|24
2733881|NCT00113607|9396680|P1|Overall Study|Complete Response (Confirmed)|14
2733882|NCT00113607|9396679|P2|Overall Study|Disease Progression|142
2733883|NCT00113607|9396680|P1|Overall Study|Disease Progression|180
2733884|NCT00113607|9396679|P2|Overall Study|Lost to Follow-up|2
2733885|NCT00113607|9396680|P1|Overall Study|Lost to Follow-up|0
2733886|NCT00113607|9396679|P2|Overall Study|Withdrawal by Subject|58
2733887|NCT00113607|9396680|P1|Overall Study|Withdrawal by Subject|50
2733888|NCT00113607|9396679|P2|Overall Study|Death|8
2733889|NCT00113607|9396680|P1|Overall Study|Death|8
2733890|NCT00113607|9396679|P2|Overall Study|Adverse Event|71
2733891|NCT00113607|9396680|P1|Overall Study|Adverse Event|40
2733892|NCT00113568|9396694|P1|Overall Study|Other|112
2733893|NCT00113568|9396694|P1|Overall Study|Withdrawal by Subject|117
2733894|NCT00113568|9396694|P1|Overall Study|Protocol Violation|32
2733895|NCT00113568|9396694|P1|Overall Study|Lost to Follow-up|156
2733896|NCT00113568|9396694|P1|Overall Study|Lack of Efficacy|30
2733897|NCT00113568|9396694|P1|Overall Study|Death|1
2733898|NCT00113568|9396694|P1|Overall Study|Adverse Event|97
2733899|NCT00113555|9396706|P1|Overall Study|Lost to Follow-up|8
2733900|NCT00113555|9396706|P1|Overall Study|Missed Followup|4
2733901|NCT00113555|9396706|P1|Overall Study|Death|1
2733902|NCT00113555|9396706|P1|Overall Study|Permanently Explanted|7
2733903|NCT00113555|9396706|P1|Overall Study|Baseline Failure|59
2733904|NCT00113529|9396716|P1|Overall Study|Withdrawal by Subject|4
2733905|NCT00113529|9396716|P1|Overall Study|Decision of sponsor|6
2733906|NCT00113529|9396716|P1|Overall Study|Lack of Efficacy|20
2733907|NCT00113529|9396716|P1|Overall Study|Adverse Event|4
2733908|NCT00113516|9396749|P2|Part 2|Ongoing|1
2733909|NCT00113516|9396750|P1|Part 2|Ongoing|0
2733910|NCT00113516|9396749|P2|Part 2|Laboratory Abnormality|1
2733911|NCT00113516|9396750|P1|Part 2|Laboratory Abnormality|0
2733912|NCT00113516|9396749|P2|Part 2|Other|3
2733913|NCT00113516|9396750|P1|Part 2|Other|0
2733914|NCT00113516|9396749|P2|Part 2|Withdrawal by Subject|3
2733915|NCT00113516|9396750|P1|Part 2|Withdrawal by Subject|0
2733916|NCT00113516|9396749|P2|Part 2|Lack of Efficacy|37
2733917|NCT00113516|9396750|P1|Part 2|Lack of Efficacy|0
2733918|NCT00113516|9396749|P2|Part 2|Death|5
2733919|NCT00113516|9396750|P1|Part 2|Death|0
2733920|NCT00113516|9396749|P2|Part 2|Adverse Event|16
2733921|NCT00113516|9396750|P1|Part 2|Adverse Event|0
2733922|NCT00113516|9396749|P2|Part 1|Missing|0
2733923|NCT00113516|9396750|P1|Part 1|Missing|65
2733924|NCT00113516|9396749|P2|Part 1|Ongoing|0
2733925|NCT00113516|9396750|P1|Part 1|Ongoing|1
2733926|NCT00113516|9396749|P2|Part 1|Laboratory Abnormality|0
2733927|NCT00113516|9396750|P1|Part 1|Laboratory Abnormality|1
2733928|NCT00113516|9396749|P2|Part 1|Did Not Meet Entrance Criteria|0
2733929|NCT00113516|9396750|P1|Part 1|Did Not Meet Entrance Criteria|1
2733930|NCT00113516|9396749|P2|Part 1|Lack of Efficacy|0
2733931|NCT00113516|9396750|P1|Part 1|Lack of Efficacy|2
2733932|NCT00113516|9396749|P2|Part 1|Withdrawal by Subject|0
2733933|NCT00113516|9396750|P1|Part 1|Withdrawal by Subject|2
2733934|NCT00113516|9396749|P2|Part 1|Other|0
2733935|NCT00113516|9396750|P1|Part 1|Other|3
2733936|NCT00113516|9396749|P2|Part 1|Death|0
2733937|NCT00113516|9396750|P1|Part 1|Death|3
2733938|NCT00113516|9396749|P2|Part 1|Adverse Event|0
2733939|NCT00113516|9396750|P1|Part 1|Adverse Event|6
2733940|NCT00113490|9396793|P2|Overall Study|Lost to Follow-up|0
2733941|NCT00113490|9396794|P1|Overall Study|Lost to Follow-up|1
2733942|NCT00113490|9396793|P2|Overall Study|Withdrawal by Subject|3
2733943|NCT00113490|9396794|P1|Overall Study|Withdrawal by Subject|1
2733944|NCT00113399|9396827|P2|Overall Study|Other|1
2733945|NCT00113399|9396828|P1|Overall Study|Other|0
2733946|NCT00113399|9396827|P2|Overall Study|Complete Response|1
2733947|NCT00113399|9396828|P1|Overall Study|Complete Response|0
2733948|NCT00113399|9396827|P2|Overall Study|Withdrawal by Subject|2
2733949|NCT00113399|9396828|P1|Overall Study|Withdrawal by Subject|1
2733950|NCT00113399|9396827|P2|Overall Study|Death|1
2733951|NCT00113399|9396828|P1|Overall Study|Death|1
2733952|NCT00113386|9396836|P2|Overall Study|Unknown - Lost to Follow-Up|1
2733953|NCT00113386|9396837|P1|Overall Study|Unknown - Lost to Follow-Up|2
2733954|NCT00113386|9396836|P2|Overall Study|Ineligible|2
2733955|NCT00113386|9396837|P1|Overall Study|Ineligible|1
2733956|NCT00113386|9396836|P2|Overall Study|Toxicity|0
2733957|NCT00113386|9396837|P1|Overall Study|Toxicity|3
2733958|NCT00113386|9396836|P2|Overall Study|Physician Decision|1
2733959|NCT00113386|9396837|P1|Overall Study|Physician Decision|0
2733960|NCT00113386|9396836|P2|Overall Study|Withdrawal by Subject|0
2733961|NCT00113386|9396837|P1|Overall Study|Withdrawal by Subject|1
2733962|NCT00113373|9396843|P1|Overall Study|Never Treated|1
2733963|NCT00113373|9396843|P1|Overall Study|Ineligible: second primary|1
2733964|NCT00113373|9396843|P1|Overall Study|Ineligible: wrong primary|1
2733965|NCT00113360|9396858|P1|Overall Study|Did not meet eligibility criteria|3
2733966|NCT00113360|9396858|P1|Overall Study|Subject required surgery|1
2733967|NCT00113360|9396858|P1|Overall Study|Adverse Event|3
2733968|NCT00113295|9396872|P2|Overall Study|Unrelated Medical Illness|0
2733969|NCT00113295|9396873|P1|Overall Study|Unrelated Medical Illness|1
2733970|NCT00113295|9396872|P2|Overall Study|Adverse Event|1
2733971|NCT00113295|9396873|P1|Overall Study|Adverse Event|4
2733972|NCT00113269|9396892|P4|Overall Study|Unable to return for follow up|0
2733973|NCT00113269|9396893|P3|Overall Study|Unable to return for follow up|0
2733974|NCT00113269|9396894|P2|Overall Study|Unable to return for follow up|1
2733975|NCT00113269|9396895|P1|Overall Study|Unable to return for follow up|2
2733976|NCT00113269|9396892|P4|Overall Study|Did not meet eligibility criteria|1
2733977|NCT00113269|9396893|P3|Overall Study|Did not meet eligibility criteria|0
2733978|NCT00113269|9396894|P2|Overall Study|Did not meet eligibility criteria|0
2733979|NCT00113269|9396895|P1|Overall Study|Did not meet eligibility criteria|1
2733980|NCT00113269|9396892|P4|Overall Study|Withdrew consent, Prednisone initiated|1
2733981|NCT00113269|9396893|P3|Overall Study|Withdrew consent, Prednisone initiated|0
2733982|NCT00113269|9396894|P2|Overall Study|Withdrew consent, Prednisone initiated|0
2733983|NCT00113269|9396895|P1|Overall Study|Withdrew consent, Prednisone initiated|0
2733984|NCT00113269|9396892|P4|Overall Study|Received pancreas transplant|2
2733985|NCT00113269|9396893|P3|Overall Study|Received pancreas transplant|0
2733986|NCT00113269|9396894|P2|Overall Study|Received pancreas transplant|0
2733987|NCT00113269|9396895|P1|Overall Study|Received pancreas transplant|0
2733988|NCT00113269|9396892|P4|Overall Study|Moved|3
2733989|NCT00113269|9396893|P3|Overall Study|Moved|0
2733990|NCT00113269|9396894|P2|Overall Study|Moved|1
2733991|NCT00113269|9396895|P1|Overall Study|Moved|0
2733992|NCT00113269|9396892|P4|Overall Study|Discontinued due to rejection|0
2733993|NCT00113269|9396893|P3|Overall Study|Discontinued due to rejection|1
2733994|NCT00113269|9396894|P2|Overall Study|Discontinued due to rejection|0
2733995|NCT00113269|9396895|P1|Overall Study|Discontinued due to rejection|0
2733996|NCT00113269|9396892|P4|Overall Study|Sponsor elected to discontinue patient|1
2733997|NCT00113269|9396893|P3|Overall Study|Sponsor elected to discontinue patient|0
2733998|NCT00113269|9396894|P2|Overall Study|Sponsor elected to discontinue patient|0
2733999|NCT00113269|9396895|P1|Overall Study|Sponsor elected to discontinue patient|1
2734000|NCT00113269|9396892|P4|Overall Study|Lost to Follow-up|3
2734001|NCT00113269|9396893|P3|Overall Study|Lost to Follow-up|6
2734002|NCT00113269|9396894|P2|Overall Study|Lost to Follow-up|3
2734003|NCT00113269|9396895|P1|Overall Study|Lost to Follow-up|2
2734004|NCT00113269|9396892|P4|Overall Study|Protocol Violation|2
2734005|NCT00113269|9396893|P3|Overall Study|Protocol Violation|4
2734006|NCT00113269|9396894|P2|Overall Study|Protocol Violation|0
2734007|NCT00113269|9396895|P1|Overall Study|Protocol Violation|1
2734008|NCT00113269|9396892|P4|Overall Study|Graft loss|9
2734009|NCT00113269|9396893|P3|Overall Study|Graft loss|4
2734010|NCT00113269|9396894|P2|Overall Study|Graft loss|6
2734011|NCT00113269|9396895|P1|Overall Study|Graft loss|6
2734012|NCT00113269|9396892|P4|Overall Study|Withdrawal by Subject|2
2734013|NCT00113269|9396893|P3|Overall Study|Withdrawal by Subject|4
2734014|NCT00113269|9396894|P2|Overall Study|Withdrawal by Subject|3
2734015|NCT00113269|9396895|P1|Overall Study|Withdrawal by Subject|4
2734016|NCT00113269|9396892|P4|Overall Study|Adverse Event|7
2734017|NCT00113269|9396893|P3|Overall Study|Adverse Event|11
2734018|NCT00113269|9396894|P2|Overall Study|Adverse Event|7
2734019|NCT00113269|9396895|P1|Overall Study|Adverse Event|2
2734020|NCT00113269|9396892|P4|Overall Study|Did not meet eligibility – pre-treatment|2
2734021|NCT00113269|9396893|P3|Overall Study|Did not meet eligibility – pre-treatment|0
2734022|NCT00113269|9396894|P2|Overall Study|Did not meet eligibility – pre-treatment|0
2734023|NCT00113269|9396895|P1|Overall Study|Did not meet eligibility – pre-treatment|0
2734024|NCT00113269|9396892|P4|Overall Study|Death in operating room|1
2734025|NCT00113269|9396893|P3|Overall Study|Death in operating room|0
2734026|NCT00113269|9396894|P2|Overall Study|Death in operating room|0
2734027|NCT00113269|9396895|P1|Overall Study|Death in operating room|0
2734028|NCT00113269|9396892|P4|Overall Study|Early graft loss, technical|0
2734029|NCT00113269|9396893|P3|Overall Study|Early graft loss, technical|2
2734030|NCT00113269|9396894|P2|Overall Study|Early graft loss, technical|0
2734031|NCT00113269|9396895|P1|Overall Study|Early graft loss, technical|0
2734032|NCT00113269|9396892|P4|Overall Study|Not transplanted, recipient issues|4
2734033|NCT00113269|9396893|P3|Overall Study|Not transplanted, recipient issues|7
2734034|NCT00113269|9396894|P2|Overall Study|Not transplanted, recipient issues|1
2734035|NCT00113269|9396895|P1|Overall Study|Not transplanted, recipient issues|2
2734036|NCT00113269|9396892|P4|Overall Study|Not transplanted, donor issues|2
2734037|NCT00113269|9396893|P3|Overall Study|Not transplanted, donor issues|2
2734038|NCT00113269|9396894|P2|Overall Study|Not transplanted, donor issues|0
2734039|NCT00113269|9396895|P1|Overall Study|Not transplanted, donor issues|4
2734040|NCT00113087|9396955|P2|Overall Study|Family or MD withdrew subject|5
2734041|NCT00113087|9396956|P1|Overall Study|Family or MD withdrew subject|10
2734042|NCT00113087|9396955|P2|Overall Study|Death or Transplant|16
2734043|NCT00113087|9396956|P1|Overall Study|Death or Transplant|14
2734044|NCT00112957|9397027|P1|Overall Study|Physician Decision|1
2734045|NCT00112957|9397027|P1|Overall Study|Progressive disease|18
2734046|NCT00112905|9397067|P1|Overall Study|performance status was deteiorating|1
2734047|NCT00112905|9397067|P1|Overall Study|Alternative treatment|1
2734048|NCT00112905|9397067|P1|Overall Study|Ineligibility|5
2734049|NCT00112905|9397067|P1|Overall Study|Death|1
2734050|NCT00112905|9397067|P1|Overall Study|Adverse Event|4
2734051|NCT00112866|9397076|P2|Overall Study|did not start treatment post-op|2
2734052|NCT00112866|9397077|P1|Overall Study|did not start treatment post-op|1
2734053|NCT00112866|9397076|P2|Overall Study|Protocol Violation|0
2734054|NCT00112866|9397077|P1|Overall Study|Protocol Violation|1
2734055|NCT00112840|9397099|P3|Overall Study|Protocol Violation|5
2734056|NCT00112840|9397100|P2|Overall Study|Protocol Violation|0
2734057|NCT00112840|9397101|P1|Overall Study|Protocol Violation|0
2734058|NCT00112840|9397099|P3|Overall Study|Withdrawal by Subject|1
2734059|NCT00112840|9397100|P2|Overall Study|Withdrawal by Subject|0
2734060|NCT00112840|9397101|P1|Overall Study|Withdrawal by Subject|1
2734061|NCT00112840|9397099|P3|Overall Study|Physician Decision|0
2734062|NCT00112840|9397100|P2|Overall Study|Physician Decision|0
2734063|NCT00112840|9397101|P1|Overall Study|Physician Decision|1
2734064|NCT00112736|9397120|P2|Overall Study|1 pt never had had RX due rapid decline|0
2734065|NCT00112736|9397121|P1|Overall Study|1 pt never had had RX due rapid decline|1
2734066|NCT00112489|9397178|P1|Overall Study|Ineligible|7
2734067|NCT00112489|9397178|P1|Overall Study|Patient never treated|2
2734068|NCT00112489|9397178|P1|Overall Study|Other, Not Specified|9
2734069|NCT00112489|9397178|P1|Overall Study|Death|2
2734070|NCT00112489|9397178|P1|Overall Study|Adverse Event|12
2734071|NCT00112489|9397178|P1|Overall Study|Refused further treatment|8
2734072|NCT00112463|9397188|P1|Overall Study|Never started treatment|2
2734073|NCT00112463|9397188|P1|Overall Study|Withdrawal by Subject|2
2734074|NCT00112463|9397188|P1|Overall Study|Toxicity|3
2734075|NCT00112463|9397188|P1|Overall Study|Second Primary|1
2734076|NCT00112463|9397188|P1|Overall Study|Progression|30
2734077|NCT00112463|9397188|P1|Overall Study|Physician Decision|1
2734078|NCT00112437|9397200|P26|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3
2734079|NCT00112437|9397201|P25|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2734080|NCT00112437|9397202|P24|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6
2734081|NCT00112437|9397203|P23|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4
2734082|NCT00112437|9397204|P22|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2734083|NCT00112437|9397205|P21|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2734084|NCT00112437|9397206|P20|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2734085|NCT00112437|9397207|P19|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2734086|NCT00112437|9397208|P18|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2734087|NCT00112437|9397209|P17|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2734088|NCT00112437|9397210|P16|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2734089|NCT00112437|9397211|P15|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2734090|NCT00112437|9397212|P14|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2734091|NCT00112437|9397213|P13|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2734092|NCT00112437|9397214|P12|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2734093|NCT00112437|9397215|P11|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2734094|NCT00112437|9397216|P10|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2734095|NCT00112437|9397217|P9|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2734096|NCT00112437|9397218|P8|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2734097|NCT00112437|9397219|P7|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2734098|NCT00112437|9397220|P6|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2734099|NCT00112437|9397221|P5|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2734100|NCT00112437|9397222|P4|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2734101|NCT00112437|9397223|P3|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2734102|NCT00112437|9397224|P2|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2734103|NCT00112437|9397225|P1|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
2734104|NCT00112437|9397200|P26|Years 6-10 (60-Month Extension)|Physician Decision|0
2734105|NCT00112437|9397201|P25|Years 6-10 (60-Month Extension)|Physician Decision|0
2734106|NCT00112437|9397202|P24|Years 6-10 (60-Month Extension)|Physician Decision|2
2734107|NCT00112437|9397203|P23|Years 6-10 (60-Month Extension)|Physician Decision|0
2734108|NCT00112437|9397204|P22|Years 6-10 (60-Month Extension)|Physician Decision|0
2734109|NCT00112437|9397205|P21|Years 6-10 (60-Month Extension)|Physician Decision|0
2734110|NCT00112437|9397206|P20|Years 6-10 (60-Month Extension)|Physician Decision|0
2734111|NCT00112437|9397207|P19|Years 6-10 (60-Month Extension)|Physician Decision|0
2734112|NCT00112437|9397208|P18|Years 6-10 (60-Month Extension)|Physician Decision|0
2734113|NCT00112437|9397209|P17|Years 6-10 (60-Month Extension)|Physician Decision|0
2734114|NCT00112437|9397210|P16|Years 6-10 (60-Month Extension)|Physician Decision|0
2734115|NCT00112437|9397211|P15|Years 6-10 (60-Month Extension)|Physician Decision|0
2734116|NCT00112437|9397212|P14|Years 6-10 (60-Month Extension)|Physician Decision|0
2734117|NCT00112437|9397213|P13|Years 6-10 (60-Month Extension)|Physician Decision|0
2734118|NCT00112437|9397214|P12|Years 6-10 (60-Month Extension)|Physician Decision|0
2734119|NCT00112437|9397215|P11|Years 6-10 (60-Month Extension)|Physician Decision|0
2734120|NCT00112437|9397216|P10|Years 6-10 (60-Month Extension)|Physician Decision|0
2734121|NCT00112437|9397217|P9|Years 6-10 (60-Month Extension)|Physician Decision|0
2734122|NCT00112437|9397218|P8|Years 6-10 (60-Month Extension)|Physician Decision|0
2734123|NCT00112437|9397219|P7|Years 6-10 (60-Month Extension)|Physician Decision|0
2734124|NCT00112437|9397220|P6|Years 6-10 (60-Month Extension)|Physician Decision|0
2734125|NCT00112437|9397221|P5|Years 6-10 (60-Month Extension)|Physician Decision|0
2734126|NCT00112437|9397222|P4|Years 6-10 (60-Month Extension)|Physician Decision|0
2734127|NCT00112437|9397223|P3|Years 6-10 (60-Month Extension)|Physician Decision|0
2734128|NCT00112437|9397224|P2|Years 6-10 (60-Month Extension)|Physician Decision|0
2734129|NCT00112437|9397225|P1|Years 6-10 (60-Month Extension)|Physician Decision|0
2734130|NCT00112437|9397200|P26|Years 6-10 (60-Month Extension)|Other|0
2734131|NCT00112437|9397201|P25|Years 6-10 (60-Month Extension)|Other|1
2734132|NCT00112437|9397202|P24|Years 6-10 (60-Month Extension)|Other|0
2734133|NCT00112437|9397203|P23|Years 6-10 (60-Month Extension)|Other|0
2734134|NCT00112437|9397204|P22|Years 6-10 (60-Month Extension)|Other|0
2734135|NCT00112437|9397205|P21|Years 6-10 (60-Month Extension)|Other|0
2734136|NCT00112437|9397206|P20|Years 6-10 (60-Month Extension)|Other|0
2734137|NCT00112437|9397207|P19|Years 6-10 (60-Month Extension)|Other|0
2734138|NCT00112437|9397208|P18|Years 6-10 (60-Month Extension)|Other|0
2734139|NCT00112437|9397209|P17|Years 6-10 (60-Month Extension)|Other|0
2734140|NCT00112437|9397210|P16|Years 6-10 (60-Month Extension)|Other|0
2734141|NCT00112437|9397211|P15|Years 6-10 (60-Month Extension)|Other|0
2734142|NCT00112437|9397212|P14|Years 6-10 (60-Month Extension)|Other|0
2734143|NCT00112437|9397213|P13|Years 6-10 (60-Month Extension)|Other|0
2734144|NCT00112437|9397214|P12|Years 6-10 (60-Month Extension)|Other|0
2734145|NCT00112437|9397215|P11|Years 6-10 (60-Month Extension)|Other|0
2734146|NCT00112437|9397216|P10|Years 6-10 (60-Month Extension)|Other|0
2734147|NCT00112437|9397217|P9|Years 6-10 (60-Month Extension)|Other|0
2734148|NCT00112437|9397218|P8|Years 6-10 (60-Month Extension)|Other|0
2734149|NCT00112437|9397219|P7|Years 6-10 (60-Month Extension)|Other|0
2734150|NCT00112437|9397220|P6|Years 6-10 (60-Month Extension)|Other|0
2734151|NCT00112437|9397221|P5|Years 6-10 (60-Month Extension)|Other|0
2734152|NCT00112437|9397222|P4|Years 6-10 (60-Month Extension)|Other|0
2734153|NCT00112437|9397223|P3|Years 6-10 (60-Month Extension)|Other|0
2734154|NCT00112437|9397224|P2|Years 6-10 (60-Month Extension)|Other|0
2734155|NCT00112437|9397225|P1|Years 6-10 (60-Month Extension)|Other|0
2734156|NCT00112437|9397200|P26|Years 6-10 (60-Month Extension)|Lost to Follow-up|1
2734157|NCT00112437|9397201|P25|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2734158|NCT00112437|9397202|P24|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2734159|NCT00112437|9397203|P23|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2734160|NCT00112437|9397204|P22|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2734161|NCT00112437|9397205|P21|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2734162|NCT00112437|9397206|P20|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2734163|NCT00112437|9397207|P19|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2734164|NCT00112437|9397208|P18|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2734165|NCT00112437|9397209|P17|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2734166|NCT00112437|9397210|P16|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2734167|NCT00112437|9397211|P15|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2734168|NCT00112437|9397212|P14|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2734169|NCT00112437|9397213|P13|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2734170|NCT00112437|9397214|P12|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2734171|NCT00112437|9397215|P11|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2734172|NCT00112437|9397216|P10|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2734173|NCT00112437|9397217|P9|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2734174|NCT00112437|9397218|P8|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2734175|NCT00112437|9397219|P7|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2734176|NCT00112437|9397220|P6|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2734177|NCT00112437|9397221|P5|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2734178|NCT00112437|9397222|P4|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2734179|NCT00112437|9397223|P3|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2734180|NCT00112437|9397224|P2|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2734181|NCT00112437|9397225|P1|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
2734182|NCT00112437|9397200|P26|Years 6-10 (60-Month Extension)|Death|0
2734183|NCT00112437|9397201|P25|Years 6-10 (60-Month Extension)|Death|0
2734184|NCT00112437|9397202|P24|Years 6-10 (60-Month Extension)|Death|2
2734185|NCT00112437|9397203|P23|Years 6-10 (60-Month Extension)|Death|0
2734186|NCT00112437|9397204|P22|Years 6-10 (60-Month Extension)|Death|0
2734187|NCT00112437|9397205|P21|Years 6-10 (60-Month Extension)|Death|0
2734188|NCT00112437|9397206|P20|Years 6-10 (60-Month Extension)|Death|0
2734189|NCT00112437|9397207|P19|Years 6-10 (60-Month Extension)|Death|0
2734190|NCT00112437|9397208|P18|Years 6-10 (60-Month Extension)|Death|0
2734191|NCT00112437|9397209|P17|Years 6-10 (60-Month Extension)|Death|0
2734192|NCT00112437|9397210|P16|Years 6-10 (60-Month Extension)|Death|0
2734193|NCT00112437|9397211|P15|Years 6-10 (60-Month Extension)|Death|0
2734194|NCT00112437|9397212|P14|Years 6-10 (60-Month Extension)|Death|0
2734195|NCT00112437|9397213|P13|Years 6-10 (60-Month Extension)|Death|0
2734196|NCT00112437|9397214|P12|Years 6-10 (60-Month Extension)|Death|0
2734197|NCT00112437|9397215|P11|Years 6-10 (60-Month Extension)|Death|0
2734198|NCT00112437|9397216|P10|Years 6-10 (60-Month Extension)|Death|0
2734199|NCT00112437|9397217|P9|Years 6-10 (60-Month Extension)|Death|0
2734200|NCT00112437|9397218|P8|Years 6-10 (60-Month Extension)|Death|0
2734201|NCT00112437|9397219|P7|Years 6-10 (60-Month Extension)|Death|0
2734202|NCT00112437|9397220|P6|Years 6-10 (60-Month Extension)|Death|0
2734203|NCT00112437|9397221|P5|Years 6-10 (60-Month Extension)|Death|0
2734204|NCT00112437|9397222|P4|Years 6-10 (60-Month Extension)|Death|0
2734205|NCT00112437|9397223|P3|Years 6-10 (60-Month Extension)|Death|0
2734206|NCT00112437|9397224|P2|Years 6-10 (60-Month Extension)|Death|0
2734207|NCT00112437|9397225|P1|Years 6-10 (60-Month Extension)|Death|0
2734208|NCT00112437|9397200|P26|Years 6-10 (60-Month Extension)|Adverse Event|1
2734209|NCT00112437|9397201|P25|Years 6-10 (60-Month Extension)|Adverse Event|0
2734210|NCT00112437|9397202|P24|Years 6-10 (60-Month Extension)|Adverse Event|2
2734211|NCT00112437|9397203|P23|Years 6-10 (60-Month Extension)|Adverse Event|1
2734212|NCT00112437|9397204|P22|Years 6-10 (60-Month Extension)|Adverse Event|0
2734213|NCT00112437|9397205|P21|Years 6-10 (60-Month Extension)|Adverse Event|0
2734214|NCT00112437|9397206|P20|Years 6-10 (60-Month Extension)|Adverse Event|0
2734215|NCT00112437|9397207|P19|Years 6-10 (60-Month Extension)|Adverse Event|0
2734216|NCT00112437|9397208|P18|Years 6-10 (60-Month Extension)|Adverse Event|0
2734217|NCT00112437|9397209|P17|Years 6-10 (60-Month Extension)|Adverse Event|0
2734218|NCT00112437|9397210|P16|Years 6-10 (60-Month Extension)|Adverse Event|0
2734219|NCT00112437|9397211|P15|Years 6-10 (60-Month Extension)|Adverse Event|0
2734220|NCT00112437|9397212|P14|Years 6-10 (60-Month Extension)|Adverse Event|0
2734221|NCT00112437|9397213|P13|Years 6-10 (60-Month Extension)|Adverse Event|0
2734222|NCT00112437|9397214|P12|Years 6-10 (60-Month Extension)|Adverse Event|0
2734223|NCT00112437|9397215|P11|Years 6-10 (60-Month Extension)|Adverse Event|0
2734224|NCT00112437|9397216|P10|Years 6-10 (60-Month Extension)|Adverse Event|0
2734225|NCT00112437|9397217|P9|Years 6-10 (60-Month Extension)|Adverse Event|0
2734226|NCT00112437|9397218|P8|Years 6-10 (60-Month Extension)|Adverse Event|0
2734227|NCT00112437|9397219|P7|Years 6-10 (60-Month Extension)|Adverse Event|0
2734228|NCT00112437|9397220|P6|Years 6-10 (60-Month Extension)|Adverse Event|0
2734229|NCT00112437|9397221|P5|Years 6-10 (60-Month Extension)|Adverse Event|0
2734230|NCT00112437|9397222|P4|Years 6-10 (60-Month Extension)|Adverse Event|0
2734231|NCT00112437|9397223|P3|Years 6-10 (60-Month Extension)|Adverse Event|0
2734232|NCT00112437|9397224|P2|Years 6-10 (60-Month Extension)|Adverse Event|0
2734233|NCT00112437|9397225|P1|Years 6-10 (60-Month Extension)|Adverse Event|0
2734234|NCT00112437|9397200|P26|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2734235|NCT00112437|9397201|P25|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2734236|NCT00112437|9397202|P24|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2734237|NCT00112437|9397203|P23|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2734238|NCT00112437|9397204|P22|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2
2734239|NCT00112437|9397205|P21|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1
2734240|NCT00112437|9397206|P20|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2734241|NCT00112437|9397207|P19|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2734242|NCT00112437|9397208|P18|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2734243|NCT00112437|9397209|P17|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2734244|NCT00112437|9397210|P16|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2734245|NCT00112437|9397211|P15|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2734246|NCT00112437|9397212|P14|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2734247|NCT00112437|9397213|P13|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2734248|NCT00112437|9397214|P12|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2734249|NCT00112437|9397215|P11|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2734250|NCT00112437|9397216|P10|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2734251|NCT00112437|9397217|P9|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2734252|NCT00112437|9397218|P8|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2734253|NCT00112437|9397219|P7|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2734254|NCT00112437|9397220|P6|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2734255|NCT00112437|9397221|P5|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2734256|NCT00112437|9397222|P4|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2734257|NCT00112437|9397223|P3|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2734258|NCT00112437|9397224|P2|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2734259|NCT00112437|9397225|P1|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
2734260|NCT00112437|9397200|P26|Years 4-5 (24-Month Extension)|Participant moved|0
2734261|NCT00112437|9397201|P25|Years 4-5 (24-Month Extension)|Participant moved|0
2734262|NCT00112437|9397202|P24|Years 4-5 (24-Month Extension)|Participant moved|0
2734263|NCT00112437|9397203|P23|Years 4-5 (24-Month Extension)|Participant moved|0
2734264|NCT00112437|9397204|P22|Years 4-5 (24-Month Extension)|Participant moved|1
2734265|NCT00112437|9397205|P21|Years 4-5 (24-Month Extension)|Participant moved|0
2734266|NCT00112437|9397206|P20|Years 4-5 (24-Month Extension)|Participant moved|0
2734267|NCT00112437|9397207|P19|Years 4-5 (24-Month Extension)|Participant moved|0
2734268|NCT00112437|9397208|P18|Years 4-5 (24-Month Extension)|Participant moved|0
2734269|NCT00112437|9397209|P17|Years 4-5 (24-Month Extension)|Participant moved|0
2734270|NCT00112437|9397210|P16|Years 4-5 (24-Month Extension)|Participant moved|0
2734271|NCT00112437|9397211|P15|Years 4-5 (24-Month Extension)|Participant moved|0
2734272|NCT00112437|9397212|P14|Years 4-5 (24-Month Extension)|Participant moved|0
2734273|NCT00112437|9397213|P13|Years 4-5 (24-Month Extension)|Participant moved|0
2734274|NCT00112437|9397214|P12|Years 4-5 (24-Month Extension)|Participant moved|0
2734275|NCT00112437|9397215|P11|Years 4-5 (24-Month Extension)|Participant moved|0
2734276|NCT00112437|9397216|P10|Years 4-5 (24-Month Extension)|Participant moved|0
2734277|NCT00112437|9397217|P9|Years 4-5 (24-Month Extension)|Participant moved|0
2734278|NCT00112437|9397218|P8|Years 4-5 (24-Month Extension)|Participant moved|0
2734279|NCT00112437|9397219|P7|Years 4-5 (24-Month Extension)|Participant moved|0
2734280|NCT00112437|9397220|P6|Years 4-5 (24-Month Extension)|Participant moved|0
2734281|NCT00112437|9397221|P5|Years 4-5 (24-Month Extension)|Participant moved|0
2734282|NCT00112437|9397222|P4|Years 4-5 (24-Month Extension)|Participant moved|0
2734283|NCT00112437|9397223|P3|Years 4-5 (24-Month Extension)|Participant moved|0
2734284|NCT00112437|9397224|P2|Years 4-5 (24-Month Extension)|Participant moved|0
2734285|NCT00112437|9397225|P1|Years 4-5 (24-Month Extension)|Participant moved|0
2734286|NCT00112437|9397200|P26|Years 4-5 (24-Month Extension)|Adverse Event|0
2734287|NCT00112437|9397201|P25|Years 4-5 (24-Month Extension)|Adverse Event|0
2734288|NCT00112437|9397202|P24|Years 4-5 (24-Month Extension)|Adverse Event|0
2734289|NCT00112437|9397203|P23|Years 4-5 (24-Month Extension)|Adverse Event|0
2734290|NCT00112437|9397204|P22|Years 4-5 (24-Month Extension)|Adverse Event|4
2734291|NCT00112437|9397205|P21|Years 4-5 (24-Month Extension)|Adverse Event|0
2734292|NCT00112437|9397206|P20|Years 4-5 (24-Month Extension)|Adverse Event|0
2734293|NCT00112437|9397207|P19|Years 4-5 (24-Month Extension)|Adverse Event|0
2734294|NCT00112437|9397208|P18|Years 4-5 (24-Month Extension)|Adverse Event|0
2734295|NCT00112437|9397209|P17|Years 4-5 (24-Month Extension)|Adverse Event|0
2734296|NCT00112437|9397210|P16|Years 4-5 (24-Month Extension)|Adverse Event|0
2734297|NCT00112437|9397211|P15|Years 4-5 (24-Month Extension)|Adverse Event|0
2734298|NCT00112437|9397212|P14|Years 4-5 (24-Month Extension)|Adverse Event|0
2734299|NCT00112437|9397213|P13|Years 4-5 (24-Month Extension)|Adverse Event|0
2734300|NCT00112437|9397214|P12|Years 4-5 (24-Month Extension)|Adverse Event|0
2734301|NCT00112437|9397215|P11|Years 4-5 (24-Month Extension)|Adverse Event|0
2734302|NCT00112437|9397216|P10|Years 4-5 (24-Month Extension)|Adverse Event|0
2734303|NCT00112437|9397217|P9|Years 4-5 (24-Month Extension)|Adverse Event|0
2734304|NCT00112437|9397218|P8|Years 4-5 (24-Month Extension)|Adverse Event|0
2734305|NCT00112437|9397219|P7|Years 4-5 (24-Month Extension)|Adverse Event|0
2734306|NCT00112437|9397220|P6|Years 4-5 (24-Month Extension)|Adverse Event|0
2734307|NCT00112437|9397221|P5|Years 4-5 (24-Month Extension)|Adverse Event|0
2734308|NCT00112437|9397222|P4|Years 4-5 (24-Month Extension)|Adverse Event|0
2734309|NCT00112437|9397223|P3|Years 4-5 (24-Month Extension)|Adverse Event|0
2734310|NCT00112437|9397224|P2|Years 4-5 (24-Month Extension)|Adverse Event|0
2734311|NCT00112437|9397225|P1|Years 4-5 (24-Month Extension)|Adverse Event|0
2734312|NCT00112437|9397200|P26|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2734313|NCT00112437|9397201|P25|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2734314|NCT00112437|9397202|P24|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2734315|NCT00112437|9397203|P23|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2734316|NCT00112437|9397204|P22|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2734317|NCT00112437|9397205|P21|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1
2734318|NCT00112437|9397206|P20|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2734319|NCT00112437|9397207|P19|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2734320|NCT00112437|9397208|P18|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2734321|NCT00112437|9397209|P17|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2734322|NCT00112437|9397210|P16|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2734323|NCT00112437|9397211|P15|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2734324|NCT00112437|9397212|P14|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2734325|NCT00112437|9397213|P13|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2734326|NCT00112437|9397214|P12|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2734327|NCT00112437|9397215|P11|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2734328|NCT00112437|9397216|P10|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2734329|NCT00112437|9397217|P9|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2734330|NCT00112437|9397218|P8|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2734331|NCT00112437|9397219|P7|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2734332|NCT00112437|9397220|P6|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2734333|NCT00112437|9397221|P5|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2734334|NCT00112437|9397222|P4|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2734335|NCT00112437|9397223|P3|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2734336|NCT00112437|9397224|P2|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2734337|NCT00112437|9397225|P1|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
2734338|NCT00112437|9397200|P26|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2734339|NCT00112437|9397201|P25|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2734340|NCT00112437|9397202|P24|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2734341|NCT00112437|9397203|P23|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2734342|NCT00112437|9397204|P22|Years 4-5 (24-Month Extension)|Lack of Efficacy|1
2734343|NCT00112437|9397205|P21|Years 4-5 (24-Month Extension)|Lack of Efficacy|2
2734344|NCT00112437|9397206|P20|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2734345|NCT00112437|9397207|P19|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2734346|NCT00112437|9397208|P18|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2734347|NCT00112437|9397209|P17|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2734348|NCT00112437|9397210|P16|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2734349|NCT00112437|9397211|P15|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2734350|NCT00112437|9397212|P14|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2734351|NCT00112437|9397213|P13|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2734352|NCT00112437|9397214|P12|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2734353|NCT00112437|9397215|P11|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2734354|NCT00112437|9397216|P10|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2734355|NCT00112437|9397217|P9|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2734356|NCT00112437|9397218|P8|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2734357|NCT00112437|9397219|P7|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2734358|NCT00112437|9397220|P6|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2734359|NCT00112437|9397221|P5|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2734360|NCT00112437|9397222|P4|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2734361|NCT00112437|9397223|P3|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2734362|NCT00112437|9397224|P2|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2734363|NCT00112437|9397225|P1|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
2734364|NCT00112437|9397200|P26|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2734365|NCT00112437|9397201|P25|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2734366|NCT00112437|9397202|P24|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2734367|NCT00112437|9397203|P23|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2734368|NCT00112437|9397204|P22|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2734369|NCT00112437|9397205|P21|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2734370|NCT00112437|9397206|P20|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2734371|NCT00112437|9397207|P19|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2734372|NCT00112437|9397208|P18|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2734373|NCT00112437|9397209|P17|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2734374|NCT00112437|9397210|P16|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2734375|NCT00112437|9397211|P15|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2734376|NCT00112437|9397212|P14|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2734377|NCT00112437|9397213|P13|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2734378|NCT00112437|9397214|P12|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
2734379|NCT00112437|9397215|P11|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
2734380|NCT00112437|9397216|P10|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2734381|NCT00112437|9397217|P9|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2734382|NCT00112437|9397218|P8|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2734383|NCT00112437|9397219|P7|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2734384|NCT00112437|9397220|P6|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2734385|NCT00112437|9397221|P5|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2734386|NCT00112437|9397222|P4|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2734387|NCT00112437|9397223|P3|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2734388|NCT00112437|9397224|P2|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2734389|NCT00112437|9397225|P1|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
2734390|NCT00112437|9397200|P26|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2734391|NCT00112437|9397201|P25|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2734392|NCT00112437|9397202|P24|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2734393|NCT00112437|9397203|P23|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2734394|NCT00112437|9397204|P22|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2734395|NCT00112437|9397205|P21|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2734396|NCT00112437|9397206|P20|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2734397|NCT00112437|9397207|P19|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2734398|NCT00112437|9397208|P18|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2734399|NCT00112437|9397209|P17|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2734400|NCT00112437|9397210|P16|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2734401|NCT00112437|9397211|P15|Year 3 (12-Month Extension)|Withdrawal by Subject|1
2734402|NCT00112437|9397212|P14|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2734403|NCT00112437|9397213|P13|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2734404|NCT00112437|9397214|P12|Year 3 (12-Month Extension)|Withdrawal by Subject|3
2734405|NCT00112437|9397215|P11|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2734406|NCT00112437|9397216|P10|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2734407|NCT00112437|9397217|P9|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2734408|NCT00112437|9397218|P8|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2734409|NCT00112437|9397219|P7|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2734410|NCT00112437|9397220|P6|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2734411|NCT00112437|9397221|P5|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2734412|NCT00112437|9397222|P4|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2734413|NCT00112437|9397223|P3|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2734414|NCT00112437|9397224|P2|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2734415|NCT00112437|9397225|P1|Year 3 (12-Month Extension)|Withdrawal by Subject|0
2734416|NCT00112437|9397200|P26|Year 3 (12-Month Extension)|Protocol Violation|0
2734417|NCT00112437|9397201|P25|Year 3 (12-Month Extension)|Protocol Violation|0
2734418|NCT00112437|9397202|P24|Year 3 (12-Month Extension)|Protocol Violation|0
2734419|NCT00112437|9397203|P23|Year 3 (12-Month Extension)|Protocol Violation|0
2734420|NCT00112437|9397204|P22|Year 3 (12-Month Extension)|Protocol Violation|0
2734421|NCT00112437|9397205|P21|Year 3 (12-Month Extension)|Protocol Violation|0
2734422|NCT00112437|9397206|P20|Year 3 (12-Month Extension)|Protocol Violation|0
2734423|NCT00112437|9397207|P19|Year 3 (12-Month Extension)|Protocol Violation|0
2734424|NCT00112437|9397208|P18|Year 3 (12-Month Extension)|Protocol Violation|0
2734425|NCT00112437|9397209|P17|Year 3 (12-Month Extension)|Protocol Violation|0
2734426|NCT00112437|9397210|P16|Year 3 (12-Month Extension)|Protocol Violation|1
2734427|NCT00112437|9397211|P15|Year 3 (12-Month Extension)|Protocol Violation|0
2734428|NCT00112437|9397212|P14|Year 3 (12-Month Extension)|Protocol Violation|0
2734429|NCT00112437|9397213|P13|Year 3 (12-Month Extension)|Protocol Violation|0
2734430|NCT00112437|9397214|P12|Year 3 (12-Month Extension)|Protocol Violation|0
2734431|NCT00112437|9397215|P11|Year 3 (12-Month Extension)|Protocol Violation|0
2734432|NCT00112437|9397216|P10|Year 3 (12-Month Extension)|Protocol Violation|0
2734433|NCT00112437|9397217|P9|Year 3 (12-Month Extension)|Protocol Violation|0
2734434|NCT00112437|9397218|P8|Year 3 (12-Month Extension)|Protocol Violation|0
2734435|NCT00112437|9397219|P7|Year 3 (12-Month Extension)|Protocol Violation|0
2734436|NCT00112437|9397220|P6|Year 3 (12-Month Extension)|Protocol Violation|0
2734437|NCT00112437|9397221|P5|Year 3 (12-Month Extension)|Protocol Violation|0
2734438|NCT00112437|9397222|P4|Year 3 (12-Month Extension)|Protocol Violation|0
2734439|NCT00112437|9397223|P3|Year 3 (12-Month Extension)|Protocol Violation|0
2734440|NCT00112437|9397224|P2|Year 3 (12-Month Extension)|Protocol Violation|0
2734441|NCT00112437|9397225|P1|Year 3 (12-Month Extension)|Protocol Violation|0
2734442|NCT00112437|9397200|P26|Year 3 (12-Month Extension)|Lost to Follow-up|0
2734443|NCT00112437|9397201|P25|Year 3 (12-Month Extension)|Lost to Follow-up|0
2734444|NCT00112437|9397202|P24|Year 3 (12-Month Extension)|Lost to Follow-up|0
2734445|NCT00112437|9397203|P23|Year 3 (12-Month Extension)|Lost to Follow-up|0
2734446|NCT00112437|9397204|P22|Year 3 (12-Month Extension)|Lost to Follow-up|0
2734447|NCT00112437|9397205|P21|Year 3 (12-Month Extension)|Lost to Follow-up|0
2734448|NCT00112437|9397206|P20|Year 3 (12-Month Extension)|Lost to Follow-up|0
2734449|NCT00112437|9397207|P19|Year 3 (12-Month Extension)|Lost to Follow-up|0
2734450|NCT00112437|9397208|P18|Year 3 (12-Month Extension)|Lost to Follow-up|0
2734451|NCT00112437|9397209|P17|Year 3 (12-Month Extension)|Lost to Follow-up|0
2734452|NCT00112437|9397210|P16|Year 3 (12-Month Extension)|Lost to Follow-up|1
2734453|NCT00112437|9397211|P15|Year 3 (12-Month Extension)|Lost to Follow-up|0
2734454|NCT00112437|9397212|P14|Year 3 (12-Month Extension)|Lost to Follow-up|0
2734455|NCT00112437|9397213|P13|Year 3 (12-Month Extension)|Lost to Follow-up|0
2734456|NCT00112437|9397214|P12|Year 3 (12-Month Extension)|Lost to Follow-up|0
2734457|NCT00112437|9397215|P11|Year 3 (12-Month Extension)|Lost to Follow-up|0
2734458|NCT00112437|9397216|P10|Year 3 (12-Month Extension)|Lost to Follow-up|0
2734459|NCT00112437|9397217|P9|Year 3 (12-Month Extension)|Lost to Follow-up|0
2734460|NCT00112437|9397218|P8|Year 3 (12-Month Extension)|Lost to Follow-up|0
2734461|NCT00112437|9397219|P7|Year 3 (12-Month Extension)|Lost to Follow-up|0
2734462|NCT00112437|9397220|P6|Year 3 (12-Month Extension)|Lost to Follow-up|0
2734463|NCT00112437|9397221|P5|Year 3 (12-Month Extension)|Lost to Follow-up|0
2734464|NCT00112437|9397222|P4|Year 3 (12-Month Extension)|Lost to Follow-up|0
2734465|NCT00112437|9397223|P3|Year 3 (12-Month Extension)|Lost to Follow-up|0
2734466|NCT00112437|9397224|P2|Year 3 (12-Month Extension)|Lost to Follow-up|0
2734467|NCT00112437|9397225|P1|Year 3 (12-Month Extension)|Lost to Follow-up|0
2734468|NCT00112437|9397200|P26|Year 3 (12-Month Extension)|Lack of Efficacy|0
2734469|NCT00112437|9397201|P25|Year 3 (12-Month Extension)|Lack of Efficacy|0
2734470|NCT00112437|9397202|P24|Year 3 (12-Month Extension)|Lack of Efficacy|0
2734471|NCT00112437|9397203|P23|Year 3 (12-Month Extension)|Lack of Efficacy|0
2734472|NCT00112437|9397204|P22|Year 3 (12-Month Extension)|Lack of Efficacy|0
2734473|NCT00112437|9397205|P21|Year 3 (12-Month Extension)|Lack of Efficacy|0
2734474|NCT00112437|9397206|P20|Year 3 (12-Month Extension)|Lack of Efficacy|0
2734475|NCT00112437|9397207|P19|Year 3 (12-Month Extension)|Lack of Efficacy|2
2734476|NCT00112437|9397208|P18|Year 3 (12-Month Extension)|Lack of Efficacy|0
2734477|NCT00112437|9397209|P17|Year 3 (12-Month Extension)|Lack of Efficacy|0
2734478|NCT00112437|9397210|P16|Year 3 (12-Month Extension)|Lack of Efficacy|1
2734479|NCT00112437|9397211|P15|Year 3 (12-Month Extension)|Lack of Efficacy|0
2734480|NCT00112437|9397212|P14|Year 3 (12-Month Extension)|Lack of Efficacy|1
2734481|NCT00112437|9397213|P13|Year 3 (12-Month Extension)|Lack of Efficacy|0
2734482|NCT00112437|9397214|P12|Year 3 (12-Month Extension)|Lack of Efficacy|1
2734483|NCT00112437|9397215|P11|Year 3 (12-Month Extension)|Lack of Efficacy|0
2734484|NCT00112437|9397216|P10|Year 3 (12-Month Extension)|Lack of Efficacy|0
2734485|NCT00112437|9397217|P9|Year 3 (12-Month Extension)|Lack of Efficacy|0
2734486|NCT00112437|9397218|P8|Year 3 (12-Month Extension)|Lack of Efficacy|0
2734487|NCT00112437|9397219|P7|Year 3 (12-Month Extension)|Lack of Efficacy|0
2734488|NCT00112437|9397220|P6|Year 3 (12-Month Extension)|Lack of Efficacy|0
2734489|NCT00112437|9397221|P5|Year 3 (12-Month Extension)|Lack of Efficacy|0
2734490|NCT00112437|9397222|P4|Year 3 (12-Month Extension)|Lack of Efficacy|0
2734491|NCT00112437|9397223|P3|Year 3 (12-Month Extension)|Lack of Efficacy|0
2734492|NCT00112437|9397224|P2|Year 3 (12-Month Extension)|Lack of Efficacy|0
2734493|NCT00112437|9397225|P1|Year 3 (12-Month Extension)|Lack of Efficacy|0
2734494|NCT00112437|9397200|P26|Year 3 (12-Month Extension)|Adverse Event|0
2734495|NCT00112437|9397201|P25|Year 3 (12-Month Extension)|Adverse Event|0
2734496|NCT00112437|9397202|P24|Year 3 (12-Month Extension)|Adverse Event|0
2734497|NCT00112437|9397203|P23|Year 3 (12-Month Extension)|Adverse Event|0
2734498|NCT00112437|9397204|P22|Year 3 (12-Month Extension)|Adverse Event|0
2734499|NCT00112437|9397205|P21|Year 3 (12-Month Extension)|Adverse Event|0
2734500|NCT00112437|9397206|P20|Year 3 (12-Month Extension)|Adverse Event|1
2734501|NCT00112437|9397207|P19|Year 3 (12-Month Extension)|Adverse Event|0
2734502|NCT00112437|9397208|P18|Year 3 (12-Month Extension)|Adverse Event|1
2734503|NCT00112437|9397209|P17|Year 3 (12-Month Extension)|Adverse Event|3
2734504|NCT00112437|9397210|P16|Year 3 (12-Month Extension)|Adverse Event|1
2734505|NCT00112437|9397211|P15|Year 3 (12-Month Extension)|Adverse Event|0
2734506|NCT00112437|9397212|P14|Year 3 (12-Month Extension)|Adverse Event|0
2734507|NCT00112437|9397213|P13|Year 3 (12-Month Extension)|Adverse Event|0
2734508|NCT00112437|9397214|P12|Year 3 (12-Month Extension)|Adverse Event|0
2734509|NCT00112437|9397215|P11|Year 3 (12-Month Extension)|Adverse Event|1
2734510|NCT00112437|9397216|P10|Year 3 (12-Month Extension)|Adverse Event|0
2734511|NCT00112437|9397217|P9|Year 3 (12-Month Extension)|Adverse Event|0
2734512|NCT00112437|9397218|P8|Year 3 (12-Month Extension)|Adverse Event|0
2734513|NCT00112437|9397219|P7|Year 3 (12-Month Extension)|Adverse Event|0
2734514|NCT00112437|9397220|P6|Year 3 (12-Month Extension)|Adverse Event|0
2734515|NCT00112437|9397221|P5|Year 3 (12-Month Extension)|Adverse Event|0
2734516|NCT00112437|9397222|P4|Year 3 (12-Month Extension)|Adverse Event|0
2734517|NCT00112437|9397223|P3|Year 3 (12-Month Extension)|Adverse Event|0
2734518|NCT00112437|9397224|P2|Year 3 (12-Month Extension)|Adverse Event|0
2734519|NCT00112437|9397225|P1|Year 3 (12-Month Extension)|Adverse Event|0
2734520|NCT00112437|9397200|P26|Year 2 (12-Month Extension)|Moved|0
2734521|NCT00112437|9397201|P25|Year 2 (12-Month Extension)|Moved|0
2734522|NCT00112437|9397202|P24|Year 2 (12-Month Extension)|Moved|0
2734523|NCT00112437|9397203|P23|Year 2 (12-Month Extension)|Moved|0
2734524|NCT00112437|9397204|P22|Year 2 (12-Month Extension)|Moved|0
2734525|NCT00112437|9397205|P21|Year 2 (12-Month Extension)|Moved|0
2734526|NCT00112437|9397206|P20|Year 2 (12-Month Extension)|Moved|0
2734527|NCT00112437|9397207|P19|Year 2 (12-Month Extension)|Moved|0
2734528|NCT00112437|9397208|P18|Year 2 (12-Month Extension)|Moved|0
2734529|NCT00112437|9397209|P17|Year 2 (12-Month Extension)|Moved|0
2734530|NCT00112437|9397210|P16|Year 2 (12-Month Extension)|Moved|0
2734531|NCT00112437|9397211|P15|Year 2 (12-Month Extension)|Moved|0
2734532|NCT00112437|9397212|P14|Year 2 (12-Month Extension)|Moved|0
2734533|NCT00112437|9397213|P13|Year 2 (12-Month Extension)|Moved|0
2734534|NCT00112437|9397214|P12|Year 2 (12-Month Extension)|Moved|0
2734535|NCT00112437|9397215|P11|Year 2 (12-Month Extension)|Moved|0
2734536|NCT00112437|9397216|P10|Year 2 (12-Month Extension)|Moved|1
2734537|NCT00112437|9397217|P9|Year 2 (12-Month Extension)|Moved|0
2734538|NCT00112437|9397218|P8|Year 2 (12-Month Extension)|Moved|0
2734539|NCT00112437|9397219|P7|Year 2 (12-Month Extension)|Moved|0
2734540|NCT00112437|9397220|P6|Year 2 (12-Month Extension)|Moved|0
2734541|NCT00112437|9397221|P5|Year 2 (12-Month Extension)|Moved|0
2734542|NCT00112437|9397222|P4|Year 2 (12-Month Extension)|Moved|0
2734543|NCT00112437|9397223|P3|Year 2 (12-Month Extension)|Moved|0
2734544|NCT00112437|9397224|P2|Year 2 (12-Month Extension)|Moved|0
2734545|NCT00112437|9397225|P1|Year 2 (12-Month Extension)|Moved|0
2734546|NCT00112437|9397200|P26|Year 2 (12-Month Extension)|patient was out of windows|0
2734547|NCT00112437|9397201|P25|Year 2 (12-Month Extension)|patient was out of windows|0
2734548|NCT00112437|9397202|P24|Year 2 (12-Month Extension)|patient was out of windows|0
2734549|NCT00112437|9397203|P23|Year 2 (12-Month Extension)|patient was out of windows|0
2734550|NCT00112437|9397204|P22|Year 2 (12-Month Extension)|patient was out of windows|0
2734551|NCT00112437|9397205|P21|Year 2 (12-Month Extension)|patient was out of windows|0
2734552|NCT00112437|9397206|P20|Year 2 (12-Month Extension)|patient was out of windows|0
2734553|NCT00112437|9397207|P19|Year 2 (12-Month Extension)|patient was out of windows|0
2734554|NCT00112437|9397208|P18|Year 2 (12-Month Extension)|patient was out of windows|0
2734555|NCT00112437|9397209|P17|Year 2 (12-Month Extension)|patient was out of windows|0
2734556|NCT00112437|9397210|P16|Year 2 (12-Month Extension)|patient was out of windows|0
2734557|NCT00112437|9397211|P15|Year 2 (12-Month Extension)|patient was out of windows|0
2734558|NCT00112437|9397212|P14|Year 2 (12-Month Extension)|patient was out of windows|0
2734559|NCT00112437|9397213|P13|Year 2 (12-Month Extension)|patient was out of windows|0
2734560|NCT00112437|9397214|P12|Year 2 (12-Month Extension)|patient was out of windows|0
2734561|NCT00112437|9397215|P11|Year 2 (12-Month Extension)|patient was out of windows|0
2734562|NCT00112437|9397216|P10|Year 2 (12-Month Extension)|patient was out of windows|1
2734563|NCT00112437|9397217|P9|Year 2 (12-Month Extension)|patient was out of windows|0
2734564|NCT00112437|9397218|P8|Year 2 (12-Month Extension)|patient was out of windows|0
2734565|NCT00112437|9397219|P7|Year 2 (12-Month Extension)|patient was out of windows|0
2734566|NCT00112437|9397220|P6|Year 2 (12-Month Extension)|patient was out of windows|0
2734567|NCT00112437|9397221|P5|Year 2 (12-Month Extension)|patient was out of windows|0
2734568|NCT00112437|9397222|P4|Year 2 (12-Month Extension)|patient was out of windows|0
2734569|NCT00112437|9397223|P3|Year 2 (12-Month Extension)|patient was out of windows|0
2734570|NCT00112437|9397224|P2|Year 2 (12-Month Extension)|patient was out of windows|0
2734571|NCT00112437|9397225|P1|Year 2 (12-Month Extension)|patient was out of windows|0
2734572|NCT00112437|9397200|P26|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2734573|NCT00112437|9397201|P25|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2734574|NCT00112437|9397202|P24|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2734575|NCT00112437|9397203|P23|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2734576|NCT00112437|9397204|P22|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2734577|NCT00112437|9397205|P21|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2734578|NCT00112437|9397206|P20|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2734579|NCT00112437|9397207|P19|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2734580|NCT00112437|9397208|P18|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2734581|NCT00112437|9397209|P17|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2734582|NCT00112437|9397210|P16|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2734583|NCT00112437|9397211|P15|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2734584|NCT00112437|9397212|P14|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2734585|NCT00112437|9397213|P13|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2734586|NCT00112437|9397214|P12|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2734587|NCT00112437|9397215|P11|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2734588|NCT00112437|9397216|P10|Year 2 (12-Month Extension)|Patient stopped taking medication|1
2734589|NCT00112437|9397217|P9|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2734590|NCT00112437|9397218|P8|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2734591|NCT00112437|9397219|P7|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2734592|NCT00112437|9397220|P6|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2734593|NCT00112437|9397221|P5|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2734594|NCT00112437|9397222|P4|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2734595|NCT00112437|9397223|P3|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2734596|NCT00112437|9397224|P2|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2734597|NCT00112437|9397225|P1|Year 2 (12-Month Extension)|Patient stopped taking medication|0
2734598|NCT00112437|9397200|P26|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2734599|NCT00112437|9397201|P25|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2734600|NCT00112437|9397202|P24|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2734601|NCT00112437|9397203|P23|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2734602|NCT00112437|9397204|P22|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2734603|NCT00112437|9397205|P21|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2734604|NCT00112437|9397206|P20|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2734605|NCT00112437|9397207|P19|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2734606|NCT00112437|9397208|P18|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2734607|NCT00112437|9397209|P17|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2734608|NCT00112437|9397210|P16|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2734609|NCT00112437|9397211|P15|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2734610|NCT00112437|9397212|P14|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2734611|NCT00112437|9397213|P13|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2734612|NCT00112437|9397214|P12|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2734613|NCT00112437|9397215|P11|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2734614|NCT00112437|9397216|P10|Year 2 (12-Month Extension)|Withdrawal by Subject|1
2734615|NCT00112437|9397217|P9|Year 2 (12-Month Extension)|Withdrawal by Subject|4
2734616|NCT00112437|9397218|P8|Year 2 (12-Month Extension)|Withdrawal by Subject|2
2734617|NCT00112437|9397219|P7|Year 2 (12-Month Extension)|Withdrawal by Subject|1
2734618|NCT00112437|9397220|P6|Year 2 (12-Month Extension)|Withdrawal by Subject|1
2734619|NCT00112437|9397221|P5|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2734620|NCT00112437|9397222|P4|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2734621|NCT00112437|9397223|P3|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2734622|NCT00112437|9397224|P2|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2734623|NCT00112437|9397225|P1|Year 2 (12-Month Extension)|Withdrawal by Subject|0
2734624|NCT00112437|9397200|P26|Year 2 (12-Month Extension)|Protocol Violation|0
2734625|NCT00112437|9397201|P25|Year 2 (12-Month Extension)|Protocol Violation|0
2734626|NCT00112437|9397202|P24|Year 2 (12-Month Extension)|Protocol Violation|0
2734627|NCT00112437|9397203|P23|Year 2 (12-Month Extension)|Protocol Violation|0
2734628|NCT00112437|9397204|P22|Year 2 (12-Month Extension)|Protocol Violation|0
2734629|NCT00112437|9397205|P21|Year 2 (12-Month Extension)|Protocol Violation|0
2734630|NCT00112437|9397206|P20|Year 2 (12-Month Extension)|Protocol Violation|0
2734631|NCT00112437|9397207|P19|Year 2 (12-Month Extension)|Protocol Violation|0
2734632|NCT00112437|9397208|P18|Year 2 (12-Month Extension)|Protocol Violation|0
2734633|NCT00112437|9397209|P17|Year 2 (12-Month Extension)|Protocol Violation|0
2734634|NCT00112437|9397210|P16|Year 2 (12-Month Extension)|Protocol Violation|0
2734635|NCT00112437|9397211|P15|Year 2 (12-Month Extension)|Protocol Violation|0
2734636|NCT00112437|9397212|P14|Year 2 (12-Month Extension)|Protocol Violation|0
2734637|NCT00112437|9397213|P13|Year 2 (12-Month Extension)|Protocol Violation|0
2734638|NCT00112437|9397214|P12|Year 2 (12-Month Extension)|Protocol Violation|0
2734639|NCT00112437|9397215|P11|Year 2 (12-Month Extension)|Protocol Violation|0
2734640|NCT00112437|9397216|P10|Year 2 (12-Month Extension)|Protocol Violation|0
2734641|NCT00112437|9397217|P9|Year 2 (12-Month Extension)|Protocol Violation|1
2734642|NCT00112437|9397218|P8|Year 2 (12-Month Extension)|Protocol Violation|0
2734643|NCT00112437|9397219|P7|Year 2 (12-Month Extension)|Protocol Violation|0
2734644|NCT00112437|9397220|P6|Year 2 (12-Month Extension)|Protocol Violation|0
2734645|NCT00112437|9397221|P5|Year 2 (12-Month Extension)|Protocol Violation|0
2734646|NCT00112437|9397222|P4|Year 2 (12-Month Extension)|Protocol Violation|0
2734647|NCT00112437|9397223|P3|Year 2 (12-Month Extension)|Protocol Violation|0
2734648|NCT00112437|9397224|P2|Year 2 (12-Month Extension)|Protocol Violation|0
2734649|NCT00112437|9397225|P1|Year 2 (12-Month Extension)|Protocol Violation|0
2734650|NCT00112437|9397200|P26|Year 2 (12-Month Extension)|Lost to Follow-up|0
2734651|NCT00112437|9397201|P25|Year 2 (12-Month Extension)|Lost to Follow-up|0
2734652|NCT00112437|9397202|P24|Year 2 (12-Month Extension)|Lost to Follow-up|0
2734653|NCT00112437|9397203|P23|Year 2 (12-Month Extension)|Lost to Follow-up|0
2734654|NCT00112437|9397204|P22|Year 2 (12-Month Extension)|Lost to Follow-up|0
2734655|NCT00112437|9397205|P21|Year 2 (12-Month Extension)|Lost to Follow-up|0
2734656|NCT00112437|9397206|P20|Year 2 (12-Month Extension)|Lost to Follow-up|0
2734657|NCT00112437|9397207|P19|Year 2 (12-Month Extension)|Lost to Follow-up|0
2734658|NCT00112437|9397208|P18|Year 2 (12-Month Extension)|Lost to Follow-up|0
2734659|NCT00112437|9397209|P17|Year 2 (12-Month Extension)|Lost to Follow-up|0
2734660|NCT00112437|9397210|P16|Year 2 (12-Month Extension)|Lost to Follow-up|0
2734661|NCT00112437|9397211|P15|Year 2 (12-Month Extension)|Lost to Follow-up|0
2734662|NCT00112437|9397212|P14|Year 2 (12-Month Extension)|Lost to Follow-up|0
2734663|NCT00112437|9397213|P13|Year 2 (12-Month Extension)|Lost to Follow-up|0
2734664|NCT00112437|9397214|P12|Year 2 (12-Month Extension)|Lost to Follow-up|0
2734665|NCT00112437|9397215|P11|Year 2 (12-Month Extension)|Lost to Follow-up|0
2734666|NCT00112437|9397216|P10|Year 2 (12-Month Extension)|Lost to Follow-up|0
2734667|NCT00112437|9397217|P9|Year 2 (12-Month Extension)|Lost to Follow-up|1
2734668|NCT00112437|9397218|P8|Year 2 (12-Month Extension)|Lost to Follow-up|0
2734669|NCT00112437|9397219|P7|Year 2 (12-Month Extension)|Lost to Follow-up|0
2734670|NCT00112437|9397220|P6|Year 2 (12-Month Extension)|Lost to Follow-up|0
2734671|NCT00112437|9397221|P5|Year 2 (12-Month Extension)|Lost to Follow-up|0
2734672|NCT00112437|9397222|P4|Year 2 (12-Month Extension)|Lost to Follow-up|0
2734673|NCT00112437|9397223|P3|Year 2 (12-Month Extension)|Lost to Follow-up|0
2734674|NCT00112437|9397224|P2|Year 2 (12-Month Extension)|Lost to Follow-up|0
2734675|NCT00112437|9397225|P1|Year 2 (12-Month Extension)|Lost to Follow-up|0
2734676|NCT00112437|9397200|P26|Year 2 (12-Month Extension)|Lack of Efficacy|0
2734677|NCT00112437|9397201|P25|Year 2 (12-Month Extension)|Lack of Efficacy|0
2734678|NCT00112437|9397202|P24|Year 2 (12-Month Extension)|Lack of Efficacy|0
2734679|NCT00112437|9397203|P23|Year 2 (12-Month Extension)|Lack of Efficacy|0
2734680|NCT00112437|9397204|P22|Year 2 (12-Month Extension)|Lack of Efficacy|0
2734681|NCT00112437|9397205|P21|Year 2 (12-Month Extension)|Lack of Efficacy|0
2734682|NCT00112437|9397206|P20|Year 2 (12-Month Extension)|Lack of Efficacy|0
2734683|NCT00112437|9397207|P19|Year 2 (12-Month Extension)|Lack of Efficacy|0
2734684|NCT00112437|9397208|P18|Year 2 (12-Month Extension)|Lack of Efficacy|0
2734685|NCT00112437|9397209|P17|Year 2 (12-Month Extension)|Lack of Efficacy|0
2734686|NCT00112437|9397210|P16|Year 2 (12-Month Extension)|Lack of Efficacy|0
2734687|NCT00112437|9397211|P15|Year 2 (12-Month Extension)|Lack of Efficacy|0
2734688|NCT00112437|9397212|P14|Year 2 (12-Month Extension)|Lack of Efficacy|0
2734689|NCT00112437|9397213|P13|Year 2 (12-Month Extension)|Lack of Efficacy|0
2734690|NCT00112437|9397214|P12|Year 2 (12-Month Extension)|Lack of Efficacy|0
2734691|NCT00112437|9397215|P11|Year 2 (12-Month Extension)|Lack of Efficacy|0
2734692|NCT00112437|9397216|P10|Year 2 (12-Month Extension)|Lack of Efficacy|2
2734693|NCT00112437|9397217|P9|Year 2 (12-Month Extension)|Lack of Efficacy|0
2734694|NCT00112437|9397218|P8|Year 2 (12-Month Extension)|Lack of Efficacy|0
2734695|NCT00112437|9397219|P7|Year 2 (12-Month Extension)|Lack of Efficacy|6
2734696|NCT00112437|9397220|P6|Year 2 (12-Month Extension)|Lack of Efficacy|1
2734697|NCT00112437|9397221|P5|Year 2 (12-Month Extension)|Lack of Efficacy|0
2734698|NCT00112437|9397222|P4|Year 2 (12-Month Extension)|Lack of Efficacy|0
2734699|NCT00112437|9397223|P3|Year 2 (12-Month Extension)|Lack of Efficacy|0
2734700|NCT00112437|9397224|P2|Year 2 (12-Month Extension)|Lack of Efficacy|0
2734701|NCT00112437|9397225|P1|Year 2 (12-Month Extension)|Lack of Efficacy|0
2734702|NCT00112437|9397200|P26|Year 2 (12-Month Extension)|Adverse Event|0
2734703|NCT00112437|9397201|P25|Year 2 (12-Month Extension)|Adverse Event|0
2734704|NCT00112437|9397202|P24|Year 2 (12-Month Extension)|Adverse Event|0
2734705|NCT00112437|9397203|P23|Year 2 (12-Month Extension)|Adverse Event|0
2734706|NCT00112437|9397204|P22|Year 2 (12-Month Extension)|Adverse Event|0
2734707|NCT00112437|9397205|P21|Year 2 (12-Month Extension)|Adverse Event|0
2734708|NCT00112437|9397206|P20|Year 2 (12-Month Extension)|Adverse Event|0
2734709|NCT00112437|9397207|P19|Year 2 (12-Month Extension)|Adverse Event|0
2734710|NCT00112437|9397208|P18|Year 2 (12-Month Extension)|Adverse Event|0
2734711|NCT00112437|9397209|P17|Year 2 (12-Month Extension)|Adverse Event|0
2734712|NCT00112437|9397210|P16|Year 2 (12-Month Extension)|Adverse Event|0
2734713|NCT00112437|9397211|P15|Year 2 (12-Month Extension)|Adverse Event|0
2734714|NCT00112437|9397212|P14|Year 2 (12-Month Extension)|Adverse Event|0
2734715|NCT00112437|9397213|P13|Year 2 (12-Month Extension)|Adverse Event|0
2734716|NCT00112437|9397214|P12|Year 2 (12-Month Extension)|Adverse Event|0
2734717|NCT00112437|9397215|P11|Year 2 (12-Month Extension)|Adverse Event|0
2734718|NCT00112437|9397216|P10|Year 2 (12-Month Extension)|Adverse Event|7
2734719|NCT00112437|9397217|P9|Year 2 (12-Month Extension)|Adverse Event|1
2734720|NCT00112437|9397218|P8|Year 2 (12-Month Extension)|Adverse Event|6
2734721|NCT00112437|9397219|P7|Year 2 (12-Month Extension)|Adverse Event|2
2734722|NCT00112437|9397220|P6|Year 2 (12-Month Extension)|Adverse Event|1
2734723|NCT00112437|9397221|P5|Year 2 (12-Month Extension)|Adverse Event|0
2734724|NCT00112437|9397222|P4|Year 2 (12-Month Extension)|Adverse Event|0
2734725|NCT00112437|9397223|P3|Year 2 (12-Month Extension)|Adverse Event|0
2734726|NCT00112437|9397224|P2|Year 2 (12-Month Extension)|Adverse Event|0
2734727|NCT00112437|9397225|P1|Year 2 (12-Month Extension)|Adverse Event|0
2734728|NCT00112437|9397200|P26|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2734729|NCT00112437|9397201|P25|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2734730|NCT00112437|9397202|P24|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2734731|NCT00112437|9397203|P23|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2734732|NCT00112437|9397204|P22|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2734733|NCT00112437|9397205|P21|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2734734|NCT00112437|9397206|P20|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2734735|NCT00112437|9397207|P19|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2734736|NCT00112437|9397208|P18|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2734737|NCT00112437|9397209|P17|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2734738|NCT00112437|9397210|P16|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2734739|NCT00112437|9397211|P15|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2734740|NCT00112437|9397212|P14|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2734741|NCT00112437|9397213|P13|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2734742|NCT00112437|9397214|P12|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2734743|NCT00112437|9397215|P11|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2734744|NCT00112437|9397216|P10|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2734745|NCT00112437|9397217|P9|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2734746|NCT00112437|9397218|P8|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2734747|NCT00112437|9397219|P7|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2734748|NCT00112437|9397220|P6|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2734749|NCT00112437|9397221|P5|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1
2734750|NCT00112437|9397222|P4|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2734751|NCT00112437|9397223|P3|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2734752|NCT00112437|9397224|P2|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2734753|NCT00112437|9397225|P1|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
2734754|NCT00112437|9397200|P26|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2734755|NCT00112437|9397201|P25|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2734756|NCT00112437|9397202|P24|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2734757|NCT00112437|9397203|P23|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2734758|NCT00112437|9397204|P22|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2734759|NCT00112437|9397205|P21|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2734760|NCT00112437|9397206|P20|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2734761|NCT00112437|9397207|P19|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2734762|NCT00112437|9397208|P18|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2734763|NCT00112437|9397209|P17|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2734764|NCT00112437|9397210|P16|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2734765|NCT00112437|9397211|P15|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2734766|NCT00112437|9397212|P14|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2734767|NCT00112437|9397213|P13|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2734768|NCT00112437|9397214|P12|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2734769|NCT00112437|9397215|P11|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2734770|NCT00112437|9397216|P10|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2734771|NCT00112437|9397217|P9|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2734772|NCT00112437|9397218|P8|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2734773|NCT00112437|9397219|P7|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2734774|NCT00112437|9397220|P6|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2734775|NCT00112437|9397221|P5|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2734776|NCT00112437|9397222|P4|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2
2734777|NCT00112437|9397223|P3|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2734778|NCT00112437|9397224|P2|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2734779|NCT00112437|9397225|P1|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
2734780|NCT00112437|9397200|P26|Year 1 (12-Month Base Study)|moved|0
2734781|NCT00112437|9397201|P25|Year 1 (12-Month Base Study)|moved|0
2734782|NCT00112437|9397202|P24|Year 1 (12-Month Base Study)|moved|0
2734783|NCT00112437|9397203|P23|Year 1 (12-Month Base Study)|moved|0
2734784|NCT00112437|9397204|P22|Year 1 (12-Month Base Study)|moved|0
2734785|NCT00112437|9397205|P21|Year 1 (12-Month Base Study)|moved|0
2734786|NCT00112437|9397206|P20|Year 1 (12-Month Base Study)|moved|0
2734787|NCT00112437|9397207|P19|Year 1 (12-Month Base Study)|moved|0
2734788|NCT00112437|9397208|P18|Year 1 (12-Month Base Study)|moved|0
2734789|NCT00112437|9397209|P17|Year 1 (12-Month Base Study)|moved|0
2734790|NCT00112437|9397210|P16|Year 1 (12-Month Base Study)|moved|0
2734791|NCT00112437|9397211|P15|Year 1 (12-Month Base Study)|moved|0
2734792|NCT00112437|9397212|P14|Year 1 (12-Month Base Study)|moved|0
2734793|NCT00112437|9397213|P13|Year 1 (12-Month Base Study)|moved|0
2734794|NCT00112437|9397214|P12|Year 1 (12-Month Base Study)|moved|0
2734795|NCT00112437|9397215|P11|Year 1 (12-Month Base Study)|moved|0
2734796|NCT00112437|9397216|P10|Year 1 (12-Month Base Study)|moved|0
2734797|NCT00112437|9397217|P9|Year 1 (12-Month Base Study)|moved|0
2734798|NCT00112437|9397218|P8|Year 1 (12-Month Base Study)|moved|0
2734799|NCT00112437|9397219|P7|Year 1 (12-Month Base Study)|moved|0
2734800|NCT00112437|9397220|P6|Year 1 (12-Month Base Study)|moved|0
2734801|NCT00112437|9397221|P5|Year 1 (12-Month Base Study)|moved|0
2734802|NCT00112437|9397222|P4|Year 1 (12-Month Base Study)|moved|0
2734803|NCT00112437|9397223|P3|Year 1 (12-Month Base Study)|moved|1
2734804|NCT00112437|9397224|P2|Year 1 (12-Month Base Study)|moved|1
2734805|NCT00112437|9397225|P1|Year 1 (12-Month Base Study)|moved|0
2734806|NCT00112437|9397200|P26|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2734807|NCT00112437|9397201|P25|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2734808|NCT00112437|9397202|P24|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2734809|NCT00112437|9397203|P23|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2734810|NCT00112437|9397204|P22|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2734811|NCT00112437|9397205|P21|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2734812|NCT00112437|9397206|P20|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2734813|NCT00112437|9397207|P19|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2734814|NCT00112437|9397208|P18|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2734815|NCT00112437|9397209|P17|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2734816|NCT00112437|9397210|P16|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2734817|NCT00112437|9397211|P15|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2734818|NCT00112437|9397212|P14|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2734819|NCT00112437|9397213|P13|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2734820|NCT00112437|9397214|P12|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2734821|NCT00112437|9397215|P11|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2734822|NCT00112437|9397216|P10|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2734823|NCT00112437|9397217|P9|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2734824|NCT00112437|9397218|P8|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2734825|NCT00112437|9397219|P7|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2734826|NCT00112437|9397220|P6|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
2734827|NCT00112437|9397221|P5|Year 1 (12-Month Base Study)|Withdrawal by Subject|7
2734828|NCT00112437|9397222|P4|Year 1 (12-Month Base Study)|Withdrawal by Subject|1
2734829|NCT00112437|9397223|P3|Year 1 (12-Month Base Study)|Withdrawal by Subject|2
2734830|NCT00112437|9397224|P2|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
2734831|NCT00112437|9397225|P1|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
2734832|NCT00112437|9397200|P26|Year 1 (12-Month Base Study)|Protocol Violation|0
2734833|NCT00112437|9397201|P25|Year 1 (12-Month Base Study)|Protocol Violation|0
2734834|NCT00112437|9397202|P24|Year 1 (12-Month Base Study)|Protocol Violation|0
2734835|NCT00112437|9397203|P23|Year 1 (12-Month Base Study)|Protocol Violation|0
2734836|NCT00112437|9397204|P22|Year 1 (12-Month Base Study)|Protocol Violation|0
2734837|NCT00112437|9397205|P21|Year 1 (12-Month Base Study)|Protocol Violation|0
2734838|NCT00112437|9397206|P20|Year 1 (12-Month Base Study)|Protocol Violation|0
2734839|NCT00112437|9397207|P19|Year 1 (12-Month Base Study)|Protocol Violation|0
2734840|NCT00112437|9397208|P18|Year 1 (12-Month Base Study)|Protocol Violation|0
2734841|NCT00112437|9397209|P17|Year 1 (12-Month Base Study)|Protocol Violation|0
2734842|NCT00112437|9397210|P16|Year 1 (12-Month Base Study)|Protocol Violation|0
2734843|NCT00112437|9397211|P15|Year 1 (12-Month Base Study)|Protocol Violation|0
2734844|NCT00112437|9397212|P14|Year 1 (12-Month Base Study)|Protocol Violation|0
2734845|NCT00112437|9397213|P13|Year 1 (12-Month Base Study)|Protocol Violation|0
2734846|NCT00112437|9397214|P12|Year 1 (12-Month Base Study)|Protocol Violation|0
2734847|NCT00112437|9397215|P11|Year 1 (12-Month Base Study)|Protocol Violation|0
2734848|NCT00112437|9397216|P10|Year 1 (12-Month Base Study)|Protocol Violation|0
2734849|NCT00112437|9397217|P9|Year 1 (12-Month Base Study)|Protocol Violation|0
2734850|NCT00112437|9397218|P8|Year 1 (12-Month Base Study)|Protocol Violation|0
2734851|NCT00112437|9397219|P7|Year 1 (12-Month Base Study)|Protocol Violation|0
2734852|NCT00112437|9397220|P6|Year 1 (12-Month Base Study)|Protocol Violation|0
2734853|NCT00112437|9397221|P5|Year 1 (12-Month Base Study)|Protocol Violation|1
2734854|NCT00112437|9397222|P4|Year 1 (12-Month Base Study)|Protocol Violation|1
2734855|NCT00112437|9397223|P3|Year 1 (12-Month Base Study)|Protocol Violation|3
2734856|NCT00112437|9397224|P2|Year 1 (12-Month Base Study)|Protocol Violation|0
2734857|NCT00112437|9397225|P1|Year 1 (12-Month Base Study)|Protocol Violation|1
2734858|NCT00112437|9397200|P26|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2734859|NCT00112437|9397201|P25|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2734860|NCT00112437|9397202|P24|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2734861|NCT00112437|9397203|P23|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2734862|NCT00112437|9397204|P22|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2734863|NCT00112437|9397205|P21|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2734864|NCT00112437|9397206|P20|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2734865|NCT00112437|9397207|P19|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2734866|NCT00112437|9397208|P18|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2734867|NCT00112437|9397209|P17|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2734868|NCT00112437|9397210|P16|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2734869|NCT00112437|9397211|P15|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2734870|NCT00112437|9397212|P14|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2734871|NCT00112437|9397213|P13|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2734872|NCT00112437|9397214|P12|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2734873|NCT00112437|9397215|P11|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2734874|NCT00112437|9397216|P10|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2734875|NCT00112437|9397217|P9|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2734876|NCT00112437|9397218|P8|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2734877|NCT00112437|9397219|P7|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2734878|NCT00112437|9397220|P6|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2734879|NCT00112437|9397221|P5|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2734880|NCT00112437|9397222|P4|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2734881|NCT00112437|9397223|P3|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2734882|NCT00112437|9397224|P2|Year 1 (12-Month Base Study)|Lost to Follow-up|1
2734883|NCT00112437|9397225|P1|Year 1 (12-Month Base Study)|Lost to Follow-up|0
2734884|NCT00112437|9397200|P26|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2734885|NCT00112437|9397201|P25|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2734886|NCT00112437|9397202|P24|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2734887|NCT00112437|9397203|P23|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2734888|NCT00112437|9397204|P22|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2734889|NCT00112437|9397205|P21|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2734890|NCT00112437|9397206|P20|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2734891|NCT00112437|9397207|P19|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2734892|NCT00112437|9397208|P18|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2734893|NCT00112437|9397209|P17|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2734894|NCT00112437|9397210|P16|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2734895|NCT00112437|9397211|P15|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2734896|NCT00112437|9397212|P14|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2734897|NCT00112437|9397213|P13|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2734898|NCT00112437|9397214|P12|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2734899|NCT00112437|9397215|P11|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2734900|NCT00112437|9397216|P10|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2734901|NCT00112437|9397217|P9|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2734902|NCT00112437|9397218|P8|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2734903|NCT00112437|9397219|P7|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2734904|NCT00112437|9397220|P6|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2734905|NCT00112437|9397221|P5|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2734906|NCT00112437|9397222|P4|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2734907|NCT00112437|9397223|P3|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2734908|NCT00112437|9397224|P2|Year 1 (12-Month Base Study)|Lack of Efficacy|1
2734909|NCT00112437|9397225|P1|Year 1 (12-Month Base Study)|Lack of Efficacy|0
2734910|NCT00112437|9397200|P26|Year 1 (12-Month Base Study)|Adverse Event|0
2734911|NCT00112437|9397201|P25|Year 1 (12-Month Base Study)|Adverse Event|0
2734912|NCT00112437|9397202|P24|Year 1 (12-Month Base Study)|Adverse Event|0
2734913|NCT00112437|9397203|P23|Year 1 (12-Month Base Study)|Adverse Event|0
2734914|NCT00112437|9397204|P22|Year 1 (12-Month Base Study)|Adverse Event|0
2734915|NCT00112437|9397205|P21|Year 1 (12-Month Base Study)|Adverse Event|0
2734916|NCT00112437|9397206|P20|Year 1 (12-Month Base Study)|Adverse Event|0
2734917|NCT00112437|9397207|P19|Year 1 (12-Month Base Study)|Adverse Event|0
2734918|NCT00112437|9397208|P18|Year 1 (12-Month Base Study)|Adverse Event|0
2734919|NCT00112437|9397209|P17|Year 1 (12-Month Base Study)|Adverse Event|0
2734920|NCT00112437|9397210|P16|Year 1 (12-Month Base Study)|Adverse Event|0
2734921|NCT00112437|9397211|P15|Year 1 (12-Month Base Study)|Adverse Event|0
2734922|NCT00112437|9397212|P14|Year 1 (12-Month Base Study)|Adverse Event|0
2734923|NCT00112437|9397213|P13|Year 1 (12-Month Base Study)|Adverse Event|0
2734924|NCT00112437|9397214|P12|Year 1 (12-Month Base Study)|Adverse Event|0
2734925|NCT00112437|9397215|P11|Year 1 (12-Month Base Study)|Adverse Event|0
2734926|NCT00112437|9397216|P10|Year 1 (12-Month Base Study)|Adverse Event|0
2734927|NCT00112437|9397217|P9|Year 1 (12-Month Base Study)|Adverse Event|0
2734928|NCT00112437|9397218|P8|Year 1 (12-Month Base Study)|Adverse Event|0
2734929|NCT00112437|9397219|P7|Year 1 (12-Month Base Study)|Adverse Event|0
2734930|NCT00112437|9397220|P6|Year 1 (12-Month Base Study)|Adverse Event|0
2734931|NCT00112437|9397221|P5|Year 1 (12-Month Base Study)|Adverse Event|3
2734932|NCT00112437|9397222|P4|Year 1 (12-Month Base Study)|Adverse Event|4
2734933|NCT00112437|9397223|P3|Year 1 (12-Month Base Study)|Adverse Event|6
2734934|NCT00112437|9397224|P2|Year 1 (12-Month Base Study)|Adverse Event|10
2734935|NCT00112437|9397225|P1|Year 1 (12-Month Base Study)|Adverse Event|9
2734936|NCT00112385|9397505|P2|Overall Study|Withdrawal by Subject|1
2734937|NCT00112385|9397506|P1|Overall Study|Withdrawal by Subject|0
2734938|NCT00112385|9397505|P2|Overall Study|Lost to Follow-up|0
2734939|NCT00112385|9397506|P1|Overall Study|Lost to Follow-up|1
2734940|NCT00112359|9397596|P2|Overall Study|Other|0
2734941|NCT00112359|9397597|P1|Overall Study|Other|3
2734942|NCT00112359|9397596|P2|Overall Study|Personal/administrative|1
2734943|NCT00112359|9397597|P1|Overall Study|Personal/administrative|1
2734944|NCT00112359|9397596|P2|Overall Study|Lost to Follow-up|1
2734945|NCT00112359|9397597|P1|Overall Study|Lost to Follow-up|0
2734946|NCT00112359|9397596|P2|Overall Study|Related adverse event|3
2734947|NCT00112359|9397597|P1|Overall Study|Related adverse event|5
2734948|NCT00112359|9397596|P2|Overall Study|Trial drug intolerance (adverse event)|0
2734949|NCT00112359|9397597|P1|Overall Study|Trial drug intolerance (adverse event)|2
2734950|NCT00112359|9397596|P2|Overall Study|Unrelated adverse event|8
2734951|NCT00112359|9397597|P1|Overall Study|Unrelated adverse event|16
2734952|NCT00112294|9397623|P2|Overall Study|Still on study|0
2734953|NCT00112294|9397624|P1|Overall Study|Still on study|5
2734954|NCT00112047|9397847|P2|Atripla Phase|Other|1
2734955|NCT00112047|9397848|P1|Atripla Phase|Other|3
2734956|NCT00112047|9397847|P2|Atripla Phase|Non-compliance|0
2734957|NCT00112047|9397848|P1|Atripla Phase|Non-compliance|1
2734958|NCT00112047|9397847|P2|Atripla Phase|Sub-optimal virological response|1
2734959|NCT00112047|9397848|P1|Atripla Phase|Sub-optimal virological response|0
2734960|NCT00112047|9397847|P2|Atripla Phase|Withdrew consent|7
2734961|NCT00112047|9397848|P1|Atripla Phase|Withdrew consent|7
2734962|NCT00112047|9397847|P2|Atripla Phase|Death|2
2734963|NCT00112047|9397848|P1|Atripla Phase|Death|0
2734964|NCT00112047|9397847|P2|Atripla Phase|Pregnancy|1
2734965|NCT00112047|9397848|P1|Atripla Phase|Pregnancy|0
2734966|NCT00112047|9397847|P2|Atripla Phase|Lost to Follow-up|7
2734967|NCT00112047|9397848|P1|Atripla Phase|Lost to Follow-up|5
2734968|NCT00112047|9397847|P2|Atripla Phase|Adverse Event|1
2734969|NCT00112047|9397848|P1|Atripla Phase|Adverse Event|2
2734970|NCT00112047|9397847|P2|Randomized Phase|High Hepatitis B DNA|1
2734971|NCT00112047|9397848|P1|Randomized Phase|High Hepatitis B DNA|0
2734972|NCT00112047|9397847|P2|Randomized Phase|Baseline NNRTI resistance mutations|0
2734973|NCT00112047|9397848|P1|Randomized Phase|Baseline NNRTI resistance mutations|4
2734974|NCT00112047|9397847|P2|Randomized Phase|Moved out of State|1
2734975|NCT00112047|9397848|P1|Randomized Phase|Moved out of State|0
2734976|NCT00112047|9397847|P2|Randomized Phase|Incarceration|2
2734977|NCT00112047|9397848|P1|Randomized Phase|Incarceration|3
2734978|NCT00112047|9397847|P2|Randomized Phase|Inability to swallow pills|1
2734979|NCT00112047|9397848|P1|Randomized Phase|Inability to swallow pills|0
2734980|NCT00112047|9397847|P2|Randomized Phase|Hepatitis C treatment contraindicated|1
2734981|NCT00112047|9397848|P1|Randomized Phase|Hepatitis C treatment contraindicated|0
2734982|NCT00112047|9397847|P2|Randomized Phase|Death|3
2734983|NCT00112047|9397848|P1|Randomized Phase|Death|1
2734984|NCT00112047|9397847|P2|Randomized Phase|Pregnancy|1
2734985|NCT00112047|9397848|P1|Randomized Phase|Pregnancy|3
2734986|NCT00112047|9397847|P2|Randomized Phase|Protocol Violation|0
2734987|NCT00112047|9397848|P1|Randomized Phase|Protocol Violation|2
2734988|NCT00112047|9397847|P2|Randomized Phase|Noncompliance|4
2734989|NCT00112047|9397848|P1|Randomized Phase|Noncompliance|8
2734990|NCT00112047|9397847|P2|Randomized Phase|Sub-optimal virological response|13
2734991|NCT00112047|9397848|P1|Randomized Phase|Sub-optimal virological response|3
2734992|NCT00112047|9397847|P2|Randomized Phase|Withrawal of consent|18
2734993|NCT00112047|9397848|P1|Randomized Phase|Withrawal of consent|10
2734994|NCT00112047|9397847|P2|Randomized Phase|Adverse Event|10
2734995|NCT00112047|9397848|P1|Randomized Phase|Adverse Event|10
2734996|NCT00112047|9397847|P2|Randomized Phase|Lost to Follow-up|33
2734997|NCT00112047|9397848|P1|Randomized Phase|Lost to Follow-up|26
2734998|NCT00111917|9397948|P2|Overall Study|Withdrawal by Subject|1
2734999|NCT00111917|9397949|P1|Overall Study|Withdrawal by Subject|1
2735000|NCT00111839|9397964|P3|Overall Study|Randomized but Not Treated|2
2735001|NCT00111839|9397965|P2|Overall Study|Randomized but Not Treated|0
2735002|NCT00111839|9397966|P1|Overall Study|Randomized but Not Treated|0
2735003|NCT00111839|9397964|P3|Overall Study|Other|3
2735004|NCT00111839|9397965|P2|Overall Study|Other|3
2735005|NCT00111839|9397966|P1|Overall Study|Other|6
2735006|NCT00111839|9397964|P3|Overall Study|Logistical Constraint|0
2735007|NCT00111839|9397965|P2|Overall Study|Logistical Constraint|0
2735008|NCT00111839|9397966|P1|Overall Study|Logistical Constraint|1
2735009|NCT00111839|9397964|P3|Overall Study|Lost to Follow-up|0
2735010|NCT00111839|9397965|P2|Overall Study|Lost to Follow-up|0
2735011|NCT00111839|9397966|P1|Overall Study|Lost to Follow-up|1
2735012|NCT00111839|9397964|P3|Overall Study|Withdrawal by Subject|2
2735013|NCT00111839|9397965|P2|Overall Study|Withdrawal by Subject|2
2735014|NCT00111839|9397966|P1|Overall Study|Withdrawal by Subject|2
2735015|NCT00111839|9397964|P3|Overall Study|Death|6
2735016|NCT00111839|9397965|P2|Overall Study|Death|1
2735017|NCT00111839|9397966|P1|Overall Study|Death|1
2735018|NCT00111839|9397964|P3|Overall Study|Protocol Violation|2
2735019|NCT00111839|9397965|P2|Overall Study|Protocol Violation|4
2735020|NCT00111839|9397966|P1|Overall Study|Protocol Violation|2
2735021|NCT00111839|9397964|P3|Overall Study|Adverse Event|1
2735022|NCT00111839|9397965|P2|Overall Study|Adverse Event|3
2735023|NCT00111839|9397966|P1|Overall Study|Adverse Event|5
2735024|NCT00111839|9397964|P3|Overall Study|Disease Progression|33
2735025|NCT00111839|9397965|P2|Overall Study|Disease Progression|33
2735026|NCT00111839|9397966|P1|Overall Study|Disease Progression|30
2735027|NCT00111813|9397986|P6|Overall Study|Other|0
2735028|NCT00111813|9397987|P5|Overall Study|Other|0
2735029|NCT00111813|9397988|P4|Overall Study|Other|0
2735030|NCT00111813|9397989|P3|Overall Study|Other|1
2735031|NCT00111813|9397990|P2|Overall Study|Other|0
2735032|NCT00111813|9397991|P1|Overall Study|Other|0
2735033|NCT00111813|9397986|P6|Overall Study|Lack of Efficacy|1
2735034|NCT00111813|9397987|P5|Overall Study|Lack of Efficacy|0
2735035|NCT00111813|9397988|P4|Overall Study|Lack of Efficacy|0
2735036|NCT00111813|9397989|P3|Overall Study|Lack of Efficacy|0
2735037|NCT00111813|9397990|P2|Overall Study|Lack of Efficacy|0
2735038|NCT00111813|9397991|P1|Overall Study|Lack of Efficacy|0
2735039|NCT00111813|9397986|P6|Overall Study|Progressive disease|3
2735040|NCT00111813|9397987|P5|Overall Study|Progressive disease|4
2735041|NCT00111813|9397988|P4|Overall Study|Progressive disease|3
2735042|NCT00111813|9397989|P3|Overall Study|Progressive disease|5
2735043|NCT00111813|9397990|P2|Overall Study|Progressive disease|1
2735044|NCT00111813|9397991|P1|Overall Study|Progressive disease|2
2735045|NCT00111813|9397986|P6|Overall Study|Adverse Event|2
2735046|NCT00111813|9397987|P5|Overall Study|Adverse Event|2
2735047|NCT00111813|9397988|P4|Overall Study|Adverse Event|2
2735048|NCT00111813|9397989|P3|Overall Study|Adverse Event|4
2735049|NCT00111813|9397990|P2|Overall Study|Adverse Event|2
2735050|NCT00111813|9397991|P1|Overall Study|Adverse Event|1
2735051|NCT00111800|9398030|P6|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
2735052|NCT00111800|9398031|P5|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
2735053|NCT00111800|9398032|P4|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
2735054|NCT00111800|9398033|P3|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1
2735055|NCT00111800|9398034|P2|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
2735056|NCT00111800|9398035|P1|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
2735057|NCT00111800|9398030|P6|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
2735058|NCT00111800|9398031|P5|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
2735059|NCT00111800|9398032|P4|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
2735060|NCT00111800|9398033|P3|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1
2735061|NCT00111800|9398034|P2|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
2735062|NCT00111800|9398035|P1|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
2735063|NCT00111800|9398030|P6|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
2735064|NCT00111800|9398031|P5|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
2735065|NCT00111800|9398032|P4|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
2735066|NCT00111800|9398033|P3|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
2735067|NCT00111800|9398034|P2|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1
2735068|NCT00111800|9398035|P1|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
2735069|NCT00111800|9398030|P6|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
2735070|NCT00111800|9398031|P5|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
2735071|NCT00111800|9398032|P4|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
2735072|NCT00111800|9398033|P3|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0
2735073|NCT00111800|9398034|P2|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
2735074|NCT00111800|9398035|P1|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
2735075|NCT00111800|9398030|P6|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
2735076|NCT00111800|9398031|P5|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
2735077|NCT00111800|9398032|P4|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
2735078|NCT00111800|9398033|P3|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
2735079|NCT00111800|9398034|P2|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
2735080|NCT00111800|9398035|P1|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
2735081|NCT00111800|9398030|P6|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
2735082|NCT00111800|9398031|P5|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3
2735083|NCT00111800|9398032|P4|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
2735084|NCT00111800|9398033|P3|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
2735227|NCT00111475|9398243|P10|Overall Study|Lost to Follow-up|0
2735085|NCT00111800|9398034|P2|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
2735086|NCT00111800|9398035|P1|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
2735087|NCT00111800|9398030|P6|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
2735088|NCT00111800|9398031|P5|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
2735089|NCT00111800|9398032|P4|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
2735090|NCT00111800|9398033|P3|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
2735091|NCT00111800|9398034|P2|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
2735092|NCT00111800|9398035|P1|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
2735093|NCT00111800|9398030|P6|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
2735094|NCT00111800|9398031|P5|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
2735095|NCT00111800|9398032|P4|Period 2: Extension Phase (12 Weeks)|Adverse Event|3
2735096|NCT00111800|9398033|P3|Period 2: Extension Phase (12 Weeks)|Adverse Event|1
2735097|NCT00111800|9398034|P2|Period 2: Extension Phase (12 Weeks)|Adverse Event|2
2735098|NCT00111800|9398035|P1|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
2735099|NCT00111800|9398030|P6|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1
2735100|NCT00111800|9398031|P5|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
2735101|NCT00111800|9398032|P4|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
2735102|NCT00111800|9398033|P3|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
2735103|NCT00111800|9398034|P2|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
2735104|NCT00111800|9398035|P1|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
2735105|NCT00111800|9398030|P6|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
2735106|NCT00111800|9398031|P5|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1
2735107|NCT00111800|9398032|P4|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
2735108|NCT00111800|9398033|P3|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
2735109|NCT00111800|9398034|P2|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
2735110|NCT00111800|9398035|P1|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
2735111|NCT00111800|9398030|P6|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
2735112|NCT00111800|9398031|P5|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1
2735113|NCT00111800|9398032|P4|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
2735114|NCT00111800|9398033|P3|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
2735115|NCT00111800|9398034|P2|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
2735116|NCT00111800|9398035|P1|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
2735117|NCT00111800|9398030|P6|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
2735118|NCT00111800|9398031|P5|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
2735119|NCT00111800|9398032|P4|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1
2735120|NCT00111800|9398033|P3|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
2735121|NCT00111800|9398034|P2|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
2735122|NCT00111800|9398035|P1|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
2735123|NCT00111800|9398030|P6|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
2735124|NCT00111800|9398031|P5|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
2735125|NCT00111800|9398032|P4|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1
2735126|NCT00111800|9398033|P3|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
2735127|NCT00111800|9398034|P2|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
2735128|NCT00111800|9398035|P1|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
2735129|NCT00111800|9398030|P6|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
2735130|NCT00111800|9398031|P5|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
2735131|NCT00111800|9398032|P4|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
2735132|NCT00111800|9398033|P3|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
2735133|NCT00111800|9398034|P2|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1
2735134|NCT00111800|9398035|P1|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
2735135|NCT00111800|9398030|P6|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
2735136|NCT00111800|9398031|P5|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
2735137|NCT00111800|9398032|P4|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
2735138|NCT00111800|9398033|P3|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
2735139|NCT00111800|9398034|P2|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1
2735140|NCT00111800|9398035|P1|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
2735141|NCT00111800|9398030|P6|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
2735142|NCT00111800|9398031|P5|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
2735143|NCT00111800|9398032|P4|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
2735144|NCT00111800|9398033|P3|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
2735145|NCT00111800|9398034|P2|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1
2735146|NCT00111800|9398035|P1|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
2735147|NCT00111800|9398030|P6|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
2735148|NCT00111800|9398031|P5|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
2735149|NCT00111800|9398032|P4|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
2735150|NCT00111800|9398033|P3|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
2735228|NCT00111475|9398244|P9|Overall Study|Lost to Follow-up|0
2735151|NCT00111800|9398034|P2|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1
2735152|NCT00111800|9398035|P1|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
2735153|NCT00111800|9398030|P6|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
2735154|NCT00111800|9398031|P5|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
2735155|NCT00111800|9398032|P4|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
2735156|NCT00111800|9398033|P3|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
2735157|NCT00111800|9398034|P2|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
2735158|NCT00111800|9398035|P1|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1
2735159|NCT00111800|9398030|P6|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
2735160|NCT00111800|9398031|P5|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
2735161|NCT00111800|9398032|P4|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
2735162|NCT00111800|9398033|P3|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
2735163|NCT00111800|9398034|P2|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
2735164|NCT00111800|9398035|P1|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
2735165|NCT00111800|9398030|P6|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
2735166|NCT00111800|9398031|P5|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
2735167|NCT00111800|9398032|P4|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
2735168|NCT00111800|9398033|P3|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
2735169|NCT00111800|9398034|P2|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
2735170|NCT00111800|9398035|P1|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
2735171|NCT00111800|9398030|P6|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
2735172|NCT00111800|9398031|P5|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
2735173|NCT00111800|9398032|P4|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
2735174|NCT00111800|9398033|P3|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
2735175|NCT00111800|9398034|P2|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
2735176|NCT00111800|9398035|P1|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
2735177|NCT00111800|9398030|P6|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
2735178|NCT00111800|9398031|P5|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
2735179|NCT00111800|9398032|P4|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1
2735180|NCT00111800|9398033|P3|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
2735181|NCT00111800|9398034|P2|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
2735182|NCT00111800|9398035|P1|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3
2735183|NCT00111800|9398030|P6|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1
2735184|NCT00111800|9398031|P5|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
2735185|NCT00111800|9398032|P4|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
2735186|NCT00111800|9398033|P3|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3
2735187|NCT00111800|9398034|P2|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
2735188|NCT00111800|9398035|P1|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
2735189|NCT00111800|9398030|P6|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
2735190|NCT00111800|9398031|P5|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
2735191|NCT00111800|9398032|P4|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
2735192|NCT00111800|9398033|P3|Period 1: Main Phase (12 Weeks)|Protocol Violation|4
2735193|NCT00111800|9398034|P2|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
2735194|NCT00111800|9398035|P1|Period 1: Main Phase (12 Weeks)|Protocol Violation|0
2735195|NCT00111800|9398030|P6|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
2735196|NCT00111800|9398031|P5|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
2735197|NCT00111800|9398032|P4|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
2735198|NCT00111800|9398033|P3|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
2735199|NCT00111800|9398034|P2|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
2735200|NCT00111800|9398035|P1|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1
2735201|NCT00111800|9398030|P6|Period 1: Main Phase (12 Weeks)|Adverse Event|0
2735202|NCT00111800|9398031|P5|Period 1: Main Phase (12 Weeks)|Adverse Event|1
2735203|NCT00111800|9398032|P4|Period 1: Main Phase (12 Weeks)|Adverse Event|0
2735204|NCT00111800|9398033|P3|Period 1: Main Phase (12 Weeks)|Adverse Event|0
2735205|NCT00111800|9398034|P2|Period 1: Main Phase (12 Weeks)|Adverse Event|4
2735206|NCT00111800|9398035|P1|Period 1: Main Phase (12 Weeks)|Adverse Event|5
2735207|NCT00111761|9398205|P2|Part 2|Other|0
2735208|NCT00111761|9398206|P1|Part 2|Other|1
2735209|NCT00111761|9398205|P2|Part 2|Protocol-specified criteria|0
2735210|NCT00111761|9398206|P1|Part 2|Protocol-specified criteria|1
2735211|NCT00111761|9398205|P2|Part 2|Disease progression|0
2735212|NCT00111761|9398206|P1|Part 2|Disease progression|3
2735213|NCT00111761|9398205|P2|Part 2|Death|0
2735214|NCT00111761|9398206|P1|Part 2|Death|1
2735215|NCT00111761|9398205|P2|Part 2|Physician Decision|0
2735216|NCT00111761|9398206|P1|Part 2|Physician Decision|1
2735217|NCT00111761|9398205|P2|Part 2|Adverse Event|0
2735218|NCT00111761|9398206|P1|Part 2|Adverse Event|1
2735219|NCT00111761|9398205|P2|Part 1|Withdrawal by Subject|1
2735220|NCT00111761|9398206|P1|Part 1|Withdrawal by Subject|0
2735221|NCT00111761|9398205|P2|Part 1|Other|1
2735222|NCT00111761|9398206|P1|Part 1|Other|0
2735223|NCT00111761|9398205|P2|Part 1|Death|2
2735224|NCT00111761|9398206|P1|Part 1|Death|0
2735225|NCT00111761|9398205|P2|Part 1|Physician Decision|1
2735226|NCT00111761|9398206|P1|Part 1|Physician Decision|0
2735229|NCT00111475|9398245|P8|Overall Study|Lost to Follow-up|0
2735230|NCT00111475|9398246|P7|Overall Study|Lost to Follow-up|0
2735231|NCT00111475|9398247|P6|Overall Study|Lost to Follow-up|1
2735232|NCT00111475|9398248|P5|Overall Study|Lost to Follow-up|0
2735233|NCT00111475|9398249|P4|Overall Study|Lost to Follow-up|0
2735234|NCT00111475|9398250|P3|Overall Study|Lost to Follow-up|0
2735235|NCT00111475|9398251|P2|Overall Study|Lost to Follow-up|0
2735236|NCT00111475|9398252|P1|Overall Study|Lost to Follow-up|0
2735237|NCT00111241|9398370|P2|Overall Study|Adverse Event|0
2735238|NCT00111241|9398371|P1|Overall Study|Adverse Event|1
2735239|NCT00111241|9398370|P2|Overall Study|Protocol Violation|8
2735240|NCT00111241|9398371|P1|Overall Study|Protocol Violation|9
2735241|NCT00111241|9398370|P2|Overall Study|Withdrawal by Subject|0
2735242|NCT00111241|9398371|P1|Overall Study|Withdrawal by Subject|4
2735243|NCT00111241|9398370|P2|Overall Study|Lost to Follow-up|0
2735244|NCT00111241|9398371|P1|Overall Study|Lost to Follow-up|1
2735245|NCT00111228|9398382|P3|Overall Study|Withdrawal by Subject|0
2735246|NCT00111228|9398383|P2|Overall Study|Withdrawal by Subject|1
2735247|NCT00111228|9398384|P1|Overall Study|Withdrawal by Subject|5
2735248|NCT00111007|9398397|P2|Long Term Follow-up|Missing|3
2735249|NCT00111007|9398398|P1|Long Term Follow-up|Missing|10
2735250|NCT00111007|9398397|P2|Long Term Follow-up|Disease progression/recurrence/relapse|1
2735251|NCT00111007|9398398|P1|Long Term Follow-up|Disease progression/recurrence/relapse|2
2735252|NCT00111007|9398397|P2|Long Term Follow-up|Withdrawal by Subject|1
2735253|NCT00111007|9398398|P1|Long Term Follow-up|Withdrawal by Subject|0
2735254|NCT00111007|9398397|P2|Long Term Follow-up|Lost to Follow-up|1
2735255|NCT00111007|9398398|P1|Long Term Follow-up|Lost to Follow-up|1
2735256|NCT00111007|9398397|P2|Long Term Follow-up|Death|39
2735257|NCT00111007|9398398|P1|Long Term Follow-up|Death|34
2735258|NCT00111007|9398397|P2|Active Follow-up|Disease progression/recurrence/relapse|2
2735259|NCT00111007|9398398|P1|Active Follow-up|Disease progression/recurrence/relapse|3
2735260|NCT00111007|9398397|P2|Active Follow-up|Death|0
2735261|NCT00111007|9398398|P1|Active Follow-up|Death|2
2735262|NCT00111007|9398397|P2|Active Follow-up|Adverse Event|0
2735263|NCT00111007|9398398|P1|Active Follow-up|Adverse Event|1
2735264|NCT00111007|9398397|P2|Double-blind (DB) Treatment|Primary reason with other category|1
2735265|NCT00111007|9398398|P1|Double-blind (DB) Treatment|Primary reason with other category|0
2735266|NCT00111007|9398397|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|93
2735267|NCT00111007|9398398|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|83
2735268|NCT00111007|9398397|P2|Double-blind (DB) Treatment|Progression by clinical judgement|2
2735269|NCT00111007|9398398|P1|Double-blind (DB) Treatment|Progression by clinical judgement|0
2735270|NCT00111007|9398397|P2|Double-blind (DB) Treatment|Relapse|0
2735271|NCT00111007|9398398|P1|Double-blind (DB) Treatment|Relapse|1
2735272|NCT00111007|9398397|P2|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0
2735273|NCT00111007|9398398|P1|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1
2735274|NCT00111007|9398397|P2|Double-blind (DB) Treatment|Withdrawal by Subject|8
2735275|NCT00111007|9398398|P1|Double-blind (DB) Treatment|Withdrawal by Subject|6
2735276|NCT00111007|9398397|P2|Double-blind (DB) Treatment|Protocol Violation|1
2735277|NCT00111007|9398398|P1|Double-blind (DB) Treatment|Protocol Violation|0
2735278|NCT00111007|9398397|P2|Double-blind (DB) Treatment|Death|2
2735279|NCT00111007|9398398|P1|Double-blind (DB) Treatment|Death|5
2735280|NCT00111007|9398397|P2|Double-blind (DB) Treatment|Adverse Event|4
2735281|NCT00111007|9398398|P1|Double-blind (DB) Treatment|Adverse Event|12
2735282|NCT00110994|9398414|P2|Long Term Follow-up|Death|17
2735283|NCT00110994|9398415|P1|Long Term Follow-up|Death|19
2735284|NCT00110994|9398414|P2|Active Follow-up|Other reasons|2
2735285|NCT00110994|9398415|P1|Active Follow-up|Other reasons|0
2735286|NCT00110994|9398414|P2|Active Follow-up|Disease progression/recurrence/replace|0
2735287|NCT00110994|9398415|P1|Active Follow-up|Disease progression/recurrence/replace|1
2735288|NCT00110994|9398414|P2|Double-blind (DB) Treatment|other reasons|3
2735289|NCT00110994|9398415|P1|Double-blind (DB) Treatment|other reasons|2
2735290|NCT00110994|9398414|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|41
2735291|NCT00110994|9398415|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|34
2735292|NCT00110994|9398414|P2|Double-blind (DB) Treatment|Progression by clinical judgement|1
2735293|NCT00110994|9398415|P1|Double-blind (DB) Treatment|Progression by clinical judgement|2
2735294|NCT00110994|9398414|P2|Double-blind (DB) Treatment|Withdrawal by Subject|2
2735295|NCT00110994|9398415|P1|Double-blind (DB) Treatment|Withdrawal by Subject|0
2735296|NCT00110994|9398414|P2|Double-blind (DB) Treatment|Death|0
2735297|NCT00110994|9398415|P1|Double-blind (DB) Treatment|Death|1
2735298|NCT00110994|9398414|P2|Double-blind (DB) Treatment|Adverse Event|0
2735299|NCT00110994|9398415|P1|Double-blind (DB) Treatment|Adverse Event|3
2735300|NCT00110890|9398441|P2|Overall Study|Did not enter follow-up phase|4
2735301|NCT00110890|9398442|P1|Overall Study|Did not enter follow-up phase|10
2735302|NCT00110890|9398441|P2|Overall Study|Parathyroidectomy|1
2735303|NCT00110890|9398442|P1|Overall Study|Parathyroidectomy|0
2735304|NCT00110890|9398441|P2|Overall Study|Disease progression|1
2735305|NCT00110890|9398442|P1|Overall Study|Disease progression|0
2735306|NCT00110890|9398441|P2|Overall Study|Requirement for alternative therapy|1
2735307|NCT00110890|9398442|P1|Overall Study|Requirement for alternative therapy|0
2735308|NCT00110890|9398441|P2|Overall Study|Ineligibility determined|0
2735309|NCT00110890|9398442|P1|Overall Study|Ineligibility determined|3
2735310|NCT00110890|9398441|P2|Overall Study|Other|23
2735311|NCT00110890|9398442|P1|Overall Study|Other|34
2735312|NCT00110890|9398441|P2|Overall Study|Invest. Product Commercially Available|110
2735313|NCT00110890|9398442|P1|Overall Study|Invest. Product Commercially Available|217
2735314|NCT00110890|9398441|P2|Overall Study|Kidney Transplant|12
2735315|NCT00110890|9398442|P1|Overall Study|Kidney Transplant|16
2735316|NCT00110890|9398441|P2|Overall Study|Noncompliance|0
2735317|NCT00110890|9398442|P1|Overall Study|Noncompliance|10
2735318|NCT00110890|9398441|P2|Overall Study|Protocol Deviation|0
2735319|NCT00110890|9398442|P1|Overall Study|Protocol Deviation|1
2735320|NCT00110890|9398441|P2|Overall Study|Withdrawal by Subject|5
2735321|NCT00110890|9398442|P1|Overall Study|Withdrawal by Subject|17
2735322|NCT00110890|9398441|P2|Overall Study|Physician Decision|5
2735323|NCT00110890|9398442|P1|Overall Study|Physician Decision|4
2735324|NCT00110890|9398441|P2|Overall Study|Lost to Follow-up|1
2735325|NCT00110890|9398442|P1|Overall Study|Lost to Follow-up|3
2735326|NCT00110890|9398441|P2|Overall Study|Death|9
2735327|NCT00110890|9398442|P1|Overall Study|Death|16
2735328|NCT00110890|9398441|P2|Overall Study|Adverse Event|7
2735329|NCT00110890|9398442|P1|Overall Study|Adverse Event|30
2735330|NCT00110812|9398459|P3|Extended Follow-up|Lost to Follow-up|1
2735331|NCT00110812|9398460|P2|Extended Follow-up|Lost to Follow-up|3
2735332|NCT00110812|9398461|P1|Extended Follow-up|Lost to Follow-up|1
2735333|NCT00110812|9398459|P3|Extended Follow-up|Withdrawal by Subject|0
2735334|NCT00110812|9398460|P2|Extended Follow-up|Withdrawal by Subject|1
2735335|NCT00110812|9398461|P1|Extended Follow-up|Withdrawal by Subject|0
2735336|NCT00110812|9398459|P3|Extended Follow-up|Death|3
2735337|NCT00110812|9398460|P2|Extended Follow-up|Death|0
2735338|NCT00110812|9398461|P1|Extended Follow-up|Death|1
2735339|NCT00110812|9398459|P3|Main Study|Lost to Follow-up|10
2735340|NCT00110812|9398460|P2|Main Study|Lost to Follow-up|11
2735341|NCT00110812|9398461|P1|Main Study|Lost to Follow-up|8
2735342|NCT00110812|9398459|P3|Main Study|Withdrawal by Subject|1
2735343|NCT00110812|9398460|P2|Main Study|Withdrawal by Subject|0
2735344|NCT00110812|9398461|P1|Main Study|Withdrawal by Subject|0
2735345|NCT00110812|9398459|P3|Main Study|Death|2
2735346|NCT00110812|9398460|P2|Main Study|Death|0
2735347|NCT00110812|9398461|P1|Main Study|Death|0
2735348|NCT00110617|9398506|P2|Overall Study|Did not receive study drug|12
2735349|NCT00110617|9398507|P1|Overall Study|Did not receive study drug|0
2735350|NCT00110617|9398506|P2|Overall Study|Death|1
2735351|NCT00110617|9398507|P1|Overall Study|Death|1
2735352|NCT00110617|9398506|P2|Overall Study|Administrative problems|5
2735353|NCT00110617|9398507|P1|Overall Study|Administrative problems|6
2735354|NCT00110617|9398506|P2|Overall Study|Lost to Follow-up|1
2735355|NCT00110617|9398507|P1|Overall Study|Lost to Follow-up|9
2735356|NCT00110617|9398506|P2|Overall Study|Withdrawal by Subject|4
2735357|NCT00110617|9398507|P1|Overall Study|Withdrawal by Subject|10
2735358|NCT00110617|9398506|P2|Overall Study|Protocol Violation|0
2735359|NCT00110617|9398507|P1|Overall Study|Protocol Violation|5
2735360|NCT00110617|9398506|P2|Overall Study|Patient no longer requires study drug|0
2735361|NCT00110617|9398507|P1|Overall Study|Patient no longer requires study drug|1
2735362|NCT00110617|9398506|P2|Overall Study|Lack of Efficacy|0
2735363|NCT00110617|9398507|P1|Overall Study|Lack of Efficacy|1
2735364|NCT00110617|9398506|P2|Overall Study|Abnormal Laboratory Value|2
2735365|NCT00110617|9398507|P1|Overall Study|Abnormal Laboratory Value|4
2735366|NCT00110617|9398506|P2|Overall Study|Adverse Event|4
2735367|NCT00110617|9398507|P1|Overall Study|Adverse Event|2
2735368|NCT00110396|9398624|P1|Overall Study|Patient is to be administered copaxone|1
2735369|NCT00110396|9398624|P1|Overall Study|The patient has refused to visit site|1
2735370|NCT00110396|9398624|P1|Overall Study|The patient has refused|2
2735371|NCT00110396|9398624|P1|Overall Study|Patient refused to come back|1
2735372|NCT00110396|9398624|P1|Overall Study|Protocol Violation|2
2735373|NCT00110396|9398624|P1|Overall Study|Pregnancy (Protocol violation)|2
2735374|NCT00110396|9398624|P1|Overall Study|Pregnancy|1
2735375|NCT00110396|9398624|P1|Overall Study|Participation in MS vaccine study|1
2735376|NCT00110396|9398624|P1|Overall Study|Patient's decision|1
2735377|NCT00110396|9398624|P1|Overall Study|Patient will|1
2735378|NCT00110396|9398624|P1|Overall Study|Patient refused to participate|1
2735379|NCT00110396|9398624|P1|Overall Study|Patient refused to continue|1
2735380|NCT00110396|9398624|P1|Overall Study|Patient non-compliance|1
2735381|NCT00110396|9398624|P1|Overall Study|Decided not to continue treatment|1
2735382|NCT00110396|9398624|P1|Overall Study|Lack of Efficacy|1
2735383|NCT00110396|9398624|P1|Overall Study|Initiated mitoxantrone therapy|1
2735384|NCT00110396|9398624|P1|Overall Study|Administration of plasmapheresis|1
2735385|NCT00110396|9398624|P1|Overall Study|Lost to Follow-up|1
2735386|NCT00110396|9398624|P1|Overall Study|Adverse Event|15
2735387|NCT00110357|9398632|P2|Overall Study|Withdrawal by Subject|1
2735388|NCT00110357|9398633|P1|Overall Study|Withdrawal by Subject|3
2735389|NCT00110357|9398632|P2|Overall Study|Study Drug Toxicity|3
2735390|NCT00110357|9398633|P1|Overall Study|Study Drug Toxicity|1
2735391|NCT00110357|9398632|P2|Overall Study|Study Closure|0
2735392|NCT00110357|9398633|P1|Overall Study|Study Closure|1
2735393|NCT00110357|9398632|P2|Overall Study|Disease progression/relapse|15
2735394|NCT00110357|9398633|P1|Overall Study|Disease progression/relapse|20
2735395|NCT00110357|9398632|P2|Overall Study|Deterioration without progression|0
2735396|NCT00110357|9398633|P1|Overall Study|Deterioration without progression|2
2735397|NCT00110305|9398721|P2|Overall Study|Other|2
2735398|NCT00110305|9398722|P1|Overall Study|Other|8
2735399|NCT00110305|9398721|P2|Overall Study|Lost to Follow-up|3
2735400|NCT00110305|9398722|P1|Overall Study|Lost to Follow-up|20
2735401|NCT00110305|9398721|P2|Overall Study|Withdrawal by Subject|7
2735402|NCT00110305|9398722|P1|Overall Study|Withdrawal by Subject|7
2735403|NCT00110305|9398721|P2|Overall Study|Protocol Violation|1
2735404|NCT00110305|9398722|P1|Overall Study|Protocol Violation|0
2735405|NCT00110305|9398721|P2|Overall Study|Subject Reached A Virologic Endpoint|3
2735406|NCT00110305|9398722|P1|Overall Study|Subject Reached A Virologic Endpoint|21
2735407|NCT00110305|9398721|P2|Overall Study|Subject Ineligible To Continue The Trial|1
2735408|NCT00110305|9398722|P1|Overall Study|Subject Ineligible To Continue The Trial|2
2735409|NCT00110305|9398721|P2|Overall Study|Subject Non-Compliant|2
2735410|NCT00110305|9398722|P1|Overall Study|Subject Non-Compliant|9
2735411|NCT00110305|9398721|P2|Overall Study|Sponsors Decision|0
2735412|NCT00110305|9398722|P1|Overall Study|Sponsors Decision|1
2735413|NCT00110305|9398721|P2|Overall Study|Adverse Event|13
2735414|NCT00110305|9398722|P1|Overall Study|Adverse Event|46
2735415|NCT00110214|9398775|P2|Overall Study|Other (not specified)|75
2735416|NCT00110214|9398776|P1|Overall Study|Other (not specified)|61
2735417|NCT00110214|9398775|P2|Overall Study|Refused further treatment|65
2735418|NCT00110214|9398776|P1|Overall Study|Refused further treatment|52
2735419|NCT00110214|9398775|P2|Overall Study|Adverse Event|192
2735420|NCT00110214|9398776|P1|Overall Study|Adverse Event|115
2735421|NCT00110214|9398775|P2|Overall Study|Disease progression or death|151
2735422|NCT00110214|9398776|P1|Overall Study|Disease progression or death|260
2735423|NCT00110214|9398775|P2|Overall Study|Never started treatment|20
2735424|NCT00110214|9398776|P1|Overall Study|Never started treatment|21
2735425|NCT00110149|9398788|P1|Overall Study|Physician Decision|3
2735426|NCT00110084|9398802|P1|Overall Study|Other|2
2735427|NCT00110084|9398802|P1|Overall Study|Intercurrent Illness|1
2735428|NCT00110084|9398802|P1|Overall Study|Alternate Therapy|5
2735429|NCT00110084|9398802|P1|Overall Study|Patient Refusal|10
2735430|NCT00110084|9398802|P1|Overall Study|Death|1
2735431|NCT00110084|9398802|P1|Overall Study|Adverse Event|9
2735432|NCT00110019|9398811|P2|Overall Study|other reasons|30
2735433|NCT00110019|9398812|P1|Overall Study|other reasons|22
2735434|NCT00110019|9398811|P2|Overall Study|Not start protocol therapy|16
2735435|NCT00110019|9398812|P1|Overall Study|Not start protocol therapy|17
2735436|NCT00110019|9398811|P2|Overall Study|symptom deterioration|16
2735437|NCT00110019|9398812|P1|Overall Study|symptom deterioration|13
2735438|NCT00110019|9398811|P2|Overall Study|complicating disease|1
2735439|NCT00110019|9398812|P1|Overall Study|complicating disease|1
2735440|NCT00110019|9398811|P2|Overall Study|alternative therapy|1
2735441|NCT00110019|9398812|P1|Overall Study|alternative therapy|5
2735442|NCT00110019|9398811|P2|Overall Study|Withdrawal by Subject|9
2735443|NCT00110019|9398812|P1|Overall Study|Withdrawal by Subject|21
2735444|NCT00110019|9398811|P2|Overall Study|Death|15
2735445|NCT00110019|9398812|P1|Overall Study|Death|13
2735446|NCT00110019|9398811|P2|Overall Study|Adverse Event|40
2735447|NCT00110019|9398812|P1|Overall Study|Adverse Event|61
2735448|NCT00110019|9398811|P2|Overall Study|Lack of Efficacy|285
2735449|NCT00110019|9398812|P1|Overall Study|Lack of Efficacy|253
2735450|NCT00109967|9398824|P2|Overall Study|Death|2
2735451|NCT00109967|9398825|P1|Overall Study|Death|0
2735452|NCT00109967|9398824|P2|Overall Study|Physician Decision|3
2735453|NCT00109967|9398825|P1|Overall Study|Physician Decision|1
2735454|NCT00109967|9398824|P2|Overall Study|Withdrawal by Subject|0
2735455|NCT00109967|9398825|P1|Overall Study|Withdrawal by Subject|5
2735456|NCT00109967|9398824|P2|Overall Study|Adverse Event|1
2735457|NCT00109967|9398825|P1|Overall Study|Adverse Event|12
2735458|NCT00109967|9398824|P2|Overall Study|Cancel Prior to Treatment|0
2735459|NCT00109967|9398825|P1|Overall Study|Cancel Prior to Treatment|2
2735460|NCT00109928|9398839|P1|Overall Study|not eligible|1
2735461|NCT00109928|9398839|P1|Overall Study|not protocol specified|2
2735462|NCT00109928|9398839|P1|Overall Study|Death|2
2735463|NCT00109928|9398839|P1|Overall Study|Progression|6
2735464|NCT00109928|9398839|P1|Overall Study|Adverse Event|2
2735465|NCT00109850|9398856|P1|Overall Study|Ineligible|1
2735466|NCT00109850|9398856|P1|Overall Study|Death|2
2735467|NCT00109850|9398856|P1|Overall Study|Adverse Event|1
2735468|NCT00109837|9398863|P1|Overall Study|Ineligible|1
2735469|NCT00109837|9398863|P1|Overall Study|Not treated|1
2735470|NCT00109837|9398863|P1|Overall Study|BCR/ABL+ or Ph+|17
2735471|NCT00109837|9398863|P1|Overall Study|Death|1
2735472|NCT00109837|9398863|P1|Overall Study|Refusal unrelated to adverse effects|1
2735473|NCT00109837|9398863|P1|Overall Study|Adverse Event|2
2735474|NCT00109772|9398873|P2|Open-label Extension|Other|10
2735475|NCT00109772|9398874|P1|Open-label Extension|Other|4
2735476|NCT00109772|9398873|P2|Open-label Extension|Protocol Violation|2
2735477|NCT00109772|9398874|P1|Open-label Extension|Protocol Violation|2
2735478|NCT00109772|9398873|P2|Open-label Extension|Death|1
2735479|NCT00109772|9398874|P1|Open-label Extension|Death|0
2735480|NCT00109772|9398873|P2|Open-label Extension|Lost to Follow-up|0
2735481|NCT00109772|9398874|P1|Open-label Extension|Lost to Follow-up|1
2735482|NCT00109772|9398873|P2|Open-label Extension|Withdrawal by Subject|6
2735483|NCT00109772|9398874|P1|Open-label Extension|Withdrawal by Subject|9
2735484|NCT00109772|9398873|P2|Open-label Extension|Lack of Efficacy|11
2735485|NCT00109772|9398874|P1|Open-label Extension|Lack of Efficacy|19
2735486|NCT00109772|9398873|P2|Open-label Extension|Adverse Event|19
2735487|NCT00109772|9398874|P1|Open-label Extension|Adverse Event|10
2735488|NCT00109772|9398873|P2|Double-blind Treatment|Withdrew prior to treatment|1
2735489|NCT00109772|9398874|P1|Double-blind Treatment|Withdrew prior to treatment|3
2735490|NCT00109772|9398873|P2|Double-blind Treatment|Other|4
2735491|NCT00109772|9398874|P1|Double-blind Treatment|Other|0
2735492|NCT00109772|9398873|P2|Double-blind Treatment|Protocol Violation|1
2735493|NCT00109772|9398874|P1|Double-blind Treatment|Protocol Violation|0
2735494|NCT00109772|9398873|P2|Double-blind Treatment|Lost to Follow-up|3
2735495|NCT00109772|9398874|P1|Double-blind Treatment|Lost to Follow-up|2
2735496|NCT00109772|9398873|P2|Double-blind Treatment|Withdrawal by Subject|1
2735497|NCT00109772|9398874|P1|Double-blind Treatment|Withdrawal by Subject|2
2735498|NCT00109772|9398873|P2|Double-blind Treatment|Lack of Efficacy|0
2735499|NCT00109772|9398874|P1|Double-blind Treatment|Lack of Efficacy|1
2735500|NCT00109772|9398873|P2|Double-blind Treatment|Adverse Event|5
2735501|NCT00109772|9398874|P1|Double-blind Treatment|Adverse Event|14
2735502|NCT00109733|9398914|P2|Overall Study|Could not commit time for study|1
2735503|NCT00109733|9398915|P1|Overall Study|Could not commit time for study|1
2735504|NCT00109733|9398914|P2|Overall Study|Non-compliant|1
2735505|NCT00109733|9398915|P1|Overall Study|Non-compliant|0
2735506|NCT00109733|9398914|P2|Overall Study|Stopped taking study drug|1
2735507|NCT00109733|9398915|P1|Overall Study|Stopped taking study drug|1
2735508|NCT00109733|9398914|P2|Overall Study|Protocol Violation|1
2735509|NCT00109733|9398915|P1|Overall Study|Protocol Violation|0
2735510|NCT00109590|9398932|P3|Overall Study|Never Started Treatment|3
2735511|NCT00109590|9398933|P2|Overall Study|Never Started Treatment|2
2735512|NCT00109590|9398934|P1|Overall Study|Never Started Treatment|1
2735513|NCT00109590|9398932|P3|Overall Study|Lost to Follow-up|1
2735514|NCT00109590|9398933|P2|Overall Study|Lost to Follow-up|0
2735515|NCT00109590|9398934|P1|Overall Study|Lost to Follow-up|1
2735516|NCT00109577|9398976|P2|Overall Study|Withdrawal by Subject|3
2735517|NCT00109577|9398977|P1|Overall Study|Withdrawal by Subject|3
2735518|NCT00109343|9399008|P3|Overall Study|Other|1
2735519|NCT00109343|9399009|P2|Overall Study|Other|2
2735520|NCT00109343|9399010|P1|Overall Study|Other|5
2735521|NCT00109343|9399008|P3|Overall Study|Subject Moved|1
2735522|NCT00109343|9399009|P2|Overall Study|Subject Moved|2
2735523|NCT00109343|9399010|P1|Overall Study|Subject Moved|6
2735524|NCT00109343|9399008|P3|Overall Study|Withdrawal by Subject|10
2735525|NCT00109343|9399009|P2|Overall Study|Withdrawal by Subject|11
2735526|NCT00109343|9399010|P1|Overall Study|Withdrawal by Subject|15
2735527|NCT00109343|9399008|P3|Overall Study|Protocol Violation|2
2735528|NCT00109343|9399009|P2|Overall Study|Protocol Violation|2
2735529|NCT00109343|9399010|P1|Overall Study|Protocol Violation|1
2735530|NCT00109343|9399008|P3|Overall Study|Lost to Follow-up|14
2735531|NCT00109343|9399009|P2|Overall Study|Lost to Follow-up|20
2735532|NCT00109343|9399010|P1|Overall Study|Lost to Follow-up|35
2735533|NCT00109343|9399008|P3|Overall Study|Lack of Efficacy|0
2735534|NCT00109343|9399009|P2|Overall Study|Lack of Efficacy|0
2735535|NCT00109343|9399010|P1|Overall Study|Lack of Efficacy|1
2735536|NCT00109343|9399008|P3|Overall Study|Adverse Event|2
2735537|NCT00109343|9399009|P2|Overall Study|Adverse Event|0
2735538|NCT00109343|9399010|P1|Overall Study|Adverse Event|1
2735539|NCT00109031|9399055|P4|Overall Study|Protocol Violation|0
2735540|NCT00109031|9399056|P3|Overall Study|Protocol Violation|1
2735541|NCT00109031|9399057|P2|Overall Study|Protocol Violation|0
2735542|NCT00109031|9399058|P1|Overall Study|Protocol Violation|0
2735543|NCT00109031|9399055|P4|Overall Study|Physician Decision|0
2735544|NCT00109031|9399056|P3|Overall Study|Physician Decision|0
2735545|NCT00109031|9399057|P2|Overall Study|Physician Decision|1
2735546|NCT00109031|9399058|P1|Overall Study|Physician Decision|0
2735547|NCT00109031|9399055|P4|Overall Study|Withdrawal by Subject|0
2735548|NCT00109031|9399056|P3|Overall Study|Withdrawal by Subject|0
2735549|NCT00109031|9399057|P2|Overall Study|Withdrawal by Subject|1
2735550|NCT00109031|9399058|P1|Overall Study|Withdrawal by Subject|0
2735551|NCT00109031|9399055|P4|Overall Study|Adverse Event|0
2735552|NCT00109031|9399056|P3|Overall Study|Adverse Event|1
2735553|NCT00109031|9399057|P2|Overall Study|Adverse Event|0
2735554|NCT00109031|9399058|P1|Overall Study|Adverse Event|0
2735555|NCT00108953|9399109|P2|Follow-up|Study terminated by sponsor|6
2735556|NCT00108953|9399110|P1|Follow-up|Study terminated by sponsor|10
2735557|NCT00108953|9399109|P2|Follow-up|Lost to Follow-up|1
2735558|NCT00108953|9399110|P1|Follow-up|Lost to Follow-up|1
2735559|NCT00108953|9399109|P2|Follow-up|Death|26
2735560|NCT00108953|9399110|P1|Follow-up|Death|18
2735561|NCT00108862|9399132|P2|Overall Study|Lost to Follow-up|19
2735562|NCT00108862|9399133|P1|Overall Study|Lost to Follow-up|27
2735563|NCT00108862|9399132|P2|Overall Study|Withdrawal by Subject|6
2735564|NCT00108862|9399133|P1|Overall Study|Withdrawal by Subject|10
2735565|NCT00108862|9399132|P2|Overall Study|Death|37
2735566|NCT00108862|9399133|P1|Overall Study|Death|31
2735567|NCT00108732|9399161|P1|Step 2 (Androgen Ablation and Vaccine)|Other|1
2735568|NCT00108732|9399161|P1|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1
2735569|NCT00108732|9399161|P1|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3
2735570|NCT00108732|9399161|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1
2735571|NCT00108732|9399161|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10
2735572|NCT00108732|9399161|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2
2735573|NCT00108732|9399161|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1
2735574|NCT00108628|9399170|P2|Overall Study|Death|0
2735575|NCT00108628|9399171|P1|Overall Study|Death|1
2735576|NCT00108628|9399170|P2|Overall Study|Lack of Efficacy|1
2735577|NCT00108628|9399171|P1|Overall Study|Lack of Efficacy|2
2735578|NCT00108628|9399170|P2|Overall Study|Withdrawal by Subject|9
2735579|NCT00108628|9399171|P1|Overall Study|Withdrawal by Subject|17
2735580|NCT00108485|9399221|P2|Overall Study|Lost to Follow-up|2
2735581|NCT00108485|9399222|P1|Overall Study|Lost to Follow-up|0
2735582|NCT00108485|9399221|P2|Overall Study|Withdrawal by Subject|0
2735583|NCT00108485|9399222|P1|Overall Study|Withdrawal by Subject|3
2735584|NCT00108433|9399230|P2|Overall Study|Other|14
2735585|NCT00108433|9399231|P1|Overall Study|Other|14
2735586|NCT00108433|9399230|P2|Overall Study|Adverse Event|1
2735587|NCT00108433|9399231|P1|Overall Study|Adverse Event|3
2735588|NCT00108433|9399230|P2|Overall Study|Death|0
2735589|NCT00108433|9399231|P1|Overall Study|Death|3
2735590|NCT00108433|9399230|P2|Overall Study|Lack of Efficacy|2
2735591|NCT00108433|9399231|P1|Overall Study|Lack of Efficacy|1
2735592|NCT00108355|9399247|P2|Overall Study|Loculated ascites, limiting paracentesis|1
2735593|NCT00108355|9399248|P1|Overall Study|Loculated ascites, limiting paracentesis|1
2735594|NCT00108355|9399247|P2|Overall Study|Peritonitis at index paracentesis|1
2735595|NCT00108355|9399248|P1|Overall Study|Peritonitis at index paracentesis|1
2735596|NCT00108160|9399297|P2|Overall Study|Protocol Violation|5
2735597|NCT00108160|9399298|P1|Overall Study|Protocol Violation|9
2735598|NCT00108160|9399297|P2|Overall Study|Withdrawal by Subject|2
2735599|NCT00108160|9399298|P1|Overall Study|Withdrawal by Subject|4
2735600|NCT00108160|9399297|P2|Overall Study|Death|2
2735601|NCT00108160|9399298|P1|Overall Study|Death|1
2735602|NCT00108160|9399297|P2|Overall Study|Lost to Follow-up|12
2735603|NCT00108160|9399298|P1|Overall Study|Lost to Follow-up|25
2735604|NCT00108082|9399311|P3|Overall Study|Blood Pressure Not Controlled|0
2735605|NCT00108082|9399312|P2|Overall Study|Blood Pressure Not Controlled|0
2735606|NCT00108082|9399313|P1|Overall Study|Blood Pressure Not Controlled|1
2735607|NCT00108082|9399311|P3|Overall Study|Investigator Not at Site|0
2735608|NCT00108082|9399312|P2|Overall Study|Investigator Not at Site|0
2735609|NCT00108082|9399313|P1|Overall Study|Investigator Not at Site|1
2735610|NCT00108082|9399311|P3|Overall Study|Subject Left Site Location|0
2735611|NCT00108082|9399312|P2|Overall Study|Subject Left Site Location|0
2735612|NCT00108082|9399313|P1|Overall Study|Subject Left Site Location|1
2735613|NCT00108082|9399311|P3|Overall Study|Study Medication Not Tapered|0
2735614|NCT00108082|9399312|P2|Overall Study|Study Medication Not Tapered|1
2735615|NCT00108082|9399313|P1|Overall Study|Study Medication Not Tapered|0
2735616|NCT00108082|9399311|P3|Overall Study|Protocol Amendment|0
2735617|NCT00108082|9399312|P2|Overall Study|Protocol Amendment|1
2735618|NCT00108082|9399313|P1|Overall Study|Protocol Amendment|0
2735619|NCT00108082|9399311|P3|Overall Study|Site Closed Study|0
2735620|NCT00108082|9399312|P2|Overall Study|Site Closed Study|2
2735621|NCT00108082|9399313|P1|Overall Study|Site Closed Study|0
2735622|NCT00108082|9399311|P3|Overall Study|Stopped Study Medication|1
2735623|NCT00108082|9399312|P2|Overall Study|Stopped Study Medication|0
2735624|NCT00108082|9399313|P1|Overall Study|Stopped Study Medication|0
2735625|NCT00108082|9399311|P3|Overall Study|Non-compliance|2
2735626|NCT00108082|9399312|P2|Overall Study|Non-compliance|0
2735627|NCT00108082|9399313|P1|Overall Study|Non-compliance|1
2735628|NCT00108082|9399311|P3|Overall Study|Incorrectly Randomized|2
2735629|NCT00108082|9399312|P2|Overall Study|Incorrectly Randomized|0
2735630|NCT00108082|9399313|P1|Overall Study|Incorrectly Randomized|0
2735631|NCT00108082|9399311|P3|Overall Study|Woman of Child-bearing Potential|2
2735632|NCT00108082|9399312|P2|Overall Study|Woman of Child-bearing Potential|0
2735633|NCT00108082|9399313|P1|Overall Study|Woman of Child-bearing Potential|2
2735634|NCT00108082|9399311|P3|Overall Study|Amendment 4: > Month 12|5
2735635|NCT00108082|9399312|P2|Overall Study|Amendment 4: > Month 12|7
2735636|NCT00108082|9399313|P1|Overall Study|Amendment 4: > Month 12|5
2735637|NCT00108082|9399311|P3|Overall Study|Lack of Efficacy|2
2735638|NCT00108082|9399312|P2|Overall Study|Lack of Efficacy|1
2735639|NCT00108082|9399313|P1|Overall Study|Lack of Efficacy|3
2735640|NCT00108082|9399311|P3|Overall Study|Protocol Violation|0
2735641|NCT00108082|9399312|P2|Overall Study|Protocol Violation|2
2735642|NCT00108082|9399313|P1|Overall Study|Protocol Violation|1
2735643|NCT00108082|9399311|P3|Overall Study|Consent Withdrawn|5
2735644|NCT00108082|9399312|P2|Overall Study|Consent Withdrawn|3
2735645|NCT00108082|9399313|P1|Overall Study|Consent Withdrawn|3
2735646|NCT00108082|9399311|P3|Overall Study|Lost to Follow-up|7
2735647|NCT00108082|9399312|P2|Overall Study|Lost to Follow-up|3
2735648|NCT00108082|9399313|P1|Overall Study|Lost to Follow-up|6
2735649|NCT00108082|9399311|P3|Overall Study|Adverse Event|17
2735650|NCT00108082|9399312|P2|Overall Study|Adverse Event|12
2735651|NCT00108082|9399313|P1|Overall Study|Adverse Event|14
2735652|NCT00108069|9399362|P2|Overall Study|Progessive disease|11
2735653|NCT00108069|9399363|P1|Overall Study|Progessive disease|27
2735654|NCT00108069|9399362|P2|Overall Study|Death|0
2735655|NCT00108069|9399363|P1|Overall Study|Death|1
2735656|NCT00108069|9399362|P2|Overall Study|Withdrawal by Subject|0
2735657|NCT00108069|9399363|P1|Overall Study|Withdrawal by Subject|1
2735658|NCT00108069|9399362|P2|Overall Study|Adverse Event|1
2735659|NCT00108069|9399363|P1|Overall Study|Adverse Event|1
2735660|NCT00108069|9399362|P2|Overall Study|Never rec'd study drug|1
2735661|NCT00108069|9399363|P1|Overall Study|Never rec'd study drug|0
2735662|NCT00107991|9399377|P1|18-Week Post Treatment Assessment|Adverse Event|2
2735663|NCT00107991|9399377|P1|12 Week Treatment Period|Incarcerated|1
2735664|NCT00107991|9399377|P1|12 Week Treatment Period|Protocol Violation|1
2735665|NCT00107991|9399377|P1|12 Week Treatment Period|Adverse Event|1
2735666|NCT00107991|9399377|P1|12 Week Treatment Period|Lack of Efficacy|2
2735667|NCT00107991|9399377|P1|Eligibility Assessment|hx of alcohol abuse in past 12 months|1
2735668|NCT00107991|9399377|P1|Eligibility Assessment|chronic uncontrolled asthma|1
2735669|NCT00107991|9399377|P1|Eligibility Assessment|Ongoing treatment with antibiotics|1
2735670|NCT00107991|9399377|P1|Eligibility Assessment|Abnormal labs|2
2735671|NCT00107991|9399377|P1|Eligibility Assessment|Positive purified protein derivative|4
2735672|NCT00107991|9399377|P1|Eligibility Assessment|Unwilling to participate|7
2735673|NCT00107991|9399377|P1|Eligibility Assessment|Disease not severe enough|7
2735674|NCT00107978|9399387|P2|Overall Study|Other|4
2735675|NCT00107978|9399388|P1|Overall Study|Other|5
2735676|NCT00107978|9399387|P2|Overall Study|Protocol Violation|1
2735677|NCT00107978|9399388|P1|Overall Study|Protocol Violation|0
2735678|NCT00107978|9399387|P2|Overall Study|Withdrawal by Subject|9
2735679|NCT00107978|9399388|P1|Overall Study|Withdrawal by Subject|4
2735680|NCT00107978|9399387|P2|Overall Study|Lost to Follow-up|28
2735681|NCT00107978|9399388|P1|Overall Study|Lost to Follow-up|20
2735682|NCT00107978|9399387|P2|Overall Study|Death|3
2735683|NCT00107978|9399388|P1|Overall Study|Death|3
2735684|NCT00107978|9399387|P2|Overall Study|Adverse Event|5
2735685|NCT00107978|9399388|P1|Overall Study|Adverse Event|1
2735686|NCT00107952|9399396|P2|Overall Study|Never received study treatment|6
2735687|NCT00107952|9399397|P1|Overall Study|Never received study treatment|9
2735688|NCT00107952|9399396|P2|Overall Study|Other|5
2735689|NCT00107952|9399397|P1|Overall Study|Other|2
2735690|NCT00107952|9399396|P2|Overall Study|Withdrawal by Subject|6
2735691|NCT00107952|9399397|P1|Overall Study|Withdrawal by Subject|9
2735692|NCT00107952|9399396|P2|Overall Study|Lost to Follow-up|3
2735693|NCT00107952|9399397|P1|Overall Study|Lost to Follow-up|0
2735694|NCT00107952|9399396|P2|Overall Study|Death|61
2735695|NCT00107952|9399397|P1|Overall Study|Death|75
2735696|NCT00107900|9399409|P6|Overall Study|Administrative Reasons|0
2735697|NCT00107900|9399410|P5|Overall Study|Administrative Reasons|2
2735698|NCT00107900|9399411|P4|Overall Study|Administrative Reasons|2
2735699|NCT00107900|9399412|P3|Overall Study|Administrative Reasons|2
2735700|NCT00107900|9399413|P2|Overall Study|Administrative Reasons|0
2735701|NCT00107900|9399414|P1|Overall Study|Administrative Reasons|1
2735702|NCT00107900|9399409|P6|Overall Study|Withdrawal by Subject|1
2735703|NCT00107900|9399410|P5|Overall Study|Withdrawal by Subject|1
2735704|NCT00107900|9399411|P4|Overall Study|Withdrawal by Subject|0
2735705|NCT00107900|9399412|P3|Overall Study|Withdrawal by Subject|5
2735706|NCT00107900|9399413|P2|Overall Study|Withdrawal by Subject|0
2735707|NCT00107900|9399414|P1|Overall Study|Withdrawal by Subject|1
2735708|NCT00107900|9399409|P6|Overall Study|Protocol Violation|0
2735709|NCT00107900|9399410|P5|Overall Study|Protocol Violation|7
2735710|NCT00107900|9399411|P4|Overall Study|Protocol Violation|5
2735711|NCT00107900|9399412|P3|Overall Study|Protocol Violation|5
2735712|NCT00107900|9399413|P2|Overall Study|Protocol Violation|0
2735713|NCT00107900|9399414|P1|Overall Study|Protocol Violation|1
2735714|NCT00107900|9399409|P6|Overall Study|Lost to Follow-up|5
2735715|NCT00107900|9399410|P5|Overall Study|Lost to Follow-up|5
2735716|NCT00107900|9399411|P4|Overall Study|Lost to Follow-up|2
2735717|NCT00107900|9399412|P3|Overall Study|Lost to Follow-up|3
2735718|NCT00107900|9399413|P2|Overall Study|Lost to Follow-up|1
2735719|NCT00107900|9399414|P1|Overall Study|Lost to Follow-up|4
2735720|NCT00107900|9399409|P6|Overall Study|Death|0
2735721|NCT00107900|9399410|P5|Overall Study|Death|1
2735722|NCT00107900|9399411|P4|Overall Study|Death|0
2735723|NCT00107900|9399412|P3|Overall Study|Death|0
2735724|NCT00107900|9399413|P2|Overall Study|Death|0
2735725|NCT00107900|9399414|P1|Overall Study|Death|0
2735726|NCT00107900|9399409|P6|Overall Study|Adverse Event|3
2735727|NCT00107900|9399410|P5|Overall Study|Adverse Event|5
2735728|NCT00107900|9399411|P4|Overall Study|Adverse Event|3
2735729|NCT00107900|9399412|P3|Overall Study|Adverse Event|10
2735730|NCT00107900|9399413|P2|Overall Study|Adverse Event|2
2735731|NCT00107900|9399414|P1|Overall Study|Adverse Event|3
2735732|NCT00107783|9399448|P2|Overall Study|Second hip replacement|1
2735733|NCT00107783|9399449|P1|Overall Study|Second hip replacement|1
2735734|NCT00107783|9399448|P2|Overall Study|Withdrawal by Subject|0
2735735|NCT00107783|9399449|P1|Overall Study|Withdrawal by Subject|2
2735736|NCT00107783|9399448|P2|Overall Study|Death|1
2735737|NCT00107783|9399449|P1|Overall Study|Death|0
2735738|NCT00107783|9399448|P2|Overall Study|Adverse Event|2
2735739|NCT00107783|9399449|P1|Overall Study|Adverse Event|0
2735740|NCT00107653|9399484|P2|Overall Study|Administrative Reasons|3
2735741|NCT00107653|9399485|P1|Overall Study|Administrative Reasons|3
2735742|NCT00107653|9399484|P2|Overall Study|Lost to Follow-up|5
2735743|NCT00107653|9399485|P1|Overall Study|Lost to Follow-up|13
2735744|NCT00107653|9399484|P2|Overall Study|Withdrawal by Subject|13
2735745|NCT00107653|9399485|P1|Overall Study|Withdrawal by Subject|12
2735746|NCT00107653|9399484|P2|Overall Study|Protocol Violation|0
2735747|NCT00107653|9399485|P1|Overall Study|Protocol Violation|1
2735748|NCT00107653|9399484|P2|Overall Study|Violation of Selection Criteria at Entry|1
2735749|NCT00107653|9399485|P1|Overall Study|Violation of Selection Criteria at Entry|1
2735750|NCT00107653|9399484|P2|Overall Study|Insufficient Therapeutic Response|11
2735751|NCT00107653|9399485|P1|Overall Study|Insufficient Therapeutic Response|25
2735752|NCT00107653|9399484|P2|Overall Study|Adverse Event|43
2735753|NCT00107653|9399485|P1|Overall Study|Adverse Event|24
2735754|NCT00107614|9399531|P1|Overall Study|Death|2
2735755|NCT00107614|9399531|P1|Overall Study|Physician Decision|10
2735756|NCT00107380|9399562|P1|Overall Study|Ineligible|2
2735757|NCT00107380|9399562|P1|Overall Study|Other - not protocol specified|7
2735758|NCT00107380|9399562|P1|Overall Study|Death|3
2735759|NCT00107380|9399562|P1|Overall Study|Progression/relapse|4
2735760|NCT00107380|9399562|P1|Overall Study|Refusal Unrelated to Adverse Event|7
2735761|NCT00107380|9399562|P1|Overall Study|Adverse Event|7
2735762|NCT00107315|9399568|P1|Overall Study|Withdrawal by Subject|2
2735763|NCT00107315|9399568|P1|Overall Study|Adverse Event|4
2735764|NCT00107315|9399568|P1|Overall Study|Disease Progression|9
2735765|NCT00107276|9399575|P1|Overall Study|Ineligible|16
2735766|NCT00107276|9399575|P1|Overall Study|Death|1
2735767|NCT00107276|9399575|P1|Overall Study|Patient refusal|1
2735768|NCT00107276|9399575|P1|Overall Study|M.D. decision|2
2735769|NCT00107276|9399575|P1|Overall Study|Adverse Event|6
2735770|NCT00107276|9399575|P1|Overall Study|Progression|46
2735771|NCT00107198|9399581|P1|Overall Study|Ineligible|5
2735772|NCT00107198|9399581|P1|Overall Study|Withdrawal by Subject|6
2735773|NCT00107198|9399581|P1|Overall Study|Protocol Violation|1
2735774|NCT00107198|9399581|P1|Overall Study|Lost to Follow-up|12
2735775|NCT00107198|9399581|P1|Overall Study|Lack of Efficacy|28
2735776|NCT00107172|9399591|P2|Overall Study|Other Reason|3
2735777|NCT00107172|9399592|P1|Overall Study|Other Reason|4
2735778|NCT00107172|9399591|P2|Overall Study|Death|2
2735779|NCT00107172|9399592|P1|Overall Study|Death|0
2735780|NCT00107172|9399591|P2|Overall Study|Withdrawal by Subject|0
2735781|NCT00107172|9399592|P1|Overall Study|Withdrawal by Subject|1
2735782|NCT00107120|9399622|P2|Overall Study|death of parent|1
2735783|NCT00107120|9399623|P1|Overall Study|death of parent|0
2735784|NCT00107120|9399622|P2|Overall Study|moving away from site|1
2735785|NCT00107120|9399623|P1|Overall Study|moving away from site|1
2735786|NCT00107120|9399622|P2|Overall Study|Pregnancy|1
2735787|NCT00107120|9399623|P1|Overall Study|Pregnancy|0
2735788|NCT00107120|9399622|P2|Overall Study|Lost to Follow-up|6
2735789|NCT00107120|9399623|P1|Overall Study|Lost to Follow-up|8
2735790|NCT00107120|9399622|P2|Overall Study|Withdrawal by Subject|9
2735791|NCT00107120|9399623|P1|Overall Study|Withdrawal by Subject|8
2735792|NCT00107120|9399622|P2|Overall Study|Protocol Violation|0
2735793|NCT00107120|9399623|P1|Overall Study|Protocol Violation|3
2735794|NCT00107120|9399622|P2|Overall Study|Lack of Efficacy|5
2735795|NCT00107120|9399623|P1|Overall Study|Lack of Efficacy|5
2735796|NCT00107120|9399622|P2|Overall Study|Adverse Event|1
2735797|NCT00107120|9399623|P1|Overall Study|Adverse Event|4
2735798|NCT00107042|9399635|P2|Overall Study|Disallowed medications|2
2735799|NCT00107042|9399636|P1|Overall Study|Disallowed medications|0
2735800|NCT00107042|9399635|P2|Overall Study|vaccinated outside window|1
2735801|NCT00107042|9399636|P1|Overall Study|vaccinated outside window|1
2735802|NCT00107042|9399635|P2|Overall Study|Inadvertent enrollment|1
2735803|NCT00107042|9399636|P1|Overall Study|Inadvertent enrollment|0
2735804|NCT00107042|9399635|P2|Overall Study|Pregnancy|1
2735805|NCT00107042|9399636|P1|Overall Study|Pregnancy|1
2735806|NCT00107042|9399635|P2|Overall Study|Moved out of area|3
2735807|NCT00107042|9399636|P1|Overall Study|Moved out of area|5
2735808|NCT00107042|9399635|P2|Overall Study|Withdrawal by Subject|1
2735809|NCT00107042|9399636|P1|Overall Study|Withdrawal by Subject|6
2735810|NCT00107042|9399635|P2|Overall Study|Lost to Follow-up|7
2735811|NCT00107042|9399636|P1|Overall Study|Lost to Follow-up|9
2735812|NCT00106964|9399702|P3|Overall Study|Required disallowed medication|0
2735813|NCT00106964|9399703|P2|Overall Study|Required disallowed medication|1
2735814|NCT00106964|9399704|P1|Overall Study|Required disallowed medication|0
2735815|NCT00106964|9399702|P3|Overall Study|Did not meet eligibility criteria|2
2735816|NCT00106964|9399703|P2|Overall Study|Did not meet eligibility criteria|2
2735817|NCT00106964|9399704|P1|Overall Study|Did not meet eligibility criteria|0
2735818|NCT00106964|9399702|P3|Overall Study|Failure to adhere|0
2735819|NCT00106964|9399703|P2|Overall Study|Failure to adhere|0
2735820|NCT00106964|9399704|P1|Overall Study|Failure to adhere|2
2735821|NCT00106964|9399702|P3|Overall Study|Site Funding Terminated|1
2735822|NCT00106964|9399703|P2|Overall Study|Site Funding Terminated|1
2735823|NCT00106964|9399704|P1|Overall Study|Site Funding Terminated|0
2735824|NCT00106964|9399702|P3|Overall Study|Incarceration|0
2735825|NCT00106964|9399703|P2|Overall Study|Incarceration|1
2735826|NCT00106964|9399704|P1|Overall Study|Incarceration|0
2735827|NCT00106964|9399702|P3|Overall Study|Death|0
2735828|NCT00106964|9399703|P2|Overall Study|Death|1
2735829|NCT00106964|9399704|P1|Overall Study|Death|1
2735830|NCT00106964|9399702|P3|Overall Study|Pregnancy|2
2735831|NCT00106964|9399703|P2|Overall Study|Pregnancy|3
2735832|NCT00106964|9399704|P1|Overall Study|Pregnancy|2
2735833|NCT00106964|9399702|P3|Overall Study|Lost to Follow-up|2
2735834|NCT00106964|9399703|P2|Overall Study|Lost to Follow-up|6
2735835|NCT00106964|9399704|P1|Overall Study|Lost to Follow-up|8
2735836|NCT00106704|9399799|P2|Overall Study|Laboratory test|1
2735837|NCT00106704|9399800|P1|Overall Study|Laboratory test|1
2735838|NCT00106704|9399799|P2|Overall Study|Unable to re-enter US|0
2735839|NCT00106704|9399800|P1|Overall Study|Unable to re-enter US|1
2735840|NCT00106704|9399799|P2|Overall Study|Patient Received Glycemic Medication|41
2735841|NCT00106704|9399800|P1|Overall Study|Patient Received Glycemic Medication|22
2735842|NCT00106704|9399799|P2|Overall Study|Planned major surgery|0
2735843|NCT00106704|9399800|P1|Overall Study|Planned major surgery|1
2735844|NCT00106704|9399799|P2|Overall Study|Site terminated|1
2735845|NCT00106704|9399800|P1|Overall Study|Site terminated|0
2735846|NCT00106704|9399799|P2|Overall Study|Patient moved|0
2735847|NCT00106704|9399800|P1|Overall Study|Patient moved|1
2735848|NCT00106704|9399799|P2|Overall Study|Withdrawal by Subject|21
2735849|NCT00106704|9399800|P1|Overall Study|Withdrawal by Subject|14
2735850|NCT00106704|9399799|P2|Overall Study|Protocol Violation|7
2735851|NCT00106704|9399800|P1|Overall Study|Protocol Violation|4
2735852|NCT00106704|9399799|P2|Overall Study|Pregnancy|0
2735853|NCT00106704|9399800|P1|Overall Study|Pregnancy|1
2735854|NCT00106704|9399799|P2|Overall Study|Lost to Follow-up|3
2735855|NCT00106704|9399800|P1|Overall Study|Lost to Follow-up|7
2735856|NCT00106704|9399799|P2|Overall Study|Lack of Efficacy|69
2735857|NCT00106704|9399800|P1|Overall Study|Lack of Efficacy|67
2735858|NCT00106704|9399799|P2|Overall Study|Death|1
2735859|NCT00106704|9399800|P1|Overall Study|Death|2
2735860|NCT00106704|9399799|P2|Overall Study|Adverse Event|7
2735861|NCT00106704|9399800|P1|Overall Study|Adverse Event|10
2735862|NCT00106639|9399811|P3|Overall Study|Participant defaulted|1
2735863|NCT00106639|9399812|P2|Overall Study|Participant defaulted|1
2735864|NCT00106639|9399813|P1|Overall Study|Participant defaulted|0
2735865|NCT00106639|9399811|P3|Overall Study|Withdrawal by Subject|0
2735866|NCT00106639|9399812|P2|Overall Study|Withdrawal by Subject|1
2735867|NCT00106639|9399813|P1|Overall Study|Withdrawal by Subject|0
2735868|NCT00106639|9399811|P3|Overall Study|Protocol Violation|0
2735869|NCT00106639|9399812|P2|Overall Study|Protocol Violation|1
2735870|NCT00106639|9399813|P1|Overall Study|Protocol Violation|0
2735871|NCT00106639|9399811|P3|Overall Study|Adverse Event|1
2735872|NCT00106639|9399812|P2|Overall Study|Adverse Event|4
2735873|NCT00106639|9399813|P1|Overall Study|Adverse Event|3
2735874|NCT00106626|9399940|P4|Overall Study|> 14 day delay in therapy start|0
2735875|NCT00106626|9399941|P3|Overall Study|> 14 day delay in therapy start|0
2735876|NCT00106626|9399942|P2|Overall Study|> 14 day delay in therapy start|1
2735877|NCT00106626|9399943|P1|Overall Study|> 14 day delay in therapy start|0
2735878|NCT00106626|9399940|P4|Overall Study|Received radiation on new therapy|0
2735879|NCT00106626|9399941|P3|Overall Study|Received radiation on new therapy|0
2735880|NCT00106626|9399942|P2|Overall Study|Received radiation on new therapy|0
2735881|NCT00106626|9399943|P1|Overall Study|Received radiation on new therapy|1
2735882|NCT00106626|9399940|P4|Overall Study|Progressive Disease|10
2735883|NCT00106626|9399941|P3|Overall Study|Progressive Disease|9
2735884|NCT00106626|9399942|P2|Overall Study|Progressive Disease|1
2735885|NCT00106626|9399943|P1|Overall Study|Progressive Disease|4
2735886|NCT00106626|9399940|P4|Overall Study|Adverse Event|3
2735887|NCT00106626|9399941|P3|Overall Study|Adverse Event|3
2735888|NCT00106626|9399942|P2|Overall Study|Adverse Event|4
2735889|NCT00106626|9399943|P1|Overall Study|Adverse Event|5
2735890|NCT00106353|9400288|P7|Part 2|Physician Decision|0
2735891|NCT00106353|9400289|P6|Part 2|Physician Decision|1
2735892|NCT00106353|9400290|P5|Part 2|Physician Decision|0
2735893|NCT00106353|9400291|P4|Part 2|Physician Decision|0
2735894|NCT00106353|9400292|P3|Part 2|Physician Decision|0
2735895|NCT00106353|9400293|P2|Part 2|Physician Decision|0
2735896|NCT00106353|9400294|P1|Part 2|Physician Decision|0
2735897|NCT00106353|9400288|P7|Part 2|Withdrawal by Subject|0
2735898|NCT00106353|9400289|P6|Part 2|Withdrawal by Subject|0
2735899|NCT00106353|9400290|P5|Part 2|Withdrawal by Subject|1
2735900|NCT00106353|9400291|P4|Part 2|Withdrawal by Subject|0
2735901|NCT00106353|9400292|P3|Part 2|Withdrawal by Subject|0
2735902|NCT00106353|9400293|P2|Part 2|Withdrawal by Subject|0
2735903|NCT00106353|9400294|P1|Part 2|Withdrawal by Subject|0
2735904|NCT00106353|9400288|P7|Part 2|Other|1
2735905|NCT00106353|9400289|P6|Part 2|Other|1
2735906|NCT00106353|9400290|P5|Part 2|Other|1
2735907|NCT00106353|9400291|P4|Part 2|Other|0
2735908|NCT00106353|9400292|P3|Part 2|Other|0
2735909|NCT00106353|9400293|P2|Part 2|Other|0
2735910|NCT00106353|9400294|P1|Part 2|Other|0
2735911|NCT00106353|9400288|P7|Part 2|Adverse Event|1
2735912|NCT00106353|9400289|P6|Part 2|Adverse Event|2
2735913|NCT00106353|9400290|P5|Part 2|Adverse Event|0
2735914|NCT00106353|9400291|P4|Part 2|Adverse Event|0
2735915|NCT00106353|9400292|P3|Part 2|Adverse Event|0
2735916|NCT00106353|9400293|P2|Part 2|Adverse Event|0
2735917|NCT00106353|9400294|P1|Part 2|Adverse Event|0
2735918|NCT00106353|9400288|P7|Part 2|Symptomatic deterioration|0
2735919|NCT00106353|9400289|P6|Part 2|Symptomatic deterioration|0
2735920|NCT00106353|9400290|P5|Part 2|Symptomatic deterioration|3
2735921|NCT00106353|9400291|P4|Part 2|Symptomatic deterioration|0
2735922|NCT00106353|9400292|P3|Part 2|Symptomatic deterioration|0
2735923|NCT00106353|9400293|P2|Part 2|Symptomatic deterioration|0
2735924|NCT00106353|9400294|P1|Part 2|Symptomatic deterioration|0
2735925|NCT00106353|9400288|P7|Part 2|Death|1
2735926|NCT00106353|9400289|P6|Part 2|Death|0
2735927|NCT00106353|9400290|P5|Part 2|Death|3
2735928|NCT00106353|9400291|P4|Part 2|Death|0
2735929|NCT00106353|9400292|P3|Part 2|Death|0
2735930|NCT00106353|9400293|P2|Part 2|Death|0
2735931|NCT00106353|9400294|P1|Part 2|Death|0
2735932|NCT00106353|9400288|P7|Part 2|Disease progression|13
2735933|NCT00106353|9400289|P6|Part 2|Disease progression|14
2735934|NCT00106353|9400290|P5|Part 2|Disease progression|8
2735935|NCT00106353|9400291|P4|Part 2|Disease progression|0
2735936|NCT00106353|9400292|P3|Part 2|Disease progression|0
2735937|NCT00106353|9400293|P2|Part 2|Disease progression|0
2735938|NCT00106353|9400294|P1|Part 2|Disease progression|0
2735939|NCT00106353|9400288|P7|Part 1|Adverse Event|0
2735940|NCT00106353|9400289|P6|Part 1|Adverse Event|0
2735941|NCT00106353|9400290|P5|Part 1|Adverse Event|0
2735942|NCT00106353|9400291|P4|Part 1|Adverse Event|1
2735943|NCT00106353|9400292|P3|Part 1|Adverse Event|0
2735944|NCT00106353|9400293|P2|Part 1|Adverse Event|0
2735945|NCT00106353|9400294|P1|Part 1|Adverse Event|0
2735946|NCT00106353|9400288|P7|Part 1|Entered follow-up phase|0
2735947|NCT00106353|9400289|P6|Part 1|Entered follow-up phase|0
2735948|NCT00106353|9400290|P5|Part 1|Entered follow-up phase|0
2735949|NCT00106353|9400291|P4|Part 1|Entered follow-up phase|1
2735950|NCT00106353|9400292|P3|Part 1|Entered follow-up phase|0
2735951|NCT00106353|9400293|P2|Part 1|Entered follow-up phase|1
2735952|NCT00106353|9400294|P1|Part 1|Entered follow-up phase|1
2735953|NCT00106353|9400288|P7|Part 1|Symptomatic deterioration|0
2735954|NCT00106353|9400289|P6|Part 1|Symptomatic deterioration|0
2735955|NCT00106353|9400290|P5|Part 1|Symptomatic deterioration|0
2735956|NCT00106353|9400291|P4|Part 1|Symptomatic deterioration|0
2735957|NCT00106353|9400292|P3|Part 1|Symptomatic deterioration|1
2735958|NCT00106353|9400293|P2|Part 1|Symptomatic deterioration|0
2735959|NCT00106353|9400294|P1|Part 1|Symptomatic deterioration|0
2735960|NCT00106353|9400288|P7|Part 1|Withdrawal by Subject|0
2735961|NCT00106353|9400289|P6|Part 1|Withdrawal by Subject|0
2735962|NCT00106353|9400290|P5|Part 1|Withdrawal by Subject|0
2735963|NCT00106353|9400291|P4|Part 1|Withdrawal by Subject|2
2735964|NCT00106353|9400292|P3|Part 1|Withdrawal by Subject|1
2735965|NCT00106353|9400293|P2|Part 1|Withdrawal by Subject|0
2735966|NCT00106353|9400294|P1|Part 1|Withdrawal by Subject|0
2735967|NCT00106353|9400288|P7|Part 1|Disease progression|0
2735968|NCT00106353|9400289|P6|Part 1|Disease progression|0
2735969|NCT00106353|9400290|P5|Part 1|Disease progression|0
2735970|NCT00106353|9400291|P4|Part 1|Disease progression|3
2735971|NCT00106353|9400292|P3|Part 1|Disease progression|1
2735972|NCT00106353|9400293|P2|Part 1|Disease progression|4
2735973|NCT00106353|9400294|P1|Part 1|Disease progression|3
2735974|NCT00106249|9400421|P2|Overall Study|Lost to Follow-up|2
2735975|NCT00106249|9400422|P1|Overall Study|Lost to Follow-up|3
2735976|NCT00106184|9400434|P2|Overall Study|Withdrawal by Subject|2
2735977|NCT00106184|9400435|P1|Overall Study|Withdrawal by Subject|3
2735978|NCT00106080|9400477|P2|Overall Study|Withdrew/Loss to follow-up|27
2735979|NCT00106080|9400478|P1|Overall Study|Withdrew/Loss to follow-up|43
2735980|NCT00106028|9400488|P2|Overall Study|Lost to Follow-up|1
2735981|NCT00106028|9400489|P1|Overall Study|Lost to Follow-up|0
2735982|NCT00106028|9400488|P2|Overall Study|Withdrawal by Subject|8
2735983|NCT00106028|9400489|P1|Overall Study|Withdrawal by Subject|2
2735984|NCT00106028|9400488|P2|Overall Study|Protocol Violation|1
2735985|NCT00106028|9400489|P1|Overall Study|Protocol Violation|1
2735986|NCT00106028|9400488|P2|Overall Study|Adverse Event|2
2735987|NCT00106028|9400489|P1|Overall Study|Adverse Event|3
2735988|NCT00106002|9400583|P1|Overall Study|Ineligible after Registration|1
2735989|NCT00106002|9400583|P1|Overall Study|Did not take any study drug|1
2735990|NCT00105989|9400591|P2|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
2735991|NCT00105989|9400592|P1|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
2735992|NCT00105989|9400591|P2|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43
2735993|NCT00105989|9400592|P1|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14
2735994|NCT00105989|9400591|P2|Maintenance - Double-Blind:Week 34-86|Death|0
2735995|NCT00105989|9400592|P1|Maintenance - Double-Blind:Week 34-86|Death|0
2735996|NCT00105989|9400591|P2|Maintenance - Double-Blind:Week 34-86|Physician Decision|1
2735997|NCT00105989|9400592|P1|Maintenance - Double-Blind:Week 34-86|Physician Decision|4
2735998|NCT00105989|9400591|P2|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0
2735999|NCT00105989|9400592|P1|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4
2736000|NCT00105989|9400591|P2|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4
2736001|NCT00105989|9400592|P1|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5
2736002|NCT00105989|9400591|P2|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
2736003|NCT00105989|9400592|P1|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
2736004|NCT00105989|9400591|P2|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
2736005|NCT00105989|9400592|P1|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
2736006|NCT00105989|9400591|P2|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18
2736007|NCT00105989|9400592|P1|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17
2736008|NCT00105989|9400591|P2|Maintenance - Double-Blind:Week 34-86|Adverse Event|3
2736009|NCT00105989|9400592|P1|Maintenance - Double-Blind:Week 34-86|Adverse Event|6
2736010|NCT00105989|9400591|P2|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
2736011|NCT00105989|9400592|P1|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
2736012|NCT00105989|9400591|P2|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0
2736013|NCT00105989|9400592|P1|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2
2736014|NCT00105989|9400591|P2|Continuation - Open Label:Week 10-34|Death|0
2736015|NCT00105989|9400592|P1|Continuation - Open Label:Week 10-34|Death|0
2736016|NCT00105989|9400591|P2|Continuation - Open Label:Week 10-34|Physician Decision|0
2736017|NCT00105989|9400592|P1|Continuation - Open Label:Week 10-34|Physician Decision|3
2736018|NCT00105989|9400591|P2|Continuation - Open Label:Week 10-34|Lost to Follow-up|0
2736019|NCT00105989|9400592|P1|Continuation - Open Label:Week 10-34|Lost to Follow-up|9
2736020|NCT00105989|9400591|P2|Continuation - Open Label:Week 10-34|Protocol Violation|0
2736021|NCT00105989|9400592|P1|Continuation - Open Label:Week 10-34|Protocol Violation|5
2736022|NCT00105989|9400591|P2|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0
2736023|NCT00105989|9400592|P1|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16
2736024|NCT00105989|9400591|P2|Continuation - Open Label:Week 10-34|Lack of Efficacy|0
2736025|NCT00105989|9400592|P1|Continuation - Open Label:Week 10-34|Lack of Efficacy|15
2736026|NCT00105989|9400591|P2|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0
2736027|NCT00105989|9400592|P1|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50
2736028|NCT00105989|9400591|P2|Continuation - Open Label:Week 10-34|Adverse Event|0
2736029|NCT00105989|9400592|P1|Continuation - Open Label:Week 10-34|Adverse Event|25
2736030|NCT00105989|9400591|P2|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
2736031|NCT00105989|9400592|P1|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
2736032|NCT00105989|9400591|P2|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
2736033|NCT00105989|9400592|P1|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
2736034|NCT00105989|9400591|P2|Acute - Open Label: Week 0-10|Death|0
2736035|NCT00105989|9400592|P1|Acute - Open Label: Week 0-10|Death|1
2736036|NCT00105989|9400591|P2|Acute - Open Label: Week 0-10|Physician Decision|0
2736037|NCT00105989|9400592|P1|Acute - Open Label: Week 0-10|Physician Decision|0
2736038|NCT00105989|9400591|P2|Acute - Open Label: Week 0-10|Lost to Follow-up|0
2736039|NCT00105989|9400592|P1|Acute - Open Label: Week 0-10|Lost to Follow-up|4
2736040|NCT00105989|9400591|P2|Acute - Open Label: Week 0-10|Protocol Violation|0
2736041|NCT00105989|9400592|P1|Acute - Open Label: Week 0-10|Protocol Violation|8
2736042|NCT00105989|9400591|P2|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0
2736043|NCT00105989|9400592|P1|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14
2736044|NCT00105989|9400591|P2|Acute - Open Label: Week 0-10|Lack of Efficacy|0
2736045|NCT00105989|9400592|P1|Acute - Open Label: Week 0-10|Lack of Efficacy|17
2736046|NCT00105989|9400591|P2|Acute - Open Label: Week 0-10|Withdrawal by Subject|0
2736047|NCT00105989|9400592|P1|Acute - Open Label: Week 0-10|Withdrawal by Subject|24
2736048|NCT00105989|9400591|P2|Acute - Open Label: Week 0-10|Adverse Event|0
2736049|NCT00105989|9400592|P1|Acute - Open Label: Week 0-10|Adverse Event|33
2736050|NCT00105586|9400708|P2|Overall Study|Physician Decision|13
2736051|NCT00105586|9400709|P1|Overall Study|Physician Decision|13
2736052|NCT00105586|9400708|P2|Overall Study|Adverse Event|3
2736053|NCT00105586|9400709|P1|Overall Study|Adverse Event|4
2736054|NCT00105560|9400717|P1|Overall Study|Lost to Follow-up|1
2736055|NCT00105534|9400739|P2|Overall Study|Other Reason|2
2736056|NCT00105534|9400740|P1|Overall Study|Other Reason|0
2736057|NCT00105534|9400739|P2|Overall Study|Treatment unmasked|0
2736058|NCT00105534|9400740|P1|Overall Study|Treatment unmasked|1
2736059|NCT00105534|9400739|P2|Overall Study|Lack of Efficacy|15
2736060|NCT00105534|9400740|P1|Overall Study|Lack of Efficacy|7
2736061|NCT00105534|9400739|P2|Overall Study|Lost to Follow-up|1
2736062|NCT00105534|9400740|P1|Overall Study|Lost to Follow-up|5
2736063|NCT00105534|9400739|P2|Overall Study|Withdrawal by Subject|6
2736064|NCT00105534|9400740|P1|Overall Study|Withdrawal by Subject|6
2736065|NCT00105534|9400739|P2|Overall Study|Protocol Violation|4
2736066|NCT00105534|9400740|P1|Overall Study|Protocol Violation|1
2736067|NCT00105534|9400739|P2|Overall Study|Adverse Event|5
2736068|NCT00105534|9400740|P1|Overall Study|Adverse Event|2
2736069|NCT00105521|9400752|P4|Overall Study|Lost to Follow-up|0
2736070|NCT00105521|9400753|P3|Overall Study|Lost to Follow-up|0
2736071|NCT00105521|9400754|P2|Overall Study|Lost to Follow-up|1
2736072|NCT00105521|9400755|P1|Overall Study|Lost to Follow-up|0
2736073|NCT00105521|9400752|P4|Overall Study|Protocol Violation|4
2736074|NCT00105521|9400753|P3|Overall Study|Protocol Violation|4
2736075|NCT00105521|9400754|P2|Overall Study|Protocol Violation|5
2736076|NCT00105521|9400755|P1|Overall Study|Protocol Violation|3
2736077|NCT00105521|9400752|P4|Overall Study|Lack of Efficacy|1
2736078|NCT00105521|9400753|P3|Overall Study|Lack of Efficacy|0
2736079|NCT00105521|9400754|P2|Overall Study|Lack of Efficacy|0
2736080|NCT00105521|9400755|P1|Overall Study|Lack of Efficacy|0
2736081|NCT00105521|9400752|P4|Overall Study|Withdrawal by Subject|4
2736082|NCT00105521|9400753|P3|Overall Study|Withdrawal by Subject|1
2736083|NCT00105521|9400754|P2|Overall Study|Withdrawal by Subject|0
2736084|NCT00105521|9400755|P1|Overall Study|Withdrawal by Subject|1
2736085|NCT00105521|9400752|P4|Overall Study|Adverse Event|8
2736086|NCT00105521|9400753|P3|Overall Study|Adverse Event|10
2736087|NCT00105521|9400754|P2|Overall Study|Adverse Event|4
2736088|NCT00105521|9400755|P1|Overall Study|Adverse Event|10
2736089|NCT00105521|9400752|P4|Overall Study|Other|0
2736090|NCT00105521|9400753|P3|Overall Study|Other|2
2736091|NCT00105521|9400754|P2|Overall Study|Other|1
2736092|NCT00105521|9400755|P1|Overall Study|Other|1
2736093|NCT00105508|9400779|P2|Overall Study|Other|9
2736094|NCT00105508|9400780|P1|Overall Study|Other|8
2736095|NCT00105508|9400779|P2|Overall Study|Protocol Violation|2
2736096|NCT00105508|9400780|P1|Overall Study|Protocol Violation|1
2736097|NCT00105508|9400779|P2|Overall Study|Lost to Follow-up|0
2736098|NCT00105508|9400780|P1|Overall Study|Lost to Follow-up|3
2736099|NCT00105508|9400779|P2|Overall Study|Withdrawal by Subject|6
2736100|NCT00105508|9400780|P1|Overall Study|Withdrawal by Subject|10
2736101|NCT00105508|9400779|P2|Overall Study|Insufficient Efficacy|0
2736102|NCT00105508|9400780|P1|Overall Study|Insufficient Efficacy|1
2736103|NCT00105508|9400779|P2|Overall Study|Adverse Event|19
2736104|NCT00105508|9400780|P1|Overall Study|Adverse Event|16
2736105|NCT00105508|9400779|P2|Overall Study|Prephase Dropout|0
2736106|NCT00105508|9400780|P1|Overall Study|Prephase Dropout|1
2736107|NCT00105482|9400794|P2|Overall Study|Withdrawn by PI|1
2736108|NCT00105482|9400795|P1|Overall Study|Withdrawn by PI|1
2736109|NCT00105482|9400794|P2|Overall Study|Scheduling Conflict|3
2736110|NCT00105482|9400795|P1|Overall Study|Scheduling Conflict|2
2736111|NCT00105482|9400794|P2|Overall Study|Lost Interest|32
2736112|NCT00105482|9400795|P1|Overall Study|Lost Interest|29
2736113|NCT00105482|9400794|P2|Overall Study|Withdrawal by Subject|1
2736114|NCT00105482|9400795|P1|Overall Study|Withdrawal by Subject|0
2736115|NCT00105482|9400794|P2|Overall Study|Lost to Follow-up|17
2736116|NCT00105482|9400795|P1|Overall Study|Lost to Follow-up|26
2736117|NCT00105482|9400794|P2|Overall Study|Adverse Event|1
2736118|NCT00105482|9400795|P1|Overall Study|Adverse Event|1
2736119|NCT00105469|9400811|P2|Overall Study|Other Reason|0
2736120|NCT00105469|9400812|P1|Overall Study|Other Reason|4
2736121|NCT00105469|9400811|P2|Overall Study|Lack of Efficacy|0
2736122|NCT00105469|9400812|P1|Overall Study|Lack of Efficacy|2
2736123|NCT00105469|9400811|P2|Overall Study|Lost to Follow-up|0
2736124|NCT00105469|9400812|P1|Overall Study|Lost to Follow-up|1
2736125|NCT00105469|9400811|P2|Overall Study|Withdrawal by Subject|3
2736126|NCT00105469|9400812|P1|Overall Study|Withdrawal by Subject|2
2736127|NCT00105469|9400811|P2|Overall Study|Protocol Violation|0
2736128|NCT00105469|9400812|P1|Overall Study|Protocol Violation|4
2736129|NCT00105469|9400811|P2|Overall Study|Adverse Event|8
2736130|NCT00105469|9400812|P1|Overall Study|Adverse Event|9
2736131|NCT00105443|9400822|P4|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11
2736132|NCT00105443|9400823|P3|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
2736133|NCT00105443|9400824|P2|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23
2736134|NCT00105443|9400825|P1|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
2736135|NCT00105443|9400822|P4|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
2736136|NCT00105443|9400823|P3|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
2736137|NCT00105443|9400824|P2|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
2736138|NCT00105443|9400825|P1|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
2736139|NCT00105443|9400822|P4|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1
2736140|NCT00105443|9400823|P3|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
2736141|NCT00105443|9400824|P2|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
2736142|NCT00105443|9400825|P1|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
2736143|NCT00105443|9400822|P4|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
2736144|NCT00105443|9400823|P3|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
2736145|NCT00105443|9400824|P2|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
2736146|NCT00105443|9400825|P1|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1
2736147|NCT00105443|9400822|P4|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
2736148|NCT00105443|9400823|P3|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1
2736149|NCT00105443|9400824|P2|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
2736150|NCT00105443|9400825|P1|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
2736151|NCT00105443|9400822|P4|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
2736152|NCT00105443|9400823|P3|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1
2736153|NCT00105443|9400824|P2|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
2736154|NCT00105443|9400825|P1|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6
2736155|NCT00105443|9400822|P4|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
2736156|NCT00105443|9400823|P3|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
2736157|NCT00105443|9400824|P2|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
2736158|NCT00105443|9400825|P1|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
2736159|NCT00105443|9400822|P4|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5
2736160|NCT00105443|9400823|P3|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
2736161|NCT00105443|9400824|P2|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2
2736162|NCT00105443|9400825|P1|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
2736163|NCT00105443|9400822|P4|Follow-up and/or Open Label Nexavar|Protocol Violation|0
2736164|NCT00105443|9400823|P3|Follow-up and/or Open Label Nexavar|Protocol Violation|0
2736165|NCT00105443|9400824|P2|Follow-up and/or Open Label Nexavar|Protocol Violation|2
2736166|NCT00105443|9400825|P1|Follow-up and/or Open Label Nexavar|Protocol Violation|0
2736167|NCT00105443|9400822|P4|Follow-up and/or Open Label Nexavar|Physician Decision|0
2736168|NCT00105443|9400823|P3|Follow-up and/or Open Label Nexavar|Physician Decision|1
2736169|NCT00105443|9400824|P2|Follow-up and/or Open Label Nexavar|Physician Decision|0
2736170|NCT00105443|9400825|P1|Follow-up and/or Open Label Nexavar|Physician Decision|1
2736171|NCT00105443|9400822|P4|Follow-up and/or Open Label Nexavar|Adverse Event|16
2736172|NCT00105443|9400823|P3|Follow-up and/or Open Label Nexavar|Adverse Event|0
2736173|NCT00105443|9400824|P2|Follow-up and/or Open Label Nexavar|Adverse Event|14
2736174|NCT00105443|9400825|P1|Follow-up and/or Open Label Nexavar|Adverse Event|0
2736175|NCT00105443|9400822|P4|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4
2736176|NCT00105443|9400823|P3|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13
2736177|NCT00105443|9400824|P2|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3
2736178|NCT00105443|9400825|P1|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24
2736179|NCT00105443|9400822|P4|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
2736180|NCT00105443|9400823|P3|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10
2736181|NCT00105443|9400824|P2|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
2736182|NCT00105443|9400825|P1|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14
2736183|NCT00105443|9400822|P4|Follow-up and/or Open Label Nexavar|Death|4
2736184|NCT00105443|9400823|P3|Follow-up and/or Open Label Nexavar|Death|219
2736185|NCT00105443|9400824|P2|Follow-up and/or Open Label Nexavar|Death|7
2736186|NCT00105443|9400825|P1|Follow-up and/or Open Label Nexavar|Death|180
2736187|NCT00105443|9400822|P4|Double-Blind Treatment|Radiological and symptomatic progression|0
2736188|NCT00105443|9400823|P3|Double-Blind Treatment|Radiological and symptomatic progression|1
2736189|NCT00105443|9400824|P2|Double-Blind Treatment|Radiological and symptomatic progression|0
2736190|NCT00105443|9400825|P1|Double-Blind Treatment|Radiological and symptomatic progression|4
2736191|NCT00105443|9400822|P4|Double-Blind Treatment|Physician Decision|0
2736192|NCT00105443|9400823|P3|Double-Blind Treatment|Physician Decision|2
2736193|NCT00105443|9400824|P2|Double-Blind Treatment|Physician Decision|0
2736194|NCT00105443|9400825|P1|Double-Blind Treatment|Physician Decision|1
2736195|NCT00105443|9400822|P4|Double-Blind Treatment|Withdrawal by Subject|0
2736196|NCT00105443|9400823|P3|Double-Blind Treatment|Withdrawal by Subject|7
2736197|NCT00105443|9400824|P2|Double-Blind Treatment|Withdrawal by Subject|0
2736198|NCT00105443|9400825|P1|Double-Blind Treatment|Withdrawal by Subject|8
2736199|NCT00105443|9400822|P4|Double-Blind Treatment|Lost to Follow-up|0
2736200|NCT00105443|9400823|P3|Double-Blind Treatment|Lost to Follow-up|1
2736201|NCT00105443|9400824|P2|Double-Blind Treatment|Lost to Follow-up|0
2736202|NCT00105443|9400825|P1|Double-Blind Treatment|Lost to Follow-up|0
2736203|NCT00105443|9400822|P4|Double-Blind Treatment|Adverse Event|0
2736204|NCT00105443|9400823|P3|Double-Blind Treatment|Adverse Event|0
2736205|NCT00105443|9400824|P2|Double-Blind Treatment|Adverse Event|0
2736206|NCT00105443|9400825|P1|Double-Blind Treatment|Adverse Event|1
2736207|NCT00105235|9400852|P1|Overall Study|Withdrawal by Subject|2
2736208|NCT00105235|9400852|P1|Overall Study|Physician Decision|1
2736209|NCT00105235|9400852|P1|Overall Study|Death|4
2736210|NCT00105196|9400865|P2|Overall Study|Subject became unblinded|1
2736211|NCT00105196|9400866|P1|Overall Study|Subject became unblinded|0
2736212|NCT00105196|9400865|P2|Overall Study|marijuana use|1
2736213|NCT00105196|9400866|P1|Overall Study|marijuana use|0
2736214|NCT00105196|9400865|P2|Overall Study|pending surgery|1
2736215|NCT00105196|9400866|P1|Overall Study|pending surgery|0
2736216|NCT00105196|9400865|P2|Overall Study|Protocol Violation|2
2736217|NCT00105196|9400866|P1|Overall Study|Protocol Violation|5
2736218|NCT00105196|9400865|P2|Overall Study|Poor/noncompliance|4
2736219|NCT00105196|9400866|P1|Overall Study|Poor/noncompliance|3
2736220|NCT00105196|9400865|P2|Overall Study|Lost to Follow-up|2
2736221|NCT00105196|9400866|P1|Overall Study|Lost to Follow-up|3
2736222|NCT00105196|9400865|P2|Overall Study|Withdrawal by Subject|6
2736223|NCT00105196|9400866|P1|Overall Study|Withdrawal by Subject|6
2736224|NCT00105196|9400865|P2|Overall Study|Adverse Event|3
2736225|NCT00105196|9400866|P1|Overall Study|Adverse Event|11
2736226|NCT00105196|9400865|P2|Overall Study|Lack of Efficacy|3
2736227|NCT00105196|9400866|P1|Overall Study|Lack of Efficacy|2
2736228|NCT00105183|9400889|P3|Overall Study|Other reason|0
2736229|NCT00105183|9400890|P2|Overall Study|Other reason|2
2736230|NCT00105183|9400891|P1|Overall Study|Other reason|1
2736231|NCT00105183|9400889|P3|Overall Study|Lost to Follow-up|1
2736232|NCT00105183|9400890|P2|Overall Study|Lost to Follow-up|1
2736233|NCT00105183|9400891|P1|Overall Study|Lost to Follow-up|0
2736234|NCT00105183|9400889|P3|Overall Study|Physician Decision|3
2736235|NCT00105183|9400890|P2|Overall Study|Physician Decision|2
2736236|NCT00105183|9400891|P1|Overall Study|Physician Decision|1
2736237|NCT00105183|9400889|P3|Overall Study|Withdrawal by Subject|4
2736238|NCT00105183|9400890|P2|Overall Study|Withdrawal by Subject|1
2736239|NCT00105183|9400891|P1|Overall Study|Withdrawal by Subject|1
2736240|NCT00105183|9400889|P3|Overall Study|Death|15
2736241|NCT00105183|9400890|P2|Overall Study|Death|13
2736242|NCT00105183|9400891|P1|Overall Study|Death|19
2736243|NCT00105157|9400927|P4|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
2736244|NCT00105157|9400928|P3|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
2736245|NCT00105157|9400929|P2|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0
2736246|NCT00105157|9400930|P1|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
2736247|NCT00105157|9400927|P4|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5
2736248|NCT00105157|9400928|P3|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
2736249|NCT00105157|9400929|P2|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
2736250|NCT00105157|9400930|P1|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
2736251|NCT00105157|9400927|P4|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
2736252|NCT00105157|9400928|P3|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
2736253|NCT00105157|9400929|P2|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
2736254|NCT00105157|9400930|P1|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
2736255|NCT00105157|9400927|P4|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10
2736256|NCT00105157|9400928|P3|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5
2736257|NCT00105157|9400929|P2|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6
2736258|NCT00105157|9400930|P1|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7
2736259|NCT00105157|9400927|P4|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1
2736260|NCT00105157|9400928|P3|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
2736261|NCT00105157|9400929|P2|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
2736262|NCT00105157|9400930|P1|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
2736263|NCT00105157|9400927|P4|Open-Label Continuation of DB|Patient moved/site stopped trial|0
2736264|NCT00105157|9400928|P3|Open-Label Continuation of DB|Patient moved/site stopped trial|2
2736265|NCT00105157|9400929|P2|Open-Label Continuation of DB|Patient moved/site stopped trial|3
2736266|NCT00105157|9400930|P1|Open-Label Continuation of DB|Patient moved/site stopped trial|1
2736267|NCT00105157|9400927|P4|Open-Label Continuation of DB|Patient did not continue in extension|0
2736268|NCT00105157|9400928|P3|Open-Label Continuation of DB|Patient did not continue in extension|0
2736269|NCT00105157|9400929|P2|Open-Label Continuation of DB|Patient did not continue in extension|0
2736270|NCT00105157|9400930|P1|Open-Label Continuation of DB|Patient did not continue in extension|1
2736271|NCT00105157|9400927|P4|Open-Label Continuation of DB|Withdrawal by Subject|0
2736272|NCT00105157|9400928|P3|Open-Label Continuation of DB|Withdrawal by Subject|3
2736273|NCT00105157|9400929|P2|Open-Label Continuation of DB|Withdrawal by Subject|1
2736274|NCT00105157|9400930|P1|Open-Label Continuation of DB|Withdrawal by Subject|0
2736275|NCT00105157|9400927|P4|Open-Label Continuation of DB|Lost to Follow-up|0
2736276|NCT00105157|9400928|P3|Open-Label Continuation of DB|Lost to Follow-up|1
2736277|NCT00105157|9400929|P2|Open-Label Continuation of DB|Lost to Follow-up|1
2736278|NCT00105157|9400930|P1|Open-Label Continuation of DB|Lost to Follow-up|1
2736279|NCT00105157|9400927|P4|Open-Label Continuation of DB|Lack of Efficacy|1
2736280|NCT00105157|9400928|P3|Open-Label Continuation of DB|Lack of Efficacy|3
2736281|NCT00105157|9400929|P2|Open-Label Continuation of DB|Lack of Efficacy|4
2736282|NCT00105157|9400930|P1|Open-Label Continuation of DB|Lack of Efficacy|1
2736283|NCT00105157|9400927|P4|Open-Label Continuation of DB|Adverse Event|0
2736284|NCT00105157|9400928|P3|Open-Label Continuation of DB|Adverse Event|0
2736285|NCT00105157|9400929|P2|Open-Label Continuation of DB|Adverse Event|1
2736286|NCT00105157|9400930|P1|Open-Label Continuation of DB|Adverse Event|3
2736287|NCT00105157|9400927|P4|Double-Blind (DB)|Lack of Efficacy|38
2736288|NCT00105157|9400928|P3|Double-Blind (DB)|Lack of Efficacy|11
2736289|NCT00105157|9400929|P2|Double-Blind (DB)|Lack of Efficacy|14
2736290|NCT00105157|9400930|P1|Double-Blind (DB)|Lack of Efficacy|11
2736291|NCT00105157|9400927|P4|Double-Blind (DB)|Adverse Event|1
2736292|NCT00105157|9400928|P3|Double-Blind (DB)|Adverse Event|1
2736293|NCT00105157|9400929|P2|Double-Blind (DB)|Adverse Event|0
2736294|NCT00105157|9400930|P1|Double-Blind (DB)|Adverse Event|2
2736295|NCT00105157|9400927|P4|Double-Blind (DB)|Never Treated|0
2736296|NCT00105157|9400928|P3|Double-Blind (DB)|Never Treated|0
2736297|NCT00105157|9400929|P2|Double-Blind (DB)|Never Treated|0
2736298|NCT00105157|9400930|P1|Double-Blind (DB)|Never Treated|1
2736299|NCT00105079|9401124|P2|Overall Study|Other|1
2736300|NCT00105079|9401125|P1|Overall Study|Other|3
2736301|NCT00105079|9401124|P2|Overall Study|Protocol Violation|0
2736302|NCT00105079|9401125|P1|Overall Study|Protocol Violation|1
2736303|NCT00105079|9401124|P2|Overall Study|Violation of selection criteria at entry|2
2736304|NCT00105079|9401125|P1|Overall Study|Violation of selection criteria at entry|0
2736305|NCT00105079|9401124|P2|Overall Study|Refused treatment|4
2736306|NCT00105079|9401125|P1|Overall Study|Refused treatment|6
2736307|NCT00105079|9401124|P2|Overall Study|Lack of Efficacy|3
2736308|NCT00105079|9401125|P1|Overall Study|Lack of Efficacy|9
2736309|NCT00105079|9401124|P2|Overall Study|Lost to Follow-up|12
2736310|NCT00105079|9401125|P1|Overall Study|Lost to Follow-up|12
2736311|NCT00105079|9401124|P2|Overall Study|Death|1
2736312|NCT00105079|9401125|P1|Overall Study|Death|3
2736313|NCT00105079|9401124|P2|Overall Study|Adverse Event|12
2736314|NCT00105079|9401125|P1|Overall Study|Adverse Event|5
2736315|NCT00105066|9401143|P2|Overall Study|Adverse Event|5
2736316|NCT00105066|9401144|P1|Overall Study|Adverse Event|2
2736317|NCT00104884|9401222|P1|Overall Study|Disease progression|4
2736318|NCT00104871|9401226|P1|Overall Study|Not evaluable|1
2736319|NCT00104728|9401247|P1|Overall Study|screen failures|19
2736320|NCT00104650|9401255|P3|Follow-up Period|Other|0
2736321|NCT00104650|9401256|P2|Follow-up Period|Other|1
2736322|NCT00104650|9401257|P1|Follow-up Period|Other|0
2736323|NCT00104650|9401255|P3|Follow-up Period|Lost to Follow-up|2
2736324|NCT00104650|9401256|P2|Follow-up Period|Lost to Follow-up|1
2736325|NCT00104650|9401257|P1|Follow-up Period|Lost to Follow-up|0
2736326|NCT00104650|9401255|P3|Follow-up Period|Disease progression|0
2736327|NCT00104650|9401256|P2|Follow-up Period|Disease progression|1
2736328|NCT00104650|9401257|P1|Follow-up Period|Disease progression|3
2736329|NCT00104650|9401255|P3|Follow-up Period|Death|4
2736330|NCT00104650|9401256|P2|Follow-up Period|Death|6
2736331|NCT00104650|9401257|P1|Follow-up Period|Death|6
2736332|NCT00104650|9401255|P3|Follow-up Period|Withdrawal by Subject|3
2736333|NCT00104650|9401256|P2|Follow-up Period|Withdrawal by Subject|3
2736334|NCT00104650|9401257|P1|Follow-up Period|Withdrawal by Subject|0
2736335|NCT00104650|9401255|P3|Follow-up Period|Adverse Event|1
2736336|NCT00104650|9401256|P2|Follow-up Period|Adverse Event|0
2736337|NCT00104650|9401257|P1|Follow-up Period|Adverse Event|1
2736338|NCT00104650|9401255|P3|Follow-up Period|Physician Decision|0
2736339|NCT00104650|9401256|P2|Follow-up Period|Physician Decision|1
2736340|NCT00104650|9401257|P1|Follow-up Period|Physician Decision|1
2736341|NCT00104650|9401255|P3|Treatment Period (25 Weeks)|Protocol deviation|0
2736342|NCT00104650|9401256|P2|Treatment Period (25 Weeks)|Protocol deviation|1
2736343|NCT00104650|9401257|P1|Treatment Period (25 Weeks)|Protocol deviation|0
2736344|NCT00104650|9401255|P3|Treatment Period (25 Weeks)|Other|0
2736345|NCT00104650|9401256|P2|Treatment Period (25 Weeks)|Other|0
2736346|NCT00104650|9401257|P1|Treatment Period (25 Weeks)|Other|1
2736347|NCT00104650|9401255|P3|Treatment Period (25 Weeks)|Ineligibility determined|0
2736348|NCT00104650|9401256|P2|Treatment Period (25 Weeks)|Ineligibility determined|1
2736349|NCT00104650|9401257|P1|Treatment Period (25 Weeks)|Ineligibility determined|0
2736350|NCT00104650|9401255|P3|Treatment Period (25 Weeks)|Disease progression|2
2736351|NCT00104650|9401256|P2|Treatment Period (25 Weeks)|Disease progression|3
2736352|NCT00104650|9401257|P1|Treatment Period (25 Weeks)|Disease progression|2
2736353|NCT00104650|9401255|P3|Treatment Period (25 Weeks)|Death|6
2736354|NCT00104650|9401256|P2|Treatment Period (25 Weeks)|Death|5
2736355|NCT00104650|9401257|P1|Treatment Period (25 Weeks)|Death|7
2736356|NCT00104650|9401255|P3|Treatment Period (25 Weeks)|Withdrawal by Subject|1
2736357|NCT00104650|9401256|P2|Treatment Period (25 Weeks)|Withdrawal by Subject|1
2736358|NCT00104650|9401257|P1|Treatment Period (25 Weeks)|Withdrawal by Subject|2
2736359|NCT00104650|9401255|P3|Treatment Period (25 Weeks)|Physician Decision|1
2736360|NCT00104650|9401256|P2|Treatment Period (25 Weeks)|Physician Decision|0
2736361|NCT00104650|9401257|P1|Treatment Period (25 Weeks)|Physician Decision|0
2736362|NCT00104637|9401289|P2|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0
2736363|NCT00104637|9401290|P1|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1
2736364|NCT00104572|9401319|P3|Overall Study|Withdrawal by Subject|0
2736365|NCT00104572|9401320|P2|Overall Study|Withdrawal by Subject|3
2736366|NCT00104572|9401321|P1|Overall Study|Withdrawal by Subject|3
2736367|NCT00104520|9401340|P2|Overall Study|Other|5
2736368|NCT00104520|9401341|P1|Overall Study|Other|1
2736369|NCT00104520|9401340|P2|Overall Study|Personal/administrative|1
2736370|NCT00104520|9401341|P1|Overall Study|Personal/administrative|1
2736371|NCT00104520|9401340|P2|Overall Study|Noncompliance|2
2736372|NCT00104520|9401341|P1|Overall Study|Noncompliance|0
2736373|NCT00104520|9401340|P2|Overall Study|Lost to Follow-up|0
2736374|NCT00104520|9401341|P1|Overall Study|Lost to Follow-up|1
2736375|NCT00104520|9401340|P2|Overall Study|Related adverse event|15
2736376|NCT00104520|9401341|P1|Overall Study|Related adverse event|13
2736377|NCT00104520|9401340|P2|Overall Study|Study drug intolerance|1
2736378|NCT00104520|9401341|P1|Overall Study|Study drug intolerance|0
2736379|NCT00104520|9401340|P2|Overall Study|Unrelated adverse event|47
2736380|NCT00104520|9401341|P1|Overall Study|Unrelated adverse event|34
2736381|NCT00104416|9401361|P5|Continuation Phase|Non-compliance|1
2736382|NCT00104416|9401362|P4|Continuation Phase|Non-compliance|0
2736383|NCT00104416|9401363|P3|Continuation Phase|Non-compliance|0
2736384|NCT00104416|9401364|P2|Continuation Phase|Non-compliance|0
2736385|NCT00104416|9401365|P1|Continuation Phase|Non-compliance|0
2736386|NCT00104416|9401361|P5|Continuation Phase|Pregnancy|0
2736387|NCT00104416|9401362|P4|Continuation Phase|Pregnancy|1
2736388|NCT00104416|9401363|P3|Continuation Phase|Pregnancy|1
2736389|NCT00104416|9401364|P2|Continuation Phase|Pregnancy|0
2736390|NCT00104416|9401365|P1|Continuation Phase|Pregnancy|0
2736391|NCT00104416|9401361|P5|Continuation Phase|Withdrawal by Subject|1
2736392|NCT00104416|9401362|P4|Continuation Phase|Withdrawal by Subject|1
2736393|NCT00104416|9401363|P3|Continuation Phase|Withdrawal by Subject|2
2736394|NCT00104416|9401364|P2|Continuation Phase|Withdrawal by Subject|0
2736395|NCT00104416|9401365|P1|Continuation Phase|Withdrawal by Subject|0
2736396|NCT00104416|9401361|P5|Continuation Phase|Lost to Follow-up|1
2736397|NCT00104416|9401362|P4|Continuation Phase|Lost to Follow-up|0
2736398|NCT00104416|9401363|P3|Continuation Phase|Lost to Follow-up|1
2736399|NCT00104416|9401364|P2|Continuation Phase|Lost to Follow-up|0
2736400|NCT00104416|9401365|P1|Continuation Phase|Lost to Follow-up|0
2736401|NCT00104416|9401361|P5|Continuation Phase|Adverse Event|2
2736402|NCT00104416|9401362|P4|Continuation Phase|Adverse Event|0
2736403|NCT00104416|9401363|P3|Continuation Phase|Adverse Event|2
2736404|NCT00104416|9401364|P2|Continuation Phase|Adverse Event|0
2736405|NCT00104416|9401365|P1|Continuation Phase|Adverse Event|0
2736406|NCT00104416|9401361|P5|Double-Blind Phase|Participant Did Not Take Drug|0
2736407|NCT00104416|9401362|P4|Double-Blind Phase|Participant Did Not Take Drug|0
2736408|NCT00104416|9401363|P3|Double-Blind Phase|Participant Did Not Take Drug|0
2736409|NCT00104416|9401364|P2|Double-Blind Phase|Participant Did Not Take Drug|4
2736410|NCT00104416|9401365|P1|Double-Blind Phase|Participant Did Not Take Drug|3
2736411|NCT00104416|9401361|P5|Double-Blind Phase|Pregnancy|0
2736412|NCT00104416|9401362|P4|Double-Blind Phase|Pregnancy|0
2736413|NCT00104416|9401363|P3|Double-Blind Phase|Pregnancy|0
2736414|NCT00104416|9401364|P2|Double-Blind Phase|Pregnancy|0
2736415|NCT00104416|9401365|P1|Double-Blind Phase|Pregnancy|1
2736416|NCT00104416|9401361|P5|Double-Blind Phase|Withdrawal by Subject|0
2736417|NCT00104416|9401362|P4|Double-Blind Phase|Withdrawal by Subject|0
2736418|NCT00104416|9401363|P3|Double-Blind Phase|Withdrawal by Subject|0
2736419|NCT00104416|9401364|P2|Double-Blind Phase|Withdrawal by Subject|3
2736420|NCT00104416|9401365|P1|Double-Blind Phase|Withdrawal by Subject|2
2736421|NCT00104416|9401361|P5|Double-Blind Phase|Protocol Violation|0
2736422|NCT00104416|9401362|P4|Double-Blind Phase|Protocol Violation|0
2736423|NCT00104416|9401363|P3|Double-Blind Phase|Protocol Violation|0
2736424|NCT00104416|9401364|P2|Double-Blind Phase|Protocol Violation|1
2736425|NCT00104416|9401365|P1|Double-Blind Phase|Protocol Violation|0
2736426|NCT00104416|9401361|P5|Double-Blind Phase|Lost to Follow-up|0
2736427|NCT00104416|9401362|P4|Double-Blind Phase|Lost to Follow-up|0
2736428|NCT00104416|9401363|P3|Double-Blind Phase|Lost to Follow-up|0
2736429|NCT00104416|9401364|P2|Double-Blind Phase|Lost to Follow-up|1
2736430|NCT00104416|9401365|P1|Double-Blind Phase|Lost to Follow-up|0
2736431|NCT00104416|9401361|P5|Double-Blind Phase|Adverse Event|0
2736432|NCT00104416|9401362|P4|Double-Blind Phase|Adverse Event|0
2736433|NCT00104416|9401363|P3|Double-Blind Phase|Adverse Event|0
2736434|NCT00104416|9401364|P2|Double-Blind Phase|Adverse Event|1
2736435|NCT00104416|9401365|P1|Double-Blind Phase|Adverse Event|2
2736436|NCT00104299|9401410|P2|Overall Study|To have renal transplant|0
2736437|NCT00104299|9401411|P1|Overall Study|To have renal transplant|1
2736438|NCT00104299|9401410|P2|Overall Study|Physician Decision|1
2736439|NCT00104299|9401411|P1|Overall Study|Physician Decision|1
2736440|NCT00104299|9401410|P2|Overall Study|Withdrawal by Subject|6
2736441|NCT00104299|9401411|P1|Overall Study|Withdrawal by Subject|2
2736442|NCT00104299|9401410|P2|Overall Study|Death|2
2736443|NCT00104299|9401411|P1|Overall Study|Death|2
2736444|NCT00104299|9401410|P2|Overall Study|Adverse Event|1
2736445|NCT00104299|9401411|P1|Overall Study|Adverse Event|3
2736446|NCT00104247|9401433|P2|Overall Study|Noncompliant with dosing|1
2736447|NCT00104247|9401434|P1|Overall Study|Noncompliant with dosing|0
2736448|NCT00104247|9401433|P2|Overall Study|Withdrawal by Subject|0
2736449|NCT00104247|9401434|P1|Overall Study|Withdrawal by Subject|1
2736450|NCT00104104|9401453|P2|Overall Study|Death|6
2736451|NCT00104104|9401454|P1|Overall Study|Death|9
2736452|NCT00104104|9401453|P2|Overall Study|Administrative problems|13
2736453|NCT00104104|9401454|P1|Overall Study|Administrative problems|12
2736454|NCT00104104|9401453|P2|Overall Study|Lost to Follow-up|7
2736455|NCT00104104|9401454|P1|Overall Study|Lost to Follow-up|3
2736456|NCT00104104|9401453|P2|Overall Study|Withdrawal by Subject|15
2736457|NCT00104104|9401454|P1|Overall Study|Withdrawal by Subject|11
2736458|NCT00104104|9401453|P2|Overall Study|Protocol Violation|2
2736459|NCT00104104|9401454|P1|Overall Study|Protocol Violation|5
2736460|NCT00104104|9401453|P2|Overall Study|Condition no longer requires study drug|4
2736461|NCT00104104|9401454|P1|Overall Study|Condition no longer requires study drug|7
2736462|NCT00104104|9401453|P2|Overall Study|Lack of Efficacy|3
2736463|NCT00104104|9401454|P1|Overall Study|Lack of Efficacy|0
2736464|NCT00104104|9401453|P2|Overall Study|Abnormal laboratory value(s)|14
2736465|NCT00104104|9401454|P1|Overall Study|Abnormal laboratory value(s)|20
2736466|NCT00104104|9401453|P2|Overall Study|Adverse Event|8
2736467|NCT00104104|9401454|P1|Overall Study|Adverse Event|8
2736468|NCT00104052|9401468|P1|Overall Study|Discontinuation unrelated to treatment|2
2736469|NCT00104052|9401468|P1|Overall Study|Lack of Efficacy|26
2736470|NCT00104052|9401468|P1|Overall Study|Adverse Event|1
2736471|NCT00103857|9401479|P7|50-Week Extension Study|reason unspecified|0
2736472|NCT00103857|9401480|P6|50-Week Extension Study|reason unspecified|0
2736473|NCT00103857|9401481|P5|50-Week Extension Study|reason unspecified|1
2736474|NCT00103857|9401482|P4|50-Week Extension Study|reason unspecified|0
2736475|NCT00103857|9401483|P3|50-Week Extension Study|reason unspecified|0
2736476|NCT00103857|9401484|P2|50-Week Extension Study|reason unspecified|0
2736477|NCT00103857|9401485|P1|50-Week Extension Study|reason unspecified|0
2736478|NCT00103857|9401479|P7|50-Week Extension Study|patient scheduled for elective surgery|0
2736479|NCT00103857|9401480|P6|50-Week Extension Study|patient scheduled for elective surgery|0
2736480|NCT00103857|9401481|P5|50-Week Extension Study|patient scheduled for elective surgery|0
2736481|NCT00103857|9401482|P4|50-Week Extension Study|patient scheduled for elective surgery|0
2736482|NCT00103857|9401483|P3|50-Week Extension Study|patient scheduled for elective surgery|1
2736483|NCT00103857|9401484|P2|50-Week Extension Study|patient scheduled for elective surgery|0
2736484|NCT00103857|9401485|P1|50-Week Extension Study|patient scheduled for elective surgery|0
2736485|NCT00103857|9401479|P7|50-Week Extension Study|patient moved|0
2736486|NCT00103857|9401480|P6|50-Week Extension Study|patient moved|0
2736487|NCT00103857|9401481|P5|50-Week Extension Study|patient moved|0
2736488|NCT00103857|9401482|P4|50-Week Extension Study|patient moved|2
2736489|NCT00103857|9401483|P3|50-Week Extension Study|patient moved|1
2736490|NCT00103857|9401484|P2|50-Week Extension Study|patient moved|0
2736491|NCT00103857|9401485|P1|50-Week Extension Study|patient moved|0
2736492|NCT00103857|9401479|P7|50-Week Extension Study|non-compliance with study procedures|0
2736493|NCT00103857|9401480|P6|50-Week Extension Study|non-compliance with study procedures|0
2736494|NCT00103857|9401481|P5|50-Week Extension Study|non-compliance with study procedures|1
2736495|NCT00103857|9401482|P4|50-Week Extension Study|non-compliance with study procedures|1
2736496|NCT00103857|9401483|P3|50-Week Extension Study|non-compliance with study procedures|0
2736497|NCT00103857|9401484|P2|50-Week Extension Study|non-compliance with study procedures|0
2736498|NCT00103857|9401485|P1|50-Week Extension Study|non-compliance with study procedures|1
2736499|NCT00103857|9401479|P7|50-Week Extension Study|protocol discontinuation criteria|0
2736500|NCT00103857|9401480|P6|50-Week Extension Study|protocol discontinuation criteria|3
2736501|NCT00103857|9401481|P5|50-Week Extension Study|protocol discontinuation criteria|3
2736502|NCT00103857|9401482|P4|50-Week Extension Study|protocol discontinuation criteria|2
2736503|NCT00103857|9401483|P3|50-Week Extension Study|protocol discontinuation criteria|3
2736504|NCT00103857|9401484|P2|50-Week Extension Study|protocol discontinuation criteria|2
2736505|NCT00103857|9401485|P1|50-Week Extension Study|protocol discontinuation criteria|2
2736506|NCT00103857|9401479|P7|50-Week Extension Study|Withdrawal by Subject|0
2736507|NCT00103857|9401480|P6|50-Week Extension Study|Withdrawal by Subject|3
2736508|NCT00103857|9401481|P5|50-Week Extension Study|Withdrawal by Subject|3
2736509|NCT00103857|9401482|P4|50-Week Extension Study|Withdrawal by Subject|8
2736510|NCT00103857|9401483|P3|50-Week Extension Study|Withdrawal by Subject|2
2736511|NCT00103857|9401484|P2|50-Week Extension Study|Withdrawal by Subject|5
2736512|NCT00103857|9401485|P1|50-Week Extension Study|Withdrawal by Subject|2
2736513|NCT00103857|9401479|P7|50-Week Extension Study|Protocol Violation|0
2736514|NCT00103857|9401480|P6|50-Week Extension Study|Protocol Violation|1
2736515|NCT00103857|9401481|P5|50-Week Extension Study|Protocol Violation|0
2736516|NCT00103857|9401482|P4|50-Week Extension Study|Protocol Violation|2
2736517|NCT00103857|9401483|P3|50-Week Extension Study|Protocol Violation|1
2736518|NCT00103857|9401484|P2|50-Week Extension Study|Protocol Violation|1
2736519|NCT00103857|9401485|P1|50-Week Extension Study|Protocol Violation|1
2736520|NCT00103857|9401479|P7|50-Week Extension Study|Pregnancy|0
2736521|NCT00103857|9401480|P6|50-Week Extension Study|Pregnancy|0
2736522|NCT00103857|9401481|P5|50-Week Extension Study|Pregnancy|1
2736523|NCT00103857|9401482|P4|50-Week Extension Study|Pregnancy|0
2736524|NCT00103857|9401483|P3|50-Week Extension Study|Pregnancy|1
2736525|NCT00103857|9401484|P2|50-Week Extension Study|Pregnancy|0
2736526|NCT00103857|9401485|P1|50-Week Extension Study|Pregnancy|0
2736527|NCT00103857|9401479|P7|50-Week Extension Study|Physician Decision|0
2736528|NCT00103857|9401480|P6|50-Week Extension Study|Physician Decision|0
2736529|NCT00103857|9401481|P5|50-Week Extension Study|Physician Decision|0
2736530|NCT00103857|9401482|P4|50-Week Extension Study|Physician Decision|0
2736531|NCT00103857|9401483|P3|50-Week Extension Study|Physician Decision|1
2736532|NCT00103857|9401484|P2|50-Week Extension Study|Physician Decision|1
2736533|NCT00103857|9401485|P1|50-Week Extension Study|Physician Decision|0
2736534|NCT00103857|9401479|P7|50-Week Extension Study|Lost to Follow-up|0
2736535|NCT00103857|9401480|P6|50-Week Extension Study|Lost to Follow-up|3
2736536|NCT00103857|9401481|P5|50-Week Extension Study|Lost to Follow-up|3
2736537|NCT00103857|9401482|P4|50-Week Extension Study|Lost to Follow-up|4
2736538|NCT00103857|9401483|P3|50-Week Extension Study|Lost to Follow-up|1
2736539|NCT00103857|9401484|P2|50-Week Extension Study|Lost to Follow-up|0
2736540|NCT00103857|9401485|P1|50-Week Extension Study|Lost to Follow-up|4
2736541|NCT00103857|9401479|P7|50-Week Extension Study|Lack of Efficacy|0
2736542|NCT00103857|9401480|P6|50-Week Extension Study|Lack of Efficacy|8
2736543|NCT00103857|9401481|P5|50-Week Extension Study|Lack of Efficacy|8
2736544|NCT00103857|9401482|P4|50-Week Extension Study|Lack of Efficacy|16
2736545|NCT00103857|9401483|P3|50-Week Extension Study|Lack of Efficacy|13
2736546|NCT00103857|9401484|P2|50-Week Extension Study|Lack of Efficacy|15
2736547|NCT00103857|9401485|P1|50-Week Extension Study|Lack of Efficacy|26
2736548|NCT00103857|9401479|P7|50-Week Extension Study|Death|0
2736549|NCT00103857|9401480|P6|50-Week Extension Study|Death|1
2736550|NCT00103857|9401481|P5|50-Week Extension Study|Death|0
2736551|NCT00103857|9401482|P4|50-Week Extension Study|Death|1
2736552|NCT00103857|9401483|P3|50-Week Extension Study|Death|0
2736553|NCT00103857|9401484|P2|50-Week Extension Study|Death|0
2736554|NCT00103857|9401485|P1|50-Week Extension Study|Death|0
2736555|NCT00103857|9401479|P7|50-Week Extension Study|Adverse Event|0
2736556|NCT00103857|9401480|P6|50-Week Extension Study|Adverse Event|1
2736557|NCT00103857|9401481|P5|50-Week Extension Study|Adverse Event|1
2736558|NCT00103857|9401482|P4|50-Week Extension Study|Adverse Event|0
2736559|NCT00103857|9401483|P3|50-Week Extension Study|Adverse Event|2
2736560|NCT00103857|9401484|P2|50-Week Extension Study|Adverse Event|3
2736561|NCT00103857|9401485|P1|50-Week Extension Study|Adverse Event|2
2736562|NCT00103857|9401479|P7|54-Week Base Study|patient intolerance to rescue therapy|0
2736563|NCT00103857|9401480|P6|54-Week Base Study|patient intolerance to rescue therapy|0
2736564|NCT00103857|9401481|P5|54-Week Base Study|patient intolerance to rescue therapy|0
2736565|NCT00103857|9401482|P4|54-Week Base Study|patient intolerance to rescue therapy|0
2736566|NCT00103857|9401483|P3|54-Week Base Study|patient intolerance to rescue therapy|0
2736567|NCT00103857|9401484|P2|54-Week Base Study|patient intolerance to rescue therapy|0
2736568|NCT00103857|9401485|P1|54-Week Base Study|patient intolerance to rescue therapy|1
2736569|NCT00103857|9401479|P7|54-Week Base Study|site error|0
2736570|NCT00103857|9401480|P6|54-Week Base Study|site error|1
2736571|NCT00103857|9401481|P5|54-Week Base Study|site error|0
2736572|NCT00103857|9401482|P4|54-Week Base Study|site error|0
2736573|NCT00103857|9401483|P3|54-Week Base Study|site error|0
2736574|NCT00103857|9401484|P2|54-Week Base Study|site error|0
2736575|NCT00103857|9401485|P1|54-Week Base Study|site error|0
2736576|NCT00103857|9401479|P7|54-Week Base Study|laboratory reporting error|0
2736577|NCT00103857|9401480|P6|54-Week Base Study|laboratory reporting error|0
2736578|NCT00103857|9401481|P5|54-Week Base Study|laboratory reporting error|1
2736579|NCT00103857|9401482|P4|54-Week Base Study|laboratory reporting error|0
2736580|NCT00103857|9401483|P3|54-Week Base Study|laboratory reporting error|0
2736581|NCT00103857|9401484|P2|54-Week Base Study|laboratory reporting error|0
2736582|NCT00103857|9401485|P1|54-Week Base Study|laboratory reporting error|0
2736583|NCT00103857|9401479|P7|54-Week Base Study|patient incarcerated|0
2736584|NCT00103857|9401480|P6|54-Week Base Study|patient incarcerated|1
2736585|NCT00103857|9401481|P5|54-Week Base Study|patient incarcerated|1
2736586|NCT00103857|9401482|P4|54-Week Base Study|patient incarcerated|0
2736587|NCT00103857|9401483|P3|54-Week Base Study|patient incarcerated|0
2736588|NCT00103857|9401484|P2|54-Week Base Study|patient incarcerated|0
2736589|NCT00103857|9401485|P1|54-Week Base Study|patient incarcerated|0
2736590|NCT00103857|9401479|P7|54-Week Base Study|non-compliance with study procedures|0
2736591|NCT00103857|9401480|P6|54-Week Base Study|non-compliance with study procedures|2
2736592|NCT00103857|9401481|P5|54-Week Base Study|non-compliance with study procedures|0
2736593|NCT00103857|9401482|P4|54-Week Base Study|non-compliance with study procedures|0
2736594|NCT00103857|9401483|P3|54-Week Base Study|non-compliance with study procedures|0
2736595|NCT00103857|9401484|P2|54-Week Base Study|non-compliance with study procedures|2
2736596|NCT00103857|9401485|P1|54-Week Base Study|non-compliance with study procedures|1
2736597|NCT00103857|9401479|P7|54-Week Base Study|patient moved|0
2736598|NCT00103857|9401480|P6|54-Week Base Study|patient moved|1
2736599|NCT00103857|9401481|P5|54-Week Base Study|patient moved|3
2736600|NCT00103857|9401482|P4|54-Week Base Study|patient moved|2
2736601|NCT00103857|9401483|P3|54-Week Base Study|patient moved|1
2736602|NCT00103857|9401484|P2|54-Week Base Study|patient moved|1
2736603|NCT00103857|9401485|P1|54-Week Base Study|patient moved|0
2736604|NCT00103857|9401479|P7|54-Week Base Study|protocol discontinuation criteria|5
2736605|NCT00103857|9401480|P6|54-Week Base Study|protocol discontinuation criteria|3
2736606|NCT00103857|9401481|P5|54-Week Base Study|protocol discontinuation criteria|5
2736607|NCT00103857|9401482|P4|54-Week Base Study|protocol discontinuation criteria|6
2736608|NCT00103857|9401483|P3|54-Week Base Study|protocol discontinuation criteria|2
2736609|NCT00103857|9401484|P2|54-Week Base Study|protocol discontinuation criteria|5
2736610|NCT00103857|9401485|P1|54-Week Base Study|protocol discontinuation criteria|2
2736611|NCT00103857|9401479|P7|54-Week Base Study|Withdrawal by Subject|4
2736612|NCT00103857|9401480|P6|54-Week Base Study|Withdrawal by Subject|15
2736613|NCT00103857|9401481|P5|54-Week Base Study|Withdrawal by Subject|10
2736614|NCT00103857|9401482|P4|54-Week Base Study|Withdrawal by Subject|15
2736615|NCT00103857|9401483|P3|54-Week Base Study|Withdrawal by Subject|16
2736616|NCT00103857|9401484|P2|54-Week Base Study|Withdrawal by Subject|16
2736617|NCT00103857|9401485|P1|54-Week Base Study|Withdrawal by Subject|17
2736618|NCT00103857|9401479|P7|54-Week Base Study|Protocol Violation|3
2736619|NCT00103857|9401480|P6|54-Week Base Study|Protocol Violation|3
2736620|NCT00103857|9401481|P5|54-Week Base Study|Protocol Violation|0
2736621|NCT00103857|9401482|P4|54-Week Base Study|Protocol Violation|4
2736622|NCT00103857|9401483|P3|54-Week Base Study|Protocol Violation|2
2736623|NCT00103857|9401484|P2|54-Week Base Study|Protocol Violation|4
2736624|NCT00103857|9401485|P1|54-Week Base Study|Protocol Violation|6
2736625|NCT00103857|9401479|P7|54-Week Base Study|Pregnancy|1
2736626|NCT00103857|9401480|P6|54-Week Base Study|Pregnancy|0
2736627|NCT00103857|9401481|P5|54-Week Base Study|Pregnancy|1
2736628|NCT00103857|9401482|P4|54-Week Base Study|Pregnancy|0
2736629|NCT00103857|9401483|P3|54-Week Base Study|Pregnancy|0
2736630|NCT00103857|9401484|P2|54-Week Base Study|Pregnancy|0
2736631|NCT00103857|9401485|P1|54-Week Base Study|Pregnancy|1
2736632|NCT00103857|9401479|P7|54-Week Base Study|Physician Decision|0
2736633|NCT00103857|9401480|P6|54-Week Base Study|Physician Decision|0
2736634|NCT00103857|9401481|P5|54-Week Base Study|Physician Decision|1
2736635|NCT00103857|9401482|P4|54-Week Base Study|Physician Decision|0
2736636|NCT00103857|9401483|P3|54-Week Base Study|Physician Decision|0
2736637|NCT00103857|9401484|P2|54-Week Base Study|Physician Decision|1
2736638|NCT00103857|9401485|P1|54-Week Base Study|Physician Decision|1
2736639|NCT00103857|9401479|P7|54-Week Base Study|Lost to Follow-up|3
2736640|NCT00103857|9401480|P6|54-Week Base Study|Lost to Follow-up|9
2736641|NCT00103857|9401481|P5|54-Week Base Study|Lost to Follow-up|10
2736642|NCT00103857|9401482|P4|54-Week Base Study|Lost to Follow-up|5
2736643|NCT00103857|9401483|P3|54-Week Base Study|Lost to Follow-up|7
2736644|NCT00103857|9401484|P2|54-Week Base Study|Lost to Follow-up|4
2736645|NCT00103857|9401485|P1|54-Week Base Study|Lost to Follow-up|5
2736646|NCT00103857|9401479|P7|54-Week Base Study|Lack of Efficacy|19
2736647|NCT00103857|9401480|P6|54-Week Base Study|Lack of Efficacy|14
2736648|NCT00103857|9401481|P5|54-Week Base Study|Lack of Efficacy|3
2736649|NCT00103857|9401482|P4|54-Week Base Study|Lack of Efficacy|4
2736650|NCT00103857|9401483|P3|54-Week Base Study|Lack of Efficacy|8
2736651|NCT00103857|9401484|P2|54-Week Base Study|Lack of Efficacy|14
2736652|NCT00103857|9401485|P1|54-Week Base Study|Lack of Efficacy|11
2736653|NCT00103857|9401479|P7|54-Week Base Study|Death|0
2736654|NCT00103857|9401480|P6|54-Week Base Study|Death|1
2736655|NCT00103857|9401481|P5|54-Week Base Study|Death|1
2736656|NCT00103857|9401482|P4|54-Week Base Study|Death|0
2736657|NCT00103857|9401483|P3|54-Week Base Study|Death|0
2736658|NCT00103857|9401484|P2|54-Week Base Study|Death|0
2736659|NCT00103857|9401485|P1|54-Week Base Study|Death|0
2736660|NCT00103857|9401479|P7|54-Week Base Study|Adverse Event|3
2736661|NCT00103857|9401480|P6|54-Week Base Study|Adverse Event|11
2736662|NCT00103857|9401481|P5|54-Week Base Study|Adverse Event|5
2736663|NCT00103857|9401482|P4|54-Week Base Study|Adverse Event|6
2736664|NCT00103857|9401483|P3|54-Week Base Study|Adverse Event|11
2736665|NCT00103857|9401484|P2|54-Week Base Study|Adverse Event|9
2736666|NCT00103857|9401485|P1|54-Week Base Study|Adverse Event|12
2736667|NCT00103740|9401584|P2|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9
2736668|NCT00103740|9401585|P1|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30
2736669|NCT00103740|9401584|P2|Period 2 - Extended Observation Period|Death|2
2736670|NCT00103740|9401585|P1|Period 2 - Extended Observation Period|Death|6
2736671|NCT00103740|9401584|P2|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6
2736672|NCT00103740|9401585|P1|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5
2736673|NCT00103740|9401584|P2|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13
2736674|NCT00103740|9401585|P1|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21
2736675|NCT00103740|9401584|P2|Period 2 - Extended Observation Period|Lost to Follow-up|6
2736676|NCT00103740|9401585|P1|Period 2 - Extended Observation Period|Lost to Follow-up|7
2736677|NCT00103740|9401584|P2|Period 1 - Core|Patient withdrew consent|2
2736678|NCT00103740|9401585|P1|Period 1 - Core|Patient withdrew consent|3
2736679|NCT00103740|9401584|P2|Period 1 - Core|Protocol Violation|2
2736680|NCT00103740|9401585|P1|Period 1 - Core|Protocol Violation|3
2736681|NCT00103740|9401584|P2|Period 1 - Core|Adverse Event|0
2736682|NCT00103740|9401585|P1|Period 1 - Core|Adverse Event|1
2736683|NCT00103662|9401613|P2|Overall Study|Intercurrent illness|0
2736684|NCT00103662|9401614|P1|Overall Study|Intercurrent illness|1
2736685|NCT00103662|9401613|P2|Overall Study|Failed mobilization|4
2736686|NCT00103662|9401614|P1|Overall Study|Failed mobilization|0
2736687|NCT00103662|9401613|P2|Overall Study|Other|9
2736688|NCT00103662|9401614|P1|Overall Study|Other|6
2736689|NCT00103662|9401613|P2|Overall Study|Lost to Follow-up|1
2736690|NCT00103662|9401614|P1|Overall Study|Lost to Follow-up|0
2736691|NCT00103662|9401613|P2|Overall Study|Elective Withdrawal|5
2736692|NCT00103662|9401614|P1|Overall Study|Elective Withdrawal|5
2736693|NCT00103662|9401613|P2|Overall Study|Death|7
2736694|NCT00103662|9401614|P1|Overall Study|Death|7
2736695|NCT00103662|9401613|P2|Overall Study|Entered Rescue Procedure|7
2736696|NCT00103662|9401614|P1|Overall Study|Entered Rescue Procedure|0
2736697|NCT00103610|9401640|P2|Overall Study|Noncompliance|1
2736698|NCT00103610|9401641|P1|Overall Study|Noncompliance|0
2736699|NCT00103610|9401640|P2|Overall Study|Failed mobilization|5
2736700|NCT00103610|9401641|P1|Overall Study|Failed mobilization|1
2736701|NCT00103610|9401640|P2|Overall Study|Other|7
2736702|NCT00103610|9401641|P1|Overall Study|Other|2
2736703|NCT00103610|9401640|P2|Overall Study|Adverse Event|2
2736704|NCT00103610|9401641|P1|Overall Study|Adverse Event|2
2736705|NCT00103610|9401640|P2|Overall Study|Lost to Follow-up|1
2736706|NCT00103610|9401641|P1|Overall Study|Lost to Follow-up|3
2736707|NCT00103610|9401640|P2|Overall Study|Elective Withdrawal|0
2736708|NCT00103610|9401641|P1|Overall Study|Elective Withdrawal|4
2736709|NCT00103610|9401640|P2|Overall Study|Death|12
2736710|NCT00103610|9401641|P1|Overall Study|Death|16
2736711|NCT00103610|9401640|P2|Overall Study|Entered Rescue Procedure|52
2736712|NCT00103610|9401641|P1|Overall Study|Entered Rescue Procedure|10
2736713|NCT00103506|9401665|P2|Overall Study|Withdrawal by Subject|21
2736714|NCT00103506|9401666|P1|Overall Study|Withdrawal by Subject|18
2736715|NCT00103506|9401665|P2|Overall Study|Lost to Follow-up|13
2736716|NCT00103506|9401666|P1|Overall Study|Lost to Follow-up|13
2736717|NCT00103506|9401665|P2|Overall Study|Death|253
2736718|NCT00103506|9401666|P1|Overall Study|Death|257
2736719|NCT00103506|9401665|P2|Overall Study|Study closed by sponsor|37
2736720|NCT00103506|9401666|P1|Overall Study|Study closed by sponsor|34
2736721|NCT00103311|9401697|P2|Overall Study|Adverse Event|0
2736722|NCT00103311|9401698|P1|Overall Study|Adverse Event|1
2736723|NCT00103311|9401697|P2|Overall Study|Withdrawal by Subject|1
2736724|NCT00103311|9401698|P1|Overall Study|Withdrawal by Subject|2
2736725|NCT00103311|9401697|P2|Overall Study|Lost to Follow-up|0
2736726|NCT00103311|9401698|P1|Overall Study|Lost to Follow-up|1
2736727|NCT00103285|9401708|P8|Response Assignment|Other|53
2736728|NCT00103285|9401709|P7|Response Assignment|Other|11
2736729|NCT00103285|9401710|P6|Response Assignment|Other|17
2736730|NCT00103285|9401711|P5|Response Assignment|Other|37
2736731|NCT00103285|9401712|P4|Response Assignment|Other|38
2736732|NCT00103285|9401713|P3|Response Assignment|Other|48
2736733|NCT00103285|9401714|P2|Response Assignment|Other|30
2736734|NCT00103285|9401715|P1|Response Assignment|Other|0
2736735|NCT00103285|9401708|P8|Response Assignment|Refusal|10
2736736|NCT00103285|9401709|P7|Response Assignment|Refusal|30
2736737|NCT00103285|9401710|P6|Response Assignment|Refusal|15
2736738|NCT00103285|9401711|P5|Response Assignment|Refusal|25
2736739|NCT00103285|9401712|P4|Response Assignment|Refusal|3
2736740|NCT00103285|9401713|P3|Response Assignment|Refusal|5
2736741|NCT00103285|9401714|P2|Response Assignment|Refusal|53
2736742|NCT00103285|9401715|P1|Response Assignment|Refusal|0
2736743|NCT00103285|9401708|P8|Response Assignment|Ineligible|5
2736744|NCT00103285|9401709|P7|Response Assignment|Ineligible|1
2736745|NCT00103285|9401710|P6|Response Assignment|Ineligible|3
2736746|NCT00103285|9401711|P5|Response Assignment|Ineligible|0
2736747|NCT00103285|9401712|P4|Response Assignment|Ineligible|2
2736748|NCT00103285|9401713|P3|Response Assignment|Ineligible|6
2736749|NCT00103285|9401714|P2|Response Assignment|Ineligible|8
2736750|NCT00103285|9401715|P1|Response Assignment|Ineligible|0
2736751|NCT00103285|9401708|P8|Response Assignment|Withdrawal by Subject|2
2736752|NCT00103285|9401709|P7|Response Assignment|Withdrawal by Subject|0
2736753|NCT00103285|9401710|P6|Response Assignment|Withdrawal by Subject|2
2736754|NCT00103285|9401711|P5|Response Assignment|Withdrawal by Subject|2
2736755|NCT00103285|9401712|P4|Response Assignment|Withdrawal by Subject|1
2736756|NCT00103285|9401713|P3|Response Assignment|Withdrawal by Subject|1
2736757|NCT00103285|9401714|P2|Response Assignment|Withdrawal by Subject|4
2736758|NCT00103285|9401715|P1|Response Assignment|Withdrawal by Subject|0
2736759|NCT00103285|9401708|P8|Response Assignment|Protocol Violation|0
2736760|NCT00103285|9401709|P7|Response Assignment|Protocol Violation|0
2736761|NCT00103285|9401710|P6|Response Assignment|Protocol Violation|0
2736762|NCT00103285|9401711|P5|Response Assignment|Protocol Violation|0
2736763|NCT00103285|9401712|P4|Response Assignment|Protocol Violation|0
2736764|NCT00103285|9401713|P3|Response Assignment|Protocol Violation|0
2736765|NCT00103285|9401714|P2|Response Assignment|Protocol Violation|2
2736766|NCT00103285|9401715|P1|Response Assignment|Protocol Violation|0
2736767|NCT00103285|9401708|P8|Response Assignment|Physician Decision|35
2736768|NCT00103285|9401709|P7|Response Assignment|Physician Decision|4
2736769|NCT00103285|9401710|P6|Response Assignment|Physician Decision|7
2736770|NCT00103285|9401711|P5|Response Assignment|Physician Decision|13
2736771|NCT00103285|9401712|P4|Response Assignment|Physician Decision|9
2736772|NCT00103285|9401713|P3|Response Assignment|Physician Decision|14
2736773|NCT00103285|9401714|P2|Response Assignment|Physician Decision|13
2736774|NCT00103285|9401715|P1|Response Assignment|Physician Decision|0
2736775|NCT00103285|9401708|P8|Response Assignment|Lost to Follow-up|5
2736776|NCT00103285|9401709|P7|Response Assignment|Lost to Follow-up|2
2736777|NCT00103285|9401710|P6|Response Assignment|Lost to Follow-up|2
2736778|NCT00103285|9401711|P5|Response Assignment|Lost to Follow-up|1
2736779|NCT00103285|9401712|P4|Response Assignment|Lost to Follow-up|5
2736780|NCT00103285|9401713|P3|Response Assignment|Lost to Follow-up|5
2736781|NCT00103285|9401714|P2|Response Assignment|Lost to Follow-up|9
2736782|NCT00103285|9401715|P1|Response Assignment|Lost to Follow-up|0
2736783|NCT00103285|9401708|P8|Response Assignment|Death|8
2736784|NCT00103285|9401709|P7|Response Assignment|Death|0
2736785|NCT00103285|9401710|P6|Response Assignment|Death|1
2736786|NCT00103285|9401711|P5|Response Assignment|Death|3
2736787|NCT00103285|9401712|P4|Response Assignment|Death|2
2736788|NCT00103285|9401713|P3|Response Assignment|Death|2
2736789|NCT00103285|9401714|P2|Response Assignment|Death|5
2736790|NCT00103285|9401715|P1|Response Assignment|Death|0
2736791|NCT00103285|9401708|P8|Response Assignment|Adverse Event|2
2736792|NCT00103285|9401709|P7|Response Assignment|Adverse Event|1
2736793|NCT00103285|9401710|P6|Response Assignment|Adverse Event|1
2736794|NCT00103285|9401711|P5|Response Assignment|Adverse Event|3
2736795|NCT00103285|9401712|P4|Response Assignment|Adverse Event|2
2736796|NCT00103285|9401713|P3|Response Assignment|Adverse Event|3
2736797|NCT00103285|9401714|P2|Response Assignment|Adverse Event|8
2736798|NCT00103285|9401715|P1|Response Assignment|Adverse Event|0
2736799|NCT00103285|9401708|P8|Induction|Other|0
2736800|NCT00103285|9401709|P7|Induction|Other|0
2736801|NCT00103285|9401710|P6|Induction|Other|0
2736802|NCT00103285|9401711|P5|Induction|Other|0
2736803|NCT00103285|9401712|P4|Induction|Other|0
2736804|NCT00103285|9401713|P3|Induction|Other|0
2736805|NCT00103285|9401714|P2|Induction|Other|0
2736806|NCT00103285|9401715|P1|Induction|Other|258
2736807|NCT00103285|9401708|P8|Induction|Refusal|0
2736808|NCT00103285|9401709|P7|Induction|Refusal|0
2736809|NCT00103285|9401710|P6|Induction|Refusal|0
2736810|NCT00103285|9401711|P5|Induction|Refusal|0
2736811|NCT00103285|9401712|P4|Induction|Refusal|0
2736812|NCT00103285|9401713|P3|Induction|Refusal|0
2736813|NCT00103285|9401714|P2|Induction|Refusal|0
2736814|NCT00103285|9401715|P1|Induction|Refusal|906
2736815|NCT00103285|9401708|P8|Induction|Ineligible|0
2736816|NCT00103285|9401709|P7|Induction|Ineligible|0
2736817|NCT00103285|9401710|P6|Induction|Ineligible|0
2736818|NCT00103285|9401711|P5|Induction|Ineligible|0
2736819|NCT00103285|9401712|P4|Induction|Ineligible|0
2736820|NCT00103285|9401713|P3|Induction|Ineligible|0
2736821|NCT00103285|9401714|P2|Induction|Ineligible|0
2736822|NCT00103285|9401715|P1|Induction|Ineligible|43
2736823|NCT00103285|9401708|P8|Induction|Withdrawal by Subject|0
2736824|NCT00103285|9401709|P7|Induction|Withdrawal by Subject|0
2736825|NCT00103285|9401710|P6|Induction|Withdrawal by Subject|0
2736826|NCT00103285|9401711|P5|Induction|Withdrawal by Subject|0
2736827|NCT00103285|9401712|P4|Induction|Withdrawal by Subject|0
2736828|NCT00103285|9401713|P3|Induction|Withdrawal by Subject|0
2736829|NCT00103285|9401714|P2|Induction|Withdrawal by Subject|0
2736830|NCT00103285|9401715|P1|Induction|Withdrawal by Subject|1
2736831|NCT00103285|9401708|P8|Induction|Physician Decision|0
2736832|NCT00103285|9401709|P7|Induction|Physician Decision|0
2736833|NCT00103285|9401710|P6|Induction|Physician Decision|0
2736834|NCT00103285|9401711|P5|Induction|Physician Decision|0
2736835|NCT00103285|9401712|P4|Induction|Physician Decision|0
2736836|NCT00103285|9401713|P3|Induction|Physician Decision|0
2736837|NCT00103285|9401714|P2|Induction|Physician Decision|0
2736838|NCT00103285|9401715|P1|Induction|Physician Decision|103
2736839|NCT00103285|9401708|P8|Induction|Death|0
2736840|NCT00103285|9401709|P7|Induction|Death|0
2736841|NCT00103285|9401710|P6|Induction|Death|0
2736842|NCT00103285|9401711|P5|Induction|Death|0
2736843|NCT00103285|9401712|P4|Induction|Death|0
2736844|NCT00103285|9401713|P3|Induction|Death|0
2736845|NCT00103285|9401714|P2|Induction|Death|0
2736846|NCT00103285|9401715|P1|Induction|Death|24
2736847|NCT00103285|9401708|P8|Induction|Adverse Event|0
2736848|NCT00103285|9401709|P7|Induction|Adverse Event|0
2736849|NCT00103285|9401710|P6|Induction|Adverse Event|0
2736850|NCT00103285|9401711|P5|Induction|Adverse Event|0
2736851|NCT00103285|9401712|P4|Induction|Adverse Event|0
2736852|NCT00103285|9401713|P3|Induction|Adverse Event|0
2736853|NCT00103285|9401714|P2|Induction|Adverse Event|0
2736854|NCT00103285|9401715|P1|Induction|Adverse Event|14
2736855|NCT00103259|9401744|P2|Overall Study|ineligible/no protocol therapy|6
2736856|NCT00103259|9401745|P1|Overall Study|ineligible/no protocol therapy|4
2736857|NCT00103259|9401744|P2|Overall Study|other (reasons were not specified)|1
2736858|NCT00103259|9401745|P1|Overall Study|other (reasons were not specified)|2
2736859|NCT00103259|9401744|P2|Overall Study|alternative therapy|0
2736860|NCT00103259|9401745|P1|Overall Study|alternative therapy|1
2736861|NCT00103259|9401744|P2|Overall Study|Withdrawal by Subject|3
2736862|NCT00103259|9401745|P1|Overall Study|Withdrawal by Subject|2
2736863|NCT00103259|9401744|P2|Overall Study|Death|2
2736864|NCT00103259|9401745|P1|Overall Study|Death|3
2736865|NCT00103207|9401757|P1|Overall Study|Diagnosis of BAC not confirmed|27
2736866|NCT00103207|9401757|P1|Overall Study|Ineligible|4
2736867|NCT00103207|9401757|P1|Overall Study|Other complicating disease|1
2736868|NCT00103207|9401757|P1|Overall Study|Withdrawal by Subject|2
2736869|NCT00103207|9401757|P1|Overall Study|Death|1
2736870|NCT00103207|9401757|P1|Overall Study|Adverse Event|3
2736871|NCT00103142|9401776|P2|Overall Study|Progression of disease|1
2736872|NCT00103142|9401777|P1|Overall Study|Progression of disease|2
2736873|NCT00103142|9401776|P2|Overall Study|Adverse Event|0
2736874|NCT00103142|9401777|P1|Overall Study|Adverse Event|1
2736875|NCT00103012|9401793|P3|Overall Study|Subject non-compliant with medications|1
2736876|NCT00103012|9401794|P2|Overall Study|Subject non-compliant with medications|0
2736877|NCT00103012|9401795|P1|Overall Study|Subject non-compliant with medications|0
2736878|NCT00103012|9401793|P3|Overall Study|Adverse Event|1
2736879|NCT00103012|9401794|P2|Overall Study|Adverse Event|0
2736880|NCT00103012|9401795|P1|Overall Study|Adverse Event|0
2736881|NCT00103012|9401793|P3|Overall Study|Pregnancy|0
2736882|NCT00103012|9401794|P2|Overall Study|Pregnancy|0
2736883|NCT00103012|9401795|P1|Overall Study|Pregnancy|1
2736884|NCT00103012|9401793|P3|Overall Study|Withdrawal by Subject|2
2736885|NCT00103012|9401794|P2|Overall Study|Withdrawal by Subject|1
2736886|NCT00103012|9401795|P1|Overall Study|Withdrawal by Subject|2
2736887|NCT00102960|9401806|P3|Overall Study|Withdrawal by Subject|1
2736888|NCT00102960|9401807|P2|Overall Study|Withdrawal by Subject|0
2736889|NCT00102960|9401808|P1|Overall Study|Withdrawal by Subject|1
2736890|NCT00102960|9401806|P3|Overall Study|Lost to Follow-up|16
2736891|NCT00102960|9401807|P2|Overall Study|Lost to Follow-up|12
2736892|NCT00102960|9401808|P1|Overall Study|Lost to Follow-up|6
2736893|NCT00102960|9401806|P3|Overall Study|Death|11
2736894|NCT00102960|9401807|P2|Overall Study|Death|11
2736895|NCT00102960|9401808|P1|Overall Study|Death|23
2736896|NCT00102804|9401857|P2|Overall Study|Alive, Receiving Treatment|2
2736897|NCT00102804|9401858|P1|Overall Study|Alive, Receiving Treatment|7
2736898|NCT00102804|9401857|P2|Overall Study|Sponsor Decision|0
2736899|NCT00102804|9401858|P1|Overall Study|Sponsor Decision|1
2736900|NCT00102804|9401857|P2|Overall Study|Satisfactory Response|0
2736901|NCT00102804|9401858|P1|Overall Study|Satisfactory Response|2
2736902|NCT00102804|9401857|P2|Overall Study|Protocol Violation|1
2736903|NCT00102804|9401858|P1|Overall Study|Protocol Violation|2
2736904|NCT00102804|9401857|P2|Overall Study|Lost to Follow-up|1
2736905|NCT00102804|9401858|P1|Overall Study|Lost to Follow-up|4
2736906|NCT00102804|9401857|P2|Overall Study|Enrollment Criteria Not Met|0
2736907|NCT00102804|9401858|P1|Overall Study|Enrollment Criteria Not Met|6
2736908|NCT00102804|9401857|P2|Overall Study|Death|6
2736909|NCT00102804|9401858|P1|Overall Study|Death|5
2736910|NCT00102804|9401857|P2|Overall Study|Physician Decision|6
2736911|NCT00102804|9401858|P1|Overall Study|Physician Decision|24
2736912|NCT00102804|9401857|P2|Overall Study|Adverse Event|3
2736913|NCT00102804|9401858|P1|Overall Study|Adverse Event|37
2736914|NCT00102804|9401857|P2|Overall Study|Withdrawal by Subject|7
2736915|NCT00102804|9401858|P1|Overall Study|Withdrawal by Subject|46
2736916|NCT00102804|9401857|P2|Overall Study|Progressive Disease (PD)|196
2736917|NCT00102804|9401858|P1|Overall Study|Progressive Disease (PD)|307
2736918|NCT00102687|9401879|P5|Maintenance Period|Physician Decision|4
2736919|NCT00102687|9401880|P4|Maintenance Period|Physician Decision|0
2736920|NCT00102687|9401881|P3|Maintenance Period|Physician Decision|3
2736921|NCT00102687|9401882|P2|Maintenance Period|Physician Decision|2
2736922|NCT00102687|9401883|P1|Maintenance Period|Physician Decision|1
2736923|NCT00102687|9401879|P5|Maintenance Period|Death|1
2736924|NCT00102687|9401880|P4|Maintenance Period|Death|1
2736925|NCT00102687|9401881|P3|Maintenance Period|Death|0
2736926|NCT00102687|9401882|P2|Maintenance Period|Death|0
2736927|NCT00102687|9401883|P1|Maintenance Period|Death|0
2736928|NCT00102687|9401879|P5|Maintenance Period|Failed Treatment (relapse,disease prog)|4
2736929|NCT00102687|9401880|P4|Maintenance Period|Failed Treatment (relapse,disease prog)|3
2736930|NCT00102687|9401881|P3|Maintenance Period|Failed Treatment (relapse,disease prog)|1
2736931|NCT00102687|9401882|P2|Maintenance Period|Failed Treatment (relapse,disease prog)|1
2736932|NCT00102687|9401883|P1|Maintenance Period|Failed Treatment (relapse,disease prog)|1
2736933|NCT00102687|9401879|P5|Maintenance Period|Transformation to AML (blast > 30%)|0
2736934|NCT00102687|9401880|P4|Maintenance Period|Transformation to AML (blast > 30%)|2
2736935|NCT00102687|9401881|P3|Maintenance Period|Transformation to AML (blast > 30%)|0
2736936|NCT00102687|9401882|P2|Maintenance Period|Transformation to AML (blast > 30%)|1
2736937|NCT00102687|9401883|P1|Maintenance Period|Transformation to AML (blast > 30%)|0
2736938|NCT00102687|9401879|P5|Maintenance Period|Adverse Event|3
2736939|NCT00102687|9401880|P4|Maintenance Period|Adverse Event|1
2736940|NCT00102687|9401881|P3|Maintenance Period|Adverse Event|0
2736941|NCT00102687|9401882|P2|Maintenance Period|Adverse Event|0
2736942|NCT00102687|9401883|P1|Maintenance Period|Adverse Event|1
2736943|NCT00102687|9401879|P5|Maintenance Period|Withdrawal by Subject|1
2736944|NCT00102687|9401880|P4|Maintenance Period|Withdrawal by Subject|3
2736945|NCT00102687|9401881|P3|Maintenance Period|Withdrawal by Subject|2
2736946|NCT00102687|9401882|P2|Maintenance Period|Withdrawal by Subject|0
2736947|NCT00102687|9401883|P1|Maintenance Period|Withdrawal by Subject|4
2736948|NCT00102687|9401879|P5|Initial Period|Death|0
2736949|NCT00102687|9401880|P4|Initial Period|Death|0
2736950|NCT00102687|9401881|P3|Initial Period|Death|1
2736951|NCT00102687|9401882|P2|Initial Period|Death|1
2736952|NCT00102687|9401883|P1|Initial Period|Death|1
2736953|NCT00102687|9401879|P5|Initial Period|Failed Treatments (relapse,disease prog)|0
2736954|NCT00102687|9401880|P4|Initial Period|Failed Treatments (relapse,disease prog)|0
2736955|NCT00102687|9401881|P3|Initial Period|Failed Treatments (relapse,disease prog)|2
2736956|NCT00102687|9401882|P2|Initial Period|Failed Treatments (relapse,disease prog)|4
2736957|NCT00102687|9401883|P1|Initial Period|Failed Treatments (relapse,disease prog)|4
2736958|NCT00102687|9401879|P5|Initial Period|Sponsor's decision|0
2736959|NCT00102687|9401880|P4|Initial Period|Sponsor's decision|0
2736960|NCT00102687|9401881|P3|Initial Period|Sponsor's decision|1
2736961|NCT00102687|9401882|P2|Initial Period|Sponsor's decision|1
2736962|NCT00102687|9401883|P1|Initial Period|Sponsor's decision|0
2736963|NCT00102687|9401879|P5|Initial Period|Physician Decision|0
2736964|NCT00102687|9401880|P4|Initial Period|Physician Decision|0
2736965|NCT00102687|9401881|P3|Initial Period|Physician Decision|6
2736966|NCT00102687|9401882|P2|Initial Period|Physician Decision|9
2736967|NCT00102687|9401883|P1|Initial Period|Physician Decision|2
2736968|NCT00102687|9401879|P5|Initial Period|Protocol Violation|0
2736969|NCT00102687|9401880|P4|Initial Period|Protocol Violation|0
2736970|NCT00102687|9401881|P3|Initial Period|Protocol Violation|2
2736971|NCT00102687|9401882|P2|Initial Period|Protocol Violation|0
2736972|NCT00102687|9401883|P1|Initial Period|Protocol Violation|0
2736973|NCT00102687|9401879|P5|Initial Period|Transformation to AML (blast > 30%)|0
2736974|NCT00102687|9401880|P4|Initial Period|Transformation to AML (blast > 30%)|0
2736975|NCT00102687|9401881|P3|Initial Period|Transformation to AML (blast > 30%)|0
2736976|NCT00102687|9401882|P2|Initial Period|Transformation to AML (blast > 30%)|3
2736977|NCT00102687|9401883|P1|Initial Period|Transformation to AML (blast > 30%)|1
2736978|NCT00102687|9401879|P5|Initial Period|Adverse Event|0
2736979|NCT00102687|9401880|P4|Initial Period|Adverse Event|0
2736980|NCT00102687|9401881|P3|Initial Period|Adverse Event|9
2736981|NCT00102687|9401882|P2|Initial Period|Adverse Event|7
2736982|NCT00102687|9401883|P1|Initial Period|Adverse Event|4
2736983|NCT00102687|9401879|P5|Initial Period|Withdrawal by Subject|0
2736984|NCT00102687|9401880|P4|Initial Period|Withdrawal by Subject|0
2736985|NCT00102687|9401881|P3|Initial Period|Withdrawal by Subject|5
2736986|NCT00102687|9401882|P2|Initial Period|Withdrawal by Subject|3
2736987|NCT00102687|9401883|P1|Initial Period|Withdrawal by Subject|6
2736988|NCT00102596|9401947|P2|Part A|Adverse Event|0
2736989|NCT00102596|9401948|P1|Part A|Adverse Event|1
2736990|NCT00102596|9401947|P2|Part A|Screen failures|0
2736991|NCT00102596|9401948|P1|Part A|Screen failures|6
2736992|NCT00102531|9401959|P2|Overall Study|Physician Decision|1
2736993|NCT00102531|9401960|P1|Overall Study|Physician Decision|0
2736994|NCT00102531|9401959|P2|Overall Study|Disease Progression|9
2736995|NCT00102531|9401960|P1|Overall Study|Disease Progression|5
2736996|NCT00102531|9401959|P2|Overall Study|Adverse Event|1
2736997|NCT00102531|9401960|P1|Overall Study|Adverse Event|0
2736998|NCT00102440|9401975|P3|Overall Study|Protocol Violation|1
2736999|NCT00102440|9401976|P2|Overall Study|Protocol Violation|2
2737000|NCT00102440|9401977|P1|Overall Study|Protocol Violation|7
2737001|NCT00102440|9401975|P3|Overall Study|Other|14
2737002|NCT00102440|9401976|P2|Overall Study|Other|14
2737003|NCT00102440|9401977|P1|Overall Study|Other|11
2737004|NCT00102440|9401975|P3|Overall Study|Personal Reason(s)|13
2737005|NCT00102440|9401976|P2|Overall Study|Personal Reason(s)|13
2737006|NCT00102440|9401977|P1|Overall Study|Personal Reason(s)|19
2737007|NCT00102440|9401975|P3|Overall Study|Gout Flare|9
2737008|NCT00102440|9401976|P2|Overall Study|Gout Flare|28
2737009|NCT00102440|9401977|P1|Overall Study|Gout Flare|10
2737010|NCT00102440|9401975|P3|Overall Study|Adverse Event|8
2737011|NCT00102440|9401976|P2|Overall Study|Adverse Event|23
2737012|NCT00102440|9401977|P1|Overall Study|Adverse Event|16
2737013|NCT00102440|9401975|P3|Overall Study|Lost to Follow-up|21
2737014|NCT00102440|9401976|P2|Overall Study|Lost to Follow-up|18
2737015|NCT00102440|9401977|P1|Overall Study|Lost to Follow-up|25
2737016|NCT00102063|9402027|P3|Overall Study|Protocol Violation|1
2737017|NCT00102063|9402028|P2|Overall Study|Protocol Violation|1
2737018|NCT00102063|9402029|P1|Overall Study|Protocol Violation|0
2737019|NCT00102063|9402027|P3|Overall Study|Lost to Follow-up|1
2737020|NCT00102063|9402028|P2|Overall Study|Lost to Follow-up|0
2737021|NCT00102063|9402029|P1|Overall Study|Lost to Follow-up|0
2737022|NCT00102063|9402027|P3|Overall Study|Withdrawal by Subject|5
2737023|NCT00102063|9402028|P2|Overall Study|Withdrawal by Subject|12
2737024|NCT00102063|9402029|P1|Overall Study|Withdrawal by Subject|4
2737025|NCT00102063|9402027|P3|Overall Study|Adverse Event|2
2737026|NCT00102063|9402028|P2|Overall Study|Adverse Event|4
2737027|NCT00102063|9402029|P1|Overall Study|Adverse Event|7
2737028|NCT00102063|9402027|P3|Overall Study|Lack of Efficacy|1
2737029|NCT00102063|9402028|P2|Overall Study|Lack of Efficacy|1
2737030|NCT00102063|9402029|P1|Overall Study|Lack of Efficacy|5
2737031|NCT00101907|9402087|P6|Overall Study|Withdrawal by Subject|0
2737032|NCT00101907|9402088|P5|Overall Study|Withdrawal by Subject|1
2737033|NCT00101907|9402089|P4|Overall Study|Withdrawal by Subject|0
2737034|NCT00101907|9402090|P3|Overall Study|Withdrawal by Subject|1
2737035|NCT00101907|9402091|P2|Overall Study|Withdrawal by Subject|0
2737036|NCT00101907|9402092|P1|Overall Study|Withdrawal by Subject|1
2737037|NCT00101907|9402087|P6|Overall Study|Physician Decision|0
2737038|NCT00101907|9402088|P5|Overall Study|Physician Decision|1
2737039|NCT00101907|9402089|P4|Overall Study|Physician Decision|1
2737040|NCT00101907|9402090|P3|Overall Study|Physician Decision|0
2737041|NCT00101907|9402091|P2|Overall Study|Physician Decision|0
2737042|NCT00101907|9402092|P1|Overall Study|Physician Decision|0
2737043|NCT00101907|9402087|P6|Overall Study|Death|0
2737044|NCT00101907|9402088|P5|Overall Study|Death|3
2737045|NCT00101907|9402089|P4|Overall Study|Death|0
2737046|NCT00101907|9402090|P3|Overall Study|Death|0
2737047|NCT00101907|9402091|P2|Overall Study|Death|1
2737048|NCT00101907|9402092|P1|Overall Study|Death|0
2737049|NCT00101907|9402087|P6|Overall Study|Adverse Event|0
2737050|NCT00101907|9402088|P5|Overall Study|Adverse Event|0
2737051|NCT00101907|9402089|P4|Overall Study|Adverse Event|0
2737052|NCT00101907|9402090|P3|Overall Study|Adverse Event|0
2737053|NCT00101907|9402091|P2|Overall Study|Adverse Event|0
2737054|NCT00101907|9402092|P1|Overall Study|Adverse Event|1
2737055|NCT00101868|9402134|P2|Overall Study|Lost to Follow-up|13
2737056|NCT00101868|9402135|P1|Overall Study|Lost to Follow-up|8
2737057|NCT00101868|9402134|P2|Overall Study|Protocol Violation|0
2737058|NCT00101868|9402135|P1|Overall Study|Protocol Violation|3
2737059|NCT00101868|9402134|P2|Overall Study|Withdrawal by Subject|9
2737060|NCT00101868|9402135|P1|Overall Study|Withdrawal by Subject|8
2737061|NCT00101868|9402134|P2|Overall Study|Death|10
2737062|NCT00101868|9402135|P1|Overall Study|Death|10
2737063|NCT00101686|9402205|P10|Overall Study|Withdrawal by Subject|9
2737064|NCT00101686|9402206|P9|Overall Study|Withdrawal by Subject|8
2737065|NCT00101686|9402207|P8|Overall Study|Withdrawal by Subject|7
2737066|NCT00101686|9402208|P7|Overall Study|Withdrawal by Subject|7
2737067|NCT00101686|9402209|P6|Overall Study|Withdrawal by Subject|7
2737068|NCT00101686|9402210|P5|Overall Study|Withdrawal by Subject|8
2737069|NCT00101686|9402211|P4|Overall Study|Withdrawal by Subject|8
2737070|NCT00101686|9402212|P3|Overall Study|Withdrawal by Subject|6
2737071|NCT00101686|9402213|P2|Overall Study|Withdrawal by Subject|8
2737072|NCT00101686|9402214|P1|Overall Study|Withdrawal by Subject|9
2737073|NCT00101686|9402205|P10|Overall Study|Other|3
2737074|NCT00101686|9402206|P9|Overall Study|Other|3
2737075|NCT00101686|9402207|P8|Overall Study|Other|5
2737076|NCT00101686|9402208|P7|Overall Study|Other|1
2737077|NCT00101686|9402209|P6|Overall Study|Other|12
2737078|NCT00101686|9402210|P5|Overall Study|Other|2
2737079|NCT00101686|9402211|P4|Overall Study|Other|6
2737080|NCT00101686|9402212|P3|Overall Study|Other|1
2737081|NCT00101686|9402213|P2|Overall Study|Other|4
2737082|NCT00101686|9402214|P1|Overall Study|Other|1
2737083|NCT00101686|9402205|P10|Overall Study|Physician Decision|1
2737084|NCT00101686|9402206|P9|Overall Study|Physician Decision|1
2737085|NCT00101686|9402207|P8|Overall Study|Physician Decision|5
2737086|NCT00101686|9402208|P7|Overall Study|Physician Decision|5
2737087|NCT00101686|9402209|P6|Overall Study|Physician Decision|9
2737088|NCT00101686|9402210|P5|Overall Study|Physician Decision|8
2737089|NCT00101686|9402211|P4|Overall Study|Physician Decision|7
2737090|NCT00101686|9402212|P3|Overall Study|Physician Decision|6
2737091|NCT00101686|9402213|P2|Overall Study|Physician Decision|13
2737092|NCT00101686|9402214|P1|Overall Study|Physician Decision|10
2737093|NCT00101686|9402205|P10|Overall Study|intercurrent non-cancer related illness|1
2737094|NCT00101686|9402206|P9|Overall Study|intercurrent non-cancer related illness|1
2737095|NCT00101686|9402207|P8|Overall Study|intercurrent non-cancer related illness|0
2737096|NCT00101686|9402208|P7|Overall Study|intercurrent non-cancer related illness|1
2737097|NCT00101686|9402209|P6|Overall Study|intercurrent non-cancer related illness|3
2737098|NCT00101686|9402210|P5|Overall Study|intercurrent non-cancer related illness|1
2737099|NCT00101686|9402211|P4|Overall Study|intercurrent non-cancer related illness|0
2737100|NCT00101686|9402212|P3|Overall Study|intercurrent non-cancer related illness|2
2737101|NCT00101686|9402213|P2|Overall Study|intercurrent non-cancer related illness|0
2737102|NCT00101686|9402214|P1|Overall Study|intercurrent non-cancer related illness|0
2737103|NCT00101686|9402205|P10|Overall Study|Randomized but did not receive treament|1
2737104|NCT00101686|9402206|P9|Overall Study|Randomized but did not receive treament|0
2737105|NCT00101686|9402207|P8|Overall Study|Randomized but did not receive treament|1
2737106|NCT00101686|9402208|P7|Overall Study|Randomized but did not receive treament|0
2737107|NCT00101686|9402209|P6|Overall Study|Randomized but did not receive treament|2
2737108|NCT00101686|9402210|P5|Overall Study|Randomized but did not receive treament|2
2737109|NCT00101686|9402211|P4|Overall Study|Randomized but did not receive treament|2
2737110|NCT00101686|9402212|P3|Overall Study|Randomized but did not receive treament|2
2737111|NCT00101686|9402213|P2|Overall Study|Randomized but did not receive treament|6
2737112|NCT00101686|9402214|P1|Overall Study|Randomized but did not receive treament|1
2737113|NCT00101686|9402205|P10|Overall Study|unacceptable toxicity|4
2737114|NCT00101686|9402206|P9|Overall Study|unacceptable toxicity|1
2737115|NCT00101686|9402207|P8|Overall Study|unacceptable toxicity|2
2737116|NCT00101686|9402208|P7|Overall Study|unacceptable toxicity|4
2737117|NCT00101686|9402209|P6|Overall Study|unacceptable toxicity|10
2737118|NCT00101686|9402210|P5|Overall Study|unacceptable toxicity|16
2737119|NCT00101686|9402211|P4|Overall Study|unacceptable toxicity|6
2737120|NCT00101686|9402212|P3|Overall Study|unacceptable toxicity|10
2737121|NCT00101686|9402213|P2|Overall Study|unacceptable toxicity|9
2737122|NCT00101686|9402214|P1|Overall Study|unacceptable toxicity|3
2737123|NCT00101686|9402205|P10|Overall Study|>3 week delay treatment due toxicity|0
2737124|NCT00101686|9402206|P9|Overall Study|>3 week delay treatment due toxicity|3
2737125|NCT00101686|9402207|P8|Overall Study|>3 week delay treatment due toxicity|1
2737126|NCT00101686|9402208|P7|Overall Study|>3 week delay treatment due toxicity|2
2737127|NCT00101686|9402209|P6|Overall Study|>3 week delay treatment due toxicity|3
2737128|NCT00101686|9402210|P5|Overall Study|>3 week delay treatment due toxicity|7
2737129|NCT00101686|9402211|P4|Overall Study|>3 week delay treatment due toxicity|2
2737130|NCT00101686|9402212|P3|Overall Study|>3 week delay treatment due toxicity|1
2737131|NCT00101686|9402213|P2|Overall Study|>3 week delay treatment due toxicity|2
2737132|NCT00101686|9402214|P1|Overall Study|>3 week delay treatment due toxicity|6
2737133|NCT00101686|9402205|P10|Overall Study|initiation other anti-cancer treatment|3
2737134|NCT00101686|9402206|P9|Overall Study|initiation other anti-cancer treatment|3
2737135|NCT00101686|9402207|P8|Overall Study|initiation other anti-cancer treatment|2
2737136|NCT00101686|9402208|P7|Overall Study|initiation other anti-cancer treatment|2
2737137|NCT00101686|9402209|P6|Overall Study|initiation other anti-cancer treatment|1
2737138|NCT00101686|9402210|P5|Overall Study|initiation other anti-cancer treatment|1
2737139|NCT00101686|9402211|P4|Overall Study|initiation other anti-cancer treatment|3
2737140|NCT00101686|9402212|P3|Overall Study|initiation other anti-cancer treatment|4
2737141|NCT00101686|9402213|P2|Overall Study|initiation other anti-cancer treatment|3
2737142|NCT00101686|9402214|P1|Overall Study|initiation other anti-cancer treatment|4
2737143|NCT00101686|9402205|P10|Overall Study|Progressive Disease|8
2737144|NCT00101686|9402206|P9|Overall Study|Progressive Disease|10
2737145|NCT00101686|9402207|P8|Overall Study|Progressive Disease|7
2737146|NCT00101686|9402208|P7|Overall Study|Progressive Disease|5
2737147|NCT00101686|9402209|P6|Overall Study|Progressive Disease|25
2737148|NCT00101686|9402210|P5|Overall Study|Progressive Disease|28
2737149|NCT00101686|9402211|P4|Overall Study|Progressive Disease|38
2737150|NCT00101686|9402212|P3|Overall Study|Progressive Disease|37
2737151|NCT00101686|9402213|P2|Overall Study|Progressive Disease|28
2737152|NCT00101686|9402214|P1|Overall Study|Progressive Disease|37
2737153|NCT00101582|9402331|P2|Overall Study|Other|1
2737154|NCT00101582|9402332|P1|Overall Study|Other|0
2737155|NCT00101582|9402331|P2|Overall Study|Death|5
2737156|NCT00101582|9402332|P1|Overall Study|Death|3
2737157|NCT00101582|9402331|P2|Overall Study|Physician Decision|0
2737158|NCT00101582|9402332|P1|Overall Study|Physician Decision|1
2737159|NCT00101582|9402331|P2|Overall Study|Withdrawal by Subject|4
2737160|NCT00101582|9402332|P1|Overall Study|Withdrawal by Subject|6
2737161|NCT00101582|9402331|P2|Overall Study|Adverse Event|4
2737162|NCT00101582|9402332|P1|Overall Study|Adverse Event|1
2737163|NCT00101582|9402331|P2|Overall Study|Ineligibility determined|1
2737164|NCT00101582|9402332|P1|Overall Study|Ineligibility determined|0
2737165|NCT00101452|9402355|P3|Overall Study|Other|12
2737166|NCT00101452|9402356|P2|Overall Study|Other|16
2737167|NCT00101452|9402357|P1|Overall Study|Other|15
2737168|NCT00101452|9402355|P3|Overall Study|Protocol Violation|3
2737169|NCT00101452|9402356|P2|Overall Study|Protocol Violation|1
2737170|NCT00101452|9402357|P1|Overall Study|Protocol Violation|2
2737171|NCT00101452|9402355|P3|Overall Study|Physician Decision|2
2737172|NCT00101452|9402356|P2|Overall Study|Physician Decision|3
2737173|NCT00101452|9402357|P1|Overall Study|Physician Decision|0
2737174|NCT00101452|9402355|P3|Overall Study|Baseline Fail|2
2737175|NCT00101452|9402356|P2|Overall Study|Baseline Fail|1
2737176|NCT00101452|9402357|P1|Overall Study|Baseline Fail|2
2737177|NCT00101452|9402355|P3|Overall Study|Withdrawal by Subject|9
2737178|NCT00101452|9402356|P2|Overall Study|Withdrawal by Subject|14
2737179|NCT00101452|9402357|P1|Overall Study|Withdrawal by Subject|10
2737180|NCT00101452|9402355|P3|Overall Study|Lost to Follow-up|14
2737181|NCT00101452|9402356|P2|Overall Study|Lost to Follow-up|8
2737182|NCT00101452|9402357|P1|Overall Study|Lost to Follow-up|13
2737183|NCT00101452|9402355|P3|Overall Study|Adverse Event|1
2737184|NCT00101452|9402356|P2|Overall Study|Adverse Event|0
2737185|NCT00101452|9402357|P1|Overall Study|Adverse Event|2
2737186|NCT00101439|9402371|P2|Period 2|Withdrawal by Subject|2
2737187|NCT00101439|9402372|P1|Period 2|Withdrawal by Subject|0
2737188|NCT00101400|9402388|P1|Survival Follow-Up|Alive|7
2737189|NCT00101283|9402408|P2|Overall Study|Prostate Cancer Recurrence|1
2737190|NCT00101283|9402409|P1|Overall Study|Prostate Cancer Recurrence|0
2737191|NCT00101283|9402408|P2|Overall Study|Insurance Refusal|1
2737192|NCT00101283|9402409|P1|Overall Study|Insurance Refusal|0
2737193|NCT00101283|9402408|P2|Overall Study|Withdrawal by Subject|1
2737194|NCT00101283|9402409|P1|Overall Study|Withdrawal by Subject|0
2737195|NCT00101192|9402419|P1|Overall Study|Inevaluable|1
2737196|NCT00101192|9402419|P1|Overall Study|Ineligible|6
2737197|NCT00101166|9402423|P1|Overall Study|progressive disease|10
2737198|NCT00101101|9402431|P1|Overall Study|never received vaccine|20
2737199|NCT00100932|9402454|P2|Overall Study|Other|2
2737200|NCT00100932|9402455|P1|Overall Study|Other|5
2737201|NCT00100932|9402454|P2|Overall Study|Physician Decision|5
2737202|NCT00100932|9402455|P1|Overall Study|Physician Decision|7
2737203|NCT00100932|9402454|P2|Overall Study|Progressive Disease|18
2737204|NCT00100932|9402455|P1|Overall Study|Progressive Disease|44
2737205|NCT00100932|9402454|P2|Overall Study|Withdrawal by Subject|0
2737206|NCT00100932|9402455|P1|Overall Study|Withdrawal by Subject|6
2737207|NCT00100932|9402454|P2|Overall Study|Adverse Event|2
2737208|NCT00100932|9402455|P1|Overall Study|Adverse Event|11
2737209|NCT00100828|9402470|P1|Overall Study|Physician Decision|6
2737210|NCT00100815|9402474|P1|Overall Study|Other|3
2737211|NCT00100815|9402474|P1|Overall Study|Death|4
2737212|NCT00100815|9402474|P1|Overall Study|Adverse Event|18
2737213|NCT00100815|9402474|P1|Overall Study|Progression|24
2737214|NCT00100802|9402482|P1|Overall Study|Ineligible|12
2737215|NCT00100802|9402482|P1|Overall Study|Withdrawal by Subject|5
2737216|NCT00100802|9402482|P1|Overall Study|Protocol Violation|1
2737217|NCT00100802|9402482|P1|Overall Study|Physician Decision|5
2737218|NCT00100802|9402482|P1|Overall Study|Lack of Efficacy|47
2737219|NCT00100802|9402482|P1|Overall Study|Death|1
2737220|NCT00100802|9402482|P1|Overall Study|Adverse Event|9
2737221|NCT00100789|9402487|P1|Overall Study|Never received treatment|1
2737222|NCT00100789|9402487|P1|Overall Study|Ineligible|3
2737223|NCT00100789|9402487|P1|Overall Study|Not protocol specified|5
2737224|NCT00100789|9402487|P1|Overall Study|Death|2
2737225|NCT00100789|9402487|P1|Overall Study|Progression/relapse|42
2737226|NCT00100789|9402487|P1|Overall Study|Withdrawal by Subject|1
2737227|NCT00100789|9402487|P1|Overall Study|Adverse Event|10
2737228|NCT00100178|9402564|P3|Overall Study|Physician Decision|3
2737229|NCT00100178|9402565|P2|Overall Study|Physician Decision|1
2737230|NCT00100178|9402566|P1|Overall Study|Physician Decision|6
2737231|NCT00100178|9402564|P3|Overall Study|Withdrawal by Subject|1
2737232|NCT00100178|9402565|P2|Overall Study|Withdrawal by Subject|1
2737233|NCT00100178|9402566|P1|Overall Study|Withdrawal by Subject|1
2737234|NCT00100178|9402564|P3|Overall Study|Adverse Event|1
2737235|NCT00100178|9402565|P2|Overall Study|Adverse Event|2
2737236|NCT00100178|9402566|P1|Overall Study|Adverse Event|2
2737237|NCT00100178|9402564|P3|Overall Study|Lost to Follow-up|5
2737238|NCT00100178|9402565|P2|Overall Study|Lost to Follow-up|6
2737239|NCT00100178|9402566|P1|Overall Study|Lost to Follow-up|0
2737240|NCT00100048|9402595|P6|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
2737241|NCT00100048|9402596|P5|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
2737242|NCT00100048|9402597|P4|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1
2737243|NCT00100048|9402598|P3|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
2737244|NCT00100048|9402599|P2|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
2737245|NCT00100048|9402600|P1|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
2737246|NCT00100048|9402595|P6|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
2737247|NCT00100048|9402596|P5|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
2737248|NCT00100048|9402597|P4|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
2737249|NCT00100048|9402598|P3|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
2737250|NCT00100048|9402599|P2|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
2737251|NCT00100048|9402600|P1|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
2737252|NCT00100048|9402595|P6|Cohort I & II-Combination Therapy Phase|Other Reason|0
2737253|NCT00100048|9402596|P5|Cohort I & II-Combination Therapy Phase|Other Reason|0
2737254|NCT00100048|9402597|P4|Cohort I & II-Combination Therapy Phase|Other Reason|2
2737255|NCT00100048|9402598|P3|Cohort I & II-Combination Therapy Phase|Other Reason|4
2737256|NCT00100048|9402599|P2|Cohort I & II-Combination Therapy Phase|Other Reason|1
2737257|NCT00100048|9402600|P1|Cohort I & II-Combination Therapy Phase|Other Reason|7
2737258|NCT00100048|9402595|P6|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4
2737259|NCT00100048|9402596|P5|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0
2737260|NCT00100048|9402597|P4|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5
2737261|NCT00100048|9402598|P3|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
2737262|NCT00100048|9402599|P2|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
2737263|NCT00100048|9402600|P1|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1
2737264|NCT00100048|9402595|P6|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
2737265|NCT00100048|9402596|P5|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0
2737266|NCT00100048|9402597|P4|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
2737267|NCT00100048|9402598|P3|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
2737268|NCT00100048|9402599|P2|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1
2737269|NCT00100048|9402600|P1|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
2737270|NCT00100048|9402595|P6|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2
2737271|NCT00100048|9402596|P5|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
2737272|NCT00100048|9402597|P4|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
2737273|NCT00100048|9402598|P3|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
2737274|NCT00100048|9402599|P2|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3
2737275|NCT00100048|9402600|P1|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1
2737276|NCT00100048|9402595|P6|Cohort I & II-Combination Therapy Phase|Adverse Event|1
2737277|NCT00100048|9402596|P5|Cohort I & II-Combination Therapy Phase|Adverse Event|0
2737278|NCT00100048|9402597|P4|Cohort I & II-Combination Therapy Phase|Adverse Event|0
2737279|NCT00100048|9402598|P3|Cohort I & II-Combination Therapy Phase|Adverse Event|2
2737280|NCT00100048|9402599|P2|Cohort I & II-Combination Therapy Phase|Adverse Event|1
2737281|NCT00100048|9402600|P1|Cohort I & II-Combination Therapy Phase|Adverse Event|0
2737282|NCT00100048|9402595|P6|Cohort I & II-Combination Therapy Phase|Never Treated|1
2737283|NCT00100048|9402596|P5|Cohort I & II-Combination Therapy Phase|Never Treated|0
2737284|NCT00100048|9402597|P4|Cohort I & II-Combination Therapy Phase|Never Treated|0
2737285|NCT00100048|9402598|P3|Cohort I & II-Combination Therapy Phase|Never Treated|0
2737286|NCT00100048|9402599|P2|Cohort I & II-Combination Therapy Phase|Never Treated|0
2737287|NCT00100048|9402600|P1|Cohort I & II-Combination Therapy Phase|Never Treated|2
2737288|NCT00099983|9402709|P2|Overall Study|Other issue|0
2737289|NCT00099983|9402710|P1|Overall Study|Other issue|1
2737290|NCT00099983|9402709|P2|Overall Study|Intolerant of burden of visits|1
2737291|NCT00099983|9402710|P1|Overall Study|Intolerant of burden of visits|0
2737292|NCT00099983|9402709|P2|Overall Study|Incarcerated|1
2737293|NCT00099983|9402710|P1|Overall Study|Incarcerated|0
2737294|NCT00099983|9402709|P2|Overall Study|Other psychiatric problem|0
2737295|NCT00099983|9402710|P1|Overall Study|Other psychiatric problem|1
2737296|NCT00099983|9402709|P2|Overall Study|Moved|0
2737297|NCT00099983|9402710|P1|Overall Study|Moved|1
2737298|NCT00099983|9402709|P2|Overall Study|Unable to return for appointments|1
2737299|NCT00099983|9402710|P1|Overall Study|Unable to return for appointments|1
2737300|NCT00099983|9402709|P2|Overall Study|Lack of Efficacy|1
2737301|NCT00099983|9402710|P1|Overall Study|Lack of Efficacy|0
2737302|NCT00099983|9402709|P2|Overall Study|Adverse Event|1
2737303|NCT00099983|9402710|P1|Overall Study|Adverse Event|1
2737304|NCT00099983|9402709|P2|Overall Study|Withdrawal by Subject|2
2737305|NCT00099983|9402710|P1|Overall Study|Withdrawal by Subject|3
2737306|NCT00099983|9402709|P2|Overall Study|Missing Source Documents|15
2737307|NCT00099983|9402710|P1|Overall Study|Missing Source Documents|14
2737308|NCT00099983|9402709|P2|Overall Study|Lost to Follow-up|3
2737309|NCT00099983|9402710|P1|Overall Study|Lost to Follow-up|2
2737310|NCT00099632|9402722|P6|Overall Study|Protocol Violation|1
2737311|NCT00099632|9402723|P5|Overall Study|Protocol Violation|0
2737312|NCT00099632|9402724|P4|Overall Study|Protocol Violation|0
2737313|NCT00099632|9402725|P3|Overall Study|Protocol Violation|0
2737314|NCT00099632|9402726|P2|Overall Study|Protocol Violation|0
2737315|NCT00099632|9402727|P1|Overall Study|Protocol Violation|0
2737316|NCT00099632|9402722|P6|Overall Study|Withdrawal by Subject|1
2737317|NCT00099632|9402723|P5|Overall Study|Withdrawal by Subject|0
2737318|NCT00099632|9402724|P4|Overall Study|Withdrawal by Subject|0
2737319|NCT00099632|9402725|P3|Overall Study|Withdrawal by Subject|0
2737320|NCT00099632|9402726|P2|Overall Study|Withdrawal by Subject|1
2737321|NCT00099632|9402727|P1|Overall Study|Withdrawal by Subject|0
2737322|NCT00099632|9402722|P6|Overall Study|Lost to Follow-up|0
2737323|NCT00099632|9402723|P5|Overall Study|Lost to Follow-up|1
2737324|NCT00099632|9402724|P4|Overall Study|Lost to Follow-up|1
2737325|NCT00099632|9402725|P3|Overall Study|Lost to Follow-up|3
2737326|NCT00099632|9402726|P2|Overall Study|Lost to Follow-up|0
2737327|NCT00099632|9402727|P1|Overall Study|Lost to Follow-up|1
2737328|NCT00099437|9402767|P2|Overall Study|Ongoing in FU but not on treatment|45
2737329|NCT00099437|9402768|P1|Overall Study|Ongoing in FU but not on treatment|37
2737330|NCT00099437|9402767|P2|Overall Study|Withdrawal by Subject|10
2737331|NCT00099437|9402768|P1|Overall Study|Withdrawal by Subject|6
2737332|NCT00099437|9402767|P2|Overall Study|Death|261
2737333|NCT00099437|9402768|P1|Overall Study|Death|293
2737334|NCT00099437|9402767|P2|Overall Study|Lost to Follow-up|33
2737335|NCT00099437|9402768|P1|Overall Study|Lost to Follow-up|30
2737336|NCT00099359|9402791|P3|Overall Study|moved out of area|4
2737337|NCT00099359|9402792|P2|Overall Study|moved out of area|7
2737338|NCT00099359|9402793|P1|Overall Study|moved out of area|9
2737339|NCT00099359|9402791|P3|Overall Study|Lost to Follow-up|24
2737340|NCT00099359|9402792|P2|Overall Study|Lost to Follow-up|24
2737341|NCT00099359|9402793|P1|Overall Study|Lost to Follow-up|15
2737342|NCT00099359|9402791|P3|Overall Study|Withdrawal by Subject|23
2737343|NCT00099359|9402792|P2|Overall Study|Withdrawal by Subject|19
2737344|NCT00099359|9402793|P1|Overall Study|Withdrawal by Subject|19
2737345|NCT00099359|9402791|P3|Overall Study|Death|17
2737346|NCT00099359|9402792|P2|Overall Study|Death|15
2737347|NCT00099359|9402793|P1|Overall Study|Death|11
2737348|NCT00099268|9402816|P2|Overall Study|Death|1
2737349|NCT00099268|9402817|P1|Overall Study|Death|3
2737350|NCT00099268|9402816|P2|Overall Study|Administrative problems|4
2737351|NCT00099268|9402817|P1|Overall Study|Administrative problems|4
2737352|NCT00099268|9402816|P2|Overall Study|Lack of Efficacy|18
2737353|NCT00099268|9402817|P1|Overall Study|Lack of Efficacy|5
2737354|NCT00099268|9402816|P2|Overall Study|Lost to Follow-up|4
2737355|NCT00099268|9402817|P1|Overall Study|Lost to Follow-up|6
2737356|NCT00099268|9402816|P2|Overall Study|Protocol Violation|8
2737357|NCT00099268|9402817|P1|Overall Study|Protocol Violation|9
2737358|NCT00099268|9402816|P2|Overall Study|Adverse Event|19
2737359|NCT00099268|9402817|P1|Overall Study|Adverse Event|19
2737360|NCT00099268|9402816|P2|Overall Study|Withdrawal by Subject|28
2737361|NCT00099268|9402817|P1|Overall Study|Withdrawal by Subject|46
2737362|NCT00098865|9402857|P1|Overall Study|Alternative Therapy|1
2737363|NCT00098865|9402857|P1|Overall Study|Adverse Event|2
2737364|NCT00098865|9402857|P1|Overall Study|Progressive Disease|6
2737365|NCT00098839|9402865|P2|Overall Study|Ineligible|0
2737366|NCT00098839|9402866|P1|Overall Study|Ineligible|2
2737367|NCT00098839|9402865|P2|Overall Study|M2/M3 marrow on Day 15 of Block 2|11
2737368|NCT00098839|9402866|P1|Overall Study|M2/M3 marrow on Day 15 of Block 2|10
2737369|NCT00098839|9402865|P2|Overall Study|Relapse|3
2737370|NCT00098839|9402866|P1|Overall Study|Relapse|6
2737371|NCT00098839|9402865|P2|Overall Study|Refusal of further protocol therapy|1
2737372|NCT00098839|9402866|P1|Overall Study|Refusal of further protocol therapy|3
2737373|NCT00098839|9402865|P2|Overall Study|Withdrawal by Subject|0
2737374|NCT00098839|9402866|P1|Overall Study|Withdrawal by Subject|1
2737375|NCT00098839|9402865|P2|Overall Study|Physician Decision|14
2737376|NCT00098839|9402866|P1|Overall Study|Physician Decision|4
2737377|NCT00098839|9402865|P2|Overall Study|Death|2
2737378|NCT00098839|9402866|P1|Overall Study|Death|1
2737379|NCT00098839|9402865|P2|Overall Study|Adverse Event|2
2737380|NCT00098839|9402866|P1|Overall Study|Adverse Event|5
2737381|NCT00098813|9402877|P1|Overall Study|Reversal of RAI resistance|1
2737382|NCT00098813|9402877|P1|Overall Study|Other complicating disease|1
2737383|NCT00098813|9402877|P1|Overall Study|Progression of Disease|1
2737384|NCT00098813|9402877|P1|Overall Study|Withdrawal by Subject|7
2737385|NCT00098813|9402877|P1|Overall Study|Protocol Violation|1
2737386|NCT00098813|9402877|P1|Overall Study|Death|8
2737387|NCT00098787|9402884|P3|Overall Study|Other|9
2737388|NCT00098787|9402885|P2|Overall Study|Other|6
2737389|NCT00098787|9402886|P1|Overall Study|Other|7
2737390|NCT00098787|9402884|P3|Overall Study|Alternative therapy|13
2737391|NCT00098787|9402885|P2|Overall Study|Alternative therapy|13
2737392|NCT00098787|9402886|P1|Overall Study|Alternative therapy|8
2737393|NCT00098787|9402884|P3|Overall Study|Withdrawal by Subject|6
2737394|NCT00098787|9402885|P2|Overall Study|Withdrawal by Subject|12
2737395|NCT00098787|9402886|P1|Overall Study|Withdrawal by Subject|4
2737396|NCT00098787|9402884|P3|Overall Study|Death|0
2737397|NCT00098787|9402885|P2|Overall Study|Death|1
2737398|NCT00098787|9402886|P1|Overall Study|Death|6
2737399|NCT00098787|9402884|P3|Overall Study|Adverse Event|8
2737400|NCT00098787|9402885|P2|Overall Study|Adverse Event|17
2737401|NCT00098787|9402886|P1|Overall Study|Adverse Event|8
2737402|NCT00098787|9402884|P3|Overall Study|Disease progression|23
2737403|NCT00098787|9402885|P2|Overall Study|Disease progression|17
2737404|NCT00098787|9402886|P1|Overall Study|Disease progression|28
2737405|NCT00098787|9402884|P3|Overall Study|Ineligible|3
2737406|NCT00098787|9402885|P2|Overall Study|Ineligible|7
2737407|NCT00098787|9402886|P1|Overall Study|Ineligible|9
2737408|NCT00098787|9402884|P3|Overall Study|Never started treatment|1
2737409|NCT00098787|9402885|P2|Overall Study|Never started treatment|2
2737410|NCT00098787|9402886|P1|Overall Study|Never started treatment|3
2737411|NCT00098774|9402900|P1|Overall Study|Physician Decision|2
2737412|NCT00098774|9402900|P1|Overall Study|Failed (to respond) during induction|4
2737413|NCT00098774|9402900|P1|Overall Study|Withdrawal by Subject|1
2737414|NCT00098774|9402900|P1|Overall Study|Disease Progression|9
2737415|NCT00098774|9402900|P1|Overall Study|Adverse Event|2
2737416|NCT00098748|9402910|P3|Continued on Open-Label Treatment|Withdrawal by Subject|0
2737417|NCT00098748|9402911|P2|Continued on Open-Label Treatment|Withdrawal by Subject|4
2737418|NCT00098748|9402912|P1|Continued on Open-Label Treatment|Withdrawal by Subject|0
2737419|NCT00098748|9402910|P3|Continued on Open-Label Treatment|Lost to Follow-up|0
2737420|NCT00098748|9402911|P2|Continued on Open-Label Treatment|Lost to Follow-up|1
2737421|NCT00098748|9402912|P1|Continued on Open-Label Treatment|Lost to Follow-up|1
2737422|NCT00098748|9402910|P3|Continued on Open-Label Treatment|Other reason includes protocol violation|0
2737423|NCT00098748|9402911|P2|Continued on Open-Label Treatment|Other reason includes protocol violation|7
2737424|NCT00098748|9402912|P1|Continued on Open-Label Treatment|Other reason includes protocol violation|6
2737425|NCT00098748|9402910|P3|Continued on Open-Label Treatment|Lack of Efficacy|0
2737426|NCT00098748|9402911|P2|Continued on Open-Label Treatment|Lack of Efficacy|2
2737427|NCT00098748|9402912|P1|Continued on Open-Label Treatment|Lack of Efficacy|1
2737428|NCT00098748|9402910|P3|Continued on Open-Label Treatment|Adverse Event|0
2737429|NCT00098748|9402911|P2|Continued on Open-Label Treatment|Adverse Event|1
2737430|NCT00098748|9402912|P1|Continued on Open-Label Treatment|Adverse Event|0
2737431|NCT00098748|9402910|P3|Received Study Treatment|Subject defaulted|4
2737432|NCT00098748|9402911|P2|Received Study Treatment|Subject defaulted|4
2737433|NCT00098748|9402912|P1|Received Study Treatment|Subject defaulted|3
2737434|NCT00098748|9402910|P3|Received Study Treatment|Other|6
2737435|NCT00098748|9402911|P2|Received Study Treatment|Other|2
2737436|NCT00098748|9402912|P1|Received Study Treatment|Other|2
2737437|NCT00098748|9402910|P3|Received Study Treatment|Lack of Efficacy|27
2737438|NCT00098748|9402911|P2|Received Study Treatment|Lack of Efficacy|27
2737439|NCT00098748|9402912|P1|Received Study Treatment|Lack of Efficacy|40
2737440|NCT00098748|9402910|P3|Received Study Treatment|Adverse Event|5
2737441|NCT00098748|9402911|P2|Received Study Treatment|Adverse Event|2
2737442|NCT00098748|9402912|P1|Received Study Treatment|Adverse Event|1
2737443|NCT00098748|9402910|P3|Received Study Treatment|Death|2
2737444|NCT00098748|9402911|P2|Received Study Treatment|Death|1
2737445|NCT00098748|9402912|P1|Received Study Treatment|Death|2
2737446|NCT00098748|9402910|P3|Assigned to Study Treatment|Randomized, but not treated|2
2737447|NCT00098748|9402911|P2|Assigned to Study Treatment|Randomized, but not treated|2
2737448|NCT00098748|9402912|P1|Assigned to Study Treatment|Randomized, but not treated|0
2737449|NCT00098722|9402968|P7|Observation Phase|Other|10
2737450|NCT00098722|9402969|P6|Observation Phase|Other|21
2737451|NCT00098722|9402970|P5|Observation Phase|Other|0
2737452|NCT00098722|9402971|P4|Observation Phase|Other|0
2737453|NCT00098722|9402972|P3|Observation Phase|Other|0
2737454|NCT00098722|9402973|P2|Observation Phase|Other|0
2737455|NCT00098722|9402974|P1|Observation Phase|Other|0
2737456|NCT00098722|9402968|P7|Observation Phase|Participant defaulted|4
2737457|NCT00098722|9402969|P6|Observation Phase|Participant defaulted|17
2737458|NCT00098722|9402970|P5|Observation Phase|Participant defaulted|0
2737459|NCT00098722|9402971|P4|Observation Phase|Participant defaulted|0
2737460|NCT00098722|9402972|P3|Observation Phase|Participant defaulted|0
2737461|NCT00098722|9402973|P2|Observation Phase|Participant defaulted|0
2737462|NCT00098722|9402974|P1|Observation Phase|Participant defaulted|0
2737463|NCT00098722|9402968|P7|Observation Phase|Lack of Efficacy|0
2737464|NCT00098722|9402969|P6|Observation Phase|Lack of Efficacy|2
2737465|NCT00098722|9402970|P5|Observation Phase|Lack of Efficacy|0
2737466|NCT00098722|9402971|P4|Observation Phase|Lack of Efficacy|0
2737467|NCT00098722|9402972|P3|Observation Phase|Lack of Efficacy|0
2737468|NCT00098722|9402973|P2|Observation Phase|Lack of Efficacy|0
2737469|NCT00098722|9402974|P1|Observation Phase|Lack of Efficacy|0
2737470|NCT00098722|9402968|P7|Observation Phase|Death|3
2737471|NCT00098722|9402969|P6|Observation Phase|Death|5
2737472|NCT00098722|9402970|P5|Observation Phase|Death|0
2737473|NCT00098722|9402971|P4|Observation Phase|Death|0
2737474|NCT00098722|9402972|P3|Observation Phase|Death|0
2737475|NCT00098722|9402973|P2|Observation Phase|Death|0
2737476|NCT00098722|9402974|P1|Observation Phase|Death|0
2737477|NCT00098722|9402968|P7|Open Label Phase|Other|0
2737478|NCT00098722|9402969|P6|Open Label Phase|Other|0
2737479|NCT00098722|9402970|P5|Open Label Phase|Other|0
2737480|NCT00098722|9402971|P4|Open Label Phase|Other|18
2737481|NCT00098722|9402972|P3|Open Label Phase|Other|0
2737482|NCT00098722|9402973|P2|Open Label Phase|Other|0
2737483|NCT00098722|9402974|P1|Open Label Phase|Other|0
2737484|NCT00098722|9402968|P7|Open Label Phase|Ongoing at cut-off date|0
2737485|NCT00098722|9402969|P6|Open Label Phase|Ongoing at cut-off date|0
2737486|NCT00098722|9402970|P5|Open Label Phase|Ongoing at cut-off date|50
2737487|NCT00098722|9402971|P4|Open Label Phase|Ongoing at cut-off date|220
2737488|NCT00098722|9402972|P3|Open Label Phase|Ongoing at cut-off date|0
2737489|NCT00098722|9402973|P2|Open Label Phase|Ongoing at cut-off date|0
2737490|NCT00098722|9402974|P1|Open Label Phase|Ongoing at cut-off date|0
2737491|NCT00098722|9402968|P7|Open Label Phase|Participant defaulted|0
2737492|NCT00098722|9402969|P6|Open Label Phase|Participant defaulted|0
2737493|NCT00098722|9402970|P5|Open Label Phase|Participant defaulted|0
2737494|NCT00098722|9402971|P4|Open Label Phase|Participant defaulted|18
2737495|NCT00098722|9402972|P3|Open Label Phase|Participant defaulted|0
2737496|NCT00098722|9402973|P2|Open Label Phase|Participant defaulted|0
2737497|NCT00098722|9402974|P1|Open Label Phase|Participant defaulted|0
2737498|NCT00098722|9402968|P7|Open Label Phase|Pregnancy|0
2737499|NCT00098722|9402969|P6|Open Label Phase|Pregnancy|0
2737500|NCT00098722|9402970|P5|Open Label Phase|Pregnancy|0
2737501|NCT00098722|9402971|P4|Open Label Phase|Pregnancy|1
2737502|NCT00098722|9402972|P3|Open Label Phase|Pregnancy|0
2737503|NCT00098722|9402973|P2|Open Label Phase|Pregnancy|0
2737504|NCT00098722|9402974|P1|Open Label Phase|Pregnancy|0
2737505|NCT00098722|9402968|P7|Open Label Phase|Lack of Efficacy|0
2737506|NCT00098722|9402969|P6|Open Label Phase|Lack of Efficacy|0
2737507|NCT00098722|9402970|P5|Open Label Phase|Lack of Efficacy|0
2737508|NCT00098722|9402971|P4|Open Label Phase|Lack of Efficacy|8
2737509|NCT00098722|9402972|P3|Open Label Phase|Lack of Efficacy|0
2737510|NCT00098722|9402973|P2|Open Label Phase|Lack of Efficacy|0
2737511|NCT00098722|9402974|P1|Open Label Phase|Lack of Efficacy|0
2737512|NCT00098722|9402968|P7|Open Label Phase|Death|0
2737513|NCT00098722|9402969|P6|Open Label Phase|Death|0
2737514|NCT00098722|9402970|P5|Open Label Phase|Death|0
2737515|NCT00098722|9402971|P4|Open Label Phase|Death|2
2737516|NCT00098722|9402972|P3|Open Label Phase|Death|0
2737517|NCT00098722|9402973|P2|Open Label Phase|Death|0
2737518|NCT00098722|9402974|P1|Open Label Phase|Death|0
2737519|NCT00098722|9402968|P7|Open Label Phase|Adverse Event|0
2737520|NCT00098722|9402969|P6|Open Label Phase|Adverse Event|0
2737521|NCT00098722|9402970|P5|Open Label Phase|Adverse Event|0
2737522|NCT00098722|9402971|P4|Open Label Phase|Adverse Event|5
2737523|NCT00098722|9402972|P3|Open Label Phase|Adverse Event|0
2737524|NCT00098722|9402973|P2|Open Label Phase|Adverse Event|0
2737525|NCT00098722|9402974|P1|Open Label Phase|Adverse Event|0
2737526|NCT00098722|9402968|P7|Double Blind Phase|Other|0
2737527|NCT00098722|9402969|P6|Double Blind Phase|Other|0
2737528|NCT00098722|9402970|P5|Double Blind Phase|Other|0
2737529|NCT00098722|9402971|P4|Double Blind Phase|Other|0
2737530|NCT00098722|9402972|P3|Double Blind Phase|Other|7
2737531|NCT00098722|9402973|P2|Double Blind Phase|Other|8
2737532|NCT00098722|9402974|P1|Double Blind Phase|Other|7
2737533|NCT00098722|9402968|P7|Double Blind Phase|Ongoing at cut-off date|0
2737534|NCT00098722|9402969|P6|Double Blind Phase|Ongoing at cut-off date|0
2737535|NCT00098722|9402970|P5|Double Blind Phase|Ongoing at cut-off date|0
2737536|NCT00098722|9402971|P4|Double Blind Phase|Ongoing at cut-off date|0
2737537|NCT00098722|9402972|P3|Double Blind Phase|Ongoing at cut-off date|57
2737538|NCT00098722|9402973|P2|Double Blind Phase|Ongoing at cut-off date|137
2737539|NCT00098722|9402974|P1|Double Blind Phase|Ongoing at cut-off date|128
2737540|NCT00098722|9402968|P7|Double Blind Phase|Randomized, not treated|0
2737541|NCT00098722|9402969|P6|Double Blind Phase|Randomized, not treated|0
2737542|NCT00098722|9402970|P5|Double Blind Phase|Randomized, not treated|0
2737543|NCT00098722|9402971|P4|Double Blind Phase|Randomized, not treated|0
2737544|NCT00098722|9402972|P3|Double Blind Phase|Randomized, not treated|3
2737545|NCT00098722|9402973|P2|Double Blind Phase|Randomized, not treated|3
2737546|NCT00098722|9402974|P1|Double Blind Phase|Randomized, not treated|4
2737547|NCT00098722|9402968|P7|Double Blind Phase|Pregnancy|0
2737548|NCT00098722|9402969|P6|Double Blind Phase|Pregnancy|0
2737549|NCT00098722|9402970|P5|Double Blind Phase|Pregnancy|0
2737550|NCT00098722|9402971|P4|Double Blind Phase|Pregnancy|0
2737551|NCT00098722|9402972|P3|Double Blind Phase|Pregnancy|0
2737552|NCT00098722|9402973|P2|Double Blind Phase|Pregnancy|0
2737553|NCT00098722|9402974|P1|Double Blind Phase|Pregnancy|1
2737554|NCT00098722|9402968|P7|Double Blind Phase|Participant defaulted|0
2737555|NCT00098722|9402969|P6|Double Blind Phase|Participant defaulted|0
2737556|NCT00098722|9402970|P5|Double Blind Phase|Participant defaulted|0
2737557|NCT00098722|9402971|P4|Double Blind Phase|Participant defaulted|0
2737558|NCT00098722|9402972|P3|Double Blind Phase|Participant defaulted|9
2737559|NCT00098722|9402973|P2|Double Blind Phase|Participant defaulted|11
2737560|NCT00098722|9402974|P1|Double Blind Phase|Participant defaulted|16
2737561|NCT00098722|9402968|P7|Double Blind Phase|Lack of Efficacy|0
2737562|NCT00098722|9402969|P6|Double Blind Phase|Lack of Efficacy|0
2737563|NCT00098722|9402970|P5|Double Blind Phase|Lack of Efficacy|0
2737564|NCT00098722|9402971|P4|Double Blind Phase|Lack of Efficacy|0
2737565|NCT00098722|9402972|P3|Double Blind Phase|Lack of Efficacy|15
2737566|NCT00098722|9402973|P2|Double Blind Phase|Lack of Efficacy|23
2737567|NCT00098722|9402974|P1|Double Blind Phase|Lack of Efficacy|21
2737568|NCT00098722|9402968|P7|Double Blind Phase|Death|0
2737569|NCT00098722|9402969|P6|Double Blind Phase|Death|0
2737570|NCT00098722|9402970|P5|Double Blind Phase|Death|0
2737571|NCT00098722|9402971|P4|Double Blind Phase|Death|0
2737572|NCT00098722|9402972|P3|Double Blind Phase|Death|0
2737573|NCT00098722|9402973|P2|Double Blind Phase|Death|5
2737574|NCT00098722|9402974|P1|Double Blind Phase|Death|2
2737575|NCT00098722|9402968|P7|Double Blind Phase|Adverse Event|0
2737576|NCT00098722|9402969|P6|Double Blind Phase|Adverse Event|0
2737577|NCT00098722|9402970|P5|Double Blind Phase|Adverse Event|0
2737578|NCT00098722|9402971|P4|Double Blind Phase|Adverse Event|0
2737579|NCT00098722|9402972|P3|Double Blind Phase|Adverse Event|3
2737580|NCT00098722|9402973|P2|Double Blind Phase|Adverse Event|7
2737581|NCT00098722|9402974|P1|Double Blind Phase|Adverse Event|7
2737582|NCT00098475|9403048|P4|Step 2|Never started treatment|0
2737583|NCT00098475|9403049|P3|Step 2|Never started treatment|0
2737584|NCT00098475|9403050|P2|Step 2|Never started treatment|1
2737585|NCT00098475|9403051|P1|Step 2|Never started treatment|1
2737586|NCT00098475|9403048|P4|Step 2|Alternative therapy|0
2737587|NCT00098475|9403049|P3|Step 2|Alternative therapy|0
2737588|NCT00098475|9403050|P2|Step 2|Alternative therapy|2
2737589|NCT00098475|9403051|P1|Step 2|Alternative therapy|1
2737590|NCT00098475|9403048|P4|Step 2|Physician Decision|0
2737591|NCT00098475|9403049|P3|Step 2|Physician Decision|0
2737592|NCT00098475|9403050|P2|Step 2|Physician Decision|1
2737593|NCT00098475|9403051|P1|Step 2|Physician Decision|0
2737594|NCT00098475|9403048|P4|Step 2|Withdrawal by Subject|0
2737595|NCT00098475|9403049|P3|Step 2|Withdrawal by Subject|0
2737596|NCT00098475|9403050|P2|Step 2|Withdrawal by Subject|2
2737597|NCT00098475|9403051|P1|Step 2|Withdrawal by Subject|0
2737598|NCT00098475|9403048|P4|Step 2|Adverse Event|0
2737599|NCT00098475|9403049|P3|Step 2|Adverse Event|0
2737600|NCT00098475|9403050|P2|Step 2|Adverse Event|0
2737601|NCT00098475|9403051|P1|Step 2|Adverse Event|2
2737602|NCT00098475|9403048|P4|Step 2|Disease progression|0
2737603|NCT00098475|9403049|P3|Step 2|Disease progression|0
2737604|NCT00098475|9403050|P2|Step 2|Disease progression|4
2737605|NCT00098475|9403051|P1|Step 2|Disease progression|1
2737606|NCT00098475|9403048|P4|Step 1|Not documented|0
2737607|NCT00098475|9403049|P3|Step 1|Not documented|0
2737608|NCT00098475|9403050|P2|Step 1|Not documented|1
2737609|NCT00098475|9403051|P1|Step 1|Not documented|0
2737610|NCT00098475|9403048|P4|Step 1|Patient fell with fracture|0
2737611|NCT00098475|9403049|P3|Step 1|Patient fell with fracture|0
2737612|NCT00098475|9403050|P2|Step 1|Patient fell with fracture|0
2737613|NCT00098475|9403051|P1|Step 1|Patient fell with fracture|1
2737614|NCT00098475|9403048|P4|Step 1|Misinterpretation of lab data|0
2737615|NCT00098475|9403049|P3|Step 1|Misinterpretation of lab data|0
2737616|NCT00098475|9403050|P2|Step 1|Misinterpretation of lab data|1
2737617|NCT00098475|9403051|P1|Step 1|Misinterpretation of lab data|0
2737618|NCT00098475|9403048|P4|Step 1|Criteria to continue treatment not met|0
2737619|NCT00098475|9403049|P3|Step 1|Criteria to continue treatment not met|0
2737620|NCT00098475|9403050|P2|Step 1|Criteria to continue treatment not met|1
2737621|NCT00098475|9403051|P1|Step 1|Criteria to continue treatment not met|0
2737622|NCT00098475|9403048|P4|Step 1|Referred to other physicians|0
2737623|NCT00098475|9403049|P3|Step 1|Referred to other physicians|0
2737624|NCT00098475|9403050|P2|Step 1|Referred to other physicians|1
2737625|NCT00098475|9403051|P1|Step 1|Referred to other physicians|0
2737626|NCT00098475|9403048|P4|Step 1|Rising paraprotein|0
2737627|NCT00098475|9403049|P3|Step 1|Rising paraprotein|0
2737628|NCT00098475|9403050|P2|Step 1|Rising paraprotein|1
2737629|NCT00098475|9403051|P1|Step 1|Rising paraprotein|0
2737630|NCT00098475|9403048|P4|Step 1|Insurance issue|0
2737631|NCT00098475|9403049|P3|Step 1|Insurance issue|0
2737632|NCT00098475|9403050|P2|Step 1|Insurance issue|1
2737633|NCT00098475|9403051|P1|Step 1|Insurance issue|0
2737634|NCT00098475|9403048|P4|Step 1|Declining performance status|0
2737635|NCT00098475|9403049|P3|Step 1|Declining performance status|0
2737636|NCT00098475|9403050|P2|Step 1|Declining performance status|1
2737637|NCT00098475|9403051|P1|Step 1|Declining performance status|0
2737638|NCT00098475|9403048|P4|Step 1|Off treatment for > specified timeframe|0
2737639|NCT00098475|9403049|P3|Step 1|Off treatment for > specified timeframe|0
2737640|NCT00098475|9403050|P2|Step 1|Off treatment for > specified timeframe|1
2737641|NCT00098475|9403051|P1|Step 1|Off treatment for > specified timeframe|1
2737642|NCT00098475|9403048|P4|Step 1|Incorrect disease assessment|0
2737643|NCT00098475|9403049|P3|Step 1|Incorrect disease assessment|0
2737644|NCT00098475|9403050|P2|Step 1|Incorrect disease assessment|0
2737645|NCT00098475|9403051|P1|Step 1|Incorrect disease assessment|2
2737646|NCT00098475|9403048|P4|Step 1|Both patient and physician's decision|0
2737647|NCT00098475|9403049|P3|Step 1|Both patient and physician's decision|0
2737648|NCT00098475|9403050|P2|Step 1|Both patient and physician's decision|1
2737649|NCT00098475|9403051|P1|Step 1|Both patient and physician's decision|2
2737650|NCT00098475|9403048|P4|Step 1|Cannot comply due to other tx|0
2737651|NCT00098475|9403049|P3|Step 1|Cannot comply due to other tx|0
2737652|NCT00098475|9403050|P2|Step 1|Cannot comply due to other tx|1
2737653|NCT00098475|9403051|P1|Step 1|Cannot comply due to other tx|0
2737654|NCT00098475|9403048|P4|Step 1|Complications|0
2737655|NCT00098475|9403049|P3|Step 1|Complications|0
2737656|NCT00098475|9403050|P2|Step 1|Complications|0
2737657|NCT00098475|9403051|P1|Step 1|Complications|1
2737658|NCT00098475|9403048|P4|Step 1|Knee surgery|0
2737659|NCT00098475|9403049|P3|Step 1|Knee surgery|0
2737660|NCT00098475|9403050|P2|Step 1|Knee surgery|0
2737661|NCT00098475|9403051|P1|Step 1|Knee surgery|1
2737662|NCT00098475|9403048|P4|Step 1|Still on treatment as of this analysis|0
2737663|NCT00098475|9403049|P3|Step 1|Still on treatment as of this analysis|0
2737664|NCT00098475|9403050|P2|Step 1|Still on treatment as of this analysis|27
2737665|NCT00098475|9403051|P1|Step 1|Still on treatment as of this analysis|14
2737666|NCT00098475|9403048|P4|Step 1|Never started treatment|0
2737667|NCT00098475|9403049|P3|Step 1|Never started treatment|0
2737668|NCT00098475|9403050|P2|Step 1|Never started treatment|2
2737669|NCT00098475|9403051|P1|Step 1|Never started treatment|0
2737670|NCT00098475|9403048|P4|Step 1|Other disease|0
2737671|NCT00098475|9403049|P3|Step 1|Other disease|1
2737672|NCT00098475|9403050|P2|Step 1|Other disease|1
2737673|NCT00098475|9403051|P1|Step 1|Other disease|2
2737674|NCT00098475|9403048|P4|Step 1|Alternative therapy|0
2737675|NCT00098475|9403049|P3|Step 1|Alternative therapy|1
2737676|NCT00098475|9403050|P2|Step 1|Alternative therapy|43
2737677|NCT00098475|9403051|P1|Step 1|Alternative therapy|31
2737678|NCT00098475|9403048|P4|Step 1|Physician Decision|0
2737679|NCT00098475|9403049|P3|Step 1|Physician Decision|0
2737680|NCT00098475|9403050|P2|Step 1|Physician Decision|2
2737681|NCT00098475|9403051|P1|Step 1|Physician Decision|5
2737682|NCT00098475|9403048|P4|Step 1|Withdrawal by Subject|0
2737683|NCT00098475|9403049|P3|Step 1|Withdrawal by Subject|0
2737684|NCT00098475|9403050|P2|Step 1|Withdrawal by Subject|11
2737685|NCT00098475|9403051|P1|Step 1|Withdrawal by Subject|14
2737686|NCT00098475|9403048|P4|Step 1|Death|1
2737687|NCT00098475|9403049|P3|Step 1|Death|0
2737688|NCT00098475|9403050|P2|Step 1|Death|5
2737689|NCT00098475|9403051|P1|Step 1|Death|8
2737690|NCT00098475|9403048|P4|Step 1|Adverse Event|1
2737691|NCT00098475|9403049|P3|Step 1|Adverse Event|0
2737692|NCT00098475|9403050|P2|Step 1|Adverse Event|37
2737693|NCT00098475|9403051|P1|Step 1|Adverse Event|56
2737694|NCT00098475|9403048|P4|Step 1|Progressive disease|1
2737695|NCT00098475|9403049|P3|Step 1|Progressive disease|2
2737696|NCT00098475|9403050|P2|Step 1|Progressive disease|35
2737697|NCT00098475|9403051|P1|Step 1|Progressive disease|33
2737698|NCT00098345|9403088|P1|Overall Study|progression|4
2737699|NCT00098345|9403088|P1|Overall Study|Withdrawal by Subject|2
2737700|NCT00098345|9403088|P1|Overall Study|Adverse Event|7
2737701|NCT00098306|9403101|P7|Observational Phase|Un-specified|4
2737702|NCT00098306|9403102|P6|Observational Phase|Un-specified|7
2737703|NCT00098306|9403103|P5|Observational Phase|Un-specified|0
2737704|NCT00098306|9403104|P4|Observational Phase|Un-specified|0
2737705|NCT00098306|9403105|P3|Observational Phase|Un-specified|0
2737706|NCT00098306|9403106|P2|Observational Phase|Un-specified|0
2737707|NCT00098306|9403107|P1|Observational Phase|Un-specified|0
2737708|NCT00098306|9403101|P7|Observational Phase|Participant defaulted|18
2737709|NCT00098306|9403102|P6|Observational Phase|Participant defaulted|34
2737710|NCT00098306|9403103|P5|Observational Phase|Participant defaulted|0
2737711|NCT00098306|9403104|P4|Observational Phase|Participant defaulted|0
2737712|NCT00098306|9403105|P3|Observational Phase|Participant defaulted|0
2737713|NCT00098306|9403106|P2|Observational Phase|Participant defaulted|0
2737714|NCT00098306|9403107|P1|Observational Phase|Participant defaulted|0
2737715|NCT00098306|9403101|P7|Observational Phase|Death|4
2737716|NCT00098306|9403102|P6|Observational Phase|Death|5
2737717|NCT00098306|9403103|P5|Observational Phase|Death|0
2737718|NCT00098306|9403104|P4|Observational Phase|Death|0
2737719|NCT00098306|9403105|P3|Observational Phase|Death|0
2737720|NCT00098306|9403106|P2|Observational Phase|Death|0
2737721|NCT00098306|9403107|P1|Observational Phase|Death|0
2737722|NCT00098306|9403101|P7|Open Label|Ongoing at cut-off date|0
2737723|NCT00098306|9403102|P6|Open Label|Ongoing at cut-off date|0
2737724|NCT00098306|9403103|P5|Open Label|Ongoing at cut-off date|62
2737725|NCT00098306|9403104|P4|Open Label|Ongoing at cut-off date|269
2737726|NCT00098306|9403105|P3|Open Label|Ongoing at cut-off date|0
2737727|NCT00098306|9403106|P2|Open Label|Ongoing at cut-off date|0
2737728|NCT00098306|9403107|P1|Open Label|Ongoing at cut-off date|0
2737729|NCT00098306|9403101|P7|Open Label|Un-specified|0
2737730|NCT00098306|9403102|P6|Open Label|Un-specified|0
2737731|NCT00098306|9403103|P5|Open Label|Un-specified|0
2737732|NCT00098306|9403104|P4|Open Label|Un-specified|15
2737733|NCT00098306|9403105|P3|Open Label|Un-specified|0
2737734|NCT00098306|9403106|P2|Open Label|Un-specified|0
2737735|NCT00098306|9403107|P1|Open Label|Un-specified|0
2737736|NCT00098306|9403101|P7|Open Label|Participant defaulted|0
2737737|NCT00098306|9403102|P6|Open Label|Participant defaulted|0
2737738|NCT00098306|9403103|P5|Open Label|Participant defaulted|0
2737739|NCT00098306|9403104|P4|Open Label|Participant defaulted|24
2737740|NCT00098306|9403105|P3|Open Label|Participant defaulted|0
2737741|NCT00098306|9403106|P2|Open Label|Participant defaulted|0
2737742|NCT00098306|9403107|P1|Open Label|Participant defaulted|0
2737743|NCT00098306|9403101|P7|Open Label|Death|0
2737744|NCT00098306|9403102|P6|Open Label|Death|0
2737745|NCT00098306|9403103|P5|Open Label|Death|0
2737746|NCT00098306|9403104|P4|Open Label|Death|4
2737747|NCT00098306|9403105|P3|Open Label|Death|0
2737748|NCT00098306|9403106|P2|Open Label|Death|0
2737749|NCT00098306|9403107|P1|Open Label|Death|0
2737750|NCT00098306|9403101|P7|Open Label|Adverse Event|0
2737751|NCT00098306|9403102|P6|Open Label|Adverse Event|0
2737752|NCT00098306|9403103|P5|Open Label|Adverse Event|0
2737753|NCT00098306|9403104|P4|Open Label|Adverse Event|2
2737754|NCT00098306|9403105|P3|Open Label|Adverse Event|0
2737755|NCT00098306|9403106|P2|Open Label|Adverse Event|0
2737756|NCT00098306|9403107|P1|Open Label|Adverse Event|0
2737757|NCT00098306|9403101|P7|Open Label|Lack of Efficacy|0
2737758|NCT00098306|9403102|P6|Open Label|Lack of Efficacy|0
2737759|NCT00098306|9403103|P5|Open Label|Lack of Efficacy|0
2737760|NCT00098306|9403104|P4|Open Label|Lack of Efficacy|13
2737761|NCT00098306|9403105|P3|Open Label|Lack of Efficacy|0
2737762|NCT00098306|9403106|P2|Open Label|Lack of Efficacy|0
2737763|NCT00098306|9403107|P1|Open Label|Lack of Efficacy|0
2737764|NCT00098306|9403101|P7|Double Blind|Un-specified|0
2737765|NCT00098306|9403102|P6|Double Blind|Un-specified|0
2737766|NCT00098306|9403103|P5|Double Blind|Un-specified|0
2737767|NCT00098306|9403104|P4|Double Blind|Un-specified|0
2737768|NCT00098306|9403105|P3|Double Blind|Un-specified|11
2737769|NCT00098306|9403106|P2|Double Blind|Un-specified|3
2737770|NCT00098306|9403107|P1|Double Blind|Un-specified|7
2737771|NCT00098306|9403101|P7|Double Blind|Participant defaulted|0
2737772|NCT00098306|9403102|P6|Double Blind|Participant defaulted|0
2737773|NCT00098306|9403103|P5|Double Blind|Participant defaulted|0
2737774|NCT00098306|9403104|P4|Double Blind|Participant defaulted|0
2737775|NCT00098306|9403105|P3|Double Blind|Participant defaulted|11
2737776|NCT00098306|9403106|P2|Double Blind|Participant defaulted|18
2737777|NCT00098306|9403107|P1|Double Blind|Participant defaulted|19
2737778|NCT00098306|9403101|P7|Double Blind|Death|0
2737779|NCT00098306|9403102|P6|Double Blind|Death|0
2737780|NCT00098306|9403103|P5|Double Blind|Death|0
2737781|NCT00098306|9403104|P4|Double Blind|Death|0
2737782|NCT00098306|9403105|P3|Double Blind|Death|1
2737783|NCT00098306|9403106|P2|Double Blind|Death|4
2737784|NCT00098306|9403107|P1|Double Blind|Death|1
2737785|NCT00098306|9403101|P7|Double Blind|Lack of Efficacy|0
2737786|NCT00098306|9403102|P6|Double Blind|Lack of Efficacy|0
2737787|NCT00098306|9403103|P5|Double Blind|Lack of Efficacy|0
2737788|NCT00098306|9403104|P4|Double Blind|Lack of Efficacy|0
2737789|NCT00098306|9403105|P3|Double Blind|Lack of Efficacy|17
2737790|NCT00098306|9403106|P2|Double Blind|Lack of Efficacy|34
2737791|NCT00098306|9403107|P1|Double Blind|Lack of Efficacy|43
2737792|NCT00098306|9403101|P7|Double Blind|Adverse Event|0
2737793|NCT00098306|9403102|P6|Double Blind|Adverse Event|0
2737794|NCT00098306|9403103|P5|Double Blind|Adverse Event|0
2737795|NCT00098306|9403104|P4|Double Blind|Adverse Event|0
2737796|NCT00098306|9403105|P3|Double Blind|Adverse Event|6
2737797|NCT00098306|9403106|P2|Double Blind|Adverse Event|10
2737798|NCT00098306|9403107|P1|Double Blind|Adverse Event|11
2737799|NCT00098306|9403101|P7|Double Blind|Ongoing at cut-off date|0
2737800|NCT00098306|9403102|P6|Double Blind|Ongoing at cut-off date|0
2737801|NCT00098306|9403103|P5|Double Blind|Ongoing at cut-off date|0
2737802|NCT00098306|9403104|P4|Double Blind|Ongoing at cut-off date|0
2737803|NCT00098306|9403105|P3|Double Blind|Ongoing at cut-off date|72
2737804|NCT00098306|9403106|P2|Double Blind|Ongoing at cut-off date|166
2737805|NCT00098306|9403107|P1|Double Blind|Ongoing at cut-off date|151
2737806|NCT00098306|9403101|P7|Double Blind|Randomized, not treated|0
2737807|NCT00098306|9403102|P6|Double Blind|Randomized, not treated|0
2737808|NCT00098306|9403103|P5|Double Blind|Randomized, not treated|0
2737809|NCT00098306|9403104|P4|Double Blind|Randomized, not treated|0
2737810|NCT00098306|9403105|P3|Double Blind|Randomized, not treated|2
2737811|NCT00098306|9403106|P2|Double Blind|Randomized, not treated|5
2737812|NCT00098306|9403107|P1|Double Blind|Randomized, not treated|9
2737813|NCT00098293|9403173|P5|Supplemental Phase (SP)|Other|22
2737814|NCT00098293|9403174|P4|Supplemental Phase (SP)|Other|0
2737815|NCT00098293|9403175|P3|Supplemental Phase (SP)|Other|0
2737816|NCT00098293|9403176|P2|Supplemental Phase (SP)|Other|0
2737817|NCT00098293|9403177|P1|Supplemental Phase (SP)|Other|0
2737818|NCT00098293|9403173|P5|Supplemental Phase (SP)|Withdrawal by Subject|8
2737819|NCT00098293|9403174|P4|Supplemental Phase (SP)|Withdrawal by Subject|0
2737820|NCT00098293|9403175|P3|Supplemental Phase (SP)|Withdrawal by Subject|0
2737821|NCT00098293|9403176|P2|Supplemental Phase (SP)|Withdrawal by Subject|0
2737822|NCT00098293|9403177|P1|Supplemental Phase (SP)|Withdrawal by Subject|0
2737823|NCT00098293|9403173|P5|Supplemental Phase (SP)|Lost to Follow-up|2
2737824|NCT00098293|9403174|P4|Supplemental Phase (SP)|Lost to Follow-up|0
2737825|NCT00098293|9403175|P3|Supplemental Phase (SP)|Lost to Follow-up|0
2737826|NCT00098293|9403176|P2|Supplemental Phase (SP)|Lost to Follow-up|0
2737827|NCT00098293|9403177|P1|Supplemental Phase (SP)|Lost to Follow-up|0
2737828|NCT00098293|9403173|P5|Supplemental Phase (SP)|Death|1
2737829|NCT00098293|9403174|P4|Supplemental Phase (SP)|Death|0
2737830|NCT00098293|9403175|P3|Supplemental Phase (SP)|Death|0
2737831|NCT00098293|9403176|P2|Supplemental Phase (SP)|Death|0
2737832|NCT00098293|9403177|P1|Supplemental Phase (SP)|Death|0
2737833|NCT00098293|9403173|P5|Open-label (OL) Phase|Death|0
2737834|NCT00098293|9403174|P4|Open-label (OL) Phase|Death|0
2737835|NCT00098293|9403175|P3|Open-label (OL) Phase|Death|3
2737836|NCT00098293|9403176|P2|Open-label (OL) Phase|Death|2
2737837|NCT00098293|9403177|P1|Open-label (OL) Phase|Death|0
2737838|NCT00098293|9403173|P5|Open-label (OL) Phase|Participant Defaulted|0
2737839|NCT00098293|9403174|P4|Open-label (OL) Phase|Participant Defaulted|20
2737840|NCT00098293|9403175|P3|Open-label (OL) Phase|Participant Defaulted|16
2737841|NCT00098293|9403176|P2|Open-label (OL) Phase|Participant Defaulted|6
2737842|NCT00098293|9403177|P1|Open-label (OL) Phase|Participant Defaulted|0
2737843|NCT00098293|9403173|P5|Open-label (OL) Phase|Protocol Violation|0
2737844|NCT00098293|9403174|P4|Open-label (OL) Phase|Protocol Violation|16
2737845|NCT00098293|9403175|P3|Open-label (OL) Phase|Protocol Violation|13
2737846|NCT00098293|9403176|P2|Open-label (OL) Phase|Protocol Violation|6
2737847|NCT00098293|9403177|P1|Open-label (OL) Phase|Protocol Violation|0
2737848|NCT00098293|9403173|P5|Open-label (OL) Phase|Pregnancy|0
2737849|NCT00098293|9403174|P4|Open-label (OL) Phase|Pregnancy|3
2737850|NCT00098293|9403175|P3|Open-label (OL) Phase|Pregnancy|0
2737851|NCT00098293|9403176|P2|Open-label (OL) Phase|Pregnancy|1
2737852|NCT00098293|9403177|P1|Open-label (OL) Phase|Pregnancy|0
2737853|NCT00098293|9403173|P5|Open-label (OL) Phase|Lack of Efficacy|0
2737854|NCT00098293|9403174|P4|Open-label (OL) Phase|Lack of Efficacy|20
2737855|NCT00098293|9403175|P3|Open-label (OL) Phase|Lack of Efficacy|2
2737856|NCT00098293|9403176|P2|Open-label (OL) Phase|Lack of Efficacy|7
2737857|NCT00098293|9403177|P1|Open-label (OL) Phase|Lack of Efficacy|0
2737858|NCT00098293|9403173|P5|Open-label (OL) Phase|Adverse Event|0
2737859|NCT00098293|9403174|P4|Open-label (OL) Phase|Adverse Event|6
2737860|NCT00098293|9403175|P3|Open-label (OL) Phase|Adverse Event|7
2737861|NCT00098293|9403176|P2|Open-label (OL) Phase|Adverse Event|3
2737862|NCT00098293|9403177|P1|Open-label (OL) Phase|Adverse Event|0
2737863|NCT00098293|9403173|P5|Between DB and OL Phase|Did Not Enter Open-label Phase|0
2737864|NCT00098293|9403174|P4|Between DB and OL Phase|Did Not Enter Open-label Phase|0
2737865|NCT00098293|9403175|P3|Between DB and OL Phase|Did Not Enter Open-label Phase|3
2737866|NCT00098293|9403176|P2|Between DB and OL Phase|Did Not Enter Open-label Phase|0
2737867|NCT00098293|9403177|P1|Between DB and OL Phase|Did Not Enter Open-label Phase|0
2737868|NCT00098293|9403173|P5|Double-blind (DB) Phase|Terminated by sponsor|0
2737869|NCT00098293|9403174|P4|Double-blind (DB) Phase|Terminated by sponsor|0
2737870|NCT00098293|9403175|P3|Double-blind (DB) Phase|Terminated by sponsor|0
2737871|NCT00098293|9403176|P2|Double-blind (DB) Phase|Terminated by sponsor|0
2737872|NCT00098293|9403177|P1|Double-blind (DB) Phase|Terminated by sponsor|135
2737873|NCT00098293|9403173|P5|Double-blind (DB) Phase|Protocol Violation|0
2737874|NCT00098293|9403174|P4|Double-blind (DB) Phase|Protocol Violation|0
2737875|NCT00098293|9403175|P3|Double-blind (DB) Phase|Protocol Violation|22
2737876|NCT00098293|9403176|P2|Double-blind (DB) Phase|Protocol Violation|18
2737877|NCT00098293|9403177|P1|Double-blind (DB) Phase|Protocol Violation|2
2737878|NCT00098293|9403173|P5|Double-blind (DB) Phase|Randomized, Not Treated|0
2737879|NCT00098293|9403174|P4|Double-blind (DB) Phase|Randomized, Not Treated|0
2737880|NCT00098293|9403175|P3|Double-blind (DB) Phase|Randomized, Not Treated|11
2737881|NCT00098293|9403176|P2|Double-blind (DB) Phase|Randomized, Not Treated|8
2737882|NCT00098293|9403177|P1|Double-blind (DB) Phase|Randomized, Not Treated|3
2737883|NCT00098293|9403173|P5|Double-blind (DB) Phase|Death|0
2737884|NCT00098293|9403174|P4|Double-blind (DB) Phase|Death|0
2737885|NCT00098293|9403175|P3|Double-blind (DB) Phase|Death|2
2737886|NCT00098293|9403176|P2|Double-blind (DB) Phase|Death|2
2737887|NCT00098293|9403177|P1|Double-blind (DB) Phase|Death|1
2737888|NCT00098293|9403173|P5|Double-blind (DB) Phase|Lack of Efficacy|0
2737889|NCT00098293|9403174|P4|Double-blind (DB) Phase|Lack of Efficacy|0
2737890|NCT00098293|9403175|P3|Double-blind (DB) Phase|Lack of Efficacy|30
2737891|NCT00098293|9403176|P2|Double-blind (DB) Phase|Lack of Efficacy|64
2737892|NCT00098293|9403177|P1|Double-blind (DB) Phase|Lack of Efficacy|11
2737893|NCT00098293|9403173|P5|Double-blind (DB) Phase|Participant Defaulted|0
2737894|NCT00098293|9403174|P4|Double-blind (DB) Phase|Participant Defaulted|0
2737895|NCT00098293|9403175|P3|Double-blind (DB) Phase|Participant Defaulted|36
2737896|NCT00098293|9403176|P2|Double-blind (DB) Phase|Participant Defaulted|40
2737897|NCT00098293|9403177|P1|Double-blind (DB) Phase|Participant Defaulted|11
2737898|NCT00098293|9403173|P5|Double-blind (DB) Phase|Pregnancy|0
2737899|NCT00098293|9403174|P4|Double-blind (DB) Phase|Pregnancy|0
2737900|NCT00098293|9403175|P3|Double-blind (DB) Phase|Pregnancy|9
2737901|NCT00098293|9403176|P2|Double-blind (DB) Phase|Pregnancy|7
2737902|NCT00098293|9403177|P1|Double-blind (DB) Phase|Pregnancy|0
2737903|NCT00098293|9403173|P5|Double-blind (DB) Phase|Adverse Event|0
2737904|NCT00098293|9403174|P4|Double-blind (DB) Phase|Adverse Event|0
2737905|NCT00098293|9403175|P3|Double-blind (DB) Phase|Adverse Event|60
2737906|NCT00098293|9403176|P2|Double-blind (DB) Phase|Adverse Event|27
2737907|NCT00098293|9403177|P1|Double-blind (DB) Phase|Adverse Event|14
2737908|NCT00098254|9403230|P1|Overall Study|Death|1
2737909|NCT00098254|9403230|P1|Overall Study|Adverse Event|2
2737910|NCT00098020|9403296|P1|Overall Study|Low epidermal growth factor receptor|1
2737911|NCT00098020|9403296|P1|Overall Study|Low urine PCR|1
2737912|NCT00098020|9403296|P1|Overall Study|elevated liver enzymes|1
2737913|NCT00098020|9403296|P1|Overall Study|Lost to Follow-up|1
2737914|NCT00098020|9403296|P1|Overall Study|Adverse Event|2
2737915|NCT00097981|9403303|P2|Overall Study|Other|13
2737916|NCT00097981|9403304|P1|Overall Study|Other|19
2737917|NCT00097981|9403303|P2|Overall Study|Transplant planned|27
2737918|NCT00097981|9403304|P1|Overall Study|Transplant planned|28
2737919|NCT00097981|9403303|P2|Overall Study|Disease Progression|2
2737920|NCT00097981|9403304|P1|Overall Study|Disease Progression|8
2737921|NCT00097981|9403303|P2|Overall Study|Physician Decision|1
2737922|NCT00097981|9403304|P1|Overall Study|Physician Decision|7
2737923|NCT00097981|9403303|P2|Overall Study|Death|4
2737924|NCT00097981|9403304|P1|Overall Study|Death|2
2737925|NCT00097981|9403303|P2|Overall Study|Protocol Violation|1
2737926|NCT00097981|9403304|P1|Overall Study|Protocol Violation|1
2737927|NCT00097981|9403303|P2|Overall Study|Withdrawal by Subject|8
2737928|NCT00097981|9403304|P1|Overall Study|Withdrawal by Subject|10
2737929|NCT00097981|9403303|P2|Overall Study|Adverse Event|44
2737930|NCT00097981|9403304|P1|Overall Study|Adverse Event|31
2737931|NCT00097786|9403326|P4|Overall Study|lost to follow-up for all-cause death|310
2737932|NCT00097786|9403327|P3|Overall Study|lost to follow-up for all-cause death|313
2737933|NCT00097786|9403328|P2|Overall Study|lost to follow-up for all-cause death|292
2737934|NCT00097786|9403329|P1|Overall Study|lost to follow-up for all-cause death|296
2737935|NCT00097773|9403351|P4|Overall Study|Other|0
2737936|NCT00097773|9403352|P3|Overall Study|Other|2
2737937|NCT00097773|9403353|P2|Overall Study|Other|0
2737938|NCT00097773|9403354|P1|Overall Study|Other|1
2737939|NCT00097773|9403351|P4|Overall Study|Adverse Event|0
2737940|NCT00097773|9403352|P3|Overall Study|Adverse Event|0
2737941|NCT00097773|9403353|P2|Overall Study|Adverse Event|1
2737942|NCT00097773|9403354|P1|Overall Study|Adverse Event|0
2737943|NCT00097773|9403351|P4|Overall Study|Withdrawal by Subject|1
2737944|NCT00097773|9403352|P3|Overall Study|Withdrawal by Subject|3
2737945|NCT00097773|9403353|P2|Overall Study|Withdrawal by Subject|3
2737946|NCT00097773|9403354|P1|Overall Study|Withdrawal by Subject|3
2737947|NCT00097773|9403351|P4|Overall Study|Physician Decision|1
2737948|NCT00097773|9403352|P3|Overall Study|Physician Decision|3
2737949|NCT00097773|9403353|P2|Overall Study|Physician Decision|2
2737950|NCT00097773|9403354|P1|Overall Study|Physician Decision|2
2737951|NCT00097773|9403351|P4|Overall Study|Lost to Follow-up|1
2737952|NCT00097773|9403352|P3|Overall Study|Lost to Follow-up|0
2737953|NCT00097773|9403353|P2|Overall Study|Lost to Follow-up|2
2737954|NCT00097773|9403354|P1|Overall Study|Lost to Follow-up|2
2737955|NCT00097721|9403374|P2|Overall Study|Reason not given|1
2737956|NCT00097721|9403375|P1|Overall Study|Reason not given|1
2737957|NCT00097721|9403374|P2|Overall Study|Physician Decision|3
2737958|NCT00097721|9403375|P1|Overall Study|Physician Decision|1
2737959|NCT00097721|9403374|P2|Overall Study|Progressive Disease|27
2737960|NCT00097721|9403375|P1|Overall Study|Progressive Disease|55
2737961|NCT00097721|9403374|P2|Overall Study|Withdrawal by Subject|1
2737962|NCT00097721|9403375|P1|Overall Study|Withdrawal by Subject|6
2737963|NCT00097721|9403374|P2|Overall Study|Adverse Event|1
2737964|NCT00097721|9403375|P1|Overall Study|Adverse Event|8
2737965|NCT00097591|9403425|P2|Overall Study|Other|3
2737966|NCT00097591|9403426|P1|Overall Study|Other|0
2737967|NCT00097591|9403425|P2|Overall Study|Lost to follow up|10
2737968|NCT00097591|9403426|P1|Overall Study|Lost to follow up|6
2737969|NCT00097591|9403425|P2|Overall Study|Unable to attend termination visit|51
2737970|NCT00097591|9403426|P1|Overall Study|Unable to attend termination visit|53
2737971|NCT00097591|9403425|P2|Overall Study|Less than 6 months on study drug|7
2737972|NCT00097591|9403426|P1|Overall Study|Less than 6 months on study drug|9
2737973|NCT00097591|9403425|P2|Overall Study|Withdrawal of consent|323
2737974|NCT00097591|9403426|P1|Overall Study|Withdrawal of consent|342
2737975|NCT00097539|9403449|P7|Overall Study|Reason not Specified|2
2737976|NCT00097539|9403450|P6|Overall Study|Reason not Specified|40
2737977|NCT00097539|9403451|P5|Overall Study|Reason not Specified|11
2737978|NCT00097539|9403452|P4|Overall Study|Reason not Specified|21
2737979|NCT00097539|9403453|P3|Overall Study|Reason not Specified|53
2737980|NCT00097539|9403454|P2|Overall Study|Reason not Specified|49
2737981|NCT00097539|9403455|P1|Overall Study|Reason not Specified|111
2737982|NCT00097539|9403449|P7|Overall Study|Reasons Other Than Above|34
2737983|NCT00097539|9403450|P6|Overall Study|Reasons Other Than Above|1244
2737984|NCT00097539|9403451|P5|Overall Study|Reasons Other Than Above|361
2737985|NCT00097539|9403452|P4|Overall Study|Reasons Other Than Above|692
2737986|NCT00097539|9403453|P3|Overall Study|Reasons Other Than Above|1757
2737987|NCT00097539|9403454|P2|Overall Study|Reasons Other Than Above|1382
2737988|NCT00097539|9403455|P1|Overall Study|Reasons Other Than Above|3602
2737989|NCT00097539|9403449|P7|Overall Study|Death|0
2737990|NCT00097539|9403450|P6|Overall Study|Death|3
2737991|NCT00097539|9403451|P5|Overall Study|Death|1
2737992|NCT00097539|9403452|P4|Overall Study|Death|0
2737993|NCT00097539|9403453|P3|Overall Study|Death|0
2737994|NCT00097539|9403454|P2|Overall Study|Death|7
2737995|NCT00097539|9403455|P1|Overall Study|Death|2
2737996|NCT00097539|9403449|P7|Overall Study|Adverse Event|1
2737997|NCT00097539|9403450|P6|Overall Study|Adverse Event|59
2737998|NCT00097539|9403451|P5|Overall Study|Adverse Event|30
2737999|NCT00097539|9403452|P4|Overall Study|Adverse Event|27
2738000|NCT00097539|9403453|P3|Overall Study|Adverse Event|37
2738001|NCT00097539|9403454|P2|Overall Study|Adverse Event|133
2738002|NCT00097539|9403455|P1|Overall Study|Adverse Event|78
2738003|NCT00097539|9403449|P7|Overall Study|Lack of Efficacy|5
2738004|NCT00097539|9403450|P6|Overall Study|Lack of Efficacy|228
2738005|NCT00097539|9403451|P5|Overall Study|Lack of Efficacy|45
2738006|NCT00097539|9403452|P4|Overall Study|Lack of Efficacy|105
2738007|NCT00097539|9403453|P3|Overall Study|Lack of Efficacy|202
2738008|NCT00097539|9403454|P2|Overall Study|Lack of Efficacy|122
2738009|NCT00097539|9403455|P1|Overall Study|Lack of Efficacy|249
2738010|NCT00097539|9403449|P7|Overall Study|Participant Non-compliant|18
2738011|NCT00097539|9403450|P6|Overall Study|Participant Non-compliant|543
2738012|NCT00097539|9403451|P5|Overall Study|Participant Non-compliant|136
2738013|NCT00097539|9403452|P4|Overall Study|Participant Non-compliant|353
2738014|NCT00097539|9403453|P3|Overall Study|Participant Non-compliant|1067
2738015|NCT00097539|9403454|P2|Overall Study|Participant Non-compliant|567
2738016|NCT00097539|9403455|P1|Overall Study|Participant Non-compliant|2140
2738017|NCT00097539|9403449|P7|Overall Study|Withdrawal by Subject|3
2738018|NCT00097539|9403450|P6|Overall Study|Withdrawal by Subject|229
2738019|NCT00097539|9403451|P5|Overall Study|Withdrawal by Subject|68
2738020|NCT00097539|9403452|P4|Overall Study|Withdrawal by Subject|217
2738021|NCT00097539|9403453|P3|Overall Study|Withdrawal by Subject|346
2738022|NCT00097539|9403454|P2|Overall Study|Withdrawal by Subject|323
2738023|NCT00097539|9403455|P1|Overall Study|Withdrawal by Subject|925
2738024|NCT00097539|9403449|P7|Overall Study|Status Unknown (Or no final evaluation)|108
2738025|NCT00097539|9403450|P6|Overall Study|Status Unknown (Or no final evaluation)|3546
2738026|NCT00097539|9403451|P5|Overall Study|Status Unknown (Or no final evaluation)|1106
2738027|NCT00097539|9403452|P4|Overall Study|Status Unknown (Or no final evaluation)|2170
2738028|NCT00097539|9403453|P3|Overall Study|Status Unknown (Or no final evaluation)|5646
2738029|NCT00097539|9403454|P2|Overall Study|Status Unknown (Or no final evaluation)|3948
2738030|NCT00097539|9403455|P1|Overall Study|Status Unknown (Or no final evaluation)|11959
2738031|NCT00097500|9403501|P2|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2
2738032|NCT00097500|9403502|P1|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3
2738033|NCT00097500|9403501|P2|Off-drug Period (Week 52 to Week 64)|Physician Decision|1
2738034|NCT00097500|9403502|P1|Off-drug Period (Week 52 to Week 64)|Physician Decision|0
2738035|NCT00097500|9403501|P2|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1
2738036|NCT00097500|9403502|P1|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2
2738037|NCT00097500|9403501|P2|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1
2738038|NCT00097500|9403502|P1|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0
2738039|NCT00097500|9403501|P2|On-drug Period (Week 0 to Week 52)|Physician Decision|1
2738040|NCT00097500|9403502|P1|On-drug Period (Week 0 to Week 52)|Physician Decision|0
2738041|NCT00097500|9403501|P2|On-drug Period (Week 0 to Week 52)|Adverse Event|0
2738042|NCT00097500|9403502|P1|On-drug Period (Week 0 to Week 52)|Adverse Event|5
2738043|NCT00097500|9403501|P2|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
2738044|NCT00097500|9403502|P1|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
2738045|NCT00097370|9403533|P1|Stage 3|Lost to Follow-up|1
2738046|NCT00097370|9403533|P1|Stage 3|Sponsor Terminated Study|52
2738047|NCT00097370|9403533|P1|Stage 3|Lack of Efficacy|1
2738048|NCT00097370|9403533|P1|Stage 3|Withdrawal by Subject|3
2738049|NCT00097370|9403533|P1|Stage 3|Adverse Event|2
2738050|NCT00097370|9403533|P1|Stage 2|Lost to Follow-up|1
2738051|NCT00097370|9403533|P1|Stage 2|Sponsor Terminated Study|2
2738052|NCT00097370|9403533|P1|Stage 2|Pregnancy|1
2738053|NCT00097370|9403533|P1|Stage 2|Lack of Efficacy|3
2738054|NCT00097370|9403533|P1|Stage 2|Withdrawal by Subject|1
2738055|NCT00097370|9403533|P1|Stage 2|Adverse Event|5
2738056|NCT00097370|9403533|P1|Stage 1|Lack of Efficacy|2
2738057|NCT00097370|9403533|P1|Stage 1|Withdrawal by Subject|1
2738058|NCT00097370|9403533|P1|Stage 1|Adverse Event|3
2738059|NCT00096993|9403567|P2|Overall Study|Other unspecified|1
2738060|NCT00096993|9403568|P1|Overall Study|Other unspecified|1
2738061|NCT00096993|9403567|P2|Overall Study|Non-compliance|1
2738062|NCT00096993|9403568|P1|Overall Study|Non-compliance|0
2738063|NCT00096993|9403567|P2|Overall Study|Physician Decision|1
2738064|NCT00096993|9403568|P1|Overall Study|Physician Decision|2
2738065|NCT00096993|9403567|P2|Overall Study|Subject's decision|1
2738066|NCT00096993|9403568|P1|Overall Study|Subject's decision|3
2738067|NCT00096993|9403567|P2|Overall Study|Adverse Event|8
2738068|NCT00096993|9403568|P1|Overall Study|Adverse Event|2
2738069|NCT00096993|9403567|P2|Overall Study|Disease progression|53
2738070|NCT00096993|9403568|P1|Overall Study|Disease progression|56
2738071|NCT00096993|9403567|P2|Overall Study|Death|0
2738072|NCT00096993|9403568|P1|Overall Study|Death|1
2738073|NCT00096954|9403584|P2|Overall Study|Lost to Follow-up|5
2738074|NCT00096954|9403585|P1|Overall Study|Lost to Follow-up|8
2738075|NCT00096954|9403584|P2|Overall Study|Non-compliance|3
2738076|NCT00096954|9403585|P1|Overall Study|Non-compliance|0
2738077|NCT00096954|9403584|P2|Overall Study|Initiation of immunotherapy|0
2738078|NCT00096954|9403585|P1|Overall Study|Initiation of immunotherapy|1
2738079|NCT00096954|9403584|P2|Overall Study|Pregnancy|1
2738080|NCT00096954|9403585|P1|Overall Study|Pregnancy|1
2738081|NCT00096954|9403584|P2|Overall Study|Sponsors Decision|1
2738082|NCT00096954|9403585|P1|Overall Study|Sponsors Decision|1
2738083|NCT00096954|9403584|P2|Overall Study|Physician Decision|1
2738084|NCT00096954|9403585|P1|Overall Study|Physician Decision|1
2738085|NCT00096954|9403584|P2|Overall Study|Withdrawal by Subject|8
2738086|NCT00096954|9403585|P1|Overall Study|Withdrawal by Subject|9
2738087|NCT00096954|9403584|P2|Overall Study|Adverse Event|1
2738088|NCT00096954|9403585|P1|Overall Study|Adverse Event|3
2738089|NCT00096941|9403597|P1|Overall Study|disease progression|3
2738090|NCT00096785|9403604|P2|Overall Study|Relocated|0
2738091|NCT00096785|9403605|P1|Overall Study|Relocated|1
2738092|NCT00096785|9403604|P2|Overall Study|Withdrawal by Subject|1
2738093|NCT00096785|9403605|P1|Overall Study|Withdrawal by Subject|0
2738094|NCT00096785|9403604|P2|Overall Study|Lost to Follow-up|0
2738095|NCT00096785|9403605|P1|Overall Study|Lost to Follow-up|1
2738096|NCT00096538|9403634|P1|Overall Study|Withdrawal by Subject|1
2738097|NCT00096486|9403642|P4|Overall Study|Not Treated|1
2738098|NCT00096486|9403643|P3|Overall Study|Not Treated|1
2738099|NCT00096486|9403644|P2|Overall Study|Not Treated|0
2738100|NCT00096486|9403645|P1|Overall Study|Not Treated|0
2738101|NCT00096486|9403642|P4|Overall Study|Withdrawal by Subject|1
2738102|NCT00096486|9403643|P3|Overall Study|Withdrawal by Subject|1
2738103|NCT00096486|9403644|P2|Overall Study|Withdrawal by Subject|0
2738104|NCT00096486|9403645|P1|Overall Study|Withdrawal by Subject|0
2738105|NCT00096447|9403664|P1|Overall Study|Never treated|1
2738106|NCT00096382|9403680|P2|Overall Study|Death during treatment|0
2738107|NCT00096382|9403681|P1|Overall Study|Death during treatment|1
2738108|NCT00096382|9403680|P2|Overall Study|Not treated|0
2738109|NCT00096382|9403681|P1|Overall Study|Not treated|1
2738110|NCT00096356|9403691|P2|Overall Study|multiple reasons|18
2738111|NCT00096356|9403692|P1|Overall Study|multiple reasons|10
2738112|NCT00096356|9403691|P2|Overall Study|Lack of Efficacy|0
2738113|NCT00096356|9403692|P1|Overall Study|Lack of Efficacy|1
2738114|NCT00096356|9403691|P2|Overall Study|Withdrawal by Subject|23
2738115|NCT00096356|9403692|P1|Overall Study|Withdrawal by Subject|17
2738116|NCT00096356|9403691|P2|Overall Study|Physician Decision|3
2738117|NCT00096356|9403692|P1|Overall Study|Physician Decision|5
2738118|NCT00096356|9403691|P2|Overall Study|Adverse Event|9
2738119|NCT00096356|9403692|P1|Overall Study|Adverse Event|11
2738120|NCT00096278|9403704|P2|Overall Study|Patient not at risk for primary endpoint|2
2738121|NCT00096278|9403705|P1|Overall Study|Patient not at risk for primary endpoint|3
2738122|NCT00096278|9403704|P2|Overall Study|No follow-up data|18
2738123|NCT00096278|9403705|P1|Overall Study|No follow-up data|15
2738124|NCT00096265|9403724|P3|Overall Study|Ineligible|0
2738125|NCT00096265|9403725|P2|Overall Study|Ineligible|0
2738126|NCT00096265|9403726|P1|Overall Study|Ineligible|1
2738127|NCT00096226|9403752|P1|Overall Study|Protocol treatment not started|1
2738128|NCT00096226|9403752|P1|Overall Study|Ineligible|2
2738129|NCT00096200|9403766|P3|Overall Study|Ineligible pathology|0
2738130|NCT00096200|9403767|P2|Overall Study|Ineligible pathology|1
2738131|NCT00096200|9403768|P1|Overall Study|Ineligible pathology|0
2738132|NCT00096200|9403766|P3|Overall Study|Withdrawal by Subject|0
2738133|NCT00096200|9403767|P2|Overall Study|Withdrawal by Subject|2
2738134|NCT00096200|9403768|P1|Overall Study|Withdrawal by Subject|1
2738135|NCT00096200|9403766|P3|Overall Study|Adverse Event|0
2738136|NCT00096200|9403767|P2|Overall Study|Adverse Event|4
2738137|NCT00096200|9403768|P1|Overall Study|Adverse Event|0
2738138|NCT00096174|9403782|P1|Overall Study|other reason|8
2738139|NCT00096174|9403782|P1|Overall Study|Ineligible|6
2738140|NCT00096174|9403782|P1|Overall Study|Not started protocol therapy|3
2738141|NCT00096174|9403782|P1|Overall Study|Withdrawal by Subject|15
2738142|NCT00096174|9403782|P1|Overall Study|Death|6
2738143|NCT00096174|9403782|P1|Overall Study|Adverse Event|15
2738144|NCT00096174|9403782|P1|Overall Study|Lack of Efficacy|9
2738145|NCT00096135|9403827|P2|Overall Study|Ineligible|0
2738146|NCT00096135|9403828|P1|Overall Study|Ineligible|2
2738147|NCT00096135|9403827|P2|Overall Study|Other, specify|3
2738148|NCT00096135|9403828|P1|Overall Study|Other, specify|15
2738149|NCT00096135|9403827|P2|Overall Study|Progressive disease, Marrow,CNS, Relapse|7
2738150|NCT00096135|9403828|P1|Overall Study|Progressive disease, Marrow,CNS, Relapse|22
2738151|NCT00096135|9403827|P2|Overall Study|Refusal of further protocol therapy|1
2738152|NCT00096135|9403828|P1|Overall Study|Refusal of further protocol therapy|4
2738153|NCT00096135|9403827|P2|Overall Study|Physician Decision|4
2738154|NCT00096135|9403828|P1|Overall Study|Physician Decision|20
2738155|NCT00096044|9403844|P1|Overall Study|Disease Progression|4
2738156|NCT00096044|9403844|P1|Overall Study|Adverse Event|21
2738157|NCT00096044|9403844|P1|Overall Study|Withdrawal by Subject|9
2738158|NCT00096031|9403853|P1|Overall Study|Not protocol specified|5
2738159|NCT00096031|9403853|P1|Overall Study|Ineligible|8
2738160|NCT00096031|9403853|P1|Overall Study|Withdrawal by Subject|1
2738161|NCT00096031|9403853|P1|Overall Study|Death|4
2738162|NCT00096031|9403853|P1|Overall Study|Lack of Efficacy|42
2738163|NCT00096031|9403853|P1|Overall Study|Adverse Event|3
2738164|NCT00096018|9403861|P2|Overall Study|Miscellaneous|1
2738165|NCT00096018|9403862|P1|Overall Study|Miscellaneous|2
2738166|NCT00096018|9403861|P2|Overall Study|Withdrawal by Subject|2
2738167|NCT00096018|9403862|P1|Overall Study|Withdrawal by Subject|0
2738168|NCT00096018|9403861|P2|Overall Study|Death|1
2738169|NCT00096018|9403862|P1|Overall Study|Death|0
2738170|NCT00096018|9403861|P2|Overall Study|Adverse Event|5
2738171|NCT00096018|9403862|P1|Overall Study|Adverse Event|0
2738172|NCT00096018|9403861|P2|Overall Study|Miscellaneous (not treated)|2
2738173|NCT00096018|9403862|P1|Overall Study|Miscellaneous (not treated)|0
2738174|NCT00096018|9403861|P2|Overall Study|Became Ineligible (not treated)|3
2738175|NCT00096018|9403862|P1|Overall Study|Became Ineligible (not treated)|0
2738176|NCT00095979|9403870|P1|Overall Study|Ineligible: Second primary cancer site|2
2738177|NCT00095940|9403888|P9|Lapatinib Continuation/Phase II|Adverse Event|0
2738178|NCT00095940|9403889|P8|Lapatinib Continuation/Phase II|Adverse Event|1
2738179|NCT00095940|9403890|P7|Lapatinib Continuation/Phase II|Adverse Event|0
2738180|NCT00095940|9403891|P6|Lapatinib Continuation/Phase II|Adverse Event|0
2738181|NCT00095940|9403892|P5|Lapatinib Continuation/Phase II|Adverse Event|0
2738182|NCT00095940|9403893|P4|Lapatinib Continuation/Phase II|Adverse Event|0
2738183|NCT00095940|9403894|P3|Lapatinib Continuation/Phase II|Adverse Event|0
2738184|NCT00095940|9403895|P2|Lapatinib Continuation/Phase II|Adverse Event|0
2738185|NCT00095940|9403896|P1|Lapatinib Continuation/Phase II|Adverse Event|0
2738186|NCT00095940|9403888|P9|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
2738187|NCT00095940|9403889|P8|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
2738188|NCT00095940|9403890|P7|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
2738189|NCT00095940|9403891|P6|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
2738190|NCT00095940|9403892|P5|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
2738191|NCT00095940|9403893|P4|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
2738192|NCT00095940|9403894|P3|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
2738193|NCT00095940|9403895|P2|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
2738194|NCT00095940|9403896|P1|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
2738195|NCT00095940|9403888|P9|Lapatinib Continuation/Phase II|Disease Progression|12
2738196|NCT00095940|9403889|P8|Lapatinib Continuation/Phase II|Disease Progression|1
2738197|NCT00095940|9403890|P7|Lapatinib Continuation/Phase II|Disease Progression|2
2738198|NCT00095940|9403891|P6|Lapatinib Continuation/Phase II|Disease Progression|13
2738199|NCT00095940|9403892|P5|Lapatinib Continuation/Phase II|Disease Progression|0
2738200|NCT00095940|9403893|P4|Lapatinib Continuation/Phase II|Disease Progression|0
2738201|NCT00095940|9403894|P3|Lapatinib Continuation/Phase II|Disease Progression|15
2738202|NCT00095940|9403895|P2|Lapatinib Continuation/Phase II|Disease Progression|1
2738203|NCT00095940|9403896|P1|Lapatinib Continuation/Phase II|Disease Progression|1
2738204|NCT00095836|9403929|P1|Overall Study|Death|2
2738205|NCT00095836|9403929|P1|Overall Study|Adverse Event|1
2738206|NCT00095836|9403929|P1|Overall Study|Lost to Follow-up|1
2738207|NCT00095628|9403959|P1|Overall Study|Disease progression prior to treatment|1
2738208|NCT00095576|9403970|P2|Overall Study|Subject moved|36
2738209|NCT00095576|9403971|P1|Overall Study|Subject moved|30
2738210|NCT00095576|9403970|P2|Overall Study|Site terminated|67
2738211|NCT00095576|9403971|P1|Overall Study|Site terminated|75
2738212|NCT00095576|9403970|P2|Overall Study|Option to switch to a rollover study|1099
2738213|NCT00095576|9403971|P1|Overall Study|Option to switch to a rollover study|1097
2738214|NCT00095576|9403970|P2|Overall Study|Withdrawal by Subject|47
2738215|NCT00095576|9403971|P1|Overall Study|Withdrawal by Subject|34
2738216|NCT00095576|9403970|P2|Overall Study|Protocol Violation|0
2738217|NCT00095576|9403971|P1|Overall Study|Protocol Violation|1
2738218|NCT00095576|9403970|P2|Overall Study|Lost to Follow-up|229
2738219|NCT00095576|9403971|P1|Overall Study|Lost to Follow-up|233
2738220|NCT00095576|9403970|P2|Overall Study|Adverse Event|3
2738221|NCT00095576|9403971|P1|Overall Study|Adverse Event|5
2738222|NCT00095498|9403995|P3|Overall Study|Requirement for alternative therapy|2
2738223|NCT00095498|9403996|P2|Overall Study|Requirement for alternative therapy|0
2738224|NCT00095498|9403997|P1|Overall Study|Requirement for alternative therapy|1
2738225|NCT00095498|9403995|P3|Overall Study|Protocol Violation|1
2738226|NCT00095498|9403996|P2|Overall Study|Protocol Violation|0
2738227|NCT00095498|9403997|P1|Overall Study|Protocol Violation|0
2738228|NCT00095498|9403995|P3|Overall Study|Other|6
2738229|NCT00095498|9403996|P2|Overall Study|Other|7
2738230|NCT00095498|9403997|P1|Overall Study|Other|6
2738231|NCT00095498|9403995|P3|Overall Study|Noncompliance|1
2738232|NCT00095498|9403996|P2|Overall Study|Noncompliance|0
2738233|NCT00095498|9403997|P1|Overall Study|Noncompliance|1
2738234|NCT00095498|9403995|P3|Overall Study|Lost to Follow-up|2
2738235|NCT00095498|9403996|P2|Overall Study|Lost to Follow-up|1
2738236|NCT00095498|9403997|P1|Overall Study|Lost to Follow-up|1
2738237|NCT00095498|9403995|P3|Overall Study|Ineligibility determined|2
2738238|NCT00095498|9403996|P2|Overall Study|Ineligibility determined|0
2738239|NCT00095498|9403997|P1|Overall Study|Ineligibility determined|3
2738240|NCT00095498|9403995|P3|Overall Study|Disease progression|1
2738241|NCT00095498|9403996|P2|Overall Study|Disease progression|1
2738242|NCT00095498|9403997|P1|Overall Study|Disease progression|0
2738243|NCT00095498|9403995|P3|Overall Study|Withdrawal by Subject|15
2738244|NCT00095498|9403996|P2|Overall Study|Withdrawal by Subject|16
2738245|NCT00095498|9403997|P1|Overall Study|Withdrawal by Subject|15
2738246|NCT00095498|9403995|P3|Overall Study|Adverse Event|1
2738247|NCT00095498|9403996|P2|Overall Study|Adverse Event|0
2738248|NCT00095498|9403997|P1|Overall Study|Adverse Event|1
2738249|NCT00095498|9403995|P3|Overall Study|Physician Decision|8
2738250|NCT00095498|9403996|P2|Overall Study|Physician Decision|10
2738251|NCT00095498|9403997|P1|Overall Study|Physician Decision|9
2738252|NCT00095303|9404424|P2|Follow Up Study|Lost to Follow-up|58
2738253|NCT00095303|9404425|P1|Follow Up Study|Lost to Follow-up|59
2738254|NCT00095303|9404424|P2|Main Study|Lost to Follow-up|87
2738255|NCT00095303|9404425|P1|Main Study|Lost to Follow-up|91
2738256|NCT00095238|9404493|P2|Overall Study|Other Reasons|88
2738257|NCT00095238|9404494|P1|Overall Study|Other Reasons|87
2738258|NCT00095238|9404493|P2|Overall Study|Missing|0
2738259|NCT00095238|9404494|P1|Overall Study|Missing|1
2738260|NCT00095238|9404493|P2|Overall Study|Study terminated by sponsor|1
2738261|NCT00095238|9404494|P1|Overall Study|Study terminated by sponsor|0
2738262|NCT00095238|9404493|P2|Overall Study|No longer met study criteria|5
2738263|NCT00095238|9404494|P1|Overall Study|No longer met study criteria|4
2738264|NCT00095238|9404493|P2|Overall Study|Noncompliance|45
2738265|NCT00095238|9404494|P1|Overall Study|Noncompliance|44
2738266|NCT00095238|9404493|P2|Overall Study|Lost to Follow-up|24
2738267|NCT00095238|9404494|P1|Overall Study|Lost to Follow-up|19
2738268|NCT00095238|9404493|P2|Overall Study|Death|170
2738269|NCT00095238|9404494|P1|Overall Study|Death|154
2738270|NCT00095238|9404493|P2|Overall Study|Subject Withdrew Consent|223
2738271|NCT00095238|9404494|P1|Overall Study|Subject Withdrew Consent|208
2738272|NCT00095238|9404493|P2|Overall Study|Adverse Event|287
2738273|NCT00095238|9404494|P1|Overall Study|Adverse Event|331
2738274|NCT00095238|9404493|P2|Overall Study|Lack of Efficacy|9
2738275|NCT00095238|9404494|P1|Overall Study|Lack of Efficacy|9
2738276|NCT00095212|9404556|P2|Overall Study|Withdrawal by Subject|3
2738277|NCT00095212|9404557|P1|Overall Study|Withdrawal by Subject|1
2738278|NCT00095199|9404587|P4|Overall Study|Data inadvertently lost by site|0
2738279|NCT00095199|9404588|P3|Overall Study|Data inadvertently lost by site|0
2738280|NCT00095199|9404589|P2|Overall Study|Data inadvertently lost by site|0
2738281|NCT00095199|9404590|P1|Overall Study|Data inadvertently lost by site|1
2738282|NCT00095199|9404587|P4|Overall Study|Primary tumor removed in other surgery|0
2738283|NCT00095199|9404588|P3|Overall Study|Primary tumor removed in other surgery|0
2738284|NCT00095199|9404589|P2|Overall Study|Primary tumor removed in other surgery|1
2738285|NCT00095199|9404590|P1|Overall Study|Primary tumor removed in other surgery|0
2738286|NCT00095199|9404587|P4|Overall Study|Started radiotherapy regimen|0
2738287|NCT00095199|9404588|P3|Overall Study|Started radiotherapy regimen|0
2738288|NCT00095199|9404589|P2|Overall Study|Started radiotherapy regimen|1
2738289|NCT00095199|9404590|P1|Overall Study|Started radiotherapy regimen|0
2738290|NCT00095199|9404587|P4|Overall Study|Started Palliative Radiotherapy|0
2738291|NCT00095199|9404588|P3|Overall Study|Started Palliative Radiotherapy|0
2738292|NCT00095199|9404589|P2|Overall Study|Started Palliative Radiotherapy|0
2738293|NCT00095199|9404590|P1|Overall Study|Started Palliative Radiotherapy|1
2738294|NCT00095199|9404587|P4|Overall Study|Not eligible|1
2738295|NCT00095199|9404588|P3|Overall Study|Not eligible|0
2738296|NCT00095199|9404589|P2|Overall Study|Not eligible|7
2738297|NCT00095199|9404590|P1|Overall Study|Not eligible|1
2738298|NCT00095199|9404587|P4|Overall Study|Physician Decision|1
2738299|NCT00095199|9404588|P3|Overall Study|Physician Decision|1
2738300|NCT00095199|9404589|P2|Overall Study|Physician Decision|6
2738301|NCT00095199|9404590|P1|Overall Study|Physician Decision|5
2738302|NCT00095199|9404587|P4|Overall Study|Surgery needed could not start in 7 days|0
2738303|NCT00095199|9404588|P3|Overall Study|Surgery needed could not start in 7 days|1
2738304|NCT00095199|9404589|P2|Overall Study|Surgery needed could not start in 7 days|0
2738305|NCT00095199|9404590|P1|Overall Study|Surgery needed could not start in 7 days|0
2738306|NCT00095199|9404587|P4|Overall Study|Liver function test results elevated|1
2738307|NCT00095199|9404588|P3|Overall Study|Liver function test results elevated|1
2738308|NCT00095199|9404589|P2|Overall Study|Liver function test results elevated|0
2738309|NCT00095199|9404590|P1|Overall Study|Liver function test results elevated|0
2738310|NCT00095199|9404587|P4|Overall Study|Protocol Violation|0
2738311|NCT00095199|9404588|P3|Overall Study|Protocol Violation|2
2738312|NCT00095199|9404589|P2|Overall Study|Protocol Violation|4
2738313|NCT00095199|9404590|P1|Overall Study|Protocol Violation|4
2738314|NCT00095199|9404587|P4|Overall Study|Withdrawal by Subject|22
2738315|NCT00095199|9404588|P3|Overall Study|Withdrawal by Subject|13
2738316|NCT00095199|9404589|P2|Overall Study|Withdrawal by Subject|16
2738317|NCT00095199|9404590|P1|Overall Study|Withdrawal by Subject|21
2738318|NCT00095199|9404587|P4|Overall Study|Death|9
2738319|NCT00095199|9404588|P3|Overall Study|Death|11
2738320|NCT00095199|9404589|P2|Overall Study|Death|6
2738321|NCT00095199|9404590|P1|Overall Study|Death|10
2738322|NCT00095199|9404587|P4|Overall Study|Progressive disease|98
2738323|NCT00095199|9404588|P3|Overall Study|Progressive disease|105
2738324|NCT00095199|9404589|P2|Overall Study|Progressive disease|179
2738325|NCT00095199|9404590|P1|Overall Study|Progressive disease|213
2738326|NCT00095199|9404587|P4|Overall Study|Adverse Event|11
2738327|NCT00095199|9404588|P3|Overall Study|Adverse Event|26
2738328|NCT00095199|9404589|P2|Overall Study|Adverse Event|22
2738329|NCT00095199|9404590|P1|Overall Study|Adverse Event|40
2738330|NCT00095173|9404628|P6|Open-Label Extension Phase (Period C)|Other|8
2738331|NCT00095173|9404629|P5|Open-Label Extension Phase (Period C)|Other|6
2738332|NCT00095173|9404630|P4|Open-Label Extension Phase (Period C)|Other|4
2738333|NCT00095173|9404631|P3|Open-Label Extension Phase (Period C)|Other|0
2738334|NCT00095173|9404632|P2|Open-Label Extension Phase (Period C)|Other|0
2738335|NCT00095173|9404633|P1|Open-Label Extension Phase (Period C)|Other|0
2738336|NCT00095173|9404628|P6|Open-Label Extension Phase (Period C)|Pregnancy|3
2738337|NCT00095173|9404629|P5|Open-Label Extension Phase (Period C)|Pregnancy|2
2738338|NCT00095173|9404630|P4|Open-Label Extension Phase (Period C)|Pregnancy|1
2738339|NCT00095173|9404631|P3|Open-Label Extension Phase (Period C)|Pregnancy|0
2738340|NCT00095173|9404632|P2|Open-Label Extension Phase (Period C)|Pregnancy|0
2738341|NCT00095173|9404633|P1|Open-Label Extension Phase (Period C)|Pregnancy|0
2738342|NCT00095173|9404628|P6|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
2738343|NCT00095173|9404629|P5|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
2738344|NCT00095173|9404630|P4|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
2738345|NCT00095173|9404631|P3|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
2738346|NCT00095173|9404632|P2|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
2738347|NCT00095173|9404633|P1|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
2738348|NCT00095173|9404628|P6|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
2738349|NCT00095173|9404629|P5|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
2738350|NCT00095173|9404630|P4|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
2738351|NCT00095173|9404631|P3|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
2738352|NCT00095173|9404632|P2|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
2738353|NCT00095173|9404633|P1|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
2738354|NCT00095173|9404628|P6|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
2738355|NCT00095173|9404629|P5|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6
2738356|NCT00095173|9404630|P4|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4
2738357|NCT00095173|9404631|P3|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
2738358|NCT00095173|9404632|P2|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
2738359|NCT00095173|9404633|P1|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
2738360|NCT00095173|9404628|P6|Open-Label Extension Phase (Period C)|Lost to Follow-up|6
2738361|NCT00095173|9404629|P5|Open-Label Extension Phase (Period C)|Lost to Follow-up|5
2738362|NCT00095173|9404630|P4|Open-Label Extension Phase (Period C)|Lost to Follow-up|2
2738363|NCT00095173|9404631|P3|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
2738364|NCT00095173|9404632|P2|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
2738365|NCT00095173|9404633|P1|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
2738366|NCT00095173|9404628|P6|Open-Label Extension Phase (Period C)|Lack of Efficacy|8
2738367|NCT00095173|9404629|P5|Open-Label Extension Phase (Period C)|Lack of Efficacy|5
2738368|NCT00095173|9404630|P4|Open-Label Extension Phase (Period C)|Lack of Efficacy|11
2738369|NCT00095173|9404631|P3|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
2738370|NCT00095173|9404632|P2|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
2738371|NCT00095173|9404633|P1|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
2738372|NCT00095173|9404628|P6|Open-Label Extension Phase (Period C)|Adverse Event|3
2738373|NCT00095173|9404629|P5|Open-Label Extension Phase (Period C)|Adverse Event|2
2738374|NCT00095173|9404630|P4|Open-Label Extension Phase (Period C)|Adverse Event|1
2738375|NCT00095173|9404631|P3|Open-Label Extension Phase (Period C)|Adverse Event|0
2738376|NCT00095173|9404632|P2|Open-Label Extension Phase (Period C)|Adverse Event|0
2738377|NCT00095173|9404633|P1|Open-Label Extension Phase (Period C)|Adverse Event|0
2738378|NCT00095173|9404628|P6|Open-Label Extension Phase (Period C)|Death|1
2738379|NCT00095173|9404629|P5|Open-Label Extension Phase (Period C)|Death|0
2738380|NCT00095173|9404630|P4|Open-Label Extension Phase (Period C)|Death|0
2738381|NCT00095173|9404631|P3|Open-Label Extension Phase (Period C)|Death|0
2738382|NCT00095173|9404632|P2|Open-Label Extension Phase (Period C)|Death|0
2738383|NCT00095173|9404633|P1|Open-Label Extension Phase (Period C)|Death|0
2738384|NCT00095173|9404628|P6|Double-Blind Phase (Period B)|Withdrawal by Subject|0
2738385|NCT00095173|9404629|P5|Double-Blind Phase (Period B)|Withdrawal by Subject|0
2738386|NCT00095173|9404630|P4|Double-Blind Phase (Period B)|Withdrawal by Subject|0
2738387|NCT00095173|9404631|P3|Double-Blind Phase (Period B)|Withdrawal by Subject|0
2738388|NCT00095173|9404632|P2|Double-Blind Phase (Period B)|Withdrawal by Subject|1
2738389|NCT00095173|9404633|P1|Double-Blind Phase (Period B)|Withdrawal by Subject|0
2738390|NCT00095173|9404628|P6|Double-Blind Phase (Period B)|Lack of Efficacy|0
2738391|NCT00095173|9404629|P5|Double-Blind Phase (Period B)|Lack of Efficacy|0
2738392|NCT00095173|9404630|P4|Double-Blind Phase (Period B)|Lack of Efficacy|0
2738393|NCT00095173|9404631|P3|Double-Blind Phase (Period B)|Lack of Efficacy|31
2738394|NCT00095173|9404632|P2|Double-Blind Phase (Period B)|Lack of Efficacy|10
2738395|NCT00095173|9404633|P1|Double-Blind Phase (Period B)|Lack of Efficacy|0
2738396|NCT00095173|9404628|P6|Open-Label Lead-In Phase (Period A)|Other|0
2738397|NCT00095173|9404629|P5|Open-Label Lead-In Phase (Period A)|Other|0
2738398|NCT00095173|9404630|P4|Open-Label Lead-In Phase (Period A)|Other|0
2738399|NCT00095173|9404631|P3|Open-Label Lead-In Phase (Period A)|Other|0
2738400|NCT00095173|9404632|P2|Open-Label Lead-In Phase (Period A)|Other|0
2738401|NCT00095173|9404633|P1|Open-Label Lead-In Phase (Period A)|Other|1
2738402|NCT00095173|9404628|P6|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
2738403|NCT00095173|9404629|P5|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
2738404|NCT00095173|9404630|P4|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
2738405|NCT00095173|9404631|P3|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
2738406|NCT00095173|9404632|P2|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
2738407|NCT00095173|9404633|P1|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1
2738408|NCT00095173|9404628|P6|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
2738409|NCT00095173|9404629|P5|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
2738410|NCT00095173|9404630|P4|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
2738411|NCT00095173|9404631|P3|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
2738412|NCT00095173|9404632|P2|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
2738413|NCT00095173|9404633|P1|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17
2738414|NCT00095173|9404628|P6|Open-Label Lead-In Phase (Period A)|Adverse Event|0
2738415|NCT00095173|9404629|P5|Open-Label Lead-In Phase (Period A)|Adverse Event|0
2738416|NCT00095173|9404630|P4|Open-Label Lead-In Phase (Period A)|Adverse Event|0
2738417|NCT00095173|9404631|P3|Open-Label Lead-In Phase (Period A)|Adverse Event|0
2738418|NCT00095173|9404632|P2|Open-Label Lead-In Phase (Period A)|Adverse Event|0
2738419|NCT00095173|9404633|P1|Open-Label Lead-In Phase (Period A)|Adverse Event|1
2738420|NCT00095147|9404671|P5|Long-term Extension Period|Leaving country|1
2738421|NCT00095147|9404672|P4|Long-term Extension Period|Leaving country|0
2738422|NCT00095147|9404673|P3|Long-term Extension Period|Leaving country|0
2738423|NCT00095147|9404674|P2|Long-term Extension Period|Leaving country|0
2738424|NCT00095147|9404675|P1|Long-term Extension Period|Leaving country|0
2738425|NCT00095147|9404671|P5|Long-term Extension Period|Participant chose to use Revellex|1
2738426|NCT00095147|9404672|P4|Long-term Extension Period|Participant chose to use Revellex|0
2738427|NCT00095147|9404673|P3|Long-term Extension Period|Participant chose to use Revellex|0
2738428|NCT00095147|9404674|P2|Long-term Extension Period|Participant chose to use Revellex|0
2738429|NCT00095147|9404675|P1|Long-term Extension Period|Participant chose to use Revellex|0
2738430|NCT00095147|9404671|P5|Long-term Extension Period|No longer meets study criteria|1
2738431|NCT00095147|9404672|P4|Long-term Extension Period|No longer meets study criteria|0
2738432|NCT00095147|9404673|P3|Long-term Extension Period|No longer meets study criteria|0
2738433|NCT00095147|9404674|P2|Long-term Extension Period|No longer meets study criteria|0
2738434|NCT00095147|9404675|P1|Long-term Extension Period|No longer meets study criteria|0
2738435|NCT00095147|9404671|P5|Long-term Extension Period|Pregnancy|1
2738436|NCT00095147|9404672|P4|Long-term Extension Period|Pregnancy|0
2738437|NCT00095147|9404673|P3|Long-term Extension Period|Pregnancy|0
2738438|NCT00095147|9404674|P2|Long-term Extension Period|Pregnancy|0
2738439|NCT00095147|9404675|P1|Long-term Extension Period|Pregnancy|0
2738440|NCT00095147|9404671|P5|Long-term Extension Period|Withdrawal of consent|12
2738441|NCT00095147|9404672|P4|Long-term Extension Period|Withdrawal of consent|0
2738442|NCT00095147|9404673|P3|Long-term Extension Period|Withdrawal of consent|0
2738443|NCT00095147|9404674|P2|Long-term Extension Period|Withdrawal of consent|0
2738444|NCT00095147|9404675|P1|Long-term Extension Period|Withdrawal of consent|0
2738445|NCT00095147|9404671|P5|Long-term Extension Period|Lost to Follow-up|6
2738446|NCT00095147|9404672|P4|Long-term Extension Period|Lost to Follow-up|0
2738447|NCT00095147|9404673|P3|Long-term Extension Period|Lost to Follow-up|0
2738448|NCT00095147|9404674|P2|Long-term Extension Period|Lost to Follow-up|0
2738449|NCT00095147|9404675|P1|Long-term Extension Period|Lost to Follow-up|0
2738450|NCT00095147|9404671|P5|Long-term Extension Period|Lack of Efficacy|9
2738451|NCT00095147|9404672|P4|Long-term Extension Period|Lack of Efficacy|0
2738452|NCT00095147|9404673|P3|Long-term Extension Period|Lack of Efficacy|0
2738453|NCT00095147|9404674|P2|Long-term Extension Period|Lack of Efficacy|0
2738454|NCT00095147|9404675|P1|Long-term Extension Period|Lack of Efficacy|0
2738455|NCT00095147|9404671|P5|Long-term Extension Period|Adverse Event|11
2738456|NCT00095147|9404672|P4|Long-term Extension Period|Adverse Event|0
2738457|NCT00095147|9404673|P3|Long-term Extension Period|Adverse Event|0
2738458|NCT00095147|9404674|P2|Long-term Extension Period|Adverse Event|0
2738459|NCT00095147|9404675|P1|Long-term Extension Period|Adverse Event|0
2738460|NCT00095147|9404671|P5|Long-term Extension Period|Death|3
2738461|NCT00095147|9404672|P4|Long-term Extension Period|Death|0
2738462|NCT00095147|9404673|P3|Long-term Extension Period|Death|0
2738463|NCT00095147|9404674|P2|Long-term Extension Period|Death|0
2738464|NCT00095147|9404675|P1|Long-term Extension Period|Death|0
2738465|NCT00095147|9404671|P5|Double-blind Period 2 (Days 198-365)|Participant relocation|0
2738466|NCT00095147|9404672|P4|Double-blind Period 2 (Days 198-365)|Participant relocation|1
2738467|NCT00095147|9404673|P3|Double-blind Period 2 (Days 198-365)|Participant relocation|0
2738468|NCT00095147|9404674|P2|Double-blind Period 2 (Days 198-365)|Participant relocation|0
2738469|NCT00095147|9404675|P1|Double-blind Period 2 (Days 198-365)|Participant relocation|1
2738470|NCT00095147|9404671|P5|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
2738471|NCT00095147|9404672|P4|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
2738472|NCT00095147|9404673|P3|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
2738473|NCT00095147|9404674|P2|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2
2738474|NCT00095147|9404675|P1|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3
2738475|NCT00095147|9404671|P5|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
2738476|NCT00095147|9404672|P4|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1
2738477|NCT00095147|9404673|P3|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
2738478|NCT00095147|9404674|P2|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4
2738479|NCT00095147|9404675|P1|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2
2738480|NCT00095147|9404671|P5|Double-blind Period 2 (Days 198-365)|Adverse Event|0
2738481|NCT00095147|9404672|P4|Double-blind Period 2 (Days 198-365)|Adverse Event|0
2738482|NCT00095147|9404673|P3|Double-blind Period 2 (Days 198-365)|Adverse Event|0
2738483|NCT00095147|9404674|P2|Double-blind Period 2 (Days 198-365)|Adverse Event|4
2738484|NCT00095147|9404675|P1|Double-blind Period 2 (Days 198-365)|Adverse Event|2
2738485|NCT00095147|9404671|P5|Double-blind Period 2 (Days 198-365)|Death|0
2738486|NCT00095147|9404672|P4|Double-blind Period 2 (Days 198-365)|Death|1
2738487|NCT00095147|9404673|P3|Double-blind Period 2 (Days 198-365)|Death|0
2738488|NCT00095147|9404674|P2|Double-blind Period 2 (Days 198-365)|Death|1
2738489|NCT00095147|9404675|P1|Double-blind Period 2 (Days 198-365)|Death|0
2738490|NCT00095147|9404671|P5|Double-blind Period 1 (Days 1-197)|Pregnancy|0
2738491|NCT00095147|9404672|P4|Double-blind Period 1 (Days 1-197)|Pregnancy|0
2738492|NCT00095147|9404673|P3|Double-blind Period 1 (Days 1-197)|Pregnancy|0
2738493|NCT00095147|9404674|P2|Double-blind Period 1 (Days 1-197)|Pregnancy|1
2738494|NCT00095147|9404675|P1|Double-blind Period 1 (Days 1-197)|Pregnancy|1
2738495|NCT00095147|9404671|P5|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
2738496|NCT00095147|9404672|P4|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
2738497|NCT00095147|9404673|P3|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
2738498|NCT00095147|9404674|P2|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
2738499|NCT00095147|9404675|P1|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
2738500|NCT00095147|9404671|P5|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
2738501|NCT00095147|9404672|P4|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
2738502|NCT00095147|9404673|P3|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
2738503|NCT00095147|9404674|P2|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
2738504|NCT00095147|9404675|P1|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
2738505|NCT00095147|9404671|P5|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
2738506|NCT00095147|9404672|P4|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
2738507|NCT00095147|9404673|P3|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1
2738508|NCT00095147|9404674|P2|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
2738509|NCT00095147|9404675|P1|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
2738510|NCT00095147|9404671|P5|Double-blind Period 1 (Days 1-197)|Adverse Event|0
2738511|NCT00095147|9404672|P4|Double-blind Period 1 (Days 1-197)|Adverse Event|0
2738512|NCT00095147|9404673|P3|Double-blind Period 1 (Days 1-197)|Adverse Event|1
2738513|NCT00095147|9404674|P2|Double-blind Period 1 (Days 1-197)|Adverse Event|8
2738514|NCT00095147|9404675|P1|Double-blind Period 1 (Days 1-197)|Adverse Event|2
2738515|NCT00095147|9404671|P5|Double-blind Period 1 (Days 1-197)|Death|0
2738516|NCT00095147|9404672|P4|Double-blind Period 1 (Days 1-197)|Death|0
2738517|NCT00095147|9404673|P3|Double-blind Period 1 (Days 1-197)|Death|0
2738518|NCT00095147|9404674|P2|Double-blind Period 1 (Days 1-197)|Death|0
2738519|NCT00095147|9404675|P1|Double-blind Period 1 (Days 1-197)|Death|1
2738520|NCT00095121|9404870|P2|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0
2738521|NCT00095121|9404871|P1|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2
2738522|NCT00095121|9404870|P2|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0
2738523|NCT00095121|9404871|P1|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1
2738524|NCT00095056|9404917|P2|Phase B (Weeks 12-54)|Protocol Violation|1
2738525|NCT00095056|9404918|P1|Phase B (Weeks 12-54)|Protocol Violation|0
2738526|NCT00095056|9404917|P2|Phase B (Weeks 12-54)|Protocol specific criteria|0
2738527|NCT00095056|9404918|P1|Phase B (Weeks 12-54)|Protocol specific criteria|1
2738528|NCT00095056|9404917|P2|Phase B (Weeks 12-54)|Death|1
2738529|NCT00095056|9404918|P1|Phase B (Weeks 12-54)|Death|3
2738530|NCT00095056|9404917|P2|Phase B (Weeks 12-54)|Patient Moved|0
2738531|NCT00095056|9404918|P1|Phase B (Weeks 12-54)|Patient Moved|1
2738532|NCT00095056|9404917|P2|Phase B (Weeks 12-54)|Withdrawal by Subject|1
2738533|NCT00095056|9404918|P1|Phase B (Weeks 12-54)|Withdrawal by Subject|2
2738534|NCT00095056|9404917|P2|Phase B (Weeks 12-54)|Lost to Follow-up|0
2738535|NCT00095056|9404918|P1|Phase B (Weeks 12-54)|Lost to Follow-up|1
2738536|NCT00095056|9404917|P2|Phase B (Weeks 12-54)|Adverse Event|2
2738537|NCT00095056|9404918|P1|Phase B (Weeks 12-54)|Adverse Event|2
2738538|NCT00095056|9404917|P2|Phase A (Weeks 0-12)|Protocol specific criteria|0
2738539|NCT00095056|9404918|P1|Phase A (Weeks 0-12)|Protocol specific criteria|2
2738540|NCT00095056|9404917|P2|Phase A (Weeks 0-12)|Death|0
2738541|NCT00095056|9404918|P1|Phase A (Weeks 0-12)|Death|1
2738542|NCT00095056|9404917|P2|Phase A (Weeks 0-12)|Withdrawal by Subject|0
2738543|NCT00095056|9404918|P1|Phase A (Weeks 0-12)|Withdrawal by Subject|3
2738544|NCT00095056|9404917|P2|Phase A (Weeks 0-12)|Adverse Event|1
2738545|NCT00095056|9404918|P1|Phase A (Weeks 0-12)|Adverse Event|1
2738546|NCT00094861|9405047|P2|Overall Study|Other|0
2738547|NCT00094861|9405048|P1|Overall Study|Other|3
2738548|NCT00094861|9405047|P2|Overall Study|Death|2
2738549|NCT00094861|9405048|P1|Overall Study|Death|4
2738550|NCT00094861|9405047|P2|Overall Study|Lost to Follow-up|1
2738551|NCT00094861|9405048|P1|Overall Study|Lost to Follow-up|0
2738552|NCT00094861|9405047|P2|Overall Study|Physician Decision|1
2738553|NCT00094861|9405048|P1|Overall Study|Physician Decision|1
2738554|NCT00094861|9405047|P2|Overall Study|Withdrawal by Subject|3
2738555|NCT00094861|9405048|P1|Overall Study|Withdrawal by Subject|5
2738556|NCT00094861|9405047|P2|Overall Study|Adverse Event|2
2738557|NCT00094861|9405048|P1|Overall Study|Adverse Event|5
2738558|NCT00094835|9405075|P7|Overall Study|Other|0
2738559|NCT00094835|9405076|P6|Overall Study|Other|0
2738560|NCT00094835|9405077|P5|Overall Study|Other|0
2738561|NCT00094835|9405078|P4|Overall Study|Other|1
2738562|NCT00094835|9405079|P3|Overall Study|Other|1
2738563|NCT00094835|9405080|P2|Overall Study|Other|1
2738564|NCT00094835|9405081|P1|Overall Study|Other|1
2738565|NCT00094835|9405075|P7|Overall Study|Non-compliance|1
2738566|NCT00094835|9405076|P6|Overall Study|Non-compliance|2
2738567|NCT00094835|9405077|P5|Overall Study|Non-compliance|2
2738568|NCT00094835|9405078|P4|Overall Study|Non-compliance|0
2738569|NCT00094835|9405079|P3|Overall Study|Non-compliance|2
2738570|NCT00094835|9405080|P2|Overall Study|Non-compliance|2
2738571|NCT00094835|9405081|P1|Overall Study|Non-compliance|1
2738572|NCT00094835|9405075|P7|Overall Study|Death|0
2738573|NCT00094835|9405076|P6|Overall Study|Death|0
2738574|NCT00094835|9405077|P5|Overall Study|Death|1
2738575|NCT00094835|9405078|P4|Overall Study|Death|0
2738576|NCT00094835|9405079|P3|Overall Study|Death|0
2738577|NCT00094835|9405080|P2|Overall Study|Death|0
2738578|NCT00094835|9405081|P1|Overall Study|Death|1
2738579|NCT00094835|9405075|P7|Overall Study|Lost to Follow-up|0
2738580|NCT00094835|9405076|P6|Overall Study|Lost to Follow-up|0
2738581|NCT00094835|9405077|P5|Overall Study|Lost to Follow-up|1
2738582|NCT00094835|9405078|P4|Overall Study|Lost to Follow-up|0
2738583|NCT00094835|9405079|P3|Overall Study|Lost to Follow-up|0
2738584|NCT00094835|9405080|P2|Overall Study|Lost to Follow-up|0
2738585|NCT00094835|9405081|P1|Overall Study|Lost to Follow-up|0
2738586|NCT00094835|9405075|P7|Overall Study|Withdrawal by Subject|1
2738587|NCT00094835|9405076|P6|Overall Study|Withdrawal by Subject|0
2738588|NCT00094835|9405077|P5|Overall Study|Withdrawal by Subject|0
2738589|NCT00094835|9405078|P4|Overall Study|Withdrawal by Subject|0
2738590|NCT00094835|9405079|P3|Overall Study|Withdrawal by Subject|0
2738591|NCT00094835|9405080|P2|Overall Study|Withdrawal by Subject|0
2738592|NCT00094835|9405081|P1|Overall Study|Withdrawal by Subject|0
2738593|NCT00094835|9405075|P7|Overall Study|Physician Decision|0
2738594|NCT00094835|9405076|P6|Overall Study|Physician Decision|1
2738595|NCT00094835|9405077|P5|Overall Study|Physician Decision|0
2738596|NCT00094835|9405078|P4|Overall Study|Physician Decision|0
2738597|NCT00094835|9405079|P3|Overall Study|Physician Decision|0
2738598|NCT00094835|9405080|P2|Overall Study|Physician Decision|0
2738599|NCT00094835|9405081|P1|Overall Study|Physician Decision|1
2738600|NCT00094809|9405159|P2|Overall Study|Other|1
2738601|NCT00094809|9405160|P1|Overall Study|Other|1
2738602|NCT00094809|9405159|P2|Overall Study|Study drug not received|8
2738603|NCT00094809|9405160|P1|Overall Study|Study drug not received|2
2738604|NCT00094809|9405159|P2|Overall Study|Informed consent signed after treatment|0
2738605|NCT00094809|9405160|P1|Overall Study|Informed consent signed after treatment|1
2738606|NCT00094809|9405159|P2|Overall Study|Other|4
2738607|NCT00094809|9405160|P1|Overall Study|Other|2
2738608|NCT00094809|9405159|P2|Overall Study|Protocol-specified criteria|1
2738609|NCT00094809|9405160|P1|Overall Study|Protocol-specified criteria|1
2738610|NCT00094809|9405159|P2|Overall Study|Death|25
2738611|NCT00094809|9405160|P1|Overall Study|Death|19
2738612|NCT00094809|9405159|P2|Overall Study|Lost to Follow-up|6
2738613|NCT00094809|9405160|P1|Overall Study|Lost to Follow-up|6
2738614|NCT00094809|9405159|P2|Overall Study|Physician Decision|5
2738615|NCT00094809|9405160|P1|Overall Study|Physician Decision|3
2738616|NCT00094809|9405159|P2|Overall Study|Disease progression|3
2738617|NCT00094809|9405160|P1|Overall Study|Disease progression|3
2738618|NCT00094809|9405159|P2|Overall Study|Withdrawal by Subject|9
2738619|NCT00094809|9405160|P1|Overall Study|Withdrawal by Subject|8
2738620|NCT00094809|9405159|P2|Overall Study|Adverse Event|1
2738621|NCT00094809|9405160|P1|Overall Study|Adverse Event|3
2738622|NCT00094809|9405159|P2|Overall Study|Noncompliance|0
2738623|NCT00094809|9405160|P1|Overall Study|Noncompliance|1
2738624|NCT00094809|9405159|P2|Overall Study|Protocol deviation|2
2738625|NCT00094809|9405160|P1|Overall Study|Protocol deviation|2
2738626|NCT00094770|9405186|P2|Year 2 (Week 0 to Week 104)|Other|23
2738627|NCT00094770|9405187|P1|Year 2 (Week 0 to Week 104)|Other|15
2738628|NCT00094770|9405186|P2|Year 2 (Week 0 to Week 104)|Site Terminated|2
2738629|NCT00094770|9405187|P1|Year 2 (Week 0 to Week 104)|Site Terminated|2
2738630|NCT00094770|9405186|P2|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38
2738631|NCT00094770|9405187|P1|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28
2738632|NCT00094770|9405186|P2|Year 2 (Week 0 to Week 104)|Patient Moved|2
2738633|NCT00094770|9405187|P1|Year 2 (Week 0 to Week 104)|Patient Moved|6
2738634|NCT00094770|9405186|P2|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30
2738635|NCT00094770|9405187|P1|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29
2738636|NCT00094770|9405186|P2|Year 2 (Week 0 to Week 104)|Protocol Violation|12
2738637|NCT00094770|9405187|P1|Year 2 (Week 0 to Week 104)|Protocol Violation|13
2738638|NCT00094770|9405186|P2|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15
2738639|NCT00094770|9405187|P1|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25
2738640|NCT00094770|9405186|P2|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162
2738641|NCT00094770|9405187|P1|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180
2738642|NCT00094770|9405186|P2|Year 2 (Week 0 to Week 104)|Adverse Event|36
2738643|NCT00094770|9405187|P1|Year 2 (Week 0 to Week 104)|Adverse Event|35
2738644|NCT00094770|9405186|P2|Year 1 ( Week 0 to Week 52)|Other|11
2738645|NCT00094770|9405187|P1|Year 1 ( Week 0 to Week 52)|Other|10
2738646|NCT00094770|9405186|P2|Year 1 ( Week 0 to Week 52)|Site Terminated|2
2738647|NCT00094770|9405187|P1|Year 1 ( Week 0 to Week 52)|Site Terminated|2
2738648|NCT00094770|9405186|P2|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28
2738649|NCT00094770|9405187|P1|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25
2738650|NCT00094770|9405186|P2|Year 1 ( Week 0 to Week 52)|Patient Moved|2
2738651|NCT00094770|9405187|P1|Year 1 ( Week 0 to Week 52)|Patient Moved|6
2738652|NCT00094770|9405186|P2|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25
2738653|NCT00094770|9405187|P1|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19
2738654|NCT00094770|9405186|P2|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
2738655|NCT00094770|9405187|P1|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
2738656|NCT00094770|9405186|P2|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10
2738657|NCT00094770|9405187|P1|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19
2738658|NCT00094770|9405186|P2|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58
2738659|NCT00094770|9405187|P1|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86
2738660|NCT00094770|9405186|P2|Year 1 ( Week 0 to Week 52)|Adverse Event|26
2738661|NCT00094770|9405187|P1|Year 1 ( Week 0 to Week 52)|Adverse Event|25
2738662|NCT00094757|9405218|P3|Overall Study|Protocol specified discontinuation|0
2738663|NCT00094757|9405219|P2|Overall Study|Protocol specified discontinuation|3
2738664|NCT00094757|9405220|P1|Overall Study|Protocol specified discontinuation|1
2738665|NCT00094757|9405218|P3|Overall Study|Other|1
2738666|NCT00094757|9405219|P2|Overall Study|Other|3
2738667|NCT00094757|9405220|P1|Overall Study|Other|3
2738668|NCT00094757|9405218|P3|Overall Study|Withdrawal by Subject|5
2738669|NCT00094757|9405219|P2|Overall Study|Withdrawal by Subject|21
2738670|NCT00094757|9405220|P1|Overall Study|Withdrawal by Subject|14
2738671|NCT00094757|9405218|P3|Overall Study|Protocol Violation|3
2738672|NCT00094757|9405219|P2|Overall Study|Protocol Violation|5
2738673|NCT00094757|9405220|P1|Overall Study|Protocol Violation|8
2738674|NCT00094757|9405218|P3|Overall Study|Patient Moved|1
2738675|NCT00094757|9405219|P2|Overall Study|Patient Moved|1
2738676|NCT00094757|9405220|P1|Overall Study|Patient Moved|2
2738677|NCT00094757|9405218|P3|Overall Study|Lost to Follow-up|6
2738678|NCT00094757|9405219|P2|Overall Study|Lost to Follow-up|5
2738679|NCT00094757|9405220|P1|Overall Study|Lost to Follow-up|3
2738680|NCT00094757|9405218|P3|Overall Study|Lack of Efficacy|8
2738681|NCT00094757|9405219|P2|Overall Study|Lack of Efficacy|15
2738682|NCT00094757|9405220|P1|Overall Study|Lack of Efficacy|11
2738683|NCT00094757|9405218|P3|Overall Study|Adverse Event|6
2738684|NCT00094757|9405219|P2|Overall Study|Adverse Event|9
2738685|NCT00094757|9405220|P1|Overall Study|Adverse Event|11
2738686|NCT00094653|9405240|P3|Overall Study|Protocol Violation|1
2738687|NCT00094653|9405241|P2|Overall Study|Protocol Violation|0
2738688|NCT00094653|9405242|P1|Overall Study|Protocol Violation|0
2738689|NCT00094653|9405240|P3|Overall Study|Lost to Follow-up|1
2738690|NCT00094653|9405241|P2|Overall Study|Lost to Follow-up|2
2738691|NCT00094653|9405242|P1|Overall Study|Lost to Follow-up|3
2738692|NCT00094653|9405240|P3|Overall Study|Other|2
2738693|NCT00094653|9405241|P2|Overall Study|Other|2
2738694|NCT00094653|9405242|P1|Overall Study|Other|2
2738695|NCT00094653|9405240|P3|Overall Study|Subject Withdrew Consent|3
2738696|NCT00094653|9405241|P2|Overall Study|Subject Withdrew Consent|2
2738697|NCT00094653|9405242|P1|Overall Study|Subject Withdrew Consent|10
2738698|NCT00094653|9405240|P3|Overall Study|Death|119
2738699|NCT00094653|9405241|P2|Overall Study|Death|100
2738700|NCT00094653|9405242|P1|Overall Study|Death|306
2738701|NCT00094575|9405305|P2|Overall Study|Death|146
2738702|NCT00094575|9405306|P1|Overall Study|Death|146
2738703|NCT00094536|9405326|P1|Treatment and Follow-up|Unable to attend visits|1
2738704|NCT00094536|9405326|P1|Treatment and Follow-up|Subject non-compliance|9
2738705|NCT00094536|9405326|P1|Treatment and Follow-up|Withdrawal by Subject|1
2738706|NCT00094536|9405326|P1|Treatment and Follow-up|Lost to Follow-up|7
2738707|NCT00094536|9405326|P1|Treatment and Follow-up|Lack of Efficacy|9
2738708|NCT00094536|9405326|P1|Treatment and Follow-up|Adverse Event|4
2738709|NCT00094536|9405326|P1|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24
2738710|NCT00094458|9405350|P6|OLE: Open-Label Extension|Patient decision|0
2738711|NCT00094458|9405351|P5|OLE: Open-Label Extension|Patient decision|1
2738712|NCT00094458|9405352|P4|OLE: Open-Label Extension|Patient decision|0
2738713|NCT00094458|9405353|P3|OLE: Open-Label Extension|Patient decision|0
2738714|NCT00094458|9405354|P2|OLE: Open-Label Extension|Patient decision|0
2738715|NCT00094458|9405355|P1|OLE: Open-Label Extension|Patient decision|0
2738716|NCT00094458|9405350|P6|OLE: Open-Label Extension|Inadequate therapeutic effect|0
2738717|NCT00094458|9405351|P5|OLE: Open-Label Extension|Inadequate therapeutic effect|1
2738718|NCT00094458|9405352|P4|OLE: Open-Label Extension|Inadequate therapeutic effect|1
2738719|NCT00094458|9405353|P3|OLE: Open-Label Extension|Inadequate therapeutic effect|0
2738720|NCT00094458|9405354|P2|OLE: Open-Label Extension|Inadequate therapeutic effect|0
2738721|NCT00094458|9405355|P1|OLE: Open-Label Extension|Inadequate therapeutic effect|0
2738722|NCT00094458|9405350|P6|OLE: Open-Label Extension|Adverse Event|4
2738723|NCT00094458|9405351|P5|OLE: Open-Label Extension|Adverse Event|3
2738724|NCT00094458|9405352|P4|OLE: Open-Label Extension|Adverse Event|0
2738725|NCT00094458|9405353|P3|OLE: Open-Label Extension|Adverse Event|0
2738726|NCT00094458|9405354|P2|OLE: Open-Label Extension|Adverse Event|0
2738727|NCT00094458|9405355|P1|OLE: Open-Label Extension|Adverse Event|0
2738728|NCT00094458|9405350|P6|Study Extension: Week 30 Through Week 50|Other|0
2738729|NCT00094458|9405351|P5|Study Extension: Week 30 Through Week 50|Other|0
2738730|NCT00094458|9405352|P4|Study Extension: Week 30 Through Week 50|Other|0
2738731|NCT00094458|9405353|P3|Study Extension: Week 30 Through Week 50|Other|3
2738732|NCT00094458|9405354|P2|Study Extension: Week 30 Through Week 50|Other|2
2738733|NCT00094458|9405355|P1|Study Extension: Week 30 Through Week 50|Other|1
2738734|NCT00094458|9405350|P6|Study Extension: Week 30 Through Week 50|Adverse Event|0
2738735|NCT00094458|9405351|P5|Study Extension: Week 30 Through Week 50|Adverse Event|0
2738736|NCT00094458|9405352|P4|Study Extension: Week 30 Through Week 50|Adverse Event|0
2738737|NCT00094458|9405353|P3|Study Extension: Week 30 Through Week 50|Adverse Event|7
2738738|NCT00094458|9405354|P2|Study Extension: Week 30 Through Week 50|Adverse Event|9
2738739|NCT00094458|9405355|P1|Study Extension: Week 30 Through Week 50|Adverse Event|3
2738740|NCT00094458|9405350|P6|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
2738741|NCT00094458|9405351|P5|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
2738742|NCT00094458|9405352|P4|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
2738743|NCT00094458|9405353|P3|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4
2738744|NCT00094458|9405354|P2|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
2738745|NCT00094458|9405355|P1|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2
2738746|NCT00094458|9405350|P6|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
2738747|NCT00094458|9405351|P5|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
2738748|NCT00094458|9405352|P4|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
2738749|NCT00094458|9405353|P3|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4
2738750|NCT00094458|9405354|P2|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1
2738751|NCT00094458|9405355|P1|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2
2738752|NCT00094458|9405350|P6|Main Study: Through Week 30|Other|0
2738753|NCT00094458|9405351|P5|Main Study: Through Week 30|Other|0
2738754|NCT00094458|9405352|P4|Main Study: Through Week 30|Other|0
2738755|NCT00094458|9405353|P3|Main Study: Through Week 30|Other|9
2738756|NCT00094458|9405354|P2|Main Study: Through Week 30|Other|16
2738757|NCT00094458|9405355|P1|Main Study: Through Week 30|Other|19
2738758|NCT00094458|9405350|P6|Main Study: Through Week 30|Death|0
2738759|NCT00094458|9405351|P5|Main Study: Through Week 30|Death|0
2738760|NCT00094458|9405352|P4|Main Study: Through Week 30|Death|0
2738761|NCT00094458|9405353|P3|Main Study: Through Week 30|Death|0
2738762|NCT00094458|9405354|P2|Main Study: Through Week 30|Death|0
2738763|NCT00094458|9405355|P1|Main Study: Through Week 30|Death|1
2738764|NCT00094458|9405350|P6|Main Study: Through Week 30|Adverse Event|0
2738765|NCT00094458|9405351|P5|Main Study: Through Week 30|Adverse Event|0
2738766|NCT00094458|9405352|P4|Main Study: Through Week 30|Adverse Event|0
2738767|NCT00094458|9405353|P3|Main Study: Through Week 30|Adverse Event|28
2738768|NCT00094458|9405354|P2|Main Study: Through Week 30|Adverse Event|20
2738769|NCT00094458|9405355|P1|Main Study: Through Week 30|Adverse Event|38
2738770|NCT00094458|9405350|P6|Main Study: Through Week 30|Withdrawal by Subject|0
2738771|NCT00094458|9405351|P5|Main Study: Through Week 30|Withdrawal by Subject|0
2738772|NCT00094458|9405352|P4|Main Study: Through Week 30|Withdrawal by Subject|0
2738773|NCT00094458|9405353|P3|Main Study: Through Week 30|Withdrawal by Subject|7
2738774|NCT00094458|9405354|P2|Main Study: Through Week 30|Withdrawal by Subject|9
2738775|NCT00094458|9405355|P1|Main Study: Through Week 30|Withdrawal by Subject|18
2738776|NCT00094458|9405350|P6|Main Study: Through Week 30|Lost to Follow-up|0
2738777|NCT00094458|9405351|P5|Main Study: Through Week 30|Lost to Follow-up|0
2738778|NCT00094458|9405352|P4|Main Study: Through Week 30|Lost to Follow-up|0
2738779|NCT00094458|9405353|P3|Main Study: Through Week 30|Lost to Follow-up|2
2738780|NCT00094458|9405354|P2|Main Study: Through Week 30|Lost to Follow-up|5
2738781|NCT00094458|9405355|P1|Main Study: Through Week 30|Lost to Follow-up|5
2738782|NCT00094458|9405350|P6|Main Study: Through Week 30|Eligibility criteria not met|0
2738783|NCT00094458|9405351|P5|Main Study: Through Week 30|Eligibility criteria not met|0
2738784|NCT00094458|9405352|P4|Main Study: Through Week 30|Eligibility criteria not met|0
2738785|NCT00094458|9405353|P3|Main Study: Through Week 30|Eligibility criteria not met|2
2738786|NCT00094458|9405354|P2|Main Study: Through Week 30|Eligibility criteria not met|8
2738787|NCT00094458|9405355|P1|Main Study: Through Week 30|Eligibility criteria not met|3
2738788|NCT00094328|9405393|P1|Overall Study|Lost to Follow-up|1
2738789|NCT00094302|9405407|P2|Overall Study|Death|246
2738790|NCT00094302|9405408|P1|Overall Study|Death|266
2738791|NCT00094302|9405407|P2|Overall Study|Withdrawal by Subject|111
2738792|NCT00094302|9405408|P1|Overall Study|Withdrawal by Subject|103
2738793|NCT00094302|9405407|P2|Overall Study|Physician Decision|8
2738794|NCT00094302|9405408|P1|Overall Study|Physician Decision|5
2738795|NCT00094302|9405407|P2|Overall Study|Lost to Follow-up|41
2738796|NCT00094302|9405408|P1|Overall Study|Lost to Follow-up|43
2738797|NCT00094172|9405497|P2|Overall Study|Started other MS therapy due to disease|0
2738798|NCT00094172|9405498|P1|Overall Study|Started other MS therapy due to disease|1
2738799|NCT00094172|9405497|P2|Overall Study|Primary endpoint met.|0
2738800|NCT00094172|9405498|P1|Overall Study|Primary endpoint met.|1
2738801|NCT00094172|9405497|P2|Overall Study|Withdrawal by Subject|5
2738802|NCT00094172|9405498|P1|Overall Study|Withdrawal by Subject|10
2738803|NCT00094172|9405497|P2|Overall Study|Protocol Violation|1
2738804|NCT00094172|9405498|P1|Overall Study|Protocol Violation|0
2738805|NCT00094172|9405497|P2|Overall Study|Lost to Follow-up|0
2738806|NCT00094172|9405498|P1|Overall Study|Lost to Follow-up|2
2738807|NCT00094172|9405497|P2|Overall Study|Adverse Event|1
2738808|NCT00094172|9405498|P1|Overall Study|Adverse Event|0
2738809|NCT00094107|9405508|P1|Overall Study|Withdrawal due to Disease Progression|1
2738810|NCT00094107|9405508|P1|Overall Study|Adverse Event|3
2738811|NCT00094107|9405508|P1|Overall Study|Death|5
2738812|NCT00094107|9405508|P1|Overall Study|Lack of Efficacy|23
2738813|NCT00094094|9405517|P1|Overall Study|Adverse Event|7
2738814|NCT00094094|9405517|P1|Overall Study|Lack of Efficacy|23
2738815|NCT00094094|9405517|P1|Overall Study|Death|2
2738816|NCT00094055|9405526|P1|Overall Study|Withdrawal by Subject|9
2738817|NCT00094055|9405526|P1|Overall Study|roll-over to another study|14
2738818|NCT00094055|9405526|P1|Overall Study|clinical progression|1
2738819|NCT00094055|9405526|P1|Overall Study|progressive disease|2
2738820|NCT00094055|9405526|P1|Overall Study|Lost to Follow-up|2
2738821|NCT00094055|9405526|P1|Overall Study|Lack of Efficacy|17
2738822|NCT00094055|9405526|P1|Overall Study|Death|4
2738823|NCT00094055|9405526|P1|Overall Study|Adverse Event|11
2738824|NCT00093808|9405583|P1|Overall Study|Protocol Violation|1
2738825|NCT00093808|9405583|P1|Overall Study|Cancel participation before receiving tx|1
2738826|NCT00093795|9405593|P3|Overall Study|No follow up data|17
2738827|NCT00093795|9405594|P2|Overall Study|No follow up data|16
2738828|NCT00093795|9405595|P1|Overall Study|No follow up data|20
2738829|NCT00093496|9405640|P2|Overall Study|Protocol Violation|3
2738830|NCT00093496|9405641|P1|Overall Study|Protocol Violation|1
2738831|NCT00093470|9405654|P2|Overall Study|ANC < 1000 on day 1 of cycle 1|0
2738832|NCT00093470|9405655|P1|Overall Study|ANC < 1000 on day 1 of cycle 1|1
2738833|NCT00093470|9405654|P2|Overall Study|Never started treatment|0
2738834|NCT00093470|9405655|P1|Overall Study|Never started treatment|1
2738835|NCT00093470|9405654|P2|Overall Study|Physician Decision|0
2738836|NCT00093470|9405655|P1|Overall Study|Physician Decision|2
2738837|NCT00093470|9405654|P2|Overall Study|Other complicating disease|0
2738838|NCT00093470|9405655|P1|Overall Study|Other complicating disease|3
2738839|NCT00093470|9405654|P2|Overall Study|Alternative therapy|0
2738840|NCT00093470|9405655|P1|Overall Study|Alternative therapy|2
2738841|NCT00093470|9405654|P2|Overall Study|Withdrawal by Subject|0
2738842|NCT00093470|9405655|P1|Overall Study|Withdrawal by Subject|8
2738843|NCT00093470|9405654|P2|Overall Study|Death|0
2738844|NCT00093470|9405655|P1|Overall Study|Death|2
2738845|NCT00093470|9405654|P2|Overall Study|Adverse Event|0
2738846|NCT00093470|9405655|P1|Overall Study|Adverse Event|15
2738847|NCT00093470|9405654|P2|Overall Study|Disease progression|0
2738848|NCT00093470|9405655|P1|Overall Study|Disease progression|39
2738849|NCT00093145|9405669|P1|Overall Study|Other|1
2738850|NCT00093145|9405669|P1|Overall Study|Withdrawal by Subject|9
2738851|NCT00093145|9405669|P1|Overall Study|Physician Decision|5
2738852|NCT00093145|9405669|P1|Overall Study|Unacceptable Toxicity Only|2
2738853|NCT00093015|9405711|P2|Overall Study|Death|385
2738854|NCT00093015|9405712|P1|Overall Study|Death|375
2738855|NCT00093015|9405711|P2|Overall Study|Lost to Follow-up|108
2738856|NCT00093015|9405712|P1|Overall Study|Lost to Follow-up|96
2738857|NCT00093015|9405711|P2|Overall Study|Withdrawal by Subject|171
2738858|NCT00093015|9405712|P1|Overall Study|Withdrawal by Subject|194
2738859|NCT00092677|9405740|P2|Overall Study|Adminstrative|9
2738860|NCT00092677|9405741|P1|Overall Study|Adminstrative|5
2738861|NCT00092677|9405740|P2|Overall Study|Lost to Follow-up|2
2738862|NCT00092677|9405741|P1|Overall Study|Lost to Follow-up|0
2738863|NCT00092547|9405785|P3|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
2738864|NCT00092547|9405786|P2|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
2738865|NCT00092547|9405787|P1|Long-term Follow-up (Month 42 Visit)|Adverse Event|1
2738866|NCT00092547|9405785|P3|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7
2738867|NCT00092547|9405786|P2|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0
2738868|NCT00092547|9405787|P1|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14
2738869|NCT00092547|9405785|P3|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9
2738870|NCT00092547|9405786|P2|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0
2738871|NCT00092547|9405787|P1|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6
2738872|NCT00092547|9405785|P3|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
2738873|NCT00092547|9405786|P2|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
2738874|NCT00092547|9405787|P1|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3
2738875|NCT00092547|9405785|P3|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
2738876|NCT00092547|9405786|P2|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
2738877|NCT00092547|9405787|P1|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1
2738878|NCT00092547|9405785|P3|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
2738879|NCT00092547|9405786|P2|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
2738880|NCT00092547|9405787|P1|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2
2738881|NCT00092547|9405785|P3|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0
2738882|NCT00092547|9405786|P2|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3
2738883|NCT00092547|9405787|P1|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1
2738884|NCT00092547|9405785|P3|Base Follow-up Phase (Month 18 to 30)|Subject moved|0
2738885|NCT00092547|9405786|P2|Base Follow-up Phase (Month 18 to 30)|Subject moved|2
2738886|NCT00092547|9405787|P1|Base Follow-up Phase (Month 18 to 30)|Subject moved|4
2738887|NCT00092547|9405785|P3|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
2738888|NCT00092547|9405786|P2|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
2738889|NCT00092547|9405787|P1|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1
2738890|NCT00092547|9405785|P3|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
2738891|NCT00092547|9405786|P2|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
2738892|NCT00092547|9405787|P1|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1
2738893|NCT00092547|9405785|P3|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0
2738894|NCT00092547|9405786|P2|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7
2738895|NCT00092547|9405787|P1|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13
2738896|NCT00092547|9405785|P3|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0
2738897|NCT00092547|9405786|P2|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2
2738898|NCT00092547|9405787|P1|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4
2738899|NCT00092547|9405785|P3|Base Follow-up Phase (Month 7 to 18)|Subject moved|0
2738900|NCT00092547|9405786|P2|Base Follow-up Phase (Month 7 to 18)|Subject moved|5
2738901|NCT00092547|9405787|P1|Base Follow-up Phase (Month 7 to 18)|Subject moved|1
2738902|NCT00092547|9405785|P3|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0
2738903|NCT00092547|9405786|P2|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3
2738904|NCT00092547|9405787|P1|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5
2738905|NCT00092547|9405785|P3|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
2738906|NCT00092547|9405786|P2|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1
2738907|NCT00092547|9405787|P1|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
2738908|NCT00092547|9405785|P3|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
2738909|NCT00092547|9405786|P2|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1
2738910|NCT00092547|9405787|P1|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
2738911|NCT00092547|9405785|P3|Base Vaccine Phase (Day 1 to Month 7)|Moved|0
2738912|NCT00092547|9405786|P2|Base Vaccine Phase (Day 1 to Month 7)|Moved|1
2738913|NCT00092547|9405787|P1|Base Vaccine Phase (Day 1 to Month 7)|Moved|3
2738914|NCT00092547|9405785|P3|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0
2738915|NCT00092547|9405786|P2|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21
2738916|NCT00092547|9405787|P1|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28
2738917|NCT00092547|9405785|P3|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0
2738918|NCT00092547|9405786|P2|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7
2738919|NCT00092547|9405787|P1|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18
2738920|NCT00092547|9405785|P3|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0
2738921|NCT00092547|9405786|P2|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1
2738922|NCT00092547|9405787|P1|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4
2738923|NCT00092547|9405785|P3|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0
2738924|NCT00092547|9405786|P2|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1
2738925|NCT00092547|9405787|P1|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5
2738926|NCT00092534|9405831|P5|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
2738927|NCT00092534|9405832|P4|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1
2738928|NCT00092534|9405833|P3|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
2738929|NCT00092534|9405834|P2|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
2738930|NCT00092534|9405835|P1|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
2738931|NCT00092534|9405831|P5|Base Study EXT|Protocol Violation|0
2738932|NCT00092534|9405832|P4|Base Study EXT|Protocol Violation|0
2738933|NCT00092534|9405833|P3|Base Study EXT|Protocol Violation|15
2738934|NCT00092534|9405834|P2|Base Study EXT|Protocol Violation|0
2738935|NCT00092534|9405835|P1|Base Study EXT|Protocol Violation|0
2738936|NCT00092534|9405831|P5|Base Study EXT|Study ended|0
2738937|NCT00092534|9405832|P4|Base Study EXT|Study ended|0
2738938|NCT00092534|9405833|P3|Base Study EXT|Study ended|29
2738939|NCT00092534|9405834|P2|Base Study EXT|Study ended|0
2738940|NCT00092534|9405835|P1|Base Study EXT|Study ended|0
2738941|NCT00092534|9405831|P5|Base Study EXT|Site closed|0
2738942|NCT00092534|9405832|P4|Base Study EXT|Site closed|0
2738943|NCT00092534|9405833|P3|Base Study EXT|Site closed|21
2738944|NCT00092534|9405834|P2|Base Study EXT|Site closed|0
2738945|NCT00092534|9405835|P1|Base Study EXT|Site closed|0
2738946|NCT00092534|9405831|P5|Base Study EXT|Travel|0
2738947|NCT00092534|9405832|P4|Base Study EXT|Travel|0
2738948|NCT00092534|9405833|P3|Base Study EXT|Travel|2
2738949|NCT00092534|9405834|P2|Base Study EXT|Travel|0
2738950|NCT00092534|9405835|P1|Base Study EXT|Travel|0
2738951|NCT00092534|9405831|P5|Base Study EXT|Participant moved|0
2738952|NCT00092534|9405832|P4|Base Study EXT|Participant moved|0
2738953|NCT00092534|9405833|P3|Base Study EXT|Participant moved|6
2738954|NCT00092534|9405834|P2|Base Study EXT|Participant moved|0
2738955|NCT00092534|9405835|P1|Base Study EXT|Participant moved|0
2738956|NCT00092534|9405831|P5|Base Study EXT|Withdrawal by Subject|0
2738957|NCT00092534|9405832|P4|Base Study EXT|Withdrawal by Subject|0
2738958|NCT00092534|9405833|P3|Base Study EXT|Withdrawal by Subject|18
2738959|NCT00092534|9405834|P2|Base Study EXT|Withdrawal by Subject|0
2738960|NCT00092534|9405835|P1|Base Study EXT|Withdrawal by Subject|0
2738961|NCT00092534|9405831|P5|Base Study EXT|Pregnancy|0
2738962|NCT00092534|9405832|P4|Base Study EXT|Pregnancy|0
2738963|NCT00092534|9405833|P3|Base Study EXT|Pregnancy|12
2738964|NCT00092534|9405834|P2|Base Study EXT|Pregnancy|0
2738965|NCT00092534|9405835|P1|Base Study EXT|Pregnancy|0
2738966|NCT00092534|9405831|P5|Base Study EXT|Physician Decision|0
2738967|NCT00092534|9405832|P4|Base Study EXT|Physician Decision|0
2738968|NCT00092534|9405833|P3|Base Study EXT|Physician Decision|1
2738969|NCT00092534|9405834|P2|Base Study EXT|Physician Decision|0
2738970|NCT00092534|9405835|P1|Base Study EXT|Physician Decision|0
2738971|NCT00092534|9405831|P5|Base Study EXT|Lost to Follow-up|0
2738972|NCT00092534|9405832|P4|Base Study EXT|Lost to Follow-up|0
2738973|NCT00092534|9405833|P3|Base Study EXT|Lost to Follow-up|41
2738974|NCT00092534|9405834|P2|Base Study EXT|Lost to Follow-up|0
2738975|NCT00092534|9405835|P1|Base Study EXT|Lost to Follow-up|0
2738976|NCT00092534|9405831|P5|Base Study Follow-Up Period|Subjects in extension|0
2738977|NCT00092534|9405832|P4|Base Study Follow-Up Period|Subjects in extension|0
2738978|NCT00092534|9405833|P3|Base Study Follow-Up Period|Subjects in extension|0
2738979|NCT00092534|9405834|P2|Base Study Follow-Up Period|Subjects in extension|371
2738980|NCT00092534|9405835|P1|Base Study Follow-Up Period|Subjects in extension|15
2738981|NCT00092534|9405831|P5|Base Study Follow-Up Period|Subjects continuing|0
2738982|NCT00092534|9405832|P4|Base Study Follow-Up Period|Subjects continuing|0
2738983|NCT00092534|9405833|P3|Base Study Follow-Up Period|Subjects continuing|0
2738984|NCT00092534|9405834|P2|Base Study Follow-Up Period|Subjects continuing|31
2738985|NCT00092534|9405835|P1|Base Study Follow-Up Period|Subjects continuing|27
2738986|NCT00092534|9405831|P5|Base Study Follow-Up Period|Site Closed|0
2738987|NCT00092534|9405832|P4|Base Study Follow-Up Period|Site Closed|0
2738988|NCT00092534|9405833|P3|Base Study Follow-Up Period|Site Closed|0
2738989|NCT00092534|9405834|P2|Base Study Follow-Up Period|Site Closed|2
2738990|NCT00092534|9405835|P1|Base Study Follow-Up Period|Site Closed|0
2738991|NCT00092534|9405831|P5|Base Study Follow-Up Period|Travel|0
2738992|NCT00092534|9405832|P4|Base Study Follow-Up Period|Travel|0
2738993|NCT00092534|9405833|P3|Base Study Follow-Up Period|Travel|0
2738994|NCT00092534|9405834|P2|Base Study Follow-Up Period|Travel|7
2738995|NCT00092534|9405835|P1|Base Study Follow-Up Period|Travel|10
2738996|NCT00092534|9405831|P5|Base Study Follow-Up Period|Moved|0
2738997|NCT00092534|9405832|P4|Base Study Follow-Up Period|Moved|0
2738998|NCT00092534|9405833|P3|Base Study Follow-Up Period|Moved|0
2738999|NCT00092534|9405834|P2|Base Study Follow-Up Period|Moved|58
2739000|NCT00092534|9405835|P1|Base Study Follow-Up Period|Moved|62
2739001|NCT00092534|9405831|P5|Base Study Follow-Up Period|Withdrawal by Subject|0
2739002|NCT00092534|9405832|P4|Base Study Follow-Up Period|Withdrawal by Subject|0
2739003|NCT00092534|9405833|P3|Base Study Follow-Up Period|Withdrawal by Subject|0
2739004|NCT00092534|9405834|P2|Base Study Follow-Up Period|Withdrawal by Subject|62
2739005|NCT00092534|9405835|P1|Base Study Follow-Up Period|Withdrawal by Subject|71
2739006|NCT00092534|9405831|P5|Base Study Follow-Up Period|Protocol Violation|0
2739007|NCT00092534|9405832|P4|Base Study Follow-Up Period|Protocol Violation|0
2739008|NCT00092534|9405833|P3|Base Study Follow-Up Period|Protocol Violation|0
2739009|NCT00092534|9405834|P2|Base Study Follow-Up Period|Protocol Violation|2
2739010|NCT00092534|9405835|P1|Base Study Follow-Up Period|Protocol Violation|1
2739011|NCT00092534|9405831|P5|Base Study Follow-Up Period|Pregnancy|0
2739012|NCT00092534|9405832|P4|Base Study Follow-Up Period|Pregnancy|0
2739013|NCT00092534|9405833|P3|Base Study Follow-Up Period|Pregnancy|0
2739014|NCT00092534|9405834|P2|Base Study Follow-Up Period|Pregnancy|10
2739015|NCT00092534|9405835|P1|Base Study Follow-Up Period|Pregnancy|6
2739016|NCT00092534|9405831|P5|Base Study Follow-Up Period|Lost to Follow-up|0
2739017|NCT00092534|9405832|P4|Base Study Follow-Up Period|Lost to Follow-up|0
2739018|NCT00092534|9405833|P3|Base Study Follow-Up Period|Lost to Follow-up|0
2739019|NCT00092534|9405834|P2|Base Study Follow-Up Period|Lost to Follow-up|146
2739020|NCT00092534|9405835|P1|Base Study Follow-Up Period|Lost to Follow-up|120
2739021|NCT00092534|9405831|P5|Base Study Follow-Up Period|Death|0
2739022|NCT00092534|9405832|P4|Base Study Follow-Up Period|Death|0
2739023|NCT00092534|9405833|P3|Base Study Follow-Up Period|Death|0
2739024|NCT00092534|9405834|P2|Base Study Follow-Up Period|Death|1
2739025|NCT00092534|9405835|P1|Base Study Follow-Up Period|Death|2
2739026|NCT00092534|9405831|P5|Base Study Follow-Up Period|Adverse Event|0
2739027|NCT00092534|9405832|P4|Base Study Follow-Up Period|Adverse Event|0
2739028|NCT00092534|9405833|P3|Base Study Follow-Up Period|Adverse Event|0
2739029|NCT00092534|9405834|P2|Base Study Follow-Up Period|Adverse Event|4
2739030|NCT00092534|9405835|P1|Base Study Follow-Up Period|Adverse Event|2
2739031|NCT00092534|9405831|P5|Base Study Vaccination Period|Site Closed|0
2739032|NCT00092534|9405832|P4|Base Study Vaccination Period|Site Closed|0
2739033|NCT00092534|9405833|P3|Base Study Vaccination Period|Site Closed|0
2739034|NCT00092534|9405834|P2|Base Study Vaccination Period|Site Closed|1
2739035|NCT00092534|9405835|P1|Base Study Vaccination Period|Site Closed|0
2739036|NCT00092534|9405831|P5|Base Study Vaccination Period|Travel|0
2739037|NCT00092534|9405832|P4|Base Study Vaccination Period|Travel|0
2739038|NCT00092534|9405833|P3|Base Study Vaccination Period|Travel|0
2739039|NCT00092534|9405834|P2|Base Study Vaccination Period|Travel|0
2739040|NCT00092534|9405835|P1|Base Study Vaccination Period|Travel|1
2739041|NCT00092534|9405831|P5|Base Study Vaccination Period|New Medical History (Not AEs)|0
2739042|NCT00092534|9405832|P4|Base Study Vaccination Period|New Medical History (Not AEs)|0
2739043|NCT00092534|9405833|P3|Base Study Vaccination Period|New Medical History (Not AEs)|0
2739044|NCT00092534|9405834|P2|Base Study Vaccination Period|New Medical History (Not AEs)|0
2739045|NCT00092534|9405835|P1|Base Study Vaccination Period|New Medical History (Not AEs)|5
2739046|NCT00092534|9405831|P5|Base Study Vaccination Period|Moved|0
2739047|NCT00092534|9405832|P4|Base Study Vaccination Period|Moved|0
2739048|NCT00092534|9405833|P3|Base Study Vaccination Period|Moved|0
2739049|NCT00092534|9405834|P2|Base Study Vaccination Period|Moved|12
2739050|NCT00092534|9405835|P1|Base Study Vaccination Period|Moved|14
2739051|NCT00092534|9405831|P5|Base Study Vaccination Period|Withdrawal by Subject|0
2739052|NCT00092534|9405832|P4|Base Study Vaccination Period|Withdrawal by Subject|0
2739053|NCT00092534|9405833|P3|Base Study Vaccination Period|Withdrawal by Subject|0
2739054|NCT00092534|9405834|P2|Base Study Vaccination Period|Withdrawal by Subject|58
2739055|NCT00092534|9405835|P1|Base Study Vaccination Period|Withdrawal by Subject|85
2739056|NCT00092534|9405831|P5|Base Study Vaccination Period|Protocol Violation|0
2739057|NCT00092534|9405832|P4|Base Study Vaccination Period|Protocol Violation|0
2739058|NCT00092534|9405833|P3|Base Study Vaccination Period|Protocol Violation|0
2739059|NCT00092534|9405834|P2|Base Study Vaccination Period|Protocol Violation|1
2739060|NCT00092534|9405835|P1|Base Study Vaccination Period|Protocol Violation|2
2739061|NCT00092534|9405831|P5|Base Study Vaccination Period|Pregnancy|0
2739062|NCT00092534|9405832|P4|Base Study Vaccination Period|Pregnancy|0
2739063|NCT00092534|9405833|P3|Base Study Vaccination Period|Pregnancy|0
2739064|NCT00092534|9405834|P2|Base Study Vaccination Period|Pregnancy|7
2739065|NCT00092534|9405835|P1|Base Study Vaccination Period|Pregnancy|9
2739066|NCT00092534|9405831|P5|Base Study Vaccination Period|Physician Decision|0
2739067|NCT00092534|9405832|P4|Base Study Vaccination Period|Physician Decision|0
2739068|NCT00092534|9405833|P3|Base Study Vaccination Period|Physician Decision|0
2739069|NCT00092534|9405834|P2|Base Study Vaccination Period|Physician Decision|0
2739070|NCT00092534|9405835|P1|Base Study Vaccination Period|Physician Decision|1
2739071|NCT00092534|9405831|P5|Base Study Vaccination Period|Lost to Follow-up|0
2739072|NCT00092534|9405832|P4|Base Study Vaccination Period|Lost to Follow-up|0
2739073|NCT00092534|9405833|P3|Base Study Vaccination Period|Lost to Follow-up|0
2739074|NCT00092534|9405834|P2|Base Study Vaccination Period|Lost to Follow-up|37
2739075|NCT00092534|9405835|P1|Base Study Vaccination Period|Lost to Follow-up|41
2739076|NCT00092534|9405831|P5|Base Study Vaccination Period|Death|0
2739077|NCT00092534|9405832|P4|Base Study Vaccination Period|Death|0
2739078|NCT00092534|9405833|P3|Base Study Vaccination Period|Death|0
2739079|NCT00092534|9405834|P2|Base Study Vaccination Period|Death|4
2739080|NCT00092534|9405835|P1|Base Study Vaccination Period|Death|5
2739081|NCT00092534|9405831|P5|Base Study Vaccination Period|Adverse Event|0
2739082|NCT00092534|9405832|P4|Base Study Vaccination Period|Adverse Event|0
2739083|NCT00092534|9405833|P3|Base Study Vaccination Period|Adverse Event|0
2739084|NCT00092534|9405834|P2|Base Study Vaccination Period|Adverse Event|1
2739085|NCT00092534|9405835|P1|Base Study Vaccination Period|Adverse Event|3
2739086|NCT00092534|9405831|P5|Base Study Vaccination Period|Randomized not Vaccinated|0
2739087|NCT00092534|9405832|P4|Base Study Vaccination Period|Randomized not Vaccinated|0
2739088|NCT00092534|9405833|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
2739089|NCT00092534|9405834|P2|Base Study Vaccination Period|Randomized not Vaccinated|5
2739090|NCT00092534|9405835|P1|Base Study Vaccination Period|Randomized not Vaccinated|5
2739091|NCT00092521|9405866|P4|Extension Study (Group 4)|Unable/unwilling to return|25
2739092|NCT00092521|9405867|P3|Extension Study (Group 4)|Unable/unwilling to return|0
2739093|NCT00092521|9405868|P2|Extension Study (Group 4)|Unable/unwilling to return|0
2739094|NCT00092521|9405869|P1|Extension Study (Group 4)|Unable/unwilling to return|0
2739095|NCT00092521|9405866|P4|Extension Study (Group 4)|Site Terminated|4
2739096|NCT00092521|9405867|P3|Extension Study (Group 4)|Site Terminated|0
2739097|NCT00092521|9405868|P2|Extension Study (Group 4)|Site Terminated|0
2739098|NCT00092521|9405869|P1|Extension Study (Group 4)|Site Terminated|0
2739099|NCT00092521|9405866|P4|Extension Study (Group 4)|Moved|16
2739100|NCT00092521|9405867|P3|Extension Study (Group 4)|Moved|0
2739101|NCT00092521|9405868|P2|Extension Study (Group 4)|Moved|0
2739102|NCT00092521|9405869|P1|Extension Study (Group 4)|Moved|0
2739103|NCT00092521|9405866|P4|Extension Study (Group 4)|Withdrawal by Subject|46
2739104|NCT00092521|9405867|P3|Extension Study (Group 4)|Withdrawal by Subject|0
2739105|NCT00092521|9405868|P2|Extension Study (Group 4)|Withdrawal by Subject|0
2739106|NCT00092521|9405869|P1|Extension Study (Group 4)|Withdrawal by Subject|0
2739107|NCT00092521|9405866|P4|Extension Study (Group 4)|Protocol Violation|2
2739108|NCT00092521|9405867|P3|Extension Study (Group 4)|Protocol Violation|0
2739109|NCT00092521|9405868|P2|Extension Study (Group 4)|Protocol Violation|0
2739110|NCT00092521|9405869|P1|Extension Study (Group 4)|Protocol Violation|0
2739111|NCT00092521|9405866|P4|Extension Study (Group 4)|Pregnancy|4
2739112|NCT00092521|9405867|P3|Extension Study (Group 4)|Pregnancy|0
2739113|NCT00092521|9405868|P2|Extension Study (Group 4)|Pregnancy|0
2739114|NCT00092521|9405869|P1|Extension Study (Group 4)|Pregnancy|0
2739115|NCT00092521|9405866|P4|Extension Study (Group 4)|Lost to Follow-up|87
2739116|NCT00092521|9405867|P3|Extension Study (Group 4)|Lost to Follow-up|0
2739117|NCT00092521|9405868|P2|Extension Study (Group 4)|Lost to Follow-up|0
2739118|NCT00092521|9405869|P1|Extension Study (Group 4)|Lost to Follow-up|0
2739119|NCT00092521|9405866|P4|Extension Study (Group 4)|Adverse Event|2
2739120|NCT00092521|9405867|P3|Extension Study (Group 4)|Adverse Event|0
2739121|NCT00092521|9405868|P2|Extension Study (Group 4)|Adverse Event|0
2739122|NCT00092521|9405869|P1|Extension Study (Group 4)|Adverse Event|0
2739123|NCT00092521|9405866|P4|Extension Study (Group 4)|Excluded ineligible for extension|23
2739124|NCT00092521|9405867|P3|Extension Study (Group 4)|Excluded ineligible for extension|0
2739125|NCT00092521|9405868|P2|Extension Study (Group 4)|Excluded ineligible for extension|0
2739126|NCT00092521|9405869|P1|Extension Study (Group 4)|Excluded ineligible for extension|0
2739127|NCT00092521|9405866|P4|Follow-Up (After Month 7)|Visits Compressed|0
2739128|NCT00092521|9405867|P3|Follow-Up (After Month 7)|Visits Compressed|5
2739129|NCT00092521|9405868|P2|Follow-Up (After Month 7)|Visits Compressed|0
2739130|NCT00092521|9405869|P1|Follow-Up (After Month 7)|Visits Compressed|5
2739131|NCT00092521|9405866|P4|Follow-Up (After Month 7)|Travel|0
2739132|NCT00092521|9405867|P3|Follow-Up (After Month 7)|Travel|0
2739133|NCT00092521|9405868|P2|Follow-Up (After Month 7)|Travel|0
2739134|NCT00092521|9405869|P1|Follow-Up (After Month 7)|Travel|2
2739135|NCT00092521|9405866|P4|Follow-Up (After Month 7)|Site Terminated|0
2739136|NCT00092521|9405867|P3|Follow-Up (After Month 7)|Site Terminated|3
2739137|NCT00092521|9405868|P2|Follow-Up (After Month 7)|Site Terminated|0
2739138|NCT00092521|9405869|P1|Follow-Up (After Month 7)|Site Terminated|3
2739139|NCT00092521|9405866|P4|Follow-Up (After Month 7)|Moved|0
2739140|NCT00092521|9405867|P3|Follow-Up (After Month 7)|Moved|28
2739141|NCT00092521|9405868|P2|Follow-Up (After Month 7)|Moved|2
2739142|NCT00092521|9405869|P1|Follow-Up (After Month 7)|Moved|32
2739143|NCT00092521|9405866|P4|Follow-Up (After Month 7)|Withdrawal by Subject|0
2739144|NCT00092521|9405867|P3|Follow-Up (After Month 7)|Withdrawal by Subject|51
2739145|NCT00092521|9405868|P2|Follow-Up (After Month 7)|Withdrawal by Subject|6
2739146|NCT00092521|9405869|P1|Follow-Up (After Month 7)|Withdrawal by Subject|40
2739147|NCT00092521|9405866|P4|Follow-Up (After Month 7)|Protocol Violation|0
2739148|NCT00092521|9405867|P3|Follow-Up (After Month 7)|Protocol Violation|5
2739149|NCT00092521|9405868|P2|Follow-Up (After Month 7)|Protocol Violation|1
2739150|NCT00092521|9405869|P1|Follow-Up (After Month 7)|Protocol Violation|1
2739151|NCT00092521|9405866|P4|Follow-Up (After Month 7)|Lost to Follow-up|0
2739152|NCT00092521|9405867|P3|Follow-Up (After Month 7)|Lost to Follow-up|108
2739153|NCT00092521|9405868|P2|Follow-Up (After Month 7)|Lost to Follow-up|14
2739154|NCT00092521|9405869|P1|Follow-Up (After Month 7)|Lost to Follow-up|113
2739155|NCT00092521|9405866|P4|Follow-Up (After Month 7)|Death|0
2739156|NCT00092521|9405867|P3|Follow-Up (After Month 7)|Death|1
2739157|NCT00092521|9405868|P2|Follow-Up (After Month 7)|Death|0
2739158|NCT00092521|9405869|P1|Follow-Up (After Month 7)|Death|2
2739159|NCT00092521|9405866|P4|Follow-Up (After Month 7)|Adverse Event|0
2739160|NCT00092521|9405867|P3|Follow-Up (After Month 7)|Adverse Event|0
2739161|NCT00092521|9405868|P2|Follow-Up (After Month 7)|Adverse Event|0
2739162|NCT00092521|9405869|P1|Follow-Up (After Month 7)|Adverse Event|1
2739163|NCT00092521|9405866|P4|Follow-Up (After Month 7)|Subjects in Extension|0
2739164|NCT00092521|9405867|P3|Follow-Up (After Month 7)|Subjects in Extension|412
2739165|NCT00092521|9405868|P2|Follow-Up (After Month 7)|Subjects in Extension|109
2739166|NCT00092521|9405869|P1|Follow-Up (After Month 7)|Subjects in Extension|13
2739167|NCT00092521|9405866|P4|Follow-Up (After Month 7)|Subjects Continuing|0
2739168|NCT00092521|9405867|P3|Follow-Up (After Month 7)|Subjects Continuing|35
2739169|NCT00092521|9405868|P2|Follow-Up (After Month 7)|Subjects Continuing|4
2739170|NCT00092521|9405869|P1|Follow-Up (After Month 7)|Subjects Continuing|34
2739171|NCT00092521|9405866|P4|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
2739172|NCT00092521|9405867|P3|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
2739173|NCT00092521|9405868|P2|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
2739174|NCT00092521|9405869|P1|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2
2739175|NCT00092521|9405866|P4|Vaccination (Day 1 Through Month 7)|Unblinded|0
2739176|NCT00092521|9405867|P3|Vaccination (Day 1 Through Month 7)|Unblinded|0
2739177|NCT00092521|9405868|P2|Vaccination (Day 1 Through Month 7)|Unblinded|0
2739178|NCT00092521|9405869|P1|Vaccination (Day 1 Through Month 7)|Unblinded|2
2739179|NCT00092521|9405866|P4|Vaccination (Day 1 Through Month 7)|Moved|0
2739180|NCT00092521|9405867|P3|Vaccination (Day 1 Through Month 7)|Moved|18
2739181|NCT00092521|9405868|P2|Vaccination (Day 1 Through Month 7)|Moved|1
2739182|NCT00092521|9405869|P1|Vaccination (Day 1 Through Month 7)|Moved|14
2739183|NCT00092521|9405866|P4|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0
2739184|NCT00092521|9405867|P3|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62
2739185|NCT00092521|9405868|P2|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7
2739186|NCT00092521|9405869|P1|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59
2739187|NCT00092521|9405866|P4|Vaccination (Day 1 Through Month 7)|Pregnancy|0
2739188|NCT00092521|9405867|P3|Vaccination (Day 1 Through Month 7)|Pregnancy|7
2739189|NCT00092521|9405868|P2|Vaccination (Day 1 Through Month 7)|Pregnancy|0
2739190|NCT00092521|9405869|P1|Vaccination (Day 1 Through Month 7)|Pregnancy|5
2739191|NCT00092521|9405866|P4|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0
2739192|NCT00092521|9405867|P3|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44
2739193|NCT00092521|9405868|P2|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6
2739194|NCT00092521|9405869|P1|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51
2739195|NCT00092521|9405866|P4|Vaccination (Day 1 Through Month 7)|Death|0
2739196|NCT00092521|9405867|P3|Vaccination (Day 1 Through Month 7)|Death|1
2739197|NCT00092521|9405868|P2|Vaccination (Day 1 Through Month 7)|Death|0
2739198|NCT00092521|9405869|P1|Vaccination (Day 1 Through Month 7)|Death|0
2739199|NCT00092521|9405866|P4|Vaccination (Day 1 Through Month 7)|Adverse Event|0
2739200|NCT00092521|9405867|P3|Vaccination (Day 1 Through Month 7)|Adverse Event|7
2739201|NCT00092521|9405868|P2|Vaccination (Day 1 Through Month 7)|Adverse Event|0
2739202|NCT00092521|9405869|P1|Vaccination (Day 1 Through Month 7)|Adverse Event|1
2739203|NCT00092521|9405866|P4|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
2739204|NCT00092521|9405867|P3|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7
2739205|NCT00092521|9405868|P2|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
2739206|NCT00092521|9405869|P1|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6
2739207|NCT00092495|9405883|P5|Base Study Follow-up Period|Withdrawal by Subject|0
2739208|NCT00092495|9405884|P4|Base Study Follow-up Period|Withdrawal by Subject|0
2739209|NCT00092495|9405885|P3|Base Study Follow-up Period|Withdrawal by Subject|0
2739290|NCT00092456|9405956|P1|Overall Study|Other|4
2739210|NCT00092495|9405886|P2|Base Study Follow-up Period|Withdrawal by Subject|0
2739211|NCT00092495|9405887|P1|Base Study Follow-up Period|Withdrawal by Subject|2
2739212|NCT00092495|9405883|P5|Base Study Follow-up Period|Lost to Follow-up|0
2739213|NCT00092495|9405884|P4|Base Study Follow-up Period|Lost to Follow-up|12
2739214|NCT00092495|9405885|P3|Base Study Follow-up Period|Lost to Follow-up|3
2739215|NCT00092495|9405886|P2|Base Study Follow-up Period|Lost to Follow-up|3
2739216|NCT00092495|9405887|P1|Base Study Follow-up Period|Lost to Follow-up|1
2739217|NCT00092495|9405883|P5|Base Study Follow-up Period|Extended|0
2739218|NCT00092495|9405884|P4|Base Study Follow-up Period|Extended|2
2739219|NCT00092495|9405885|P3|Base Study Follow-up Period|Extended|1
2739220|NCT00092495|9405886|P2|Base Study Follow-up Period|Extended|0
2739221|NCT00092495|9405887|P1|Base Study Follow-up Period|Extended|0
2739222|NCT00092495|9405883|P5|Base Study Vaccination Period|Withdrawal by Subject|0
2739223|NCT00092495|9405884|P4|Base Study Vaccination Period|Withdrawal by Subject|25
2739224|NCT00092495|9405885|P3|Base Study Vaccination Period|Withdrawal by Subject|14
2739225|NCT00092495|9405886|P2|Base Study Vaccination Period|Withdrawal by Subject|10
2739226|NCT00092495|9405887|P1|Base Study Vaccination Period|Withdrawal by Subject|9
2739227|NCT00092495|9405883|P5|Base Study Vaccination Period|Protocol Violation|0
2739228|NCT00092495|9405884|P4|Base Study Vaccination Period|Protocol Violation|0
2739229|NCT00092495|9405885|P3|Base Study Vaccination Period|Protocol Violation|0
2739230|NCT00092495|9405886|P2|Base Study Vaccination Period|Protocol Violation|0
2739231|NCT00092495|9405887|P1|Base Study Vaccination Period|Protocol Violation|1
2739232|NCT00092495|9405883|P5|Base Study Vaccination Period|Parent Withdrew Consent|0
2739233|NCT00092495|9405884|P4|Base Study Vaccination Period|Parent Withdrew Consent|5
2739234|NCT00092495|9405885|P3|Base Study Vaccination Period|Parent Withdrew Consent|1
2739235|NCT00092495|9405886|P2|Base Study Vaccination Period|Parent Withdrew Consent|1
2739236|NCT00092495|9405887|P1|Base Study Vaccination Period|Parent Withdrew Consent|1
2739237|NCT00092495|9405883|P5|Base Study Vaccination Period|Pregnancy|0
2739238|NCT00092495|9405884|P4|Base Study Vaccination Period|Pregnancy|0
2739239|NCT00092495|9405885|P3|Base Study Vaccination Period|Pregnancy|0
2739240|NCT00092495|9405886|P2|Base Study Vaccination Period|Pregnancy|0
2739241|NCT00092495|9405887|P1|Base Study Vaccination Period|Pregnancy|2
2739242|NCT00092495|9405883|P5|Base Study Vaccination Period|Other|0
2739243|NCT00092495|9405884|P4|Base Study Vaccination Period|Other|2
2739244|NCT00092495|9405885|P3|Base Study Vaccination Period|Other|0
2739245|NCT00092495|9405886|P2|Base Study Vaccination Period|Other|1
2739246|NCT00092495|9405887|P1|Base Study Vaccination Period|Other|1
2739247|NCT00092495|9405883|P5|Base Study Vaccination Period|Moved|0
2739248|NCT00092495|9405884|P4|Base Study Vaccination Period|Moved|2
2739249|NCT00092495|9405885|P3|Base Study Vaccination Period|Moved|2
2739250|NCT00092495|9405886|P2|Base Study Vaccination Period|Moved|1
2739251|NCT00092495|9405887|P1|Base Study Vaccination Period|Moved|3
2739252|NCT00092495|9405883|P5|Base Study Vaccination Period|Lost to Follow-up|0
2739253|NCT00092495|9405884|P4|Base Study Vaccination Period|Lost to Follow-up|36
2739254|NCT00092495|9405885|P3|Base Study Vaccination Period|Lost to Follow-up|11
2739255|NCT00092495|9405886|P2|Base Study Vaccination Period|Lost to Follow-up|6
2739256|NCT00092495|9405887|P1|Base Study Vaccination Period|Lost to Follow-up|16
2739257|NCT00092495|9405883|P5|Base Study Vaccination Period|Adverse Event|0
2739258|NCT00092495|9405884|P4|Base Study Vaccination Period|Adverse Event|3
2739259|NCT00092495|9405885|P3|Base Study Vaccination Period|Adverse Event|0
2739260|NCT00092495|9405886|P2|Base Study Vaccination Period|Adverse Event|0
2739261|NCT00092495|9405887|P1|Base Study Vaccination Period|Adverse Event|1
2739262|NCT00092495|9405883|P5|Base Study Vaccination Period|*Pregnancy|0
2739263|NCT00092495|9405884|P4|Base Study Vaccination Period|*Pregnancy|7
2739264|NCT00092495|9405885|P3|Base Study Vaccination Period|*Pregnancy|5
2739265|NCT00092495|9405886|P2|Base Study Vaccination Period|*Pregnancy|2
2739266|NCT00092495|9405887|P1|Base Study Vaccination Period|*Pregnancy|0
2739267|NCT00092495|9405883|P5|Base Study Vaccination Period|*Other reasons|0
2739268|NCT00092495|9405884|P4|Base Study Vaccination Period|*Other reasons|1
2739269|NCT00092495|9405885|P3|Base Study Vaccination Period|*Other reasons|0
2739270|NCT00092495|9405886|P2|Base Study Vaccination Period|*Other reasons|0
2739271|NCT00092495|9405887|P1|Base Study Vaccination Period|*Other reasons|1
2739272|NCT00092495|9405883|P5|Base Study Vaccination Period|*Clinical AE|0
2739273|NCT00092495|9405884|P4|Base Study Vaccination Period|*Clinical AE|2
2739274|NCT00092495|9405885|P3|Base Study Vaccination Period|*Clinical AE|1
2739275|NCT00092495|9405886|P2|Base Study Vaccination Period|*Clinical AE|0
2739276|NCT00092495|9405887|P1|Base Study Vaccination Period|*Clinical AE|1
2739277|NCT00092495|9405883|P5|Base Study Vaccination Period|Extended|0
2739278|NCT00092495|9405884|P4|Base Study Vaccination Period|Extended|1
2739279|NCT00092495|9405885|P3|Base Study Vaccination Period|Extended|0
2739280|NCT00092495|9405886|P2|Base Study Vaccination Period|Extended|0
2739281|NCT00092495|9405887|P1|Base Study Vaccination Period|Extended|0
2739282|NCT00092495|9405883|P5|Base Study Vaccination Period|Randomized Not Vaccinated|0
2739283|NCT00092495|9405884|P4|Base Study Vaccination Period|Randomized Not Vaccinated|4
2739284|NCT00092495|9405885|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
2739285|NCT00092495|9405886|P2|Base Study Vaccination Period|Randomized Not Vaccinated|1
2739286|NCT00092495|9405887|P1|Base Study Vaccination Period|Randomized Not Vaccinated|1
2739287|NCT00092456|9405953|P4|Overall Study|Other|0
2739288|NCT00092456|9405954|P3|Overall Study|Other|3
2739289|NCT00092456|9405955|P2|Overall Study|Other|2
2739291|NCT00092456|9405953|P4|Overall Study|Moved|1
2739292|NCT00092456|9405954|P3|Overall Study|Moved|0
2739293|NCT00092456|9405955|P2|Overall Study|Moved|1
2739294|NCT00092456|9405956|P1|Overall Study|Moved|1
2739295|NCT00092456|9405953|P4|Overall Study|Withdrawal by Subject|6
2739296|NCT00092456|9405954|P3|Overall Study|Withdrawal by Subject|16
2739297|NCT00092456|9405955|P2|Overall Study|Withdrawal by Subject|5
2739298|NCT00092456|9405956|P1|Overall Study|Withdrawal by Subject|13
2739299|NCT00092456|9405953|P4|Overall Study|Protocol Violation|6
2739300|NCT00092456|9405954|P3|Overall Study|Protocol Violation|8
2739301|NCT00092456|9405955|P2|Overall Study|Protocol Violation|7
2739302|NCT00092456|9405956|P1|Overall Study|Protocol Violation|5
2739303|NCT00092456|9405953|P4|Overall Study|Lost to Follow-up|2
2739304|NCT00092456|9405954|P3|Overall Study|Lost to Follow-up|1
2739305|NCT00092456|9405955|P2|Overall Study|Lost to Follow-up|2
2739306|NCT00092456|9405956|P1|Overall Study|Lost to Follow-up|2
2739307|NCT00092456|9405953|P4|Overall Study|Adverse Event|1
2739308|NCT00092456|9405954|P3|Overall Study|Adverse Event|1
2739309|NCT00092456|9405955|P2|Overall Study|Adverse Event|0
2739310|NCT00092456|9405956|P1|Overall Study|Adverse Event|0
2739311|NCT00092443|9406004|P2|Overall Study|Other|13
2739312|NCT00092443|9406005|P1|Overall Study|Other|17
2739313|NCT00092443|9406004|P2|Overall Study|Moved|5
2739314|NCT00092443|9406005|P1|Overall Study|Moved|5
2739315|NCT00092443|9406004|P2|Overall Study|Withdrawal by Subject|11
2739316|NCT00092443|9406005|P1|Overall Study|Withdrawal by Subject|9
2739317|NCT00092443|9406004|P2|Overall Study|Protocol Violation|9
2739318|NCT00092443|9406005|P1|Overall Study|Protocol Violation|11
2739319|NCT00092443|9406004|P2|Overall Study|Lost to Follow-up|3
2739320|NCT00092443|9406005|P1|Overall Study|Lost to Follow-up|7
2739321|NCT00092443|9406004|P2|Overall Study|Adverse Event|13
2739322|NCT00092443|9406005|P1|Overall Study|Adverse Event|9
2739323|NCT00092417|9406023|P2|Overall Study|Other|0
2739324|NCT00092417|9406024|P1|Overall Study|Other|1
2739325|NCT00092417|9406023|P2|Overall Study|Withdrawal by Subject|1
2739326|NCT00092417|9406024|P1|Overall Study|Withdrawal by Subject|2
2739327|NCT00092417|9406023|P2|Overall Study|Lost to Follow-up|0
2739328|NCT00092417|9406024|P1|Overall Study|Lost to Follow-up|2
2739329|NCT00092131|9406038|P2|Treatment Period II|Adverse Event|1
2739330|NCT00092131|9406039|P1|Treatment Period II|Adverse Event|0
2739331|NCT00092131|9406038|P2|Treatment Period I|Adverse Event|0
2739332|NCT00092131|9406039|P1|Treatment Period I|Adverse Event|1
2739333|NCT00092118|9406069|P2|Overall Study|Other|5
2739334|NCT00092118|9406070|P1|Overall Study|Other|6
2739335|NCT00092118|9406069|P2|Overall Study|Withdrawal by Subject|10
2739336|NCT00092118|9406070|P1|Overall Study|Withdrawal by Subject|4
2739337|NCT00092118|9406069|P2|Overall Study|Protocol Violation|25
2739338|NCT00092118|9406070|P1|Overall Study|Protocol Violation|23
2739339|NCT00092118|9406069|P2|Overall Study|Lost to Follow-up|3
2739340|NCT00092118|9406070|P1|Overall Study|Lost to Follow-up|4
2739341|NCT00092118|9406069|P2|Overall Study|Lack of Efficacy|14
2739342|NCT00092118|9406070|P1|Overall Study|Lack of Efficacy|12
2739343|NCT00092118|9406069|P2|Overall Study|Adverse Event|32
2739344|NCT00092118|9406070|P1|Overall Study|Adverse Event|35
2739345|NCT00091949|9406104|P2|Overall Study|Lost to Follow-up|41
2739346|NCT00091949|9406105|P1|Overall Study|Lost to Follow-up|58
2739347|NCT00091949|9406104|P2|Overall Study|Withdrawal by Subject|110
2739348|NCT00091949|9406105|P1|Overall Study|Withdrawal by Subject|117
2739349|NCT00091832|9406129|P6|Overall Study|Protocol Violation|1
2739350|NCT00091832|9406130|P5|Overall Study|Protocol Violation|0
2739351|NCT00091832|9406131|P4|Overall Study|Protocol Violation|0
2739352|NCT00091832|9406132|P3|Overall Study|Protocol Violation|1
2739353|NCT00091832|9406133|P2|Overall Study|Protocol Violation|0
2739354|NCT00091832|9406134|P1|Overall Study|Protocol Violation|0
2739355|NCT00091832|9406129|P6|Overall Study|Other|0
2739356|NCT00091832|9406130|P5|Overall Study|Other|0
2739357|NCT00091832|9406131|P4|Overall Study|Other|0
2739358|NCT00091832|9406132|P3|Overall Study|Other|2
2739359|NCT00091832|9406133|P2|Overall Study|Other|1
2739360|NCT00091832|9406134|P1|Overall Study|Other|0
2739361|NCT00091832|9406129|P6|Overall Study|Noncompliance|0
2739362|NCT00091832|9406130|P5|Overall Study|Noncompliance|0
2739363|NCT00091832|9406131|P4|Overall Study|Noncompliance|0
2739364|NCT00091832|9406132|P3|Overall Study|Noncompliance|0
2739365|NCT00091832|9406133|P2|Overall Study|Noncompliance|1
2739366|NCT00091832|9406134|P1|Overall Study|Noncompliance|0
2739367|NCT00091832|9406129|P6|Overall Study|Lost to Follow-up|1
2739368|NCT00091832|9406130|P5|Overall Study|Lost to Follow-up|2
2739369|NCT00091832|9406131|P4|Overall Study|Lost to Follow-up|3
2739370|NCT00091832|9406132|P3|Overall Study|Lost to Follow-up|3
2739371|NCT00091832|9406133|P2|Overall Study|Lost to Follow-up|0
2739372|NCT00091832|9406134|P1|Overall Study|Lost to Follow-up|1
2739373|NCT00091832|9406129|P6|Overall Study|Ineligibility Determined|0
2739374|NCT00091832|9406130|P5|Overall Study|Ineligibility Determined|1
2739375|NCT00091832|9406131|P4|Overall Study|Ineligibility Determined|0
2739376|NCT00091832|9406132|P3|Overall Study|Ineligibility Determined|1
2739377|NCT00091832|9406133|P2|Overall Study|Ineligibility Determined|0
2739378|NCT00091832|9406134|P1|Overall Study|Ineligibility Determined|0
2739379|NCT00091832|9406129|P6|Overall Study|Disease Progression|2
2739380|NCT00091832|9406130|P5|Overall Study|Disease Progression|1
2739381|NCT00091832|9406131|P4|Overall Study|Disease Progression|1
2739382|NCT00091832|9406132|P3|Overall Study|Disease Progression|0
2739383|NCT00091832|9406133|P2|Overall Study|Disease Progression|0
2739384|NCT00091832|9406134|P1|Overall Study|Disease Progression|2
2739385|NCT00091832|9406129|P6|Overall Study|Death|6
2739386|NCT00091832|9406130|P5|Overall Study|Death|5
2739387|NCT00091832|9406131|P4|Overall Study|Death|8
2739388|NCT00091832|9406132|P3|Overall Study|Death|5
2739389|NCT00091832|9406133|P2|Overall Study|Death|4
2739390|NCT00091832|9406134|P1|Overall Study|Death|6
2739391|NCT00091832|9406129|P6|Overall Study|Withdrawal by Subject|1
2739392|NCT00091832|9406130|P5|Overall Study|Withdrawal by Subject|3
2739393|NCT00091832|9406131|P4|Overall Study|Withdrawal by Subject|1
2739394|NCT00091832|9406132|P3|Overall Study|Withdrawal by Subject|0
2739395|NCT00091832|9406133|P2|Overall Study|Withdrawal by Subject|5
2739396|NCT00091832|9406134|P1|Overall Study|Withdrawal by Subject|4
2739397|NCT00091832|9406129|P6|Overall Study|Adverse Event|0
2739398|NCT00091832|9406130|P5|Overall Study|Adverse Event|3
2739399|NCT00091832|9406131|P4|Overall Study|Adverse Event|1
2739400|NCT00091832|9406132|P3|Overall Study|Adverse Event|0
2739401|NCT00091832|9406133|P2|Overall Study|Adverse Event|0
2739402|NCT00091832|9406134|P1|Overall Study|Adverse Event|0
2739403|NCT00091832|9406129|P6|Overall Study|Physician Decision|0
2739404|NCT00091832|9406130|P5|Overall Study|Physician Decision|0
2739405|NCT00091832|9406131|P4|Overall Study|Physician Decision|0
2739406|NCT00091832|9406132|P3|Overall Study|Physician Decision|0
2739407|NCT00091832|9406133|P2|Overall Study|Physician Decision|0
2739408|NCT00091832|9406134|P1|Overall Study|Physician Decision|1
2739409|NCT00091819|9406252|P2|Overall Study|Never received study treatment|4
2739410|NCT00091819|9406253|P1|Overall Study|Never received study treatment|3
2739411|NCT00091819|9406252|P2|Overall Study|Other|3
2739412|NCT00091819|9406253|P1|Overall Study|Other|2
2739413|NCT00091819|9406252|P2|Overall Study|Protocol Violation|2
2739414|NCT00091819|9406253|P1|Overall Study|Protocol Violation|1
2739415|NCT00091819|9406252|P2|Overall Study|Withdrawal by Subject|8
2739416|NCT00091819|9406253|P1|Overall Study|Withdrawal by Subject|5
2739417|NCT00091819|9406252|P2|Overall Study|Lost to Follow-up|23
2739418|NCT00091819|9406253|P1|Overall Study|Lost to Follow-up|26
2739419|NCT00091819|9406252|P2|Overall Study|Death|5
2739420|NCT00091819|9406253|P1|Overall Study|Death|4
2739421|NCT00091819|9406252|P2|Overall Study|Adverse Event|1
2739422|NCT00091819|9406253|P1|Overall Study|Adverse Event|1
2739423|NCT00091793|9406261|P2|Overall Study|Other|0
2739424|NCT00091793|9406262|P1|Overall Study|Other|2
2739425|NCT00091793|9406261|P2|Overall Study|Noncompliance|0
2739426|NCT00091793|9406262|P1|Overall Study|Noncompliance|2
2739427|NCT00091793|9406261|P2|Overall Study|Lost to Follow-up|5
2739428|NCT00091793|9406262|P1|Overall Study|Lost to Follow-up|7
2739429|NCT00091793|9406261|P2|Overall Study|Ineligibility determined|0
2739430|NCT00091793|9406262|P1|Overall Study|Ineligibility determined|2
2739431|NCT00091793|9406261|P2|Overall Study|Withdrawal by Subject|15
2739432|NCT00091793|9406262|P1|Overall Study|Withdrawal by Subject|10
2739433|NCT00091793|9406261|P2|Overall Study|Adverse Event|2
2739434|NCT00091793|9406262|P1|Overall Study|Adverse Event|1
2739435|NCT00091572|9406286|P2|Overall Study|Toxicity (Related AE)|9
2739436|NCT00091572|9406287|P1|Overall Study|Toxicity (Related AE)|53
2739437|NCT00091572|9406286|P2|Overall Study|Major Protocol Violation|0
2739438|NCT00091572|9406287|P1|Overall Study|Major Protocol Violation|2
2739439|NCT00091572|9406286|P2|Overall Study|Ongoing (still on treatment)|12
2739440|NCT00091572|9406287|P1|Overall Study|Ongoing (still on treatment)|8
2739441|NCT00091572|9406286|P2|Overall Study|Other Reason|13
2739442|NCT00091572|9406287|P1|Overall Study|Other Reason|6
2739443|NCT00091572|9406286|P2|Overall Study|Medical Decision unrelated toxicity/PD|22
2739444|NCT00091572|9406287|P1|Overall Study|Medical Decision unrelated toxicity/PD|10
2739445|NCT00091572|9406286|P2|Overall Study|Death not due to malignancy/toxicity|3
2739446|NCT00091572|9406287|P1|Overall Study|Death not due to malignancy/toxicity|1
2739447|NCT00091572|9406286|P2|Overall Study|Subject's Refusal unrelated to toxicity|22
2739448|NCT00091572|9406287|P1|Overall Study|Subject's Refusal unrelated to toxicity|14
2739449|NCT00091572|9406286|P2|Overall Study|Lost to Follow-up|1
2739450|NCT00091572|9406287|P1|Overall Study|Lost to Follow-up|1
2739451|NCT00091442|9406318|P2|Overall Study|Other|6
2739452|NCT00091442|9406319|P1|Overall Study|Other|2
2739453|NCT00091442|9406318|P2|Overall Study|Lost to Follow-up|3
2739454|NCT00091442|9406319|P1|Overall Study|Lost to Follow-up|1
2739455|NCT00091442|9406318|P2|Overall Study|Death|7
2739456|NCT00091442|9406319|P1|Overall Study|Death|9
2739457|NCT00091442|9406318|P2|Overall Study|2cycles therapy beyond Complete response|16
2739458|NCT00091442|9406319|P1|Overall Study|2cycles therapy beyond Complete response|9
2739459|NCT00091442|9406318|P2|Overall Study|Adverse Event|48
2739460|NCT00091442|9406319|P1|Overall Study|Adverse Event|29
2739461|NCT00091442|9406318|P2|Overall Study|Withdrawal by Subject|46
2739462|NCT00091442|9406319|P1|Overall Study|Withdrawal by Subject|38
2739463|NCT00091442|9406318|P2|Overall Study|Physician Decision|58
2739464|NCT00091442|9406319|P1|Overall Study|Physician Decision|61
2739465|NCT00091442|9406318|P2|Overall Study|Progressive Disease|189
2739466|NCT00091442|9406319|P1|Overall Study|Progressive Disease|220
2739467|NCT00091390|9406329|P1|Overall Study|Protocol Violation|2
2739468|NCT00091390|9406329|P1|Overall Study|Withdrawal by Subject|2
2739469|NCT00091169|9406347|P2|Overall Study|Not start protocol therapy|17
2739470|NCT00091169|9406348|P1|Overall Study|Not start protocol therapy|26
2739471|NCT00091169|9406347|P2|Overall Study|Other|4
2739472|NCT00091169|9406348|P1|Overall Study|Other|3
2739473|NCT00091169|9406347|P2|Overall Study|Withdrawal by Subject|13
2739474|NCT00091169|9406348|P1|Overall Study|Withdrawal by Subject|10
2739475|NCT00091169|9406347|P2|Overall Study|Death|1
2739476|NCT00091169|9406348|P1|Overall Study|Death|4
2739477|NCT00091169|9406347|P2|Overall Study|Adverse Event|17
2739478|NCT00091169|9406348|P1|Overall Study|Adverse Event|11
2739479|NCT00091169|9406347|P2|Overall Study|Disease progression|1
2739480|NCT00091169|9406348|P1|Overall Study|Disease progression|3
2739481|NCT00091026|9406366|P2|Overall Study|Unknown-never received treatment|1
2739482|NCT00091026|9406367|P1|Overall Study|Unknown-never received treatment|0
2739483|NCT00091026|9406366|P2|Overall Study|Patient withdrew and never received trea|2
2739484|NCT00091026|9406367|P1|Overall Study|Patient withdrew and never received trea|0
2739485|NCT00091026|9406366|P2|Overall Study|Patient deemed non eligible-never receiv|0
2739486|NCT00091026|9406367|P1|Overall Study|Patient deemed non eligible-never receiv|1
2739487|NCT00090987|9406377|P1|Overall Study|Incarcerated|1
2739488|NCT00090987|9406377|P1|Overall Study|Non-compliance|4
2739489|NCT00090987|9406377|P1|Overall Study|alternative therapy|1
2739490|NCT00090987|9406377|P1|Overall Study|Withdrawal by Subject|3
2739491|NCT00090987|9406377|P1|Overall Study|Lack of Efficacy|7
2739492|NCT00090987|9406377|P1|Overall Study|Adverse Event|5
2739493|NCT00090857|9406390|P2|Overall Study|Adverse Event|2
2739494|NCT00090857|9406391|P1|Overall Study|Adverse Event|2
2739495|NCT00090857|9406390|P2|Overall Study|Withdrawal by Subject|0
2739496|NCT00090857|9406391|P1|Overall Study|Withdrawal by Subject|2
2739497|NCT00090857|9406390|P2|Overall Study|Lost to Follow-up|1
2739498|NCT00090857|9406391|P1|Overall Study|Lost to Follow-up|0
2739499|NCT00090779|9406430|P2|Step 3|Off extended study due to study closure|3
2739500|NCT00090779|9406431|P1|Step 3|Off extended study due to study closure|4
2739501|NCT00090779|9406430|P2|Step 3|Initiation of ART and off extended study|2
2739502|NCT00090779|9406431|P1|Step 3|Initiation of ART and off extended study|3
2739503|NCT00090779|9406430|P2|Step 2|Non-compliance to study requirements|1
2739504|NCT00090779|9406431|P1|Step 2|Non-compliance to study requirements|0
2739505|NCT00090779|9406430|P2|Step 2|Subject relocated|1
2739506|NCT00090779|9406431|P1|Step 2|Subject relocated|0
2739507|NCT00090779|9406430|P2|Step 2|Off study per study closure|16
2739508|NCT00090779|9406431|P1|Step 2|Off study per study closure|6
2739509|NCT00090779|9406430|P2|Step 1|Subject relocated|8
2739510|NCT00090779|9406431|P1|Step 1|Subject relocated|2
2739511|NCT00090779|9406430|P2|Step 1|Non-compliance to study requirements|1
2739512|NCT00090779|9406431|P1|Step 1|Non-compliance to study requirements|0
2739513|NCT00090779|9406430|P2|Step 1|Pregnancy|0
2739514|NCT00090779|9406431|P1|Step 1|Pregnancy|1
2739515|NCT00090779|9406430|P2|Step 1|Physician Decision|0
2739516|NCT00090779|9406431|P1|Step 1|Physician Decision|1
2739517|NCT00090779|9406430|P2|Step 1|Death|2
2739518|NCT00090779|9406431|P1|Step 1|Death|0
2739519|NCT00090779|9406430|P2|Step 1|Lost to Follow-up|2
2739520|NCT00090779|9406431|P1|Step 1|Lost to Follow-up|3
2739521|NCT00090779|9406430|P2|Step 1|Withdrawal by Subject|2
2739522|NCT00090779|9406431|P1|Step 1|Withdrawal by Subject|4
2739523|NCT00090766|9406455|P3|Overall Study|Lost to Follow-up|2
2739524|NCT00090766|9406456|P2|Overall Study|Lost to Follow-up|0
2739525|NCT00090766|9406457|P1|Overall Study|Lost to Follow-up|2
2739526|NCT00090766|9406455|P3|Overall Study|Admin|0
2739527|NCT00090766|9406456|P2|Overall Study|Admin|2
2739528|NCT00090766|9406457|P1|Overall Study|Admin|0
2739529|NCT00090766|9406455|P3|Overall Study|Death|0
2739530|NCT00090766|9406456|P2|Overall Study|Death|0
2739531|NCT00090766|9406457|P1|Overall Study|Death|1
2739532|NCT00090766|9406455|P3|Overall Study|Nephrectomy Planned|1
2739533|NCT00090766|9406456|P2|Overall Study|Nephrectomy Planned|0
2739534|NCT00090766|9406457|P1|Overall Study|Nephrectomy Planned|0
2739535|NCT00090753|9406499|P2|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43
2739536|NCT00090753|9406500|P1|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65
2739537|NCT00090753|9406499|P2|Extended Treatment Period|Mircera Commercialization|93
2739538|NCT00090753|9406500|P1|Extended Treatment Period|Mircera Commercialization|188
2739539|NCT00090753|9406499|P2|Extended Treatment Period|Renal Transplant|12
2739540|NCT00090753|9406500|P1|Extended Treatment Period|Renal Transplant|15
2739541|NCT00090753|9406499|P2|Extended Treatment Period|Lost to Follow-up|1
2739542|NCT00090753|9406500|P1|Extended Treatment Period|Lost to Follow-up|3
2739543|NCT00090753|9406499|P2|Extended Treatment Period|Refused Treatment|12
2739544|NCT00090753|9406500|P1|Extended Treatment Period|Refused Treatment|18
2739545|NCT00090753|9406499|P2|Extended Treatment Period|Lack of Efficacy|0
2739546|NCT00090753|9406500|P1|Extended Treatment Period|Lack of Efficacy|1
2739547|NCT00090753|9406499|P2|Extended Treatment Period|Death|30
2739548|NCT00090753|9406500|P1|Extended Treatment Period|Death|58
2739549|NCT00090753|9406499|P2|Extended Treatment Period|Adverse Event|0
2739550|NCT00090753|9406500|P1|Extended Treatment Period|Adverse Event|11
2739551|NCT00090753|9406499|P2|First Treatment Period|Other Unrelated to Safety and Efficacy|28
2739552|NCT00090753|9406500|P1|First Treatment Period|Other Unrelated to Safety and Efficacy|39
2739553|NCT00090753|9406499|P2|First Treatment Period|Mircera Commercialization|0
2739554|NCT00090753|9406500|P1|First Treatment Period|Mircera Commercialization|1
2739555|NCT00090753|9406499|P2|First Treatment Period|Renal Transplant|50
2739556|NCT00090753|9406500|P1|First Treatment Period|Renal Transplant|70
2739557|NCT00090753|9406499|P2|First Treatment Period|Lost to Follow-up|4
2739558|NCT00090753|9406500|P1|First Treatment Period|Lost to Follow-up|4
2739559|NCT00090753|9406499|P2|First Treatment Period|Refused Treatment|25
2739560|NCT00090753|9406500|P1|First Treatment Period|Refused Treatment|32
2739561|NCT00090753|9406499|P2|First Treatment Period|Lack of Efficacy|1
2739562|NCT00090753|9406500|P1|First Treatment Period|Lack of Efficacy|2
2739563|NCT00090753|9406499|P2|First Treatment Period|Death|62
2739564|NCT00090753|9406500|P1|First Treatment Period|Death|88
2739565|NCT00090753|9406499|P2|First Treatment Period|Adverse Event|8
2739566|NCT00090753|9406500|P1|First Treatment Period|Adverse Event|20
2739567|NCT00090610|9406510|P2|Overall Study|Withdrawal by Subject|1
2739568|NCT00090610|9406511|P1|Overall Study|Withdrawal by Subject|1
2739569|NCT00090584|9406527|P2|Baseline to 8 Months|Lost to Follow-up|41
2739570|NCT00090584|9406528|P1|Baseline to 8 Months|Lost to Follow-up|44
2739571|NCT00090584|9406527|P2|Baseline to 10 Weeks|Lost to Follow-up|12
2739572|NCT00090584|9406528|P1|Baseline to 10 Weeks|Lost to Follow-up|15
2739573|NCT00090519|9406560|P2|Overall Study|Sponsor Decision|1
2739574|NCT00090519|9406561|P1|Overall Study|Sponsor Decision|3
2739575|NCT00090519|9406560|P2|Overall Study|Physician Decision|3
2739576|NCT00090519|9406561|P1|Overall Study|Physician Decision|2
2739577|NCT00090519|9406560|P2|Overall Study|Withdrawal by Subject|29
2739578|NCT00090519|9406561|P1|Overall Study|Withdrawal by Subject|28
2739579|NCT00090519|9406560|P2|Overall Study|Lost to Follow-up|29
2739580|NCT00090519|9406561|P1|Overall Study|Lost to Follow-up|26
2739581|NCT00090519|9406560|P2|Overall Study|Death|9
2739582|NCT00090519|9406561|P1|Overall Study|Death|9
2739583|NCT00090519|9406560|P2|Overall Study|Adverse Event|4
2739584|NCT00090519|9406561|P1|Overall Study|Adverse Event|5
2739585|NCT00090493|9406585|P1|Overall Study|Physician Decision|2
2739586|NCT00090363|9406592|P3|Overall Study|Continuing on study off treatment|16
2739587|NCT00090363|9406593|P2|Overall Study|Continuing on study off treatment|13
2739588|NCT00090363|9406594|P1|Overall Study|Continuing on study off treatment|14
2739589|NCT00090363|9406592|P3|Overall Study|Reasons not specified|1
2739590|NCT00090363|9406593|P2|Overall Study|Reasons not specified|1
2739591|NCT00090363|9406594|P1|Overall Study|Reasons not specified|2
2739592|NCT00090363|9406592|P3|Overall Study|Consent expired|9
2739593|NCT00090363|9406593|P2|Overall Study|Consent expired|10
2739594|NCT00090363|9406594|P1|Overall Study|Consent expired|7
2739595|NCT00090363|9406592|P3|Overall Study|Eligibility criteria not fulfilled|1
2739596|NCT00090363|9406593|P2|Overall Study|Eligibility criteria not fulfilled|0
2739597|NCT00090363|9406594|P1|Overall Study|Eligibility criteria not fulfilled|0
2739598|NCT00090363|9406592|P3|Overall Study|Study-specific discontinuation criteria|62
2739599|NCT00090363|9406593|P2|Overall Study|Study-specific discontinuation criteria|74
2739600|NCT00090363|9406594|P1|Overall Study|Study-specific discontinuation criteria|75
2739601|NCT00090363|9406592|P3|Overall Study|Withdrawal by Subject|6
2739602|NCT00090363|9406593|P2|Overall Study|Withdrawal by Subject|7
2739603|NCT00090363|9406594|P1|Overall Study|Withdrawal by Subject|7
2739604|NCT00090363|9406592|P3|Overall Study|Lost to Follow-up|1
2739605|NCT00090363|9406593|P2|Overall Study|Lost to Follow-up|2
2739606|NCT00090363|9406594|P1|Overall Study|Lost to Follow-up|1
2739607|NCT00090545|9406616|P2|Overall Study|Adverse Event|2
2739608|NCT00090545|9406617|P1|Overall Study|Adverse Event|0
2739609|NCT00090545|9406616|P2|Overall Study|Death|1
2739610|NCT00090545|9406617|P1|Overall Study|Death|0
2739611|NCT00090545|9406616|P2|Overall Study|Refused further treatment|4
2739612|NCT00090545|9406617|P1|Overall Study|Refused further treatment|1
2739613|NCT00090545|9406616|P2|Overall Study|Disease progression on study|17
2739614|NCT00090545|9406617|P1|Overall Study|Disease progression on study|21
2739615|NCT00090285|9406637|P6|Long-term Follow-up (EXT2)|Physician Decision|5
2739616|NCT00090285|9406638|P5|Long-term Follow-up (EXT2)|Physician Decision|6
2739617|NCT00090285|9406639|P4|Long-term Follow-up (EXT2)|Physician Decision|0
2739618|NCT00090285|9406640|P3|Long-term Follow-up (EXT2)|Physician Decision|0
2739619|NCT00090285|9406641|P2|Long-term Follow-up (EXT2)|Physician Decision|0
2739620|NCT00090285|9406642|P1|Long-term Follow-up (EXT2)|Physician Decision|0
2739621|NCT00090285|9406637|P6|Long-term Follow-up (EXT2)|Withdrawal by Subject|53
2739622|NCT00090285|9406638|P5|Long-term Follow-up (EXT2)|Withdrawal by Subject|60
2739623|NCT00090285|9406639|P4|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
2739624|NCT00090285|9406640|P3|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
2739625|NCT00090285|9406641|P2|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
2739626|NCT00090285|9406642|P1|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
2739627|NCT00090285|9406637|P6|Long-term Follow-up (EXT2)|Lost to Follow-up|143
2739628|NCT00090285|9406638|P5|Long-term Follow-up (EXT2)|Lost to Follow-up|156
2739629|NCT00090285|9406639|P4|Long-term Follow-up (EXT2)|Lost to Follow-up|0
2739630|NCT00090285|9406640|P3|Long-term Follow-up (EXT2)|Lost to Follow-up|0
2739631|NCT00090285|9406641|P2|Long-term Follow-up (EXT2)|Lost to Follow-up|0
2739632|NCT00090285|9406642|P1|Long-term Follow-up (EXT2)|Lost to Follow-up|0
2739633|NCT00090285|9406637|P6|Long-term Follow-up (EXT2)|Adverse Event|2
2739634|NCT00090285|9406638|P5|Long-term Follow-up (EXT2)|Adverse Event|5
2739635|NCT00090285|9406639|P4|Long-term Follow-up (EXT2)|Adverse Event|0
2739636|NCT00090285|9406640|P3|Long-term Follow-up (EXT2)|Adverse Event|0
2739637|NCT00090285|9406641|P2|Long-term Follow-up (EXT2)|Adverse Event|0
2739638|NCT00090285|9406642|P1|Long-term Follow-up (EXT2)|Adverse Event|0
2739639|NCT00090285|9406637|P6|Extension 1|Moved|0
2739640|NCT00090285|9406638|P5|Extension 1|Moved|0
2739641|NCT00090285|9406639|P4|Extension 1|Moved|0
2739642|NCT00090285|9406640|P3|Extension 1|Moved|3
2739643|NCT00090285|9406641|P2|Extension 1|Moved|0
2739644|NCT00090285|9406642|P1|Extension 1|Moved|0
2739645|NCT00090285|9406637|P6|Extension 1|Other|0
2739646|NCT00090285|9406638|P5|Extension 1|Other|0
2739647|NCT00090285|9406639|P4|Extension 1|Other|0
2739648|NCT00090285|9406640|P3|Extension 1|Other|4
2739649|NCT00090285|9406641|P2|Extension 1|Other|0
2739650|NCT00090285|9406642|P1|Extension 1|Other|0
2739651|NCT00090285|9406637|P6|Extension 1|Withdrawal by Subject|0
2739652|NCT00090285|9406638|P5|Extension 1|Withdrawal by Subject|0
2739653|NCT00090285|9406639|P4|Extension 1|Withdrawal by Subject|1
2739654|NCT00090285|9406640|P3|Extension 1|Withdrawal by Subject|13
2739655|NCT00090285|9406641|P2|Extension 1|Withdrawal by Subject|0
2739656|NCT00090285|9406642|P1|Extension 1|Withdrawal by Subject|0
2739657|NCT00090285|9406637|P6|Extension 1|Lost to Follow-up|0
2739658|NCT00090285|9406638|P5|Extension 1|Lost to Follow-up|0
2739659|NCT00090285|9406639|P4|Extension 1|Lost to Follow-up|0
2739660|NCT00090285|9406640|P3|Extension 1|Lost to Follow-up|35
2739661|NCT00090285|9406641|P2|Extension 1|Lost to Follow-up|0
2739662|NCT00090285|9406642|P1|Extension 1|Lost to Follow-up|0
2739663|NCT00090285|9406637|P6|Extension 1|Adverse Event|0
2739664|NCT00090285|9406638|P5|Extension 1|Adverse Event|0
2739665|NCT00090285|9406639|P4|Extension 1|Adverse Event|0
2739666|NCT00090285|9406640|P3|Extension 1|Adverse Event|2
2739667|NCT00090285|9406641|P2|Extension 1|Adverse Event|0
2739668|NCT00090285|9406642|P1|Extension 1|Adverse Event|0
2739669|NCT00090285|9406637|P6|Base Study Follow-up Period|Subject Incarcerated|0
2739670|NCT00090285|9406638|P5|Base Study Follow-up Period|Subject Incarcerated|0
2739671|NCT00090285|9406639|P4|Base Study Follow-up Period|Subject Incarcerated|0
2739672|NCT00090285|9406640|P3|Base Study Follow-up Period|Subject Incarcerated|0
2739673|NCT00090285|9406641|P2|Base Study Follow-up Period|Subject Incarcerated|2
2739674|NCT00090285|9406642|P1|Base Study Follow-up Period|Subject Incarcerated|0
2739675|NCT00090285|9406637|P6|Base Study Follow-up Period|Uncooperative|0
2739676|NCT00090285|9406638|P5|Base Study Follow-up Period|Uncooperative|0
2739677|NCT00090285|9406639|P4|Base Study Follow-up Period|Uncooperative|0
2739678|NCT00090285|9406640|P3|Base Study Follow-up Period|Uncooperative|0
2739679|NCT00090285|9406641|P2|Base Study Follow-up Period|Uncooperative|4
2739680|NCT00090285|9406642|P1|Base Study Follow-up Period|Uncooperative|3
2739681|NCT00090285|9406637|P6|Base Study Follow-up Period|Protocol Violation|0
2739682|NCT00090285|9406638|P5|Base Study Follow-up Period|Protocol Violation|0
2739683|NCT00090285|9406639|P4|Base Study Follow-up Period|Protocol Violation|0
2739684|NCT00090285|9406640|P3|Base Study Follow-up Period|Protocol Violation|0
2739685|NCT00090285|9406641|P2|Base Study Follow-up Period|Protocol Violation|0
2739686|NCT00090285|9406642|P1|Base Study Follow-up Period|Protocol Violation|1
2739687|NCT00090285|9406637|P6|Base Study Follow-up Period|Other|0
2739688|NCT00090285|9406638|P5|Base Study Follow-up Period|Other|0
2739689|NCT00090285|9406639|P4|Base Study Follow-up Period|Other|0
2739690|NCT00090285|9406640|P3|Base Study Follow-up Period|Other|0
2739691|NCT00090285|9406641|P2|Base Study Follow-up Period|Other|0
2739692|NCT00090285|9406642|P1|Base Study Follow-up Period|Other|2
2739693|NCT00090285|9406637|P6|Base Study Follow-up Period|Moved|0
2739694|NCT00090285|9406638|P5|Base Study Follow-up Period|Moved|0
2739695|NCT00090285|9406639|P4|Base Study Follow-up Period|Moved|0
2739696|NCT00090285|9406640|P3|Base Study Follow-up Period|Moved|0
2739697|NCT00090285|9406641|P2|Base Study Follow-up Period|Moved|36
2739698|NCT00090285|9406642|P1|Base Study Follow-up Period|Moved|41
2739699|NCT00090285|9406637|P6|Base Study Follow-up Period|Withdrawal by Subject|0
2739700|NCT00090285|9406638|P5|Base Study Follow-up Period|Withdrawal by Subject|0
2739701|NCT00090285|9406639|P4|Base Study Follow-up Period|Withdrawal by Subject|0
2739702|NCT00090285|9406640|P3|Base Study Follow-up Period|Withdrawal by Subject|0
2739703|NCT00090285|9406641|P2|Base Study Follow-up Period|Withdrawal by Subject|64
2739704|NCT00090285|9406642|P1|Base Study Follow-up Period|Withdrawal by Subject|53
2739705|NCT00090285|9406637|P6|Base Study Follow-up Period|Lost to Follow-up|0
2739706|NCT00090285|9406638|P5|Base Study Follow-up Period|Lost to Follow-up|0
2739707|NCT00090285|9406639|P4|Base Study Follow-up Period|Lost to Follow-up|0
2739708|NCT00090285|9406640|P3|Base Study Follow-up Period|Lost to Follow-up|0
2739709|NCT00090285|9406641|P2|Base Study Follow-up Period|Lost to Follow-up|226
2739710|NCT00090285|9406642|P1|Base Study Follow-up Period|Lost to Follow-up|232
2739711|NCT00090285|9406637|P6|Base Study Follow-up Period|Adverse Event|0
2739712|NCT00090285|9406638|P5|Base Study Follow-up Period|Adverse Event|0
2739713|NCT00090285|9406639|P4|Base Study Follow-up Period|Adverse Event|0
2739714|NCT00090285|9406640|P3|Base Study Follow-up Period|Adverse Event|0
2739715|NCT00090285|9406641|P2|Base Study Follow-up Period|Adverse Event|10
2739716|NCT00090285|9406642|P1|Base Study Follow-up Period|Adverse Event|3
2739717|NCT00090285|9406637|P6|Base Study Vaccination Period|HIV positive|0
2739718|NCT00090285|9406638|P5|Base Study Vaccination Period|HIV positive|0
2739719|NCT00090285|9406639|P4|Base Study Vaccination Period|HIV positive|0
2739720|NCT00090285|9406640|P3|Base Study Vaccination Period|HIV positive|0
2739721|NCT00090285|9406641|P2|Base Study Vaccination Period|HIV positive|1
2739722|NCT00090285|9406642|P1|Base Study Vaccination Period|HIV positive|1
2739723|NCT00090285|9406637|P6|Base Study Vaccination Period|Subject Incarcerated|0
2739724|NCT00090285|9406638|P5|Base Study Vaccination Period|Subject Incarcerated|0
2739725|NCT00090285|9406639|P4|Base Study Vaccination Period|Subject Incarcerated|0
2739726|NCT00090285|9406640|P3|Base Study Vaccination Period|Subject Incarcerated|0
2739727|NCT00090285|9406641|P2|Base Study Vaccination Period|Subject Incarcerated|2
2739728|NCT00090285|9406642|P1|Base Study Vaccination Period|Subject Incarcerated|2
2739729|NCT00090285|9406637|P6|Base Study Vaccination Period|Other|0
2739730|NCT00090285|9406638|P5|Base Study Vaccination Period|Other|0
2739731|NCT00090285|9406639|P4|Base Study Vaccination Period|Other|0
2739732|NCT00090285|9406640|P3|Base Study Vaccination Period|Other|0
2739733|NCT00090285|9406641|P2|Base Study Vaccination Period|Other|2
2739734|NCT00090285|9406642|P1|Base Study Vaccination Period|Other|2
2739735|NCT00090285|9406637|P6|Base Study Vaccination Period|Site Terminated|0
2739736|NCT00090285|9406638|P5|Base Study Vaccination Period|Site Terminated|0
2739737|NCT00090285|9406639|P4|Base Study Vaccination Period|Site Terminated|0
2739738|NCT00090285|9406640|P3|Base Study Vaccination Period|Site Terminated|0
2739739|NCT00090285|9406641|P2|Base Study Vaccination Period|Site Terminated|0
2739740|NCT00090285|9406642|P1|Base Study Vaccination Period|Site Terminated|1
2739741|NCT00090285|9406637|P6|Base Study Vaccination Period|Moved|0
2739742|NCT00090285|9406638|P5|Base Study Vaccination Period|Moved|0
2739743|NCT00090285|9406639|P4|Base Study Vaccination Period|Moved|0
2739744|NCT00090285|9406640|P3|Base Study Vaccination Period|Moved|0
2739745|NCT00090285|9406641|P2|Base Study Vaccination Period|Moved|21
2739746|NCT00090285|9406642|P1|Base Study Vaccination Period|Moved|20
2739747|NCT00090285|9406637|P6|Base Study Vaccination Period|Uncooperative|0
2739748|NCT00090285|9406638|P5|Base Study Vaccination Period|Uncooperative|0
2739749|NCT00090285|9406639|P4|Base Study Vaccination Period|Uncooperative|0
2739750|NCT00090285|9406640|P3|Base Study Vaccination Period|Uncooperative|0
2739751|NCT00090285|9406641|P2|Base Study Vaccination Period|Uncooperative|2
2739752|NCT00090285|9406642|P1|Base Study Vaccination Period|Uncooperative|2
2739753|NCT00090285|9406637|P6|Base Study Vaccination Period|Withdrawal by Subject|0
2739754|NCT00090285|9406638|P5|Base Study Vaccination Period|Withdrawal by Subject|0
2739755|NCT00090285|9406639|P4|Base Study Vaccination Period|Withdrawal by Subject|0
2739756|NCT00090285|9406640|P3|Base Study Vaccination Period|Withdrawal by Subject|0
2739757|NCT00090285|9406641|P2|Base Study Vaccination Period|Withdrawal by Subject|69
2739758|NCT00090285|9406642|P1|Base Study Vaccination Period|Withdrawal by Subject|64
2739759|NCT00090285|9406637|P6|Base Study Vaccination Period|Protocol Violation|0
2739760|NCT00090285|9406638|P5|Base Study Vaccination Period|Protocol Violation|0
2739761|NCT00090285|9406639|P4|Base Study Vaccination Period|Protocol Violation|0
2739762|NCT00090285|9406640|P3|Base Study Vaccination Period|Protocol Violation|0
2739763|NCT00090285|9406641|P2|Base Study Vaccination Period|Protocol Violation|3
2739764|NCT00090285|9406642|P1|Base Study Vaccination Period|Protocol Violation|2
2739765|NCT00090285|9406637|P6|Base Study Vaccination Period|Lost to Follow-up|0
2739766|NCT00090285|9406638|P5|Base Study Vaccination Period|Lost to Follow-up|0
2739767|NCT00090285|9406639|P4|Base Study Vaccination Period|Lost to Follow-up|0
2739768|NCT00090285|9406640|P3|Base Study Vaccination Period|Lost to Follow-up|0
2739769|NCT00090285|9406641|P2|Base Study Vaccination Period|Lost to Follow-up|112
2739770|NCT00090285|9406642|P1|Base Study Vaccination Period|Lost to Follow-up|111
2739771|NCT00090285|9406637|P6|Base Study Vaccination Period|Adverse Event|0
2739772|NCT00090285|9406638|P5|Base Study Vaccination Period|Adverse Event|0
2739773|NCT00090285|9406639|P4|Base Study Vaccination Period|Adverse Event|0
2739774|NCT00090285|9406640|P3|Base Study Vaccination Period|Adverse Event|0
2739775|NCT00090285|9406641|P2|Base Study Vaccination Period|Adverse Event|4
2739776|NCT00090285|9406642|P1|Base Study Vaccination Period|Adverse Event|2
2739777|NCT00090285|9406637|P6|Base Study Vaccination Period|Randomized Not Vaccinated|0
2739778|NCT00090285|9406638|P5|Base Study Vaccination Period|Randomized Not Vaccinated|0
2739779|NCT00090285|9406639|P4|Base Study Vaccination Period|Randomized Not Vaccinated|0
2739780|NCT00090285|9406640|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
2739781|NCT00090285|9406641|P2|Base Study Vaccination Period|Randomized Not Vaccinated|3
2739782|NCT00090285|9406642|P1|Base Study Vaccination Period|Randomized Not Vaccinated|7
2739783|NCT00090259|9406679|P2|Overall Study|Investigator site closed|7
2739784|NCT00090259|9406680|P1|Overall Study|Investigator site closed|11
2739785|NCT00090259|9406679|P2|Overall Study|Withdrawal by Subject|15
2739786|NCT00090259|9406680|P1|Overall Study|Withdrawal by Subject|21
2739787|NCT00090259|9406679|P2|Overall Study|Lost to Follow-up|26
2739788|NCT00090259|9406680|P1|Overall Study|Lost to Follow-up|30
2739789|NCT00090233|9406696|P2|Overall Study|Data not available at data cut-off point|1563
2739790|NCT00090233|9406697|P1|Overall Study|Data not available at data cut-off point|1552
2739791|NCT00090233|9406696|P2|Overall Study|Other|1160
2739792|NCT00090233|9406697|P1|Overall Study|Other|1211
2739793|NCT00090233|9406696|P2|Overall Study|Moved|189
2739794|NCT00090233|9406697|P1|Overall Study|Moved|203
2739795|NCT00090233|9406696|P2|Overall Study|Withdrawal by Subject|211
2739796|NCT00090233|9406697|P1|Overall Study|Withdrawal by Subject|182
2739797|NCT00090233|9406696|P2|Overall Study|Protocol Violation|1022
2739798|NCT00090233|9406697|P1|Overall Study|Protocol Violation|960
2739799|NCT00090233|9406696|P2|Overall Study|Lost to Follow-up|95
2739800|NCT00090233|9406697|P1|Overall Study|Lost to Follow-up|68
2739801|NCT00090233|9406696|P2|Overall Study|Adverse Event|198
2739802|NCT00090233|9406697|P1|Overall Study|Adverse Event|214
2739803|NCT00090233|9406696|P2|Overall Study|Randomized Not Vaccinated (Visit 1)|627
2739804|NCT00090233|9406697|P1|Overall Study|Randomized Not Vaccinated (Visit 1)|609
2739805|NCT00090220|9406721|P6|Long-term Follow-up (EXT2)|Other|0
2739806|NCT00090220|9406722|P5|Long-term Follow-up (EXT2)|Other|1
2739807|NCT00090220|9406723|P4|Long-term Follow-up (EXT2)|Other|0
2739808|NCT00090220|9406724|P3|Long-term Follow-up (EXT2)|Other|0
2739809|NCT00090220|9406725|P2|Long-term Follow-up (EXT2)|Other|0
2739810|NCT00090220|9406726|P1|Long-term Follow-up (EXT2)|Other|0
2739811|NCT00090220|9406721|P6|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
2739812|NCT00090220|9406722|P5|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
2739813|NCT00090220|9406723|P4|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
2739814|NCT00090220|9406724|P3|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
2739815|NCT00090220|9406725|P2|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
2739816|NCT00090220|9406726|P1|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
2739817|NCT00090220|9406721|P6|Long-term Follow-up (EXT2)|Death|1
2739818|NCT00090220|9406722|P5|Long-term Follow-up (EXT2)|Death|1
2739819|NCT00090220|9406723|P4|Long-term Follow-up (EXT2)|Death|0
2739820|NCT00090220|9406724|P3|Long-term Follow-up (EXT2)|Death|0
2739821|NCT00090220|9406725|P2|Long-term Follow-up (EXT2)|Death|0
2739822|NCT00090220|9406726|P1|Long-term Follow-up (EXT2)|Death|0
2739823|NCT00090220|9406721|P6|Long-term Follow-up (EXT2)|Lost to Follow-up|23
2739824|NCT00090220|9406722|P5|Long-term Follow-up (EXT2)|Lost to Follow-up|38
2739825|NCT00090220|9406723|P4|Long-term Follow-up (EXT2)|Lost to Follow-up|0
2739826|NCT00090220|9406724|P3|Long-term Follow-up (EXT2)|Lost to Follow-up|0
2739827|NCT00090220|9406725|P2|Long-term Follow-up (EXT2)|Lost to Follow-up|0
2739828|NCT00090220|9406726|P1|Long-term Follow-up (EXT2)|Lost to Follow-up|0
2739829|NCT00090220|9406721|P6|Extension 1 (EXT1)|Other reason|0
2739830|NCT00090220|9406722|P5|Extension 1 (EXT1)|Other reason|0
2739831|NCT00090220|9406723|P4|Extension 1 (EXT1)|Other reason|0
2739832|NCT00090220|9406724|P3|Extension 1 (EXT1)|Other reason|2
2739833|NCT00090220|9406725|P2|Extension 1 (EXT1)|Other reason|0
2739834|NCT00090220|9406726|P1|Extension 1 (EXT1)|Other reason|0
2739835|NCT00090220|9406721|P6|Extension 1 (EXT1)|Protocol Violation|0
2739836|NCT00090220|9406722|P5|Extension 1 (EXT1)|Protocol Violation|0
2739837|NCT00090220|9406723|P4|Extension 1 (EXT1)|Protocol Violation|1
2739838|NCT00090220|9406724|P3|Extension 1 (EXT1)|Protocol Violation|0
2739839|NCT00090220|9406725|P2|Extension 1 (EXT1)|Protocol Violation|0
2739840|NCT00090220|9406726|P1|Extension 1 (EXT1)|Protocol Violation|0
2739841|NCT00090220|9406721|P6|Extension 1 (EXT1)|Withdrawal by Subject|0
2739842|NCT00090220|9406722|P5|Extension 1 (EXT1)|Withdrawal by Subject|0
2739843|NCT00090220|9406723|P4|Extension 1 (EXT1)|Withdrawal by Subject|0
2739844|NCT00090220|9406724|P3|Extension 1 (EXT1)|Withdrawal by Subject|25
2739845|NCT00090220|9406725|P2|Extension 1 (EXT1)|Withdrawal by Subject|0
2739846|NCT00090220|9406726|P1|Extension 1 (EXT1)|Withdrawal by Subject|0
2739847|NCT00090220|9406721|P6|Extension 1 (EXT1)|Moved|0
2739848|NCT00090220|9406722|P5|Extension 1 (EXT1)|Moved|0
2739849|NCT00090220|9406723|P4|Extension 1 (EXT1)|Moved|1
2739850|NCT00090220|9406724|P3|Extension 1 (EXT1)|Moved|2
2739851|NCT00090220|9406725|P2|Extension 1 (EXT1)|Moved|0
2739852|NCT00090220|9406726|P1|Extension 1 (EXT1)|Moved|0
2739853|NCT00090220|9406721|P6|Extension 1 (EXT1)|Lost to Follow-up|0
2739854|NCT00090220|9406722|P5|Extension 1 (EXT1)|Lost to Follow-up|0
2739855|NCT00090220|9406723|P4|Extension 1 (EXT1)|Lost to Follow-up|0
2739856|NCT00090220|9406724|P3|Extension 1 (EXT1)|Lost to Follow-up|22
2739857|NCT00090220|9406725|P2|Extension 1 (EXT1)|Lost to Follow-up|0
2739858|NCT00090220|9406726|P1|Extension 1 (EXT1)|Lost to Follow-up|0
2739859|NCT00090220|9406721|P6|Extension 1 (EXT1)|Adverse Event|0
2739860|NCT00090220|9406722|P5|Extension 1 (EXT1)|Adverse Event|0
2739861|NCT00090220|9406723|P4|Extension 1 (EXT1)|Adverse Event|0
2739862|NCT00090220|9406724|P3|Extension 1 (EXT1)|Adverse Event|4
2739863|NCT00090220|9406725|P2|Extension 1 (EXT1)|Adverse Event|0
2739864|NCT00090220|9406726|P1|Extension 1 (EXT1)|Adverse Event|0
2739865|NCT00090220|9406721|P6|Base Study Follow-up Period|Other|0
2739866|NCT00090220|9406722|P5|Base Study Follow-up Period|Other|0
2739867|NCT00090220|9406723|P4|Base Study Follow-up Period|Other|0
2739868|NCT00090220|9406724|P3|Base Study Follow-up Period|Other|0
2739869|NCT00090220|9406725|P2|Base Study Follow-up Period|Other|21
2739870|NCT00090220|9406726|P1|Base Study Follow-up Period|Other|19
2739871|NCT00090220|9406721|P6|Base Study Follow-up Period|Patient Moved|0
2739872|NCT00090220|9406722|P5|Base Study Follow-up Period|Patient Moved|0
2739873|NCT00090220|9406723|P4|Base Study Follow-up Period|Patient Moved|0
2739874|NCT00090220|9406724|P3|Base Study Follow-up Period|Patient Moved|0
2739875|NCT00090220|9406725|P2|Base Study Follow-up Period|Patient Moved|28
2739876|NCT00090220|9406726|P1|Base Study Follow-up Period|Patient Moved|20
2739877|NCT00090220|9406721|P6|Base Study Follow-up Period|Withdrawal by Subject|0
2739878|NCT00090220|9406722|P5|Base Study Follow-up Period|Withdrawal by Subject|0
2739879|NCT00090220|9406723|P4|Base Study Follow-up Period|Withdrawal by Subject|0
2739880|NCT00090220|9406724|P3|Base Study Follow-up Period|Withdrawal by Subject|0
2739881|NCT00090220|9406725|P2|Base Study Follow-up Period|Withdrawal by Subject|36
2739882|NCT00090220|9406726|P1|Base Study Follow-up Period|Withdrawal by Subject|27
2739883|NCT00090220|9406721|P6|Base Study Follow-up Period|Lost to Follow-up|0
2739884|NCT00090220|9406722|P5|Base Study Follow-up Period|Lost to Follow-up|0
2739885|NCT00090220|9406723|P4|Base Study Follow-up Period|Lost to Follow-up|0
2739886|NCT00090220|9406724|P3|Base Study Follow-up Period|Lost to Follow-up|0
2739887|NCT00090220|9406725|P2|Base Study Follow-up Period|Lost to Follow-up|78
2739888|NCT00090220|9406726|P1|Base Study Follow-up Period|Lost to Follow-up|88
2739889|NCT00090220|9406721|P6|Base Study Follow-up Period|Adverse Event|0
2739890|NCT00090220|9406722|P5|Base Study Follow-up Period|Adverse Event|0
2739891|NCT00090220|9406723|P4|Base Study Follow-up Period|Adverse Event|0
2739892|NCT00090220|9406724|P3|Base Study Follow-up Period|Adverse Event|0
2739893|NCT00090220|9406725|P2|Base Study Follow-up Period|Adverse Event|1
2739894|NCT00090220|9406726|P1|Base Study Follow-up Period|Adverse Event|6
2739895|NCT00090220|9406721|P6|Base Study Vaccination Period|Other|0
2739896|NCT00090220|9406722|P5|Base Study Vaccination Period|Other|0
2739897|NCT00090220|9406723|P4|Base Study Vaccination Period|Other|0
2739898|NCT00090220|9406724|P3|Base Study Vaccination Period|Other|0
2739899|NCT00090220|9406725|P2|Base Study Vaccination Period|Other|4
2739900|NCT00090220|9406726|P1|Base Study Vaccination Period|Other|4
2739901|NCT00090220|9406721|P6|Base Study Vaccination Period|Patient Moved|0
2739902|NCT00090220|9406722|P5|Base Study Vaccination Period|Patient Moved|0
2739903|NCT00090220|9406723|P4|Base Study Vaccination Period|Patient Moved|0
2739904|NCT00090220|9406724|P3|Base Study Vaccination Period|Patient Moved|0
2739905|NCT00090220|9406725|P2|Base Study Vaccination Period|Patient Moved|2
2739906|NCT00090220|9406726|P1|Base Study Vaccination Period|Patient Moved|6
2739907|NCT00090220|9406721|P6|Base Study Vaccination Period|Withdrawal by Subject|0
2739908|NCT00090220|9406722|P5|Base Study Vaccination Period|Withdrawal by Subject|0
2739909|NCT00090220|9406723|P4|Base Study Vaccination Period|Withdrawal by Subject|0
2739910|NCT00090220|9406724|P3|Base Study Vaccination Period|Withdrawal by Subject|0
2739911|NCT00090220|9406725|P2|Base Study Vaccination Period|Withdrawal by Subject|27
2739912|NCT00090220|9406726|P1|Base Study Vaccination Period|Withdrawal by Subject|23
2739913|NCT00090220|9406721|P6|Base Study Vaccination Period|Lost to Follow-up|0
2739914|NCT00090220|9406722|P5|Base Study Vaccination Period|Lost to Follow-up|0
2739915|NCT00090220|9406723|P4|Base Study Vaccination Period|Lost to Follow-up|0
2739916|NCT00090220|9406724|P3|Base Study Vaccination Period|Lost to Follow-up|0
2739917|NCT00090220|9406725|P2|Base Study Vaccination Period|Lost to Follow-up|28
2739918|NCT00090220|9406726|P1|Base Study Vaccination Period|Lost to Follow-up|24
2739919|NCT00090220|9406721|P6|Base Study Vaccination Period|Adverse Event|0
2739920|NCT00090220|9406722|P5|Base Study Vaccination Period|Adverse Event|0
2739921|NCT00090220|9406723|P4|Base Study Vaccination Period|Adverse Event|0
2739922|NCT00090220|9406724|P3|Base Study Vaccination Period|Adverse Event|0
2739923|NCT00090220|9406725|P2|Base Study Vaccination Period|Adverse Event|1
2739924|NCT00090220|9406726|P1|Base Study Vaccination Period|Adverse Event|6
2739925|NCT00090220|9406721|P6|Base Study Vaccination Period|Randomized not Vaccinated|0
2739926|NCT00090220|9406722|P5|Base Study Vaccination Period|Randomized not Vaccinated|0
2739927|NCT00090220|9406723|P4|Base Study Vaccination Period|Randomized not Vaccinated|0
2739928|NCT00090220|9406724|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
2739929|NCT00090220|9406725|P2|Base Study Vaccination Period|Randomized not Vaccinated|1
2739930|NCT00090220|9406726|P1|Base Study Vaccination Period|Randomized not Vaccinated|1
2739931|NCT00090402|9406821|P3|Overall Study|stopped taking study medication|1
2739932|NCT00090402|9406822|P2|Overall Study|stopped taking study medication|0
2739933|NCT00090402|9406823|P1|Overall Study|stopped taking study medication|1
2739934|NCT00090402|9406821|P3|Overall Study|subject moved|0
2739935|NCT00090402|9406822|P2|Overall Study|subject moved|1
2739936|NCT00090402|9406823|P1|Overall Study|subject moved|0
2739937|NCT00090402|9406821|P3|Overall Study|Death|0
2739938|NCT00090402|9406822|P2|Overall Study|Death|1
2739939|NCT00090402|9406823|P1|Overall Study|Death|1
2739940|NCT00090142|9406837|P2|Treatment Period II|Other|0
2739941|NCT00090142|9406838|P1|Treatment Period II|Other|1
2739942|NCT00090142|9406837|P2|Treatment Period I|Other|1
2739943|NCT00090142|9406838|P1|Treatment Period I|Other|0
2739944|NCT00090142|9406837|P2|Treatment Period I|Withdrawal by Subject|0
2739945|NCT00090142|9406838|P1|Treatment Period I|Withdrawal by Subject|2
2739946|NCT00090142|9406837|P2|Treatment Period I|Protocol Violation|0
2739947|NCT00090142|9406838|P1|Treatment Period I|Protocol Violation|2
2739948|NCT00090142|9406837|P2|Treatment Period I|Lost to Follow-up|2
2739949|NCT00090142|9406838|P1|Treatment Period I|Lost to Follow-up|1
2739950|NCT00090103|9406869|P3|16-Week Safety Follow-up Period|Other|0
2739951|NCT00090103|9406870|P2|16-Week Safety Follow-up Period|Other|1
2739952|NCT00090103|9406871|P1|16-Week Safety Follow-up Period|Other|0
2739953|NCT00090103|9406869|P3|16-Week Safety Follow-up Period|Jailed|0
2739954|NCT00090103|9406870|P2|16-Week Safety Follow-up Period|Jailed|1
2739955|NCT00090103|9406871|P1|16-Week Safety Follow-up Period|Jailed|0
2739956|NCT00090103|9406869|P3|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
2739957|NCT00090103|9406870|P2|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1
2739958|NCT00090103|9406871|P1|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
2739959|NCT00090103|9406869|P3|16-Week Safety Follow-up Period|Depression|0
2739960|NCT00090103|9406870|P2|16-Week Safety Follow-up Period|Depression|1
2739961|NCT00090103|9406871|P1|16-Week Safety Follow-up Period|Depression|0
2739962|NCT00090103|9406869|P3|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3
2739963|NCT00090103|9406870|P2|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2
2739964|NCT00090103|9406871|P1|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0
2739965|NCT00090103|9406869|P3|16-Week Safety Follow-up Period|Scheduling Issues|4
2739966|NCT00090103|9406870|P2|16-Week Safety Follow-up Period|Scheduling Issues|2
2739967|NCT00090103|9406871|P1|16-Week Safety Follow-up Period|Scheduling Issues|0
2739968|NCT00090103|9406869|P3|16-Week Safety Follow-up Period|Back Pain|0
2739969|NCT00090103|9406870|P2|16-Week Safety Follow-up Period|Back Pain|1
2739970|NCT00090103|9406871|P1|16-Week Safety Follow-up Period|Back Pain|0
2739971|NCT00090103|9406869|P3|16-Week Safety Follow-up Period|Angina Pectoris|0
2739972|NCT00090103|9406870|P2|16-Week Safety Follow-up Period|Angina Pectoris|1
2739973|NCT00090103|9406871|P1|16-Week Safety Follow-up Period|Angina Pectoris|0
2739974|NCT00090103|9406869|P3|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3
2739975|NCT00090103|9406870|P2|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2
2739976|NCT00090103|9406871|P1|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0
2739977|NCT00090103|9406869|P3|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4
2739978|NCT00090103|9406870|P2|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5
2739979|NCT00090103|9406871|P1|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0
2739980|NCT00090103|9406869|P3|16-Week Safety Follow-up Period|Gyneomastia|0
2739981|NCT00090103|9406870|P2|16-Week Safety Follow-up Period|Gyneomastia|0
2739982|NCT00090103|9406871|P1|16-Week Safety Follow-up Period|Gyneomastia|1
2739983|NCT00090103|9406869|P3|16-Week Safety Follow-up Period|Death|1
2739984|NCT00090103|9406870|P2|16-Week Safety Follow-up Period|Death|0
2739985|NCT00090103|9406871|P1|16-Week Safety Follow-up Period|Death|1
2739986|NCT00090103|9406869|P3|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6
2739987|NCT00090103|9406870|P2|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3
2739988|NCT00090103|9406871|P1|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1
2739989|NCT00090103|9406869|P3|16-Week Safety Follow-up Period|Enrollment Error|2
2739990|NCT00090103|9406870|P2|16-Week Safety Follow-up Period|Enrollment Error|0
2739991|NCT00090103|9406871|P1|16-Week Safety Follow-up Period|Enrollment Error|1
2739992|NCT00090103|9406869|P3|16-Week Safety Follow-up Period|Loss of Libido|0
2739993|NCT00090103|9406870|P2|16-Week Safety Follow-up Period|Loss of Libido|0
2739994|NCT00090103|9406871|P1|16-Week Safety Follow-up Period|Loss of Libido|1
2739995|NCT00090103|9406869|P3|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13
2739996|NCT00090103|9406870|P2|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5
2739997|NCT00090103|9406871|P1|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1
2739998|NCT00090103|9406869|P3|16-Week Safety Follow-up Period|Alcohol Dependent|1
2739999|NCT00090103|9406870|P2|16-Week Safety Follow-up Period|Alcohol Dependent|0
2740000|NCT00090103|9406871|P1|16-Week Safety Follow-up Period|Alcohol Dependent|1
2740001|NCT00090103|9406869|P3|16-Week Safety Follow-up Period|Prohibited Medication|5
2740002|NCT00090103|9406870|P2|16-Week Safety Follow-up Period|Prohibited Medication|3
2740003|NCT00090103|9406871|P1|16-Week Safety Follow-up Period|Prohibited Medication|2
2740004|NCT00090103|9406869|P3|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
2740005|NCT00090103|9406870|P2|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1
2740006|NCT00090103|9406871|P1|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
2740007|NCT00090103|9406869|P3|16-Week Safety Follow-up Period|Participant relocated|1
2740008|NCT00090103|9406870|P2|16-Week Safety Follow-up Period|Participant relocated|3
2740009|NCT00090103|9406871|P1|16-Week Safety Follow-up Period|Participant relocated|2
2740010|NCT00090103|9406869|P3|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
2740011|NCT00090103|9406870|P2|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
2740012|NCT00090103|9406871|P1|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3
2740013|NCT00090103|9406869|P3|16-Week Safety Follow-up Period|Loss of Contact|2
2740014|NCT00090103|9406870|P2|16-Week Safety Follow-up Period|Loss of Contact|0
2740015|NCT00090103|9406871|P1|16-Week Safety Follow-up Period|Loss of Contact|4
2740016|NCT00090103|9406869|P3|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4
2740017|NCT00090103|9406870|P2|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6
2740018|NCT00090103|9406871|P1|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8
2740019|NCT00090103|9406869|P3|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4
2740020|NCT00090103|9406870|P2|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5
2740021|NCT00090103|9406871|P1|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8
2740022|NCT00090103|9406869|P3|16-Week Safety Follow-up Period|Protocol Violation|17
2740023|NCT00090103|9406870|P2|16-Week Safety Follow-up Period|Protocol Violation|18
2740024|NCT00090103|9406871|P1|16-Week Safety Follow-up Period|Protocol Violation|18
2740025|NCT00090103|9406869|P3|16-Week Safety Follow-up Period|Lost to Follow-up|111
2740026|NCT00090103|9406870|P2|16-Week Safety Follow-up Period|Lost to Follow-up|97
2740027|NCT00090103|9406871|P1|16-Week Safety Follow-up Period|Lost to Follow-up|101
2740028|NCT00090103|9406869|P3|16-Week Safety Follow-up Period|Withdrawal by Subject|229
2740029|NCT00090103|9406870|P2|16-Week Safety Follow-up Period|Withdrawal by Subject|212
2740030|NCT00090103|9406871|P1|16-Week Safety Follow-up Period|Withdrawal by Subject|185
2740031|NCT00090103|9406869|P3|16-Week Safety Follow-up Period|Adverse Event|44
2740032|NCT00090103|9406870|P2|16-Week Safety Follow-up Period|Adverse Event|39
2740033|NCT00090103|9406871|P1|16-Week Safety Follow-up Period|Adverse Event|34
2740034|NCT00090103|9406869|P3|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
2740035|NCT00090103|9406870|P2|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1
2740036|NCT00090103|9406871|P1|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
2740037|NCT00090103|9406869|P3|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1
2740038|NCT00090103|9406870|P2|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
2740039|NCT00090103|9406871|P1|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
2740040|NCT00090103|9406869|P3|Four-Year Double-Blind Treatment Period|Enrollment Error|2
2740041|NCT00090103|9406870|P2|Four-Year Double-Blind Treatment Period|Enrollment Error|0
2740042|NCT00090103|9406871|P1|Four-Year Double-Blind Treatment Period|Enrollment Error|0
2740043|NCT00090103|9406869|P3|Four-Year Double-Blind Treatment Period|Investigator Decision|3
2740044|NCT00090103|9406870|P2|Four-Year Double-Blind Treatment Period|Investigator Decision|1
2740045|NCT00090103|9406871|P1|Four-Year Double-Blind Treatment Period|Investigator Decision|0
2740046|NCT00090103|9406869|P3|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
2740047|NCT00090103|9406870|P2|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1
2740048|NCT00090103|9406871|P1|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
2740049|NCT00090103|9406869|P3|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
2740050|NCT00090103|9406870|P2|Four-Year Double-Blind Treatment Period|Scheduling Issues|1
2740051|NCT00090103|9406871|P1|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
2740052|NCT00090103|9406869|P3|Four-Year Double-Blind Treatment Period|Back Pain|0
2740053|NCT00090103|9406870|P2|Four-Year Double-Blind Treatment Period|Back Pain|1
2740054|NCT00090103|9406871|P1|Four-Year Double-Blind Treatment Period|Back Pain|0
2740055|NCT00090103|9406869|P3|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
2740056|NCT00090103|9406870|P2|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1
2740057|NCT00090103|9406871|P1|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
2740058|NCT00090103|9406869|P3|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
2740059|NCT00090103|9406870|P2|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2
2740060|NCT00090103|9406871|P1|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
2740061|NCT00090103|9406869|P3|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
2740062|NCT00090103|9406870|P2|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
2740063|NCT00090103|9406871|P1|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0
2740064|NCT00090103|9406869|P3|Four-Year Double-Blind Treatment Period|Loss of Contact|0
2740065|NCT00090103|9406870|P2|Four-Year Double-Blind Treatment Period|Loss of Contact|1
2740066|NCT00090103|9406871|P1|Four-Year Double-Blind Treatment Period|Loss of Contact|0
2740067|NCT00090103|9406869|P3|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
2740068|NCT00090103|9406870|P2|Four-Year Double-Blind Treatment Period|Angina Pectoris|2
2740069|NCT00090103|9406871|P1|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
2740070|NCT00090103|9406869|P3|Four-Year Double-Blind Treatment Period|Loss of Libido|0
2740071|NCT00090103|9406870|P2|Four-Year Double-Blind Treatment Period|Loss of Libido|0
2740072|NCT00090103|9406871|P1|Four-Year Double-Blind Treatment Period|Loss of Libido|1
2740073|NCT00090103|9406869|P3|Four-Year Double-Blind Treatment Period|Financial Problems|0
2740074|NCT00090103|9406870|P2|Four-Year Double-Blind Treatment Period|Financial Problems|0
2740075|NCT00090103|9406871|P1|Four-Year Double-Blind Treatment Period|Financial Problems|1
2740076|NCT00090103|9406869|P3|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5
2740077|NCT00090103|9406870|P2|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0
2740078|NCT00090103|9406871|P1|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1
2740079|NCT00090103|9406869|P3|Four-Year Double-Blind Treatment Period|No Improvement|0
2740080|NCT00090103|9406870|P2|Four-Year Double-Blind Treatment Period|No Improvement|0
2740081|NCT00090103|9406871|P1|Four-Year Double-Blind Treatment Period|No Improvement|1
2740082|NCT00090103|9406869|P3|Four-Year Double-Blind Treatment Period|Screen Failure|0
2740083|NCT00090103|9406870|P2|Four-Year Double-Blind Treatment Period|Screen Failure|0
2740084|NCT00090103|9406871|P1|Four-Year Double-Blind Treatment Period|Screen Failure|1
2740085|NCT00090103|9406869|P3|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
2740086|NCT00090103|9406870|P2|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
2740087|NCT00090103|9406871|P1|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1
2740088|NCT00090103|9406869|P3|Four-Year Double-Blind Treatment Period|Investigator Departure|0
2740089|NCT00090103|9406870|P2|Four-Year Double-Blind Treatment Period|Investigator Departure|0
2740090|NCT00090103|9406871|P1|Four-Year Double-Blind Treatment Period|Investigator Departure|2
2740091|NCT00090103|9406869|P3|Four-Year Double-Blind Treatment Period|Prohibited Medication|8
2740092|NCT00090103|9406870|P2|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
2740093|NCT00090103|9406871|P1|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
2740094|NCT00090103|9406869|P3|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6
2740095|NCT00090103|9406870|P2|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3
2740096|NCT00090103|9406871|P1|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2
2740097|NCT00090103|9406869|P3|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4
2740098|NCT00090103|9406870|P2|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0
2740099|NCT00090103|9406871|P1|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2
2740100|NCT00090103|9406869|P3|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19
2740101|NCT00090103|9406870|P2|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7
2740102|NCT00090103|9406871|P1|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3
2740103|NCT00090103|9406869|P3|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7
2740104|NCT00090103|9406870|P2|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4
2740105|NCT00090103|9406871|P1|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6
2740106|NCT00090103|9406869|P3|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4
2740107|NCT00090103|9406870|P2|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
2740108|NCT00090103|9406871|P1|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
2740109|NCT00090103|9406869|P3|Four-Year Double-Blind Treatment Period|Participant Relocated|8
2740110|NCT00090103|9406870|P2|Four-Year Double-Blind Treatment Period|Participant Relocated|2
2740111|NCT00090103|9406871|P1|Four-Year Double-Blind Treatment Period|Participant Relocated|7
2740112|NCT00090103|9406869|P3|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104
2740113|NCT00090103|9406870|P2|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71
2740114|NCT00090103|9406871|P1|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53
2740115|NCT00090103|9406869|P3|Four-Year Double-Blind Treatment Period|Protocol Violation|34
2740116|NCT00090103|9406870|P2|Four-Year Double-Blind Treatment Period|Protocol Violation|29
2740117|NCT00090103|9406871|P1|Four-Year Double-Blind Treatment Period|Protocol Violation|29
2740118|NCT00090103|9406869|P3|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58
2740119|NCT00090103|9406870|P2|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48
2740120|NCT00090103|9406871|P1|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53
2740121|NCT00090103|9406869|P3|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148
2740122|NCT00090103|9406870|P2|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160
2740123|NCT00090103|9406871|P1|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114
2740124|NCT00090103|9406869|P3|Four-Year Double-Blind Treatment Period|Adverse Event|210
2740125|NCT00090103|9406870|P2|Four-Year Double-Blind Treatment Period|Adverse Event|185
2740126|NCT00090103|9406871|P1|Four-Year Double-Blind Treatment Period|Adverse Event|211
2740127|NCT00089999|9407037|P2|Overall Study|Skin Nodule Over Right Mastectomy|1
2740128|NCT00089999|9407038|P1|Overall Study|Skin Nodule Over Right Mastectomy|0
2740129|NCT00089999|9407037|P2|Overall Study|Patient Underwent Surgery|0
2740130|NCT00089999|9407038|P1|Overall Study|Patient Underwent Surgery|2
2740131|NCT00089999|9407037|P2|Overall Study|Physician Decision|2
2740132|NCT00089999|9407038|P1|Overall Study|Physician Decision|2
2740133|NCT00089999|9407037|P2|Overall Study|Clinical Progression|2
2740134|NCT00089999|9407038|P1|Overall Study|Clinical Progression|1
2740135|NCT00089999|9407037|P2|Overall Study|Poor General Condition|0
2740136|NCT00089999|9407038|P1|Overall Study|Poor General Condition|1
2740137|NCT00089999|9407037|P2|Overall Study|Death|3
2740138|NCT00089999|9407038|P1|Overall Study|Death|3
2740139|NCT00089999|9407037|P2|Overall Study|Symptomatic Progression of Cancer|5
2740140|NCT00089999|9407038|P1|Overall Study|Symptomatic Progression of Cancer|2
2740141|NCT00089999|9407037|P2|Overall Study|Radiological Progression of Cancer|44
2740142|NCT00089999|9407038|P1|Overall Study|Radiological Progression of Cancer|52
2740143|NCT00089999|9407037|P2|Overall Study|Lost to Follow-up|1
2740144|NCT00089999|9407038|P1|Overall Study|Lost to Follow-up|2
2740145|NCT00089999|9407037|P2|Overall Study|Withdrawal by Subject|4
2740146|NCT00089999|9407038|P1|Overall Study|Withdrawal by Subject|0
2740147|NCT00089999|9407037|P2|Overall Study|Adverse Event|7
2740148|NCT00089999|9407038|P1|Overall Study|Adverse Event|4
2740149|NCT00089986|9407061|P3|Overall Study|Withdrawal by Subject|2
2740150|NCT00089986|9407062|P2|Overall Study|Withdrawal by Subject|6
2740151|NCT00089986|9407063|P1|Overall Study|Withdrawal by Subject|3
2740152|NCT00089986|9407061|P3|Overall Study|Do not resuscitate (DNR)|1
2740153|NCT00089986|9407062|P2|Overall Study|Do not resuscitate (DNR)|0
2740154|NCT00089986|9407063|P1|Overall Study|Do not resuscitate (DNR)|0
2740155|NCT00089986|9407061|P3|Overall Study|Family decision|0
2740156|NCT00089986|9407062|P2|Overall Study|Family decision|1
2740157|NCT00089986|9407063|P1|Overall Study|Family decision|0
2740158|NCT00089986|9407061|P3|Overall Study|Enrollment in another study|0
2740159|NCT00089986|9407062|P2|Overall Study|Enrollment in another study|1
2740160|NCT00089986|9407063|P1|Overall Study|Enrollment in another study|0
2740161|NCT00089986|9407061|P3|Overall Study|Investigator decision to withdrew|0
2740162|NCT00089986|9407062|P2|Overall Study|Investigator decision to withdrew|1
2740163|NCT00089986|9407063|P1|Overall Study|Investigator decision to withdrew|0
2740164|NCT00089986|9407061|P3|Overall Study|Hemohlobin stopping rule|0
2740165|NCT00089986|9407062|P2|Overall Study|Hemohlobin stopping rule|1
2740166|NCT00089986|9407063|P1|Overall Study|Hemohlobin stopping rule|0
2740167|NCT00089986|9407061|P3|Overall Study|Subject withdrew but agreed follow up|0
2740168|NCT00089986|9407062|P2|Overall Study|Subject withdrew but agreed follow up|2
2740169|NCT00089986|9407063|P1|Overall Study|Subject withdrew but agreed follow up|1
2740170|NCT00089986|9407061|P3|Overall Study|Patient transferred to another hospital|0
2740171|NCT00089986|9407062|P2|Overall Study|Patient transferred to another hospital|1
2740172|NCT00089986|9407063|P1|Overall Study|Patient transferred to another hospital|2
2740173|NCT00089986|9407061|P3|Overall Study|Protocol Violation|0
2740174|NCT00089986|9407062|P2|Overall Study|Protocol Violation|1
2740175|NCT00089986|9407063|P1|Overall Study|Protocol Violation|0
2740176|NCT00089986|9407061|P3|Overall Study|Lost to Follow-up|1
2740177|NCT00089986|9407062|P2|Overall Study|Lost to Follow-up|1
2740178|NCT00089986|9407063|P1|Overall Study|Lost to Follow-up|3
2740179|NCT00089986|9407061|P3|Overall Study|Adverse Event|6
2740180|NCT00089986|9407062|P2|Overall Study|Adverse Event|9
2740181|NCT00089986|9407063|P1|Overall Study|Adverse Event|6
2740182|NCT00089973|9407080|P1|Overall Study|Death|1
2740183|NCT00089973|9407080|P1|Overall Study|Disease progression|45
2740184|NCT00089973|9407080|P1|Overall Study|Withdrawal by Subject|1
2740185|NCT00089973|9407080|P1|Overall Study|Adverse Event|3
2740186|NCT00089895|9407095|P2|Overall Study|Missing|2
2740187|NCT00089895|9407096|P1|Overall Study|Missing|4
2740188|NCT00089895|9407095|P2|Overall Study|Not otherwise specified|8
2740189|NCT00089895|9407096|P1|Overall Study|Not otherwise specified|4
2740190|NCT00089895|9407095|P2|Overall Study|Exclusion criteria met|6
2740191|NCT00089895|9407096|P1|Overall Study|Exclusion criteria met|6
2740192|NCT00089895|9407095|P2|Overall Study|Physician Decision|7
2740193|NCT00089895|9407096|P1|Overall Study|Physician Decision|3
2740194|NCT00089895|9407095|P2|Overall Study|Bleeding|2
2740195|NCT00089895|9407096|P1|Overall Study|Bleeding|0
2740196|NCT00089895|9407095|P2|Overall Study|Surgery|1
2740197|NCT00089895|9407096|P1|Overall Study|Surgery|0
2740198|NCT00089895|9407095|P2|Overall Study|Technical reason|2
2740199|NCT00089895|9407096|P1|Overall Study|Technical reason|7
2740200|NCT00089895|9407095|P2|Overall Study|Consent Withdrawn|14
2740201|NCT00089895|9407096|P1|Overall Study|Consent Withdrawn|11
2740202|NCT00089843|9407108|P4|Overall Study|Physician Decision|1
2740203|NCT00089843|9407109|P3|Overall Study|Physician Decision|0
2740204|NCT00089843|9407110|P2|Overall Study|Physician Decision|0
2740205|NCT00089843|9407111|P1|Overall Study|Physician Decision|1
2740206|NCT00089843|9407108|P4|Overall Study|Withdrawal by Subject|6
2740207|NCT00089843|9407109|P3|Overall Study|Withdrawal by Subject|5
2740208|NCT00089843|9407110|P2|Overall Study|Withdrawal by Subject|4
2740209|NCT00089843|9407111|P1|Overall Study|Withdrawal by Subject|1
2740210|NCT00089791|9407123|P2|Overall Study|Requirement for alternative therapy|4
2740211|NCT00089791|9407124|P1|Overall Study|Requirement for alternative therapy|7
2740212|NCT00089791|9407123|P2|Overall Study|Protocol deviation|10
2740213|NCT00089791|9407124|P1|Overall Study|Protocol deviation|12
2740214|NCT00089791|9407123|P2|Overall Study|Other|32
2740215|NCT00089791|9407124|P1|Overall Study|Other|20
2740216|NCT00089791|9407123|P2|Overall Study|Noncompliance|13
2740217|NCT00089791|9407124|P1|Overall Study|Noncompliance|17
2740218|NCT00089791|9407123|P2|Overall Study|Lost to Follow-up|57
2740219|NCT00089791|9407124|P1|Overall Study|Lost to Follow-up|57
2740220|NCT00089791|9407123|P2|Overall Study|Ineligibility determined|9
2740221|NCT00089791|9407124|P1|Overall Study|Ineligibility determined|12
2740222|NCT00089791|9407123|P2|Overall Study|Disease progression|3
2740223|NCT00089791|9407124|P1|Overall Study|Disease progression|7
2740224|NCT00089791|9407123|P2|Overall Study|Death|62
2740225|NCT00089791|9407124|P1|Overall Study|Death|78
2740226|NCT00089791|9407123|P2|Overall Study|Withdrawal by Subject|344
2740227|NCT00089791|9407124|P1|Overall Study|Withdrawal by Subject|403
2740228|NCT00089791|9407123|P2|Overall Study|Adverse Event|93
2740229|NCT00089791|9407124|P1|Overall Study|Adverse Event|81
2740230|NCT00089791|9407123|P2|Overall Study|Physician Decision|3
2740231|NCT00089791|9407124|P1|Overall Study|Physician Decision|6
2740232|NCT00089778|9407158|P3|Overall Study|Protocol Violation|1
2740233|NCT00089778|9407159|P2|Overall Study|Protocol Violation|0
2740234|NCT00089778|9407160|P1|Overall Study|Protocol Violation|0
2740235|NCT00089674|9407173|P2|Overall Study|Requirement for alternative therapy|4
2740236|NCT00089674|9407174|P1|Overall Study|Requirement for alternative therapy|14
2740237|NCT00089674|9407173|P2|Overall Study|Other|9
2740238|NCT00089674|9407174|P1|Overall Study|Other|5
2740239|NCT00089674|9407173|P2|Overall Study|Noncompliance|3
2740240|NCT00089674|9407174|P1|Overall Study|Noncompliance|7
2740241|NCT00089674|9407173|P2|Overall Study|Lost to Follow-up|17
2740242|NCT00089674|9407174|P1|Overall Study|Lost to Follow-up|21
2740243|NCT00089674|9407173|P2|Overall Study|Ineligibility determined|10
2740244|NCT00089674|9407174|P1|Overall Study|Ineligibility determined|8
2740245|NCT00089674|9407173|P2|Overall Study|Disease progression|23
2740246|NCT00089674|9407174|P1|Overall Study|Disease progression|21
2740247|NCT00089674|9407173|P2|Overall Study|Death|43
2740248|NCT00089674|9407174|P1|Overall Study|Death|43
2740249|NCT00089674|9407173|P2|Overall Study|Withdrawal by Subject|127
2740250|NCT00089674|9407174|P1|Overall Study|Withdrawal by Subject|143
2740251|NCT00089674|9407173|P2|Overall Study|Adverse Event|29
2740252|NCT00089674|9407174|P1|Overall Study|Adverse Event|23
2740253|NCT00089674|9407173|P2|Overall Study|Physician Decision|2
2740254|NCT00089674|9407174|P1|Overall Study|Physician Decision|4
2740255|NCT00089661|9407200|P2|Overall Study|Other|1
2740256|NCT00089661|9407201|P1|Overall Study|Other|2
2740257|NCT00089661|9407200|P2|Overall Study|Noncompliance|4
2740258|NCT00089661|9407201|P1|Overall Study|Noncompliance|2
2740259|NCT00089661|9407200|P2|Overall Study|Ineligibility determined|4
2740260|NCT00089661|9407201|P1|Overall Study|Ineligibility determined|4
2740261|NCT00089661|9407200|P2|Overall Study|Disease progression|3
2740262|NCT00089661|9407201|P1|Overall Study|Disease progression|1
2740263|NCT00089661|9407200|P2|Overall Study|Withdrawal by Subject|9
2740264|NCT00089661|9407201|P1|Overall Study|Withdrawal by Subject|11
2740265|NCT00089661|9407200|P2|Overall Study|Lost to Follow-up|3
2740266|NCT00089661|9407201|P1|Overall Study|Lost to Follow-up|0
2740267|NCT00089661|9407200|P2|Overall Study|Death|0
2740268|NCT00089661|9407201|P1|Overall Study|Death|1
2740269|NCT00089661|9407200|P2|Overall Study|Adverse Event|2
2740270|NCT00089661|9407201|P1|Overall Study|Adverse Event|0
2740271|NCT00089648|9407217|P1|Overall Study|Lack of Efficacy|33
2740272|NCT00089648|9407217|P1|Overall Study|Withdrawal by Subject|1
2740273|NCT00089648|9407217|P1|Overall Study|Adverse Event|7
2740274|NCT00089635|9407233|P1|Overall Study|Other|2
2740275|NCT00089635|9407233|P1|Overall Study|Ineligibility determined|1
2740276|NCT00089635|9407233|P1|Overall Study|Withdrawal by Subject|6
2740277|NCT00089635|9407233|P1|Overall Study|Lost to Follow-up|3
2740278|NCT00089635|9407233|P1|Overall Study|Disease Progression|12
2740279|NCT00089635|9407233|P1|Overall Study|Death|17
2740280|NCT00089635|9407233|P1|Overall Study|Adverse Event|2
2740281|NCT00089583|9407247|P2|Overall Study|Participant Incarcerated|1
2740282|NCT00089583|9407248|P1|Overall Study|Participant Incarcerated|0
2740283|NCT00089583|9407247|P2|Overall Study|Necessity to Use Prohibited Drug|0
2740284|NCT00089583|9407248|P1|Overall Study|Necessity to Use Prohibited Drug|1
2740285|NCT00089583|9407247|P2|Overall Study|Start of Disallowed Medication|1
2740286|NCT00089583|9407248|P1|Overall Study|Start of Disallowed Medication|0
2740287|NCT00089583|9407247|P2|Overall Study|Principal Investigator Decision|10
2740288|NCT00089583|9407248|P1|Overall Study|Principal Investigator Decision|0
2740289|NCT00089583|9407247|P2|Overall Study|Protocol Violation|3
2740290|NCT00089583|9407248|P1|Overall Study|Protocol Violation|0
2740291|NCT00089583|9407247|P2|Overall Study|Reason Not Provided|1
2740292|NCT00089583|9407248|P1|Overall Study|Reason Not Provided|0
2740293|NCT00089583|9407247|P2|Overall Study|Participant Management Criteria Met|1
2740294|NCT00089583|9407248|P1|Overall Study|Participant Management Criteria Met|0
2740295|NCT00089583|9407247|P2|Overall Study|Poor Medical Compliance/Adherence Issues|3
2740296|NCT00089583|9407248|P1|Overall Study|Poor Medical Compliance/Adherence Issues|0
2740297|NCT00089583|9407247|P2|Overall Study|Non-Compliance|4
2740298|NCT00089583|9407248|P1|Overall Study|Non-Compliance|0
2740299|NCT00089583|9407247|P2|Overall Study|Participant Refused Study Medication|2
2740300|NCT00089583|9407248|P1|Overall Study|Participant Refused Study Medication|0
2740301|NCT00089583|9407247|P2|Overall Study|Participant (Par) Didn't Take Medication|0
2740302|NCT00089583|9407248|P1|Overall Study|Participant (Par) Didn't Take Medication|1
2740303|NCT00089583|9407247|P2|Overall Study|Withdrawal by Subject|4
2740304|NCT00089583|9407248|P1|Overall Study|Withdrawal by Subject|0
2740305|NCT00089583|9407247|P2|Overall Study|Insufficient Viral Load Response|5
2740306|NCT00089583|9407248|P1|Overall Study|Insufficient Viral Load Response|5
2740307|NCT00089583|9407247|P2|Overall Study|Adverse Event|3
2740308|NCT00089583|9407248|P1|Overall Study|Adverse Event|0
2740309|NCT00089609|9407342|P2|Overall Study|Withdrawal by Subject|1
2740310|NCT00089609|9407343|P1|Overall Study|Withdrawal by Subject|3
2740311|NCT00089544|9407362|P2|Overall Study|Ineligible|0
2740312|NCT00089544|9407363|P1|Overall Study|Ineligible|1
2740313|NCT00089505|9407377|P4|Overall Study|Protocol Violation|0
2740314|NCT00089505|9407378|P3|Overall Study|Protocol Violation|1
2740315|NCT00089505|9407379|P2|Overall Study|Protocol Violation|0
2740316|NCT00089505|9407380|P1|Overall Study|Protocol Violation|0
2740317|NCT00089505|9407377|P4|Overall Study|Physician Decision|0
2740318|NCT00089505|9407378|P3|Overall Study|Physician Decision|0
2740319|NCT00089505|9407379|P2|Overall Study|Physician Decision|0
2740320|NCT00089505|9407380|P1|Overall Study|Physician Decision|1
2740321|NCT00089505|9407377|P4|Overall Study|Lost to Follow-up|7
2740322|NCT00089505|9407378|P3|Overall Study|Lost to Follow-up|9
2740323|NCT00089505|9407379|P2|Overall Study|Lost to Follow-up|1
2740324|NCT00089505|9407380|P1|Overall Study|Lost to Follow-up|1
2740325|NCT00089505|9407377|P4|Overall Study|Withdrawal by Subject|6
2740326|NCT00089505|9407378|P3|Overall Study|Withdrawal by Subject|6
2740327|NCT00089505|9407379|P2|Overall Study|Withdrawal by Subject|0
2740328|NCT00089505|9407380|P1|Overall Study|Withdrawal by Subject|3
2740329|NCT00089505|9407377|P4|Overall Study|Death|8
2740330|NCT00089505|9407378|P3|Overall Study|Death|5
2740331|NCT00089505|9407379|P2|Overall Study|Death|1
2740332|NCT00089505|9407380|P1|Overall Study|Death|4
2740333|NCT00089479|9407424|P2|Overall Study|Lost to Follow-up|107
2740334|NCT00089479|9407425|P1|Overall Study|Lost to Follow-up|137
2740335|NCT00089479|9407424|P2|Overall Study|Withdrawal by Subject|107
2740336|NCT00089479|9407425|P1|Overall Study|Withdrawal by Subject|86
2740337|NCT00089479|9407424|P2|Overall Study|Death|75
2740338|NCT00089479|9407425|P1|Overall Study|Death|108
2740339|NCT00089297|9407468|P1|Overall Study|Non-compliance|1
2740340|NCT00089297|9407468|P1|Overall Study|IRB approval not ready|1
2740341|NCT00089297|9407468|P1|Overall Study|Secondary malignancy|1
2740342|NCT00089297|9407468|P1|Overall Study|Ineligible|11
2740343|NCT00089297|9407468|P1|Overall Study|Disease progression|2
2740344|NCT00089297|9407468|P1|Overall Study|Withdrawal by Subject|12
2740345|NCT00089297|9407468|P1|Overall Study|Death|1
2740346|NCT00089297|9407468|P1|Overall Study|Adverse Event|9
2740347|NCT00089284|9407480|P7|Overall Study|Adverse event before starting treatment|1
2740348|NCT00089284|9407481|P6|Overall Study|Adverse event before starting treatment|0
2740349|NCT00089284|9407482|P5|Overall Study|Adverse event before starting treatment|0
2740350|NCT00089284|9407483|P4|Overall Study|Adverse event before starting treatment|0
2740351|NCT00089284|9407484|P3|Overall Study|Adverse event before starting treatment|0
2740352|NCT00089284|9407485|P2|Overall Study|Adverse event before starting treatment|0
2740353|NCT00089284|9407486|P1|Overall Study|Adverse event before starting treatment|0
2740354|NCT00089141|9407523|P2|Overall Study|Termination of trial|24
2740355|NCT00089141|9407524|P1|Overall Study|Termination of trial|18
2740356|NCT00089076|9407560|P1|Overall Study|Progression|7
2740357|NCT00089076|9407560|P1|Overall Study|Withdrawal by Subject|2
2740358|NCT00089076|9407560|P1|Overall Study|Alternate Therapy|1
2740359|NCT00088907|9407617|P2|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0
2740360|NCT00088907|9407618|P1|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5
2740361|NCT00088907|9407617|P2|Single Gefitinib Treatment (Step 2)|unknown/not specify|0
2740362|NCT00088907|9407618|P1|Single Gefitinib Treatment (Step 2)|unknown/not specify|2
2740363|NCT00088907|9407617|P2|Single Gefitinib Treatment (Step 2)|Death|0
2740364|NCT00088907|9407618|P1|Single Gefitinib Treatment (Step 2)|Death|1
2740365|NCT00088907|9407617|P2|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0
2740366|NCT00088907|9407618|P1|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16
2740367|NCT00088907|9407617|P2|Randomized Study (Step 1)|ineligible or not start protocol therapy|12
2740368|NCT00088907|9407618|P1|Randomized Study (Step 1)|ineligible or not start protocol therapy|19
2740369|NCT00088907|9407617|P2|Randomized Study (Step 1)|unknown/not specify|13
2740370|NCT00088907|9407618|P1|Randomized Study (Step 1)|unknown/not specify|24
2740371|NCT00088907|9407617|P2|Randomized Study (Step 1)|complicating disease|1
2740372|NCT00088907|9407618|P1|Randomized Study (Step 1)|complicating disease|3
2740373|NCT00088907|9407617|P2|Randomized Study (Step 1)|Withdrawal by Subject|15
2740374|NCT00088907|9407618|P1|Randomized Study (Step 1)|Withdrawal by Subject|10
2740375|NCT00088907|9407617|P2|Randomized Study (Step 1)|Death|12
2740376|NCT00088907|9407618|P1|Randomized Study (Step 1)|Death|11
2740377|NCT00088907|9407617|P2|Randomized Study (Step 1)|Adverse Event|19
2740378|NCT00088907|9407618|P1|Randomized Study (Step 1)|Adverse Event|14
2740379|NCT00088907|9407617|P2|Randomized Study (Step 1)|Lack of Efficacy|62
2740380|NCT00088907|9407618|P1|Randomized Study (Step 1)|Lack of Efficacy|55
2740381|NCT00088881|9407629|P1|Step 2 - Zevalin™ Radioimmunotherapy|Other|3
2740382|NCT00088881|9407629|P1|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8
2740383|NCT00088881|9407629|P1|Step 1 - R-CHOP|Insurance company refused to cover|1
2740384|NCT00088881|9407629|P1|Step 1 - R-CHOP|Physician Decision|1
2740385|NCT00088881|9407629|P1|Step 1 - R-CHOP|Withdrawal by Subject|2
2740386|NCT00088881|9407629|P1|Step 1 - R-CHOP|Adverse Event|1
2740387|NCT00088881|9407629|P1|Step 1 - R-CHOP|Patient ineligible|9
2740388|NCT00088829|9407638|P1|Overall Study|PI left institution and study was close|22
2740389|NCT00088595|9407680|P1|Overall Study|New Cancer Therapy|2
2740390|NCT00088595|9407680|P1|Overall Study|Ongoing (After Core)|7
2740391|NCT00088595|9407680|P1|Overall Study|Withdrawal by Subject|8
2740392|NCT00088595|9407680|P1|Overall Study|Adverse Event|11
2740393|NCT00088530|9407698|P2|Overall Study|Patient never treated|0
2740394|NCT00088530|9407699|P1|Overall Study|Patient never treated|1
2740395|NCT00088530|9407698|P2|Overall Study|Sponsor decision|1
2740396|NCT00088530|9407699|P1|Overall Study|Sponsor decision|0
2740397|NCT00088530|9407698|P2|Overall Study|Physician Decision|0
2740398|NCT00088530|9407699|P1|Overall Study|Physician Decision|2
2740399|NCT00088530|9407698|P2|Overall Study|Lost to Follow-up|0
2740400|NCT00088530|9407699|P1|Overall Study|Lost to Follow-up|2
2740401|NCT00088530|9407698|P2|Overall Study|Withdrawal by Subject|5
2740402|NCT00088530|9407699|P1|Overall Study|Withdrawal by Subject|2
2740403|NCT00088530|9407698|P2|Overall Study|Adverse Event|9
2740404|NCT00088530|9407699|P1|Overall Study|Adverse Event|15
2740405|NCT00088530|9407698|P2|Overall Study|Progressive/Relapsed Disease|39
2740406|NCT00088530|9407699|P1|Overall Study|Progressive/Relapsed Disease|28
2740407|NCT00088465|9407711|P1|Overall Study|Death|11
2740408|NCT00088465|9407711|P1|Overall Study|Protocol Violation|17
2740409|NCT00088465|9407711|P1|Overall Study|Lack of Efficacy|27
2740410|NCT00088465|9407711|P1|Overall Study|Sponsor Decision|37
2740411|NCT00088465|9407711|P1|Overall Study|Physician Decision|45
2740412|NCT00088465|9407711|P1|Overall Study|Lost to Follow-up|57
2740413|NCT00088465|9407711|P1|Overall Study|Adverse Event|77
2740414|NCT00088465|9407711|P1|Overall Study|Withdrawal by Subject|290
2740415|NCT00088413|9407738|P4|Overall Study|Patient unevaluable due to adverse event|0
2740416|NCT00088413|9407739|P3|Overall Study|Patient unevaluable due to adverse event|1
2740417|NCT00088413|9407740|P2|Overall Study|Patient unevaluable due to adverse event|0
2740418|NCT00088413|9407741|P1|Overall Study|Patient unevaluable due to adverse event|0
2740419|NCT00088413|9407738|P4|Overall Study|Other|0
2740420|NCT00088413|9407739|P3|Overall Study|Other|0
2740421|NCT00088413|9407740|P2|Overall Study|Other|1
2740422|NCT00088413|9407741|P1|Overall Study|Other|0
2740423|NCT00088413|9407738|P4|Overall Study|Progressive disease|14
2740424|NCT00088413|9407739|P3|Overall Study|Progressive disease|8
2740425|NCT00088413|9407740|P2|Overall Study|Progressive disease|11
2740426|NCT00088413|9407741|P1|Overall Study|Progressive disease|9
2740427|NCT00088413|9407738|P4|Overall Study|Death|0
2740428|NCT00088413|9407739|P3|Overall Study|Death|0
2740429|NCT00088413|9407740|P2|Overall Study|Death|1
2740430|NCT00088413|9407741|P1|Overall Study|Death|0
2740431|NCT00088413|9407738|P4|Overall Study|Off study due to missing a vaccine dose|0
2740432|NCT00088413|9407739|P3|Overall Study|Off study due to missing a vaccine dose|0
2740433|NCT00088413|9407740|P2|Overall Study|Off study due to missing a vaccine dose|0
2740434|NCT00088413|9407741|P1|Overall Study|Off study due to missing a vaccine dose|1
2740435|NCT00088413|9407738|P4|Overall Study|Refused trmt Off-study per pt wishes|0
2740436|NCT00088413|9407739|P3|Overall Study|Refused trmt Off-study per pt wishes|1
2740437|NCT00088413|9407740|P2|Overall Study|Refused trmt Off-study per pt wishes|1
2740438|NCT00088413|9407741|P1|Overall Study|Refused trmt Off-study per pt wishes|0
2740439|NCT00088413|9407738|P4|Overall Study|Adverse Events/Side Effects|0
2740440|NCT00088413|9407739|P3|Overall Study|Adverse Events/Side Effects|1
2740441|NCT00088413|9407740|P2|Overall Study|Adverse Events/Side Effects|1
2740442|NCT00088413|9407741|P1|Overall Study|Adverse Events/Side Effects|0
2740443|NCT00088413|9407738|P4|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
2740444|NCT00088413|9407739|P3|Overall Study|Limited supply of trmt drug (PANVAC-f)|1
2740445|NCT00088413|9407740|P2|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
2740446|NCT00088413|9407741|P1|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
2740447|NCT00088374|9407755|P1|Overall Study|patient received <1 cycle only of 17AAG|1
2740448|NCT00088374|9407755|P1|Overall Study|patient did not receive any 17AAG|1
2740449|NCT00088166|9407775|P2|Overall Study|Withdrawal by Subject|5
2740450|NCT00088166|9407776|P1|Overall Study|Withdrawal by Subject|5
2740451|NCT00088166|9407775|P2|Overall Study|Patient deterioration|39
2740452|NCT00088166|9407776|P1|Overall Study|Patient deterioration|29
2740453|NCT00088166|9407775|P2|Overall Study|Protocol Violation|5
2740454|NCT00088166|9407776|P1|Overall Study|Protocol Violation|1
2740455|NCT00088166|9407775|P2|Overall Study|Physician Decision|1
2740456|NCT00088166|9407776|P1|Overall Study|Physician Decision|4
2740457|NCT00088166|9407775|P2|Overall Study|Lost to Follow-up|1
2740458|NCT00088166|9407776|P1|Overall Study|Lost to Follow-up|0
2740459|NCT00088166|9407775|P2|Overall Study|Death|1
2740460|NCT00088166|9407776|P1|Overall Study|Death|3
2740461|NCT00088166|9407775|P2|Overall Study|Adverse Event|9
2740462|NCT00088166|9407776|P1|Overall Study|Adverse Event|11
2740463|NCT00088153|9407800|P2|Overall Study|Lost to Follow-up|12
2740464|NCT00088153|9407801|P1|Overall Study|Lost to Follow-up|11
2740465|NCT00088153|9407800|P2|Overall Study|Withdrawal by Subject|10
2740466|NCT00088153|9407801|P1|Overall Study|Withdrawal by Subject|10
2740467|NCT00088153|9407800|P2|Overall Study|Physician Decision|3
2740468|NCT00088153|9407801|P1|Overall Study|Physician Decision|3
2740469|NCT00087698|9407811|P1|Overall Study|Protocol Violation|1
2740470|NCT00087698|9407811|P1|Overall Study|Death from Study Drug Toxicity|2
2740471|NCT00087698|9407811|P1|Overall Study|Death from Study Disease|2
2740472|NCT00087698|9407811|P1|Overall Study|Clinical Relapse|1
2740473|NCT00087698|9407811|P1|Overall Study|Protocol Entry Criteria Not Met|2
2740474|NCT00087698|9407811|P1|Overall Study|Lack of Efficacy, Physician Perception|3
2740475|NCT00087698|9407811|P1|Overall Study|Withdrawal by Subject|4
2740476|NCT00087698|9407811|P1|Overall Study|Adverse Event|4
2740477|NCT00087698|9407811|P1|Overall Study|Death from Other Causes|3
2740478|NCT00087698|9407811|P1|Overall Study|Lack of Efficacy, Progressive Disease|14
2740479|NCT00087685|9407820|P1|Overall Study|Withdrawal by Subject|3
2740480|NCT00087685|9407820|P1|Overall Study|Progressive Disease|5
2740481|NCT00087685|9407820|P1|Overall Study|Non-Compliance|1
2740482|NCT00087685|9407820|P1|Overall Study|Adverse Event|5
2740483|NCT00087646|9407833|P4|Overall Study|Violation of Selection Criteria at Entry|1
2740484|NCT00087646|9407834|P3|Overall Study|Violation of Selection Criteria at Entry|0
2740485|NCT00087646|9407835|P2|Overall Study|Violation of Selection Criteria at Entry|0
2740486|NCT00087646|9407836|P1|Overall Study|Violation of Selection Criteria at Entry|1
2740487|NCT00087646|9407833|P4|Overall Study|Other Protocol Violation|0
2740488|NCT00087646|9407834|P3|Overall Study|Other Protocol Violation|0
2740489|NCT00087646|9407835|P2|Overall Study|Other Protocol Violation|1
2740490|NCT00087646|9407836|P1|Overall Study|Other Protocol Violation|3
2740491|NCT00087646|9407833|P4|Overall Study|Administrative/Other|2
2740492|NCT00087646|9407834|P3|Overall Study|Administrative/Other|1
2740493|NCT00087646|9407835|P2|Overall Study|Administrative/Other|1
2740494|NCT00087646|9407836|P1|Overall Study|Administrative/Other|6
2740495|NCT00087646|9407833|P4|Overall Study|Failure to Return|3
2740496|NCT00087646|9407834|P3|Overall Study|Failure to Return|2
2740497|NCT00087646|9407835|P2|Overall Study|Failure to Return|2
2740498|NCT00087646|9407836|P1|Overall Study|Failure to Return|5
2740499|NCT00087646|9407833|P4|Overall Study|Refused Treatment/Did Not Cooperate|5
2740500|NCT00087646|9407834|P3|Overall Study|Refused Treatment/Did Not Cooperate|4
2740501|NCT00087646|9407835|P2|Overall Study|Refused Treatment/Did Not Cooperate|6
2740502|NCT00087646|9407836|P1|Overall Study|Refused Treatment/Did Not Cooperate|13
2740503|NCT00087646|9407833|P4|Overall Study|Insufficient therapeutic response|51
2740504|NCT00087646|9407834|P3|Overall Study|Insufficient therapeutic response|38
2740505|NCT00087646|9407835|P2|Overall Study|Insufficient therapeutic response|24
2740506|NCT00087646|9407836|P1|Overall Study|Insufficient therapeutic response|64
2740507|NCT00087646|9407833|P4|Overall Study|Withdrawal by Subject|2
2740508|NCT00087646|9407834|P3|Overall Study|Withdrawal by Subject|2
2740509|NCT00087646|9407835|P2|Overall Study|Withdrawal by Subject|1
2740510|NCT00087646|9407836|P1|Overall Study|Withdrawal by Subject|6
2740511|NCT00087646|9407833|P4|Overall Study|Death|0
2740512|NCT00087646|9407834|P3|Overall Study|Death|0
2740513|NCT00087646|9407835|P2|Overall Study|Death|1
2740514|NCT00087646|9407836|P1|Overall Study|Death|0
2740515|NCT00087646|9407833|P4|Overall Study|Adverse Event|20
2740516|NCT00087646|9407834|P3|Overall Study|Adverse Event|18
2740517|NCT00087646|9407835|P2|Overall Study|Adverse Event|6
2740518|NCT00087646|9407836|P1|Overall Study|Adverse Event|37
2740519|NCT00087607|9407875|P2|Overall Study|Violation of Selection Criteria at Entry|1
2740520|NCT00087607|9407876|P1|Overall Study|Violation of Selection Criteria at Entry|0
2740521|NCT00087607|9407875|P2|Overall Study|Other Protocol Violation|2
2740522|NCT00087607|9407876|P1|Overall Study|Other Protocol Violation|5
2740523|NCT00087607|9407875|P2|Overall Study|Refused Treatment|7
2740524|NCT00087607|9407876|P1|Overall Study|Refused Treatment|5
2740525|NCT00087607|9407875|P2|Overall Study|Administrative|12
2740526|NCT00087607|9407876|P1|Overall Study|Administrative|12
2740527|NCT00087607|9407875|P2|Overall Study|Withdrew Consent|16
2740528|NCT00087607|9407876|P1|Overall Study|Withdrew Consent|12
2740529|NCT00087607|9407875|P2|Overall Study|Failure to return|17
2740530|NCT00087607|9407876|P1|Overall Study|Failure to return|21
2740531|NCT00087607|9407875|P2|Overall Study|Insufficient Therapeutic Response|42
2740532|NCT00087607|9407876|P1|Overall Study|Insufficient Therapeutic Response|53
2740533|NCT00087607|9407875|P2|Overall Study|Death|1
2740534|NCT00087607|9407876|P1|Overall Study|Death|0
2740535|NCT00087607|9407875|P2|Overall Study|Adverse Event|24
2740536|NCT00087607|9407876|P1|Overall Study|Adverse Event|14
2740537|NCT00087594|9407916|P2|Overall Study|Lack of Efficacy|5
2740538|NCT00087594|9407917|P1|Overall Study|Lack of Efficacy|2
2740539|NCT00087594|9407916|P2|Overall Study|Withdrawal by Subject|2
2740540|NCT00087594|9407917|P1|Overall Study|Withdrawal by Subject|4
2740541|NCT00087594|9407916|P2|Overall Study|Lost to Follow-up|2
2740542|NCT00087594|9407917|P1|Overall Study|Lost to Follow-up|0
2740543|NCT00087594|9407916|P2|Overall Study|Adverse Event|3
2740544|NCT00087594|9407917|P1|Overall Study|Adverse Event|2
2740545|NCT00087568|9407951|P2|Overall Study|Lack of Efficacy|1
2740546|NCT00087568|9407952|P1|Overall Study|Lack of Efficacy|24
2740547|NCT00087568|9407951|P2|Overall Study|Lost to Follow-up|0
2740548|NCT00087568|9407952|P1|Overall Study|Lost to Follow-up|1
2740549|NCT00087568|9407951|P2|Overall Study|Withdrawal by Subject|1
2740550|NCT00087568|9407952|P1|Overall Study|Withdrawal by Subject|1
2740551|NCT00087568|9407951|P2|Overall Study|Adverse Event|0
2740552|NCT00087568|9407952|P1|Overall Study|Adverse Event|4
2740553|NCT00087555|9407979|P3|Overall Study|Patient wanted to go back on Med|0
2740554|NCT00087555|9407980|P2|Overall Study|Patient wanted to go back on Med|0
2740555|NCT00087555|9407981|P1|Overall Study|Patient wanted to go back on Med|1
2740556|NCT00087555|9407979|P3|Overall Study|Chronic Migraine Headaches (Med History)|0
2740557|NCT00087555|9407980|P2|Overall Study|Chronic Migraine Headaches (Med History)|0
2740558|NCT00087555|9407981|P1|Overall Study|Chronic Migraine Headaches (Med History)|1
2740559|NCT00087555|9407979|P3|Overall Study|Non Compliance|1
2740560|NCT00087555|9407980|P2|Overall Study|Non Compliance|0
2740561|NCT00087555|9407981|P1|Overall Study|Non Compliance|0
2740562|NCT00087555|9407979|P3|Overall Study|Lack of Efficacy|1
2740563|NCT00087555|9407980|P2|Overall Study|Lack of Efficacy|0
2740564|NCT00087555|9407981|P1|Overall Study|Lack of Efficacy|2
2740565|NCT00087555|9407979|P3|Overall Study|Withdrawal by Subject|1
2740566|NCT00087555|9407980|P2|Overall Study|Withdrawal by Subject|2
2740567|NCT00087555|9407981|P1|Overall Study|Withdrawal by Subject|3
2740568|NCT00087555|9407979|P3|Overall Study|Pregnancy|1
2740569|NCT00087555|9407980|P2|Overall Study|Pregnancy|1
2740570|NCT00087555|9407981|P1|Overall Study|Pregnancy|0
2740571|NCT00087555|9407979|P3|Overall Study|Screen Failure|0
2740572|NCT00087555|9407980|P2|Overall Study|Screen Failure|1
2740573|NCT00087555|9407981|P1|Overall Study|Screen Failure|1
2740574|NCT00087555|9407979|P3|Overall Study|Protocol Violation|2
2740575|NCT00087555|9407980|P2|Overall Study|Protocol Violation|0
2740576|NCT00087555|9407981|P1|Overall Study|Protocol Violation|0
2740577|NCT00087555|9407979|P3|Overall Study|Non - Compliance|0
2740578|NCT00087555|9407980|P2|Overall Study|Non - Compliance|0
2740579|NCT00087555|9407981|P1|Overall Study|Non - Compliance|1
2740580|NCT00087555|9407979|P3|Overall Study|Lost to Follow-up|1
2740581|NCT00087555|9407980|P2|Overall Study|Lost to Follow-up|1
2740582|NCT00087555|9407981|P1|Overall Study|Lost to Follow-up|0
2740583|NCT00087555|9407979|P3|Overall Study|Adverse Event|14
2740584|NCT00087555|9407980|P2|Overall Study|Adverse Event|6
2740585|NCT00087555|9407981|P1|Overall Study|Adverse Event|3
2740586|NCT00087529|9407991|P2|Overall Study|Did Not Continue to Safety Follow-Up|5
2740587|NCT00087529|9407992|P1|Overall Study|Did Not Continue to Safety Follow-Up|5
2740588|NCT00087529|9407991|P2|Overall Study|Disease Progression|4
2740589|NCT00087529|9407992|P1|Overall Study|Disease Progression|5
2740590|NCT00087529|9407991|P2|Overall Study|Participant Noncompliance|1
2740591|NCT00087529|9407992|P1|Overall Study|Participant Noncompliance|0
2740592|NCT00087529|9407991|P2|Overall Study|Initiation of Excluded Therapy|1
2740593|NCT00087529|9407992|P1|Overall Study|Initiation of Excluded Therapy|0
2740594|NCT00087529|9407991|P2|Overall Study|Physician Decision|8
2740595|NCT00087529|9407992|P1|Overall Study|Physician Decision|4
2740596|NCT00087529|9407991|P2|Overall Study|Participant Decision|37
2740597|NCT00087529|9407992|P1|Overall Study|Participant Decision|14
2740598|NCT00087529|9407991|P2|Overall Study|Lost to Follow-up|3
2740599|NCT00087529|9407992|P1|Overall Study|Lost to Follow-up|2
2740600|NCT00087529|9407991|P2|Overall Study|Pregnancy|1
2740601|NCT00087529|9407992|P1|Overall Study|Pregnancy|0
2740602|NCT00087529|9407991|P2|Overall Study|Adverse Event|8
2740603|NCT00087529|9407992|P1|Overall Study|Adverse Event|0
2740604|NCT00087529|9407991|P2|Overall Study|Death|0
2740605|NCT00087529|9407992|P1|Overall Study|Death|1
2740606|NCT00087516|9408007|P4|Overall Study|Other|0
2740607|NCT00087516|9408008|P3|Overall Study|Other|1
2740608|NCT00087516|9408009|P2|Overall Study|Other|0
2740609|NCT00087516|9408010|P1|Overall Study|Other|0
2740610|NCT00087516|9408007|P4|Overall Study|Recommendation of Primary Care Physician|1
2740611|NCT00087516|9408008|P3|Overall Study|Recommendation of Primary Care Physician|0
2740612|NCT00087516|9408009|P2|Overall Study|Recommendation of Primary Care Physician|0
2740613|NCT00087516|9408010|P1|Overall Study|Recommendation of Primary Care Physician|0
2740614|NCT00087516|9408007|P4|Overall Study|Patient was non-compliant|0
2740615|NCT00087516|9408008|P3|Overall Study|Patient was non-compliant|0
2740616|NCT00087516|9408009|P2|Overall Study|Patient was non-compliant|1
2740617|NCT00087516|9408010|P1|Overall Study|Patient was non-compliant|3
2740618|NCT00087516|9408007|P4|Overall Study|Patient moved|0
2740619|NCT00087516|9408008|P3|Overall Study|Patient moved|1
2740620|NCT00087516|9408009|P2|Overall Study|Patient moved|2
2740621|NCT00087516|9408010|P1|Overall Study|Patient moved|3
2740622|NCT00087516|9408007|P4|Overall Study|Protocol specified discontinuation|26
2740623|NCT00087516|9408008|P3|Overall Study|Protocol specified discontinuation|33
2740624|NCT00087516|9408009|P2|Overall Study|Protocol specified discontinuation|33
2740625|NCT00087516|9408010|P1|Overall Study|Protocol specified discontinuation|35
2740626|NCT00087516|9408007|P4|Overall Study|Site terminated|0
2740627|NCT00087516|9408008|P3|Overall Study|Site terminated|1
2740628|NCT00087516|9408009|P2|Overall Study|Site terminated|2
2740629|NCT00087516|9408010|P1|Overall Study|Site terminated|0
2740630|NCT00087516|9408007|P4|Overall Study|Withdrawal by Subject|12
2740631|NCT00087516|9408008|P3|Overall Study|Withdrawal by Subject|11
2740632|NCT00087516|9408009|P2|Overall Study|Withdrawal by Subject|27
2740633|NCT00087516|9408010|P1|Overall Study|Withdrawal by Subject|16
2740634|NCT00087516|9408007|P4|Overall Study|Protocol Violation|6
2740635|NCT00087516|9408008|P3|Overall Study|Protocol Violation|3
2740636|NCT00087516|9408009|P2|Overall Study|Protocol Violation|8
2740637|NCT00087516|9408010|P1|Overall Study|Protocol Violation|4
2740638|NCT00087516|9408007|P4|Overall Study|Lost to Follow-up|5
2740639|NCT00087516|9408008|P3|Overall Study|Lost to Follow-up|5
2740640|NCT00087516|9408009|P2|Overall Study|Lost to Follow-up|6
2740641|NCT00087516|9408010|P1|Overall Study|Lost to Follow-up|8
2740642|NCT00087516|9408007|P4|Overall Study|Lack of Efficacy|29
2740643|NCT00087516|9408008|P3|Overall Study|Lack of Efficacy|39
2740644|NCT00087516|9408009|P2|Overall Study|Lack of Efficacy|80
2740645|NCT00087516|9408010|P1|Overall Study|Lack of Efficacy|82
2740646|NCT00087516|9408007|P4|Overall Study|Adverse Event|6
2740647|NCT00087516|9408008|P3|Overall Study|Adverse Event|3
2740648|NCT00087516|9408009|P2|Overall Study|Adverse Event|10
2740649|NCT00087516|9408010|P1|Overall Study|Adverse Event|10
2740650|NCT00087490|9408039|P2|Overall Study|Randomized but not treated|18
2740651|NCT00087490|9408040|P1|Overall Study|Randomized but not treated|7
2740652|NCT00087490|9408039|P2|Overall Study|Lost to Follow-Up/participant withdrawal|36
2740653|NCT00087490|9408040|P1|Overall Study|Lost to Follow-Up/participant withdrawal|28
2740654|NCT00087490|9408039|P2|Overall Study|Protocol Violation or (/) Unspecified|201
2740655|NCT00087490|9408040|P1|Overall Study|Protocol Violation or (/) Unspecified|214
2740656|NCT00087490|9408039|P2|Overall Study|Lack of Efficacy|2
2740657|NCT00087490|9408040|P1|Overall Study|Lack of Efficacy|0
2740658|NCT00087490|9408039|P2|Overall Study|Adverse Event|8
2740659|NCT00087490|9408040|P1|Overall Study|Adverse Event|3
2740660|NCT00087490|9408039|P2|Overall Study|Death|4
2740661|NCT00087490|9408040|P1|Overall Study|Death|6
2740662|NCT00087438|9408074|P1|Overall Study|Ineligible / No protocol treatment|4
2740663|NCT00087152|9408084|P1|Overall Study|Ineligible|6
2740664|NCT00087139|9408093|P3|Overall Study|Extradural disease|1
2740665|NCT00087139|9408094|P2|Overall Study|Extradural disease|0
2740666|NCT00087139|9408095|P1|Overall Study|Extradural disease|0
2740667|NCT00087139|9408093|P3|Overall Study|Response achieved|0
2740668|NCT00087139|9408094|P2|Overall Study|Response achieved|1
2740669|NCT00087139|9408095|P1|Overall Study|Response achieved|0
2740670|NCT00087139|9408093|P3|Overall Study|Use of coumadin|0
2740671|NCT00087139|9408094|P2|Overall Study|Use of coumadin|0
2740672|NCT00087139|9408095|P1|Overall Study|Use of coumadin|1
2740673|NCT00087139|9408093|P3|Overall Study|Symptomatic deterioration|3
2740674|NCT00087139|9408094|P2|Overall Study|Symptomatic deterioration|1
2740675|NCT00087139|9408095|P1|Overall Study|Symptomatic deterioration|1
2740676|NCT00087139|9408093|P3|Overall Study|Ineligible|4
2740677|NCT00087139|9408094|P2|Overall Study|Ineligible|7
2740678|NCT00087139|9408095|P1|Overall Study|Ineligible|4
2740679|NCT00087139|9408093|P3|Overall Study|Disease progression|12
2740680|NCT00087139|9408094|P2|Overall Study|Disease progression|19
2740681|NCT00087139|9408095|P1|Overall Study|Disease progression|9
2740682|NCT00087139|9408093|P3|Overall Study|Physician Decision|1
2740683|NCT00087139|9408094|P2|Overall Study|Physician Decision|1
2740684|NCT00087139|9408095|P1|Overall Study|Physician Decision|1
2740685|NCT00087139|9408093|P3|Overall Study|Withdrawal by Subject|2
2740686|NCT00087139|9408094|P2|Overall Study|Withdrawal by Subject|2
2740687|NCT00087139|9408095|P1|Overall Study|Withdrawal by Subject|3
2740688|NCT00087139|9408093|P3|Overall Study|Death|0
2740689|NCT00087139|9408094|P2|Overall Study|Death|1
2740690|NCT00087139|9408095|P1|Overall Study|Death|2
2740691|NCT00087139|9408093|P3|Overall Study|Adverse Event|13
2740692|NCT00087139|9408094|P2|Overall Study|Adverse Event|17
2740693|NCT00087139|9408095|P1|Overall Study|Adverse Event|18
2740694|NCT00087126|9408110|P1|Overall Study|Never treated|1
2740695|NCT00087126|9408110|P1|Overall Study|Ineligible - second primary|1
2740696|NCT00086996|9408135|P1|Overall Study|not eligible|5
2740697|NCT00086996|9408135|P1|Overall Study|Other|6
2740698|NCT00086996|9408135|P1|Overall Study|Withdrawal by Subject|13
2740699|NCT00086996|9408135|P1|Overall Study|progression/relapse|7
2740700|NCT00086996|9408135|P1|Overall Study|Death|4
2740701|NCT00086996|9408135|P1|Overall Study|Adverse Event|29
2740702|NCT00086684|9408157|P3|Overall Study|Other|3
2740703|NCT00086684|9408158|P2|Overall Study|Other|2
2740704|NCT00086684|9408159|P1|Overall Study|Other|4
2740705|NCT00086684|9408157|P3|Overall Study|WITHDRAWAL OF CONSENT|5
2740706|NCT00086684|9408158|P2|Overall Study|WITHDRAWAL OF CONSENT|7
2740707|NCT00086684|9408159|P1|Overall Study|WITHDRAWAL OF CONSENT|5
2740708|NCT00086684|9408157|P3|Overall Study|STUDY TERMINATED BY SPONSOR|0
2740709|NCT00086684|9408158|P2|Overall Study|STUDY TERMINATED BY SPONSOR|1
2740710|NCT00086684|9408159|P1|Overall Study|STUDY TERMINATED BY SPONSOR|0
2740711|NCT00086684|9408157|P3|Overall Study|NONCOMPLIANCE|6
2740712|NCT00086684|9408158|P2|Overall Study|NONCOMPLIANCE|7
2740713|NCT00086684|9408159|P1|Overall Study|NONCOMPLIANCE|5
2740714|NCT00086684|9408157|P3|Overall Study|Withdrawal by Subject|10
2740715|NCT00086684|9408158|P2|Overall Study|Withdrawal by Subject|4
2740716|NCT00086684|9408159|P1|Overall Study|Withdrawal by Subject|0
2740717|NCT00086684|9408157|P3|Overall Study|Protocol Violation|0
2740718|NCT00086684|9408158|P2|Overall Study|Protocol Violation|3
2740719|NCT00086684|9408159|P1|Overall Study|Protocol Violation|8
2740720|NCT00086684|9408157|P3|Overall Study|Lost to Follow-up|10
2740721|NCT00086684|9408158|P2|Overall Study|Lost to Follow-up|8
2740722|NCT00086684|9408159|P1|Overall Study|Lost to Follow-up|15
2740723|NCT00086684|9408157|P3|Overall Study|Lack of Efficacy|5
2740724|NCT00086684|9408158|P2|Overall Study|Lack of Efficacy|6
2740725|NCT00086684|9408159|P1|Overall Study|Lack of Efficacy|6
2740726|NCT00086684|9408157|P3|Overall Study|Adverse Event|14
2740727|NCT00086684|9408158|P2|Overall Study|Adverse Event|17
2740728|NCT00086684|9408159|P1|Overall Study|Adverse Event|12
2740729|NCT00086619|9408172|P2|Overall Study|Protocol Violation|1
2740730|NCT00086619|9408173|P1|Overall Study|Protocol Violation|1
2740731|NCT00086619|9408172|P2|Overall Study|Adverse Event|10
2740732|NCT00086619|9408173|P1|Overall Study|Adverse Event|8
2740733|NCT00086619|9408172|P2|Overall Study|Withdrawal by Subject|6
2740734|NCT00086619|9408173|P1|Overall Study|Withdrawal by Subject|6
2740735|NCT00086580|9408183|P2|Observation Period|Other|7
2740736|NCT00086580|9408184|P1|Observation Period|Other|8
2740737|NCT00086580|9408183|P2|Observation Period|Death|55
2740738|NCT00086580|9408184|P1|Observation Period|Death|33
2740739|NCT00086580|9408183|P2|Observation Period|Withdrawal by Subject|2
2740740|NCT00086580|9408184|P1|Observation Period|Withdrawal by Subject|4
2740741|NCT00086580|9408183|P2|Observation Period|Unable to comply with protocol|1
2740742|NCT00086580|9408184|P1|Observation Period|Unable to comply with protocol|1
2740743|NCT00086580|9408183|P2|Follow-up Period|Other|6
2740744|NCT00086580|9408184|P1|Follow-up Period|Other|7
2740745|NCT00086580|9408183|P2|Follow-up Period|Death|7
2740746|NCT00086580|9408184|P1|Follow-up Period|Death|13
2740747|NCT00086580|9408183|P2|Follow-up Period|AE - not related|0
2740748|NCT00086580|9408184|P1|Follow-up Period|AE - not related|1
2740749|NCT00086580|9408183|P2|Follow-up Period|Physician Decision|1
2740750|NCT00086580|9408184|P1|Follow-up Period|Physician Decision|0
2740751|NCT00086580|9408183|P2|Follow-up Period|Withdrawal by Subject|6
2740752|NCT00086580|9408184|P1|Follow-up Period|Withdrawal by Subject|6
2740753|NCT00086580|9408183|P2|Follow-up Period|Unable to comply with protocol|0
2740754|NCT00086580|9408184|P1|Follow-up Period|Unable to comply with protocol|5
2740755|NCT00086580|9408183|P2|Follow-up Period|Disease progression|99
2740756|NCT00086580|9408184|P1|Follow-up Period|Disease progression|72
2740757|NCT00086580|9408183|P2|Treatment Period|Other|3
2740758|NCT00086580|9408184|P1|Treatment Period|Other|5
2740759|NCT00086580|9408183|P2|Treatment Period|Death|7
2740760|NCT00086580|9408184|P1|Treatment Period|Death|5
2740761|NCT00086580|9408183|P2|Treatment Period|Anemia or thrombocytopenia|4
2740762|NCT00086580|9408184|P1|Treatment Period|Anemia or thrombocytopenia|1
2740763|NCT00086580|9408183|P2|Treatment Period|Toxicity - treatment related|15
2740764|NCT00086580|9408184|P1|Treatment Period|Toxicity - treatment related|15
2740765|NCT00086580|9408183|P2|Treatment Period|AE - not treatment related|7
2740766|NCT00086580|9408184|P1|Treatment Period|AE - not treatment related|7
2740767|NCT00086580|9408183|P2|Treatment Period|Physician Decision|7
2740768|NCT00086580|9408184|P1|Treatment Period|Physician Decision|13
2740769|NCT00086580|9408183|P2|Treatment Period|Withdrawal by Subject|8
2740770|NCT00086580|9408184|P1|Treatment Period|Withdrawal by Subject|7
2740771|NCT00086580|9408183|P2|Treatment Period|Unable to comply with protocol|1
2740772|NCT00086580|9408184|P1|Treatment Period|Unable to comply with protocol|3
2740773|NCT00086580|9408183|P2|Treatment Period|Disease progression|8
2740774|NCT00086580|9408184|P1|Treatment Period|Disease progression|9
2740775|NCT00086411|9408232|P4|Overall Study|Lost to Follow-up|12
2740776|NCT00086411|9408233|P3|Overall Study|Lost to Follow-up|13
2740777|NCT00086411|9408234|P2|Overall Study|Lost to Follow-up|11
2740778|NCT00086411|9408235|P1|Overall Study|Lost to Follow-up|11
2740779|NCT00086385|9408253|P4|Overall Study|Death|1
2740780|NCT00086385|9408254|P3|Overall Study|Death|1
2740781|NCT00086385|9408255|P2|Overall Study|Death|2
2740782|NCT00086385|9408256|P1|Overall Study|Death|2
2740783|NCT00086515|9408268|P2|Phase B (Weeks 24-104)|Discontinued in error|0
2740784|NCT00086515|9408269|P1|Phase B (Weeks 24-104)|Discontinued in error|1
2740785|NCT00086515|9408268|P2|Phase B (Weeks 24-104)|Personal Circumstance|0
2740786|NCT00086515|9408269|P1|Phase B (Weeks 24-104)|Personal Circumstance|1
2740787|NCT00086515|9408268|P2|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1
2740788|NCT00086515|9408269|P1|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0
2740789|NCT00086515|9408268|P2|Phase B (Weeks 24-104)|Patient Died|1
2740790|NCT00086515|9408269|P1|Phase B (Weeks 24-104)|Patient Died|3
2740791|NCT00086515|9408268|P2|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10
2740792|NCT00086515|9408269|P1|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36
2740793|NCT00086515|9408268|P2|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3
2740794|NCT00086515|9408269|P1|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5
2740795|NCT00086515|9408268|P2|Phase B (Weeks 24-104)|Patient Moved|2
2740796|NCT00086515|9408269|P1|Phase B (Weeks 24-104)|Patient Moved|2
2740797|NCT00086515|9408268|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|5
2740798|NCT00086515|9408269|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|15
2740799|NCT00086515|9408268|P2|Phase B (Weeks 24-104)|Protocol Violation|0
2740800|NCT00086515|9408269|P1|Phase B (Weeks 24-104)|Protocol Violation|1
2740801|NCT00086515|9408268|P2|Phase B (Weeks 24-104)|Physician Decision|0
2740802|NCT00086515|9408269|P1|Phase B (Weeks 24-104)|Physician Decision|3
2740803|NCT00086515|9408268|P2|Phase B (Weeks 24-104)|Lost to Follow-up|4
2740804|NCT00086515|9408269|P1|Phase B (Weeks 24-104)|Lost to Follow-up|13
2740805|NCT00086515|9408268|P2|Phase B (Weeks 24-104)|Lack of Efficacy|19
2740806|NCT00086515|9408269|P1|Phase B (Weeks 24-104)|Lack of Efficacy|94
2740807|NCT00086515|9408268|P2|Phase B (Weeks 24-104)|Adverse Event|10
2740808|NCT00086515|9408269|P1|Phase B (Weeks 24-104)|Adverse Event|16
2740809|NCT00086515|9408268|P2|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0
2740810|NCT00086515|9408269|P1|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1
2740811|NCT00086515|9408268|P2|Phase A to Phase B Transition Period|Poor compliance|0
2740812|NCT00086515|9408269|P1|Phase A to Phase B Transition Period|Poor compliance|1
2740813|NCT00086515|9408268|P2|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
2740814|NCT00086515|9408269|P1|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
2740815|NCT00086515|9408268|P2|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23
2740816|NCT00086515|9408269|P1|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16
2740817|NCT00086515|9408268|P2|Phase A to Phase B Transition Period|Protocol Violation|1
2740818|NCT00086515|9408269|P1|Phase A to Phase B Transition Period|Protocol Violation|0
2740819|NCT00086515|9408268|P2|Phase A to Phase B Transition Period|Withdrawal by Subject|0
2740820|NCT00086515|9408269|P1|Phase A to Phase B Transition Period|Withdrawal by Subject|1
2740821|NCT00086515|9408268|P2|Phase A to Phase B Transition Period|Lack of Efficacy|2
2740822|NCT00086515|9408269|P1|Phase A to Phase B Transition Period|Lack of Efficacy|2
2740823|NCT00086515|9408268|P2|Phase A to Phase B Transition Period|Adverse Event|1
2740824|NCT00086515|9408269|P1|Phase A to Phase B Transition Period|Adverse Event|2
2740825|NCT00086515|9408268|P2|Phase A (Weeks 0-24)|Personal Circumstance|0
2740826|NCT00086515|9408269|P1|Phase A (Weeks 0-24)|Personal Circumstance|1
2740827|NCT00086515|9408268|P2|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1
2740828|NCT00086515|9408269|P1|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0
2740829|NCT00086515|9408268|P2|Phase A (Weeks 0-24)|Poor compliance|0
2740830|NCT00086515|9408269|P1|Phase A (Weeks 0-24)|Poor compliance|1
2740831|NCT00086515|9408268|P2|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3
2740832|NCT00086515|9408269|P1|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4
2740833|NCT00086515|9408268|P2|Phase A (Weeks 0-24)|Patient Moved|3
2740834|NCT00086515|9408269|P1|Phase A (Weeks 0-24)|Patient Moved|2
2740835|NCT00086515|9408268|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|10
2740836|NCT00086515|9408269|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|10
2740837|NCT00086515|9408268|P2|Phase A (Weeks 0-24)|Protocol Violation|1
2740838|NCT00086515|9408269|P1|Phase A (Weeks 0-24)|Protocol Violation|3
2740839|NCT00086515|9408268|P2|Phase A (Weeks 0-24)|Lost to Follow-up|5
2740840|NCT00086515|9408269|P1|Phase A (Weeks 0-24)|Lost to Follow-up|4
2740841|NCT00086515|9408268|P2|Phase A (Weeks 0-24)|Lack of Efficacy|13
2740842|NCT00086515|9408269|P1|Phase A (Weeks 0-24)|Lack of Efficacy|7
2740843|NCT00086515|9408268|P2|Phase A (Weeks 0-24)|Adverse Event|9
2740844|NCT00086515|9408269|P1|Phase A (Weeks 0-24)|Adverse Event|17
2740845|NCT00086502|9408281|P2|Overall Study|Patient Accidentally Unblinded|0
2740846|NCT00086502|9408282|P1|Overall Study|Patient Accidentally Unblinded|1
2740847|NCT00086502|9408281|P2|Overall Study|Protocol Discontinuation Criteria|3
2740848|NCT00086502|9408282|P1|Overall Study|Protocol Discontinuation Criteria|1
2740849|NCT00086502|9408281|P2|Overall Study|Patient Moved|1
2740850|NCT00086502|9408282|P1|Overall Study|Patient Moved|1
2740851|NCT00086502|9408281|P2|Overall Study|Withdrawal by Subject|6
2740852|NCT00086502|9408282|P1|Overall Study|Withdrawal by Subject|5
2740853|NCT00086502|9408281|P2|Overall Study|Protocol Violation|3
2740854|NCT00086502|9408282|P1|Overall Study|Protocol Violation|3
2740855|NCT00086502|9408281|P2|Overall Study|Pregnancy|1
2740856|NCT00086502|9408282|P1|Overall Study|Pregnancy|0
2740857|NCT00086502|9408281|P2|Overall Study|Physician Decision|1
2740858|NCT00086502|9408282|P1|Overall Study|Physician Decision|1
2740859|NCT00086502|9408281|P2|Overall Study|Lost to Follow-up|1
2740860|NCT00086502|9408282|P1|Overall Study|Lost to Follow-up|3
2740861|NCT00086502|9408281|P2|Overall Study|Lack of Efficacy|2
2740862|NCT00086502|9408282|P1|Overall Study|Lack of Efficacy|0
2740863|NCT00086502|9408281|P2|Overall Study|Adverse Event|2
2740864|NCT00086502|9408282|P1|Overall Study|Adverse Event|11
2740865|NCT00086346|9408307|P2|Patients Dosed With Test Article|Lack of Efficacy|0
2740866|NCT00086346|9408308|P1|Patients Dosed With Test Article|Lack of Efficacy|11
2740867|NCT00086346|9408307|P2|Patients Dosed With Test Article|Protocol Violation|3
2740868|NCT00086346|9408308|P1|Patients Dosed With Test Article|Protocol Violation|11
2740869|NCT00086346|9408307|P2|Patients Dosed With Test Article|Withdrawal by Subject|3
2740870|NCT00086346|9408308|P1|Patients Dosed With Test Article|Withdrawal by Subject|16
2740871|NCT00086346|9408307|P2|Patients Dosed With Test Article|Nonmedical event|3
2740872|NCT00086346|9408308|P1|Patients Dosed With Test Article|Nonmedical event|7
2740873|NCT00086346|9408307|P2|Patients Dosed With Test Article|Lost to Follow-up|3
2740874|NCT00086346|9408308|P1|Patients Dosed With Test Article|Lost to Follow-up|1
2740875|NCT00086346|9408307|P2|Patients Dosed With Test Article|Adverse Event|11
2740876|NCT00086346|9408308|P1|Patients Dosed With Test Article|Adverse Event|94
2740877|NCT00086346|9408307|P2|Randomization|Did not receive test article|4
2740878|NCT00086346|9408308|P1|Randomization|Did not receive test article|4
2740879|NCT00086281|9408335|P15|Phase 2|Adverse Event|0
2740880|NCT00086281|9408336|P14|Phase 2|Adverse Event|1
2740881|NCT00086281|9408337|P13|Phase 2|Adverse Event|1
2740882|NCT00086281|9408338|P12|Phase 2|Adverse Event|0
2740883|NCT00086281|9408339|P11|Phase 2|Adverse Event|0
2740884|NCT00086281|9408340|P10|Phase 2|Adverse Event|0
2740885|NCT00086281|9408341|P9|Phase 2|Adverse Event|0
2740886|NCT00086281|9408342|P8|Phase 2|Adverse Event|0
2740887|NCT00086281|9408343|P7|Phase 2|Adverse Event|0
2740888|NCT00086281|9408344|P6|Phase 2|Adverse Event|0
2740889|NCT00086281|9408345|P5|Phase 2|Adverse Event|0
2740890|NCT00086281|9408346|P4|Phase 2|Adverse Event|0
2740891|NCT00086281|9408347|P3|Phase 2|Adverse Event|0
2740892|NCT00086281|9408348|P2|Phase 2|Adverse Event|0
2740893|NCT00086281|9408349|P1|Phase 2|Adverse Event|0
2740894|NCT00086281|9408335|P15|Phase 1|Serious Adverse Event|1
2740895|NCT00086281|9408336|P14|Phase 1|Serious Adverse Event|0
2740896|NCT00086281|9408337|P13|Phase 1|Serious Adverse Event|0
2740897|NCT00086281|9408338|P12|Phase 1|Serious Adverse Event|0
2740898|NCT00086281|9408339|P11|Phase 1|Serious Adverse Event|0
2740899|NCT00086281|9408340|P10|Phase 1|Serious Adverse Event|0
2740900|NCT00086281|9408341|P9|Phase 1|Serious Adverse Event|0
2740901|NCT00086281|9408342|P8|Phase 1|Serious Adverse Event|0
2740902|NCT00086281|9408343|P7|Phase 1|Serious Adverse Event|0
2740903|NCT00086281|9408344|P6|Phase 1|Serious Adverse Event|0
2740904|NCT00086281|9408345|P5|Phase 1|Serious Adverse Event|0
2740905|NCT00086281|9408346|P4|Phase 1|Serious Adverse Event|0
2740906|NCT00086281|9408347|P3|Phase 1|Serious Adverse Event|0
2740907|NCT00086281|9408348|P2|Phase 1|Serious Adverse Event|0
2740908|NCT00086281|9408349|P1|Phase 1|Serious Adverse Event|0
2740909|NCT00086281|9408335|P15|Phase 1|Protocol Violation|0
2740910|NCT00086281|9408336|P14|Phase 1|Protocol Violation|0
2740911|NCT00086281|9408337|P13|Phase 1|Protocol Violation|0
2740912|NCT00086281|9408338|P12|Phase 1|Protocol Violation|0
2740913|NCT00086281|9408339|P11|Phase 1|Protocol Violation|1
2740914|NCT00086281|9408340|P10|Phase 1|Protocol Violation|0
2740915|NCT00086281|9408341|P9|Phase 1|Protocol Violation|0
2740916|NCT00086281|9408342|P8|Phase 1|Protocol Violation|0
2740917|NCT00086281|9408343|P7|Phase 1|Protocol Violation|0
2740918|NCT00086281|9408344|P6|Phase 1|Protocol Violation|0
2740919|NCT00086281|9408345|P5|Phase 1|Protocol Violation|0
2740920|NCT00086281|9408346|P4|Phase 1|Protocol Violation|0
2740921|NCT00086281|9408347|P3|Phase 1|Protocol Violation|0
2740922|NCT00086281|9408348|P2|Phase 1|Protocol Violation|0
2740923|NCT00086281|9408349|P1|Phase 1|Protocol Violation|0
2740924|NCT00086281|9408335|P15|Phase 1|Adverse Event|2
2740925|NCT00086281|9408336|P14|Phase 1|Adverse Event|1
2740926|NCT00086281|9408337|P13|Phase 1|Adverse Event|1
2740927|NCT00086281|9408338|P12|Phase 1|Adverse Event|1
2740928|NCT00086281|9408339|P11|Phase 1|Adverse Event|2
2740929|NCT00086281|9408340|P10|Phase 1|Adverse Event|1
2740930|NCT00086281|9408341|P9|Phase 1|Adverse Event|0
2740931|NCT00086281|9408342|P8|Phase 1|Adverse Event|0
2740932|NCT00086281|9408343|P7|Phase 1|Adverse Event|0
2740933|NCT00086281|9408344|P6|Phase 1|Adverse Event|0
2740934|NCT00086281|9408345|P5|Phase 1|Adverse Event|0
2740935|NCT00086281|9408346|P4|Phase 1|Adverse Event|0
2740936|NCT00086281|9408347|P3|Phase 1|Adverse Event|0
2740937|NCT00086281|9408348|P2|Phase 1|Adverse Event|0
2740938|NCT00086281|9408349|P1|Phase 1|Adverse Event|0
2740939|NCT00086307|9408362|P3|Overall Study|Withdrawal by Subject|2
2740940|NCT00086307|9408363|P2|Overall Study|Withdrawal by Subject|0
2740941|NCT00086307|9408364|P1|Overall Study|Withdrawal by Subject|0
2740942|NCT00086307|9408362|P3|Overall Study|Fatigue and difficulty falling asleep|1
2740943|NCT00086307|9408363|P2|Overall Study|Fatigue and difficulty falling asleep|0
2740944|NCT00086307|9408364|P1|Overall Study|Fatigue and difficulty falling asleep|0
2740945|NCT00086307|9408362|P3|Overall Study|Suicidal ideation|1
2740946|NCT00086307|9408363|P2|Overall Study|Suicidal ideation|0
2740947|NCT00086307|9408364|P1|Overall Study|Suicidal ideation|0
2740948|NCT00086307|9408362|P3|Overall Study|Constipation and sleepiness|1
2740949|NCT00086307|9408363|P2|Overall Study|Constipation and sleepiness|0
2740950|NCT00086307|9408364|P1|Overall Study|Constipation and sleepiness|0
2740951|NCT00086307|9408362|P3|Overall Study|Nausea and headaches|1
2740952|NCT00086307|9408363|P2|Overall Study|Nausea and headaches|0
2740953|NCT00086307|9408364|P1|Overall Study|Nausea and headaches|0
2740954|NCT00086307|9408362|P3|Overall Study|Shortness of breath and muscle spasms|0
2740955|NCT00086307|9408363|P2|Overall Study|Shortness of breath and muscle spasms|0
2740956|NCT00086307|9408364|P1|Overall Study|Shortness of breath and muscle spasms|1
2740957|NCT00086307|9408362|P3|Overall Study|Lack of Efficacy|2
2740958|NCT00086307|9408363|P2|Overall Study|Lack of Efficacy|1
2740959|NCT00086307|9408364|P1|Overall Study|Lack of Efficacy|1
2740960|NCT00086190|9408375|P3|Overall Study|Worsening depression|2
2740961|NCT00086190|9408376|P2|Overall Study|Worsening depression|0
2740962|NCT00086190|9408377|P1|Overall Study|Worsening depression|0
2740963|NCT00086190|9408375|P3|Overall Study|Moved|0
2740964|NCT00086190|9408376|P2|Overall Study|Moved|0
2740965|NCT00086190|9408377|P1|Overall Study|Moved|1
2740966|NCT00086190|9408375|P3|Overall Study|Protocol Violation|0
2740967|NCT00086190|9408376|P2|Overall Study|Protocol Violation|0
2740968|NCT00086190|9408377|P1|Overall Study|Protocol Violation|1
2740969|NCT00086190|9408375|P3|Overall Study|Withdrawal by Subject|2
2740970|NCT00086190|9408376|P2|Overall Study|Withdrawal by Subject|2
2740971|NCT00086190|9408377|P1|Overall Study|Withdrawal by Subject|0
2740972|NCT00086190|9408375|P3|Overall Study|Adverse Event|2
2740973|NCT00086190|9408376|P2|Overall Study|Adverse Event|2
2740974|NCT00086190|9408377|P1|Overall Study|Adverse Event|6
2740975|NCT00086047|9408446|P2|Overall Study|Physician Decision|1
2740976|NCT00086047|9408447|P1|Overall Study|Physician Decision|0
2740977|NCT00086047|9408446|P2|Overall Study|Lost to Follow-up|6
2740978|NCT00086047|9408447|P1|Overall Study|Lost to Follow-up|7
2740979|NCT00085917|9408455|P2|Overall Study|Adverse Event|3
2740980|NCT00085917|9408456|P1|Overall Study|Adverse Event|4
2740981|NCT00085735|9408485|P6|Overall Study|Pt transferred to inst w/out study open|0
2740982|NCT00085735|9408486|P5|Overall Study|Pt transferred to inst w/out study open|0
2740983|NCT00085735|9408487|P4|Overall Study|Pt transferred to inst w/out study open|0
2740984|NCT00085735|9408488|P3|Overall Study|Pt transferred to inst w/out study open|0
2740985|NCT00085735|9408489|P2|Overall Study|Pt transferred to inst w/out study open|0
2740986|NCT00085735|9408490|P1|Overall Study|Pt transferred to inst w/out study open|1
2740987|NCT00085735|9408485|P6|Overall Study|Reason not documented|0
2740988|NCT00085735|9408486|P5|Overall Study|Reason not documented|1
2740989|NCT00085735|9408487|P4|Overall Study|Reason not documented|0
2740990|NCT00085735|9408488|P3|Overall Study|Reason not documented|1
2740991|NCT00085735|9408489|P2|Overall Study|Reason not documented|0
2740992|NCT00085735|9408490|P1|Overall Study|Reason not documented|1
2740993|NCT00085735|9408485|P6|Overall Study|Excess residual disease|4
2740994|NCT00085735|9408486|P5|Overall Study|Excess residual disease|1
2740995|NCT00085735|9408487|P4|Overall Study|Excess residual disease|1
2740996|NCT00085735|9408488|P3|Overall Study|Excess residual disease|1
2740997|NCT00085735|9408489|P2|Overall Study|Excess residual disease|2
2740998|NCT00085735|9408490|P1|Overall Study|Excess residual disease|2
2740999|NCT00085735|9408485|P6|Overall Study|Patient ineligible|8
2741000|NCT00085735|9408486|P5|Overall Study|Patient ineligible|17
2741001|NCT00085735|9408487|P4|Overall Study|Patient ineligible|7
2741002|NCT00085735|9408488|P3|Overall Study|Patient ineligible|3
2741003|NCT00085735|9408489|P2|Overall Study|Patient ineligible|0
2741004|NCT00085735|9408490|P1|Overall Study|Patient ineligible|1
2741005|NCT00085735|9408485|P6|Overall Study|Withdrawal by Subject|8
2741006|NCT00085735|9408486|P5|Overall Study|Withdrawal by Subject|7
2741007|NCT00085735|9408487|P4|Overall Study|Withdrawal by Subject|5
2741008|NCT00085735|9408488|P3|Overall Study|Withdrawal by Subject|4
2741009|NCT00085735|9408489|P2|Overall Study|Withdrawal by Subject|0
2741010|NCT00085735|9408490|P1|Overall Study|Withdrawal by Subject|1
2741011|NCT00085735|9408485|P6|Overall Study|Protocol Violation|0
2741012|NCT00085735|9408486|P5|Overall Study|Protocol Violation|0
2741013|NCT00085735|9408487|P4|Overall Study|Protocol Violation|0
2741014|NCT00085735|9408488|P3|Overall Study|Protocol Violation|0
2741015|NCT00085735|9408489|P2|Overall Study|Protocol Violation|0
2741016|NCT00085735|9408490|P1|Overall Study|Protocol Violation|1
2741017|NCT00085735|9408485|P6|Overall Study|Physician Decision|8
2741018|NCT00085735|9408486|P5|Overall Study|Physician Decision|11
2741019|NCT00085735|9408487|P4|Overall Study|Physician Decision|3
2741020|NCT00085735|9408488|P3|Overall Study|Physician Decision|2
2741021|NCT00085735|9408489|P2|Overall Study|Physician Decision|3
2741022|NCT00085735|9408490|P1|Overall Study|Physician Decision|2
2741023|NCT00085735|9408485|P6|Overall Study|Lost to Follow-up|0
2741024|NCT00085735|9408486|P5|Overall Study|Lost to Follow-up|1
2741025|NCT00085735|9408487|P4|Overall Study|Lost to Follow-up|0
2741026|NCT00085735|9408488|P3|Overall Study|Lost to Follow-up|0
2741027|NCT00085735|9408489|P2|Overall Study|Lost to Follow-up|1
2741028|NCT00085735|9408490|P1|Overall Study|Lost to Follow-up|0
2741029|NCT00085735|9408485|P6|Overall Study|Lack of Efficacy|3
2741030|NCT00085735|9408486|P5|Overall Study|Lack of Efficacy|4
2741031|NCT00085735|9408487|P4|Overall Study|Lack of Efficacy|3
2741032|NCT00085735|9408488|P3|Overall Study|Lack of Efficacy|6
2741033|NCT00085735|9408489|P2|Overall Study|Lack of Efficacy|4
2741034|NCT00085735|9408490|P1|Overall Study|Lack of Efficacy|2
2741035|NCT00085735|9408485|P6|Overall Study|Adverse Event|0
2741036|NCT00085735|9408486|P5|Overall Study|Adverse Event|0
2741037|NCT00085735|9408487|P4|Overall Study|Adverse Event|0
2741038|NCT00085735|9408488|P3|Overall Study|Adverse Event|0
2741039|NCT00085735|9408489|P2|Overall Study|Adverse Event|0
2741040|NCT00085735|9408490|P1|Overall Study|Adverse Event|1
2741041|NCT00085709|9408545|P2|Overall Study|Withdrawal by Subject|1
2741042|NCT00085709|9408546|P1|Overall Study|Withdrawal by Subject|2
2741043|NCT00085709|9408545|P2|Overall Study|Not eligible|19
2741044|NCT00085709|9408546|P1|Overall Study|Not eligible|19
2741045|NCT00085709|9408545|P2|Overall Study|Not protocol specified|22
2741046|NCT00085709|9408546|P1|Overall Study|Not protocol specified|12
2741047|NCT00085709|9408545|P2|Overall Study|Progression|4
2741048|NCT00085709|9408546|P1|Overall Study|Progression|3
2741049|NCT00085709|9408545|P2|Overall Study|Refusal unrelated to adverse events|2
2741050|NCT00085709|9408546|P1|Overall Study|Refusal unrelated to adverse events|1
2741051|NCT00085709|9408545|P2|Overall Study|Death|2
2741052|NCT00085709|9408546|P1|Overall Study|Death|8
2741053|NCT00085709|9408545|P2|Overall Study|Adverse Event|0
2741054|NCT00085709|9408546|P1|Overall Study|Adverse Event|8
2741055|NCT00085644|9408562|P3|Open-Label Period|Personal reason|4
2741056|NCT00085644|9408563|P2|Open-Label Period|Personal reason|0
2741057|NCT00085644|9408564|P1|Open-Label Period|Personal reason|0
2741058|NCT00085644|9408562|P3|Open-Label Period|Protocol Violation|4
2741059|NCT00085644|9408563|P2|Open-Label Period|Protocol Violation|0
2741060|NCT00085644|9408564|P1|Open-Label Period|Protocol Violation|0
2741061|NCT00085644|9408562|P3|Open-Label Period|Contemplating pregnancy|3
2741062|NCT00085644|9408563|P2|Open-Label Period|Contemplating pregnancy|0
2741063|NCT00085644|9408564|P1|Open-Label Period|Contemplating pregnancy|0
2741064|NCT00085644|9408562|P3|Open-Label Period|Pregnancy|3
2741065|NCT00085644|9408563|P2|Open-Label Period|Pregnancy|0
2741066|NCT00085644|9408564|P1|Open-Label Period|Pregnancy|0
2741067|NCT00085644|9408562|P3|Open-Label Period|Lack of Efficacy|15
2741068|NCT00085644|9408563|P2|Open-Label Period|Lack of Efficacy|0
2741069|NCT00085644|9408564|P1|Open-Label Period|Lack of Efficacy|0
2741070|NCT00085644|9408562|P3|Open-Label Period|Lost to Follow-up|13
2741071|NCT00085644|9408563|P2|Open-Label Period|Lost to Follow-up|0
2741072|NCT00085644|9408564|P1|Open-Label Period|Lost to Follow-up|0
2741073|NCT00085644|9408562|P3|Open-Label Period|Withdrawal by Subject|29
2741074|NCT00085644|9408563|P2|Open-Label Period|Withdrawal by Subject|0
2741075|NCT00085644|9408564|P1|Open-Label Period|Withdrawal by Subject|0
2741076|NCT00085644|9408562|P3|Open-Label Period|Adverse Event|38
2741077|NCT00085644|9408563|P2|Open-Label Period|Adverse Event|0
2741078|NCT00085644|9408564|P1|Open-Label Period|Adverse Event|0
2741079|NCT00085644|9408562|P3|Double-Blind Period|Undiagnosed pre-existing condition|0
2741080|NCT00085644|9408563|P2|Double-Blind Period|Undiagnosed pre-existing condition|1
2741081|NCT00085644|9408564|P1|Double-Blind Period|Undiagnosed pre-existing condition|0
2741082|NCT00085644|9408562|P3|Double-Blind Period|Contemplating pregnancy|0
2741083|NCT00085644|9408563|P2|Double-Blind Period|Contemplating pregnancy|0
2741084|NCT00085644|9408564|P1|Double-Blind Period|Contemplating pregnancy|1
2741085|NCT00085644|9408562|P3|Double-Blind Period|Lack/loss of efficacy|0
2741086|NCT00085644|9408563|P2|Double-Blind Period|Lack/loss of efficacy|2
2741087|NCT00085644|9408564|P1|Double-Blind Period|Lack/loss of efficacy|2
2741088|NCT00085644|9408562|P3|Double-Blind Period|Lost to Follow-up|0
2741089|NCT00085644|9408563|P2|Double-Blind Period|Lost to Follow-up|1
2741090|NCT00085644|9408564|P1|Double-Blind Period|Lost to Follow-up|2
2741091|NCT00085644|9408562|P3|Double-Blind Period|Withdrawal by Subject|0
2741092|NCT00085644|9408563|P2|Double-Blind Period|Withdrawal by Subject|0
2741093|NCT00085644|9408564|P1|Double-Blind Period|Withdrawal by Subject|3
2741094|NCT00085644|9408562|P3|Double-Blind Period|Adverse Event|0
2741095|NCT00085644|9408563|P2|Double-Blind Period|Adverse Event|2
2741096|NCT00085644|9408564|P1|Double-Blind Period|Adverse Event|5
2741097|NCT00085631|9408605|P3|Overall Study|Missing Data|7
2741098|NCT00085631|9408606|P2|Overall Study|Missing Data|11
2741099|NCT00085631|9408607|P1|Overall Study|Missing Data|4
2741100|NCT00085566|9408617|P3|Overall Study|Clinical progression|1
2741101|NCT00085566|9408618|P2|Overall Study|Clinical progression|0
2741102|NCT00085566|9408619|P1|Overall Study|Clinical progression|0
2741103|NCT00085566|9408617|P3|Overall Study|Patient Not treated|3
2741104|NCT00085566|9408618|P2|Overall Study|Patient Not treated|0
2741105|NCT00085566|9408619|P1|Overall Study|Patient Not treated|0
2741106|NCT00085566|9408617|P3|Overall Study|Adverse Event|10
2741107|NCT00085566|9408618|P2|Overall Study|Adverse Event|0
2741108|NCT00085566|9408619|P1|Overall Study|Adverse Event|0
2741109|NCT00085540|9408629|P2|Overall Study|Protocol Violation|1
2741110|NCT00085540|9408630|P1|Overall Study|Protocol Violation|0
2741111|NCT00085540|9408629|P2|Overall Study|Withdrawal by Subject|1
2741112|NCT00085540|9408630|P1|Overall Study|Withdrawal by Subject|0
2741113|NCT00085423|9408642|P1|Overall Study|screen failure|1
2741114|NCT00085423|9408642|P1|Overall Study|Withdrawal by Subject|1
2741115|NCT00085202|9408693|P2|Overall Study|Progressive disease|11
2741116|NCT00085202|9408694|P1|Overall Study|Progressive disease|1
2741117|NCT00085202|9408693|P2|Overall Study|Physician Decision|1
2741118|NCT00085202|9408694|P1|Overall Study|Physician Decision|4
2741119|NCT00085202|9408693|P2|Overall Study|Withdrawal by Subject|1
2741120|NCT00085202|9408694|P1|Overall Study|Withdrawal by Subject|2
2741121|NCT00085202|9408693|P2|Overall Study|Non-specified|5
2741122|NCT00085202|9408694|P1|Overall Study|Non-specified|3
2741123|NCT00085202|9408693|P2|Overall Study|Excessive toxicity|5
2741124|NCT00085202|9408694|P1|Overall Study|Excessive toxicity|6
2741125|NCT00085202|9408693|P2|Overall Study|Bone involvement confirmed by bone scan|1
2741126|NCT00085202|9408694|P1|Overall Study|Bone involvement confirmed by bone scan|0
2741127|NCT00085202|9408693|P2|Overall Study|Still on therapy|0
2741128|NCT00085202|9408694|P1|Overall Study|Still on therapy|2
2741129|NCT00085098|9408715|P2|Overall Study|Ineligible|1
2741130|NCT00085098|9408716|P1|Overall Study|Ineligible|1
2741131|NCT00085098|9408715|P2|Overall Study|Withdrawal by Subject|1
2741132|NCT00085098|9408716|P1|Overall Study|Withdrawal by Subject|0
2741133|NCT00084864|9408730|P4|Overall Study|Adverse Event|0
2741134|NCT00084864|9408731|P3|Overall Study|Adverse Event|0
2741135|NCT00084864|9408732|P2|Overall Study|Adverse Event|0
2741136|NCT00084864|9408733|P1|Overall Study|Adverse Event|1
2741137|NCT00084838|9408759|P1|Overall Study|Ineligible|4
2741138|NCT00084838|9408759|P1|Overall Study|Pt Non-Compliance|1
2741139|NCT00084838|9408759|P1|Overall Study|Progressive Disease|4
2741140|NCT00084838|9408759|P1|Overall Study|Withdrawal by Subject|1
2741141|NCT00084838|9408759|P1|Overall Study|Adverse Event|2
2741142|NCT00084838|9408759|P1|Overall Study|Death|1
2741143|NCT00084747|9408781|P1|Overall Study|Withdrawal by Subject|2
2741144|NCT00084747|9408781|P1|Overall Study|Death|3
2741145|NCT00084747|9408781|P1|Overall Study|Relapsed|8
2741146|NCT00084682|9408786|P1|Overall Study|Withdrawal by Subject|1
2741147|NCT00084617|9408790|P1|Overall Study|Protocol Violation|1
2741148|NCT00084617|9408790|P1|Overall Study|Lack of Efficacy|1
2741149|NCT00084617|9408790|P1|Overall Study|Withdrawal by Subject|7
2741150|NCT00084487|9408796|P1|Overall Study|Death|1
2741151|NCT00084318|9408840|P2|Overall Study|No protocol treatment|0
2741152|NCT00084318|9408841|P1|Overall Study|No protocol treatment|2
2741153|NCT00084318|9408840|P2|Overall Study|Protocol Violation|11
2741154|NCT00084318|9408841|P1|Overall Study|Protocol Violation|15
2741155|NCT00084318|9408840|P2|Overall Study|Withdrawal by Subject|2
2741156|NCT00084318|9408841|P1|Overall Study|Withdrawal by Subject|5
2741157|NCT00084266|9408861|P2|Overall Study|Randomized not treated|20
2741158|NCT00084266|9408862|P1|Overall Study|Randomized not treated|21
2741159|NCT00084266|9408861|P2|Overall Study|Other|344
2741160|NCT00084266|9408862|P1|Overall Study|Other|360
2741161|NCT00084266|9408861|P2|Overall Study|Participant not willing to participate|8
2741162|NCT00084266|9408862|P1|Overall Study|Participant not willing to participate|3
2741163|NCT00084266|9408861|P2|Overall Study|Lost to Follow-up|3
2741164|NCT00084266|9408862|P1|Overall Study|Lost to Follow-up|5
2741165|NCT00084266|9408861|P2|Overall Study|Lack of Efficacy|4
2741166|NCT00084266|9408862|P1|Overall Study|Lack of Efficacy|2
2741167|NCT00084266|9408861|P2|Overall Study|Adverse Event|5
2741168|NCT00084266|9408862|P1|Overall Study|Adverse Event|8
2741169|NCT00084266|9408861|P2|Overall Study|Death|39
2741170|NCT00084266|9408862|P1|Overall Study|Death|42
2741171|NCT00084136|9408920|P3|NRTI Comparison|Not reason above|0
2741172|NCT00084136|9408921|P2|NRTI Comparison|Not reason above|0
2741173|NCT00084136|9408922|P1|NRTI Comparison|Not reason above|1
2741174|NCT00084136|9408920|P3|NRTI Comparison|Clinic site closed|14
2741175|NCT00084136|9408921|P2|NRTI Comparison|Clinic site closed|0
2741176|NCT00084136|9408922|P1|NRTI Comparison|Clinic site closed|12
2741177|NCT00084136|9408920|P3|NRTI Comparison|Withdrawal by Subject|38
2741178|NCT00084136|9408921|P2|NRTI Comparison|Withdrawal by Subject|0
2741179|NCT00084136|9408922|P1|NRTI Comparison|Withdrawal by Subject|54
2741180|NCT00084136|9408920|P3|NRTI Comparison|Lost to Follow-up|12
2741181|NCT00084136|9408921|P2|NRTI Comparison|Lost to Follow-up|0
2741182|NCT00084136|9408922|P1|NRTI Comparison|Lost to Follow-up|14
2741183|NCT00084136|9408920|P3|NRTI Comparison|Death|18
2741184|NCT00084136|9408921|P2|NRTI Comparison|Death|0
2741185|NCT00084136|9408922|P1|NRTI Comparison|Death|20
2741186|NCT00084136|9408920|P3|PI Comparison|Clinic site closed|0
2741187|NCT00084136|9408921|P2|PI Comparison|Clinic site closed|0
2741188|NCT00084136|9408922|P1|PI Comparison|Clinic site closed|1
2741189|NCT00084136|9408920|P3|PI Comparison|Withdrawal by Subject|0
2741190|NCT00084136|9408921|P2|PI Comparison|Withdrawal by Subject|30
2741191|NCT00084136|9408922|P1|PI Comparison|Withdrawal by Subject|33
2741192|NCT00084136|9408920|P3|PI Comparison|Lost to Follow-up|0
2741193|NCT00084136|9408921|P2|PI Comparison|Lost to Follow-up|8
2741194|NCT00084136|9408922|P1|PI Comparison|Lost to Follow-up|11
2741195|NCT00084136|9408920|P3|PI Comparison|Death|0
2741196|NCT00084136|9408921|P2|PI Comparison|Death|9
2741197|NCT00084136|9408922|P1|PI Comparison|Death|10
2741198|NCT00084084|9408981|P1|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1
2741199|NCT00084084|9408981|P1|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1
2741200|NCT00083915|9408991|P2|Overall Study|Insurance issues|1
2741201|NCT00083915|9408992|P1|Overall Study|Insurance issues|1
2741202|NCT00083915|9408991|P2|Overall Study|No response|1
2741203|NCT00083915|9408992|P1|Overall Study|No response|3
2741204|NCT00083915|9408991|P2|Overall Study|Failure to collect|0
2741205|NCT00083915|9408992|P1|Overall Study|Failure to collect|3
2741206|NCT00083915|9408991|P2|Overall Study|disease progression|23
2741207|NCT00083915|9408992|P1|Overall Study|disease progression|18
2741208|NCT00083915|9408991|P2|Overall Study|Withdrawal by Subject|3
2741209|NCT00083915|9408992|P1|Overall Study|Withdrawal by Subject|8
2741210|NCT00083915|9408991|P2|Overall Study|Physician Decision|6
2741211|NCT00083915|9408992|P1|Overall Study|Physician Decision|11
2741212|NCT00083915|9408991|P2|Overall Study|Death|3
2741213|NCT00083915|9408992|P1|Overall Study|Death|6
2741214|NCT00083889|9409000|P2|Overall Study|Crossover to SU011248|25
2741215|NCT00083889|9409001|P1|Overall Study|Crossover to SU011248|0
2741216|NCT00083889|9409000|P2|Overall Study|Completed on marketed sunitinub|0
2741217|NCT00083889|9409001|P1|Overall Study|Completed on marketed sunitinub|3
2741218|NCT00083889|9409000|P2|Overall Study|Randomized: did not take study drug|15
2741219|NCT00083889|9409001|P1|Overall Study|Randomized: did not take study drug|0
2741220|NCT00083889|9409000|P2|Overall Study|Decision of sponsor|4
2741221|NCT00083889|9409001|P1|Overall Study|Decision of sponsor|32
2741222|NCT00083889|9409000|P2|Overall Study|Lack of Efficacy|219
2741223|NCT00083889|9409001|P1|Overall Study|Lack of Efficacy|240
2741224|NCT00083889|9409000|P2|Overall Study|Withdrawal by Subject|24
2741225|NCT00083889|9409001|P1|Overall Study|Withdrawal by Subject|22
2741226|NCT00083889|9409000|P2|Overall Study|Protocol Violation|2
2741227|NCT00083889|9409001|P1|Overall Study|Protocol Violation|2
2741228|NCT00083889|9409000|P2|Overall Study|Adverse Event|86
2741229|NCT00083889|9409001|P1|Overall Study|Adverse Event|76
2741230|NCT00083759|9409059|P2|Overall Study|Other|13
2741231|NCT00083759|9409060|P1|Overall Study|Other|14
2741232|NCT00083759|9409059|P2|Overall Study|Sponsor's Discretion|29
2741233|NCT00083759|9409060|P1|Overall Study|Sponsor's Discretion|28
2741234|NCT00083759|9409059|P2|Overall Study|Non-Compliance|0
2741235|NCT00083759|9409060|P1|Overall Study|Non-Compliance|1
2741236|NCT00083759|9409059|P2|Overall Study|Subject Withdrew Consent|2
2741237|NCT00083759|9409060|P1|Overall Study|Subject Withdrew Consent|2
2741238|NCT00083759|9409059|P2|Overall Study|Inadequate Therapeutic Response|35
2741239|NCT00083759|9409060|P1|Overall Study|Inadequate Therapeutic Response|32
2741240|NCT00083759|9409059|P2|Overall Study|Death|1
2741241|NCT00083759|9409060|P1|Overall Study|Death|1
2741242|NCT00083759|9409059|P2|Overall Study|Lost to Follow-up|0
2741243|NCT00083759|9409060|P1|Overall Study|Lost to Follow-up|1
2741244|NCT00083759|9409059|P2|Overall Study|Adverse Event|3
2741245|NCT00083759|9409060|P1|Overall Study|Adverse Event|5
2741246|NCT00083616|9409078|P1|Overall Study|Other|6
2741247|NCT00083616|9409078|P1|Overall Study|Non-compliance|1
2741248|NCT00083616|9409078|P1|Overall Study|Ineligibility determined|2
2741249|NCT00083616|9409078|P1|Overall Study|Withdrawal by Subject|3
2741250|NCT00083616|9409078|P1|Overall Study|Physician Decision|2
2741251|NCT00083616|9409078|P1|Overall Study|Lost to Follow-up|1
2741252|NCT00083616|9409078|P1|Overall Study|Disease Progression|16
2741253|NCT00082888|9409106|P3|Overall Study|Ineligible|0
2741254|NCT00082888|9409107|P2|Overall Study|Ineligible|0
2741255|NCT00082888|9409108|P1|Overall Study|Ineligible|1
2741256|NCT00082810|9409128|P1|Overall Study|Withdrawal by Subject|4
2741257|NCT00082810|9409128|P1|Overall Study|Progressive disease|24
2741258|NCT00082810|9409128|P1|Overall Study|Adverse Event|3
2741259|NCT00082758|9409139|P3|Overall Study|Protocol Violation|0
2741260|NCT00082758|9409140|P2|Overall Study|Protocol Violation|1
2741261|NCT00082758|9409141|P1|Overall Study|Protocol Violation|0
2741262|NCT00082758|9409139|P3|Overall Study|Withdrawal by Subject|0
2741263|NCT00082758|9409140|P2|Overall Study|Withdrawal by Subject|0
2741264|NCT00082758|9409141|P1|Overall Study|Withdrawal by Subject|3
2741265|NCT00082758|9409139|P3|Overall Study|Physician Decision|0
2741266|NCT00082758|9409140|P2|Overall Study|Physician Decision|1
2741267|NCT00082758|9409141|P1|Overall Study|Physician Decision|0
2741268|NCT00082758|9409139|P3|Overall Study|Lack of Efficacy|0
2741269|NCT00082758|9409140|P2|Overall Study|Lack of Efficacy|13
2741270|NCT00082758|9409141|P1|Overall Study|Lack of Efficacy|12
2741271|NCT00082758|9409139|P3|Overall Study|Adverse Event|0
2741272|NCT00082758|9409140|P2|Overall Study|Adverse Event|2
2741273|NCT00082758|9409141|P1|Overall Study|Adverse Event|0
2741274|NCT00083226|9409161|P1|Overall Study|ineligible or not receiving treatment|4
2741275|NCT00083226|9409161|P1|Overall Study|Other|2
2741276|NCT00083226|9409161|P1|Overall Study|Withdrawal by Subject|4
2741277|NCT00083226|9409161|P1|Overall Study|Death|4
2741278|NCT00083226|9409161|P1|Overall Study|Adverse Event|9
2741279|NCT00083226|9409161|P1|Overall Study|Lack of Efficacy|19
2741280|NCT00082628|9409205|P5|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17
2741281|NCT00082628|9409206|P4|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
2741282|NCT00082628|9409207|P3|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
2741283|NCT00082628|9409208|P2|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
2741284|NCT00082628|9409209|P1|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
2741285|NCT00082628|9409205|P5|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
2741286|NCT00082628|9409206|P4|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1
2741287|NCT00082628|9409207|P3|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
2741288|NCT00082628|9409208|P2|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
2741289|NCT00082628|9409209|P1|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
2741290|NCT00082628|9409205|P5|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1
2741291|NCT00082628|9409206|P4|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
2741292|NCT00082628|9409207|P3|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
2741293|NCT00082628|9409208|P2|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
2741294|NCT00082628|9409209|P1|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
2741295|NCT00082628|9409205|P5|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
2741296|NCT00082628|9409206|P4|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
2741297|NCT00082628|9409207|P3|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
2741298|NCT00082628|9409208|P2|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15
2741299|NCT00082628|9409209|P1|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1
2741300|NCT00082628|9409205|P5|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
2741301|NCT00082628|9409206|P4|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
2741302|NCT00082628|9409207|P3|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
2741303|NCT00082628|9409208|P2|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43
2741304|NCT00082628|9409209|P1|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5
2741305|NCT00082628|9409205|P5|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
2741306|NCT00082628|9409206|P4|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
2741307|NCT00082628|9409207|P3|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
2741308|NCT00082628|9409208|P2|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1
2741309|NCT00082628|9409209|P1|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2
2741310|NCT00082628|9409205|P5|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
2741311|NCT00082628|9409206|P4|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
2741312|NCT00082628|9409207|P3|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
2741313|NCT00082628|9409208|P2|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1
2741314|NCT00082628|9409209|P1|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
2741315|NCT00082433|9409229|P2|Overall Study|Impending surgery|1
2741316|NCT00082433|9409230|P1|Overall Study|Impending surgery|0
2741317|NCT00082433|9409229|P2|Overall Study|New primary cancer|0
2741318|NCT00082433|9409230|P1|Overall Study|New primary cancer|1
2741319|NCT00082433|9409229|P2|Overall Study|Noncompliance|1
2741320|NCT00082433|9409230|P1|Overall Study|Noncompliance|2
2741321|NCT00082433|9409229|P2|Overall Study|Ineligible|1
2741322|NCT00082433|9409230|P1|Overall Study|Ineligible|2
2741323|NCT00082433|9409229|P2|Overall Study|Not Treated|11
2741324|NCT00082433|9409230|P1|Overall Study|Not Treated|12
2741325|NCT00082433|9409229|P2|Overall Study|Still On Treatment|1
2741326|NCT00082433|9409230|P1|Overall Study|Still On Treatment|2
2741327|NCT00082433|9409229|P2|Overall Study|Withdrawal by Subject|30
2741328|NCT00082433|9409230|P1|Overall Study|Withdrawal by Subject|55
2741329|NCT00082433|9409229|P2|Overall Study|Study Drug Toxicity|66
2741330|NCT00082433|9409230|P1|Overall Study|Study Drug Toxicity|179
2741331|NCT00082433|9409229|P2|Overall Study|Lost to Follow-up|2
2741332|NCT00082433|9409230|P1|Overall Study|Lost to Follow-up|1
2741333|NCT00082433|9409229|P2|Overall Study|Physician Decision|61
2741334|NCT00082433|9409230|P1|Overall Study|Physician Decision|50
2741335|NCT00082433|9409229|P2|Overall Study|Disease Progression/Relapse|388
2741336|NCT00082433|9409230|P1|Overall Study|Disease Progression/Relapse|270
2741337|NCT00082433|9409229|P2|Overall Study|Death|18
2741338|NCT00082433|9409230|P1|Overall Study|Death|8
2741339|NCT00082433|9409229|P2|Overall Study|Adverse Event|17
2741340|NCT00082433|9409230|P1|Overall Study|Adverse Event|12
2741341|NCT00082381|9409250|P2|Overall Study|Loss of Glucose Control|0
2741342|NCT00082381|9409251|P1|Overall Study|Loss of Glucose Control|4
2741343|NCT00082381|9409250|P2|Overall Study|Protocol Violation|11
2741344|NCT00082381|9409251|P1|Overall Study|Protocol Violation|10
2741345|NCT00082381|9409250|P2|Overall Study|Physician Decision|2
2741346|NCT00082381|9409251|P1|Overall Study|Physician Decision|1
2741347|NCT00082381|9409250|P2|Overall Study|Patient Decision|4
2741348|NCT00082381|9409251|P1|Overall Study|Patient Decision|8
2741349|NCT00082381|9409250|P2|Overall Study|Lost to Follow-up|7
2741350|NCT00082381|9409251|P1|Overall Study|Lost to Follow-up|5
2741351|NCT00082381|9409250|P2|Overall Study|Adverse Event|2
2741352|NCT00082381|9409251|P1|Overall Study|Adverse Event|27
2741353|NCT00082407|9409271|P2|Overall Study|Lost to Follow-up|3
2741354|NCT00082407|9409272|P1|Overall Study|Lost to Follow-up|0
2741355|NCT00082407|9409271|P2|Overall Study|Death|1
2741356|NCT00082407|9409272|P1|Overall Study|Death|2
2741357|NCT00082407|9409271|P2|Overall Study|Loss of Glucose Control|2
2741358|NCT00082407|9409272|P1|Overall Study|Loss of Glucose Control|2
2741359|NCT00082407|9409271|P2|Overall Study|Physician Decision|3
2741360|NCT00082407|9409272|P1|Overall Study|Physician Decision|5
2741361|NCT00082407|9409271|P2|Overall Study|Patient Decision|6
2741362|NCT00082407|9409272|P1|Overall Study|Patient Decision|13
2741363|NCT00082407|9409271|P2|Overall Study|Protocol Violation|12
2741364|NCT00082407|9409272|P1|Overall Study|Protocol Violation|14
2741365|NCT00082407|9409271|P2|Overall Study|Adverse Event|0
2741366|NCT00082407|9409272|P1|Overall Study|Adverse Event|20
2741367|NCT00082368|9409290|P1|Overall Study|Not treated-pt had poor IV access|1
2741368|NCT00082355|9409295|P1|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28
2741369|NCT00082355|9409295|P1|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1
2741370|NCT00082355|9409295|P1|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1
2741371|NCT00082173|9409329|P2|Overall Study|Culture negative or resistant at baselin|6
2741372|NCT00082173|9409330|P1|Overall Study|Culture negative or resistant at baselin|5
2741373|NCT00082173|9409329|P2|Overall Study|Adverse Event|0
2741374|NCT00082173|9409330|P1|Overall Study|Adverse Event|1
2741375|NCT00082173|9409329|P2|Overall Study|Lost to Follow-up|0
2741376|NCT00082173|9409330|P1|Overall Study|Lost to Follow-up|1
2741377|NCT00082173|9409329|P2|Overall Study|Withdrawal by Subject|5
2741378|NCT00082173|9409330|P1|Overall Study|Withdrawal by Subject|3
2741379|NCT00081770|9409375|P3|Overall Study|Other|8
2741380|NCT00081770|9409376|P2|Overall Study|Other|7
2741381|NCT00081770|9409377|P1|Overall Study|Other|2
2741382|NCT00081770|9409375|P3|Overall Study|Administrative|1
2741383|NCT00081770|9409376|P2|Overall Study|Administrative|0
2741384|NCT00081770|9409377|P1|Overall Study|Administrative|1
2741385|NCT00081770|9409375|P3|Overall Study|Did not meet protocol eligibility|3
2741386|NCT00081770|9409376|P2|Overall Study|Did not meet protocol eligibility|0
2741387|NCT00081770|9409377|P1|Overall Study|Did not meet protocol eligibility|2
2741388|NCT00081770|9409375|P3|Overall Study|Withdrawal by Subject|42
2741389|NCT00081770|9409376|P2|Overall Study|Withdrawal by Subject|40
2741390|NCT00081770|9409377|P1|Overall Study|Withdrawal by Subject|45
2741391|NCT00081770|9409375|P3|Overall Study|Protocol Violation|10
2741392|NCT00081770|9409376|P2|Overall Study|Protocol Violation|10
2741393|NCT00081770|9409377|P1|Overall Study|Protocol Violation|15
2741394|NCT00081770|9409375|P3|Overall Study|Lost to Follow-up|45
2741395|NCT00081770|9409376|P2|Overall Study|Lost to Follow-up|34
2741396|NCT00081770|9409377|P1|Overall Study|Lost to Follow-up|45
2741397|NCT00081770|9409375|P3|Overall Study|Lack of Efficacy|211
2741398|NCT00081770|9409376|P2|Overall Study|Lack of Efficacy|357
2741399|NCT00081770|9409377|P1|Overall Study|Lack of Efficacy|262
2741400|NCT00081770|9409375|P3|Overall Study|Adverse Event|136
2741401|NCT00081770|9409376|P2|Overall Study|Adverse Event|98
2741402|NCT00081770|9409377|P1|Overall Study|Adverse Event|130
2741403|NCT00081731|9409396|P2|Overall Study|scientific integrity issue|8
2741404|NCT00081731|9409397|P1|Overall Study|scientific integrity issue|8
2741405|NCT00081653|9409417|P2|Overall Study|Loss of bone mass|2
2741406|NCT00081653|9409418|P1|Overall Study|Loss of bone mass|0
2741407|NCT00081653|9409417|P2|Overall Study|Participant leaving country|0
2741408|NCT00081653|9409418|P1|Overall Study|Participant leaving country|1
2741409|NCT00081653|9409417|P2|Overall Study|Bone loss|0
2741410|NCT00081653|9409418|P1|Overall Study|Bone loss|2
2741411|NCT00081653|9409417|P2|Overall Study|Low bone mineral density|0
2741412|NCT00081653|9409418|P1|Overall Study|Low bone mineral density|1
2741413|NCT00081653|9409417|P2|Overall Study|Refused Treatment|14
2741414|NCT00081653|9409418|P1|Overall Study|Refused Treatment|18
2741415|NCT00081653|9409417|P2|Overall Study|Lost to Follow-up|4
2741416|NCT00081653|9409418|P1|Overall Study|Lost to Follow-up|2
2741417|NCT00081653|9409417|P2|Overall Study|Adverse Event|17
2741418|NCT00081653|9409418|P1|Overall Study|Adverse Event|23
2741419|NCT00081497|9409436|P2|Overall Study|Non-compliance|1
2741420|NCT00081497|9409437|P1|Overall Study|Non-compliance|0
2741421|NCT00081497|9409436|P2|Overall Study|Withdrawal by Subject|0
2741422|NCT00081497|9409437|P1|Overall Study|Withdrawal by Subject|1
2741423|NCT00081497|9409436|P2|Overall Study|Death|1
2741424|NCT00081497|9409437|P1|Overall Study|Death|0
2741425|NCT00081497|9409436|P2|Overall Study|Adverse Event|0
2741426|NCT00081497|9409437|P1|Overall Study|Adverse Event|2
2741427|NCT00081458|9409455|P3|Overall Study|Randomized but not dosed|1
2741428|NCT00081458|9409456|P2|Overall Study|Randomized but not dosed|0
2741429|NCT00081458|9409457|P1|Overall Study|Randomized but not dosed|0
2741430|NCT00081458|9409455|P3|Overall Study|Withdrawal by Subject|1
2741431|NCT00081458|9409456|P2|Overall Study|Withdrawal by Subject|3
2741432|NCT00081458|9409457|P1|Overall Study|Withdrawal by Subject|0
2741433|NCT00081458|9409455|P3|Overall Study|Adverse Event|2
2741434|NCT00081458|9409456|P2|Overall Study|Adverse Event|5
2741435|NCT00081458|9409457|P1|Overall Study|Adverse Event|1
2741436|NCT00081289|9409513|P2|Overall Study|Ineligible / no protocol treatment|4
2741437|NCT00081289|9409514|P1|Overall Study|Ineligible / no protocol treatment|3
2741438|NCT00081289|9409513|P2|Overall Study|Accrued prior to chemotherapy amendment|17
2741439|NCT00081289|9409514|P1|Overall Study|Accrued prior to chemotherapy amendment|18
2741440|NCT00081263|9409558|P2|Overall Study|Inadequate data|10
2741441|NCT00081263|9409559|P1|Overall Study|Inadequate data|5
2741442|NCT00081263|9409558|P2|Overall Study|Never treated|5
2741443|NCT00081263|9409559|P1|Overall Study|Never treated|4
2741444|NCT00081263|9409558|P2|Overall Study|Inadequate pathology|1
2741445|NCT00081263|9409559|P1|Overall Study|Inadequate pathology|0
2741446|NCT00081263|9409558|P2|Overall Study|improper pre-protocol therapy|1
2741447|NCT00081263|9409559|P1|Overall Study|improper pre-protocol therapy|0
2741448|NCT00081263|9409558|P2|Overall Study|wrong cell type|5
2741449|NCT00081263|9409559|P1|Overall Study|wrong cell type|7
2741450|NCT00081263|9409558|P2|Overall Study|clerical error|0
2741451|NCT00081263|9409559|P1|Overall Study|clerical error|1
2741452|NCT00081159|9409569|P2|Overall Study|Lost to Follow-up|1
2741453|NCT00081159|9409570|P1|Overall Study|Lost to Follow-up|2
2741454|NCT00081159|9409569|P2|Overall Study|Myelosuppression prior to treatment|1
2741455|NCT00081159|9409570|P1|Overall Study|Myelosuppression prior to treatment|0
2741456|NCT00081159|9409569|P2|Overall Study|Withdrawal by Subject|3
2741457|NCT00081159|9409570|P1|Overall Study|Withdrawal by Subject|0
2741458|NCT00080938|9409580|P1|Overall Study|Ineligible|4
2741459|NCT00080938|9409580|P1|Overall Study|Not started protocol therapy|1
2741460|NCT00080938|9409580|P1|Overall Study|other disease|1
2741461|NCT00080938|9409580|P1|Overall Study|Lack of Efficacy|7
2741462|NCT00080938|9409580|P1|Overall Study|Death|2
2741463|NCT00080938|9409580|P1|Overall Study|Withdrawal by Subject|6
2741464|NCT00080938|9409580|P1|Overall Study|Adverse Event|3
2741465|NCT00080899|9409596|P1|Overall Study|Adverse Event|1
2741466|NCT00080483|9409608|P2|Overall Study|Physician Decision|1
2741467|NCT00080483|9409609|P1|Overall Study|Physician Decision|1
2741468|NCT00080483|9409608|P2|Overall Study|Lost to Follow-up|1
2741469|NCT00080483|9409609|P1|Overall Study|Lost to Follow-up|1
2741470|NCT00002525|9409617|P2|Overall Study|Never start protocol therapy|0
2741471|NCT00002525|9409618|P1|Overall Study|Never start protocol therapy|8
2741472|NCT00002525|9409617|P2|Overall Study|Other|0
2741473|NCT00002525|9409618|P1|Overall Study|Other|26
2741474|NCT00002525|9409617|P2|Overall Study|Error|0
2741475|NCT00002525|9409618|P1|Overall Study|Error|6
2741476|NCT00002525|9409617|P2|Overall Study|Duke's A, B1, D disease|0
2741477|NCT00002525|9409618|P1|Overall Study|Duke's A, B1, D disease|92
2741478|NCT00002525|9409617|P2|Overall Study|Other complicating disease|0
2741479|NCT00002525|9409618|P1|Overall Study|Other complicating disease|1
2741480|NCT00002525|9409617|P2|Overall Study|Start non-protocol therapy|0
2741481|NCT00002525|9409618|P1|Overall Study|Start non-protocol therapy|1
2741482|NCT00002525|9409617|P2|Overall Study|Withdrawal by Subject|0
2741483|NCT00002525|9409618|P1|Overall Study|Withdrawal by Subject|11
2741484|NCT00002525|9409617|P2|Overall Study|Death|0
2741485|NCT00002525|9409618|P1|Overall Study|Death|5
2741486|NCT00002525|9409617|P2|Overall Study|Adverse Event|0
2741487|NCT00002525|9409618|P1|Overall Study|Adverse Event|36
2741488|NCT00080301|9409645|P2|Overall Study|Still on Treatment as of CSR date|1
2741489|NCT00080301|9409646|P1|Overall Study|Still on Treatment as of CSR date|0
2741490|NCT00080301|9409645|P2|Overall Study|Randomized but Never Treated|10
2741491|NCT00080301|9409646|P1|Overall Study|Randomized but Never Treated|5
2741492|NCT00080288|9409666|P2|Overall Study|Miscellaneous|11
2741493|NCT00080288|9409667|P1|Overall Study|Miscellaneous|11
2741494|NCT00080288|9409666|P2|Overall Study|Withdrawal by Subject|16
2741495|NCT00080288|9409667|P1|Overall Study|Withdrawal by Subject|3
2741496|NCT00080288|9409666|P2|Overall Study|Physician Decision|2
2741497|NCT00080288|9409667|P1|Overall Study|Physician Decision|6
2741498|NCT00080288|9409666|P2|Overall Study|Lost to Follow-up|5
2741499|NCT00080288|9409667|P1|Overall Study|Lost to Follow-up|3
2741500|NCT00080288|9409666|P2|Overall Study|Adverse Event|4
2741501|NCT00080288|9409667|P1|Overall Study|Adverse Event|7
2741502|NCT00080223|9409675|P1|Overall Study|Physician Decision|1
2741503|NCT00080223|9409675|P1|Overall Study|Participant unwilling to continue|2
2741504|NCT00080223|9409675|P1|Overall Study|Non-compliance With Study Treatment|7
2741505|NCT00080223|9409675|P1|Overall Study|Lung Transplantation|9
2741506|NCT00080223|9409675|P1|Overall Study|Withdrawal by Subject|13
2741507|NCT00080223|9409675|P1|Overall Study|Death|21
2741508|NCT00080223|9409675|P1|Overall Study|Adverse Event|23
2741509|NCT00002540|9409685|P2|Overall Study|Refused Screen (Prostate Screening)|2433
2741510|NCT00002540|9409686|P1|Overall Study|Refused Screen (Prostate Screening)|0
2741511|NCT00002540|9409685|P2|Overall Study|Refused ASU (Control)|0
2741512|NCT00002540|9409686|P1|Overall Study|Refused ASU (Control)|597
2741513|NCT00002540|9409685|P2|Overall Study|Died Before ASU (Control)|0
2741514|NCT00002540|9409686|P1|Overall Study|Died Before ASU (Control)|202
2741515|NCT00002540|9409685|P2|Overall Study|Died Before Randomization|6
2741516|NCT00002540|9409686|P1|Overall Study|Died Before Randomization|2
2741517|NCT00002540|9409685|P2|Overall Study|Cancer Before Rand. (Prostate Screening)|25
2741518|NCT00002540|9409686|P1|Overall Study|Cancer Before Rand. (Prostate Screening)|0
2741519|NCT00080119|9409716|P4|Overall Study|Lost to Follow-up|14
2741520|NCT00080119|9409717|P3|Overall Study|Lost to Follow-up|19
2741521|NCT00080119|9409718|P2|Overall Study|Lost to Follow-up|19
2741522|NCT00080119|9409719|P1|Overall Study|Lost to Follow-up|16
2741523|NCT00080119|9409716|P4|Overall Study|Unwilling to adhere to study requirement|1
2741524|NCT00080119|9409717|P3|Overall Study|Unwilling to adhere to study requirement|5
2741525|NCT00080119|9409718|P2|Overall Study|Unwilling to adhere to study requirement|2
2741526|NCT00080119|9409719|P1|Overall Study|Unwilling to adhere to study requirement|3
2741527|NCT00080119|9409716|P4|Overall Study|Consent withdrawn|6
2741528|NCT00080119|9409717|P3|Overall Study|Consent withdrawn|4
2741529|NCT00080119|9409718|P2|Overall Study|Consent withdrawn|17
2741530|NCT00080119|9409719|P1|Overall Study|Consent withdrawn|13
2741531|NCT00080119|9409716|P4|Overall Study|Unable to get to clinic|1
2741532|NCT00080119|9409717|P3|Overall Study|Unable to get to clinic|7
2741533|NCT00080119|9409718|P2|Overall Study|Unable to get to clinic|24
2741534|NCT00080119|9409719|P1|Overall Study|Unable to get to clinic|24
2741535|NCT00080119|9409716|P4|Overall Study|Discontinued because of study closure|141
2741536|NCT00080119|9409717|P3|Overall Study|Discontinued because of study closure|130
2741537|NCT00080119|9409718|P2|Overall Study|Discontinued because of study closure|0
2741538|NCT00080119|9409719|P1|Overall Study|Discontinued because of study closure|0
2741539|NCT00079937|9409753|P2|Overall Study|Administrative problems|11
2741540|NCT00079937|9409754|P1|Overall Study|Administrative problems|22
2741541|NCT00079937|9409753|P2|Overall Study|Lost to Follow-up|5
2741542|NCT00079937|9409754|P1|Overall Study|Lost to Follow-up|12
2741543|NCT00079937|9409753|P2|Overall Study|Withdrawal by Subject|7
2741544|NCT00079937|9409754|P1|Overall Study|Withdrawal by Subject|21
2741545|NCT00079937|9409753|P2|Overall Study|Protocol Violation|6
2741546|NCT00079937|9409754|P1|Overall Study|Protocol Violation|8
2741547|NCT00079937|9409753|P2|Overall Study|Subject no longer requires study drug|0
2741548|NCT00079937|9409754|P1|Overall Study|Subject no longer requires study drug|3
2741549|NCT00079937|9409753|P2|Overall Study|Unsatisfactory therapeutic effect|2
2741550|NCT00079937|9409754|P1|Overall Study|Unsatisfactory therapeutic effect|1
2741551|NCT00079937|9409753|P2|Overall Study|Adverse Event|1
2741552|NCT00079937|9409754|P1|Overall Study|Adverse Event|2
2741553|NCT00009737|9409772|P2|Overall Study|Administrative/Other Reasons|1
2741554|NCT00009737|9409773|P1|Overall Study|Administrative/Other Reasons|7
2741555|NCT00009737|9409772|P2|Overall Study|Lost to Follow-up|1
2741556|NCT00009737|9409773|P1|Overall Study|Lost to Follow-up|1
2741557|NCT00009737|9409772|P2|Overall Study|Refused Treatment|16
2741558|NCT00009737|9409773|P1|Overall Study|Refused Treatment|15
2741559|NCT00009737|9409772|P2|Overall Study|Other Protocol Violation|0
2741560|NCT00009737|9409773|P1|Overall Study|Other Protocol Violation|1
2741561|NCT00009737|9409772|P2|Overall Study|Violation of Selection Criteria at Entry|9
2741654|NCT00079274|9409876|P4|Overall Study|Recurrence|15
2741562|NCT00009737|9409773|P1|Overall Study|Violation of Selection Criteria at Entry|13
2741563|NCT00009737|9409772|P2|Overall Study|Lack of Efficacy|15
2741564|NCT00009737|9409773|P1|Overall Study|Lack of Efficacy|17
2741565|NCT00009737|9409772|P2|Overall Study|Death|6
2741566|NCT00009737|9409773|P1|Overall Study|Death|4
2741567|NCT00009737|9409772|P2|Overall Study|Adverse Event|75
2741568|NCT00009737|9409773|P1|Overall Study|Adverse Event|112
2741569|NCT00079781|9409792|P3|Follow-up Period|Death|1
2741570|NCT00079781|9409793|P2|Follow-up Period|Death|0
2741571|NCT00079781|9409794|P1|Follow-up Period|Death|0
2741572|NCT00079781|9409792|P3|Follow-up Period|Lost to Follow-up|0
2741573|NCT00079781|9409793|P2|Follow-up Period|Lost to Follow-up|0
2741574|NCT00079781|9409794|P1|Follow-up Period|Lost to Follow-up|1
2741575|NCT00079781|9409792|P3|Follow-up Period|Withdrawal by Subject|1
2741576|NCT00079781|9409793|P2|Follow-up Period|Withdrawal by Subject|0
2741577|NCT00079781|9409794|P1|Follow-up Period|Withdrawal by Subject|3
2741578|NCT00079781|9409792|P3|Pre-implant Period|Did not meet I/E criteria|1
2741579|NCT00079781|9409793|P2|Pre-implant Period|Did not meet I/E criteria|1
2741580|NCT00079781|9409794|P1|Pre-implant Period|Did not meet I/E criteria|1
2741581|NCT00079781|9409792|P3|Pre-implant Period|Withdrawal by Subject|0
2741582|NCT00079781|9409793|P2|Pre-implant Period|Withdrawal by Subject|0
2741583|NCT00079781|9409794|P1|Pre-implant Period|Withdrawal by Subject|2
2741584|NCT00079677|9409803|P2|Overall Study|Miscellaneous|0
2741585|NCT00079677|9409804|P1|Overall Study|Miscellaneous|2
2741586|NCT00079677|9409803|P2|Overall Study|Withdrawal by Subject|3
2741587|NCT00079677|9409804|P1|Overall Study|Withdrawal by Subject|5
2741588|NCT00079677|9409803|P2|Overall Study|Protocol Violation|3
2741589|NCT00079677|9409804|P1|Overall Study|Protocol Violation|2
2741590|NCT00079677|9409803|P2|Overall Study|Physician Decision|0
2741591|NCT00079677|9409804|P1|Overall Study|Physician Decision|3
2741592|NCT00079677|9409803|P2|Overall Study|Lost to Follow-up|2
2741593|NCT00079677|9409804|P1|Overall Study|Lost to Follow-up|2
2741594|NCT00079677|9409803|P2|Overall Study|Lack of Efficacy|0
2741595|NCT00079677|9409804|P1|Overall Study|Lack of Efficacy|1
2741596|NCT00079677|9409803|P2|Overall Study|Adverse Event|6
2741597|NCT00079677|9409804|P1|Overall Study|Adverse Event|5
2741598|NCT00079417|9409820|P1|Overall Study|Ineligible|7
2741599|NCT00079417|9409820|P1|Overall Study|Physician Decision|2
2741600|NCT00079391|9409828|P1|Overall Study|Withdrawal by Subject|1
2741601|NCT00079339|9409840|P3|Overall Study|Disease progression|2
2741602|NCT00079339|9409841|P2|Overall Study|Disease progression|28
2741603|NCT00079339|9409842|P1|Overall Study|Disease progression|3
2741604|NCT00079339|9409840|P3|Overall Study|Withdrawal by Subject|1
2741605|NCT00079339|9409841|P2|Overall Study|Withdrawal by Subject|4
2741606|NCT00079339|9409842|P1|Overall Study|Withdrawal by Subject|0
2741607|NCT00079339|9409840|P3|Overall Study|Non-compliance|1
2741608|NCT00079339|9409841|P2|Overall Study|Non-compliance|0
2741609|NCT00079339|9409842|P1|Overall Study|Non-compliance|0
2741610|NCT00079339|9409840|P3|Overall Study|Death|0
2741611|NCT00079339|9409841|P2|Overall Study|Death|0
2741612|NCT00079339|9409842|P1|Overall Study|Death|1
2741613|NCT00079339|9409840|P3|Overall Study|Adverse Event|2
2741614|NCT00079339|9409841|P2|Overall Study|Adverse Event|7
2741615|NCT00079339|9409842|P1|Overall Study|Adverse Event|1
2741616|NCT00079274|9409873|P7|Overall Study|Other|0
2741617|NCT00079274|9409874|P6|Overall Study|Other|2
2741618|NCT00079274|9409875|P5|Overall Study|Other|1
2741619|NCT00079274|9409876|P4|Overall Study|Other|55
2741620|NCT00079274|9409877|P3|Overall Study|Other|5
2741621|NCT00079274|9409878|P2|Overall Study|Other|7
2741622|NCT00079274|9409879|P1|Overall Study|Other|43
2741623|NCT00079274|9409873|P7|Overall Study|Cytogenetic resistance|0
2741624|NCT00079274|9409874|P6|Overall Study|Cytogenetic resistance|0
2741625|NCT00079274|9409875|P5|Overall Study|Cytogenetic resistance|0
2741626|NCT00079274|9409876|P4|Overall Study|Cytogenetic resistance|2
2741627|NCT00079274|9409877|P3|Overall Study|Cytogenetic resistance|0
2741628|NCT00079274|9409878|P2|Overall Study|Cytogenetic resistance|0
2741629|NCT00079274|9409879|P1|Overall Study|Cytogenetic resistance|0
2741630|NCT00079274|9409873|P7|Overall Study|Death|0
2741631|NCT00079274|9409874|P6|Overall Study|Death|0
2741632|NCT00079274|9409875|P5|Overall Study|Death|0
2741633|NCT00079274|9409876|P4|Overall Study|Death|15
2741634|NCT00079274|9409877|P3|Overall Study|Death|1
2741635|NCT00079274|9409878|P2|Overall Study|Death|0
2741636|NCT00079274|9409879|P1|Overall Study|Death|4
2741637|NCT00079274|9409873|P7|Overall Study|Other Medical Problems|0
2741638|NCT00079274|9409874|P6|Overall Study|Other Medical Problems|0
2741639|NCT00079274|9409875|P5|Overall Study|Other Medical Problems|0
2741640|NCT00079274|9409876|P4|Overall Study|Other Medical Problems|7
2741641|NCT00079274|9409877|P3|Overall Study|Other Medical Problems|0
2741642|NCT00079274|9409878|P2|Overall Study|Other Medical Problems|1
2741643|NCT00079274|9409879|P1|Overall Study|Other Medical Problems|6
2741644|NCT00079274|9409873|P7|Overall Study|Alternate Treatment|0
2741645|NCT00079274|9409874|P6|Overall Study|Alternate Treatment|0
2741646|NCT00079274|9409875|P5|Overall Study|Alternate Treatment|0
2741647|NCT00079274|9409876|P4|Overall Study|Alternate Treatment|3
2741648|NCT00079274|9409877|P3|Overall Study|Alternate Treatment|0
2741649|NCT00079274|9409878|P2|Overall Study|Alternate Treatment|1
2741650|NCT00079274|9409879|P1|Overall Study|Alternate Treatment|6
2741651|NCT00079274|9409873|P7|Overall Study|Recurrence|0
2741652|NCT00079274|9409874|P6|Overall Study|Recurrence|2
2741653|NCT00079274|9409875|P5|Overall Study|Recurrence|0
2741655|NCT00079274|9409877|P3|Overall Study|Recurrence|1
2741656|NCT00079274|9409878|P2|Overall Study|Recurrence|0
2741657|NCT00079274|9409879|P1|Overall Study|Recurrence|21
2741658|NCT00079274|9409873|P7|Overall Study|Adverse Event|0
2741659|NCT00079274|9409874|P6|Overall Study|Adverse Event|8
2741660|NCT00079274|9409875|P5|Overall Study|Adverse Event|7
2741661|NCT00079274|9409876|P4|Overall Study|Adverse Event|184
2741662|NCT00079274|9409877|P3|Overall Study|Adverse Event|8
2741663|NCT00079274|9409878|P2|Overall Study|Adverse Event|8
2741664|NCT00079274|9409879|P1|Overall Study|Adverse Event|130
2741665|NCT00079274|9409873|P7|Overall Study|Withdrawal by Subject|0
2741666|NCT00079274|9409874|P6|Overall Study|Withdrawal by Subject|8
2741667|NCT00079274|9409875|P5|Overall Study|Withdrawal by Subject|7
2741668|NCT00079274|9409876|P4|Overall Study|Withdrawal by Subject|163
2741669|NCT00079274|9409877|P3|Overall Study|Withdrawal by Subject|12
2741670|NCT00079274|9409878|P2|Overall Study|Withdrawal by Subject|10
2741671|NCT00079274|9409879|P1|Overall Study|Withdrawal by Subject|111
2741672|NCT00079183|9409900|P1|Overall Study|Specimen collection non-compliance|1
2741673|NCT00079183|9409900|P1|Overall Study|Study medication non-compliance|2
2741674|NCT00079183|9409900|P1|Overall Study|Withdrawal by Subject|4
2741675|NCT00079040|9409915|P1|Overall Study|Ineligible|1
2741676|NCT00079040|9409915|P1|Overall Study|Withdrew before treatment|1
2741677|NCT00078949|9409938|P4|Overall Study|No treated|3
2741678|NCT00078949|9409939|P3|Overall Study|No treated|3
2741679|NCT00078949|9409940|P2|Overall Study|No treated|5
2741680|NCT00078949|9409941|P1|Overall Study|No treated|4
2741681|NCT00078819|9409970|P4|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1
2741682|NCT00078819|9409971|P3|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
2741683|NCT00078819|9409972|P2|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
2741684|NCT00078819|9409973|P1|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
2741685|NCT00078819|9409970|P4|Withdrawal Period: Weeks 37-48|Entered Retreatment|13
2741686|NCT00078819|9409971|P3|Withdrawal Period: Weeks 37-48|Entered Retreatment|29
2741687|NCT00078819|9409972|P2|Withdrawal Period: Weeks 37-48|Entered Retreatment|0
2741688|NCT00078819|9409973|P1|Withdrawal Period: Weeks 37-48|Entered Retreatment|0
2741689|NCT00078819|9409970|P4|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0
2741690|NCT00078819|9409971|P3|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0
2741691|NCT00078819|9409972|P2|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25
2741692|NCT00078819|9409973|P1|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34
2741693|NCT00078819|9409970|P4|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0
2741694|NCT00078819|9409971|P3|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0
2741695|NCT00078819|9409972|P2|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2
2741696|NCT00078819|9409973|P1|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2
2741697|NCT00078819|9409970|P4|Open-label Treatment Period: Weeks 13-36|Adverse Event|0
2741698|NCT00078819|9409971|P3|Open-label Treatment Period: Weeks 13-36|Adverse Event|0
2741699|NCT00078819|9409972|P2|Open-label Treatment Period: Weeks 13-36|Adverse Event|2
2741700|NCT00078819|9409973|P1|Open-label Treatment Period: Weeks 13-36|Adverse Event|3
2741701|NCT00078819|9409970|P4|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0
2741702|NCT00078819|9409971|P3|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0
2741703|NCT00078819|9409972|P2|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1
2741704|NCT00078819|9409973|P1|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1
2741705|NCT00078819|9409970|P4|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
2741706|NCT00078819|9409971|P3|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
2741707|NCT00078819|9409972|P2|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
2741708|NCT00078819|9409973|P1|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1
2741709|NCT00078819|9409970|P4|Double-blind Treatment Period: Week 1-12|Adverse Event|0
2741710|NCT00078819|9409971|P3|Double-blind Treatment Period: Week 1-12|Adverse Event|0
2741711|NCT00078819|9409972|P2|Double-blind Treatment Period: Week 1-12|Adverse Event|1
2741712|NCT00078819|9409973|P1|Double-blind Treatment Period: Week 1-12|Adverse Event|0
2741713|NCT00078806|9409998|P4|Part 2|Adverse Event|0
2741714|NCT00078806|9409999|P3|Part 2|Adverse Event|0
2741715|NCT00078806|9410000|P2|Part 2|Adverse Event|1
2741716|NCT00078806|9410001|P1|Part 2|Adverse Event|0
2741717|NCT00078806|9409998|P4|Part 1B|Lack of Efficacy|0
2741718|NCT00078806|9409999|P3|Part 1B|Lack of Efficacy|0
2741719|NCT00078806|9410000|P2|Part 1B|Lack of Efficacy|0
2741720|NCT00078806|9410001|P1|Part 1B|Lack of Efficacy|7
2741721|NCT00078806|9409998|P4|Part 1B|Adverse Event|0
2741722|NCT00078806|9409999|P3|Part 1B|Adverse Event|0
2741723|NCT00078806|9410000|P2|Part 1B|Adverse Event|0
2741724|NCT00078806|9410001|P1|Part 1B|Adverse Event|1
2741725|NCT00078806|9409998|P4|Part 1A|Other|0
2741726|NCT00078806|9409999|P3|Part 1A|Other|0
2741727|NCT00078806|9410000|P2|Part 1A|Other|0
2741728|NCT00078806|9410001|P1|Part 1A|Other|1
2741729|NCT00078806|9409998|P4|Part 1A|Lack of Efficacy|0
2741730|NCT00078806|9409999|P3|Part 1A|Lack of Efficacy|0
2741731|NCT00078806|9410000|P2|Part 1A|Lack of Efficacy|0
2741732|NCT00078806|9410001|P1|Part 1A|Lack of Efficacy|7
2741733|NCT00078806|9409998|P4|Part 1A|Adverse Event|0
2741734|NCT00078806|9409999|P3|Part 1A|Adverse Event|0
2741735|NCT00078806|9410000|P2|Part 1A|Adverse Event|0
2741736|NCT00078806|9410001|P1|Part 1A|Adverse Event|2
2741737|NCT00078767|9410037|P2|Overall Study|Withdrawal by Subject|1
2741738|NCT00078767|9410038|P1|Overall Study|Withdrawal by Subject|1
2741739|NCT00005947|9410085|P2|Overall Study|Site Closure|0
2741740|NCT00005947|9410086|P1|Overall Study|Site Closure|1
2741741|NCT00005947|9410085|P2|Overall Study|Patient Refused to Continue|1
2741742|NCT00005947|9410086|P1|Overall Study|Patient Refused to Continue|2
2741743|NCT00005947|9410085|P2|Overall Study|Death|40
2741744|NCT00005947|9410086|P1|Overall Study|Death|54
2741745|NCT00002597|9410122|P2|Overall Study|Withdrawal by Subject|6
2741746|NCT00002597|9410123|P1|Overall Study|Withdrawal by Subject|7
2741747|NCT00002597|9410122|P2|Overall Study|Protocol Violation|17
2741748|NCT00002597|9410123|P1|Overall Study|Protocol Violation|19
2741749|NCT00078377|9410148|P3|Overall Study|Miscellaneous|1
2741750|NCT00078377|9410149|P2|Overall Study|Miscellaneous|6
2741751|NCT00078377|9410150|P1|Overall Study|Miscellaneous|2
2741752|NCT00078377|9410148|P3|Overall Study|Withdrawal by Subject|4
2741753|NCT00078377|9410149|P2|Overall Study|Withdrawal by Subject|4
2741754|NCT00078377|9410150|P1|Overall Study|Withdrawal by Subject|3
2741755|NCT00078377|9410148|P3|Overall Study|Physician Decision|0
2741756|NCT00078377|9410149|P2|Overall Study|Physician Decision|0
2741757|NCT00078377|9410150|P1|Overall Study|Physician Decision|2
2741758|NCT00078377|9410148|P3|Overall Study|Lost to Follow-up|1
2741759|NCT00078377|9410149|P2|Overall Study|Lost to Follow-up|1
2741760|NCT00078377|9410150|P1|Overall Study|Lost to Follow-up|0
2741761|NCT00078377|9410148|P3|Overall Study|Lack of Efficacy|2
2741762|NCT00078377|9410149|P2|Overall Study|Lack of Efficacy|0
2741763|NCT00078377|9410150|P1|Overall Study|Lack of Efficacy|2
2741764|NCT00078377|9410148|P3|Overall Study|Adverse Event|1
2741765|NCT00078377|9410149|P2|Overall Study|Adverse Event|5
2741766|NCT00078377|9410150|P1|Overall Study|Adverse Event|2
2741767|NCT00078338|9410165|P2|Overall Study|Subjects randomized, but not treated|3
2741768|NCT00078338|9410166|P1|Overall Study|Subjects randomized, but not treated|3
2741769|NCT00078338|9410165|P2|Overall Study|Other|16
2741770|NCT00078338|9410166|P1|Overall Study|Other|28
2741771|NCT00078338|9410165|P2|Overall Study|Disease Progression|7
2741772|NCT00078338|9410166|P1|Overall Study|Disease Progression|4
2741773|NCT00078338|9410165|P2|Overall Study|Protocol Violation|2
2741774|NCT00078338|9410166|P1|Overall Study|Protocol Violation|2
2741775|NCT00078338|9410165|P2|Overall Study|Lost to Follow-up|2
2741776|NCT00078338|9410166|P1|Overall Study|Lost to Follow-up|17
2741777|NCT00078338|9410165|P2|Overall Study|Adverse Event|24
2741778|NCT00078338|9410166|P1|Overall Study|Adverse Event|31
2741779|NCT00078325|9410259|P3|Overall Study|Miscellaneous|1
2741780|NCT00078325|9410260|P2|Overall Study|Miscellaneous|1
2741781|NCT00078325|9410261|P1|Overall Study|Miscellaneous|1
2741782|NCT00078325|9410259|P3|Overall Study|Physician Decision|1
2741783|NCT00078325|9410260|P2|Overall Study|Physician Decision|0
2741784|NCT00078325|9410261|P1|Overall Study|Physician Decision|2
2741785|NCT00078325|9410259|P3|Overall Study|Lost to Follow-up|1
2741786|NCT00078325|9410260|P2|Overall Study|Lost to Follow-up|1
2741787|NCT00078325|9410261|P1|Overall Study|Lost to Follow-up|0
2741788|NCT00078325|9410259|P3|Overall Study|Withdrawal by Subject|3
2741789|NCT00078325|9410260|P2|Overall Study|Withdrawal by Subject|5
2741790|NCT00078325|9410261|P1|Overall Study|Withdrawal by Subject|1
2741791|NCT00078325|9410259|P3|Overall Study|Protocol Violation|0
2741792|NCT00078325|9410260|P2|Overall Study|Protocol Violation|2
2741793|NCT00078325|9410261|P1|Overall Study|Protocol Violation|2
2741794|NCT00078325|9410259|P3|Overall Study|Adverse Event|5
2741795|NCT00078325|9410260|P2|Overall Study|Adverse Event|10
2741796|NCT00078325|9410261|P1|Overall Study|Adverse Event|15
2741797|NCT00078312|9410272|P1|Overall Study|Miscellaneous|33
2741798|NCT00078312|9410272|P1|Overall Study|Withdrawal by Subject|33
2741799|NCT00078312|9410272|P1|Overall Study|Protocol Violation|3
2741800|NCT00078312|9410272|P1|Overall Study|Physician Decision|9
2741801|NCT00078312|9410272|P1|Overall Study|Lost to Follow-up|41
2741802|NCT00078312|9410272|P1|Overall Study|Lack of Efficacy|15
2741803|NCT00078312|9410272|P1|Overall Study|Adverse Event|43
2741804|NCT00077974|9410287|P1|Overall Study|Decision of Sponsor|2
2741805|NCT00077974|9410287|P1|Overall Study|Lack of Efficacy|76
2741806|NCT00077974|9410287|P1|Overall Study|Withdrawal by Subject|3
2741807|NCT00077974|9410287|P1|Overall Study|Protocol Violation|1
2741808|NCT00077974|9410287|P1|Overall Study|Adverse Event|22
2741809|NCT00077857|9410304|P2|Overall Study|Other|13
2741810|NCT00077857|9410305|P1|Overall Study|Other|15
2741811|NCT00077857|9410304|P2|Overall Study|Failure to return|5
2741812|NCT00077857|9410305|P1|Overall Study|Failure to return|5
2741813|NCT00077857|9410304|P2|Overall Study|Refused treatment|21
2741814|NCT00077857|9410305|P1|Overall Study|Refused treatment|29
2741815|NCT00077857|9410304|P2|Overall Study|Other protocol violation|1
2741816|NCT00077857|9410305|P1|Overall Study|Other protocol violation|0
2741817|NCT00077857|9410304|P2|Overall Study|Violation of selection criteria at entry|1
2741818|NCT00077857|9410305|P1|Overall Study|Violation of selection criteria at entry|3
2741819|NCT00077857|9410304|P2|Overall Study|Insufficient therapeutic response|128
2741820|NCT00077857|9410305|P1|Overall Study|Insufficient therapeutic response|112
2741821|NCT00077857|9410304|P2|Overall Study|Death|3
2741822|NCT00077857|9410305|P1|Overall Study|Death|7
2741823|NCT00077857|9410304|P2|Overall Study|Adverse Event|32
2741824|NCT00077857|9410305|P1|Overall Study|Adverse Event|30
2741825|NCT00077766|9410325|P2|Overall Study|Participants Vacation|1
2741826|NCT00077766|9410326|P1|Overall Study|Participants Vacation|2
2741827|NCT00077766|9410325|P2|Overall Study|Stop Dialysis|1
2741828|NCT00077766|9410326|P1|Overall Study|Stop Dialysis|0
2741829|NCT00077766|9410325|P2|Overall Study|Started Nocturnal Dialysis|1
2741830|NCT00077766|9410326|P1|Overall Study|Started Nocturnal Dialysis|0
2741831|NCT00077766|9410325|P2|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1
2741832|NCT00077766|9410326|P1|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0
2741833|NCT00077766|9410325|P2|Overall Study|Dialysis|1
2741834|NCT00077766|9410326|P1|Overall Study|Dialysis|0
2741835|NCT00077766|9410325|P2|Overall Study|Dialysis Discontinued|0
2741836|NCT00077766|9410326|P1|Overall Study|Dialysis Discontinued|1
2741837|NCT00077766|9410325|P2|Overall Study|Participant's decision|0
2741838|NCT00077766|9410326|P1|Overall Study|Participant's decision|1
2741839|NCT00077766|9410325|P2|Overall Study|Investigators Discretion|0
2741840|NCT00077766|9410326|P1|Overall Study|Investigators Discretion|1
2741841|NCT00077766|9410325|P2|Overall Study|Transplantation|1
2741842|NCT00077766|9410326|P1|Overall Study|Transplantation|5
2741843|NCT00077766|9410325|P2|Overall Study|Kidney Transplantation|5
2741844|NCT00077766|9410326|P1|Overall Study|Kidney Transplantation|9
2741845|NCT00077766|9410325|P2|Overall Study|Protocol Violation|0
2741846|NCT00077766|9410326|P1|Overall Study|Protocol Violation|1
2741847|NCT00077766|9410325|P2|Overall Study|Lost to Follow-up|0
2741848|NCT00077766|9410326|P1|Overall Study|Lost to Follow-up|2
2741849|NCT00077766|9410325|P2|Overall Study|Death|10
2741850|NCT00077766|9410326|P1|Overall Study|Death|12
2741851|NCT00077766|9410325|P2|Overall Study|Withdrawal by Subject|3
2741852|NCT00077766|9410326|P1|Overall Study|Withdrawal by Subject|4
2741853|NCT00077766|9410325|P2|Overall Study|Adverse Event|1
2741854|NCT00077766|9410326|P1|Overall Study|Adverse Event|1
2741855|NCT00077675|9410351|P2|Overall Study|Never received study treatment|3
2741856|NCT00077675|9410352|P1|Overall Study|Never received study treatment|3
2741857|NCT00077675|9410351|P2|Overall Study|Other|1
2741858|NCT00077675|9410352|P1|Overall Study|Other|0
2741859|NCT00077675|9410351|P2|Overall Study|Withdrawal by Subject|0
2741860|NCT00077675|9410352|P1|Overall Study|Withdrawal by Subject|1
2741861|NCT00077675|9410351|P2|Overall Study|Lost to Follow-up|3
2741862|NCT00077675|9410352|P1|Overall Study|Lost to Follow-up|6
2741863|NCT00077675|9410351|P2|Overall Study|Adverse Event|2
2741864|NCT00077675|9410352|P1|Overall Study|Adverse Event|1
2741865|NCT00077649|9410362|P4|Overall Study|Randomized but never dosed|0
2741866|NCT00077649|9410363|P3|Overall Study|Randomized but never dosed|0
2741867|NCT00077649|9410364|P2|Overall Study|Randomized but never dosed|0
2741868|NCT00077649|9410365|P1|Overall Study|Randomized but never dosed|1
2741869|NCT00077649|9410362|P4|Overall Study|Abnormality of Laboratory Test|2
2741870|NCT00077649|9410363|P3|Overall Study|Abnormality of Laboratory Test|1
2741871|NCT00077649|9410364|P2|Overall Study|Abnormality of Laboratory Test|2
2741872|NCT00077649|9410365|P1|Overall Study|Abnormality of Laboratory Test|1
2741873|NCT00077649|9410362|P4|Overall Study|Lost to Follow-up|2
2741874|NCT00077649|9410363|P3|Overall Study|Lost to Follow-up|3
2741875|NCT00077649|9410364|P2|Overall Study|Lost to Follow-up|2
2741876|NCT00077649|9410365|P1|Overall Study|Lost to Follow-up|2
2741877|NCT00077649|9410362|P4|Overall Study|Withdrawal by Subject|2
2741878|NCT00077649|9410363|P3|Overall Study|Withdrawal by Subject|1
2741879|NCT00077649|9410364|P2|Overall Study|Withdrawal by Subject|1
2741880|NCT00077649|9410365|P1|Overall Study|Withdrawal by Subject|0
2741881|NCT00077649|9410362|P4|Overall Study|Lack of Efficacy|2
2741882|NCT00077649|9410363|P3|Overall Study|Lack of Efficacy|3
2741883|NCT00077649|9410364|P2|Overall Study|Lack of Efficacy|3
2741884|NCT00077649|9410365|P1|Overall Study|Lack of Efficacy|5
2741885|NCT00077649|9410362|P4|Overall Study|Adverse Event|9
2741886|NCT00077649|9410363|P3|Overall Study|Adverse Event|7
2741887|NCT00077649|9410364|P2|Overall Study|Adverse Event|1
2741888|NCT00077649|9410365|P1|Overall Study|Adverse Event|5
2741889|NCT00077636|9410413|P2|Overall Study|Abnormality Of Laboratory Test|2
2741890|NCT00077636|9410414|P1|Overall Study|Abnormality Of Laboratory Test|3
2741891|NCT00077636|9410413|P2|Overall Study|Lost to Follow-up|18
2741892|NCT00077636|9410414|P1|Overall Study|Lost to Follow-up|10
2741893|NCT00077636|9410413|P2|Overall Study|Protocol Violation|2
2741894|NCT00077636|9410414|P1|Overall Study|Protocol Violation|0
2741895|NCT00077636|9410413|P2|Overall Study|Adverse Event|34
2741896|NCT00077636|9410414|P1|Overall Study|Adverse Event|17
2741897|NCT00077636|9410413|P2|Overall Study|Withdrawal by Subject|2
2741898|NCT00077636|9410414|P1|Overall Study|Withdrawal by Subject|2
2741899|NCT00077636|9410413|P2|Overall Study|Admin|3
2741900|NCT00077636|9410414|P1|Overall Study|Admin|3
2741901|NCT00077636|9410413|P2|Overall Study|Refused Treatment|31
2741902|NCT00077636|9410414|P1|Overall Study|Refused Treatment|9
2741903|NCT00077623|9410435|P3|Overall Study|Failure to return|0
2741904|NCT00077623|9410436|P2|Overall Study|Failure to return|0
2741905|NCT00077623|9410437|P1|Overall Study|Failure to return|1
2741906|NCT00077623|9410435|P3|Overall Study|Death|11
2741907|NCT00077623|9410436|P2|Overall Study|Death|18
2741908|NCT00077623|9410437|P1|Overall Study|Death|12
2741909|NCT00077623|9410435|P3|Overall Study|Insufficient therapeutic response|0
2741910|NCT00077623|9410436|P2|Overall Study|Insufficient therapeutic response|0
2741911|NCT00077623|9410437|P1|Overall Study|Insufficient therapeutic response|2
2741912|NCT00077623|9410435|P3|Overall Study|Other-Non safety reason|19
2741913|NCT00077623|9410436|P2|Overall Study|Other-Non safety reason|15
2741914|NCT00077623|9410437|P1|Overall Study|Other-Non safety reason|18
2741915|NCT00077623|9410435|P3|Overall Study|Withdrawal by Subject|1
2741916|NCT00077623|9410436|P2|Overall Study|Withdrawal by Subject|10
2741917|NCT00077623|9410437|P1|Overall Study|Withdrawal by Subject|2
2741918|NCT00077623|9410435|P3|Overall Study|Adverse Event|1
2741919|NCT00077623|9410436|P2|Overall Study|Adverse Event|0
2741920|NCT00077623|9410437|P1|Overall Study|Adverse Event|1
2741921|NCT00077610|9410472|P3|Overall Study|Sponsors decision to withdraw|1
2741922|NCT00077610|9410473|P2|Overall Study|Sponsors decision to withdraw|0
2741923|NCT00077610|9410474|P1|Overall Study|Sponsors decision to withdraw|0
2741924|NCT00077610|9410472|P3|Overall Study|Financial issues|0
2741925|NCT00077610|9410473|P2|Overall Study|Financial issues|1
2741926|NCT00077610|9410474|P1|Overall Study|Financial issues|0
2741927|NCT00077610|9410472|P3|Overall Study|Relocation|5
2741928|NCT00077610|9410473|P2|Overall Study|Relocation|8
2741929|NCT00077610|9410474|P1|Overall Study|Relocation|0
2741930|NCT00077610|9410472|P3|Overall Study|Change in dialysis modality|0
2741931|NCT00077610|9410473|P2|Overall Study|Change in dialysis modality|0
2741932|NCT00077610|9410474|P1|Overall Study|Change in dialysis modality|1
2741933|NCT00077610|9410472|P3|Overall Study|Transfer to other center for surgery|0
2741934|NCT00077610|9410473|P2|Overall Study|Transfer to other center for surgery|0
2741935|NCT00077610|9410474|P1|Overall Study|Transfer to other center for surgery|1
2741936|NCT00077610|9410472|P3|Overall Study|Transfer to satellite unit|0
2741937|NCT00077610|9410473|P2|Overall Study|Transfer to satellite unit|0
2741938|NCT00077610|9410474|P1|Overall Study|Transfer to satellite unit|1
2741939|NCT00077610|9410472|P3|Overall Study|Transferred to nursing home|1
2741940|NCT00077610|9410473|P2|Overall Study|Transferred to nursing home|0
2741941|NCT00077610|9410474|P1|Overall Study|Transferred to nursing home|0
2741942|NCT00077610|9410472|P3|Overall Study|Transferred to other unit|1
2741943|NCT00077610|9410473|P2|Overall Study|Transferred to other unit|0
2741944|NCT00077610|9410474|P1|Overall Study|Transferred to other unit|0
2741945|NCT00077610|9410472|P3|Overall Study|Given Epogen in hospital|0
2741946|NCT00077610|9410473|P2|Overall Study|Given Epogen in hospital|0
2741947|NCT00077610|9410474|P1|Overall Study|Given Epogen in hospital|1
2741948|NCT00077610|9410472|P3|Overall Study|Worsening of health condition|0
2741949|NCT00077610|9410473|P2|Overall Study|Worsening of health condition|1
2741950|NCT00077610|9410474|P1|Overall Study|Worsening of health condition|1
2741951|NCT00077610|9410472|P3|Overall Study|Principal Investigator's decision|1
2741952|NCT00077610|9410473|P2|Overall Study|Principal Investigator's decision|0
2741953|NCT00077610|9410474|P1|Overall Study|Principal Investigator's decision|1
2741954|NCT00077610|9410472|P3|Overall Study|Multiple blood transfusions|1
2741955|NCT00077610|9410473|P2|Overall Study|Multiple blood transfusions|0
2741956|NCT00077610|9410474|P1|Overall Study|Multiple blood transfusions|0
2741957|NCT00077610|9410472|P3|Overall Study|Insufficient Therapeutic Response|0
2741958|NCT00077610|9410473|P2|Overall Study|Insufficient Therapeutic Response|0
2741959|NCT00077610|9410474|P1|Overall Study|Insufficient Therapeutic Response|1
2741960|NCT00077610|9410472|P3|Overall Study|Withdrew from dialysis care|3
2741961|NCT00077610|9410473|P2|Overall Study|Withdrew from dialysis care|0
2741962|NCT00077610|9410474|P1|Overall Study|Withdrew from dialysis care|5
2741963|NCT00077610|9410472|P3|Overall Study|Renal transplant|11
2741964|NCT00077610|9410473|P2|Overall Study|Renal transplant|15
2741965|NCT00077610|9410474|P1|Overall Study|Renal transplant|12
2741966|NCT00077610|9410472|P3|Overall Study|Death|13
2741967|NCT00077610|9410473|P2|Overall Study|Death|13
2741968|NCT00077610|9410474|P1|Overall Study|Death|17
2741969|NCT00077610|9410472|P3|Overall Study|Withdrawal by Subject|6
2741970|NCT00077610|9410473|P2|Overall Study|Withdrawal by Subject|10
2741971|NCT00077610|9410474|P1|Overall Study|Withdrawal by Subject|4
2741972|NCT00077610|9410472|P3|Overall Study|Lost to Follow-up|2
2741973|NCT00077610|9410473|P2|Overall Study|Lost to Follow-up|1
2741974|NCT00077610|9410474|P1|Overall Study|Lost to Follow-up|0
2741975|NCT00077610|9410472|P3|Overall Study|Adverse Event|1
2741976|NCT00077610|9410473|P2|Overall Study|Adverse Event|7
2741977|NCT00077610|9410474|P1|Overall Study|Adverse Event|9
2741978|NCT00077376|9410503|P1|Overall Study|Insurance ran out|1
2741979|NCT00077376|9410503|P1|Overall Study|Surgery|1
2741980|NCT00077376|9410503|P1|Overall Study|Symptomatic deterioration|1
2741981|NCT00077376|9410503|P1|Overall Study|Still on treatment|1
2741982|NCT00077376|9410503|P1|Overall Study|Complicating disease|1
2741983|NCT00077376|9410503|P1|Overall Study|Alternative therapy|5
2741984|NCT00077376|9410503|P1|Overall Study|Physician Decision|1
2741985|NCT00077376|9410503|P1|Overall Study|Death|1
2741986|NCT00077376|9410503|P1|Overall Study|Withdrawal by Subject|2
2741987|NCT00077376|9410503|P1|Overall Study|Adverse Event|8
2741988|NCT00077207|9410514|P1|Overall Study|Ineligible|1
2741989|NCT00077207|9410514|P1|Overall Study|Withdrawal by Subject|6
2741990|NCT00077207|9410514|P1|Overall Study|Physician Decision|6
2741991|NCT00077207|9410514|P1|Overall Study|Lack of Efficacy|12
2741992|NCT00077207|9410514|P1|Overall Study|Adverse Event|5
2741993|NCT00077064|9410526|P2|Overall Study|Patient refusal|2
2741994|NCT00077064|9410527|P1|Overall Study|Patient refusal|0
2741995|NCT00077064|9410526|P2|Overall Study|Adverse Event|4
2741996|NCT00077064|9410527|P1|Overall Study|Adverse Event|0
2741997|NCT00076999|9410543|P5|Overall Study|Other reason (not specified)|13
2741998|NCT00076999|9410544|P4|Overall Study|Other reason (not specified)|1
2741999|NCT00076999|9410545|P3|Overall Study|Other reason (not specified)|4
2742000|NCT00076999|9410546|P2|Overall Study|Other reason (not specified)|8
2742001|NCT00076999|9410547|P1|Overall Study|Other reason (not specified)|8
2742002|NCT00076999|9410543|P5|Overall Study|Withdrawal by Subject|1
2742003|NCT00076999|9410544|P4|Overall Study|Withdrawal by Subject|0
2742004|NCT00076999|9410545|P3|Overall Study|Withdrawal by Subject|3
2742005|NCT00076999|9410546|P2|Overall Study|Withdrawal by Subject|4
2742006|NCT00076999|9410547|P1|Overall Study|Withdrawal by Subject|0
2742007|NCT00076999|9410543|P5|Overall Study|Lost to Follow-up|0
2742008|NCT00076999|9410544|P4|Overall Study|Lost to Follow-up|0
2742009|NCT00076999|9410545|P3|Overall Study|Lost to Follow-up|0
2742010|NCT00076999|9410546|P2|Overall Study|Lost to Follow-up|1
2742011|NCT00076999|9410547|P1|Overall Study|Lost to Follow-up|2
2742012|NCT00076999|9410543|P5|Overall Study|Protocol Violation|9
2742013|NCT00076999|9410544|P4|Overall Study|Protocol Violation|0
2742014|NCT00076999|9410545|P3|Overall Study|Protocol Violation|4
2742015|NCT00076999|9410546|P2|Overall Study|Protocol Violation|3
2742016|NCT00076999|9410547|P1|Overall Study|Protocol Violation|0
2742017|NCT00076999|9410543|P5|Overall Study|Adverse Event|2
2742018|NCT00076999|9410544|P4|Overall Study|Adverse Event|0
2742019|NCT00076999|9410545|P3|Overall Study|Adverse Event|6
2742020|NCT00076999|9410546|P2|Overall Study|Adverse Event|8
2742021|NCT00076999|9410547|P1|Overall Study|Adverse Event|2
2742022|NCT00003222|9410666|P2|Overall Study|Physician Decision|1
2742023|NCT00003222|9410667|P1|Overall Study|Physician Decision|0
2742024|NCT00076804|9410679|P2|Overall Study|Early study Closure|32
2742025|NCT00076804|9410680|P1|Overall Study|Early study Closure|32
2742026|NCT00076804|9410679|P2|Overall Study|Withdrawal by Subject|8
2742027|NCT00076804|9410680|P1|Overall Study|Withdrawal by Subject|10
2742028|NCT00076804|9410679|P2|Overall Study|Lost to Follow-up|9
2742029|NCT00076804|9410680|P1|Overall Study|Lost to Follow-up|9
2742030|NCT00076804|9410679|P2|Overall Study|Death|20
2742031|NCT00076804|9410680|P1|Overall Study|Death|9
2742032|NCT00076752|9410692|P1|Overall Study|Withdrawal per PI, PI put study on hold|1
2742033|NCT00076752|9410692|P1|Overall Study|Death|2
2742034|NCT00076570|9410738|P2|Overall Study|Drug intolerance|8
2742035|NCT00076570|9410739|P1|Overall Study|Drug intolerance|8
2742036|NCT00003298|9410747|P1|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2
2742037|NCT00003298|9410747|P1|Step 2 (Adjuvant Therapy)|Excessive complication|1
2742038|NCT00003298|9410747|P1|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1
2742039|NCT00003298|9410747|P1|Step 2 (Adjuvant Therapy)|Death|1
2742040|NCT00003298|9410747|P1|Step 2 (Adjuvant Therapy)|Ineligible|1
2742041|NCT00003298|9410747|P1|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3
2742042|NCT00003298|9410747|P1|Re-register to Step 2 After Surgery|Reason unknown|1
2742043|NCT00003298|9410747|P1|Re-register to Step 2 After Surgery|Other complications|2
2742044|NCT00003298|9410747|P1|Re-register to Step 2 After Surgery|Positive margins|5
2742045|NCT00003298|9410747|P1|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7
2742046|NCT00003298|9410747|P1|Surgery|Unevaluable and off study|2
2742047|NCT00003298|9410747|P1|Surgery|Progression before surgery|2
2742048|NCT00003298|9410747|P1|Surgery|Unresectable at surgery|3
2742049|NCT00003298|9410747|P1|Step 1 (Neoadjuvant Therapy)|Adverse Event|3
2742050|NCT00003298|9410747|P1|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1
2742051|NCT00076336|9410757|P2|Overall Study|Treatment failure|5
2742052|NCT00076336|9410758|P1|Overall Study|Treatment failure|4
2742053|NCT00076336|9410757|P2|Overall Study|Virologic Breakthrough|16
2742054|NCT00076336|9410758|P1|Overall Study|Virologic Breakthrough|14
2742055|NCT00076336|9410757|P2|Overall Study|Liver Transplantation|3
2742056|NCT00076336|9410758|P1|Overall Study|Liver Transplantation|3
2742057|NCT00076336|9410757|P2|Overall Study|Patient, Investigator, Sponsor request|6
2742058|NCT00076336|9410758|P1|Overall Study|Patient, Investigator, Sponsor request|8
2742059|NCT00076336|9410757|P2|Overall Study|Creatinine Clearance < 30 or Dialysis|1
2742060|NCT00076336|9410758|P1|Overall Study|Creatinine Clearance < 30 or Dialysis|0
2742061|NCT00076336|9410757|P2|Overall Study|Non-Compliance|0
2742062|NCT00076336|9410758|P1|Overall Study|Non-Compliance|2
2742063|NCT00076336|9410757|P2|Overall Study|Lost to Follow-up|4
2742064|NCT00076336|9410758|P1|Overall Study|Lost to Follow-up|4
2742065|NCT00076336|9410757|P2|Overall Study|Adverse Event|4
2742066|NCT00076336|9410758|P1|Overall Study|Adverse Event|4
2742067|NCT00076336|9410757|P2|Overall Study|Death|17
2742068|NCT00076336|9410758|P1|Overall Study|Death|13
2742069|NCT00076102|9410811|P1|Overall Study|refusal of further therapy|2
2742070|NCT00076102|9410811|P1|Overall Study|plexiform neurofibroma surgery|1
2742071|NCT00076102|9410811|P1|Overall Study|Progression in pre-existing brain tumor|1
2742072|NCT00076102|9410811|P1|Overall Study|Clinical progression|1
2742073|NCT00076024|9410839|P4|Phase 2, Open-label|Other|2
2742074|NCT00076024|9410840|P3|Phase 2, Open-label|Other|0
2742075|NCT00076024|9410841|P2|Phase 2, Open-label|Other|0
2742076|NCT00076024|9410842|P1|Phase 2, Open-label|Other|0
2742077|NCT00076024|9410839|P4|Phase 2, Open-label|Withdrawal by Subject|1
2742078|NCT00076024|9410840|P3|Phase 2, Open-label|Withdrawal by Subject|0
2742079|NCT00076024|9410841|P2|Phase 2, Open-label|Withdrawal by Subject|0
2742080|NCT00076024|9410842|P1|Phase 2, Open-label|Withdrawal by Subject|0
2742081|NCT00076024|9410839|P4|Phase 2, Open-label|Lack of Efficacy|11
2742082|NCT00076024|9410840|P3|Phase 2, Open-label|Lack of Efficacy|0
2742083|NCT00076024|9410841|P2|Phase 2, Open-label|Lack of Efficacy|0
2742084|NCT00076024|9410842|P1|Phase 2, Open-label|Lack of Efficacy|0
2742085|NCT00076024|9410839|P4|Phase 2, Open-label|Adverse Event|2
2742086|NCT00076024|9410840|P3|Phase 2, Open-label|Adverse Event|0
2742087|NCT00076024|9410841|P2|Phase 2, Open-label|Adverse Event|0
2742088|NCT00076024|9410842|P1|Phase 2, Open-label|Adverse Event|0
2742089|NCT00076024|9410839|P4|Phase 2, Double-blind|Randomized but not treated|0
2742090|NCT00076024|9410840|P3|Phase 2, Double-blind|Randomized but not treated|0
2742091|NCT00076024|9410841|P2|Phase 2, Double-blind|Randomized but not treated|1
2742092|NCT00076024|9410842|P1|Phase 2, Double-blind|Randomized but not treated|0
2742093|NCT00076024|9410839|P4|Phase 2, Double-blind|Un-specified|0
2742094|NCT00076024|9410840|P3|Phase 2, Double-blind|Un-specified|6
2742095|NCT00076024|9410841|P2|Phase 2, Double-blind|Un-specified|14
2742096|NCT00076024|9410842|P1|Phase 2, Double-blind|Un-specified|0
2742097|NCT00076024|9410839|P4|Phase 2, Double-blind|Adverse Event|0
2742098|NCT00076024|9410840|P3|Phase 2, Double-blind|Adverse Event|6
2742099|NCT00076024|9410841|P2|Phase 2, Double-blind|Adverse Event|25
2742100|NCT00076024|9410842|P1|Phase 2, Double-blind|Adverse Event|0
2742101|NCT00076024|9410839|P4|Phase 2, Double-blind|Withdrawal by Subject|0
2742102|NCT00076024|9410840|P3|Phase 2, Double-blind|Withdrawal by Subject|4
2742103|NCT00076024|9410841|P2|Phase 2, Double-blind|Withdrawal by Subject|13
2742104|NCT00076024|9410842|P1|Phase 2, Double-blind|Withdrawal by Subject|0
2742105|NCT00076024|9410839|P4|Phase 2, Double-blind|Lack of Efficacy|0
2742106|NCT00076024|9410840|P3|Phase 2, Double-blind|Lack of Efficacy|40
2742107|NCT00076024|9410841|P2|Phase 2, Double-blind|Lack of Efficacy|59
2742108|NCT00076024|9410842|P1|Phase 2, Double-blind|Lack of Efficacy|0
2742109|NCT00076024|9410839|P4|Phase 1, Lead-in|Clinical progression|0
2742110|NCT00076024|9410840|P3|Phase 1, Lead-in|Clinical progression|0
2742111|NCT00076024|9410841|P2|Phase 1, Lead-in|Clinical progression|0
2742112|NCT00076024|9410842|P1|Phase 1, Lead-in|Clinical progression|1
2742113|NCT00076024|9410839|P4|Phase 1, Lead-in|Adverse Event|0
2742114|NCT00076024|9410840|P3|Phase 1, Lead-in|Adverse Event|0
2742115|NCT00076024|9410841|P2|Phase 1, Lead-in|Adverse Event|0
2742116|NCT00076024|9410842|P1|Phase 1, Lead-in|Adverse Event|1
2742117|NCT00076024|9410839|P4|Phase 1, Lead-in|Lack of Efficacy|0
2742118|NCT00076024|9410840|P3|Phase 1, Lead-in|Lack of Efficacy|0
2742119|NCT00076024|9410841|P2|Phase 1, Lead-in|Lack of Efficacy|0
2742120|NCT00076024|9410842|P1|Phase 1, Lead-in|Lack of Efficacy|4
2742121|NCT00076011|9410856|P1|Overall Study|Ongoing|1
2742122|NCT00076011|9410856|P1|Overall Study|Other|11
2742123|NCT00076011|9410856|P1|Overall Study|Study terminated by sponsor|3
2742124|NCT00076011|9410856|P1|Overall Study|Withdrawal by Subject|1
2742125|NCT00076011|9410856|P1|Overall Study|Lack of Efficacy|25
2742126|NCT00076011|9410856|P1|Overall Study|Adverse Event|10
2742127|NCT00076011|9410856|P1|Overall Study|Death|1
2742128|NCT00075946|9410868|P5|Overall Study|Other|0
2742129|NCT00075946|9410869|P4|Overall Study|Other|2
2742130|NCT00075946|9410870|P3|Overall Study|Other|0
2742131|NCT00075946|9410871|P2|Overall Study|Other|13
2742132|NCT00075946|9410872|P1|Overall Study|Other|5
2742133|NCT00075946|9410868|P5|Overall Study|Time to progression less than 6 months|0
2742134|NCT00075946|9410869|P4|Overall Study|Time to progression less than 6 months|3
2742135|NCT00075946|9410870|P3|Overall Study|Time to progression less than 6 months|8
2742136|NCT00075946|9410871|P2|Overall Study|Time to progression less than 6 months|30
2742137|NCT00075946|9410872|P1|Overall Study|Time to progression less than 6 months|15
2742138|NCT00075946|9410868|P5|Overall Study|No response to retreatment|0
2742139|NCT00075946|9410869|P4|Overall Study|No response to retreatment|0
2742140|NCT00075946|9410870|P3|Overall Study|No response to retreatment|2
2742141|NCT00075946|9410871|P2|Overall Study|No response to retreatment|0
2742142|NCT00075946|9410872|P1|Overall Study|No response to retreatment|23
2742143|NCT00075946|9410868|P5|Overall Study|Other complicating disease|0
2742144|NCT00075946|9410869|P4|Overall Study|Other complicating disease|4
2742145|NCT00075946|9410870|P3|Overall Study|Other complicating disease|1
2742146|NCT00075946|9410871|P2|Overall Study|Other complicating disease|13
2742147|NCT00075946|9410872|P1|Overall Study|Other complicating disease|7
2742148|NCT00075946|9410868|P5|Overall Study|Alternative therapy|0
2742149|NCT00075946|9410869|P4|Overall Study|Alternative therapy|0
2742150|NCT00075946|9410870|P3|Overall Study|Alternative therapy|5
2742151|NCT00075946|9410871|P2|Overall Study|Alternative therapy|2
2742152|NCT00075946|9410872|P1|Overall Study|Alternative therapy|16
2742153|NCT00075946|9410868|P5|Overall Study|Withdrawal by Subject|0
2742154|NCT00075946|9410869|P4|Overall Study|Withdrawal by Subject|9
2742155|NCT00075946|9410870|P3|Overall Study|Withdrawal by Subject|4
2742156|NCT00075946|9410871|P2|Overall Study|Withdrawal by Subject|58
2742157|NCT00075946|9410872|P1|Overall Study|Withdrawal by Subject|23
2742158|NCT00075946|9410868|P5|Overall Study|Death|0
2742159|NCT00075946|9410869|P4|Overall Study|Death|0
2742160|NCT00075946|9410870|P3|Overall Study|Death|0
2742161|NCT00075946|9410871|P2|Overall Study|Death|1
2742162|NCT00075946|9410872|P1|Overall Study|Death|0
2742163|NCT00075946|9410868|P5|Overall Study|Adverse Event|0
2742164|NCT00075946|9410869|P4|Overall Study|Adverse Event|2
2742165|NCT00075946|9410870|P3|Overall Study|Adverse Event|0
2742166|NCT00075946|9410871|P2|Overall Study|Adverse Event|10
2742167|NCT00075946|9410872|P1|Overall Study|Adverse Event|2
2742168|NCT00075946|9410868|P5|Overall Study|Still on treatment at time of analysis|0
2742169|NCT00075946|9410869|P4|Overall Study|Still on treatment at time of analysis|9
2742170|NCT00075946|9410870|P3|Overall Study|Still on treatment at time of analysis|3
2742171|NCT00075946|9410871|P2|Overall Study|Still on treatment at time of analysis|19
2742172|NCT00075946|9410872|P1|Overall Study|Still on treatment at time of analysis|52
2742173|NCT00075946|9410868|P5|Overall Study|Incorrectly randomized (no response)|0
2742174|NCT00075946|9410869|P4|Overall Study|Incorrectly randomized (no response)|1
2742175|NCT00075946|9410870|P3|Overall Study|Incorrectly randomized (no response)|5
2742176|NCT00075946|9410871|P2|Overall Study|Incorrectly randomized (no response)|5
2742177|NCT00075946|9410872|P1|Overall Study|Incorrectly randomized (no response)|5
2742178|NCT00075946|9410868|P5|Overall Study|Did not achieve response after induction|182
2742179|NCT00075946|9410869|P4|Overall Study|Did not achieve response after induction|0
2742180|NCT00075946|9410870|P3|Overall Study|Did not achieve response after induction|0
2742181|NCT00075946|9410871|P2|Overall Study|Did not achieve response after induction|0
2742182|NCT00075946|9410872|P1|Overall Study|Did not achieve response after induction|0
2742183|NCT00075946|9410868|P5|Overall Study|Path ineligible: undetermined histology|6
2742184|NCT00075946|9410869|P4|Overall Study|Path ineligible: undetermined histology|0
2742185|NCT00075946|9410870|P3|Overall Study|Path ineligible: undetermined histology|0
2742186|NCT00075946|9410871|P2|Overall Study|Path ineligible: undetermined histology|0
2742187|NCT00075946|9410872|P1|Overall Study|Path ineligible: undetermined histology|0
2742188|NCT00075881|9410887|P1|Overall Study|never start protocol therapy|1
2742189|NCT00075881|9410887|P1|Overall Study|Ineligible|1
2742190|NCT00075881|9410887|P1|Overall Study|missing data|2
2742191|NCT00075881|9410887|P1|Overall Study|other|4
2742192|NCT00075881|9410887|P1|Overall Study|other complicating disease|3
2742193|NCT00075881|9410887|P1|Overall Study|Protocol Violation|4
2742194|NCT00075881|9410887|P1|Overall Study|Withdrawal by Subject|2
2742195|NCT00075881|9410887|P1|Overall Study|Death|1
2742196|NCT00075881|9410887|P1|Overall Study|Adverse Event|7
2742197|NCT00075881|9410887|P1|Overall Study|Lack of Efficacy|18
2742198|NCT00075816|9410931|P2|Overall Study|Did not undergo transplantation|11
2742199|NCT00075816|9410932|P1|Overall Study|Did not undergo transplantation|14
2742200|NCT00075764|9411001|P2|Overall Study|Under review|1
2742201|NCT00075764|9411002|P1|Overall Study|Under review|0
2742202|NCT00075764|9411001|P2|Overall Study|Not protocol specified|19
2742203|NCT00075764|9411002|P1|Overall Study|Not protocol specified|27
2742204|NCT00075764|9411001|P2|Overall Study|Delinquent|2
2742205|NCT00075764|9411002|P1|Overall Study|Delinquent|4
2742206|NCT00075764|9411001|P2|Overall Study|Still on treatment|15
2742207|NCT00075764|9411002|P1|Overall Study|Still on treatment|8
2742208|NCT00075764|9411001|P2|Overall Study|Progression|274
2742209|NCT00075764|9411002|P1|Overall Study|Progression|269
2742210|NCT00075764|9411001|P2|Overall Study|Withdrawal by Subject|18
2742211|NCT00075764|9411002|P1|Overall Study|Withdrawal by Subject|28
2742212|NCT00075764|9411001|P2|Overall Study|Death|8
2742213|NCT00075764|9411002|P1|Overall Study|Death|4
2742214|NCT00075764|9411001|P2|Overall Study|Adverse Event|12
2742215|NCT00075764|9411002|P1|Overall Study|Adverse Event|5
2742216|NCT00075725|9411026|P12|Overall Study|Pt incarcerated|0
2742217|NCT00075725|9411027|P11|Overall Study|Pt incarcerated|0
2742218|NCT00075725|9411028|P10|Overall Study|Pt incarcerated|0
2742219|NCT00075725|9411029|P9|Overall Study|Pt incarcerated|0
2742220|NCT00075725|9411030|P8|Overall Study|Pt incarcerated|1
2742221|NCT00075725|9411031|P7|Overall Study|Pt incarcerated|0
2742222|NCT00075725|9411032|P6|Overall Study|Pt incarcerated|0
2742223|NCT00075725|9411033|P5|Overall Study|Pt incarcerated|0
2742224|NCT00075725|9411034|P4|Overall Study|Pt incarcerated|0
2742225|NCT00075725|9411035|P3|Overall Study|Pt incarcerated|0
2742226|NCT00075725|9411036|P2|Overall Study|Pt incarcerated|0
2742227|NCT00075725|9411037|P1|Overall Study|Pt incarcerated|0
2742228|NCT00075725|9411026|P12|Overall Study|Pt care terminated due to pt behavior|0
2742229|NCT00075725|9411027|P11|Overall Study|Pt care terminated due to pt behavior|0
2742230|NCT00075725|9411028|P10|Overall Study|Pt care terminated due to pt behavior|0
2742231|NCT00075725|9411029|P9|Overall Study|Pt care terminated due to pt behavior|0
2742232|NCT00075725|9411030|P8|Overall Study|Pt care terminated due to pt behavior|1
2742233|NCT00075725|9411031|P7|Overall Study|Pt care terminated due to pt behavior|0
2742234|NCT00075725|9411032|P6|Overall Study|Pt care terminated due to pt behavior|0
2742235|NCT00075725|9411033|P5|Overall Study|Pt care terminated due to pt behavior|0
2742236|NCT00075725|9411034|P4|Overall Study|Pt care terminated due to pt behavior|0
2742237|NCT00075725|9411035|P3|Overall Study|Pt care terminated due to pt behavior|0
2742238|NCT00075725|9411036|P2|Overall Study|Pt care terminated due to pt behavior|0
2742239|NCT00075725|9411037|P1|Overall Study|Pt care terminated due to pt behavior|0
2742240|NCT00075725|9411026|P12|Overall Study|Other complications|0
2742241|NCT00075725|9411027|P11|Overall Study|Other complications|0
2742242|NCT00075725|9411028|P10|Overall Study|Other complications|0
2742243|NCT00075725|9411029|P9|Overall Study|Other complications|0
2742244|NCT00075725|9411030|P8|Overall Study|Other complications|0
2742245|NCT00075725|9411031|P7|Overall Study|Other complications|0
2742246|NCT00075725|9411032|P6|Overall Study|Other complications|1
2742247|NCT00075725|9411033|P5|Overall Study|Other complications|0
2742248|NCT00075725|9411034|P4|Overall Study|Other complications|0
2742249|NCT00075725|9411035|P3|Overall Study|Other complications|0
2742250|NCT00075725|9411036|P2|Overall Study|Other complications|0
2742251|NCT00075725|9411037|P1|Overall Study|Other complications|0
2742252|NCT00075725|9411026|P12|Overall Study|Study Closure|0
2742253|NCT00075725|9411027|P11|Overall Study|Study Closure|0
2742254|NCT00075725|9411028|P10|Overall Study|Study Closure|0
2742255|NCT00075725|9411029|P9|Overall Study|Study Closure|0
2742256|NCT00075725|9411030|P8|Overall Study|Study Closure|1
2742257|NCT00075725|9411031|P7|Overall Study|Study Closure|0
2742258|NCT00075725|9411032|P6|Overall Study|Study Closure|3
2742259|NCT00075725|9411033|P5|Overall Study|Study Closure|1
2742260|NCT00075725|9411034|P4|Overall Study|Study Closure|0
2742261|NCT00075725|9411035|P3|Overall Study|Study Closure|0
2742262|NCT00075725|9411036|P2|Overall Study|Study Closure|0
2742263|NCT00075725|9411037|P1|Overall Study|Study Closure|1
2742264|NCT00075725|9411026|P12|Overall Study|Institution Terminated|0
2742265|NCT00075725|9411027|P11|Overall Study|Institution Terminated|0
2742266|NCT00075725|9411028|P10|Overall Study|Institution Terminated|0
2742267|NCT00075725|9411029|P9|Overall Study|Institution Terminated|0
2742268|NCT00075725|9411030|P8|Overall Study|Institution Terminated|3
2742269|NCT00075725|9411031|P7|Overall Study|Institution Terminated|0
2742270|NCT00075725|9411032|P6|Overall Study|Institution Terminated|0
2742271|NCT00075725|9411033|P5|Overall Study|Institution Terminated|1
2742272|NCT00075725|9411034|P4|Overall Study|Institution Terminated|0
2742273|NCT00075725|9411035|P3|Overall Study|Institution Terminated|0
2742274|NCT00075725|9411036|P2|Overall Study|Institution Terminated|0
2742275|NCT00075725|9411037|P1|Overall Study|Institution Terminated|0
2742276|NCT00075725|9411026|P12|Overall Study|Pt relocated|0
2742277|NCT00075725|9411027|P11|Overall Study|Pt relocated|0
2742278|NCT00075725|9411028|P10|Overall Study|Pt relocated|0
2742279|NCT00075725|9411029|P9|Overall Study|Pt relocated|1
2742280|NCT00075725|9411030|P8|Overall Study|Pt relocated|2
2742281|NCT00075725|9411031|P7|Overall Study|Pt relocated|1
2742282|NCT00075725|9411032|P6|Overall Study|Pt relocated|1
2742283|NCT00075725|9411033|P5|Overall Study|Pt relocated|0
2742284|NCT00075725|9411034|P4|Overall Study|Pt relocated|2
2742285|NCT00075725|9411035|P3|Overall Study|Pt relocated|0
2742286|NCT00075725|9411036|P2|Overall Study|Pt relocated|0
2742287|NCT00075725|9411037|P1|Overall Study|Pt relocated|0
2742288|NCT00075725|9411026|P12|Overall Study|Pt received additional steroids|0
2742289|NCT00075725|9411027|P11|Overall Study|Pt received additional steroids|0
2742290|NCT00075725|9411028|P10|Overall Study|Pt received additional steroids|0
2742291|NCT00075725|9411029|P9|Overall Study|Pt received additional steroids|0
2742292|NCT00075725|9411030|P8|Overall Study|Pt received additional steroids|0
2742293|NCT00075725|9411031|P7|Overall Study|Pt received additional steroids|0
2742294|NCT00075725|9411032|P6|Overall Study|Pt received additional steroids|0
2742295|NCT00075725|9411033|P5|Overall Study|Pt received additional steroids|0
2742296|NCT00075725|9411034|P4|Overall Study|Pt received additional steroids|1
2742297|NCT00075725|9411035|P3|Overall Study|Pt received additional steroids|0
2742298|NCT00075725|9411036|P2|Overall Study|Pt received additional steroids|0
2742299|NCT00075725|9411037|P1|Overall Study|Pt received additional steroids|0
2742300|NCT00075725|9411026|P12|Overall Study|Pt went to transplant|0
2742301|NCT00075725|9411027|P11|Overall Study|Pt went to transplant|0
2742302|NCT00075725|9411028|P10|Overall Study|Pt went to transplant|0
2742303|NCT00075725|9411029|P9|Overall Study|Pt went to transplant|0
2742304|NCT00075725|9411030|P8|Overall Study|Pt went to transplant|0
2742305|NCT00075725|9411031|P7|Overall Study|Pt went to transplant|0
2742306|NCT00075725|9411032|P6|Overall Study|Pt went to transplant|1
2742307|NCT00075725|9411033|P5|Overall Study|Pt went to transplant|0
2742308|NCT00075725|9411034|P4|Overall Study|Pt went to transplant|1
2742309|NCT00075725|9411035|P3|Overall Study|Pt went to transplant|0
2742310|NCT00075725|9411036|P2|Overall Study|Pt went to transplant|0
2742311|NCT00075725|9411037|P1|Overall Study|Pt went to transplant|0
2742312|NCT00075725|9411026|P12|Overall Study|specimen(s) not submitted|0
2742313|NCT00075725|9411027|P11|Overall Study|specimen(s) not submitted|0
2742314|NCT00075725|9411028|P10|Overall Study|specimen(s) not submitted|0
2742315|NCT00075725|9411029|P9|Overall Study|specimen(s) not submitted|0
2742316|NCT00075725|9411030|P8|Overall Study|specimen(s) not submitted|0
2742317|NCT00075725|9411031|P7|Overall Study|specimen(s) not submitted|0
2742318|NCT00075725|9411032|P6|Overall Study|specimen(s) not submitted|0
2742319|NCT00075725|9411033|P5|Overall Study|specimen(s) not submitted|0
2742320|NCT00075725|9411034|P4|Overall Study|specimen(s) not submitted|0
2742321|NCT00075725|9411035|P3|Overall Study|specimen(s) not submitted|2
2742322|NCT00075725|9411036|P2|Overall Study|specimen(s) not submitted|0
2742323|NCT00075725|9411037|P1|Overall Study|specimen(s) not submitted|0
2742324|NCT00075725|9411026|P12|Overall Study|Unsuccessful institutional transfer|0
2742325|NCT00075725|9411027|P11|Overall Study|Unsuccessful institutional transfer|0
2742326|NCT00075725|9411028|P10|Overall Study|Unsuccessful institutional transfer|1
2742327|NCT00075725|9411029|P9|Overall Study|Unsuccessful institutional transfer|0
2742328|NCT00075725|9411030|P8|Overall Study|Unsuccessful institutional transfer|0
2742329|NCT00075725|9411031|P7|Overall Study|Unsuccessful institutional transfer|0
2742330|NCT00075725|9411032|P6|Overall Study|Unsuccessful institutional transfer|0
2742331|NCT00075725|9411033|P5|Overall Study|Unsuccessful institutional transfer|0
2742332|NCT00075725|9411034|P4|Overall Study|Unsuccessful institutional transfer|0
2742333|NCT00075725|9411035|P3|Overall Study|Unsuccessful institutional transfer|2
2742334|NCT00075725|9411036|P2|Overall Study|Unsuccessful institutional transfer|0
2742335|NCT00075725|9411037|P1|Overall Study|Unsuccessful institutional transfer|0
2742336|NCT00075725|9411026|P12|Overall Study|Clinic chart lost unable to recreate|0
2742337|NCT00075725|9411027|P11|Overall Study|Clinic chart lost unable to recreate|0
2742338|NCT00075725|9411028|P10|Overall Study|Clinic chart lost unable to recreate|0
2742339|NCT00075725|9411029|P9|Overall Study|Clinic chart lost unable to recreate|0
2742340|NCT00075725|9411030|P8|Overall Study|Clinic chart lost unable to recreate|0
2742341|NCT00075725|9411031|P7|Overall Study|Clinic chart lost unable to recreate|0
2742342|NCT00075725|9411032|P6|Overall Study|Clinic chart lost unable to recreate|0
2742343|NCT00075725|9411033|P5|Overall Study|Clinic chart lost unable to recreate|0
2742344|NCT00075725|9411034|P4|Overall Study|Clinic chart lost unable to recreate|0
2742345|NCT00075725|9411035|P3|Overall Study|Clinic chart lost unable to recreate|1
2742346|NCT00075725|9411036|P2|Overall Study|Clinic chart lost unable to recreate|0
2742347|NCT00075725|9411037|P1|Overall Study|Clinic chart lost unable to recreate|0
2742348|NCT00075725|9411026|P12|Overall Study|Pt trying to find a BM donor|0
2742349|NCT00075725|9411027|P11|Overall Study|Pt trying to find a BM donor|0
2742350|NCT00075725|9411028|P10|Overall Study|Pt trying to find a BM donor|0
2742351|NCT00075725|9411029|P9|Overall Study|Pt trying to find a BM donor|0
2742352|NCT00075725|9411030|P8|Overall Study|Pt trying to find a BM donor|0
2742353|NCT00075725|9411031|P7|Overall Study|Pt trying to find a BM donor|0
2742354|NCT00075725|9411032|P6|Overall Study|Pt trying to find a BM donor|0
2742355|NCT00075725|9411033|P5|Overall Study|Pt trying to find a BM donor|0
2742356|NCT00075725|9411034|P4|Overall Study|Pt trying to find a BM donor|0
2742357|NCT00075725|9411035|P3|Overall Study|Pt trying to find a BM donor|0
2742358|NCT00075725|9411036|P2|Overall Study|Pt trying to find a BM donor|1
2742359|NCT00075725|9411037|P1|Overall Study|Pt trying to find a BM donor|0
2742360|NCT00075725|9411026|P12|Overall Study|Other|3
2742361|NCT00075725|9411027|P11|Overall Study|Other|0
2742362|NCT00075725|9411028|P10|Overall Study|Other|1
2742363|NCT00075725|9411029|P9|Overall Study|Other|2
2742364|NCT00075725|9411030|P8|Overall Study|Other|9
2742365|NCT00075725|9411031|P7|Overall Study|Other|2
2742366|NCT00075725|9411032|P6|Overall Study|Other|4
2742367|NCT00075725|9411033|P5|Overall Study|Other|1
2742368|NCT00075725|9411034|P4|Overall Study|Other|1
2742369|NCT00075725|9411035|P3|Overall Study|Other|1
2742370|NCT00075725|9411036|P2|Overall Study|Other|2
2742371|NCT00075725|9411037|P1|Overall Study|Other|4
2742372|NCT00075725|9411026|P12|Overall Study|Inevaluable|0
2742373|NCT00075725|9411027|P11|Overall Study|Inevaluable|1
2742374|NCT00075725|9411028|P10|Overall Study|Inevaluable|0
2742375|NCT00075725|9411029|P9|Overall Study|Inevaluable|2
2742376|NCT00075725|9411030|P8|Overall Study|Inevaluable|11
2742377|NCT00075725|9411031|P7|Overall Study|Inevaluable|1
2742378|NCT00075725|9411032|P6|Overall Study|Inevaluable|9
2742379|NCT00075725|9411033|P5|Overall Study|Inevaluable|2
2742380|NCT00075725|9411034|P4|Overall Study|Inevaluable|2
2742381|NCT00075725|9411035|P3|Overall Study|Inevaluable|4
2742382|NCT00075725|9411036|P2|Overall Study|Inevaluable|1
2742383|NCT00075725|9411037|P1|Overall Study|Inevaluable|1
2742384|NCT00075725|9411026|P12|Overall Study|Pt has very high risk ALL characteristic|3
2742385|NCT00075725|9411027|P11|Overall Study|Pt has very high risk ALL characteristic|0
2742386|NCT00075725|9411028|P10|Overall Study|Pt has very high risk ALL characteristic|1
2742387|NCT00075725|9411029|P9|Overall Study|Pt has very high risk ALL characteristic|29
2742388|NCT00075725|9411030|P8|Overall Study|Pt has very high risk ALL characteristic|74
2742389|NCT00075725|9411031|P7|Overall Study|Pt has very high risk ALL characteristic|23
2742390|NCT00075725|9411032|P6|Overall Study|Pt has very high risk ALL characteristic|75
2742391|NCT00075725|9411033|P5|Overall Study|Pt has very high risk ALL characteristic|11
2742392|NCT00075725|9411034|P4|Overall Study|Pt has very high risk ALL characteristic|18
2742393|NCT00075725|9411035|P3|Overall Study|Pt has very high risk ALL characteristic|26
2742394|NCT00075725|9411036|P2|Overall Study|Pt has very high risk ALL characteristic|11
2742395|NCT00075725|9411037|P1|Overall Study|Pt has very high risk ALL characteristic|15
2742396|NCT00075725|9411026|P12|Overall Study|MRD positive after extended ind|0
2742397|NCT00075725|9411027|P11|Overall Study|MRD positive after extended ind|0
2742398|NCT00075725|9411028|P10|Overall Study|MRD positive after extended ind|0
2742399|NCT00075725|9411029|P9|Overall Study|MRD positive after extended ind|0
2742400|NCT00075725|9411030|P8|Overall Study|MRD positive after extended ind|1
2742401|NCT00075725|9411031|P7|Overall Study|MRD positive after extended ind|0
2742402|NCT00075725|9411032|P6|Overall Study|MRD positive after extended ind|2
2742403|NCT00075725|9411033|P5|Overall Study|MRD positive after extended ind|1
2742404|NCT00075725|9411034|P4|Overall Study|MRD positive after extended ind|0
2742405|NCT00075725|9411035|P3|Overall Study|MRD positive after extended ind|1
2742406|NCT00075725|9411036|P2|Overall Study|MRD positive after extended ind|1
2742407|NCT00075725|9411037|P1|Overall Study|MRD positive after extended ind|0
2742408|NCT00075725|9411026|P12|Overall Study|Insurance issues|0
2742409|NCT00075725|9411027|P11|Overall Study|Insurance issues|0
2742410|NCT00075725|9411028|P10|Overall Study|Insurance issues|0
2742411|NCT00075725|9411029|P9|Overall Study|Insurance issues|0
2742412|NCT00075725|9411030|P8|Overall Study|Insurance issues|1
2742413|NCT00075725|9411031|P7|Overall Study|Insurance issues|0
2742414|NCT00075725|9411032|P6|Overall Study|Insurance issues|1
2742415|NCT00075725|9411033|P5|Overall Study|Insurance issues|1
2742416|NCT00075725|9411034|P4|Overall Study|Insurance issues|1
2742417|NCT00075725|9411035|P3|Overall Study|Insurance issues|0
2742418|NCT00075725|9411036|P2|Overall Study|Insurance issues|1
2742419|NCT00075725|9411037|P1|Overall Study|Insurance issues|0
2742420|NCT00075725|9411026|P12|Overall Study|Pt age out of range for treatment|0
2742421|NCT00075725|9411027|P11|Overall Study|Pt age out of range for treatment|0
2742422|NCT00075725|9411028|P10|Overall Study|Pt age out of range for treatment|0
2742423|NCT00075725|9411029|P9|Overall Study|Pt age out of range for treatment|0
2742424|NCT00075725|9411030|P8|Overall Study|Pt age out of range for treatment|1
2742425|NCT00075725|9411031|P7|Overall Study|Pt age out of range for treatment|0
2742426|NCT00075725|9411032|P6|Overall Study|Pt age out of range for treatment|1
2742427|NCT00075725|9411033|P5|Overall Study|Pt age out of range for treatment|0
2742428|NCT00075725|9411034|P4|Overall Study|Pt age out of range for treatment|0
2742429|NCT00075725|9411035|P3|Overall Study|Pt age out of range for treatment|0
2742430|NCT00075725|9411036|P2|Overall Study|Pt age out of range for treatment|1
2742431|NCT00075725|9411037|P1|Overall Study|Pt age out of range for treatment|0
2742432|NCT00075725|9411026|P12|Overall Study|Pt non compliant with therapy|0
2742433|NCT00075725|9411027|P11|Overall Study|Pt non compliant with therapy|0
2742434|NCT00075725|9411028|P10|Overall Study|Pt non compliant with therapy|0
2742435|NCT00075725|9411029|P9|Overall Study|Pt non compliant with therapy|3
2742436|NCT00075725|9411030|P8|Overall Study|Pt non compliant with therapy|5
2742437|NCT00075725|9411031|P7|Overall Study|Pt non compliant with therapy|2
2742438|NCT00075725|9411032|P6|Overall Study|Pt non compliant with therapy|14
2742439|NCT00075725|9411033|P5|Overall Study|Pt non compliant with therapy|2
2742440|NCT00075725|9411034|P4|Overall Study|Pt non compliant with therapy|0
2742441|NCT00075725|9411035|P3|Overall Study|Pt non compliant with therapy|1
2742442|NCT00075725|9411036|P2|Overall Study|Pt non compliant with therapy|1
2742443|NCT00075725|9411037|P1|Overall Study|Pt non compliant with therapy|2
2742444|NCT00075725|9411026|P12|Overall Study|Pt/Guardian refused RT therapy|0
2742445|NCT00075725|9411027|P11|Overall Study|Pt/Guardian refused RT therapy|0
2742446|NCT00075725|9411028|P10|Overall Study|Pt/Guardian refused RT therapy|0
2742447|NCT00075725|9411029|P9|Overall Study|Pt/Guardian refused RT therapy|0
2742448|NCT00075725|9411030|P8|Overall Study|Pt/Guardian refused RT therapy|0
2742449|NCT00075725|9411031|P7|Overall Study|Pt/Guardian refused RT therapy|0
2742450|NCT00075725|9411032|P6|Overall Study|Pt/Guardian refused RT therapy|0
2742451|NCT00075725|9411033|P5|Overall Study|Pt/Guardian refused RT therapy|1
2742452|NCT00075725|9411034|P4|Overall Study|Pt/Guardian refused RT therapy|2
2742453|NCT00075725|9411035|P3|Overall Study|Pt/Guardian refused RT therapy|1
2742454|NCT00075725|9411036|P2|Overall Study|Pt/Guardian refused RT therapy|0
2742455|NCT00075725|9411037|P1|Overall Study|Pt/Guardian refused RT therapy|1
2742456|NCT00075725|9411026|P12|Overall Study|Ineligible or wrong diagnosis|4
2742457|NCT00075725|9411027|P11|Overall Study|Ineligible or wrong diagnosis|2
2742458|NCT00075725|9411028|P10|Overall Study|Ineligible or wrong diagnosis|1
2742459|NCT00075725|9411029|P9|Overall Study|Ineligible or wrong diagnosis|10
2742460|NCT00075725|9411030|P8|Overall Study|Ineligible or wrong diagnosis|9
2742461|NCT00075725|9411031|P7|Overall Study|Ineligible or wrong diagnosis|6
2742462|NCT00075725|9411032|P6|Overall Study|Ineligible or wrong diagnosis|17
2742463|NCT00075725|9411033|P5|Overall Study|Ineligible or wrong diagnosis|3
2742464|NCT00075725|9411034|P4|Overall Study|Ineligible or wrong diagnosis|10
2742465|NCT00075725|9411035|P3|Overall Study|Ineligible or wrong diagnosis|3
2742466|NCT00075725|9411036|P2|Overall Study|Ineligible or wrong diagnosis|3
2742467|NCT00075725|9411037|P1|Overall Study|Ineligible or wrong diagnosis|8
2742468|NCT00075725|9411026|P12|Overall Study|Patient off treatment|0
2742469|NCT00075725|9411027|P11|Overall Study|Patient off treatment|0
2742470|NCT00075725|9411028|P10|Overall Study|Patient off treatment|0
2742471|NCT00075725|9411029|P9|Overall Study|Patient off treatment|1
2742472|NCT00075725|9411030|P8|Overall Study|Patient off treatment|2
2742473|NCT00075725|9411031|P7|Overall Study|Patient off treatment|0
2742474|NCT00075725|9411032|P6|Overall Study|Patient off treatment|0
2742475|NCT00075725|9411033|P5|Overall Study|Patient off treatment|1
2742476|NCT00075725|9411034|P4|Overall Study|Patient off treatment|2
2742477|NCT00075725|9411035|P3|Overall Study|Patient off treatment|1
2742478|NCT00075725|9411036|P2|Overall Study|Patient off treatment|0
2742479|NCT00075725|9411037|P1|Overall Study|Patient off treatment|0
2742480|NCT00075725|9411026|P12|Overall Study|Disease Progression, all other reasons|5
2742481|NCT00075725|9411027|P11|Overall Study|Disease Progression, all other reasons|0
2742482|NCT00075725|9411028|P10|Overall Study|Disease Progression, all other reasons|4
2742483|NCT00075725|9411029|P9|Overall Study|Disease Progression, all other reasons|21
2742484|NCT00075725|9411030|P8|Overall Study|Disease Progression, all other reasons|46
2742485|NCT00075725|9411031|P7|Overall Study|Disease Progression, all other reasons|20
2742486|NCT00075725|9411032|P6|Overall Study|Disease Progression, all other reasons|59
2742487|NCT00075725|9411033|P5|Overall Study|Disease Progression, all other reasons|21
2742488|NCT00075725|9411034|P4|Overall Study|Disease Progression, all other reasons|6
2742489|NCT00075725|9411035|P3|Overall Study|Disease Progression, all other reasons|33
2742490|NCT00075725|9411036|P2|Overall Study|Disease Progression, all other reasons|5
2742491|NCT00075725|9411037|P1|Overall Study|Disease Progression, all other reasons|17
2742492|NCT00075725|9411026|P12|Overall Study|Withdrawal by Subject|0
2742493|NCT00075725|9411027|P11|Overall Study|Withdrawal by Subject|0
2742494|NCT00075725|9411028|P10|Overall Study|Withdrawal by Subject|2
2742495|NCT00075725|9411029|P9|Overall Study|Withdrawal by Subject|10
2742496|NCT00075725|9411030|P8|Overall Study|Withdrawal by Subject|31
2742497|NCT00075725|9411031|P7|Overall Study|Withdrawal by Subject|7
2742498|NCT00075725|9411032|P6|Overall Study|Withdrawal by Subject|27
2742499|NCT00075725|9411033|P5|Overall Study|Withdrawal by Subject|6
2742500|NCT00075725|9411034|P4|Overall Study|Withdrawal by Subject|10
2742501|NCT00075725|9411035|P3|Overall Study|Withdrawal by Subject|6
2742502|NCT00075725|9411036|P2|Overall Study|Withdrawal by Subject|3
2742503|NCT00075725|9411037|P1|Overall Study|Withdrawal by Subject|12
2742504|NCT00075725|9411026|P12|Overall Study|Protocol Violation|1
2742505|NCT00075725|9411027|P11|Overall Study|Protocol Violation|0
2742506|NCT00075725|9411028|P10|Overall Study|Protocol Violation|0
2742507|NCT00075725|9411029|P9|Overall Study|Protocol Violation|3
2742508|NCT00075725|9411030|P8|Overall Study|Protocol Violation|2
2742509|NCT00075725|9411031|P7|Overall Study|Protocol Violation|1
2742510|NCT00075725|9411032|P6|Overall Study|Protocol Violation|2
2742511|NCT00075725|9411033|P5|Overall Study|Protocol Violation|3
2742512|NCT00075725|9411034|P4|Overall Study|Protocol Violation|3
2742513|NCT00075725|9411035|P3|Overall Study|Protocol Violation|0
2742514|NCT00075725|9411036|P2|Overall Study|Protocol Violation|1
2742515|NCT00075725|9411037|P1|Overall Study|Protocol Violation|1
2742516|NCT00075725|9411026|P12|Overall Study|Pregnancy|0
2742517|NCT00075725|9411027|P11|Overall Study|Pregnancy|0
2742518|NCT00075725|9411028|P10|Overall Study|Pregnancy|0
2742519|NCT00075725|9411029|P9|Overall Study|Pregnancy|0
2742520|NCT00075725|9411030|P8|Overall Study|Pregnancy|1
2742521|NCT00075725|9411031|P7|Overall Study|Pregnancy|0
2742522|NCT00075725|9411032|P6|Overall Study|Pregnancy|1
2742523|NCT00075725|9411033|P5|Overall Study|Pregnancy|0
2742524|NCT00075725|9411034|P4|Overall Study|Pregnancy|0
2742525|NCT00075725|9411035|P3|Overall Study|Pregnancy|0
2742526|NCT00075725|9411036|P2|Overall Study|Pregnancy|0
2742527|NCT00075725|9411037|P1|Overall Study|Pregnancy|0
2742528|NCT00075725|9411026|P12|Overall Study|Physician Decision|0
2742529|NCT00075725|9411027|P11|Overall Study|Physician Decision|1
2742530|NCT00075725|9411028|P10|Overall Study|Physician Decision|0
2742531|NCT00075725|9411029|P9|Overall Study|Physician Decision|5
2742532|NCT00075725|9411030|P8|Overall Study|Physician Decision|17
2742533|NCT00075725|9411031|P7|Overall Study|Physician Decision|3
2742534|NCT00075725|9411032|P6|Overall Study|Physician Decision|19
2742535|NCT00075725|9411033|P5|Overall Study|Physician Decision|4
2742536|NCT00075725|9411034|P4|Overall Study|Physician Decision|8
2742537|NCT00075725|9411035|P3|Overall Study|Physician Decision|5
2742538|NCT00075725|9411036|P2|Overall Study|Physician Decision|6
2742539|NCT00075725|9411037|P1|Overall Study|Physician Decision|2
2742540|NCT00075725|9411026|P12|Overall Study|Lost to Follow-up|0
2742541|NCT00075725|9411027|P11|Overall Study|Lost to Follow-up|0
2742542|NCT00075725|9411028|P10|Overall Study|Lost to Follow-up|0
2742543|NCT00075725|9411029|P9|Overall Study|Lost to Follow-up|1
2742544|NCT00075725|9411030|P8|Overall Study|Lost to Follow-up|4
2742545|NCT00075725|9411031|P7|Overall Study|Lost to Follow-up|2
2742546|NCT00075725|9411032|P6|Overall Study|Lost to Follow-up|13
2742547|NCT00075725|9411033|P5|Overall Study|Lost to Follow-up|0
2742548|NCT00075725|9411034|P4|Overall Study|Lost to Follow-up|1
2742549|NCT00075725|9411035|P3|Overall Study|Lost to Follow-up|4
2742550|NCT00075725|9411036|P2|Overall Study|Lost to Follow-up|1
2742551|NCT00075725|9411037|P1|Overall Study|Lost to Follow-up|1
2742552|NCT00075725|9411026|P12|Overall Study|Death|0
2742553|NCT00075725|9411027|P11|Overall Study|Death|3
2742554|NCT00075725|9411028|P10|Overall Study|Death|4
2742555|NCT00075725|9411029|P9|Overall Study|Death|14
2742556|NCT00075725|9411030|P8|Overall Study|Death|22
2742557|NCT00075725|9411031|P7|Overall Study|Death|4
2742558|NCT00075725|9411032|P6|Overall Study|Death|25
2742559|NCT00075725|9411033|P5|Overall Study|Death|3
2742560|NCT00075725|9411034|P4|Overall Study|Death|2
2742561|NCT00075725|9411035|P3|Overall Study|Death|10
2742562|NCT00075725|9411036|P2|Overall Study|Death|5
2742563|NCT00075725|9411037|P1|Overall Study|Death|3
2742564|NCT00075725|9411026|P12|Overall Study|Adverse Event|2
2742565|NCT00075725|9411027|P11|Overall Study|Adverse Event|2
2742566|NCT00075725|9411028|P10|Overall Study|Adverse Event|4
2742567|NCT00075725|9411029|P9|Overall Study|Adverse Event|15
2742568|NCT00075725|9411030|P8|Overall Study|Adverse Event|51
2742569|NCT00075725|9411031|P7|Overall Study|Adverse Event|3
2742570|NCT00075725|9411032|P6|Overall Study|Adverse Event|38
2742571|NCT00075725|9411033|P5|Overall Study|Adverse Event|4
2742572|NCT00075725|9411034|P4|Overall Study|Adverse Event|8
2742573|NCT00075725|9411035|P3|Overall Study|Adverse Event|20
2742574|NCT00075725|9411036|P2|Overall Study|Adverse Event|6
2742575|NCT00075725|9411037|P1|Overall Study|Adverse Event|6
2742576|NCT00075582|9411134|P2|Overall Study|Ineligible for study|16
2742577|NCT00075582|9411135|P1|Overall Study|Ineligible for study|36
2742578|NCT00075582|9411134|P2|Overall Study|Withdrawal by Subject|2
2742579|NCT00075582|9411135|P1|Overall Study|Withdrawal by Subject|2
2742580|NCT00075582|9411134|P2|Overall Study|Physician Decision|8
2742581|NCT00075582|9411135|P1|Overall Study|Physician Decision|5
2742582|NCT00075582|9411134|P2|Overall Study|Lack of Efficacy|8
2742583|NCT00075582|9411135|P1|Overall Study|Lack of Efficacy|4
2742584|NCT00075582|9411134|P2|Overall Study|Adverse Event|1
2742585|NCT00075582|9411135|P1|Overall Study|Adverse Event|3
2742586|NCT00075504|9411149|P2|Overall Study|Withdrawal by Subject|7
2742587|NCT00075504|9411150|P1|Overall Study|Withdrawal by Subject|9
2742588|NCT00075478|9411162|P2|Overall Study|Physician Decision|1
2742589|NCT00075478|9411163|P1|Overall Study|Physician Decision|0
2742590|NCT00075478|9411162|P2|Overall Study|not eligible|0
2742591|NCT00075478|9411163|P1|Overall Study|not eligible|1
2742592|NCT00075400|9411183|P1|Overall Study|Never treated|2
2742593|NCT00075400|9411183|P1|Overall Study|Ineligible: wrong primary|1
2742594|NCT00075270|9411204|P2|Overall Study|Missing|13
2742595|NCT00075270|9411205|P1|Overall Study|Missing|26
2742596|NCT00075270|9411204|P2|Overall Study|Other/Unknown|5
2742597|NCT00075270|9411205|P1|Overall Study|Other/Unknown|9
2742598|NCT00075270|9411204|P2|Overall Study|Death|215
2742599|NCT00075270|9411205|P1|Overall Study|Death|198
2742600|NCT00075270|9411204|P2|Overall Study|Protocol Violation|2
2742601|NCT00075270|9411205|P1|Overall Study|Protocol Violation|0
2742602|NCT00075270|9411204|P2|Overall Study|Lost to Follow-up|28
2742603|NCT00075270|9411205|P1|Overall Study|Lost to Follow-up|25
2742604|NCT00075270|9411204|P2|Overall Study|Withdrawal by Subject|21
2742605|NCT00075270|9411205|P1|Overall Study|Withdrawal by Subject|28
2742606|NCT00075218|9411251|P3|Open-Label Treatment|enrolled in a separate continuation|9
2742607|NCT00075218|9411252|P2|Open-Label Treatment|enrolled in a separate continuation|0
2742608|NCT00075218|9411253|P1|Open-Label Treatment|enrolled in a separate continuation|0
2742609|NCT00075218|9411251|P3|Open-Label Treatment|Protocol Violation|1
2742610|NCT00075218|9411252|P2|Open-Label Treatment|Protocol Violation|0
2742611|NCT00075218|9411253|P1|Open-Label Treatment|Protocol Violation|0
2742612|NCT00075218|9411251|P3|Open-Label Treatment|Decision of Sponsor|8
2742613|NCT00075218|9411252|P2|Open-Label Treatment|Decision of Sponsor|0
2742614|NCT00075218|9411253|P1|Open-Label Treatment|Decision of Sponsor|0
2742615|NCT00075218|9411251|P3|Open-Label Treatment|Withdrawal by Subject|12
2742616|NCT00075218|9411252|P2|Open-Label Treatment|Withdrawal by Subject|0
2742617|NCT00075218|9411253|P1|Open-Label Treatment|Withdrawal by Subject|0
2742618|NCT00075218|9411251|P3|Open-Label Treatment|Adverse Event|51
2742619|NCT00075218|9411252|P2|Open-Label Treatment|Adverse Event|0
2742620|NCT00075218|9411253|P1|Open-Label Treatment|Adverse Event|0
2742621|NCT00075218|9411251|P3|Open-Label Treatment|Lack of Efficacy|174
2742622|NCT00075218|9411252|P2|Open-Label Treatment|Lack of Efficacy|0
2742623|NCT00075218|9411253|P1|Open-Label Treatment|Lack of Efficacy|0
2742624|NCT00075218|9411251|P3|Double-Blind Treatment|No study medication taken|0
2742625|NCT00075218|9411252|P2|Double-Blind Treatment|No study medication taken|0
2742626|NCT00075218|9411253|P1|Double-Blind Treatment|No study medication taken|2
2742627|NCT00075218|9411251|P3|Double-Blind Treatment|Decision of Sponsor|0
2742628|NCT00075218|9411252|P2|Double-Blind Treatment|Decision of Sponsor|1
2742629|NCT00075218|9411253|P1|Double-Blind Treatment|Decision of Sponsor|0
2742630|NCT00075218|9411251|P3|Double-Blind Treatment|Lack of Efficacy|0
2742631|NCT00075218|9411252|P2|Double-Blind Treatment|Lack of Efficacy|6
2742632|NCT00075218|9411253|P1|Double-Blind Treatment|Lack of Efficacy|58
2742633|NCT00075218|9411251|P3|Double-Blind Treatment|Lost to Follow-up|0
2742634|NCT00075218|9411252|P2|Double-Blind Treatment|Lost to Follow-up|0
2742635|NCT00075218|9411253|P1|Double-Blind Treatment|Lost to Follow-up|1
2742636|NCT00075218|9411251|P3|Double-Blind Treatment|Withdrawal by Subject|0
2742637|NCT00075218|9411252|P2|Double-Blind Treatment|Withdrawal by Subject|4
2742638|NCT00075218|9411253|P1|Double-Blind Treatment|Withdrawal by Subject|7
2742639|NCT00075218|9411251|P3|Double-Blind Treatment|Adverse Event|0
2742640|NCT00075218|9411252|P2|Double-Blind Treatment|Adverse Event|4
2742641|NCT00075218|9411253|P1|Double-Blind Treatment|Adverse Event|23
2742642|NCT00075023|9411302|P2|Pilot Study|Withdrawal by Subject|0
2742643|NCT00075023|9411303|P1|Pilot Study|Withdrawal by Subject|1
2742644|NCT00075023|9411302|P2|Pilot Study|Physician Decision|2
2742645|NCT00075023|9411303|P1|Pilot Study|Physician Decision|1
2742646|NCT00074984|9411312|P2|Overall Study|Patient Withdrawn Per Protocol|3
2742647|NCT00074984|9411313|P1|Overall Study|Patient Withdrawn Per Protocol|0
2742648|NCT00074984|9411312|P2|Overall Study|Withdrawal by Subject|3
2742649|NCT00074984|9411313|P1|Overall Study|Withdrawal by Subject|2
2742650|NCT00074984|9411312|P2|Overall Study|Death|2
2742651|NCT00074984|9411313|P1|Overall Study|Death|1
2742652|NCT00074958|9411328|P1|Overall Study|Adverse Event|1
2742653|NCT00074711|9411369|P2|Overall Study|Participant stopped study drug|6
2742654|NCT00074711|9411370|P1|Overall Study|Participant stopped study drug|4
2742655|NCT00074711|9411369|P2|Overall Study|Lost to Follow-up|8
2742656|NCT00074711|9411370|P1|Overall Study|Lost to Follow-up|10
2742657|NCT00074711|9411369|P2|Overall Study|Withdrawal by Subject|1
2742658|NCT00074711|9411370|P1|Overall Study|Withdrawal by Subject|1
2742659|NCT00074581|9411388|P2|Overall Study|Other|19
2742660|NCT00074581|9411389|P1|Overall Study|Other|14
2742661|NCT00074581|9411388|P2|Overall Study|Ended relationship w. index participant|106
2742662|NCT00074581|9411389|P1|Overall Study|Ended relationship w. index participant|117
2742663|NCT00074581|9411388|P2|Overall Study|Lost to Follow-up|11
2742664|NCT00074581|9411389|P1|Overall Study|Lost to Follow-up|16
2742665|NCT00074581|9411388|P2|Overall Study|Were withdrawn by investigator|2
2742666|NCT00074581|9411389|P1|Overall Study|Were withdrawn by investigator|5
2742667|NCT00074581|9411388|P2|Overall Study|Relocated|9
2742668|NCT00074581|9411389|P1|Overall Study|Relocated|14
2742669|NCT00074581|9411388|P2|Overall Study|Unable to adhere to visit schedule|14
2742670|NCT00074581|9411389|P1|Overall Study|Unable to adhere to visit schedule|13
2742671|NCT00074581|9411388|P2|Overall Study|Withdrawal by Subject|49
2742672|NCT00074581|9411389|P1|Overall Study|Withdrawal by Subject|50
2742673|NCT00074581|9411388|P2|Overall Study|Death|16
2742674|NCT00074581|9411389|P1|Overall Study|Death|15
2742675|NCT00074490|9411402|P6|Overall Study|Progressive malignancy|0
2742676|NCT00074490|9411403|P5|Overall Study|Progressive malignancy|3
2742677|NCT00074490|9411404|P4|Overall Study|Progressive malignancy|0
2742678|NCT00074490|9411405|P3|Overall Study|Progressive malignancy|0
2742679|NCT00074490|9411406|P2|Overall Study|Progressive malignancy|7
2742680|NCT00074490|9411407|P1|Overall Study|Progressive malignancy|0
2742681|NCT00074412|9411441|P2|Overall Study|Lost to Follow-up|58
2742682|NCT00074412|9411442|P1|Overall Study|Lost to Follow-up|52
2742683|NCT00074412|9411441|P2|Overall Study|Death|26
2742684|NCT00074412|9411442|P1|Overall Study|Death|30
2742685|NCT00074282|9411473|P3|Step 2|Ineligible|1
2742686|NCT00074282|9411474|P2|Step 2|Ineligible|0
2742687|NCT00074282|9411475|P1|Step 2|Ineligible|0
2742688|NCT00074282|9411473|P3|Step 2|Physician Decision|1
2742689|NCT00074282|9411474|P2|Step 2|Physician Decision|0
2742690|NCT00074282|9411475|P1|Step 2|Physician Decision|0
2742691|NCT00074282|9411473|P3|Step 2|Withdrawal by Subject|2
2742692|NCT00074282|9411474|P2|Step 2|Withdrawal by Subject|0
2742693|NCT00074282|9411475|P1|Step 2|Withdrawal by Subject|0
2742694|NCT00074282|9411473|P3|Step 2|Death|3
2742695|NCT00074282|9411474|P2|Step 2|Death|0
2742696|NCT00074282|9411475|P1|Step 2|Death|0
2742697|NCT00074282|9411473|P3|Step 2|Disease progression|5
2742698|NCT00074282|9411474|P2|Step 2|Disease progression|0
2742699|NCT00074282|9411475|P1|Step 2|Disease progression|0
2742700|NCT00074282|9411473|P3|Step 2|Adverse Event|12
2742701|NCT00074282|9411474|P2|Step 2|Adverse Event|2
2742702|NCT00074282|9411475|P1|Step 2|Adverse Event|0
2742703|NCT00074282|9411473|P3|Step 1|Never started treatment|0
2742704|NCT00074282|9411474|P2|Step 1|Never started treatment|0
2742705|NCT00074282|9411475|P1|Step 1|Never started treatment|2
2742706|NCT00074282|9411473|P3|Step 1|Ineligible|0
2742707|NCT00074282|9411474|P2|Step 1|Ineligible|0
2742708|NCT00074282|9411475|P1|Step 1|Ineligible|4
2742709|NCT00074282|9411473|P3|Step 1|Physician Decision|0
2742710|NCT00074282|9411474|P2|Step 1|Physician Decision|0
2742711|NCT00074282|9411475|P1|Step 1|Physician Decision|1
2742712|NCT00074282|9411473|P3|Step 1|Other complicating disease|0
2742713|NCT00074282|9411474|P2|Step 1|Other complicating disease|0
2742714|NCT00074282|9411475|P1|Step 1|Other complicating disease|2
2742715|NCT00074282|9411473|P3|Step 1|Alternative therapy|0
2742716|NCT00074282|9411474|P2|Step 1|Alternative therapy|0
2742717|NCT00074282|9411475|P1|Step 1|Alternative therapy|2
2742718|NCT00074282|9411473|P3|Step 1|Disease progression|0
2742719|NCT00074282|9411474|P2|Step 1|Disease progression|0
2742720|NCT00074282|9411475|P1|Step 1|Disease progression|2
2742721|NCT00074282|9411473|P3|Step 1|Withdrawal by Subject|0
2742722|NCT00074282|9411474|P2|Step 1|Withdrawal by Subject|0
2742723|NCT00074282|9411475|P1|Step 1|Withdrawal by Subject|7
2742724|NCT00074282|9411473|P3|Step 1|Death|0
2742725|NCT00074282|9411474|P2|Step 1|Death|0
2742726|NCT00074282|9411475|P1|Step 1|Death|6
2742727|NCT00074282|9411473|P3|Step 1|Adverse Event|0
2742728|NCT00074282|9411474|P2|Step 1|Adverse Event|0
2742729|NCT00074282|9411475|P1|Step 1|Adverse Event|32
2742730|NCT00074152|9411501|P2|Overall Study|Lack of Efficacy|24
2742731|NCT00074152|9411502|P1|Overall Study|Lack of Efficacy|34
2742732|NCT00074152|9411501|P2|Overall Study|Death|9
2742733|NCT00074152|9411502|P1|Overall Study|Death|21
2742734|NCT00073983|9411519|P1|Overall Study|not evaluable|1
2742735|NCT00073918|9411540|P1|Overall Study|Eligibility requirement not met-low CD20|1
2742736|NCT00073918|9411540|P1|Overall Study|Rapid disease progression|2
2742737|NCT00073918|9411540|P1|Overall Study|Eligibility requirement not met - HAMA+|1
2742738|NCT00073749|9411554|P7|Overall Study|Other|0
2742739|NCT00073749|9411555|P6|Overall Study|Other|2
2742740|NCT00073749|9411556|P5|Overall Study|Other|0
2742741|NCT00073749|9411557|P4|Overall Study|Other|0
2742742|NCT00073749|9411558|P3|Overall Study|Other|0
2742743|NCT00073749|9411559|P2|Overall Study|Other|0
2742744|NCT00073749|9411560|P1|Overall Study|Other|0
2742745|NCT00073749|9411554|P7|Overall Study|Lost to Follow-up|2
2742746|NCT00073749|9411555|P6|Overall Study|Lost to Follow-up|0
2742747|NCT00073749|9411556|P5|Overall Study|Lost to Follow-up|0
2742748|NCT00073749|9411557|P4|Overall Study|Lost to Follow-up|0
2742749|NCT00073749|9411558|P3|Overall Study|Lost to Follow-up|0
2742750|NCT00073749|9411559|P2|Overall Study|Lost to Follow-up|0
2742751|NCT00073749|9411560|P1|Overall Study|Lost to Follow-up|0
2742752|NCT00073749|9411554|P7|Overall Study|Discontinuation of Study by Sponsor|4
2742753|NCT00073749|9411555|P6|Overall Study|Discontinuation of Study by Sponsor|0
2742754|NCT00073749|9411556|P5|Overall Study|Discontinuation of Study by Sponsor|0
2742755|NCT00073749|9411557|P4|Overall Study|Discontinuation of Study by Sponsor|0
2742756|NCT00073749|9411558|P3|Overall Study|Discontinuation of Study by Sponsor|0
2742757|NCT00073749|9411559|P2|Overall Study|Discontinuation of Study by Sponsor|0
2742758|NCT00073749|9411560|P1|Overall Study|Discontinuation of Study by Sponsor|0
2742759|NCT00073749|9411554|P7|Overall Study|Withdrawal by Subject|2
2742760|NCT00073749|9411555|P6|Overall Study|Withdrawal by Subject|0
2742761|NCT00073749|9411556|P5|Overall Study|Withdrawal by Subject|1
2742762|NCT00073749|9411557|P4|Overall Study|Withdrawal by Subject|0
2742763|NCT00073749|9411558|P3|Overall Study|Withdrawal by Subject|0
2742764|NCT00073749|9411559|P2|Overall Study|Withdrawal by Subject|1
2742765|NCT00073749|9411560|P1|Overall Study|Withdrawal by Subject|0
2742766|NCT00073749|9411554|P7|Overall Study|Physician Decision|0
2742767|NCT00073749|9411555|P6|Overall Study|Physician Decision|2
2742768|NCT00073749|9411556|P5|Overall Study|Physician Decision|0
2742769|NCT00073749|9411557|P4|Overall Study|Physician Decision|0
2742770|NCT00073749|9411558|P3|Overall Study|Physician Decision|1
2742771|NCT00073749|9411559|P2|Overall Study|Physician Decision|0
2742772|NCT00073749|9411560|P1|Overall Study|Physician Decision|0
2742773|NCT00073749|9411554|P7|Overall Study|Adverse Event|0
2742774|NCT00073749|9411555|P6|Overall Study|Adverse Event|1
2742775|NCT00073749|9411556|P5|Overall Study|Adverse Event|2
2742776|NCT00073749|9411557|P4|Overall Study|Adverse Event|4
2742777|NCT00073749|9411558|P3|Overall Study|Adverse Event|6
2742778|NCT00073749|9411559|P2|Overall Study|Adverse Event|3
2742779|NCT00073749|9411560|P1|Overall Study|Adverse Event|0
2742780|NCT00073749|9411554|P7|Overall Study|Death|29
2742781|NCT00073749|9411555|P6|Overall Study|Death|0
2742782|NCT00073749|9411556|P5|Overall Study|Death|0
2742783|NCT00073749|9411557|P4|Overall Study|Death|0
2742784|NCT00073749|9411558|P3|Overall Study|Death|1
2742785|NCT00073749|9411559|P2|Overall Study|Death|1
2742786|NCT00073749|9411560|P1|Overall Study|Death|0
2742787|NCT00073749|9411554|P7|Overall Study|Disease Progression|3
2742788|NCT00073749|9411555|P6|Overall Study|Disease Progression|1
2742789|NCT00073749|9411556|P5|Overall Study|Disease Progression|3
2742790|NCT00073749|9411557|P4|Overall Study|Disease Progression|2
2742791|NCT00073749|9411558|P3|Overall Study|Disease Progression|3
2742792|NCT00073749|9411559|P2|Overall Study|Disease Progression|0
2742793|NCT00073749|9411560|P1|Overall Study|Disease Progression|2
2742794|NCT00073528|9411591|P2|Overall Study|Ongoing|344
2742795|NCT00073528|9411592|P1|Overall Study|Ongoing|349
2742796|NCT00073528|9411591|P2|Overall Study|Non-compliance|1
2742797|NCT00073528|9411592|P1|Overall Study|Non-compliance|0
2742798|NCT00073528|9411591|P2|Overall Study|Enrolled in Error|1
2742799|NCT00073528|9411592|P1|Overall Study|Enrolled in Error|0
2742800|NCT00073528|9411591|P2|Overall Study|Participant Was Unblinded|1
2742801|NCT00073528|9411592|P1|Overall Study|Participant Was Unblinded|0
2742802|NCT00073528|9411591|P2|Overall Study|Progressive Disease|1
2742803|NCT00073528|9411592|P1|Overall Study|Progressive Disease|0
2742804|NCT00073528|9411591|P2|Overall Study|Randomized in Error; Not Treated|0
2742805|NCT00073528|9411592|P1|Overall Study|Randomized in Error; Not Treated|2
2742806|NCT00073528|9411591|P2|Overall Study|Mastectomy Intervention|0
2742807|NCT00073528|9411592|P1|Overall Study|Mastectomy Intervention|1
2742808|NCT00073528|9411591|P2|Overall Study|Death|238
2742809|NCT00073528|9411592|P1|Overall Study|Death|229
2742810|NCT00073528|9411591|P2|Overall Study|Protocol Violation|5
2742811|NCT00073528|9411592|P1|Overall Study|Protocol Violation|3
2742812|NCT00073528|9411591|P2|Overall Study|Lost to Follow-up|22
2742813|NCT00073528|9411592|P1|Overall Study|Lost to Follow-up|26
2742814|NCT00073528|9411591|P2|Overall Study|Withdrawal by Subject|29
2742815|NCT00073528|9411592|P1|Overall Study|Withdrawal by Subject|34
2742816|NCT00073307|9411681|P3|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83
2742817|NCT00073307|9411682|P2|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0
2742818|NCT00073307|9411683|P1|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35
2742819|NCT00073307|9411681|P3|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9
2742820|NCT00073307|9411682|P2|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0
2742821|NCT00073307|9411683|P1|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19
2742822|NCT00073307|9411681|P3|Open Label-Sorafenib Only [30Jun2008]|Missing|1
2742823|NCT00073307|9411682|P2|Open Label-Sorafenib Only [30Jun2008]|Missing|0
2742824|NCT00073307|9411683|P1|Open Label-Sorafenib Only [30Jun2008]|Missing|3
2742825|NCT00073307|9411681|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3
2742826|NCT00073307|9411682|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
2742827|NCT00073307|9411683|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
2742828|NCT00073307|9411681|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
2742829|NCT00073307|9411682|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0
2742830|NCT00073307|9411683|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
2742831|NCT00073307|9411681|P3|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
2742832|NCT00073307|9411682|P2|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0
2742833|NCT00073307|9411683|P1|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
2742834|NCT00073307|9411681|P3|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28
2742835|NCT00073307|9411682|P2|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0
2742836|NCT00073307|9411683|P1|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37
2742837|NCT00073307|9411681|P3|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9
2742838|NCT00073307|9411682|P2|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0
2742839|NCT00073307|9411683|P1|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19
2742840|NCT00073307|9411681|P3|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
2742841|NCT00073307|9411682|P2|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0
2742842|NCT00073307|9411683|P1|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
2742843|NCT00073307|9411681|P3|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19
2742844|NCT00073307|9411682|P2|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0
2742845|NCT00073307|9411683|P1|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17
2742846|NCT00073307|9411681|P3|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
2742847|NCT00073307|9411682|P2|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1
2742848|NCT00073307|9411683|P1|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
2742849|NCT00073307|9411681|P3|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0
2742850|NCT00073307|9411682|P2|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114
2742851|NCT00073307|9411683|P1|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165
2742852|NCT00073307|9411681|P3|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
2742853|NCT00073307|9411682|P2|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1
2742854|NCT00073307|9411683|P1|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
2742855|NCT00073307|9411681|P3|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
2742856|NCT00073307|9411682|P2|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
2742857|NCT00073307|9411683|P1|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1
2742858|NCT00073307|9411681|P3|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0
2742859|NCT00073307|9411682|P2|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2
2742860|NCT00073307|9411683|P1|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1
2742861|NCT00073307|9411681|P3|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0
2742862|NCT00073307|9411682|P2|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
2742863|NCT00073307|9411683|P1|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
2742864|NCT00073307|9411681|P3|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0
2742865|NCT00073307|9411682|P2|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11
2742866|NCT00073307|9411683|P1|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6
2742867|NCT00073307|9411681|P3|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0
2742868|NCT00073307|9411682|P2|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6
2742869|NCT00073307|9411683|P1|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1
2742870|NCT00073307|9411681|P3|Double-Blind (DB, as of ~31May2005)|Adverse Event|0
2742871|NCT00073307|9411682|P2|Double-Blind (DB, as of ~31May2005)|Adverse Event|17
2742872|NCT00073307|9411683|P1|Double-Blind (DB, as of ~31May2005)|Adverse Event|22
2742873|NCT00073021|9411714|P2|Overall Study|Lack of Efficacy|5
2742874|NCT00073021|9411715|P1|Overall Study|Lack of Efficacy|11
2742875|NCT00073021|9411714|P2|Overall Study|Physician Decision|1
2742876|NCT00073021|9411715|P1|Overall Study|Physician Decision|3
2742877|NCT00073021|9411714|P2|Overall Study|Withdrawal by Subject|5
2742878|NCT00073021|9411715|P1|Overall Study|Withdrawal by Subject|6
2742879|NCT00073021|9411714|P2|Overall Study|Adverse Event|4
2742880|NCT00073021|9411715|P1|Overall Study|Adverse Event|4
2742881|NCT00073021|9411714|P2|Overall Study|Protocol Violation|1
2742882|NCT00073021|9411715|P1|Overall Study|Protocol Violation|2
2742883|NCT00073008|9411745|P2|Overall Study|"Other selected on Case Report Form"|5
2742884|NCT00073008|9411746|P1|Overall Study|"Other selected on Case Report Form"|7
2742885|NCT00073008|9411745|P2|Overall Study|Death|47
2742886|NCT00073008|9411746|P1|Overall Study|Death|46
2742887|NCT00073008|9411745|P2|Overall Study|Lost to Follow-up|3
2742888|NCT00073008|9411746|P1|Overall Study|Lost to Follow-up|1
2742889|NCT00073008|9411745|P2|Overall Study|Withdrawal by Subject|2
2742890|NCT00073008|9411746|P1|Overall Study|Withdrawal by Subject|2
2742891|NCT00073008|9411745|P2|Overall Study|Missing|6
2742892|NCT00073008|9411746|P1|Overall Study|Missing|6
2742893|NCT00072475|9411785|P1|Overall Study|Patient/Investigator Decision|4
2742894|NCT00072475|9411785|P1|Overall Study|Withdrawal by Subject|46
2742895|NCT00072475|9411785|P1|Overall Study|Death|3
2742896|NCT00072475|9411785|P1|Overall Study|Adverse Event|44
2742897|NCT00072384|9411800|P1|Overall Study|Ineligible|8
2742898|NCT00072384|9411800|P1|Overall Study|Physician Decision|1
2742899|NCT00072293|9411813|P2|Overall Study|Withdrawal by Subject|1
2742900|NCT00072293|9411814|P1|Overall Study|Withdrawal by Subject|0
2742901|NCT00072293|9411813|P2|Overall Study|Lost to Follow-up|1
2742902|NCT00072293|9411814|P1|Overall Study|Lost to Follow-up|1
2742903|NCT00072280|9411826|P2|Follow-up|Early termination of study|2
2742904|NCT00072280|9411827|P1|Follow-up|Early termination of study|2
2742905|NCT00072280|9411826|P2|Treatment|Found ineligible|2
2742906|NCT00072280|9411827|P1|Treatment|Found ineligible|1
2742907|NCT00072189|9411832|P1|Overall Study|Withdrawal by Subject|1
2742908|NCT00072176|9411840|P2|Overall Study|Protocol Violation|1
2742909|NCT00072176|9411841|P1|Overall Study|Protocol Violation|0
2742910|NCT00072176|9411840|P2|Overall Study|Withdrawal by Subject|0
2742911|NCT00072176|9411841|P1|Overall Study|Withdrawal by Subject|1
2742912|NCT00071981|9411853|P4|Overall Study|others (not specified in the study)|0
2742913|NCT00071981|9411854|P3|Overall Study|others (not specified in the study)|2
2742914|NCT00071981|9411855|P2|Overall Study|others (not specified in the study)|2
2742915|NCT00071981|9411856|P1|Overall Study|others (not specified in the study)|0
2742916|NCT00071981|9411853|P4|Overall Study|No protocol therapy|0
2742917|NCT00071981|9411854|P3|Overall Study|No protocol therapy|1
2742918|NCT00071981|9411855|P2|Overall Study|No protocol therapy|5
2742919|NCT00071981|9411856|P1|Overall Study|No protocol therapy|2
2742920|NCT00071981|9411853|P4|Overall Study|Withdrawal by Subject|0
2742921|NCT00071981|9411854|P3|Overall Study|Withdrawal by Subject|0
2742922|NCT00071981|9411855|P2|Overall Study|Withdrawal by Subject|1
2742923|NCT00071981|9411856|P1|Overall Study|Withdrawal by Subject|3
2742924|NCT00071981|9411853|P4|Overall Study|Death|1
2742925|NCT00071981|9411854|P3|Overall Study|Death|1
2742926|NCT00071981|9411855|P2|Overall Study|Death|0
2742927|NCT00071981|9411856|P1|Overall Study|Death|0
2742928|NCT00071981|9411853|P4|Overall Study|Adverse Event|1
2742929|NCT00071981|9411854|P3|Overall Study|Adverse Event|3
2742930|NCT00071981|9411855|P2|Overall Study|Adverse Event|4
2742931|NCT00071981|9411856|P1|Overall Study|Adverse Event|4
2742932|NCT00071981|9411853|P4|Overall Study|Lack of Efficacy|43
2742933|NCT00071981|9411854|P3|Overall Study|Lack of Efficacy|30
2742934|NCT00071981|9411855|P2|Overall Study|Lack of Efficacy|29
2742935|NCT00071981|9411856|P1|Overall Study|Lack of Efficacy|37
2742936|NCT00071812|9411899|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
2742937|NCT00071812|9411900|P3|24-Week Open-Label Extension Period|Lack of Compliance|1
2742938|NCT00071812|9411901|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
2742939|NCT00071812|9411902|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
2742940|NCT00071812|9411899|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|12
2742941|NCT00071812|9411900|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
2742942|NCT00071812|9411901|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
2742943|NCT00071812|9411902|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
2742944|NCT00071812|9411899|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
2742945|NCT00071812|9411900|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
2742946|NCT00071812|9411901|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
2742947|NCT00071812|9411902|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
2742948|NCT00071812|9411899|P4|24-Week Open-Label Extension Period|Lack of Efficacy|17
2742949|NCT00071812|9411900|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
2742950|NCT00071812|9411901|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
2742951|NCT00071812|9411902|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
2742952|NCT00071812|9411899|P4|24-Week Open-Label Extension Period|Adverse Event|7
2742953|NCT00071812|9411900|P3|24-Week Open-Label Extension Period|Adverse Event|0
2742954|NCT00071812|9411901|P2|24-Week Open-Label Extension Period|Adverse Event|0
2742955|NCT00071812|9411902|P1|24-Week Open-Label Extension Period|Adverse Event|0
2742956|NCT00071812|9411899|P4|24-Week Double-Blind Period|Protocol Violation|1
2742957|NCT00071812|9411900|P3|24-Week Double-Blind Period|Protocol Violation|0
2742958|NCT00071812|9411901|P2|24-Week Double-Blind Period|Protocol Violation|0
2742959|NCT00071812|9411902|P1|24-Week Double-Blind Period|Protocol Violation|0
2742960|NCT00071812|9411899|P4|24-Week Double-Blind Period|Withdrawal by Subject|5
2742961|NCT00071812|9411900|P3|24-Week Double-Blind Period|Withdrawal by Subject|1
2742962|NCT00071812|9411901|P2|24-Week Double-Blind Period|Withdrawal by Subject|1
2742963|NCT00071812|9411902|P1|24-Week Double-Blind Period|Withdrawal by Subject|5
2742964|NCT00071812|9411899|P4|24-Week Double-Blind Period|Lost to Follow-up|0
2742965|NCT00071812|9411900|P3|24-Week Double-Blind Period|Lost to Follow-up|1
2742966|NCT00071812|9411901|P2|24-Week Double-Blind Period|Lost to Follow-up|1
2742967|NCT00071812|9411902|P1|24-Week Double-Blind Period|Lost to Follow-up|0
2742968|NCT00071812|9411899|P4|24-Week Double-Blind Period|Lack of Efficacy|1
2742969|NCT00071812|9411900|P3|24-Week Double-Blind Period|Lack of Efficacy|2
2742970|NCT00071812|9411901|P2|24-Week Double-Blind Period|Lack of Efficacy|1
2742971|NCT00071812|9411902|P1|24-Week Double-Blind Period|Lack of Efficacy|3
2742972|NCT00071812|9411899|P4|24-Week Double-Blind Period|Adverse Event|4
2742973|NCT00071812|9411900|P3|24-Week Double-Blind Period|Adverse Event|4
2742974|NCT00071812|9411901|P2|24-Week Double-Blind Period|Adverse Event|3
2742975|NCT00071812|9411902|P1|24-Week Double-Blind Period|Adverse Event|2
2742976|NCT00071799|9411944|P2|Overall Study|Not Documented|2
2742977|NCT00071799|9411945|P1|Overall Study|Not Documented|0
2742978|NCT00071799|9411944|P2|Overall Study|Different Central+Local Pathology Review|1
2742979|NCT00071799|9411945|P1|Overall Study|Different Central+Local Pathology Review|0
2742980|NCT00071799|9411944|P2|Overall Study|Disease Progression|20
2742981|NCT00071799|9411945|P1|Overall Study|Disease Progression|23
2742982|NCT00071799|9411944|P2|Overall Study|Lack of Efficacy|18
2742983|NCT00071799|9411945|P1|Overall Study|Lack of Efficacy|11
2742984|NCT00071799|9411944|P2|Overall Study|Physician Decision|2
2742985|NCT00071799|9411945|P1|Overall Study|Physician Decision|0
2742986|NCT00071799|9411944|P2|Overall Study|Withdrawal by Subject|37
2742987|NCT00071799|9411945|P1|Overall Study|Withdrawal by Subject|15
2742988|NCT00071799|9411944|P2|Overall Study|Lost to Follow-up|1
2742989|NCT00071799|9411945|P1|Overall Study|Lost to Follow-up|1
2742990|NCT00071799|9411944|P2|Overall Study|Protocol Violation|7
2742991|NCT00071799|9411945|P1|Overall Study|Protocol Violation|1
2742992|NCT00071799|9411944|P2|Overall Study|Adverse Event|10
2742993|NCT00071799|9411945|P1|Overall Study|Adverse Event|19
2742994|NCT00071760|9411998|P1|Overall Study|Ongoing|25
2742995|NCT00071760|9411998|P1|Overall Study|Study Team Rec./Resistance|1
2742996|NCT00071760|9411998|P1|Overall Study|Investigator's Recommendation (Rec.)|4
2742997|NCT00071760|9411998|P1|Overall Study|Relocation|1
2742998|NCT00071760|9411998|P1|Overall Study|Unavailability of RTV|8
2742999|NCT00071760|9411998|P1|Overall Study|Pulmonary Tuberculosis|1
2743000|NCT00071760|9411998|P1|Overall Study|Insufficient Viral Load Response|3
2743001|NCT00071760|9411998|P1|Overall Study|Withdrawal by Subject|3
2743002|NCT00071760|9411998|P1|Overall Study|Protocol Violation|1
2743003|NCT00071760|9411998|P1|Overall Study|Lost to Follow-up|4
2743004|NCT00071760|9411998|P1|Overall Study|Adverse Event|3
2743005|NCT00071513|9412078|P2|Follow-up Assessment|Withdrawal by Subject|6
2743006|NCT00071513|9412079|P1|Follow-up Assessment|Withdrawal by Subject|6
2743007|NCT00071513|9412078|P2|Intervention Component|Withdrawal by Subject|3
2743008|NCT00071513|9412079|P1|Intervention Component|Withdrawal by Subject|2
2743009|NCT00071487|9412091|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
2743010|NCT00071487|9412092|P3|24-Week Open-Label Extension Period|Lack of Compliance|0
2743011|NCT00071487|9412093|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
2743012|NCT00071487|9412094|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
2743013|NCT00071487|9412091|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
2743014|NCT00071487|9412092|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
2743015|NCT00071487|9412093|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
2743016|NCT00071487|9412094|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
2743017|NCT00071487|9412091|P4|24-Week Open-Label Extension Period|Pregnancy|1
2743018|NCT00071487|9412092|P3|24-Week Open-Label Extension Period|Pregnancy|0
2743019|NCT00071487|9412093|P2|24-Week Open-Label Extension Period|Pregnancy|0
2743020|NCT00071487|9412094|P1|24-Week Open-Label Extension Period|Pregnancy|0
2743021|NCT00071487|9412091|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|9
2743022|NCT00071487|9412092|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
2743023|NCT00071487|9412093|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
2743024|NCT00071487|9412094|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
2743025|NCT00071487|9412091|P4|24-Week Open-Label Extension Period|Lack of Efficacy|3
2743026|NCT00071487|9412092|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
2743027|NCT00071487|9412093|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
2743028|NCT00071487|9412094|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
2743029|NCT00071487|9412091|P4|24-Week Open-Label Extension Period|Adverse Event|6
2743030|NCT00071487|9412092|P3|24-Week Open-Label Extension Period|Adverse Event|1
2743031|NCT00071487|9412093|P2|24-Week Open-Label Extension Period|Adverse Event|0
2743032|NCT00071487|9412094|P1|24-Week Open-Label Extension Period|Adverse Event|0
2743033|NCT00071487|9412091|P4|52-Week Double-Blind Period|Lack of Compliance|3
2743034|NCT00071487|9412092|P3|52-Week Double-Blind Period|Lack of Compliance|3
2743035|NCT00071487|9412093|P2|52-Week Double-Blind Period|Lack of Compliance|3
2743036|NCT00071487|9412094|P1|52-Week Double-Blind Period|Lack of Compliance|6
2743037|NCT00071487|9412091|P4|52-Week Double-Blind Period|Death|0
2743038|NCT00071487|9412092|P3|52-Week Double-Blind Period|Death|0
2743039|NCT00071487|9412093|P2|52-Week Double-Blind Period|Death|1
2743040|NCT00071487|9412094|P1|52-Week Double-Blind Period|Death|0
2743041|NCT00071487|9412091|P4|52-Week Double-Blind Period|Protocol Violation|0
2743042|NCT00071487|9412092|P3|52-Week Double-Blind Period|Protocol Violation|1
2743043|NCT00071487|9412093|P2|52-Week Double-Blind Period|Protocol Violation|1
2743044|NCT00071487|9412094|P1|52-Week Double-Blind Period|Protocol Violation|0
2743045|NCT00071487|9412091|P4|52-Week Double-Blind Period|Pregnancy|0
2743046|NCT00071487|9412092|P3|52-Week Double-Blind Period|Pregnancy|0
2743047|NCT00071487|9412093|P2|52-Week Double-Blind Period|Pregnancy|1
2743048|NCT00071487|9412094|P1|52-Week Double-Blind Period|Pregnancy|0
2743049|NCT00071487|9412091|P4|52-Week Double-Blind Period|Lost to Follow-up|2
2743050|NCT00071487|9412092|P3|52-Week Double-Blind Period|Lost to Follow-up|2
2743051|NCT00071487|9412093|P2|52-Week Double-Blind Period|Lost to Follow-up|0
2743052|NCT00071487|9412094|P1|52-Week Double-Blind Period|Lost to Follow-up|0
2743053|NCT00071487|9412091|P4|52-Week Double-Blind Period|Physician Decision|0
2743054|NCT00071487|9412092|P3|52-Week Double-Blind Period|Physician Decision|0
2743055|NCT00071487|9412093|P2|52-Week Double-Blind Period|Physician Decision|0
2743056|NCT00071487|9412094|P1|52-Week Double-Blind Period|Physician Decision|1
2743057|NCT00071487|9412091|P4|52-Week Double-Blind Period|Withdrawal by Subject|7
2743058|NCT00071487|9412092|P3|52-Week Double-Blind Period|Withdrawal by Subject|7
2743059|NCT00071487|9412093|P2|52-Week Double-Blind Period|Withdrawal by Subject|11
2743060|NCT00071487|9412094|P1|52-Week Double-Blind Period|Withdrawal by Subject|7
2743061|NCT00071487|9412091|P4|52-Week Double-Blind Period|Lack of Efficacy|1
2743062|NCT00071487|9412092|P3|52-Week Double-Blind Period|Lack of Efficacy|0
2743063|NCT00071487|9412093|P2|52-Week Double-Blind Period|Lack of Efficacy|2
2743064|NCT00071487|9412094|P1|52-Week Double-Blind Period|Lack of Efficacy|1
2743065|NCT00071487|9412091|P4|52-Week Double-Blind Period|Adverse Event|8
2743066|NCT00071487|9412092|P3|52-Week Double-Blind Period|Adverse Event|4
2743067|NCT00071487|9412093|P2|52-Week Double-Blind Period|Adverse Event|8
2743068|NCT00071487|9412094|P1|52-Week Double-Blind Period|Adverse Event|5
2743069|NCT00071396|9412138|P1|Overall Study|Physician Decision|2
2743070|NCT00071396|9412138|P1|Overall Study|Withdrawal by Subject|1
2743071|NCT00071110|9412144|P2|Overall Study|Protocol Violation|4
2743072|NCT00071110|9412145|P1|Overall Study|Protocol Violation|0
2743073|NCT00071032|9412159|P2|Overall Study|Missing Primary Outcome|1
2743074|NCT00071032|9412160|P1|Overall Study|Missing Primary Outcome|0
2743075|NCT00071032|9412159|P2|Overall Study|Withdrawal by Subject|6
2743076|NCT00071032|9412160|P1|Overall Study|Withdrawal by Subject|8
2743077|NCT00071032|9412159|P2|Overall Study|Lost to Follow-up|1
2743078|NCT00071032|9412160|P1|Overall Study|Lost to Follow-up|1
2743079|NCT00071006|9412168|P1|Overall Study|Other|3
2743080|NCT00071006|9412168|P1|Overall Study|Withdrawal by Subject|1
2743081|NCT00071006|9412168|P1|Overall Study|Adverse Event|1
2743082|NCT00071006|9412168|P1|Overall Study|Lack of Efficacy|7
2743083|NCT00070941|9412181|P3|Overall Study|Adverse Event|4
2743084|NCT00070941|9412182|P2|Overall Study|Adverse Event|8
2743085|NCT00070941|9412183|P1|Overall Study|Adverse Event|10
2743086|NCT00071058|9412191|P1|Overall Study|brain tumor-removed from study|1
2743087|NCT00070707|9412198|P2|Overall Study|Unrelated to Study Medication|0
2743088|NCT00070707|9412199|P1|Overall Study|Unrelated to Study Medication|1
2743089|NCT00070707|9412198|P2|Overall Study|Protocol Violation|4
2743090|NCT00070707|9412199|P1|Overall Study|Protocol Violation|8
2743091|NCT00070707|9412198|P2|Overall Study|Lack of Efficacy|1
2743092|NCT00070707|9412199|P1|Overall Study|Lack of Efficacy|4
2743093|NCT00070707|9412198|P2|Overall Study|Adverse Event|2
2743094|NCT00070707|9412199|P1|Overall Study|Adverse Event|1
2743095|NCT00003907|9412247|P2|Overall Study|ineligible or not treated|2
2743096|NCT00003907|9412248|P1|Overall Study|ineligible or not treated|2
2743097|NCT00003907|9412247|P2|Overall Study|Other|3
2743098|NCT00003907|9412248|P1|Overall Study|Other|1
2743099|NCT00003907|9412247|P2|Overall Study|Complicating disease|0
2743100|NCT00003907|9412248|P1|Overall Study|Complicating disease|1
2743101|NCT00003907|9412247|P2|Overall Study|Progressive disease|4
2743102|NCT00003907|9412248|P1|Overall Study|Progressive disease|4
2743103|NCT00003907|9412247|P2|Overall Study|Withdrawal by Subject|3
2743104|NCT00003907|9412248|P1|Overall Study|Withdrawal by Subject|1
2743105|NCT00003907|9412247|P2|Overall Study|Death|0
2743106|NCT00003907|9412248|P1|Overall Study|Death|2
2743107|NCT00003907|9412247|P2|Overall Study|Adverse Event|11
2743108|NCT00003907|9412248|P1|Overall Study|Adverse Event|2
2743109|NCT00070564|9412264|P6|Overall Study|Not reported|0
2743110|NCT00070564|9412265|P5|Overall Study|Not reported|1
2743111|NCT00070564|9412266|P4|Overall Study|Not reported|0
2743112|NCT00070564|9412267|P3|Overall Study|Not reported|0
2743113|NCT00070564|9412268|P2|Overall Study|Not reported|0
2743114|NCT00070564|9412269|P1|Overall Study|Not reported|0
2743115|NCT00070564|9412264|P6|Overall Study|Withdrawal by Subject|8
2743116|NCT00070564|9412265|P5|Overall Study|Withdrawal by Subject|8
2743117|NCT00070564|9412266|P4|Overall Study|Withdrawal by Subject|30
2743118|NCT00070564|9412267|P3|Overall Study|Withdrawal by Subject|23
2743119|NCT00070564|9412268|P2|Overall Study|Withdrawal by Subject|37
2743120|NCT00070564|9412269|P1|Overall Study|Withdrawal by Subject|26
2743121|NCT00070564|9412264|P6|Overall Study|Other, not protocol specified|7
2743122|NCT00070564|9412265|P5|Overall Study|Other, not protocol specified|6
2743123|NCT00070564|9412266|P4|Overall Study|Other, not protocol specified|19
2743124|NCT00070564|9412267|P3|Overall Study|Other, not protocol specified|14
2743125|NCT00070564|9412268|P2|Overall Study|Other, not protocol specified|15
2743126|NCT00070564|9412269|P1|Overall Study|Other, not protocol specified|17
2743127|NCT00070564|9412264|P6|Overall Study|Death|1
2743128|NCT00070564|9412265|P5|Overall Study|Death|0
2743129|NCT00070564|9412266|P4|Overall Study|Death|3
2743130|NCT00070564|9412267|P3|Overall Study|Death|5
2743131|NCT00070564|9412268|P2|Overall Study|Death|1
2743132|NCT00070564|9412269|P1|Overall Study|Death|4
2743133|NCT00070564|9412264|P6|Overall Study|Adverse Event|36
2743134|NCT00070564|9412265|P5|Overall Study|Adverse Event|63
2743135|NCT00070564|9412266|P4|Overall Study|Adverse Event|108
2743136|NCT00070564|9412267|P3|Overall Study|Adverse Event|120
2743137|NCT00070564|9412268|P2|Overall Study|Adverse Event|142
2743138|NCT00070564|9412269|P1|Overall Study|Adverse Event|150
2743139|NCT00070564|9412264|P6|Overall Study|Delinquent|0
2743140|NCT00070564|9412265|P5|Overall Study|Delinquent|0
2743141|NCT00070564|9412266|P4|Overall Study|Delinquent|0
2743142|NCT00070564|9412267|P3|Overall Study|Delinquent|2
2743143|NCT00070564|9412268|P2|Overall Study|Delinquent|4
2743144|NCT00070564|9412269|P1|Overall Study|Delinquent|1
2743145|NCT00070564|9412264|P6|Overall Study|Progression|0
2743146|NCT00070564|9412265|P5|Overall Study|Progression|1
2743147|NCT00070564|9412266|P4|Overall Study|Progression|7
2743148|NCT00070564|9412267|P3|Overall Study|Progression|7
2743149|NCT00070564|9412268|P2|Overall Study|Progression|4
2743150|NCT00070564|9412269|P1|Overall Study|Progression|2
2743151|NCT00070499|9412323|P4|Overall Study|Not eligible|2
2743152|NCT00070499|9412324|P3|Overall Study|Not eligible|3
2743153|NCT00070499|9412325|P2|Overall Study|Not eligible|5
2743154|NCT00070499|9412326|P1|Overall Study|Not eligible|2
2743155|NCT00070499|9412323|P4|Overall Study|Did not start treatment|2
2743156|NCT00070499|9412324|P3|Overall Study|Did not start treatment|0
2743157|NCT00070499|9412325|P2|Overall Study|Did not start treatment|0
2743158|NCT00070499|9412326|P1|Overall Study|Did not start treatment|1
2743159|NCT00070499|9412323|P4|Overall Study|Still on protocol treatment|57
2743160|NCT00070499|9412324|P3|Overall Study|Still on protocol treatment|79
2743161|NCT00070499|9412325|P2|Overall Study|Still on protocol treatment|4
2743162|NCT00070499|9412326|P1|Overall Study|Still on protocol treatment|10
2743163|NCT00070499|9412323|P4|Overall Study|Other - not protocol specified|20
2743164|NCT00070499|9412324|P3|Overall Study|Other - not protocol specified|12
2743165|NCT00070499|9412325|P2|Overall Study|Other - not protocol specified|3
2743166|NCT00070499|9412326|P1|Overall Study|Other - not protocol specified|7
2743167|NCT00070499|9412323|P4|Overall Study|Death|2
2743168|NCT00070499|9412324|P3|Overall Study|Death|1
2743169|NCT00070499|9412325|P2|Overall Study|Death|1
2743170|NCT00070499|9412326|P1|Overall Study|Death|1
2743171|NCT00070499|9412323|P4|Overall Study|Progression/relapse|4
2743172|NCT00070499|9412324|P3|Overall Study|Progression/relapse|1
2743173|NCT00070499|9412325|P2|Overall Study|Progression/relapse|2
2743174|NCT00070499|9412326|P1|Overall Study|Progression/relapse|4
2743175|NCT00070499|9412323|P4|Overall Study|Refusal unrelated to adverse effects|8
2743176|NCT00070499|9412324|P3|Overall Study|Refusal unrelated to adverse effects|5
2743177|NCT00070499|9412325|P2|Overall Study|Refusal unrelated to adverse effects|5
2743178|NCT00070499|9412326|P1|Overall Study|Refusal unrelated to adverse effects|7
2743179|NCT00070499|9412323|P4|Overall Study|Adverse Event|15
2743180|NCT00070499|9412324|P3|Overall Study|Adverse Event|19
2743181|NCT00070499|9412325|P2|Overall Study|Adverse Event|6
2743182|NCT00070499|9412326|P1|Overall Study|Adverse Event|6
2743183|NCT00070317|9412352|P1|Overall Study|Ineligible-Inadequate pathology|6
2743184|NCT00070317|9412352|P1|Overall Study|Ineligible-Improper prior treatment|2
2743185|NCT00070317|9412352|P1|Overall Study|Ineligible required test not done|1
2743186|NCT00070317|9412352|P1|Overall Study|Ineligible Wrong Cell type/primary/stage|3
2743187|NCT00070317|9412352|P1|Overall Study|Inevaluable (Never Treated)|1
2743188|NCT00070291|9412357|P1|Step 2|Adverse Event|1
2743189|NCT00070291|9412357|P1|Step 1|Adverse Event|1
2743190|NCT00070291|9412357|P1|Step 1|Withdrawal by Subject|1
2743191|NCT00070109|9412373|P5|Overall Study|removed from prot thpy prior to chemo|0
2743192|NCT00070109|9412374|P4|Overall Study|removed from prot thpy prior to chemo|1
2743193|NCT00070109|9412375|P3|Overall Study|removed from prot thpy prior to chemo|0
2743194|NCT00070109|9412376|P2|Overall Study|removed from prot thpy prior to chemo|0
2743195|NCT00070109|9412377|P1|Overall Study|removed from prot thpy prior to chemo|0
2743196|NCT00070109|9412373|P5|Overall Study|Adverse Event|2
2743197|NCT00070109|9412374|P4|Overall Study|Adverse Event|4
2743198|NCT00070109|9412375|P3|Overall Study|Adverse Event|2
2743199|NCT00070109|9412376|P2|Overall Study|Adverse Event|0
2743200|NCT00070109|9412377|P1|Overall Study|Adverse Event|0
2743201|NCT00070109|9412373|P5|Overall Study|Withdrawal by Subject|0
2743202|NCT00070109|9412374|P4|Overall Study|Withdrawal by Subject|0
2743203|NCT00070109|9412375|P3|Overall Study|Withdrawal by Subject|1
2743204|NCT00070109|9412376|P2|Overall Study|Withdrawal by Subject|1
2743205|NCT00070109|9412377|P1|Overall Study|Withdrawal by Subject|0
2743206|NCT00070109|9412373|P5|Overall Study|Physician Decision|0
2743207|NCT00070109|9412374|P4|Overall Study|Physician Decision|0
2743208|NCT00070109|9412375|P3|Overall Study|Physician Decision|0
2743209|NCT00070109|9412376|P2|Overall Study|Physician Decision|0
2743210|NCT00070109|9412377|P1|Overall Study|Physician Decision|1
2743211|NCT00070109|9412373|P5|Overall Study|Lack of Efficacy|5
2743212|NCT00070109|9412374|P4|Overall Study|Lack of Efficacy|15
2743213|NCT00070109|9412375|P3|Overall Study|Lack of Efficacy|5
2743214|NCT00070109|9412376|P2|Overall Study|Lack of Efficacy|4
2743215|NCT00070109|9412377|P1|Overall Study|Lack of Efficacy|6
2743216|NCT00070109|9412373|P5|Overall Study|Death|1
2743217|NCT00070109|9412374|P4|Overall Study|Death|0
2743218|NCT00070109|9412375|P3|Overall Study|Death|0
2743219|NCT00070109|9412376|P2|Overall Study|Death|1
2743220|NCT00070109|9412377|P1|Overall Study|Death|1
2743221|NCT00070018|9412405|P1|Overall Study|Withdrawal by Subject|1
2743222|NCT00070018|9412405|P1|Overall Study|Lack of Efficacy|1
2743223|NCT00070018|9412405|P1|Overall Study|Adverse Event|2
2743224|NCT00069953|9412409|P1|Overall Study|Protocol Violation|2
2743225|NCT00069784|9412415|P2|Overall Study|Other|0
2743226|NCT00069784|9412416|P1|Overall Study|Other|17
2743227|NCT00069784|9412415|P2|Overall Study|Withdrawal by Subject|0
2743228|NCT00069784|9412416|P1|Overall Study|Withdrawal by Subject|1090
2743229|NCT00069784|9412415|P2|Overall Study|Adverse Event|0
2743230|NCT00069784|9412416|P1|Overall Study|Adverse Event|105
2743231|NCT00069823|9412436|P2|Overall Study|Did not have follow-up diary cards|3
2743232|NCT00069823|9412437|P1|Overall Study|Did not have follow-up diary cards|6
2743233|NCT00069641|9412480|P3|Overall Study|Death|1
2743234|NCT00069641|9412481|P2|Overall Study|Death|0
2743235|NCT00069641|9412482|P1|Overall Study|Death|1
2743236|NCT00069576|9412509|P2|Follow-up Study at 5-10 Years|Not eligible or did not consent|204
2743237|NCT00069576|9412510|P1|Follow-up Study at 5-10 Years|Not eligible or did not consent|196
2743238|NCT00069576|9412509|P2|Original Trial|Lost to Follow-up|33
2743239|NCT00069576|9412510|P1|Original Trial|Lost to Follow-up|25
2743240|NCT00069277|9412560|P1|Overall Study|Physician Decision|2
2743241|NCT00069277|9412560|P1|Overall Study|Progressive Disease|15
2743242|NCT00069277|9412560|P1|Overall Study|Withdrawal by Subject|1
2743243|NCT00069277|9412560|P1|Overall Study|Adverse Event|3
2743244|NCT00069264|9412564|P1|Overall Study|Discon Therapy|3
2743245|NCT00069264|9412564|P1|Overall Study|Withdrawal by Subject|3
2743246|NCT00069264|9412564|P1|Overall Study|Progressive Disease|23
2743247|NCT00069264|9412564|P1|Overall Study|Adverse Event|3
2743248|NCT00069238|9412592|P3|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2
2743249|NCT00069238|9412593|P2|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
2743250|NCT00069238|9412594|P1|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
2743251|NCT00069238|9412592|P3|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
2743252|NCT00069238|9412593|P2|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2
2743253|NCT00069238|9412594|P1|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
2743254|NCT00069238|9412592|P3|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
2743255|NCT00069238|9412593|P2|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
2743256|NCT00069238|9412594|P1|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9
2743257|NCT00069121|9412602|P2|Overall Study|Lost to Follow-up|63
2743258|NCT00069121|9412603|P1|Overall Study|Lost to Follow-up|63
2743259|NCT00069121|9412602|P2|Overall Study|Withdrawal by Subject|20
2743260|NCT00069121|9412603|P1|Overall Study|Withdrawal by Subject|18
2743261|NCT00069121|9412602|P2|Overall Study|Death|242
2743262|NCT00069121|9412603|P1|Overall Study|Death|286
2743263|NCT00069108|9412625|P2|Overall Study|Refused treatment|10
2743264|NCT00069108|9412626|P1|Overall Study|Refused treatment|5
2743265|NCT00069108|9412625|P2|Overall Study|Violation criteria|4
2743266|NCT00069108|9412626|P1|Overall Study|Violation criteria|1
2743267|NCT00069108|9412625|P2|Overall Study|Insufficient therapy|144
2743268|NCT00069108|9412626|P1|Overall Study|Insufficient therapy|117
2743269|NCT00069108|9412625|P2|Overall Study|Administration|4
2743270|NCT00069108|9412626|P1|Overall Study|Administration|15
2743271|NCT00069108|9412625|P2|Overall Study|Death|6
2743272|NCT00069108|9412626|P1|Overall Study|Death|6
2743273|NCT00069108|9412625|P2|Overall Study|Adverse Event|42
2743274|NCT00069108|9412626|P1|Overall Study|Adverse Event|64
2743275|NCT00069108|9412625|P2|Overall Study|Withdrawal by Subject|9
2743276|NCT00069108|9412626|P1|Overall Study|Withdrawal by Subject|5
2743277|NCT00069095|9412658|P6|Follow-up Phase|Death|101
2743278|NCT00069095|9412659|P5|Follow-up Phase|Death|92
2743279|NCT00069095|9412660|P4|Follow-up Phase|Death|112
2743280|NCT00069095|9412661|P3|Follow-up Phase|Death|120
2743281|NCT00069095|9412662|P2|Follow-up Phase|Death|206
2743282|NCT00069095|9412663|P1|Follow-up Phase|Death|174
2743283|NCT00069095|9412658|P6|Post-study Treatment Phase|Investigator decision|1
2743284|NCT00069095|9412659|P5|Post-study Treatment Phase|Investigator decision|0
2743285|NCT00069095|9412660|P4|Post-study Treatment Phase|Investigator decision|0
2743286|NCT00069095|9412661|P3|Post-study Treatment Phase|Investigator decision|0
2743287|NCT00069095|9412662|P2|Post-study Treatment Phase|Investigator decision|0
2743288|NCT00069095|9412663|P1|Post-study Treatment Phase|Investigator decision|0
2743289|NCT00069095|9412658|P6|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
2743290|NCT00069095|9412659|P5|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1
2743291|NCT00069095|9412660|P4|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
2743292|NCT00069095|9412661|P3|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
2743293|NCT00069095|9412662|P2|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
2743294|NCT00069095|9412663|P1|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
2743295|NCT00069095|9412658|P6|Post-study Treatment Phase|Participant/Physician decision to stop|0
2743296|NCT00069095|9412659|P5|Post-study Treatment Phase|Participant/Physician decision to stop|1
2743297|NCT00069095|9412660|P4|Post-study Treatment Phase|Participant/Physician decision to stop|0
2743298|NCT00069095|9412661|P3|Post-study Treatment Phase|Participant/Physician decision to stop|0
2743299|NCT00069095|9412662|P2|Post-study Treatment Phase|Participant/Physician decision to stop|0
2743300|NCT00069095|9412663|P1|Post-study Treatment Phase|Participant/Physician decision to stop|0
2743301|NCT00069095|9412658|P6|Post-study Treatment Phase|Participant had progressive disease|0
2743302|NCT00069095|9412659|P5|Post-study Treatment Phase|Participant had progressive disease|1
2743303|NCT00069095|9412660|P4|Post-study Treatment Phase|Participant had progressive disease|0
2743304|NCT00069095|9412661|P3|Post-study Treatment Phase|Participant had progressive disease|0
2743305|NCT00069095|9412662|P2|Post-study Treatment Phase|Participant had progressive disease|0
2743306|NCT00069095|9412663|P1|Post-study Treatment Phase|Participant had progressive disease|0
2743307|NCT00069095|9412658|P6|Post-study Treatment Phase|Death|0
2743308|NCT00069095|9412659|P5|Post-study Treatment Phase|Death|1
2743309|NCT00069095|9412660|P4|Post-study Treatment Phase|Death|0
2743310|NCT00069095|9412661|P3|Post-study Treatment Phase|Death|0
2743311|NCT00069095|9412662|P2|Post-study Treatment Phase|Death|0
2743312|NCT00069095|9412663|P1|Post-study Treatment Phase|Death|0
2743313|NCT00069095|9412658|P6|Post-study Treatment Phase|Surgery|0
2743314|NCT00069095|9412659|P5|Post-study Treatment Phase|Surgery|1
2743315|NCT00069095|9412660|P4|Post-study Treatment Phase|Surgery|1
2743316|NCT00069095|9412661|P3|Post-study Treatment Phase|Surgery|0
2743317|NCT00069095|9412662|P2|Post-study Treatment Phase|Surgery|0
2743318|NCT00069095|9412663|P1|Post-study Treatment Phase|Surgery|0
2743319|NCT00069095|9412658|P6|Post-study Treatment Phase|Participant completed treatment|0
2743320|NCT00069095|9412659|P5|Post-study Treatment Phase|Participant completed treatment|0
2743321|NCT00069095|9412660|P4|Post-study Treatment Phase|Participant completed treatment|1
2743322|NCT00069095|9412661|P3|Post-study Treatment Phase|Participant completed treatment|0
2743323|NCT00069095|9412662|P2|Post-study Treatment Phase|Participant completed treatment|0
2743324|NCT00069095|9412663|P1|Post-study Treatment Phase|Participant completed treatment|0
2743325|NCT00069095|9412658|P6|Post-study Treatment Phase|Participant wanted break from treatment|0
2743326|NCT00069095|9412659|P5|Post-study Treatment Phase|Participant wanted break from treatment|0
2743327|NCT00069095|9412660|P4|Post-study Treatment Phase|Participant wanted break from treatment|1
2743328|NCT00069095|9412661|P3|Post-study Treatment Phase|Participant wanted break from treatment|0
2743329|NCT00069095|9412662|P2|Post-study Treatment Phase|Participant wanted break from treatment|0
2743330|NCT00069095|9412663|P1|Post-study Treatment Phase|Participant wanted break from treatment|0
2743331|NCT00069095|9412658|P6|Post-study Treatment Phase|Participant will start new treatment|0
2743332|NCT00069095|9412659|P5|Post-study Treatment Phase|Participant will start new treatment|0
2743333|NCT00069095|9412660|P4|Post-study Treatment Phase|Participant will start new treatment|0
2743334|NCT00069095|9412661|P3|Post-study Treatment Phase|Participant will start new treatment|1
2743335|NCT00069095|9412662|P2|Post-study Treatment Phase|Participant will start new treatment|0
2743336|NCT00069095|9412663|P1|Post-study Treatment Phase|Participant will start new treatment|0
2743337|NCT00069095|9412658|P6|Post-study Treatment Phase|Participant withdrew consent|0
2743338|NCT00069095|9412659|P5|Post-study Treatment Phase|Participant withdrew consent|0
2743339|NCT00069095|9412660|P4|Post-study Treatment Phase|Participant withdrew consent|0
2743340|NCT00069095|9412661|P3|Post-study Treatment Phase|Participant withdrew consent|1
2743341|NCT00069095|9412662|P2|Post-study Treatment Phase|Participant withdrew consent|0
2743342|NCT00069095|9412663|P1|Post-study Treatment Phase|Participant withdrew consent|0
2743343|NCT00069095|9412658|P6|Post-study Treatment Phase|Investigator decision (enough treatment)|0
2743344|NCT00069095|9412659|P5|Post-study Treatment Phase|Investigator decision (enough treatment)|1
2743345|NCT00069095|9412660|P4|Post-study Treatment Phase|Investigator decision (enough treatment)|0
2743346|NCT00069095|9412661|P3|Post-study Treatment Phase|Investigator decision (enough treatment)|1
2743347|NCT00069095|9412662|P2|Post-study Treatment Phase|Investigator decision (enough treatment)|1
2743348|NCT00069095|9412663|P1|Post-study Treatment Phase|Investigator decision (enough treatment)|0
2743349|NCT00069095|9412658|P6|Post-study Treatment Phase|More than 21 days delay between cycles|0
2743350|NCT00069095|9412659|P5|Post-study Treatment Phase|More than 21 days delay between cycles|0
2743351|NCT00069095|9412660|P4|Post-study Treatment Phase|More than 21 days delay between cycles|0
2743352|NCT00069095|9412661|P3|Post-study Treatment Phase|More than 21 days delay between cycles|0
2743353|NCT00069095|9412662|P2|Post-study Treatment Phase|More than 21 days delay between cycles|1
2743354|NCT00069095|9412663|P1|Post-study Treatment Phase|More than 21 days delay between cycles|0
2743355|NCT00069095|9412658|P6|Post-study Treatment Phase|Participant had complete response|0
2743356|NCT00069095|9412659|P5|Post-study Treatment Phase|Participant had complete response|0
2743357|NCT00069095|9412660|P4|Post-study Treatment Phase|Participant had complete response|0
2743358|NCT00069095|9412661|P3|Post-study Treatment Phase|Participant had complete response|0
2743359|NCT00069095|9412662|P2|Post-study Treatment Phase|Participant had complete response|1
2743360|NCT00069095|9412663|P1|Post-study Treatment Phase|Participant had complete response|1
2743361|NCT00069095|9412658|P6|Post-study Treatment Phase|Participant refusal/Admin reasons|1
2743362|NCT00069095|9412659|P5|Post-study Treatment Phase|Participant refusal/Admin reasons|0
2743363|NCT00069095|9412660|P4|Post-study Treatment Phase|Participant refusal/Admin reasons|0
2743364|NCT00069095|9412661|P3|Post-study Treatment Phase|Participant refusal/Admin reasons|0
2743365|NCT00069095|9412662|P2|Post-study Treatment Phase|Participant refusal/Admin reasons|0
2743366|NCT00069095|9412663|P1|Post-study Treatment Phase|Participant refusal/Admin reasons|1
2743367|NCT00069095|9412658|P6|Post-study Treatment Phase|Insufficient therapeutic response|9
2743368|NCT00069095|9412659|P5|Post-study Treatment Phase|Insufficient therapeutic response|7
2743369|NCT00069095|9412660|P4|Post-study Treatment Phase|Insufficient therapeutic response|6
2743370|NCT00069095|9412661|P3|Post-study Treatment Phase|Insufficient therapeutic response|5
2743371|NCT00069095|9412662|P2|Post-study Treatment Phase|Insufficient therapeutic response|4
2743372|NCT00069095|9412663|P1|Post-study Treatment Phase|Insufficient therapeutic response|1
2743373|NCT00069095|9412658|P6|Post-study Treatment Phase|Eligible for surgery|0
2743374|NCT00069095|9412659|P5|Post-study Treatment Phase|Eligible for surgery|0
2743375|NCT00069095|9412660|P4|Post-study Treatment Phase|Eligible for surgery|0
2743376|NCT00069095|9412661|P3|Post-study Treatment Phase|Eligible for surgery|0
2743377|NCT00069095|9412662|P2|Post-study Treatment Phase|Eligible for surgery|0
2743378|NCT00069095|9412663|P1|Post-study Treatment Phase|Eligible for surgery|2
2743379|NCT00069095|9412658|P6|Post-study Treatment Phase|Adverse Event|1
2743380|NCT00069095|9412659|P5|Post-study Treatment Phase|Adverse Event|5
2743381|NCT00069095|9412660|P4|Post-study Treatment Phase|Adverse Event|0
2743382|NCT00069095|9412661|P3|Post-study Treatment Phase|Adverse Event|1
2743383|NCT00069095|9412662|P2|Post-study Treatment Phase|Adverse Event|3
2743384|NCT00069095|9412663|P1|Post-study Treatment Phase|Adverse Event|2
2743385|NCT00069095|9412658|P6|Post-study Treatment Phase|Missing reason|17
2743386|NCT00069095|9412659|P5|Post-study Treatment Phase|Missing reason|18
2743387|NCT00069095|9412660|P4|Post-study Treatment Phase|Missing reason|8
2743388|NCT00069095|9412661|P3|Post-study Treatment Phase|Missing reason|12
2743389|NCT00069095|9412662|P2|Post-study Treatment Phase|Missing reason|3
2743390|NCT00069095|9412663|P1|Post-study Treatment Phase|Missing reason|1
2743391|NCT00069095|9412658|P6|Primary Treatment Phase|Violation criteria|5
2743392|NCT00069095|9412659|P5|Primary Treatment Phase|Violation criteria|1
2743393|NCT00069095|9412660|P4|Primary Treatment Phase|Violation criteria|3
2743394|NCT00069095|9412661|P3|Primary Treatment Phase|Violation criteria|4
2743395|NCT00069095|9412662|P2|Primary Treatment Phase|Violation criteria|2
2743396|NCT00069095|9412663|P1|Primary Treatment Phase|Violation criteria|0
2743397|NCT00069095|9412658|P6|Primary Treatment Phase|Other Violation|1
2743398|NCT00069095|9412659|P5|Primary Treatment Phase|Other Violation|0
2743399|NCT00069095|9412660|P4|Primary Treatment Phase|Other Violation|1
2743400|NCT00069095|9412661|P3|Primary Treatment Phase|Other Violation|1
2743401|NCT00069095|9412662|P2|Primary Treatment Phase|Other Violation|1
2743402|NCT00069095|9412663|P1|Primary Treatment Phase|Other Violation|0
2743403|NCT00069095|9412658|P6|Primary Treatment Phase|Withdrew|9
2743404|NCT00069095|9412659|P5|Primary Treatment Phase|Withdrew|4
2743405|NCT00069095|9412660|P4|Primary Treatment Phase|Withdrew|2
2743406|NCT00069095|9412661|P3|Primary Treatment Phase|Withdrew|8
2743407|NCT00069095|9412662|P2|Primary Treatment Phase|Withdrew|3
2743408|NCT00069095|9412663|P1|Primary Treatment Phase|Withdrew|2
2743409|NCT00069095|9412658|P6|Primary Treatment Phase|Refused treatment|27
2743410|NCT00069095|9412659|P5|Primary Treatment Phase|Refused treatment|24
2743411|NCT00069095|9412660|P4|Primary Treatment Phase|Refused treatment|31
2743412|NCT00069095|9412661|P3|Primary Treatment Phase|Refused treatment|17
2743413|NCT00069095|9412662|P2|Primary Treatment Phase|Refused treatment|26
2743414|NCT00069095|9412663|P1|Primary Treatment Phase|Refused treatment|15
2743415|NCT00069095|9412658|P6|Primary Treatment Phase|Insufficient Therapeutic Response|102
2743416|NCT00069095|9412659|P5|Primary Treatment Phase|Insufficient Therapeutic Response|101
2743417|NCT00069095|9412660|P4|Primary Treatment Phase|Insufficient Therapeutic Response|154
2743418|NCT00069095|9412661|P3|Primary Treatment Phase|Insufficient Therapeutic Response|175
2743419|NCT00069095|9412662|P2|Primary Treatment Phase|Insufficient Therapeutic Response|127
2743420|NCT00069095|9412663|P1|Primary Treatment Phase|Insufficient Therapeutic Response|131
2743421|NCT00069095|9412658|P6|Primary Treatment Phase|Failure to return|2
2743422|NCT00069095|9412659|P5|Primary Treatment Phase|Failure to return|0
2743423|NCT00069095|9412660|P4|Primary Treatment Phase|Failure to return|0
2743424|NCT00069095|9412661|P3|Primary Treatment Phase|Failure to return|0
2743425|NCT00069095|9412662|P2|Primary Treatment Phase|Failure to return|5
2743426|NCT00069095|9412663|P1|Primary Treatment Phase|Failure to return|5
2743427|NCT00069095|9412658|P6|Primary Treatment Phase|Death|8
2743428|NCT00069095|9412659|P5|Primary Treatment Phase|Death|8
2743429|NCT00069095|9412660|P4|Primary Treatment Phase|Death|5
2743430|NCT00069095|9412661|P3|Primary Treatment Phase|Death|2
2743431|NCT00069095|9412662|P2|Primary Treatment Phase|Death|8
2743432|NCT00069095|9412663|P1|Primary Treatment Phase|Death|14
2743433|NCT00069095|9412658|P6|Primary Treatment Phase|Adverse Event|101
2743434|NCT00069095|9412659|P5|Primary Treatment Phase|Adverse Event|109
2743435|NCT00069095|9412660|P4|Primary Treatment Phase|Adverse Event|72
2743436|NCT00069095|9412661|P3|Primary Treatment Phase|Adverse Event|71
2743437|NCT00069095|9412662|P2|Primary Treatment Phase|Adverse Event|92
2743438|NCT00069095|9412663|P1|Primary Treatment Phase|Adverse Event|99
2743439|NCT00069095|9412658|P6|Primary Treatment Phase|Admin/Other|42
2743440|NCT00069095|9412659|P5|Primary Treatment Phase|Admin/Other|48
2743441|NCT00069095|9412660|P4|Primary Treatment Phase|Admin/Other|45
2743442|NCT00069095|9412661|P3|Primary Treatment Phase|Admin/Other|31
2743443|NCT00069095|9412662|P2|Primary Treatment Phase|Admin/Other|38
2743444|NCT00069095|9412663|P1|Primary Treatment Phase|Admin/Other|29
2743445|NCT00069095|9412658|P6|Primary Treatment Phase|Ongoing|4
2743446|NCT00069095|9412659|P5|Primary Treatment Phase|Ongoing|7
2743447|NCT00069095|9412660|P4|Primary Treatment Phase|Ongoing|7
2743448|NCT00069095|9412661|P3|Primary Treatment Phase|Ongoing|5
2743449|NCT00069095|9412662|P2|Primary Treatment Phase|Ongoing|0
2743450|NCT00069095|9412663|P1|Primary Treatment Phase|Ongoing|0
2743451|NCT00068822|9412733|P2|First Randomized Intervention|Lost to Follow-up|2
2743452|NCT00068822|9412734|P1|First Randomized Intervention|Lost to Follow-up|1
2743453|NCT00068692|9412768|P8|Step 2: Randomization|never start protocol therapy|0
2743454|NCT00068692|9412769|P7|Step 2: Randomization|never start protocol therapy|0
2743455|NCT00068692|9412770|P6|Step 2: Randomization|never start protocol therapy|0
2743456|NCT00068692|9412771|P5|Step 2: Randomization|never start protocol therapy|1
2743457|NCT00068692|9412772|P4|Step 2: Randomization|never start protocol therapy|0
2743458|NCT00068692|9412773|P3|Step 2: Randomization|never start protocol therapy|1
2743459|NCT00068692|9412774|P2|Step 2: Randomization|never start protocol therapy|0
2743460|NCT00068692|9412775|P1|Step 2: Randomization|never start protocol therapy|0
2743461|NCT00068692|9412768|P8|Step 2: Randomization|Other|0
2743462|NCT00068692|9412769|P7|Step 2: Randomization|Other|0
2743463|NCT00068692|9412770|P6|Step 2: Randomization|Other|1
2743464|NCT00068692|9412771|P5|Step 2: Randomization|Other|0
2743465|NCT00068692|9412772|P4|Step 2: Randomization|Other|1
2743466|NCT00068692|9412773|P3|Step 2: Randomization|Other|0
2743467|NCT00068692|9412774|P2|Step 2: Randomization|Other|0
2743468|NCT00068692|9412775|P1|Step 2: Randomization|Other|0
2743469|NCT00068692|9412768|P8|Step 2: Randomization|Physician Decision|0
2743470|NCT00068692|9412769|P7|Step 2: Randomization|Physician Decision|0
2743471|NCT00068692|9412770|P6|Step 2: Randomization|Physician Decision|0
2743472|NCT00068692|9412771|P5|Step 2: Randomization|Physician Decision|1
2743473|NCT00068692|9412772|P4|Step 2: Randomization|Physician Decision|1
2743474|NCT00068692|9412773|P3|Step 2: Randomization|Physician Decision|0
2743475|NCT00068692|9412774|P2|Step 2: Randomization|Physician Decision|0
2743476|NCT00068692|9412775|P1|Step 2: Randomization|Physician Decision|0
2743477|NCT00068692|9412768|P8|Step 2: Randomization|alternative therapy|0
2743478|NCT00068692|9412769|P7|Step 2: Randomization|alternative therapy|0
2743479|NCT00068692|9412770|P6|Step 2: Randomization|alternative therapy|0
2743480|NCT00068692|9412771|P5|Step 2: Randomization|alternative therapy|1
2743481|NCT00068692|9412772|P4|Step 2: Randomization|alternative therapy|1
2743482|NCT00068692|9412773|P3|Step 2: Randomization|alternative therapy|0
2743483|NCT00068692|9412774|P2|Step 2: Randomization|alternative therapy|0
2743484|NCT00068692|9412775|P1|Step 2: Randomization|alternative therapy|0
2743485|NCT00068692|9412768|P8|Step 2: Randomization|Withdrawal by Subject|3
2743486|NCT00068692|9412769|P7|Step 2: Randomization|Withdrawal by Subject|0
2743487|NCT00068692|9412770|P6|Step 2: Randomization|Withdrawal by Subject|2
2743488|NCT00068692|9412771|P5|Step 2: Randomization|Withdrawal by Subject|3
2743489|NCT00068692|9412772|P4|Step 2: Randomization|Withdrawal by Subject|6
2743490|NCT00068692|9412773|P3|Step 2: Randomization|Withdrawal by Subject|4
2743491|NCT00068692|9412774|P2|Step 2: Randomization|Withdrawal by Subject|0
2743492|NCT00068692|9412775|P1|Step 2: Randomization|Withdrawal by Subject|0
2743493|NCT00068692|9412768|P8|Step 2: Randomization|Death|1
2743494|NCT00068692|9412769|P7|Step 2: Randomization|Death|0
2743495|NCT00068692|9412770|P6|Step 2: Randomization|Death|0
2743496|NCT00068692|9412771|P5|Step 2: Randomization|Death|1
2743497|NCT00068692|9412772|P4|Step 2: Randomization|Death|0
2743498|NCT00068692|9412773|P3|Step 2: Randomization|Death|0
2743499|NCT00068692|9412774|P2|Step 2: Randomization|Death|0
2743500|NCT00068692|9412775|P1|Step 2: Randomization|Death|0
2743501|NCT00068692|9412768|P8|Step 2: Randomization|Adverse Event|4
2743502|NCT00068692|9412769|P7|Step 2: Randomization|Adverse Event|4
2743503|NCT00068692|9412770|P6|Step 2: Randomization|Adverse Event|3
2743504|NCT00068692|9412771|P5|Step 2: Randomization|Adverse Event|2
2743505|NCT00068692|9412772|P4|Step 2: Randomization|Adverse Event|2
2743506|NCT00068692|9412773|P3|Step 2: Randomization|Adverse Event|4
2743507|NCT00068692|9412774|P2|Step 2: Randomization|Adverse Event|0
2743508|NCT00068692|9412775|P1|Step 2: Randomization|Adverse Event|0
2743509|NCT00068692|9412768|P8|Step 2: Randomization|Disesae progression/replase|0
2743510|NCT00068692|9412769|P7|Step 2: Randomization|Disesae progression/replase|0
2743511|NCT00068692|9412770|P6|Step 2: Randomization|Disesae progression/replase|0
2743512|NCT00068692|9412771|P5|Step 2: Randomization|Disesae progression/replase|0
2743513|NCT00068692|9412772|P4|Step 2: Randomization|Disesae progression/replase|1
2743514|NCT00068692|9412773|P3|Step 2: Randomization|Disesae progression/replase|1
2743515|NCT00068692|9412774|P2|Step 2: Randomization|Disesae progression/replase|0
2743516|NCT00068692|9412775|P1|Step 2: Randomization|Disesae progression/replase|0
2743517|NCT00068692|9412768|P8|Step 1: Registration|Registered but not randomized|0
2743518|NCT00068692|9412769|P7|Step 1: Registration|Registered but not randomized|0
2743519|NCT00068692|9412770|P6|Step 1: Registration|Registered but not randomized|0
2743520|NCT00068692|9412771|P5|Step 1: Registration|Registered but not randomized|0
2743521|NCT00068692|9412772|P4|Step 1: Registration|Registered but not randomized|0
2743522|NCT00068692|9412773|P3|Step 1: Registration|Registered but not randomized|0
2743523|NCT00068692|9412774|P2|Step 1: Registration|Registered but not randomized|1
2743524|NCT00068692|9412775|P1|Step 1: Registration|Registered but not randomized|0
2743525|NCT00068692|9412768|P8|Step 1: Registration|Not start protocol therapy|0
2743526|NCT00068692|9412769|P7|Step 1: Registration|Not start protocol therapy|0
2743527|NCT00068692|9412770|P6|Step 1: Registration|Not start protocol therapy|0
2743528|NCT00068692|9412771|P5|Step 1: Registration|Not start protocol therapy|0
2743529|NCT00068692|9412772|P4|Step 1: Registration|Not start protocol therapy|0
2743530|NCT00068692|9412773|P3|Step 1: Registration|Not start protocol therapy|0
2743531|NCT00068692|9412774|P2|Step 1: Registration|Not start protocol therapy|0
2743532|NCT00068692|9412775|P1|Step 1: Registration|Not start protocol therapy|3
2743533|NCT00068692|9412768|P8|Step 1: Registration|Other|0
2743534|NCT00068692|9412769|P7|Step 1: Registration|Other|0
2743535|NCT00068692|9412770|P6|Step 1: Registration|Other|0
2743536|NCT00068692|9412771|P5|Step 1: Registration|Other|0
2743537|NCT00068692|9412772|P4|Step 1: Registration|Other|0
2743538|NCT00068692|9412773|P3|Step 1: Registration|Other|0
2743539|NCT00068692|9412774|P2|Step 1: Registration|Other|0
2743540|NCT00068692|9412775|P1|Step 1: Registration|Other|2
2743541|NCT00068692|9412768|P8|Step 1: Registration|Not eligible|0
2743542|NCT00068692|9412769|P7|Step 1: Registration|Not eligible|0
2743543|NCT00068692|9412770|P6|Step 1: Registration|Not eligible|0
2743544|NCT00068692|9412771|P5|Step 1: Registration|Not eligible|0
2743545|NCT00068692|9412772|P4|Step 1: Registration|Not eligible|0
2743546|NCT00068692|9412773|P3|Step 1: Registration|Not eligible|0
2743547|NCT00068692|9412774|P2|Step 1: Registration|Not eligible|0
2743548|NCT00068692|9412775|P1|Step 1: Registration|Not eligible|6
2743549|NCT00068692|9412768|P8|Step 1: Registration|Protocol Violation|0
2743550|NCT00068692|9412769|P7|Step 1: Registration|Protocol Violation|0
2743551|NCT00068692|9412770|P6|Step 1: Registration|Protocol Violation|0
2743552|NCT00068692|9412771|P5|Step 1: Registration|Protocol Violation|0
2743553|NCT00068692|9412772|P4|Step 1: Registration|Protocol Violation|0
2743554|NCT00068692|9412773|P3|Step 1: Registration|Protocol Violation|0
2743555|NCT00068692|9412774|P2|Step 1: Registration|Protocol Violation|0
2743556|NCT00068692|9412775|P1|Step 1: Registration|Protocol Violation|1
2743557|NCT00068692|9412768|P8|Step 1: Registration|Complicating disease|0
2743558|NCT00068692|9412769|P7|Step 1: Registration|Complicating disease|0
2743559|NCT00068692|9412770|P6|Step 1: Registration|Complicating disease|0
2743560|NCT00068692|9412771|P5|Step 1: Registration|Complicating disease|0
2743561|NCT00068692|9412772|P4|Step 1: Registration|Complicating disease|0
2743562|NCT00068692|9412773|P3|Step 1: Registration|Complicating disease|0
2743563|NCT00068692|9412774|P2|Step 1: Registration|Complicating disease|0
2743564|NCT00068692|9412775|P1|Step 1: Registration|Complicating disease|2
2743565|NCT00068692|9412768|P8|Step 1: Registration|Alternative therapy|0
2743566|NCT00068692|9412769|P7|Step 1: Registration|Alternative therapy|0
2743567|NCT00068692|9412770|P6|Step 1: Registration|Alternative therapy|0
2743568|NCT00068692|9412771|P5|Step 1: Registration|Alternative therapy|0
2743569|NCT00068692|9412772|P4|Step 1: Registration|Alternative therapy|0
2743570|NCT00068692|9412773|P3|Step 1: Registration|Alternative therapy|0
2743571|NCT00068692|9412774|P2|Step 1: Registration|Alternative therapy|0
2743572|NCT00068692|9412775|P1|Step 1: Registration|Alternative therapy|2
2743573|NCT00068692|9412768|P8|Step 1: Registration|Withdrawal by Subject|0
2743574|NCT00068692|9412769|P7|Step 1: Registration|Withdrawal by Subject|0
2743575|NCT00068692|9412770|P6|Step 1: Registration|Withdrawal by Subject|0
2743576|NCT00068692|9412771|P5|Step 1: Registration|Withdrawal by Subject|0
2743577|NCT00068692|9412772|P4|Step 1: Registration|Withdrawal by Subject|0
2743578|NCT00068692|9412773|P3|Step 1: Registration|Withdrawal by Subject|0
2743579|NCT00068692|9412774|P2|Step 1: Registration|Withdrawal by Subject|0
2743580|NCT00068692|9412775|P1|Step 1: Registration|Withdrawal by Subject|11
2743581|NCT00068692|9412768|P8|Step 1: Registration|Death|0
2743582|NCT00068692|9412769|P7|Step 1: Registration|Death|0
2743583|NCT00068692|9412770|P6|Step 1: Registration|Death|0
2743584|NCT00068692|9412771|P5|Step 1: Registration|Death|0
2743585|NCT00068692|9412772|P4|Step 1: Registration|Death|0
2743586|NCT00068692|9412773|P3|Step 1: Registration|Death|0
2743587|NCT00068692|9412774|P2|Step 1: Registration|Death|0
2743588|NCT00068692|9412775|P1|Step 1: Registration|Death|1
2743589|NCT00068692|9412768|P8|Step 1: Registration|Adverse Event|0
2743590|NCT00068692|9412769|P7|Step 1: Registration|Adverse Event|0
2743591|NCT00068692|9412770|P6|Step 1: Registration|Adverse Event|0
2743592|NCT00068692|9412771|P5|Step 1: Registration|Adverse Event|0
2743593|NCT00068692|9412772|P4|Step 1: Registration|Adverse Event|0
2743594|NCT00068692|9412773|P3|Step 1: Registration|Adverse Event|0
2743595|NCT00068692|9412774|P2|Step 1: Registration|Adverse Event|0
2743596|NCT00068692|9412775|P1|Step 1: Registration|Adverse Event|7
2743597|NCT00068692|9412768|P8|Step 1: Registration|Disese progression/relapse|0
2743598|NCT00068692|9412769|P7|Step 1: Registration|Disese progression/relapse|0
2743599|NCT00068692|9412770|P6|Step 1: Registration|Disese progression/relapse|0
2743600|NCT00068692|9412771|P5|Step 1: Registration|Disese progression/relapse|0
2743601|NCT00068692|9412772|P4|Step 1: Registration|Disese progression/relapse|0
2743602|NCT00068692|9412773|P3|Step 1: Registration|Disese progression/relapse|0
2743603|NCT00068692|9412774|P2|Step 1: Registration|Disese progression/relapse|0
2743604|NCT00068692|9412775|P1|Step 1: Registration|Disese progression/relapse|5
2743605|NCT00068601|9412798|P2|Overall Study|Missing primary outcome data|34
2743606|NCT00068601|9412799|P1|Overall Study|Missing primary outcome data|30
2743607|NCT00068601|9412798|P2|Overall Study|Lost to Follow-up|2
2743608|NCT00068601|9412799|P1|Overall Study|Lost to Follow-up|3
2743609|NCT00068601|9412798|P2|Overall Study|Death|3
2743610|NCT00068601|9412799|P1|Overall Study|Death|11
2743611|NCT00068601|9412798|P2|Overall Study|Not evaluable: hysterectomy/oophorectomy|4
2743612|NCT00068601|9412799|P1|Overall Study|Not evaluable: hysterectomy/oophorectomy|2
2743613|NCT00068601|9412798|P2|Overall Study|Not evaluable: withdrew consent|4
2743614|NCT00068601|9412799|P1|Overall Study|Not evaluable: withdrew consent|5
2743615|NCT00068601|9412798|P2|Overall Study|Ineligible|13
2743616|NCT00068601|9412799|P1|Overall Study|Ineligible|11
2743617|NCT00068588|9412812|P3|Overall Study|Poor KPS|1
2743618|NCT00068588|9412813|P2|Overall Study|Poor KPS|0
2743619|NCT00068588|9412814|P1|Overall Study|Poor KPS|0
2743620|NCT00068588|9412812|P3|Overall Study|Withdrawal by Subject|1
2743621|NCT00068588|9412813|P2|Overall Study|Withdrawal by Subject|0
2743622|NCT00068588|9412814|P1|Overall Study|Withdrawal by Subject|0
2743623|NCT00068588|9412812|P3|Overall Study|Adverse Event|2
2743624|NCT00068588|9412813|P2|Overall Study|Adverse Event|0
2743625|NCT00068588|9412814|P1|Overall Study|Adverse Event|0
2743626|NCT00068445|9412830|P2|Treatment|Other (Specifics not available)|5
2743627|NCT00068445|9412831|P1|Treatment|Other (Specifics not available)|9
2743628|NCT00068445|9412830|P2|Treatment|Adverse Event|1
2743629|NCT00068445|9412831|P1|Treatment|Adverse Event|7
2743630|NCT00068445|9412830|P2|Treatment|Refused Further Treatment|10
2743631|NCT00068445|9412831|P1|Treatment|Refused Further Treatment|13
2743632|NCT00068445|9412830|P2|Randomization|Ineligible|1
2743633|NCT00068445|9412831|P1|Randomization|Ineligible|1
2743634|NCT00068445|9412830|P2|Randomization|Cancel|3
2743635|NCT00068445|9412831|P1|Randomization|Cancel|1
2743636|NCT00068419|9412855|P1|Overall Study|Ineligible|11
2743637|NCT00068419|9412855|P1|Overall Study|Withdrawal by Subject|14
2743638|NCT00068419|9412855|P1|Overall Study|Physician Decision|7
2743639|NCT00068419|9412855|P1|Overall Study|Lost to Follow-up|1
2743640|NCT00068419|9412855|P1|Overall Study|Lack of Efficacy|24
2743641|NCT00068419|9412855|P1|Overall Study|Adverse Event|3
2743642|NCT00068406|9412864|P1|Overall Study|Ineligible-Inadequate Pathology|2
2743643|NCT00068406|9412864|P1|Overall Study|Ineligible-improper pre-protocol treatm|1
2743644|NCT00068393|9412869|P1|Overall Study|Quality of life worsening|1
2743645|NCT00068393|9412869|P1|Overall Study|Alternative treatment|1
2743646|NCT00068393|9412869|P1|Overall Study|Withdrawal by Subject|3
2743647|NCT00068393|9412869|P1|Overall Study|Death|3
2743648|NCT00068393|9412869|P1|Overall Study|Adverse Event|2
2743649|NCT00068380|9412875|P1|Overall Study|Adverse Event|2
2743650|NCT00068380|9412875|P1|Overall Study|Withdrawal by Subject|3
2743651|NCT00068250|9412919|P4|Phase I: Dose Level 2|Protocol Violation|0
2743652|NCT00068250|9412920|P3|Phase I: Dose Level 2|Protocol Violation|0
2743653|NCT00068250|9412921|P2|Phase I: Dose Level 2|Protocol Violation|1
2743654|NCT00068250|9412922|P1|Phase I: Dose Level 2|Protocol Violation|0
2743655|NCT00068237|9412932|P1|Overall Study|No protocol treatment received|2
2743656|NCT00068237|9412932|P1|Overall Study|Ineligible|3
2743657|NCT00068107|9412944|P1|Overall Study|Withdrawal by Subject|1
2743658|NCT00068107|9412944|P1|Overall Study|Death|2
2743659|NCT00068107|9412944|P1|Overall Study|end-stage renal disease|6
2743660|NCT00067990|9412957|P2|Overall Study|Withdrawal by Subject|12
2743661|NCT00067990|9412958|P1|Overall Study|Withdrawal by Subject|4
2743662|NCT00067990|9412957|P2|Overall Study|ESRD, Non IF/TA|3
2743663|NCT00067990|9412958|P1|Overall Study|ESRD, Non IF/TA|1
2743664|NCT00067990|9412957|P2|Overall Study|Death|7
2743665|NCT00067990|9412958|P1|Overall Study|Death|5
2743666|NCT00067470|9412981|P2|Overall Study|Withdrawal by Subject|1
2743667|NCT00067470|9412982|P1|Overall Study|Withdrawal by Subject|0
2743668|NCT00067002|9413003|P2|Overall Study|Graft Failure|6
2743669|NCT00067002|9413004|P1|Overall Study|Graft Failure|5
2743670|NCT00067002|9413003|P2|Overall Study|Delayed|1
2743671|NCT00067002|9413004|P1|Overall Study|Delayed|1
2743672|NCT00067002|9413003|P2|Overall Study|Early Death|2
2743673|NCT00067002|9413004|P1|Overall Study|Early Death|1
2743674|NCT00066807|9413062|P2|Overall Study|Study was terminated early|15
2743675|NCT00066807|9413063|P1|Overall Study|Study was terminated early|14
2743676|NCT00066742|9413088|P1|Consolidation Chemotherapy|Ineligible|2
2743677|NCT00066742|9413088|P1|Consolidation Chemotherapy|not protocol specified|1
2743678|NCT00066742|9413088|P1|Induction Chemoradiotherapy|Ineligible|3
2743679|NCT00066742|9413088|P1|Induction Chemoradiotherapy|not protocol specified|2
2743680|NCT00066742|9413088|P1|Induction Chemoradiotherapy|Withdrawal by Subject|2
2743681|NCT00066742|9413088|P1|Induction Chemoradiotherapy|Adverse Event|21
2743682|NCT00066742|9413088|P1|Induction Chemoradiotherapy|Did not receive any protocol treatment|1
2743683|NCT00066703|9413097|P2|Overall Study|Treatment ongoing|311
2743684|NCT00066703|9413098|P1|Overall Study|Treatment ongoing|346
2743685|NCT00066703|9413097|P2|Overall Study|Withdrawal by Subject|63
2743686|NCT00066703|9413098|P1|Overall Study|Withdrawal by Subject|38
2743687|NCT00066703|9413097|P2|Overall Study|Lost to Follow-up|28
2743688|NCT00066703|9413098|P1|Overall Study|Lost to Follow-up|31
2743689|NCT00066703|9413097|P2|Overall Study|Lack of Efficacy|69
2743690|NCT00066703|9413098|P1|Overall Study|Lack of Efficacy|114
2743691|NCT00066703|9413097|P2|Overall Study|Death|0
2743692|NCT00066703|9413098|P1|Overall Study|Death|3
2743693|NCT00066703|9413097|P2|Overall Study|Adverse Event|111
2743694|NCT00066703|9413098|P1|Overall Study|Adverse Event|80
2743695|NCT00066690|9413113|P3|Overall Study|Treatment Ongoing|282
2743696|NCT00066690|9413114|P2|Overall Study|Treatment Ongoing|278
2743697|NCT00066690|9413115|P1|Overall Study|Treatment Ongoing|246
2743698|NCT00066690|9413113|P3|Overall Study|Withdrawal by Subject|49
2743699|NCT00066690|9413114|P2|Overall Study|Withdrawal by Subject|55
2743700|NCT00066690|9413115|P1|Overall Study|Withdrawal by Subject|50
2743701|NCT00066690|9413113|P3|Overall Study|Lost to Follow-up|29
2743702|NCT00066690|9413114|P2|Overall Study|Lost to Follow-up|21
2743703|NCT00066690|9413115|P1|Overall Study|Lost to Follow-up|40
2743704|NCT00066690|9413113|P3|Overall Study|Lack of Efficacy|76
2743705|NCT00066690|9413114|P2|Overall Study|Lack of Efficacy|110
2743706|NCT00066690|9413115|P1|Overall Study|Lack of Efficacy|114
2743707|NCT00066690|9413113|P3|Overall Study|Death|2
2743708|NCT00066690|9413114|P2|Overall Study|Death|0
2743709|NCT00066690|9413115|P1|Overall Study|Death|3
2743710|NCT00066690|9413113|P3|Overall Study|Adverse Event|126
2743711|NCT00066690|9413114|P2|Overall Study|Adverse Event|58
2743712|NCT00066690|9413115|P1|Overall Study|Adverse Event|145
2743713|NCT00066573|9413134|P2|Overall Study|Did not received protocol treatment|28
2743714|NCT00066573|9413135|P1|Overall Study|Did not received protocol treatment|28
2743715|NCT00066469|9413147|P1|Overall Study|ineligible|1
2743716|NCT00066469|9413147|P1|Overall Study|Withdrawal by Subject|1
2743717|NCT00066469|9413147|P1|Overall Study|Physician Decision|1
2743718|NCT00066469|9413147|P1|Overall Study|Lost to Follow-up|1
2743719|NCT00066469|9413147|P1|Overall Study|Lack of Efficacy|9
2743720|NCT00066469|9413147|P1|Overall Study|Death|3
2743721|NCT00066365|9413153|P2|Overall Study|Ineligible|2
2743722|NCT00066365|9413154|P1|Overall Study|Ineligible|4
2743723|NCT00066365|9413153|P2|Overall Study|No viable tumor after 1 cycle of therapy|0
2743724|NCT00066365|9413154|P1|Overall Study|No viable tumor after 1 cycle of therapy|2
2743725|NCT00066365|9413153|P2|Overall Study|Physician Decision|0
2743726|NCT00066365|9413154|P1|Overall Study|Physician Decision|1
2743727|NCT00066365|9413153|P2|Overall Study|Lack of Efficacy|12
2743728|NCT00066365|9413154|P1|Overall Study|Lack of Efficacy|15
2743729|NCT00066365|9413153|P2|Overall Study|Adverse Event|0
2743730|NCT00066365|9413154|P1|Overall Study|Adverse Event|1
2743731|NCT00066222|9413182|P1|Overall Study|No protocol treatment received|1
2743732|NCT00066170|9413195|P4|Overall Study|Other|0
2743733|NCT00066170|9413196|P3|Overall Study|Other|2
2743734|NCT00066170|9413197|P2|Overall Study|Other|5
2743735|NCT00066170|9413198|P1|Overall Study|Other|1
2743736|NCT00066170|9413195|P4|Overall Study|Protocol Violation|0
2743737|NCT00066170|9413196|P3|Overall Study|Protocol Violation|0
2743738|NCT00066170|9413197|P2|Overall Study|Protocol Violation|0
2743739|NCT00066170|9413198|P1|Overall Study|Protocol Violation|3
2743740|NCT00066170|9413195|P4|Overall Study|Non-Compliance with Trial Medicine|1
2743741|NCT00066170|9413196|P3|Overall Study|Non-Compliance with Trial Medicine|0
2743742|NCT00066170|9413197|P2|Overall Study|Non-Compliance with Trial Medicine|0
2743743|NCT00066170|9413198|P1|Overall Study|Non-Compliance with Trial Medicine|1
2743744|NCT00066170|9413195|P4|Overall Study|Lost to Follow-up|0
2743745|NCT00066170|9413196|P3|Overall Study|Lost to Follow-up|0
2743746|NCT00066170|9413197|P2|Overall Study|Lost to Follow-up|1
2743747|NCT00066170|9413198|P1|Overall Study|Lost to Follow-up|0
2743748|NCT00066170|9413195|P4|Overall Study|Serious Adverse Event|1
2743749|NCT00066170|9413196|P3|Overall Study|Serious Adverse Event|1
2743750|NCT00066170|9413197|P2|Overall Study|Serious Adverse Event|0
2743751|NCT00066170|9413198|P1|Overall Study|Serious Adverse Event|0
2743752|NCT00066170|9413195|P4|Overall Study|Adverse Event|7
2743753|NCT00066170|9413196|P3|Overall Study|Adverse Event|1
2743754|NCT00066170|9413197|P2|Overall Study|Adverse Event|4
2743755|NCT00066170|9413198|P1|Overall Study|Adverse Event|2
2743756|NCT00066066|9413211|P6|Overall Study|Lost to Follow-up|5
2743757|NCT00066066|9413212|P5|Overall Study|Lost to Follow-up|3
2743758|NCT00066066|9413213|P4|Overall Study|Lost to Follow-up|4
2743759|NCT00066066|9413214|P3|Overall Study|Lost to Follow-up|7
2743760|NCT00066066|9413215|P2|Overall Study|Lost to Follow-up|4
2743761|NCT00066066|9413216|P1|Overall Study|Lost to Follow-up|6
2743762|NCT00065507|9413294|P2|Overall Study|Subject No Longer Meets Study Criteria|0
2743763|NCT00065507|9413295|P1|Overall Study|Subject No Longer Meets Study Criteria|1
2743764|NCT00065507|9413294|P2|Overall Study|Subject Withdrew Consent|1
2743765|NCT00065507|9413295|P1|Overall Study|Subject Withdrew Consent|2
2743766|NCT00065507|9413294|P2|Overall Study|Lost to Follow-up|0
2743767|NCT00065507|9413295|P1|Overall Study|Lost to Follow-up|3
2743768|NCT00065507|9413294|P2|Overall Study|Poor/Non-compliance|2
2743769|NCT00065507|9413295|P1|Overall Study|Poor/Non-compliance|3
2743770|NCT00065507|9413294|P2|Overall Study|Lack of Efficacy|6
2743771|NCT00065507|9413295|P1|Overall Study|Lack of Efficacy|0
2743772|NCT00065507|9413294|P2|Overall Study|Adverse Event|3
2743773|NCT00065507|9413295|P1|Overall Study|Adverse Event|4
2743774|NCT00065507|9413294|P2|Overall Study|Death|17
2743775|NCT00065507|9413295|P1|Overall Study|Death|16
2743776|NCT00065468|9413360|P3|Overall Study|Other|18
2743777|NCT00065468|9413361|P2|Overall Study|Other|24
2743778|NCT00065468|9413362|P1|Overall Study|Other|14
2743779|NCT00065468|9413360|P3|Overall Study|Disease progression|1
2743780|NCT00065468|9413361|P2|Overall Study|Disease progression|0
2743781|NCT00065468|9413362|P1|Overall Study|Disease progression|0
2743782|NCT00065468|9413360|P3|Overall Study|Discontinuation of study by Sponsor|13
2743783|NCT00065468|9413361|P2|Overall Study|Discontinuation of study by Sponsor|9
2743784|NCT00065468|9413362|P1|Overall Study|Discontinuation of study by Sponsor|13
2743785|NCT00065468|9413360|P3|Overall Study|Lost to Follow-up|2
2743786|NCT00065468|9413361|P2|Overall Study|Lost to Follow-up|3
2743787|NCT00065468|9413362|P1|Overall Study|Lost to Follow-up|5
2743788|NCT00065468|9413360|P3|Overall Study|Withdrawal by Subject|5
2743789|NCT00065468|9413361|P2|Overall Study|Withdrawal by Subject|4
2743790|NCT00065468|9413362|P1|Overall Study|Withdrawal by Subject|3
2743791|NCT00065468|9413360|P3|Overall Study|Death|171
2743792|NCT00065468|9413361|P2|Overall Study|Death|169
2743793|NCT00065468|9413362|P1|Overall Study|Death|172
2743794|NCT00065442|9413393|P2|Overall Study|Withdrawal by Subject|9
2743795|NCT00065442|9413394|P1|Overall Study|Withdrawal by Subject|3
2743796|NCT00065442|9413393|P2|Overall Study|Death|210
2743797|NCT00065442|9413394|P1|Overall Study|Death|121
2743798|NCT00065442|9413393|P2|Overall Study|Lost to Follow-up|1
2743799|NCT00065442|9413394|P1|Overall Study|Lost to Follow-up|1
2743800|NCT00065429|9413409|P7|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
2743801|NCT00065429|9413410|P6|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
2743802|NCT00065429|9413411|P5|Phase II - Apr 2003 - Aug 2008|Adverse Event|2
2743803|NCT00065429|9413412|P4|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
2743804|NCT00065429|9413413|P3|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
2743805|NCT00065429|9413414|P2|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
2743806|NCT00065429|9413415|P1|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
2743807|NCT00065429|9413409|P7|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
2743808|NCT00065429|9413410|P6|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
2743809|NCT00065429|9413411|P5|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4
2743810|NCT00065429|9413412|P4|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
2743811|NCT00065429|9413413|P3|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
2743812|NCT00065429|9413414|P2|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
2743813|NCT00065429|9413415|P1|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
2743814|NCT00065429|9413409|P7|Phase I - May 2001 - Oct 2002|Adverse Event|2
2743815|NCT00065429|9413410|P6|Phase I - May 2001 - Oct 2002|Adverse Event|1
2743816|NCT00065429|9413411|P5|Phase I - May 2001 - Oct 2002|Adverse Event|0
2743817|NCT00065429|9413412|P4|Phase I - May 2001 - Oct 2002|Adverse Event|1
2743818|NCT00065429|9413413|P3|Phase I - May 2001 - Oct 2002|Adverse Event|0
2743819|NCT00065429|9413414|P2|Phase I - May 2001 - Oct 2002|Adverse Event|0
2743820|NCT00065429|9413415|P1|Phase I - May 2001 - Oct 2002|Adverse Event|0
2743821|NCT00065429|9413409|P7|Phase I - May 2001 - Oct 2002|Death|0
2743822|NCT00065429|9413410|P6|Phase I - May 2001 - Oct 2002|Death|0
2743823|NCT00065429|9413411|P5|Phase I - May 2001 - Oct 2002|Death|1
2743824|NCT00065429|9413412|P4|Phase I - May 2001 - Oct 2002|Death|0
2743825|NCT00065429|9413413|P3|Phase I - May 2001 - Oct 2002|Death|0
2743826|NCT00065429|9413414|P2|Phase I - May 2001 - Oct 2002|Death|0
2743827|NCT00065429|9413415|P1|Phase I - May 2001 - Oct 2002|Death|0
2743828|NCT00065429|9413409|P7|Phase I - May 2001 - Oct 2002|Physician Decision|0
2743829|NCT00065429|9413410|P6|Phase I - May 2001 - Oct 2002|Physician Decision|0
2743830|NCT00065429|9413411|P5|Phase I - May 2001 - Oct 2002|Physician Decision|0
2743831|NCT00065429|9413412|P4|Phase I - May 2001 - Oct 2002|Physician Decision|0
2743832|NCT00065429|9413413|P3|Phase I - May 2001 - Oct 2002|Physician Decision|0
2743833|NCT00065429|9413414|P2|Phase I - May 2001 - Oct 2002|Physician Decision|0
2743834|NCT00065429|9413415|P1|Phase I - May 2001 - Oct 2002|Physician Decision|1
2743835|NCT00065429|9413409|P7|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
2743836|NCT00065429|9413410|P6|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
2743837|NCT00065429|9413411|P5|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
2743838|NCT00065429|9413412|P4|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
2743839|NCT00065429|9413413|P3|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1
2743840|NCT00065429|9413414|P2|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
2743841|NCT00065429|9413415|P1|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
2743842|NCT00065429|9413409|P7|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
2743843|NCT00065429|9413410|P6|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1
2743844|NCT00065429|9413411|P5|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
2743845|NCT00065429|9413412|P4|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
2743846|NCT00065429|9413413|P3|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
2743847|NCT00065429|9413414|P2|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
2743848|NCT00065429|9413415|P1|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
2743849|NCT00065260|9413429|P2|Overall Study|Death|1
2743850|NCT00065260|9413430|P1|Overall Study|Death|0
2743851|NCT00065182|9413438|P2|Overall Study|Decline in Status|1
2743852|NCT00065182|9413439|P1|Overall Study|Decline in Status|0
2743853|NCT00065182|9413438|P2|Overall Study|Death|1
2743854|NCT00065182|9413439|P1|Overall Study|Death|0
2743855|NCT00065182|9413438|P2|Overall Study|No clinical benefit|0
2743856|NCT00065182|9413439|P1|Overall Study|No clinical benefit|1
2743857|NCT00065182|9413438|P2|Overall Study|Withdrawal by Subject|3
2743858|NCT00065182|9413439|P1|Overall Study|Withdrawal by Subject|8
2743859|NCT00065182|9413438|P2|Overall Study|Sponsor Decision|7
2743860|NCT00065182|9413439|P1|Overall Study|Sponsor Decision|11
2743861|NCT00065182|9413438|P2|Overall Study|Serious adverse events (SAE)|0
2743862|NCT00065182|9413439|P1|Overall Study|Serious adverse events (SAE)|1
2743863|NCT00065182|9413438|P2|Overall Study|Protocol Violation|4
2743864|NCT00065182|9413439|P1|Overall Study|Protocol Violation|3
2743865|NCT00065182|9413438|P2|Overall Study|Lost to Follow-up|4
2743866|NCT00065182|9413439|P1|Overall Study|Lost to Follow-up|0
2743867|NCT00065182|9413438|P2|Overall Study|Adverse Event|17
2743868|NCT00065182|9413439|P1|Overall Study|Adverse Event|24
2743869|NCT00065156|9413465|P1|Overall Study|Secondary Malign Disease|1
2743870|NCT00065156|9413465|P1|Overall Study|Loss of Response|1
2743871|NCT00065156|9413465|P1|Overall Study|Non-Compliance|2
2743872|NCT00065156|9413465|P1|Overall Study|Investigator Decision|2
2743873|NCT00065156|9413465|P1|Overall Study|Disease Progression|7
2743874|NCT00065156|9413465|P1|Overall Study|Study Closed by Sponsor|2
2743875|NCT00065156|9413465|P1|Overall Study|Death|11
2743876|NCT00065156|9413465|P1|Overall Study|Lost to Follow-up|1
2743877|NCT00065156|9413465|P1|Overall Study|Withdrawal by Subject|8
2743878|NCT00065156|9413465|P1|Overall Study|Lack of Efficacy|52
2743879|NCT00065156|9413465|P1|Overall Study|Adverse Event|37
2743880|NCT00065065|9413482|P2|Overall Study|Other|2
2743881|NCT00065065|9413483|P1|Overall Study|Other|2
2743882|NCT00065065|9413482|P2|Overall Study|Lack of Efficacy|11
2743883|NCT00065065|9413483|P1|Overall Study|Lack of Efficacy|4
2743884|NCT00065065|9413482|P2|Overall Study|Withdrawal by Subject|5
2743885|NCT00065065|9413483|P1|Overall Study|Withdrawal by Subject|1
2743886|NCT00065065|9413482|P2|Overall Study|Adverse Event|2
2743887|NCT00065065|9413483|P1|Overall Study|Adverse Event|3
2743888|NCT00003895|9413495|P2|Overall Study|Withdrawal by Subject|3
2743889|NCT00003895|9413496|P1|Overall Study|Withdrawal by Subject|0
2743890|NCT00003895|9413495|P2|Overall Study|Patient Vacation|0
2743891|NCT00003895|9413496|P1|Overall Study|Patient Vacation|2
2743892|NCT00003895|9413495|P2|Overall Study|Lack of Efficacy|1
2743893|NCT00003895|9413496|P1|Overall Study|Lack of Efficacy|1
2743894|NCT00003895|9413495|P2|Overall Study|Adverse Event|0
2743895|NCT00003895|9413496|P1|Overall Study|Adverse Event|4
2743896|NCT00064987|9413504|P2|Overall Study|Physician Decision|0
2743897|NCT00064987|9413505|P1|Overall Study|Physician Decision|3
2743898|NCT00064753|9413536|P2|Overall Study|Lost to Follow-up|235
2743899|NCT00064753|9413537|P1|Overall Study|Lost to Follow-up|225
2743900|NCT00064753|9413536|P2|Overall Study|Withdrawal by Subject|171
2743901|NCT00064753|9413537|P1|Overall Study|Withdrawal by Subject|198
2743902|NCT00064753|9413536|P2|Overall Study|Death|242
2743903|NCT00064753|9413537|P1|Overall Study|Death|251
2743904|NCT00003645|9413567|P2|Overall Study|Withdrawal by Subject|3
2743905|NCT00003645|9413568|P1|Overall Study|Withdrawal by Subject|1
2743906|NCT00003645|9413567|P2|Overall Study|Lost to Follow-up|8
2743907|NCT00003645|9413568|P1|Overall Study|Lost to Follow-up|7
2743908|NCT00003645|9413567|P2|Overall Study|Death|1
2743909|NCT00003645|9413568|P1|Overall Study|Death|4
2743910|NCT00064792|9413582|P2|Overall Study|Adverse Event|0
2743911|NCT00064792|9413583|P1|Overall Study|Adverse Event|3
2743912|NCT00064792|9413582|P2|Overall Study|Withdrawal by Subject|0
2743913|NCT00064792|9413583|P1|Overall Study|Withdrawal by Subject|2
2743914|NCT00064701|9413594|P3|Clinical Continuation Phase|Patient opted out|1
2743915|NCT00064701|9413595|P2|Clinical Continuation Phase|Patient opted out|0
2743916|NCT00064701|9413596|P1|Clinical Continuation Phase|Patient opted out|0
2743917|NCT00064701|9413594|P3|Clinical Continuation Phase|Incorrect study drug dispensed|0
2743918|NCT00064701|9413595|P2|Clinical Continuation Phase|Incorrect study drug dispensed|1
2743919|NCT00064701|9413596|P1|Clinical Continuation Phase|Incorrect study drug dispensed|0
2743920|NCT00064701|9413594|P3|Clinical Continuation Phase|Discharged to nursing home|0
2743921|NCT00064701|9413595|P2|Clinical Continuation Phase|Discharged to nursing home|1
2743922|NCT00064701|9413596|P1|Clinical Continuation Phase|Discharged to nursing home|0
2743923|NCT00064701|9413594|P3|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
2743924|NCT00064701|9413595|P2|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1
2743925|NCT00064701|9413596|P1|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
2743926|NCT00064701|9413594|P3|Clinical Continuation Phase|Pancreas transplant|0
2743927|NCT00064701|9413595|P2|Clinical Continuation Phase|Pancreas transplant|0
2743928|NCT00064701|9413596|P1|Clinical Continuation Phase|Pancreas transplant|1
2743929|NCT00064701|9413594|P3|Clinical Continuation Phase|Unable to return to site for study visit|1
2743930|NCT00064701|9413595|P2|Clinical Continuation Phase|Unable to return to site for study visit|0
2743931|NCT00064701|9413596|P1|Clinical Continuation Phase|Unable to return to site for study visit|1
2743932|NCT00064701|9413594|P3|Clinical Continuation Phase|Physician Decision|0
2743933|NCT00064701|9413595|P2|Clinical Continuation Phase|Physician Decision|3
2743934|NCT00064701|9413596|P1|Clinical Continuation Phase|Physician Decision|1
2743935|NCT00064701|9413594|P3|Clinical Continuation Phase|Immunosuppressive treatment crossover|6
2743936|NCT00064701|9413595|P2|Clinical Continuation Phase|Immunosuppressive treatment crossover|3
2743937|NCT00064701|9413596|P1|Clinical Continuation Phase|Immunosuppressive treatment crossover|0
2743938|NCT00064701|9413594|P3|Clinical Continuation Phase|Sponsor discontinued study|79
2743939|NCT00064701|9413595|P2|Clinical Continuation Phase|Sponsor discontinued study|129
2743940|NCT00064701|9413596|P1|Clinical Continuation Phase|Sponsor discontinued study|113
2743941|NCT00064701|9413594|P3|Clinical Continuation Phase|Rejection|2
2743942|NCT00064701|9413595|P2|Clinical Continuation Phase|Rejection|2
2743943|NCT00064701|9413596|P1|Clinical Continuation Phase|Rejection|1
2743944|NCT00064701|9413594|P3|Clinical Continuation Phase|Graft Failure|2
2743945|NCT00064701|9413595|P2|Clinical Continuation Phase|Graft Failure|5
2743946|NCT00064701|9413596|P1|Clinical Continuation Phase|Graft Failure|5
2743947|NCT00064701|9413594|P3|Clinical Continuation Phase|Lost to Follow-up|6
2743948|NCT00064701|9413595|P2|Clinical Continuation Phase|Lost to Follow-up|3
2743949|NCT00064701|9413596|P1|Clinical Continuation Phase|Lost to Follow-up|6
2743950|NCT00064701|9413594|P3|Clinical Continuation Phase|Withdrawal by Subject|22
2743951|NCT00064701|9413595|P2|Clinical Continuation Phase|Withdrawal by Subject|3
2743952|NCT00064701|9413596|P1|Clinical Continuation Phase|Withdrawal by Subject|22
2743953|NCT00064701|9413594|P3|Clinical Continuation Phase|Non-compliance|7
2743954|NCT00064701|9413595|P2|Clinical Continuation Phase|Non-compliance|6
2743955|NCT00064701|9413596|P1|Clinical Continuation Phase|Non-compliance|8
2743956|NCT00064701|9413594|P3|Clinical Continuation Phase|Adverse Event|14
2743957|NCT00064701|9413595|P2|Clinical Continuation Phase|Adverse Event|21
2743958|NCT00064701|9413596|P1|Clinical Continuation Phase|Adverse Event|12
2743959|NCT00064701|9413594|P3|One Year Post-transplant|Pancreas transplant|1
2743960|NCT00064701|9413595|P2|One Year Post-transplant|Pancreas transplant|0
2743961|NCT00064701|9413596|P1|One Year Post-transplant|Pancreas transplant|0
2743962|NCT00064701|9413594|P3|One Year Post-transplant|Poor absorption|0
2743963|NCT00064701|9413595|P2|One Year Post-transplant|Poor absorption|1
2743964|NCT00064701|9413596|P1|One Year Post-transplant|Poor absorption|0
2743965|NCT00064701|9413594|P3|One Year Post-transplant|Crossover secondary to possible toxicity|0
2743966|NCT00064701|9413595|P2|One Year Post-transplant|Crossover secondary to possible toxicity|1
2743967|NCT00064701|9413596|P1|One Year Post-transplant|Crossover secondary to possible toxicity|0
2743968|NCT00064701|9413594|P3|One Year Post-transplant|Incorrect study drug dispensed|0
2743969|NCT00064701|9413595|P2|One Year Post-transplant|Incorrect study drug dispensed|1
2743970|NCT00064701|9413596|P1|One Year Post-transplant|Incorrect study drug dispensed|0
2743971|NCT00064701|9413594|P3|One Year Post-transplant|Acute tubular necrosis|0
2743972|NCT00064701|9413595|P2|One Year Post-transplant|Acute tubular necrosis|0
2743973|NCT00064701|9413596|P1|One Year Post-transplant|Acute tubular necrosis|1
2743974|NCT00064701|9413594|P3|One Year Post-transplant|Converted to rapamycin|0
2743975|NCT00064701|9413595|P2|One Year Post-transplant|Converted to rapamycin|0
2743976|NCT00064701|9413596|P1|One Year Post-transplant|Converted to rapamycin|1
2743977|NCT00064701|9413594|P3|One Year Post-transplant|Lost to Follow-up|0
2743978|NCT00064701|9413595|P2|One Year Post-transplant|Lost to Follow-up|0
2743979|NCT00064701|9413596|P1|One Year Post-transplant|Lost to Follow-up|1
2743980|NCT00064701|9413594|P3|One Year Post-transplant|Withdrawal by Subject|1
2743981|NCT00064701|9413595|P2|One Year Post-transplant|Withdrawal by Subject|4
2743982|NCT00064701|9413596|P1|One Year Post-transplant|Withdrawal by Subject|0
2743983|NCT00064701|9413594|P3|One Year Post-transplant|Graft Failure|1
2743984|NCT00064701|9413595|P2|One Year Post-transplant|Graft Failure|2
2743985|NCT00064701|9413596|P1|One Year Post-transplant|Graft Failure|3
2743986|NCT00064701|9413594|P3|One Year Post-transplant|Non-compliance|5
2743987|NCT00064701|9413595|P2|One Year Post-transplant|Non-compliance|2
2743988|NCT00064701|9413596|P1|One Year Post-transplant|Non-compliance|4
2743989|NCT00064701|9413594|P3|One Year Post-transplant|Rejection|16
2743990|NCT00064701|9413595|P2|One Year Post-transplant|Rejection|1
2743991|NCT00064701|9413596|P1|One Year Post-transplant|Rejection|0
2743992|NCT00064701|9413594|P3|One Year Post-transplant|Adverse Event|37
2743993|NCT00064701|9413595|P2|One Year Post-transplant|Adverse Event|19
2743994|NCT00064701|9413596|P1|One Year Post-transplant|Adverse Event|23
2743995|NCT00064701|9413594|P3|One Year Post-transplant|Did not receive study drug|11
2743996|NCT00064701|9413595|P2|One Year Post-transplant|Did not receive study drug|12
2743997|NCT00064701|9413596|P1|One Year Post-transplant|Did not receive study drug|7
2743998|NCT00064662|9413648|P2|Overall Study|Administratively withdrawn|2
2743999|NCT00064662|9413649|P1|Overall Study|Administratively withdrawn|2
2744000|NCT00064662|9413648|P2|Overall Study|Withdrawal by Subject|14
2744001|NCT00064662|9413649|P1|Overall Study|Withdrawal by Subject|14
2744002|NCT00064662|9413648|P2|Overall Study|Lost to Follow-up|44
2744003|NCT00064662|9413649|P1|Overall Study|Lost to Follow-up|57
2744004|NCT00064662|9413648|P2|Overall Study|Death|1
2744005|NCT00064662|9413649|P1|Overall Study|Death|1
2744006|NCT00064350|9413660|P3|Cross-Over|Other|0
2744007|NCT00064350|9413661|P2|Cross-Over|Other|2
2744008|NCT00064350|9413662|P1|Cross-Over|Other|0
2744009|NCT00064350|9413660|P3|Cross-Over|Ineligible or never started treatment|0
2744010|NCT00064350|9413661|P2|Cross-Over|Ineligible or never started treatment|6
2744011|NCT00064350|9413662|P1|Cross-Over|Ineligible or never started treatment|3
2744012|NCT00064350|9413660|P3|Cross-Over|Withdrawal by Subject|0
2744013|NCT00064350|9413661|P2|Cross-Over|Withdrawal by Subject|2
2744014|NCT00064350|9413662|P1|Cross-Over|Withdrawal by Subject|2
2744015|NCT00064350|9413660|P3|Cross-Over|Death|0
2744016|NCT00064350|9413661|P2|Cross-Over|Death|3
2744017|NCT00064350|9413662|P1|Cross-Over|Death|1
2744018|NCT00064350|9413660|P3|Cross-Over|Adverse Event|0
2744019|NCT00064350|9413661|P2|Cross-Over|Adverse Event|1
2744020|NCT00064350|9413662|P1|Cross-Over|Adverse Event|0
2744021|NCT00064350|9413660|P3|Randomization|Other|0
2744022|NCT00064350|9413661|P2|Randomization|Other|0
2744023|NCT00064350|9413662|P1|Randomization|Other|5
2744024|NCT00064350|9413660|P3|Randomization|Ineligible or never started treatment|0
2744025|NCT00064350|9413661|P2|Randomization|Ineligible or never started treatment|15
2744026|NCT00064350|9413662|P1|Randomization|Ineligible or never started treatment|9
2744027|NCT00064350|9413660|P3|Randomization|Withdrawal by Subject|0
2744028|NCT00064350|9413661|P2|Randomization|Withdrawal by Subject|0
2744029|NCT00064350|9413662|P1|Randomization|Withdrawal by Subject|1
2744030|NCT00064350|9413660|P3|Randomization|Death|0
2744031|NCT00064350|9413661|P2|Randomization|Death|0
2744032|NCT00064350|9413662|P1|Randomization|Death|3
2744033|NCT00064350|9413660|P3|Randomization|Adverse Event|0
2744034|NCT00064350|9413661|P2|Randomization|Adverse Event|3
2744035|NCT00064350|9413662|P1|Randomization|Adverse Event|8
2744036|NCT00064350|9413660|P3|Induction Treatment|Other|13
2744037|NCT00064350|9413661|P2|Induction Treatment|Other|0
2744038|NCT00064350|9413662|P1|Induction Treatment|Other|0
2744039|NCT00064350|9413660|P3|Induction Treatment|Ineligible or never started treatment|34
2744040|NCT00064350|9413661|P2|Induction Treatment|Ineligible or never started treatment|6
2744041|NCT00064350|9413662|P1|Induction Treatment|Ineligible or never started treatment|3
2744042|NCT00064350|9413660|P3|Induction Treatment|Withdrawal by Subject|21
2744043|NCT00064350|9413661|P2|Induction Treatment|Withdrawal by Subject|0
2744044|NCT00064350|9413662|P1|Induction Treatment|Withdrawal by Subject|0
2744045|NCT00064350|9413660|P3|Induction Treatment|Death|9
2744046|NCT00064350|9413661|P2|Induction Treatment|Death|0
2744047|NCT00064350|9413662|P1|Induction Treatment|Death|0
2744048|NCT00064350|9413660|P3|Induction Treatment|Adverse Event|49
2744049|NCT00064350|9413661|P2|Induction Treatment|Adverse Event|2
2744050|NCT00064350|9413662|P1|Induction Treatment|Adverse Event|0
2744051|NCT00064350|9413660|P3|Induction Treatment|Disease Progression|110
2744052|NCT00064350|9413661|P2|Induction Treatment|Disease Progression|1
2744053|NCT00064350|9413662|P1|Induction Treatment|Disease Progression|5
2744054|NCT00064337|9413677|P1|Maintenance|Death|1
2744055|NCT00064337|9413677|P1|Maintenance|Not protocol-specified|2
2744056|NCT00064337|9413677|P1|Maintenance|On treatment at time of analysis|2
2744057|NCT00064337|9413677|P1|Maintenance|Progression|2
2744058|NCT00064337|9413677|P1|Maintenance|Adverse Event|3
2744059|NCT00064337|9413677|P1|Transplant|Progression|2
2744060|NCT00064337|9413677|P1|Transplant|Patient Refusal|2
2744061|NCT00064337|9413677|P1|Transplant|Death|3
2744062|NCT00064337|9413677|P1|Transplant|Not protocol-specified|5
2744063|NCT00064337|9413677|P1|Transplant|Adverse Event|9
2744064|NCT00064337|9413677|P1|PBSCC or Induction/PBSCC|Death|2
2744065|NCT00064337|9413677|P1|PBSCC or Induction/PBSCC|Patient Refusal|2
2744066|NCT00064337|9413677|P1|PBSCC or Induction/PBSCC|Progression|3
2744067|NCT00064337|9413677|P1|PBSCC or Induction/PBSCC|Adverse Event|6
2744068|NCT00064337|9413677|P1|PBSCC or Induction/PBSCC|Not protocol-specified|7
2744069|NCT00064298|9413686|P2|Overall Study|Disease Progression|1
2744070|NCT00064298|9413687|P1|Overall Study|Disease Progression|2
2744071|NCT00064298|9413686|P2|Overall Study|Death|1
2744072|NCT00064298|9413687|P1|Overall Study|Death|0
2744073|NCT00064298|9413686|P2|Overall Study|Lost to Follow-up|2
2744074|NCT00064298|9413687|P1|Overall Study|Lost to Follow-up|2
2744075|NCT00064298|9413686|P2|Overall Study|Withdrawal by Subject|1
2744076|NCT00064298|9413687|P1|Overall Study|Withdrawal by Subject|2
2744077|NCT00064259|9413695|P4|Overall Study|Adverse Event|1
2744078|NCT00064259|9413696|P3|Overall Study|Adverse Event|0
2744079|NCT00064259|9413697|P2|Overall Study|Adverse Event|0
2744080|NCT00064259|9413698|P1|Overall Study|Adverse Event|1
2744081|NCT00064077|9413706|P4|Overall Study|Other reasons|2
2744082|NCT00064077|9413707|P3|Overall Study|Other reasons|1
2744083|NCT00064077|9413708|P2|Overall Study|Other reasons|2
2744084|NCT00064077|9413709|P1|Overall Study|Other reasons|2
2744085|NCT00064077|9413706|P4|Overall Study|No tumor|0
2744086|NCT00064077|9413707|P3|Overall Study|No tumor|1
2744087|NCT00064077|9413708|P2|Overall Study|No tumor|0
2744088|NCT00064077|9413709|P1|Overall Study|No tumor|0
2744089|NCT00064077|9413706|P4|Overall Study|No surgery|0
2744090|NCT00064077|9413707|P3|Overall Study|No surgery|1
2744091|NCT00064077|9413708|P2|Overall Study|No surgery|0
2744092|NCT00064077|9413709|P1|Overall Study|No surgery|0
2744093|NCT00064077|9413706|P4|Overall Study|Pathology|4
2744094|NCT00064077|9413707|P3|Overall Study|Pathology|3
2744095|NCT00064077|9413708|P2|Overall Study|Pathology|7
2744096|NCT00064077|9413709|P1|Overall Study|Pathology|10
2744097|NCT00064077|9413706|P4|Overall Study|Poor risk|1
2744098|NCT00064077|9413707|P3|Overall Study|Poor risk|1
2744099|NCT00064077|9413708|P2|Overall Study|Poor risk|0
2744100|NCT00064077|9413709|P1|Overall Study|Poor risk|2
2744101|NCT00064077|9413706|P4|Overall Study|Improper prior treatment|0
2744102|NCT00064077|9413707|P3|Overall Study|Improper prior treatment|0
2744103|NCT00064077|9413708|P2|Overall Study|Improper prior treatment|0
2744104|NCT00064077|9413709|P1|Overall Study|Improper prior treatment|1
2744105|NCT00064025|9413753|P1|Overall Study|Inevaluable|3
2744106|NCT00064025|9413753|P1|Overall Study|Ineligible|4
2744107|NCT00063999|9413762|P2|Overall Study|Ineligible|24
2744108|NCT00063999|9413763|P1|Overall Study|Ineligible|44
2744109|NCT00063999|9413762|P2|Overall Study|Withdrawal by Subject|0
2744110|NCT00063999|9413763|P1|Overall Study|Withdrawal by Subject|1
2744111|NCT00063986|9413779|P1|Overall Study|Intra-operatively ineligible|4
2744112|NCT00063986|9413779|P1|Overall Study|Ineligible|1
2744113|NCT00063986|9413779|P1|Overall Study|Withdrawal by Subject|1
2744114|NCT00063934|9413791|P1|Overall Study|Ineligible|1
2744115|NCT00063882|9413800|P2|Overall Study|Withdrawal by Subject|1
2744116|NCT00063882|9413801|P1|Overall Study|Withdrawal by Subject|2
2744117|NCT00063882|9413800|P2|Overall Study|Protocol Violation|3
2744118|NCT00063882|9413801|P1|Overall Study|Protocol Violation|3
2744119|NCT00063258|9413928|P2|Overall Study|Lack of Efficacy|0
2744120|NCT00063258|9413929|P1|Overall Study|Lack of Efficacy|2
2744121|NCT00063258|9413928|P2|Overall Study|Physician Decision|0
2744122|NCT00063258|9413929|P1|Overall Study|Physician Decision|2
2744123|NCT00063154|9413935|P1|Overall Study|Did not receive treatment|8
2744124|NCT00063154|9413935|P1|Overall Study|Reason unspecified|1
2744125|NCT00063154|9413935|P1|Overall Study|Death|3
2744126|NCT00063154|9413935|P1|Overall Study|Physician Decision|10
2744127|NCT00063154|9413935|P1|Overall Study|Adverse Event|2
2744128|NCT00063154|9413935|P1|Overall Study|Disease progression|27
2744129|NCT00062868|9413969|P21|Dose Level 3|Withdrew|0
2744130|NCT00062868|9413970|P20|Dose Level 3|Withdrew|0
2744131|NCT00062868|9413971|P19|Dose Level 3|Withdrew|0
2744132|NCT00062868|9413972|P18|Dose Level 3|Withdrew|0
2744133|NCT00062868|9413973|P17|Dose Level 3|Withdrew|0
2744134|NCT00062868|9413974|P16|Dose Level 3|Withdrew|0
2744135|NCT00062868|9413975|P15|Dose Level 3|Withdrew|0
2744136|NCT00062868|9413976|P14|Dose Level 3|Withdrew|0
2744137|NCT00062868|9413977|P13|Dose Level 3|Withdrew|0
2744138|NCT00062868|9413978|P12|Dose Level 3|Withdrew|0
2744139|NCT00062868|9413979|P11|Dose Level 3|Withdrew|0
2744140|NCT00062868|9413980|P10|Dose Level 3|Withdrew|0
2744141|NCT00062868|9413981|P9|Dose Level 3|Withdrew|0
2744142|NCT00062868|9413982|P8|Dose Level 3|Withdrew|0
2744143|NCT00062868|9413983|P7|Dose Level 3|Withdrew|0
2744144|NCT00062868|9413984|P6|Dose Level 3|Withdrew|0
2744145|NCT00062868|9413985|P5|Dose Level 3|Withdrew|0
2744146|NCT00062868|9413986|P4|Dose Level 3|Withdrew|0
2744147|NCT00062868|9413987|P3|Dose Level 3|Withdrew|2
2744148|NCT00062868|9413988|P2|Dose Level 3|Withdrew|0
2744149|NCT00062868|9413989|P1|Dose Level 3|Withdrew|0
2744150|NCT00062868|9413969|P21|Dose Level 3|Lost to Follow-up|0
2744151|NCT00062868|9413970|P20|Dose Level 3|Lost to Follow-up|0
2744152|NCT00062868|9413971|P19|Dose Level 3|Lost to Follow-up|0
2744153|NCT00062868|9413972|P18|Dose Level 3|Lost to Follow-up|0
2744154|NCT00062868|9413973|P17|Dose Level 3|Lost to Follow-up|0
2744155|NCT00062868|9413974|P16|Dose Level 3|Lost to Follow-up|0
2744156|NCT00062868|9413975|P15|Dose Level 3|Lost to Follow-up|1
2744157|NCT00062868|9413976|P14|Dose Level 3|Lost to Follow-up|0
2744158|NCT00062868|9413977|P13|Dose Level 3|Lost to Follow-up|0
2744159|NCT00062868|9413978|P12|Dose Level 3|Lost to Follow-up|0
2744160|NCT00062868|9413979|P11|Dose Level 3|Lost to Follow-up|0
2744161|NCT00062868|9413980|P10|Dose Level 3|Lost to Follow-up|0
2744162|NCT00062868|9413981|P9|Dose Level 3|Lost to Follow-up|0
2744163|NCT00062868|9413982|P8|Dose Level 3|Lost to Follow-up|0
2744164|NCT00062868|9413983|P7|Dose Level 3|Lost to Follow-up|0
2744165|NCT00062868|9413984|P6|Dose Level 3|Lost to Follow-up|0
2744166|NCT00062868|9413985|P5|Dose Level 3|Lost to Follow-up|0
2744167|NCT00062868|9413986|P4|Dose Level 3|Lost to Follow-up|0
2744168|NCT00062868|9413987|P3|Dose Level 3|Lost to Follow-up|0
2744169|NCT00062868|9413988|P2|Dose Level 3|Lost to Follow-up|0
2744170|NCT00062868|9413989|P1|Dose Level 3|Lost to Follow-up|0
2744171|NCT00062868|9413969|P21|Dose Level 3|Death|0
2744172|NCT00062868|9413970|P20|Dose Level 3|Death|0
2744173|NCT00062868|9413971|P19|Dose Level 3|Death|0
2744174|NCT00062868|9413972|P18|Dose Level 3|Death|1
2744175|NCT00062868|9413973|P17|Dose Level 3|Death|0
2744176|NCT00062868|9413974|P16|Dose Level 3|Death|0
2744177|NCT00062868|9413975|P15|Dose Level 3|Death|0
2744178|NCT00062868|9413976|P14|Dose Level 3|Death|0
2744179|NCT00062868|9413977|P13|Dose Level 3|Death|0
2744180|NCT00062868|9413978|P12|Dose Level 3|Death|1
2744181|NCT00062868|9413979|P11|Dose Level 3|Death|0
2744182|NCT00062868|9413980|P10|Dose Level 3|Death|0
2744183|NCT00062868|9413981|P9|Dose Level 3|Death|0
2744184|NCT00062868|9413982|P8|Dose Level 3|Death|0
2744185|NCT00062868|9413983|P7|Dose Level 3|Death|0
2744186|NCT00062868|9413984|P6|Dose Level 3|Death|0
2744187|NCT00062868|9413985|P5|Dose Level 3|Death|0
2744188|NCT00062868|9413986|P4|Dose Level 3|Death|0
2744189|NCT00062868|9413987|P3|Dose Level 3|Death|0
2744190|NCT00062868|9413988|P2|Dose Level 3|Death|0
2744191|NCT00062868|9413989|P1|Dose Level 3|Death|0
2744192|NCT00062868|9413969|P21|Dose Level 2|Lost to Follow-up|0
2744193|NCT00062868|9413970|P20|Dose Level 2|Lost to Follow-up|0
2744194|NCT00062868|9413971|P19|Dose Level 2|Lost to Follow-up|0
2744195|NCT00062868|9413972|P18|Dose Level 2|Lost to Follow-up|0
2744196|NCT00062868|9413973|P17|Dose Level 2|Lost to Follow-up|1
2744197|NCT00062868|9413974|P16|Dose Level 2|Lost to Follow-up|0
2744198|NCT00062868|9413975|P15|Dose Level 2|Lost to Follow-up|0
2744199|NCT00062868|9413976|P14|Dose Level 2|Lost to Follow-up|1
2744200|NCT00062868|9413977|P13|Dose Level 2|Lost to Follow-up|0
2744201|NCT00062868|9413978|P12|Dose Level 2|Lost to Follow-up|0
2744202|NCT00062868|9413979|P11|Dose Level 2|Lost to Follow-up|0
2744203|NCT00062868|9413980|P10|Dose Level 2|Lost to Follow-up|0
2744204|NCT00062868|9413981|P9|Dose Level 2|Lost to Follow-up|0
2744205|NCT00062868|9413982|P8|Dose Level 2|Lost to Follow-up|0
2744206|NCT00062868|9413983|P7|Dose Level 2|Lost to Follow-up|0
2744207|NCT00062868|9413984|P6|Dose Level 2|Lost to Follow-up|0
2744208|NCT00062868|9413985|P5|Dose Level 2|Lost to Follow-up|0
2744209|NCT00062868|9413986|P4|Dose Level 2|Lost to Follow-up|0
2744210|NCT00062868|9413987|P3|Dose Level 2|Lost to Follow-up|0
2744211|NCT00062868|9413988|P2|Dose Level 2|Lost to Follow-up|0
2744212|NCT00062868|9413989|P1|Dose Level 2|Lost to Follow-up|0
2744213|NCT00062868|9413969|P21|Dose Level 2|Death|0
2744214|NCT00062868|9413970|P20|Dose Level 2|Death|0
2744215|NCT00062868|9413971|P19|Dose Level 2|Death|0
2744216|NCT00062868|9413972|P18|Dose Level 2|Death|0
2744217|NCT00062868|9413973|P17|Dose Level 2|Death|2
2744218|NCT00062868|9413974|P16|Dose Level 2|Death|0
2744219|NCT00062868|9413975|P15|Dose Level 2|Death|0
2744220|NCT00062868|9413976|P14|Dose Level 2|Death|0
2744221|NCT00062868|9413977|P13|Dose Level 2|Death|0
2744222|NCT00062868|9413978|P12|Dose Level 2|Death|0
2744223|NCT00062868|9413979|P11|Dose Level 2|Death|1
2744224|NCT00062868|9413980|P10|Dose Level 2|Death|0
2744225|NCT00062868|9413981|P9|Dose Level 2|Death|0
2744226|NCT00062868|9413982|P8|Dose Level 2|Death|0
2744227|NCT00062868|9413983|P7|Dose Level 2|Death|0
2744228|NCT00062868|9413984|P6|Dose Level 2|Death|0
2744229|NCT00062868|9413985|P5|Dose Level 2|Death|2
2744230|NCT00062868|9413986|P4|Dose Level 2|Death|0
2744231|NCT00062868|9413987|P3|Dose Level 2|Death|0
2744232|NCT00062868|9413988|P2|Dose Level 2|Death|3
2744233|NCT00062868|9413989|P1|Dose Level 2|Death|0
2744234|NCT00062868|9413969|P21|Dose Level 1|Lost to Follow-up|1
2744235|NCT00062868|9413970|P20|Dose Level 1|Lost to Follow-up|0
2744236|NCT00062868|9413971|P19|Dose Level 1|Lost to Follow-up|2
2744237|NCT00062868|9413972|P18|Dose Level 1|Lost to Follow-up|0
2744238|NCT00062868|9413973|P17|Dose Level 1|Lost to Follow-up|0
2744239|NCT00062868|9413974|P16|Dose Level 1|Lost to Follow-up|0
2744240|NCT00062868|9413975|P15|Dose Level 1|Lost to Follow-up|0
2744241|NCT00062868|9413976|P14|Dose Level 1|Lost to Follow-up|0
2744242|NCT00062868|9413977|P13|Dose Level 1|Lost to Follow-up|1
2744243|NCT00062868|9413978|P12|Dose Level 1|Lost to Follow-up|0
2744244|NCT00062868|9413979|P11|Dose Level 1|Lost to Follow-up|0
2744245|NCT00062868|9413980|P10|Dose Level 1|Lost to Follow-up|0
2744246|NCT00062868|9413981|P9|Dose Level 1|Lost to Follow-up|0
2744247|NCT00062868|9413982|P8|Dose Level 1|Lost to Follow-up|0
2744248|NCT00062868|9413983|P7|Dose Level 1|Lost to Follow-up|0
2744249|NCT00062868|9413984|P6|Dose Level 1|Lost to Follow-up|0
2744250|NCT00062868|9413985|P5|Dose Level 1|Lost to Follow-up|0
2744251|NCT00062868|9413986|P4|Dose Level 1|Lost to Follow-up|0
2744252|NCT00062868|9413987|P3|Dose Level 1|Lost to Follow-up|0
2744253|NCT00062868|9413988|P2|Dose Level 1|Lost to Follow-up|0
2744254|NCT00062868|9413989|P1|Dose Level 1|Lost to Follow-up|0
2744255|NCT00062868|9413969|P21|Dose Level 1|Death|1
2744256|NCT00062868|9413970|P20|Dose Level 1|Death|0
2744257|NCT00062868|9413971|P19|Dose Level 1|Death|7
2744258|NCT00062868|9413972|P18|Dose Level 1|Death|0
2744259|NCT00062868|9413973|P17|Dose Level 1|Death|0
2744260|NCT00062868|9413974|P16|Dose Level 1|Death|0
2744261|NCT00062868|9413975|P15|Dose Level 1|Death|0
2744262|NCT00062868|9413976|P14|Dose Level 1|Death|0
2744263|NCT00062868|9413977|P13|Dose Level 1|Death|0
2744264|NCT00062868|9413978|P12|Dose Level 1|Death|0
2744265|NCT00062868|9413979|P11|Dose Level 1|Death|0
2744266|NCT00062868|9413980|P10|Dose Level 1|Death|0
2744267|NCT00062868|9413981|P9|Dose Level 1|Death|0
2744268|NCT00062868|9413982|P8|Dose Level 1|Death|0
2744269|NCT00062868|9413983|P7|Dose Level 1|Death|3
2744270|NCT00062868|9413984|P6|Dose Level 1|Death|0
2744271|NCT00062868|9413985|P5|Dose Level 1|Death|0
2744272|NCT00062868|9413986|P4|Dose Level 1|Death|2
2744273|NCT00062868|9413987|P3|Dose Level 1|Death|0
2744274|NCT00062868|9413988|P2|Dose Level 1|Death|0
2744275|NCT00062868|9413989|P1|Dose Level 1|Death|2
2744276|NCT00062751|9414088|P5|Overall Study|Death|0
2744277|NCT00062751|9414089|P4|Overall Study|Death|0
2744278|NCT00062751|9414090|P3|Overall Study|Death|1
2744279|NCT00062751|9414091|P2|Overall Study|Death|0
2744280|NCT00062751|9414092|P1|Overall Study|Death|1
2744281|NCT00062751|9414088|P5|Overall Study|Symptomatic deterioration|1
2744282|NCT00062751|9414089|P4|Overall Study|Symptomatic deterioration|0
2744283|NCT00062751|9414090|P3|Overall Study|Symptomatic deterioration|0
2744284|NCT00062751|9414091|P2|Overall Study|Symptomatic deterioration|1
2744285|NCT00062751|9414092|P1|Overall Study|Symptomatic deterioration|1
2744286|NCT00062751|9414088|P5|Overall Study|Withdrawal by Subject|0
2744287|NCT00062751|9414089|P4|Overall Study|Withdrawal by Subject|1
2744288|NCT00062751|9414090|P3|Overall Study|Withdrawal by Subject|2
2744289|NCT00062751|9414091|P2|Overall Study|Withdrawal by Subject|2
2744290|NCT00062751|9414092|P1|Overall Study|Withdrawal by Subject|1
2744291|NCT00062751|9414088|P5|Overall Study|Other|1
2744292|NCT00062751|9414089|P4|Overall Study|Other|0
2744293|NCT00062751|9414090|P3|Overall Study|Other|1
2744294|NCT00062751|9414091|P2|Overall Study|Other|3
2744295|NCT00062751|9414092|P1|Overall Study|Other|2
2744296|NCT00062751|9414088|P5|Overall Study|Adverse Event|2
2744297|NCT00062751|9414089|P4|Overall Study|Adverse Event|2
2744298|NCT00062751|9414090|P3|Overall Study|Adverse Event|2
2744299|NCT00062751|9414091|P2|Overall Study|Adverse Event|7
2744300|NCT00062751|9414092|P1|Overall Study|Adverse Event|4
2744301|NCT00062751|9414088|P5|Overall Study|Disease progression|2
2744302|NCT00062751|9414089|P4|Overall Study|Disease progression|2
2744303|NCT00062751|9414090|P3|Overall Study|Disease progression|24
2744304|NCT00062751|9414091|P2|Overall Study|Disease progression|17
2744305|NCT00062751|9414092|P1|Overall Study|Disease progression|24
2744306|NCT00062647|9414178|P2|Overall Study|Never received study treatment|1
2744307|NCT00062647|9414179|P1|Overall Study|Never received study treatment|1
2744308|NCT00062647|9414178|P2|Overall Study|Other|4
2744309|NCT00062647|9414179|P1|Overall Study|Other|4
2744310|NCT00062647|9414178|P2|Overall Study|Failed continuation criteria|2
2744311|NCT00062647|9414179|P1|Overall Study|Failed continuation criteria|4
2744312|NCT00062647|9414178|P2|Overall Study|Lost to Follow-up|2
2744313|NCT00062647|9414179|P1|Overall Study|Lost to Follow-up|1
2744314|NCT00062647|9414178|P2|Overall Study|Protocol Violation|0
2744315|NCT00062647|9414179|P1|Overall Study|Protocol Violation|1
2744316|NCT00062647|9414178|P2|Overall Study|Withdrawal by Subject|1
2744317|NCT00062647|9414179|P1|Overall Study|Withdrawal by Subject|2
2744318|NCT00062647|9414178|P2|Overall Study|Adverse Event|1
2744319|NCT00062647|9414179|P1|Overall Study|Adverse Event|1
2744320|NCT00062647|9414178|P2|Overall Study|Death|2
2744321|NCT00062647|9414179|P1|Overall Study|Death|2
2744322|NCT00062439|9414185|P1|Consolidation Chemotherapy|Adverse Event|2
2744323|NCT00062439|9414185|P1|Surgery|Adverse Event|2
2744324|NCT00062439|9414185|P1|Surgery|Death|1
2744325|NCT00062439|9414185|P1|Surgery|Physician Decision|4
2744326|NCT00062439|9414185|P1|Post Chemoradiation Assessment|Not eligible to continue to surgery|4
2744327|NCT00062439|9414185|P1|Post Chemoradiation Assessment|Physician Decision|1
2744328|NCT00062439|9414185|P1|Post Chemoradiation Assessment|Withdrawal by Subject|1
2744329|NCT00062439|9414185|P1|Post Chemoradiation Assessment|Disease progression|2
2744330|NCT00062439|9414185|P1|Post Chemoradiation Assessment|Death|1
2744331|NCT00062439|9414185|P1|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3
2744332|NCT00062439|9414185|P1|Induction Chemotherapy + Radiotherapy|Adverse Event|3
2744333|NCT00062439|9414185|P1|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1
2744334|NCT00062439|9414185|P1|Induction Chemotherapy + Radiotherapy|Ineligible|1
2744335|NCT00062374|9414197|P1|Overall Study|Not treated|12
2744336|NCT00062166|9414202|P1|Overall Study|Withdrawal by Subject|6
2744337|NCT00062010|9414210|P1|Overall Study|Ineligible|3
2744338|NCT00061945|9414218|P2|Course IV: Alemtuzumab|Early exits|15
2744339|NCT00061945|9414219|P1|Course IV: Alemtuzumab|Early exits|6
2744340|NCT00061945|9414218|P2|Course IV: Alemtuzumab|Declined Alemtuzumab|1
2744341|NCT00061945|9414219|P1|Course IV: Alemtuzumab|Declined Alemtuzumab|1
2744342|NCT00061945|9414218|P2|Registration Through Course 3|Early discontinuation during course I-IV|90
2744343|NCT00061945|9414219|P1|Registration Through Course 3|Early discontinuation during course I-IV|76
2744344|NCT00061945|9414218|P2|Registration Through Course 3|Not Alemtuzumab Eligible|25
2744345|NCT00061945|9414219|P1|Registration Through Course 3|Not Alemtuzumab Eligible|18
2744346|NCT00061932|9414229|P2|Overall Study|Withdrawal by Subject|4
2744347|NCT00061932|9414230|P1|Overall Study|Withdrawal by Subject|13
2744348|NCT00061633|9414243|P2|Overall Study|Never received study treatment|2
2744349|NCT00061633|9414244|P1|Overall Study|Never received study treatment|0
2744350|NCT00061633|9414243|P2|Overall Study|Other|1
2744351|NCT00061633|9414244|P1|Overall Study|Other|1
2744352|NCT00061633|9414243|P2|Overall Study|Lost to Follow-up|4
2744353|NCT00061633|9414244|P1|Overall Study|Lost to Follow-up|1
2744354|NCT00061633|9414243|P2|Overall Study|Withdrawal by Subject|2
2744355|NCT00061633|9414244|P1|Overall Study|Withdrawal by Subject|2
2744356|NCT00061633|9414243|P2|Overall Study|Adverse Event|2
2744357|NCT00061633|9414244|P1|Overall Study|Adverse Event|1
2744358|NCT00061048|9414269|P1|Overall Study|disease progression|20
2744359|NCT00061048|9414269|P1|Overall Study|Adverse Event|2
2744360|NCT00060944|9414279|P2|Overall Study|randomized but not treated|4
2744361|NCT00060944|9414280|P1|Overall Study|randomized but not treated|6
2744362|NCT00060944|9414279|P2|Overall Study|Other|4
2744363|NCT00060944|9414280|P1|Overall Study|Other|2
2744364|NCT00060944|9414279|P2|Overall Study|Treatment Switch|13
2744365|NCT00060944|9414280|P1|Overall Study|Treatment Switch|0
2744366|NCT00060944|9414279|P2|Overall Study|Subject Ineligible To Continue|1
2744367|NCT00060944|9414280|P1|Overall Study|Subject Ineligible To Continue|2
2744368|NCT00060944|9414279|P2|Overall Study|Lost to Follow-up|0
2744369|NCT00060944|9414280|P1|Overall Study|Lost to Follow-up|1
2744370|NCT00060944|9414279|P2|Overall Study|Disease Progression|94
2744371|NCT00060944|9414280|P1|Overall Study|Disease Progression|93
2744372|NCT00060944|9414279|P2|Overall Study|Withdrawal by Subject|5
2744373|NCT00060944|9414280|P1|Overall Study|Withdrawal by Subject|18
2744374|NCT00060944|9414279|P2|Overall Study|Death|3
2744375|NCT00060944|9414280|P1|Overall Study|Death|2
2744376|NCT00060944|9414279|P2|Overall Study|Adverse Event|10
2744377|NCT00060944|9414280|P1|Overall Study|Adverse Event|12
2744378|NCT00060840|9414296|P2|Overall Study|Other|0
2744379|NCT00060840|9414297|P1|Overall Study|Other|1
2744380|NCT00060840|9414296|P2|Overall Study|Physician Decision|0
2744381|NCT00060840|9414297|P1|Overall Study|Physician Decision|1
2744382|NCT00060840|9414296|P2|Overall Study|Subinvestigator unavailable|1
2744383|NCT00060840|9414297|P1|Overall Study|Subinvestigator unavailable|0
2744384|NCT00060840|9414296|P2|Overall Study|Withdrawal by Subject|1
2744385|NCT00060840|9414297|P1|Overall Study|Withdrawal by Subject|0
2744386|NCT00060840|9414296|P2|Overall Study|Death|1
2744387|NCT00060840|9414297|P1|Overall Study|Death|0
2744388|NCT00060840|9414296|P2|Overall Study|Change in surgical plan|6
2744389|NCT00060840|9414297|P1|Overall Study|Change in surgical plan|2
2744390|NCT00059839|9414350|P2|Overall Study|Ineligible|3
2744391|NCT00059839|9414351|P1|Overall Study|Ineligible|1
2744392|NCT00059839|9414350|P2|Overall Study|Withdrawal by Subject|6
2744393|NCT00059839|9414351|P1|Overall Study|Withdrawal by Subject|1
2744394|NCT00059839|9414350|P2|Overall Study|Physician Decision|2
2744395|NCT00059839|9414351|P1|Overall Study|Physician Decision|1
2744396|NCT00059839|9414350|P2|Overall Study|Lost to Follow-up|0
2744397|NCT00059839|9414351|P1|Overall Study|Lost to Follow-up|2
2744398|NCT00059839|9414350|P2|Overall Study|Lack of Efficacy|5
2744399|NCT00059839|9414351|P1|Overall Study|Lack of Efficacy|6
2744400|NCT00059839|9414350|P2|Overall Study|Death|1
2744401|NCT00059839|9414351|P1|Overall Study|Death|1
2744402|NCT00059787|9414357|P1|Overall Study|Other|4
2744403|NCT00059787|9414357|P1|Overall Study|ineligible|1
2744404|NCT00059787|9414357|P1|Overall Study|disease progression|2
2744405|NCT00059787|9414357|P1|Overall Study|Adverse Event|13
2744406|NCT00059332|9414408|P2|Overall Study|Lost to Follow-up|1
2744407|NCT00059332|9414409|P1|Overall Study|Lost to Follow-up|1
2744408|NCT00059332|9414408|P2|Overall Study|Withdrawal by Subject|1
2744409|NCT00059332|9414409|P1|Overall Study|Withdrawal by Subject|2
2744410|NCT00059215|9414435|P4|Overall Study|Physician Decision|1
2744411|NCT00059215|9414436|P3|Overall Study|Physician Decision|1
2744412|NCT00059215|9414437|P2|Overall Study|Physician Decision|2
2744413|NCT00059215|9414438|P1|Overall Study|Physician Decision|1
2744414|NCT00059215|9414435|P4|Overall Study|Protocol entry criteria not met|2
2744415|NCT00059215|9414436|P3|Overall Study|Protocol entry criteria not met|0
2744416|NCT00059215|9414437|P2|Overall Study|Protocol entry criteria not met|1
2744417|NCT00059215|9414438|P1|Overall Study|Protocol entry criteria not met|1
2744418|NCT00059215|9414435|P4|Overall Study|Protocol Violation|0
2744419|NCT00059215|9414436|P3|Overall Study|Protocol Violation|1
2744420|NCT00059215|9414437|P2|Overall Study|Protocol Violation|0
2744421|NCT00059215|9414438|P1|Overall Study|Protocol Violation|1
2744422|NCT00059215|9414435|P4|Overall Study|Withdrawal by Subject|3
2744423|NCT00059215|9414436|P3|Overall Study|Withdrawal by Subject|1
2744424|NCT00059215|9414437|P2|Overall Study|Withdrawal by Subject|4
2744425|NCT00059215|9414438|P1|Overall Study|Withdrawal by Subject|4
2744426|NCT00059215|9414435|P4|Overall Study|Lost to Follow-up|0
2744427|NCT00059215|9414436|P3|Overall Study|Lost to Follow-up|0
2744428|NCT00059215|9414437|P2|Overall Study|Lost to Follow-up|2
2744429|NCT00059215|9414438|P1|Overall Study|Lost to Follow-up|1
2744430|NCT00059215|9414435|P4|Overall Study|Death|0
2744431|NCT00059215|9414436|P3|Overall Study|Death|3
2744432|NCT00059215|9414437|P2|Overall Study|Death|0
2744433|NCT00059215|9414438|P1|Overall Study|Death|0
2744434|NCT00059215|9414435|P4|Overall Study|Adverse Event|9
2744435|NCT00059215|9414436|P3|Overall Study|Adverse Event|9
2744436|NCT00059215|9414437|P2|Overall Study|Adverse Event|5
2744437|NCT00059215|9414438|P1|Overall Study|Adverse Event|5
2744438|NCT00058825|9414475|P1|Overall Study|Death|3
2744439|NCT00058825|9414475|P1|Overall Study|Graft Failure|5
2744440|NCT00058825|9414475|P1|Overall Study|Progressive Disease|5
2744441|NCT00058825|9414475|P1|Overall Study|Relapse|9
2744442|NCT00058552|9414491|P2|Overall Study|Clinical disease progression|4
2744443|NCT00058552|9414492|P1|Overall Study|Clinical disease progression|0
2744444|NCT00058552|9414491|P2|Overall Study|Physician Decision|5
2744445|NCT00058552|9414492|P1|Overall Study|Physician Decision|2
2744446|NCT00058552|9414491|P2|Overall Study|Withdrawal by Subject|5
2744447|NCT00058552|9414492|P1|Overall Study|Withdrawal by Subject|3
2744448|NCT00058552|9414491|P2|Overall Study|Adverse Event|2
2744449|NCT00058552|9414492|P1|Overall Study|Adverse Event|4
2744450|NCT00058552|9414491|P2|Overall Study|Disease progression|44
2744451|NCT00058552|9414492|P1|Overall Study|Disease progression|52
2744452|NCT00058552|9414491|P2|Overall Study|Died prior to receiving treatment|2
2744453|NCT00058552|9414492|P1|Overall Study|Died prior to receiving treatment|4
2744454|NCT00058539|9414510|P1|Overall Study|Death|1
2744455|NCT00058539|9414510|P1|Overall Study|Physician Decision|9
2744456|NCT00058539|9414510|P1|Overall Study|Withdrawal by Subject|5
2744457|NCT00058539|9414510|P1|Overall Study|Adverse Event|3
2744458|NCT00058539|9414510|P1|Overall Study|Disease progression|24
2744459|NCT00058214|9414537|P1|Overall Study|Adverse Event|1
2744460|NCT00058123|9414542|P1|Overall Study|Received >3 prior treatments|1
2744461|NCT00058123|9414542|P1|Overall Study|Wrong histology|9
2744462|NCT00058058|9414549|P1|Overall Study|Poor positioning, illness,pain|3
2744463|NCT00058058|9414549|P1|Overall Study|technical issues|6
2744464|NCT00058058|9414549|P1|Overall Study|Claustrophobic|5
2744465|NCT00058058|9414549|P1|Overall Study|Ineligible|20
2744466|NCT00058058|9414549|P1|Overall Study|Withdrawal by Subject|4
2744467|NCT00057954|9414574|P1|Overall Study|Disease progression|1
2744468|NCT00057954|9414574|P1|Overall Study|Death|1
2744469|NCT00057941|9414582|P2|Overall Study|Ineligible|5
2744470|NCT00057941|9414583|P1|Overall Study|Ineligible|2
2744471|NCT00057941|9414582|P2|Overall Study|insurance, symptomatic deterioration|3
2744472|NCT00057941|9414583|P1|Overall Study|insurance, symptomatic deterioration|1
2744473|NCT00057941|9414582|P2|Overall Study|still on treatment|1
2744474|NCT00057941|9414583|P1|Overall Study|still on treatment|3
2744475|NCT00057941|9414582|P2|Overall Study|Withdrawal by Subject|1
2744476|NCT00057941|9414583|P1|Overall Study|Withdrawal by Subject|6
2744477|NCT00057941|9414582|P2|Overall Study|Lack of Efficacy|53
2744478|NCT00057941|9414583|P1|Overall Study|Lack of Efficacy|54
2744479|NCT00057941|9414582|P2|Overall Study|Adverse Event|9
2744480|NCT00057941|9414583|P1|Overall Study|Adverse Event|7
2744481|NCT00057941|9414582|P2|Overall Study|Death|2
2744482|NCT00057941|9414583|P1|Overall Study|Death|1
2744483|NCT00057876|9414591|P2|Overall Study|other complicating disease|0
2744484|NCT00057876|9414592|P1|Overall Study|other complicating disease|1
2744485|NCT00057876|9414591|P2|Overall Study|other reason|2
2744486|NCT00057876|9414592|P1|Overall Study|other reason|2
2744487|NCT00057876|9414591|P2|Overall Study|Ineligible|2
2744488|NCT00057876|9414592|P1|Overall Study|Ineligible|1
2744489|NCT00057876|9414591|P2|Overall Study|Lack of Efficacy|8
2744490|NCT00057876|9414592|P1|Overall Study|Lack of Efficacy|10
2744491|NCT00057876|9414591|P2|Overall Study|Withdrawal by Subject|6
2744492|NCT00057876|9414592|P1|Overall Study|Withdrawal by Subject|5
2744493|NCT00057876|9414591|P2|Overall Study|Death|1
2744494|NCT00057876|9414592|P1|Overall Study|Death|2
2744495|NCT00057876|9414591|P2|Overall Study|Adverse Event|8
2744496|NCT00057876|9414592|P1|Overall Study|Adverse Event|8
2744497|NCT00057863|9414602|P1|Overall Study|Withdrawal by Subject|2
2744498|NCT00057863|9414602|P1|Overall Study|Death|1
2744499|NCT00057837|9414611|P2|Overall Study|Never started treatment|1
2744500|NCT00057837|9414612|P1|Overall Study|Never started treatment|1
2744501|NCT00057837|9414611|P2|Overall Study|Ineligible|3
2744502|NCT00057837|9414612|P1|Overall Study|Ineligible|3
2744503|NCT00057837|9414611|P2|Overall Study|Physician Decision|0
2744504|NCT00057837|9414612|P1|Overall Study|Physician Decision|1
2744505|NCT00057837|9414611|P2|Overall Study|Other complicating disease|1
2744506|NCT00057837|9414612|P1|Overall Study|Other complicating disease|2
2744507|NCT00057837|9414611|P2|Overall Study|Alternative therapy|1
2744508|NCT00057837|9414612|P1|Overall Study|Alternative therapy|0
2744509|NCT00057837|9414611|P2|Overall Study|Withdrawal by Subject|3
2744510|NCT00057837|9414612|P1|Overall Study|Withdrawal by Subject|5
2744511|NCT00057837|9414611|P2|Overall Study|Death|4
2744512|NCT00057837|9414612|P1|Overall Study|Death|5
2744513|NCT00057837|9414611|P2|Overall Study|Adverse Event|12
2744514|NCT00057837|9414612|P1|Overall Study|Adverse Event|2
2744515|NCT00057837|9414611|P2|Overall Study|Progression/relapse|14
2744516|NCT00057837|9414612|P1|Overall Study|Progression/relapse|12
2744517|NCT00057811|9414624|P2|Overall Study|Inevaluable|2
2744518|NCT00057811|9414625|P1|Overall Study|Inevaluable|1
2744519|NCT00057811|9414624|P2|Overall Study|Ineligible|2
2744520|NCT00057811|9414625|P1|Overall Study|Ineligible|4
2744521|NCT00057811|9414624|P2|Overall Study|Withdrawal by Subject|4
2744522|NCT00057811|9414625|P1|Overall Study|Withdrawal by Subject|3
2744523|NCT00057811|9414624|P2|Overall Study|Physician Decision|0
2744524|NCT00057811|9414625|P1|Overall Study|Physician Decision|1
2744525|NCT00057811|9414624|P2|Overall Study|Lack of Efficacy|4
2744526|NCT00057811|9414625|P1|Overall Study|Lack of Efficacy|1
2744527|NCT00057746|9414644|P3|Overall Study|Withdrawal by Subject|1
2744528|NCT00057746|9414645|P2|Overall Study|Withdrawal by Subject|0
2744529|NCT00057746|9414646|P1|Overall Study|Withdrawal by Subject|0
2744530|NCT00023673|9414657|P4|Overall Study|Patient withdrew consent|1
2744531|NCT00023673|9414658|P3|Overall Study|Patient withdrew consent|0
2744532|NCT00023673|9414659|P2|Overall Study|Patient withdrew consent|0
2744533|NCT00023673|9414660|P1|Overall Study|Patient withdrew consent|0
2744534|NCT00023673|9414657|P4|Overall Study|Ineligible / no protocol treatment|1
2744535|NCT00023673|9414658|P3|Overall Study|Ineligible / no protocol treatment|0
2744536|NCT00023673|9414659|P2|Overall Study|Ineligible / no protocol treatment|0
2744537|NCT00023673|9414660|P1|Overall Study|Ineligible / no protocol treatment|0
2744538|NCT00057330|9414724|P2|Overall Study|Other|206
2744539|NCT00057330|9414725|P1|Overall Study|Other|260
2744540|NCT00057330|9414724|P2|Overall Study|Physician Decision|0
2744541|NCT00057330|9414725|P1|Overall Study|Physician Decision|1
2744542|NCT00057330|9414724|P2|Overall Study|Lost to Follow-up|617
2744543|NCT00057330|9414725|P1|Overall Study|Lost to Follow-up|745
2744544|NCT00057330|9414724|P2|Overall Study|Withdrawal by Subject|84
2744545|NCT00057330|9414725|P1|Overall Study|Withdrawal by Subject|115
2744546|NCT00057330|9414724|P2|Overall Study|Protocol Violation|1
2744547|NCT00057330|9414725|P1|Overall Study|Protocol Violation|1
2744548|NCT00057330|9414724|P2|Overall Study|Death|0
2744549|NCT00057330|9414725|P1|Overall Study|Death|1
2744550|NCT00057330|9414724|P2|Overall Study|Adverse Event|12
2744551|NCT00057330|9414725|P1|Overall Study|Adverse Event|9
2744552|NCT00056862|9414755|P2|Overall Study|Protocol Violation|0
2744553|NCT00056862|9414756|P1|Overall Study|Protocol Violation|1
2744554|NCT00056407|9414814|P2|Overall Study|Missing|34
2744555|NCT00056407|9414815|P1|Overall Study|Missing|25
2744556|NCT00056407|9414814|P2|Overall Study|"Listed as Other on Case Report Form"|60
2744557|NCT00056407|9414815|P1|Overall Study|"Listed as Other on Case Report Form"|98
2744558|NCT00056407|9414814|P2|Overall Study|Diagnosed with Prostate Cancer|166
2744559|NCT00056407|9414815|P1|Overall Study|Diagnosed with Prostate Cancer|202
2744560|NCT00056407|9414814|P2|Overall Study|Protocol Violation|95
2744561|NCT00056407|9414815|P1|Overall Study|Protocol Violation|104
2744562|NCT00056407|9414814|P2|Overall Study|Lost to Follow-up|113
2744563|NCT00056407|9414815|P1|Overall Study|Lost to Follow-up|123
2744564|NCT00056407|9414814|P2|Overall Study|Withdrawal by Subject|361
2744565|NCT00056407|9414815|P1|Overall Study|Withdrawal by Subject|377
2744566|NCT00056407|9414814|P2|Overall Study|Adverse Event|364
2744567|NCT00056407|9414815|P1|Overall Study|Adverse Event|282
2744568|NCT00056316|9414873|P2|Overall Study|Death/NH placement of pt|1
2744569|NCT00056316|9414874|P1|Overall Study|Death/NH placement of pt|1
2744570|NCT00056316|9414873|P2|Overall Study|Withdrawal by Subject|2
2744571|NCT00056316|9414874|P1|Overall Study|Withdrawal by Subject|2
2744572|NCT00056160|9414888|P2|Final Follow-up|Adverse Event|0
2744573|NCT00056160|9414889|P1|Final Follow-up|Adverse Event|1
2744574|NCT00056160|9414888|P2|Final Follow-up|Transferred into RevAssist Program|0
2744575|NCT00056160|9414889|P1|Final Follow-up|Transferred into RevAssist Program|2
2744576|NCT00056160|9414888|P2|Final Follow-up|Transferred into expanded access study.|0
2744577|NCT00056160|9414889|P1|Final Follow-up|Transferred into expanded access study.|3
2744578|NCT00056160|9414888|P2|Extended Follow-up Cutoff (23 Jul 2008)|Other|0
2744579|NCT00056160|9414889|P1|Extended Follow-up Cutoff (23 Jul 2008)|Other|21
2744580|NCT00056160|9414888|P2|Extended Follow-up Cutoff (23 Jul 2008)|Death|0
2744581|NCT00056160|9414889|P1|Extended Follow-up Cutoff (23 Jul 2008)|Death|5
2744582|NCT00056160|9414888|P2|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0
2744583|NCT00056160|9414889|P1|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11
2744584|NCT00056160|9414888|P2|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0
2744585|NCT00056160|9414889|P1|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3
2744586|NCT00056160|9414888|P2|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0
2744587|NCT00056160|9414889|P1|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87
2744588|NCT00056160|9414888|P2|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0
2744589|NCT00056160|9414889|P1|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44
2744590|NCT00056160|9414888|P2|Up to Unblinding (07 Jun 2005)|Other|7
2744591|NCT00056160|9414889|P1|Up to Unblinding (07 Jun 2005)|Other|8
2744592|NCT00056160|9414888|P2|Up to Unblinding (07 Jun 2005)|Death|1
2744593|NCT00056160|9414889|P1|Up to Unblinding (07 Jun 2005)|Death|2
2744594|NCT00056160|9414888|P2|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
2744595|NCT00056160|9414889|P1|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
2744596|NCT00056160|9414888|P2|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5
2744597|NCT00056160|9414889|P1|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3
2744598|NCT00056160|9414888|P2|Up to Unblinding (07 Jun 2005)|Progression of disease|124
2744599|NCT00056160|9414889|P1|Up to Unblinding (07 Jun 2005)|Progression of disease|57
2744600|NCT00056160|9414888|P2|Up to Unblinding (07 Jun 2005)|Adverse Event|18
2744601|NCT00056160|9414889|P1|Up to Unblinding (07 Jun 2005)|Adverse Event|35
2744602|NCT00055601|9414912|P2|Overall Study|No protocol treatment received|1
2744603|NCT00055601|9414913|P1|Overall Study|No protocol treatment received|1
2744604|NCT00055601|9414912|P2|Overall Study|Protocol Violation|1
2744605|NCT00055601|9414913|P1|Overall Study|Protocol Violation|1
2744606|NCT00055497|9414927|P4|Overall Study|Other|11
2744607|NCT00055497|9414928|P3|Overall Study|Other|0
2744608|NCT00055497|9414929|P2|Overall Study|Other|0
2744609|NCT00055497|9414930|P1|Overall Study|Other|0
2744610|NCT00055497|9414927|P4|Overall Study|Administrative Reasons|1
2744611|NCT00055497|9414928|P3|Overall Study|Administrative Reasons|0
2744612|NCT00055497|9414929|P2|Overall Study|Administrative Reasons|0
2744613|NCT00055497|9414930|P1|Overall Study|Administrative Reasons|0
2744614|NCT00055497|9414927|P4|Overall Study|Lack of Efficacy|27
2744615|NCT00055497|9414928|P3|Overall Study|Lack of Efficacy|0
2744616|NCT00055497|9414929|P2|Overall Study|Lack of Efficacy|0
2744617|NCT00055497|9414930|P1|Overall Study|Lack of Efficacy|1
2744618|NCT00055497|9414927|P4|Overall Study|Protocol Violation|3
2744619|NCT00055497|9414928|P3|Overall Study|Protocol Violation|0
2744620|NCT00055497|9414929|P2|Overall Study|Protocol Violation|0
2744621|NCT00055497|9414930|P1|Overall Study|Protocol Violation|0
2744622|NCT00055497|9414927|P4|Overall Study|Lost to Follow-up|5
2744623|NCT00055497|9414928|P3|Overall Study|Lost to Follow-up|0
2744624|NCT00055497|9414929|P2|Overall Study|Lost to Follow-up|1
2744625|NCT00055497|9414930|P1|Overall Study|Lost to Follow-up|0
2744626|NCT00055497|9414927|P4|Overall Study|Withdrawal by Subject|15
2744627|NCT00055497|9414928|P3|Overall Study|Withdrawal by Subject|1
2744628|NCT00055497|9414929|P2|Overall Study|Withdrawal by Subject|1
2744629|NCT00055497|9414930|P1|Overall Study|Withdrawal by Subject|3
2744630|NCT00055497|9414927|P4|Overall Study|Adverse Event|28
2744631|NCT00055497|9414928|P3|Overall Study|Adverse Event|1
2744632|NCT00055497|9414929|P2|Overall Study|Adverse Event|1
2744633|NCT00055497|9414930|P1|Overall Study|Adverse Event|1
2744634|NCT00055471|9414975|P3|Period 1: Dose Escalation Period|Disease progression|0
2744635|NCT00055471|9414976|P2|Period 1: Dose Escalation Period|Disease progression|1
2744636|NCT00055471|9414977|P1|Period 1: Dose Escalation Period|Disease progression|0
2744637|NCT00055471|9414975|P3|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1
2744638|NCT00055471|9414976|P2|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
2744639|NCT00055471|9414977|P1|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
2744640|NCT00055471|9414975|P3|Period 1: Dose Escalation Period|Adverse Event|2
2744641|NCT00055471|9414976|P2|Period 1: Dose Escalation Period|Adverse Event|1
2744642|NCT00055471|9414977|P1|Period 1: Dose Escalation Period|Adverse Event|0
2744643|NCT00054717|9415032|P2|Overall Study|Other reason not defined above|217
2744644|NCT00054717|9415033|P1|Overall Study|Other reason not defined above|117
2744645|NCT00054717|9415032|P2|Overall Study|Withdrawal by Subject|20
2744646|NCT00054717|9415033|P1|Overall Study|Withdrawal by Subject|32
2744647|NCT00054717|9415032|P2|Overall Study|Lost to Follow-up|13
2744648|NCT00054717|9415033|P1|Overall Study|Lost to Follow-up|23
2744649|NCT00054717|9415032|P2|Overall Study|Protocol Violation|19
2744650|NCT00054717|9415033|P1|Overall Study|Protocol Violation|18
2744651|NCT00054717|9415032|P2|Overall Study|Adverse Event|22
2744652|NCT00054717|9415033|P1|Overall Study|Adverse Event|70
2744653|NCT00054717|9415032|P2|Overall Study|Randomized but not treated|8
2744654|NCT00054717|9415033|P1|Overall Study|Randomized but not treated|2
2744655|NCT00054704|9415221|P2|Overall Study|Lost to Follow-up|1
2744656|NCT00054704|9415222|P1|Overall Study|Lost to Follow-up|0
2744657|NCT00054704|9415221|P2|Overall Study|Adverse Event|1
2744658|NCT00054704|9415222|P1|Overall Study|Adverse Event|3
2744659|NCT00054704|9415221|P2|Overall Study|Lack of Efficacy|3
2744660|NCT00054704|9415222|P1|Overall Study|Lack of Efficacy|2
2744661|NCT00054691|9415228|P1|Overall Study|Noncompliant|1
2744662|NCT00054691|9415228|P1|Overall Study|Unmeasurable Disease|2
2744663|NCT00054639|9415242|P1|Overall Study|Physician Decision|1
2744664|NCT00054639|9415242|P1|Overall Study|Lack of Efficacy|1
2744665|NCT00054327|9415275|P6|Overall Study|Engraftment failure|0
2744666|NCT00054327|9415276|P5|Overall Study|Engraftment failure|0
2744667|NCT00054327|9415277|P4|Overall Study|Engraftment failure|0
2744668|NCT00054327|9415278|P3|Overall Study|Engraftment failure|0
2744669|NCT00054327|9415279|P2|Overall Study|Engraftment failure|0
2744670|NCT00054327|9415280|P1|Overall Study|Engraftment failure|1
2744671|NCT00054275|9415318|P1|Overall Study|Physician Decision|1
2744672|NCT00054275|9415318|P1|Overall Study|Progressive disease in cycle 1|1
2744673|NCT00054275|9415318|P1|Overall Study|Adverse Event|5
2744674|NCT00054275|9415318|P1|Overall Study|Withdrawal by Subject|4
2744675|NCT00054132|9415324|P1|Overall Study|Not Treated|1
2744676|NCT00053898|9415351|P2|Overall Study|Follow-up from telephone contact only|1
2744677|NCT00053898|9415352|P1|Overall Study|Follow-up from telephone contact only|5
2744678|NCT00053898|9415351|P2|Overall Study|No follow-up data from any source|12
2744679|NCT00053898|9415352|P1|Overall Study|No follow-up data from any source|9
2744680|NCT00053846|9415378|P2|Overall Study|Pills too large|1
2744681|NCT00053846|9415379|P1|Overall Study|Pills too large|0
2744682|NCT00053846|9415378|P2|Overall Study|Quit due to side effects|3
2744683|NCT00053846|9415379|P1|Overall Study|Quit due to side effects|1
2744684|NCT00053846|9415378|P2|Overall Study|Did not return data|2
2744685|NCT00053846|9415379|P1|Overall Study|Did not return data|1
2744686|NCT00053846|9415378|P2|Overall Study|Became ineligible|1
2744687|NCT00053846|9415379|P1|Overall Study|Became ineligible|3
2744688|NCT00053846|9415378|P2|Overall Study|Expired|0
2744689|NCT00053846|9415379|P1|Overall Study|Expired|5
2744690|NCT00053846|9415378|P2|Overall Study|Became too ill|7
2744691|NCT00053846|9415379|P1|Overall Study|Became too ill|8
2744692|NCT00053846|9415378|P2|Overall Study|Changed mind|13
2744693|NCT00053846|9415379|P1|Overall Study|Changed mind|8
2744694|NCT00053417|9415538|P4|Overall Study|Lost to Follow-up|0
2744695|NCT00053417|9415539|P3|Overall Study|Lost to Follow-up|0
2744696|NCT00053417|9415540|P2|Overall Study|Lost to Follow-up|1
2744697|NCT00053417|9415541|P1|Overall Study|Lost to Follow-up|1
2744698|NCT00053417|9415538|P4|Overall Study|Withdrawal by Subject|0
2744699|NCT00053417|9415539|P3|Overall Study|Withdrawal by Subject|0
2744700|NCT00053417|9415540|P2|Overall Study|Withdrawal by Subject|1
2744701|NCT00053417|9415541|P1|Overall Study|Withdrawal by Subject|0
2744702|NCT00053417|9415538|P4|Overall Study|Non-Compliance|1
2744703|NCT00053417|9415539|P3|Overall Study|Non-Compliance|0
2744704|NCT00053417|9415540|P2|Overall Study|Non-Compliance|0
2744705|NCT00053417|9415541|P1|Overall Study|Non-Compliance|0
2744706|NCT00053417|9415538|P4|Overall Study|Adverse Event|5
2744707|NCT00053417|9415539|P3|Overall Study|Adverse Event|1
2744708|NCT00053417|9415540|P2|Overall Study|Adverse Event|0
2744709|NCT00053417|9415541|P1|Overall Study|Adverse Event|1
2744710|NCT00053365|9415551|P1|Overall Study|Never treated|4
2744711|NCT00053365|9415551|P1|Overall Study|Platinum-sensitive interval >12 months|1
2744712|NCT00053365|9415551|P1|Overall Study|Incorrect cell type|1
2744713|NCT00053352|9415560|P2|Overall Study|Disease at new site|0
2744714|NCT00053352|9415561|P1|Overall Study|Disease at new site|1
2744715|NCT00053352|9415560|P2|Overall Study|Ineligible|8
2744716|NCT00053352|9415561|P1|Overall Study|Ineligible|8
2744717|NCT00053352|9415560|P2|Overall Study|Withdrawal by Subject|0
2744718|NCT00053352|9415561|P1|Overall Study|Withdrawal by Subject|1
2744719|NCT00053352|9415560|P2|Overall Study|Physician Decision|1
2744720|NCT00053352|9415561|P1|Overall Study|Physician Decision|11
2744721|NCT00053352|9415560|P2|Overall Study|Lost to Follow-up|1
2744722|NCT00053352|9415561|P1|Overall Study|Lost to Follow-up|0
2744723|NCT00003830|9415577|P2|Overall Study|Sentinel node positive patients|793
2744724|NCT00003830|9415578|P1|Overall Study|Sentinel node positive patients|829
2744725|NCT00003830|9415577|P2|Overall Study|No follow up data|0
2744726|NCT00003830|9415578|P1|Overall Study|No follow up data|3
2744727|NCT00052962|9415604|P2|Overall Study|Not randomized/not evaluable|0
2744728|NCT00052962|9415605|P1|Overall Study|Not randomized/not evaluable|1
2744729|NCT00052962|9415604|P2|Overall Study|Not evaluable|2
2744730|NCT00052962|9415605|P1|Overall Study|Not evaluable|0
2744731|NCT00052715|9415624|P1|Overall Study|wrong histology|1
2744732|NCT00049543|9415640|P2|Overall Study|still on treatment|9
2744733|NCT00049543|9415641|P1|Overall Study|still on treatment|2
2744734|NCT00049530|9415651|P1|Overall Study|ineligible|3
2744735|NCT00049530|9415651|P1|Overall Study|symptomatic deterioration|1
2744736|NCT00049530|9415651|P1|Overall Study|Death|1
2744737|NCT00049530|9415651|P1|Overall Study|Adverse Event|2
2744738|NCT00049530|9415651|P1|Overall Study|Lack of Efficacy|25
2744739|NCT00049517|9415660|P6|Conditioning/Transplant|Reasons not reported|5
2744740|NCT00049517|9415661|P5|Conditioning/Transplant|Reasons not reported|5
2744741|NCT00049517|9415662|P4|Conditioning/Transplant|Reasons not reported|15
2744742|NCT00049517|9415663|P3|Conditioning/Transplant|Reasons not reported|18
2744743|NCT00049517|9415664|P2|Conditioning/Transplant|Reasons not reported|31
2744744|NCT00049517|9415665|P1|Conditioning/Transplant|Reasons not reported|25
2744745|NCT00049517|9415660|P6|Conditioning/Transplant|Other complicating disease|1
2744746|NCT00049517|9415661|P5|Conditioning/Transplant|Other complicating disease|0
2744747|NCT00049517|9415662|P4|Conditioning/Transplant|Other complicating disease|4
2744748|NCT00049517|9415663|P3|Conditioning/Transplant|Other complicating disease|0
2744749|NCT00049517|9415664|P2|Conditioning/Transplant|Other complicating disease|0
2744750|NCT00049517|9415665|P1|Conditioning/Transplant|Other complicating disease|2
2744751|NCT00049517|9415660|P6|Conditioning/Transplant|Alternative therapy|0
2744752|NCT00049517|9415661|P5|Conditioning/Transplant|Alternative therapy|1
2744753|NCT00049517|9415662|P4|Conditioning/Transplant|Alternative therapy|1
2744754|NCT00049517|9415663|P3|Conditioning/Transplant|Alternative therapy|2
2744755|NCT00049517|9415664|P2|Conditioning/Transplant|Alternative therapy|4
2744756|NCT00049517|9415665|P1|Conditioning/Transplant|Alternative therapy|4
2744757|NCT00049517|9415660|P6|Conditioning/Transplant|Withdrawal by Subject|0
2744758|NCT00049517|9415661|P5|Conditioning/Transplant|Withdrawal by Subject|0
2744759|NCT00049517|9415662|P4|Conditioning/Transplant|Withdrawal by Subject|7
2744760|NCT00049517|9415663|P3|Conditioning/Transplant|Withdrawal by Subject|4
2744761|NCT00049517|9415664|P2|Conditioning/Transplant|Withdrawal by Subject|8
2744762|NCT00049517|9415665|P1|Conditioning/Transplant|Withdrawal by Subject|4
2744763|NCT00049517|9415660|P6|Conditioning/Transplant|Death|0
2744764|NCT00049517|9415661|P5|Conditioning/Transplant|Death|0
2744765|NCT00049517|9415662|P4|Conditioning/Transplant|Death|2
2744766|NCT00049517|9415663|P3|Conditioning/Transplant|Death|0
2744767|NCT00049517|9415664|P2|Conditioning/Transplant|Death|0
2744768|NCT00049517|9415665|P1|Conditioning/Transplant|Death|1
2744769|NCT00049517|9415660|P6|Conditioning/Transplant|Adverse Event|0
2744770|NCT00049517|9415661|P5|Conditioning/Transplant|Adverse Event|0
2744771|NCT00049517|9415662|P4|Conditioning/Transplant|Adverse Event|8
2744772|NCT00049517|9415663|P3|Conditioning/Transplant|Adverse Event|4
2744773|NCT00049517|9415664|P2|Conditioning/Transplant|Adverse Event|1
2744774|NCT00049517|9415665|P1|Conditioning/Transplant|Adverse Event|2
2744775|NCT00049517|9415660|P6|Conditioning/Transplant|Disease progression|0
2744776|NCT00049517|9415661|P5|Conditioning/Transplant|Disease progression|0
2744777|NCT00049517|9415662|P4|Conditioning/Transplant|Disease progression|6
2744778|NCT00049517|9415663|P3|Conditioning/Transplant|Disease progression|10
2744779|NCT00049517|9415664|P2|Conditioning/Transplant|Disease progression|6
2744780|NCT00049517|9415665|P1|Conditioning/Transplant|Disease progression|14
2744781|NCT00049517|9415660|P6|Induction|Reasons not reported|25
2744782|NCT00049517|9415661|P5|Induction|Reasons not reported|22
2744783|NCT00049517|9415662|P4|Induction|Reasons not reported|0
2744784|NCT00049517|9415663|P3|Induction|Reasons not reported|0
2744785|NCT00049517|9415664|P2|Induction|Reasons not reported|0
2744786|NCT00049517|9415665|P1|Induction|Reasons not reported|0
2744787|NCT00049517|9415660|P6|Induction|Other complicating disease|0
2744788|NCT00049517|9415661|P5|Induction|Other complicating disease|3
2744789|NCT00049517|9415662|P4|Induction|Other complicating disease|0
2744790|NCT00049517|9415663|P3|Induction|Other complicating disease|0
2744791|NCT00049517|9415664|P2|Induction|Other complicating disease|0
2744792|NCT00049517|9415665|P1|Induction|Other complicating disease|0
2744793|NCT00049517|9415660|P6|Induction|Alternative therapy|2
2744794|NCT00049517|9415661|P5|Induction|Alternative therapy|2
2744795|NCT00049517|9415662|P4|Induction|Alternative therapy|0
2744796|NCT00049517|9415663|P3|Induction|Alternative therapy|0
2744797|NCT00049517|9415664|P2|Induction|Alternative therapy|0
2744798|NCT00049517|9415665|P1|Induction|Alternative therapy|0
2744799|NCT00049517|9415660|P6|Induction|Withdrawal by Subject|3
2744800|NCT00049517|9415661|P5|Induction|Withdrawal by Subject|1
2744801|NCT00049517|9415662|P4|Induction|Withdrawal by Subject|0
2744802|NCT00049517|9415663|P3|Induction|Withdrawal by Subject|0
2744803|NCT00049517|9415664|P2|Induction|Withdrawal by Subject|0
2744804|NCT00049517|9415665|P1|Induction|Withdrawal by Subject|0
2744805|NCT00049517|9415660|P6|Induction|Death|6
2744806|NCT00049517|9415661|P5|Induction|Death|9
2744807|NCT00049517|9415662|P4|Induction|Death|0
2744808|NCT00049517|9415663|P3|Induction|Death|0
2744809|NCT00049517|9415664|P2|Induction|Death|0
2744810|NCT00049517|9415665|P1|Induction|Death|0
2744811|NCT00049517|9415660|P6|Induction|Adverse Event|7
2744812|NCT00049517|9415661|P5|Induction|Adverse Event|5
2744813|NCT00049517|9415662|P4|Induction|Adverse Event|0
2744814|NCT00049517|9415663|P3|Induction|Adverse Event|0
2744815|NCT00049517|9415664|P2|Induction|Adverse Event|0
2744816|NCT00049517|9415665|P1|Induction|Adverse Event|0
2744817|NCT00049517|9415660|P6|Induction|Disease progression|11
2744818|NCT00049517|9415661|P5|Induction|Disease progression|18
2744819|NCT00049517|9415662|P4|Induction|Disease progression|0
2744820|NCT00049517|9415663|P3|Induction|Disease progression|0
2744821|NCT00049517|9415664|P2|Induction|Disease progression|0
2744822|NCT00049517|9415665|P1|Induction|Disease progression|0
2744823|NCT00049322|9415683|P2|Overall Study|refused angio|3
2744824|NCT00049322|9415684|P1|Overall Study|refused angio|0
2744825|NCT00049322|9415683|P2|Overall Study|Adverse Event|0
2744826|NCT00049322|9415684|P1|Overall Study|Adverse Event|1
2744827|NCT00049322|9415683|P2|Overall Study|disease burden|3
2744828|NCT00049322|9415684|P1|Overall Study|disease burden|0
2744829|NCT00049257|9415696|P1|Follow-up Period for Survival Status|Lost to Follow-up|4
2744830|NCT00049257|9415696|P1|Carboplatin, Paclitaxel|Death|2
2744831|NCT00049257|9415696|P1|Carboplatin, Paclitaxel|Lost to Follow-up|1
2744832|NCT00049257|9415696|P1|Carboplatin, Paclitaxel|Withdrawal by Subject|10
2744833|NCT00049127|9415708|P5|Overall Study|Withdrawal by Subject|0
2744834|NCT00049127|9415709|P4|Overall Study|Withdrawal by Subject|0
2744835|NCT00049127|9415710|P3|Overall Study|Withdrawal by Subject|1
2744836|NCT00049127|9415711|P2|Overall Study|Withdrawal by Subject|0
2744837|NCT00049127|9415712|P1|Overall Study|Withdrawal by Subject|0
2744838|NCT00048997|9415750|P2|Overall Study|Withdrawal by Subject|1
2744839|NCT00048997|9415751|P1|Overall Study|Withdrawal by Subject|6
2744840|NCT00048997|9415750|P2|Overall Study|Protocol Violation|2
2744841|NCT00048997|9415751|P1|Overall Study|Protocol Violation|7
2744842|NCT00047385|9415774|P2|Overall Study|Eligible for screening but had no screen|492
2744843|NCT00047385|9415775|P1|Overall Study|Eligible for screening but had no screen|260
2744844|NCT00047385|9415774|P2|Overall Study|Lung Cancer diagnosed before screening|3
2744845|NCT00047385|9415775|P1|Overall Study|Lung Cancer diagnosed before screening|5
2744846|NCT00047385|9415774|P2|Overall Study|Death before any screening|5
2744847|NCT00047385|9415775|P1|Overall Study|Death before any screening|2
2744848|NCT00047320|9415793|P1|Overall Study|Ineligible|2
2744849|NCT00047320|9415793|P1|Overall Study|Withdrawal by Subject|9
2744850|NCT00047320|9415793|P1|Overall Study|Physician Decision|8
2744851|NCT00047320|9415793|P1|Overall Study|Lost to Follow-up|1
2744852|NCT00047320|9415793|P1|Overall Study|Lack of Efficacy|8
2744853|NCT00047008|9415808|P2|Overall Study|Ineligible|8
2744854|NCT00047008|9415809|P1|Overall Study|Ineligible|9
2744855|NCT00047008|9415808|P2|Overall Study|Withdrawn consent|3
2744856|NCT00047008|9415809|P1|Overall Study|Withdrawn consent|2
2744857|NCT00046930|9415817|P2|Overall Study|Ineligible|4
2744858|NCT00046930|9415818|P1|Overall Study|Ineligible|12
2744859|NCT00046891|9415833|P2|Overall Study|Adverse Event|5
2744860|NCT00046891|9415834|P1|Overall Study|Adverse Event|5
2744861|NCT00046891|9415833|P2|Overall Study|Withdrawal by Subject|15
2744862|NCT00046891|9415834|P1|Overall Study|Withdrawal by Subject|18
2744863|NCT00046891|9415833|P2|Overall Study|Ineligible|1
2744864|NCT00046891|9415834|P1|Overall Study|Ineligible|1
2744865|NCT00046891|9415833|P2|Overall Study|Cancels|9
2744866|NCT00046891|9415834|P1|Overall Study|Cancels|5
2744867|NCT00046839|9415854|P2|Overall Study|Withdrawal of consent|0
2744868|NCT00046839|9415855|P1|Overall Study|Withdrawal of consent|1
2744869|NCT00046839|9415854|P2|Overall Study|Ineligible / No protocol treatment|2
2744870|NCT00046839|9415855|P1|Overall Study|Ineligible / No protocol treatment|0
2744871|NCT00045734|9415862|P1|Overall Study|Protocol Violation|1
2744872|NCT00045708|9415877|P3|Phase 1|early progressive disease|0
2744873|NCT00045708|9415878|P2|Phase 1|early progressive disease|1
2744874|NCT00045708|9415879|P1|Phase 1|early progressive disease|0
2744875|NCT00045630|9415904|P1|Overall Study|Ineligible|2
2744876|NCT00045630|9415904|P1|Overall Study|Death|1
2744877|NCT00045630|9415904|P1|Overall Study|Progression/relapse|1
2744878|NCT00045630|9415904|P1|Overall Study|Refusal unrelated to adverse event|1
2744879|NCT00045630|9415904|P1|Overall Study|Adverse Event|1
2744880|NCT00045305|9415923|P1|Overall Study|site error|2
2744881|NCT00045305|9415923|P1|Overall Study|Death|3
2744882|NCT00045305|9415923|P1|Overall Study|Adverse Event|3
2744883|NCT00045305|9415923|P1|Overall Study|Lack of Efficacy|6
2744884|NCT00045162|9415934|P2|Overall Study|Other|16
2744885|NCT00045162|9415935|P1|Overall Study|Other|21
2744886|NCT00045162|9415934|P2|Overall Study|Withdrawal by Subject|3
2744887|NCT00045162|9415935|P1|Overall Study|Withdrawal by Subject|5
2744888|NCT00045162|9415934|P2|Overall Study|Death|10
2744889|NCT00045162|9415935|P1|Overall Study|Death|10
2744890|NCT00045162|9415934|P2|Overall Study|Lack of Efficacy|29
2744891|NCT00045162|9415935|P1|Overall Study|Lack of Efficacy|32
2744892|NCT00045162|9415934|P2|Overall Study|Adverse Event|50
2744893|NCT00045162|9415935|P1|Overall Study|Adverse Event|55
2744894|NCT00045162|9415934|P2|Overall Study|Not treated|2
2744895|NCT00045162|9415935|P1|Overall Study|Not treated|7
2744896|NCT00045162|9415934|P2|Overall Study|Ineligible|8
2744897|NCT00045162|9415935|P1|Overall Study|Ineligible|12
2744898|NCT00045110|9415950|P3|100mg Phase 1 Dose Escalalation|ineligible histology|1
2744899|NCT00045110|9415951|P2|100mg Phase 1 Dose Escalalation|ineligible histology|0
2744900|NCT00045110|9415952|P1|100mg Phase 1 Dose Escalalation|ineligible histology|0
2744901|NCT00045110|9415950|P3|100mg Phase 1 Dose Escalalation|prior treatment history|0
2744902|NCT00045110|9415951|P2|100mg Phase 1 Dose Escalalation|prior treatment history|4
2744903|NCT00045110|9415952|P1|100mg Phase 1 Dose Escalalation|prior treatment history|0
2744904|NCT00045110|9415950|P3|100mg Phase 1 Dose Escalalation|did not initiate treatment|1
2744905|NCT00045110|9415951|P2|100mg Phase 1 Dose Escalalation|did not initiate treatment|2
2744906|NCT00045110|9415952|P1|100mg Phase 1 Dose Escalalation|did not initiate treatment|0
2744907|NCT00045032|9416001|P3|Overall Study|Other|105
2744908|NCT00045032|9416002|P2|Overall Study|Other|84
2744909|NCT00045032|9416003|P1|Overall Study|Other|93
2744910|NCT00045032|9416001|P3|Overall Study|Failure to Return|61
2744911|NCT00045032|9416002|P2|Overall Study|Failure to Return|62
2744912|NCT00045032|9416003|P1|Overall Study|Failure to Return|57
2744913|NCT00045032|9416001|P3|Overall Study|Refused/Did Not Cooperate/Withdrew|84
2744914|NCT00045032|9416002|P2|Overall Study|Refused/Did Not Cooperate/Withdrew|93
2744915|NCT00045032|9416003|P1|Overall Study|Refused/Did Not Cooperate/Withdrew|142
2744916|NCT00045032|9416001|P3|Overall Study|Other Protocol Violation|1
2744917|NCT00045032|9416002|P2|Overall Study|Other Protocol Violation|0
2744918|NCT00045032|9416003|P1|Overall Study|Other Protocol Violation|2
2744919|NCT00045032|9416001|P3|Overall Study|Violation of Selection Criteria at Entry|6
2744920|NCT00045032|9416002|P2|Overall Study|Violation of Selection Criteria at Entry|6
2744921|NCT00045032|9416003|P1|Overall Study|Violation of Selection Criteria at Entry|3
2744922|NCT00045032|9416001|P3|Overall Study|Insufficient Therapeutic Response|445
2744923|NCT00045032|9416002|P2|Overall Study|Insufficient Therapeutic Response|437
2744924|NCT00045032|9416003|P1|Overall Study|Insufficient Therapeutic Response|542
2744925|NCT00045032|9416001|P3|Overall Study|Death|17
2744926|NCT00045032|9416002|P2|Overall Study|Death|24
2744927|NCT00045032|9416003|P1|Overall Study|Death|22
2744928|NCT00045032|9416001|P3|Overall Study|Adverse Event/Intercurrent Illness|7
2744929|NCT00045032|9416002|P2|Overall Study|Adverse Event/Intercurrent Illness|2
2744930|NCT00045032|9416003|P1|Overall Study|Adverse Event/Intercurrent Illness|2
2744931|NCT00042991|9416137|P7|Overall Study|Alternative Therapy|0
2744932|NCT00042991|9416138|P6|Overall Study|Alternative Therapy|0
2744933|NCT00042991|9416139|P5|Overall Study|Alternative Therapy|1
2744934|NCT00042991|9416140|P4|Overall Study|Alternative Therapy|0
2744935|NCT00042991|9416141|P3|Overall Study|Alternative Therapy|0
2744936|NCT00042991|9416142|P2|Overall Study|Alternative Therapy|0
2744937|NCT00042991|9416143|P1|Overall Study|Alternative Therapy|0
2744938|NCT00042991|9416137|P7|Overall Study|Disease Progression|2
2744939|NCT00042991|9416138|P6|Overall Study|Disease Progression|4
2744940|NCT00042991|9416139|P5|Overall Study|Disease Progression|1
2744941|NCT00042991|9416140|P4|Overall Study|Disease Progression|2
2744942|NCT00042991|9416141|P3|Overall Study|Disease Progression|2
2744943|NCT00042991|9416142|P2|Overall Study|Disease Progression|29
2744944|NCT00042991|9416143|P1|Overall Study|Disease Progression|5
2744945|NCT00042991|9416137|P7|Overall Study|Withdrawal by Subject|0
2744946|NCT00042991|9416138|P6|Overall Study|Withdrawal by Subject|0
2744947|NCT00042991|9416139|P5|Overall Study|Withdrawal by Subject|1
2744948|NCT00042991|9416140|P4|Overall Study|Withdrawal by Subject|0
2744949|NCT00042991|9416141|P3|Overall Study|Withdrawal by Subject|2
2744950|NCT00042991|9416142|P2|Overall Study|Withdrawal by Subject|7
2744951|NCT00042991|9416143|P1|Overall Study|Withdrawal by Subject|0
2744952|NCT00042991|9416137|P7|Overall Study|Adverse Event|0
2744953|NCT00042991|9416138|P6|Overall Study|Adverse Event|1
2744954|NCT00042991|9416139|P5|Overall Study|Adverse Event|0
2744955|NCT00042991|9416140|P4|Overall Study|Adverse Event|0
2744956|NCT00042991|9416141|P3|Overall Study|Adverse Event|2
2744957|NCT00042991|9416142|P2|Overall Study|Adverse Event|4
2744958|NCT00042991|9416143|P1|Overall Study|Adverse Event|1
2744959|NCT00042939|9416186|P2|Overall Study|Did not start treatment|1
2744960|NCT00042939|9416187|P1|Overall Study|Did not start treatment|2
2744961|NCT00042939|9416186|P2|Overall Study|Treatment break > 4 weeks|1
2744962|NCT00042939|9416187|P1|Overall Study|Treatment break > 4 weeks|0
2744963|NCT00042939|9416186|P2|Overall Study|Still on treatment|0
2744964|NCT00042939|9416187|P1|Overall Study|Still on treatment|1
2744965|NCT00042939|9416186|P2|Overall Study|Patient non-compliance|0
2744966|NCT00042939|9416187|P1|Overall Study|Patient non-compliance|1
2744967|NCT00042939|9416186|P2|Overall Study|Rising ca 19-9|0
2744968|NCT00042939|9416187|P1|Overall Study|Rising ca 19-9|1
2744969|NCT00042939|9416186|P2|Overall Study|QOL diminished|0
2744970|NCT00042939|9416187|P1|Overall Study|QOL diminished|1
2744971|NCT00042939|9416186|P2|Overall Study|Deterioration of health|4
2744972|NCT00042939|9416187|P1|Overall Study|Deterioration of health|3
2744973|NCT00042939|9416186|P2|Overall Study|Ineligible|2
2744974|NCT00042939|9416187|P1|Overall Study|Ineligible|2
2744975|NCT00042939|9416186|P2|Overall Study|Other disease|0
2744976|NCT00042939|9416187|P1|Overall Study|Other disease|1
2744977|NCT00042939|9416186|P2|Overall Study|Withdrawal by Subject|4
2744978|NCT00042939|9416187|P1|Overall Study|Withdrawal by Subject|3
2744979|NCT00042939|9416186|P2|Overall Study|Death|2
2744980|NCT00042939|9416187|P1|Overall Study|Death|3
2744981|NCT00042939|9416186|P2|Overall Study|Adverse Event|7
2744982|NCT00042939|9416187|P1|Overall Study|Adverse Event|6
2744983|NCT00041132|9416201|P1|Overall Study|Physician Decision|2
2744984|NCT00041132|9416201|P1|Overall Study|Withdrawal by Subject|1
2744985|NCT00041132|9416201|P1|Overall Study|Not Eligible|7
2744986|NCT00041132|9416201|P1|Overall Study|Death|1
2744987|NCT00041132|9416201|P1|Overall Study|Adverse Event|19
2744988|NCT00041080|9416236|P2|Overall Study|Ineligible|0
2744989|NCT00041080|9416237|P1|Overall Study|Ineligible|1
2744990|NCT00041080|9416236|P2|Overall Study|Did not start therapy|1
2744991|NCT00041080|9416237|P1|Overall Study|Did not start therapy|1
2744992|NCT00041080|9416236|P2|Overall Study|Concommitant Illness/Other|2
2744993|NCT00041080|9416237|P1|Overall Study|Concommitant Illness/Other|1
2744994|NCT00041080|9416236|P2|Overall Study|Withdrawal by Subject|6
2744995|NCT00041080|9416237|P1|Overall Study|Withdrawal by Subject|6
2744996|NCT00041080|9416236|P2|Overall Study|Adverse Event|1
2744997|NCT00041080|9416237|P1|Overall Study|Adverse Event|21
2744998|NCT00041067|9416243|P1|Overall Study|Ineligible|2
2744999|NCT00041067|9416243|P1|Overall Study|Other reasons|23
2745000|NCT00041067|9416243|P1|Overall Study|Patient refusal|12
2745001|NCT00041067|9416243|P1|Overall Study|Progression|19
2745002|NCT00041067|9416243|P1|Overall Study|Adverse Event|20
2745003|NCT00040742|9416310|P4|Overall Study|Other medical|5
2745004|NCT00040742|9416311|P3|Overall Study|Other medical|5
2745005|NCT00040742|9416312|P2|Overall Study|Other medical|5
2745006|NCT00040742|9416313|P1|Overall Study|Other medical|7
2745007|NCT00040742|9416310|P4|Overall Study|Incomplete Forms|5
2745008|NCT00040742|9416311|P3|Overall Study|Incomplete Forms|4
2745009|NCT00040742|9416312|P2|Overall Study|Incomplete Forms|10
2745010|NCT00040742|9416313|P1|Overall Study|Incomplete Forms|6
2745011|NCT00040742|9416310|P4|Overall Study|Chemotoxicity|2
2745012|NCT00040742|9416311|P3|Overall Study|Chemotoxicity|5
2745013|NCT00040742|9416312|P2|Overall Study|Chemotoxicity|3
2745014|NCT00040742|9416313|P1|Overall Study|Chemotoxicity|4
2745015|NCT00040742|9416310|P4|Overall Study|Withdrawal by Subject|13
2745016|NCT00040742|9416311|P3|Overall Study|Withdrawal by Subject|10
2745017|NCT00040742|9416312|P2|Overall Study|Withdrawal by Subject|15
2745018|NCT00040742|9416313|P1|Overall Study|Withdrawal by Subject|7
2745019|NCT00040742|9416310|P4|Overall Study|Adverse Event|9
2745020|NCT00040742|9416311|P3|Overall Study|Adverse Event|21
2745021|NCT00040742|9416312|P2|Overall Study|Adverse Event|16
2745022|NCT00040742|9416313|P1|Overall Study|Adverse Event|15
2745023|NCT00040742|9416310|P4|Overall Study|Death|0
2745024|NCT00040742|9416311|P3|Overall Study|Death|1
2745025|NCT00040742|9416312|P2|Overall Study|Death|0
2745026|NCT00040742|9416313|P1|Overall Study|Death|0
2745027|NCT00039377|9416327|P4|Initial Registration|Withdrawal by Subject|0
2745028|NCT00039377|9416328|P3|Initial Registration|Withdrawal by Subject|0
2745029|NCT00039377|9416329|P2|Initial Registration|Withdrawal by Subject|0
2745030|NCT00039377|9416330|P1|Initial Registration|Withdrawal by Subject|3
2745031|NCT00039377|9416327|P4|Initial Registration|Received non-protocol therapy|0
2745032|NCT00039377|9416328|P3|Initial Registration|Received non-protocol therapy|0
2745033|NCT00039377|9416329|P2|Initial Registration|Received non-protocol therapy|0
2745034|NCT00039377|9416330|P1|Initial Registration|Received non-protocol therapy|11
2745035|NCT00039377|9416327|P4|Initial Registration|Relapsed|0
2745036|NCT00039377|9416328|P3|Initial Registration|Relapsed|0
2745037|NCT00039377|9416329|P2|Initial Registration|Relapsed|0
2745038|NCT00039377|9416330|P1|Initial Registration|Relapsed|6
2745039|NCT00039377|9416327|P4|Initial Registration|Adverse Event|0
2745040|NCT00039377|9416328|P3|Initial Registration|Adverse Event|0
2745041|NCT00039377|9416329|P2|Initial Registration|Adverse Event|0
2745042|NCT00039377|9416330|P1|Initial Registration|Adverse Event|2
2745043|NCT00039130|9416346|P1|Overall Study|Physician Decision|3
2745044|NCT00039130|9416346|P1|Overall Study|Subsequent treatment|2
2745045|NCT00039130|9416346|P1|Overall Study|Progression|2
2745046|NCT00039130|9416346|P1|Overall Study|Withdrawal by Subject|3
2745047|NCT00039130|9416346|P1|Overall Study|Death|9
2745048|NCT00039130|9416346|P1|Overall Study|Adverse Event|11
2745049|NCT00033657|9416362|P2|Adjuvant Chemotherapy|Other|2
2745050|NCT00033657|9416363|P1|Adjuvant Chemotherapy|Other|0
2745051|NCT00033657|9416362|P2|Adjuvant Chemotherapy|alternative therapy|0
2745052|NCT00033657|9416363|P1|Adjuvant Chemotherapy|alternative therapy|1
2745053|NCT00033657|9416362|P2|Adjuvant Chemotherapy|Withdrawal by Subject|3
2745054|NCT00033657|9416363|P1|Adjuvant Chemotherapy|Withdrawal by Subject|5
2745055|NCT00033657|9416362|P2|Adjuvant Chemotherapy|Death|1
2745056|NCT00033657|9416363|P1|Adjuvant Chemotherapy|Death|2
2745057|NCT00033657|9416362|P2|Adjuvant Chemotherapy|Adverse Event|10
2745058|NCT00033657|9416363|P1|Adjuvant Chemotherapy|Adverse Event|7
2745059|NCT00033657|9416362|P2|Adjuvant Chemotherapy|Lack of Efficacy|1
2745060|NCT00033657|9416363|P1|Adjuvant Chemotherapy|Lack of Efficacy|3
2745061|NCT00033657|9416362|P2|Surgical Resection|not complete resection|3
2745062|NCT00033657|9416363|P1|Surgical Resection|not complete resection|0
2745063|NCT00033657|9416362|P2|Neoadjuvant Chemotherapy|Not started protocol therapy|1
2745064|NCT00033657|9416363|P1|Neoadjuvant Chemotherapy|Not started protocol therapy|3
2745065|NCT00033657|9416362|P2|Neoadjuvant Chemotherapy|Ineligible|4
2745066|NCT00033657|9416363|P1|Neoadjuvant Chemotherapy|Ineligible|8
2745067|NCT00033657|9416362|P2|Neoadjuvant Chemotherapy|other complicating disease|1
2745068|NCT00033657|9416363|P1|Neoadjuvant Chemotherapy|other complicating disease|0
2745069|NCT00033657|9416362|P2|Neoadjuvant Chemotherapy|Withdrawal by Subject|0
2745070|NCT00033657|9416363|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
2745071|NCT00033657|9416362|P2|Neoadjuvant Chemotherapy|Death|1
2745072|NCT00033657|9416363|P1|Neoadjuvant Chemotherapy|Death|1
2745073|NCT00033657|9416362|P2|Neoadjuvant Chemotherapy|Adverse Event|2
2745074|NCT00033657|9416363|P1|Neoadjuvant Chemotherapy|Adverse Event|0
2745075|NCT00033657|9416362|P2|Neoadjuvant Chemotherapy|Lack of Efficacy|2
2745076|NCT00033657|9416363|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|1
2745077|NCT00033631|9416377|P2|Overall Study|Withdrawal by Subject|4
2745078|NCT00033631|9416378|P1|Overall Study|Withdrawal by Subject|4
2745079|NCT00033631|9416377|P2|Overall Study|Protocol Violation|11
2745080|NCT00033631|9416378|P1|Overall Study|Protocol Violation|14
2745081|NCT00033540|9416396|P1|Overall Study|Never received treatment|2
2745082|NCT00033540|9416396|P1|Overall Study|Ineligible|3
2745083|NCT00033540|9416396|P1|Overall Study|Other|5
2745084|NCT00033540|9416396|P1|Overall Study|Withdrawal by Subject|6
2745085|NCT00033540|9416396|P1|Overall Study|Progression|26
2745086|NCT00033540|9416396|P1|Overall Study|Death|1
2745087|NCT00033540|9416396|P1|Overall Study|Adverse Event|14
2745088|NCT00033514|9416406|P2|Overall Study|Withdrawal by Subject|3
2745089|NCT00033514|9416407|P1|Overall Study|Withdrawal by Subject|0
2745090|NCT00033514|9416406|P2|Overall Study|Lost to Follow-up|1
2745091|NCT00033514|9416407|P1|Overall Study|Lost to Follow-up|1
2745092|NCT00033371|9416417|P2|Overall Study|Disease Progression|1
2745093|NCT00033371|9416418|P1|Overall Study|Disease Progression|0
2745094|NCT00033371|9416417|P2|Overall Study|Withdrawal by Subject|3
2745095|NCT00033371|9416418|P1|Overall Study|Withdrawal by Subject|3
2745096|NCT00033371|9416417|P2|Overall Study|Lost to Follow-up|1
2745097|NCT00033371|9416418|P1|Overall Study|Lost to Follow-up|2
2745098|NCT00033371|9416417|P2|Overall Study|Adverse Event|5
2745099|NCT00033371|9416418|P1|Overall Study|Adverse Event|1
2745100|NCT00033293|9416426|P2|Overall Study|Treatment refused|6
2745101|NCT00033293|9416427|P1|Overall Study|Treatment refused|0
2745102|NCT00033293|9416426|P2|Overall Study|Could not be weaned from steroid therapy|1
2745103|NCT00033293|9416427|P1|Overall Study|Could not be weaned from steroid therapy|1
2745104|NCT00033293|9416426|P2|Overall Study|Withdrawal by Subject|0
2745105|NCT00033293|9416427|P1|Overall Study|Withdrawal by Subject|1
2745106|NCT00033293|9416426|P2|Overall Study|Physician Decision|1
2745107|NCT00033293|9416427|P1|Overall Study|Physician Decision|3
2745108|NCT00033293|9416426|P2|Overall Study|Lost to Follow-up|1
2745109|NCT00033293|9416427|P1|Overall Study|Lost to Follow-up|0
2745110|NCT00033293|9416426|P2|Overall Study|Lack of Efficacy|8
2745111|NCT00033293|9416427|P1|Overall Study|Lack of Efficacy|5
2745112|NCT00033293|9416426|P2|Overall Study|Death|1
2745113|NCT00033293|9416427|P1|Overall Study|Death|0
2745114|NCT00031694|9416445|P1|Overall Study|Withdrawal by Subject|5
2745115|NCT00031694|9416445|P1|Overall Study|Death|2
2745116|NCT00031694|9416445|P1|Overall Study|Adverse Event|12
2745117|NCT00031590|9416449|P1|Overall Study|Withdrawal by parents|2
2745118|NCT00031590|9416449|P1|Overall Study|Adverse Event|1
2745119|NCT00030901|9416456|P3|Randomization|Ineligible|14
2745120|NCT00030901|9416457|P2|Randomization|Ineligible|15
2745121|NCT00030901|9416458|P1|Randomization|Ineligible|0
2745122|NCT00030901|9416456|P3|Randomization|Other|33
2745123|NCT00030901|9416457|P2|Randomization|Other|36
2745124|NCT00030901|9416458|P1|Randomization|Other|0
2745125|NCT00030901|9416456|P3|Randomization|Death|3
2745126|NCT00030901|9416457|P2|Randomization|Death|1
2745127|NCT00030901|9416458|P1|Randomization|Death|0
2745128|NCT00030901|9416456|P3|Randomization|Progression/Relapse|21
2745129|NCT00030901|9416457|P2|Randomization|Progression/Relapse|22
2745130|NCT00030901|9416458|P1|Randomization|Progression/Relapse|0
2745131|NCT00030901|9416456|P3|Randomization|Refusal Unrelated to Adverse Event|10
2745132|NCT00030901|9416457|P2|Randomization|Refusal Unrelated to Adverse Event|16
2745133|NCT00030901|9416458|P1|Randomization|Refusal Unrelated to Adverse Event|0
2745134|NCT00030901|9416456|P3|Randomization|Adverse Event|7
2745135|NCT00030901|9416457|P2|Randomization|Adverse Event|11
2745136|NCT00030901|9416458|P1|Randomization|Adverse Event|0
2745137|NCT00030901|9416456|P3|Initial Registration|Ineligible|0
2745138|NCT00030901|9416457|P2|Initial Registration|Ineligible|0
2745139|NCT00030901|9416458|P1|Initial Registration|Ineligible|167
2745140|NCT00030823|9416466|P1|Overall Study|Withdrawal by Subject|1
2745141|NCT00028769|9416474|P1|Overall Study|Not Analyzable|1
2745142|NCT00028769|9416474|P1|Overall Study|Ineligible|5
2745143|NCT00028769|9416474|P1|Overall Study|Other - Not Protocol Specified|1
2745144|NCT00028769|9416474|P1|Overall Study|Progression or Death|31
2745145|NCT00028769|9416474|P1|Overall Study|Refusal Unrelated to Adverse Events|1
2745146|NCT00028769|9416474|P1|Overall Study|Adverse Event|2
2745147|NCT00028002|9416480|P1|Overall Study|Ineligible|8
2745148|NCT00028002|9416480|P1|Overall Study|Withdrawal by Subject|3
2745149|NCT00027846|9416490|P3|Overall Study|Neuraxis dissemination during/after ther|5
2745150|NCT00027846|9416491|P2|Overall Study|Neuraxis dissemination during/after ther|2
2745151|NCT00027846|9416492|P1|Overall Study|Neuraxis dissemination during/after ther|0
2745152|NCT00027846|9416490|P3|Overall Study|Entry into another COG therapeutic study|2
2745153|NCT00027846|9416491|P2|Overall Study|Entry into another COG therapeutic study|5
2745154|NCT00027846|9416492|P1|Overall Study|Entry into another COG therapeutic study|0
2745155|NCT00027846|9416490|P3|Overall Study|Ineligible for study|14
2745156|NCT00027846|9416491|P2|Overall Study|Ineligible for study|6
2745157|NCT00027846|9416492|P1|Overall Study|Ineligible for study|2
2745158|NCT00027846|9416490|P3|Overall Study|Withdrawal by Subject|7
2745159|NCT00027846|9416491|P2|Overall Study|Withdrawal by Subject|14
2745160|NCT00027846|9416492|P1|Overall Study|Withdrawal by Subject|0
2745161|NCT00027846|9416490|P3|Overall Study|Lost to Follow-up|9
2745162|NCT00027846|9416491|P2|Overall Study|Lost to Follow-up|41
2745163|NCT00027846|9416492|P1|Overall Study|Lost to Follow-up|0
2745164|NCT00027560|9416510|P1|Overall Study|Withdrawal by Subject|1
2745165|NCT00026494|9416523|P4|Overall Study|Clinical progression|0
2745166|NCT00026494|9416524|P3|Overall Study|Clinical progression|3
2745167|NCT00026494|9416525|P2|Overall Study|Clinical progression|0
2745168|NCT00026494|9416526|P1|Overall Study|Clinical progression|0
2745169|NCT00026494|9416523|P4|Overall Study|Patient not treated|0
2745170|NCT00026494|9416524|P3|Overall Study|Patient not treated|2
2745171|NCT00026494|9416525|P2|Overall Study|Patient not treated|0
2745172|NCT00026494|9416526|P1|Overall Study|Patient not treated|0
2745173|NCT00026494|9416523|P4|Overall Study|Patient non-compliance|0
2745174|NCT00026494|9416524|P3|Overall Study|Patient non-compliance|0
2745175|NCT00026494|9416525|P2|Overall Study|Patient non-compliance|0
2745176|NCT00026494|9416526|P1|Overall Study|Patient non-compliance|1
2745177|NCT00026494|9416523|P4|Overall Study|Withdrawal by Subject|0
2745178|NCT00026494|9416524|P3|Overall Study|Withdrawal by Subject|1
2745179|NCT00026494|9416525|P2|Overall Study|Withdrawal by Subject|0
2745180|NCT00026494|9416526|P1|Overall Study|Withdrawal by Subject|1
2745181|NCT00026312|9416538|P2|Overall Study|Refusal by patient/parent/guardian|59
2745182|NCT00026312|9416539|P1|Overall Study|Refusal by patient/parent/guardian|8
2745183|NCT00026312|9416538|P2|Overall Study|Entry onto another COG study|1
2745184|NCT00026312|9416539|P1|Overall Study|Entry onto another COG study|0
2745185|NCT00026312|9416538|P2|Overall Study|Ineligible|5
2745186|NCT00026312|9416539|P1|Overall Study|Ineligible|4
2745187|NCT00026312|9416538|P2|Overall Study|Withdrawal by Subject|6
2745188|NCT00026312|9416539|P1|Overall Study|Withdrawal by Subject|1
2745189|NCT00026312|9416538|P2|Overall Study|Protocol Violation|3
2745190|NCT00026312|9416539|P1|Overall Study|Protocol Violation|0
2745191|NCT00026312|9416538|P2|Overall Study|Physician Decision|37
2745192|NCT00026312|9416539|P1|Overall Study|Physician Decision|1
2745193|NCT00026312|9416538|P2|Overall Study|Lost to Follow-up|5
2745194|NCT00026312|9416539|P1|Overall Study|Lost to Follow-up|0
2745195|NCT00026312|9416538|P2|Overall Study|Lack of Efficacy|114
2745196|NCT00026312|9416539|P1|Overall Study|Lack of Efficacy|19
2745197|NCT00026312|9416538|P2|Overall Study|Death|7
2745198|NCT00026312|9416539|P1|Overall Study|Death|1
2745199|NCT00026312|9416538|P2|Overall Study|Adverse Event|32
2745200|NCT00026312|9416539|P1|Overall Study|Adverse Event|0
2745201|NCT00026208|9416578|P2|Overall Study|Complications of auto accident|0
2745202|NCT00026208|9416579|P1|Overall Study|Complications of auto accident|1
2745203|NCT00025662|9416597|P1|Overall Study|Technical failure of manipulation|1
2745204|NCT00025662|9416597|P1|Overall Study|Withdrawal by Subject|2
2745205|NCT00025506|9416605|P1|Overall Study|Never Treated|2
2745206|NCT00025506|9416605|P1|Overall Study|Ineligible: inadequate pathology|2
2745207|NCT00025506|9416605|P1|Overall Study|Ineligible: wrong cell type|5
2745208|NCT00025506|9416605|P1|Overall Study|Ineligible: clerical error|1
2745209|NCT00025259|9416626|P7|Overall Study|Adverse Event|0
2745210|NCT00025259|9416627|P6|Overall Study|Adverse Event|0
2745211|NCT00025259|9416628|P5|Overall Study|Adverse Event|0
2745212|NCT00025259|9416629|P4|Overall Study|Adverse Event|0
2745213|NCT00025259|9416630|P3|Overall Study|Adverse Event|0
2745214|NCT00025259|9416631|P2|Overall Study|Adverse Event|0
2745215|NCT00025259|9416632|P1|Overall Study|Adverse Event|1
2745216|NCT00025259|9416626|P7|Overall Study|Randomization error|2
2745217|NCT00025259|9416627|P6|Overall Study|Randomization error|7
2745218|NCT00025259|9416628|P5|Overall Study|Randomization error|1
2745219|NCT00025259|9416629|P4|Overall Study|Randomization error|0
2745220|NCT00025259|9416630|P3|Overall Study|Randomization error|0
2745221|NCT00025259|9416631|P2|Overall Study|Randomization error|0
2745222|NCT00025259|9416632|P1|Overall Study|Randomization error|1
2745223|NCT00025259|9416626|P7|Overall Study|Ineligible|1
2745224|NCT00025259|9416627|P6|Overall Study|Ineligible|0
2745225|NCT00025259|9416628|P5|Overall Study|Ineligible|6
2745226|NCT00025259|9416629|P4|Overall Study|Ineligible|0
2745227|NCT00025259|9416630|P3|Overall Study|Ineligible|0
2745228|NCT00025259|9416631|P2|Overall Study|Ineligible|1
2745229|NCT00025259|9416632|P1|Overall Study|Ineligible|14
2745230|NCT00025259|9416626|P7|Overall Study|Withdrawal by Subject|3
2745231|NCT00025259|9416627|P6|Overall Study|Withdrawal by Subject|8
2745232|NCT00025259|9416628|P5|Overall Study|Withdrawal by Subject|11
2745233|NCT00025259|9416629|P4|Overall Study|Withdrawal by Subject|14
2745234|NCT00025259|9416630|P3|Overall Study|Withdrawal by Subject|6
2745235|NCT00025259|9416631|P2|Overall Study|Withdrawal by Subject|27
2745236|NCT00025259|9416632|P1|Overall Study|Withdrawal by Subject|9
2745237|NCT00025259|9416626|P7|Overall Study|Protocol Violation|3
2745238|NCT00025259|9416627|P6|Overall Study|Protocol Violation|1
2745239|NCT00025259|9416628|P5|Overall Study|Protocol Violation|2
2745240|NCT00025259|9416629|P4|Overall Study|Protocol Violation|1
2745241|NCT00025259|9416630|P3|Overall Study|Protocol Violation|2
2745242|NCT00025259|9416631|P2|Overall Study|Protocol Violation|2
2745243|NCT00025259|9416632|P1|Overall Study|Protocol Violation|3
2745244|NCT00025259|9416626|P7|Overall Study|Physician Decision|1
2745245|NCT00025259|9416627|P6|Overall Study|Physician Decision|2
2745246|NCT00025259|9416628|P5|Overall Study|Physician Decision|4
2745247|NCT00025259|9416629|P4|Overall Study|Physician Decision|5
2745248|NCT00025259|9416630|P3|Overall Study|Physician Decision|0
2745249|NCT00025259|9416631|P2|Overall Study|Physician Decision|1
2745250|NCT00025259|9416632|P1|Overall Study|Physician Decision|12
2745251|NCT00025259|9416626|P7|Overall Study|Lost to Follow-up|1
2745252|NCT00025259|9416627|P6|Overall Study|Lost to Follow-up|3
2745253|NCT00025259|9416628|P5|Overall Study|Lost to Follow-up|1
2745254|NCT00025259|9416629|P4|Overall Study|Lost to Follow-up|13
2745255|NCT00025259|9416630|P3|Overall Study|Lost to Follow-up|13
2745256|NCT00025259|9416631|P2|Overall Study|Lost to Follow-up|9
2745257|NCT00025259|9416632|P1|Overall Study|Lost to Follow-up|2
2745258|NCT00025259|9416626|P7|Overall Study|Lack of Efficacy|38
2745259|NCT00025259|9416627|P6|Overall Study|Lack of Efficacy|30
2745260|NCT00025259|9416628|P5|Overall Study|Lack of Efficacy|11
2745261|NCT00025259|9416629|P4|Overall Study|Lack of Efficacy|78
2745262|NCT00025259|9416630|P3|Overall Study|Lack of Efficacy|60
2745263|NCT00025259|9416631|P2|Overall Study|Lack of Efficacy|46
2745264|NCT00025259|9416632|P1|Overall Study|Lack of Efficacy|2
2745265|NCT00025259|9416626|P7|Overall Study|Death|2
2745266|NCT00025259|9416627|P6|Overall Study|Death|1
2745267|NCT00025259|9416628|P5|Overall Study|Death|0
2745268|NCT00025259|9416629|P4|Overall Study|Death|3
2745269|NCT00025259|9416630|P3|Overall Study|Death|0
2745270|NCT00025259|9416631|P2|Overall Study|Death|3
2745271|NCT00025259|9416632|P1|Overall Study|Death|1
2745272|NCT00025233|9416668|P1|Overall Study|Never treated|1
2745273|NCT00025233|9416668|P1|Overall Study|Ineligible: improper prior treatment|1
2745274|NCT00025233|9416668|P1|Overall Study|Ineligible: wrong primary|1
2745275|NCT00025233|9416668|P1|Overall Study|Ineligible: wrong cell type|1
2745276|NCT00025155|9416683|P1|Overall Study|Ineligible: Second primary cancer site|1
2745277|NCT00025155|9416683|P1|Overall Study|Ineligible: Wrong primary cancer site|1
2745278|NCT00024258|9416694|P1|Overall Study|Disease Progression|8
2745279|NCT00024258|9416694|P1|Overall Study|Withdrawal by Subject|1
2745280|NCT00024167|9416701|P2|Overall Study|Death|47
2745281|NCT00024167|9416702|P1|Overall Study|Death|53
2745282|NCT00023764|9416726|P1|Overall Study|delay in obtaining staging images|1
2745283|NCT00023764|9416726|P1|Overall Study|patient received other treatment|1
2745284|NCT00023764|9416726|P1|Overall Study|Progression of disease|6
2745285|NCT00023764|9416726|P1|Overall Study|Withdrawal by Subject|1
2745286|NCT00023764|9416726|P1|Overall Study|Adverse Event|4
2745287|NCT00023764|9416726|P1|Overall Study|Other|1
2745288|NCT00023712|9416733|P2|Overall Study|Never treated|1
2745289|NCT00023712|9416734|P1|Overall Study|Never treated|1
2745290|NCT00023712|9416733|P2|Overall Study|Not platinum sensitive|0
2745291|NCT00023712|9416734|P1|Overall Study|Not platinum sensitive|1
2745292|NCT00022698|9416758|P2|Overall Study|Administrative /other|7
2745293|NCT00022698|9416759|P1|Overall Study|Administrative /other|1
2745294|NCT00022698|9416758|P2|Overall Study|Insufficient therapeutic response|14
2745295|NCT00022698|9416759|P1|Overall Study|Insufficient therapeutic response|2
2745296|NCT00022698|9416758|P2|Overall Study|Refused treatment|2
2745297|NCT00022698|9416759|P1|Overall Study|Refused treatment|0
2745298|NCT00022698|9416758|P2|Overall Study|Failure to return|1
2745299|NCT00022698|9416759|P1|Overall Study|Failure to return|0
2745300|NCT00022698|9416758|P2|Overall Study|Death|2
2745301|NCT00022698|9416759|P1|Overall Study|Death|0
2745302|NCT00022698|9416758|P2|Overall Study|Adverse Event|9
2745303|NCT00022698|9416759|P1|Overall Study|Adverse Event|5
2745304|NCT00022672|9416784|P2|Extension Phase|Other|1
2745305|NCT00022672|9416785|P1|Extension Phase|Other|1
2745306|NCT00022672|9416784|P2|Extension Phase|Refused Treatment|2
2745307|NCT00022672|9416785|P1|Extension Phase|Refused Treatment|0
2745308|NCT00022672|9416784|P2|Extension Phase|Insufficient Therapeutic Response|44
2745309|NCT00022672|9416785|P1|Extension Phase|Insufficient Therapeutic Response|1
2745310|NCT00022672|9416784|P2|Extension Phase|Death|1
2745311|NCT00022672|9416785|P1|Extension Phase|Death|0
2745312|NCT00022672|9416784|P2|Extension Phase|Adverse Event|3
2745313|NCT00022672|9416785|P1|Extension Phase|Adverse Event|1
2745314|NCT00022672|9416784|P2|Main Phase: 24 Months|Other|0
2745315|NCT00022672|9416785|P1|Main Phase: 24 Months|Other|1
2745316|NCT00022672|9416784|P2|Main Phase: 24 Months|Failure to Return|1
2745317|NCT00022672|9416785|P1|Main Phase: 24 Months|Failure to Return|1
2745318|NCT00022672|9416784|P2|Main Phase: 24 Months|Refused Treatment|4
2745319|NCT00022672|9416785|P1|Main Phase: 24 Months|Refused Treatment|3
2745320|NCT00022672|9416784|P2|Main Phase: 24 Months|Other Protocol Violation|0
2745321|NCT00022672|9416785|P1|Main Phase: 24 Months|Other Protocol Violation|1
2745322|NCT00022672|9416784|P2|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1
2745323|NCT00022672|9416785|P1|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0
2745324|NCT00022672|9416784|P2|Main Phase: 24 Months|Insufficient Therapeutic Response|91
2745325|NCT00022672|9416785|P1|Main Phase: 24 Months|Insufficient Therapeutic Response|75
2745326|NCT00022672|9416784|P2|Main Phase: 24 Months|Death|3
2745327|NCT00022672|9416785|P1|Main Phase: 24 Months|Death|0
2745328|NCT00022672|9416784|P2|Main Phase: 24 Months|Adverse Event|0
2745329|NCT00022672|9416785|P1|Main Phase: 24 Months|Adverse Event|6
2745330|NCT00022659|9416818|P1|Overall Study|Never treated|1
2745331|NCT00022659|9416818|P1|Overall Study|Ineligible: wrong primary|1
2745332|NCT00022633|9416831|P2|Overall Study|Ineligible|0
2745333|NCT00022633|9416832|P1|Overall Study|Ineligible|4
2745334|NCT00022633|9416831|P2|Overall Study|Other - not protocol specified|2
2745335|NCT00022633|9416832|P1|Overall Study|Other - not protocol specified|3
2745336|NCT00022633|9416831|P2|Overall Study|Death|0
2745337|NCT00022633|9416832|P1|Overall Study|Death|4
2745338|NCT00022633|9416831|P2|Overall Study|Progression/relapse|2
2745339|NCT00022633|9416832|P1|Overall Study|Progression/relapse|9
2745340|NCT00022633|9416831|P2|Overall Study|Refusal unrelated to adverse event|0
2745341|NCT00022633|9416832|P1|Overall Study|Refusal unrelated to adverse event|1
2745342|NCT00022633|9416831|P2|Overall Study|Adverse Event|1
2745343|NCT00022633|9416832|P1|Overall Study|Adverse Event|11
2745344|NCT00022516|9416845|P2|Overall Study|Incomplete documentation|27
2745345|NCT00022516|9416846|P1|Overall Study|Incomplete documentation|0
2745346|NCT00022516|9416845|P2|Overall Study|Withdrawal by Subject|113
2745347|NCT00022516|9416846|P1|Overall Study|Withdrawal by Subject|2
2745348|NCT00022516|9416845|P2|Overall Study|Protocol Violation|3
2745349|NCT00022516|9416846|P1|Overall Study|Protocol Violation|1
2745350|NCT00022516|9416845|P2|Overall Study|Physician Decision|1
2745351|NCT00022516|9416846|P1|Overall Study|Physician Decision|0
2745352|NCT00022516|9416845|P2|Overall Study|Lack of Efficacy|27
2745353|NCT00022516|9416846|P1|Overall Study|Lack of Efficacy|0
2745354|NCT00022516|9416845|P2|Overall Study|Adverse Event|59
2745355|NCT00022516|9416846|P1|Overall Study|Adverse Event|0
2745356|NCT00021255|9416865|P3|Overall Study|Randomized but not treated|18
2745357|NCT00021255|9416866|P2|Overall Study|Randomized but not treated|2
2745358|NCT00021255|9416867|P1|Overall Study|Randomized but not treated|28
2745359|NCT00021255|9416865|P3|Overall Study|Missing|13
2745360|NCT00021255|9416866|P2|Overall Study|Missing|27
2745361|NCT00021255|9416867|P1|Overall Study|Missing|0
2745362|NCT00021255|9416865|P3|Overall Study|Other than specified above|19
2745363|NCT00021255|9416866|P2|Overall Study|Other than specified above|38
2745364|NCT00021255|9416867|P1|Overall Study|Other than specified above|0
2745365|NCT00021255|9416865|P3|Overall Study|Protocol Violation|0
2745366|NCT00021255|9416866|P2|Overall Study|Protocol Violation|2
2745367|NCT00021255|9416867|P1|Overall Study|Protocol Violation|0
2745368|NCT00021255|9416865|P3|Overall Study|Adverse Event|18
2745369|NCT00021255|9416866|P2|Overall Study|Adverse Event|30
2745370|NCT00021255|9416867|P1|Overall Study|Adverse Event|46
2745371|NCT00021255|9416865|P3|Overall Study|Herceptin toxicity|6
2745372|NCT00021255|9416866|P2|Overall Study|Herceptin toxicity|22
2745373|NCT00021255|9416867|P1|Overall Study|Herceptin toxicity|0
2745374|NCT00021255|9416865|P3|Overall Study|Cardiac toxicity|32
2745375|NCT00021255|9416866|P2|Overall Study|Cardiac toxicity|61
2745376|NCT00021255|9416867|P1|Overall Study|Cardiac toxicity|0
2745377|NCT00021255|9416865|P3|Overall Study|Lost to Follow-up|3
2745378|NCT00021255|9416866|P2|Overall Study|Lost to Follow-up|2
2745379|NCT00021255|9416867|P1|Overall Study|Lost to Follow-up|0
2745380|NCT00021255|9416865|P3|Overall Study|Withdrawal by Subject|26
2745381|NCT00021255|9416866|P2|Overall Study|Withdrawal by Subject|64
2745382|NCT00021255|9416867|P1|Overall Study|Withdrawal by Subject|41
2745383|NCT00021255|9416865|P3|Overall Study|Second primary malignancy|1
2745384|NCT00021255|9416866|P2|Overall Study|Second primary malignancy|4
2745385|NCT00021255|9416867|P1|Overall Study|Second primary malignancy|0
2745386|NCT00021255|9416865|P3|Overall Study|Breast cancer relapse|11
2745387|NCT00021255|9416866|P2|Overall Study|Breast cancer relapse|18
2745388|NCT00021255|9416867|P1|Overall Study|Breast cancer relapse|5
2745389|NCT00021255|9416865|P3|Overall Study|Death|2
2745390|NCT00021255|9416866|P2|Overall Study|Death|0
2745391|NCT00021255|9416867|P1|Overall Study|Death|1
2745392|NCT00021229|9416884|P3|Overall Study|Punctate hemmorrhage post RT|0
2745393|NCT00021229|9416885|P2|Overall Study|Punctate hemmorrhage post RT|0
2745394|NCT00021229|9416886|P1|Overall Study|Punctate hemmorrhage post RT|2
2745395|NCT00021229|9416884|P3|Overall Study|Physician Decision|1
2745396|NCT00021229|9416885|P2|Overall Study|Physician Decision|0
2745397|NCT00021229|9416886|P1|Overall Study|Physician Decision|0
2745398|NCT00021229|9416884|P3|Overall Study|Protocol Violation|0
2745399|NCT00021229|9416885|P2|Overall Study|Protocol Violation|1
2745400|NCT00021229|9416886|P1|Overall Study|Protocol Violation|1
2745401|NCT00021229|9416884|P3|Overall Study|Progressive Disease|12
2745402|NCT00021229|9416885|P2|Overall Study|Progressive Disease|19
2745403|NCT00021229|9416886|P1|Overall Study|Progressive Disease|15
2745404|NCT00021229|9416884|P3|Overall Study|Withdrawal by Subject|1
2745405|NCT00021229|9416885|P2|Overall Study|Withdrawal by Subject|7
2745406|NCT00021229|9416886|P1|Overall Study|Withdrawal by Subject|7
2745407|NCT00021229|9416884|P3|Overall Study|Death|0
2745408|NCT00021229|9416885|P2|Overall Study|Death|1
2745409|NCT00021229|9416886|P1|Overall Study|Death|0
2745410|NCT00021229|9416884|P3|Overall Study|Adverse Event|2
2745411|NCT00021229|9416885|P2|Overall Study|Adverse Event|5
2745412|NCT00021229|9416886|P1|Overall Study|Adverse Event|10
2745413|NCT00019604|9416941|P1|Overall Study|Details for other not available|4
2745414|NCT00019604|9416941|P1|Overall Study|Unable to evaluate|1
2745415|NCT00019604|9416941|P1|Overall Study|Too much disease|1
2745416|NCT00019604|9416941|P1|Overall Study|Pt going to immunotherapy study|1
2745417|NCT00019604|9416941|P1|Overall Study|Started new chemo regimen|1
2745418|NCT00019604|9416941|P1|Overall Study|Resectable disease|1
2745419|NCT00019604|9416941|P1|Overall Study|Non compliant|1
2745420|NCT00019604|9416941|P1|Overall Study|Non compliant on systemic CH|1
2745421|NCT00019604|9416941|P1|Overall Study|Move to a different study|1
2745422|NCT00019604|9416941|P1|Overall Study|Going to have liver transplant|1
2745423|NCT00019604|9416941|P1|Overall Study|Carcinoid tumor, not treatable|1
2745424|NCT00019604|9416941|P1|Overall Study|Refused treatment|1
2745425|NCT00019604|9416941|P1|Overall Study|Progressive disease|23
2745426|NCT00019604|9416941|P1|Overall Study|Death|1
2745427|NCT00016354|9416964|P8|Overall Study|Lack of Efficacy|1
2745428|NCT00016354|9416965|P7|Overall Study|Lack of Efficacy|0
2745429|NCT00016354|9416966|P6|Overall Study|Lack of Efficacy|0
2745430|NCT00016354|9416967|P5|Overall Study|Lack of Efficacy|0
2745431|NCT00016354|9416968|P4|Overall Study|Lack of Efficacy|0
2745432|NCT00016354|9416969|P3|Overall Study|Lack of Efficacy|0
2745433|NCT00016354|9416970|P2|Overall Study|Lack of Efficacy|0
2745434|NCT00016354|9416971|P1|Overall Study|Lack of Efficacy|0
2745435|NCT00014495|9416985|P4|Overall Study|Clinical deterioration|1
2745436|NCT00014495|9416986|P3|Overall Study|Clinical deterioration|0
2745437|NCT00014495|9416987|P2|Overall Study|Clinical deterioration|0
2745438|NCT00014495|9416988|P1|Overall Study|Clinical deterioration|0
2745439|NCT00014495|9416985|P4|Overall Study|Death|0
2745440|NCT00014495|9416986|P3|Overall Study|Death|1
2745441|NCT00014495|9416987|P2|Overall Study|Death|0
2745442|NCT00014495|9416988|P1|Overall Study|Death|0
2745443|NCT00012012|9417054|P2|Overall Study|Withdrawal by Subject|2
2745444|NCT00012012|9417055|P1|Overall Study|Withdrawal by Subject|0
2745445|NCT00012012|9417054|P2|Overall Study|Protocol Violation|1
2745446|NCT00012012|9417055|P1|Overall Study|Protocol Violation|1
2745447|NCT00010257|9417094|P2|Overall Study|Withdrawal by Subject|0
2745448|NCT00010257|9417095|P1|Overall Study|Withdrawal by Subject|1
2745449|NCT00009945|9417105|P2|Overall Study|no follow up data|5
2745450|NCT00009945|9417106|P1|Overall Study|no follow up data|7
2745451|NCT00008385|9417122|P2|Overall Study|Not start protocol therapy|175
2745452|NCT00008385|9417123|P1|Overall Study|Not start protocol therapy|44
2745453|NCT00008385|9417122|P2|Overall Study|Other|212
2745454|NCT00008385|9417123|P1|Overall Study|Other|105
2745455|NCT00008385|9417122|P2|Overall Study|Maximum dose reached|2
2745456|NCT00008385|9417123|P1|Overall Study|Maximum dose reached|0
2745457|NCT00008385|9417122|P2|Overall Study|Other complicating disease|30
2745458|NCT00008385|9417123|P1|Overall Study|Other complicating disease|17
2745459|NCT00008385|9417122|P2|Overall Study|Start non-protocol therapy|1
2745460|NCT00008385|9417123|P1|Overall Study|Start non-protocol therapy|3
2745461|NCT00008385|9417122|P2|Overall Study|Withdrawal by Subject|157
2745462|NCT00008385|9417123|P1|Overall Study|Withdrawal by Subject|67
2745463|NCT00008385|9417122|P2|Overall Study|Death|18
2745464|NCT00008385|9417123|P1|Overall Study|Death|12
2745465|NCT00008385|9417122|P2|Overall Study|Adverse Event|20
2745466|NCT00008385|9417123|P1|Overall Study|Adverse Event|8
2745467|NCT00008385|9417122|P2|Overall Study|Progressive disease|117
2745468|NCT00008385|9417123|P1|Overall Study|Progressive disease|52
2745469|NCT00008385|9417122|P2|Overall Study|Off treatment reasons not reported|70
2745470|NCT00008385|9417123|P1|Overall Study|Off treatment reasons not reported|79
2745471|NCT00008138|9417133|P1|Post-Cytoreduction Chemotherapy|not protocol specified|1
2745472|NCT00008138|9417133|P1|Post-Cytoreduction Chemotherapy|Progression|1
2745473|NCT00008138|9417133|P1|Post-Cytoreduction Chemotherapy|Adverse Event|6
2745474|NCT00008138|9417133|P1|Interval Debulking|Withdrawal by Subject|2
2745475|NCT00008138|9417133|P1|Neoadjuvant Chemotherapy|not protocol specified|8
2745476|NCT00008138|9417133|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|6
2745477|NCT00008138|9417133|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|3
2745478|NCT00008138|9417133|P1|Neoadjuvant Chemotherapy|Adverse Event|3
2745479|NCT00006916|9417139|P1|Overall Study|Complication of device insertion|1
2745480|NCT00006916|9417139|P1|Overall Study|Device not inserted|4
2745481|NCT00006903|9417145|P3|Overall Study|Ineligible|2
2745482|NCT00006903|9417146|P2|Overall Study|Ineligible|1
2745483|NCT00006903|9417147|P1|Overall Study|Ineligible|10
2745484|NCT00006903|9417145|P3|Overall Study|Patient never treated|1
2745485|NCT00006903|9417146|P2|Overall Study|Patient never treated|0
2745486|NCT00006903|9417147|P1|Overall Study|Patient never treated|0
2745487|NCT00006903|9417145|P3|Overall Study|Death|0
2745488|NCT00006903|9417146|P2|Overall Study|Death|1
2745489|NCT00006903|9417147|P1|Overall Study|Death|0
2745490|NCT00006903|9417145|P3|Overall Study|Adverse Event|1
2745491|NCT00006903|9417146|P2|Overall Study|Adverse Event|0
2745492|NCT00006903|9417147|P1|Overall Study|Adverse Event|0
2745493|NCT00006903|9417145|P3|Overall Study|Refused further treatment|1
2745494|NCT00006903|9417146|P2|Overall Study|Refused further treatment|2
2745495|NCT00006903|9417147|P1|Overall Study|Refused further treatment|0
2745496|NCT00006903|9417145|P3|Overall Study|Still receiving treatment|1
2745497|NCT00006903|9417146|P2|Overall Study|Still receiving treatment|0
2745498|NCT00006903|9417147|P1|Overall Study|Still receiving treatment|0
2745499|NCT00006721|9417160|P3|Overall Study|Eligible but no Treatment Received|0
2745500|NCT00006721|9417161|P2|Overall Study|Eligible but no Treatment Received|0
2745501|NCT00006721|9417162|P1|Overall Study|Eligible but no Treatment Received|1
2745502|NCT00006721|9417160|P3|Overall Study|Ineligible|10
2745503|NCT00006721|9417161|P2|Overall Study|Ineligible|12
2745504|NCT00006721|9417162|P1|Overall Study|Ineligible|2
2745505|NCT00006721|9417160|P3|Overall Study|Other - Not Protocol Specified|7
2745506|NCT00006721|9417161|P2|Overall Study|Other - Not Protocol Specified|7
2745507|NCT00006721|9417162|P1|Overall Study|Other - Not Protocol Specified|0
2745508|NCT00006721|9417160|P3|Overall Study|Death|2
2745509|NCT00006721|9417161|P2|Overall Study|Death|1
2745510|NCT00006721|9417162|P1|Overall Study|Death|0
2745511|NCT00006721|9417160|P3|Overall Study|Progression/Relapse|2
2745512|NCT00006721|9417161|P2|Overall Study|Progression/Relapse|1
2745513|NCT00006721|9417162|P1|Overall Study|Progression/Relapse|0
2745514|NCT00006721|9417160|P3|Overall Study|Refusal Unrelated to Adverse Event|8
2745515|NCT00006721|9417161|P2|Overall Study|Refusal Unrelated to Adverse Event|0
2745516|NCT00006721|9417162|P1|Overall Study|Refusal Unrelated to Adverse Event|1
2745517|NCT00006721|9417160|P3|Overall Study|Adverse Event|4
2745518|NCT00006721|9417161|P2|Overall Study|Adverse Event|4
2745519|NCT00006721|9417162|P1|Overall Study|Adverse Event|0
2745520|NCT00006478|9417180|P1|Overall Study|Physician Decision|6
2745521|NCT00006478|9417180|P1|Overall Study|Vaccine could not be produced|1
2745522|NCT00006392|9417191|P4|Overall Study|Poor data/ppt mgmt, regulatory problems|155
2745523|NCT00006392|9417192|P3|Overall Study|Poor data/ppt mgmt, regulatory problems|155
2745524|NCT00006392|9417193|P2|Overall Study|Poor data/ppt mgmt, regulatory problems|155
2745525|NCT00006392|9417194|P1|Overall Study|Poor data/ppt mgmt, regulatory problems|156
2745526|NCT00006392|9417191|P4|Overall Study|Ineligible|5
2745527|NCT00006392|9417192|P3|Overall Study|Ineligible|5
2745528|NCT00006392|9417193|P2|Overall Study|Ineligible|3
2745529|NCT00006392|9417194|P1|Overall Study|Ineligible|11
2745530|NCT00006389|9417224|P1|Overall Study|Adverse Event|1
2745531|NCT00006237|9417241|P2|Overall Study|Not protocol specified|5
2745532|NCT00006237|9417242|P1|Overall Study|Not protocol specified|14
2745533|NCT00006237|9417241|P2|Overall Study|Withdrawal by Subject|1
2745534|NCT00006237|9417242|P1|Overall Study|Withdrawal by Subject|0
2745535|NCT00006237|9417241|P2|Overall Study|Not eligible|20
2745536|NCT00006237|9417242|P1|Overall Study|Not eligible|9
2745537|NCT00006237|9417241|P2|Overall Study|Progression/relapse|2
2745538|NCT00006237|9417242|P1|Overall Study|Progression/relapse|54
2745539|NCT00006237|9417241|P2|Overall Study|Refusal unrelated to adverse effects|4
2745540|NCT00006237|9417242|P1|Overall Study|Refusal unrelated to adverse effects|8
2745541|NCT00006237|9417241|P2|Overall Study|Death|0
2745542|NCT00006237|9417242|P1|Overall Study|Death|1
2745543|NCT00006237|9417241|P2|Overall Study|Adverse Event|29
2745544|NCT00006237|9417242|P1|Overall Study|Adverse Event|39
2745545|NCT00006011|9417285|P3|Overall Study|Ineligible|9
2745546|NCT00006011|9417286|P2|Overall Study|Ineligible|16
2745547|NCT00006011|9417287|P1|Overall Study|Ineligible|18
2745548|NCT00006011|9417285|P3|Overall Study|Other|5
2745549|NCT00006011|9417286|P2|Overall Study|Other|2
2745550|NCT00006011|9417287|P1|Overall Study|Other|4
2745551|NCT00006011|9417285|P3|Overall Study|Death|2
2745552|NCT00006011|9417286|P2|Overall Study|Death|1
2745553|NCT00006011|9417287|P1|Overall Study|Death|0
2745554|NCT00006011|9417285|P3|Overall Study|Adverse Event|5
2745555|NCT00006011|9417286|P2|Overall Study|Adverse Event|39
2745556|NCT00006011|9417287|P1|Overall Study|Adverse Event|15
2745557|NCT00006011|9417285|P3|Overall Study|Refused further treatment|26
2745558|NCT00006011|9417286|P2|Overall Study|Refused further treatment|13
2745559|NCT00006011|9417287|P1|Overall Study|Refused further treatment|15
2745560|NCT00006011|9417285|P3|Overall Study|Disease progression|26
2745561|NCT00006011|9417286|P2|Overall Study|Disease progression|6
2745562|NCT00006011|9417287|P1|Overall Study|Disease progression|13
2745563|NCT00005957|9417295|P2|Overall Study|Crossover to the other arm|19
2745564|NCT00005957|9417296|P1|Overall Study|Crossover to the other arm|5
2745565|NCT00005957|9417295|P2|Overall Study|No treated|9
2745566|NCT00005957|9417296|P1|Overall Study|No treated|3
2745567|NCT00005879|9417306|P2|Overall Study|Withdrawal by Subject|10
2745568|NCT00005879|9417307|P1|Overall Study|Withdrawal by Subject|8
2745569|NCT00005047|9417330|P4|Overall Study|Lack of Efficacy|0
2745570|NCT00005047|9417331|P3|Overall Study|Lack of Efficacy|0
2745571|NCT00005047|9417332|P2|Overall Study|Lack of Efficacy|0
2745572|NCT00005047|9417333|P1|Overall Study|Lack of Efficacy|1
2745573|NCT00005047|9417330|P4|Overall Study|Lost to Follow-up|0
2745574|NCT00005047|9417331|P3|Overall Study|Lost to Follow-up|0
2745575|NCT00005047|9417332|P2|Overall Study|Lost to Follow-up|0
2745576|NCT00005047|9417333|P1|Overall Study|Lost to Follow-up|1
2745577|NCT00005047|9417330|P4|Overall Study|Adverse Event|0
2745578|NCT00005047|9417331|P3|Overall Study|Adverse Event|0
2745579|NCT00005047|9417332|P2|Overall Study|Adverse Event|0
2745580|NCT00005047|9417333|P1|Overall Study|Adverse Event|5
2745581|NCT00005047|9417330|P4|Overall Study|Withdrawal by Subject|0
2745582|NCT00005047|9417331|P3|Overall Study|Withdrawal by Subject|0
2745583|NCT00005047|9417332|P2|Overall Study|Withdrawal by Subject|0
2745584|NCT00005047|9417333|P1|Overall Study|Withdrawal by Subject|12
2745585|NCT00005044|9417349|P2|Overall Study|No protocol treatment|1
2745586|NCT00005044|9417350|P1|Overall Study|No protocol treatment|0
2745587|NCT00005044|9417349|P2|Overall Study|Withdrawal by Subject|5
2745588|NCT00005044|9417350|P1|Overall Study|Withdrawal by Subject|1
2745589|NCT00005044|9417349|P2|Overall Study|Protocol Violation|46
2745590|NCT00005044|9417350|P1|Overall Study|Protocol Violation|37
2745591|NCT00004888|9417370|P2|Overall Study|Toxic death|0
2745592|NCT00004888|9417371|P1|Overall Study|Toxic death|1
2745593|NCT00004888|9417370|P2|Overall Study|Death without progressive disease|1
2745594|NCT00004888|9417371|P1|Overall Study|Death without progressive disease|0
2745595|NCT00004888|9417370|P2|Overall Study|Progressive Disease|9
2745596|NCT00004888|9417371|P1|Overall Study|Progressive Disease|4
2745597|NCT00004888|9417370|P2|Overall Study|Physician Decision|1
2745598|NCT00004888|9417371|P1|Overall Study|Physician Decision|1
2745599|NCT00004888|9417370|P2|Overall Study|Withdrawal by Subject|3
2745600|NCT00004888|9417371|P1|Overall Study|Withdrawal by Subject|0
2745601|NCT00004888|9417370|P2|Overall Study|Adverse Event|10
2745602|NCT00004888|9417371|P1|Overall Study|Adverse Event|5
2745603|NCT00004859|9417389|P2|Overall Study|Other|21
2745604|NCT00004859|9417390|P1|Overall Study|Other|13
2745605|NCT00004859|9417389|P2|Overall Study|missing data|11
2745606|NCT00004859|9417390|P1|Overall Study|missing data|14
2745607|NCT00004859|9417389|P2|Overall Study|error|1
2745608|NCT00004859|9417390|P1|Overall Study|error|3
2745609|NCT00004859|9417389|P2|Overall Study|other disease|3
2745610|NCT00004859|9417390|P1|Overall Study|other disease|0
2745611|NCT00004859|9417389|P2|Overall Study|Protocol Violation|2
2745612|NCT00004859|9417390|P1|Overall Study|Protocol Violation|2
2745613|NCT00004859|9417389|P2|Overall Study|Withdrawal by Subject|33
2745614|NCT00004859|9417390|P1|Overall Study|Withdrawal by Subject|7
2745615|NCT00004859|9417389|P2|Overall Study|Death|5
2745616|NCT00004859|9417390|P1|Overall Study|Death|5
2745617|NCT00004859|9417389|P2|Overall Study|Adverse Event|93
2745618|NCT00004859|9417390|P1|Overall Study|Adverse Event|31
2745619|NCT00004859|9417389|P2|Overall Study|Lack of Efficacy|113
2745620|NCT00004859|9417390|P1|Overall Study|Lack of Efficacy|43
2745621|NCT00004259|9417404|P4|Overall Study|Withdrawal by Subject|0
2745622|NCT00004259|9417405|P3|Overall Study|Withdrawal by Subject|0
2745623|NCT00004259|9417406|P2|Overall Study|Withdrawal by Subject|2
2745624|NCT00004259|9417407|P1|Overall Study|Withdrawal by Subject|0
2745625|NCT00004259|9417404|P4|Overall Study|Protocol Violation|0
2745626|NCT00004259|9417405|P3|Overall Study|Protocol Violation|0
2745627|NCT00004259|9417406|P2|Overall Study|Protocol Violation|2
2745628|NCT00004259|9417407|P1|Overall Study|Protocol Violation|1
2745629|NCT00004228|9417432|P7|Overall Study|ineligible|5
2745630|NCT00004228|9417433|P6|Overall Study|ineligible|2
2745631|NCT00004228|9417434|P5|Overall Study|ineligible|1
2745632|NCT00004228|9417435|P4|Overall Study|ineligible|1
2745633|NCT00004228|9417436|P3|Overall Study|ineligible|4
2745634|NCT00004228|9417437|P2|Overall Study|ineligible|2
2745635|NCT00004228|9417438|P1|Overall Study|ineligible|4
2745636|NCT00004228|9417432|P7|Overall Study|Other|0
2745637|NCT00004228|9417433|P6|Overall Study|Other|0
2745638|NCT00004228|9417434|P5|Overall Study|Other|0
2745639|NCT00004228|9417435|P4|Overall Study|Other|0
2745640|NCT00004228|9417436|P3|Overall Study|Other|1
2745641|NCT00004228|9417437|P2|Overall Study|Other|0
2745642|NCT00004228|9417438|P1|Overall Study|Other|0
2745643|NCT00004228|9417432|P7|Overall Study|Withdrawal by Subject|2
2745644|NCT00004228|9417433|P6|Overall Study|Withdrawal by Subject|1
2745645|NCT00004228|9417434|P5|Overall Study|Withdrawal by Subject|2
2745646|NCT00004228|9417435|P4|Overall Study|Withdrawal by Subject|0
2745647|NCT00004228|9417436|P3|Overall Study|Withdrawal by Subject|1
2745648|NCT00004228|9417437|P2|Overall Study|Withdrawal by Subject|0
2745649|NCT00004228|9417438|P1|Overall Study|Withdrawal by Subject|3
2745650|NCT00004228|9417432|P7|Overall Study|Protocol Violation|0
2745651|NCT00004228|9417433|P6|Overall Study|Protocol Violation|2
2745652|NCT00004228|9417434|P5|Overall Study|Protocol Violation|1
2745653|NCT00004228|9417435|P4|Overall Study|Protocol Violation|1
2745654|NCT00004228|9417436|P3|Overall Study|Protocol Violation|2
2745655|NCT00004228|9417437|P2|Overall Study|Protocol Violation|5
2745656|NCT00004228|9417438|P1|Overall Study|Protocol Violation|0
2745657|NCT00004228|9417432|P7|Overall Study|Physician Decision|1
2745658|NCT00004228|9417433|P6|Overall Study|Physician Decision|1
2745659|NCT00004228|9417434|P5|Overall Study|Physician Decision|1
2745660|NCT00004228|9417435|P4|Overall Study|Physician Decision|2
2745661|NCT00004228|9417436|P3|Overall Study|Physician Decision|3
2745662|NCT00004228|9417437|P2|Overall Study|Physician Decision|0
2745663|NCT00004228|9417438|P1|Overall Study|Physician Decision|1
2745664|NCT00004228|9417432|P7|Overall Study|Lost to Follow-up|0
2745665|NCT00004228|9417433|P6|Overall Study|Lost to Follow-up|0
2745666|NCT00004228|9417434|P5|Overall Study|Lost to Follow-up|0
2745667|NCT00004228|9417435|P4|Overall Study|Lost to Follow-up|0
2745668|NCT00004228|9417436|P3|Overall Study|Lost to Follow-up|1
2745669|NCT00004228|9417437|P2|Overall Study|Lost to Follow-up|0
2745670|NCT00004228|9417438|P1|Overall Study|Lost to Follow-up|0
2745671|NCT00004228|9417432|P7|Overall Study|Lack of Efficacy|4
2745672|NCT00004228|9417433|P6|Overall Study|Lack of Efficacy|8
2745673|NCT00004228|9417434|P5|Overall Study|Lack of Efficacy|9
2745674|NCT00004228|9417435|P4|Overall Study|Lack of Efficacy|3
2745675|NCT00004228|9417436|P3|Overall Study|Lack of Efficacy|5
2745676|NCT00004228|9417437|P2|Overall Study|Lack of Efficacy|6
2745677|NCT00004228|9417438|P1|Overall Study|Lack of Efficacy|1
2745678|NCT00004228|9417432|P7|Overall Study|Death|0
2745679|NCT00004228|9417433|P6|Overall Study|Death|0
2745680|NCT00004228|9417434|P5|Overall Study|Death|1
2745681|NCT00004228|9417435|P4|Overall Study|Death|0
2745682|NCT00004228|9417436|P3|Overall Study|Death|2
2745683|NCT00004228|9417437|P2|Overall Study|Death|1
2745684|NCT00004228|9417438|P1|Overall Study|Death|0
2745685|NCT00004228|9417432|P7|Overall Study|Adverse Event|0
2745686|NCT00004228|9417433|P6|Overall Study|Adverse Event|0
2745687|NCT00004228|9417434|P5|Overall Study|Adverse Event|1
2745688|NCT00004228|9417435|P4|Overall Study|Adverse Event|0
2745689|NCT00004228|9417436|P3|Overall Study|Adverse Event|0
2745690|NCT00004228|9417437|P2|Overall Study|Adverse Event|1
2745691|NCT00004228|9417438|P1|Overall Study|Adverse Event|0
2745692|NCT00004124|9417472|P2|Overall Study|Received no protocol therapy|20
2745693|NCT00004124|9417473|P1|Overall Study|Received no protocol therapy|12
2745694|NCT00004088|9417498|P1|Overall Study|Physician Decision|1
2745695|NCT00004088|9417498|P1|Overall Study|Protocol Violation|3
2745696|NCT00004088|9417498|P1|Overall Study|Withdrawal by Subject|1
2745697|NCT00004088|9417498|P1|Overall Study|No C2 given due to study on hold by IRB|4
2745698|NCT00003901|9417531|P1|Overall Study|Medical problems|6
2745699|NCT00003901|9417531|P1|Overall Study|Chest X-Ray not done prior registration|1
2745700|NCT00003901|9417531|P1|Overall Study|CT Scan not within protocol requirement|2
2745701|NCT00003901|9417531|P1|Overall Study|Ineligible|6
2745702|NCT00003901|9417531|P1|Overall Study|Withdrawal by Subject|1
2745703|NCT00003901|9417531|P1|Overall Study|Adverse Event|1
2745704|NCT00003896|9417542|P1|Overall Study|ineligible|5
2745705|NCT00003896|9417542|P1|Overall Study|not protocol specified|3
2745706|NCT00003896|9417542|P1|Overall Study|Death|3
2745707|NCT00003896|9417542|P1|Overall Study|Lack of Efficacy|1
2745708|NCT00003896|9417542|P1|Overall Study|Withdrawal by Subject|1
2745709|NCT00003896|9417542|P1|Overall Study|Adverse Event|16
2745710|NCT00003875|9417548|P1|Overall Study|Screen Failed|1
2745711|NCT00003869|9417557|P2|Overall Study|Alternative treatmnt, medical problems|4
2745712|NCT00003869|9417558|P1|Overall Study|Alternative treatmnt, medical problems|5
2745713|NCT00003869|9417557|P2|Overall Study|Death|2
2745714|NCT00003869|9417558|P1|Overall Study|Death|1
2745715|NCT00003869|9417557|P2|Overall Study|Withdrawal by Subject|3
2745716|NCT00003869|9417558|P1|Overall Study|Withdrawal by Subject|21
2745717|NCT00003869|9417557|P2|Overall Study|Adverse Event|3
2745718|NCT00003869|9417558|P1|Overall Study|Adverse Event|14
2745719|NCT00003782|9417584|P3|Overall Study|No follow up data|26
2745720|NCT00003782|9417585|P2|Overall Study|No follow up data|31
2745721|NCT00003782|9417586|P1|Overall Study|No follow up data|30
2745722|NCT00003702|9417596|P2|Overall Study|Inadequate documentation of disease|3
2745723|NCT00003702|9417597|P1|Overall Study|Inadequate documentation of disease|1
2745724|NCT00003702|9417596|P2|Overall Study|WHO score > 6|1
2745725|NCT00003702|9417597|P1|Overall Study|WHO score > 6|2
2745726|NCT00003702|9417596|P2|Overall Study|Did not meet criteria for persistence|5
2745727|NCT00003702|9417597|P1|Overall Study|Did not meet criteria for persistence|8
2745728|NCT00003702|9417596|P2|Overall Study|Ineligible cell types|2
2745729|NCT00003702|9417597|P1|Overall Study|Ineligible cell types|2
2745730|NCT00003659|9417606|P1|Overall Study|Withdrawal by Subject|3
2745731|NCT00003641|9417627|P2|Overall Study|Never started interferon|12
2745732|NCT00003641|9417628|P1|Overall Study|Never started interferon|567
2745733|NCT00003641|9417627|P2|Overall Study|Should not receive interferon therapy|0
2745734|NCT00003641|9417628|P1|Overall Study|Should not receive interferon therapy|2
2745735|NCT00003641|9417627|P2|Overall Study|Unknown/missing|22
2745736|NCT00003641|9417628|P1|Overall Study|Unknown/missing|0
2745737|NCT00003641|9417627|P2|Overall Study|Disease progression|2
2745738|NCT00003641|9417628|P1|Overall Study|Disease progression|0
2745739|NCT00003641|9417627|P2|Overall Study|Adverse Event|38
2745740|NCT00003641|9417628|P1|Overall Study|Adverse Event|0
2745741|NCT00003641|9417627|P2|Overall Study|Withdrawal by Subject|100
2745742|NCT00003641|9417628|P1|Overall Study|Withdrawal by Subject|0
2745743|NCT00003631|9417639|P3|Overall Study|Evaluable for toxicity only|2
2745744|NCT00003631|9417640|P2|Overall Study|Evaluable for toxicity only|0
2745745|NCT00003631|9417641|P1|Overall Study|Evaluable for toxicity only|0
2745746|NCT00003631|9417639|P3|Overall Study|Death|1
2745747|NCT00003631|9417640|P2|Overall Study|Death|0
2745748|NCT00003631|9417641|P1|Overall Study|Death|0
2745749|NCT00003631|9417639|P3|Overall Study|Adverse Event|5
2745750|NCT00003631|9417640|P2|Overall Study|Adverse Event|1
2745751|NCT00003631|9417641|P1|Overall Study|Adverse Event|1
2745752|NCT00003631|9417639|P3|Overall Study|Protocol Violation|0
2745753|NCT00003631|9417640|P2|Overall Study|Protocol Violation|0
2745754|NCT00003631|9417641|P1|Overall Study|Protocol Violation|1
2745755|NCT00003631|9417639|P3|Overall Study|Patient not treated|1
2745756|NCT00003631|9417640|P2|Overall Study|Patient not treated|0
2745757|NCT00003631|9417641|P1|Overall Study|Patient not treated|1
2745758|NCT00003590|9417649|P1|Overall Study|Physician Decision|1
2745759|NCT00003590|9417649|P1|Overall Study|Death|1
2745760|NCT00003590|9417649|P1|Overall Study|Lack of Efficacy|11
2745761|NCT00003590|9417649|P1|Overall Study|Withdrawal by Subject|1
2745762|NCT00003590|9417649|P1|Overall Study|Adverse Event|7
2745763|NCT00003590|9417649|P1|Overall Study|Ineligible Patient|1
2745764|NCT00003537|9417654|P1|Overall Study|Not evalauable|1
2745765|NCT00003535|9417659|P1|Overall Study|Not evaluable|5
2745766|NCT00003499|9417664|P1|Overall Study|Not evaluable|8
2745767|NCT00003483|9417669|P1|Overall Study|Not evaluable|1
2745768|NCT00003479|9417674|P1|Overall Study|Not evaluable|3
2745769|NCT00003477|9417679|P1|Overall Study|Not evalauable|4
2745770|NCT00003476|9417684|P1|Overall Study|Not evaluable|1
2745771|NCT00003475|9417689|P1|Overall Study|Not evaluable|13
2745772|NCT00003474|9417694|P1|Overall Study|Not Evaluable|14
2745773|NCT00003473|9417699|P1|Overall Study|Three patients were not evaluable.|3
2745774|NCT00003472|9417704|P1|Overall Study|Not evaluable|3
2745775|NCT00003471|9417709|P1|Overall Study|Not evaluable|4
2745776|NCT00003470|9417714|P1|Overall Study|Not evaluable|6
2745777|NCT00003458|9417739|P1|Overall Study|Not evaluable|4
2745778|NCT00003457|9417744|P1|Overall Study|Not evaluable|9
2745779|NCT00003456|9417749|P1|Overall Study|Not evaluable|8
2745780|NCT00003389|9417766|P2|Overall Study|Ineligible|27
2745781|NCT00003389|9417767|P1|Overall Study|Ineligible|33
2745782|NCT00003389|9417766|P2|Overall Study|Off-treatment reason missing|21
2745783|NCT00003389|9417767|P1|Overall Study|Off-treatment reason missing|31
2745784|NCT00003389|9417766|P2|Overall Study|Complicating disease|0
2745785|NCT00003389|9417767|P1|Overall Study|Complicating disease|1
2745786|NCT00003389|9417766|P2|Overall Study|Alternative therapy|1
2745787|NCT00003389|9417767|P1|Overall Study|Alternative therapy|2
2745788|NCT00003389|9417766|P2|Overall Study|Withdrawal by Subject|5
2745789|NCT00003389|9417767|P1|Overall Study|Withdrawal by Subject|12
2745790|NCT00003389|9417766|P2|Overall Study|Death|3
2745791|NCT00003389|9417767|P1|Overall Study|Death|0
2745792|NCT00003389|9417766|P2|Overall Study|Adverse Event|2
2745793|NCT00003389|9417767|P1|Overall Study|Adverse Event|13
2745794|NCT00003389|9417766|P2|Overall Study|Disease progression|1
2745795|NCT00003389|9417767|P1|Overall Study|Disease progression|6
2745796|NCT00003377|9417782|P5|Period II|Ureteral stent complications|1
2745797|NCT00003377|9417783|P4|Period II|Ureteral stent complications|0
2745798|NCT00003377|9417784|P3|Period II|Ureteral stent complications|0
2745799|NCT00003377|9417785|P2|Period II|Ureteral stent complications|0
2745800|NCT00003377|9417786|P1|Period II|Ureteral stent complications|0
2745801|NCT00003377|9417782|P5|Period I|Dose Limiting Toxicity(DLT)|0
2745802|NCT00003377|9417783|P4|Period I|Dose Limiting Toxicity(DLT)|1
2745803|NCT00003377|9417784|P3|Period I|Dose Limiting Toxicity(DLT)|1
2745804|NCT00003377|9417785|P2|Period I|Dose Limiting Toxicity(DLT)|0
2745805|NCT00003377|9417786|P1|Period I|Dose Limiting Toxicity(DLT)|0
2745806|NCT00003199|9417800|P1|Overall Study|Screen fail|15
2745807|NCT00003199|9417800|P1|Overall Study|Lack of insurance clearance|2
2745808|NCT00003199|9417800|P1|Overall Study|Refused Post-Transplant Immunotherapy|5
2745809|NCT00003138|9417808|P2|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7
2745810|NCT00003138|9417809|P1|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6
2745811|NCT00003138|9417808|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1
2745812|NCT00003138|9417809|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0
2745813|NCT00003138|9417808|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19
2745814|NCT00003138|9417809|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12
2745815|NCT00003138|9417808|P2|Step 2 (Cross Over)|Reasons off treatment not documented|0
2745816|NCT00003138|9417809|P1|Step 2 (Cross Over)|Reasons off treatment not documented|26
2745817|NCT00003138|9417808|P2|Step 1|Never started treatment|0
2745818|NCT00003138|9417809|P1|Step 1|Never started treatment|1
2745819|NCT00003138|9417808|P2|Step 1|Reasons off treatment not documented|57
2745820|NCT00003138|9417809|P1|Step 1|Reasons off treatment not documented|60
2745821|NCT00002931|9417826|P1|Overall Study|rapidly progressing disease during|2
2745822|NCT00002874|9417834|P2|Overall Study|Protocol Violation|34
2745823|NCT00002874|9417835|P1|Overall Study|Protocol Violation|44
2745824|NCT00002874|9417834|P2|Overall Study|Withdrawal by Subject|1
2745825|NCT00002874|9417835|P1|Overall Study|Withdrawal by Subject|1
2745826|NCT00002850|9417860|P3|Overall Study|Withdrawal by Subject|0
2745827|NCT00002850|9417861|P2|Overall Study|Withdrawal by Subject|1
2745828|NCT00002850|9417862|P1|Overall Study|Withdrawal by Subject|0
2745829|NCT00002850|9417860|P3|Overall Study|Protocol Violation|1
2745830|NCT00002850|9417861|P2|Overall Study|Protocol Violation|0
2745831|NCT00002850|9417862|P1|Overall Study|Protocol Violation|1
2745832|NCT00002850|9417860|P3|Overall Study|Death|3
2745833|NCT00002850|9417861|P2|Overall Study|Death|1
2745834|NCT00002850|9417862|P1|Overall Study|Death|4
2745835|NCT00002842|9417870|P1|Overall Study|ineligible for surgical resection|27
2745836|NCT00002766|9417876|P2|Overall Study|Protocol Violation|0
2745837|NCT00002766|9417877|P1|Overall Study|Protocol Violation|1
2745838|NCT00002766|9417876|P2|Overall Study|Adverse Event|1
2745839|NCT00002766|9417877|P1|Overall Study|Adverse Event|1
2745840|NCT00002766|9417876|P2|Overall Study|Patient Not Treated|2
2745841|NCT00002766|9417877|P1|Overall Study|Patient Not Treated|1
2745842|NCT00002766|9417876|P2|Overall Study|Withdrawal by Subject|1
2745843|NCT00002766|9417877|P1|Overall Study|Withdrawal by Subject|0
2745844|NCT00002651|9417885|P3|Consolidation and Randomization|not eligible|112
2745845|NCT00002651|9417886|P2|Consolidation and Randomization|not eligible|102
2745846|NCT00002651|9417887|P1|Consolidation and Randomization|not eligible|0
2745847|NCT00002651|9417885|P3|Consolidation and Randomization|Other|313
2745848|NCT00002651|9417886|P2|Consolidation and Randomization|Other|314
2745849|NCT00002651|9417887|P1|Consolidation and Randomization|Other|0
2745850|NCT00002651|9417885|P3|Consolidation and Randomization|Death|48
2745851|NCT00002651|9417886|P2|Consolidation and Randomization|Death|38
2745852|NCT00002651|9417887|P1|Consolidation and Randomization|Death|0
2745853|NCT00002651|9417885|P3|Consolidation and Randomization|Progression/relapse|298
2745854|NCT00002651|9417886|P2|Consolidation and Randomization|Progression/relapse|295
2745855|NCT00002651|9417887|P1|Consolidation and Randomization|Progression/relapse|0
2745856|NCT00002651|9417885|P3|Consolidation and Randomization|Refusal unrelated to adverse event|75
2745857|NCT00002651|9417886|P2|Consolidation and Randomization|Refusal unrelated to adverse event|53
2745858|NCT00002651|9417887|P1|Consolidation and Randomization|Refusal unrelated to adverse event|0
2745859|NCT00002651|9417885|P3|Consolidation and Randomization|Adverse Event|14
2745860|NCT00002651|9417886|P2|Consolidation and Randomization|Adverse Event|36
2745861|NCT00002651|9417887|P1|Consolidation and Randomization|Adverse Event|0
2745862|NCT00002651|9417885|P3|Induction|not eligible|0
2745863|NCT00002651|9417886|P2|Induction|not eligible|0
2745864|NCT00002651|9417887|P1|Induction|not eligible|90
2745865|NCT00002651|9417885|P3|Induction|Other|0
2745866|NCT00002651|9417886|P2|Induction|Other|0
2745867|NCT00002651|9417887|P1|Induction|Other|823
2745868|NCT00002651|9417885|P3|Induction|Death|0
2745869|NCT00002651|9417886|P2|Induction|Death|0
2745870|NCT00002651|9417887|P1|Induction|Death|62
2745871|NCT00002651|9417885|P3|Induction|Progression/relapse|0
2745872|NCT00002651|9417886|P2|Induction|Progression/relapse|0
2745873|NCT00002651|9417887|P1|Induction|Progression/relapse|274
2745874|NCT00002651|9417885|P3|Induction|Refusal unrelated to adverse event|0
2745875|NCT00002651|9417886|P2|Induction|Refusal unrelated to adverse event|0
2745876|NCT00002651|9417887|P1|Induction|Refusal unrelated to adverse event|50
2745877|NCT00002651|9417885|P3|Induction|Adverse Event|0
2745878|NCT00002651|9417886|P2|Induction|Adverse Event|0
2745879|NCT00002651|9417887|P1|Induction|Adverse Event|44
2745880|NCT00002558|9417905|P2|Overall Study|Withdrawal by Subject|1
2745881|NCT00002558|9417906|P1|Overall Study|Withdrawal by Subject|0
2745882|NCT00051636|9417931|P2|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12
2745883|NCT00051636|9417932|P1|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40
2745884|NCT00051636|9417931|P2|Period 2- Extended Observation Period|Death|5
2745885|NCT00051636|9417932|P1|Period 2- Extended Observation Period|Death|4
2745886|NCT00051636|9417931|P2|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2
2745887|NCT00051636|9417932|P1|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9
2745888|NCT00051636|9417931|P2|Period 2- Extended Observation Period|withdrew for nonclinical reason|7
2745889|NCT00051636|9417932|P1|Period 2- Extended Observation Period|withdrew for nonclinical reason|12
2745890|NCT00051636|9417931|P2|Period 2- Extended Observation Period|Lost to Follow-up|4
2745891|NCT00051636|9417932|P1|Period 2- Extended Observation Period|Lost to Follow-up|5
2745892|NCT00051636|9417931|P2|Period 1 - Core|Lost to Follow-up|2
2745893|NCT00051636|9417932|P1|Period 1 - Core|Lost to Follow-up|0
2745894|NCT00051636|9417931|P2|Period 1 - Core|Withdrawal by Subject|2
2745895|NCT00051636|9417932|P1|Period 1 - Core|Withdrawal by Subject|1
2745896|NCT00051636|9417931|P2|Period 1 - Core|Protocol Violation|0
2745897|NCT00051636|9417932|P1|Period 1 - Core|Protocol Violation|1
2745898|NCT00051636|9417931|P2|Period 1 - Core|Adverse Event|2
2745899|NCT00051636|9417932|P1|Period 1 - Core|Adverse Event|2
2745900|NCT00051558|9417960|P2|Overall Study|Physician Decision|0
2745901|NCT00051558|9417961|P1|Overall Study|Physician Decision|5
2745902|NCT00051558|9417960|P2|Overall Study|Significant Lab Value|0
2745903|NCT00051558|9417961|P1|Overall Study|Significant Lab Value|2
2745904|NCT00051558|9417960|P2|Overall Study|Other|1
2745905|NCT00051558|9417961|P1|Overall Study|Other|2
2745906|NCT00051558|9417960|P2|Overall Study|Sponsor Decision|1
2745907|NCT00051558|9417961|P1|Overall Study|Sponsor Decision|6
2745908|NCT00051558|9417960|P2|Overall Study|Protocol Entry Criteria Unmet|2
2745909|NCT00051558|9417961|P1|Overall Study|Protocol Entry Criteria Unmet|1
2745910|NCT00051558|9417960|P2|Overall Study|Protocol Violation|4
2745911|NCT00051558|9417961|P1|Overall Study|Protocol Violation|3
2745912|NCT00051558|9417960|P2|Overall Study|Lost to Follow-up|13
2745913|NCT00051558|9417961|P1|Overall Study|Lost to Follow-up|4
2745914|NCT00051558|9417960|P2|Overall Study|Death|15
2745915|NCT00051558|9417961|P1|Overall Study|Death|9
2745916|NCT00051558|9417960|P2|Overall Study|Withdrawal by Subject|42
2745917|NCT00051558|9417961|P1|Overall Study|Withdrawal by Subject|29
2745918|NCT00051558|9417960|P2|Overall Study|Adverse Event|18
2745919|NCT00051558|9417961|P1|Overall Study|Adverse Event|30
2745920|NCT00051363|9417997|P2|Overall Study|Excluded Pre-Randomization|5
2745921|NCT00051363|9417998|P1|Overall Study|Excluded Pre-Randomization|2
2745922|NCT00051363|9417997|P2|Overall Study|Death|2
2745923|NCT00051363|9417998|P1|Overall Study|Death|2
2745924|NCT00051363|9417997|P2|Overall Study|Disqualified Post-Rand for Any Reason|11
2745925|NCT00051363|9417998|P1|Overall Study|Disqualified Post-Rand for Any Reason|9
2745926|NCT00051363|9417997|P2|Overall Study|Dropped Post-Rand for Any Reason|126
2745927|NCT00051363|9417998|P1|Overall Study|Dropped Post-Rand for Any Reason|102
2745928|NCT00051025|9418038|P2|Overall Study|Death|1
2745929|NCT00051025|9418039|P1|Overall Study|Death|0
2745930|NCT00051025|9418038|P2|Overall Study|Withdrawal by Subject|1
2745931|NCT00051025|9418039|P1|Overall Study|Withdrawal by Subject|0
2745932|NCT00051025|9418038|P2|Overall Study|Adverse Event|1
2745933|NCT00051025|9418039|P1|Overall Study|Adverse Event|1
2745934|NCT00051025|9418038|P2|Overall Study|Progressive Disease|1
2745935|NCT00051025|9418039|P1|Overall Study|Progressive Disease|1
2745936|NCT00050960|9418053|P2|Overall Study|Death|15
2745937|NCT00050960|9418054|P1|Overall Study|Death|13
2745938|NCT00050960|9418053|P2|Overall Study|Non-compliance|1
2745939|NCT00050960|9418054|P1|Overall Study|Non-compliance|3
2745940|NCT00050960|9418053|P2|Overall Study|Administrative|46
2745941|NCT00050960|9418054|P1|Overall Study|Administrative|31
2745942|NCT00050960|9418053|P2|Overall Study|Withdrawal by Subject|18
2745943|NCT00050960|9418054|P1|Overall Study|Withdrawal by Subject|23
2745944|NCT00050960|9418053|P2|Overall Study|Lost to Follow-up|1
2745945|NCT00050960|9418054|P1|Overall Study|Lost to Follow-up|0
2745946|NCT00050960|9418053|P2|Overall Study|Adverse Event|61
2745947|NCT00050960|9418054|P1|Overall Study|Adverse Event|62
2745948|NCT00050960|9418053|P2|Overall Study|Complete Response|2
2745949|NCT00050960|9418054|P1|Overall Study|Complete Response|0
2745950|NCT00050960|9418053|P2|Overall Study|Partial Response|19
2745951|NCT00050960|9418054|P1|Overall Study|Partial Response|14
2745952|NCT00050960|9418053|P2|Overall Study|Stable Disease|48
2745953|NCT00050960|9418054|P1|Overall Study|Stable Disease|19
2745954|NCT00050960|9418053|P2|Overall Study|Progressive Disease|93
2745955|NCT00050960|9418054|P1|Overall Study|Progressive Disease|137
2745956|NCT00050778|9418063|P3|Overall Study|Familial and personal reasons|0
2745957|NCT00050778|9418064|P2|Overall Study|Familial and personal reasons|0
2745958|NCT00050778|9418065|P1|Overall Study|Familial and personal reasons|1
2745959|NCT00050778|9418063|P3|Overall Study|Randomized but not treated|2
2745960|NCT00050778|9418064|P2|Overall Study|Randomized but not treated|5
2745961|NCT00050778|9418065|P1|Overall Study|Randomized but not treated|4
2745962|NCT00050778|9418063|P3|Overall Study|Withdrawal by Subject|4
2745963|NCT00050778|9418064|P2|Overall Study|Withdrawal by Subject|8
2745964|NCT00050778|9418065|P1|Overall Study|Withdrawal by Subject|6
2745965|NCT00050778|9418063|P3|Overall Study|Protocol Violation|1
2745966|NCT00050778|9418064|P2|Overall Study|Protocol Violation|0
2745967|NCT00050778|9418065|P1|Overall Study|Protocol Violation|2
2745968|NCT00050778|9418063|P3|Overall Study|Physician Decision|2
2745969|NCT00050778|9418064|P2|Overall Study|Physician Decision|0
2745970|NCT00050778|9418065|P1|Overall Study|Physician Decision|3
2745971|NCT00050778|9418063|P3|Overall Study|Lost to Follow-up|4
2745972|NCT00050778|9418064|P2|Overall Study|Lost to Follow-up|2
2745973|NCT00050778|9418065|P1|Overall Study|Lost to Follow-up|0
2745974|NCT00050778|9418063|P3|Overall Study|Lack of Efficacy|2
2745975|NCT00050778|9418064|P2|Overall Study|Lack of Efficacy|2
2745976|NCT00050778|9418065|P1|Overall Study|Lack of Efficacy|16
2745977|NCT00050778|9418063|P3|Overall Study|Death|1
2745978|NCT00050778|9418064|P2|Overall Study|Death|1
2745979|NCT00050778|9418065|P1|Overall Study|Death|0
2745980|NCT00050778|9418063|P3|Overall Study|Adverse Event|2
2745981|NCT00050778|9418064|P2|Overall Study|Adverse Event|3
2745982|NCT00050778|9418065|P1|Overall Study|Adverse Event|13
2745983|NCT00050622|9418091|P1|Overall Study|Adverse Event|1
2745984|NCT00050167|9418129|P2|Overall Study|not eligible not invasive|1
2745985|NCT00050167|9418130|P1|Overall Study|not eligible not invasive|1
2745986|NCT00050011|9418163|P2|Overall Study|Unknown - Reason is missing|2
2745987|NCT00050011|9418164|P1|Overall Study|Unknown - Reason is missing|0
2745988|NCT00050011|9418163|P2|Overall Study|Death|4
2745989|NCT00050011|9418164|P1|Overall Study|Death|7
2745990|NCT00050011|9418163|P2|Overall Study|Administrative problems|6
2745991|NCT00050011|9418164|P1|Overall Study|Administrative problems|10
2745992|NCT00050011|9418163|P2|Overall Study|Lost to Follow-up|9
2745993|NCT00050011|9418164|P1|Overall Study|Lost to Follow-up|7
2745994|NCT00050011|9418163|P2|Overall Study|Withdrawal by Subject|26
2745995|NCT00050011|9418164|P1|Overall Study|Withdrawal by Subject|34
2745996|NCT00050011|9418163|P2|Overall Study|Protocol Violation|10
2745997|NCT00050011|9418164|P1|Overall Study|Protocol Violation|4
2745998|NCT00050011|9418163|P2|Overall Study|Participant condition no longer required|0
2745999|NCT00050011|9418164|P1|Overall Study|Participant condition no longer required|1
2746000|NCT00050011|9418163|P2|Overall Study|Lack of Efficacy|21
2746001|NCT00050011|9418164|P1|Overall Study|Lack of Efficacy|16
2746002|NCT00050011|9418163|P2|Overall Study|Abnormal test procedure results|1
2746003|NCT00050011|9418164|P1|Overall Study|Abnormal test procedure results|0
2746004|NCT00050011|9418163|P2|Overall Study|Abnormal laboratory value(s)|1
2746005|NCT00050011|9418164|P1|Overall Study|Abnormal laboratory value(s)|1
2746006|NCT00050011|9418163|P2|Overall Study|Adverse Event|46
2746007|NCT00050011|9418164|P1|Overall Study|Adverse Event|41
2746008|NCT00049842|9418186|P2|Follow-up Phase|Other|4
2746009|NCT00049842|9418187|P1|Follow-up Phase|Other|1
2746010|NCT00049842|9418186|P2|Follow-up Phase|Adverse Event|1
2746011|NCT00049842|9418187|P1|Follow-up Phase|Adverse Event|6
2746012|NCT00049842|9418186|P2|Treatment Phase|Did not meet protocol eligibility|1
2746013|NCT00049842|9418187|P1|Treatment Phase|Did not meet protocol eligibility|0
2746014|NCT00049842|9418186|P2|Treatment Phase|Administrative|3
2746015|NCT00049842|9418187|P1|Treatment Phase|Administrative|0
2746016|NCT00049842|9418186|P2|Treatment Phase|Lost to Follow-up|8
2746017|NCT00049842|9418187|P1|Treatment Phase|Lost to Follow-up|4
2746018|NCT00049842|9418186|P2|Treatment Phase|Non-compliance with protocol|8
2746019|NCT00049842|9418187|P1|Treatment Phase|Non-compliance with protocol|7
2746020|NCT00049842|9418186|P2|Treatment Phase|Withdrawal by Subject|46
2746021|NCT00049842|9418187|P1|Treatment Phase|Withdrawal by Subject|35
2746022|NCT00049842|9418186|P2|Treatment Phase|Adverse Event|12
2746023|NCT00049842|9418187|P1|Treatment Phase|Adverse Event|47
2746024|NCT00048932|9418205|P3|Open Label Period (OL)|Participant Surgery|1
2746025|NCT00048932|9418206|P2|Open Label Period (OL)|Participant Surgery|0
2746026|NCT00048932|9418207|P1|Open Label Period (OL)|Participant Surgery|0
2746027|NCT00048932|9418205|P3|Open Label Period (OL)|Site Not Participating in Open Label|9
2746028|NCT00048932|9418206|P2|Open Label Period (OL)|Site Not Participating in Open Label|0
2746029|NCT00048932|9418207|P1|Open Label Period (OL)|Site Not Participating in Open Label|0
2746030|NCT00048932|9418205|P3|Open Label Period (OL)|Site Staff Issues|2
2746031|NCT00048932|9418206|P2|Open Label Period (OL)|Site Staff Issues|0
2746032|NCT00048932|9418207|P1|Open Label Period (OL)|Site Staff Issues|0
2746033|NCT00048932|9418205|P3|Open Label Period (OL)|Investigator Decision|4
2746034|NCT00048932|9418206|P2|Open Label Period (OL)|Investigator Decision|0
2746035|NCT00048932|9418207|P1|Open Label Period (OL)|Investigator Decision|0
2746036|NCT00048932|9418205|P3|Open Label Period (OL)|Medication Lost Efficacy|1
2746037|NCT00048932|9418206|P2|Open Label Period (OL)|Medication Lost Efficacy|0
2746038|NCT00048932|9418207|P1|Open Label Period (OL)|Medication Lost Efficacy|0
2746039|NCT00048932|9418205|P3|Open Label Period (OL)|Participant Missed Consecutive Doses|5
2746040|NCT00048932|9418206|P2|Open Label Period (OL)|Participant Missed Consecutive Doses|0
2746041|NCT00048932|9418207|P1|Open Label Period (OL)|Participant Missed Consecutive Doses|0
2746042|NCT00048932|9418205|P3|Open Label Period (OL)|Participant Desires Pregnancy|2
2746043|NCT00048932|9418206|P2|Open Label Period (OL)|Participant Desires Pregnancy|0
2746044|NCT00048932|9418207|P1|Open Label Period (OL)|Participant Desires Pregnancy|0
2746045|NCT00048932|9418205|P3|Open Label Period (OL)|Participant Received Wrong Medication|1
2746046|NCT00048932|9418206|P2|Open Label Period (OL)|Participant Received Wrong Medication|0
2746047|NCT00048932|9418207|P1|Open Label Period (OL)|Participant Received Wrong Medication|0
2746048|NCT00048932|9418205|P3|Open Label Period (OL)|Patient Decision|4
2746049|NCT00048932|9418206|P2|Open Label Period (OL)|Patient Decision|0
2746050|NCT00048932|9418207|P1|Open Label Period (OL)|Patient Decision|0
2746051|NCT00048932|9418205|P3|Open Label Period (OL)|Difficult IV Access with Participant|1
2746052|NCT00048932|9418206|P2|Open Label Period (OL)|Difficult IV Access with Participant|0
2746053|NCT00048932|9418207|P1|Open Label Period (OL)|Difficult IV Access with Participant|0
2746054|NCT00048932|9418205|P3|Open Label Period (OL)|Trial Terminated|1
2746055|NCT00048932|9418206|P2|Open Label Period (OL)|Trial Terminated|0
2746056|NCT00048932|9418207|P1|Open Label Period (OL)|Trial Terminated|0
2746057|NCT00048932|9418205|P3|Open Label Period (OL)|Site Closure|3
2746058|NCT00048932|9418206|P2|Open Label Period (OL)|Site Closure|0
2746059|NCT00048932|9418207|P1|Open Label Period (OL)|Site Closure|0
2746060|NCT00048932|9418205|P3|Open Label Period (OL)|Investigator Dosing the Trial|1
2746061|NCT00048932|9418206|P2|Open Label Period (OL)|Investigator Dosing the Trial|0
2746062|NCT00048932|9418207|P1|Open Label Period (OL)|Investigator Dosing the Trial|0
2746063|NCT00048932|9418205|P3|Open Label Period (OL)|Participant Relocated|6
2746064|NCT00048932|9418206|P2|Open Label Period (OL)|Participant Relocated|0
2746065|NCT00048932|9418207|P1|Open Label Period (OL)|Participant Relocated|0
2746066|NCT00048932|9418205|P3|Open Label Period (OL)|Participant Transportation Issues|1
2746067|NCT00048932|9418206|P2|Open Label Period (OL)|Participant Transportation Issues|0
2746068|NCT00048932|9418207|P1|Open Label Period (OL)|Participant Transportation Issues|0
2746069|NCT00048932|9418205|P3|Open Label Period (OL)|Investigator Retiring|2
2746070|NCT00048932|9418206|P2|Open Label Period (OL)|Investigator Retiring|0
2746071|NCT00048932|9418207|P1|Open Label Period (OL)|Investigator Retiring|0
2746072|NCT00048932|9418205|P3|Open Label Period (OL)|Administrative Reason By Sponsor|20
2746073|NCT00048932|9418206|P2|Open Label Period (OL)|Administrative Reason By Sponsor|0
2746074|NCT00048932|9418207|P1|Open Label Period (OL)|Administrative Reason By Sponsor|0
2746075|NCT00048932|9418205|P3|Open Label Period (OL)|Pregnancy|6
2746076|NCT00048932|9418206|P2|Open Label Period (OL)|Pregnancy|0
2746077|NCT00048932|9418207|P1|Open Label Period (OL)|Pregnancy|0
2746078|NCT00048932|9418205|P3|Open Label Period (OL)|Poor/Non-Compliance|13
2746079|NCT00048932|9418206|P2|Open Label Period (OL)|Poor/Non-Compliance|0
2746080|NCT00048932|9418207|P1|Open Label Period (OL)|Poor/Non-Compliance|0
2746081|NCT00048932|9418205|P3|Open Label Period (OL)|No Longer Meets Study Criteria|5
2746082|NCT00048932|9418206|P2|Open Label Period (OL)|No Longer Meets Study Criteria|0
2746083|NCT00048932|9418207|P1|Open Label Period (OL)|No Longer Meets Study Criteria|0
2746084|NCT00048932|9418205|P3|Open Label Period (OL)|Withdrawal by Subject|117
2746085|NCT00048932|9418206|P2|Open Label Period (OL)|Withdrawal by Subject|0
2746086|NCT00048932|9418207|P1|Open Label Period (OL)|Withdrawal by Subject|0
2746087|NCT00048932|9418205|P3|Open Label Period (OL)|Lost to Follow-up|27
2746088|NCT00048932|9418206|P2|Open Label Period (OL)|Lost to Follow-up|0
2746089|NCT00048932|9418207|P1|Open Label Period (OL)|Lost to Follow-up|0
2746090|NCT00048932|9418205|P3|Open Label Period (OL)|Lack of Efficacy|81
2746091|NCT00048932|9418206|P2|Open Label Period (OL)|Lack of Efficacy|0
2746092|NCT00048932|9418207|P1|Open Label Period (OL)|Lack of Efficacy|0
2746093|NCT00048932|9418205|P3|Open Label Period (OL)|Adverse Event|103
2746094|NCT00048932|9418206|P2|Open Label Period (OL)|Adverse Event|0
2746095|NCT00048932|9418207|P1|Open Label Period (OL)|Adverse Event|0
2746096|NCT00048932|9418205|P3|Open Label Period (OL)|Death|25
2746097|NCT00048932|9418206|P2|Open Label Period (OL)|Death|0
2746098|NCT00048932|9418207|P1|Open Label Period (OL)|Death|0
2746099|NCT00048932|9418205|P3|Double Blind Period (DB)|Poor/Non-Compliance|0
2746100|NCT00048932|9418206|P2|Double Blind Period (DB)|Poor/Non-Compliance|4
2746101|NCT00048932|9418207|P1|Double Blind Period (DB)|Poor/Non-Compliance|2
2746102|NCT00048932|9418205|P3|Double Blind Period (DB)|Withdrawal by Subject|0
2746103|NCT00048932|9418206|P2|Double Blind Period (DB)|Withdrawal by Subject|10
2746104|NCT00048932|9418207|P1|Double Blind Period (DB)|Withdrawal by Subject|24
2746105|NCT00048932|9418205|P3|Double Blind Period (DB)|No Longer Meets Study Criteria|0
2746106|NCT00048932|9418206|P2|Double Blind Period (DB)|No Longer Meets Study Criteria|2
2746107|NCT00048932|9418207|P1|Double Blind Period (DB)|No Longer Meets Study Criteria|8
2746108|NCT00048932|9418205|P3|Double Blind Period (DB)|Pregnancy|0
2746109|NCT00048932|9418206|P2|Double Blind Period (DB)|Pregnancy|0
2746110|NCT00048932|9418207|P1|Double Blind Period (DB)|Pregnancy|1
2746111|NCT00048932|9418205|P3|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
2746112|NCT00048932|9418206|P2|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
2746113|NCT00048932|9418207|P1|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1
2746114|NCT00048932|9418205|P3|Double Blind Period (DB)|Uncontrolled hypertension|0
2746115|NCT00048932|9418206|P2|Double Blind Period (DB)|Uncontrolled hypertension|1
2746116|NCT00048932|9418207|P1|Double Blind Period (DB)|Uncontrolled hypertension|0
2746117|NCT00048932|9418205|P3|Double Blind Period (DB)|Relocation|0
2746118|NCT00048932|9418206|P2|Double Blind Period (DB)|Relocation|0
2746119|NCT00048932|9418207|P1|Double Blind Period (DB)|Relocation|1
2746120|NCT00048932|9418205|P3|Double Blind Period (DB)|Lost to Follow-up|0
2746121|NCT00048932|9418206|P2|Double Blind Period (DB)|Lost to Follow-up|4
2746122|NCT00048932|9418207|P1|Double Blind Period (DB)|Lost to Follow-up|3
2746123|NCT00048932|9418205|P3|Double Blind Period (DB)|Lack of Efficacy|0
2746124|NCT00048932|9418206|P2|Double Blind Period (DB)|Lack of Efficacy|44
2746125|NCT00048932|9418207|P1|Double Blind Period (DB)|Lack of Efficacy|26
2746126|NCT00048932|9418205|P3|Double Blind Period (DB)|Death|0
2746127|NCT00048932|9418206|P2|Double Blind Period (DB)|Death|3
2746128|NCT00048932|9418207|P1|Double Blind Period (DB)|Death|5
2746129|NCT00048932|9418205|P3|Double Blind Period (DB)|Adverse Event|0
2746130|NCT00048932|9418206|P2|Double Blind Period (DB)|Adverse Event|19
2746131|NCT00048932|9418207|P1|Double Blind Period (DB)|Adverse Event|51
2746132|NCT00048932|9418205|P3|Double Blind Period (DB)|Administrative Reason By Sponsor|0
2746215|NCT00048568|9418420|P1|Open-Label Period|Adverse Event|0
2746133|NCT00048932|9418206|P2|Double Blind Period (DB)|Administrative Reason By Sponsor|0
2746134|NCT00048932|9418207|P1|Double Blind Period (DB)|Administrative Reason By Sponsor|1
2746135|NCT00048581|9418249|P3|Open-Label Period|Study Ended By Sponsor|1
2746136|NCT00048581|9418250|P2|Open-Label Period|Study Ended By Sponsor|0
2746137|NCT00048581|9418251|P1|Open-Label Period|Study Ended By Sponsor|0
2746138|NCT00048581|9418249|P3|Open-Label Period|Primary Investigator Retired|2
2746139|NCT00048581|9418250|P2|Open-Label Period|Primary Investigator Retired|0
2746140|NCT00048581|9418251|P1|Open-Label Period|Primary Investigator Retired|0
2746141|NCT00048581|9418249|P3|Open-Label Period|Problem With Transportation To Site|1
2746142|NCT00048581|9418250|P2|Open-Label Period|Problem With Transportation To Site|0
2746143|NCT00048581|9418251|P1|Open-Label Period|Problem With Transportation To Site|0
2746144|NCT00048581|9418249|P3|Open-Label Period|Continue ABA With Primary Rheumatologist|3
2746145|NCT00048581|9418250|P2|Open-Label Period|Continue ABA With Primary Rheumatologist|0
2746146|NCT00048581|9418251|P1|Open-Label Period|Continue ABA With Primary Rheumatologist|0
2746147|NCT00048581|9418249|P3|Open-Label Period|Study Site Closure|2
2746148|NCT00048581|9418250|P2|Open-Label Period|Study Site Closure|0
2746149|NCT00048581|9418251|P1|Open-Label Period|Study Site Closure|0
2746150|NCT00048581|9418249|P3|Open-Label Period|Pregnancy|7
2746151|NCT00048581|9418250|P2|Open-Label Period|Pregnancy|0
2746152|NCT00048581|9418251|P1|Open-Label Period|Pregnancy|0
2746153|NCT00048581|9418249|P3|Open-Label Period|Poor/Non-compliance|5
2746154|NCT00048581|9418250|P2|Open-Label Period|Poor/Non-compliance|0
2746155|NCT00048581|9418251|P1|Open-Label Period|Poor/Non-compliance|0
2746156|NCT00048581|9418249|P3|Open-Label Period|No Longer Meets Study Criteria|2
2746157|NCT00048581|9418250|P2|Open-Label Period|No Longer Meets Study Criteria|0
2746158|NCT00048581|9418251|P1|Open-Label Period|No Longer Meets Study Criteria|0
2746159|NCT00048581|9418249|P3|Open-Label Period|Withdrawal by Subject|20
2746160|NCT00048581|9418250|P2|Open-Label Period|Withdrawal by Subject|0
2746161|NCT00048581|9418251|P1|Open-Label Period|Withdrawal by Subject|0
2746162|NCT00048581|9418249|P3|Open-Label Period|Lost to Follow-up|14
2746163|NCT00048581|9418250|P2|Open-Label Period|Lost to Follow-up|0
2746164|NCT00048581|9418251|P1|Open-Label Period|Lost to Follow-up|0
2746165|NCT00048581|9418249|P3|Open-Label Period|Lack of Efficacy|69
2746166|NCT00048581|9418250|P2|Open-Label Period|Lack of Efficacy|0
2746167|NCT00048581|9418251|P1|Open-Label Period|Lack of Efficacy|0
2746168|NCT00048581|9418249|P3|Open-Label Period|Adverse Event|37
2746169|NCT00048581|9418250|P2|Open-Label Period|Adverse Event|0
2746170|NCT00048581|9418251|P1|Open-Label Period|Adverse Event|0
2746171|NCT00048581|9418249|P3|Open-Label Period|Death|4
2746172|NCT00048581|9418250|P2|Open-Label Period|Death|0
2746173|NCT00048581|9418251|P1|Open-Label Period|Death|0
2746174|NCT00048581|9418249|P3|Double-Blind Period|Investigator Decision|0
2746175|NCT00048581|9418250|P2|Double-Blind Period|Investigator Decision|0
2746176|NCT00048581|9418251|P1|Double-Blind Period|Investigator Decision|1
2746177|NCT00048581|9418249|P3|Double-Blind Period|Participant Has History of Lymphopenia|0
2746178|NCT00048581|9418250|P2|Double-Blind Period|Participant Has History of Lymphopenia|0
2746179|NCT00048581|9418251|P1|Double-Blind Period|Participant Has History of Lymphopenia|1
2746180|NCT00048581|9418249|P3|Double-Blind Period|Withdrawal by Subject|0
2746181|NCT00048581|9418250|P2|Double-Blind Period|Withdrawal by Subject|2
2746182|NCT00048581|9418251|P1|Double-Blind Period|Withdrawal by Subject|5
2746183|NCT00048581|9418249|P3|Double-Blind Period|Lost to Follow-up|0
2746184|NCT00048581|9418250|P2|Double-Blind Period|Lost to Follow-up|0
2746185|NCT00048581|9418251|P1|Double-Blind Period|Lost to Follow-up|5
2746186|NCT00048581|9418249|P3|Double-Blind Period|Lack of Efficacy|0
2746187|NCT00048581|9418250|P2|Double-Blind Period|Lack of Efficacy|27
2746188|NCT00048581|9418251|P1|Double-Blind Period|Lack of Efficacy|14
2746189|NCT00048581|9418249|P3|Double-Blind Period|Adverse Event|0
2746190|NCT00048581|9418250|P2|Double-Blind Period|Adverse Event|5
2746191|NCT00048581|9418251|P1|Double-Blind Period|Adverse Event|9
2746192|NCT00048568|9418418|P3|Open-Label Period|Lost to Follow-up|7
2746193|NCT00048568|9418419|P2|Open-Label Period|Lost to Follow-up|0
2746194|NCT00048568|9418420|P1|Open-Label Period|Lost to Follow-up|0
2746195|NCT00048568|9418418|P3|Open-Label Period|Unknown Reasons|25
2746196|NCT00048568|9418419|P2|Open-Label Period|Unknown Reasons|0
2746197|NCT00048568|9418420|P1|Open-Label Period|Unknown Reasons|0
2746198|NCT00048568|9418418|P3|Open-Label Period|Administrative Decision By Sponsor|1
2746199|NCT00048568|9418419|P2|Open-Label Period|Administrative Decision By Sponsor|0
2746200|NCT00048568|9418420|P1|Open-Label Period|Administrative Decision By Sponsor|0
2746201|NCT00048568|9418418|P3|Open-Label Period|No Longer Met Study Criteria|2
2746202|NCT00048568|9418419|P2|Open-Label Period|No Longer Met Study Criteria|0
2746203|NCT00048568|9418420|P1|Open-Label Period|No Longer Met Study Criteria|0
2746204|NCT00048568|9418418|P3|Open-Label Period|Pregnancy|5
2746205|NCT00048568|9418419|P2|Open-Label Period|Pregnancy|0
2746206|NCT00048568|9418420|P1|Open-Label Period|Pregnancy|0
2746207|NCT00048568|9418418|P3|Open-Label Period|Withdrawal by Subject|26
2746208|NCT00048568|9418419|P2|Open-Label Period|Withdrawal by Subject|0
2746209|NCT00048568|9418420|P1|Open-Label Period|Withdrawal by Subject|0
2746210|NCT00048568|9418418|P3|Open-Label Period|Lack of Efficacy|32
2746211|NCT00048568|9418419|P2|Open-Label Period|Lack of Efficacy|0
2746212|NCT00048568|9418420|P1|Open-Label Period|Lack of Efficacy|0
2746213|NCT00048568|9418418|P3|Open-Label Period|Adverse Event|49
2746214|NCT00048568|9418419|P2|Open-Label Period|Adverse Event|0
2746216|NCT00048568|9418418|P3|Open-Label Period|Death|13
2746217|NCT00048568|9418419|P2|Open-Label Period|Death|0
2746218|NCT00048568|9418420|P1|Open-Label Period|Death|0
2746219|NCT00048568|9418418|P3|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0
2746220|NCT00048568|9418419|P2|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
2746221|NCT00048568|9418420|P1|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
2746222|NCT00048568|9418418|P3|Double-Blind Period Days 170 to 365|Pregnancy|0
2746223|NCT00048568|9418419|P2|Double-Blind Period Days 170 to 365|Pregnancy|0
2746224|NCT00048568|9418420|P1|Double-Blind Period Days 170 to 365|Pregnancy|2
2746225|NCT00048568|9418418|P3|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
2746226|NCT00048568|9418419|P2|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1
2746227|NCT00048568|9418420|P1|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
2746228|NCT00048568|9418418|P3|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0
2746229|NCT00048568|9418419|P2|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1
2746230|NCT00048568|9418420|P1|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3
2746231|NCT00048568|9418418|P3|Double-Blind Period Days 170 to 365|Lack of Efficacy|0
2746232|NCT00048568|9418419|P2|Double-Blind Period Days 170 to 365|Lack of Efficacy|7
2746233|NCT00048568|9418420|P1|Double-Blind Period Days 170 to 365|Lack of Efficacy|2
2746234|NCT00048568|9418418|P3|Double-Blind Period Days 170 to 365|Adverse Event|0
2746235|NCT00048568|9418419|P2|Double-Blind Period Days 170 to 365|Adverse Event|1
2746236|NCT00048568|9418420|P1|Double-Blind Period Days 170 to 365|Adverse Event|7
2746237|NCT00048568|9418418|P3|Double-Blind Period Days 170 to 365|Death|0
2746238|NCT00048568|9418419|P2|Double-Blind Period Days 170 to 365|Death|1
2746239|NCT00048568|9418420|P1|Double-Blind Period Days 170 to 365|Death|1
2746240|NCT00048568|9418418|P3|Double-Blind Period Days 1 to 169|Unknown Reasons|0
2746241|NCT00048568|9418419|P2|Double-Blind Period Days 1 to 169|Unknown Reasons|4
2746242|NCT00048568|9418420|P1|Double-Blind Period Days 1 to 169|Unknown Reasons|2
2746243|NCT00048568|9418418|P3|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0
2746244|NCT00048568|9418419|P2|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4
2746245|NCT00048568|9418420|P1|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7
2746246|NCT00048568|9418418|P3|Double-Blind Period Days 1 to 169|Lost to Follow-up|0
2746247|NCT00048568|9418419|P2|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
2746248|NCT00048568|9418420|P1|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
2746249|NCT00048568|9418418|P3|Double-Blind Period Days 1 to 169|Lack of Efficacy|0
2746250|NCT00048568|9418419|P2|Double-Blind Period Days 1 to 169|Lack of Efficacy|33
2746251|NCT00048568|9418420|P1|Double-Blind Period Days 1 to 169|Lack of Efficacy|11
2746252|NCT00048568|9418418|P3|Double-Blind Period Days 1 to 169|Adverse Event|0
2746253|NCT00048568|9418419|P2|Double-Blind Period Days 1 to 169|Adverse Event|3
2746254|NCT00048568|9418420|P1|Double-Blind Period Days 1 to 169|Adverse Event|11
2746255|NCT00048724|9418725|P2|Overall Study|Administrative|1
2746256|NCT00048724|9418726|P1|Overall Study|Administrative|1
2746257|NCT00048724|9418725|P2|Overall Study|Did Not Meet Protocol Eligibility|2
2746258|NCT00048724|9418726|P1|Overall Study|Did Not Meet Protocol Eligibility|2
2746259|NCT00048724|9418725|P2|Overall Study|Noncompliance With Protocol|12
2746260|NCT00048724|9418726|P1|Overall Study|Noncompliance With Protocol|4
2746261|NCT00048724|9418725|P2|Overall Study|Protocol-defined Clinical Event|32
2746262|NCT00048724|9418726|P1|Overall Study|Protocol-defined Clinical Event|17
2746263|NCT00048724|9418725|P2|Overall Study|Lost to Follow-up|5
2746264|NCT00048724|9418726|P1|Overall Study|Lost to Follow-up|5
2746265|NCT00048724|9418725|P2|Overall Study|Withdrawal by Subject|54
2746266|NCT00048724|9418726|P1|Overall Study|Withdrawal by Subject|34
2746267|NCT00048724|9418725|P2|Overall Study|Adverse Event|12
2746268|NCT00048724|9418726|P1|Overall Study|Adverse Event|53
2746269|NCT00048542|9418738|P8|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8
2746270|NCT00048542|9418739|P7|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5
2746271|NCT00048542|9418740|P6|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
2746272|NCT00048542|9418741|P5|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
2746273|NCT00048542|9418742|P4|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
2746274|NCT00048542|9418743|P3|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
2746275|NCT00048542|9418744|P2|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
2746276|NCT00048542|9418745|P1|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
2746277|NCT00048542|9418738|P8|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1
2746278|NCT00048542|9418739|P7|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2
2746279|NCT00048542|9418740|P6|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
2746280|NCT00048542|9418741|P5|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
2746281|NCT00048542|9418742|P4|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
2746282|NCT00048542|9418743|P3|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
2746283|NCT00048542|9418744|P2|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
2746284|NCT00048542|9418745|P1|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
2746285|NCT00048542|9418738|P8|Open-Label Extension Fixed Dose Phase|Adverse Event|2
2746286|NCT00048542|9418739|P7|Open-Label Extension Fixed Dose Phase|Adverse Event|2
2746287|NCT00048542|9418740|P6|Open-Label Extension Fixed Dose Phase|Adverse Event|0
2746288|NCT00048542|9418741|P5|Open-Label Extension Fixed Dose Phase|Adverse Event|0
2746289|NCT00048542|9418742|P4|Open-Label Extension Fixed Dose Phase|Adverse Event|0
2746290|NCT00048542|9418743|P3|Open-Label Extension Fixed Dose Phase|Adverse Event|0
2746291|NCT00048542|9418744|P2|Open-Label Extension Fixed Dose Phase|Adverse Event|0
2746292|NCT00048542|9418745|P1|Open-Label Extension Fixed Dose Phase|Adverse Event|0
2746293|NCT00048542|9418738|P8|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7
2746294|NCT00048542|9418739|P7|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6
2746295|NCT00048542|9418740|P6|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
2746296|NCT00048542|9418741|P5|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
2746297|NCT00048542|9418742|P4|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
2746298|NCT00048542|9418743|P3|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
2746299|NCT00048542|9418744|P2|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
2746300|NCT00048542|9418745|P1|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
2746301|NCT00048542|9418738|P8|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
2746302|NCT00048542|9418739|P7|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
2746303|NCT00048542|9418740|P6|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
2746304|NCT00048542|9418741|P5|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
2746305|NCT00048542|9418742|P4|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
2746306|NCT00048542|9418743|P3|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
2746307|NCT00048542|9418744|P2|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
2746308|NCT00048542|9418745|P1|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
2746309|NCT00048542|9418738|P8|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3
2746310|NCT00048542|9418739|P7|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6
2746311|NCT00048542|9418740|P6|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
2746312|NCT00048542|9418741|P5|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
2746313|NCT00048542|9418742|P4|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
2746314|NCT00048542|9418743|P3|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
2746315|NCT00048542|9418744|P2|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
2746316|NCT00048542|9418745|P1|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
2746317|NCT00048542|9418738|P8|Open-Label Extension BSA Phase|Lack of Efficacy|0
2746318|NCT00048542|9418739|P7|Open-Label Extension BSA Phase|Lack of Efficacy|0
2746319|NCT00048542|9418740|P6|Open-Label Extension BSA Phase|Lack of Efficacy|1
2746320|NCT00048542|9418741|P5|Open-Label Extension BSA Phase|Lack of Efficacy|3
2746321|NCT00048542|9418742|P4|Open-Label Extension BSA Phase|Lack of Efficacy|0
2746322|NCT00048542|9418743|P3|Open-Label Extension BSA Phase|Lack of Efficacy|0
2746323|NCT00048542|9418744|P2|Open-Label Extension BSA Phase|Lack of Efficacy|0
2746324|NCT00048542|9418745|P1|Open-Label Extension BSA Phase|Lack of Efficacy|0
2746325|NCT00048542|9418738|P8|Open-Label Extension BSA Phase|Adverse Event|0
2746326|NCT00048542|9418739|P7|Open-Label Extension BSA Phase|Adverse Event|0
2746327|NCT00048542|9418740|P6|Open-Label Extension BSA Phase|Adverse Event|1
2746328|NCT00048542|9418741|P5|Open-Label Extension BSA Phase|Adverse Event|1
2746329|NCT00048542|9418742|P4|Open-Label Extension BSA Phase|Adverse Event|0
2746330|NCT00048542|9418743|P3|Open-Label Extension BSA Phase|Adverse Event|0
2746331|NCT00048542|9418744|P2|Open-Label Extension BSA Phase|Adverse Event|0
2746332|NCT00048542|9418745|P1|Open-Label Extension BSA Phase|Adverse Event|0
2746333|NCT00048542|9418738|P8|Open-Label Extension BSA Phase|Sponsor request or decision|0
2746334|NCT00048542|9418739|P7|Open-Label Extension BSA Phase|Sponsor request or decision|0
2746335|NCT00048542|9418740|P6|Open-Label Extension BSA Phase|Sponsor request or decision|1
2746336|NCT00048542|9418741|P5|Open-Label Extension BSA Phase|Sponsor request or decision|5
2746337|NCT00048542|9418742|P4|Open-Label Extension BSA Phase|Sponsor request or decision|0
2746338|NCT00048542|9418743|P3|Open-Label Extension BSA Phase|Sponsor request or decision|0
2746339|NCT00048542|9418744|P2|Open-Label Extension BSA Phase|Sponsor request or decision|0
2746340|NCT00048542|9418745|P1|Open-Label Extension BSA Phase|Sponsor request or decision|0
2746341|NCT00048542|9418738|P8|Open-Label Extension BSA Phase|Protocol Violation|0
2746342|NCT00048542|9418739|P7|Open-Label Extension BSA Phase|Protocol Violation|0
2746343|NCT00048542|9418740|P6|Open-Label Extension BSA Phase|Protocol Violation|1
2746344|NCT00048542|9418741|P5|Open-Label Extension BSA Phase|Protocol Violation|0
2746345|NCT00048542|9418742|P4|Open-Label Extension BSA Phase|Protocol Violation|0
2746346|NCT00048542|9418743|P3|Open-Label Extension BSA Phase|Protocol Violation|0
2746347|NCT00048542|9418744|P2|Open-Label Extension BSA Phase|Protocol Violation|0
2746348|NCT00048542|9418745|P1|Open-Label Extension BSA Phase|Protocol Violation|0
2746349|NCT00048542|9418738|P8|Open-Label Extension BSA Phase|Withdrawal by Subject|0
2746350|NCT00048542|9418739|P7|Open-Label Extension BSA Phase|Withdrawal by Subject|0
2746351|NCT00048542|9418740|P6|Open-Label Extension BSA Phase|Withdrawal by Subject|6
2746352|NCT00048542|9418741|P5|Open-Label Extension BSA Phase|Withdrawal by Subject|3
2746353|NCT00048542|9418742|P4|Open-Label Extension BSA Phase|Withdrawal by Subject|0
2746354|NCT00048542|9418743|P3|Open-Label Extension BSA Phase|Withdrawal by Subject|0
2746355|NCT00048542|9418744|P2|Open-Label Extension BSA Phase|Withdrawal by Subject|0
2746356|NCT00048542|9418745|P1|Open-Label Extension BSA Phase|Withdrawal by Subject|0
2746357|NCT00048542|9418738|P8|Double-Blind Phase|Randomized in error|0
2746358|NCT00048542|9418739|P7|Double-Blind Phase|Randomized in error|0
2746359|NCT00048542|9418740|P6|Double-Blind Phase|Randomized in error|0
2746360|NCT00048542|9418741|P5|Double-Blind Phase|Randomized in error|0
2746361|NCT00048542|9418742|P4|Double-Blind Phase|Randomized in error|0
2746362|NCT00048542|9418743|P3|Double-Blind Phase|Randomized in error|0
2746363|NCT00048542|9418744|P2|Double-Blind Phase|Randomized in error|0
2746364|NCT00048542|9418745|P1|Double-Blind Phase|Randomized in error|1
2746365|NCT00048542|9418738|P8|Double-Blind Phase|Sponsor request or decision|0
2746366|NCT00048542|9418739|P7|Double-Blind Phase|Sponsor request or decision|0
2746367|NCT00048542|9418740|P6|Double-Blind Phase|Sponsor request or decision|0
2746368|NCT00048542|9418741|P5|Double-Blind Phase|Sponsor request or decision|0
2746369|NCT00048542|9418742|P4|Double-Blind Phase|Sponsor request or decision|0
2746370|NCT00048542|9418743|P3|Double-Blind Phase|Sponsor request or decision|0
2746371|NCT00048542|9418744|P2|Double-Blind Phase|Sponsor request or decision|0
2746372|NCT00048542|9418745|P1|Double-Blind Phase|Sponsor request or decision|2
2746373|NCT00048542|9418738|P8|Double-Blind Phase|Protocol Violation|0
2746374|NCT00048542|9418739|P7|Double-Blind Phase|Protocol Violation|0
2746375|NCT00048542|9418740|P6|Double-Blind Phase|Protocol Violation|0
2746376|NCT00048542|9418741|P5|Double-Blind Phase|Protocol Violation|0
2746377|NCT00048542|9418742|P4|Double-Blind Phase|Protocol Violation|0
2746378|NCT00048542|9418743|P3|Double-Blind Phase|Protocol Violation|1
2746379|NCT00048542|9418744|P2|Double-Blind Phase|Protocol Violation|0
2746380|NCT00048542|9418745|P1|Double-Blind Phase|Protocol Violation|0
2746381|NCT00048542|9418738|P8|Double-Blind Phase|Withdrawal by Subject|0
2746382|NCT00048542|9418739|P7|Double-Blind Phase|Withdrawal by Subject|0
2746383|NCT00048542|9418740|P6|Double-Blind Phase|Withdrawal by Subject|0
2746384|NCT00048542|9418741|P5|Double-Blind Phase|Withdrawal by Subject|0
2746385|NCT00048542|9418742|P4|Double-Blind Phase|Withdrawal by Subject|0
2746386|NCT00048542|9418743|P3|Double-Blind Phase|Withdrawal by Subject|0
2746387|NCT00048542|9418744|P2|Double-Blind Phase|Withdrawal by Subject|1
2746388|NCT00048542|9418745|P1|Double-Blind Phase|Withdrawal by Subject|0
2746389|NCT00048347|9418811|P1|Overall Study|Screen failure|2
2746390|NCT00048165|9418817|P2|Completed 12 Months Study|Did not co-operate/Withdrew|0
2746391|NCT00048165|9418818|P1|Completed 12 Months Study|Did not co-operate/Withdrew|1
2746392|NCT00048165|9418817|P2|Completed 12 Months Study|Death|1
2746393|NCT00048165|9418818|P1|Completed 12 Months Study|Death|2
2746394|NCT00048165|9418817|P2|Completed 12 Months Study|Administration/Other|2
2746395|NCT00048165|9418818|P1|Completed 12 Months Study|Administration/Other|0
2746396|NCT00048165|9418817|P2|Completed 6 Months Study|Did not receive study drug|6
2746397|NCT00048165|9418818|P1|Completed 6 Months Study|Did not receive study drug|6
2746398|NCT00048165|9418817|P2|Completed 6 Months Study|Violation criteria|2
2746399|NCT00048165|9418818|P1|Completed 6 Months Study|Violation criteria|0
2746400|NCT00048165|9418817|P2|Completed 6 Months Study|Refused treatment|5
2746401|NCT00048165|9418818|P1|Completed 6 Months Study|Refused treatment|5
2746402|NCT00048165|9418817|P2|Completed 6 Months Study|Other violation|6
2746403|NCT00048165|9418818|P1|Completed 6 Months Study|Other violation|4
2746404|NCT00048165|9418817|P2|Completed 6 Months Study|Insufficient therapy|4
2746405|NCT00048165|9418818|P1|Completed 6 Months Study|Insufficient therapy|1
2746406|NCT00048165|9418817|P2|Completed 6 Months Study|Death|6
2746407|NCT00048165|9418818|P1|Completed 6 Months Study|Death|12
2746408|NCT00048165|9418817|P2|Completed 6 Months Study|Adverse event/intermittent illness|11
2746409|NCT00048165|9418818|P1|Completed 6 Months Study|Adverse event/intermittent illness|14
2746410|NCT00048165|9418817|P2|Completed 6 Months Study|Abnormality of laboratory test|0
2746411|NCT00048165|9418818|P1|Completed 6 Months Study|Abnormality of laboratory test|1
2746412|NCT00048165|9418817|P2|Completed 6 Months Study|Administration/Other|8
2746413|NCT00048165|9418818|P1|Completed 6 Months Study|Administration/Other|8
2746414|NCT00048074|9418853|P3|Overall Study|Social reasons|0
2746415|NCT00048074|9418854|P2|Overall Study|Social reasons|0
2746416|NCT00048074|9418855|P1|Overall Study|Social reasons|1
2746417|NCT00048074|9418853|P3|Overall Study|Out of station|1
2746418|NCT00048074|9418854|P2|Overall Study|Out of station|1
2746419|NCT00048074|9418855|P1|Overall Study|Out of station|0
2746420|NCT00048074|9418853|P3|Overall Study|Poor compliance|0
2746421|NCT00048074|9418854|P2|Overall Study|Poor compliance|1
2746422|NCT00048074|9418855|P1|Overall Study|Poor compliance|0
2746423|NCT00048074|9418853|P3|Overall Study|Husband ill|0
2746424|NCT00048074|9418854|P2|Overall Study|Husband ill|1
2746425|NCT00048074|9418855|P1|Overall Study|Husband ill|0
2746426|NCT00048074|9418853|P3|Overall Study|Study participation was terminated|0
2746427|NCT00048074|9418854|P2|Overall Study|Study participation was terminated|1
2746428|NCT00048074|9418855|P1|Overall Study|Study participation was terminated|0
2746429|NCT00048074|9418853|P3|Overall Study|Protocol Violation|0
2746430|NCT00048074|9418854|P2|Overall Study|Protocol Violation|3
2746431|NCT00048074|9418855|P1|Overall Study|Protocol Violation|1
2746432|NCT00048074|9418853|P3|Overall Study|Withdrawal by Subject|35
2746433|NCT00048074|9418854|P2|Overall Study|Withdrawal by Subject|30
2746434|NCT00048074|9418855|P1|Overall Study|Withdrawal by Subject|28
2746435|NCT00048074|9418853|P3|Overall Study|Lost to Follow-up|6
2746436|NCT00048074|9418854|P2|Overall Study|Lost to Follow-up|6
2746437|NCT00048074|9418855|P1|Overall Study|Lost to Follow-up|2
2746438|NCT00048074|9418853|P3|Overall Study|Death|2
2746439|NCT00048074|9418854|P2|Overall Study|Death|3
2746440|NCT00048074|9418855|P1|Overall Study|Death|3
2746441|NCT00048074|9418853|P3|Overall Study|Adverse Event|53
2746442|NCT00048074|9418854|P2|Overall Study|Adverse Event|41
2746443|NCT00048074|9418855|P1|Overall Study|Adverse Event|46
2746444|NCT00048061|9418912|P4|Overall Study|Early improvement|0
2746445|NCT00048061|9418913|P3|Overall Study|Early improvement|3
2746446|NCT00048061|9418914|P2|Overall Study|Early improvement|5
2746447|NCT00048061|9418915|P1|Overall Study|Early improvement|6
2746448|NCT00048061|9418912|P4|Overall Study|Did not follow-up|5
2746449|NCT00048061|9418913|P3|Overall Study|Did not follow-up|4
2746450|NCT00048061|9418914|P2|Overall Study|Did not follow-up|5
2746451|NCT00048061|9418915|P1|Overall Study|Did not follow-up|5
2746452|NCT00048061|9418912|P4|Overall Study|Withdrawal by Subject|32
2746453|NCT00048061|9418913|P3|Overall Study|Withdrawal by Subject|29
2746454|NCT00048061|9418914|P2|Overall Study|Withdrawal by Subject|29
2746455|NCT00048061|9418915|P1|Overall Study|Withdrawal by Subject|20
2746456|NCT00048061|9418912|P4|Overall Study|Lost to Follow-up|5
2746457|NCT00048061|9418913|P3|Overall Study|Lost to Follow-up|4
2746458|NCT00048061|9418914|P2|Overall Study|Lost to Follow-up|2
2746459|NCT00048061|9418915|P1|Overall Study|Lost to Follow-up|3
2746460|NCT00048061|9418912|P4|Overall Study|Adverse Event|37
2746461|NCT00048061|9418913|P3|Overall Study|Adverse Event|44
2746462|NCT00048061|9418914|P2|Overall Study|Adverse Event|32
2746463|NCT00048061|9418915|P1|Overall Study|Adverse Event|41
2746464|NCT00048048|9418994|P12|Extension Year 2|Early withdrawals|2
2746465|NCT00048048|9418995|P11|Extension Year 2|Early withdrawals|4
2746466|NCT00048048|9418996|P10|Extension Year 2|Early withdrawals|0
2746467|NCT00048048|9418997|P9|Extension Year 2|Early withdrawals|0
2746468|NCT00048048|9418998|P8|Extension Year 2|Early withdrawals|0
2746469|NCT00048048|9418999|P7|Extension Year 2|Early withdrawals|0
2746470|NCT00048048|9419000|P6|Extension Year 2|Early withdrawals|0
2746471|NCT00048048|9419001|P5|Extension Year 2|Early withdrawals|0
2746472|NCT00048048|9419002|P4|Extension Year 2|Early withdrawals|0
2746473|NCT00048048|9419003|P3|Extension Year 2|Early withdrawals|0
2746474|NCT00048048|9419004|P2|Extension Year 2|Early withdrawals|0
2746475|NCT00048048|9419005|P1|Extension Year 2|Early withdrawals|0
2746476|NCT00048048|9418994|P12|Extension Year 1|Early withdrawals|4
2746477|NCT00048048|9418995|P11|Extension Year 1|Early withdrawals|2
2746478|NCT00048048|9418996|P10|Extension Year 1|Early withdrawals|2
2746479|NCT00048048|9418997|P9|Extension Year 1|Early withdrawals|0
2746480|NCT00048048|9418998|P8|Extension Year 1|Early withdrawals|0
2746481|NCT00048048|9418999|P7|Extension Year 1|Early withdrawals|0
2746482|NCT00048048|9419000|P6|Extension Year 1|Early withdrawals|0
2746483|NCT00048048|9419001|P5|Extension Year 1|Early withdrawals|0
2746484|NCT00048048|9419002|P4|Extension Year 1|Early withdrawals|0
2746485|NCT00048048|9419003|P3|Extension Year 1|Early withdrawals|0
2746486|NCT00048048|9419004|P2|Extension Year 1|Early withdrawals|0
2746487|NCT00048048|9419005|P1|Extension Year 1|Early withdrawals|0
2746488|NCT00048048|9418994|P12|Core Treatment|Adverse Event|0
2746489|NCT00048048|9418995|P11|Core Treatment|Adverse Event|0
2746490|NCT00048048|9418996|P10|Core Treatment|Adverse Event|0
2746491|NCT00048048|9418997|P9|Core Treatment|Adverse Event|0
2746492|NCT00048048|9418998|P8|Core Treatment|Adverse Event|1
2746493|NCT00048048|9418999|P7|Core Treatment|Adverse Event|0
2746494|NCT00048048|9419000|P6|Core Treatment|Adverse Event|0
2746495|NCT00048048|9419001|P5|Core Treatment|Adverse Event|0
2746496|NCT00048048|9419002|P4|Core Treatment|Adverse Event|0
2746497|NCT00048048|9419003|P3|Core Treatment|Adverse Event|0
2746498|NCT00048048|9419004|P2|Core Treatment|Adverse Event|0
2746499|NCT00048048|9419005|P1|Core Treatment|Adverse Event|0
2746500|NCT00048048|9418994|P12|Core Treatment|Withdrawal by Subject|0
2746501|NCT00048048|9418995|P11|Core Treatment|Withdrawal by Subject|0
2746502|NCT00048048|9418996|P10|Core Treatment|Withdrawal by Subject|0
2746503|NCT00048048|9418997|P9|Core Treatment|Withdrawal by Subject|0
2746504|NCT00048048|9418998|P8|Core Treatment|Withdrawal by Subject|0
2746505|NCT00048048|9418999|P7|Core Treatment|Withdrawal by Subject|0
2746506|NCT00048048|9419000|P6|Core Treatment|Withdrawal by Subject|0
2746507|NCT00048048|9419001|P5|Core Treatment|Withdrawal by Subject|0
2746508|NCT00048048|9419002|P4|Core Treatment|Withdrawal by Subject|0
2746509|NCT00048048|9419003|P3|Core Treatment|Withdrawal by Subject|1
2746510|NCT00048048|9419004|P2|Core Treatment|Withdrawal by Subject|0
2746511|NCT00048048|9419005|P1|Core Treatment|Withdrawal by Subject|0
2746512|NCT00048035|9419061|P8|Extension Year 2|Early Withdrawals|3
2746513|NCT00048035|9419062|P7|Extension Year 2|Early Withdrawals|3
2746514|NCT00048035|9419063|P6|Extension Year 2|Early Withdrawals|0
2746515|NCT00048035|9419064|P5|Extension Year 2|Early Withdrawals|0
2746516|NCT00048035|9419065|P4|Extension Year 2|Early Withdrawals|0
2746517|NCT00048035|9419066|P3|Extension Year 2|Early Withdrawals|0
2746518|NCT00048035|9419067|P2|Extension Year 2|Early Withdrawals|0
2746519|NCT00048035|9419068|P1|Extension Year 2|Early Withdrawals|0
2746520|NCT00048035|9419061|P8|Extension Year 1|Early Withdrawals|11
2746521|NCT00048035|9419062|P7|Extension Year 1|Early Withdrawals|11
2746522|NCT00048035|9419063|P6|Extension Year 1|Early Withdrawals|0
2746523|NCT00048035|9419064|P5|Extension Year 1|Early Withdrawals|0
2746524|NCT00048035|9419065|P4|Extension Year 1|Early Withdrawals|0
2746525|NCT00048035|9419066|P3|Extension Year 1|Early Withdrawals|0
2746526|NCT00048035|9419067|P2|Extension Year 1|Early Withdrawals|0
2746527|NCT00048035|9419068|P1|Extension Year 1|Early Withdrawals|0
2746528|NCT00048035|9419061|P8|Core Period|Early Withdrawals|0
2746529|NCT00048035|9419062|P7|Core Period|Early Withdrawals|0
2746530|NCT00048035|9419063|P6|Core Period|Early Withdrawals|1
2746531|NCT00048035|9419064|P5|Core Period|Early Withdrawals|1
2746532|NCT00048035|9419065|P4|Core Period|Early Withdrawals|1
2746533|NCT00048035|9419066|P3|Core Period|Early Withdrawals|1
2746534|NCT00048035|9419067|P2|Core Period|Early Withdrawals|2
2746535|NCT00048035|9419068|P1|Core Period|Early Withdrawals|4
2746536|NCT00047879|9419106|P2|Overall Study|Progressive disease|3
2746537|NCT00047879|9419107|P1|Overall Study|Progressive disease|4
2746538|NCT00047463|9419143|P2|Overall Study|Withdrawal by Subject|3
2746539|NCT00047463|9419144|P1|Overall Study|Withdrawal by Subject|0
2746540|NCT00045942|9419261|P9|PKC412A2104E2|Death|0
2746541|NCT00045942|9419262|P8|PKC412A2104E2|Death|0
2746542|NCT00045942|9419263|P7|PKC412A2104E2|Death|2
2746543|NCT00045942|9419264|P6|PKC412A2104E2|Death|1
2746544|NCT00045942|9419265|P5|PKC412A2104E2|Death|0
2746545|NCT00045942|9419266|P4|PKC412A2104E2|Death|0
2746546|NCT00045942|9419267|P3|PKC412A2104E2|Death|0
2746547|NCT00045942|9419268|P2|PKC412A2104E2|Death|0
2746548|NCT00045942|9419269|P1|PKC412A2104E2|Death|0
2746549|NCT00045942|9419261|P9|PKC412A2104E2|Adverse Event|0
2746550|NCT00045942|9419262|P8|PKC412A2104E2|Adverse Event|1
2746551|NCT00045942|9419263|P7|PKC412A2104E2|Adverse Event|3
2746552|NCT00045942|9419264|P6|PKC412A2104E2|Adverse Event|4
2746553|NCT00045942|9419265|P5|PKC412A2104E2|Adverse Event|0
2746554|NCT00045942|9419266|P4|PKC412A2104E2|Adverse Event|0
2746555|NCT00045942|9419267|P3|PKC412A2104E2|Adverse Event|0
2746556|NCT00045942|9419268|P2|PKC412A2104E2|Adverse Event|0
2746557|NCT00045942|9419269|P1|PKC412A2104E2|Adverse Event|0
2746558|NCT00045942|9419261|P9|PKC412A2104E2|Lack of Efficacy|6
2746559|NCT00045942|9419262|P8|PKC412A2104E2|Lack of Efficacy|2
2746560|NCT00045942|9419263|P7|PKC412A2104E2|Lack of Efficacy|2
2746561|NCT00045942|9419264|P6|PKC412A2104E2|Lack of Efficacy|3
2746562|NCT00045942|9419265|P5|PKC412A2104E2|Lack of Efficacy|0
2746563|NCT00045942|9419266|P4|PKC412A2104E2|Lack of Efficacy|0
2746564|NCT00045942|9419267|P3|PKC412A2104E2|Lack of Efficacy|0
2746565|NCT00045942|9419268|P2|PKC412A2104E2|Lack of Efficacy|0
2746566|NCT00045942|9419269|P1|PKC412A2104E2|Lack of Efficacy|0
2746567|NCT00045942|9419261|P9|PKC412A2104E2|Withdrawal by Subject|0
2746568|NCT00045942|9419262|P8|PKC412A2104E2|Withdrawal by Subject|1
2746569|NCT00045942|9419263|P7|PKC412A2104E2|Withdrawal by Subject|0
2746570|NCT00045942|9419264|P6|PKC412A2104E2|Withdrawal by Subject|1
2746571|NCT00045942|9419265|P5|PKC412A2104E2|Withdrawal by Subject|0
2746572|NCT00045942|9419266|P4|PKC412A2104E2|Withdrawal by Subject|0
2746573|NCT00045942|9419267|P3|PKC412A2104E2|Withdrawal by Subject|0
2746574|NCT00045942|9419268|P2|PKC412A2104E2|Withdrawal by Subject|0
2746575|NCT00045942|9419269|P1|PKC412A2104E2|Withdrawal by Subject|0
2746576|NCT00045942|9419261|P9|PKC412A2104E2|Lost to Follow-up|0
2746577|NCT00045942|9419262|P8|PKC412A2104E2|Lost to Follow-up|3
2746578|NCT00045942|9419263|P7|PKC412A2104E2|Lost to Follow-up|0
2746579|NCT00045942|9419264|P6|PKC412A2104E2|Lost to Follow-up|0
2746580|NCT00045942|9419265|P5|PKC412A2104E2|Lost to Follow-up|0
2746581|NCT00045942|9419266|P4|PKC412A2104E2|Lost to Follow-up|0
2746582|NCT00045942|9419267|P3|PKC412A2104E2|Lost to Follow-up|0
2746583|NCT00045942|9419268|P2|PKC412A2104E2|Lost to Follow-up|0
2746584|NCT00045942|9419269|P1|PKC412A2104E2|Lost to Follow-up|0
2746585|NCT00045942|9419261|P9|PKC412A2104E1|Enrolled into PKC412A2104E2|0
2746586|NCT00045942|9419262|P8|PKC412A2104E1|Enrolled into PKC412A2104E2|0
2746587|NCT00045942|9419263|P7|PKC412A2104E1|Enrolled into PKC412A2104E2|0
2746588|NCT00045942|9419264|P6|PKC412A2104E1|Enrolled into PKC412A2104E2|0
2746589|NCT00045942|9419265|P5|PKC412A2104E1|Enrolled into PKC412A2104E2|0
2746590|NCT00045942|9419266|P4|PKC412A2104E1|Enrolled into PKC412A2104E2|1
2746591|NCT00045942|9419267|P3|PKC412A2104E1|Enrolled into PKC412A2104E2|1
2746592|NCT00045942|9419268|P2|PKC412A2104E1|Enrolled into PKC412A2104E2|0
2746593|NCT00045942|9419269|P1|PKC412A2104E1|Enrolled into PKC412A2104E2|0
2746594|NCT00045942|9419261|P9|PKC412A2104E1|Death|0
2746595|NCT00045942|9419262|P8|PKC412A2104E1|Death|0
2746596|NCT00045942|9419263|P7|PKC412A2104E1|Death|0
2746597|NCT00045942|9419264|P6|PKC412A2104E1|Death|0
2746598|NCT00045942|9419265|P5|PKC412A2104E1|Death|1
2746599|NCT00045942|9419266|P4|PKC412A2104E1|Death|1
2746600|NCT00045942|9419267|P3|PKC412A2104E1|Death|1
2746601|NCT00045942|9419268|P2|PKC412A2104E1|Death|4
2746602|NCT00045942|9419269|P1|PKC412A2104E1|Death|0
2746603|NCT00045942|9419261|P9|PKC412A2104E1|Adverse Event|0
2746604|NCT00045942|9419262|P8|PKC412A2104E1|Adverse Event|0
2746605|NCT00045942|9419263|P7|PKC412A2104E1|Adverse Event|0
2746606|NCT00045942|9419264|P6|PKC412A2104E1|Adverse Event|0
2746607|NCT00045942|9419265|P5|PKC412A2104E1|Adverse Event|6
2746608|NCT00045942|9419266|P4|PKC412A2104E1|Adverse Event|3
2746609|NCT00045942|9419267|P3|PKC412A2104E1|Adverse Event|1
2746610|NCT00045942|9419268|P2|PKC412A2104E1|Adverse Event|1
2746611|NCT00045942|9419269|P1|PKC412A2104E1|Adverse Event|0
2746612|NCT00045942|9419261|P9|PKC412A2104E1|Abnormal laboratory value|0
2746613|NCT00045942|9419262|P8|PKC412A2104E1|Abnormal laboratory value|0
2746614|NCT00045942|9419263|P7|PKC412A2104E1|Abnormal laboratory value|0
2746615|NCT00045942|9419264|P6|PKC412A2104E1|Abnormal laboratory value|0
2746616|NCT00045942|9419265|P5|PKC412A2104E1|Abnormal laboratory value|0
2746617|NCT00045942|9419266|P4|PKC412A2104E1|Abnormal laboratory value|0
2746618|NCT00045942|9419267|P3|PKC412A2104E1|Abnormal laboratory value|0
2746619|NCT00045942|9419268|P2|PKC412A2104E1|Abnormal laboratory value|1
2746620|NCT00045942|9419269|P1|PKC412A2104E1|Abnormal laboratory value|0
2746621|NCT00045942|9419261|P9|PKC412A2104E1|Lack of Efficacy|0
2746622|NCT00045942|9419262|P8|PKC412A2104E1|Lack of Efficacy|0
2746623|NCT00045942|9419263|P7|PKC412A2104E1|Lack of Efficacy|0
2746624|NCT00045942|9419264|P6|PKC412A2104E1|Lack of Efficacy|0
2746625|NCT00045942|9419265|P5|PKC412A2104E1|Lack of Efficacy|17
2746626|NCT00045942|9419266|P4|PKC412A2104E1|Lack of Efficacy|23
2746627|NCT00045942|9419267|P3|PKC412A2104E1|Lack of Efficacy|11
2746628|NCT00045942|9419268|P2|PKC412A2104E1|Lack of Efficacy|11
2746629|NCT00045942|9419269|P1|PKC412A2104E1|Lack of Efficacy|0
2746630|NCT00045942|9419261|P9|PKC412A2104E1|Condition no longer requires study drug|0
2746631|NCT00045942|9419262|P8|PKC412A2104E1|Condition no longer requires study drug|0
2746632|NCT00045942|9419263|P7|PKC412A2104E1|Condition no longer requires study drug|0
2746633|NCT00045942|9419264|P6|PKC412A2104E1|Condition no longer requires study drug|0
2746634|NCT00045942|9419265|P5|PKC412A2104E1|Condition no longer requires study drug|1
2746635|NCT00045942|9419266|P4|PKC412A2104E1|Condition no longer requires study drug|0
2746636|NCT00045942|9419267|P3|PKC412A2104E1|Condition no longer requires study drug|1
2746637|NCT00045942|9419268|P2|PKC412A2104E1|Condition no longer requires study drug|1
2746638|NCT00045942|9419269|P1|PKC412A2104E1|Condition no longer requires study drug|0
2746639|NCT00045942|9419261|P9|PKC412A2104E1|Withdrawal by Subject|0
2746640|NCT00045942|9419262|P8|PKC412A2104E1|Withdrawal by Subject|0
2746641|NCT00045942|9419263|P7|PKC412A2104E1|Withdrawal by Subject|0
2746642|NCT00045942|9419264|P6|PKC412A2104E1|Withdrawal by Subject|0
2746643|NCT00045942|9419265|P5|PKC412A2104E1|Withdrawal by Subject|2
2746644|NCT00045942|9419266|P4|PKC412A2104E1|Withdrawal by Subject|5
2746645|NCT00045942|9419267|P3|PKC412A2104E1|Withdrawal by Subject|2
2746646|NCT00045942|9419268|P2|PKC412A2104E1|Withdrawal by Subject|0
2746647|NCT00045942|9419269|P1|PKC412A2104E1|Withdrawal by Subject|0
2746648|NCT00045942|9419261|P9|PKC412A2104 (Core)|Death|0
2746649|NCT00045942|9419262|P8|PKC412A2104 (Core)|Death|0
2746650|NCT00045942|9419263|P7|PKC412A2104 (Core)|Death|0
2746651|NCT00045942|9419264|P6|PKC412A2104 (Core)|Death|0
2746652|NCT00045942|9419265|P5|PKC412A2104 (Core)|Death|0
2746653|NCT00045942|9419266|P4|PKC412A2104 (Core)|Death|0
2746654|NCT00045942|9419267|P3|PKC412A2104 (Core)|Death|0
2746655|NCT00045942|9419268|P2|PKC412A2104 (Core)|Death|0
2746656|NCT00045942|9419269|P1|PKC412A2104 (Core)|Death|1
2746657|NCT00045942|9419261|P9|PKC412A2104 (Core)|Lack of Efficacy|0
2746658|NCT00045942|9419262|P8|PKC412A2104 (Core)|Lack of Efficacy|0
2746659|NCT00045942|9419263|P7|PKC412A2104 (Core)|Lack of Efficacy|0
2746660|NCT00045942|9419264|P6|PKC412A2104 (Core)|Lack of Efficacy|0
2746661|NCT00045942|9419265|P5|PKC412A2104 (Core)|Lack of Efficacy|0
2746662|NCT00045942|9419266|P4|PKC412A2104 (Core)|Lack of Efficacy|0
2746663|NCT00045942|9419267|P3|PKC412A2104 (Core)|Lack of Efficacy|0
2746664|NCT00045942|9419268|P2|PKC412A2104 (Core)|Lack of Efficacy|0
2746665|NCT00045942|9419269|P1|PKC412A2104 (Core)|Lack of Efficacy|13
2746666|NCT00045942|9419261|P9|PKC412A2104 (Core)|Adverse Event|0
2746667|NCT00045942|9419262|P8|PKC412A2104 (Core)|Adverse Event|0
2746668|NCT00045942|9419263|P7|PKC412A2104 (Core)|Adverse Event|0
2746669|NCT00045942|9419264|P6|PKC412A2104 (Core)|Adverse Event|0
2746670|NCT00045942|9419265|P5|PKC412A2104 (Core)|Adverse Event|0
2746671|NCT00045942|9419266|P4|PKC412A2104 (Core)|Adverse Event|0
2746672|NCT00045942|9419267|P3|PKC412A2104 (Core)|Adverse Event|0
2746673|NCT00045942|9419268|P2|PKC412A2104 (Core)|Adverse Event|0
2746674|NCT00045942|9419269|P1|PKC412A2104 (Core)|Adverse Event|5
2746675|NCT00045942|9419261|P9|PKC412A2104 (Core)|Withdrawal by Subject|0
2746676|NCT00045942|9419262|P8|PKC412A2104 (Core)|Withdrawal by Subject|0
2746677|NCT00045942|9419263|P7|PKC412A2104 (Core)|Withdrawal by Subject|0
2746678|NCT00045942|9419264|P6|PKC412A2104 (Core)|Withdrawal by Subject|0
2746679|NCT00045942|9419265|P5|PKC412A2104 (Core)|Withdrawal by Subject|0
2746680|NCT00045942|9419266|P4|PKC412A2104 (Core)|Withdrawal by Subject|0
2746681|NCT00045942|9419267|P3|PKC412A2104 (Core)|Withdrawal by Subject|0
2746682|NCT00045942|9419268|P2|PKC412A2104 (Core)|Withdrawal by Subject|0
2746683|NCT00045942|9419269|P1|PKC412A2104 (Core)|Withdrawal by Subject|1
2746684|NCT00044512|9419358|P1|Follow Up|Lost to Follow-up|2
2746685|NCT00044213|9419373|P4|Overall Study|Lost to Follow-up|4
2746686|NCT00044213|9419374|P3|Overall Study|Lost to Follow-up|5
2746687|NCT00044213|9419375|P2|Overall Study|Lost to Follow-up|5
2746688|NCT00044213|9419376|P1|Overall Study|Lost to Follow-up|8
2746689|NCT00044213|9419373|P4|Overall Study|Death|49
2746690|NCT00044213|9419374|P3|Overall Study|Death|42
2746691|NCT00044213|9419375|P2|Overall Study|Death|42
2746692|NCT00044213|9419376|P1|Overall Study|Death|42
2746693|NCT00044213|9419373|P4|Overall Study|Withdrawal by Subject|83
2746694|NCT00044213|9419374|P3|Overall Study|Withdrawal by Subject|91
2746695|NCT00044213|9419375|P2|Overall Study|Withdrawal by Subject|65
2746696|NCT00044213|9419376|P1|Overall Study|Withdrawal by Subject|50
2746697|NCT00044083|9419441|P2|Second Intervention (One Week) Patients|Withdrawal by Subject|1
2746698|NCT00044083|9419442|P1|Second Intervention (One Week) Patients|Withdrawal by Subject|0
2746699|NCT00044083|9419441|P2|First Intervention (One Week) Patients|Used illegal drug|0
2746700|NCT00044083|9419442|P1|First Intervention (One Week) Patients|Used illegal drug|1
2746701|NCT00044083|9419441|P2|First Intervention (One Week) Patients|Not follow directions|2
2746702|NCT00044083|9419442|P1|First Intervention (One Week) Patients|Not follow directions|0
2746703|NCT00044083|9419441|P2|First Intervention (One Week)- HV's|Drank while on protocol|1
2746704|NCT00044083|9419442|P1|First Intervention (One Week)- HV's|Drank while on protocol|0
2746705|NCT00044083|9419441|P2|First Intervention (One Week)- HV's|Abnormal MRI|1
2746706|NCT00044083|9419442|P1|First Intervention (One Week)- HV's|Abnormal MRI|0
2746707|NCT00044083|9419441|P2|First Intervention (One Week)- HV's|Used illegal drugs|0
2746708|NCT00044083|9419442|P1|First Intervention (One Week)- HV's|Used illegal drugs|1
2746709|NCT00044083|9419441|P2|First Intervention (One Week)- HV's|Pregnancy|0
2746710|NCT00044083|9419442|P1|First Intervention (One Week)- HV's|Pregnancy|1
2746711|NCT00044083|9419441|P2|First Intervention (One Week)- HV's|Withdrawal by Subject|3
2746712|NCT00044083|9419442|P1|First Intervention (One Week)- HV's|Withdrawal by Subject|5
2746713|NCT00044083|9419441|P2|First Intervention (One Week)- HV's|Not follow directions|2
2746714|NCT00044083|9419442|P1|First Intervention (One Week)- HV's|Not follow directions|2
2746715|NCT00044083|9419441|P2|First Intervention (One Week)- HV's|Adverse Event|0
2746716|NCT00044083|9419442|P1|First Intervention (One Week)- HV's|Adverse Event|1
2746717|NCT00043979|9419480|P3|Period 1|recipient with progressive disease|3
2746718|NCT00043979|9419481|P2|Period 1|recipient with progressive disease|4
2746719|NCT00043979|9419482|P1|Period 1|recipient with progressive disease|7
2746720|NCT00043550|9419503|P3|Overall Study|Withdrawal by Subject|20
2746721|NCT00043550|9419504|P2|Overall Study|Withdrawal by Subject|12
2746722|NCT00043550|9419505|P1|Overall Study|Withdrawal by Subject|22
2746723|NCT00043186|9419522|P9|Overall Study|Other|0
2746724|NCT00043186|9419523|P8|Overall Study|Other|0
2746725|NCT00043186|9419524|P7|Overall Study|Other|0
2746726|NCT00043186|9419525|P6|Overall Study|Other|0
2746727|NCT00043186|9419526|P5|Overall Study|Other|0
2746728|NCT00043186|9419527|P4|Overall Study|Other|1
2746729|NCT00043186|9419528|P3|Overall Study|Other|1
2746730|NCT00043186|9419529|P2|Overall Study|Other|0
2746731|NCT00043186|9419530|P1|Overall Study|Other|0
2746732|NCT00043186|9419522|P9|Overall Study|Noncompliance|0
2746733|NCT00043186|9419523|P8|Overall Study|Noncompliance|0
2746734|NCT00043186|9419524|P7|Overall Study|Noncompliance|0
2746735|NCT00043186|9419525|P6|Overall Study|Noncompliance|0
2746736|NCT00043186|9419526|P5|Overall Study|Noncompliance|0
2746737|NCT00043186|9419527|P4|Overall Study|Noncompliance|1
2746738|NCT00043186|9419528|P3|Overall Study|Noncompliance|1
2746739|NCT00043186|9419529|P2|Overall Study|Noncompliance|0
2746740|NCT00043186|9419530|P1|Overall Study|Noncompliance|0
2746741|NCT00043186|9419522|P9|Overall Study|Lost to Follow-up|2
2746742|NCT00043186|9419523|P8|Overall Study|Lost to Follow-up|1
2746743|NCT00043186|9419524|P7|Overall Study|Lost to Follow-up|1
2746744|NCT00043186|9419525|P6|Overall Study|Lost to Follow-up|1
2746745|NCT00043186|9419526|P5|Overall Study|Lost to Follow-up|1
2746746|NCT00043186|9419527|P4|Overall Study|Lost to Follow-up|1
2746747|NCT00043186|9419528|P3|Overall Study|Lost to Follow-up|1
2746748|NCT00043186|9419529|P2|Overall Study|Lost to Follow-up|5
2746749|NCT00043186|9419530|P1|Overall Study|Lost to Follow-up|3
2746750|NCT00043186|9419522|P9|Overall Study|Ineligibility determined|1
2746751|NCT00043186|9419523|P8|Overall Study|Ineligibility determined|0
2746752|NCT00043186|9419524|P7|Overall Study|Ineligibility determined|0
2746753|NCT00043186|9419525|P6|Overall Study|Ineligibility determined|0
2746754|NCT00043186|9419526|P5|Overall Study|Ineligibility determined|0
2746755|NCT00043186|9419527|P4|Overall Study|Ineligibility determined|0
2746756|NCT00043186|9419528|P3|Overall Study|Ineligibility determined|0
2746757|NCT00043186|9419529|P2|Overall Study|Ineligibility determined|0
2746758|NCT00043186|9419530|P1|Overall Study|Ineligibility determined|0
2746759|NCT00043186|9419522|P9|Overall Study|Disease progression|0
2746760|NCT00043186|9419523|P8|Overall Study|Disease progression|4
2746761|NCT00043186|9419524|P7|Overall Study|Disease progression|0
2746762|NCT00043186|9419525|P6|Overall Study|Disease progression|0
2746763|NCT00043186|9419526|P5|Overall Study|Disease progression|0
2746764|NCT00043186|9419527|P4|Overall Study|Disease progression|3
2746765|NCT00043186|9419528|P3|Overall Study|Disease progression|0
2746766|NCT00043186|9419529|P2|Overall Study|Disease progression|0
2746767|NCT00043186|9419530|P1|Overall Study|Disease progression|1
2746768|NCT00043186|9419522|P9|Overall Study|Death|0
2746769|NCT00043186|9419523|P8|Overall Study|Death|0
2746770|NCT00043186|9419524|P7|Overall Study|Death|2
2746771|NCT00043186|9419525|P6|Overall Study|Death|0
2746772|NCT00043186|9419526|P5|Overall Study|Death|0
2746773|NCT00043186|9419527|P4|Overall Study|Death|0
2746774|NCT00043186|9419528|P3|Overall Study|Death|1
2746775|NCT00043186|9419529|P2|Overall Study|Death|0
2746776|NCT00043186|9419530|P1|Overall Study|Death|0
2746777|NCT00043186|9419522|P9|Overall Study|Withdrawal by Subject|10
2746778|NCT00043186|9419523|P8|Overall Study|Withdrawal by Subject|9
2746779|NCT00043186|9419524|P7|Overall Study|Withdrawal by Subject|12
2746780|NCT00043186|9419525|P6|Overall Study|Withdrawal by Subject|6
2746781|NCT00043186|9419526|P5|Overall Study|Withdrawal by Subject|14
2746782|NCT00043186|9419527|P4|Overall Study|Withdrawal by Subject|13
2746783|NCT00043186|9419528|P3|Overall Study|Withdrawal by Subject|11
2746784|NCT00043186|9419529|P2|Overall Study|Withdrawal by Subject|8
2746785|NCT00043186|9419530|P1|Overall Study|Withdrawal by Subject|11
2746786|NCT00043186|9419522|P9|Overall Study|Adverse Event|3
2746787|NCT00043186|9419523|P8|Overall Study|Adverse Event|1
2746788|NCT00043186|9419524|P7|Overall Study|Adverse Event|2
2746789|NCT00043186|9419525|P6|Overall Study|Adverse Event|1
2746790|NCT00043186|9419526|P5|Overall Study|Adverse Event|2
2746791|NCT00043186|9419527|P4|Overall Study|Adverse Event|3
2746792|NCT00043186|9419528|P3|Overall Study|Adverse Event|2
2746793|NCT00043186|9419529|P2|Overall Study|Adverse Event|2
2746794|NCT00043186|9419530|P1|Overall Study|Adverse Event|2
2746795|NCT00043186|9419522|P9|Overall Study|Physician Decision|1
2746796|NCT00043186|9419523|P8|Overall Study|Physician Decision|1
2746797|NCT00043186|9419524|P7|Overall Study|Physician Decision|0
2746798|NCT00043186|9419525|P6|Overall Study|Physician Decision|0
2746799|NCT00043186|9419526|P5|Overall Study|Physician Decision|1
2746800|NCT00043186|9419527|P4|Overall Study|Physician Decision|0
2746801|NCT00043186|9419528|P3|Overall Study|Physician Decision|3
2746802|NCT00043186|9419529|P2|Overall Study|Physician Decision|0
2746803|NCT00043186|9419530|P1|Overall Study|Physician Decision|0
2746804|NCT00042432|9419858|P2|Overall Study|Other|0
2746805|NCT00042432|9419859|P1|Overall Study|Other|2
2746806|NCT00042432|9419858|P2|Overall Study|Initiation of maintenance dialysis|1
2746807|NCT00042432|9419859|P1|Overall Study|Initiation of maintenance dialysis|1
2746808|NCT00042432|9419858|P2|Overall Study|Ineligibility determined|0
2746809|NCT00042432|9419859|P1|Overall Study|Ineligibility determined|1
2746810|NCT00042432|9419858|P2|Overall Study|Death|2
2746811|NCT00042432|9419859|P1|Overall Study|Death|0
2746812|NCT00042432|9419858|P2|Overall Study|Withdrawal by Subject|3
2746813|NCT00042432|9419859|P1|Overall Study|Withdrawal by Subject|1
2746814|NCT00042432|9419858|P2|Overall Study|Adverse Event|1
2746815|NCT00042432|9419859|P1|Overall Study|Adverse Event|4
2746816|NCT00041756|9419912|P5|Overall Study|Data Monitoring Committee Recommendation|21
2746817|NCT00041756|9419913|P4|Overall Study|Data Monitoring Committee Recommendation|0
2746818|NCT00041756|9419914|P3|Overall Study|Data Monitoring Committee Recommendation|0
2746819|NCT00041756|9419915|P2|Overall Study|Data Monitoring Committee Recommendation|0
2746820|NCT00041756|9419916|P1|Overall Study|Data Monitoring Committee Recommendation|0
2746821|NCT00041756|9419912|P5|Overall Study|Unable to meet protocol criteria|1
2746822|NCT00041756|9419913|P4|Overall Study|Unable to meet protocol criteria|0
2746823|NCT00041756|9419914|P3|Overall Study|Unable to meet protocol criteria|1
2746824|NCT00041756|9419915|P2|Overall Study|Unable to meet protocol criteria|0
2746825|NCT00041756|9419916|P1|Overall Study|Unable to meet protocol criteria|0
2746826|NCT00041756|9419912|P5|Overall Study|Lost to Follow-up|0
2746827|NCT00041756|9419913|P4|Overall Study|Lost to Follow-up|1
2746828|NCT00041756|9419914|P3|Overall Study|Lost to Follow-up|0
2746829|NCT00041756|9419915|P2|Overall Study|Lost to Follow-up|1
2746830|NCT00041756|9419916|P1|Overall Study|Lost to Follow-up|0
2746831|NCT00041756|9419912|P5|Overall Study|Withdrawal by Subject|3
2746832|NCT00041756|9419913|P4|Overall Study|Withdrawal by Subject|2
2746833|NCT00041756|9419914|P3|Overall Study|Withdrawal by Subject|4
2746834|NCT00041756|9419915|P2|Overall Study|Withdrawal by Subject|3
2746835|NCT00041756|9419916|P1|Overall Study|Withdrawal by Subject|3
2746836|NCT00041756|9419912|P5|Overall Study|Protocol Violation|1
2746837|NCT00041756|9419913|P4|Overall Study|Protocol Violation|2
2746838|NCT00041756|9419914|P3|Overall Study|Protocol Violation|2
2746839|NCT00041756|9419915|P2|Overall Study|Protocol Violation|1
2746840|NCT00041756|9419916|P1|Overall Study|Protocol Violation|1
2746841|NCT00041756|9419912|P5|Overall Study|Adverse Event|34
2746842|NCT00041756|9419913|P4|Overall Study|Adverse Event|11
2746843|NCT00041756|9419914|P3|Overall Study|Adverse Event|6
2746844|NCT00041756|9419915|P2|Overall Study|Adverse Event|10
2746845|NCT00041756|9419916|P1|Overall Study|Adverse Event|4
2746846|NCT00041470|9419944|P1|Overall Study|Loss of Funding|38
2746847|NCT00040664|9419949|P4|Overall Study|Non-viability of oral suspension|0
2746848|NCT00040664|9419950|P3|Overall Study|Non-viability of oral suspension|1
2746849|NCT00040664|9419951|P2|Overall Study|Non-viability of oral suspension|0
2746850|NCT00040664|9419952|P1|Overall Study|Non-viability of oral suspension|1
2746851|NCT00040664|9419949|P4|Overall Study|Change of formulation|0
2746852|NCT00040664|9419950|P3|Overall Study|Change of formulation|0
2746853|NCT00040664|9419951|P2|Overall Study|Change of formulation|2
2746854|NCT00040664|9419952|P1|Overall Study|Change of formulation|2
2746855|NCT00040664|9419949|P4|Overall Study|Pharmacokinetic target not achieved|1
2746856|NCT00040664|9419950|P3|Overall Study|Pharmacokinetic target not achieved|0
2746857|NCT00040664|9419951|P2|Overall Study|Pharmacokinetic target not achieved|1
2746858|NCT00040664|9419952|P1|Overall Study|Pharmacokinetic target not achieved|2
2746859|NCT00040664|9419949|P4|Overall Study|Poor taste|0
2746860|NCT00040664|9419950|P3|Overall Study|Poor taste|2
2746861|NCT00040664|9419951|P2|Overall Study|Poor taste|0
2746862|NCT00040664|9419952|P1|Overall Study|Poor taste|2
2746863|NCT00040664|9419949|P4|Overall Study|Medication adherence/compliance problems|5
2746864|NCT00040664|9419950|P3|Overall Study|Medication adherence/compliance problems|1
2746865|NCT00040664|9419951|P2|Overall Study|Medication adherence/compliance problems|2
2746866|NCT00040664|9419952|P1|Overall Study|Medication adherence/compliance problems|8
2746867|NCT00040664|9419949|P4|Overall Study|Pregnancy|3
2746868|NCT00040664|9419950|P3|Overall Study|Pregnancy|0
2746869|NCT00040664|9419951|P2|Overall Study|Pregnancy|0
2746870|NCT00040664|9419952|P1|Overall Study|Pregnancy|3
2746871|NCT00040664|9419949|P4|Overall Study|Withdrawal by Subject|4
2746872|NCT00040664|9419950|P3|Overall Study|Withdrawal by Subject|3
2746873|NCT00040664|9419951|P2|Overall Study|Withdrawal by Subject|0
2746874|NCT00040664|9419952|P1|Overall Study|Withdrawal by Subject|7
2746875|NCT00040664|9419949|P4|Overall Study|Protocol Violation|1
2746876|NCT00040664|9419950|P3|Overall Study|Protocol Violation|0
2746877|NCT00040664|9419951|P2|Overall Study|Protocol Violation|1
2746878|NCT00040664|9419952|P1|Overall Study|Protocol Violation|2
2746879|NCT00040664|9419949|P4|Overall Study|Lost to Follow-up|2
2746880|NCT00040664|9419950|P3|Overall Study|Lost to Follow-up|0
2746881|NCT00040664|9419951|P2|Overall Study|Lost to Follow-up|2
2746882|NCT00040664|9419952|P1|Overall Study|Lost to Follow-up|4
2746883|NCT00040664|9419949|P4|Overall Study|Insufficient CD4 response|0
2746884|NCT00040664|9419950|P3|Overall Study|Insufficient CD4 response|1
2746885|NCT00040664|9419951|P2|Overall Study|Insufficient CD4 response|0
2746886|NCT00040664|9419952|P1|Overall Study|Insufficient CD4 response|1
2746887|NCT00040664|9419949|P4|Overall Study|Lack of Efficacy|4
2746888|NCT00040664|9419950|P3|Overall Study|Lack of Efficacy|3
2746889|NCT00040664|9419951|P2|Overall Study|Lack of Efficacy|2
2746890|NCT00040664|9419952|P1|Overall Study|Lack of Efficacy|9
2746891|NCT00040664|9419949|P4|Overall Study|Adverse Event|7
2746892|NCT00040664|9419950|P3|Overall Study|Adverse Event|2
2746893|NCT00040664|9419951|P2|Overall Study|Adverse Event|3
2746894|NCT00040664|9419952|P1|Overall Study|Adverse Event|12
2746895|NCT00040365|9420018|P1|Overall Study|Lost to Follow-up|3
2746896|NCT00040365|9420018|P1|Overall Study|Progressive disease|7
2746897|NCT00040365|9420018|P1|Overall Study|Death|1
2746898|NCT00039871|9420027|P1|Overall Study|Never entered follow-up|7
2746899|NCT00039871|9420027|P1|Overall Study|Discontinued at Week 12 per protocol|1061
2746900|NCT00039871|9420027|P1|Overall Study|Administrative|1
2746901|NCT00039871|9420027|P1|Overall Study|Did not meet eligibility criteria|11
2746902|NCT00039871|9420027|P1|Overall Study|Withdrawal by Subject|97
2746903|NCT00039871|9420027|P1|Overall Study|Protocol Violation|24
2746904|NCT00039871|9420027|P1|Overall Study|Lost to Follow-up|18
2746905|NCT00039871|9420027|P1|Overall Study|Adverse Event|165
2746906|NCT00039741|9420037|P4|Overall Study|Missed final visit|2
2746907|NCT00039741|9420038|P3|Overall Study|Missed final visit|2
2746908|NCT00039741|9420039|P2|Overall Study|Missed final visit|1
2746909|NCT00039741|9420040|P1|Overall Study|Missed final visit|2
2746910|NCT00039741|9420037|P4|Overall Study|Withdrew consent|1
2746911|NCT00039741|9420038|P3|Overall Study|Withdrew consent|0
2746912|NCT00039741|9420039|P2|Overall Study|Withdrew consent|5
2746913|NCT00039741|9420040|P1|Overall Study|Withdrew consent|0
2746914|NCT00039741|9420037|P4|Overall Study|Non-compliance with protocol|0
2746915|NCT00039741|9420038|P3|Overall Study|Non-compliance with protocol|1
2746916|NCT00039741|9420039|P2|Overall Study|Non-compliance with protocol|0
2746917|NCT00039741|9420040|P1|Overall Study|Non-compliance with protocol|1
2746918|NCT00039741|9420037|P4|Overall Study|Moved|6
2746919|NCT00039741|9420038|P3|Overall Study|Moved|3
2746920|NCT00039741|9420039|P2|Overall Study|Moved|2
2746921|NCT00039741|9420040|P1|Overall Study|Moved|3
2746922|NCT00039741|9420037|P4|Overall Study|Not able to get to clinic|3
2746923|NCT00039741|9420038|P3|Overall Study|Not able to get to clinic|0
2746924|NCT00039741|9420039|P2|Overall Study|Not able to get to clinic|2
2746925|NCT00039741|9420040|P1|Overall Study|Not able to get to clinic|5
2746926|NCT00039741|9420037|P4|Overall Study|Confounding medical condition|0
2746927|NCT00039741|9420038|P3|Overall Study|Confounding medical condition|0
2746928|NCT00039741|9420039|P2|Overall Study|Confounding medical condition|0
2746929|NCT00039741|9420040|P1|Overall Study|Confounding medical condition|1
2746930|NCT00039741|9420037|P4|Overall Study|Lost to Follow-up|2
2746931|NCT00039741|9420038|P3|Overall Study|Lost to Follow-up|5
2746932|NCT00039741|9420039|P2|Overall Study|Lost to Follow-up|1
2746933|NCT00039741|9420040|P1|Overall Study|Lost to Follow-up|3
2746934|NCT00039741|9420037|P4|Overall Study|Death|0
2746935|NCT00039741|9420038|P3|Overall Study|Death|0
2746936|NCT00039741|9420039|P2|Overall Study|Death|1
2746937|NCT00039741|9420040|P1|Overall Study|Death|0
2746938|NCT00038948|9420084|P2|Overall Study|Lack of Efficacy|6
2746939|NCT00038948|9420085|P1|Overall Study|Lack of Efficacy|3
2746940|NCT00038948|9420084|P2|Overall Study|Protocol Violation|7
2746941|NCT00038948|9420085|P1|Overall Study|Protocol Violation|3
2746942|NCT00038948|9420084|P2|Overall Study|Withdrawal by Subject|10
2746943|NCT00038948|9420085|P1|Overall Study|Withdrawal by Subject|23
2746944|NCT00038948|9420084|P2|Overall Study|Nonmedical event|7
2746945|NCT00038948|9420085|P1|Overall Study|Nonmedical event|5
2746946|NCT00038948|9420084|P2|Overall Study|Lost to Follow-up|4
2746947|NCT00038948|9420085|P1|Overall Study|Lost to Follow-up|4
2746948|NCT00038948|9420084|P2|Overall Study|Adverse Event|43
2746949|NCT00038948|9420085|P1|Overall Study|Adverse Event|131
2746950|NCT00038649|9420120|P1|Overall Study|Adverse Event|9
2746951|NCT00038467|9420133|P2|Overall Study|Other|28
2746952|NCT00038467|9420134|P1|Overall Study|Other|26
2746953|NCT00038467|9420133|P2|Overall Study|Randomized, but not treated|35
2746954|NCT00038467|9420134|P1|Overall Study|Randomized, but not treated|31
2746955|NCT00038467|9420133|P2|Overall Study|Recurrence|179
2746956|NCT00038467|9420134|P1|Overall Study|Recurrence|109
2746957|NCT00038467|9420133|P2|Overall Study|Lost to Follow-up|10
2746958|NCT00038467|9420134|P1|Overall Study|Lost to Follow-up|15
2746959|NCT00038467|9420133|P2|Overall Study|Death|16
2746960|NCT00038467|9420134|P1|Overall Study|Death|22
2746961|NCT00038467|9420133|P2|Overall Study|Protocol Violation|22
2746962|NCT00038467|9420134|P1|Overall Study|Protocol Violation|19
2746963|NCT00038467|9420133|P2|Overall Study|Withdrawal by Subject|107
2746964|NCT00038467|9420134|P1|Overall Study|Withdrawal by Subject|150
2746965|NCT00038467|9420133|P2|Overall Study|Adverse Event|145
2746966|NCT00038467|9420134|P1|Overall Study|Adverse Event|170
2746967|NCT00038142|9420196|P2|Overall Study|Unknown Reason|0
2746968|NCT00038142|9420197|P1|Overall Study|Unknown Reason|8
2746969|NCT00038142|9420196|P2|Overall Study|Adverse Event|0
2746970|NCT00038142|9420197|P1|Overall Study|Adverse Event|1
2746971|NCT00038142|9420196|P2|Overall Study|Death|0
2746972|NCT00038142|9420197|P1|Overall Study|Death|1
2746973|NCT00038142|9420196|P2|Overall Study|Progressive Disease|7
2746974|NCT00038142|9420197|P1|Overall Study|Progressive Disease|11
2746975|NCT00038142|9420196|P2|Overall Study|Ineligible|0
2746976|NCT00038142|9420197|P1|Overall Study|Ineligible|1
2746977|NCT00038103|9420205|P2|Overall Study|Randomized/never treated|0
2746978|NCT00038103|9420206|P1|Overall Study|Randomized/never treated|2
2746979|NCT00038103|9420205|P2|Overall Study|Sponsor Decision|1
2746980|NCT00038103|9420206|P1|Overall Study|Sponsor Decision|0
2746981|NCT00038103|9420205|P2|Overall Study|Protocol Violation|2
2746982|NCT00038103|9420206|P1|Overall Study|Protocol Violation|0
2746983|NCT00038103|9420205|P2|Overall Study|Lost to Follow-up|3
2746984|NCT00038103|9420206|P1|Overall Study|Lost to Follow-up|0
2746985|NCT00038103|9420205|P2|Overall Study|Withdrawal by Subject|3
2746986|NCT00038103|9420206|P1|Overall Study|Withdrawal by Subject|0
2746987|NCT00038103|9420205|P2|Overall Study|Lack of Efficacy|41
2746988|NCT00038103|9420206|P1|Overall Study|Lack of Efficacy|48
2746989|NCT00038103|9420205|P2|Overall Study|Adverse Event|6
2746990|NCT00038103|9420206|P1|Overall Study|Adverse Event|5
2746991|NCT00037830|9420229|P3|Overall Study|Unrelated Medical Problem|0
2746992|NCT00037830|9420230|P2|Overall Study|Unrelated Medical Problem|0
2746993|NCT00037830|9420231|P1|Overall Study|Unrelated Medical Problem|2
2746994|NCT00037830|9420229|P3|Overall Study|Protocol Violation|0
2746995|NCT00037830|9420230|P2|Overall Study|Protocol Violation|2
2746996|NCT00037830|9420231|P1|Overall Study|Protocol Violation|2
2746997|NCT00037830|9420229|P3|Overall Study|Withdrawal by Subject|1
2746998|NCT00037830|9420230|P2|Overall Study|Withdrawal by Subject|5
2746999|NCT00037830|9420231|P1|Overall Study|Withdrawal by Subject|4
2747000|NCT00037830|9420229|P3|Overall Study|Adverse Event|0
2747001|NCT00037830|9420230|P2|Overall Study|Adverse Event|0
2747002|NCT00037830|9420231|P1|Overall Study|Adverse Event|2
2747003|NCT00036270|9420263|P2|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750
2747004|NCT00036270|9420264|P1|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0
2747005|NCT00036270|9420263|P2|Study Treatment to 5 Year Report|Too early switch|103
2747006|NCT00036270|9420264|P1|Study Treatment to 5 Year Report|Too early switch|0
2747007|NCT00036270|9420263|P2|Study Treatment to 5 Year Report|Intercurrent illness|29
2747008|NCT00036270|9420264|P1|Study Treatment to 5 Year Report|Intercurrent illness|17
2747009|NCT00036270|9420263|P2|Study Treatment to 5 Year Report|Protocol Violation|91
2747010|NCT00036270|9420264|P1|Study Treatment to 5 Year Report|Protocol Violation|23
2747011|NCT00036270|9420263|P2|Study Treatment to 5 Year Report|Randomized but not treated|54
2747012|NCT00036270|9420264|P1|Study Treatment to 5 Year Report|Randomized but not treated|46
2747013|NCT00036270|9420263|P2|Study Treatment to 5 Year Report|Treatment refusal|208
2747014|NCT00036270|9420264|P1|Study Treatment to 5 Year Report|Treatment refusal|113
2747015|NCT00036270|9420263|P2|Study Treatment to 5 Year Report|Other|288
2747016|NCT00036270|9420264|P1|Study Treatment to 5 Year Report|Other|277
2747017|NCT00036270|9420263|P2|Study Treatment to 5 Year Report|Adverse Event|782
2747018|NCT00036270|9420264|P1|Study Treatment to 5 Year Report|Adverse Event|501
2747019|NCT00036270|9420263|P2|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447
2747020|NCT00036270|9420264|P1|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507
2747021|NCT00036270|9420263|P2|Study Treatment to 5 Year Report|Ongoing|736
2747022|NCT00036270|9420264|P1|Study Treatment to 5 Year Report|Ongoing|1081
2747023|NCT00036270|9420263|P2|Randomized to Study Treatment|Withdrawal by Subject|7
2747024|NCT00036270|9420264|P1|Randomized to Study Treatment|Withdrawal by Subject|6
2747025|NCT00035932|9420283|P3|Overall Study|Lack of Efficacy|28
2747026|NCT00035932|9420284|P2|Overall Study|Lack of Efficacy|33
2747027|NCT00035932|9420285|P1|Overall Study|Lack of Efficacy|33
2747028|NCT00035932|9420283|P3|Overall Study|Study Termination by Sponsor|0
2747029|NCT00035932|9420284|P2|Overall Study|Study Termination by Sponsor|0
2747030|NCT00035932|9420285|P1|Overall Study|Study Termination by Sponsor|1
2747031|NCT00035932|9420283|P3|Overall Study|Withdrawal by Subject|0
2747032|NCT00035932|9420284|P2|Overall Study|Withdrawal by Subject|5
2747033|NCT00035932|9420285|P1|Overall Study|Withdrawal by Subject|1
2747034|NCT00035932|9420283|P3|Overall Study|Protocol Violation While on Study|2
2747035|NCT00035932|9420284|P2|Overall Study|Protocol Violation While on Study|1
2747036|NCT00035932|9420285|P1|Overall Study|Protocol Violation While on Study|0
2747037|NCT00035932|9420283|P3|Overall Study|Noncompliance|6
2747038|NCT00035932|9420284|P2|Overall Study|Noncompliance|7
2747039|NCT00035932|9420285|P1|Overall Study|Noncompliance|6
2747040|NCT00035932|9420283|P3|Overall Study|Lost to Follow-up|3
2747041|NCT00035932|9420284|P2|Overall Study|Lost to Follow-up|4
2747042|NCT00035932|9420285|P1|Overall Study|Lost to Follow-up|4
2747043|NCT00035932|9420283|P3|Overall Study|Disease Progression / Relapse|0
2747044|NCT00035932|9420284|P2|Overall Study|Disease Progression / Relapse|1
2747045|NCT00035932|9420285|P1|Overall Study|Disease Progression / Relapse|1
2747046|NCT00035932|9420283|P3|Overall Study|Death|1
2747047|NCT00035932|9420284|P2|Overall Study|Death|0
2747048|NCT00035932|9420285|P1|Overall Study|Death|0
2747049|NCT00035932|9420283|P3|Overall Study|Adverse Event|9
2747050|NCT00035932|9420284|P2|Overall Study|Adverse Event|9
2747051|NCT00035932|9420285|P1|Overall Study|Adverse Event|10
2747052|NCT00035815|9420411|P2|Overall Study|Withdrawal by Subject|11
2747053|NCT00035815|9420412|P1|Overall Study|Withdrawal by Subject|17
2747054|NCT00035555|9420425|P3|Overall Study|Received cyclosporin in error|1
2747055|NCT00035555|9420426|P2|Overall Study|Received cyclosporin in error|0
2747056|NCT00035555|9420427|P1|Overall Study|Received cyclosporin in error|0
2747057|NCT00035555|9420425|P3|Overall Study|Investigator deemed not a good candidate|1
2747058|NCT00035555|9420426|P2|Overall Study|Investigator deemed not a good candidate|0
2747059|NCT00035555|9420427|P1|Overall Study|Investigator deemed not a good candidate|0
2747060|NCT00035555|9420425|P3|Overall Study|Withdrawal by Subject|2
2747061|NCT00035555|9420426|P2|Overall Study|Withdrawal by Subject|0
2747062|NCT00035555|9420427|P1|Overall Study|Withdrawal by Subject|2
2747063|NCT00035555|9420425|P3|Overall Study|Treatment failure/lack of efficacy|3
2747064|NCT00035555|9420426|P2|Overall Study|Treatment failure/lack of efficacy|5
2747065|NCT00035555|9420427|P1|Overall Study|Treatment failure/lack of efficacy|7
2747066|NCT00035555|9420425|P3|Overall Study|Prohibited medication|0
2747067|NCT00035555|9420426|P2|Overall Study|Prohibited medication|1
2747068|NCT00035555|9420427|P1|Overall Study|Prohibited medication|1
2747069|NCT00035555|9420425|P3|Overall Study|Noncompliance|1
2747070|NCT00035555|9420426|P2|Overall Study|Noncompliance|1
2747071|NCT00035555|9420427|P1|Overall Study|Noncompliance|0
2747072|NCT00035555|9420425|P3|Overall Study|Lost to Follow-up|1
2747073|NCT00035555|9420426|P2|Overall Study|Lost to Follow-up|0
2747074|NCT00035555|9420427|P1|Overall Study|Lost to Follow-up|0
2747075|NCT00035555|9420425|P3|Overall Study|Death|2
2747076|NCT00035555|9420426|P2|Overall Study|Death|0
2747077|NCT00035555|9420427|P1|Overall Study|Death|0
2747078|NCT00035555|9420425|P3|Overall Study|Allograft loss|2
2747079|NCT00035555|9420426|P2|Overall Study|Allograft loss|1
2747080|NCT00035555|9420427|P1|Overall Study|Allograft loss|1
2747081|NCT00035555|9420425|P3|Overall Study|Adverse Event|9
2747082|NCT00035555|9420426|P2|Overall Study|Adverse Event|8
2747083|NCT00035555|9420427|P1|Overall Study|Adverse Event|5
2747084|NCT00032487|9420511|P2|Overall Study|Had other reason|12
2747085|NCT00032487|9420512|P1|Overall Study|Had other reason|12
2747086|NCT00032487|9420511|P2|Overall Study|Lost to Follow-up|58
2747087|NCT00032487|9420512|P1|Overall Study|Lost to Follow-up|57
2747088|NCT00032487|9420511|P2|Overall Study|Adverse Event|7
2747089|NCT00032487|9420512|P1|Overall Study|Adverse Event|3
2747090|NCT00032487|9420511|P2|Overall Study|Withdrawal by Subject|43
2747091|NCT00032487|9420512|P1|Overall Study|Withdrawal by Subject|67
2747092|NCT00031551|9420522|P2|Overall Study|Withdrew due to chemotherapy effects|0
2747093|NCT00031551|9420523|P1|Overall Study|Withdrew due to chemotherapy effects|2
2747094|NCT00031486|9420535|P2|Overall Study|Other|1
2747095|NCT00031486|9420536|P1|Overall Study|Other|1
2747096|NCT00031486|9420535|P2|Overall Study|Did not meet eligibility requirement|1
2747097|NCT00031486|9420536|P1|Overall Study|Did not meet eligibility requirement|2
2747098|NCT00031486|9420535|P2|Overall Study|Non-compliant|4
2747099|NCT00031486|9420536|P1|Overall Study|Non-compliant|0
2747100|NCT00031486|9420535|P2|Overall Study|Death|3
2747101|NCT00031486|9420536|P1|Overall Study|Death|0
2747102|NCT00031486|9420535|P2|Overall Study|Withdrawal by Subject|2
2747103|NCT00031486|9420536|P1|Overall Study|Withdrawal by Subject|3
2747104|NCT00031486|9420535|P2|Overall Study|Lost to Follow-up|1
2747105|NCT00031486|9420536|P1|Overall Study|Lost to Follow-up|0
2747106|NCT00031486|9420535|P2|Overall Study|Adverse Event|0
2747107|NCT00031486|9420536|P1|Overall Study|Adverse Event|1
2747108|NCT00031460|9420562|P2|Overall Study|Confirmed unevaluable|1
2747109|NCT00031460|9420563|P1|Overall Study|Confirmed unevaluable|0
2747110|NCT00031460|9420562|P2|Overall Study|Disruption of blinded drug supply|0
2747111|NCT00031460|9420563|P1|Overall Study|Disruption of blinded drug supply|2
2747112|NCT00031460|9420562|P2|Overall Study|Reactivation of Disease|9
2747113|NCT00031460|9420563|P1|Overall Study|Reactivation of Disease|5
2747114|NCT00031460|9420562|P2|Overall Study|Death|1
2747115|NCT00031460|9420563|P1|Overall Study|Death|0
2747116|NCT00031460|9420562|P2|Overall Study|Non-Compliant|1
2747117|NCT00031460|9420563|P1|Overall Study|Non-Compliant|1
2747118|NCT00031460|9420562|P2|Overall Study|Withdrawal by Subject|1
2747119|NCT00031460|9420563|P1|Overall Study|Withdrawal by Subject|1
2747120|NCT00031460|9420562|P2|Overall Study|Lost to Follow-up|1
2747121|NCT00031460|9420563|P1|Overall Study|Lost to Follow-up|0
2747122|NCT00031447|9420577|P2|Overall Study|Disruption of blinded study drug supply|4
2747123|NCT00031447|9420578|P1|Overall Study|Disruption of blinded study drug supply|7
2747124|NCT00031447|9420577|P2|Overall Study|Re-activation of Disease|1
2747125|NCT00031447|9420578|P1|Overall Study|Re-activation of Disease|2
2747126|NCT00031447|9420577|P2|Overall Study|Non-compliant|1
2747127|NCT00031447|9420578|P1|Overall Study|Non-compliant|1
2747128|NCT00031447|9420577|P2|Overall Study|Lost to Follow-up|1
2747129|NCT00031447|9420578|P1|Overall Study|Lost to Follow-up|0
2747130|NCT00029146|9420653|P2|Overall Study|Lost to Follow-up|1
2747131|NCT00029146|9420654|P1|Overall Study|Lost to Follow-up|2
2747132|NCT00027378|9420705|P2|Overall Study|Physician Decision|3
2747133|NCT00027378|9420706|P1|Overall Study|Physician Decision|0
2747134|NCT00027027|9420719|P5|Overall Study|Withdrawal by Subject|1
2747135|NCT00027027|9420720|P4|Overall Study|Withdrawal by Subject|0
2747136|NCT00027027|9420721|P3|Overall Study|Withdrawal by Subject|0
2747137|NCT00027027|9420722|P2|Overall Study|Withdrawal by Subject|0
2747138|NCT00027027|9420723|P1|Overall Study|Withdrawal by Subject|0
2747139|NCT00027027|9420719|P5|Overall Study|Physician Decision Due To PD|5
2747140|NCT00027027|9420720|P4|Overall Study|Physician Decision Due To PD|3
2747141|NCT00027027|9420721|P3|Overall Study|Physician Decision Due To PD|2
2747142|NCT00027027|9420722|P2|Overall Study|Physician Decision Due To PD|3
2747143|NCT00027027|9420723|P1|Overall Study|Physician Decision Due To PD|2
2747144|NCT00027027|9420719|P5|Overall Study|PD Requiring Surgery|0
2747145|NCT00027027|9420720|P4|Overall Study|PD Requiring Surgery|0
2747146|NCT00027027|9420721|P3|Overall Study|PD Requiring Surgery|1
2747147|NCT00027027|9420722|P2|Overall Study|PD Requiring Surgery|0
2747148|NCT00027027|9420723|P1|Overall Study|PD Requiring Surgery|0
2747149|NCT00027027|9420719|P5|Overall Study|Clinical Symptoms Progression not PD|0
2747150|NCT00027027|9420720|P4|Overall Study|Clinical Symptoms Progression not PD|0
2747151|NCT00027027|9420721|P3|Overall Study|Clinical Symptoms Progression not PD|0
2747152|NCT00027027|9420722|P2|Overall Study|Clinical Symptoms Progression not PD|0
2747153|NCT00027027|9420723|P1|Overall Study|Clinical Symptoms Progression not PD|1
2747154|NCT00027027|9420719|P5|Overall Study|Admitted for Signs of PD|1
2747155|NCT00027027|9420720|P4|Overall Study|Admitted for Signs of PD|0
2747156|NCT00027027|9420721|P3|Overall Study|Admitted for Signs of PD|0
2747157|NCT00027027|9420722|P2|Overall Study|Admitted for Signs of PD|0
2747158|NCT00027027|9420723|P1|Overall Study|Admitted for Signs of PD|0
2747159|NCT00027027|9420719|P5|Overall Study|Adverse Event|1
2747160|NCT00027027|9420720|P4|Overall Study|Adverse Event|0
2747161|NCT00027027|9420721|P3|Overall Study|Adverse Event|1
2747162|NCT00027027|9420722|P2|Overall Study|Adverse Event|0
2747163|NCT00027027|9420723|P1|Overall Study|Adverse Event|0
2747164|NCT00025883|9420770|P1|Overall Study|didn't reach 6 months of Metreleptin|10
2747165|NCT00025883|9420770|P1|Overall Study|Adverse Event|1
2747166|NCT00025883|9420770|P1|Overall Study|Death|1
2747167|NCT00025883|9420770|P1|Overall Study|no baseline data|1
2747168|NCT00025883|9420770|P1|Overall Study|had atypical progeriod lipodystrophy|4
2747169|NCT00023595|9420782|P5|10 Year Follow up|Lost to Follow-up|0
2747170|NCT00023595|9420783|P4|10 Year Follow up|Lost to Follow-up|0
2747171|NCT00023595|9420784|P3|10 Year Follow up|Lost to Follow-up|3
2747172|NCT00023595|9420785|P2|10 Year Follow up|Lost to Follow-up|10
2747173|NCT00023595|9420786|P1|10 Year Follow up|Lost to Follow-up|12
2747174|NCT00023595|9420782|P5|5 Year Follow up|Lost to Follow-up|3
2747175|NCT00023595|9420783|P4|5 Year Follow up|Lost to Follow-up|7
2747176|NCT00023595|9420784|P3|5 Year Follow up|Lost to Follow-up|1
2747177|NCT00023595|9420785|P2|5 Year Follow up|Lost to Follow-up|2
2747178|NCT00023595|9420786|P1|5 Year Follow up|Lost to Follow-up|2
2747179|NCT00023452|9420997|P2|Overall Study|Other|69
2747180|NCT00023452|9420998|P1|Overall Study|Other|204
2747181|NCT00023452|9420997|P2|Overall Study|Pregnant|20
2747182|NCT00023452|9420998|P1|Overall Study|Pregnant|53
2747183|NCT00023452|9420997|P2|Overall Study|Refused Treatment (continued follow-up)|224
2747184|NCT00023452|9420998|P1|Overall Study|Refused Treatment (continued follow-up)|225
2747185|NCT00023452|9420997|P2|Overall Study|Physician Decision|21
2747186|NCT00023452|9420998|P1|Overall Study|Physician Decision|49
2747187|NCT00023452|9420997|P2|Overall Study|Lost to Follow-up|60
2747188|NCT00023452|9420998|P1|Overall Study|Lost to Follow-up|293
2747189|NCT00023452|9420997|P2|Overall Study|Adverse Event|196
2747190|NCT00023452|9420998|P1|Overall Study|Adverse Event|139
2747191|NCT00023452|9420997|P2|Overall Study|Withdrawal by Subject|54
2747192|NCT00023452|9420998|P1|Overall Study|Withdrawal by Subject|66
2747193|NCT00023452|9420997|P2|Overall Study|Death|0
2747194|NCT00023452|9420998|P1|Overall Study|Death|2
2747195|NCT00023452|9420997|P2|Overall Study|Out of Window|69
2747196|NCT00023452|9420998|P1|Overall Study|Out of Window|129
2747197|NCT00023452|9420997|P2|Overall Study|Ineligible for Study|159
2747198|NCT00023452|9420998|P1|Overall Study|Ineligible for Study|163
2747199|NCT00023322|9421022|P1|Overall Study|Lost to Follow-up|1
2747200|NCT00022763|9421046|P2|Overall Study|Admin|2
2747201|NCT00022763|9421047|P1|Overall Study|Admin|3
2747202|NCT00022763|9421046|P2|Overall Study|Insufficient Therapy|0
2747203|NCT00022763|9421047|P1|Overall Study|Insufficient Therapy|1
2747204|NCT00022763|9421046|P2|Overall Study|Withdrawal by Subject|7
2747205|NCT00022763|9421047|P1|Overall Study|Withdrawal by Subject|4
2747206|NCT00022763|9421046|P2|Overall Study|Lost to Follow-up|3
2747207|NCT00022763|9421047|P1|Overall Study|Lost to Follow-up|0
2747208|NCT00022763|9421046|P2|Overall Study|Death|1
2747209|NCT00022763|9421047|P1|Overall Study|Death|0
2747210|NCT00022763|9421046|P2|Overall Study|Injection Site Reactions|2
2747211|NCT00022763|9421047|P1|Overall Study|Injection Site Reactions|0
2747212|NCT00022763|9421046|P2|Overall Study|Adverse Event|2
2747213|NCT00022763|9421047|P1|Overall Study|Adverse Event|1
2747214|NCT00014911|9421089|P1|Overall Study|Immunosuppression-related Side Effects|1
2747215|NCT00014911|9421089|P1|Overall Study|Unknown Reasons|2
2747216|NCT00014911|9421089|P1|Overall Study|Withdrawal by Subject|6
2747217|NCT00014911|9421089|P1|Overall Study|Lost to Follow-up|1
2747218|NCT00014911|9421089|P1|Overall Study|Adverse Event|1
2747219|NCT00006604|9421105|P17|Overall Study|Other Reason|0
2747220|NCT00006604|9421106|P16|Overall Study|Other Reason|0
2747221|NCT00006604|9421107|P15|Overall Study|Other Reason|0
2747222|NCT00006604|9421108|P14|Overall Study|Other Reason|0
2747223|NCT00006604|9421109|P13|Overall Study|Other Reason|0
2747224|NCT00006604|9421110|P12|Overall Study|Other Reason|0
2747225|NCT00006604|9421111|P11|Overall Study|Other Reason|0
2747226|NCT00006604|9421112|P10|Overall Study|Other Reason|1
2747227|NCT00006604|9421113|P9|Overall Study|Other Reason|0
2747228|NCT00006604|9421114|P8|Overall Study|Other Reason|0
2747229|NCT00006604|9421115|P7|Overall Study|Other Reason|0
2747230|NCT00006604|9421116|P6|Overall Study|Other Reason|1
2747231|NCT00006604|9421117|P5|Overall Study|Other Reason|0
2747232|NCT00006604|9421118|P4|Overall Study|Other Reason|0
2747233|NCT00006604|9421119|P3|Overall Study|Other Reason|0
2747234|NCT00006604|9421120|P2|Overall Study|Other Reason|0
2747235|NCT00006604|9421121|P1|Overall Study|Other Reason|0
2747236|NCT00006604|9421105|P17|Overall Study|Lost to Follow-up|3
2747237|NCT00006604|9421106|P16|Overall Study|Lost to Follow-up|1
2747238|NCT00006604|9421107|P15|Overall Study|Lost to Follow-up|0
2747239|NCT00006604|9421108|P14|Overall Study|Lost to Follow-up|0
2747240|NCT00006604|9421109|P13|Overall Study|Lost to Follow-up|0
2747241|NCT00006604|9421110|P12|Overall Study|Lost to Follow-up|0
2747242|NCT00006604|9421111|P11|Overall Study|Lost to Follow-up|0
2747243|NCT00006604|9421112|P10|Overall Study|Lost to Follow-up|2
2747244|NCT00006604|9421113|P9|Overall Study|Lost to Follow-up|0
2747245|NCT00006604|9421114|P8|Overall Study|Lost to Follow-up|1
2747246|NCT00006604|9421115|P7|Overall Study|Lost to Follow-up|0
2747247|NCT00006604|9421116|P6|Overall Study|Lost to Follow-up|0
2747248|NCT00006604|9421117|P5|Overall Study|Lost to Follow-up|0
2747249|NCT00006604|9421118|P4|Overall Study|Lost to Follow-up|0
2747250|NCT00006604|9421119|P3|Overall Study|Lost to Follow-up|0
2747251|NCT00006604|9421120|P2|Overall Study|Lost to Follow-up|0
2747252|NCT00006604|9421121|P1|Overall Study|Lost to Follow-up|0
2747253|NCT00006604|9421105|P17|Overall Study|Subj/parent not willing to adhere to req|4
2747254|NCT00006604|9421106|P16|Overall Study|Subj/parent not willing to adhere to req|3
2747255|NCT00006604|9421107|P15|Overall Study|Subj/parent not willing to adhere to req|3
2747256|NCT00006604|9421108|P14|Overall Study|Subj/parent not willing to adhere to req|2
2747257|NCT00006604|9421109|P13|Overall Study|Subj/parent not willing to adhere to req|0
2747258|NCT00006604|9421110|P12|Overall Study|Subj/parent not willing to adhere to req|0
2747259|NCT00006604|9421111|P11|Overall Study|Subj/parent not willing to adhere to req|3
2747260|NCT00006604|9421112|P10|Overall Study|Subj/parent not willing to adhere to req|6
2747261|NCT00006604|9421113|P9|Overall Study|Subj/parent not willing to adhere to req|0
2747262|NCT00006604|9421114|P8|Overall Study|Subj/parent not willing to adhere to req|1
2747263|NCT00006604|9421115|P7|Overall Study|Subj/parent not willing to adhere to req|3
2747264|NCT00006604|9421116|P6|Overall Study|Subj/parent not willing to adhere to req|0
2747265|NCT00006604|9421117|P5|Overall Study|Subj/parent not willing to adhere to req|0
2747266|NCT00006604|9421118|P4|Overall Study|Subj/parent not willing to adhere to req|3
2747267|NCT00006604|9421119|P3|Overall Study|Subj/parent not willing to adhere to req|1
2747268|NCT00006604|9421120|P2|Overall Study|Subj/parent not willing to adhere to req|0
2747269|NCT00006604|9421121|P1|Overall Study|Subj/parent not willing to adhere to req|0
2747270|NCT00006604|9421105|P17|Overall Study|Withdrawal by Subject|1
2747271|NCT00006604|9421106|P16|Overall Study|Withdrawal by Subject|0
2747272|NCT00006604|9421107|P15|Overall Study|Withdrawal by Subject|1
2747273|NCT00006604|9421108|P14|Overall Study|Withdrawal by Subject|2
2747274|NCT00006604|9421109|P13|Overall Study|Withdrawal by Subject|1
2747275|NCT00006604|9421110|P12|Overall Study|Withdrawal by Subject|0
2747276|NCT00006604|9421111|P11|Overall Study|Withdrawal by Subject|2
2747277|NCT00006604|9421112|P10|Overall Study|Withdrawal by Subject|3
2747278|NCT00006604|9421113|P9|Overall Study|Withdrawal by Subject|1
2747279|NCT00006604|9421114|P8|Overall Study|Withdrawal by Subject|0
2747280|NCT00006604|9421115|P7|Overall Study|Withdrawal by Subject|2
2747281|NCT00006604|9421116|P6|Overall Study|Withdrawal by Subject|2
2747282|NCT00006604|9421117|P5|Overall Study|Withdrawal by Subject|1
2747283|NCT00006604|9421118|P4|Overall Study|Withdrawal by Subject|0
2747284|NCT00006604|9421119|P3|Overall Study|Withdrawal by Subject|2
2747285|NCT00006604|9421120|P2|Overall Study|Withdrawal by Subject|0
2747286|NCT00006604|9421121|P1|Overall Study|Withdrawal by Subject|1
2747287|NCT00006604|9421105|P17|Overall Study|Site closing|1
2747288|NCT00006604|9421106|P16|Overall Study|Site closing|0
2747289|NCT00006604|9421107|P15|Overall Study|Site closing|0
2747290|NCT00006604|9421108|P14|Overall Study|Site closing|1
2747291|NCT00006604|9421109|P13|Overall Study|Site closing|1
2747292|NCT00006604|9421110|P12|Overall Study|Site closing|1
2747293|NCT00006604|9421111|P11|Overall Study|Site closing|0
2747294|NCT00006604|9421112|P10|Overall Study|Site closing|0
2747295|NCT00006604|9421113|P9|Overall Study|Site closing|0
2747296|NCT00006604|9421114|P8|Overall Study|Site closing|1
2747297|NCT00006604|9421115|P7|Overall Study|Site closing|0
2747298|NCT00006604|9421116|P6|Overall Study|Site closing|0
2747299|NCT00006604|9421117|P5|Overall Study|Site closing|0
2747300|NCT00006604|9421118|P4|Overall Study|Site closing|1
2747301|NCT00006604|9421119|P3|Overall Study|Site closing|1
2747302|NCT00006604|9421120|P2|Overall Study|Site closing|0
2747303|NCT00006604|9421121|P1|Overall Study|Site closing|0
2747304|NCT00006604|9421105|P17|Overall Study|Subj/Parent not able to get to clinic|0
2747305|NCT00006604|9421106|P16|Overall Study|Subj/Parent not able to get to clinic|0
2747306|NCT00006604|9421107|P15|Overall Study|Subj/Parent not able to get to clinic|3
2747307|NCT00006604|9421108|P14|Overall Study|Subj/Parent not able to get to clinic|1
2747308|NCT00006604|9421109|P13|Overall Study|Subj/Parent not able to get to clinic|1
2747309|NCT00006604|9421110|P12|Overall Study|Subj/Parent not able to get to clinic|1
2747310|NCT00006604|9421111|P11|Overall Study|Subj/Parent not able to get to clinic|2
2747311|NCT00006604|9421112|P10|Overall Study|Subj/Parent not able to get to clinic|1
2747312|NCT00006604|9421113|P9|Overall Study|Subj/Parent not able to get to clinic|0
2747313|NCT00006604|9421114|P8|Overall Study|Subj/Parent not able to get to clinic|0
2747314|NCT00006604|9421115|P7|Overall Study|Subj/Parent not able to get to clinic|1
2747315|NCT00006604|9421116|P6|Overall Study|Subj/Parent not able to get to clinic|0
2747316|NCT00006604|9421117|P5|Overall Study|Subj/Parent not able to get to clinic|1
2747317|NCT00006604|9421118|P4|Overall Study|Subj/Parent not able to get to clinic|1
2747318|NCT00006604|9421119|P3|Overall Study|Subj/Parent not able to get to clinic|0
2747319|NCT00006604|9421120|P2|Overall Study|Subj/Parent not able to get to clinic|0
2747320|NCT00006604|9421121|P1|Overall Study|Subj/Parent not able to get to clinic|0
2747321|NCT00006604|9421105|P17|Overall Study|Severe debilitation, unable to continue|0
2747322|NCT00006604|9421106|P16|Overall Study|Severe debilitation, unable to continue|0
2747323|NCT00006604|9421107|P15|Overall Study|Severe debilitation, unable to continue|2
2747324|NCT00006604|9421108|P14|Overall Study|Severe debilitation, unable to continue|0
2747325|NCT00006604|9421109|P13|Overall Study|Severe debilitation, unable to continue|1
2747326|NCT00006604|9421110|P12|Overall Study|Severe debilitation, unable to continue|2
2747327|NCT00006604|9421111|P11|Overall Study|Severe debilitation, unable to continue|0
2747328|NCT00006604|9421112|P10|Overall Study|Severe debilitation, unable to continue|5
2747329|NCT00006604|9421113|P9|Overall Study|Severe debilitation, unable to continue|0
2747330|NCT00006604|9421114|P8|Overall Study|Severe debilitation, unable to continue|0
2747331|NCT00006604|9421115|P7|Overall Study|Severe debilitation, unable to continue|3
2747332|NCT00006604|9421116|P6|Overall Study|Severe debilitation, unable to continue|0
2747333|NCT00006604|9421117|P5|Overall Study|Severe debilitation, unable to continue|0
2747334|NCT00006604|9421118|P4|Overall Study|Severe debilitation, unable to continue|0
2747335|NCT00006604|9421119|P3|Overall Study|Severe debilitation, unable to continue|0
2747336|NCT00006604|9421120|P2|Overall Study|Severe debilitation, unable to continue|0
2747337|NCT00006604|9421121|P1|Overall Study|Severe debilitation, unable to continue|0
2747338|NCT00006604|9421105|P17|Overall Study|Death|0
2747339|NCT00006604|9421106|P16|Overall Study|Death|0
2747340|NCT00006604|9421107|P15|Overall Study|Death|0
2747341|NCT00006604|9421108|P14|Overall Study|Death|0
2747342|NCT00006604|9421109|P13|Overall Study|Death|0
2747343|NCT00006604|9421110|P12|Overall Study|Death|1
2747344|NCT00006604|9421111|P11|Overall Study|Death|1
2747345|NCT00006604|9421112|P10|Overall Study|Death|1
2747346|NCT00006604|9421113|P9|Overall Study|Death|0
2747347|NCT00006604|9421114|P8|Overall Study|Death|0
2747348|NCT00006604|9421115|P7|Overall Study|Death|0
2747349|NCT00006604|9421116|P6|Overall Study|Death|0
2747350|NCT00006604|9421117|P5|Overall Study|Death|0
2747351|NCT00006604|9421118|P4|Overall Study|Death|0
2747352|NCT00006604|9421119|P3|Overall Study|Death|0
2747353|NCT00006604|9421120|P2|Overall Study|Death|0
2747354|NCT00006604|9421121|P1|Overall Study|Death|0
2747355|NCT00006604|9421105|P17|Overall Study|Randomization entry error-no RX, no FU|0
2747356|NCT00006604|9421106|P16|Overall Study|Randomization entry error-no RX, no FU|0
2747357|NCT00006604|9421107|P15|Overall Study|Randomization entry error-no RX, no FU|0
2747358|NCT00006604|9421108|P14|Overall Study|Randomization entry error-no RX, no FU|0
2747359|NCT00006604|9421109|P13|Overall Study|Randomization entry error-no RX, no FU|0
2747360|NCT00006604|9421110|P12|Overall Study|Randomization entry error-no RX, no FU|1
2747361|NCT00006604|9421111|P11|Overall Study|Randomization entry error-no RX, no FU|0
2747362|NCT00006604|9421112|P10|Overall Study|Randomization entry error-no RX, no FU|0
2747363|NCT00006604|9421113|P9|Overall Study|Randomization entry error-no RX, no FU|0
2747364|NCT00006604|9421114|P8|Overall Study|Randomization entry error-no RX, no FU|0
2747365|NCT00006604|9421115|P7|Overall Study|Randomization entry error-no RX, no FU|0
2747366|NCT00006604|9421116|P6|Overall Study|Randomization entry error-no RX, no FU|0
2747367|NCT00006604|9421117|P5|Overall Study|Randomization entry error-no RX, no FU|0
2747368|NCT00006604|9421118|P4|Overall Study|Randomization entry error-no RX, no FU|0
2747369|NCT00006604|9421119|P3|Overall Study|Randomization entry error-no RX, no FU|0
2747370|NCT00006604|9421120|P2|Overall Study|Randomization entry error-no RX, no FU|0
2747371|NCT00006604|9421121|P1|Overall Study|Randomization entry error-no RX, no FU|0
2747372|NCT00006604|9421105|P17|Overall Study|Met study objective - no further FU|0
2747373|NCT00006604|9421106|P16|Overall Study|Met study objective - no further FU|1
2747374|NCT00006604|9421107|P15|Overall Study|Met study objective - no further FU|1
2747375|NCT00006604|9421108|P14|Overall Study|Met study objective - no further FU|0
2747376|NCT00006604|9421109|P13|Overall Study|Met study objective - no further FU|0
2747377|NCT00006604|9421110|P12|Overall Study|Met study objective - no further FU|0
2747378|NCT00006604|9421111|P11|Overall Study|Met study objective - no further FU|0
2747379|NCT00006604|9421112|P10|Overall Study|Met study objective - no further FU|0
2747380|NCT00006604|9421113|P9|Overall Study|Met study objective - no further FU|0
2747381|NCT00006604|9421114|P8|Overall Study|Met study objective - no further FU|0
2747382|NCT00006604|9421115|P7|Overall Study|Met study objective - no further FU|0
2747383|NCT00006604|9421116|P6|Overall Study|Met study objective - no further FU|0
2747384|NCT00006604|9421117|P5|Overall Study|Met study objective - no further FU|0
2747385|NCT00006604|9421118|P4|Overall Study|Met study objective - no further FU|0
2747386|NCT00006604|9421119|P3|Overall Study|Met study objective - no further FU|0
2747387|NCT00006604|9421120|P2|Overall Study|Met study objective - no further FU|0
2747388|NCT00006604|9421121|P1|Overall Study|Met study objective - no further FU|1
2747389|NCT00004978|9421237|P2|Overall Study|site closure - not in analysis cohort|20
2747390|NCT00004978|9421238|P1|Overall Study|site closure - not in analysis cohort|19
2747391|NCT00004978|9421237|P2|Overall Study|Withdrawal by Subject|26
2747392|NCT00004978|9421238|P1|Overall Study|Withdrawal by Subject|17
2747393|NCT00004978|9421237|P2|Overall Study|Lost to Follow-up|108
2747394|NCT00004978|9421238|P1|Overall Study|Lost to Follow-up|101
2747395|NCT00004978|9421237|P2|Overall Study|Death|116
2747396|NCT00004978|9421238|P1|Overall Study|Death|107
2747397|NCT00021541|9421264|P2|Period 2-crossover|Pts that did not progress|3
2747398|NCT00021541|9421265|P1|Period 2-crossover|Pts that did not progress|2
2747399|NCT00021541|9421264|P2|Period 2-crossover|non-adherence|0
2747400|NCT00021541|9421265|P1|Period 2-crossover|non-adherence|1
2747401|NCT00021541|9421264|P2|Period 2-crossover|Adverse Event|2
2747402|NCT00021541|9421265|P1|Period 2-crossover|Adverse Event|2
2747403|NCT00021541|9421264|P2|Period 2-crossover|Withdrawal by Subject|4
2747404|NCT00021541|9421265|P1|Period 2-crossover|Withdrawal by Subject|3
2747405|NCT00021541|9421264|P2|Period 2-crossover|refused phase B|2
2747406|NCT00021541|9421265|P1|Period 2-crossover|refused phase B|2
2747407|NCT00021541|9421264|P2|Period 1-First Treatment|Ineligible|2
2747408|NCT00021541|9421265|P1|Period 1-First Treatment|Ineligible|0
2747409|NCT00021541|9421264|P2|Period 1-First Treatment|Pts that did not progress|2
2747410|NCT00021541|9421265|P1|Period 1-First Treatment|Pts that did not progress|2
2747411|NCT00021541|9421264|P2|Period 1-First Treatment|Death|0
2747412|NCT00021541|9421265|P1|Period 1-First Treatment|Death|1
2747413|NCT00021541|9421264|P2|Period 1-First Treatment|non-adherence|0
2747414|NCT00021541|9421265|P1|Period 1-First Treatment|non-adherence|3
2747415|NCT00021541|9421264|P2|Period 1-First Treatment|Adverse Event|1
2747416|NCT00021541|9421265|P1|Period 1-First Treatment|Adverse Event|2
2747417|NCT00021541|9421264|P2|Period 1-First Treatment|Withdrawal by Subject|3
2747418|NCT00021541|9421265|P1|Period 1-First Treatment|Withdrawal by Subject|3
2747419|NCT00015457|9421279|P2|Second Intervention|Withdrawal by Subject|0
2747420|NCT00015457|9421280|P1|Second Intervention|Withdrawal by Subject|1
2747421|NCT00015457|9421279|P2|First Intervention|Lack of Efficacy|1
2747422|NCT00015457|9421280|P1|First Intervention|Lack of Efficacy|0
2747423|NCT00015457|9421279|P2|First Intervention|Adverse Event|2
2747424|NCT00015457|9421280|P1|First Intervention|Adverse Event|0
2747425|NCT00013611|9421290|P2|Overall Study|Lost to Follow-up|100
2747426|NCT00013611|9421291|P1|Overall Study|Lost to Follow-up|91
2747427|NCT00010803|9421309|P2|Overall Study|Withdrawal by Subject|98
2747428|NCT00010803|9421310|P1|Overall Study|Withdrawal by Subject|97
2747429|NCT00007475|9421337|P4|Overall Study|Adverse Event|0
2747430|NCT00007475|9421338|P3|Overall Study|Adverse Event|0
2747431|NCT00007475|9421339|P2|Overall Study|Adverse Event|0
2747432|NCT00007475|9421340|P1|Overall Study|Adverse Event|3
2747433|NCT00007475|9421337|P4|Overall Study|Withdrawal by Subject|0
2747434|NCT00007475|9421338|P3|Overall Study|Withdrawal by Subject|0
2747435|NCT00007475|9421339|P2|Overall Study|Withdrawal by Subject|0
2747436|NCT00007475|9421340|P1|Overall Study|Withdrawal by Subject|1
2747437|NCT00007345|9421362|P2|Overall Study|Death on study|1
2747438|NCT00007345|9421363|P1|Overall Study|Death on study|1
2747439|NCT00007345|9421362|P2|Overall Study|Intercurrent illness|0
2747440|NCT00007345|9421363|P1|Overall Study|Intercurrent illness|1
2747441|NCT00007345|9421362|P2|Overall Study|Switched to alternative treatment|3
2747442|NCT00007345|9421363|P1|Overall Study|Switched to alternative treatment|0
2747443|NCT00007345|9421362|P2|Overall Study|Refused further treatment|7
2747444|NCT00007345|9421363|P1|Overall Study|Refused further treatment|0
2747445|NCT00006489|9421385|P4|Overall Study|Death|1
2747446|NCT00006489|9421386|P3|Overall Study|Death|0
2747447|NCT00006489|9421387|P2|Overall Study|Death|0
2747448|NCT00006489|9421388|P1|Overall Study|Death|0
2747449|NCT00006489|9421385|P4|Overall Study|Scheduling Conflict|1
2747450|NCT00006489|9421386|P3|Overall Study|Scheduling Conflict|2
2747451|NCT00006489|9421387|P2|Overall Study|Scheduling Conflict|3
2747452|NCT00006489|9421388|P1|Overall Study|Scheduling Conflict|0
2747453|NCT00006489|9421385|P4|Overall Study|Withdrawal by Subject|6
2747454|NCT00006489|9421386|P3|Overall Study|Withdrawal by Subject|9
2747455|NCT00006489|9421387|P2|Overall Study|Withdrawal by Subject|9
2747456|NCT00006489|9421388|P1|Overall Study|Withdrawal by Subject|10
2747457|NCT00006489|9421385|P4|Overall Study|Adverse Event|3
2747458|NCT00006489|9421386|P3|Overall Study|Adverse Event|4
2747459|NCT00006489|9421387|P2|Overall Study|Adverse Event|2
2747460|NCT00006489|9421388|P1|Overall Study|Adverse Event|3
2747461|NCT00006409|9421423|P6|Post-3 Year Intervention|Protocol Violation|62
2747462|NCT00006409|9421424|P5|Post-3 Year Intervention|Protocol Violation|62
2747463|NCT00006409|9421425|P4|Post-3 Year Intervention|Protocol Violation|0
2747464|NCT00006409|9421426|P3|Post-3 Year Intervention|Protocol Violation|0
2747465|NCT00006409|9421427|P2|Post-3 Year Intervention|Protocol Violation|0
2747466|NCT00006409|9421428|P1|Post-3 Year Intervention|Protocol Violation|0
2747467|NCT00006409|9421423|P6|Post-2 Year Intervention|Protocol Violation|0
2747468|NCT00006409|9421424|P5|Post-2 Year Intervention|Protocol Violation|0
2747469|NCT00006409|9421425|P4|Post-2 Year Intervention|Protocol Violation|168
2747470|NCT00006409|9421426|P3|Post-2 Year Intervention|Protocol Violation|251
2747471|NCT00006409|9421427|P2|Post-2 Year Intervention|Protocol Violation|0
2747472|NCT00006409|9421428|P1|Post-2 Year Intervention|Protocol Violation|0
2747473|NCT00006409|9421423|P6|Baseline|Protocol Violation|0
2747474|NCT00006409|9421424|P5|Baseline|Protocol Violation|0
2747475|NCT00006409|9421425|P4|Baseline|Protocol Violation|0
2747476|NCT00006409|9421426|P3|Baseline|Protocol Violation|0
2747477|NCT00006409|9421427|P2|Baseline|Protocol Violation|70
2747478|NCT00006409|9421428|P1|Baseline|Protocol Violation|48
2747479|NCT00006305|9421452|P4|Overall Study|Withdrawal by Subject|14
2747480|NCT00006305|9421453|P3|Overall Study|Withdrawal by Subject|15
2747481|NCT00006305|9421454|P2|Overall Study|Withdrawal by Subject|10
2747482|NCT00006305|9421455|P1|Overall Study|Withdrawal by Subject|17
2747483|NCT00006289|9421471|P2|Second Intervention (5 Weeks)|Protocol Violation|1
2747484|NCT00006289|9421472|P1|Second Intervention (5 Weeks)|Protocol Violation|1
2747485|NCT00006289|9421471|P2|First Intervention (5 Weeks)|Adverse Event|0
2747486|NCT00006289|9421472|P1|First Intervention (5 Weeks)|Adverse Event|1
2747487|NCT00006184|9421490|P2|Overall Study|Death|0
2747488|NCT00006184|9421491|P1|Overall Study|Death|1
2747489|NCT00006164|9421542|P2|Overall Study|Withdrew or lost to follow-up|81
2747490|NCT00006164|9421543|P1|Overall Study|Withdrew or lost to follow-up|70
2747491|NCT00005937|9421586|P1|Overall Study|Lack of Efficacy|5
2747492|NCT00005908|9421590|P2|Overall Study|Withdrawal by Subject|0
2747493|NCT00005908|9421591|P1|Overall Study|Withdrawal by Subject|1
2747494|NCT00005906|9421600|P1|Overall Study|Lack of Efficacy|3
2747495|NCT00004980|9421644|P2|Overall Study|Physician Decision|1
2747496|NCT00004980|9421645|P1|Overall Study|Physician Decision|0
2747497|NCT00004980|9421644|P2|Overall Study|memory difficulties|1
2747498|NCT00004980|9421645|P1|Overall Study|memory difficulties|1
2747499|NCT00004980|9421644|P2|Overall Study|Withdrawal by Subject|0
2747500|NCT00004980|9421645|P1|Overall Study|Withdrawal by Subject|1
2747501|NCT00004732|9421659|P2|Overall Study|Lost to Follow-up|47
2747502|NCT00004732|9421660|P1|Overall Study|Lost to Follow-up|33
2747503|NCT00004732|9421659|P2|Overall Study|Withdrawal by Subject|64
2747504|NCT00004732|9421660|P1|Overall Study|Withdrawal by Subject|36
2747505|NCT00004635|9421670|P2|Period Two|discrepancy in data entry|1
2747506|NCT00004635|9421671|P1|Period Two|discrepancy in data entry|0
2747507|NCT00004635|9421670|P2|Period Two|Lost to Follow-up|0
2747508|NCT00004635|9421671|P1|Period Two|Lost to Follow-up|1
2747509|NCT00004635|9421670|P2|Period Two|secondary malignancy|1
2747510|NCT00004635|9421671|P1|Period Two|secondary malignancy|1
2747511|NCT00004635|9421670|P2|Period Two|travel issues|1
2747512|NCT00004635|9421671|P1|Period Two|travel issues|0
2747513|NCT00004635|9421670|P2|Period Two|health problem|1
2747514|NCT00004635|9421671|P1|Period Two|health problem|1
2747515|NCT00004635|9421670|P2|Period Two|refused|2
2747516|NCT00004635|9421671|P1|Period Two|refused|0
2747517|NCT00004635|9421670|P2|Period Two|Adverse Event|0
2747518|NCT00004635|9421671|P1|Period Two|Adverse Event|1
2747519|NCT00004635|9421670|P2|Period Two|progression|3
2747520|NCT00004635|9421671|P1|Period Two|progression|2
2747521|NCT00004635|9421670|P2|Period One|discrepancy in data entry|1
2747522|NCT00004635|9421671|P1|Period One|discrepancy in data entry|0
2747523|NCT00004635|9421670|P2|Period One|health problem|1
2747524|NCT00004635|9421671|P1|Period One|health problem|0
2747525|NCT00004635|9421670|P2|Period One|progressed|2
2747526|NCT00004635|9421671|P1|Period One|progressed|0
2747527|NCT00004635|9421670|P2|Period One|second malignancy|0
2747528|NCT00004635|9421671|P1|Period One|second malignancy|1
2747529|NCT00004635|9421670|P2|Period One|PSA did not go <5 ng/mL|0
2747530|NCT00004635|9421671|P1|Period One|PSA did not go <5 ng/mL|1
2747531|NCT00004635|9421670|P2|Period One|Protocol Violation|0
2747532|NCT00004635|9421671|P1|Period One|Protocol Violation|1
2747533|NCT00004635|9421670|P2|Period One|Withdrawal by Subject|1
2747534|NCT00004635|9421671|P1|Period One|Withdrawal by Subject|1
2747535|NCT00004635|9421670|P2|Period One|refused|1
2747536|NCT00004635|9421671|P1|Period One|refused|2
2747537|NCT00004563|9421683|P2|Overall Study|Death|3
2747538|NCT00004563|9421684|P1|Overall Study|Death|2
2747539|NCT00004563|9421683|P2|Overall Study|Lack of Efficacy|5
2747540|NCT00004563|9421684|P1|Overall Study|Lack of Efficacy|3
2747541|NCT00004563|9421683|P2|Overall Study|Withdrawal by Subject|16
2747542|NCT00004563|9421684|P1|Overall Study|Withdrawal by Subject|20
2747543|NCT00004562|9421696|P2|Overall Study|Lost to Follow-up|91
2747544|NCT00004562|9421697|P1|Overall Study|Lost to Follow-up|102
2747545|NCT00001962|9421738|P1|Overall Study|Adverse Event|1
2747546|NCT00001962|9421738|P1|Overall Study|Lost to Follow-up|2
2747547|NCT00001962|9421738|P1|Overall Study|Death|1
2747548|NCT00001962|9421738|P1|Overall Study|Lack of Accrual|6
2747549|NCT00001962|9421738|P1|Overall Study|Lack of Efficacy|18
2747550|NCT00001959|9421742|P1|Overall Study|non-compliance|1
2747551|NCT00001959|9421742|P1|Overall Study|disabling sedation|1
2747552|NCT00001959|9421742|P1|Overall Study|newly diagnosed colon cancer|1
2747553|NCT00001941|9421748|P5|Overall Study|not treated- rapidly progressing disease|1
2747554|NCT00001941|9421749|P4|Overall Study|not treated- rapidly progressing disease|0
2747555|NCT00001941|9421750|P3|Overall Study|not treated- rapidly progressing disease|0
2747556|NCT00001941|9421751|P2|Overall Study|not treated- rapidly progressing disease|0
2747557|NCT00001941|9421752|P1|Overall Study|not treated- rapidly progressing disease|0
2747558|NCT00001832|9421784|P15|Treatment Period|Not treated|0
2747559|NCT00001832|9421785|P14|Treatment Period|Not treated|0
2747560|NCT00001832|9421786|P13|Treatment Period|Not treated|0
2747561|NCT00001832|9421787|P12|Treatment Period|Not treated|0
2747562|NCT00001832|9421788|P11|Treatment Period|Not treated|0
2747563|NCT00001832|9421789|P10|Treatment Period|Not treated|0
2747564|NCT00001832|9421790|P9|Treatment Period|Not treated|0
2747565|NCT00001832|9421791|P8|Treatment Period|Not treated|1
2747566|NCT00001832|9421792|P7|Treatment Period|Not treated|0
2747567|NCT00001832|9421793|P6|Treatment Period|Not treated|0
2747568|NCT00001832|9421794|P5|Treatment Period|Not treated|0
2747569|NCT00001832|9421795|P4|Treatment Period|Not treated|0
2747570|NCT00001832|9421796|P3|Treatment Period|Not treated|0
2747571|NCT00001832|9421797|P2|Treatment Period|Not treated|0
2747572|NCT00001832|9421798|P1|Treatment Period|Not treated|0
2747573|NCT00001832|9421784|P15|Treatment Period|Death during treatment|0
2747574|NCT00001832|9421785|P14|Treatment Period|Death during treatment|0
2747575|NCT00001832|9421786|P13|Treatment Period|Death during treatment|0
2747576|NCT00001832|9421787|P12|Treatment Period|Death during treatment|0
2747577|NCT00001832|9421788|P11|Treatment Period|Death during treatment|0
2747578|NCT00001832|9421789|P10|Treatment Period|Death during treatment|0
2747579|NCT00001832|9421790|P9|Treatment Period|Death during treatment|0
2747580|NCT00001832|9421791|P8|Treatment Period|Death during treatment|0
2747581|NCT00001832|9421792|P7|Treatment Period|Death during treatment|0
2747582|NCT00001832|9421793|P6|Treatment Period|Death during treatment|1
2747583|NCT00001832|9421794|P5|Treatment Period|Death during treatment|0
2747584|NCT00001832|9421795|P4|Treatment Period|Death during treatment|0
2747585|NCT00001832|9421796|P3|Treatment Period|Death during treatment|0
2747586|NCT00001832|9421797|P2|Treatment Period|Death during treatment|0
2747587|NCT00001832|9421798|P1|Treatment Period|Death during treatment|0
2747588|NCT00001832|9421784|P15|Apheresis Period|not able to manufacture treatment cells|0
2747589|NCT00001832|9421785|P14|Apheresis Period|not able to manufacture treatment cells|0
2747590|NCT00001832|9421786|P13|Apheresis Period|not able to manufacture treatment cells|0
2747591|NCT00001832|9421787|P12|Apheresis Period|not able to manufacture treatment cells|0
2747592|NCT00001832|9421788|P11|Apheresis Period|not able to manufacture treatment cells|0
2747593|NCT00001832|9421789|P10|Apheresis Period|not able to manufacture treatment cells|0
2747594|NCT00001832|9421790|P9|Apheresis Period|not able to manufacture treatment cells|0
2747595|NCT00001832|9421791|P8|Apheresis Period|not able to manufacture treatment cells|0
2747596|NCT00001832|9421792|P7|Apheresis Period|not able to manufacture treatment cells|0
2747597|NCT00001832|9421793|P6|Apheresis Period|not able to manufacture treatment cells|0
2747598|NCT00001832|9421794|P5|Apheresis Period|not able to manufacture treatment cells|0
2747599|NCT00001832|9421795|P4|Apheresis Period|not able to manufacture treatment cells|0
2747600|NCT00001832|9421796|P3|Apheresis Period|not able to manufacture treatment cells|0
2747601|NCT00001832|9421797|P2|Apheresis Period|not able to manufacture treatment cells|0
2747602|NCT00001832|9421798|P1|Apheresis Period|not able to manufacture treatment cells|60
2747603|NCT00001723|9421844|P2|Overall Study|medication intolerance|2
2747604|NCT00001723|9421845|P1|Overall Study|medication intolerance|1
2747605|NCT00001723|9421844|P2|Overall Study|Lost to Follow-up|2
2747606|NCT00001723|9421845|P1|Overall Study|Lost to Follow-up|2
2747607|NCT00001723|9421844|P2|Overall Study|Lack of family interest|5
2747608|NCT00001723|9421845|P1|Overall Study|Lack of family interest|4
2747609|NCT00001723|9421844|P2|Overall Study|Lack of Efficacy|7
2747610|NCT00001723|9421845|P1|Overall Study|Lack of Efficacy|6
2747611|NCT00001703|9421861|P1|Overall Study|recurrent disease|2
2747612|NCT00001703|9421861|P1|Overall Study|No evidence of disease|1
2747613|NCT00001703|9421861|P1|Overall Study|progressed disease|2
2747614|NCT00001596|9421899|P2|Overall Study|Adverse Event|0
2747615|NCT00001596|9421900|P1|Overall Study|Adverse Event|1
2747616|NCT00001596|9421899|P2|Overall Study|Study Termination|9
2747617|NCT00001596|9421900|P1|Overall Study|Study Termination|12
2747618|NCT00001596|9421899|P2|Overall Study|Withdrawal by Subject|1
2747619|NCT00001596|9421900|P1|Overall Study|Withdrawal by Subject|3
2747620|NCT00001596|9421899|P2|Overall Study|Death|0
2747621|NCT00001596|9421900|P1|Overall Study|Death|1
2747622|NCT00001575|9421931|P1|Overall Study|Withdrawn/deaths|23
2747623|NCT00001575|9421931|P1|Overall Study|Screening failures-Ph I portion|22
2747624|NCT00001566|9421937|P1|Overall Study|unable to complete initial apheresis|1
2747625|NCT00001566|9421937|P1|Overall Study|Lost to Follow-up|1
2747626|NCT00001566|9421937|P1|Overall Study|Death|13
2747627|NCT00001566|9421937|P1|Overall Study|stopped after C3 due to symptomatic PD|1
2747628|NCT00001566|9421937|P1|Overall Study|patients' choice to discontinue protocol|3
2747629|NCT00001262|9421977|P3|Overall Study|Withdrawal by Subject|0
2747630|NCT00001262|9421978|P2|Overall Study|Withdrawal by Subject|3
2747631|NCT00001262|9421979|P1|Overall Study|Withdrawal by Subject|0
2747632|NCT00001262|9421977|P3|Overall Study|Death|0
2747633|NCT00001262|9421978|P2|Overall Study|Death|11
2747634|NCT00001262|9421979|P1|Overall Study|Death|10
2747635|NCT00001213|9422005|P1|Overall Study|Death|18
2747636|NCT00000378|9422016|P2|Overall Study|Lack of Efficacy|14
2747637|NCT00000378|9422017|P1|Overall Study|Lack of Efficacy|16
2747638|NCT00000620|9422034|P8|Overall Study|missed closeout visit|16
2747639|NCT00000620|9422035|P7|Overall Study|missed closeout visit|13
2747640|NCT00000620|9422036|P6|Overall Study|missed closeout visit|28
2747641|NCT00000620|9422037|P5|Overall Study|missed closeout visit|26
2747642|NCT00000620|9422038|P4|Overall Study|missed closeout visit|11
2747643|NCT00000620|9422039|P3|Overall Study|missed closeout visit|16
2747644|NCT00000620|9422040|P2|Overall Study|missed closeout visit|28
2747645|NCT00000620|9422041|P1|Overall Study|missed closeout visit|22
2747646|NCT00000620|9422034|P8|Overall Study|Withdrawal by Subject|21
2747647|NCT00000620|9422035|P7|Overall Study|Withdrawal by Subject|32
2747648|NCT00000620|9422036|P6|Overall Study|Withdrawal by Subject|32
2747649|NCT00000620|9422037|P5|Overall Study|Withdrawal by Subject|30
2747650|NCT00000620|9422038|P4|Overall Study|Withdrawal by Subject|27
2747651|NCT00000620|9422039|P3|Overall Study|Withdrawal by Subject|28
2747652|NCT00000620|9422040|P2|Overall Study|Withdrawal by Subject|27
2747653|NCT00000620|9422041|P1|Overall Study|Withdrawal by Subject|40
2747654|NCT00000620|9422034|P8|Overall Study|Lost to Follow-up|14
2747655|NCT00000620|9422035|P7|Overall Study|Lost to Follow-up|13
2747656|NCT00000620|9422036|P6|Overall Study|Lost to Follow-up|15
2747657|NCT00000620|9422037|P5|Overall Study|Lost to Follow-up|15
2747658|NCT00000620|9422038|P4|Overall Study|Lost to Follow-up|14
2747659|NCT00000620|9422039|P3|Overall Study|Lost to Follow-up|14
2747660|NCT00000620|9422040|P2|Overall Study|Lost to Follow-up|14
2747661|NCT00000620|9422041|P1|Overall Study|Lost to Follow-up|14
2747662|NCT00000620|9422034|P8|Overall Study|Death|95
2747663|NCT00000620|9422035|P7|Overall Study|Death|91
2747664|NCT00000620|9422036|P6|Overall Study|Death|77
2747665|NCT00000620|9422037|P5|Overall Study|Death|64
2747666|NCT00000620|9422038|P4|Overall Study|Death|126
2747667|NCT00000620|9422039|P3|Overall Study|Death|112
2747668|NCT00000620|9422040|P2|Overall Study|Death|67
2747669|NCT00000620|9422041|P1|Overall Study|Death|86
2747670|NCT00004445|9422122|P1|Overall Study|Withdrawal by Subject|1
2747671|NCT00004445|9422122|P1|Overall Study|Physician Decision|2
2747672|NCT00004412|9422130|P3|Randomized Period|Moved to Crossover Period|0
2747673|NCT00004412|9422131|P2|Randomized Period|Moved to Crossover Period|0
2747674|NCT00004412|9422132|P1|Randomized Period|Moved to Crossover Period|3
2747675|NCT00000135|9422173|P2|Overall Study|Death|14
2747676|NCT00000135|9422174|P1|Overall Study|Death|27
